nsaids/anti-inflammatory	JJ	B-TREATMENT	B-TEST
classifier	NN	I-TREATMENT	I-TEST
/	NNP	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT

mesenteric	JJ	B-TEST	O
angiograpm	NN	I-TEST	O
w/	NN	O	O
coil	NN	B-TREATMENT	B-TREATMENT
embolization	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
bleeding	VBG	B-PROBLEM	B-PROBLEM
vessel	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

sigmoidoscopy	NN	B-TEST	B-TEST
.	.	O	O

colonoscopy	NN	B-TEST	B-TEST
.	.	O	O

hpi:	NN	O	O
pt	NN	O	O
is	VBZ	O	O
a	DT	O	O
71	CD	O	O
y/o	NN	O	O
male	NN	O	O
with	IN	O	O
h/o	JJ	O	O
dm2	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cad	NN	B-PROBLEM	O
s/p	NN	O	O
cabg	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
dvt/pe	NN	B-PROBLEM	O
on	IN	O	O
long	JJ	B-TREATMENT	O
term	NN	I-TREATMENT	O
anti-coagulation	NN	I-TREATMENT	O
,	,	O	O
ulcerative	JJ	B-PROBLEM	B-PROBLEM
colitis	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
asacol	JJ	B-TREATMENT	B-TREATMENT
presents	NNS	O	I-TREATMENT
with	IN	O	O
brbpr	JJ	B-PROBLEM	O
starting	VBG	O	O
at	IN	O	O
9am	CD	O	O
of	IN	O	O
the	DT	O	O
morning	NN	O	O
of	IN	O	O
admission	NN	O	O
.	.	O	O

he	PRP	O	O
'd	MD	O	O
been	VBN	O	O
having	VBG	O	O
lower	RBR	B-PROBLEM	B-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
for	IN	O	O
approximately	RB	O	O
the	DT	O	O
past	JJ	O	O
week	NN	O	O
,	,	O	O
a	DT	B-PROBLEM	B-PROBLEM
symptom	NN	I-PROBLEM	I-PROBLEM
for	IN	O	O
which	WDT	O	O
he	PRP	O	O
's	VBZ	O	O
been	VBN	O	O
admitted	VBN	O	O
in	IN	O	O
the	DT	O	O
past	NN	O	O
.	.	O	O

his	PRP$	O	O
pcp	NN	O	O
had	VBD	O	O
recently	RB	O	O
started	VBN	O	O
ciprofloxacin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
uti	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

at	IN	O	O
9am	CD	O	O
the	DT	O	O
morning	NN	O	O
of	IN	O	O
admission	NN	O	O
he	PRP	O	O
passed	VBD	O	O
a	DT	B-PROBLEM	O
large	JJ	I-PROBLEM	O
,	,	I-PROBLEM	O
bloody	JJ	I-PROBLEM	B-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
movement	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
came	VBD	O	O
to	TO	O	O
the	DT	O	O
michael	NN	O	O
.	.	O	O
there	RB	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
vitals	NNS	I-TEST	I-TEST
were	VBD	O	O
intially	RB	O	O
stable	JJ	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
hct	NN	I-TEST	I-TEST
of	IN	O	O
36.7	CD	O	O
,	,	O	O
though	IN	O	O
he	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
hypovolemic	JJ	B-PROBLEM	O
and	CC	O	O
this	DT	O	O
hemoconcentrated	VBN	B-PROBLEM	O
;	:	O	O
his	PRP$	B-TEST	B-TEST
previous	JJ	I-TEST	I-TEST
hct	NN	I-TEST	I-TEST
was	VBD	O	O
39	CD	O	O
about	IN	O	O
five	CD	O	O
months	NNS	O	O
ago	RB	O	O
.	.	O	O

he	PRP	O	O
refused	VBD	O	O
an	DT	B-TREATMENT	B-TEST
ng	JJ	I-TREATMENT	I-TEST
lavage	NN	I-TREATMENT	I-TEST
.	.	O	O

although	IN	O	O
an	DT	B-TEST	B-TEST
initial	JJ	I-TEST	I-TEST
dre	NN	I-TEST	I-TEST
showed	VBD	O	O
only	RB	O	B-PROBLEM
clot	NN	B-PROBLEM	I-PROBLEM
,	,	O	O
he	PRP	O	O
later	RB	O	O
passed	VBD	O	O
a	DT	B-PROBLEM	O
large	JJ	I-PROBLEM	O
,	,	I-PROBLEM	O
bloody	JJ	I-PROBLEM	B-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
movement	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
his	PRP$	B-TEST	O
bp	NN	I-TEST	O
nadired	VBD	O	O
to	TO	O	O
the	DT	O	O
low	JJ	O	O
90's	CD	O	O
but	CC	O	O
rested	VBD	O	O
there	EX	O	O
only	RB	O	O
transiently	RB	O	O
and	CC	O	O
easily	RB	O	O
rebounded	VBD	O	O
to	TO	O	O
the	DT	O	O
130's-140's	JJ	O	O
with	IN	O	O
fluid	NN	B-TREATMENT	O
;	:	O	O
he	PRP	O	O
then	RB	O	O
went	VBD	O	O
to	TO	O	O
angiography	VB	O	B-TEST
for	IN	O	O
a	DT	B-TEST	O
tagged	JJ	I-TEST	O
rbc	NN	I-TEST	B-TEST
scan	JJ	I-TEST	I-TEST
where	WRB	O	O
they	PRP	O	O
found	VBD	O	O
and	CC	O	O
embolized	VBD	O	O
two	CD	O	O
vessels	NNS	O	O
to	TO	O	O
the	DT	O	B-PROBLEM
sigmoid	NN	O	I-PROBLEM
colon	NN	O	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
hct	NN	I-TEST	I-TEST
had	VBD	O	O
dropped	VBN	O	O
from	IN	O	O
36.7	CD	O	O
to	TO	O	O
30.8	CD	O	O
despite	IN	O	O
2u	CD	B-TREATMENT	O
prbc	NNS	I-TREATMENT	O
and	CC	O	O
3	CD	B-TREATMENT	O
u	JJ	I-TREATMENT	O
ffp	NN	I-TREATMENT	O
.	.	O	O

is	VBZ	O	O
called	VBN	O	O
out	IN	O	O
of	IN	O	O
the	DT	O	O
ficu	NN	O	O
as	IN	O	O
has	VBZ	O	O
been	VBN	O	O
been	VBN	O	O
hd	JJ	O	O
and	CC	O	O
stable	JJ	O	O
hct	NN	B-TEST	O
.	.	O	O

currently	RB	O	O
denies	VBZ	O	O
cp	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
sob	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
abd	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
continued	VBN	B-PROBLEM	O
brbpr	NN	I-PROBLEM	O
.	.	O	O

1.)	CD	O	O
dm-2	JJ	B-PROBLEM	O

2.)	CD	O	O
cad	JJ	B-PROBLEM	O
s/p	NN	O	O
3v-cabg	JJ	B-TREATMENT	B-TREATMENT
2003	CD	O	O
and	CC	O	O
subsequent	JJ	O	B-TREATMENT
stenting	NN	B-TREATMENT	I-TREATMENT
of	IN	O	I-TREATMENT
svg	NN	B-TREATMENT	I-TREATMENT
and	CC	O	O
lima	NN	O	B-PROBLEM

3.)	CD	O	O
chf	NN	B-PROBLEM	O
with	IN	O	O
ef	JJ	B-TEST	O
30-35%	JJ	O	O
on	IN	O	O
07-10	JJ	O	O
echo	NN	B-TEST	B-TEST

4.)	CD	O	O
right	JJ	B-PROBLEM	B-PROBLEM
parietal	JJ	I-PROBLEM	I-PROBLEM
intracranial	JJ	I-PROBLEM	I-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
following	VBG	O	O
1996	CD	O	B-TREATMENT
cardiac	JJ	B-TEST	I-TREATMENT
cath	NN	I-TEST	I-TREATMENT

5.)	CD	O	O
lbbb	NN	B-PROBLEM	O

6.)	CD	O	O
sinus	NN	B-PROBLEM	B-PROBLEM
node	JJ	I-PROBLEM	I-PROBLEM
dysfunction	NN	I-PROBLEM	I-PROBLEM
s/p	NN	O	O
pacemaker	NN	B-TREATMENT	B-TREATMENT

7.)	CD	O	O
h/o	NN	O	O
dvt	NN	B-PROBLEM	B-PROBLEM
(	(	O	O
right	RB	O	O
sided	VBN	O	O
)	)	O	O
and	CC	O	O
subsequent	JJ	O	O
pe	NN	B-PROBLEM	O
,	,	O	O
put	VBD	O	O
onto	IN	O	O
lifetime	NN	O	O
warfarin	NN	B-TREATMENT	B-TREATMENT

8.)	CD	O	O
ulcerative	JJ	B-PROBLEM	B-PROBLEM
colitis	NN	I-PROBLEM	I-PROBLEM

1.)	CD	O	O
c4-7	JJ	B-TREATMENT	O
anterior	JJ	I-TREATMENT	O
discectomies	NNS	I-TREATMENT	O

2.)	CD	O	O
cabg	NN	B-TREATMENT	B-TREATMENT
2003	CD	O	O

3.)	CD	O	B-PROBLEM
r	JJ	B-TREATMENT	I-PROBLEM
intracerebral	JJ	I-TREATMENT	I-PROBLEM
hemorrhage	NN	I-TREATMENT	I-PROBLEM
drainage	NN	I-TREATMENT	I-PROBLEM

sochx	NN	O	O
:	:	O	O
mr	NN	O	O
peres	VBZ	O	O
generally	RB	O	O
lives	VBZ	O	O
with	IN	O	O
his	PRP$	O	O
wife	NN	O	O
but	CC	O	O
has	VBZ	O	O
spent	VBN	O	O
a	DT	O	O
great	JJ	O	O
deal	NN	O	O
of	IN	O	O
time	NN	O	O
recently	RB	O	O
at	IN	O	O
rehab	NN	B-TREATMENT	O
.	.	O	O

vs	NN	B-TEST	O
98.4	CD	O	O
,	,	O	O
62	CD	O	O
,	,	O	O
103/37	CD	O	O
,	,	O	O
15	CD	O	O
97%2l	CD	O	O

gen	NN	O	O
-	:	O	O
lying	NN	O	O
in	IN	O	O
bed	NN	O	O
,	,	O	O
nad	NN	B-PROBLEM	B-PROBLEM

heent	NN	O	O
-	:	O	O
anicteric	JJ	B-PROBLEM	B-PROBLEM
sclera	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
op	JJ	O	O
clear	JJ	O	O
with	IN	O	O
mmm	NN	O	O

neck	SYM	O	B-TEST
-	:	O	O
jvd	NN	B-PROBLEM	O
flat	JJ	O	O

cv	SYM	O	O
-	:	O	O
rrr	NN	O	O
,	,	O	O
s1s2	NN	O	O
,	,	O	O
no	DT	O	O
m/r/g	NN	B-PROBLEM	B-PROBLEM

pul	SYM	O	B-TEST
-	:	O	O
ctab	NN	O	O
without	IN	O	O
rales	NNS	B-PROBLEM	B-PROBLEM

abd	SYM	O	B-TEST
-	:	O	O
soft	JJ	O	O
,	,	O	O
minimally	RB	B-PROBLEM	B-PROBLEM
distended	VBN	I-PROBLEM	I-PROBLEM
,	,	O	O
nt	RB	B-PROBLEM	O
,	,	O	O
no	DT	O	O
rebound/guarding	NN	B-PROBLEM	O
,	,	O	O
nabs	NN	O	O

extrm	SYM	O	B-TEST
-	:	O	O
trace	NN	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
ankles	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
warm/dry	NN	O	O

color	NN	B-TEST	B-TEST
-	:	O	O
straw	NN	O	O
appear	VBP	B-TEST	O
-	:	O	O
clear	JJ	O	O
sp	NN	O	O
marquez	SYM	O	O
-	:	O	O
1.021	CD	O	O

blood	NN	O	B-TEST
-	:	O	I-TEST
lg	NN	O	I-TEST
nitrite	JJ	B-TEST	I-TEST
-	:	O	O
neg	NN	O	O
protein	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O

glucose	JJ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
ketone	NN	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
bilirubin	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
urobilngn	JJ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
ph	SYM	B-TEST	B-TEST
-	:	O	O
7.0	CD	O	O
leuk	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O

rbc-21-50*	JJ	B-TEST	B-PROBLEM
wbc-0-2	JJ	B-TEST	I-PROBLEM
bacteria	NNS	B-TEST	I-PROBLEM
-	:	O	O
few	JJ	O	O

yeast	SYM	B-TEST	B-TEST
-	:	O	O
none	NN	O	O
epi	SYM	B-TEST	O
-	:	O	O
<1	NN	O	O

lactate	NN	B-TEST	B-TEST
-	:	O	O
1.8	CD	O	O

glucose	JJ	B-TEST	B-TEST
-	:	O	O
197*	CD	O	O
urea	JJ	B-TEST	B-TEST
n-25*	JJ	I-TEST	I-TEST
creat	NN	B-TEST	I-TEST
-	:	O	O
0.8	CD	O	O
sodium	NN	B-TEST	B-TEST
-	:	O	O
141	CD	O	O

potassium	NN	B-TEST	B-TEST
-	:	O	O
3.7	CD	O	O
chloride	NN	B-TEST	B-TEST
-	:	O	O
105	CD	O	O
total	JJ	B-TEST	B-TEST
co2	NN	I-TEST	I-TEST
-	:	O	O
22	CD	O	O
anion	NN	B-TEST	B-TEST
gap	NN	I-TEST	I-TEST
-	:	O	O
18	CD	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
5.6	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
4.35*	CD	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
12.6*	CD	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
36.7*	CD	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
84	CD	O	O

mch	SYM	B-TEST	B-TEST
-	:	O	O
28.9	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.3	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
15.7*	CD	O	O

neuts	NNS	B-TEST	B-TEST
-	:	O	O
80.5*	CD	O	O
lymphs	SYM	B-TEST	B-TEST
-	:	O	O
13.1*	CD	O	O
monos	NNS	B-TEST	B-TEST
-	:	O	O
3.5	CD	O	O
eos	SYM	B-TEST	B-TEST
-	:	O	O
2.5	CD	O	O

basos	SYM	B-TEST	B-TEST
-	:	O	O
0.4	CD	O	O

poikilocy	SYM	B-TEST	B-TEST
-	:	O	O
1+	CD	O	O
microcyt	SYM	B-TEST	O
-	:	O	O
1+	CD	O	O

plt	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
-	:	O	O
102*	CD	O	O

pt	SYM	B-TEST	B-TEST
-	:	O	O
20.5*	CD	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
29.4	CD	O	O
inr(pt)	JJ	B-TEST	O
-	:	O	O
3.0	CD	O	O

gi	NN	B-TEST	B-PROBLEM
bleeding	NN	I-TEST	I-PROBLEM
study	NN	I-TEST	I-PROBLEM

impression	NN	O	O
:	:	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
tracer	NN	I-PROBLEM	I-PROBLEM
activity	NN	I-PROBLEM	I-PROBLEM
demonstrated	VBD	O	I-PROBLEM
within	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	NN	O	I-PROBLEM
lower	RBR	O	I-PROBLEM
quadrant	NN	O	I-PROBLEM
,	,	O	O
most	RBS	O	O
likely	JJ	O	O
sigmoid	NN	O	B-PROBLEM
colonic	JJ	O	I-PROBLEM
loops	NNS	O	I-PROBLEM
of	IN	O	I-PROBLEM
bowel	NN	O	I-PROBLEM
,	,	O	O
consistent	JJ	O	O
with	IN	O	O
active	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

ct	JJ	B-TEST	B-TEST
abdomen	NNS	I-TEST	I-TEST
w/contrast	VBP	I-TEST	I-TEST

1.	CD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
colitis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
other	JJ	B-PROBLEM	B-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
pathology	NN	I-PROBLEM	I-PROBLEM
present	NN	O	O
to	TO	O	O
explain	VB	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
bright	JJ	I-PROBLEM	I-PROBLEM
red	JJ	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
per	IN	I-PROBLEM	I-PROBLEM
rectum	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
stable	JJ	O	O
appearance	NN	O	O
of	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
adrenal	JJ	I-PROBLEM	I-PROBLEM
fat-containing	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
consistent	NN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
myelolipoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
stable	JJ	O	O
appearance	NN	O	O
of	IN	O	O
hypodense	NN	B-PROBLEM	B-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
within	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
caudate	NN	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
liver	NN	O	I-PROBLEM
,	,	O	O
too	RB	O	O
small	JJ	O	O
to	TO	O	O
fully	RB	O	O
characterize	VB	O	O
.	.	O	O

4.	CD	O	O
subcentimeter	JJ	B-PROBLEM	B-PROBLEM
attenuation	NN	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
within	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
pole	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
right	JJ	O	I-PROBLEM
kidney	NN	O	I-PROBLEM
,	,	O	O
too	RB	O	O
small	JJ	O	O
to	TO	O	O
characterize	VB	O	O
.	.	O	O

5.	CD	O	O
3-mm	JJ	B-PROBLEM	B-PROBLEM
noncalcified	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
nodule	NN	I-PROBLEM	I-PROBLEM
within	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

if	IN	O	O
the	DT	O	O
patient	NN	O	O
does	VBZ	O	O
not	RB	O	O
have	VB	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
primary	JJ	I-PROBLEM	I-PROBLEM
malignancy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
followup	JJ	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
chest	NN	I-TEST	I-TEST
in	IN	O	O
1	CD	O	O
year	NN	O	O
is	VBZ	O	O
recommended	VBN	O	O
to	TO	O	O
evaluate	VB	O	O
for	IN	O	O
stability	NN	O	O
of	IN	O	O
this	DT	O	O
finding	NN	O	O
.	.	O	O

71	CD	O	O
y/o	NNS	O	O
male	JJ	O	O
with	IN	O	O
dm2	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cad	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
chf	NN	B-PROBLEM	O
,	,	O	O
uc	JJ	B-PROBLEM	O
presents	NNS	O	O
with	IN	O	O
one	CD	O	O
week	NN	O	O
of	IN	O	O
lower	JJR	B-PROBLEM	B-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
2	CD	O	O
episodes	NNS	O	O
of	IN	O	O
brpbr	NN	B-PROBLEM	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
admission	NN	O	O
.	.	O	O

#	#	O	O
brbpr	NN	B-PROBLEM	B-TEST
--	:	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
in	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
given	VBN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
gi	NN	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
angiography	NN	I-TEST	I-TEST
showed	VBD	O	O
bleeding	VBG	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	O
two	CD	I-PROBLEM	O
vessels	NNS	I-PROBLEM	O
off	IN	O	O
of	IN	O	O
the	DT	O	O
minnie	NN	O	O
supplying	VBG	O	O
the	DT	O	O
sigmoid	NN	O	O
that	WDT	O	O
were	VBD	O	O
succesfully	RB	O	O
embolized	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transfused	VBN	O	O
from	IN	O	O
a	DT	B-TEST	B-TEST
hct	NN	I-TEST	I-TEST
29	CD	O	O
to	TO	O	O
34	CD	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
held	VBN	O	O
during	IN	O	O
his	PRP$	O	O
stay	NN	O	O
given	VBN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
acute	JJ	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
restarted	VBN	O	O
per	IN	O	O
his	PRP$	O	O
pcp	NN	O	O
with	IN	O	O
the	DT	O	O
guidance	NN	O	O
of	IN	O	O
gi	NN	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

-	:	O	O
the	DT	O	O
patient	JJ	O	O
underwent	NN	O	O
a	DT	B-TEST	B-TEST
flex	JJ	I-TEST	I-TEST
sigmoidoscopy	NN	I-TEST	I-TEST
on	IN	O	O
friday	NN	O	O
,	,	O	O
11-02	JJ	O	O
,	,	O	O
which	WDT	O	O
showed	VBD	O	O
old	JJ	B-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
rectal	JJ	I-PROBLEM	I-PROBLEM
vault	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
no	DT	O	O
active	JJ	B-PROBLEM	O
source	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
bleeding	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

given	VBN	O	O
this	DT	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
advised	VBN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
have	VBP	O	O
a	DT	B-TEST	B-TEST
colonoscopy	NN	I-TEST	I-TEST
to	TO	O	O
rule	VB	O	O
out	RP	O	O
further	RB	O	B-PROBLEM
bleeding	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

-	:	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
colonoscopy	NN	I-TEST	I-TEST
on	IN	O	O
monday	JJ	O	O
11-05	JJ	O	O
but	CC	O	O
unfortunately	RB	O	O
,	,	O	O
was	VBD	O	O
unable	JJ	O	O
to	TO	O	O
complete	VB	O	O
the	DT	O	B-TEST
study	NN	O	I-TEST
as	IN	O	O
his	PRP$	O	O
bowel	NN	O	O

therefore	RB	O	O
,	,	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
colonoscopy	NN	I-TEST	I-TEST
on	IN	O	O
11-06	JJ	O	O
which	WDT	O	O
showed	VBD	O	O
expected	VBN	O	O
mucosal	JJ	B-PROBLEM	O
signs	NNS	I-PROBLEM	O
of	IN	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
ulcerative	JJ	I-PROBLEM	I-PROBLEM
colitis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
polyps	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
w/	VBD	O	O
8	CD	B-PROBLEM	B-PROBLEM
mm	JJ	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
junction	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
descending	NN	I-PROBLEM	I-PROBLEM
colon	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
sigmoid	JJ	I-PROBLEM	B-PROBLEM
colon	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

-	:	O	O
biopsies	NNS	B-TEST	B-TEST
were	VBD	O	O
obtained	VBN	O	O
during	IN	O	O
his	PRP$	B-TEST	B-TEST
colonoscopy	NN	I-TEST	I-TEST
and	CC	O	O
he	PRP	O	O
should	MD	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
gastroenterology	NN	O	O
for	IN	O	O
the	DT	O	O
results	NNS	O	O
.	.	O	O

#	#	O	O
ulcerative	JJ	B-PROBLEM	B-PROBLEM
colitis	NN	I-PROBLEM	I-PROBLEM
--	:	O	O
the	DT	B-TREATMENT	B-TEST
patient	NN	I-TREATMENT	I-TEST
's	POS	I-TREATMENT	I-TEST
asacol	NN	I-TREATMENT	I-TEST
was	VBD	O	O
originally	RB	O	O
held	VBN	O	O
but	CC	O	O
restarted	VBN	O	O
the	DT	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
per	IN	O	O
gi	NN	O	O
.	.	O	O

#	#	O	O
cad/chf	SYM	B-PROBLEM	B-TEST
-	:	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
restarted	VBN	O	O
on	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
home	NN	I-TREATMENT	I-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
as	IN	O	O
it	PRP	O	O
was	VBD	O	O
held	VBN	O	O
temporarily	RB	O	O
given	VBN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
acute	NN	I-PROBLEM	I-PROBLEM
gi	NN	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
exception	NN	O	O
is	VBZ	O	O
that	IN	O	O
per	IN	O	O
his	PRP$	O	O
pcp	NN	O	O
,	,	O	O
jason	NN	O	B-TREATMENT
aspirin	NN	B-TREATMENT	I-TREATMENT
will	MD	O	O
be	VB	O	O
held	VBN	O	O
for	IN	O	O
2	CD	O	O
weeks	NNS	O	O
given	VBN	O	O
that	IN	O	O
he	PRP	O	O
was	VBD	O	O
restarted	VBN	O	O
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O

his	PRP$	B-PROBLEM	O
risk	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
bleeding	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

#	#	O	O
dm-2	NN	B-PROBLEM	O
--	:	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
maintained	VBN	O	O
on	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
home	NN	I-TREATMENT	I-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

#	#	O	O
h/o	NN	O	O
dvt/pe	NN	B-PROBLEM	O
:	:	O	O

coumadin	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
initially	RB	O	O
held	VBN	O	O
.	.	O	O

it	PRP	O	O
was	VBD	O	O
unclear	JJ	O	O
at	IN	O	O
first	RB	O	O
as	IN	O	O
to	TO	O	O
why	WRB	O	O
the	DT	O	O
patient	NN	O	O
required	VBN	O	O
life-long	JJ	B-TREATMENT	B-TREATMENT
anticoagulation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

after	IN	O	O
discussing	VBG	O	O
this	DT	O	O
with	IN	O	O
his	PRP$	O	O
pcp	NN	O	O
,	,	O	O
leon	NN	O	O
was	VBD	O	O
clear	JJ	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
had	VBN	O	O
recurrent	VBN	B-PROBLEM	O
dvts	NNS	I-PROBLEM	O
and	CC	O	O
ultimately	RB	O	O
a	DT	B-PROBLEM	O
pe	NN	I-PROBLEM	O
and	CC	O	O
his	PRP$	O	O
pcp	NN	O	O
felt	VBD	O	O
strongly	RB	O	O
that	IN	O	O
he	PRP	O	O
required	VBD	O	O
long-term	JJ	B-TREATMENT	B-TREATMENT
anticoagulation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-TEST	O
goal	NN	I-TEST	O
inr	NN	I-TEST	O
should	MD	O	O
be	VB	O	O
1.6-2.0	JJ	O	O
.	.	O	O
if	IN	O	O
bleeding	VBG	B-PROBLEM	B-PROBLEM
continues	VBZ	O	O
to	TO	O	O
occur	VB	O	O
,	,	O	O
consider	VB	O	O
v.	JJ	B-TREATMENT	O
winchester	NN	I-TREATMENT	O
filter	NN	I-TREATMENT	O
.	.	O	O

#	#	O	O
access	NN	O	O
--	:	O	O
2	CD	B-TREATMENT	O
large	JJ	I-TREATMENT	O
bore	NN	I-TREATMENT	O
piv's	NN	I-TREATMENT	O

1.)	CD	O	O
spironolactone/hctz	JJ	B-TREATMENT	O
25/25	CD	O	O
daily	JJ	O	O

2.)	CD	O	O
atenolol	JJ	B-TREATMENT	B-TREATMENT
12.5mg	CD	O	O
daily	JJ	O	O

3.)	CD	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
45n/8r	CD	O	I-TREATMENT
qam	NN	O	I-TREATMENT
and	CC	O	O
33n	CD	O	O
qpm	NN	O	O

4.)	CD	O	O
furosemide	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
every	DT	O	O
other	JJ	O	O
day	NN	O	O

5.)	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
81	CD	O	O
mg	NNS	O	O
daily	RB	O	O

6.)	CD	O	O
zoloft	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
qam	NN	O	O

7.)	CD	O	O
flomax	NN	B-TREATMENT	B-TREATMENT

8.)	CD	O	O
atorvastatin	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NNS	O	O
daily	RB	O	O

9.)	CD	O	O
ritalin	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	JJ	O	O
daily	JJ	O	O

10.)	CD	O	O
ramipril	NN	B-TREATMENT	B-TREATMENT
2.5	CD	O	O
mg	JJ	O	O
daily	JJ	O	O

11.)	CD	O	O
asacol	JJ	B-TREATMENT	B-TREATMENT
400	CD	O	O
mg	NN	O	O
3	CD	O	O
,	,	O	O
tid	NN	O	O

12.)	CD	O	O
carafate	NN	B-TREATMENT	O
1	CD	O	O
gm	NN	O	O
bid	NN	O	O

13.)	CD	O	O
actos	NNS	B-TREATMENT	B-TEST
15	CD	O	O
mg	NNS	O	O
daily	RB	O	O

14.)	CD	O	O
folate	JJ	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	NNS	O	O
daily	RB	O	O

15.)	CD	O	O
warfarin	JJ	B-TREATMENT	B-TREATMENT
2	CD	O	O
mg	NNS	O	O
daily	RB	O	O

1.	CD	O	O
tamsulosin	NN	B-TREATMENT	B-TREATMENT
0.4	CD	O	O
mg	NN	O	O
capsule	NN	O	O
,	,	O	O
sust	NN	O	O
.	.	O	O
release	VB	O	O
24hr	CD	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
,	,	O	O
sust	NN	O	O
.	.	O	O
release	VB	O	O
24hr	CD	O	O
po	NN	O	O
hs	NN	O	O
(	(	O	O
at	IN	O	O
bedtime	NN	O	O
)	)	O	O
.	.	O	O

2.	CD	O	O
atorvastatin	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

3.	CD	O	O
methylphenidate	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

4.	CD	O	O
acetaminophen	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
q4-6h	NN	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
to	TO	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

5.	CD	O	O
folic	JJ	B-TREATMENT	B-TREATMENT
acid	RB	I-TREATMENT	I-TREATMENT
1	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

6.	CD	O	O
atenolol	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
0.5	CD	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

7.	CD	O	O
spironolactone	NN	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

8.	CD	O	O
ramipril	NN	B-TREATMENT	B-TREATMENT
1.25	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
capsule	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

9.	CD	O	O
hydrochlorothiazide	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

10.	CD	O	O
pioglitazone	NN	B-TREATMENT	B-TREATMENT
15	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	RB	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
dm	NN	B-PROBLEM	O
.	.	O	O

11.	CD	O	O
mesalamine	NN	B-TREATMENT	B-TREATMENT
400	CD	O	O
mg	NN	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
three	CD	O	O
(	(	O	O
3	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
ulcerative	JJ	B-PROBLEM	B-PROBLEM
colitis	NN	I-PROBLEM	I-PROBLEM
w/o	NN	O	I-PROBLEM
recent	JJ	O	I-PROBLEM
severe	JJ	B-PROBLEM	I-PROBLEM
flares	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

12.	CD	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
45	CD	O	O
nph	NN	B-TREATMENT	O
in	IN	O	O
am	VBP	O	O
with	IN	O	O
33	CD	O	O
nph	NNS	B-TREATMENT	O
at	IN	O	O
bedtime	NN	O	O

continue	NN	O	O
sliding	VBG	B-TREATMENT	B-TREATMENT
scale	JJ	I-TREATMENT	I-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
as	IN	O	O
needed	VBN	O	O
.	.	O	O

13.	CD	O	O
sertraline	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg/ml	NN	O	O
concentrate	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
po	NN	O	O
at	IN	O	O
bedtime	NN	O	O
.	.	O	O

14.	CD	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
2	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

rectal	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
from	IN	I-PROBLEM	I-PROBLEM
inferior	JJ	I-PROBLEM	I-PROBLEM
mesenteric	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
tributaries	NNS	I-PROBLEM	I-PROBLEM
supplying	VBG	O	I-PROBLEM
sigmoid	JJ	O	I-PROBLEM
colon	NN	O	I-PROBLEM
.	.	O	O

please	VB	O	O
call	VB	O	O
physician	JJ	O	O
if	IN	O	O
you	PRP	O	O
develop	VBP	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
weakness	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
your	PRP$	I-PROBLEM	I-PROBLEM
legs	NNS	I-PROBLEM	I-PROBLEM
or	CC	I-PROBLEM	O
arms	NNS	I-PROBLEM	O
,	,	O	O
sudden	JJ	B-PROBLEM	B-PROBLEM
blurry	NN	I-PROBLEM	I-PROBLEM
vision	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
slurred	VBN	B-PROBLEM	B-PROBLEM
speech	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
faintness	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
unexplained	JJ	I-PROBLEM	I-PROBLEM
weight	NN	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
28-year-old	JJ	O	O
woman	NN	O	O
who	WP	O	O
is	VBZ	O	O
hiv	JJ	B-PROBLEM	O
positive	JJ	I-PROBLEM	O
for	IN	O	O
two	CD	O	O
years	NNS	O	O
.	.	O	O

she	PRP	O	O
presented	VBD	O	O
with	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
which	WDT	O	O
is	VBZ	O	O
a	DT	B-PROBLEM	O
long-standing	JJ	I-PROBLEM	O
complaint	NN	I-PROBLEM	O
.	.	O	O

she	PRP	O	O
claims	VBZ	O	O
she	PRP	O	O
does	VBZ	O	O
not	RB	O	O
know	VB	O	O
why	WRB	O	O
she	PRP	O	O
is	VBZ	O	O
hiv	JJ	B-PROBLEM	O
positive	JJ	I-PROBLEM	O
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
from	IN	O	O
maryland	NN	O	O
,	,	O	O
apparently	RB	O	O
had	VBD	O	O
no	DT	O	O
blood	NN	B-TREATMENT	B-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
before	IN	O	O
the	DT	O	O
birth	NN	O	O
of	IN	O	O
her	PRP$	O	O
children	NNS	O	O
so	IN	O	O
it	PRP	O	O
is	VBZ	O	O
presumed	VBN	O	O
heterosexual	JJ	B-PROBLEM	B-PROBLEM
transmission	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

at	IN	O	O
that	DT	O	O
time	NN	O	O
,	,	O	O
she	PRP	O	O
also	RB	O	O
had	VBD	O	O
cat	VBN	B-PROBLEM	B-PROBLEM
scratch	NN	I-PROBLEM	I-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
she	PRP	O	O
had	VBD	O	O
resection	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
abscess	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
not	RB	O	O
used	VBN	O	O
any	DT	B-TREATMENT	B-TREATMENT
anti	JJ	I-TREATMENT	I-TREATMENT
retroviral	JJ	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
since	IN	O	O
then	RB	O	O
,	,	O	O
because	IN	O	O
of	IN	O	O
pancytopenia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
on	IN	O	O
ddi	NN	B-TREATMENT	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
complaints	NNS	O	O
of	IN	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
left	VBN	B-PROBLEM	B-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
and	CC	O	O
off	IN	O	O
getting	VBG	O	O
progressively	RB	O	O
worse	JJR	O	O
over	IN	O	O
the	DT	O	O
past	JJ	O	O
month	NN	O	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
had	VBD	O	O
similar	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
intermittently	RB	O	O
for	IN	O	O
last	JJ	O	O
year	NN	O	O
.	.	O	O

she	PRP	O	O
described	VBD	O	O
the	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
as	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
burning	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
is	VBZ	O	O
positional	JJ	O	O
,	,	O	O
worse	JJR	O	O
when	WRB	O	O
she	PRP	O	O
walks	VBD	O	O
or	CC	O	O
does	VBZ	O	O
any	DT	O	O
type	NN	O	O
of	IN	O	O
exercise	NN	O	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
no	DT	O	O
relief	NN	O	B-PROBLEM
from	IN	O	O
antacids	NNS	B-TREATMENT	B-TREATMENT
or	CC	O	O
h2	NN	B-TREATMENT	B-PROBLEM
blockers	NNS	I-TREATMENT	I-PROBLEM
.	.	O	O

in	IN	O	O
10/92	CD	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
fatty	JJ	B-PROBLEM	B-PROBLEM
infiltration	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
liver	NN	I-PROBLEM	I-PROBLEM
diffusely	RB	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
1	CD	I-PROBLEM	I-PROBLEM
cm	NN	I-PROBLEM	I-PROBLEM
cyst	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
liver	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	O	O
normal	JJ	O	O
pancreas	NN	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
,	,	O	O
however	RB	O	O
,	,	O	O
hyperdense	JJ	B-PROBLEM	B-TEST
kidneys	NNS	I-PROBLEM	I-TEST
.	.	O	O

her	PRP$	B-TEST	B-TEST
alkaline	JJ	I-TEST	I-TEST
phosphatase	NN	I-TEST	I-TEST
was	VBD	O	O
slightly	RB	B-PROBLEM	B-PROBLEM
elevated	VBN	I-PROBLEM	I-PROBLEM
but	CC	O	O
otherwise	RB	O	O
relatively	RB	O	O
normal	JJ	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
amylase	NN	I-TEST	I-TEST
was	VBD	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
elevated	VBN	I-PROBLEM	I-PROBLEM
but	CC	O	O
has	VBZ	O	O
been	VBN	O	O
down	RB	O	O
since	IN	O	O
then	RB	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
had	VBN	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
thrive	VB	I-PROBLEM	I-PROBLEM
and	CC	O	O
steady	JJ	B-PROBLEM	B-PROBLEM
weight	NN	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
brought	VBN	O	O
in	IN	O	O
for	IN	O	O
an	DT	B-TEST	B-TEST
esophagogastroduodenoscopy	NN	I-TEST	I-TEST
on	IN	O	O
9/26	CD	O	O
but	CC	O	O
she	PRP	O	O
basically	RB	O	O
was	VBD	O	O
not	RB	O	O
sufficiently	RB	O	B-PROBLEM
sedated	VBN	B-TREATMENT	I-PROBLEM
and	CC	O	O
readmitted	VBN	O	O
at	IN	O	O
this	DT	O	O
time	NN	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
gi	JJ	I-TEST	I-TEST
work-up	NN	I-TEST	I-TEST
as	RB	O	O
well	RB	O	O
as	IN	O	O
an	DT	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
of	IN	O	O
new	JJ	B-PROBLEM	B-PROBLEM
abscess	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
calf	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
right	JJ	O	I-PROBLEM
medial	NN	O	I-PROBLEM
lower	JJR	O	I-PROBLEM
extremity	NN	O	I-PROBLEM
quadriceps	NNS	O	I-PROBLEM
muscle	NN	O	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
also	RB	O	O
admitted	VBN	O	O
to	TO	O	O
be	VB	O	O
connected	VBN	O	O
up	RP	O	O
with	IN	O	O
social	JJ	O	O
services	NNS	O	O
for	IN	O	O
hiv	JJ	B-PROBLEM	O
patients	NNS	O	O
.	.	O	O

bactrim	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

on	IN	O	O
admission	NN	O	O
included	VBD	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
prinovil	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
dapsone	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
mycelex	JJ	B-TREATMENT	B-PROBLEM
troches	NNS	I-TREATMENT	I-PROBLEM
.	.	O	O

on	IN	O	O
admission	NN	O	O
revealed	VBD	O	O
a	DT	O	O
cachetic	JJ	O	O
woman	NN	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
stable	JJ	O	O
vital	JJ	O	O
signs	NNS	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
not	RB	O	O
orthostatic	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
110/80	CD	O	O
.	.	O	O

heent	NN	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
was	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

lungs	NNS	O	O
were	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	NN	B-TEST	B-TEST
and	CC	O	O
percussion	NN	B-TEST	B-TEST
bilaterally	RB	O	O
.	.	O	O

cardiovascular	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
without	IN	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBD	B-PROBLEM	B-PROBLEM
with	IN	O	O
positive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

extremities	NNS	O	O
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
2	CD	I-PROBLEM	I-PROBLEM
x	NN	I-PROBLEM	I-PROBLEM
3	CD	I-PROBLEM	I-PROBLEM
cm	JJ	I-PROBLEM	I-PROBLEM
tender	NN	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lateral	JJ	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
calf	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
medial	JJ	B-PROBLEM	B-PROBLEM
1	CD	I-PROBLEM	I-PROBLEM
cm	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
above	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
knee	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
admission	NN	O	O
included	VBD	O	O
bun	JJ	B-TEST	B-TEST
/	NNP	O	I-TEST
creatinine	NN	B-TEST	I-TEST
of	IN	O	O
33/2.1	CD	O	O
.	.	O	O

sodium	NN	B-TEST	B-TEST
141	CD	O	O
.	.	O	O

potassium	NN	B-TEST	B-TEST
4.2	CD	O	O
.	.	O	O

hematocrit	NN	B-TEST	B-TEST
23	CD	O	O
.	.	O	O

white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
2.1	CD	O	O
with	IN	O	O
56	CD	B-TEST	O
polys	NNS	I-TEST	B-TEST
and	CC	O	O
1	CD	B-TEST	O
band	NN	I-TEST	O
.	.	O	O

platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
411,000	CD	O	O
.	.	O	O

amylase	NN	B-TEST	B-TEST
143	CD	O	O
.	.	O	O

lipase	NN	B-TEST	B-TEST
was	VBD	O	O
elevated	VBN	B-PROBLEM	O
to	TO	O	O
600	CD	O	O
.	.	O	O

esr	NN	B-TEST	O
was	VBD	O	O
greater	JJR	O	O
than	IN	O	O
140	CD	O	O
.	.	O	O

alkaline	JJ	B-TEST	B-TEST
phosphatase	NN	I-TEST	I-TEST
190	CD	O	O
.	.	O	O

alt	RB	B-TEST	O
52	CD	O	O
.	.	O	O

ast	RB	B-TEST	B-TEST
65	CD	O	O
.	.	O	O

beta	NN	B-TEST	B-TREATMENT
hcg	NN	I-TEST	I-TREATMENT
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

urinalysis	NN	B-TEST	B-TEST
was	VBD	O	O
positive	JJ	B-PROBLEM	O
for	IN	I-PROBLEM	O
protein	NN	I-PROBLEM	B-TREATMENT
.	.	O	O

bilirubin	NN	B-TEST	B-TEST
0.4	CD	O	O
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	JJ	I-TEST	I-TEST
revealed	VBD	O	O
clear	JJ	O	O
lung	NN	O	O
fields	NNS	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
rib	JJ	B-PROBLEM	B-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
and	CC	O	O
many	JJ	B-TEST	B-PROBLEM
cultures	NNS	I-TEST	I-PROBLEM
were	VBD	O	O
sent	VBN	O	O
which	WDT	O	O
were	VBD	O	O
all	DT	O	O
negative	JJ	O	O
.	.	O	O

she	PRP	O	O
did	VBD	O	O
not	RB	O	O
have	VB	O	O
any	DT	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
hospital	NN	O	O
.	.	O	O

on	IN	O	O
the	DT	O	O
third	JJ	O	O
hospital	NN	O	O
day	NN	O	O
,	,	O	O
she	PRP	O	O
did	VBD	O	O
have	VB	O	O
some	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
went	VBD	O	O
for	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
debridement	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
calf	NN	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
10/2/93	CD	O	O
and	CC	O	O
was	VBD	O	O
started	VBN	O	O
empirically	RB	O	O
on	IN	O	O
iv	NN	B-TREATMENT	B-TREATMENT
ceftriaxone	NN	I-TREATMENT	I-TREATMENT
which	WDT	O	O
was	VBD	O	O
changed	VBN	O	O
to	TO	O	O
po	VB	B-TREATMENT	O
doxycycline	NN	I-TREATMENT	B-TREATMENT
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
follow-up	JJ	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
was	VBD	O	O
done	VBN	O	O
which	WDT	O	O
did	VBD	O	O
not	RB	O	O
show	VB	O	O
any	DT	O	O
evidence	NN	O	O
for	IN	O	O
splenomegaly	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
hepatomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
1	CD	I-PROBLEM	I-PROBLEM
cm	NN	I-PROBLEM	I-PROBLEM
cyst	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
seen	VBN	O	O
in	IN	O	O
10/92	CD	O	O
was	VBD	O	O
still	RB	O	O
present	JJ	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
a	DT	O	O
question	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
cyst	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
kidney	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
stone	NN	I-PROBLEM	I-PROBLEM
right	RB	O	I-PROBLEM
below	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
cyst	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
although	IN	O	O
this	DT	O	O
did	VBD	O	O
not	RB	O	O
seem	VB	O	O
to	TO	O	O
be	VB	O	O
clinically	RB	O	O
significant	JJ	O	O
.	.	O	O

cultures	NNS	B-TEST	B-TEST
were	VBD	O	O
pending	VBG	O	O
on	IN	O	O
her	PRP$	B-TEST	B-TREATMENT
aspirate	NN	I-TEST	I-TREATMENT
and	CC	O	O
will	MD	O	O
be	VB	O	O
treated	VBN	O	O
with	IN	O	O
po	JJ	B-TREATMENT	B-TREATMENT
doxycycline	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

cough	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
rhinorrhea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
dehydration	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
an	DT	O	O
80	CD	O	O
year	NN	O	O
old	JJ	O	O
female	NN	O	O
with	IN	O	O
breast	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
lumpectomy	NN	B-TREATMENT	B-TREATMENT
/	NNP	O	I-TREATMENT
radiation	NN	B-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
/	NNP	O	O
tamoxifen	NN	B-TREATMENT	B-TREATMENT
(	(	O	O
2000	CD	O	O
)	)	O	O
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hyperlipidemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
urinary	JJ	I-PROBLEM	I-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infections	NNS	I-PROBLEM	I-PROBLEM
who	WP	O	O
presents	VBP	O	O
with	IN	O	O
a	DT	O	O
four	CD	O	O
day	NN	O	O
prodrome	NN	O	B-PROBLEM
of	IN	O	I-PROBLEM
dry	JJ	B-PROBLEM	I-PROBLEM
cough	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
rhinorrhea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
coryza	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
malaise	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
headache	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
decreased	VBD	B-PROBLEM	B-PROBLEM
p.o.	JJ	I-PROBLEM	I-PROBLEM
intake	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
loose	JJ	B-PROBLEM	O
bowel	NN	I-PROBLEM	O
movements	NNS	I-PROBLEM	O
with	IN	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
no	DT	O	O
blood	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
decreased	VBD	B-PROBLEM	B-PROBLEM
urine	JJ	I-PROBLEM	I-PROBLEM
output	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
sick	JJ	O	O
contacts	NNS	O	O
,	,	O	O
had	VBD	O	O
flu	VBN	B-TREATMENT	B-PROBLEM
shot	NN	I-TREATMENT	I-PROBLEM
this	DT	O	O
year	NN	O	O
.	.	O	O

in	IN	O	O
the	DT	O	O
emergency	NN	O	O
department	NN	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
labile	JJ	B-PROBLEM	B-TEST
blood	NN	I-PROBLEM	I-TEST
pressure	NN	I-PROBLEM	I-TEST
with	IN	O	O
systolic	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
in	IN	O	O
the	DT	O	O
80	CD	O	O
s	NN	O	O
.	.	O	O

her	PRP$	O	O
usual	JJ	O	O
is	VBZ	O	O
systolic	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
in	IN	O	O
the	DT	O	O
120	CD	O	O
s	NN	O	O
,	,	O	O
this	DT	O	O
was	VBD	O	O
despite	IN	O	O
two	CD	B-TREATMENT	O
liters	NNS	I-TREATMENT	O
of	IN	I-TREATMENT	O
intravenous	JJ	I-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
medical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
closer	RBR	O	O
monitoring	NN	O	O
for	IN	O	O
possible	JJ	O	O
early	JJ	B-PROBLEM	B-PROBLEM
sepsis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
course	NN	O	O
was	VBD	O	O
notable	JJ	O	O
for	IN	O	O
initially	RB	O	O
receiving	VBG	O	O
broad	JJ	B-TREATMENT	B-TREATMENT
spectrum	NN	I-TREATMENT	I-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
as	RB	O	O
well	RB	O	O
as	IN	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
11.0	CD	O	O
with	IN	O	O
15	CD	O	O
bands	NNS	B-TEST	B-TEST
.	.	O	O

she	PRP	O	O
was	VBD	O	O
ultimately	RB	O	O
changed	VBN	O	O
to	TO	O	O
levaquin	VB	B-TREATMENT	O
for	IN	O	O
a	DT	O	O
possible	JJ	O	O
early	JJ	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
pending	VBG	B-TEST	O
cultures	NNS	I-TEST	O
.	.	O	O

the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
course	NN	O	O
was	VBD	O	O
also	RB	O	O
notable	JJ	O	O
for	IN	O	O
negative	JJ	O	O
chest	NN	O	B-TEST
x-ray	NN	O	I-TEST
,	,	O	O
two	CD	B-TREATMENT	O
units	NNS	I-TREATMENT	O
of	IN	I-TREATMENT	O
packed	JJ	I-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
a	DT	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
of	IN	O	O
24.0	CD	O	O
with	IN	O	O
appropriate	JJ	O	O
bump	NN	O	O
in	IN	O	O
her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
and	CC	O	O
no	DT	O	O
evidence	NN	B-PROBLEM	O
of	IN	I-PROBLEM	O
bleeding	NN	I-PROBLEM	B-PROBLEM
,	,	O	O
stable	JJ	O	O
blood	NN	B-TEST	O
pressure	NN	I-TEST	O
despite	IN	O	O
a	DT	B-TEST	B-TEST
net	JJ	I-TEST	I-TEST
fluid	NN	I-TEST	I-TEST
balance	NN	I-TEST	I-TEST
of	IN	O	O
negative	JJ	O	O
2.5	CD	O	O
liters	NNS	O	O
.	.	O	O

no	DT	O	O
central	JJ	B-TREATMENT	O
access	NN	I-TREATMENT	O
was	VBD	O	O
needed	VBN	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TEST
sepsis	NN	I-TREATMENT	I-TEST
protocol	NN	I-TREATMENT	I-TEST
was	VBD	O	O
aborted	VBN	O	O
.	.	O	O

also	RB	O	O
of	IN	O	O
note	NN	O	O
,	,	O	O
her	PRP$	B-TEST	B-TEST
liver	JJ	I-TEST	I-TEST
function	NN	I-TEST	I-TEST
tests	NNS	I-TEST	I-TEST
had	VBD	O	O
been	VBN	O	O
normal	JJ	O	O
.	.	O	O

random	NN	B-TEST	B-TEST
cortisol	NN	I-TEST	I-TEST
was	VBD	O	O
17	CD	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
dfa	NN	I-TEST	I-TEST
was	VBD	O	O
positive	JJ	O	O
for	IN	O	O
influenzae	NN	B-PROBLEM	O
a	DT	I-PROBLEM	O
with	IN	O	O
a	DT	B-TEST	B-TEST
viral	JJ	I-TEST	I-TEST
culture	NN	I-TEST	I-TEST
pending	VBG	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

blood	NN	B-TEST	B-TEST
and	CC	I-TEST	I-TEST
urine	JJ	I-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
were	VBD	O	O
no	DT	O	O
growth	NN	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
as	IN	O	O
well	RB	O	O
.	.	O	O

she	PRP	O	O
also	RB	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
right	JJ	I-TEST	I-TEST
lower	JJR	I-TEST	I-TEST
extremity	NN	I-TEST	I-TEST
noninvasive	JJ	I-TEST	I-TEST
ultrasound	NN	I-TEST	I-TEST
that	WDT	O	O
was	VBD	O	O
negative	JJ	O	O
for	IN	O	O
deep	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
thrombosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

past	JJ	O	O
medical	JJ	O	O
history	NN	O	O
:	:	O	O
breast	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
diagnosed	VBN	O	O
in	IN	O	O
2010	CD	O	O
,	,	O	O
stage	NN	O	O
i	NN	O	O
,	,	O	O
status	NN	B-TREATMENT	O
post	NN	I-TREATMENT	O
left	VBD	I-TREATMENT	B-TREATMENT
lumpectomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
on	IN	O	O
2012-05-08	JJ	O	O
,	,	O	O
and	CC	O	O
repeat	NN	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
sentinel	NN	B-TREATMENT	B-TREATMENT
node	NN	I-TREATMENT	I-TREATMENT
dissection	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
2012-06-05	JJ	O	O
.	.	O	O

invasive	JJ	B-PROBLEM	B-PROBLEM
mucinous	JJ	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
estrogen	NN	B-PROBLEM	B-PROBLEM
receptor	NN	I-PROBLEM	I-PROBLEM
positivity	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
her2/neu	NN	B-PROBLEM	B-TEST
negative	JJ	O	O
.	.	O	O

left	VBN	B-TREATMENT	B-PROBLEM
chest	JJS	I-TREATMENT	I-PROBLEM
radiation	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
on	IN	O	O
tamoxifen	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

question	NN	O	O
of	IN	O	O
vertebral	JJ	B-PROBLEM	B-PROBLEM
basilar	JJ	I-PROBLEM	I-PROBLEM
cerebrovascular	JJ	I-PROBLEM	I-PROBLEM
accident	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
2016-08-17	JJ	O	O
,	,	O	O
with	IN	O	O
associated	VBN	O	B-PROBLEM
limb	NN	B-PROBLEM	I-PROBLEM
ataxia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

magnetic	JJ	B-TEST	B-TEST
resonance	NN	I-TEST	I-TEST
imaging	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
except	IN	O	O
for	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
microvascular	JJ	I-PROBLEM	I-PROBLEM
cerebral	JJ	I-PROBLEM	I-PROBLEM
white	JJ	I-PROBLEM	I-PROBLEM
matter	NN	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

question	NN	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
vertigo	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
takes	VBZ	O	O
meclizine	JJ	B-TREATMENT	O
p.r.n.	NN	O	O

hypothyroidism	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

glaucoma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

cataract	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

osteopenia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

left	VBN	B-PROBLEM	B-PROBLEM
hip	NN	I-PROBLEM	I-PROBLEM
arthritis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

history	NN	O	O
of	IN	O	O
urinary	JJ	B-PROBLEM	B-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infections	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

anemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
baseline	NN	I-TEST	I-TEST
hematocrit	NN	I-TEST	I-TEST
of	IN	O	O
31.0	CD	O	O
,	,	O	O
with	IN	O	O
a	DT	B-TEST	O
tibc	NN	I-TEST	O
that	WDT	O	O
was	VBD	O	O
low	JJ	B-PROBLEM	O
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
high	JJ	I-PROBLEM	I-PROBLEM
ferritin	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

echocardiogram	NN	B-TEST	B-TEST
in	IN	O	O
2016-09-16	JJ	O	O
,	,	O	O
with	IN	O	O
preserved	JJ	O	O
ejection	NN	B-TEST	O
fraction	NN	I-TEST	O
of	IN	O	O
60	CD	O	O
percent	NN	O	O
with	IN	O	O
trivial	JJ	B-PROBLEM	B-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
mild	NN	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
enlargement	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

cardiac	JJ	B-TEST	B-TEST
stress	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
in	IN	O	O
2016-03-17	JJ	O	O
,	,	O	O
that	WDT	O	O
was	VBD	O	O
negative	JJ	O	O
for	IN	O	O
inducible	JJ	B-PROBLEM	B-PROBLEM
ischemia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
evista	JJ	B-TREATMENT	B-TREATMENT
60	CD	O	O
mg	JJ	O	O
p.o.	JJ	O	O
daily	NN	O	O
.	.	O	O

2.	CD	O	O
tamoxifen	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	JJ	O	O
p.o.	JJ	O	O
daily	NN	O	O
.	.	O	O

3.	CD	O	O
lisinopril	JJ	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	JJ	O	O
p.o.	JJ	O	O
daily	NN	O	O
.	.	O	O

4.	CD	O	O
triamterene/hydrochlorothiazide	JJ	B-TREATMENT	B-TREATMENT
37.5/25	CD	O	O
mg	JJ	O	O
p.o.	JJ	O	O
daily	NN	O	O
.	.	O	O

5.	CD	O	O
enteric	JJ	B-TREATMENT	B-TREATMENT
coated	VBD	I-TREATMENT	I-TREATMENT
aspirin	JJ	I-TREATMENT	I-TREATMENT
325	CD	O	O
mg	JJ	O	O
p.o.	JJ	O	O
daily	NN	O	O
.	.	O	O

6.	CD	O	O
meclizine	NN	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
q8hours	NNS	O	O
p.r.n.	VBP	O	O

7.	CD	O	O
aggrenox	JJ	B-TREATMENT	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
,	,	O	O
the	DT	O	O
dose	NN	O	O
was	VBD	O	O
not	RB	O	O
known	VBN	O	O
.	.	O	O

8.	CD	O	O
synthroid	JJ	B-TREATMENT	B-TREATMENT
125	CD	O	O
mcg	JJ	O	O
daily	RB	O	O
.	.	O	O

breast	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
multiple	JJ	O	O
female	JJ	O	O
relatives	NNS	O	O
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
presentation	NN	O	O
,	,	O	O
temperature	NN	B-TEST	B-TEST
100.8	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
89	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
106	CD	O	O
systolic	NN	B-TEST	B-TEST
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
18	CD	O	O
,	,	O	O
oxygen	NN	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST
97	CD	O	O
percent	NN	O	O
in	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

physical	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
is	VBZ	O	O
read	VBN	O	O
off	IN	O	O
the	DT	O	O
admitting	VBG	O	O
note	NN	O	O
from	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
team	NN	O	O
and	CC	O	O
is	VBZ	O	O
not	RB	O	O
reflective	JJ	O	O
of	IN	O	O
the	DT	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
by	IN	O	O
this	DT	O	O
dictator	NN	O	O
.	.	O	O

general	JJ	O	O
-	:	O	O
the	DT	O	O
patient	NN	O	O
appears	VBZ	O	O
stated	VBN	O	O
age	NN	O	O
,	,	O	O
found	VBD	O	O
lying	VBG	O	O
flat	JJ	O	O
in	IN	O	O
bed	NN	O	O
,	,	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

head	NN	O	B-TEST
,	,	O	I-TEST
eyes	NNS	O	I-TEST
,	,	O	I-TEST
ears	NNS	O	I-TEST
,	,	O	I-TEST
nose	RB	O	I-TEST
and	CC	O	I-TEST
throat	VB	O	I-TEST
-	:	O	O
sclera	NN	B-PROBLEM	B-PROBLEM
anicteric	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
conjunctiva	NN	B-PROBLEM	B-PROBLEM
injected	VBD	I-PROBLEM	O
,	,	O	O
the	DT	O	O
pupils	NNS	O	O
are	VBP	O	O
equal	JJ	O	O
,	,	O	O
round	NN	O	O
and	CC	O	O
reactive	JJ	O	O
to	TO	O	O
light	JJ	O	O
and	CC	O	O
accommodation	NN	O	O
,	,	O	O
the	DT	O	O
mucous	JJ	O	O
membranes	NNS	O	O
are	VBP	O	O
dry	JJ	B-PROBLEM	O
,	,	O	O
oropharynx	JJ	O	O
clear	JJ	O	O
.	.	O	O

neck	SYM	O	B-TEST
-	:	O	O
no	DT	O	O
jugular	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
distention	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

cardiac	JJ	O	O
regular	JJ	O	O
rate	NN	B-TEST	O
and	CC	O	O
rhythm	NN	B-TEST	O
,	,	O	O
normal	JJ	O	O
s1	NN	O	O
and	CC	O	O
s2	NN	O	O
,	,	O	O
i/vi	JJ	B-PROBLEM	B-PROBLEM
holosystolic	JJ	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
apex	NN	I-PROBLEM	O
.	.	O	O

chest	NN	O	O
clear	JJ	O	O
to	TO	O	O
percussion	NN	B-TEST	B-TEST
and	CC	O	O
auscultation	NN	B-TEST	B-TEST
.	.	O	O

abdomen	NNS	O	O
is	VBZ	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBD	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

extremities	NNS	O	O
-	:	O	O
no	DT	O	O
calf	NN	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

neurologically	RB	O	O
,	,	O	O
mental	JJ	B-TEST	B-TEST
status	NN	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
is	VBZ	O	O
normal	JJ	O	O
.	.	O	O

cranial	JJ	B-TEST	O
nerves	NNS	I-TEST	O
ii	VBP	I-TEST	O
through	IN	I-TEST	O
xii	NNS	I-TEST	O
are	VBP	O	O
intact	JJ	O	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
chest	VB	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
with	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
cardiopulmonary	JJ	I-PROBLEM	I-PROBLEM
process	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

electrocardiogram	NN	B-TEST	B-TEST
notable	JJ	O	O
for	IN	O	O
sinus	JJ	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
104	CD	O	O
beats	NNS	O	O
per	IN	O	O
minute	NN	O	O
,	,	O	O
normal	JJ	O	O
axis	NN	O	O
,	,	O	O
normal	JJ	O	O
intervals	NNS	O	O
,	,	O	O
new	JJ	B-PROBLEM	B-PROBLEM
t	NN	I-PROBLEM	I-PROBLEM
wave	VBP	I-PROBLEM	I-PROBLEM
inversion	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
iii	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
old	JJ	B-PROBLEM	B-PROBLEM
t	NN	I-PROBLEM	I-PROBLEM
wave	NN	I-PROBLEM	I-PROBLEM
inversions	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
avl	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
v1	NN	I-PROBLEM	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
7.3	CD	O	O
,	,	O	O
73	CD	O	O
percent	NN	O	O
neutrophils	NNS	B-TEST	O
,	,	O	O
15	CD	O	O
percent	NN	O	O
bands	NNS	B-TEST	O
,	,	O	O
6	CD	O	O
percent	NN	O	O
lymphocytes	NNS	B-TEST	B-TEST
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
30.4	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
228,000	CD	O	O
.	.	O	O

sodium	NN	B-TEST	B-TEST
136	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
3.5	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
98	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
23	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
urea	JJ	I-TEST	I-TEST
nitrogen	NN	I-TEST	I-TEST
16	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
0.8	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
142	CD	O	O
.	.	O	O

this	DT	O	O
is	VBZ	O	O
an	DT	O	O
80	CD	O	O
year	NN	O	O
old	JJ	O	O
female	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
stage	NN	B-PROBLEM	B-PROBLEM
i	JJ	I-PROBLEM	I-PROBLEM
breast	NN	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hyperlipidemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
who	WP	O	O
presents	VBZ	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
leukocytosis/bandemia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
dehydration	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
influenza	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

hypotension	NN	B-PROBLEM	B-PROBLEM
-	:	O	O
this	DT	O	O
was	VBD	O	O
likely	JJ	O	O
secondary	JJ	O	O
to	TO	O	O
volume	NN	B-PROBLEM	B-PROBLEM
depletion	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
diarrheal	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
viral	JJ	I-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
stable	JJ	O	O
after	IN	O	O
three	CD	B-TREATMENT	O
liters	NNS	I-TREATMENT	O
of	IN	I-TREATMENT	O
normal	JJ	I-TREATMENT	B-TREATMENT
saline	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
did	VBD	O	O
receive	VB	O	O
two	CD	B-TREATMENT	O
units	NNS	I-TREATMENT	O
of	IN	I-TREATMENT	O
packed	JJ	I-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
gastrointestinal	JJ	B-PROBLEM	B-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
adrenal	JJ	B-PROBLEM	B-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
during	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
her	PRP$	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
.	.	O	O

her	PRP$	B-TREATMENT	B-TEST
antihypertensives	NNS	I-TREATMENT	I-TEST
were	VBD	O	O
initially	RB	O	O
held	VBN	O	O
and	CC	O	O
reinstated	VBN	O	O
upon	IN	O	O
discharge	NN	O	O
.	.	O	O

influenza	VB	B-PROBLEM	O
a	DT	I-PROBLEM	O
-	:	O	O
dfa	NN	B-TEST	O
confirmed	VBD	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
viral	JJ	I-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
were	VBD	O	O
pending	VBG	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

the	DT	B-PROBLEM	O
initial	JJ	I-PROBLEM	O
bandemia	NN	I-PROBLEM	O
would	MD	O	O
not	RB	O	O
have	VB	O	O
been	VBN	O	O
consistent	JJ	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
typical	JJ	I-PROBLEM	I-PROBLEM
influenza	NN	I-PROBLEM	I-PROBLEM
presentation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
so	IN	O	O
she	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
a	DT	O	O
fourteen	JJ	O	O
day	NN	O	O
course	NN	O	O
of	IN	O	O
levaquin	NN	B-TREATMENT	B-TREATMENT
to	TO	O	O
eliminate	VB	O	O
any	DT	O	O
possibility	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
bacterial	JJ	I-PROBLEM	I-PROBLEM
superinfection	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
early	JJ	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

loose	JJ	B-PROBLEM	O
bowel	NN	I-PROBLEM	O
movements	NNS	I-PROBLEM	O
-	:	O	O
this	DT	O	O
problem	NN	O	O
was	VBD	O	O
resolved	VBN	O	O
and	CC	O	O
had	VBD	O	O
been	VBN	O	O
a	DT	B-PROBLEM	B-PROBLEM
viral	JJ	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
presentation	NN	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
during	IN	O	O
medical	JJ	O	O
lawrence	NN	O	O
memorial	JJ	O	O
hospital	NN	O	O
stay	NN	O	O
.	.	O	O

anemia	SYM	B-PROBLEM	B-PROBLEM
-	:	O	O
this	DT	O	O
is	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
chronic	JJ	I-PROBLEM	I-PROBLEM
problem	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
known	VBN	B-PROBLEM	B-PROBLEM
iron	NN	I-PROBLEM	I-PROBLEM
deficiency	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
evidence	NN	B-PROBLEM	O
of	IN	I-PROBLEM	O
bleeding	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
guaiac	JJ	B-TEST	B-TEST
negative	JJ	O	O
and	CC	O	O
the	DT	B-TEST	B-TEST
hemophilus	JJ	I-TEST	I-TEST
panel	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
reinstated	VBN	O	O
on	IN	O	O
iron	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
discharge	NN	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
stable	JJ	O	O
.	.	O	O

hypothyroid	NN	B-PROBLEM	B-PROBLEM
-	:	O	O
she	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
synthroid	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

osteopenia	SYM	B-PROBLEM	B-PROBLEM
-	:	O	O
she	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
evista	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

fluids	NNS	B-TREATMENT	O
,	,	O	O
electrolytes	NNS	B-TREATMENT	B-TEST
and	CC	O	O
nutrition	NN	B-TREATMENT	O
-	:	O	O
she	PRP	O	O
was	VBD	O	O
tolerating	VBG	O	O
a	DT	O	O
house	NN	O	O
diet	JJ	O	O
upon	IN	O	O
discharge	NN	O	O
.	.	O	O

1.	CD	O	O
evista	JJ	B-TREATMENT	B-TREATMENT
60	CD	O	O
mg	JJ	O	O
p.o.	JJ	O	O
daily	NN	O	O
.	.	O	O

2.	CD	O	O
tamoxifen	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	JJ	O	O
p.o.	JJ	O	O
daily	NN	O	O
.	.	O	O

3.	CD	O	O
lisinopril	JJ	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	JJ	O	O
p.o.	JJ	O	O
daily	NN	O	O
.	.	O	O

4.	CD	O	O
triamterene/hydrochlorothiazide	JJ	B-TREATMENT	B-TREATMENT
37.5/25	CD	O	O
mg	JJ	O	O
p.o.	JJ	O	O
daily	NN	O	O
.	.	O	O

5.	CD	O	O
enteric	JJ	B-TREATMENT	B-TREATMENT
coated	VBD	I-TREATMENT	I-TREATMENT
aspirin	JJ	I-TREATMENT	I-TREATMENT
325	CD	O	O
mg	JJ	O	O
p.o.	JJ	O	O
daily	NN	O	O
.	.	O	O

6.	CD	O	O
meclizine	NN	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
q8hours	NNS	O	O
p.r.n.	VBP	O	O

7.	CD	O	O
aggrenox	JJ	B-TREATMENT	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
,	,	O	O
the	DT	O	O
dose	NN	O	O
was	VBD	O	O
not	RB	O	O
known	VBN	O	O
.	.	O	O

8.	CD	O	O
synthroid	JJ	B-TREATMENT	B-TREATMENT
125	CD	O	O
mcg	JJ	O	O
daily	RB	O	O
.	.	O	O

9.	CD	O	O
levofloxacin	JJ	B-TREATMENT	B-TREATMENT
250	CD	O	O
mg	JJ	O	O
p.o.	JJ	O	O
daily	JJ	O	O
to	TO	O	O
complete	VB	O	O
a	DT	O	O
fourteen	JJ	O	O
day	NN	O	O
course	NN	O	O
.	.	O	O

influenza	NN	B-PROBLEM	O
a	DT	I-PROBLEM	O
.	.	O	O

hypotension	NN	B-PROBLEM	B-PROBLEM
secondary	JJ	O	O
to	TO	O	O
volume	NN	B-PROBLEM	B-PROBLEM
depletion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

anemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

hypothyroidism	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
normotensive	JJ	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
stable	JJ	O	O
at	IN	O	O
her	PRP$	O	O
baseline	NN	O	O
upon	IN	O	O
discharge	NN	O	O
.	.	O	O

vt	NN	B-PROBLEM	O
s/p	NN	O	O
cardiac	JJ	B-TEST	B-TREATMENT
cath	NN	I-TEST	I-TREATMENT
,	,	O	O
stent	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
amp	NN	O	O
;	:	O	O
amio	CC	B-TREATMENT	O
loading	VBG	I-TREATMENT	O

amiodarone	RB	B-TREATMENT	B-TREATMENT
400	CD	O	O
mg	JJ	O	O
po	NN	O	O
bid	NN	O	O
starting	VBG	O	O
today	NN	O	O
(	(	O	O
01/06	CD	O	O
)	)	O	O

serious	JJ	B-PROBLEM	O
interaction	NN	I-PROBLEM	O
:	:	O	O

digoxin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
hcl	NN	I-TREATMENT	I-TREATMENT

ok	JJ	O	O
enteric	NN	B-TREATMENT	O
coated	VBN	I-TREATMENT	O
asa	NN	I-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
aspirin	JJ	I-TREATMENT	I-TREATMENT
enteric	RB	I-TREATMENT	I-TREATMENT
coated	VBN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
325	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
0.0625	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O

override	RB	O	O
added	VBD	O	O
on	IN	O	O
01/03/04	CD	O	O
by	IN	O	O
tikneav	NN	O	O
,	,	O	O
jeffci	NN	O	B-PROBLEM
suot	NN	O	I-PROBLEM
a.	NN	O	I-PROBLEM
,	,	O	O
m.d.	NN	O	O
on	IN	O	O
order	NN	O	O
for	IN	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
po	NN	I-TREATMENT	I-TREATMENT
(	(	O	O
ref	JJ	O	O
#	#	O	O
23731718	CD	O	O
)	)	O	O

serious	JJ	B-PROBLEM	O
interaction	NN	I-PROBLEM	O
:	:	O	O

digoxin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
hcl	NN	I-TREATMENT	I-TREATMENT

override	RB	O	O
added	VBD	O	O
on	IN	O	O
01/02/04	CD	O	O
by	IN	O	O
koteslent	NN	O	O
,	,	O	O
ant	JJ	O	O
odewyju	NN	O	O
,	,	O	O
m.d.	NN	O	O
on	IN	O	O
order	NN	O	O
for	IN	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
iv	NN	I-TREATMENT	I-TREATMENT
1	CD	O	O
(	(	O	O
ref	JJ	O	O
#	#	O	O
45803793	CD	O	O
)	)	O	O

serious	JJ	B-PROBLEM	O
interaction	NN	I-PROBLEM	O
:	:	O	O

digoxin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
hcl	NN	I-TREATMENT	I-TREATMENT

serious	JJ	B-PROBLEM	O
interaction	NN	I-PROBLEM	O
:	:	O	O

amiodarone	NN	B-TREATMENT	B-TREATMENT
hcl	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT

mvi	NN	B-TREATMENT	B-TREATMENT
therapeutic	JJ	I-TREATMENT	I-TREATMENT
w	NN	I-TREATMENT	I-TREATMENT
/	NN	I-TREATMENT	I-TREATMENT
minerals	NNS	I-TREATMENT	I-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
therap	VB	I-TREATMENT	I-TREATMENT
vits	NNS	I-TREATMENT	I-TREATMENT
/	NNP	I-TREATMENT	I-TREATMENT
minerals	NNS	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
1	CD	O	O
tab	NN	O	O
po	NN	O	O
qd	NN	O	O

override	RB	O	O
added	VBD	O	O
on	IN	O	O
01/02/04	CD	O	O
by	IN	O	O
koteslent	NN	O	O
,	,	O	O
ant	JJ	O	O
odewyju	NN	O	O
,	,	O	O
m.d.	NN	O	O
on	IN	O	O
order	NN	O	O
for	IN	O	O
zocor	NN	B-TREATMENT	B-TREATMENT
po	NN	I-TREATMENT	I-TREATMENT
(	(	O	I-TREATMENT
ref	JJ	O	I-TREATMENT
#	#	O	I-TREATMENT
71920299	CD	O	I-TREATMENT
)	)	O	I-TREATMENT

niacin	RB	B-TREATMENT	B-TREATMENT
,	,	O	O
vit	NN	O	B-TREATMENT
.	.	O	O

b-3	NN	O	O
and	CC	O	O
simvastatin	NN	B-TREATMENT	B-TREATMENT

zocor	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
simvastatin	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
40	CD	O	O
mg	NN	O	O
po	NN	O	O
qhs	NN	O	O

potentially	RB	O	O
serious	JJ	B-PROBLEM	O
interaction	NN	I-PROBLEM	O
:	:	O	O

niacin	RB	B-TREATMENT	B-TREATMENT
,	,	O	O
vit	NN	O	B-TREATMENT
.	.	O	O

b-3	NN	O	O
and	CC	O	O
simvastatin	NN	B-TREATMENT	B-TREATMENT

toprol	NN	B-TREATMENT	B-TREATMENT
xl	NNP	I-TREATMENT	I-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
metoprolol	NN	I-TREATMENT	I-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
sust.	JJ	I-TREATMENT	I-TREATMENT
rel.	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O

5	CD	B-TREATMENT	O
plavix	NN	I-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
clopidogrel	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
75	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
starting	VBG	O	O
today	NN	O	O
(	(	O	O
01/06	CD	O	O
)	)	O	O
keflex	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
cephalexin	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
500	CD	O	O
mg	NN	O	O
po	NN	O	O
qid	NN	O	O
x	VBD	O	O
40	CD	O	O
doses	NNS	O	O
amiodarone	RB	B-TREATMENT	B-TREATMENT
400	CD	O	O
mg	NNS	O	O
po	JJ	O	O
qd	NN	O	O

serious	JJ	B-PROBLEM	O
interaction	NN	I-PROBLEM	O
:	:	O	O

digoxin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
hcl	NN	I-TREATMENT	I-TREATMENT

nka	NN	B-PROBLEM	O

principal	JJ	O	O
discharge	NN	O	O
diagnosis	NN	O	O
;	:	O	O
responsible	JJ	O	O
after	IN	O	O
study	NN	O	O
for	IN	O	O
causing	VBG	O	O
admission	NN	O	O
)	)	O	O
vt	NN	B-PROBLEM	O
s	JJ	O	O
/	NNP	O	O
p	NN	O	O
cardiac	JJ	B-TEST	B-TREATMENT
cath	NN	I-TEST	I-TREATMENT
,	,	O	O
stent	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
amio	NN	B-TREATMENT	B-TREATMENT
loading	NN	I-TREATMENT	I-TREATMENT

other	JJ	O	O
diagnosis	NN	O	O
;	:	O	O
conditions	NNS	O	O
,	,	O	O
infections	NNS	O	O
,	,	O	O
complications	NNS	O	O
,	,	O	O
affecting	VBG	O	O
treatment	NN	O	O
/	NNP	O	O
stay	NN	O	O
vt	RB	B-PROBLEM	O
,	,	O	O
cad	JJ	B-PROBLEM	B-PROBLEM
s	NN	O	I-PROBLEM
/	NNP	O	I-PROBLEM
p	NN	O	I-PROBLEM
mi	NN	B-PROBLEM	I-PROBLEM
ischemic	JJ	B-PROBLEM	I-PROBLEM
cardiomyopathy	JJ	I-PROBLEM	I-PROBLEM
bilateral	JJ	B-TREATMENT	I-PROBLEM
knee	NN	I-TREATMENT	I-PROBLEM
replacement	NN	I-TREATMENT	I-PROBLEM

cardiac	JJ	B-TEST	B-TEST
cath	NN	I-TEST	I-TEST
1/6/0004	CD	O	O

78	CD	O	O
m	NN	O	O
w/	NN	O	O
longstanding	VBG	B-PROBLEM	O
cad	JJ	I-PROBLEM	O
s	NN	O	O
/	NNP	O	O
p	NN	O	O
cabg	NN	B-TREATMENT	B-TREATMENT
'97	CD	O	O
,	,	O	O
had	VBD	O	O
ppm	NN	B-TREATMENT	O
and	CC	O	O
aicd	NN	B-TREATMENT	O
placed	VBN	O	O
in	IN	O	O
'02	CD	O	O
after	IN	O	O
admitted	VBN	O	O
for	IN	O	O
presyncope	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
inducible	JJ	B-PROBLEM	O
vt	NN	I-PROBLEM	O
.	.	O	O

in	IN	O	O
usoh	JJ	O	O
until	IN	O	O
this	DT	O	O
am	VBP	O	O
when	WRB	O	O
felt	NN	O	O
lh	NN	B-PROBLEM	O
and	CC	O	O
then	RB	O	O
icd	VB	B-TREATMENT	O
discharge	NN	I-TREATMENT	O
.	.	O	O

subsequent	JJ	O	O
4	CD	B-TREATMENT	O
icd	NN	I-TREATMENT	O
discharges	NNS	I-TREATMENT	O
at	IN	O	O
rest	NN	O	O
.	.	O	O

denies	NNS	O	O
change	VBP	B-PROBLEM	O
in	IN	I-PROBLEM	O
et	NN	I-PROBLEM	O
,	,	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
sob	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

went	VBD	O	O
to	TO	O	O
osh	VB	O	O
c	VB	O	O
further	JJ	B-TREATMENT	B-TEST
icd	NN	I-TREATMENT	I-TEST
shocks	NNS	I-TREATMENT	I-TEST
,	,	O	O
vt	NN	B-PROBLEM	O
on	IN	O	O
monitor	NN	B-TEST	O
but	CC	O	O
stable	JJ	O	O
vs	NN	O	O
.	.	O	O

given	VBN	O	O
amio	JJ	B-TREATMENT	B-PROBLEM
bolu	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
started	VBD	O	O
on	IN	O	O
gtt	NN	B-TREATMENT	O
and	CC	O	O
transferred	VBD	O	O
to	TO	O	O
nvh	VB	O	O
for	IN	O	O
further	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
.	.	O	O

exam	NN	B-TEST	B-TEST
remarkable	NN	O	O
for	IN	O	O
b	NN	B-PROBLEM	O
/	NNP	I-PROBLEM	O
l	NN	I-PROBLEM	B-PROBLEM
carotid	NN	I-PROBLEM	I-PROBLEM
bruits	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
soft	JJ	B-PROBLEM	B-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
l	JJ	I-PROBLEM	I-PROBLEM
sternal	JJ	I-PROBLEM	I-PROBLEM
border	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
clear	JJ	O	O
chest	NN	O	O
,	,	O	O
1+	CD	B-PROBLEM	O
b	NN	I-PROBLEM	O
/	NN	I-PROBLEM	O
l	NN	I-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

labs	NNS	B-TEST	B-TEST
at	IN	O	O
osh	JJ	O	O
c	JJ	O	O
cr	NN	B-TEST	O
:	:	O	O

hct	NN	B-TEST	B-TEST
:	:	O	O

gluc	NN	B-TEST	O
:	:	O	O

ck	NN	B-TEST	O
:	:	O	O

mb	NN	B-TEST	O
:	:	O	O

ecg	NN	B-TEST	O
is	VBZ	O	O
av	JJ	O	O
paced	JJ	O	O
but	CC	O	O
prior	JJ	O	O
shower	JJR	B-PROBLEM	O
r	NN	I-PROBLEM	O
on	IN	I-PROBLEM	O
t	NN	I-PROBLEM	O
vpb	NN	I-PROBLEM	O
c	VBP	O	O
monomorphic	JJ	B-PROBLEM	B-PROBLEM
vt	NN	I-PROBLEM	I-PROBLEM
then	RB	O	I-PROBLEM
overdrive	JJ	O	I-PROBLEM
paced	NNS	O	I-PROBLEM
.	.	O	O

1)	CD	O	O
cv	NN	O	O
(	(	O	O
r	NN	O	O
)	)	O	O
finished	VBD	O	O
amio	JJ	B-TREATMENT	O
iv	NN	I-TREATMENT	O
load	NN	I-TREATMENT	O
then	RB	O	O
started	VBD	O	O
on	IN	O	O
po	NN	O	O
,	,	O	O
agressive	JJ	B-TREATMENT	B-PROBLEM
lytes	NNS	I-TREATMENT	I-PROBLEM
;	:	O	O
although	IN	O	O
interrogation	NN	B-TEST	O
showed	VBD	O	O
>100	NNP	O	O
episodes	NNS	O	O
of	IN	O	O
vt	NN	B-PROBLEM	O
(	(	O	O
as	IN	O	O
/	NNP	O	O
x	NNP	O	O
)	)	O	O
,	,	O	O
pt	JJ	O	O
prefers	NNS	O	O
med	VBD	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
as	IN	O	O
opposed	VBN	O	O
to	TO	O	O
ablation	NN	B-TREATMENT	B-TREATMENT
(	(	O	O
i	NN	O	O
)	)	O	O
enzymes	VBZ	B-TEST	O
mildly	RB	B-PROBLEM	B-PROBLEM
elevated	VBN	I-PROBLEM	I-PROBLEM
but	CC	O	O
not	RB	O	O
actively	RB	B-PROBLEM	B-PROBLEM
ischemic	JJ	I-PROBLEM	I-PROBLEM
;	:	O	O
lipids	NNS	B-TEST	B-TEST
,	,	O	O
asa	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
statin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
bb	NN	B-TREATMENT	O
;	:	O	O
adenosine	JJ	B-TEST	B-TREATMENT
thal	NN	I-TEST	I-TREATMENT
1/4	CD	O	O
and	CC	O	O
echo	$	B-TEST	B-TEST
1/4	CD	O	O
to	TO	O	O
look	VB	O	O
for	IN	O	O
signs	NNS	O	O
of	IN	O	O
ischemia	NN	B-PROBLEM	B-PROBLEM
as	IN	O	O
active	JJ	O	O
cause	NN	O	O
for	IN	O	O
vt	NN	B-PROBLEM	O
(	(	O	O
p	NN	O	O
)	)	O	O
jvp	NN	B-TEST	O
at	IN	O	O
angle	NN	O	O
of	IN	O	O
jaw	NN	O	B-TEST
1/4	CD	O	O
-->	NN	O	O
giving	VBG	O	O
20	CD	B-TREATMENT	O
lasix	NN	I-TREATMENT	B-TREATMENT
;	:	O	O
dig	CC	B-TEST	O
level	VBP	I-TEST	O
1/4	CD	O	O
1.3	CD	O	O
-->	JJ	O	O
1/2	CD	O	O
dose	NN	O	O
as	IN	O	O
on	IN	O	O
amio	NN	B-TREATMENT	B-TREATMENT

elevated	VBN	B-PROBLEM	B-PROBLEM
glu	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
admit	NN	O	O
bmp	NN	B-TEST	O
and	CC	O	O
fsg	NN	B-TEST	B-TREATMENT
also	RB	O	O
concurring	VBG	O	O
-->	NNP	O	O
follow	NN	O	O
and	CC	O	O
lispro	NN	B-TREATMENT	O
;	:	O	O
will	MD	O	O
probably	RB	O	O
need	VB	O	O
w	JJ	B-TEST	O
/	NNP	I-TEST	O
u	NN	I-TEST	O
as	IN	O	O
outpt	NN	O	O

baseline	NN	B-TEST	O
pfts	NNS	I-TEST	O
as	IN	O	O
staring	VBG	O	B-PROBLEM
amio	NN	B-TREATMENT	I-PROBLEM

baseline	NN	B-TEST	B-TEST
lfts	NNS	I-TEST	I-TEST
wnl	VBP	O	O
;	:	O	O
taking	VBG	O	O
cardiac	JJ	B-TREATMENT	O
/	NNP	I-TREATMENT	O
ada	NN	I-TREATMENT	O
diet	NN	I-TREATMENT	O
as	IN	O	O
glu	NN	B-TEST	O
remains	VBZ	O	O
elevated	JJ	B-PROBLEM	B-PROBLEM

baseline	NN	B-TEST	O
cri	NN	I-TEST	O
(	(	O	O
1.2-1.6	JJ	O	O
)	)	O	O
with	IN	O	O
elevation	NN	B-PROBLEM	B-TREATMENT
at	IN	O	O
admission	NN	O	O
probably	RB	O	O
prerenal	JJ	O	O
;	:	O	O
will	MD	O	O
monitor	VB	O	O
bun	JJ	B-TEST	O
/	NNP	O	O
cr	NN	B-TEST	O
after	IN	O	O
giving	VBG	O	O
lasix	NN	B-TREATMENT	B-TREATMENT

ppi	NN	B-TREATMENT	O
and	CC	O	O
pneumoboots	NNS	B-TREATMENT	B-PROBLEM

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
cardiology	NN	O	O
service	NN	O	O
and	CC	O	O
commenced	VBD	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
loading	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

adenosine	JJ	B-TEST	B-TEST
stress	NN	I-TEST	I-TEST
mibi	NN	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
reversible	JJ	I-PROBLEM	I-PROBLEM
defect	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
pda	NN	I-PROBLEM	O
territory	NN	I-PROBLEM	O
and	CC	O	O
the	DT	O	O
patient	JJ	O	O
underwent	JJ	O	O
coronary	JJ	B-TEST	B-TEST
catheterisation	NN	I-TEST	I-TEST
on	IN	O	O
1/6/0004	CD	O	O
which	WDT	O	O
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
70%	CD	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
svg	NN	I-PROBLEM	O
to	TO	I-PROBLEM	O
pda	VB	I-PROBLEM	O
->	NNP	O	O
cypher	NN	B-TREATMENT	O
stented	VBD	I-TREATMENT	O
successfully	RB	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
occasional	JJ	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
extopyon	NN	I-PROBLEM	I-PROBLEM
telemetry	NN	B-TEST	I-PROBLEM
but	CC	O	O
no	DT	O	O
further	JJ	B-PROBLEM	B-PROBLEM
recurrence	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
ventricular	JJ	B-PROBLEM	I-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

during	IN	O	O
his	PRP$	O	O
admission	NN	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
am	VBP	I-TEST	I-TEST
fasting	VBG	I-TEST	I-TEST
glucose	NN	I-TEST	I-TEST
levels	NNS	I-TEST	I-TEST
were	VBD	O	O
intermittently	RB	B-PROBLEM	B-PROBLEM
elevated	VBN	I-PROBLEM	I-PROBLEM
and	CC	O	O
his	PRP$	B-TEST	O
hba1c	NN	I-TEST	O
was	VBD	O	O
greater	JJR	O	O
than	IN	O	O
7	CD	O	O
.	.	O	O

i	NNS	O	O
have	VBP	O	O
explained	VBN	O	O
to	TO	O	O
him	PRP	O	O
that	IN	O	O
he	PRP	O	O
may	MD	O	O
have	VB	O	O
developed	VBN	O	O
some	DT	B-PROBLEM	B-PROBLEM
glucose	JJ	I-PROBLEM	I-PROBLEM
intolerance	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
that	DT	O	O
,	,	O	O
in	IN	O	O
the	DT	O	O
first	JJ	O	O
instance	NN	O	O
,	,	O	O
he	PRP	O	O
should	MD	O	O
see	VB	O	O
his	PRP$	O	O
primary	JJ	O	O
care	NN	O	O
physician	NN	O	O
and	CC	O	O
attempt	JJ	O	B-TREATMENT
dietary	JJ	B-TREATMENT	I-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
the	DT	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
he	PRP	O	O
noticed	VBD	O	O
a	DT	O	B-PROBLEM
small	JJ	O	I-PROBLEM
area	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
erythema	NN	B-PROBLEM	I-PROBLEM
surrounding	VBG	O	O
his	PRP$	B-TREATMENT	O
r	NN	I-TREATMENT	O
antecubital	VBP	I-TREATMENT	O
venous	JJ	I-TREATMENT	B-PROBLEM
access	NN	I-TREATMENT	I-PROBLEM
site	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

this	DT	O	O
will	MD	O	O
be	VB	O	O
treated	VBN	O	O
empirically	RB	O	O
with	IN	O	O
a	DT	O	O
10	CD	O	O
day	NN	O	O
course	NN	O	O
of	IN	O	O
keflex	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

i	NNS	O	O
have	VBP	O	O
instructed	VBN	O	O
him	PRP	O	O
to	TO	O	O
see	VB	O	O
his	PRP$	O	O
pcp	NN	O	O
if	IN	O	O
it	PRP	O	O
does	VBZ	O	O
not	RB	O	O
improve	VB	O	O
in	IN	O	O
a	DT	O	O
few	JJ	O	O
days	NNS	O	O
or	CC	O	O
if	IN	O	O
he	PRP	O	O
develops	VBZ	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

in	IN	O	O
terms	NNS	O	O
of	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
amiodarone	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
he	PRP	O	O
will	MD	O	O
be	VB	O	O
discharged	VBN	O	O
on	IN	O	O
400mg	CD	O	O
po	NNS	O	O
bid	NN	O	O
for	IN	O	O
a	DT	O	O
further	JJ	O	O
7	CD	O	O
days	NNS	O	O
followed	VBN	O	O
by	IN	O	O
400mg	CD	O	O
qd	JJ	O	O
thereafter	RB	O	O
.	.	O	O

i	NNS	O	O
have	VBP	O	O
advised	VBN	O	O
him	PRP	O	O
that	IN	O	O
he	PRP	O	O
must	MD	O	O
not	RB	O	O
drive	VB	O	O
until	IN	O	O
he	PRP	O	O
is	VBZ	O	O
seena	JJ	O	B-PROBLEM
gain	NN	O	I-PROBLEM
in	IN	O	O
clinic	NN	O	O
and	CC	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
device	NN	I-TREATMENT	I-TREATMENT
interrogated	VBD	O	O
.	.	O	O

coumadin	NN	B-TREATMENT	B-TREATMENT

fever	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
left	VBD	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
redness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
dysuria	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
inability	NN	B-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
urinate	VB	I-PROBLEM	I-PROBLEM

transesophageal	NN	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST

62	CD	O	O
year-old	JJ	O	B-TREATMENT
status-post	JJ	O	I-TREATMENT
gastric	JJ	B-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
laprascopic	NN	B-TREATMENT	B-TREATMENT
cholecystectomy	VBP	I-TREATMENT	I-TREATMENT
7	CD	O	O
weeks	NNS	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
who	WP	O	O
presented	VBD	O	O
with	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
left	VBD	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extemity	NN	I-PROBLEM	I-PROBLEM
redness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
multiple	JJ	O	B-PROBLEM
hospitalizations	NNS	O	I-PROBLEM
for	IN	O	I-PROBLEM
lower	JJR	B-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
cellulitis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
noted	VBD	O	O
that	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
the	DT	O	O
appearance	NN	O	O
of	IN	O	O
his	PRP$	O	B-PROBLEM
left	JJ	O	I-PROBLEM
leg	NN	O	I-PROBLEM
mirrored	VBD	O	O
previous	JJ	B-PROBLEM	O
episodes	NNS	I-PROBLEM	O
.	.	O	O

he	PRP	O	O
denied	VBD	O	O
recent	JJ	B-PROBLEM	B-PROBLEM
trauma	NN	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	O
the	DT	I-PROBLEM	O
area	NN	I-PROBLEM	O
or	CC	O	O
travel	NN	O	O
.	.	O	O

review	NN	B-TEST	B-TEST
of	IN	I-TEST	I-TEST
systems	NNS	I-TEST	I-TEST
was	VBD	O	O
significant	JJ	O	O
only	RB	O	O
for	IN	O	O
painful	JJ	B-PROBLEM	B-PROBLEM
urination	NN	I-PROBLEM	I-PROBLEM
over	IN	O	O
the	DT	O	O
past	JJ	O	O
few	JJ	O	O
days	NNS	O	O
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
reduction	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
urine	JJ	I-PROBLEM	I-PROBLEM
output	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
denied	VBD	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
palpitations	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
n/v	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
penile	JJ	B-PROBLEM	O
discharge	NN	I-PROBLEM	O
.	.	O	O

1.	CD	O	O
morbid	NN	B-PROBLEM	B-PROBLEM
obesity	NN	I-PROBLEM	I-PROBLEM

2.	CD	O	O
frequent	JJ	B-PROBLEM	B-PROBLEM
cellulitis	NN	I-PROBLEM	I-PROBLEM

3.	CD	O	O
lymphedema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

4.	CD	O	O
cad	NN	B-PROBLEM	B-PROBLEM
s/p	NN	O	B-TREATMENT
velocity	NN	B-TREATMENT	I-TREATMENT
stenting	VBG	I-TREATMENT	I-TREATMENT
proximal	JJ	I-TREATMENT	I-TREATMENT
lad	NN	I-TREATMENT	I-TREATMENT
2002	CD	O	O

5.	CD	O	O
osteoarthritis	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
knees	NNS	I-PROBLEM	I-PROBLEM

6.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM

7.	CD	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM

8.	CD	O	O
obstructive	JJ	B-PROBLEM	B-PROBLEM
sleep	NN	I-PROBLEM	I-PROBLEM
apnea	NN	I-PROBLEM	I-PROBLEM

9.	CD	O	O
cva	NNS	B-PROBLEM	O
x2	JJ	O	O
with	IN	O	O
left-sided	JJ	B-PROBLEM	B-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM

10.	CD	O	O
gastric	JJ	B-TREATMENT	B-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
7	CD	O	O
weeks	NNS	O	O
pta	NN	O	O

11.	CD	O	O
lap	JJ	B-TREATMENT	B-TREATMENT
cholecystectomy	NN	I-TREATMENT	I-TREATMENT
7	CD	O	O
weeks	NNS	O	O
pta	NN	O	O

vs	NN	B-TEST	O
t	VBZ	O	O
101.4	CD	O	O
bp	NN	B-TEST	O
85/50	CD	O	O
hr	NN	B-TEST	B-TEST
130	CD	O	O

rr	NN	B-TEST	B-TEST
20	CD	O	O
o2	JJ	B-TEST	B-TEST
sat	NN	I-TEST	I-TEST
:	:	O	O
98%	CD	O	O
ra	NN	O	O

gen	NN	O	O
:	:	O	O
obese	JJ	B-PROBLEM	O
male	NN	O	O
,	,	O	O
aaox3	NN	O	O

heent	NN	O	O
:	:	O	O
mm	NN	B-PROBLEM	O
dry	NN	I-PROBLEM	O
,	,	O	O
jvd	NN	B-PROBLEM	O
cannot	NN	O	O
be	VB	O	O
assessed	VBN	O	O

cv	NN	O	O
:	:	O	O
irregularly	RB	B-PROBLEM	B-PROBLEM
irregular	JJ	I-PROBLEM	I-PROBLEM
rhytmm	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
m/r/g	NN	B-PROBLEM	B-PROBLEM

abd	NN	O	O
:	:	O	O
obese	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
nt/nd	JJ	B-PROBLEM	O
,	,	O	O
no	DT	O	O
rebound/guarding	NN	B-PROBLEM	O

ext	NN	O	O
:	:	O	O
3+	CD	B-PROBLEM	O
bilateral	JJ	I-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
lle	CC	B-PROBLEM	O
edema	NN	I-PROBLEM	B-PROBLEM
and	CC	O	O
erythema	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
chords	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
+	NNP	O	O
warmth	NN	B-PROBLEM	O
,	,	O	O
+	NNP	O	O
chronic	VBZ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
negative	JJ	O	O
homens	NNS	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
6.3	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
4.90	CD	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
14.1	CD	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
41.0	CD	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
84	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
28.7	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.4	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
15.0	CD	O	O

neuts	NNS	B-TEST	B-TEST
-	:	O	O
92	CD	O	O
*	NN	O	O
bands	NNS	B-TEST	B-TEST
-	:	O	O
4	CD	O	O
lymphs	SYM	B-TEST	B-TEST
-	:	O	O
2	CD	O	O
*	JJ	O	O
monos	NNS	B-TEST	B-TEST
-	:	O	O
2	CD	O	O
eos	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
basos	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
atyps	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
metas	NNS	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
myelos	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O

plt	NN	B-TEST	B-TEST
smr	SYM	I-TEST	I-TEST
-	:	O	O
normal	JJ	O	O
plt	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
-	:	O	O
143	CD	O	O
*#	NN	O	O

2015-10-10	JJ	O	O
02:16pm	CD	O	O
urine	NN	B-TEST	B-TEST

blood	NN	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
nitrite	JJ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
protein	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
ketone	NN	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
bilirubin	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
urobilngn	JJ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
ph	SYM	B-TEST	B-TEST
-	:	O	O
5.0	CD	O	O
leuk	SYM	B-TEST	B-TEST
-	:	O	O
sm	NN	O	O

calcium	NN	B-TEST	B-TEST
-	:	O	O
9.6	CD	O	O
phosphate	NN	B-TEST	B-TEST
-	:	O	O
0.8	CD	O	O
*#	JJ	O	O
magnesium	NN	B-TEST	B-TEST
-	:	O	O
1.4	CD	O	O
*	NN	O	O

ck-mb	JJ	B-TEST	B-TEST
-	:	O	O
2	CD	O	O
ctropnt	NN	B-TEST	B-TEST
-<	CD	O	O
0.01	CD	O	O

ck(cpk)	SYM	B-TEST	B-TEST
-	:	O	O
109	CD	O	O

lactate	NN	B-TEST	B-TEST
-	:	O	O
2.4	CD	O	O
*	NN	O	O

pt	SYM	B-TEST	B-TEST
-	:	O	O
16.6	CD	O	O
*	NN	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
32.2	CD	O	O
inr(pt)	JJ	B-TEST	O
-	:	O	O
1.7	CD	O	O

albumin	SYM	B-TEST	B-TEST
-	:	O	O
3.0	CD	O	O
*	JJ	O	O
calcium	NN	B-TEST	B-TEST
-	:	O	O
7.6	CD	O	O
*	NN	O	O
phosphate	NN	B-TEST	B-TEST
-	:	O	O
1.6	CD	O	O
*	JJ	O	O
magnesium	NN	B-TEST	B-TEST
-	:	O	O
1.1	CD	O	O
*	NN	O	O

alt(sgpt)	SYM	B-TEST	B-TEST
-	:	O	O
28	CD	O	O
ast(sgot)	SYM	B-TEST	B-TEST
-	:	O	O
27	CD	O	O
ld(ldh)	SYM	B-TEST	B-TEST
-	:	O	O
191	CD	O	O
ck(cpk)	NN	B-TEST	B-TEST
-	:	O	O
58	CD	O	O
alk	NN	B-TEST	B-TEST
phos	NN	I-TEST	I-TEST
-	:	O	O
63	CD	O	O
amylase	NN	B-TEST	B-TEST
-	:	O	O
27	CD	O	O
tot	NN	B-TEST	O
bili	SYM	I-TEST	B-TEST
-	:	O	O
0.9	CD	O	O

lactate	NN	B-TEST	B-TEST
-	:	O	O
1.9	CD	O	O

this	DT	O	O
62	CD	O	O
year-old	JJ	O	O
obese	JJ	O	O
male	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
with	IN	O	O
cellulitis	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
presumed	JJ	O	O
bacteremia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

in	IN	O	O
the	DT	O	O
john	NN	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
in	IN	O	O
hypotensive	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
medical	JJ	O	O
icu	NN	O	O
where	WRB	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
hypotension	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
managed	VBN	O	O
with	IN	O	O
ivf	JJ	B-TREATMENT	B-TREATMENT
hydration	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
maintained	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
diltiazam	NN	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

after	IN	O	O
his	PRP$	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
was	VBD	O	O
controlled	VBN	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
transitioned	VBN	O	O
to	TO	O	O
oral	JJ	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
medicine	NN	O	O
service	NN	O	O
.	.	O	O

1.	CD	O	O
cellulitis	NN	B-PROBLEM	B-PROBLEM
/	NN	O	O
bacteremia	NN	B-PROBLEM	B-PROBLEM

review	NN	O	O
of	IN	O	O
the	DT	O	O
medical	JJ	O	O
record	NN	O	O
revealed	VBD	O	O
several	JJ	O	O
previous	JJ	O	O
admissions	NNS	O	O
for	IN	O	O
cellulitis	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
bacteremia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
on	IN	O	O
this	DT	O	O
admission	NN	O	O
and	CC	O	O
were	VBD	O	O
positive	JJ	O	O
for	IN	O	O
beta	NN	B-PROBLEM	B-PROBLEM
streptococcus	NN	I-PROBLEM	I-PROBLEM
group	NN	I-PROBLEM	O
b	NN	I-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
previous	JJ	O	B-PROBLEM
episodes	NNS	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
same	JJ	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
lower	JJR	B-PROBLEM	B-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
cellulitis	NN	I-PROBLEM	I-PROBLEM
the	DT	O	O
likely	JJ	O	O
source	NN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
left	VBD	I-TEST	I-TEST
lower	JJR	I-TEST	I-TEST
extremity	NN	I-TEST	I-TEST
ultrasound	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
for	IN	O	O
deep	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
thrombosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
too	RB	B-PROBLEM	O
large	JJ	I-PROBLEM	O
to	TO	O	O
have	VB	O	O
a	DT	B-TEST	B-PROBLEM
cta	NN	I-TEST	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
initially	RB	O	O
treated	VBN	O	O
with	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
zosyn	NN	B-TREATMENT	B-TREATMENT
while	IN	O	O
awaiting	VBG	O	O
culture	NN	B-TEST	O
results	NNS	O	O
.	.	O	O

once	RB	O	O
the	DT	B-PROBLEM	O
organism	NN	I-PROBLEM	O
was	VBD	O	O
identified	VBN	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
transitioned	VBN	O	O
to	TO	O	O
a	DT	O	B-TREATMENT
regimen	NN	O	I-TREATMENT
of	IN	O	I-TREATMENT
intravenous	JJ	B-TREATMENT	I-TREATMENT
penicillin	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
oral	JJ	B-TREATMENT	B-TREATMENT
levofloxacin	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
which	WDT	O	O
had	VBD	O	O
successfully	RB	O	B-PROBLEM
treated	VBN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
during	IN	O	O
his	PRP$	O	O
most	RBS	O	O
recent	JJ	O	O
admission	NN	O	O
1	CD	O	O
year	NN	O	O
prior	RB	O	O
.	.	O	O

he	PRP	O	O
completed	VBD	O	O
7	CD	O	O
days	NNS	O	O
of	IN	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
picc	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
placed	VBN	O	O
to	TO	O	O
facilitate	VB	O	O
a	DT	O	O
2	CD	O	O
week	NN	O	O
course	NN	O	O
of	IN	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
penicillin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

2.	CD	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM

the	DT	O	O
patient	NN	O	O
's	POS	O	O
development	NN	O	O
of	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
believed	VBN	O	O
to	TO	O	O
be	VB	O	O
secondary	JJ	O	O
to	TO	O	O
infection	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
structural	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

it	PRP	O	O
was	VBD	O	O
initially	RB	O	O
managed	VBN	O	O
with	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
diltiazam	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
later	RB	O	O
managed	VBN	O	O
with	IN	O	O
metoprolol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
anticoagulation	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

a	DT	B-TEST	B-TEST
transthoracic	NN	I-TEST	I-TEST
echocardiogram	NN	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
mildly	RB	I-PROBLEM	I-PROBLEM
dilated	VBN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
elongated	VBN	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
atrium	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
markedly	RB	I-PROBLEM	I-PROBLEM
dilated	VBN	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
atrium	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
occasional	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
rapid	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
were	VBD	O	O
controlled	VBN	O	O
with	IN	O	O
responded	VBN	O	O
to	TO	O	O
iv	VB	B-TREATMENT	O
metoprolol	NN	I-TREATMENT	B-TREATMENT
.	.	O	O

however	RB	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
proved	VBD	O	O
difficult	JJ	O	O
to	TO	O	O
control	VB	O	O
despite	IN	O	O
metoprolol	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
diltiazam	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

the	DT	O	O
ep	JJ	O	O
service	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
and	CC	O	O
recommended	VBN	O	O
transesophageal	NN	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
and	CC	O	O
cardioversion	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	B-TEST	O
tee	NN	I-TEST	O
was	VBD	O	O
negative	JJ	O	O
for	IN	O	O
thrombus	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
successfully	RB	O	O
cardioverted	VBN	O	O
to	TO	O	O
normal	JJ	O	O
sinus	NNS	O	O
rhythm	VBP	O	O
with	IN	O	O
ibutilide	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
subsequently	RB	O	O
started	VBN	O	O
on	IN	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
is	VBZ	O	O
scheduled	VBN	O	O
to	TO	O	O
complete	VB	O	O
a	DT	O	O
10	CD	O	O
week	NN	O	O
course	NN	O	O
.	.	O	O

ekg	NN	B-TEST	O
before	IN	O	O
discharge	NN	O	O
showed	VBD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
qt	JJ	I-PROBLEM	I-PROBLEM
prolongation	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
no	DT	O	O
effect	NN	O	O
from	IN	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

ekg	NN	B-TEST	O
and	CC	O	O
lfts	NNS	B-TEST	B-TREATMENT
should	MD	O	O
be	VB	O	O
monitored	VBN	O	O
by	IN	O	O
his	PRP$	O	O
pcp	NN	O	O
,	,	O	O
william	VB	O	O
given	VBN	O	O
the	DT	O	O
high	JJ	O	O
dose	NN	O	O
of	IN	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
he	PRP	O	O
will	MD	O	O
receive	VB	O	O
.	.	O	O

he	PRP	O	O
demonstrated	VBD	O	O
several	JJ	B-PROBLEM	B-PROBLEM
asymptomatic	JJ	I-PROBLEM	I-PROBLEM
electrolyte	NN	I-PROBLEM	I-PROBLEM
deficiecies	NNS	I-PROBLEM	I-PROBLEM
;	:	O	O
these	DT	O	O
were	VBD	O	O
likely	RB	O	O
due	JJ	O	O
to	TO	O	O
inadequate	VB	B-PROBLEM	B-PROBLEM
absorption	NN	I-PROBLEM	I-PROBLEM
following	VBG	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
he	PRP	O	O
responded	VBD	O	O
well	RB	O	O
to	TO	O	O
repletion	NN	B-TREATMENT	O
.	.	O	O

vitamin	NN	B-TEST	B-TREATMENT
d	NN	I-TEST	I-TREATMENT
and	CC	O	O
parathyroid	JJ	B-TEST	B-TEST
tests	NNS	I-TEST	I-TEST
were	VBD	O	O
pending	VBG	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
sent	VBN	O	O
with	IN	O	O
a	DT	B-TEST	O
king	NN	I-TEST	O
of	IN	I-TEST	O
hearts	NNS	I-TEST	O
monitor	NN	I-TEST	O
and	CC	O	O
scheduled	VBN	O	O
for	IN	O	O
follow-up	NN	O	O
with	IN	O	O
cardiology	NN	O	O
and	CC	O	O
his	PRP$	O	O
primary	JJ	O	O
care	NN	O	O
physician	NN	O	O
.	.	O	O

1.	CD	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
hcl	NN	I-TREATMENT	I-TREATMENT
400	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	VBP	O	O
one	CD	O	O
tid	NN	O	O
for	IN	O	O
2	CD	O	O
weeks	NNS	O	O
,	,	O	O
then	RB	O	O
1	CD	O	O
qd	NN	O	O
for	IN	O	O
2	CD	O	O
months	NNS	O	O
for	IN	O	O
2	CD	O	O
months	NNS	O	O
:	:	O	O
please	VB	O	O
take	VB	O	O
1	CD	O	O
tablet	NN	O	O
3	CD	O	O
times	NNS	O	O
per	IN	O	O
day	NN	O	O
for	IN	O	O
2	CD	O	O
weeks	NNS	O	O
,	,	O	O
then	RB	O	O
take	VB	O	O
1	CD	O	O
tablet	NNS	O	O
per	IN	O	O
day	NN	O	O
for	IN	O	O
2	CD	O	O
months	NNS	O	O
.	.	O	O

2.	CD	O	O
atorvastatin	JJ	B-TREATMENT	B-TREATMENT
calcium	NN	I-TREATMENT	I-TREATMENT
20	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
qd	NN	O	O
(	(	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

3.	CD	O	O
zolpidem	NN	B-TREATMENT	B-TREATMENT
tartrate	NN	I-TREATMENT	I-TREATMENT
5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
tablets	NNS	O	O
po	VBP	O	O
hs	NN	O	O
(	(	O	O
at	IN	O	O
bedtime	NN	O	O
).	NN	O	O

4.	CD	O	O
potassium	NN	B-TREATMENT	B-TEST
&	CC	I-TREATMENT	I-TEST
sodium	NN	I-TREATMENT	I-TEST
phosphates	NNS	I-TREATMENT	I-TEST
(	(	O	O
875	CD	O	O
)	)	O	O
623	CD	O	O
9797	CD	O	O
mg	NN	O	O
packet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
packet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

5.	CD	O	O
warfarin	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
hs	NN	O	O
(	(	O	O
at	IN	O	O
bedtime	NN	O	O
).	NN	O	O

6.	CD	O	O
penicillin	NN	B-TREATMENT	B-TREATMENT
g	NN	I-TREATMENT	I-TREATMENT
pot	NN	I-TREATMENT	I-TREATMENT
in	IN	I-TREATMENT	I-TREATMENT
dextrose	JJ	I-TREATMENT	I-TREATMENT
2,000,000	CD	O	O
unit	NN	O	O
/	VBD	O	O
50	CD	O	O
ml	NN	O	O
piggyback	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
intravenous	JJ	O	O
q4h	NN	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
hours	NNS	O	O
).	VBP	O	O

7.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
qd	NN	O	O
(	(	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

8.	CD	O	O
acetaminophen	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
tablets	NNS	O	O
po	JJ	O	O
q4-6h	JJ	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
to	TO	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

9.	CD	O	O
pantoprazole	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
40	CD	O	O
mg	NN	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
q24h	NN	O	O
(	(	O	O
every	DT	O	O
24	CD	O	O
hours	NNS	O	O
).	VBP	O	O

10.	CD	O	O
calcium	NN	B-TREATMENT	B-TREATMENT
carbonate	NN	I-TREATMENT	I-TREATMENT
500	CD	O	O
mg	NN	O	O
tablet	NN	O	O
,	,	O	O
chewable	JJ	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
chewable	JJ	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
cellulitis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
bacteremia	NN	B-PROBLEM	B-PROBLEM

please	VB	O	O
take	VB	O	O
all	DT	O	O
over	IN	O	O
your	PRP$	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

return	NN	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
department	NN	O	O
if	IN	O	O
you	PRP	O	O
develop	VBP	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
palpitations	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
lightheadedness	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

please	VB	O	O
call	VB	O	O
dr.	JJ	O	O
pytel	NN	O	O
(	(	O	O
760	CD	O	O
)	)	O	O
496-3627	CD	O	O
and	CC	O	O
make	VB	O	O
a	DT	O	O
follow-up	JJ	O	O
appointment	NN	O	O
for	IN	O	O
1	CD	O	O
week	NN	O	O
,	,	O	O
and	CC	O	O
discuss	VB	O	O
resuming	VBG	O	O
your	PRP$	B-TREATMENT	B-TREATMENT
other	JJ	I-TREATMENT	I-TREATMENT
outpatient	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
at	IN	O	O
that	DT	O	O
time	NN	O	O
.	.	O	O

left	VBN	B-PROBLEM	B-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

left	VBN	B-PROBLEM	B-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	VBP	I-PROBLEM	I-PROBLEM
with	IN	O	O
diabetic	JJ	B-PROBLEM	B-PROBLEM
renopathy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
renovascular	JJ	B-PROBLEM	B-PROBLEM
occlusive	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
thrombosis	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
probably	RB	O	B-PROBLEM
renal	JJ	O	I-PROBLEM
vascular	NN	O	I-PROBLEM
,	,	O	O
hypertensive	JJ	B-PROBLEM	B-PROBLEM
cardiac	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
history	NN	O	O
of	IN	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

03/03/92	CD	O	O
-	:	O	O
left	VBD	B-TREATMENT	B-TREATMENT
carotid	JJ	I-TREATMENT	I-TREATMENT
endarterectomy	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
continuous	JJ	B-TEST	B-TEST
interoperative	JJ	I-TEST	I-TEST
electroencephalogram	NN	I-TEST	I-TEST
monitoring	NN	I-TEST	I-TEST
and	CC	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NNS	I-TREATMENT	I-TREATMENT
patch	VBP	I-TREATMENT	I-TREATMENT
closure	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

sep/24/05	JJ	O	B-TEST
cardiac	JJ	B-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
and	CC	O	O
coronary	JJ	B-TEST	B-TEST
angiography	NN	I-TEST	I-TEST
,	,	O	O
02/23/92	CD	O	O
-	:	O	O
transfemoral	JJ	B-TEST	O
aortogram	NN	I-TEST	O
,	,	O	O
bilateral	JJ	B-TEST	B-TEST
carotid	NN	I-TEST	I-TEST
arteriogram	NN	I-TEST	I-TEST
,	,	O	O
abdominal	JJ	B-TEST	O
aortogram	NN	I-TEST	O
.	.	O	O

patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
72	CD	O	O
year	NN	O	O
old	JJ	O	O
female	NN	O	O
with	IN	O	O
known	VBN	B-PROBLEM	B-PROBLEM
carotid	NN	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
recent	JJ	B-TEST	B-PROBLEM
carotid	NN	I-TEST	I-PROBLEM
noninvasives	NNS	I-TEST	I-PROBLEM
at	IN	O	O
an	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
,	,	O	O
which	WDT	O	O
showed	VBD	O	O
90%	CD	B-PROBLEM	O
left	NNS	I-PROBLEM	O
sided	VBD	I-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
not	RB	O	O
had	VBN	O	O
a	DT	B-PROBLEM	B-PROBLEM
stroke	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
transient	JJ	B-PROBLEM	B-PROBLEM
ischemic	JJ	I-PROBLEM	I-PROBLEM
attack	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
recently	RB	O	O
discharged	VBN	O	O
from	IN	O	O
the	DT	O	O
per	NN	O	O
naplesspecrycet	NN	O	O
hospital	NN	O	O
after	IN	O	O
an	DT	O	O
admission	NN	O	O
for	IN	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

significant	JJ	O	O
for	IN	O	O
having	VBG	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
cholecystectomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
hysterectomy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
tonsillectomy	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
adenoidectomy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
mastoidectomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

insulin	NN	B-TREATMENT	B-TREATMENT
44	CD	O	O
units	NNS	O	O
nph	JJ	B-TREATMENT	O
qam	NN	O	O
;	:	O	O
8	CD	O	O
units	NNS	O	O
qpm	RB	O	O
;	:	O	O
vasotec	JJ	B-TREATMENT	B-TREATMENT
2.5	CD	O	O
qd	NN	O	O
;	:	O	O
lasix	CC	B-TREATMENT	B-TREATMENT
40	CD	O	O
qd	NN	O	O
;	:	O	O
mevacor	CC	B-TREATMENT	O
40	CD	O	O
qd	NN	O	O
;	:	O	O
cardizem	JJ	B-TREATMENT	B-TREATMENT
cd	NN	I-TREATMENT	I-TREATMENT
180	CD	O	O
qd	NN	O	O
;	:	O	O
ciprofloxacin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
urinary	JJ	B-PROBLEM	B-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

seldane	NN	B-TREATMENT	O
causes	VBZ	O	O
gastrointestinal	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

revealed	VBD	O	O
2+	CD	B-TEST	B-PROBLEM
carotid	NN	I-TEST	I-PROBLEM
pulses	NNS	I-TEST	I-PROBLEM
with	IN	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM
,	,	O	O
2+	CD	B-TEST	O
radial	NN	I-TEST	O
,	,	O	O
2+	CD	B-TEST	O
femoral	JJ	I-TEST	O
,	,	O	O
1+	CD	B-TEST	O
dorsalis	NN	I-TEST	B-TEST
pedis	NN	I-TEST	I-TEST
bilaterally	RB	I-TEST	O
.	.	O	O

significant	JJ	O	O
for	IN	O	O
bun	NN	B-TEST	B-TEST
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
33/2.4	CD	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
seen	VBN	O	O
by	IN	O	O
dr.	JJ	O	O
freiermthalskush	NN	O	O
of	IN	O	O
the	DT	O	O
renal	JJ	O	O
service	NN	O	O
for	IN	O	O
management	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
chronic	JJ	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
02/22	CD	O	O
,	,	O	O
she	PRP	O	O
underwent	JJ	O	O
angiography	NN	B-TEST	B-TEST
,	,	O	O
which	WDT	O	O
revealed	VBD	O	O
minimal	JJ	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
internal	JJ	I-PROBLEM	I-PROBLEM
carotid	NN	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
proximal	JJ	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
internal	JJ	I-PROBLEM	I-PROBLEM
carotid	NN	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
2	CD	O	O
cm	NN	O	O
in	IN	O	O
length	NN	O	O
for	IN	O	O
the	DT	O	O
1	CD	O	O
mm	NN	O	O
residual	JJ	O	O
lumen	NNS	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
also	RB	O	O
seen	VBN	O	O
by	IN	O	O
cardiology	NN	O	O
,	,	O	O
and	CC	O	O
she	PRP	O	O
underwent	JJ	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
,	,	O	O
as	IN	O	O
part	NN	O	O
of	IN	O	O
her	PRP$	B-TEST	B-TEST
preop	JJ	I-TEST	I-TEST
evaluation	NN	I-TEST	I-TEST
,	,	O	O
which	WDT	O	O
revealed	VBD	O	O
normal	JJ	O	O
resting	VBG	O	O
hemodynamics	NNS	O	O
,	,	O	O
and	CC	O	O
a	DT	O	B-PROBLEM
moderate	JJ	O	I-PROBLEM
posterior	NN	O	I-PROBLEM
descending	VBG	O	O
artery	NN	O	O
,	,	O	O
and	CC	O	O
obtuse	IN	B-PROBLEM	B-PROBLEM
marginal	JJ	I-PROBLEM	I-PROBLEM
stenoses	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
,	,	O	O
therefore	RB	O	O
,	,	O	O
cleared	VBD	O	O
for	IN	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
,	,	O	O
and	CC	O	O
on	IN	O	O
3/3/92	CD	O	O
,	,	O	O
she	PRP	O	O
underwent	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
left	JJ	I-TREATMENT	I-TREATMENT
carotid	NN	I-TREATMENT	I-TREATMENT
endarterectomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
with	IN	O	O
continuous	JJ	B-TEST	B-TEST
electroencephalogram	NNS	I-TEST	I-TEST
monitoring	NN	I-TEST	I-TEST
and	CC	O	O
vein	JJ	B-TREATMENT	B-TREATMENT
patch	NN	I-TREATMENT	I-TREATMENT
angioplasty	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
which	WDT	O	O
was	VBD	O	O
uneventful	JJ	O	O
.	.	O	O

her	PRP$	O	O
postoperative	JJ	O	O
course	NN	O	O
was	VBD	O	O
marked	VBN	O	O
only	RB	O	O
by	IN	O	O
prolonged	JJ	B-PROBLEM	B-PROBLEM
ileus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
perhaps	RB	O	O
secondary	JJ	O	O
to	TO	O	O
constipation	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
with	IN	O	O
persistent	JJ	B-PROBLEM	B-PROBLEM
vomiting	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
requiring	VBG	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
however	RB	O	O
,	,	O	O
on	IN	O	O
03/07/92	CD	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	O	B-PROBLEM
large	JJ	O	I-PROBLEM
bowel	NN	O	I-PROBLEM
movement	NN	O	I-PROBLEM
,	,	O	O
after	IN	O	O
aggressive	JJ	B-TREATMENT	B-TREATMENT
bowel	NN	I-TREATMENT	I-TREATMENT
regime	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
felt	VBD	O	O
significantly	RB	O	O
better	JJR	O	O
,	,	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
tolerate	VB	O	O
po	JJ	O	O
&apos;s	NN	O	O
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
now	RB	O	O
able	JJ	O	O
to	TO	O	O
be	VB	O	O
discharged	VBN	O	O
home	NN	O	O
on	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
admission	NN	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
with	IN	O	O
the	DT	O	O
exception	NN	O	O
of	IN	O	O
the	DT	O	O
fact	NN	O	O
that	IN	O	O
vasotec	NN	B-TREATMENT	O
was	VBD	O	O
increased	VBN	O	O
to	TO	O	O
10	CD	O	O
mg	NNS	O	O
po	JJ	O	O
bid	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
30	CD	O	O
and	CC	O	O
08-01	JJ	O	O
week	NN	O	O
gestation	NN	O	O
female	NN	O	O
,	,	O	O
triplet	VB	O	O
number	NN	O	O
two	CD	O	O
,	,	O	O
delivered	VBN	O	O
by	IN	O	O
cesarean	JJ	B-TREATMENT	B-TREATMENT
section	NN	I-TREATMENT	I-TREATMENT
due	JJ	O	O
to	TO	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
preterm	JJ	I-PROBLEM	I-PROBLEM
labor	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
triplet	NN	B-PROBLEM	I-PROBLEM
gestation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

prenatal	JJ	B-TEST	O
screen	NN	I-TEST	O
,	,	O	O
o	RB	O	O
positive	JJ	O	O
,	,	O	O
antibody	JJ	B-TEST	B-TEST
negative	JJ	O	O
,	,	O	O
rpr	JJ	B-TEST	O
nonreactive	JJ	O	O
,	,	O	O
hepatitis	NN	B-TEST	B-TEST
b	NN	I-TEST	I-TEST
surface	NN	I-TEST	I-TEST
antigen	NN	I-TEST	I-TEST
negative	JJ	O	O
,	,	O	O
reportedly	RB	O	O
gbs	JJ	B-TEST	B-TEST
negative	JJ	O	O
,	,	O	O
rubella	JJ	B-TEST	B-TEST
immune	NN	O	O
.	.	O	O

pregnancy	NN	O	O
complicated	VBN	O	O
by	IN	O	O
gestational	JJ	B-PROBLEM	B-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
mellitus	VBP	I-PROBLEM	I-PROBLEM
,	,	O	O
then	RB	O	O
possible	JJ	O	O
preterm	JJ	B-PROBLEM	B-PROBLEM
labor	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mother	RB	O	O
presented	VBN	O	O
with	IN	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
discomfort	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
vaginal	JJ	B-PROBLEM	B-TEST
pressure	NN	I-PROBLEM	I-TEST
at	IN	O	O
23	CD	O	O
and	CC	O	O
1/7	CD	O	O
weeks	NNS	O	O
.	.	O	O

at	IN	O	O
that	DT	O	O
time	NN	O	O
she	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
and	CC	O	O
received	VBN	O	O
a	DT	B-TREATMENT	O
full	JJ	I-TREATMENT	O
course	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
betamethasone	NN	I-TREATMENT	B-TREATMENT
at	IN	O	O
24	CD	O	O
weeks	NNS	O	O
and	CC	O	O
remained	VBD	O	O
in	IN	O	O
house	NN	O	O
until	IN	O	O
delivery	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

mother	RB	O	O
presented	VBN	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
delivery	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
preterm	JJ	B-PROBLEM	B-PROBLEM
labor	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
cervical	JJ	B-PROBLEM	B-PROBLEM
dilation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
therefore	RB	O	O
delivered	VBN	O	O
by	IN	O	O
repeat	NN	B-TREATMENT	B-TREATMENT
cesarean	JJ	I-TREATMENT	I-TREATMENT
section	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

this	DT	O	O
triplet	NN	O	O
required	VBN	O	O
only	RB	O	O
blow	VB	B-TREATMENT	O
by	IN	I-TREATMENT	O
oxygen	NN	I-TREATMENT	B-TREATMENT
and	CC	O	O
routine	JJ	B-TREATMENT	B-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
delivery	NN	O	O
room	NN	O	O
.	.	O	O

apgars	NNS	B-TEST	B-TEST
were	VBD	O	O
8	CD	O	O
at	IN	O	O
one	CD	O	O
minute	NN	O	O
and	CC	O	O
9	CD	O	O
at	IN	O	O
five	CD	O	O
minutes	NNS	O	O
.	.	O	O

infant	NN	O	O
demonstrated	VBD	O	O
mild	NNS	B-PROBLEM	B-PROBLEM
increased	VBD	I-PROBLEM	I-PROBLEM
work	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breathing	VBG	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
delivery	NN	O	O
room	NN	O	O
.	.	O	O

infant	NN	O	O
transported	VBD	O	O
to	TO	O	O
neonatal	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
on	IN	O	O
facial	JJ	B-TREATMENT	B-TREATMENT
cpap	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

birth	NN	B-TEST	B-TEST
weight	NN	I-TEST	I-TEST
1455	CD	O	O
grams	NN	O	O
(	(	O	O
50th	CD	O	O
percentile	NN	O	B-TEST
),	JJ	O	I-TEST
head	NN	B-TEST	I-TEST
circumference	NN	I-TEST	I-TEST
29.25	CD	O	O
cm	NN	O	O
(	(	O	O
50th	CD	O	O
percentile	NN	O	O
),	NN	O	O
length	NN	B-TEST	B-TEST
41.5	CD	O	O
cm	NN	O	O
(	(	O	O
50th	CD	O	O
percentile	NN	O	O
).	NN	O	O

nondysmorphic	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
overall	JJ	O	O
appearance	NN	O	O
consistent	NN	O	O
with	IN	O	O
gestational	JJ	O	O
age	NN	O	O
.	.	O	O

anterior	JJ	O	O
fontanel	NN	O	O
soft	JJ	O	O
,	,	O	O
open	JJ	O	O
,	,	O	O
flat	JJ	O	O
,	,	O	O
red	JJ	B-TEST	B-TEST
reflex	JJ	I-TEST	I-TEST
present	NN	O	I-TEST
bilaterally	RB	O	O
,	,	O	O
palate	JJ	O	O
intact	NN	O	O
.	.	O	O

intermittent	NN	B-PROBLEM	B-PROBLEM
grunting	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
intercostal	JJ	I-PROBLEM	I-PROBLEM
retractions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
diminished	VBD	B-PROBLEM	B-PROBLEM
air	NN	I-PROBLEM	I-PROBLEM
entry	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
without	IN	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
2+	CD	O	O
femoral	JJ	B-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
.	.	O	O

abdomen	NNS	O	O
benign	VBP	O	O
with	IN	O	O
no	DT	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
admission	NN	O	O
the	DT	O	O
infant	NN	O	O
required	VBN	O	O
cpap	RB	B-TREATMENT	B-TREATMENT
6	CD	O	O
cm	NN	O	O
of	IN	O	O
water	NN	O	O
,	,	O	O
30%	CD	B-TREATMENT	B-TREATMENT
oxygen	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

initial	JJ	B-TEST	B-TEST
capillary	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
gas	NN	I-TEST	I-TEST
was	VBD	O	O
ph	JJ	B-TEST	O
7.29	CD	O	O
,	,	O	O
co2	NN	B-TEST	B-TEST
47	CD	O	O
.	.	O	O

infant	NN	O	O
was	VBD	O	O
intubated	VBN	B-TREATMENT	B-TREATMENT
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
two	CD	O	O
for	IN	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
received	VBD	O	O
one	CD	O	O
dose	NN	O	O
of	IN	O	O
surfactant	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

infant	NN	O	O
was	VBD	O	O
extubated	VBN	B-TREATMENT	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
four	CD	O	O
to	TO	O	O
cpap	VB	B-TREATMENT	O
and	CC	O	O
transitioned	VBN	O	O
to	TO	O	O
room	NN	O	O
air	NN	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
six	CD	O	O
.	.	O	O

caffeine	NN	B-TREATMENT	B-TREATMENT
citrate	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
six	CD	O	O
and	CC	O	O
was	VBD	O	O
discontinued	VBN	O	O
on	IN	O	O
05-23	JJ	O	O
(	(	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
18	CD	O	O
).	NN	O	O

the	DT	B-PROBLEM	B-TEST
last	JJ	I-PROBLEM	I-TEST
apnea	NN	I-PROBLEM	I-TEST
and	CC	O	O
bradycardia	NN	B-PROBLEM	B-PROBLEM
was	VBD	O	O
on	IN	O	O
06-10	NN	O	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
has	VBZ	O	O
remained	VBN	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
throughout	IN	O	O
this	DT	O	O
hospitalization	NN	O	O
,	,	O	O
no	DT	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
150	CD	O	O
to	TO	O	O
160	CD	O	O
,	,	O	O
mean	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
40	CD	O	O
to	TO	O	O
54	CD	O	O
.	.	O	O

infant	NN	O	O
was	VBD	O	O
initially	RB	O	O
nothing	NN	B-TREATMENT	O
by	IN	I-TREATMENT	O
mouth	NN	I-TREATMENT	O
receiving	VBG	O	O
80	CD	O	O
cc	JJ	O	O
per	IN	O	O
kilogram	FW	O	O
per	IN	O	O
day	NN	O	O
of	IN	O	O
d10w	NN	B-TREATMENT	B-TREATMENT
intravenously	RB	I-TREATMENT	I-TREATMENT
.	.	O	O

infant	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
enteral	JJ	B-TREATMENT	B-TREATMENT
feedings	NNS	I-TREATMENT	I-TREATMENT
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
four	CD	O	O
and	CC	O	O
advanced	VBD	O	O
to	TO	O	O
full	JJ	O	B-TREATMENT
volume	NN	O	I-TREATMENT
feedings	NNS	O	I-TREATMENT
of	IN	O	O
150	CD	O	O
cc	NNS	O	O
per	IN	O	O
kilogram	FW	O	O
per	IN	O	O
day	NN	O	O
by	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
seven	CD	O	O
.	.	O	O

during	IN	O	O
feeding	VBG	B-TREATMENT	O
advancement	JJ	I-TREATMENT	O
infant	NN	O	O
was	VBD	O	O
given	VBN	O	O
parenteral	JJ	B-TREATMENT	B-TREATMENT
nutrition	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
intralipids	NNS	B-TREATMENT	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
tolerated	VBD	O	O
feeding	JJ	B-TREATMENT	O
advancement	NN	I-TREATMENT	O
without	IN	O	O
difficulty	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

infant	NN	O	O
was	VBD	O	O
advanced	VBN	O	O
to	TO	O	O
maximum	VB	O	O
caloric	JJ	O	B-TEST
density	NN	O	I-TEST
of	IN	O	I-TEST
breast	NN	O	I-TEST
milk	NN	O	I-TEST
or	CC	O	O
premature	NN	B-TREATMENT	B-PROBLEM
enfamil	VBP	I-TREATMENT	O
26	CD	O	O
calories	NNS	O	O
per	IN	O	O
ounce	NN	O	O
with	IN	O	O
promod	JJ	B-TREATMENT	O
by	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
11	CD	O	O
.	.	O	O

infant	NN	O	O
is	VBZ	O	O
currently	RB	O	O
on	IN	O	O
breast	NN	O	B-TREATMENT
milk	NN	O	I-TREATMENT
or	CC	O	O
enfamil	JJ	B-TREATMENT	B-TREATMENT
24	CD	O	O
calories	NNS	O	O
per	IN	O	O
ounce	NN	O	O
po	NN	O	O
minimum	JJ	O	O
140	CD	O	O
cc	NN	O	O
per	IN	O	O
kilogram	FW	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

the	DT	B-TEST	O
most	RBS	I-TEST	O
recent	JJ	I-TEST	O
weight	NN	I-TEST	O
is	VBZ	O	O
2525	CD	O	O
g.	NN	O	O

head	NN	B-TEST	B-TEST
circumference	NN	I-TEST	I-TEST
24.5	CD	O	O
cm	NN	O	O
,	,	O	O
length	VBZ	B-TEST	B-TEST
45.5	CD	O	O
cm	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
most	RBS	I-TEST	I-TEST
recent	JJ	I-TEST	I-TEST
electrolytes	NNS	I-TEST	I-TEST
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
five	CD	O	O
were	VBD	O	O
sodium	NN	B-TEST	B-TEST
145	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
115	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4	CD	O	O
,	,	O	O
tco2	NN	B-TEST	O
of	IN	O	O
21	CD	O	O
.	.	O	O

on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
25	CD	O	O
,	,	O	O
calcium	NN	B-TEST	B-TEST
10.1	CD	O	O
,	,	O	O
phosphorus	NN	B-TEST	B-TEST
6.9	CD	O	O
,	,	O	O
alkaline	JJ	B-TEST	B-TEST
phosphatase	NN	I-TEST	I-TEST
341	CD	O	O
.	.	O	O

infant	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
double	JJ	B-TREATMENT	B-TREATMENT
phototherapy	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
two	CD	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
maximum	JJ	I-TEST	I-TEST
bilirubin	JJ	I-TEST	I-TEST
level	NN	I-TEST	I-TEST
of	IN	O	O
8.1	CD	O	O
with	IN	O	O
a	DT	B-TEST	O
direct	NN	I-TEST	O
of	IN	O	O
0.3	CD	O	O
.	.	O	O

infant	NN	O	O
decreased	VBD	O	O
to	TO	O	O
single	JJ	B-TREATMENT	O
phototherapy	NN	I-TREATMENT	B-TREATMENT
and	CC	O	O
phototherapy	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
six	CD	O	O
.	.	O	O

rebound	NN	B-TEST	B-TEST
bilirubin	VBZ	I-TEST	I-TEST
level	NN	I-TEST	I-TEST
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
seven	CD	O	O
was	VBD	O	O
5.3	CD	O	O
with	IN	O	O
a	DT	B-TEST	O
direct	NN	I-TEST	O
of	IN	O	O
0.3	CD	O	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
did	VBD	O	O
not	RB	O	O
receive	VB	O	O
any	DT	B-TREATMENT	B-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
this	DT	B-TREATMENT	I-TREATMENT
hospitalization	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	B-TEST	O
most	RBS	I-TEST	O
recent	JJ	I-TEST	O
hematocrit	NN	I-TEST	B-TEST
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
two	CD	O	O
was	VBD	O	O
47%	CD	O	O
.	.	O	O

cbc	NN	B-TEST	B-TEST
on	IN	O	O
admission	NN	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
8.9	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
47%	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
243,000	CD	O	O
,	,	O	O
6%	CD	O	O
neutrophils	NNS	B-TEST	B-TEST
,	,	O	O
0	CD	O	O
bands	NNS	B-TEST	B-TEST
.	.	O	O

repeat	NN	B-TEST	B-TEST
cbc	NNS	I-TEST	I-TEST
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
two	CD	O	O
showed	VBD	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
8.4	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
95	CD	O	O
,	,	O	O
41%	CD	O	O
neutrophils	NNS	B-TEST	B-TEST
,	,	O	O
0	CD	O	O
bands	NNS	B-TEST	B-TEST
.	.	O	O

repeat	NN	B-TEST	B-TEST
platelet	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
three	CD	O	O
was	VBD	O	O
229	CD	O	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
received	VBD	O	O
48	CD	O	O
hours	NNS	O	O
of	IN	O	O
ampicillin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
rule	NN	O	O
out	IN	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
remained	VBD	O	O
negative	JJ	O	O
to	TO	O	O
date	NN	O	O
.	.	O	O

infant	NN	O	O
has	VBZ	O	O
not	RB	O	O
had	VBN	O	O
any	DT	B-PROBLEM	O
issues	NNS	I-PROBLEM	O
with	IN	I-PROBLEM	O
sepsis	NN	I-PROBLEM	B-PROBLEM
this	DT	B-TREATMENT	I-PROBLEM
hospitalization	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

head	NN	B-TEST	B-TEST
ultrasound	NN	I-TEST	I-TEST
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
seven	CD	O	O
showed	VBD	O	O
no	DT	O	O
intraventricular	JJ	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
ultrasound	NN	I-TEST	I-TEST
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
33	CD	O	O
06-07	NN	O	O
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
slight	JJ	I-PROBLEM	I-PROBLEM
increase	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
echogenicity	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
caudothalamic	JJ	I-PROBLEM	I-PROBLEM
groove	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
may	MD	O	O
represent	VB	O	O
tiny	JJ	B-PROBLEM	B-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
germinal	JJ	I-PROBLEM	I-PROBLEM
matrix	NN	I-PROBLEM	I-PROBLEM
hemorrhages	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
periventricular	JJ	B-PROBLEM	B-PROBLEM
leukomalacia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
ultrasound	NN	I-TEST	I-TEST
is	VBZ	O	O
recommended	VBN	O	O
in	IN	O	O
one	CD	O	O
month	NN	O	O
.	.	O	O

sensory	NN	B-TEST	O
,	,	I-TEST	O
hearing	VBG	I-TEST	B-TEST
screening	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
with	IN	O	O
automated	JJ	O	O
auditory	NN	O	O
brain	NN	O	O
stem	NN	O	O
responses	NNS	O	O
.	.	O	O

ophthalmology	NN	O	O
,	,	O	O
eyes	NNS	O	O
examined	VBD	O	O
most	JJS	O	O
recently	RB	O	O
on	IN	O	O
05-30	JJ	O	O
revealing	JJ	O	O
immaturity	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
retinal	JJ	I-PROBLEM	I-PROBLEM
vessels	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
no	DT	O	O
rop	NN	B-PROBLEM	B-PROBLEM
as	IN	O	O
of	IN	O	O
yet	RB	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
follow	JJ	I-TEST	I-TEST
up	RP	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
should	MD	O	O
be	VB	O	O
scheduled	VBN	O	O
for	IN	O	O
the	DT	O	O
week	NN	O	O
of	IN	O	O
06-20	NN	O	O
.	.	O	O

feedings	NNS	O	B-TREATMENT
breast	VBP	O	I-TREATMENT
milk	NN	O	I-TREATMENT
or	CC	O	O
enfamil	JJ	B-TREATMENT	B-TREATMENT
24	CD	O	O
calories	NNS	O	O
per	IN	O	O
ounce	NN	O	O
,	,	O	O
breast	NN	O	B-TREATMENT
milk	NN	O	I-TREATMENT
mixed	VBN	O	O
with	IN	O	O
4	CD	O	O
calories	NNS	O	O
per	IN	O	O
ounce	NN	O	O
of	IN	O	O
enfamil	JJ	B-TREATMENT	B-TREATMENT
powder	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
minimum	NN	O	O
of	IN	O	O
140	CD	O	O
cc	NNS	O	O
per	IN	O	O
kilogram	FW	O	O
per	IN	O	O
day	NN	O	O
po	NN	O	O
.	.	O	O

ferrous	JJ	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mg	NN	O	O
per	IN	O	O
ml	NN	O	O
,	,	O	O
2	CD	O	O
mg	NN	O	O
per	IN	O	O
kilogram	FW	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

car	NN	B-TEST	B-TEST
seat	NN	I-TEST	I-TEST
position	NN	I-TEST	I-TEST
screening	VBG	I-TEST	I-TEST
passed	VBN	O	O
on	IN	O	O
06-07	NN	O	O
.	.	O	O

hearing	VBG	B-TEST	B-TEST
screen	NN	I-TEST	I-TEST
passed	VBN	O	O
on	IN	O	O
2016-06-07	JJ	O	O
.	.	O	O

state	NN	B-TEST	B-TEST
newborn	JJ	I-TEST	I-TEST
screens	NNS	I-TEST	I-TEST
were	VBD	O	O
sent	VBN	O	O
on	IN	O	O
05-08	JJ	O	O
and	CC	O	O
05-19	JJ	O	O
.	.	O	O

no	DT	O	O
abnormal	JJ	B-PROBLEM	B-PROBLEM
results	NNS	I-PROBLEM	I-PROBLEM
have	VBP	O	O
been	VBN	O	O
reported	VBN	O	O
.	.	O	O

immunizations	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
the	DT	O	O
infant	NN	O	O
received	VBD	O	O
hepatitis	NN	B-TREATMENT	B-TREATMENT
b	NN	I-TREATMENT	I-TREATMENT
vaccine	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
2016-06-02	JJ	O	O
.	.	O	O

immunizations	NNS	B-TREATMENT	B-TREATMENT
recommended	VBD	O	O
,	,	O	O
synagis	JJ	B-TREATMENT	B-TREATMENT
rsv	NN	I-TREATMENT	I-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
should	MD	O	O
be	VB	O	O
considered	VBN	O	O
from	IN	O	O
october	VBN	O	O
through	IN	O	O
april	NN	O	O
for	IN	O	O
infants	NNS	O	O
who	WP	O	O
meet	VBP	O	O
any	DT	O	O
of	IN	O	O
the	DT	O	O
following	JJ	O	O
three	CD	O	O
criteria	NNS	O	O
,	,	O	O
born	VBN	O	O
at	IN	O	O
less	JJR	O	O
then	RB	O	O
32	CD	O	O
weeks	NNS	O	O
,	,	O	O
born	VBN	O	O
between	IN	O	O
32	CD	O	O
and	CC	O	O
35	CD	O	O
weeks	NNS	O	O
with	IN	O	O
two	CD	O	O
of	IN	O	O
three	CD	O	O
of	IN	O	O
the	DT	O	O
following	JJ	O	O
,	,	O	O
day	NN	O	O
care	NN	O	O
during	IN	O	O
rsv	NN	O	O
season	NN	O	O
,	,	O	O
smoker	NN	O	O
on	IN	O	O
the	DT	O	O
household	NN	O	O
,	,	O	O
neuromuscular	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	I-PROBLEM
airway	JJ	B-PROBLEM	I-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
or	CC	O	O
school	NN	O	O
age	NN	O	O
siblings	NNS	O	O
or	CC	O	O
with	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

influenza	JJ	B-TREATMENT	B-TREATMENT
immunization	NN	I-TREATMENT	I-TREATMENT
is	VBZ	O	O
recommended	VBN	O	O
annually	RB	O	O
in	IN	O	O
the	DT	O	O
fall	NN	O	O
for	IN	O	O
all	DT	O	O
infants	NNS	O	O
once	IN	O	O
they	PRP	O	O
reach	VBP	O	O
six	CD	O	O
months	NNS	O	O
of	IN	O	O
age	NN	O	O
.	.	O	O

before	IN	O	O
this	DT	O	O
age	NN	O	O
and	CC	O	O
for	IN	O	O
the	DT	O	O
first	JJ	O	O
24	CD	O	O
months	NNS	O	O
of	IN	O	O
the	DT	O	B-TREATMENT
child	NN	O	I-TREATMENT
's	POS	O	I-TREATMENT
life	NN	O	I-TREATMENT
immunization	NN	B-TREATMENT	I-TREATMENT
against	IN	O	O
influenza	NN	B-PROBLEM	B-PROBLEM
is	VBZ	O	O
recommended	VBN	O	O
for	IN	O	O
household	NN	O	O
contacts	NNS	O	O
and	CC	O	O
out	IN	O	O
of	IN	O	O
home	NN	O	O
caregivers	NNS	O	O
.	.	O	O

1.	CD	O	O
prematurity	NN	B-PROBLEM	B-PROBLEM
triplet	NN	O	O
number	NN	O	O
two	CD	O	O
.	.	O	O

2.	CD	O	O
status	NN	O	O
post	NN	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
status	NN	O	O
post	NN	O	O
rule	NN	O	O
out	IN	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
ruled	VBD	O	O
out	RP	O	O
.	.	O	O

4.	CD	O	O
status	NN	O	O
post	NN	O	O
apnea	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
prematurity	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

5.	CD	O	O
status	NN	O	O
post	NN	O	O
indirect	JJ	B-PROBLEM	B-PROBLEM
hyperbilirubinemia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

osteochondromatosis	NN	B-PROBLEM	B-PROBLEM
,	,	I-PROBLEM	O
right	JJ	I-PROBLEM	B-PROBLEM
knee	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

osteochondromatosis	NN	B-PROBLEM	B-PROBLEM
,	,	I-PROBLEM	O
right	JJ	I-PROBLEM	B-PROBLEM
knee	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
68	CD	O	O
year	NN	O	O
old	JJ	O	O
white	JJ	O	O
male	NN	O	O
who	WP	O	O
had	VBD	O	O
a	DT	O	O
seven	CD	O	O
to	TO	O	O
eight	CD	O	O
year	NN	O	O
history	NN	O	O
of	IN	O	O
knee	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

in	IN	O	O
1984	CD	O	O
,	,	O	O
he	PRP	O	O
had	VBD	O	O
the	DT	O	O
right	JJ	O	O
knee	NN	O	O
aspirated	VBD	O	O
and	CC	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
some	DT	O	B-PROBLEM
uric	JJ	B-PROBLEM	I-PROBLEM
acid	NN	I-PROBLEM	I-PROBLEM
crystals	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
although	IN	O	O
serum	JJ	B-TEST	B-TEST
uric	JJ	I-TEST	I-TEST
acid	NN	I-TEST	I-TEST
was	VBD	O	O
normal	JJ	O	O
and	CC	O	O
erythrocyte	JJ	B-TEST	B-TEST
sedimentation	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
.	.	O	O

he	PRP	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
intermittent	NN	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
some	DT	B-PROBLEM	B-PROBLEM
fullness	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
suprapatellar	JJ	I-PROBLEM	I-PROBLEM
pouch	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

plain	NN	B-TEST	O
films	NNS	I-TEST	O
taken	VBN	O	O
by	IN	O	O
his	PRP$	O	O
orthopedist	NN	O	O
in	IN	O	O
mongcana	NN	O	O
ster	NN	O	O
staarv	NN	O	O
revealed	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
soft	JJ	I-PROBLEM	I-PROBLEM
tissue	NN	I-PROBLEM	I-PROBLEM
calcification	NN	I-PROBLEM	I-PROBLEM
within	IN	O	O
the	DT	O	O
medial	JJ	O	O
and	CC	O	O
lateral	JJ	O	O
compartments	NNS	O	O
of	IN	O	O
the	DT	O	O
joint	JJ	O	O
.	.	O	O

an	DT	B-TEST	B-TEST
magnetic	JJ	I-TEST	I-TEST
resonance	NN	I-TEST	I-TEST
imaging	NN	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
demonstrated	VBD	O	O
calcification	NN	B-PROBLEM	B-PROBLEM
densities	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
suprapatellar	JJ	I-PROBLEM	I-PROBLEM
bursa	NN	I-PROBLEM	I-PROBLEM
region	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
also	RB	O	O
with	IN	O	O
hypertrophia	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
synovium	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
synovial	JJ	B-PROBLEM	B-PROBLEM
chondromatosis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
would	MD	O	O
benefit	VB	O	O
from	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
open	JJ	I-TREATMENT	I-TREATMENT
synovectomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
debridement	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
that	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
had	VBD	O	O
tonsillectomy	VBN	B-TREATMENT	B-TREATMENT
at	IN	O	O
the	DT	O	O
age	NN	O	O
of	IN	O	O
five	CD	O	O
,	,	O	O
and	CC	O	O
appendectomy	NN	B-TREATMENT	B-TREATMENT
in	IN	O	O
1940	CD	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
right	JJ	B-TREATMENT	B-PROBLEM
knee	NN	I-TREATMENT	I-PROBLEM
aspirations	NNS	I-TREATMENT	I-PROBLEM
done	VBN	O	O
in	IN	O	O
1986	CD	O	O
,	,	O	O
otherwise	RB	O	O
,	,	O	O
he	PRP	O	O
does	VBZ	O	O
not	RB	O	O
suffer	VB	O	O
from	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
other	JJ	I-PROBLEM	I-PROBLEM
medical	JJ	I-PROBLEM	I-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
general	JJ	I-TEST	I-TEST
physical	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
did	VBD	O	O
not	RB	O	O
reveal	VB	O	O
any	DT	B-PROBLEM	B-PROBLEM
abnormality	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

heart	NN	B-TEST	O
,	,	I-TEST	O
chest	NN	I-TEST	O
,	,	I-TEST	O
and	CC	I-TEST	O
abdominal	JJ	I-TEST	B-TEST
examinations	NNS	I-TEST	I-TEST
were	VBD	O	O
normal	JJ	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
right	JJ	I-TEST	I-TEST
knee	NN	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
showed	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
peripheral	JJ	I-TEST	I-TEST
pulses	NNS	I-TEST	I-TEST
were	VBD	O	O
palpable	JJ	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
44.4	CD	O	O
,	,	O	O
with	IN	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
11.9	CD	O	O
,	,	O	O
and	CC	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
410	CD	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
mcv	NN	I-TEST	I-TEST
was	VBD	O	O
92	CD	O	O
,	,	O	O
mch	FW	B-TEST	B-TEST
32.1	CD	O	O
,	,	O	O
and	CC	O	O
mche	$	B-TEST	O
34.8	CD	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
did	VBD	O	O
not	RB	O	O
reveal	VB	O	O
any	DT	B-PROBLEM	B-PROBLEM
abnormality	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
showed	VBD	O	O
nonspecific	JJ	B-PROBLEM	B-PROBLEM
t-wave	JJ	I-PROBLEM	I-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
otherwise	RB	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
normal	JJ	O	O
.	.	O	O

he	PRP	O	O
underwent	VBD	O	O
right	JJ	B-TREATMENT	B-TREATMENT
knee	NN	I-TREATMENT	I-TREATMENT
open	JJ	I-TREATMENT	I-TREATMENT
synovectomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
debridement	NN	B-TREATMENT	B-TREATMENT
of	IN	O	I-TREATMENT
synovial	JJ	B-PROBLEM	I-TREATMENT
chondromatosis	NN	I-PROBLEM	I-TREATMENT
on	IN	O	O
10-28-93	JJ	O	O
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
mobilized	VBN	O	O
with	IN	O	O
the	DT	O	O
help	NN	O	O
of	IN	O	O
physical	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
continuous	JJ	I-TREATMENT	I-TREATMENT
passive	JJ	I-TREATMENT	I-TREATMENT
motion	NN	I-TREATMENT	I-TREATMENT
machine	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
on	IN	O	O
pain	NN	B-TREATMENT	B-TREATMENT
medication	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
also	RB	O	O
on	IN	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
but	CC	O	O
now	RB	O	O
he	PRP	O	O
can	MD	O	O
manage	VB	O	O
without	IN	O	O
the	DT	O	O
percocet	NN	B-TREATMENT	O
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
which	WDT	O	O
is	VBZ	O	O
to	TO	O	O
be	VB	O	O
continued	VBN	O	O
for	IN	O	O
six	CD	O	O
weeks	NNS	O	O
.	.	O	O

percocet	JJ	B-TREATMENT	B-TREATMENT
1-2	JJ	O	O
po	NN	O	O
q4h	NN	O	O
prn	NN	O	O
.	.	O	O

on	IN	O	O
discharge	NN	O	O
,	,	O	O
he	PRP	O	O
is	VBZ	O	O
mobilized	VBN	O	O
,	,	O	O
partial	JJ	O	B-TEST
weight	NN	O	I-TEST
bearing	VBG	O	O
with	IN	O	O
the	DT	O	O
help	NN	O	O
of	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
walker	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

neuropathic	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

post	NN	B-PROBLEM	O
thoracotomy	NN	I-PROBLEM	B-TREATMENT
syndrome	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
spinal	JJ	I-TREATMENT	I-TREATMENT
cord	NN	I-TREATMENT	I-TREATMENT
stimulator	NN	I-TREATMENT	I-TREATMENT
trial	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
07/21/99	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
an	DT	B-TREATMENT	B-PROBLEM
epidural	JJ	I-TREATMENT	I-PROBLEM
trial	NN	I-TREATMENT	I-PROBLEM
on	IN	O	O
07/24/99	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
65	CD	O	O
year	NN	O	O
old	JJ	O	O
female	NN	O	O
with	IN	O	O
post	NN	B-PROBLEM	O
thoracotomy	NN	I-PROBLEM	B-TREATMENT
syndrome	NN	I-PROBLEM	I-TREATMENT
that	WDT	O	O
occurred	VBD	O	O
on	IN	O	O
the	DT	O	O
site	NN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-TREATMENT
thoracotomy	JJ	I-PROBLEM	I-TREATMENT
incision	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
thoracic	JJ	I-PROBLEM	I-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
repaired	VBN	O	O
in	IN	O	O
the	DT	O	O
past	JJ	O	O
and	CC	O	O
subsequently	RB	O	O
developed	VBD	O	O
neuropathic	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
at	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
site	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
currently	RB	O	O
on	IN	O	O
vicodin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
one	CD	O	O
to	TO	O	O
two	CD	O	O
tablets	NNS	O	O
every	DT	O	O
four	CD	O	O
hours	NNS	O	O
p.r.n.	RB	O	O
,	,	O	O
fentanyl	JJ	B-TREATMENT	B-TREATMENT
patch	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mcg	NN	O	O
an	DT	O	O
hour	NN	O	O
,	,	O	O
change	NN	O	O
of	IN	O	O
patch	NN	O	O
every	DT	O	O
72	CD	O	O
hours	NNS	O	O
,	,	O	O
elavil	VBP	B-TREATMENT	B-TREATMENT
50	CD	O	O
mgq	JJ	O	O
.h.s.	NN	O	O
,	,	O	O
neurontin	RB	B-TREATMENT	B-TREATMENT
600	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
t.i.d.	NN	O	O
with	IN	O	O
still	RB	O	O
what	WP	O	O
she	PRP	O	O
reports	VBZ	O	O
as	IN	O	O
stabbing	VBG	B-PROBLEM	B-PROBLEM
left-sided	JJ	I-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
can	MD	O	O
be	VB	O	O
as	RB	O	O
severe	JJ	O	O
as	IN	O	O
a	DT	O	O
7/10.	CD	O	O

she	PRP	O	O
has	VBZ	O	O
failed	VBN	O	O
conservative	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
is	VBZ	O	O
admitted	VBN	O	O
for	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
spinal	JJ	I-TREATMENT	I-TREATMENT
cord	NN	I-TREATMENT	I-TREATMENT
stimulator	NN	I-TREATMENT	I-TREATMENT
trial	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

1.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2.	CD	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

3.	CD	O	O
paraplegia	NN	B-PROBLEM	B-PROBLEM
status	NN	O	O
post	NN	O	O
thoracic	NN	B-TREATMENT	B-PROBLEM
aortic	JJ	I-TREATMENT	I-PROBLEM
aneurysm	NN	I-TREATMENT	I-PROBLEM
repair	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

4.	CD	O	O
left	VBD	B-PROBLEM	B-PROBLEM
hemidiaphragmatic	JJ	I-PROBLEM	I-PROBLEM
paralysis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
history	NN	O	O
of	IN	O	O
recurrent	NN	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
infections	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

5.	CD	O	O
sacral	JJ	B-PROBLEM	B-PROBLEM
decubitus	NN	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

6.	CD	O	O
home	NN	B-TREATMENT	B-TREATMENT
oxygen	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
two	CD	O	O
liters	NNS	O	O
a	DT	O	O
minute	NN	O	O
when	WRB	O	O
she	PRP	O	O
is	VBZ	O	O
at	IN	O	O
home	NN	O	O
;	:	O	O
she	PRP	O	O
does	VBZ	O	O
not	RB	O	O
use	VB	O	O
the	DT	B-TREATMENT	O
oxygen	NN	I-TREATMENT	O
when	WRB	O	O
she	PRP	O	O
is	VBZ	O	O
in	IN	O	O
a	DT	B-TREATMENT	B-PROBLEM
wheelchair	NN	I-TREATMENT	I-PROBLEM
or	CC	O	O
is	VBZ	O	O
out	IN	O	O
of	IN	O	O
the	DT	O	O
house	NN	O	O
.	.	O	O

1.	CD	O	O
atrovent	JJ	B-TREATMENT	B-TREATMENT
nebulizers	NNS	I-TREATMENT	I-TREATMENT
0.5	CD	O	O
mg	NNS	O	O
mixed	JJ	O	O
with	IN	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
nebulizer	NN	B-TREATMENT	B-TREATMENT
is	VBZ	O	O
given	VBN	O	O
every	DT	O	O
six	CD	O	O
hours	NNS	O	O
.	.	O	O

2.	CD	O	O
norvasc	JJ	B-TREATMENT	B-TREATMENT
2.5	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

3.	CD	O	O
colistin	NN	B-TREATMENT	B-TREATMENT
30	CD	O	O
mg	NN	O	O
nebulizer	NN	O	B-TREATMENT
twice	RB	O	O
a	DT	O	O
day	NN	O	O
,	,	O	O
give	VB	O	O
30	CD	O	O
minutes	NNS	O	O
post	VBP	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	I-TREATMENT
atrovent	NN	B-TREATMENT	I-TREATMENT
.	.	O	O

4.	CD	O	O
pressure	NN	B-TREATMENT	B-PROBLEM
,	,	I-TREATMENT	O
dermal	JJ	I-TREATMENT	B-PROBLEM
ulcer	NN	I-TREATMENT	I-PROBLEM
care	NN	I-TREATMENT	I-PROBLEM
b.i.d.	IN	O	O
dressing	VBG	B-TREATMENT	B-TREATMENT
change	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
antibiotic	JJ	B-TREATMENT	B-TREATMENT
solution	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

5.	CD	O	O
neurontin	JJ	B-TREATMENT	B-TREATMENT
600	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O

6.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

7.	CD	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
neb	RB	I-TREATMENT	I-TREATMENT
2.5	CD	O	O
mg	NN	O	O
every	DT	O	O
six	CD	O	O
hours	NNS	O	O
,	,	O	O
30	CD	O	O
minutes	NNS	O	O
before	IN	O	O
colistin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

8.	CD	O	O
amitriptyline	JJ	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NNS	O	O
q.h.s.	NN	O	O

9.	CD	O	O
vitamin	JJ	B-TREATMENT	B-TREATMENT
c	NN	I-TREATMENT	I-TREATMENT
500	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

10.	CD	O	O
calcium	NN	B-TREATMENT	B-TREATMENT
carbonate	NN	I-TREATMENT	I-TREATMENT
125.0	CD	O	O
mg	NN	O	O
t.i.d.	NN	O	O

11.	CD	O	O
fentanyl	JJ	B-TREATMENT	B-TREATMENT
patch	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mcg	NN	O	O
an	DT	O	O
hour	NN	O	O
,	,	O	O
change	NN	O	O
patch	NN	B-TREATMENT	O
every	DT	O	O
72	CD	O	O
hours	NNS	O	O
.	.	O	O

12.	CD	O	O
folate	JJ	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

13.	CD	O	O
synthroid	JJ	B-TREATMENT	B-TREATMENT
50	CD	O	O
mcg	NN	O	O
p.o.	NN	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

14.	CD	O	O
zinc	NN	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
220	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

15.	CD	O	O
multivitamin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
one	CD	O	O
tablet	NN	O	O
p.o.	NN	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

16.	CD	O	O
hydrocodone	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
with	IN	O	O
tylenol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
one	CD	O	O
to	TO	O	O
two	CD	O	O
tablets	NNS	O	O
every	DT	O	O
four	CD	O	O
hours	NNS	O	O
p.r.n.	RB	O	O
pain	VBP	B-PROBLEM	B-PROBLEM
.	.	O	O

17.	CD	O	O
milk	NN	B-TREATMENT	O
of	IN	I-TREATMENT	O
magnesia	NN	I-TREATMENT	B-TREATMENT
30	CD	O	O
cc	NN	O	O
p.o.	NN	O	O
q	JJ	O	O
day	NN	O	O
constipation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

penicillin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
well-appearing	JJ	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
is	VBZ	O	O
150/90	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
90	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
20	CD	O	O
with	IN	O	O
saturation	NN	B-TEST	B-TEST
of	IN	O	O
98%	CD	O	O
.	.	O	O

the	DT	O	B-TREATMENT
patient	NN	O	I-TREATMENT
wears	VBZ	O	I-TREATMENT
dentures	NNS	B-TREATMENT	I-TREATMENT
.	.	O	O

full	JJ	O	O
range	NN	O	O
of	IN	O	O
motion	NN	O	O
with	IN	O	O
no	DT	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

decreased	VBN	B-PROBLEM	B-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
sounds	NNS	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
base	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
coarse	JJ	B-PROBLEM	B-PROBLEM
rales	NNS	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
base	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

soft	JJ	O	O
,	,	O	O
nondistended	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

epidural	JJ	O	B-PROBLEM
site	NN	O	I-PROBLEM
is	VBZ	O	O
without	IN	O	O
erythema	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
drainage	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
tenderness	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

left	VBN	O	O
buttock	NN	O	O
area	NN	O	O
has	VBZ	O	O
a	DT	B-TREATMENT	B-TREATMENT
dressing	NN	I-TREATMENT	I-TREATMENT
over	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
sacral	JJ	I-PROBLEM	I-PROBLEM
decubitus	NN	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

flaccid	JJ	B-PROBLEM	B-PROBLEM
paralysis	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremities	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
on	IN	O	O
07/20/99	CD	O	O
for	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
chest	JJS	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
postthoracotomy	JJ	B-PROBLEM	B-TREATMENT
syndrome	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
developed	VBD	O	O
the	DT	B-PROBLEM	B-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
after	IN	O	O
her	PRP$	B-TREATMENT	B-PROBLEM
thoracic	JJ	I-TREATMENT	I-PROBLEM
aortic	JJ	I-TREATMENT	I-PROBLEM
aneurysm	NN	I-TREATMENT	I-PROBLEM
repair	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
failed	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
conservative	JJ	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
is	VBZ	O	O
admitted	VBN	O	O
for	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
spinal	JJ	I-TREATMENT	I-TREATMENT
cord	NN	I-TREATMENT	I-TREATMENT
stimulator	NN	I-TREATMENT	I-TREATMENT
trial	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
spinal	JJ	I-TREATMENT	I-TREATMENT
cord	NN	I-TREATMENT	I-TREATMENT
stimulator	NN	I-TREATMENT	I-TREATMENT
placed	VBD	O	O
on	IN	O	O
07/21/99	CD	O	O
.	.	O	O

she	PRP	O	O
underwent	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
very	RB	O	O
well	RB	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
spinal	JJ	I-TREATMENT	I-TREATMENT
cord	NN	I-TREATMENT	I-TREATMENT
stimulator	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
programmed	VBN	O	O
with	IN	O	O
setting	NN	O	O
of	IN	O	O
a	DT	O	B-TEST
rate	NN	O	I-TEST
of	IN	O	O
80	CD	O	O
,	,	O	O
power	NN	O	O
450	CD	O	O
and	CC	O	O
4.0	CD	O	O
amps	NNS	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
the	DT	O	O
next	JJ	O	O
two	CD	O	O
days	NNS	O	O
did	VBD	O	O
not	RB	O	O
notice	VB	O	O
any	DT	O	B-PROBLEM
significant	JJ	O	I-PROBLEM
change	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
her	PRP$	B-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
pattern	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
also	RB	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	O	O
lot	NN	O	O
of	IN	O	O
musculoskeletal	JJ	B-PROBLEM	O
component	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
her	PRP$	I-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

so	RB	O	O
,	,	O	O
an	DT	B-TREATMENT	B-TREATMENT
epidural	JJ	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
07/23/99	CD	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
epidural	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
in	IN	O	O
the	DT	O	O
l1-2	JJ	O	O
region	NN	O	O
and	CC	O	O
the	DT	B-TREATMENT	B-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
in	IN	O	O
the	DT	O	O
t7	JJ	O	O
region	NN	O	O
using	VBG	O	O
fluoroscope	NN	B-TEST	O
to	TO	O	O
guide	VB	O	O
the	DT	B-TREATMENT	B-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

within	IN	O	O
the	DT	O	O
next	JJ	O	O
couple	NN	O	O
of	IN	O	O
days	NNS	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
noticed	VBD	O	O
a	DT	O	O
significant	JJ	O	O
improvement	NN	O	O
in	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
pattern	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	O
stabbing	NN	I-PROBLEM	O
,	,	I-PROBLEM	O
sharp	JJ	I-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
that	IN	O	O
she	PRP	O	O
occasionally	RB	O	O
has	VBZ	O	O
on	IN	O	O
the	DT	O	B-TEST
left	NN	O	I-TEST
chest	JJS	O	I-TEST
wall	NN	O	I-TEST
was	VBD	O	O
significantly	RB	O	O
diminished	VBN	O	O
and	CC	O	O
she	PRP	O	O
also	RB	O	O
noticed	VBD	O	O
periods	NNS	O	O
of	IN	O	O
time	NN	O	O
when	WRB	O	O
she	PRP	O	O
did	VBD	O	O
not	RB	O	O
have	VB	O	O
any	DT	O	O
of	IN	O	O
that	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
epidural	JJ	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
morphine	JJ	I-TREATMENT	I-TREATMENT
infusion	NN	I-TREATMENT	I-TREATMENT
initially	RB	O	O
started	VBD	O	O
at	IN	O	O
1	CD	O	O
mg	NNS	O	O
a	DT	O	O
day	NN	O	O
and	CC	O	O
increased	VBD	O	O
to	TO	O	O
3	CD	O	O
mg	NNS	O	O
a	DT	O	O
day	NN	O	O
in	IN	O	O
a	DT	O	O
period	NN	O	O
of	IN	O	O
three	CD	O	O
days	NNS	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
epidural	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
on	IN	O	O
07/26/99	CD	O	O
and	CC	O	O
was	VBD	O	O
considered	VBN	O	O
a	DT	B-TREATMENT	O
successful	JJ	I-TREATMENT	O
trial	NN	I-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
schedule	VB	O	O
with	IN	O	O
the	DT	O	B-PROBLEM
pain	NN	O	I-PROBLEM
clinic	JJ	O	O
regarding	VBG	O	O
upcoming	JJ	B-TREATMENT	B-TREATMENT
epidural	JJ	I-TREATMENT	I-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

dr.	NN	O	O
falccouette	NN	O	O
would	MD	O	O
like	VB	O	O
to	TO	O	O
perform	VB	O	O
an	DT	B-TREATMENT	B-TREATMENT
excision	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
closure	NN	B-TREATMENT	B-PROBLEM
flap	NN	I-TREATMENT	I-PROBLEM
of	IN	O	I-PROBLEM
her	PRP$	B-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
ischial	JJ	I-PROBLEM	I-PROBLEM
decubitusin	NN	I-PROBLEM	I-PROBLEM
the	DT	O	I-PROBLEM
near	JJ	O	I-PROBLEM
future	NN	O	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
discharged	VBN	O	O
in	IN	O	O
stable	JJ	O	O
conditionand	NN	O	O
will	MD	O	O
follow	VB	O	O
up	RP	O	O
for	IN	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
sacral	JJ	B-TREATMENT	B-PROBLEM
decubitus	NN	I-TREATMENT	I-PROBLEM
closure	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
and	CC	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
placement	NN	B-TREATMENT	O
of	IN	I-TREATMENT	O
epidural	JJ	I-TREATMENT	B-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
the	DT	O	O
future	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
have	VB	O	O
smh	JJ	O	O
service	NN	O	O
that	WDT	O	O
comes	VBZ	O	O
to	TO	O	O
her	PRP$	O	O
home	NN	O	O
once	IN	O	O
a	DT	O	O
day	NN	O	O
for	IN	O	O
adressing	VBG	B-TREATMENT	O
change	NN	I-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
dr.	JJ	O	O
kayschird	NN	O	O
to	TO	O	O
schedule	NN	O	O
for	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
epidural	JJ	I-TREATMENT	I-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
dr.	NN	O	O
falccouette	NN	O	O
to	TO	O	O
schedule	NN	O	O
for	IN	O	O
excision	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
closure	NN	B-TREATMENT	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
ischial	JJ	I-PROBLEM	I-PROBLEM
sacral	JJ	I-PROBLEM	I-PROBLEM
decubitus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

chronic	JJ	B-PROBLEM	B-PROBLEM
myelomonocytic	JJ	I-PROBLEM	I-PROBLEM
leukemia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
without	IN	O	O
remission	NN	O	B-PROBLEM
,	,	O	O

chronic	JJ	B-PROBLEM	B-PROBLEM
myelomonocytic	JJ	I-PROBLEM	I-PROBLEM
leukemia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
without	IN	O	O
remission	NN	O	B-PROBLEM
,	,	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
airway	NN	I-PROBLEM	I-PROBLEM
obstruction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypopotassemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cellulitis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
orbital	JJ	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
protein	NN	B-PROBLEM	B-TREATMENT
calorie	NN	I-PROBLEM	I-TREATMENT
malnutrition	NN	I-PROBLEM	I-TREATMENT
,	,	O	O
gastrointestinal	JJ	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
/	NNP	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hyperglycemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
renal	JJ	B-PROBLEM	B-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hyperuricemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypophosphatemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

this	DT	O	O
75	CD	O	O
year	NN	O	O
old	JJ	O	O
male	NN	O	O
had	VBD	O	O
been	VBN	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
anemic	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
abnormal	JJ	I-PROBLEM	I-PROBLEM
white	JJ	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
count	NN	I-PROBLEM	I-PROBLEM
since	IN	O	O
at	IN	O	O
least	JJS	O	O
november	JJ	O	O
1993	CD	O	O
,	,	O	O
while	IN	O	O
he	PRP	O	O
was	VBD	O	O
living	VBG	O	O
in	IN	O	O
aersing	VBG	O	O
rocuch	JJ	O	O
sun	NN	O	O
and	CC	O	O
his	PRP$	O	O
physicians	NNS	O	O
there	EX	O	O
had	VBD	O	O
begun	VBN	O	O
to	TO	O	O
manage	VB	O	O
him	PRP	O	O
with	IN	O	O
transfusions	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
low	JJ	B-TREATMENT	B-PROBLEM
dose	JJ	I-TREATMENT	I-PROBLEM
hydroxyurea	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

apparently	RB	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
bone	NN	I-TEST	I-TEST
marrow	NN	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
at	IN	O	O
the	DT	O	O
time	NN	O	O
confirmed	VBD	O	O
the	DT	O	O
diagnosis	NN	O	O
of	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
myelomonocytic	JJ	I-PROBLEM	I-PROBLEM
leukemia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
been	VBN	O	O
noting	VBG	O	O
night	NN	B-PROBLEM	B-PROBLEM
sweats	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
fatigue	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
anorexia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
which	WDT	O	O
were	VBD	O	O
not	RB	O	O
particularly	RB	O	O
improved	VBN	O	O
by	IN	O	O
increased	JJ	B-TREATMENT	B-PROBLEM
transfusions	NNS	I-TREATMENT	I-PROBLEM
or	CC	O	O
alterations	NNS	O	O
of	IN	O	O
hydroxy	JJ	B-TREATMENT	B-TREATMENT
urea	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
became	VBD	O	O
profoundly	RB	B-PROBLEM	B-PROBLEM
thrombocytopenic	JJ	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
ultimately	RB	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
hospital	NN	O	O
on	IN	O	O
2/15	CD	O	O
with	IN	O	O
headache	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
weakness	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

significant	JJ	O	O
for	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
managed	VBD	O	O
with	IN	O	O
an	DT	O	B-TEST
italian	JJ	O	I-TEST
variation	NN	O	I-TEST
of	IN	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
amioadrone	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
managed	VBD	O	O
with	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
ace	NN	I-TREATMENT	I-TREATMENT
inhibitor	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
obstructive	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
managed	VBD	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
zanthine	NN	I-TREATMENT	I-TREATMENT
preparation	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
low	JJ	B-TREATMENT	B-TREATMENT
dose	NN	I-TREATMENT	I-TREATMENT
steroids	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
an	DT	B-TREATMENT	O
occasional	JJ	I-TREATMENT	O
inhaler	NN	I-TREATMENT	O
.	.	O	O

other	JJ	B-PROBLEM	B-PROBLEM
medical	JJ	I-PROBLEM	I-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
included	VBD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
liver	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
uncertain	JJ	O	O
etiology	NN	O	O
,	,	O	O
for	IN	O	O
which	WDT	O	O
he	PRP	O	O
had	VBD	O	O
been	VBN	O	O
advised	VBN	O	O
not	RB	O	O
to	TO	O	O
drink	VB	O	O
any	DT	O	O
alcohol	NN	O	O
.	.	O	O

he	PRP	O	O
also	RB	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
penetrating	JJ	I-PROBLEM	I-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	O
the	DT	I-PROBLEM	O
right	NN	I-PROBLEM	O
eye	NN	I-PROBLEM	O
,	,	O	O
which	WDT	O	O
had	VBD	O	O
rendered	VBN	O	O
him	PRP	O	O
blind	IN	B-PROBLEM	O
10	CD	O	O
years	NNS	O	O
previously	RB	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
a	DT	O	O
chronically	RB	O	O
ill	JJ	O	O
appearing	VBG	O	O
elderly	JJ	O	O
man	NN	O	O
,	,	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
respiratory	JJ	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
30	CD	O	O
,	,	O	O
temperature	NN	B-TEST	B-TEST
99.6	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
100	CD	O	O
,	,	O	O
and	CC	O	O
irregularly	RB	B-PROBLEM	O
irregular	JJ	I-PROBLEM	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
148/71	CD	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
petechiae	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	O
his	PRP$	I-PROBLEM	O
extremities	NNS	I-PROBLEM	O
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
in	IN	O	O
his	PRP$	O	B-TEST
mucosal	NN	O	I-TEST
membranes	NNS	O	I-TEST
with	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
hemorrhagic	JJ	I-PROBLEM	I-PROBLEM
bullae	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
were	VBD	O	O
bibasilar	JJ	B-PROBLEM	B-PROBLEM
rales	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
wheezing	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
no	DT	O	O
cardiac	JJ	B-PROBLEM	B-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	O	O
abdomen	NNS	O	O
was	VBD	O	O
distended	VBN	B-PROBLEM	B-PROBLEM
with	IN	O	O
massive	JJ	B-PROBLEM	B-PROBLEM
hepatosplenomegaly	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
was	VBD	O	O
somewhat	RB	B-PROBLEM	B-PROBLEM
tender	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
neurological	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
aside	RB	O	O
from	IN	O	O
the	DT	B-PROBLEM	O
blind	NN	I-PROBLEM	O
right	JJ	I-PROBLEM	O
eye	NN	I-PROBLEM	O
was	VBD	O	O
unremarkable	JJ	O	O
.	.	O	O

included	VBD	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
140,000	CD	O	O
,	,	O	O
7%	CD	B-TEST	O
polys	NN	I-TEST	B-TEST
,	,	O	O
1%	CD	B-TEST	O
bands	NNS	I-TEST	B-TEST
,	,	O	O
3%	CD	B-TEST	O
lymphs	NN	I-TEST	B-TEST
,	,	O	O
1%	CD	B-TEST	O
monos	NNS	I-TEST	B-TEST
,	,	O	O
2	CD	B-TEST	O
basos	NN	I-TEST	O
,	,	O	O
4	CD	B-TEST	O
blasts	NNS	I-TEST	O
,	,	O	O
76%	CD	B-TEST	O
pearl	NN	I-TEST	O
monocytes	NNS	I-TEST	O
,	,	O	O
6%	CD	B-TEST	O
meta	NN	I-TEST	O
&apos;s	NN	I-TEST	O
,	,	O	O
3	CD	B-TEST	B-TREATMENT
nucleated	VBN	I-TEST	I-TREATMENT
red	JJ	I-TEST	I-TREATMENT
blood	NN	I-TEST	I-TREATMENT
cells	NNS	I-TEST	I-TREATMENT
.	.	O	O

there	EX	O	O
were	VBD	O	O
some	DT	O	B-PROBLEM
oval	JJ	B-PROBLEM	I-PROBLEM
tear	JJ	I-PROBLEM	I-PROBLEM
drop	NN	I-PROBLEM	I-PROBLEM
cells	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
target	NN	B-PROBLEM	O
cells	NNS	I-PROBLEM	O
with	IN	O	O
a	DT	B-PROBLEM	O
few	JJ	I-PROBLEM	O
schistocytes	NNS	I-PROBLEM	O
.	.	O	O

the	DT	B-TEST	B-TEST
platelet	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
9,000	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
was	VBD	O	O
26.5	CD	O	O
,	,	O	O
with	IN	O	O
an	DT	B-TEST	B-TEST
mean	JJ	I-TEST	I-TEST
corpuscular	JJ	I-TEST	I-TEST
volume	NN	I-TEST	I-TEST
of	IN	O	O
about	IN	O	O
73	CD	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
prothrombin	NN	I-TEST	I-TEST
time	NN	I-TEST	I-TEST
and	CC	O	O
partial	JJ	B-TEST	B-TEST
thromboplastin	NN	I-TEST	I-TEST
time	NN	I-TEST	I-TEST
were	VBD	O	O
normal	JJ	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
uric	JJ	I-TEST	I-TEST
acid	NN	I-TEST	I-TEST
was	VBD	O	O
up	RB	O	O
at	IN	O	O
97	CD	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
total	JJ	I-TEST	I-TEST
bilirubin	NN	I-TEST	I-TEST
was	VBD	O	O
up	RB	O	O
at	IN	O	O
1.8	CD	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
ldh	NN	I-TEST	I-TEST
was	VBD	O	O
428	CD	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
phosphorus	NN	I-TEST	I-TEST
was	VBD	O	O
1.2	CD	O	O
,	,	O	O
calcium	NN	B-TEST	B-TEST
8.6	CD	O	O
,	,	O	O
digoxin	NN	B-TEST	B-TEST
level	NN	I-TEST	I-TEST
was	VBD	O	O
1.0	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
on	IN	O	O
admission	NN	O	O
was	VBD	O	O
2.9	CD	O	O
,	,	O	O
sodium	NN	B-TEST	B-TEST
135	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
13/1.6	CD	O	O
,	,	O	O
and	CC	O	O
sugar	NN	B-TEST	O
of	IN	O	O
267	CD	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
computerized	JJ	I-TEST	I-TEST
tomography	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
of	IN	O	I-TEST
his	PRP$	O	I-TEST
head	NN	O	I-TEST
showed	VBD	O	O
no	DT	O	O
signs	NNS	O	O
of	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
acute	JJ	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
a	DT	B-TEST	B-TEST
chest	NN	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
showed	VBD	O	O
no	DT	O	O
new	JJ	B-PROBLEM	B-PROBLEM
infiltrates	NNS	I-PROBLEM	I-PROBLEM
or	CC	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
cardiomegaly	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
prominent	JJ	B-PROBLEM	B-PROBLEM
vascularity	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
no	DT	O	O
effusions	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
was	VBD	O	O
consistent	JJ	O	O
with	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
hospital	NN	O	O
and	CC	O	O
begun	VBN	O	O
on	IN	O	O
high	JJ	B-TREATMENT	B-TREATMENT
dose	JJ	I-TREATMENT	I-TREATMENT
hydroxyurea	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
with	IN	O	O
a	DT	O	O
gradual	JJ	O	O
improvement	NN	O	O
in	IN	O	O
his	PRP$	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
over	IN	O	O
the	DT	O	O
next	JJ	O	O
few	JJ	O	O
days	NNS	O	O
.	.	O	O

he	PRP	O	O
did	VBD	O	O
spike	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
began	VBD	O	O
ancef	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
although	IN	O	O
cultures	NNS	B-TEST	B-TEST
never	RB	O	O
revealed	VBD	O	O
a	DT	O	O
source	NN	O	O
for	IN	O	O
this	DT	O	O
.	.	O	O

he	PRP	O	O
also	RB	O	O
tried	VBD	O	O
amicar	NN	B-TREATMENT	O
and	CC	O	O
continued	VBN	O	O
on	IN	O	O
low	JJ	B-TREATMENT	B-TREATMENT
dose	NN	I-TREATMENT	I-TREATMENT
prednisone	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-PROBLEM	B-PROBLEM
headache	NN	I-PROBLEM	I-PROBLEM
improved	VBD	O	O
,	,	O	O
but	CC	O	O
her	PRP$	O	O
remained	VBD	O	O
profoundly	RB	B-PROBLEM	B-PROBLEM
weak	JJ	I-PROBLEM	I-PROBLEM
and	CC	O	O
intermittently	RB	B-PROBLEM	O
febrile	JJ	I-PROBLEM	O
with	IN	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
hemoptysis	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
intermittent	JJ	B-PROBLEM	B-PROBLEM
gastrointestinal	JJ	I-PROBLEM	I-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
while	IN	O	O
he	PRP	O	O
remained	VBD	O	O
profoundly	RB	B-PROBLEM	B-PROBLEM
thrombocytopenia	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

transfusions	NNS	B-TREATMENT	B-TEST
of	IN	I-TREATMENT	I-TEST
platelets	NNS	I-TREATMENT	I-TEST
did	VBD	O	O
not	RB	O	O
change	VB	O	O
his	PRP$	B-TEST	B-TEST
platelet	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
,	,	O	O
presumably	RB	O	O
because	IN	O	O
of	IN	O	O
sequestration	NN	B-PROBLEM	O
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
massive	JJ	I-PROBLEM	I-PROBLEM
spleen	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

amicar	NN	B-TREATMENT	O
was	VBD	O	O
of	IN	O	O
uncertain	JJ	O	O
value	NN	O	O
,	,	O	O
but	CC	O	O
used	VBD	O	O
intermittently	RB	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
bone	NN	I-TEST	I-TEST
marrow	NN	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
revealed	VBD	O	O
the	DT	O	O
transformation	NN	O	O
of	IN	O	O
his	PRP$	B-PROBLEM	O
cmml	NN	I-PROBLEM	O
to	TO	O	O
acute	VB	B-PROBLEM	O
myelogenous	JJ	I-PROBLEM	B-PROBLEM
leukemia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
given	VBN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
other	JJ	I-PROBLEM	I-PROBLEM
underlying	JJ	I-PROBLEM	I-PROBLEM
medical	JJ	I-PROBLEM	I-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
we	PRP	O	O
chose	VBD	O	O
chemotherapy	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
subcutaneous	JJ	B-TREATMENT	B-TREATMENT
cystosine	NN	I-TREATMENT	I-TREATMENT
arabinoside	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
6-thioguanine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
which	WDT	O	O
he	PRP	O	O
tolerated	VBD	O	O
without	IN	O	O
incident	NN	O	O
and	CC	O	O
this	DT	O	O
brought	VBD	O	O
his	PRP$	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
down	RB	O	O
to	TO	O	O
below	IN	O	O
1,000	CD	O	O
,	,	O	O
and	CC	O	O
his	PRP$	O	O
spleen	JJ	O	O
shrank	NN	O	O
noticeably	RB	O	O
,	,	O	O
but	CC	O	O
he	PRP	O	O
still	RB	O	O
could	MD	O	O
not	RB	O	O
maintain	VB	O	O
a	DT	O	B-PROBLEM
bump	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
platelet	NN	B-TEST	I-PROBLEM
count	NN	I-TEST	I-PROBLEM
with	IN	O	O
platelet	NN	B-TREATMENT	B-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
intermittently	RB	B-PROBLEM	B-PROBLEM
congested	VBN	I-PROBLEM	I-PROBLEM
limiting	VBG	O	O
our	PRP$	O	O
ability	NN	O	O
to	TO	O	O
give	VB	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
fluid	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
for	IN	O	O
his	PRP$	B-TREATMENT	B-PROBLEM
hydrea	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
although	IN	O	O
we	PRP	O	O
kept	VBD	O	O
him	PRP	O	O
on	IN	O	O
allopurinol	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
renal	JJ	O	O
function	NN	O	O
deteriorated	VBD	O	O
somewhat	RB	O	O
,	,	O	O
hampering	VBG	O	O
our	PRP$	O	O
ability	NN	O	O
to	TO	O	O
give	VB	O	O
him	PRP	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
gentamicin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
family	NN	O	O
maintained	VBD	O	O
an	DT	O	O
extraordinary	JJ	O	O
vigil	NN	O	O
over	IN	O	O
the	DT	O	O
days	NNS	O	O
of	IN	O	O
his	PRP$	O	O
hospitalization	NN	O	O
,	,	O	O
providing	VBG	O	O
him	PRP	O	O
with	IN	O	O
some	DT	O	B-TREATMENT
food	NN	O	I-TREATMENT
and	CC	O	O
constant	JJ	O	O
attention	NN	O	O
,	,	O	O
while	IN	O	O
we	PRP	O	O
awaited	VBD	O	O
the	DT	O	O
results	NNS	O	O
of	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
intermittently	RB	B-PROBLEM	B-PROBLEM
restless	JJ	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
somewhat	RB	B-PROBLEM	I-PROBLEM
confused	JJ	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
as	IN	O	O
his	PRP$	O	B-PROBLEM
respiratory	NN	O	I-PROBLEM
status	NN	O	I-PROBLEM
deteriorated	VBN	O	I-PROBLEM
,	,	O	O
the	DT	O	O
family	NN	O	O
agreed	VBD	O	O
to	TO	O	O
a	DT	B-TREATMENT	B-TREATMENT
low	JJ	I-TREATMENT	I-TREATMENT
dose	JJ	I-TREATMENT	I-TREATMENT
morphine	NN	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
which	WDT	O	O
made	VBD	O	O
him	PRP	O	O
much	RB	O	O
more	RBR	O	O
comfortable	JJ	O	O
.	.	O	O

they	PRP	O	O
agreed	VBD	O	O
with	IN	O	O
a	DT	O	O
do	NN	O	O
not	RB	O	O
resuscitate	VB	O	O
status	NN	O	O
early	RB	O	O
on	IN	O	O
in	IN	O	O
the	DT	O	O
hospitalization	NN	O	O
and	CC	O	O
in	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
being	VBG	O	O
maintain	VBN	O	O
on	IN	O	O
low	JJ	B-TREATMENT	B-TREATMENT
dose	JJ	I-TREATMENT	I-TREATMENT
morphine	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
he	PRP	O	O
ultimately	RB	O	O
expired	VBD	O	O
on	IN	O	O
2/28/94	CD	O	O
with	IN	O	O
the	DT	O	O
family	NN	O	O
present	NN	O	O
.	.	O	O

no	DT	O	O
autopsy	NN	B-TEST	B-TEST
was	VBD	O	O
obtained	VBN	O	O
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
64-year-old	JJ	O	O
man	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
endocarditis	NN	B-PROBLEM	B-PROBLEM
status	NN	O	O
post	NN	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
mitral	JJ	B-TREATMENT	B-TREATMENT
valve	FW	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
2010-08-13	JJ	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
erich	VB	O	O
lindemann	JJ	O	O
mental	JJ	O	O
health	NN	O	O
center	NN	O	O
from	IN	O	O
the	DT	O	O
rehabilitation	NN	O	O
center	NN	O	O
where	WRB	O	O
he	PRP	O	O
had	VBD	O	O
been	VBN	O	O
discharged	VBN	O	O
to	TO	O	O
on	IN	O	O
2010-08-25	JJ	O	O
following	VBG	O	O
his	PRP$	B-TREATMENT	O
cabg/mvr	NN	I-TREATMENT	O
.	.	O	O

at	IN	O	O
the	DT	O	O
rehabilitation	NN	O	O
center	NN	O	O
the	DT	O	O
patient	NN	O	O
developed	VBD	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
chest	JJ	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
done	VBN	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
left-sided	JJ	I-PROBLEM	I-PROBLEM
infiltrate	NN	I-PROBLEM	I-PROBLEM
versus	NN	O	O
effusion	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
mass.	VB	O	O
eye	NN	O	O
&	CC	O	O
ear	JJ	O	O
infirmary	NN	O	O
for	IN	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
he	PRP	O	O
complained	VBD	O	O
of	IN	O	O
no	DT	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
weakness	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
cough	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
although	IN	O	O
he	PRP	O	O
is	VBZ	O	O
intermittently	RB	B-PROBLEM	B-PROBLEM
short	JJ	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
been	VBN	O	O
anticoagulated	VBN	B-TREATMENT	O
during	IN	O	O
his	PRP$	O	O
stay	NN	O	O
at	IN	O	O
rehabilitation	NN	O	O
for	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
significant	JJ	O	O
for	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
status	NN	O	O
post	NN	O	O
cabg/mvr	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

2.	CD	O	O
endocarditis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

3.	CD	O	O
rectal	JJ	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
200	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

2.	CD	O	O
lasix	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O

3.	CD	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
20	CD	O	O
meq	NN	O	O
b.i.d.	NN	O	O

4.	CD	O	O
ampicillin	JJ	B-TREATMENT	B-TREATMENT
2	CD	O	O
grams	NNS	O	O
q.	RB	O	O
4	CD	O	O
hours	NNS	O	O
.	.	O	O

5.	CD	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
atrovent	JJ	B-TREATMENT	O
p.r.n.	NN	O	O

6.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
q.d.	NN	O	O

7.	CD	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
q.d.	NN	O	O

8.	CD	O	O
nystatin	JJ	B-TREATMENT	B-TREATMENT
swish	JJ	O	I-TREATMENT
and	CC	O	I-TREATMENT
swallow	JJ	O	I-TREATMENT
5	CD	O	O
cc	NN	O	O
t.i.d.	NN	O	O

9.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
b.i.d.	NN	O	O

10.	CD	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
5/325	CD	O	O
,	,	O	O
1-2	JJ	O	O
tablets	NNS	O	O
q.	VBD	O	O
4	CD	O	O
hours	NNS	O	O
p.r.n.	NN	O	O

white	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
12.6	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
28.9	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
259	CD	O	O
,	,	O	O
pt	NN	B-TEST	O
21.4	CD	O	O
,	,	O	O
ptt	NN	B-TEST	B-TEST
40.2	CD	O	O
,	,	O	O
inr	NN	B-TEST	B-TEST
3.0	CD	O	O
,	,	O	O
sodium	NN	B-TEST	B-TEST
137	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.2	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
100	CD	O	O
,	,	O	O
co2	NN	B-TEST	B-TEST
27	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
26	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
1.3	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
120	CD	O	O
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
shows	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
admission	NN	O	B-TEST
vital	JJ	B-TEST	I-TEST
signs	NNS	I-TEST	I-TEST
were	VBD	O	O
temperature	JJ	B-TEST	B-TEST
100.1	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
83	CD	O	O
and	CC	O	O
sinus	JJ	O	B-PROBLEM
rhythm	NN	O	I-PROBLEM
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
108/50	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
25	CD	O	O
,	,	O	O
oxygen	NN	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST
97%	CD	O	O
on	IN	O	O
three	CD	B-TREATMENT	O
liters	NNS	I-TREATMENT	O
.	.	O	O

generally	RB	O	O
he	PRP	O	O
was	VBD	O	O
a	DT	O	O
pleasant	JJ	O	O
man	NN	O	O
with	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

lungs	NNS	O	O
had	VBD	O	O
decreased	VBN	B-PROBLEM	B-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
sounds	NNS	I-PROBLEM	I-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	NN	O	I-PROBLEM
.	.	O	O

cardiac	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
showed	VBD	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
s1	NN	O	O
and	CC	O	O
s2	NN	O	O
.	.	O	O

chest	JJS	B-PROBLEM	B-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
with	IN	O	O
steri-strips	NNS	B-TREATMENT	O
,	,	O	O
open	JJ	O	O
to	TO	O	O
air	NN	O	O
,	,	O	O
clean	JJ	O	O
and	CC	O	O
dry	JJ	O	O
.	.	O	O

abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
and	CC	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBD	B-PROBLEM	B-PROBLEM
,	,	O	O
with	IN	O	O
positive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
.	.	O	O

extremities	NNS	O	O
had	VBD	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
pedal	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

right	JJ	B-PROBLEM	B-PROBLEM
leg	NN	I-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
had	VBD	O	O
steri-strips	NNS	B-TREATMENT	O
,	,	O	O
open	JJ	O	O
to	TO	O	O
air	NN	O	O
,	,	O	O
clean	JJ	O	O
and	CC	O	O
dry	JJ	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
given	VBN	O	O
fresh	JJ	B-TREATMENT	B-TREATMENT
frozen	JJ	I-TREATMENT	I-TREATMENT
plasma	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
correct	VB	O	O
his	PRP$	B-TEST	O
inr	NN	I-TEST	O
and	CC	O	O
a	DT	B-TREATMENT	B-TREATMENT
left	JJ	I-TREATMENT	I-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
.	.	O	O

over	IN	O	O
the	DT	O	O
first	JJ	O	O
12	CD	O	O
hours	NNS	O	O
the	DT	B-TREATMENT	B-TREATMENT
chest	JJS	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
drained	VBD	O	O
2,500	CD	O	O
cc	NN	O	O
.	.	O	O

his	PRP$	B-PROBLEM	B-TREATMENT
chest	JJS	I-PROBLEM	I-TREATMENT
tube	NN	I-PROBLEM	I-TREATMENT
drainage	NN	I-PROBLEM	I-TREATMENT
reduced	VBD	O	O
significantly	RB	O	O
after	IN	O	O
the	DT	O	O
first	JJ	O	O
24	CD	O	O
hours	NNS	O	O
and	CC	O	O
on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
three	CD	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
chest	JJS	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
.	.	O	O

over	IN	O	O
the	DT	O	O
next	JJ	O	O
several	JJ	O	O
days	NNS	O	O
the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
in	IN	O	O
the	DT	O	O
hospital	NN	O	O
to	TO	O	O
reassess	VB	O	O
for	IN	O	O
recurrent	JJ	B-PROBLEM	B-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

at	IN	O	O
this	DT	O	O
time	NN	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
physical	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
is	VBZ	O	O
as	IN	O	O
follows	VBZ	O	O
:	:	O	O

vital	JJ	B-TEST	B-TEST
signs	NNS	I-TEST	I-TEST
were	VBD	O	O
temperature	JJ	B-TEST	B-TEST
97.8	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
80	CD	O	O
and	CC	O	O
sinus	JJ	O	B-PROBLEM
rhythm	NN	O	I-PROBLEM
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
140/82	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
18	CD	O	O
,	,	O	O

o2	JJ	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST
96%	CD	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

weight	NN	B-TEST	B-TEST
on	IN	I-TEST	O
admission	NN	I-TEST	O
was	VBD	O	O
64	CD	O	O
kg	NN	O	O
,	,	O	O
at	IN	O	O
discharge	NN	O	O
was	VBD	O	O
51.6	CD	O	O
kg	NN	O	O
.	.	O	O

laboratory	NN	O	B-TEST
data	NNS	O	I-TEST
showed	VBD	O	O
an	DT	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
of	IN	O	O
31.6	CD	O	O
,	,	O	O
pt	NN	B-TEST	O
13	CD	O	O
,	,	O	O
inr	NN	B-TEST	B-TEST
1.2	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.5	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
18	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
0.9	CD	O	O
.	.	O	O

respiratory	NN	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	I-TEST	O
.	.	O	O

incisions	NNS	B-PROBLEM	B-TREATMENT
had	VBD	O	I-TREATMENT
steri-strips	NNS	B-TREATMENT	I-TREATMENT
,	,	O	O
open	JJ	O	O
to	TO	O	O
air	NN	O	O
,	,	O	O
clean	JJ	O	O
and	CC	O	O
dry	JJ	O	O
.	.	O	O

abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBD	B-PROBLEM	B-PROBLEM
,	,	O	O
with	IN	O	O
normal	JJ	O	O
active	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
.	.	O	O

extremities	NNS	O	O
were	VBD	O	O
warm	JJ	O	O
and	CC	O	O
well	RB	O	O
perfused	VBN	O	O
with	IN	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

right	RB	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
steri-strips	NNS	B-TREATMENT	O
,	,	O	O
open	JJ	O	O
to	TO	O	O
air	NN	O	O
,	,	O	O
clean	JJ	O	O
and	CC	O	O
dry	JJ	O	O
.	.	O	O

1.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O

2.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

3.	CD	O	O
nystatin	JJ	B-TREATMENT	B-TREATMENT
swish	JJ	O	I-TREATMENT
and	CC	O	I-TREATMENT
swallow	JJ	O	I-TREATMENT
,	,	O	O
5	CD	O	O
cc	NN	O	O
q.	NN	O	O
8	CD	O	O
hours	NNS	O	O
.	.	O	O

4.	CD	O	O
ampicillin	JJ	B-TREATMENT	B-TREATMENT
2	CD	O	O
grams	NNS	O	O
iv	VBP	O	O
q.	JJ	O	O
6	CD	O	O
through	IN	O	O
09-08	NN	O	O
.	.	O	O

5.	CD	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
200	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

6.	CD	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
5/325	CD	O	O
,	,	O	O
1-2	JJ	O	O
tablets	NNS	O	O
q.	VBD	O	O
6	CD	O	O
hours	NNS	O	O
p.r.n.	NN	O	O

7.	CD	O	O
milk	NN	B-TREATMENT	O
of	IN	I-TREATMENT	O
magnesia	NN	I-TREATMENT	B-TREATMENT
30	CD	O	O
cc	NN	O	O
q.h.s.	NN	O	O
p.r.n.	NN	O	O

metastatic	JJ	B-PROBLEM	B-PROBLEM
cervical	JJ	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

secondary	JJ	O	O
diagnoses	NNS	O	O
include	VBP	O	O
pericardial	JJ	B-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
lymphangitic	JJ	I-PROBLEM	I-PROBLEM
spread	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
liver	RB	B-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
spleen	JJ	I-PROBLEM	I-PROBLEM
metastases	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

echocardiogram	JJ	B-TEST	B-TEST
times	NNS	O	O
two	CD	O	O
.	.	O	O

patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
28	CD	O	O
year	NN	O	O
old	JJ	O	O
gravida	NN	O	O
iv	NN	O	O
,	,	O	O
para	VBZ	O	O
2	CD	O	O
with	IN	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
cervical	JJ	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
admitted	VBN	O	O
with	IN	O	O
a	DT	O	O
question	NN	O	O
of	IN	O	O
malignant	JJ	B-PROBLEM	B-PROBLEM
pericardial	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	JJ	O	O
underwent	NN	O	O
a	DT	B-TREATMENT	B-TREATMENT
total	JJ	I-TREATMENT	I-TREATMENT
abdominal	JJ	I-TREATMENT	I-TREATMENT
hysterectomy	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
02/90	CD	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
4x3.6x2	CD	I-PROBLEM	I-PROBLEM
cm	NN	I-PROBLEM	I-PROBLEM
cervical	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
felt	VBD	O	O
to	TO	O	O
be	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
fibroid	NN	I-PROBLEM	I-PROBLEM
at	IN	O	I-PROBLEM
vanor	NN	O	I-PROBLEM
.	.	O	O

pathology	NN	B-TEST	B-TEST
revealed	VBD	O	O
poorly	RB	B-PROBLEM	B-PROBLEM
differentiated	VBN	I-PROBLEM	I-PROBLEM
squamous	JJ	I-PROBLEM	I-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
cervix	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
spots	NNS	O	O
of	IN	O	O
vaginal	JJ	O	B-TREATMENT
margins	NNS	O	I-TREATMENT
and	CC	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
squamous	JJ	I-PROBLEM	I-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
cardinal	JJ	I-PROBLEM	I-PROBLEM
ligaments	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
extensive	JJ	B-PROBLEM	B-PROBLEM
lymphatic	JJ	I-PROBLEM	I-PROBLEM
invasion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
have	VB	O	O
stage	NN	B-PROBLEM	B-PROBLEM
2b	CD	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
post-operatively	RB	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
intracavitary	JJ	B-TREATMENT	B-TREATMENT
and	CC	I-TREATMENT	I-TREATMENT
external	JJ	I-TREATMENT	I-TREATMENT
beam	NN	I-TREATMENT	I-TREATMENT
radiation	NN	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
low	JJ	B-TREATMENT	B-TREATMENT
dose	NN	I-TREATMENT	I-TREATMENT
cisplatin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
ultrasound	NN	B-TEST	B-TEST
in	IN	O	O
02/91	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
cystic	JJ	I-PROBLEM	I-PROBLEM
adnexal	NN	I-PROBLEM	I-PROBLEM
masses	NNS	I-PROBLEM	I-PROBLEM
confirmed	VBD	O	O
on	IN	O	O
physical	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
.	.	O	O

she	PRP	O	O
underwent	JJ	O	O
exploratory	JJ	B-TEST	B-TEST
laparotomy	NN	I-TEST	I-TEST
and	CC	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
bilateral	JJ	I-TREATMENT	I-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
appendectomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

pathology	NN	B-TEST	B-TEST
was	VBD	O	O
negative	JJ	O	O
for	IN	O	O
tumor	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
showed	VBD	O	O
peritubal	NNS	B-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	O
periovarian	JJ	I-PROBLEM	B-PROBLEM
adhesions	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
now	RB	O	O
presents	VBZ	O	O
with	IN	O	O
a	DT	O	O
three	CD	O	O
to	TO	O	O
four	CD	O	O
week	NN	O	O
history	NN	O	O
of	IN	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
dry	JJ	I-PROBLEM	I-PROBLEM
non-productive	JJ	I-PROBLEM	I-PROBLEM
cough	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
evaluated	VBN	O	O
by	IN	O	O
dr.	NN	O	O
mielke	NN	O	O
,	,	O	O
a	DT	O	O
pulmonologist	NN	O	O
,	,	O	O
who	WP	O	O
found	VBD	O	O
her	PRP	O	O
to	TO	O	O
be	VB	O	O
wheezing	VBG	B-PROBLEM	B-PROBLEM
and	CC	O	O
performed	VBD	O	O
pulmonary	JJ	B-TEST	B-TEST
function	NN	I-TEST	I-TEST
tests	NNS	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
an	DT	B-TEST	O
fev1	NN	I-TEST	O
of	IN	O	O
1.1	CD	O	O
and	CC	O	O
an	DT	B-TEST	O
fvc	NN	I-TEST	O
of	IN	O	O
1.8	CD	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
weekscook	VB	O	O
university	NN	O	O
medical	JJ	O	O
center	NN	O	O
with	IN	O	O
a	DT	O	O
diagnosis	NN	O	O
of	IN	O	O
possible	JJ	O	O
asthma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

room	NN	B-TEST	B-TEST
air	NN	I-TEST	I-TEST
arterial	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
gas	NN	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-TEST	B-TEST
po2	NN	I-TEST	I-TEST
of	IN	O	O
56	CD	O	O
,	,	O	O
a	DT	B-TEST	O
pco2	NN	I-TEST	O
of	IN	O	O
35	CD	O	O
,	,	O	O
and	CC	O	O
a	DT	B-TEST	O
ph	NN	I-TEST	O
of	IN	O	O
7.52	CD	O	O
.	.	O	O

ekg	NN	B-TEST	O
showed	VBD	O	O
sinus	JJ	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
100	CD	O	O
and	CC	O	O
echo	VB	B-TEST	B-TEST
revealed	VBN	O	O
pericardial	JJ	B-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
a	DT	B-PROBLEM	B-PROBLEM
10	CD	I-PROBLEM	I-PROBLEM
mm	NN	I-PROBLEM	I-PROBLEM
pulsus	NN	I-PROBLEM	I-PROBLEM
paradoxus	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
,	,	O	O
and	CC	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
tamponade	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

given	VBN	O	O
the	DT	O	O
patient	JJ	O	O
&apos;s	NNP	O	O
history	NN	O	O
of	IN	O	O
cervical	JJ	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
the	DT	B-PROBLEM	B-PROBLEM
pericardial	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
felt	VBN	O	O
most	RBS	O	O
likely	JJ	O	O
to	TO	O	O
be	VB	O	O
malignant	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
therefore	RB	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
retelk	JJ	O	O
county	NN	O	O
medical	JJ	O	O
center	NN	O	O
for	IN	O	O
further	JJ	B-TREATMENT	B-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

02/90	CD	O	O
,	,	O	O
total	JJ	B-TREATMENT	B-TREATMENT
abdominal	JJ	I-TREATMENT	I-TREATMENT
hysterectomy	NN	I-TREATMENT	I-TREATMENT
complicated	VBN	O	O
by	IN	O	O
ureteral	JJ	B-TREATMENT	B-PROBLEM
transection	NN	I-TREATMENT	I-PROBLEM
with	IN	O	O
right	JJ	B-TREATMENT	B-TREATMENT
ureteral	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
placed	VBD	O	O
for	IN	O	O
six	CD	O	O
weeks	NNS	O	O
,	,	O	O
stent	JJ	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
placed	VBN	O	I-TREATMENT
in	IN	O	I-TREATMENT
left	JJ	O	I-TREATMENT
ureter	JJ	O	I-TREATMENT
six	CD	O	O
weeks	NNS	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
for	IN	O	O
a	DT	B-PROBLEM	O
hydronephrosis	NN	I-PROBLEM	O
post	NN	O	O
,	,	O	O
in	IN	O	O
03/91	CD	O	O
,	,	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
appendectomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

prednisone	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.a.m.	NN	O	O
with	IN	O	O
10	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
q.p.m.	RB	O	O
,	,	O	O
uniphyl	JJ	B-TREATMENT	B-TREATMENT
400	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
,	,	O	O
augmentin	RB	B-TREATMENT	B-TREATMENT
250	CD	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O
,	,	O	O
estrase	VB	B-TREATMENT	B-TEST
2	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
,	,	O	O
ms	NN	B-TREATMENT	B-TREATMENT
contin	NN	I-TREATMENT	I-TREATMENT
30	CD	O	O
mg	NN	O	O
q.12h.	NN	O	O
,	,	O	O
and	CC	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
p.r.n.	NN	O	O

emaciated	VBN	O	O
white	JJ	O	O
female	NN	O	O
in	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

temperature	NN	B-TEST	B-TEST
was	VBD	O	O
98.1	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
116	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
120/68	CD	O	O
,	,	O	O
and	CC	O	O
room	NN	B-TEST	O
air	NN	I-TEST	B-TEST
o2	JJ	I-TEST	I-TEST
saturation	NN	I-TEST	I-TEST
was	VBD	O	O
93%	CD	O	O
.	.	O	O

dry	JJ	B-PROBLEM	B-PROBLEM
mucous	JJ	I-PROBLEM	I-PROBLEM
membranes	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
myotic	JJ	B-PROBLEM	B-PROBLEM
pupils	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

few	JJ	B-PROBLEM	B-PROBLEM
inspiratory	NN	I-PROBLEM	I-PROBLEM
wheezes	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
no	DT	O	O
rhonchi	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
with	IN	O	O
tachycardia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
no	DT	O	O
rubs	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

well	RB	B-PROBLEM	B-PROBLEM
healed	VBN	I-PROBLEM	I-PROBLEM
pfannenstiel	NN	I-PROBLEM	I-PROBLEM
scars	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
guaiac	JJ	B-TEST	O
negative	NN	O	O
.	.	O	O

no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

hematocrit	NN	B-TEST	B-TEST
was	VBD	O	O
40	CD	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
21	CD	O	O
,	,	O	O
and	CC	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
723,000	CD	O	O
.	.	O	O

pt	NN	B-TEST	O
and	CC	O	O
ptt	NN	B-TEST	B-TEST
were	VBD	O	O
12	CD	O	O
and	CC	O	O
26	CD	O	O
.	.	O	O

electrolytes	NNS	B-TEST	B-TEST
were	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
,	,	O	O
liver	JJ	B-TEST	B-TEST
function	NN	I-TEST	I-TEST
tests	NNS	I-TEST	I-TEST
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
,	,	O	O
and	CC	O	O
ekg	NN	B-TEST	O
showed	VBD	O	O
a	DT	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
128	CD	O	O
,	,	O	O
axis	RB	B-TEST	B-TEST
73	CD	O	O
,	,	O	O
and	CC	O	O
possible	JJ	O	O
ectopic	NN	B-PROBLEM	B-PROBLEM
p	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
new	JJ	I-PROBLEM	I-PROBLEM
pericardial	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
felt	VBN	O	O
most	RBS	O	O
likely	JJ	O	O
to	TO	O	O
be	VB	O	O
secondary	JJ	O	O
to	TO	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
cervical	JJ	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
tamponade	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
was	VBD	O	O
scheduled	VBN	O	O
and	CC	O	O
cardiology	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
.	.	O	O

echocardiogram	NN	B-TEST	B-TEST
showed	VBD	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
pericardial	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
approximately	RB	O	O
600	CD	O	O
cc	NNS	O	O
with	IN	O	O
diastolic	JJ	B-PROBLEM	B-PROBLEM
indications	NNS	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
ventricle	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
low	JJ	B-PROBLEM	B-PROBLEM
velocity	NN	I-PROBLEM	I-PROBLEM
paradox	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

cardiology	NN	O	O
did	VBD	O	O
not	RB	O	O
feel	VB	O	O
that	IN	O	O
tamponade	NN	B-PROBLEM	B-PROBLEM
at	IN	O	O
this	DT	O	O
time	NN	O	O
was	VBD	O	O
a	DT	O	O
concern	NN	O	O
and	CC	O	O
that	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
tap	NN	I-TREATMENT	I-TREATMENT
need	MD	O	O
not	RB	O	O
be	VB	O	O
performed	VBN	O	O
.	.	O	O

she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
wheezing	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
unknown	JJ	O	O
origin	NN	O	O
,	,	O	O
without	IN	O	O
history	NN	O	O
of	IN	O	O
asthma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

her	PRP$	B-TREATMENT	B-TEST
steroids	NNS	I-TREATMENT	I-TEST
were	VBD	O	O
tapered	VBN	O	O
and	CC	O	O
pulmonary	JJ	O	O
was	VBD	O	O
consulted	VBN	O	O
who	WP	O	O
recommended	VBD	O	O
a	DT	B-TEST	B-TEST
ct	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
chest	NN	I-TEST	I-TEST
to	TO	O	O
evaluate	VB	O	O
the	DT	O	B-PROBLEM
lung	NN	O	I-PROBLEM
parenchyma	NN	O	I-PROBLEM
,	,	O	O
induce	VB	O	B-TEST
sputum	NN	O	I-TEST
for	IN	O	O
cbc	NN	B-TEST	B-TEST
,	,	O	O
arterial	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
gas	NN	I-TEST	I-TEST
,	,	O	O
continuing	VBG	O	B-TREATMENT
of	IN	O	I-TREATMENT
the	DT	B-TREATMENT	I-TREATMENT
beta	NN	I-TREATMENT	I-TREATMENT
agonist	NN	I-TREATMENT	I-TREATMENT
inhalers	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
trial	NN	O	O
of	IN	O	O
steroid	JJ	B-TREATMENT	B-TREATMENT
inhalers	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

they	PRP	O	O
felt	VBD	O	O
it	PRP	O	O
was	VBD	O	O
most	RBS	O	O
likely	JJ	O	O
a	DT	B-PROBLEM	B-PROBLEM
malignant	JJ	I-PROBLEM	I-PROBLEM
lymphangitic	JJ	I-PROBLEM	I-PROBLEM
spread	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
pericardial	JJ	B-PROBLEM	O
involvement	NN	I-PROBLEM	O
versus	NN	O	O
infectious	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
other	JJ	B-PROBLEM	B-PROBLEM
cardiovascular	JJ	I-PROBLEM	I-PROBLEM
causes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
viral	JJ	B-PROBLEM	B-PROBLEM
bronchiolitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
pulmonary	JJ	B-TEST	B-TEST
function	NN	I-TEST	I-TEST
tests	NNS	I-TEST	I-TEST
repeated	VBD	O	O
which	WDT	O	O
showed	VBD	O	O
an	DT	B-TEST	O
fev1	NN	I-TEST	O
of	IN	O	O
36%	CD	O	O
of	IN	O	O
predicted	VBN	O	O
and	CC	O	O
fvc	NN	B-TEST	O
of	IN	O	O
56%	CD	O	O
of	IN	O	O
predicted	VBN	O	O
.	.	O	O

room	NN	B-TEST	B-TEST
air	NN	I-TEST	I-TEST
arterial	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
gas	NN	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-TEST	O
ph	NN	I-TEST	O
of	IN	O	O
7.45	CD	O	O
,	,	O	O
po2	NN	B-TEST	O
of	IN	O	O
63	CD	O	O
,	,	O	O
a	DT	B-TEST	O
pco2	NN	I-TEST	O
of	IN	O	O
41	CD	O	O
,	,	O	O
and	CC	O	O
fairly	RB	B-PROBLEM	O
significant	JJ	I-PROBLEM	O
aa	JJ	I-PROBLEM	O
gradient	NN	I-PROBLEM	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
two	CD	O	O
liters	NNS	O	O
of	IN	O	O
oxygen	NN	B-TREATMENT	B-TREATMENT
awaiting	VBG	O	O
her	PRP$	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
on	IN	O	O
06/14	CD	O	O
and	CC	O	O
she	PRP	O	O
developed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
new	JJ	I-PROBLEM	I-PROBLEM
junctional	JJ	I-PROBLEM	I-PROBLEM
rhythm	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	O	O
question	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
new	JJ	I-PROBLEM	I-PROBLEM
rub	NN	I-PROBLEM	I-PROBLEM
versus	NN	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
examination	NN	B-TEST	B-TEST
.	.	O	O

cardiology	NN	O	O
felt	VBD	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
rub	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
her	PRP$	B-TEST	O
pulsus	NN	I-TEST	O
was	VBD	O	O
still	RB	O	O
10	CD	O	O
.	.	O	O

ekg	NN	B-TEST	O
showed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
ectopic	NN	I-PROBLEM	I-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
p	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
they	PRP	O	O
thought	VBD	O	O
she	PRP	O	O
was	VBD	O	O
still	RB	O	O
stable	JJ	O	O
without	IN	O	O
evidence	NN	O	O
of	IN	O	O
tamponade	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
should	MD	O	O
have	VB	O	O
a	DT	B-TEST	B-TEST
follow-up	JJ	I-TEST	I-TEST
echocardiogram	NN	I-TEST	I-TEST
.	.	O	O

echocardiogram	NN	B-TEST	B-TEST
showed	VBD	O	O
left	JJ	O	B-PROBLEM
ventricle	NN	O	I-PROBLEM
at	IN	O	O
the	DT	O	O
upper	JJ	O	O
limits	NNS	O	O
of	IN	O	O
normal	JJ	O	O
for	IN	O	O
size	NN	O	O
,	,	O	O
low	JJ	B-PROBLEM	O
normal	JJ	I-PROBLEM	O
function	NN	I-PROBLEM	O
,	,	O	O
moderate	VB	B-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
mild	VB	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
pericardial	JJ	B-TEST	B-TEST
pressures	NNS	I-TEST	I-TEST
exceeding	VBG	O	I-TEST
right	JJ	B-TEST	I-TEST
atrial	JJ	I-TEST	I-TEST
pressures	NNS	I-TEST	I-TEST
,	,	O	O
and	CC	O	O
right	RB	B-TEST	B-TEST
ventricular	JJ	I-TEST	I-TEST
pressures	NNS	I-TEST	I-TEST
at	IN	O	O
various	JJ	O	O
points	NNS	O	O
of	IN	O	O
patient	JJ	O	O
&apos;s	JJ	O	O
cycle	NN	O	O
without	IN	O	O
any	DT	O	B-PROBLEM
change	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
06/11	CD	O	O
.	.	O	O

thoracic	NN	O	B-TREATMENT
surgery	NN	O	I-TREATMENT
was	VBD	O	O
also	RB	O	O
consulted	VBN	O	O
and	CC	O	O
they	PRP	O	O
felt	VBD	O	O
that	IN	O	O
there	EX	O	O
was	VBD	O	O
no	DT	O	O
need	NN	O	O
for	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
pericardial	JJ	I-TREATMENT	I-TREATMENT
window	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
the	DT	O	O
time	NN	O	O
.	.	O	O

she	PRP	O	O
should	MD	O	O
be	VB	O	O
continued	VBN	O	O
with	IN	O	O
pulmonary	JJ	B-TEST	B-TEST
oximetry	NN	I-TEST	I-TEST
testing	NN	I-TEST	I-TEST
.	.	O	O

she	PRP	O	O
underwent	VBD	O	O
her	PRP	B-TEST	B-TEST
ct	JJ	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
.	.	O	O

this	DT	O	O
showed	VBD	O	O
lymphangitic	JJ	B-PROBLEM	B-PROBLEM
spread	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
cancer	NN	B-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
question	NN	O	O
of	IN	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
nodules	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
,	,	O	I-PROBLEM
pericardial	JJ	B-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
liver	NN	I-PROBLEM	I-PROBLEM
metastases	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
decreased	VBN	B-PROBLEM	B-PROBLEM
function	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
kidney	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
dilated	VBN	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
intrarenal	JJ	I-PROBLEM	I-PROBLEM
collecting	NN	I-PROBLEM	I-PROBLEM
system	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
proximal	JJ	I-PROBLEM	B-PROBLEM
ureter	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
periaortic	JJ	B-PROBLEM	B-PROBLEM
lymphadenopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pulmonary	JJ	O	O
felt	VBD	O	O
this	DT	O	O
was	VBD	O	O
consistent	JJ	O	O
also	RB	O	O
with	IN	O	O
lymphangitic	JJ	B-PROBLEM	B-PROBLEM
spread	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
they	PRP	O	O
did	VBD	O	O
not	RB	O	O
feel	VB	O	O
that	IN	O	O
a	DT	B-TEST	B-TEST
bronchoscopy	NN	I-TEST	I-TEST
would	MD	O	O
be	VB	O	O
of	IN	O	O
any	DT	O	O
assistance	NN	O	O
at	IN	O	O
this	DT	O	O
time	NN	O	O
.	.	O	O

chemotherapy	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
cervical	JJ	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
discussed	VBN	O	O
with	IN	O	O
the	DT	O	O
patient	NN	O	O
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
5-fu	JJ	B-TREATMENT	O
800	CD	O	O
mg	NN	O	O
per	IN	O	O
meter	NN	O	O
squared	VBD	O	O
days	NNS	O	O
06/18	CD	O	O
,	,	O	O
06/19	CD	O	O
,	,	O	O
and	CC	O	O
06/20	CD	O	O
.	.	O	O

she	PRP	O	O
also	RB	O	O
received	VBD	O	O
cisplatin	JJ	B-TREATMENT	B-TREATMENT
35	CD	O	O
per	IN	O	O
meter	NN	O	O
squared	VBN	O	O
on	IN	O	O
06/19	CD	O	O
and	CC	O	O
ifex	NN	B-TREATMENT	O
and	CC	O	O
mesna	NN	B-TREATMENT	O
on	IN	O	O
06/18	CD	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
,	,	O	O
on	IN	O	O
06/16	CD	O	O
,	,	O	O
to	TO	O	O
have	VB	O	O
numerous	JJ	B-PROBLEM	B-PROBLEM
erythematous	JJ	I-PROBLEM	I-PROBLEM
maculopapules	NNS	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	O
her	PRP$	I-PROBLEM	O
back	NN	I-PROBLEM	O
and	CC	O	O
chest	NN	O	O
.	.	O	O

dermatology	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
and	CC	O	O
they	PRP	O	O
felt	VBD	O	O
that	IN	O	O
this	DT	O	O
was	VBD	O	O
most	RBS	O	O
likely	JJ	O	O
steroid	JJ	B-PROBLEM	B-PROBLEM
acne	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

they	PRP	O	O
therefore	VBP	O	O
felt	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
rapid	JJ	I-TREATMENT	I-TREATMENT
steroid	JJ	I-TREATMENT	I-TREATMENT
taper	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
indicated	VBN	O	O
and	CC	O	O
topical	JJ	B-TREATMENT	B-TREATMENT
erythromycin	NN	I-TREATMENT	I-TREATMENT
if	IN	O	O
desired	VBN	O	O
by	IN	O	O
the	DT	O	O
patient	NN	O	O
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NNP	I-PROBLEM	I-PROBLEM
shortness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
wheezing	VBG	B-PROBLEM	B-PROBLEM
continued	VBN	O	O
but	CC	O	O
without	IN	O	O
change	NN	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
remained	VBD	O	O
the	DT	O	O
same	JJ	O	O
and	CC	O	O
there	EX	O	O
continued	VBN	O	O
to	TO	O	O
be	VB	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
tamponade	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

cardiology	NN	O	O
felt	VBD	O	O
that	IN	O	O
follow-up	JJ	B-TEST	B-TEST
echo	NN	I-TEST	I-TEST
was	VBD	O	O
indicated	VBN	O	O
on	IN	O	O
06/18	CD	O	O
as	IN	O	O
she	PRP	O	O
had	VBD	O	O
another	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
no	DT	O	O
change	NN	O	B-PROBLEM
or	CC	O	O
evidence	NN	O	O
of	IN	O	O
tamponade	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

they	PRP	O	O
therefore	VBP	O	O
felt	VBD	O	O
that	IN	O	O
she	PRP	O	O
could	MD	O	O
be	VB	O	O
continued	VBN	O	O
to	TO	O	O
be	VB	O	O
followed	VBN	O	O
by	IN	O	O
examination	NN	B-TEST	B-TEST
.	.	O	O

she	PRP	O	O
had	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
confusion	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
hallucinations	NNS	B-PROBLEM	B-PROBLEM
on	IN	O	O
06/18	CD	O	O
originating	VBG	O	O
from	IN	O	O
narcotics	NNS	B-TREATMENT	O
versus	NNS	O	O
decreased	VBD	B-PROBLEM	B-PROBLEM
po2	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	O
ifex	NN	I-TREATMENT	O
was	VBD	O	O
held	VBN	O	O
as	IN	O	O
it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
that	IN	O	O
it	PRP	O	O
could	MD	O	O
have	VB	O	O
precipitated	VBN	O	B-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
that	IN	O	O
she	PRP	O	O
was	VBD	O	O
to	TO	O	O
receive	VB	O	O
no	DT	O	O
further	JJ	B-TREATMENT	O
ifex	NN	I-TREATMENT	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
no	DT	O	O
further	JJ	B-PROBLEM	B-PROBLEM
hallucinations	NNS	I-PROBLEM	I-PROBLEM
since	IN	O	O
stopping	VBG	O	O
the	DT	O	O
ifex	NN	B-TREATMENT	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
hooked	VBN	O	O
up	RP	O	O
with	IN	O	O
support	NN	O	O
services	NNS	O	O
in	IN	O	O
collot	NN	O	O
ln	NN	O	O
,	,	O	O
dugo	NN	O	O
,	,	O	O
indiana	VBP	O	O
68961	CD	O	O
for	IN	O	O
further	JJ	B-TREATMENT	O
counselling	NN	I-TREATMENT	O
and	CC	O	O
given	VBN	O	O
xanax	NNS	B-TREATMENT	B-TREATMENT
for	IN	O	O
symptoms	NNS	B-PROBLEM	B-PROBLEM
of	IN	O	O
anxiety	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
no	DT	O	O
change	NN	O	B-PROBLEM
in	IN	O	I-PROBLEM
her	PRP$	B-PROBLEM	I-PROBLEM
shortness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
cardiac	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
and	CC	O	O
was	VBD	O	O
discharged	VBN	O	O
home	NN	O	O
on	IN	O	O
06/22/91	CD	O	O
after	IN	O	O
completing	VBG	O	O
her	PRP$	B-TREATMENT	O
5-fu	JJ	I-TREATMENT	O
and	CC	O	O
cisplatin	JJ	B-TREATMENT	B-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

premarin	NN	B-TREATMENT	B-TREATMENT
0.625	CD	O	O
q.d.	NN	O	O
,	,	O	O
proventil	JJ	B-TREATMENT	B-TREATMENT
inhaler	NN	I-TREATMENT	I-TREATMENT
two	CD	O	O
puffs	NNS	O	O
q.i.d.	RB	O	O
,	,	O	O
beclovent	JJ	B-TREATMENT	B-TREATMENT
four	CD	O	O
puffs	NNS	O	O
b.i.d.	RB	O	O
,	,	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O
,	,	O	O
ms	NN	B-TREATMENT	B-TREATMENT
contin	NN	I-TREATMENT	I-TREATMENT
30	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O
,	,	O	O
elavil	VBZ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.h.s.	NN	O	O
,	,	O	O
trilisate	VB	B-TREATMENT	B-TEST
750	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
ms	NN	B-TREATMENT	B-TREATMENT
elixir	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.2h.	NN	O	O
p.r.n.	NN	O	O
,	,	O	O
robitussin	NN	B-TREATMENT	O
with	IN	O	O
codeine	JJ	B-TREATMENT	B-TREATMENT
5	CD	O	O
cc	NN	O	O
p.o.	NN	O	O
q.2h.	NN	O	O
,	,	O	O
and	CC	O	O
home	NN	B-TREATMENT	B-TREATMENT
o2	NN	I-TREATMENT	I-TREATMENT
two	CD	I-TREATMENT	O
liters	NNS	I-TREATMENT	O
via	IN	O	O
nasal	NN	B-TREATMENT	O
prong	IN	I-TREATMENT	O
with	IN	O	O
increase	NN	O	O
to	TO	O	O
four	CD	O	O
liters	NNS	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
symptoms	NNS	B-PROBLEM	B-PROBLEM
p.r.n.	NNS	O	O

prenatal	NN	B-TEST	B-TEST
screens	NNS	I-TEST	I-TEST
-	:	O	O
a	DT	O	O
positive	JJ	O	O
,	,	O	O
antibody	JJ	B-TEST	B-TEST
negative	JJ	O	O
,	,	O	O
hepatitis	JJ	B-TEST	B-TEST
surface	NN	I-TEST	I-TEST
antigen	NN	I-TEST	I-TEST
negative	JJ	O	O
,	,	O	O
rpr	JJ	B-TEST	O
nonreactive	JJ	O	O
,	,	O	O
rubella	NN	B-TEST	B-TEST
immune	NN	O	O
,	,	O	O
gbs	JJ	B-TEST	O
unknown	NN	O	O
.	.	O	O

remarkable	NN	O	O
for	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
intrauterine	JJ	I-PROBLEM	I-PROBLEM
fetal	JJ	I-PROBLEM	I-PROBLEM
demise	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
30	CD	O	O
weeks	NNS	O	O
gestation	NN	O	O
.	.	O	O

this	DT	O	B-PROBLEM
pregnancy	NN	O	I-PROBLEM
complicated	VBN	O	O
by	IN	O	O
hydramnios	NNS	B-PROBLEM	B-TEST
also	RB	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
baby	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
autopsy	NN	I-TEST	I-TEST
was	VBD	O	O
reported	VBN	O	O
to	TO	O	O
be	VB	O	O
normal	JJ	O	O
.	.	O	O

dates	NNS	O	O
are	VBP	O	O
by	IN	O	O
first	JJ	B-TEST	B-PROBLEM
trimester	NN	I-TEST	I-PROBLEM
ultrasound	NN	I-TEST	I-PROBLEM
.	.	O	O

pregnancy	NN	O	O
was	VBD	O	O
complicated	VBN	O	O
by	IN	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
polyhydramnios	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
an	DT	B-TEST	O
afi	NN	I-TEST	O
of	IN	O	O
45	CD	O	O
just	RB	O	O
prior	RB	O	O
to	TO	O	O
delivery	NN	O	B-TREATMENT
.	.	O	O

mother	NN	O	O
has	VBZ	O	O
had	VBN	O	O
multiple	JJ	B-TEST	B-PROBLEM
ultrasounds	NNS	I-TEST	I-PROBLEM
and	CC	O	O
fetal	JJ	B-TEST	B-TEST
surveys	NNS	I-TEST	I-TEST
at	IN	O	O
17	CD	O	O
and	CC	O	O
21	CD	O	O
weeks	NNS	O	O
that	WDT	O	O
had	VBD	O	O
been	VBN	O	O
unremarkable	JJ	O	O
.	.	O	O

mother	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
debbie-monaco	NN	O	O
from	IN	O	O
western	JJ	O	O
mass.	NNS	O	O
hospital	VBP	O	O
hospital	NN	O	O
in	IN	O	O
the	DT	O	O
middle	NN	O	O
of	IN	O	O
january	JJ	O	O
with	IN	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
polyhydramnios	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
preterm	JJ	B-PROBLEM	B-PROBLEM
labor	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
received	VBD	O	O
a	DT	B-TREATMENT	O
full	JJ	I-TREATMENT	O
course	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
betamethasone	NN	I-TREATMENT	B-TREATMENT
on	IN	O	O
03-28	JJ	O	O
and	CC	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
magnesium	NN	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
until	IN	O	O
04-12	NNP	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
given	VBN	O	O
1	CD	O	O
dose	NN	O	O
of	IN	O	O
nifedipine	JJ	B-TREATMENT	B-TREATMENT
2	CD	O	O
days	NNS	O	O
ago	RB	O	O
as	IN	O	O
a	DT	B-TREATMENT	O
tocolytic	JJ	I-TREATMENT	O
without	IN	O	O
effect	NN	O	O
.	.	O	O

delivery	NN	O	B-TREATMENT
by	IN	O	O
cesarean	JJ	B-TREATMENT	B-TREATMENT
section	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
prompted	VBN	O	O
by	IN	O	O
ongoing	VBG	B-PROBLEM	O
labor	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

preterm	JJ	B-PROBLEM	B-PROBLEM
labor	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
new	JJ	O	B-PROBLEM
onset	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
late	JJ	B-PROBLEM	I-PROBLEM
decelerations	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
breech	JJ	B-PROBLEM	O
presentation	NN	I-PROBLEM	O
.	.	O	O

nuchal	JJ	B-PROBLEM	B-PROBLEM
cord	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
at	IN	O	O
delivery	NN	O	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
cried	VBD	O	O
after	IN	O	O
bulb	NN	B-TREATMENT	B-TREATMENT
suctioning	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
stimulation	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

apgars	NNS	B-TEST	B-TEST
were	VBD	O	O
8	CD	O	O
and	CC	O	O
8	CD	O	O
.	.	O	O

weight	NN	B-TEST	B-TEST
2.985	CD	O	O
kg	NN	O	O
,	,	O	O
95th	CD	O	O
percentile;	NN	O	O
length	NN	B-TEST	B-TEST
48	CD	O	O
cm	NN	O	O
,	,	O	O
85th	CD	O	O
percentile;	NN	O	B-TEST
head	NN	B-TEST	I-TEST
circumference	NN	I-TEST	I-TEST
35	CD	O	O
cm	NN	O	O
,	,	O	O
greater	JJR	O	O
than	IN	O	O
95th	CD	O	O
percentile	NN	O	O
.	.	O	O

anterior	JJ	O	O
fontanel	NNS	O	O
soft	JJ	O	O
and	CC	O	O
flat.	JJ	O	O
head	NN	O	O
shape	NN	O	O
normal	JJ	O	O
with	IN	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
flattened	VBN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	O
top	JJ	I-PROBLEM	O
consistent	NN	O	O
with	IN	O	O
breech	NN	B-PROBLEM	B-PROBLEM
positioning	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
utero	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

facies	NNS	O	B-TEST
nondysmorphic	JJ	B-PROBLEM	O
,	,	O	O
palate	JJ	O	O
intact	NN	O	O
.	.	O	O

mild	JJ	B-PROBLEM	B-PROBLEM
intermittent	NN	I-PROBLEM	I-PROBLEM
grunting	VBG	I-PROBLEM	I-PROBLEM
noted	VBN	O	O
with	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
subcostal	JJ	I-PROBLEM	I-PROBLEM
retractions	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
noted	VBD	O	O
.	.	O	O

abdomen	NNS	O	O
soft	JJ	O	O
with	IN	O	O
no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

tone	NN	B-PROBLEM	O
initially	RB	I-PROBLEM	O
low	JJ	I-PROBLEM	O
normal	JJ	I-PROBLEM	O
but	CC	O	O
improved	JJ	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
on	IN	O	O
admission	NN	O	O
.	.	O	O

hips	NNS	O	B-PROBLEM
increased	VBD	B-PROBLEM	I-PROBLEM
lax	JJ	I-PROBLEM	I-PROBLEM
knee	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
no	DT	O	O
obvious	JJ	B-PROBLEM	B-PROBLEM
dislocation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

infant	NN	O	O
has	VBZ	O	O
an	DT	B-PROBLEM	B-PROBLEM
audible	JJ	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

echocardiogram	JJ	B-TEST	B-TEST
results	NNS	I-TEST	I-TEST
were	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
revealing	VBG	O	O
a	DT	B-PROBLEM	B-PROBLEM
pps	NN	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

birth	NN	B-TEST	B-TEST
weight	NN	I-TEST	I-TEST
was	VBD	O	O
2.985	CD	O	O
kg	NN	O	O
.	.	O	O

discharge	NN	B-TEST	O
weight	VBD	I-TEST	O
..	NNS	O	O

the	DT	O	O
infant	NN	O	O
was	VBD	O	O
initially	RB	O	O
started	VBN	O	O
on	IN	O	O
60	CD	O	O
cc	NNS	O	O
per	IN	O	O
kg	FW	O	O
per	IN	O	O
day	NN	O	O
of	IN	O	O
d10w	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

enteral	JJ	B-TREATMENT	B-TREATMENT
feedings	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
initiated	VBN	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
no.1	NN	O	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
is	VBZ	O	O
currently	RB	O	O
on	IN	O	O
a	DT	O	O
120	CD	O	O
cc	NN	O	O
per	IN	O	O
kg	FW	O	O
per	IN	O	O
day	NN	O	O
of	IN	O	O
premature	NN	B-TREATMENT	B-PROBLEM
enfamil	FW	I-TREATMENT	B-TREATMENT
20	CD	O	I-TREATMENT
calorie	NN	O	I-TREATMENT
or	CC	O	I-TREATMENT
breast	NN	O	I-TREATMENT
milk	NN	O	I-TREATMENT
,	,	O	O
tolerating	VBG	O	O
feeds	NNS	O	O
well	RB	O	O
.	.	O	O

electrolytes	NNS	B-TEST	B-TEST
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
1	CD	O	O
showed	VBD	O	O
a	DT	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
of	IN	O	O
142	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
of	IN	O	O
5.1	CD	O	O
,	,	O	O
chloride	NN	B-TEST	B-TEST
of	IN	O	O
108	CD	O	O
,	,	O	O
and	CC	O	O
total	JJ	B-TEST	B-TEST
co2	NN	I-TEST	I-TEST
of	IN	O	O
23	CD	O	O
.	.	O	O

bilirubin	NN	B-TEST	B-TEST
on	IN	O	O
04-17	NN	O	O
was	VBD	O	O
8.2/0.3	CD	O	O
.	.	O	O

surgery	NN	O	B-TREATMENT
was	VBD	O	O
consulted	VBN	O	O
to	TO	O	O
rule	VB	O	O
out	RP	O	O
a	DT	B-PROBLEM	B-PROBLEM
te	JJ	I-PROBLEM	I-PROBLEM
fistula	NN	I-PROBLEM	I-PROBLEM
as	IN	O	O
the	DT	O	O
infant	NN	O	O
had	VBD	O	O
an	DT	B-PROBLEM	B-TREATMENT
incidental	JJ	I-PROBLEM	I-TREATMENT
pass	NN	I-PROBLEM	I-TREATMENT
of	IN	O	I-TREATMENT
a	DT	B-TREATMENT	I-TREATMENT
gavage	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
into	IN	O	O
his	PRP$	O	O
right	JJ	O	O
bronchus	NN	O	O
.	.	O	O

tef	NN	B-PROBLEM	O
was	VBD	O	O
primarily	RB	O	O
ruled	VBN	O	O
out	RP	O	O
as	IN	O	O
baker	NN	O	O
was	VBD	O	O
passed	VBN	O	O
easily	RB	O	O
to	TO	O	O
stomach	VB	O	O
and	CC	O	O
x-ray	JJ	B-TEST	O
revealed	VBD	O	O
good	JJ	O	O
position	NN	O	O
.	.	O	O

hematocrit	NN	B-TEST	B-TEST
on	IN	I-TEST	O
admission	NN	I-TEST	O
was	VBD	O	O
38.2	CD	O	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
has	VBZ	O	O
not	RB	O	O
required	VBN	O	O
any	DT	B-TREATMENT	B-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

cbc	NN	B-TEST	B-TEST
and	CC	O	O
blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
were	VBD	O	O
obtained	VBN	O	O
on	IN	O	O
admission	NN	O	O
.	.	O	O

cbc	NN	B-TEST	B-TEST
was	VBD	O	O
benign	JJ	O	O
and	CC	O	O
blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
remained	VBD	O	O
negative	JJ	O	O
at	IN	O	O
48	CD	O	O
hours	NNS	O	O
at	IN	O	O
which	WDT	O	O
time	NN	O	O
ampicillin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
were	VBD	O	O
discontinued	VBN	O	O
.	.	O	O

initial	JJ	B-TEST	O
cbc	NN	I-TEST	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
16	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
204	CD	O	O
,	,	O	O
53	CD	O	O
polys	NN	B-TEST	O
and	CC	O	O
0	CD	O	O
bands	NNS	B-TEST	B-TEST
.	.	O	O

of	IN	O	O
note	NN	O	O
incidental	JJ	O	O
finding	NN	O	O
on	IN	O	O
x-ray	NN	B-TEST	O
,	,	O	O
the	DT	O	O
infant	NN	O	O
has	VBZ	O	O
a	DT	B-PROBLEM	O
hemivertebra	NN	I-PROBLEM	O
at	IN	I-PROBLEM	O
t11	NN	I-PROBLEM	O
.	.	O	O

hearing	VBG	B-TEST	O
screen	NN	I-TEST	O
has	VBZ	O	O
not	RB	O	O
been	VBN	O	O
done	VBN	O	O
but	CC	O	O
should	MD	O	O
be	VB	O	O
done	VBN	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

2.	CD	O	O
medications	NNS	B-TREATMENT	B-TREATMENT
:	:	O	O
not	RB	O	O
applicable	JJ	O	O
.	.	O	O

3.	CD	O	O
car	NN	B-TEST	B-TEST
seat	NN	I-TEST	I-TEST
position	NN	I-TEST	I-TEST
screening	NN	I-TEST	I-TEST
has	VBZ	O	O
not	RB	O	O
been	VBN	O	O
performed	VBN	O	O
.	.	O	O

4.	CD	O	O
state	NN	B-TEST	B-TEST
newborn	JJ	I-TEST	I-TEST
screen	NN	I-TEST	I-TEST
was	VBD	O	O
sent	VBN	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
3	CD	O	O
.	.	O	O

5.	CD	O	O
immunizations	NNS	B-TREATMENT	B-TREATMENT
received:	VBP	O	O
the	DT	O	O
infant	NN	O	O
has	VBZ	O	O
not	RB	O	O
received	VBN	O	O
any	DT	B-TREATMENT	B-TREATMENT
immunizations	NNS	I-TREATMENT	I-TREATMENT
at	IN	O	O
this	DT	O	O
time	NN	O	O
.	.	O	O

rule	NN	O	O
out	IN	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

left	VBN	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
a	DT	O	O
63	CD	O	O
year	NN	O	O
old	JJ	O	O
female	NN	O	O
with	IN	O	O
long-standing	JJ	O	O
history	NN	O	O
of	IN	O	O
polycythemia	NN	B-PROBLEM	B-PROBLEM
vera	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
managed	VBD	O	O
medically	RB	O	O
,	,	O	O
who	WP	O	O
on	IN	O	O
a	DT	B-TEST	B-TEST
routine	JJ	I-TEST	I-TEST
follow-up	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
complained	VBD	O	O
of	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
side	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
had	VBD	O	O
an	DT	B-TEST	B-TEST
ultrasound	NN	I-TEST	I-TEST
that	WDT	O	O
demonstrated	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
complex	JJ	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
computerized	JJ	I-TEST	I-TEST
tomography	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
demonstrated	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
contrast	NN	I-PROBLEM	I-PROBLEM
enhancing	VBG	I-PROBLEM	I-PROBLEM
complex	JJ	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

metastatic	JJ	B-TEST	B-TEST
work-up	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
presented	VBD	O	O
for	IN	O	O
nephrectomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

past	JJ	O	O
medical	JJ	O	O
history	NN	O	O
included	VBD	O	O
polycythemia	NN	B-PROBLEM	B-PROBLEM
vera	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

past	JJ	O	O
surgical	JJ	O	O
history	NN	O	O
included	VBD	O	O
appendectomy	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
bunionectomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

medications	NNS	O	B-TREATMENT
on	IN	O	O
admission	NN	O	O
were	VBD	O	O
hydrea	NNS	B-TREATMENT	B-PROBLEM
.	.	O	O

review	NN	B-TEST	B-TEST
of	IN	I-TEST	I-TEST
systems	NNS	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
in	IN	O	O
detail	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
a	DT	O	O
robust	JJ	O	O
white	JJ	O	O
female	NN	O	O
in	IN	O	O
no	DT	O	O
acute	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
165/80	CD	O	O
.	.	O	O

rectal	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
guaiac	JJ	B-TEST	B-TEST
negative	JJ	O	O
.	.	O	O

extremities	NNS	B-TEST	O
and	CC	I-TEST	O
neurological	JJ	I-TEST	B-TEST
examinations	NNS	I-TEST	I-TEST
were	VBD	O	O
unremarkable	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
by	IN	O	O
dr.	JJ	O	O
suot	NN	O	O
n.	JJ	O	O
dragtente	NN	O	O
on	IN	O	O
02-21-91	NN	O	O
,	,	O	O
where	WRB	O	O
a	DT	B-TREATMENT	B-TREATMENT
left	JJ	I-TREATMENT	I-TREATMENT
radical	JJ	I-TREATMENT	I-TREATMENT
nephrectomy	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
performed	VBN	O	O
.	.	O	O

at	IN	O	O
operation	NN	B-TREATMENT	O
,	,	O	O
there	EX	O	O
was	VBD	O	O
no	DT	O	O
gross	JJ	B-PROBLEM	B-PROBLEM
adenopathy	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
renal	JJ	B-PROBLEM	B-PROBLEM
vein	NN	I-PROBLEM	I-PROBLEM
involvement	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
that	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
completely	RB	O	O
excised	VBN	O	O
.	.	O	O

the	DT	O	O
oncology	NN	O	O
fellows	VBZ	O	O
from	IN	O	O
venbonlea	NN	O	B-PROBLEM
health	NN	O	I-PROBLEM
followed	VBD	O	O
her	PRP$	O	O
course	NN	O	O
and	CC	O	O
recommended	VBD	O	O
holding	VBG	O	O
off	RP	O	O
on	IN	O	O
her	PRP$	B-TREATMENT	O
hydrea	NN	I-TREATMENT	O
while	IN	O	O
she	PRP	O	O
is	VBZ	O	O
hospitalized	VBN	O	O
,	,	O	O
and	CC	O	O
they	PRP	O	O
will	MD	O	O
follow	VB	O	O
her	PRP	O	O
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
and	CC	O	O
restart	VB	O	O
her	PRP$	B-TREATMENT	O
hydrea	NN	I-TREATMENT	O
when	WRB	O	O
her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
is	VBZ	O	O
over	IN	O	O
40%	CD	O	O
.	.	O	O

medications	NNS	O	B-TREATMENT
on	IN	O	O
discharge	NN	O	O
included	VBD	O	O
percocet	RB	B-TREATMENT	B-TREATMENT
1	CD	O	O
to	TO	O	O
2	CD	O	O
tablets	NNS	O	O
by	IN	O	O
mouth	NN	O	O
every	DT	O	O
4	CD	O	O
hours	NNS	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
milligrams	NNS	O	O
by	IN	O	O
mouth	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
3285	CD	O	O
gm	NN	O	O
infant	NN	O	O
born	VBN	O	O
at	IN	O	O
37	CD	O	O
5/7	CD	O	O
weeks	NNS	O	O
to	TO	O	O
a	DT	O	O
21	CD	O	O
year	NN	O	O
old	JJ	O	O
g3	NN	O	O
p1	NN	O	O
now	RB	O	O
2	CD	O	O
mother	NN	O	O
with	IN	O	O
prenatal	JJ	B-TEST	B-TEST
screens	NNS	I-TEST	I-TEST
as	IN	O	O
follows	VBZ	O	O
:	:	O	O

o	RB	O	O
positive	JJ	O	O
,	,	O	O
antibody	JJ	B-TEST	B-TEST
negative	JJ	O	O
,	,	O	O
hepatitis	NN	B-TEST	B-TEST
b	NN	I-TEST	I-TEST
surface	NN	I-TEST	I-TEST
antigen	NN	I-TEST	I-TEST
negative	JJ	O	O
,	,	O	O
rpr	JJ	B-TEST	O
nonreactive	JJ	O	O
,	,	O	O
gbs	JJ	B-TEST	B-TEST
negative	JJ	O	O
.	.	O	O

unremarkable	JJ	O	B-PROBLEM
pregnancy	NN	O	I-PROBLEM
except	IN	O	O
for	IN	O	O
minor	JJ	B-PROBLEM	B-PROBLEM
fullness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
pelvis	NN	I-PROBLEM	I-PROBLEM
reported	VBD	O	O
during	IN	O	O
the	DT	O	O
week	NN	O	O
prior	RB	O	O
to	TO	O	O
delivery	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

past	JJ	O	O
ob	JJ	O	O
history	NN	O	O
remarkable	NN	O	O
for	IN	O	O
postpartum	NN	B-PROBLEM	B-PROBLEM
depression	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mother	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
in	IN	O	O
labor	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

baby	NN	O	O
was	VBD	O	O
delivered	VBN	O	O
by	IN	O	O
repeat	NN	B-TREATMENT	O
c-section	NN	I-TREATMENT	O
with	IN	O	O
rupture	NN	B-TREATMENT	B-PROBLEM
of	IN	I-TREATMENT	I-PROBLEM
membranes	NNS	I-TREATMENT	I-PROBLEM
at	IN	O	I-PROBLEM
delivery	NN	B-TREATMENT	I-PROBLEM
.	.	O	O

apgars	NNS	B-TEST	B-TEST
were	VBD	O	O
8	CD	O	O
and	CC	O	O
9	CD	O	O
.	.	O	O

cmed	VBN	O	O
csru	JJ	O	O
staff	NN	O	O
was	VBD	O	O
called	VBN	O	O
about	RB	O	O
30	CD	O	O
minutes	NNS	O	O
of	IN	O	O
age	NN	O	O
for	IN	O	O
grunting	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
flaring	VBG	B-PROBLEM	B-PROBLEM
and	CC	O	O
retractions	NNS	B-PROBLEM	O
and	CC	O	O
the	DT	O	O
baby	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
csru	NN	O	O
.	.	O	O

exam	NN	B-TEST	B-TEST
was	VBD	O	O
notable	JJ	O	O
for	IN	O	O
a	DT	O	O
term	NN	O	O
infant	NN	O	O
with	IN	O	O
flat	JJ	O	B-PROBLEM
anterior	JJ	O	I-PROBLEM
fontanelle	NN	O	I-PROBLEM
,	,	O	O
pink	VBP	O	O
color	NN	O	O
,	,	O	O
normal	JJ	O	O
facies	NNS	O	O
,	,	O	O
intact	JJ	O	O
palate	NN	O	O
,	,	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
retractions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
good	JJ	O	O
air	NN	O	O
entry	NN	O	O
,	,	O	O
no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

femoral	JJ	B-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
present	JJ	O	O
.	.	O	O

flat	JJ	O	O
,	,	O	O
soft	JJ	O	O
and	CC	O	O
nontender	JJ	B-PROBLEM	B-PROBLEM
abdomen	NNS	I-PROBLEM	I-PROBLEM
without	IN	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

initial	JJ	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
19.4	CD	O	O
thousand	NN	O	O
,	,	O	O
64	CD	O	O
polys	NN	B-TEST	B-TEST
,	,	O	O
3	CD	O	O
bands	NNS	B-TEST	B-TEST
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
35.8	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
281,000	CD	O	O
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
revealed	VBD	O	O
streaky	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
fields	NNS	I-PROBLEM	I-PROBLEM
of	IN	O	O
normal	JJ	O	O
situs	NN	O	O
,	,	O	O
no	DT	O	O
consolidation	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
consistent	JJ	O	O
with	IN	O	O
retained	JJ	B-PROBLEM	B-PROBLEM
fetal	JJ	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
athol	NN	O	O
memorial	JJ	O	O
hospital	NN	O	O
hospital	NN	O	O
course	NN	O	O
was	VBD	O	O
initially	RB	O	O
consistent	JJ	O	O
with	IN	O	O
transient	JJ	B-PROBLEM	B-PROBLEM
tachypnea	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
newborn	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
revealed	VBD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
streakiness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
fields	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
initially	RB	O	O
placed	VBN	O	O
on	IN	O	O
nasal	JJ	B-TREATMENT	B-TREATMENT
cannula	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
subsequent	JJ	O	O
resolution	NN	O	O
of	IN	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

nasal	JJ	B-TREATMENT	B-TREATMENT
cannula	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
weaned	VBN	O	O
off	RP	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
3	CD	O	O
and	CC	O	O
he	PRP	O	O
initially	RB	O	O
was	VBD	O	O
maintaining	VBG	O	B-TEST
o2	JJ	B-TEST	I-TEST
sat	NNS	I-TEST	I-TEST
above	IN	O	O
94%	CD	O	O
and	CC	O	O
breathing	VBG	O	O
comfortably	RB	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
subsequently	RB	O	O
placed	VBN	O	O
back	RP	O	O
on	IN	O	O
nasal	NN	B-TREATMENT	B-TREATMENT
cannula	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
oxygen	NN	I-PROBLEM	I-PROBLEM
desaturation	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
requiring	VBG	O	O
25	CD	O	O
c/min	NN	O	B-TREATMENT
flow	NN	O	I-TREATMENT
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

no	DT	O	O
apneic	NN	B-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	O
brady	JJ	I-PROBLEM	B-PROBLEM
episodes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
exam	NN	B-TEST	B-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
been	VBN	O	O
tolerating	VBG	O	O
oral	JJ	O	B-TREATMENT
feeding	NN	O	I-TREATMENT
as	IN	O	O
of	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
2	CD	O	O
and	CC	O	O
is	VBZ	O	O
currently	RB	O	O
taking	VBG	O	O
enfamil	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
p.o.	NN	O	O
ad	NN	O	O
lib	NN	O	O
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
weaned	VBN	O	O
off	RP	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
has	VBZ	O	O
been	VBN	O	O
maintaining	VBG	O	O
good	JJ	O	O
blood	NN	O	O
glucose	NN	O	B-TEST
.	.	O	O

his	PRP$	B-TEST	B-TEST
birth	NN	I-TEST	I-TEST
weight	NN	I-TEST	I-TEST
was	VBD	O	O
3285	CD	O	O
gm	NN	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
weight	NN	I-TEST	I-TEST
is	VBZ	O	O
3015	CD	O	O
gm	NN	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
5	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
bilirubin	JJ	I-TEST	I-TEST
level	NN	I-TEST	I-TEST
at	IN	O	O
24	CD	O	O
hours	NNS	O	O
of	IN	O	O
life	NN	O	O
was	VBD	O	O
4.6.	CD	O	O

no	DT	O	O
phototherapy	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
started	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
not	RB	O	O
started	VBN	O	O
on	IN	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
given	VBN	O	O
lack	NN	O	O
of	IN	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
risk	NN	I-PROBLEM	I-PROBLEM
factors	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
initial	JJ	I-TEST	I-TEST
cbc	NN	I-TEST	I-TEST
showed	VBD	O	O
no	DT	O	O
left	JJ	B-PROBLEM	B-PROBLEM
shift	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

blood	NN	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
had	VBD	O	O
remained	VBN	O	O
no	RB	O	O
growth	NN	B-PROBLEM	O
to	TO	O	O
date	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
initial	JJ	I-TEST	I-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
35.8	CD	O	O
.	.	O	O

no	DT	O	O
transfusion	NN	B-TREATMENT	B-PROBLEM
during	IN	O	O
this	DT	B-TREATMENT	O
admission	NN	I-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
been	VBN	O	O
doing	VBG	O	O
well	RB	O	O
on	IN	O	O
low	JJ	B-TREATMENT	B-PROBLEM
flow	NN	I-TREATMENT	I-PROBLEM
nasal	NN	I-TREATMENT	I-PROBLEM
cannula.	NN	I-TREATMENT	I-PROBLEM
he	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
tolerating	VBG	O	O
p.o.	NN	O	B-TREATMENT
ad	NN	O	I-TREATMENT
lib	NN	O	I-TREATMENT
feeds	NNS	O	I-TREATMENT
.	.	O	O

1.	CD	O	O
feeds	NNS	O	O
at	IN	O	O
discharge	NN	O	O
:	:	O	O
enfamil	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
p.o.	NN	O	O
ad	NN	O	O
lib	NN	O	O
.	.	O	O

2.	CD	O	O
medications	NNS	B-TREATMENT	B-TREATMENT
:	:	O	O
none	NN	O	O
.	.	O	O

4.	CD	O	O
state	NN	B-TEST	B-TEST
newborn	JJ	I-TEST	I-TEST
screening	NN	I-TEST	I-TEST
sent	NN	O	O
.	.	O	O

5.	CD	O	O
immunizations	NNS	B-TREATMENT	B-TREATMENT
:	:	O	O
received	VBN	O	O
hepatitis	NN	B-TREATMENT	B-TREATMENT
b	NN	I-TREATMENT	O
on	IN	O	O
09-16	NN	O	O
.	.	O	O

1.	CD	O	O
prolonged	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
transition	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
hyaline	JJ	B-PROBLEM	B-PROBLEM
membrane	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
rule	NN	O	O
out	IN	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
without	IN	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
73-year-old	JJ	O	O
man	NN	O	O
with	IN	O	O
squamous	JJ	B-PROBLEM	B-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
lobectomy	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
resection	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
cervical	JJ	I-PROBLEM	I-PROBLEM
recurrence	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
admitted	VBN	O	O
here	RB	O	O
with	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
neutropenia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

recently	RB	O	O
he	PRP	O	O
had	VBD	O	O
been	VBN	O	O
receiving	VBG	O	O
a	DT	O	B-TREATMENT
combination	NN	O	I-TREATMENT
of	IN	O	I-TREATMENT
outpatient	JJ	B-TREATMENT	I-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
the	DT	O	O
camp	NN	O	O
program	NN	O	O
.	.	O	O

other	JJ	B-PROBLEM	B-PROBLEM
medical	JJ	I-PROBLEM	I-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
include	VBP	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
neuropathy	JJ	B-PROBLEM	B-PROBLEM
from	IN	O	O
taxol	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

temperature	NN	B-TEST	B-TEST
was	VBD	O	O
101.3	CD	O	O
.	.	O	O

lungs	NNS	O	O
were	VBD	O	O
clear	JJ	O	O
to	TO	O	O
percussion	NN	B-TEST	B-TEST
and	CC	O	O
auscultation	NN	B-TEST	B-TEST
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
few	JJ	I-PROBLEM	I-PROBLEM
scattered	JJ	I-PROBLEM	I-PROBLEM
rales	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
left	VBD	O	O
greater	JJR	O	O
than	IN	O	O
right	NN	O	O
.	.	O	O

abdominal	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
normal	JJ	O	O
.	.	O	O

neurological	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
nonfocal	JJ	O	O
.	.	O	O

the	DT	B-TEST	O
wbc	NN	I-TEST	O
was	VBD	O	O
0.9	CD	O	O
,	,	O	O
the	DT	B-TEST	O
anc	NN	I-TEST	O
was	VBD	O	O
540	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
were	VBD	O	O
156,000	CD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
neupogen	NN	B-TREATMENT	O
,	,	O	O
400	CD	O	O
mcg.	NN	O	O
subq.	NN	O	O
q.d.	NN	O	O

he	PRP	O	O
was	VBD	O	O
initially	RB	O	O
treated	VBN	O	O
with	IN	O	O
antibiotic	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
showed	VBD	O	O
questionable	JJ	O	B-PROBLEM
nodule	NN	B-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
reasonably	RB	O	O
stable	JJ	O	O
.	.	O	O

calcium	NN	B-TEST	B-TEST
8.7	CD	O	O
,	,	O	O
bilirubin	NN	B-TEST	B-TEST
0.3/1.3	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
1.1	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
128	CD	O	O
.	.	O	O

hematocrit	NN	B-TEST	B-TEST
24.6	CD	O	O
.	.	O	O

wbc	NN	B-TEST	B-TEST
rose	VBD	O	O
to	TO	O	O
1.7	CD	O	O
on	IN	O	O
10/19	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
diarrhea	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
10/20	CD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
feeling	VBG	O	O
well	RB	O	O
and	CC	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
neutropenia	NN	I-PROBLEM	I-PROBLEM
resolved	VBD	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
in	IN	O	O
satisfactory	JJ	O	O
condition	NN	O	O
on	IN	O	O
discharge	NN	O	O
on	IN	O	O
10/20/95	CD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
discharged	VBN	O	O
home	NN	O	O
on	IN	O	O
neupogen	NN	B-TREATMENT	O
.	.	O	O

fever	NN	B-PROBLEM	B-PROBLEM
neutropenia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
squamous	JJ	I-PROBLEM	I-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

include	NN	O	O
neupogen	NN	B-TREATMENT	O
,	,	O	O
480	CD	O	O
mcg.	NN	O	O
subq.	NN	O	O
q.d.	NN	O	O
and	CC	O	O
usual	JJ	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

penicillins	NNS	B-TREATMENT	B-TREATMENT
/	VBP	O	O
norvasc	JJ	B-TREATMENT	B-TREATMENT
/	NNP	O	O
verapamil	NN	B-TREATMENT	B-TREATMENT

preop	NN	B-TEST	O
w/	NN	I-TEST	O
for	IN	O	O
knee	NN	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
revealed	VBD	O	O
cardiac	JJ	B-PROBLEM	B-PROBLEM
dz	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
asymptomatic	JJ	B-PROBLEM	B-PROBLEM

cabgx4	NN	B-TREATMENT	B-PROBLEM
(	(	O	O
06-26	CD	O	O
)	)	O	O

69yom	CD	O	O
with	IN	O	O
oa	JJ	B-PROBLEM	O
having	VBG	O	O
workup	NN	B-TEST	B-TEST
for	IN	O	O
knee	NN	B-TREATMENT	B-TREATMENT
replacements	NNS	I-TREATMENT	I-TREATMENT
found	VBD	O	O
to	TO	O	O
be	VB	O	O
in	IN	O	O
afib	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
had	VBD	O	O
stress	JJ	B-TEST	B-TEST
test	NN	I-TEST	I-TEST
that	WDT	O	O
was	VBD	O	O
positive	JJ	O	O
followed	VBN	O	O
by	IN	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
which	WDT	O	O
revealed	VBD	O	O
severe	JJ	B-PROBLEM	O
3vd	CD	I-PROBLEM	O
.	.	O	O

then	RB	O	O
referred	VBN	O	O
for	IN	O	O
cabg	NN	B-TREATMENT	B-TREATMENT

htn	NN	B-PROBLEM	B-PROBLEM

chol	NN	B-PROBLEM	B-TREATMENT

afib	NN	B-PROBLEM	B-PROBLEM

oa	NN	B-PROBLEM	O
needs	VBZ	O	O
bilat	JJ	B-TREATMENT	B-TREATMENT
arthroplasty	NN	I-TREATMENT	I-TREATMENT

cri	NN	B-PROBLEM	B-PROBLEM

brother	NN	O	O
died	VBD	O	O
64	CD	O	O
/	NNP	O	O
mi	NN	B-PROBLEM	B-PROBLEM

vs	NN	B-TEST	O
t	VBZ	B-TEST	O
98	CD	O	O
hr	NN	B-TEST	B-TEST
74	CD	O	O
bp	NN	B-TEST	O
136/88	CD	O	O
rr	NN	B-TEST	B-TEST
18	CD	O	O

gen	NN	O	O
nad	NN	B-PROBLEM	O

cv	JJ	O	O
irreg-irreg	NN	B-PROBLEM	O
,	,	O	O
no	DT	O	O
m/r	NN	B-PROBLEM	B-PROBLEM

abdn	NN	O	O
soft	JJ	O	O
,	,	O	O
nt/nd/+bs	JJ	B-PROBLEM	B-PROBLEM

ext	JJ	O	O
warm	JJ	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM

t99.9	NN	B-TEST	O
hr	VBD	B-TEST	O
70af	CD	O	O
bp	NN	B-TEST	O
120/69	CD	O	O
rr	NN	B-TEST	B-TEST
20	CD	O	O
o2sat	VBD	B-TEST	O
94%ra	CD	O	O

neuro	JJ	O	O
a&ox3	NN	O	O
mae	NN	O	O
,	,	O	O
non	JJ	B-TEST	B-TEST
focal	JJ	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST

cv	NN	O	O
irreg	NN	B-PROBLEM	O
irreg	NN	I-PROBLEM	O
,	,	O	O
sternum	NN	B-PROBLEM	B-PROBLEM
stable	JJ	I-PROBLEM	I-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
cdi	NN	O	I-PROBLEM

abdm	NN	O	O
soft	JJ	O	O
,	,	O	O
nt/nd/+bs	JJ	B-PROBLEM	B-PROBLEM

ext	JJ	O	O
warm	JJ	O	O
2+	CD	B-PROBLEM	O
edema	NN	I-PROBLEM	B-PROBLEM

glucose	JJ	B-TEST	B-TEST
-	:	O	O
97	CD	O	O
urea	JJ	B-TEST	B-TEST
n	SYM	O	I-TEST
-	:	O	O
44	CD	O	O
*	NN	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
2.0	CD	O	O
*	JJ	O	O
sodium	NN	B-TEST	B-TEST
-	:	O	O
143	CD	O	O
potassium	NN	B-TEST	B-TEST
-	:	O	O
4.1	CD	O	O
chloride	NN	B-TEST	B-TEST
-	:	O	O
107	CD	O	O
total	JJ	B-TEST	B-TEST
co2	NN	I-TEST	I-TEST
-	:	O	O
27	CD	O	O
anion	NN	B-TEST	B-TEST
gap	NN	I-TEST	I-TEST
-	:	O	O
13	CD	O	O

alt(sgpt)	SYM	B-TEST	B-TEST
-	:	O	O
19	CD	O	O
ast(sgot)	SYM	B-TEST	B-TEST
-	:	O	O
19	CD	O	O
ld(ldh)	SYM	B-TEST	B-TEST
-	:	O	O
153	CD	O	O
alk	NN	B-TEST	B-TEST
phos	NN	I-TEST	I-TEST
-	:	O	O
58	CD	O	O
tot	NN	B-TEST	O
bili	SYM	I-TEST	B-TEST
-	:	O	O
0.4	CD	O	O

albumin	SYM	B-TEST	B-TEST
-	:	O	O
4.3	CD	O	O

%hba1c	SYM	B-TEST	B-TEST
-	:	O	O
5.7	CD	O	O

tsh	SYM	B-TEST	B-TEST
-	:	O	O
1.2	CD	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
7.0	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.92	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
12.6	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
36.4	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
93	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
32.1	CD	O	O
*	NN	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.6	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
13.6	CD	O	O

plt	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
-	:	O	O
207	CD	O	O

pt	SYM	B-TEST	B-TEST
-	:	O	O
11.8	CD	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
22.4	CD	O	O
inr(pt)	JJ	B-TEST	O
-	:	O	O
1.0	CD	O	O

2019-07-01	JJ	O	O
07:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	B-TEST	B-TEST
-	:	O	O
8.7	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.18	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
10.4	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
30.4	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
96	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
32.7	CD	O	O
*	NN	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.3	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
13.5	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
303	CD	O	O

2019-07-01	JJ	O	O
07:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
plt	NN	B-TEST	I-TEST
ct	VBD	I-TEST	I-TEST
-	:	O	O
303	CD	O	O

2019-07-01	JJ	O	O
07:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
pt	NN	B-TEST	I-TEST
-	:	O	O
14.4	CD	O	O
*	NN	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
24.2	CD	O	O
inr(pt)-	JJ	B-TEST	O
1.3	CD	O	O
*	NN	O	O

2019-06-30	JJ	O	O
06:45	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
99	CD	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
40	CD	O	O
*	NN	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.9	CD	O	O
*	NN	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
137	CD	O	O
k	SYM	O	B-TEST
-	:	O	O
4.1	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
99	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
28	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
14	CD	O	O

chest	NN	B-TEST	O
(	(	I-TEST	O
portable	JJ	I-TEST	O
a	DT	I-TEST	O
p)	NN	I-TEST	O

chest	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
portable	JJ	I-TEST	I-TEST
ap	NN	I-TEST	I-TEST
)	)	I-TEST	I-TEST

reason	NN	O	O
:	:	O	O
effusion	NN	B-PROBLEM	B-PROBLEM
?	.	O	O
pntx	NN	B-PROBLEM	B-PROBLEM
?	.	O	O

69	CD	O	O
year	NN	O	O
old	JJ	O	O
man	NN	O	O
with	IN	O	O
s/p	JJ	O	B-TREATMENT
off	RP	B-TREATMENT	I-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
cabg	NN	I-TREATMENT	I-TREATMENT

effusion	NN	B-PROBLEM	B-PROBLEM
?	.	O	O
pntx	NN	B-PROBLEM	B-PROBLEM
?	.	O	O

portable	JJ	B-TEST	O
chest	NN	I-TEST	O
on	IN	O	O
2019-06-30	JJ	O	O
at	IN	O	O
11:39	CD	O	O

indication	NN	O	O
:	:	O	O
cabg	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
chest	JJ	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
place	NN	O	O
.	.	O	O

findings	NNS	O	O
:	:	O	O
left	VBD	B-TREATMENT	B-TREATMENT
chest	JJS	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
remains	VBZ	O	O
in	IN	O	O
place	NN	O	O
with	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
density	NN	I-PROBLEM	I-PROBLEM
adjacent	JJ	I-PROBLEM	O
to	TO	I-PROBLEM	O
the	DT	I-PROBLEM	O
tip	NN	I-PROBLEM	O
,	,	O	O
but	CC	O	O
there	EX	O	O
is	VBZ	O	O
no	DT	O	O
significant	JJ	B-PROBLEM	O
interval	JJ	I-PROBLEM	O
change	NN	I-PROBLEM	O
vs	NN	O	O
.	.	O	O
prior	RB	O	O
.	.	O	O

specifically	RB	O	O
,	,	O	O
there	EX	O	O
is	VBZ	O	O
no	DT	O	O
pneumothorax	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
no	DT	O	O
interval	JJ	B-PROBLEM	B-PROBLEM
development	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

69	CD	O	O
yo	NNS	O	O
m	JJ	O	O
with	IN	O	O
known	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
admitted	VBD	O	O
preop	NN	O	O
for	IN	O	O
transition	NN	O	O
fro	NN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
to	TO	O	O
heparin	VB	B-TREATMENT	B-TREATMENT
.	.	O	O

brought	VBN	O	O
to	TO	O	O
the	DT	O	O
or	CC	O	O
on	IN	O	O
06-26	JJ	O	O
for	IN	O	O
cabg	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
please	VB	O	O
see	VB	O	O
or	CC	O	O
report	VB	O	O
for	IN	O	O
details	NNS	O	O
.	.	O	O

in	IN	O	O
summary	JJ	O	O
pt	NN	O	O
had	VBD	O	O
off	RP	B-TREATMENT	O
pump	JJ	I-TREATMENT	O
cabgx4	NN	I-TREATMENT	O
with	IN	O	O
lima-lad	JJ	B-TREATMENT	O
,	,	O	O
svg	JJ	B-TREATMENT	B-TREATMENT
om-y	JJ	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
-	:	I-TREATMENT	O
diag	NN	I-TREATMENT	B-PROBLEM
,	,	O	O
svg-pda	NN	B-TREATMENT	O
.	.	O	O

pt	NN	O	O
tolerated	VBD	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
well	RB	O	O
and	CC	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
ct	VB	O	O
cmed	JJ	O	O
icu	NN	O	O
.	.	O	O

he	PRP	O	O
did	VBD	O	O
well	RB	O	O
in	IN	O	O
immediate	JJ	O	O
post-op	JJ	O	O
period	NN	O	O
was	VBD	O	O
extubated	VBN	B-TREATMENT	O
and	CC	O	O
on	IN	O	O
pod1	NN	O	O
he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
step	NN	O	O
down	RP	O	O
floor	NN	O	O
.	.	O	O

on	IN	O	O
pod2	PDT	O	B-TREATMENT
his	PRP$	B-TREATMENT	I-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
tubes	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
epicardial	JJ	B-TREATMENT	B-TREATMENT
pacing	NN	I-TREATMENT	I-TREATMENT
wires	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
removed	VBN	O	O
and	CC	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
restarted	VBN	O	O
.	.	O	O

atenolol	RB	B-TREATMENT	B-TREATMENT
200	CD	O	O
'	''	O	O

hctz	RB	B-TREATMENT	O
25	CD	O	O
'	''	O	O

lisinopril	RB	B-TREATMENT	B-TREATMENT
20	CD	O	O
'	''	O	O

ultram	JJ	B-TREATMENT	B-TREATMENT
50	CD	O	O
'	''	O	O

prilosec	RB	B-TREATMENT	B-TREATMENT
20	CD	O	O
'	''	O	O

zocor	NN	B-TREATMENT	B-TREATMENT
40	CD	O	O
'	''	O	O

levitra	JJ	B-TREATMENT	O
/	NNP	O	O
prn	NN	O	O

warfarin	RB	B-TREATMENT	B-TREATMENT
4	CD	O	O
'	''	O	O

1.	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
tartrate	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
ellis	NN	O	O
).	NN	O	O

2.	CD	O	O
furosemide	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
leukhardt	NN	O	O
for	IN	O	O
2	CD	O	O
weeks	NNS	O	O
.	.	O	O

3.	CD	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
10	CD	O	O
meq	NN	O	O
tablet	NN	O	O
sustained	VBD	O	O
release	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
sustained	VBN	O	O
release	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
sine	NN	O	O
for	IN	O	O
2	CD	O	O
weeks	NNS	O	O
.	.	O	O

4.	CD	O	O
docusate	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
costa	NN	O	O
).	NN	O	O

5.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
81	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

6.	CD	O	O
warfarin	JJ	B-TREATMENT	B-TREATMENT
2	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
avrett	NN	O	O
:	:	O	O
target	NN	B-TEST	O
inr	JJ	I-TEST	O
1.5-2	JJ	O	O
.	.	O	O

7.	CD	O	O
oxycodone	CD	B-TREATMENT	B-TREATMENT
-	:	I-TREATMENT	I-TREATMENT
acetaminophen	NN	I-TREATMENT	I-TREATMENT
5-325	JJ	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
tablets	NNS	O	O
po	JJ	O	O
every	DT	O	O
4-6	JJ	O	O
hours	NNS	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

8.	CD	O	O
simvastatin	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

9.	CD	O	O
prilosec	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
capsule	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
gray	NN	O	O
.	.	O	O

10.	CD	O	O
ultram	JJ	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q6	NN	O	O
hrs	NN	O	O
/	NNP	O	O
prn	NN	O	O
.	.	O	O

s/p	VB	O	O
off	RP	B-TREATMENT	B-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
cabgx4	NN	I-TREATMENT	I-TREATMENT
lima-lad	JJ	B-TREATMENT	I-TREATMENT
,y	JJ	B-TREATMENT	I-TREATMENT
svg-om-diag,	JJ	I-TREATMENT	I-TREATMENT
svg-pda	NN	B-TREATMENT	I-TREATMENT
(	(	O	O
06-26	JJ	O	O
)	)	O	O
pmh	NN	O	O
:	:	O	O
htn	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
chol	NN	B-PROBLEM	B-TREATMENT
,	,	O	O
af	NN	B-PROBLEM	O
,	,	O	O
oa	NN	B-PROBLEM	O
,	,	O	O
cri	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
s/p	JJ	O	B-TREATMENT
bilat	JJ	B-TREATMENT	I-TREATMENT
knee	NN	I-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT

keep	VB	O	O
wounds	NNS	B-PROBLEM	B-PROBLEM
clean	JJ	O	O
and	CC	O	O
dry	JJ	O	O
.	.	O	O

take	VB	O	O
all	DT	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
as	IN	O	O
prescribed	NN	O	O

call	NN	O	O
for	IN	O	O
any	DT	O	B-PROBLEM
fever	NN	B-PROBLEM	I-PROBLEM
,	,	O	O
redness	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
drainage	NN	B-PROBLEM	B-PROBLEM
from	IN	O	O
wounds	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

right	JJ	B-PROBLEM	B-PROBLEM
le	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

tylenol	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
acetaminophen	JJ	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
325-650	JJ	O	O
mg	NN	O	O
po	NN	O	O
q4h	NN	O	O
prn	NN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
headache	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
temperature	NN	B-TEST	B-TEST
greater	JJR	O	O
than	IN	O	O
:	:	O	O

101	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
docusate	JJ	I-TREATMENT	I-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	JJ	O	O
po	NN	O	O
bid	NN	O	O
oxycodone	CD	B-TREATMENT	O
10-25	JJ	O	O
mg	NN	O	O
po	NN	O	O
q3h	NN	O	O
prn	NN	O	O
pain	NN	B-PROBLEM	B-PROBLEM

excesive	JJ	B-PROBLEM	B-PROBLEM
sedation	NN	I-PROBLEM	I-PROBLEM
rr	NN	B-TEST	I-PROBLEM
&lt;	VBD	O	O
6	CD	O	O
flexeril	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
cyclobenzaprine	JJ	I-TREATMENT	I-TREATMENT
hcl	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
10	CD	O	O
mg	NN	O	O
po	NN	O	O
tid	NN	O	O
prn	NN	O	O
pain	NN	B-PROBLEM	B-PROBLEM

nka	NN	B-PROBLEM	O

r	NN	B-PROBLEM	B-PROBLEM
leg	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

responsible	JJ	O	O
after	IN	O	O
study	NN	O	O
for	IN	O	O
causing	VBG	O	O
admission	NN	O	O
)	)	O	O
right	NN	B-PROBLEM	B-PROBLEM
le	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

dm	NN	B-PROBLEM	O

pt	NN	B-TEST	B-TEST
spien	NN	I-TEST	I-TEST
mri	NN	I-TEST	I-TEST
pelvis	NN	B-TEST	I-TEST
xr	NNP	I-TEST	I-TEST
r	NN	B-TEST	I-TEST
hip	NN	I-TEST	I-TEST
xray	NN	I-TEST	I-TEST

hibbskote	NN	O	O
has	VBZ	O	O
severe	RB	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
back	RB	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
radiating	VBG	O	O
down	RP	O	O
the	DT	O	O
right	JJ	O	O
leg	NN	O	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
suffering	VBG	O	O
from	IN	O	O
this	DT	B-PROBLEM	O
problem	NN	I-PROBLEM	O
for	IN	O	O
the	DT	O	O
last	JJ	O	O
few	JJ	O	O
weeks	NNS	O	O
.	.	O	O

a	DT	O	O
week	NN	O	O
and	CC	O	O
half	NN	O	O
ago	RB	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
steroid	JJ	I-TREATMENT	I-TREATMENT
injection	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
an	DT	O	O
efforts	NNS	O	O
to	TO	O	O
ameliorate	VB	O	O
the	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
presents	VBZ	O	O
now	RB	O	O
with	IN	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
back	RB	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
radiating	VBG	O	O
down	RP	O	O
the	DT	O	O
right	JJ	O	O
leg	NN	O	O
.	.	O	O

she	PRP	O	O
denies	VBZ	O	O
numbness	RB	B-PROBLEM	B-PROBLEM
or	CC	O	I-PROBLEM
weakness	NN	B-PROBLEM	I-PROBLEM
in	IN	O	O
any	DT	O	O
part	NN	O	O
of	IN	O	O
the	DT	O	O
body	NN	O	O
.	.	O	O

she	PRP	O	O
denies	VBZ	O	O
fever	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
denies	VBZ	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
denies	VBZ	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
says	VBZ	O	O
the	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
sharp	JJ	O	O
in	IN	O	O
character	NN	O	O
,	,	O	O
and	CC	O	O
radiates	VBZ	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
shock	NN	I-PROBLEM	I-PROBLEM
like	IN	I-PROBLEM	I-PROBLEM
intensity	NN	I-PROBLEM	I-PROBLEM
down	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
leg	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
says	VBZ	O	O
that	IN	O	O
oral	JJ	B-TREATMENT	B-TREATMENT
analgesics	NNS	I-TREATMENT	I-TREATMENT
have	VBP	O	O
been	VBN	O	O
of	IN	O	O
little	JJ	O	O
help	NN	O	O
.	.	O	O

on	IN	O	O
detailed	JJ	B-TEST	O
review	NN	I-TEST	O
of	IN	I-TEST	O
systems	NNS	I-TEST	O
,	,	O	O
she	PRP	O	O
admitted	VBD	O	O
to	TO	O	O
one	CD	O	O
episode	NN	O	O
of	IN	O	O
urinary	JJ	B-PROBLEM	B-PROBLEM
incontinence	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
denied	VBD	O	O
any	DT	B-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
habits	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

non-insulin-requiring	JJ	B-PROBLEM	B-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
mellitus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

metformin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
zocor	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
analgesics	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

awake	NN	O	O
,	,	O	O
alert	NN	O	O
,	,	O	O
spontaneous	JJ	O	O
and	CC	O	O
appropriate	JJ	O	O
,	,	O	O
and	CC	O	O
somewhat	RB	B-PROBLEM	O
uncomfortable	JJ	I-PROBLEM	O
due	JJ	O	O
to	TO	O	O
pain	VB	B-PROBLEM	B-PROBLEM
but	CC	O	O
looked	VBD	O	O
well	RB	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
had	VBD	O	O
normal	JJ	O	O
vital	JJ	O	O
signs	NNS	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
oxygen	NN	I-TEST	I-TEST
saturation	NN	I-TEST	I-TEST
was	VBD	O	O
normal	JJ	O	O
at	IN	O	O
98%	CD	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
head	NN	B-PROBLEM	B-PROBLEM
trauma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
scleral	JJ	B-PROBLEM	B-PROBLEM
icterus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
neck	NN	O	O
was	VBD	O	O
supple	JJ	O	O
with	IN	O	O
no	DT	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

heart	NN	O	O
was	VBD	O	O
regular	JJ	O	O
with	IN	O	O
no	DT	O	O
murmurs	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
rubs	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
gallops	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
and	CC	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
organomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
skin	NN	O	O
and	CC	O	O
extremities	NNS	O	O
were	VBD	O	O
normal	JJ	O	O
with	IN	O	O
no	DT	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
clubbing	VBG	B-PROBLEM	B-PROBLEM
,	,	O	I-PROBLEM
edema	NN	B-PROBLEM	I-PROBLEM
,	,	O	O
lesions	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
rashes	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

neurologic	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
normal	JJ	O	O
.	.	O	O

straight	RB	B-TEST	B-TEST
leg	NN	I-TEST	I-TEST
raise	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
was	VBD	O	O
difficult	JJ	O	O
to	TO	O	O
perform	VB	O	O
due	JJ	O	O
to	TO	O	O
pain	VB	B-PROBLEM	B-PROBLEM
but	CC	O	O
seemed	VBD	O	O
to	TO	O	O
be	VB	O	O
positive	JJ	B-PROBLEM	O
on	IN	O	O
the	DT	O	O
right	NN	O	O
.	.	O	O

psychiatric	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
normal	JJ	O	O
.	.	O	O

examination	NN	B-TEST	B-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
back	NN	I-TEST	I-TEST
revealed	VBD	O	O
lumbar	NN	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
no	DT	O	O
point	NN	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
mri	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
spine	NN	I-TEST	I-TEST
showed	VBD	O	O
l4/5	JJ	B-PROBLEM	O
facet	JJ	I-PROBLEM	O
enhancement	NN	I-PROBLEM	O
.	.	O	O

thad	JJ	B-PROBLEM	B-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
read	VBN	O	O
as	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
facet	NN	I-PROBLEM	I-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
not	RB	O	O
an	DT	B-PROBLEM	B-PROBLEM
infectious	JJ	I-PROBLEM	I-PROBLEM
process	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
remained	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

esr	NN	B-TEST	O
was	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
and	CC	O	O
cpr	NN	B-TEST	O
was	VBD	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
elevated	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
ap	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
pelvis	NN	I-TEST	I-TEST
and	CC	O	I-TEST
r	NN	B-TEST	I-TEST
hip	NN	I-TEST	I-TEST
films	NNS	I-TEST	I-TEST
were	VBD	O	O
unremarkable	JJ	O	O
.	.	O	O

physical	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
rle	NN	I-TEST	I-TEST
showed	VBD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
hip	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
some	DT	O	O
movements	NNS	O	O
.	.	O	O

when	WRB	O	O
patient	NN	O	O
was	VBD	O	O
distracted	VBN	O	O
,	,	O	O
some	DT	O	B-TREATMENT
maneuvers	NNS	O	I-TREATMENT
were	VBD	O	O
not	RB	O	O
painful	JJ	B-PROBLEM	O
.	.	O	O

patient	NN	O	O
was	VBD	O	O
weaned	VBN	O	O
from	IN	O	O
supplemental	JJ	B-TREATMENT	B-TREATMENT
oxygen	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
tolerated	VBD	O	O
a	DT	O	O
regular	JJ	O	O
diet	JJ	O	O
prior	NN	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
received	VBD	O	O
pneumoboots	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
lovenox	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
dvt	NN	B-TREATMENT	B-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
.	.	O	O
.	.	O	O

patient	NN	O	O
should	MD	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
her	PRP$	O	B-PROBLEM
pain	NN	O	I-PROBLEM
doctor	NN	O	O
,	,	O	O
dr.	NN	O	O
maa	NN	O	O
bloch	IN	O	O
381-389-5852	JJ	O	O
,	,	O	O
for	IN	O	O
her	PRP$	B-TREATMENT	B-PROBLEM
chronic	JJ	I-TREATMENT	I-PROBLEM
pain	NN	I-TREATMENT	I-PROBLEM
management	NN	I-TREATMENT	I-PROBLEM

do	VB	O	O
not	RB	O	O
drive	VB	O	O
or	CC	O	O
drink	VB	O	O
alcohol	NN	O	O
while	IN	O	O
taking	VBG	O	O
narcotics	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

resume	VB	O	O
all	DT	O	O
of	IN	O	O
your	PRP$	B-TREATMENT	B-TREATMENT
home	NN	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
but	CC	O	O
please	VB	O	O
avoid	JJ	O	O
motrin	NN	B-TREATMENT	B-TREATMENT
/	NNP	I-TREATMENT	O
advil	NN	I-TREATMENT	B-TREATMENT
for	IN	O	O
1	CD	O	O
week	NN	O	O
.	.	O	O

if	IN	O	O
you	PRP	O	O
have	VBP	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
&gt;	VBP	O	O
101.5	CD	O	O
f	NN	O	O
,	,	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
increased	VBD	B-PROBLEM	B-PROBLEM
redness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
swelling	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
discharge	NN	B-PROBLEM	O
from	IN	O	O
your	PRP$	B-PROBLEM	B-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
call	VB	O	O
your	PRP$	O	O
md	NN	O	O
or	CC	O	O
go	VB	O	O
to	TO	O	O
the	DT	O	O
nearest	JJS	O	O
er	NN	O	O
.	.	O	O

penicillins	NNS	B-TREATMENT	B-TREATMENT

respiratory	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hemoptysis	NN	B-PROBLEM	B-PROBLEM
transferred	VBD	O	O
from	IN	O	O
osh	NN	O	O

debridement	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
mass	NN	B-PROBLEM	B-PROBLEM
from	IN	O	O
tracheal	JJ	O	O
lumen	NNS	O	O
by	IN	O	O
interventional	JJ	O	O
pulmonary	NN	O	O

95	CD	O	O
yo	NNS	O	O
male	JJ	O	O
with	IN	O	O
pmh	JJ	O	B-PROBLEM
large	JJ	B-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
thyroid	NN	I-PROBLEM	I-PROBLEM
cystic	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
eroding	VBG	I-PROBLEM	I-PROBLEM
into	IN	O	I-PROBLEM
trachea	NN	O	I-PROBLEM
,	,	O	O
who	WP	O	O
presented	VBD	O	O
to	TO	O	O
st.	VB	O	O
anne	NN	O	O
's	POS	O	O
hospital	JJ	O	O
2018-04-22	JJ	O	O
with	IN	O	O
hemoptysis	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
now	RB	O	O
diagnosed	VBN	O	O
with	IN	O	O
anaplastic	JJ	B-PROBLEM	B-PROBLEM
thyroid	NN	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pt	NN	O	O
reports	NNS	O	O
that	IN	O	O
he	PRP	O	O
noticed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
neck	NN	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
last	JJ	O	O
october	NN	O	O
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
grew	VBD	O	O
larger	JJR	O	O
,	,	O	O
to	TO	O	O
the	DT	O	O
size	NN	O	O
of	IN	O	O
a	DT	O	B-PROBLEM
baseball	NN	O	I-PROBLEM
.	.	O	O

it	PRP	O	O
appears	VBZ	O	O
that	IN	O	O
fna	NN	B-TEST	O
was	VBD	O	O
performed	VBN	O	O
but	CC	O	O
was	VBD	O	O
non-diagnostic	JJ	O	O
(	(	O	O
probably	RB	O	O
because	IN	O	O
anaplastic	JJ	B-PROBLEM	B-PROBLEM
tumors	NNS	I-PROBLEM	I-PROBLEM
tend	VBP	O	O
to	TO	O	O
be	VB	O	O
necrotic	JJ	O	B-PROBLEM
)	)	O	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
appears	VBZ	O	O
to	TO	O	O
be	VB	O	O
cystic	JJ	B-PROBLEM	B-PROBLEM
in	IN	O	I-PROBLEM
nature	NN	O	I-PROBLEM
and	CC	O	O
has	VBZ	O	O
been	VBN	O	O
aspirated	VBN	O	O
at	IN	O	O
least	JJS	O	O
3	CD	O	O
times	NNS	O	O
,	,	O	O
which	WDT	O	O
decrease	VBP	O	O
in	IN	O	O
size	NN	O	O
each	DT	O	O
time	NN	O	O
.	.	O	O

plan	NN	O	O
for	IN	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
in	IN	O	O
oct	NN	O	O
was	VBD	O	O
deferred	VBN	O	O
04-05	JJ	O	O
syncope	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
pacer	NN	B-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
sss;	NN	B-PROBLEM	O
again	RB	O	O
deferred	VBD	O	O
2	CD	O	O
weeks	NNS	O	O
ago	RB	O	O
04-05	JJ	O	O
uri;	NN	B-PROBLEM	O
was	VBD	O	O
planned	VBN	O	O
for	IN	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
this	DT	O	O
thurday	NN	O	O
.	.	O	O

pt	NN	O	O
was	VBD	O	O
o/w	VBN	O	O
in	IN	O	O
his	PRP$	O	O
usoh	JJ	O	O
until	IN	O	O
2-3	JJ	O	O
weeks	NNS	O	O
ago	RB	O	O
when	WRB	O	O
he	PRP	O	O
developed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
uri	JJ	I-PROBLEM	I-PROBLEM
with	IN	O	I-PROBLEM
symptoms	NNS	B-PROBLEM	I-PROBLEM
of	IN	O	O
dry	JJ	B-PROBLEM	O
cough;	NN	I-PROBLEM	O
no	DT	O	O
fever	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
sore	RB	B-PROBLEM	B-PROBLEM
throat	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
myalgias	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

pt	NN	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
3	CD	O	O
days	NNS	O	O
of	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
followed	VBN	O	O
by	IN	O	O
a	DT	O	O
10	CD	O	O
day	NN	O	O
course	NN	O	O
of	IN	O	O
levaquin	NN	B-TREATMENT	B-TREATMENT
(	(	O	O
completed	VBN	O	O
2	CD	O	O
days	NNS	O	O
pta	RB	O	O
)	)	O	O
.	.	O	O

per	IN	O	O
pt	NN	O	O
and	CC	O	O
son	NN	O	O
,	,	O	O
no	DT	O	O
james	NNS	B-PROBLEM	O
pna	RB	I-PROBLEM	O
.	.	O	O

2	CD	O	O
days	NNS	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
,	,	O	O
pt	NN	O	O
developed	VBD	O	O
hemoptysis;	VB	B-PROBLEM	O
states	NNS	O	O
he	PRP	O	O
coughed	VBD	O	O
up	RP	O	O
4	CD	O	O
tsp	NNS	O	O
of	IN	O	O
blood	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1	CD	O	O
day	NN	O	O
pta	NN	O	O
,	,	O	O
pt	NN	O	O
developed	VBD	O	O
stridorous	JJ	B-PROBLEM	B-PROBLEM
breathing	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pt	NN	O	O
was	VBD	O	O
initially	RB	O	O
seen	VBN	O	O
at	IN	O	O
lahey	JJ	O	O
north	NN	O	O
,	,	O	O
where	WRB	O	O
he	PRP	O	O
was	VBD	O	O
given	VBN	O	O
steroids	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
with	IN	O	O
improvement	NN	O	O
in	IN	O	O
respiratory	NN	O	O
status	NN	O	O
.	.	O	O

thyroid	JJ	B-PROBLEM	B-PROBLEM
cyst	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
aspirated	VBN	O	O
with	IN	O	O
removal	NN	O	B-TREATMENT
of	IN	O	O
300cc	CD	O	O
of	IN	O	O
fluid	NN	O	B-PROBLEM
.	.	O	O

pt	NN	O	O
was	VBD	O	O
given	VBN	O	O
racemic	JJ	B-TREATMENT	B-TREATMENT
epinephrine	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
decadron	NN	B-TREATMENT	B-TREATMENT
10mg	CD	O	O
iv	NN	O	O
x1.	NNP	O	O
ct	NN	B-TEST	O
neck	NN	I-TEST	O
showed	VBD	O	O
tracheal	JJ	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
per	IN	O	O
nursing	NN	O	O
s/o	NN	O	O
(	(	O	O
pt	JJ	O	O
brought	VBN	O	O
ct	NN	B-TEST	O
)	)	O	O
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
not	RB	O	O
had	VBN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
night	NN	B-PROBLEM	B-PROBLEM
sweats	NNS	I-PROBLEM	I-PROBLEM
but	CC	O	O
reports	NNS	O	O
weakness	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
weight	JJ	B-PROBLEM	B-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
for	IN	O	O
several	JJ	O	O
months	NNS	O	O
recently	RB	O	O
.	.	O	O

r	NN	B-PROBLEM	B-PROBLEM
thyroid	JJ	I-PROBLEM	I-PROBLEM
cyst	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
as	IN	O	O
above	NN	O	O
)	)	O	O

goiter	NN	B-PROBLEM	B-PROBLEM

cri	NN	B-PROBLEM	B-PROBLEM

htn	NN	B-PROBLEM	B-PROBLEM

sss	NN	B-PROBLEM	B-PROBLEM
(	(	O	O
s/p	JJ	O	O
pacer	NN	B-TREATMENT	B-TREATMENT
michelle	NN	O	I-TREATMENT
matthew	NNP	O	I-TREATMENT
mccaulley	NN	O	I-TREATMENT
)	)	O	O
prostate	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
-dx	VBZ	O	O
10	CD	O	O
years	NNS	O	O
ago;	RB	O	O
received	VBD	O	O
monthly	JJ	B-TREATMENT	O
shots	NNS	I-TREATMENT	O
which	WDT	O	O
were	VBD	O	O
discontinued	VBN	O	O
recently	RB	O	O
.	.	O	O

anemia	NN	B-PROBLEM	B-PROBLEM
afib	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
19	CD	O	O
episodes	NNS	O	O
since	IN	O	O
2017-12-02	JJ	O	O
,	,	O	O
as	IN	O	O
documented	VBN	O	O
on	IN	O	O
pacer	NN	B-TEST	B-TREATMENT
interogation	NN	I-TEST	I-TREATMENT
2018-04-04	CD	O	O
)	)	O	O

no	DT	O	O
history	NN	O	O
of	IN	O	O
thyroid	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

sister	NN	O	O
with	IN	O	O
lung	NN	B-PROBLEM	B-PROBLEM
ca	MD	I-PROBLEM	I-PROBLEM
.	.	O	O

brother	NN	O	O
with	IN	O	O
gastric	JJ	B-PROBLEM	B-PROBLEM
ca	MD	I-PROBLEM	I-PROBLEM
.	.	O	O

sister	NN	O	O
with	IN	O	O
unknown	JJ	B-PROBLEM	O
ca	MD	I-PROBLEM	O
.	.	O	O

father	NN	O	O
with	IN	O	O
stroke	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

vs	NN	B-TEST	O
:	:	O	O

t	NN	B-TEST	O
99.4	CD	O	O
,	,	O	O
bp	NN	B-TEST	B-TEST
119/59	CD	O	O
,	,	O	O
hr	NN	B-TEST	B-TEST
76	CD	O	O
,	,	O	O
rr	NN	B-TEST	B-TEST
18	CD	O	O
,	,	O	O
99%	CD	O	O
ra	NN	O	O

nad	NN	B-PROBLEM	B-PROBLEM

large	JJ	B-PROBLEM	O
~6	NNP	I-PROBLEM	O
x	NNP	I-PROBLEM	O
6	CD	I-PROBLEM	O
cm	NN	I-PROBLEM	O
sized	VBN	I-PROBLEM	O
right	RB	I-PROBLEM	O
thyroid	JJ	I-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
soft	JJ	O	O
,	,	O	O
possibly	RB	O	O
cystic	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
non-tender.	JJ	B-PROBLEM	O

l	NN	O	O
lobe	NN	O	O
of	IN	O	O
the	DT	O	O
thyroid	NN	O	O
gland	NN	O	O
also	RB	O	O
prominent	JJ	B-PROBLEM	O
.	.	O	O

rrr	NN	O	O
,	,	O	O
nl	JJ	O	O
s1	NN	O	O
s2	NN	O	O
,	,	O	O
no	DT	O	O
m/g/r	NN	B-PROBLEM	B-PROBLEM

lungs	NNS	O	O
:	:	O	O
transmitted	VBN	B-PROBLEM	O
upper	JJ	I-PROBLEM	O
airway	RB	I-PROBLEM	O
stridor;	JJ	I-PROBLEM	O
otherwise	RB	O	O
clear	JJ	O	O

abd	NN	O	O
:	:	O	O
soft	JJ	O	O
,	,	O	O
nt	JJ	B-PROBLEM	O
,	,	O	O
nd	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
+bs	VB	O	O

ext	NN	O	O
:	:	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM

cn	JJ	B-TEST	O
04-15	JJ	O	O
intact	JJ	O	O
,	,	O	O
07-06	JJ	O	B-PROBLEM
bilateral	JJ	O	I-PROBLEM
upper	NN	O	I-PROBLEM
and	CC	O	I-PROBLEM
lower	JJR	O	I-PROBLEM
extremity	NN	O	I-PROBLEM
strength	NN	O	I-PROBLEM
.	.	O	O

ct	NN	B-TEST	B-TEST
neck	SYM	I-TEST	I-TEST
-	:	O	O
impression	NN	O	O
:	:	O	O

1.	CD	O	O
7-cm	JJ	B-PROBLEM	B-PROBLEM
diameter	NN	I-PROBLEM	I-PROBLEM
right	RB	I-PROBLEM	I-PROBLEM
neck	RB	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
direct	JJ	B-PROBLEM	B-TEST
invasion	NN	I-PROBLEM	I-TEST
of	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
subglottic	JJ	I-PROBLEM	O
,	,	I-PROBLEM	O
cervical	JJ	I-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
proximal	JJ	I-PROBLEM	I-PROBLEM
thoracic	NN	I-PROBLEM	I-PROBLEM
trachea	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
reportedly	RB	O	O
thyroid	JJ	O	O
in	IN	O	O
origin	NN	O	O
.	.	O	O

differential	JJ	O	O
diagnosis	NN	O	O
includes	VBZ	O	O
primary	JJ	B-PROBLEM	B-PROBLEM
head/neck	NN	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
lymphoma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2.	CD	O	O
left	VBD	B-PROBLEM	B-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
thyroid	JJ	I-PROBLEM	I-PROBLEM
enlargement	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
heterogeneous	JJ	O	B-PROBLEM
appearance	NN	O	I-PROBLEM
.	.	O	O

3.	CD	O	O
right	JJ	B-PROBLEM	O
upper	JJ	I-PROBLEM	O
paratracheal	NN	I-PROBLEM	O
and	CC	I-PROBLEM	O
prevascular	JJ	I-PROBLEM	B-PROBLEM
lymphadenopathy	NN	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
additional	JJ	B-PROBLEM	O
nodes	NNS	I-PROBLEM	O
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
right	JJ	I-PROBLEM	O
side	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
neck	NN	I-PROBLEM	O
.	.	O	O

dedicated	VBN	B-TEST	O
mr	NN	I-TEST	O
of	IN	I-TEST	O
the	DT	I-TEST	O
neck	NN	I-TEST	O
may	MD	O	O
be	VB	O	O
helpful	JJ	O	O
for	IN	O	O
more	JJR	B-TEST	O
complete	JJ	I-TEST	O
assessment	NN	I-TEST	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
neck	NN	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
lymphadenopathy	JJ	B-PROBLEM	B-PROBLEM
if	IN	O	O
warranted	VBN	O	O
clinically	RB	O	O
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
composed	VBN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
relatively	RB	I-PROBLEM	I-PROBLEM
monotonous	JJ	I-PROBLEM	I-PROBLEM
proliferation	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
spindle	NN	I-PROBLEM	I-PROBLEM
cells	NNS	I-PROBLEM	I-PROBLEM
which	WDT	O	O
grow	VBP	O	O
in	IN	O	O
sheets	NNS	O	O
with	IN	O	O
a	DT	O	B-PROBLEM
prominent	JJ	O	I-PROBLEM
vascular	JJ	O	I-PROBLEM
pattern	NN	O	I-PROBLEM
.	.	O	O

immunostains	NNS	B-TEST	O
for	IN	O	O
cytokeratin	NN	B-TEST	B-TREATMENT
ae1/3	NN	I-TEST	I-TREATMENT
and	CC	O	O
cam	NN	B-TEST	B-TEST
5.2	CD	I-TEST	O
,	,	O	O
cd-68	NN	B-TEST	O
,	,	O	O
cd-79a	JJ	B-TEST	O
,	,	O	O
cd-138	JJ	B-TEST	O
,	,	O	O
s-100	JJ	B-TEST	O
,	,	O	O
lca	JJ	B-TEST	O
absorbed	VBD	I-TEST	O
cea	NN	I-TEST	B-PROBLEM
,	,	O	O
ema	NN	B-TEST	B-PROBLEM
,	,	O	O
cd34	NN	B-TEST	O
,	,	O	O
cd31	NN	B-TEST	O
,	,	O	O
ttf-1	JJ	B-TEST	O
,	,	O	O
actin	NN	B-TEST	B-TEST
,	,	O	O
desmin	NN	B-TEST	B-TREATMENT
,	,	O	O
mnf-116	NN	B-TEST	O
,	,	O	O
calcitonin	NN	B-TEST	B-TREATMENT
,	,	O	O
and	CC	O	O
thyroglobulin	NNS	B-TEST	B-TEST
are	VBP	O	O
negative	JJ	O	O
.	.	O	O

these	DT	O	O
results	NNS	O	O
exclude	VBP	O	O
both	DT	O	O
melanoma	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
hematopoietic	JJ	B-PROBLEM	B-TEST
neoplasms	NNS	I-PROBLEM	I-TEST
.	.	O	O

the	DT	O	O
differential	JJ	O	O
diagnosis	NN	O	O
includes	VBZ	O	O
,	,	O	O
but	CC	O	O
is	VBZ	O	O
not	RB	O	O
limited	VBN	O	O
to	TO	O	O
,	,	O	O
sarcoma	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
spindle	JJ	B-PROBLEM	B-TEST
cell	NN	I-PROBLEM	I-TEST
carcinomas	NN	I-PROBLEM	B-PROBLEM
(	(	O	I-PROBLEM
sarcomatoid	JJ	B-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
aerodigestive	JJ	I-PROBLEM	I-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
anaplastic	JJ	B-PROBLEM	B-PROBLEM
thyroid	NN	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
)	)	O	I-PROBLEM
,	,	O	O
and	CC	O	O
malignant	JJ	B-PROBLEM	B-PROBLEM
salivary	JJ	I-PROBLEM	I-PROBLEM
gland	NN	I-PROBLEM	I-PROBLEM
neoplasms	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

pt	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
here	RB	O	O
for	IN	O	O
further	JJ	B-TREATMENT	O
mgmt	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
airway	NN	I-TREATMENT	O
and	CC	O	O
large	JJ	B-PROBLEM	B-PROBLEM
thyroid	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
by	IN	O	O
our	PRP$	O	O
ip	NN	O	O
team	NN	O	O
.	.	O	O

ip	NN	O	O
found	VBD	O	O
endotracheal	RB	B-PROBLEM	B-PROBLEM
obstructing	VBG	I-PROBLEM	I-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
extrinsic	JJ	B-PROBLEM	B-PROBLEM
compression	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
high	JJ	I-PROBLEM	I-PROBLEM
trachea	NN	I-PROBLEM	I-PROBLEM
by	IN	O	O
thyroid	JJ	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

after	IN	O	O
rigid	JJ	B-TEST	B-TEST
bronchoscopy	NN	I-TEST	I-TEST
with	IN	O	O
removal	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
intratracheal	JJ	I-PROBLEM	I-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
component	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
2018-04-24	JJ	O	O
,	,	O	O
stat	JJ	B-TEST	B-TEST
pathology	NN	I-TEST	I-TEST
showed	VBD	O	O
anaplastic	JJ	B-PROBLEM	B-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

subsequently	RB	O	O
extubated	VBN	O	O
and	CC	O	O
his	PRP$	O	B-TEST
respiratory	NN	B-PROBLEM	I-TEST
sx	NNS	I-PROBLEM	I-TEST
are	VBP	O	O
now	RB	O	O
improved	VBN	O	O
.	.	O	O

pt	NN	O	O
was	VBD	O	O
seen	VBN	O	O
by	IN	O	O
rad	NN	O	O
onc	NN	O	O
,	,	O	O
who	WP	O	O
recommended	VBD	O	O
transfer	NN	O	O
to	TO	O	O
the	DT	O	O
east	JJ	O	O
campus	NN	O	O
for	IN	O	O
xrt	NN	B-TREATMENT	O
.	.	O	O

on	IN	O	O
the	DT	O	O
morning	NN	O	O
of	IN	O	O
possible	JJ	B-TREATMENT	O
radiation	NN	I-TREATMENT	O
,	,	O	O
patient	NN	O	O
and	CC	O	O
family	NN	O	O
met	VBD	O	O
with	IN	O	O
interventional	JJ	O	O
pulmonary	JJ	O	O
team	NN	O	O
who	WP	O	O
explained	VBD	O	O
that	IN	O	O
the	DT	B-TEST	B-TEST
most	RBS	I-TEST	I-TEST
recent	JJ	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
showed	VBD	O	O
further	JJ	B-PROBLEM	O
invasion	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
the	DT	I-PROBLEM	B-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
into	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
trachea	NN	O	I-PROBLEM
.	.	O	O

after	IN	O	O
a	DT	O	O
long	JJ	O	O
discussion	NN	O	O
,	,	O	O
patient	NN	O	O
and	CC	O	O
family	NN	O	O
asked	VBD	O	O
to	TO	O	O
be	VB	O	O
made	VBN	O	O
cmo	NN	B-TREATMENT	O
.	.	O	O

patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
palliative	JJ	O	O
care	NN	O	O
team	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
with	IN	O	O
recommendations	NNS	O	O
to	TO	O	O
ensure	VB	O	O
comfort	NN	O	O
.	.	O	O

acute	NN	B-PROBLEM	B-PROBLEM
pancreatitis	NN	I-PROBLEM	I-PROBLEM

acute	JJ	B-PROBLEM	B-PROBLEM
pancreatitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

gastroesophageal	NN	B-PROBLEM	B-PROBLEM
reflux	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

ri	NN	O	O
strength	NN	O	O
is	VBZ	O	O
a	DT	O	O
40	CD	O	O
year	NN	O	O
old	JJ	O	O
man	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
gerd	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
who	WP	O	O
presents	VBZ	O	O
with	IN	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
seven	CD	O	O
days	NNS	O	O
duration	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
in	IN	O	O
general	JJ	O	O
good	JJ	O	O
health	NN	O	O
until	IN	O	O
seven	CD	O	O
days	NNS	O	O
ago	RB	O	O
(	(	O	O
2/11/00	CD	O	O
)	)	O	O
,	,	O	O
when	WRB	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	O	B-PROBLEM
sudden	JJ	O	I-PROBLEM
onset	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
sharp	JJ	B-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
flank	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
radiation	NN	B-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
abdomen	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
then	RB	O	O
to	TO	O	O
the	DT	O	O
epigastrium	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
described	VBD	O	O
the	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
as	IN	O	O
&quot;	JJ	O	B-PROBLEM
knife-like	JJ	B-PROBLEM	I-PROBLEM
&quot;	NN	O	I-PROBLEM
with	IN	O	O
a	DT	O	B-PROBLEM
severity	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
1/25	CD	O	I-PROBLEM
at	IN	O	I-PROBLEM
its	PRP$	O	I-PROBLEM
worse	NN	O	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
reports	VBZ	O	O
blood-streaked	JJ	B-PROBLEM	O
diarrhea	NNS	I-PROBLEM	B-PROBLEM
for	IN	O	O
two	CD	O	O
days	NNS	O	O
.	.	O	O

he	PRP	O	O
denies	VBZ	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
had	VBN	O	O
no	DT	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
had	VBN	O	O
no	DT	O	O
recent	JJ	B-PROBLEM	B-PROBLEM
weight	NN	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
light-headedness	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
dizziness	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
denies	VBZ	O	O
increased	VBD	B-PROBLEM	B-PROBLEM
urinary	JJ	I-PROBLEM	I-PROBLEM
frequent	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
urgency	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
presented	VBD	O	O
to	TO	O	O
the	DT	O	O
sloan-	JJ	O	O
center	NN	O	O
emergency	NN	O	O
department	NN	O	O
,	,	O	O
where	WRB	O	O
he	PRP	O	O
was	VBD	O	O
resuscitated	VBN	O	O
with	IN	O	O
normal	JJ	B-TREATMENT	B-TREATMENT
saline	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
received	VBD	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
then	RB	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
general	JJ	O	O
medicine	NN	O	O
service	NN	O	O
for	IN	O	O
further	JJ	B-TREATMENT	B-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

(1)	JJ	O	B-PROBLEM
gerd	NN	B-PROBLEM	I-PROBLEM
;	:	O	O
(2)	CC	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
partially	RB	B-PROBLEM	B-PROBLEM
collapsed	VBN	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
1999	CD	O	O
.	.	O	O

prilosec	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

gerd	NN	B-PROBLEM	O
and	CC	O	O
pud	NN	B-PROBLEM	O
.	.	O	O

temp	NN	B-TEST	B-TEST
98.5	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
74	CD	O	O
,	,	O	O
bp	NN	B-TEST	B-TEST
140/90	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
18	CD	O	O
,	,	O	O
o2	PRP	B-TEST	B-TEST
sat	VBD	I-TEST	I-TEST
98%	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
alert	JJ	O	O
but	CC	O	O
in	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
discomfort	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
jvd	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

bibasilar	JJ	B-PROBLEM	B-PROBLEM
crackles	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
normal	JJ	O	O
s1	NN	O	O
,	,	O	O
s2	NN	O	O
,	,	O	O
no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
rubs	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
gallops	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

soft	JJ	O	O
,	,	O	O
non-distended	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

tender	NN	B-PROBLEM	O
to	TO	O	O
palpation	NN	B-TEST	B-TEST
at	IN	I-TEST	O
the	DT	I-TEST	O
left	NN	I-TEST	O
lower	RBR	I-TEST	O
quadrant	NN	I-TEST	O
and	CC	O	O
especially	RB	O	B-PROBLEM
at	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
epigastrium	NN	O	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
splenomegaly	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

point	NN	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
left	JJ	I-PROBLEM	O
costovertebral	JJ	I-PROBLEM	O
angle	NN	I-PROBLEM	O
.	.	O	O

warm	NN	O	O
to	TO	O	O
touch	VB	O	O
,	,	O	O
no	DT	O	O
clubbing	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

deep	JJ	B-TEST	B-TEST
tendon	NN	I-TEST	I-TEST
reflexes	NNS	I-TEST	I-TEST
were	VBD	O	O
equal	JJ	O	O
and	CC	O	O
adequate	JJ	O	O
in	IN	O	O
upper	JJ	O	O
and	CC	O	O
lower	JJR	O	O
extremities	NNS	O	O
.	.	O	O

sensation	NN	O	O
was	VBD	O	O
intact	JJ	O	O
to	TO	O	O
pain	VB	B-PROBLEM	B-PROBLEM
and	CC	O	O
light	JJ	B-TEST	B-TEST
touch	NN	I-TEST	I-TEST
.	.	O	O

chem-7	JJ	B-TEST	B-TEST
-	:	O	O
na	NN	B-TEST	O
139	CD	O	O
,	,	O	O
k	VBD	B-TEST	O
3.7	CD	O	O
,	,	O	O
cl	NN	B-TEST	B-TEST
99	CD	O	O
,	,	O	O
bicarb	NN	B-TEST	B-TEST
28	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
15	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
0.9	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
89	CD	O	O
.	.	O	O

liver	JJ	B-TEST	B-TEST
function	NN	I-TEST	I-TEST
tests	NNS	I-TEST	I-TEST
were	VBD	O	O
significant	JJ	O	O
for	IN	O	O
an	DT	B-TEST	B-TREATMENT
alt	NN	I-TEST	I-TREATMENT
41	CD	O	O
,	,	O	O
ast	RB	B-TEST	B-TEST
31	CD	O	O
,	,	O	O
alk	VBP	B-TEST	O
phos	JJ	I-TEST	B-TEST
76	CD	O	O
,	,	O	O
t.	NN	B-TEST	B-TEST
bili	NN	I-TEST	I-TEST
0.7	CD	O	O
,	,	O	O
d.	NN	B-TEST	O
bili	NN	I-TEST	B-TEST
0.2	CD	O	O
,	,	O	O
amylase	NN	B-TEST	B-TEST
345	CD	O	O
,	,	O	O
lipase	NN	B-TEST	B-TEST
2510	CD	O	O
,	,	O	O
t.	EX	B-TEST	B-TEST
protein	RB	I-TEST	I-TEST
8.1	CD	O	O
,	,	O	O
albumin	RB	B-TEST	B-TEST
4.9	CD	O	O
,	,	O	O
globulin	NN	B-TEST	B-TEST
3.2	CD	O	O
,	,	O	O
ca	MD	B-TEST	O
9.9	CD	O	O
.	.	O	O

cbc	SYM	B-TEST	B-TEST
-	:	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
8.82	CD	O	O
,	,	O	O
hemoglobin	NN	B-TEST	B-TEST
15.2	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
43	CD	O	O
,	,	O	O
and	CC	O	O
platelets	VBZ	B-TEST	B-TEST
322	CD	O	O
.	.	O	O

imaging	VBG	B-TEST	B-TEST
studies	NNS	I-TEST	I-TEST
:	:	O	O

abdominal	JJ	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
on	IN	O	O
2/21/00	CD	O	O
-	:	O	B-TEST
study	NN	B-TEST	I-TEST
revealed	VBD	O	O
a	DT	B-PROBLEM	O
prominent	JJ	I-PROBLEM	O
pancreas	NN	I-PROBLEM	O
with	IN	O	O
associated	JJ	B-PROBLEM	B-PROBLEM
mesenteric	JJ	I-PROBLEM	I-PROBLEM
stranding	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
abscess	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
pseudocyst	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
gallstone	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
in	IN	O	O
the	DT	O	B-PROBLEM
gallbladder	NN	O	I-PROBLEM
neck	NN	O	I-PROBLEM
.	.	O	O

bilateral	JJ	B-PROBLEM	B-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
were	VBD	O	O
seen	VBN	O	O
with	IN	O	O
associated	JJ	B-PROBLEM	B-PROBLEM
compression	NN	I-PROBLEM	I-PROBLEM
atelectasis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

abdominal	JJ	B-TEST	B-TEST
ultrasound	NN	I-TEST	I-TEST
on	IN	O	O
2/23/00	CD	O	O
-	:	O	O
this	DT	B-TEST	B-TEST
study	NN	I-TEST	I-TEST
revealed	VBD	O	O
gallbladder	NN	B-PROBLEM	B-PROBLEM
sludge	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
no	DT	O	O
cholelithiasis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
swelling	VBG	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
body	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
tail	NN	O	B-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
pancreas	NNS	O	I-PROBLEM
.	.	O	O

portable	JJ	B-TEST	O
chest	NN	I-TEST	O
on	IN	O	O
2/23/00	CD	O	O
-	:	O	O
lungs	NNS	O	O
were	VBD	O	O
clear	JJ	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
pleural	JJ	B-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

chest	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
pa	JJ	I-TEST	I-TEST
and	CC	I-TEST	I-TEST
lateral	JJ	I-TEST	I-TEST
)	)	I-TEST	I-TEST
on	IN	O	O
2/25/00	CD	O	O
-	:	O	O
lungs	NNS	O	O
were	VBD	O	O
clear	JJ	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
infiltrates	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
consolidation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
diagnosed	VBN	O	O
with	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
pancreatitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
made	VBN	O	O
npo	NN	B-TREATMENT	O
and	CC	O	O
was	VBD	O	O
resuscitated	VBN	O	O
with	IN	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

pain	NN	B-TREATMENT	B-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
initiated	VBN	O	O
with	IN	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
but	CC	O	O
was	VBD	O	O
then	RB	O	O
changed	VBN	O	O
to	TO	O	O
demerol	VB	B-TREATMENT	B-TREATMENT
,	,	O	O
which	WDT	O	O
gave	VBD	O	O
the	DT	O	O
patient	NN	O	O
better	RBR	O	O
relief	NN	O	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
epigastric	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

from	IN	O	O
2/17/00	CD	O	O
to	TO	O	O
2/21/00	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
complained	VBD	O	O
of	IN	O	O
persistent	JJ	B-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
occasionally	RB	I-PROBLEM	I-PROBLEM
severe	JJ	I-PROBLEM	I-PROBLEM
epigastric	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
pain	NN	I-TREATMENT	I-TREATMENT
medication	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
then	RB	O	O
changed	VBN	O	O
to	TO	O	O
dilaudid	VB	B-TREATMENT	O
iv	NN	I-TREATMENT	O
in	IN	O	O
an	DT	O	O
attempt	NN	O	O
to	TO	O	O
better	JJR	O	O
alleviate	VB	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

dilaudid	NN	B-TREATMENT	B-TREATMENT
iv	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
continued	VBN	O	O
for	IN	O	O
the	DT	O	O
remainder	NN	O	O
of	IN	O	O
the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
hospitalization	NN	O	O
.	.	O	O

the	DT	O	O
severity	NN	O	O
and	CC	O	O
persistent	NN	O	B-PROBLEM
of	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NNP	I-PROBLEM	I-PROBLEM
epigastric	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
concerning	VBG	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
pancreatic	JJ	I-PROBLEM	I-PROBLEM
complication	NN	I-PROBLEM	I-PROBLEM
such	JJ	O	O
as	IN	O	O
necrosis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
abscess	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
ct	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
,	,	O	O
which	WDT	O	O
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
gallbladder	NN	I-PROBLEM	I-PROBLEM
neck	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
no	DT	O	O
biliary	JJ	B-PROBLEM	B-PROBLEM
dilatation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
stranding	VBG	B-PROBLEM	O
along	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
pancreas	NNS	I-PROBLEM	O
,	,	O	O
but	CC	O	O
no	DT	O	O
necrosis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
abscess	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
pseudocyst	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
2/22/00	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
to	TO	O	O
103.5	CD	O	O
.	.	O	O

blood	NN	B-TEST	B-TEST
and	CC	I-TEST	I-TEST
urine	JJ	I-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
were	VBD	O	O
sent	VBN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
chest	JJ	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
was	VBD	O	O
done	VBN	O	O
,	,	O	O
which	WDT	O	O
revealed	VBD	O	O
no	DT	O	O
infiltrate	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
effusion	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
cefotaxime	NN	B-TREATMENT	B-TREATMENT
1	CD	O	O
gm	NN	O	O
iv	NN	O	O
for	IN	O	O
empiric	JJ	B-TREATMENT	B-TREATMENT
antibiotic	JJ	I-TREATMENT	I-TREATMENT
treatment	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

all	DT	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

on	IN	O	O
2/23/00	CD	O	O
,	,	O	O
the	DT	B-PROBLEM	B-PROBLEM
high	JJ	I-PROBLEM	I-PROBLEM
grade	NN	I-PROBLEM	I-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
persisted	VBN	O	I-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
ultrasound	NN	I-TEST	I-TEST
was	VBD	O	O
done	VBN	O	O
to	TO	O	O
r	VB	O	O
/	NNP	O	O
o	JJ	O	O
cholestasis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
cholangitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
ultrasound	NN	I-TEST	I-TEST
showed	VBD	O	O
biliary	JJ	B-PROBLEM	B-PROBLEM
sludge	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
swelling	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
body	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
tail	NN	O	B-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
pancreas	NNS	O	I-PROBLEM
.	.	O	O

no	DT	O	O
other	JJ	B-PROBLEM	B-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
were	VBD	O	O
noted	VBN	O	O
.	.	O	O

on	IN	O	O
2/24/00	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
an	DT	O	O
episode	NN	O	O
of	IN	O	O
exacerbation	NN	O	B-PROBLEM
of	IN	O	I-PROBLEM
epigastric	JJ	B-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
radiation	NN	B-PROBLEM	O
to	TO	I-PROBLEM	O
the	DT	I-PROBLEM	O
left	VBN	I-PROBLEM	O
upper	JJ	I-PROBLEM	O
quadrant	NN	I-PROBLEM	O
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
subsequently	RB	O	O
relieved	VBN	O	O
with	IN	O	O
high	JJ	B-TREATMENT	O
dose	NN	I-TREATMENT	O
dilaudid	NN	I-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
follow-up	JJ	I-TEST	I-TEST
chest	NN	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
,	,	O	O
which	WDT	O	O
was	VBD	O	O
essentially	RB	O	O
unchanged	JJ	O	O
from	IN	O	O
previously	RB	O	O
,	,	O	O
showing	VBG	O	O
a	DT	O	O
normal	JJ	O	O
heart	NN	O	O
and	CC	O	O
lungs	NNS	O	O
without	IN	O	O
infiltrate	NN	B-PROBLEM	O
.	.	O	O

from	IN	O	O
2/25	CD	O	O
-	:	O	O
2/27/00	CD	O	O
,	,	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NN	I-PROBLEM	I-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
defervesced	VBD	O	O
and	CC	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
gradually	RB	O	I-PROBLEM
subsided	VBD	O	I-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	B-TEST
cefotaxime	NN	I-TREATMENT	I-TEST
was	VBD	O	O
discontinued	VBN	O	O
since	IN	O	O
no	DT	O	O
infection	NN	B-PROBLEM	B-PROBLEM
was	VBD	O	O
identified	VBN	O	O
.	.	O	O

on	IN	O	O
2/28/00	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
diet	NN	O	O
was	VBD	O	O
advanced	VBN	O	O
to	TO	O	O
a	DT	B-TREATMENT	B-TREATMENT
low	JJ	I-TREATMENT	I-TREATMENT
fat	NN	I-TREATMENT	I-TREATMENT
solids	NNS	I-TREATMENT	I-TREATMENT
(	(	O	O
per	IN	O	O
pancreatitis	NN	B-TEST	B-PROBLEM
study	NN	I-TEST	I-PROBLEM
)	)	O	O
,	,	O	O
which	WDT	O	O
the	DT	O	O
patient	NN	O	O
tolerated	VBN	O	O
well	RB	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
discharged	VBN	O	O
home	NN	O	O
on	IN	O	O
2/29/00	CD	O	O
,	,	O	O
with	IN	O	O
much	JJ	O	O
improvement	NN	O	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

prilosec	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
;	:	O	O
percocet	CC	B-TREATMENT	O
1-2	JJ	O	O
tabs	NNS	O	O
p.o.	IN	O	O
q.6-8h.	JJ	O	O
x5	NNP	O	O
days	NNS	O	O
;	:	O	O
mvi	CC	B-TREATMENT	O
1	CD	O	O
tab	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
37-year-old	JJ	O	O
female	NN	O	O
who	WP	O	O
presents	VBZ	O	O
on	IN	O	O
an	DT	O	B-TREATMENT
elective	JJ	O	I-TREATMENT
basis	NN	O	I-TREATMENT
for	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
living-related	JJ	I-TREATMENT	I-TREATMENT
kidney	NN	I-TREATMENT	I-TREATMENT
transplant	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
end-stage	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
secondary	JJ	O	O
to	TO	O	O
type	VB	B-PROBLEM	B-PROBLEM
1	CD	I-PROBLEM	I-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-TEST	B-TEST
baseline	JJ	I-TEST	I-TEST
creatinine	NN	I-TEST	I-TEST
of	IN	O	O
around	IN	O	O
5	CD	O	O
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
receiving	VBG	O	O
a	DT	B-TREATMENT	B-TREATMENT
kidney	NN	I-TREATMENT	I-TREATMENT
from	IN	O	O
her	PRP$	O	O
sister	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
insulin-dependent	JJ	B-PROBLEM	B-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
for	IN	O	O
32	CD	O	O
years	NNS	O	O
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
status	NN	O	O
post	NN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
april	NN	O	O
of	IN	O	O
this	DT	O	O
year	NN	O	O
and	CC	O	O
subsequently	RB	O	O
underwent	JJ	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
present	VBD	O	O
electively	RB	O	O
on	IN	O	O
the	DT	O	O
morning	NN	O	O
of	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
no	DT	O	O
recent	JJ	O	B-PROBLEM
changes	NNS	O	I-PROBLEM
in	IN	O	I-PROBLEM
her	PRP$	B-PROBLEM	I-PROBLEM
medical	JJ	I-PROBLEM	I-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
sarcoidosis	NN	B-PROBLEM	B-PROBLEM
since	IN	O	O
2001	CD	O	O
.	.	O	O

2.	CD	O	O
she	PRP	O	O
is	VBZ	O	O
status	NN	O	O
post	NN	O	O
cholecystectomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

3.	CD	O	O
status	NN	O	O
post	NN	O	O
tubal	JJ	B-TREATMENT	B-TREATMENT
ligation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

4.	CD	O	O
status	NN	O	O
post	NN	O	O
left	VBD	B-TREATMENT	B-TREATMENT
arteriovenous	JJ	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
hemodialysis	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

5.	CD	O	O
insulin-dependent	JJ	B-PROBLEM	B-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
mellitus	VBP	I-PROBLEM	I-PROBLEM
times	NNS	O	O
32	CD	O	O
years	NNS	O	O
.	.	O	O

6.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

7.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
2012-05-06	JJ	O	O
.	.	O	O

8.	CD	O	O
end-stage	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
on	IN	O	O
hemodialysis	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
1.5	CD	O	O
years	NNS	O	O
.	.	O	O

allergies	NNS	B-PROBLEM	B-PROBLEM
include	VBP	O	O
amoxicillin	JJ	B-TREATMENT	B-TREATMENT
and	CC	O	O
codeine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

1.	CD	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
by	IN	O	O
sliding-scale	JJ	O	O
,	,	O	O
nph	JJ	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
16	CD	O	O
units	NNS	O	O
in	IN	O	O
the	DT	O	O
morning	NN	O	O
and	CC	O	O
6	CD	O	O
units	NNS	O	O
in	IN	O	O
the	DT	O	O
evening	NN	O	O
.	.	O	O

2.	CD	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

3.	CD	O	O
zoloft	JJ	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O

4.	CD	O	O
reglan	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O

5.	CD	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

6.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
81	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

7.	CD	O	O
multivitamin	NN	B-TREATMENT	B-TREATMENT
1	CD	O	O
p.o.	NN	O	O
q.d.	NN	O	O

8.	CD	O	O
remeron	NN	B-TREATMENT	B-TREATMENT
p.o.	NN	O	O
q.d.	NN	O	O

physical	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
admission	NN	O	O
revealed	VBD	O	O
she	PRP	O	O
was	VBD	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
150/79	CD	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
pulse	NN	I-TEST	I-TEST
of	IN	O	O
81	CD	O	O
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
legally	RB	B-PROBLEM	O
blind	JJ	I-PROBLEM	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
without	IN	O	O
any	DT	B-PROBLEM	O
adenopathy	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

her	PRP$	O	B-TEST
chest	NN	O	I-TEST
was	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	NN	B-TEST	B-TEST
.	.	O	O

heart	NN	O	O
had	VBD	O	O
a	DT	O	O
normal	JJ	O	O
s1	NN	O	O
and	CC	O	O
s2	NN	O	O
,	,	O	O
with	IN	O	O
no	DT	O	O
murmurs	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
gallops	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
rubs	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

her	PRP$	O	O
abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
with	IN	O	O
well-healed	JJ	B-PROBLEM	B-PROBLEM
incisions	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
organomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

extremities	NNS	O	O
were	VBD	O	O
without	IN	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
functioning	VBG	I-PROBLEM	I-PROBLEM
arteriovenous	JJ	I-PROBLEM	I-PROBLEM
fistula	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
thrill	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
bruit	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
her	PRP$	O	I-PROBLEM
left	JJ	O	I-PROBLEM
arm	NN	O	I-PROBLEM
.	.	O	O

she	PRP	O	O
underwent	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
living-related	JJ	I-TREATMENT	I-TREATMENT
renal	JJ	I-TREATMENT	I-TREATMENT
transplant	NN	I-TREATMENT	I-TREATMENT
in	IN	I-TREATMENT	O
the	DT	I-TREATMENT	O
right	JJ	I-TREATMENT	O
iliac	NN	I-TREATMENT	O
fossa	NN	I-TREATMENT	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
operation	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
somewhat	RB	O	O
technically	RB	O	O
difficult	JJ	O	O
secondary	JJ	O	O
to	TO	O	O
a	DT	B-PROBLEM	O
short	JJ	I-PROBLEM	O
segment	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
ureter	NN	I-PROBLEM	B-PROBLEM
which	WDT	O	O
was	VBD	O	O
anastomosed	VBN	O	O
over	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
the	DT	O	O
bladder	NN	O	O
.	.	O	O

otherwise	RB	O	O
,	,	O	O
there	EX	O	O
were	VBD	O	O
difficulties	NNS	B-PROBLEM	B-PROBLEM
,	,	O	I-PROBLEM
and	CC	O	I-PROBLEM
estimated	VBD	B-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
minimal	JJ	O	O
.	.	O	O

intraoperatively	RB	O	O
,	,	O	O
for	IN	O	O
immunosuppression	NN	B-TREATMENT	B-TREATMENT
she	PRP	O	O
received	VBD	O	O
thymoglobulin	JJ	B-TREATMENT	B-TREATMENT
and	CC	O	O
solu-medrol	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
prograf	NN	B-TREATMENT	O
and	CC	O	O
cellcept	NN	B-TREATMENT	B-TREATMENT
in	IN	O	O
the	DT	O	O
postoperative	JJ	O	O
period	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
also	RB	O	O
maintained	VBN	O	O
on	IN	O	O
bactrim	NN	B-TREATMENT	B-TREATMENT
postoperatively	RB	O	O
and	CC	O	O
did	VBD	O	O
not	RB	O	O
require	VB	O	O
ganciclovir	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
as	IN	O	O
she	PRP	O	O
and	CC	O	O
her	PRP$	O	O
sister	NN	O	O
were	VBD	O	O
cytomegalovirus	JJ	B-PROBLEM	O
negative	JJ	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
,	,	O	O
which	WDT	O	O
was	VBD	O	O
5	CD	O	O
initially	RB	O	O
postoperatively	RB	O	O
,	,	O	O
slowly	RB	O	B-PROBLEM
dropped	VBD	O	I-PROBLEM
over	IN	O	O
the	DT	O	O
next	JJ	O	O
few	JJ	O	O
days	NNS	O	O
until	IN	O	O
eventually	RB	O	O
reaching	VBG	O	O
a	DT	O	O
low	NN	O	O
of	IN	O	O
1	CD	O	O
.	.	O	O

she	PRP	O	O
did	VBD	O	O
receive	VB	O	O
pamidronate	NN	B-TREATMENT	B-TREATMENT
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
one	CD	O	O
and	CC	O	O
received	VBD	O	O
a	DT	O	O
total	NN	O	O
of	IN	O	O
four	CD	O	B-TREATMENT
doses	NNS	O	I-TREATMENT
thymoglobulin	NN	B-TREATMENT	I-TREATMENT
.	.	O	O

her	PRP$	B-TREATMENT	B-TEST
steroid	JJ	I-TREATMENT	I-TEST
doses	NNS	I-TREATMENT	I-TEST
were	VBD	O	O
slowly	RB	O	O
tapered	VBN	O	O
over	IN	O	O
her	PRP$	O	O
hospital	JJ	O	O
course	NN	O	O
,	,	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
prograf	JJ	I-TEST	I-TEST
level	NN	I-TEST	I-TEST
was	VBD	O	O
adjusted	VBN	O	O
to	TO	O	O
maintain	VB	O	O
therapeutic	JJ	O	O
values	NNS	O	O
between	IN	O	O
10	CD	O	O
and	CC	O	O
15	CD	O	O
.	.	O	O

she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
make	VB	O	O
good	JJ	O	O
urine	NN	O	O
over	IN	O	O
the	DT	O	O
first	JJ	O	O
few	JJ	O	O
days	NNS	O	O
and	CC	O	O
had	VBD	O	O
her	PRP$	O	B-PROBLEM
urine	JJ	O	I-PROBLEM
losses	NNS	O	I-PROBLEM
replaced	VBN	O	O
with	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
three	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
an	DT	B-PROBLEM	O
episode	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
shortness	NN	I-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
was	VBD	O	O
evaluated	VBN	O	O
by	IN	O	O
both	DT	O	O
the	DT	O	O
renal	NN	O	O
and	CC	O	O
surgical	JJ	O	B-TREATMENT
residents	NNS	O	I-TREATMENT
.	.	O	O

it	PRP	O	O
was	VBD	O	O
found	VBN	O	O
that	IN	O	O
she	PRP	O	O
was	VBD	O	O
in	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
required	VBN	O	O
transfer	NN	O	O
to	TO	O	O
the	DT	O	O
surgical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
this	DT	O	O
incident	NN	O	O
was	VBD	O	O
in	IN	O	O
the	DT	O	O
range	NN	O	O
of	IN	O	O
200/120	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
showed	VBD	O	O
no	DT	O	O
specific	JJ	B-PROBLEM	B-PROBLEM
st	NN	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
there	EX	O	O
was	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
r	NN	I-PROBLEM	I-PROBLEM
wave	NN	I-PROBLEM	I-PROBLEM
progression	NN	I-PROBLEM	I-PROBLEM
laterally	RB	I-PROBLEM	I-PROBLEM
.	.	O	O

serial	JJ	B-TEST	B-TEST
enzymes	NNS	I-TEST	I-TEST
were	VBD	O	O
drawn	VBN	O	O
,	,	O	O
and	CC	O	O
cardiology	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
.	.	O	O

with	IN	O	O
blood	NN	B-TREATMENT	B-TREATMENT
pressure	NN	I-TREATMENT	I-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
via	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
nitroglycerin	JJ	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
fluid	JJ	B-TREATMENT	B-TREATMENT
restriction	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
the	DT	O	O
patient	JJ	O	O
quickly	RB	O	O
improved	VBN	O	O
and	CC	O	O
a	DT	O	O
had	VBD	O	O
a	DT	O	O
relatively	RB	O	O
short	JJ	O	O
stay	NN	O	O
in	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
.	.	O	O

throughout	IN	O	O
this	DT	O	O
time	NN	O	O
,	,	O	O
her	PRP$	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
continued	VBD	O	O
to	TO	O	O
drop	VB	O	O
,	,	O	O
and	CC	O	O
there	EX	O	O
was	VBD	O	O
no	DT	O	O
apparent	JJ	B-PROBLEM	B-PROBLEM
deleterious	JJ	I-PROBLEM	I-PROBLEM
effect	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
transplant	NN	I-TREATMENT	I-TREATMENT
from	IN	O	O
this	DT	O	B-PROBLEM
episode	NN	O	I-PROBLEM
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
beta	NN	I-TREATMENT	I-TREATMENT
blocker	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
progressively	RB	O	O
increased	VBN	O	O
,	,	O	O
and	CC	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
nitroglycerin	JJ	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
weaned	VBN	O	O
down	RP	O	O
.	.	O	O

two	CD	O	O
days	NNS	O	O
after	IN	O	O
this	DT	O	O
event	NN	O	O
,	,	O	O
she	PRP	O	O
underwent	VBD	O	O
an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
which	WDT	O	O
was	VBD	O	O
significant	JJ	O	O
for	IN	O	O
slightly	RB	B-PROBLEM	B-PROBLEM
depressed	VBN	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
function	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
posterior	NN	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
hypokinesis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
was	VBD	O	O
a	DT	O	O
change	NN	O	O
from	IN	O	O
her	PRP$	B-TEST	B-TEST
prior	JJ	I-TEST	I-TEST
echocardiogram	NN	I-TEST	I-TEST
and	CC	O	O
demonstrated	VBD	O	O
evidence	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

clinically	RB	O	O
,	,	O	O
she	PRP	O	O
did	VBD	O	O
much	RB	O	O
better	RBR	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
optimized	VBN	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

1.	CD	O	O
prograf	JJ	B-TREATMENT	O
4	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
(	(	O	O
this	DT	O	O
may	MD	O	O
change	VB	O	O
depending	VBG	O	O
on	IN	O	O
her	PRP	B-TEST	O
most	RBS	I-TEST	O
recent	JJ	I-TEST	O
prograf	NN	I-TEST	O
level	NN	I-TEST	O
which	WDT	O	O
will	MD	O	O
be	VB	O	O
drawn	VBN	O	O
on	IN	O	O
the	DT	O	O
morning	NN	O	O
of	IN	O	O
11-28	JJ	O	O
)	)	O	O
.	.	O	O

2.	CD	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

3.	CD	O	O
cellcept	JJ	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

4.	CD	O	O
bactrim	JJ	B-TREATMENT	B-TREATMENT
1	CD	O	O
single-strength	JJ	O	O
tablet	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

5.	CD	O	O
zantac	NN	B-TREATMENT	B-TREATMENT
150	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

6.	CD	O	O
nph	JJ	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
16	CD	O	O
units	NNS	O	O
q.a.m.	RB	O	O
and	CC	O	O
6	CD	O	O
units	NNS	O	O
q.p.m.	RB	O	O

7.	CD	O	O
zoloft	JJ	B-TREATMENT	B-TREATMENT
175	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

8.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

9.	CD	O	O
reglan	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O

10.	CD	O	O
percocet	JJ	B-TREATMENT	B-TREATMENT
one	CD	O	O
to	TO	O	O
two	CD	O	O
tablets	NNS	O	O
p.o.	VBP	O	O
q.4-6h.	JJ	O	O
p.r.n.	NN	O	O

11.	CD	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
125	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

12.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
81	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

13.	CD	O	O
cardizem-cd	JJ	B-TREATMENT	B-TREATMENT
180	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

status	NN	O	O
post	NN	O	O
living-related	JJ	B-TREATMENT	B-TREATMENT
renal	JJ	I-TREATMENT	I-TREATMENT
transplant	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
perioperative	JJ	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM

saujule	NN	O	B-TEST
study	NN	O	I-TEST
is	VBZ	O	O
a	DT	O	O
77-year-old	JJ	O	O
woman	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
obesity	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
who	WP	O	O
presents	VBZ	O	O
with	IN	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
shortness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
x	$	O	O
5	CD	O	O
days	NNS	O	O
.	.	O	O

her	PRP$	B-PROBLEM	B-PROBLEM
shortness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
has	VBZ	O	O
been	VBN	O	O
progressive	JJ	O	O
over	IN	O	O
the	DT	O	O
last	JJ	O	O
2-3	JJ	O	O
years	NNS	O	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
an	DT	B-PROBLEM	B-PROBLEM
associated	VBN	I-PROBLEM	I-PROBLEM
dry	JJ	I-PROBLEM	I-PROBLEM
cough	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
no	DT	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
leg	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
dyspnea	VBN	B-PROBLEM	B-PROBLEM
on	IN	O	O
exertion	NN	O	O
.	.	O	O

she	PRP	O	O
ambulates	VBZ	O	O
with	IN	O	O
walker	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
a	DT	B-TREATMENT	B-TREATMENT
cane	NN	I-TREATMENT	I-TREATMENT
secondary	JJ	O	O
to	TO	O	O
osteoarthritis	VB	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
becomes	VBZ	O	O
short	JJ	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
just	RB	O	O
by	IN	O	O
getting	VBG	O	O
up	RP	O	O
from	IN	O	O
her	PRP$	O	O
chair	NN	O	O
and	CC	O	O
can	MD	O	O
only	RB	O	O
walk	VB	O	O
2-3	JJ	O	O
steps	NNS	O	O
on	IN	O	O
a	DT	O	O
flat	JJ	O	O
surface	NN	O	O
.	.	O	O

she	PRP	O	O
feels	VBD	O	O
light	NN	B-PROBLEM	O
headed	VBN	I-PROBLEM	O
when	WRB	O	O
getting	VBG	O	O
up	RP	O	O
.	.	O	O

her	PRP$	B-PROBLEM	B-PROBLEM
shortness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
exertion	NN	O	O
has	VBZ	O	O
been	VBN	O	O
progressive	JJ	O	O
for	IN	O	O
the	DT	O	O
past	JJ	O	O
several	JJ	O	O
years	NNS	O	O
.	.	O	O

she	PRP	O	O
sleeps	VBZ	O	O
in	IN	O	O
a	DT	O	O
chair	NN	O	O
up	RP	O	O
right	RB	O	O
for	IN	O	O
the	DT	O	O
last	JJ	O	O
2	CD	O	O
1/2	CD	O	O
years	NNS	O	O
secondary	JJ	O	O
to	TO	O	O
osteoarthritis	VB	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
orthopnea	VBN	B-PROBLEM	O
as	RB	O	O
well	RB	O	O
but	CC	O	O
noparoxysmal	JJ	B-PROBLEM	B-PROBLEM
nocturnal	JJ	I-PROBLEM	I-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
occasionally	RB	O	O
feels	VBZ	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
twinges	NNS	I-PROBLEM	I-PROBLEM
which	WDT	O	O
are	VBP	O	O
nonradiating	VBG	B-PROBLEM	O
but	CC	O	O
are	VBP	O	O
sharp	JJ	B-PROBLEM	O
.	.	O	O

they	PRP	O	O
last	JJ	O	O
a	DT	O	O
few	JJ	O	O
seconds	NNS	O	O
on	IN	O	O
the	DT	O	O
left	JJ	O	O
side	NN	O	O
and	CC	O	O
are	VBP	O	O
not	RB	O	O
associated	VBN	O	O
with	IN	O	O
sweating	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
or	CC	O	O
syncope	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
had	VBD	O	O
lower	JJR	B-PROBLEM	B-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
for	IN	O	O
thelast	JJ	O	O
several	JJ	O	O
years	NNS	O	O
with	IN	O	O
multiple	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
cellulitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

her	PRP$	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
has	VBZ	O	O
increased	VBN	O	O
for	IN	O	O
the	DT	O	O
several	JJ	O	O
weeks	NNS	O	O
prior	RB	O	O
to	TO	O	O
admission	VB	O	O
secondary	JJ	O	O
to	TO	O	O
an	DT	O	B-PROBLEM
inability	NN	O	I-PROBLEM
to	TO	O	I-PROBLEM
elevate	VB	O	I-PROBLEM
her	PRP$	O	I-PROBLEM
legs	NNS	O	I-PROBLEM
due	JJ	O	O
to	TO	O	O
a	DT	O	O
broken	JJ	O	O
chair	NN	O	O
at	IN	O	O
home	NN	O	O
.	.	O	O

she	PRP	O	O
denies	VBZ	O	O
any	DT	B-PROBLEM	B-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

negative	JJ	O	O
for	IN	O	O
headaches	NNS	B-PROBLEM	B-PROBLEM
,	,	O	I-PROBLEM
vision	NN	B-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
numbness	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
tingling	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hematuria	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
melena	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
hematochezia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

obesity	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	I-PROBLEM
lower	JJR	B-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
cellulitis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
edema	NN	B-PROBLEM	I-PROBLEM
,	,	O	O
breast	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
1988	CD	O	O
treated	VBD	O	O
with	IN	O	O
right	JJ	B-TREATMENT	B-TREATMENT
lumpectomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
xrt	NN	B-TREATMENT	O
,	,	O	O
partial	JJ	B-TREATMENT	B-TREATMENT
thyroidectomy	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
1963	CD	O	O
,	,	O	O
osteoarthritis	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
right	JJ	B-PROBLEM	B-PROBLEM
leg	NN	I-PROBLEM	I-PROBLEM
deformities	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
hernia	VBP	B-TREATMENT	B-PROBLEM
repair	NN	I-TREATMENT	B-TREATMENT
50	CD	O	O
years	NNS	O	O
ago	RB	O	O
,	,	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
cataract	NN	I-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

codeine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

hydrochlorothiazide	RB	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
q	JJ	O	O
day	NN	O	O
,	,	O	O
atenolol	RB	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
q	JJ	O	O
day	NN	O	O
,	,	O	O
dicloxacillin	NN	B-TREATMENT	O
started	VBD	O	O
on	IN	O	O
december	NN	O	O
29	CD	O	O
,	,	O	O
2002	CD	O	O
,	,	O	O
naproxen	CC	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O
,	,	O	O
aspirin	RB	B-TREATMENT	B-TREATMENT
81	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
q	JJ	O	O
day	NN	O	O
,	,	O	O
tylenol	NN	B-TREATMENT	B-TREATMENT
p.r.n.	NN	O	O

son	NN	O	O
died	VBD	O	O
at	IN	O	O
50	CD	O	O
of	IN	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	I-PROBLEM
myocardial	JJ	B-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

in	IN	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
,	,	O	O
vitals	NNS	B-TEST	B-TEST
were	VBD	O	O
temperature	JJ	B-TEST	B-TEST
96.4	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
40-50	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
154-58	CD	O	O
,	,	O	O
satting	VBG	O	B-TEST
86%	CD	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
,	,	O	O
99%	CD	O	O
on	IN	O	O
3	CD	O	O
liters	NNS	O	O
of	IN	O	O
3	CD	B-TREATMENT	B-TREATMENT
liters	NNS	I-TREATMENT	I-TREATMENT
cannula	VBP	I-TREATMENT	I-TREATMENT
.	.	O	O

rate	NN	B-TEST	B-TEST
28	CD	O	O
.	.	O	O

anicteric	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2	CD	B-TEST	O
plus	JJ	I-TEST	O
carotids	NNS	I-TEST	O
.	.	O	O

no	DT	O	O
delayed	JJ	B-PROBLEM	B-PROBLEM
upstroke	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

oropharynx	NN	O	O
is	VBZ	O	O
clear	JJ	O	O
without	IN	O	O
lymphadenopathyin	PDT	B-PROBLEM	B-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
neck	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

jugular	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
distention	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
the	DT	O	O
jaw	NN	O	O
.	.	O	O

crackles	NNS	B-PROBLEM	B-TEST
1/3	CD	I-PROBLEM	O
up	RB	I-PROBLEM	O
bilaterally	RB	I-PROBLEM	O
.	.	O	O

3/6	CD	B-PROBLEM	O
crescendo	NN	I-PROBLEM	B-PROBLEM
decrescendo	NN	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
sternal	JJ	I-PROBLEM	I-PROBLEM
border	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
radiation	NN	B-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
carotids	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
rubs	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
gallops	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

soft	JJ	O	O
,	,	O	O
obese	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBD	B-PROBLEM	B-PROBLEM
,	,	O	O
normal	JJ	O	O
active	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
.	.	O	O

no	DT	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

3	CD	B-PROBLEM	O
plus	CC	I-PROBLEM	O
pitting	VBG	I-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	O
the	DT	I-PROBLEM	O
knee	NN	I-PROBLEM	O
bilaterally	RB	I-PROBLEM	O
with	IN	O	O
areas	NNS	O	O
of	IN	O	O
darkened	VBN	B-PROBLEM	B-PROBLEM
erythema	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
is	VBZ	O	O
crusted	VBN	B-PROBLEM	O
,	,	O	O
indented	VBN	B-PROBLEM	O
.	.	O	O

a	DT	B-PROBLEM	B-PROBLEM
shallow	JJ	I-PROBLEM	I-PROBLEM
chronic	JJ	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
shin	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
desquamation	NN	B-PROBLEM	B-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM
around	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
ankle	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
half	NN	O	O
way	NN	O	O
up	IN	O	O
the	DT	O	O
shin	NN	O	O
.	.	O	O

1	CD	B-PROBLEM	O
x	JJ	I-PROBLEM	O
2	CD	I-PROBLEM	O
cm	JJ	I-PROBLEM	B-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
clean	JJ	O	O
sharp	JJ	O	O
borders	NNS	O	O
to	TO	O	O
the	DT	O	O
dermatome	NN	O	O
on	IN	O	O
the	DT	O	O
left	NN	O	O
posterior	JJ	O	O
thigh	NN	O	O
.	.	O	O

unable	JJ	O	O
to	TO	O	O
assess	VB	O	O
reflexes	NNS	B-TEST	B-TEST
due	JJ	O	O
to	TO	O	O
the	DT	B-PROBLEM	B-PROBLEM
knee	NN	I-PROBLEM	I-PROBLEM
deformities	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

2	CD	B-TEST	O
plus	CC	I-TEST	O
reflexes	NNS	I-TEST	B-TEST
in	IN	O	O
the	DT	O	O
upper	JJ	O	O
extremities	NNS	O	O
symmetrically	RB	O	O
bilaterally	RB	O	O
.	.	O	O

sodium	NN	B-TEST	B-TEST
134	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.0	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
91	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
33	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
21	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
1.1	CD	O	O
,	,	O	O
glucose	RB	B-TEST	B-TEST
99	CD	O	O
,	,	O	O
ck	NN	B-TEST	B-TEST
22	CD	O	O
,	,	O	O
troponin	NN	B-TEST	B-TEST
0	CD	O	O
.	.	O	O

calcium	NN	B-TEST	B-TEST
8.8	CD	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
10.6	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
37.1	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
289	CD	O	O
.	.	O	O

inr	NN	B-TEST	B-TEST
1.1	CD	O	O
,	,	O	O
ptt	VBD	B-TEST	B-TEST
30.3.chest	CD	B-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
shows	NNS	O	O
cardiomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

small	JJ	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

lobular	JJ	B-PROBLEM	B-PROBLEM
density	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
hilum	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

electrocardiogram	NN	B-TEST	B-TEST
shows	NNS	O	O
normal	JJ	O	O
sinus	JJ	O	O
rhythm	NN	O	O
at	IN	O	O
50	CD	O	O
.	.	O	O

primary	JJ	B-PROBLEM	B-PROBLEM
av	NN	I-PROBLEM	I-PROBLEM
block	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

left	VBD	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
hospital	NN	O	O
for	IN	O	O
acute	NN	B-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	O
chronic	JJ	I-PROBLEM	B-PROBLEM
shortness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
in	IN	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
thought	VBD	O	O
likely	RB	O	O
secondary	JJ	O	O
to	TO	O	O
diastolic	JJ	B-PROBLEM	B-PROBLEM
dysfunction	NN	I-PROBLEM	I-PROBLEM
secondary	JJ	O	O
to	TO	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
also	RB	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
ruled	VBD	O	O
out	RP	O	O
for	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
3	CD	O	O
negative	JJ	O	O
enzymes	NNS	O	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
diuresed	VBN	O	O
with	IN	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
was	VBD	O	O
negative	JJ	O	O
1-2	JJ	O	O
liters	NNS	O	O
per	IN	O	O
day	NN	O	O
for	IN	O	O
several	JJ	O	O
days	NNS	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
diuresis	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
backed	VBN	O	O
off	RP	O	O
when	WRB	O	O
her	PRP$	B-TEST	B-TREATMENT
bicarbonate	NN	I-TEST	I-TREATMENT
increased	VBD	O	O
from	IN	O	O
36	CD	O	O
to	TO	O	O
39	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
lipids	NNS	I-TEST	I-TEST
were	VBD	O	O
checked	VBN	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
total	JJ	I-TEST	I-TEST
cholesterol	NN	I-TEST	I-TEST
of	IN	O	O
110	CD	O	O
,	,	O	O
triglycerides	NNS	B-TEST	B-TEST
59	CD	O	O
,	,	O	O
hdl32	NN	B-TEST	O
,	,	O	O
ldl	VBZ	B-TEST	O
64	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	O
d-dimer	JJ	I-TEST	O
greater	JJR	O	O
than	IN	O	O
1000	CD	O	O
with	IN	O	O
lower	JJR	B-TEST	B-TEST
extremity	NN	I-TEST	I-TEST
non-invasive	JJ	I-TEST	I-TEST
studies	NNS	I-TEST	I-TEST
which	WDT	O	O
were	VBD	O	O
positive	JJ	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
common	JJ	I-PROBLEM	I-PROBLEM
femoral	JJ	I-PROBLEM	I-PROBLEM
clot	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
tte	NN	I-TEST	I-TEST
showed	VBD	O	O
an	DT	B-TEST	B-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
60%	CD	O	O
,	,	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
left	VBD	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
enlargement	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
tricuspid	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
pulmonary	JJ	B-TEST	B-TEST
artery	NN	I-TEST	I-TEST
pressures	NNS	I-TEST	I-TEST
of	IN	O	O
44	CD	B-TEST	O
plus	CC	I-TEST	O
right	JJ	I-TEST	B-TEST
atrial	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
.	.	O	O

there	EX	O	O
was	VBD	O	O
an	DT	B-PROBLEM	B-TREATMENT
intra-atrial	JJ	I-PROBLEM	I-TREATMENT
shunt	NN	I-PROBLEM	I-TREATMENT
from	IN	O	O
the	DT	O	O
right	NN	O	O
to	TO	O	O
the	DT	O	O
left	VBN	O	O
through	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
patent	NN	I-PROBLEM	I-PROBLEM
foramen	NNS	I-PROBLEM	I-PROBLEM
ovale	VBP	I-PROBLEM	I-PROBLEM
.	.	O	O

chest	JJS	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
was	VBD	O	O
a	DT	B-TEST	B-TEST
poor	JJ	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
but	CC	O	O
did	VBD	O	O
not	RB	O	O
show	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
embolus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
subsequent	JJ	B-TEST	B-TREATMENT
dobutamine	NN	I-TEST	I-TREATMENT
mibi	NN	I-TEST	I-TREATMENT
which	WDT	O	O
was	VBD	O	O
positive	JJ	O	O
for	IN	O	O
inducible	JJ	B-PROBLEM	B-PROBLEM
ischemia	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
distribution	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
posterior	JJ	O	I-PROBLEM
descending	VBG	O	I-PROBLEM
coronary	JJ	O	I-PROBLEM
artery	NN	O	I-PROBLEM
and	CC	O	O
posterolateral	JJ	O	B-PROBLEM
coronary	JJ	O	I-PROBLEM
artery	NN	O	I-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
medium	VB	I-PROBLEM	I-PROBLEM
perfusion	NN	I-PROBLEM	I-PROBLEM
defect	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
inferolateral	JJ	O	I-PROBLEM
wall	NN	O	I-PROBLEM
and	CC	O	O
basal	NN	O	B-TEST
inferior	VBP	O	I-TEST
wall	NN	O	I-TEST
which	WDT	O	O
was	VBD	O	O
partially	RB	O	O
reversible	JJ	O	O
.	.	O	O

the	DT	O	O
cardiology	NN	O	O
service	NN	O	O
saw	VBD	O	O
the	DT	O	O
patient	NN	O	O
and	CC	O	O
recommended	VBD	O	O
medical	JJ	O	B-TREATMENT
management	NN	O	I-TREATMENT
only	RB	O	O
without	IN	O	O
catheterization	NN	B-TEST	B-TEST
.	.	O	O

her	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
high	JJ	B-PROBLEM	O
so	RB	O	O
captopril	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
titrated	VBN	O	O
up	RB	O	O
to	TO	O	O
50	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
t.i.d.	NN	O	O
.	.	O	O

she	PRP	O	O
will	MD	O	O
be	VB	O	O
discharged	VBN	O	O
on	IN	O	O
lisinopril	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
further	JJ	O	B-TREATMENT
titration	NN	O	I-TREATMENT
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
on	IN	O	O
hydrochlorothiazide	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

her	PRP$	B-TREATMENT	B-TEST
atenolol	NN	I-TREATMENT	I-TEST
was	VBD	O	O
stopped	VBN	O	O
due	JJ	O	O
to	TO	O	O
bradycardia	VB	B-PROBLEM	B-PROBLEM
on	IN	O	O
admission	NN	O	O
but	CC	O	O
this	DT	O	O
may	MD	O	O
be	VB	O	O
restarted	VBN	O	O
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
in	IN	O	O
gentle	JJ	B-TREATMENT	O
doses	NNS	I-TREATMENT	O
with	IN	O	O
careful	JJ	O	B-TEST
monitoring	NN	O	I-TEST
of	IN	O	I-TEST
heart	NN	B-TEST	I-TEST
rate	NN	I-TEST	I-TEST
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
on	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
aspirin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
will	MD	O	O
be	VB	O	O
discharged	VBN	O	O
on	IN	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
for	IN	O	O
continued	JJ	O	O
control	NN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pulmonary	JJ	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
as	IN	O	O
seen	VBN	O	O
on	IN	O	O
echocardiogram	NN	B-TEST	B-TEST
.	.	O	O

unclear	JJ	O	O
whether	IN	O	O
there	EX	O	O
are	VBP	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
embolus	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
did	VBD	O	O
have	VB	O	O
positive	JJ	O	B-PROBLEM
test	NN	O	I-PROBLEM
for	IN	O	O
deep	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
thrombosis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
will	MD	O	O
be	VB	O	O
treated	VBN	O	O
with	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

an	DT	B-TEST	B-TEST
abg	NN	I-TEST	I-TEST
was	VBD	O	O
done	VBN	O	O
which	WDT	O	O
showed	VBD	O	O
ph	IN	B-TEST	O
7.34	CD	O	O
,	,	O	O
pco2	NN	B-TEST	O
78	CD	O	O
,	,	O	O
po2	RB	B-TEST	O
92	CD	O	O
on	IN	O	O
2	CD	O	O
liters	NNS	O	O
.	.	O	O

her	PRP$	B-TEST	B-TREATMENT
bicarbonate	NN	I-TEST	I-TREATMENT
peaked	VBD	O	O
at	IN	O	O
39	CD	O	O
and	CC	O	O
generally	RB	O	O
is	VBZ	O	O
in	IN	O	O
the	DT	O	O
36-38	JJ	O	O
range	NN	O	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
sleep	JJ	I-PROBLEM	I-PROBLEM
apnea	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
falls	VBZ	O	O
asleep	JJ	O	O
midsentence	NN	O	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
episodes	NNS	O	O
of	IN	O	O
not	RB	B-PROBLEM	O
breathing	VBG	I-PROBLEM	O
.	.	O	O

bipap	NN	B-TREATMENT	B-TEST
was	VBD	O	O
attempted	VBN	O	O
for	IN	O	O
3	CD	O	O
nights	NNS	O	O
in	IN	O	O
a	DT	O	O
row	NN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
did	VBD	O	O
not	RB	O	O
tolerate	VB	O	O
this	DT	O	O
.	.	O	O

she	PRP	O	O
will	MD	O	O
need	VB	O	O
pulmonary	JJ	B-TEST	B-TEST
function	NN	I-TEST	I-TEST
studies	NNS	I-TEST	I-TEST
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
as	IN	O	O
these	DT	O	O
were	VBD	O	O
not	RB	O	O
done	VBN	O	O
in	IN	O	O
the	DT	O	O
hospital	NN	O	O
.	.	O	O

the	DT	O	O
pulmonary	JJ	O	O
team	NN	O	O
saw	VBD	O	O
the	DT	O	O
patient	NN	O	O
and	CC	O	O
only	RB	O	O
recommended	VBD	O	O
the	DT	B-TEST	B-TEST
above	JJ	I-TEST	I-TEST
testing	NN	I-TEST	I-TEST
.	.	O	O

she	PRP	O	O
needs	VBZ	O	O
home	NN	B-TREATMENT	B-TREATMENT
oxygen	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
is	VBZ	O	O
currently	RB	O	O
at	IN	O	O
2	CD	B-TREATMENT	O
liters	NNS	I-TREATMENT	O
nasal	JJ	I-TREATMENT	B-TREATMENT
cannula	JJ	I-TREATMENT	I-TREATMENT
oxygen	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

3.	CD	O	O
infectious	JJ	B-PROBLEM	O
disease	NN	I-PROBLEM	O
:	:	O	O

evidence	NN	O	O
for	IN	O	O
cellulitis	NN	B-PROBLEM	B-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
legs	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
likely	RB	O	O
due	JJ	O	O
to	TO	O	O
distention	NN	B-PROBLEM	B-PROBLEM
from	IN	O	I-PROBLEM
edema	NN	B-PROBLEM	I-PROBLEM
and	CC	O	O
poor	JJ	B-PROBLEM	B-PROBLEM
perfusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
originally	RB	O	O
started	VBN	O	O
on	IN	O	O
cefazolin	NN	B-TREATMENT	B-TREATMENT
which	WDT	O	O
was	VBD	O	O
then	RB	O	O
changed	VBN	O	O
to	TO	O	O
keflex	VB	B-TREATMENT	O
with	IN	O	O
good	JJ	O	O
improvement	NN	O	O
.	.	O	O

she	PRP	O	O
will	MD	O	O
need	VB	O	O
to	TO	O	O
continue	VB	O	O
for	IN	O	O
at	IN	O	O
least	JJS	O	O
10	CD	O	O
more	JJR	O	O
days	NNS	O	O
or	CC	O	O
as	IN	O	O
clinically	RB	O	O
indicated	VBN	O	O
by	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
cellulitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

d-dimer	NN	B-TEST	O
in	IN	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
was	VBD	O	O
greater	JJR	O	O
than	IN	O	O
1000	CD	O	O
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
common	JJ	I-PROBLEM	I-PROBLEM
femoral	JJ	I-PROBLEM	I-PROBLEM
clot	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
seen	VBN	O	O
.	.	O	O

this	DT	B-PROBLEM	B-PROBLEM
clot	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
small	JJ	O	O
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
questionable	JJ	O	O
as	IN	O	O
to	TO	O	O
whether	IN	O	O
it	PRP	O	O
was	VBD	O	O
old	JJ	O	O
or	CC	O	O
new	JJ	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
anticoagulation	NN	B-TREATMENT	B-TREATMENT
given	VBN	O	O
the	DT	B-PROBLEM	B-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
d-dimer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

chest	JJS	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
was	VBD	O	O
nondiagnostic	JJ	O	O
but	CC	O	O
did	VBD	O	O
not	RB	O	O
show	VB	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
embolus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

it	PRP	O	O
was	VBD	O	O
a	DT	B-TEST	B-TEST
poor	JJ	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
.	.	O	O

heparin	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
maintained	VBN	O	O
during	IN	O	O
her	PRP$	O	B-TREATMENT
hospital	JJ	O	I-TREATMENT
course	NN	O	I-TREATMENT
and	CC	O	O
then	RB	O	O
lovenox	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
started	VBN	O	O
.	.	O	O

her	PRP$	B-TREATMENT	O
dose	NN	I-TREATMENT	O
was	VBD	O	O
increased	VBN	O	O
to	TO	O	O
7.5	CD	O	O
mg	NNS	O	O
q	JJ	O	O
day	NN	O	O
the	DT	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

she	PRP	O	O
will	MD	O	O
be	VB	O	O
discharged	VBN	O	O
on	IN	O	O
this	DT	O	O
dose	NN	O	O
in	IN	O	O
addition	NN	O	O
to	TO	O	O
1	CD	O	O
day	NN	O	O
of	IN	O	O
lovenox	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

discharge	NN	B-TEST	O
inr	VBZ	I-TEST	O
1.8	CD	O	O
.	.	O	O

goal	NN	B-TEST	O
inr	NN	I-TEST	O
is	VBZ	O	O
2.0-3.0	JJ	O	O
.	.	O	O

low	JJ	B-TREATMENT	B-TREATMENT
salt	NN	I-TREATMENT	I-TREATMENT
diet	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

low	JJ	B-TREATMENT	B-PROBLEM
cholesterol	NN	I-TREATMENT	I-PROBLEM
,	,	I-TREATMENT	O
low	JJ	I-TREATMENT	B-TREATMENT
fat	NN	I-TREATMENT	I-TREATMENT
diet	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

to	TO	O	O
rehabilitation	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
needs	VBZ	O	O
physical	JJ	B-TREATMENT	O
therapy	NN	I-TREATMENT	O
to	TO	O	O
increase	VB	O	O
stability	NN	O	O
in	IN	O	O
mobilization	NN	O	O
.	.	O	O

need	NN	O	O
to	TO	O	O
try	VB	O	O
to	TO	O	O
control	VB	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
.	.	O	O

can	MD	O	O
increase	VB	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
ace	JJ	I-TREATMENT	I-TREATMENT
inhibitor	NN	I-TREATMENT	I-TREATMENT
as	IN	O	O
tolerated	VBN	O	O
.	.	O	O

may	MD	O	O
start	VB	O	O
beta-blocker	NN	B-TREATMENT	O
at	IN	O	O
a	DT	O	O
low	JJ	O	O
dose	NN	O	O
given	VBN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
bradycardia	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
atenolol	JJ	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

need	NN	O	O
to	TO	O	O
continue	VB	O	O
oxygen	NN	B-TREATMENT	B-TREATMENT
2	CD	O	O
liters	NNS	O	O
via	IN	O	O
nasal	JJ	B-TREATMENT	B-TREATMENT
cannula	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

needs	NNS	O	O
anticoagulation	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
6	CD	O	O
months	NNS	O	O
for	IN	O	O
right	JJ	B-PROBLEM	B-PROBLEM
common	JJ	I-PROBLEM	I-PROBLEM
femoral	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
deep	RB	I-PROBLEM	I-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
thrombosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

goal	NN	B-TEST	O
inr	NN	I-TEST	O
is	VBZ	O	O
2.0-3.0	JJ	O	O
.	.	O	O

should	MD	O	O
continue	VB	O	O
keflex	VB	B-TREATMENT	B-TREATMENT
for	IN	O	O
10	CD	O	O
more	JJR	O	O
days	NNS	O	O
or	CC	O	O
as	IN	O	O
clinically	RB	O	O
indicated	VBN	O	O
.	.	O	O

need	NN	O	O
to	TO	O	O
follow	VB	O	O
inr	NN	B-TEST	O
after	IN	O	O
keflex	NN	B-TREATMENT	B-TREATMENT
is	VBZ	O	O
discontinued	VBN	O	O
as	IN	O	O
expect	NN	O	O
it	PRP	O	O
will	MD	O	O
change	VB	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
sleep	JJ	I-PROBLEM	I-PROBLEM
apnea	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
stops	VBZ	O	O
breathing	VBG	O	O
during	IN	O	O
sleep	NN	O	O
.	.	O	O

tylenol	RB	B-TREATMENT	B-TREATMENT
650	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
q	JJ	O	O
4-6	JJ	O	O
hours	NNS	O	O
p.r.n.	VBP	O	O
headache	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
enteric	RB	B-TREATMENT	B-TREATMENT
coated	VBD	I-TREATMENT	I-TREATMENT
aspirin	JJ	I-TREATMENT	I-TREATMENT
325	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q	JJ	O	O
day	NN	O	O
,	,	O	O
calcium	NN	B-TREATMENT	B-TREATMENT
gluconate	NN	I-TREATMENT	I-TREATMENT
1000	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
enema	NN	B-TREATMENT	B-TEST
of	IN	I-TREATMENT	O
choice	NN	I-TREATMENT	O
and	CC	O	O
laxative	NN	B-TREATMENT	B-TREATMENT
of	IN	I-TREATMENT	O
choice	NN	I-TREATMENT	O
p.o.	NNS	O	O
q	VBP	O	O
day	NN	O	O
p.r.n.	JJ	O	O
constipation	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
lasix	VBZ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q	JJ	O	O
day	NN	O	O
,	,	O	O
coumadin	VBP	B-TREATMENT	B-TREATMENT
7.5	CD	O	O
mg	NNS	O	O
p.o.q.h.s.	NN	O	O
for	IN	O	O
goal	NN	B-TEST	O
inr	NN	I-TEST	O
of	IN	O	O
2.0-3.0	JJ	O	O
.	.	O	O

keflex	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.i.d.	NN	O	O
x	VBD	O	O
10	CD	O	O
more	JJR	O	O
days	NNS	O	O
,	,	O	O
miconazole	JJ	B-TREATMENT	B-TREATMENT
2%	CD	O	I-TREATMENT
powder	NN	O	I-TREATMENT
topically	RB	O	O
b.i.d.	VBZ	O	O
apply	VB	O	O
to	TO	O	O
affected	JJ	O	B-PROBLEM
areas	NNS	O	I-PROBLEM
of	IN	O	I-PROBLEM
breasts	NNS	O	I-PROBLEM
and	CC	O	I-PROBLEM
groins	NNS	O	I-PROBLEM
b.i.d.	VBP	O	O
,	,	O	O
lisinopril	VBP	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q	NN	O	O
day	NN	O	O
hold	VB	O	O
of	IN	O	O
systolic	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
less	JJR	O	O
than	IN	O	O
110	CD	O	O
,	,	O	O
lovenox	VBD	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
subcutaneously	RB	O	O
q	VBZ	O	O
12	CD	O	O
hours	NNS	O	O
x	VBD	O	O
2	CD	O	O
doses	NNS	O	O
and	CC	O	O
then	RB	O	O
discontinued	VBN	O	O
,	,	O	O
atenolol	VBZ	B-TREATMENT	B-TREATMENT
12.5	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q	NN	O	O
day	NN	O	O
hold	VB	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
systolic	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
less	JJR	O	O
than	IN	O	O
110	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
less	JJR	O	O
than	IN	O	O
55	CD	O	O
.	.	O	O

ciprofloxacin	NN	B-TREATMENT	B-TREATMENT
/	CD	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT

pelvic	JJ	B-PROBLEM	B-PROBLEM
organ	NN	I-PROBLEM	I-PROBLEM
prolapse	NN	I-PROBLEM	I-PROBLEM

total	JJ	B-TREATMENT	B-TEST
vaginal	JJ	I-TREATMENT	I-TEST
hysterectomy;	NN	I-TREATMENT	I-TEST
combined	VBN	O	I-TEST
anterior-posterior	JJ	B-TREATMENT	I-TEST
colporrhaphy	NN	I-TREATMENT	I-TEST
with	IN	O	O
posterior	JJ	B-TREATMENT	B-PROBLEM
mesh;	NN	I-TREATMENT	I-PROBLEM
subpubic	JJ	B-TREATMENT	I-PROBLEM
urethral	JJ	I-TREATMENT	I-PROBLEM
sling;	NN	I-TREATMENT	I-PROBLEM
sacrospinous	JJ	B-TEST	I-PROBLEM
colpopexy	NN	I-TEST	I-PROBLEM
exploratory	NN	I-TEST	I-PROBLEM
laparotomy	NN	I-TEST	I-PROBLEM

reexploration	NN	B-TEST	B-PROBLEM
of	IN	I-TEST	I-PROBLEM
vaginal	JJ	I-TEST	I-PROBLEM
surgical	JJ	I-TEST	I-PROBLEM
area	NN	I-TEST	I-PROBLEM
pelvic	NN	I-TEST	I-PROBLEM
angiography	NN	I-TEST	I-PROBLEM

34	CD	O	O
yo	NNS	O	O
g3p3	NN	O	O
with	IN	O	O
pelvic	JJ	B-PROBLEM	B-PROBLEM
organ	NNS	I-PROBLEM	I-PROBLEM
prolapse	NN	I-PROBLEM	I-PROBLEM
after	IN	O	O
her	PRP$	O	O
second	JJ	O	O
delivery;	NN	O	O
after	IN	O	O
her	PRP$	O	B-TREATMENT
third	JJ	O	I-TREATMENT
delivery	NN	O	I-TREATMENT
it	PRP	O	O
became	VBD	O	O
much	JJ	B-PROBLEM	O
worse	JJR	I-PROBLEM	O
.	.	O	O

she	PRP	O	O
urinates	VBZ	O	O
frequently	RB	O	O
,	,	O	O
but	CC	O	O
occasionally	RB	O	O
the	DT	O	O
urine	NN	O	O
is	VBZ	O	O
very	RB	B-PROBLEM	O
slow	JJ	I-PROBLEM	O
to	TO	I-PROBLEM	O
start	VB	I-PROBLEM	O
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
prolapse	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
especailly	RB	O	O
large	JJ	B-PROBLEM	O
and	CC	I-PROBLEM	O
uncomfotable	JJ	I-PROBLEM	O
when	WRB	O	O
she	PRP	O	O
tries	VBZ	O	O
to	TO	O	O
move	VB	O	O
her	PRP$	O	O
bowels	NNS	O	O
and	CC	O	O
it	PRP	O	O
is	VBZ	O	O
easier	JJR	O	O
for	IN	O	O
her	PRP$	O	O
to	TO	O	O
do	VB	O	O
sowhile	VB	O	O
standing	VBG	O	O
rather	RB	O	O
than	IN	O	O
sitting	VBG	O	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
deep	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
intercourse	NN	O	I-PROBLEM
.	.	O	O

chronic	JJ	B-PROBLEM	B-PROBLEM
back	RB	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
:	:	O	O
several	JJ	B-PROBLEM	O
discs	NNS	I-PROBLEM	O
and	CC	O	O
spondylolisthesis	NN	B-PROBLEM	B-PROBLEM

left	VBN	B-TREATMENT	B-TREATMENT
salpingo	JJ	I-TREATMENT	I-TREATMENT
oophorectomy	NN	I-TREATMENT	I-TREATMENT
2002	CD	O	O
for	IN	O	O
torsion;	NN	B-PROBLEM	B-PROBLEM
coloposcopy	NN	B-TEST	I-PROBLEM
and	CC	O	O
cryotherapy	NN	B-TREATMENT	B-TREATMENT
2001;	CD	O	O
appendectomy;	NN	B-TREATMENT	O
t	NN	B-TREATMENT	O
+	VBZ	I-TREATMENT	O
a	DT	I-TREATMENT	O

mother	NN	O	O
had	VBD	O	O
breast	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM

nad	NN	B-PROBLEM	B-PROBLEM

rrr	NN	O	O
,	,	O	O
no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM

clear	JJ	O	O
to	TO	O	O
percussion	NN	B-TEST	B-TEST
and	CC	O	O
auscultation	NN	B-TEST	B-TEST

anterior	RB	B-PROBLEM	B-TEST
wall	NN	I-PROBLEM	I-TEST
prolapses	VBZ	I-PROBLEM	I-TEST
3	CD	O	O
cm	NN	O	O
past	IN	O	O
the	DT	O	O
hymen	NNS	O	O
with	IN	O	O
loss	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
urine	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
valsalva;	NN	I-PROBLEM	I-PROBLEM
cervix	NN	O	I-PROBLEM
1cm	CD	O	I-PROBLEM
above	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
hymen;	NN	O	I-PROBLEM
posterior	NN	B-PROBLEM	I-PROBLEM
prolapse	NN	I-PROBLEM	I-PROBLEM
only	RB	O	O
to	TO	O	O
the	DT	O	O
hymen	NNS	O	O
but	CC	O	O
3.4	CD	O	O
cm	NN	O	O
of	IN	O	O
perineal	JJ	B-PROBLEM	B-PROBLEM
descent	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

anterior	RB	O	O
,	,	O	O
tender	NN	B-PROBLEM	O
on	IN	O	O
motion	NN	O	O

radiolabled	VBN	B-TEST	O
red	JJ	I-TEST	B-TEST
cell	NN	I-TEST	I-TEST
study	VB	I-TEST	I-TEST
12-05	JJ	O	O

no	DT	O	O
evidence	NN	O	O
of	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
abdomen	NNS	I-PROBLEM	I-PROBLEM
or	CC	I-PROBLEM	I-PROBLEM
pelvis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pelvic	JJ	B-TEST	O
arterogram	VBZ	I-TEST	O
12-05	JJ	O	O

images	NNS	O	O
demonstrate	VBP	O	O
diffusely	RB	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
caliber	NN	I-PROBLEM	I-PROBLEM
vasculature	NN	I-PROBLEM	I-PROBLEM
consistent	JJ	O	O
with	IN	O	O
shock	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
luminal	JJ	B-PROBLEM	B-PROBLEM
irregularity	NN	I-PROBLEM	I-PROBLEM
seen	VBN	O	O
in	IN	O	O
segments	NNS	O	O
of	IN	O	O
both	DT	O	O
the	DT	O	O
left	NN	O	O
and	CC	O	O
right	JJ	O	B-TREATMENT
external	JJ	O	I-TREATMENT
iliac	NN	O	I-TREATMENT
arteries	NNS	O	I-TREATMENT
consistent	VBP	O	O
with	IN	O	O
spasm	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

specifically	RB	O	O
,	,	O	O
no	DT	O	O
extravasation	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
contrast	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
obstruction	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
flow	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
av	JJ	B-PROBLEM	B-TEST
fistulization	NN	I-PROBLEM	I-TEST
or	CC	O	O
intimal	JJ	B-PROBLEM	B-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
observed	VBN	O	O
.	.	O	O

thus	RB	O	O
,	,	O	O
no	DT	O	O
embolotherapy	NN	B-TREATMENT	O
was	VBD	O	O
embarked	VBN	O	O
upon	IN	O	O
.	.	O	O

no	DT	O	O
active	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
observed	VBN	O	O
.	.	O	O

1.	CD	O	O
uterus	JJ	O	O
and	CC	O	O
cervix	NN	O	B-PROBLEM
,	,	O	O
hysterectomy	NN	B-TREATMENT	B-TREATMENT
(	(	O	O
a-e	JJ	O	O
):	NN	O	O

a.	JJ	O	B-PROBLEM
secretory	JJ	B-PROBLEM	I-PROBLEM
endometrium	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

b.	NN	O	B-PROBLEM
cervix	NN	O	I-PROBLEM
with	IN	O	O
squamous	JJ	B-PROBLEM	B-PROBLEM
metaplasia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

d.	VB	O	O
one	CD	B-TREATMENT	O
intrauterine	NN	I-TREATMENT	B-TREATMENT
device	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
gross	JJ	O	B-PROBLEM
description	NN	O	I-PROBLEM
.	.	O	O

squamous	JJ	B-PROBLEM	B-PROBLEM
mucosa	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
skin	NN	O	O
with	IN	O	O
no	DT	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
pathologic	JJ	I-PROBLEM	I-PROBLEM
change	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
20.0*	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.31*	CD	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
10.2*#	CD	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
31.2*	CD	O	O

mcv	SYM	B-TEST	B-TEST
-	:	O	O
95	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
30.9	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
32.7	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
13.6	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
297	CD	O	O

hct	SYM	B-TEST	B-TEST
-	:	O	O
19.5*#	CD	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
20.0*	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.96*	CD	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
12.5	CD	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
34.4*#	CD	O	O

mcv	SYM	B-TEST	B-TEST
-	:	O	O
87#	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
31.5	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
36.4*#	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
13.6	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
89*#	CD	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
12.7*	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.17*	CD	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
9.9*	CD	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
27.6*	CD	O	O

mcv	SYM	B-TEST	B-TEST
-	:	O	O
87	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
31.3	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
35.9*	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
14.2	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
104*	CD	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
12.1*	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.73*	CD	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
11.3*	CD	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
31.5*	CD	O	O

mcv	SYM	B-TEST	B-TEST
-	:	O	O
84	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
30.2	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
35.8*	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
15.4	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
91*	CD	O	O

hct	SYM	B-TEST	B-TEST
-	:	O	O
28.7*	CD	O	O

hct	SYM	B-TEST	B-TEST
-	:	O	O
27.9*	CD	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
12.6*	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.53*	CD	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
10.5*	CD	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
30.1*	CD	O	O

mcv	SYM	B-TEST	B-TEST
-	:	O	O
85	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
29.8	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
35.0	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
14.6	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
308#	CD	O	O

pt	SYM	B-TEST	B-TEST
-	:	O	O
13.0	CD	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
26.1	CD	O	O
inr	NN	B-TEST	O
(	(	O	O
pt	NN	B-TEST	O
)	)	O	O
-	:	O	O
1.1	CD	O	O

pt	SYM	B-TEST	B-TEST
-	:	O	O
13.2*	CD	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
24.2	CD	O	O
inr	NN	B-TEST	O
(	(	O	O
pt	NN	B-TEST	O
)	)	O	O
-	:	O	O
1.1	CD	O	O

pt	SYM	B-TEST	B-TEST
-	:	O	O
11.6	CD	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
23.8	CD	O	O
inr	NN	B-TEST	O
(	(	O	O
pt	NN	B-TEST	O
)	)	O	O
-	:	O	O
1.0	CD	O	O

glucose	JJ	B-TEST	B-TEST
-	:	O	O
146*	CD	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
12	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
0.6	CD	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
140	CD	O	O

k	SYM	B-TEST	B-TEST
-	:	O	O
4.1	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
108	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
21*	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
15	CD	O	O

glucose	JJ	B-TEST	B-TEST
-	:	O	O
96	CD	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
5*	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
0.4	CD	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
139	CD	O	O

k	SYM	B-TEST	B-TEST
-	:	O	O
3.1*	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
108	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
26	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
8	CD	O	O

urean	JJ	B-TEST	B-TEST
-	:	O	O
4*	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
0.3*	CD	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
140	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
4.0	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
108	CD	O	O

hco3	SYM	B-TEST	B-TEST
-	:	O	O
27	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
9	CD	O	O

calcium	NN	B-TEST	B-TEST
-	:	O	O
7.9*	CD	O	O
phos	NN	B-TEST	B-TEST
-	:	O	O
4.5	CD	O	O
mg	SYM	B-TEST	O
-	:	O	O
1.5*	CD	O	O

calcium	NN	B-TEST	B-TEST
-	:	O	O
7.3*	CD	O	O
phos	NN	B-TEST	B-TEST
-	:	O	O
2.3*	CD	O	O
mg	SYM	B-TEST	O
-	:	O	O
1.7	CD	O	O

calcium	NN	B-TEST	B-TEST
-	:	O	O
7.5*	CD	O	O
mg	SYM	B-TEST	O
-	:	O	O
1.6	CD	O	O

calcium	NN	B-TEST	B-TEST
-	:	O	O
7.5*	CD	O	O
phos	NN	B-TEST	B-TEST
-	:	O	O
2.7	CD	O	O
mg	SYM	B-TEST	O
-	:	O	O
1.9	CD	O	O

type	NN	O	O
-	:	O	O
art	NN	O	O
po2	VBZ	B-TEST	O
-	:	O	O
229*	CD	O	O
pco2	NN	B-TEST	O
-	:	O	O
44	CD	O	O
ph	NN	B-TEST	B-TEST
-	:	O	O
7.26*	CD	O	O
caltco2	NN	B-TEST	O
-	:	O	O
21	CD	O	O
base	NN	B-TEST	B-TEST
xs	NNP	I-TEST	I-TEST
-	:	O	I-TEST
-6	NN	O	I-TEST
intubat	NN	O	I-TEST
-	:	O	O
intubated	JJ	O	B-TREATMENT
vent	NN	O	I-TREATMENT
-	:	O	O
controlled	VBD	O	O

type	NN	O	O
-	:	O	O
art	NN	O	O
temp	SYM	B-TEST	B-TEST
-	:	O	O
37.2	CD	O	O
rates	NNS	B-TEST	B-TEST
-	:	O	O
/12	NN	O	O
tidal	JJ	B-TEST	B-TEST
v	NN	I-TEST	I-TEST
-	:	O	O
560	CD	O	O

peep	JJ	B-TEST	O
-	:	O	O
5	CD	O	O
fio2	JJ	B-TEST	O
-	:	O	O
50	CD	O	O
po2	NN	B-TEST	O
-	:	O	O
176*	CD	O	O
pco2	NN	B-TEST	O
-	:	O	O
42	CD	O	O
ph	NN	B-TEST	B-TEST
-	:	O	O
7.35	CD	O	O
caltco2	NN	B-TEST	O
-	:	O	O
24	CD	O	O
base	NN	B-TEST	B-TEST
xs	NNP	I-TEST	I-TEST
-	:	O	O
-2	NN	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
on	IN	O	O
2018-12-04	JJ	O	O
for	IN	O	O
tvh	NN	B-TREATMENT	O
,	,	O	O
sacrospinous	JJ	B-TREATMENT	B-TREATMENT
fixation	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
sparc	NN	B-TREATMENT	O
,	,	O	O
anterior	JJ	B-TREATMENT	O
and	CC	I-TREATMENT	O
posterior	JJ	I-TREATMENT	B-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT
with	IN	I-TREATMENT	O
mesh	NN	I-TREATMENT	O
,	,	O	O
cystoscopy;	NN	B-TEST	O
for	IN	O	O
pelvic	JJ	B-PROBLEM	B-PROBLEM
organ	JJ	I-PROBLEM	I-PROBLEM
prolapse	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
were	VBD	O	O
no	DT	O	O
intraoperative	JJ	B-PROBLEM	B-PROBLEM
complications	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
the	DT	O	O
surgical	JJ	O	O
field	NN	O	O
was	VBD	O	O
hemostatic	JJ	O	B-TREATMENT
at	IN	O	O
the	DT	O	O
conclusion	NN	O	O
of	IN	O	O
the	DT	O	O
case	NN	O	O
(	(	O	O
see	VB	O	O
operative	JJ	O	O
report	NN	O	O
for	IN	O	O
full	JJ	O	O
description	NN	O	O
)	)	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
and	CC	O	O
was	VBD	O	O
stable	JJ	O	O
in	IN	O	O
the	DT	O	O
pacu	NN	O	O
and	CC	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
ccu	NN	O	O
floor	NN	O	O
for	IN	O	O
routine	JJ	B-TREATMENT	B-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

at	IN	O	O
1645	CD	O	O
12-04	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
hypotensive	JJ	B-PROBLEM	O
to	TO	O	O
70/40	CD	O	O

hr	NN	B-TEST	B-TEST
84	CD	O	O
with	IN	O	O
symptoms	NNS	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	O
lightheadedness	NN	I-PROBLEM	B-PROBLEM
while	IN	O	I-PROBLEM
lying	VBG	O	I-PROBLEM
supine	NN	O	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
active	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
noted	VBD	O	I-PROBLEM
at	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
surgical	JJ	O	I-PROBLEM
site	NN	O	I-PROBLEM
on	IN	O	O
examination	NN	B-TEST	B-TEST
.	.	O	O

a	DT	B-TEST	B-TEST
stat	NN	I-TEST	I-TEST
hct	NN	I-TEST	I-TEST
drawn	NN	O	I-TEST
at	IN	O	O
this	DT	O	O
time	NN	O	O
was	VBD	O	O
31.2	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
re-evalutated	VBN	O	O
at	IN	O	O
2000	CD	O	O
and	CC	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
tacchycardic	JJ	B-PROBLEM	O
to	TO	O	O
115	CD	O	O
with	IN	O	O
bp	NN	B-TEST	B-TEST
104/50	CD	O	O
using	VBG	O	O
a	DT	O	B-TREATMENT
manual	JJ	O	I-TREATMENT
cuff	NN	O	I-TREATMENT
.	.	O	O

urine	JJ	B-TEST	B-TEST
output	NN	I-TEST	I-TEST
during	IN	O	O
the	DT	O	O
prior	JJ	O	O
two	CD	O	O
hours	NNS	O	O
had	VBD	O	O
been	VBN	O	O
50cc	CD	O	O
and	CC	O	O
24cc	CD	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
stat	NN	I-TEST	I-TEST
hct	NN	I-TEST	I-TEST
drawn	NN	O	I-TEST
at	IN	O	O
this	DT	O	O
time	NN	O	O
was	VBD	O	O
19.5	CD	O	O
.	.	O	O

the	DT	O	O
clinical	JJ	O	O
picture	NN	O	O
was	VBD	O	O
concerning	VBG	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
post-operative	JJ	I-PROBLEM	I-PROBLEM
hematoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
icu	NN	O	O
was	VBD	O	O
alerted	VBN	O	O
to	TO	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
disposition	NN	O	O
and	CC	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
was	VBD	O	O
activated	VBN	O	O
for	IN	O	O
urgent	JJ	B-TEST	B-TREATMENT
re-exploration	NN	I-TEST	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
or	CC	O	O
on	IN	O	O
pod#0	NN	O	O
for	IN	O	O
re-exploration	NN	B-TEST	O
with	IN	I-TEST	O
incision	NN	I-TEST	B-TREATMENT
at	IN	O	O
2243	CD	O	O
.	.	O	O

exploratory	JJ	B-TEST	B-TEST
laparotomy	NN	I-TEST	I-TEST
revealed	VBD	O	O
hemoperitonium	NN	B-PROBLEM	B-TREATMENT
and	CC	O	O
approximately	RB	O	O
1	CD	O	O
l	NN	O	O
of	IN	O	O
blood	NN	B-PROBLEM	O
was	VBD	O	O
evacuated	VBN	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
approximately	RB	O	O
500cc	CD	O	O
of	IN	O	O
retroperitoneal	NN	B-PROBLEM	B-PROBLEM
clot	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

despite	IN	O	O
laparotomy	JJ	B-TEST	B-TREATMENT
and	CC	O	O
re-exploration	NN	B-TEST	O
through	IN	I-TEST	O
the	DT	I-TEST	O
vaginal	JJ	I-TEST	O
cuff	NN	I-TEST	O
,	,	O	O
no	DT	O	O
source	NN	O	O
for	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
could	MD	O	O
be	VB	O	O
found	VBN	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
endotracheal	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
left	VBN	O	O
in	IN	O	O
place	NN	O	O
.	.	O	O

intraoperatively	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
recieved	VBD	O	O
5u	CD	O	O
prbc	NN	B-TREATMENT	O
.	.	O	O

ir	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
to	TO	O	O
identify	VB	O	O
the	DT	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
vessel	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
angiography	NN	B-TEST	B-TEST
,	,	O	O
then	RB	O	O
perform	VB	O	O
embolization	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

tagged	VBN	B-TEST	O
cell	NN	I-TEST	O
and	CC	I-TEST	O
angiographic	JJ	I-TEST	B-TEST
studies	NNS	I-TEST	I-TEST
performed	VBD	O	O
immediately	RB	O	O
after	IN	O	O
re-exploration	NN	B-TEST	O
on	IN	O	O
12-05	NNS	O	O
did	VBD	O	O
not	RB	O	O
indetify	VB	O	O
active	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
no	DT	O	O
emobolization	NN	B-TREATMENT	B-PROBLEM
was	VBD	O	O
indicated	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
stable	JJ	O	O
and	CC	O	O
remained	VBD	O	O
intubated	VBN	B-PROBLEM	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
icu	NN	O	O
for	IN	O	O
further	JJ	B-TREATMENT	B-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
continued	JJ	O	B-PROBLEM
bleeding	NN	B-PROBLEM	I-PROBLEM
and	CC	O	O
her	PRP$	B-TEST	B-TEST
hct	NN	I-TEST	I-TEST
remained	VBD	O	O
stable	JJ	O	O
around	IN	O	O
30	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
developed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
grade	NN	I-PROBLEM	I-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
100.1	CD	O	O
on	IN	O	O
pod#1	NN	O	O
which	WDT	O	O
persisted	VBD	O	O
to	TO	O	O
pod#2	VB	O	O
and	CC	O	O
imperic	VB	B-TREATMENT	O
treatment	NN	I-TREATMENT	B-TREATMENT
with	IN	O	O
gent/clinda	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
started	VBN	O	O
.	.	O	O

antibiotics	NNS	B-TREATMENT	B-TREATMENT
were	VBD	O	O
discontinued	VBN	O	O
on	IN	O	O
pod#8	NN	O	O
and	CC	O	O
pt	NN	O	O
remained	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
thereafter	RB	O	O
.	.	O	O

on	IN	O	O
pod#9	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
,	,	O	O
tolerating	VBG	O	O
a	DT	O	O
regular	JJ	O	O
diet	NN	O	O
,	,	O	O
ambultating	VBG	O	O
without	IN	O	O
difficulty	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
voiding	VBG	O	O
spontaneously	RB	O	O
.	.	O	O

zoloft	RB	B-TREATMENT	B-TREATMENT
100mg	CD	O	O
qd	NN	O	O

ritalin	NN	B-TREATMENT	B-TREATMENT
0.5mg	CD	O	O
bid	NN	O	O

loraze3pam	RB	B-TREATMENT	O
0.5mg	CD	O	O
bid	NN	O	O

percocet	NN	B-TREATMENT	B-TREATMENT
5/325	CD	O	O
qhs	NN	O	O

cipro	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT

1.	CD	O	O
ibuprofen	JJ	B-TREATMENT	B-TREATMENT
600	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q6h	NN	O	O
(	(	O	O
every	DT	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

2.	CD	O	O
oxycodone-acetaminophen	JJ	B-TREATMENT	O
5-325	JJ	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
tablets	NNS	O	O
po	JJ	O	O
q4-6h	JJ	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
to	TO	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

3.	CD	O	O
docusate	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

continue	NN	O	O
home	NN	B-TREATMENT	B-TREATMENT
meds	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

pelvic	JJ	B-PROBLEM	B-PROBLEM
organ	MD	I-PROBLEM	I-PROBLEM
prolapse	VB	I-PROBLEM	I-PROBLEM
stress	NN	B-PROBLEM	I-PROBLEM
urinary	JJ	I-PROBLEM	I-PROBLEM
incontinence	NN	I-PROBLEM	I-PROBLEM
retroperitoneal	NN	B-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
hemoperitoneum	NN	I-PROBLEM	I-PROBLEM

the	DT	O	O
patient	NN	O	O
presented	VBN	O	O
with	IN	O	O
a	DT	O	O
chief	JJ	O	O
complaint	NN	O	O
of	IN	O	O
s	JJ	O	O
/	NNP	O	O
p	NN	O	O
fall	NN	O	O
/	NNP	O	O
weak	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

following	VBG	O	O
evaluation	NN	B-TEST	B-TEST
and	CC	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
the	DT	O	O
patient	NN	O	O
&apos;s	JJ	O	O
disposition	NN	O	O
at	IN	O	O
the	DT	O	O
end	NN	O	O
of	IN	O	O
the	DT	O	O
visit	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
as	IN	O	O
an	DT	O	O
inpatient	NN	O	O
to	TO	O	O
tecal	JJ	O	O
galencounxopt	NN	O	O
community	NN	O	O
hospital	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
preliminary	JJ	O	O
admitting	VBG	O	O
physician	NN	O	O
is	VBZ	O	O
shuffcuch	JJ	O	O
,	,	O	O
seysharmse	JJ	O	O
n	NN	O	O
and	CC	O	O
the	DT	O	O
preliminary	JJ	O	O
diagnosis	NN	O	O
is	VBZ	O	O
hyperglycemia	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
be	VB	O	O
discharged	VBN	O	O
to	TO	O	O
rehabilitation	VB	B-TREATMENT	O
in	IN	O	O
brain	NN	O	O
tree	NN	O	O
maryland	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
be	VB	O	O
continued	VBN	O	O
on	IN	O	O
medications	NNS	B-TREATMENT	B-TREATMENT
per	IN	O	O
discharge	NN	O	O
summary	NN	O	O
with	IN	O	O
the	DT	O	O
addition	NN	O	O
of	IN	O	O
captopril	NN	B-TREATMENT	B-TREATMENT
ace	NN	I-TREATMENT	I-TREATMENT
inhibitor	NN	I-TREATMENT	I-TREATMENT
since	IN	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
is	VBZ	O	O
stable	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
with	IN	O	O
no	DT	O	O
new	JJ	B-PROBLEM	B-PROBLEM
events	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
continues	VBZ	O	O
to	TO	O	O
improve	VB	O	O
with	IN	O	O
regard	NN	O	O
to	TO	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
scrotal	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
no	DT	O	O
lower	JJR	B-PROBLEM	B-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
ulcers	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
all	DT	B-PROBLEM	B-PROBLEM
former	JJ	I-PROBLEM	I-PROBLEM
leg	NN	I-PROBLEM	I-PROBLEM
excoriations	NNS	I-PROBLEM	I-PROBLEM
are	VBP	O	O
healing	VBG	O	O
well	RB	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
ambulating	VBG	O	O
three	CD	O	O
to	TO	O	O
four	CD	O	O
times	NNS	O	O
per	IN	O	O
day	NN	O	O
and	CC	O	O
able	JJ	O	O
to	TO	O	O
get	VB	O	O
out	IN	O	O
of	IN	O	O
bed	NN	O	O
using	VBG	O	O
a	DT	B-TREATMENT	B-TREATMENT
walker	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
get	VB	O	O
rehabilitation	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
continue	VB	O	O
to	TO	O	O
get	VB	O	O
care	NN	O	O
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

syncope	NN	B-PROBLEM	B-PROBLEM

1	CD	O	O
)	)	O	O
presyncope	NN	B-PROBLEM	O
.	.	O	O

2	CD	O	O
)	)	O	O
dizziness	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1	CD	O	O
)	)	O	O
iron	NN	B-PROBLEM	B-PROBLEM
deficiency	NN	I-PROBLEM	I-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
colonoscopy	NN	B-TEST	B-TEST
in	IN	O	O
1990	CD	O	O
followed	NN	O	O
by	IN	O	O
hematology	NN	O	O
oncology	NN	O	O
through	IN	O	O
lympnanier	JJR	O	O
health	NN	O	O
services	NNS	O	O
,	,	O	O
dr.	JJ	O	O
number	NN	O	O
.	.	O	O

2	CD	O	O
)	)	O	O
history	NN	O	O
of	IN	O	O
diastolic	JJ	B-PROBLEM	B-PROBLEM
dysfunction	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
in	IN	O	O
february	NN	O	O
of	IN	O	O
1998	CD	O	O
demonstrating	VBG	O	O
a	DT	O	O
normal	JJ	O	O
ejection	NN	O	O
fraction	NN	O	O
with	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
admission	NN	O	O
at	IN	O	O
lympnanier	JJR	O	O
health	NN	O	O
services	NNS	O	O
in	IN	O	O
january	NN	O	O
of	IN	O	O
1999	CD	O	O
for	IN	O	O
diastolic	JJ	B-PROBLEM	B-PROBLEM
congestive	JJ	I-PROBLEM	I-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
requiring	VBG	O	O
an	DT	O	O
admission	NN	O	O
to	TO	O	O
the	DT	O	O
coronary	JJ	O	O
care	NN	O	O
unit	NN	O	O
.	.	O	O

3	LS	O	O
)	)	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

4	CD	O	O
)	)	O	O
rheumatoid	NN	B-PROBLEM	B-PROBLEM
arthritis	NN	I-PROBLEM	I-PROBLEM
/	NNP	O	O
cutaneous	JJ	B-PROBLEM	B-PROBLEM
lupus	NN	I-PROBLEM	I-PROBLEM
(	(	I-PROBLEM	I-PROBLEM
mixed	JJ	I-PROBLEM	I-PROBLEM
connective	JJ	I-PROBLEM	I-PROBLEM
tissue	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
)	)	I-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
an	DT	O	O
80	CD	O	O
female	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
diastolic	JJ	B-PROBLEM	B-PROBLEM
function	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
heart	NN	B-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
rheumatoid	JJ	B-PROBLEM	B-PROBLEM
arthritis	NN	I-PROBLEM	I-PROBLEM
who	WP	O	O
presents	VBZ	O	O
from	IN	O	O
an	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
with	IN	O	O
presyncope	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
reports	NNS	O	O
dizziness	NN	B-PROBLEM	B-PROBLEM
intermittently	RB	I-PROBLEM	O
times	VBZ	O	O
several	JJ	O	O
months	NNS	O	O
now	RB	O	O
increasing	VBG	O	O
in	IN	O	O
frequency	NN	O	O
described	VBN	O	O
as	IN	O	O
episodes	NNS	O	O
where	WRB	O	O
she	PRP	O	O
feels	VBZ	O	O
faint	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
room	NN	O	O
spins	VBZ	O	O
with	IN	O	O
no	DT	O	O
visual	JJ	B-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
loss	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
consciousness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
palpitations	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
diaphoresis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
admission	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
with	IN	O	O
some	DT	O	O
friends	NNS	O	O
,	,	O	O
rose	VBD	O	O
from	IN	O	O
a	DT	O	O
chair	NN	O	O
to	TO	O	O
leave	VB	O	O
and	CC	O	O
felt	VBD	O	O
dizzy	NNS	B-PROBLEM	B-PROBLEM
while	IN	O	O
ambulating	VBG	O	O
,	,	O	O
fell	VBD	O	O
and	CC	O	O
hit	VBD	O	O
elbow	NNS	O	O
with	IN	O	O
minor	JJ	B-PROBLEM	B-PROBLEM
head	NN	I-PROBLEM	I-PROBLEM
trauma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
denied	VBD	O	O
loss	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
consciousness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
bowel	NN	B-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	I-PROBLEM
bladder	NN	I-PROBLEM	I-PROBLEM
incontinence	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
an	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
where	WRB	O	O
she	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
50	CD	I-PROBLEM	I-PROBLEM
point	NN	I-PROBLEM	I-PROBLEM
discrepancy	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
her	PRP$	B-TEST	I-PROBLEM
upper	JJ	I-TEST	I-PROBLEM
extremity	NN	I-TEST	I-PROBLEM
blood	NN	I-TEST	I-PROBLEM
pressures	NNS	I-TEST	I-PROBLEM
,	,	O	O
right	RB	O	O
greater	JJR	O	O
than	IN	O	O
left	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
no	DT	O	O
mediastinal	JJ	B-PROBLEM	B-PROBLEM
widening	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
chest	JJ	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
,	,	O	O
but	CC	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
verg	VB	O	O
medical	JJ	O	O
center	NN	O	O
for	IN	O	O
further	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
.	.	O	O

in	IN	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
&apos;s	JJ	I-TEST	I-TEST
temperature	NN	I-TEST	I-TEST
was	VBD	O	O
98.8	CD	O	O
degrees	NNS	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
73	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
18	CD	O	O
,	,	O	O
oxygen	NN	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST
98%	CD	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
in	IN	I-TEST	O
the	DT	I-TEST	O
left	JJ	I-TEST	O
arm	NN	I-TEST	O
demonstrated	VBD	O	O
125/89	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
in	IN	I-TEST	O
the	DT	I-TEST	O
right	JJ	I-TEST	O
arm	NN	I-TEST	O
was	VBD	O	O
177/119	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
3/6	CD	O	O
that	WDT	O	O
radiated	VBD	O	O
to	TO	O	O
the	DT	O	O
carotids	NNS	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
decreased	JJ	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
radial	JJ	I-PROBLEM	I-PROBLEM
pulse	NN	I-PROBLEM	I-PROBLEM
per	IN	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
chest	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
demonstrating	VBG	O	O
no	DT	O	O
dissection	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
evidence	NN	O	O
of	IN	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
received	VBD	O	O
nitropaste	NN	B-TREATMENT	O
,	,	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
laboratory	NN	B-TEST	B-TEST
studies	NNS	I-TEST	I-TEST
and	CC	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
for	IN	O	O
further	JJ	O	B-TREATMENT
management	NN	O	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
denies	VBZ	O	O
melena	RBS	B-PROBLEM	B-PROBLEM
,	,	O	O
bright	JJ	B-PROBLEM	B-PROBLEM
red	JJ	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
per	IN	I-PROBLEM	I-PROBLEM
rectum	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
emesis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
anemia	NN	B-PROBLEM	B-PROBLEM
as	IN	O	O
per	IN	O	O
past	JJ	O	O
medical	JJ	O	O
history	NN	O	O
above	IN	O	O
.	.	O	O

heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
62	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
16	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
right	JJ	I-TEST	I-TEST
arm	NN	I-TEST	I-TEST
205/84	CD	O	O
,	,	O	O
oxygen	NN	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST
97%	CD	O	O
on	IN	O	O
two	CD	B-TREATMENT	B-TREATMENT
liters	NNS	I-TREATMENT	I-TREATMENT
nasal	JJ	I-TREATMENT	I-TREATMENT
cannula	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
in	IN	O	O
no	DT	O	O
apparent	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
tired	VBD	B-PROBLEM	O
,	,	O	O
easily	RB	O	O
arousable	JJ	O	O
older	JJR	O	O
female	NN	O	O
.	.	O	O

heent	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
demonstrated	VBD	O	O
that	IN	O	O
the	DT	O	O
pupils	NNS	O	O
were	VBD	O	O
equal	JJ	O	O
,	,	O	O
round	NN	O	O
and	CC	O	O
reactive	JJ	O	O
to	TO	O	O
light	NN	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
cataract	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
the	DT	B-TEST	B-TEST
fundoscopic	NN	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
.	.	O	O

neck	NN	O	O
was	VBD	O	O
supple	JJ	O	O
,	,	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
bruits	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
although	IN	O	O
possibly	RB	O	O
radiating	VBG	O	B-PROBLEM
from	IN	O	I-PROBLEM
cardiac	JJ	O	I-PROBLEM
base	NN	O	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
jugular	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
distension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

chest	NN	O	B-PROBLEM
demonstrated	VBD	O	I-PROBLEM
bilateral	JJ	B-PROBLEM	I-PROBLEM
holosystolic	JJ	I-PROBLEM	I-PROBLEM
bruits	NNS	I-PROBLEM	I-PROBLEM
over	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
subclavians	NNS	I-PROBLEM	O
,	,	O	O
left	VBD	O	O
greater	JJR	O	O
than	IN	O	O
right	NN	O	O
with	IN	O	O
few	JJ	B-PROBLEM	B-PROBLEM
bibasilar	JJ	I-PROBLEM	I-PROBLEM
crackles	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

cardiovascular	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
demonstrated	VBD	O	O
a	DT	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
with	IN	O	O
2/6	CD	B-PROBLEM	O
cresendo	NNS	I-PROBLEM	O
/	JJ	I-PROBLEM	O
descrecendo	JJ	I-PROBLEM	B-PROBLEM
murmur	FW	I-PROBLEM	I-PROBLEM
heard	NN	O	O
best	JJS	O	O
at	IN	O	O
the	DT	O	O
apex	NN	O	O
with	IN	O	O
preservation	NN	O	O
of	IN	O	O
the	DT	O	B-PROBLEM
second	JJ	O	I-PROBLEM
heart	NN	O	I-PROBLEM
sound	NN	O	I-PROBLEM
,	,	O	O
no	DT	O	O
s3	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
s4	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

abdominal	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
soft	JJ	O	O
,	,	O	O
non-tender	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
non-distended	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
positive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
,	,	O	O
no	DT	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

however	RB	O	O
,	,	O	O
there	EX	O	O
were	VBD	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
bruits	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
femoral	JJ	B-PROBLEM	I-PROBLEM
bruits	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
guaiac	JJ	B-TEST	B-TEST
negative	JJ	O	O
per	IN	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
.	.	O	O

extremities	NNS	O	O
demonstrated	VBD	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

extremity	NN	B-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	B-TEST	O
right	JJ	I-TEST	O
radial	NN	I-TEST	O
of	IN	O	O
2+	CD	O	O
,	,	O	O
left	VBD	B-TEST	O
radial	NN	I-TEST	O
of	IN	O	O
1+	CD	O	O
,	,	O	O
2+	CD	B-TEST	B-PROBLEM
distal	JJ	I-TEST	I-PROBLEM
pulses	NNS	I-TEST	I-PROBLEM
in	IN	I-TEST	I-PROBLEM
the	DT	I-TEST	I-PROBLEM
lower	JJR	I-TEST	I-PROBLEM
extremities	NNS	I-TEST	I-PROBLEM
bilaterally	RB	I-TEST	I-PROBLEM
.	.	O	O

lower	JJR	B-TEST	B-TEST
extremity	NN	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
pressures	NNS	I-TEST	I-TEST
demonstrated	VBD	O	O
systolics	NNS	B-TEST	O
of	IN	O	O
205-210	JJ	O	O
.	.	O	O

laboratory	NN	O	B-TEST
values	NNS	O	I-TEST
on	IN	O	O
admission	NN	O	O
included	VBD	O	O
a	DT	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
of	IN	O	O
142	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.8	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
106	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
27	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
of	IN	O	O
39	CD	O	O
and	CC	O	O
1.6	CD	O	O
respectively	RB	O	O
,	,	O	O
glucose	JJ	B-TEST	B-TEST
113	CD	O	O
.	.	O	O

calcium	NN	B-TEST	B-TEST
was	VBD	O	O
9.6	CD	O	O
.	.	O	O

ck	NN	B-TEST	O
was	VBD	O	O
62	CD	O	O
.	.	O	O

troponin	NN	B-TEST	B-TEST
was	VBD	O	O
0.2	CD	O	O
.	.	O	O

white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
11.5	CD	O	O
,	,	O	O
85	CD	B-TEST	O
polys	NN	I-TEST	B-TEST
,	,	O	O
5	CD	B-TEST	O
bands	NNS	I-TEST	B-TEST
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
37.6	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
328	CD	O	O
.	.	O	O

coagulation	NN	B-TEST	B-TEST
studies	NNS	I-TEST	I-TEST
were	VBD	O	O
11.3/25.5/0.9	CD	O	O
.	.	O	O

urinalysis	NN	B-TEST	B-TEST
demonstrated	VBD	O	O
trace	NN	B-PROBLEM	B-PROBLEM
leukocyte	NN	I-PROBLEM	I-PROBLEM
esterase	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
5-10	JJ	B-PROBLEM	O
white	JJ	I-PROBLEM	B-TEST
blood	NN	I-PROBLEM	I-TEST
cells	NNS	I-PROBLEM	I-TEST
and	CC	O	O
1+	CD	B-PROBLEM	B-PROBLEM
squamous	JJ	I-PROBLEM	I-PROBLEM
epithelial	JJ	I-PROBLEM	I-PROBLEM
cells	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

ekg	RB	B-TEST	O
demonstrated	VBN	O	O
normal	JJ	O	O
sinus	NN	O	O
rhythm	NN	O	O
,	,	O	O
rate	NN	B-TEST	O
of	IN	O	O
73	CD	O	O
,	,	O	O
borderline	NN	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
enlargement	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
axis	JJ	B-TEST	O
of-28	JJ	O	O
,	,	O	O
t-wave	JJ	B-PROBLEM	B-PROBLEM
inversions	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
v4	NN	I-PROBLEM	I-PROBLEM
through	IN	O	I-PROBLEM
v6	NN	O	I-PROBLEM
,	,	O	O
i	NN	O	O
and	CC	O	O
avl	NN	O	B-PROBLEM
,	,	O	O
borderline	NN	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
strain	NN	B-PROBLEM	B-PROBLEM
compared	VBN	O	O
to	TO	O	O
earlier	RBR	O	O
this	DT	O	O
am	VBP	O	O
.	.	O	O

there	RB	O	O
appeared	VBN	O	O
to	TO	O	O
be	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
new	JJ	I-PROBLEM	I-PROBLEM
t-wave	JJ	I-PROBLEM	I-PROBLEM
inversion	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
v4	NN	O	I-PROBLEM
.	.	O	O

1	CD	O	O
)	)	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
81	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

2	CD	O	O
)	)	O	O
os-cal	JJ	B-TREATMENT	O
1250	CD	O	O
mg	NN	O	O
p.o.	VBD	O	O
three	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

3	LS	O	O
)	)	O	O
lasix	VBD	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.o.d.	NN	O	O

4	CD	O	O
)	)	O	O
plaquenil	NN	B-TREATMENT	O
200	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

5	CD	O	O
)	)	O	O
ibuprofen	NN	B-TREATMENT	B-TREATMENT
400	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O

6	CD	O	O
)	)	O	O
levoxyl	NN	B-TREATMENT	O
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

7	CD	O	O
)	)	O	O
arava	NN	B-TREATMENT	O
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

8	CD	O	O
)	)	O	O
zantac	NN	B-TREATMENT	O
150	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

9	CD	O	O
)	)	O	O
isosorbide	NN	B-TREATMENT	O
dinitrate	NN	I-TREATMENT	O
unclear	JJ	O	O
dose	NN	O	O
.	.	O	O

10	CD	O	O
)	)	O	O
diltiazem	NN	B-TREATMENT	B-TREATMENT
240	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

11	CD	O	O
)	)	O	O
epogen	NN	B-TREATMENT	O
q.	RB	O	O
two	CD	O	O
weeks	NNS	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
rule	NN	O	O
out	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
remained	VBD	O	O
on	IN	O	O
telemetry	NN	B-TEST	B-TEST
for	IN	O	O
greater	JJR	O	O
than	IN	O	O
48	CD	O	O
hours	NNS	O	O
which	WDT	O	O
demonstrated	VBD	O	O
no	DT	O	O
dysrhythmia	NN	B-PROBLEM	B-PROBLEM
during	IN	O	O
this	DT	O	O
time	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
underwent	VBD	O	O
an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
which	WDT	O	O
demonstrated	VBD	O	O
a	DT	O	O
preserved	JJ	O	O
ejection	NN	O	O
fraction	NN	O	O
with	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
no	DT	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
valvular	JJ	I-PROBLEM	I-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
maintained	VBN	O	O
on	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
aspirin	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	B-TREATMENT	O
patient	NN	I-TREATMENT	O
&apos;s	NNP	I-TREATMENT	O
diltiazem	NN	I-TREATMENT	B-TREATMENT
was	VBD	O	O
stopped	VBN	O	O
due	JJ	O	O
to	TO	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
increased	JJ	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
pressure	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
labetalol	NN	B-TREATMENT	B-TREATMENT
which	WDT	O	O
was	VBD	O	O
gradually	RB	O	O
titrated	VBN	O	O
up	RP	O	O
to	TO	O	O
a	DT	B-TEST	B-TEST
target	NN	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	I-TEST
160-170	JJ	B-TEST	I-TEST
systolic	NN	I-TEST	I-TEST
in	IN	O	O
her	PRP$	O	O
right	JJ	O	O
arm	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
underwent	VBD	O	O
an	DT	B-TEST	B-TEST
adenosine	NN	I-TEST	I-TEST
mibi	NN	I-TEST	I-TEST
stress	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
only	RB	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
lateral	JJ	I-PROBLEM	I-PROBLEM
ischemia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

at	IN	O	O
this	DT	O	O
time	NN	O	O
,	,	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NN	I-PROBLEM	I-PROBLEM
presyncopal	NN	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
were	VBD	O	O
not	RB	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
secondary	JJ	O	O
to	TO	O	O
a	DT	O	O
cardiovascular	JJ	O	O
etiology	NN	O	O
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
discrepancy	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	B-TEST	I-PROBLEM
patient	NN	I-TEST	I-PROBLEM
&apos;s	NN	I-TEST	I-PROBLEM
pulses	NNS	I-TEST	I-PROBLEM
and	CC	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
consistent	JJ	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
subclavian	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	JJ	O	O
underwent	JJ	O	O
mri	NN	B-TEST	B-TEST
/	NNP	I-TEST	O
mra	NN	I-TEST	O
of	IN	I-TEST	O
the	DT	I-TEST	O
head	NN	I-TEST	O
,	,	I-TEST	O
neck	NN	I-TEST	O
and	CC	I-TEST	O
upper	JJ	I-TEST	B-PROBLEM
chest	NN	I-TEST	I-PROBLEM
which	WDT	O	O
demonstrated	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
proximal	JJ	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
subclavian	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
proximal	NN	O	O
to	TO	O	O
the	DT	O	O
take	VB	O	O
off	NN	O	O
of	IN	O	O
the	DT	O	O
left	JJ	O	O
vertebral	JJ	O	O
artery	NN	O	O
.	.	O	O

the	DT	O	O
left	JJ	O	O
vertebral	JJ	O	O
artery	NN	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
decreased	VBN	I-PROBLEM	I-PROBLEM
flow	NN	I-PROBLEM	I-PROBLEM
consistent	NN	O	O
with	IN	O	O
either	DT	O	O
native	JJ	B-PROBLEM	B-PROBLEM
vessel	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
some	DT	B-PROBLEM	B-PROBLEM
degree	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
retrograde	NN	I-PROBLEM	I-PROBLEM
flow	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
subclavian	JJ	B-PROBLEM	B-PROBLEM
steal	NN	I-PROBLEM	I-PROBLEM
phenomenon	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
patent	NN	O	B-TREATMENT
carotids	NNS	O	I-TREATMENT
bilaterally	RB	O	O
on	IN	O	O
her	PRP$	B-TEST	O
neck	NN	I-TEST	O
mra	NN	I-TEST	O
.	.	O	O

mri	NN	B-TEST	B-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
demonstrated	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
vessel	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
likely	RB	O	O
an	DT	B-PROBLEM	B-PROBLEM
old	JJ	I-PROBLEM	I-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
cerebellar	NN	I-PROBLEM	I-PROBLEM
infarct	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	JJ	O	O
underwent	JJ	O	O
non-invasive	JJ	B-TEST	B-TEST
carotid	NN	I-TEST	I-TEST
ultrasounds	NNS	I-TEST	I-TEST
which	WDT	O	O
demonstrated	VBD	O	O
no	DT	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
carotid	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
also	RB	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
antegrade	VBN	B-PROBLEM	B-PROBLEM
flow	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
both	DT	O	O
of	IN	O	O
her	PRP$	O	O
vertebral	JJ	O	O
arteries	NNS	O	O
bilaterally	RB	O	O
.	.	O	O

the	DT	O	O
results	NNS	O	O
of	IN	O	O
these	DT	B-TEST	B-TEST
studies	NNS	I-TEST	I-TEST
suggested	VBD	O	O
that	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NN	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
were	VBD	O	O
not	RB	O	O
due	JJ	O	O
to	TO	O	O
subclavian	JJ	B-PROBLEM	B-PROBLEM
steal	NN	I-PROBLEM	I-PROBLEM
phenomenon	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
therefore	RB	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
would	MD	O	O
not	RB	O	O
go	VB	O	O
further	RBR	O	O
to	TO	O	O
angio	VB	B-TREATMENT	O
and	CC	O	O
/	VB	O	O
or	CC	O	O
surgical	JJ	B-TREATMENT	B-TREATMENT
or	CC	I-TREATMENT	I-TREATMENT
percutaneous	JJ	I-TREATMENT	I-TREATMENT
intervention	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

a	DT	O	O
neurology	NN	O	O
consult	NN	O	O
was	VBD	O	O
obtained	VBN	O	O
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
that	IN	O	O
the	DT	B-TREATMENT	O
most	RBS	I-TREATMENT	O
valuable	JJ	I-TREATMENT	O
intervention	NN	I-TREATMENT	O
that	WDT	O	O
could	MD	O	O
be	VB	O	O
done	VBN	O	O
for	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NNP	I-PROBLEM	I-PROBLEM
intervascular	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
would	MD	O	O
be	VB	O	O
adequate	JJ	O	O
control	NN	O	O
of	IN	O	O
her	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
.	.	O	O

outside	JJ	B-TEST	B-TREATMENT
hip	NN	I-TEST	I-TREATMENT
films	NNS	I-TEST	I-TREATMENT
were	VBD	O	O
obtained	VBN	O	O
,	,	O	O
but	CC	O	O
were	VBD	O	O
not	RB	O	O
available	JJ	O	O
for	IN	O	O
view	NN	O	O
.	.	O	O

repeat	NN	B-TEST	B-TEST
hip	NN	I-TEST	I-TEST
films	NNS	I-TEST	I-TEST
demonstrated	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
sided	VBN	I-PROBLEM	I-PROBLEM
pubic	JJ	I-PROBLEM	I-PROBLEM
rami	NN	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
likely	JJ	O	O
new	JJ	O	O
.	.	O	O

an	DT	O	O
orthopedics	NNS	O	O
consult	NN	O	O
was	VBD	O	O
obtained	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
encouraged	VBN	O	O
to	TO	O	O
weight	VB	O	O
bear	NN	O	O
as	IN	O	O
tolerated	VBN	O	O
with	IN	O	O
physical	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
assistance	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

a	DT	B-TEST	B-TEST
bone	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
was	VBD	O	O
also	RB	O	O
obtained	VBN	O	O
to	TO	O	O
rule	VB	O	O
out	RP	O	O
an	DT	B-PROBLEM	B-PROBLEM
occult	NN	I-PROBLEM	I-PROBLEM
hip	NN	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
this	DT	O	O
dictation	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
bear	VB	O	O
weight	NN	O	B-TEST
with	IN	O	O
the	DT	O	O
assistance	NN	O	O
of	IN	O	O
physical	JJ	O	B-TREATMENT
therapy	NN	O	I-TREATMENT
and	CC	O	O
a	DT	B-TREATMENT	B-TREATMENT
walker	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

plans	NNS	O	O
were	VBD	O	O
made	VBN	O	O
for	IN	O	O
the	DT	O	O
patient	NN	O	O
to	TO	O	O
be	VB	O	O
discharged	VBN	O	O
to	TO	O	O
dwardmegriff	VB	O	B-TREATMENT
rehabilitation	NN	O	I-TREATMENT
for	IN	O	O
rehabilitation	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
rami	JJ	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
an	DT	O	O
episode	NN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
described	JJ	I-PROBLEM	I-PROBLEM
vertigo	NN	I-PROBLEM	I-PROBLEM
while	IN	O	O
lying	VBG	O	O
in	IN	O	O
bed	NN	O	O
and	CC	O	O
on	IN	O	O
the	DT	B-TEST	O
monitor	NN	I-TEST	O
during	IN	O	O
which	WDT	O	O
no	DT	O	O
dysrhythmia	NN	B-PROBLEM	B-PROBLEM
was	VBD	O	O
noted	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
complained	VBD	O	O
of	IN	O	O
frequent	JJ	B-PROBLEM	B-PROBLEM
vomiting	VBG	I-PROBLEM	I-PROBLEM
at	IN	O	O
least	JJS	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
,	,	O	O
occasionally	RB	O	O
associated	VBN	O	O
with	IN	O	O
ingestion	NN	O	B-TREATMENT
of	IN	O	I-TREATMENT
her	PRP$	B-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
but	CC	O	O
sometimes	RB	O	O
associated	VBN	O	O
with	IN	O	O
ambulation	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	O	O
long-standing	JJ	O	O
history	NN	O	O
of	IN	O	O
spontaneous	JJ	B-PROBLEM	B-PROBLEM
emesis	NN	I-PROBLEM	I-PROBLEM
due	JJ	O	O
to	TO	O	O
overwhelming	JJ	O	B-PROBLEM
stress	NN	O	I-PROBLEM
or	CC	O	O
excitement	NN	O	B-PROBLEM
.	.	O	O

however	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
reports	NNS	O	O
emesis	NN	B-PROBLEM	B-PROBLEM
in	IN	O	O
the	DT	O	O
hospital	NN	O	O
more	RBR	O	O
frequently	RB	O	O
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NNP	I-PROBLEM	I-PROBLEM
emesis	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
bilious	JJ	B-PROBLEM	B-PROBLEM
without	IN	O	O
evidence	NN	O	O
of	IN	O	O
new	JJ	B-PROBLEM	O
or	CC	I-PROBLEM	O
old	JJ	I-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
etiology	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	O
patient	NN	I-PROBLEM	O
&apos;s	NNP	I-PROBLEM	O
nausea	NN	I-PROBLEM	B-PROBLEM
remained	VBD	O	O
unclear	JJ	O	O
as	IN	O	O
she	PRP	O	O
demonstrated	VBD	O	O
ability	NN	O	O
to	TO	O	O
keep	VB	O	O
down	RP	O	O
many	JJ	O	O
of	IN	O	O
her	PRP$	O	B-TREATMENT
meals	NNS	O	I-TREATMENT
which	WDT	O	O
did	VBD	O	O
not	RB	O	O
suggest	VB	O	O
an	DT	B-PROBLEM	B-PROBLEM
anatomical	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
gastrointestinal	JJ	I-PROBLEM	I-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
meclizine	NN	B-TREATMENT	B-TREATMENT
on	IN	O	O
december	NN	O	O
31	CD	O	O
,	,	O	O
2000	CD	O	O
for	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
nausea	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
vertigo	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

an	DT	O	B-TEST
attempt	NN	O	I-TEST
was	VBD	O	O
also	RB	O	O
made	VBN	O	O
to	TO	O	O
reduce	VB	O	O
the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
large	JJ	O	O
number	NN	O	O
of	IN	O	O
medications	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
the	DT	B-TREATMENT	O
patient	JJ	I-TREATMENT	O
&apos;s	NNP	I-TREATMENT	O
os-cal	JJ	I-TREATMENT	O
,	,	O	O
multivitamin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
colace	NN	B-TREATMENT	B-TREATMENT
were	VBD	O	O
discontinued	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
complained	VBD	O	O
of	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
urinary	JJ	I-PROBLEM	I-PROBLEM
incontinence	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
difficulty	NN	O	B-PROBLEM
initiating	VBG	O	I-PROBLEM
urine	NN	O	I-PROBLEM
on	IN	O	O
december	NN	O	O
30	CD	O	O
,	,	O	O
2000	CD	O	O
.	.	O	O

urinalysis	NN	B-TEST	B-TEST
demonstrated	VBD	O	O
a	DT	B-PROBLEM	O
likely	JJ	I-PROBLEM	O
urinary	JJ	I-PROBLEM	B-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
250	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	NN	O	O
day	NN	O	O
times	NNS	O	O
seven	CD	O	O
days	NNS	O	O
for	IN	O	O
a	DT	O	O
possible	JJ	O	O
nosocomial	JJ	B-PROBLEM	B-PROBLEM
urinary	JJ	I-PROBLEM	I-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
urine	JJ	I-TEST	I-TEST
culture	NN	I-TEST	I-TEST
was	VBD	O	O
pending	VBG	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
this	DT	O	O
dictation	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
mild	JJ	I-PROBLEM	I-PROBLEM
increase	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
her	PRP$	B-TEST	I-PROBLEM
bun	NN	I-TEST	I-PROBLEM
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
during	IN	O	O
her	PRP$	O	O
hospitalization	NN	O	O
which	WDT	O	O
promptly	RB	O	O
returned	VBD	O	O
to	TO	O	O
her	PRP$	O	B-TEST
baseline	NN	O	I-TEST
levels	NNS	O	I-TEST
with	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

patient	NN	O	O
recorded	VBD	O	O
as	IN	O	O
having	VBG	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
to	TO	O	O
drugs	NNS	B-TREATMENT	B-TREATMENT

lightheadedness	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
slight	JJ	B-PROBLEM	B-PROBLEM
doe	NN	I-PROBLEM	I-PROBLEM

redo	NN	B-TREATMENT	O
avr	NN	I-TREATMENT	O
with	IN	O	O
aortic	JJ	B-TREATMENT	B-PROBLEM
root	NN	I-TREATMENT	I-PROBLEM
enlargement	NN	I-TREATMENT	I-PROBLEM
(	(	O	O
21	CD	O	O
mm	NN	O	O
ce	NN	O	O
magna	VBP	O	O
pericardial	JJ	O	B-TREATMENT
valve	NN	O	I-TREATMENT
)	)	O	I-TREATMENT

68	CD	O	O
yo	JJ	O	O
female	NN	O	O
trasnferred	VBN	O	O
in	IN	O	O
from	IN	O	O
catholic	NN	O	O
cmed	VBN	O	O
csru.	JJ	O	O
ctr.	NN	O	O
with	IN	O	O
periprosthetic	JJ	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
valve	NN	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
aortic	JJ	B-PROBLEM	B-PROBLEM
valve	NN	I-PROBLEM	I-PROBLEM
thrombus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
cath	NN	B-TEST	B-TEST
done	VBN	O	O
,	,	O	O
but	CC	O	O
echo	VBP	B-TEST	B-TEST
05-07	JJ	O	O
showed	VBD	O	O
ef	JJ	B-TEST	O
60-65%	JJ	O	O
,	,	O	O
stenotic	JJ	B-PROBLEM	B-PROBLEM
mech.	NN	I-PROBLEM	I-PROBLEM
valve	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
mean	JJ	B-TEST	B-TEST
gradient	NN	I-TEST	I-TEST
33	CD	O	O
mm	NN	O	O
,	,	O	O
decreased	VBD	B-PROBLEM	B-PROBLEM
disc	JJ	I-PROBLEM	I-PROBLEM
motion	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
mobile	JJ	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
lvot	NN	I-PROBLEM	O
,	,	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
ai	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
mild	NN	B-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
moderate	VB	I-PROBLEM	I-PROBLEM
mr	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
trace	NN	B-PROBLEM	O
tr.	NN	I-PROBLEM	O
referred	VBD	O	O
for	IN	O	O
surgical	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
.	.	O	O

htn	NN	B-PROBLEM	B-PROBLEM
elev.	NN	B-PROBLEM	I-PROBLEM
lipids	NNS	I-PROBLEM	I-PROBLEM
hypothyroidism	NN	B-PROBLEM	I-PROBLEM
back	RB	B-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

gerd	NN	B-PROBLEM	B-PROBLEM

s/p	NN	O	O
avr	NN	B-TREATMENT	B-TREATMENT
2000	CD	O	O
remote	JJ	B-TREATMENT	B-TREATMENT
tonsillectomy/adenoidectomy	NN	I-TREATMENT	I-TREATMENT
partial	JJ	B-TREATMENT	I-TREATMENT
thyroidectomy	NN	I-TREATMENT	I-TREATMENT
rem.	NN	B-TREATMENT	I-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
wrist	NN	I-TREATMENT	I-TREATMENT
ganglion	NN	I-TREATMENT	I-TREATMENT
cyst	NN	I-TREATMENT	I-TREATMENT
left	VBD	B-TREATMENT	I-TREATMENT
foot	JJ	I-TREATMENT	I-TREATMENT
bunionectomy	NN	I-TREATMENT	I-TREATMENT
breast	NN	B-TEST	I-TREATMENT
biopsies	NNS	I-TEST	I-TREATMENT

father	RB	O	O
died	VBD	O	O
at	IN	O	O
57	CD	O	O
of	IN	O	O
heart	NN	B-PROBLEM	B-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
brother	RB	O	O
died	VBD	O	O
at	IN	O	O
age	NN	O	O
7	CD	O	O
of	IN	O	O
"leaky	JJ	B-PROBLEM	O
valve"	NNS	I-PROBLEM	O
sister	NN	O	O
with	IN	O	O
cad/cabg	NN	B-PROBLEM	B-PROBLEM

hr	NN	B-TEST	B-TEST
68	CD	O	O

rr	NN	B-TEST	B-TEST
18	CD	O	O

95%	CD	O	O
sat	VBD	B-TEST	O

nad	JJ	B-PROBLEM	O
skin/heent	NN	O	O
unremarkable	JJ	O	O
neck	NN	O	O
supple	NN	O	O
,	,	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
radiates	NNS	O	I-PROBLEM
bilat.	VBP	O	I-PROBLEM
to	TO	O	I-PROBLEM
carotids	NNS	O	I-PROBLEM

rrr	NN	O	O
with	IN	O	O
holosystolic	JJ	B-PROBLEM	B-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
soft	JJ	O	O
,	,	O	O
nt	JJ	B-PROBLEM	O
,	,	O	O
nd	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
+	JJ	O	O
bs	NN	O	O
warm	NN	O	O
,	,	O	O
well-perfused	JJ	O	O
,	,	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
superficial	JJ	B-PROBLEM	B-PROBLEM
varicosities	NNS	I-PROBLEM	I-PROBLEM
neuro	VBP	O	I-PROBLEM
grossly	RB	O	I-PROBLEM
intact	JJ	O	I-PROBLEM

cardiology	NN	O	O
report	NN	O	O
echo	VBP	B-TEST	B-TEST
study	NN	I-TEST	I-TEST
date	NN	O	O
of	IN	O	O
2014-05-11	JJ	O	O

pt	NN	O	O
is	VBZ	O	O
being	VBG	O	O
av	RB	O	O
paced	VBN	O	O
,	,	O	O
on	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
infusion	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	O
phenylephrine	NN	I-TREATMENT	B-TREATMENT

1.	CD	O	O
a	DT	B-TREATMENT	B-PROBLEM
bioprosthesis	NN	I-TREATMENT	I-PROBLEM
is	VBZ	O	O
well	RB	O	O
seated	VBN	O	O
in	IN	O	O
the	DT	O	O
aortic	JJ	O	O
position	NN	O	O
,	,	O	O
leaflets	VBZ	O	O
open	JJ	O	O
well	RB	O	O
,	,	O	O
trace	JJ	B-PROBLEM	O
central	JJ	I-PROBLEM	O
ai	NN	I-PROBLEM	O
is	VBZ	O	O
seen	VBN	O	O
.	.	O	O

trace	NN	B-PROBLEM	O
ai	NN	I-PROBLEM	O
is	VBZ	O	O
also	RB	O	O
noted	VBN	O	O
between	IN	O	O
the	DT	O	O
left	NN	O	O
and	CC	O	O
right	JJ	O	B-PROBLEM
coronary	NN	O	I-PROBLEM
cusps	NN	O	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
paravavluar	NN	I-PROBLEM	I-PROBLEM
leak	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
area	NN	O	I-PROBLEM
adjacent	NN	O	I-PROBLEM
to	TO	O	I-PROBLEM
the	DT	O	I-PROBLEM
anterior	JJ	O	I-PROBLEM
mitral	JJ	O	I-PROBLEM
leaflet	NN	O	I-PROBLEM
,	,	O	O
resulting	VBG	O	O
in	IN	O	O
some	DT	B-PROBLEM	O
trace	NN	I-PROBLEM	O
insuffiency	NN	I-PROBLEM	O
outside	IN	O	O
the	DT	O	O
sewing	VBG	O	O
ring	NN	O	O
.	.	O	O

2.	CD	O	O
mitral	JJ	B-PROBLEM	B-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
unchanged	JJ	O	O
from	IN	O	O
before	IN	O	O
.	.	O	O

4.	CD	O	O
aorta	NN	O	O
is	VBZ	O	O
intact	JJ	O	O
post	NN	O	O
decannulation	NN	B-TREATMENT	B-TREATMENT

6.	CD	O	O
all	DT	O	O
findings	NNS	O	O
discussed	VBN	O	O
with	IN	O	O
surgeon	NN	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
the	DT	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
.	.	O	O

hct	SYM	B-TEST	B-TEST
-	:	O	O
29.2*	CD	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
12.4*	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
2.89*	CD	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
9.0*	CD	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
26.0*	CD	O	O

mcv	SYM	B-TEST	B-TEST
-	:	O	O
90	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
31.3	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.9	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
13.5	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
262	CD	O	O

pt	SYM	B-TEST	B-TEST
-	:	O	O
16.8*	CD	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
65.3*	CD	O	O
inr	NN	B-TEST	O
(	(	O	O
pt	NN	B-TEST	O
)	)	O	O
-	:	O	O
1.5*	CD	O	O

glucose	JJ	B-TEST	B-TEST
-	:	O	O
115*	CD	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
20	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.3*	CD	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
137	CD	O	O

k	SYM	B-TEST	B-TEST
-	:	O	O
4.8	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
96	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
34*	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
12	CD	O	O

admitted	VBN	O	O
05-08	CD	O	O
to	TO	O	O
cardiology	VB	O	O
service	NN	O	O
for	IN	O	O
surgical	JJ	B-TEST	B-TEST
work-up	NN	I-TEST	I-TEST
.	.	O	O

inr	NN	B-TEST	B-TEST
2.7	CD	O	O
and	CC	O	O
echo	RB	B-TEST	B-TEST
repeated	VBN	O	O
,	,	O	O
coumadin	JJ	B-TREATMENT	B-TREATMENT
held	NN	O	I-TREATMENT
,	,	O	O
and	CC	O	O
heparin	JJ	B-TREATMENT	B-TREATMENT
drips	NNS	I-TREATMENT	I-TREATMENT
started	VBD	O	O
.	.	O	O

review	NN	O	O
of	IN	O	O
osh	JJ	B-TEST	O
echo	NN	I-TEST	B-TEST
revealed	VBD	O	O
peak	JJ	B-TEST	B-TEST
gradient	NN	I-TEST	I-TEST
of	IN	O	O
64mm	CD	O	O
(	(	O	O
not	RB	O	O
30	CD	O	O
's	POS	O	O
)	)	O	O
.	.	O	O

new	JJ	B-TEST	O
echo	NN	I-TEST	B-TEST
showed	VBD	O	O
pannus	IN	B-PROBLEM	O
involving	VBG	O	O
the	DT	O	O
valve	NN	O	O
and	CC	O	O
?	.	O	O
thrombus	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

seen	VBN	O	O
by	IN	O	O
dr.	JJ	O	O
laura	NN	O	O
of	IN	O	O
cardiac	JJ	O	B-TREATMENT
surgery	NN	O	I-TREATMENT
and	CC	O	O
underwent	JJ	O	O
redo	NN	B-TREATMENT	O
avr	NN	I-TREATMENT	O
with	IN	O	O
aortic	JJ	B-TREATMENT	B-PROBLEM
root	NN	I-TREATMENT	I-PROBLEM
enlargement	NN	I-TREATMENT	I-PROBLEM
on	IN	O	O
05-11	NN	O	O
.	.	O	O

transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
csru	NN	O	O
in	IN	O	O
stable	JJ	O	O
condition	NN	O	O
on	IN	O	O
phenylephrine	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
propofol	JJ	B-TREATMENT	B-TREATMENT
drips	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

weaned	VBN	O	O
to	TO	O	O
extubation	VB	O	O
on	IN	O	O
pod	NN	O	O
#2	NNS	O	O
and	CC	O	O
off	IN	O	O
all	DT	B-TREATMENT	B-TREATMENT
drips	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

episode	NN	B-PROBLEM	O
of	IN	I-PROBLEM	O
afib	NN	I-PROBLEM	B-PROBLEM
that	IN	O	O
evening	VBG	O	O
treated	VBN	O	O
with	IN	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
converted	VBD	O	O
to	TO	O	O
sr	VB	O	O
.	.	O	O

chest	NN	B-TREATMENT	B-TREATMENT
tubes	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	I-TREATMENT
wires	NNS	B-TREATMENT	I-TREATMENT
removed	VBN	O	O
without	IN	O	O
incident	NN	B-PROBLEM	O
.	.	O	O

synthroid	JJ	B-TREATMENT	B-TREATMENT
75	CD	O	O
mcg	NNS	O	O
daily	RB	O	O

hctz	NN	B-TREATMENT	O
37.5	CD	O	O
mg	JJ	O	O
daily	JJ	O	O

mvi	NNS	B-TREATMENT	O
daily	RB	O	O

vit.c	NN	B-TREATMENT	B-TEST
500	CD	O	O
mg	JJ	O	O
daily	JJ	O	O
prevacid	NN	B-TREATMENT	B-TREATMENT
15	CD	O	O
mg	JJ	O	O
daily	JJ	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
(	(	O	I-TREATMENT
held	VBN	O	I-TREATMENT
)	)	O	I-TREATMENT
toprol	NN	B-TREATMENT	I-TREATMENT
xl	$	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	JJ	O	O
daily	JJ	O	O
zocor	NN	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
daily	JJ	O	O

kcl	VB	B-TREATMENT	O
12-27	JJ	O	O
meq	NNS	O	O
daily	JJ	O	O
cozaar	VBP	B-TREATMENT	O
25	CD	O	O
mg	NNS	O	O
daily	RB	O	O

1.	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
tartrate	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
three	CD	O	O
(	(	O	O
3	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

2.	CD	O	O
docusate	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
for	IN	O	O
1	CD	O	O
months	NNS	O	O
.	.	O	O

3.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
81	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

4.	CD	O	O
oxycodone-acetaminophen	JJ	B-TREATMENT	O
5-325	JJ	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
tablets	NNS	O	O
po	VBP	O	O
q4h	NN	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

5.	CD	O	O
levothyroxine	JJ	B-TREATMENT	B-TREATMENT
75	CD	O	O
mcg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

6.	CD	O	O
simvastatin	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

7.	CD	O	O
pantoprazole	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
q24h	NN	O	O
(	(	O	O
every	DT	O	O
24	CD	O	O
hours	NNS	O	O
)	)	O	O
.	.	O	O

8.	CD	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
200	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
for	IN	O	O
2	CD	O	O
days	NNS	O	O
:	:	O	O
for	IN	O	O
2	CD	O	O
days	NNS	O	O
,	,	O	O
then	RB	O	O
start	VB	O	O
200	CD	O	O
mg	JJ	O	O
daily	JJ	O	O
ongoing	VBG	O	O
on	IN	O	O
05-20	NN	O	O
.	.	O	O

9.	CD	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
10	CD	O	O
meq	NN	O	O
capsule	NN	O	O
,	,	O	O
sustained	VBD	O	O
release	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
capsule	NN	O	O
,	,	O	O
sustained	VBD	O	O
release	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
for	IN	O	O
7	CD	O	O
days	NNS	O	O
.	.	O	O

10.	CD	O	O
furosemide	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
for	IN	O	O
7	CD	O	O
days	NNS	O	O
.	.	O	O

prosthetic	JJ	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
valve	NN	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM

htn	NN	B-PROBLEM	B-PROBLEM
elev.	NN	B-PROBLEM	I-PROBLEM
lipds	VBD	I-PROBLEM	I-PROBLEM
hypothyroidism	NN	B-PROBLEM	I-PROBLEM
back	RB	B-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

gerd	NN	B-PROBLEM	B-PROBLEM

a	DT	B-PROBLEM	B-PROBLEM
fib	JJ	I-PROBLEM	I-PROBLEM
s/p	NN	O	O
avr	NN	B-TREATMENT	B-TREATMENT
2000	CD	O	O

no	DT	O	O
driving	NN	O	O
for	IN	O	O
one	CD	O	O
month	NN	O	O
no	DT	O	O
lifting	VBG	O	O
greater	JJR	O	O
than	IN	O	O
10	CD	O	O
pounds	NNS	O	O
for	IN	O	O
10	CD	O	O
weeks	NNS	O	O
no	DT	O	O
lotions	NNS	O	B-TREATMENT
,	,	O	O
creams	NNS	O	B-TREATMENT
or	CC	O	O
powders	NNS	O	B-TREATMENT
on	IN	O	O
any	DT	O	B-PROBLEM
incision	NN	B-PROBLEM	I-PROBLEM
may	MD	O	I-PROBLEM
shower	VB	O	I-PROBLEM
over	IN	O	I-PROBLEM
incisions	NNS	B-PROBLEM	I-PROBLEM
and	CC	O	O
pat	VB	O	O
dry	JJ	O	O
call	NN	O	O
for	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
greater	JJR	O	O
than	IN	O	O
100.5	CD	O	O
,	,	O	O
redness	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
drainage	NN	B-PROBLEM	B-PROBLEM

uterine	JJ	B-PROBLEM	B-PROBLEM
prolapse	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
70	CD	O	O
year	NN	O	O
old	JJ	O	O
gravida	NN	O	O
iv	NN	O	O
,	,	O	O
para	VBP	O	O
4	CD	O	O
who	WP	O	O
presented	VBD	O	O
for	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
vaginal	JJ	I-TREATMENT	I-TREATMENT
hysterectomy	NN	I-TREATMENT	I-TREATMENT
secondary	JJ	O	O
to	TO	O	O
uterine	VB	B-PROBLEM	O
prolapse	NN	I-PROBLEM	B-PROBLEM
and	CC	O	O
also	RB	O	O
presented	VBN	O	O
for	IN	O	O
evaluation	NN	B-TEST	B-TEST
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
suspicious	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
seen	VBN	O	O
on	IN	O	O
a	DT	B-TEST	B-TEST
mammogram	NN	I-TEST	I-TEST
.	.	O	O

patient	NN	B-PROBLEM	B-PROBLEM
&apos;s	NN	I-PROBLEM	I-PROBLEM
problem	NN	I-PROBLEM	I-PROBLEM
started	VBD	O	O
four	CD	O	O
years	NNS	O	O
ago	RB	O	O
when	WRB	O	O
she	PRP	O	O
first	RB	O	O
experienced	VBD	O	O
a	DT	B-PROBLEM	O
pushing	VBG	I-PROBLEM	O
forward	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
her	PRP$	I-PROBLEM	O
uterus	NN	I-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
described	VBD	O	O
this	DT	O	O
sensation	NN	O	O
as	IN	O	O
uncomfortable	JJ	B-PROBLEM	O
and	CC	O	O
becoming	VBG	O	O
more	RBR	O	O
prominent	JJ	O	O
over	IN	O	O
the	DT	O	O
following	JJ	O	O
three	CD	O	O
years	NNS	O	O
with	IN	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
pressure	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

two	CD	O	O
months	NNS	O	O
ago	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
slipped	VBD	O	O
and	CC	O	O
fell	VBD	O	O
with	IN	O	O
valsalva	NN	O	O
that	WDT	O	O
precipitated	VBD	O	O
an	DT	O	B-PROBLEM
exacerbation	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
her	PRP$	B-PROBLEM	I-PROBLEM
prolapse	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
subsequently	RB	O	O
could	MD	O	O
not	RB	O	O
urinate	VB	O	O
and	CC	O	O
was	VBD	O	O
in	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
secondary	JJ	O	O
to	TO	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
problem	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

at	IN	O	O
this	DT	O	O
time	NN	O	O
,	,	O	O
she	PRP	O	O
decided	VBD	O	O
that	IN	O	O
she	PRP	O	O
needed	VBD	O	O
the	DT	B-PROBLEM	B-PROBLEM
prolapse	NN	I-PROBLEM	I-PROBLEM
fixed	VBN	O	O
and	CC	O	O
actually	RB	O	O
wrote	VBD	O	O
to	TO	O	O
the	DT	O	O
norri	JJ	O	O
hospital	NN	O	O
to	TO	O	O
try	VB	O	O
and	CC	O	O
find	VB	O	O
a	DT	O	O
gynecologist	NN	O	O
.	.	O	O

her	PRP$	O	O
letter	NN	O	O
was	VBD	O	O
referred	VBN	O	O
to	TO	O	O
dr.	VB	O	O
earllamarg	JJ	O	O
para	NN	O	O
who	WP	O	O
saw	VBD	O	O
her	PRP	O	O
in	IN	O	O
the	DT	O	O
office	NN	O	O
and	CC	O	O
recommended	VBD	O	O
vaginal	JJ	B-TREATMENT	B-TREATMENT
hysterectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

patient	NN	O	O
has	VBZ	O	O
never	RB	O	O
had	VBD	O	O
a	DT	B-TREATMENT	O
pessary	JJ	I-TREATMENT	O
and	CC	O	O
refused	VBD	O	O
one	CD	O	O
and	CC	O	O
denies	VBZ	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
fever	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
dysuria	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
stress	JJ	B-PROBLEM	B-PROBLEM
incontinence	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
her	PRP$	O	O
current	JJ	O	O
admission	NN	O	O
.	.	O	O

significant	JJ	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
left	RBR	I-PROBLEM	I-PROBLEM
saphenous	JJ	I-PROBLEM	I-PROBLEM
vein	JJ	I-PROBLEM	I-PROBLEM
thrombosis	NN	I-PROBLEM	I-PROBLEM
diagnosed	VBN	O	I-PROBLEM
with	IN	O	I-PROBLEM
lower	JJR	B-TEST	I-PROBLEM
extremity	NN	I-TEST	I-PROBLEM
non-invasives	NNS	I-TEST	I-PROBLEM
and	CC	O	O
on	IN	O	O
may	MD	O	O
2	CD	O	O
,	,	O	O
1993	CD	O	O
with	IN	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
deep	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
thrombosis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
clearance	NN	O	O
by	IN	O	O
dr.	NN	O	O
ribreefcheampner	NN	O	O
for	IN	O	O
further	JJ	B-TREATMENT	B-TREATMENT
intervention	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
also	RB	O	O
has	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
since	IN	O	O
childhood	NN	O	O
.	.	O	O

last	JJ	O	O
menstrual	JJ	O	O
period	NN	O	O
was	VBD	O	O
at	IN	O	O
age	NN	O	O
fifty	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
not	RB	O	O
on	IN	O	O
hormonal	JJ	B-TREATMENT	B-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
she	PRP	O	O
has	VBZ	O	O
a	DT	O	O
four	CD	O	O
history	NN	O	O
of	IN	O	O
uterine	JJ	B-PROBLEM	B-PROBLEM
prolapse	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

aspirin	RB	B-TREATMENT	B-TREATMENT
one	CD	O	O
per	IN	O	O
day	NN	O	O
which	WDT	O	O
the	DT	O	O
patient	NN	O	O
quit	NN	O	O
taking	VBG	O	O
two	CD	O	O
weeks	NNS	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
.	.	O	O

this	DT	O	O
was	VBD	O	O
a	DT	O	O
well-developed	JJ	O	O
,	,	O	O
well-nourished	JJ	O	O
female	NN	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
128/72	CD	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
pulse	NN	I-TEST	I-TEST
of	IN	O	O
84	CD	O	O
that	WDT	O	O
was	VBD	O	O
regular	JJ	O	O
,	,	O	O
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
at	IN	O	O
98.4	CD	O	O
.	.	O	O

examination	NN	B-TEST	B-TEST
showed	VBD	O	O
right	JJ	B-PROBLEM	B-PROBLEM
axillary	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
posterior	NN	I-PROBLEM	I-PROBLEM
axillary	JJ	I-PROBLEM	I-PROBLEM
skin	NN	I-PROBLEM	I-PROBLEM
tags	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
crusted	JJ	B-PROBLEM	B-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

pupils	NNS	O	O
were	VBD	O	O
equal	JJ	O	O
,	,	O	O
round	NN	O	O
,	,	O	O
and	CC	O	O
reactive	JJ	O	O
to	TO	O	O
light	JJ	O	O
,	,	O	O
extraocular	JJ	O	B-PROBLEM
muscles	NNS	O	I-PROBLEM
were	VBD	O	O
intact	JJ	O	O
,	,	O	O
and	CC	O	O
no	DT	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

examination	NN	B-TEST	B-TEST
showed	VBD	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
with	IN	O	O
no	DT	O	O
s3	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
s4	VB	B-PROBLEM	O
heard	NN	O	O
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
grade	NN	I-PROBLEM	I-PROBLEM
ii/vi	NN	I-PROBLEM	I-PROBLEM
holosystolic	JJ	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
loudest	JJS	O	I-PROBLEM
at	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	JJ	O	I-PROBLEM
sternal	JJ	O	I-PROBLEM
border	NN	O	I-PROBLEM
.	.	O	O

examination	NN	B-TEST	B-TEST
was	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	NN	B-TEST	B-TEST
.	.	I-TEST	O

examination	NN	B-TEST	B-TEST
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
upper	NN	I-PROBLEM	I-PROBLEM
mid	NN	I-PROBLEM	I-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
breast	NN	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
detected	VBN	O	O
actually	RB	O	O
by	IN	O	O
dr.	JJ	O	O
para	NN	O	O
.	.	O	O

soft	JJ	O	O
and	CC	O	O
non-tender	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
left	VBN	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
leg	NN	I-PROBLEM	I-PROBLEM
varicose	NN	I-PROBLEM	I-PROBLEM
veins	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
venous	JJ	B-PROBLEM	B-PROBLEM
cords	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
bilateral	JJ	B-TEST	O
2+	CD	I-TEST	O
pedal	JJ	I-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TREATMENT
bun	NN	I-TEST	I-TREATMENT
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
of	IN	O	O
12	CD	O	O
and	CC	O	O
1.2	CD	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
6.7	CD	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
of	IN	O	O
39.4	CD	O	O
,	,	O	O
negative	JJ	O	O
urinalysis	NN	O	B-TEST
,	,	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
potassium	NN	I-TEST	I-TEST
of	IN	O	O
4.6	CD	O	O
.	.	O	O

her	PRP$	O	B-TEST
ca-125	NN	B-TEST	I-TEST
was	VBD	O	O
20	CD	O	O
and	CC	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
chest	JJ	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
that	WDT	O	O
showed	VBD	O	O
no	DT	O	O
infiltrates	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
a	DT	B-TEST	B-TEST
mammogram	NN	I-TEST	I-TEST
that	WDT	O	O
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
calcified	VBD	I-PROBLEM	I-PROBLEM
fibroadenoma	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
right	JJ	B-PROBLEM	I-PROBLEM
upper	NN	I-PROBLEM	I-PROBLEM
mid	JJ	I-PROBLEM	I-PROBLEM
area	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
calcification	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
an	DT	B-TEST	B-TREATMENT
ekg	NN	I-TEST	I-TREATMENT
that	WDT	O	O
showed	VBD	O	O
a	DT	O	O
question	NN	O	O
of	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
old	JJ	I-PROBLEM	I-PROBLEM
inferior	JJ	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

cardiology	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
to	TO	O	O
evaluate	VB	O	O
this	DT	O	O
and	CC	O	O
felt	VBD	O	O
that	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
seen	VBN	O	O
on	IN	O	O
the	DT	B-TEST	O
ekg	NN	I-TEST	O
were	VBD	O	O
not	RB	O	O
significant	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
also	RB	O	O
seen	VBN	O	O
by	IN	O	O
dr.	JJ	O	O
nusc	NN	O	O
from	IN	O	O
general	JJ	O	B-TREATMENT
surgery	NN	O	I-TREATMENT
for	IN	O	O
evaluation	NN	B-TEST	B-TEST
of	IN	O	O
micro	JJ	B-PROBLEM	B-PROBLEM
calcifications	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
breast	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
refused	VBD	O	O
a	DT	B-TEST	B-TEST
biopsy	NN	I-TEST	I-TEST
for	IN	O	O
this	DT	O	O
admission	NN	O	O
and	CC	O	O
desires	VBZ	O	B-TEST
follow-up	JJ	B-TEST	I-TEST
mammograms	NNS	I-TEST	I-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
underwent	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
total	JJ	I-TREATMENT	I-TREATMENT
vaginal	JJ	I-TREATMENT	I-TREATMENT
hysterectomy	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
june	NN	O	O
4	CD	O	O
,	,	O	O
1993	CD	O	O
which	WDT	O	O
she	PRP	O	O
tolerated	VBD	O	O
without	IN	O	O
complications	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
remained	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
throughout	IN	O	O
her	PRP$	O	O
admission	NN	O	O
tolerating	VBG	O	O
a	DT	O	O
regular	JJ	O	O
diet	NN	O	O
by	IN	O	O
post-operative	JJ	O	O
day	NN	O	O
two	CD	O	O
and	CC	O	O
was	VBD	O	O
discharged	VBN	O	O
on	IN	O	O
june	NN	O	O
6	CD	O	O
,	,	O	O
1993	CD	O	O
with	IN	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
foley	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
urinating	VBG	O	O
on	IN	O	O
her	PRP$	O	O
own	JJ	O	O
.	.	O	O

percocet	RB	B-TREATMENT	B-TREATMENT
one	CD	O	O
to	TO	O	O
two	CD	O	O
tablets	NNS	O	O
p.o.	VBP	O	O
q.4-6h.	JJ	O	O
p.r.n.	NN	O	O
,	,	O	O
iron	NN	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
325	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
and	CC	O	O
one	CD	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
q.d.	NN	O	O

patient	NN	O	O
recorded	VBD	O	O
as	IN	O	O
having	VBG	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	O
drugs	NNS	I-PROBLEM	B-TREATMENT

tia/palpitations	NNS	B-PROBLEM	B-PROBLEM

2014-04-21	JJ	O	O
-	:	O	O
pfo	NN	B-TREATMENT	O
closure	NN	I-TREATMENT	O
via	IN	O	O
right	JJ	B-TREATMENT	B-TREATMENT
mini	NN	I-TREATMENT	I-TREATMENT
thoracotomy	NN	I-TREATMENT	I-TREATMENT

this	DT	O	O
53-year-old	JJ	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
transient	JJ	I-PROBLEM	I-PROBLEM
ischemic	JJ	I-PROBLEM	I-PROBLEM
attacks	NNS	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
past	NN	O	O
was	VBD	O	O
investigated	VBN	O	O
and	CC	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
patent	NN	I-PROBLEM	I-PROBLEM
foramen	NNS	I-PROBLEM	I-PROBLEM
ovale	VBP	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
electively	RB	O	O
admitted	VBN	O	O
for	IN	O	O
closure	NN	B-TREATMENT	O
of	IN	O	O
the	DT	O	O
same	JJ	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
preoperative	JJ	I-TEST	I-TEST
investigations	NNS	I-TEST	I-TEST
with	IN	O	O
coronary	JJ	B-TEST	B-TEST
angiogram	NN	I-TEST	I-TEST
showed	VBD	O	O
normal	JJ	O	O
coronary	JJ	O	O
arteries	NNS	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
no	DT	O	O
valvular	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

right	JJ	B-PROBLEM	B-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
nodule	NN	I-PROBLEM	I-PROBLEM

tia	NN	B-PROBLEM	B-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM

childhood	NN	B-PROBLEM	B-PROBLEM
skull	NN	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM

pfo	NN	B-PROBLEM	O

brother	NN	O	O
with	IN	O	O
mi	NN	B-PROBLEM	B-PROBLEM
at	IN	O	O
age	NN	O	O
35	CD	O	O

father	NN	O	O
with	IN	O	O
mi/cabg	NN	B-PROBLEM	B-TREATMENT
died	VBN	O	O
at	IN	O	O
age	NN	O	O
60	CD	O	O
.	.	O	O

bp	NN	B-TEST	B-TEST
144/90	CD	O	O
,	,	O	O
hr	NN	B-TEST	B-TEST
64	CD	O	O
,	,	O	O
rr	VBD	B-TEST	O
14	CD	O	O

well	RB	O	O
developed	VBN	O	O
male	NN	O	O
in	IN	O	O
no	DT	O	O
acute	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM

oropharynx	JJ	O	B-PROBLEM
benign	NN	O	I-PROBLEM
,	,	O	O
poor	JJ	B-PROBLEM	O
dental	JJ	I-PROBLEM	O
health	NN	I-PROBLEM	O

supple	NN	O	O
,	,	O	O
no	DT	O	O
jvd	NN	B-PROBLEM	B-PROBLEM

regular	JJ	O	O
rate	NN	O	O
,	,	O	O
normal	JJ	O	O
s1s2	NN	O	O
,	,	O	O
no	DT	O	O
murmur	NN	B-PROBLEM	B-PROBLEM

soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
normoactive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O

warm	NN	O	O
,	,	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
varicosities	NNS	B-PROBLEM	B-PROBLEM

2014-04-24	JJ	O	O
07:30am	CD	O	O
blood	NN	B-TEST	O

hct	SYM	B-TEST	B-TEST
-	:	O	O
25.9*	CD	O	O

2014-04-23	JJ	O	O
07:05am	CD	O	O
blood	NN	B-TEST	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
5.9	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
2.72*	CD	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
8.6*	CD	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
25.2*	CD	O	O

mcv	SYM	B-TEST	B-TEST
-	:	O	O
93	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
31.5	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.0	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
13.0	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
150	CD	O	O

2014-04-23	JJ	O	O
07:05am	CD	O	O
blood	NN	B-TEST	O

plt	NN	B-TEST	B-TEST
ct	SYM	I-TEST	I-TEST
-	:	O	O
150	CD	O	O

2014-04-24	JJ	O	O
07:30am	CD	O	O
blood	NN	B-TEST	O

urean	JJ	B-TEST	B-TEST
-	:	O	O
11	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
0.8	CD	O	O
k	SYM	O	B-TEST
-	:	O	O
4.4	CD	O	O

2014-04-21	JJ	O	O
echo	NN	B-TEST	B-TEST

no	DT	O	O
spontaneous	JJ	B-PROBLEM	B-TEST
echo	NN	I-PROBLEM	I-TEST
contrast	NN	I-PROBLEM	I-TEST
is	VBZ	O	O
seen	VBN	O	O
in	IN	O	O
the	DT	O	O
body	NN	O	O
of	IN	O	O
the	DT	O	O
left	JJ	O	O
atrium	NN	O	O
.	.	O	O

no	DT	O	O
mass/thrombus	NN	B-PROBLEM	O
is	VBZ	O	O
seen	VBN	O	O
in	IN	O	O
the	DT	O	O
left	JJ	O	O
atrium	NN	O	O
or	CC	O	O
left	VBN	O	O
atrial	JJ	O	O
appendage	NN	O	O
.	.	O	O

no	DT	O	O
spontaneous	JJ	B-PROBLEM	B-TEST
echo	NN	I-PROBLEM	I-TEST
contrast	NN	I-PROBLEM	I-TEST
is	VBZ	O	O
seen	VBN	O	O
in	IN	O	O
the	DT	O	O
body	NN	O	O
of	IN	O	O
the	DT	O	O
right	JJ	O	O
atrium	NN	O	O
.	.	O	O

a	DT	B-PROBLEM	B-PROBLEM
patent	NN	I-PROBLEM	I-PROBLEM
foramen	NNS	I-PROBLEM	I-PROBLEM
ovale/secundum	VBP	I-PROBLEM	I-PROBLEM
asd	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
present	JJ	O	O
.	.	O	O

a	DT	B-PROBLEM	B-PROBLEM
left-to-right	JJ	I-PROBLEM	I-PROBLEM
shunt	NN	I-PROBLEM	I-PROBLEM
across	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
interatrial	JJ	I-PROBLEM	I-PROBLEM
septum	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
seen	VBN	O	O
at	IN	O	O
rest	NN	O	O
.	.	O	O

a	DT	B-PROBLEM	B-PROBLEM
right-to-left	JJ	I-PROBLEM	I-PROBLEM
shunt	NN	I-PROBLEM	I-PROBLEM
across	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
interatrial	JJ	I-PROBLEM	I-PROBLEM
septum	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
seen	VBN	O	O
at	IN	O	O
rest	NN	O	O
with	IN	O	O
injection	NN	B-TEST	O
of	IN	I-TEST	O
agitated	JJ	I-TEST	B-PROBLEM
saline	NN	I-TEST	I-PROBLEM
contrast	NN	I-TEST	I-PROBLEM
.	.	O	O

the	DT	O	O
inferior	JJ	O	O
vena	NN	O	O
cava	NN	O	O
is	VBZ	O	O
dilated	VBN	B-PROBLEM	B-PROBLEM
(	(	O	O
>2.5	NNP	O	O
cm	NN	O	O
)	)	O	O
.	.	O	O

left	VBN	O	B-PROBLEM
ventricular	JJ	O	I-PROBLEM
wall	NN	O	I-PROBLEM
thickness	NN	O	I-PROBLEM
,	,	O	O
cavity	NN	O	O
size	NN	O	O
,	,	O	O
and	CC	O	O
systolic	JJ	O	O
function	NN	O	O
are	VBP	O	O
normal	JJ	O	O
(	(	O	O
lvef	JJ	B-TEST	O
>55%	NN	I-TEST	O
)	)	O	O
.	.	O	O

overall	JJ	O	B-TEST
left	VBD	O	I-TEST
ventricular	JJ	O	I-TEST
systolic	JJ	O	I-TEST
function	NN	O	I-TEST
is	VBZ	O	O
normal	JJ	O	O
(	(	O	O
lvef>55%	JJ	B-TEST	O
)	)	O	O
.	.	O	O

the	DT	O	O
ascending	NN	O	O
,	,	O	O
transverse	NN	O	O
and	CC	O	O
descending	VBG	O	B-PROBLEM
thoracic	NN	O	I-PROBLEM
aorta	NNS	O	I-PROBLEM
are	VBP	O	O
normal	JJ	O	O
in	IN	O	O
diameter	NN	O	O
and	CC	O	O
free	JJ	O	O
of	IN	O	O
atherosclerotic	JJ	B-PROBLEM	B-PROBLEM
plaque	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
aortic	JJ	O	O
valve	NN	O	O
leaflets	NNS	O	O
(	(	O	O
3	CD	O	O
)	)	O	O
appear	VBP	O	O
structurally	RB	O	O
normal	JJ	O	O
with	IN	O	O
good	JJ	O	O
leaflet	NN	O	O
excursion	NN	O	O
and	CC	O	O
no	DT	O	O
aortic	JJ	B-PROBLEM	B-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
aortic	JJ	B-PROBLEM	B-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
seen	VBN	O	O
.	.	O	O

the	DT	O	O
mitral	JJ	O	O
valve	NN	O	O
appears	VBZ	O	O
structurally	RB	O	O
normal	JJ	O	O
with	IN	O	O
trivial	JJ	B-PROBLEM	B-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
pericardial	JJ	B-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

post	NN	O	B-PROBLEM
bypass	NN	B-TREATMENT	I-PROBLEM

flow	NN	O	B-PROBLEM
across	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
interatrial	JJ	O	I-PROBLEM
septum	NN	O	I-PROBLEM
is	VBZ	O	O
no	RB	O	O
longer	RBR	O	O
visualized	VBN	O	O
with	IN	O	O
color	NN	B-TEST	B-TEST
flow	NN	I-TEST	I-TEST
doppler	NN	I-TEST	I-TEST
or	CC	O	O
with	IN	O	O
injection	NN	B-TEST	B-TREATMENT
of	IN	I-TEST	I-TREATMENT
agitatated	JJ	I-TEST	I-TREATMENT
saline	NN	I-TEST	I-TREATMENT
at	IN	O	O
rest	NN	O	O
or	CC	O	O
with	IN	O	O
valsalva	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
study	NN	I-TEST	I-TEST
is	VBZ	O	O
otherwise	RB	O	O
unchanged	JJ	O	O
from	IN	O	O
pre-bypass	NN	B-TEST	B-PROBLEM
.	.	O	O

2014-04-22	JJ	O	O
cxr	NN	B-TEST	O

previous	JJ	B-PROBLEM	B-TEST
right	NN	I-PROBLEM	I-TEST
pneumothorax	NN	I-PROBLEM	I-TEST
has	VBZ	O	O
resolved	VBN	O	O
except	IN	O	O
for	IN	O	O
what	WP	O	O
is	VBZ	O	O
either	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
fissural	JJ	I-PROBLEM	I-PROBLEM
component	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
bulla	NN	I-PROBLEM	I-PROBLEM
adjacent	NN	O	I-PROBLEM
to	TO	O	I-PROBLEM
the	DT	O	I-PROBLEM
minor	JJ	O	I-PROBLEM
fissure	NN	O	I-PROBLEM
.	.	O	O

may	MD	O	O
be	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

right	RB	B-TREATMENT	B-PROBLEM
apical	JJ	I-TREATMENT	I-PROBLEM
pleural	JJ	I-TREATMENT	I-PROBLEM
tube	NN	I-TREATMENT	I-PROBLEM
in	IN	O	O
place	NN	O	O
.	.	O	O

left	VBN	O	O
lung	NN	O	O
clear	JJ	O	O
from	IN	O	O
basal	JJ	B-PROBLEM	B-PROBLEM
atelectasis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

paratracheal	JJ	B-PROBLEM	B-PROBLEM
mediastinal	JJ	I-PROBLEM	I-PROBLEM
hematoma	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
resolving	VBG	O	O
.	.	O	O

mr.	NN	O	O
freeman	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
nantucket	NN	O	O
cottage	NN	O	O
hospital	NN	O	O
on	IN	O	O
2014-04-21	JJ	O	O
for	IN	O	O
surgical	JJ	B-TREATMENT	B-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
his	PRP$	B-PROBLEM	O
pfo	NN	I-PROBLEM	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
where	WRB	O	O
he	PRP	O	O
underwent	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
mini-thoracotomy	JJ	I-TREATMENT	I-TREATMENT
with	IN	O	O
closure	NN	B-TREATMENT	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
patent	NN	I-PROBLEM	I-PROBLEM
foramen	NNS	I-PROBLEM	I-PROBLEM
ovale	VBP	I-PROBLEM	I-PROBLEM
(	(	I-PROBLEM	O
pfo	NN	I-PROBLEM	O
)	)	I-PROBLEM	O
.	.	O	O

within	IN	O	O
a	DT	O	O
few	JJ	O	O
hours	NNS	O	O
,	,	O	O
he	PRP	O	O
woke	VBD	O	O
neurologically	RB	O	O
intact	JJ	O	O
and	CC	O	O
was	VBD	O	O
extubated	VBN	B-TREATMENT	O
.	.	O	O

aspirin	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
resumed.	VBN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
one	CD	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	B-PROBLEM
cardiac	JJ	O	I-PROBLEM
surgical	JJ	O	I-PROBLEM
step	NN	O	I-PROBLEM
down	RB	O	I-PROBLEM
unit	NN	O	I-PROBLEM
.	.	O	O

iron	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
vitamin	JJ	B-TREATMENT	B-TREATMENT
c	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
started	VBN	O	O
for	IN	O	O
postoperative	JJ	B-PROBLEM	B-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

plavix	RB	B-TREATMENT	B-TREATMENT
75mg	CD	O	O
daily	JJ	O	O
aspirin	RB	B-TREATMENT	B-TREATMENT
81mg	CD	O	O
daily	JJ	O	O

1.	CD	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
10	CD	O	O
meq	NN	O	O
capsule	NN	O	O
,	,	O	O
sustained	VBD	O	O
release	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
capsule	NN	O	O
,	,	O	O
sustained	VBD	O	O
release	NN	O	O
po	NN	O	O
q12h	NN	O	O
(	(	O	O
every	DT	O	O
12	CD	O	O
hours	NNS	O	O
)	)	O	O
for	IN	O	O
5	CD	O	O
days	NNS	O	O
.	.	O	O

2.	CD	O	O
docusate	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

3.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
81	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

4.	CD	O	O
oxycodone-acetaminophen	JJ	B-TREATMENT	O
5-325	JJ	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
tablets	NNS	O	O
po	JJ	O	O
every	DT	O	O
4-6	JJ	O	O
hours	NNS	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

5.	CD	O	O
ferrous	JJ	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
325	CD	O	O
(	(	O	O
65	CD	O	O
)	)	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
:	:	O	O
take	VB	O	O
for	IN	O	O
one	CD	O	O
month	NN	O	O
then	RB	O	O
stop	VB	O	O
.	.	O	O

6.	CD	O	O
camphor-menthol	JJ	B-TREATMENT	B-TREATMENT
0.5-0.5	CD	O	O
%	NN	O	O
lotion	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
appl	RB	O	O
topical	JJ	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

7.	CD	O	O
ascorbic	JJ	B-TREATMENT	B-TREATMENT
acid	RB	I-TREATMENT	I-TREATMENT
500	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
:	:	O	O
take	VB	O	O
for	IN	O	O
one	CD	O	O
month	NN	O	O
then	RB	O	O
stop	VB	O	O
.	.	O	O

8.	CD	O	O
furosemide	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
for	IN	O	O
5	CD	O	O
days	NNS	O	O
.	.	O	O

pfo	NN	B-PROBLEM	O

tia	NN	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
nodule	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
followed	VBN	O	O
by	IN	O	O
dr.	NN	O	O
belt	NN	O	O
)	)	O	O
s/p	VBZ	O	O
fissurectomy/skull	JJ	B-PROBLEM	B-PROBLEM
fx	NN	I-PROBLEM	I-PROBLEM

1)	CD	O	O
shower	NN	O	O
,	,	O	O
wash	JJ	O	B-PROBLEM
incisions	NNS	B-PROBLEM	I-PROBLEM
with	IN	O	O
mild	JJ	O	B-PROBLEM
soap	NN	O	I-PROBLEM
and	CC	O	O
water	NN	O	O
and	CC	O	O
pat	NN	O	O
dry	NN	O	O
.	.	O	O

no	DT	O	O
lotions	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
creams	NNS	B-TREATMENT	B-TREATMENT
or	CC	O	O
powders	NNS	B-TREATMENT	B-TREATMENT
to	TO	O	O
incisions	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

2)	CD	O	O
call	NN	O	O
with	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
>101	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
redness	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
drainage	NN	B-PROBLEM	B-PROBLEM
from	IN	I-PROBLEM	I-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
weight	VBD	B-PROBLEM	B-PROBLEM
gain	NN	I-PROBLEM	I-PROBLEM
more	JJR	I-PROBLEM	O
than	IN	I-PROBLEM	O
2	CD	I-PROBLEM	O
pounds	NNS	I-PROBLEM	O
in	IN	O	O
one	CD	O	O
day	NN	O	O
or	CC	O	O
five	CD	O	O
pounds	NNS	O	O
in	IN	O	O
one	CD	O	O
week	NN	O	O
.	.	O	O

3)	CD	O	O
no	DT	O	O
driving	VBG	O	O
while	NN	O	O
on	IN	O	O
narcotics	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

4)	CD	O	O
take	NN	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
twice	RB	O	O
daily	RB	O	O
with	IN	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
five	CD	O	O
days	NNS	O	O
then	RB	O	O
stop	VB	O	O
.	.	O	O

5)	CD	O	O
take	NN	O	O
vitamin	NN	B-TREATMENT	B-TREATMENT
c	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
iron	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
one	CD	O	O
month	NN	O	O
then	RB	O	O
stop	VB	O	O
.	.	O	O

sternal	JJ	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

infected	VBN	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
graft	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

08/31/98	CD	O	O
ascending	VBG	B-TREATMENT	O
aortic	JJ	I-TREATMENT	B-TREATMENT
root	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
homograft	NN	B-TREATMENT	O
with	IN	O	O
omentopexy	NN	B-TREATMENT	O
.	.	O	O

09/02/98	CD	O	O
sternal	JJ	B-TREATMENT	B-TREATMENT
debridement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

bilateral	JJ	B-TREATMENT	B-PROBLEM
pectoralis	NN	I-TREATMENT	I-PROBLEM
major	JJ	I-TREATMENT	I-PROBLEM
myocutaneous	JJ	I-TREATMENT	I-PROBLEM
advancement	NN	I-TREATMENT	I-PROBLEM
flap	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

right	RB	B-TREATMENT	O
superiorly	RB	I-TREATMENT	O
based	VBN	I-TREATMENT	O
rectus	NN	I-TREATMENT	B-PROBLEM
abdominis	NN	I-TREATMENT	I-PROBLEM
flap	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

primary	JJ	B-TREATMENT	B-PROBLEM
closure	NN	I-TREATMENT	I-PROBLEM
of	IN	O	I-PROBLEM
wound	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
79	CD	O	O
year	NN	O	O
old	JJ	O	O
gentleman	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
ascending	VBG	I-TREATMENT	I-TREATMENT
aortic	JJ	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
1991	CD	O	O
for	IN	O	O
aortic	JJ	B-PROBLEM	B-PROBLEM
dissection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

at	IN	O	O
that	DT	O	O
time	NN	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
hospital	JJ	O	O
course	NN	O	O
was	VBD	O	O
complicated	VBN	O	O
by	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
sternal	JJ	I-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
requiring	VBG	O	O
a	DT	B-TREATMENT	B-TREATMENT
sternal	JJ	I-TREATMENT	I-TREATMENT
debridement	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
subsequent	JJ	B-TREATMENT	B-TREATMENT
abdominal	JJ	I-TREATMENT	I-TREATMENT
flap	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
then	RB	O	O
continued	VBN	O	O
by	IN	O	O
report	NN	O	O
on	IN	O	O
dicloxacillin	NN	B-TREATMENT	O
for	IN	O	O
approximately	RB	O	O
one	CD	O	O
year	NN	O	O
following	VBG	O	O
that	IN	B-TREATMENT	O
reconstructive	JJ	I-TREATMENT	B-TREATMENT
operation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
apparently	RB	O	O
did	VBD	O	O
well	RB	O	O
until	IN	O	O
june	NNS	O	O
1998	CD	O	O
when	WRB	O	O
he	PRP	O	O
noted	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
bulge	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
sternal	JJ	I-PROBLEM	I-PROBLEM
area	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-PROBLEM	B-PROBLEM
ruptured	JJ	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
pseudoaneurysm	NN	B-PROBLEM	B-PROBLEM
at	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
junction	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	B-TREATMENT	I-PROBLEM
graft	NN	I-TREATMENT	I-PROBLEM
and	CC	O	O
arch	NN	O	O
was	VBD	O	O
diagnosed	VBN	O	O
and	CC	O	O
this	DT	O	O
was	VBD	O	O
subsequently	RB	O	O
repaired	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
then	RB	O	O
had	VBD	O	O
recurrent	VBN	B-PROBLEM	B-PROBLEM
bleeding	VBG	I-PROBLEM	I-PROBLEM
two	CD	O	O
weeks	NNS	O	O
later	RB	O	O
which	WDT	O	O
was	VBD	O	O
once	RB	O	O
again	RB	O	O
repaired	VBN	O	O
.	.	O	O

however	RB	O	O
the	DT	B-PROBLEM	O
same	JJ	I-PROBLEM	O
problem	NN	I-PROBLEM	O
recurred	VBD	O	O
for	IN	O	O
a	DT	O	O
third	JJ	O	O
time	NN	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
computer	NN	I-TEST	I-TEST
tomogram	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
at	IN	O	O
an	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
showed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
hematoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

by	IN	O	O
report	NN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
told	VBD	O	O
that	IN	O	O
there	EX	O	O
was	VBD	O	O
no	DT	O	O
more	JJR	O	O
that	DT	O	O
could	MD	O	O
be	VB	O	O
done	VBN	O	O
for	IN	O	O
him	PRP	O	O
and	CC	O	O
was	VBD	O	O
then	RB	O	O
apparently	RB	O	O
placed	VBN	O	O
on	IN	O	O
comfort	NN	B-TREATMENT	B-TREATMENT
measures	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
pain	VB	B-TREATMENT	B-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
the	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
.	.	O	O

however	RB	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
then	RB	O	O
subsequently	RB	O	O
transferred	VBN	O	O
to	TO	O	O
fairm	VB	O	O
of	IN	O	O
ijordcompmac	JJ	O	O
hospital	NN	O	O
upon	IN	O	O
request	NN	O	O
of	IN	O	O
the	DT	O	O
family	NN	O	O
on	IN	O	O
8/24/98	CD	O	O
for	IN	O	O
further	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
and	CC	O	O
possible	JJ	O	O
intervention	NN	B-TREATMENT	O
.	.	O	O

as	IN	O	O
the	DT	B-TEST	O
patient	NN	I-TEST	O
's	POS	I-TEST	O
early	JJ	I-TEST	O
evaluation	NN	I-TEST	O
the	DT	O	O
patient	NN	O	O
underwent	VBD	O	O
an	DT	B-TEST	B-TEST
aortogram	NN	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
an	DT	B-TREATMENT	B-PROBLEM
ascending	VBG	I-TREATMENT	I-PROBLEM
aortic	JJ	I-TREATMENT	I-PROBLEM
graft	NN	I-TREATMENT	I-PROBLEM
with	IN	O	O
bulging	VBG	B-PROBLEM	B-PROBLEM
flaps	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-TREATMENT
pseudoaneurysm	NN	I-PROBLEM	I-TREATMENT
at	IN	O	I-TREATMENT
the	DT	O	I-TREATMENT
anastomosis	NN	O	I-TREATMENT
of	IN	O	I-TREATMENT
the	DT	B-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
arch	NN	O	O
just	RB	O	O
below	IN	O	O
the	DT	O	O
great	JJ	O	O
vessels	NNS	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
evidence	NN	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
definite	JJ	I-PROBLEM	I-PROBLEM
leak	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
there	EX	O	O
was	VBD	O	O
evidence	NN	O	O
for	IN	O	O
gas	NN	B-PROBLEM	B-PROBLEM
bubbles	NNS	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
anterior	JJ	O	I-PROBLEM
posterior	JJ	O	I-PROBLEM
distal	JJ	O	I-PROBLEM
ends	NNS	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	B-TREATMENT	I-PROBLEM
grafts	NNS	I-TREATMENT	I-PROBLEM
consistent	NN	O	O
with	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
infectious	JJ	I-PROBLEM	I-PROBLEM
process	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

at	IN	O	O
the	DT	O	O
same	JJ	O	O
time	NN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
seen	VBN	O	O
in	IN	O	O
consultation	NN	O	O
by	IN	O	O
the	DT	O	O
infectious	JJ	O	O
disease	NN	O	O
service	NN	O	O
who	WP	O	O
upon	IN	O	O
culturing	VBG	O	O
the	DT	B-PROBLEM	B-TREATMENT
patient	NN	I-PROBLEM	I-TREATMENT
's	POS	I-PROBLEM	I-TREATMENT
sternal	JJ	I-PROBLEM	I-TREATMENT
drainage	NN	I-PROBLEM	I-TREATMENT
switched	VBD	O	O
the	DT	O	O
patient	NN	O	O
from	IN	O	O
intravenous	JJ	B-TREATMENT	O
unasyn	NNS	I-TREATMENT	O
to	TO	O	O
levofloxacin	VB	B-TREATMENT	B-TREATMENT
for	IN	O	O
what	WP	O	O
appeared	VBD	O	O
to	TO	O	O
be	VB	O	O
citrobacter	NN	B-PROBLEM	B-PROBLEM
and	CC	O	I-PROBLEM
diphtheroids	NNS	B-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	B-TEST	I-PROBLEM
wound	NN	I-TEST	I-PROBLEM
cultures	NNS	I-TEST	I-PROBLEM
.	.	O	O

subsequent	NN	O	O
to	TO	O	O
starting	VBG	O	O
this	DT	B-TREATMENT	B-TREATMENT
antibiotic	JJ	I-TREATMENT	I-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
the	DT	B-PROBLEM	I-TREATMENT
patient	NN	I-PROBLEM	I-TREATMENT
's	POS	I-PROBLEM	I-TREATMENT
wound	JJ	I-PROBLEM	I-TREATMENT
drainage	NN	I-PROBLEM	I-TREATMENT
appeared	VBD	O	O
to	TO	O	O
subside	VB	O	O
.	.	O	O

given	VBN	O	O
all	PDT	O	O
the	DT	O	O
findings	NNS	O	O
on	IN	O	O
the	DT	B-TEST	O
aortogram	NN	I-TEST	O
and	CC	O	O
the	DT	B-TEST	B-TEST
subsequent	JJ	I-TEST	I-TEST
chest	NN	I-TEST	I-TEST
computer	NN	I-TEST	I-TEST
tomogram	NN	I-TEST	I-TEST
scan	VBD	I-TEST	I-TEST
it	PRP	O	O
was	VBD	O	O
discovered	VBN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
only	JJ	O	O
real	JJ	O	B-TREATMENT
surgical	JJ	O	I-TREATMENT
option	NN	O	I-TREATMENT
for	IN	O	O
cure	NN	O	B-TREATMENT
was	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
risky	JJ	I-TREATMENT	I-TREATMENT
operation	NN	I-TREATMENT	I-TREATMENT
that	WDT	O	O
involved	VBD	O	O
removal	NN	B-TREATMENT	B-TREATMENT
and	CC	I-TREATMENT	O
replacement	NN	I-TREATMENT	B-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
aortic	JJ	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
probably	RB	O	O
with	IN	O	O
homograft	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
long	JJ	B-TREATMENT	B-TREATMENT
term	NN	I-TREATMENT	I-TREATMENT
antibiotic	JJ	I-TREATMENT	I-TREATMENT
coverage	NN	I-TREATMENT	I-TREATMENT
as	RB	O	O
well	RB	O	O
as	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
plastic	JJ	I-TREATMENT	I-TREATMENT
surgical	JJ	I-TREATMENT	I-TREATMENT
reconstructive	JJ	I-TREATMENT	I-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
understood	VBD	O	O
the	DT	O	O
risks	NNS	O	O
and	CC	O	O
potential	JJ	O	O
benefits	NNS	O	O
of	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
was	VBD	O	O
willing	JJ	O	O
to	TO	O	O
proceed	VB	O	O
.	.	O	O

the	DT	O	O
patient	JJ	O	O
otherwise	NN	O	O
complained	VBD	O	O
of	IN	O	O
no	DT	O	O
angina	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
paroxysmal	JJ	B-PROBLEM	B-PROBLEM
nocturnal	JJ	I-PROBLEM	I-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
palpitations	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
symptoms	NNS	O	B-PROBLEM
of	IN	O	O
syncope	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
did	VBD	O	O
report	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
20	CD	I-PROBLEM	I-PROBLEM
lbs	JJ	I-PROBLEM	I-PROBLEM
weight	JJ	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
over	IN	O	O
the	DT	O	O
last	JJ	O	O
several	JJ	O	O
months	NNS	O	O
.	.	O	O

1.	CD	O	O
thoracic	JJ	B-TREATMENT	B-PROBLEM
aneurysm	RB	I-TREATMENT	I-PROBLEM
repair	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

2.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

3.	CD	O	O
status	NN	O	B-TREATMENT
post	NN	O	I-TREATMENT
hernia	NN	B-TREATMENT	I-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

1.	CD	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
po	NN	O	O
three	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

2.	CD	O	O
captopril	NN	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
po	NN	O	O
three	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

3.	CD	O	O
prilosec	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
po	NN	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

4.	CD	O	O
hydralazine	NN	B-TREATMENT	B-TREATMENT
12.5	CD	O	O
mg	NN	O	O
four	CD	O	O
times	NNS	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

5.	CD	O	O
reglan	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
po	NN	O	O
three	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
,	,	O	O
vital	JJ	B-TEST	B-TEST
signs	NNS	I-TEST	I-TEST
were	VBD	O	O
stable	JJ	O	O
.	.	O	O

head	NN	B-TEST	B-TEST
,	,	I-TEST	I-TEST
eyes	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
ears	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
nose	RB	I-TEST	I-TEST
and	CC	I-TEST	I-TEST
throat	JJ	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
:	:	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
jugular	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
distention	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2+	CD	B-TEST	O
carotids	NNS	I-TEST	O
without	IN	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

cardiovascular	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
:	:	O	O

regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
2/6	CD	I-PROBLEM	I-PROBLEM
diastolic	JJ	I-PROBLEM	I-PROBLEM
___	NN	O	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
1/6	CD	I-PROBLEM	I-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
ejection	NN	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	O	O
lungs	NNS	O	O
were	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	O	O
without	IN	O	O
any	DT	O	O
evidence	NN	O	O
for	IN	O	O
crackles	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
2+	CD	B-TEST	O
femoral	JJ	I-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
and	CC	O	O
1+	CD	B-TEST	O
pedal	NN	I-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
.	.	O	O

sodium	NN	B-TEST	B-TEST
137	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.0	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
urea	JJ	I-TEST	I-TEST
nitrogen	NN	I-TEST	I-TEST
16	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
.9	NN	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
4.9	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
29.7	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
207	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
preoperative	JJ	I-TEST	I-TEST
chest	NN	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
showed	VBD	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
effusions	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
bibasilar	JJ	B-PROBLEM	B-PROBLEM
atelectasis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
sternal	JJ	I-PROBLEM	I-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
had	VBD	O	O
a	DT	O	B-PROBLEM
superior	JJ	O	I-PROBLEM
edge	NN	O	I-PROBLEM
that	WDT	O	O
was	VBD	O	O
dehisced	VBN	B-PROBLEM	O
with	IN	O	O
evidence	NN	O	O
for	IN	O	O
stay	NN	B-TREATMENT	B-TREATMENT
sutures	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
some	DT	O	B-TREATMENT
superficial	JJ	B-TREATMENT	I-TREATMENT
closure	NN	I-TREATMENT	I-TREATMENT
sutures	NNS	I-TREATMENT	I-TREATMENT
exposed	VBN	O	O
.	.	O	O

over	IN	O	O
the	DT	O	O
next	JJ	O	O
several	JJ	O	O
hospital	NN	O	O
days	NNS	O	O
the	DT	O	O
patient	JJ	O	O
underwent	JJ	O	O
aortogram	NN	B-TEST	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
chest	NN	B-TEST	B-TEST
computer	NN	I-TEST	I-TEST
tomogram	NN	I-TEST	I-TEST
as	IN	O	O
outlined	VBN	O	O
earlier	RBR	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
also	RB	O	O
seen	VBN	O	O
in	IN	O	O
consultation	NN	O	O
by	IN	O	O
the	DT	O	O
infectious	JJ	O	O
disease	NN	O	O
service	NN	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
the	DT	O	O
cardiology	NN	O	O
service	NN	O	O
who	WP	O	O
assisted	VBD	O	O
in	IN	O	O
managing	VBG	O	O
the	DT	B-PROBLEM	O
patient	NN	I-PROBLEM	O
's	POS	I-PROBLEM	O
intermittent	JJ	I-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
also	RB	O	O
seen	VBN	O	O
preoperatively	RB	O	O
in	IN	O	O
consultation	NN	O	O
by	IN	O	O
the	DT	O	O
plastic	JJ	O	O
surgical	JJ	O	O
service	NN	O	O
for	IN	O	O
potential	JJ	B-TREATMENT	B-TREATMENT
sternal	JJ	I-TREATMENT	I-TREATMENT
reconstruction	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

after	IN	O	O
lengthy	JJ	O	B-PROBLEM
discussions	NNS	O	I-PROBLEM
with	IN	O	O
the	DT	O	O
patient	NN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
family	NN	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
the	DT	O	O
various	JJ	O	O
consultant	NN	O	O
services	NNS	O	O
it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
a	DT	O	O
viable	JJ	O	O
candidate	NN	O	O
for	IN	O	O
aortic	JJ	B-TREATMENT	B-TREATMENT
root	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
using	VBG	O	O
homograft	NN	B-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
then	RB	O	O
subsequently	RB	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
on	IN	O	O
08/31/98	CD	O	O
with	IN	O	O
the	DT	O	O
preoperative	JJ	O	O
diagnosis	NN	O	O
of	IN	O	O
ascending	VBG	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
graft	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
performed	VBD	O	O
was	VBD	O	O
homograft	JJ	B-TREATMENT	B-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	O
the	DT	I-TREATMENT	O
ascending	VBG	I-TREATMENT	O
aorta	NN	I-TREATMENT	O
with	IN	O	O
omentopexy	NN	B-TREATMENT	O
and	CC	O	O
an	DT	B-PROBLEM	B-TREATMENT
open	JJ	I-PROBLEM	I-TREATMENT
chest	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
used	VBN	O	O
was	VBD	O	O
a	DT	B-TREATMENT	O
homograft	NN	I-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
fairly	RB	O	O
well	RB	O	O
and	CC	O	O
was	VBD	O	O
transferred	VBN	O	O
intubated	VBN	B-TREATMENT	O
to	TO	O	O
the	DT	O	O
cardiac	JJ	O	O
surgical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
with	IN	O	O
his	PRP$	B-PROBLEM	B-TREATMENT
chest	NN	I-PROBLEM	I-TREATMENT
open	JJ	I-PROBLEM	I-TREATMENT
.	.	O	O

the	DT	O	O
immediate	JJ	O	O
postoperative	JJ	O	O
plans	NNS	O	O
were	VBD	O	O
for	IN	O	O
a	DT	O	O
short	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
stay	NN	O	O
and	CC	O	O
subsequent	JJ	B-TREATMENT	B-TREATMENT
plastic	NN	I-TREATMENT	I-TREATMENT
surgical	JJ	I-TREATMENT	I-TREATMENT
reconstruction	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
patient	NN	I-TREATMENT	I-TREATMENT
's	POS	I-TREATMENT	I-TREATMENT
sternum	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

of	IN	O	O
note	NN	O	O
,	,	O	O
intraoperatively	RB	B-TEST	B-TEST
multiple	JJ	I-TEST	I-TEST
tissue	NN	I-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
had	VBD	O	O
been	VBN	O	O
sent	VBN	O	O
.	.	O	O

in	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
kept	VBN	O	O
intubated	JJ	B-TREATMENT	B-TREATMENT
and	CC	O	O
sedated	VBD	B-TREATMENT	B-TREATMENT
until	IN	O	O
09/02/98	CD	O	O
which	WDT	O	O
was	VBD	O	O
postoperative	JJ	O	O
day	NN	O	O
no.	IN	O	O
1	CD	O	O
following	VBG	O	O
the	DT	B-TREATMENT	B-TREATMENT
homograft	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
that	DT	O	O
day	NN	O	O
the	DT	O	O
plastic	JJ	O	O
surgical	JJ	O	O
service	NN	O	O
performed	VBD	O	O
further	JJ	B-TREATMENT	B-TREATMENT
sternal	JJ	I-TREATMENT	I-TREATMENT
debridement	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
subsequent	JJ	B-TREATMENT	B-TREATMENT
reconstruction	NN	I-TREATMENT	I-TREATMENT
using	VBG	O	O
bilateral	JJ	B-TREATMENT	B-PROBLEM
pectoralis	NNS	I-TREATMENT	I-PROBLEM
major	JJ	I-TREATMENT	I-PROBLEM
myocutaneous	JJ	I-TREATMENT	I-PROBLEM
advancement	NN	I-TREATMENT	I-PROBLEM
flaps	NNS	I-TREATMENT	I-PROBLEM
and	CC	O	I-PROBLEM
right	JJ	B-TREATMENT	I-PROBLEM
superiorly	RB	I-TREATMENT	I-PROBLEM
rectus	VBP	I-TREATMENT	I-PROBLEM
abdominis	RB	I-TREATMENT	I-PROBLEM
flap	JJ	I-TREATMENT	I-PROBLEM
to	TO	O	I-PROBLEM
cover	VB	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
sternal	JJ	I-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
subsequent	JJ	B-TREATMENT	O
primary	JJ	I-TREATMENT	O
closure	NN	I-TREATMENT	O
of	IN	O	O
that	DT	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
and	CC	O	O
there	EX	O	O
were	VBD	O	O
no	DT	O	O
complications	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

a	DT	O	O
number	NN	O	O
of	IN	O	O
indwelling	VBG	B-TREATMENT	B-TREATMENT
closed	JJ	I-TREATMENT	I-TREATMENT
suction	NN	I-TREATMENT	I-TREATMENT
drains	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
left	VBN	O	O
in	IN	O	O
place	NN	O	O
so	RB	O	O
as	IN	O	O
to	TO	O	O
drain	VB	O	O
the	DT	O	O
bed	NN	O	O
underneath	IN	O	O
the	DT	O	O
muscle	NN	O	O
flaps	NNS	O	O
.	.	O	O

at	IN	O	O
this	DT	O	O
point	NN	O	O
the	DT	O	O
patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
followed	VBN	O	O
by	IN	O	O
infectious	JJ	O	O
disease	NN	O	O
service	NN	O	O
and	CC	O	O
continued	VBD	O	O
to	TO	O	O
be	VB	O	O
on	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
which	WDT	O	O
included	VBD	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	B-TEST	O
operating	NN	I-TEST	O
room	NN	I-TEST	O
cultures	NNS	I-TEST	O
at	IN	O	O
that	DT	O	O
point	NN	O	O
were	VBD	O	O
positive	JJ	O	O
for	IN	O	O
crinobactermium	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
sputum	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
being	VBG	O	O
sensitive	JJ	O	O
for	IN	O	O
yeast	NN	B-PROBLEM	B-TREATMENT
and	CC	O	O
gram	NN	B-PROBLEM	B-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
cocci	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
clusters	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

over	IN	O	O
the	DT	O	O
next	JJ	O	O
postoperative	JJ	O	O
day	NN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
awakened	VBN	O	O
and	CC	O	O
weaned	VBN	O	O
to	TO	O	O
extubate	VB	O	O
without	IN	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
difficulties	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
's	POS	O	O
subsequent	JJ	O	O
postoperative	JJ	O	O
course	NN	O	O
was	VBD	O	O
characterized	VBN	O	O
by	IN	O	O
persistent	JJ	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
required	VBD	O	O
a	DT	O	O
significant	JJ	O	O
amount	NN	O	O
of	IN	O	O
antihypertensives	NNS	B-TREATMENT	B-TREATMENT
including	VBG	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
po	NN	O	O
three	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
,	,	O	O
captopril	VBP	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
po	NN	O	O
three	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
procardia	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
otherwise	RB	O	O
continued	VBN	O	O
to	TO	O	O
do	VB	O	O
well	RB	O	O
and	CC	O	O
was	VBD	O	O
becoming	VBG	O	O
more	RB	O	O
oriented	VBN	O	O
as	IN	O	O
time	NN	O	O
went	VBD	O	O
on	IN	O	O
and	CC	O	O
as	IN	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
brought	VBN	O	O
under	IN	O	O
control	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
be	VB	O	O
followed	VBN	O	O
by	IN	O	O
the	DT	O	O
infectious	JJ	O	O
disease	NN	O	O
service	NN	O	O
who	WP	O	O
felt	VBD	O	O
that	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
patient	NN	I-TREATMENT	I-TREATMENT
's	POS	I-TREATMENT	I-TREATMENT
jackson	NN	I-TREATMENT	I-TREATMENT
pratt	NN	I-TREATMENT	I-TREATMENT
drains	VBZ	I-TREATMENT	I-TREATMENT
needed	VBN	O	O
to	TO	O	O
stay	VB	O	O
in	IN	O	O
as	IN	O	O
there	EX	O	O
was	VBD	O	O
still	RB	O	O
some	DT	B-PROBLEM	O
significant	JJ	I-PROBLEM	O
drainage	NN	I-PROBLEM	O
from	IN	O	O
them	PRP	O	O
.	.	O	O

as	IN	O	O
per	IN	O	O
the	DT	O	O
infectious	JJ	O	O
disease	NN	O	O
service	NN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
as	IN	O	O
antibiotic	JJ	B-TREATMENT	B-TREATMENT
coverage	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

however	RB	O	O
on	IN	O	O
09/08/98	CD	O	O
the	DT	O	O
infectious	JJ	O	O
disease	NN	O	O
service	NN	O	O
was	VBD	O	O
made	VBN	O	O
aware	JJ	O	O
that	IN	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
intraoperative	JJ	I-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
had	VBD	O	O
also	RB	O	O
grown	VBN	O	O
out	RP	O	O
mycoplasma	JJ	B-PROBLEM	B-PROBLEM
humilius	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

given	VBN	O	O
this	DT	O	O
finding	VBG	O	O
it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
would	MD	O	O
certainly	RB	O	O
need	VB	O	O
long	JJ	B-TREATMENT	B-TREATMENT
term	NN	I-TREATMENT	I-TREATMENT
intravenous	JJ	I-TREATMENT	I-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
to	TO	O	O
include	VB	O	O
at	IN	O	O
least	JJS	O	O
six	CD	O	O
weeks	NNS	O	O
of	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
then	RB	O	O
subsequent	JJ	B-TREATMENT	O
levofloxacin	NN	I-TREATMENT	B-TREATMENT
for	IN	O	O
the	DT	B-PROBLEM	O
citrobacter	NN	I-PROBLEM	O
and	CC	O	O
mycoplasma	NN	B-PROBLEM	B-PROBLEM
as	RB	O	O
well	RB	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
scheduled	VBN	O	O
for	IN	O	O
peripherally	RB	B-TREATMENT	B-TREATMENT
inserted	JJ	I-TREATMENT	I-TREATMENT
central	JJ	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
knowing	NN	O	O
that	IN	O	O
he	PRP	O	O
was	VBD	O	O
going	VBG	O	O
to	TO	O	O
need	VB	O	O
long	JJ	B-TREATMENT	B-TREATMENT
term	NN	I-TREATMENT	I-TREATMENT
intravenous	JJ	I-TREATMENT	I-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

this	DT	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
no.	NN	O	O
9	CD	O	O
without	IN	O	O
any	DT	B-PROBLEM	O
difficulty	NN	I-PROBLEM	O
.	.	O	O

at	IN	O	O
the	DT	O	O
same	JJ	O	O
time	NN	O	O
the	DT	O	O
patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
be	VB	O	O
stable	JJ	O	O
on	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
antihypertensive	JJ	I-TREATMENT	I-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
becoming	VBG	O	O
more	JJR	O	O
mobile	JJ	O	O
and	CC	O	O
was	VBD	O	O
taking	VBG	O	O
a	DT	B-TREATMENT	B-TREATMENT
high	JJ	I-TREATMENT	I-TREATMENT
protein	NN	I-TREATMENT	I-TREATMENT
high	JJ	I-TREATMENT	I-TREATMENT
calories	NNS	I-TREATMENT	I-TREATMENT
diet	VBP	I-TREATMENT	I-TREATMENT
which	WDT	O	O
he	PRP	O	O
tolerated	VBD	O	O
well	RB	O	O
.	.	O	O

he	PRP	O	O
continued	VBD	O	O
to	TO	O	O
be	VB	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
otherwise	RB	O	O
very	RB	O	O
stable	JJ	O	O
.	.	O	O

subsequent	JJ	B-TEST	O
hand	NN	I-TEST	O
x-rays	NNS	I-TEST	O
obtained	VBD	O	O
showed	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
fracture	NN	B-PROBLEM	B-PROBLEM
but	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
seen	VBN	O	O
in	IN	O	O
consultation	NN	O	O
by	IN	O	O
the	DT	O	O
plastic	NN	O	O
surgery	NN	O	O
hand	NN	O	O
service	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
benefit	VB	O	O
from	IN	O	O
splinting	VBG	B-TREATMENT	O
of	IN	I-TREATMENT	O
his	PRP$	I-TREATMENT	B-PROBLEM
finger	NN	I-TREATMENT	I-PROBLEM
while	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
swelling	VBG	I-PROBLEM	I-PROBLEM
subsided	VBD	O	I-PROBLEM
and	CC	O	O
subsequent	JJ	B-TREATMENT	O
early	JJ	I-TREATMENT	O
mobilization	NN	I-TREATMENT	O
to	TO	O	O
prevent	VB	O	O
any	DT	B-PROBLEM	B-PROBLEM
rigidity	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
that	DT	I-PROBLEM	O
joint	JJ	I-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
also	RB	O	O
seen	VBN	O	O
subsequently	RB	O	O
in	IN	O	O
consultation	NN	O	O
by	IN	O	O
the	DT	O	O
plastic	JJ	O	O
surgical	JJ	O	O
service	NN	O	O
who	WP	O	O
discontinued	VBD	O	O
a	DT	O	O
number	NN	O	O
of	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
patient	NN	I-TREATMENT	I-TREATMENT
's	POS	I-TREATMENT	I-TREATMENT
indwelling	NN	I-TREATMENT	I-TREATMENT
drains	NNS	I-TREATMENT	I-TREATMENT
but	CC	O	O
they	PRP	O	O
felt	VBD	O	O
that	IN	O	O
others	NNS	O	O
needed	VBN	O	O
to	TO	O	O
stay	VB	O	O
while	IN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
sent	VBN	O	O
to	TO	O	O
rehabilitation	NN	O	B-TREATMENT
.	.	O	O

these	DT	B-TREATMENT	B-TREATMENT
drains	NNS	I-TREATMENT	I-TREATMENT
will	MD	O	O
then	RB	O	O
be	VB	O	O
subsequently	RB	O	O
taken	VBN	O	O
out	RP	O	O
by	IN	O	O
dr.	JJ	O	O
general	JJ	O	O
upon	IN	O	O
his	PRP$	O	O
followup	NN	O	O
with	IN	O	O
the	DT	O	O
patient	NN	O	O
.	.	O	O

prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
the	DT	O	O
patient	NN	O	O
also	RB	O	O
underwent	VBD	O	O
an	DT	B-TEST	B-TEST
audiogram	NN	I-TEST	I-TEST
as	IN	O	O
a	DT	B-TEST	B-TEST
baseline	NN	I-TEST	I-TEST
hearing	VBG	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
while	IN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
to	TO	O	O
stay	VB	O	O
on	IN	O	O
long	JJ	B-TREATMENT	B-TREATMENT
term	NN	I-TREATMENT	I-TREATMENT
intravenous	JJ	I-TREATMENT	I-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

as	IN	O	O
a	DT	O	O
matter	NN	O	O
of	IN	O	O
fact	NN	O	O
the	DT	O	O
patient	NN	O	O
made	VBD	O	O
remarkable	JJ	O	O
progress	NN	O	O
given	VBN	O	O
the	DT	O	B-PROBLEM
severity	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
his	PRP$	B-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
condition	NN	I-PROBLEM	I-PROBLEM
prior	RB	O	O
to	TO	O	O
the	DT	B-TREATMENT	O
operation	NN	I-TREATMENT	O
.	.	O	O

in	IN	O	O
consultation	NN	O	O
with	IN	O	O
the	DT	O	O
infectious	JJ	O	O
disease	NN	O	O
service	NN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
to	TO	O	O
stay	VB	O	O
on	IN	O	O
long	JJ	B-TREATMENT	B-TREATMENT
term	NN	I-TREATMENT	I-TREATMENT
intravenous	JJ	I-TREATMENT	I-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

high	JJ	B-TREATMENT	B-PROBLEM
calorie	NN	I-TREATMENT	I-PROBLEM
,	,	I-TREATMENT	O
high	JJ	I-TREATMENT	B-PROBLEM
protein	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
patient	NN	I-TREATMENT	I-TREATMENT
's	POS	I-TREATMENT	I-TREATMENT
treatment	NN	I-TREATMENT	I-TREATMENT
will	MD	O	O
include	VB	O	O
typical	JJ	B-TREATMENT	O
peripherally	RB	I-TREATMENT	O
inserted	JJ	I-TREATMENT	B-TREATMENT
central	JJ	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
frequent	JJ	B-TEST	B-TEST
wound	NN	I-TEST	I-TEST
checks	NNS	I-TEST	I-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
was	VBD	O	O
fitted	VBN	O	O
with	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
orthoplast	JJ	I-TREATMENT	I-TREATMENT
finger	NN	I-TREATMENT	I-TREATMENT
splint	NN	I-TREATMENT	I-TREATMENT
as	IN	O	O
manufactured	VBN	O	O
by	IN	O	O
occupational	JJ	O	O
therapy	NN	O	O
services	NNS	O	O
fairm	NN	O	O
of	IN	O	O
ijordcompmac	JJ	O	O
hospital	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
also	RB	O	O
instructed	VBN	O	O
in	IN	O	O
range	NN	B-TREATMENT	O
of	IN	I-TREATMENT	O
motion	NN	I-TREATMENT	B-TREATMENT
exercises	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
the	DT	O	B-PROBLEM
left	NN	O	I-PROBLEM
middle	JJ	O	I-PROBLEM
finger	NN	O	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
on	IN	O	O
discharge	NN	O	O
is	VBZ	O	O
to	TO	O	O
have	VB	O	O
twice	RB	O	O
weekly	JJ	O	O
vancomycin	NN	B-TEST	B-TEST
peak	NN	I-TEST	I-TEST
and	CC	I-TEST	I-TEST
trough	NN	I-TEST	I-TEST
levels	NNS	I-TEST	I-TEST
while	IN	O	O
he	PRP	O	O
continues	VBZ	O	O
on	IN	O	O
long	JJ	B-TREATMENT	B-TREATMENT
term	NN	I-TREATMENT	I-TREATMENT
vancomycin	NN	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
instructed	VBN	O	O
to	TO	O	O
return	VB	O	O
to	TO	O	O
fairm	VB	O	O
of	IN	O	O
ijordcompmac	JJ	O	O
hospital	NN	O	O
if	IN	O	O
he	PRP	O	O
developed	VBD	O	O
any	DT	O	B-PROBLEM
signs	NNS	O	I-PROBLEM
of	IN	O	I-PROBLEM
wound	JJ	B-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
such	PDT	O	I-PROBLEM
a	DT	B-PROBLEM	I-PROBLEM
erythema	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
drainage	NN	B-PROBLEM	B-TREATMENT
,	,	O	O
or	CC	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
incisional	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
instructed	VBN	O	O
to	TO	O	O
be	VB	O	O
vigilant	JJ	O	O
for	IN	O	O
any	DT	B-PROBLEM	O
fevers	NNS	I-PROBLEM	B-PROBLEM
or	CC	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

1.	CD	O	O
vancomycin	JJ	B-TREATMENT	B-TREATMENT
750	CD	O	O
mg	RB	O	O
intravenous	JJ	O	O
q	NNS	O	O
18h.	CD	O	O

2.	CD	O	O
levofloxacin	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
po	NN	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

3.	CD	O	O
prilosec	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
po	NN	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

4.	CD	O	O
captopril	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
po	NN	O	O
three	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

5.	CD	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
po	NN	O	O
three	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

6.	CD	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
nebulizers	NNS	I-TREATMENT	I-TREATMENT
q6h	VBP	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

7.	CD	O	O
atrovent	JJ	B-TREATMENT	B-TREATMENT
nebulizers	NNS	I-TREATMENT	I-TREATMENT
q6h	VBP	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

8.	CD	O	O
lasix	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
po	NN	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

9.	CD	O	O
kay-ciel	JJ	B-TREATMENT	O
20	CD	O	O
meq	NN	O	O
po	NN	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
also	RB	O	O
instructed	VBN	O	O
to	TO	O	O
followup	VB	O	O
with	IN	O	O
dr.	JJ	O	O
both	DT	O	O
of	IN	O	O
the	DT	O	O
cardiology	NN	O	O
service	NN	O	O
fairm	NN	O	O
of	IN	O	O
ijordcompmac	JJ	O	O
hospital	NN	O	O
following	VBG	O	O
his	PRP$	O	O
discharge	NN	O	O
so	IN	O	O
that	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
antihypertension	NN	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
could	MD	O	O
be	VB	O	O
appropriately	RB	O	O
adjusted	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
also	RB	O	O
be	VB	O	O
seen	VBN	O	O
in	IN	O	O
followup	NN	O	O
by	IN	O	O
dr.	NN	O	O
chpo	NN	O	O
e.	NN	O	O
enla	VBZ	O	O
general	JJ	O	O
of	IN	O	O
the	DT	O	O
plastic	NN	O	O
surgery	NN	O	O
service	NN	O	O
fairm	NN	O	O
of	IN	O	O
ijordcompmac	JJ	O	O
hospital	NN	O	O
so	IN	O	O
that	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
indwelling	VBG	I-TREATMENT	I-TREATMENT
jackson	NN	I-TREATMENT	I-TREATMENT
pratt	NN	I-TREATMENT	I-TREATMENT
drains	VBZ	I-TREATMENT	I-TREATMENT
be	VB	O	I-TREATMENT
appropriately	JJ	O	I-TREATMENT
management	NN	O	I-TREATMENT
and	CC	O	O
if	IN	O	O
needed	VBN	O	O
be	VB	O	O
discontinued	VBN	O	O
by	IN	O	O
him	PRP	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
also	RB	O	O
be	VB	O	O
followed	VBN	O	O
by	IN	O	O
the	DT	O	O
infectious	JJ	O	O
disease	NN	O	O
service	NN	O	O
so	RB	O	O
as	IN	O	O
to	TO	O	O
ascertain	VB	O	O
the	DT	O	O
exact	JJ	O	O
length	NN	O	O
and	CC	O	O
course	NN	O	O
of	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
antibiotic	JJ	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

dr.	NN	O	O
dau	NN	O	O
's	POS	O	O
recommendation	NN	O	O
is	VBZ	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
to	TO	O	O
stay	VB	O	O
on	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
approximately	RB	O	O
six	CD	O	O
weeks	NNS	O	O
following	VBG	O	O
discharge	NN	O	O
and	CC	O	O
then	RB	O	O
subsequently	RB	O	O
on	IN	O	O
antibiotic	JJ	B-TREATMENT	B-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
chronic	JJ	B-TREATMENT	B-PROBLEM
suppression	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

medicine	NN	B-TREATMENT	B-TREATMENT

zosyn	NN	B-TREATMENT	B-TREATMENT

transfer	NN	O	O
from	IN	O	O
tewksbury	NN	O	O
state	NN	O	O
hospital	NN	O	O
hospital	NN	O	O
cmed	VBD	O	O
ccu	NN	O	O
for	IN	O	O
neurologic	JJ	B-PROBLEM	B-PROBLEM
compromise	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
at	IN	O	O
request	NN	O	O
of	IN	O	O
family	NN	O	O
for	IN	O	O
second	JJ	O	O
opinion	NN	O	O
.	.	O	O

30-year-old	JJ	O	O
woman	NN	O	O
with	IN	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
squamous	JJ	I-PROBLEM	I-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
unknown	JJ	O	O
primary	NN	O	O
.	.	O	O

at	IN	O	O
chelseawomens	NNS	O	O
'	POS	O	O
,	,	O	O
about	IN	O	O
04-25	NN	O	O
,	,	O	O
she	PRP	O	O
developed	VBD	O	O
pseudomonal	JJ	B-PROBLEM	B-PROBLEM
urosepsis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
vaginal	JJ	B-PROBLEM	I-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
from	IN	O	I-PROBLEM
tumor	NN	B-PROBLEM	I-PROBLEM
extension/anti-coagulation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	O	O
course	NN	O	O
was	VBD	O	O
complicated	VBN	O	O
by	IN	O	O
post-hypotensive	JJ	B-PROBLEM	B-PROBLEM
coma	NN	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
subarachnoid	JJ	B-PROBLEM	B-PROBLEM
hemorrhages	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
intraparenchymal	JJ	B-PROBLEM	B-PROBLEM
bleeds	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
transferred	VBD	O	O
from	IN	O	O
women	NNS	O	O
and	CC	O	O
infants	NNS	O	O
hospital	NN	O	O
to	TO	O	O
ri	VB	O	O
hospital	JJ	O	O
2016-04-25	JJ	O	O
with	IN	O	O
weaknes	NNS	B-PROBLEM	B-TREATMENT
,	,	O	O
vag	NN	B-PROBLEM	B-PROBLEM
bleeding	VBG	I-PROBLEM	I-PROBLEM
x	JJ	O	O
several	JJ	O	O
days	NNS	O	O
,	,	O	O
fever	RB	B-PROBLEM	B-PROBLEM
102.5	CD	O	I-PROBLEM
,	,	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypoxic	VBZ	B-PROBLEM	B-TEST
84%	CD	O	O
on	IN	O	O
4l	CD	B-TREATMENT	O
nc	NNS	I-TREATMENT	O
,	,	O	O
tachypnic	JJ	B-PROBLEM	O
to	TO	O	O
30	CD	O	O
,	,	O	O
with	IN	O	O
labs	JJ	B-TEST	O
significant	JJ	O	O
for	IN	O	O
lactate	JJ	B-TEST	B-TEST
6.3	CD	O	O
,	,	O	O
wbc	NN	B-TEST	B-TEST
<1.0	NN	O	I-TEST
,	,	O	O
plt	NN	B-TEST	B-TEST
9	CD	O	O
,	,	O	O
hgb	NN	B-TEST	B-TEST
8.9	CD	O	O
,	,	O	O
and	CC	O	O
inr	RB	B-TEST	O
greater	JJR	O	O
than	IN	O	O
lab	JJR	O	O
threshold	NN	O	O
.	.	O	O

intubated	VBN	B-TREATMENT	B-TREATMENT
for	IN	O	O
airway	NN	B-TREATMENT	B-TREATMENT
protection	NN	I-TREATMENT	I-TREATMENT
(	(	O	O
abg	JJ	B-TEST	B-TEST
7.39/26.5/73.6	CD	O	O
)	)	O	O
and	CC	O	O
placed	VBN	O	O
on	IN	O	O
levophed	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

placed	VBN	O	O
on	IN	O	O
reynolds/vanc/fluc/gentamicin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
neutropenic	JJ	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
thrush	NN	B-PROBLEM	B-PROBLEM
initially	RB	O	O
.	.	O	O

ivc	JJ	B-TREATMENT	B-TREATMENT
filter	NN	I-TREATMENT	I-TREATMENT
placed	VBD	O	O
04-26	CD	O	O
.	.	O	O

ct	JJ	B-TEST	B-TEST
abdomen	NNS	I-TEST	I-TEST
consistent	JJ	O	O
with	IN	O	O
large	JJ	B-PROBLEM	B-PROBLEM
necrotic	JJ	I-PROBLEM	I-PROBLEM
pelvic	NN	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
-	:	O	O
not	RB	O	O
sampled	VBN	O	O
02-12	NN	O	B-PROBLEM
coagulopathy	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

04-27	JJ	O	O
results	NNS	O	O
from	IN	O	O
blood	NN	B-TEST	B-TEST
cx	NN	I-TEST	I-TEST
from	IN	O	O
w+i	NN	O	O
:	:	O	O

04-24	JJ	O	O
picc	NN	B-TEST	O
bld	NN	I-TEST	O
cx	NN	I-TEST	O
:	:	O	O
pseudomonas	NN	B-PROBLEM	B-PROBLEM
diaz	NN	O	I-PROBLEM
to	TO	O	O
zosyn	VB	B-TREATMENT	B-TREATMENT
,	,	O	O
cipro	VB	B-TREATMENT	B-TREATMENT
,	,	O	O
cefepime	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
tardugno	NN	O	B-PROBLEM
--	:	O	O
staph	JJ	B-PROBLEM	B-PROBLEM
epi-	JJ	I-PROBLEM	I-PROBLEM
gray	NN	O	I-PROBLEM
to	TO	O	O
vanc	VB	B-TREATMENT	O

04-24	JJ	O	O
peripheral	JJ	B-TEST	O
bld	NN	I-TEST	O
cx	NN	I-TEST	O
:	:	O	O
pseudomonas	NN	B-PROBLEM	B-PROBLEM
as	IN	O	O
above	IN	O	O

04-24	JJ	O	O
urine	JJ	B-TEST	B-TEST
cx	NN	I-TEST	I-TEST
:	:	O	O
pseudomonas	NN	B-PROBLEM	B-PROBLEM
as	IN	O	O
above	IN	O	O

abx	RB	B-TREATMENT	O
changed	VBN	O	O
to	TO	O	O
vanc	VB	B-TREATMENT	O
,	,	O	O
zosyn	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
cipro	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
fluc	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
azith	NN	B-TREATMENT	O
.	.	O	O

pressors	NNS	B-TREATMENT	B-TEST
weaned	VBD	O	O
off	RP	O	O
by	IN	O	O
04-27	NN	O	O
.	.	O	O

completed	VBN	O	O
7	CD	O	O
days	NNS	O	O
of	IN	O	O
vanc/fluc	NN	B-TREATMENT	O
,	,	O	O
13/14	CD	O	O
days	NNS	O	O
of	IN	O	O
cipro/zosyn	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

continued	VBN	O	O
to	TO	O	O
have	VB	O	O
recurrent	JJ	B-PROBLEM	B-PROBLEM
fevers	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

seen	VBN	O	O
by	IN	O	O
urology	NN	O	O
who	WP	O	O
did	VBD	O	O
not	RB	O	O
change	VB	O	O
stents	NNS	B-TREATMENT	B-TREATMENT
given	VBN	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
coagulopathy	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
function	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

found	VBN	O	O
to	TO	O	O
be	VB	O	O
in	IN	O	O
dic	JJ	B-PROBLEM	O
and	CC	O	O
supported	VBD	O	O
with	IN	O	O
daily	JJ	B-TREATMENT	O
blood	NN	I-TREATMENT	B-TREATMENT
products	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

seen	VBN	O	O
by	IN	O	O
heme	NN	O	O
and	CC	O	O
gcsf	NN	B-TREATMENT	O
started	VBD	O	O
.	.	O	O

despite	IN	O	O
aggressive	JJ	B-TREATMENT	B-PROBLEM
blood	NN	I-TREATMENT	I-PROBLEM
product	NN	I-TREATMENT	I-PROBLEM
repletion	NN	I-TREATMENT	I-PROBLEM
patient	JJ	O	O
poorly	RB	B-PROBLEM	O
responsive	JJ	I-PROBLEM	O
02-12	JJ	O	O
alloimmunization	NN	B-PROBLEM	O
.	.	O	O

plt	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
1	CD	O	O
on	IN	O	O
2016-04-29	JJ	O	O
.	.	O	O

supported	VBN	O	O
on	IN	O	O
tpn	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
nutrition	NN	O	O
then	RB	O	O
switched	VBD	O	O
to	TO	O	O
tube	VB	B-TREATMENT	B-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

developed	VBN	O	O
renal	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
cr	JJ	B-TEST	B-TEST
peak	NN	I-TEST	I-TEST
of	IN	O	O
2.9.	CD	O	O

seen	VBN	O	O
by	IN	O	O
renal	NN	O	O
who	WP	O	O
felt	VBD	O	O
was	VBD	O	O
c/w	JJ	O	O
atn	NN	B-PROBLEM	O
.	.	O	O

head	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
done	VBN	O	O
05-04	JJ	O	O
with	IN	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
sah	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
l	JJ	B-PROBLEM	I-PROBLEM
temporal	JJ	I-PROBLEM	I-PROBLEM
parenchymal	JJ	I-PROBLEM	I-PROBLEM
hematoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

also	RB	O	O
with	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
masses	NNS	I-PROBLEM	I-PROBLEM
consistent	JJ	O	O
with	IN	O	O
metastasis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

placed	VBN	O	O
on	IN	O	O
dilantin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

felt	RB	O	O
secondary	JJ	O	O
to	TO	O	O
low	JJ	B-PROBLEM	B-PROBLEM
platelets	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
no	DT	O	O
surgical	JJ	B-TREATMENT	B-TREATMENT
intervention	NN	I-TREATMENT	I-TREATMENT
indicated	VBD	O	O
.	.	O	O

then	RB	O	O
progressed	VBN	O	O
to	TO	O	O
withdrawal	VB	O	O
of	IN	O	O
care	NN	O	O
05-06	JJ	O	O
with	IN	O	O
plan	NN	O	O
to	TO	O	O
extubate	VB	B-TREATMENT	O
05-07	NN	O	O
.	.	O	O

however	RB	O	O
there	EX	O	O
was	VBD	O	O
dissent	NN	O	O
among	IN	O	O
neurologists	NNS	O	O
about	IN	O	O
patient	NN	O	O
's	POS	O	O
ability	NN	O	O
to	TO	O	O
recover	VB	O	O
from	IN	O	O
the	DT	B-PROBLEM	O
sah	NN	I-PROBLEM	O
while	IN	O	O
awaiting	VBG	O	O
family	NN	O	O
members	NNS	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
changed	VBN	O	O
to	TO	O	O
full	JJ	O	O
code	NN	O	O
.	.	O	O

given	VBN	O	O
48	CD	O	O
hours	NNS	O	O
off	IN	O	O
sedation	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
out	RP	O	O
change	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
last	JJ	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
2016-05-07	JJ	O	O
)	)	O	O
.	.	O	O

on	IN	O	O
arrival	NN	O	O
to	TO	O	O
the	DT	O	O
ficu	NN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
intubated	VBN	B-TREATMENT	B-TREATMENT
and	CC	O	O
non-sedated	JJ	O	O
.	.	O	O

-	:	O	O
retroperitoneal	NN	B-PROBLEM	B-PROBLEM
squamous	JJ	I-PROBLEM	I-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
unknown	JJ	O	O
primary	NN	O	O
,	,	O	O
dx	NN	O	O

12-15	JJ	O	O
,	,	O	O
s/p	JJ	O	B-TREATMENT
xrt	NNP	B-TREATMENT	I-TREATMENT
(	(	O	O
last	JJ	O	O
tx	IN	O	O
2015-04-20	JJ	O	O
)	)	O	O
,	,	O	O
s/p	JJ	O	O
cisplatin	NN	B-TREATMENT	B-TREATMENT
(	(	O	O
last	JJ	O	O
dose	RB	O	O
3/22	CD	O	O
)	)	O	O

-	:	O	O
l	NN	B-PROBLEM	O
hydroureter	NN	I-PROBLEM	B-PROBLEM
obstruction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
s/p	NN	O	B-TREATMENT
r	NN	B-TREATMENT	I-TREATMENT
ureteral	JJ	I-TREATMENT	I-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
2016-03-24	JJ	O	O

-	:	O	O
h/o	NN	O	O
lle	VBZ	B-PROBLEM	O
dvt	NN	I-PROBLEM	O
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT

-	:	O	O
laser	NN	B-TREATMENT	O
conization	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
cervix	NN	I-TREATMENT	B-TREATMENT
2004	CD	O	O

vs	SYM	B-TEST	O
-	:	O	O
tm	NN	B-TEST	O
101.7	CD	O	O

tc	RB	B-TEST	O
99.7	CD	O	O
p	JJ	B-TEST	O
123	CD	O	O
bp	NN	B-TEST	O
137/75	CD	O	O

resp	LS	O	O
-	:	O	O
pcv	NN	B-TEST	O
pinsp	NN	I-TEST	O
26	CD	O	O
r	NN	B-TEST	O
16	CD	O	O
fio2	JJ	B-TEST	B-TEST
50%	CD	O	I-TEST
rate	NN	B-TEST	I-TEST
8	CD	O	O
,	,	O	O
breathing	VBG	B-TEST	B-TREATMENT
20	CD	O	O
,	,	O	O
sat	VBD	B-TEST	B-TEST
100%	CD	O	O

gen	NN	O	O
-	:	O	O
lying	NN	O	O
in	IN	O	O
bed	NN	O	O
unresponsive	JJ	B-PROBLEM	B-PROBLEM

chest	JJS	O	O
-	:	O	O
diffuse	NN	B-PROBLEM	B-PROBLEM
ronchi	NN	I-PROBLEM	I-PROBLEM

abd	SYM	O	B-TEST
-	:	O	O
mass	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
llq	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
nephrostomy	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
yellow	JJ	O	B-PROBLEM
clear	JJ	O	I-PROBLEM
output	NN	O	I-PROBLEM

ext	JJ	O	O
-	:	O	O
diffuse	NN	B-PROBLEM	B-PROBLEM
anasarca	NN	I-PROBLEM	I-PROBLEM
x	VBD	O	O
4	CD	O	O
ext	NN	O	O

neuro	SYM	O	B-TEST
-	:	O	O
perrl	NN	O	O
,	,	O	O
corneal	NN	O	B-TEST
reflex	NN	O	I-TEST
,	,	O	O
gag	NN	O	B-TEST
reflex	NN	O	I-TEST
,	,	O	O
dolls	VBZ	B-PROBLEM	O
eyes	NNS	I-PROBLEM	O
,	,	O	O
spont	JJ	O	O
mvt	NN	O	O
of	IN	O	O
head	NN	O	O
with	IN	O	O
out	RP	O	O
purpose	JJ	O	O
side	NN	O	O
to	TO	O	O
side	VB	O	O

pt	SYM	B-TEST	B-TEST
-	:	O	O
14.6*	CD	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
29.1	CD	O	O
inr	NN	B-TEST	O
(	(	I-TEST	O
pt	NN	I-TEST	O
)	)	I-TEST	O
-	:	O	O
1.3*	CD	O	O

plt	NN	B-TEST	B-TEST
smr	SYM	I-TEST	I-TEST
-	:	O	O
low	JJ	B-PROBLEM	O
plt	NN	I-PROBLEM	B-TEST
count	NN	I-PROBLEM	I-TEST
-	:	O	O
86*	CD	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
3.7*	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
2.78*	CD	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
8.6	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
25.8*	CD	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
93	CD	O	O

mch	SYM	B-TEST	B-TEST
-	:	O	O
31.1	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
33.5	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
14.9	CD	O	O

calcium	NN	B-TEST	B-TEST
-	:	O	O
7.1*	CD	O	O
phosphate	NN	B-TEST	B-TEST
-	:	O	O
5.1*	CD	O	O
magnesium	NN	B-TEST	B-TEST
-	:	O	O
1.7	CD	O	O

alt	NN	B-TEST	O
(	(	I-TEST	O
sgpt	NN	I-TEST	O
)	)	I-TEST	O
-	:	O	O
23	CD	O	O
ast	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
sgot	NN	I-TEST	I-TEST
)	)	I-TEST	O
-	:	O	O
19	CD	O	O
alk	NN	B-TEST	B-TEST
phos	NN	I-TEST	I-TEST
-	:	O	O
101	CD	O	O

estgfr	SYM	B-TEST	B-TEST
-	:	O	O
using	VBG	O	O
this	DT	O	O

glucose	JJ	B-TEST	B-TEST
-	:	O	O
96	CD	O	O
urea	JJ	B-TEST	B-TEST
n	SYM	I-TEST	I-TEST
-	:	O	O
113*	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
2.3*	CD	O	O
sodium	NN	B-TEST	B-TEST
-	:	O	O
150*	CD	O	O

potassium	NN	B-TEST	B-TEST
-	:	O	O
3.9	CD	O	O
chloride	NN	B-TEST	B-TEST
-	:	O	O
110*	CD	O	O
total	JJ	B-TEST	B-TEST
co2	NN	I-TEST	I-TEST
-	:	O	O
28	CD	O	O
anion	NN	B-TEST	B-TEST
gap	NN	I-TEST	I-TEST
-	:	O	O
16	CD	O	O

2016-05-15	JJ	O	O
06:02am	CD	O	O
blood	NN	B-TEST	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
9.5	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
2.78*	CD	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
8.8*	CD	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
25.7*	CD	O	O

mcv	SYM	B-TEST	B-TEST
-	:	O	O
93	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
31.7	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.2	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
14.6	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
26*	CD	O	O

2016-05-11	JJ	O	O
04:30am	CD	O	O
blood	NN	B-TEST	O

neuts	NNS	B-TEST	B-TEST
-	:	O	O
80.4*	CD	O	O
bands	NNS	B-TEST	B-TEST
-	:	O	O
9.3*	CD	O	O
lymphs	SYM	B-TEST	B-TEST
-	:	O	O
4.1*	CD	O	O

monos	SYM	B-TEST	B-TEST
-	:	O	O
3.1	CD	O	O
eos	SYM	B-TEST	B-TEST
-	:	O	O
1.0	CD	O	O
baso	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
atyps	SYM	B-TEST	B-TEST
-	:	O	O
1.0*	CD	O	O
metas	NNS	B-TEST	B-TEST
-	:	O	O
1.0*	CD	O	O

2016-05-15	JJ	O	O
06:02am	CD	O	O
blood	NN	B-TEST	O

fibrino	NN	B-TEST	O
-	:	O	O
406*	CD	O	O

2016-05-15	JJ	O	O
06:02am	CD	O	O
blood	NN	B-TEST	O

glucose	JJ	B-TEST	B-TEST
-	:	O	O
120*	CD	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
79*	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.8*	CD	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
144	CD	O	O

k	SYM	B-TEST	B-TEST
-	:	O	O
3.6	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
110*	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
23	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
15	CD	O	O

2016-05-11	JJ	O	O
04:30am	CD	O	O
blood	NN	B-TEST	O

alt	SYM	B-TEST	B-TEST
-	:	O	O
19	CD	O	O
ast	IN	B-TEST	O
-	:	O	O
18	CD	O	O
ld	NN	B-TEST	O
(	(	I-TEST	O
ldh	NN	I-TEST	O
)	)	I-TEST	O
-	:	O	O
313*	CD	O	O
alkphos	SYM	B-TEST	B-TEST
-	:	O	O
104	CD	O	O

amylase	NN	B-TEST	B-TEST
-	:	O	O
37	CD	O	O
totbili	SYM	B-TEST	B-TEST
-	:	O	O
0.8	CD	O	O

calcium	NN	B-TEST	B-TEST
-	:	O	O
7.4*	CD	O	O
phos	NN	B-TEST	B-TEST
-	:	O	O
3.6	CD	O	O
mg	SYM	B-TEST	O
-	:	O	O
2.2	CD	O	O

2016-05-11	JJ	O	O
04:30am	CD	O	O
blood	NN	B-TEST	O

albumin	SYM	B-TEST	B-TEST
-	:	O	O
2.3	CD	O	O

2016-05-13	JJ	O	O
08:32am	CD	O	O
blood	NN	B-TEST	O

type	NN	O	O
-	:	O	O
art	NN	B-TEST	O
temp	SYM	I-TEST	B-TEST
-	:	O	O
38.2	CD	O	O
tidal	JJ	B-TEST	B-TEST
v	NN	I-TEST	I-TEST
-	:	O	O
500	CD	O	O
peep	JJ	B-TEST	O
-	:	O	O
5	CD	O	O

fio2	SYM	B-TEST	B-TEST
-	:	O	O
40	CD	O	O
po2	NN	B-TEST	O
-	:	O	O
104	CD	O	O
pco2	NN	B-TEST	O
-	:	O	O
50*	CD	O	O
ph	NN	B-TEST	B-TEST
-	:	O	O
7.36	CD	O	O
caltco2	NN	B-TEST	O
-	:	O	O
29	CD	O	O
base	NN	B-TEST	B-TEST
xs	NNP	I-TEST	I-TEST
-	:	O	O
1	CD	O	O

-assist/con	NN	O	B-TEST
intubat	NN	O	I-TEST
-	:	O	O
intubated	VBN	B-TREATMENT	B-TREATMENT

2016-05-11	JJ	O	O
02:08am	CD	O	O
blood	NN	B-TEST	O

lactate	NN	B-TEST	B-TEST
-	:	O	O
1.6	CD	O	O

2016-05-11	JJ	O	O
mri	NN	B-TEST	O
head:	NN	I-TEST	O

the	DT	B-TEST	B-TEST
sagittal	JJ	I-TEST	I-TEST
t1	NN	I-TEST	I-TEST
images	NNS	I-TEST	I-TEST
demonstrate	VBP	O	O
several	JJ	O	O
areas	NNS	O	O
of	IN	O	O
high	JJ	B-PROBLEM	B-PROBLEM
signal	NN	I-PROBLEM	I-PROBLEM
along	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
sulci	NN	I-PROBLEM	I-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM
which	WDT	O	O
could	MD	O	O
be	VB	O	O
secondary	JJ	O	O
to	TO	O	O
subarachnoid	VB	B-PROBLEM	B-PROBLEM
hemorrhages	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
are	VBP	O	O
several	JJ	O	O
areas	NNS	O	O
of	IN	O	O
hyperintensities	NNS	B-PROBLEM	B-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
convexity	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
could	MD	O	O
be	VB	O	O
intraaxial	JJ	O	O
and	CC	O	O
could	MD	O	O
be	VB	O	O
related	VBN	O	O
to	TO	O	O
hemorrhage	VB	B-PROBLEM	B-PROBLEM
within	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
metastatic	JJ	I-PROBLEM	I-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
but	CC	O	O
in	IN	O	O
absence	NN	O	O
of	IN	O	O
gradient	NN	B-TEST	B-PROBLEM
echo	NN	I-TEST	I-PROBLEM
images	NNS	I-TEST	I-PROBLEM
,	,	O	O
this	DT	O	O
could	MD	O	O
not	RB	O	O
be	VB	O	O
further	RB	O	O
confirmed	VBN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
would	MD	O	O
help	VB	O	O
for	IN	O	O
further	JJ	O	O
assessment	NN	O	O
if	IN	O	O
indicated	VBN	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
signal	NN	I-PROBLEM	I-PROBLEM
seen	VBN	O	O
in	IN	O	O
both	DT	O	O
basal	NN	O	B-PROBLEM
ganglia	JJ	O	I-PROBLEM
region	NN	O	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
along	IN	O	O
the	DT	O	O
rolandic	JJ	O	O
region	NN	O	O
bilaterally	RB	O	O
which	WDT	O	O
is	VBZ	O	O
suggestive	JJ	O	O
of	IN	O	O
global	JJ	B-PROBLEM	B-PROBLEM
hypoxic	JJ	I-PROBLEM	I-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
brain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
are	VBP	O	O
several	JJ	O	B-PROBLEM
areas	NNS	O	I-PROBLEM
of	IN	O	I-PROBLEM
brain	NN	B-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
identified	VBN	O	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	JJ	O	I-PROBLEM
frontal	NN	O	I-PROBLEM
and	CC	O	I-PROBLEM
parietal	JJ	O	I-PROBLEM
lobe	NN	O	I-PROBLEM
and	CC	O	O
both	DT	O	O
temporal	JJ	O	O
lobes	NN	O	O
,	,	O	O
which	WDT	O	O
are	VBP	O	O
suspicious	JJ	O	O
for	IN	O	O
areas	NNS	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
metastatic	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
surrounding	VBG	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
hydrocephalus	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
midline	NN	B-PROBLEM	B-PROBLEM
shift	NN	I-PROBLEM	I-PROBLEM
seen	VBN	O	O
.	.	O	O

no	DT	O	O
herniation	NN	B-PROBLEM	B-PROBLEM
is	VBZ	O	O
identified	VBN	O	O
.	.	O	O

images	NNS	B-TEST	O
through	IN	I-TEST	O
the	DT	I-TEST	B-PROBLEM
skull	JJ	I-TEST	I-PROBLEM
base	NN	I-TEST	I-PROBLEM
demonstrate	NN	O	I-PROBLEM
soft	JJ	B-PROBLEM	I-PROBLEM
tissue	NN	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
sphenoid	NN	I-PROBLEM	I-PROBLEM
sinus	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
could	MD	O	O
be	VB	O	O
due	JJ	O	O
to	TO	O	O
retained	JJ	B-PROBLEM	O
secretions	NNS	I-PROBLEM	O
from	IN	O	O
intubation	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

there	EX	O	O
is	VBZ	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
signal	NN	I-PROBLEM	I-PROBLEM
seen	VBN	O	I-PROBLEM
along	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
sulci	NN	O	I-PROBLEM
on	IN	O	I-PROBLEM
flair	NN	B-TEST	I-PROBLEM
images	NNS	I-TEST	I-PROBLEM
at	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
convexity	NN	O	I-PROBLEM
which	WDT	O	O
could	MD	O	O
be	VB	O	O
secondary	JJ	O	O
to	TO	O	O
subarachnoid	VB	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
would	MD	O	O
help	VB	O	O
for	IN	O	O
further	JJ	O	B-TEST
assessment	NN	O	I-TEST
and	CC	O	O
exclude	VBP	O	O
proteinaceous	JJ	B-PROBLEM	B-PROBLEM
material	NN	I-PROBLEM	I-PROBLEM
within	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
sulci	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

gadolinium-enhanced	JJ	B-TEST	B-PROBLEM
mri	NN	I-TEST	I-PROBLEM
would	MD	O	O
also	RB	O	O
help	VB	O	O
for	IN	O	O
further	JJ	O	B-TEST
assessment	NN	O	I-TEST
.	.	O	O

pcxr	JJ	B-TEST	B-TEST
2016-05-11	CD	O	O
5:01am:	CD	O	O

tip	NN	O	O
of	IN	O	O
the	DT	B-TREATMENT	O
ett	JJ	I-TREATMENT	O
projects	NNS	O	O
roughly	RB	O	O
5	CD	O	O
cm	NNS	O	O
above	IN	O	O
the	DT	O	O
carina	NN	O	O
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
ij	JJ	I-TREATMENT	I-TREATMENT
central	JJ	I-TREATMENT	I-TREATMENT
venous	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
is	VBZ	O	O
at	IN	O	O
the	DT	O	O
level	NN	O	O
of	IN	O	O
the	DT	O	O
mid	NN	O	O
svc	NN	O	O
.	.	O	O

tip	NN	O	O
of	IN	O	O
the	DT	B-TREATMENT	O
ngt	NN	I-TREATMENT	O
is	VBZ	O	O
below	IN	O	O
the	DT	O	O
edge	NN	O	O
of	IN	O	O
the	DT	O	O
image	NN	O	O
.	.	O	O

ivc	NN	B-TREATMENT	O
filter	NN	I-TREATMENT	O
and	CC	O	O
probable	JJ	O	B-TREATMENT
nu	JJ	B-TREATMENT	I-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
on	IN	I-TREATMENT	O
the	DT	I-TREATMENT	O
left	NN	I-TREATMENT	O
also	RB	O	O
noted	VBD	O	O
.	.	O	O

heart	NN	O	O
and	CC	O	O
mediastinum	NN	O	B-TEST
are	VBP	O	O
unremarkable	JJ	O	O
allowing	VBG	O	O
for	IN	O	O
technique	NN	O	O
,	,	O	O
no	DT	O	O
sizeable	JJ	B-PROBLEM	B-PROBLEM
pneumothorax	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
somewhat	RB	I-PROBLEM	I-PROBLEM
wedge-shaped	JJ	I-PROBLEM	I-PROBLEM
opacity	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
base	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
could	MD	O	O
represent	VB	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
other	JJ	B-PROBLEM	B-PROBLEM
confluent	NN	I-PROBLEM	I-PROBLEM
infiltrates	NNS	I-PROBLEM	I-PROBLEM
are	VBP	O	O
appreciated	VBN	O	O

pcxr	JJ	B-TEST	B-TEST
2016-05-11.	CD	O	O
1:46pm:	CD	O	O

1.	CD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
vague	JJ	B-PROBLEM	B-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
lower	RBR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
opacity	NN	I-PROBLEM	I-PROBLEM
most	RBS	O	O
likely	JJ	O	O
represents	VBZ	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
edema	NNS	I-PROBLEM	I-PROBLEM
though	IN	O	O
if	IN	O	O
opacity	NN	B-PROBLEM	B-PROBLEM
persistent	NN	O	I-PROBLEM
after	IN	O	O
diuresis	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
will	MD	O	O
become	VB	O	O
considerations	NNS	O	O
.	.	O	O

3.	CD	O	O
ett	JJ	B-TREATMENT	O
4	CD	O	O
cm	NN	O	O
above	IN	O	O
the	DT	O	O
carina	NN	O	O
with	IN	O	O
ng	JJ	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
advancement	NN	O	I-TREATMENT
into	IN	O	O
the	DT	O	O
stomach	NN	O	O
.	.	O	O

eeg	JJ	B-TEST	O
2016-05-12:	JJ	O	O

abnormal	JJ	B-PROBLEM	B-PROBLEM
portable	JJ	I-PROBLEM	I-PROBLEM
eeg	NN	I-PROBLEM	I-PROBLEM
due	JJ	O	O
to	TO	O	O
the	DT	B-PROBLEM	O
slow	JJ	I-PROBLEM	O
and	CC	I-PROBLEM	O
disorganized	VBN	I-PROBLEM	B-PROBLEM
background	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
bursts	NNS	B-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
generalized	JJ	I-PROBLEM	I-PROBLEM
slowing	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

these	DT	O	O
findings	NNS	O	O
indicate	VBP	O	O
a	DT	B-PROBLEM	B-PROBLEM
widespread	JJ	I-PROBLEM	I-PROBLEM
encephalopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

medications	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
metabolic	JJ	B-PROBLEM	B-PROBLEM
disturbances	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
infection	NN	B-PROBLEM	B-PROBLEM
are	VBP	O	O
among	IN	O	O
the	DT	O	O
most	RBS	O	O
common	JJ	O	O
causes	NNS	O	O
.	.	O	O

subarachnoid	JJ	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
another	DT	O	O
possible	JJ	O	O
explanation	NN	O	O
.	.	O	O

there	EX	O	O
were	VBD	O	O
no	DT	O	O
areas	NNS	O	B-PROBLEM
of	IN	O	I-PROBLEM
prominent	JJ	B-PROBLEM	I-PROBLEM
focal	JJ	I-PROBLEM	I-PROBLEM
slowing	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
there	EX	O	O
were	VBD	O	O
no	DT	O	O
epileptiform	NN	B-PROBLEM	B-PROBLEM
features	NNS	I-PROBLEM	I-PROBLEM

trans-thoracic	JJ	B-TEST	B-TEST
echocardiogram	JJ	I-TEST	I-TEST
2016-05-12	NN	O	I-TEST
:	:	O	O

left	VBN	O	B-PROBLEM
ventricular	JJ	O	I-PROBLEM
wall	NN	O	I-PROBLEM
thickness	NN	O	I-PROBLEM
,	,	O	O
cavity	NN	O	O
size	NN	O	O
,	,	O	O
and	CC	O	O
systolic	JJ	O	O
function	NN	O	O
are	VBP	O	O
normal	JJ	O	O
(	(	O	O
lvef>55%	JJ	B-TEST	O
)	)	O	O
.	.	O	O

the	DT	O	O
aortic	JJ	O	O
valve	NN	O	O
leaflets	NNS	O	O
(	(	O	O
3	CD	O	O
)	)	O	O
appear	VBP	O	O
structurally	RB	O	O
normal	JJ	O	O
with	IN	O	O
good	JJ	O	O
leaflet	NN	O	O
excursion	NN	O	O
and	CC	O	O
no	DT	O	O
aortic	JJ	B-PROBLEM	B-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
mitral	JJ	O	O
valve	NN	O	O
appears	VBZ	O	O
structurally	RB	O	O
normal	JJ	O	O
with	IN	O	O
trivial	JJ	B-PROBLEM	B-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
mitral	JJ	B-PROBLEM	B-PROBLEM
valve	NN	I-PROBLEM	I-PROBLEM
prolapse	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
pulmonary	JJ	I-TEST	I-TEST
artery	NN	I-TEST	I-TEST
systolic	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
could	MD	O	O
not	RB	O	O
be	VB	O	O
determined	VBN	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
pericardial	JJ	B-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
pericardial	JJ	B-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pcxr	JJ	B-TEST	B-TEST
2016-05-13	CD	O	O
:	:	O	O

mild	NN	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
perihilar	JJ	I-PROBLEM	I-PROBLEM
opacification	NN	I-PROBLEM	I-PROBLEM
has	VBZ	O	O
improved	VBN	O	O
,	,	O	O
probably	RB	O	O
resolving	VBG	B-PROBLEM	O
edema	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
more	JJR	B-PROBLEM	O
rightward	JJ	I-PROBLEM	B-PROBLEM
mediastinal	JJ	I-PROBLEM	I-PROBLEM
shift	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
suggesting	VBG	O	O
new	JJ	B-PROBLEM	B-PROBLEM
atelectasis	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

enlargement	NN	B-PROBLEM	O
of	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
right	JJ	I-PROBLEM	O
hilus	NN	I-PROBLEM	O
could	MD	O	O
represent	VB	O	O
adenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

et	NN	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
in	IN	O	I-TREATMENT
standard	JJ	O	I-TREATMENT
placement	NN	O	I-TREATMENT
.	.	O	O

nasogastric	JJ	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
passes	NNS	O	I-TREATMENT
below	IN	O	O
the	DT	O	O
diaphragm	NN	O	O
and	CC	O	O
out	IN	O	O
of	IN	O	O
view	NN	O	O
.	.	O	O

no	DT	O	O
appreciable	JJ	B-PROBLEM	B-PROBLEM
pneumothorax	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
pleural	JJ	B-PROBLEM	B-PROBLEM
effusions	NNS	I-PROBLEM	I-PROBLEM

pcxr	JJ	B-TEST	B-TEST
2016-05-14	CD	O	O
:	:	O	O

increasing	VBG	B-PROBLEM	B-PROBLEM
opacification	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lungs	NNS	I-PROBLEM	I-PROBLEM
could	MD	O	O
be	VB	O	O
due	JJ	O	O
to	TO	O	O
mild	VB	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
micrometastases	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
worsened	VBD	O	O
slightly	RB	O	O
since	IN	O	O
05-13	NN	O	O
at	IN	O	O
10:57	CD	O	O
p.m.	NN	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
pleural	JJ	B-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	O
et	NN	I-TREATMENT	O
tube	NN	I-TREATMENT	O
and	CC	O	O
right	JJ	B-TREATMENT	B-TREATMENT
picc	NN	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
standard	JJ	O	O
placements	NNS	O	O
.	.	O	O

nasogastric	JJ	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
passes	NNS	O	I-TREATMENT
below	IN	O	O
the	DT	O	O
diaphragm	NN	O	O
and	CC	O	O
out	IN	O	O
of	IN	O	O
view	NN	O	O
.	.	O	O

no	DT	O	O
pneumothorax	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

05-11-	JJ	O	B-TEST
blood	NN	B-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
:	:	O	O
no	DT	O	O
growth	NN	B-PROBLEM	O
to	TO	O	O
date	NN	O	O
on	IN	O	O
2/2	CD	O	O
bottles	NNS	O	O

05-12-	JJ	O	B-TEST
blood	NN	B-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
:	:	O	O
no	DT	O	O
growth	NN	B-PROBLEM	O
to	TO	O	O
date	NN	O	O
on	IN	O	O
6/6	CD	O	O
bottles	NNS	O	O

05-14-	JJ	O	B-TEST
blood	NN	B-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
:	:	O	O
no	DT	O	O
growth	NN	B-PROBLEM	O
to	TO	O	O
date	NN	O	O
on	IN	O	O
4/4	CD	O	O
bottles	NNS	O	O

05-11-	JJ	O	B-TEST
urine	JJ	B-TEST	I-TEST
culture	NN	I-TEST	I-TEST
:	:	O	O
no	DT	O	O
growth	NN	B-PROBLEM	B-PROBLEM
(	(	O	O
final	JJ	O	O
)	)	O	O

05-12-	JJ	O	B-TEST
urine	JJ	B-TEST	I-TEST
culture	NN	I-TEST	I-TEST
:	:	O	O
no	DT	O	O
growth	NN	B-PROBLEM	B-PROBLEM
(	(	O	O
final	JJ	O	O
)	)	O	O

05-14-	JJ	O	B-TEST
urine	JJ	B-TEST	I-TEST
culture	NN	I-TEST	I-TEST
:	:	O	O
no	DT	O	O
growth	NN	B-PROBLEM	O
to	TO	O	O
date	NN	O	O

05-11-	JJ	O	B-PROBLEM
stool	NN	B-TEST	I-PROBLEM
:	:	O	O
negative	JJ	O	O
for	IN	O	O
cdiff	NN	B-PROBLEM	B-PROBLEM
toxin	NN	I-PROBLEM	I-PROBLEM

05-12-	JJ	O	O
stool	NN	B-TEST	O
:	:	O	O
negative	JJ	O	O
for	IN	O	O
cdiff	NN	B-PROBLEM	B-PROBLEM
toxin	NN	I-PROBLEM	I-PROBLEM

05-12-	JJ	O	B-TEST
swab	NN	B-TEST	I-TEST
from	IN	O	O
nephrostomy	NN	B-TREATMENT	B-TREATMENT
:	:	O	O

gram	NN	B-TEST	B-TEST
stain	NN	I-TEST	I-TEST
(	(	O	O
final	JJ	O	O
2016-05-12	NN	O	O
)	)	O	O
:	:	O	O

no	DT	O	O
polymorphonuclear	NN	B-PROBLEM	B-PROBLEM
leukocytes	VBZ	I-PROBLEM	I-PROBLEM
seen	VBN	O	O
.	.	O	O

no	DT	O	O
microorganisms	NN	B-PROBLEM	B-PROBLEM
seen	VBN	O	O
.	.	O	O

wound	JJ	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
(	(	O	O
preliminary	JJ	O	O
)	)	O	O
:	:	O	O

due	JJ	O	O
to	TO	O	O
mixed	JJ	B-PROBLEM	B-PROBLEM
bacterial	JJ	I-PROBLEM	I-PROBLEM
types	NNS	I-PROBLEM	I-PROBLEM
(	(	O	O
>=	$	O	O
3	CD	O	O
colony	NN	O	O
types	NNS	O	O
)	)	O	O
an	DT	B-TEST	O
abbreviated	JJ	I-TEST	O
workup	NN	I-TEST	B-TEST
is	VBZ	O	O
performed	VBN	O	O
appropriate	JJ	O	O
to	TO	O	O
the	DT	O	O
isolates	NNS	O	O
recovered	VBD	O	O
from	IN	O	O
the	DT	O	O
site	NN	O	O
(	(	O	O
including	VBG	O	O
a	DT	B-TEST	O
screen	NN	I-TEST	O
for	IN	O	O
pseudomonas	NN	B-PROBLEM	B-PROBLEM
aeruginosa	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
staphylococcus	VB	B-PROBLEM	B-PROBLEM
aureus	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
beta	NN	B-PROBLEM	B-TREATMENT
streptococcus	NN	I-PROBLEM	I-TREATMENT
)	)	O	O
.	.	O	O

staphylococcus	NN	B-PROBLEM	B-PROBLEM
,	,	I-PROBLEM	O
coagulase	NN	I-PROBLEM	B-TEST
negative	JJ	O	O
.	.	O	O

rare	JJ	B-PROBLEM	B-PROBLEM
growth	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

corynebacterium	NN	B-PROBLEM	B-PROBLEM
species	NNS	I-PROBLEM	I-PROBLEM
(	(	I-PROBLEM	I-PROBLEM
diphtheroids	NNS	I-PROBLEM	I-PROBLEM
)	)	I-PROBLEM	O
.	.	O	O

sparse	JJ	B-PROBLEM	B-PROBLEM
growth	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pseudomonas	NNS	B-PROBLEM	B-PROBLEM
aeruginosa	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

rare	JJ	B-PROBLEM	B-PROBLEM
growth	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pseudomonas	NNS	B-PROBLEM	B-PROBLEM
aeruginosa	VBP	I-PROBLEM	I-PROBLEM

gram	NN	B-TEST	B-TEST
stain	NN	I-TEST	I-TEST
(	(	O	O
final	JJ	O	O
2016-05-12	NN	O	O
)	)	O	O
:	:	O	O

11-03	JJ	O	O
pmns	NN	B-TEST	O
and	CC	O	O
<10	NNP	O	B-PROBLEM
epithelial	JJ	O	I-PROBLEM
cells/100x	NN	O	I-PROBLEM
field	NN	O	I-PROBLEM
.	.	O	O

no	DT	O	O
microorganisms	NN	B-PROBLEM	B-PROBLEM
seen	VBN	O	O
.	.	O	O

respiratory	JJ	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
(	(	O	O
final	JJ	O	O
2016-05-14	NN	O	O
)	)	O	O
:	:	O	O

no	DT	O	O
growth	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

fungal	JJ	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
(	(	O	O
preliminary	JJ	O	O
)	)	O	O
:	:	O	O

no	DT	O	O
fungus	NN	B-PROBLEM	B-PROBLEM
isolated	VBD	O	I-PROBLEM
.	.	O	O

nocardia	JJ	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
(	(	O	O
preliminary	JJ	O	O
)	)	O	O
:	:	O	O

no	DT	O	O
nocardia	NN	B-PROBLEM	B-PROBLEM
isolated	VBD	O	I-PROBLEM
.	.	O	O

gram	NN	B-TEST	B-TEST
stain	NN	I-TEST	I-TEST
(	(	O	O
final	JJ	O	O
2016-05-14	NN	O	O
)	)	O	O
:	:	O	O

>25	JJ	O	O
pmns	NN	B-TEST	O
and	CC	O	O
<10	NNP	O	B-PROBLEM
epithelial	JJ	O	I-PROBLEM
cells/100x	NN	O	I-PROBLEM
field	NN	O	I-PROBLEM
.	.	O	O

gram	NN	B-PROBLEM	B-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
cocci	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

yeast(	RB	B-PROBLEM	O
s	NN	I-PROBLEM	O
)	)	I-PROBLEM	O
.	.	O	O

05-14-	JJ	O	B-TREATMENT
catheter	NN	B-TREATMENT	I-TREATMENT
tip	NN	I-TREATMENT	I-TREATMENT
(	(	I-TREATMENT	O
iv	JJ	I-TREATMENT	O
):	NN	I-TREATMENT	O

wound	JJ	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
(	(	O	O
final	JJ	O	O
2016-05-15	NN	O	O
)	)	O	O
:	:	O	O

no	DT	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
growth	NN	I-PROBLEM	I-PROBLEM

30	CD	O	O
yo	NNS	O	O
f	JJ	O	O
with	IN	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
squamous	JJ	I-PROBLEM	I-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
unknown	JJ	O	O
primary	NN	O	O
who	WP	O	O
presented	VBD	O	O
to	TO	O	O
osh	VB	O	O
04-25	JJ	O	O
with	IN	O	O
pseudomonal	JJ	B-PROBLEM	B-TREATMENT
urosepsis	NN	I-PROBLEM	I-TREATMENT
,	,	O	O
vaginal	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
from	IN	O	I-PROBLEM
tumor	NN	B-PROBLEM	I-PROBLEM
extension/anti-coagulation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

course	NN	O	O
complicated	VBN	O	O
by	IN	O	O
sub	JJ	B-PROBLEM	B-PROBLEM
arachnoid	JJ	I-PROBLEM	I-PROBLEM
hemorrhages	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
intraparenchymal	JJ	B-PROBLEM	B-PROBLEM
bleeds	NNS	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
potential	JJ	O	B-PROBLEM
hypotensive	NN	B-PROBLEM	I-PROBLEM
brain	NN	I-PROBLEM	I-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
poor	JJ	O	O
prognosis	NN	O	O
per	IN	O	O
neurology	NN	O	O
.	.	O	O

#	#	O	O
neurologic	JJ	O	B-PROBLEM
-	:	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
seen	VBN	O	O
by	IN	O	O
the	DT	O	O
neurology	NN	O	O
consult	NN	O	O
service	NN	O	O
and	CC	O	O
underwent	JJ	O	O
mri	NN	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
which	WDT	O	O
revealed	VBD	O	O
lesions	NNS	B-PROBLEM	B-PROBLEM
suspicious	JJ	O	O
for	IN	O	O
metastases	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
possible	JJ	O	O
hemorrhages	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
findings	NNS	O	O
consistent	JJ	O	O
with	IN	O	O
hypoxic	JJ	B-PROBLEM	B-PROBLEM
brain	NN	I-PROBLEM	I-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

eeg	NN	B-TEST	O
was	VBD	O	O
performed	VBN	O	O
and	CC	O	O
revealed	VBN	O	O
encephalopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
neurologic	JJ	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
(	(	O	O
performed	VBN	O	O
after	IN	O	O
sedation	NN	B-TREATMENT	B-TREATMENT
removed	VBD	O	O
>48	NNP	O	O
hours	NNS	O	O
)	)	O	O
revealed	VBD	O	O
intact	JJ	O	O
brainstem	NN	O	O
function	NN	O	O
without	IN	O	O
evidence	NN	O	O
of	IN	O	O
higher	JJR	O	B-PROBLEM
cortical	JJ	O	I-PROBLEM
activity	NN	O	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
metabolic	JJ	I-PROBLEM	I-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
which	WDT	O	O
were	VBD	O	O
corrected	VBN	O	O
(	(	O	O
hypernatremia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hyperphosphatemia	NN	B-PROBLEM	B-PROBLEM
)	)	O	I-PROBLEM
,	,	O	O
but	CC	O	O
neurologic	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
was	VBD	O	O
unchanged	JJ	O	O
.	.	O	O

final	JJ	B-TEST	B-TEST
neurologic	NN	I-TEST	I-TEST
assessment	NN	I-TEST	I-TEST
was	VBD	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
unlikely	JJ	O	O
to	TO	O	O
regain	VB	O	B-PROBLEM
meaningful	JJ	O	I-PROBLEM
neurologic	JJ	O	I-PROBLEM
functioning	NN	O	I-PROBLEM
.	.	O	O

#	#	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
-	:	O	O
pt	NN	O	O
arrived	VBD	O	O
on	IN	O	O
pressure	NN	B-TREATMENT	B-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
ventilation	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
which	WDT	O	O
was	VBD	O	O
changed	VBN	O	O
to	TO	O	O
assist	VB	B-TREATMENT	O
control	NN	I-TREATMENT	O
to	TO	O	O
make	VB	O	O
patient	NN	O	O
more	RBR	O	O
comfortable	JJ	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
originally	RB	O	O
intubated	VBN	B-TREATMENT	B-TREATMENT
for	IN	O	O
airway	NN	B-TREATMENT	B-TREATMENT
protection	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
it	PRP	O	O
is	VBZ	O	O
felt	VBN	O	O
she	PRP	O	O
could	MD	O	O
likely	RB	O	O
be	VB	O	O
weaned	VBN	O	O
from	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
ventilator	NN	I-TREATMENT	I-TREATMENT
although	IN	O	O
she	PRP	O	O
would	MD	O	O
be	VB	O	O
extremely	RB	O	O
high	JJ	O	O
risk	NN	O	O
for	IN	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

due	JJ	O	O
to	TO	O	O
family	NN	O	O
request	NN	O	O
to	TO	O	O
move	VB	O	O
patient	NN	O	O
to	TO	O	O
a	DT	O	O
hospital	NN	O	O
closer	NN	O	O
to	TO	O	O
home	NN	O	O
,	,	O	O
she	PRP	O	O
will	MD	O	O
remain	VB	O	O
intubated	JJ	B-TREATMENT	B-TREATMENT
until	IN	O	O
transfer	NN	O	O
,	,	O	O
with	IN	O	O
plan	NN	O	O
to	TO	O	O
extubate	VB	B-TREATMENT	O
upon	IN	O	O
arrival	NN	O	O
to	TO	O	O
women	NNS	O	O
and	CC	O	O
infants	NNS	O	O
hospital	NN	O	O
with	IN	O	O
initiation	NN	O	O
of	IN	O	O
full	JJ	B-TREATMENT	O
palliative	NN	I-TREATMENT	O
care	NN	I-TREATMENT	O
and	CC	O	O
compliance	NN	O	O
of	IN	O	O
dni	NN	O	O
status	NN	O	O
.	.	O	O

#	#	O	O
fevers/infection	NN	B-PROBLEM	B-TEST
-	:	O	O
per	IN	O	O
outside	IN	O	O
hospital	NN	O	O
records	NNS	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
grew	VBD	O	O
pseudomonas	NNS	B-PROBLEM	B-PROBLEM
from	IN	O	I-PROBLEM
blood	NN	O	I-PROBLEM
and	CC	O	I-PROBLEM
urine	NN	O	I-PROBLEM
.	.	O	O

at	IN	O	O
osh	NN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
7	CD	O	O
days	NNS	O	O
of	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
13	CD	O	O
days	NNS	O	O
(	(	O	O
of	IN	O	O
14-day	JJ	O	O
planned	JJ	O	O
course	NN	O	O
)	)	O	O
of	IN	O	O
ciprofloxacin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
zosyn	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
intially	RB	O	O
continued	VBN	O	O
on	IN	O	O
cipro/zosyn	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

cxr	JJ	B-TEST	O
05-11	NN	O	O
revealed	VBN	O	O
?	.	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
vs	NN	O	O
atelectasis	NN	B-PROBLEM	B-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
r	NN	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
base	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

continues	VBZ	O	O
to	TO	O	O
spike	VB	O	B-PROBLEM
fever	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

could	MD	O	O
have	VB	O	O
still	RB	O	O
seeding	VBG	O	O
of	IN	O	O
nephrostomy	JJ	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

urology	NN	O	O
at	IN	O	O
osh	FW	O	O
against	IN	O	O
pulling	VBG	O	O
tube	NN	B-TREATMENT	B-TREATMENT
because	IN	O	O
coagulopathy	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
may	MD	O	O
not	RB	O	O
be	VB	O	O
able	JJ	O	O
to	TO	O	O
replace	VB	O	O
.	.	O	O

fevers	NNS	B-PROBLEM	B-PROBLEM
also	RB	O	O
may	MD	O	O
be	VB	O	O
from	IN	O	O
head	NN	B-PROBLEM	B-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
cancer	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
drug	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
zosyn	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
to	TO	O	O
complete	VB	O	O
a	DT	O	O
>14	JJ	O	O
day	NN	O	O
course	NN	O	O
.	.	O	O

she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

antibiotics	NNS	B-TREATMENT	B-TREATMENT
were	VBD	O	O
discontinued	VBN	O	O
on	IN	O	O
05-15	NN	O	O
.	.	O	O

no	DT	O	O
further	JJ	B-PROBLEM	O
infectious	JJ	I-PROBLEM	O
course	NN	I-PROBLEM	O
was	VBD	O	O
identified	VBN	O	O
and	CC	O	O
the	DT	B-PROBLEM	B-PROBLEM
fevers	NNS	I-PROBLEM	I-PROBLEM
may	MD	O	O
have	VB	O	O
been	VBN	O	O
due	JJ	O	O
to	TO	O	O
underlying	VBG	B-PROBLEM	B-PROBLEM
malignant	JJ	I-PROBLEM	I-PROBLEM
process	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

#	#	O	O
squamous	JJ	B-PROBLEM	B-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
-	:	O	O
unknown	JJ	O	O
primary	NN	O	O
.	.	O	O

upon	IN	O	O
discussion	NN	O	O
with	IN	O	O
him	PRP	O	O
it	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
progression	NN	O	B-PROBLEM
of	IN	O	I-PROBLEM
her	PRP$	B-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
after	IN	O	O
systemic	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
topotecan	JJ	B-TREATMENT	B-TREATMENT
and	CC	O	I-TREATMENT
cisplatin	NN	B-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
then	RB	O	O
proceed	VBD	O	O
to	TO	O	O
xrt	VB	B-TREATMENT	O
with	IN	O	O
cisplatin	NN	B-TREATMENT	B-TREATMENT
which	WDT	O	O
she	PRP	O	O
was	VBD	O	O
unable	JJ	O	O
to	TO	O	O
tolerate	VB	O	O
this	DT	O	O
secondary	JJ	O	O
to	TO	O	O
thrombocytopenia	VB	B-PROBLEM	B-PROBLEM
(	(	O	O
40-50k	JJ	O	O
)	)	O	O
.	.	O	O

given	VBN	O	O
this	DT	O	O
we	PRP	O	O
were	VBD	O	O
unable	JJ	O	O
to	TO	O	O
offer	VB	O	O
her	PRP$	O	O
additional	JJ	B-TREATMENT	O
therapy.	NN	I-TREATMENT	O
hematology/oncology	NN	O	O
service	NN	O	O
at	IN	O	O
mediplex	JJ	O	O
rehab	JJ	O	O
hospital	NN	O	O
confirmed	VBD	O	O
her	PRP$	O	B-PROBLEM
grim	JJ	O	I-PROBLEM
prognosis	NN	O	I-PROBLEM
and	CC	O	O
expective	JJ	O	B-TREATMENT
survival	NN	O	I-TREATMENT
in	IN	O	O
terms	NNS	O	O
of	IN	O	O
weeks	NNS	O	O
to	TO	O	O
months	NNS	O	O
with	IN	O	O
no	DT	O	O
further	JJ	B-TREATMENT	O
available	JJ	I-TREATMENT	O
treatment	NN	I-TREATMENT	O
.	.	O	O

#	#	O	O
h/o	NN	O	O
dvt	SYM	B-PROBLEM	O
-	:	O	O
patient	NN	O	O
with	IN	O	O
head	NN	B-PROBLEM	B-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
is	VBZ	O	O
contraindication	NN	O	B-TREATMENT
to	TO	O	O
anti-coagulation	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

ivc	NN	B-TREATMENT	O
filter	NN	I-TREATMENT	O
in	IN	O	O
place	NN	O	O
.	.	O	O

patient	NN	O	O
was	VBD	O	O
on	IN	O	O
pneumoboots	NNS	B-TREATMENT	O
while	IN	O	O
in	IN	O	O
hospital	NN	O	O
.	.	O	O

#	#	O	O
hypernatremia	NN	B-PROBLEM	B-PROBLEM
-	:	O	O
improved	VBN	O	O
from	IN	O	O
osh	NN	O	O
.	.	O	O

total	JJ	B-PROBLEM	B-TEST
body	NN	I-PROBLEM	I-TEST
volume	NN	I-PROBLEM	I-TEST
overloaded	VBD	I-PROBLEM	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
free	JJ	B-TREATMENT	B-TREATMENT
h20	NN	I-TREATMENT	I-TREATMENT
boluses	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
d5	$	B-TREATMENT	B-TREATMENT
1/2	CD	I-TREATMENT	O
ns	NN	I-TREATMENT	O
and	CC	O	O
corrected	VBN	O	O
.	.	O	O

#	#	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
-	:	O	O
stable	NN	O	O
,	,	O	O
likely	JJ	O	O
02-12	JJ	O	B-PROBLEM
hypotension	NN	B-PROBLEM	I-PROBLEM
leading	VBG	O	O
to	TO	O	O
atn	VB	B-PROBLEM	O
that	DT	O	O
is	VBZ	O	O
slowly	RB	O	O
improving	VBG	O	O
.	.	O	O

#	#	O	O
access	NN	O	O
-	:	O	O
r	NN	B-TREATMENT	O
ij	NN	I-TREATMENT	O
changed	VBD	O	O
sterilly	RB	O	O
over	IN	O	O
wire	NN	B-TREATMENT	O
05-01	NN	O	O

#	#	O	O
fen	SYM	O	B-TEST
-	:	O	O
tube	NN	B-TREATMENT	B-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
are	VBP	O	O
held	VBN	O	O
in	IN	O	O
route	NN	O	O
in	IN	O	O
anticipation	NN	O	O
of	IN	O	O
extubation	NN	O	B-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
made	VBN	O	O
dnr/dni	NN	O	O
and	CC	O	O
the	DT	O	O
plan	NN	O	O
is	VBZ	O	O
that	IN	O	O
she	PRP	O	O
will	MD	O	O
be	VB	O	O
transferred	VBN	O	O
to	TO	O	O
wih	VB	O	O
and	CC	O	O
extubated	VB	B-TREATMENT	O
there	RB	O	O
upon	IN	O	O
arrival	NN	O	O
with	IN	O	O
initiation	NN	O	O
of	IN	O	O
full	JJ	B-TREATMENT	B-TREATMENT
palliative	NN	I-TREATMENT	I-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

they	PRP	O	O
understand	VBP	O	O
that	IN	O	O
there	EX	O	O
is	VBZ	O	O
no	DT	O	O
icu	NN	O	B-PROBLEM
at	IN	O	O
wih	NN	O	O
and	CC	O	O
no	DT	O	O
further	RB	O	B-PROBLEM
advanced	JJ	B-TREATMENT	I-PROBLEM
pulmonary	JJ	I-TREATMENT	I-PROBLEM
support	NN	I-TREATMENT	I-PROBLEM
can	MD	O	O
be	VB	O	O
offered	VBN	O	O
.	.	O	O

1.	CD	O	O
acetaminophen	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
q4-6h	NN	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
to	TO	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2.	CD	O	O
albuterol-ipratropium	JJ	B-TREATMENT	O
103-18	JJ	O	O
mcg/actuation	NN	O	O
aerosol	NN	O	O
sig	NN	O	O
:	:	O	O
06-17	JJ	O	O
puffs	NNS	O	O
inhalation	NN	O	O
q2-4h	NN	O	O
(	(	O	O
every	DT	O	O
2	CD	O	O
to	TO	O	O
4	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

3.	CD	O	O
calcium	NN	B-TREATMENT	B-TREATMENT
acetate	NN	I-TREATMENT	I-TREATMENT
667	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
tid	NN	O	O
w/meals	NNS	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
with	IN	O	O
meals	NNS	O	O
)	)	O	O
.	.	O	O

4.	CD	O	O
fentanyl	JJ	B-TREATMENT	B-TREATMENT
citrate	NN	I-TREATMENT	I-TREATMENT
(	(	O	I-TREATMENT
pf	NN	O	I-TREATMENT
)	)	O	I-TREATMENT
0.05	CD	O	O
mg/ml	JJ	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
25-100	JJ	O	O
mcg	NN	O	O
injection	NN	O	O
q2h	NN	O	O
(	(	O	O
every	DT	O	O
2	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
comfort	NN	O	O
.	.	O	O

5.	CD	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
regular	JJ	I-TREATMENT	O
human	JJ	I-TREATMENT	O
100	CD	O	O
unit/ml	JJ	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
2-10	JJ	O	O
units	NNS	O	O
injection	NN	O	O
asdir	RB	O	O
(	(	O	O
as	IN	O	O
directed	VBN	O	O
)	)	O	O
:	:	O	O
per	IN	O	O
sliding	VBG	B-TREATMENT	O
scale	NN	I-TREATMENT	O
for	IN	O	O
blood	NN	B-TEST	B-TEST
sugars	NNS	I-TEST	I-TEST
>	VBD	O	O
150mg/dl	CD	O	O
.	.	O	O

6.	CD	O	O
midazolam	JJ	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg/ml	JJ	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
mg	NN	O	O
injection	NN	O	O
q2h	NN	O	O
(	(	O	O
every	DT	O	O
2	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
comfort	NN	O	O
.	.	O	O

7.	CD	O	O
phenytoin	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
50	CD	O	O
mg/ml	JJ	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
95y	CD	O	O
(	(	O	O
150	CD	O	O
)	)	O	O
mg	NN	O	O
intravenous	JJ	O	O
q8h	NN	O	O
(	(	O	O
every	DT	O	O
8	CD	O	O
hours	NNS	O	O
)	)	O	O
.	.	O	O

8.	CD	O	O
ranitidine	NN	B-TREATMENT	B-TREATMENT
hcl	NN	O	I-TREATMENT
15	CD	O	O
mg/ml	NN	O	O
syrup	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
95y	CD	O	O
(	(	O	O
150	CD	O	O
)	)	O	O
mg	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

9.	CD	O	O
polyvinyl	JJ	B-TREATMENT	O
alcohol-povidone	JJ	I-TREATMENT	O
1.4-0.6	JJ	O	O
%	NN	O	O
dropperette	NN	O	O
sig	NN	O	O
:	:	O	O
01-12	JJ	O	O
drops	NNS	O	O
ophthalmic	JJ	O	O
qid	NN	O	O
(	(	O	O
4	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

1.	CD	O	O
hypoxic	NN	B-PROBLEM	B-PROBLEM
brain	NN	I-PROBLEM	I-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM

2.	CD	O	O
cranial	JJ	B-PROBLEM	O
hemorrages	NNS	I-PROBLEM	O
(	(	I-PROBLEM	O
sub	JJ	I-PROBLEM	O
arachnoid	NN	I-PROBLEM	O
and	CC	I-PROBLEM	O
parenchemal	NN	I-PROBLEM	O
)	)	I-PROBLEM	O

3.	CD	O	O
pseudomonal	JJ	B-PROBLEM	B-PROBLEM
sepsis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
completed	VBN	O	O
antibiotic	JJ	B-TREATMENT	B-TREATMENT
course	NN	I-TREATMENT	I-TREATMENT

4.	CD	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
squamous	JJ	I-PROBLEM	I-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
unknown	JJ	O	O
primary	NN	O	O
.	.	O	O

5.	CD	O	O
thrombocytopenia	NN	B-PROBLEM	B-PROBLEM

6.	CD	O	O
blood	NN	B-PROBLEM	B-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM

intubated	VBN	B-TREATMENT	B-TREATMENT
,	,	O	O
stable	JJ	O	O

you	PRP	O	O
are	VBP	O	O
being	VBG	O	O
transferred	VBN	O	O
to	TO	O	O
another	DT	O	O
hospital	NN	O	O
,	,	O	O
intubated	VBN	B-TREATMENT	B-TREATMENT
,	,	O	O
with	IN	O	O
the	DT	O	O
plan	NN	O	O
to	TO	O	O
extubate	VB	B-TREATMENT	O
upon	IN	O	O
arrival	NN	O	O
to	TO	O	O
women	NNS	O	O
's	POS	O	O
and	CC	O	O
infants	NNS	O	O
hosptial	JJ	O	O
and	CC	O	O
initiation	NN	O	O
of	IN	O	O
palliative	JJ	B-TREATMENT	B-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

your	PRP$	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
stopped	VBN	O	O
2016-05-15	JJ	O	O
(	(	O	O
vancomycin	JJ	B-TREATMENT	B-TREATMENT
1000mg	CD	O	O
q24	NN	O	O
and	CC	O	O
aztreonam	$	B-TREATMENT	B-TREATMENT
1000mg	CD	O	O
q8	NN	O	O
)	)	O	O
as	IN	O	O
your	PRP$	O	O
micorbiology	NN	B-TEST	O
data	NNS	I-TEST	O
has	VBZ	O	O
been	VBN	O	O
negative	JJ	O	O
and	CC	O	O
your	PRP$	O	O
course	NN	O	O
for	IN	O	O
pseudomonal	JJ	B-PROBLEM	B-PROBLEM
sepsis	NN	I-PROBLEM	I-PROBLEM
has	VBZ	O	O
been	VBN	O	O
completed	VBN	O	O
.	.	O	O

if	IN	O	O
you	PRP	O	O
continue	VBP	O	O
to	TO	O	O
have	VB	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
should	MD	O	O
be	VB	O	O
repeated	VBN	O	O
.	.	O	O

pneumonia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1.	CD	O	O
pill	NN	B-PROBLEM	B-TREATMENT
esophagitis	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

2.	CD	O	O
right	JJ	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
hypokinesis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

dobutamine	NN	B-TEST	B-TEST
stress	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
,	,	O	O
cardiac	JJ	B-TEST	B-TEST
ultrasound	NN	I-TEST	I-TEST
,	,	O	O
egd	NN	B-TEST	B-PROBLEM
,	,	O	O
chest	JJ	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
,	,	O	O
picc	JJ	B-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
62-year-old	JJ	O	O
female	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
copd	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
depression	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
chf	NN	B-PROBLEM	O
who	WP	O	O
was	VBD	O	O
lying	VBG	O	O
in	IN	O	O
bed	NN	O	O
on	IN	O	O
the	DT	O	O
night	NN	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
when	WRB	O	O
she	PRP	O	O
developed	VBD	O	O
left-sided	JJ	B-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
located	VBN	O	O
in	IN	O	O
the	DT	O	O
mid-breast	JJ	O	O
region	NN	O	O
with	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
fluttering	VBG	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
radiated	VBD	O	O
down	IN	O	O
her	PRP$	O	O
left	JJ	O	O
arm	NN	O	O
associated	VBN	O	O
with	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
nausea	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
cough	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
slept	VBD	O	O
through	IN	O	O
the	DT	O	O
night	NN	O	O
,	,	O	O
woke	VBD	O	O
with	IN	O	O
persistent	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
went	VBD	O	O
with	IN	O	O
her	PRP$	O	O
sister	NN	O	O
&apos;s	NN	O	O
husband	NN	O	O
to	TO	O	O
la	VB	O	O
community	NN	O	O
hospital	NN	O	O
where	WRB	O	O
she	PRP	O	O
was	VBD	O	O
given	VBN	O	O
sublingual	JJ	B-TREATMENT	B-TREATMENT
nitroglycerin	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
complete	JJ	O	O
relief	NN	O	O
of	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
arrived	VBD	O	O
pain	RB	B-PROBLEM	B-PROBLEM
free	JJ	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
given	VBN	O	O
aspirin	RB	B-TREATMENT	B-TREATMENT
,	,	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
hyperglycemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

ekg	NN	B-TEST	O
was	VBD	O	O
unchanged	JJ	O	O
compared	VBN	O	O
to	TO	O	O
the	DT	B-TEST	O
prior	JJ	I-TEST	O
ekg	JJ	I-TEST	O
several	JJ	O	O
months	NNS	O	O
ago	RB	O	O
.	.	O	O

insulin-dependent	JJ	B-PROBLEM	B-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
mellitus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
depression	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
back	RB	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
copd	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
allergic	JJ	B-PROBLEM	B-PROBLEM
rhinitis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
gerd	NN	B-PROBLEM	O
,	,	O	O
obesity	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hyperlipidemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

codeine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
reaction	NN	O	O
unknown	NN	O	O
.	.	O	O

atrovent	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

aspirin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

flonase	NN	B-TREATMENT	O
.	.	O	O

quinine	NN	B-TREATMENT	B-TREATMENT
celebrex	NN	B-TREATMENT	I-TREATMENT
.	.	O	O

compazine	NN	B-TREATMENT	O
.	.	O	O

oxybutynin	JJ	B-TREATMENT	B-TREATMENT
amitriptyline	NN	B-TREATMENT	I-TREATMENT
.	.	O	O

zyrtec	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

prozac	NN	B-TREATMENT	O
.	.	O	O

trazodone	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

humulin	NN	B-TREATMENT	O
70	CD	O	O
units	NNS	O	O
bid	NN	O	O
.	.	O	O

albuterol	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

lasix	RB	B-TREATMENT	B-TREATMENT
40	CD	O	O
po	JJ	O	O
bid	NN	O	O
.	.	O	O

triamcinolone	NN	B-TREATMENT	B-TREATMENT
cream	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

miconazole	JJ	B-TREATMENT	B-TREATMENT
cream	NN	I-TREATMENT	I-TREATMENT
flovent	NN	B-TREATMENT	I-TREATMENT
.	.	O	O

nifedipine	JJ	B-TREATMENT	B-TREATMENT
er	$	I-TREATMENT	I-TREATMENT
60	CD	O	O
daily	RB	O	O
.	.	O	O

lisinopril	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
30	CD	O	O
daily	RB	O	O
.	.	O	O

kcl	VB	B-TREATMENT	B-TREATMENT
10	CD	O	O
meq	JJ	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

protonix	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
40	CD	O	O
daily	RB	O	O
.	.	O	O

lipitor	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
20	CD	O	O
daily	RB	O	O
.	.	O	O

methadone	RB	B-TREATMENT	B-TREATMENT
10	CD	O	O
bid	NN	O	O
.	.	O	O

on	IN	O	O
admission	NN	O	B-TEST
blood	NN	B-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
165/70	CD	O	O
.	.	O	O

temperature	NN	B-TEST	B-TEST
99.8	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
86	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
18	CD	O	O
.	.	O	O

obese	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

heent	NN	O	O
,	,	O	O
ears	VBZ	O	O
poor	JJ	B-PROBLEM	B-PROBLEM
hearing	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

chest	NN	O	O
,	,	O	O
lungs	NNS	O	O
clear	VBP	O	O
to	TO	O	O
auscultation	NN	B-TEST	B-TEST
with	IN	O	O
faint	NN	B-PROBLEM	B-PROBLEM
wheezes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
rales	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

cardiac	JJ	O	O
,	,	O	O
normal	JJ	O	O
s1	NN	O	O
,	,	O	O
s2	NN	O	O
,	,	O	O
no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
rubs	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
gallops	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

abdomen	NNS	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

feet	NNS	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

pulses	NNS	O	B-TEST
2+	CD	B-TEST	O
pt	NN	I-TEST	O
and	CC	O	O
dp	NN	B-TEST	O
.	.	O	O

unremarkable	JJ	O	O
with	IN	O	O
normal	JJ	O	O
electrolytes	NNS	O	O
except	IN	O	O
for	IN	O	O
glucose	NN	B-TEST	B-TEST
of	IN	O	O
328	CD	O	O
.	.	O	O

cbc	NN	B-TEST	B-TEST
,	,	O	O
white	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
6.7	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
37.4	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
280	CD	O	O
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
was	VBD	O	O
low	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
volumes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
consolidation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

ekg	NN	B-TEST	O
showed	VBD	O	O
sinus	JJ	B-PROBLEM	B-PROBLEM
brady	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
16	CD	O	O
,	,	O	O
normal	JJ	O	O
axis	NN	O	O
,	,	O	O
normal	JJ	O	O
intervals	NNS	O	O
,	,	O	O
no	DT	O	O
stt	NN	B-PROBLEM	B-PROBLEM
wave	NN	I-PROBLEM	I-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
team	VB	O	O
four	CD	O	O
for	IN	O	O
cardiac	JJ	O	B-TEST
monitoring	NN	O	I-TEST
and	CC	O	O
ruling	VBG	O	O
out	RP	O	O
for	IN	O	O
mi	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
ruled	VBD	O	O
out	RP	O	O
for	IN	O	O
mi	NN	B-PROBLEM	O
by	IN	O	O
cardiac	JJ	B-TEST	O
markers	NNS	I-TEST	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
set	VBN	O	O
to	TO	O	O
go	VB	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
dobutamine	NN	I-TEST	I-TEST
stress	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
on	IN	O	O
11/16/04	CD	O	O
given	VBN	O	O
her	PRP$	O	O
history	NN	O	O
of	IN	O	O
copd	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
but	CC	O	O
the	DT	B-TEST	B-PROBLEM
stress	JJ	I-TEST	I-PROBLEM
portion	NN	I-TEST	I-PROBLEM
was	VBD	O	O
canceled	VBN	O	O
when	WRB	O	O
she	PRP	O	O
was	VBD	O	O
down	RB	O	O
there	RB	O	O
due	JJ	O	O
to	TO	O	O
fever	VB	B-PROBLEM	B-PROBLEM
and	CC	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
next	JJ	O	O
day	NN	O	O
,	,	O	O
she	PRP	O	O
underwent	VBD	O	O
a	DT	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
echo	NN	I-TEST	I-TEST
(	(	I-TEST	I-TEST
transthoracic	JJ	I-TEST	I-TEST
echocardiogram	NN	I-TEST	I-TEST
)	)	I-TEST	O
.	.	O	O

this	DT	B-TEST	B-TEST
echo	NN	I-TEST	I-TEST
showed	VBD	O	O
lv	JJ	B-TEST	B-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
50%	CD	O	O
with	IN	O	O
no	DT	O	O
wall	NN	B-PROBLEM	B-PROBLEM
motion	NN	I-PROBLEM	I-PROBLEM
abnormality	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

however	RB	O	O
,	,	O	O
the	DT	O	O
right	JJ	O	O
ventricular	NN	O	O
was	VBD	O	O
diffusely	RB	B-PROBLEM	B-PROBLEM
hypokinetic	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

it	PRP	O	O
was	VBD	O	O
suboptimally	RB	O	O
imaged	VBN	O	O
,	,	O	O
so	IN	O	O
there	EX	O	O
was	VBD	O	O
no	DT	O	O
rvsp	NN	B-TEST	B-PROBLEM
given	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
suffered	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
hypotensive	JJ	I-PROBLEM	I-PROBLEM
episode	NN	I-PROBLEM	I-PROBLEM
while	IN	O	O
in	IN	O	O
the	DT	O	O
endoscopy	NN	O	O
suite	NN	O	O
for	IN	O	O
her	PRP$	B-TEST	B-TEST
egd	NN	I-TEST	I-TEST
on	IN	O	O
11/17/04	CD	O	O
.	.	O	O

this	DT	O	O
responded	VBD	O	O
to	TO	O	O
fluid	VB	B-TREATMENT	B-PROBLEM
bolus	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
then	RB	O	O
transferred	VBN	O	O
to	TO	O	O
medicine	VB	O	O
team	NN	O	O
d	NN	O	O
given	VBN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
tenuous	JJ	I-PROBLEM	I-PROBLEM
hemodynamic	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
,	,	O	O
several	JJ	O	O
days	NNS	O	O
later	RB	O	O
11/23	CD	O	O
,	,	O	O
underwent	JJ	O	O
another	DT	B-TEST	B-TEST
dobutamine	NN	I-TEST	I-TEST
stress	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
.	.	O	O

this	DT	B-TEST	B-TEST
stress	JJ	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
,	,	O	O
although	IN	O	O
complicated	VBN	O	O
by	IN	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
again	RB	O	O
,	,	O	O
to	TO	O	O
the	DT	O	O
60	CD	O	O
&apos;s	NN	O	O
or	CC	O	O
70	CD	O	O
&apos;s	NN	O	O
was	VBD	O	O
completed	VBN	O	O
and	CC	O	O
there	EX	O	O
was	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
mild	JJ	I-PROBLEM	I-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
septal	NN	I-PROBLEM	I-PROBLEM
thinning	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
ischemia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
an	DT	B-TEST	O
ef	NN	I-TEST	O
from	IN	O	O
this	DT	B-TEST	B-TEST
test	NN	I-TEST	I-TEST
was	VBD	O	O
76%	CD	O	O
.	.	O	O

clearly	RB	O	O
,	,	O	O
the	DT	O	B-PROBLEM
patient	NN	O	I-PROBLEM
&apos;s	NNP	O	I-PROBLEM
hemodynamic	VBD	O	I-PROBLEM
vascular	JJ	O	I-PROBLEM
status	NN	O	I-PROBLEM
was	VBD	O	O
very	RB	O	B-PROBLEM
sensitive	JJ	O	I-PROBLEM
to	TO	O	I-PROBLEM
dobutamine	VB	B-TREATMENT	I-PROBLEM
.	.	O	O

on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
#2	NNP	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
increased	VBN	B-PROBLEM	B-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
exertion	NN	O	O
.	.	O	O

the	DT	O	O
next	JJ	O	O
day	NN	O	O
she	PRP	O	O
developed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
a	DT	O	B-PROBLEM
potential	JJ	O	I-PROBLEM
uti	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
low-grade	JJ	B-PROBLEM	B-PROBLEM
fevers	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
on	IN	O	O
the	DT	O	O
next	JJ	O	O
day	NN	O	O
,	,	O	O
11/17/04	CD	O	O
,	,	O	O
her	PRP	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	JJ	I-TEST	I-TEST
showed	VBD	O	O
possible	JJ	O	O
new	JJ	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
infiltrates	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
then	RB	O	O
started	VBN	O	O
on	IN	O	O
ceftriaxone	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
azithromycin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

her	PRP$	B-TEST	B-TEST
urine	JJ	I-TEST	I-TEST
legionella	NN	I-TEST	I-TEST
antigen	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

on	IN	O	O
11/22/04	CD	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
gram-positive	JJ	B-PROBLEM	B-PROBLEM
cocci	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
her	PRP$	O	I-PROBLEM
sputum	NN	O	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
this	DT	O	O
.	.	O	O

these	DT	B-PROBLEM	B-PROBLEM
bacteria	NNS	I-PROBLEM	I-PROBLEM
turned	VBD	O	O
out	RP	O	O
to	TO	O	O
be	VB	O	O
mrsa	JJ	B-PROBLEM	O
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
vancomycin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
picc	JJ	B-TREATMENT	B-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
placed	VBN	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
for	IN	O	O
home	NN	B-TREATMENT	B-TREATMENT
vancomycin	NN	I-TREATMENT	I-TREATMENT
administration	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
an	DT	O	O
episode	NN	O	O
of	IN	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
the	DT	O	O
morning	NN	O	O
of	IN	O	O
11/16/04	CD	O	O
associated	VBN	O	O
with	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
cough	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
apparent	JJ	B-PROBLEM	B-PROBLEM
emesis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

gi	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
for	IN	O	O
an	DT	B-TEST	B-TEST
egd	NN	I-TEST	I-TEST
,	,	O	O
however	RB	O	O
,	,	O	O
while	IN	O	O
she	PRP	O	O
was	VBD	O	O
in	IN	O	O
the	DT	O	O
endoscopy	NN	O	O
suite	NN	O	O
,	,	O	O
as	IN	O	O
mentioned	VBN	O	O
above	IN	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
hypotensive	JJ	I-PROBLEM	I-PROBLEM
episode	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
responded	VBD	O	O
to	TO	O	O
some	DT	B-TREATMENT	B-PROBLEM
fluid	NN	I-TREATMENT	I-PROBLEM
boluses	NNS	I-TREATMENT	I-PROBLEM
.	.	O	O

finally	RB	O	O
,	,	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
stabilized	VBN	O	O
to	TO	O	O
the	DT	O	O
point	NN	O	O
that	IN	O	O
she	PRP	O	O
could	MD	O	O
have	VB	O	O
her	PRP$	B-TEST	B-PROBLEM
egd	NN	I-TEST	I-PROBLEM
.	.	O	O

the	DT	B-TEST	O
egd	NN	I-TEST	O
did	VBD	O	O
show	VB	O	O
three	CD	B-PROBLEM	O
esophageal	JJ	I-PROBLEM	B-PROBLEM
ulcers	NNS	I-PROBLEM	I-PROBLEM
that	WDT	O	O
were	VBD	O	O
localized	VBN	O	O
and	CC	O	O
apparent	JJ	O	O
suggestion	NN	O	O
of	IN	O	O
pill	NN	B-PROBLEM	B-TREATMENT
esophagitis	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

her	PRP$	O	B-PROBLEM
stomach	NN	O	I-PROBLEM
and	CC	O	I-PROBLEM
duodenum	NN	O	I-PROBLEM
were	VBD	O	O
normal	JJ	O	O
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
suggested	VBN	O	O
that	IN	O	O
she	PRP	O	O
change	VBD	O	O
her	PRP	B-TREATMENT	B-PROBLEM
nexium	NN	I-TREATMENT	I-PROBLEM
doses	VBZ	I-TREATMENT	O
to	TO	O	O
daily	VB	O	O
and	CC	O	O
that	IN	O	O
she	PRP	O	O
also	RB	O	O
drink	VBP	O	O
plenty	NN	O	O
of	IN	O	O
fluids	NNS	O	O
and	CC	O	O
water	NN	O	O
with	IN	O	O
meals	NNS	O	O
,	,	O	O
sit	NN	O	O
upright	NN	O	O
when	WRB	O	O
she	PRP	O	O
would	MD	O	O
eat	VB	O	O
her	PRP$	O	O
meals	NNS	O	O
to	TO	O	O
decrease	VB	O	O
the	DT	O	O
chance	NN	O	O
of	IN	O	O
pills	NNS	B-TREATMENT	B-PROBLEM
eroding	VBG	O	I-PROBLEM
her	PRP$	O	I-PROBLEM
esophagus	NN	O	I-PROBLEM
.	.	O	O

4.	CD	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

as	IN	O	O
mentioned	VBN	O	O
above	IN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
did	VBD	O	O
develop	VB	O	O
mrsa	NN	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
was	VBD	O	O
started	VBN	O	O
to	TO	O	O
be	VB	O	O
treated	VBN	O	O
with	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
she	PRP	O	O
did	VBD	O	O
also	RB	O	O
develop	VB	O	O
an	DT	B-PROBLEM	B-PROBLEM
oxygen	NN	I-PROBLEM	I-PROBLEM
requirement	NN	I-PROBLEM	I-PROBLEM
the	DT	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

at	IN	O	O
most	JJS	O	O
,	,	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
oxygen	NN	I-PROBLEM	I-PROBLEM
requirement	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
4-5	JJ	O	O
liters	NNS	O	O
and	CC	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
satting	VBG	O	O
well	RB	O	O
on	IN	O	O
two	CD	O	O
liters	NNS	O	O
of	IN	O	O
nasal	JJ	B-TREATMENT	B-TREATMENT
cannula	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

this	DT	O	O
was	VBD	O	O
thought	VBN	O	O
to	TO	O	O
be	VB	O	O
due	JJ	O	O
to	TO	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
however	RB	O	O
,	,	O	O
with	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
hypokinesis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
it	PRP	O	O
is	VBZ	O	O
also	RB	O	O
possible	JJ	O	O
that	IN	O	O
she	PRP	O	O
may	MD	O	O
have	VB	O	O
an	DT	O	O
element	NN	O	O
of	IN	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
may	MD	O	O
warrant	VB	O	O
further	JJ	O	O
investigation	NN	O	O
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
,	,	O	O
for	IN	O	O
example	NN	O	O
,	,	O	O
with	IN	O	O
chest	JJ	B-TEST	B-PROBLEM
ct	NN	I-TEST	I-PROBLEM
.	.	O	O

several	JJ	O	O
days	NNS	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
developed	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
erythematous	JJ	I-PROBLEM	I-PROBLEM
rash	NN	I-PROBLEM	I-PROBLEM
under	IN	O	I-PROBLEM
her	PRP$	O	I-PROBLEM
left	JJ	O	I-PROBLEM
breast	NN	O	I-PROBLEM
and	CC	O	O
left	VBD	O	O
side	NN	O	O
that	IN	O	O
was	VBD	O	O
thought	VBN	O	O
to	TO	O	O
be	VB	O	O
due	JJ	O	O
to	TO	O	O
yeast	VB	B-PROBLEM	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
some	DT	B-TREATMENT	B-TREATMENT
miconazole	JJ	I-TREATMENT	I-TREATMENT
cream	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	B-PROBLEM	O
rash	NN	I-PROBLEM	O
was	VBD	O	O
always	RB	O	O
localized	VBN	O	O
to	TO	O	O
her	PRP$	O	O
left	JJ	O	O
side	NN	O	O
,	,	O	O
sometimes	RB	O	O
extending	VBG	O	O
down	RP	O	O
to	TO	O	O
her	PRP$	O	B-PROBLEM
leg	NN	O	I-PROBLEM
,	,	O	O
but	CC	O	O
never	RB	O	O
on	IN	O	O
the	DT	O	O
right	JJ	O	O
side	NN	O	O
.	.	O	O

the	DT	B-PROBLEM	O
rash	NN	I-PROBLEM	O
appeared	VBD	O	O
to	TO	O	O
be	VB	O	O
resolving	VBG	O	O
by	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

tums	NNS	B-TREATMENT	O
,	,	O	O
500-1250	JJ	O	O
mg	NN	O	O
po	NN	O	O
tid	NN	O	O
.	.	O	O

albuterol	NN	B-TREATMENT	B-TREATMENT
inhaler	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

lipitor	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
20	CD	O	O
daily	RB	O	O
.	.	O	O

prozac	NN	B-TREATMENT	O
,	,	O	O
60	CD	O	O
daily	RB	O	O
.	.	O	O

flovent	JJ	B-TREATMENT	B-TREATMENT
inhaler	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
220	CD	O	O
mcg	NN	O	O
bid	NN	O	O
.	.	O	O

atrovent	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
two	CD	O	O
puffs	NNS	O	O
qid	RB	O	O
.	.	O	O

ditropan	NN	B-TREATMENT	B-PROBLEM
,	,	O	O
5	CD	O	O
mg	NN	O	O
tid	NN	O	O
.	.	O	O

colace	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
100	CD	O	O
mg	NN	O	O
tid	NN	O	O
.	.	O	O

aspirin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
325	CD	O	O
mg	JJ	O	O
daily	RB	O	O
.	.	O	O

insulin	NN	B-TREATMENT	B-TREATMENT
nph	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
36	CD	O	O
subcu	NN	O	O
q	NN	O	O
am	VBP	O	O
,	,	O	O
30	CD	O	O
subcu	NN	O	O
q	NN	O	O
pm	NN	O	O
.	.	O	O

nystatin	JJ	B-TREATMENT	B-TREATMENT
mouthwash	NN	I-TREATMENT	I-TREATMENT
swish	NN	O	I-TREATMENT
and	CC	O	I-TREATMENT
swallow	NN	O	I-TREATMENT
.	.	O	O

nexium	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
20	CD	O	O
mg	NN	O	O
po	JJ	O	O
daily	RB	O	O
.	.	O	O

vancomycin	NN	B-TREATMENT	B-TREATMENT
1	CD	O	O
gm	NN	O	O
iv	NN	O	O
q12h	NN	O	O
.	.	O	O

shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
71-year-old-female	JJ	O	O
with	IN	O	O
asthma	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
recent	JJ	B-PROBLEM	B-PROBLEM
exacerbation	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
lower	JJR	B-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
who	WP	O	O
,	,	O	O
at	IN	O	O
her	PRP$	O	O
baseline	NN	O	O
,	,	O	O
gets	VBZ	O	O
short	JJ	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
walking	NN	O	I-PROBLEM
across	IN	O	O
the	DT	O	O
room	NN	O	O
and	CC	O	O
sleeps	NNS	O	O
on	IN	O	O
four	CD	O	O
pillows	NNS	O	O
times	RB	O	O
several	JJ	O	O
years	NNS	O	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
reported	VBN	O	O
that	IN	O	O
she	PRP	O	O
has	VBZ	O	O
had	VBN	O	O
upper	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
times	NNS	O	O
several	JJ	O	O
days	NNS	O	O
with	IN	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
exertion	NN	O	O
and	CC	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
eventually	RB	O	O
at	IN	O	O
rest	NN	O	O
with	IN	O	O
marked	JJ	B-PROBLEM	B-PROBLEM
wheezing	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
also	RB	O	O
has	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
cough	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	O	B-PROBLEM
small	JJ	O	I-PROBLEM
amount	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
white	JJ	B-PROBLEM	I-PROBLEM
sputum	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

at	IN	O	O
3	CD	O	O
a.m.	NN	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
admission	NN	O	O
,	,	O	O
she	PRP	O	O
became	VBD	O	O
much	JJ	O	O
worse	JJR	O	O
and	CC	O	O
after	IN	O	O
several	JJ	O	O
days	NNS	O	O
of	IN	O	O
increasing	VBG	O	O
her	PRP$	B-TREATMENT	O
meter-dosed	JJ	I-TREATMENT	O
inhaler	NN	I-TREATMENT	O
use	NN	O	O
,	,	O	O
she	PRP	O	O
call	VBP	O	O
emergency	NN	O	O
medical	JJ	O	O
services	NNS	O	O
which	WDT	O	O
assessed	VBD	O	O
her	PRP	O	O
as	IN	O	O
having	VBG	O	O
heart	NN	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
elevated	JJ	B-PROBLEM	B-PROBLEM
jugular	NN	I-PROBLEM	I-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
distention	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
rales	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
received	VBD	O	O
aspirin	RB	B-TREATMENT	B-TREATMENT
,	,	O	O
lasix	VBD	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
intravenously	RB	O	O
times	RB	O	O
two	CD	O	O
,	,	O	O
0.8	CD	O	O
mg	NN	O	O
of	IN	O	O
nitroglycerin	JJ	B-TREATMENT	B-TREATMENT
times	NNS	O	O
four	CD	O	O
,	,	O	O
plus	CC	O	O
morphine	JJ	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

her	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
up	RB	O	O
to	TO	O	O
220/110	CD	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
the	DT	O	O
hospital	NN	O	O
for	IN	O	O
orthopedics	NNS	O	O
emergency	NN	O	O
room	NN	O	O
where	WRB	O	O
she	PRP	O	O
was	VBD	O	O
assessed	VBN	O	O
as	IN	O	O
having	VBG	O	O
asthma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
then	RB	O	O
received	VBD	O	O
continuous	JJ	B-TREATMENT	B-TREATMENT
nebulizer	NN	I-TREATMENT	I-TREATMENT
treatments	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
approximately	RB	O	O
eight	CD	O	O
hours	NNS	O	O
with	IN	O	O
minimal	JJ	O	O
improvement	NN	O	O
.	.	O	O

she	PRP	O	O
did	VBD	O	O
receive	VB	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
nitroglycerin	NNS	I-TREATMENT	I-TREATMENT
in	IN	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
for	IN	O	O
blood	NN	O	B-TEST
pressure	NN	O	I-TEST
controlled	VBD	O	O
to	TO	O	O
the	DT	O	O
170s	NNS	O	O
.	.	O	O

she	PRP	O	O
initially	RB	O	O
received	VBD	O	O
a	DT	O	B-TREATMENT
treatment	NN	O	I-TREATMENT
of	IN	O	O
bipap	NN	B-TREATMENT	B-TREATMENT
on	IN	O	O
arrival	NN	O	O
as	IN	O	O
she	PRP	O	O
was	VBD	O	O
barely	RB	O	O
able	JJ	O	O
to	TO	O	O
speak	VB	O	O
.	.	O	O

she	PRP	O	O
also	RB	O	O
received	VBD	O	O
80	CD	B-TREATMENT	O
mg	NNS	I-TREATMENT	O
of	IN	I-TREATMENT	O
solu-medrol	NN	I-TREATMENT	B-TREATMENT
in	IN	O	O
the	DT	O	O
emergency	NN	O	O
department	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
never	RB	O	B-PROBLEM
hypoxic	VBN	B-PROBLEM	I-PROBLEM
but	CC	O	O
initially	RB	O	O
her	PRP$	B-TEST	B-TEST
arterial	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
gas	NN	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
respiratory	JJ	I-PROBLEM	I-PROBLEM
acidosis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-TEST	O
pco2	NN	I-TEST	O
of	IN	O	O
71	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
does	VBZ	O	O
have	VB	O	O
a	DT	O	O
vague	JJ	O	O
history	NN	O	O
of	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
obstructive	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
this	DT	O	O
is	VBZ	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
inaccurate	JJ	O	O
.	.	O	O

she	PRP	O	O
also	RB	O	O
received	VBD	O	O
captopril	JJ	B-TREATMENT	B-TREATMENT
12.5	CD	O	O
mg	NN	O	O
times	NNS	O	O
one	CD	O	O
.	.	O	O

recently	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
been	VBN	O	O
treated	VBN	O	O
with	IN	O	O
several	JJ	B-TREATMENT	B-TREATMENT
steroid	JJ	I-TREATMENT	I-TREATMENT
tapers	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

it	PRP	O	O
either	DT	O	O
ended	VBD	O	O
in	IN	O	O
2011-04-11	JJ	O	O
or	CC	O	O
continued	VBN	O	O
through	IN	O	O
2011-05-11	JJ	O	O
with	IN	O	O
use	NN	O	O
of	IN	O	O
augmentin	NN	B-TREATMENT	B-TREATMENT
;	:	O	O
and	CC	O	O
,	,	O	O
by	IN	O	O
report	NN	O	O
,	,	O	O
lasted	VBN	O	O
until	IN	O	O
06-07	NNP	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
the	DT	O	O
family	NN	O	O
said	VBD	O	O
the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
been	VBN	O	O
on	IN	O	O
steroids	NNS	B-TREATMENT	B-TREATMENT
for	IN	O	O
several	JJ	O	O
weeks	NNS	O	O
.	.	O	O

1.	CD	O	O
asthma	NN	B-PROBLEM	B-PROBLEM
as	IN	O	O
a	DT	O	O
child	NN	O	O
which	WDT	O	O
recurred	VBD	O	O
in	IN	O	O
2001	CD	O	O
.	.	O	O

she	PRP	O	O
takes	VBZ	O	O
an	DT	B-TREATMENT	B-TREATMENT
albuterol	NN	I-TREATMENT	I-TREATMENT
and	CC	O	I-TREATMENT
atrovent	JJ	B-TREATMENT	I-TREATMENT
inhalers	NNS	I-TREATMENT	I-TREATMENT
as	RB	O	O
well	RB	O	O
as	IN	O	O
serevent	NN	B-TREATMENT	O
and	CC	O	O
flovent	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
had	VBN	O	O
multiple	JJ	O	B-PROBLEM
hospitalizations	NNS	O	I-PROBLEM
and	CC	O	O
has	VBZ	O	O
never	RB	O	O
been	VBN	O	O
intubated	VBN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
had	VBN	O	O
multiple	VBN	B-TREATMENT	O
prednisone	NN	I-TREATMENT	B-TREATMENT
tapers	NNS	I-TREATMENT	I-TREATMENT
(	(	O	O
see	VB	O	O
history	NN	O	O
of	IN	O	O
present	JJ	O	B-PROBLEM
illness	NN	O	I-PROBLEM
)	)	O	O
.	.	O	O

on	IN	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
or	CC	O	O
sometime	RB	O	O
after	IN	O	O
it	PRP	O	O
was	VBD	O	O
discontinued	VBN	O	O
,	,	O	O
depending	VBG	O	O
on	IN	O	O
the	DT	O	O
version	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
developed	VBD	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
has	VBZ	O	O
been	VBN	O	O
a	DT	B-PROBLEM	B-PROBLEM
vega	NN	I-PROBLEM	I-PROBLEM
problem	NN	I-PROBLEM	I-PROBLEM
for	IN	O	O
her	PRP$	O	O
and	CC	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
dyazide	NN	B-TREATMENT	B-TREATMENT
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
.	.	O	O

pulmonary	JJ	B-TEST	B-TEST
function	NN	I-TEST	I-TEST
tests	NNS	I-TEST	I-TEST
most	RBS	O	O
recently	RB	O	O
in	IN	O	O
2009-01-10	JJ	O	O
were	VBD	O	O
not	RB	O	O
obstructive	JJ	O	B-PROBLEM
.	.	O	O

they	PRP	O	O
showed	VBD	O	O
an	DT	B-TEST	O
fvc	NN	I-TEST	O
of	IN	O	O
91%	CD	O	O
of	IN	O	O
predicted	VBN	O	O
,	,	O	O
and	CC	O	O
a	DT	B-TEST	O
fev1	NN	I-TEST	O
of	IN	O	O
104%	CD	O	O
of	IN	O	O
predicted	VBN	O	O
,	,	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
ratio	NN	I-TEST	I-TEST
of	IN	O	O
114%	CD	O	O
.	.	O	O

in	IN	O	O
2003	CD	O	O
,	,	O	O
there	EX	O	O
was	VBD	O	O
19%	CD	O	O
change	NN	O	O
of	IN	O	O
the	DT	O	O
fev1	NN	O	O
and	CC	O	O
an	DT	O	O
11%	CD	O	O
change	NN	O	O
in	IN	O	O
the	DT	O	O
fvc	NN	O	O
with	IN	O	O
bronchodilators	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

2.	CD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
especially	RB	O	O
on	IN	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

3.	CD	O	O
hypoplastic	JJ	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
hip	NN	B-TREATMENT	B-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
the	DT	O	O
age	NN	O	O
of	IN	O	O
five	CD	O	O
.	.	O	O

4.	CD	O	O
polio	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

5.	CD	O	O
status	NN	O	O
post	NN	O	O
cesarean	JJ	B-TREATMENT	B-TREATMENT
section	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

6.	CD	O	O
history	NN	O	O
of	IN	O	O
zoster	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

7.	CD	O	O
past	JJ	O	O
discharge	NN	O	O
summary	JJ	O	O
mention	NN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
obstructive	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
never	RB	O	O
smoked	VBN	O	O
.	.	O	O

8.	CD	O	O
incontinent	NN	B-PROBLEM	O
of	IN	I-PROBLEM	O
both	DT	I-PROBLEM	O
stool	NN	I-PROBLEM	O
and	CC	I-PROBLEM	O
urine	NN	I-PROBLEM	B-TEST
.	.	O	O

9.	CD	O	O
allergic	JJ	B-PROBLEM	B-PROBLEM
rhinitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

brother	NN	O	O
and	CC	O	O
sister	NN	O	O
both	DT	O	O
have	VBP	O	O
asthma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

brother	NN	O	O
has	VBZ	O	O
diabetes	VBZ	B-PROBLEM	B-PROBLEM
mellitus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
family	NN	O	O
history	NN	O	O
of	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

dyazide	RB	B-TREATMENT	O
25/37.5	CD	O	O
p.o.	NN	O	O
q.d.	NN	O	O
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
atrovent	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
flovent	JJ	B-TREATMENT	B-TREATMENT
inhalers	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
swanson	$	B-TREATMENT	O
60	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
and	CC	O	O
serevent	JJ	B-TREATMENT	O
2	CD	O	O
puffs	NNS	O	O
q.12h.	NN	O	O

on	IN	O	O
transfer	NN	O	O
,	,	O	O
she	PRP	O	O
also	RB	O	O
arrived	VBD	O	O
on	IN	O	O
200	CD	O	O
mcg	NN	O	O
of	IN	O	O
nitroglycerin	JJ	B-TREATMENT	B-TREATMENT
and	CC	O	O
reports	NNS	O	O
p.r.n.	IN	O	O
alka-seltzer	NN	B-TREATMENT	B-PROBLEM
,	,	O	O
sinus	NN	B-TREATMENT	B-PROBLEM
and	CC	O	O
nyquil	NN	B-TREATMENT	O
use	NN	O	O
.	.	O	O

review	NN	B-TEST	B-TEST
of	IN	I-TEST	I-TEST
systems	NNS	I-TEST	I-TEST
were	VBD	O	O
notable	JJ	O	O
for	IN	O	O
lower	JJR	B-PROBLEM	B-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
worsened	VBD	O	O
in	IN	O	O
may	MD	O	O
.	.	O	O

she	PRP	O	O
denies	VBZ	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
does	VBZ	O	O
have	VB	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
tightness	NN	I-PROBLEM	I-PROBLEM
since	IN	O	O
two	CD	O	O
days	NNS	O	O
ago	RB	O	O
,	,	O	O
coinciding	VBG	O	O
with	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
wheezing	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
paroxysms	NNS	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
cough	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
resolves	VBZ	O	O
with	IN	O	O
water	NN	O	O
and	CC	O	O
sitting	VBG	O	O
up	RP	O	O
.	.	O	O

this	DT	O	O
is	VBZ	O	O
worse	JJR	O	O
when	WRB	O	O
she	PRP	O	O
has	VBZ	O	O
asthma	JJ	B-PROBLEM	B-PROBLEM
flares	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
denies	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
rash	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
any	DT	B-PROBLEM	B-PROBLEM
genitourinary	JJ	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-TEST
constant	JJ	I-PROBLEM	I-TEST
runny	NN	I-PROBLEM	I-TEST
nose	NN	I-PROBLEM	I-TEST
and	CC	O	O
has	VBZ	O	O
had	VBN	O	O
no	DT	O	O
sick	JJ	O	B-PROBLEM
contacts	NNS	O	I-PROBLEM
.	.	O	O

physical	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
revealed	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
,	,	O	O
respiratory	JJ	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
23	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
113	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
130s/90s	CD	O	O
.	.	O	O

in	IN	O	O
general	JJ	O	O
,	,	O	O
this	DT	O	O
was	VBD	O	O
a	DT	O	O
female	NN	O	O
in	IN	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
secondary	JJ	O	O
to	TO	O	O
shortness	VB	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
spoke	VBD	O	O
in	IN	O	O
short	JJ	O	B-PROBLEM
phrases	NNS	O	I-PROBLEM
and	CC	O	O
then	RB	O	O
in	IN	O	O
complete	JJ	O	O
sentences	NNS	O	O
as	IN	O	O
the	DT	O	O
night	NN	O	O
went	VBD	O	O
on	IN	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
jugular	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
distention	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
hdr	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

sclerae	NN	O	O
were	VBD	O	O
anicteric	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

cardiovascular	NN	O	O
revealed	VBD	O	O
she	PRP	O	O
was	VBD	O	O
tachycardic	JJ	B-PROBLEM	O
with	IN	O	O
a	DT	O	O
regular	JJ	O	O
first	JJ	O	O
heart	NN	O	O
sound	NN	O	O
and	CC	O	O
second	JJ	O	B-PROBLEM
heart	NN	O	I-PROBLEM
sound	NN	O	I-PROBLEM
.	.	O	O

pulmonary	NN	O	O
revealed	VBD	O	O
she	PRP	O	O
had	VBD	O	O
diffuse	NN	B-PROBLEM	B-PROBLEM
wheezes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
were	VBD	O	O
no	DT	O	O
rales	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
reduced	VBN	B-PROBLEM	O
but	CC	I-PROBLEM	O
adequate	JJ	I-PROBLEM	O
air	NN	I-PROBLEM	O
movement	NN	I-PROBLEM	O
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
revealed	VBD	O	O
normal	JJ	O	O
active	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
,	,	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
obese	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
nondistended	VBD	B-PROBLEM	B-PROBLEM
.	.	O	O

extremities	NNS	O	O
revealed	VBD	O	O
left	VBD	O	B-PROBLEM
lower	JJR	O	I-PROBLEM
extremity	NN	O	I-PROBLEM
was	VBD	O	O
hypoplastic	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
pitting	VBG	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	O
both	DT	I-PROBLEM	O
sides	NNS	I-PROBLEM	O
of	IN	O	O
the	DT	O	O
lower	JJR	O	O
extremities	NNS	O	O
.	.	O	O

the	DT	O	O
right	JJ	O	O
ankle	NN	O	O
was	VBD	O	O
somewhat	RB	B-PROBLEM	O
tender	NN	I-PROBLEM	O
from	IN	O	O
this	DT	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

neurologically	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
oriented	VBN	O	O
to	TO	O	O
person	NN	O	O
,	,	O	O
place	NN	O	O
,	,	O	O
and	CC	O	O
time	NN	O	O
;	:	O	O
however	RB	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
somewhat	RB	B-PROBLEM	B-PROBLEM
drowsy	JJ	I-PROBLEM	I-PROBLEM
and	CC	O	O
at	IN	O	O
times	NNS	O	O
was	VBD	O	O
difficult	JJ	O	O
to	TO	O	O
keep	VB	O	O
awake	NN	O	O
during	IN	O	O
conversations	NNS	O	O
.	.	O	O

white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
10.2	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
of	IN	O	O
37.5	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
of	IN	O	O
236	CD	O	O
.	.	O	O

inr	NN	B-TEST	O
of	IN	O	O
1.3	CD	O	O
,	,	O	O
ptt	NN	B-TEST	B-TEST
of	IN	O	O
30.3	CD	O	O
.	.	O	O

urinalysis	NN	B-TEST	B-TEST
revealed	VBD	O	O
6	CD	O	O
to	TO	O	O
10	CD	O	O
red	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cells	NNS	I-TEST	I-TEST
,	,	O	O
0	CD	O	O
to	TO	O	O
2	CD	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cells	NNS	I-TEST	I-TEST
,	,	O	O
4	CD	O	O
epithelial	JJ	B-TEST	O
cells	NNS	I-TEST	O
with	IN	O	O
foley	NN	B-TREATMENT	B-TREATMENT
in	IN	O	O
place	NN	O	O
.	.	O	O

urine	JJ	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
later	RB	O	O
grew	VBD	O	O
out	RP	O	O
contaminated	JJ	O	B-PROBLEM
specimen	NNS	O	I-PROBLEM
.	.	O	O

differential	NN	B-TEST	O
with	IN	O	O
72	CD	O	O
polys	NNS	B-TEST	B-TEST
,	,	O	O
16	CD	O	O
lymphocytes	NNS	B-TEST	B-TEST
,	,	O	O
4.6	CD	O	O
monocytes	NNS	B-TEST	O
,	,	O	O
6.3	CD	O	O
eosinophils	NNS	B-TEST	B-PROBLEM
.	.	O	O

chem-7	NN	B-TEST	B-TEST
was	VBD	O	O
notable	JJ	O	O
for	IN	O	O
a	DT	B-TEST	B-TREATMENT
bicarbonate	NN	I-TEST	I-TREATMENT
of	IN	O	O
31	CD	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
glucose	NN	I-TEST	I-TEST
of	IN	O	O
156	CD	O	O
.	.	O	O

arterial	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
gas	NN	I-TEST	I-TEST
was	VBD	O	O
7.24/71/227	CD	O	O
.	.	O	O

creatine	NN	B-TEST	B-TEST
kinase	NN	I-TEST	I-TEST
was	VBD	O	O
243	CD	O	O
,	,	O	O
with	IN	O	O
a	DT	B-TEST	O
mb	NN	I-TEST	O
of	IN	O	O
9	CD	O	O
,	,	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
troponin	NN	I-TEST	I-TEST
of	IN	O	O
less	JJR	O	O
than	IN	O	O
0.3.	CD	O	O

chest	JJS	B-TEST	B-TEST
x-ray	JJ	I-TEST	I-TEST
showed	VBD	O	O
low	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
volumes	NNS	I-PROBLEM	I-PROBLEM
but	CC	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

electrocardiogram	NN	B-TEST	B-TEST
showed	VBD	O	O
sinus	JJ	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
115	CD	O	O
with	IN	O	O
a	DT	O	O
normal	JJ	O	O
axis	NN	O	O
,	,	O	O
intermittent	JJ	B-PROBLEM	B-PROBLEM
q	NN	I-PROBLEM	I-PROBLEM
wave	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
iii;	NN	I-PROBLEM	O
a	DT	B-PROBLEM	O
wavy	JJ	I-PROBLEM	O
baseline	NN	I-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
stress	JJ	I-TEST	I-TEST
echocardiogram	NN	I-TEST	I-TEST
with	IN	O	O
a	DT	O	O
normal	JJ	O	O
ejection	NN	O	O
fraction	NN	O	O
in	IN	O	O
2007	CD	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	I-TREATMENT
atrovent	NN	B-TREATMENT	I-TREATMENT
continuous	JJ	I-TREATMENT	I-TREATMENT
nebulizers	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
was	VBD	O	O
weaned	VBN	O	O
then	RB	O	O
to	TO	O	O
intermittent	VB	B-TREATMENT	O
nebulizer	JJ	I-TREATMENT	B-TREATMENT
treatments	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
then	RB	O	O
to	TO	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
meter-dosed	JJ	I-TREATMENT	I-TREATMENT
inhalers	NNS	I-TREATMENT	I-TREATMENT
taking	VBG	O	O
them	PRP	O	O
q.4h.	NN	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
salmeterol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
flovent	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
solu-medrol	NN	B-TREATMENT	B-TREATMENT
80	CD	O	O
mg	NN	O	O
q.8h.	NN	O	O
then	RB	O	O
converted	VBD	O	O
to	TO	O	O
prednisone	VB	B-TREATMENT	B-TREATMENT
at	IN	O	O
60	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
singulair	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

serial	JJ	B-TEST	B-TEST
arterial	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
gases	NNS	I-TEST	I-TEST
were	VBD	O	O
followed	VBN	O	O
after	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
arterial	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
.	.	O	O

her	PRP$	B-TEST	O
pco2	NN	I-TEST	O
gradually	RB	O	O
declined	VBD	O	O
to	TO	O	O
the	DT	O	O
48	CD	O	O
range	NN	O	O
.	.	O	O

despite	IN	O	O
episodes	NNS	O	O
of	IN	O	O
somnolence	NN	B-PROBLEM	B-PROBLEM
the	DT	O	O
first	JJ	O	O
night	NN	O	O
which	WDT	O	O
were	VBD	O	O
presumably	RB	O	O
due	JJ	O	O
to	TO	O	O
having	VBG	O	O
spent	VBN	O	O
the	DT	O	O
entire	JJ	O	O
night	NN	O	O
in	IN	O	O
the	DT	O	O
emergency	NN	O	O
department	NN	O	O
,	,	O	O
she	PRP	O	O
never	RB	O	O
became	VBD	O	O
more	RBR	B-PROBLEM	O
hypercarbic	JJ	I-PROBLEM	O
,	,	O	O
and	CC	O	O
her	PRP$	B-TEST	O
pco2	NN	I-TEST	O
trended	VBD	O	O
to	TO	O	O
48	CD	O	O
by	IN	O	O
the	DT	O	O
time	NN	O	O
the	DT	B-TREATMENT	O
arterial	JJ	I-TREATMENT	O
line	NN	I-TREATMENT	O
was	VBD	O	O
discontinued	VBN	O	O
.	.	O	O

on	IN	O	O
the	DT	O	O
night	NN	O	O
of	IN	O	O
admission	NN	O	O
and	CC	O	O
thereafter	RB	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
very	RB	I-PROBLEM	I-PROBLEM
stridorous	JJ	I-PROBLEM	I-PROBLEM
sounding	VBG	I-PROBLEM	I-PROBLEM
breathing	NN	I-PROBLEM	I-PROBLEM
when	WRB	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
asleep	RB	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
given	VBN	O	O
a	DT	B-TREATMENT	O
trial	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
80/20	CD	I-TREATMENT	O
mixed	JJ	I-TREATMENT	B-PROBLEM
helium/oxygen	NN	I-TREATMENT	I-PROBLEM
to	TO	O	I-PROBLEM
decrease	VB	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
stridor	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
had	VBD	O	O
minimal	JJ	O	B-PROBLEM
effect	NN	O	I-PROBLEM
.	.	O	O

ear/nose/throat	NN	O	O
recommended	VBD	O	O
not	RB	O	O
considering	VBG	O	O
this	DT	O	O
an	DT	B-PROBLEM	O
airway	NN	I-PROBLEM	O
problem	NN	I-PROBLEM	O
unless	IN	O	O
she	PRP	O	O
was	VBD	O	O
stridorous	JJ	B-PROBLEM	O
while	IN	I-PROBLEM	O
awake	NN	I-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
ruled	VBD	O	O
out	RP	O	O
for	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
serial	JJ	B-TEST	B-TEST
creatine	NN	I-TEST	I-TEST
kinases	NNS	I-TEST	I-TEST
,	,	O	O
although	IN	O	O
these	DT	O	O
did	VBD	O	O
rise	NN	O	O
to	TO	O	O
816	CD	O	O
.	.	O	O

mb	NN	B-TEST	O
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
captopril	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
this	DT	O	O
was	VBD	O	O
switched	VBN	O	O
to	TO	O	O
norvasc	VB	B-TREATMENT	B-TEST
7.5	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
on	IN	O	O
discharge	NN	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
hyperdynamic	JJ	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
ventricular	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
normal	JJ	O	O
thickness	NN	O	O
and	CC	O	O
size	NN	O	O
,	,	O	O
and	CC	O	O
no	DT	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
valvular	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
apparently	RB	O	O
did	VBD	O	O
not	RB	O	O
have	VB	O	O
a	DT	O	B-TREATMENT
cardiovascular	JJ	O	I-TREATMENT
component	NN	O	I-TREATMENT
to	TO	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
wheezing	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
however	RB	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
to	TO	O	O
go	VB	O	O
home	NN	O	O
on	IN	O	O
lasix	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
to	TO	O	O
help	VB	O	O
with	IN	O	O
lower	JJR	B-PROBLEM	B-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
as	IN	O	O
she	PRP	O	O
experiences	VBZ	O	O
discomfort	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
this	DT	O	O
,	,	O	O
and	CC	O	O
the	DT	O	O
team	NN	O	O
felt	VBD	O	O
this	DT	O	O
may	MD	O	O
be	VB	O	O
a	DT	O	O
limiting	JJ	O	O
factor	NN	O	O
with	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
prednisone	NN	I-TREATMENT	I-TREATMENT
compliance	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
a	DT	B-TREATMENT	O
sliding-scale	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
regular	JJ	I-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
while	IN	O	O
she	PRP	O	O
was	VBD	O	O
in	IN	O	O
house	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
given	VBN	O	O
500	CD	O	O
mg	JJ	O	O
p.o.	NN	O	O
q.d.	NN	O	O
of	IN	O	O
metformin	NN	B-TREATMENT	B-TREATMENT
to	TO	O	O
treat	VB	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
steroid-induced	JJ	I-PROBLEM	I-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
on	IN	O	O
discharge	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
briefly	NN	O	O
with	IN	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
because	IN	O	O
of	IN	O	O
the	DT	B-PROBLEM	O
gram-positive	JJ	I-PROBLEM	O
cocci	NN	I-PROBLEM	O
in	IN	O	O
her	PRP$	B-TEST	B-TEST
sputum	JJ	I-TEST	I-TEST
culture	NN	I-TEST	I-TEST
;	:	O	O
however	RB	O	O
,	,	O	O
her	PRP	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
were	VBD	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
consistent	JJ	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
viral	JJ	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
continued	VBN	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

1.	CD	O	O
lasix	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

2.	CD	O	O
combivent	JJ	B-TREATMENT	B-TREATMENT
meter-dosed	JJ	I-TREATMENT	I-TREATMENT
inhaler	NN	I-TREATMENT	I-TREATMENT
2	CD	O	O
puffs	NNS	O	O
q.4h.	RB	O	O
weaning	VBG	O	O
to	TO	O	O
albuterol	VB	B-TREATMENT	B-TREATMENT
meter-dosed	JJ	I-TREATMENT	I-TREATMENT
inhaler	NN	I-TREATMENT	I-TREATMENT
2	CD	O	O
puffs	NNS	O	O
q.4h.	NN	O	O

3.	CD	O	O
salmeterol	NN	B-TREATMENT	B-TREATMENT
2	CD	O	O
puffs	NNS	O	O
q.12h.	NN	O	O

4.	CD	O	O
flovent	JJ	B-TREATMENT	B-TREATMENT
220	CD	O	O
mcg	NN	O	O
2	CD	O	O
puffs	NNS	O	O
q.12h.	NN	O	O

5.	CD	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
with	IN	O	O
taper	NN	O	O
.	.	O	O

6.	CD	O	O
fentress	JJ	B-TREATMENT	O
60	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

7.	CD	O	O
singulair	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

8.	CD	O	O
univasc	JJ	B-TREATMENT	O
7.5	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

9.	CD	O	O
metformin	NN	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

dyazide	NN	B-TREATMENT	O
was	VBD	O	O
discontinued	VBN	O	O
.	.	O	O

discharge	NN	O	O
services	NNS	O	O
included	VBD	O	O
visiting	VBG	O	O
nursing	NN	O	O
which	WDT	O	O
was	VBD	O	O
to	TO	O	O
assess	VB	O	O
in	IN	O	O
her	PRP$	O	B-TREATMENT
inhaler	NN	O	I-TREATMENT
technique	NN	O	I-TREATMENT
,	,	O	O
monitor	VB	O	O
her	PRP$	B-TEST	B-TEST
fasting	NN	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
sugars	NNS	I-TEST	I-TEST
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
her	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
,	,	O	O
monitor	NN	O	O
her	PRP$	B-TEST	O
peak	NN	I-TEST	O
flows	VBZ	I-TEST	O
,	,	O	O
and	CC	O	O
assess	IN	O	O
her	PRP$	O	B-PROBLEM
mobility	NN	O	I-PROBLEM
and	CC	O	O
activities	NNS	O	O
of	IN	O	O
daily	JJ	O	O
living	NN	O	O
at	IN	O	O
home	NN	O	O
.	.	O	O

1.	CD	O	O
asthma	JJ	B-PROBLEM	B-PROBLEM
flare	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

3.	CD	O	O
steroid-induced	JJ	B-PROBLEM	B-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
presented	VBN	O	O
with	IN	O	O
a	DT	O	O
chief	JJ	O	O
complaint	NN	O	O
of	IN	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

following	VBG	O	O
evaluation	NN	B-TEST	B-TEST
and	CC	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
the	DT	O	O
patient	NN	O	O
&apos;s	JJ	O	O
disposition	NN	O	O
at	IN	O	O
the	DT	O	O
end	NN	O	O
of	IN	O	O
the	DT	O	O
visit	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
as	IN	O	O
an	DT	O	O
inpatient	NN	O	O
to	TO	O	O
oaksgekesser/	VB	O	O
memorial	JJ	O	O
hospital	NN	O	O
.	.	O	O

your	PRP$	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
under	IN	O	O
the	DT	O	O
care	NN	O	O
of	IN	O	O
tubbolm	NN	O	O
,	,	O	O
lisswhiti	JJ	O	O
n	NN	O	O
with	IN	O	O
a	DT	O	O
preliminary	JJ	O	O
diagnosis	NN	O	O
of	IN	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

a	DT	O	O
40-year-old	JJ	O	O
female	NN	O	O
with	IN	O	O
history	NN	O	O
of	IN	O	O
non-st-elevation	JJ	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
2016-09-30	JJ	O	O
with	IN	O	O
stent	NN	B-TREATMENT	B-TREATMENT
to	TO	I-TREATMENT	O
the	DT	I-TREATMENT	O
lad	NN	I-TREATMENT	O
and	CC	O	O
50%	CD	O	O
to	TO	O	O
the	DT	O	O
mid	NN	O	O
lad	NN	O	O
,	,	O	O
had	VBD	O	O
instent	JJ	B-PROBLEM	B-TREATMENT
restenosis	NN	I-PROBLEM	I-TREATMENT
in	IN	O	O
2017-04-02	JJ	O	O
and	CC	O	O
then	RB	O	O
underwent	JJ	O	O
brachytherapy	NN	B-TREATMENT	O
to	TO	I-TREATMENT	O
the	DT	I-TREATMENT	O
rca	NN	I-TREATMENT	O
,	,	O	O
who	WP	O	O
presented	VBD	O	O
to	TO	O	O
baldpate	VB	O	O
hospital	NN	O	O
with	IN	O	O
several	JJ	O	O
weeks	NNS	O	O
of	IN	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
similar	JJ	O	O
to	TO	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
anginal	JJ	I-PROBLEM	I-PROBLEM
equivalent	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
mi	NN	B-PROBLEM	O
in	IN	O	O
the	DT	O	O
past	NN	O	O
.	.	O	O

no	DT	O	O
relief	NN	O	O
with	IN	O	O
nitroglycerin	JJ	B-TREATMENT	B-TREATMENT
x3	NN	O	I-TREATMENT
.	.	O	O

positive	JJ	O	B-PROBLEM
shortness	NN	B-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

troponins	NNS	B-TEST	B-TEST
have	VBP	O	O
been	VBN	O	O
less	JJR	O	O
than	IN	O	O
0.01.	CD	O	O

with	IN	O	O
history	NN	O	O
,	,	O	O
will	MD	O	O
go	VB	O	O
for	IN	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
evaluation	NN	I-TEST	I-TEST
.	.	O	O

still	RB	O	O
getting	VBG	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
intermittently	RB	O	O
,	,	O	O
but	CC	O	O
relieved	VBN	O	O
by	IN	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

was	VBD	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
heparin	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
nitroglycerin	JJ	B-TREATMENT	B-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
only	JJ	O	B-PROBLEM
intermittent	JJ	O	I-PROBLEM
relief	NN	O	I-PROBLEM
.	.	O	O

1.	CD	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2.	CD	O	O
obesity	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

3.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

5.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

2016-09-30	JJ	O	B-PROBLEM
non-st-elevation	JJ	B-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
100%	CD	O	O
rca	NN	O	O
,	,	O	O
three	CD	B-TREATMENT	B-TREATMENT
stents	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
50%	CD	O	O
mid	NN	O	O
lad	NN	O	O
.	.	O	O

2017-04-02	JJ	O	O
instent	NN	B-PROBLEM	B-TREATMENT
restenosis	NN	I-PROBLEM	I-TREATMENT
status	NN	O	I-TREATMENT
post	NN	O	I-TREATMENT
brachytherapy	NN	B-TREATMENT	I-TREATMENT
.	.	O	O

6.	CD	O	O
gerd	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

7.	CD	O	O
asthma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

8.	CD	O	O
sciatica	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

9.	CD	O	O
degenerative	JJ	B-PROBLEM	B-PROBLEM
joint	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

10.	CD	O	O
glomerulosclerosis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

brothers	NNS	O	O
with	IN	O	O
william	JJ	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
mi	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

father	NN	O	O
with	IN	O	O
emphysema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

mother	NN	O	O
with	IN	O	O
lung	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

aspirin	NN	B-TREATMENT	B-TREATMENT
under	IN	O	O
which	WDT	O	O
she	PRP	O	O
develops	VBZ	O	O
worsening	NN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
shortness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
asthma	NN	B-PROBLEM	B-PROBLEM
flare	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
tetracycline	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
sulfa	NN	B-TREATMENT	B-TREATMENT
,	,	O	O

demerol	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

1.	CD	O	O
diovan	NN	B-TREATMENT	B-TREATMENT
106	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

2.	CD	O	O
advair	JJ	B-TREATMENT	B-TREATMENT
500/50	CD	O	O
two	CD	O	O
puffs	NNS	O	O
b.i.d.	VBP	O	O

3.	CD	O	O
plavix	JJ	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

4.	CD	O	O
crestor	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

5.	CD	O	O
neurontin	JJ	B-TREATMENT	B-TREATMENT
300	CD	O	O
mg	NN	O	O
t.i.d.	NN	O	O

6.	CD	O	O
prilosec	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O

7.	CD	O	O
vicodin	NN	B-TREATMENT	B-TREATMENT
as	IN	O	O
needed	VBN	O	O
.	.	O	O

8.	CD	O	O
trazodone	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

9.	CD	O	O
singulair	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

10.	CD	O	O
flexeril	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
t.i.d.	NN	O	O

11.	CD	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O

12.	CD	O	O
humibid	NN	B-TREATMENT	B-TREATMENT
3600	CD	O	O
b.i.d.	NN	O	O

13.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O

14.	CD	O	O
zetia	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

15.	CD	O	O
benadryl	NN	B-TREATMENT	B-TREATMENT
as	IN	O	O
needed	VBN	O	O
.	.	O	O

16.	CD	O	O
tricor	JJ	B-TREATMENT	O
106	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

17.	CD	O	O
premarin	JJ	B-TREATMENT	B-TREATMENT
0.3	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

18.	CD	O	O
prozac	JJ	B-TREATMENT	O
40	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

19.	CD	O	O
omega-3	JJ	B-TREATMENT	B-TREATMENT
fatty	JJ	I-TREATMENT	I-TREATMENT
acids	NNS	I-TREATMENT	I-TREATMENT
t.i.d.	NN	O	O

well	RB	O	O
appearing	VBG	O	O
in	IN	O	O
no	DT	O	O
apparent	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
jvd	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

positive	JJ	O	B-PROBLEM
tenderness	NN	B-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
sternum	VB	I-PROBLEM	I-PROBLEM
.	.	O	O

chest	NN	O	O
was	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	I-TEST	O
.	.	O	O

obese	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
soft	JJ	O	O
.	.	O	O

extremities	NNS	O	O
show	VBP	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
2+	CD	B-TEST	O
dorsalis	NN	I-TEST	B-TEST
pedis	NN	I-TEST	I-TEST
,	,	O	O

1+	CD	B-TEST	O
femoral	JJ	I-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
.	.	O	O

troponin-t	NN	B-TEST	O
less	JJR	O	O
than	IN	O	O
0.01.	CD	O	O

ekg	NN	B-TEST	O
:	:	O	O

sinus	NN	B-TEST	B-PROBLEM
,	,	O	O
84	CD	O	O
,	,	O	O
normal	JJ	O	O
axis	NN	O	O
,	,	O	O
qtc	RB	B-TEST	O
430	CD	O	O
,	,	O	O
q	NN	B-PROBLEM	O
's	POS	I-PROBLEM	O
in	IN	I-PROBLEM	O
iii	NN	I-PROBLEM	O
and	CC	I-PROBLEM	O
avf	NN	I-PROBLEM	O
,	,	O	O
no	DT	O	O

st	NN	B-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
as	IN	O	O
compared	VBN	O	O
to	TO	O	O
2017-05-01	JJ	O	O
ekg	NN	B-TEST	O
.	.	O	O

1.	CD	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

the	DT	O	O
patient	NN	O	O
ruled	VBD	O	O
out	RP	O	O
for	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

however	RB	O	O
,	,	O	O
with	IN	O	O
her	PRP$	O	O
history	NN	O	O
of	IN	O	O
disease	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
patient	JJ	O	O
underwent	NN	O	O
a	DT	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
found	VBN	O	O
at	IN	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
to	TO	O	O
have	VB	O	O
mild	VBN	B-PROBLEM	B-PROBLEM
diffuse	JJ	I-PROBLEM	I-PROBLEM
instent	JJ	I-PROBLEM	I-PROBLEM
restenosis	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
mid	NN	I-PROBLEM	I-PROBLEM
stent	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
otherwise	RB	O	O
hemodynamically	RB	O	O
normal	JJ	O	O
and	CC	O	O
the	DT	O	O
coronary	JJ	O	O
arteries	NNS	O	O
otherwise	RB	O	O
were	VBD	O	O
without	IN	O	O
flow-limiting	JJ	B-PROBLEM	B-PROBLEM
stenoses	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
then	RB	O	O
continued	VBN	O	O
on	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
cardiac	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
that	IN	O	O
if	IN	O	O
we	PRP	O	O
attempted	VBD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
desensitize	VB	O	O
her	PRP$	O	O
while	IN	O	O
an	DT	O	O
inpatient	NN	O	O
,	,	O	O
then	RB	O	O
she	PRP	O	O
would	MD	O	O
benefit	VB	O	O
from	IN	O	O
the	DT	O	O
use	NN	O	O
of	IN	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
plavix	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
sent	VBN	O	O
to	TO	O	O
the	DT	O	O
ccu	NN	O	O
and	CC	O	O
underwent	JJ	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
desensitization	NN	I-TREATMENT	I-TREATMENT
protocol	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
which	WDT	O	O
she	PRP	O	O
tolerated	VBD	O	O
well	RB	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
mild	JJ	O	B-PROBLEM
worsening	NN	O	I-PROBLEM
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
asthma	NN	I-PROBLEM	I-PROBLEM
attacks	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
was	VBD	O	O
relieved	VBN	O	O
by	IN	O	O
benadryl	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
occasionally	RB	O	O
albuterol	VB	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
found	VBD	O	O
that	IN	O	O
if	IN	O	O
she	PRP	O	O
took	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
aspirin	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
the	DT	O	O
evening	NN	O	O
with	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
benadryl	NN	I-TREATMENT	I-TREATMENT
that	IN	O	O
she	PRP	O	O
takes	VBZ	O	O
for	IN	O	O
sleep	NN	O	O
,	,	O	O
that	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
asthma	JJ	I-PROBLEM	I-PROBLEM
exacerbation	NN	I-PROBLEM	I-PROBLEM
did	VBD	O	O
not	RB	O	O
occur	VB	O	O
.	.	O	O

aspirin	NN	B-TREATMENT	B-TREATMENT
no	RB	O	O
longer	RBR	O	O
should	MD	O	O
be	VB	O	O
considered	VBN	O	O
an	DT	B-PROBLEM	B-PROBLEM
allergy	NN	I-PROBLEM	I-PROBLEM
for	IN	O	O
this	DT	O	O
patient	NN	O	O
,	,	O	O
and	CC	O	O
she	PRP	O	O
is	VBZ	O	O
going	VBG	O	O
to	TO	O	O
take	VB	O	O
this	DT	O	O
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
.	.	O	O

2.	CD	O	O
hyperlipidemia	NN	B-PROBLEM	B-PROBLEM
:	:	O	O

the	DT	B-TREATMENT	B-TREATMENT
patient	NN	I-TREATMENT	I-TREATMENT
's	POS	I-TREATMENT	I-TREATMENT
lipitor	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
increased	VBN	O	O
to	TO	O	O
80	CD	O	O
mg	NNS	O	O
q.d.	NN	O	O

3.	CD	O	O
back	RB	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
chronic	JJ	I-PROBLEM	I-PROBLEM
issue	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
controlled	VBN	O	O
with	IN	O	O
flexeril	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
vicodin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

patient	NN	O	O
is	VBZ	O	O
able	JJ	O	O
to	TO	O	O
ambulate	VB	O	O
without	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
discomfort	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1.	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O

2.	CD	O	O
plavix	JJ	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

3.	CD	O	O
advair	NN	B-TREATMENT	B-TREATMENT
550	CD	O	O
mcg	NN	O	O
two	CD	O	O
puffs	NNS	O	O
b.i.d.	VBP	O	O

4.	CD	O	O
neurontin	JJ	B-TREATMENT	B-TREATMENT
300	CD	O	O
mg	NN	O	O
t.i.d.	NN	O	O

5.	CD	O	O
protonix	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

6.	CD	O	O
montelukast	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

7.	CD	O	O
bethanechol	NN	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O

8.	CD	O	O
docusate	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O

9.	CD	O	O
zetia	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

10.	CD	O	O
estrogen	NN	B-TREATMENT	B-TREATMENT
0.3	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

11.	CD	O	O
fluoxetine	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

12.	CD	O	O
vicodin	JJ	B-TREATMENT	B-TREATMENT
5-500	JJ	O	O
mg	NN	O	O
tablets	NNS	O	O
q.4-6h.	RB	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

13.	CD	O	O
cyclobenzaprine	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
tablet	NN	O	O
one	CD	O	O
tablet	NN	O	O
orally	RB	O	O
t.i.d.	VB	O	O

14.	CD	O	O
atorvastatin	JJ	B-TREATMENT	B-TREATMENT
80	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

15.	CD	O	O
valsartan	JJ	B-TREATMENT	B-TREATMENT
320	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

16.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
one	CD	O	O
q.d.	NN	O	O

17.	CD	O	O
benadryl	NN	B-TREATMENT	B-TREATMENT
as	IN	O	O
needed	VBN	O	O
.	.	O	O

occipital	JJ	B-PROBLEM	B-PROBLEM
cerebrovascular	JJ	I-PROBLEM	I-PROBLEM
accident	NN	I-PROBLEM	I-PROBLEM

1)	CD	O	O
extensive	JJ	B-PROBLEM	B-PROBLEM
posterior	JJ	I-PROBLEM	I-PROBLEM
circulation	NN	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2)	CD	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
an	DT	O	O
82	CD	O	O
year-old	JJ	O	O
right	NN	O	O
handed	VBN	O	O
gentleman	NN	O	O
who	WP	O	O
has	VBZ	O	O
a	DT	O	O
past	JJ	O	O
medical	JJ	O	O
history	NN	O	O
of	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
tobacco	NN	O	O
use	NN	O	O
presented	VBN	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
with	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
change	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
well	RB	O	O
until	IN	O	O
the	DT	O	O
evening	VBG	O	O
prior	JJ	O	O
to	TO	O	O
presentation	NN	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
when	WRB	O	O
he	PRP	O	O
complained	VBD	O	O
of	IN	O	O
headache	NN	B-PROBLEM	B-PROBLEM
across	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
forehead	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
presentation	NN	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
then	RB	O	O
found	VBN	O	O
by	IN	O	O
his	PRP$	O	O
daughter	NN	O	O
lying	VBG	O	O
on	IN	O	O
his	PRP$	O	O
bed	NN	O	O
groaning	NN	O	B-PROBLEM
,	,	O	O
being	VBG	O	O
relatively	RB	B-PROBLEM	O
unresponsive	JJ	I-PROBLEM	B-PROBLEM
and	CC	O	O
unable	JJ	O	O
to	TO	O	O
speak	VB	O	O
.	.	O	O

the	DT	O	O
family	NN	O	O
reported	VBD	O	O
one	CD	O	O
episode	NN	O	O
of	IN	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
at	IN	O	O
home	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
73	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
158/53	CD	O	O
,	,	O	O
respiratory	JJ	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
16-20	NNS	O	O
,	,	O	O
oxygen	NN	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST
97%	CD	O	O
on	IN	O	O
three	CD	B-TREATMENT	O
liters	NNS	I-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
somnolent	JJ	B-PROBLEM	O
,	,	O	O
breathing	VBG	O	O
comfortably	RB	O	O
,	,	O	O
occasionally	RB	B-PROBLEM	B-PROBLEM
coughing	VBG	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
were	VBD	O	O
heard	VBN	O	O
.	.	O	O

chest	NN	O	O
was	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
but	CC	O	O
with	IN	O	O
poor	JJ	B-PROBLEM	B-PROBLEM
air	NN	I-PROBLEM	I-PROBLEM
entry	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

heart	NN	O	B-TEST
sounds	NNS	O	I-TEST
were	VBD	O	O
regular	JJ	O	O
with	IN	O	O
one	CD	B-PROBLEM	O
out	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
six	CD	I-PROBLEM	B-PROBLEM
holosystolic	JJ	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
at	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	NN	O	I-PROBLEM
lower	RBR	O	I-PROBLEM
sternal	JJ	O	I-PROBLEM
border	NN	O	I-PROBLEM
.	.	O	O

abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
,	,	O	O
non-tender	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
bowel	JJ	O	O
sounds	VBZ	O	O
present	JJ	O	O
.	.	O	O

extremities	NNS	O	O
were	VBD	O	O
without	IN	O	O
clubbing	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

neurological	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	O	O
patient	NN	O	O
who	WP	O	O
was	VBD	O	O
intermittently	RB	B-PROBLEM	O
alert	JJ	I-PROBLEM	O
,	,	O	O
opening	VBG	O	O
eyes	NNS	O	O
to	TO	O	O
voice	VB	O	O
,	,	O	O
following	VBG	O	O
simple	JJ	O	O
commands	NNS	O	O
,	,	O	O
but	CC	O	O
without	IN	B-PROBLEM	O
any	DT	I-PROBLEM	O
speech	NN	I-PROBLEM	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
pupillary	JJ	B-PROBLEM	B-PROBLEM
defect	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

dolls	NNS	B-TEST	O
eye	NN	I-TEST	O
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
a	DT	O	O
possible	JJ	O	O
right	NN	B-PROBLEM	O
gaze	NN	I-PROBLEM	O
preference	NN	I-PROBLEM	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
did	VBD	O	O
not	RB	O	O
move	VB	O	O
his	PRP$	O	O
eyes	NNS	O	O
.	.	O	O

corneals	NNS	B-TEST	B-TEST
were	VBD	O	O
present	JJ	O	O
bilaterally	RB	O	O
.	.	O	O

gag	NN	B-TEST	B-TEST
was	VBD	O	O
present	JJ	O	O
weakly	RB	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
only	RB	O	O
minimal	JJ	B-PROBLEM	B-PROBLEM
movement	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
side	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
sensory	JJ	B-TEST	B-TEST
testing	NN	I-TEST	I-TEST
,	,	O	O
the	DT	O	O
patient	NN	O	O
withdrew	VBD	O	O
all	DT	O	O
extremities	NNS	O	O
to	TO	O	O
pain	VB	B-PROBLEM	B-PROBLEM
.	.	O	O

reflexes	NNS	B-TEST	B-TEST
were	VBD	O	O
2+	CD	O	O
and	CC	O	O
symmetrical	JJ	O	O
all	DT	O	O
over	IN	O	O
.	.	O	O

the	DT	O	O
left	NN	O	O
toe	NN	O	O
was	VBD	O	O
upgoing	JJ	B-PROBLEM	O
,	,	O	O
the	DT	O	O
right	JJ	O	O
toe	NN	O	O
was	VBD	O	O
downgoing	VBG	O	O
.	.	O	O

laboratory	NN	O	B-TEST
data	NNS	O	I-TEST
revealed	VBD	O	O
a	DT	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
of	IN	O	O
139	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
3.4	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
101	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
28	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
11	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
1.2	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
151	CD	O	O
.	.	O	O

ast	NN	B-TEST	B-TEST
was	VBD	O	O
20	CD	O	O
,	,	O	O
alt	RB	B-TEST	O
12	CD	O	O
,	,	O	O
alkaline	JJ	B-TEST	B-TEST
phosphatase	NN	I-TEST	I-TEST
80	CD	O	O
,	,	O	O
bilirubin	VBD	B-TEST	B-TEST
0.5.	CD	O	O
ck	NN	B-TEST	O
was	VBD	O	O
113	CD	O	O
.	.	O	O

thyroid	JJ	B-TEST	B-TEST
function	NN	I-TEST	I-TEST
tests	NNS	I-TEST	I-TEST
were	VBD	O	O
normal	JJ	O	O
.	.	O	O

troponin	NN	B-TEST	B-TEST
i	NN	I-TEST	I-TEST
was	VBD	O	O
0.05	CD	O	O
.	.	O	O

total	JJ	B-TEST	B-TEST
protein	NN	I-TEST	I-TEST
was	VBD	O	O
8	CD	O	O
,	,	O	O
albumin	RB	B-TEST	B-TEST
4.3	CD	O	O
,	,	O	O
globulin	NN	B-TEST	B-TEST
3.7	CD	O	O
,	,	O	O
calcium	NN	B-TEST	B-TEST
9.9	CD	O	O
,	,	O	O
phosphate	NN	B-TEST	B-TREATMENT
2.7	CD	O	O
,	,	O	O
magnesium	NN	B-TEST	B-TEST
2.0.	CD	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
7	CD	O	O
,	,	O	O
hemoglobin	NN	B-TEST	B-TEST
14.1	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
43.6	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
241	CD	O	O
.	.	O	O

erythrocyte	JJ	B-TEST	B-TEST
sedimentation	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
was	VBD	O	O
41	CD	O	O
.	.	O	O

pt	NN	B-TEST	O
was	VBD	O	O
12.3	CD	O	O
,	,	O	O
ptt	RB	B-TEST	B-TEST
27.1.	CD	O	O
an	DT	B-TEST	B-TEST
ekg	NN	I-TEST	I-TEST
showed	VBD	O	O
sinus	JJ	B-PROBLEM	B-PROBLEM
bradycardia	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
53	CD	O	O
with	IN	O	O
a	DT	O	O
normal	JJ	O	O
axis	NN	O	O
,	,	O	O
first	RB	B-PROBLEM	B-PROBLEM
degree	JJ	I-PROBLEM	I-PROBLEM
atrioventricular	JJ	I-PROBLEM	I-PROBLEM
block	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
biphasic	JJ	B-PROBLEM	B-TEST
t-waves	NNS	I-PROBLEM	I-TEST
in	IN	O	O
v1	NN	O	O
to	TO	O	O
v3	VB	O	O
without	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
acute	JJ	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
chest	NN	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
shows	NNS	O	O
left	VBD	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
consolidation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
occipital	NN	I-PROBLEM	I-PROBLEM
infarct	NN	I-PROBLEM	I-PROBLEM
without	IN	O	O
midline	NN	B-PROBLEM	B-PROBLEM
shift	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
positive	JJ	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
effect	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
temporal	JJ	I-PROBLEM	I-PROBLEM
horn	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
on	IN	O	O
the	DT	O	O
right	JJ	O	O
ventricle	NN	O	O
and	CC	O	O
some	DT	B-PROBLEM	B-PROBLEM
effacement	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
sulci	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
right	JJ	O	I-PROBLEM
parietal	JJ	O	I-PROBLEM
area	NN	O	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
a	DT	O	O
telemetry	NN	O	O
bed	NN	O	O
and	CC	O	O
started	VBD	O	O
on	IN	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

around	IN	O	O
4:00	CD	O	O
am	VBP	O	O
the	DT	O	O
next	JJ	O	O
day	NN	O	O
,	,	O	O
an	DT	B-PROBLEM	B-PROBLEM
acute	JJ	I-PROBLEM	I-PROBLEM
decompensation	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
.	.	O	O

lung	NN	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
at	IN	O	O
that	DT	O	O
point	NN	O	O
showed	VBD	O	O
good	JJ	O	O
air	NN	O	O
entry	NN	O	O
,	,	O	O
no	DT	O	O
wheezing	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
coarse	JJ	B-PROBLEM	B-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
sounds	VBZ	I-PROBLEM	I-PROBLEM
throughout	IN	I-PROBLEM	O
.	.	O	O

withdrawal	NN	O	O
to	TO	O	O
pain	NN	B-TEST	B-PROBLEM
was	VBD	O	O
still	RB	O	O
present	JJ	O	O
.	.	O	O

both	DT	O	O
plantars	NNS	O	O
were	VBD	O	O
upgoing	VBG	B-PROBLEM	O
.	.	O	O

a	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
gas	NN	I-TEST	I-TEST
at	IN	O	O
this	DT	O	O
point	NN	O	O
showed	VBD	O	O
a	DT	B-TEST	O
ph	NN	I-TEST	O
of	IN	O	O
7.49	CD	O	O
,	,	O	O
po2	NN	B-TEST	B-TREATMENT
61	CD	O	O
,	,	O	O
pco2	NN	B-TEST	O
of	IN	O	O
33	CD	O	O
on	IN	O	O
100%	CD	B-TREATMENT	B-TREATMENT
non-rebreather	JJ	I-TREATMENT	I-TREATMENT
mask	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

ekg	NN	B-TEST	O
showed	VBD	O	O
sinus	JJ	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
&apos;s	JJ	I-TEST	I-TEST
temperature	NN	I-TEST	I-TEST
was	VBD	O	O
102	CD	O	O
degrees	NNS	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
cat	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
.	.	O	O

this	DT	O	O
showed	VBD	O	O
continued	JJ	O	B-PROBLEM
evolution	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
posterior	JJ	I-PROBLEM	I-PROBLEM
cerebral	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
now	RB	O	O
extending	VBG	O	O
into	IN	O	O
the	DT	O	O
right	JJ	O	O
cerebellar	NN	O	O
hemisphere	RB	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
also	RB	O	O
a	DT	B-PROBLEM	B-PROBLEM
high	JJ	I-PROBLEM	I-PROBLEM
density	NN	I-PROBLEM	I-PROBLEM
adjacent	NN	O	I-PROBLEM
to	TO	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
cerebellar	NN	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
suggesting	VBG	O	O
the	DT	O	O
presence	NN	O	O
of	IN	O	O
hemorrhage	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
mri	NN	I-TEST	I-TEST
and	CC	O	O
mra	NN	B-TEST	O
of	IN	I-TEST	O
the	DT	I-TEST	O
head	NN	I-TEST	O
was	VBD	O	O
arranged	VBN	O	O
to	TO	O	O
evaluate	VB	O	O
the	DT	O	O
extent	NN	O	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
stroke	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
the	DT	B-PROBLEM	O
posterior	JJ	I-PROBLEM	O
circulation	NN	I-PROBLEM	O
.	.	O	O

the	DT	B-TEST	B-TEST
mri	NN	I-TEST	I-TEST
showed	VBD	O	O
infarct	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
cerebellar	JJ	I-PROBLEM	I-PROBLEM
hemispheres	NNS	I-PROBLEM	I-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM
,	,	O	I-PROBLEM
the	DT	O	I-PROBLEM
right	JJ	O	I-PROBLEM
occipital	NN	O	I-PROBLEM
lobe	NN	O	I-PROBLEM
,	,	O	I-PROBLEM
the	DT	O	I-PROBLEM
right	JJ	O	I-PROBLEM
thalamus	NN	O	I-PROBLEM
and	CC	O	I-PROBLEM
bilateral	JJ	O	I-PROBLEM
pons	NNS	O	I-PROBLEM
.	.	O	O

the	DT	B-TEST	O
mra	NN	I-TEST	O
of	IN	I-TEST	O
the	DT	I-TEST	B-TEST
intracranial	JJ	I-TEST	I-TEST
circulation	NN	I-TEST	I-TEST
demonstrated	VBD	O	O
gross	JJ	B-PROBLEM	B-PROBLEM
patency	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
internal	JJ	I-PROBLEM	I-PROBLEM
carotid	NN	I-PROBLEM	I-PROBLEM
arteries	NNS	I-PROBLEM	I-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
the	DT	I-PROBLEM	O
basilar	JJ	I-PROBLEM	O
arteries	NNS	I-PROBLEM	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
reduced	VBN	I-PROBLEM	I-PROBLEM
flow	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
branches	NNS	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
right	JJ	O	I-PROBLEM
middle	JJ	O	I-PROBLEM
cerebral	JJ	O	I-PROBLEM
artery	NN	O	I-PROBLEM
compared	VBN	O	O
to	TO	O	O
the	DT	O	O
left	NN	O	O
.	.	O	O

neurosurgery	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
,	,	O	O
however	RB	O	O
the	DT	O	O
neurosurgeons	NNS	O	O
felt	VBD	O	O
that	IN	O	O
there	EX	O	O
was	VBD	O	O
no	DT	O	O
surgical	JJ	O	B-TREATMENT
option	NN	O	I-TREATMENT
,	,	O	O
since	IN	O	O
even	RB	O	O
in	IN	O	O
the	DT	O	O
case	NN	O	O
of	IN	O	O
cerebellar	JJ	B-PROBLEM	B-PROBLEM
swelling	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
there	EX	O	O
would	MD	O	O
be	VB	O	O
no	DT	O	O
improvement	NN	O	O
from	IN	O	O
decompensation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
therefore	RB	O	O
treated	JJ	O	O
conservatively	RB	O	O
with	IN	O	O
fluid	JJ	B-TREATMENT	B-TREATMENT
restriction	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
blood	NN	B-TREATMENT	B-TREATMENT
pressure	NN	I-TREATMENT	I-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

heparin	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
because	IN	O	O
of	IN	O	O
the	DT	O	O
risk	NN	O	O
of	IN	O	O
intercerebral	JJ	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
aspiration	NN	I-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
cefotaxime	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
metronidazole	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
alert	JJ	O	O
and	CC	O	O
oriented	VBD	O	O
times	NNS	O	O
three	CD	O	O
with	IN	O	O
n.	JJ	B-TEST	B-PROBLEM
ramirez	NN	I-TEST	I-PROBLEM
coma	NN	I-TEST	I-PROBLEM
scale	NN	I-TEST	I-PROBLEM
of	IN	O	O
15	CD	O	O
on	IN	O	O
arrival	NN	O	O
.	.	O	O

cardiovascular	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
revealed	VBD	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
.	.	O	O

chest	NN	O	O
was	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	I-TEST	O
.	.	O	O

no	DT	O	O
crepitus	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

positive	JJ	O	B-PROBLEM
tenderness	NN	B-PROBLEM	I-PROBLEM
over	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
distal	JJ	O	I-PROBLEM
half	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	JJ	O	I-PROBLEM
rib	NN	O	I-PROBLEM
cage	NN	O	I-PROBLEM
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
was	VBD	O	O
tender	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

positive	JJ	O	O
guarding	NN	B-PROBLEM	O
.	.	O	O

no	DT	O	O
deformities	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
costovertebral	JJ	B-PROBLEM	B-PROBLEM
angle	NN	I-PROBLEM	I-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
bilaterally	RB	I-PROBLEM	O
.	.	O	O

no	DT	O	O
deformities	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
stepoff	NN	B-PROBLEM	O
,	,	O	O
or	CC	O	O
tenderness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
cervical	JJ	I-PROBLEM	I-PROBLEM
spine	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

rectal	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
guaiac-negative	JJ	O	O
.	.	O	O

the	DT	O	O
right	JJ	O	O
upper	JJ	O	O
extremity	NN	O	O
was	VBD	O	O
positive	JJ	O	O
for	IN	O	O
abrasions	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
right	NN	O	O
lower	JJR	O	O
extremity	NN	O	O
was	VBD	O	O
positive	JJ	O	O
for	IN	O	O
abrasions	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

left	VBN	O	O
upper	JJ	O	O
and	CC	O	O
lower	JJR	O	O
extremities	NNS	O	O
revealed	VBD	O	O
no	DT	O	O
deformities	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
brought	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
for	IN	O	O
resuscitation	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
responded	VBD	O	O
to	TO	O	O
aggressive	JJ	B-TREATMENT	B-TREATMENT
resuscitation	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
was	VBD	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
kept	VBN	O	O
nothing	NN	O	O
by	IN	O	O
mouth	NN	O	O
with	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
bed	VBD	B-TREATMENT	O
rest	NN	I-TREATMENT	O
,	,	O	O
every	DT	B-TEST	O
4-hour	CD	I-TEST	O
hematocrit	NN	I-TEST	B-TEST
checks	NNS	I-TEST	I-TEST
,	,	O	O
and	CC	O	O
serial	JJ	B-TEST	B-TEST
abdominal	JJ	I-TEST	I-TEST
examinations	NNS	I-TEST	I-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
throughout	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
his	PRP$	O	O
hospital	NN	O	O
stay	NN	O	O
,	,	O	O
and	CC	O	O
his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
relatively	RB	O	O
stable	JJ	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
gradual	JJ	I-PROBLEM	I-PROBLEM
drop	NN	I-PROBLEM	I-PROBLEM
due	JJ	O	O
to	TO	O	O
dilutional	JJ	B-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
post	NN	O	O
trauma	NNS	O	O
day	NN	O	O
four	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
with	IN	O	O
a	DT	O	O
stable	JJ	O	O
hematocrit	NN	O	B-TEST
and	CC	O	O
a	DT	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
nondistended	VBD	B-PROBLEM	B-PROBLEM
abdomen	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
ambulated	VBD	O	O
with	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
secondary	JJ	O	O
to	TO	O	O
the	DT	B-PROBLEM	B-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
pubic	NN	I-PROBLEM	I-PROBLEM
rami	NN	I-PROBLEM	I-PROBLEM
fractures	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

physical	JJ	O	B-TREATMENT
therapy	NN	O	I-TREATMENT
was	VBD	O	O
consulted	VBN	O	O
,	,	O	O
and	CC	O	O
crutches	NNS	B-TREATMENT	B-TREATMENT
were	VBD	O	O
given	VBN	O	O
to	TO	O	O
the	DT	O	O
patient	NN	O	O
.	.	O	O

pain	NN	B-PROBLEM	B-PROBLEM
was	VBD	O	O
managed	VBN	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
fentanyl	JJ	I-TREATMENT	I-TREATMENT
patch	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
by	IN	B-TREATMENT	O
mouth	NN	I-TREATMENT	O
dilaudid	NN	I-TREATMENT	O
with	IN	O	O
adequate	JJ	O	B-TREATMENT
pain	NN	B-TREATMENT	I-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
discharge	NN	O	O
.	.	O	O

1.	CD	O	O
grade	VBD	B-PROBLEM	B-PROBLEM
3	CD	I-PROBLEM	I-PROBLEM
splenic	JJ	I-PROBLEM	I-PROBLEM
laceration	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
left	VBD	B-PROBLEM	B-PROBLEM
rib	NN	I-PROBLEM	I-PROBLEM
8	CD	I-PROBLEM	I-PROBLEM
through	IN	I-PROBLEM	I-PROBLEM
12	CD	I-PROBLEM	I-PROBLEM
fractures	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
left	VBD	B-PROBLEM	B-PROBLEM
superior/inferior	JJ	I-PROBLEM	I-PROBLEM
pubic	JJ	I-PROBLEM	I-PROBLEM
rami	NN	I-PROBLEM	I-PROBLEM
fractures	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
comorbidities	NNS	O	B-PROBLEM
of	IN	O	I-PROBLEM
anxiety	NN	B-PROBLEM	I-PROBLEM
disorder/depression	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
asked	VBN	O	O
to	TO	O	O
call	VB	O	O
his	PRP$	O	O
physician	NN	O	O
if	IN	O	O
he	PRP	O	O
experienced	VBD	O	O
any	DT	B-PROBLEM	O
lightheadedness	NN	I-PROBLEM	B-PROBLEM
,	,	O	O
dizziness	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

1.	CD	O	O
fentanyl	JJ	B-TREATMENT	B-TREATMENT
75-mcg	JJ	O	O
per	IN	O	O
hour	NN	O	O
patch	NN	O	O
q.72h.	NN	O	O

2.	CD	O	O
zoloft	JJ	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
by	IN	O	O
mouth	NN	O	O
once	RB	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

3.	CD	O	O
wellbutrin	JJ	B-TREATMENT	B-TREATMENT
200	CD	O	O
mg	NN	O	O
by	IN	O	O
mouth	NN	O	O
twice	RB	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

4.	CD	O	O
dilaudid	JJ	B-TREATMENT	B-TREATMENT
one	CD	O	O
to	TO	O	O
two	CD	O	O
tablets	NNS	O	O
by	IN	O	O
mouth	JJ	O	O
q.4-6h.	JJ	O	O
as	IN	O	O
needed	VBN	O	O
(	(	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
)	)	O	O
.	.	O	O

abdominal	JJ	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
64	CD	O	O
year	NN	O	O
old	JJ	O	O
white	JJ	O	O
male	NN	O	O
with	IN	O	O
a	DT	O	O
past	JJ	O	O
medical	JJ	O	O
history	NN	O	O
of	IN	O	O
smoking	NN	O	O
,	,	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disese	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
l0	JJ	I-PROBLEM	I-PROBLEM
cm	NN	I-PROBLEM	I-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
presented	VBD	O	O
to	TO	O	O
his	PRP$	O	O
private	JJ	O	O
medical	JJ	O	O
doctor	NN	O	O
in	IN	O	O
gewestster	NN	O	O
with	IN	O	O
transient	JJ	B-PROBLEM	B-PROBLEM
calf	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
walking	VBG	O	O
less	JJR	O	O
than	IN	O	O
fifty	JJ	O	O
yards	NNS	O	O
.	.	O	O

abdominal	JJ	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
discovered	VBN	O	O
on	IN	O	O
examination	NN	B-TEST	B-TEST
and	CC	O	O
patient	NN	O	O
was	VBD	O	O
referred	VBN	O	O
to	TO	O	O
retelk	VB	O	O
county	RB	O	O
medical	JJ	O	O
center	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
on	IN	O	O
10/17/06	CD	O	O
and	CC	O	O
echocardiogram	VB	B-TEST	B-TEST
done	VBN	O	O
on	IN	O	O
11/13/09	CD	O	O
revealed	JJ	O	O
poor	JJ	B-PROBLEM	O
left	VBD	I-PROBLEM	O
ventricular	JJ	I-PROBLEM	O
function	NN	I-PROBLEM	O
and	CC	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
was	VBD	O	O
done	VBN	O	O
on	IN	O	O
admission	NN	O	O
which	WDT	O	O
showed	VBD	O	O
three	CD	B-PROBLEM	B-PROBLEM
vessel	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
was	VBD	O	O
referred	VBN	O	O
to	TO	O	O
cardiology	VB	O	O
and	CC	O	O
underwent	VB	O	O
a	DT	B-TREATMENT	B-TREATMENT
three	CD	I-TREATMENT	I-TREATMENT
vessel	NN	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
11/25/09	CD	O	O
.	.	O	O

his	PRP$	O	O
post-operative	JJ	O	O
course	NN	O	O
was	VBD	O	O
complicated	VBN	O	O
by	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
e.	JJ	I-PROBLEM	I-PROBLEM
coli	NNS	I-PROBLEM	I-PROBLEM
urinary	JJ	I-PROBLEM	I-PROBLEM
tract	JJ	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
transient	JJ	B-PROBLEM	B-PROBLEM
acute	JJ	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
creatinine	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	JJ	B-TEST	B-TEST
&apos;s	NNP	I-TEST	I-TEST
renal	NN	I-TEST	I-TEST
function	NN	I-TEST	I-TEST
returned	VBD	O	O
to	TO	O	O
normal	JJ	O	O
over	IN	O	O
several	JJ	O	O
days	NNS	O	O
,	,	O	O
however	RB	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
&apos;s	NN	I-TEST	I-TEST
last	JJ	I-TEST	I-TEST
ultrasound	NN	I-TEST	I-TEST
of	IN	I-TEST	O
his	PRP$	I-TEST	O
aorta	NN	I-TEST	O
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
l0	JJ	I-PROBLEM	I-PROBLEM
cm	NN	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
he	PRP	O	O
presented	VBD	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
admission	NN	O	O
for	IN	O	O
an	DT	B-TREATMENT	B-PROBLEM
abdominal	JJ	I-TREATMENT	I-PROBLEM
aortic	JJ	I-TREATMENT	I-PROBLEM
aneurysm	NN	I-TREATMENT	I-PROBLEM
repair	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
also	RB	O	O
in	IN	O	O
l983	NN	O	O
and	CC	O	O
l988	NN	O	B-TEST
,	,	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
l989	NN	O	I-PROBLEM
,	,	O	O
diverticulitis	NN	B-PROBLEM	B-PROBLEM
in	IN	O	I-PROBLEM
l978	NN	O	I-PROBLEM
,	,	O	O
and	CC	O	O
spontaneous	JJ	B-PROBLEM	B-PROBLEM
pneumothorax	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
l956	NN	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
times	NNS	I-TREATMENT	O
three	CD	I-TREATMENT	O
as	IN	O	O
mentioned	VBN	O	O
above	IN	O	O
.	.	O	O

he	PRP	O	O
came	VBD	O	O
in	IN	O	O
on	IN	O	O
carafate	NN	B-TREATMENT	O
,	,	O	O
enteric	RB	B-TREATMENT	B-TREATMENT
coated	VBN	I-TREATMENT	I-TREATMENT
aspirin	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
inhaler	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
atrovent	JJ	B-TREATMENT	B-TREATMENT
inhaler	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
procan	JJ	B-TREATMENT	B-TREATMENT
sr	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
mevacor	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
allergic	JJ	B-PROBLEM	B-PROBLEM
to	TO	O	O
penicillin	VB	B-TREATMENT	B-TREATMENT
,	,	O	O
inderal	JJ	B-TREATMENT	O
,	,	O	O
and	CC	O	O
also	RB	O	O
to	TO	O	O
procan	VB	B-TREATMENT	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
was	VBD	O	O
remarkable	JJ	O	O
for	IN	O	O
an	DT	O	B-TEST
abdomen	NN	O	I-TEST
which	WDT	O	O
was	VBD	O	O
soft	JJ	O	O
and	CC	O	O
non-tender	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
pulsatile	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
felt	VBD	O	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
right	JJ	O	I-PROBLEM
upper	NN	O	I-PROBLEM
quadrant	NN	O	I-PROBLEM
near	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
midline	NN	O	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
dopplerable	JJ	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
pulses	NNS	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
right	NN	O	I-PROBLEM
,	,	O	O
they	PRP	O	O
were	VBD	O	O
palpable	JJ	O	O
.	.	O	O

patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
and	CC	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
the	DT	O	O
next	JJ	O	O
day	NN	O	O
on	IN	O	O
12/24/09	CD	O	O
where	WRB	O	O
patient	NN	O	O
underwent	VBD	O	O
an	DT	B-TREATMENT	B-PROBLEM
abdominal	JJ	I-TREATMENT	I-PROBLEM
aortic	JJ	I-TREATMENT	I-PROBLEM
aneurysm	NN	I-TREATMENT	I-PROBLEM
repair	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

in	IN	O	O
his	PRP$	O	O
post-operative	JJ	O	O
course	NN	O	O
,	,	O	O
patient	NN	O	O
was	VBD	O	O
sent	VBN	O	O
to	TO	O	O
the	DT	O	O
unit	NN	O	O
and	CC	O	O
was	VBD	O	O
put	VBN	O	O
on	IN	O	O
perioperative	JJ	B-TREATMENT	B-TREATMENT
vancomycin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

post-operatively	RB	O	O
,	,	O	O
patient	NN	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
frequent	JJ	B-PROBLEM	B-PROBLEM
aberrant	JJ	I-PROBLEM	I-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
premature	NN	I-PROBLEM	I-PROBLEM
beats	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
some	DT	B-PROBLEM	B-PROBLEM
rare	JJ	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
premature	NN	I-PROBLEM	I-PROBLEM
beats	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	O	O
lungs	NNS	O	O
were	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
decreased	VBN	B-PROBLEM	B-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
sounds	VBZ	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	O	O
question	NN	O	O
of	IN	O	O
fluid	NN	B-PROBLEM	B-PROBLEM
overload	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
a	DT	O	O
question	NN	O	O
of	IN	O	O
whether	IN	O	O
to	TO	O	O
start	VB	O	O
him	PRP	O	O
on	IN	O	O
quinidine	NN	B-TREATMENT	B-TREATMENT
versus	NN	O	O
beta	NN	B-TREATMENT	B-TREATMENT
blockers	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
was	VBD	O	O
obtained	VBN	O	O
which	WDT	O	O
showed	VBD	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
dysfunction	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
hypokinetic	JJ	B-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
akinetic	JJ	I-PROBLEM	I-PROBLEM
areas	NNS	I-PROBLEM	I-PROBLEM
throughout	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
ventricle	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
was	VBD	O	O
loaded	VBN	O	O
with	IN	O	O
quinidine	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
then	RB	O	O
started	VBD	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
maintenance	NN	I-TREATMENT	I-TREATMENT
dose	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

patient	NN	O	O
converted	VBD	O	O
to	TO	O	O
normal	JJ	O	O
sinus	NN	O	O
rhythm	NN	O	O
once	RB	O	O
on	IN	O	O
quinidine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

his	PRP$	B-TREATMENT	B-TEST
digoxin	NN	I-TREATMENT	I-TEST
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
elevated	VBN	B-PROBLEM	O
so	RB	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
digoxin	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
held	VBN	O	O
for	IN	O	O
four	CD	O	O
days	NNS	O	O
while	IN	O	O
levels	NNS	B-TEST	O
slowly	RB	O	O
came	VBD	O	O
down	RB	O	O
.	.	O	O

patient	NN	O	O
was	VBD	O	O
restarted	VBN	O	O
on	IN	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
just	RB	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

patient	NN	O	O
also	RB	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
elevated	VBN	B-PROBLEM	B-PROBLEM
ldh	NN	I-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	O
alkaline	JJ	I-PROBLEM	B-TEST
phosphatase	NN	I-PROBLEM	I-TEST
,	,	I-PROBLEM	O
and	CC	I-PROBLEM	O
amylase	VB	I-PROBLEM	B-TEST
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
.	.	O	O

lipase	NN	B-TEST	B-TEST
was	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

ultrasound	NN	B-TEST	B-TEST
was	VBD	O	O
obtained	VBN	O	O
of	IN	O	O
the	DT	O	B-PROBLEM
biliary	JJ	O	I-PROBLEM
tree	NN	O	I-PROBLEM
which	WDT	O	O
demonstrated	VBD	O	O
no	DT	O	O
abnormalities	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

patient	NN	O	O
was	VBD	O	O
also	RB	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
several	JJ	O	O
complaints	NNS	O	O
of	IN	O	O
awaking	VBG	O	O
in	IN	O	O
the	DT	O	O
middle	NN	O	O
of	IN	O	O
the	DT	O	O
night	NN	O	O
with	IN	O	O
tachypnea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
some	DT	B-PROBLEM	B-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
associated	VBN	O	O
with	IN	O	O
breathing	NN	O	B-PROBLEM
.	.	O	O

serial	JJ	B-TEST	B-TEST
ekg	NN	I-TEST	I-TEST
and	CC	I-TEST	O
ck	NN	I-TEST	O
were	VBD	O	O
obtained	VBN	O	O
which	WDT	O	O
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
chest	JJ	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
demonstrated	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
arterial	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
gas	NN	I-TEST	I-TEST
at	IN	O	O
that	DT	O	O
time	NN	O	O
showed	VBD	O	O
po2	NNS	B-TEST	O
of	IN	O	O
68	CD	O	O
,	,	O	O
saturation	NN	B-TEST	B-TEST
of	IN	O	O
95%	CD	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
ph	NN	I-TEST	I-TEST
of	IN	O	O
7.5l	CD	O	O
,	,	O	O
pco2	NN	B-TEST	O
of	IN	O	O
37	CD	O	O
,	,	O	O
a	DT	B-TEST	B-TREATMENT
bicarbonate	NN	I-TEST	I-TREATMENT
of	IN	O	O
37	CD	O	O
,	,	O	O
and	CC	O	O
a	DT	B-TEST	O
pco2	NN	I-TEST	O
of	IN	O	O
3l	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-PROBLEM
+7	JJ	I-TEST	I-PROBLEM
base	NN	I-TEST	I-PROBLEM
.	.	O	O

patient	JJ	B-TEST	B-TEST
&apos;s	JJ	I-TEST	I-TEST
chest	JJS	I-TEST	I-TEST
x-ray	JJ	I-TEST	I-TEST
,	,	O	O
as	IN	O	O
mentioned	VBN	O	O
above	IN	O	O
,	,	O	O
showed	VBD	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
was	VBD	O	O
aggressively	RB	O	O
diuresed	VBN	O	O
with	IN	O	O
resolution	NN	O	O
of	IN	O	O
symptoms	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

patient	NN	O	O
is	VBZ	O	O
being	VBG	O	O
sent	VBN	O	O
home	NN	O	O
on	IN	O	O
ecotrin	JJ	B-TREATMENT	B-TREATMENT
one	CD	O	O
q.d.	NN	O	O
,	,	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
0.l25	CD	O	O
mg	NN	O	O
every	DT	O	O
three	CD	O	O
days	NNS	O	O
,	,	O	O
quinidine	JJ	B-TREATMENT	B-TREATMENT
648	CD	O	O
mg	NN	O	O
q.a.m.	NN	O	O
and	CC	O	O
324	CD	O	O
mg	NN	O	O
q.p.m.	NN	O	O
and	CC	O	O
q.h.s.	NN	O	O
,	,	O	O
mevacor	FW	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
,	,	O	O
carafate	VB	B-TREATMENT	O
one	CD	O	O
gram	NN	O	O
p.o.	NN	O	O
q.i.d.	NN	O	O
,	,	O	O
colace	NN	B-TREATMENT	B-TREATMENT
l00	NN	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O
,	,	O	O
lasix	VBZ	B-TREATMENT	B-TREATMENT
80	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
,	,	O	O
potassium	NN	B-TREATMENT	B-TEST
20	CD	O	O
meq	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
,	,	O	O
and	CC	O	O
iron	NN	B-TREATMENT	B-TREATMENT
supplements	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

patient	NN	O	O
recorded	VBD	O	O
as	IN	O	O
having	VBG	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
to	TO	O	O
drugs	NNS	B-TREATMENT	B-TREATMENT

mental	JJ	B-PROBLEM	B-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
change	NN	I-PROBLEM	I-PROBLEM

intubation	NN	B-TREATMENT	B-TREATMENT

39	CD	O	O
year	NN	O	O
old	JJ	O	O
male	NN	O	O
w/	NN	O	O
h/o	VBD	O	O
low	JJ	B-PROBLEM	B-PROBLEM
back	RB	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
chronic	JJ	B-TREATMENT	B-TREATMENT
narcotics	NNS	I-TREATMENT	I-TREATMENT
presents	NNS	O	I-TREATMENT
after	IN	O	O
being	VBG	O	O
found	VBD	O	O
unresponsive	JJ	B-PROBLEM	B-PROBLEM
at	IN	O	O
home	NN	O	O
.	.	O	O

his	PRP$	O	O
daughter	NN	O	O
awoke	VBD	O	O
him	PRP	O	O
at	IN	O	O
7	CD	O	O
a.m.	RB	O	O
,	,	O	O
reports	NNS	O	O
he	PRP	O	O
said	VBD	O	O
he	PRP	O	O
felt	VBD	O	O
"	NNP	O	O
cold	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
shivery	NN	B-PROBLEM	B-PROBLEM
,"	RB	O	I-PROBLEM
vomited	VBD	O	I-PROBLEM
several	JJ	O	O
times	NNS	O	O
,	,	O	O
then	RB	O	O
drove	VBD	O	O
her	PRP	O	O
to	TO	O	O
school	NN	O	O
.	.	O	O

she	PRP	O	O
did	VBD	O	O
not	RB	O	O
notice	VB	O	O
any	DT	B-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
/	NN	I-PROBLEM	I-PROBLEM
urine	JJ	I-PROBLEM	I-PROBLEM
/	NNP	I-PROBLEM	O
emesis	NN	I-PROBLEM	B-PROBLEM
/	NNP	I-PROBLEM	O
stool	NN	I-PROBLEM	O
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
bed	NN	I-PROBLEM	O
.	.	O	O

ems	NNS	O	O
found	VBD	O	O
him	PRP	O	O
with	IN	O	O
agonal	JJ	B-PROBLEM	B-PROBLEM
respirations	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
pinpoint	NN	B-PROBLEM	O
pupils	NNS	I-PROBLEM	O
.	.	O	O

fs	RB	B-TEST	O
420	CD	O	O
.	.	O	O

he	PRP	O	O
received	VBD	O	O
1	CD	O	O
mg	NNS	O	O
iv	JJ	B-TREATMENT	O
narcan	JJ	I-TREATMENT	O
(	(	O	O
numerous	JJ	O	O
bottles	NNS	O	O
of	IN	O	O
oxycontin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
were	VBD	O	O
found	VBN	O	O
in	IN	O	O
room	NN	O	O
);	IN	O	O
his	PRP$	O	O
pupils	NNS	O	O
dilated	VBN	O	O
to	TO	O	O
~	VB	O	O
8	CD	O	O
mm	NN	O	O
and	CC	O	O
he	PRP	O	O
became	VBD	O	O
combative	JJ	B-PROBLEM	B-PROBLEM
/	NN	O	I-PROBLEM
agitated	VBD	B-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
then	RB	O	O
intubated	VBN	O	O
for	IN	O	O
airway	NN	B-TREATMENT	B-TREATMENT
protection	NN	I-TREATMENT	I-TREATMENT
(	(	O	I-TREATMENT
etomidate	JJ	B-TREATMENT	I-TREATMENT
/	NN	O	I-TREATMENT
succinate	NN	B-TREATMENT	I-TREATMENT
);	VBD	O	O
it	PRP	O	O
was	VBD	O	O
a	DT	B-TREATMENT	B-PROBLEM
traumatic	JJ	I-TREATMENT	I-PROBLEM
intubation	NN	I-TREATMENT	I-PROBLEM

he	PRP	O	O
was	VBD	O	O
transported	VBN	O	O
to	TO	O	O
hallmark	VB	O	O
health	NN	O	O
system	NN	O	O
monica	NN	O	O
,	,	O	O
where	WRB	O	O
abg	RB	B-TEST	B-TEST
7.14/82/44	CD	O	O
while	IN	O	O
bagging	VBG	O	O
on	IN	O	O
100%	CD	B-TREATMENT	O
fio2	NN	I-TREATMENT	O
.	.	O	O

in	IN	O	O
monica	NN	O	O
,	,	O	O
pt	NN	O	O
received	VBD	O	O
charcoal	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
500	CD	O	O
mg	NN	O	O
iv	NN	B-TREATMENT	O
levofloxacin	NN	I-TREATMENT	B-TREATMENT
,	,	O	O
500	CD	O	O
mg	NN	O	O
iv	NN	B-TREATMENT	O
metronidazole	NN	I-TREATMENT	B-TREATMENT
for	IN	O	O
presumed	JJ	O	O
aspiration	NN	B-PROBLEM	O
pna	NN	I-PROBLEM	O
.	.	O	O

chronic	JJ	B-PROBLEM	B-PROBLEM
lbp	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
htn	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
anxiety	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
depression	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
l	JJ	B-TREATMENT	B-TREATMENT
arm	NN	I-TREATMENT	I-TREATMENT
surgeries	NNS	I-TREATMENT	I-TREATMENT
(	(	O	I-TREATMENT
hardware	NN	B-TREATMENT	I-TREATMENT
in	IN	O	O
place	NN	O	O
)	)	O	O

on	IN	O	O
disability	NN	O	O
secondary	JJ	O	O
to	TO	O	O
work-related	JJ	B-PROBLEM	B-PROBLEM
back	JJ	I-PROBLEM	I-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
other	JJ	O	O
known	VBN	O	O
drug	NN	O	O
use	NN	O	O
other	JJ	O	O
than	IN	O	O
oxycontin	JJ	B-TREATMENT	B-TREATMENT
/	JJ	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

no	DT	O	O
family	NN	O	O
history	NN	O	O
of	IN	O	O
heart	NN	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
cancer	NN	B-PROBLEM	B-PROBLEM

pe	NN	O	O
:	:	O	O
tc	NN	B-TEST	O
98.7	CD	O	O
,	,	O	O
pc	NN	B-TEST	O
88	CD	O	O
,	,	O	O
bpc	NN	B-TEST	O
120/60	CD	O	O
,	,	O	O
ac	RB	B-TEST	O
600/20	CD	O	O
,	,	O	O
fio2	RB	B-TEST	O
100%	CD	O	O
,	,	O	O
peep	RB	B-TEST	O
10	CD	O	O

gen	NN	O	O
:	:	O	O
young	JJ	O	O
male	NN	O	O
,	,	O	O
intubated	VBN	B-TREATMENT	B-TREATMENT
,	,	O	O
sedated	VBN	B-TREATMENT	B-TREATMENT
,	,	O	O
in	IN	O	O
hard	JJ	B-TREATMENT	B-PROBLEM
collar	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

heent	NN	O	O
:	:	O	O
pupils	NNS	B-PROBLEM	O
pinpoint	NN	I-PROBLEM	O
,	,	O	O
equal	JJ	O	O
,	,	O	O
anicteric	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
normal	JJ	O	O
conjunctiva	NN	O	O
,	,	O	O
intubated	VBN	B-TREATMENT	B-TREATMENT
,	,	O	O
ogt	PRP	B-TREATMENT	O
in	IN	O	O
place	NN	O	O
,	,	O	O
ommm	NN	O	O
,	,	O	O
normocephalic	JJ	O	O
,	,	O	O
atraumatic	JJ	B-PROBLEM	B-PROBLEM

cardiac	NN	O	O
:	:	O	O
rrr	NN	O	O
,	,	O	O
i/vi	JJ	B-PROBLEM	O
sm	NN	I-PROBLEM	O
at	IN	I-PROBLEM	O
apex	NN	I-PROBLEM	O
,	,	O	O
no	DT	O	O
r/g	NN	B-PROBLEM	B-PROBLEM
appreciated	VBD	O	O

pulm	NN	O	O
:	:	O	O
coarse	JJ	B-PROBLEM	B-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
sounds	NNS	I-PROBLEM	I-PROBLEM
throughout	IN	I-PROBLEM	O

abd	NN	O	O
:	:	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
distended	VBD	I-PROBLEM	I-PROBLEM
,	,	O	O
hypoactive	JJ	B-PROBLEM	B-PROBLEM
bs	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
soft	JJ	O	O
,	,	O	O
no	DT	O	O
hsm	NN	B-PROBLEM	B-PROBLEM

ext	NN	O	O
:	:	O	O
trace	NN	B-PROBLEM	B-PROBLEM
le	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
ankles	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
extremities	NNS	B-PROBLEM	O
cool	VBP	I-PROBLEM	O
w/	RB	O	O
2+	CD	O	O
radial	JJ	B-TEST	O
,	,	O	O
1+	CD	O	O
dp/pt	NN	B-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
.	.	O	O

well-healed	JJ	B-PROBLEM	B-PROBLEM
scars	NNS	I-PROBLEM	I-PROBLEM
over	IN	I-PROBLEM	I-PROBLEM
dorsal	JJ	I-PROBLEM	I-PROBLEM
/	JJ	I-PROBLEM	I-PROBLEM
lateral	JJ	I-PROBLEM	I-PROBLEM
distal	NN	I-PROBLEM	I-PROBLEM
lue	NN	I-PROBLEM	I-PROBLEM

neuro	NN	O	O
:	:	O	O
dtr	NN	B-TEST	O
3+	CD	O	O
upper	NN	O	O
and	CC	O	O
lower	JJR	O	O
extremities	NNS	O	O
,	,	O	O
symmetric	JJ	O	O
bilaterally	RB	O	O
.	.	O	O

ekg	NN	B-TEST	O
nsr	NN	O	O
@	VBD	O	O
92	CD	O	O
bpm	NN	O	O
,	,	O	O
nl	JJ	O	O
axis	NN	O	O
,	,	O	O
borderline	NN	B-PROBLEM	O
qt	NN	I-PROBLEM	O
(	(	O	O
qtc	JJ	B-TEST	O
0.442	CD	O	O
),	JJ	O	O
j	NN	B-PROBLEM	O
pt	NN	I-PROBLEM	O
elevtation	NN	I-PROBLEM	O
v3	NN	B-TEST	O
,	,	O	O
twf	NN	B-TEST	O
ii	NN	I-TEST	O
,	,	O	O
iii	NN	B-TEST	O
,	,	O	O
avf	NN	B-TEST	O
,	,	O	O
i	NN	B-TEST	O
,	,	O	O
avl	NN	B-TEST	B-PROBLEM
(	(	O	O
no	DT	O	O
prior	RB	B-TEST	O
ekg	NN	I-TEST	O
for	IN	O	O
comparison	NN	O	O
)	)	O	O

type	NN	O	O
-	:	O	O
art	NN	B-TEST	O
po2	VBZ	I-TEST	O
-	:	O	O
122	CD	O	O
*	NN	O	O
pco2	NN	B-TEST	B-TEST
-	:	O	O
38	CD	O	O
ph	NN	B-TEST	B-TEST
-	:	O	O
7.43	CD	O	O
total	JJ	B-TEST	B-TEST
co2	NN	I-TEST	I-TEST
-	:	O	O
26	CD	O	O
base	NN	B-TEST	B-TEST
xs	NNP	I-TEST	I-TEST
-	:	O	O
1	CD	O	O

lactate	NN	B-TEST	B-TEST
-	:	O	O
2.0	CD	O	O

2012-03-23	JJ	O	O
01:30	CD	O	O
pm	NN	O	O
urine	NN	B-TEST	O

2012-03-23	JJ	O	O
01:30	CD	O	O
pm	NN	O	O
urine	NN	B-TEST	O

bnzodzpn	SYM	B-TEST	B-TEST
-	:	O	O
pos	NN	B-PROBLEM	B-TEST
barbitrt	SYM	B-TEST	I-TEST
-	:	O	O
neg	NN	O	O
opiates	VBZ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
cocaine	NN	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
amphetmn	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
mthdone	NN	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O

2012-03-23	JJ	O	O
01:30	CD	O	O
pm	NN	O	O
urine	NN	B-TEST	O

color	NN	O	B-TEST
-	:	O	O
straw	NN	O	O
appear	VBP	O	O
-	:	O	O
clear	JJ	O	O
sp	NN	B-TEST	O
barajas	SYM	I-TEST	O
-	:	O	O
1.015	CD	O	O

2012-03-23	JJ	O	O
01:30	CD	O	O
pm	NN	O	O
urine	NN	B-TEST	O

blood	NN	B-TEST	B-TEST
-	:	O	I-TEST
sm	NN	O	I-TEST
nitrite	JJ	B-TEST	I-TEST
-	:	O	O
neg	NN	O	O
protein	SYM	B-TEST	B-TEST
-	:	O	O
30	CD	O	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
1000	CD	O	O
ketone	NN	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
bilirubin	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
urobilngn	JJ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
ph	SYM	B-TEST	B-TEST
-	:	O	O
6.0	CD	O	O
leuk	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O

2012-03-23	JJ	O	O
01:30	CD	O	O
pm	NN	O	O
urine	NN	B-TEST	O

rbc	LS	B-TEST	B-TEST
-	:	O	O
03-10	JJ	O	O
*	NN	O	O
wbc	SYM	B-TEST	B-TEST
-	:	O	I-TEST
0-2	JJ	O	I-TEST
bacteria	NNS	B-TEST	I-TEST
-	:	O	O
few	JJ	B-PROBLEM	O
yeast	JJ	B-TEST	B-TEST
-	:	O	O
none	NN	O	O
epi	SYM	B-TEST	O
-	:	O	O
0	CD	O	O

2012-03-23	JJ	O	O
01:30	CD	O	O
pm	NN	O	O
urine	NN	B-TEST	O

mucous	JJ	B-TEST	B-PROBLEM
-	:	O	O
few	JJ	O	O

po2	SYM	B-TEST	B-TEST
-	:	O	O
44	CD	O	O
*	NN	O	O
pco2	NN	B-TEST	B-TEST
-	:	O	O
82	CD	O	O
*	NN	O	O
ph	NN	B-TEST	B-TEST
-	:	O	O
7.14	CD	O	O
*	JJ	O	O
total	NN	B-TEST	B-TEST
co2	NN	I-TEST	I-TEST
-	:	O	O
30	CD	O	O
base	NN	B-TEST	O
xs	NNP	I-TEST	O
--	:	O	O
4	CD	O	O

glucose	JJ	B-TEST	B-TEST
-	:	O	O
296	CD	O	O
*	NN	O	O
lactate	NN	B-TEST	B-TEST
-	:	O	O
4.8	CD	O	O
*	NN	O	O
na+	SYM	B-TEST	B-TEST
-	:	O	O
140	CD	O	O
k+	SYM	B-TEST	B-TEST
-	:	O	O
5.2	CD	O	O
cl	NN	B-TEST	O
--	:	O	O
101	CD	O	O

urea	JJ	B-TEST	B-TEST
n	SYM	O	I-TEST
-	:	O	O
20	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.1	CD	O	O

alt(sgpt)	SYM	B-TEST	B-TEST
-	:	O	O
30	CD	O	O
ast(sgot)	SYM	B-TEST	B-TEST
-	:	O	O
38	CD	O	O
ld(ldh)	SYM	B-TEST	B-TEST
-	:	O	O
217	CD	O	O
ck(cpk)	NN	B-TEST	B-TEST
-	:	O	O
1152	CD	O	O
*	NN	O	O
alk	NN	B-TEST	B-TEST
phos	IN	I-TEST	I-TEST
-	:	O	O
52	CD	O	O
amylase	NN	B-TEST	B-TEST
-	:	O	O
426	CD	O	O
*	JJ	O	O
tot	NN	B-TEST	O
bili	SYM	I-TEST	B-TEST
-	:	O	O
0.4	CD	O	O

lipase	NN	B-TEST	B-TEST
-	:	O	O
22	CD	O	O

ck-mb	JJ	B-TEST	B-TEST
-	:	O	O
45	CD	O	O
*	JJ	O	O
mb	NN	B-TEST	B-TEST
indx	SYM	I-TEST	I-TEST
-	:	O	O
3.9	CD	O	O
ctropnt	NN	B-TEST	B-TEST
-<	CD	O	O
0.01	CD	O	O

albumin	SYM	B-TEST	B-TEST
-	:	O	O
4.4	CD	O	O

asa	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
ethanol	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
acetmnphn	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
bnzodzpn	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
barbitrt	SYM	B-TEST	B-TEST
-	:	O	O
neg	JJ	O	O
tricyclic	JJ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
8.9	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.93	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
12.1	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
36.7	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
93	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
30.8	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
33.0	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
13.0	CD	O	O

neuts	NNS	B-TEST	B-TEST
-	:	O	O
84.7	CD	O	O
*	NN	O	O
lymphs	SYM	B-TEST	B-TEST
-	:	O	O
13.1	CD	O	O
*	JJ	O	O
monos	NNS	B-TEST	B-TEST
-	:	O	O
1.5	CD	O	O
*	NN	O	O
eos	SYM	B-TEST	B-TEST
-	:	O	O
0.3	CD	O	O
basos	SYM	B-TEST	B-TEST
-	:	O	O
0.4	CD	O	O

plt	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
-	:	O	O
227	CD	O	O

pt	SYM	B-TEST	B-TEST
-	:	O	O
14.1	CD	O	O
*	NN	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
21.0	CD	O	O
*	NN	O	O
inr(pt)	NN	B-TEST	B-TEST
-	:	O	O
1.2	CD	O	O

fibrinoge	SYM	B-TEST	B-TEST
-	:	O	O
375	CD	O	O

2012-03-26	JJ	O	O
04:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	B-TEST	B-TEST
-	:	O	O
6.9	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.28	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
9.8	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
29.0	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
89	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
29.7	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
33.6	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
13.1	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
206	CD	O	O

2012-03-26	JJ	O	O
04:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
plt	NN	B-TEST	I-TEST
ct	VBD	I-TEST	I-TEST
-	:	O	O
206	CD	O	O

2012-03-26	JJ	O	O
04:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
88	CD	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
10	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
0.7	CD	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
143	CD	O	O
k-3.6	JJ	B-TEST	O
cl	NN	B-TEST	O
-	:	O	O
108	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
28	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
11	CD	O	O

2012-03-26	JJ	O	O
04:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
calcium	NN	B-TEST	I-TEST
-	:	O	O
8.5	CD	O	O
phos	NN	B-TEST	B-TEST
-	:	O	O
3.1	CD	O	O
mg	SYM	B-TEST	O
-	:	O	O
1.9	CD	O	O

2012-03-25	JJ	O	O
04:00	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
caltibc	NN	B-TEST	B-TEST
-	:	O	O
237	CD	O	O
*	NN	O	O
ferritn	SYM	B-TEST	B-TEST
-	:	O	O
534	CD	O	O
*	NN	O	O
trf	SYM	B-TEST	B-TEST
-	:	O	O
182	CD	O	O
*	NN	O	O

a	DT	O	O
:	:	O	O
39	CD	O	O
year	NN	O	O
old	JJ	O	O
male	NN	O	O
w/	NN	O	O
htn	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
lbp	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
narcotics	NNS	B-TREATMENT	B-TREATMENT
presents	NNS	O	I-TREATMENT
after	IN	O	O
being	VBG	O	O
found	VBD	O	O
unresponsive	JJ	B-PROBLEM	B-PROBLEM
at	IN	O	O
home	NN	O	O
.	.	O	O

1)	CD	O	O
unresponsiveness	JJ	B-PROBLEM	O
:	:	O	O
this	DT	O	O
is	VBZ	O	O
likely	JJ	O	O
due	JJ	O	O
todrug	NNS	B-PROBLEM	O
overdose	VBP	I-PROBLEM	O
(	(	O	O
known	VBN	O	O
oxycontin	NN	B-TREATMENT	O
use	NN	O	O
,	,	O	O
(+)	NNP	B-PROBLEM	O
bnz	NN	I-PROBLEM	O
on	IN	O	O
tox	NN	B-TEST	B-TREATMENT
screen	NN	I-TEST	O
).	NN	O	O

ddx	NN	O	O
:	:	O	O
cardiac	JJ	B-PROBLEM	B-PROBLEM
ischemia	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
no	DT	O	O
ischemic	NN	B-PROBLEM	B-PROBLEM
ekg	NN	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
noted	VBD	O	O
),	JJ	O	O
seizure	NN	B-PROBLEM	O
w/	VBD	O	O
post-ictal	JJ	B-PROBLEM	B-PROBLEM
state	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
cva	NN	B-PROBLEM	B-PROBLEM
(	(	O	O
head	JJ	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
neg	NN	O	O
).	NN	O	O

his	PRP$	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
enzymes	NNS	I-TEST	I-TEST
include	VBP	O	O
only	RB	O	B-PROBLEM
elevated	JJ	B-PROBLEM	I-PROBLEM
ck	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
not	RB	O	O
shaffer	VB	O	O
,	,	O	O
juan	NN	O	O
he	PRP	O	O
ruled	VBD	O	O
out	RP	O	O
for	IN	O	O
mi	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
communicate	VB	O	O
appropriately	RB	O	O
as	IN	O	O
his	PRP$	B-TEST	O
level	NN	I-TEST	O
of	IN	O	O
narcotic	JJ	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
waned	VBD	O	O
in	IN	O	O
his	PRP$	B-TEST	O
blood	NN	I-TEST	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
maintain	VB	O	O
a	DT	O	O
stable	JJ	O	O
mental	JJ	O	O
level	NN	O	O
for	IN	O	O
extubation	NN	B-TREATMENT	B-TREATMENT
on	IN	O	O
03-24	NN	O	O
.	.	O	O

as	IN	O	O
of	IN	O	O
3/21	CD	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
alert	JJ	O	O
,	,	O	O
appropriate	JJ	O	O
and	CC	O	O
answers	NNS	O	O
questions	NNS	O	O
and	CC	O	O
follows	VBZ	O	O
command	NN	O	O
on	IN	O	O
exam	NN	B-TEST	B-TEST
.	.	O	O

2)	CD	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
infiltrates	NNS	I-PROBLEM	I-PROBLEM
:	:	O	O
there	EX	O	O
was	VBD	O	O
initially	RB	O	O
concern	NN	O	O
that	IN	O	O
he	PRP	O	O
was	VBD	O	O
developing	VBG	O	O
ards	NNS	B-PROBLEM	O
from	IN	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
being	VBG	O	O
found	VBN	O	O
unconscious	JJ	B-PROBLEM	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
intubated	VBN	O	B-TREATMENT
and	CC	O	O
was	VBD	O	O
on	IN	O	O
mechanical	JJ	B-TREATMENT	B-TREATMENT
ventilation	NN	I-TREATMENT	I-TREATMENT
from	IN	O	O
9/13-10/11	CD	O	O
,	,	O	O
but	CC	O	O
he	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT

and	CC	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
total	NN	O	O
of	IN	O	O
4	CD	O	O
days	NNS	O	O
.	.	O	O

on	IN	O	O
03-26	NN	O	O
,	,	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
started	VBN	O	O
as	IN	O	O
this	DT	O	O
most	RBS	O	O
likely	JJ	O	O
represent	NN	O	O
a	DT	B-PROBLEM	B-PROBLEM
transiet	JJ	I-PROBLEM	I-PROBLEM
aspiration	NN	I-PROBLEM	I-PROBLEM
episode	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
not	RB	O	O
ards	NNS	B-PROBLEM	O
.	.	O	O

3)	CD	O	O
airway	JJ	B-TREATMENT	O
protection	NN	I-TREATMENT	O
:	:	O	O
he	PRP	O	O
was	VBD	O	O
intubated	VBN	B-TREATMENT	B-TREATMENT
in	IN	O	O
the	DT	O	O
field	NN	O	O
for	IN	O	O
airway	NN	B-TREATMENT	B-TREATMENT
protection	NN	I-TREATMENT	I-TREATMENT

he	PRP	O	O
was	VBD	O	O
extubated	VBN	B-TREATMENT	O
on	IN	O	O
03-24	NN	O	O
and	CC	O	O
was	VBD	O	O
weaned	VBN	O	O
off	RP	O	O
oxygen	JJ	B-TREATMENT	O
slowly	RB	O	O
from	IN	O	O
03-24	JJ	O	O
to	TO	O	O
03-26	CD	O	O
without	IN	O	O
significant	JJ	O	B-PROBLEM
event	NN	O	I-PROBLEM
.	.	O	O

4)	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
:	:	O	O
he	PRP	O	O
was	VBD	O	O
restarted	VBN	O	O
on	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
atenolol	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
verapamil	NN	B-TREATMENT	B-TREATMENT
once	RB	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
stabilized	VBN	O	O
on	IN	O	O
03-25	NN	O	O
.	.	O	O

5)	CD	O	O
depression	NN	B-PROBLEM	B-PROBLEM
:	:	O	O
he	PRP	O	O
was	VBD	O	O
restarted	VBN	O	O
on	IN	O	O
his	PRP$	B-TREATMENT	O
paxil	NN	I-TREATMENT	O
on	IN	O	O
03-25	JJ	O	O
and	CC	O	O
was	VBD	O	O
given	VBN	B-TREATMENT	O
1:1	CD	I-TREATMENT	O
sitter	NN	I-TREATMENT	O
for	IN	O	O
suicidal	JJ	B-PROBLEM	B-PROBLEM
ideation	NN	I-PROBLEM	I-PROBLEM
leading	VBG	O	O
up	RP	O	O
to	TO	O	O
his	PRP$	O	B-PROBLEM
suicide	NN	O	I-PROBLEM
leading	VBG	O	O
up	RP	O	O
to	TO	O	O
this	DT	O	O
admission	NN	O	O
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
not	RB	O	O
had	VBN	O	O
further	RBR	B-PROBLEM	O
episodes	NNS	I-PROBLEM	O
while	IN	O	O
he	PRP	O	O
was	VBD	O	O
in	IN	O	O
the	DT	O	O
hospital	NN	O	O
.	.	O	O

-	:	O	O
plan	NN	O	O
to	TO	O	O
restart	VB	O	O
paxil	NN	B-TREATMENT	B-TREATMENT
when	WRB	O	O
taking	VBG	O	O
po	NN	O	O

6)	CD	O	O
hyperglycemia	NN	B-PROBLEM	B-PROBLEM
:	:	O	O
although	IN	O	O
he	PRP	O	O
has	VBZ	O	O
no	DT	O	O
known	VBN	O	O
history	NN	O	O
of	IN	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
elevated	JJ	I-PROBLEM	I-PROBLEM
fs	NN	I-PROBLEM	I-PROBLEM
noted	VBD	O	O
in	IN	O	O
field	NN	O	O
with	IN	O	O
glycosuria	NNS	B-PROBLEM	B-PROBLEM
prompted	VBN	O	O
fingerstick	JJ	B-TEST	O
check	NN	I-TEST	O
but	CC	O	O
he	PRP	O	O
has	VBZ	O	O
not	RB	O	O
required	VBN	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
coverage	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

7)	CD	O	O
high	JJ	B-PROBLEM	B-PROBLEM
amylase	NN	I-PROBLEM	I-PROBLEM
:	:	O	O
he	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
on	IN	O	O
03-23	NN	O	O
with	IN	O	O
elevated	JJ	B-PROBLEM	B-PROBLEM
amylase	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
non-elevated	JJ	B-PROBLEM	B-PROBLEM
lipase	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
amylase	NN	I-TEST	I-TEST
trended	VBD	O	O
down	RB	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
restarted	VBN	O	O
on	IN	O	O
regular	JJ	O	O
diet	NN	O	O
on	IN	O	O
4/14-4/17	JJ	O	O
after	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
extubation	NN	I-TREATMENT	I-TREATMENT

8)	CD	O	O
anemia	NN	B-PROBLEM	B-PROBLEM
-	:	O	O
he	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
with	IN	O	O
borderline	JJ	B-PROBLEM	B-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
fe	JJ	B-TEST	O
studies	NNS	I-TEST	O
suggestive	VBP	O	O
of	IN	O	O
anemia	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
chronic	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
his	PRP$	B-TEST	B-TEST
hct	NN	I-TEST	I-TEST
decreased	VBN	O	O
in	IN	O	O
the	DT	O	O
setting	NN	O	O
fluid	JJ	B-TREATMENT	O
resucitation	NN	I-TREATMENT	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
hct	NN	I-TEST	I-TEST
has	VBZ	O	O
stabilized	VBN	O	O
and	CC	O	O
improved	VBN	O	O
to	TO	O	O
close	VB	O	O
to	TO	O	O
30	CD	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
3/21	CD	O	O
.	.	O	O

he	PRP	O	O
reports	VBZ	O	O
that	IN	O	O
his	PRP$	O	O
primary	JJ	O	O
physician	NN	O	O
is	VBZ	O	O
aware	JJ	O	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
in	IN	O	O
the	DT	O	O
process	NN	O	O
of	IN	O	O
followup	NN	O	O
.	.	O	O

oxycontin	NN	B-TREATMENT	B-TREATMENT

percocet	NN	B-TREATMENT	B-TREATMENT

paxil	NN	B-TREATMENT	B-TREATMENT

gabapentin	NN	B-TREATMENT	B-TREATMENT

atenolol	NN	B-TREATMENT	B-TREATMENT

benzodiazipine	NN	B-PROBLEM	B-PROBLEM
overdose	NN	I-PROBLEM	I-PROBLEM

please	VB	O	O
take	VB	O	O
your	PRP$	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
call	VB	O	O
your	PRP$	O	O
doctor	NN	O	O
if	IN	O	O
you	PRP	O	O
experience	VBP	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
any	DT	B-PROBLEM	O
thoughts	NNS	I-PROBLEM	O
of	IN	I-PROBLEM	O
hurting	VBG	I-PROBLEM	O
yourself	PRP	I-PROBLEM	O
or	CC	I-PROBLEM	O
anyone	NN	I-PROBLEM	O
else	RB	I-PROBLEM	O
.	.	O	O

chronic	JJ	B-PROBLEM	B-PROBLEM
lymphocytic	JJ	I-PROBLEM	I-PROBLEM
leukemia	NN	I-PROBLEM	I-PROBLEM

chronic	JJ	B-PROBLEM	B-PROBLEM
lymphocytic	JJ	I-PROBLEM	I-PROBLEM
leukemia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
frequent	JJ	B-PROBLEM	B-PROBLEM
headaches	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
cholecystitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

3.	CD	O	O
spastic	JJ	B-PROBLEM	B-PROBLEM
colon	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
47-year-old	JJ	O	O
man	NN	O	O
with	IN	O	O
advanced	JJ	B-PROBLEM	B-PROBLEM
stage	NN	I-PROBLEM	I-PROBLEM
chronic	JJ	I-PROBLEM	I-PROBLEM
lymphocytic	JJ	I-PROBLEM	I-PROBLEM
leukemia	NN	I-PROBLEM	I-PROBLEM
who	WP	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
autologous	JJ	B-TREATMENT	B-TREATMENT
bone	NN	I-TREATMENT	I-TREATMENT
marrow	NN	I-TREATMENT	I-TREATMENT
transplant	NN	I-TREATMENT	I-TREATMENT
as	IN	O	O
per	IN	O	O
protocol	NN	O	O
94-055	CD	O	O
of	IN	O	O
the	DT	O	O
santusli	JJ	O	O
hospital	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
originally	RB	O	O
diagnosed	VBN	O	O
in	IN	O	O
06/98	CD	O	O
during	IN	O	O
a	DT	B-TEST	B-TREATMENT
routine	JJ	I-TEST	I-TREATMENT
physical	NN	I-TEST	I-TREATMENT
when	WRB	O	O
he	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
20,000	CD	O	O
,	,	O	O
weight	JJ	B-PROBLEM	B-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
swelling	VBG	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
neck	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
groin	NN	I-PROBLEM	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
watched	VBN	O	O
after	IN	O	O
his	PRP$	B-PROBLEM	O
initial	JJ	I-PROBLEM	O
diagnosis	NN	I-PROBLEM	O
,	,	O	O
but	CC	O	O
six	CD	O	O
months	NNS	O	O
later	RB	O	O
he	PRP	O	O
developed	VBD	O	O
rapidly	RB	B-PROBLEM	B-PROBLEM
increasing	VBG	I-PROBLEM	I-PROBLEM
leukocytosis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
he	PRP	O	O
became	VBD	O	O
more	RBR	B-PROBLEM	B-PROBLEM
symptomatic	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

after	IN	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
with	IN	I-TREATMENT	O
three	CD	I-TREATMENT	O
cycles	NNS	I-TREATMENT	O
of	IN	I-TREATMENT	O
fludarabine	NN	I-TREATMENT	B-TREATMENT
he	PRP	O	O
had	VBD	O	O
90%	CD	B-PROBLEM	O
involvement	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
his	PRP$	I-PROBLEM	O
intratrabecular	JJ	I-PROBLEM	O
space	NN	I-PROBLEM	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
therefore	RB	O	O
treated	VBN	O	O
with	IN	O	O
three	CD	B-TREATMENT	O
cycles	NNS	I-TREATMENT	O
of	IN	I-TREATMENT	O
fludarabine	NN	I-TREATMENT	B-TREATMENT
in	IN	O	O
combination	NN	O	O
with	IN	O	O
cytoxan	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

after	IN	O	O
this	DT	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
he	PRP	O	O
achieved	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
protocol	NN	I-PROBLEM	I-PROBLEM
eligible	JJ	I-PROBLEM	I-PROBLEM
minimal	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
state	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

however	RB	O	O
,	,	O	O
he	PRP	O	O
did	VBD	O	O
have	VB	O	O
relative	JJ	B-PROBLEM	B-PROBLEM
pancytopenia	NN	I-PROBLEM	I-PROBLEM
following	VBG	O	O
this	DT	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
bone	VB	B-TREATMENT	B-TREATMENT
marrow	NN	I-TREATMENT	I-TREATMENT
harvest	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
08/22	CD	O	O
at	IN	O	O
which	WDT	O	O
time	NN	O	O
insufficient	NN	B-PROBLEM	O
cells	NNS	I-PROBLEM	O
were	VBD	O	O
obtained	VBN	O	O
to	TO	O	O
proceed	VB	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
returned	VBN	O	O
previous	JJ	O	O
to	TO	O	O
this	DT	O	O
admission	NN	O	O
for	IN	O	O
repeat	NN	B-TREATMENT	B-TREATMENT
bone	NN	I-TREATMENT	I-TREATMENT
marrow	NN	I-TREATMENT	I-TREATMENT
harvest	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
he	PRP	O	O
was	VBD	O	O
given	VBN	O	O
neupogen	RB	B-TREATMENT	O
prior	JJ	O	O
to	TO	O	O
his	PRP$	B-TREATMENT	O
harvest	NN	I-TREATMENT	O
,	,	O	O
and	CC	O	O
sufficient	JJ	O	O
cells	NNS	O	O
were	VBD	O	O
not	RB	O	O
obtained	VBN	O	O
to	TO	O	O
proceed	VB	O	O
with	IN	O	O
autologous	JJ	B-TREATMENT	B-TREATMENT
bone	NN	I-TREATMENT	I-TREATMENT
marrow	NN	I-TREATMENT	I-TREATMENT
transplantation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-TEST	B-TEST
most	RBS	I-TEST	I-TEST
recent	JJ	I-TEST	I-TEST
bone	NN	I-TEST	I-TEST
marrow	NN	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
revealed	VBD	O	O
less	JJR	B-PROBLEM	O
than	IN	I-PROBLEM	O
5%	CD	I-PROBLEM	O
of	IN	I-PROBLEM	O
intratrabecular	JJ	I-PROBLEM	O
space	NN	I-PROBLEM	O
involvement	NN	I-PROBLEM	O
.	.	O	O

recent	JJ	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
showed	VBD	O	O
no	DT	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
lymphadenopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
episode	NN	O	O
of	IN	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
in	IN	O	O
1996	CD	O	O
.	.	O	O

2.	CD	O	O
at	IN	O	O
the	DT	O	O
age	NN	O	O
of	IN	O	O
40	CD	O	O
he	PRP	O	O
had	VBD	O	O
problems	NNS	O	O
with	IN	O	O
frequent	JJ	B-PROBLEM	B-PROBLEM
headaches	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
episodes	NNS	O	O
of	IN	O	O
cholecystitis	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
spastic	JJ	B-PROBLEM	B-PROBLEM
colon	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
medications	NNS	B-TREATMENT	B-TREATMENT
upon	IN	O	O
admission	NN	O	O
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	O	O
father	NN	O	O
had	VBD	O	O
prostate	JJ	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mother	NN	O	O
had	VBD	O	O
breast	VBN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

has	VBZ	O	O
a	DT	O	O
cousin	NN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
brain	NN	I-PROBLEM	I-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
family	NN	O	O
history	NN	O	O
of	IN	O	O
leukemia	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
lymphoma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
admission	NN	O	O
he	PRP	O	O
had	VBD	O	O
no	DT	O	O
upper	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
recent	JJ	B-PROBLEM	B-PROBLEM
infections	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
change	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
habits	NNS	I-PROBLEM	I-PROBLEM
or	CC	O	O
abdomen	NNS	B-PROBLEM	B-PROBLEM
pain	VBP	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
did	VBD	O	O
complain	NN	O	O
of	IN	O	O
frequent	JJ	B-PROBLEM	B-PROBLEM
headaches	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

following	VBG	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
recent	JJ	I-TREATMENT	I-TREATMENT
bone	NN	I-TREATMENT	I-TREATMENT
marrow	NN	I-TREATMENT	I-TREATMENT
harvest	NN	I-TREATMENT	I-TREATMENT
he	PRP	O	O
had	VBD	O	O
protracted	VBN	O	O
episodes	NNS	O	O
of	IN	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
well-appearing	JJ	O	O
and	CC	O	O
in	IN	O	O
no	DT	O	O
apparent	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

weight	NN	B-TEST	B-TEST
70.4	CD	O	O
kilograms	NNS	O	O
,	,	O	O
temperature	NN	B-TEST	B-TEST
96.5	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
20	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
105/60	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
76	CD	O	O
.	.	O	O

unremarkable	JJ	O	O
without	IN	O	O
rashes	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
lesions	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

sclerae	NN	B-PROBLEM	B-PROBLEM
anicteric	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

oropharynx	NN	O	O
,	,	O	O
lips	NNS	O	O
,	,	O	O
teeth	NNS	O	O
and	CC	O	O
gums	NNS	O	B-PROBLEM
were	VBD	O	O
without	IN	O	O
lesions	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
without	IN	O	O
evidence	NN	O	O
of	IN	O	O
mucositis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
cervical	JJ	B-PROBLEM	B-PROBLEM
,	,	I-PROBLEM	I-PROBLEM
supraclavicular	JJ	I-PROBLEM	I-PROBLEM
or	CC	I-PROBLEM	O
axillary	JJ	I-PROBLEM	B-PROBLEM
adenopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

heart	NN	B-TEST	B-TEST
sounds	VBZ	I-TEST	I-TEST
normal	JJ	O	O
.	.	O	O

soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
without	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
masses	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
without	IN	O	O
any	DT	B-PROBLEM	O
hepatosplenomegaly	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

without	IN	O	O
clubbing	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

electrolytes	NNS	B-TEST	B-TEST
were	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

liver	JJ	B-TEST	B-TEST
function	NN	I-TEST	I-TEST
tests	NNS	I-TEST	I-TEST
were	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
10.4	CD	O	O
,	,	O	O
hemoglobin	NN	B-TEST	B-TEST
11.9	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
124	CD	O	O
,	,	O	O
pt	NN	B-TEST	O
and	CC	O	O
ptt	NN	B-TEST	B-TEST
were	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
on	IN	O	O
10/22/00	CD	O	O
and	CC	O	O
received	VBD	O	O
cytoxan	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
total	JJ	B-TREATMENT	B-TEST
body	NN	I-TREATMENT	I-TEST
irradiation	NN	I-TREATMENT	I-TEST
per	IN	O	O
protocol	NN	O	O
.	.	O	O

autologous	JJ	B-TREATMENT	B-TREATMENT
bone	NN	I-TREATMENT	I-TREATMENT
marrow	NN	I-TREATMENT	I-TREATMENT
infusion	NN	I-TREATMENT	I-TREATMENT
occurred	VBD	O	O
on	IN	O	O
10/29/00	CD	O	O
and	CC	O	O
was	VBD	O	O
uneventful	JJ	O	O
.	.	O	O

his	PRP$	O	O
post-transplant	JJ	O	O
course	NN	O	O
was	VBD	O	O
complicated	VBN	O	O
by	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
from	IN	O	O
mucositis	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
recalcitrant	JJ	B-PROBLEM	B-PROBLEM
nausea	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
vomiting	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
did	VBD	O	O
not	RB	O	O
tolerate	VB	O	O
antiemetics	NNS	B-TREATMENT	O
well	RB	O	O
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
subsequently	RB	O	O
decided	VBN	O	O
to	TO	O	O
avoid	VB	O	O
phenothiazides	NNS	B-TREATMENT	O
secondary	JJ	O	O
to	TO	O	O
jitteryness	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
restless	NN	B-PROBLEM	B-PROBLEM
legs	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
until	IN	O	O
day	NN	O	O
+11	VBD	O	O
when	WRB	O	O
he	PRP	O	O
spiked	VBD	O	O
and	CC	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
ceftazidime	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
and	CC	O	O
urine	JJ	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
were	VBD	O	O
all	DT	O	O
negative	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
acquired	VBD	O	O
intermittent	JJ	B-TREATMENT	B-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
pancytopenia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
well	RB	O	O
nourished	VBN	O	O
so	RB	O	O
tpn	JJ	B-TREATMENT	O
was	VBD	O	O
not	RB	O	O
started	VBN	O	O
.	.	O	O

i	NN	B-TEST	O
&apos;s	NN	I-TEST	O
and	CC	I-TEST	O
o	JJ	I-TEST	O
&apos;s	NNS	I-TEST	O
were	VBD	O	O
balanced	VBN	O	O
and	CC	O	O
maintained	VBN	O	O
with	IN	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

tylenol	RB	B-TREATMENT	B-TREATMENT
650	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
q.	JJ	O	O
4-6h	JJ	O	O
p.r.n.	NN	O	O
headache	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
pain	NN	B-PROBLEM	B-PROBLEM
;	:	O	O
acyclovir	CC	B-TREATMENT	B-TREATMENT
400	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.;	NN	O	O
acyclovir	JJ	B-TREATMENT	B-TREATMENT
topical	JJ	I-TREATMENT	I-TREATMENT
t.i.d.	NN	O	O
to	TO	O	O
be	VB	O	O
applied	VBN	O	O
to	TO	O	O
lesion	VB	B-PROBLEM	O
on	IN	I-PROBLEM	O
corner	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
mouth	NN	I-PROBLEM	O
;	:	O	O
peridex	CC	B-TREATMENT	O
15	CD	O	O
ml	NN	O	O
p.o.	NN	O	O
b.i.d.;	NN	O	O
mycelex	VBD	B-TREATMENT	O
1	CD	O	O
troche	NN	O	O
p.o.	NN	O	O
t.i.d.;	VBD	O	O
g-csf	JJ	O	O
404	CD	O	O
mcg	NN	O	O
subcu	NN	O	O
q.d.;	VBZ	O	O
folic	JJ	B-TREATMENT	B-TREATMENT
acid	RB	I-TREATMENT	I-TREATMENT
1	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
q.d.;	JJ	O	O
lorazepam	JJ	B-TREATMENT	O
1-2	JJ	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
4-6h	JJ	O	O
p.r.n.	NN	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
;	:	O	O
miracle	CC	B-TREATMENT	O
cream	VB	I-TREATMENT	O
topical	JJ	O	O
q.d.	NN	O	O
p.r.n.	JJ	O	O
perianal	JJ	B-PROBLEM	B-PROBLEM
irritation	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
eucerin	CC	B-TREATMENT	B-TREATMENT
cream	VB	I-TREATMENT	I-TREATMENT
topical	JJ	O	I-TREATMENT
b.i.d.;	NN	O	I-TREATMENT
zantac	NN	B-TREATMENT	I-TREATMENT
150	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.;	NN	O	O
restoril	VBD	B-TREATMENT	O
15-30	JJ	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
h.s.	NN	O	O
p.r.n.	NN	O	O
insomnia	NN	B-PROBLEM	B-PROBLEM
;	:	O	O
multivitamin	CC	B-TREATMENT	B-TREATMENT
1	CD	O	O
tablet	NN	O	O
p.o.	NN	O	O
q.d.;	RB	O	O
viscous	JJ	B-TREATMENT	B-TREATMENT
lidocaine	NN	I-TREATMENT	I-TREATMENT
15	CD	O	O
ml	NN	O	O
p.o.	NN	O	O
q.	$	O	O
3h	CD	O	O
can	MD	O	O
be	VB	O	O
applied	VBN	O	O
to	TO	O	O
corner	NN	O	O
of	IN	O	O
mouth	NN	O	O
or	CC	O	O
lips	NNS	O	O
p.r.n.	VBP	O	O
pain	NN	B-TREATMENT	B-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
knows	VBZ	O	O
to	TO	O	O
go	VB	O	O
to	TO	O	O
sper	VB	O	O
medical	JJ	O	O
center	NN	O	O
every	DT	O	O
day	NN	O	O
for	IN	O	O
line	NN	B-TREATMENT	O
care	NN	I-TREATMENT	O
,	,	O	O
blood	NN	B-TEST	B-TEST
draws	NNS	I-TEST	I-TEST
,	,	O	O
and	CC	O	O
monitoring	NN	B-TEST	O
.	.	O	O

penicillins	NNS	B-TREATMENT	B-TREATMENT
/	VBP	O	O
estrogens	NNS	B-TREATMENT	B-TREATMENT
/	VBP	O	O
ancef	JJ	B-TREATMENT	B-TREATMENT
/	NNP	O	I-TREATMENT
tegretol	NN	B-TREATMENT	I-TREATMENT
/	NN	O	O
keflex	NN	B-TREATMENT	B-TREATMENT

hypotension	NN	B-PROBLEM	B-PROBLEM

nephrostomy	JJ	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT

47	CD	O	O
yo	JJ	O	O
f	NN	O	O
w/	NN	O	O
h/o	VBD	O	O
steroid-induced	JJ	B-PROBLEM	B-PROBLEM
hyperglycemia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
sle	JJ	B-PROBLEM	O
w/	NN	O	O
h/o	NN	O	O
pericarditis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
transverse	JJ	B-PROBLEM	O
myelitis	NN	I-PROBLEM	O
w/	NN	O	O
paraplegia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	I-PROBLEM
neurogenic	JJ	B-PROBLEM	I-PROBLEM
bladder	NN	I-PROBLEM	I-PROBLEM
s/p	NN	B-TREATMENT	O
urostomy	JJ	I-TREATMENT	B-TREATMENT
w/	JJ	O	O
ileal	NN	B-TREATMENT	B-TREATMENT
conduit	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
h/o	NN	O	O
ureteropelvic	JJ	B-PROBLEM	B-PROBLEM
stone	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
urosepsis	NN	B-PROBLEM	B-TREATMENT
,	,	O	O
and	CC	O	O
h/o	JJ	O	O
rle	NN	B-PROBLEM	O
dvt	NN	I-PROBLEM	O
a/w	JJ	O	O
f	JJ	O	O
2014-11-29	JJ	O	O
transferred	VBN	O	O
to	TO	O	O
cmed	VB	O	O
2014-11-30	JJ	O	O
for	IN	O	O
hypotn	NN	B-PROBLEM	B-PROBLEM
resistant	NN	O	I-PROBLEM
to	TO	O	I-PROBLEM
ivfs	VB	B-TREATMENT	I-PROBLEM
and	CC	O	I-PROBLEM
stress	VB	B-TREATMENT	I-PROBLEM
steroids	NNS	I-TREATMENT	I-PROBLEM
.	.	O	O

patient	NN	O	O
initially	RB	O	O
p/w	JJ	O	O
c/o	NN	O	O
sudden	JJ	B-PROBLEM	O
onset	NN	I-PROBLEM	O
n/abd	NN	I-PROBLEM	O
pain/chills	NNS	I-PROBLEM	O
w/	VBP	O	O
t	JJ	B-TEST	O
103	CD	O	O
at	IN	O	O
nh	NN	O	O
.	.	O	O

rigors	NNS	B-PROBLEM	O
progressed	VBD	O	O
so	RB	O	O
she	PRP	O	O
was	VBD	O	O
brought	VBN	O	O
to	TO	O	O
robert	VB	O	O
.	.	O	O

she	PRP	O	O
reported	VBD	O	O
h/o	JJ	O	O
fatigue	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
anorexia	NN	B-PROBLEM	B-PROBLEM
for	IN	O	O
the	DT	O	O
past	JJ	O	O
few	JJ	O	O
days	NNS	O	O
and	CC	O	O
had	VBD	O	O
noticed	VBN	O	B-PROBLEM
foul	JJ	B-PROBLEM	I-PROBLEM
smelling	VBG	I-PROBLEM	I-PROBLEM
urine	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
some	DT	O	B-PROBLEM
abdominal	JJ	B-PROBLEM	I-PROBLEM
distension	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
similar	JJ	O	O
to	TO	O	O
prior	VB	O	O
episodes	NNS	O	O
of	IN	O	O
pyelo	NN	B-PROBLEM	O
.	.	O	O

she	PRP	O	O
also	RB	O	O
c/o	VBP	O	O
llq	NNS	B-PROBLEM	O
and	CC	I-PROBLEM	O
groin	NN	I-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
responded	VBD	O	O
to	TO	O	O
tylenol	VB	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
denies	VBZ	O	O
v	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
d	NN	B-PROBLEM	O
.	.	O	O

no	DT	O	O
ams	NN	B-PROBLEM	O
.	.	O	O

no	DT	O	O
c/o	NN	O	B-PROBLEM
cp	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
arrival	NN	O	O
to	TO	O	O
shirley	VB	O	O
,	,	O	O
temperature	NN	B-TEST	B-TEST
was	VBD	O	O
101.2	CD	O	O
.	.	O	O

ct	NN	B-TEST	B-TEST
abd	NN	I-TEST	I-TEST
showed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
8	CD	I-PROBLEM	I-PROBLEM
mm	NN	I-PROBLEM	I-PROBLEM
right	RB	I-PROBLEM	I-PROBLEM
proximal	JJ	I-PROBLEM	I-PROBLEM
ureteral	JJ	I-PROBLEM	I-PROBLEM
stone	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
right-sided	JJ	B-PROBLEM	B-PROBLEM
hydronephrosis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
inflammatory	NN	B-PROBLEM	B-PROBLEM
stranding	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
in	IN	O	O
addition	NN	O	O
to	TO	O	O
pyelonephritis	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
kidney	NN	I-PROBLEM	I-PROBLEM
without	IN	O	O
left	NN	B-PROBLEM	B-PROBLEM
sided	VBD	I-PROBLEM	I-PROBLEM
hydronephrosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

labs	NNS	B-TEST	B-TEST
were	VBD	O	O
remarkable	JJ	O	O
for	IN	O	O
wbc	JJ	B-TEST	B-TEST
23.5	CD	O	O
w/	NN	O	O
1%	CD	O	O
bands	NNS	B-TEST	B-TEST
which	WDT	O	O
decreased	VBD	O	O
to	TO	O	O
14	CD	O	O
today	NN	O	O
but	CC	O	O
now	RB	O	O
w/	VBZ	O	O
15%	CD	O	O
bands	NNS	B-TEST	B-TEST
on	IN	O	O
vanc	NN	B-TREATMENT	B-TREATMENT
(	(	O	O
h/o	JJ	O	O
mrsa	NN	B-PROBLEM	O
urosepsis	NN	I-PROBLEM	O
)	)	O	O
and	CC	O	O
gent	NN	B-TREATMENT	B-PROBLEM
(	(	O	I-PROBLEM
mult	JJ	B-PROBLEM	I-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
)	)	O	O
.	.	O	O

ag	NN	B-TEST	B-TEST
on	IN	O	O
admission	NN	O	O
18	CD	O	O
(	(	O	O
bicarb	NN	B-TEST	B-TEST
17	CD	O	O
,	,	O	O
down	RB	O	O
from	IN	O	O
23	CD	O	O
on	IN	O	O
a	DT	O	O
previous	JJ	O	O
admission	NN	O	O
)	)	O	O
,	,	O	O
down	RB	O	O
to	TO	O	O
ag	VB	B-TEST	B-TEST
15	CD	O	O
this	DT	O	O
am	VBP	O	O
.	.	O	O

abg	RB	B-TEST	O
prior	RB	O	O
to	TO	O	O
transfer	VB	O	O
(	(	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
)	)	O	O
:	:	O	O

7.43/24/69	CD	O	O
w/	JJ	O	O
lactate	NN	B-TEST	B-TEST
1.3	CD	O	O
(	(	O	O
down	IN	O	O
from	IN	O	O
1.4	CD	O	O
on	IN	O	O
the	DT	O	O
prior	JJ	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

currently	RB	O	O
,	,	O	O
03-14	JJ	O	O
blood	NN	B-TEST	B-TEST
cx	NNS	I-TEST	I-TEST
are	VBP	O	O
growing	VBG	O	O
gnr	NN	B-PROBLEM	O
in	IN	O	O
both	DT	O	O
anaerobic	JJ	O	B-TREATMENT
bottles	NNS	O	I-TREATMENT
.	.	O	O

urine	JJ	B-TEST	B-TEST
cx	NN	I-TEST	I-TEST
is	VBZ	O	O
pending	VBG	O	O
.	.	O	O

prior	RB	O	O
to	TO	O	O
transfer	VB	O	O
,	,	O	O
patient	NN	O	O
dropped	VBD	O	O
bp	NN	B-TEST	O
to	TO	O	O
68/40s	CD	O	O
.	.	O	O

bp	NN	B-TEST	O
did	VBD	O	O
not	RB	O	O
improve	VB	O	O
despite	IN	O	O
2	CD	O	O
l	NN	O	O
ns	NN	B-TREATMENT	O
and	CC	O	O
100	CD	O	O
mg	NN	O	O
iv	NN	B-TREATMENT	O
hydrocortisone	NN	I-TREATMENT	B-TREATMENT
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
central	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
sent	VBN	O	O
to	TO	O	O
ir	VB	O	O
for	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
nephrostomy	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

##	JJ	O	O
h/o	NN	O	O
nephrolithiasis	NN	B-PROBLEM	B-PROBLEM
s/p	NN	O	O
lithotripsy	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
h/o	NN	O	O
left	VBD	B-PROBLEM	B-PROBLEM
ureteropelvic	JJ	I-PROBLEM	I-PROBLEM
junction	NN	I-PROBLEM	I-PROBLEM
stone	NN	I-PROBLEM	I-PROBLEM
'03	POS	O	O
spontaneously	RB	O	O
passing	VBG	O	O
by	IN	O	O
u/s	JJ	B-TEST	O
,	,	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
right	JJ	B-PROBLEM	O
stone	NN	I-PROBLEM	O
on	IN	O	O
most	JJS	B-TEST	O
recent	JJ	I-TEST	O
u/s	JJ	I-TEST	O
5	CD	O	O
months	NNS	O	O
ago	RB	O	O

##	JJ	O	O
h/o	NN	O	O
pyelo	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
last	JJ	O	O
episode	NN	O	O
in	IN	O	O
'03	NNP	O	O
(	(	O	O
mrsa	NN	B-PROBLEM	O
in	IN	I-PROBLEM	O
blood	NN	I-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
urine	NN	I-PROBLEM	I-PROBLEM
)	)	O	I-PROBLEM

##	JJ	O	O
sle	NN	B-PROBLEM	O
w/	NN	O	O
h/o	NN	O	O
pericarditis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
last	JJ	O	O
flare	JJ	O	O
couple	NN	O	O
years	NNS	O	O
ago	RB	O	O
,	,	O	O
didn	NN	O	O
't	POS	O	O
flare	NN	O	O
w/	NN	O	O
urosepsis	NN	B-PROBLEM	B-PROBLEM

##	JJ	O	B-PROBLEM
devic	NN	B-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

recurrent	JJ	B-PROBLEM	B-PROBLEM
transverse	NN	I-PROBLEM	I-PROBLEM
myelitis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
sequelae	NN	O	B-PROBLEM
of	IN	O	I-PROBLEM
paraplegia-exacerbation	NN	B-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
93	CD	O	I-PROBLEM
recurrent	JJ	B-PROBLEM	I-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
optic	JJ	I-PROBLEM	I-PROBLEM
neuritis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
legal	JJ	O	O

(	(	O	O
neurologist	NN	O	O
:	:	O	O
dr.	JJ	O	O
heaton	NN	O	O
,	,	O	O
umass	JJ	O	O
memorial	JJ	O	O
medical	JJ	O	O
center	NN	O	O
)	)	O	O
-	:	O	O
(	(	O	O
steroids	NNS	B-TREATMENT	O
increased	VBD	O	O
to	TO	O	O
40	CD	O	O
qd	NNS	O	O
in	IN	O	O
renee	NN	O	O
for	IN	O	O
concern	NN	O	O
for	IN	O	O
recurrent	NN	B-PROBLEM	B-PROBLEM
optic	JJ	I-PROBLEM	I-PROBLEM
neuritis	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
turned	VBD	O	O
out	RP	O	O
to	TO	O	O
be	VB	O	O
capsular	JJ	B-PROBLEM	B-PROBLEM
ossification	NN	I-PROBLEM	I-PROBLEM
)	)	O	I-PROBLEM

##	JJ	O	B-PROBLEM
blindness	NN	B-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
cmed	VBN	O	I-PROBLEM
csru	NN	O	I-PROBLEM
.	.	O	O

##	JJ	O	B-PROBLEM
bilateral	JJ	B-PROBLEM	I-PROBLEM
knee	NN	I-PROBLEM	I-PROBLEM
arthritis	NN	I-PROBLEM	I-PROBLEM

##	RB	O	B-PROBLEM
suspected	VBN	O	I-PROBLEM
glaucoma	NN	B-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
cmed	VBN	O	I-PROBLEM
csru	NN	O	I-PROBLEM
,	,	O	O
turned	VBD	O	O
out	RP	O	O
to	TO	O	O
be	VB	O	O
capsular	JJ	B-PROBLEM	B-PROBLEM
ossification	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
secondary	JJ	I-PROBLEM	I-PROBLEM
cataract	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
corrected	VBN	O	O
w/	NN	O	O
laser	NN	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT

##	JJ	O	B-TREATMENT
urostomy	JJ	B-TREATMENT	I-TREATMENT
s/p	NN	O	I-TREATMENT
ileal	NN	B-TREATMENT	I-TREATMENT
loop	NN	I-TREATMENT	I-TREATMENT
conduit	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
2007	CD	O	O
for	IN	O	O
neurogenic	JJ	B-PROBLEM	B-PROBLEM
bladder	NN	I-PROBLEM	I-PROBLEM
w/	NN	O	O
persistent	NN	B-PROBLEM	B-PROBLEM
leak	NN	I-PROBLEM	I-PROBLEM

##	JJ	O	B-PROBLEM
steroid-induced	JJ	B-PROBLEM	I-PROBLEM
hyperglycemia	NN	I-PROBLEM	I-PROBLEM

##	NN	O	B-PROBLEM
hypothyroid	NN	B-PROBLEM	I-PROBLEM

##	JJ	O	B-PROBLEM
osteoporosis	NN	B-PROBLEM	I-PROBLEM

##	JJ	O	O
hx	NN	O	O
of	IN	O	O
dvt	NN	B-PROBLEM	O
in	IN	I-PROBLEM	O
rle	NN	I-PROBLEM	O
'93	CD	O	O
-	:	O	O
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
a	DT	O	O
couple	NN	O	O
years	NNS	O	O
and	CC	O	O
then	RB	O	O
asa	VB	B-TREATMENT	O
until	IN	O	O
a	DT	O	O
couple	JJ	O	O
months	NNS	O	O
ago	IN	O	O

lives	NNS	O	O
at	IN	O	O
lowell	NNP	O	O
home	NN	O	O
nh	NN	O	O
x	VBD	O	O
11	CD	O	O
yrs	NNS	O	O
due	JJ	O	O
to	TO	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
cmed	JJ	I-PROBLEM	I-PROBLEM
issues	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

wheelchair	NN	B-PROBLEM	B-PROBLEM
dependent	JJ	I-PROBLEM	I-PROBLEM
+	NN	O	I-PROBLEM
requires	VBZ	O	I-PROBLEM
hoyer	JJ	B-TREATMENT	I-PROBLEM
lift	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

ue	JJ	B-TEST	O
strength	NN	I-TEST	O
intact	JJ	O	O
but	CC	O	O
poor	JJ	B-PROBLEM	O
motor	NN	I-PROBLEM	O
movements	NNS	I-PROBLEM	O
due	JJ	O	O
to	TO	O	O
loss	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
sensation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mother	NN	O	O
died	VBD	O	O
at	IN	O	O
51	CD	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
bca	NN	I-PROBLEM	I-PROBLEM

father	RB	O	O
died	VBD	O	O
at	IN	O	O
36	CD	O	O
aplastic	JJ	B-PROBLEM	B-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM
only	RB	O	O
child	NN	O	O

t	RB	B-TEST	O
100.0	CD	O	O
bp	NNS	B-TEST	O
109/56	CD	O	O

cvp	NN	B-TEST	O
11	CD	O	O
hr	NN	B-TEST	B-TEST
113	CD	O	O
rr	NN	B-TEST	B-TEST
16	CD	O	O

o2	RB	B-TEST	O
95%	CD	O	O
on	IN	O	O
3l	CD	B-TREATMENT	O
nc	JJ	I-TREATMENT	B-TREATMENT
mixed	JJ	O	I-TREATMENT
quinn	NN	O	I-TREATMENT
82%	CD	O	O
genrl	NN	O	O
:	:	O	O
in	IN	O	O
nad	NN	B-PROBLEM	O
,	,	O	O
resting	VBG	O	O
comfortably	RB	O	O
heent	NN	O	O
:	:	O	O
perrla	NN	O	B-PROBLEM
(	(	O	O
4->3	JJ	O	O
mm	NN	O	O
)	)	O	O
bilaterally	RB	O	O
,	,	O	O
blind	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
visual	JJ	I-PROBLEM	I-PROBLEM
field	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
eomi	RB	O	O
,	,	O	O
dry	JJ	B-PROBLEM	O
mm	NN	I-PROBLEM	O
,	,	O	O
?	.	O	O
thrush	JJ	B-PROBLEM	B-PROBLEM
neck	NN	O	I-PROBLEM
:	:	O	O
no	DT	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
cv	NN	O	O
:	:	O	O
rrr	NN	O	O
,	,	O	O
no	DT	O	O
m/r/g	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
faint	NN	B-PROBLEM	B-PROBLEM
s1/s2	NN	I-PROBLEM	I-PROBLEM
pulm	NN	O	I-PROBLEM
:	:	O	O
cta	NN	O	O
bilaterally	RB	O	O
abd	VBZ	O	O
:	:	O	O
midline	NN	B-PROBLEM	B-PROBLEM
scar	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
from	IN	O	O
urostomy	NN	B-TREATMENT	B-TREATMENT
)	)	O	I-TREATMENT
,	,	O	O
nabs	UH	O	O
,	,	O	O
soft	JJ	O	O
,	,	O	O
appears	VBZ	O	O
distended	JJ	B-PROBLEM	B-PROBLEM
but	CC	O	O
patient	JJ	O	O
denies	NNS	O	O
,	,	O	O
ostomy	JJ	B-TREATMENT	B-TREATMENT
rlq	NN	O	I-TREATMENT
c/d/i	NN	O	I-TREATMENT
,	,	O	O
nt	NN	B-PROBLEM	O
to	TO	O	O
palpation	VB	B-TEST	B-TEST
back	RB	O	O
:	:	O	O
right	NN	B-TREATMENT	B-TREATMENT
flank	NN	I-TREATMENT	I-TREATMENT
urostomy	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
c/d/i	NN	O	O
,	,	O	O
nt	NN	B-PROBLEM	O
to	TO	O	O
palpation	NN	B-TEST	B-TEST
extr	NN	O	I-TEST
:	:	O	O
no	DT	O	O
gardner	NN	B-TEST	O
neuro	RB	O	O
:	:	O	O
a	DT	O	O
,	,	O	O
ox3	NN	O	O
,	,	O	O
wiggles	VBZ	O	B-PROBLEM
toes	NNS	O	I-PROBLEM
bilaterally	RB	O	I-PROBLEM
,	,	O	O
unable	JJ	B-PROBLEM	O
to	TO	I-PROBLEM	O
lift	VB	I-PROBLEM	O
le	NN	I-PROBLEM	O
,	,	O	O
06-12	JJ	O	O
grip	NN	O	O
bilaterally	RB	O	O
w/	JJ	O	O
ue	NN	O	O
,	,	O	O
decrease	NN	B-PROBLEM	O
sensation	NN	I-PROBLEM	O
to	TO	O	O
soft	JJ	O	O
touch	NN	O	O
in	IN	O	O
left	NN	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
23.5*#	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.81*	CD	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
9.4*	CD	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
29.2*	CD	O	O

mcv	SYM	B-TEST	B-TEST
-	:	O	O
77*#	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
24.6*#	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
32.1	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
18.1*	CD	O	O

neuts	NNS	B-TEST	B-TEST
-	:	O	O
93*	CD	O	O
bands	NNS	B-TEST	B-TEST
-	:	O	O
1	CD	O	O
lymphs	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
monos	NNS	B-TEST	B-TEST
-	:	O	O
6	CD	O	O
eos	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O

basos	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
atyps	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
metas	NNS	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
myelos	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O

glucose	JJ	B-TEST	B-TEST
-	:	O	O
229*	CD	O	O
urea	JJ	B-TEST	B-TEST
n	SYM	O	I-TEST
-	:	O	O
25*	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
0.8	CD	O	O
sodium	NN	B-TEST	B-TEST
-	:	O	O
136	CD	O	O

potassium	NN	B-TEST	B-TEST
-	:	O	O
5.3*	CD	O	O
chloride	NN	B-TEST	B-TEST
-	:	O	O
101	CD	O	O
total	JJ	B-TEST	B-TEST
co2	NN	I-TEST	I-TEST
-	:	O	O
17*	CD	O	O
anion	NN	B-TEST	B-TEST
gap	NN	I-TEST	I-TEST
-	:	O	O
23*	CD	O	O

ld	NN	B-TEST	O
(	(	I-TEST	O
ldh	NN	I-TEST	O
)	)	I-TEST	O
-	:	O	O
214	CD	O	O

lactate	NN	B-TEST	B-TEST
-	:	O	O
1.4	CD	O	O

2014-11-29	JJ	O	O
05:11pm	CD	O	O
urine	NN	B-TEST	B-TEST

color	NN	B-TEST	B-TEST
-	:	O	O
straw	NN	O	O
appear	VBP	B-TEST	O
-	:	O	O
hazy	NN	O	B-PROBLEM
sp	NN	O	I-PROBLEM
thibodeaux	SYM	B-TEST	O
-	:	O	O
1.008	CD	O	O

2014-11-29	JJ	O	O
05:11pm	CD	O	O
urine	NN	B-TEST	B-TEST

blood	NN	B-TEST	B-TEST
-	:	O	I-TEST
lg	NN	O	I-TEST
nitrite	JJ	B-TEST	I-TEST
-	:	O	O
neg	NN	O	O
protein	SYM	B-TEST	B-TEST
-	:	O	O
tr	NN	O	O

glucose	JJ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
ketone	NN	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
bilirubin	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
urobilngn	JJ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
ph	SYM	B-TEST	B-TEST
-	:	O	O
9.0*	CD	O	O

leuk	SYM	B-TEST	B-TEST
-	:	O	O
sm	NN	O	O

2014-11-29	JJ	O	O
05:11pm	CD	O	O
urine	NN	B-TEST	B-TEST

rbc	LS	B-TEST	B-TEST
-	:	O	O
21-50*	JJ	O	O
wbc	JJ	B-TEST	B-TEST
-	:	O	I-TEST
04-12	NN	O	I-TEST
bacteria	NNS	B-TEST	I-TEST
-	:	O	O
many	JJ	O	O

yeast	SYM	B-TEST	B-TEST
-	:	O	O
none	NN	O	O
epi	SYM	B-TEST	O
-	:	O	O
0-2	NN	O	O

2014-11-29	JJ	O	O
05:11pm	CD	O	O
urine	NN	B-TEST	B-TEST

3phosphat	LS	B-TEST	O
-	:	O	O
occ	NN	O	O

2014-11-29	JJ	O	B-TEST
ct	NN	B-TEST	I-TEST
cap	NN	I-TEST	I-TEST
:	:	O	O

1.	CD	O	O
an	DT	B-PROBLEM	O
8	CD	I-PROBLEM	O
x	NN	I-PROBLEM	O
7	CD	I-PROBLEM	O
x	JJ	I-PROBLEM	O
7	CD	I-PROBLEM	O
mm	JJ	I-PROBLEM	O
stone	NN	I-PROBLEM	O
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
proximal	JJ	I-PROBLEM	O
right	JJ	I-PROBLEM	O
ureter	NN	I-PROBLEM	O
with	IN	O	O
associated	JJ	O	B-PROBLEM
right	JJ	B-PROBLEM	I-PROBLEM
hydronephrosis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
inflammatory	JJ	B-PROBLEM	B-PROBLEM
perinephric	JJ	I-PROBLEM	I-PROBLEM
stranding	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

additional	JJ	B-PROBLEM	B-TREATMENT
smaller	JJR	I-PROBLEM	I-TREATMENT
non-obstructing	JJ	I-PROBLEM	I-TREATMENT
right	JJ	I-PROBLEM	I-TREATMENT
renal	JJ	I-PROBLEM	I-TREATMENT
stones	NNS	I-PROBLEM	I-TREATMENT
.	.	O	O

2.	CD	O	O
left	VBD	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
stones	NNS	I-PROBLEM	I-PROBLEM
without	IN	O	O
evidence	NN	O	O
of	IN	O	O
hydronephrosis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

ileal	JJ	B-TREATMENT	B-TREATMENT
conduit	NN	I-TREATMENT	I-TREATMENT
is	VBZ	O	O
not	RB	O	O
well	RB	O	O
evaluated	VBN	O	O
.	.	O	O

3.	CD	O	O
right	JJ	B-PROBLEM	B-PROBLEM
breast	NN	I-PROBLEM	I-PROBLEM
calcification	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

correlation	NN	O	B-TEST
with	IN	O	I-TEST
mammography	NN	B-TEST	I-TEST
is	VBZ	O	O
suggested	VBN	O	O
.	.	O	O

2014-11-29	JJ	O	O
cxr	NN	B-TEST	O
:	:	O	O

no	DT	O	O
evidence	NN	O	O
of	IN	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2014-11-29	JJ	O	B-TEST
ct	NN	B-TEST	I-TEST
ap	NN	I-TEST	I-TEST
#2	NNP	I-TEST	I-TEST
(	(	I-TEST	O
with	IN	I-TEST	O
contrast	NN	I-TEST	O
)	)	I-TEST	O
:	:	O	O

1.	CD	O	O
eight	CD	B-PROBLEM	O
mm	NNS	I-PROBLEM	O
right	RB	I-PROBLEM	O
proximal	JJ	I-PROBLEM	O
ureteral	JJ	I-PROBLEM	O
stone	NN	I-PROBLEM	O
with	IN	O	O
right-sided	JJ	B-PROBLEM	B-PROBLEM
hydronephrosis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
inflammatory	JJ	B-PROBLEM	B-PROBLEM
stranding	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pyelonephritis	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
kidney	NN	I-PROBLEM	I-PROBLEM
without	IN	O	O
left	NN	B-PROBLEM	B-PROBLEM
sided	VBD	I-PROBLEM	I-PROBLEM
hydronephrosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
intraabdominal	JJ	B-PROBLEM	B-PROBLEM
abscess	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
of	IN	O	O
diverticulitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

3.	CD	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
round	NN	I-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	O
hypodense	JJ	I-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
too	RB	O	O
small	JJ	O	O
to	TO	O	O
accurately	RB	O	O
characterize	VB	O	O
but	CC	O	O
likely	JJ	O	O
representing	VBG	O	O
cysts	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

4.	CD	O	O
1.4	CD	B-PROBLEM	B-PROBLEM
cm	NN	I-PROBLEM	I-PROBLEM
hypodense	NN	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
liver	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
incompletely	RB	O	B-PROBLEM
characterized	VBN	O	I-PROBLEM
.	.	O	O

2014-11-30	JJ	O	B-TEST
ct	NN	B-TEST	I-TEST
cap	NN	I-TEST	I-TEST
:	:	O	O

1.	CD	O	O
nephrostomy	JJ	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
in	IN	I-TREATMENT	O
the	DT	I-TREATMENT	O
right	JJ	I-TREATMENT	O
kidney	NN	I-TREATMENT	O
with	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
8	CD	I-PROBLEM	I-PROBLEM
mm	NN	I-PROBLEM	I-PROBLEM
right	RB	I-PROBLEM	I-PROBLEM
ureteric	JJ	I-PROBLEM	I-PROBLEM
stone	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
6	CD	B-PROBLEM	O
mm	NN	I-PROBLEM	O
nonobstructing	VBG	I-PROBLEM	O
calculus	NN	I-PROBLEM	O
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
left	JJ	I-PROBLEM	O
kidney	NN	I-PROBLEM	O
.	.	O	O

3.	CD	O	O
calcified	JJ	B-PROBLEM	O
focus	NN	I-PROBLEM	O
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
hypodense	NN	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
liver	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
incompletely	RB	O	B-PROBLEM
characterized	VBN	O	I-PROBLEM
.	.	O	O

4.	CD	O	O
bibasilar	JJ	B-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
dependent	JJ	I-PROBLEM	I-PROBLEM
atelectasis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2014-11-29	JJ	O	O
5:10	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST

aerobic	JJ	B-TEST	B-TREATMENT
bottle	NN	I-TEST	I-TREATMENT
(	(	O	O
final	JJ	O	O
2014-12-04	NN	O	O
)	)	O	O
:	:	O	O

klebsiella	NN	B-PROBLEM	B-PROBLEM
pneumoniae	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

identification	NN	B-TEST	B-TEST
and	CC	O	I-TEST
sensitivities	NNS	B-TEST	I-TEST
performed	VBN	O	O
from	IN	O	O

anaerobic	JJ	B-TEST	B-TREATMENT
bottle	NN	I-TEST	I-TREATMENT
.	.	O	O

of	IN	O	O
two	CD	B-PROBLEM	B-PROBLEM
colonial	JJ	I-PROBLEM	I-PROBLEM
morphologies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

anaerobic	JJ	B-TEST	B-TREATMENT
bottle	NN	I-TEST	I-TREATMENT
(	(	O	O
final	JJ	O	O
2014-12-04	NN	O	O
)	)	O	O
:	:	O	O

klebsiella	NN	B-PROBLEM	B-PROBLEM
pneumoniae	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

final	JJ	B-TEST	B-PROBLEM
sensitivities	NNS	I-TEST	I-PROBLEM
.	.	O	O

trimethoprim/sulfa	JJ	B-TEST	B-TEST
sensitivity	NN	I-TEST	I-TEST
testing	VBG	I-TEST	I-TEST
available	JJ	O	O
on	IN	O	O
request	NN	O	O
.	.	O	O

klebsiella	NN	B-PROBLEM	B-PROBLEM
pneumoniae	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

final	JJ	B-TEST	B-PROBLEM
sensitivities	NNS	I-TEST	I-PROBLEM
.	.	O	O

trimethoprim/sulfa	JJ	B-TEST	B-TEST
sensitivity	NN	I-TEST	I-TEST
testing	VBG	I-TEST	I-TEST
available	JJ	O	O
on	IN	O	O
request	NN	O	O
.	.	O	O

sensitivities	NNS	B-TEST	O
:	:	O	O

mic	NNS	B-TEST	O
expressed	VBN	O	O
in	IN	O	O
mcg/ml	NN	O	O

klebsiella	NN	B-PROBLEM	B-PROBLEM
pneumoniae	NN	I-PROBLEM	I-PROBLEM

klebsiella	NN	B-PROBLEM	B-PROBLEM
pneumoniae	NN	I-PROBLEM	I-PROBLEM

ampicillin/sulbactam--	NN	B-TREATMENT	B-PROBLEM

cefazolin-------------	NN	B-TREATMENT	O

cefepime--------------	NN	B-TREATMENT	O

ceftazidime-----------	NN	B-TREATMENT	O

ceftriaxone-----------	NN	B-TREATMENT	O

cefuroxime------------	NN	B-TREATMENT	O

ciprofloxacin---------	NN	B-TREATMENT	O

gentamicin------------	NN	B-TREATMENT	B-PROBLEM

imipenem--------------	NN	B-TREATMENT	O

levofloxacin----------	NN	B-TREATMENT	B-TREATMENT

meropenem-------------	NN	B-TREATMENT	O

piperacillin/tazo-----	NN	B-TREATMENT	O

tobramycin------------	NN	B-TREATMENT	O

fluid	JJ	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
(	(	O	O
final	JJ	O	O
2014-12-03	NN	O	O
)	)	O	O
:	:	O	O

due	JJ	O	O
to	TO	O	O
mixed	JJ	B-PROBLEM	B-PROBLEM
bacterial	JJ	I-PROBLEM	I-PROBLEM
types	NNS	I-PROBLEM	I-PROBLEM
(	(	O	O
>=	$	O	O
3	CD	B-PROBLEM	O
colony	NN	I-PROBLEM	O
types	NNS	I-PROBLEM	O
)	)	O	O
an	DT	B-TEST	O
abbreviated	JJ	I-TEST	O
workup	NN	I-TEST	B-TEST
is	VBZ	O	O
performed	VBN	O	O
appropriate	JJ	O	O
to	TO	O	O
the	DT	O	O
isolates	NNS	O	O
recovered	VBD	O	O
from	IN	O	O
the	DT	O	O
site	NN	O	O
(	(	O	O
including	VBG	O	O
a	DT	B-TEST	O
screen	NN	I-TEST	O
for	IN	O	O
pseudomonas	NN	B-PROBLEM	B-PROBLEM
aeruginosa	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
staphylococcus	VB	B-PROBLEM	B-PROBLEM
aureus	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
beta	NN	B-PROBLEM	B-TREATMENT
streptococcus	NN	I-PROBLEM	I-TREATMENT
)	)	O	O
.	.	O	O

staph	NN	B-PROBLEM	B-PROBLEM
aureus	NN	I-PROBLEM	I-PROBLEM
coag	NN	I-PROBLEM	I-PROBLEM
+	NN	I-PROBLEM	O
.	.	O	O

>100,000	CD	O	O
organisms/ml.	NN	B-TEST	O
.	.	O	O

of	IN	O	O
two	CD	B-PROBLEM	B-PROBLEM
colonial	JJ	I-PROBLEM	I-PROBLEM
morphologies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

oxacillin	NN	B-PROBLEM	B-PROBLEM
resistant	JJ	I-PROBLEM	I-PROBLEM
staphylococci	NN	I-PROBLEM	I-PROBLEM
must	MD	O	O
be	VB	O	O
reported	VBN	O	O
as	IN	O	O
also	RB	O	O
resistant	VBP	O	O
to	TO	O	O
other	JJ	O	O
penicillins	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
cephalosporins	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
carbacephems	NNS	B-TREATMENT	O
,	,	O	O
carbapenems	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
beta-lactamase	JJ	B-TREATMENT	B-TREATMENT
inhibitor	NN	I-TREATMENT	I-TREATMENT
combinations	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

rifampin	NN	B-TREATMENT	B-TREATMENT
should	MD	O	O
not	RB	O	O
be	VB	O	O
used	VBN	O	O
alone	RB	O	O
for	IN	O	O
therapy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

>100,000	CD	O	O
organisms/ml.	NN	B-TEST	O
.	.	O	O

of	IN	O	O
two	CD	B-PROBLEM	B-PROBLEM
colonial	JJ	I-PROBLEM	I-PROBLEM
morphologies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

sensitivities	NNS	B-TEST	O
:	:	O	O

mic	NNS	B-TEST	O
expressed	VBN	O	O
in	IN	O	O

staph	NN	B-PROBLEM	B-PROBLEM
aureus	NN	I-PROBLEM	I-PROBLEM
coag	NN	I-PROBLEM	I-PROBLEM
+	NN	O	I-PROBLEM

gentamicin------------	NN	B-TREATMENT	B-PROBLEM

levofloxacin----------	NN	B-TREATMENT	B-TREATMENT

nitrofurantoin--------	JJ	B-TREATMENT	O

oxacillin-------------	NN	B-TREATMENT	B-PROBLEM

penicillin------------	NN	B-TREATMENT	B-PROBLEM

tetracycline----------	NN	B-TREATMENT	O

vancomycin------------	NN	B-TREATMENT	O

2014-12-03	JJ	O	O
blood	NN	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST

aerobic	JJ	B-TEST	O
bottle	SYM	I-TEST	O
-	:	O	O
pending	NN	O	O
;	:	O	O
anaerobic	JJ	B-TEST	B-TREATMENT
bottle	SYM	I-TEST	I-TREATMENT
-	:	O	O
pending	VBG	O	O

2014-12-03	JJ	O	O
blood	NN	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST

aerobic	JJ	B-TEST	O
bottle	SYM	I-TEST	O
-	:	O	O
pending	NN	O	O
;	:	O	O
anaerobic	JJ	B-TEST	B-TREATMENT
bottle	SYM	I-TEST	I-TREATMENT
-	:	O	O
pending	VBG	O	O

2014-12-02	JJ	O	O
urine	NN	B-TEST	O

urine	JJ	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
-	:	O	O
final	JJ	O	O
no	DT	O	O
growth	NN	O	B-PROBLEM

2014-12-02	JJ	O	B-TREATMENT
catheter	NN	B-TREATMENT	I-TREATMENT
tip	SYM	I-TREATMENT	I-TREATMENT
-	:	I-TREATMENT	O
iv	NN	I-TREATMENT	O

wound	JJ	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
-	:	O	O
final	JJ	O	O
no	DT	O	O
growth	NN	O	B-PROBLEM

2014-12-02	JJ	O	B-TEST
blood	NN	B-TEST	I-TEST
culture	NN	I-TEST	I-TEST

aerobic	JJ	B-TEST	O
bottle	SYM	I-TEST	O
-	:	O	O
pending	NN	O	O
;	:	O	O
anaerobic	JJ	B-TEST	B-TREATMENT
bottle	SYM	I-TEST	I-TREATMENT
-	:	O	O
pending	VBG	O	O

47	CD	O	O
yo	JJ	O	O
f	NN	O	O
w/	NN	O	O
h/o	VBD	O	O
steroid-induced	JJ	B-PROBLEM	B-PROBLEM
hyperglycemia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
sle	JJ	B-PROBLEM	O
w/	NN	O	O
h/o	NN	O	O
pericarditis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
transverse	JJ	B-PROBLEM	O
myelitis	NN	I-PROBLEM	O
w/	NN	O	O
paraplegia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	I-PROBLEM
neurogenic	JJ	B-PROBLEM	I-PROBLEM
bladder	NN	I-PROBLEM	I-PROBLEM
s/p	NN	O	O
urostomy	JJ	B-TREATMENT	B-TREATMENT
w/	JJ	O	O
ileal	NN	B-TREATMENT	B-TREATMENT
conduit	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
h/o	NN	O	O
ureteropelvic	JJ	B-PROBLEM	B-PROBLEM
stone	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
urosepsis	NN	B-PROBLEM	B-TREATMENT
,	,	O	O
and	CC	O	O
h/o	JJ	O	O
rle	NN	B-PROBLEM	O
dvt	NN	I-PROBLEM	O
admitted	VBD	O	O
11-29	JJ	O	O
w/	NN	O	O
left	VBD	B-PROBLEM	O
pyelo	NN	I-PROBLEM	O
and	CC	O	O
right	JJ	B-PROBLEM	O
8	CD	I-PROBLEM	O
mm	NN	I-PROBLEM	O
proximal	JJ	I-PROBLEM	O
ureteral	JJ	I-PROBLEM	O
stone	NN	I-PROBLEM	O
w/	NN	O	O
right	JJ	B-PROBLEM	O
hydro	NN	I-PROBLEM	O
s/p	NN	O	O
perc	NN	B-TREATMENT	B-TREATMENT
urostomy	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
to	TO	O	I-TREATMENT
relieve	VB	O	I-TREATMENT
right	JJ	B-PROBLEM	I-TREATMENT
hydro	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

##	JJ	O	O
gnr	NN	B-PROBLEM	O
sepsis:	NN	I-PROBLEM	O

upon	IN	O	O
admission	NN	O	O
,	,	O	O
pt	NN	O	O
was	VBD	O	O
febrile	JJ	B-PROBLEM	B-PROBLEM
to	TO	O	O
101.2	CD	O	O
with	IN	O	O
u/a	JJ	B-TEST	O
consistent	JJ	O	O
with	IN	O	O
uti	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
abd	NN	I-TEST	I-TEST
showed	VBD	O	O
8mm	CD	B-PROBLEM	O
obstructing	VBG	I-PROBLEM	O
stone	NN	I-PROBLEM	O
,	,	O	O
hydro	NN	B-PROBLEM	O
with	IN	O	O
stranding	VBG	B-PROBLEM	O
consistent	JJ	O	O
with	IN	O	O
pylonephritis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

her	PRP$	O	O
presentation	NN	O	O
was	VBD	O	O
thought	VBN	O	O
likely	RB	O	O
due	JJ	O	O
to	TO	O	O
urosepsis	VB	B-PROBLEM	O
given	VBN	O	O
h/o	JJ	O	O
foul	NN	B-PROBLEM	B-PROBLEM
smelling	VBG	I-PROBLEM	I-PROBLEM
urine	JJ	I-PROBLEM	I-PROBLEM
and	CC	O	O
in	IN	O	O
setting	NN	O	O
of	IN	O	O
stone	NN	B-PROBLEM	O
w/	NN	O	O
hydro	NN	B-PROBLEM	O
+	NNP	O	O
pyelo	NN	B-PROBLEM	O
by	IN	O	O
ct.	VBG	B-TEST	O
the	DT	O	O
patient	NN	O	O
went	VBD	O	O
to	TO	O	O
ir	VB	O	O
on	IN	O	O
2014-11-30	JJ	O	O
given	VBN	O	O
evidence	NN	O	O
of	IN	O	O
right	JJ	B-PROBLEM	B-PROBLEM
hydronephrosis	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
imaging	VBG	B-TEST	O
for	IN	O	O
decompression	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
drainage.	NN	B-TREATMENT	O
upon	IN	O	O
admission	NN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
gentamycin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
the	DT	B-TREATMENT	O
must	MD	I-TREATMENT	O
protocol	VB	I-TREATMENT	O
with	IN	O	O
high	JJ	B-TREATMENT	B-TREATMENT
dose	JJ	I-TREATMENT	I-TREATMENT
steroids	NNS	I-TREATMENT	I-TREATMENT
as	IN	O	O
well	RB	O	O
and	CC	O	O
a	DT	O	B-TREATMENT
goal	NN	O	I-TREATMENT
svo2	NN	B-TEST	I-TREATMENT
>70%	NN	O	I-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
hypoxic	JJ	B-PROBLEM	B-PROBLEM
requiring	VBG	O	O
3l	CD	B-TREATMENT	B-TREATMENT
nasal	JJ	I-TREATMENT	I-TREATMENT
cannula	NN	I-TREATMENT	I-TREATMENT
o2	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
subsequently	RB	O	O
developed	VBD	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
sbp	NN	B-TEST	O
in	IN	O	O
the	DT	O	O
70s	CD	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
where	WRB	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
the	DT	B-TREATMENT	O
must	MD	I-TREATMENT	O
protocol	VB	I-TREATMENT	O
with	IN	O	O
goais	NN	O	O
of	IN	O	O
cvp	JJ	B-TEST	O
10-12	JJ	O	O
,	,	O	O
svo2	RB	B-TEST	O
greater	JJR	O	O
than	IN	O	O
70%	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
bolused	VBN	O	O
with	IN	O	O
ns	JJ	B-TREATMENT	O
and	CC	O	O
did	VBD	O	O
not	RB	O	O
required	VBN	O	O
pressors	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

on	IN	O	O
the	DT	O	O
day	NN	O	O
after	IN	O	O
admission	NN	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
small	JJ	B-PROBLEM	B-PROBLEM
oxygen	NN	I-PROBLEM	I-PROBLEM
requirement	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
2l	CD	B-TREATMENT	O
nc	NNS	I-TREATMENT	O
.	.	O	O

repeat	NN	B-TEST	B-TEST
imaging	VBG	I-TEST	I-TEST
revealed	VBD	O	O
evidence	NN	O	O
of	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
congestion	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
thought	VBN	O	O
to	TO	O	O
account	VB	O	O
for	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
mild	JJ	I-PROBLEM	I-PROBLEM
hypoxia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

given	VBN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
been	VBN	O	O
maintaining	VBG	O	O
a	DT	B-TEST	O
map	NN	I-TEST	O
of	IN	O	O
60	CD	O	O
without	IN	O	O
fluids	NNS	B-TREATMENT	O
or	CC	O	O
pressors	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
her	PRP$	O	O
goal	NN	O	O
cvp	NN	B-TEST	O
was	VBD	O	O
decreased	VBN	O	O
to	TO	O	O
>8	VB	O	O
to	TO	O	O
avoid	VB	O	O
fluid	JJ	B-PROBLEM	B-PROBLEM
overload	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
gentamycin	NN	B-TREATMENT	B-TREATMENT
while	IN	O	O
speciation	NN	B-TEST	B-TEST
and	CC	O	I-TEST
sensitivities	NNS	B-TEST	I-TEST
were	VBD	O	O
pending	VBG	O	O
.	.	O	O

ciprofloxacin	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
added	VBN	O	O
on	IN	O	O
2014-12-01	JJ	O	O
for	IN	O	O
synergy	NN	O	O
when	WRB	O	O
surveillance	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
were	VBD	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
growing	VBG	O	O
again	RB	O	O
gnr	NN	B-PROBLEM	O
.	.	O	O

gent	NN	B-TREATMENT	O
and	CC	O	O
cipro	NN	B-TREATMENT	B-TREATMENT
were	VBD	O	O
then	RB	O	O
discontinued	VBN	O	O
and	CC	O	O
changed	VBN	O	O
to	TO	O	O
meropenem	VB	B-TREATMENT	O
when	WRB	O	O
blood	NN	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
sensitivities	NNS	I-TEST	I-TEST
became	VBD	O	O
available	JJ	O	O
revealing	VBG	O	O
gnr	NN	B-PROBLEM	B-PROBLEM
sensitive	JJ	O	O
to	TO	O	O
jacoby	VB	B-TREATMENT	O
but	CC	O	O
resistant	VB	O	O
to	TO	O	O
both	DT	O	O
gent	NN	B-TREATMENT	O
and	CC	O	O
cipro	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

additionaly	JJ	O	B-TEST
surveillance	NN	B-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
were	VBD	O	O
drawn	VBN	O	O
daily	RB	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
back	RB	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
with	IN	O	O
no	DT	O	O
subsequent	JJ	B-PROBLEM	B-PROBLEM
pressor	NN	I-PROBLEM	I-PROBLEM
requirement	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

blood	NN	B-TEST	B-TEST
cltures	NNS	I-TEST	I-TEST
from	IN	O	O
11-30	JJ	O	O
grew	VBD	O	O
klebsiella	NN	B-PROBLEM	B-PROBLEM
pneumoniae	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
12-01	JJ	O	O
grew	VBD	O	O
klebsiella	NN	B-PROBLEM	B-PROBLEM
pneumoniae	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
proteus	NN	B-PROBLEM	O
mirabilis	NNS	I-PROBLEM	O
both	DT	O	O
sensitive	JJ	O	O
to	TO	O	O
the	DT	B-TREATMENT	O
meropenam	NN	I-TREATMENT	O
which	WDT	O	O
she	PRP	O	O
had	VBD	O	O
already	RB	O	O
been	VBN	O	O
receiving	VBG	O	O
.	.	O	O

urine	JJ	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
from	IN	O	O
11-30	JJ	O	O
grew	VBD	O	O
staph	JJ	B-PROBLEM	B-PROBLEM
aureus	JJ	I-PROBLEM	I-PROBLEM
coag	NN	I-PROBLEM	I-PROBLEM
+	NN	O	O
,	,	O	O
and	CC	O	O
gram	JJ	B-PROBLEM	B-PROBLEM
negative	JJ	I-PROBLEM	I-PROBLEM
rods	NNS	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
two	CD	O	I-PROBLEM
morphologies	NNS	O	I-PROBLEM
(	(	O	O
not	RB	O	O
further	RB	O	O
speciated	VBN	O	O
)	)	O	O
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
from	IN	O	O
12-02	JJ	O	O
and	CC	O	O
12-03	NNS	O	O
have	VBP	O	O
no	DT	O	O
growth	NN	B-PROBLEM	O
to	TO	O	O
date	NN	O	O
.	.	O	O

she	PRP	O	O
received	VBD	O	O
a	DT	B-TREATMENT	B-PROBLEM
midline	NN	I-TREATMENT	I-PROBLEM
on	IN	O	O
12-04	JJ	O	O
with	IN	O	O
a	DT	O	O
goal	NN	O	O
of	IN	O	O
16	CD	O	O
days	NNS	O	O
of	IN	O	O
further	JJ	B-TREATMENT	B-TREATMENT
antibiotic	JJ	I-TREATMENT	I-TREATMENT
treatment	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
meropenam	NN	B-TREATMENT	B-PROBLEM
(	(	O	O
for	IN	O	O
a	DT	O	O
total	NN	O	O
of	IN	O	O
3	CD	O	O
weeks	NNS	O	O
)	)	O	O
upon	IN	O	O
discharge	NN	O	O
back	RB	O	O
to	TO	O	O
the	DT	O	O
nursing	NN	O	O
home	NN	O	O
where	WRB	O	O
she	PRP	O	O
lives	VBZ	O	O
.	.	O	O

##	RB	O	B-PROBLEM
right	JJ	B-PROBLEM	I-PROBLEM
hydronephrosis	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

given	VBN	O	O
right	RB	B-PROBLEM	B-PROBLEM
sided	VBN	I-PROBLEM	I-PROBLEM
hydronephrosis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
gnr	NN	B-PROBLEM	B-PROBLEM
bactermeia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
a	DT	B-TREATMENT	B-TREATMENT
percutaneous	JJ	I-TREATMENT	I-TREATMENT
nephrostomy	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
by	IN	O	O
ir	JJ	O	O
2014-11-30	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
put	VBD	O	O
out	RP	O	O
1385	CD	O	O
cc	NN	O	O
urine	JJ	O	O
the	DT	O	O
day	NN	O	O
after	IN	O	O
placement	NN	O	B-TREATMENT
,	,	O	O
950	CD	O	O
cc	NN	O	O
of	IN	O	O
which	WDT	O	O
came	VBD	O	O
from	IN	O	O
nephrostomy	JJ	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	B-TREATMENT	O
tube	NN	I-TREATMENT	O
appeared	VBD	O	O
to	TO	O	O
be	VB	O	O
functioning	VBG	O	O
well	RB	O	O
,	,	O	O
draining	VBG	O	O
urine	JJ	O	O
with	IN	O	O
occasional	JJ	B-PROBLEM	B-PROBLEM
clot	NN	I-PROBLEM	I-PROBLEM
passage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

urology	NN	O	O
was	VBD	O	O
notified	VBN	O	O
about	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
clots	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
occasional	JJ	B-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
tinged	VBD	I-PROBLEM	I-PROBLEM
urine	JJ	I-PROBLEM	I-PROBLEM
but	CC	O	O
they	PRP	O	O
did	VBD	O	O
not	RB	O	O
make	VB	O	O
any	DT	O	O
further	JJ	O	O
recommendations	NNS	O	O
.	.	O	O

cultures	NNS	B-TEST	B-TEST
from	IN	I-TEST	O
urine	JJ	I-TEST	B-TEST
drawn	NN	O	I-TEST
from	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
nephrostomy	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
are	VBP	O	O
currently	RB	O	O
growing	VBG	O	O
>	PRP	O	O
100k	CD	O	O
gnr	NN	B-PROBLEM	O
,	,	O	O
possibly	RB	O	O
of	IN	O	O
two	CD	B-PROBLEM	B-PROBLEM
colony	NN	I-PROBLEM	I-PROBLEM
morphologies	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
speciation	NN	B-TEST	B-TEST
and	CC	O	O
sensitivity	NN	B-TEST	O
pending	NN	O	O
.	.	O	O

##	JJ	O	B-PROBLEM
hct	JJ	B-PROBLEM	I-PROBLEM
drop	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

on	IN	O	O
admission	NN	O	O
to	TO	O	O
hospital	VB	O	O
patient	NN	O	O
had	VBD	O	O
hct	NN	B-TEST	B-TEST
of	IN	O	O
29.2	CD	O	O
.	.	O	O

in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
right	JJ	B-TREATMENT	B-TREATMENT
sublavian	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
as	RB	O	O
well	RB	O	O
as	IN	O	O
nephrostomy	JJ	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
placement	VBD	I-TREATMENT	I-TREATMENT
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
drifting	NN	I-PROBLEM	I-PROBLEM
hct	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
concerning	VBG	O	O
for	IN	O	O
bleed	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
with	IN	O	O
nadir	NN	B-TEST	O
of	IN	O	O
22.8	CD	O	O
on	IN	O	O
2014-12-01	JJ	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
ct	JJ	I-TEST	I-TEST
abdomen	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
which	WDT	O	O
did	VBD	O	O
not	RB	O	O
demonstrate	VB	O	O
any	DT	B-PROBLEM	B-PROBLEM
retroperitoneal	JJ	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

hct	NN	B-TEST	B-TEST
stabilized	VBD	O	O
to	TO	O	O
24	CD	O	O
for	IN	O	O
three	CD	O	O
days	NNS	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

anemia	NN	B-TEST	B-PROBLEM
workup	NN	I-TEST	I-PROBLEM
revealed	VBD	O	O
a	DT	O	O
picture	NN	O	O
of	IN	O	O
anemia	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
chronic	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
tibc	JJ	B-TEST	B-TEST
225	CD	O	O
,	,	O	O
b12	NN	B-TEST	O
and	CC	O	O
folate	NN	B-TEST	B-TEST
normal	JJ	O	O
,	,	O	O
hapto	JJ	B-TEST	O
397	CD	O	O
,	,	O	O
ferritin	RB	B-TEST	B-TEST
51	CD	O	O
,	,	O	O
trf	NN	B-TEST	O
173	CD	O	O
,	,	O	O
iron	RB	B-TEST	B-TREATMENT
35	CD	O	O
)	)	O	O
.	.	O	O

##	NN	O	O
hypoxia:	NN	B-PROBLEM	O

the	DT	O	O
patient	NN	O	O
on	IN	O	O
admission	NN	O	O
was	VBD	O	O
requiring	VBG	O	O
3	CD	B-TREATMENT	O
l	NN	I-TREATMENT	O
nc	NN	I-TREATMENT	O
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
receiving	VBG	O	O
2l	CD	B-TREATMENT	O
ns	JJ	I-TREATMENT	O
and	CC	O	O
chest	JJS	B-TEST	B-TREATMENT
film	NN	I-TEST	I-TREATMENT
which	WDT	O	O
demonstrated	VBD	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
congestion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
not	RB	O	O
diuresed	VBN	O	O
but	CC	O	O
allowed	VBN	O	O
to	TO	O	O
auto-diurese	JJ	O	B-TREATMENT
any	DT	O	I-TREATMENT
additional	JJ	O	I-TREATMENT
fluids	NNS	O	I-TREATMENT
and	CC	O	O
is	VBZ	O	O
currently	RB	O	O
with	IN	O	O
o2	JJ	B-TEST	B-TEST
sats	NNS	I-TEST	I-TEST
97-98%	VBP	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

as	IN	O	O
her	PRP$	B-TEST	O
bp	NN	I-TEST	O
remained	VBD	O	O
stable	JJ	O	O
she	PRP	O	O
did	VBD	O	O
not	RB	O	O
receiving	VBG	O	O
any	DT	B-TREATMENT	B-TREATMENT
standing	JJ	I-TREATMENT	I-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
but	CC	O	O
was	VBD	O	O
be	VB	O	O
bolused	VBN	B-TREATMENT	O
as	IN	O	O
appropriate	NN	O	O
for	IN	O	O
a	DT	B-TEST	O
map	NN	I-TEST	O
<	VBZ	O	O
60	CD	O	O
or	CC	O	O
cvp	VB	B-TEST	O
<	JJ	O	O
8	CD	O	O
with	IN	O	O
careful	JJ	O	O
monitoring	NN	O	O
of	IN	O	O
pulmonary	JJ	O	B-PROBLEM
status	NN	O	I-PROBLEM
.	.	O	O

patient	NN	O	O
had	VBD	O	O
an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
in	IN	O	O
2012	CD	O	O
which	WDT	O	O
demonstrated	VBD	O	O
an	DT	B-TEST	O
ef	NN	I-TEST	O
of	IN	O	O
60-65%	JJ	O	O
.	.	O	O

her	PRP$	B-PROBLEM	B-PROBLEM
o2	JJ	I-PROBLEM	I-PROBLEM
requirement	NN	I-PROBLEM	I-PROBLEM
by	IN	O	O
discharge	NN	O	O
was	VBD	O	O
96%	CD	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
with	IN	O	O
no	DT	O	O
sob	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

##	JJ	O	B-PROBLEM
steroid-induced	JJ	B-PROBLEM	I-PROBLEM
hyperglycemia	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

at	IN	O	O
home	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
received	VBD	O	O
metformin	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
ssi	NN	B-TREATMENT	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
patient	NN	I-TREATMENT	I-TREATMENT
's	POS	I-TREATMENT	I-TREATMENT
metformin	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
held	VBN	O	O
and	CC	O	O
she	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
maintained	VBN	O	O
on	IN	O	O
ssi	NNS	B-TREATMENT	O
qid	NNS	O	O
while	IN	O	O
in	IN	O	O
the	DT	O	O
cmed	NN	O	O
.	.	O	O

as	IN	O	O
the	DT	O	O
patient	NN	O	O
appeared	VBD	O	O
to	TO	O	O
be	VB	O	O
clinically	RB	O	O
stable	JJ	O	O
,	,	O	O
her	PRP$	B-TREATMENT	B-TEST
stress	NN	I-TREATMENT	I-TEST
dose	JJ	I-TREATMENT	I-TEST
steroids	NNS	I-TREATMENT	I-TEST
were	VBD	O	O
discontinued	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
changed	VBN	O	O
back	RB	O	O
to	TO	O	O
her	PRP$	O	O
home	NN	O	O
dose	NN	O	O
of	IN	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
40mg	CD	O	O
po	NN	O	O
qd	NN	O	O
for	IN	O	O
maintenance	NN	O	O
with	IN	O	O
anticipated	JJ	O	B-PROBLEM
decrease	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
her	PRP$	B-TEST	I-PROBLEM
blood	NN	I-TEST	I-PROBLEM
sugars	NNS	I-TEST	I-PROBLEM
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
metformin	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
re-added	JJ	O	O
2	CD	O	O
days	NNS	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
as	RB	O	O
well	RB	O	O
and	CC	O	O
fingerstick	JJ	B-TEST	B-TEST
glucoses	NNS	I-TEST	I-TEST
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
were	VBD	O	O
93	CD	O	O
and	CC	O	O
156	CD	O	O
,	,	O	O
respectively	RB	O	O
.	.	O	O

##	JJ	O	B-PROBLEM
hypothyroidism	NN	B-PROBLEM	I-PROBLEM
:	:	O	O

repeat	NN	B-TEST	B-PROBLEM
tsh	NNS	I-TEST	I-PROBLEM
and	CC	O	O
free	JJ	B-TEST	O
t4	NN	I-TEST	O
were	VBD	O	O
appropriate	JJ	O	O
on	IN	O	O
current	JJ	B-TREATMENT	O
outpatient	JJ	I-TREATMENT	O
regimen.	NN	I-TREATMENT	O
patient	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
levothyroxine	NN	B-TREATMENT	B-TREATMENT
75mcg	CD	O	O
po	NN	O	O
qd	NN	O	O
.	.	O	O

##	JJ	O	O
h/o	NN	O	O
transverse	NN	B-PROBLEM	B-PROBLEM
myelitis/optic	JJ	I-PROBLEM	I-PROBLEM
neuritis	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

on	IN	O	O
stress	NN	B-TREATMENT	B-TREATMENT
dose	JJ	I-TREATMENT	I-TREATMENT
steroids	NNS	I-TREATMENT	I-TREATMENT
originally	RB	O	O
given	VBN	O	O
must	MD	B-TREATMENT	O
protocol	VB	I-TREATMENT	O
and	CC	O	O
sepsis	VB	B-PROBLEM	B-PROBLEM
,	,	O	O
as	IN	O	O
patient	JJ	O	O
clinically	RB	O	O
stabilized	VBN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
changed	VBN	O	O
back	RB	O	O
to	TO	O	O
home	NN	O	O
dose	NN	O	O
of	IN	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
40mg	CD	O	O
po	NN	O	O
qd	NN	O	O
.	.	O	O

##	JJ	O	O
sle	NN	B-PROBLEM	O
:	:	O	O

currently	RB	O	O
no	DT	O	O
sx	NN	B-PROBLEM	O
of	IN	I-PROBLEM	O
active	JJ	I-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
manifestations	NNS	O	B-PROBLEM
of	IN	O	I-PROBLEM
sle	NN	B-PROBLEM	I-PROBLEM
during	IN	O	O
this	DT	O	O
admission	NN	O	O
.	.	O	O

#	#	O	O
osteoporosis	SYM	B-PROBLEM	B-TEST
-	:	O	O
we	PRP	O	O
continued	VBD	O	O
actonel/vit	JJ	B-TREATMENT	B-TREATMENT
d	NN	I-TREATMENT	I-TREATMENT
,	,	O	I-TREATMENT
tums	NNS	B-TREATMENT	I-TREATMENT

##	JJ	O	B-PROBLEM
capsular	JJ	B-PROBLEM	I-PROBLEM
ossification	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

we	PRP	O	O
continued	VBD	O	O
cmed	VBN	B-TREATMENT	O
csru	JJ	I-TREATMENT	B-PROBLEM
gtt	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
bicarb	NN	I-PROBLEM	I-PROBLEM
likely	RB	O	O
due	JJ	O	O
to	TO	O	O
renal	JJ	B-PROBLEM	O
wasting	NN	I-PROBLEM	O
but	CC	O	O
there	EX	O	O
is	VBZ	O	O
an	DT	B-PROBLEM	B-TEST
anion	NN	I-PROBLEM	I-TEST
gap	NN	I-PROBLEM	I-TEST
present	NN	O	O
.	.	O	O

serum	NN	B-TEST	B-TEST
acetone	NN	I-TEST	I-TEST
was	VBD	O	O
normal	JJ	O	O
.	.	O	O

we	PRP	O	O
followed	VBD	O	O
lactate	NN	B-TEST	B-TEST
while	IN	O	O
she	PRP	O	O
was	VBD	O	O
in	IN	O	O
the	DT	O	O
cmed	NN	O	O
which	WDT	O	O
was	VBD	O	O
normal	JJ	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
npo	JJ	B-TREATMENT	O
periodically	RB	O	O
but	CC	O	O
maintained	VBD	O	O
a	DT	O	O
normal	JJ	O	O
diet	JJ	O	O
prior	JJ	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

#	#	O	O
ppx	SYM	O	B-TEST
-	:	O	O
sq	NN	B-TREATMENT	O
heparin	NN	I-TREATMENT	B-TREATMENT
during	IN	O	O
this	DT	O	O
admission	NN	O	O
,	,	O	O
ppi	NN	B-TREATMENT	O

home	NN	B-TREATMENT	B-TREATMENT
meds	NNS	I-TREATMENT	I-TREATMENT
:	:	O	O

ascorbic	JJ	B-TREATMENT	B-TREATMENT
acid	NN	I-TREATMENT	I-TREATMENT
500	CD	O	O
tid	NN	O	O

cranberry	NN	B-TREATMENT	O
extract	JJ	I-TREATMENT	O
425	CD	O	O
bid	NN	O	O

bisacodyl	NN	B-TREATMENT	B-TREATMENT
10mg	CD	O	O

senna	NN	B-TREATMENT	B-TREATMENT

dephenhydramine	NN	B-TREATMENT	B-TEST
50mg	CD	O	O
prn	NN	O	O
loperamide	NN	B-TREATMENT	B-TREATMENT
prn	NN	O	O
famotidine	NN	B-TREATMENT	B-TREATMENT
20mg	CD	O	O

kcl	VB	B-TREATMENT	B-TEST
20mg	CD	O	O
qd	NN	O	O

metformin	NN	B-TREATMENT	B-TREATMENT
1000	CD	O	O
qd	NN	O	O
tums	NNS	B-TREATMENT	B-TREATMENT
1500	CD	O	O
bid	NN	O	O

mvi	NN	B-TREATMENT	O

timolol	NN	B-TREATMENT	B-TREATMENT
1	CD	O	O
drop	NN	O	O
bid	NN	O	O
0.5%	CD	O	O
l	NN	O	O
cmed	VBD	O	O
csru	NN	O	B-PROBLEM

synthroid	JJ	B-TREATMENT	B-TREATMENT
75	CD	O	O
qd	NN	O	O

compro	JJ	B-TREATMENT	O
25mg	CD	O	O
pr	NN	O	O

citrucel	NN	B-TREATMENT	O

vitamin	NN	B-TREATMENT	B-TREATMENT
d	VBZ	I-TREATMENT	I-TREATMENT
50k	CD	O	I-TREATMENT
qmondays	NNS	O	I-TREATMENT

oxazepam	RB	B-TREATMENT	B-TEST
15mg	CD	O	O
qhs	JJ	O	O
tizamidine	NN	B-TREATMENT	B-TREATMENT
8mg	CD	O	O
qhs	NN	O	O
actonel	NN	B-TREATMENT	O
35	CD	O	O
qwed	VBD	O	O

diovan	NN	B-TREATMENT	B-TREATMENT
80	CD	O	O
qd	NN	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
40	CD	O	O
qd	NN	O	O
bactrim	JJ	B-TREATMENT	B-TREATMENT
ds	NN	I-TREATMENT	I-TREATMENT
qmwf	NN	O	I-TREATMENT
baclofen	JJ	B-TREATMENT	I-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
2-3yrs	JJ	O	I-TREATMENT

insulin	NN	B-TREATMENT	B-TREATMENT
ss	NN	I-TREATMENT	O

actonel	RB	B-TREATMENT	O
35	CD	O	O
mg	JJ	O	O
oral	JJ	O	O
qwednesdays	NNS	O	O

ascorbic	JJ	B-TREATMENT	B-TREATMENT
acid	NN	I-TREATMENT	I-TREATMENT
500	CD	O	O
mg	NN	O	O
po	NN	O	O
tid	NN	O	O

sodium	NN	B-TREATMENT	B-TREATMENT
polystyrene	NN	I-TREATMENT	I-TREATMENT
sulfonate	NN	I-TREATMENT	I-TREATMENT
15	CD	O	O
gm	NN	O	O
po	NN	O	O
once	RB	O	O
11-29	CD	O	O
@	NN	O	O
2201	CD	O	O

famotidine	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
po	NNS	O	O
daily	RB	O	O

sulfameth/trimethoprim	JJ	B-TREATMENT	B-TREATMENT
ds	NN	O	I-TREATMENT
1	CD	O	O
tab	NN	O	O
po	NN	O	O
qmowefr	NN	O	O

gentamicin	NN	B-TREATMENT	B-TREATMENT
80	CD	O	O
mg	NN	O	O
iv	NN	O	O
q8h	NN	O	O

timolol	NN	B-TREATMENT	B-TREATMENT
maleate	NN	I-TREATMENT	I-TREATMENT
0.5%	CD	O	O
1	CD	O	O
drop	NN	O	O
os	NN	O	O
bid	NN	O	O

heparin	NN	B-TREATMENT	B-TREATMENT
5000	CD	O	O
unit	NN	O	O
sc	VBD	O	O
tid	NN	O	O

tizanidine	NN	B-TREATMENT	B-TREATMENT
hcl	NN	I-TREATMENT	I-TREATMENT
8	CD	O	O
mg	NN	O	O
po	NN	O	O
qhs	NN	O	O

hydrocortisone	NN	B-TREATMENT	B-TREATMENT
na	TO	I-TREATMENT	O
succ.	VB	I-TREATMENT	O
100	CD	O	O
mg	NN	O	O
iv	NN	O	O
q8h	NN	O	O

valsartan	RB	B-TREATMENT	B-TREATMENT
80	CD	O	O
mg	NNS	O	O
po	JJ	O	O
daily	JJ	O	O

insulin	NN	B-TREATMENT	B-TREATMENT
sc	NN	I-TREATMENT	I-TREATMENT
(	(	O	O
per	IN	O	O
insulin	NN	O	B-TREATMENT
flowsheet	NN	O	I-TREATMENT
)	)	O	I-TREATMENT

vancomycin	NN	B-TREATMENT	B-TREATMENT
hcl	NN	I-TREATMENT	I-TREATMENT
1000	CD	O	O
mg	NN	O	O
iv	NN	O	O
q	VBD	O	O
12h	CD	O	O

levothyroxine	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
75	CD	O	O
mcg	NN	O	O
po	NNS	O	O
daily	RB	O	O

vitamin	NN	B-TREATMENT	B-TREATMENT
d	VBZ	I-TREATMENT	O
50,000	CD	O	O
unit	NN	O	O
po	NN	O	O
qwednesdays	NNS	O	O

gnr	JJ	B-PROBLEM	B-PROBLEM
sepsis	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
steroid	CC	B-PROBLEM	B-PROBLEM
induced	JJ	I-PROBLEM	I-PROBLEM
hyperglycemia	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
hydronephrosis	NN	B-PROBLEM	B-PROBLEM
;	:	O	O
sle	NN	B-PROBLEM	B-PROBLEM

pls	NNS	O	O
take	VBP	O	O
all	DT	B-TREATMENT	B-TREATMENT
meds	NNS	I-TREATMENT	I-TREATMENT
as	IN	O	O
prescribed	NN	O	O
.	.	O	O

call	VB	O	O
your	PRP$	O	O
doctor	NN	O	O
immediately	RB	O	O
if	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
new	JJ	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
develop	VBP	O	O
including	VBG	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
rash	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
increase	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
bloody	JJ	I-PROBLEM	I-PROBLEM
urine	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
nephrostomy	NN	B-TREATMENT	B-TREATMENT
or	CC	O	O
urostomy	NN	B-TREATMENT	B-TREATMENT
bags	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
etc	FW	O	O
.	.	O	O

myasthenia	NN	B-PROBLEM	B-PROBLEM
gravis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2.	CD	O	O
history	NN	O	O
of	IN	O	O
thymoma	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
resection	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

3.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

4.	CD	O	O
history	NN	O	O
of	IN	O	O
colon	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
resection	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

5.	CD	O	O
benign	JJ	B-PROBLEM	B-PROBLEM
prostatic	JJ	I-PROBLEM	I-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

6.	CD	O	O
hydrocele	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

echocardiogram	NN	B-TEST	B-TEST
,	,	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
,	,	O	O
emg	NN	B-TEST	O
,	,	O	O
ct	JJ	B-TEST	B-TEST
scan	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
chest	NN	I-TEST	I-TEST
.	.	O	O

aspirin	RB	B-TREATMENT	B-TREATMENT
325	CD	O	O
q.d.	NN	O	O
;	:	O	O
albuterol	CC	B-TREATMENT	B-TREATMENT
nebs	$	I-TREATMENT	I-TREATMENT
2.5	CD	O	O
mg	NN	O	O
q.	NN	O	O
4h	CD	O	O
;	:	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O
;	:	O	O
heparin	CC	B-TREATMENT	B-TREATMENT
5,000	CD	O	O
units	NNS	O	O
subcu	JJ	O	O
b.i.d.	NN	O	O
;	:	O	O
synthroid	CC	B-TREATMENT	O
200	CD	O	O
mcg	NN	O	O
q.d.	NN	O	O
;	:	O	O
ocean	JJ	B-TREATMENT	B-TEST
spray	NN	I-TREATMENT	I-TEST
2	CD	O	O
sprays	NNS	O	O
q.	JJ	O	O
i.d.	NN	O	O
;	:	O	O
simvastatin	CC	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
q.	JJ	O	O
h.s.	NN	O	O
;	:	O	O
flovent	JJ	B-TREATMENT	B-TREATMENT
220	CD	O	O
mcg	NN	O	O
2	CD	O	O
puffs	NNS	O	O
b.i.d.	RB	O	O
;	:	O	O
zantac	CC	B-TREATMENT	O
150	CD	O	O
b.i.d.	NN	O	O
;	:	O	O
nystatin	CC	B-TREATMENT	B-TREATMENT
ointment	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
the	DT	O	O
gluteal	NN	O	O
fold	JJ	O	O
b.i.d.	NN	O	O
;	:	O	O
lisinopril	CC	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
q.d.	NN	O	O
;	:	O	O
mestinon	CC	B-TREATMENT	O
controlled	VBD	I-TREATMENT	O
release	NN	I-TREATMENT	O
180	CD	O	O
q.	JJ	O	O
h.s.	NN	O	O
;	:	O	O
mestinon	CC	B-TREATMENT	O
30	CD	O	O
mg	NN	O	O
q.	VBD	O	O
4h	CD	O	O
while	IN	O	O
awake	NN	O	O
;	:	O	O
prednisone	CC	B-TREATMENT	B-TREATMENT
60	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	NN	O	O
im	NN	O	O
;	:	O	O
atrovent	JJ	B-TREATMENT	B-TREATMENT
nebs	FW	I-TREATMENT	I-TREATMENT
0.5	CD	O	O
mg	NN	O	O
q.	NN	O	O
i.d.	NN	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
72-year-old	JJ	O	O
male	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
thymoma	NN	B-PROBLEM	B-PROBLEM
resected	VBN	O	I-PROBLEM
in	IN	O	O
1996	CD	O	O
,	,	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
obstructive	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
who	WP	O	O
was	VBD	O	O
transferred	VBN	O	O
from	IN	O	O
gobay	JJ	O	O
hos	NN	O	O
memorial	JJ	O	O
hospital	NN	O	O
for	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
developed	VBD	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
home	NN	O	O
and	CC	O	O
the	DT	O	B-TEST
emts	NN	O	I-TEST
were	VBD	O	O
called	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
in	IN	O	O
respiratory	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
gobay	VB	O	O
hos	JJ	O	O
memorial	JJ	O	O
hospital	NN	O	O
where	WRB	O	O
chest	NN	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
showed	VBD	O	O
left	VBD	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
infiltrate	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
cardiac	JJ	B-TEST	B-TEST
enzymes	NNS	I-TEST	I-TEST
were	VBD	O	O
elevated	VBN	B-PROBLEM	O
with	IN	O	O
a	DT	B-TEST	O
ck	NN	I-TEST	O
of	IN	O	O
297	CD	O	O
,	,	O	O
mb	JJR	B-TEST	B-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
38	CD	O	O
and	CC	O	O
troponin	NN	B-TEST	B-TEST
of	IN	O	O
12	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
medicine	NN	O	O
service	NN	O	O
at	IN	O	O
the	DT	O	O
retelk	JJ	O	O
county	NN	O	O
medical	JJ	O	O
center	NN	O	O
and	CC	O	O
underwent	JJ	O	O
cardiac	NN	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
which	WDT	O	O
was	VBD	O	O
negative	JJ	O	O
for	IN	O	O
disease	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
continued	VBD	O	O
to	TO	O	O
complain	VB	O	O
of	IN	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
an	DT	O	O
episode	NN	O	O
of	IN	O	O
respiratory	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
hospital	NN	O	O
requiring	VBG	O	O
100%	CD	B-TREATMENT	O
nonrebreather	RB	I-TREATMENT	O
.	.	O	O

neurology	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
for	IN	O	O
difficulty	NN	B-PROBLEM	B-PROBLEM
lifting	VBG	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
arms	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
consultation	NN	O	O
the	DT	O	O
patient	NN	O	O
admitted	VBD	O	O
to	TO	O	O
dysphasia	VB	B-PROBLEM	B-PROBLEM
and	CC	O	O
periods	NNS	O	O
of	IN	O	O
diplopia	NN	B-PROBLEM	B-PROBLEM
in	IN	O	O
the	DT	O	O
past	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
weakness	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
proximal	JJ	I-PROBLEM	O
muscles	NNS	I-PROBLEM	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
the	DT	O	O
capability	NN	O	O
of	IN	O	O
the	DT	O	O
muscles	NNS	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
iv	NN	B-TREATMENT	O
ig	NN	I-TREATMENT	O
and	CC	O	O
iv	JJ	B-TREATMENT	O
solu-medrol	NN	I-TREATMENT	O
for	IN	O	O
a	DT	O	O
diagnosis	NN	O	O
of	IN	O	O
myasthenia	NN	B-PROBLEM	B-PROBLEM
gravis	NN	I-PROBLEM	I-PROBLEM
given	VBN	O	O
his	PRP$	O	O
past	JJ	O	O
history	NN	O	O
of	IN	O	O
thymoma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
markedly	RB	O	O
improved	VBD	O	O
after	IN	O	O
a	DT	O	O
dose	NN	O	O
of	IN	O	O
mestinon	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

he	PRP	O	O
completed	VBD	O	O
a	DT	O	O
five-day	JJ	O	O
course	NN	O	O
of	IN	O	O
iv	JJ	B-TREATMENT	O
ig	NN	I-TREATMENT	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
work	NN	I-TEST	I-TEST
up	RB	I-TEST	I-TEST
included	VBD	O	O
acetylcholine	JJ	B-TEST	B-TEST
esterase	NN	I-TEST	I-TEST
,	,	O	I-TEST
receptor	NN	B-TEST	I-TEST
antibodies	NNS	I-TEST	I-TEST
,	,	O	O
thyroglobulin	NN	B-TEST	B-TEST
antibody	NN	I-TEST	I-TEST
is	VBZ	O	O
pending	VBG	O	O
.	.	O	O

an	DT	B-TEST	B-PROBLEM
ana	NN	I-TEST	I-PROBLEM
and	CC	O	O
rheumatoid	JJ	B-TEST	B-PROBLEM
factor	NN	I-TEST	I-PROBLEM
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

sed	JJ	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
was	VBD	O	O
58	CD	O	O
and	CC	O	O
repeat	VB	O	O
75	CD	O	O
.	.	O	O

emg	JJ	B-TEST	O
studies	NNS	I-TEST	O
were	VBD	O	O
performed	VBN	O	O
,	,	O	O
the	DT	O	O
result	NN	O	O
is	VBZ	O	O
pending	VBG	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
this	DT	O	O
dictation	NN	O	O
.	.	O	O

he	PRP	O	O
also	RB	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
chest	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
a	DT	O	O
question	NN	O	O
of	IN	O	O
recurrence	NN	O	B-PROBLEM
of	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
thymoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

thoracic	NN	O	B-TREATMENT
surgery	NN	O	I-TREATMENT
was	VBD	O	O
consulted	VBN	O	O
and	CC	O	O
recommended	VBN	O	O
repeating	VBG	O	O
the	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
in	IN	O	O
six	CD	O	O
weeks	NNS	O	O
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
.	.	O	O

this	DT	O	O
could	MD	O	O
represent	VB	O	O
either	CC	O	O
recurrence	NN	O	B-PROBLEM
of	IN	O	I-PROBLEM
scar	NN	B-PROBLEM	I-PROBLEM
tissue	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
tapered	VBN	O	O
to	TO	O	O
p.o.	VB	B-TREATMENT	O
prednisone	NN	I-TREATMENT	B-TREATMENT
and	CC	O	O
tolerated	VBD	O	O
mestinon	NN	B-TREATMENT	B-TREATMENT
30	CD	O	O
mg	NN	O	O
q.	VBD	O	O
4h	CD	O	O
with	IN	O	O
180	CD	O	O
mg	NNS	O	O
longacting	VBG	O	O
at	IN	O	O
bedtime	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
extubated	VBN	O	O
overnight	RB	O	O
without	IN	O	O
incident	NN	B-PROBLEM	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	O	O
good	JJ	O	O
cardiac	NN	O	O
index	NN	O	O
off	IN	O	O
all	DT	B-TREATMENT	B-TREATMENT
inotropic	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
swan-ganz	JJ	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
underwent	VBD	O	O
an	DT	B-TREATMENT	B-TREATMENT
exchange	NN	I-TREATMENT	I-TREATMENT
peritoneal	JJ	I-TREATMENT	I-TREATMENT
dialysis	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
parrack	NN	O	O
diabetes	VBZ	O	O
center	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
to	TO	O	O
help	VB	O	O
manage	VB	O	O
the	DT	B-PROBLEM	O
patient	NN	I-PROBLEM	O
's	POS	I-PROBLEM	O
hyperglycemia	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

by	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
two	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
remained	VBN	O	O
in	IN	O	O
sinus	NN	O	B-TEST
rhythm	NN	O	I-TEST
and	CC	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
lopressor	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
increased	VBN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
having	VBG	O	O
a	DT	O	O
bit	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
respiratory	JJ	I-PROBLEM	I-PROBLEM
acidosis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
therefore	RB	O	O
,	,	O	O
bicarbonate	NN	B-TREATMENT	B-TEST
was	VBD	O	O
added	VBN	O	O
to	TO	O	O
the	DT	B-TREATMENT	B-TREATMENT
dialysate	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-TREATMENT	B-TEST
mediastinal	JJ	I-TREATMENT	I-TEST
chest	NN	I-TREATMENT	I-TEST
tubes	NNS	I-TREATMENT	I-TEST
were	VBD	O	O
removed	VBN	O	O
,	,	O	O
however	RB	O	O
,	,	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
pleural	JJ	I-TREATMENT	I-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
tubes	NNS	I-TREATMENT	I-TREATMENT
remained	VBN	O	O
in	IN	O	O
place	NN	O	O
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
three	CD	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
apparent	JJ	O	O
that	IN	O	O
,	,	O	O
despite	IN	O	O
an	DT	B-TEST	B-TEST
oxygen	NN	I-TEST	I-TEST
saturation	NN	I-TEST	I-TEST
of	IN	O	O
99%	CD	O	O
on	IN	O	O
three	CD	O	O
liters	NNS	O	O
,	,	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
still	RB	O	O
in	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
respiratory	JJ	I-PROBLEM	I-PROBLEM
acidosis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
he	PRP	O	O
received	VBD	O	O
aggressive	JJ	B-TREATMENT	B-PROBLEM
pulmonary	JJ	I-TREATMENT	I-PROBLEM
toilette	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
pleural	JJ	I-TREATMENT	I-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
tubes	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
removed	VBN	O	O
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
four	CD	O	O
,	,	O	O
the	DT	B-TREATMENT	O
patient	NN	I-TREATMENT	O
cordis	NN	I-TREATMENT	O
was	VBD	O	O
removed	VBN	O	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
lopressor	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
increased	VBN	O	B-PROBLEM
another	DT	O	I-PROBLEM
increment	NN	O	I-PROBLEM
.	.	O	O

once	RB	O	O
on	IN	O	O
the	DT	O	O
floor	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
an	DT	O	B-TREATMENT
uneventful	JJ	O	I-TREATMENT
hospital	NN	O	I-TREATMENT
course	NN	O	I-TREATMENT
,	,	O	O
remaining	VBG	O	O
afebrile	NN	B-PROBLEM	B-PROBLEM
for	IN	O	O
the	DT	O	O
remainder	NN	O	O
of	IN	O	O
his	PRP$	O	O
hospital	NN	O	O
stay	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
's	POS	O	O
only	JJ	O	O
issue	NN	O	O
was	VBD	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
seven	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
peak	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
210/100	CD	O	O
.	.	O	O

the	DT	O	O
decision	NN	O	O
was	VBD	O	O
made	VBN	O	O
to	TO	O	O
start	VB	O	O
the	DT	O	O
patient	NN	O	O
on	IN	O	O
lisinopril	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
the	DT	O	O
initial	JJ	O	O
dose	NN	O	O
of	IN	O	O
7.5	CD	O	O
mg	NN	O	O
was	VBD	O	O
increased	VBN	O	O
to	TO	O	O
10	CD	O	O
mg	NNS	O	O
daily	RB	O	O
by	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
in	IN	O	O
order	NN	O	O
to	TO	O	O
control	VB	O	O
his	PRP$	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
more	RBR	O	O
tightly	RB	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
discharged	VBN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
seven	CD	O	O
and	CC	O	O
arrangements	NNS	O	O
were	VBD	O	O
made	VBN	O	O
to	TO	O	O
have	VB	O	O
physical	JJ	O	B-TEST
therapy	NN	O	I-TEST
perform	NN	O	I-TEST
a	DT	B-TEST	I-TEST
home	NN	I-TEST	I-TEST
safety	NN	I-TEST	I-TEST
evaluation	NN	I-TEST	I-TEST
for	IN	O	O
the	DT	O	O
patient	NN	O	O
,	,	O	O
to	TO	O	O
which	WDT	O	O
he	PRP	O	O
agreed	VBD	O	O
.	.	O	O

coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	VBG	I-TREATMENT	I-TREATMENT
times	NNS	O	O
three	CD	O	O
.	.	O	O

lopressor	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.b.i.d.	NN	O	O

lisinopril	RB	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NNS	O	O
p.o.q.d.	NN	O	O

lipitor	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.q.d.	NN	O	O

aspirin	RB	B-TREATMENT	B-TREATMENT
81	CD	O	O
mg	NNS	O	O
p.o.q.d.	NN	O	O

percocet	RB	B-TREATMENT	B-TREATMENT
one	CD	O	O
to	TO	O	O
two	CD	O	O
tablets	NNS	O	O
p.o.q.	VBP	O	O
3-4	JJ	O	O
h.	NN	O	O
p.r.n.	NN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.b.i.d.	NN	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
of	IN	O	O
98.4	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
72	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
154/89	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
18	CD	O	O
and	CC	O	O
oxygen	JJ	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST
90%	CD	O	O
in	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

his	PRP$	O	O
neck	NN	O	O
was	VBD	O	O
supple	RB	O	O
without	IN	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
faint	NN	B-PROBLEM	B-PROBLEM
bibasilar	JJ	I-PROBLEM	I-PROBLEM
crackles	NNS	I-PROBLEM	I-PROBLEM
on	IN	O	O
lung	NN	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
.	.	O	O

his	PRP$	O	O
heart	NN	O	O
had	VBD	O	O
a	DT	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
with	IN	O	O
no	DT	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
rub	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
gallop	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

his	PRP$	O	O
abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
nondistended	VBN	B-PROBLEM	B-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-TREATMENT
nonerythematous	JJ	I-PROBLEM	I-TREATMENT
peritoneal	JJ	I-PROBLEM	I-TREATMENT
dialysis	NN	I-PROBLEM	I-TREATMENT
insertion	NN	I-PROBLEM	I-TREATMENT
site	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
69	JJ	O	O
year-old	JJ	O	O
white	JJ	O	O
gentleman	NN	O	O
who	WP	O	O
is	VBZ	O	O
status	NN	O	O
post	NN	O	O
a	DT	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
1985	CD	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
septal	JJ	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
intraoperatively	RB	O	O
.	.	O	O

two	CD	O	O
years	NNS	O	O
after	IN	O	O
this	DT	B-TREATMENT	B-TREATMENT
operation	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
he	PRP	O	O
required	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
pacer	NN	I-TREATMENT	I-TREATMENT
implantation	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
sick	JJ	B-PROBLEM	B-PROBLEM
sinus	NN	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	JJ	O	O
presents	NNS	O	O
now	RB	O	O
with	IN	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
no	DT	O	O
anginal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

ejection	NN	B-TEST	B-TEST
fraction	NN	I-TEST	I-TEST
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
20%	CD	O	O
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
status	NN	O	O
post	NN	O	O
multiple	NN	B-TREATMENT	B-TREATMENT
angioplasty	JJ	I-TREATMENT	I-TREATMENT
stents	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
presents	VBZ	O	O
now	RB	O	O
for	IN	O	O
possible	JJ	O	O
reoperative	JJ	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

1	CD	O	O
)	)	O	O
non-insulin	JJ	B-PROBLEM	B-PROBLEM
dependent	NN	I-PROBLEM	I-PROBLEM
diabetes	VBZ	I-PROBLEM	I-PROBLEM
mellitus	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

2	CD	O	O
)	)	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
status	NN	O	O
post	NN	O	O
anterior	RB	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
sick	JJ	B-PROBLEM	B-PROBLEM
sinus	NN	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
a	DT	B-TREATMENT	B-TREATMENT
vvi	NN	I-TREATMENT	I-TREATMENT
pacer	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
demonstrates	VBZ	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
triple	JJ	I-PROBLEM	I-PROBLEM
vessel	NN	I-PROBLEM	I-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
rca	VBZ	B-PROBLEM	O
100%	CD	I-PROBLEM	O
occluded	JJ	I-PROBLEM	O
,	,	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	O	I-TREATMENT
om1	VB	B-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
100%	CD	B-PROBLEM	O
occluded	JJ	I-PROBLEM	B-PROBLEM
and	CC	O	O
a	DT	O	B-PROBLEM
patent	NN	O	I-PROBLEM
lima	NN	O	I-PROBLEM
,	,	O	O
but	CC	O	O
severely	RB	B-PROBLEM	B-PROBLEM
diseased	JJ	I-PROBLEM	I-PROBLEM
lad	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1	CD	O	O
)	)	O	O
enteric	NN	B-TREATMENT	O
coated	VBD	I-TREATMENT	O
aspirin	RB	I-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

2	CD	O	O
)	)	O	O
capoten	VBD	B-TREATMENT	O
25	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O

3	LS	O	O
)	)	O	O
lanoxin	NN	B-TREATMENT	O
0.25	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

4	CD	O	O
)	)	O	O
cardizem	NN	B-TREATMENT	O
125	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

5	CD	O	O
)	)	O	O
glucotrol	NN	B-TREATMENT	B-TREATMENT
xl	$	I-TREATMENT	I-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

6	CD	O	O
)	)	O	O
glucophage	NN	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

7	CD	O	O
)	)	O	O
amaryl	NN	B-TREATMENT	O
2	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.h.s.	NN	O	O

physical	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
revealed	VBD	O	O
that	IN	O	O
the	DT	B-TEST	B-TEST
vital	JJ	I-TEST	I-TEST
signs	NNS	I-TEST	I-TEST
were	VBD	O	O
stable	JJ	O	O
.	.	O	O

lungs	NNS	O	O
were	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	O	O
.	.	O	O

heart	NN	O	O
was	VBD	O	O
irregular	JJ	B-PROBLEM	O
with	IN	O	O
no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM
palpated	VBD	O	I-PROBLEM
.	.	O	O

pulses	NNS	B-TEST	B-TEST
were	VBD	O	O
2+	CD	O	O
throughout	IN	O	O
.	.	O	O

subsequent	JJ	B-TEST	B-TEST
exercise	NN	I-TEST	I-TEST
treadmill	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
demonstrated	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
ischemia	NN	B-PROBLEM	B-PROBLEM
by	IN	O	O
ekg	NN	B-TEST	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
subsequently	RB	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
where	WRB	O	O
he	PRP	O	O
underwent	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
reoperative	JJ	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
times	NNS	I-TREATMENT	O
three	CD	I-TREATMENT	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
subaortic	JJ	I-TREATMENT	I-TREATMENT
proximal	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
from	IN	O	O
the	DT	O	O
aorta	NN	O	O
to	TO	O	O
the	DT	O	O
om1	NN	O	O
and	CC	O	O
then	RB	O	O
om2	NN	O	O
and	CC	O	O
aorta	NN	O	O
to	TO	O	O
the	DT	O	O
lad	NN	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
wide	JJ	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
per	IN	O	O
dr.	NN	O	O
lumar	NN	O	O
jongguild	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
weaned	VBN	O	O
off	RP	O	O
an	DT	B-TREATMENT	B-TREATMENT
epinephrine	NN	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

rhythm	NN	B-TEST	O
became	VBD	O	O
more	RBR	O	O
stable	JJ	O	O
.	.	O	O

balloon	NN	B-TREATMENT	O
was	VBD	O	O
weaned	VBN	O	O
and	CC	O	O
finally	RB	O	O
discontinued	VBN	O	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TEST
melranon	NN	I-TREATMENT	I-TEST
was	VBD	O	O
weaned	VBN	O	O
off	RP	O	O
and	CC	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
ace	NN	I-TREATMENT	I-TREATMENT
inhibitor	NN	I-TREATMENT	I-TREATMENT
began	VBD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
diuresed	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
lower	JJR	O	O
extremities	NNS	O	O
began	VBD	O	O
to	TO	O	O
swell	VB	O	B-PROBLEM
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
begun	VBN	O	O
on	IN	O	O
hirudin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
deep	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
thrombosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	B-TREATMENT
patient	NN	I-PROBLEM	I-TREATMENT
&apos;s	NNP	I-PROBLEM	I-TREATMENT
heparin	NN	I-PROBLEM	I-TREATMENT
induced	VBD	I-PROBLEM	O
thrombocytopenia	NN	I-PROBLEM	B-PROBLEM
became	VBD	O	O
positive	JJ	O	B-PROBLEM
and	CC	O	O
so	RB	O	O
he	PRP	O	O
is	VBZ	O	O
allergic	JJ	B-PROBLEM	B-PROBLEM
to	TO	O	O
heparin	VB	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
begun	VBN	O	O
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
he	PRP	O	O
stayed	VBD	O	O
several	JJ	O	O
days	NNS	O	O
for	IN	O	O
coumadinization	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
was	VBD	O	O
finally	RB	O	O
discharged	VBN	O	O
on	IN	O	O
therapeutic	JJ	B-TREATMENT	B-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
tolerated	VBD	O	O
a	DT	O	O
regular	JJ	O	O
diet	NN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
thirteen	NN	O	O
from	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
reoperative	JJ	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

1	CD	O	O
)	)	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
400	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

2	CD	O	O
)	)	O	O
captopril	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O

3	LS	O	O
)	)	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
0.125	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

4	CD	O	O
)	)	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O

5	CD	O	O
)	)	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
80	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

6	CD	O	O
)	)	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
40	CD	O	O
meq	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

7	CD	O	O
)	)	O	O
glucophage	NN	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

8	CD	O	O
)	)	O	O
glucotrol	NN	B-TREATMENT	B-TREATMENT
xl	$	I-TREATMENT	I-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

9	CD	O	O
)	)	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

vicodin	NN	B-TREATMENT	B-TREATMENT

chief	JJ	O	O
complaint	NN	O	O
:	:	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST

50	CD	O	O
yo	JJ	O	O
male	NN	O	O
,	,	O	O
h/o	JJ	O	O
cad	NN	B-PROBLEM	B-PROBLEM
s/p	NN	O	O
stent	NN	B-TREATMENT	B-TREATMENT
to	TO	I-TREATMENT	O
lad	VB	I-TREATMENT	O
in	IN	O	O
2011	CD	O	O
,	,	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
dm	NN	B-PROBLEM	O
,	,	O	O
cocaine	NN	O	O
abuse	NN	O	O
,	,	O	O
presenting	VBG	O	O
with	IN	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
states	VBZ	O	O
he	PRP	O	O
had	VBD	O	O
onset	VBN	O	O
of	IN	O	O
this	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
today	NN	O	O
;	:	O	O
described	VBN	O	O
as	IN	O	O
anterior	JJ	B-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
radiation	NN	B-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
shoulder	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
09-26	JJ	O	O
,	,	O	O
was	VBD	O	O
increasing	VBG	O	O
over	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
45	CD	O	O
minutes	NNS	O	O
to	TO	O	O
1	CD	O	O
hour	NN	O	O
(	(	O	O
occurred	VBN	O	O
after	IN	O	O
arrested	VBN	O	O
).	NN	O	O

he	PRP	O	O
states	VBZ	O	O
that	IN	O	O
he	PRP	O	O
also	RB	O	O
felt	VBD	O	O
sob	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	I-PROBLEM
diaphoretic	JJ	B-PROBLEM	I-PROBLEM
but	CC	O	O
denies	VBZ	O	O
n/v/palpitations	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
reports	VBZ	O	O
that	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
increasing	VBG	O	B-PROBLEM
in	IN	O	I-PROBLEM
intensity	NN	O	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
brought	VBN	O	O
to	TO	O	O
providence	VB	O	O
behavioral	JJ	O	O
health	NN	O	O
hospital	NN	O	O
where	WRB	O	O
he	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
positive	JJ	O	B-PROBLEM
urine	JJ	O	I-PROBLEM
cocaine	NN	O	I-PROBLEM
,	,	O	O
ekg	FW	B-TEST	O
with	IN	O	O
new	JJ	O	B-PROBLEM
2-7392	JJ	O	I-PROBLEM
w.	JJ	O	I-PROBLEM
second	JJ	O	I-PROBLEM
cr.	NN	O	I-PROBLEM
elevations	NNS	B-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
leads	NNS	I-PROBLEM	I-PROBLEM
(	(	I-PROBLEM	O
v2-5	NN	I-PROBLEM	O
)	)	I-PROBLEM	O
and	CC	O	O
some	DT	B-PROBLEM	B-PROBLEM
st	JJ	I-PROBLEM	I-PROBLEM
depressions	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
ii	NN	I-PROBLEM	O
,	,	I-PROBLEM	O
iii	NN	I-PROBLEM	O
,	,	I-PROBLEM	O
avf	NN	I-PROBLEM	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
given	VBN	O	O
lopressor	RB	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NNS	O	O
x	JJ	O	O
2	CD	O	O
(	(	O	O
3rd	CD	O	O
dose	RB	O	O
given	VBN	O	O
by	IN	O	O
medflight	NN	O	O
,	,	O	O
5	CD	O	O
mg	NN	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
ativan	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
nitro	JJ	B-TREATMENT	B-TREATMENT
gtt	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
integrillin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

pain	NN	B-PROBLEM	B-PROBLEM
was	VBD	O	O
12-28	JJ	O	O
at	IN	O	O
time	NN	O	O
of	IN	O	O
transfer	NN	O	O
.	.	O	O

in	IN	O	O
the	DT	O	O
cath	NN	O	O
lab	NN	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
hazy	JJ	B-PROBLEM	B-PROBLEM
plaque	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
lad	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
prior	JJ	B-TREATMENT	B-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
)	)	O	I-TREATMENT
,	,	O	O
80%	CD	B-PROBLEM	O
hazy	NN	I-PROBLEM	B-PROBLEM
plaque	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
circumflex	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
totally	RB	I-PROBLEM	I-PROBLEM
occluded	JJ	I-PROBLEM	I-PROBLEM
plb	NN	I-PROBLEM	I-PROBLEM
(	(	I-PROBLEM	O
with	IN	I-PROBLEM	O
collaterals	NNS	I-PROBLEM	O
)	)	I-PROBLEM	O
.	.	O	O

1	CD	B-TREATMENT	B-TREATMENT
cypher	NN	I-TREATMENT	I-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
place	NN	O	O
in	IN	O	O
the	DT	O	O
lad	NN	O	O
while	IN	O	O
2	CD	O	O
were	VBD	O	O
placed	VBN	O	O
in	IN	O	O
lcx	NN	O	O
.	.	O	O

right	JJ	O	O
system	NN	O	O
was	VBD	O	O
not	RB	O	O
intervened	VBN	O	O
upon	IN	O	O
,	,	O	O
for	IN	O	O
the	DT	O	O
plb	NN	O	O
was	VBD	O	O
unable	JJ	O	O
to	TO	O	O
be	VB	O	O
crossed	VBN	O	O
by	IN	O	O
wire	NN	B-TREATMENT	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
ccu	NN	O	O
for	IN	O	O
observation	NN	B-TEST	O
.	.	O	O

1.	CD	O	O
cad	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
s/p	JJ	O	O
mi	NN	B-PROBLEM	O
in	IN	O	O
2011	CD	O	O
with	IN	O	O
stenting	NN	B-TREATMENT	B-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
lad	NN	I-TREATMENT	I-TREATMENT

2.	CD	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM

3.	CD	O	O
dm	NN	B-PROBLEM	O

no	DT	O	O
cad	NN	B-PROBLEM	B-PROBLEM
in	IN	O	I-PROBLEM
1st	CD	O	I-PROBLEM
degree	JJ	O	I-PROBLEM
relatives	NNS	O	I-PROBLEM
.	.	O	O

robert	JJ	O	O
sudden	JJ	B-PROBLEM	O
death	NN	I-PROBLEM	O

vs	NN	B-TEST	O
:	:	O	O
94.1	CD	O	O
130/81	CD	O	O
71	CD	O	O
21	CD	O	O
99%	CD	O	O
4l	CD	B-TREATMENT	O
nc	NN	I-TREATMENT	O

gen	NN	O	O
:	:	O	O
somnolent	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
pleasant	JJ	O	O
male	NN	O	O
,	,	O	O
lying	VBG	O	O
in	IN	O	O
bed	NN	O	O

heent	NN	O	O
:	:	O	O
perrl	NN	O	O
,	,	O	O
some	DT	B-PROBLEM	B-PROBLEM
dried	VBD	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	O
lips	NNS	I-PROBLEM	O
,	,	I-PROBLEM	O
tongue	NN	I-PROBLEM	O

neck	NN	O	O
:	:	O	O
no	DT	O	O
lad	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
?	.	O	O
enlarged	VBD	B-PROBLEM	B-PROBLEM
parotid	NN	I-PROBLEM	I-PROBLEM
glands	NNS	I-PROBLEM	I-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM

cv	NN	O	O
:	:	O	O
rrr	NN	O	O
,	,	O	O
nl	JJ	O	O
s1/s2	NN	O	O
,	,	O	O
with	IN	O	O
s4	NN	B-PROBLEM	O
,	,	O	O
no	DT	O	O
m/r	NN	B-PROBLEM	B-PROBLEM

lungs	NNS	O	O
:	:	O	O
cta	NN	O	O
bilaterally	RB	O	O
,	,	O	O
no	DT	O	O
w/r/r	NN	B-PROBLEM	B-PROBLEM

abdomen	NNS	O	O
:	:	O	O
protuberant	NN	B-PROBLEM	O
,	,	O	O
nt/nd	RB	B-PROBLEM	O
,	,	O	O
nabs	NNS	O	O

right	JJ	O	O
groin	NN	O	O
:	:	O	O
with	IN	O	O
sheath	NN	B-TREATMENT	B-TREATMENT
in	IN	O	O
place	NN	O	O

extr	NN	O	O
:	:	O	O
dp/pt	NN	B-TEST	B-TEST
2+	CD	O	O
bilaterally	RB	O	O
,	,	O	O
no	DT	O	O
c/c/e	NN	B-PROBLEM	B-PROBLEM

catheterization	NN	B-TEST	B-TEST
on	IN	O	O
2016-03-31	JJ	O	O
:	:	O	O

hemoglobin	NN	B-TEST	B-TEST
:	:	O	O

fick	NN	B-TEST	B-PROBLEM

right	RB	B-TEST	B-TEST
atrium	NN	I-TEST	I-TEST
{	(	O	I-TEST
a/v/m	JJ	O	I-TEST
}	)	O	I-TEST
18/17/13	CD	O	O

right	JJ	B-TEST	O
ventricle	NN	I-TEST	O
{	(	O	O
s/ruben	NN	O	O
}	)	O	O
45/18	CD	O	O

pulmonary	JJ	B-TEST	B-TREATMENT
artery	NN	I-TEST	I-TREATMENT
{	(	O	I-TREATMENT
s/d/m	NN	O	I-TREATMENT
}	)	O	I-TREATMENT
45/22	CD	O	O

pulmonary	JJ	B-TEST	B-TEST
wedge	NN	I-TEST	I-TEST
{	(	O	I-TEST
a/v/m	JJ	O	I-TEST
}	)	O	I-TEST
21/22/20	CD	O	O

aorta	RB	B-TEST	O
{	(	O	O
s/d/m	NN	O	O
}	)	O	O
97/66/81	CD	O	O

heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
{	(	O	I-TEST
beats/min	NN	O	I-TEST
}	)	O	O
88	CD	O	O

o2	JJ	B-TEST	B-TEST
cons.	NN	I-TEST	I-TEST
ind	NN	I-TEST	I-TEST
{	(	O	I-TEST
ml/min/m2	NN	O	I-TEST
}	)	O	O
125	CD	O	O

a-v	JJ	B-TEST	B-TEST
o2	NN	I-TEST	I-TEST
difference	NN	I-TEST	I-TEST
{	(	O	I-TEST
ml/ltr	NN	O	I-TEST
}	)	O	O
32	CD	O	O

card.	NN	B-TEST	O
op/ind	MD	I-TEST	O
fick	VB	I-TEST	O
{	(	O	O
l/mn/m2	NN	O	O
}	)	O	O
7.3/3.9	CD	O	O

systemic	JJ	B-TEST	B-PROBLEM
vasc.	NN	I-TEST	I-PROBLEM
resistance	NN	I-TEST	I-PROBLEM
745	CD	O	I-PROBLEM

svc	RB	B-TEST	O
low	JJ	I-TEST	O
81	CD	O	O

pa	NN	B-TEST	O
main	JJ	I-TEST	O
81	CD	O	O

ao	RB	B-TEST	O
98	CD	O	O

the	DT	B-TEST	B-TEST
oxygen	NN	I-TEST	I-TEST
consumption	NN	I-TEST	I-TEST
was	VBD	O	O
assumed	VBN	O	O
.	.	O	O

1)	CD	O	O
proximal	JJ	B-TEST	O
rca	NN	I-TEST	O
:	:	O	O
normal	JJ	O	O

2)	CD	O	O
mid	JJ	B-TEST	O
rca	NN	I-TEST	O
:	:	O	O
normal	JJ	O	O

2a)	CD	O	O
acute	JJ	B-TEST	O
marginal	JJ	I-TEST	O
:	:	O	O
normal	JJ	O	O

3)	CD	O	O
distal	JJ	B-TEST	O
rca	NN	I-TEST	O
:	:	O	O
normal	JJ	O	O

4)	CD	O	O
r-pda	JJ	B-TEST	O
:	:	O	O
normal	JJ	O	O

4a)	CD	O	O
r-post-lat	JJ	B-TEST	O
:	:	O	O
discrete	JJ	O	O
100	CD	O	O

4b)	CD	O	O
r-lv	JJ	B-TEST	O
:	:	O	O
normal	JJ	O	O

5)	CD	O	O
left	VBD	B-TEST	O
main	JJ	I-TEST	O
:	:	O	O
normal	JJ	O	O

6)	CD	O	O
proximal	JJ	B-TEST	O
lad	NN	I-TEST	O
:	:	O	O
ulcerated	JJ	B-PROBLEM	B-PROBLEM

6a)	CD	O	O
septal-1	JJ	B-TEST	O
:	:	O	O
normal	JJ	O	O

7)	CD	O	O
mid-lad	JJ	B-TEST	O
:	:	O	O
normal	JJ	O	O

8)	CD	O	O
distal	JJ	B-TEST	O
lad	NN	I-TEST	O
:	:	O	O
normal	JJ	O	O

9)	CD	O	O
diagonal-1	JJ	B-TEST	O
:	:	O	O
normal	JJ	O	O

10)	CD	O	O
diagonal-2	JJ	B-TEST	O
:	:	O	O
normal	JJ	O	O

12)	CD	O	O
proximal	JJ	B-TEST	O
cx	NN	I-TEST	O
:	:	O	O
discrete	JJ	O	O
80	CD	O	O

13)	CD	O	O
mid	JJ	B-TEST	O
cx	NN	I-TEST	O
:	:	O	O
normal	JJ	O	O

13a)	CD	O	O
distal	JJ	B-TEST	B-TEST
cx	NN	I-TEST	I-TEST
:normal	NN	O	I-TEST

14)	CD	O	O
obtuse	IN	B-TEST	O
marginal	JJ	I-TEST	O
-	:	I-TEST	O
1	CD	I-TEST	O
:	:	O	O
normal	JJ	O	O

15)	CD	O	O
obtuse	IN	B-TEST	O
marginal	JJ	I-TEST	O
-	:	I-TEST	O
2	CD	I-TEST	O
:	:	O	O
normal	JJ	O	O

16)	CD	O	O
obtuse	IN	B-TEST	O
marginal	JJ	I-TEST	O
-	:	I-TEST	O
3	CD	I-TEST	O
:	:	O	O
normal	JJ	O	O

proximal	JJ	O	O
lad	NN	O	O
with	IN	O	O
hazy	JJ	B-PROBLEM	B-PROBLEM
ulceration	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
proximal	JJ	O	B-PROBLEM
circumflex	NN	O	I-PROBLEM
with	IN	O	O
80%	CD	B-PROBLEM	O
hazy	NN	I-PROBLEM	B-PROBLEM
,	,	O	O
totally	RB	B-PROBLEM	O
occluded	VBD	I-PROBLEM	B-PROBLEM
plb	NN	I-PROBLEM	I-PROBLEM
with	IN	I-PROBLEM	O
collaterals	NNS	I-PROBLEM	O

1	CD	B-TREATMENT	B-TREATMENT
cypher	JJ	I-TREATMENT	I-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
placed	VBN	O	O
in	IN	O	O
lad	NN	O	O
,	,	O	O
2	CD	B-TREATMENT	B-TREATMENT
cypher	NN	I-TREATMENT	I-TREATMENT
stents	NNS	I-TREATMENT	I-TREATMENT
placed	VBN	O	O
in	IN	O	O
left	NN	O	O

echo	NN	B-TEST	B-TEST
:	:	O	O

1.	CD	O	O
the	DT	O	B-TEST
left	NN	O	I-TEST
ventricular	JJ	O	I-TEST
cavity	NN	O	I-TEST
is	VBZ	O	O
moderately	RB	B-PROBLEM	B-PROBLEM
dilated	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
global	JJ	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
hypokinesis	NN	I-PROBLEM	I-PROBLEM
to	TO	O	I-PROBLEM
akinesis	VB	B-PROBLEM	I-PROBLEM
with	IN	O	O
some	DT	O	O
sparing	NN	O	O
of	IN	O	O
basal	NN	O	B-PROBLEM
wall	NN	O	I-PROBLEM
motion	NN	O	I-PROBLEM
.	.	O	O

overall	JJ	B-TEST	B-TEST
left	VBD	I-TEST	I-TEST
ventricular	JJ	I-TEST	I-TEST
systolic	JJ	I-TEST	I-TEST
function	NN	I-TEST	I-TEST
is	VBZ	O	O
severely	RB	B-PROBLEM	B-PROBLEM
depressed	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
the	DT	O	O
mitral	JJ	O	O
valve	NN	O	O
leaflets	NNS	O	O
are	VBP	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
thickened	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

trivial	JJ	B-PROBLEM	B-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
seen	VBN	O	O
."	NNS	O	O

glucose	JJ	B-TEST	B-TEST
-	:	O	O
180	CD	O	O
*	JJ	O	O
urea	JJ	B-TEST	B-TEST
n	SYM	I-TEST	I-TEST
-	:	O	O
10	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
0.8	CD	O	O
sodium	NN	B-TEST	B-TEST
-	:	O	O
142	CD	O	O
potassium	NN	B-TEST	B-TEST
-	:	O	O
3.7	CD	O	O
chloride	NN	B-TEST	B-TEST
-	:	O	O
104	CD	O	O
total	JJ	B-TEST	B-TEST
co2	NN	I-TEST	I-TEST
-	:	O	O
30	CD	O	O
*	JJ	O	O
anion	NN	B-TEST	B-TEST
gap	NN	I-TEST	I-TEST
-	:	O	O
12	CD	O	O

ck	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
cpk	JJ	I-TEST	I-TEST
)-	CD	I-TEST	I-TEST
137	CD	O	O

ck-mb	JJ	B-TEST	B-TEST
-	:	O	O
4	CD	O	O
ctropnt	NN	B-TEST	B-TEST
-<	CD	O	O
0.01	CD	O	O

calcium	NN	B-TEST	B-TEST
-	:	O	O
8.6	CD	O	O
phosphate	NN	B-TEST	B-TEST
-	:	O	O
3.4	CD	O	O
magnesium	NN	B-TEST	B-TEST
-	:	O	O
1.7	CD	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
9.1	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
4.08	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
12.7	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
35.7	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
88	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
31.0	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
35.4	CD	O	O
*	NN	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
12.7	CD	O	O

plt	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
-	:	O	O
253	CD	O	O

1.	CD	O	O
cad	NN	B-PROBLEM	O
:	:	O	O
presented	VBN	O	O
with	IN	O	O
anginal	JJ	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
ekg	JJ	B-PROBLEM	O
changes	NNS	I-PROBLEM	O
(	(	O	O
stemi	NN	B-PROBLEM	O
)	)	O	O
,	,	O	O
with	IN	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
revealing	VBG	O	O
lesions	NNS	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
lad	NN	I-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	O
lcx	NN	I-PROBLEM	O
,	,	I-PROBLEM	O
and	CC	I-PROBLEM	O
plb	NN	I-PROBLEM	O
.	.	O	O

unclear	JJ	O	O
if	IN	O	O
hazy	JJ	B-PROBLEM	B-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
significant	JJ	O	I-PROBLEM
or	CC	O	O
if	IN	O	O
this	DT	O	O
was	VBD	O	O
cocaine	NN	O	O
induced	VBN	O	O
vasospasm	NN	O	B-PROBLEM
.	.	O	O

lad	NN	O	O
and	CC	O	O
lcx	NN	O	B-TREATMENT
were	VBD	O	O
stented	VBN	B-TREATMENT	O
,	,	O	O
but	CC	O	O
plb	NNS	O	O
could	MD	O	O
not	RB	O	O
be	VB	O	O
crossed	VBN	O	O
by	IN	O	O
guidewire	NN	B-TREATMENT	O
(	(	O	O
were	VBD	O	O
collaterals	NNS	O	O
)	)	O	O
.	.	O	O

-	:	O	O
continue	NN	O	O
asa	NN	B-TREATMENT	O
,	,	O	O
statin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
plavix	NN	B-TREATMENT	B-TREATMENT
;	:	O	O
will	MD	O	O
hold	VB	O	O
bb	VB	B-TREATMENT	O
given	VBN	O	O
recent	JJ	O	O
cocaine	NN	O	O
use	NN	O	O
(	(	O	O
?	.	O	O
can	MD	O	O
consider	VB	O	O
labetalol	JJ	B-TREATMENT	O
if	IN	O	O
necessary	JJ	O	O
)	)	O	O
,	,	O	O
integrillin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
18	CD	O	O
hours	NNS	O	O

-	:	O	O
ck	NN	B-TEST	O
negative	JJ	O	O
.	.	O	O

tn	NN	B-TEST	O
wnl	NN	O	O
.	.	O	O

-	:	O	O
post	NN	B-TEST	O
cath	NN	I-TEST	B-TEST
check	NN	I-TEST	I-TEST
normal	JJ	O	O

2.	CD	O	O
chf	NN	B-PROBLEM	O
:	:	O	O
ef	JJ	B-TEST	O
25%	CD	O	O
on	IN	O	O
echo	NN	B-TEST	B-TEST
,	,	O	O
states	VBZ	O	O
he	PRP	O	O
takes	VBZ	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
home	NN	O	O

-	:	O	O
started	VBD	O	O
lisinopril	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

-	:	O	O
consider	NN	O	O
repeat	NN	B-TEST	O
echo	NN	I-TEST	B-TEST
in	IN	O	O
1	CD	O	O
month	NN	O	O
and	CC	O	O
quincy	NN	O	O
medical	JJ	O	O
center	NN	O	O
-	:	O	O
v/icd	NN	B-TREATMENT	O
per	IN	O	O
discretion	NN	O	O
of	IN	O	O
primary	JJ	O	O
cardiologist	NN	O	O
.	.	O	O

-	:	O	O
kept	NN	O	O
euvolemic	JJ	O	O
and	CC	O	O
monitored	VBD	O	O
for	IN	O	O
signs	NNS	O	O
of	IN	O	O
overload	NN	B-PROBLEM	B-PROBLEM

-	:	O	O
low	NN	B-TREATMENT	O
na	TO	I-TREATMENT	O
diet	NN	I-TREATMENT	O
with	IN	O	O
1	CD	B-TREATMENT	B-TREATMENT
liter	NN	I-TREATMENT	I-TREATMENT
fluid	NN	I-TREATMENT	I-TREATMENT
restriction	NN	I-TREATMENT	I-TREATMENT

-	:	O	O
may	MD	O	O
need	VB	O	O
to	TO	O	O
diurese	VB	O	O
based	VBN	O	O
on	IN	O	O
clinical	JJ	O	O
status	NN	O	O
,	,	O	O
swan	NN	B-TEST	O
numbers	NNS	I-TEST	O

3.	CD	O	O
rhythm	NN	B-TEST	O
:	:	O	O
no	DT	O	O
ectopy	NN	B-PROBLEM	B-PROBLEM
post	NN	I-PROBLEM	I-PROBLEM
cath/mi	NN	I-PROBLEM	I-PROBLEM

4.	CD	O	O
dm	NN	B-PROBLEM	O
:	:	O	O
on	IN	O	O
metformin	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
home	NN	O	O
,	,	O	O
will	MD	O	O
hold	VB	O	O
given	VBN	O	O
cath	JJ	B-TREATMENT	B-TREATMENT
/	NNP	I-TREATMENT	I-TREATMENT
dye	NN	I-TREATMENT	I-TREATMENT
adn	NN	O	I-TREATMENT
cover	NN	O	I-TREATMENT
with	IN	O	O
ssi	NN	B-TREATMENT	O

5.	CD	O	O
cocaine	NN	O	O
use	NN	O	O
:	:	O	O
last	JJ	O	O
use	NN	O	O
this	DT	O	O
morning	NN	O	O
,	,	O	O
no	DT	O	O
bb	NN	B-TREATMENT	O
given	VBN	O	O
this	DT	O	O
;	:	O	O
considered	VBN	O	O
using	VBG	O	O
ccb	JJ	B-TREATMENT	O
/	NNP	O	O
phentolamine	NN	B-TREATMENT	B-TREATMENT
if	IN	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
recurs	NN	O	I-PROBLEM
.	.	O	O

--	:	O	O
will	MD	O	O
discuss	VB	O	O
beta-blocker	NN	B-TREATMENT	O
risks	NNS	O	O
and	CC	O	O
benefits	NNS	O	O
with	IN	O	O
primary	JJ	O	O
cardiologist	NN	O	O

6.	CD	O	O
etoh	JJ	O	O
use	NN	O	O
:	:	O	O
unclear	JJ	O	O
how	WRB	O	O
much	RB	O	O
,	,	O	O
monitor	NN	O	O
on	IN	O	O
ciwa	NN	B-TEST	O
for	IN	O	O
signs	NNS	O	O
of	IN	O	O
withdrawal	NN	B-PROBLEM	O
,	,	O	O
ativan	NN	B-TREATMENT	B-TREATMENT
prn	NN	O	O

--	:	O	O
ciwas	NN	B-TEST	O
were	VBD	O	O
0	CD	O	O
throughout	IN	O	O
admission	NN	O	O

7.	CD	O	O
hyperlipidemia	NN	B-PROBLEM	B-PROBLEM
:	:	O	O
on	IN	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
80	CD	O	O
.	.	O	O

ldl	NN	B-TEST	B-TEST
79	CD	O	O
,	,	O	O
hdl	VBD	B-TEST	B-TEST
51	CD	O	O

9.	CD	O	O
fen	NN	O	O
:	:	O	O
cardiac	JJ	B-TREATMENT	O
diet	NN	I-TREATMENT	O
,	,	O	O
watch	NN	O	O
for	IN	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
given	VBN	O	I-PROBLEM
somnolent	JJ	B-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
this	DT	O	O
time	NN	O	O
,	,	O	O
ck	NN	B-TEST	O
and	CC	O	O
replete	JJ	O	O
mg/k/ca	NN	B-TREATMENT	O
aggressively	RB	O	O

lipitor	NN	B-TREATMENT	B-TREATMENT
80	CD	O	O

coreg	NN	B-TREATMENT	O

asa	RB	B-TREATMENT	O
81	CD	O	O
mg	NN	O	O

lasix	NN	B-TREATMENT	B-TREATMENT

glucophage	NN	B-TREATMENT	B-TREATMENT

all	DT	O	O
:	:	O	O
vicodin	NN	B-TREATMENT	B-TREATMENT
-?	VBZ	O	O
rash	NN	B-PROBLEM	B-PROBLEM

1.	CD	O	O
please	NN	O	O
continue	VB	O	O
your	PRP$	B-TREATMENT	B-TREATMENT
previous	JJ	I-TREATMENT	I-TREATMENT
diabetes	NNS	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT

2.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

3.	CD	O	O
clopidogrel	NN	B-TREATMENT	B-TREATMENT
bisulfate	NN	I-TREATMENT	I-TREATMENT
75	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

4.	CD	O	O
multivitamin	NN	B-TREATMENT	B-TREATMENT
capsule	NN	I-TREATMENT	I-TREATMENT
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
cap	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

5.	CD	O	O
pantoprazole	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
40	CD	O	O
mg	NN	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
q24h	NN	O	O
(	(	O	O
every	DT	O	O
24	CD	O	O
hours	NNS	O	O
)	)	O	O
.	.	O	O

6.	CD	O	O
atorvastatin	JJ	B-TREATMENT	B-TREATMENT
calcium	NN	I-TREATMENT	I-TREATMENT
80	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

7.	CD	O	O
lisinopril	JJ	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

st	JJ	B-PROBLEM	B-PROBLEM
elevation	NN	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM

please	VB	O	O
notify	JJ	O	O
nurses	NNS	O	O
,	,	O	O
doctors	NNS	O	O
marilyn	VBP	O	O
kristen	JJ	O	O
layne	JJ	O	O
workers	NNS	O	O
of	IN	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
palpitations	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
lightheadedness	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

cocaine	NN	O	O
use	NN	O	O
has	VBZ	O	O
been	VBN	O	O
associated	VBN	O	O
with	IN	O	O
an	DT	O	B-PROBLEM
increased	VBN	O	I-PROBLEM
risk	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
heart	NN	B-PROBLEM	I-PROBLEM
attacks	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
stroke	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
death	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

you	PRP	O	O
must	MD	O	O
continue	VB	O	O
to	TO	O	O
take	VB	O	O
plavix	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

please	VB	O	O
discuss	VB	O	O
the	DT	O	O
use	NN	O	O
of	IN	O	O
beta-blockers	NNS	B-TREATMENT	B-PROBLEM
with	IN	O	O
your	PRP$	O	O
cardiologist	NN	O	O
.	.	O	O

beta-blockers	NNS	B-TREATMENT	O
should	MD	O	O
not	RB	O	O
be	VB	O	O
used	VBN	O	O
while	IN	O	O
using	VBG	O	O
cocaine	NN	O	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
37-year-old	JJ	O	O
white	JJ	O	O
male	NN	O	O
with	IN	O	O
aids	NNS	B-PROBLEM	O
complicated	VBN	O	O
by	IN	O	O
recurrent	NN	B-PROBLEM	B-PROBLEM
pseudomonas	NNS	I-PROBLEM	I-PROBLEM
infections	NNS	I-PROBLEM	I-PROBLEM
presently	RB	O	O
on	IN	O	O
ceftazidime	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
aztrenam	NN	B-TREATMENT	O
complicated	VBN	O	O
by	IN	O	O
mai	NN	B-PROBLEM	O
who	WP	O	O
comes	VBZ	O	O
in	IN	O	O
with	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
positive	JJ	O	O
for	IN	O	O
candida	JJ	B-PROBLEM	B-PROBLEM
species	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
aids	NNS	I-PROBLEM	I-PROBLEM
illnesses	NNS	I-PROBLEM	I-PROBLEM
including	VBG	O	O
mai	NN	B-PROBLEM	O
who	WP	O	O
has	VBZ	O	O
multiple	JJ	O	O
admissions	NNS	O	O
for	IN	O	O
pseudomonas	JJ	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	O	O
most	RBS	O	O
recent	JJ	O	O
admission	NN	O	O
was	VBD	O	O
on	IN	O	O
08/23/92	CD	O	O
to	TO	O	O
08/25/92	CD	O	O
with	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
again	RB	O	O
treated	VBN	O	O
with	IN	O	O
iv	JJ	B-TREATMENT	O
ceftazidime	NN	I-TREATMENT	O
for	IN	O	O
presumed	JJ	O	O
pseudomonal	JJ	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
discharged	VBD	O	O
home	NN	O	O
on	IN	O	O
iv	NN	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
which	WDT	O	O
he	PRP	O	O
is	VBZ	O	O
presently	RB	O	O
on	IN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
did	VBD	O	O
well	RB	O	O
at	IN	O	O
home	NN	O	O
with	IN	O	O
decreasing	VBG	O	B-PROBLEM
fever	NN	O	I-PROBLEM
and	CC	O	O
good	JJ	O	O
appetite	NN	O	O
until	IN	O	O
the	DT	O	O
night	NN	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
when	WRB	O	O
he	PRP	O	O
developed	VBD	O	O
fever	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

concurrent	NN	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
grew	VBD	O	O
out	RP	O	O
candida	JJ	B-PROBLEM	B-PROBLEM
species	NNS	I-PROBLEM	I-PROBLEM
at	IN	O	O
hchp	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
&apos;s	NNP	I-TEST	I-TEST
baseline	NN	I-TEST	I-TEST
o2	NN	I-TEST	I-TEST
saturation	NN	I-TEST	I-TEST
is	VBZ	O	O
92%	CD	O	O
on	IN	O	O
three	CD	B-TREATMENT	O
liters	NNS	I-TREATMENT	O
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
a	DT	B-TREATMENT	B-TREATMENT
left	JJ	I-TREATMENT	I-TREATMENT
arm	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
placed	VBD	O	O
for	IN	O	O
access	NN	O	O
three	CD	O	O
weeks	NNS	O	O
ago	RB	O	O
which	WDT	O	O
is	VBZ	O	O
used	VBN	O	O
for	IN	O	O
blood	NN	B-TREATMENT	B-TEST
drawing	NN	I-TREATMENT	I-TEST
and	CC	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
notes	VBZ	O	O
no	DT	O	O
tenderness	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
erythema	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
warmth	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
exudate	NN	B-PROBLEM	B-PROBLEM
from	IN	O	O
the	DT	B-TREATMENT	O
passport	NN	I-TREATMENT	O
site	NN	I-TREATMENT	O
.	.	O	O

medications	NNS	O	B-TREATMENT
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
admission	NN	O	O
include	VBP	O	O
dapsone	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
on	IN	O	O
monday	NN	O	O
,	,	O	O
wednesday	JJ	O	O
and	CC	O	O
friday	JJ	O	O
,	,	O	O
ceftazidime	JJ	B-TREATMENT	B-TREATMENT
1	CD	O	O
gram	NN	O	O
iv	NN	O	O
q.	VBD	O	O
8	CD	O	O
hours	NNS	O	O
,	,	O	O
cipro	VBP	B-TREATMENT	B-TREATMENT
750	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
acyclovir	RB	B-TREATMENT	B-TREATMENT
400	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
q.	JJ	O	O
day	NN	O	O
,	,	O	O
megastrol	NN	B-TREATMENT	B-TREATMENT
80	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O
and	CC	O	O
g-csf	JJ	B-TREATMENT	O
150	CD	O	O
micrograms	NNS	O	O
subcu	VBP	O	O
b.i.d.	NN	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
admission	NN	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
was	VBD	O	O
101	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
110/60	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
96	CD	O	O
,	,	O	O
respirations	NNS	B-TEST	B-TEST
16	CD	O	O
.	.	O	O

o2	JJ	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST
on	IN	O	O
three	CD	B-TREATMENT	O
liters	NNS	I-TREATMENT	O
was	VBD	O	O
96%	CD	O	O
.	.	O	O

heent	NN	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
was	VBD	O	O
unremarkable	JJ	O	O
.	.	O	O

no	DT	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
thyromegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

chest	NN	O	O
revealed	VBD	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
basilar	JJ	I-PROBLEM	I-PROBLEM
rales	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

cardiovascular	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
has	VBZ	O	O
a	DT	O	O
normal	JJ	O	O
s1	NN	O	O
and	CC	O	O
s2	NN	O	O
without	IN	O	O
murmurs	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
extremities	NNS	O	O
had	VBD	O	O
no	DT	O	O
clubbing	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

neurological	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
was	VBD	O	O
alert	JJ	O	O
and	CC	O	O
oriented	VBD	O	O
x	NNP	O	O
three	CD	O	O
.	.	O	O

notable	JJ	O	O
on	IN	O	O
admission	NN	O	O
were	VBD	O	O
bun	JJ	B-TEST	O
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
of	IN	O	O
8.0	CD	O	O
and	CC	O	O
0.7	CD	O	O
.	.	O	O

sodium	NN	B-TEST	B-TEST
134	CD	O	O
,	,	O	O
alt	RB	B-TEST	O
18	CD	O	O
,	,	O	O
ast	RB	B-TEST	B-TEST
27	CD	O	O
,	,	O	O
ldh	VBD	B-TEST	O
221	CD	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
2.05	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
23	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
137,000	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
differential	NN	I-TEST	I-TEST
showed	VBD	O	O
45	CD	B-TEST	O
polys	NN	I-TEST	B-TEST
,	,	O	O
6	CD	B-TEST	O
bands	NNS	I-TEST	B-TEST
,	,	O	O
8	CD	B-TEST	O
lymphs	NN	I-TEST	B-TEST
,	,	O	O
32	CD	B-TEST	O
monos	NNS	I-TEST	B-TEST
.	.	O	O

urinalysis	NN	B-TEST	B-TEST
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

sputum	NN	B-TEST	B-TEST
gram	NN	I-TEST	I-TEST
stain	NN	I-TEST	I-TEST
showed	VBD	O	O
no	DT	O	O
polys	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
no	DT	O	O
bacteria	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

afb	NN	B-TEST	O
stain	NN	I-TEST	O
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
was	VBD	O	O
consistent	JJ	O	O
with	IN	O	O
an	DT	B-TEST	B-TEST
old	JJ	I-TEST	I-TEST
chest	NN	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
on	IN	O	O
08/08/92	CD	O	O
showing	VBG	O	O
a	DT	B-PROBLEM	B-PROBLEM
resolving	NN	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
lingular	JJ	I-PROBLEM	B-PROBLEM
infiltrate	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
resolution	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
mid	NN	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
infiltrate	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
infectious	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
amphotericine	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
.6	NNP	O	O
mg	FW	O	O
/	NNP	O	O
kg	NN	O	O
for	IN	O	O
a	DT	O	O
total	NN	O	O
of	IN	O	O
250	CD	O	O
mg	NN	O	O
for	IN	O	O
positive	JJ	B-PROBLEM	O
blood	NN	I-PROBLEM	B-TEST
cultures	NNS	I-PROBLEM	I-TEST
for	IN	O	O
candida	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	O
passport	NN	I-TREATMENT	O
in	IN	I-TREATMENT	O
his	PRP$	I-TREATMENT	O
left	JJ	I-TREATMENT	O
arm	NN	I-TREATMENT	O
was	VBD	O	O
pulled	VBN	O	O
and	CC	O	O
will	MD	O	O
be	VB	O	O
replaced	VBN	O	O
if	IN	O	O
needed	VBN	O	O
after	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
amphotericine	NN	I-TREATMENT	I-TREATMENT
is	VBZ	O	O
completed	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
continue	VB	O	O
on	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
pseudomonas	NNS	B-PROBLEM	B-PROBLEM
pneumonia	VBP	I-PROBLEM	I-PROBLEM
to	TO	O	O
complete	VB	O	O
the	DT	O	O
fourteen	JJ	O	O
day	NN	O	O
course	NN	O	O
which	WDT	O	O
was	VBD	O	O
completed	VBN	O	O
on	IN	O	O
09/06/92	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
admission	NN	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
his	PRP$	B-TREATMENT	O
g-csf	NN	I-TREATMENT	O
with	IN	O	O
an	DT	O	O
increase	NN	O	O
in	IN	O	O
his	PRP$	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
to	TO	O	O
8	CD	O	O
from	IN	O	O
1.8	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
required	VBN	O	O
multiple	JJ	B-TREATMENT	B-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
hematocrit	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

medications	NNS	B-TREATMENT	B-TREATMENT
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
are	VBP	O	O
g-csf	JJ	B-TREATMENT	O
300	CD	O	O
micrograms	NNS	O	O
subcu	JJ	O	O
q.	JJ	O	O
day	NN	O	O
,	,	O	O
acyclovir	RB	B-TREATMENT	B-TREATMENT
200	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
b.i.d.	NN	O	O
,	,	O	O
erythromycin	VBZ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
dapsone	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
monday	NN	O	O
,	,	O	O
wednesday	JJ	O	O
and	CC	O	O
friday	JJ	O	O
,	,	O	O
imodium	JJ	B-TREATMENT	O
1-2	JJ	O	O
tablets	NNS	O	O
p.o.	VBP	O	O
q.	RB	O	O
6	CD	O	O
hours	NNS	O	O
p.r.n.	RB	O	O
,	,	O	O
nystatin	RB	B-TREATMENT	B-TREATMENT
5	CD	O	O
cc	JJ	O	O
swish	JJ	O	O
and	CC	O	O
swallow	JJ	O	O
q.i.d.	NN	O	O
,	,	O	O
serax	VBD	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	VBD	O	O
6	CD	O	O
hours	NNS	O	O
p.r.n.	JJ	O	O
and	CC	O	O
kay-ceil	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
meq	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

the	DT	O	O
patient	NN	O	O
needs	VBZ	O	O
to	TO	O	O
have	VB	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
drawn	NN	I-TEST	I-TEST
the	DT	O	O
day	NN	O	O
after	IN	O	O
discharge	NN	O	O
to	TO	O	O
check	VB	O	O
a	DT	B-TEST	B-TEST
potassium	NN	I-TEST	I-TEST
and	CC	O	O
magnesium	NN	B-TEST	B-TEST
which	WDT	O	O
he	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
wasting	VBG	O	O
secondary	JJ	O	O
to	TO	O	O
amphotericine	VB	B-TREATMENT	O
.	.	O	O

he	PRP	O	O
will	MD	O	O
probably	RB	O	O
need	VB	O	O
potassium	NN	B-TREATMENT	B-TEST
and	CC	O	O
magnesium	NN	B-TREATMENT	B-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
will	MD	O	O
need	VB	O	O
follow	VB	B-TEST	O
up	RP	I-TEST	O
lytes	NNS	I-TEST	O
drawn	VBN	O	O
throughout	IN	O	O
the	DT	O	O
week	NN	O	O
.	.	O	O

patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
53	JJ	O	O
-	:	O	O
year-old	JJ	O	O
female	NN	O	O
found	VBD	O	O
down	RB	O	O
in	IN	O	O
hotel	NN	O	O
room	NN	O	O
by	IN	O	O
ems	NNS	O	O
with	IN	O	O
change	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
lethargy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

a	DT	O	O
suicide	JJ	O	O
note	NN	O	O
found	VBD	O	O
at	IN	O	O
the	DT	O	O
scene	NN	O	O
referenced	VBD	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
medical	JJ	I-PROBLEM	I-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
suggested	VBN	O	O
ingestion	NN	O	O
of	IN	O	O
beta	NN	B-TREATMENT	B-TREATMENT
blocker	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
muscle	NN	B-TREATMENT	B-PROBLEM
relaxant	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
and	CC	O	O
neurontin	RB	B-TREATMENT	B-TREATMENT
.	.	O	O

vital	JJ	B-TEST	B-TEST
signs	NNS	I-TEST	I-TEST
were	VBD	O	O
stable	JJ	O	O
on	IN	O	O
arrival	NN	O	O
in	IN	O	O
the	DT	O	O
david	NN	O	O
,	,	O	O
but	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
minimally	RB	B-PROBLEM	O
responsive	JJ	I-PROBLEM	O
and	CC	O	O
subsequently	RB	O	O
intubated	VBN	O	B-TREATMENT
for	IN	O	O
airway	NN	B-TREATMENT	B-TREATMENT
protection	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

patient	NN	O	O
initially	RB	O	O
given	VBN	O	O
2	CD	O	O
mg	NN	O	O
of	IN	O	O
narcan	JJ	B-TREATMENT	O
,	,	O	O
4	CD	O	O
amps	NNS	O	O
of	IN	O	O
sodium	NN	B-TREATMENT	B-TREATMENT
bicarb	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
5	CD	O	O
grams	NNS	O	O
of	IN	O	O
activated	JJ	B-TREATMENT	B-PROBLEM
charcoal	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

patient	NN	B-TEST	B-TEST
's	POS	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
pressures	NNS	I-TEST	I-TEST
were	VBD	O	O
noted	VBN	O	O
to	TO	O	O
decrease	VB	B-PROBLEM	O
systolics	NNS	I-PROBLEM	O
to	TO	O	O
the	DT	O	O
80s	CD	O	O
,	,	O	O
which	WDT	O	O
responded	VBD	O	O
to	TO	O	O
iv	VB	B-TREATMENT	O
fluids	NNS	I-TREATMENT	O
and	CC	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
/	VBP	O	O
glucose	JJ	B-TREATMENT	B-TREATMENT
drips	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

also	RB	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
bradycardic	JJ	B-PROBLEM	O
to	TO	O	O
the	DT	O	O
50s	CD	O	O
,	,	O	O
which	WDT	O	O
responded	VBD	O	O
to	TO	O	O
atropine	VB	B-TREATMENT	B-TREATMENT
.	.	O	O

1.	CD	O	O
hepatitis	NN	B-PROBLEM	B-PROBLEM
c	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
hypertrophic	JJ	B-PROBLEM	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
lumbar	NN	B-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	O
cervical	JJ	I-PROBLEM	B-PROBLEM
degenerative	JJ	I-PROBLEM	I-PROBLEM
disk	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
sarcoid	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

5.	CD	O	O
depression	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

6.	CD	O	O
headaches	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

1.	CD	O	O
neurontin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

2.	CD	O	O
propanolol	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

3.	CD	O	O
tylenol	JJ	B-TREATMENT	B-TREATMENT
#3	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

4.	CD	O	O
butalbital	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

5.	CD	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

6.	CD	O	O
protonix	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

7.	CD	O	O
doxepin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

8.	CD	O	O
dilaudid	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

9.	CD	O	O
inderal	JJ	B-TREATMENT	O
.	.	O	O

10.	CD	O	O
skelaxin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

11.	CD	O	O
zantac	NN	B-TREATMENT	O
.	.	O	O

12.	CD	O	O
flexeril	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

13.	CD	O	O
ms	NN	B-TREATMENT	B-TREATMENT
contin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

temperature	NN	B-TEST	B-TEST
96.8	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
81	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
92/47	CD	O	O
,	,	O	O
and	CC	O	O
saturating	VBG	O	O
100%	CD	O	O
on	IN	O	O
40%	CD	O	O
fio2	NN	B-TREATMENT	O
.	.	O	O

regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

pulmonary	NN	O	O
is	VBZ	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	O	O
.	.	O	O

abdomen	NNS	O	O
is	VBZ	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
nondistended	VBD	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

white	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
20.0	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
52	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
439	CD	O	O
.	.	O	O

chem-7	NN	B-TEST	B-TEST
:	:	O	O

urinalysis	NN	B-TEST	B-TEST
negative	JJ	O	O
except	IN	O	O
for	IN	O	O
large	JJ	B-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

ekg	NN	B-TEST	O
:	:	O	O

sinus	NN	B-PROBLEM	B-PROBLEM
bradycardia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
left	VBD	B-PROBLEM	B-PROBLEM
bundle	JJ	I-PROBLEM	I-PROBLEM
branch	NN	I-PROBLEM	I-PROBLEM
block	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
prolonged	VBD	B-PROBLEM	B-PROBLEM
qrs	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

urine	JJ	B-TEST	B-TEST
tox	NN	I-TEST	I-TEST
positive	JJ	B-PROBLEM	O
for	IN	I-PROBLEM	O
barbiturates	NNS	I-PROBLEM	B-TREATMENT
,	,	I-PROBLEM	O
opiates	NNS	I-PROBLEM	B-TREATMENT
,	,	I-PROBLEM	O
and	CC	I-PROBLEM	O
methadone	NN	I-PROBLEM	B-TREATMENT
.	.	O	O

serum	NN	B-TEST	B-TEST
tylenol	NN	I-TEST	I-TEST
level	NN	I-TEST	I-TEST
is	VBZ	O	O
8.3	CD	O	O
.	.	O	O

positive	JJ	B-PROBLEM	O
for	IN	I-PROBLEM	O
serum	NN	I-PROBLEM	B-TREATMENT
barbiturates	NNS	I-PROBLEM	I-TREATMENT
.	.	O	O

ck	NN	B-TEST	B-TEST
15,000	CD	O	O
.	.	O	O

alt	RB	B-TEST	O
77	CD	O	O
,	,	O	O
ast	RB	B-TEST	B-TEST
159	CD	O	O
,	,	O	O
amylase	NN	B-TEST	B-TEST
153	CD	O	O
,	,	O	O
alkaline	JJ	B-TEST	B-TEST
phosphatase	NN	I-TEST	I-TEST
216	CD	O	O
,	,	O	O
total	JJ	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
0.6	CD	O	O
.	.	O	O

inr	RB	B-TEST	O
1.1	CD	O	O
.	.	O	O

in	IN	O	O
summary	JJ	O	O
,	,	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
53	JJ	O	O
-	:	O	O
year-old	JJ	O	O
female	NN	O	O
with	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
medical	JJ	I-PROBLEM	I-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
history	NN	O	O
of	IN	O	O
depression	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
intentional	JJ	O	B-PROBLEM
overdose	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
barbiturates	NNS	B-TREATMENT	I-PROBLEM
,	,	O	O
opiates	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
tylenol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
beta	NN	B-TREATMENT	B-TREATMENT
blocker	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

patient	NN	O	O
was	VBD	O	O
maintained	VBN	O	O
on	IN	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
d10	NN	B-TREATMENT	O
and	CC	O	O
glucagon	NN	B-TREATMENT	B-TREATMENT
drips	NNS	I-TREATMENT	I-TREATMENT
to	TO	O	O
maintain	VB	O	O
her	PRP$	O	O
hemodynamics	NNS	O	O
.	.	O	O

psychiatry	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
after	IN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
extubated	VBN	O	O
,	,	O	O
and	CC	O	O
felt	VBD	O	O
that	IN	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
high	JJ	I-PROBLEM	I-PROBLEM
suicide	NN	I-PROBLEM	I-PROBLEM
risk	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
plan	NN	O	O
was	VBD	O	O
for	IN	O	O
her	PRP$	O	O
to	TO	O	O
be	VB	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
psychiatry	NN	O	O
service	NN	O	O
once	RB	O	O
medically	RB	O	O
stable	JJ	O	O
.	.	O	O

patient	NN	O	B-TEST
's	POS	O	I-TEST
renal	JJ	O	I-TEST
function	NN	O	I-TEST
remained	VBD	O	O
stable	JJ	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
cks	NNS	I-TEST	I-TEST
trended	VBD	O	O
down	RB	O	O
gradually	RB	O	O
.	.	O	O

patient	NN	O	O
remained	VBD	O	O
on	IN	O	O
suicide	JJ	B-TREATMENT	B-TREATMENT
precautions	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
but	CC	O	O
was	VBD	O	O
deemed	VBN	O	O
not	RB	O	O
to	TO	O	O
need	VB	O	O
icu	JJ	B-TEST	B-TEST
level	NN	I-TEST	I-TEST
monitoring	NN	I-TEST	I-TEST
,	,	O	O
and	CC	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
on	IN	O	O
01-11	NN	O	O
.	.	O	O

in	IN	O	O
the	DT	O	O
a.m.	NN	O	O
of	IN	O	O
01/08	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
experienced	VBD	O	O
episode	NN	O	O
of	IN	O	O
tongue	NN	B-PROBLEM	B-PROBLEM
biting	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
unresponsiveness	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
disorientation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

was	VBD	O	O
loaded	VBN	O	O
on	IN	O	O
dilantin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

became	VBD	O	O
progressively	RB	O	B-PROBLEM
hypoxic	JJ	B-PROBLEM	I-PROBLEM
and	CC	O	O
tachypneic	JJ	B-PROBLEM	B-PROBLEM
throughout	IN	O	O
the	DT	O	O
day	NN	O	O
with	IN	O	O
respiratory	JJ	B-TEST	O
rates	NNS	I-TEST	O
of	IN	O	O
30-40	JJ	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
max	JJ	I-TEST	I-TEST
respiratory	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
116	CD	O	O
,	,	O	O
tachycardia	NN	B-PROBLEM	B-PROBLEM
to	TO	O	O
120s	CD	O	O
.	.	O	O

patient	NN	O	O
subsequently	RB	O	O
was	VBD	O	O
transferred	VBN	O	O
back	RB	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
ccu	NN	O	O
on	IN	O	O
2017-01-13	JJ	O	O
for	IN	O	O
further	JJ	B-TEST	B-TEST
monitoring	NN	I-TEST	I-TEST
.	.	O	O

patient	NN	B-PROBLEM	B-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
hypoxia	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
felt	VBN	O	O
most	RBS	O	O
likely	JJ	O	O
to	TO	O	O
be	VB	O	O
caused	VBN	O	O
by	IN	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
appropriate	JJ	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

etiology	NN	O	O
of	IN	O	O
patient	NN	B-PROBLEM	B-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
tachypnea	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
unclear	JJ	O	O
.	.	O	O

initially	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
etiology	NN	O	O
of	IN	O	O
seizure	NN	B-PROBLEM	B-PROBLEM
was	VBD	O	O
not	RB	O	O
quite	RB	O	O
clear	JJ	O	O
,	,	O	O
but	CC	O	O
thought	VBD	O	O
possibly	RB	O	O
secondary	JJ	O	O
to	TO	O	O
alcohol	VB	B-PROBLEM	O
and	CC	I-PROBLEM	O
benzodiazepine	VB	I-PROBLEM	B-TREATMENT
withdrawal	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

she	PRP	O	O
received	VBD	O	O
eeg	RB	B-TEST	O
,	,	O	O
mri	NN	B-TEST	O
,	,	O	O
lp	NN	B-TEST	O
.	.	O	O

subsequently	RB	O	O
eeg	NN	B-TEST	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
no	DT	O	O
seizure	NN	B-PROBLEM	B-PROBLEM
activity	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mri	NN	B-TEST	B-TEST
was	VBD	O	O
suboptimal	JJ	O	O
due	JJ	O	O
to	TO	O	O
motion	VB	O	O
artifact	NN	O	O
and	CC	O	O
lp	NN	B-TEST	O
was	VBD	O	O
unremarkable	JJ	O	O
.	.	O	O

despite	IN	O	O
absence	NN	O	O
of	IN	O	O
seizure	NN	B-PROBLEM	B-PROBLEM
activity	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
eeg	NN	B-TEST	O
,	,	O	O
patient	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
dilantin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

her	PRP$	B-PROBLEM	B-PROBLEM
delirium	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
felt	VBN	O	O
possibly	RB	O	O
secondary	JJ	O	O
to	TO	O	O
withdrawal	VB	B-PROBLEM	O
versus	NN	O	O
toxic	JJ	B-PROBLEM	B-PROBLEM
metabolic	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
gradually	RB	O	O
improved	JJ	O	O
slowly	RB	O	O
,	,	O	O
and	CC	O	O
therefore	RB	O	O
patient	NN	O	O
did	VBD	O	O
not	RB	O	O
receive	VB	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
barbiturate	NN	B-PROBLEM	B-TREATMENT
withdrawal	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

her	PRP$	O	B-PROBLEM
mental	JJ	O	I-PROBLEM
status	NN	O	I-PROBLEM
,	,	O	O
tachypnea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
hypoxia	VB	B-PROBLEM	B-PROBLEM
all	DT	O	O
improved	VBN	O	O
,	,	O	O
and	CC	O	O
patient	NN	O	O
was	VBD	O	O
subsequently	RB	O	O
transferred	VBN	O	O
back	RB	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
medical	JJ	O	O
team	NN	O	O
on	IN	O	O
2017-01-15	JJ	O	O
.	.	O	O

while	IN	O	O
on	IN	O	O
the	DT	O	O
floor	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
mental	JJ	O	O
status	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
improved	VBN	O	O
back	RB	O	O
at	IN	O	O
baseline	NN	O	O
compared	VBN	O	O
to	TO	O	O
that	DT	O	O
back	RB	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
ccu	NN	O	O
,	,	O	O
and	CC	O	O
she	PRP	O	O
exhibited	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
barbiturate	NN	B-PROBLEM	B-TREATMENT
withdrawal	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
suicide	JJ	B-TREATMENT	B-TREATMENT
precautions	NNS	I-TREATMENT	I-TREATMENT
with	IN	O	O
a	DT	B-TREATMENT	O
one-to-one	JJ	I-TREATMENT	O
sitter	NN	I-TREATMENT	O
,	,	O	O
and	CC	O	O
plan	NN	O	O
was	VBD	O	O
for	IN	O	O
psychiatric	JJ	O	O
admission	NN	O	O
when	WRB	O	O
medical	JJ	B-PROBLEM	O
issues	NNS	I-PROBLEM	O
had	VBD	O	O
resolved	VBN	O	O
.	.	O	O

on	IN	O	O
2017-01-16	JJ	O	O
,	,	O	O
the	DT	O	O
night	NN	O	O
float	NN	O	O
intern	NN	O	O
was	VBD	O	O
called	VBN	O	O
to	TO	O	O
see	VB	O	O
the	DT	O	O
patient	NN	O	O
as	IN	O	O
she	PRP	O	O
was	VBD	O	O
unresponsive	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

patient	JJ	O	O
unresponsive	JJ	B-PROBLEM	O
to	TO	O	O
verbal	JJ	B-TEST	O
command	NN	I-TEST	O
,	,	O	O
sternal	JJ	B-TEST	B-PROBLEM
rub	NN	I-TEST	I-PROBLEM
.	.	O	O

pupils	NNS	O	O
were	VBD	O	O
fixed	VBN	B-PROBLEM	O
and	CC	O	O
dilated	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

patient	NN	O	O
noted	VBD	O	O
to	TO	O	O
be	VB	O	O
without	IN	B-PROBLEM	O
corneal	JJ	I-PROBLEM	B-TEST
reflexes	NNS	I-PROBLEM	I-TEST
,	,	I-PROBLEM	O
spontaneous	JJ	I-PROBLEM	B-PROBLEM
breathing	NN	I-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	O
heart	NN	I-PROBLEM	B-TEST
sounds	VBZ	I-PROBLEM	I-TEST
,	,	I-PROBLEM	O
or	CC	I-PROBLEM	O
palpable	JJ	I-PROBLEM	B-PROBLEM
pulses	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
's	POS	O	O
family	NN	O	O
was	VBD	O	O
notified	VBN	O	O
and	CC	O	O
declined	VBD	O	O
autopsy	NN	B-TEST	B-TEST
.	.	O	O

of	IN	O	O
note	NN	O	O
at	IN	O	O
time	NN	O	O
of	IN	O	O
death	NN	O	B-PROBLEM
,	,	O	O
patient	NN	O	O
was	VBD	O	O
dnr	JJ	B-TREATMENT	O
/	NNP	O	O
dni	NN	B-TREATMENT	O
.	.	O	O

this	DT	O	O
was	VBD	O	O
initiated	VBN	O	O
after	IN	O	O
several	JJ	O	O
conversations	NNS	O	O
with	IN	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
mother	NN	O	O
,	,	O	O
who	WP	O	O
stated	VBD	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
desired	VBN	O	O
to	TO	O	O
be	VB	O	O
dnr	JJ	B-TREATMENT	O
/	NNP	O	O
dni	NN	B-TREATMENT	O
for	IN	O	O
many	JJ	O	O
years	NNS	O	O
,	,	O	O
not	RB	O	O
just	RB	O	O
in	IN	O	O
the	DT	O	O
recent	JJ	O	O
past	NN	O	O
.	.	O	O

neuropathic	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

post	NN	B-PROBLEM	O
thoracotomy	NN	I-PROBLEM	B-TREATMENT
syndrome	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TREATMENT
spinal	JJ	I-TEST	I-TREATMENT
cord	NN	I-TEST	I-TREATMENT
stimulator	NN	I-TEST	I-TREATMENT
trial	NN	I-TEST	I-TREATMENT
on	IN	O	O
07/21/99	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
an	DT	B-TEST	B-PROBLEM
epidural	JJ	I-TEST	I-PROBLEM
trial	NN	I-TEST	I-PROBLEM
on	IN	O	O
07/24/99	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
65	CD	O	O
year	NN	O	O
old	JJ	O	O
female	NN	O	O
with	IN	O	O
post	NN	B-PROBLEM	O
thoracotomy	NN	I-PROBLEM	B-TREATMENT
syndrome	NN	I-PROBLEM	I-TREATMENT
that	WDT	O	O
occurred	VBD	O	O
on	IN	O	O
the	DT	O	O
site	NN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-TREATMENT
thoracotomy	JJ	I-PROBLEM	I-TREATMENT
incision	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
thoracic	JJ	I-PROBLEM	I-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
repaired	VBN	O	O
in	IN	O	O
the	DT	O	O
past	JJ	O	O
and	CC	O	O
subsequently	RB	O	O
developed	VBD	O	O
neuropathic	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
at	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
site	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
currently	RB	O	O
on	IN	O	O
vicodin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
one	CD	O	O
to	TO	O	O
two	CD	O	O
tablets	NNS	O	O
every	DT	O	O
four	CD	O	O
hours	NNS	O	O
p.r.n.	RB	O	O
,	,	O	O
fentanyl	JJ	B-TREATMENT	B-TREATMENT
patch	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mcg	NN	O	O
an	DT	O	O
hour	NN	O	O
,	,	O	O
change	NN	O	O
of	IN	O	O
patch	NN	O	O
every	DT	O	O
72	CD	O	O
hours	NNS	O	O
,	,	O	O
elavil	VBP	B-TREATMENT	B-TREATMENT
50	CD	O	O
mgq	JJ	O	O
.h.s.	NN	O	O
,	,	O	O
neurontin	RB	B-TREATMENT	B-TREATMENT
600	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
t.i.d.	NN	O	O
with	IN	O	O
still	RB	O	O
what	WP	O	O
she	PRP	O	O
reports	VBZ	O	O
as	IN	O	O
stabbing	VBG	B-PROBLEM	B-PROBLEM
left-sided	JJ	I-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
can	MD	O	O
be	VB	O	O
as	RB	O	O
severe	JJ	O	O
as	IN	O	O
a	DT	O	O
7/10.	CD	O	O

she	PRP	O	O
has	VBZ	O	O
failed	VBN	O	O
conservative	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
is	VBZ	O	O
admitted	VBN	O	O
for	IN	O	O
a	DT	B-TEST	B-TREATMENT
spinal	JJ	I-TEST	I-TREATMENT
cord	NN	I-TEST	I-TREATMENT
stimulator	NN	I-TEST	I-TREATMENT
trial	NN	I-TEST	I-TREATMENT
.	.	O	O

1.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2.	CD	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

3.	CD	O	O
paraplegia	NN	B-PROBLEM	B-PROBLEM
status	NN	O	O
post	NN	O	O
thoracic	NN	B-TREATMENT	B-PROBLEM
aortic	JJ	I-TREATMENT	I-PROBLEM
aneurysm	NN	I-TREATMENT	I-PROBLEM
repair	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

4.	CD	O	O
left	VBD	B-PROBLEM	B-PROBLEM
hemidiaphragmatic	JJ	I-PROBLEM	I-PROBLEM
paralysis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
history	NN	O	O
of	IN	O	O
recurrent	NN	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
infections	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

5.	CD	O	O
sacral	JJ	B-PROBLEM	B-PROBLEM
decubitus	NN	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

6.	CD	O	O
home	NN	B-TREATMENT	B-TREATMENT
oxygen	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
two	CD	O	O
liters	NNS	O	O
a	DT	O	O
minute	NN	O	O
when	WRB	O	O
she	PRP	O	O
is	VBZ	O	O
at	IN	O	O
home	NN	O	O
;	:	O	O
she	PRP	O	O
does	VBZ	O	O
not	RB	O	O
use	VB	O	O
the	DT	B-TREATMENT	O
oxygen	NN	I-TREATMENT	O
when	WRB	O	O
she	PRP	O	O
is	VBZ	O	O
in	IN	O	O
a	DT	B-TREATMENT	B-PROBLEM
wheelchair	NN	I-TREATMENT	I-PROBLEM
or	CC	O	O
is	VBZ	O	O
out	IN	O	O
of	IN	O	O
the	DT	O	O
house	NN	O	O
.	.	O	O

1.	CD	O	O
atrovent	JJ	B-TREATMENT	B-TREATMENT
nebulizers	NNS	I-TREATMENT	I-TREATMENT
0.5	CD	O	O
mg	NNS	O	O
mixed	JJ	O	O
with	IN	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
nebulizer	NN	B-TREATMENT	B-TREATMENT
is	VBZ	O	O
given	VBN	O	O
every	DT	O	O
six	CD	O	O
hours	NNS	O	O
.	.	O	O

2.	CD	O	O
norvasc	JJ	B-TREATMENT	B-TREATMENT
2.5	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

3.	CD	O	O
colistin	NN	B-TREATMENT	B-TREATMENT
30	CD	O	O
mg	NN	O	O
nebulizer	NN	O	B-TREATMENT
twice	RB	O	O
a	DT	O	O
day	NN	O	O
,	,	O	O
give	VB	O	O
30	CD	O	O
minutes	NNS	O	O
post	VBP	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	I-TREATMENT
atrovent	NN	B-TREATMENT	I-TREATMENT
.	.	O	O

4.	CD	O	O
pressure	NN	B-TREATMENT	B-PROBLEM
,	,	I-TREATMENT	O
dermal	JJ	I-TREATMENT	B-PROBLEM
ulcer	NN	I-TREATMENT	I-PROBLEM
care	NN	I-TREATMENT	I-PROBLEM
b.i.d.	IN	O	O
dressing	VBG	B-TREATMENT	B-TREATMENT
change	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
antibiotic	JJ	B-TREATMENT	B-TREATMENT
solution	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

5.	CD	O	O
neurontin	JJ	B-TREATMENT	B-TREATMENT
600	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O

6.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

7.	CD	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
neb	RB	I-TREATMENT	I-TREATMENT
2.5	CD	O	O
mg	NN	O	O
every	DT	O	O
six	CD	O	O
hours	NNS	O	O
,	,	O	O
30	CD	O	O
minutes	NNS	O	O
before	IN	O	O
colistin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

8.	CD	O	O
amitriptyline	JJ	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NNS	O	O
q.h.s.	NN	O	O

9.	CD	O	O
vitamin	JJ	B-TREATMENT	B-TREATMENT
c	NN	I-TREATMENT	I-TREATMENT
500	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

10.	CD	O	O
calcium	NN	B-TREATMENT	B-TREATMENT
carbonate	NN	I-TREATMENT	I-TREATMENT
125.0	CD	O	O
mg	NN	O	O
t.i.d.	NN	O	O

11.	CD	O	O
fentanyl	JJ	B-TREATMENT	B-TREATMENT
patch	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mcg	NN	O	O
an	DT	O	O
hour	NN	O	O
,	,	O	O
change	NN	O	O
patch	NN	O	O
every	DT	O	O
72	CD	O	O
hours	NNS	O	O
.	.	O	O

12.	CD	O	O
folate	JJ	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

13.	CD	O	O
synthroid	JJ	B-TREATMENT	B-TREATMENT
50	CD	O	O
mcg	NN	O	O
p.o.	NN	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

14.	CD	O	O
zinc	NN	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
220	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

15.	CD	O	O
multivitamin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
one	CD	O	O
tablet	NN	O	O
p.o.	NN	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

16.	CD	O	O
hydrocodone	NN	B-TREATMENT	B-TREATMENT
5	CD	I-TREATMENT	O
mg	NN	I-TREATMENT	O
with	IN	I-TREATMENT	O
tylenol	NN	I-TREATMENT	B-TREATMENT
,	,	O	O
one	CD	O	O
to	TO	O	O
two	CD	O	O
tablets	NNS	O	O
every	DT	O	O
four	CD	O	O
hours	NNS	O	O
p.r.n.	RB	O	O
pain	VBP	B-PROBLEM	B-PROBLEM
.	.	O	O

17.	CD	O	O
milk	NN	B-TREATMENT	O
of	IN	I-TREATMENT	O
magnesia	NN	I-TREATMENT	B-TREATMENT
30	CD	O	O
cc	NN	O	O
p.o.	NN	O	O
q	JJ	O	O
day	NN	O	O
constipation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

penicillin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
well-appearing	JJ	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
is	VBZ	O	O
150/90	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
90	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
20	CD	O	O
with	IN	O	O
saturation	NN	B-TEST	B-TEST
of	IN	O	O
98%	CD	O	O
.	.	O	O

the	DT	O	B-TREATMENT
patient	NN	O	I-TREATMENT
wears	VBZ	O	I-TREATMENT
dentures	NNS	B-TREATMENT	I-TREATMENT
.	.	O	O

full	JJ	O	O
range	NN	O	O
of	IN	O	O
motion	NN	O	O
with	IN	O	O
no	DT	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
on	IN	O	O
the	DT	O	O
right	NN	O	O
.	.	O	O

decreased	VBN	B-PROBLEM	B-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
sounds	NNS	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
base	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
coarse	JJ	B-PROBLEM	B-PROBLEM
rales	NNS	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
base	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

soft	JJ	O	O
,	,	O	O
nondistended	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

epidural	JJ	B-TREATMENT	B-PROBLEM
site	NN	I-TREATMENT	I-PROBLEM
is	VBZ	O	O
without	IN	O	O
erythema	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
drainage	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
tenderness	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

left	VBN	O	O
buttock	NN	O	O
area	NN	O	O
has	VBZ	O	O
a	DT	B-TREATMENT	B-TREATMENT
dressing	NN	I-TREATMENT	I-TREATMENT
over	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
sacral	JJ	I-PROBLEM	I-PROBLEM
decubitus	NN	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

flaccid	JJ	B-PROBLEM	B-PROBLEM
paralysis	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremities	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
on	IN	O	O
07/20/99	CD	O	O
for	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
chest	JJS	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
postthoracotomy	JJ	B-PROBLEM	B-TREATMENT
syndrome	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
developed	VBD	O	O
the	DT	B-PROBLEM	B-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
after	IN	O	O
her	PRP$	B-TREATMENT	B-PROBLEM
thoracic	JJ	I-TREATMENT	I-PROBLEM
aortic	JJ	I-TREATMENT	I-PROBLEM
aneurysm	NN	I-TREATMENT	I-PROBLEM
repair	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
failed	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
conservative	JJ	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
is	VBZ	O	O
admitted	VBN	O	O
for	IN	O	O
a	DT	B-TEST	B-TREATMENT
spinal	JJ	I-TEST	I-TREATMENT
cord	NN	I-TEST	I-TREATMENT
stimulator	NN	I-TEST	I-TREATMENT
trial	NN	I-TEST	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
spinal	JJ	I-TREATMENT	I-TREATMENT
cord	NN	I-TREATMENT	I-TREATMENT
stimulator	NN	I-TREATMENT	I-TREATMENT
placed	VBD	O	O
on	IN	O	O
07/21/99	CD	O	O
.	.	O	O

she	PRP	O	O
underwent	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
very	RB	O	O
well	RB	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
spinal	JJ	I-TREATMENT	I-TREATMENT
cord	NN	I-TREATMENT	I-TREATMENT
stimulator	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
programmed	VBN	O	O
with	IN	O	O
setting	NN	O	O
of	IN	O	O
a	DT	O	B-TEST
rate	NN	O	I-TEST
of	IN	O	O
80	CD	O	O
,	,	O	O
power	NN	O	O
450	CD	O	O
and	CC	O	O
4.0	CD	O	O
amps	NNS	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
the	DT	O	O
next	JJ	O	O
two	CD	O	O
days	NNS	O	O
did	VBD	O	O
not	RB	O	O
notice	VB	O	O
any	DT	O	B-PROBLEM
significant	JJ	O	I-PROBLEM
change	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
her	PRP$	B-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
pattern	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
also	RB	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	O	O
lot	NN	O	O
of	IN	O	O
musculoskeletal	JJ	B-PROBLEM	O
component	NN	I-PROBLEM	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

so	RB	O	O
,	,	O	O
an	DT	B-TREATMENT	B-TREATMENT
epidural	JJ	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
07/23/99	CD	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
epidural	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
in	IN	O	O
the	DT	O	O
l1-2	JJ	O	O
region	NN	O	O
and	CC	O	O
the	DT	B-TREATMENT	B-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
in	IN	O	O
the	DT	O	O
t7	JJ	O	O
region	NN	O	O
using	VBG	O	O
fluoroscope	NN	B-TREATMENT	O
to	TO	O	O
guide	VB	O	O
the	DT	B-TREATMENT	B-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

within	IN	O	O
the	DT	O	O
next	JJ	O	O
couple	NN	O	O
of	IN	O	O
days	NNS	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
noticed	VBD	O	O
a	DT	O	O
significant	JJ	O	O
improvement	NN	O	O
in	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
pattern	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	O
stabbing	NN	I-PROBLEM	O
,	,	I-PROBLEM	O
sharp	JJ	I-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
that	IN	O	O
she	PRP	O	O
occasionally	RB	O	O
has	VBZ	O	O
on	IN	O	O
the	DT	O	B-TEST
left	NN	O	I-TEST
chest	JJS	O	I-TEST
wall	NN	O	I-TEST
was	VBD	O	O
significantly	RB	O	O
diminished	VBN	O	O
and	CC	O	O
she	PRP	O	O
also	RB	O	O
noticed	VBD	O	O
periods	NNS	O	O
of	IN	O	O
time	NN	O	O
when	WRB	O	O
she	PRP	O	O
did	VBD	O	O
not	RB	O	O
have	VB	O	O
any	DT	O	O
of	IN	O	O
that	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
epidural	JJ	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
morphine	JJ	I-TREATMENT	I-TREATMENT
infusion	NN	I-TREATMENT	I-TREATMENT
initially	RB	O	O
started	VBD	O	O
at	IN	O	O
1	CD	O	O
mg	NNS	O	O
a	DT	O	O
day	NN	O	O
and	CC	O	O
increased	VBD	O	O
to	TO	O	O
3	CD	O	O
mg	NNS	O	O
a	DT	O	O
day	NN	O	O
in	IN	O	O
a	DT	O	O
period	NN	O	O
of	IN	O	O
three	CD	O	O
days	NNS	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
epidural	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
on	IN	O	O
07/26/99	CD	O	O
and	CC	O	O
was	VBD	O	O
considered	VBN	O	O
a	DT	O	O
successful	JJ	O	O
trial	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
schedule	VB	O	O
with	IN	O	O
the	DT	O	B-PROBLEM
pain	NN	O	I-PROBLEM
clinic	JJ	O	O
regarding	VBG	O	O
upcoming	JJ	O	B-TREATMENT
epidural	JJ	B-TREATMENT	I-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

dr.	NN	O	O
falccouette	NN	O	O
would	MD	O	O
like	VB	O	O
to	TO	O	O
perform	VB	O	O
an	DT	B-TREATMENT	B-TREATMENT
excision	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
closure	NN	B-TREATMENT	B-PROBLEM
flap	NN	I-TREATMENT	I-PROBLEM
of	IN	O	I-PROBLEM
her	PRP$	B-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
ischial	JJ	I-PROBLEM	I-PROBLEM
decubitusin	NN	I-PROBLEM	I-PROBLEM
the	DT	O	I-PROBLEM
near	JJ	O	I-PROBLEM
future	NN	O	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
discharged	VBN	O	O
in	IN	O	O
stable	JJ	O	O
conditionand	NN	O	O
will	MD	O	O
follow	VB	O	O
up	RP	O	O
for	IN	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
sacral	JJ	B-TREATMENT	B-PROBLEM
decubitus	NN	I-TREATMENT	I-PROBLEM
closure	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
and	CC	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
placement	NN	B-TREATMENT	O
of	IN	I-TREATMENT	O
epidural	JJ	I-TREATMENT	B-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
the	DT	O	O
future	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
have	VB	O	O
smh	JJ	O	O
service	NN	O	O
that	WDT	O	O
comes	VBZ	O	O
to	TO	O	O
her	PRP$	O	O
home	NN	O	O
once	IN	O	O
a	DT	O	O
day	NN	O	O
for	IN	O	O
adressing	VBG	B-TREATMENT	O
change	NN	I-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
dr.	JJ	O	O
kayschird	NN	O	O
to	TO	O	O
schedule	NN	O	O
for	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
epidural	JJ	I-TREATMENT	I-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
dr.	NN	O	O
falccouette	NN	O	O
to	TO	O	O
schedule	NN	O	O
for	IN	O	O
excision	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
closure	NN	B-TREATMENT	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
ischial	JJ	I-PROBLEM	I-PROBLEM
sacral	JJ	I-PROBLEM	I-PROBLEM
decubitus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
20	CD	O	O
year	NN	O	O
old	JJ	O	O
driver	NN	O	O
was	VBD	O	O
in	IN	O	O
a	DT	O	O
major	JJ	O	O
motor	NN	O	O
vehicle	NN	O	O
accident	NN	O	O
and	CC	O	O
brought	VBD	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
saints	VBZ	O	O
medical	JJ	O	O
center	NN	O	O
following	VBG	O	O
this	DT	O	O
,	,	O	O
with	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
trauma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
involved	VBN	O	O
in	IN	O	O
a	DT	O	B-TREATMENT
long	JJ	O	I-TREATMENT
extrication	NN	O	I-TREATMENT
with	IN	O	O
a	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
88	CD	O	O
at	IN	O	O
the	DT	O	O
scene	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
tachycardic	JJ	B-PROBLEM	O
with	IN	O	O
an	DT	B-TEST	B-TEST
initial	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
120	CD	O	O
/	NNS	O	O
palpable	JJ	O	B-PROBLEM
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
groin	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
sedated	VBN	O	O
and	CC	O	O
paralyzed	VBN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
resuscitated	VBN	O	O
with	IN	O	O
crystalloid	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
remained	VBD	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
grossly	RB	I-PROBLEM	I-PROBLEM
deformed	VBN	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
examination	NN	B-TEST	B-TEST
,	,	O	O
belmont	JJ	B-TEST	B-PROBLEM
coma	NN	I-TEST	I-PROBLEM
scale	NN	I-TEST	I-PROBLEM
was	VBD	O	O
6t	CD	O	O
;	:	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
120	CD	O	O
/	NNP	O	O
palpable	JJ	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
122	CD	O	O
.	.	O	O

rectal	NN	O	O
was	VBD	O	O
heme	JJ	B-PROBLEM	O
positive	JJ	I-PROBLEM	O
with	IN	O	O
normal	JJ	O	O
prostate	NN	O	O
.	.	O	O

there	EX	O	O
were	VBD	O	O
no	DT	O	O
meatal	JJ	B-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
left	NN	O	O
femur	NN	O	O
was	VBD	O	O
grossly	RB	B-PROBLEM	O
deformed	VBN	I-PROBLEM	O
with	IN	O	O
a	DT	B-PROBLEM	B-TREATMENT
pinhole	JJ	I-PROBLEM	I-TREATMENT
opening	NN	I-PROBLEM	I-TREATMENT
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
lateral	JJ	I-PROBLEM	O
thigh	NN	I-PROBLEM	O
.	.	O	O

his	PRP$	O	B-TEST
left	VBD	O	I-TEST
forearm	NN	O	I-TEST
was	VBD	O	O
also	RB	O	O
grossly	RB	B-PROBLEM	O
deformed	VBN	I-PROBLEM	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
step-off	NN	B-PROBLEM	B-PROBLEM
at	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
back	NN	I-PROBLEM	O
.	.	O	O

admission	NN	B-TEST	B-TEST
laboratories	NNS	I-TEST	I-TEST
included	VBD	O	O
a	DT	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
of	IN	O	O
43.3	CD	O	O
and	CC	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
25.2	CD	O	O
,	,	O	O
normal	JJ	O	O
electrolytes	NNS	O	O
and	CC	O	O
amylase	NN	B-TEST	B-TEST
of	IN	O	O
98	CD	O	O
.	.	O	O

arterial	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
gas	NN	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
mild	JJ	I-PROBLEM	I-PROBLEM
metabolic	JJ	I-PROBLEM	I-PROBLEM
acidosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

additional	JJ	B-TEST	O
assay	NN	I-TEST	O
shows	NNS	O	O
slight	VBD	B-PROBLEM	B-PROBLEM
widening	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
mediastinum	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
chest	JJ	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
.	.	O	O

the	DT	B-TEST	B-TEST
ct	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
and	CC	I-TEST	I-TEST
chest	NN	I-TEST	I-TEST
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
liver	NN	I-PROBLEM	I-PROBLEM
laceration	NN	I-PROBLEM	I-PROBLEM
seen	VBN	O	O
on	IN	O	O
the	DT	B-TEST	O
a/p	NN	I-TEST	O
pelvis	NN	I-TEST	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
ulnar	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
radial	JJ	I-PROBLEM	B-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
mid-shaft	NN	I-PROBLEM	I-PROBLEM
comminuted	JJ	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
femur	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
went	VBD	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
quickly	RB	O	O
and	CC	O	O
had	VBD	O	O
an	DT	B-TREATMENT	B-TREATMENT
intramedullary	JJ	I-TREATMENT	I-TREATMENT
rodding	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
femur	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
open	JJ	B-TREATMENT	B-TREATMENT
reduction	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
internal	JJ	B-TREATMENT	B-TREATMENT
fixation	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	O
the	DT	I-TREATMENT	O
radius	NN	I-TREATMENT	O
and	CC	I-TREATMENT	O
ulna	NN	I-TREATMENT	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
evaluated	VBN	O	O
by	IN	O	O
neurosurgery	NN	O	O
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
head	NN	I-PROBLEM	I-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
showed	VBD	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
contusions	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
frontal	JJ	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
did	VBD	O	O
have	VB	O	O
some	DT	B-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
of	IN	O	O
20.9	CD	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
showed	VBD	O	O
no	DT	O	O
change	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
begun	VBN	O	O
on	IN	O	O
physical	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
but	CC	O	O
remained	VBD	O	O
agitated	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
remained	VBD	O	O
stable	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
seen	VBN	O	O
by	IN	O	O
psychiatry	NN	O	O
due	JJ	O	O
to	TO	O	O
some	DT	B-PROBLEM	B-PROBLEM
delirium	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
question	NN	O	O
of	IN	O	O
suicidal	JJ	B-PROBLEM	B-PROBLEM
ideation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
also	RB	O	O
evaluated	VBN	O	O
by	IN	O	O
the	DT	O	O
neuro-rehabilitation	JJ	O	O
service	NN	O	O
who	WP	O	O
thought	VBD	O	O
that	IN	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
post-head	JJ	I-PROBLEM	I-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
diffuse	NN	B-PROBLEM	B-PROBLEM
cognitive	JJ	I-PROBLEM	I-PROBLEM
deficits	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
some	DT	O	B-PROBLEM
episodes	NNS	O	I-PROBLEM
of	IN	O	I-PROBLEM
agitation	NN	B-PROBLEM	I-PROBLEM
which	WDT	O	O
were	VBD	O	O
treated	VBN	O	O
with	IN	O	O
medication	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
required	VBD	O	O
some	DT	B-TREATMENT	B-TREATMENT
sedation	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
restraint	NN	B-TREATMENT	O
and	CC	O	O
was	VBD	O	O
begun	VBN	O	O
on	IN	O	O
whatever	WDT	O	O
physical	JJ	B-TREATMENT	O
therapy	NN	I-TREATMENT	O
he	PRP	O	O
could	MD	O	O
have	VB	O	O
given	VBN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
head	NN	I-PROBLEM	I-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
episodes	NNS	O	O
of	IN	O	O
confusion	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
removed	VBD	O	O
the	DT	B-TREATMENT	O
cast	NN	I-TREATMENT	O
that	WDT	O	O
had	VBD	O	O
been	VBN	O	O
placed	VBN	O	O
and	CC	O	O
then	RB	O	O
a	DT	B-TREATMENT	O
long-leg	JJ	I-TREATMENT	O
cast	NN	I-TREATMENT	O
was	VBD	O	O
then	RB	O	O
placed	VBN	O	O
so	IN	O	O
it	PRP	O	O
would	MD	O	O
be	VB	O	O
difficult	JJ	O	O
for	IN	O	O
him	PRP	O	O
to	TO	O	O
remove	VB	O	O
or	CC	O	O
to	TO	O	O
ambulate	VB	O	O
on	IN	O	O
his	PRP$	O	O
leg	NN	O	O
,	,	O	O
which	WDT	O	O
might	MD	O	O
jeopardize	VB	O	O
his	PRP$	O	B-TREATMENT
closure	NN	O	I-TREATMENT
.	.	O	O

he	PRP	O	O
does	VBZ	O	O
of	IN	O	O
buspar	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
trazodone	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
haldol	NN	B-TREATMENT	B-TREATMENT
were	VBD	O	O
continued	VBN	O	O
and	CC	O	O
were	VBD	O	O
adjusted	VBN	O	O
by	IN	O	O
psychiatry	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
observation	NN	B-TEST	O
and	CC	O	O
sitters	NNS	O	O
and	CC	O	O
finally	RB	O	O
became	VBD	O	O
more	RBR	O	B-PROBLEM
docile	JJ	O	I-PROBLEM
and	CC	O	O
cooperative	JJ	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
physical	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
with	IN	O	O
his	PRP$	O	O
mother	NN	O	O
present	NN	O	O
,	,	O	O
he	PRP	O	O
began	VBD	O	O
to	TO	O	O
follow	VB	O	O
commands	NNS	O	O
much	RB	O	O
more	RBR	O	O
appropriately	RB	O	O
and	CC	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
be	VB	O	O
rehabilitated	VBN	B-TREATMENT	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
finally	RB	O	O
sent	VBN	O	O
home	NN	O	O
for	IN	O	O
home	NN	B-TREATMENT	B-TREATMENT
rehabilitation	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
2011-02-23	JJ	O	O
.	.	O	O

1.	CD	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
trauma	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
frontal	JJ	I-PROBLEM	I-PROBLEM
head	NN	I-PROBLEM	I-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
open	JJ	B-PROBLEM	B-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
femur	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
radial	JJ	B-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
ulnar	JJ	I-PROBLEM	I-PROBLEM
fractures	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
liver	JJ	B-PROBLEM	B-PROBLEM
laceration	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
open	JJ	B-TREATMENT	B-TREATMENT
reduction	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
internal	JJ	B-TREATMENT	B-TREATMENT
fixation	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
femur	JJ	I-TREATMENT	I-TREATMENT
2011-01-21	JJ	O	O
.	.	O	O

2.	CD	O	O
open	JJ	B-TREATMENT	B-TREATMENT
reduction	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
internal	JJ	B-TREATMENT	B-TREATMENT
fixation	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	O
radius	NN	I-TREATMENT	O
and	CC	I-TREATMENT	O
ulna	JJ	I-TREATMENT	O
2011-01-21	JJ	O	O
.	.	O	O

1.	CD	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
one	CD	O	O
p.o.	NN	O	O
q.	VB	O	O
four	CD	O	O
hours	NNS	O	O
p.r.n.	RB	O	O
pain	VBP	B-PROBLEM	B-PROBLEM
.	.	O	O

2.	CD	O	O
haldol	JJ	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	RB	O	O
four	CD	O	O
to	TO	O	O
six	CD	O	O
hours	NNS	O	O
p.r.n.	JJ	O	O
agitation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

3.	CD	O	O
trazodone	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	VBD	O	O
h.s.	NN	O	O

4.	CD	O	O
droperidol	JJ	B-TREATMENT	B-TREATMENT
1.5	CD	O	O
to	TO	O	O
2.5	CD	O	O
mg	NNS	O	O
p.r.n.	JJ	O	O
agitation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
discharged	VBN	O	O
home	NN	O	O
with	IN	O	O
home	NN	B-TREATMENT	B-TREATMENT
rehabilitation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

pelvic	JJ	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM

pelvic	JJ	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

include	JJ	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
57-year-old	JJ	O	O
female	NN	O	O
status	NN	O	O
post	NN	O	O
ert	NN	B-TREATMENT	O
with	IN	O	O
recurrence	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
pelvic	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
resection	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
an	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
in	IN	O	O
06/22	CD	O	O
.	.	O	O

per	IN	O	O
the	DT	O	O
patient	NN	O	O
,	,	O	O
the	DT	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
benign	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
developed	VBD	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
left	VBN	I-PROBLEM	I-PROBLEM
lower	RBR	I-PROBLEM	I-PROBLEM
quadrant	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
07/24	CD	O	O
.	.	O	O

an	DT	B-TEST	B-TEST
mri	NN	I-TEST	I-TEST
was	VBD	O	O
done	VBN	O	O
on	IN	O	O
08/27/03	CD	O	O
that	WDT	O	O
showed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
8	CD	I-PROBLEM	I-PROBLEM
cm	NN	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
quadrant	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
both	DT	B-PROBLEM	B-PROBLEM
cystic	JJ	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
solid	JJ	I-PROBLEM	O
components	NNS	I-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
lupron	NN	B-TREATMENT	B-TREATMENT
on	IN	O	O
10/18/03	CD	O	O
,	,	O	O
but	CC	O	O
pain	NN	B-PROBLEM	B-PROBLEM
was	VBD	O	O
not	RB	O	O
affected	VBN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
put	VBN	O	O
on	IN	O	O
vicodin	NN	B-TREATMENT	B-TREATMENT
es	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
ultram	JJ	B-TREATMENT	O
with	IN	O	O
minimal	JJ	O	B-PROBLEM
relief	NN	O	I-PROBLEM
.	.	O	O

on	IN	O	O
11/16/03	CD	O	O
,	,	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NNP	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
increased	VBD	O	O
and	CC	O	O
she	PRP	O	O
presented	VBD	O	O
to	TO	O	O
an	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
with	IN	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
an	DT	B-PROBLEM	B-PROBLEM
inability	NN	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
tolerate	VB	I-PROBLEM	I-PROBLEM
p.o.	NNS	I-PROBLEM	I-PROBLEM
intake	VB	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
lower	RBR	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
groin	NN	I-PROBLEM	I-PROBLEM
radiated	VBD	O	I-PROBLEM
to	TO	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	JJ	O	I-PROBLEM
knee	NN	O	I-PROBLEM
.	.	O	O

no	DT	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
vaginal	JJ	B-PROBLEM	B-PROBLEM
discharge	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
bleeding	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

potassium	NN	B-TEST	B-TEST
at	IN	O	O
the	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
was	VBD	O	O
3.1	CD	O	O
.	.	O	O

white	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
27.3	CD	O	O
with	IN	O	O
16%	CD	B-TEST	O
bands	NNS	I-TEST	B-TEST
.	.	O	O

hematocrit	NN	B-TEST	B-TEST
was	VBD	O	O
28.7	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
nvh	VB	O	O
after	IN	O	O
receiving	VBG	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
fluid	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
demerol	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
pain	NN	B-TREATMENT	B-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
clindamycin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
valium	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
droperidol	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

hypothyroidism	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
arthritis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
anemia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
asthma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

a	DT	B-TREATMENT	O
tah-bso	NN	I-TREATMENT	O
in	IN	O	O
1980	CD	O	O
and	CC	O	O
an	DT	B-TEST	B-TEST
exploratory	JJ	I-TEST	I-TEST
laparotomy	NN	I-TEST	I-TEST
with	IN	O	O
resection	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
pelvic	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
06/22	CD	O	O
.	.	O	O

1.	CD	O	O
vicodin	JJ	B-TREATMENT	B-TREATMENT
75/750	CD	O	O
p.r.n.	NN	O	O

2.	CD	O	O
ultram	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

3.	CD	O	O
verapamil	JJ	B-TREATMENT	B-TREATMENT
240	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O

4.	CD	O	O
synthroid	JJ	B-TREATMENT	B-TREATMENT
100	CD	O	O
mcg	NN	O	O
q.d.	NN	O	O

5.	CD	O	O
hctz	JJ	B-TREATMENT	O
25	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

6.	CD	O	O
arthrotec	JJ	B-TREATMENT	O
0.2	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O

7.	CD	O	O
advair	NN	B-TREATMENT	B-TREATMENT
250/50	CD	O	O
mcg	NN	O	O
one	CD	O	O
puff	NN	O	O
q.a.m.	NN	O	O

8.	CD	O	O
tofranil	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

9.	CD	O	O
ambien	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NNS	O	O
q.h.s.	NN	O	O

10.	CD	O	O
trazadone	NN	B-TREATMENT	B-TREATMENT
150	CD	O	O
mg	NN	O	O
q.h.s.	NN	O	O

11.	CD	O	O
ferrous	JJ	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
325	CD	O	O
mg	NN	O	O
t.i.d.	NN	O	O

12.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

her	PRP$	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
are	VBP	O	O
penicillin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
which	WDT	O	O
cause	VBP	O	O
throat	NN	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
nvh	VB	O	O
and	CC	O	O
started	VBN	O	O
on	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

cultures	NNS	B-TEST	B-TEST
were	VBD	O	O
taken	VBN	O	O
.	.	O	O

blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
were	VBD	O	O
done	VBN	O	O
for	IN	O	O
a	DT	O	O
possible	JJ	O	O
rectosigmoid	JJ	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
fistula	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
a	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
showed	VBD	I-TEST	O
questionable	JJ	O	O
abscess	JJ	B-PROBLEM	B-PROBLEM
versus	NN	O	I-PROBLEM
tumor	NN	B-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
lower	RBR	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
done	VBN	O	O
on	IN	O	O
11/17/03	CD	O	O
grew	VBD	O	O
c.	NN	B-PROBLEM	O
perfringens	NNS	I-PROBLEM	O
.	.	O	O

other	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
culture	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

on	IN	O	O
11/20/03	CD	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
pe	NN	I-TEST	I-TEST
protocol	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
for	IN	O	O
both	DT	O	O
dvt	NN	B-PROBLEM	O
and	CC	O	O
pe	NN	B-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
for	IN	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
resection	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
pelvic	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
lysis	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
adhesions	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
left	VBD	B-TREATMENT	B-PROBLEM
ureterolysis	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
rectosigmoid	JJ	B-TREATMENT	B-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
sbr	NN	B-TREATMENT	O
,	,	O	O
removal	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
vaginal	JJ	I-PROBLEM	I-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
omentectomy	RB	B-TREATMENT	B-TREATMENT
complicated	VBN	O	O
by	IN	O	O
an	DT	B-PROBLEM	B-TREATMENT
enterotomy	NN	I-PROBLEM	I-TREATMENT
and	CC	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
icu	NN	O	O
postoperatively	RB	O	O
on	IN	O	O
11/21/03	CD	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TEST
pcea	NN	I-TREATMENT	I-TEST
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
then	RB	O	O
a	DT	B-TREATMENT	O
dilaudid	NN	I-TREATMENT	O
pca	NN	I-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
anxious	JJ	B-PROBLEM	O
with	IN	O	O
depression	NN	B-PROBLEM	B-PROBLEM
poorly	RB	I-PROBLEM	O
controlled	VBN	I-PROBLEM	O
until	IN	O	O
12/14/03	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
seen	VBN	O	O
by	IN	O	O
onc	JJ	O	B-TREATMENT
psychiatry	NN	O	I-TREATMENT
consult	NN	O	O
,	,	O	O
who	WP	O	O
recommended	VBD	O	O
imipramine	NN	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
;	:	O	O
that	WDT	O	O
was	VBD	O	O
subsequently	RB	O	O
increased	VBN	O	O
to	TO	O	O
150	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
q.h.s.	NN	O	O
,	,	O	O
trazadone	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
q.h.s.	NN	O	O
and	CC	O	O
ambien	$	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
q.h.s.	NN	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
baseline	VBN	B-PROBLEM	O
hypertension	NN	I-PROBLEM	B-PROBLEM
that	WDT	O	O
was	VBD	O	O
difficult	JJ	O	O
to	TO	O	O
control	VB	O	O
.	.	O	O

in	IN	O	O
the	DT	O	O
icu	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
on	IN	O	O
enalapril	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
hydralazine	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
labetalol	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

after	IN	O	O
a	DT	O	O
cardiology	NN	O	O
consulton	NN	O	O
12/13/03	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
metoprolol	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.i.d.	NN	O	O
,	,	O	O
lisinopril	VBZ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
q.d.	NN	O	O
,	,	O	O
hydrochlorothiazide	RB	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
q.d.	NN	O	O
.	.	O	O

hydralazine	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
stopped	VBN	O	O
.	.	O	O

blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
stayed	VBD	O	O
high	JJ	B-PROBLEM	O
with	IN	O	O
an	DT	B-TEST	O
sbp	NN	I-TEST	O
in	IN	O	O
the	DT	O	O
170s	CD	O	O
,	,	O	O
so	RB	O	O
amlodipine	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
q.d.	NN	O	O
was	VBD	O	O
added	VBN	O	O
and	CC	O	O
that	IN	B-TEST	O
blood	NN	I-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
still	RB	B-PROBLEM	B-PROBLEM
elevated	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
transfer	NN	O	O
to	TO	O	O
the	DT	O	O
________	NNP	O	O
onc	MD	O	O
service	VB	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
within	IN	O	O
the	DT	O	O
normal	JJ	O	O
range	NN	O	O
.	.	O	O

once	RB	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
extubated	VBN	O	O
,	,	O	O
after	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
third	JJ	I-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
the	DT	O	O
patient	NN	O	O
could	MD	O	O
not	RB	O	O
be	VB	O	O
weaned	VBN	O	O
off	RP	O	O
2	CD	B-TREATMENT	O
liters	NNS	I-TREATMENT	O
of	IN	I-TREATMENT	O
nasal	JJ	I-TREATMENT	B-TREATMENT
cannula	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
was	VBD	O	O
to	TO	O	O
______	VB	O	O
to	TO	O	O
20	CD	O	O
breaths	NNS	O	O
per	IN	O	O
minute	NN	O	O
despite	IN	O	O
nebulizer	JJ	B-TREATMENT	B-TREATMENT
treatment	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
restarted	VBN	O	O
on	IN	O	O
advair	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
by	IN	O	O
12/15/03	CD	O	O
,	,	O	O
was	VBD	O	O
weaned	VBN	O	O
to	TO	O	O
room	NN	O	O
air	NN	O	O
likely	RB	O	O
an	DT	O	B-PROBLEM
effective	JJ	O	I-PROBLEM
advair	NN	B-TREATMENT	I-PROBLEM
and	CC	O	O
control	NN	O	O
of	IN	O	O
anxiety	NN	B-PROBLEM	B-PROBLEM
and	CC	O	I-PROBLEM
psychiatric	JJ	B-PROBLEM	I-PROBLEM
issues	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
4	CD	O	O
,	,	O	O
after	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
initial	JJ	I-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
increased	VBN	B-PROBLEM	B-PROBLEM
shortness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
tachycardia	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
chest	JJ	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
revealed	VBD	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
free	JJ	I-PROBLEM	I-PROBLEM
air	NN	I-PROBLEM	I-PROBLEM
under	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
diaphragm	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	O	O
large	JJ	O	O
amount	NN	O	O
of	IN	O	O
free	JJ	B-PROBLEM	B-PROBLEM
air	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
or	CC	O	O
on	IN	O	O
postop	JJ	O	O
day	NN	O	O
5	CD	O	O
for	IN	O	O
emergent	JJ	B-TEST	O
exploratory	NN	I-TEST	B-TEST
laparotomy	NN	I-TEST	I-TEST
that	WDT	O	O
disclosed	VBD	O	O
a	DT	B-PROBLEM	B-TREATMENT
small	JJ	I-PROBLEM	I-TREATMENT
bowel	NN	I-PROBLEM	I-TREATMENT
enterotomy	NN	I-PROBLEM	I-TREATMENT
with	IN	O	O
2	CD	O	O
liters	NNS	O	O
of	IN	O	O
bilious	JJ	B-PROBLEM	B-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
within	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
peritoneum	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
postop	JJ	O	O
day	NN	O	O
9	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
similar	JJ	I-PROBLEM	I-PROBLEM
increased	VBN	I-PROBLEM	I-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
episode	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
taken	VBN	O	O
back	RB	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
for	IN	O	O
another	DT	B-TEST	O
emergent	JJ	I-TEST	O
exploratory	NN	I-TEST	B-TEST
laparotomy	NN	I-TEST	I-TEST
revealing	VBG	O	O
another	DT	B-PROBLEM	O
peroration	NN	I-PROBLEM	O
at	IN	O	O
the	DT	B-PROBLEM	O
site	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
previous	JJ	I-PROBLEM	B-TREATMENT
repair	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

intraoperatively	RB	B-TREATMENT	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
suffered	VBD	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
induction	NN	O	B-TREATMENT
and	CC	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
icu	NN	O	O
intubated	VBN	B-TREATMENT	O
with	IN	O	O
stable	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
kept	VBN	O	O
npo	RB	B-TREATMENT	O
with	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
ng	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
until	IN	O	O
postop	JJ	O	O
day	NN	O	O
14	CD	O	O
and_____	NN	O	O
started	VBD	O	O
on	IN	O	O
clear	JJ	B-TREATMENT	B-TREATMENT
sips	NNS	I-TREATMENT	I-TREATMENT
with	IN	O	O
tpn	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
nutritional	JJ	B-TREATMENT	B-TREATMENT
supplementation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
intermittently	RB	O	O
tolerated	VBD	O	O
diet	JJ	B-TREATMENT	O
advancement	NN	I-TREATMENT	O
,	,	O	O
but	CC	O	O
then	RB	O	O
would	MD	O	O
vomit	VB	O	O
and	CC	O	O
would	MD	O	O
have	VB	O	O
the	DT	B-TREATMENT	B-TREATMENT
ng	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
replaced	VBD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
,	,	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
transfer	NN	O	O
,	,	O	O
was	VBD	O	O
tolerating	VBG	O	O
clears	NNS	B-TREATMENT	O
with	IN	O	O
low	JJ	B-PROBLEM	B-PROBLEM
stoma	NN	I-PROBLEM	I-PROBLEM
output	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
likely	RB	O	O
to	TO	O	O
tolerate	VB	O	O
slow	JJ	O	B-PROBLEM
advancement	NN	O	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
still	RB	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
picc	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
the	DT	O	O
time	NN	O	O
,	,	O	O
although	IN	O	O
tpn	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
being	VBG	O	O
held	VBN	O	O
and	CC	O	O
calorie	JJ	B-TREATMENT	B-TEST
counts	NNS	I-TREATMENT	I-TEST
were	VBD	O	O
done	VBN	O	O
to	TO	O	O
evaluate	VB	O	O
the	DT	O	O
benefit	NN	O	O
of	IN	O	O
p.o.	JJ	O	O
nutrition	NN	O	O
.	.	O	O

presumably	RB	O	O
,	,	O	O
should	MD	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
the	DT	O	O
urology	NN	O	O
clinic	NN	O	O
for	IN	O	O
removal	NN	B-TREATMENT	B-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
ureteral	JJ	I-TREATMENT	I-TREATMENT
stents	NNS	I-TREATMENT	I-TREATMENT
at	IN	O	O
some	DT	O	O
point	NN	O	O
.	.	O	O

6.	CD	O	O
infectious	JJ	B-PROBLEM	O
disease	NN	I-PROBLEM	O
:	:	O	O

blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
mentioned	VBD	O	O
previously	RB	O	O
were	VBD	O	O
positive	JJ	O	O
for	IN	O	O
c.	NN	B-PROBLEM	O
perfringens	NNS	I-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
empiricvancomycin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
after	IN	O	O
the	DT	B-TEST	O
second	JJ	I-TEST	O
exploratory	JJ	I-TEST	B-TEST
laparotomy	NN	I-TEST	I-TEST
.	.	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
doxycycline	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
fluconazole	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
drawn	VBP	O	O
on	IN	O	O
12/01/03	CD	O	O
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

jp	NN	B-TREATMENT	B-TREATMENT
drain	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
cultured	VBN	B-TEST	O
on	IN	O	O
12/11/03	CD	O	O
along	IN	O	O
with	IN	O	O
aurine	JJ	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
.	.	O	O

tlc	NN	B-TEST	O
,	,	O	O
tib	NN	B-TEST	B-PROBLEM
and	CC	O	O
blood	NN	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
were	VBD	O	O
all	DT	O	O
negative	JJ	O	O
.	.	O	O

these	DT	O	O
were	VBD	O	O
cultured	VBN	O	O
because	IN	O	O
the	DT	B-TEST	O
patient	NN	I-TEST	O
&apos;s	NNP	I-TEST	O
white	JJ	I-TEST	B-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
increasing	VBG	O	O
to	TO	O	O
the	DT	O	O
mid	NN	O	O
20s	CD	O	O
without	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
other	JJ	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
for	IN	O	O
explanation	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
,	,	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
transfer	NN	O	O
,	,	O	O
to	TO	O	O
the	DT	O	O
gyn	NN	O	O
/	NNP	O	O
onc	NN	O	O
service	NN	O	O
was	VBD	O	O
not	RB	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
the	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
trending	VBG	O	O
down	RP	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
receiving	VBG	O	O
sub	JJ	B-TREATMENT	O
.q.	NNP	I-TREATMENT	O
heparin	NN	I-TREATMENT	B-TREATMENT
for	IN	O	O
dvt	NN	B-TREATMENT	B-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
postoperatively	RB	O	O
.	.	O	O

on	IN	O	O
postop	JJ	O	O
day	NN	O	O
6	CD	O	O
,	,	O	O
an	DT	O	B-TEST
id	NN	O	I-TEST
consult	NN	O	I-TEST
noted	VBD	O	O
erythema	NN	B-PROBLEM	B-PROBLEM
at	IN	O	I-PROBLEM
the	DT	B-TREATMENT	I-PROBLEM
right	JJ	I-TREATMENT	I-PROBLEM
ij	NN	I-TREATMENT	I-PROBLEM
line	NN	I-TREATMENT	I-PROBLEM
site	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

on	IN	O	O
postop	JJ	O	O
day	NN	O	O
8	CD	O	O
,	,	O	O
the	DT	B-TREATMENT	O
right	JJ	I-TREATMENT	O
ij	NN	I-TREATMENT	O
line	NN	I-TREATMENT	O
was	VBD	O	O
pulled	VBN	O	O
.	.	O	O

the	DT	O	O
tip	NN	O	O
was	VBD	O	O
cultured	VBN	O	O
with	IN	O	O
no	DT	O	O
growth	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
postop	JJ	O	O
day	NN	O	O
9	CD	O	O
,	,	O	O
bilateral	JJ	B-TEST	B-TEST
upper	JJ	I-TEST	I-TEST
extremity	NN	I-TEST	I-TEST
dopplers	NNS	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
ij	NN	I-PROBLEM	I-PROBLEM
clot	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
transitioned	VBD	O	O
to	TO	O	O
lovenox	VB	B-TREATMENT	B-TREATMENT
on	IN	O	O
12/09/03	CD	O	O
after	IN	O	O
a	DT	O	O
cardiology	NN	O	O
consult	NN	O	O
indicated	VBD	O	O
increased	VBD	O	B-PROBLEM
survival	NN	O	I-PROBLEM
with	IN	O	O
lovenox	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
on	IN	O	O
home	NN	B-TREATMENT	B-TREATMENT
synthroid	NN	I-TREATMENT	I-TREATMENT
dose	NN	I-TREATMENT	I-TREATMENT
during	IN	O	O
her	PRP$	O	O
hospitalization	NN	O	O
,	,	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
q.6h.	JJ	O	B-PROBLEM
fingersticks	NNS	B-TEST	I-PROBLEM
while	IN	O	O
she	PRP	O	O
was	VBD	O	O
on	IN	O	O
tpn	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
104	CD	O	O
year	NN	O	O
old	JJ	O	O
female	JJ	O	O
patient	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
obstructive	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
cerebrovascular	JJ	B-PROBLEM	O
accident	NN	I-PROBLEM	O
who	WP	O	O
presents	VBZ	O	O
with	IN	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
cough	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
states	VBZ	O	O
that	IN	O	O
she	PRP	O	O
has	VBZ	O	O
no	DT	O	O
idea	NN	O	B-PROBLEM
why	WRB	O	O
she	PRP	O	O
was	VBD	O	O
brought	VBN	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
department	NN	O	O
and	CC	O	O
denies	VBZ	O	O
any	DT	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
reports	VBZ	O	O
an	DT	B-PROBLEM	B-PROBLEM
occasional	JJ	I-PROBLEM	I-PROBLEM
nonproductive	JJ	I-PROBLEM	I-PROBLEM
cough	NN	I-PROBLEM	I-PROBLEM
that	IN	O	O
she	PRP	O	O
has	VBZ	O	O
had	VBN	O	O
"for	VBN	O	O
years"	NNS	O	O
and	CC	O	O
feels	NNS	O	O
that	IN	O	O
she	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
experiencing	VBG	O	O
alternating	VBG	B-PROBLEM	O
chills	NNS	I-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	O
feeling	VBG	I-PROBLEM	O
hot	JJ	I-PROBLEM	O
.	.	O	O

a	DT	O	O
progress	NN	O	O
note	NN	O	O
in	IN	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
chart	NN	O	O
from	IN	O	O
her	PRP$	O	O
assisted	JJ	O	O
living	NN	O	O
facility	NN	O	O
indicates	VBZ	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
had	VBN	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
cough	NN	B-PROBLEM	B-PROBLEM
for	IN	O	O
one	CD	O	O
day	NN	O	O
with	IN	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
but	CC	O	O
no	DT	O	O
fever	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
recently	RB	O	O
evaluated	VBN	O	O
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
for	IN	O	O
bradycardia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
seen	VBN	O	O
by	IN	O	O
her	PRP$	O	O
cardiologist	NN	O	O
,	,	O	O
dr.	JJ	O	O
clements	NNS	O	O
and	CC	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
holter	NN	I-TEST	I-TEST
monitor	NN	I-TEST	I-TEST
on	IN	O	O
2015-05-01	JJ	O	O
,	,	O	O
that	WDT	O	O
showed	VBD	O	O
first	JJ	B-PROBLEM	B-PROBLEM
degree	NN	I-PROBLEM	I-PROBLEM
av	NN	I-PROBLEM	I-PROBLEM
block	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
that	WDT	O	O
ranged	VBD	O	O
between	IN	O	O
35	CD	O	O
to	TO	O	O
53	CD	O	O
beats	NNS	O	O
per	IN	O	O
minute	NN	O	O
.	.	O	O

in	IN	O	O
the	DT	O	O
emergency	NN	O	O
department	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
given	VBN	O	O
nebulizer	JJ	B-TREATMENT	B-TREATMENT
treatment	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
started	VBD	O	O
on	IN	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
for	IN	O	O
presumed	JJ	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
obstructive	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
exacerbation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
lateral	JJ	B-PROBLEM	B-PROBLEM
st	NN	I-PROBLEM	I-PROBLEM
depressions	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
given	VBN	O	O
aspirin	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
continues	VBZ	O	O
to	TO	O	O
deny	VB	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
palpitations	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
bright	JJ	B-PROBLEM	B-PROBLEM
red	JJ	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
per	IN	I-PROBLEM	I-PROBLEM
rectum	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
melena	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
dysuria	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
urinary	JJ	B-PROBLEM	B-PROBLEM
frequency	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
urgency	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

chronic	JJ	B-PROBLEM	B-PROBLEM
obstructive	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
asthmatic	JJ	B-PROBLEM	B-PROBLEM
component	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

hypothyroidism	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

gastroenteritis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

anxiety	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

insomnia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

osteoporosis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

history	NN	O	O
of	IN	O	O
cerebrovascular	JJ	B-PROBLEM	B-PROBLEM
accident	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
residual	JJ	B-PROBLEM	B-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
sided	VBD	I-PROBLEM	I-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

scoliosis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

history	NN	O	O
of	IN	O	O
kidney	NN	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

history	NN	O	O
of	IN	O	O
lower	JJR	B-PROBLEM	B-PROBLEM
gastrointestinal	JJ	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

status	NN	O	O
post	NN	O	O
total	JJ	B-TREATMENT	B-TREATMENT
abdominal	JJ	I-TREATMENT	I-TREATMENT
hysterectomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
salpingo-	JJ	I-TREATMENT	I-TREATMENT
oophorectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

left	VBN	B-PROBLEM	B-PROBLEM
cataract	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

bradycardia	NN	B-PROBLEM	B-PROBLEM
followed	VBN	O	O
by	IN	O	O
outpatient	JJ	O	O
cardiologist	NN	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
holter	NN	I-TEST	I-TEST
monitor	NN	I-TEST	I-TEST
on	IN	O	O
2015-05-01	JJ	O	O
,	,	O	O
with	IN	O	O
first	JJ	B-PROBLEM	B-PROBLEM
degree	NN	I-PROBLEM	I-PROBLEM
av	NN	I-PROBLEM	I-PROBLEM
block	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
ranging	VBG	O	O
between	IN	O	O
35	CD	O	O
to	TO	O	O
53	CD	O	O
beats	NNS	O	O
per	IN	O	O
minute	NN	O	O
.	.	O	O

penicillin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
erythromycin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
valium	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
compazine	NN	B-TREATMENT	O
,	,	O	O

demerol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
percodan	NN	B-TREATMENT	O
.	.	O	O

1.	CD	O	O
levothyroxine	JJ	B-TREATMENT	B-TREATMENT
50	CD	O	O
mcg	NN	O	O
p.o.	NN	O	O
once	RB	O	O
daily	RB	O	O
.	.	O	O

2.	CD	O	O
combivent	JJ	B-TREATMENT	B-TREATMENT
two	CD	O	O
puffs	NNS	O	O
four	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

3.	CD	O	O
flovent	JJ	B-TREATMENT	B-TREATMENT
two	CD	O	O
puffs	NNS	O	O
four	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

4.	CD	O	O
protonix	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
once	RB	O	O
daily	RB	O	O
.	.	O	O

5.	CD	O	O
lisinopril	JJ	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
once	RB	O	O
daily	RB	O	O
.	.	O	O

6.	CD	O	O
norvasc	JJ	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

7.	CD	O	O
lasix	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
once	RB	O	O
daily	RB	O	O
.	.	O	O

8.	CD	O	O
senna	JJ	B-TREATMENT	B-TREATMENT
one	CD	O	O
once	RB	O	O
daily	JJ	O	O
.	.	O	O

9.	CD	O	O
dulcolax	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
once	RB	O	O
daily	JJ	O	O
p.r.n.	NN	O	O

tums	NNS	B-TREATMENT	B-TEST
500	CD	O	O
mg	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

temperature	NN	B-TEST	B-TEST
98.1	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST

144/38	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
41	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
20	CD	O	O
,	,	O	O
oxygen	NN	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST

in	IN	O	O
general	JJ	O	O
,	,	O	O
a	DT	O	O
well	RB	O	O
appearing	VBG	O	O
elderly	JJ	O	O
female	NN	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

skin	NN	O	O
is	VBZ	O	O
warm	JJ	O	O
and	CC	O	O
dry	JJ	O	O
with	IN	O	O
decreased	JJ	B-PROBLEM	B-PROBLEM
skin	NN	I-PROBLEM	I-PROBLEM
turgor	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

head	NN	B-TEST	B-TEST
,	,	I-TEST	I-TEST
eyes	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
ears	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
nose	RB	I-TEST	I-TEST
and	CC	I-TEST	I-TEST
throat	VB	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
-	:	O	O
the	DT	O	O
pupils	NNS	O	O
are	VBP	O	O
equal	JJ	O	O
,	,	O	O
round	NN	O	O
and	CC	O	O
reactive	JJ	O	O
to	TO	O	O
light	JJ	O	O
and	CC	O	O
accommodation	NN	O	O
.	.	O	O

dry	JJ	B-PROBLEM	B-PROBLEM
mucous	JJ	I-PROBLEM	I-PROBLEM
membranes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

neck	NN	O	O
is	VBZ	O	O
supple	JJ	O	O
,	,	O	O
full	JJ	O	O
range	NN	O	O
of	IN	O	O
motion	NN	O	O
,	,	O	O
no	DT	O	O
jugular	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
distension	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
heart	NN	O	O
was	VBD	O	O
bradycardic	JJ	B-PROBLEM	O
with	IN	O	O
regular	JJ	O	O
rhythm	NN	O	O
,	,	O	O
no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
rubs	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
gallops	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

lungs	NNS	O	O
-	:	O	O
diffuse	NN	B-PROBLEM	B-PROBLEM
expiratory	NN	I-PROBLEM	I-PROBLEM
wheezes	VBZ	I-PROBLEM	I-PROBLEM
with	IN	O	O
bibasilar	JJ	B-PROBLEM	B-PROBLEM
rales	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
left	VBD	O	O
over	RP	O	O
right	JJ	O	O
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
revealed	VBD	O	O
normoactive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
,	,	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

rectal	NN	O	O
is	VBZ	O	O
guaiac	JJ	B-PROBLEM	O
positive	JJ	I-PROBLEM	O
per	IN	O	O
emergency	NN	O	O
department	NN	O	O
.	.	O	O

extremities	NNS	O	O
-	:	O	O
no	DT	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
clubbing	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
one	CD	B-PROBLEM	O
plus	CC	I-PROBLEM	O
bilateral	JJ	I-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
right	JJ	O	O
worse	JJR	O	O
than	IN	O	O
left	JJR	O	O
.	.	O	O

white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
8.5	CD	O	O
(	(	O	O
80	CD	O	O
percent	NN	O	O
neutrophils	NNS	B-TEST	O
,	,	O	O
13	CD	O	O
percent	NN	O	O
lymphocytes	NNS	B-TEST	B-TEST
)	)	O	O
,	,	O	O
hematocrit	$	B-TEST	B-TEST
27.4	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
277,000	CD	O	O
.	.	O	O

sodium	NN	B-TEST	B-TEST
133	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.8	CD	O	O
,	,	O	O
chloride	NN	B-TEST	B-TEST

94	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
24	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
urea	JJ	I-TEST	I-TEST
nitrogen	NN	I-TEST	I-TEST
39	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
2.0	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
111	CD	O	O
.	.	O	O

ck	NN	B-TEST	B-TEST
152	CD	O	O
,	,	O	O
ck	NN	B-TEST	B-TEST
mb	NN	I-TEST	I-TEST
3.0	CD	O	O
,	,	O	O
troponin	NN	B-TEST	B-TEST
0.04.	CD	O	O

inr	NN	B-TEST	B-TEST
1.1.	CD	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
showed	VBD	O	O
equivocal	JJ	B-PROBLEM	B-PROBLEM
retrocardiac	NN	I-PROBLEM	I-PROBLEM
opacity	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

electrocardiogram	NN	B-TEST	B-TEST
showed	VBD	O	O
sinus	JJ	B-PROBLEM	B-PROBLEM
bradycardia	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
40	CD	O	O
beats	NNS	O	O
per	IN	O	O
minute	NN	O	O
.	.	O	O

first	RB	B-PROBLEM	B-PROBLEM
degree	JJ	I-PROBLEM	I-PROBLEM
av	NN	I-PROBLEM	I-PROBLEM
block	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
pr	NN	B-TEST	O
interval	NN	I-TEST	O
220	CD	O	O
,	,	O	O
left	VBD	B-PROBLEM	B-PROBLEM
axis	JJ	I-PROBLEM	I-PROBLEM
deviation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
right	JJ	B-PROBLEM	B-PROBLEM
bundle	NN	I-PROBLEM	I-PROBLEM
branch	NN	I-PROBLEM	I-PROBLEM
block	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
fascicular	JJ	I-PROBLEM	I-PROBLEM
block	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
0.1103	CD	O	O
n.	JJ	O	O
fifth	JJ	O	O
cir.	NN	O	O
depressions	NNS	O	O
in	IN	O	O

shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
-	:	O	O
though	IN	O	O
the	DT	O	O
patient	NN	O	O
denied	VBD	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
admission	NN	O	O
,	,	O	O
a	DT	O	O
progress	NN	O	O
note	NN	O	O
from	IN	O	O

norwood	NN	O	O
nursing	NN	O	O
facility	NN	O	O
suggested	VBD	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
been	VBN	O	O
having	VBG	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
cough	NN	B-PROBLEM	B-PROBLEM
for	IN	O	O
approximately	RB	O	O
one	CD	O	O
day	NN	O	O
with	IN	O	O
difficulty	NN	B-PROBLEM	B-PROBLEM
ambulating	VBG	I-PROBLEM	I-PROBLEM
,	,	O	O
needing	VBG	O	O
to	TO	O	O
travel	VB	O	O
in	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
wheelchair	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
on	IN	O	O
admission	NN	O	O
with	IN	O	O
a	DT	O	O
normal	JJ	O	O
white	JJ	O	B-TEST
blood	NN	O	I-TEST
cell	NN	O	I-TEST
count	NN	O	I-TEST
but	CC	O	O
had	VBD	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
wheezing	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
rales	NNS	B-PROBLEM	B-PROBLEM
on	IN	O	O
physical	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
with	IN	O	O
a	DT	O	O
possible	JJ	O	O
left	NN	B-PROBLEM	B-PROBLEM
lower	RBR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
opacity	NN	I-PROBLEM	I-PROBLEM
seen	VBN	O	O
on	IN	O	O
chest	JJ	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
.	.	O	O

the	DT	O	O
etiology	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
shortness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
considered	VBN	O	O
a	DT	O	O
likely	JJ	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
obstructive	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
exacerbation	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	I-TREATMENT
atrovent	JJ	B-TREATMENT	I-TREATMENT
nebulizers	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
also	RB	O	O
started	VBN	O	O
on	IN	O	O
doxycycline	NN	B-TREATMENT	B-TREATMENT
given	VBN	O	O
the	DT	O	O
concern	NN	O	O
for	IN	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
chest	JJ	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
.	.	O	O

she	PRP	O	O
was	VBD	O	O
also	RB	O	O
continued	VBN	O	O
on	IN	O	O
steroids	NNS	B-TREATMENT	B-TREATMENT
given	VBN	O	O
evidence	NN	O	O
of	IN	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
airway	JJ	I-PROBLEM	I-PROBLEM
obstruction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
shortness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
also	RB	O	O
considered	VBN	O	O
possibly	RB	O	O
related	VBN	O	O
to	TO	O	O
a	DT	B-PROBLEM	B-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
event	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
rule	NN	O	O
out	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
enzymes	NNS	I-TEST	I-TEST
were	VBD	O	O
cycled	VBN	O	O
and	CC	O	O
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
electrocardiogram	NN	I-TEST	I-TEST
performed	VBN	O	O
on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
number	NN	O	O
two	CD	O	O
was	VBD	O	O
concerning	VBG	O	O
for	IN	O	O
2:1	CD	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
block	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
the	DT	O	O
cardiology	NN	O	O
consult	NN	O	O
service	NN	O	O
was	VBD	O	O
contacted	VBN	O	O
for	IN	O	O
evaluation	NN	B-TEST	B-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
coronary	JJ	O	O
care	NN	O	O
unit	NN	O	O
late	RB	O	O
on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
number	NN	O	O
two	CD	O	O
and	CC	O	O
received	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
temporary	JJ	I-TREATMENT	I-TREATMENT
wire	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
following	JJ	O	O
day	NN	O	O
the	DT	O	O
patient	NN	O	O
received	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
permanent	JJ	I-TREATMENT	I-TREATMENT
dual	JJ	I-TREATMENT	I-TREATMENT
chamber	NN	I-TREATMENT	I-TREATMENT
rate	NN	I-TREATMENT	I-TREATMENT
responsive	JJ	I-TREATMENT	I-TREATMENT
pacemaker	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
back	RB	O	O
to	TO	O	O
the	DT	O	O
general	JJ	O	O
medicine	NN	O	O
service	NN	O	O
where	WRB	O	O
she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
exhibit	VB	O	O
signs	NNS	O	O
of	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
obstructive	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
exacerbation	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
nebulizers	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
steroids	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
were	VBD	O	O
continued	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
's	POS	O	O
respiratory	NN	O	O
status	NN	O	O
improved	VBN	O	O
throughout	IN	O	O
the	DT	O	O
remainder	NN	O	O
of	IN	O	O
her	PRP$	O	B-TREATMENT
hospitalization	NN	O	I-TREATMENT
and	CC	O	O
oxygen	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
eventually	RB	O	O
weaned	VBN	O	O
.	.	O	O

once	RB	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
out	IN	O	O
of	IN	O	O
the	DT	O	O
coronary	JJ	O	O
care	NN	O	O
unit	NN	O	O
,	,	O	O
she	PRP	O	O
appeared	VBD	O	O
to	TO	O	O
have	VB	O	O
an	DT	B-PROBLEM	B-PROBLEM
element	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
addition	NN	O	O
to	TO	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
chronic	JJ	I-PROBLEM	I-PROBLEM
obstructive	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
given	VBN	O	O
20	CD	O	O
mg	NN	O	O
of	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
lasix	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
impressive	JJ	O	B-PROBLEM
urine	JJ	O	I-PROBLEM
output	NN	O	I-PROBLEM
and	CC	O	O
improvement	NN	O	O
in	IN	O	O
her	PRP$	B-TEST	O
overall	JJ	I-TEST	O
fluid	NN	I-TEST	O
status	NN	I-TEST	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
eventually	RB	O	O
restarted	VBN	O	O
on	IN	O	O
her	PRP$	O	O
outpatient	NN	O	O
dose	NN	O	O
of	IN	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
once	IN	O	O
her	PRP$	B-TEST	O
renal	JJ	I-TEST	O
function	NN	I-TEST	O
improved	VBD	O	O
to	TO	O	O
baseline	VB	O	O
and	CC	O	O
remained	VBD	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
throughout	IN	O	O
the	DT	O	O
remainder	NN	O	O
of	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
hospitalization	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

heart	NN	B-PROBLEM	B-PROBLEM
block	NN	I-PROBLEM	I-PROBLEM
-	:	O	O
as	IN	O	O
noted	VBN	O	O
previously	RB	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
electrocardiogram	NN	I-TEST	I-TEST
was	VBD	O	O
significant	JJ	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
2:1	CD	I-PROBLEM	I-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
block	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
cardiology	NN	O	O
consult	NN	O	O
service	NN	O	O
was	VBD	O	O
contacted	VBN	O	O
for	IN	O	O
evaluation	NN	B-TEST	B-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
received	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
temporary	JJ	I-TREATMENT	I-TREATMENT
pacing	NN	I-TREATMENT	I-TREATMENT
wire	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
the	DT	O	O
evening	NN	O	O
of	IN	O	O
hospital	JJ	O	O
day	NN	O	O
number	NN	O	O
two	CD	O	O
and	CC	O	O
on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
number	NN	O	O
three	CD	O	O
received	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
dual	JJ	I-TREATMENT	I-TREATMENT
chamber	NN	I-TREATMENT	I-TREATMENT
pacemaker	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

renal	JJ	O	B-TEST
-	:	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
of	IN	O	O
1.8	CD	O	O
,	,	O	O
considered	VBN	O	O
likely	RB	O	O
secondary	JJ	O	O
to	TO	O	O
hypovolemia	VB	B-PROBLEM	B-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
calculated	JJ	I-TEST	I-TEST
fractional	JJ	I-TEST	I-TEST
excretion	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
sodium	NN	I-TEST	I-TEST
was	VBD	O	O
0.13	CD	O	O
percent	NN	O	O
suggesting	VBG	O	O
a	DT	B-PROBLEM	B-PROBLEM
prerenal	JJ	I-PROBLEM	I-PROBLEM
cause	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
creatinine	NN	I-TEST	I-TEST
improved	VBD	O	O
to	TO	O	O
1.1	CD	O	O
with	IN	O	O
hydration	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

once	RB	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
creatinine	NN	I-TEST	I-TEST
had	VBD	O	O
improved	VBN	O	O
to	TO	O	O
baseline	VB	O	O
,	,	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
lasix	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
ace	NN	B-TREATMENT	B-TREATMENT
inhibitor	NN	I-TREATMENT	I-TREATMENT
were	VBD	O	O
restarted	VBN	O	O
and	CC	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
creatinine	NN	I-TEST	I-TEST
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
stable	JJ	O	O
.	.	O	O

gastrointestinal	JJ	O	O
-	:	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
gastrointestinal	JJ	B-PROBLEM	B-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
guaiac	JJ	B-PROBLEM	B-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
stools	NNS	I-PROBLEM	I-PROBLEM
on	IN	O	O
admission	NN	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
trend	NN	O	O
down	RP	O	O
after	IN	O	O
transfusion	NN	B-TREATMENT	O
of	IN	O	O
one	CD	O	O
unit	NN	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
on	IN	O	O
admission	NN	O	O
.	.	O	O

given	VBN	O	O
guaiac	NNS	B-PROBLEM	B-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
stools	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
her	PRP$	O	O
history	NN	O	O
of	IN	O	O
gastrointestinal	JJ	B-PROBLEM	B-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
addition	NN	O	O
to	TO	O	O
use	VB	O	O
of	IN	O	O
steroids	NNS	B-TREATMENT	B-TREATMENT
for	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
obstructive	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
exacerbation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
the	DT	O	O
gastroenterology	NN	O	O
consult	NN	O	O
service	NN	O	O
was	VBD	O	O
contacted	VBN	O	O
.	.	O	O

the	DT	O	O
results	NNS	O	O
of	IN	O	O
that	DT	O	O
consultation	NN	O	O
and	CC	O	O
potential	JJ	O	O
esophagogastroduodenoscopy	NN	B-TEST	O
are	VBP	O	O
pending	VBG	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
dictation	NN	O	B-PROBLEM
.	.	O	O

hypertension	NN	B-PROBLEM	B-PROBLEM
-	:	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
moderate	JJ	O	O
control	NN	O	O
of	IN	O	O
her	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
throughout	IN	O	O
her	PRP$	O	O
admission	NN	O	O
.	.	O	O

her	PRP$	B-TREATMENT	B-TEST
calcium	NN	I-TREATMENT	I-TEST
channel	NN	I-TREATMENT	I-TEST
blocker	NN	I-TREATMENT	I-TEST
and	CC	O	O
ace	NN	B-TREATMENT	B-TREATMENT
inhibitor	NN	I-TREATMENT	I-TREATMENT
were	VBD	O	O
continued	VBN	O	O
.	.	O	O

hematology	NN	O	B-TEST
-	:	O	O
as	IN	O	O
noted	VBN	O	O
previously	RB	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
drop	VB	O	O
after	IN	O	O
transfusion	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
one	CD	O	O
unit	NN	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
on	IN	O	O
admission	NN	O	O
.	.	O	O

given	VBN	O	O
guaiac	NNS	B-PROBLEM	B-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
stools	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
history	NN	O	O
of	IN	O	O
gastrointestinal	JJ	B-PROBLEM	B-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
gastroenterology	NN	O	O
consult	NN	O	O
service	NN	O	O
was	VBD	O	O
contacted	VBN	O	O
for	IN	O	O
possible	JJ	O	O
esophagogastroduodenoscopy	NN	B-TEST	B-TEST
and/or	NN	O	I-TEST
colonoscopy	NN	B-TEST	I-TEST
.	.	O	O

the	DT	O	O
remainder	NN	O	O
of	IN	O	O
the	DT	O	O
hubbard	JJ	O	O
regional	JJ	O	O
hospital	NN	O	O
hospital	NN	O	O
course	NN	O	O
,	,	O	O
discharge	NN	O	O
diagnoses	NNS	O	O
,	,	O	O
medications	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
follow-up	NN	O	O
will	MD	O	O
be	VB	O	O
dictated	VBN	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

1.	CD	O	O
status	NN	O	O
post	NN	O	O
motorvehicle	NN	O	O
accident	NN	O	O
with	IN	O	O
transient	JJ	B-PROBLEM	B-PROBLEM
paraplegia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
right	JJ	B-PROBLEM	B-PROBLEM
hydronephrosis	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
ct	JJ	B-TEST	B-TEST
scan	JJ	I-TEST	I-TEST
.	.	O	O

there	EX	O	O
was	VBD	O	O
apparent	JJ	B-PROBLEM	B-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
consciousness	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
the	DT	O	O
scene	NN	O	O
and	CC	O	O
significant	JJ	O	B-PROBLEM
deformity	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
anterior	JJ	O	I-PROBLEM
portion	NN	O	I-PROBLEM
of	IN	O	O
the	DT	O	O
motorvehicle	NN	O	O
with	IN	O	O
positive	JJ	O	O
starring	NN	O	O
of	IN	O	O
the	DT	O	O
windshield	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
conscious	JJ	O	O
on	IN	O	O
the	DT	O	O
scene	NN	O	O
when	WRB	O	O
evaluated	VBN	O	O
by	IN	O	O
emt	JJ	O	O
&apos;s	NNS	O	O
but	CC	O	O
at	IN	O	O
the	DT	O	O
scene	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
apparently	RB	B-PROBLEM	O
paraplegic	JJ	I-PROBLEM	B-PROBLEM
below	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
umbilicus	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
absence	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
movement	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
sensation	NN	I-PROBLEM	I-PROBLEM
below	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
umbilicus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

status	NN	O	O
post	NN	O	O
laparotomy	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
ovarian	JJ	I-PROBLEM	I-PROBLEM
cyst	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
1988	CD	O	O
.	.	O	O

on	IN	O	O
initial	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
,	,	O	O
her	PRP$	O	B-PROBLEM
left	JJ	O	I-PROBLEM
shoulder	NN	O	I-PROBLEM
was	VBD	O	O
tender	NN	B-PROBLEM	O
to	TO	O	O
palpation	NN	B-TEST	B-TEST
over	IN	O	O
the	DT	O	O
proximal	JJ	O	O
humerus	NN	O	O
with	IN	O	O
decreased	JJ	B-PROBLEM	B-PROBLEM
range	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
motion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
without	IN	O	O
the	DT	O	O
ability	NN	O	O
to	TO	O	O
move	VB	O	O
her	PRP$	O	B-PROBLEM
left	JJ	O	I-PROBLEM
lower	JJR	O	I-PROBLEM
extremity	NN	O	I-PROBLEM
with	IN	O	O
decreased	JJ	B-PROBLEM	B-PROBLEM
sensation	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
leg	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
right	JJ	O	O
leg	NN	O	O
was	VBD	O	O
with	IN	O	O
decreased	JJ	B-PROBLEM	B-PROBLEM
range	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
motion	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
thigh	JJ	O	I-PROBLEM
flexion	NN	O	I-PROBLEM
and	CC	O	O
extension	NN	O	O
.	.	O	O

the	DT	O	O
back	NN	O	O
was	VBD	O	O
notable	JJ	O	O
for	IN	O	O
tenderness	NN	B-PROBLEM	B-PROBLEM
at	IN	O	O
the	DT	O	O
level	NN	O	O
of	IN	O	O
l3-l5	NN	O	O
.	.	O	O

initial	JJ	B-TEST	B-TEST
radiologic	NN	I-TEST	I-TEST
evaluation	NN	I-TEST	I-TEST
showed	VBD	O	O
negative	JJ	O	O
c-spine	NN	O	O
,	,	O	O
thoracic	JJ	O	B-PROBLEM
spine	NN	O	I-PROBLEM
,	,	O	O
and	CC	O	O
lumbosacral	JJ	O	B-PROBLEM
spine	NN	O	I-PROBLEM
films	NNS	O	I-PROBLEM
.	.	O	O

abdominal	JJ	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
except	IN	O	O
for	IN	O	O
right	JJ	B-PROBLEM	B-PROBLEM
hydronephrosis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
hydroureter	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

back	RB	B-TEST	O
mri	NN	I-TEST	O
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

film	NN	B-TEST	O
of	IN	I-TEST	O
the	DT	I-TEST	O
left	NN	I-TEST	O
humerus	NN	I-TEST	O
was	VBD	O	O
also	RB	O	O
negative	JJ	O	O
.	.	O	O

a	DT	O	B-TEST
neurosurgery	JJ	O	I-TEST
consultation	NN	O	I-TEST
was	VBD	O	O
obtained	VBN	O	O
,	,	O	O
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
their	PRP$	O	O
impression	NN	O	O
that	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NNP	I-PROBLEM	I-PROBLEM
paraplegia	NN	I-PROBLEM	I-PROBLEM
might	MD	O	O
possibly	RB	O	O
represent	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
cord	NN	I-PROBLEM	I-PROBLEM
concussion	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
recommended	VBD	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
with	IN	I-TREATMENT	O
intravenous	JJ	I-TREATMENT	B-TREATMENT
steroids	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
24	CD	O	O
hours	NNS	O	O
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NNP	I-PROBLEM	I-PROBLEM
paraplegia	NN	I-PROBLEM	I-PROBLEM
resolved	VBN	O	O
by	IN	O	O
the	DT	O	O
morning	NN	O	O
of	IN	O	O
her	PRP$	O	O
second	JJ	O	O
hospital	JJ	O	O
day	NN	O	O
,	,	O	O
and	CC	O	O
she	PRP	O	O
maintained	VBD	O	O
5/5	CD	O	O
motor	NN	O	O
strength	NN	O	O
in	IN	O	O
all	DT	O	O
groups	NNS	O	O
.	.	O	O

a	DT	O	B-TEST
urology	JJ	O	I-TEST
consultation	NN	O	I-TEST
was	VBD	O	O
obtained	VBN	O	O
,	,	O	O
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
recommended	VBN	O	O
that	IN	O	O
an	DT	B-TEST	O
ivp	NN	I-TEST	O
be	VB	O	O
obtained	VBN	O	O
.	.	O	O

this	DT	O	O
was	VBD	O	O
obtained	VBN	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
,	,	O	O
however	RB	O	O
,	,	O	O
due	JJ	O	O
to	TO	O	O
residual	JJ	B-PROBLEM	O
contrast	NN	I-PROBLEM	O
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
colon	NN	I-PROBLEM	O
from	IN	O	O
the	DT	B-TEST	O
patient	NN	I-TEST	O
&apos;s	NNP	I-TEST	O
prior	JJ	I-TEST	B-TEST
abdominal	JJ	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
,	,	O	O
the	DT	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
was	VBD	O	O
postponed	VBN	O	O
after	IN	O	O
a	DT	B-TEST	O
scout	NN	I-TEST	O
film	NN	I-TEST	O
was	VBD	O	O
obtained	VBN	O	O
.	.	O	O

she	PRP	O	O
remained	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
throughout	IN	O	O
her	PRP$	O	O
hospital	JJ	O	O
course	NN	O	O
.	.	O	O

additionally	RB	O	O
on	IN	O	O
the	DT	O	O
night	NN	O	O
before	IN	O	O
discharge	NN	O	O
,	,	O	O
flexion	NN	B-TEST	B-TEST
and	CC	I-TEST	O
extension	NN	I-TEST	O
views	NNS	I-TEST	O
of	IN	I-TEST	O
the	DT	I-TEST	B-PROBLEM
lumbosacral	JJ	I-TEST	I-PROBLEM
spine	NN	I-TEST	I-PROBLEM
were	VBD	O	O
obtained	VBN	O	O
,	,	O	O
and	CC	O	O
showed	VBD	O	O
no	DT	O	O
fracture	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
instability	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

tylenol	RB	B-TREATMENT	B-TREATMENT
650	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
q4	JJ	O	O
hours	NNS	O	O
p.r.n.	VBP	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
will	MD	O	O
have	VB	O	O
an	DT	B-TEST	O
ivp	NN	I-TEST	O
repeated	VBN	O	O
in	IN	O	O
one	CD	O	O
week	NN	O	O
at	IN	O	O
which	WDT	O	O
time	NN	O	O
she	PRP	O	O
should	MD	O	O
have	VB	O	O
cleared	VBN	O	B-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
residual	JJ	I-PROBLEM	I-PROBLEM
contrast	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
colon	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
will	MD	O	O
have	VB	O	O
urology	JJ	O	O
followup	NNS	O	O
after	IN	O	O
her	PRP$	B-TEST	O
ivp	NN	I-TEST	O
.	.	O	O

mychelia	NNS	O	B-PROBLEM
boyd	NN	O	I-PROBLEM
was	VBD	O	O
born	VBN	O	O
at	IN	O	O
28-2/7	JJ	O	O
weeks	NNS	O	O
gestation	NN	O	O
and	CC	O	O
delivered	VBN	O	O
due	JJ	O	O
to	TO	O	O
unstoppable	JJ	B-PROBLEM	O
premature	NN	I-PROBLEM	B-PROBLEM
labor	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

prenatal	JJ	B-TEST	B-TEST
screens	NNS	I-TEST	I-TEST
include	VBP	O	O
blood	NN	B-TEST	B-TEST
type	NN	I-TEST	I-TEST
o	NN	O	O
negative	JJ	O	O
.	.	O	O

other	JJ	B-TEST	O
prenatal	JJ	I-TEST	B-TEST
screens	NNS	I-TEST	I-TEST
were	VBD	O	O
unknown	JJ	O	O
at	IN	O	O
time	NN	O	O
of	IN	O	O
delivery	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

pregnancy	NN	O	O
was	VBD	O	O
uncomplicated	VBN	O	O
until	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
delivery	NN	B-TREATMENT	B-TREATMENT
when	WRB	O	O
mother	NN	O	O
presented	VBD	O	O
to	TO	O	O
healthsouth	VB	O	O
new	JJ	O	O
england	NN	O	O
rehab	NN	O	O
hospital	JJ	O	O
hospital	NN	O	O
with	IN	O	O
bleeding	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
was	VBD	O	O
sent	VBN	O	O
home	NN	O	O
.	.	O	O

she	PRP	O	O
then	RB	O	O
presented	VBD	O	O
to	TO	O	O
jordan	VB	O	O
hospital	JJ	O	O
hospital	NN	O	O
where	WRB	O	O
she	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
5	CD	B-PROBLEM	O
cm	NNS	I-PROBLEM	O
dilated	VBN	I-PROBLEM	O
with	IN	O	O
a	DT	B-PROBLEM	O
transverse	JJ	I-PROBLEM	O
lie	NN	I-PROBLEM	O
presentation	NN	I-PROBLEM	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
given	VBN	O	O
betamethasone	NN	B-TREATMENT	B-TREATMENT
times	CC	O	O
one	CD	O	O
and	CC	O	O
transferred	VBD	O	O
to	TO	O	O
the	DT	O	O
nantucket	NN	O	O
cottage	NN	O	O
hospital	NN	O	O
where	WRB	O	O
she	PRP	O	O
was	VBD	O	O
delivered	VBN	O	O
by	IN	O	O
cesarean	JJ	B-TREATMENT	B-TREATMENT
section	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
rupture	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
membranes	NNS	I-PROBLEM	I-PROBLEM
at	IN	O	O
time	NN	O	O
of	IN	O	O
delivery	NN	B-TREATMENT	B-TREATMENT
notable	JJ	O	O
for	IN	O	O
slight	JJ	B-PROBLEM	B-PROBLEM
meconium	NN	I-PROBLEM	I-PROBLEM
stained	VBD	I-PROBLEM	I-PROBLEM
amniotic	JJ	I-PROBLEM	I-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
baby	NN	O	O
emerged	VBD	O	O
with	IN	O	O
spontaneous	JJ	O	B-PROBLEM
cry	NN	O	I-PROBLEM
,	,	O	O
received	VBD	O	O
routine	JJ	B-TREATMENT	B-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
then	RB	O	O
was	VBD	O	O
intubated	VBN	O	B-TREATMENT
in	IN	O	O
the	DT	O	O
delivery	NN	O	O
room	NN	O	O
due	JJ	O	O
to	TO	O	O
inconsistent	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
effort	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
work	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breathing	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

apgars	NNS	B-TEST	B-TEST
were	VBD	O	O
6	CD	O	O
at	IN	O	O
one	CD	O	O
minute	NN	O	O
and	CC	O	O
8	CD	O	O
at	IN	O	O
five	CD	O	O
minutes	NNS	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
newborn	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
further	JJ	B-TREATMENT	B-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

her	PRP$	B-TEST	B-TEST
admission	NN	I-TEST	I-TEST
physical	NN	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	B-TEST	B-TEST
birth	NN	I-TEST	I-TEST
weight	NN	I-TEST	I-TEST
of	IN	O	O
901	CD	O	O
gm	NN	O	O
,	,	O	O
20th	CD	O	O
percentile	NN	O	O
;	:	O	O
length	CC	B-TEST	O
34	CD	O	O
cm	NN	O	O
,	,	O	O
25th	CD	O	O
percentile	NN	O	O
;	:	O	O
head	NN	B-TEST	B-TEST
circumference	NN	I-TEST	I-TEST
25	CD	O	O
cm	NN	O	O
,	,	O	O
25th	CD	O	O
percentile	NN	O	O
.	.	O	O

red	JJ	B-TEST	B-TEST
reflex	NN	I-TEST	I-TEST
was	VBD	O	O
difficult	JJ	O	O
to	TO	O	O
appreciate	VB	O	O
bilaterally	RB	O	O
.	.	O	O

palate	NN	O	O
deferred	VBD	O	O
due	JJ	O	O
to	TO	O	O
oral	JJ	B-TREATMENT	B-TREATMENT
intubation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

no	DT	O	O
defect	NN	B-PROBLEM	B-PROBLEM
noted	VBD	O	O
during	IN	O	O
procedure	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

increased	JJ	B-PROBLEM	B-PROBLEM
work	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breathing	VBG	I-PROBLEM	I-PROBLEM
prior	JJ	O	O
to	TO	O	O
intubation	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
but	CC	O	O
presently	RB	O	O
comfortable	JJ	O	O
.	.	O	O

breath	NN	O	B-TEST
sounds	VBZ	O	I-TEST
slightly	RB	B-PROBLEM	B-PROBLEM
crackly	JJ	I-PROBLEM	I-PROBLEM
,	,	O	I-PROBLEM
symmetric	JJ	O	I-PROBLEM
equal	JJ	O	I-PROBLEM
air	NN	O	I-PROBLEM
entry	NN	O	I-PROBLEM
.	.	O	O

cardiovascular	JJ	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
without	IN	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

peripheral	JJ	B-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
plus	CC	O	O
2	CD	O	O
and	CC	O	O
symmetric	JJ	O	O
.	.	O	O

abdomen	NNS	O	O
soft	VBP	O	O
without	IN	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
baby	NN	O	O
was	VBD	O	O
intubated	VBN	O	B-TREATMENT
in	IN	O	O
the	DT	O	O
delivery	NN	O	O
room	NN	O	O
,	,	O	O
received	VBD	O	O
two	CD	O	O
doses	NNS	O	O
of	IN	O	O
surfactant	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

radiograph	NN	B-TEST	B-TEST
revealed	VBD	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
diffuse	NN	I-PROBLEM	I-PROBLEM
granular	JJ	I-PROBLEM	I-PROBLEM
pattern	NN	I-PROBLEM	I-PROBLEM
consistent	JJ	O	O
with	IN	O	O
surfactant	JJ	B-PROBLEM	B-PROBLEM
deficiency	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

maximum	JJ	B-TREATMENT	B-TREATMENT
mechanical	JJ	I-TREATMENT	I-TREATMENT
ventilation	NN	I-TREATMENT	I-TREATMENT
pip	NN	B-TREATMENT	I-TREATMENT
26	CD	O	O
,	,	O	O
peep	RB	B-TREATMENT	O
6	CD	O	O
,	,	O	O
rate	NN	B-TREATMENT	O
of	IN	O	O
25	CD	O	O
,	,	O	O
maximum	JJ	B-TREATMENT	O
fio2	JJ	I-TREATMENT	O
35	CD	O	O
percent	NN	O	O
.	.	O	O

mychelia	NN	O	B-PROBLEM
was	VBD	O	O
extubated	VBN	O	O
to	TO	O	O
a	DT	B-TREATMENT	B-TREATMENT
cpap	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
6	CD	O	O
cm	NNS	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
two	CD	O	O
where	WRB	O	O
she	PRP	O	O
remained	VBD	O	O
until	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
20	CD	O	O
.	.	O	O

on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
two	CD	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
also	RB	O	O
loaded	VBN	O	O
with	IN	O	O
caffeine	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
continues	VBZ	O	O
on	IN	O	O
caffeine	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
time	NN	O	O
of	IN	O	O
transfer	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
transitioned	VBN	O	O
to	TO	O	O
a	DT	B-TREATMENT	B-TREATMENT
nasal	JJ	I-TREATMENT	I-TREATMENT
cannula	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
20	CD	O	O
and	CC	O	O
remains	VBZ	O	O
on	IN	O	O
nasal	JJ	B-TREATMENT	B-TREATMENT
cannula	NN	I-TREATMENT	I-TREATMENT
o2	VBZ	I-TREATMENT	I-TREATMENT
100	CD	O	O
percent	NN	O	O
at	IN	O	O
13	CD	O	O
cc	NN	O	O
flow	NN	O	O
.	.	O	O

she	PRP	O	O
averaged	VBD	O	O
2-3	JJ	O	B-TEST
apnea	NN	B-PROBLEM	I-TEST
episodes	VBZ	I-PROBLEM	O
a	DT	O	O
day	NN	O	O
with	IN	O	O
bradycardia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
desaturations	NNS	B-PROBLEM	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
a	DT	O	O
comfortable	JJ	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
and	CC	O	O
good	JJ	O	O
air	NN	O	O
exchange	NN	O	O
.	.	O	O

she	PRP	O	O
received	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
normal	JJ	I-TREATMENT	I-TREATMENT
saline	NN	I-TREATMENT	I-TREATMENT
bolus	NN	I-TREATMENT	I-TREATMENT
times	NNS	O	O
one	CD	O	O
initially	RB	O	O
for	IN	O	O
poor	JJ	B-PROBLEM	B-PROBLEM
perfusion	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
dopamine	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
a	DT	O	B-TEST
maximum	JJ	O	I-TEST
infusion	NN	O	I-TEST
rate	NN	O	I-TEST
of	IN	O	O
6	CD	O	O
mcg	NNS	O	O
per	IN	O	O
kg	FW	O	O
per	IN	O	O
hour	NN	O	O
.	.	O	O

this	DT	O	O
was	VBD	O	O
discontinued	VBN	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
two	CD	O	O
to	TO	O	O
maintain	VB	O	O
a	DT	B-TEST	B-TEST
mean	JJ	I-TEST	I-TEST
arterial	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
greater	JJR	O	O
than	IN	O	O
33	CD	O	O
.	.	O	O

initially	RB	O	O
maintained	VBN	O	O
npo	NN	B-TREATMENT	O
.	.	O	O

uac	JJ	B-TREATMENT	O
and	CC	I-TREATMENT	O
uvc	JJ	I-TREATMENT	B-TREATMENT
lines	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
placed	VBN	O	O
upon	IN	O	O
admission	NN	O	O
to	TO	O	O
the	DT	O	O
cmed	NN	O	O
.	.	O	O

the	DT	B-TREATMENT	O
uac	NN	I-TREATMENT	O
was	VBD	O	O
left	VBN	O	O
in	IN	O	O
place	NN	O	O
until	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
two	CD	O	O
and	CC	O	O
was	VBD	O	O
removed	VBN	O	O
after	IN	O	O
wean	NN	O	B-TREATMENT
from	IN	O	O
dopamine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

uvc	NN	B-TREATMENT	O
remained	VBD	O	O
in	IN	O	O
place	NN	O	O
through	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
six	CD	O	O
and	CC	O	O
was	VBD	O	O
utilized	VBN	O	O
to	TO	O	O
administer	VB	O	O
parenteral	JJ	B-TREATMENT	B-TREATMENT
nutrition	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

electrolytes	NNS	B-TEST	B-TEST
and	CC	O	O
glucose	NN	B-TEST	B-TEST
remained	VBN	O	O
in	IN	O	O
the	DT	O	O
normal	JJ	O	O
range	NN	O	O
throughout	IN	O	O
the	DT	O	O
first	JJ	O	O
week	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
enteral	JJ	B-TREATMENT	B-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
six	CD	O	O
with	IN	O	O
a	DT	O	B-PROBLEM
slow	JJ	O	I-PROBLEM
advance	NN	O	I-PROBLEM
secondary	JJ	O	O
to	TO	O	O
increased	VBN	B-PROBLEM	B-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
girth	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
due	JJ	O	O
to	TO	O	O
cpap	VB	B-TREATMENT	O
.	.	O	O

calories	NNS	O	O
were	VBD	O	O
gradually	RB	O	O
increased	VBN	O	O
to	TO	O	O
breast	VB	O	O
milk	NN	O	B-TEST
30	CD	O	O
calories	NNS	O	O
with	IN	O	O
promod	JJ	B-TREATMENT	O
consisting	VBG	O	O
of	IN	O	O
four	CD	O	O
of	IN	O	O
human	JJ	O	O
milk	NN	O	O
fortifier	NN	O	O
,	,	O	O
four	CD	O	O
of	IN	O	O
mct	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
two	CD	O	O
of	IN	O	O
polycose	NN	B-TREATMENT	B-PROBLEM
with	IN	O	O
a	DT	O	O
12-28	JJ	O	O
teaspoon	NN	O	O
of	IN	O	O
promod	NN	B-TREATMENT	O
per	IN	O	O
50	CD	O	O
ml	NN	O	O
of	IN	O	O
breast	NN	O	B-TREATMENT
milk	NN	O	I-TREATMENT
or	CC	O	O
60	CD	O	O
ml	NN	O	O
of	IN	O	O
formula	NN	O	O
.	.	O	O

on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
six	CD	O	O
due	JJ	O	O
to	TO	O	O
concerns	NNS	O	O
for	IN	O	O
hyperglycemia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
distention	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
sepsis	NN	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
was	VBD	O	O
obtained	VBN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
at	IN	O	O
this	DT	O	O
time	NN	O	O
to	TO	O	O
have	VB	O	O
hyperglycemia	VBN	B-PROBLEM	B-PROBLEM
requiring	VBG	O	O
two	CD	O	O
subcutaneous	JJ	O	O
doses	NNS	O	O
of	IN	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
a	DT	B-TREATMENT	B-PROBLEM
decreased	JJ	I-TREATMENT	I-PROBLEM
glucose	JJ	I-TREATMENT	I-PROBLEM
infusion	NN	I-TREATMENT	I-PROBLEM
rate	NN	I-TREATMENT	I-PROBLEM
to	TO	O	O
achieve	VB	O	O
euglycemia	NN	O	B-PROBLEM
.	.	O	O

urine	JJ	B-TEST	B-TEST
output	NN	I-TEST	I-TEST
was	VBD	O	O
always	RB	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
of	IN	O	O
sufficient	JJ	O	O
quantity	NN	O	O
.	.	O	O

mychelia	NNS	O	B-PROBLEM
demonstrated	VBD	O	I-PROBLEM
slow	JJ	B-PROBLEM	I-PROBLEM
gastrointestinal	JJ	I-PROBLEM	I-PROBLEM
motility	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
distention	NN	I-PROBLEM	I-PROBLEM
felt	VBD	O	O
to	TO	O	O
be	VB	O	O
due	JJ	O	O
to	TO	O	O
cpap	VB	B-TREATMENT	O
.	.	O	O

on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
15	CD	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
made	VBN	O	O
npo	NN	B-TREATMENT	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
distended	JJ	I-PROBLEM	I-PROBLEM
abdomen	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
bilious	JJ	I-PROBLEM	I-PROBLEM
spit	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

serial	JJ	B-TEST	B-TEST
kubs	NNS	I-TEST	I-TEST
revealed	VBD	O	O
nonspecific	JJ	B-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
dilated	JJ	B-PROBLEM	B-PROBLEM
loops	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
pneumatosis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
free	JJ	B-PROBLEM	B-PROBLEM
air	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
seen	VBN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
bluish	JJ	B-PROBLEM	B-PROBLEM
discoloration	NN	I-PROBLEM	I-PROBLEM
thought	VBD	O	O
to	TO	O	O
perhaps	RB	O	O
be	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
bruise	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

again	RB	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
advanced	VBN	O	O
to	TO	O	O
full	JJ	O	O
volume	NN	O	O
but	CC	O	O
was	VBD	O	O
made	VBN	O	O
npo	NNS	B-TREATMENT	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
20	CD	O	O
for	IN	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
distention	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	B-TREATMENT	O
npo	NN	I-TREATMENT	O
was	VBD	O	O
temporary	JJ	O	O
for	IN	O	O
that	DT	O	O
day	NN	O	O
and	CC	O	O
she	PRP	O	O
then	RB	O	O
resumed	VBD	O	O
feedings	NNS	O	B-TREATMENT
and	CC	O	O
has	VBZ	O	O
been	VBN	O	O
tolerating	VBG	O	O
full	JJ	B-TREATMENT	B-TREATMENT
enteral	JJ	I-TREATMENT	I-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
well	RB	O	O
,	,	O	O
improved	VBN	O	O
since	IN	O	O
off	NN	O	O
of	IN	O	O
cpap	NN	B-TREATMENT	B-PROBLEM
,	,	O	O
passing	VBG	O	O
normal	JJ	O	O
stools	NNS	O	O
,	,	O	O
guaiac	JJ	B-TEST	B-TEST
negative	NN	O	O
.	.	O	O

mychelia	NN	O	B-PROBLEM
was	VBD	O	O
also	RB	O	O
treated	VBN	O	O
for	IN	O	O
physiologic	JJ	B-PROBLEM	B-PROBLEM
jaundice	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
under	IN	O	O
phototherapy	NN	B-TREATMENT	B-TREATMENT
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
one	CD	O	O
through	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
three	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
peak	JJ	I-TEST	I-TEST
serum	NN	I-TEST	I-TEST
bilirubin	NN	I-TEST	I-TEST
of	IN	O	O
4.7/0.3	CD	O	O
.	.	O	O

initial	JJ	B-TEST	B-TEST
cbc	NN	I-TEST	I-TEST
was	VBD	O	O
notable	JJ	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
5.5	CD	O	O
with	IN	O	O
49	CD	B-TEST	O
polys	NNS	I-TEST	B-TEST
,	,	O	O
1	CD	B-TEST	O
band	NN	I-TEST	O
and	CC	O	O
47	CD	B-TEST	O
lymphs	NN	I-TEST	B-TEST
.	.	O	O

initial	JJ	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
46.3	CD	O	O
percent	NN	O	O
and	CC	O	O
platelets	NNS	B-TEST	B-TEST
320,000	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
initial	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
culture	NN	I-TEST	I-TEST
remained	VBD	O	O
negative	JJ	O	O
and	CC	O	O
she	PRP	O	O
received	VBD	O	O
48	CD	O	O
hours	NNS	O	O
of	IN	O	O
ampicillin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

as	IN	O	O
previously	RB	O	O
noted	VBN	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
six	CD	O	O
with	IN	O	O
hyperglycemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
distention	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
a	DT	B-TEST	B-TEST
cbc	NN	I-TEST	I-TEST
and	CC	O	O
blood	NN	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
were	VBD	O	O
again	RB	O	O
obtained	VBN	O	O
revealing	VBG	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
9.1	CD	O	O
with	IN	O	O
30	CD	B-TEST	O
polys	NNS	I-TEST	B-TEST
,	,	O	O
0	CD	B-TEST	O
bands	NNS	I-TEST	B-TEST
and	CC	O	O
58	CD	B-TEST	O
lymphs	NN	I-TEST	B-TEST
.	.	O	O

hematocrit	NN	B-TEST	B-TEST
at	IN	O	O
that	DT	O	O
time	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
31	CD	O	O
and	CC	O	O
platelets	NNS	B-TEST	B-TEST
370,000	CD	O	O
.	.	O	O

blood	NN	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
grew	VBD	O	O
staph	JJ	B-PROBLEM	B-PROBLEM
coagulase	NN	I-PROBLEM	I-PROBLEM
negative	JJ	I-PROBLEM	O
and	CC	O	O
the	DT	O	O
baby	NN	O	O
received	VBD	O	O
seven	CD	O	O
days	NNS	O	O
of	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

a	DT	B-TEST	B-TEST
lumbar	NN	I-TEST	I-TEST
puncture	NN	I-TEST	I-TEST
was	VBD	O	O
also	RB	O	O
performed	VBN	O	O
to	TO	O	O
rule	VB	O	O
out	RP	O	O
meningitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

this	DT	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
remained	VBD	O	O
negative	JJ	O	O
with	IN	O	O
normal	JJ	O	O
cell	NN	O	O
counts	NNS	O	O
and	CC	O	O
chemistries	NNS	O	B-TEST
.	.	O	O

antibiotic	JJ	B-TEST	B-TEST
levels	NNS	I-TEST	I-TEST
were	VBD	O	O
monitored	VBN	O	O
and	CC	O	O
doses	NNS	O	O
adjusted	VBN	O	O
accordingly	RB	O	O
.	.	O	O

mychelia	NNS	O	B-PROBLEM
required	VBD	O	O
two	CD	B-TREATMENT	B-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
during	IN	O	O
her	PRP$	O	O
hospital	NN	O	O
stay	NN	O	O
.	.	O	O

on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
15	CD	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
of	IN	O	O
29	CD	O	O
,	,	O	O
she	PRP	O	O
received	VBD	O	O
20	CD	O	O
cc	NN	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
started	VBD	O	O
on	IN	O	O
iron	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
vitamin	NN	B-TREATMENT	B-TREATMENT
e	NN	I-TREATMENT	I-TREATMENT
supplements	NNS	I-TREATMENT	I-TREATMENT
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
25	CD	O	O
and	CC	O	O
continues	VBZ	O	O
on	IN	O	O
that	DT	O	O
at	IN	O	O
this	DT	O	O
time	NN	O	O
of	IN	O	O
transfer	NN	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
34	CD	O	O
,	,	O	O
12-04	CD	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
pale	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	I-PROBLEM
less	JJR	B-PROBLEM	I-PROBLEM
stress	NN	I-PROBLEM	I-PROBLEM
tolerant	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
mottling	VBG	O	B-PROBLEM
easily	RB	O	O
with	IN	O	O
care	NN	O	B-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
and	CC	O	I-TEST
reticulocyte	NN	B-TEST	I-TEST
count	NN	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
of	IN	O	O
23	CD	O	O
percent	NN	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
reticulocyte	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
1.9	CD	O	O
percent	NN	O	O
.	.	O	O

therefore	RB	O	O
,	,	O	O
with	IN	O	O
blood	NN	B-TREATMENT	O
available	JJ	O	O
from	IN	O	O
the	DT	O	O
first	JJ	O	O
aliquot	NN	O	O
,	,	O	O
a	DT	O	O
second	JJ	O	O
20	CD	O	O
cc	NN	O	O
per	IN	O	O
kg	NN	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
infused	VBN	O	O
without	IN	O	O
incident	NN	O	O
.	.	O	O

initial	JJ	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
ultrasound	NN	I-TEST	I-TEST
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
seven	CD	O	O
was	VBD	O	O
normal	JJ	O	O
.	.	O	O

at	IN	O	O
one	CD	O	O
month	NN	O	O
of	IN	O	O
age	NN	O	O
,	,	O	O
on	IN	O	O
12-03	JJ	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
an	DT	B-PROBLEM	B-PROBLEM
absent	JJ	I-PROBLEM	I-PROBLEM
septum	NN	I-PROBLEM	I-PROBLEM
pellucidum	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
mri	NN	I-TEST	I-TEST
obtained	VBN	O	O
and	CC	O	O
reviewed	VBN	O	O
by	IN	O	O
the	DT	O	O
hallmark	NN	O	O
health	NN	O	O
system	NN	O	O
radiology	NN	O	O
department	NN	O	O
revealed	VBD	O	O
focal	JJ	B-PROBLEM	B-TEST
gyral	JJ	I-PROBLEM	I-TEST
morphology	NN	I-PROBLEM	I-TEST
consistent	JJ	O	O
with	IN	O	O
prematurity	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
normal	JJ	O	O
midline	NN	O	O
structures	NNS	O	O
,	,	O	O
normal	JJ	O	O
myelination	NN	O	O
,	,	O	O
no	DT	O	O
lesions	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
signal	JJ	B-PROBLEM	B-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
or	CC	O	O
extracerebral	JJ	B-PROBLEM	O
collections	NNS	I-PROBLEM	O
.	.	O	O

the	DT	O	O
septal	JJ	O	O
leaflets	NNS	O	O
may	MD	O	O
be	VB	O	O
partially	RB	B-PROBLEM	O
absent	JJ	I-PROBLEM	O
,	,	O	O
but	CC	O	O
there	EX	O	O
are	VBP	O	O
no	DT	O	O
coronal	JJ	B-TEST	B-PROBLEM
images	NNS	I-TEST	I-PROBLEM
provided	VBN	O	O
for	IN	O	O
confirmation	NN	O	O
and	CC	O	O
the	DT	O	O
pituitary	JJ	O	O
stalk	NN	O	O
is	VBZ	O	O
present	JJ	O	O
.	.	O	O

several	JJ	B-TEST	B-TEST
labs	NNS	I-TEST	I-TEST
were	VBD	O	O
ordered	VBN	O	O
.	.	O	O

electrolytes	NNS	B-TEST	B-TEST
and	CC	O	O
thyroid	JJ	B-TEST	B-TEST
studies	NNS	I-TEST	I-TEST
were	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
in	IN	O	O
the	DT	O	O
normal	JJ	O	O
range	NN	O	O
with	IN	O	O
serum	JJ	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
of	IN	O	O
136	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.7	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
98	CD	O	O
and	CC	O	O
co2	VB	B-TEST	O
34	CD	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
calcium	NN	I-TEST	I-TEST
of	IN	O	O
10.3	CD	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
phosphorus	NN	I-TEST	I-TEST
of	IN	O	O
4.8	CD	O	O
and	CC	O	O
alkaline	JJ	B-TEST	B-TEST
phosphatase	NN	I-TEST	I-TEST
of	IN	O	O
440	CD	O	O
.	.	O	O

thyroid	JJ	B-TEST	B-TEST
function	NN	I-TEST	I-TEST
studies	NNS	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	B-TEST	O
tsh	NN	I-TEST	O
of	IN	O	O
2.2	CD	O	O
,	,	O	O
t4	NN	B-TEST	O
of	IN	O	O
5.7	CD	O	O
,	,	O	O
t3	NN	B-TEST	O
of	IN	O	O
101	CD	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
cortisol	JJ	I-TEST	I-TEST
level	NN	I-TEST	I-TEST
of	IN	O	O
43	CD	O	O
,	,	O	O
all	DT	O	O
within	IN	O	O
the	DT	O	O
normal	JJ	O	O
range	NN	O	O
.	.	O	O

a	DT	B-TEST	B-TREATMENT
growth	NN	I-TEST	I-TREATMENT
hormone	NN	I-TEST	I-TREATMENT
was	VBD	O	O
sent	VBN	O	O
and	CC	O	O
the	DT	O	O
results	NNS	O	O
were	VBD	O	O
pending	VBG	O	O
at	IN	O	O
time	NN	O	O
of	IN	O	O
transfer	NN	O	O
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
an	DT	B-TEST	B-TEST
fsh	NN	I-TEST	I-TEST
and	CC	O	I-TEST
lh	NN	B-TEST	I-TEST
were	VBD	O	O
obtained	VBN	O	O
on	IN	O	O
12-10	JJ	O	O
and	CC	O	O
results	NNS	O	O
are	VBP	O	O
pending	VBG	O	O
at	IN	O	O
time	NN	O	O
of	IN	O	O
transfer	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
baby	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
neurologic	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
is	VBZ	O	O
appropriate	JJ	O	O
for	IN	O	O
corrected	JJ	O	O
gestational	JJ	O	O
age	NN	O	O
which	WDT	O	O
is	VBZ	O	O
33	CD	O	O
and	CC	O	O
6/7	CD	O	O
weeks	NNS	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
transfer	NN	O	O
.	.	O	O

by	IN	O	O
mother	NN	O	O
's	POS	O	O
report	NN	O	O
,	,	O	O
a	DT	O	O
maternal	JJ	O	O
cousin	NN	O	O
also	RB	O	O
has	VBZ	O	O
an	DT	B-PROBLEM	B-PROBLEM
absent	JJ	I-PROBLEM	I-PROBLEM
septum	NN	I-PROBLEM	I-PROBLEM
pellucidum	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

given	VBN	O	O
normal	JJ	O	O
pituitary	JJ	O	B-TEST
tests	NNS	O	I-TEST
thus	RB	O	O
far	RB	O	O
and	CC	O	O
normal	JJ	O	O
optic	JJ	O	O
nerve	NN	O	O
,	,	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
septic	JJ	B-PROBLEM	B-PROBLEM
optic	JJ	I-PROBLEM	I-PROBLEM
dysplasia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pediatrician	NN	O	O
should	MD	O	O
have	VB	O	O
low	JJ	O	B-PROBLEM
threshold	NN	O	I-PROBLEM
for	IN	O	O
endocrinology	NN	O	O
reconsult	NN	O	O
if	IN	O	O
any	DT	B-PROBLEM	O
signs	NNS	I-PROBLEM	O
of	IN	I-PROBLEM	O
pituitary	JJ	I-PROBLEM	B-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

initial	JJ	B-TEST	B-TEST
rop	NN	I-TEST	I-TEST
screen	NN	I-TEST	I-TEST
was	VBD	O	O
done	VBN	O	O
on	IN	O	O
12-02	JJ	O	O
and	CC	O	O
revealed	JJ	O	O
immature	NN	B-PROBLEM	O
retinas	NN	I-PROBLEM	O
to	TO	I-PROBLEM	O
zone	CD	I-PROBLEM	O
2	CD	I-PROBLEM	O
bilaterally	RB	I-PROBLEM	O
.	.	O	O

they	PRP	O	O
recommended	VBD	O	O
follow-up	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
due	JJ	O	O
on	IN	O	O
the	DT	O	O
week	NN	O	O
of	IN	O	O
12/20	CD	O	O
.	.	O	O

feedings	NNS	O	B-TREATMENT
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
transfer	NN	O	O
include	VBP	O	O
breast	NN	O	B-TREATMENT
milk	NN	O	I-TREATMENT
30	CD	O	O
with	IN	O	O
promod	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
150	CD	O	O
cc	NN	O	O
per	IN	O	O
kg	FW	O	O
per	IN	O	O
day	NN	O	O
,	,	O	O
all	DT	O	B-TREATMENT
gavage	NN	B-TREATMENT	I-TREATMENT
given	VBN	O	O
over	IN	O	O
one	CD	O	O
hour	NN	O	O
.	.	O	O

medications	NNS	B-TREATMENT	B-TREATMENT
include	VBP	O	O
fer-in-norman	JJ	B-TREATMENT	O
,	,	O	O
vitamin	JJ	B-TREATMENT	B-TREATMENT
e	NN	I-TREATMENT	I-TREATMENT
5	CD	O	O
international	JJ	O	O
units	NNS	O	O
each	DT	O	O
day	NN	O	O
and	CC	O	O
caffeine	NN	B-TREATMENT	B-TREATMENT
citrate	NN	I-TREATMENT	I-TREATMENT
once	IN	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

car	NN	B-TEST	B-TEST
seat	NN	I-TEST	I-TEST
positioning	VBG	I-TEST	I-TEST
screening	NN	I-TEST	I-TEST
has	VBZ	O	O
not	RB	O	O
been	VBN	O	O
obtained	VBN	O	O
.	.	O	O

newborn	JJ	B-TEST	B-TEST
state	NN	I-TEST	I-TEST
screens	NNS	I-TEST	I-TEST
have	VBP	O	O
been	VBN	O	O
sent	VBN	O	O
per	IN	O	O
protocol	NN	O	O
.	.	O	O

mychelia	NNS	O	B-PROBLEM
received	VBD	O	O
hepatitis	NN	B-TREATMENT	B-TREATMENT
b	NN	I-TREATMENT	I-TREATMENT
vaccine	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
11-02	JJ	O	O
due	JJ	O	O
to	TO	O	O
unknown	JJ	O	O
maternal	JJ	O	B-PROBLEM
hepatitis	NN	O	I-PROBLEM
b	NN	O	I-PROBLEM
surface	NN	O	I-PROBLEM
antigen	NN	O	I-PROBLEM
status	NN	O	I-PROBLEM
.	.	O	O

she	PRP	O	O
also	RB	O	O
received	VBD	O	O
hepatitis	NN	B-TREATMENT	B-TREATMENT
b	NN	I-TREATMENT	I-TREATMENT
immune	JJ	I-TREATMENT	I-TREATMENT
globulin	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
11-02	JJ	O	O
.	.	O	O

on	IN	O	O
12-06	JJ	O	O
,	,	O	O
she	PRP	O	O
received	VBD	O	O
her	PRP	B-TREATMENT	B-TREATMENT
second	JJ	I-TREATMENT	I-TREATMENT
hepatitis	NN	I-TREATMENT	I-TREATMENT
b	NN	I-TREATMENT	I-TREATMENT
vaccine	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

her	PRP$	B-TREATMENT	O
two	CD	I-TREATMENT	O
month	NN	I-TREATMENT	O
immunizations	NNS	I-TREATMENT	O
have	VBP	O	O
not	RB	O	O
yet	RB	O	O
been	VBN	O	O
given	VBN	O	O
.	.	O	O

synagis	NN	B-TREATMENT	B-TREATMENT
rsv	NN	I-TREATMENT	I-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
should	MD	O	O
be	VB	O	O
considered	VBN	O	O
from	IN	O	O
november	CC	O	O
through	IN	O	O
march	NN	O	O
for	IN	O	O
infants	NNS	O	O
who	WP	O	O
meet	VBP	O	O
any	DT	O	O
of	IN	O	O
the	DT	O	O
following	JJ	O	O
three	CD	O	O
criteria	NNS	O	O
:	:	O	O

daycare	NN	O	O
during	IN	O	O
rsv	NN	O	O
season	NN	O	O
,	,	O	O
a	DT	O	O
smoker	NN	O	O
in	IN	O	O
the	DT	O	O
household	NN	O	O
,	,	O	O
neuromuscular	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	I-PROBLEM
airway	JJ	B-PROBLEM	I-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
or	CC	O	O
school	NN	O	O
age	NN	O	O
siblings	NNS	O	O
or	CC	O	O

3)	CD	O	O
infants	NNS	O	O
with	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

influenza	JJ	B-TREATMENT	B-TREATMENT
immunization	NN	I-TREATMENT	I-TREATMENT
is	VBZ	O	O
recommended	VBN	O	O
annually	RB	O	O
in	IN	O	O
the	DT	O	O
fall	NN	O	O
for	IN	O	O
all	DT	O	O
infants	NNS	O	O
once	IN	O	O
they	PRP	O	O
reach	VBP	O	O
6	CD	O	O
months	NNS	O	O
of	IN	O	O
age	NN	O	O
.	.	O	O

before	IN	O	O
this	DT	O	O
age	NN	O	O
and	CC	O	O
for	IN	O	O
the	DT	O	O
first	JJ	O	O
24	CD	O	O
months	NNS	O	O
of	IN	O	O
the	DT	O	O
infant	NN	O	O
's	POS	O	O
life	NN	O	O
,	,	O	O
immunization	NN	B-TREATMENT	B-TREATMENT
against	IN	O	O
influenza	NN	B-PROBLEM	B-PROBLEM
is	VBZ	O	O
recommended	VBN	O	O
for	IN	O	O
household	NN	O	O
contacts	NNS	O	O
and	CC	O	O
out	IN	O	O
of	IN	O	O
home	NN	O	O
caregivers	NNS	O	O
.	.	O	O

1.	CD	O	O
prematurity	NN	B-PROBLEM	B-PROBLEM
at	IN	O	O
28-2/7	JJ	O	O
weeks	NNS	O	O
.	.	O	O

2.	CD	O	O
surfactant	JJ	B-PROBLEM	B-PROBLEM
deficiency	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

4.	CD	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
suspect	NN	O	I-PROBLEM
.	.	O	O

5.	CD	O	O
physiologic	JJ	B-PROBLEM	B-PROBLEM
jaundice	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

6.	CD	O	O
coagulase	NN	B-PROBLEM	B-TEST
negative	JJ	I-PROBLEM	O
bacteremia	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

7.	CD	O	O
anemia	NN	B-PROBLEM	B-PROBLEM
of	IN	O	I-PROBLEM
prematurity	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

8.	CD	O	O
apnea	NN	B-PROBLEM	B-PROBLEM
of	IN	O	I-PROBLEM
prematurity	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

9.	CD	O	O
absent	JJ	B-PROBLEM	B-PROBLEM
septum	NN	I-PROBLEM	I-PROBLEM
pellucidum	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

c.	NN	B-PROBLEM	B-PROBLEM
difficile	NN	I-PROBLEM	I-PROBLEM
colitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
obstructive	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
history	NN	O	O
of	IN	O	O
ischemic	JJ	B-PROBLEM	B-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
azotemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

thoracentesis	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
performed	VBN	O	O
on	IN	O	O
7-12-91	NNS	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
an	DT	O	O
85-year-old	JJ	O	O
white	JJ	O	O
male	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
ischemic	JJ	B-PROBLEM	B-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
status	NN	O	O
post	NN	O	O
recent	JJ	O	O
admission	NN	O	O
for	IN	O	O
urosepsis	NN	B-PROBLEM	B-PROBLEM
and	CC	O	I-PROBLEM
c.	NN	B-PROBLEM	I-PROBLEM
difficile	NN	I-PROBLEM	I-PROBLEM
colitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
returns	VBZ	O	O
from	IN	O	O
the	DT	O	O
nursing	NN	O	O
home	NN	O	O
with	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
leukocytosis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
azotemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

briefly	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
obstructive	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
ethanol	JJ	O	O
abuse	NN	O	O
,	,	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
presented	VBD	O	O
to	TO	O	O
gaanvantsir	VB	O	O
on	IN	O	O
04-17-92	JJ	O	O
with	IN	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
bloody	NN	B-PROBLEM	B-PROBLEM
diarrhea	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

workup	NN	B-TEST	B-TEST
revealed	VBD	O	O
ischemic	JJ	B-PROBLEM	B-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
secondary	JJ	O	O
to	TO	O	O
celiac	VB	B-PROBLEM	B-PROBLEM
and	CC	O	I-PROBLEM
sma	VB	B-PROBLEM	I-PROBLEM
stenoses	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
underwent	VBD	O	O
an	DT	B-TREATMENT	B-TREATMENT
angioplasty	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
sma	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
90-20%	JJ	O	B-PROBLEM
residual	NN	O	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
also	RB	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
gram	VBN	B-PROBLEM	O
negative	JJ	I-PROBLEM	O
rod	NN	I-PROBLEM	O
sepsis	NN	I-PROBLEM	B-PROBLEM
with	IN	O	O
blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
times	NNS	O	O
two	CD	O	O
growing	VBG	O	O
e.	NNS	B-PROBLEM	B-PROBLEM
coli	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
b.	NN	B-PROBLEM	I-PROBLEM
fragilis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
ampicillin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
readmitted	VBN	O	O
on	IN	O	O
5-21-91	JJ	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
falling	VBG	I-PROBLEM	I-PROBLEM
hematocrit	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
36	CD	O	O
to	TO	O	O
22	CD	O	O
,	,	O	O
mild	FW	B-PROBLEM	B-PROBLEM
congestive	JJ	I-PROBLEM	I-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
guaiac	JJ	B-PROBLEM	B-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
stool	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
colonoscopy	NN	I-TEST	I-TEST
and	CC	O	O
upper	JJ	B-TEST	B-PROBLEM
gastrointestinal	JJ	I-TEST	I-PROBLEM
series	NN	I-TEST	I-PROBLEM
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
given	VBN	O	O
two	CD	O	O
units	NNS	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
h2	NN	B-TREATMENT	B-TREATMENT
blockers	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
31	CD	O	O
on	IN	O	O
discharge	NN	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
31	CD	O	O
on	IN	O	O
discharge	NN	O	O
.	.	O	O

on	IN	O	O
6-12-91	JJ	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
ingtermst.gay	VB	O	O
health	NN	O	O
center	NN	O	O
with	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	O
bun	NN	I-TEST	O
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
equalled	VBD	O	O
128/8.6	CD	O	O
,	,	O	O
co2	NN	B-TEST	O
equaled	VBD	O	O
12	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
kefzol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
gaanvantsir	VB	O	O
.	.	O	O

1)	CD	O	O
serratia	JJ	B-PROBLEM	B-PROBLEM
urosepsis	NN	I-PROBLEM	I-PROBLEM
treated	VBN	O	O
with	IN	O	O
ceftizoxime	NN	B-TREATMENT	O
.	.	O	O

2)	CD	O	O
azotemia	NN	B-PROBLEM	B-PROBLEM
presumed	VBD	O	O
secondary	JJ	O	O
to	TO	O	O
sepsis	VB	B-PROBLEM	B-PROBLEM
and	CC	O	O
dehydration	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
creatinine	NN	B-TEST	B-TEST
decreased	VBD	O	O
to	TO	O	O
2.1	CD	O	O
with	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

renal	JJ	B-TEST	B-TEST
ultrasound	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
for	IN	O	O
abscess	JJ	B-PROBLEM	B-PROBLEM
orhydronephrosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3)	CD	O	O
loculated	JJ	B-PROBLEM	B-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusions	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

thoracentesis	NN	B-TEST	B-PROBLEM
revealed	VBD	O	O
a	DT	B-TEST	O
ph	NN	I-TEST	O
of	IN	O	O
7.18	CD	O	O
,	,	O	O
glucose	RB	B-TEST	B-TEST
52	CD	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
200	CD	O	O
;	:	O	O
evaluated	VBN	O	O
by	IN	O	O
thoracic	NN	O	B-TREATMENT
surgery	NN	O	I-TREATMENT
,	,	O	O
no	DT	O	O
chest	NN	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
placed	VBD	O	O
.	.	O	O

4)	CD	O	B-PROBLEM
c.	NN	B-PROBLEM	I-PROBLEM
difficile	NN	I-PROBLEM	I-PROBLEM
colitis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
rising	VBG	O	O
to	TO	O	O
51,000	CD	O	O
,	,	O	O
treated	VBN	O	O
with	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
and	CC	I-TREATMENT	O
p.o.	JJ	I-TREATMENT	O
flagyl	NN	I-TREATMENT	B-TREATMENT
.	.	O	O

c.	NN	B-TEST	O
difficile	NN	I-TEST	O
was	VBD	O	O
negative	JJ	O	O
times	NNS	O	O
three	CD	O	O
prior	JJ	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
went	VBD	O	O
to	TO	O	O
his	PRP$	O	O
nursing	NN	O	O
home	NN	O	O
on	IN	O	O
7-9-91	JJ	O	O
but	CC	O	O
the	DT	O	O
next	JJ	O	O
day	NN	O	O
he	PRP	O	O
developed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
temperature	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
102.4	CD	O	O
degrees	NNS	O	O
,	,	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
orthostasis	NN	B-PROBLEM	B-TREATMENT
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
back	RB	O	O
to	TO	O	O
gaanvantsir	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
medical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
with	IN	O	O
question	NN	O	O
of	IN	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
40,000	CD	O	O
with	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
shift	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	O
bun	NN	I-TEST	O
was	VBD	O	O
35	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
4.3	CD	O	O
.	.	O	O

urinalysis	NN	B-TEST	B-TEST
had	VBD	O	O
5-10	JJ	B-TEST	O
white	JJ	I-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cells	NNS	I-TEST	I-TEST
and	CC	O	O
2+	CD	B-TEST	B-PROBLEM
bacteria	NNS	I-TEST	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	JJ	O	O
underwent	JJ	O	O
thoracentesis	NN	B-TEST	B-TREATMENT
without	IN	O	O
evidence	NN	O	O
of	IN	O	O
empyema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
with	IN	O	O
ceftizoxime	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
also	RB	O	O
started	VBN	O	O
on	IN	O	O
p.o.	NN	B-TREATMENT	B-TREATMENT
vancomycin	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
question	NN	O	B-PROBLEM
c.	NN	B-PROBLEM	I-PROBLEM
difficile	NN	I-PROBLEM	I-PROBLEM
colitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
now	RB	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
medicine	NN	O	O
service	NN	O	O
for	IN	O	O
further	JJ	B-TREATMENT	B-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

2)	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
obstructive	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3)	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusions	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

4)	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
baseline	JJ	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
1.8-2	CD	O	O
.	.	O	O

5)	CD	O	O
ischemic	JJ	B-PROBLEM	O
bowel	NN	I-PROBLEM	O
status	NN	O	O
post	NN	O	O
sma	VBP	B-TREATMENT	B-PROBLEM
percutaneous	JJ	I-TREATMENT	B-TREATMENT
transluminal	JJ	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
angioplasty	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

6)	CD	O	O
serratiaurosepsis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

7)	CD	O	O
positive	JJ	B-PROBLEM	O
ppd	NN	I-PROBLEM	O
.	.	O	O

8)	CD	O	O
status	NN	O	O
post	NN	O	O
total	JJ	B-TREATMENT	B-TREATMENT
hip	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

9)	CD	O	O
right	JJ	B-PROBLEM	O
bundle	NN	I-PROBLEM	O
branch	NN	I-PROBLEM	O
block	NN	I-PROBLEM	O
with	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
hemiblock	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
electrocardiogram	NN	B-TEST	B-TEST
.	.	O	O

allergies	NNS	B-PROBLEM	B-PROBLEM
to	TO	O	O
penicillin	VB	B-TREATMENT	B-TREATMENT
,	,	O	O
sulfa	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
codeine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
morphine	JJ	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
.medications	NNS	B-TREATMENT	I-TREATMENT
on	IN	I-TREATMENT	O
transfer	NN	I-TREATMENT	O
included	VBD	O	O
thiamine	NN	B-TREATMENT	B-TREATMENT
;	:	O	O
multivitamin	CC	B-TREATMENT	B-TREATMENT
;	:	O	O
pepcid	NN	B-TREATMENT	B-PROBLEM
;	:	O	O
ceftizoxime	CC	B-TREATMENT	O
1	CD	O	O
gm	NN	O	O
intravenously	RB	O	O
q.	JJ	O	O
eight	CD	O	O
hours	NNS	O	O
;	:	O	O
flagyl	VBZ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
intravenously	RB	O	O
q.	JJ	O	O
eight	CD	O	O
hours	NNS	O	O
;	:	O	O
gentamicin	VBZ	B-TREATMENT	B-TREATMENT
80	CD	O	O
mg	NN	O	O
iv	NN	O	O
q.	VBD	O	O
24	CD	O	O
hours	NNS	O	O
;	:	O	O
ventolin	NNP	B-TREATMENT	B-TREATMENT
inhaler	NN	I-TREATMENT	I-TREATMENT
;	:	O	I-TREATMENT
lotrimin	CC	B-TREATMENT	I-TREATMENT
cream	NN	I-TREATMENT	I-TREATMENT
;	:	O	O
sliding	VBG	B-TREATMENT	B-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT
nitro	JJ	I-TREATMENT	I-TREATMENT
paste	NN	I-TREATMENT	I-TREATMENT
;	:	O	O
pyridium	NN	B-TREATMENT	B-TREATMENT
;	:	O	O
vancomycin	CC	B-TREATMENT	B-TREATMENT
125	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.i.d.	NN	O	O
;	:	O	O
and	CC	O	O
calcium	NN	B-TREATMENT	B-TREATMENT
carbonate	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

family	NN	O	O
history	NN	O	O
is	VBZ	O	O
positive	JJ	O	O
for	IN	O	O
tuberculosis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
alcoholism	NN	O	B-PROBLEM
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
a	DT	O	B-PROBLEM
drowsy	NN	O	I-PROBLEM
,	,	O	O
elderly	JJ	O	O
white	JJ	O	O
male	NN	O	O
lying	VBG	O	O
with	IN	O	O
o2	NN	B-TREATMENT	O
on	IN	O	O
,	,	O	O
asking	VBG	O	O
to	TO	O	O
be	VB	O	O
scratched	VBN	O	O
.	.	O	O

blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
110/50	CD	O	O
,	,	O	O
pulse	JJ	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
94	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
22	CD	O	O
,	,	O	O
temperature	NN	B-TEST	B-TEST
maximum	JJ	I-TEST	I-TEST
101	CD	O	O
degrees	NNS	O	O
,	,	O	O
decreasing	VBG	O	O
to	TO	O	O
99	CD	O	O
degrees	NNS	O	O
.	.	O	O

without	IN	O	O
rash	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
petechiae	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

dry	JJ	B-PROBLEM	B-PROBLEM
mucous	JJ	I-PROBLEM	I-PROBLEM
membranes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

bibasilar	JJ	B-PROBLEM	B-PROBLEM
crackles	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
right	RB	O	O
greater	JJR	O	O
than	IN	O	O
left	JJR	O	O
,	,	O	O
no	DT	O	O
wheezes	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
s1	NN	O	O
,	,	O	O
s2	NN	O	O
,	,	O	O
i	JJ	B-PROBLEM	O
/	VBP	I-PROBLEM	O
vi	JJ	I-PROBLEM	B-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
ejection	NN	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

distended	VBN	B-PROBLEM	B-PROBLEM
,	,	O	O
positive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
,	,	O	O
soft	JJ	O	O
,	,	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
lower	RBR	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
rebound	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

tender	NN	B-PROBLEM	O
,	,	O	O
external	JJ	B-PROBLEM	B-PROBLEM
hemorrhoids	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
guaiac	JJ	B-TEST	B-TEST
negative	NN	O	O
.	.	O	O

without	IN	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

alert	NN	O	O
and	CC	O	O
oriented	VBN	O	O
to	TO	O	O
person	NN	O	O
and	CC	O	O
place	NN	O	O
,	,	O	O
no	DT	O	O
asterixis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
tremor	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

significant	JJ	O	O
for	IN	O	O
sodium	NN	B-TEST	B-TEST
140	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
3	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
35	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
3.6	CD	O	O
,	,	O	O
liver	JJR	B-TEST	B-TEST
function	NN	I-TEST	I-TEST
tests	NNS	I-TEST	I-TEST
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
,	,	O	O
calcium	NN	B-TEST	B-TEST
6.6	CD	O	O
,	,	O	O
albumin	RB	B-TEST	B-TEST
2	CD	O	O
,	,	O	O
magnesium1.4	NN	B-TEST	O
,	,	O	O
pt	NN	B-TEST	O
14	CD	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
30.1	CD	O	O
with	IN	O	O
77	CD	O	O
polys	NNS	B-TEST	B-TEST
,	,	O	O
13	CD	O	O
bands	NNS	B-TEST	B-TEST
,	,	O	O
5	CD	O	O
lymphs	NN	B-TEST	B-TEST
,	,	O	O
and	CC	O	O
5	CD	O	O
monos	NNS	B-TEST	B-TEST
.	.	O	O

urine	JJ	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
is	VBZ	O	O
75	CD	O	O
,	,	O	O
urine	JJ	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
143	CD	O	O
,	,	O	O
urine	JJ	B-TEST	O
osmose	RB	I-TEST	O
392	CD	O	O
.	.	O	O

pleural	JJ	B-TEST	B-TEST
fluid	NN	I-TEST	I-TEST
ph	NN	I-TEST	I-TEST
is	VBZ	O	O
7.29	CD	O	O
,	,	O	O
glucose	RB	B-TEST	B-TEST
91	CD	O	O
,	,	O	O
total	JJ	B-TEST	B-TEST
protein3.1	NN	I-TEST	I-TEST
,	,	O	O
ldh	VBZ	B-TEST	O
296	CD	O	O
,	,	O	O
70	CD	B-TEST	O
white	JJ	I-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cells	NNS	I-TEST	I-TEST
,	,	O	O
50	CD	B-TEST	O
red	JJ	I-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cells	NNS	I-TEST	I-TEST
.	.	O	O

1.	CD	O	O
colitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
ischemic	JJ	B-PROBLEM	B-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
status	NN	O	O
post	NN	O	O
sma	VBP	B-TREATMENT	B-PROBLEM
percutaneous	JJ	I-TREATMENT	B-TREATMENT
transluminal	JJ	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
angioplasty	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
recent	JJ	O	O
admission	NN	O	O
for	IN	O	O
gram	JJ	B-PROBLEM	O
negative	JJ	I-PROBLEM	O
rod	NN	I-PROBLEM	O
urosepsis	NN	I-PROBLEM	O
complicated	VBN	O	O
by	IN	O	O
c.	NN	B-PROBLEM	B-PROBLEM
difficile	NN	I-PROBLEM	I-PROBLEM
colitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
received	VBD	O	O
a	DT	B-TREATMENT	O
full	JJ	I-TREATMENT	O
course	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
flagyl	NN	I-TREATMENT	B-TREATMENT
and	CC	O	O
was	VBD	O	O
c.	VBN	B-TEST	O
difficile	JJ	I-TEST	B-PROBLEM
toxin	NN	I-TEST	I-PROBLEM
negative	JJ	O	O
times	NNS	O	O
three	CD	O	O
prior	JJ	O	O
to	TO	O	O
transfer	VB	O	O
.	.	O	O

he	PRP	O	O
now	RB	O	O
returns	VBZ	O	O
with	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
rising	VBG	B-PROBLEM	B-PROBLEM
white	JJ	I-PROBLEM	I-PROBLEM
count	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
dehydration	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

initially	RB	O	O
treated	VBN	O	O
with	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
ceftizoxime	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
presumed	JJ	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
either	RB	O	O
with	IN	O	O
urine	NN	O	B-TEST
or	CC	O	O
bowel	NN	O	O
source	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
also	RB	O	O
started	VBN	O	O
on	IN	O	O
p.o.	NN	B-TREATMENT	B-TREATMENT
vancomycin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
and	CC	O	O
urine	JJ	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
came	VBD	O	O
back	RB	O	O
negative	JJ	O	O
.	.	O	O

stool	NN	B-TEST	O
for	IN	I-TEST	O
c.	NN	I-TEST	B-PROBLEM
difficile	NN	I-TEST	I-PROBLEM
returned	VBD	O	O
positive	JJ	B-PROBLEM	O
.	.	O	O

the	DT	O	O
diagnosis	NN	O	O
,	,	O	O
therefore	RB	O	O
,	,	O	O
was	VBD	O	O
relapsed	VBN	B-PROBLEM	B-PROBLEM
c.	NN	I-PROBLEM	I-PROBLEM
difficile	NN	I-PROBLEM	I-PROBLEM
colitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

intravenous	JJ	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
discontinued	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
p.o.	NN	B-TREATMENT	B-TREATMENT
vancomycin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
improved	VBD	O	O
clinically	RB	O	O
with	IN	O	O
defervescence	NN	O	O
,	,	O	O
decreased	VBD	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
to	TO	O	O
10,000	CD	O	O
with	IN	O	O
resolution	NN	O	O
of	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
shift	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
some	DT	O	B-PROBLEM
decrease	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
abdominal	JJ	B-PROBLEM	I-PROBLEM
distention	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
exam	NN	B-TEST	B-TEST
.	.	O	O

an	DT	B-TEST	B-TEST
abdominal	JJ	I-TEST	I-TEST
cat	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
revealed	VBD	O	O
thickened	JJ	B-PROBLEM	B-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
thumb	NN	B-PROBLEM	O
printing	NN	I-PROBLEM	O
,	,	O	O
primarily	RB	O	O
involving	VBG	O	O
the	DT	O	B-TEST
cecum	NN	O	I-TEST
and	CC	O	I-TEST
right	JJ	O	I-TEST
colon	NN	O	I-TEST
greater	JJR	O	O
than	IN	O	O
the	DT	O	O
left	NN	O	O
,	,	O	O
consistent	JJ	O	O
with	IN	O	O
c.	NN	B-PROBLEM	B-PROBLEM
difficile	NN	I-PROBLEM	I-PROBLEM
colitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
diagnosis	NN	O	O
of	IN	O	O
recurrent	NN	B-PROBLEM	B-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
ischemia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
however	RB	O	O
,	,	O	O
was	VBD	O	O
not	RB	O	O
ruled	VBN	O	O
out	RP	O	O
and	CC	O	O
this	DT	O	O
will	MD	O	O
continue	VB	O	O
to	TO	O	O
be	VB	O	O
a	DT	O	O
concern	NN	O	O
in	IN	O	O
the	DT	O	O
future	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
initially	RB	O	O
n.p.o.	JJ	B-TREATMENT	O
and	CC	O	O
was	VBD	O	O
then	RB	O	O
advanced	JJ	O	O
to	TO	O	O
clear	JJ	B-TREATMENT	B-TREATMENT
liquids	NNS	I-TREATMENT	I-TREATMENT
which	WDT	O	O
he	PRP	O	O
tolerated	VBD	O	O
.	.	O	O

he	PRP	O	O
will	MD	O	O
be	VB	O	O
advanced	VBN	O	O
to	TO	O	O
soft	JJ	B-TREATMENT	O
solids	NNS	I-TREATMENT	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

2.	CD	O	O
azotemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
baseline	JJ	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
1.8-2	CD	O	O
.	.	O	O

creatinine	NN	B-TEST	B-TEST
had	VBD	O	O
risen	VBN	O	O
to	TO	O	O
4.3	CD	O	O
on	IN	O	O
admission	NN	O	O
presumed	VBN	O	O
secondary	JJ	O	O
to	TO	O	O
sepsis	VB	B-PROBLEM	B-PROBLEM
and	CC	O	O
dehydration	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

with	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
hydration	NN	I-TREATMENT	I-TREATMENT
the	DT	B-TEST	I-TREATMENT
bun	NN	I-TEST	I-TREATMENT
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
fell	VBD	O	O
to	TO	O	O
12/1.9	CD	O	O
which	WDT	O	O
is	VBZ	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
for	IN	O	O
this	DT	O	O
patient	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
abdominal	JJ	I-TEST	I-TEST
cat	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
showed	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
hydronephrosis	NN	B-PROBLEM	B-PROBLEM
orrenal	JJ	B-PROBLEM	I-PROBLEM
abscess	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
written	VBN	O	O
for	IN	O	O
haldol	NN	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	NN	O	O
p.o.b.i.d.	NN	O	O
p.r.n.	NN	O	O
to	TO	O	O
help	VB	O	O
with	IN	O	O
this	DT	B-PROBLEM	B-PROBLEM
problem	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

medications	NNS	B-TREATMENT	B-TREATMENT
on	IN	I-TREATMENT	O
transfer	NN	I-TREATMENT	O
include	VBP	O	O
multivitamin	$	B-TREATMENT	B-TREATMENT
1	CD	O	O
tablet	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
;	:	O	O
pepcid	CC	B-TREATMENT	O
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
;	:	O	O
ventolin	CC	B-TREATMENT	B-TREATMENT
inhaler	VB	I-TREATMENT	I-TREATMENT
two	CD	O	O
puffs	NNS	O	O
q.i.d.	VBP	O	O
;	:	O	O
vancomycin	$	B-TREATMENT	B-TREATMENT
125	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.i.d.	NN	O	O
times	NNS	O	O
seven	CD	O	O
days	NNS	O	O
;	:	O	O
calcium	NN	B-TREATMENT	B-TREATMENT
carbonate	NN	I-TREATMENT	I-TREATMENT
1250	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
;	:	O	O
lotrimin	CC	B-TREATMENT	B-TREATMENT
cream	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
groin	VB	O	O
b.i.d.	JJ	O	O
p.r.n.	NN	O	O
;	:	O	O
o2	CC	B-TREATMENT	O
at	IN	O	O
four	CD	O	O
liters	NNS	O	O
per	IN	O	O
minute	NN	O	O
;	:	O	O
and	CC	O	O
haldol	VB	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
p.r.n.	NN	O	O

patient	NN	O	O
recorded	VBD	O	O
as	IN	O	O
having	VBG	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	O
drugs	NNS	I-PROBLEM	B-TREATMENT

abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

major	JJ	O	O
surgical	JJ	O	O
or	CC	O	O
invasive	JJ	O	B-TREATMENT
procedure	NN	O	I-TREATMENT
:	:	O	O
pheresis	NN	B-TEST	B-TEST
renal	JJ	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
32	CD	O	O
year	NN	O	O
old	JJ	O	O
male	NN	O	O
who	WP	O	O
was	VBD	O	O
recently	RB	O	O
discharged	VBN	O	O
from	IN	O	O
mediplex	JJ	O	O
rehab	NN	O	O
hospital	NN	O	O
and	CC	O	O
presents	NNS	O	O
again	RB	O	O
to	TO	O	O
us	PRP	O	O
with	IN	O	O
chief	JJ	O	O
complaint	NN	O	O
of	IN	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
sudden	JJ	B-PROBLEM	B-PROBLEM
onset	VBN	I-PROBLEM	I-PROBLEM
left-sided	JJ	I-PROBLEM	I-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
).	NN	O	O

of	IN	O	O
note	NN	O	O
,	,	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
recent	JJ	I-TEST	I-TEST
kidney	NN	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
on	IN	O	O
2018-07-30	JJ	O	O
and	CC	O	O
his	PRP$	B-TEST	B-TEST
cr	NN	I-TEST	I-TEST
bumped	VBD	O	O
from	IN	O	O
4.7	CD	O	O
to	TO	O	O
5.7	CD	O	O
.	.	O	O

also	RB	O	O
,	,	O	O
hct	NN	B-TEST	B-TEST
on	IN	O	O
admission	NN	O	O
21	CD	O	O
from	IN	O	O
25	CD	O	O
.	.	O	O

esrd	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
hd	NN	B-TREATMENT	O
(	(	O	O
m,w,f	NN	O	O
)	)	O	O
(	(	O	O
03-30	JJ	O	B-PROBLEM
glomerulonephritis	NN	B-PROBLEM	I-PROBLEM
)	)	O	I-PROBLEM

htn	NN	B-PROBLEM	B-PROBLEM

hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM

avf	SYM	B-TREATMENT	O
-	:	I-TREATMENT	O
r	NN	I-TREATMENT	O
radial	JJ	I-TREATMENT	O
-	:	I-TREATMENT	O
cephalic	NN	I-TREATMENT	B-PROBLEM

avf	SYM	B-TREATMENT	O
-	:	I-TREATMENT	O
l	NN	I-TREATMENT	O
aneurysm	NN	I-TREATMENT	B-PROBLEM
resection	NN	I-TREATMENT	I-PROBLEM

tunneled	VBN	B-TREATMENT	B-TREATMENT
l	NN	I-TREATMENT	I-TREATMENT
subclavian	JJ	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT

family	NN	O	O
history	NN	O	O
:	:	O	O
sister	NN	O	O
who	WP	O	O
is	VBZ	O	O
26	CD	O	O
also	RB	O	O
has	VBZ	O	O
esrd	VBN	B-PROBLEM	O
on	IN	O	O
hd	NN	B-TREATMENT	O
(	(	O	O
?	.	O	O
etiology	NN	O	O
)	)	O	O

vs	NN	B-TEST	O
:	:	O	O
afebrile	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hr	NN	B-TEST	O
:	:	O	O
70-80	JJ	O	O
,	,	O	O
99/70	CD	O	O

abd	NN	O	O
:	:	O	O
non-distended	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
tender	NN	B-PROBLEM	O
to	TO	O	O
palpation	NN	B-TEST	B-TEST
llq	NN	I-TEST	I-TEST

wbc	SYM	B-TEST	B-TEST
-	:	O	O
6.8	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
2.50	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
6.8	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
21.2	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
85	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
27.2	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
32.1	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
18.0	CD	O	O
*	JJ	O	O
plt	NN	B-TEST	B-TEST
ct	SYM	I-TEST	I-TEST
-	:	O	O
149	CD	O	O
*	NN	O	O
pt	NN	B-TEST	B-TEST
-	:	O	O
11.9	CD	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
31.1	CD	O	O
inr	NN	B-TEST	O
(	(	I-TEST	O
pt	NN	I-TEST	O
)	)	I-TEST	O
-	:	O	O
1.0	CD	O	O
fibrinogen	NN	B-TEST	B-TEST
-	:	O	O
148	CD	O	O
*	NN	O	O
glucose	VBD	B-TEST	B-TEST
-	:	O	O
144	CD	O	O
*	JJ	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
52	CD	O	O
*	NN	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
5.7	CD	O	O
*	NN	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
138	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
4.1	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
107	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
17	CD	O	O
*	NN	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
18	CD	O	O

2018-08-04	JJ	O	O
06:09	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
calcium	NN	B-TEST	I-TEST
-	:	O	O
8.3	CD	O	O
*	NN	O	O
phos	NN	B-TEST	B-TEST
-	:	O	O
5.0	CD	O	O
*	NN	O	O
mg	SYM	B-TEST	O
-	:	O	O
2.2	CD	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
5.7	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.10	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
8.9	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
26.2	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
85	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
28.7	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
33.9	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
15.4	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
186	CD	O	O
pt	NN	B-TEST	O
-	:	O	O
11.5	CD	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
25.6	CD	O	O
inr	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
pt	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
1.0	CD	O	I-TEST
fibrinogen	NN	B-TEST	I-TEST
-	:	O	O
443	CD	O	O
*	NN	O	O
glucose	VBD	B-TEST	B-TEST
-	:	O	O
104	CD	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
60	CD	O	O
*	NN	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
4.8	CD	O	O
*	NN	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
139	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
4.3	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
105	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
26	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
12	CD	O	O
calcium	NN	B-TEST	B-TEST
-	:	O	O
8.8	CD	O	O
phos	NN	B-TEST	B-TEST
-	:	O	O
5.0	CD	O	O
*	NN	O	O
mg	SYM	B-TEST	O
-	:	O	O
2.2	CD	O	O

blood	NN	B-TEST	B-TEST
wbc	SYM	B-TEST	B-TEST
-	:	O	O
5.7	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.10	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
8.9	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
26.2	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
85	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
28.7	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
33.9	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
15.4	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
186	CD	O	O

blood	NN	B-TEST	B-TEST
plt	NN	B-TEST	I-TEST
ct	VBD	I-TEST	I-TEST
-	:	O	O
186	CD	O	O

blood	NN	B-TEST	B-TEST
pt	SYM	B-TEST	B-TEST
-	:	O	O
11.5	CD	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
25.6	CD	O	O
inr	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
pt	JJ	I-TEST	I-TEST
)-	CD	I-TEST	I-TEST
1.0	CD	O	O

blood	NN	B-TEST	B-TEST
fibrino	NN	B-TEST	I-TEST
-	:	O	O
443	CD	O	O
*	NN	O	O

blood	NN	B-TEST	B-TEST
glucose	VB	B-TEST	I-TEST
-	:	O	O
104	CD	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
60	CD	O	O
*	NN	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
4.8	CD	O	O
*	NN	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
139	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
4.3	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
105	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
26	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
12	CD	O	O

blood	NN	B-TEST	B-TEST
calcium	NN	B-TEST	I-TEST
-	:	O	O
8.8	CD	O	O
phos	NN	B-TEST	B-TEST
-	:	O	O
5.0	CD	O	O
*	NN	O	O
mg	SYM	B-TEST	O
-	:	O	O
2.2	CD	O	O

this	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
on	IN	O	O
08-04	NN	O	O
after	IN	O	O
a	DT	O	O
recent	JJ	O	O
discharge	NN	O	O
from	IN	O	O
the	DT	O	O
hospital	NN	O	O
for	IN	O	O
sudden	JJ	O	B-PROBLEM
onset	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
left	NN	B-PROBLEM	I-PROBLEM
sided	VBD	I-PROBLEM	I-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

in	IN	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
ultrasound	NN	I-TEST	I-TEST
showed	VBD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
hydronephrosis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
new	JJ	B-PROBLEM	B-PROBLEM
perinephric	JJ	I-PROBLEM	I-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
surrounding	VBG	O	O
the	DT	O	B-TREATMENT
transplant	NN	O	I-TREATMENT
kidney	NN	O	I-TREATMENT
and	CC	O	O
hence	NN	O	O
,	,	O	O
underwent	VBD	O	O
a	DT	B-TEST	B-TEST
ct	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
his	PRP$	I-TEST	I-TEST
abdomen	NNS	I-TEST	I-TEST
/	NNP	I-TEST	I-TEST
pelvis	NN	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
a	DT	O	B-PROBLEM
large	JJ	O	I-PROBLEM
left-sided	JJ	O	I-PROBLEM
of	IN	O	I-PROBLEM
retroperitoneal	JJ	B-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
extending	VBG	O	O
down	RP	O	O
to	TO	O	O
the	DT	O	O
level	NN	O	O
of	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
renal	JJ	I-TREATMENT	I-TREATMENT
transplant	NN	I-TREATMENT	I-TREATMENT
possibly	RB	O	O
related	VBN	O	O
to	TO	O	O
recent	JJ	B-TEST	B-TREATMENT
transplant	NN	I-TEST	I-TREATMENT
biopsy	NN	I-TEST	I-TREATMENT
.	.	O	O

serial	JJ	B-TEST	B-PROBLEM
hematocrits	NNS	I-TEST	I-PROBLEM
and	CC	O	O
abdominal	JJ	B-TEST	B-TEST
exams	NNS	I-TEST	I-TEST
were	VBD	O	O
performed	VBN	O	O
.	.	O	O

on	IN	O	O
08-06	NN	O	O
,	,	O	O
he	PRP	O	O
received	VBD	O	O
2	CD	O	O
units	NNS	O	O
of	IN	O	O
prbc	NN	B-TREATMENT	O
and	CC	O	O
underwent	JJ	O	O
plasmaphersis	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
followed	VBN	O	O
by	IN	O	O
10mg	CD	O	O
of	IN	O	O
ivig	NN	B-TREATMENT	O
.	.	O	O

he	PRP	O	O
received	VBD	O	O
another	DT	B-TREATMENT	O
unit	NN	I-TREATMENT	O
prbc	NN	I-TREATMENT	O
on	IN	O	O
08-07	NN	O	O
.	.	O	O

by	IN	O	O
08-07	JJ	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
thought	VBN	O	O
there	RB	O	O
was	VBD	O	O
improvement	NN	O	O
of	IN	O	O
his	PRP$	B-TEST	B-TEST
labs	NN	I-TEST	I-TEST
.	.	O	O

in	IN	O	O
the	DT	O	O
am	VBP	O	O
of	IN	O	O
6/13	CD	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
given	VBN	O	O
1	CD	B-TREATMENT	O
unit	NN	I-TREATMENT	O
prbc	NN	I-TREATMENT	O
for	IN	O	O
a	DT	B-TEST	B-TEST
hct	NN	I-TEST	I-TEST
of	IN	O	O
21.8	CD	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
hct	NN	I-TEST	I-TEST
was	VBD	O	O
stable	JJ	O	O
on	IN	O	O
08-09	NN	O	O
at	IN	O	O
24.4	CD	O	O
;	:	O	O
he	PRP	O	O
had	VBD	O	O
plasmapheresis	NN	B-TREATMENT	B-PROBLEM
on	IN	O	O
08-09	NN	O	O
(	(	O	O
followed	VBN	O	O
by	IN	O	O
10	CD	O	O
mg	NNS	O	O
ivig	JJ	B-TREATMENT	O
).	NN	O	O

on	IN	O	O
08-10	NN	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
am	VBP	I-TEST	I-TEST
hct	NN	I-TEST	I-TEST
was	VBD	O	O
21.9	CD	O	O
,	,	O	O
hence	RB	O	O
,	,	O	O
he	PRP	O	O
received	VBD	O	O
1	CD	B-TREATMENT	O
unit	NN	I-TREATMENT	O
prbc	NN	I-TREATMENT	O
.	.	O	O

on	IN	O	O
08-10	JJ	O	O
class	NN	B-TEST	O
i	NN	I-TEST	O
and	CC	I-TEST	O
ii	VB	I-TEST	B-TEST
antibody	NN	I-TEST	I-TEST
levels	NNS	I-TEST	I-TEST
were	VBD	O	O
sent	VBN	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
plasmapheresis	NN	B-TREATMENT	B-PROBLEM
on	IN	O	O
08-11	NN	O	O
,	,	O	O
followed	VBN	O	O
by	IN	O	O
10	CD	B-TREATMENT	O
mg	NNS	I-TREATMENT	O
ivig	NN	I-TREATMENT	O
.	.	O	O

hct	NN	B-TEST	B-TEST
remained	VBD	O	O
stable	JJ	O	O
.	.	O	O

on	IN	O	O
08-15	NN	O	O
,	,	O	O
he	PRP	O	O
went	VBD	O	O
for	IN	O	O
pheresis	NN	B-TREATMENT	B-PROBLEM
/	NNP	O	O
ivig	NN	B-TREATMENT	O
.	.	O	O

no	DT	O	O
new	JJ	B-PROBLEM	B-PROBLEM
issues	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

llq	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
has	VBZ	O	O
improved	VBN	O	O
over	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
this	DT	O	B-TREATMENT
hospitalization	NN	O	I-TREATMENT
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
eating	VBG	O	O
and	CC	O	O
ambulating	VBG	O	B-PROBLEM
w/o	JJ	O	I-PROBLEM
difficulties	NNS	B-PROBLEM	I-PROBLEM
.	.	O	O

pheresis	NN	B-TREATMENT	O
to	TO	O	O
continue	VB	O	O
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
with	IN	O	O
supervision	NN	O	O
of	IN	O	O
transplant	JJ	O	O
nephrology	NN	O	O
on	IN	O	O
08-17	JJ	O	O
,	,	O	O
08-20	JJ	O	O
and	CC	O	O
08-22	JJ	O	O
.	.	O	O

prograf	NN	B-TREATMENT	O
was	VBD	O	O
increased	VBN	O	O
to	TO	O	O
12	CD	O	O
mg	NNS	O	O
bid	NN	O	O
on	IN	O	O
08-16	NN	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
trough	JJ	I-TEST	I-TEST
level	NN	I-TEST	I-TEST
of	IN	O	O
7.1	CD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
instructed	VBN	O	O
to	TO	O	O
have	VB	O	O
labs	NNS	B-TEST	B-TEST
drawn	VBN	O	O
on	IN	O	O
08-17	NN	O	O
to	TO	O	O
check	VB	O	B-TEST
trough	IN	B-TEST	I-TEST
level	NN	I-TEST	I-TEST
of	IN	I-TEST	O
prograf	NN	I-TEST	B-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
cbc	NN	B-TEST	B-TEST
,	,	O	O
chem	NN	B-TEST	B-TREATMENT
10	CD	I-TEST	O
,	,	O	O
coags	NNS	B-TEST	O
.	.	O	O

bactrim	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
valcyte	NN	B-TREATMENT	O
,	,	O	O
mmf	NN	B-TREATMENT	O
,	,	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
fk	NN	B-TREATMENT	O
,	,	O	O
nifedipine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
protonix	NN	B-TREATMENT	B-TREATMENT

1.	CD	O	O
docusate	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

2.	CD	O	O
mycophenolate	NN	B-TREATMENT	B-TREATMENT
mofetil	NN	I-TREATMENT	I-TREATMENT
500	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
three	CD	O	O
(	(	O	O
3	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

3.	CD	O	O
valganciclovir	JJ	B-TREATMENT	B-TREATMENT
450	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q48h	NN	O	O
(	(	O	O
every	DT	O	O
48	CD	O	O
hours	NNS	O	O
)	)	O	O
.	.	O	O

4.	CD	O	O
trimethoprim	JJ	B-TREATMENT	B-TEST
-	:	O	O
sulfamethoxazole	JJ	B-TREATMENT	O
80-400	JJ	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

5.	CD	O	O
nifedipine	JJ	B-TREATMENT	B-TREATMENT
60	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sustained	VBD	O	O
release	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
sustained	VBN	O	O
release	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

6.	CD	O	O
labetalol	JJ	B-TREATMENT	B-TREATMENT
200	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
four	CD	O	O
(	(	O	O
4	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

7.	CD	O	O
senna	JJ	B-TREATMENT	B-TREATMENT
8.6	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

8.	CD	O	O
oxycodone	CD	B-TREATMENT	B-TREATMENT
-	:	O	I-TREATMENT
acetaminophen	NN	B-TREATMENT	I-TREATMENT
5-325	JJ	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
tablets	NNS	O	O
po	JJ	O	O
q4-6h	JJ	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
to	TO	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

9.	CD	O	O
sevelamer	JJ	B-TREATMENT	B-TREATMENT
800	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

10.	CD	O	O
pantoprazole	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
q12h	NN	O	O
(	(	O	O
every	DT	O	O
12	CD	O	O
hours	NNS	O	O
)	)	O	O
.	.	O	O

11.	CD	O	O
minoxidil	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
0.5	CD	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

12.	CD	O	O
nystatin	JJ	B-TREATMENT	B-TREATMENT
100,000	CD	O	O
unit	NN	O	O
/	NNP	O	O
ml	NN	O	O
suspension	NN	O	O
sig	NN	O	O
:	:	O	O
five	CD	O	O
(	(	O	O
5	CD	O	O
)	)	O	O
ml	NN	O	O
po	NN	O	O
qid	NN	O	O
(	(	O	O
4	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

13.	CD	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
three	CD	O	O
(	(	O	O
3	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

14.	CD	O	O
epogen	NN	B-TREATMENT	B-TREATMENT
40,000	CD	O	O
unit	NN	O	O
/	NNP	O	O
ml	NN	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
ml	NN	O	O
injection	NN	O	O
once	RB	O	O
a	DT	O	O
week	NN	O	O
.	.	O	O

15.	CD	O	O
syringes	NNS	B-TREATMENT	O
for	IN	O	O
epogen	NN	B-TREATMENT	O
q	NN	O	O
week	NN	O	O

16.	CD	O	O
tacrolimus	JJ	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
q12h	NN	O	O
(	(	O	O
every	DT	O	O
12	CD	O	O
hours	NNS	O	O
)	)	O	O
.	.	O	O

17.	CD	O	O
tacrolimus	JJ	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

18.	CD	O	O
outpatient	JJ	B-TEST	O
lab	NN	I-TEST	O
work	NN	I-TEST	O

friday	JJ	O	O
08-17	CD	O	O
and	CC	O	O
monday	JJ	O	O
08-20	JJ	O	O
cbc	NN	B-TEST	O
,	,	O	O
chem10	NN	B-TEST	O
,	,	O	O
pt/ptt/inr	NN	B-TEST	O
and	CC	O	O
trough	JJ	B-TEST	B-PROBLEM
prograf	NN	I-TEST	I-PROBLEM
level	NN	I-TEST	I-PROBLEM
.	.	O	O

discharge	NN	O	O
diagnosis	NN	O	O
:	:	O	O
humoral	JJ	B-PROBLEM	B-PROBLEM
rejection	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
transplant	NN	I-PROBLEM	I-PROBLEM
perinephric	NN	B-PROBLEM	I-PROBLEM
transplant	NN	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM

please	VB	O	O
call	VB	O	O
transplant	JJ	O	O
office	NN	O	O
(	(	O	O
789	CD	O	O
)	)	O	O
583	CD	O	O
5023	CD	O	O
if	IN	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
/	NNP	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
bleeding	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
decreased	VBN	B-PROBLEM	B-PROBLEM
urine	JJ	I-PROBLEM	I-PROBLEM
output	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
weight	VBD	B-PROBLEM	B-TEST
gain	NN	I-PROBLEM	I-TEST
of	IN	O	O
3	CD	O	O
pounds	NNS	O	O
in	IN	O	O
a	DT	O	O
day	NN	O	O
,	,	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM

pheresis	NN	B-TREATMENT	O
friday	JJ	O	O
08-17	JJ	O	O
then	RB	O	O
monday	VBZ	O	O
08-20	NN	O	O

labwork	NN	B-TEST	O
every	DT	O	O
monday	NN	O	O
and	CC	O	O
thursday	JJ	O	O
per	IN	O	O
transplant	NN	O	O
clinic	NN	O	O
:	:	O	O
cbc	NN	B-TEST	B-TEST
,	,	O	O
chem	NN	B-TEST	B-TEST
7	CD	I-TEST	O
,	,	O	O
ca	MD	B-TEST	O
,	,	O	O
phos	VB	B-TEST	B-TEST
,	,	O	O
ast	NN	B-TEST	B-TEST
,	,	O	O
t	NN	B-TEST	O
bili	NN	I-TEST	O
,	,	O	O
u/a	JJ	B-TEST	O
and	CC	O	O
trough	JJ	B-TEST	B-PROBLEM
prograf	NN	I-TEST	I-PROBLEM
level	NN	I-TEST	I-PROBLEM
.	.	O	O

pheresis	NN	B-TREATMENT	B-PROBLEM
,	,	O	O
bed	VBD	O	O
five	CD	O	O
pheresis	NN	O	O
rooms	NNS	O	O
date	NN	O	O
/	JJ	O	O
time	NN	O	O
:	:	O	O
2018-08-17	JJ	O	O
9:15	CD	O	O

pheresis	NN	B-TREATMENT	B-PROBLEM
,	,	O	O
bed	VBD	O	O
six	CD	O	B-TREATMENT
pheresis	NN	O	I-TREATMENT
rooms	NNS	O	O
date	NN	O	O
/	JJ	O	O
time	NN	O	O
:	:	O	O
2018-08-20	JJ	O	O
2:00	CD	O	O

chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

07/09/00	CD	O	O
at	IN	O	O
04:00	CD	O	O
pm	NN	O	O
contingent	NN	O	O
upon	IN	O	O
attending	VBG	B-TEST	O
evaluation	NN	I-TEST	B-TEST

tylenol	NN	B-TREATMENT	B-TREATMENT
#3	NNP	I-TREATMENT	I-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
acetaminophen	JJ	I-TREATMENT	I-TREATMENT
w	NN	I-TREATMENT	I-TREATMENT
/	NNP	I-TREATMENT	O
codeine	NN	I-TREATMENT	B-TREATMENT
30mg	CD	O	O
)	)	O	O
1-2	CD	O	O
tab	NN	O	O
po	NN	O	O
q4h	NN	O	O
prn	NN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
allopurinol	IN	B-TREATMENT	B-TREATMENT
300	CD	O	O
mg	NNS	O	O
po	JJ	O	O
qd	JJ	O	O
colace	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
docusate	JJ	I-TREATMENT	I-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	JJ	O	O
po	NN	O	O
bid	NN	O	O
hydrochlorothiazide	RB	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NNS	O	O
po	JJ	O	O
qd	JJ	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
starting	VBG	O	O
today	NN	O	O
(	(	O	O
07/09	CD	O	O
)	)	O	O

flagyl	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
metronidazole	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
500	CD	O	O
mg	NN	O	O
po	NN	O	O
tid	NN	O	O

dr.	NN	O	O
mandessquarc	NN	O	O
,	,	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM

chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
unclear	JJ	I-PROBLEM	O
etiology	NN	I-PROBLEM	O

principal	JJ	O	O
discharge	NN	O	O
diagnosis	NN	O	O
;	:	O	O
responsible	JJ	O	O
after	IN	O	O
study	NN	O	O
for	IN	O	O
causing	VBG	O	O
admission	NN	O	O
)	)	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

80	CD	O	O
yo	JJ	O	O
woman	NN	O	O
recently	RB	O	O
diagnosed	VBD	O	O
with	IN	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
squamous	JJ	I-PROBLEM	I-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
ca	MD	I-PROBLEM	I-PROBLEM
.	.	O	O

mets	NNS	B-PROBLEM	O
to	TO	I-PROBLEM	O
spine	VB	I-PROBLEM	O
,	,	I-PROBLEM	O
femur	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
xrt	NN	B-TREATMENT	O
.	.	O	O

tumor	NN	B-PROBLEM	B-PROBLEM
invasive	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
pleura	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
rib	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

admitted	VBN	O	O
after	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
onset	NN	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
chest	JJS	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

transferred	VBN	O	O
today	NN	O	O
from	IN	O	O
ez	FW	O	O
ephtro	FW	O	O
health	NN	O	O
center	NN	O	O
on	IN	O	O
lmwh	NN	O	O
for	IN	O	O
r	NN	O	O
/	NNP	O	O
o	VBZ	O	O
pe	JJ	B-PROBLEM	O
vs	NN	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
vs	NN	O	I-PROBLEM
tumor	NN	B-PROBLEM	I-PROBLEM
invasion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

following	VBG	O	O
enzymes	NNS	B-TEST	B-TEST
to	TO	O	O
rule	VB	O	O
out	RP	O	O
unstable	JJ	B-PROBLEM	B-PROBLEM
angina	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
no	DT	O	O
ekg	NN	B-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
)	)	O	O
.	.	O	O

v	NN	B-TEST	O
/	NN	I-TEST	O
q	NN	I-TEST	O
at	IN	O	O
outside	JJ	O	O
hospital	NN	O	O
read	VBD	O	O
as	IN	O	O
low	JJ	O	B-PROBLEM
prob.	NN	O	I-PROBLEM
leni	NN	O	I-PROBLEM
&apos;s	NN	O	I-PROBLEM
here	RB	O	O
neg.	JJ	O	O
d/c&apos;ed	NN	O	O
on	IN	O	O
levo	NN	B-TREATMENT	B-TREATMENT
/	NNP	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
presumed	JJ	O	O
post-obstructive	JJ	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
continue	NN	O	O
with	IN	O	O
medications	NNS	B-TREATMENT	B-TREATMENT
as	IN	O	O
prescribed	NNS	O	O
,	,	O	O
including	VBG	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
(	(	O	O
levofloxacin	JJ	B-TREATMENT	B-TREATMENT
/	NNP	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
)	)	O	O
through	IN	O	O
7/16/00	CD	O	O
.	.	O	O

2.	CD	O	O
if	IN	O	O
you	PRP	O	O
have	VBP	O	O
further	JJ	B-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
other	JJ	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
which	WDT	O	O
concern	NN	O	O
you	PRP	O	O
,	,	O	O
call	VB	O	O
your	PRP$	O	O
doctor	NN	O	O
.	.	O	O

iodine	NN	B-TREATMENT	B-TREATMENT

chief	JJ	O	O
complaint	NN	O	O
:	:	O	O
sp	JJ	O	O
cardiac	JJ	B-PROBLEM	O
arrest	NN	I-PROBLEM	O
/	NN	O	O
colitis	NN	B-PROBLEM	B-PROBLEM

sp	NN	O	B-TREATMENT
left	VBD	B-TREATMENT	I-TREATMENT
subclavian	JJ	I-TREATMENT	I-TREATMENT
cvl	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT

sp	RB	O	B-TREATMENT
right	JJ	B-TREATMENT	I-TREATMENT
femoral	JJ	I-TREATMENT	I-TREATMENT
cvl	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT

79f	CD	O	O
pmhx	NN	O	O
chf,copd	NN	B-PROBLEM	O
,	,	O	O
found	VBD	O	O
down	RB	O	O
at	IN	O	O
home	NN	O	O
,	,	O	O
pulseless	JJ	B-PROBLEM	B-TEST
-	:	O	O
cpr	NN	B-TREATMENT	O
initiated	JJ	O	O
w/	NN	O	O
conciousness	NN	O	O
regained	VBD	O	O
on	IN	O	O
scene	NN	O	O
.	.	O	O

at	IN	O	O
osh	JJ	O	O
abg	NN	B-TEST	B-TEST
7.19/94/110	CD	O	O
,	,	O	O
bipap	NN	B-TREATMENT	B-TEST
started	VBD	O	O
.	.	O	O

pt	NN	O	O
found	VBD	O	O
to	TO	O	O
be	VB	O	O
hypothermic	JJ	B-PROBLEM	O
w/	NN	O	O
wbc	NN	B-TEST	B-TEST
17	CD	O	O
(	(	O	O
pt	NN	O	O
on	IN	O	O
steroids	NNS	B-TREATMENT	B-TREATMENT
)	)	O	O
pnuemobilia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
thickening	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
sigmoid	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

currently	RB	O	O
on	IN	O	O
nasal	JJ	B-TREATMENT	B-TREATMENT
cannula	NN	I-TREATMENT	I-TREATMENT
02	CD	I-TREATMENT	O
+	NNP	O	O
hemodymamically	RB	O	O
stable	JJ	O	O
.	.	O	O

chf	NN	B-PROBLEM	O
(	(	O	O
ef	JJ	B-TEST	O
25%	CD	O	O
,	,	O	O
mod	NN	B-PROBLEM	O
as,ar	NN	I-PROBLEM	O
,	,	O	O
mod	NN	B-PROBLEM	O
mr	NN	I-PROBLEM	O
,	,	O	O
cad,paf	NN	B-PROBLEM	O
,	,	O	O
angina	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
copd	NN	B-PROBLEM	B-PROBLEM
(	(	O	O
o2	JJ	B-PROBLEM	O
dependent	NN	I-PROBLEM	O
-	:	O	O
2	CD	O	O
l	NN	O	O
)	)	O	O
pvd	NN	B-PROBLEM	O
,	,	O	O
recurrent	NN	B-PROBLEM	B-PROBLEM
uti	NN	I-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
,	,	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
bronchitis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
?	.	O	O
h/o	NN	O	O

dm	NN	B-PROBLEM	O
,	,	O	O
sp	JJ	O	B-PROBLEM
l	NN	B-TREATMENT	I-PROBLEM
ax-bifem	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
l	JJ	B-TREATMENT	O
fem-cmed	JJ	I-TREATMENT	O
,	,	O	O
ercp	JJ	B-TREATMENT	O
'04	CD	O	O
,	,	O	O
t+a	NN	B-TREATMENT	O
,	,	O	O
appy	JJ	B-TREATMENT	O
,	,	O	O
cea	JJ	B-TREATMENT	O
,	,	O	O
l4-l5	JJ	B-TREATMENT	B-TREATMENT
laminectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

irrr	NN	B-PROBLEM	O

decreased	VBN	B-PROBLEM	B-PROBLEM
bs	NNS	I-PROBLEM	I-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM

soft	JJ	O	O
,	,	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
r	NN	I-PROBLEM	O
and	CC	I-PROBLEM	O
l	NN	I-PROBLEM	B-TEST
lower	JJR	I-PROBLEM	I-TEST
quadrants	NNS	I-PROBLEM	I-TEST
-	:	O	O
not	RB	O	O
reproducible	VB	O	O

visible	JJ	B-TREATMENT	B-PROBLEM
fem-fem	JJ	I-TREATMENT	I-PROBLEM
graft	NN	I-TREATMENT	I-PROBLEM

ext	JJ	O	O
warm	NN	O	O
,	,	O	O
+	$	B-PROBLEM	O
1	CD	I-PROBLEM	O
edema	NN	I-PROBLEM	B-PROBLEM

2013-09-22	JJ	O	O
04:20	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	B-TEST	B-TEST
-	:	O	O
13.8	CD	O	O
*	NN	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.17	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
8.9	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
28.4	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
90	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
28.2	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
31.4	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
15.0	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
185	CD	O	O

2013-09-24	JJ	O	O
03:15	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	B-TEST	B-TEST
-	:	O	O
6.8	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
2.86	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
7.7	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
25.9	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
91	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
27.0	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
29.9	CD	O	O
*	NN	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
15.1	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
178	CD	O	O

2013-09-25	JJ	O	O
02:41	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	B-TEST	B-TEST
-	:	O	O
5.3	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
2.94	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
8.2	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
27.4	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
93	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
27.9	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
29.9	CD	O	O
*	NN	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
15.0	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
194	CD	O	O

2013-09-23	JJ	O	O
03:07	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
pt	NN	B-TEST	I-TEST
-	:	O	O
14.0	CD	O	O
*	NN	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
30.1	CD	O	O
inr	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
pt	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
1.2	CD	O	O
*	NN	O	O

2013-09-22	JJ	O	O
04:20	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
86	CD	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
18	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
0.8	CD	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
144	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
3.7	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
101	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
40	CD	O	O
*	NN	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
7	CD	O	O
*	NN	O	O

2013-09-24	JJ	O	O
09:36	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
202	CD	O	O
*	JJ	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
25	CD	O	O
*	NN	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.1	CD	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
139	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
3.9	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
100	CD	O	O
hco3	NN	B-TEST	O
-	:	O	O
37	CD	O	O
*	NN	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
6	CD	O	O
*	NN	O	O

2013-09-25	JJ	O	O
02:41	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
122	CD	O	O
*	JJ	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
31	CD	O	O
*	NN	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.3	CD	O	O
*	NN	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
139	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
4.1	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
99	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
35	CD	O	O
*	NN	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
9	CD	O	O

2013-09-22	JJ	O	O
04:20	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
alt	NN	B-TEST	I-TEST
-	:	O	O
51	CD	O	O
*	NN	O	O
ast	VBD	B-TEST	B-TEST
-	:	O	O
86	CD	O	O
*	JJ	O	O
ck	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
cpk	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
638	CD	O	O
*	NN	O	O
alkphos	SYM	B-TEST	B-TEST
-	:	O	O
65	CD	O	O
amylase	NN	B-TEST	B-TEST
-	:	O	O
120	CD	O	O
*	NN	O	O
totbili	SYM	B-TEST	B-TEST
-	:	O	O
0.4	CD	O	O

2013-09-22	JJ	O	O
12:38	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
ck	NN	B-TEST	I-TEST
(	(	I-TEST	I-TEST
cpk	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
1086	CD	O	O
*	NN	O	O

2013-09-22	JJ	O	O
09:45	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
ck	NN	B-TEST	I-TEST
(	(	I-TEST	I-TEST
cpk	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
972	CD	O	O
*	NN	O	O

2013-09-25	JJ	O	O
02:41	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
ck	NN	B-TEST	I-TEST
(	(	I-TEST	I-TEST
cpk	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
218	CD	O	O
*	NN	O	O

2013-09-22	JJ	O	O
04:20	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
ctropnt	NN	B-TEST	B-TEST
-	:	O	O
0.18	CD	O	O
*	NN	O	O

2013-09-22	JJ	O	O
12:38	CD	O	O
pm	JJ	O	O
blood	NN	B-TEST	B-TEST
ck-mb	JJ	B-TEST	B-TEST
-	:	O	O
18	CD	O	O
*	JJ	O	O
mb	NN	B-TEST	B-TEST
indx	SYM	I-TEST	I-TEST
-	:	O	O
1.7	CD	O	O
ctropnt	NN	B-TEST	B-TEST
-	:	O	O
0.17	CD	O	O
*	NN	O	O

2013-09-22	JJ	O	O
09:45	CD	O	O
pm	JJ	O	O
blood	NN	B-TEST	O
ck-mb	JJ	B-TEST	O
-14	NN	O	O
*	NNP	O	O
mb	NN	B-TEST	B-TEST
indx	NN	I-TEST	I-TEST
-	:	O	O
1.4	CD	O	O

2013-09-23	JJ	O	O
04:26	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
ck-mb	JJ	B-TEST	B-TEST
-	:	O	O
10	CD	O	O
mb	NN	B-TEST	B-TEST
indx	NN	I-TEST	I-TEST
-	:	O	O
1.4	CD	O	O
ctropnt	NN	B-TEST	B-TEST
-	:	O	O
0.12	CD	O	O
*	NN	O	O

2013-09-25	JJ	O	O
02:41	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
ck-mb	JJ	B-TEST	B-TEST
-	:	O	O
5	CD	O	O
ctropnt	NN	B-TEST	B-TEST
-	:	O	O
0.10	CD	O	O
*	NN	O	O

2013-09-22	JJ	O	O
04:20	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
calcium	NN	B-TEST	I-TEST
-	:	O	O
8.1	CD	O	O
*	NN	O	O
phos	NN	B-TEST	B-TEST
-	:	O	O
3.2	CD	O	O
mg	SYM	B-TEST	O
-	:	O	O
2.0	CD	O	O

2013-09-25	JJ	O	O
02:41	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
calcium	NN	B-TEST	I-TEST
-	:	O	O
8.2	CD	O	O
*	NN	O	O
phos	NN	B-TEST	B-TEST
-	:	O	O
5.3	CD	O	O
*	NN	O	O
mg	SYM	B-TEST	O
-	:	O	O
1.9	CD	O	O

2013-09-23	JJ	O	O
07:36	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
vanco	NN	B-TEST	I-TEST
-	:	O	O
16.2	CD	O	O
*	NN	O	O

2013-09-24	JJ	O	O
10:26	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
type	NN	I-TEST	I-TEST
-	:	O	O
art	NN	O	O
po2	VBZ	B-TEST	O
-	:	O	O
105	CD	O	O
pco2	NN	B-TEST	O
-	:	O	O
95	CD	O	O
*	NN	O	O
ph	NN	B-TEST	B-TEST
-	:	O	O
7.19	CD	O	O
*	NN	O	O
caltco2	NN	B-TEST	B-TEST
-	:	O	O
38	CD	O	O
*	JJ	O	O
base	NN	B-TEST	B-TEST
xs	NNP	I-TEST	I-TEST
-	:	O	O
4	CD	O	O

2013-09-24	JJ	O	O
11:05	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
type	NN	I-TEST	I-TEST
-	:	O	O
may	MD	O	O
po2	VB	B-TEST	O
-	:	O	O
35	CD	O	O
*	NN	O	O
pco2	NN	B-TEST	B-TEST
-	:	O	O
107	CD	O	O
*	NN	O	O
ph	NN	B-TEST	B-TEST
-	:	O	O
7.17	CD	O	O
*	NN	O	O
caltco2	NN	B-TEST	B-TEST
-	:	O	O
41	CD	O	O
*	JJ	O	O
base	NN	B-TEST	B-TEST
xs	NNP	I-TEST	I-TEST
-	:	O	O
5	CD	O	O

2013-09-24	JJ	O	O
11:31	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
type	NN	I-TEST	I-TEST
-	:	O	O
art	NN	O	O
po2	VBZ	B-TEST	O
-	:	O	O
144	CD	O	O
*	NN	O	O
pco2	NN	B-TEST	B-TEST
-	:	O	O
80	CD	O	O
*	NN	O	O
ph	NN	B-TEST	B-TEST
-	:	O	O
7.23	CD	O	O
*	NN	O	O
caltco2	NN	B-TEST	B-TEST
-	:	O	O
35	CD	O	O
*	JJ	O	O
base	NN	B-TEST	B-TEST
xs	NNP	I-TEST	I-TEST
-	:	O	O
3	CD	O	O

2013-09-24	JJ	O	O
07:42	CD	O	O
pm	NN	O	B-TEST
blood	NN	B-TEST	I-TEST
type	NN	I-TEST	I-TEST
-	:	O	O
art	NN	O	O
po2	VBZ	B-TEST	O
-	:	O	O
127	CD	O	O
*	NN	O	O
pco2	NN	B-TEST	B-TEST
-	:	O	O
105	CD	O	O
*	NN	O	O
ph	NN	B-TEST	B-TEST
-	:	O	O
7.16	CD	O	O
*	NN	O	O
caltco2	NN	B-TEST	B-TEST
-	:	O	O
40	CD	O	O
*	JJ	O	O
base	NN	B-TEST	B-TEST
xs	NNP	I-TEST	I-TEST
-	:	O	O
4	CD	O	O

2013-09-24	JJ	O	O
09:19	CD	O	O
pm	NN	O	B-TEST
blood	NN	B-TEST	I-TEST
type	NN	I-TEST	I-TEST
-	:	O	O
art	NN	O	O
po2	VBZ	B-TEST	O
-	:	O	O
76	CD	O	O
*	NN	O	O
pco2	NN	B-TEST	B-TEST
-	:	O	O
85	CD	O	O
*	NN	O	O
ph	NN	B-TEST	B-TEST
-	:	O	O
7.26	CD	O	O
*	NN	O	O
caltco2	NN	B-TEST	B-TEST
-	:	O	O
40	CD	O	O
*	JJ	O	O
base	NN	B-TEST	B-TEST
xs	NNP	I-TEST	I-TEST
-	:	O	O
7	CD	O	O

2013-09-25	JJ	O	O
01:50	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
type	NN	I-TEST	I-TEST
-	:	O	O
art	NN	O	O
po2	VBZ	B-TEST	O
-	:	O	O
47	CD	O	O
*	NN	O	O
pco2	NN	B-TEST	B-TEST
-	:	O	O
105	CD	O	O
*	NN	O	O
ph	NN	B-TEST	B-TEST
-	:	O	O
7.15	CD	O	O
*	NN	O	O
caltco2	NN	B-TEST	B-TEST
-	:	O	O
39	CD	O	O
*	JJ	O	O
base	NN	B-TEST	B-TEST
xs	NNP	I-TEST	I-TEST
-	:	O	O
3	CD	O	O

2013-09-25	JJ	O	O
02:54	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
type	NN	I-TEST	I-TEST
-	:	O	O
art	NN	O	O
po2	VBZ	B-TEST	O
-	:	O	O
64	CD	O	O
*	NN	O	O
pco2	NN	B-TEST	B-TEST
-	:	O	O
91	CD	O	O
*	NN	O	O
ph	NN	B-TEST	B-TEST
-	:	O	O
7.23	CD	O	O
*	NN	O	O
caltco2	NN	B-TEST	B-TEST
-	:	O	O
40	CD	O	O
*	JJ	O	O
base	NN	B-TEST	B-TEST
xs	NNP	I-TEST	I-TEST
-	:	O	O
6	CD	O	O

ct	JJ	B-TEST	B-TEST
cspine	NN	I-TEST	I-TEST
:	:	O	O

no	DT	O	O
evidence	NN	O	O
of	IN	O	O
cervical	JJ	B-PROBLEM	B-PROBLEM
spine	NN	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

cervical	JJ	B-PROBLEM	B-PROBLEM
spondylosis	NN	I-PROBLEM	I-PROBLEM
as	IN	O	O
described	VBN	O	O
above	IN	O	O
.	.	O	O

cxr	NN	B-TEST	O
post	NN	O	O
cvl	JJ	B-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
09-23	NN	O	O
:	:	O	O

a	DT	B-TREATMENT	B-TREATMENT
left	JJ	I-TREATMENT	I-TREATMENT
subclavian	JJ	I-TREATMENT	I-TREATMENT
vascular	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
terminates	NNS	O	O
in	IN	O	O
the	DT	O	O
superior	JJ	O	O
vena	NN	O	O
cava	NN	O	O
.	.	O	O

several	JJ	O	O
skin	NN	O	O
folds	NNS	O	O
are	VBP	O	O
present	JJ	O	O
in	IN	O	O
the	DT	O	O
left	JJ	O	O
hemithorax	NN	O	O
but	CC	O	O
there	EX	O	O
is	VBZ	O	O
no	DT	O	O
pneumothorax	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
are	VBP	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
moderate	JJ	I-PROBLEM	I-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
both	DT	O	O
of	IN	O	O
which	WDT	O	O
have	VBP	O	O
increased	VBN	O	B-PROBLEM
in	IN	O	I-PROBLEM
size	NN	O	I-PROBLEM
since	IN	O	O
the	DT	B-TEST	B-TEST
previous	JJ	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
.	.	O	O

new	JJ	B-PROBLEM	B-PROBLEM
perihilar	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
basilar	JJ	I-PROBLEM	B-PROBLEM
opacities	NNS	I-PROBLEM	I-PROBLEM
may	MD	O	I-PROBLEM
reflect	VB	O	I-PROBLEM
pulmonary	JJ	B-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
sparing	VBG	O	O
the	DT	O	O
upper	JJ	O	O
lobes	NN	O	O
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
emphysema	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
but	CC	O	O
it	PRP	O	O
is	VBZ	O	O
difficult	JJ	O	O
to	TO	O	O
exclude	VB	O	O
underlying	JJ	B-PROBLEM	B-PROBLEM
aspiration	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
infectious	JJ	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
bases	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

surgical	JJ	B-TREATMENT	B-TREATMENT
clips	NNS	I-TREATMENT	I-TREATMENT
are	VBP	O	O
present	JJ	O	O
in	IN	O	O
the	DT	O	O
left	JJ	O	O
axilla	NN	O	O
.	.	O	O

09-25	JJ	O	O
cxr	NN	B-TEST	O
:	:	O	O

interval	NN	O	B-PROBLEM
development	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
large	JJ	B-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
pneumothorax	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
almost	RB	B-PROBLEM	B-PROBLEM
complete	JJ	I-PROBLEM	I-PROBLEM
collapse	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

79f	CD	O	O
w/	WRB	O	O
a	DT	O	B-PROBLEM
multiple	JJ	B-PROBLEM	I-PROBLEM
medical	JJ	I-PROBLEM	I-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
including	VBG	O	O
sylvia	NN	O	B-PROBLEM
(	(	O	O
ef20%	NN	B-TEST	O
)	)	O	O
,	,	O	O
copd	NN	B-PROBLEM	B-PROBLEM
(	(	O	O
on	IN	O	O
home	NN	B-TREATMENT	B-TREATMENT
o2	NN	I-TREATMENT	I-TREATMENT
)	)	O	I-TREATMENT
,	,	O	O
found	VBD	O	O
down	RB	O	O
at	IN	O	O
home	NN	O	O
,	,	O	O
pulseless	JJ	B-PROBLEM	B-TEST
-	:	O	O
cpr	NN	B-TREATMENT	O
initiated	JJ	O	O
w/conciousness	NN	O	O
regained	VBD	O	O
on	IN	O	O
scene	NN	O	O
.	.	O	O

at	IN	O	O
osh	JJ	O	O
abg	NN	B-TEST	B-TEST
7.19/94/110	CD	O	O
,	,	O	O
bipap	NN	B-TREATMENT	B-TEST
started	VBD	O	O
.	.	O	O

pt	NN	O	O
found	VBD	O	O
to	TO	O	O
be	VB	O	O
hypothermic	JJ	B-PROBLEM	O
w/	NN	O	O
wbc	NN	B-TEST	B-TEST
17	CD	O	O
(	(	O	O
pt	NN	O	O
on	IN	O	O
steroids	NNS	B-TREATMENT	B-TREATMENT
)	)	O	O
pnuemobilia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
thickening	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
sigmoid	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pt	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
hospital	NN	O	O
for	IN	O	O
orthopedics	NNS	O	O
for	IN	O	O
further	JJ	B-TREATMENT	B-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
wishes	NNS	O	O
from	IN	O	O
the	DT	O	O
pt	NN	O	O
and	CC	O	O
family	NN	O	O
to	TO	O	O
reverse	VB	O	O
dnr/dni	NN	O	O
status	NN	O	O
if	IN	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
indicated	VBN	O	O
.	.	O	O

on	IN	O	O
transfer	NN	O	O
,	,	O	O
the	DT	O	O
pt	NN	O	O
had	VBD	O	O
vss	VBN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
mildly	RB	I-PROBLEM	I-PROBLEM
tender	NN	I-PROBLEM	I-PROBLEM
abdomen	NNS	I-PROBLEM	I-PROBLEM
without	IN	O	O
peritoneal	JJ	O	O
signs	NNS	O	O
.	.	O	O

it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
to	TO	O	O
treat	VB	O	O
her	PRP$	O	O
conservatively	RB	O	O
with	IN	O	O
bowel	NN	B-TREATMENT	O
and	CC	I-TREATMENT	O
iv	JJ	I-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
improved	VBD	O	O
and	CC	O	O
was	VBD	O	O
tolerating	VBG	O	O
po	NN	O	O
's	POS	O	O
without	IN	O	O
difficulty	NN	O	O
after	IN	O	O
passing	VBG	O	O
a	DT	B-TEST	B-TEST
swallow	NN	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
.	.	O	O

her	PRP$	O	B-TEST
cpine	NN	O	I-TEST
was	VBD	O	O
clearly	RB	O	O
with	IN	O	O
both	DT	O	O
a	DT	O	O
negative	JJ	O	O
ct	NN	O	O
cspine	NN	O	O
and	CC	O	O
clinical	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
.	.	O	O

her	PRP$	B-TREATMENT	B-TEST
groin	NN	I-TREATMENT	I-TEST
cvl	NN	I-TREATMENT	I-TEST
was	VBD	O	O
dc	JJ	O	O
'd	MD	O	O
after	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
l	NN	I-TREATMENT	I-TREATMENT
sc	NN	I-TREATMENT	I-TREATMENT
svl	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
palced	VBN	O	O
.	.	O	O

cxr	NN	B-TEST	O
confirmed	VBD	O	O
good	JJ	O	O
position	NN	O	O
and	CC	O	O
no	DT	O	O
ptx	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

overnight	VBN	O	O
on	IN	O	O
hd	NN	O	B-TREATMENT
3	CD	O	O
,	,	O	O
pt	NN	O	O
became	VBD	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
agitated	VBN	I-PROBLEM	I-PROBLEM
and	CC	O	O
an	DT	B-TEST	B-TEST
abg	NN	I-TEST	I-TEST
was	VBD	O	O
drawn	VBN	O	O
which	WDT	O	O
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
severe	JJ	I-PROBLEM	I-PROBLEM
resp	NN	I-PROBLEM	I-PROBLEM
acidosis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
bipap	NN	B-TREATMENT	B-TEST
was	VBD	O	O
initiated	VBN	O	O
.	.	O	O

the	DT	O	O
pt	NN	O	O
subsequently	RB	O	O
developed	VBD	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
hypoxia	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
cxr	NN	I-TEST	I-TEST
was	VBD	O	O
obtained	VBN	O	O
which	WDT	O	O
showed	VBD	O	O
complete	JJ	B-PROBLEM	O
collapse	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
l	NN	I-PROBLEM	O
lung	NN	I-PROBLEM	O
thought	VBD	O	O
to	TO	O	O
be	VB	O	O
a	DT	O	O
result	NN	O	O
of	IN	O	O
bursting	VBG	O	O
a	DT	B-PROBLEM	O
bleb	NN	I-PROBLEM	O
associated	VBN	O	O
with	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
severe	JJ	I-PROBLEM	I-PROBLEM
copd	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

family	NN	O	O
did	VBD	O	O
not	RB	O	O
want	VB	O	O
a	DT	B-TREATMENT	B-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
placed	VBD	O	O
and	CC	O	O
decided	VBD	O	O
to	TO	O	O
make	VB	O	O
the	DT	O	O
pt	NN	O	O
cmo	NN	B-TREATMENT	O
measures	NNS	I-TREATMENT	O
.	.	O	O

on	IN	O	O
hd	$	O	O
4	CD	O	O
pt	NN	O	O
continued	VBD	O	O
to	TO	O	O
show	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
severe	JJ	I-PROBLEM	I-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
acidosis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
morphine	NN	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
was	VBD	O	O
difficult	JJ	O	O
to	TO	O	O
arouse	VB	O	O
.	.	O	O

coreg	NN	B-TREATMENT	O
6.25	CD	O	O
"	NN	O	O
,	,	O	O
captopril	VBP	B-TREATMENT	B-TREATMENT
12.5	CD	O	O
"	NN	O	O
,	,	O	O
effexor	RB	B-TREATMENT	B-TREATMENT
150	CD	O	O
'	''	O	O
,	,	O	O
colace	VBP	B-TREATMENT	B-TREATMENT
100	CD	O	O
"	JJ	O	O
prn	NN	O	O
,	,	O	O
calcium	NN	B-TREATMENT	B-TEST
"	NN	O	O
,	,	O	O
lasix	VBZ	B-TREATMENT	B-TREATMENT
40	CD	O	O
'	''	O	O
,	,	O	O
kcl	VBD	B-TREATMENT	B-TREATMENT
20	CD	O	O
'	''	O	O
,	,	O	O
pred	VBD	B-TREATMENT	O
5	CD	O	O
'	''	O	O
,	,	O	O
opscal	JJ	B-TREATMENT	O
'	''	O	O
,	,	O	O
protonix	VBZ	B-TREATMENT	B-TREATMENT
40	CD	O	O
'	''	O	O
,	,	O	O
diamoxx	VBZ	B-TREATMENT	O
250	CD	O	O
'	''	O	O
,	,	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
prn	NN	O	O
,	,	O	O
darvocet	NN	B-TREATMENT	O
prn	NN	O	O
,	,	O	O
senekot	NN	B-TREATMENT	O
,	,	O	O
trazadone	RB	B-TREATMENT	B-TREATMENT
25	CD	O	O
'	''	O	O

discharge	NN	O	O
diagnosis	NN	O	O
:	:	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM

sepsis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
ards	NNS	B-PROBLEM	O
,	,	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM

penicillins	NNS	B-TREATMENT	B-TREATMENT

sepsis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
ards	NNS	B-PROBLEM	O
,	,	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM

principal	JJ	O	O
discharge	NN	O	O
diagnosis	NN	O	O
;	:	O	O
responsible	JJ	O	O
after	IN	O	O
study	NN	O	O
for	IN	O	O
causing	VBG	O	O
admission	NN	O	O
)	)	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
ards	NNS	B-PROBLEM	O
,	,	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM

other	JJ	O	O
diagnosis	NN	O	O
;	:	O	O
conditions	NNS	O	O
,	,	O	O
infections	NNS	O	O
,	,	O	O
complications	NNS	O	O
,	,	O	O
affecting	VBG	O	O
treatment	NN	O	O
/	NNP	O	O
stay	NN	O	O
dm2	RB	B-PROBLEM	O
,	,	O	O
s	JJ	O	O
/	NNP	O	O
p	NN	O	O
splenectomy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
depression	NN	B-PROBLEM	B-PROBLEM

patient	NN	O	O
on	IN	O	O
vent	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
febrile	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypotensive	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

developed	JJ	O	O
requirement	NN	B-PROBLEM	O
for	IN	O	O
multiple	JJ	B-TREATMENT	B-TREATMENT
pressors	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
then	RB	O	O
arrhythmias	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

full	JJ	B-TREATMENT	O
code	NN	I-TREATMENT	O
carried	VBD	O	O
out	RP	O	O
.	.	O	O

despite	IN	O	O
extraordinary	JJ	B-TREATMENT	O
measures	NNS	I-TREATMENT	O
,	,	O	O
stable	JJ	O	O
sinus	NN	O	O
rhythm	NN	O	O
could	MD	O	O
not	RB	O	O
be	VB	O	O
restored	VBN	O	O
.	.	O	O

subarachnoid	JJ	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	O
posttraumatic	JJ	I-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
a	DT	O	O
79	CD	O	O
-	:	O	O
year-old	JJ	O	O
gentleman	NN	O	O
found	VBD	O	O
down	RB	O	O
at	IN	O	O
home	NN	O	O
unresponsive	NN	B-PROBLEM	O
by	IN	O	O
his	PRP$	O	O
wife	NN	O	O
after	IN	O	O
lunch	NN	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
no	DT	O	O
history	NN	O	O
of	IN	O	O
headaches	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
recent	JJ	B-PROBLEM	B-PROBLEM
illness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
remained	VBD	O	O
unresponsive	JJ	B-PROBLEM	B-PROBLEM
when	WRB	O	O
the	DT	O	O
ambulance	NN	O	O
arrived	VBD	O	O
.	.	O	O

systolic	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
reported	VBN	O	O
250	CD	O	O
on	IN	O	O
arrival	NN	O	O
to	TO	O	O
the	DT	O	O
mass.	NN	O	O
eye	NN	O	O
&	CC	O	O
ear	JJ	O	O
infirmary	JJ	O	O
emergency	NN	O	O
department	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
intubated	VBN	O	B-TREATMENT
and	CC	O	O
given	VBN	O	O
versed	JJ	B-TREATMENT	B-TREATMENT
and	CC	O	O
fentanyl	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

his	PRP$	B-TEST	O
gcs	NN	I-TEST	O
was	VBD	O	O
reported	VBN	O	O
as	IN	O	O
3	CD	O	O
on	IN	O	O
arrival	NN	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
department	NN	O	O
.	.	O	O

hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

status	NN	O	O
post	NN	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

pacemaker	NN	B-TREATMENT	B-TREATMENT
implantation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

cerebrovascular	JJ	B-PROBLEM	B-PROBLEM
accident	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

previous	JJ	B-PROBLEM	B-PROBLEM
intracranial	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

aspirin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
folate	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
multivitamin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
imdur	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
celexa	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
potassium	NN	B-TREATMENT	B-TEST
.	.	O	O

he	PRP	O	O
was	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
154/75	CD	O	O
,	,	O	O
on	IN	O	O
nipride	JJ	B-TREATMENT	B-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
81	CD	O	O
,	,	O	O
oxygen	NN	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST
97%	CD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
intubated	VBN	B-TREATMENT	B-TREATMENT
and	CC	O	O
sedated	VBN	B-TREATMENT	B-TREATMENT
at	IN	O	O
the	DT	O	O
time	NN	O	O
.	.	O	O

pinpoint	NN	B-PROBLEM	O
pupils	NNS	I-PROBLEM	O
,	,	O	O
intact	JJ	O	B-TEST
corneal	NN	O	I-TEST
reflexes	NNS	O	I-TEST
bilaterally	RB	O	O
.	.	O	O

doll	NN	B-PROBLEM	B-TEST
's	POS	I-PROBLEM	I-TEST
eyes	NNS	I-PROBLEM	I-TEST
.	.	O	O

he	PRP	O	O
withdrew	VBD	O	O
both	DT	O	O
lower	JJR	O	O
extremities	NNS	O	O
to	TO	O	O
peripheral	JJ	B-TEST	B-PROBLEM
stimulation	NN	I-TEST	I-PROBLEM
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
his	PRP$	O	O
upper	JJ	O	O
extremities	NNS	O	O
to	TO	O	O
peripheral	JJ	B-TEST	B-PROBLEM
stimulation	NN	I-TEST	I-PROBLEM
.	.	O	O

he	PRP	O	O
also	RB	O	O
withdrew	VBD	O	O
his	PRP$	O	O
left	JJ	O	O
upper	JJ	O	O
extremity	NN	O	O
to	TO	O	O
peripheral	JJ	B-TEST	B-PROBLEM
stimulation	NN	I-TEST	I-PROBLEM
but	CC	O	O
not	RB	O	O
his	PRP$	O	B-PROBLEM
right	JJ	O	I-PROBLEM
upper	JJ	O	I-PROBLEM
extremity	NN	O	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
reflexes	NNS	I-TEST	I-TEST
were	VBD	O	O
brisk	VBN	O	O
in	IN	O	O
his	PRP$	O	O
patellas	NN	O	O
bilaterally	RB	O	O
,	,	O	O
and	CC	O	O
he	PRP	O	O
had	VBD	O	O
upgoing	JJ	B-PROBLEM	O
toes	NNS	I-PROBLEM	O
bilaterally	RB	I-PROBLEM	O
.	.	O	O

head	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
showed	VBD	O	O
diffuse	IN	B-PROBLEM	B-PROBLEM
subarachnoid	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
neuro	JJ	O	O
surgical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
close	JJ	O	B-TEST
monitoring	NN	O	I-TEST
and	CC	O	O
neuro-checks	NNS	B-TEST	O
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
vent	NN	I-TREATMENT	I-TREATMENT
drain	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
to	TO	O	O
monitor	VB	O	O
and	CC	O	O
cp	VB	O	O
and	CC	O	O
relieved	VB	O	O
fluid	NN	O	O
.	.	O	O

he	PRP	O	O
received	VBD	O	O
12	CD	O	O
u	NN	O	O
of	IN	O	O
platelets	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

his	PRP$	B-TEST	B-TEST
neurologic	JJ	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
did	VBD	O	O
not	RB	O	O
change	VB	O	O
significantly	RB	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
icps	NN	I-TEST	I-TEST
were	VBD	O	O
in	IN	O	O
the	DT	O	O
range	NN	O	O
of	IN	O	O
11-22	JJ	O	O
,	,	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
weaned	VBN	O	O
off	RP	O	O
the	DT	B-TREATMENT	B-TREATMENT
nipride	JJ	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
developed	VBD	O	O
extensive	JJ	B-PROBLEM	B-PROBLEM
posturing	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
cta	NN	I-TEST	I-TEST
showed	VBD	O	O
diffuse	IN	B-PROBLEM	B-PROBLEM
subarachnoid	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
intraventricular	JJ	B-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
on	IN	O	O
09-26	NN	O	O
showed	VBD	O	O
worsening	NN	O	B-PROBLEM
of	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
diffuse	NN	I-PROBLEM	I-PROBLEM
subarachnoid	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
new	JJ	I-PROBLEM	I-PROBLEM
cerebellar	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
family	NN	O	O
was	VBD	O	O
informed	VBN	O	O
of	IN	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
condition	NN	O	O
and	CC	O	O
repeat	NN	B-TEST	B-TEST
scan	JJ	I-TEST	I-TEST
.	.	O	O

a	DT	O	O
family	NN	O	O
discussion	NN	O	O
resulted	VBD	O	O
in	IN	O	O
the	DT	O	O
decision	NN	O	O
to	TO	O	O
make	VB	O	O
the	DT	O	O
patient	NN	O	O
comfort	NN	B-TREATMENT	O
measures	VBZ	I-TREATMENT	O
only	RB	I-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
morphine	NN	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
extubated	VBN	O	B-TREATMENT
and	CC	O	O
passed	VBN	O	O
away	RB	O	O
at	IN	O	O
10:55	CD	O	O
a.m.	RB	O	O
on	IN	O	O
2011-09-27	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
40	CD	O	O
year	NN	O	O
old	JJ	O	O
woman	NN	O	O
with	IN	O	O
end	NN	B-PROBLEM	B-PROBLEM
stage	NN	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
on	IN	O	O
hemodialysis	NN	B-TREATMENT	B-TREATMENT
since	IN	O	O
12/91	CD	O	O
.	.	O	O

this	DT	O	O
was	VBD	O	O
secondary	JJ	O	O
to	TO	O	O
polycystic	JJ	B-PROBLEM	B-PROBLEM
kidneydisease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
was	VBD	O	O
noted	VBN	O	O
since	IN	O	O
age	NN	O	O
12	CD	O	O
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
status	NN	O	O
post	NN	O	O
cadaveric	JJ	B-TREATMENT	B-TREATMENT
renal	NN	I-TREATMENT	I-TREATMENT
allograft	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
03/93	CD	O	O
,	,	O	O
and	CC	O	O
she	PRP	O	O
subsequently	RB	O	O
underwent	VBD	O	O
an	DT	B-TREATMENT	B-TREATMENT
early	JJ	I-TREATMENT	I-TREATMENT
postoperative	NN	I-TREATMENT	I-TREATMENT
transplant	NN	I-TREATMENT	I-TREATMENT
nephrectomy	JJ	I-TREATMENT	I-TREATMENT
secondary	JJ	O	O
to	TO	O	O
rupture	VB	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
having	VBG	O	O
difficult	JJ	B-PROBLEM	B-PROBLEM
access	NN	I-PROBLEM	I-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
now	RB	O	O
has	VBZ	O	O
a	DT	B-TREATMENT	B-TREATMENT
left	VBN	I-TREATMENT	I-TREATMENT
upper	JJ	I-TREATMENT	I-TREATMENT
arm	NN	I-TREATMENT	I-TREATMENT
ptfe	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
been	VBN	O	O
placed	VBN	O	O
on	IN	O	O
emergency	NN	B-TREATMENT	B-TREATMENT
transplant	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
this	DT	B-PROBLEM	B-PROBLEM
difficult	JJ	I-PROBLEM	I-PROBLEM
access	NN	I-PROBLEM	I-PROBLEM
problem	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

otherwise	RB	O	O
,	,	O	O
she	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
healthy	JJ	O	O
and	CC	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
last	JJ	I-TREATMENT	I-TREATMENT
hemodialysis	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
the	DT	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
transplant	VB	B-TREATMENT	O
.	.	O	O

significant	JJ	O	O
for	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

multiple	JJ	B-TREATMENT	B-PROBLEM
angio	NN	I-TREATMENT	I-PROBLEM
accesses	NNS	I-TREATMENT	I-PROBLEM
,	,	O	O
tah	NN	B-TREATMENT	O
at	IN	O	O
age	NN	O	O
18	CD	O	O
,	,	O	O
cadaveric	JJ	B-TREATMENT	B-TREATMENT
renal	NN	I-TREATMENT	I-TREATMENT
allograft	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
03/93	CD	O	O
,	,	O	O
reoperation	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
bleed	NN	B-PROBLEM	B-PROBLEM
followed	VBN	O	O
by	IN	O	O
transplant	JJ	B-TREATMENT	B-TREATMENT
nephrectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

iron	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
nephro-caps	JJ	B-TREATMENT	O
,	,	O	O
calcium	JJ	B-TREATMENT	B-TREATMENT
carbonate	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
valium	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
on	IN	O	O
11/30/93	CD	O	O
where	WRB	O	O
dr.	NN	O	O
tiveloydherdes	NNS	O	O
performed	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
cadaveric	JJ	I-TREATMENT	I-TREATMENT
renal	NN	I-TREATMENT	I-TREATMENT
allograft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
left	JJ	I-TREATMENT	I-TREATMENT
iliac	NN	I-TREATMENT	I-TREATMENT
fossa	NN	I-TREATMENT	I-TREATMENT
which	WDT	O	O
she	PRP	O	O
tolerated	VBD	O	O
well	RB	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
immunosuppressive	JJ	I-TREATMENT	I-TREATMENT
agents	NNS	I-TREATMENT	I-TREATMENT
as	IN	O	O
per	IN	O	O
protocol	NN	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
fell	VBD	O	O
to	TO	O	O
the	DT	O	O
normal	JJ	O	O
range	NN	O	O
early	RB	O	O
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
prednisone	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
tapered	VBN	O	O
to	TO	O	O
a	DT	B-TREATMENT	O
stable	JJ	I-TREATMENT	O
dose	NN	I-TREATMENT	O
.	.	O	O

discharge	NN	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
prednisone	RB	B-TREATMENT	B-TREATMENT
30	CD	O	O
q.d.	NN	O	O
,	,	O	O
imuran	VBD	B-TREATMENT	O
120	CD	O	O
q.d.	NN	O	O
,	,	O	O
cyclosporin	VBP	B-TREATMENT	B-TREATMENT
400	CD	O	O
b.i.d.	NN	O	O
and	CC	O	O
pepcid	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
b.i.d.	NN	O	O
and	CC	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
b.i.d.	NN	O	O

no	DT	O	O
drug	NN	B-PROBLEM	B-PROBLEM
allergy	VBZ	I-PROBLEM	I-PROBLEM
information	NN	O	O
on	IN	O	O
file	NN	O	O

left	VBN	B-PROBLEM	B-PROBLEM
sided	JJ	I-PROBLEM	I-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
slurred	VBD	B-PROBLEM	B-PROBLEM
speech	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

intubation	NN	B-TREATMENT	B-TREATMENT
and	CC	O	I-TREATMENT
mechanical	JJ	B-TREATMENT	I-TREATMENT
ventilation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
75	CD	O	O
year	NN	O	O
old	JJ	O	O
right	NN	O	O
handed	VBD	O	O
male	NN	O	O
with	IN	O	O
past	JJ	O	O
medical	JJ	O	O
history	NN	O	O
of	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
s/p	JJ	O	O
nqwmi	JJ	B-PROBLEM	B-TREATMENT
02-25	NN	O	I-TREATMENT
,	,	O	O
s/p	NN	O	B-TREATMENT
lad	NN	B-TREATMENT	I-TREATMENT
angioplasty	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
stent	JJ	B-TREATMENT	O
05-26	NN	O	O
,	,	O	O
dementia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hyperlipidemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
aortic	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
who	WP	O	O
presented	VBD	O	O
from	IN	O	O
his	PRP$	O	O
cmed	VBN	O	O
csru	NN	O	B-PROBLEM
doctor	NN	O	I-PROBLEM
's	POS	O	I-PROBLEM
office	NN	O	I-PROBLEM
wtih	NN	O	I-PROBLEM
acute	NN	B-PROBLEM	I-PROBLEM
onset	NN	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
sided	JJ	I-PROBLEM	I-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
dysarthria	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

was	VBD	O	O
at	IN	O	O
this	DT	O	O
doctor	NN	O	O
's	POS	O	O
office	NN	O	O
and	CC	O	O
complained	VBD	O	O
of	IN	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
headache	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

thereafter	RB	O	O
,	,	O	O
wife	NN	O	O
noted	VBD	O	O
development	NN	O	O
of	IN	O	O
left	NN	B-PROBLEM	B-PROBLEM
sided	VBD	I-PROBLEM	I-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
facial	JJ	B-PROBLEM	B-PROBLEM
droop	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
slurring	VBG	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
speech	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

sent	NN	O	O
to	TO	O	O
hahnemann	VB	O	O
general	JJ	O	O
hospital	NN	O	O
for	IN	O	O
evaluation	NN	B-TEST	B-TEST
emergently	RB	O	O
.	.	O	O

finger	NN	B-TEST	B-TEST
stick	VB	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
glucose	JJ	I-TEST	I-TEST
120	CD	O	O
.	.	O	O

rest	NN	O	O
of	IN	O	O
vitals	NNS	B-TEST	B-TEST
bp	VBP	B-TEST	O
112/70	CD	O	O
,	,	O	O
hr	VBD	B-TEST	O
60	CD	O	O
.	.	O	O

blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
up	IN	O	O
to	TO	O	O
230	CD	O	O
s	NNS	O	O
systolic	JJ	O	O
.	.	O	O

initial	JJ	B-TEST	O
nih	NNS	I-TEST	O
stroke	VBD	I-TEST	O
scale	NN	I-TEST	O
of	IN	O	O
33	CD	O	O
.	.	O	O

head	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
showed	VBD	O	O
large	JJ	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
intracerebral	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

intubated	VBN	O	B-TREATMENT
for	IN	O	O
airway	NN	B-TREATMENT	B-TREATMENT
protection	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
13:35	CD	O	O
after	IN	O	O
fentanyl	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
etomidate	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
vecuronium	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
succhinylcholine	VB	B-TREATMENT	O
given	VBN	O	O
.	.	O	O

started	VBN	O	O
on	IN	O	O
labetalol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
then	RB	O	O
nipride	RB	B-TREATMENT	O
drip	NN	I-TREATMENT	O
for	IN	O	O
bp	NN	B-TREATMENT	B-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
;	:	O	O
discontinued	VBN	O	O
as	IN	O	O
goal	NN	B-TEST	O
bp	NN	I-TEST	O
in	IN	O	O
130-160	JJ	O	O
s.	NN	O	O

received	VBD	O	O
10	CD	B-TREATMENT	O
mg	NNS	I-TREATMENT	O
sc	JJ	I-TREATMENT	O
vitamin	NN	I-TREATMENT	B-TREATMENT
k	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
2	CD	B-TREATMENT	O
units	NNS	I-TREATMENT	O
ffp	VBP	I-TREATMENT	O
while	IN	O	O
in	IN	O	O
gary	NN	O	O
.	.	O	O

pupils	NNS	O	O
noted	VBD	O	O
to	TO	O	O
be	VB	O	O
fixed	VBN	B-PROBLEM	O
and	CC	O	O
dilated	VBN	B-PROBLEM	O
at	IN	O	O
14:10	CD	O	O
.	.	O	O

loaded	VBN	O	O
with	IN	O	O
dilantin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
50	CD	B-TREATMENT	O
grams	NNS	I-TREATMENT	O
mannitol	NN	I-TREATMENT	B-TREATMENT
.	.	O	O

1.	CD	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT

2.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
status	NN	O	O
post	NN	O	O
nqwmi	IN	B-PROBLEM	O
02-25	NN	O	O
,	,	O	O
s/p	NN	O	B-TREATMENT
lad	NN	B-TREATMENT	I-TREATMENT
angioplasty	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
stent	JJ	B-TREATMENT	B-TREATMENT
05-26	JJ	O	O
.	.	O	O
known	VBN	B-PROBLEM	B-PROBLEM
non-dominant	JJ	I-PROBLEM	I-PROBLEM
90%	CD	I-PROBLEM	I-PROBLEM
rca	NN	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
not	RB	O	O
intervened	VBN	O	O
upon	IN	O	O
.	.	O	O

3.	CD	O	O
dementia	NN	B-PROBLEM	B-PROBLEM

4.	CD	O	O
mild-moderate	JJ	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM

5.	CD	O	O
hyperlipidemia	NN	B-PROBLEM	B-PROBLEM

6.	CD	O	O
colon	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM

7.	CD	O	O
obstructive	JJ	B-PROBLEM	B-PROBLEM
sleep	NN	I-PROBLEM	I-PROBLEM
apnea	NN	I-PROBLEM	I-PROBLEM

8.	CD	O	O
anxiety	NN	B-PROBLEM	B-PROBLEM

9.	CD	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	RB	I-PROBLEM	I-PROBLEM
,	,	O	O
on	IN	O	O
oral	JJ	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT

physical	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
(	(	O	O
examined	VBN	O	O
off	IN	O	O
of	IN	O	O
propofol	NN	B-TREATMENT	B-TREATMENT
):	NN	O	I-TREATMENT

tc	NN	B-TEST	O
:	:	O	O
96.7	CD	O	O

bp	NN	B-TEST	O
:	:	O	O
120/48	CD	O	O

hr	NN	B-TEST	O
:	:	O	O
61	CD	O	O

rr	NN	B-TEST	O
:	:	O	O
14	CD	O	O

o2sat.	NN	B-TEST	O
:	:	O	O
100%	CD	O	O
,	,	O	O
ventilated	VBN	B-TREATMENT	O
.	.	O	O

gen	NN	O	O
:	:	O	O
wd/wn	JJ	O	O
male	NN	O	O
,	,	O	O
comfortable	JJ	O	O
appearing	VBG	O	O
,	,	O	O
intubated	VBN	B-TREATMENT	B-TREATMENT
,	,	O	O
not	RB	O	O
sedated	VBN	B-TREATMENT	O
.	.	O	O

heent	NN	O	O
:	:	O	O
nc/at	NN	B-PROBLEM	O
.	.	O	O

anicteric	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

+endotracheal	JJ	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
lad	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
jvd	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
thyromegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
carotid	NN	B-PROBLEM	B-PROBLEM
bruits	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

lungs	NNS	O	O
:	:	O	O
coarse	JJ	B-PROBLEM	B-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
sounds	VBZ	I-PROBLEM	I-PROBLEM
anterolaterally	RB	I-PROBLEM	O
.	.	O	O

cardiac	NN	O	O
:	:	O	O
irregularly	RB	B-PROBLEM	B-PROBLEM
irregular	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
m/r/g	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

abd	NN	O	O
:	:	O	O
soft	JJ	O	O
,	,	O	O
nt	JJ	B-PROBLEM	O
,	,	O	O
nd	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
+nabs	NNS	O	B-PROBLEM
.	.	O	O

no	DT	O	O
rebound	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
guarding	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
hsm	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
c/c/e	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	B-PROBLEM	O
response	NN	I-PROBLEM	O
to	TO	I-PROBLEM	O
voice	NN	I-PROBLEM	O
,	,	O	O
sternal	JJ	B-TEST	B-PROBLEM
rub	NN	I-TEST	I-PROBLEM
.	.	O	O

grimaces	NNS	O	B-PROBLEM
to	TO	O	I-PROBLEM
nasal	VB	B-TEST	I-PROBLEM
tickle	NN	I-TEST	I-PROBLEM
.	.	O	O

pupils	NNS	B-PROBLEM	O
fixed	VBN	I-PROBLEM	O
at	IN	O	O
7	CD	O	O
mm	NNS	O	O
bilaterally	RB	O	O
.	.	O	O

very	RB	O	B-PROBLEM
weak	JJ	O	I-PROBLEM
flicker	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
inner	JJ	O	I-PROBLEM
canthus	NNS	O	I-PROBLEM
on	IN	O	O
left	NN	O	O
with	IN	O	O
corneal	JJ	B-TEST	B-TREATMENT
stimulation	NN	I-TEST	I-TREATMENT
.	.	O	O

no	DT	B-PROBLEM	O
oculocephalic	JJ	I-PROBLEM	B-PROBLEM
reflex	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

left	VBN	B-PROBLEM	B-PROBLEM
facial	JJ	I-PROBLEM	I-PROBLEM
droop	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	B-PROBLEM	O
gag	NN	I-PROBLEM	B-PROBLEM
provoked	VBD	O	O
,	,	O	O
but	CC	O	O
biting	VBG	O	B-PROBLEM
ett	NN	B-TREATMENT	I-PROBLEM
at	IN	O	O
times	NNS	O	O
.	.	O	O

no	DT	B-PROBLEM	O
withdrawal	NN	I-PROBLEM	O
to	TO	O	O
noxious	JJ	B-TEST	B-PROBLEM
stimuli	NNS	I-TEST	I-PROBLEM
.	.	O	O

no	DT	B-PROBLEM	O
withdrawal	NN	I-PROBLEM	O
to	TO	O	O
noxious	JJ	B-TEST	B-PROBLEM
stimuli	NNS	I-TEST	I-PROBLEM
.	.	O	O

reflexes	NNS	B-TEST	B-TEST
:	:	O	O

striking	VBG	O	B-PROBLEM
left	VBD	O	I-PROBLEM
patellar	JJ	O	I-PROBLEM
tendon	NN	O	I-PROBLEM
results	NNS	O	I-PROBLEM
in	IN	O	I-PROBLEM
sustained	JJ	B-PROBLEM	I-PROBLEM
clonus	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
leg	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

toes	NNS	B-PROBLEM	O
upgoing	VBG	I-PROBLEM	O
bilaterally	RB	I-PROBLEM	O
.	.	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
9.1	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
4.29	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
14.1	CD	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
38.7	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
90	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
32.8	CD	O	O
*	NN	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
36.4	CD	O	O
*	NN	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
14.7	CD	O	O

plt	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
-	:	O	O
147	CD	O	O
*	NN	O	O

pt	SYM	B-TEST	B-TEST
-	:	O	O
20.0	CD	O	O
*	NN	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
32.4	CD	O	O
inr	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
pt	JJ	I-TEST	I-TEST
)-	CD	I-TEST	I-TEST
2.5	CD	O	O

glucose	JJ	B-TEST	B-TEST
-	:	O	O
101	CD	O	O
urea	JJ	B-TEST	B-TEST
n	SYM	I-TEST	I-TEST
-	:	O	O
25	CD	O	O
*	NN	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.0	CD	O	O
sodium	NN	B-TEST	B-TEST
-	:	O	O
142	CD	O	O
potassium	NN	B-TEST	B-TEST
-	:	O	O
4.2	CD	O	O
chloride	NN	B-TEST	B-TEST
-	:	O	O
106	CD	O	O
total	JJ	B-TEST	B-TEST
co2	NN	I-TEST	I-TEST
-	:	O	O
27	CD	O	O
anion	NN	B-TEST	B-TEST
gap	NN	I-TEST	I-TEST
-	:	O	O
13	CD	O	O

ck	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
cpk	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
200	CD	O	O
*	NN	O	O

2013-11-11	JJ	O	O
12:39	CD	O	O
pm	NN	O	O
ctropnt	NN	B-TEST	O
-<	VBD	O	O
0.01	CD	O	O

ck-mb	JJ	B-TEST	B-TEST
-	:	O	O
7	CD	O	O

ck	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
cpk	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
196	CD	O	O
*	NN	O	O

ck-mb	JJ	B-TEST	B-TEST
-	:	O	O
3	CD	O	O
ctropnt	NN	B-TEST	B-TEST
-<	CD	O	O
0.01	CD	O	O

2013-11-12	JJ	O	O
03:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
ck	NN	B-TEST	I-TEST
(	(	I-TEST	I-TEST
cpk	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
312	CD	O	O
*	NN	O	O

2013-11-12	JJ	O	O
03:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
ck-mb	JJ	B-TEST	B-TEST
-	:	O	O
5	CD	O	O
ctropnt	NN	B-TEST	B-TEST
-<	CD	O	O
0.01	CD	O	O

2013-11-11	JJ	O	O
01:55	CD	O	O
pm	JJ	O	O
urine	JJ	B-TEST	B-TEST
blood	NN	B-TEST	I-TEST
-	:	O	I-TEST
sm	NN	O	I-TEST
nitrite	JJ	B-TEST	I-TEST
-	:	O	O
neg	NN	O	O
protein	SYM	B-TEST	B-TEST
-	:	O	O
100	CD	O	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
ketone	NN	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
bilirubin	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
urobilngn	JJ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
ph	SYM	B-TEST	B-TEST
-	:	O	O
6.5	CD	O	O
leuk	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O

2013-11-12	JJ	O	O
11:16	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
asa	NN	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
ethanol	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
acetmnp	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
bnzodzp	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
barbitr	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
tricycl	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O

2013-11-12	JJ	O	O
10:17	CD	O	O
am	VBP	O	O
urine	JJ	B-TEST	B-TEST
bnzodzp	NN	B-TEST	I-TEST
-	:	O	O
neg	NN	O	O
barbitr	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
opiates	VBZ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
cocaine	NN	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
amphetm	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
mthdone	NN	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O

ct	JJ	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
without	IN	I-TEST	I-TEST
contrast	NN	I-TEST	I-TEST
2013-11-11	CD	O	O
:	:	O	O

there	EX	O	O
is	VBZ	O	O
a	DT	O	O
large	JJ	O	O
region	NN	O	O
of	IN	O	O
high	JJ	B-PROBLEM	B-PROBLEM
attenuation	NN	I-PROBLEM	I-PROBLEM
within	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
frontal	NN	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
the	DT	O	O
region	NN	O	O
of	IN	O	O
the	DT	O	O
right	JJ	O	O
basal	NN	O	O
ganglia	NNS	O	B-PROBLEM
.	.	O	O

this	DT	O	O
is	VBZ	O	O
consistent	JJ	O	O
with	IN	O	O
intraparenchymal	JJ	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
more	RBR	O	O
likely	JJ	O	O
hypertensive	NN	B-PROBLEM	B-PROBLEM
in	IN	O	O
etiology	NN	O	O
.	.	O	O

no	DT	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
subarachnoid	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
intraventricular	JJ	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
appreciated	VBN	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
mass	JJ	B-PROBLEM	B-PROBLEM
effect	NN	I-PROBLEM	I-PROBLEM
present	NN	O	O
with	IN	O	O
shift	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
normally	RB	I-PROBLEM	I-PROBLEM
midline	JJ	I-PROBLEM	I-PROBLEM
structures	NNS	I-PROBLEM	I-PROBLEM
towards	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	NN	O	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
also	RB	O	O
left	VBN	B-PROBLEM	B-PROBLEM
sided	JJ	I-PROBLEM	I-PROBLEM
subfalcine	NN	I-PROBLEM	I-PROBLEM
herniation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
hydrocephalus	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

large	JJ	B-PROBLEM	B-PROBLEM
intraparenchymal	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
within	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
frontal	NN	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
most	RBS	O	O
likely	JJ	O	O
relates	NNS	O	O
to	TO	O	O
hypertensive	JJ	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
as	IN	O	O
opposed	VBN	O	O
to	TO	O	O
a	DT	B-PROBLEM	B-PROBLEM
ruptured	VBN	I-PROBLEM	I-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
middle	JJ	I-PROBLEM	I-PROBLEM
cerebral	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
was	VBD	O	O
a	DT	O	O
75	CD	O	O
year	NN	O	O
old	JJ	O	O
right	NN	O	O
handed	VBD	O	O
male	NN	O	O
with	IN	O	O
past	JJ	O	O
medical	JJ	O	O
history	NN	O	O
of	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hyperlipidemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
dementia	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
sudden	JJ	B-PROBLEM	B-PROBLEM
onset	NN	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
sided	JJ	I-PROBLEM	I-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
dysarthria	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

head	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
demonstrated	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
intracerebral	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
centered	VBN	O	O
around	IN	O	O
basal	NN	O	B-PROBLEM
ganglia	NNS	O	I-PROBLEM
and	CC	O	O
putamen	NNS	O	O
.	.	O	O

we	PRP	O	O
felt	VBD	O	O
this	DT	O	O
was	VBD	O	O
likely	JJ	O	O
secondary	JJ	O	O
to	TO	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

while	IN	O	O
still	RB	O	O
in	IN	O	O
the	DT	O	O
emergency	NN	O	O
department	NN	O	O
,	,	O	O
he	PRP	O	O
had	VBD	O	O
rapid	JJ	B-PROBLEM	B-PROBLEM
decompensation	NN	I-PROBLEM	I-PROBLEM
necessitating	VBG	O	O
intubation	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
airway	NN	B-TREATMENT	B-TREATMENT
protection	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

examination	NN	B-TEST	B-TEST
post	NN	O	O
intubation	NN	B-TREATMENT	B-TREATMENT
but	CC	O	O
off	IN	O	O
intubations	NNS	B-TREATMENT	O
showed	VBD	O	O
clinical	JJ	O	O
evidence	NN	O	O
of	IN	O	O
elevated	JJ	B-PROBLEM	B-PROBLEM
intracranial	JJ	I-PROBLEM	I-PROBLEM
pressure	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
brainstem	NN	B-PROBLEM	I-PROBLEM
compression	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
loaded	VBN	O	O
with	IN	O	O
mannitol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
dilantin	NN	B-TREATMENT	B-TREATMENT
in	IN	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
evaluated	VBN	O	O
by	IN	O	O
the	DT	O	O
neurosurgery	NN	O	O
service	NN	O	O
and	CC	O	O
they	PRP	O	O
did	VBD	O	O
not	RB	O	O
feel	VB	O	O
a	DT	B-TREATMENT	B-TREATMENT
surgical	JJ	I-TREATMENT	I-TREATMENT
intervention	NN	I-TREATMENT	I-TREATMENT
or	CC	O	O
ventriculary	JJ	B-TREATMENT	B-TREATMENT
drain	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
warranted	VBN	O	O
.	.	O	O

after	IN	O	O
arrival	NN	O	O
in	IN	O	O
the	DT	O	O
icu	NN	O	O
,	,	O	O
patient	NN	O	O
was	VBD	O	O
followed	VBN	O	O
with	IN	O	O
neuro	JJ	B-TEST	B-TEST
checks	NNS	I-TEST	I-TEST
every	DT	O	O
1	CD	O	O
hour	NN	O	O
.	.	O	O

sedation	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
held	VBN	O	O
to	TO	O	O
allow	VB	O	O
for	IN	O	O
frequent	JJ	B-TEST	B-TEST
exams	NNS	I-TEST	I-TEST
.	.	O	O

labetalol	RB	B-TREATMENT	B-TREATMENT
continuous	JJ	I-TREATMENT	I-TREATMENT
infusion	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
titrated	VBN	O	O
for	IN	O	O
systolic	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
130-160	JJ	O	O
.	.	O	O

mannitol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
dilantin	NN	B-TREATMENT	B-TREATMENT
were	VBD	O	O
continued	VBN	O	O
.	.	O	O

overnight	RB	O	O
,	,	O	O
fresh	JJ	B-TREATMENT	B-TREATMENT
frozen	JJ	I-TREATMENT	I-TREATMENT
plasma	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
given	VBN	O	O
for	IN	O	O
goal	NN	B-TEST	O
inr	NN	I-TEST	O
of	IN	O	O
<	$	O	O
1.4	CD	O	O
.	.	O	O

on	IN	O	O
serial	JJ	B-TEST	B-TEST
exams	NNS	I-TEST	I-TEST
by	IN	O	O
neurology	NN	O	O
and	CC	O	O
icu	JJ	O	O
attendings	NNS	O	O
in	IN	O	O
the	DT	O	O
morning	NN	O	O
on	IN	O	O
2013-11-12	JJ	O	O
,	,	O	O
patient	JJ	O	O
had	VBD	O	O
no	DT	B-PROBLEM	O
clinical	JJ	I-PROBLEM	B-PROBLEM
signs	NNS	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
brainstem	NN	I-PROBLEM	I-PROBLEM
activity	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

namely	RB	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
unresponsive	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

pupils	NNS	O	O
were	VBD	O	O
fixed	VBN	B-PROBLEM	O
and	CC	O	O
dilated	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
corneal	NN	B-TEST	B-PROBLEM
,	,	I-TEST	O
gag	NN	I-TEST	B-PROBLEM
,	,	I-TEST	O
oculocephalic	JJ	I-TEST	O
,	,	I-TEST	O
and	CC	I-TEST	O
oculovestibular	JJ	I-TEST	B-TEST
reflexes	NNS	I-TEST	I-TEST
were	VBD	O	O
elicited	VBN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
not	RB	O	O
overbreathing	VBG	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
ventilator	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

at	IN	O	O
this	DT	O	O
point	NN	O	O
,	,	O	O
patient	NN	O	O
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
have	VB	O	O
clinical	JJ	O	B-TEST
signs	NNS	O	I-TEST
consistent	JJ	O	O
with	IN	O	O
brain	NN	B-PROBLEM	B-PROBLEM
death	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

plans	NNS	O	O
were	VBD	O	O
made	VBN	O	O
to	TO	O	O
proceed	VB	O	O
with	IN	O	O
apnea	JJ	B-TEST	B-TEST
testing	VBG	I-TEST	I-TEST
.	.	O	O

however	RB	O	O
,	,	O	O
after	IN	O	O
discussion	NN	O	O
with	IN	O	O
patient	NN	O	O
's	POS	O	O
wife	NN	O	O
,	,	O	O
this	DT	O	O
was	VBD	O	O
postponed	VBN	O	O
with	IN	O	O
test	NN	B-TEST	B-TEST
planned	VBN	O	O
on	IN	O	O
2013-11-13	JJ	O	O
.	.	O	O

full	JJ	B-TREATMENT	O
medical	JJ	I-TREATMENT	O
care	NN	I-TREATMENT	O
and	CC	O	O
managment	NN	B-TREATMENT	O
continued	VBD	O	O
overnight	JJ	O	O
11/9-11/20/2002	NNS	O	O
.	.	O	O

at	IN	O	O
approximately	RB	O	O
06:00	CD	O	O
on	IN	O	O
2013-11-13	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
became	VBD	O	O
bradycardic	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
lapsed	VBD	O	O
first	RB	O	O
into	IN	O	O
a	DT	B-PROBLEM	B-TEST
junctional	JJ	I-PROBLEM	I-TEST
rhythm	NN	I-PROBLEM	I-TEST
and	CC	O	O
then	RB	O	O
had	VBD	O	O
very	RB	B-PROBLEM	B-PROBLEM
infrequent	JJ	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
escape	NN	I-PROBLEM	I-PROBLEM
beats	NNS	I-PROBLEM	I-PROBLEM
on	IN	O	I-PROBLEM
telemetry	NN	B-TEST	I-PROBLEM
.	.	O	O

finally	RB	O	O
,	,	O	O
he	PRP	O	O
went	VBD	O	O
asystolic	JJ	B-PROBLEM	O
.	.	O	O

ronald	NN	O	O
was	VBD	O	O
pronounced	VBN	O	O
dead	JJ	B-PROBLEM	O
at	IN	O	O
06:59	CD	O	O
am	VBP	O	O
.	.	O	O

1.	CD	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT

2.	CD	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT

3.	CD	O	O
toprol	NN	B-TREATMENT	B-TREATMENT
xl	NN	I-TREATMENT	I-TREATMENT

4.	CD	O	O
asa	NN	B-TREATMENT	B-TREATMENT

5.	CD	O	O
zoloft	NN	B-TREATMENT	B-TREATMENT

6.	CD	O	O
glucophage	NN	B-TREATMENT	B-TREATMENT

7.	CD	O	O
aricept	NN	B-TREATMENT	O

8.	CD	O	O
namenda	NN	B-TREATMENT	O

9.	CD	O	O
artificial	JJ	B-TREATMENT	B-PROBLEM
tears	NNS	I-TREATMENT	I-PROBLEM

probably	RB	O	O
sigmoid	JJ	B-PROBLEM	B-PROBLEM
volvulus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
an	DT	O	O
81	CD	O	O
year	NN	O	O
old	JJ	O	O
female	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
cerebrovascular	JJ	B-PROBLEM	B-PROBLEM
accident	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
dementia	NN	B-PROBLEM	B-PROBLEM
who	WP	O	O
is	VBZ	O	O
status	NN	O	O
post	NN	O	O
laparoscopic	NN	B-TREATMENT	B-TREATMENT
cholecystectomy	NN	I-TREATMENT	I-TREATMENT
one	CD	O	O
week	NN	O	O
ago	IN	O	O
who	WP	O	O
currently	RB	O	O
presents	VBZ	O	O
with	IN	O	O
a	DT	O	O
4	CD	O	O
day	NN	O	O
history	NN	O	O
of	IN	O	O
no	DT	B-PROBLEM	O
bowel	NN	I-PROBLEM	B-PROBLEM
movement	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
complaints	NNS	O	O
of	IN	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
distention	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
emesis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
constipation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
no	DT	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
fever	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
no	DT	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
dysuria	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
hematochezia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
melena	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
presented	VBD	O	O
to	TO	O	O
the	DT	O	O
ponta,itri-	JJ	O	O
university	NN	O	O
medical	JJ	O	O
center	NN	O	O
emergency	NN	O	O
department	NN	O	O
on	IN	O	O
12/01/02	CD	O	O
for	IN	O	O
evaluation	NN	B-TEST	B-TEST
of	IN	O	O
this	DT	B-PROBLEM	B-PROBLEM
constipation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
cerebrovascular	JJ	B-PROBLEM	B-PROBLEM
accident	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

3.	CD	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	VBP	I-PROBLEM	I-PROBLEM
type	JJ	I-PROBLEM	I-PROBLEM
2	CD	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

5.	CD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
dementia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

6.	CD	O	O
proteinuria	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

7.	CD	O	O
nephropathy	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

8.	CD	O	O
anemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

9.	CD	O	O
hearing	NN	B-PROBLEM	O
impaired	VBN	I-PROBLEM	O
.	.	O	O

1.	CD	O	O
laparoscopic	JJ	B-TREATMENT	B-TREATMENT
cholecystectomy	NN	I-TREATMENT	I-TREATMENT
as	IN	O	O
above	NN	O	O
.	.	O	O

2.	CD	O	O
total	JJ	B-TREATMENT	B-TREATMENT
hip	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
2002	CD	O	O
.	.	O	O

3.	CD	O	O
appendectomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

4.	CD	O	O
diskectomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

1.	CD	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
.125	NNP	O	O
mg	NN	O	O
qod	NN	O	O
,	,	O	O
.25	NNP	O	O
mg	NN	O	O
qod	NN	O	O
.	.	O	O

2.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
po	NN	O	O
tid	NN	O	O
.	.	O	O

3.	CD	O	O
levoxyl	JJ	B-TREATMENT	B-TREATMENT
100	CD	O	O
ugm	JJ	O	O
po	NN	O	O
qd	NN	O	O
.	.	O	O

4.	CD	O	O
prinivil	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
.	.	O	O

5.	CD	O	O
zantac	NN	B-TREATMENT	B-TREATMENT
150	CD	O	O
mg	NN	O	O
po	NN	O	O
bid	NN	O	O
.	.	O	O

6.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NN	O	O
qd	NN	O	O
.	.	O	O

7.	CD	O	O
aricept	JJ	B-TREATMENT	O
5	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
.	.	O	O

8.	CD	O	O
glyburide	JJ	B-TREATMENT	B-TREATMENT
1.25	CD	O	O
mg	NN	O	O
po	NN	O	O
qam	NN	O	O
.	.	O	O

9.	CD	O	O
oxybutynin	JJ	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	JJ	O	O
po	NN	O	O
bid	NN	O	O
.	.	O	O

10.	CD	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
7.5	CD	O	O
mg	NN	O	O
on	IN	O	O
sun	NN	O	O
,	,	O	O
tues	NNS	O	O
,	,	O	O
wed	VBD	O	O
,	,	O	O
fri	NN	O	O
and	CC	O	O
sat	NN	O	B-PROBLEM
.	.	O	O

fluoroquinolones	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

temperature	NN	B-TEST	B-TEST
96.7f	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
63	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
20	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
167/68	CD	O	O
,	,	O	O
02	CD	O	B-TEST
sat	VBD	O	I-TEST
99%	CD	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

in	IN	O	O
general	JJ	O	O
the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
in	IN	O	O
no	DT	O	O
apparent	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

head	NN	B-TEST	B-TEST
,	,	I-TEST	I-TEST
eyes	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
ears	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
nose	RB	I-TEST	I-TEST
and	CC	I-TEST	I-TEST
throat	VB	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
is	VBZ	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

abdomen	NNS	B-PROBLEM	B-PROBLEM
grossly	RB	I-PROBLEM	I-PROBLEM
distended	VBD	I-PROBLEM	I-PROBLEM
,	,	O	O
tympanitic	JJ	B-PROBLEM	O
,	,	O	O
plus	CC	O	O
right	JJ	B-PROBLEM	B-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
no	DT	O	O
rebound	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

rectal	NN	O	O
had	VBD	O	O
normal	JJ	O	O
tone	NN	O	O
,	,	O	O
empty	JJ	B-PROBLEM	O
rectal	NN	I-PROBLEM	O
vault	NN	I-PROBLEM	O
,	,	O	O
and	CC	O	O
guaiac	JJ	B-TEST	O
negative	NN	O	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
7.3	CD	O	O
,	,	O	O
sodium	NN	B-TREATMENT	B-TEST
142	CD	O	O
,	,	O	O
potassium	NN	B-TREATMENT	B-TEST
2.8	CD	O	O
(	(	O	O
was	VBD	O	O
supplemented	VBN	O	O
)	)	O	O
,	,	O	O
blood	VBD	B-TREATMENT	B-TEST
urea	JJ	I-TREATMENT	I-TEST
nitrogen	NN	I-TREATMENT	I-TEST
15	CD	O	O
,	,	O	O
creatinine	NN	B-TREATMENT	B-TEST
.9	NN	O	O
,	,	O	O
calcium	NN	B-TREATMENT	B-TEST
9.3	CD	O	O
,	,	O	O
phosphorus	NN	B-TREATMENT	B-TEST
1.9	CD	O	O
,	,	O	O
magnesium	NN	B-TREATMENT	B-TEST
1.8	CD	O	O
.	.	O	O

liver	JJ	B-TEST	B-TEST
function	NN	I-TEST	I-TEST
tests	NNS	I-TEST	I-TEST
were	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

hematocrit	NN	B-TEST	B-TEST
36	CD	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
8.3	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
342	CD	O	O
.	.	O	O

electrocardiogram	NN	B-TEST	B-TEST
shows	NNS	O	O
sinus	VBP	B-PROBLEM	B-PROBLEM
bradycardia	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
digitalis	JJ	B-PROBLEM	B-PROBLEM
effect	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

urinalysis	NN	B-TEST	B-TEST
is	VBZ	O	O
pending	VBG	O	O
.	.	O	O

abdominal	JJ	B-TEST	B-TEST
series	NN	I-TEST	I-TEST
showed	VBD	O	O
non-specific	JJ	B-PROBLEM	B-PROBLEM
dilatation	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
ileus	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

ct	NN	B-TEST	B-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
abdomen	NNS	I-TEST	I-TEST
and	CC	I-TEST	I-TEST
pelvis	NN	I-TEST	I-TEST
showed	VBD	O	O
dilated	JJ	B-PROBLEM	B-PROBLEM
colon	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	O
large	JJ	I-PROBLEM	O
amount	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
fluid	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
free	JJ	B-PROBLEM	B-PROBLEM
air	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
no	DT	O	O
bowel	NN	B-PROBLEM	B-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
thickening	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
obstruction	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
bowel	JJ	I-TREATMENT	I-TREATMENT
regimen	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
dulcolax	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
fleet	NN	B-TREATMENT	B-TREATMENT
enema	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
colace	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

on	IN	O	O
12/03/02	CD	O	O
the	DT	O	O
patient	NN	O	O
underwent	NN	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
kub	NN	I-TEST	I-TEST
which	WDT	O	O
was	VBD	O	O
suggestive	NN	O	O
of	IN	O	O
volvulus	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
then	RB	O	O
underwent	VBD	O	O
a	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
volvulus	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

rigid	JJ	B-TEST	B-TEST
sigmoidoscopy	NN	I-TEST	I-TEST
revealed	VBD	O	O
no	DT	O	O
obvious	JJ	B-PROBLEM	B-PROBLEM
mucosal	NN	I-PROBLEM	I-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
but	CC	O	O
during	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
the	DT	O	B-TREATMENT
procedure	NN	O	I-TREATMENT
22cc	CD	O	O
of	IN	O	O
mucous	JJ	B-PROBLEM	B-PROBLEM
like	IN	I-PROBLEM	I-PROBLEM
stool	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
evacuated	VBN	O	O
with	IN	O	O
a	DT	B-PROBLEM	O
large	JJ	I-PROBLEM	O
amount	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
gas	NN	I-PROBLEM	O
.	.	O	O

subsequent	NN	O	O
to	TO	O	O
that	IN	O	O
the	DT	O	O
patients	NNS	O	O
abdomen	NNS	O	O
was	VBD	O	O
significantly	RB	B-PROBLEM	B-PROBLEM
less	JJR	I-PROBLEM	I-PROBLEM
distended	JJ	I-PROBLEM	I-PROBLEM
and	CC	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
decreased	VBD	O	O
as	RB	O	O
well	RB	O	O
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
was	VBD	O	O
again	RB	O	O
far	RB	B-PROBLEM	O
less	RBR	I-PROBLEM	O
distended	JJ	I-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
tolerating	VBG	O	O
clear	JJ	B-TREATMENT	B-TREATMENT
liquids	NNS	I-TREATMENT	I-TREATMENT
ad	NN	O	I-TREATMENT
lib	NN	O	I-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
stable	JJ	O	O
vital	JJ	O	O
signs	NNS	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
kub	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
which	WDT	O	O
showed	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
volvulus	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1.	CD	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
.125	NNP	O	O
mg	NN	O	O
qod	NN	O	O
,	,	O	O
.25	NNP	O	O
mg	NN	O	O
qod	NN	O	O
.	.	O	O

2.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
po	NN	O	O
tid	NN	O	O
.	.	O	O

3.	CD	O	O
levoxyl	JJ	B-TREATMENT	B-TREATMENT
100	CD	O	O
ugm	JJ	O	O
po	NN	O	O
qd	NN	O	O
.	.	O	O

4.	CD	O	O
prinivil	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
.	.	O	O

5.	CD	O	O
zantac	NN	B-TREATMENT	B-TREATMENT
150	CD	O	O
mg	NN	O	O
po	NN	O	O
bid	NN	O	O
.	.	O	O

6.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NN	O	O
qd	NN	O	O
.	.	O	O

7.	CD	O	O
aricept	JJ	B-TREATMENT	O
5	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
.	.	O	O

8.	CD	O	O
glyburide	JJ	B-TREATMENT	B-TREATMENT
1.25	CD	O	O
mg	NN	O	O
po	NN	O	O
qam	NN	O	O
.	.	O	O

9.	CD	O	O
oxybutynin	JJ	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	JJ	O	O
po	NN	O	O
bid	NN	O	O
.	.	O	O

10.	CD	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
7.5	CD	O	O
mg	NN	O	O
on	IN	O	O
sun	NN	O	O
,	,	O	O
tues	NNS	O	O
,	,	O	O
wed	VBD	O	O
,	,	O	O
fri	NN	O	O
and	CC	O	O
sat	NN	O	B-PROBLEM
.	.	O	O

bactrim	NN	B-TREATMENT	B-TREATMENT

chief	JJ	O	O
complaint	NN	O	O
:	:	O	O
altered	VBD	B-PROBLEM	B-PROBLEM
metnal	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM

major	JJ	O	O
surgical	JJ	O	O
or	CC	O	O
invasive	JJ	O	B-TREATMENT
procedure	NN	O	I-TREATMENT
:	:	O	O
bronchoscopy	NN	B-TEST	B-TEST

79	CD	O	O
-	:	O	O
year-old	JJ	O	O
m	NN	O	O
recently	RB	O	O
diagnosed	VBN	O	O
by	IN	O	O
biopsy	NN	B-TEST	B-TEST
with	IN	O	O
gliomatosis	NN	B-PROBLEM	B-PROBLEM
cerebri	NN	I-PROBLEM	I-PROBLEM
(	(	I-PROBLEM	I-PROBLEM
grade	JJ	I-PROBLEM	I-PROBLEM
ii	NN	I-PROBLEM	I-PROBLEM
astrocytoma	NN	I-PROBLEM	I-PROBLEM
)	)	I-PROBLEM	O
in	IN	O	O
8/04	CD	O	O
,	,	O	O
being	VBG	O	O
treated	VBN	O	O
with	IN	O	O
xrt	NNP	B-TREATMENT	O
,	,	O	O
timidar	NN	B-TREATMENT	O
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
currently	RB	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
decadron	NN	I-TREATMENT	I-TREATMENT
taper	NN	I-TREATMENT	I-TREATMENT
after	IN	O	O
it	PRP	O	O
was	VBD	O	O
increased	VBN	O	O
several	JJ	O	O
months	NNS	O	O
ago	RB	O	O
secondary	JJ	O	O
to	TO	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
ocular	JJ	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

seen	VBN	O	O
by	IN	O	O
pmd	NN	O	O
on	IN	O	O
12-14	JJ	O	O
w/	NN	O	O
symptoms	NNS	O	B-PROBLEM
of	IN	O	O
cough	JJ	B-PROBLEM	B-PROBLEM
productive	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
yellow	JJ	B-PROBLEM	I-PROBLEM
sputum	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
wife	NN	O	O
also	RB	O	O
had	VBD	O	O
,	,	O	O
prescribed	VBN	O	O
zpak	NN	B-TREATMENT	O
w/o	NN	O	O
improvement	NN	O	O
.	.	O	O

pt	NN	O	O
was	VBD	O	O
brought	VBN	O	O
to	TO	O	O
the	DT	O	O
victor	NN	O	O
for	IN	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
somnolence	NN	I-PROBLEM	I-PROBLEM
over	IN	O	O
past	JJ	O	O
several	JJ	O	O
days-weeks	NNS	O	O
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
confused	VBN	B-PROBLEM	B-PROBLEM
,	,	O	O
has	VBZ	O	O
had	VBN	O	O
hallucinations	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

family	NN	O	O
believed	VBD	O	O
pt	NN	O	O
was	VBD	O	O
becoming	VBG	O	O
dehydrated	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
used	VBD	O	O
to	TO	O	O
be	VB	O	O
able	JJ	O	O
to	TO	O	O
walk	VB	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
walker	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
the	DT	O	O
past	JJ	O	O
few	JJ	O	O
days	NNS	O	O
has	VBZ	O	O
required	VBN	O	O
a	DT	B-TREATMENT	B-TREATMENT
wheelchair	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

+	JJ	O	O
incontinence	NN	B-PROBLEM	B-PROBLEM
over	IN	O	O
the	DT	O	O
past	JJ	O	O
2	CD	O	O
weeks	NNS	O	O
.	.	O	O

+	JJ	O	O
non-bloody	JJ	B-PROBLEM	B-PROBLEM
diarrhea	NN	I-PROBLEM	I-PROBLEM
x	$	O	O
1	CD	O	O
on	IN	O	O
doa	NN	O	O
.	.	O	O

in	IN	O	O
the	DT	O	O
deborah	NN	O	O
vs	NN	B-TEST	O
on	IN	O	O
arrival	NN	O	O
were	VBD	O	O
t	NNS	B-TEST	O
:	:	O	O
97.5	CD	O	O
;	:	O	O
bp	NN	B-TEST	O
:	:	O	O
90/65	CD	O	O
;	:	O	O
hr	NN	B-TEST	O
:	:	O	O
82	CD	O	O
;	:	O	O
rr	NN	B-TEST	O
:	:	O	O
16	CD	O	O
;	:	O	O
94	CD	O	O
on	IN	O	O
ra	NN	O	O
.	.	O	O

cxr	NN	B-TEST	O
shows	NNS	O	O
diffuse	VBP	B-PROBLEM	B-PROBLEM
b/l	NN	I-PROBLEM	I-PROBLEM
infiltrates	NNS	I-PROBLEM	I-PROBLEM
r	VBP	I-PROBLEM	O
>	JJ	I-PROBLEM	O
l	NN	I-PROBLEM	O
and	CC	O	O
pt	NN	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
bandemia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

ldh	NN	B-TEST	O
was	VBD	O	O
511	CD	O	O
.	.	O	O

pt	NN	O	O
received	VBD	O	O
bactrim	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
x	VBD	O	O
1	CD	O	O
for	IN	O	O
possible	JJ	O	O
pcp	NN	B-PROBLEM	O
.	.	O	O

lillian	JJ	O	O
r.	NN	O	O
/	NNP	O	O
hypoxic	NN	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

during	IN	O	O
admission	NN	O	O
,	,	O	O
became	VBD	O	O
steadily	RB	B-PROBLEM	B-PROBLEM
more	RBR	I-PROBLEM	I-PROBLEM
sob	JJ	I-PROBLEM	I-PROBLEM
,	,	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
lethargy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

12-20	JJ	O	O
satting	VBG	O	O
initially	RB	O	O
~	$	O	O
90%	CD	O	O
on	IN	O	O
40%	CD	O	B-TREATMENT
face	NN	B-TREATMENT	I-TREATMENT
mask	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

abg	RB	B-TEST	B-TEST
7.45/33/57	CD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
switched	VBN	O	O
to	TO	O	O
a	DT	B-TREATMENT	B-TREATMENT
100%	CD	I-TREATMENT	I-TREATMENT
nrb	NN	I-TREATMENT	I-TREATMENT
mask	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
abg	NN	B-TEST	B-TEST
was	VBD	O	O
7.47/31/80	CD	O	O
.	.	O	O

on	IN	O	O
floor	NN	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
transfer	NN	O	O
7.25/50/70	CD	O	O
on	IN	O	O
100%	CD	B-TREATMENT	O
nrb	NNS	I-TREATMENT	O
.	.	O	O

during	IN	O	O
evaluation	NN	B-TEST	B-TEST
pt	NNS	O	O
responsive	VBP	O	O
to	TO	O	O
sternal	JJ	B-TEST	B-PROBLEM
rub	NN	I-TEST	I-PROBLEM
but	CC	O	O
could	MD	O	O
not	RB	O	O
follow	VB	O	O
commands	NNS	O	O
.	.	O	O

intubated	VBN	O	B-TREATMENT
for	IN	O	O
failure	NN	B-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
protect	VB	I-PROBLEM	I-PROBLEM
airway	RB	I-PROBLEM	I-PROBLEM
,	,	O	O
transferred	VBD	O	O
to	TO	O	O
icu	VB	O	O
.	.	O	O

1.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
s/p	VBD	O	O
mi	JJ	B-PROBLEM	B-TREATMENT
20	CD	O	O
years	NNS	O	O
ago	RB	O	O

2.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM

3.	CD	O	O
hyperlipidemia	NN	B-PROBLEM	B-PROBLEM

4.	CD	O	O
djd	NN	B-PROBLEM	B-TREATMENT
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
c-spine	NN	I-PROBLEM	O

5.	CD	O	O
depression	NN	B-PROBLEM	B-PROBLEM

6.	CD	O	O
h/o	NN	O	O
dvt	NN	B-PROBLEM	B-PROBLEM

7.	CD	O	O
shingles	NNS	B-PROBLEM	B-PROBLEM
recently	RB	O	O
finished	VBD	O	O
treatment	NN	B-TREATMENT	B-TREATMENT

physical	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
:	:	O	O
t	NN	B-TEST	O
98.9	CD	O	O
,	,	O	O
bp	RB	B-TEST	O
63/28	CD	O	O
on	IN	O	O
neo	NN	B-TREATMENT	O
,	,	O	O
p	NN	B-TEST	O
114	CD	O	O
,	,	O	O
ac	RB	B-TREATMENT	O
fi02	JJ	B-TREATMENT	O
1/	CD	O	O
vt	NN	B-TREATMENT	O
550/	CD	O	O
peep	NN	B-TREATMENT	O
5/	CD	O	O
breathing	NN	O	O
at	IN	O	O
16/22	CD	O	O
,	,	O	O
w/	JJR	O	O
volumes	NNS	B-TEST	O
of	IN	O	O
500	CD	O	O
s	NNS	O	O
.	.	O	O

intubated	VBN	O	B-TREATMENT
,	,	O	O
minimally	RB	B-PROBLEM	B-PROBLEM
responsive	JJ	I-PROBLEM	I-PROBLEM
,	,	O	O
localized	JJ	O	B-PROBLEM
pain	NN	O	I-PROBLEM
.	.	O	O

jvd	NN	B-PROBLEM	O
not	RB	O	O
appreciated	VBD	O	O
03-07	JJ	O	O
to	TO	O	O
deep	VB	O	B-PROBLEM
inspiratory	JJ	O	I-PROBLEM
breaths	NNS	O	I-PROBLEM
.	.	O	O

distended	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

nt	NNS	B-PROBLEM	O
>	VBP	O	O

no	DT	O	O
le	NN	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2011-12-23	JJ	O	O
07:54	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
wbc	SYM	B-TEST	B-TEST
-	:	O	O
9.7	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.02	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
10.0	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
29.0	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
96	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
33.1	CD	O	O
*	NN	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.4	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
17.7	CD	O	O
*	JJ	O	O
plt	NN	B-TEST	B-TEST
ct	SYM	I-TEST	I-TEST
-	:	O	O
307	CD	O	O

2011-12-23	JJ	O	O
07:54	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	O
neuts	NNS	B-TEST	B-TEST
-	:	O	O
88	CD	O	O
*	NN	O	O
bands	NNS	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
lymphs	SYM	B-TEST	B-TEST
-	:	O	O
7	CD	O	O
*	JJ	O	O
monos	NNS	B-TEST	B-TEST
-	:	O	O
3	CD	O	O
eos	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
baso	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
atyps	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
metas	NNS	B-TEST	B-TEST
-	:	O	O
1	CD	O	O
*	NN	O	O
myelos	SYM	B-TEST	B-TEST
-	:	O	O
1	CD	O	O
*	NN	O	O

2011-12-23	JJ	O	O
07:54	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
pt	NN	B-TEST	I-TEST
-	:	O	O
16.0	CD	O	O
*	NN	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
35.7	CD	O	O
*	JJ	O	O
inr	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
pt	JJ	I-TEST	I-TEST
)-	CD	I-TEST	I-TEST
1.6	CD	O	O

chem	NN	B-TEST	B-TEST
7	CD	I-TEST	O
:	:	O	O

2011-12-23	JJ	O	O
07:54	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	O
glucose	VB	B-TEST	B-TEST
-	:	O	O
108	CD	O	O
*	JJ	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
27	CD	O	O
*	NN	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.9	CD	O	O
*	NN	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
132	CD	O	O
*	NN	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
4.6	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
102	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
20	CD	O	O
*	NN	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
15	CD	O	O

2011-12-18	JJ	O	O
06:15	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
alt	NN	B-TEST	I-TEST
-	:	O	O
29	CD	O	O
ast	IN	B-TEST	O
-	:	O	O
25	CD	O	O
ld	NN	B-TEST	O
(	(	I-TEST	B-TEST
ldh	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
400	CD	O	O
*	NN	O	O
alkphos	SYM	B-TEST	B-TEST
-	:	O	O
52	CD	O	O
totbili	SYM	B-TEST	B-TEST
-	:	O	O
0.3	CD	O	O

2011-12-23	JJ	O	O
11:16	CD	O	O
pm	NN	O	B-TEST
blood	NN	B-TEST	I-TEST
type	NN	B-TEST	I-TEST
-	:	O	O
art	NN	O	O
po2	VBZ	B-TEST	O
-	:	O	O
202	CD	O	O
*	NN	O	O
pco2	NN	B-TEST	B-TEST
-	:	O	O
40	CD	O	O
ph	NN	B-TEST	B-TEST
-	:	O	O
7.29	CD	O	O
*	NN	O	O
calhco3	NN	B-TEST	B-TEST
-	:	O	O
20	CD	O	O
*	JJ	O	O
base	NN	B-TEST	O
xs	NNP	I-TEST	O
--	:	O	O
6	CD	O	O

2011-12-20	JJ	O	O
07:53	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
lactate	NN	B-TEST	I-TEST
-	:	O	O
1.1	CD	O	O

71	CD	O	O
yo	JJ	O	O
m	NN	O	O
w/	NN	O	O
astrocytoma	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
xrt	NN	B-TREATMENT	O
and	CC	O	O
chemotx	NN	B-TREATMENT	O
,	,	O	O
who	WP	O	O
p/w	VBD	O	O
1	CD	O	O
wk	NN	O	O
h/o	NN	O	O
productive	JJ	B-PROBLEM	B-PROBLEM
cough	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
sick	JJ	O	O
contact	NN	O	O
,	,	O	O
hypoxic	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
now	RB	O	O
intubated	VBN	O	B-TREATMENT
,	,	O	O
w/	JJ	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
infiltrates	NNS	I-PROBLEM	I-PROBLEM
b/l	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1)	CD	O	O
resp	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
-	:	O	O
pt	NN	O	O
admitted	VBD	O	O
w/	JJ	O	O
primarily	RB	B-PROBLEM	B-PROBLEM
hypoxic	JJ	I-PROBLEM	I-PROBLEM
respiratory	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

following	VBG	O	O
admission	NN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
the	DT	O	O
pt	NN	O	O
developed	VBD	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
hypoxia	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
somnolence	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
requiring	VBG	O	O
intubation	NN	B-TREATMENT	B-TREATMENT
on	IN	O	O
hd	NN	O	B-TREATMENT
5	CD	O	O
.	.	O	O

pulm	NN	O	O
had	VBD	O	O
previously	RB	O	O
been	VBN	O	O
consulted	VBN	O	O
and	CC	O	O
felt	VBD	O	O
that	IN	O	O
presentation	NN	O	O
was	VBD	O	O
c/w	JJ	O	O
pcp	NN	B-PROBLEM	O
,	,	O	O
joann	NN	O	O
started	VBD	O	O
on	IN	O	O
bactrim	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

previously	RB	O	O
treated	VBN	O	O
for	IN	O	O
cap	NN	B-PROBLEM	B-TREATMENT
as	IN	O	O
outpt	NN	O	O
but	CC	O	O
hypoxia	NN	B-PROBLEM	B-PROBLEM
continued	VBD	O	O
to	TO	O	O
progress	VB	O	O
.	.	O	O

similar	JJ	O	O
lack	NN	O	O
of	IN	O	O
improvement	NN	O	O
w/	VBP	O	O
additional	JJ	B-TREATMENT	B-TREATMENT
broad	JJ	I-TREATMENT	I-TREATMENT
spectrum	NN	I-TREATMENT	I-TREATMENT
coverage	NN	I-TREATMENT	I-TREATMENT
following	VBG	O	O
admission	NN	O	O
.	.	O	O

pt	JJ	O	O
underwent	JJ	O	O
bronchoscopy	NN	B-TEST	B-TEST
on	IN	O	O
11-22	JJ	O	O
following	VBG	O	O
transfer	NN	O	O
to	TO	O	O
the	DT	O	O
icu	NN	O	O
for	IN	O	O
hypoxic	JJ	B-PROBLEM	B-PROBLEM
respiratory	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
intubation	NN	B-TREATMENT	B-TREATMENT
(	(	O	O
7.25/52/70	CD	O	O
on	IN	O	O
100%	CD	B-TREATMENT	O
nrb	NN	I-TREATMENT	O
)	)	O	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
to	TO	O	O
the	DT	O	O
icu	NN	O	O
the	DT	B-TREATMENT	O
pt	NN	I-TREATMENT	O
'	POS	I-TREATMENT	O
steroid	NN	I-TREATMENT	B-TREATMENT
dose	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
increased	VBN	O	O
to	TO	O	O
8	CD	O	O
mg	NNS	O	O
bid	VBD	O	O
03-07	CD	O	O
to	TO	O	O
a	DT	B-TEST	B-TEST
dead	JJ	I-TEST	I-TEST
space	NN	I-TEST	I-TEST
measurement	NN	I-TEST	I-TEST
of	IN	O	O
50%	CD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
subsequently	RB	O	O
tranferred	VBN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
,	,	O	O
where	WRB	O	O
he	PRP	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
stable	JJ	I-PROBLEM	I-PROBLEM
oxygen	NN	I-PROBLEM	I-PROBLEM
requirement	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

repeat	NN	B-TEST	B-TEST
cxr	NN	I-TEST	I-TEST
was	VBD	O	O
unchanged	JJ	O	O
from	IN	O	O
previously	RB	O	O
in	IN	O	O
the	DT	O	O
icu	NN	O	O
(	(	O	O
official	JJ	O	O
read	NN	O	O
noted	VBD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
chf	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
pt	NN	O	O
was	VBD	O	O
continuing	VBG	O	O
to	TO	O	O
autodiurese	JJ	O	O
and	CC	O	O
has	VBZ	O	O
remained	VBN	O	O
net	JJ	O	O
negative	JJ	O	O
everyday	NN	O	O
while	IN	O	O
on	IN	O	O
the	DT	O	O
floor	NN	O	O
.	.	O	O

on	IN	O	O
discharge	PDT	O	O
the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
stable	JJ	B-PROBLEM	O
o2	NN	I-PROBLEM	O
req	NN	I-PROBLEM	O
,	,	O	O
90%	CD	O	O
on	IN	O	O
ra	NN	O	O
.	.	O	O

2)	CD	O	O
astrocytoma	SYM	B-PROBLEM	B-TEST
-	:	I-PROBLEM	O
grade	NN	I-PROBLEM	O
ii	NN	I-PROBLEM	O
,	,	O	O
as	IN	O	O
per	IN	O	O
d/w	NN	O	O
pmd	NN	O	O
,	,	O	O
dr.	NN	O	O
holscher	NN	O	O
,	,	O	O
pt	NN	O	O
has	VBZ	O	O
poor	JJ	O	O
prognosis	NN	O	O
,	,	O	O
but	CC	O	O
reasonable	JJ	O	O
for	IN	O	O
ongoing	VBG	B-TREATMENT	B-TREATMENT
treatment	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

pt	NN	O	O
has	VBZ	O	O
had	VBN	O	O
two	CD	O	O
recent	JJ	O	O
neg	NNS	O	O
head	VBP	O	B-TEST
ct	JJ	O	I-TEST
s	NN	O	I-TEST
,	,	O	O
so	RB	O	O
unlikely	JJ	O	O
the	DT	O	O
etiology	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-TEST
patient	NN	I-PROBLEM	I-TEST
's	POS	I-PROBLEM	I-TEST
ms	JJ	I-PROBLEM	I-TEST
change	NN	I-PROBLEM	I-TEST
.	.	O	O

pt	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
keppra	NN	B-TREATMENT	O
during	IN	O	O
admission	NN	O	O
for	IN	O	O
sz	JJ	B-PROBLEM	B-PROBLEM
px	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

initially	RB	O	O
he	PRP	O	O
had	VBD	O	O
been	VBN	O	O
on	IN	O	O
lamotrigine	NN	B-TREATMENT	B-TREATMENT
but	CC	O	O
the	DT	O	O
was	VBD	O	O
stopped	VBN	O	O
in	IN	O	O
10/12	CD	O	O
when	WRB	O	O
the	DT	O	O
pt	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
developing	VBG	O	O
a	DT	B-PROBLEM	B-PROBLEM
new	JJ	I-PROBLEM	I-PROBLEM
rash	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

decadron	NN	B-TREATMENT	B-TREATMENT
has	VBZ	O	O
been	VBN	O	O
steadily	RB	O	O
tapered	VBN	O	O
since	IN	O	O
arrival	NN	O	O
on	IN	O	O
the	DT	O	O
floor	NN	O	O
.	.	O	O

the	DT	B-TREATMENT	O
patient	NN	I-TREATMENT	O
's	POS	I-TREATMENT	O
keppra	NN	I-TREATMENT	O
should	MD	O	O
be	VB	O	O
continued	VBN	O	O
for	IN	O	O
sz	NN	B-TREATMENT	B-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

3)	CD	O	B-TEST
ms	NN	B-PROBLEM	I-TEST
change	NN	I-PROBLEM	I-TEST
-	:	O	O
on	IN	O	O
admission	NN	O	O
pt	NN	O	O
was	VBD	O	O
agitated	VBN	B-PROBLEM	B-PROBLEM
,	,	O	O
requiring	VBG	O	O
restraints	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
antipsychotics	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
however	RB	O	O
as	IN	O	O
he	PRP	O	O
became	VBD	O	O
increasingly	RB	B-PROBLEM	B-PROBLEM
hypoxic	JJ	I-PROBLEM	I-PROBLEM
he	PRP	O	O
became	VBD	O	O
somnolent	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

in	IN	O	O
the	DT	O	O
icu	NN	O	O
the	DT	O	O
pt	NN	O	O
remained	VBD	O	O
stuporous	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
responsive	JJ	O	O
to	TO	O	O
painful	JJ	B-TEST	B-TEST
stimuli	NNS	I-TEST	I-TEST
.	.	O	O

on	IN	O	O
the	DT	O	O
floor	NN	O	O
the	DT	O	O
patient	NN	O	O
intially	RB	O	O
was	VBD	O	O
imporved	VBN	O	O
,	,	O	O
but	CC	O	O
has	VBZ	O	O
plateaued	VBN	O	O
,	,	O	O
responding	VBG	O	O
to	TO	O	O
simple	VB	O	O
commands	NNS	O	O
and	CC	O	O
verbalizing	VBG	O	B-PROBLEM
groans	NNS	O	I-PROBLEM
but	CC	O	O
no	DT	B-PROBLEM	O
real	JJ	I-PROBLEM	B-PROBLEM
speech	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

improvement	NN	O	O
has	VBZ	O	O
correlated	VBN	O	O
w/	IN	O	O
tapering	NN	O	O
of	IN	O	O
steroids	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
one	CD	O	O
of	IN	O	O
the	DT	O	O
causes	NNS	O	O
in	IN	O	O
the	DT	B-TEST	O
differential	NN	I-TEST	O
.	.	O	O

pt	NN	O	O
had	VBD	O	O
multiple	JJ	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
s	NN	I-TEST	I-TEST
which	WDT	O	O
ruled	VBD	O	O
out	RP	O	O
progression	NN	O	B-PROBLEM
of	IN	O	I-PROBLEM
astrocytoma	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

mri	NN	B-TEST	O
has	VBZ	O	O
been	VBN	O	O
deferred	VBN	O	O
given	VBN	O	O
that	IN	O	O
the	DT	O	O
pt	NN	O	O
currently	RB	O	O
would	MD	O	O
not	RB	O	O
tolerate	VB	O	O
the	DT	B-TEST	B-TREATMENT
procedure	NN	I-TEST	I-TREATMENT
.	.	O	O

eeg	NN	B-TEST	O
was	VBD	O	O
w/o	JJ	O	O
evidence	NN	O	O
of	IN	O	O
epileptiform	NN	B-PROBLEM	O
activity	NN	I-PROBLEM	O
and	CC	O	O
c/w	NN	O	O
toxic	NN	B-PROBLEM	B-PROBLEM
encephalopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

plan	NN	O	O
to	TO	O	O
continue	VB	O	O
to	TO	O	O
follow	VB	O	O
ms	NN	B-PROBLEM	O
,	,	O	O
expect	VBP	O	O
improvement	NN	O	O
as	IN	O	O
steroids	NNS	B-TREATMENT	B-TREATMENT
are	VBP	O	O
continued	VBN	O	O
to	TO	O	O
be	VB	O	O
tapered	VBN	O	O
.	.	O	O

4)	CD	O	O
h/o	NN	O	O
dvt	SYM	B-PROBLEM	O
-	:	O	O
cont	NN	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
previously	RB	O	O
on	IN	O	O
enoxaparin	JJ	B-TREATMENT	B-TREATMENT
x10	JJ	O	I-TREATMENT
days	NNS	O	O
at	IN	O	O
treatment	NN	O	O
dose	NN	O	O
,	,	O	O
followed	VBN	O	O
by	IN	O	O
prophylactic	JJ	B-TREATMENT	B-TREATMENT
dose	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
the	DT	O	O
pt	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
treatment	NN	O	B-TREATMENT
doses	NNS	O	O
of	IN	O	O
enoxaparin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

upon	NN	O	O
transfer	NN	O	O
to	TO	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
the	DT	O	O
pt	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
gtt	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

course	NN	O	O
was	VBD	O	O
c/b	JJ	O	O
one	CD	O	O
episode	NN	O	O
of	IN	O	O
gross	JJ	B-PROBLEM	B-PROBLEM
hematochezia	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
12-28	JJ	O	O
,	,	O	O
w/	JJ	O	O
concomitant	NN	B-PROBLEM	O
hct	VBD	I-PROBLEM	O
drop	NN	I-PROBLEM	O
of	IN	O	O
~	$	O	O
3	CD	O	O
pts	NNS	O	O
.	.	O	O

b/l	NN	B-TEST	O
lower	RBR	I-TEST	O
ext	NN	I-TEST	O
duplex	JJ	I-TEST	O
us	PRP	I-TEST	O
and	CC	O	O
a	DT	B-TEST	O
cta	NN	I-TEST	O
were	VBD	O	O
performed	VBN	O	O
,	,	O	O
both	DT	O	O
of	IN	O	O
which	WDT	O	O
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

given	VBN	O	O
that	IN	O	O
the	DT	O	O
pt	NN	O	O
was	VBD	O	O
w/o	JJ	O	O
evidence	NN	O	O
of	IN	O	O
dvt	NN	B-PROBLEM	O
it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
that	IN	O	O
the	DT	O	O
risks	NNS	O	O
of	IN	O	O
anticoagulation	NN	B-TREATMENT	B-TREATMENT
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
gross	JJ	B-PROBLEM	B-PROBLEM
gib	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
outweigh	VBP	O	O
the	DT	O	O
risks	NNS	O	O
of	IN	O	O
undetected	JJ	B-PROBLEM	B-PROBLEM
deep	JJ	I-PROBLEM	I-PROBLEM
vv	NN	I-PROBLEM	I-PROBLEM
thrombosis/pe	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pt	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
prophylactic	JJ	B-TREATMENT	B-TREATMENT
heparin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

4)	CD	O	O
hypersensitivity	NN	B-PROBLEM	B-PROBLEM
reaction	NN	I-PROBLEM	I-PROBLEM
-	:	O	O
on	IN	O	O
11-24	JJ	O	O
pt	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
developing	VBG	O	B-PROBLEM
rash	NN	B-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
abdomen	NNS	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
thighs	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

derm	NNS	O	O
initially	RB	O	O
reviewed	VBD	O	O
and	CC	O	O
thought	VBD	O	O
that	IN	O	O
it	PRP	O	O
was	VBD	O	O
not	RB	O	O
c/w	JJ	O	O
hypersensitivity	NN	B-PROBLEM	B-PROBLEM
rxn	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

over	IN	O	O
the	DT	O	O
next	JJ	O	O
the	DT	B-PROBLEM	O
rash	NN	I-PROBLEM	O
progressed	VBD	O	O
,	,	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
subsequently	RB	O	O
began	VBD	O	O
spiking	VBG	O	B-PROBLEM
fevers	NNS	B-PROBLEM	I-PROBLEM
to	TO	O	O
approx	VB	O	O
103	CD	O	O
f	NN	O	O
,	,	O	O
c/b	JJ	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
requiring	VBG	O	O
aggressive	JJ	B-TREATMENT	B-TREATMENT
fluid	NN	I-TREATMENT	I-TREATMENT
repletion	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
pressors	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
tachycardia	NN	B-PROBLEM	B-PROBLEM
to	TO	O	O
the	DT	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
developed	VBD	O	O
elevated	JJ	B-PROBLEM	B-PROBLEM
transaminases	NNS	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
pancreatic	JJ	I-PROBLEM	B-TEST
enzymes	NNS	I-PROBLEM	I-TEST
during	IN	O	O
this	DT	O	O
time	NN	O	O
.	.	O	O

on	IN	O	O
the	DT	O	O
second	JJ	O	O
day	NN	O	O
that	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
rash	NN	I-PROBLEM	I-PROBLEM
had	VBD	O	O
been	VBN	O	O
noted	VBN	O	O
,	,	O	O
derm	NN	O	O
was	VBD	O	O
asked	VBN	O	O
to	TO	O	O
see	VB	O	O
again	RB	O	O
,	,	O	O
felt	VBD	O	O
c/w	JJ	O	O
hypersensitivity	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
bactrim	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
switched	VBN	O	O
to	TO	O	O
pentamidine	VB	B-TREATMENT	O
,	,	O	O
and	CC	O	O
lamictal	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
held	VBN	O	O
.	.	O	O

pt	NN	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
elev	VBN	B-PROBLEM	B-PROBLEM
pancreatic	JJ	I-PROBLEM	I-PROBLEM
enzymes	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
pentamidine	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
switched	VBN	O	O
to	TO	O	O
clinda/primaquine	VB	B-TREATMENT	O
.	.	O	O

following	VBG	O	O
discontinuation	NN	O	O
of	IN	O	O
the	DT	B-TREATMENT	O
bactrim	NN	I-TREATMENT	O
the	DT	O	O
patient	NN	O	O
defervesced	VBD	O	O
,	,	O	O
and	CC	O	O
remained	VBD	O	O
normotensive	JJ	O	B-PROBLEM
.	.	O	O

he	PRP	O	O
received	VBD	O	O
one	CD	O	O
dose	NN	O	O
of	IN	O	O
furosemide	NN	B-TREATMENT	B-TREATMENT
in	IN	O	O
the	DT	O	O
icu	NN	O	O
and	CC	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
the	DT	O	O
next	JJ	O	O
day	NN	O	O
.	.	O	O

on	IN	O	O
arrival	NN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
lacy	NN	I-PROBLEM	I-PROBLEM
reticular	JJ	I-PROBLEM	I-PROBLEM
rash	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
arms	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
resolved	VBD	O	O
over	IN	O	O
the	DT	O	O
next	JJ	O	O
48h	CD	O	O
.	.	O	O

felt	RBR	O	O
likely	JJ	O	O
03-07	JJ	O	O
the	DT	B-TREATMENT	B-TREATMENT
sulfa	JJ	I-TREATMENT	I-TREATMENT
moiety	NN	O	I-TREATMENT
of	IN	O	I-TREATMENT
the	DT	B-TREATMENT	I-TREATMENT
furosemide	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

plan	NN	O	O
for	IN	O	O
pt	NN	O	O
to	TO	O	O
complete	VB	O	O
total	NN	O	O
of	IN	O	O
28	CD	O	O
day	NN	O	O
course	NN	O	O
of	IN	O	O
therapy	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
pcp	NN	B-PROBLEM	O
,	,	O	O
james	NNS	O	O
will	MD	O	O
be	VB	O	O
completed	VBN	O	O
on	IN	O	O
01-16	NN	O	O
.	.	O	O

5)	CD	O	O
anemia	SYM	B-PROBLEM	B-PROBLEM
-	:	O	O
previous	JJ	B-TEST	O
w/u	NN	I-TEST	O
c/w	NN	O	O
acd	NN	B-PROBLEM	B-PROBLEM
(	(	O	I-PROBLEM
elev	JJ	B-PROBLEM	I-PROBLEM
ferritin	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
low	JJ	B-PROBLEM	B-TEST
transferrin	NN	I-PROBLEM	I-TEST
saturation	NN	I-PROBLEM	I-TEST
)	)	O	O
.	.	O	O

-	:	O	O
transfuse	NN	B-TEST	O
threshold	VBD	I-TEST	O
<	CD	O	O
24	CD	O	O

6)	CD	O	O
arf	JJ	B-PROBLEM	O
-	:	O	O
cr	NN	B-TEST	B-PROBLEM
mildly	RB	B-PROBLEM	I-PROBLEM
elevated	VBD	I-PROBLEM	I-PROBLEM
on	IN	O	O
tx	NN	O	O
to	TO	O	O
icu	VB	O	O
,	,	O	O
u	JJ	B-TEST	O
lytes	NNS	I-TEST	O
c/w	VBP	O	O
prerenal	JJ	B-PROBLEM	B-PROBLEM
azotemia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
resolved	VBD	O	O
w/	NN	O	O
ivf	NN	B-TREATMENT	O
.	.	O	O

7)	CD	O	O
hyponatremia	NN	B-PROBLEM	B-PROBLEM
-	:	O	O
also	RB	O	O
hyponatremic	VBP	B-PROBLEM	O
on	IN	O	O
transfer	NN	O	O
,	,	O	O
resolved	VBD	O	O
w/	JJ	O	O
ivf	NN	B-TREATMENT	O
.	.	O	O

8)	CD	O	O
cad	SYM	B-PROBLEM	O
-	:	O	O
w/	NN	O	O
abnl	NN	B-PROBLEM	O
ef	NN	I-PROBLEM	O
,	,	O	O
however	RB	O	O
pt	RB	O	O
tolerated	VBN	O	O
aggressive	JJ	B-TREATMENT	B-PROBLEM
fluid	NN	I-TREATMENT	I-PROBLEM
resusciation	NN	I-TREATMENT	I-PROBLEM
w/o	NN	O	I-PROBLEM
significant	JJ	B-PROBLEM	I-PROBLEM
hypoxia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

continued	VBN	O	O
on	IN	O	O
valsartan	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
bb	NN	B-TREATMENT	O
continued	VBD	O	O
,	,	O	O
statin	NN	B-TREATMENT	B-TREATMENT

9)	CD	O	O
nutrition	NN	O	O
-	:	O	O
pt	NN	O	O
was	VBD	O	O
maintained	VBN	O	O
on	IN	O	O
tfs	JJ	B-TREATMENT	O
via	IN	O	O
post-pyloric	JJ	B-TREATMENT	O

10)	CD	O	O
px	NN	O	O
:	:	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
(	(	O	O
full	JJ	O	O
dose	NN	O	O
)	)	O	O
,	,	O	O
iv	JJ	B-TREATMENT	O
ppi	NN	I-TREATMENT	O

11)	CD	O	O
comm	NN	O	O
:	:	O	O
family	NN	O	O
very	RB	O	O
involved	JJ	O	O
at	IN	O	O
bedside	NN	O	O
,	,	O	O
evaluating	VBG	O	O
rehab	NN	B-TREATMENT	O
today	NN	O	O

18)	CD	O	O
restraint	NN	B-TREATMENT	O

acyclovir	NN	B-TREATMENT	B-TREATMENT

bactrim	NN	B-TREATMENT	B-TREATMENT

zoloft	NN	B-TREATMENT	B-TREATMENT

valsartan	NN	B-TREATMENT	B-TREATMENT

metoprolol	NN	B-TREATMENT	B-TREATMENT

keppra	NN	B-TREATMENT	O

lovenox	NN	B-TREATMENT	B-TREATMENT

levofloxacin	NN	B-TREATMENT	B-TREATMENT

ambisone	NN	B-TREATMENT	B-TREATMENT

atrovent	NN	B-TREATMENT	B-TREATMENT
nebs	NN	I-TREATMENT	I-TREATMENT

albuterol	NN	B-TREATMENT	B-TREATMENT
nebs	NN	I-TREATMENT	I-TREATMENT

lasix	RB	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NNS	O	O
qd	NN	O	O

lipitor	NN	B-TREATMENT	B-TREATMENT

haldol	NN	B-TREATMENT	B-TREATMENT
prn	NN	O	O

1.	CD	O	O
miconazole	JJ	B-TREATMENT	B-TREATMENT
nitrate	RB	I-TREATMENT	I-TREATMENT
2	CD	O	O
%	NN	O	O
powder	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
appl	RB	O	O
topical	JJ	O	O
qid	NN	O	O
(	(	O	O
4	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

2.	CD	O	O
sertraline	JJ	B-TREATMENT	B-TREATMENT
hcl	NN	I-TREATMENT	I-TREATMENT
50	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

3.	CD	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
sulfate	VB	I-TREATMENT	I-TREATMENT
0.083	CD	O	O
%	NN	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
inhalation	NN	O	O
q4h	NN	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
hours	NNS	O	O
)	)	O	O
.	.	O	O

4.	CD	O	O
ipratropium	NN	B-TREATMENT	B-TREATMENT
bromide	RB	I-TREATMENT	I-TREATMENT
0.02	CD	O	O
%	NN	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
inhalation	NN	O	O
q4h	NN	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
hours	NNS	O	O
)	)	O	O
.	.	O	O

5.	CD	O	O
senna	JJ	B-TREATMENT	B-TREATMENT
8.6	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

6.	CD	O	O
bisacodyl	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
suppository	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
suppository	NN	O	O
rectal	JJ	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
constipation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

7.	CD	O	O
levetiracetam	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
three	CD	O	O
(	(	O	O
3	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

8.	CD	O	O
nystatin	JJ	B-TREATMENT	B-TREATMENT
100,000	CD	O	O
unit	NN	O	O
/	NNP	O	O
ml	NN	O	O
suspension	NN	O	O
sig	NN	O	O
:	:	O	O
five	CD	O	O
(	(	O	O
5	CD	O	O
)	)	O	O
ml	NN	O	O
po	NN	O	O
qid	NN	O	O
(	(	O	O
4	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

9.	CD	O	O
heparin	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
porcine	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
5,000	CD	O	O
unit	NN	O	O
/	NNP	O	O
ml	NN	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
injection	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

10.	CD	O	O
acetaminophen	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
tablets	NNS	O	O
po	JJ	O	O
q4-6h	JJ	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
to	TO	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

11.	CD	O	O
primaquine	JJ	B-TREATMENT	B-TREATMENT
phosphate	NN	I-TREATMENT	I-TREATMENT
26.3	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
for	IN	O	O
3	CD	O	O
days	NNS	O	O
.	.	O	O

12.	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
tartrate	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

13.	CD	O	O
dexamethasone	NN	B-TREATMENT	B-TREATMENT
0.5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q12h	NN	O	O
(	(	O	O
every	DT	O	O
12	CD	O	O
hours	NNS	O	O
)	)	O	O
:	:	O	O
take	VB	O	O
2	CD	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
for	IN	O	O
four	CD	O	O
days	NNS	O	O
,	,	O	O
then	RB	O	O
2	CD	O	O
tablet	NN	O	O
po	NN	O	O
qday	NN	O	O
for	IN	O	O
7	CD	O	O
days	NNS	O	O
,	,	O	O
then	RB	O	O
take	VB	O	O
one	CD	O	O
tablet	NN	O	O
qday	NN	O	O
for	IN	O	O
7	CD	O	O
days	NNS	O	O
.	.	O	O

then	RB	O	O
stop	VB	O	O
taking	VBG	O	O
the	DT	B-TREATMENT	B-TREATMENT
medication	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

14.	CD	O	O
acyclovir	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
500	CD	O	O
mg	NN	O	O
recon	NN	O	O
soln	NN	O	O
sig	NN	O	O
:	:	O	O
200mg	CD	O	O
recon	NN	O	B-TREATMENT
solns	NN	O	I-TREATMENT
intravenous	JJ	O	I-TREATMENT
q12h	NN	O	I-TREATMENT
(	(	O	O
every	DT	O	O
12	CD	O	O
hours	NNS	O	O
)	)	O	O
.	.	O	O

15.	CD	O	O
pantoprazole	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
40	CD	O	O
mg	NN	O	O
recon	NN	O	O
soln	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
recon	NN	O	O
soln	VBP	O	O
intravenous	JJ	O	B-TREATMENT
q12h	NN	O	I-TREATMENT
(	(	O	O
every	DT	O	O
12	CD	O	O
hours	NNS	O	O
)	)	O	O
.	.	O	O

16.	CD	O	O
clindamycin	JJ	B-TREATMENT	B-TREATMENT
phosphate	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
d5w	NN	B-TREATMENT	O
600	CD	O	O
mg	NN	O	O
/	VBD	O	O
50	CD	O	O
ml	NN	O	O
piggyback	NN	O	O
sig	NN	O	O
:	:	O	O
600	CD	O	O
mg	NN	O	O
intravenous	JJ	O	O
q8h	NN	O	O
(	(	O	O
every	DT	O	O
8	CD	O	O
hours	NNS	O	O
)	)	O	O
for	IN	O	O
3	CD	O	O
days	NNS	O	O
.	.	O	O

1)	CD	O	O
pcp	NN	B-PROBLEM	O
pna	NN	I-PROBLEM	O

2)	CD	O	O
astrocytoma	NN	B-PROBLEM	B-PROBLEM

3)	CD	O	O
hypersensitivity	NN	B-PROBLEM	B-PROBLEM
to	TO	O	I-PROBLEM
bactrim	VB	B-TREATMENT	I-PROBLEM

4)	CD	O	O
hematochezia	NN	B-PROBLEM	B-PROBLEM

5)	CD	O	O
h/o	NN	O	O
dvt	NN	B-PROBLEM	B-PROBLEM

good	JJ	O	O
,	,	O	O
still	RB	O	O
w/	VBZ	O	O
altered	JJ	B-PROBLEM	B-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
improving	VBG	O	O
.	.	O	O

1)	CD	O	O
take	VB	O	O
your	PRP$	O	B-TREATMENT
medications	NNS	B-TREATMENT	I-TREATMENT

renal	JJ	B-PROBLEM	B-PROBLEM
tubular	JJ	I-PROBLEM	I-PROBLEM
acidosis	NN	I-PROBLEM	I-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
type	NN	I-PROBLEM	I-PROBLEM
i	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
shock	NN	B-PROBLEM	O
;	:	O	O
seizure	NN	B-PROBLEM	B-PROBLEM
disorder	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
acidosis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
electrolyte	NN	I-PROBLEM	I-PROBLEM
imbalance	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
rule	NN	O	O
out	IN	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

renal	JJ	B-PROBLEM	B-PROBLEM
tubular	JJ	I-PROBLEM	I-PROBLEM
acidosis	NN	I-PROBLEM	I-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
type	NN	I-PROBLEM	I-PROBLEM
i	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
shock	NN	B-PROBLEM	O
;	:	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
acidosis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
electrolyte	NN	I-PROBLEM	I-PROBLEM
imbalance	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
seizure	NN	B-PROBLEM	B-PROBLEM
disorder	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
rule	NN	O	O
out	IN	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
varicella	NN	B-PROBLEM	B-TEST
.	.	O	O

this	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
5	CD	O	O
year	NN	O	O
old	JJ	O	O
white	JJ	O	O
female	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
type	NN	B-PROBLEM	B-PROBLEM
i	NN	I-PROBLEM	I-PROBLEM
renal	VBP	I-PROBLEM	I-PROBLEM
tubular	JJ	I-PROBLEM	I-PROBLEM
acidosis	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
nephrocalcinosis	NN	B-PROBLEM	B-TREATMENT
who	WP	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
noughwell	VB	O	O
entanbon	JJ	O	O
health	NN	O	O
of	IN	O	O
washington	NN	O	O
on	IN	O	O
9/5/93	CD	O	O
at	IN	O	O
21:16	CD	O	O
hours	NNS	O	O
with	IN	O	O
a	DT	O	O
2-3	JJ	O	O
day	NN	O	O
history	NN	O	O
of	IN	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
cough	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
and	CC	O	O
weakness	NN	B-PROBLEM	B-PROBLEM
(	(	O	O
unable	JJ	O	O
to	TO	O	O
walk	VB	O	O
)	)	O	O
.	.	O	O

at	IN	O	O
noughwell	RB	O	O
entanbon	FW	O	O
health	NN	O	O
,	,	O	O
her	PRP$	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
was	VBD	O	O
101	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
135	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
94/74	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
20	CD	O	O
.	.	O	O

positive	JJ	O	O
findings	NNS	O	O
of	IN	O	O
physical	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
include	VBP	O	O
chicken	VBN	B-PROBLEM	B-PROBLEM
pox	JJ	I-PROBLEM	I-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
thorax	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
sunken	JJ	B-PROBLEM	O
eyes	NNS	I-PROBLEM	O
,	,	O	O
thick	JJ	B-PROBLEM	B-PROBLEM
nasal	NN	I-PROBLEM	I-PROBLEM
discharge	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
dry	JJ	B-PROBLEM	B-TREATMENT
lips	NNS	I-PROBLEM	I-TREATMENT
,	,	I-PROBLEM	O
tongue	NN	I-PROBLEM	O
and	CC	I-PROBLEM	O
mucous	JJ	I-PROBLEM	B-PROBLEM
membranes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
red	JJ	B-PROBLEM	B-PROBLEM
tonsils	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
remainder	NN	O	O
of	IN	O	O
the	DT	B-TEST	B-TEST
physical	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
considered	VBN	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

vomiting	VBG	B-PROBLEM	B-PROBLEM
and	CC	O	O
dehydration	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypokalemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hyponatremia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
tonsillitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
peripheral	JJ	I-TREATMENT	I-TREATMENT
intravenous	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
labor	NN	O	O
day	NN	O	O
in	IN	O	O
the	DT	O	O
a.m.	NN	O	O
no	DT	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
.	.	O	O

oral	JJ	B-PROBLEM	B-PROBLEM
cyanosis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
shallow	JJ	B-PROBLEM	I-PROBLEM
respirations	NNS	I-PROBLEM	I-PROBLEM
were	VBD	O	O
noted	VBN	O	O
on	IN	O	O
9/7/93	CD	O	O
at	IN	O	O
2:45	CD	O	O
a.m.	NN	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
was	VBD	O	O
unremarkable	JJ	O	O
.	.	O	O

cardiovascular	JJ	O	O
stable	NN	O	O
,	,	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
on	IN	O	O
9/7/93	CD	O	O
at	IN	O	O
5:10	CD	O	O
a.m.	NN	O	O
and	CC	O	O
therefore	RB	O	O
10	CD	B-TREATMENT	O
cc&apos;s	NN	I-TREATMENT	O
per	IN	I-TREATMENT	O
kilo	FW	I-TREATMENT	O
albumin	NN	I-TREATMENT	B-TEST
was	VBD	O	O
given	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
clear	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
tolerated	VBD	O	O
,	,	O	O
with	IN	O	O
d5	JJ	B-TREATMENT	B-TREATMENT
normal	JJ	I-TREATMENT	I-TREATMENT
saline	NN	I-TREATMENT	I-TREATMENT
plus	CC	O	O
40	CD	O	O
meq	NN	O	O
per	IN	O	O
liter	NN	O	O
of	IN	O	O
kcl	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
a	DT	O	O
rate	NN	O	O
of	IN	O	O
50	CD	O	O
cc	NNS	O	O
&apos;s	FW	O	O
per	IN	O	O
hour	NN	O	O
for	IN	O	O
9	CD	O	O
hours	NNS	O	O
.	.	O	O
(	(	O	O
100	CD	O	O
cc&apos;s	NN	O	O
per	IN	O	O
kilo	NN	O	O
)	)	O	O
.	.	O	O

sodium	NN	B-TEST	B-TEST
and	CC	O	O
potassium	NN	B-TEST	B-TREATMENT
at	IN	O	O
this	DT	O	O
time	NN	O	O
were	VBD	O	O
128/1.5	CD	O	O
.	.	O	O

at	IN	O	O
labor	NN	O	O
day	NN	O	O
,	,	O	O
9:30	CD	O	O
a.m.	NN	O	O
,	,	O	O
the	DT	B-TREATMENT	B-TEST
fluids	NNS	I-TREATMENT	I-TEST
were	VBD	O	O
increased	VBN	O	O
to	TO	O	O
100	CD	O	O
cc&apos;s	NNS	O	O
per	IN	O	O
hour	NN	O	O
(	(	O	O
200	CD	O	O
cc&apos;s	NN	O	O
per	IN	O	O
kilo	NN	O	O
for	IN	O	O
5	CD	O	O
hours	NNS	O	O
)	)	O	O
.	.	O	O

electrolytes	NNS	B-TEST	B-TEST
at	IN	O	O
this	DT	O	O
point	NN	O	O
were	VBD	O	O
sodium	JJ	B-TEST	B-TEST
132	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
1.8	CD	O	O
.	.	O	O

at	IN	O	O
9/6/93	CD	O	O
,	,	O	O
2:30	CD	O	O
p.m.	NN	O	O
,	,	O	O
fluids	NNS	B-TREATMENT	B-TEST
were	VBD	O	O
decreased	VBN	O	O
to	TO	O	O
75	CD	O	O
cc&apos;s	NNS	O	O
per	IN	O	O
hour	NN	O	O
,	,	O	O
150	CD	O	O
cc&apos;s	NN	O	O
per	IN	O	O
kilo	NN	O	O
,	,	O	O
40	CD	O	O
meq	NN	O	O
of	IN	O	O
k	NN	B-TREATMENT	B-TREATMENT
phosphate	NN	I-TREATMENT	I-TREATMENT
added	VBD	O	I-TREATMENT
to	TO	O	I-TREATMENT
the	DT	B-TREATMENT	I-TREATMENT
intravenous	JJ	I-TREATMENT	I-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

electrolytes	NNS	B-TEST	B-TEST
at	IN	O	O
this	DT	O	O
point	NN	O	O
were	VBD	O	O
a	DT	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
of	IN	O	O
143	CD	O	O
and	CC	O	O
potassium	NN	B-TEST	B-TEST
1.7	CD	O	O
.	.	O	O

on	IN	O	O
9/6/93	CD	O	O
,	,	O	O
22:00	CD	O	O
,	,	O	O
fluids	NNS	B-TREATMENT	B-TEST
were	VBD	O	O
changed	VBN	O	O
to	TO	O	O
d5	VB	B-TREATMENT	O
normal	JJ	I-TREATMENT	B-TREATMENT
saline	JJ	I-TREATMENT	I-TREATMENT
plus	CC	O	O
40	CD	O	O
kcl	NN	B-TREATMENT	O
and	CC	O	O
40	CD	O	O
k	NN	B-TREATMENT	B-TREATMENT
phosphate	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
75	CD	O	O
cc	NN	O	O
&apos;s	FW	O	O
per	IN	O	O
hour	NN	O	O
.	.	O	O

electrolytes	NNS	B-TEST	B-TEST
at	IN	O	O
this	DT	O	O
time	NN	O	O
were	VBD	O	O
a	DT	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
of	IN	O	O
148	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
1.7	CD	O	O
.	.	O	O

at	IN	O	O
9/7/93	CD	O	O
,	,	O	O
1:00	CD	O	O
a.m.	NN	O	O
,	,	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
rate	NN	O	I-TREATMENT
was	VBD	O	O
decreased	VBN	O	O
to	TO	O	O
50	CD	O	O
cc&apos;s	NNS	O	O
per	IN	O	O
hour	NN	O	O
,	,	O	O
total	JJ	B-TREATMENT	B-TEST
fluids	NNS	I-TREATMENT	I-TEST
given	VBN	O	O
during	IN	O	O
the	DT	O	O
first	JJ	O	O
24	CD	O	O
hours	NNS	O	O
were	VBD	O	O
140	CD	O	O
to	TO	O	O
150	CD	O	O
cc&apos;s	NNS	O	O
per	IN	O	O
kilo	FW	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

at	IN	O	O
this	DT	O	O
time	NN	O	O
,	,	O	O
sodium	NN	B-TEST	B-TEST
was	VBD	O	O
147	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
2.6	CD	O	O
,	,	O	O
total	JJ	B-TREATMENT	B-TEST
sodium	NN	I-TREATMENT	I-TEST
given	VBN	O	O
during	IN	O	O
the	DT	O	O
first	JJ	O	O
24	CD	O	O
hours	NNS	O	O
20	CD	O	O
meq	NNS	O	O
per	IN	O	O
kilo	FW	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

on	IN	O	O
9/7/93	CD	O	O
at	IN	O	O
4:00	CD	O	O
a.m.	RB	O	O
,	,	O	O
albumin	JJ	B-TREATMENT	B-TEST
bolus	CC	I-TREATMENT	I-TEST
5%	CD	O	O
10	CD	O	O
cc&apos;s	NN	O	O
per	IN	O	O
kilo	NN	O	O
was	VBD	O	O
given	VBN	O	O
,	,	O	O
a	DT	O	O
total	NN	O	O
of	IN	O	O
120	CD	O	O
cc&apos;s	NN	O	O
,	,	O	O
electrolytes	NNS	B-TEST	B-TEST
were	VBD	O	O
sodium	JJ	B-TEST	B-TEST
155	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
3.1	CD	O	O
.	.	O	O

at	IN	O	O
9/7/93	CD	O	O
at	IN	O	O
5:00	CD	O	O
a.m.	RB	O	O
,	,	O	O
sodium	NN	B-TREATMENT	B-TREATMENT
bicarbonate	NN	I-TREATMENT	I-TREATMENT
given	VBN	O	O
60	CD	O	O
meq	NNS	O	O
,	,	O	O
calcium	NN	B-TREATMENT	B-TREATMENT
bolus	NN	I-TREATMENT	I-TREATMENT
10	CD	O	O
cc&apos;s	NN	O	O
given	VBN	O	O
.	.	O	O

on	IN	O	O
9/7	CD	O	O
,	,	O	O
5:30	CD	O	O
a.m.	NN	O	O
,	,	O	O
d5	JJ	B-TREATMENT	B-TREATMENT
quarter	NN	I-TREATMENT	I-TREATMENT
normal	JJ	I-TREATMENT	I-TREATMENT
saline	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
40	CD	O	O
of	IN	O	O
k	NN	B-TREATMENT	B-TREATMENT
phosphate	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
100	CD	O	O
cc&apos;s	NNS	O	O
per	IN	O	O
hour	NN	O	O
was	VBD	O	O
given	VBN	O	O
.	.	O	O

there	EX	O	O
were	VBD	O	O
no	DT	O	O
abnormal	JJ	B-PROBLEM	B-PROBLEM
findings	NNS	I-PROBLEM	I-PROBLEM
in	IN	O	O
abdominal	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
.	.	O	O

on	IN	O	O
9/5/93	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
48	CD	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
11.2	CD	O	O
,	,	O	O
neutrophiles	NNS	B-TEST	B-TEST
67	CD	O	O
,	,	O	O
bands	VBZ	B-TEST	B-TEST
14	CD	O	O
,	,	O	O
lymphs	VBD	B-TEST	B-TEST
11	CD	O	O
,	,	O	O
monos	FW	B-TEST	B-TEST
6%	CD	O	O
,	,	O	O
meta	NN	B-TEST	B-TEST
2%	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
220,000	CD	O	O
.	.	O	O

copious	JJ	B-PROBLEM	B-PROBLEM
urine	NN	I-PROBLEM	I-PROBLEM
output	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
bun	NN	B-TEST	B-TEST
1.0	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
.8	NN	O	O
.	.	O	O

normal	JJ	O	O
neurologic	JJ	O	B-TEST
exam	NN	O	I-TEST
on	IN	O	O
admission	NN	O	O
,	,	O	O
then	RB	O	O
lethargic	VBZ	B-PROBLEM	B-PROBLEM
on	IN	O	O
9/6/93	CD	O	O
at	IN	O	O
17:45	CD	O	O
,	,	O	O
then	RB	O	O
patient	NN	O	O
became	VBD	O	O
unresponsive	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
areflexic	JJ	B-PROBLEM	O
and	CC	O	O
limp	NN	B-PROBLEM	B-PROBLEM
at	IN	O	O
9/6/93	CD	O	O
,	,	O	O
at	IN	O	O
17:45	CD	O	O
to	TO	O	O
22:00	CD	O	O
.	.	O	O

patient	NN	O	O
was	VBD	O	O
having	VBG	O	O
seizures	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
twitching	VBG	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
face	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
rapid	JJ	B-PROBLEM	O
movements	NNS	I-PROBLEM	O
of	IN	I-PROBLEM	O
eyes	NNS	I-PROBLEM	O
.	.	O	O

pupils	NNS	B-PROBLEM	O
dilated	VBN	I-PROBLEM	O
and	CC	I-PROBLEM	O
sluggish	JJ	I-PROBLEM	B-PROBLEM
.	.	O	O

valium	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
given	VBN	O	O
at	IN	O	O
9/7/93	CD	O	O
,	,	O	O
00:02	CD	O	O
.	.	O	O

iv	NN	B-TREATMENT	O
ampicillin	NN	I-TREATMENT	B-TREATMENT
,	,	O	O
chloramphenicol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
ceftriaxone	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
culture	NN	B-TEST	B-TEST
were	VBD	O	O
sent	VBN	O	O
.	.	O	O

finally	RB	O	O
,	,	O	O
fairm	NN	O	O
of	IN	O	O
ijordcompmac	JJ	O	O
hospital	NN	O	O
transport	NN	O	O
team	NN	O	O
was	VBD	O	O
called	VBN	O	O
and	CC	O	O
transport	NN	O	O
team	NN	O	O
arrived	VBD	O	O
on	IN	O	O
9/7/93	CD	O	O
,	,	O	O
6:30	CD	O	O
a.m.	NN	O	O
,	,	O	O
and	CC	O	O
on	IN	O	O
arrival	JJ	O	O
patient	NN	O	O
was	VBD	O	O
seizing	VBG	O	O
with	IN	O	O
rhythmic	JJ	B-PROBLEM	B-PROBLEM
eye	NN	I-PROBLEM	I-PROBLEM
movement	NN	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
left	VB	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
unresponsive	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
poor	JJ	B-PROBLEM	B-PROBLEM
perfusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

temperature	NN	B-TEST	B-TEST
was	VBD	O	O
101.8	CD	O	O
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
second	JJ	I-TREATMENT	I-TREATMENT
intravenous	JJ	I-TREATMENT	I-TREATMENT
was	VBD	O	O
started	VBN	O	O
and	CC	O	O
given	VBN	O	O
normal	JJ	B-TREATMENT	B-TREATMENT
saline	NN	I-TREATMENT	I-TREATMENT
bolus	NN	I-TREATMENT	I-TREATMENT
,	,	O	I-TREATMENT
change	NN	O	I-TREATMENT
in	IN	O	I-TREATMENT
intravenous	JJ	B-TREATMENT	I-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
to	TO	O	O
d5	VB	B-TREATMENT	O
water	NN	I-TREATMENT	O
with	IN	O	O
80	CD	O	O
meq	NNS	O	O
of	IN	O	O
bicarbonate	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
plus	CC	O	O
40	CD	O	O
meq	NN	O	O
of	IN	O	O
kcl	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
45	CD	O	O
cc&apos;s	NNS	O	O
per	IN	O	O
hour	NN	O	O
,	,	O	O
bicarbonate	VB	B-TREATMENT	B-TEST
given	VBN	O	O
2	CD	O	O
meq	NNS	O	O
per	IN	O	O
kilo	NN	O	O
,	,	O	O
attempted	VBN	O	O
to	TO	O	O
start	VB	O	O
dopa	NN	B-TREATMENT	O
for	IN	O	O
poor	JJ	B-PROBLEM	B-PROBLEM
perfusion	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
perfusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

therefore	RB	O	O
,	,	O	O
dopa	NN	B-TREATMENT	O
was	VBD	O	O
stopped	VBN	O	O
.	.	O	O

total	JJ	O	B-TEST
volume	NN	O	I-TEST
given	VBN	O	O
as	IN	O	O
bolus	JJ	B-TREATMENT	B-TREATMENT
50	CD	O	O
cc&apos;s	NN	O	O
per	IN	O	O
kilo	NN	O	O
,	,	O	O
sodium	NN	B-TREATMENT	B-TREATMENT
bicarbonate	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
2	CD	O	O
meq	NNS	O	O
per	IN	O	O
kilo	NN	O	O
was	VBD	O	O
given	VBN	O	O
.	.	O	O

last	JJ	O	O
abg	NN	B-TEST	O
there	EX	O	O
was	VBD	O	O
6.98	CD	O	O
,	,	O	O
31	CD	O	O
,	,	O	O
171	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
of	IN	O	O
7	CD	O	O
.	.	O	O

phenobarbital	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
dilantin	VB	B-TREATMENT	B-TREATMENT
given	VBN	O	O
for	IN	O	O
seizure	NN	B-TREATMENT	B-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

electrolytes	NNS	B-TEST	B-TEST
before	IN	O	O
departure	NN	O	O
for	IN	O	O
fairm	NN	O	O
of	IN	O	O
ijordcompmac	JJ	O	O
hospital	NN	O	O
was	VBD	O	O
a	DT	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
of	IN	O	O
176	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
2.5	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
140	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
14	CD	O	O
,	,	O	O
calcium	NN	B-TEST	B-TEST
7.2	CD	O	O
,	,	O	O
magnesium	NN	B-TEST	B-TEST
2.7	CD	O	O
.	.	O	O

lines	NNS	B-TREATMENT	O
placed	VBN	O	O
were	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
femoral	JJ	I-TREATMENT	I-TREATMENT
triple	JJ	I-TREATMENT	I-TREATMENT
lumen	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
endotracheal	JJ	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
4.0	CD	O	O
,	,	O	O
arterial	JJ	B-TREATMENT	B-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
right	JJ	B-TREATMENT	B-TREATMENT
radial	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
,	,	O	I-TREATMENT
foley	NN	B-TREATMENT	I-TREATMENT
placed	VBD	O	O
,	,	O	O
peripheral	JJ	B-TREATMENT	B-TREATMENT
intravenous	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
nasogastric	JJ	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
admission	NN	O	O
to	TO	O	O
fairm	NN	O	O
of	IN	O	O
ijordcompmac	JJ	O	O
hospital	NN	O	O
,	,	O	O
temperature	NN	B-TEST	B-TEST
100.2	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
149	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
50	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
98/66	CD	O	O
,	,	O	O
mean	JJ	B-TEST	B-TEST
arterial	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
73	CD	O	O
,	,	O	O
weight	VBD	B-TEST	B-TEST
12	CD	O	O
kilos	NN	O	O
.	.	O	O

rta	NN	B-PROBLEM	O
diagnosed	VBD	O	O
at	IN	O	O
14	CD	O	O
months	NNS	O	O
of	IN	O	O
age	NN	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
scarlet	NN	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
14	CD	O	O
months	NNS	O	O
of	IN	O	O
age	NN	O	O
.	.	O	O

she	PRP	O	O
also	RB	O	O
had	VBD	O	O
a	DT	O	B-PROBLEM
recent	JJ	O	I-PROBLEM
exposure	NN	O	I-PROBLEM
to	TO	O	I-PROBLEM
varicella	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	O	O
brother	NN	O	O
had	VBD	O	O
developed	VBN	O	O
the	DT	B-PROBLEM	B-PROBLEM
typical	JJ	I-PROBLEM	I-PROBLEM
rash	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
9/3/93	CD	O	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
fi02	NN	B-TREATMENT	B-TEST
was	VBD	O	O
50-60%	JJ	O	O
,	,	O	O
pid	JJ	B-TREATMENT	B-TEST
30-32/peep	CD	B-TREATMENT	O
of	IN	O	O
5.7	CD	O	O
,	,	O	O
total	JJ	B-TEST	B-TEST
volume	NN	I-TEST	I-TEST
was	VBD	O	O
between	IN	O	O
140	CD	O	O
to	TO	O	O
210	CD	O	O
during	IN	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
stay	NN	O	O
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
showed	VBD	O	O
right	JJ	B-PROBLEM	B-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

cvp	NN	B-TEST	O
on	IN	O	O
admission	NN	O	O
was	VBD	O	O
1	CD	O	O
cm	NN	O	O
of	IN	O	O
water	NN	O	O
.	.	O	O

then	RB	O	O
during	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
stay	NN	O	O
,	,	O	O
the	DT	O	O
cvp	NN	B-TEST	O
remained	VBD	O	O
between	IN	O	O
7	CD	O	O
to	TO	O	O
8	CD	O	O
after	IN	O	O
volume	NN	B-TREATMENT	B-TREATMENT
resuscitation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

dopamine	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
epinephrine	VB	B-TREATMENT	B-TREATMENT
given	VBN	O	O
for	IN	O	O
cardiovascular	JJ	B-TREATMENT	B-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

her	PRP$	B-TEST	B-TEST
electrocardiogram	JJ	I-TEST	I-TEST
findings	NNS	O	O
were	VBD	O	O
compatible	JJ	O	O
with	IN	O	O
hypokalemia	NN	B-PROBLEM	B-PROBLEM
(	(	O	I-PROBLEM
flattening	VBG	B-PROBLEM	I-PROBLEM
t	NN	I-PROBLEM	I-PROBLEM
waves	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
st	JJ	B-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
)	)	O	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
to	TO	O	O
fairm	NN	O	O
of	IN	O	O
ijordcompmac	JJ	O	O
hospital	NN	O	O
,	,	O	O
hypernatremia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
hypovolemic	JJ	B-PROBLEM	B-PROBLEM
shock	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

fluids	NNS	B-TREATMENT	O
of	IN	I-TREATMENT	O
d5	JJ	I-TREATMENT	O
water	NN	I-TREATMENT	O
with	IN	O	O
30	CD	O	O
meq	NNS	O	O
of	IN	O	O
sodium	NN	B-TREATMENT	B-TREATMENT
acetate	NN	I-TREATMENT	I-TREATMENT
per	IN	O	O
liter	NN	O	O
,	,	O	O
30	CD	O	O
ml	NN	O	O
per	IN	O	O
liter	NN	O	O
of	IN	O	O
phosphate	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
30	CD	O	O
meq	NN	O	O
of	IN	O	O
k	NN	B-TREATMENT	B-TREATMENT
acetate	NN	I-TREATMENT	I-TREATMENT
per	IN	O	O
liter	NN	O	O
at	IN	O	O
90	CD	O	O
cc&apos;s	NNS	O	O
per	IN	O	O
hour	NN	O	O
was	VBD	O	O
given	VBN	O	O
.	.	O	O

free	JJ	B-TREATMENT	O
water	NN	I-TREATMENT	O
deficit	NN	I-TREATMENT	O
over	IN	O	O
48	CD	O	O
hours	NNS	O	O
was	VBD	O	O
given	VBN	O	O
,	,	O	O
plus	CC	O	O
maintenance	NN	O	O
,	,	O	O
plus	CC	O	O
adjusting	VBG	O	O
the	DT	O	O
ongoing	JJ	O	O
losses	NNS	O	O
.	.	O	O

pediatric	JJ	O	O
nephrology	NN	O	O
recommended	VBD	O	O
on	IN	O	O
9/7/93	CD	O	O
,	,	O	O
5:50	CD	O	O
p.m.	NN	O	O
,	,	O	O
10	CD	O	O
cc	NN	O	O
&apos;s	FW	O	O
per	IN	O	O
kilo	NN	O	O
of	IN	O	O
150	CD	O	O
meq	NN	O	O
of	IN	O	O
sodium	NN	B-TREATMENT	B-TREATMENT
bicarbonate	NN	I-TREATMENT	I-TREATMENT
per	IN	O	O
liter	NN	O	O
,	,	O	O
(	(	O	O
1.5	CD	O	O
meq	NN	O	O
per	IN	O	O
kilo	NN	O	B-TREATMENT
bicarbonate	NN	B-TREATMENT	I-TREATMENT
,	,	O	O
one	CD	O	O
dose	NN	O	O
of	IN	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
volume	NN	B-TREATMENT	O
as	IN	O	O
needed	VBN	O	O
)	)	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
required	VBN	O	O
multiple	JJ	B-TREATMENT	B-TREATMENT
boluses	NNS	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
albumin	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
patient	NN	O	O
also	RB	O	O
required	VBD	O	O
multiple	JJ	B-TREATMENT	B-TREATMENT
boluses	NNS	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
calcium	NN	I-TREATMENT	I-TREATMENT
because	IN	O	O
of	IN	O	O
hypocalcemia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

magnesium	NN	B-TREATMENT	B-TEST
2.0	CD	O	O
meq	NN	O	O
per	IN	O	O
liter	NN	O	O
,	,	O	O
phosphate	VBP	B-TREATMENT	O
8	CD	O	O
mg	NN	O	O
/	NNP	O	O
dl	NN	O	O
.	.	O	O

npo	NN	B-TREATMENT	O
.	.	O	O

albumin	NN	B-TEST	B-TEST
was	VBD	O	O
4.9	CD	O	O
.	.	O	O

globulin	NN	B-TEST	B-TREATMENT
was	VBD	O	O
1.6	CD	O	O
,	,	O	O
uric	JJ	B-TEST	B-TEST
acid	NN	I-TEST	I-TEST
was	VBD	O	O
6.5	CD	O	O
,	,	O	O
alkaline	JJ	B-TEST	B-TEST
phosphatase	NN	I-TEST	I-TEST
150	CD	O	O
,	,	O	O
sgpt	VBD	B-TEST	B-TEST
11	CD	O	O
,	,	O	O
sgot	VBD	B-TEST	B-TEST
85	CD	O	O
,	,	O	O
ldh	VBD	B-TEST	O
524	CD	O	O
,	,	O	O
ck	NN	B-TEST	B-TEST
152	CD	O	O
,	,	O	O
nh3	RB	B-TEST	B-TREATMENT
81	CD	O	O
.	.	O	O

white	JJ	B-TEST	B-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
9.4	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
42	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
151,000	CD	O	O
.	.	O	O

differential	NN	B-TEST	O
was	VBD	O	O
polys	JJ	B-TEST	B-TEST
59	CD	O	O
,	,	O	O
bands	VBZ	B-TEST	B-TEST
3	CD	O	O
,	,	O	O
lymphs	VBD	B-TEST	B-TEST
25	CD	O	O
.	.	O	O

repeat	NN	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
6.4	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
34	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
103	CD	O	O
.	.	O	O

pt	NN	B-TEST	O
11.6/10.1	CD	O	O
,	,	O	O
repeat	NN	B-TEST	B-TEST
pt	NN	I-TEST	I-TEST
12.8/10.5	CD	O	O
.	.	O	O

ptt	NN	B-TEST	B-TEST
36.4	CD	O	O
,	,	O	O
repeat	NN	B-TEST	B-TEST
ptt	NN	I-TEST	I-TEST
50.9	CD	O	O
.	.	O	O

fibrinogen	NN	B-TEST	B-TEST
211	CD	O	O
.	.	O	O

urine	JJ	B-TEST	B-TEST
output	NN	I-TEST	I-TEST
was	VBD	O	O
about	RB	O	O
5	CD	O	O
to	TO	O	O
8	CD	O	O
cc&apos;s	NNS	O	O
per	IN	O	O
kilo	FW	O	O
per	IN	O	O
hour	NN	O	O
.	.	O	O

renal	JJ	B-TEST	B-TEST
ultrasound	NN	I-TEST	I-TEST
was	VBD	O	O
scheduled	VBN	O	O
during	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
stay	NN	O	O
.	.	O	O

urinalysis	NN	B-TEST	B-TEST
showed	VBD	O	O
specific	JJ	B-TEST	B-TEST
gravity	NN	I-TEST	I-TEST
1.005	CD	O	O
,	,	O	O
ph	NN	B-TEST	B-TEST
8.0	CD	O	O
,	,	O	O
positive	JJ	B-PROBLEM	B-PROBLEM
proteins	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
positive	JJ	B-PROBLEM	O
red	JJ	I-PROBLEM	B-TEST
blood	NN	I-PROBLEM	I-TEST
cells	NNS	I-PROBLEM	I-TEST
,	,	O	O
negative	JJ	O	O
white	JJ	O	B-TEST
cell	NN	O	I-TEST
count	NN	O	I-TEST
,	,	O	O
positive	JJ	B-PROBLEM	B-PROBLEM
glucose	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
did	VBD	O	O
not	RB	O	O
receive	VB	O	O
sedation	NN	B-TREATMENT	B-TREATMENT
or	CC	O	O
muscle	NN	B-TREATMENT	B-PROBLEM
relaxant	NN	I-TREATMENT	I-PROBLEM
since	IN	O	O
admission	NN	O	O
to	TO	O	O
the	DT	O	O
pediatric	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
.	.	O	O

phenobarbital	JJ	B-TEST	B-TEST
levels	NNS	I-TEST	I-TEST
were	VBD	O	O
31.4	CD	O	O
,	,	O	O
30.2	CD	O	O
,	,	O	O
and	CC	O	O
50	CD	O	O
.	.	O	O

dilantin	NN	B-TEST	B-TEST
level	NN	I-TEST	I-TEST
was	VBD	O	O
22.6	CD	O	O
,	,	O	O
20.2	CD	O	O
,	,	O	O
20	CD	O	O
.	.	O	O

neurology	NN	O	O
consultation	NN	O	O
on	IN	O	O
the	DT	O	O
evening	NN	O	O
of	IN	O	O
9/7/93	CD	O	O
revealed	JJ	O	O
supple	NN	O	O
neck	NN	O	O
,	,	O	O
no	DT	B-PROBLEM	O
response	NN	I-PROBLEM	O
to	TO	O	O
external	JJ	B-TEST	O
rub	NN	I-TEST	O
.	.	O	O

pupils	NNS	O	O
were	VBD	O	O
3.5	CD	O	O
od	NN	O	O
,	,	O	O
and	CC	O	O
3.0	CD	O	O
os	NN	O	O
,	,	O	O
irregular	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
non	JJ	B-PROBLEM	B-PROBLEM
reactive	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

corneal	NN	B-TEST	B-TEST
reflexes	NNS	I-TEST	I-TEST
and	CC	O	O
oculocephalic	JJ	B-TEST	B-TEST
reflexes	NNS	I-TEST	I-TEST
were	VBD	O	O
absent	JJ	B-PROBLEM	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	B-PROBLEM	O
gag	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

muscle	NN	B-TEST	B-PROBLEM
tone	NN	I-TEST	I-PROBLEM
was	VBD	O	O
increased	VBN	B-PROBLEM	O
throughout	IN	I-PROBLEM	O
,	,	O	O
and	CC	O	O
the	DT	O	O
legs	NNS	O	O
were	VBD	O	O
both	DT	B-PROBLEM	O
extended	VBN	I-PROBLEM	O
and	CC	I-PROBLEM	O
internally	RB	I-PROBLEM	O
rotated	VBN	I-PROBLEM	O
.	.	O	O

deep	JJ	B-TEST	B-TEST
tendon	NN	I-TEST	I-TEST
reflexes	NNS	I-TEST	I-TEST
could	MD	O	O
not	RB	O	O
be	VB	O	O
elicited	VBN	O	O
and	CC	O	O
plantar	JJ	B-TEST	B-TEST
responses	NNS	I-TEST	I-TEST
were	VBD	O	O
silent	JJ	B-PROBLEM	O
.	.	O	O

repeat	NN	B-TEST	B-TEST
neurological	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
revealed	VBD	O	O
no	DT	B-PROBLEM	O
spontaneous	JJ	I-PROBLEM	B-PROBLEM
movement	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
no	DT	B-PROBLEM	O
response	NN	I-PROBLEM	O
to	TO	O	O
voice	NN	B-TEST	O
or	CC	I-TEST	O
noxious	JJ	I-TEST	B-PROBLEM
stimulation	NN	I-TEST	I-PROBLEM
.	.	O	O

pupils	NNS	O	O
were	VBD	O	O
dilated	VBN	B-PROBLEM	O
and	CC	O	O
non	JJ	B-PROBLEM	B-PROBLEM
reactive	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

disc	NN	O	B-TEST
margins	NNS	O	I-TEST
appeared	VBD	O	O
blurred	VBN	B-PROBLEM	B-PROBLEM
on	IN	O	O
funduscopic	NN	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
.	.	O	O

a	DT	B-TEST	B-TEST
non	JJ	I-TEST	I-TEST
contrast	NN	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
ct	VBP	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
was	VBD	O	O
obtained	VBN	O	O
and	CC	O	O
ct	VB	B-TEST	O
revealed	VBN	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
cerebral	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
thalamic	JJ	B-PROBLEM	B-PROBLEM
mid	NN	I-PROBLEM	I-PROBLEM
brain	NN	I-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	I-PROBLEM
pons	NNS	I-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	O
medullar	JJ	I-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
attenuation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
diffuse	VB	B-PROBLEM	B-PROBLEM
cerebral	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
loss	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
gray	JJ	I-PROBLEM	I-PROBLEM
white	JJ	I-PROBLEM	I-PROBLEM
matter	NN	I-PROBLEM	I-PROBLEM
differentiation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

cerebral	JJ	B-TEST	B-PROBLEM
blood	NN	I-TEST	I-PROBLEM
flow	NN	I-TEST	I-PROBLEM
was	VBD	O	O
done	VBN	O	O
on	IN	O	O
9/7/93	CD	O	O
at	IN	O	O
2:30	CD	O	O
p.m.	NN	O	O
,	,	O	O
revealed	VBD	O	O
complete	JJ	B-PROBLEM	O
absence	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
blood	NN	I-PROBLEM	B-PROBLEM
flow	NN	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
brain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
a	DT	B-PROBLEM	O
tiny	JJ	I-PROBLEM	O
region	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
activity	NN	I-PROBLEM	O
in	IN	O	O
what	WP	O	O
appears	VBZ	O	O
to	TO	O	O
be	VB	O	O
anterior	JJ	O	B-PROBLEM
scalp	NN	O	I-PROBLEM
.	.	O	O

ampicillin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
chloramphenicol	NN	B-TREATMENT	B-TREATMENT
were	VBD	O	O
given	VBN	O	O
at	IN	O	O
noughwell	RB	O	O
entanbon	FW	O	O
health	NN	O	O
,	,	O	O
and	CC	O	O
ceftriaxone	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
given	VBN	O	O
at	IN	O	O
fairm	NN	O	O
of	IN	O	O
ijordcompmac	JJ	O	O
hospital	NN	O	O
.	.	O	O

acyclovir	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
started	VBN	O	O
,	,	O	O
also	RB	O	O
considering	VBG	O	O
the	DT	B-PROBLEM	O
varicella	NN	I-PROBLEM	O
at	IN	O	O
120	CD	O	O
mg	NNS	O	O
intravenously	RB	O	O
every	DT	O	O
8	CD	O	O
hours	NNS	O	O
.	.	O	O

urine	JJ	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
,	,	O	O
blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
and	CC	O	O
sputum	JJ	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
were	VBD	O	O
sent	VBN	O	O
.	.	O	O

the	DT	O	O
situation	NN	O	O
of	IN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
extensively	RB	O	O
discussed	VBN	O	O
with	IN	O	O
the	DT	O	O
parents	NNS	O	O
,	,	O	O
and	CC	O	O
the	DT	O	O
attending	VBG	O	O
physician	NN	O	O
from	IN	O	O
neurology	NN	O	O
,	,	O	O
dr.	JJ	O	O
breunkote	NN	O	O
,	,	O	O
and	CC	O	O
the	DT	O	O
attending	VBG	O	O
physician	NN	O	O
from	IN	O	O
pediatric	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
,	,	O	O
dr.	NN	O	O
boormcose	NN	O	O
,	,	O	O
and	CC	O	O
the	DT	O	O
decision	NN	O	O
was	VBD	O	O
finally	RB	O	O
made	VBN	O	O
with	IN	O	O
the	DT	O	O
family	NN	O	O
and	CC	O	O
attendings	NNS	O	O
to	TO	O	O
disconnect	VB	O	O
the	DT	O	O
patient	NN	O	O
from	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
mechanical	JJ	I-TREATMENT	I-TREATMENT
ventilation	NN	I-TREATMENT	I-TREATMENT
due	JJ	O	O
to	TO	O	O
severe	VB	B-PROBLEM	B-PROBLEM
neurological	JJ	I-PROBLEM	I-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
poor	JJ	B-PROBLEM	B-PROBLEM
prognosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

penicillins	NNS	B-TREATMENT	B-TREATMENT
/	VBP	O	O
codeine	JJ	B-TREATMENT	B-TREATMENT
/	NNP	O	I-TREATMENT
heparin	NN	B-TREATMENT	I-TREATMENT
agents	NNS	I-TREATMENT	I-TREATMENT
/	VBP	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT

chief	JJ	O	O
complaint	NN	O	O
:	:	O	O
rectal	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM

major	JJ	O	O
surgical	JJ	O	O
or	CC	O	O
invasive	JJ	O	B-TREATMENT
procedure	NN	O	I-TREATMENT
:	:	O	O
colonoscopy	NN	B-TEST	B-TEST
egd	NN	B-TEST	I-TEST

gi	NN	B-TEST	B-PROBLEM
bleeding	NN	I-TEST	I-PROBLEM
study	NN	I-TEST	I-PROBLEM

patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
77	CD	O	O
year	NN	O	O
old	JJ	O	O
female	NN	O	O
with	IN	O	O
a	DT	O	O
past	JJ	O	O
medical	JJ	O	O
history	NN	O	O
significant	JJ	O	O
for	IN	O	O
gi	NN	B-PROBLEM	B-PROBLEM
bleeding	VBG	I-PROBLEM	I-PROBLEM
secondary	JJ	O	O
to	TO	O	O
arteriovenous	JJ	B-PROBLEM	B-PROBLEM
malformations	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
who	WP	O	O
presents	VBZ	O	O
with	IN	O	O
maroon	NN	B-PROBLEM	B-PROBLEM
stool	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
hematocrit	JJ	I-PROBLEM	I-PROBLEM
drop	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

three	CD	O	O
days	NNS	O	O
ago	RB	O	O
began	VBD	O	O
to	TO	O	O
develop	VB	O	O
black	JJ	B-PROBLEM	B-PROBLEM
stools	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
clear	JJ	B-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
toilet	NN	O	I-PROBLEM
bowl	NN	O	I-PROBLEM
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
she	PRP	O	O
developed	VBD	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
decreased	VBD	B-PROBLEM	B-PROBLEM
po	NNS	I-PROBLEM	I-PROBLEM
intake	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
cough	JJ	I-PROBLEM	I-PROBLEM
productive	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
white	JJ	B-PROBLEM	I-PROBLEM
sputum	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
felt	VBD	O	O
warm	NN	O	O
,	,	O	O
although	IN	O	O
she	PRP	O	O
did	VBD	O	O
not	RB	O	O
record	VB	O	O
her	PRP$	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
.	.	O	O

at	IN	O	O
dialysis	NN	O	B-TREATMENT
on	IN	O	O
day	NN	O	O
of	IN	O	O
admission	NN	O	O
,	,	O	O
she	PRP	O	O
related	VBD	O	O
these	DT	O	B-PROBLEM
symptoms	NNS	O	I-PROBLEM
for	IN	O	O
the	DT	O	O
first	JJ	O	O
time	NN	O	O
and	CC	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
bloody	JJ	I-PROBLEM	I-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
movement	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

in	IN	O	O
the	DT	O	O
deanna	NN	O	O
,	,	O	O
her	PRP$	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
was	VBD	O	O
96.5	CD	O	O
,	,	O	O
hr	NN	B-TEST	B-TEST
51	CD	O	O
,	,	O	O
bp	NN	B-TEST	B-TEST
112/60	CD	O	O
,	,	O	O
rr	NN	B-TEST	B-TEST
18	CD	O	O
,	,	O	O
and	CC	O	O
oxygen	NN	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST
was	VBD	O	O
98%	CD	O	O
on	IN	O	O
ambient	JJ	O	O
air	NN	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
measured	VBN	O	O
at	IN	O	O
23.5	CD	O	O
,	,	O	O
while	IN	O	O
her	PRP$	B-TEST	B-TEST
baseline	NN	I-TEST	I-TEST
hematocrit	NN	I-TEST	I-TEST
is	VBZ	O	O
in	IN	O	O
the	DT	O	O
low	JJ	O	O
30	CD	O	O
s.	NN	O	O

an	DT	B-TEST	B-TEST
ng	JJ	I-TEST	I-TEST
lavage	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
and	CC	O	O
there	EX	O	O
was	VBD	O	O
bilious	JJ	B-PROBLEM	B-PROBLEM
return	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

rectal	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
notable	JJ	O	O
for	IN	O	O
guiaiac	JJ	B-PROBLEM	B-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
maroon	NN	I-PROBLEM	I-PROBLEM
stool	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
type	NN	O	B-PROBLEM
and	CC	O	O
crossed	VBN	O	O
and	CC	O	O
transfused	VBN	O	O
two	CD	O	O
units	NNS	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

iv	NN	B-TREATMENT	O
ppi	NN	I-TREATMENT	O
was	VBD	O	O
given	VBN	O	O
and	CC	O	O
the	DT	O	B-TEST
gi	NN	O	I-TEST
team	NN	O	I-TEST
was	VBD	O	O
consulted	VBN	O	O
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
scheduled	VBN	O	O
for	IN	O	O
colonoscopy	NN	B-TEST	B-TREATMENT
and	CC	O	O
egd	NN	B-TEST	O
on	IN	O	O
the	DT	O	O
morning	NN	O	O
of	IN	O	O
6/8	CD	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
ccu	NN	O	O
for	IN	O	O
observation	NN	B-TEST	O
.	.	O	O

dm2	NN	B-PROBLEM	O
on	IN	O	O
insulin	NN	B-TREATMENT	B-TREATMENT

cri	JJ	B-PROBLEM	O
03-30	JJ	O	O
htn	NN	B-PROBLEM	O
and	CC	O	O
dm	NN	B-PROBLEM	B-PROBLEM
nephropathy	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
baseline	JJ	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
4-4.5	JJ	O	O

chronic	JJ	B-PROBLEM	B-PROBLEM
gi	NN	I-PROBLEM	I-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
:	:	O	O
documented	VBN	B-PROBLEM	O
avms	NN	I-PROBLEM	O

anemia	NN	B-PROBLEM	B-PROBLEM
w/	WRB	O	O
baseline	NN	B-TEST	B-TEST
hct	NN	I-TEST	I-TEST
27-30	JJ	O	O

thrombocytopenia	NN	B-PROBLEM	B-PROBLEM

coagulopathy	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hit	VBN	B-PROBLEM	O
in	IN	O	O
2014	CD	O	O

cardiomyopathy	NN	B-PROBLEM	B-PROBLEM

mrsa	NN	B-PROBLEM	O
endocardiitis	NN	I-PROBLEM	O
(	(	O	O
01-28	CD	O	O
)	)	O	O

cad	NN	B-PROBLEM	O
;	:	O	O
status	NN	O	O
post	NN	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
times	NNS	O	O
two	CD	O	O
and	CC	O	O
status	NN	O	O
post	NN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
2001	CD	O	O
and	CC	O	O
2000	CD	O	O
.	.	O	O

asthma	NN	B-PROBLEM	B-PROBLEM

hypothyroidism	NN	B-PROBLEM	B-PROBLEM

osteoarthritis	NN	B-PROBLEM	B-PROBLEM

paroxysmal	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM

pud	NN	B-PROBLEM	O
,	,	O	O
barrett	NN	B-PROBLEM	B-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
esophagus	NN	I-PROBLEM	I-PROBLEM

chf	NN	B-PROBLEM	O
ef	VBZ	B-TEST	O
50%	CD	O	O

primarily	RB	O	O
togolese	JJ	O	O
speaking	NN	O	O
,	,	O	O
wheelchair	NN	B-PROBLEM	B-PROBLEM
bound	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
lives	VBZ	O	O
alone	RB	O	O
but	CC	O	O
cared	VBD	O	O
for	IN	O	O
entirely	RB	O	O
by	IN	O	O
her	PRP$	O	O
daughter	NN	O	O
.	.	O	O

cad	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
dm	NN	B-PROBLEM	O

t	NN	B-TEST	O
:	:	O	O
97.2	CD	O	O
bp	NN	B-TEST	O
:	:	O	O
127/57	CD	O	O
hr	NN	B-TEST	O
:	:	O	O
68	CD	O	O
rr	NN	B-TEST	O
:	:	O	O
11	CD	O	O
o2saturation	NN	B-TEST	O
:	:	O	O
97%	CD	O	O
on	IN	O	O
ambient	NN	O	O
air	NN	O	O

slight	JJ	B-PROBLEM	B-PROBLEM
conjunctival	NN	I-PROBLEM	I-PROBLEM
pallor	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
scleral	JJ	B-PROBLEM	B-PROBLEM
icterus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

slightly	RB	B-PROBLEM	B-PROBLEM
dry	JJ	I-PROBLEM	I-PROBLEM
mucous	JJ	I-PROBLEM	I-PROBLEM
membranes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
jvd	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

systolic	JJ	B-PROBLEM	B-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
sternal	JJ	I-PROBLEM	I-PROBLEM
border	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
rubs	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
andringa	NN	B-PROBLEM	B-PROBLEM
appreciated	VBN	O	O
.	.	O	O

crackles	NNS	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
fields	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
wheezes	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
rhonci	NN	B-PROBLEM	B-PROBLEM
appreciated	VBN	O	O
.	.	O	O

slightly	RB	B-PROBLEM	B-PROBLEM
hyperactive	JJ	I-PROBLEM	I-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
sounds	VBZ	I-PROBLEM	I-PROBLEM
throughout	IN	I-PROBLEM	O
.	.	O	O

nontender	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
nondistended	VBD	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
guarding	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
rebound	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
splenomegaly	NN	B-PROBLEM	B-PROBLEM
appreciated	VBD	O	O
.	.	O	O

guaiac	JJ	B-PROBLEM	B-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
maroon	NN	I-PROBLEM	I-PROBLEM
stool	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
deanna	NN	O	I-PROBLEM
.	.	O	O

no	DT	O	O
clubbing	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
lower	JJR	B-PROBLEM	B-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	O
bilaterally	RB	I-PROBLEM	O
.	.	O	O

2+	CD	B-TEST	O
dorsalis	JJ	I-TEST	B-TEST
pedis	NN	I-TEST	I-TEST
and	CC	I-TEST	O
radial	JJ	I-TEST	B-TEST
pulse	NN	I-TEST	I-TEST
on	IN	I-TEST	O
left	NN	I-TEST	O
.	.	O	O

no	DT	B-PROBLEM	O
radial	JJ	I-PROBLEM	B-TEST
pulse	NN	I-PROBLEM	I-TEST
on	IN	I-PROBLEM	O
right	NN	I-PROBLEM	O
.	.	O	O

av	JJ	B-TREATMENT	B-PROBLEM
fistula	NN	I-TREATMENT	I-PROBLEM
on	IN	O	O
right	NN	O	O
.	.	O	O

2018-08-07	JJ	O	O
12:56	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	B-TEST	B-TEST
-	:	O	O
4.0	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.54	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
11.6	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
32.9	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
93	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
32.8	CD	O	O
*	NN	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
35.2	CD	O	O
*	NN	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
18.5	CD	O	O
*	JJ	O	O
plt	NN	B-TEST	B-TEST
ct	SYM	I-TEST	I-TEST
-	:	O	O
65	CD	O	O
*	NN	O	O

2018-08-02	JJ	O	O
12:29	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
hct	SYM	B-TEST	B-TEST
-	:	O	O
23.5	CD	O	O
*#	NN	O	O

2018-08-02	JJ	O	O
04:40	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
wbc	SYM	B-TEST	B-TEST
-	:	O	O
3.2	CD	O	O
*	NN	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
2.49	CD	O	O
*#	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
8.4	CD	O	O
*#	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
24.5	CD	O	O
*#	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
98	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
33.7	CD	O	O
*	NN	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.3	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
18.5	CD	O	O
*	JJ	O	O
plt	NN	B-TEST	B-TEST
ct	SYM	I-TEST	I-TEST
-	:	O	O
69	CD	O	O
*	NN	O	O

2018-08-06	JJ	O	O
04:52	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
pt	NN	B-TEST	I-TEST
-	:	O	O
14.7	CD	O	O
*	NN	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
28.9	CD	O	O
inr	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
pt	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
1.3	CD	O	O
*	NN	O	O

2018-08-07	JJ	O	O
12:56	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
urean	JJ	B-TEST	B-TEST
-	:	O	O
27	CD	O	O
*	NN	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
4.1	CD	O	O
*	NN	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
130	CD	O	O
*	NN	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
3.7	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
94	CD	O	O
*	NN	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
27	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
13	CD	O	O

2018-08-06	JJ	O	O
04:52	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
129	CD	O	O
*	JJ	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
24	CD	O	O
*	NN	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
3.4	CD	O	O
*	NN	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
134	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
3.2	CD	O	O
*	NN	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
96	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
29	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
12	CD	O	O

2018-08-02	JJ	O	O
04:40	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	O
glucose	VB	B-TEST	B-TEST
-	:	O	O
187	CD	O	O
*	JJ	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
21	CD	O	O
*	NN	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
2.0	CD	O	O
*#	NN	O	O
na	SYM	B-TEST	O
-	:	O	O
139	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
3.2	CD	O	O
*	NN	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
96	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
35	CD	O	O
*	NN	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
11	CD	O	O

2018-08-07	JJ	O	O
12:56	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
calcium	NN	B-TEST	I-TEST
-	:	O	O
8.0	CD	O	O
*	NN	O	O
phos	NN	B-TEST	B-TEST
-	:	O	O
3.5	CD	O	O
mg	SYM	B-TEST	O
-	:	O	O
1.8	CD	O	O

cardiology	NN	O	B-TEST
report	NN	O	I-TEST
ecg	NN	B-TEST	I-TEST
study	NN	I-TEST	I-TEST
date	NN	O	O
of	IN	O	O
2018-08-02	JJ	O	O
5:40:48	CD	O	O
pm	NN	O	O

sinus	NNS	B-PROBLEM	B-PROBLEM
bradycardia	VBP	I-PROBLEM	I-PROBLEM
with	IN	O	O
markedly	RB	B-PROBLEM	B-PROBLEM
prolonged	VBN	I-PROBLEM	I-PROBLEM
p-r	JJ	I-PROBLEM	I-PROBLEM
interval	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
wenckebach	NN	B-PROBLEM	O
type	NN	I-PROBLEM	O

atrio-ventricular	JJ	B-PROBLEM	O
conduction	NN	I-PROBLEM	O
delay	NN	I-PROBLEM	O
.	.	O	O

right	JJ	B-PROBLEM	B-PROBLEM
bundle-branch	NN	I-PROBLEM	I-PROBLEM
block	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

indeterminate	JJ	B-PROBLEM	B-PROBLEM
frontal	JJ	I-PROBLEM	I-PROBLEM
plane	NN	I-PROBLEM	I-PROBLEM
qrs	NN	I-PROBLEM	I-PROBLEM
axis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

compared	VBN	O	O
to	TO	O	O
the	DT	B-TEST	O
previous	JJ	I-TEST	O
tracing	NN	I-TEST	O
of	IN	O	O
2017-10-12	JJ	O	B-PROBLEM
multiple	JJ	B-PROBLEM	I-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
as	IN	O	O
previously	RB	O	O
noted	VBN	O	O
persist	NN	O	O
without	IN	O	O
major	JJ	B-PROBLEM	O
change	NN	I-PROBLEM	O
.	.	O	O

intervals	NNS	B-TEST	O
axes	NNS	I-TEST	O

rate	NN	B-TEST	O
pr	NNS	B-TEST	O
qrs	VBP	B-TEST	O
qt/qtc	JJ	B-TEST	O
p	NN	B-TEST	O
qrs	NN	B-TEST	O
t	NN	B-TEST	O

2018-08-03	JJ	O	O
5:40	CD	O	O
pm	NN	O	O
serology/blood	NN	B-TEST	O

line-central	JJ	B-TREATMENT	O
.	.	O	O

helicobacter	NN	B-TEST	B-TEST
pylori	NN	I-TEST	I-TEST
antibody	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
(	(	O	O
final	JJ	O	O
2018-08-06	NN	O	O
)	)	O	O
:	:	O	O

gi	NNS	B-TEST	B-TEST
bleed	VBP	I-TEST	I-TEST
study	SYM	I-TEST	I-TEST
-	:	O	O
impression	NN	O	O
:	:	O	O

active	JJ	B-PROBLEM	O
radiotracer	NN	I-PROBLEM	O
activity	NN	I-PROBLEM	O
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
right	NN	I-PROBLEM	O
lower	RBR	I-PROBLEM	O
quadrant	NN	I-PROBLEM	O
in	IN	O	O
a	DT	O	O
serpingneous	JJ	O	O
f	JJ	O	O
fashion	NN	O	O
suggestive	NN	O	O
of	IN	O	O
distal	JJ	O	B-PROBLEM
small	JJ	O	I-PROBLEM
bowel	NN	O	I-PROBLEM
.	.	O	O

egd	SYM	B-TEST	B-TEST
-	:	O	O
impression	NN	O	O
:	:	O	O

angioectasias	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
fundus	NN	I-PROBLEM	I-PROBLEM

angioectasias	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
antrum	NN	I-PROBLEM	I-PROBLEM

angioectasias	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
proximal	JJ	I-PROBLEM	I-PROBLEM
jejunum	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
mid	NN	I-PROBLEM	B-PROBLEM
jejunum	NN	I-PROBLEM	I-PROBLEM

angioectasia	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
duodenum	NN	I-PROBLEM	I-PROBLEM

no	DT	O	O
site	NN	O	O
of	IN	O	O
active	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
seen	VBN	O	O
.	.	O	O

the	DT	B-PROBLEM	B-TEST
fundal	JJ	I-PROBLEM	I-TEST
avms	NN	I-PROBLEM	I-TEST
are	VBP	O	O
a	DT	O	B-PROBLEM
potential	JJ	O	I-PROBLEM
site	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
bleeding	VBG	B-PROBLEM	I-PROBLEM
although	IN	O	O
do	NN	O	O
not	RB	O	O
explain	VB	O	O
the	DT	O	O
extent	NN	O	O
of	IN	O	O
bleeding	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

consider	VB	O	O
endoscopic	NN	B-TREATMENT	B-TREATMENT
argon	NN	I-TREATMENT	I-TREATMENT
plasma	NN	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT

proceed	NN	O	O
with	IN	O	O
colonoscopy	NN	B-TEST	B-TREATMENT
.	.	O	O

colonoscopy	NN	B-TEST	B-TEST
-	:	O	O

blood	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
colon	NN	I-PROBLEM	I-PROBLEM

grade	NN	B-PROBLEM	B-PROBLEM
1	CD	I-PROBLEM	I-PROBLEM
external	JJ	I-PROBLEM	I-PROBLEM
hemorrhoids	NNS	I-PROBLEM	I-PROBLEM

angioectasia	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
colon	NN	I-PROBLEM	I-PROBLEM

diverticulosis	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
colon	NN	I-PROBLEM	I-PROBLEM

blood	NN	B-PROBLEM	B-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM
from	IN	O	I-PROBLEM
gi	NN	B-PROBLEM	I-PROBLEM
bleeding	VBG	I-PROBLEM	I-PROBLEM
-	:	O	O
the	DT	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
likely	RB	O	O
from	IN	O	O
an	DT	B-PROBLEM	O
avm	NN	I-PROBLEM	O
.	.	O	O

egd	NN	B-TEST	O
,	,	O	O
colonoscopy	NN	B-TEST	B-TEST
and	CC	O	I-TEST
tagged	VBD	B-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
results	NNS	O	I-TEST
as	IN	O	O
above	NN	O	O
.	.	O	O

eventhough	IN	O	O
uptake	NN	O	O
was	VBD	O	O
noted	VBN	O	O
in	IN	O	O
the	DT	O	O
rt	NN	O	O
lq	NN	O	O
,	,	O	O
no	DT	O	O
clear	JJ	O	B-PROBLEM
site	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
bleeding	NN	B-PROBLEM	I-PROBLEM
was	VBD	O	O
noticed	VBN	O	O
on	IN	O	O
colonoscopy	NN	B-TEST	B-TREATMENT
.	.	O	O

hence	NN	O	O
,	,	O	O
no	DT	O	O
intervention	NN	B-TREATMENT	O
was	VBD	O	O
performed	VBN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
transfused	VBN	O	O
with	IN	O	O
5	CD	O	O
units	NNS	O	O
of	IN	O	O
prbc	NN	B-TREATMENT	O
in	IN	O	O
the	DT	O	O
icu	JJ	O	O
andsent	NN	O	O
to	TO	O	O
the	DT	O	O
lahey	NN	O	O
clinic	JJ	O	O
-	:	O	O
north	NN	O	O
shore	NN	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
remained	VBD	O	O
stable	JJ	O	O
for	IN	O	O
4	CD	O	O
days	NNS	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

no	DT	O	O
further	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
noted	VBD	O	O
.	.	O	O

on	IN	O	O
discussion	NN	O	O
with	IN	O	O
dr	JJ	O	O
leigh	JJ	O	O
and	CC	O	O
dr	JJ	O	O
white	JJ	O	O
from	IN	O	O
gi	JJ	O	O
-	:	O	O
they	PRP	O	O
recommended	VBD	O	O
that	IN	O	O
she	PRP	O	O
follow	VB	O	O
with	IN	O	O
dr.	NN	O	O
taylor	NN	O	O
for	IN	O	O
consideration	NN	O	O
of	IN	O	O
argon	JJ	B-TREATMENT	B-TREATMENT
photocoagulation	NN	I-TREATMENT	I-TREATMENT
as	IN	O	O
out-patient	NN	O	B-TREATMENT
.	.	O	O

given	VBN	O	O
the	DT	O	O
innumerable	JJ	O	O
number	NN	O	O
of	IN	O	O
avm	NN	B-PROBLEM	O
's	POS	I-PROBLEM	O
,	,	O	O
it	PRP	O	O
is	VBZ	O	O
diffcult	VBN	O	O
to	TO	O	O
assess	VB	O	O
which	WDT	O	O
the	DT	B-PROBLEM	B-PROBLEM
culprit	NN	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
and	CC	O	O
gi	NN	O	O
may	MD	O	O
start	VB	O	O
apl	NN	B-TREATMENT	O
from	IN	I-TREATMENT	O
the	DT	I-TREATMENT	O
fundus	NN	I-TREATMENT	O
of	IN	O	O
stomach	NN	O	B-PROBLEM
.	.	O	O

patient	NN	O	O
to	TO	O	O
get	VB	O	O
cbc	JJ	B-TEST	O
checked	VBN	O	O
with	IN	O	O
pcp	NN	O	O
this	DT	O	O
week	NN	O	O
as	IN	O	O
below	NN	O	O
.	.	O	O

asa	NN	B-TREATMENT	O
was	VBD	O	O
held	VBN	O	O
and	CC	O	O
may	MD	O	O
be	VB	O	O
restarted	VBN	O	O
if	IN	O	O
hct	JJ	B-TEST	B-TEST
stable	JJ	O	O
in	IN	O	O
clinic	NN	O	O
at	IN	O	O
the	DT	O	O
pcp	NN	O	O
's	POS	O	O
discretion	NN	O	O
.	.	O	O

chronic	JJ	B-PROBLEM	B-PROBLEM
thrombocytopenia	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
,	,	O	O
however	RB	O	O
the	DT	O	O
patient	NN	O	O
did	VBD	O	O
not	RB	O	O
require	VB	O	O
platelet	NN	B-TREATMENT	B-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

has	VBZ	O	O
a	DT	O	O
h/o	NN	O	O
hit	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
metoprolol	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
held	VBN	O	O
during	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
bleeding	VBG	I-PROBLEM	I-PROBLEM
phase	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
restarted	VBD	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
as	IN	O	O
her	PRP$	B-TEST	O
bp	NN	I-TEST	O
stabilized	VBN	O	O
.	.	O	O

other	JJ	B-PROBLEM	B-PROBLEM
medical	JJ	I-PROBLEM	I-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
stable	JJ	O	O
.	.	O	O

dialysis	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
continued	VBN	O	O
3	CD	O	O
/	JJ	O	O
week	NN	O	O
.	.	O	O

-	:	O	O
atorvastatin	NN	B-TREATMENT	B-TREATMENT
80	CD	O	O
mg	NN	O	O
qd	NN	O	O

-	:	O	O
hydroxyzine	NN	B-TREATMENT	B-TREATMENT
hcl	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mg	NN	O	O
tablet	NN	O	O
po	VB	O	O
q4-6h	JJ	O	O
prn	NN	O	O
for	IN	O	O
itching	VBG	B-PROBLEM	B-PROBLEM

-	:	O	O
levothyroxine	NN	B-TREATMENT	B-TREATMENT
175	CD	O	O
mcg	NN	O	O
po	NN	O	O
qd	NN	O	O

-	:	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
90	CD	O	O
mcg	JJ	O	O
1-2	JJ	O	O
puffs	NNS	O	O
inh	VBP	O	O
q6hr	JJ	O	O
prn	NN	O	O

-	:	O	O
nitroglycerin	NN	B-TREATMENT	B-TREATMENT
0.3	CD	O	O
mg	NN	O	O
tablet	NN	O	O
prn	NN	O	O

-	:	O	O
metoprolol	NN	B-TREATMENT	B-TREATMENT
tartrate	NN	I-TREATMENT	I-TREATMENT
12.5	CD	O	O
mg	NN	O	O
bid	NN	O	O

-	:	O	O
b	NN	B-TREATMENT	O
complex	JJ	I-TREATMENT	O
-	:	O	O
vitamin	NN	B-TREATMENT	B-TREATMENT
c	SYM	I-TREATMENT	I-TREATMENT
-	:	O	I-TREATMENT
folic	JJ	B-TREATMENT	I-TREATMENT
acid	VBP	I-TREATMENT	I-TREATMENT
1	CD	O	O
mg	NN	O	O
capsule	NN	O	O
qd	NN	O	O

-	:	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
nph	JJ	I-TREATMENT	I-TREATMENT
75-25	JJ	O	I-TREATMENT
20units	CD	O	I-TREATMENT
qam	NN	O	I-TREATMENT
and	CC	O	O
humalog	NN	B-TREATMENT	B-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT

1.	CD	O	O
atorvastatin	JJ	B-TREATMENT	B-TREATMENT
80	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

2.	CD	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
90	CD	O	O
mcg	NN	O	O
/	NNP	O	O
actuation	NN	O	O
aerosol	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
puffs	NNS	O	O
inhalation	NN	O	O
q6h	NN	O	O
(	(	O	O
every	DT	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

3.	CD	O	O
levothyroxine	JJ	B-TREATMENT	B-TREATMENT
175	CD	O	O
mcg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

4.	CD	O	O
hydroxyzine	NN	B-TREATMENT	B-TREATMENT
hcl	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
q4-6h	NN	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
to	TO	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

5.	CD	O	O
b-complex	JJ	B-TREATMENT	O
with	IN	O	O
vitamin	JJ	B-TREATMENT	B-TREATMENT
c	NNS	I-TREATMENT	I-TREATMENT
tablet	NN	I-TREATMENT	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

6.	CD	O	O
menthol	SYM	B-TREATMENT	B-TEST
-	:	I-TREATMENT	O
cetylpyridinium	NN	I-TREATMENT	O
cl	VBZ	I-TREATMENT	O
2	CD	O	O
mg	NN	O	O
lozenge	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
lozenge	NN	O	O
mucous	JJ	O	O
membrane	NN	O	O
prn	NN	O	O
(	(	O	O
as	IN	O	O
needed	VBN	O	O
)	)	O	O
.	.	O	O

7.	CD	O	O
pantoprazole	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
q12h	NN	O	O
(	(	O	O
every	DT	O	O
12	CD	O	O
hours	NNS	O	O
)	)	O	O
.	.	O	O

8.	CD	O	O
nitroglycerin	JJ	B-TREATMENT	B-TREATMENT
0.3	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
sublingual	JJ	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
sublingual	NN	O	O
as	RB	O	O
needed	VBN	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

9.	CD	O	O
insulin	NN	B-TREATMENT	B-TREATMENT

continue	NN	O	O
to	TO	O	O
take	VB	O	O
the	DT	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
as	IN	O	O
you	PRP	O	O
were	VBD	O	O
taking	VBG	O	O
prior	JJ	O	O
to	TO	O	O
the	DT	O	O
hospital	NN	O	O
visit	NN	O	O

10.	CD	O	O
outpatient	JJ	B-TEST	O
lab	NN	I-TEST	O
work	NN	I-TEST	O

cbc	NN	B-TEST	B-TEST
(	(	O	O
to	TO	O	O
be	VB	O	O
checked	VBN	O	O
by	IN	O	O
dr	NN	O	O
pannell	NN	O	O
444-1034	JJ	O	O
on	IN	O	O
2018-08-10	JJ	O	O
)	)	O	O

11.	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
tartrate	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
0.5	CD	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

acute	JJ	B-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM
from	IN	O	I-PROBLEM
rectal	JJ	B-PROBLEM	I-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM

thrombocytopenia	SYM	B-PROBLEM	B-TEST
-	:	I-PROBLEM	O
chronic	NN	I-PROBLEM	B-PROBLEM

htn	NN	B-PROBLEM	B-PROBLEM

dm	NN	B-PROBLEM	O
type	NN	I-PROBLEM	O
1	CD	I-PROBLEM	O

ckd	NN	B-PROBLEM	B-TEST
stage	NN	I-PROBLEM	I-TEST
5	CD	I-PROBLEM	O

hypothyroidism	NN	B-PROBLEM	B-PROBLEM

asthma	NN	B-PROBLEM	B-PROBLEM

coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM

weigh	JJ	O	O
yourself	PRP	O	O
every	DT	O	O
morning	NN	O	O
,	,	O	O
call	VB	O	O
md	NN	O	O
if	IN	O	O
weight	VBN	B-PROBLEM	B-TEST
>	VBP	I-PROBLEM	O
3	CD	I-PROBLEM	O
lbs	NN	I-PROBLEM	O
.	.	O	O

adhere	RB	O	O
to	TO	O	O
2	CD	B-TREATMENT	O
gm	NNS	I-TREATMENT	O
sodium	NN	I-TREATMENT	O
diet	NN	I-TREATMENT	O

do	VB	O	O
not	RB	O	O
take	VB	O	O
the	DT	B-TREATMENT	B-TREATMENT
aspirin	NN	I-TREATMENT	I-TREATMENT
unless	IN	O	O
you	PRP	O	O
see	VBP	O	O
dr	JJ	O	O
pannell	NN	O	O
.	.	O	O

continue	NN	O	O
to	TO	O	O
take	VB	O	O
the	DT	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
as	IN	O	O
you	PRP	O	O
were	VBD	O	O
taking	VBG	O	O
prior	JJ	O	O
to	TO	O	O
hospital	JJ	O	O
visit	NN	O	O
.	.	O	O

please	VB	O	O
see	VB	O	O
your	PRP$	O	O
doctor	NN	O	O
(	(	O	O
dr	VB	O	O
pannell	NN	O	O
)	)	O	O
on	IN	O	O
friday	JJ	O	O
2018-08-10	JJ	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
(	(	O	O
cbc	NN	B-TEST	B-TEST
)	)	O	O
.	.	O	O

continue	VB	O	O
the	DT	B-TREATMENT	B-TREATMENT
dialysis	NN	I-TREATMENT	I-TREATMENT
three	CD	O	O
times	NNS	O	O
a	DT	O	O
week	NN	O	O
.	.	O	O

return	NN	O	O
to	TO	O	O
the	DT	O	O
hospital	NN	O	O
if	IN	O	O
you	PRP	O	O
notice	VBP	O	O
bleeding	VBG	B-PROBLEM	B-PROBLEM
or	CC	O	O
any	DT	B-PROBLEM	B-PROBLEM
other	JJ	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
of	IN	O	O
concern	NN	O	O
to	TO	O	O
you	PRP	O	O
.	.	O	O

primary	JJ	O	O
doctor	NN	O	O
-	:	O	O
dr	NN	O	O
shirley	NN	O	O
,	,	O	O
james	NNS	O	O
m.	VBP	O	O
444-1034	JJ	O	O
-	:	O	O
please	NN	O	O
see	VB	O	O
your	PRP$	O	O
doctor	NN	O	O
mary	JJ	O	O
powell	NN	O	O
2018-08-10	JJ	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
(	(	O	O
cbc	NN	B-TEST	B-TEST
)	)	O	O
.	.	O	O

dialysis	NN	B-TREATMENT	B-TREATMENT
as	IN	O	O
scheduled	VBN	O	O
.	.	O	O

mitral	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mitral	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

tricuspid	JJ	B-PROBLEM	B-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
obstructive	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

04/22/94	CD	O	O
,	,	O	O
mitral	JJ	B-TREATMENT	B-TREATMENT
valve	FW	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
tricuspid	JJ	B-TREATMENT	B-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
reconstruction	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

this	DT	O	O
68	CD	O	O
year	NN	O	O
old	JJ	O	O
female	NN	O	O
had	VBD	O	O
rheumatic	JJ	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
past	NN	O	O
,	,	O	O
and	CC	O	O
has	VBZ	O	O
had	VBN	O	O
chronic	VBN	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
had	VBN	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
an	DT	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
demonstrated	VBD	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

because	IN	O	O
of	IN	O	O
her	PRP$	O	B-PROBLEM
deteriorating	NN	O	I-PROBLEM
status	NN	O	I-PROBLEM
,	,	O	O
she	PRP	O	O
underwent	VBD	O	O
prior	JJ	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
,	,	O	O
which	WDT	O	O
confirmed	VBD	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
secondary	JJ	B-PROBLEM	B-PROBLEM
tricuspid	JJ	I-PROBLEM	I-PROBLEM
valve	NN	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
due	JJ	O	O
to	TO	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
referred	VBN	O	O
for	IN	O	O
valve	NN	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

past	JJ	O	O
medical	JJ	O	O
history	NN	O	O
is	VBZ	O	O
remarkable	JJ	O	O
for	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
due	JJ	O	O
to	TO	O	O
smoking	VBG	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
undergone	PRP	O	O
a	DT	B-TREATMENT	O
previous	JJ	I-TREATMENT	O
nasal	JJ	I-TREATMENT	B-TREATMENT
arterial	JJ	I-TREATMENT	I-TREATMENT
embolization	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
recurrent	NN	B-PROBLEM	B-PROBLEM
epistaxis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
partial	JJ	I-TREATMENT	I-TREATMENT
gastrectomy	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
1972	CD	O	O
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
on	IN	I-TREATMENT	O
admission	NN	I-TREATMENT	O
included	VBD	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
0.125	CD	O	O
,	,	O	O
qd	NN	O	O
,	,	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
40	CD	O	O
,	,	O	O
q.i.d.	NN	O	O
,	,	O	O
and	CC	O	O
vanceril	JJ	B-TREATMENT	B-TREATMENT
inhaler	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

pertinent	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
demonstrated	VBD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
elevation	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
her	PRP$	B-TEST	I-PROBLEM
jugular	JJ	I-TEST	I-PROBLEM
venous	JJ	I-TEST	I-PROBLEM
pulse	NN	I-TEST	I-PROBLEM
,	,	O	O
with	IN	O	O
prominent	JJ	B-PROBLEM	O
v-waves	NNS	I-PROBLEM	O
,	,	O	O
and	CC	O	O
systolic	JJ	B-PROBLEM	O
and	CC	I-PROBLEM	O
diastolic	JJ	I-PROBLEM	B-PROBLEM
murmurs	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

peripheral	JJ	B-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
were	VBD	O	O
all	DT	O	O
intact	JJ	O	O
,	,	O	O
and	CC	O	O
there	RB	O	O
was	VBD	O	O
venous	JJ	B-PROBLEM	B-PROBLEM
stasis	NN	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
legs	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
underwent	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
mitral	JJ	I-TREATMENT	I-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
utilizing	VBG	O	O
a	DT	O	O
27	CD	O	O
mm	NN	O	O
.	.	O	O

st.	JJ	B-TREATMENT	B-TREATMENT
jude	NN	I-TREATMENT	I-TREATMENT
prosthesis	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
tricuspid	JJ	B-TREATMENT	B-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
reconstruction	NN	I-TREATMENT	I-TREATMENT
by	IN	O	O
ring	VBG	B-TREATMENT	O
anuloplasty	NN	I-TREATMENT	O
.	.	O	O

she	PRP	O	O
weaned	VBD	O	O
from	IN	O	O
cardiopulmonary	JJ	B-TREATMENT	B-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
good	JJ	O	O
hemodynamics	NNS	O	O
.	.	O	O

she	PRP	O	O
initially	RB	O	O
awoke	VBD	O	O
after	IN	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
with	IN	O	O
good	JJ	O	O
hemodynamics	NNS	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
transiently	RB	O	O
in	IN	O	O
sinus	NN	O	O
rhythm	NN	O	O
,	,	O	O
but	CC	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
recurred	VBD	O	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
extubated	VBN	O	O
on	IN	O	O
the	DT	O	O
third	JJ	O	O
postoperative	JJ	O	O
day	NN	O	O
,	,	O	O
and	CC	O	O
was	VBD	O	O
initially	RB	B-PROBLEM	O
slightly	RB	I-PROBLEM	B-PROBLEM
agitated	VBN	I-PROBLEM	I-PROBLEM
and	CC	O	O
confused	VBN	B-PROBLEM	B-PROBLEM
,	,	O	O
largely	RB	O	O
due	JJ	O	O
to	TO	O	O
an	DT	B-PROBLEM	O
intensive	JJ	I-PROBLEM	O
care	NN	I-PROBLEM	O
unit	NN	I-PROBLEM	O
psychosis	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
initially	RB	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
slow	JJ	I-PROBLEM	I-PROBLEM
ventricular	NN	I-PROBLEM	I-PROBLEM
response	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
atrial	JJ	B-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
this	DT	O	O
gradually	RB	O	O
improved	VBN	O	O
over	IN	O	O
time	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
initially	RB	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
somewhat	RB	B-PROBLEM	B-PROBLEM
anemic	JJ	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
received	VBD	O	O
transfusions	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

coumadin	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
restarted	VBN	O	O
,	,	O	O
and	CC	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
anticoagulation	NN	I-TREATMENT	I-TREATMENT
came	VBD	O	O
into	IN	O	O
range	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
ultimately	RB	O	O
discharged	VBN	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
in	IN	O	O
the	DT	O	O
90	CD	O	O
's	POS	O	O
,	,	O	O
and	CC	O	O
with	IN	O	O
resolving	VBG	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	O	O
clear	JJ	O	O
chest	NN	O	O
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
on	IN	I-TREATMENT	O
discharge	NN	I-TREATMENT	O
included	VBD	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
40	CD	O	O
,	,	O	O
b.i.d.	NN	O	O
,	,	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
20	CD	O	O
meq.	NN	O	O
,	,	O	O
b.i.d.	NN	O	O
,	,	O	O
iron	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
folic	JJ	B-TREATMENT	B-TREATMENT
acid	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

leona	JJ	O	O
wheeler	NN	O	O
had	VBD	O	O
continued	VBN	O	O
episodes	NNS	O	O
of	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
were	VBD	O	O
treated	VBN	O	O
with	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
amiodarone	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
later	RB	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
diltiazem	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
lopressor	NN	I-TREATMENT	I-TREATMENT
dose	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
progressively	RB	O	O
increased	VBN	O	O
to	TO	O	O
100	CD	O	O
mg	NN	O	O
tid	NN	O	O
.	.	O	O

amiodarone	RB	B-TREATMENT	B-TREATMENT
400	CD	O	O
mg	NNS	O	O
tid	NN	O	O
was	VBD	O	O
continued	VBN	O	O
as	RB	O	O
well	RB	O	O
.	.	O	O

due	JJ	O	O
to	TO	O	O
this	DT	B-PROBLEM	O
continued	VBN	I-PROBLEM	O
atrial	JJ	I-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
leona	FW	O	O
wheeler	NN	O	O
was	VBD	O	O
anticoagulated	VBN	O	O
with	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
heparin	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

coumadin	NN	B-TREATMENT	B-TREATMENT
dose	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
started	VBN	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
inr	NN	I-TEST	I-TEST
were	VBD	O	O
followed	VBN	O	O
.	.	O	O

these	DT	O	O
episodes	NNS	O	O
of	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
have	VBP	O	O
diminished	VBN	O	B-PROBLEM
and	CC	O	O
she	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
in	IN	O	O
sinus	NN	O	O
rhythm	NN	O	O
for	IN	O	O
over	IN	O	O
24	CD	O	O
hours	NNS	O	O
now	RB	O	O
.	.	O	O

she	PRP	O	O
will	MD	O	O
be	VB	O	O
monitored	VBN	O	O
with	IN	O	O
a	DT	B-TEST	O
king	NN	I-TEST	O
of	IN	I-TEST	O
hearts	NNS	I-TEST	O
monitor	NN	I-TEST	O
.	.	O	O

metoprolol	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
tid	NN	O	O
,	,	O	O
amiodarone	RB	B-TREATMENT	B-TREATMENT
400	CD	O	O
mg	NN	O	O
tid	NN	O	O
times	NNS	O	O
7	CD	O	O
days	NNS	O	O
,	,	O	O
then	RB	O	O
bid	VBD	O	O
times	NNS	O	O
14	CD	O	O
days	NNS	O	O
,	,	O	O
then	RB	O	O
q	VBZ	O	O
d	JJ	O	O
times	NNS	O	O
14	CD	O	O
days	NNS	O	O
,	,	O	O
then	RB	O	O
200	CD	O	O
mg	NNS	O	O
q	JJ	O	O
d	NN	O	O
.	.	O	O

1.	CD	O	O
status	NN	O	O
post	NN	O	O
cabg	NN	B-TREATMENT	B-TREATMENT
times	NNS	O	O
four	CD	O	O
.	.	O	O

epistaxis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

epistaxis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

mitral	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
tricuspid	JJ	B-PROBLEM	B-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
heart	NN	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
ventricular	NN	I-PROBLEM	I-PROBLEM
ectopy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
obstructive	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

epistaxis	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
in	IN	O	O
the	DT	O	O
past	NN	O	O
.	.	O	O

partial	JJ	B-TREATMENT	B-PROBLEM
embolization	NN	I-TREATMENT	I-PROBLEM
of	IN	I-TREATMENT	I-PROBLEM
blood	NN	I-TREATMENT	I-PROBLEM
supply	NN	I-TREATMENT	I-PROBLEM
to	TO	O	I-PROBLEM
nose	VB	O	I-PROBLEM
,	,	O	O
8/22	CD	O	O
.	.	O	O

this	DT	O	O
68	CD	O	O
year	NN	O	O
old	JJ	O	O
female	NN	O	O
has	VBZ	O	O
rheumatic	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mitral	JJ	B-TREATMENT	O
and	CC	I-TREATMENT	O
possibly	RB	I-TREATMENT	O
tricuspid	JJ	I-TREATMENT	B-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
is	VBZ	O	O
scheduled	VBN	O	O
for	IN	O	O
labor	NN	O	O
day	NN	O	O
by	IN	O	O
dr.	NN	O	O
riemund	NN	O	O
c.	NN	O	O
kennedy	NN	O	O
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
admitted	VBN	O	O
now	RB	O	O
for	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
neuro-interventional	JJ	I-TREATMENT	I-TREATMENT
radiology	NN	I-TREATMENT	I-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
decrease	VB	O	O
the	DT	O	O
likelihood	NN	O	O
of	IN	O	O
epistaxis	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

right	JJ	B-PROBLEM	O
neck	NN	I-PROBLEM	O
and	CC	I-PROBLEM	O
right	JJ	I-PROBLEM	B-TEST
groin	NN	I-PROBLEM	I-TEST
catheterization	NN	I-PROBLEM	I-TEST
sites	NNS	I-PROBLEM	I-TEST
were	VBD	O	O
benign	JJ	O	O
.	.	O	O

no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

examination	NN	B-TEST	B-TEST
was	VBD	O	O
otherwise	RB	O	O
unchanged	JJ	O	O
.	.	O	O

hematocrit	NN	B-TEST	B-TEST
was	VBD	O	O
42	CD	O	O
,	,	O	O
pt	NN	B-TEST	O
was	VBD	O	O
10	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
was	VBD	O	O
3.6	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
was	VBD	O	O
29	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
was	VBD	O	O
1.4	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
sugar	NN	I-TEST	I-TEST
was	VBD	O	O
111	CD	O	O
.	.	O	O

ekg	NN	B-TEST	O
showed	VBD	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
ventricular	NN	I-PROBLEM	I-PROBLEM
response	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
right	JJ	B-PROBLEM	B-PROBLEM
ventricular	NN	I-PROBLEM	I-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
right	JJ	B-PROBLEM	B-PROBLEM
axis	NN	I-PROBLEM	I-PROBLEM
deviation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
interventional	JJ	I-TREATMENT	I-TREATMENT
neuro-radiology	JJ	I-TREATMENT	I-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
performed	VBN	O	O
by	IN	O	O
dr.	VBG	O	O
a	DT	O	O
skizeis	NN	O	O
,	,	O	O
on	IN	O	O
august	JJ	O	O
22	CD	O	O
,	,	O	O
via	IN	O	O
the	DT	O	O
right	JJ	O	O
femoral	JJ	O	O
artery	NN	O	O
.	.	O	O

the	DT	O	O
right	JJ	O	O
internal	JJ	O	O
maxillary	JJ	O	O
artery	NN	O	O
supply	NN	O	O
to	TO	O	O
the	DT	O	B-PROBLEM
nasal	NN	O	I-PROBLEM
mucosa	NN	O	I-PROBLEM
was	VBD	O	O
embolized	VBN	B-TREATMENT	O
.	.	O	O

the	DT	O	B-TREATMENT
left	JJ	O	I-TREATMENT
external	JJ	O	I-TREATMENT
carotid	NN	O	I-TREATMENT
artery	NN	O	I-TREATMENT
was	VBD	O	O
occluded	VBN	B-PROBLEM	B-PROBLEM
at	IN	O	I-PROBLEM
its	PRP$	O	I-PROBLEM
origin	NN	O	I-PROBLEM
,	,	O	O
with	IN	O	O
collaterals	NNS	O	O
from	IN	O	O
the	DT	O	O
internal	JJ	O	O
carotid	NN	O	O
artery	NN	O	O
.	.	O	O

thus	RB	O	O
,	,	O	O
embolization	NN	B-TREATMENT	B-TREATMENT
on	IN	I-TREATMENT	O
the	DT	I-TREATMENT	O
left	JJ	I-TREATMENT	O
side	NN	I-TREATMENT	O
was	VBD	O	O
not	RB	O	O
possible	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
received	VBD	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
10	CD	O	O
mg.	NN	O	O
,	,	O	O
on	IN	O	O
the	DT	O	O
evening	NN	O	O
following	VBG	O	O
the	DT	O	B-TREATMENT
procedure	NN	O	I-TREATMENT
,	,	O	O
and	CC	O	O
is	VBZ	O	O
discharged	VBN	O	O
the	DT	O	O
next	JJ	O	O
day	NN	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
prothrombin	NN	I-TEST	I-TEST
time	NN	I-TEST	I-TEST
will	MD	O	O
be	VB	O	O
rechecked	VBN	O	O
on	IN	O	O
august	JJ	O	O
27	CD	O	O
by	IN	O	O
her	PRP$	O	O
primary	JJ	O	O
care	NN	O	O
physician	NN	O	O
,	,	O	O
dr.	NN	O	O
naka	NN	O	O
gift	NN	O	O
.	.	O	O

once	RB	O	O
her	PRP$	B-TEST	B-TEST
prothrombin	NN	I-TEST	I-TEST
time	NN	I-TEST	I-TEST
is	VBZ	O	O
in	IN	O	O
therapeutic	JJ	O	O
range	NN	O	O
,	,	O	O
she	PRP	O	O
will	MD	O	O
be	VB	O	O
observed	VBN	O	O
for	IN	O	O
epistaxis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
will	MD	O	O
take	VB	O	O
her	PRP$	O	O
last	JJ	O	O
dose	NN	O	O
of	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
on	IN	O	O
september	NN	O	O
1	CD	O	O
in	IN	O	O
anticipation	NN	O	O
of	IN	O	O
cardiac	JJ	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

if	IN	O	O
her	PRP$	B-TEST	B-TEST
prothrombin	JJ	I-TEST	I-TEST
time	NN	I-TEST	I-TEST
does	VBZ	O	O
not	RB	O	O
come	VBN	O	O
into	IN	O	O
therapeutic	JJ	O	O
range	NN	O	O
promptly	RB	O	O
,	,	O	O
then	RB	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
may	MD	O	O
be	VB	O	O
delayed	VBN	O	O
.	.	O	O

coumadin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
5	CD	O	O
mg.	NN	O	O
,	,	O	O
alternating	VBG	O	O
with	IN	O	O
2.5	CD	O	O
mg.	NNS	O	O
,	,	O	O
qd	NN	O	O
,	,	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
0.125	CD	O	O
mg.	NN	O	O
,	,	O	O
qd	NN	O	O
,	,	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
80	CD	O	O
mg.	NN	O	O
,	,	O	O
qam	NN	O	O
and	CC	O	O
40	CD	O	O
mg.	NN	O	O
,	,	O	O
qpm	NN	O	O
,	,	O	O
vanceril	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
3	CD	O	O
puffs	NNS	O	O
,	,	O	O
b.i.d.	NN	O	O

baby	NN	O	O
boy	NNS	O	O
timberlake	NN	O	O
was	VBD	O	O
born	VBN	O	O
to	TO	O	O
a	DT	O	O
25	CD	O	O
-	:	O	O
year-old	JJ	O	O
g-8	JJ	O	O
,	,	O	O
p-4	JJ	O	O
to	TO	O	O
5	CD	O	O
mom	NN	O	O
with	IN	O	O
julie	NN	O	O
type	NN	O	O
b	NN	O	O
positive	JJ	O	O
,	,	O	O
antibody	JJ	B-TEST	B-TEST
negative	JJ	O	O
,	,	O	O
hepatitis	NN	B-TEST	B-TEST
b	NN	I-TEST	I-TEST
surface	NN	I-TEST	I-TEST
antigen	NN	I-TEST	I-TEST
negative	JJ	O	O
,	,	O	O
rubella	NN	B-TEST	B-TEST
immune	NN	I-TEST	O
,	,	O	O
rpr	NN	B-TEST	O
nonreactive	JJ	O	O
,	,	O	O
gbs	JJ	B-PROBLEM	B-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
infrequent	NN	O	B-TREATMENT
prenatal	NN	O	I-TREATMENT
care	NN	O	I-TREATMENT
since	IN	O	O
28	CD	O	O
weeks	NNS	O	O
time	NN	O	O
and	CC	O	O
preterm	JJ	B-PROBLEM	B-PROBLEM
labor	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mother	NN	O	O
had	VBD	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
anxiety	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
asthma	NN	B-PROBLEM	B-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
moderate	JJ	O	B-PROBLEM
cigarette	NN	O	I-PROBLEM
smoking	NN	O	I-PROBLEM
.	.	O	O

the	DT	O	O
baby	NN	O	O
was	VBD	O	O
delivered	VBN	O	O
through	IN	O	O
normal	JJ	O	O
spontaneous	JJ	O	O
vaginal	JJ	O	O
delivery	NN	O	O
with	IN	O	O
brief	JJ	B-TREATMENT	B-PROBLEM
blow	NN	I-TREATMENT	I-PROBLEM
by	IN	I-TREATMENT	O
with	IN	O	O
apgars	NNS	B-TEST	B-TEST
of	IN	O	O
8	CD	O	O
and	CC	O	O
9	CD	O	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
birth	NN	I-TEST	I-TEST
weight	NN	I-TEST	I-TEST
was	VBD	O	O
1.705	CD	O	O
kilograms	NNS	O	O
,	,	O	O
which	WDT	O	O
is	VBZ	O	O
50th	CD	O	O
percentile	NN	O	O
.	.	O	O

length	NN	B-TEST	B-TEST
was	VBD	O	O
40	CD	O	O
cm	NN	O	O
,	,	O	O
50th	CD	O	O
percentile	NN	O	O
.	.	O	O

head	NN	B-TEST	B-TEST
circumference	NN	I-TEST	I-TEST
was	VBD	O	O
30	CD	O	O
cm	NN	O	O
,	,	O	O
50th	CD	O	O
percentile	NN	O	O
.	.	O	O

after	IN	O	O
receiving	VBG	O	O
brief	JJ	B-TREATMENT	B-TREATMENT
blow	NN	I-TREATMENT	I-TREATMENT
by	IN	I-TREATMENT	O
oxygen	NN	I-TREATMENT	B-TREATMENT
in	IN	O	O
the	DT	O	O
delivery	NN	O	O
room	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
no	DT	O	O
further	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
ventilatory	JJ	B-TREATMENT	O
assistance	NN	I-TREATMENT	O
required	VBN	O	O
with	IN	O	O
good	JJ	O	O
respiratory	NN	O	O
rate	NN	O	O
consistently	RB	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
never	RB	O	O
placed	VBN	O	O
on	IN	O	O
caffeine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

no	DT	O	O
history	NN	O	O
of	IN	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
no	DT	O	O
medications	NNS	B-TREATMENT	B-TREATMENT
at	IN	O	O
this	DT	O	O
time	NN	O	O
.	.	O	O

notably	RB	O	O
with	IN	O	O
respect	NN	O	O
to	TO	O	O
apnea	VB	B-PROBLEM	B-PROBLEM
and	CC	O	O
bradycardia	VB	B-PROBLEM	B-PROBLEM
of	IN	O	I-PROBLEM
prematurity	NN	B-PROBLEM	I-PROBLEM
,	,	O	O
the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
reached	VBN	O	O
5	CD	O	O
days	NNS	O	O
without	IN	O	O
significant	JJ	B-PROBLEM	O
apneic	NN	I-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	O
bradycardic	JJ	I-PROBLEM	B-PROBLEM
spells	NNS	I-PROBLEM	I-PROBLEM
as	IN	O	O
of	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
reached	VBD	O	O
full	JJ	O	B-TREATMENT
volume	NN	O	I-TREATMENT
feeds	NNS	O	I-TREATMENT
by	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
6	CD	O	O
and	CC	O	O
had	VBD	O	O
calories	NNS	O	B-PROBLEM
increased	VBN	O	O
to	TO	O	O
maximum	VB	O	O
of	IN	O	O
26	CD	O	O
kilocalories	NNS	O	O
per	IN	O	O
ounce	NN	O	O
of	IN	O	O
similac	NN	B-TREATMENT	B-TREATMENT
special	JJ	I-TREATMENT	I-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
until	IN	O	O
2014-12-03	JJ	O	O
,	,	O	O
at	IN	O	O
which	WDT	O	O
point	NN	O	O
this	DT	O	O
was	VBD	O	O
weaned	VBN	O	O
to	TO	O	O
24	CD	O	O
kilocalories	NNS	O	O
per	IN	O	O
ounce	NN	O	O
of	IN	O	O
straight	JJ	B-TREATMENT	O
similac	NN	I-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
with	IN	O	O
peak	JJ	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
of	IN	O	O
6.5	CD	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
3	CD	O	O
.	.	O	O

no	DT	O	O
phototherapy	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
required	VBN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
hematocrit	NN	I-TEST	I-TEST
at	IN	O	O
delivery	NN	O	O
was	VBD	O	O
48	CD	O	O
,	,	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
11.2	CD	O	O
and	CC	O	O
platelets	NNS	B-TEST	B-TEST
of	IN	O	O
301,000	CD	O	O
.	.	O	O

initial	JJ	B-TEST	B-TEST
differential	NN	I-TEST	I-TEST
was	VBD	O	O
35	CD	B-TEST	O
polys	NN	I-TEST	O
and	CC	O	O
zero	NN	B-TEST	B-TREATMENT
bands	NNS	I-TEST	I-TREATMENT
,	,	O	O
not	RB	O	O
suspicious	JJ	O	O
for	IN	O	O
infectious	JJ	B-PROBLEM	B-PROBLEM
condition	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
initially	RB	O	O
treated	VBN	O	O
with	IN	O	O
48	CD	O	O
hours	NNS	O	O
of	IN	O	O
ampicillin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
until	IN	O	O
blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
has	VBZ	O	O
had	VBN	O	O
no	DT	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
since	IN	O	O
that	DT	O	O
time	NN	O	O
.	.	O	O

hearing	VBG	B-TEST	B-TEST
screen	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
with	IN	O	O
automated	JJ	B-TEST	B-TEST
auditory	NN	I-TEST	I-TEST
brainstem	NN	I-TEST	I-TEST
responses	NNS	I-TEST	I-TEST
and	CC	O	O
was	VBD	O	O
normal	JJ	O	O
on	IN	O	O
2014-11-24	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
did	VBD	O	O
not	RB	O	O
qualify	VB	O	O
for	IN	O	O
routine	JJ	B-TEST	B-TEST
ophthalmology	NN	I-TEST	I-TEST
exams	NNS	I-TEST	I-TEST
due	JJ	O	O
to	TO	O	O
his	PRP$	O	O
gestational	JJ	O	O
age	NN	O	O
at	IN	O	O
birth	NN	O	O
.	.	O	O

1.	CD	O	O
feedings	NNS	O	B-TREATMENT
at	IN	O	O
discharge	NN	O	O
-	:	O	O
similac	NN	B-TREATMENT	O
24	CD	O	O
kilocalories	NNS	O	O
per	IN	O	O
ounce	NN	O	O
p.o.	NN	O	O
ad	NN	O	O
lib	NN	O	O
.	.	O	O

2.	CD	O	O
car	NN	B-TEST	B-TEST
seat	NN	I-TEST	I-TEST
positioning	VBG	I-TEST	I-TEST
screening	VBG	I-TEST	I-TEST
passed	VBN	O	O
.	.	O	O

3.	CD	O	O
state	NN	B-TEST	B-TEST
newborn	JJ	I-TEST	I-TEST
screening	NN	I-TEST	I-TEST
sent	VBD	O	O
per	IN	O	O
protocol	NN	O	O
and	CC	O	O
no	DT	O	O
abnormal	JJ	B-PROBLEM	B-PROBLEM
reports	NNS	I-PROBLEM	I-PROBLEM
have	VBP	O	O
been	VBN	O	O
received	VBN	O	O
.	.	O	O

4.	CD	O	O
immunizations	NNS	B-TREATMENT	B-TREATMENT
received	VBD	O	O
:	:	O	O

synagis	NN	B-TREATMENT	B-TREATMENT
rsv	NN	I-TREATMENT	I-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
given	VBN	O	O
today	NN	O	O
due	JJ	O	O
to	TO	O	O
multiple	JJ	O	O
siblings	NNS	O	O
at	IN	O	O
home	NN	O	O
with	IN	O	O
daycare	JJ	O	B-TREATMENT
exposure	NN	O	I-TREATMENT
and	CC	O	O
the	DT	O	O
patient	NN	O	O
being	VBG	O	O
between	IN	O	O
32	CD	O	O
and	CC	O	O
35	CD	O	O
weeks	NNS	O	O
.	.	O	O

synagis	NN	B-TREATMENT	B-TREATMENT
rsv	NN	I-TREATMENT	I-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
should	MD	O	O
be	VB	O	O
considered	VBN	O	O
in	IN	O	O
general	JJ	O	O
from	IN	O	O
november	NN	O	O
through	IN	O	O
march	NN	O	O
for	IN	O	O
infants	NNS	O	O
who	WP	O	O
meet	VBP	O	O
any	DT	O	O
of	IN	O	O
the	DT	O	O
following	VBG	O	O
3	CD	O	O
criteria	NNS	O	O
:	:	O	O

daycare	NN	O	O
during	IN	O	O
rsv	NN	O	O
season	NN	O	O
,	,	O	O
a	DT	O	O
smoker	NN	O	O
in	IN	O	O
the	DT	O	O
household	NN	O	O
,	,	O	O
neuromuscular	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	I-PROBLEM
airway	JJ	B-PROBLEM	I-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
or	CC	O	O
school	NN	O	O
age	NN	O	O
sibling	NN	O	O
,	,	O	O
or	CC	O	O
3.	CD	O	O
with	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

influenza	JJ	B-TREATMENT	B-TREATMENT
immunization	NN	I-TREATMENT	I-TREATMENT
is	VBZ	O	O
recommended	VBN	O	O
annually	RB	O	O
in	IN	O	O
the	DT	O	O
fall	NN	O	O
for	IN	O	O
all	DT	O	O
infants	NNS	O	O
once	IN	O	O
they	PRP	O	O
reach	VBP	O	O
6	CD	O	O
months	NNS	O	O
of	IN	O	O
age	NN	O	O
.	.	O	O

before	IN	O	O
this	DT	O	O
age	NN	O	O
and	CC	O	O
for	IN	O	O
the	DT	O	O
first	JJ	O	O
24	CD	O	O
months	NNS	O	O
of	IN	O	O
the	DT	O	O
child	NN	O	O
's	POS	O	O
life	NN	O	O
,	,	O	O
immunization	NN	B-TREATMENT	B-TREATMENT
against	IN	O	O
influenza	NN	B-PROBLEM	B-PROBLEM
is	VBZ	O	O
recommended	VBN	O	O
for	IN	O	O
household	NN	O	O
contacts	NNS	O	O
and	CC	O	O
out	IN	O	O
of	IN	O	O
home	NN	O	O
caregivers	NNS	O	O
.	.	O	O

1.	CD	O	O
prematurity	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2.	CD	O	O
apnea	NN	B-PROBLEM	B-PROBLEM
of	IN	O	I-PROBLEM
prematurity	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
rule	NN	O	O
out	IN	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

this	DT	O	O
82	CD	O	O
year	NN	O	O
old	JJ	O	O
retired	VBD	O	O
engineer	NN	O	O
has	VBZ	O	O
had	VBN	O	O
multiple	JJ	O	O
admissions	NNS	O	O
to	TO	O	O
the	DT	O	O
ph	NN	O	O
university	NN	O	O
of	IN	O	O
medical	JJ	O	O
center	NN	O	O
for	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
strokes	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
spontaneous	JJ	I-PROBLEM	I-PROBLEM
subdural	JJ	I-PROBLEM	I-PROBLEM
hematoma	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
prostatic	JJ	B-PROBLEM	I-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
managing	VBG	O	O
at	IN	O	O
home	NN	O	O
on	IN	O	O
restricted	JJ	B-TREATMENT	O
activity	NN	I-TREATMENT	O
but	CC	O	O
able	JJ	O	O
to	TO	O	O
get	VB	O	O
around	RP	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
walker	NN	I-TREATMENT	I-TREATMENT
but	CC	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
before	IN	O	O
admission	NN	O	O
he	PRP	O	O
became	VBD	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
dyspneic	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
admission	NN	O	O
he	PRP	O	O
collapsed	VBD	O	O
and	CC	O	O
was	VBD	O	O
unable	JJ	O	O
to	TO	O	O
walk	VB	O	O
to	TO	O	O
his	PRP$	O	O
bed	NN	O	O
.	.	O	O

on	IN	B-TEST	O
physical	JJ	I-TEST	B-TEST
examination	NN	I-TEST	I-TEST
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
both	DT	O	O
chronically	RB	B-PROBLEM	O
and	CC	I-PROBLEM	O
acutely	RB	I-PROBLEM	B-PROBLEM
ill	VB	I-PROBLEM	I-PROBLEM
,	,	O	O
dyspneic	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
febrile	JJ	I-PROBLEM	I-PROBLEM
and	CC	O	O
with	IN	O	O
coarse	JJ	B-PROBLEM	B-PROBLEM
rales	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
both	DT	I-PROBLEM	O
bases	NNS	I-PROBLEM	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
in	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
his	PRP$	B-TEST	B-TEST
vital	JJ	I-TEST	I-TEST
signs	NNS	I-TEST	I-TEST
were	VBD	O	O
otherwise	RB	O	O
stable	JJ	O	O
.	.	O	O

his	PRP$	B-PROBLEM	B-TEST
prostate	NN	I-PROBLEM	I-TEST
enlarged	VBD	I-PROBLEM	O
and	CC	O	O
he	PRP	O	O
had	VBD	O	O
no	DT	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
elevation	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	B-TEST	I-PROBLEM
wbc	NN	I-TEST	I-PROBLEM
intermittently	RB	B-PROBLEM	I-PROBLEM
grossly	RB	I-PROBLEM	I-PROBLEM
bloody	JJ	I-PROBLEM	I-PROBLEM
urine	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
cultures	NNS	B-TEST	B-PROBLEM
were	VBD	O	O
positive	JJ	B-PROBLEM	O
but	CC	O	O
the	DT	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	JJ	I-TEST	I-TEST
showed	VBD	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
densities	NNS	I-PROBLEM	I-PROBLEM
more	RBR	O	O
on	IN	O	O
the	DT	O	O
left	NN	O	O
than	IN	O	O
the	DT	O	O
right	JJ	O	O
compatible	NN	O	O
with	IN	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
were	VBD	O	O
no	DT	O	O
radiographic	JJ	O	B-PROBLEM
indications	NNS	O	I-PROBLEM
of	IN	O	I-PROBLEM
congestive	JJ	B-PROBLEM	I-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
clindamycin	NN	B-TREATMENT	B-TREATMENT
intravenous	JJ	I-TREATMENT	I-TREATMENT
and	CC	O	O
cefuroxime	JJ	B-TREATMENT	B-TREATMENT
intravenous	JJ	I-TREATMENT	I-TREATMENT
with	IN	O	O
clearing	NN	O	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
persistence	NN	O	O
of	IN	O	O
cough	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
choking	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
intermittently	RB	B-PROBLEM	O
many	JJ	I-PROBLEM	B-PROBLEM
coarse	JJ	I-PROBLEM	I-PROBLEM
rales	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
base	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
no	DT	O	O
clearing	NN	O	O
by	IN	B-TEST	O
x-ray	NN	I-TEST	O
.	.	O	O

his	PRP$	O	O
ambulation	NN	O	O
was	VBD	O	O
minimal	JJ	O	O
and	CC	O	O
always	RB	O	O
with	IN	O	O
assistance	NN	O	O
but	CC	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
transurethral	JJ	I-TREATMENT	I-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
prostate	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
09/14/96	CD	O	O
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
transferred	VBN	O	O
to	TO	O	O
louline	VB	O	O
mauikings	NNS	O	O
medical	JJ	O	O
center	NN	O	O
for	IN	O	O
future	JJ	B-TREATMENT	B-TREATMENT
rehabilitation	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
hopeful	JJ	O	O
return	NN	O	O
home	NN	O	O
with	IN	O	O
considerable	JJ	O	B-TREATMENT
support	NN	O	I-TREATMENT
and	CC	O	O
assistance	NN	O	O
.	.	O	O

aspiration	NN	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
bilateral	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
strokes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
prostatic	JJ	B-PROBLEM	B-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
gross	JJ	B-PROBLEM	B-PROBLEM
hematuria	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

digoxin	NN	B-TREATMENT	B-TREATMENT
0.25	CD	O	O
mg	NN	O	O
.	.	O	O

hytrin	NN	B-TREATMENT	B-TREATMENT
2mg	CD	O	O
at	IN	O	O
bedtime	NN	O	O
.	.	O	O

ticlid	JJ	B-TREATMENT	O
0.25	CD	O	O
g	JJ	O	O
po	NN	O	O
bid	NN	O	O
.	.	O	O

bronchodilators	NNS	B-TREATMENT	B-TREATMENT
as	IN	O	O
needed	VBN	O	O
.	.	O	O

strict	JJ	B-TREATMENT	B-TREATMENT
aspiration	NN	I-TREATMENT	I-TREATMENT
precautions	NNS	I-TREATMENT	I-TREATMENT
with	IN	O	O
avoidance	NN	B-TREATMENT	B-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
clear	JJ	I-TREATMENT	I-TREATMENT
liquids	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
all	DT	O	B-TREATMENT
other	JJ	O	I-TREATMENT
liquids	NNS	O	I-TREATMENT
thickened	VBD	O	O
.	.	O	O

increased	VBN	O	B-PROBLEM
ambulation	NN	O	I-PROBLEM
with	IN	O	O
assistance	NN	O	O
and	CC	O	O
daily	JJ	B-TREATMENT	O
pulmonary	JJ	I-TREATMENT	B-TREATMENT
physical	JJ	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
no	DT	O	O
loss	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
consciousness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
found	VBN	O	O
by	IN	O	O
family	NN	O	O
and	CC	O	O
friends	NNS	O	O
to	TO	O	O
be	VB	O	O
somewhat	RB	B-PROBLEM	O
confused	JJ	I-PROBLEM	B-PROBLEM
and	CC	O	O
was	VBD	O	O
therefore	RB	O	O
taken	VBN	O	O
to	TO	O	O
newton-wellesley	JJ	O	O
hospital	NN	O	O
thereafter	RB	O	O
.	.	O	O

workup	NN	B-TEST	B-TEST
at	IN	O	O
the	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
included	VBD	O	O
a	DT	B-TEST	B-TEST
ct	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
revealing	VBG	O	O
a	DT	O	O
possible	JJ	O	O
parietal	JJ	B-PROBLEM	B-PROBLEM
subdural	JJ	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
side	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	O
patient	NN	I-TEST	O
's	POS	I-TEST	O
gcs	NN	I-TEST	O
was	VBD	O	O
15	CD	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
thereafter	RB	O	O
transferred	VBN	O	O
to	TO	O	O
beverly	VB	O	O
hospital	NN	O	O
for	IN	O	O
further	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
and	CC	O	O
management	NN	B-TREATMENT	O
.	.	O	O

significant	JJ	O	O
for	IN	O	O
depression	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1.	CD	O	O
prozac	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

2.	CD	O	O
tetracycline	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
acne	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
presentation	NN	O	O
,	,	O	O
her	PRP$	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
was	VBD	O	O
98.8	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
100	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
110/65	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
18	CD	O	O
,	,	O	O
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
saturating	VBG	O	O
at	IN	O	O
100%	CD	O	O
in	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

in	IN	O	O
general	JJ	O	O
,	,	O	O
she	PRP	O	O
is	VBZ	O	O
well	RB	O	O
appearing	VBG	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

head	NN	B-TEST	B-TEST
,	,	I-TEST	I-TEST
eyes	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
ears	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
nose	RB	I-TEST	I-TEST
and	CC	I-TEST	I-TEST
throat	VB	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
-	:	O	O
the	DT	O	O
pupils	NNS	O	O
are	VBP	O	O
equal	JJ	O	O
,	,	O	O
round	NN	O	O
,	,	O	O
and	CC	O	O
reactive	JJ	O	O
to	TO	O	O
light	JJ	O	O
and	CC	O	O
accommodation	NN	O	O
.	.	O	O

no	DT	O	O
obvious	JJ	O	O
evidence	NN	O	O
of	IN	O	O
trauma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
lungs	NNS	O	O
were	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	O	O
.	.	O	O

no	DT	O	O
crepitus	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

extremities	NNS	O	O
with	IN	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
step-off	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
palpable	JJ	O	B-TEST
pulses	NNS	O	I-TEST
peripherally	RB	O	O
.	.	O	O

rectal	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
heme	JJ	B-TEST	O
negative	JJ	O	O
with	IN	O	O
normal	JJ	O	O
tone	NN	O	O
.	.	O	O

neurologic	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
nonfocal	JJ	O	O
.	.	O	O

admission	NN	B-TEST	B-TEST
laboratories	NNS	I-TEST	I-TEST
were	VBD	O	O
notable	JJ	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
13.1	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
34.0	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
280,000	CD	O	O
.	.	O	O

chemistries	NNS	B-TEST	B-TEST
were	VBD	O	O
notable	JJ	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
of	IN	O	O
143	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
3.2	CD	O	O
,	,	O	O
chloride	NN	B-TEST	B-TEST
and	CC	O	O
bicarbonate	NN	B-TEST	B-TEST
of	IN	O	O
104	CD	O	O
and	CC	O	O
24	CD	O	O
,	,	O	O
respectively	RB	O	O
,	,	O	O
with	IN	O	O
blood	NN	B-TEST	B-TEST
urea	JJ	I-TEST	I-TEST
nitrogen	NN	I-TEST	I-TEST
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
of	IN	O	O
7	CD	O	O
and	CC	O	O
0.4	CD	O	O
,	,	O	O
respectively	RB	O	O
.	.	O	O

blood	NN	B-TEST	B-TEST
glucose	NN	I-TEST	I-TEST
was	VBD	O	O
116	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
admission	NN	I-TEST	I-TEST
coagulation	NN	I-TEST	I-TEST
studies	NNS	I-TEST	I-TEST
were	VBD	O	O
notable	JJ	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
prothrombin	JJ	I-TEST	I-TEST
time	NN	I-TEST	I-TEST
inr	NN	B-TEST	I-TEST
of	IN	O	O
11.8	CD	O	O
and	CC	O	O
0.9	CD	O	O
,	,	O	O
respectively	RB	O	O
with	IN	O	O
a	DT	B-TEST	B-TREATMENT
partial	JJ	I-TEST	I-TREATMENT
thromboplastin	NN	I-TEST	I-TREATMENT
time	NN	I-TEST	O
of	IN	O	O
25.2	CD	O	O
.	.	O	O

admission	NN	B-TEST	B-TEST
lactate	NN	I-TEST	I-TEST
was	VBD	O	O
0.8	CD	O	O
.	.	O	O

amylase	NN	B-TEST	B-TEST
was	VBD	O	O
87	CD	O	O
.	.	O	O

fibrinogen	NN	B-TEST	B-TEST
was	VBD	O	O
346	CD	O	O
.	.	O	O

hcg	NN	B-TEST	O
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

serum	NN	B-TEST	B-TEST
toxicology	NN	I-TEST	I-TEST
and	CC	O	O
urine	JJ	B-TEST	B-TEST
toxicology	NN	I-TEST	I-TEST
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

urinalysis	NN	B-TEST	B-TEST
obtained	VBN	O	O
on	IN	O	O
admission	NN	O	O
was	VBD	O	O
additionally	RB	O	O
negative	JJ	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
three	CD	B-TEST	O
views	NNS	I-TEST	O
of	IN	I-TEST	O
the	DT	I-TEST	O
cervical	JJ	I-TEST	O
spine	NN	I-TEST	O
that	WDT	O	O
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

pelvis	NN	B-TEST	O
film	NN	I-TEST	O
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

head	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
from	IN	O	O
the	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
just	RB	O	O
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
parietal	JJ	I-PROBLEM	I-PROBLEM
subdural	JJ	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
off	RB	O	O
tls	JJ	B-TREATMENT	B-TREATMENT
precautions	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
sent	VBN	O	O
to	TO	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
monitoring	VBG	O	O
overnight	JJ	O	O
for	IN	O	O
neural	JJ	B-TEST	B-TEST
checks	NNS	I-TEST	I-TEST
and	CC	O	O
neurosurgical	JJ	O	O
consultation	NN	O	O
was	VBD	O	O
obtained	VBN	O	O
.	.	O	O

neurosurgical	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
just	RB	O	O
recommended	VBN	O	O
serial	JJ	B-TEST	B-TEST
neurologic	JJ	I-TEST	I-TEST
checks	NNS	I-TEST	I-TEST
and	CC	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
cat	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
on	IN	O	O
the	DT	O	O
second	JJ	O	O
day	NN	O	O
of	IN	O	O
admission	NN	O	O
to	TO	O	O
see	VB	O	O
if	IN	O	O
there	EX	O	O
was	VBD	O	O
any	DT	O	O
evidence	NN	O	O
of	IN	O	O
progression	NN	O	B-PROBLEM
of	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
2010-02-05	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
cat	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
revealing	VBG	O	O
no	DT	O	O
change	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
subdural	JJ	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
neurologic	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
remained	VBD	O	O
nonfocal	JJ	O	B-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
kept	VBN	O	O
in	IN	O	O
the	DT	O	O
hospital	NN	O	O
for	IN	O	O
an	DT	O	O
additional	JJ	O	O
24	CD	O	O
hours	NNS	O	O
for	IN	O	O
further	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
.	.	O	O

by	IN	O	O
2010-02-06	CD	O	O
,	,	O	O
which	WDT	O	O
would	MD	O	O
correlate	VB	O	O
with	IN	O	O
hospital	JJ	O	O
day	NN	O	O
number	NN	O	O
two	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
no	DT	O	O
complaints	NNS	O	B-PROBLEM
except	IN	O	O
for	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
frontal	JJ	I-PROBLEM	I-PROBLEM
pressure	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
region	NN	O	O
of	IN	O	O
where	WRB	O	O
the	DT	B-PROBLEM	O
bleed	NN	I-PROBLEM	O
had	VBD	O	O
been	VBN	O	O
localized	VBN	O	O
on	IN	O	O
the	DT	O	O
right	JJ	O	O
side	NN	O	O
.	.	O	O

she	PRP	O	O
remained	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
hemodynamically	RB	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
no	DT	O	O
other	JJ	O	B-PROBLEM
complaints	NNS	O	I-PROBLEM
by	IN	O	O
examination	NN	B-TEST	B-TEST
.	.	O	O

her	PRP$	B-TEST	B-TEST
neurologic	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
remained	VBD	O	O
completely	RB	O	B-PROBLEM
nonfocal	JJ	O	I-PROBLEM
and	CC	O	O
otherwise	RB	O	O
normal	JJ	O	O
.	.	O	O

1.	CD	O	O
tylenol	JJ	B-TREATMENT	B-TREATMENT
#3	RB	I-TREATMENT	O
one	CD	O	O
to	TO	O	O
two	CD	O	O
tablets	NNS	O	O
p.o.	JJ	O	O
q	JJ	O	O
4-6	JJ	O	O
hours	NNS	O	O
p.r.n.	VBP	O	O

2.	CD	O	O
motrin	NN	B-TREATMENT	B-TREATMENT
as	IN	O	O
needed	VBN	O	O
.	.	O	O

3.	CD	O	O
prozac	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
once	RB	O	O
daily	RB	O	O
.	.	O	O

4.	CD	O	O
tetracycline	NN	B-TREATMENT	B-TREATMENT
which	WDT	O	O
she	PRP	O	O
was	VBD	O	O
taking	VBG	O	O
for	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
acne	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
right	JJ	B-PROBLEM	B-PROBLEM
parietal	JJ	I-PROBLEM	I-PROBLEM
subdural	JJ	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
fall	NN	O	B-PROBLEM
from	IN	O	O
standing	VBG	O	O
position	NN	O	O
with	IN	O	O
no	DT	O	O
loss	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
consciousness	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
no	DT	O	O
neurologic	JJ	B-PROBLEM	B-PROBLEM
deficits	NNS	I-PROBLEM	I-PROBLEM
or	CC	O	O
progression	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2.	CD	O	O
depression	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

3.	CD	O	O
acne	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

metastatic	JJ	B-PROBLEM	B-PROBLEM
adenocarcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
breast	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
hyponatremia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
1-13-94	JJ	O	O
.	.	O	O

2.	CD	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
embolus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
1-14-94	JJ	O	B-PROBLEM
.	.	O	O

3.	CD	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
fever	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

4.	CD	O	O
history	NN	O	O
of	IN	O	O
ovarian	JJ	B-TREATMENT	B-PROBLEM
cyst	NN	I-TREATMENT	I-PROBLEM
resection	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
1975	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
49	CD	O	O
year	NN	O	O
old	JJ	O	O
woman	NN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
metastatic	JJ	I-PROBLEM	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
breast	NN	I-PROBLEM	I-PROBLEM
who	WP	O	O
is	VBZ	O	O
status	NN	O	O
post	NN	O	O
high	JJ	B-TREATMENT	B-TREATMENT
dose	NN	I-TREATMENT	I-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
pbse	NN	B-TREATMENT	B-PROBLEM
and	CC	O	O
ccss	JJ	B-TREATMENT	B-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
ending	VBG	O	O
june	NN	O	O
1994	CD	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
on	IN	O	O
1-5-94	NNS	O	O
for	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
chest	VBP	B-PROBLEM	B-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
ulceration	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
cellulitis	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
pain	NN	B-TREATMENT	B-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
first	RB	O	O
presented	VBN	O	O
in	IN	O	O
october	JJ	O	O
1991	CD	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
tender	NN	I-PROBLEM	I-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
axillary	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
mammogram	NN	I-TEST	I-TEST
done	VBN	O	O
in	IN	O	O
november	JJ	O	O
1990	CD	O	O
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
mammography	NN	B-TEST	B-TEST
repeated	VBN	O	O
in	IN	O	O
october	NN	O	O
1991	CD	O	O
showed	VBD	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
breast	NN	I-PROBLEM	I-PROBLEM
masses	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
suspicious	JJ	O	O
for	IN	O	O
carcinoma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

fine	JJ	B-TEST	B-TEST
needle	JJ	I-TEST	I-TEST
aspiration	NN	I-TEST	I-TEST
on	IN	O	O
october	$	O	O
23	CD	O	O
,	,	O	O
1991	CD	O	O
demonstrated	VBD	O	O
atypical	JJ	B-PROBLEM	B-PROBLEM
cells	NNS	I-PROBLEM	I-PROBLEM
which	WDT	O	O
occurred	VBD	O	O
singly	RB	O	O
and	CC	O	O
in	IN	O	O
clusters	NNS	O	O
.	.	O	O

staging	VBG	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
included	VBD	O	O
normal	JJ	O	B-TEST
liver	JJ	O	I-TEST
function	NN	O	I-TEST
tests	NNS	O	I-TEST
,	,	O	O
normal	JJ	O	O
blood	NN	O	O
counts	NNS	O	O
and	CC	O	O
normal	JJ	O	O
chest	JJ	O	B-TEST
x-ray	NN	O	I-TEST
.	.	O	O

bone	NN	B-TEST	B-TEST
scan	JJ	I-TEST	I-TEST
showed	VBD	O	O
degenerative	JJ	B-PROBLEM	B-PROBLEM
joint	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
shoulders	NNS	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
lumbar	NN	I-PROBLEM	B-TEST
spine	NN	I-PROBLEM	I-TEST
as	RB	O	O
well	RB	O	O
as	IN	O	O
increased	VBN	B-PROBLEM	B-PROBLEM
radio	NN	I-PROBLEM	I-PROBLEM
chaser	NN	I-PROBLEM	I-PROBLEM
uptake	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
breast	NN	I-PROBLEM	I-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM
.	.	O	O

dr.	NN	O	O
berca	NN	O	O
gachfrum	NN	O	O
performed	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
modified	VBN	I-TREATMENT	I-TREATMENT
mastectomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
left	VBD	B-TREATMENT	B-TREATMENT
simple	JJ	I-TREATMENT	I-TREATMENT
mastectomy	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
november	JJ	O	O
4	CD	O	O
,	,	O	O
1991	CD	O	O
.	.	O	O

the	DT	B-TREATMENT	O
right	NN	I-TREATMENT	O
modified	VBD	I-TREATMENT	O
radical	JJ	I-TREATMENT	B-TREATMENT
mastectomy	NN	I-TREATMENT	I-TREATMENT
contained	VBD	O	O
a	DT	B-PROBLEM	O
5.5	CD	I-PROBLEM	O
cm	NN	I-PROBLEM	O
poorly	RB	I-PROBLEM	O
differentiated	VBN	I-PROBLEM	O
,	,	I-PROBLEM	O
grade	VB	I-PROBLEM	O
iii	NN	I-PROBLEM	O
out	IN	I-PROBLEM	O
of	IN	I-PROBLEM	O
iii	NN	I-PROBLEM	B-PROBLEM
infiltrating	VBG	I-PROBLEM	I-PROBLEM
ductal	JJ	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
margins	NNS	O	O
were	VBD	O	O
free	JJ	O	O
of	IN	O	O
tumor	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
but	CC	O	O
10	CD	O	O
out	IN	O	O
of	IN	O	O
21	CD	O	O
lymph	NN	O	B-TEST
nodes	NNS	O	I-TEST
were	VBD	O	O
positive	JJ	O	O
for	IN	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

furthermore	RB	O	O
there	EX	O	O
was	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
pectoralis	NN	I-PROBLEM	I-PROBLEM
muscle	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
is	VBZ	O	O
supposed	VBN	O	O
to	TO	O	O
be	VB	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	O
left	JJ	I-TREATMENT	O
simple	JJ	I-TREATMENT	O
mastectomy	NN	I-TREATMENT	B-TREATMENT
also	RB	O	O
contained	VBD	O	O
5.5	CD	B-PROBLEM	O
cm	NNS	I-PROBLEM	O
poorly	RB	I-PROBLEM	O
differentiated	VBD	I-PROBLEM	O
infiltrating	JJ	I-PROBLEM	O
ductal	NN	I-PROBLEM	O
and	CC	I-PROBLEM	O
intraductal	JJ	I-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
extensive	JJ	B-PROBLEM	B-PROBLEM
lymphatic	JJ	I-PROBLEM	I-PROBLEM
vessel	NN	I-PROBLEM	I-PROBLEM
invasion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

estrogen	NN	B-TEST	B-TEST
receptor	NN	I-TEST	I-TEST
was	VBD	O	O
0%	CD	O	O
by	IN	O	O
erica	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
developed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
hematoma	NN	I-PROBLEM	I-PROBLEM
requiring	VBG	O	O
surgical	JJ	B-TREATMENT	B-TREATMENT
drainage	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

therefore	RB	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
stage	NN	I-PROBLEM	I-PROBLEM
iii-a	JJ	I-PROBLEM	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
breast	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

since	IN	O	O
she	PRP	O	O
was	VBD	O	O
at	IN	O	O
high	JJ	O	O
risk	NN	O	O
for	IN	O	O
both	DT	O	O
local	JJ	B-PROBLEM	O
and	CC	I-PROBLEM	O
metastatic	JJ	I-PROBLEM	B-PROBLEM
recurrence	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
her	PRP$	B-PROBLEM	I-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
she	PRP	O	O
received	VBD	O	O
both	DT	O	O
systemic	JJ	B-TREATMENT	B-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
radiation	NN	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
cmsap	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
which	WDT	O	O
is	VBZ	O	O
cytoxan	NN	B-TREATMENT	O
,	,	O	O
methotrexate	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
leukovoranrescue	NN	B-TREATMENT	O
,	,	O	O
5-fu	JJ	B-TREATMENT	O
,	,	O	O
adriamycin	JJ	B-TREATMENT	B-TREATMENT
and	CC	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
four	CD	O	O
cycles	NNS	O	O
.	.	O	O

there	EX	O	O
were	VBD	O	O
no	DT	O	O
dose	JJ	O	O
reductions	NNS	O	O
for	IN	O	O
mucositis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
myelosuppression	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

however	RB	O	O
,	,	O	O
following	VBG	O	O
cycle	NN	O	O
4	CD	O	O
,	,	O	O
she	PRP	O	O
developed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
flu-like	JJ	I-PROBLEM	I-PROBLEM
illness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
followed	VBN	O	O
by	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nonproductive	JJ	B-PROBLEM	B-PROBLEM
cough	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
exertion	NN	O	O
.	.	O	O

abgs	NN	B-TEST	O
showed	VBD	O	O
a	DT	B-TEST	B-TEST
po2	NN	I-TEST	I-TEST
of	IN	O	O
79	CD	O	O
,	,	O	O
ph	NN	B-TEST	B-TEST
7.44	CD	O	O
,	,	O	O
po2	RB	B-TEST	O
33	CD	O	O
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
showed	VBD	O	O
diffuse	IN	B-PROBLEM	B-PROBLEM
interstitial	JJ	I-PROBLEM	I-PROBLEM
infiltrates	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
differential	JJ	O	O
diagnosis	NN	O	O
included	VBD	O	O
viral	JJ	B-PROBLEM	B-PROBLEM
pneumonitis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
mycoplasma	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
chlamydia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

basically	RB	O	O
in	IN	O	O
december	NN	O	O
1993	CD	O	O
,	,	O	O
she	PRP	O	O
returned	VBD	O	O
to	TO	O	O
the	DT	O	O
hem	NN	O	O
/	NNP	O	O
onc	VBZ	O	O
clinic	JJ	O	O
with	IN	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
nodules	NNS	I-PROBLEM	I-PROBLEM
which	WDT	O	O
turned	VBD	O	O
out	RP	O	O
to	TO	O	O
be	VB	O	O
tumor	JJ	B-PROBLEM	B-PROBLEM
recurrences	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
biopsied	VBN	O	O
.	.	O	O

although	IN	O	O
she	PRP	O	O
had	VBD	O	O
mediastinal	JJ	B-PROBLEM	B-PROBLEM
recurrence	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
bone	NN	B-TEST	B-TEST
scan	JJ	I-TEST	I-TEST
,	,	O	I-TEST
head	NN	B-TEST	I-TEST
and	CC	I-TEST	I-TEST
liver	NN	I-TEST	I-TEST
ct	NNS	I-TEST	I-TEST
were	VBD	O	O
negative	JJ	O	O
for	IN	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
thus	RB	O	O
started	VBN	O	O
on	IN	O	O
a	DT	O	B-TREATMENT
protocol	NN	O	I-TREATMENT
of	IN	O	I-TREATMENT
high	JJ	B-TREATMENT	I-TREATMENT
dose	JJ	I-TREATMENT	I-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
gcsf	NN	B-TREATMENT	O
and	CC	O	O
peripheral	JJ	B-TREATMENT	O
stem	NN	I-TREATMENT	O
cell	NN	I-TREATMENT	O
support	NN	I-TREATMENT	O
.	.	O	O

complications	NNS	B-PROBLEM	B-PROBLEM
has	VBZ	O	O
mainly	RB	O	O
included	VBN	O	O
myelosuppression	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
mucositis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
also	RB	O	O
developed	VBD	O	O
klebsiella	NN	B-PROBLEM	B-PROBLEM
uti	NN	I-PROBLEM	I-PROBLEM
after	IN	O	O
the	DT	O	O
second	JJ	O	O
cycle	NN	O	O
of	IN	O	O
high	JJ	B-TREATMENT	B-TREATMENT
dose	JJ	I-TREATMENT	I-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

it	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
gent	NN	B-TREATMENT	B-PROBLEM
and	CC	O	O
cipro	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

re-staging	VBG	B-TEST	O
done	VBN	O	O
in	IN	O	O
april	NN	O	O
1993	CD	O	O
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
decrease	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
pretracheal	NN	I-PROBLEM	I-PROBLEM
nodes	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
question	NN	O	O
of	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
lymphangitic	JJ	I-PROBLEM	I-PROBLEM
spread	NN	I-PROBLEM	I-PROBLEM
versus	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
pneumonitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

in	IN	O	O
may	MD	O	O
1994	CD	O	O
she	PRP	O	O
received	VBD	O	O
her	PRP	O	O
first	JJ	O	O
course	NN	O	O
of	IN	O	O
thiotepa	NN	B-TREATMENT	O
and	CC	O	O
velban	NN	B-TREATMENT	B-TREATMENT
and	CC	O	I-TREATMENT
methotrexate	NN	B-TREATMENT	I-TREATMENT
,	,	O	O
which	WDT	O	O
required	VBD	O	O
some	DT	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
cell	NN	I-TREATMENT	I-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

in	IN	O	O
mid	NN	O	O
may	MD	O	O
she	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
neutropenia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
uti	JJ	I-PROBLEM	I-PROBLEM
with	IN	O	I-PROBLEM
blood	NN	B-PROBLEM	I-PROBLEM
clots	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
urine	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
presents	NNS	O	O
today	NN	O	O
with	IN	O	O
complaints	NNS	O	O
of	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
a	DT	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
of	IN	O	O
100	CD	O	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
also	RB	O	O
been	VBN	O	O
having	VBG	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
since	IN	O	O
november	NN	O	O
and	CC	O	O
her	PRP$	O	B-PROBLEM
other	JJ	O	I-PROBLEM
complaints	NNS	O	I-PROBLEM
of	IN	O	O
admission	NN	O	O
include	VBP	O	O
confusion	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

significant	JJ	O	O
for	IN	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
breast	NN	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
complicated	VBN	O	O
by	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
neutropenia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

utis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
obstruction	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
subclavian	JJ	I-PROBLEM	I-PROBLEM
vein	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
brachial	NN	I-PROBLEM	I-PROBLEM
cephalic	NN	I-PROBLEM	I-PROBLEM
vein	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
herpes	VBZ	B-PROBLEM	B-PROBLEM
zoster	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

status	NN	O	O
post	NN	O	O
ovarian	JJ	B-TREATMENT	B-TREATMENT
cyst	NN	I-TREATMENT	I-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
1975	CD	O	O
.	.	O	O

she	PRP	O	O
used	VBD	O	O
the	DT	B-TREATMENT	O
pill	NN	I-TREATMENT	O
for	IN	O	O
five	CD	O	O
years	NNS	O	O
in	IN	O	O
the	DT	O	O
past	NN	O	O
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
g	JJ	O	O
2	CD	O	O
,	,	O	O
p	VBD	O	O
2	CD	O	O
with	IN	O	O
spontaneous	JJ	B-TREATMENT	B-PROBLEM
vaginal	JJ	I-TREATMENT	I-PROBLEM
deliveries	NNS	I-TREATMENT	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
easy	JJ	B-PROBLEM	B-PROBLEM
bruis	JJ	I-PROBLEM	I-PROBLEM
ability	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
allergic	JJ	B-PROBLEM	B-PROBLEM
to	TO	O	I-PROBLEM
augmentin	VB	B-TREATMENT	I-PROBLEM
which	WDT	O	O
gives	VBZ	O	O
her	PRP	O	O
a	DT	B-PROBLEM	B-PROBLEM
rash	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

ms	NN	B-TREATMENT	B-TREATMENT
contin	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
msir	NN	B-TREATMENT	O
,	,	O	O
and	CC	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
.	.	I-TREATMENT	O

t	NN	B-TEST	O
100.1	CD	O	O
,	,	O	O
p	NN	B-TEST	O
104	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
130/90	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
16	CD	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
sating	VBG	B-TEST	O
95%	CD	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

heent	NN	O	O
-	:	O	O
pupils	NNS	O	O
were	VBD	O	O
miotic	JJ	B-PROBLEM	O
,	,	O	O
measuring	VBG	O	O
2	CD	O	O
mm	NNS	O	O
but	CC	O	O
responsive	JJ	O	O
to	TO	O	O
light	NN	O	O
.	.	O	O

neck	SYM	O	B-TEST
-	:	O	O
tender	NN	B-PROBLEM	O
on	IN	O	O
the	DT	O	O
leftside	NN	O	O
with	IN	O	O
no	DT	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
thyromegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

chest	JJS	O	O
actually	RB	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
5	CD	I-PROBLEM	I-PROBLEM
x	NN	I-PROBLEM	I-PROBLEM
7	CD	I-PROBLEM	I-PROBLEM
cm	JJ	I-PROBLEM	I-PROBLEM
necrotic	JJ	I-PROBLEM	I-PROBLEM
area	NN	I-PROBLEM	I-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	NN	O	I-PROBLEM
chest	JJS	O	I-PROBLEM
wall	NN	O	I-PROBLEM
with	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
pus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
hsm	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

extremities	NNS	O	O
-	:	O	O
her	PRP$	O	O
left	JJ	O	O
arm	NN	O	O
was	VBD	O	O
very	RB	B-PROBLEM	B-PROBLEM
swollen	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

it	PRP	O	O
was	VBD	O	O
tested	VBN	O	O
with	IN	O	O
no	DT	B-PROBLEM	O
voluntary	JJ	I-PROBLEM	O
movement	NN	I-PROBLEM	O
except	IN	O	O
at	IN	O	O
the	DT	O	O
finger	NN	O	O
tips	NNS	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
elsewhere	RB	O	O
in	IN	O	O
her	PRP$	O	O
extremities	NNS	O	O
,	,	O	O
only	RB	O	O
the	DT	O	O
left	JJ	O	O
arm	NN	O	O
.	.	O	O

neuro	SYM	O	B-TEST
-	:	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
oriented	VBN	O	O
to	TO	O	O
place	VB	O	O
,	,	O	O
but	CC	O	O
had	VBD	O	O
difficulty	NN	B-PROBLEM	B-PROBLEM
with	IN	I-PROBLEM	I-PROBLEM
recent	JJ	I-PROBLEM	I-PROBLEM
memory	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
also	RB	O	O
had	VBD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
left	NN	I-PROBLEM	O
extremities	VBZ	I-PROBLEM	O
,	,	O	O
both	DT	O	O
upper	JJ	O	O
and	CC	O	O
lower	JJR	O	O
.	.	O	O

of	IN	O	O
note	NN	O	O
-	:	O	O
na	NN	B-TEST	O
133	CD	O	O
,	,	O	O
k	VBD	B-TEST	O
4	CD	O	O
,	,	O	O
wbc	VBD	B-TEST	B-TEST
8.82	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
35.1	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
229	CD	O	O
.	.	O	O

pt	NN	B-TEST	O
13.8	CD	O	O
with	IN	O	O
an	DT	B-TEST	O
inr	NN	I-TEST	O
of	IN	O	O
1.3	CD	O	O
,	,	O	O
ptt	NN	B-TEST	B-TEST
25.5	CD	O	O
,	,	O	O
total	JJ	B-TEST	B-TEST
protein	NN	I-TEST	I-TEST
was	VBD	O	O
6.2	CD	O	O
,	,	O	O
albumin	RB	B-TEST	B-TEST
3.4	CD	O	O
,	,	O	O
globulin	NN	B-TEST	B-TEST
of	IN	O	O
2.8	CD	O	O
,	,	O	O
calcium	NN	B-TEST	B-TEST
of	IN	O	O
9.1	CD	O	O
,	,	O	O
phos	NN	B-TEST	B-TEST
2.7	CD	O	O
,	,	O	O
mag	FW	B-TEST	O
2.1	CD	O	O
,	,	O	O
urea	JJ	B-TEST	B-TEST
3.7	CD	O	O
.	.	O	O

alt	NN	B-TEST	O
was	VBD	O	O
elevated	VBN	B-PROBLEM	B-PROBLEM
at	IN	O	O
240	CD	O	O
,	,	O	O
ast	RB	B-TEST	B-TEST
85	CD	O	O
,	,	O	O
ldh	VBD	B-TEST	O
305	CD	O	O
,	,	O	O
alk	VBP	B-TEST	O
phos	JJ	I-TEST	B-TEST
85	CD	O	O
,	,	O	O
total	JJ	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
was	VBD	O	O
1.3	CD	O	O
,	,	O	O
direct	JJ	B-TEST	B-TEST
bili	NN	I-TEST	I-TEST
was	VBD	O	O
.8	NNP	O	O
.	.	O	O

cholesterol	NN	B-TEST	B-TEST
188	CD	O	O
,	,	O	O
triglyceride	NN	B-TEST	B-TEST
was	VBD	O	O
127	CD	O	O
.	.	O	O

ua	JJ	B-TEST	O
-	:	O	O
trace	NN	B-PROBLEM	B-PROBLEM
protein	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
trace	NN	B-PROBLEM	B-PROBLEM
ketones	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
positive	JJ	B-PROBLEM	O
for	IN	I-PROBLEM	O
bilirubin	NN	I-PROBLEM	B-TEST
and	CC	I-PROBLEM	I-TEST
nitrogen	NN	I-PROBLEM	I-TEST
and	CC	O	O
also	RB	O	O
4	CD	B-PROBLEM	O
to	TO	I-PROBLEM	O
6	CD	I-PROBLEM	O
wbcs	NN	I-PROBLEM	O
with	IN	O	O
1+	CD	B-PROBLEM	B-PROBLEM
bacteria	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	JJ	I-TEST	I-TEST
-	:	O	O
showed	VBD	O	O
a	DT	B-PROBLEM	B-TEST
left	JJ	I-PROBLEM	I-TEST
paratracheal	NN	I-PROBLEM	I-TEST
adenopathy	NN	I-PROBLEM	I-TEST
and	CC	O	O
small	JJ	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

in	IN	O	O
summary	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
49	CD	O	O
year	NN	O	O
old	JJ	O	O
woman	NN	O	O
with	IN	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
breast	NN	I-PROBLEM	I-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
ca	MD	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
chemotherapy	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
cmsap	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
pvsc	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
xrt	NN	B-TREATMENT	O
who	WP	O	O
presented	VBD	O	O
with	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
four	CD	O	O
days	NNS	O	O
of	IN	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
had	VBD	O	O
been	VBN	O	O
on	IN	O	O
keflex	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
erythema	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	O
keflex	NN	I-TREATMENT	O
was	VBD	O	O
stopped	VBN	O	O
when	WRB	O	O
she	PRP	O	O
developed	VBD	O	O
the	DT	B-PROBLEM	B-PROBLEM
diarrhea	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

when	WRB	O	O
she	PRP	O	O
arrived	VBD	O	O
the	DT	O	O
plan	NN	O	O
was	VBD	O	O
to	TO	O	O
go	VB	O	O
ahead	RB	O	O
and	CC	O	O
treat	VB	O	O
here	RB	B-PROBLEM	O
rythematous	JJ	I-PROBLEM	B-PROBLEM
induration	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
possible	JJ	O	O
cellulitis	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

so	IN	O	O
she	PRP	O	O
was	VBD	O	O
put	VBN	O	O
on	IN	O	O
dicloxicillin	NN	B-TREATMENT	O
and	CC	O	O
we	PRP	O	O
did	VBD	O	O
local	JJ	B-TREATMENT	B-TREATMENT
wound	NN	I-TREATMENT	I-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
an	DT	B-TREATMENT	O
agent	NN	I-TREATMENT	O
called	VBN	O	O
santyl	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
which	WDT	O	O
is	VBZ	O	O
a	DT	B-TREATMENT	O
collagenace	NN	I-TREATMENT	O
ondebrided	VBD	I-TREATMENT	O
which	WDT	O	O
worked	VBD	O	O
very	RB	O	O
well	RB	O	O
for	IN	O	O
her	PRP$	O	O
.	.	O	O

also	RB	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
admission	NN	O	O
we	PRP	O	O
were	VBD	O	O
also	RB	O	O
considering	VBG	O	O
palliative	JJ	B-TREATMENT	B-TREATMENT
taxol	NN	I-TREATMENT	I-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
which	WDT	O	O
the	DT	O	O
patient	NN	O	O
declined	VBD	O	O
.	.	O	O

she	PRP	O	O
refused	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
taxol	NN	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
so	IN	O	O
that	DT	O	O
was	VBD	O	O
not	RB	O	O
done	VBN	O	O
.	.	O	O

another	DT	O	O
major	JJ	O	O
issue	NN	O	O
with	IN	O	O
this	DT	O	O
patient	NN	O	O
was	VBD	O	O
pain	VBN	B-TREATMENT	B-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
been	VBN	O	O
in	IN	O	O
a	DT	O	O
whole	JJ	O	O
lot	NN	O	O
of	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
from	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
arm	NN	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

so	RB	O	O
pain	JJ	B-TREATMENT	B-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
a	DT	O	O
big	JJ	O	O
issue	NN	O	O
so	IN	O	O
she	PRP	O	O
was	VBD	O	O
on	IN	O	O
ms	NN	B-TREATMENT	B-TREATMENT
contin	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
msir	NN	B-TREATMENT	O
at	IN	O	O
home	NN	O	O
she	PRP	O	O
thought	VBD	O	O
that	IN	O	O
clouded	VBD	O	B-PROBLEM
her	PRP	O	I-PROBLEM
thinking	NN	O	I-PROBLEM
,	,	O	O
so	IN	O	O
we	PRP	O	O
tried	VBD	O	O
different	JJ	O	O
things	NNS	O	O
for	IN	O	O
pain	NN	B-TREATMENT	B-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

one	CD	O	O
of	IN	O	O
them	PRP	O	O
was	VBD	O	O
to	TO	O	O
do	VB	O	O
a	DT	B-TREATMENT	B-PROBLEM
subarachnoid	NN	I-TREATMENT	I-PROBLEM
neurologic	JJ	I-TREATMENT	I-PROBLEM
block	NN	I-TREATMENT	I-PROBLEM
at	IN	I-TREATMENT	I-PROBLEM
c6-c7	JJ	I-TREATMENT	I-PROBLEM
interface	NN	I-TREATMENT	I-PROBLEM
on	IN	O	O
1-6-94	NNS	O	O
.	.	O	O

after	IN	O	O
that	DT	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
minimal	JJ	O	B-PROBLEM
relief	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
pain	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

however	RB	O	O
,	,	O	O
she	PRP	O	O
declined	VBD	O	O
further	RBR	B-TREATMENT	O
blocks	NNS	I-TREATMENT	O
,	,	O	O
which	WDT	O	O
were	VBD	O	O
offered	VBN	O	O
to	TO	O	O
her	PRP$	O	O
.	.	O	O

so	RB	O	O
accepted	VBN	O	O
to	TO	O	O
be	VB	O	O
on	IN	O	O
dilaudid	NN	B-TREATMENT	B-TREATMENT
p.o.	NN	I-TREATMENT	I-TREATMENT
which	WDT	O	O
was	VBD	O	O
started	VBN	O	O
at	IN	O	O
a	DT	O	O
dosage	NN	O	O
of	IN	O	O
2-4	JJ	O	O
meg	NN	O	O
but	CC	O	O
since	IN	O	O
then	RB	O	O
we	PRP	O	O
have	VBP	O	O
tapered	VBN	O	O
it	PRP	O	O
up	RP	O	O
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
now	RB	O	O
getting	VBG	O	O
dilaudid	RB	B-TREATMENT	B-TREATMENT
8	CD	O	O
mg	NNS	O	O
q2h	NN	O	O
and	CC	O	O
in	IN	O	O
addition	NN	O	O
she	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
on	IN	O	O
fentanyl	JJ	B-TREATMENT	B-TREATMENT
patch	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
now	RB	O	O
getting	VBG	O	O
75	CD	O	O
micrograms	NNS	O	O
per	IN	O	O
hour	NN	O	O
of	IN	O	O
the	DT	B-TREATMENT	O
fentanyl	NN	I-TREATMENT	B-TREATMENT
patch	NN	I-TREATMENT	I-TREATMENT
which	WDT	O	O
is	VBZ	O	O
changed	VBN	O	O
every	DT	O	O
72	CD	O	O
hours	NNS	O	O
.	.	O	O

we	PRP	O	O
can	MD	O	O
go	VB	O	O
up	RP	O	O
by	IN	O	O
25	CD	O	O
mg	NNS	O	O
on	IN	O	O
the	DT	B-TREATMENT	O
fentanyl	JJ	I-TREATMENT	B-TREATMENT
patch	NN	I-TREATMENT	I-TREATMENT
as	IN	O	O
needed	VBN	O	O
to	TO	O	O
control	VB	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
we	PRP	O	O
can	MD	O	O
always	RB	O	O
go	VB	O	O
up	RP	O	O
on	IN	O	O
the	DT	B-TREATMENT	O
dilaudid	NN	I-TREATMENT	O
because	IN	O	O
she	PRP	O	O
is	VBZ	O	O
still	RB	O	O
in	IN	O	O
considerable	JJ	O	O
amount	NN	O	O
of	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

other	JJ	O	O
things	NNS	O	O
that	WDT	O	O
happened	VBD	O	O
during	IN	O	O
this	DT	O	O
admission	NN	O	O
-	:	O	O
we	PRP	O	O
obtained	VBD	O	O
ahead	RB	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
for	IN	O	O
her	PRP$	O	O
on	IN	O	O
the	DT	O	O
8th	CD	O	O
of	IN	O	O
january	JJ	O	O
because	IN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
clouded	JJ	I-PROBLEM	I-PROBLEM
thinking	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
altered	VBD	B-PROBLEM	B-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
was	VBD	O	O
probably	RB	O	O
due	JJ	O	O
to	TO	O	O
the	DT	B-TREATMENT	B-TREATMENT
morphine	NN	I-TREATMENT	I-TREATMENT
that	IN	O	O
she	PRP	O	O
was	VBD	O	O
taking	VBG	O	O
.	.	O	O

we	PRP	O	O
went	VBD	O	O
ahead	RB	O	O
and	CC	O	O
got	VBD	O	O
a	DT	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
scanand	NN	O	I-TEST
it	PRP	O	O
showed	VBD	O	O
no	DT	O	O
enhancing	VBG	B-PROBLEM	B-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

in	IN	O	O
addition	NN	O	O
her	PRP$	B-TEST	B-PROBLEM
liver	NN	I-TEST	I-PROBLEM
transaminases	NNS	I-TEST	I-PROBLEM
were	VBD	O	O
elevated	VBN	B-PROBLEM	O
,	,	O	O
we	PRP	O	O
thought	VBD	O	O
about	IN	O	O
doing	VBG	O	O
further	JJ	B-TEST	B-TEST
work-up	NN	I-TEST	I-TEST
,	,	O	O
but	CC	O	O
that	DT	O	O
was	VBD	O	O
deferred	VBN	O	O
because	IN	O	O
the	DT	O	O
patient	NN	O	O
wanted	VBD	O	O
to	TO	O	O
wait	VB	O	O
on	IN	O	O
that	DT	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
on	IN	O	O
january	JJ	O	O
13	CD	O	O
became	VBD	O	O
hyponatremic	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
went	VBD	O	O
down	RB	O	O
to	TO	O	O
121	CD	O	O
and	CC	O	O
before	IN	O	O
that	DT	O	O
on	IN	O	O
admission	NN	O	O
she	PRP	O	O
was	VBD	O	O
133	CD	O	O
.	.	O	O

a	DT	O	O
renal	JJ	O	O
consult	NN	O	O
was	VBD	O	O
obtained	VBN	O	O
and	CC	O	O
their	PRP$	B-TEST	B-TEST
assessment	NN	I-TEST	I-TEST
was	VBD	O	O
that	IN	O	O
this	DT	O	O
was	VBD	O	O
probably	RB	O	O
a	DT	O	O
mixture	NN	O	O
of	IN	O	O
hypovolemia	NN	B-PROBLEM	B-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
siadh	NN	B-PROBLEM	O
.	.	O	O

we	PRP	O	O
proceeded	VBD	O	O
to	TO	O	O
do	VB	O	O
for	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
hyponatremia	NN	I-PROBLEM	I-PROBLEM
-	:	O	O
we	PRP	O	O
gave	VBD	O	O
her	PRP	O	O
some	DT	B-TREATMENT	O
fluid	NN	I-TREATMENT	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
urine	JJ	I-TEST	I-TEST
sodium	NN	I-TEST	I-TEST
became	VBD	O	O
higher	JJR	O	O
than	IN	O	O
her	PRP$	B-TEST	B-TEST
serum	JJ	I-TEST	I-TEST
sodium	NN	I-TEST	I-TEST
;	:	O	O
we	PRP	O	O
stopped	VBD	O	O
it	PRP	O	O
.	.	O	O

we	PRP	O	O
had	VBD	O	O
given	VBN	O	O
her	PRP$	O	B-TREATMENT
some	DT	B-TREATMENT	I-TREATMENT
normal	JJ	I-TREATMENT	I-TREATMENT
saline	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
then	RB	O	O
we	PRP	O	O
proceeded	VBD	O	O
to	TO	O	O
just	RB	O	O
do	VB	O	O
fluid	JJR	B-TREATMENT	B-TREATMENT
restriction	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

in	IN	O	O
addition	NN	O	O
we	PRP	O	O
gave	VBD	O	O
her	PRP	O	B-TEST
a	DT	B-TREATMENT	I-TEST
sodium	NN	I-TREATMENT	I-TEST
chloride	NN	I-TREATMENT	I-TEST
one	CD	O	O
gram	NN	O	O
per	IN	O	O
day	NN	O	O
and	CC	O	O
that	IN	O	O
also	RB	O	O
helped	VBD	O	O
,	,	O	O
so	IN	O	O
that	DT	O	O
now	RB	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
&apos;s	NNP	I-TEST	I-TEST
sodium	NN	I-TEST	I-TEST
is	VBZ	O	O
between	IN	O	O
126	CD	O	O
and	CC	O	O
129	CD	O	O
;	:	O	O
prior	RB	O	O
to	TO	O	O
that	IN	O	O
it	PRP	O	O
had	VBD	O	O
gone	VBN	O	O
down	RB	O	O
to	TO	O	O
as	IN	O	O
low	JJ	O	O
116.	CD	O	O

we	PRP	O	O
suggest	VBP	O	O
continuing	VBG	O	O
increased	VBD	B-TREATMENT	B-PROBLEM
salt	JJ	I-TREATMENT	I-PROBLEM
intake	NN	I-TREATMENT	I-PROBLEM
in	IN	O	O
her	PRP$	O	O
diet	NN	O	O
and	CC	O	O
also	RB	O	O
continuing	VBG	O	O
with	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
fluid	JJ	I-TREATMENT	I-TREATMENT
restriction	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
free	JJ	I-TREATMENT	I-TREATMENT
water	NN	I-TREATMENT	I-TREATMENT
intake	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
one	CD	O	O
liter	NN	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

on	IN	O	O
the	DT	O	O
14th	CD	O	O
of	IN	O	O
january	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
developed	VBD	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
shortness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
was	VBD	O	O
taken	VBN	O	O
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
wedge	NN	I-PROBLEM	I-PROBLEM
shaped	VBN	I-PROBLEM	I-PROBLEM
infiltrate	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
upper	NN	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
consistent	JJ	O	O
with	IN	O	O
hampton	NN	B-PROBLEM	B-PROBLEM
&apos;s	NNP	I-PROBLEM	I-PROBLEM
hump	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

also	RB	O	O
a	DT	B-TEST	B-TEST
vq	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
obtained	VBD	O	O
the	DT	O	O
next	JJ	O	O
day	NN	O	O
showed	VBD	O	O
high	JJ	O	B-PROBLEM
probability	NN	O	I-PROBLEM
for	IN	O	O
pe	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

so	IN	O	O
we	PRP	O	O
proceeded	VBD	O	O
to	TO	O	O
put	VB	O	O
her	PRP$	O	O
on	IN	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
anticoagulation	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
then	RB	O	O
when	WRB	O	O
she	PRP	O	O
was	VBD	O	O
therapeutic	JJ	O	O
on	IN	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
we	PRP	O	O
went	VBD	O	O
ahead	RB	O	O
and	CC	O	O
started	VBD	O	O
her	PRP$	O	O
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
she	PRP	O	O
is	VBZ	O	O
currently	RB	O	O
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
2.5	CD	O	O
mg	NNS	O	O
q.h.s.	NN	O	O

her	PRP$	B-TEST	B-TEST
inr	NN	I-TEST	I-TEST
is	VBZ	O	O
2.3	CD	O	O
.	.	O	O

we	PRP	O	O
want	VBP	O	O
her	PRP$	B-TEST	O
inr	NN	I-TEST	O
to	TO	O	O
remain	VB	O	O
between	IN	O	O
2	CD	O	O
and	CC	O	O
3	CD	O	O
.	.	O	O

so	RB	O	O
if	IN	O	O
it	PRP	O	O
goes	VBZ	O	O
much	RB	O	O
lower	JJR	O	O
than	IN	O	O
2	CD	O	O
,	,	O	O
then	RB	O	O
we	PRP	O	O
would	MD	O	O
consider	VB	O	O
increasing	VBG	O	O
it	PRP	O	O
to	TO	O	O
perhaps	RB	O	O
coumadin	VB	B-TREATMENT	B-TREATMENT
2.5	CD	O	O
and	CC	O	O
5	CD	O	O
alternating	NN	O	O
every	DT	O	O
other	JJ	O	O
night	NN	O	O
.	.	O	O

other	JJ	O	B-PROBLEM
major	JJ	O	I-PROBLEM
issues	NNS	O	I-PROBLEM
-	:	O	O
as	IN	O	O
a	DT	O	O
result	NN	O	O
of	IN	O	O
all	PDT	O	O
the	DT	O	O
things	NNS	O	O
happened	VBD	O	O
and	CC	O	O
with	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
hyponatremia	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
also	RB	O	O
the	DT	B-PROBLEM	B-PROBLEM
other	JJ	I-PROBLEM	I-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
her	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
elevated	VBN	B-PROBLEM	O
also	RB	O	O
.	.	O	O

we	PRP	O	O
put	VBD	O	O
her	PRP	O	O
on	IN	O	O
nifedipine	NN	B-TREATMENT	B-TREATMENT
ir	NN	I-TREATMENT	O
,	,	O	O
sl	NN	O	O
and	CC	O	O
that	DT	O	O
was	VBD	O	O
not	RB	O	O
enough	RB	O	O
to	TO	O	O
control	VB	O	O
her	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
which	WDT	O	O
was	VBD	O	O
in	IN	O	O
the	DT	O	O
200s	CD	O	O
in	IN	O	O
the	DT	B-TEST	O
systolic	NN	I-TEST	O
,	,	O	O
so	IN	O	O
we	PRP	O	O
had	VBD	O	O
started	VBN	O	O
her	PRP$	O	O
on	IN	O	O
atenolol	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

so	RB	O	O
on	IN	O	O
discharge	NN	O	O
she	PRP	O	O
is	VBZ	O	O
on	IN	O	O
atenolol	JJ	B-TREATMENT	B-TREATMENT
100	CD	O	O
.	.	O	O

if	IN	O	O
needed	VBN	O	O
to	TO	O	O
you	PRP	O	O
can	MD	O	O
give	VB	O	O
her	PRP$	O	O
some	DT	B-TREATMENT	O
nifedipine	JJ	I-TREATMENT	B-TREATMENT
sl	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
decrease	VB	O	O
her	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
has	VBZ	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
both	DT	I-PROBLEM	O
arms	NNS	I-PROBLEM	O
now	RB	O	O
and	CC	O	O
also	RB	O	O
some	DT	B-PROBLEM	B-PROBLEM
mild	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremities	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
so	IN	O	O
i	JJ	O	O
think	VBP	O	O
that	IN	O	O
fluid	JJ	B-TREATMENT	B-TREATMENT
restriction	NN	I-TREATMENT	I-TREATMENT
should	MD	O	O
help	VB	O	O
with	IN	O	O
that	DT	O	O
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
also	RB	O	O
a	DT	B-PROBLEM	O
little	JJ	I-PROBLEM	O
dry	JJ	I-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
on	IN	O	O
oxygen	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

ever	RB	O	O
since	IN	O	O
the	DT	B-PROBLEM	O
pulmonary	JJ	I-PROBLEM	O
embolus	NN	I-PROBLEM	O
she	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
on	IN	O	O
oxygen	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
on	IN	O	O
4	CD	B-TREATMENT	O
liters	NNS	I-TREATMENT	O
;	:	O	O
now	RB	O	O
she	PRP	O	O
is	VBZ	O	O
on	IN	O	O
5	CD	B-TREATMENT	O
liters	NNS	I-TREATMENT	O
,	,	O	O
sating	VBG	B-TEST	O
94	CD	O	O
to	TO	O	O
96%	CD	O	O
on	IN	O	O
5	CD	B-TREATMENT	O
liters	NNS	I-TREATMENT	O
.	.	O	O

we	PRP	O	O
would	MD	O	O
like	VB	O	O
for	IN	O	O
her	PRP$	O	O
to	TO	O	O
remain	VB	O	O
on	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
oxygen	NN	I-TREATMENT	I-TREATMENT
as	RB	O	O
well	RB	O	O
.	.	O	O

the	DT	B-PROBLEM	O
complications	NNS	I-PROBLEM	O
that	IN	O	O
i	NN	O	O
have	VBP	O	O
listed	VBN	O	O
include	VBP	O	O
the	DT	B-PROBLEM	B-PROBLEM
hyponatremia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
embolus	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
also	RB	O	O
the	DT	B-PROBLEM	O
elevatd	NN	I-PROBLEM	O
blood	NN	I-PROBLEM	B-TEST
pressure	NN	I-PROBLEM	I-TEST
.	.	O	O

discharge	NN	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
-	:	O	O
baclofen	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O
,	,	O	O
mvi	VB	B-TREATMENT	O
one	CD	O	O
tablet	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
,	,	O	O
mycostatin	NN	B-TREATMENT	B-TREATMENT
powder	NN	I-TREATMENT	I-TREATMENT
tp	NN	I-TREATMENT	O
q.d.	NN	O	O
to	TO	O	O
be	VB	O	O
applied	VBN	O	O
to	TO	O	O
the	DT	B-PROBLEM	B-PROBLEM
rash	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
groin	JJ	I-PROBLEM	I-PROBLEM
area	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
also	RB	O	O
dilaudid	VBZ	B-TREATMENT	B-TREATMENT
8	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q2h	NN	O	O
,	,	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
coumadin	VBP	B-TREATMENT	B-TREATMENT
2.5	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.h.s.	NN	O	O
fentanyl	JJ	B-TREATMENT	B-TREATMENT
patch	NN	I-TREATMENT	I-TREATMENT
75	CD	O	O
micrograms	NNS	O	O
per	IN	O	O
hour	NN	O	O
topical	JJ	O	O
q72	NN	O	O
hours	NNS	O	O
,	,	O	O
atenolol	RB	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
q.d.	NN	O	O

she	PRP	O	O
remains	VBZ	O	O
very	RB	B-PROBLEM	B-PROBLEM
weak	JJ	I-PROBLEM	I-PROBLEM
and	CC	O	O
will	MD	O	O
most	RBS	O	O
likely	JJ	O	O
benefit	NN	O	O
from	IN	O	O
some	DT	B-TREATMENT	O
physical	JJ	I-TREATMENT	O
therapy	NN	I-TREATMENT	O
andshe	NN	O	O
still	RB	O	O
has	VBZ	O	O
the	DT	B-PROBLEM	B-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
to	TO	O	O
go	VB	O	O
to	TO	O	O
the	DT	O	O
necsoncardel	JJ	O	O
medical	JJ	O	O
center	NN	O	O
for	IN	O	O
more	JJR	B-TREATMENT	O
chronic	JJ	I-TREATMENT	B-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
very	RB	O	O
limited	JJ	O	O
in	IN	O	O
how	WRB	O	O
much	JJ	O	O
she	PRP	O	O
can	MD	O	O
do	VB	O	O
right	RB	O	O
now	RB	O	O
because	IN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
primarily	RB	O	O
and	CC	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
difficulty	NN	I-PROBLEM	I-PROBLEM
breathing	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
mother	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
prenatal	JJ	I-TEST	I-TEST
screens	NNS	I-TEST	I-TEST
were	VBD	O	O
blood	NN	B-TEST	B-TEST
type	NN	I-TEST	I-TEST
b	NN	O	O
positive	JJ	O	O
,	,	O	O
antibody	JJ	B-TEST	B-TEST
negative	JJ	O	O
,	,	O	O
rubella	NN	B-TEST	B-TEST
immune	NN	O	O
,	,	O	O
rpr	NN	B-TEST	O
nonreactive	JJ	O	O
,	,	O	O
hepatitis	JJ	B-TEST	B-TEST
surface	NN	I-TEST	I-TEST
antigen	NN	I-TEST	I-TEST
negative	JJ	O	O
and	CC	O	O
group	NN	B-TEST	B-TEST
b	VBP	I-TEST	I-TEST
strep	NN	I-TEST	I-TEST
negative	JJ	O	O
.	.	O	O

this	DT	O	O
pregnancy	NN	O	O
was	VBD	O	O
complicated	VBN	O	O
by	IN	O	O
a	DT	O	O
prenatal	JJ	O	O
diagnosis	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
congenital	JJ	I-PROBLEM	I-PROBLEM
cystic	JJ	I-PROBLEM	I-PROBLEM
adenomatoid	NN	I-PROBLEM	I-PROBLEM
malformation	NN	I-PROBLEM	I-PROBLEM

(	(	O	O
ccam	NN	B-PROBLEM	O
).	NN	O	O

the	DT	O	O
infant	NN	O	O
emerged	VBD	O	O
vigorous	JJ	O	O
with	IN	O	O
apgars	NNS	B-TEST	B-TEST
of	IN	O	O
9	CD	O	O
at	IN	O	O
one	CD	O	O
and	CC	O	O
five	CD	O	O
minutes	NNS	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
birth	NN	I-TEST	I-TEST
weight	NN	I-TEST	I-TEST
was	VBD	O	O
2905	CD	O	O
grams	NNS	O	O
.	.	O	O

wt	NN	B-TEST	B-TEST
2905	CD	O	O
gm	NN	O	O

length	NN	B-TEST	B-TEST
19	CD	O	O
inches	NNS	O	O

hc	NN	B-TEST	O
34.5	CD	O	O
cm	NN	O	O

his	PRP$	B-TEST	B-TEST
admission	NN	I-TEST	I-TEST
physical	JJ	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
reveals	VBZ	O	O
a	DT	B-PROBLEM	O
vigorous	JJ	I-PROBLEM	O
nondysmorphic	JJ	I-PROBLEM	O
term	NN	O	O
infant	NN	O	O
.	.	O	O

red	JJ	B-TEST	B-TEST
reflex	NN	I-TEST	I-TEST
not	RB	O	O
checked	VBN	O	O
.	.	O	O

neck	NN	O	O
supple	NN	O	O
and	CC	O	O
without	IN	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

lungs	NNS	O	O
clear	JJ	O	O
bilaterally	RB	O	O
with	IN	O	O
slightly	RB	B-PROBLEM	B-PROBLEM
decreased	VBN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
sounds	NNS	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
symmetric	JJ	O	B-PROBLEM
chest	JJS	O	I-PROBLEM
rise	NN	O	I-PROBLEM
and	CC	O	O
fall	NN	O	B-PROBLEM
.	.	O	O

heart	NN	O	O
was	VBD	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
no	DT	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

femoral	JJ	B-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
present	JJ	O	O
bilaterally	RB	O	O
.	.	O	O

abdomen	NNS	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBD	B-PROBLEM	B-PROBLEM
,	,	O	O
active	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
.	.	O	O

no	DT	O	O
sacral	JJ	B-PROBLEM	B-PROBLEM
anomalies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
remained	VBN	O	O
in	IN	O	O
room	NN	O	O
air	NN	O	O
well	RB	O	O
saturated	VBN	O	O
with	IN	O	O
comfortable	JJ	O	B-PROBLEM
respirations	NNS	O	I-PROBLEM
until	IN	O	O
approximately	RB	O	O
22	CD	O	O
hours	NNS	O	O
of	IN	O	O
age	NN	O	O
when	WRB	O	O
he	PRP	O	O
started	VBD	O	O
with	IN	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
work	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breathing	VBG	I-PROBLEM	I-PROBLEM
although	IN	O	O
he	PRP	O	O
has	VBZ	O	O
remained	VBN	O	O
well-saturated	JJ	O	O
in	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
was	VBD	O	O
initially	RB	O	O
remarkable	JJ	O	O
for	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
mediastinal	JJ	I-PROBLEM	I-PROBLEM
shift	NN	I-PROBLEM	I-PROBLEM
due	JJ	O	O
to	TO	O	O
the	DT	B-PROBLEM	B-PROBLEM
right-sided	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
shift	NN	I-PROBLEM	I-PROBLEM
present	NN	O	I-PROBLEM
on	IN	O	I-PROBLEM
the	DT	B-TEST	I-PROBLEM
last	JJ	I-TEST	I-PROBLEM
x-ray	NN	I-TEST	I-PROBLEM
.	.	O	O

there	EX	O	O
are	VBP	O	O
no	DT	O	O
cardiovascular	JJ	B-PROBLEM	B-PROBLEM
issues	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
weight	NN	I-TEST	I-TEST
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
transfer	NN	O	O
is	VBZ	O	O
2800	CD	O	O
grams	NN	O	O
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
breast	VBN	O	O
feeding	NN	O	O
or	CC	O	O
taking	VBG	O	O
20	CD	O	O
calorie	NN	O	O
per	IN	O	O
ounce	NN	O	O
formula	NN	O	O
until	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
increased	JJ	I-PROBLEM	I-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
so	IN	O	O
that	DT	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
transfer	NN	O	O
he	PRP	O	O
is	VBZ	O	O
npo	JJ	B-TREATMENT	O
with	IN	O	O
a	DT	B-TREATMENT	O
peripheral	JJ	I-TREATMENT	O
iv	NN	I-TREATMENT	O
with	IN	O	O
total	JJ	B-TREATMENT	B-TEST
fluids	NNS	I-TREATMENT	I-TEST
of	IN	O	O
150	CD	O	O
ml	NNS	O	O
/	JJ	O	O
kg	JJ	O	O
/	NNP	O	O
day	NN	O	O
of	IN	O	O
10%	CD	B-TREATMENT	B-TREATMENT
dextrose	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
electrolytes	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
had	VBN	O	O
no	DT	O	O
blood	NN	B-TEST	B-PROBLEM
work	NN	I-TEST	I-PROBLEM
except	IN	O	O
for	IN	O	O
blood	NN	B-TEST	B-TEST
glucose	NN	I-TEST	I-TEST
checks	NNS	I-TEST	I-TEST
and	CC	O	O
he	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
euglycemic	JJ	O	O
throughout	IN	O	O
his	PRP$	O	O
cmed	JJ	O	O
stay	NN	O	O
with	IN	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
glucose	NN	I-TEST	I-TEST
being	VBG	O	O
in	IN	O	O
the	DT	O	O
70s	CD	O	O
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
not	RB	O	O
had	VBN	O	O
a	DT	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
checked	VBN	O	O
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
not	RB	O	O
had	VBN	O	O
any	DT	B-TEST	O
blood	NN	I-TEST	B-TEST
work	NN	I-TEST	I-TEST
done	VBN	O	O
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
had	VBN	O	O
no	DT	O	O
antibiotic	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
or	CC	O	O
blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
sent	VBD	O	O
.	.	O	O

hearing	VBG	B-TEST	B-TEST
screening	NN	I-TEST	I-TEST
is	VBZ	O	O
recommended	VBN	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
is	VBZ	O	O
discharged	VBN	O	O
in	IN	O	O
guarded	JJ	B-PROBLEM	B-PROBLEM
condition	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
being	VBG	O	O
transferred	VBN	O	O
to	TO	O	O
massachusetts	VB	O	O
general	JJ	O	O
hospital	NN	O	O
newborn	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
continuing	VBG	B-TREATMENT	B-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
infant	NN	O	O
is	VBZ	O	O
npo	JJ	B-TREATMENT	O
.	.	O	O

2.	CD	O	O
he	PRP	O	O
is	VBZ	O	O
on	IN	O	O
peripheral	JJ	B-TREATMENT	O
iv	NN	I-TREATMENT	O
of	IN	O	O
total	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
150	CD	O	O
ml	NNS	O	O
/	JJ	O	O
kg	JJ	O	O
/	NNP	O	O
day	NN	O	O
of	IN	O	O
10%	CD	O	B-TREATMENT
dextrose	NN	B-TREATMENT	I-TREATMENT
with	IN	O	O
2	CD	O	O
meq	NNS	O	O
of	IN	O	O
sodium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
per	IN	O	O
100	CD	O	O
ml	NN	O	O
and	CC	O	O
1	CD	O	O
meq	NN	O	O
of	IN	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
per	IN	O	O
100	CD	O	O
ml	NN	O	O
.	.	O	O

3.	LS	O	O
he	PRP	O	O
has	VBZ	O	O
not	RB	O	O
had	VBN	O	O
a	DT	B-TEST	B-TEST
car	NN	I-TEST	I-TEST
seat	NN	I-TEST	I-TEST
position	NN	I-TEST	I-TEST
screening	VBG	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
.	.	O	O

4.	CD	O	O
a	DT	B-TEST	B-TEST
state	NN	I-TEST	I-TEST
newborn	JJ	I-TEST	I-TEST
screen	NN	I-TEST	I-TEST
will	MD	O	O
be	VB	O	O
done	VBN	O	O
prior	RB	O	O
to	TO	O	O
transfer	VB	O	O
.	.	O	O

5.	CD	O	O
he	PRP	O	O
has	VBZ	O	O
received	VBN	O	O
no	DT	O	O
immunizations	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

2.	CD	O	O
right-sided	JJ	B-PROBLEM	B-PROBLEM
congenital	JJ	I-PROBLEM	I-PROBLEM
cystic	JJ	I-PROBLEM	I-PROBLEM
adenomatoid	NN	I-PROBLEM	I-PROBLEM
malformation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
presented	VBN	O	O
with	IN	O	O
a	DT	O	O
chief	JJ	O	O
complaint	NN	O	O
of	IN	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
lethargy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

following	VBG	O	O
evaluation	NN	B-TEST	B-TEST
and	CC	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
the	DT	O	O
patient	NN	O	O
&apos;s	JJ	O	O
disposition	NN	O	O
at	IN	O	O
the	DT	O	O
end	NN	O	O
of	IN	O	O
the	DT	O	O
visit	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
as	IN	O	O
an	DT	O	O
inpatient	NN	O	O
to	TO	O	O
tecal	JJ	O	O
galencounxopt	NN	O	O
community	NN	O	O
hospital	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
preliminary	JJ	O	O
admitting	VBG	O	O
physician	NN	O	O
is	VBZ	O	O
scimewhildajesc	JJ	O	O
,	,	O	O
la	JJ	O	O
r	NN	O	O
and	CC	O	O
the	DT	O	O
preliminary	JJ	O	O
diagnosis	NN	O	O
is	VBZ	O	O
dehydration	JJ	B-PROBLEM	B-PROBLEM
..	NNS	O	I-PROBLEM

lorazepam	NN	B-TREATMENT	B-TREATMENT
/	NN	O	O
penicillins	VBZ	B-TREATMENT	B-TREATMENT
/	NNP	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
/	NNP	O	O
hydrochlorothiazide	NN	B-TREATMENT	B-TREATMENT
/	NNP	O	O
ceftriaxone	NN	B-TREATMENT	B-TREATMENT
/	NN	O	O
phenytoin	NN	B-TREATMENT	B-TREATMENT

chief	JJ	O	O
complaint	NN	O	O
:	:	O	O
progressing	VBG	B-PROBLEM	O
slowing	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
mentation	NN	I-PROBLEM	B-PROBLEM
and	CC	O	I-PROBLEM
gait	NN	B-PROBLEM	I-PROBLEM
difficulties	NNS	I-PROBLEM	I-PROBLEM
since	IN	O	O
a	DT	O	O
week	NN	O	O
;	:	O	O
evaluation	NN	B-TEST	B-TEST
for	IN	O	O
ich	NN	B-PROBLEM	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
83	CD	O	O
yo	JJ	O	O
r-handed	JJ	O	O
man	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
intracranial	JJ	I-PROBLEM	I-PROBLEM
hemorrhages	NNS	I-PROBLEM	I-PROBLEM
during	IN	O	O
the	DT	O	O
last	JJ	O	O
few	JJ	O	O
years	NNS	O	O
,	,	O	O
pacemaker	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
hyperlipidemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
arrhythmia	NN	B-PROBLEM	B-PROBLEM
who	WP	O	O
now	RB	O	O
presents	VBZ	O	O
with	IN	O	O
gradual	JJ	B-PROBLEM	B-PROBLEM
decline	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
gait	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
slowing	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
mentation	NN	I-PROBLEM	I-PROBLEM
over	IN	O	O
the	DT	O	O
last	JJ	O	O
week	NN	O	O
.	.	O	O

according	VBG	O	O
to	TO	O	O
his	PRP$	O	O
wife	NN	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
abrasion	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
the	DT	O	O
top	NN	O	O
of	IN	O	O
his	PRP$	O	O
head	NN	O	O
,	,	O	O
but	CC	O	O
nothing	NN	O	O
major	JJ	O	O
.	.	O	O

he	PRP	O	O
did	VBD	O	O
not	RB	O	O
complain	VB	O	O
about	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
headache	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
at	IN	O	O
baseline	NN	O	O
with	IN	O	O
respect	NN	O	O
to	TO	O	O
his	PRP$	O	B-PROBLEM
gait	NN	O	I-PROBLEM
(	(	O	O
at	IN	O	O
baseline	NN	O	O
unsteady	JJ	B-PROBLEM	O
,	,	O	O
though	IN	O	O
he	PRP	O	O
refuses	VBZ	O	O
to	TO	O	O
walk	VB	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
walker	NN	I-TREATMENT	I-TREATMENT
)	)	O	I-TREATMENT
and	CC	O	O
his	PRP$	O	B-TEST
mentation	NN	O	I-TEST
(	(	O	O
at	IN	O	O
baseline	NN	O	O
difficulties	NNS	B-PROBLEM	O
with	IN	I-PROBLEM	O
memory	NN	I-PROBLEM	O
since	IN	O	O
months	NNS	O	O
;	:	O	O
keeps	VBZ	O	O
forgetting	VBG	O	O
appointments	NNS	O	O
).	VB	O	O

then	RB	O	O
about	IN	O	O
a	DT	O	O
week	NN	O	O
ago	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
and	CC	O	O
his	PRP$	O	O
wife	NN	O	O
noted	VBD	O	O
that	IN	O	O
his	PRP$	O	B-PROBLEM
gait	NN	O	I-PROBLEM
became	VBD	O	O
even	RB	B-PROBLEM	B-PROBLEM
more	RBR	I-PROBLEM	I-PROBLEM
unsteady	JJ	I-PROBLEM	I-PROBLEM
,	,	O	O
though	IN	O	O
he	PRP	O	O
did	VBD	O	O
not	RB	O	O
fall	VB	O	O
.	.	O	O

he	PRP	O	O
also	RB	O	O
had	VBD	O	O
difficulties	NNS	B-PROBLEM	B-PROBLEM
navigating	VBG	O	O
through	IN	O	O
his	PRP$	O	O
apartment	NN	O	O
,	,	O	O
having	VBG	O	O
difficulties	NNS	B-PROBLEM	B-PROBLEM
finding	VBG	O	I-PROBLEM
the	DT	O	I-PROBLEM
fridge	NN	O	I-PROBLEM
for	IN	O	O
example	NN	O	O
.	.	O	O

they	PRP	O	O
were	VBD	O	O
concerned	VBN	O	O
that	IN	O	O
the	DT	O	B-PROBLEM
fall	NN	O	I-PROBLEM
might	MD	O	O
have	VB	O	O
caused	VBN	O	O
another	DT	B-PROBLEM	B-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
as	IN	O	O
had	VBD	O	O
happened	VBN	O	O
in	IN	O	O
the	DT	O	O
past	NN	O	O
,	,	O	O
and	CC	O	O
this	DT	O	O
prompted	VBD	O	O
them	PRP	O	O
to	TO	O	O
come	VB	O	O
to	TO	O	O
the	DT	O	O
deanna	NN	O	O
.	.	O	O

no	DT	O	O
headache	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
neckpain	NN	B-PROBLEM	O
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
or	CC	O	O
focal	JJ	B-PROBLEM	B-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
/	NNP	O	O
numbness	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

review	NN	O	O
of	IN	O	O
systems	NNS	O	O
:	:	O	O
denies	VBZ	O	O
any	DT	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
weight	JJ	B-PROBLEM	B-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
visual	JJ	B-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
hearing	NN	B-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
dysphagia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
tingling	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
numbness	RB	B-PROBLEM	B-PROBLEM
,	,	O	O
bowel-bladder	JJ	B-PROBLEM	B-PROBLEM
dysfunction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
dysuria	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hematuria	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
bright	RB	B-PROBLEM	B-PROBLEM
red	JJ	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
per	IN	I-PROBLEM	I-PROBLEM
rectum	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	O	O
legs	NNS	O	O
have	VBP	O	O
been	VBN	O	O
feeling	VBG	O	B-PROBLEM
weaker	NN	B-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	O
bilaterally	RB	I-PROBLEM	O
since	IN	O	O
the	DT	O	O
last	JJ	O	O
week	NN	O	O
.	.	O	O

1.	CD	O	O
previous	JJ	B-PROBLEM	B-PROBLEM
interventricular	JJ	I-PROBLEM	I-PROBLEM
hemorrhages	NNS	I-PROBLEM	I-PROBLEM
:	:	O	O

06-30	JJ	O	O
resolved	VBD	O	O
as	IN	O	O
of	IN	O	O
repeat	NN	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
ct	VBP	I-TEST	I-TEST
one	CD	O	O
month	NN	O	O
later	RB	O	O
,	,	O	O
no	DT	O	O
residual	JJ	B-PROBLEM	O
deficits;	NN	I-PROBLEM	O
03-03	NN	O	O
:	:	O	O
ich	NN	B-PROBLEM	O
in	IN	I-PROBLEM	O
3rd	CD	I-PROBLEM	O
,	,	I-PROBLEM	O
4th	CD	I-PROBLEM	O
,	,	I-PROBLEM	O
and	CC	I-PROBLEM	O
l-lat	JJ	I-PROBLEM	B-PROBLEM
ventricle	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
no	DT	O	O
aneurysm	NN	B-PROBLEM	B-PROBLEM
;	:	O	O
07-01	JJ	O	O
:	:	O	O
ich	NN	B-PROBLEM	O
in	IN	I-PROBLEM	O
r-temporal	JJ	I-PROBLEM	B-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
question	NN	O	O
of	IN	O	O
underlying	VBG	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
that	DT	O	O
time	NN	O	O
per	IN	O	O
contrast	NN	B-TEST	O
ct	NN	I-TEST	O
;	:	O	O
decided	VBD	O	O
to	TO	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
serial	JJ	B-TEST	B-TEST
scans	NNS	I-TEST	I-TEST
rather	RB	O	O
than	IN	O	O
to	TO	O	O
biopsy	VB	B-TEST	B-TEST

2.	CD	O	O
pacemaker	NN	B-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
arrhythmia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
afibb	NN	B-PROBLEM	O
;	:	O	O
during	IN	O	O
last	JJ	O	O
hospitalization	NN	O	O
episodes	NNS	O	O
of	IN	O	O
nsvt	NN	B-PROBLEM	B-PROBLEM

3.	CD	O	O
history	NN	O	O
of	IN	O	O
slowness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
gait	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
?	.	O	O
parkinsons	NNS	B-PROBLEM	B-PROBLEM
?	.	O	O
and	CC	O	O
possibly	RB	O	O
dementia	NN	B-PROBLEM	B-PROBLEM
followed	VBN	O	O
by	IN	O	O
dr.	NN	O	O
ahern	NN	O	O
(	(	O	O
laurence	NN	O	O
eichorn	VBN	O	O
).	NN	O	O

sinemet	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
stopped	VBN	O	O
during	IN	O	O
last	JJ	O	O
admission	JJ	O	O
06-30	NN	O	O
as	IN	O	O
he	PRP	O	O
was	VBD	O	O
thought	VBN	O	O
to	TO	O	O
not	RB	O	O
have	VB	O	O
pd	NN	B-PROBLEM	O
.	.	O	O

4.	CD	O	O
depression	NN	B-PROBLEM	B-PROBLEM

5.	CD	O	O
copd	NN	B-PROBLEM	B-PROBLEM

6.	CD	O	O
hyperlipidemia	NN	B-PROBLEM	B-PROBLEM

7.	CD	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
cataract	NN	I-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT

8.	CD	O	O
orthostatic	JJ	B-PROBLEM	B-PROBLEM
hypotension	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
on	IN	O	O
midodrine	NN	B-TREATMENT	B-TREATMENT

wife	NN	O	O
states	NNS	O	O
that	IN	O	O
he	PRP	O	O
would	MD	O	O
not	RB	O	O
want	VB	O	O
to	TO	O	O
be	VB	O	O
recussitated	VBN	O	O
,	,	O	O
and	CC	O	O
that	IN	O	O
osh	NN	O	O
placed	VBD	O	O
ett	NN	B-TREATMENT	O
before	IN	O	O
asking	VBG	O	O
her	PRP$	O	O
.	.	O	O

family	NN	O	O
history	NN	O	O
:	:	O	O
no	DT	O	O
kids	NNS	O	O
,	,	O	O
no	DT	O	O
bleeds	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
strokes	NNS	B-PROBLEM	B-PROBLEM
in	IN	O	O
other	JJ	O	O
family	NN	O	O
members	NNS	O	O

vitals	NNS	B-TEST	B-TEST
:	:	O	O

96.7	CD	O	O
hr60	NN	B-TEST	O
bp153/52	NN	B-TEST	O
,	,	O	O
later	RB	O	O
178/85	CD	O	O
rr	NNS	B-TEST	B-TEST
18t	CD	O	O
so298%	NNS	B-TEST	O
ra	NN	I-TEST	O

nad	NN	B-PROBLEM	O
,	,	O	O
in	IN	O	O
bed	NN	O	O

neck	NN	O	O
:	:	O	O
no	DT	O	O
lad	NN	B-PROBLEM	O
;	:	O	O
no	DT	O	O
carotid	NN	B-PROBLEM	B-PROBLEM
bruits	VBZ	I-PROBLEM	I-PROBLEM
;	:	O	O
limited	JJ	B-PROBLEM	B-PROBLEM
range	NN	I-PROBLEM	I-PROBLEM
neck	NN	I-PROBLEM	I-PROBLEM
movements	NNS	I-PROBLEM	I-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM

clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	O	O

regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
normal	JJ	O	O
s1	NN	O	O
and	CC	O	O
s2	NN	O	O
,	,	O	O
no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
gallops	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
rubs	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

abdomen	NNS	O	O
:	:	O	O
normal	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
,	,	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBD	B-PROBLEM	B-PROBLEM

extremities	NNS	O	O
:	:	O	O
no	DT	O	O
edema;	NN	B-PROBLEM	B-PROBLEM
cold	JJ	B-PROBLEM	I-PROBLEM
feet	NNS	I-PROBLEM	I-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM

awake	NN	O	O
and	CC	O	O
alert	NN	O	O
,	,	O	O
cooperative	JJ	O	O
with	IN	O	O
exam	JJ	B-TEST	B-TEST
,	,	O	O
normal	JJ	O	O
affect	NN	O	O
;	:	O	O
facial	JJ	B-PROBLEM	B-PROBLEM
expression	NN	I-PROBLEM	I-PROBLEM
somewhat	RB	I-PROBLEM	I-PROBLEM
sparse	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

language	NN	O	O
:	:	O	O
fluent	NN	O	O
;	:	O	O
repetition	NN	O	O
:	:	O	O
intact	JJ	O	O
;	:	O	O
naming	VBG	O	O
intact	JJ	O	O
;	:	O	O
comprehension	NN	O	O
intact	NN	O	O
;	:	O	O
no	DT	O	O
dysarthria	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
paraphasic	JJ	B-PROBLEM	B-PROBLEM
errors	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

3d-construction	NN	O	O
:	:	O	O
poor	JJ	O	O
,	,	O	O
difficulties	NNS	B-PROBLEM	B-PROBLEM
putting	VBG	I-PROBLEM	I-PROBLEM
handles	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
clock	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
no	DT	O	O
apraxia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
neglect	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

extraocular	JJ	O	O
movements	NNS	O	O
intact	JJ	O	O
with	IN	O	O
few	JJ	O	B-PROBLEM
beats	NNS	O	I-PROBLEM
of	IN	O	I-PROBLEM
horizontal	JJ	B-PROBLEM	I-PROBLEM
endgaze	NN	I-PROBLEM	I-PROBLEM
nystagmus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

limited	VBN	B-PROBLEM	O
cmed	VBD	I-PROBLEM	O
ccu	JJ	I-PROBLEM	O
movements	NNS	I-PROBLEM	O
in	IN	I-PROBLEM	O
upgaze	NN	I-PROBLEM	O
.	.	O	O

facial	JJ	O	O
sensation	NN	O	O
intact	JJ	O	O
to	TO	O	O
light	JJ	B-TEST	B-TEST
touch	NN	I-TEST	I-TEST
and	CC	O	O
pinprick	NN	B-TEST	B-TEST
.	.	O	O

facial	JJ	O	B-PROBLEM
movement	NN	O	I-PROBLEM
symmetrical	NN	O	I-PROBLEM
;	:	O	O
no	DT	O	O
facial	JJ	B-PROBLEM	B-PROBLEM
droop	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

hearing	VBG	O	O
intact	JJ	O	O
to	TO	O	O
finger	VB	B-TEST	O
rub	VB	I-TEST	O
bilaterally	RB	O	O
.	.	O	O

tongue	NN	O	B-PROBLEM
protrudes	NNS	O	I-PROBLEM
in	IN	O	I-PROBLEM
midline	NN	O	I-PROBLEM
,	,	O	O
no	DT	O	O
fasciculations	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

decreased	VBN	B-PROBLEM	B-PROBLEM
bulk	NN	I-PROBLEM	I-PROBLEM
throughout	IN	I-PROBLEM	O
;	:	O	O
tone	NN	O	O
normal	JJ	O	O
bilaterally	RB	O	O
.	.	O	O

no	DT	O	O
adventitious	JJ	B-PROBLEM	B-PROBLEM
movements	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
tremor	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
asterixis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

d	LS	B-TEST	O
-	:	O	O
5	CD	O	O
;	:	O	O
t	SYM	B-TEST	B-TEST
-	:	O	O
5	CD	O	O
;	:	O	O
b	SYM	B-TEST	O
-	:	O	O
5	CD	O	O
;	:	O	O
wf	SYM	B-TEST	B-TEST
-	:	O	O
5	CD	O	O
;	:	O	O
we	PRP	B-TEST	O
-	:	O	O
5	CD	O	O
;	:	O	O
fif	SYM	B-TEST	B-TEST
-	:	O	O
5	CD	O	O
;	:	O	O
bruner	SYM	B-TEST	B-TEST
-	:	O	O
5	CD	O	O
;	:	O	O
ip	JJ	B-TEST	O
-	:	O	O
5	CD	O	O
;	:	O	O
gl	SYM	B-TEST	B-TEST
-	:	O	O
5	CD	O	O
;	:	O	O
q	JJ	B-TEST	O
-	:	O	O
5-	JJ	O	O
;	:	O	O
h	PRP$	B-TEST	O
-	:	O	O
5	CD	O	O
;	:	O	O
af	SYM	B-TEST	B-TEST
-	:	O	O
5	CD	O	O
;	:	O	O
tf	SYM	B-TEST	O
-	:	O	O
5	CD	O	O
;	:	O	O
te	SYM	B-TEST	O
-	:	O	O
5	CD	O	O

d	LS	B-TEST	O
-	:	O	O
5	CD	O	O
;	:	O	O
t	SYM	B-TEST	B-TEST
-	:	O	O
5	CD	O	O
;	:	O	O
b	SYM	B-TEST	O
-	:	O	O
5	CD	O	O
;	:	O	O
wf	SYM	B-TEST	B-TEST
-	:	O	O
5	CD	O	O
;	:	O	O
we	PRP	B-TEST	O
-	:	O	O
5	CD	O	O
;	:	O	O
fif	SYM	B-TEST	B-TEST
-	:	O	O
5	CD	O	O
;	:	O	O
bruner	SYM	B-TEST	B-TEST
-	:	O	O
5	CD	O	O
;	:	O	O
ip	JJ	B-TEST	O
-	:	O	O
5	CD	O	O
;	:	O	O
gl	SYM	B-TEST	B-TEST
-	:	O	O
5	CD	O	O
;	:	O	O
q	JJ	B-TEST	O
-	:	O	O
5-	JJ	O	O
;	:	O	O
h	PRP$	B-TEST	O
-	:	O	O
5	CD	O	O
;	:	O	O
af	SYM	B-TEST	B-TEST
-	:	O	O
5	CD	O	O
;	:	O	O
tf	SYM	B-TEST	O
-	:	O	O
5	CD	O	O
;	:	O	O
te	JJ	B-TEST	O
-	:	O	O
5-	JJ	O	O

no	DT	O	O
pronator	NN	B-PROBLEM	B-PROBLEM
drift	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
rebound	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

sensation	NN	O	O
intact	JJ	O	O
to	TO	O	O
light	JJ	B-TEST	B-TEST
touch	NN	I-TEST	I-TEST
,	,	O	O
pin	NN	B-TEST	B-TEST
prick	NN	I-TEST	I-TEST
,	,	O	O
temperature	NN	B-TEST	B-TEST
(	(	I-TEST	O
cold	JJ	I-TEST	O
)	)	I-TEST	O
.	.	O	O

decreased	VBN	B-PROBLEM	B-PROBLEM
vibration	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
feet	NNS	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
ankles	NNS	I-PROBLEM	I-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM
,	,	O	O
some	DT	O	B-PROBLEM
in	IN	O	I-PROBLEM
knees	NNS	O	I-PROBLEM
;	:	O	O
proprioception	NN	B-PROBLEM	B-PROBLEM
decreased	VBD	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
feet	NNS	I-PROBLEM	I-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM
.	.	O	O

reflexes	NNS	B-TEST	B-TEST
:	:	O	O

right	RB	B-TEST	O
b	SYM	I-TEST	O
-	:	O	O
2	CD	O	O
;	:	O	O
t	SYM	B-TEST	B-TEST
-	:	O	O
2	CD	O	O
;	:	O	O
br	SYM	B-TEST	B-TEST
-	:	O	O
2	CD	O	O
;	:	O	O
pa	SYM	B-TEST	B-TEST
-	:	O	O
1	CD	O	O
;	:	O	O
pl	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O

b	SYM	B-TEST	O
-	:	O	O
2	CD	O	O
;	:	O	O
t	SYM	B-TEST	B-TEST
-	:	O	O
2	CD	O	O
;	:	O	O
br	SYM	B-TEST	B-TEST
-	:	O	O
2	CD	O	O
;	:	O	O
pa	SYM	B-TEST	B-TEST
-	:	O	O
1	CD	O	O
;	:	O	O
pl	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
(	(	O	O
less	JJR	O	O
brisk	RB	O	O
than	IN	O	O
on	IN	O	O
r	NN	O	O
,	,	O	O
but	CC	O	O
exam	RB	B-TEST	B-TEST
limited	VBD	O	O
due	JJ	O	O
to	TO	O	O
cuff	VB	O	O
)	)	O	O

toes	NNS	O	O
:	:	O	O
mute	NN	O	O
bilaterally	RB	O	O
;	:	O	O
tfl	PRP	B-PROBLEM	O
contracted	VBD	I-PROBLEM	O
on	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
l	NN	I-PROBLEM	O
.	.	O	O

no	DT	O	O
dysmetria	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
pastpointing	NN	B-PROBLEM	O
.	.	O	O

(	(	O	O
later	RB	O	O
tested	VBN	O	O
and	CC	O	O
patient	JJ	O	O
markedly	RB	B-PROBLEM	B-PROBLEM
unstable	JJ	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
feet	NNS	I-PROBLEM	I-PROBLEM
)	)	O	I-PROBLEM

glucose	JJ	B-TEST	B-TEST
-	:	O	O
89	CD	O	O

ck	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
cpk	JJ	I-TEST	I-TEST
)-	CD	I-TEST	I-TEST
128	CD	O	O

ck	SYM	B-TEST	B-TEST
-	:	I-TEST	I-TEST
mb	NN	I-TEST	I-TEST
-	:	O	O
6	CD	O	O
ctropnt	NN	B-TEST	B-TEST
-<	CD	O	O
0.01	CD	O	O

2019-03-29	JJ	O	O
04:00	CD	O	O
pm	NN	O	O
urine	NN	B-TEST	O

2019-03-29	JJ	O	O
04:00	CD	O	O
pm	NN	O	O
urine	NN	B-TEST	O

gr	NN	B-TEST	O
hold	VBP	O	O
-	:	O	O
hold	NN	O	O

2019-03-29	JJ	O	O
04:00	CD	O	O
pm	NN	O	O
urine	NN	B-TEST	O

color	NN	B-TEST	B-TEST
-	:	O	O
straw	NN	O	O
appear	VBP	B-TEST	O
-	:	O	O
clear	JJ	O	O
sp	NN	B-TEST	O
stickney	NN	I-TEST	O
-	:	O	O
1.017	CD	O	O

2019-03-29	JJ	O	O
04:00	CD	O	O
pm	NN	O	O
urine	NN	B-TEST	O

blood	NN	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
nitrite	JJ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
protein	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
ketone	NN	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
bilirubin	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
urobilngn	JJ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
ph	SYM	B-TEST	B-TEST
-	:	O	O
7.0	CD	O	O
leuk	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O

glucose	JJ	B-TEST	B-TEST
-	:	O	O
72	CD	O	O
urea	JJ	B-TEST	B-TEST
n	SYM	I-TEST	I-TEST
-	:	O	O
17	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
0.8	CD	O	O
sodium	NN	B-TEST	B-TEST
-	:	O	O
140	CD	O	O
potassium	NN	B-TEST	B-TEST
-	:	O	O
4.4	CD	O	O
chloride	NN	B-TEST	B-TEST
-	:	O	O
103	CD	O	O
total	JJ	B-TEST	B-TEST
co2	NN	I-TEST	I-TEST
-	:	O	O
29	CD	O	O
anion	NN	B-TEST	B-TEST
gap	NN	I-TEST	I-TEST
-	:	O	O
12	CD	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
6.7	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
4.53	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
14.8	CD	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
44.6	CD	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
99	CD	O	O
*	NN	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
32.8	CD	O	O
*	NN	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
33.3	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
12.6	CD	O	O

neuts	NNS	B-TEST	B-TEST
-	:	O	O
65.5	CD	O	O
lymphs	SYM	B-TEST	B-TEST
-	:	O	O
25.8	CD	O	O
monos	NNS	B-TEST	B-TEST
-	:	O	O
7.0	CD	O	O
eos	SYM	B-TEST	B-TEST
-	:	O	O
1.4	CD	O	O
basos	SYM	B-TEST	B-TEST
-	:	O	O
0.2	CD	O	O

macrocyt	SYM	B-TEST	B-TEST
-	:	O	O
1+	CD	O	O

plt	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
-	:	O	O
213	CD	O	O

pt	SYM	B-TEST	B-TEST
-	:	O	O
12.3	CD	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
24.5	CD	O	O
inr	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
pt	JJ	I-TEST	I-TEST
)-	CD	I-TEST	I-TEST
1.1	CD	O	O

ct	NN	B-TEST	B-TEST
brain	NN	I-TEST	I-TEST
(	(	I-TEST	O
initial	JJ	I-TEST	O
)	)	I-TEST	O

there	EX	O	O
is	VBZ	O	O
a	DT	O	O
41	JJ	O	O
x	NN	O	O
23	CD	O	O
mm	JJ	O	O
area	NN	O	O
of	IN	O	O
hyperdensity	NN	B-PROBLEM	B-PROBLEM
within	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
frontal	NN	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
surrounding	VBG	I-PROBLEM	I-PROBLEM
vasogenic	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM

(	(	O	O
series	NN	O	O
2	CD	O	O
,	,	O	O
image	NN	O	O
23	CD	O	O
)	)	O	O
,	,	O	O
compatible	JJ	O	O
with	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
intraparenchymal	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
chronic	JJ	I-PROBLEM	I-PROBLEM
encephalomalacic	NN	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
adjacent	JJ	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
frontal	NN	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
the	DT	O	O
right	JJ	O	O
parietal	NN	O	O
/	NNP	O	O
occipital	JJ	O	B-PROBLEM
region	NN	O	I-PROBLEM
remain	VBP	O	O
stable	JJ	O	O
in	IN	O	O
appearance	NN	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
effect	NN	I-PROBLEM	I-PROBLEM
upon	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
anterior	JJ	I-PROBLEM	O
mims	NNS	I-PROBLEM	O
of	IN	O	O
the	DT	O	O
right	JJ	O	O
lateral	JJ	O	O
ventricle	NN	O	O
.	.	O	O

no	DT	O	O
further	JJ	O	B-PROBLEM
intraaxial	NN	B-PROBLEM	I-PROBLEM
or	CC	I-PROBLEM	O
extraaxial	JJ	I-PROBLEM	B-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
collections	NNS	I-PROBLEM	I-PROBLEM
or	CC	O	O
hematoma	NN	B-PROBLEM	B-PROBLEM
are	VBP	O	O
identified	VBN	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
displacement	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
normally	RB	I-PROBLEM	I-PROBLEM
midline	JJ	I-PROBLEM	I-PROBLEM
structures	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
hydrocephalus	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
effacement	NN	B-PROBLEM	O
of	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
basal	NN	I-PROBLEM	O
cisterns	VBZ	I-PROBLEM	O
at	IN	O	O
present	NN	O	O
.	.	O	O

review	NN	B-TEST	O
of	IN	I-TEST	O
bone	NN	I-TEST	O
windows	NNS	I-TEST	O
demonstrates	VBZ	O	O
no	DT	O	O
skull	JJ	B-PROBLEM	B-PROBLEM
bulge	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
skull	JJ	B-PROBLEM	B-PROBLEM
base	NN	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
an	DT	B-PROBLEM	B-PROBLEM
air	NN	I-PROBLEM	I-PROBLEM
/	JJ	I-PROBLEM	I-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
level	NN	I-PROBLEM	I-PROBLEM
within	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
maxillary	NN	I-PROBLEM	I-PROBLEM
sinus	SYM	I-PROBLEM	I-PROBLEM
-	:	O	O
?	.	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
sinusitis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
cannot	NN	O	I-PROBLEM
be	VB	O	O
excluded	VBN	O	O
,	,	O	O
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
trauma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

41	CD	B-PROBLEM	O
x	JJ	I-PROBLEM	O
23	CD	I-PROBLEM	O
mm	JJ	I-PROBLEM	B-PROBLEM
acute	NN	I-PROBLEM	I-PROBLEM
intraparenchymal	JJ	I-PROBLEM	I-PROBLEM
hematoma	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
frontal	NN	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
causing	VBG	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
effect	NN	I-PROBLEM	I-PROBLEM
upon	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
ipsilateral	JJ	I-PROBLEM	O
lateral	JJ	I-PROBLEM	O
ventricle	NN	I-PROBLEM	O
,	,	O	O
suspicious	JJ	O	O
of	IN	O	O
hemorrhage	NN	B-PROBLEM	B-PROBLEM
secondary	JJ	O	O
to	TO	O	O
congophilic	VB	B-PROBLEM	O
angiopathy	RB	I-PROBLEM	O
in	IN	O	O
this	DT	O	O
age	NN	O	O
group	NN	O	O
.	.	O	O

chronic	JJ	B-PROBLEM	B-PROBLEM
encephalomalacic	NN	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
frontal	NN	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
right	JJ	O	I-PROBLEM
parietal	NN	O	I-PROBLEM
/	NNP	O	O
occipital	JJ	O	O
region	NN	O	O
are	VBP	O	O
unchanged	JJ	O	O
in	IN	O	O
appearance	NN	O	O
since	IN	O	O
2018-11-27	CD	O	O
.	.	O	O

repeat	NN	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
ct	VBD	I-TEST	I-TEST
03-30	JJ	O	O
:	:	O	O
no	DT	O	O
significant	JJ	B-PROBLEM	O
change	NN	I-PROBLEM	O
from	IN	O	O
above	IN	O	O
.	.	O	O

ekg	NN	B-TEST	O
:	:	O	O

atrial	JJ	B-TREATMENT	B-PROBLEM
pacing	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

since	IN	O	O
the	DT	B-TEST	O
previous	JJ	I-TEST	O
tracing	NN	I-TEST	O
of	IN	O	O
2018-03-15	JJ	O	B-PROBLEM
atrial	JJ	B-TREATMENT	I-PROBLEM
pacing	NN	I-TREATMENT	I-PROBLEM
is	VBZ	O	O
a	DT	O	O
new	JJ	O	O
finding	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
is	VBZ	O	O
otherwise	RB	O	O
,	,	O	O
unchanged	JJ	O	O
and	CC	O	O
continues	VBZ	O	O
to	TO	O	O
weymouth	VB	B-TREATMENT	O
voltage	NN	I-TREATMENT	O
in	IN	I-TREATMENT	O
the	DT	I-TREATMENT	O
limb	NN	I-TREATMENT	O
leads	VBZ	I-TREATMENT	O
and	CC	O	O
non-specific	JJ	B-PROBLEM	B-PROBLEM
st-t	JJ	I-PROBLEM	I-PROBLEM
wave	NN	I-PROBLEM	I-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

intervals	NNS	B-TEST	O
axes	NNS	I-TEST	O

rate	NN	B-TEST	B-TEST
60	CD	O	O
pr	NN	B-TEST	O
188	CD	O	O
qrs	NN	B-TEST	O
104	CD	O	O
qt/qtc	NN	B-TEST	O
460/460	CD	O	O
p	NN	B-TEST	O
85	CD	O	O
qrs	NN	B-TEST	O
55	CD	O	O
t	NN	B-TEST	O
75	CD	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
83	CD	O	O
yo	NN	O	O
man	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
past	JJ	B-PROBLEM	B-PROBLEM
intracranial	JJ	I-PROBLEM	I-PROBLEM
hemorrhages	NNS	I-PROBLEM	I-PROBLEM
(	(	O	O
most	RBS	O	O
recent	JJ	O	O
07-01	JJ	O	O
with	IN	O	O
r-frontal	JJ	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
)	)	O	O
who	WP	O	O
presented	VBD	O	O
with	IN	O	O
gradually	RB	B-PROBLEM	O
slowing	VBG	I-PROBLEM	O
of	IN	I-PROBLEM	O
mentation	NN	I-PROBLEM	B-PROBLEM
and	CC	O	O
increased	VBD	B-PROBLEM	B-PROBLEM
gait	NN	I-PROBLEM	I-PROBLEM
instability	NN	I-PROBLEM	I-PROBLEM
since	IN	O	O
one	CD	O	O
week	NN	O	O
.	.	O	O

on	IN	O	O
initial	JJ	B-TEST	O
exam	IN	I-TEST	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
not	RB	B-PROBLEM	O
oriented	VBN	I-PROBLEM	O
to	TO	I-PROBLEM	O
time	NN	I-PROBLEM	O
,	,	O	O
seemed	VBD	O	O
somewhat	RB	B-PROBLEM	B-PROBLEM
slow	JJ	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
had	VBD	O	O
difficulties	NNS	B-PROBLEM	B-PROBLEM
generating	VBG	I-PROBLEM	O
a	DT	I-PROBLEM	O
list	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
animals	NNS	I-PROBLEM	O
.	.	O	O

his	PRP$	O	B-PROBLEM
cranial	JJ	O	I-PROBLEM
nerves	NNS	O	I-PROBLEM
and	CC	O	O
strength	NN	O	B-TEST
were	VBD	O	O
full	JJ	O	O
,	,	O	O
and	CC	O	O
the	DT	B-TEST	B-TEST
sensory	JJ	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
showed	VBD	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
decreased	VBN	I-PROBLEM	I-PROBLEM
vibration	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
proprioception	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
both	DT	I-PROBLEM	O
le	NN	I-PROBLEM	O
,	,	O	O
suggesting	VBG	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
neuropathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
in	IN	O	O
the	DT	O	O
deanna	NN	O	O
that	WDT	O	O
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
new	JJ	I-PROBLEM	I-PROBLEM
significant	JJ	I-PROBLEM	I-PROBLEM
r-frontal	JJ	I-PROBLEM	I-PROBLEM
intraparenchymal	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
same	JJ	I-PROBLEM	O
location	NN	I-PROBLEM	O
as	IN	O	O
the	DT	B-PROBLEM	O
prior	JJ	I-PROBLEM	O
bleed	NN	I-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
seen	VBN	O	O
by	IN	O	O
both	DT	O	O
neurology	NN	O	O
and	CC	O	O
neurosurgery	NN	O	O
,	,	O	O
and	CC	O	O
the	DT	O	O
two	CD	O	O
teams	NNS	O	O
agreed	VBD	O	O
that	IN	O	O
the	DT	O	O
etiology	NN	O	O
seemed	VBD	O	O
to	TO	O	O
be	VB	O	O
related	VBN	O	O
to	TO	O	O
underlying	JJ	B-PROBLEM	B-PROBLEM
amyloidosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

during	IN	O	O
the	DT	O	O
last	JJ	O	O
admission	NN	O	O
the	DT	O	O
question	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
underlying	VBG	O	I-PROBLEM
a	DT	B-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
r-frontal	JJ	I-PROBLEM	O
region	NN	I-PROBLEM	O
was	VBD	O	O
raised	VBN	O	O
.	.	O	O

the	DT	O	O
location	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
not	RB	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
typical	JJ	O	O
for	IN	O	O
hypertensive	JJ	B-PROBLEM	B-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
(	(	I-PROBLEM	O
cortical	JJ	I-PROBLEM	O
)	)	I-PROBLEM	O
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
unlikely	JJ	O	O
that	IN	O	O
the	DT	O	B-PROBLEM
recent	JJ	O	I-PROBLEM
fall	NN	O	I-PROBLEM
was	VBD	O	O
related	VBN	O	O
to	TO	O	O
the	DT	B-PROBLEM	B-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
could	MD	O	O
not	RB	O	O
undergo	VB	O	O
an	DT	B-TEST	B-TEST
mri	NN	I-TEST	I-TEST
due	JJ	O	O
to	TO	O	O
his	PRP$	B-TREATMENT	B-PROBLEM
pacer	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
neurology	NN	O	O
icu	NN	O	O
for	IN	O	O
closer	JJR	B-TEST	B-TEST
monitoring	NN	I-TEST	I-TEST
and	CC	O	O
was	VBD	O	O
stable	JJ	O	O
overnight	JJ	O	O
-	:	O	O
bp	NN	B-TEST	O
was	VBD	O	O
initially	RB	B-PROBLEM	B-PROBLEM
elevated	VBN	I-PROBLEM	I-PROBLEM
and	CC	O	O
required	VBN	O	O
a	DT	B-TREATMENT	B-TREATMENT
labetalol	JJ	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
<	$	O	O
24	CD	O	O
hours	NNS	O	O
,	,	O	O
then	RB	O	O
stabilized	VBN	O	O
.	.	O	O

the	DT	B-TEST	O
goal	NN	I-TEST	O
sbp	NN	I-TEST	O
of	IN	O	O
<	$	O	B-TREATMENT
150	CD	O	O
was	VBD	O	O
achieved	VBN	O	O
.	.	O	O

coags	NNS	B-TEST	O
and	CC	O	O
ua	NNS	B-TEST	O
were	VBD	O	O
checked	VBN	O	O
and	CC	O	O
were	VBD	O	O
normal	JJ	O	O
.	.	O	O

for	IN	O	O
the	DT	O	O
question	NN	O	O
of	IN	O	O
seizure	NN	B-PROBLEM	B-PROBLEM
activity	NN	I-PROBLEM	I-PROBLEM
associated	VBN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
cortical	JJ	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
he	PRP	O	O
was	VBD	O	O
started	VBN	O	O
prophylactically	RB	O	O
on	IN	O	O
keppra	NN	B-TREATMENT	O
(	(	O	O
given	VBN	O	O
questionable	JJ	O	O
allergy	NN	B-PROBLEM	B-PROBLEM
to	TO	O	I-PROBLEM
dilantin	VB	B-TREATMENT	I-PROBLEM
)	)	O	I-PROBLEM
,	,	O	O
at	IN	O	O
500	CD	O	O
mg	JJ	O	O
bid	NN	O	O
;	:	O	O
no	DT	O	O
seizure	NN	B-PROBLEM	B-PROBLEM
activity	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
seen	VBN	O	O
.	.	O	O

this	DT	B-TREATMENT	B-TREATMENT
medication	NN	I-TREATMENT	I-TREATMENT
should	MD	O	O
be	VB	O	O
continued	VBN	O	O
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
at	IN	O	O
least	JJS	O	O
while	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
has	VBZ	O	O
time	NN	O	O
to	TO	O	O
clear	VB	O	O
up	RP	O	O
,	,	O	O
with	IN	O	O
planned	VBN	O	O
titration	NN	O	O
up	RB	O	O
to	TO	O	O
1000	CD	O	O
mg	NN	O	O
bid	NN	O	O
on	IN	O	O
04-05	NN	O	O
.	.	O	O

head	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
repeated	VBN	O	O
on	IN	O	O
03-30	NN	O	O
was	VBD	O	O
unchanged	JJ	O	O
,	,	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
stable	JJ	O	O
with	IN	O	O
only	JJ	O	O
very	RB	O	O
suble	JJ	O	O
focal	JJ	O	B-TEST
exam	NN	O	I-TEST
findings	NNS	O	I-TEST
(	(	O	O
very	RB	B-PROBLEM	B-PROBLEM
mild	RB	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
pronator	NN	I-PROBLEM	I-PROBLEM
drift	NN	I-PROBLEM	I-PROBLEM
)	)	O	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
his	PRP$	B-PROBLEM	O
persistently	RB	I-PROBLEM	O
poor	JJ	I-PROBLEM	O
memory	NN	I-PROBLEM	O
related	VBN	O	O
to	TO	O	O
dementia	VB	B-PROBLEM	B-PROBLEM
.	.	O	O

cardiovascularly	RB	O	O
,	,	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
were	VBD	O	O
continued	VBN	O	O
.	.	O	O

he	PRP	O	O
could	MD	O	O
not	RB	O	O
get	VB	O	O
an	DT	B-TEST	O
mri	NN	I-TEST	O
due	JJ	O	O
to	TO	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
pacemaker	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

there	EX	O	O
were	VBD	O	O
no	DT	O	O
telemetry	NN	B-PROBLEM	B-PROBLEM
events	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
he	PRP	O	O
ruled	VBD	O	O
out	RP	O	O
by	IN	O	O
enzyme	NN	B-TEST	O
.	.	O	O

pulmonlologically	RB	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
xray	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
and	CC	O	O
he	PRP	O	O
complained	VBD	O	O
of	IN	O	O
no	DT	O	O
breathing	NN	B-PROBLEM	B-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

endocrinologically	RB	O	O
,	,	O	O
bg	NN	B-TEST	O
was	VBD	O	O
monitored	VBN	O	O
to	TO	O	O
improve	VB	O	O
outcome	NN	O	O
in	IN	O	O
icu	JJ	O	O
setting	NN	O	O
though	IN	O	O
he	PRP	O	O
had	VBD	O	O
no	DT	O	O
history	NN	O	O
of	IN	O	O
dm	NN	B-PROBLEM	O
.	.	O	O

of	IN	O	O
note	NN	O	O
,	,	O	O
hba1c	VB	B-TEST	O
done	VBN	O	O
03-04	CD	O	O
was	VBD	O	O
slightly	RB	B-PROBLEM	B-PROBLEM
elevated	VBN	I-PROBLEM	I-PROBLEM
(	(	O	O
"	JJ	O	O
borderline	NN	B-PROBLEM	O
dm	NN	I-PROBLEM	O
"	NN	O	O
)	)	O	O
at	IN	O	O
6.3	CD	O	O
;	:	O	O
this	DT	O	O
was	VBD	O	O
repeated	VBN	O	O
and	CC	O	O
was	VBD	O	O
still	RB	O	O
pending	VBG	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

ins	NNS	B-TEST	O
/	VBP	I-TEST	O
outs	NNS	I-TEST	O
and	CC	O	O
electrolytes	NNS	B-TEST	B-TEST
were	VBD	O	O
monitored	VBN	O	O
and	CC	O	O
were	VBD	O	O
not	RB	O	O
abnormal	JJ	B-PROBLEM	O
;	:	O	O
he	PRP	O	O
was	VBD	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
bowel	NN	I-TREATMENT	I-TREATMENT
regimen	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
vd	JJ	B-TREATMENT	B-TREATMENT
boots	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
pud	JJ	B-TREATMENT	B-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
protonix	NN	B-TREATMENT	B-TREATMENT
during	IN	O	O
the	DT	O	O
admission	NN	O	O
.	.	O	O

walking	NN	O	O
was	VBD	O	O
assessed	VBN	O	O
later	RB	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
unstable	JJ	B-PROBLEM	O
on	IN	I-PROBLEM	O
his	PRP$	I-PROBLEM	O
feet	NNS	I-PROBLEM	O
.	.	O	O

pt	NN	O	O
was	VBD	O	O
asked	VBN	O	O
to	TO	O	O
see	VB	O	O
him	PRP	O	O
for	IN	O	O
this	DT	B-PROBLEM	B-PROBLEM
gait	NN	I-PROBLEM	I-PROBLEM
problem	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

follow-up	NN	O	O
was	VBD	O	O
arranged	VBN	O	O
with	IN	O	O
neurosurgery	NN	O	O
in	IN	O	O
5-6	JJ	O	O
weeks	NNS	O	O
with	IN	O	O
repeat	NN	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
to	TO	O	O
be	VB	O	O
arranged	VBN	O	O
by	IN	O	O
neurosurgery	JJ	O	O
office	NN	O	O
to	TO	O	O
make	VB	O	O
sure	JJ	O	O
blood	NN	B-PROBLEM	O
has	VBZ	O	O
cleared	VBN	O	O
,	,	O	O
and	CC	O	O
if	IN	O	O
indicated	VBN	O	O
,	,	O	O
to	TO	O	O
look	VB	O	O
for	IN	O	O
a	DT	O	O
possible	JJ	O	O
underlying	JJ	B-PROBLEM	B-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
although	IN	O	O
unlikely	RB	O	O
)	)	O	O
.	.	O	O

amiodarone	RB	B-TREATMENT	B-TREATMENT
200	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
0.5	CD	O	O
tablet	NN	O	O
po	NN	O	O
qod	SYM	O	O
-	:	O	O
in	IN	O	O
march	NN	O	O
,	,	O	O
should	MD	O	O
be	VB	O	O
on	IN	O	O
odd	JJ	O	O
days	NNS	O	O
.	.	O	O

donepezil	RB	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
hs	NN	O	O
(	(	O	O
at	IN	O	O
bedtime	NN	O	O
)	)	O	O
.	.	O	O

docusate	NN	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

multivitamin	NN	B-TREATMENT	B-TREATMENT
capsule	NN	I-TREATMENT	I-TREATMENT
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
cap	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

mirtazapine	NN	B-TREATMENT	B-TREATMENT
30	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
0.5	CD	O	O
tablet	NN	O	O
po	NN	O	O
hs	NN	O	O
(	(	O	O
at	IN	O	O
bedtime	NN	O	O
)	)	O	O
.	.	O	O

atorvastatin	RB	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
at	IN	O	O
bedtime	NN	O	O
.	.	O	O

ocuvite	JJ	B-TREATMENT	O
tablet	NN	I-TREATMENT	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

artificial	JJ	B-TREATMENT	B-PROBLEM
tears	NNS	I-TREATMENT	I-PROBLEM
drops	VBZ	I-TREATMENT	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
drop	NN	O	O
ophthalmic	JJ	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
:	:	O	O
ou	NN	O	O
.	.	O	O

ensure	VB	B-TREATMENT	O
liquid	JJ	I-TREATMENT	O
sig	NN	O	O
:	:	O	O
0.5	CD	O	O
to	TO	O	O
1	CD	O	O
can	MD	O	O
po	VB	O	O
three	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

midodrine	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1.5	CD	O	O
tablets	NNS	O	O
po	JJ	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
:	:	O	O
at	IN	O	O
8am	CD	O	O
and	CC	O	O
noon	NN	O	O
.	.	O	O

ritalin	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
see	NN	O	O
below	IN	O	O
tablet	NN	O	O
po	NN	O	O
see	VBP	O	O
below	IN	O	O
:	:	O	O
1.5	CD	O	O
tablets	NNS	O	O
at	IN	O	O
10am	CD	O	O
(	(	O	O
7.5mg	CD	O	O
)	)	O	O
,	,	O	O
1	CD	O	O
tablet	NN	O	O
2pm	CD	O	O
(	(	O	O
5mg	CD	O	O
)	)	O	O
.	.	O	O

prilosec	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
capsule	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

guaifenesin	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
/	VBD	O	O
5	CD	O	O
ml	NN	O	O
liquid	NN	O	O
sig	NN	O	O
:	:	O	O
01-28	JJ	O	O
teaspoons	NNS	O	O
po	VBP	O	O
every	DT	O	O
six	CD	O	O
(	(	O	O
6	CD	O	O
)	)	O	O
hours	NNS	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
cold	JJ	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
200	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
0.5	CD	O	O
tablet	NN	O	O
po	NN	O	O
qod	SYM	O	O
-	:	O	O
in	IN	O	O
march	NN	O	O
,	,	O	O
should	MD	O	O
be	VB	O	O
on	IN	O	O
odd	JJ	O	O
days	NNS	O	O
.	.	O	O

2.	CD	O	O
donepezil	JJ	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
hs	NN	O	O
(	(	O	O
at	IN	O	O
bedtime	NN	O	O
)	)	O	O
.	.	O	O

3.	CD	O	O
docusate	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

4.	CD	O	O
multivitamin	NN	B-TREATMENT	B-TREATMENT
capsule	NN	I-TREATMENT	I-TREATMENT
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
cap	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

5.	CD	O	O
mirtazapine	NN	B-TREATMENT	B-TREATMENT
30	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
0.5	CD	O	O
tablet	NN	O	O
po	NN	O	O
hs	NN	O	O
(	(	O	O
at	IN	O	O
bedtime	NN	O	O
)	)	O	O
.	.	O	O

6.	CD	O	O
atorvastatin	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
at	IN	O	O
bedtime	NN	O	O
.	.	O	O

7.	CD	O	O
levetiracetam	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
:	:	O	O
on	IN	O	O
04-05	NN	O	O
,	,	O	O
please	VB	O	O
increase	VB	O	O
to	TO	O	O
two	CD	O	O
tablets	NNS	O	O
bid	VBD	O	O
(	(	O	O
1000	CD	O	O
mg	RB	O	O
bid	NN	O	O
)	)	O	O
.	.	O	O

8.	CD	O	O
ocuvite	JJ	B-TREATMENT	O
tablet	NN	I-TREATMENT	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

9.	CD	O	O
artificial	JJ	B-TREATMENT	O
tears	NNS	I-TREATMENT	O
drops	VBZ	I-TREATMENT	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
drop	NN	O	O
ophthalmic	JJ	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
:	:	O	O
ou	NN	O	O
.	.	O	O

10.	CD	O	O
ensure	VB	B-TREATMENT	O
liquid	JJ	I-TREATMENT	O
sig	NN	O	O
:	:	O	O
0.5	CD	O	O
to	TO	O	O
1	CD	O	O
can	MD	O	O
po	VB	O	O
three	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

11.	CD	O	O
midodrine	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1.5	CD	O	O
tablets	NNS	O	O
po	JJ	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
:	:	O	O
at	IN	O	O
8	CD	O	O
am	VBP	O	O
and	CC	O	O
noon	NN	O	O
.	.	O	O

12.	CD	O	O
ritalin	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
see	NN	O	O
below	IN	O	O
tablet	NN	O	O
po	NN	O	O
see	VBP	O	O
below	IN	O	O
:	:	O	O
1.5	CD	O	O
tablets	NNS	O	O
at	IN	O	O
10	CD	O	O
am	VBP	O	O
(	(	O	O
7.5	CD	O	O
mg	NN	O	O
)	)	O	O
,	,	O	O
1	CD	O	O
tablet	NN	O	O
2	CD	O	O
pm	NN	O	O
(	(	O	O
5	CD	O	O
mg	NN	O	O
)	)	O	O
.	.	O	O

13.	CD	O	O
prilosec	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
capsule	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

14.	CD	O	O
guaifenesin	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
/	VBD	O	O
5	CD	O	O
ml	NN	O	O
liquid	NN	O	O
sig	NN	O	O
:	:	O	O
01-28	JJ	O	O
teaspoons	NNS	O	O
po	VBP	O	O
every	DT	O	O
six	CD	O	O
(	(	O	O
6	CD	O	O
)	)	O	O
hours	NNS	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
cold	JJ	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

right	RB	B-PROBLEM	B-PROBLEM
sided	VBN	I-PROBLEM	I-PROBLEM
intraparenchymal	JJ	I-PROBLEM	I-PROBLEM
cerebral	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM

stable	JJ	O	O
-	:	O	O
still	RB	O	O
with	IN	O	O
difficulty	NN	B-PROBLEM	B-PROBLEM
walking	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
mental	JJ	B-TEST	B-TEST
status	NN	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
with	IN	O	O
memory	NN	B-PROBLEM	B-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
c/w	NN	O	O
dementia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
but	CC	O	O
otherwise	RB	O	O
no	DT	O	O
focal	JJ	B-PROBLEM	B-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

please	VB	O	O
call	VB	O	O
md	NN	O	O
or	CC	O	O
return	NN	O	O
to	TO	O	O
deanna	VB	O	O
if	IN	O	O
new	JJ	O	B-PROBLEM
symptoms	NNS	O	I-PROBLEM
suggestive	NN	O	O
of	IN	O	O
stroke	NN	B-PROBLEM	B-PROBLEM
or	CC	O	I-PROBLEM
brain	NN	B-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
including	VBG	O	O
weakness	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
numbness	JJ	B-PROBLEM	B-PROBLEM
/	NN	O	I-PROBLEM
tingling	NN	B-PROBLEM	I-PROBLEM
,	,	O	O
facial	JJ	B-PROBLEM	B-PROBLEM
droop	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
visual	JJ	B-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
vertigo	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
loss	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
coordination	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
worsened	VBD	B-PROBLEM	B-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
with	IN	I-PROBLEM	O
walking	NN	I-PROBLEM	O
.	.	O	O

please	VB	O	O
f/u	NN	O	O
with	IN	O	O
dr.	JJ	O	O
hernandez	NN	O	O
/	JJ	O	O
neurosurgery	NN	O	O
in	IN	O	O
6	CD	O	O
weeks	NNS	O	O
-	:	O	O
patient	NN	O	O
will	MD	O	O
receive	VB	O	O
a	DT	O	O
call	NN	O	O
from	IN	O	O
the	DT	O	O
neurosurgery	NN	O	O
office	NN	O	O
to	TO	O	O
set	VB	O	O
up	RP	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
prior	RB	O	O
and	CC	O	O
to	TO	O	O
schedule	VB	O	O
this	DT	O	O
visit	NN	O	O
.	.	O	O

diverticulitis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
s	JJ	O	O
/	NNP	O	O
p	NN	O	O
aortic	JJ	B-TREATMENT	B-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT

diverticulitis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
presenting	VBG	O	O
for	IN	O	O
sigmoid	JJ	B-TREATMENT	B-TREATMENT
colectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
67-year-old	JJ	O	O
woman	NN	O	O
with	IN	O	O
occasional	JJ	B-PROBLEM	B-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
lower	RBR	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
left	VBD	O	I-PROBLEM
lower	JJR	O	I-PROBLEM
quadrant	NN	O	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
not	RB	O	O
complained	VBN	O	O
of	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
shaking	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
change	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
movements	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
had	VBD	O	O
attacks	NNS	B-PROBLEM	B-PROBLEM
treated	VBN	O	O
with	IN	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
in	IN	O	O
the	DT	O	O
past	NN	O	O
notably	RB	O	O
in	IN	O	O
12/96	CD	O	O
and	CC	O	O
08/97	CD	O	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
had	VBD	O	O
a	DT	O	O
diagnosis	NN	O	O
of	IN	O	O
diverticulitis	NN	B-PROBLEM	B-PROBLEM
flairs	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
baseline	JJ	B-PROBLEM	B-PROBLEM
diverticulosis	NN	I-PROBLEM	I-PROBLEM
flairing	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
09/96	CD	O	O
.	.	O	O

also	RB	O	O
,	,	O	O
three	CD	O	O
years	NNS	O	O
prior	RB	O	O
in	IN	O	O
1993	CD	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
attack	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
diverticulitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
worked	VBN	O	O
up	RP	O	O
with	IN	O	O
barium	NN	B-TEST	B-TREATMENT
enema	NN	I-TEST	I-TREATMENT
in	IN	O	O
09/97	CD	O	O
which	WDT	O	O
showed	VBD	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
diverticula	NN	I-PROBLEM	I-PROBLEM
throughout	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
colon	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
mostly	RB	O	B-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
sigmoid	NN	O	I-PROBLEM
.	.	O	O

at	IN	O	O
this	DT	O	O
time	NN	O	O
,	,	O	O
there	EX	O	O
was	VBD	O	O
diverticulosis	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
diverticulitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
also	RB	O	O
no	DT	O	O
obstruction	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
also	RB	O	O
status	NN	O	O
post	NN	O	O
aortic	JJ	B-TREATMENT	B-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
1996	CD	O	O
,	,	O	O
and	CC	O	O
presented	VBD	O	O
for	IN	O	O
heparinization	NN	B-TREATMENT	B-PROBLEM
prior	RB	O	O
to	TO	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
elective	JJ	I-TREATMENT	I-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
rheumatic	JJ	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
age	NN	O	O
6	CD	O	O
with	IN	O	O
aortic	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

aortic	JJ	B-TREATMENT	B-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
11/96	CD	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
st.	JJ	I-TREATMENT	I-TREATMENT
jude	NN	I-TREATMENT	I-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
chronic	JJ	B-TREATMENT	B-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
;	:	O	O
breast	CC	B-TEST	O
biopsy	VB	I-TEST	B-TEST
negative	JJ	O	O
in	IN	O	O
1984	CD	O	O
;	:	O	O
appendectomy	JJ	B-TREATMENT	B-TREATMENT
age	NN	O	I-TREATMENT
15	CD	O	O
;	:	O	O
tonsillectomy	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
adenoidectomy	JJ	B-TREATMENT	B-TREATMENT
age	NN	O	O
6	CD	O	O
;	:	O	O
hysterotomy	JJ	B-TREATMENT	B-TREATMENT
age	NN	O	I-TREATMENT
30	CD	O	O
;	:	O	O
c-section	JJ	B-TREATMENT	O
age	NN	O	O
37	CD	O	O
due	JJ	O	O
to	TO	O	O
placenta	VB	B-PROBLEM	O
previa	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

lopressor	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
q.a.m.	NN	O	O
,	,	O	O
25	CD	O	O
mg	NN	O	O
q.p.m.	NN	O	O
,	,	O	O
and	CC	O	O
25	CD	O	O
mg	NN	O	O
q.h.s.;	NN	O	O
synthroid	VBD	B-TREATMENT	O
88	CD	O	O
mcg	NN	O	O
q.d.;	NN	O	O
norvasc	RB	B-TREATMENT	O
5	CD	O	O
mg	NNS	O	O
q.d.;	JJ	O	O
lescol	VBP	B-TREATMENT	O
20	CD	O	O
mg	NNS	O	O
q.p.m.	RB	O	O
with	IN	O	O
meal	NN	O	O
;	:	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
is	VBZ	O	O
usually	RB	O	O
4	CD	O	O
mg	NNS	O	O
p.o.	RB	O	O
3x	CD	O	O
a	DT	O	O
week	NN	O	O
and	CC	O	O
3	CD	O	O
mg	NN	O	O
4x	CD	O	O
a	DT	O	O
week	NN	O	O
.	.	O	O

percodan	NN	B-TREATMENT	O
and	CC	O	O
codeine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

negative	JJ	O	O
for	IN	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
positive	JJ	O	O
for	IN	O	O
occasional	JJ	B-PROBLEM	B-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
exertion	NN	O	O
,	,	O	O
negative	JJ	O	O
for	IN	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
she	PRP	O	O
has	VBZ	O	O
excellent	JJ	O	O
exercise	NN	O	O
tolerance	NN	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
occasional	JJ	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
tightening	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
is	VBZ	O	O
brief	NN	O	O
.	.	O	O

no	DT	O	O
bleeding	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
urine	NN	I-PROBLEM	I-PROBLEM
or	CC	I-PROBLEM	O
stool	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

occasional	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
when	WRB	O	O
she	PRP	O	O
flosses	VBZ	O	O
and	CC	O	O
occasional	JJ	B-PROBLEM	B-PROBLEM
dizziness	NN	I-PROBLEM	I-PROBLEM
secondary	JJ	O	O
to	TO	O	O
a	DT	B-PROBLEM	B-PROBLEM
drop	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
blood	NN	B-TEST	I-PROBLEM
pressure	NN	I-TEST	I-PROBLEM
transiently	RB	O	I-PROBLEM
at	IN	O	I-PROBLEM
home	NN	O	I-PROBLEM
.	.	O	O

vital	JJ	O	B-TEST
signs	NNS	O	I-TEST
-	:	O	O
temp	NN	B-TEST	B-TEST
98.8	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
60	CD	O	O
,	,	O	O
bp	NN	B-TEST	B-TEST
150/94	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
18	CD	O	O
,	,	O	O
and	CC	O	O
saturation	NN	B-TEST	B-TEST
96%	CD	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

general	JJ	O	O
-	:	O	O
the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
pleasant	JJ	O	O
older	JJR	O	O
woman	NN	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

heent	NN	O	O
-	:	O	O
normocephalic	JJ	O	O
,	,	O	O
atraumatic	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

neck	SYM	O	B-TEST
-	:	O	O
no	DT	O	O
carotid	NN	B-PROBLEM	B-PROBLEM
bruits	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
2+	CD	B-TEST	B-PROBLEM
carotid	NN	I-TEST	I-PROBLEM
pulses	NNS	I-TEST	I-PROBLEM
.	.	O	O

heart	NN	O	B-TEST
-	:	O	O
regular	NN	O	O
,	,	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
iii	JJ	I-PROBLEM	I-PROBLEM
/	NN	I-PROBLEM	I-PROBLEM
vi	NN	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
sternal	JJ	I-PROBLEM	I-PROBLEM
border	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

abdomen	NNS	O	O
-	:	O	O
there	EX	O	O
is	VBZ	O	O
a	DT	O	O
soft	JJ	O	O
abdomen	NNS	O	O
with	IN	O	O
a	DT	O	O
question	NN	O	O
of	IN	O	O
eventful	JJ	B-PROBLEM	B-PROBLEM
hernia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

rectal	JJ	O	O
-	:	O	O
guaiac	JJ	B-TEST	O
negative	JJ	O	O
with	IN	O	O
normal	JJ	O	O
tone	NN	O	O
.	.	O	O

extremities	NNS	O	O
-	:	O	O
bilateral	JJ	B-TEST	O
radial	NN	I-TEST	O
,	,	O	O
dorsalis	NN	B-TEST	B-TEST
pedis	NN	I-TEST	I-TEST
,	,	O	O
posterior	JJ	B-TEST	B-PROBLEM
tibial	NN	I-TEST	I-PROBLEM
,	,	O	O
and	CC	O	O
femoral	JJ	B-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
are	VBP	O	O
all	DT	O	O
2+	CD	O	O
.	.	O	O

no	DT	O	O
clubbing	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
extremities	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

coagulation	NN	B-TEST	O
profile	NN	I-TEST	O
notable	JJ	O	O
for	IN	O	O
a	DT	B-TEST	O
pt	NN	I-TEST	O
18	CD	O	O
,	,	O	O
ptt	NN	B-TEST	B-TEST
36.7	CD	O	O
and	CC	O	O
an	DT	B-TEST	B-TEST
inr	NN	I-TEST	I-TEST
of	IN	O	O
2.4	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
and	CC	O	O
begun	VBN	O	O
on	IN	O	O
cefotetan	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

her	PRP$	B-TEST	B-TEST
inr	NN	I-TEST	I-TEST
dropped	VBD	O	O
to	TO	O	O
1.6	CD	O	O
prior	RB	O	O
to	TO	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TREATMENT
ptt	NN	I-TEST	I-TREATMENT
was	VBD	O	O
in	IN	O	O
the	DT	O	O
mid	NN	O	O
80s	CD	O	O
prior	RB	O	O
to	TO	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
and	CC	O	O
placed	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
bowel	NN	I-TREATMENT	I-TREATMENT
prep	NN	I-TREATMENT	I-TREATMENT
two	CD	O	O
days	NNS	O	O
before	IN	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
#	#	O	O
3	CD	O	O
,	,	O	O
10/28/97	CD	O	O
.	.	O	O

at	IN	O	O
that	DT	O	O
time	NN	O	O
,	,	O	O
she	PRP	O	O
underwent	JJ	O	O
sigmoid	JJ	B-TREATMENT	B-TREATMENT
colectomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
ventral	JJ	B-TREATMENT	B-PROBLEM
hernia	NN	I-TREATMENT	I-PROBLEM
repair	NN	I-TREATMENT	I-PROBLEM
.	.	O	O
(	(	O	O
a	DT	O	O
full	JJ	O	O
account	NN	O	O
of	IN	O	O
this	DT	B-TREATMENT	B-TREATMENT
operation	NN	I-TREATMENT	I-TREATMENT
can	MD	O	O
be	VB	O	O
found	VBN	O	O
in	IN	O	O
the	DT	O	O
operative	JJ	O	O
note	NN	O	O
)	)	O	O
.	.	O	O

she	PRP	O	O
tolerated	VBD	O	O
this	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
without	IN	O	O
complications	NNS	B-PROBLEM	B-PROBLEM
initially	RB	O	O
and	CC	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
recovery	NN	O	O
room	NN	O	O
in	IN	O	O
stable	JJ	O	O
condition	NN	O	O
.	.	O	O

postoperatively	RB	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
her	PRP	B-TREATMENT	B-TREATMENT
heparin	NN	I-TREATMENT	I-TREATMENT
restarted	VBN	O	O
,	,	O	O
and	CC	O	O
had	VBD	O	O
a	DT	B-TEST	B-TREATMENT
ptt	NN	I-TEST	I-TREATMENT
rising	VBG	O	O
to	TO	O	O
142.8	CD	O	O
and	CC	O	O
then	RB	O	O
down	RB	O	O
to	TO	O	O
92	CD	O	O
.	.	O	O

her	PRP$	O	O
primary	JJ	O	O
postoperative	JJ	O	O
development	NN	O	O
was	VBD	O	O
the	DT	B-PROBLEM	O
passage	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
some	DT	I-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
clots	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
blood	NN	B-PROBLEM	B-TEST
per	IN	I-PROBLEM	I-TEST
rectum	NN	I-PROBLEM	I-TEST
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#	#	O	O
2	CD	O	O
.	.	O	O

she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
pass	VB	O	O
blood	NN	B-PROBLEM	O
per	IN	I-PROBLEM	O
rectum	NN	I-PROBLEM	O
and	CC	O	O
was	VBD	O	O
transfused	VBN	O	O
with	IN	O	O
one	CD	B-TREATMENT	O
unit	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
packed	JJ	I-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

her	PRP$	B-TEST	B-TEST
preoperative	JJ	I-TEST	I-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
41	CD	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
dropped	VBD	O	O
to	TO	O	O
30.4	CD	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#	#	O	O
2	CD	O	O
.	.	O	O

this	DT	O	O
was	VBD	O	O
a	DT	O	O
drop	NN	O	O
from	IN	O	O
an	DT	B-TEST	O
immediate	JJ	I-TEST	O
postoperative	JJ	I-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
of	IN	O	O
35.4	CD	O	O
.	.	O	O

upon	IN	O	O
receiving	VBG	O	O
the	DT	B-TREATMENT	O
one	CD	I-TREATMENT	O
unit	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
red	JJ	I-TREATMENT	B-PROBLEM
blood	NN	I-TREATMENT	I-PROBLEM
cells	NNS	I-TREATMENT	I-PROBLEM
,	,	O	O
her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
returned	VBD	O	O
to	TO	O	O
33	CD	O	O
,	,	O	O
and	CC	O	O
in	IN	O	O
the	DT	O	O
two	CD	O	O
days	NNS	O	O
subsequent	JJ	O	O
to	TO	O	O
the	DT	B-TREATMENT	O
transfusion	NN	I-TREATMENT	O
,	,	O	O
returned	VBD	O	O
to	TO	O	O
34	CD	O	O
.	.	O	O

otherwise	RB	O	O
,	,	O	O
her	PRP	O	O
postoperative	JJ	O	O
course	NN	O	O
was	VBD	O	O
uneventful	JJ	O	O
with	IN	O	O
gradual	JJ	O	O
resolution	NN	O	O
of	IN	O	O
the	DT	O	O
passage	NN	O	O
of	IN	O	O
blood	NN	B-PROBLEM	B-PROBLEM
per	IN	I-PROBLEM	I-PROBLEM
rectum	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
heparin	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
when	WRB	O	O
it	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
that	IN	O	O
she	PRP	O	O
was	VBD	O	O
bleeding	VBG	B-PROBLEM	B-PROBLEM
per	IN	I-PROBLEM	I-PROBLEM
rectum	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
her	PRP$	B-TEST	B-TREATMENT
ptt	NN	I-TEST	I-TREATMENT
drifted	VBD	O	O
to	TO	O	O
a	DT	O	O
normal	JJ	O	O
range	NN	O	O
of	IN	O	O
35	CD	O	O
by	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#	#	O	O
3	CD	O	O
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#	#	O	O
1	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
restarted	VBN	O	O
on	IN	O	O
2	CD	O	O
mg	NN	O	O
of	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

however	RB	O	O
,	,	O	O
due	JJ	O	O
to	TO	O	O
the	DT	O	O
episode	NN	O	O
of	IN	O	O
bleeding	VBG	B-PROBLEM	B-PROBLEM
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#	#	O	O
2	CD	O	O
,	,	O	O
the	DT	B-TREATMENT	B-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
held	VBN	O	O
for	IN	O	O
two	CD	O	O
consecutive	JJ	O	O
days	NNS	O	O
,	,	O	O
and	CC	O	O
then	RB	O	O
restarted	VBD	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#	#	O	O
4	CD	O	O
.	.	O	O

at	IN	O	O
this	DT	O	O
time	NN	O	O
,	,	O	O
she	PRP	O	O
is	VBZ	O	O
given	VBN	O	O
3	CD	O	O
mg	NNS	O	O
and	CC	O	O
was	VBD	O	O
gradually	RB	O	O
increased	VBN	O	O
to	TO	O	O
her	PRP$	B-TREATMENT	O
regular	JJ	I-TREATMENT	O
regimen	NNS	I-TREATMENT	O
of	IN	O	O
4	CD	O	O
mg	NNS	O	O
alternating	VBG	O	O
with	IN	O	O
3	CD	O	O
mg.	NNS	O	O

the	DT	B-TEST	O
patient	NN	I-TEST	O
&apos;s	NNP	I-TEST	O
inr	NN	I-TEST	O
had	VBD	O	O
dropped	VBN	O	O
to	TO	O	O
1.7	CD	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
operation	NN	B-TREATMENT	O
,	,	O	O
and	CC	O	O
remained	VBD	O	O
in	IN	O	O
this	DT	O	O
range	NN	O	O
initially	RB	O	O
,	,	O	O
but	CC	O	O
began	VBD	O	O
to	TO	O	O
rise	VB	O	O
to	TO	O	O
2.0	CD	O	O
with	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
dosing	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
the	DT	O	O
next	JJ	O	O
day	NN	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
1.6	CD	O	O
and	CC	O	O
she	PRP	O	O
returned	VBD	O	O
to	TO	O	O
a	DT	B-TREATMENT	O
normal	JJ	I-TREATMENT	O
dosing	NN	I-TREATMENT	O
of	IN	O	O
4	CD	O	O
mg	NN	O	O
followed	VBN	O	O
by	IN	O	O
outpatient	JJ	B-TEST	O
draws	NNS	I-TEST	O
to	TO	O	O
determine	VB	O	O
the	DT	B-TREATMENT	O
further	JJ	I-TREATMENT	O
coumadin	NN	I-TREATMENT	B-TREATMENT
dosing	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
rest	NN	O	O
of	IN	O	O
her	PRP$	O	B-TREATMENT
hospital	JJ	O	I-TREATMENT
course	NN	O	I-TREATMENT
was	VBD	O	O
unremarkable	JJ	O	O
,	,	O	O
with	IN	O	O
perioperative	JJ	B-TREATMENT	B-TREATMENT
ampicillin	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
flagyl	JJ	B-TREATMENT	B-TREATMENT
discontinued	VBN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#	#	O	O
1	CD	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
initial	JJ	I-PROBLEM	I-PROBLEM
nausea	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
had	VBD	O	O
no	DT	O	O
emesis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
nasogastric	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#	#	O	O
1	CD	O	O
,	,	O	O
and	CC	O	O
she	PRP	O	O
tolerated	VBD	O	O
a	DT	O	O
regular	JJ	O	O
diet	NN	O	O
by	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#	#	O	O
3	CD	O	O
.	.	O	O

she	PRP	O	O
also	RB	O	O
complained	VBD	O	O
of	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
slight	JJ	I-PROBLEM	I-PROBLEM
dizziness	NN	I-PROBLEM	I-PROBLEM
upon	IN	O	O
getting	VBG	O	O
up	RP	O	O
.	.	O	O

for	IN	O	O
this	DT	O	O
reason	NN	O	O
,	,	O	O
her	PRP$	B-TREATMENT	O
normal	JJ	I-TREATMENT	O
lopressor	NN	I-TREATMENT	O
and	CC	O	O
norvasc	NN	B-TREATMENT	B-TEST
were	VBD	O	O
held	VBN	O	O
.	.	O	O

it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
that	IN	O	O
this	DT	O	O
was	VBD	O	O
re-equalibration	NN	O	B-TREATMENT
after	IN	O	O
being	VBG	O	O
sedentary	JJ	O	O
and	CC	O	O
mostly	RB	O	O
in	IN	O	O
bed	NN	O	O
following	VBG	O	O
the	DT	B-TREATMENT	B-TREATMENT
operation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
slight	JJ	I-PROBLEM	I-PROBLEM
headaches	NNS	I-PROBLEM	I-PROBLEM
which	WDT	O	O
resolved	VBD	O	O
with	IN	O	O
tylenol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
the	DT	B-PROBLEM	B-PROBLEM
dizziness	NN	I-PROBLEM	I-PROBLEM
resolved	VBD	O	O
as	RB	O	O
well	RB	O	O
.	.	O	O

her	PRP$	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
remained	VBD	O	O
benign	JJ	O	O
and	CC	O	O
was	VBD	O	O
healing	VBG	O	O
nicely	RB	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

lopressor	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
q.a.m.	NN	O	O
,	,	O	O
25	CD	O	O
mg	NN	O	O
q.p.m.	NN	O	O
,	,	O	O
and	CC	O	O
25	CD	O	O
mg	NNS	O	O
q.h.s.	RB	O	O
,	,	O	O
synthroid	JJ	B-TREATMENT	B-TREATMENT
88	CD	O	O
mcg	NN	O	O
q.d.	NN	O	O
,	,	O	O
norvasc	RB	B-TREATMENT	B-TEST
5	CD	O	O
mg	NN	O	O
q.d.	NN	O	O
,	,	O	O
lescol	VBZ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
q.p.m.	NN	O	O
with	IN	O	O
meal	NN	O	B-TREATMENT
,	,	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
is	VBZ	O	O
usually	RB	O	O
4	CD	O	O
mg	NNS	O	O
p.o.	RB	O	O
3x	CD	O	O
a	DT	O	O
week	NN	O	O
and	CC	O	O
3	CD	O	O
mg	NN	O	O
4x	CD	O	O
a	DT	O	O
week	NN	O	O
;	:	O	O
percocet	CC	B-TREATMENT	O
1-2	JJ	O	O
tabs	NN	O	O
q.4h.	NN	O	O
p.r.n.	NN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

a	DT	B-TEST	O
negative	JJ	O	O
,	,	O	O
antibody	JJ	B-TEST	B-TEST
negative	JJ	O	O
,	,	O	O
hepatitis	JJ	B-TEST	B-TEST
surface	NN	I-TEST	I-TEST
antigen	NN	I-TEST	I-TEST
negative	JJ	O	O
,	,	O	O
rpr	JJ	B-TEST	O
nonreactive	JJ	O	O
,	,	O	O
rubella	NN	B-TEST	B-TEST
immune	NN	O	O
and	CC	O	O
gbs	NN	B-TEST	B-TEST
negative	JJ	O	O
.	.	O	O

pregnancy	NN	O	O
was	VBD	O	O
iui	RB	O	O
assisted	VBN	O	O
for	IN	O	O
di-di	JJ	O	B-PROBLEM
twin	JJ	O	I-PROBLEM
gestation	NN	O	I-PROBLEM
and	CC	O	O
was	VBD	O	O
relatively	RB	O	O
uncomplicated	JJ	B-PROBLEM	O
until	IN	O	O
mother	RB	O	O
presented	VBN	O	O
on	IN	O	O
12-15	NNS	O	O
,	,	O	O
with	IN	O	O
spontaneous	JJ	O	B-PROBLEM
rupture	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
membranes	NNS	O	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
having	VBG	O	O
preterm	JJ	B-PROBLEM	B-PROBLEM
contractions	NNS	I-PROBLEM	I-PROBLEM
without	IN	O	O
cervical	JJ	B-PROBLEM	B-PROBLEM
change	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
bedrest	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

she	PRP	O	O
received	VBD	O	O
a	DT	O	O
full	JJ	O	O
course	NN	O	O
of	IN	O	O
betamethasone	NN	B-TREATMENT	B-TREATMENT
complete	JJ	O	O
on	IN	O	O
12-17	JJ	O	O
,	,	O	O
magnesium	NN	B-TREATMENT	B-TEST
and	CC	O	O
erythromycin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
latency	NN	O	O
through	IN	O	O
12-21	JJ	O	O
.	.	O	O

intermittent	JJ	B-PROBLEM	B-PROBLEM
maternal	JJ	I-PROBLEM	I-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
noted	VBD	O	O
but	CC	O	O
without	IN	O	O
proteinuria	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

ultrasounds	NNS	B-TEST	B-TEST
have	VBP	O	O
been	VBN	O	O
reassuring	VBG	O	O
with	IN	O	O
biophysicals	NNS	B-TEST	O
8	CD	O	O
out	IN	O	O
of	IN	O	O
8	CD	O	O
x2	NNS	O	O
.	.	O	O

on	IN	O	O
the	DT	O	O
evening	NN	O	O
of	IN	O	O
12-27	JJ	O	O
,	,	O	O
monitoring	NN	B-TEST	B-TEST
noted	VBD	O	O
child	NN	O	B-PROBLEM
's	POS	O	I-PROBLEM
increased	JJ	B-PROBLEM	I-PROBLEM
preterm	NN	I-PROBLEM	I-PROBLEM
contractions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
uterine	JJ	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
increased	VBD	I-PROBLEM	I-PROBLEM
fetal	JJ	I-PROBLEM	I-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
rates	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
due	JJ	O	O
to	TO	O	O
concerns	NNS	O	O
of	IN	O	O
possible	JJ	O	O
chorioamnionitis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
the	DT	O	O
mother	NN	O	O
was	VBD	O	O
taken	VBN	O	O
for	IN	O	O
cesarean	JJ	B-TREATMENT	B-TREATMENT
delivery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
infant	NN	O	O
delivered	VBN	O	O
with	IN	O	O
moderate	JJ	O	B-PROBLEM
tone	NN	O	I-PROBLEM
and	CC	O	O
respiratory	NN	O	B-PROBLEM
effort	NN	O	I-PROBLEM
responding	VBG	O	O
well	RB	O	O
to	TO	O	O
stimulation	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
brief	JJ	B-TREATMENT	O
blow	NN	I-TREATMENT	O
by	IN	I-TREATMENT	O
o2	NN	I-TREATMENT	O
.	.	O	O

apgars	NNS	B-TEST	B-TEST
were	VBD	O	O
8	CD	O	O
and	CC	O	O
8	CD	O	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
weight	NN	B-TEST	B-TEST
1515	CD	O	O
grams	NN	O	O
,	,	O	O
10th	CD	O	O
to	TO	O	O
25th	CD	O	O
percentile	NN	O	O
,	,	O	O
head	NN	B-TEST	B-TEST
circumference	NN	I-TEST	I-TEST
30	CD	O	O
cm	NN	O	O
,	,	O	O
25th	CD	O	O
to	TO	O	O
50th	CD	O	O
percentile	NN	O	O
,	,	O	O
length	VBZ	B-TEST	B-TEST
41	CD	O	O
cm	NN	O	O
,	,	O	O
10th	CD	O	O
to	TO	O	O
25th	CD	O	O
percentile	NN	O	O
.	.	O	O

warm	NN	O	O
,	,	O	O
dry	JJ	O	O
,	,	O	O
premature	JJ	B-PROBLEM	B-PROBLEM
infant	NN	O	I-PROBLEM
,	,	O	O
active	JJ	O	O
with	IN	O	O
exam	NN	B-TEST	B-TEST
,	,	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
rest	NN	O	O
.	.	O	O

thin	NN	O	O
,	,	O	O
warm	JJ	O	O
,	,	O	O
dry	JJ	O	O
,	,	O	O
pink	VB	O	O
,	,	O	O
no	DT	O	O
rashes	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

nondysmorphic	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

positive	JJ	O	O
red	JJ	B-TEST	B-TEST
reflex	NN	I-TEST	I-TEST
bilaterally	RB	I-TEST	O
.	.	O	O

neck	NN	O	O
supple	NN	O	O
,	,	O	O
no	DT	O	O
lesions	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

mild	JJ	B-PROBLEM	B-PROBLEM
grunting	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
no	DT	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
femoral	JJ	B-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
2+	CD	O	O
.	.	O	O

abdomen	NNS	O	O
soft	JJ	O	O
,	,	O	O
no	DT	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
quiet	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
,	,	O	O
3	CD	O	O
vessel	NN	O	O
cord	NN	O	O
.	.	O	O

no	DT	O	O
lesions	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

pocasset	NN	O	B-TREATMENT
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
newborn	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
with	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
pneumothorax	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
resolved	VBD	O	O
on	IN	O	O
its	PRP$	O	O
own	JJ	O	O
without	IN	O	O
intervention	NN	B-TREATMENT	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
has	VBZ	O	O
remained	VBN	O	O
in	IN	O	O
room	NN	O	O
air	NN	O	O
throughout	IN	O	O
her	PRP$	O	O
hospital	JJ	O	O
course	NN	O	O
with	IN	O	O
occasional	JJ	B-PROBLEM	B-PROBLEM
apnea	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
bradycardia	NN	B-PROBLEM	B-PROBLEM
episodes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
the	DT	O	O
last	JJ	O	O
being	VBG	O	O
documented	VBN	O	O
on	IN	O	O
2020-01-14	JJ	O	O
.	.	O	O

birth	NN	B-TEST	B-TEST
weight	NN	I-TEST	I-TEST
was	VBD	O	O
1515	CD	O	O
grams	NNS	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
initially	RB	O	O
started	VBN	O	O
on	IN	O	O
80	CD	O	O
cc	NNS	O	O
per	IN	O	O
kilo	FW	O	O
per	IN	O	O
day	NN	O	O
of	IN	O	O
d10w	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

enteral	JJ	B-TREATMENT	B-TREATMENT
feedings	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
initiated	VBN	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
#1	NN	O	O
.	.	O	O

full	JJ	B-TREATMENT	B-TREATMENT
enteral	JJ	I-TREATMENT	I-TREATMENT
feedings	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
achieved	VBN	O	O
by	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
#7	NN	O	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
had	VBD	O	O
a	DT	O	O
course	NN	O	O
of	IN	O	O
heme	JJ	B-PROBLEM	B-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
stools	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
grossly	RB	B-PROBLEM	B-PROBLEM
bloody	JJ	I-PROBLEM	I-PROBLEM
streaks	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
mucus	VB	B-PROBLEM	I-PROBLEM
felt	VBD	O	O
to	TO	O	O
be	VB	O	O
protein	JJ	B-PROBLEM	B-PROBLEM
allergy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
infant	NN	O	O
is	VBZ	O	O
now	RB	O	O
receiving	VBG	O	O
breast	NN	O	B-TREATMENT
milk	NN	O	I-TREATMENT
with	IN	O	O
nutramigen	JJ	B-TREATMENT	O
powder	NN	I-TREATMENT	O
concentrate	NN	I-TREATMENT	O
to	TO	O	O
24	CD	O	O
calorie	NN	O	O
.	.	O	O

stools	NNS	O	O
have	VBP	O	O
been	VBN	O	O
negative	JJ	O	O
to	TO	O	O
trace	VB	B-PROBLEM	O
positive	JJ	I-PROBLEM	O
and	CC	O	O
abdominal	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
is	VBZ	O	O
reassuring	VBG	O	O
.	.	O	O

discharge	NN	B-TEST	B-TEST
weight	NN	I-TEST	I-TEST
is	VBZ	O	O
2040	CD	O	O
gm	NN	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
circumference	NN	I-TEST	I-TEST
is	VBZ	O	O
32	CD	O	O
cm	NN	O	O
and	CC	O	O
the	DT	B-TEST	O
length	NN	I-TEST	O
is	VBZ	O	O
46	CD	O	O
cm.	NN	O	O
.	.	O	O

peak	NN	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
was	VBD	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
#2	NN	O	O
of	IN	O	O
4.8/0.3	CD	O	O
.	.	O	O

hematocrit	NN	B-TEST	B-TEST
on	IN	O	O
admission	NN	O	O
was	VBD	O	O
41	CD	O	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
did	VBD	O	O
not	RB	O	O
require	VB	O	O
any	DT	B-TREATMENT	B-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
during	IN	O	O
this	DT	O	O
hospital	JJ	O	O
course	NN	O	O
.	.	O	O

cbc	NN	B-TEST	B-TEST
and	CC	O	O
blood	NN	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
were	VBD	O	O
obtained	VBN	O	O
on	IN	O	O
admission	NN	O	O
.	.	O	O

white	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
4.8	CD	O	O
,	,	O	O
7	CD	B-TEST	O
polys	NN	I-TEST	B-TEST
,	,	O	O
zero	CD	B-TEST	O
bands	NNS	I-TEST	B-TEST
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
316,000	CD	O	O
.	.	O	O

anc	NN	B-TEST	B-TREATMENT
at	IN	O	O
that	DT	O	O
time	NN	O	O
was	VBD	O	O
336	CD	O	O
.	.	O	O

a	DT	B-TEST	O
24	CD	I-TEST	O
hour	NN	I-TEST	O
cbc	NN	I-TEST	O
was	VBD	O	O
obtained	VBN	O	O
.	.	O	O

white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
5.1	CD	O	O
,	,	O	O
22	CD	B-TEST	O
polys	NN	I-TEST	B-TEST
,	,	O	O
zero	CD	B-TEST	O
bands	NNS	I-TEST	B-TEST
with	IN	O	O
a	DT	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
of	IN	O	O
39.3	CD	O	O
and	CC	O	O
platelets	NNS	B-TEST	B-TEST
of	IN	O	O
313,000	CD	O	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
received	VBD	O	O
48	CD	O	O
hours	NNS	O	O
of	IN	O	O
ampicillin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
which	WDT	O	O
were	VBD	O	O
discontinued	VBN	O	O
with	IN	O	O
a	DT	O	O
negative	JJ	O	O
blood	NN	O	B-TEST
culture	NN	O	I-TEST
.	.	O	O

audiology	NN	B-TEST	O
hearing	VBG	I-TEST	O
screen	NN	I-TEST	O
was	VBD	O	O
performed	VBN	O	O
with	IN	O	O
automated	JJ	B-TEST	B-TEST
auditory	NN	I-TEST	I-TEST
brainstem	NN	I-TEST	I-TEST
responses	NNS	I-TEST	I-TEST
and	CC	O	O
the	DT	O	O
infant	NN	O	O
passed	VBN	O	O
on	IN	O	O
both	DT	O	O
ears	NNS	O	O
.	.	O	O

1.	CD	O	O
continue	NN	O	O
breast	NN	O	B-TREATMENT
milk	NN	O	I-TREATMENT
24	CD	O	O
calories	NNS	O	O
of	IN	O	O
nutramigen	NN	B-TREATMENT	O
for	IN	O	O
concentration	NN	O	B-PROBLEM
.	.	O	O

2.	CD	O	O
medications	NNS	B-TREATMENT	B-TREATMENT
:	:	O	O
the	DT	O	O
infant	NN	O	O
is	VBZ	O	O
receiving	VBG	O	O
fer-in-phillip	JJ	B-TREATMENT	B-TREATMENT
supplementation	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
0.15	CD	O	O
ml	NNS	O	O
p.o.	JJ	O	O
once	RB	O	O
daily	JJ	O	O
.	.	O	O

3.	CD	O	O
car	NN	B-TEST	B-TEST
seat	NN	I-TEST	I-TEST
position	NN	I-TEST	I-TEST
screening	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
for	IN	O	O
screening	NN	O	B-TEST
and	CC	O	O
the	DT	O	O
infant	NN	O	O
passed	VBD	O	O
.	.	O	O

4.	CD	O	O
state	NN	B-TEST	B-TEST
newborn	JJ	I-TEST	I-TEST
screens	NNS	I-TEST	I-TEST
have	VBP	O	O
been	VBN	O	O
sent	VBN	O	O
per	IN	O	O
protocol	NN	O	O
,	,	O	O
most	RBS	O	O
recently	RB	O	O
on	IN	O	O
01-11	NN	O	O
,	,	O	O
and	CC	O	O
have	VBP	O	O
been	VBN	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

5.	CD	O	O
immunizations	NNS	B-TREATMENT	B-TREATMENT
received	VBD	O	O
:	:	O	O
hepatitis	NN	B-TREATMENT	B-PROBLEM
b	NN	I-TREATMENT	I-PROBLEM
vaccine	NN	I-TREATMENT	I-PROBLEM
on	IN	O	O
2020-01-19	JJ	O	O
.	.	O	O

6.	CD	O	O
immunizations	NNS	B-TREATMENT	B-TREATMENT
recommended	VBD	O	O
:	:	O	O

synagis	NN	B-TREATMENT	B-TREATMENT
rsv	NN	I-TREATMENT	I-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
should	MD	O	O
be	VB	O	O
considered	VBN	O	O
from	IN	O	O
november	CC	O	O
through	IN	O	O
march	NN	O	O
for	IN	O	O
infants	NNS	O	O
who	WP	O	O
meet	VBP	O	O
any	DT	O	O
of	IN	O	O
the	DT	O	O
following	VBG	O	O
3	CD	O	O
criteria	NNS	O	O
:	:	O	O

daycare	NN	O	O
during	IN	O	O
rsv	NN	O	O
season	NN	O	O
,	,	O	O
a	DT	O	O
smoker	NN	O	O
in	IN	O	O
the	DT	O	O
household	NN	O	O
,	,	O	O
neuromuscular	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	I-PROBLEM
airway	JJ	B-PROBLEM	I-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
or	CC	O	O
school	NN	O	O
age	NN	O	O
sibling	NN	O	O
,	,	O	O
or	CC	O	O
3	CD	O	O
with	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

influenza	JJ	B-TREATMENT	B-TREATMENT
immunization	NN	I-TREATMENT	I-TREATMENT
is	VBZ	O	O
recommended	VBN	O	O
annually	RB	O	O
in	IN	O	O
the	DT	O	O
fall	NN	O	O
for	IN	O	O
all	DT	O	O
infants	NNS	O	O
once	IN	O	O
they	PRP	O	O
reach	VBP	O	O
6	CD	O	O
months	NNS	O	O
of	IN	O	O
age	NN	O	O
.	.	O	O

before	IN	O	O
this	DT	O	O
age	NN	O	O
and	CC	O	O
for	IN	O	O
the	DT	O	O
first	JJ	O	O
24	CD	O	O
months	NNS	O	O
of	IN	O	O
the	DT	O	O
child	NN	O	O
's	POS	O	O
life	NN	O	O
,	,	O	O
immunization	NN	B-TREATMENT	B-TREATMENT
against	IN	O	O
influenza	NN	B-PROBLEM	B-PROBLEM
is	VBZ	O	O
recommended	VBN	O	O
for	IN	O	O
household	NN	O	O
contacts	NNS	O	O
and	CC	O	O
out	IN	O	O
of	IN	O	O
home	NN	O	O
caregivers	NNS	O	O
.	.	O	O

1.	CD	O	O
premature	NN	B-PROBLEM	O
twin	NN	I-PROBLEM	O
#1	NNP	O	O
born	NN	O	O
at	IN	O	O
32	CD	O	O
and	CC	O	O
5/7	CD	O	O
weeks	NNS	O	O
.	.	O	O

2.	CD	O	O
rule	NN	O	O
out	IN	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

3.	CD	O	O
respiratory	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
pneumothorax	NN	I-PROBLEM	I-PROBLEM
resolved	VBD	O	O
.	.	O	O

4.	CD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
hyperbilirubinemia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

5.	CD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
apnea	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
bradycardia	NN	I-PROBLEM	B-PROBLEM
of	IN	O	I-PROBLEM
prematurity	NN	B-PROBLEM	I-PROBLEM
resolved	VBN	O	O
.	.	O	O

6.	CD	O	O
possible	JJ	O	O
milk	NN	B-PROBLEM	B-PROBLEM
proteine	NN	I-PROBLEM	I-PROBLEM
allergy	NN	I-PROBLEM	I-PROBLEM

a	DT	B-TEST	B-TEST
hip	NN	I-TEST	I-TEST
ultrasound	NN	I-TEST	I-TEST
due	JJ	O	O
to	TO	O	O
breech	VB	B-PROBLEM	O
/	NNP	O	O
breech	JJ	B-PROBLEM	O
presentation	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
twins	NNS	I-PROBLEM	O
.	.	O	O

savd	NN	B-TREATMENT	O

dr.	JJ	O	O
kote	VB	O	O
6	CD	O	O
weeks	NNS	O	O
,	,	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM

spontaneous	JJ	B-PROBLEM	B-PROBLEM
vaginal	JJ	I-PROBLEM	I-PROBLEM
delivery	NN	I-PROBLEM	I-PROBLEM
laceration	NN	I-PROBLEM	I-PROBLEM
2	CD	O	I-PROBLEM
degrees	NNS	O	I-PROBLEM

responsible	JJ	O	O
after	IN	O	O
study	NN	O	O
for	IN	O	O
causing	VBG	O	O
admission	NN	O	O
)	)	O	O
savd	NN	B-TREATMENT	O

savd	NN	B-TREATMENT	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
no	DT	O	O
complications	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
further	JJ	B-PROBLEM	B-PROBLEM
events	NNS	I-PROBLEM	I-PROBLEM
while	IN	O	O
in	IN	O	O
house	NN	O	O
.	.	O	O

on	IN	O	O
thursday	JJ	O	O
-	:	O	O
2014-02-06	JJ	O	O
-	:	O	O
the	DT	O	O
patient	NN	O	O
did	VBD	O	O
have	VB	O	O
two	CD	O	O
episodes	NNS	O	O
of	IN	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
discomfort	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
for	IN	O	O
which	WDT	O	O
he	PRP	O	O
was	VBD	O	O
given	VBN	O	O
nitroglycerin	JJ	B-TREATMENT	B-TREATMENT
and	CC	O	O
those	DT	O	O
resolved	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
did	VBD	O	O
have	VB	O	O
an	DT	O	B-TEST
evaluation	NN	O	I-TEST
of	IN	O	I-TEST
electrocardiogram	NN	B-TEST	I-TEST
done	VBN	O	O
by	IN	O	O
cardiology	NN	O	O
which	WDT	O	O
was	VBD	O	O
negative	JJ	O	O
and	CC	O	O
had	VBD	O	O
laboratory	NN	B-TEST	O
results	NNS	I-TEST	O
for	IN	O	O
rule	NN	O	O
out	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
were	VBD	O	O
also	RB	O	O
negative	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
no	DT	O	O
further	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
chest	NN	B-PROBLEM	B-PROBLEM
discomfort	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
remained	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
while	IN	O	O
in	IN	O	O
house	NN	O	O
.	.	O	O

endometrial	JJ	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM

endometrial	JJ	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

endometrial	JJ	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

total	JJ	B-TREATMENT	B-TREATMENT
abdominal	JJ	I-TREATMENT	I-TREATMENT
hysterectomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT	I-TREATMENT

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
48-year-old	JJ	O	O
g	NN	O	O
3	CD	O	O
p	NN	O	O
3	CD	O	O
who	WP	O	O
presented	VBD	O	O
to	TO	O	O
dr.	VB	O	O
fuscmadril	JJ	O	O
&apos;s	NNP	O	O
clinic	NN	O	O
after	IN	O	O
having	VBG	O	O
an	DT	B-PROBLEM	B-PROBLEM
abnormal	JJ	I-PROBLEM	I-PROBLEM
pap	NN	I-PROBLEM	I-PROBLEM
smear	NN	I-PROBLEM	I-PROBLEM
followed	VBN	O	O
by	IN	O	O
an	DT	B-TEST	B-TEST
endometrial	JJ	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
that	WDT	O	O
was	VBD	O	O
suggestive	JJ	O	O
of	IN	O	O
grade	NN	B-PROBLEM	B-PROBLEM
1	CD	I-PROBLEM	I-PROBLEM
endometrial	JJ	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
patient	NN	O	O
who	WP	O	O
,	,	O	O
over	IN	O	O
the	DT	O	O
past	JJ	O	O
year	NN	O	O
,	,	O	O
has	VBZ	O	O
had	VBN	O	O
no	DT	B-PROBLEM	O
menses	NNS	I-PROBLEM	B-PROBLEM
and	CC	O	O
thought	VBD	O	O
she	PRP	O	O
had	VBD	O	O
become	VBN	O	O
menopausal	NN	B-PROBLEM	O
.	.	O	O

she	PRP	O	O
then	RB	O	O
began	VBD	O	O
spotting	VBG	B-PROBLEM	O
for	IN	O	O
several	JJ	O	O
months	NNS	O	O
with	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
constant	JJ	I-PROBLEM	I-PROBLEM
brown	JJ	I-PROBLEM	I-PROBLEM
discharge	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
pap	NN	I-TEST	I-TEST
smear	NN	I-TEST	I-TEST
that	WDT	O	O
was	VBD	O	O
obtained	VBN	O	O
by	IN	O	O
her	PRP$	O	O
primary	JJ	O	O
care	NN	O	O
physician	NN	O	O
showed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
endometrial	JJ	I-PROBLEM	I-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
thus	RB	O	O
she	PRP	O	O
was	VBD	O	O
referred	VBN	O	O
to	TO	O	O
a	DT	O	O
gynecologist	NN	O	O
for	IN	O	O
an	DT	B-TEST	B-TEST
endometrial	JJ	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
.	.	O	O

the	DT	B-TEST	B-TEST
endometrial	JJ	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
showed	VBD	O	O
grade	JJ	B-PROBLEM	B-PROBLEM
1	CD	I-PROBLEM	I-PROBLEM
endometrial	JJ	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	O	O
decision	NN	O	O
was	VBD	O	O
made	VBN	O	O
to	TO	O	O
proceed	VB	O	O
with	IN	O	O
surgical	JJ	B-TREATMENT	B-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
this	DT	O	O
finding	NN	O	O
.	.	O	O

migraines	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

penicillin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

two	CD	B-TREATMENT	B-TREATMENT
cesarean	JJ	I-TREATMENT	I-TREATMENT
sections	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

then	RB	O	O
becoming	VBG	O	O
irregular	NN	B-PROBLEM	O
for	IN	O	O
several	JJ	O	O
years	NNS	O	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
had	VBD	O	O
one	CD	O	O
normal	JJ	B-TREATMENT	O
spontaneous	JJ	I-TREATMENT	O
vaginal	JJ	I-TREATMENT	O
delivery	NN	I-TREATMENT	O
and	CC	O	O
two	CD	O	B-TREATMENT
cesarean	JJ	B-TREATMENT	I-TREATMENT
sections	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

imitrex	NN	B-TREATMENT	O
;	:	O	O
indocin	NN	B-TREATMENT	O
;	:	O	O
celebrex	NN	B-TREATMENT	B-TREATMENT
;	:	O	O
verapamil	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
migraines	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

mother	NN	O	O
with	IN	O	O
colonic	JJ	B-PROBLEM	B-PROBLEM
polyps	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
a	DT	O	O
maternal	JJ	O	O
uncle	NN	O	O
and	CC	O	O
maternal	JJ	O	O
aunt	NN	O	O
both	DT	O	O
with	IN	O	O
colon	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
who	WP	O	O
have	VBP	O	O
passed	VBN	O	O
away	RB	O	O
from	IN	O	O
this	DT	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
additional	JJ	O	O
history	NN	O	O
of	IN	O	O
breast	NN	B-PROBLEM	O
,	,	I-PROBLEM	O
ovarian	JJ	I-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	I-PROBLEM
uterine	JJ	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
her	PRP$	O	O
family	NN	O	O
.	.	O	O

no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

clear	JJ	O	O
to	TO	O	O
auscultation	NN	B-TEST	B-TEST
.	.	O	O

soft	JJ	O	O
,	,	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
obese	JJ	I-PROBLEM	I-PROBLEM
with	IN	O	O
pfannenstiel	JJ	B-PROBLEM	B-PROBLEM
scar	NN	I-PROBLEM	I-PROBLEM
visualized	VBN	O	O
.	.	O	O

no	DT	O	O
additional	JJ	B-PROBLEM	B-PROBLEM
masses	NNS	I-PROBLEM	I-PROBLEM
or	CC	O	O
nodules	NNS	B-PROBLEM	B-PROBLEM
appreciated	VBN	O	O
on	IN	O	O
exam	NN	B-TEST	B-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
which	WDT	O	O
was	VBD	O	O
09/20/00	CD	O	O
.	.	O	O

she	PRP	O	O
underwent	VBD	O	O
a	DT	B-TREATMENT	B-TEST
tah-bso	JJ	I-TREATMENT	I-TEST
which	WDT	O	O
was	VBD	O	O
uncomplicated	VBN	B-PROBLEM	O
.	.	O	O

details	NNS	O	O
of	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
can	MD	O	O
be	VB	O	O
found	VBN	O	O
in	IN	O	O
the	DT	O	O
operative	JJ	O	O
dictation	NN	O	O
.	.	O	O

in	IN	O	O
short	JJ	O	O
,	,	O	O
frozen	JJ	B-TEST	B-TEST
pathology	NN	I-TEST	I-TEST
from	IN	I-TEST	O
the	DT	I-TEST	O
uterus	NN	I-TEST	O
showed	VBD	O	O
that	IN	O	O
there	EX	O	O
was	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
grade	JJ	I-PROBLEM	I-PROBLEM
1	CD	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
no	DT	O	O
invasion	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
myometrium	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
nodal	JJ	B-TEST	B-TEST
dissection	NN	I-TEST	I-TEST
done	VBN	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
extremely	RB	O	O
well	RB	O	O
and	CC	O	O
did	VBD	O	O
well	RB	O	O
during	IN	O	O
her	PRP$	O	B-TREATMENT
postoperative	JJ	O	I-TREATMENT
course	NN	O	I-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
discharged	VBN	O	O
home	NN	O	O
with	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
following	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
:	:	O	O

percocet	NN	B-TREATMENT	B-TREATMENT
;	:	O	O
colace	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

patient	NN	O	O
recorded	VBD	O	O
as	IN	O	O
having	VBG	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
to	TO	O	O
drugs	NNS	B-TREATMENT	B-TREATMENT

right-sided	JJ	B-PROBLEM	B-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
difficulty	NN	B-PROBLEM	B-PROBLEM
speaking	NN	I-PROBLEM	I-PROBLEM

tpa	JJ	B-TREATMENT	O
administration	NN	I-TREATMENT	O

68	CD	O	O
year	NN	O	O
old	JJ	O	O
right	NN	O	O
handed	VBD	O	O
man	NN	O	O
with	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
vascular	JJ	I-PROBLEM	I-PROBLEM
risk	NN	I-PROBLEM	I-PROBLEM
factors	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
including	VBG	O	O
2	CD	B-PROBLEM	O
previous	JJ	I-PROBLEM	O
strokes	NNS	I-PROBLEM	O
and	CC	O	O
two	CD	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarctions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
who	WP	O	O
presents	VBZ	O	O
with	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
onset	NN	I-PROBLEM	I-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
sided	VBD	I-PROBLEM	I-PROBLEM
hemiplegia	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
dysarthria	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

his	PRP$	O	O
wife	NN	O	O
found	VBD	O	O
him	PRP	O	O
with	IN	O	O
weak	JJ	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
leg	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
flaccid	RB	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
arm	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
dysarthria	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

wife	NN	O	O
denies	VBZ	O	O
any	DT	B-PROBLEM	O
recent	JJ	I-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
surgeries	NNS	B-TREATMENT	O
,	,	O	O
or	CC	O	O
upper	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
1992	CD	O	B-PROBLEM
anterior	JJ	B-PROBLEM	I-PROBLEM
cerebellar	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM

2.	CD	O	O
silent	JJ	B-PROBLEM	B-PROBLEM
stroke	NN	I-PROBLEM	I-PROBLEM
affecting	VBG	O	O
anterior	JJ	O	O
part	NN	O	O
of	IN	O	O
brain	NN	O	O

3.	CD	O	O
2014-09-24	JJ	O	O
left	VBD	B-PROBLEM	O
mca	JJ	I-PROBLEM	B-PROBLEM
stroke	NN	I-PROBLEM	I-PROBLEM
leaving	VBG	O	O
him	PRP	O	O
with	IN	O	O
right	JJ	B-PROBLEM	B-PROBLEM
facial	JJ	I-PROBLEM	I-PROBLEM
droop	NN	I-PROBLEM	I-PROBLEM

4.	CD	O	O
cad	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
mi	NN	B-PROBLEM	O
1999	CD	O	O
and	CC	O	O
cabg	VB	B-TREATMENT	B-TREATMENT

5.	CD	O	O
hypercholesterolinemia	NN	B-PROBLEM	B-PROBLEM

6.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM

8.	CD	O	O
depression	NN	B-PROBLEM	B-PROBLEM

9.	CD	O	O
bipolar	JJ	B-PROBLEM	B-PROBLEM
disorder	NN	I-PROBLEM	I-PROBLEM

patient	NN	O	O
's	POS	O	O
mother	NN	O	O
died	VBD	O	O
of	IN	O	O
stroke	NN	B-PROBLEM	B-PROBLEM
at	IN	O	O
the	DT	O	O
age	NN	O	O
of	IN	O	O
54	CD	O	O
.	.	O	O

vitals	NNS	B-TEST	B-TEST
97.2	CD	O	O
164/97	CD	O	O
59	CD	O	O
20	CD	O	O
100%	CD	O	O
room	NN	O	O
air	NN	O	O

general	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
including	VBG	O	O
head	NN	B-TEST	O
,	,	I-TEST	O
neck	NN	I-TEST	O
,	,	I-TEST	O
heart	NN	I-TEST	O
,	,	I-TEST	O
lung	NN	I-TEST	O
,	,	I-TEST	O
abdominal	JJ	I-TEST	O
and	CC	I-TEST	O
extremity	NN	I-TEST	B-TEST
exam	NN	I-TEST	I-TEST
,	,	O	O
was	VBD	O	O
normal	JJ	O	O
.	.	O	O

nonfluent	JJ	B-PROBLEM	O
speech	NN	I-PROBLEM	O
with	IN	O	O
inability	NN	O	B-PROBLEM
to	TO	O	I-PROBLEM
repeat	VB	O	I-PROBLEM
.	.	O	O

no	DT	O	O
neglect	NN	B-PROBLEM	B-PROBLEM

visual	JJ	O	O
field	NN	O	O
full	JJ	O	O
to	TO	O	O
hand	NN	B-TEST	O
waving	NN	I-TEST	O
.	.	O	O

right	JJ	B-PROBLEM	B-PROBLEM
facial	JJ	I-PROBLEM	I-PROBLEM
droop	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

motor	NN	O	B-TEST
-	:	O	O
decreased	VBN	B-PROBLEM	B-PROBLEM
tone	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	O
right	JJ	I-PROBLEM	B-TREATMENT
arm	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

sensory	JJ	O	O
-	:	O	O
dense	NN	B-PROBLEM	B-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
to	TO	O	I-PROBLEM
touch	VB	B-TEST	I-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
right	JJ	O	I-PROBLEM
arm	NN	O	I-PROBLEM
and	CC	O	I-PROBLEM
leg	NN	O	I-PROBLEM

reflex	JJ	B-TEST	B-TEST
-	:	O	O
1+	CD	O	O
/	JJ	O	O
4	CD	O	O
in	IN	O	O
upper	JJ	O	O
extremity	NN	O	O
,	,	O	O
2+	CD	O	O
/	NN	O	O
4	CD	O	O
at	IN	O	O
patellar	NN	O	O
,	,	O	O
trace	NN	O	B-PROBLEM
ankle	NN	O	I-PROBLEM
.	.	O	O

intact	NN	O	O
on	IN	O	O
left	JJ	O	O
finger	NN	B-TEST	O
to	TO	I-TEST	O
nose	VB	I-TEST	O
but	CC	O	O
limited	VBD	B-PROBLEM	O
on	IN	O	O
right	NN	O	O
due	JJ	O	O
to	TO	O	O
weakness	NN	B-PROBLEM	B-PROBLEM

creatinine	NN	B-PROBLEM	B-PROBLEM
slightly	RB	I-PROBLEM	I-PROBLEM
elevated	VBD	I-PROBLEM	I-PROBLEM
at	IN	O	O
1.3	CD	O	O
,	,	O	O
otherwise	RB	O	O
cbc	NN	B-TEST	O
,	,	O	O
chemistries	NNS	B-TEST	B-TEST
normal	JJ	O	O
.	.	O	O

cardiac	JJ	B-TEST	B-TEST
enzymes	NNS	I-TEST	I-TEST
normal	JJ	O	O
.	.	O	O

valproate	NN	B-TEST	B-PROBLEM
level	NN	I-TEST	I-PROBLEM
within	IN	O	I-PROBLEM
range	NN	O	I-PROBLEM
.	.	O	O

ct	JJ	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
:	:	O	O

slight	JJ	B-PROBLEM	B-PROBLEM
effacement	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
posterior	JJ	I-PROBLEM	I-PROBLEM
insular	JJ	I-PROBLEM	I-PROBLEM
cortex	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mri	JJ	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
:	:	O	O

restricted	VBN	B-PROBLEM	B-PROBLEM
diffusion	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
frontotemporal	JJ	I-PROBLEM	I-PROBLEM
region	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
distribution	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
right	JJ	O	I-PROBLEM
middle	JJ	O	I-PROBLEM
cerebral	JJ	O	I-PROBLEM
artery	NN	O	I-PROBLEM
indicating	VBG	O	I-PROBLEM
acute	JJ	B-PROBLEM	I-PROBLEM
infarct	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

brain	NN	B-PROBLEM	B-PROBLEM
atrophy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

changes	NNS	O	O
of	IN	O	O
small	JJ	B-PROBLEM	B-PROBLEM
vessel	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
lacunes	NNS	I-PROBLEM	I-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
basal	NN	I-PROBLEM	I-PROBLEM
ganglia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

probable	JJ	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
infarct	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
occipital	JJ	I-PROBLEM	I-PROBLEM
cortex	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

also	RB	O	O
a	DT	B-PROBLEM	B-PROBLEM
chronic	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
cerebellum	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mra	NN	B-TEST	O
:	:	O	O

subtle	NN	B-PROBLEM	B-PROBLEM
decreased	VBD	I-PROBLEM	I-PROBLEM
flow	JJ	I-PROBLEM	I-PROBLEM
signal	NN	I-PROBLEM	I-PROBLEM
within	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
sylvian	JJ	I-PROBLEM	O
branches	NNS	I-PROBLEM	O
of	IN	O	O
the	DT	O	B-PROBLEM
left	NN	O	I-PROBLEM
middle	JJ	O	I-PROBLEM
cerebral	JJ	O	I-PROBLEM
artery	NN	O	I-PROBLEM
.	.	O	O

no	DT	O	O
evidence	NN	O	O
of	IN	O	O
major	JJ	B-PROBLEM	B-PROBLEM
vascular	JJ	I-PROBLEM	I-PROBLEM
occlusion	NN	I-PROBLEM	I-PROBLEM
seen	VBN	O	O
.	.	O	O

carotid	NN	B-TEST	B-TEST
ultrasound	NN	I-TEST	I-TEST
:	:	O	O

no	DT	O	O
stenosis	NN	B-PROBLEM	B-PROBLEM

echo	NN	B-TEST	B-TEST
:	:	O	O

elongated	VBN	B-PROBLEM	O
left	VBD	I-PROBLEM	O
atrium	NN	I-PROBLEM	O
.	.	O	O

lv	JJ	B-PROBLEM	O
cavity	NN	I-PROBLEM	O
moderately	RB	I-PROBLEM	O
dilated	VBD	I-PROBLEM	O
.	.	O	O

lvef	JJ	B-TEST	O
30-35%	CD	O	O
.	.	O	O

no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
thrombi	NNS	B-PROBLEM	B-PROBLEM
are	VBP	O	O
seen	VBN	O	O
in	IN	O	O
the	DT	O	O
left	JJ	O	O
ventricle	NN	O	O
.	.	O	O

resting	VBG	B-PROBLEM	B-PROBLEM
regional	JJ	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
motion	NN	I-PROBLEM	I-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
include	VBP	O	O
apical	JJ	B-PROBLEM	B-PROBLEM
dyskinesis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
distal	JJ	O	O
anterior	NN	O	O
,	,	O	O
septal	JJ	O	O
,	,	O	O
mid	JJ	O	B-PROBLEM
and	CC	O	I-PROBLEM
distal	JJ	B-PROBLEM	I-PROBLEM
inferior	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
inferolateral	JJ	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
akinesis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mildly	RB	B-PROBLEM	B-PROBLEM
dilated	VBN	I-PROBLEM	I-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
root	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
ascending	VBG	I-PROBLEM	O
aorta	NN	I-PROBLEM	O
.	.	O	O

no	DT	O	O
aortic	JJ	B-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	O
mitral	JJ	I-PROBLEM	B-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
pericardial	JJ	B-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

68m	CD	O	O
with	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
vascular	JJ	I-PROBLEM	I-PROBLEM
risk	NN	I-PROBLEM	I-PROBLEM
factors	NNS	I-PROBLEM	I-PROBLEM
presents	NNS	O	I-PROBLEM
with	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
onset	VBN	I-PROBLEM	I-PROBLEM
right-sided	JJ	I-PROBLEM	I-PROBLEM
hemiparesis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
dysarthria	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
aphasia	NN	B-PROBLEM	B-PROBLEM
concerning	VBG	O	O
for	IN	O	O
acute	NN	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
mca	JJ	I-PROBLEM	I-PROBLEM
infarct	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
arrived	VBN	O	O
in	IN	O	O
daniel	NN	O	O
within	IN	O	O
3	CD	O	O
hours	NNS	O	O
of	IN	O	O
symptom	JJ	B-PROBLEM	B-PROBLEM
onset	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
head	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
showed	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
bleed	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

however	RB	O	O
,	,	O	O
as	IN	O	O
wife	NN	O	O
had	VBD	O	O
not	RB	O	O
seen	VBN	O	O
patient	NN	O	O
before	IN	O	O
he	PRP	O	O
became	VBD	O	O
symptomatic	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
there	EX	O	O
was	VBD	O	O
some	DT	O	O
concern	NN	O	O
that	IN	O	O
he	PRP	O	O
had	VBD	O	O
symptoms	NNS	B-PROBLEM	B-PROBLEM
earlier	RBR	O	O
than	IN	O	O
6	CD	O	O
am	VBP	O	O
,	,	O	O
and	CC	O	O
therefore	RB	O	O
would	MD	O	O
be	VB	O	O
outside	IN	O	O
the	DT	O	O
3	CD	O	O
hour	NN	O	O
window	NN	O	O
for	IN	O	O
tpa	NN	B-TREATMENT	O
.	.	O	O

mri	NN	B-TEST	B-TEST
was	VBD	O	O
performed	VBN	O	O
which	WDT	O	O
showed	VBD	O	O
diffusion	NN	B-PROBLEM	B-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
but	CC	O	O
no	DT	O	O
hyperintensity	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
t2	NN	B-TEST	B-TEST
/	NNP	I-TEST	I-TEST
flair	NN	I-TEST	I-TEST
imaging	VBG	I-TEST	I-TEST
supporting	VBG	O	O
the	DT	O	B-PROBLEM
acute	NN	O	I-PROBLEM
onset	NN	O	I-PROBLEM
.	.	O	O

therefore	RB	O	O
,	,	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
tpa	NN	I-TREATMENT	I-TREATMENT
thrombolytics	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
administered	VBN	O	O
within	IN	O	O
3	CD	O	O
hours	NNS	O	O
of	IN	O	O
symptom	JJ	B-PROBLEM	B-PROBLEM
onset	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

within	IN	O	O
minutes	NNS	O	O
the	DT	O	O
patient	NN	O	O
showed	VBD	O	O
decreased	JJ	B-PROBLEM	B-PROBLEM
right	RB	I-PROBLEM	I-PROBLEM
sided	VBN	I-PROBLEM	I-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
improved	VBN	O	O
from	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
global	JJ	I-PROBLEM	I-PROBLEM
aphasia	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
an	DT	B-PROBLEM	B-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
aphasia	NN	I-PROBLEM	I-PROBLEM
picture	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

given	VBN	O	O
the	DT	O	O
likely	JJ	O	O
embolic	JJ	B-PROBLEM	O
etiology	NN	I-PROBLEM	O
of	IN	O	O
infarct	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
carotid	VBP	B-TEST	B-TEST
doppler	NN	I-TEST	I-TEST
and	CC	O	O
tte	NN	B-TEST	O
were	VBD	O	O
performed	VBN	O	O
.	.	O	O

doppler	NN	B-TEST	O
revealed	VBD	O	O
no	DT	O	O
hemodynamically	RB	B-PROBLEM	B-PROBLEM
significant	JJ	I-PROBLEM	I-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM
.	.	O	O

echo	NN	B-TEST	B-TEST
did	VBD	O	O
not	RB	O	O
reveal	VB	O	O
potential	JJ	O	O
source	NN	O	O
of	IN	O	O
emboli	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
but	CC	O	O
showed	VBD	O	O
striking	JJ	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
ventricle	NN	I-PROBLEM	I-PROBLEM
akinesis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
hypokinesis	NN	B-PROBLEM	B-PROBLEM
presumbly	RB	O	O
due	JJ	O	O
to	TO	O	O
past	VB	B-PROBLEM	O
mi	NN	I-PROBLEM	O
x	NN	O	O
2	CD	O	O
.	.	O	O

given	VBN	O	O
that	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
stroke	NN	I-PROBLEM	I-PROBLEM
occurred	VBD	O	O
while	IN	O	O
taking	VBG	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
plavix	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
given	VBN	O	O
the	DT	B-PROBLEM	B-PROBLEM
severe	JJ	I-PROBLEM	I-PROBLEM
akinesis	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
ventricle	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
we	PRP	O	O
decided	VBD	O	O
to	TO	O	O
initiate	VB	O	O
anticoagulation	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
warfarin	NN	B-TREATMENT	B-TREATMENT
to	TO	O	O
help	VB	O	O
prevent	VB	O	O
future	JJ	B-PROBLEM	B-PROBLEM
strokes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

anticoagulation	NN	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
initiated	VBN	O	O
with	IN	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
beginning	NN	O	O
on	IN	O	O
the	DT	O	O
evening	NN	O	O
of	IN	O	O
2016-08-23	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
and	CC	O	O
his	PRP$	O	O
wife	NN	O	O
,	,	O	O
a	DT	O	O
nurse	NN	O	O
,	,	O	O
were	VBD	O	O
educated	VBN	O	O
on	IN	O	O
low	JJ	B-TREATMENT	B-TEST
molecular	JJ	I-TREATMENT	I-TEST
wt	NN	I-TREATMENT	I-TEST
heparin	NN	I-TREATMENT	I-TEST
,	,	O	O
which	WDT	O	O
was	VBD	O	O
started	VBN	O	O
in	IN	O	O
the	DT	O	O
hospital	NN	O	O
on	IN	O	O
2015-08-26	JJ	O	O
with	IN	O	O
close	JJ	O	O
follow-up	NNS	O	O
scheduled	VBN	O	O
with	IN	O	O
dr.	JJ	O	O
demmert	NN	O	O
of	IN	O	O
the	DT	O	O
wareham	NN	O	O
va	NN	O	O
primary	JJ	O	O
care	NN	O	O
clinic	VBZ	O	O
the	DT	O	O
next	JJ	O	O
morning	NN	O	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TEST
depakote	NN	I-TREATMENT	I-TEST
was	VBD	O	O
continued	VBN	O	O
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
bipolar	JJ	I-PROBLEM	I-PROBLEM
disorder	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
discharge	NN	O	O
,	,	O	O
strength	NN	O	B-TEST
was	VBD	O	O
nearly	RB	O	O
intact	JJ	O	O
in	IN	O	O
the	DT	O	O
limbs	NN	O	O
,	,	O	O
though	IN	O	O
he	PRP	O	O
still	RB	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
right-sided	JJ	I-PROBLEM	I-PROBLEM
facial	JJ	I-PROBLEM	I-PROBLEM
droop	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

additionally	RB	O	O
,	,	O	O
he	PRP	O	O
still	RB	O	O
had	VBD	O	O
mild	VBN	B-PROBLEM	B-PROBLEM
dysarthria	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
aphasia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

additionally	RB	O	O
,	,	O	O
risk	NN	B-TREATMENT	O
factor	NN	I-TREATMENT	O
modification	NN	I-TREATMENT	O
was	VBD	O	O
continued	VBN	O	O
.	.	O	O

lipid	JJ	B-TEST	B-TEST
panel	NN	I-TEST	I-TEST
was	VBD	O	O
checked	VBN	O	O
and	CC	O	O
showed	VBD	O	O
good	JJ	O	O
control	NN	O	O
of	IN	O	O
lipids	NNS	O	O
on	IN	O	O
his	PRP$	B-TREATMENT	O
home	NN	I-TREATMENT	O
dose	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
zocor	NN	I-TREATMENT	B-TREATMENT
.	.	O	O

patient	NN	O	O
has	VBZ	O	O
no	DT	O	O
history	NN	O	O
of	IN	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
fasting	VBG	B-TEST	B-TEST
glucose	NN	I-TEST	I-TEST
was	VBD	O	O
78	CD	O	O
,	,	O	O
but	CC	O	O
a1c	NN	B-TEST	O
was	VBD	O	O
slightly	RB	B-PROBLEM	B-PROBLEM
elevated	VBN	I-PROBLEM	I-PROBLEM
at	IN	O	O
5.9	CD	O	O
.	.	O	O

he	PRP	O	O
may	MD	O	O
need	VB	O	O
further	JJR	B-TEST	B-TEST
glucose	VB	I-TEST	I-TEST
monitoring	NN	I-TEST	I-TEST
in	IN	O	O
the	DT	O	O
future	NN	O	O
.	.	O	O

his	PRP$	B-TREATMENT	O
home	NN	I-TREATMENT	O
hypertensive	NN	I-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
held	VBN	O	O
while	IN	O	O
in	IN	O	O
the	DT	O	O
hospital	NN	O	O
to	TO	O	O
help	VB	O	O
increase	VB	O	O
cerebral	JJ	O	O
perfusion	NN	O	O
and	CC	O	O
prevent	NN	O	O
further	RB	B-PROBLEM	O
ischemia	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

speech	NN	O	B-TREATMENT
therapy	NN	O	I-TREATMENT
was	VBD	O	O
also	RB	O	O
consulted	VBN	O	O
,	,	O	O
and	CC	O	O
recommended	VBD	O	O
oupatient	JJ	B-TREATMENT	B-TREATMENT
speech	NN	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

similarly	RB	O	O
,	,	O	O
outpatient	JJ	B-TREATMENT	O
pt	NN	I-TREATMENT	O
was	VBD	O	O
recommended	VBN	O	O
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
gait	NN	I-PROBLEM	I-PROBLEM
difficulties	NNS	I-PROBLEM	I-PROBLEM
from	IN	O	I-PROBLEM
his	PRP$	B-PROBLEM	I-PROBLEM
previous	JJ	I-PROBLEM	I-PROBLEM
strokes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

residual	JJ	B-PROBLEM	B-PROBLEM
deficits	NNS	I-PROBLEM	I-PROBLEM
include	VBP	O	O
right	JJ	B-PROBLEM	B-PROBLEM
side	NN	I-PROBLEM	I-PROBLEM
facial	JJ	I-PROBLEM	I-PROBLEM
droop	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
previous	JJ	B-PROBLEM	B-PROBLEM
stroke	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
moderately	RB	B-PROBLEM	B-PROBLEM
severe	JJ	I-PROBLEM	I-PROBLEM
dysarthria	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
anterior	JJ	B-PROBLEM	I-PROBLEM
aphasia	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
word	NN	B-PROBLEM	B-PROBLEM
finding	VBG	I-PROBLEM	I-PROBLEM
difficulties	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

captopril	JJ	B-TREATMENT	B-TREATMENT
50	CD	O	O
bid	NN	O	O
,	,	O	O
asa	RB	B-TREATMENT	O
81	CD	O	O
,	,	O	O
plavix	NN	B-TREATMENT	B-TREATMENT
75	CD	O	O
,	,	O	O
zocor	NN	B-TREATMENT	B-TREATMENT
40	CD	O	O
,	,	O	O
imdur	NN	B-TREATMENT	B-TREATMENT
30	CD	O	O
,	,	O	O
lasix	VBD	B-TREATMENT	B-TREATMENT
10	CD	O	O
,	,	O	O
prozac	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
,	,	O	O
iron	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
mvi	NN	B-TREATMENT	O

1.	CD	O	O
enoxaparin	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
80	CD	O	O
mg	NN	O	O
/	VBD	O	O
0.8	CD	O	O
ml	NN	O	O
syringe	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
syringe	NN	O	O
subcutaneous	JJ	O	O
q12h	NN	O	O
(	(	O	O
every	DT	O	O
12	CD	O	O
hours	NNS	O	O
)	)	O	O
:	:	O	O
may	MD	O	O
discontinue	VB	O	O
once	RB	O	O
inr	JJ	B-TEST	O
therapeutic	JJ	O	O
as	IN	O	O
directed	VBN	O	O
by	IN	O	O
your	PRP$	O	O
physician	NN	O	O
.	.	O	O

2.	CD	O	O
divalproex	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
500	CD	O	O
mg	NN	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

3.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
qd	NN	O	O
(	(	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
for	IN	O	O
7	CD	O	O
days	NNS	O	O
.	.	O	O

4.	CD	O	O
warfarin	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
hs	NN	O	O
(	(	O	O
at	IN	O	O
bedtime	NN	O	O
)	)	O	O
.	.	O	O

5.	CD	O	O
simvastatin	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

6.	CD	O	O
prozac	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

7.	CD	O	O
multivitamin	NN	B-TREATMENT	B-TREATMENT
capsule	NN	O	I-TREATMENT
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

8.	CD	O	O
captopril	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

9.	CD	O	O
imdur	JJ	B-TREATMENT	B-TREATMENT
30	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sustained	VBD	O	O
release	NN	O	O
24	CD	O	O
hr	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
sustained	VBD	O	O
release	NN	O	O
24hr	CD	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

infarction	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
middle	JJ	I-PROBLEM	I-PROBLEM
cerebral	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
inferior	JJ	I-PROBLEM	I-PROBLEM
division	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
s/p	NN	O	O

tpa	NN	B-TREATMENT	O
,	,	O	O
with	IN	O	O
residual	JJ	B-PROBLEM	B-PROBLEM
dysarthria	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
aphasia	NN	B-PROBLEM	B-PROBLEM

hypertension	NN	B-PROBLEM	B-PROBLEM

hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM

coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM

good	JJ	O	O
,	,	O	O
with	IN	O	O
no	DT	O	O
motor	NN	B-PROBLEM	B-PROBLEM
deficits	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
dysarthria	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
aphasia	NN	I-PROBLEM	I-PROBLEM

take	VB	O	O
all	DT	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
as	IN	O	O
directed	JJ	O	O
and	CC	O	O
go	VB	O	O
for	IN	O	O
all	DT	O	O
scheduled	JJ	O	O
appointments	NNS	O	O
for	IN	O	O
anticoagulation	NN	B-TEST	B-TREATMENT
monitoring	NN	I-TEST	I-TREATMENT
.	.	O	O

if	IN	O	O
problems	NNS	B-PROBLEM	O
with	IN	I-PROBLEM	O
speech	NN	I-PROBLEM	B-PROBLEM
or	CC	O	O
weakness	NN	B-PROBLEM	B-PROBLEM
worsen	NN	O	I-PROBLEM
,	,	O	O
go	VB	O	O
immediately	RB	O	O
to	TO	O	O
an	DT	O	O
emergency	NN	O	O
room	NN	O	O
for	IN	O	O
evaluation	NN	B-TEST	B-TEST
.	.	O	O

intravenous	JJ	B-TREATMENT	B-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

intravenous	JJ	B-TREATMENT	B-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

left	VBN	B-PROBLEM	B-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

intravenous	JJ	B-TREATMENT	B-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
63	CD	O	O
year	NN	O	O
old	JJ	O	O
woman	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
mixed	JJ	B-PROBLEM	B-PROBLEM
adenocarcinoma	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
large	JJ	B-PROBLEM	B-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
lung	NN	O	I-PROBLEM
who	WP	O	O
is	VBZ	O	O
being	VBG	O	O
admitted	VBN	O	O
for	IN	O	O
neoadjuvant	JJ	B-TREATMENT	B-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
cisplatinum	NN	B-TREATMENT	O
,	,	O	O
5-fu	JJ	B-TREATMENT	O
and	CC	O	O
velban	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

briefly	NN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
originally	RB	O	O
diagnosed	VBN	O	O
in	IN	O	O
april	JJ	O	O
1993	CD	O	O
with	IN	O	O
lung	NN	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

bronchoscopy	NN	B-TEST	B-TEST
and	CC	O	I-TEST
mediastinoscopy	NN	B-TEST	I-TEST
revealed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
unresectable	JJ	I-PROBLEM	I-PROBLEM
mediastinal	JJ	I-PROBLEM	I-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
the	DT	O	O
left	JJ	O	O
tracheobronchial	JJ	O	O
angle	NN	O	O
node	NN	O	O
positive	JJ	O	O
for	IN	O	O
cancer	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
the	DT	O	O
right	JJ	O	O
paratracheal	NN	O	O
node	RB	O	O
positive	JJ	O	O
for	IN	O	O
anthracosis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

formal	JJ	B-TEST	B-TEST
pathology	NN	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
poorly	RB	I-PROBLEM	I-PROBLEM
differentiated	VBN	I-PROBLEM	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
focal	JJ	B-PROBLEM	B-PROBLEM
giant	JJ	I-PROBLEM	I-PROBLEM
cells	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

bone	NN	B-TEST	B-TEST
scan	NN	I-TEST	I-TEST
,	,	O	O
head	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
and	CC	O	I-TEST
other	JJ	B-TEST	I-TEST
staging	VBG	I-TEST	I-TEST
studies	NNS	I-TEST	I-TEST
were	VBD	O	O
all	DT	O	O
negative	JJ	O	O
for	IN	O	O
evidence	NN	O	O
of	IN	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
being	VBG	O	O
treated	VBN	O	O
with	IN	O	O
preoperative	JJ	B-TREATMENT	B-TREATMENT
neoadjuvant	JJ	I-TREATMENT	I-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
using	VBG	I-TREATMENT	O
5	CD	I-TREATMENT	O
fu	NN	I-TREATMENT	O
,	,	O	O
vinblastine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
cisplatinum	NN	B-TREATMENT	O
and	CC	O	O
concomitant	JJ	B-TREATMENT	B-TREATMENT
radiation	NN	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
now	RB	O	O
admitted	VBN	O	O
for	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
second	JJ	I-TREATMENT	I-TREATMENT
course	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
that	DT	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

temperature	NN	B-TEST	B-TEST
98.9	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
82	CD	O	O
,	,	O	O
respirations	NNS	B-TEST	B-TEST
20	CD	O	O
.	.	O	O

sclera	NN	O	O
were	VBD	O	O
anicteric	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
neck	NN	O	O
was	VBD	O	O
supple	RB	O	O
without	IN	O	O
jvd	NN	B-PROBLEM	O
.	.	O	O

the	DT	O	O
lungs	NNS	O	O
showed	VBD	O	O
decreased	JJ	B-PROBLEM	B-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
sounds	NNS	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
base	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
otherwise	RB	O	O
were	VBD	O	O
clear	JJ	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
cardiac	NN	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
showed	VBD	O	O
a	DT	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
i	JJ	I-PROBLEM	I-PROBLEM
/	NN	I-PROBLEM	I-PROBLEM
vi	NN	I-PROBLEM	I-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
ejection	NN	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
and	CC	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
without	IN	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

rectal	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
was	VBD	O	O
guaiac	JJ	B-TEST	B-TEST
negative	JJ	O	O
.	.	O	O

extremities	NNS	O	O
were	VBD	O	O
without	IN	O	O
clubbing	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

neurologic	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
resting	VBG	I-PROBLEM	I-PROBLEM
tremor	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
arm	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
hand	NN	I-PROBLEM	O
.	.	O	O

white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
6.2	CD	O	O
,	,	O	O
hemoglobin	NN	B-TEST	B-TEST
12.4	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
36.1	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
265,000	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
liver	NN	I-TEST	I-TEST
function	NN	I-TEST	I-TEST
tests	NNS	I-TEST	I-TEST
were	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

bun	NN	B-TEST	B-TEST
8	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
0.9	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
oncology	NN	O	O
service	NN	O	O
on	IN	O	O
founder	NN	O	O
&apos;s	NN	O	O
7	CD	O	O
and	CC	O	O
received	VBD	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
a	DT	B-TREATMENT	O
72	CD	I-TREATMENT	O
hour	NN	I-TREATMENT	O
continuous	JJ	I-TREATMENT	O
infusion	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
5-fu	JJ	I-TREATMENT	O
,	,	O	O
vinblastine	JJ	B-TREATMENT	B-TREATMENT
on	IN	O	O
day	NN	O	O
1	CD	O	O
and	CC	O	O
day	NN	O	O
3	CD	O	O
,	,	O	O
and	CC	O	O
cisplatinum	NN	B-TREATMENT	O
on	IN	O	O
day	NN	O	O
1	CD	O	O
.	.	O	O

she	PRP	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
with	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
nausea	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
increase	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
her	PRP$	B-PROBLEM	I-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
during	IN	O	O
the	DT	O	O
hospitalization	NN	O	O
,	,	O	O
likely	RB	O	O
secondary	JJ	O	O
to	TO	O	O
fluid	VB	B-PROBLEM	B-PROBLEM
overload	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
also	RB	O	O
had	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
modest	JJ	I-PROBLEM	I-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
30.9	CD	O	O
.	.	O	O

overall	JJ	O	O
there	EX	O	O
were	VBD	O	O
no	DT	O	O
unanticipated	JJ	B-PROBLEM	B-PROBLEM
side	NN	I-PROBLEM	I-PROBLEM
effects	NNS	I-PROBLEM	I-PROBLEM
of	IN	O	O
this	DT	B-TREATMENT	B-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

following	VBG	O	O
her	PRP$	O	O
recovery	NN	O	O
from	IN	O	O
chemotherapy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
she	PRP	O	O
will	MD	O	O
proceed	VB	O	O
to	TO	O	O
surgical	JJ	B-TREATMENT	B-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

intravenous	JJ	B-TREATMENT	B-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
lung	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

slo-mag	JJ	B-TREATMENT	B-TEST
one	CD	O	O
tab	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
stelazine	NN	B-TREATMENT	B-TREATMENT
2	CD	O	O
mg.	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
ativan	VBD	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
or	CC	O	O
s.l.	JJ	O	O
q.	JJ	O	O
4-6	JJ	O	O
hr.	NN	O	O
p.r.n.	NN	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

cephalosporins	NNS	B-TREATMENT	B-TREATMENT
/	VBP	O	O
dilaudid	JJ	B-TREATMENT	B-TREATMENT
/	NNP	O	I-TREATMENT
metoclopramide	NN	B-TREATMENT	I-TREATMENT

chief	JJ	O	O
complaint	NN	O	O
:	:	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM

intubation	NN	B-TREATMENT	B-TREATMENT

central	JJ	B-TREATMENT	B-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT

bronchoscopy	NN	B-TEST	B-TEST

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
39	CD	O	O
year-old	JJ	O	O
female	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
type	VBP	I-PROBLEM	I-PROBLEM
i	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
anemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
gastroparesis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
gerd	NN	B-PROBLEM	O
,	,	O	O
who	WP	O	O
was	VBD	O	O
transferred	VBN	O	O
from	IN	O	O
mediplex	JJ	O	O
rehab	NN	O	O
hospital	NN	O	O
hospital	NN	O	O
for	IN	O	O
further	JJ	B-TREATMENT	B-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
hypoxic	NN	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
arrived	VBD	O	O
at	IN	O	O
mediplex	JJ	O	O
rehab	NN	O	O
hospital	NN	O	O
hospital	NN	O	O
on	IN	O	O
07-01	NN	O	O
for	IN	O	O
1	CD	O	O
day	NN	O	O
of	IN	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
febrile	JJ	B-PROBLEM	B-PROBLEM
to	TO	O	O
99	CD	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
likely	JJ	O	O
gastroparesis	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
eventually	RB	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
complete	JJ	I-TEST	I-TEST
fever	NN	I-TEST	I-TEST
work-up	NN	I-TEST	I-TEST
that	WDT	O	O
included	VBD	O	O
a	DT	O	B-TEST
negative	JJ	O	I-TEST
chest	NN	O	I-TEST
x-ray	NN	O	I-TEST
,	,	O	O
blood	NN	O	B-TEST
cultures	NNS	O	I-TEST
,	,	O	O
and	CC	O	O
urine	JJ	O	B-TEST
culture	NN	O	I-TEST
.	.	O	O

she	PRP	O	O
was	VBD	O	O
discharged	VBN	O	O
on	IN	O	O
07-02	NN	O	O
and	CC	O	O
represented	VBD	O	O
that	DT	O	O
day	NN	O	O
with	IN	O	O
continued	JJ	B-PROBLEM	B-PROBLEM
nause	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
fever	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
readmitted	VBN	O	O
and	CC	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
complete	JJ	I-TEST	I-TEST
febrile	NN	I-TEST	I-TEST
work-up	NN	I-TEST	I-TEST
that	WDT	O	O
included	VBD	O	O
ct	JJ	B-TEST	B-TEST
abdomene	NN	I-TEST	I-TEST
/	NNP	I-TEST	I-TEST
pelvis	NN	I-TEST	I-TEST
,	,	O	I-TEST
chest	JJ	B-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
,	,	O	O
blood	NN	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
,	,	O	I-TEST
urine	JJ	B-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
,	,	O	O
all	DT	O	O
of	IN	O	O
which	WDT	O	O
were	VBD	O	O
unremarkable	JJ	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
intubated	VBN	O	B-TREATMENT
on	IN	O	O
07-03	NN	O	O
for	IN	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

workup	NN	B-TEST	B-TEST
continued	VBD	O	O
to	TO	O	O
be	VB	O	O
negative	JJ	O	O
.	.	O	O

extubation	NN	B-TREATMENT	O
was	VBD	O	O
attempted	VBN	O	O
on	IN	O	O
07-14	NN	O	O
,	,	O	O
but	CC	O	O
she	PRP	O	O
was	VBD	O	O
re-intubated	JJ	O	O
due	JJ	O	O
to	TO	O	O
inspiratory	JJ	B-PROBLEM	B-PROBLEM
stridor	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
neck	NN	I-TEST	I-TEST
showed	VBD	O	O
soft	JJ	B-PROBLEM	B-PROBLEM
tissue	NN	I-PROBLEM	I-PROBLEM
swelling	VBG	I-PROBLEM	I-PROBLEM
obliterating	VBG	O	I-PROBLEM
the	DT	O	I-PROBLEM
airway	NN	O	I-PROBLEM
surrounding	VBG	O	O
the	DT	B-TREATMENT	B-TREATMENT
ett	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

1.	CD	O	O
type	NN	B-PROBLEM	B-PROBLEM
i	NN	I-PROBLEM	I-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
diagnosed	VBD	O	I-PROBLEM
at	IN	O	O
age	NN	O	O
27	CD	O	O
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
usually	RB	O	O
managed	VBN	O	O
on	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

2.	CD	O	O
hashimoto	NN	B-PROBLEM	B-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
thyroiditis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
gastroparesis	NN	B-PROBLEM	B-PROBLEM

4.	CD	O	O
history	NN	O	O
of	IN	O	O
bulemia	NN	B-PROBLEM	B-PROBLEM

5.	CD	O	O
anxiety	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
clonazepam	NN	B-TREATMENT	B-TREATMENT

6.	CD	O	O
history	NN	O	O
of	IN	O	O
diabetic	JJ	B-PROBLEM	B-PROBLEM
foot	NN	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

vitals	NNS	B-TEST	B-TEST
:	:	O	O

temperature	NN	B-TEST	B-TEST
:	:	O	O
98.8	CD	O	O
pulse	NN	B-TEST	B-TEST
:	:	O	O
79	CD	O	O

blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
:	:	O	O
125/89	CD	O	O

respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
:	:	O	O
12	CD	O	O

oxygen	NN	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST
:	:	O	O
100%	CD	O	O
on	IN	O	O
ac	NN	B-TREATMENT	O
500x12	CD	O	O
,	,	O	O
peep5	NN	B-TREATMENT	O
,	,	O	O
50%	CD	O	O

intubated	VBN	B-TREATMENT	B-TREATMENT
,	,	O	O
sedated	VBN	B-TREATMENT	B-TREATMENT
,	,	O	O
not	RB	B-PROBLEM	O
responsive	JJ	I-PROBLEM	O
to	TO	O	O
command	VB	B-TEST	O
,	,	O	O
retracts	NNS	O	O
to	TO	O	O
pain	VB	B-TEST	B-PROBLEM

anicteric	JJ	B-PROBLEM	B-PROBLEM
sclera	NN	I-PROBLEM	I-PROBLEM
bilat	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pupils	NNS	B-PROBLEM	B-PROBLEM
minimally	RB	I-PROBLEM	I-PROBLEM
reactive	VBP	I-PROBLEM	I-PROBLEM

no	DT	O	O
elevated	JJ	B-PROBLEM	B-PROBLEM
jvp	NN	I-PROBLEM	I-PROBLEM
appreciated	VBD	O	O
.	.	O	O

no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM

clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
anteriorly	RB	O	O
.	.	O	O

nondistended	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
hepatosplenomegally	RB	B-PROBLEM	B-PROBLEM
.	.	O	O

mildly	RB	B-PROBLEM	B-PROBLEM
hypoactive	JJ	I-PROBLEM	I-PROBLEM
bowelsounds	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM
.	.	O	O

pulses	NNS	B-PROBLEM	B-TEST
diminished	VBD	I-PROBLEM	O
but	CC	O	O
symmetric	JJ	O	O
.	.	O	O

sedated	VBN	B-TREATMENT	O
.	.	O	O

retracts	NNS	O	O
to	TO	O	O
painful	VB	B-TEST	B-TEST
stimuli	NNS	I-TEST	I-TEST

no	DT	O	O
rashes	NNS	B-PROBLEM	B-PROBLEM

wbc	SYM	B-TEST	B-TEST
-	:	O	O
29.9	CD	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
8.5	CD	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
26.8	CD	O	O
plt	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
-	:	O	O
323	CD	O	O
neuts	NNS	B-TEST	B-TEST
-	:	O	O
75	CD	O	O
bands	NNS	B-TEST	B-TEST
-	:	O	O
13	CD	O	O
lymphs	SYM	B-TEST	B-TEST
-	:	O	O
6	CD	O	O
monos	NNS	B-TEST	B-TEST
-	:	O	O
5	CD	O	O
eos	SYM	B-TEST	B-TEST
-	:	O	O
1	CD	O	O
basos	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
atyps	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
metas	NNS	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
myelos	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O

sodium	NN	B-TEST	B-TEST
-	:	O	O
137	CD	O	O
potassium	NN	B-TEST	B-TEST
-	:	O	O
4.5	CD	O	O
chloride	NN	B-TEST	B-TEST
-	:	O	O
106	CD	O	O
total	JJ	B-TEST	B-TEST
co2	NN	I-TEST	I-TEST
-	:	O	O
22	CD	O	O
urea	JJ	B-TEST	B-TEST
n	SYM	I-TEST	I-TEST
-	:	O	O
41	CD	O	O
*	NN	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.3	CD	O	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
231	CD	O	O
calcium	NN	B-TEST	B-TEST
-	:	O	O
7.7	CD	O	O
phosphate	NN	B-TEST	B-TEST
-	:	O	O
3.6	CD	O	O
magnesium	NN	B-TEST	B-TEST
-	:	O	O
2.4	CD	O	O

alt	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
sgpt	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
249	CD	O	O
ast	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
sgot	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
147	CD	O	I-TEST
ld	NN	B-TEST	I-TEST
(	(	I-TEST	I-TEST
ldh	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
241	CD	O	I-TEST
alk	NN	B-TEST	I-TEST
phos	NN	I-TEST	I-TEST
-	:	O	O
230	CD	O	O
amylase	NN	B-TEST	B-TEST
-	:	O	O
28	CD	O	O
tot	NN	B-TEST	O
bili	SYM	I-TEST	B-TEST
-	:	O	O
0.9	CD	O	O
lipase	NN	B-TEST	B-TEST
-	:	O	O
12	CD	O	O
albumin	SYM	B-TEST	B-TEST
-	:	O	O
2.6	CD	O	O

pt	SYM	B-TEST	B-TEST
-	:	O	O
13.8	CD	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
24.3	CD	O	O
inr	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
pt	JJ	I-TEST	I-TEST
)-	CD	I-TEST	I-TEST
1.2	CD	O	O

tsh	SYM	B-TEST	B-TEST
-	:	O	O
3.3	CD	O	O

1.	CD	O	O
nexk	JJ	B-TEST	O
ct	NN	I-TEST	O
:	:	O	O

increased	VBN	B-PROBLEM	B-PROBLEM
soft	JJ	I-PROBLEM	I-PROBLEM
tissues	NNS	I-PROBLEM	I-PROBLEM
within	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
pharynx	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
may	MD	O	O
be	VB	O	O
secondary	JJ	O	O
to	TO	O	O
soft	JJ	B-PROBLEM	B-PROBLEM
tissue	NN	I-PROBLEM	I-PROBLEM
swelling	VBG	I-PROBLEM	I-PROBLEM
as	IN	O	O
indicated	VBN	O	O
in	IN	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
history	NN	O	O
,	,	O	O
and	CC	O	O
some	DT	O	O
may	MD	O	O
be	VB	O	O
secondary	JJ	O	O
to	TO	O	O
secretions	NNS	B-PROBLEM	O
above	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
ett	NN	I-PROBLEM	O
balloon	NN	I-PROBLEM	O
.	.	O	O

no	DT	O	O
retropharyngeal	NN	B-PROBLEM	B-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
identified	VBN	O	O
.	.	O	O

dependent	JJ	B-PROBLEM	O
atelectasis	NN	I-PROBLEM	O
is	VBZ	O	O
present	JJ	O	O
within	IN	O	O
the	DT	O	O
visualized	JJ	O	O
portions	NNS	O	O
of	IN	O	O
the	DT	O	O
lung	NN	O	O
apices	NNS	O	O
.	.	O	O

2.	CD	O	O
chest	JJS	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
:	:	O	O

bilateral	JJ	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
consolidations	NNS	I-PROBLEM	I-PROBLEM
mostly	RB	O	I-PROBLEM
in	IN	O	I-PROBLEM
dependent	JJ	O	I-PROBLEM
portion	NN	O	I-PROBLEM
,	,	O	O
with	IN	O	O
small	JJ	B-PROBLEM	B-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
diffuse	VB	B-PROBLEM	B-PROBLEM
ground-glass	JJ	I-PROBLEM	I-PROBLEM
opacity	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
upper	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
consistent	JJ	O	O
with	IN	O	O
ards	NNS	B-PROBLEM	O
with	IN	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
given	VBN	O	O
the	DT	O	O
history	NN	O	O
.	.	O	O

ground-glass	NN	B-PROBLEM	B-PROBLEM
opacity	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
somewhat	RB	O	O
more	RBR	O	O
prominent	JJ	O	O
in	IN	O	O
right	JJ	O	O
upper	JJ	O	O
lobe	NN	O	O
,	,	O	O
and	CC	O	O
superimposed	VBD	B-PROBLEM	B-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
cannot	NN	O	O
be	VB	O	O
totally	RB	O	O
excluded	VBN	O	O
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
39	CD	O	O
year-old	JJ	O	O
female	NN	O	O
with	IN	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
type	VBP	I-PROBLEM	I-PROBLEM
i	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
gastroparesis	NN	B-PROBLEM	B-PROBLEM
who	WP	O	O
was	VBD	O	O
transfered	VBN	O	O
for	IN	O	O
hypoxic	JJ	B-PROBLEM	B-PROBLEM
respiratory	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
hypoxic	JJ	B-PROBLEM	B-PROBLEM
rspiratory	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

she	PRP	O	O
arrived	VBD	O	O
intubated	JJ	B-TREATMENT	B-TREATMENT
and	CC	O	O
sedated	VBN	B-TREATMENT	B-TREATMENT
from	IN	O	O
esteban	JJ	O	O
hospital	NN	O	O
.	.	O	O

on	IN	O	O
arrival	PDT	O	O
a	DT	B-TEST	B-TEST
chest	NN	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
showed	VBD	O	O
perihilar	JJ	B-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
bibasilar	JJ	I-PROBLEM	I-PROBLEM
opacities	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
appeared	VBD	O	O
conistent	NN	O	B-TREATMENT
with	IN	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
also	RB	O	O
possibly	RB	O	O
consistent	JJ	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
ards	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
known	VBN	O	O
to	TO	O	O
have	VB	O	O
gram-positive	JJ	B-PROBLEM	B-PROBLEM
cocci	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
sputum	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
the	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
bronchoscopy	NN	I-TEST	I-TEST
with	IN	O	O
bal	NN	B-TEST	O
was	VBD	O	O
performed	VBN	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
sputum	NN	I-TEST	I-TEST
sample	NN	I-TEST	I-TEST
eventually	RB	O	O
grew	VBD	O	O
out	RP	O	O
mrsa	NN	B-PROBLEM	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
to	TO	O	O
cover	VB	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
mrsa	JJ	I-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
ct	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
on	IN	O	O
07-17	NN	O	O
to	TO	O	O
evaluate	VB	O	O
the	DT	B-PROBLEM	B-PROBLEM
soft	JJ	I-PROBLEM	I-PROBLEM
tissue	NN	I-PROBLEM	I-PROBLEM
swelling	VBG	I-PROBLEM	I-PROBLEM
seen	VBN	O	O
on	IN	O	O
ct	NN	B-TEST	O
at	IN	O	O
the	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
showed	VBD	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
soft	JJ	I-PROBLEM	I-PROBLEM
tissues	NNS	I-PROBLEM	I-PROBLEM
within	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
pharynx	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
secondary	JJ	O	O
to	TO	O	O
prolonged	JJ	B-TREATMENT	B-PROBLEM
intubation	NN	I-TREATMENT	I-PROBLEM
/	NNP	O	I-PROBLEM
trauma	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
steroids	NNS	B-TREATMENT	B-TREATMENT
for	IN	O	O
this	DT	B-PROBLEM	B-PROBLEM
swelling	VBG	I-PROBLEM	I-PROBLEM
at	IN	O	O
the	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
,	,	O	O
and	CC	O	O
these	DT	O	O
were	VBD	O	O
continued	VBN	O	O
.	.	O	O

it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
that	IN	O	O
patient	NN	O	O
should	MD	O	O
receive	VB	O	O
one	CD	O	O
more	JJR	O	O
trial	NN	O	O
off	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
vent	NN	I-TREATMENT	I-TREATMENT
before	IN	O	O
committing	VBG	O	O
her	PRP$	O	O
to	TO	O	O
a	DT	B-TREATMENT	B-TREATMENT
tracheotomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
did	VBD	O	O
well	RB	O	O
on	IN	O	O
minimal	JJ	B-TREATMENT	B-TREATMENT
vent	JJ	I-TREATMENT	I-TREATMENT
settings	NNS	I-TREATMENT	I-TREATMENT
but	CC	O	O
it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
to	TO	O	O
delay	VB	O	O
extubating	VBG	O	O
the	DT	O	O
patient	NN	O	O
until	IN	O	O
the	DT	O	O
morning	NN	O	O
of	IN	O	O
6/2	CD	O	O
.	.	O	O

overnight	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
became	VBD	O	O
hypoxic	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
dropping	VBG	O	O
to	TO	O	O
the	DT	O	O
80	CD	O	O
's	POS	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
chest	NN	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
showed	VBD	O	O
that	IN	O	O
the	DT	B-TREATMENT	O
et	NN	I-TREATMENT	O
tube	NN	I-TREATMENT	O
was	VBD	O	O
displaced	VBN	B-PROBLEM	O
to	TO	O	O
very	RB	O	B-PROBLEM
high	JJ	O	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
trachea	NN	O	I-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	O
cuff	NN	I-TREATMENT	O
was	VBD	O	O
deflated	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
extubated	VBN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
placed	VBN	O	O
in	IN	O	O
supplemental	JJ	B-TREATMENT	O
oxygen	NN	I-TREATMENT	O
by	IN	O	O
shovel	NN	B-TREATMENT	B-TREATMENT
mask	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
her	PRP$	B-TEST	O
sats	NNS	I-TEST	O
immediately	RB	O	O
improved	VBN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
weaned	VBN	O	O
down	RP	O	O
until	IN	O	O
she	PRP	O	O
was	VBD	O	O
maintaining	VBG	O	O
her	PRP$	B-TEST	B-TEST
oxygen	NN	I-TEST	I-TEST
saturation	NN	I-TEST	I-TEST
above	IN	O	O
90%	CD	O	O
on	IN	O	O
6l	CD	O	O
by	IN	O	O
nasal	JJ	B-TREATMENT	O
cannuala	NN	I-TREATMENT	O
.	.	O	O

as	IN	O	O
she	PRP	O	O
was	VBD	O	O
doing	VBG	O	O
well	RB	O	O
without	IN	O	O
evidence	NN	O	O
of	IN	O	O
stridor	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
the	DT	B-TREATMENT	B-TREATMENT
steroids	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
stopped	VBN	O	O
.	.	O	O

she	PRP	O	O
did	VBD	O	O
well	RB	O	O
and	CC	O	O
was	VBD	O	O
weaned	VBN	O	O
from	IN	O	O
supplemental	JJ	B-TREATMENT	B-TREATMENT
oxygen	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
will	MD	O	O
need	VB	O	O
to	TO	O	O
complete	VB	O	O
a	DT	O	O
14	CD	O	O
day	NN	O	O
course	NN	O	O
of	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
mrsa	NN	I-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
2019-07-30	JJ	O	O
.	.	O	O

2.	CD	O	O
enterobacter	JJ	B-PROBLEM	B-PROBLEM
bacteremia	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

she	PRP	O	O
was	VBD	O	O
initially	RB	O	O
covered	VBN	O	O
broadly	RB	O	O
with	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
ciprofloxacin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
falgyl	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
positive	JJ	B-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
cultures	NNS	I-PROBLEM	I-PROBLEM
at	IN	O	O
mediplex	JJ	O	O
rehab	NN	O	O
hospital	NN	O	O
hospital	NN	O	O
for	IN	O	O
gram	JJ	B-PROBLEM	B-PROBLEM
negative	JJ	I-PROBLEM	I-PROBLEM
rods	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

subsequently	RB	O	O
,	,	O	O
zosyn	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
added	VBN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
grew	VBD	O	O
out	RP	O	O
enterobacter	JJ	B-PROBLEM	B-PROBLEM
cloacae	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

it	PRP	O	O
was	VBD	O	O
unclear	JJ	O	O
the	DT	O	O
source	NN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
bacteremia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
stool	NN	I-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
central	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
removed	VBN	O	O
and	CC	O	O
the	DT	B-TREATMENT	O
tip	NN	I-TREATMENT	O
was	VBD	O	O
culture	NN	O	B-TEST
negative	JJ	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
transitioned	VBN	O	O
to	TO	O	O
on	IN	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
bacteremia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
no	DT	O	O
positive	JJ	B-PROBLEM	B-PROBLEM
cultures	NNS	I-PROBLEM	I-PROBLEM
during	IN	O	O
this	DT	O	O
admission	NN	O	O
.	.	O	O

once	RB	O	O
she	PRP	O	O
was	VBD	O	O
more	RBR	O	O
stable	JJ	O	O
,	,	O	O
an	DT	B-TEST	B-TEST
abdominal	JJ	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
to	TO	O	O
look	VB	O	O
for	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
abscess	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	B-TEST	B-TEST
study	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
study	NN	I-TEST	I-TEST
was	VBD	O	O
limited	VBN	O	O
due	JJ	O	O
to	TO	O	O
inadequate	VB	O	O
po	NN	O	O
contrast	NN	O	O
intake	NN	O	O
by	IN	O	O
the	DT	O	O
patient	NN	O	O
;	:	O	O
it	PRP	O	O
did	VBD	O	O
show	VB	O	O
a	DT	O	O
question	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
cecal	JJ	I-PROBLEM	I-PROBLEM
cystic	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
verse	NN	O	O
normal	JJ	O	O
loop	NN	O	O
of	IN	O	O
bowel	NN	O	O
.	.	O	O

this	DT	B-TEST	B-TEST
study	NN	I-TEST	I-TEST
will	MD	O	O
need	VB	O	O
to	TO	O	O
be	VB	O	O
repeated	VBN	O	O
once	IN	O	O
she	PRP	O	O
is	VBZ	O	O
tolerating	VBG	O	O
po	NN	O	O
's	POS	O	O
.	.	O	O

she	PRP	O	O
will	MD	O	O
complete	VB	O	O
a	DT	O	O
14	CD	O	O
day	NN	O	O
course	NN	O	O
of	IN	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
bacteremia	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
2019-07-30	JJ	O	O
.	.	O	O

3.	CD	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
type	JJ	I-PROBLEM	I-PROBLEM
i	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

she	PRP	O	O
was	VBD	O	O
intially	RB	O	O
maintained	VBN	O	O
on	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
tight	JJ	B-TREATMENT	B-TREATMENT
glycemic	JJ	I-TREATMENT	I-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
initially	RB	O	O
maintained	VBN	O	O
on	IN	O	O
d5w	NN	B-TREATMENT	O
,	,	O	O
which	WDT	O	O
was	VBD	O	O
increased	VBN	O	O
to	TO	O	O
d10w	VB	B-TREATMENT	O
as	IN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
persistently	RB	B-PROBLEM	B-PROBLEM
borderline	JJ	I-PROBLEM	I-PROBLEM
hypoglycemic	NN	I-PROBLEM	I-PROBLEM
while	IN	O	O
on	IN	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

once	RB	O	O
she	PRP	O	O
began	VBD	O	O
to	TO	O	O
take	VB	O	O
po	NN	O	O
's	POS	O	O
,	,	O	O
the	DT	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
stopped	VBN	O	O
and	CC	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
glargine	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
humalog	NN	I-TREATMENT	I-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

while	IN	O	O
her	PRP$	O	O
po	NNS	O	O
intake	NN	O	O
was	VBD	O	O
minimal	JJ	O	O
she	PRP	O	O
was	VBD	O	O
maintained	VBN	O	O
on	IN	O	O
supplemental	JJ	B-TREATMENT	B-TREATMENT
iv	NN	I-TREATMENT	I-TREATMENT
dextrose	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
suppress	VB	O	O
ketosis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

while	IN	O	O
she	PRP	O	O
was	VBD	O	O
on	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
iv	NN	I-TREATMENT	I-TREATMENT
dextrose	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
she	PRP	O	O
required	VBD	O	O
up	RB	O	O
to	TO	O	O
26	CD	O	O
units	NNS	O	O
of	IN	O	O
glargine	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
glycemic	JJ	B-TREATMENT	B-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

as	IN	O	O
she	PRP	O	O
starting	VBG	O	O
taking	VBG	O	O
some	DT	O	B-TREATMENT
foods	NNS	O	I-TREATMENT
,	,	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
glargine	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
decrease	NN	O	O
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
her	PRP$	B-TREATMENT	O
glargine	NN	I-TREATMENT	O
was	VBD	O	O
10	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
glucose	NN	I-TEST	I-TEST
were	VBD	O	O
under	IN	O	O
good	JJ	O	O
control	NN	O	O
.	.	O	O

the	DT	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
nauseated	VBN	B-PROBLEM	O
and	CC	O	O
not	RB	O	O
taking	VBG	O	O
pos	NN	O	O
.	.	O	O

therefore	RB	O	O
,	,	O	O
she	PRP	O	O
received	VBD	O	O
1l	CD	O	O
of	IN	O	O
d5	NN	B-TREATMENT	B-PROBLEM
,	,	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
sugars	NNS	I-TEST	I-TEST
were	VBD	O	O
elevated	VBN	B-PROBLEM	O
to	TO	O	O
400	CD	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

4.	CD	O	O
gastroparesis	NN	B-PROBLEM	B-PROBLEM
:	:	O	O

she	PRP	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
gastroparesis	NN	B-PROBLEM	B-PROBLEM
secondary	JJ	O	O
to	TO	O	O
long-standing	JJ	B-PROBLEM	O
type	NN	I-PROBLEM	B-PROBLEM
i	NN	I-PROBLEM	I-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

once	RB	O	O
she	PRP	O	O
was	VBD	O	O
extubated	VBN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
nauseated	VBN	B-PROBLEM	O
with	IN	O	O
emesis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
intially	RB	O	O
treated	VBN	O	O
with	IN	O	O
erythromycin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
pro-motility	NN	O	B-PROBLEM
as	IN	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
bad	JJ	I-PROBLEM	I-PROBLEM
reaction	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
reglan	VB	B-TREATMENT	O
in	IN	O	O
the	DT	O	O
past	NN	O	O
.	.	O	O

she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
remained	VB	O	O
nauseated	VBN	B-PROBLEM	B-PROBLEM
so	RB	O	O
she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
phenergan	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
anzemet	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
zofran	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
ativan	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

her	PRP$	B-PROBLEM	B-PROBLEM
nausea	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
accompanied	VBN	O	O
by	IN	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
for	IN	O	O
which	WDT	O	O
she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
transitioned	VBN	O	O
to	TO	O	O
a	DT	B-TREATMENT	O
pca	NN	I-TREATMENT	O
for	IN	O	O
better	JJR	B-TREATMENT	O
pain	NN	I-TREATMENT	B-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
nausea	VBN	B-PROBLEM	B-PROBLEM
despite	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
agressive	JJ	I-TREATMENT	I-TREATMENT
anti-emetic	JJ	I-TREATMENT	I-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
that	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
were	VBD	O	O
secondary	JJ	O	O
to	TO	O	O
gastroparesis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

however	RB	O	O
,	,	O	O
other	JJ	O	O
causes	NNS	O	O
were	VBD	O	O
looked	VBN	O	O
for	IN	O	O
including	VBG	O	O
adrenal	JJ	B-PROBLEM	B-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
bowel	NN	B-PROBLEM	B-PROBLEM
obstruction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
abdominal	JJ	I-TEST	I-TEST
plain	NN	I-TEST	I-TEST
film	NN	I-TEST	I-TEST
showed	VBD	O	O
non-specific	JJ	B-PROBLEM	B-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
gas	NN	I-PROBLEM	I-PROBLEM
patterns	NNS	I-PROBLEM	I-PROBLEM
that	WDT	O	O
may	MD	O	O
represent	VB	O	O
an	DT	B-PROBLEM	B-PROBLEM
early	JJ	I-PROBLEM	I-PROBLEM
obstruction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
ng	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
for	IN	O	O
decompression	NN	B-TREATMENT	B-TREATMENT
given	VBN	O	O
the	DT	O	O
signs	NNS	O	O
of	IN	O	O
early	JJ	B-PROBLEM	O
obstruction	NN	I-PROBLEM	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
transfer	NN	O	O
.	.	O	O

the	DT	O	O
gi	NN	O	O
service	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
and	CC	O	O
they	PRP	O	O
felt	VBD	O	O
that	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
were	VBD	O	O
all	DT	O	O
gastroparesis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

they	PRP	O	O
recommended	VBD	O	O
erythromycin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
zelnorm	NN	B-TREATMENT	O
.	.	O	O

she	PRP	O	O
should	MD	O	O
eventually	RB	O	O
have	VB	O	O
a	DT	B-TEST	B-PROBLEM
tissue	NN	I-TEST	I-PROBLEM
transglutaminase	NN	I-TEST	I-PROBLEM
to	TO	O	O
rule	VB	O	O
out	RP	O	O
celiac	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

5.	CD	O	O
transaminitis	NN	B-PROBLEM	O
:	:	O	O

per	IN	O	O
report	NN	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
elevated	VBN	B-PROBLEM	B-PROBLEM
lfts	NNS	I-PROBLEM	I-PROBLEM
at	IN	O	O
the	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
right	JJ	I-TEST	I-TEST
upper	NN	I-TEST	I-TEST
quadrant	NN	I-TEST	I-TEST
ultrasound	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
and	CC	O	O
was	VBD	O	O
negative	JJ	O	O
for	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
acute	JJ	I-PROBLEM	I-PROBLEM
pathology	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-PROBLEM
lfts	NNS	I-TEST	I-PROBLEM
trended	VBD	O	I-PROBLEM
down	RB	O	O
during	IN	O	O
this	DT	O	O
admission	NN	O	O
.	.	O	O

6.	CD	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
:	:	O	O

she	PRP	O	O
was	VBD	O	O
maintained	VBN	O	O
on	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
levothyroxine	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

while	IN	O	O
she	PRP	O	O
was	VBD	O	O
not	RB	O	O
taking	VBG	O	O
adequate	JJ	O	O
pos	NN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
on	IN	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
levothyroxine	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
npo	RB	B-TREATMENT	O
while	IN	O	O
intubated	VBN	B-TREATMENT	B-TREATMENT
and	CC	O	O
recived	VBN	O	O
tube	JJ	B-TREATMENT	B-TREATMENT
feedings	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
nutrition	NN	O	O
.	.	O	O

after	IN	O	O
extubation	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
sips	NNS	O	B-TREATMENT
and	CC	O	O
had	VBD	O	O
a	DT	B-TEST	B-PROBLEM
speech	NN	I-TEST	I-PROBLEM
and	CC	I-TEST	O
swallow	JJ	I-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
transfer	NN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
npo	RB	B-TREATMENT	O
given	VBN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
ng	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

8.	CD	O	O
prophylaxis	NN	B-TREATMENT	O
:	:	O	O

ppi	NN	B-TREATMENT	O
,	,	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
sq	NN	I-TREATMENT	O
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
central	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
removed	VBN	O	O
given	VBN	O	O
the	DT	O	O
concern	NN	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
line	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	O
double	JJ	I-TREATMENT	O
lumen	NNS	I-TREATMENT	O
picc	JJ	I-TREATMENT	O
place	NN	O	O
.	.	O	O

full	JJ	B-TREATMENT	O

anti-gbm	NN	B-TEST	O
is	VBZ	O	O
pending	VBG	O	O
.	.	O	O

vitamin	NN	B-TREATMENT	B-TREATMENT
d	VBZ	I-TREATMENT	O
50000	CD	O	O
4662442	CD	O	O
one	CD	O	O
time	NN	O	O
a	DT	O	O
week	NN	O	O

cozaar	NN	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
1	CD	O	O
time	NN	O	O
per	IN	O	O
day	NN	O	O

procrit	NN	B-TREATMENT	B-TEST
-	:	O	O
multidose	JJ	O	O
20000	CD	O	O
u	JJ	O	O
/	NNP	O	O
ml	NN	O	O
20,000	CD	O	O
units	NNS	O	O
sq	VBN	O	O
every	DT	O	O
other	JJ	O	O
week	NN	O	O

levoxyl	RB	B-TREATMENT	B-TREATMENT
150	CD	O	O
mcg	VBD	O	O
1	CD	O	O
1	CD	O	O
time	NN	O	O
per	IN	O	O
day	NN	O	O

iron	NN	B-TREATMENT	B-TREATMENT
325	CD	O	O
(	(	O	O
65	CD	O	O
)	)	O	O
mg	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O

zoloft	RB	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NNS	O	O
1	CD	O	O
per	IN	O	O
day	NN	O	O
,	,	O	O
2	CD	O	O
tabs	NN	O	O

clonazepam	NN	B-TREATMENT	B-TREATMENT
0.5	CD	O	O
mg	NN	O	O

humalog	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
u	JJ	O	O
/	NNP	O	O
ml	NN	O	O
1	CD	O	O
as	IN	O	O
directed	VBN	O	O
pump	NN	O	O

zofran	NN	B-TREATMENT	B-TREATMENT
8	CD	O	O
mg	NN	O	O
1	CD	O	O
as	IN	O	O
directed	VBN	O	O

prevacid	NN	B-TREATMENT	B-TREATMENT
30	CD	O	O
mg	NN	O	O
1	CD	O	O
1	CD	O	O
time	NN	O	O
per	IN	O	O
day	NN	O	O

lorazepam	RB	B-TREATMENT	B-TREATMENT
0.5	CD	O	O
mg	NNS	O	O
1	CD	O	O
to	TO	O	O
2	CD	O	O
tablets	NNS	O	O
twice	RB	O	O
daily	RB	O	O
if	IN	O	O
needed	VBN	O	O

cipro	JJ	B-TREATMENT	B-TREATMENT
400	CD	O	O
"	NN	O	O

vanco	NN	B-TREATMENT	B-TREATMENT
1	CD	O	O
g	NN	O	O
qd	NN	O	O

flagyl	RB	B-TREATMENT	B-TREATMENT
500	CD	O	O
q8	NN	O	O

levophed	VBN	B-TREATMENT	B-TREATMENT
gtt	NN	I-TREATMENT	I-TREATMENT

propofol	NN	B-TREATMENT	B-TREATMENT
gtt	NN	I-TREATMENT	I-TREATMENT

solumedrol	NN	B-TREATMENT	B-TREATMENT
40	CD	O	O
q6	NN	O	O

pepcid	NN	B-TREATMENT	B-PROBLEM

feso4	RB	B-TREATMENT	O
325	CD	O	O
'	''	O	O

insulin	NN	B-TREATMENT	B-TREATMENT
35	CD	O	O
lantus	NN	B-TREATMENT	O
qhs	NN	O	O

synthroid	JJ	B-TREATMENT	B-TREATMENT
150	CD	O	O
'	''	O	O

losartan	RB	B-TREATMENT	B-TREATMENT
25	CD	O	O
'	''	O	O

zoloft	RB	B-TREATMENT	B-TREATMENT
200	CD	O	O
'	''	O	O

zelnorm	NN	B-TREATMENT	O
6	CD	O	O
"	NN	O	O

1.	CD	O	O
sertraline	JJ	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

2.	CD	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
porcine	NN	I-TREATMENT	I-TREATMENT
)	)	O	I-TREATMENT
5,000	CD	O	O
unit	NN	O	O
/	NNP	O	O
ml	NN	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
injection	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

3.	CD	O	O
acetaminophen	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
headache	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

4.	CD	O	O
ondansetron	NN	B-TREATMENT	B-TREATMENT
hcl	NN	I-TREATMENT	I-TREATMENT
2	CD	O	O
mg	NN	O	O
/	NNP	O	O
ml	NN	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
ml	NN	O	O
intravenous	JJ	O	O
q12h	NN	O	O
(	(	O	O
every	DT	O	O
12	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

5.	CD	O	O
pyridoxine	JJ	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

6.	CD	O	O
olanzapine	JJ	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
rapid	JJ	O	O
dissolve	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
rapid	JJ	O	O
dissolve	VBP	O	O
po	JJ	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

7.	CD	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
glargine	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
unit	NN	O	O
/	NNP	O	O
ml	NN	O	O
cartridge	NN	O	O
sig	NN	O	O
:	:	O	O
ten	NN	O	O
(	(	O	O
10	CD	O	O
)	)	O	O
units	NNS	O	O
subcutaneous	JJ	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

8.	CD	O	O
humalog	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
unit	NN	O	O
/	NNP	O	O
ml	NN	O	O
cartridge	NN	O	O
sig	NN	O	O
:	:	O	O
asdir	RB	O	O
subcutaneous	JJ	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
:	:	O	O
see	VB	O	O
attached	JJ	O	O
sheet	NN	O	O
for	IN	O	O
sliding	VBG	O	B-TREATMENT
scale	NN	O	I-TREATMENT
.	.	O	O

9.	CD	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
2	CD	O	O
mg	NN	O	O
/	NNP	O	O
ml	NN	O	O
syringe	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
injection	NN	O	O
q4h	NN	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

10.	CD	O	O
tegaserod	JJ	B-TREATMENT	B-TREATMENT
hydrogen	NN	I-TREATMENT	I-TREATMENT
maleate	NN	I-TREATMENT	I-TREATMENT
6	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
)	)	O	O
.	.	O	O

11.	CD	O	O
levofloxacin	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
iv	NN	O	O
q24h	NN	O	O

12.	CD	O	O
vancomycin	JJ	B-TREATMENT	B-TREATMENT
hcl	NN	O	I-TREATMENT
750	CD	O	O
mg	NN	O	O
iv	NN	O	O
q	VBD	O	O
12h	CD	O	O

13.	CD	O	O
dolasetron	NN	B-TREATMENT	B-TREATMENT
mesylate	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mg	NN	O	O
iv	NN	O	O
q8h	NN	O	O
:	:	O	O
prn	NN	O	O
nausea	NN	B-PROBLEM	B-PROBLEM

14.	CD	O	O
promethazine	NN	B-TREATMENT	B-TREATMENT
hcl	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mg	NN	O	O
iv	NN	O	O
q6h	NN	O	O
:	:	O	O
prn	NN	O	O

15.	CD	O	O
lorazepam	JJ	B-TREATMENT	O
0.5-1	JJ	O	O
mg	NN	O	O
iv	JJ	O	O
q3-4h	NN	O	O
:	:	O	O
prn	NN	O	O
anxiety	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
hold	NN	O	O
for	IN	O	O
sedation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

16.	CD	O	O
levothyroxine	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
75	CD	O	O
mcg	NN	O	O
iv	JJ	O	O
daily	JJ	O	O

17.	CD	O	O
pantoprazole	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
iv	NN	O	O
q12h	NN	O	O

18.	CD	O	O
erythromycin	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
iv	NN	O	O
q6h	NN	O	O

mrsa	NN	B-PROBLEM	O
pneumonia	NN	I-PROBLEM	B-PROBLEM

gastroparesis	NN	B-PROBLEM	B-PROBLEM

enterobacter	NN	B-PROBLEM	B-PROBLEM
bacteremia	NN	I-PROBLEM	I-PROBLEM

diabetes	NNS	B-PROBLEM	B-PROBLEM
type	VBP	I-PROBLEM	I-PROBLEM
i	NN	I-PROBLEM	I-PROBLEM

hypothyroidism	NN	B-PROBLEM	B-PROBLEM

she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

you	PRP	O	O
should	MD	O	O
have	VB	O	O
a	DT	B-TEST	B-PROBLEM
anti-tissue	JJ	I-TEST	I-PROBLEM
transglutaminase	NN	I-TEST	I-PROBLEM
antibody	NN	I-TEST	I-PROBLEM
,	,	O	O
iga	NN	B-TEST	O
to	TO	O	O
rule	VB	O	O
out	RP	O	O
celiac	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
given	VBN	O	O
your	PRP$	B-PROBLEM	B-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

back	RB	B-PROBLEM	B-PROBLEM
pian	JJ	I-PROBLEM	I-PROBLEM
standardized	NN	O	I-PROBLEM

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
given	VBN	O	O
printed	JJ	O	O
instructions	NNS	O	O
for	IN	O	O
back	RB	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
english	JJ	O	O
)	)	O	O
.	.	O	O

back	RB	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

evaluation	NN	B-TEST	B-TEST

ibuoprofen	RB	B-TREATMENT	O
800	CD	O	O
every	DT	O	O
6-8	JJ	O	O
hrs	NN	O	O
as	IN	O	O
needed	VBN	O	O
skelaxin	NN	B-TREATMENT	B-TREATMENT
800mg	CD	O	O
for	IN	O	O
muscle	NN	B-TREATMENT	B-TREATMENT
relaxation	NN	I-TREATMENT	I-TREATMENT
vicodin	VBD	B-TREATMENT	I-TREATMENT
1	CD	O	O
tab	NN	O	O
po	NN	O	O
every	DT	O	O
4-6	CD	O	O
hrs	NN	O	O
for	IN	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

take	VB	O	O
medication	NN	B-TREATMENT	B-TREATMENT
as	IN	O	O
directed	JJ	O	O
,	,	O	O
return	NN	O	O
for	IN	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	I-PROBLEM
significantly	RB	I-PROBLEM	I-PROBLEM
worsening	VBG	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
weakness	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
loss	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
sensation	NN	I-PROBLEM	I-PROBLEM
work	NN	O	I-PROBLEM
restrictions	NNS	O	I-PROBLEM
as	IN	O	O
written	VBN	O	O
on	IN	O	O
accompanying	VBG	O	O
form	NN	O	O
.	.	O	O

penicillins	NNS	B-TREATMENT	B-TREATMENT
/	VBP	O	O
keflex	JJ	B-TREATMENT	B-TREATMENT
/	NNP	O	I-TREATMENT
sulfa	NN	B-TREATMENT	I-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
sulfonamides	NNS	I-TREATMENT	I-TREATMENT
)	)	O	I-TREATMENT
/	VBP	O	O
nickel	JJ	O	O
/	NNP	O	O
erythromycin	NN	B-TREATMENT	B-TREATMENT
ethylsuccinate	NN	I-TREATMENT	I-TREATMENT

disconnected	VBN	B-PROBLEM	O
pigtail	NN	I-PROBLEM	B-TREATMENT
catheter	NN	I-PROBLEM	I-TREATMENT

removal	NN	B-TREATMENT	B-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT

70	CD	O	O
y/o	JJ	O	O
f	NN	O	O
w/	NN	O	O
tracheobronchomalacia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
copd	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
pmr	NN	B-PROBLEM	O
,	,	O	O
recurrent	NN	B-PROBLEM	B-PROBLEM
pneumonias	NN	I-PROBLEM	I-PROBLEM
who	WP	O	O
was	VBD	O	O
recently	RB	O	O
discharged	VBN	O	O
from	IN	O	O
hallmark	NN	O	O
health	NN	O	O
system	NN	O	O
to	TO	O	O
pocasset	VB	O	O
mental	JJ	O	O
health	NN	O	O
center	NN	O	O

06-07	NN	O	O
after	IN	O	O
tracheobronchoplasty	JJ	B-TREATMENT	B-TREATMENT
/	JJ	O	I-TREATMENT
tracheostomy	NN	B-TREATMENT	I-TREATMENT
and	CC	O	O
pigtail	NN	B-TREATMENT	B-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
pleural	JJ	B-PROBLEM	B-PROBLEM
effusions	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

since	IN	O	O
discharge	NN	O	O
pt	NN	O	O
has	VBZ	O	O
continued	VBN	O	O
at	IN	O	O
rehab	NN	O	O
on	IN	O	O
ps	JJ	B-TREATMENT	B-TREATMENT
vent	JJ	I-TREATMENT	I-TREATMENT
settings	NNS	I-TREATMENT	I-TREATMENT
but	CC	O	O
pigtail	VBP	B-TREATMENT	B-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
fell	VBD	O	O
out	RP	O	O
today	NN	O	O
so	IN	O	O
pt	NN	O	O
was	VBD	O	O
referred	VBN	O	O
here	RB	O	O
for	IN	O	O
monitoring	NN	O	O
.	.	O	O

on	IN	O	O
ros	NNS	B-TEST	B-TREATMENT
,	,	O	O
she	PRP	O	O
notes	VBZ	O	O
feeling	VBG	O	O
poorly	RB	B-PROBLEM	O
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
since	IN	O	O
d/c	NN	O	B-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
pleuritic	JJ	B-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
she	PRP	O	O
has	VBZ	O	O
had	VBN	O	O
since	IN	O	O
she	PRP	O	O
arrested	VBD	O	O
during	IN	O	O
her	PRP$	O	O
admission	NN	O	O
here	RB	O	O
and	CC	O	O
had	VBD	O	O
cpr	NNS	B-TREATMENT	O
.	.	O	O

per	IN	O	O
husband	NN	O	O
she	PRP	O	O
has	VBZ	O	O
no	DT	O	O
cardiac	JJ	B-PROBLEM	O
history	NN	I-PROBLEM	O
,	,	O	O
and	CC	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
stress	JJ	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
(	(	O	O
unclr	JJ	O	O
how	WRB	O	O
recent	JJ	O	O
)	)	O	O
that	WDT	O	O
was	VBD	O	O
normal	JJ	O	O

tracheobronchomalacia	NN	B-PROBLEM	B-PROBLEM

pmr	NN	B-PROBLEM	O
s/p	NN	O	O
tah	NN	B-TREATMENT	B-TREATMENT

copd	NN	B-PROBLEM	B-PROBLEM

afib	NN	B-PROBLEM	B-TREATMENT
post	NN	O	I-TREATMENT
op	NN	O	I-TREATMENT

recent	JJ	B-PROBLEM	B-PROBLEM
uti	JJ	I-PROBLEM	I-PROBLEM
rx	NN	O	I-PROBLEM
w/aztreonam	NN	B-TREATMENT	I-PROBLEM

mrsa	NN	B-PROBLEM	O
pna	NN	I-PROBLEM	O
rx	NN	O	O
w/vanc	NN	B-TREATMENT	O

anxiety	NN	B-PROBLEM	B-PROBLEM

hx	NN	O	O
resp	NN	B-PROBLEM	O
arrest	IN	I-PROBLEM	O
post-op	NN	O	O

vs	NN	B-TEST	O
:	:	O	O

nad	NN	B-PROBLEM	B-PROBLEM

rrr	NN	O	O
,	,	O	O
nl	JJ	O	O
s1	NN	O	O
,	,	O	O
s2	NN	O	O
,	,	O	O
no	DT	O	O
m/r/g	NN	B-PROBLEM	B-PROBLEM

abd	NN	O	O
:	:	O	O
soft	JJ	O	O
,	,	O	O
nt,nd	JJ	B-PROBLEM	O
,	,	O	O
nabs	JJ	O	O

1+	CD	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
blt	NN	I-PROBLEM	I-PROBLEM

ecg	NNS	B-TEST	O
:	:	O	O
rate	NN	B-TEST	B-TEST
66	CD	O	O
,	,	O	O
sinus	VBD	O	B-PROBLEM
w/pac	NN	B-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
,	,	O	O
qt	VBZ	B-TEST	O
476	CD	O	O
,	,	O	O
twi	NN	B-PROBLEM	O
in	IN	I-PROBLEM	O
v1-6	NN	I-PROBLEM	O
(	(	O	O
deep	JJ	O	O
in	IN	O	O
v2-4	NN	O	O
)	)	O	O

cxr	NN	B-TEST	O
:	:	O	O

interval	JJ	O	B-PROBLEM
resolution	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
pneumothorax	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
?	.	O	O

no	DT	O	O
changes	NNS	O	O
in	IN	O	O
the	DT	O	O
position	NN	O	O
or	CC	O	O
alignment	NN	O	O
of	IN	O	O
multiple	JJ	B-TREATMENT	B-TREATMENT
lines	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	I-TREATMENT
tubes	NNS	B-TREATMENT	I-TREATMENT

congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

height	NN	B-TEST	O
:	:	O	O
(	(	O	O
in	IN	O	O
)	)	O	O
62	CD	O	O

weight	NN	B-TEST	B-TEST
(	(	O	O
lb	JJ	O	O
)	)	O	O
:	:	O	O
180	CD	O	O

bsa	NN	B-TEST	O
(	(	O	O
m2	NN	O	O
)	)	O	O
:	:	O	O
1.83	CD	O	O
m2	NN	O	O

bp	NN	B-TEST	O
(	(	O	O
mm	JJ	O	O
hg	NN	O	O
)	)	O	O
:	:	O	O
115/48	CD	O	O

hr	NN	B-TEST	O
(	(	O	O
bpm	NN	O	O
)	)	O	O
:	:	O	O
60	CD	O	O

test	NN	O	B-TEST
:	:	O	O
tte	NN	B-TEST	O
(	(	O	O
complete	JJ	O	O
)	)	O	O

doppler	NN	B-TEST	O
:	:	O	O
full	JJ	B-TEST	B-TEST
doppler	NN	I-TEST	I-TEST
and	CC	O	O
color	NN	B-TEST	B-TEST
doppler	NN	I-TEST	I-TEST

left	JJ	B-TEST	O
atrium	NN	I-TEST	O
-	:	I-TEST	O
four	CD	I-TEST	O
chamber	NN	I-TEST	O
length	NN	I-TEST	O
:	:	O	O
5.1	CD	O	O
cm	NN	O	O
(	(	O	O
nl	JJ	O	O
<=	$	O	O
5.2	CD	O	O
cm	NN	O	O
)	)	O	O

right	RB	B-TEST	B-TEST
atrium	NN	I-TEST	I-TEST
-	:	I-TEST	O
four	CD	I-TEST	O
chamber	NN	I-TEST	O
length	NN	I-TEST	O
:	:	O	O
*	JJ	O	O
6.2	CD	O	O
cm	NN	O	O
(	(	O	O
nl	JJ	O	O
<=	$	O	O
5.0	CD	O	O
cm	NN	O	O
)	)	O	O

left	VBN	B-TEST	O
ventricle	NN	I-TEST	O
-	:	I-TEST	O
septal	NN	I-TEST	O
wall	NN	I-TEST	O
thickness	NN	I-TEST	O
:	:	O	O
0.8	CD	O	O
cm	NN	O	O
(	(	O	O
nl	JJ	O	O
0.6	CD	O	O
-	:	O	O
1.1	CD	O	O
cm	NN	O	O
)	)	O	O

left	VBN	B-TEST	O
ventricle	NN	I-TEST	O
-	:	I-TEST	O
inferolateral	JJ	I-TEST	O
thickness	NN	I-TEST	O
:	:	O	O
0.8	CD	O	O
cm	NN	O	O
(	(	O	O
nl	JJ	O	O
0.6	CD	O	O
-	:	O	O
1.1	CD	O	O
cm	NN	O	O
)	)	O	O

left	VBN	B-TEST	O
ventricle	NN	I-TEST	O
-	:	I-TEST	O
diastolic	JJ	I-TEST	O
dimension	NN	I-TEST	O
:	:	O	O
5.3	CD	O	O
cm	NN	O	O
(	(	O	O
nl	JJ	O	O
<=	$	O	O
5.6	CD	O	O
cm	NN	O	O
)	)	O	O

left	VBN	B-TEST	O
ventricle	NN	I-TEST	O
-	:	I-TEST	O
ejection	NN	I-TEST	O
fraction	NN	I-TEST	O
:	:	O	O
>=	NN	O	O
40%	CD	O	O
(	(	O	O
nl	JJ	O	O
>=	NNP	O	O
55%	CD	O	O
)	)	O	O

aortic	JJ	B-TEST	B-TEST
valve	SYM	I-TEST	I-TEST
-	:	I-TEST	O
peak	JJ	I-TEST	B-PROBLEM
velocity	NN	I-TEST	I-PROBLEM
:	:	O	O
1.4	CD	O	O
m	NN	O	O
/	NN	O	O
sec	NN	O	B-TREATMENT
(	(	O	I-TREATMENT
nl	JJ	O	I-TREATMENT
<=	$	O	I-TREATMENT
2.0	CD	O	O
m	NN	O	O
/	NNP	O	O
sec	NN	O	O
)	)	O	O

mitral	JJ	B-TEST	O
valve	SYM	I-TEST	O
-	:	I-TEST	O
e	NN	I-TEST	O
wave	NN	I-TEST	O
:	:	O	O
1.1	CD	O	O
m	NN	O	O
/	NN	O	O
sec	NN	O	O

mitral	JJ	B-TEST	O
valve	SYM	I-TEST	O
-	:	I-TEST	O
a	DT	I-TEST	B-PROBLEM
wave	NN	I-TEST	I-PROBLEM
:	:	O	O
1.0	CD	O	O
m	NN	O	O
/	NN	O	O
sec	NN	O	O

mitral	JJ	B-TEST	O
valve	SYM	I-TEST	O
-	:	I-TEST	O
e/a	NN	I-TEST	O
ratio	NN	I-TEST	O
:	:	O	O
1.10	CD	O	O

tr	JJ	B-TEST	O
gradient	NN	I-TEST	O
(	(	I-TEST	O
+	JJ	I-TEST	O
ra	NN	I-TEST	O
=	NNP	I-TEST	O
pasp	NN	I-TEST	O
)	)	I-TEST	O
:	:	O	O
*	$	O	O
36	CD	O	O
mm	NN	O	O
hg	NN	O	O
(	(	O	O
nl	JJ	O	O
<=	$	O	O
25	CD	O	O
mm	NN	O	O
hg	NN	O	O
)	)	O	O

this	DT	B-TEST	B-TEST
study	NN	I-TEST	I-TEST
was	VBD	O	O
compared	VBN	O	O
to	TO	O	O
the	DT	B-TEST	B-TEST
prior	JJ	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
of	IN	O	O
2017-06-01	JJ	O	O
.	.	O	O

wall	NN	B-TEST	B-TEST
thickness	NN	I-TEST	I-TEST
and	CC	O	I-TEST
cavity	NN	B-TEST	I-TEST
dimensions	NNS	I-TEST	I-TEST
were	VBD	O	O
obtained	VBN	O	O
from	IN	O	O
2d	CD	B-TEST	O
images	NNS	I-TEST	O
.	.	O	O

suboptimal	JJ	O	B-PROBLEM
technical	JJ	O	I-PROBLEM
quality	NN	O	I-PROBLEM
,	,	O	O
a	DT	B-PROBLEM	B-PROBLEM
focal	JJ	I-PROBLEM	I-PROBLEM
lv	NN	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
motion	NN	I-PROBLEM	I-PROBLEM
abnormality	NN	I-PROBLEM	I-PROBLEM
cannot	NN	O	O
be	VB	O	O
fully	RB	O	O
excluded	VBN	O	O
.	.	O	O

focal	JJ	B-PROBLEM	B-PROBLEM
calcifications	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
root	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
ar	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

mild	NN	B-PROBLEM	B-PROBLEM
(	(	I-PROBLEM	O
1+	CD	I-PROBLEM	O
)	)	I-PROBLEM	O
mr	NN	I-PROBLEM	O
.	.	O	O

mild	JJ	B-PROBLEM	B-PROBLEM
pa	VBZ	I-PROBLEM	I-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
pericardial	JJ	B-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

based	VBN	O	O
on	IN	O	O
1997	CD	O	O
aha	NN	O	B-PROBLEM
endocarditis	NN	O	I-PROBLEM
prophylaxis	NN	O	I-PROBLEM
recommendations	NNS	O	I-PROBLEM
,	,	O	O
the	DT	O	B-TEST
echo	JJ	O	I-TEST
findings	NNS	O	I-TEST
indicate	VBP	O	O
a	DT	O	B-PROBLEM
low	JJ	O	I-PROBLEM
risk	NN	O	I-PROBLEM
(	(	O	O
prophylaxis	IN	B-TREATMENT	O
not	RB	O	O
recommended	VBN	O	O
).	NN	O	O

clinical	JJ	O	O
decisions	NNS	O	O
regarding	VBG	O	O
the	DT	O	O
need	NN	O	O
for	IN	O	O
prophylaxis	NN	B-TREATMENT	B-TREATMENT
should	MD	O	O
be	VB	O	O
based	VBN	O	O
on	IN	O	O
clinical	JJ	O	O
and	CC	O	O
echocardiographic	JJ	O	B-TEST
data	NNS	O	I-TEST
.	.	O	O

left	VBN	B-TEST	B-TEST
ventricular	JJ	I-TEST	I-TEST
wall	NN	I-TEST	I-TEST
thicknesses	NNS	I-TEST	I-TEST
and	CC	O	I-TEST
cavity	NN	B-TEST	I-TEST
size	NN	I-TEST	I-TEST
are	VBP	O	O
normal	JJ	O	O
.	.	O	O

due	JJ	O	O
to	TO	O	O
suboptimal	VB	O	B-PROBLEM
technical	JJ	O	I-PROBLEM
quality	NN	O	I-PROBLEM
,	,	O	O
a	DT	B-PROBLEM	B-PROBLEM
focal	JJ	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
motion	NN	I-PROBLEM	I-PROBLEM
abnormality	NN	I-PROBLEM	I-PROBLEM
cannot	NN	O	O
be	VB	O	O
fully	RB	O	O
excluded	VBN	O	O
.	.	O	O

overall	JJ	B-TEST	O
systolic	JJ	I-TEST	O
function	NN	I-TEST	O
is	VBZ	O	O
good	JJ	O	O
(	(	O	O
lvef	JJ	B-TEST	O
>	$	O	O
40%	CD	O	O
).	NN	O	O

right	RB	B-TEST	O
ventricular	JJ	I-TEST	O
chamber	NN	I-TEST	O
size	NN	I-TEST	O
and	CC	O	O
free	JJ	B-TEST	O
wall	NN	I-TEST	O
motion	NN	I-TEST	O
are	VBP	O	O
normal	JJ	O	O
.	.	O	O

no	DT	O	O
aortic	JJ	B-PROBLEM	B-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
seen	VBN	O	O
.	.	O	O

mild	NN	B-PROBLEM	B-PROBLEM
(	(	I-PROBLEM	I-PROBLEM
1+	CD	I-PROBLEM	I-PROBLEM
)	)	I-PROBLEM	I-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
seen	VBN	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
pericardial	JJ	B-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mild	JJ	B-PROBLEM	B-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
prior	JJ	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
of	IN	O	O
2017-06-01	JJ	O	O
(	(	O	O
tape	NN	O	O
reviewed	VBN	O	O
)	)	O	O
was	VBD	O	O
of	IN	O	O
very	RB	O	B-PROBLEM
suboptimal	JJ	O	I-PROBLEM
technical	JJ	O	I-PROBLEM
quality	NN	O	I-PROBLEM
and	CC	O	O
not	RB	O	O
directly	RB	O	O
comparable	JJ	O	O
to	TO	O	O
the	DT	B-TEST	B-TEST
current	JJ	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
.	.	O	O

if	IN	O	O
more	RBR	O	O
definitive	JJ	O	O
information	NN	O	O
regarding	VBG	O	O
ventricualr	NN	O	O
fuynction	NN	O	O
is	VBZ	O	O
needed	VBN	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
mri	NN	I-TEST	I-TEST
(	(	O	O
(	(	O	O
951	CD	O	O
)	)	O	O
247-0244	CD	O	O
)	)	O	O
or	CC	O	O
radionuclide	VB	B-TEST	B-TEST
study	NN	I-TEST	I-TEST
is	VBZ	O	O
suggested	VBN	O	O
.	.	O	O

based	VBN	O	O
on	IN	O	O
1997	CD	O	O
aha	NN	O	B-PROBLEM
endocarditis	NN	O	I-PROBLEM
prophylaxis	NN	O	I-PROBLEM
recommendations	NNS	O	I-PROBLEM
,	,	O	O
the	DT	O	B-TEST
echo	JJ	O	I-TEST
findings	NNS	O	I-TEST
indicate	VBP	O	O
a	DT	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
risk	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
prophylaxis	IN	B-TREATMENT	O
not	RB	O	O
recommended	VBN	O	O
).	NN	O	O

clinical	JJ	O	O
decisions	NNS	O	O
regarding	VBG	O	O
the	DT	O	O
need	NN	O	O
for	IN	O	O
prophylaxis	NN	B-TREATMENT	B-TREATMENT
should	MD	O	O
be	VB	O	O
based	VBN	O	O
on	IN	O	O
clinical	JJ	O	O
and	CC	O	O
echocardiographic	JJ	O	B-TEST
data	NNS	O	I-TEST
.	.	O	O

pleural	JJ	B-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
:	:	O	O
s/p	JJ	O	O
pigtail	NN	B-TREATMENT	B-TREATMENT
cath	NN	I-TREATMENT	I-TREATMENT
drain	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

imaging	VBG	B-TEST	O
indicated	VBD	O	O
that	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusions	NNS	I-PROBLEM	I-PROBLEM
had	VBD	O	O
resolved	VBN	O	O
.	.	O	O

thoracics	NNS	O	O
agreed	VBD	O	O
to	TO	O	O
no	DT	O	O
need	NN	O	O
for	IN	O	O
pigtail	JJ	B-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

chf	NN	B-PROBLEM	O
:	:	O	O

they	PRP	O	O
recommended	VBD	O	O
continuing	VBG	O	O
beta-blocker	NN	B-TREATMENT	O
and	CC	O	O
titarting	VBG	O	O
ace	NN	B-TREATMENT	O
as	IN	O	O
tolerated	VBN	O	O
.	.	O	O

patient	NN	O	O
should	MD	O	O
be	VB	O	O
kept	VBN	O	O
euvolemic	JJ	O	B-PROBLEM
once	RB	O	I-PROBLEM
peripheral	JJ	B-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
resolves	NNS	O	I-PROBLEM
(	(	O	O
may	MD	O	O
use	VB	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
to	TO	O	O
decrease	VB	O	O
edema	NN	B-PROBLEM	B-PROBLEM
).	NN	O	O

she	PRP	O	O
will	MD	O	O
need	VB	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
echo	NN	I-TEST	I-TEST
in	IN	O	O
3-6	JJ	O	O
months	NNS	O	O
(	(	O	O
since	IN	O	O
this	DT	B-TEST	B-TEST
echo	NN	I-TEST	I-TEST
showed	VBD	O	O
a	DT	O	O
question	NN	O	O
of	IN	O	O
focal	JJ	B-PROBLEM	B-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
motion	NN	I-PROBLEM	I-PROBLEM
abnormality	NN	I-PROBLEM	I-PROBLEM
).	NN	O	O

also	RB	O	O
,	,	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
held	VBN	O	O
secondary	JJ	O	O
to	TO	O	O
high	JJ	B-PROBLEM	B-TEST
levels	NNS	I-PROBLEM	I-TEST
(	(	O	O
please	VB	O	O
restart	NN	O	O
when	WRB	O	O
level	NN	B-TEST	O
less	JJR	O	O
than	IN	O	O
2	CD	O	O
)	)	O	O

diarrhea	NN	B-PROBLEM	B-PROBLEM
:	:	O	O

stool	NN	B-TEST	B-TEST
c.	NN	I-TEST	I-TEST
diff	NN	I-TEST	I-TEST
neg	JJ	O	O
x1	NN	O	O
.	.	O	O

she	PRP	O	O
will	MD	O	O
need	VB	O	O
two	CD	B-TEST	O
more	JJR	I-TEST	O
specimens	NNS	I-TEST	O
.	.	O	O

copd	NN	B-PROBLEM	O
:	:	O	O
cont	NN	O	B-PROBLEM
nebs	NN	B-TREATMENT	I-PROBLEM
.	.	O	O

paf	NN	B-PROBLEM	O
:	:	O	O
started	VBN	O	O
on	IN	O	O
amio	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
cont	JJ	O	O
b-blocker	NN	B-TREATMENT	O
,	,	O	O
and	CC	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
-	:	O	O
levels	NNS	B-TEST	O
(	(	I-TEST	O
inr	NN	I-TEST	O
)	)	I-TEST	O
should	MD	O	O
be	VB	O	O
monitored	VBN	O	O
.	.	O	O

patient	NN	O	O
should	MD	O	O
be	VB	O	O
started	VBN	O	O
on	IN	O	O
tube	NN	B-TREATMENT	B-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
at	IN	O	O
rehab	NN	O	O

rash	NN	B-PROBLEM	O
:	:	O	O

patient	NN	O	O
developed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
diffuse	NN	I-PROBLEM	I-PROBLEM
erythematous	JJ	I-PROBLEM	I-PROBLEM
rash	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
though	IN	O	O
to	TO	O	O
be	VB	O	O
an	DT	B-PROBLEM	B-PROBLEM
id	JJ	I-PROBLEM	I-PROBLEM
reaction	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
a	DT	B-PROBLEM	B-PROBLEM
recent	JJ	I-PROBLEM	I-PROBLEM
fungal	JJ	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
satrted	VBN	O	O
on	IN	O	O
benadryl	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
hydrocort	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
sx	JJ	O	B-TREATMENT
relief	NN	O	I-TREATMENT
.	.	O	O

also	RB	O	O
a	DT	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
reaction	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
in	IN	O	O
the	DT	O	O
ddx	NN	O	O
but	CC	O	O
unlikely	JJ	O	O
as	IN	O	O
rash	NN	B-PROBLEM	O
started	VBD	O	O
at	IN	O	O
rehab	NN	O	O
prior	RB	O	O
to	TO	O	O
receiving	VBG	O	O
drugs	NNS	B-TREATMENT	B-TREATMENT
here	RB	O	O
.	.	O	O

meds	NNS	B-TREATMENT	B-TREATMENT
at	IN	O	O
pocasset	JJ	O	O
mental	JJ	O	O
health	NN	O	O
center	NN	O	O
:	:	O	O

sq	NN	B-TREATMENT	O
heparin	NN	I-TREATMENT	B-TREATMENT
,	,	O	O
mvi	NN	B-TREATMENT	O
,	,	O	O
nystatin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
colace	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
atrovent	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
amiodarone	RB	B-TREATMENT	B-TREATMENT
400	CD	O	O
bid	NN	O	O
,	,	O	O
pulmicort	NN	B-TREATMENT	O
,	,	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
metoprolol	FW	B-TREATMENT	B-TREATMENT
12.5	CD	O	O
tid	NN	O	O
,	,	O	O
reglan	NN	B-TREATMENT	O

discharge	NN	O	O
diagnosis	NN	O	O
:	:	O	O
tracheobronchomalecia	NN	B-PROBLEM	B-PROBLEM
chf	NN	B-PROBLEM	I-PROBLEM

paf	NN	B-PROBLEM	O

copd	NN	B-PROBLEM	B-PROBLEM

discharge	NN	O	O
condition	NN	O	O
:	:	O	O
deconditioned	VBN	B-PROBLEM	O
but	CC	O	O
stable	JJ	O	O

please	VB	O	O
call	VB	O	O
your	PRP$	O	O
doctor	NN	O	O
or	CC	O	O
come	VBN	O	O
to	TO	O	O
robert	VB	O	O
if	IN	O	O
you	PRP	O	O
develop	VBP	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
cp	NN	B-PROBLEM	O
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
any	DT	B-PROBLEM	O
other	JJ	I-PROBLEM	O
concerning	NN	I-PROBLEM	O
sx	NN	I-PROBLEM	O

you	PRP	O	O
will	MD	O	O
need	VB	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
echo	NN	I-TEST	I-TEST
within	IN	O	O
3-6	JJ	O	O
months	NNS	O	O

it	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
on	IN	O	O
10/8/94	CD	O	O
that	IN	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
decreased	JJ	I-PROBLEM	I-PROBLEM
range	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
motion	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
both	DT	O	I-PROBLEM
her	PRP$	O	I-PROBLEM
knees	NNS	O	I-PROBLEM
with	IN	O	O
flexion	NN	O	B-TEST
to	TO	O	O
approximately	RB	O	O
40	CD	O	O
degrees	NNS	O	O
with	IN	O	O
maximum	JJ	O	B-TREATMENT
physical	JJ	B-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
to	TO	O	O
postpone	VB	O	O
her	PRP$	O	O
discharge	NN	O	O
to	TO	O	O
rehab	VB	O	O
and	CC	O	O
take	VB	O	O
her	PRP$	O	O
back	NN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
for	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
manipulation	NN	I-TREATMENT	I-TREATMENT
under	IN	O	I-TREATMENT
anesthesia	NN	B-TREATMENT	I-TREATMENT
.	.	O	O

baby	NN	O	O
girl	NN	O	O
kathryn	NN	O	O
frazier	NN	O	O
,	,	O	O
triplet	NN	O	O
iii	NN	O	O
,	,	O	O
delivered	VBN	O	O
at	IN	O	O
32	CD	O	O
-	:	O	O
5/7	CD	O	O
weeks	NNS	O	O
gestation	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
newborn	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
management	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
prematurity	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

birth	NN	B-TEST	B-TEST
weight	NN	I-TEST	I-TEST
was	VBD	O	O
1630	CD	O	O
grams	NNS	O	O
.	.	O	O

prenatal	JJ	B-TEST	B-TEST
screens	NNS	I-TEST	I-TEST
included	VBD	O	O
blood	NN	B-TEST	B-TEST
type	NN	I-TEST	I-TEST
a+	NN	O	O
,	,	O	O
antibody	NN	B-TEST	B-TEST
screen	JJ	I-TEST	I-TEST
negative	JJ	O	O
,	,	O	O
rubella	NN	B-TEST	B-TEST
immune	NN	O	O
,	,	O	O
rpr	JJ	B-TEST	O
nonreactive	NN	O	O
.	.	O	O

hepatitis	NN	B-TEST	B-TEST
b	NN	I-TEST	I-TEST
surface	NN	I-TEST	I-TEST
antigen	NN	I-TEST	I-TEST
negative	JJ	O	O
,	,	O	O
cystic	JJ	B-TEST	B-PROBLEM
fibrosis	NN	I-TEST	I-PROBLEM
negative	JJ	O	O
,	,	O	O
and	CC	O	O
group	NN	B-TEST	B-TEST
b	NN	I-TEST	I-TEST
strep	NN	I-TEST	I-TEST
unknown	JJ	O	O
.	.	O	O

mother	NN	O	O
's	POS	O	O
medical	JJ	O	O
history	NN	O	O
was	VBD	O	O
notable	JJ	O	O
for	IN	O	O
depression	NN	B-PROBLEM	B-PROBLEM
treated	VBN	O	O
with	IN	O	O
zoloft	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

ob	JJ	O	O
history	NN	O	O
notable	JJ	O	O
for	IN	O	O
infertility	NN	B-PROBLEM	B-PROBLEM
treated	VBN	O	O
with	IN	O	O
clomid	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

this	DT	O	O
pregnancy	NN	O	O
was	VBD	O	O
complicate	VBN	O	O
by	IN	O	O
triplet	NN	B-PROBLEM	O
gestation	NN	I-PROBLEM	O
,	,	O	O
cervical	JJ	B-PROBLEM	B-PROBLEM
shortening	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
pregnancy	NN	B-PROBLEM	B-PROBLEM
induced	JJ	I-PROBLEM	I-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

delivery	NN	O	B-TREATMENT
was	VBD	O	O
by	IN	O	O
cesarean	JJ	B-TREATMENT	B-TREATMENT
section	NN	I-TREATMENT	I-TREATMENT
under	IN	O	I-TREATMENT
spinal	JJ	B-TREATMENT	I-TREATMENT
anesthesia	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
pre-eclampsia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
labor	NN	B-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	O
maternal	JJ	I-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mother	NN	O	O
did	VBD	O	O
not	RB	O	O
receive	VB	O	O
any	DT	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
prior	VBP	O	O
to	TO	O	O
delivery	NN	O	B-TREATMENT
.	.	O	O

the	DT	O	O
infant	NN	O	O
emerged	VBD	O	O
vigorous	JJ	O	O
,	,	O	O
was	VBD	O	O
dried	VBN	O	O
,	,	O	O
bulb	NN	O	O
suctioned	VBD	O	O
and	CC	O	O
given	VBN	O	O
free	JJ	B-TREATMENT	B-TREATMENT
flow	NN	I-TREATMENT	I-TREATMENT
oxygen	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

apgar	NN	B-TEST	B-TEST
scores	NNS	I-TEST	I-TEST
were	VBD	O	O
7	CD	O	O
at	IN	O	O
one	CD	O	O
minute	NN	O	O
and	CC	O	O
8	CD	O	O
at	IN	O	O
5	CD	O	O
minutes	NNS	O	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
birth	NN	B-TEST	O
weight	NN	I-TEST	B-TEST
1630	CD	O	O
grams	NN	O	O
(	(	O	O
50th	CD	O	O
percentile	NN	O	O
)	)	O	O
,	,	O	O
length	$	B-TEST	B-TEST
43.5	CD	O	O
cm	NN	O	O
(	(	O	O
50th	CD	O	O
percentile	NN	O	O
)	)	O	O
,	,	O	O
head	VBD	B-TEST	B-TEST
circumference	NN	I-TEST	I-TEST
31.5	CD	O	O
cm	NN	O	O
(	(	O	O
75th	CD	O	O
percentile	NN	O	O
).	NN	O	O

infant	NN	O	O
with	IN	O	O
non-	JJ	B-PROBLEM	B-PROBLEM
dysmorphic	JJ	I-PROBLEM	I-PROBLEM
facies	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
palate	JJ	O	O
intact	NN	O	O
.	.	O	O

anterior	JJ	O	O
fontanel	NNS	O	O
soft	JJ	O	O
and	CC	O	O
flat	JJ	O	O
,	,	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
nasal	NN	I-PROBLEM	I-PROBLEM
flaring	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

chest	NN	O	O
with	IN	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
intercostal	JJ	I-PROBLEM	I-PROBLEM
retractions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
fair	JJ	O	B-TEST
breath	NN	O	I-TEST
sounds	VBZ	O	I-TEST
bilaterally	RB	O	O
,	,	O	O
no	DT	O	O
crackles	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

cardiovascular	NN	O	O
is	VBZ	O	O
well	RB	O	O
perfused	VBN	O	O
with	IN	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
and	CC	O	O
normal	JJ	O	O
s1	NN	O	O
and	CC	O	O
s2	NN	O	O
,	,	O	O
no	DT	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
normal	JJ	O	O
pulses	NNS	O	O
and	CC	O	O
perfusion	NN	O	B-TEST
.	.	O	O

abdomen	NNS	O	O
soft	JJ	O	O
,	,	O	O
not	RB	O	O
distended	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
organomegaly	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

skin	NN	O	O
without	IN	O	O
rashes	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
lesions	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

active	JJ	O	O
,	,	O	O
alert	JJ	O	O
,	,	O	O
responding	VBG	O	O
to	TO	O	O
stimulation	NN	B-TEST	O
.	.	O	O

tone	NN	B-PROBLEM	B-PROBLEM
decreased	VBD	I-PROBLEM	I-PROBLEM
slightly	RB	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
symmetric	JJ	O	I-PROBLEM
distribution	NN	O	I-PROBLEM
,	,	O	O
moves	VBZ	O	O
all	DT	O	O
extremities	NNS	O	O
equally	RB	O	O
.	.	O	O

initially	RB	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
continuous	JJ	B-TREATMENT	B-TREATMENT
positive	JJ	I-TREATMENT	I-TREATMENT
airway	NN	I-TREATMENT	I-TREATMENT
pressure	NN	I-TREATMENT	I-TREATMENT
40%	CD	B-TREATMENT	I-TREATMENT
oxygen	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

due	JJ	O	O
to	TO	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
intubated	VBN	O	B-TREATMENT
,	,	O	O
placed	VBN	O	O
on	IN	O	O
conventional	JJ	B-TREATMENT	B-TREATMENT
ventilation	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
pressures	NNS	B-TREATMENT	O
of	IN	O	O
24/6	CD	O	O
,	,	O	O
rate	NN	B-TREATMENT	O
of	IN	O	O
25	CD	O	O
.	.	O	O

she	PRP	O	O
received	VBD	O	O
one	CD	O	O
dose	NN	O	O
of	IN	O	O
survanta	NN	B-TREATMENT	B-PROBLEM
and	CC	O	O
then	RB	O	O
weaned	VBD	O	O
well	RB	O	O
on	IN	O	O
ventilator	NN	B-TREATMENT	B-TREATMENT
settings	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

has	VBZ	O	O
remained	VBN	O	O
in	IN	O	O
room	NN	O	O
air	NN	O	O
since	IN	O	O
with	IN	O	O
comfortable	JJ	O	O
work	NN	O	O
of	IN	O	O
breathing	NN	O	B-PROBLEM
,	,	O	O
respiratory	NN	B-TEST	B-PROBLEM
rates	NNS	I-TEST	I-PROBLEM
in	IN	O	O
the	DT	O	O
40	CD	O	O
's	POS	O	O
to	TO	O	O
70	CD	O	O
's.	NNS	O	O

no	DT	O	O
apnea	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

heart	NN	B-TEST	B-TEST
rates	NNS	I-TEST	I-TEST
range	VBP	O	O
in	IN	O	O
the	DT	O	O
140	CD	O	O
to	TO	O	O
160	CD	O	O
's	POS	O	O
,	,	O	O
no	DT	O	O
heart	NN	B-PROBLEM	B-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

recent	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
71/31	CD	O	O
with	IN	O	O
a	DT	O	O
mean	NN	O	O
of	IN	O	O
48	CD	O	O
.	.	O	O

was	VBD	O	O
initially	RB	O	O
npo	JJ	B-TREATMENT	O
on	IN	O	O
receiving	VBG	O	O
d10-w	JJ	B-TREATMENT	B-TREATMENT
by	IN	O	O
peripheral	JJ	O	O
intravenous	JJ	O	O
.	.	O	O

enteral	JJ	B-TREATMENT	B-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
started	VBN	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
one	CD	O	O
and	CC	O	O
she	PRP	O	O
advanced	VBD	O	O
to	TO	O	O
full	JJ	B-TREATMENT	B-TREATMENT
volume	NN	I-TREATMENT	I-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
of	IN	O	I-TREATMENT
breast	NN	O	I-TREATMENT
milk	NN	O	I-TREATMENT
or	CC	O	O
special	JJ	B-TREATMENT	B-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
formula	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
six	CD	O	O
(	(	O	O
2013-07-29	JJ	O	O
)	)	O	O
without	IN	O	O
problems	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
presently	RB	O	O
receiving	VBG	O	O
breast	NN	O	B-TREATMENT
milk	NN	O	I-TREATMENT
or	CC	O	O
special	JJ	B-TREATMENT	B-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
formula	NN	I-TREATMENT	I-TREATMENT
24	CD	O	O
cal	NN	O	O
at	IN	O	O
150	CD	O	O
mls	NNS	O	O
per	IN	O	O
kilo	FW	O	O
per	IN	O	O
day	NN	O	O
with	IN	O	O
tolerance	NN	O	O
.	.	O	O

most	RBS	B-TEST	B-TEST
recent	JJ	I-TEST	I-TEST
electrolytes	NNS	I-TEST	I-TEST
done	VBN	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
one	CD	O	O
showed	VBD	O	O
a	DT	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
of	IN	O	O
132	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
6.1	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
100	CD	O	O
,	,	O	O
co2	NN	B-TEST	B-TREATMENT
20	CD	O	O
.	.	O	O

discharge	NN	B-TEST	B-TEST
weight	NN	I-TEST	I-TEST
is	VBZ	O	O
1700	CD	O	O
grams	NN	O	O
up	RB	O	O
15	CD	O	O
grams	NNS	O	O
..	VBP	O	O

received	VBN	O	O
phototherapy	NN	B-TREATMENT	B-TREATMENT
from	IN	O	O
07-27	JJ	O	O
to	TO	O	O
2013-07-28	JJ	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
peak	JJ	I-TEST	I-TEST
bilirubin	NN	I-TEST	I-TEST
of	IN	O	O
8.1	CD	O	O
.	.	O	O

phototherapy	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
when	WRB	O	O
bilirubin	NN	B-TEST	B-TEST
was	VBD	O	O
a	DT	B-TEST	O
total	NN	I-TEST	O
of	IN	O	O
4.7	CD	O	O
.	.	O	O

most	RBS	B-TEST	B-TEST
recent	JJ	I-TEST	I-TEST
bilirubin	NN	I-TEST	I-TEST
on	IN	O	O
2013-07-29	JJ	O	O
total	NN	B-TEST	O
of	IN	O	O
4.2	CD	O	O
,	,	O	O
direct	JJ	B-TEST	O
.4	NN	O	O
.	.	O	O

hematocrit	NN	B-TEST	B-TEST
on	IN	O	O
admission	NN	O	O
47%	CD	O	O
.	.	O	O

no	DT	O	O
transfusions	NNS	B-TREATMENT	B-TREATMENT
given	VBN	O	O
.	.	O	O

received	VBD	O	O
48	CD	O	O
hours	NNS	O	O
of	IN	O	O
ampicillin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
rule	NN	O	O
out	IN	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

cbc	NN	B-TEST	B-TEST
on	IN	O	O
admission	NN	O	O
showed	VBD	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
9.3	CD	O	O
with	IN	O	O
37	CD	B-TEST	O
polys	NNS	I-TEST	B-TEST
,	,	O	O
0	CD	B-TEST	O
bands	NNS	I-TEST	B-TEST
,	,	O	O
platelets	NNS	B-TEST	B-TEST
399,000	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
culture	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

head	NN	B-TEST	B-TEST
ultrasound	IN	I-TEST	I-TEST
not	RB	O	O
indicated	VBN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
hearing	NN	I-TEST	I-TEST
screening	NN	I-TEST	I-TEST
has	VBZ	O	O
not	RB	O	O
been	VBN	O	O
performed	VBN	O	O
,	,	O	O
will	MD	O	O
need	VB	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
home	NN	O	O
.	.	O	O

breast	NN	O	O
milk	NN	O	O
or	CC	O	O
special	JJ	B-TREATMENT	B-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
formula	NN	I-TREATMENT	I-TREATMENT
24	CD	O	O
calories	NNS	O	O
per	IN	O	O
ounce	NN	O	O
at	IN	O	O
150	CD	O	O
mls	NNS	O	O
per	IN	O	O
kilo	FW	O	O
per	IN	O	O
day	NN	O	O
with	IN	O	O
plans	NNS	O	O
to	TO	O	O
advance	VB	O	O
calories	NNS	O	O
.	.	O	O

currently	RB	O	O
on	IN	O	O
no	DT	O	O
medications	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

3.	CD	O	O
state	NN	B-TEST	B-TEST
newborn	JJ	I-TEST	I-TEST
screen	NN	I-TEST	I-TEST
was	VBD	O	O
sent	VBN	O	O
on	IN	O	O
2013-07-26	JJ	O	O
and	CC	O	O
is	VBZ	O	O
pending	VBG	O	O
.	.	O	O

4.	CD	O	O
has	VBZ	O	O
not	RB	O	O
received	VBN	O	O
any	DT	B-TREATMENT	B-TREATMENT
immunization	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

3.	CD	O	O
respiratory	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
resolved	VBD	O	O
.	.	O	O

4.	CD	O	O
physiologic	JJ	B-PROBLEM	B-PROBLEM
jaundice	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

5.	CD	O	O
perinatal	JJ	B-PROBLEM	B-PROBLEM
sepsis	NN	I-PROBLEM	I-PROBLEM
ruled	VBD	O	O
out	RP	O	O
.	.	O	O

abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

partial	JJ	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
obstruction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
49	CD	O	O
year-old	JJ	O	O
male	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
low	JJ	I-TREATMENT	I-TREATMENT
anterior	JJ	I-TREATMENT	I-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
may	MD	O	O
of	IN	O	O
1998	CD	O	O
and	CC	O	O
a	DT	B-PROBLEM	O
recurrence	NN	I-PROBLEM	O
of	IN	O	O
metastasis	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
asleeve	NN	O	O
of	IN	O	O
section	NN	O	O
of	IN	O	O
left	JJ	B-TREATMENT	B-PROBLEM
colon	NN	I-TREATMENT	I-PROBLEM
diverting	VBG	I-TREATMENT	O
ileostomy	NN	I-TREATMENT	B-TREATMENT
for	IN	O	O
recurrent	NN	B-PROBLEM	B-PROBLEM
metastasis	NN	I-PROBLEM	I-PROBLEM
later	RB	O	O
in	IN	O	O
may	MD	O	O
of	IN	O	O
1999	CD	O	O
who	WP	O	O
presents	VBZ	O	O
with	IN	O	O
anterior	JJ	B-PROBLEM	B-PROBLEM
midepigastric	JJ	I-PROBLEM	I-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
states	VBZ	O	O
that	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
began	VBD	O	O
at	IN	O	O
10:30	CD	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
admission	NN	O	O
with	IN	O	O
increase	NN	O	O
during	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
admission	NN	O	O
with	IN	O	O
positive	JJ	O	B-PROBLEM
nausea	NN	B-PROBLEM	I-PROBLEM
and	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
decreased	VBN	B-PROBLEM	B-PROBLEM
output	NN	I-PROBLEM	I-PROBLEM
from	IN	I-PROBLEM	O
the	DT	I-PROBLEM	B-TREATMENT
ostomy	NN	I-PROBLEM	I-TREATMENT
,	,	O	O
and	CC	O	O
the	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
radiating	VBG	O	O
to	TO	O	O
the	DT	O	O
back	NN	O	O
.	.	O	O

percocet	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
naprosyn	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

demerol	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

temperature	NN	B-TEST	B-TEST
98.8	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
68	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
107/82	CD	O	O
,	,	O	O
and	CC	O	O
oxygen	NN	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST
99%	CD	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

clear	JJ	O	O
to	TO	O	O
auscultation	NN	B-TEST	B-TEST
.	.	O	O

regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
with	IN	O	O
no	DT	O	O
murmurs	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

soft	JJ	O	O
,	,	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
distended	VBD	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
tympanic	JJ	B-PROBLEM	O
with	IN	O	O
midepigastric	JJ	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
palpation	NN	B-TEST	B-TEST
and	CC	O	O
no	DT	O	O
rebound	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
ostomy	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
pink	VBN	O	O
with	IN	O	O
minimal	JJ	O	B-TREATMENT
fluid	NN	O	I-TREATMENT
in	IN	O	I-TREATMENT
the	DT	B-TREATMENT	I-TREATMENT
ostomy	JJ	I-TREATMENT	I-TREATMENT
bag	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

it	PRP	O	O
was	VBD	O	O
guaiac	JJ	B-TEST	B-TEST
negative	JJ	O	O
.	.	O	O

no	DT	O	O
signs	NNS	O	O
of	IN	O	O
edema	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
warm	JJ	O	O
and	CC	O	O
palpable	JJ	O	B-TEST
pulses	NNS	O	I-TEST
distally	RB	O	O
.	.	O	O

assessment	NN	B-TEST	O
was	VBD	O	O
continued	VBN	O	O
with	IN	O	O
laboratory	NN	B-TEST	B-TEST
studies	NNS	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
the	DT	O	O
patient	NN	O	O
to	TO	O	O
have	VB	O	O
a	DT	O	B-TEST
white	JJ	B-TEST	I-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
9	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
39	CD	O	O
,	,	O	O
and	CC	O	O
platelets	VBZ	B-TEST	B-TEST
470	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	O	O
normal	JJ	O	O
amylase	NN	O	O
and	CC	O	O
lipase	NN	B-TEST	B-TEST
,	,	O	O
and	CC	O	O
a	DT	O	O
normal	JJ	O	O
basic	JJ	O	O
metabolic	JJ	O	O
panel	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
kub	NNS	B-TEST	O
that	WDT	O	O
showed	VBD	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
dilated	JJ	I-PROBLEM	I-PROBLEM
loops	NNS	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
a	DT	O	B-PROBLEM
partial	JJ	B-PROBLEM	I-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
obstruction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

an	DT	B-TREATMENT	B-TREATMENT
nasogastric	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
and	CC	O	O
had	VBD	O	O
an	DT	B-TREATMENT	B-TREATMENT
h2	NN	I-TREATMENT	I-TREATMENT
blocker	NN	I-TREATMENT	I-TREATMENT
started	VBD	O	O
,	,	O	O
and	CC	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
bowel	NN	B-TREATMENT	B-TREATMENT
rest	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
decompression	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
nasogastric	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
nasogastric	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
removed	VBN	O	O
on	IN	O	O
hsp	JJ	O	O
day	NN	O	O
#	#	O	O
3	CD	O	O
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
improved	VBD	O	O
quickly	RB	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
a	DT	O	B-TREATMENT
clear	JJ	B-TREATMENT	I-TREATMENT
liquid	NN	I-TREATMENT	I-TREATMENT
diet	NN	I-TREATMENT	I-TREATMENT
which	WDT	O	O
was	VBD	O	O
advanced	VBN	O	O
as	IN	O	O
tolerated	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
minimal	JJ	I-PROBLEM	I-PROBLEM
back	RB	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
that	IN	O	O
occurred	VBD	O	O
after	IN	O	O
food	NN	O	O
but	CC	O	O
with	IN	O	O
negative	JJ	O	O
urinalysis	NN	O	B-TEST
and	CC	O	O
negative	JJ	O	O
fever	NN	B-PROBLEM	B-PROBLEM
spikes	NNS	I-PROBLEM	I-PROBLEM
over	IN	O	O
the	DT	O	O
entire	JJ	O	O
course	NN	O	O
of	IN	O	O
this	DT	O	O
stay	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
be	VB	O	O
discharged	VBN	O	O
home	NN	O	O
on	IN	O	O
zantac	NN	B-TREATMENT	O
,	,	O	O
simethicone	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
preoperative	JJ	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
with	IN	O	O
follow-up	JJ	O	O
with	IN	O	O
dr.	JJ	O	O
ur	NNS	O	O
in	IN	O	O
two	CD	O	O
weeks	NNS	O	O
.	.	O	O

patient	NN	O	O
recorded	VBD	O	O
as	IN	O	O
having	VBG	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
to	TO	O	O
drugs	NNS	B-TREATMENT	B-TREATMENT

chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

major	JJ	O	O
surgical	JJ	O	O
or	CC	O	O
invasive	JJ	O	B-TREATMENT
procedure	NN	O	I-TREATMENT
:	:	O	O
persantine	NN	B-TEST	B-TEST
mibi	NN	I-TEST	I-TEST
cardiac	JJ	I-TEST	I-TEST
stress	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
thoracentesis	NN	B-TEST	I-TEST

chest	NN	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT

74	CD	O	O
yo	NNS	O	O
m	NN	O	O
with	IN	O	O
lung	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
dvt	NN	B-PROBLEM	I-PROBLEM
who	WP	O	O
presents	VBZ	O	O
with	IN	O	O
1	CD	O	O
day	NN	O	O
of	IN	O	O
substernal	JJ	B-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
developed	VBD	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
the	DT	O	O
night	NN	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
substernal	JJ	O	O
07-08	JJ	O	O
,	,	O	O
did	VBD	O	O
not	RB	O	O
radiate	VB	O	O
.	.	O	O

he	PRP	O	O
reports	VBZ	O	O
that	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
similar	JJ	O	O
to	TO	O	O
his	PRP$	B-PROBLEM	O
prior	JJ	I-PROBLEM	O
mi	NN	I-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

in	IN	O	O
the	DT	O	O
amanda	NN	O	O
the	DT	B-PROBLEM	O
patients	NNS	I-PROBLEM	O
pain	VBP	I-PROBLEM	B-PROBLEM
resolved	VBN	O	O
with	IN	O	O
ntg	NNS	B-TREATMENT	O
and	CC	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
given	VBN	O	O
asa	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
bblocker	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

at	IN	O	O
time	NN	O	O
of	IN	O	O
my	PRP$	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
,	,	O	O
the	DT	O	O
patient	NN	O	O
denied	VBD	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
vomitting	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
dysuria	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
dizziness	NN	B-PROBLEM	B-PROBLEM
,	,	O	I-PROBLEM
changes	NNS	B-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
vision	NN	I-PROBLEM	I-PROBLEM
/hearing	NN	I-PROBLEM	I-PROBLEM

-	:	O	O
lung	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
-	:	O	O
non-small	JJ	B-PROBLEM	B-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
stage	NN	I-PROBLEM	I-PROBLEM
iiia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
weekly	JJ	B-TREATMENT	B-TREATMENT
carboplatin	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
taxol	NN	B-TREATMENT	B-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
xrt	NNP	B-TREATMENT	O
for	IN	O	O
seven	CD	O	O
weeks	NNS	O	O
followed	VBN	O	O
by	IN	O	O
surgery	NN	B-TREATMENT	O
on	IN	O	O
2015-04-14	NN	O	O
.	.	O	O

-	:	O	O
cad	NN	B-PROBLEM	O
-	:	O	O
s/p	NN	O	O
inferior	JJ	B-PROBLEM	O
stemi	JJ	I-PROBLEM	O
12-03	JJ	O	O
,	,	O	O
stent	JJ	B-TREATMENT	B-TREATMENT
to	TO	I-TREATMENT	O
l	VB	I-TREATMENT	O
cx	NN	I-TREATMENT	O

-	:	O	O
chf	NN	B-PROBLEM	O
(	(	O	O
ef	JJ	B-TEST	O
55%	CD	O	O
on	IN	O	O
05-04	NN	O	O
)	)	O	O

-	:	O	O
htn	NN	B-PROBLEM	B-PROBLEM

-	:	O	O
paroxismal	NN	B-PROBLEM	B-PROBLEM
afib	NN	I-PROBLEM	I-PROBLEM

-	:	O	O
cva	NN	B-PROBLEM	B-PROBLEM

-	:	O	O
left	NN	B-PROBLEM	O
le	VBZ	I-PROBLEM	O
dvt	NN	I-PROBLEM	O
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT

-	:	O	O
s/p	NN	O	O
ivc	NN	B-TREATMENT	B-TREATMENT
filter	NN	I-TREATMENT	I-TREATMENT

family	NN	O	O
history	NN	O	O
:	:	O	O
father	NN	O	O
and	CC	O	O
mother	NN	O	O
with	IN	O	O
cad	NN	B-PROBLEM	B-PROBLEM

vs	SYM	B-TEST	O
-	:	O	O
98.0	CD	O	O
67	CD	O	O
140/63	CD	O	O
22	CD	O	O
99%	CD	O	O
on	IN	O	O
ra	NN	O	O

gen	NN	O	O
-	:	O	O
a+ox3	NN	O	O
,	,	O	O
nad	NN	B-PROBLEM	B-PROBLEM

neck	SYM	O	B-TEST
-	:	O	O
supple	NN	O	O
,	,	O	O
no	DT	O	O
lad	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
jvd	NN	B-PROBLEM	B-PROBLEM

cor	SYM	O	B-TEST
-	:	O	O
rrr	NN	O	O
no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM

chest	JJS	O	O
-	:	O	O
r	NN	O	O
base	NN	O	O
with	IN	O	O
poor	JJ	B-PROBLEM	B-PROBLEM
excursion	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
poor	JJ	B-PROBLEM	B-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
sounds	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

abd	SYM	O	B-TEST
-	:	O	O
s/nt/nd	NN	B-PROBLEM	O
+bs	NN	O	O

ext	JJ	O	O
-	:	O	O
w/wp	NN	O	O
,	,	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
r	NN	B-PROBLEM	B-PROBLEM
leg	NN	I-PROBLEM	I-PROBLEM
swollen	VBN	I-PROBLEM	I-PROBLEM
compared	VBN	O	O
to	TO	O	O
left	VB	O	O

ck	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
cpk	JJ	I-TEST	I-TEST
)-	CD	I-TEST	I-TEST
67	CD	O	O

ck	SYM	B-TEST	B-TEST
-	:	I-TEST	I-TEST
mb	NN	I-TEST	I-TEST
-	:	O	O
notdone	NN	O	O
ctropnt	NN	B-TEST	O
-<	VBD	O	O
0.01	CD	O	O

glucose	JJ	B-TEST	B-TEST
-	:	O	O
159	CD	O	O
*	JJ	O	O
urea	JJ	B-TEST	B-TEST
n	SYM	I-TEST	I-TEST
-	:	O	O
17	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.0	CD	O	O
sodium	NN	B-TEST	B-TEST
-	:	O	O
137	CD	O	O
potassium	NN	B-TEST	B-TEST
-	:	O	O
3.6	CD	O	O
chloride	NN	B-TEST	B-TEST
-	:	O	O
100	CD	O	O
total	JJ	B-TEST	B-TEST
co2	NN	I-TEST	I-TEST
-	:	O	O
27	CD	O	O
anion	NN	B-TEST	B-TEST
gap	NN	I-TEST	I-TEST
-	:	O	O
14	CD	O	O

ck	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
cpk	JJ	I-TEST	I-TEST
)-	CD	I-TEST	I-TEST
76	CD	O	O

2015-06-29	JJ	O	O
09:55	CD	O	O
am	VBP	O	O
ctropnt	JJ	B-TEST	B-TEST
-<	CD	O	O
0.01	CD	O	O

ck	SYM	B-TEST	B-TEST
-	:	I-TEST	I-TEST
mb	NN	I-TEST	I-TEST
-	:	O	O
notdone	NN	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
10.4	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
4.41	CD	O	O
*#	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
12.8	CD	O	O
*#	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
38.2	CD	O	O
*#	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
87	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
29.0	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
33.5	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
15.9	CD	O	O
*	NN	O	O

neuts	NNS	B-TEST	B-TEST
-	:	O	O
86.1	CD	O	O
*	NN	O	O
lymphs	SYM	B-TEST	B-TEST
-	:	O	O
5.4	CD	O	O
*	JJ	O	O
monos	NNS	B-TEST	B-TEST
-	:	O	O
5.7	CD	O	O
eos	SYM	B-TEST	B-TEST
-	:	O	O
2.2	CD	O	O
basos	SYM	B-TEST	B-TEST
-	:	O	O
0.6	CD	O	O

microcyt	SYM	B-TEST	O
-	:	O	O
1+	CD	O	O

plt	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
-	:	O	O
372	CD	O	O

2015-06-29	JJ	O	O
09:50	CD	O	O
am	VBP	O	O
urine	JJ	B-TEST	O

2015-06-29	JJ	O	O
09:50	CD	O	O
am	VBP	O	O
urine	JJ	B-TEST	O

pt	SYM	B-TEST	B-TEST
-	:	O	O
20.4	CD	O	O
*	NN	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
28.6	CD	O	O
inr	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
pt	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
2.0	CD	O	O
*	NN	O	O

2015-06-29	JJ	O	O
09:50	CD	O	O
am	VBP	O	O
urine	JJ	B-TEST	O

color	NN	B-TEST	B-TEST
-	:	O	O
yellow	NN	O	O
appear	VBP	O	O
-	:	O	O
clear	JJ	O	O
sp	NN	B-TEST	O
dickson	NN	I-TEST	O
-	:	O	O
1.013	CD	O	O

2015-06-29	JJ	O	O
09:50	CD	O	O
am	VBP	O	O
urine	JJ	B-TEST	O

blood	NN	B-TEST	B-TEST
-	:	O	I-TEST
mod	NN	O	I-TEST
nitrite	JJ	B-TEST	I-TEST
-	:	O	O
neg	NN	O	O
protein	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
ketone	NN	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
bilirubin	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
urobilngn	JJ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
ph	SYM	B-TEST	B-TEST
-	:	O	O
6.0	CD	O	O
leuk	SYM	O	B-TEST
-	:	O	O
neg	NN	O	O

2015-06-29	JJ	O	O
09:50	CD	O	O
am	VBP	O	O
urine	JJ	B-TEST	O

rbc	LS	B-TEST	B-TEST
-	:	O	O
05-03	JJ	O	O
*	NN	O	O
wbc	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
bacteria	NNS	B-TEST	B-TEST
-	:	O	O
none	NN	O	O
yeast	SYM	B-TEST	B-TEST
-	:	O	O
none	NN	O	O
epi	NN	B-TEST	O
-<	VBD	O	O
1	CD	O	O

cxr	SYM	B-TEST	B-TEST
-	:	O	O
increased	VBN	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
partial	JJ	B-PROBLEM	B-PROBLEM
collapse	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

ekg	SYM	B-TEST	B-TEST
-	:	O	O
nsr	NN	O	O
70	CD	O	O
,	,	O	O
nl	RB	O	O
axis	NN	O	O
,	,	O	O
nl	JJ	O	O
int	NN	O	O
,	,	O	O
old	JJ	B-PROBLEM	O
twi	NN	I-PROBLEM	O
iii	NN	I-PROBLEM	O
,	,	O	O
f	NN	O	O
;	:	O	O
old	JJ	B-PROBLEM	O
j	NN	I-PROBLEM	O
pointing	VBG	I-PROBLEM	O
v	JJ	I-PROBLEM	O
04-04	JJ	O	O

07-03	JJ	O	O
ct	NN	B-TEST	O

ct	NN	B-TEST	B-TEST
chest	NN	I-TEST	I-TEST
:	:	O	O

there	EX	O	O
is	VBZ	O	O
a	DT	O	B-PROBLEM
small	JJ	O	I-PROBLEM
amount	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
pericardial	JJ	B-PROBLEM	I-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
definite	JJ	B-PROBLEM	B-PROBLEM
axillary	NN	I-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	O
mediastinal	JJ	I-PROBLEM	O
,	,	I-PROBLEM	O
or	CC	I-PROBLEM	O
hilar	JJ	I-PROBLEM	B-PROBLEM
lymphadenopathy	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
seen	VBN	O	O
.	.	O	O

again	RB	O	O
seen	VBN	O	O
is	VBZ	O	O
a	DT	B-PROBLEM	O
moderate	JJ	I-PROBLEM	O
-	:	I-PROBLEM	O
to	TO	I-PROBLEM	O
large	JJ	I-PROBLEM	O
-	:	I-PROBLEM	O
sized	VBN	I-PROBLEM	O
right	JJ	I-PROBLEM	B-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
has	VBZ	O	O
been	VBN	O	O
interval	JJ	O	O
development	NN	O	O
of	IN	O	O
moderate	JJ	O	O
amount	NN	O	O
of	IN	O	O
high-attenuation	NN	B-PROBLEM	B-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
within	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
consistent	NN	O	O
with	IN	O	O
hemorrhage	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

patchy	JJ	B-PROBLEM	B-PROBLEM
consolidation	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
stable	JJ	O	O
.	.	O	O

hazy	JJ	B-PROBLEM	B-PROBLEM
patchy	NN	I-PROBLEM	I-PROBLEM
opacities	NNS	I-PROBLEM	I-PROBLEM
are	VBP	O	O
noted	VBN	O	O
in	IN	O	O
the	DT	O	O
left	JJ	O	O
lung	NN	O	O
field	NN	O	O
but	CC	O	O
no	DT	O	O
frank	JJ	B-PROBLEM	O
consolidation	NN	I-PROBLEM	O
is	VBZ	O	O
seen	VBN	O	O
.	.	O	O

ct	JJ	B-TEST	O
abdomen	NNS	I-TEST	O
:	:	O	O

within	IN	O	O
the	DT	O	O
limits	NNS	O	O
of	IN	O	O
this	DT	B-TEST	B-TEST
non-contrast	JJ	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
,	,	O	O
the	DT	O	O
liver	NN	O	O
,	,	O	O
gallbladder	NN	O	B-PROBLEM
,	,	O	O
pancreas	NNS	O	B-PROBLEM
,	,	O	O
spleen	NN	O	O
,	,	O	O
adrenal	JJ	O	B-PROBLEM
glands	NNS	O	I-PROBLEM
,	,	O	O
kidneys	NNS	O	O
,	,	O	O
stomach	NN	O	O
,	,	O	O
and	CC	O	O
small	JJ	O	O
bowel	NN	O	O
loops	NNS	O	O
are	VBP	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
colonic	JJ	B-PROBLEM	B-PROBLEM
diverticulosis	NN	I-PROBLEM	I-PROBLEM
most	RBS	O	I-PROBLEM
prominent	JJ	O	I-PROBLEM
at	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
hepatic	JJ	O	I-PROBLEM
flexure	NN	O	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
free	JJ	B-PROBLEM	B-PROBLEM
air	NN	I-PROBLEM	I-PROBLEM
or	CC	O	I-PROBLEM
free	JJ	B-PROBLEM	I-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
mesenteric	NN	B-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	I-PROBLEM
retroperitoneal	VB	I-PROBLEM	I-PROBLEM
lymphadenopathy	JJ	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
identified	VBN	O	O
.	.	O	O

an	DT	B-TREATMENT	B-TEST
ivc	JJ	I-TREATMENT	I-TEST
filter	NN	I-TREATMENT	I-TEST
is	VBZ	O	O
seen	VBN	O	O
.	.	O	O

ct	NN	B-TEST	B-TEST
pelvis	NN	I-TEST	I-TEST
:	:	O	O

the	DT	O	O
patient	NN	O	O
appears	VBZ	O	O
to	TO	O	O
be	VB	O	O
status	NN	O	O
post	NN	O	O
prostatectomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
free	JJ	B-PROBLEM	B-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
no	DT	O	O
pelvic	NN	B-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	I-PROBLEM
inguinal	JJ	I-PROBLEM	I-PROBLEM
lymphadenopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-PROBLEM	B-PROBLEM
lytic	JJ	I-PROBLEM	I-PROBLEM
area	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
again	RB	O	O
seen	VBN	O	O
in	IN	O	O
the	DT	O	O
l5	JJ	O	O
vertebral	JJ	O	O
body	NN	O	O
but	CC	O	O
unchanged	JJ	O	O
from	IN	O	O
prior	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
.	.	O	O

several	JJ	B-PROBLEM	B-PROBLEM
subacute	NN	I-PROBLEM	I-PROBLEM
or	CC	I-PROBLEM	O
chronic	JJ	I-PROBLEM	B-PROBLEM
rib	NN	I-PROBLEM	I-PROBLEM
fractures	NNS	I-PROBLEM	I-PROBLEM
are	VBP	O	O
identified	VBN	O	O
on	IN	O	O
the	DT	O	O
right	NN	O	O
.	.	O	O

1.	CD	O	O
interval	JJ	O	O
development	NN	O	O
of	IN	O	O
a	DT	O	B-PROBLEM
moderate	JJ	O	I-PROBLEM
amount	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
hemorrhage	NN	B-PROBLEM	I-PROBLEM
within	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
intra-abdominal	JJ	I-PROBLEM	I-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
identified	VBN	O	O
.	.	O	O

07-01	JJ	O	B-PROBLEM
stress	NN	B-TEST	I-PROBLEM
mibi	NN	I-TEST	I-PROBLEM

new	JJ	B-PROBLEM	B-PROBLEM
moderate	JJ	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
fixed	JJ	I-PROBLEM	I-PROBLEM
inferior	JJ	I-PROBLEM	I-PROBLEM
myocardial	NN	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
perfusion	NN	I-PROBLEM	I-PROBLEM
defect	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mild	JJ	B-PROBLEM	B-PROBLEM
inferior	JJ	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
hypokinesis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

calculated	VBN	B-TEST	O
lvef	JJ	I-TEST	O
42%	CD	O	O
.	.	O	O

a/p	RB	O	O
74	CD	O	O
yo	NNS	O	O
m	NN	O	O
with	IN	O	O
lung	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
dvt	NN	B-PROBLEM	O
,	,	O	O
cad	NN	B-PROBLEM	O
s/p	NN	O	O
mi	NN	B-PROBLEM	O
presents	NNS	O	O
with	IN	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
shortness	NN	B-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

#	#	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
/	NN	O	O
ischemia	NN	B-PROBLEM	B-PROBLEM
-	:	O	O
patient	NN	O	O
with	IN	O	O
history	NN	O	O
of	IN	O	O
cad	NN	B-PROBLEM	B-PROBLEM
a/p	NN	O	I-PROBLEM
mi	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

now	RB	O	O
with	IN	O	O
an	DT	O	O
episode	NN	O	O
of	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
consistent	JJ	O	O
with	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
anginal	JJ	I-PROBLEM	I-PROBLEM
equivalent	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
changes	NNS	B-PROBLEM	O
on	IN	O	O
ekg	NN	B-TEST	O
but	CC	O	O
not	RB	O	O
in	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
at	IN	O	O
time	NN	O	O
of	IN	O	O
ekg	NN	B-TEST	O
.	.	O	O

patient	NN	O	O
was	VBD	O	O
ruled	VBN	O	O
out	RP	O	O
by	IN	O	O
enzymes	NNS	B-TEST	B-TEST
.	.	O	O

he	PRP	O	O
also	RB	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
stress	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
which	WDT	O	O
revealed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
irreversible	JJ	I-PROBLEM	I-PROBLEM
deficit	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
his	PRP$	B-PROBLEM	O
prior	JJ	I-PROBLEM	O
known	VBN	I-PROBLEM	O
imi	NN	I-PROBLEM	O
.	.	O	O

continued	VBN	O	O
on	IN	O	O
asa	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
bblocker	NN	B-TREATMENT	B-PROBLEM
,	,	O	O
hicks	NNS	B-TREATMENT	O
,	,	O	O
statin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
plavix	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

bp	NN	B-TREATMENT	B-TREATMENT
meds	NNS	I-TREATMENT	I-TREATMENT
held	VBD	O	O
while	IN	O	O
was	VBD	O	O
unstable	JJ	B-PROBLEM	O
.	.	O	O

asa	NN	B-TREATMENT	O
,	,	O	O
plavix	JJ	B-TREATMENT	B-TREATMENT
held	VBD	O	O
during	IN	O	O
hemothorax	NN	B-PROBLEM	O
.	.	O	O

#	#	O	O
chf	SYM	B-PROBLEM	B-TEST
-	:	O	O
patient	NN	O	O
does	VBZ	O	O
not	RB	O	O
seem	VB	O	O
volume	NN	B-PROBLEM	B-PROBLEM
overloaded	VBN	I-PROBLEM	I-PROBLEM
at	IN	O	O
this	DT	O	O
time	NN	O	O
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
no	DT	O	O
jvd	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
legs	NNS	I-PROBLEM	I-PROBLEM
(	(	O	I-PROBLEM
other	JJ	O	I-PROBLEM
than	IN	O	I-PROBLEM
swelling	VBG	B-PROBLEM	I-PROBLEM
from	IN	O	O
dvt	NN	B-PROBLEM	O
)	)	O	O
.	.	O	O

last	JJ	B-TEST	O
echo	NN	I-TEST	B-TEST
with	IN	O	O
ef	JJ	B-TEST	O
55%	CD	O	O
.	.	O	O

does	VBZ	O	O
have	VB	O	O
increased	VBN	B-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
although	IN	O	O
loculated	VBN	O	O
.	.	O	O

continued	VBN	O	O
on	IN	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
bblocker	NN	B-TREATMENT	B-PROBLEM
robertson	NN	O	I-PROBLEM
.	.	O	O

bp	NN	B-TREATMENT	B-TREATMENT
meds	NNS	I-TREATMENT	I-TREATMENT
held	VBD	O	O
while	IN	O	O
unstable	JJ	B-PROBLEM	O
.	.	O	O

#	#	O	O
afib	SYM	B-PROBLEM	B-TEST
-	:	O	O
in	IN	O	O
sinus	NN	O	B-PROBLEM
during	IN	O	O
admission	NN	O	O
.	.	O	O

patients	NNS	B-TREATMENT	O
anticoag	JJ	I-TREATMENT	O
held	VBD	O	O
during	IN	O	O
hemothorax	NN	B-PROBLEM	O
.	.	O	O

#	#	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
/	NN	O	O
loculated	VBD	B-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
-	:	O	O
patient	NN	O	O
with	IN	O	O
increaing	VBG	B-PROBLEM	B-PROBLEM
loculated	JJ	I-PROBLEM	I-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

has	VBZ	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
shortness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
has	VBZ	O	O
worsened	VBN	O	O
over	IN	O	O
the	DT	O	O
past	JJ	O	O
few	JJ	O	O
days	NNS	O	O
.	.	O	O

no	DT	O	O
sign	NN	O	O
of	IN	O	O
infeciton	NN	B-PROBLEM	B-TREATMENT
at	IN	O	O
this	DT	O	O
time	NN	O	O
.	.	O	O

had	VBD	O	O
thoracentesis	VBN	B-TEST	O
by	IN	O	O
interventional	JJ	O	O
pumonology	NN	O	O
on	IN	O	O
2015-07-01	JJ	O	O
revealing	NN	O	O
almost	RB	O	O
2	CD	O	O
l	NN	O	O
of	IN	O	O
serous	JJ	B-PROBLEM	B-PROBLEM
exudative	JJ	I-PROBLEM	I-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

cytology	NN	B-TEST	B-TEST
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

however	RB	O	O
on	IN	O	O
07-02	JJ	O	B-TEST
hct	NN	B-TEST	I-TEST
dropped	VBD	O	O
.	.	O	O

ct	NN	B-TEST	B-TEST
revealed	VBD	O	O
hemothorax	NN	B-PROBLEM	O
.	.	O	O

all	DT	B-TREATMENT	B-TREATMENT
anticoagulation	NN	I-TREATMENT	I-TREATMENT
stopped	VBD	O	O
despite	IN	O	O
the	DT	O	O
risk	NN	O	O
of	IN	O	O
dvt	NN	B-PROBLEM	O
,	,	O	O
afib	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

thoracics	NNS	O	O
consulted	VBN	O	O
and	CC	O	O
chest	JJS	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
placed	VBD	O	O
.	.	O	O

frank	JJ	B-PROBLEM	B-TEST
blood	NN	I-PROBLEM	I-TEST
was	VBD	O	O
taken	VBN	O	O
out	RP	O	O
.	.	O	O

patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
bleed	VB	O	O
in	IN	O	O
and	CC	O	O
around	IN	O	O
the	DT	B-TREATMENT	O
tube	NN	I-TREATMENT	O
.	.	O	O

patient	NN	O	O
sent	VBD	O	O
to	TO	O	O
cmed	VB	O	O
for	IN	O	O
observation	NN	B-TEST	O
after	IN	O	O
hct	NN	B-TEST	B-TEST
continued	VBD	O	O
to	TO	O	O
drop	VB	O	O
.	.	O	O

patient	NN	O	O
spontaneously	RB	O	O
stablized	VBN	O	O
and	CC	O	O
output	NN	B-TEST	B-TEST
of	IN	O	I-TEST
ct	NN	B-TEST	I-TEST
became	VBD	O	O
more	RBR	O	B-PROBLEM
serous	JJ	O	I-PROBLEM
.	.	O	O

output	NN	B-TEST	O
resent	NN	O	O
for	IN	O	O
cytology	NN	B-TEST	B-TEST
which	WDT	O	O
was	VBD	O	O
pending	VBG	O	O
at	IN	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

when	WRB	O	O
output	NN	B-TEST	O
became	VBD	O	O
<	JJ	O	O
100	CD	O	O
cc	NN	O	O
the	DT	B-TREATMENT	O
tube	NN	I-TREATMENT	O
was	VBD	O	O
removed	VBN	O	O
.	.	O	O

patient	NN	O	O
follwed	VBN	O	O
with	IN	O	O
serial	JJ	B-TEST	B-TEST
cxr	NN	I-TEST	I-TEST
that	WDT	O	O
did	VBD	O	O
not	RB	O	O
demonstrate	VB	O	O
reaccumulation	NN	B-PROBLEM	O
.	.	O	O

hct	NN	B-TEST	B-TEST
also	RB	O	O
remained	VBD	O	O
stable	JJ	O	O
.	.	O	O

#	#	O	O
dvt	SYM	B-PROBLEM	B-TEST
-	:	O	O
patient	JJ	O	O
therapeutic	JJ	O	O
on	IN	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

improving	VBG	O	B-PROBLEM
clots	NNS	B-PROBLEM	I-PROBLEM
on	IN	O	O
leni	NN	B-TREATMENT	O
.	.	O	O

cta	NN	B-TEST	O
neg	NN	O	O
for	IN	O	O
pe	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

anticoagulaiton	RB	B-TREATMENT	O
held	VBN	O	O
during	IN	O	O
hemothorax	NN	B-PROBLEM	O
.	.	O	O

patient	NN	O	O
restarted	VBN	O	O
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
will	MD	O	O
be	VB	O	O
discharged	VBN	O	O
on	IN	O	O
3mg	CD	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
qday	NN	O	O
.	.	O	O

#	#	O	O
lung	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
-	:	O	O
patient	NN	O	O
currently	RB	O	O
with	IN	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
disease	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

s/p	NN	O	O
neoadjuvant	JJ	B-TREATMENT	B-TREATMENT
chemo/xrt	NN	I-TREATMENT	I-TREATMENT
now	RB	O	O
s/p	VBZ	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

1st	CD	B-TEST	O
cytology	NN	I-TEST	B-TEST
negative	JJ	O	O
.	.	O	O

2ng	CD	B-TEST	O
cytology	NN	I-TEST	B-TEST
pending	VBG	O	O
.	.	O	O

lipitor	NN	B-TREATMENT	B-TREATMENT
80	CD	O	O
mg	NN	O	O
qday	NN	O	O

asa	RB	B-TREATMENT	O
81	CD	O	O
mg	NNS	O	O
qday	JJ	O	O

bowel	NN	B-TREATMENT	O
reg	NN	I-TREATMENT	O

percocet	NN	B-TREATMENT	B-TREATMENT
prn	NN	O	O

plavix	NN	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
qday	NN	O	O

losartan	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
qday	NN	O	O

coumadin	NN	B-TREATMENT	B-TREATMENT
3	CD	O	O
mg	NN	O	O
qday	NN	O	O

lasix	RB	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NNS	O	O
qday	JJ	O	O

atenolol	RB	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NNS	O	O
qday	JJ	O	O

1.	CD	O	O
atorvastatin	JJ	B-TREATMENT	B-TREATMENT
80	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

2.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

3.	CD	O	O
senna	JJ	B-TREATMENT	B-TREATMENT
8.6	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
constipation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

4.	CD	O	O
bisacodyl	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
daily	JJ	O	O
(	(	O	O
daily	RB	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
constipation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

5.	CD	O	O
oxycodone	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q4h	NN	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

6.	CD	O	O
clopidogrel	NN	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

7.	CD	O	O
furosemide	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

8.	CD	O	O
nitroglycerin	JJ	B-TREATMENT	B-TREATMENT
0.3	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
sublingual	JJ	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
sublingual	JJ	O	B-TREATMENT
sublingual	JJ	O	I-TREATMENT
prn	NN	O	O
(	(	O	O
as	IN	O	O
needed	VBN	O	O
)	)	O	O
.	.	O	O

9.	CD	O	O
atenolol	JJ	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

10.	CD	O	O
losartan	JJ	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

11.	CD	O	O
benzonatate	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
cough	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

12.	CD	O	O
acetaminophen	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q6h	NN	O	O
(	(	O	O
every	DT	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

13.	CD	O	O
oxycodone	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q4h	NN	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

14.	CD	O	O
codeine	JJ	B-TREATMENT	B-TREATMENT
-	:	O	I-TREATMENT
guaifenesin	NN	B-TREATMENT	I-TREATMENT
10-100	JJ	O	O
mg	NN	O	O
/	$	O	O
5	CD	O	O
ml	NN	O	O
syrup	NN	O	O
sig	NN	O	O
:	:	O	O
5-10	JJ	O	O
mls	NN	O	O
po	NN	O	O
q6h	NN	O	O
(	(	O	O
every	DT	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

15.	CD	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
3	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

angina	NN	B-PROBLEM	B-PROBLEM

pleural	JJ	B-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM

htn	NN	B-PROBLEM	B-PROBLEM

non	RB	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM

cad	NN	B-PROBLEM	B-PROBLEM

dvt	NN	B-PROBLEM	O
h/o	NN	O	O
afib	NN	B-PROBLEM	B-PROBLEM

please	VB	O	O
take	VB	O	O
all	DT	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
as	IN	O	O
listed	VBN	O	O
in	IN	O	O
the	DT	O	O
discharge	NN	O	O
paperwork	NN	O	O
.	.	O	O

if	IN	O	O
you	PRP	O	O
have	VBP	O	O
chest	VBN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
other	JJ	B-PROBLEM	B-PROBLEM
concerning	VBG	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
please	VB	O	O
call	VB	O	O
your	PRP$	O	O
md	NN	O	O
or	CC	O	O
come	VBN	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
.	.	O	O

i	NNS	O	O
have	VBP	O	O
changed	VBN	O	O
some	DT	O	O
of	IN	O	O
your	PRP$	B-TREATMENT	B-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
pressure	NN	I-TREATMENT	I-TREATMENT
meds	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

your	PRP$	B-TREATMENT	B-TEST
atenolol	NN	I-TREATMENT	I-TEST
has	VBZ	O	O
increased	VBN	O	O
to	TO	O	O
50	CD	O	O
mg	NNS	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

your	PRP$	B-TREATMENT	B-TREATMENT
losartan	NN	I-TREATMENT	I-TREATMENT
has	VBZ	O	O
increased	VBN	O	O
to	TO	O	O
50	CD	O	O
mg	NNS	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

please	VB	O	O
see	VB	O	O
dr.	JJ	O	O
holbrook	NN	O	O
(	(	O	O
984	CD	O	O
)	)	O	O
452	CD	O	O
0816	CD	O	O
on	IN	O	O
monday	NN	O	O
and	CC	O	O
have	VB	O	O
your	PRP$	B-TEST	B-TEST
coumadin	NNS	I-TEST	I-TEST
level	NN	I-TEST	I-TEST
checked	VBD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
status	NN	O	O
post	NN	O	O
a	DT	B-TREATMENT	B-TREATMENT
rehabilitation	NN	I-TREATMENT	I-TREATMENT
hospitalization	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
the	DT	O	O
raya	NN	O	O
ma	NN	O	O
den	NN	O	O
erinmarg	NN	O	O
hospital	NN	O	O
with	IN	O	O
a	DT	O	B-TEST
recent	JJ	O	I-TEST
recrudescence	NN	O	I-TEST
of	IN	O	O
his	PRP$	O	O
drug	NN	O	O
abuse	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
sephsandpot	NN	O	O
center	NN	O	O
on	IN	O	O
the	DT	O	O
morning	NN	O	O
of	IN	O	O
4/9	CD	O	O
and	CC	O	O
was	VBD	O	O
subsequently	RB	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
fairm	NN	O	O
of	IN	O	O
ijordcompmac	JJ	O	O
hospital	NN	O	O
for	IN	O	O
further	JJ	B-TREATMENT	B-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

at	IN	O	O
3:00	CD	O	O
a.m.	NN	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
admission	NN	O	O
he	PRP	O	O
was	VBD	O	O
found	VBN	O	O
by	IN	O	O
the	DT	O	O
emergency	NN	O	O
medical	JJ	O	O
technicians	NNS	O	O
&quot;	VBP	O	O
crawling	VBG	O	O
on	IN	O	O
all	DT	O	O
fours	NNS	O	O
&quot;	NNP	O	O
,	,	O	O
confused	VBD	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
combative	JJ	B-PROBLEM	O
outside	IN	O	O
his	PRP$	O	O
home	NN	O	O
.	.	O	O

he	PRP	O	O
gave	VBD	O	O
an	DT	O	O
equivocal	JJ	O	O
history	NN	O	O
of	IN	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
on	IN	O	O
the	DT	O	O
days	NNS	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
sephsandpot	NN	O	O
center	NN	O	O
where	WRB	O	O
he	PRP	O	O
was	VBD	O	O
hypotensive	JJ	B-PROBLEM	O
with	IN	O	O
a	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
105/85	CD	O	O
,	,	O	O
tachycardic	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
a	DT	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
to	TO	O	O
186	CD	O	O
,	,	O	O
aneuric	NN	B-PROBLEM	O
,	,	O	O
hyperthermic	JJ	B-PROBLEM	O
,	,	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
to	TO	O	O
105	CD	O	O
degrees	NNS	O	O
f	RB	O	O
,	,	O	O
and	CC	O	O
progressively	RB	B-PROBLEM	O
more	RBR	I-PROBLEM	O
confused	JJ	I-PROBLEM	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
was	VBD	O	O
clear	JJ	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
dopamine	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
inderal	JJ	B-TREATMENT	O
for	IN	O	O
tachycardia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
received	VBD	O	O
two	CD	O	O
amps	NNS	O	O
of	IN	O	O
narcan	JJ	B-TREATMENT	O
.	.	O	O

he	PRP	O	O
received	VBD	O	O
one	CD	O	O
gram	NN	O	O
of	IN	O	O
ceftriaxone	NN	B-TREATMENT	B-TREATMENT
intravenously	RB	O	I-TREATMENT
after	IN	O	O
blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
were	VBD	O	O
drawn	VBN	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
initial	JJ	I-TEST	I-TEST
arterial	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
gas	NN	I-TEST	I-TEST
at	IN	O	O
the	DT	O	O
sephsandpot	NN	O	O
center	NN	O	O
revealed	VBD	O	O
a	DT	B-TEST	O
p02	NN	I-TEST	O
of	IN	O	O
76	CD	O	O
,	,	O	O
pc02	NN	B-TEST	B-TEST
14	CD	O	O
,	,	O	O
and	CC	O	O
a	DT	B-TEST	O
ph	NN	I-TEST	O
of	IN	O	O
7.44	CD	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

toxicology	NN	B-TEST	O
screen	NN	I-TEST	O
at	IN	O	O
sephsandpot	NN	O	O
center	NN	O	O
revealed	VBD	O	O
cocaine	NN	O	B-TREATMENT
and	CC	O	O
quinine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

shortly	RB	O	O
after	IN	O	O
his	PRP$	O	O
arrival	NN	O	O
to	TO	O	O
that	DT	O	O
hospital	NN	O	O
he	PRP	O	O
had	VBD	O	O
been	VBN	O	O
intubated	VBN	O	B-TREATMENT
for	IN	O	O
a	DT	B-TEST	B-TEST
respiratory	JJ	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
60	CD	O	O
.	.	O	O

he	PRP	O	O
required	VBD	O	O
medical	JJ	B-TREATMENT	B-PROBLEM
paralysis	NN	I-TREATMENT	I-PROBLEM
for	IN	O	O
this	DT	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
reported	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
seizure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
although	IN	O	O
the	DT	O	O
nature	NN	O	O
of	IN	O	O
this	DT	O	O
was	VBD	O	O
unclear	JJ	O	O
,	,	O	O
and	CC	O	O
received	VBD	O	O
valium	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
this	DT	O	O
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
status	NN	O	O
post	NN	O	O
recent	JJ	B-TREATMENT	B-TREATMENT
left	VBD	I-TREATMENT	I-TREATMENT
knee	NN	I-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
status	NN	O	O
post	NN	O	O
left	VBD	B-TREATMENT	B-PROBLEM
carpal	JJ	I-TREATMENT	I-PROBLEM
tunnel	NN	I-TREATMENT	I-PROBLEM
release	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
meds	NNS	I-TREATMENT	I-TREATMENT
on	IN	O	O
transfer	NN	O	O
to	TO	O	O
fih	VB	O	O
were	VBD	O	O
levophed	VBN	B-TREATMENT	O
,	,	O	O
dopamine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
ceftriaxone	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

revealed	VBD	O	O
an	DT	O	B-PROBLEM
obtunded	JJ	O	I-PROBLEM
white	JJ	O	I-PROBLEM
muscular	JJ	O	I-PROBLEM
man	NN	O	I-PROBLEM
who	WP	O	O
was	VBD	O	O
intubated	VBN	B-TREATMENT	B-TREATMENT
and	CC	O	O
sedated	VBN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	B-TEST	B-TEST
vital	JJ	I-TEST	I-TEST
signs	NNS	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
69	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
80	CD	O	O
,	,	O	O
respirations	NNS	B-TEST	B-TEST
14	CD	O	O
,	,	O	O
and	CC	O	O
temperature	NN	B-TEST	B-TEST
99.8	CD	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
contusion	NN	I-PROBLEM	I-PROBLEM
over	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
eye	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
no	DT	O	O
laceration	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
abrasion	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
shoulder	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
flank	JJ	B-PROBLEM	B-PROBLEM
discoloration	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
blanching	VBG	B-PROBLEM	B-PROBLEM
papules	NNS	I-PROBLEM	I-PROBLEM
over	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
knees	NNS	I-PROBLEM	I-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM
without	IN	O	O
central	JJ	B-PROBLEM	B-PROBLEM
necrosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

lymphatic-he	NN	O	O
had	VBD	O	O
shotty	JJ	B-PROBLEM	B-PROBLEM
cervical	JJ	I-PROBLEM	I-PROBLEM
adenopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
,	,	I-TEST	I-TEST
eyes	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
ears	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
nose	RB	I-TEST	I-TEST
,	,	I-TEST	I-TEST
throat	NN	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
was	VBD	O	O
normocephalic	JJ	O	O
,	,	O	O
with	IN	O	O
trauma	NN	B-PROBLEM	B-PROBLEM
as	IN	O	O
described	NN	O	O
,	,	O	O
pupils	NNS	O	O
were	VBD	O	O
2	CD	O	O
mm	NNS	O	O
bilaterally	RB	O	O
which	WDT	O	O
were	VBD	O	O
minimally	RB	B-PROBLEM	B-PROBLEM
reactive	JJ	I-PROBLEM	I-PROBLEM
,	,	O	O
fundi	NN	O	O
was	VBD	O	O
not	RB	O	O
seen	VBN	O	O
,	,	O	O
conjunctivae	VB	O	O
without	IN	O	O
erythema	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
sclerae	NN	O	B-PROBLEM
anicteric	NN	B-PROBLEM	I-PROBLEM
,	,	O	O
positive	JJ	O	O
corneal	NN	B-TEST	B-TEST
reflexes	NNS	I-TEST	I-TEST
noted	VBD	O	O
.	.	O	O

ears-the	JJ	O	B-TEST
tympanic	JJ	O	I-TEST
membranes	NNS	O	I-TEST
were	VBD	O	O
clear	JJ	O	O
with	IN	O	O
no	DT	O	O
hemorrhage	NN	B-PROBLEM	B-PROBLEM
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
admission	NN	O	O
.	.	O	O

nose-no	JJ	O	B-PROBLEM
sinus	NN	B-PROBLEM	I-PROBLEM
discharge	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
hemorrhage	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
oropharynx	NN	O	O
was	VBD	O	O
intubated	VBN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
had	VBD	O	O
scattered	VBN	B-PROBLEM	B-PROBLEM
wheezes	NNS	I-PROBLEM	I-PROBLEM
following	VBG	O	O
a	DT	B-TREATMENT	B-TREATMENT
3	CD	I-TREATMENT	I-TREATMENT
liter	NN	I-TREATMENT	I-TREATMENT
bolus	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
effusion	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
rub	NN	B-PROBLEM	B-PROBLEM
was	VBD	O	O
heard	VBN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
cardiac	NN	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
showed	VBD	O	O
point	NN	O	O
of	IN	O	O
maximal	JJ	O	O
impulse	NN	O	O
was	VBD	O	O
not	RB	O	O
displaced	VBN	O	O
,	,	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
with	IN	O	O
normal	JJ	O	O
s1	NN	O	O
,	,	O	O
s2	NN	O	O
,	,	O	O
no	DT	O	O
s3	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
s4	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
a	DT	B-PROBLEM	B-PROBLEM
grade	NN	I-PROBLEM	I-PROBLEM
ii	NN	I-PROBLEM	I-PROBLEM
/	NNP	I-PROBLEM	I-PROBLEM
vi	VBZ	I-PROBLEM	I-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
heard	VBN	O	O
at	IN	O	O
the	DT	O	O
left	JJ	O	O
upper	JJ	O	O
sternal	JJ	O	O
border	NN	O	O
without	IN	O	O
radiation	NN	B-PROBLEM	O
,	,	O	O
likely	RB	O	O
representing	VBG	O	O
a	DT	B-PROBLEM	B-PROBLEM
flow	JJ	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
jugular	JJ	I-TEST	I-TEST
venous	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
not	RB	O	O
assessed	JJ	O	O
secondary	JJ	O	O
to	TO	O	O
cervical	JJ	B-TREATMENT	B-TREATMENT
collar	NN	I-TREATMENT	I-TREATMENT
being	VBG	O	O
in	IN	O	O
place	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
carotid	NN	I-TEST	I-TEST
pulses	NNS	I-TEST	I-TEST
were	VBD	O	O
brisk	JJ	O	B-PROBLEM
bilaterally	RB	O	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
vascular	JJ	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
showed	VBD	O	O
normal	JJ	O	O
pulses	NNS	O	O
bilaterally	RB	O	O
without	IN	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
,	,	O	O
bowel	JJ	O	O
sounds	NNS	O	O
of	IN	O	O
normal	JJ	O	O
character	NN	O	O
,	,	O	O
and	CC	O	O
there	RB	O	O
was	VBD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
percussion	NN	I-PROBLEM	I-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
tenderness	NN	B-PROBLEM	B-PROBLEM
to	TO	O	O
modest	JJ	B-TEST	B-PROBLEM
palpation	NN	I-TEST	I-PROBLEM
in	IN	I-TEST	I-PROBLEM
all	DT	I-TEST	I-PROBLEM
four	CD	I-TEST	I-PROBLEM
quadrants	NNS	I-TEST	I-PROBLEM
.	.	O	O

it	PRP	O	O
was	VBD	O	O
unclear	JJ	O	O
whether	IN	O	O
this	DT	O	O
was	VBD	O	O
due	JJ	O	O
to	TO	O	O
superficial	JJ	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
marked	VBN	B-PROBLEM	O
voluntary	JJ	I-PROBLEM	O
guarding	NN	I-PROBLEM	O
without	IN	O	O
rigidity	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
were	VBD	O	O
felt	VBN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
genitourinary	JJ	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
showed	VBD	O	O
normal	JJ	O	O
penis	NN	O	O
with	IN	O	O
normal	JJ	O	O
testicles	NNS	O	O
which	WDT	O	O
were	VBD	O	O
nontender	JJR	B-PROBLEM	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
urethritis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
balinitis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
normal	JJ	O	O
prostate	NN	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
tan	JJ	B-PROBLEM	B-PROBLEM
guaiac	JJ	I-PROBLEM	I-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
stool	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
musculoskeletal	JJ	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
showed	VBD	O	O
well	RB	O	O
developed	VBN	O	O
,	,	O	O
symmetrical	JJ	O	B-PROBLEM
muscular	NN	O	I-PROBLEM
development	NN	O	I-PROBLEM
with	IN	O	O
no	DT	O	O
fasciculations	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
joint	JJ	B-PROBLEM	B-PROBLEM
erythema	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
effusions	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

neuro	JJ	B-TEST	B-TEST
exam-the	JJ	I-TEST	I-TEST
mental	NN	B-TEST	I-TEST
status	NN	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
was	VBD	O	O
variable	JJ	O	O
,	,	O	O
intermittently	RB	B-PROBLEM	O
responsive	JJ	I-PROBLEM	O
,	,	O	O
unable	JJ	B-PROBLEM	O
to	TO	O	O
follow	VB	O	O
commands	NNS	B-TEST	O
.	.	O	O

the	DT	B-TEST	O
motor	NN	I-TEST	O
exam-moves	VBZ	I-TEST	O
all	DT	O	O
four	CD	O	O
extremities	NNS	O	O
easily	RB	O	O
and	CC	O	O
on	IN	O	O
command	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
sensory	JJ	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
revealed	VBD	O	O
no	DT	O	O
focal	JJ	B-PROBLEM	B-PROBLEM
deficits	NNS	I-PROBLEM	I-PROBLEM
to	TO	O	O
limited	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
.	.	O	O

reflexes	NNS	B-TEST	B-TEST
were	VBD	O	O
trace	NN	O	O
in	IN	O	O
the	DT	O	O
upper	JJ	O	O
extremities	NNS	O	O
and	CC	O	O
absent	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
knees	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
downgoing	VBG	O	O
toes	NNS	O	O
bilaterally	RB	O	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
the	DT	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
was	VBD	O	O
144	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
2.6	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
114	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
12.3	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
30	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
4.0	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
89	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
sgot	NN	I-TEST	I-TEST
was	VBD	O	O
994	CD	O	O
,	,	O	O
ldh	VBD	B-TEST	O
1,888	CD	O	O
,	,	O	O
alkaline	JJ	B-TEST	B-TEST
phosphatase	NN	I-TEST	I-TEST
92	CD	O	O
,	,	O	O
total	JJ	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
2.9	CD	O	O
and	CC	O	O
direct	JJ	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
11.2	CD	O	O
.	.	O	O

lactate	NN	B-TEST	B-TEST
was	VBD	O	O
6.3	CD	O	O
,	,	O	O
acetone	RB	B-TEST	B-TEST
negative	JJ	O	O
,	,	O	O
ammonia	JJ	B-TEST	B-TEST
26	CD	O	O
,	,	O	O
uric	JJ	B-TEST	B-TREATMENT
acids	NNS	I-TEST	I-TREATMENT
26.9	CD	O	O
,	,	O	O
albumin	RB	B-TEST	B-TEST
4.0	CD	O	O
,	,	O	O
globulin	NN	B-TEST	B-TEST
3.0	CD	O	O
,	,	O	O
amylase	NN	B-TEST	B-TEST
259	CD	O	O
,	,	O	O
lipase	NN	B-TEST	B-TEST
34	CD	O	O
,	,	O	O
magnesium	NN	B-TEST	B-TEST
3.5	CD	O	O
,	,	O	O
phosphorus	NN	B-TEST	B-TEST
1.9	CD	O	O
,	,	O	O
calcium	NN	B-TEST	B-TEST
9.4.	CD	O	O
the	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
19.7	CD	O	O
with	IN	O	O
89%	CD	O	O
polys	NNS	B-TEST	B-TEST
,	,	O	O
7%	CD	O	O
bands	NNS	B-TEST	B-TEST
,	,	O	O
4%	CD	O	O
lymphs	NN	B-TEST	B-TEST
,	,	O	O
with	IN	O	O
toxic	JJ	B-PROBLEM	B-PROBLEM
granulations	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

hematocrit	NN	B-TEST	B-TEST
was	VBD	O	O
45.2	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
platelet	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
132,000	CD	O	O
,	,	O	O
falling	VBG	O	O
rapidly	RB	O	O
to	TO	O	O
24,000	CD	O	O
.	.	O	O

the	DT	B-TEST	O
mcv	NN	I-TEST	O
is	VBZ	O	O
88	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
prothrombin	NN	I-TEST	I-TEST
time	NN	I-TEST	I-TEST
is	VBZ	O	O
27.7	CD	O	O
,	,	O	O
partial	JJ	B-TEST	B-TEST
thromboplastin	NN	I-TEST	I-TEST
time	NN	I-TEST	I-TEST
is	VBZ	O	O
greater	JJR	O	O
than	IN	O	O
100	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
urinalysis	NN	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	B-TEST	B-TEST
specific	JJ	I-TEST	I-TEST
gravity	NN	I-TEST	I-TEST
of	IN	O	O
1.15	CD	O	O
,	,	O	O
ph	NN	B-TEST	B-TEST
5.0	CD	O	O
,	,	O	O
and	CC	O	O
4+	CD	B-PROBLEM	O
albumin	NN	I-PROBLEM	B-TEST
,	,	O	O
positive	JJ	B-PROBLEM	B-PROBLEM
occult	NN	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
0-5	JJ	B-PROBLEM	O
granular	JJ	I-PROBLEM	O
casts	NNS	I-PROBLEM	O
and	CC	O	O
5-10	JJ	B-PROBLEM	O
rbcs	NN	I-PROBLEM	O
and	CC	O	O
3-5	JJ	B-PROBLEM	O
wbcs	NN	I-PROBLEM	O
.	.	O	O

the	DT	B-TEST	O
ck	NN	I-TEST	O
was	VBD	O	O
17,890	CD	O	O
with	IN	O	O
0.6%	CD	O	O
mb	NNS	B-TEST	O
.	.	O	O

the	DT	B-TEST	B-TEST
urine	JJ	I-TEST	I-TEST
sodium	NN	I-TEST	I-TEST
was	VBD	O	O
147	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
serum	NN	I-TEST	I-TEST
toxicology	NN	I-TEST	I-TEST
was	VBD	O	O
positive	JJ	B-PROBLEM	O
for	IN	O	O
cocaine	NN	O	B-TREATMENT
on	IN	O	O
admission	NN	O	O
to	TO	O	O
the	DT	O	O
fairm	NN	O	O
of	IN	O	O
ijordcompmac	JJ	O	O
hospital	NN	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
the	DT	O	O
sephsandpot	NN	O	O
center	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
revealed	VBD	O	O
normal	JJ	O	O
sinus	NN	O	O
rhythm	NN	O	O
at	IN	O	O
85	CD	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
prolonged	JJ	I-PROBLEM	I-PROBLEM
qt	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
0.572	CD	O	O
.	.	O	O

an	DT	B-TEST	B-TEST
i-head	JJ	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
revealed	VBD	O	O
left	VBN	O	B-PROBLEM
sphenoid	NN	O	I-PROBLEM
and	CC	O	I-PROBLEM
left	VBD	B-PROBLEM	I-PROBLEM
maxillary	JJ	I-PROBLEM	I-PROBLEM
sinusitis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
cerebral	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
no	DT	O	O
focal	JJ	B-PROBLEM	B-PROBLEM
hemorrhages	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
abdominal	JJ	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
revealed	VBD	O	O
mesenteric	JJ	B-PROBLEM	B-PROBLEM
adenopathy	RB	I-PROBLEM	I-PROBLEM
,	,	O	O
normal	JJ	O	O
bowels	NNS	O	O
,	,	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
?	.	O	O
fatty	JJ	B-PROBLEM	B-PROBLEM
liver	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
revealed	VBD	O	O
early	JJ	B-PROBLEM	B-PROBLEM
interstitial	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
with	IN	O	O
the	DT	O	O
diagnosis	NN	O	O
of	IN	O	O
cocaine	NN	B-PROBLEM	B-TREATMENT
induced	VBN	I-PROBLEM	O
rhabdomyolysis	NN	I-PROBLEM	B-PROBLEM
,	,	O	O
renal	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
disseminated	VBD	B-PROBLEM	B-TREATMENT
intravascular	JJ	I-PROBLEM	I-TREATMENT
coagulation	NN	I-PROBLEM	I-TREATMENT
,	,	O	O
shock	NN	B-PROBLEM	O
,	,	O	O
hepatic	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
pancreatitis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
thrombocytopenia	NN	B-PROBLEM	B-PROBLEM
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
cocaine	NN	O	B-PROBLEM
intoxication	NN	O	I-PROBLEM
.	.	O	O

1-rhabdomyolysis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
massive	JJ	B-PROBLEM	B-PROBLEM
cocaine	NN	I-PROBLEM	I-PROBLEM
induced	VBN	I-PROBLEM	I-PROBLEM
rhabdomyolysis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
resulted	VBD	O	O
in	IN	O	O
tremendous	JJ	B-PROBLEM	O
third	JJ	I-PROBLEM	O
spacing	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
fluid	NN	I-PROBLEM	B-PROBLEM
and	CC	O	O
persistent	JJ	B-PROBLEM	B-PROBLEM
intervascular	JJ	I-PROBLEM	I-PROBLEM
hypovolemia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	O
patient	NN	I-TEST	O
&apos;s	NNP	I-TEST	O
creatinine	NN	I-TEST	B-TEST
______________	NNP	I-TEST	B-TEST
kinase	NN	I-TEST	I-TEST
peaked	VBD	O	O
at	IN	O	O
56,160	CD	O	O
with	IN	O	O
negative	JJ	O	O
mb	NN	B-TEST	O
percentages	NNS	I-TEST	O
.	.	O	O

the	DT	B-TEST	O
aldolase	NN	I-TEST	O
was	VBD	O	O
positive	JJ	O	O
at	IN	O	O
142	CD	O	O
.	.	O	O

this	DT	O	O
was	VBD	O	O
further	RBR	O	O
complicated	VBN	O	O
by	IN	O	O
hypocalcemia	NN	B-PROBLEM	B-PROBLEM
which	WDT	O	O
resulted	VBD	O	O
in	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
electrocardiographic	JJ	I-PROBLEM	I-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	B-TEST
patient	NN	O	I-TEST
&apos;s	NNP	O	I-TEST
urine	NN	O	I-TEST
was	VBD	O	O
alkalinized	VBN	B-TREATMENT	O
with	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
bicarbonate	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
maximize	VB	O	O
the	DT	O	B-TEST
myoglobin	NN	O	I-TEST
secretion	NN	O	I-TEST
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
&apos;s	NNP	I-TEST	I-TEST
urine	NN	I-TEST	I-TEST
output	NN	I-TEST	I-TEST
was	VBD	O	O
further	RB	O	O
augmented	VBN	O	O
by	IN	O	O
adding	VBG	O	O
dopamine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

nevertheless	RB	O	O
,	,	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NNP	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
continued	VBD	O	O
to	TO	O	O
progress	VB	O	O
.	.	O	O

over	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
the	DT	O	O
hospitalization	NN	O	O
his	PRP$	B-TEST	O
ck	NN	I-TEST	O
fell	VBD	O	O
in	IN	O	O
the	DT	O	O
serum	NN	O	O
.	.	O	O

much	JJ	O	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
diffuse	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
due	JJ	O	O
to	TO	O	O
this	DT	B-PROBLEM	B-PROBLEM
massive	JJ	I-PROBLEM	I-PROBLEM
rhabdomyolysis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2-renal	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
was	VBD	O	O
4.4	CD	O	O
on	IN	O	O
admission	NN	O	O
and	CC	O	O
peaked	VBD	O	O
at	IN	O	O
10.5	CD	O	O
on	IN	O	O
the	DT	O	O
15th	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
urinalysis	NN	I-TEST	I-TEST
revealed	VBD	O	O
4+	CD	B-PROBLEM	O
albumin	NN	I-PROBLEM	B-TEST
with	IN	O	O
marked	JJ	B-PROBLEM	B-PROBLEM
occult	NN	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

peritoneal	JJ	B-TREATMENT	B-TREATMENT
dialysis	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
instituted	VBN	O	O
on	IN	O	O
4/11	CD	O	O
after	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
tenckhoff	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
by	IN	O	O
drs.	JJ	O	O
freierm	NN	O	O
,	,	O	O
le	NN	O	O
,	,	O	O
and	CC	O	O
round	NN	O	O
.	.	O	O

subsequently	RB	O	O
his	PRP$	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
rose	VBD	O	O
for	IN	O	O
three	CD	O	O
days	NNS	O	O
and	CC	O	O
then	RB	O	O
stabilized	VBD	O	O
at	IN	O	O
10	CD	O	O
.	.	O	O

he	PRP	O	O
continued	VBD	O	O
to	TO	O	O
make	VB	O	O
minimal	JJ	B-PROBLEM	B-PROBLEM
urine	NN	I-PROBLEM	I-PROBLEM
throughout	IN	O	O
the	DT	O	O
hospitalization	NN	O	O
.	.	O	O

3-disseminated	JJ	B-PROBLEM	B-PROBLEM
intravascular	JJ	I-PROBLEM	I-PROBLEM
coagulation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
admission	NN	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
&apos;s	NNP	I-TEST	I-TEST
prothrombin	NN	I-TEST	I-TEST
time	NN	I-TEST	I-TEST
was	VBD	O	O
27.7	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TREATMENT
partial	JJ	I-TEST	I-TREATMENT
thromboplastin	NN	I-TEST	I-TREATMENT
time	NN	I-TEST	O
of	IN	O	O
greater	JJR	O	O
than	IN	O	O
100	CD	O	O
and	CC	O	O
a	DT	B-TEST	O
d-dimer	JJ	I-TEST	O
positive	JJ	O	O
at	IN	O	O
8	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
fibrinogen	NN	I-TEST	I-TEST
of	IN	O	O
69	CD	O	O
.	.	O	O

he	PRP	O	O
went	VBD	O	O
on	IN	O	O
to	TO	O	O
develop	VB	O	O
profound	JJ	B-PROBLEM	B-PROBLEM
thrombocytopenia	NN	I-PROBLEM	I-PROBLEM
complicated	VBN	O	O
by	IN	O	O
hemorrhage	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
supported	VBN	O	O
with	IN	O	O
abundant	JJ	O	O
use	NN	O	O
of	IN	O	O
fresh	JJ	B-TREATMENT	B-TREATMENT
frozen	JJ	I-TREATMENT	I-TREATMENT
plasma	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
cryoprecipitate	NN	B-TREATMENT	O
,	,	O	O
platelets	NNS	B-TREATMENT	B-TEST
,	,	O	O
and	CC	O	O
packed	VBD	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-PROBLEM	O
dic	NN	I-PROBLEM	O
was	VBD	O	O
further	RB	O	O
complicated	VBN	O	O
by	IN	O	O
hepatic	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
resulted	VBD	O	O
in	IN	O	O
poor	JJ	B-PROBLEM	B-PROBLEM
endogenous	JJ	I-PROBLEM	I-PROBLEM
production	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
clotting	VBG	I-PROBLEM	I-PROBLEM
factors	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
he	PRP	O	O
remained	VBD	O	O
fresh	JJ	B-PROBLEM	B-PROBLEM
frozen	JJ	I-PROBLEM	I-PROBLEM
plasma	NN	I-PROBLEM	I-PROBLEM
dependent	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4-septic	JJ	B-PROBLEM	B-PROBLEM
shock	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
pressor	JJ	B-PROBLEM	B-PROBLEM
dependent	NN	I-PROBLEM	I-PROBLEM
throughout	IN	O	O
his	PRP$	O	O
hospitalization	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
maintained	VBN	O	O
variously	RB	O	O
on	IN	O	O
levophed	VBN	B-TREATMENT	O
,	,	O	O
dobutamine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
dopamine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
ultimately	RB	O	O
epinephrine	VB	B-TREATMENT	B-TREATMENT
for	IN	O	O
blood	NN	B-TREATMENT	B-TREATMENT
pressure	NN	I-TREATMENT	I-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

hemodynamic	JJ	B-TEST	B-TEST
monitoring	NN	I-TEST	I-TEST
revealed	VBD	O	O
low	JJ	B-PROBLEM	B-PROBLEM
systemic	JJ	I-PROBLEM	I-PROBLEM
vascular	NN	I-PROBLEM	I-PROBLEM
resistance	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
high	JJ	B-PROBLEM	B-PROBLEM
cardiac	NN	I-PROBLEM	I-PROBLEM
output	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
multiple	JJ	O	O
sources	NNS	O	O
of	IN	O	O
infection	NN	B-PROBLEM	B-PROBLEM
including	VBG	O	O
his	PRP$	O	B-PROBLEM
sinuses	NNS	O	I-PROBLEM
,	,	O	O
lungs	NNS	O	O
,	,	O	O
and	CC	O	O
multiple	JJ	B-TREATMENT	B-TREATMENT
lines	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

further	RB	O	O
he	PRP	O	O
had	VBD	O	O
massive	JJ	B-PROBLEM	B-PROBLEM
muscle	NN	I-PROBLEM	I-PROBLEM
necrosis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
hepatic	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
on	IN	O	O
4/12	CD	O	O
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
dilated	JJ	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
ventricle	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
diffusely	RB	B-PROBLEM	B-PROBLEM
mildly	RB	I-PROBLEM	I-PROBLEM
hypokinetic	JJ	I-PROBLEM	I-PROBLEM
with	IN	O	O
no	DT	O	O
vegetations	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
was	VBD	O	O
55%	CD	O	O
.	.	O	O

on	IN	O	O
4/16	CD	O	O
the	DT	B-TEST	B-TREATMENT
pulmonary	JJ	I-TEST	I-TREATMENT
artery	NN	I-TEST	I-TREATMENT
catheter	NN	I-TEST	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
which	WDT	O	O
revealed	VBD	O	O
a	DT	B-TEST	B-TEST
wedge	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
8	CD	O	O
,	,	O	O
cardiac	JJ	B-TEST	B-TEST
index	NN	I-TEST	I-TEST
of	IN	O	O
4.5	CD	O	O
,	,	O	O
and	CC	O	O
an	DT	B-TEST	B-TEST
svr	NN	I-TEST	I-TEST
of	IN	O	O
5.8	CD	O	O
.	.	O	O

5-hepatic	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	O
sgpt	NN	I-TEST	O
on	IN	O	O
admission	NN	O	O
was	VBD	O	O
2,520	CD	O	O
with	IN	O	O
a	DT	O	B-PROBLEM
peak	NN	O	I-PROBLEM
at	IN	O	O
7,680	CD	O	O
on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
two	CD	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
complete	JJ	B-PROBLEM	B-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
synthetic	JJ	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
conjugation	NN	I-PROBLEM	B-TEST
function	NN	I-PROBLEM	I-TEST
of	IN	O	I-TEST
the	DT	O	I-TEST
liver	NN	O	I-TEST
with	IN	O	O
rising	VBG	B-PROBLEM	B-TEST
bilirubin	NN	I-PROBLEM	I-TEST
and	CC	O	O
falling	VBG	B-PROBLEM	O
albumin	NN	I-PROBLEM	O
with	IN	O	O
dependence	NN	B-PROBLEM	O
on	IN	I-PROBLEM	O
transfusion	NN	I-PROBLEM	B-TREATMENT
for	IN	O	O
support	NN	O	O
of	IN	O	O
his	PRP$	B-TEST	B-TEST
prothrombin	NN	I-TEST	I-TEST
time	NN	I-TEST	I-TEST
.	.	O	O

given	VBN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
multiple	NN	I-PROBLEM	I-PROBLEM
other	JJ	I-PROBLEM	I-PROBLEM
medical	JJ	I-PROBLEM	I-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
the	DT	O	O
direness	NN	O	O
of	IN	O	O
his	PRP$	O	O
situation	NN	O	O
,	,	O	O
and	CC	O	O
his	PRP$	O	O
ongoing	JJ	O	O
substance	NN	O	O
abuse	NN	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
admission	NN	O	O
he	PRP	O	O
was	VBD	O	O
deemed	VBN	O	O
not	RB	O	O
to	TO	O	O
be	VB	O	O
a	DT	O	O
candidate	NN	O	O
for	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
liver	JJ	I-TREATMENT	I-TREATMENT
transplantation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

serum	NN	B-TEST	B-TEST
cocaine	NN	I-TEST	I-TEST
was	VBD	O	O
positive	JJ	B-PROBLEM	O
6-12	JJ	O	O
hours	NNS	O	O
ingestion	NN	O	O
at	IN	O	O
the	DT	O	O
fairm	NN	O	O
of	IN	O	O
ijordcompmac	JJ	O	O
hospital	NN	O	O
.	.	O	O

further	RB	O	O
,	,	O	O
at	IN	O	O
ceanotsit	NN	O	O
ortgold	NN	O	O
center	NN	O	O
his	PRP$	B-TEST	B-TEST
serum	NN	I-TEST	I-TEST
toxicology	NN	I-TEST	I-TEST
screens	NNS	I-TEST	I-TEST
were	VBD	O	O
positive	JJ	B-PROBLEM	O
.	.	O	O

this	DT	O	O
is	VBZ	O	O
thought	VBN	O	O
to	TO	O	O
be	VB	O	O
the	DT	O	O
insighting	NN	O	O
cause	NN	O	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
massive	JJ	I-PROBLEM	I-PROBLEM
rhabdomyolysis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
hepatic	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

7-pneumonia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
developed	VBD	O	O
two	CD	B-PROBLEM	B-PROBLEM
pneumonias	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
two	CD	B-PROBLEM	O
separate	JJ	I-PROBLEM	O
organisms	NNS	I-PROBLEM	O
.	.	O	O

the	DT	O	O
first	JJ	O	O
was	VBD	O	O
acinetobacter	JJ	B-PROBLEM	B-PROBLEM
calcoaceticus	NN	I-PROBLEM	I-PROBLEM
subspecies	NNS	I-PROBLEM	I-PROBLEM
anitratus	VBP	I-PROBLEM	I-PROBLEM
,	,	O	O
treated	VBN	O	O
with	IN	O	O
ciprofloxacin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
subsequently	RB	O	O
developed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
staphylococcus	NN	I-PROBLEM	I-PROBLEM
aureus	NN	I-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
dosed	VBN	O	O
to	TO	O	O
levels	NNS	O	O
appropriate	VB	O	O
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
seen	VBN	O	O
in	IN	O	O
consultation	NN	O	O
by	IN	O	O
the	DT	O	O
infectious	JJ	O	O
disease	NN	O	O
service	NN	O	O
who	WP	O	O
advised	VBD	O	O
us	PRP	O	O
on	IN	O	O
antibiotic	JJ	B-TREATMENT	B-TREATMENT
choices	NNS	I-TREATMENT	O
daily	RB	O	O
.	.	O	O

8-pancreatitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
amylase	NN	I-TEST	I-TEST
on	IN	O	O
admission	NN	O	O
was	VBD	O	O
279	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TREATMENT
lipase	NN	I-TEST	I-TREATMENT
of	IN	O	O
161	CD	O	O
.	.	O	O

although	IN	O	O
not	RB	O	O
fully	RB	O	O
this	DT	O	O
may	MD	O	O
have	VB	O	O
contributed	VBN	O	O
to	TO	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
hypocalcemia	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
volume	NN	B-PROBLEM	B-PROBLEM
requirements	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

9-catheter	JJ	B-PROBLEM	B-PROBLEM
tip	NN	I-PROBLEM	I-PROBLEM
infections	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
grew	VBD	O	O
out	RP	O	O
coagulase	JJ	B-PROBLEM	O
negative	JJ	I-PROBLEM	O
staphylococcus	NN	I-PROBLEM	O
from	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
femoral	JJ	I-TREATMENT	I-TREATMENT
lines	NNS	I-TREATMENT	I-TREATMENT
which	WDT	O	O
were	VBD	O	O
placed	VBN	O	O
during	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
profound	JJ	I-PROBLEM	I-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

these	DT	O	O
were	VBD	O	O
treated	VBN	O	O
with	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

10-anemia	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
&apos;s	NNP	I-TEST	I-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
33%	CD	O	O
on	IN	O	O
admission	NN	O	O
and	CC	O	O
fell	VBD	O	O
to	TO	O	O
28	CD	O	O
requiring	VBG	O	O
4	CD	O	O
units	NNS	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
over	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
his	PRP$	O	B-TREATMENT
hospitalization	NN	O	I-TREATMENT
.	.	O	O

11-coma	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
,	,	O	O
although	IN	O	O
initially	RB	O	O
minimally	RB	B-PROBLEM	O
responsive	JJ	I-PROBLEM	O
,	,	O	O
went	VBD	O	O
on	IN	O	O
to	TO	O	O
develop	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
deep	JJ	I-PROBLEM	I-PROBLEM
comatose	NN	I-PROBLEM	I-PROBLEM
state	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
ct	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
on	IN	O	O
admission	NN	O	O
revealed	VBN	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
hemorrhage	NN	B-PROBLEM	B-PROBLEM
though	IN	O	O
he	PRP	O	O
did	VBD	O	O
have	VB	O	O
sphenoid	NN	B-PROBLEM	B-PROBLEM
sinusitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
lumbar	NN	I-TEST	I-TEST
puncture	NN	I-TEST	I-TEST
and	CC	O	I-TEST
sinus	NN	B-TEST	I-TEST
exploration	NN	I-TEST	I-TEST
were	VBD	O	O
unable	JJ	O	O
to	TO	O	O
be	VB	O	O
performed	VBN	O	O
given	VBN	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NNP	I-PROBLEM	I-PROBLEM
persistent	NN	I-PROBLEM	I-PROBLEM
coagulopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
treated	VBN	O	O
empirically	RB	O	O
with	IN	O	O
nafcillin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
ceftriaxone	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
meningitis	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
sinusitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

further	RB	O	O
complicating	VBG	O	O
this	DT	O	O
was	VBD	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
profound	NN	I-PROBLEM	I-PROBLEM
liver	VBZ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
rising	VBG	B-PROBLEM	B-PROBLEM
ammonias	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
hepatic	JJ	B-PROBLEM	B-PROBLEM
encephalopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

despite	IN	O	O
maximal	JJ	B-TREATMENT	O
supports	NNS	I-TREATMENT	O
the	DT	O	O
patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
be	VB	O	O
hypotensive	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

mid-way	NN	O	O
through	IN	O	O
his	PRP$	O	O
hospital	NN	O	O
course	NN	O	O
he	PRP	O	O
developed	VBD	O	O
trilobar	NN	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
this	DT	O	O
was	VBD	O	O
probably	RB	O	O
complicated	VBN	O	O
further	RB	O	O
by	IN	O	O
adult	NN	B-PROBLEM	O
respiratory	NN	I-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
multi-organ	JJ	I-PROBLEM	I-PROBLEM
system	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
mechanically	RB	B-TREATMENT	O
ventilated	VBN	I-TREATMENT	O
throughout	IN	O	O
his	PRP$	O	O
hospitalization	NN	O	O
.	.	O	O

nevertheless	RB	O	O
,	,	O	O
he	PRP	O	O
developed	VBD	O	O
refractory	NN	B-PROBLEM	B-PROBLEM
hypoxemia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
ultimately	RB	O	O
the	DT	O	O
patient	NN	O	O
died	VBD	O	O
despite	IN	O	O
total	JJ	B-TREATMENT	B-TREATMENT
life	NN	I-TREATMENT	I-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

cocaine	NN	O	B-TEST
intoxication	NN	O	I-TEST
,	,	O	O
rhabdomyolysis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
renal	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
disseminated	VBD	B-PROBLEM	B-TREATMENT
intravascular	JJ	I-PROBLEM	I-TREATMENT
coagulation	NN	I-PROBLEM	I-TREATMENT
,	,	O	O
septic	JJ	B-PROBLEM	B-PROBLEM
shock	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hepatic	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
pancreatitis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
catheter	NN	B-PROBLEM	B-TREATMENT
tip	NN	I-PROBLEM	I-TREATMENT
infection	NN	I-PROBLEM	I-TREATMENT
,	,	O	O
anemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
coma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

peritoneal	JJ	B-TREATMENT	B-TREATMENT
dialysis	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
peritoneal	JJ	B-TREATMENT	B-TREATMENT
dialysis	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
arterial	JJ	B-TREATMENT	B-TEST
catheterization	NN	I-TREATMENT	I-TEST
,	,	O	O
venous	JJ	B-TREATMENT	B-TEST
catheterization	NN	I-TREATMENT	I-TEST
,	,	O	O
continuous	JJ	B-TREATMENT	B-TREATMENT
mechanical	JJ	I-TREATMENT	I-TREATMENT
ventilation	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
parenteral	JJ	B-TREATMENT	B-TREATMENT
nutrition	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

neck	NN	B-PROBLEM	B-PROBLEM
hematoma	NN	I-PROBLEM	I-PROBLEM
secondary	JJ	O	O
to	TO	O	O
pulmonary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
requiring	VBG	O	I-TREATMENT
transfusion	NN	B-TREATMENT	I-TREATMENT
,	,	O	I-TREATMENT
catheter	NN	B-PROBLEM	I-TREATMENT
tip	NN	I-PROBLEM	I-TREATMENT
infection	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

1.	CD	O	O
unstable	JJ	B-PROBLEM	B-PROBLEM
angina	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
non-st	JJ	B-PROBLEM	B-PROBLEM
elevation	NN	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
persistent	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	VBG	I-TREATMENT	I-TREATMENT
times	NNS	O	O
two	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
63	JJ	O	O
-	:	O	O
year-old	JJ	O	O
man	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
prior	JJ	O	O
history	NN	O	O
of	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
secondary	JJ	O	O
to	TO	O	O
hyperthyroidism	VB	B-PROBLEM	B-PROBLEM
who	WP	O	O
presented	VBD	O	O
to	TO	O	O
an	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
left-sided	JJ	B-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
rest	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
awoke	NN	O	O
with	IN	O	O
chest	JJ	B-PROBLEM	B-TEST
pressure	NN	I-PROBLEM	I-TEST
radiating	VBG	O	I-TEST
to	TO	O	I-TEST
the	DT	O	I-TEST
right	JJ	O	I-TEST
chest	NN	O	I-TEST
associated	VBN	O	O
with	IN	O	O
diaphoresis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
170/108	CD	O	O
with	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
rapid	JJ	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
response	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
a	DT	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
140s	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
rate	NN	O	O
controlled	VBN	O	O
and	CC	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
stillman	NN	O	O
infirmary	NN	O	O
for	IN	O	O
emergent	JJ	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
.	.	O	O

1.	CD	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
secondary	JJ	O	O
to	TO	O	O
hyperthyroidism	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
initially	RB	O	O
diagnosed	VBN	O	O
in	IN	O	O
2005	CD	O	O
.	.	O	O

2.	CD	O	O
status	NN	O	O
post	NN	O	O
current	JJ	O	B-TREATMENT
cardioversion	NN	B-TREATMENT	I-TREATMENT
times	NNS	O	O
four	CD	O	O
.	.	O	O

3.	CD	O	O
hyperthyroidism	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
radioactive	JJ	B-TREATMENT	B-TREATMENT
iodine	NN	I-TREATMENT	I-TREATMENT
ablation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

4.	CD	O	O
status	NN	O	O
post	NN	O	O
carpal	JJ	B-TREATMENT	B-PROBLEM
tunnel	NN	I-TREATMENT	I-PROBLEM
release	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

5.	CD	O	O
status	NN	O	O
post	NN	O	O
umbilical	JJ	B-TREATMENT	B-TREATMENT
hernia	NN	I-TREATMENT	I-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

6.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1.	CD	O	O
accupril	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

2.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

3.	CD	O	O
clonidine	NN	B-TREATMENT	B-TREATMENT
0.1	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
in	IN	O	O
no	DT	O	O
acute	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
well	RB	O	O
developed	VBN	O	O
.	.	O	O

stable	JJ	O	O
,	,	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

normocephalic	JJ	O	O
,	,	O	O
atraumatic	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

perrl	NN	O	O
,	,	O	O
anicteric	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
eomi	NN	O	O
.	.	O	O

supple	NN	O	O
,	,	O	O
midline	NN	O	O
,	,	O	O
without	IN	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
bruit	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
jvd	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

irregularly	RB	B-PROBLEM	O
/	JJ	I-PROBLEM	O
irregular	NN	I-PROBLEM	B-PROBLEM
without	IN	O	O
murmurs	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
rubs	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
gallops	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	O	O
.	.	O	O

soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBN	B-PROBLEM	B-PROBLEM
,	,	O	O
without	IN	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
organomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

warm	NN	O	O
,	,	O	O
noncyanotic	JJ	B-PROBLEM	O
,	,	O	O
nonedematous	JJ	B-PROBLEM	O
times	NNS	O	O
four	CD	O	O
.	.	O	O

cbc	NN	B-TEST	B-TEST
11.3	CD	O	O
/	NN	O	O
15.7	CD	O	O
/	NN	O	O
44.6	CD	O	O
/	NN	O	O
183	CD	O	O
.	.	O	O

pt	NN	B-TEST	O
14	CD	O	O
,	,	O	O
inr	NN	B-TEST	B-TEST
1.3	CD	O	O
,	,	O	O
ptt	RB	B-TEST	B-TEST
115	CD	O	O
.	.	O	O

chemistries	NNS	B-TEST	B-TEST
:	:	O	O

alt	RB	B-TEST	O
27	CD	O	O
,	,	O	O
ast	RB	B-TEST	B-TEST
21	CD	O	O
,	,	O	O
alkaline	JJ	B-TEST	B-TEST
phosphatase	NN	I-TEST	I-TEST
72	CD	O	O
,	,	O	O
total	JJ	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
1.2	CD	O	O
,	,	O	O
amylase	NN	B-TEST	B-TEST
47	CD	O	O
.	.	O	O

the	DT	B-TEST	O
u/a	NN	I-TEST	O
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
for	IN	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
.	.	O	O

emergent	JJ	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
revealed	VBD	O	O
an	DT	B-TEST	B-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
45%	CD	O	O
,	,	O	O
right	RB	B-PROBLEM	B-PROBLEM
dominant	JJ	I-PROBLEM	I-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
system	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
occlusive	JJ	B-PROBLEM	B-PROBLEM
single	JJ	I-PROBLEM	I-PROBLEM
vessel	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lad	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

multiple	JJ	B-TREATMENT	B-TREATMENT
wires	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
used	VBN	O	O
to	TO	O	O
attempt	VB	O	O
to	TO	O	O
cross	VB	O	B-TREATMENT
the	DT	B-PROBLEM	I-TREATMENT
total	JJ	I-PROBLEM	I-TREATMENT
occlusion	NN	I-PROBLEM	I-TREATMENT
,	,	O	O
but	CC	O	O
were	VBD	O	O
ultimately	RB	O	O
unsuccessful	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
heparin	NN	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

cardiothoracic	NN	O	O
surgery	NN	O	O
consultation	NN	O	O
was	VBD	O	O
obtained	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
on	IN	O	O
2010-03-12	JJ	O	O
for	IN	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	VBG	I-TREATMENT	I-TREATMENT
times	NNS	O	O
two	CD	O	O
;	:	O	O
lima	NNS	O	B-PROBLEM
to	TO	O	O
the	DT	O	O
lad	NN	O	O
,	,	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
diagonal	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
deemed	VBN	O	O
to	TO	O	O
be	VB	O	O
too	RB	B-PROBLEM	B-PROBLEM
lethargic	JJ	I-PROBLEM	I-PROBLEM
and	CC	O	O
sleepy	NN	B-PROBLEM	B-PROBLEM
to	TO	O	O
be	VB	O	O
extubated	VBN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
zero	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
extubated	VBN	O	O
early	RB	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
one	CD	O	O
without	IN	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
complication	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
remained	VBD	O	O
in	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
ep	JJ	O	O
service	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
regarding	VBG	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
was	VBD	O	O
his	PRP$	B-PROBLEM	O
main	JJ	I-PROBLEM	O
issue	NN	I-PROBLEM	O
in	IN	O	O
the	DT	O	O
postoperative	JJ	O	O
course	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
attempted	VBN	O	O
on	IN	O	O
multiple	JJ	B-TREATMENT	B-TREATMENT
different	JJ	I-TREATMENT	I-TREATMENT
drugs	NNS	I-TREATMENT	I-TREATMENT
including	VBG	O	O
procainamide	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
diltiazem	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
esmolol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
sotalol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
kept	VBN	O	O
therapeutically	RB	B-TREATMENT	O
anticoagulated	VBN	I-TREATMENT	O
throughout	IN	O	O
this	DT	O	O
period	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
also	RB	O	O
started	VBN	O	O
on	IN	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

ultimately	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
and	CC	O	O
anticoagulation	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
begun	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
arrived	VBD	O	O
on	IN	O	O
the	DT	O	O
floor	NN	O	O
with	IN	O	O
medications	NNS	B-TREATMENT	B-TREATMENT
as	IN	O	O
follows	VBZ	O	O
:	:	O	O

sotalol	NN	B-TREATMENT	B-TREATMENT
180	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
diltiazem	VBZ	B-TREATMENT	B-TREATMENT
90	CD	O	O
mg	NN	O	O
q.i.d.	NN	O	O
,	,	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
0.125	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

while	IN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
awaiting	VBG	O	O
therapeutic	JJ	B-TREATMENT	B-TREATMENT
anticoagulation	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
he	PRP	O	O
spontaneously	RB	O	O
converted	VBD	O	O
into	IN	O	O
normal	JJ	O	O
sinus	NN	O	O
rhythm	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-TEST	B-TEST
resting	JJ	I-TEST	I-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
approximately	RB	O	O
50	CD	O	O
subsequent	JJ	O	O
to	TO	O	O
this	DT	O	O
.	.	O	O

in	IN	O	O
consultation	NN	O	O
with	IN	O	O
the	DT	O	O
ep	NN	O	O
service	NN	O	O
,	,	O	O
diltiazem	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
stopped	VBN	O	O
.	.	O	O

after	IN	O	O
approximately	RB	O	O
24	CD	O	O
hours	NNS	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
converted	VBD	O	O
back	RB	O	O
into	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
diltiazem	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
restarted	VBN	O	O
at	IN	O	O
60	CD	O	O
mg	NNS	O	O
q.i.d.	NN	O	O

the	DT	O	O
patient	NN	O	O
then	RB	O	O
had	VBD	O	O
one	CD	B-PROBLEM	O
more	JJR	I-PROBLEM	O
episode	NN	I-PROBLEM	O
where	WRB	O	O
he	PRP	O	O
was	VBD	O	O
converted	VBN	O	O
to	TO	O	O
normal	JJ	O	O
sinus	JJ	O	O
rhythm	NN	O	O
but	CC	O	O
this	DT	O	O
lasted	VBD	O	O
only	RB	O	O
a	DT	O	O
few	JJ	O	O
hours	NNS	O	O
before	IN	O	O
reverting	VBG	O	O
back	RB	O	O
to	TO	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
ultimately	RB	O	O
discharged	VBN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
16	CD	O	O
,	,	O	O
tolerating	VBG	O	O
a	DT	O	O
regular	JJ	O	O
diet	NN	O	O
,	,	O	O
and	CC	O	O
adequate	JJ	O	O
pain	NN	O	O
control	NN	O	O
on	IN	O	O
p.o.	NN	B-TREATMENT	B-TREATMENT
pain	NN	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
having	VBG	O	O
no	DT	O	O
anginal	JJ	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
with	IN	O	O
an	DT	B-TEST	O
inr	NN	I-TEST	O
of	IN	O	O
2.0	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
failed	VBD	O	O
multiple	JJ	O	O
attempts	NNS	O	O
at	IN	O	O
cardioversion	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

inr	NN	B-TEST	B-TEST
2.0.	CD	O	O

1.	CD	O	O
percocet	JJ	B-TREATMENT	B-TREATMENT
5/325	CD	O	O
mg	NN	O	O
one	CD	O	O
to	TO	O	O
two	CD	O	O
q.	NNS	O	O
four	CD	O	O
hours	NNS	O	O
p.r.n.	VBP	O	O

2.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

3.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O

4.	CD	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

5.	CD	O	O
sotalol	JJ	B-TREATMENT	B-TREATMENT
180	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O

6.	CD	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
0.125	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

7.	CD	O	O
diltiazem	JJ	B-TREATMENT	B-TREATMENT
60	CD	O	O
mg	NN	O	O
q.i.d.	NN	O	O

8.	CD	O	O
ambien	JJ	B-TREATMENT	O
5-10	JJ	O	O
mg	NN	O	O
q.h.s.	NN	O	O
p.r.n.	NN	O	O

he	PRP	O	O
will	MD	O	O
also	RB	O	O
go	VB	O	O
home	NN	O	O
with	IN	O	O
vna	NN	O	O
for	IN	O	O
inrs	JJ	B-TEST	O
twice	JJ	O	O
weekly	RB	O	O
with	IN	O	O
the	DT	O	O
results	NNS	O	O
reported	VBD	O	O
to	TO	O	O
his	PRP$	O	O
pcp	NN	O	O
or	CC	O	O
cardiologist	NN	O	O
for	IN	O	O
coumadin	JJ	B-TREATMENT	B-TREATMENT
adjustment	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

back	RB	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
given	VBN	O	O
printed	JJ	O	O
instructions	NNS	O	O
for	IN	O	O
back	RB	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
english	JJ	O	O
)	)	O	O
.	.	O	O

back	RB	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

if	IN	O	O
you	PRP	O	O
have	VBP	O	O
any	DT	O	B-PROBLEM
bladder	NN	B-PROBLEM	I-PROBLEM
incontinence	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
bowel	NN	B-PROBLEM	B-PROBLEM
incontinence	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
worse	JJR	B-PROBLEM	B-PROBLEM
numbness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
any	DT	B-PROBLEM	B-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
any	DT	O	B-PROBLEM
other	JJ	B-PROBLEM	I-PROBLEM
concerns	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
call	VB	O	O
your	PRP$	O	O
doctor	NN	O	O
or	CC	O	O
return	NN	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
department	NN	O	O
immediately	RB	O	O
.	.	O	O

blood	NN	B-TEST	B-TEST
type	NN	I-TEST	I-TEST
o+	NN	O	I-TEST
,	,	O	O
antibody	NN	B-TEST	B-TEST
negative	JJ	O	O
,	,	O	O
rubella	NN	B-TEST	B-TEST
immune	NN	O	O
,	,	O	O
rpr	NN	B-TEST	O
nonreactive	JJ	O	O
,	,	O	O
hepatitis	NN	B-TEST	B-TEST
b	NN	I-TEST	I-TEST
surface	NN	I-TEST	I-TEST
antigen	NN	I-TEST	I-TEST
negative	JJ	O	O
,	,	O	O
group	NN	B-PROBLEM	O
beta	VBD	I-PROBLEM	O
strep	RB	I-PROBLEM	B-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
pregnancy	NN	O	O
was	VBD	O	O
complicated	VBN	O	O
by	IN	O	O
anemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

mother	NN	O	O
has	VBZ	O	O
a	DT	O	O
prior	JJ	O	O
history	NN	O	O
of	IN	O	O
mitral	JJ	B-PROBLEM	B-PROBLEM
valve	NN	I-PROBLEM	I-PROBLEM
prolapse	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
prior	JJ	I-TREATMENT	I-TREATMENT
cesarean	JJ	I-TREATMENT	I-TREATMENT
section	NN	I-TREATMENT	I-TREATMENT
done	VBN	O	O
,	,	O	O
two	CD	O	O
vaginal	JJ	O	O
births	NNS	O	O
after	IN	O	O
cesarean	JJ	B-TREATMENT	B-TREATMENT
section	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

these	DT	O	O
infants	NNS	O	O
were	VBD	O	O
delivered	VBN	O	O
by	IN	O	O
repeat	NN	B-TREATMENT	B-TREATMENT
cesarean	JJ	I-TREATMENT	I-TREATMENT
section	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
this	DT	O	O
twin	NN	O	O
emerged	VBD	O	O
with	IN	O	O
good	JJ	O	O
tone	NN	O	O
,	,	O	O
color	NN	O	O
,	,	O	O
and	CC	O	O
cry	NN	O	B-PROBLEM
.	.	O	O

apgars	NNS	B-TEST	B-TEST
were	VBD	O	O
eight	CD	O	O
at	IN	O	O
one	CD	O	O
minute	NN	O	O
and	CC	O	O
nine	CD	O	O
at	IN	O	O
five	CD	O	O
minutes	NNS	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
neonatal	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
prematurity	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

weight	NN	B-TEST	B-TEST
2.252	CD	O	O
kg	NN	O	O
,	,	O	O
65th	CD	O	O
percentile;	NN	O	O
length	NN	B-TEST	B-TEST
46	CD	O	O
cm	NN	O	O
,	,	O	O
50th	CD	O	O
percentile	NN	O	O
;	:	O	O
head	NN	B-TEST	B-TEST
circumference	NN	I-TEST	I-TEST
33	CD	O	O
cm	NN	O	O
75th	CD	O	O
percentile	NN	O	O
.	.	O	O

mild	JJ	B-PROBLEM	B-PROBLEM
retractions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
occasional	JJ	B-PROBLEM	B-PROBLEM
grunting	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

breath	NN	B-TEST	B-TEST
sounds	VBZ	I-TEST	I-TEST
equal	JJ	O	O
with	IN	O	O
good	JJ	O	O
aeration	NN	O	O
.	.	O	O

regular	JJ	O	O
,	,	O	O
rate	NN	O	O
,	,	O	O
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
no	DT	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

pulses	NNS	B-TEST	B-TEST
+2	VBP	O	O
.	.	O	O

abdomen	NNS	O	O
is	VBZ	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
no	DT	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

raymond	NN	O	O
required	VBD	O	O
some	DT	B-TREATMENT	B-TREATMENT
intermittent	JJ	I-TREATMENT	I-TREATMENT
blow-by	JJ	I-TREATMENT	I-TREATMENT
oxygen	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
the	DT	O	O
first	JJ	O	O
two	CD	O	O
hours	NNS	O	O
of	IN	O	O
birth	NN	O	O
.	.	O	O

the	DT	B-PROBLEM	O
grunting	NN	I-PROBLEM	O
noted	VBD	O	O
on	IN	O	O
admission	NN	O	O
resolved	VBN	O	O
within	IN	O	O
the	DT	O	O
first	JJ	O	O
few	JJ	O	O
hours	NNS	O	O
after	IN	O	O
birth	NN	O	O
.	.	O	O

he	PRP	O	O
did	VBD	O	O
not	RB	O	O
have	VB	O	O
any	DT	O	O
episodes	NNS	O	O
of	IN	O	O
spontaneous	JJ	B-PROBLEM	B-PROBLEM
apnea	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
bradycardia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
murmurs	NNS	B-PROBLEM	B-PROBLEM
were	VBD	O	O
noted	VBN	O	O
,	,	O	O
although	IN	O	O
normal	JJ	O	O
heart	NN	O	O
rates	NNS	O	O
and	CC	O	O
blood	NN	O	B-TEST
pressures	NNS	O	I-TEST
.	.	O	O

enteral	JJ	B-TREATMENT	B-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
started	VBN	O	O
on	IN	O	O
the	DT	O	O
date	NN	O	O
of	IN	O	O
birth	NN	O	O
and	CC	O	O
gradually	RB	O	O
advanced	VBD	O	O
to	TO	O	O
full	JJ	O	O
volume	NN	O	O
.	.	O	O

he	PRP	O	O
required	VBD	O	O
some	DT	B-TREATMENT	B-TREATMENT
gavage	NN	I-TREATMENT	I-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
through	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
#4	NNP	O	O
,	,	O	O
and	CC	O	O
has	VBZ	O	O
been	VBN	O	O
all	DT	O	O
po	JJ	O	O
since	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
#5	NN	O	O
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
,	,	O	O
he	PRP	O	O
is	VBZ	O	O
taking	VBG	O	O
enfamil	JJ	B-TREATMENT	B-TREATMENT
20	CD	I-TREATMENT	I-TREATMENT
calories	NNS	I-TREATMENT	I-TREATMENT
/	JJ	I-TREATMENT	O
ounce	NN	I-TREATMENT	O
with	IN	I-TREATMENT	O
iron	NN	I-TREATMENT	B-TREATMENT
.	.	O	O

discharge	NN	B-TEST	B-TEST
weight	NN	I-TEST	I-TEST
is	VBZ	O	O
2.37	CD	O	O
kg	NN	O	O
,	,	O	O
head	NN	B-TEST	B-TEST
circumference	NN	I-TEST	I-TEST
32	CD	O	O
cm	NN	O	O
,	,	O	O
length	VBZ	B-TEST	B-TEST
47	CD	O	O
cm	NN	O	O
.	.	O	O

due	JJ	O	O
to	TO	O	O
the	DT	B-PROBLEM	O
unknown	JJ	I-PROBLEM	O
group	NN	I-PROBLEM	O
b	VBD	I-PROBLEM	O
strep	NN	I-PROBLEM	B-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
prematurity	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
raymond	NN	O	O
was	VBD	O	O
evaluated	VBN	O	O
for	IN	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
complete	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
had	VBD	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
13,800	CD	O	O
with	IN	O	O
17%	CD	B-TEST	O
polys	NNS	I-TEST	B-TEST
,	,	O	O
0%	CD	B-TEST	B-TREATMENT
bands	NNS	I-TEST	I-TREATMENT
.	.	O	O

a	DT	O	O
repeat	NN	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
two	CD	O	O
,	,	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
13,000	CD	O	O
with	IN	O	O
50%	CD	B-TEST	O
polys	NNS	I-TEST	B-TEST
,	,	O	O
0%	CD	B-TEST	B-TREATMENT
bands	NNS	I-TEST	I-TREATMENT
.	.	O	O

a	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
culture	NN	I-TEST	I-TEST
obtained	VBD	O	O
prior	RB	O	O
to	TO	O	O
starting	VBG	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
was	VBD	O	O
no	DT	O	O
growth	NN	B-PROBLEM	O
at	IN	O	O
48	CD	O	O
hours	NNS	O	O
.	.	O	O

peak	NN	B-TEST	B-TEST
serum	NN	I-TEST	I-TEST
bilirubin	NN	I-TEST	I-TEST
occurred	VBD	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
#4	NNP	O	O
,	,	O	O
a	DT	B-TEST	O
total	NN	I-TEST	O
of	IN	O	O
10.0/0.3	CD	O	O
direct	JJ	B-TEST	O
.	.	O	O

a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
bilirubin	NN	I-TEST	I-TEST
on	IN	O	O
2012-05-19	JJ	O	O
was	VBD	O	O
8.0/0.3	CD	O	O
direct	JJ	B-TEST	O
.	.	O	O

hematocrit	NN	B-TEST	B-TEST
at	IN	O	O
birth	NN	O	O
was	VBD	O	O
43.8%.	CD	O	O

raymond	NN	O	O
did	VBD	O	O
not	RB	O	O
receive	VB	O	O
any	DT	B-TREATMENT	B-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	O
blood	NN	I-TREATMENT	B-TREATMENT
products	NNS	I-TREATMENT	I-TREATMENT
during	IN	O	O
admission	NN	O	O
.	.	O	O

audiology	NN	B-TEST	B-TEST
hearing	VBG	I-TEST	I-TEST
screening	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
with	IN	O	O
automated	JJ	O	O
auditory	NN	O	O
brain	NN	O	O
stem	NN	O	O
responses	NNS	O	O
.	.	O	O

adlib	NN	O	O
po	NN	B-TREATMENT	O
enfamil	NN	I-TREATMENT	O
with	IN	I-TREATMENT	O
iron	NN	I-TREATMENT	B-TREATMENT
.	.	O	O

2.	CD	O	O
no	DT	O	O
medications	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

3.	CD	O	O
car	NN	B-TEST	B-TEST
seat	NN	I-TEST	I-TEST
position	NN	I-TEST	I-TEST
screening	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
successfully	RB	O	O
.	.	O	O

4.	CD	O	O
state	NN	B-TEST	B-TEST
newborn	JJ	I-TEST	I-TEST
screen	NN	I-TEST	I-TEST
was	VBD	O	O
sent	VBN	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
#3	NN	O	O
.	.	O	O

a	DT	O	O
report	NN	O	O
of	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
elevated	JJ	I-PROBLEM	I-PROBLEM
17-oh	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
called	VBN	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
ccu	NN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
subsequent	JJ	I-TEST	I-TEST
sample	NN	I-TEST	I-TEST
was	VBD	O	O
done	VBN	O	O
(	(	O	O
05-21	JJ	O	O
)	)	O	O
and	CC	O	O
results	NNS	O	O
are	VBP	O	O
pending	VBG	O	O
.	.	O	O

5.	CD	O	O
immunizations	NNS	B-TREATMENT	B-TREATMENT
received	VBD	O	O
:	:	O	O

hepatitis	NN	B-TREATMENT	B-TREATMENT
b	NN	I-TREATMENT	I-TREATMENT
vaccine	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
administered	VBN	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
birth	NN	O	O
on	IN	O	O
2012-05-13	JJ	O	O
.	.	O	O

1.	CD	O	O
synagis	JJ	B-TREATMENT	B-TREATMENT
rsv	NN	I-TREATMENT	I-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
should	MD	O	O
be	VB	O	O
considered	VBN	O	O
from	IN	O	O
october	VBN	O	O
through	IN	O	O
april	NN	O	O
for	IN	O	O
infants	NNS	O	O
who	WP	O	O
meet	VBP	O	O
any	DT	O	O
of	IN	O	O
the	DT	O	O
following	JJ	O	O
three	CD	O	O
criteria	NNS	O	O
:	:	O	O

3)	CD	O	O
with	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
influenza	JJ	B-TREATMENT	B-TREATMENT
immunization	NN	I-TREATMENT	I-TREATMENT
should	MD	O	O
be	VB	O	O
considered	VBN	O	O
annually	RB	O	O
in	IN	O	O
the	DT	O	O
fall	NN	O	O
for	IN	O	O
preterm	JJ	B-PROBLEM	O
infants	NNS	I-PROBLEM	O
with	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
once	IN	O	O
they	PRP	O	O
reach	VBP	O	O
six	CD	O	O
months	NNS	O	O
of	IN	O	O
age	NN	O	O
.	.	O	O

before	IN	O	O
this	DT	O	O
age	NN	O	O
,	,	O	O
the	DT	O	O
family	NN	O	O
and	CC	O	O
other	JJ	O	O
caregivers	NNS	O	O
should	MD	O	O
be	VB	O	O
considered	VBN	O	O
for	IN	O	O
immunization	NN	B-TREATMENT	B-TREATMENT
against	IN	O	O
influenza	NN	B-PROBLEM	B-PROBLEM
to	TO	O	O
protect	VB	O	O
the	DT	O	O
infant	NN	O	O
.	.	O	O

3.	CD	O	O
transitional	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
suspicion	NN	O	O
for	IN	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
ruled	VBN	O	O
out	RP	O	O
.	.	O	O

s	NN	O	O
/	NNP	O	O
p	NN	O	O
total	JJ	B-TREATMENT	B-TREATMENT
thyoidectomy	NN	I-TREATMENT	I-TREATMENT

rocaltrol	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
calcitriol	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
0.5	CD	O	O
mcg	NN	O	O
po	NN	O	O
qd	NN	O	O
starting	VBG	O	O
today	NN	O	O
(	(	O	O
05/31	CD	O	O
)	)	O	O

start	NN	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
continue	VB	O	O
throughout	IN	O	O
hospitalization	NN	O	O
.	.	O	O

synthroid	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
levothyroxine	JJ	I-TREATMENT	I-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
125	CD	O	O
mcg	NN	O	O
po	NN	O	O
qd	NN	O	O

oxycodone	RB	B-TREATMENT	B-TREATMENT
5-10	JJ	O	O
mg	NN	O	O
po	NN	O	O
q4h	NN	O	O
prn	NN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
advair	NN	B-TREATMENT	I-PROBLEM
diskus	VBZ	I-TREATMENT	O
100/50	CD	O	O
(	(	O	O
fluticasone	NN	B-TREATMENT	B-TREATMENT
propionate/...	NN	I-TREATMENT	I-TREATMENT
)	)	O	I-TREATMENT
1	CD	O	O
puff	JJ	O	O
inh	NN	O	O
bid	NN	O	O
calcium	NN	B-TREATMENT	B-TREATMENT
carbonate	NN	I-TREATMENT	I-TREATMENT
2,400	CD	O	O
mg	NN	O	O
po	NN	O	O
qid	NN	O	O
starting	VBG	O	O
today	NN	O	O
(	(	O	O
05/31	CD	O	O
)	)	O	O

nka	JJ	B-PROBLEM	O
admit	NN	O	O
diagnosis	NN	O	O
:	:	O	O

total	JJ	B-TREATMENT	B-TREATMENT
thyroidectomy	NN	I-TREATMENT	I-TREATMENT

responsible	JJ	O	O
after	IN	O	O
study	NN	O	O
for	IN	O	O
causing	VBG	O	O
admission	NN	O	O
)	)	O	O
s	NN	O	O
/	NNP	O	O
p	NN	O	O
total	JJ	B-TREATMENT	B-TREATMENT
thyoidectomy	NN	I-TREATMENT	I-TREATMENT

conditions	NNS	O	O
,	,	O	O
infections	NNS	O	O
,	,	O	O
complications	NNS	O	O
,	,	O	O
affecting	VBG	O	O
treatment	NN	O	O
/	NNP	O	O
stay	NN	O	O
asthma	RB	B-PROBLEM	B-PROBLEM

05/30/05	CD	O	O
tland	NN	O	O
,	,	O	O
jr	NN	O	O
,	,	O	O
votribrendeve	VBP	O	B-PROBLEM
n.	NN	O	I-PROBLEM
,	,	O	O
m.d.	JJ	O	O
total	JJ	B-TREATMENT	O
thyroidectomy	NN	I-TREATMENT	B-TREATMENT

40f	CD	O	O
with	IN	O	O
hurtle	NN	B-PROBLEM	B-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
thyroid	NN	I-PROBLEM	I-PROBLEM
had	VBD	O	O
total	JJ	B-TREATMENT	B-TREATMENT
thyroidectomy	NN	I-TREATMENT	I-TREATMENT
without	IN	O	O
complication	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

pod#	NN	O	O
1	CD	O	O
pt	NN	O	O
was	VBD	O	O
tolerating	VBG	O	O
regular	JJ	O	O
diet	NN	O	O
,	,	O	O
ambulating	VBG	O	O
,	,	O	O
afebrile	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
calcium	NN	B-TEST	B-TEST
was	VBD	O	O
stable	JJ	O	O
.	.	O	O

incicsion	NN	B-PROBLEM	O
was	VBD	O	O
clean	JJ	O	O
dry	JJ	O	O
and	CC	O	O
intact	JJ	O	O
and	CC	O	O
pt	NN	O	O
was	VBD	O	O
discharged	VBN	O	O
home	NN	O	O
in	IN	O	O
stable	JJ	O	O
condition	NN	O	O

keep	VB	O	O
incision	NN	B-PROBLEM	B-TREATMENT
clean	JJ	O	I-TREATMENT
and	CC	O	O
dry	JJ	O	O
,	,	O	O
may	MD	O	O
shower	VB	O	O
wed	NN	O	O
.	.	O	O

do	VB	O	O
not	RB	O	O
drive	VB	O	O
if	IN	O	O
taking	VBG	O	O
narcotics	NNS	B-TREATMENT	B-TREATMENT
call	JJ	O	O
doctor	NN	O	O
if	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
&gt;	VBP	O	O
101.5	CD	O	O
,	,	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
swelling	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
redness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
numbness	NN	B-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	O
tingling	NN	I-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
extremities	NNS	I-PROBLEM	I-PROBLEM
or	CC	O	O
face	NN	O	B-PROBLEM
or	CC	O	O
any	DT	O	B-PROBLEM
other	JJ	O	I-PROBLEM
concerns	NNS	O	I-PROBLEM
.	.	O	O

patient	NN	O	O
recorded	VBD	O	O
as	IN	O	O
having	VBG	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
to	TO	O	O
drugs	NNS	B-TREATMENT	B-TREATMENT

chief	JJ	O	O
complaint	NN	O	O
:	:	O	O
worsening	NN	B-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM

coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
x	VBD	O	O
2	CD	O	O
/	NNP	O	O
aortic	JJ	B-TREATMENT	B-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
05-08	NN	O	O

mr.	NN	O	O
williams	NNP	O	O
is	VBZ	O	O
an	DT	O	O
85	CD	O	O
yo	NN	O	O
gentleman	NN	O	O
who	WP	O	O
has	VBZ	O	O
a	DT	B-PROBLEM	O
known	VBN	I-PROBLEM	O
cardiac	JJ	I-PROBLEM	O
history	NN	I-PROBLEM	O
and	CC	O	O
has	VBZ	O	O
had	VBN	O	O
a	DT	O	O
h/o	NN	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
chest	JJS	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
an	DT	B-TEST	O
ef	JJ	I-TEST	O
40-45%	JJ	O	O
and	CC	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
underwent	JJ	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
80%	CD	I-PROBLEM	I-PROBLEM
lad	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
chronically	RB	B-PROBLEM	B-PROBLEM
occluded	VBD	I-PROBLEM	I-PROBLEM
rca	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
anneurysmal	JJ	B-PROBLEM	B-PROBLEM
mid	NN	I-PROBLEM	I-PROBLEM
lcx	NN	I-PROBLEM	I-PROBLEM
w/50%	JJ	B-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
refered	VBN	O	O
to	TO	O	O
dr.	VB	O	O
barber	NN	O	O
for	IN	O	O
surgical	JJ	B-TREATMENT	B-TREATMENT
treatment	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

s/p	NN	O	O
mi	NN	B-PROBLEM	B-TREATMENT
1992	CD	O	O

as	IN	B-PROBLEM	O

h/o	NN	O	O
prostate	NN	B-PROBLEM	B-PROBLEM
ca	MD	I-PROBLEM	I-PROBLEM
s/p	VB	O	O
brachytherapy	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
hormone	NN	B-TREATMENT	B-TREATMENT
treatment	NN	I-TREATMENT	I-TREATMENT

hyperlipidemia	NN	B-PROBLEM	B-PROBLEM

htn	NN	B-PROBLEM	B-PROBLEM

paf	NN	B-PROBLEM	O
h/o	NN	O	O
rectal	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
s/p	NN	O	O
cauterization	NN	B-TREATMENT	B-TREATMENT

cholelithiasis	NN	B-PROBLEM	B-PROBLEM

s/p	JJ	O	B-TREATMENT
aaa	NN	B-TREATMENT	I-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT
'95	POS	O	I-TREATMENT

s/p	JJ	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
hernia	NN	I-TREATMENT	I-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT

s/p	NN	O	B-TREATMENT
r	NN	B-TREATMENT	I-TREATMENT
lung	NN	I-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT

cri	NN	B-PROBLEM	B-PROBLEM

chronic	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM

2017-05-16	JJ	O	O
06:20	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	B-TEST	B-TEST
-	:	O	O
8.0	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.35	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
10.3	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
31.0	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
93	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
30.7	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
33.1	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
13.0	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
201	CD	O	O

2017-05-16	JJ	O	O
06:20	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
plt	NN	B-TEST	I-TEST
ct	VBD	I-TEST	I-TEST
-	:	O	O
201	CD	O	O

2017-05-16	JJ	O	O
06:20	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
pt	NN	B-TEST	I-TEST
-	:	O	O
19.0	CD	O	O
*	JJ	O	O
inr	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
pt	JJ	I-TEST	I-TEST
)-	CD	O	I-TEST
2.3	CD	O	O

2017-05-16	JJ	O	O
09:50	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
118	CD	O	O
*	JJ	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
18	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.6	CD	O	O
*	NN	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
137	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
5.1	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
98	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
29	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
15	CD	O	O

mr.	NN	O	O
williams	NNS	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
hallmark	VB	O	O
health	NN	O	O
system	NN	O	O
on	IN	O	O
05-08	NN	O	O
and	CC	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
with	IN	O	O
dr.	JJ	O	O
barber	NN	O	O
for	IN	O	O
a	DT	B-TREATMENT	O
cabgx2	NN	I-TREATMENT	O
and	CC	O	O
avr	NN	B-TREATMENT	O
w/	VBP	O	O
25	CD	B-TREATMENT	O
mm	JJ	I-TREATMENT	O
pericardial	JJ	I-TREATMENT	O
valve	NN	I-TREATMENT	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
weaned	VBN	O	O
and	CC	O	O
extubated	VBN	O	O
from	IN	O	O
mechanical	JJ	B-TREATMENT	B-TEST
ventillation	NN	I-TREATMENT	I-TEST
on	IN	O	O
pod#1	NN	O	O
without	IN	O	O
difficulty	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
developed	VBD	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
pod#2	NN	O	O
with	IN	O	O
well	RB	O	O
controlled	VBN	O	O
rate	NN	O	O
and	CC	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
anticoagulation	NN	B-TREATMENT	B-TREATMENT
on	IN	O	O
pod#5	NN	O	O
.	.	O	O

lasix	RB	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
q	CD	O	O
m-w-f	NN	O	O

klorcon	NN	B-TREATMENT	O
10	CD	O	O
meq	NN	O	O
q	CD	O	O
m-w-f	NN	O	O

pepcid	NN	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
qd	NN	O	O

colexa	NN	B-TREATMENT	O
10	CD	O	O
mg	NN	O	O
qd	NN	O	O

metoprolol	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
bid	NN	O	O

lipitor	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
qd	NN	O	O

aspirin	RB	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NNS	O	O
qd	NN	O	O

flovent	JJ	B-TREATMENT	O
110	CD	O	O
mcg	JJ	O	O
inhaler	NN	O	O
bid	NN	O	O

atrovent	JJ	B-TREATMENT	B-TREATMENT
inhaler	NN	I-TREATMENT	I-TREATMENT
tid	NN	O	I-TREATMENT

1.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
81	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

2.	CD	O	O
docusate	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

3.	CD	O	O
fluticasone	NN	B-TREATMENT	B-TREATMENT
propionate	NN	I-TREATMENT	I-TREATMENT
110	CD	O	O
mcg	NN	O	O
/	NNP	O	O
actuation	NN	O	O
aerosol	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
puff	NN	O	O
inhalation	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

4.	CD	O	O
oxycodone	CD	B-TREATMENT	B-TREATMENT
-	:	I-TREATMENT	I-TREATMENT
acetaminophen	NN	I-TREATMENT	I-TREATMENT
5-325	JJ	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
tablets	NNS	O	O
po	JJ	O	O
every	DT	O	O
4-6	JJ	O	O
hours	NNS	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

5.	CD	O	O
ipratropium	NN	B-TREATMENT	B-TREATMENT
bromide	NN	I-TREATMENT	I-TREATMENT
18	CD	O	O
mcg	NN	O	O
/	NNP	O	O
actuation	NN	O	O
aerosol	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
puff	NN	O	O
inhalation	NN	O	O
qid	NN	O	O
(	(	O	O
4	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

6.	CD	O	O
pantoprazole	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
40	CD	O	O
mg	NN	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
q24h	NN	O	O
(	(	O	O
every	DT	O	O
24	CD	O	O
hours	NNS	O	O
)	)	O	O
.	.	O	O

7.	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
tartrate	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

8.	CD	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

9.	CD	O	O
bacitracin	NN	B-TREATMENT	B-TREATMENT
zinc	NN	I-TREATMENT	I-TREATMENT
500	CD	O	O
unit	NN	O	O
/	NNP	O	O
g	NN	O	O
ointment	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
appl	RB	O	O
topical	JJ	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

10.	CD	O	O
celexa	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

11.	CD	O	O
warfarin	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
1	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
five	CD	O	O
(	(	O	O
5	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
:	:	O	O
take	VB	O	O
5	CD	O	O
mg	NNS	O	O
on	IN	O	O
04-18	NN	O	O
.	.	O	O

12.	CD	O	O
lasix	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
q	JJ	O	O
m-w-f	NN	O	O
.	.	O	O

13.	CD	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
10	CD	O	O
meq	NN	O	O
capsule	NN	O	O
,	,	O	O
sustained	VBD	O	O
release	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
,	,	O	O
sustained	VBD	O	O
release	NN	O	O
po	NN	O	O
q	JJ	O	O
m-w-f	NN	O	O
.	.	O	O

14.	CD	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
:	:	O	O
as	IN	O	O
directed	VBN	O	O
for	IN	O	O
goal	NN	B-TEST	B-TREATMENT
inr	CD	I-TEST	O
2.0-2.5.	JJ	O	O

coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

aortic	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

hyperlipidemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

chronic	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM

shower	JJR	O	O
daily	JJ	O	O
and	CC	O	O
wash	JJ	O	B-PROBLEM
incisions	NNS	B-PROBLEM	I-PROBLEM
with	IN	O	O
soap	NN	O	B-TREATMENT
and	CC	O	O
water	NN	O	O
.	.	O	O

10%	CD	B-PROBLEM	B-PROBLEM
body	NN	I-PROBLEM	I-PROBLEM
burns	NNS	I-PROBLEM	I-PROBLEM

(1)	JJ	O	B-PROBLEM
third	JJ	B-PROBLEM	I-PROBLEM
degree	NN	I-PROBLEM	I-PROBLEM
burn	NN	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	O
right	JJ	I-PROBLEM	O
hand	NN	I-PROBLEM	O
and	CC	I-PROBLEM	O
forearm	NN	I-PROBLEM	B-PROBLEM

(2)	JJ	O	O
second	JJ	B-PROBLEM	O
degree	NN	I-PROBLEM	O
burn	NN	I-PROBLEM	O
to	TO	I-PROBLEM	O
face	NN	I-PROBLEM	B-TREATMENT
procedure	NN	O	I-TREATMENT
:	:	O	O

debridement	NN	B-TREATMENT	B-TREATMENT
of	IN	O	I-TREATMENT
burn	NN	B-PROBLEM	I-TREATMENT
and	CC	O	O
application	NN	B-TREATMENT	O
of	IN	I-TREATMENT	O
artificial	JJ	I-TREATMENT	B-PROBLEM
skin	NN	I-TREATMENT	I-PROBLEM

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
59	CD	O	O
year	NN	O	O
old	JJ	O	O
gentleman	NN	O	O
who	WP	O	O
experienced	VBD	O	O
a	DT	B-PROBLEM	B-TEST
flash	JJ	I-PROBLEM	I-TEST
burn	NN	I-PROBLEM	I-TEST
from	IN	O	O
grease	NN	O	O
while	IN	O	O
working	VBG	O	O
on	IN	O	O
a	DT	O	B-TREATMENT
stove	NN	O	I-TREATMENT
on	IN	O	O
the	DT	O	O
night	NN	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
treated	VBD	O	O
himself	PRP	O	O
symptomatically	RB	O	O
at	IN	O	O
home	NN	O	O
but	CC	O	O
presented	VBD	O	O
to	TO	O	O
roing	VBG	O	O
hospital	NN	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
after	IN	O	O
the	DT	O	O
event	NN	O	O
and	CC	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
nimaconwood	NN	O	O
valley	NN	O	O
hospital	NN	O	O
immediately	RB	O	O
for	IN	O	O
evaluation	NN	B-TEST	B-TEST
because	IN	O	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
extensive	JJ	I-PROBLEM	I-PROBLEM
burns	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
walking	VBG	O	O
,	,	O	O
talking	VBG	O	O
,	,	O	O
and	CC	O	O
was	VBD	O	O
breathing	VBG	O	O
without	IN	O	O
difficulty	NN	B-PROBLEM	O
on	IN	O	O
arrival	NN	O	O
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

99%	CD	O	O
saturation	NN	B-TEST	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
76	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
169/100	CD	O	O
.	.	O	O

other	JJ	B-TEST	B-TEST
vital	JJ	I-TEST	I-TEST
signs	NNS	I-TEST	I-TEST
were	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
not	RB	O	O
anxious	JJ	O	B-PROBLEM
or	CC	O	O
ill-appearing	JJ	B-PROBLEM	O
.	.	O	O

extensive	JJ	B-PROBLEM	O
first	JJ	I-PROBLEM	O
degree	NN	I-PROBLEM	O
and	CC	I-PROBLEM	O
second	JJ	I-PROBLEM	B-PROBLEM
degree	NN	I-PROBLEM	I-PROBLEM
burns	NNS	I-PROBLEM	I-PROBLEM
around	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
face	NN	I-PROBLEM	O
,	,	O	O
superficial	JJ	O	O
in	IN	O	O
nature	NN	O	O
,	,	O	O
with	IN	O	O
no	DT	O	O
blistering	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

his	PRP$	O	B-TEST
oropharynx	NN	O	I-TEST
was	VBD	O	O
wide	JJ	O	B-TREATMENT
open	JJ	O	I-TREATMENT
with	IN	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
burn	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

lungs	NNS	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	O	O
.	.	O	O

soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

third	JJ	B-PROBLEM	B-PROBLEM
degree	JJ	I-PROBLEM	I-PROBLEM
burn	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
dorsum	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
forearm	NN	O	I-PROBLEM
and	CC	O	O
on	IN	O	O
dorsum	NN	O	O
of	IN	O	O
hand	NN	O	O
with	IN	O	O
extensive	JJ	B-PROBLEM	B-PROBLEM
second	JJ	I-PROBLEM	I-PROBLEM
degree	NN	I-PROBLEM	I-PROBLEM
burn	NN	I-PROBLEM	I-PROBLEM
around	IN	O	O
the	DT	O	O
remainder	NN	O	O
of	IN	O	O
his	PRP$	O	O
hand	NN	O	O
circumferentially	RB	O	O
and	CC	O	O
on	IN	O	O
his	PRP$	O	B-TEST
forearm	NN	O	I-TEST
.	.	O	O

no	DT	O	O
evidence	NN	O	O
of	IN	O	O
compartment	JJ	B-PROBLEM	B-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

evaluation	NN	B-TEST	B-TEST
in	IN	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
revealed	VBD	O	O
the	DT	O	O
patient	NN	O	O
to	TO	O	O
be	VB	O	O
stable	JJ	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
evaluated	VBN	O	O
by	IN	O	O
ophthalmology	NN	O	O
who	WP	O	O
also	RB	O	O
felt	VBD	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
no	DT	O	O
injury	NN	B-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	O
his	PRP$	I-PROBLEM	O
eyes	NNS	I-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
taken	VBN	O	O
from	IN	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
and	CC	O	O
transferred	VBD	O	O
to	TO	O	O
the	DT	O	O
surgical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
airway	JJ	B-TEST	O
observation	NN	I-TEST	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
given	VBN	O	O
three	CD	O	O
liters	NNS	O	O
of	IN	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
hydration	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
good	JJ	O	O
urine	NN	O	O
output	NN	O	O
response	NN	O	O
.	.	O	O

his	PRP$	B-PROBLEM	B-PROBLEM
wounds	NNS	I-PROBLEM	I-PROBLEM
were	VBD	O	O
dressed	VBN	O	O
with	IN	O	O
antiointment	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
xeroform	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
the	DT	O	O
plan	NN	O	O
to	TO	O	O
take	VB	O	O
him	PRP	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
for	IN	O	O
debridement	NN	B-TREATMENT	B-TREATMENT
under	IN	O	O
general	JJ	B-TREATMENT	B-TREATMENT
anesthesia	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
application	NN	B-TREATMENT	O
of	IN	I-TREATMENT	O
artificial	JJ	I-TREATMENT	B-PROBLEM
skin	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

while	IN	O	O
in	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
put	VBN	O	O
on	IN	O	O
delirium	NN	B-TREATMENT	B-TREATMENT
tremons	NNS	I-TREATMENT	I-TREATMENT
prophylaxis	VBP	I-TREATMENT	I-TREATMENT
with	IN	O	O
serax	NN	B-TREATMENT	B-TREATMENT
around	IN	O	O
the	DT	O	O
clock	NN	O	O
.	.	O	O

at	IN	O	O
that	DT	O	O
time	NN	O	O
the	DT	O	O
patient	JJ	O	O
underwent	JJ	O	O
debridement	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
facial	JJ	I-PROBLEM	I-PROBLEM
wounds	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
debridement	NN	B-TREATMENT	B-TREATMENT
of	IN	I-TREATMENT	O
his	PRP$	I-TREATMENT	O
right	JJ	I-TREATMENT	O
hand	NN	I-TREATMENT	O
and	CC	I-TREATMENT	O
forearm	NN	I-TREATMENT	O
with	IN	O	O
application	NN	B-TREATMENT	O
of	IN	I-TREATMENT	O
artificial	JJ	I-TREATMENT	B-PROBLEM
skin	NN	I-TREATMENT	I-PROBLEM
which	WDT	O	O
is	VBZ	O	O
the	DT	O	O
dermagraft	NN	B-TREATMENT	O
tc	NN	I-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
.	.	O	O

there	EX	O	O
were	VBD	O	O
no	DT	O	O
complications	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

postoperatively	RB	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
out	IN	O	O
of	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
to	TO	O	O
the	DT	O	O
burn	NN	O	O
floor	NN	O	O
where	WRB	O	O
he	PRP	O	O
received	VBD	O	O
dressing	VBG	B-TREATMENT	B-TREATMENT
changes	NNS	I-TREATMENT	I-TREATMENT
p.r.n.	VBP	O	O

the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
other	JJ	B-TEST	B-TEST
vital	JJ	I-TEST	I-TEST
signs	NNS	I-TEST	I-TEST
were	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
the	DT	B-TREATMENT	O
patient	NN	I-TREATMENT	O
&apos;s	NN	I-TREATMENT	B-TREATMENT
dressing	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
taken	VBN	O	O
down	RP	O	O
completely	RB	O	O
and	CC	O	O
evaluation	NN	B-TEST	B-TEST
of	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
derma	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
made	VBN	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
infection	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
folate	VBP	B-TREATMENT	B-TEST
1	CD	O	O
mg	NN	O	O
q.d.	NN	O	O
,	,	O	O
artificial	JJ	B-TREATMENT	O
tears	NNS	I-TREATMENT	O
2	CD	O	O
drops	NNS	O	O
each	DT	O	O
eye	NN	O	O
b.i.d.	NN	O	O
and	CC	O	O
p.r.n.	NN	O	O
,	,	O	O
serax	VBD	B-TREATMENT	B-TREATMENT
15	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q6h	SYM	O	O
-	:	O	O
hold	NN	O	O
if	IN	O	O
patient	JJ	O	O
excessively	RB	B-PROBLEM	O
sleepy	JJ	I-PROBLEM	O
,	,	O	O
thiamine	JJ	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
,	,	O	O
ms	SYM	B-TREATMENT	B-TEST
-	:	I-TREATMENT	O
contin	NN	I-TREATMENT	B-TREATMENT
30	CD	O	O
mg	NN	O	O
p.o.b.i.d.	NN	O	O
,	,	O	O
multivitamin	NN	B-TREATMENT	B-TREATMENT
q.d.	NN	O	O
,	,	O	O
msir	FW	B-TREATMENT	B-TREATMENT
15	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q3-4h	JJ	O	O
p.r.n.	NN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
axid	RB	B-TREATMENT	O
150	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
b.i.d.	NN	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
to	TO	O	O
undergo	VB	O	O
dry	JJ	B-TREATMENT	B-TREATMENT
dressing	NN	I-TREATMENT	I-TREATMENT
changes	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
splint	NN	B-TREATMENT	O
to	TO	I-TREATMENT	O
his	PRP$	I-TREATMENT	O
right	JJ	I-TREATMENT	O
arm	NN	I-TREATMENT	O
q.d.	NN	O	O

codeine	NN	B-TREATMENT	B-TREATMENT
/	''	O	O
shellfish	JJ	O	O
/	NN	O	O
ciprofloxacin	NN	B-TREATMENT	B-TREATMENT

exertional	JJ	B-PROBLEM	B-PROBLEM
angina	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
exertion	NN	O	O

2013-10-21	JJ	O	O
cabg	NN	B-TREATMENT	O
x	$	O	O
3	CD	O	O
(	(	O	O
lima	JJ	O	O
->	NNP	O	O
lad	NN	O	O
,	,	O	O
svg	JJ	O	B-TEST
->	NNP	O	I-TEST
om	NN	O	I-TEST
,	,	O	O
svg	JJ	O	B-TREATMENT
->	NNP	O	I-TREATMENT
pda	NN	O	I-TREATMENT
)	)	O	I-TREATMENT

this	DT	O	O
is	VBZ	O	O
an	DT	O	O
85	CD	O	O
year	NN	O	O
old	JJ	O	O
female	NN	O	O
with	IN	O	O
prior	JJ	O	O
history	NN	O	O
of	IN	O	O
non-hodgkins	JJ	B-PROBLEM	B-PROBLEM
lymphoma	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
s/p	JJ	O	O
cytoxan	NN	B-TREATMENT	B-TREATMENT
in	IN	O	O
2003	CD	O	O
a	DT	O	O
with	IN	O	O
recurrence	NN	B-PROBLEM	B-PROBLEM
in	IN	O	O
2009	CD	O	O
.	.	O	O

follow	VB	B-TEST	B-TEST
up	RP	I-TEST	I-TEST
examinations	NNS	I-TEST	I-TEST
have	VBP	O	O
found	VBN	O	O
a	DT	B-PROBLEM	B-PROBLEM
suspicious	JJ	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
lower	RBR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
finding	VBG	I-PROBLEM	O
.	.	O	O

cardiac	JJ	B-TEST	B-TEST
workup	NN	I-TEST	I-TEST
prior	RB	O	O
to	TO	O	O
left	VB	B-TREATMENT	B-PROBLEM
lower	JJR	I-TREATMENT	I-PROBLEM
lobe	NN	I-TREATMENT	I-PROBLEM
resection	NN	I-TREATMENT	I-PROBLEM
led	VBD	O	O
to	TO	O	O
cardiac	VB	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
which	WDT	O	O
found	VBD	O	O
severe	RB	B-PROBLEM	B-PROBLEM
three	CD	I-PROBLEM	I-PROBLEM
vessel	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
04-05+	JJ	B-PROBLEM	B-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
now	RB	O	O
present	VBP	O	O
for	IN	O	O
surgical	JJ	B-TREATMENT	B-TREATMENT
intervention	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

non-hodgkins	NNS	B-PROBLEM	B-PROBLEM
lymphoma	SYM	I-PROBLEM	I-PROBLEM
-	:	O	O
s/p	NN	O	O
cytoxan	NN	B-TREATMENT	B-TREATMENT
in	IN	O	O
2003	CD	O	O
and	CC	O	O
2001	CD	O	O
,	,	O	O
history	NN	O	O
of	IN	O	O
varicella	NN	B-PROBLEM	B-PROBLEM
zoster	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
opthalmic	JJ	B-PROBLEM	B-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
history	NN	O	O
of	IN	O	O
menieres	NNS	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
gerd	NN	B-PROBLEM	O
,	,	O	O
glaucoma	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
history	NN	O	O
of	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
sinusitis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
s/p	JJ	O	O
cataract	NN	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
s/p	NN	O	O
tah	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
bso	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
s/p	JJ	O	O
appendectomy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
s/p	JJ	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
breast	NN	I-TREATMENT	I-TREATMENT
reduction	NN	I-TREATMENT	I-TREATMENT

daughter	NN	O	O
died	VBD	O	O
of	IN	O	O
mi	NN	B-PROBLEM	B-PROBLEM
at	IN	O	O
age	NN	O	O
49	CD	O	O
.	.	O	O

vitals	NNS	B-TEST	B-TEST
:	:	O	O

bp	JJ	B-TEST	O
160-170/80-84	CD	O	O
,	,	O	O
hr	VBZ	B-TEST	B-TEST
82	CD	O	O
,	,	O	O
resp	VBD	B-TEST	O
20	CD	O	O

elderly	JJ	O	O
female	NN	O	O
in	IN	O	O
no	DT	O	O
acute	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM

supple	NN	O	O
,	,	O	O
no	DT	O	O
jvd	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
carotid	NN	B-PROBLEM	B-PROBLEM
bruits	NNS	I-PROBLEM	I-PROBLEM

regular	JJ	O	O
rate	NN	O	O
,	,	O	O
04-07	JJ	O	O
holosystolic	NN	B-PROBLEM	O
murmur	NN	I-PROBLEM	B-PROBLEM

soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBD	B-PROBLEM	B-PROBLEM

warm	NN	O	O
,	,	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM

pulses	NNS	B-TEST	B-TEST
:	:	O	O

2013-10-29	JJ	O	O
06:10	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	B-TEST	B-TEST
-	:	O	O
10.9	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.99	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
12.6	CD	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
37.9	CD	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
95	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
31.5	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
33.2	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
13.9	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
330	CD	O	O
#	#	O	O

2013-10-29	JJ	O	O
06:10	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
76	CD	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
12	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
0.9	CD	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
141	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
3.5	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
104	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
26	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
15	CD	O	O

2013-10-30	JJ	O	O
06:28	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
phenyto	NN	B-TEST	I-TEST
-	:	O	O
5.5	CD	O	O
*	NN	O	O

mrs.	NN	O	O
mandelbaum	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
and	CC	O	O
underwent	JJ	O	O
three	CD	B-TREATMENT	B-TREATMENT
vessel	NN	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	NN	I-TREATMENT	I-TREATMENT
by	IN	O	O
dr.	NN	O	O
larry	NN	O	O
mckinney	NN	O	O
.	.	O	O

of	IN	O	O
note	NN	O	O
,	,	O	O
intraoperative	JJ	B-TEST	B-TEST
transesophageal	NN	I-TEST	I-TEST
echocardiogram	NN	I-TEST	I-TEST
evaluation	NN	I-TEST	I-TEST
showed	VBD	O	O
only	RB	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
so	IN	O	O
no	DT	O	O
repair/replacement	NN	B-TREATMENT	B-PROBLEM
was	VBD	O	O
indicated	VBN	O	O
.	.	O	O

following	VBG	O	O
the	DT	B-TREATMENT	B-TREATMENT
operation	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
she	PRP	O	O
was	VBD	O	O
brought	VBN	O	O
to	TO	O	O
the	DT	O	O
csru	NN	O	O
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
one	CD	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
largely	RB	B-PROBLEM	B-PROBLEM
unresponsive	JJ	I-PROBLEM	I-PROBLEM
with	IN	O	I-PROBLEM
left	JJ	B-PROBLEM	I-PROBLEM
hemiparesis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

restlessness	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
body	NN	B-PROBLEM	B-PROBLEM
tremors	NNS	I-PROBLEM	I-PROBLEM
were	VBD	O	O
also	RB	O	O
noted	VBN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
stat	NN	I-TEST	I-TEST
mri	NN	I-TEST	I-TEST
was	VBD	O	O
notable	JJ	O	O
for	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
abnormal	JJ	I-PROBLEM	I-PROBLEM
foci	NN	I-PROBLEM	I-PROBLEM
consistent	NN	O	O
with	IN	O	O
systemic	JJ	B-PROBLEM	B-PROBLEM
emboli	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
neurology	NN	O	O
service	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
and	CC	O	O
attributed	VBN	O	O
these	DT	O	O
findings	NNS	O	O
to	TO	O	O
cholesterol	VB	B-PROBLEM	B-PROBLEM
emboli	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

due	JJ	O	O
to	TO	O	O
seizure	NN	B-PROBLEM	B-PROBLEM
activity	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
dilantin	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
started	VBN	O	O
.	.	O	O

anticoagulation	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
not	RB	O	O
recommended	VBN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
eventually	RB	O	O
extubated	VBN	O	O
without	IN	O	O
incident	NN	B-PROBLEM	O
.	.	O	O

she	PRP	O	O
went	VBD	O	O
on	IN	O	O
to	TO	O	O
experience	VB	O	O
paroxysmal	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
initially	RB	O	O
treated	VBN	O	O
with	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
amiodarone	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
concomitantly	RB	O	O
had	VBD	O	O
loose	JJ	B-PROBLEM	B-PROBLEM
stools	NNS	I-PROBLEM	I-PROBLEM
which	WDT	O	O
were	VBD	O	O
c.	NNS	B-TEST	O
diff	JJ	I-TEST	O
negative	JJ	O	O
.	.	O	O

she	PRP	O	O
remained	VBD	O	O
mostly	RB	O	O
in	IN	O	O
a	DT	O	O
normal	JJ	O	O
sinus	NN	O	O
rhythm	NN	O	O
and	CC	O	O
transitioned	VBD	O	O
to	TO	O	O
oral	VB	B-TREATMENT	O
amiodarone	NN	I-TREATMENT	B-TREATMENT
which	WDT	O	O
will	MD	O	O
need	VB	O	O
to	TO	O	O
continue	VB	O	O
for	IN	O	O
three	CD	O	O
months	NNS	O	O
postop	RB	O	O
.	.	O	O

she	PRP	O	O
tolerated	VBD	O	O
beta	NN	B-TREATMENT	B-TREATMENT
blockade	NN	I-TREATMENT	I-TREATMENT
which	WDT	O	O
was	VBD	O	O
slowly	RB	O	O
advanced	JJ	O	O
as	IN	O	O
tolerated	VBN	O	O
.	.	O	O

acyclovir	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
eventually	RB	O	O
increased	VBN	O	O
from	IN	O	O
her	PRP$	B-TREATMENT	O
maintenance	NN	I-TREATMENT	O
dose	NN	I-TREATMENT	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
herpes	NNS	I-PROBLEM	I-PROBLEM
zoster	NN	I-PROBLEM	I-PROBLEM
breakout	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	O
her	PRP$	I-PROBLEM	O
right	JJ	I-PROBLEM	O
upper	JJ	I-PROBLEM	O
back	RB	I-PROBLEM	O
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
empirically	RB	O	O
started	VBN	O	O
on	IN	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
persistent	JJ	B-PROBLEM	B-PROBLEM
diarrhea	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
despite	IN	O	O
negative	JJ	O	O
c.	NN	O	B-TEST
diff	NN	O	I-TEST
cultures	NNS	O	I-TEST
)	)	O	O
,	,	O	O
however	RB	O	O
she	PRP	O	O
developed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
additional	JJ	I-PROBLEM	I-PROBLEM
rash	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	O
her	PRP$	I-PROBLEM	B-TEST
buttocks	NNS	I-PROBLEM	I-TEST
after	IN	O	O
the	DT	O	O
first	JJ	O	O
dose	NN	O	O
of	IN	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
so	IN	O	O
the	DT	B-TREATMENT	O
flagyl	NN	I-TREATMENT	O
was	VBD	O	O
discontinued	VBN	O	O
.	.	O	O

she	PRP	O	O
developed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
urinary	JJ	I-PROBLEM	I-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
for	IN	O	O
which	WDT	O	O
she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
bactrim	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
foley	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
inserted	VBN	O	O
given	VBN	O	O
her	PRP$	O	O
mutiple	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
incontinence	NN	B-PROBLEM	B-PROBLEM
that	WDT	O	O
were	VBD	O	O
adding	VBG	O	O
to	TO	O	O
skin	VB	B-PROBLEM	O
irritation	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
insertion	NN	B-TREATMENT	O
she	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
retaining	VBG	O	O
1400	CD	O	O
cc	NN	O	O
of	IN	O	O
urine	NN	O	O
,	,	O	O
so	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
foley	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
left	VBN	O	O
in	IN	O	O
.	.	O	O

acyclovir	RB	B-TREATMENT	B-TREATMENT
800	CD	O	O
qd	NN	O	O
,	,	O	O
nexium	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
qd	NN	O	O
,	,	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
40	CD	O	O
qd	NN	O	O
,	,	O	O
coreg	JJ	B-TREATMENT	O
6.25	CD	O	O
bid	NN	O	O
,	,	O	O
asa	VBZ	B-TREATMENT	B-TREATMENT
81	CD	O	O
qd	NN	O	O
,	,	O	O
timolol	NN	B-TREATMENT	B-TREATMENT
cmed	VBD	I-TREATMENT	O
csru	JJ	I-TREATMENT	B-PROBLEM
gtts	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
calcium	NN	B-TREATMENT	B-TEST
,	,	O	O
mvi	NN	B-TREATMENT	O
,	,	O	O
vitamin	FW	B-TREATMENT	B-TREATMENT
c	NN	I-TREATMENT	I-TREATMENT

1.	CD	O	O
acetaminophen	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
tablets	NNS	O	O
po	VBP	O	O
q4h	NN	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2.	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
tartrate	NN	I-TREATMENT	I-TREATMENT
50	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

3.	CD	O	O
phenytoin	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
extended	VBD	I-TREATMENT	O
100	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

4.	CD	O	O
furosemide	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

5.	CD	O	O
pantoprazole	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
q24h	NN	O	O
(	(	O	O
every	DT	O	O
24	CD	O	O
hours	NNS	O	O
)	)	O	O
.	.	O	O

6.	CD	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
200	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
for	IN	O	O
7	CD	O	O
days	NNS	O	O
:	:	O	O
400	CD	O	O
mg	NNS	O	O
po	JJ	O	O
daily	JJ	O	O
for	IN	O	O
1	CD	O	O
week	NN	O	O
,	,	O	O
then	RB	O	O
decrease	NN	O	O
to	TO	O	O
200	CD	O	O
mg	NNS	O	O
po	JJ	O	O
daily	RB	O	O
.	.	O	O

7.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
81	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

8.	CD	O	O
acyclovir	JJ	B-TREATMENT	B-TREATMENT
800	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
0.5	CD	O	O
tablet	NN	O	O
po	NN	O	O
5x/d	CD	O	O
(	(	O	O
5	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
for	IN	O	O
5	CD	O	O
days	NNS	O	O
:	:	O	O
then	RB	O	O
decrease	VB	O	O
dose	NN	O	O
to	TO	O	O
800	CD	O	O
mg	NNS	O	O
po	JJ	O	O
daily	RB	O	O
.	.	O	O

9.	CD	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

10.	CD	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
20	CD	O	O
meq	NN	O	O
packet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
packet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

11.	CD	O	O
trimethoprim	JJ	B-TREATMENT	O
-	:	I-TREATMENT	O
sulfamethoxazole	JJ	I-TREATMENT	O
160-800	JJ	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

12.	CD	O	O
miconazole	JJ	B-TREATMENT	B-TREATMENT
nitrate	RB	I-TREATMENT	I-TREATMENT
2	CD	O	O
%	NN	O	O
powder	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
appl	RB	O	O
topical	JJ	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
-	:	O	O
s/p	NN	O	O
cabg	NN	B-TREATMENT	B-TREATMENT

varicella	NN	B-PROBLEM	B-PROBLEM
zoster	NN	I-PROBLEM	I-PROBLEM

postop	NN	B-PROBLEM	B-PROBLEM
cva	NN	I-PROBLEM	I-PROBLEM

postop	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM

follow	JJ	O	B-TREATMENT
medications	NNS	B-TREATMENT	I-TREATMENT
on	IN	O	O
discharge	NN	O	O
instructions	NNS	O	O
.	.	O	O

call	VB	O	O
our	PRP$	O	O
office	NN	O	O
for	IN	O	O
sternal	JJ	B-PROBLEM	B-TREATMENT
drainage	NN	I-PROBLEM	I-TREATMENT
,	,	O	O
temp	EX	B-PROBLEM	B-TEST
>	VBZ	O	O
101.5	CD	O	O

no	DT	O	O
lotions	NNS	O	B-TREATMENT
,	,	O	O
creams	NNS	O	B-TREATMENT
,	,	O	O
or	CC	O	O
powders	NNS	O	B-TREATMENT
on	IN	O	O
wounds	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

severe	JJ	B-PROBLEM	B-PROBLEM
blunt	NN	I-PROBLEM	I-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
trauma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

severe	JJ	B-PROBLEM	B-PROBLEM
blunt	NN	I-PROBLEM	I-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
trauma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
grade	NN	B-PROBLEM	B-PROBLEM
ii	NN	I-PROBLEM	I-PROBLEM
/	NNP	I-PROBLEM	I-PROBLEM
v	NN	I-PROBLEM	I-PROBLEM
laceration	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
liver	NN	I-PROBLEM	I-PROBLEM
,	,	O	O

2.	CD	O	O
rupture	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
vein	NN	I-PROBLEM	I-PROBLEM
,	,	O	O

3.	CD	O	O
tear	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
transverse	NN	I-PROBLEM	I-PROBLEM
mesocolon	NN	I-PROBLEM	I-PROBLEM
,	,	O	O

4.	CD	O	O
serosal	JJ	B-PROBLEM	B-PROBLEM
tear	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
transverse	NN	I-PROBLEM	I-PROBLEM
colon	NN	I-PROBLEM	I-PROBLEM
,	,	O	O

5.	CD	O	O
blunt	JJ	B-PROBLEM	B-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
neck	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
pancreas	NNS	O	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
found	VBN	O	O
awake	RB	O	O
at	IN	O	O
the	DT	O	O
scene	NN	O	O
,	,	O	O
complaining	NN	O	O
of	IN	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
60	CD	O	O
systolic	JJ	O	O
upon	IN	O	O
arrival	NN	O	O
of	IN	O	O
the	DT	O	O
giles	NNS	O	O
min	VBP	O	O
general	JJ	O	O
hospital	NN	O	O
crew	NN	O	O
.	.	O	O

intravenous	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
was	VBD	O	O
given	VBN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
paralyzed	VBN	B-PROBLEM	O
and	CC	O	O
endotracheally	RB	O	O
intubated	VBN	O	B-TREATMENT
,	,	O	O
and	CC	O	O
a	DT	B-TREATMENT	O
14	CD	I-TREATMENT	O
gauge	NN	I-TREATMENT	B-TEST
catheter	NN	I-TREATMENT	I-TEST
was	VBD	O	O
inserted	VBN	O	O
in	IN	O	O
his	PRP$	O	O
left	JJ	O	O
chest	NN	O	O
because	IN	O	O
of	IN	O	O
poor	JJ	B-PROBLEM	B-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
sounds	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
arrived	VBD	O	O
at	IN	O	O
the	DT	O	O
fairm	NN	O	O
of	IN	O	O
ijordcompmac	JJ	O	O
hospital	NN	O	O
at	IN	O	O
02:30	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
86	CD	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
170	CD	O	O
.	.	O	O

large	JJ	B-TREATMENT	B-TEST
bore	NN	I-TREATMENT	I-TEST
cannulas	NNS	I-TREATMENT	I-TEST
were	VBD	O	O
inserted	VBN	O	O
into	IN	O	O
the	DT	O	O
femoral	JJ	O	O
veins	NNS	O	O
,	,	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
tubes	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
placed	VBN	O	O
,	,	O	O
and	CC	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
rose	VBD	O	O
to	TO	O	O
110	CD	O	O
systolic	NNS	O	B-TEST
after	IN	O	O
two	CD	O	O
liters	NNS	O	O
of	IN	O	O
crystalloid	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
ecchymosis	NN	I-PROBLEM	I-PROBLEM
over	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
medial	JJ	O	I-PROBLEM
right	JJ	O	I-PROBLEM
costal	NN	O	I-PROBLEM
margin	NN	O	I-PROBLEM
and	CC	O	O
his	PRP$	O	O
abdomen	NNS	O	O
was	VBD	O	O
distended	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
36	CD	O	O
,	,	O	O
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
1.6	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
abdominal	JJ	I-TEST	I-TEST
tap	NN	I-TEST	I-TEST
was	VBD	O	O
grossly	RB	B-PROBLEM	O
positive	JJ	I-PROBLEM	O
for	IN	I-PROBLEM	O
blood	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
fell	VBD	O	O
to	TO	O	O
60	CD	O	O
systolic	NN	O	B-TEST
as	IN	O	O
he	PRP	O	O
was	VBD	O	O
being	VBG	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	B-TEST
computerized	JJ	O	I-TEST
tomography	NN	O	I-TEST
scan	JJ	O	I-TEST
table	NN	O	I-TEST
;	:	O	O
the	DT	B-TEST	B-TEST
scan	NN	I-TEST	I-TEST
was	VBD	O	O
aborted	VBN	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
taken	VBN	O	O
directly	RB	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
at	IN	O	O
03:00	CD	O	O
.	.	O	O

at	IN	O	O
laparotomy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
there	EX	O	O
was	VBD	O	O
a	DT	O	O
liter	NN	O	O
of	IN	O	O
blood	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
peritoneal	JJ	I-PROBLEM	I-PROBLEM
cavity	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
class	NN	I-PROBLEM	I-PROBLEM
ii	NN	I-PROBLEM	I-PROBLEM
laceration	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
liver	NN	I-PROBLEM	I-PROBLEM
at	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
falciform	NN	O	I-PROBLEM
ligament	NN	O	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
actively	RB	O	B-PROBLEM
bleeding	VBG	O	I-PROBLEM
,	,	O	O
a	DT	B-PROBLEM	B-PROBLEM
tear	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
transverse	NN	I-PROBLEM	I-PROBLEM
mesocolon	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
its	PRP$	O	O
base	NN	O	O
to	TO	O	O
the	DT	O	O
bowel	NN	O	O
wall	NN	O	O
with	IN	O	O
active	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
a	DT	B-PROBLEM	B-PROBLEM
7	CD	I-PROBLEM	I-PROBLEM
cm	NN	I-PROBLEM	I-PROBLEM
serosal	NN	I-PROBLEM	I-PROBLEM
tear	IN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
adjacent	JJ	I-PROBLEM	I-PROBLEM
transverse	NN	I-PROBLEM	I-PROBLEM
colon	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
central	JJ	I-PROBLEM	I-PROBLEM
retroperitoneal	NN	I-PROBLEM	I-PROBLEM
hematoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

control	NN	O	O
of	IN	O	O
the	DT	O	O
super-celiac	JJ	O	O
aorta	NN	O	O
was	VBD	O	O
obtained	VBN	O	O
,	,	O	O
and	CC	O	O
both	DT	O	O
left	VBD	B-TREATMENT	O
and	CC	I-TREATMENT	O
right	RB	I-TREATMENT	B-TREATMENT
sided	VBD	I-TREATMENT	I-TREATMENT
&quot;	NNP	I-TREATMENT	I-TREATMENT
mattox	NN	I-TREATMENT	I-TREATMENT
&quot;	NN	I-TREATMENT	I-TREATMENT
maneuvers	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
performed	VBN	O	O
.	.	O	O

the	DT	O	O
retroperitoneum	NN	O	O
was	VBD	O	O
opened	VBN	O	O
,	,	O	O
with	IN	O	O
vigorous	JJ	B-PROBLEM	B-PROBLEM
bleeding	VBG	I-PROBLEM	I-PROBLEM
resulting	VBG	O	O
.	.	O	O

this	DT	O	O
was	VBD	O	O
controlled	VBN	O	O
,	,	O	O
necessitating	VBG	O	O
ten	JJ	O	O
minutes	NNS	O	O
of	IN	O	O
aortic	JJ	B-TREATMENT	B-TREATMENT
clamping	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
originated	VBN	O	O
from	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
rupture	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
vein	NN	I-PROBLEM	I-PROBLEM
one	CD	O	I-PROBLEM
centimeter	NN	O	I-PROBLEM
from	IN	O	I-PROBLEM
its	PRP$	O	I-PROBLEM
junction	NN	O	I-PROBLEM
with	IN	O	O
the	DT	O	B-PROBLEM
inferior	JJ	O	I-PROBLEM
vena	NN	O	I-PROBLEM
cava	NN	O	I-PROBLEM
.	.	O	O

the	DT	O	O
vein	NN	O	O
was	VBD	O	O
divided	VBN	O	O
and	CC	O	O
suture	NN	B-TREATMENT	B-TREATMENT
ligated	VBN	O	I-TREATMENT
.	.	O	O

bleeding	VBG	B-PROBLEM	B-PROBLEM
from	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
liver	NN	I-PROBLEM	O
was	VBD	O	O
controlled	VBN	O	O
with	IN	O	O
sutures	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	B-PROBLEM	O
tears	NNS	I-PROBLEM	O
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
transverse	NN	I-PROBLEM	O
mesocolon	NN	I-PROBLEM	O
and	CC	I-PROBLEM	O
colon	NN	I-PROBLEM	B-TREATMENT
serosa	NN	I-PROBLEM	I-TREATMENT
were	VBD	O	O
repaired	VBN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
of	IN	O	I-TEST
the	DT	O	I-TEST
remainder	NN	O	I-TEST
of	IN	O	I-TEST
the	DT	O	I-TEST
abdominal	JJ	O	I-TEST
contents	NNS	O	I-TEST
revealed	VBD	O	O
no	DT	O	O
other	JJ	B-PROBLEM	B-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
in	IN	O	O
particular	JJ	O	O
,	,	O	O
the	DT	O	O
entire	JJ	O	O
anterior	JJ	O	O
surface	NN	O	O
and	CC	O	O
the	DT	O	O
immediately	RB	O	O
juxtaduodenal	JJ	O	O
posterior	JJ	O	O
surface	NN	O	O
of	IN	O	O
the	DT	O	O
pancreas	NNS	O	O
were	VBD	O	O
normal	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
received	VBN	O	O
ten	JJ	O	O
units	NNS	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
five	CD	O	O
units	NNS	O	O
of	IN	O	O
fresh	JJ	B-TREATMENT	B-TREATMENT
frozen	JJ	I-TREATMENT	I-TREATMENT
plasma	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
seven	CD	O	O
units	NNS	O	O
of	IN	O	O
platelets	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
nine	CD	O	O
liters	NNS	O	O
of	IN	O	O
ringer	NN	B-TREATMENT	B-PROBLEM
&apos;s	NNP	I-TREATMENT	I-PROBLEM
lactate	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
intracranial	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
monitoring	NN	I-TEST	I-TEST
bolt	NN	I-TEST	O
had	VBD	O	O
been	VBN	O	O
placed	VBN	O	O
by	IN	O	O
the	DT	O	O
neurosurgery	JJ	O	O
service	NN	O	O
staff	NN	O	O
during	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
laparotomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

intracranial	JJ	B-TEST	B-TEST
pressures	NNS	I-TEST	I-TEST
were	VBD	O	O
normal	JJ	O	O
.	.	O	O

that	DT	O	O
day	NN	O	O
,	,	O	O
cranial	JJ	B-TEST	B-TEST
computerized	JJ	I-TEST	I-TEST
tomography	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
and	CC	O	I-TEST
cervical	JJ	B-TEST	I-TEST
spine	NN	I-TEST	I-TEST
films	NNS	I-TEST	I-TEST
were	VBD	O	O
normal	JJ	O	O
.	.	O	O

an	DT	B-TEST	O
arch	NN	I-TEST	O
aortogram	NN	I-TEST	O
was	VBD	O	O
normal	JJ	O	O
.	.	O	O

over	IN	O	O
the	DT	O	O
ensuing	VBG	O	O
twenty-four	JJ	O	O
hours	NNS	O	O
,	,	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
infiltrates	NNS	I-PROBLEM	I-PROBLEM
on	IN	O	O
chest	JJS	B-TEST	B-TEST
x-ray	JJ	I-TEST	I-TEST
with	IN	O	O
poor	JJ	B-PROBLEM	B-PROBLEM
oxygenation	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
labile	JJ	B-PROBLEM	B-TEST
blood	NN	I-PROBLEM	I-TEST
pressure	NN	I-PROBLEM	I-TEST
requiring	VBG	O	I-TEST
pa	JJ	B-TREATMENT	I-TEST
line	NN	I-TREATMENT	I-TEST
guided	VBN	I-TREATMENT	I-TEST
fluid	NN	I-TREATMENT	I-TEST
and	CC	O	I-TEST
pressors	NNS	B-TREATMENT	I-TEST
developed	VBD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
requirement	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
total	JJ	B-PROBLEM	B-PROBLEM
body	NN	I-PROBLEM	I-PROBLEM
capillary	JJ	I-PROBLEM	I-PROBLEM
leak	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
decreasing	VBG	B-PROBLEM	O
svr	NN	I-PROBLEM	O
,	,	O	O
oliguria	RB	B-PROBLEM	B-PROBLEM
unresponsive	JJ	O	I-PROBLEM
to	TO	O	I-PROBLEM
lasix	VB	B-TREATMENT	I-PROBLEM
/	NNP	O	O
mannitol	NNP	B-TREATMENT	B-TREATMENT
accompanied	VBN	O	O
by	IN	O	O
a	DT	B-PROBLEM	O
rise	NN	I-PROBLEM	O
in	IN	O	O
creatinine	NN	B-TEST	B-TEST
to	TO	O	O
3.2	CD	O	O
,	,	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
ards	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
a	DT	B-PROBLEM	B-PROBLEM
rise	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
temperature	NN	B-TEST	I-PROBLEM
to	TO	O	O
103	CD	O	O
,	,	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
serum	JJ	I-TEST	I-TEST
amylase	NN	I-TEST	I-TEST
of	IN	O	O
1265	CD	O	O
.	.	O	O

three	CD	O	O
liters	NNS	O	O
of	IN	O	O
clear	JJ	B-PROBLEM	B-PROBLEM
green	JJ	I-PROBLEM	I-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
were	VBD	O	O
found	VBN	O	O
in	IN	O	O
the	DT	O	O
abdominal	JJ	O	O
cavity	NN	O	O
.	.	O	O

exploration	NN	B-TEST	B-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
pancreas	NNS	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
posterior	JJ	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
a	DT	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
superior	JJ	I-PROBLEM	I-PROBLEM
mesenteric	NN	I-PROBLEM	I-PROBLEM
vessels	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

because	IN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
intense	JJ	I-PROBLEM	I-PROBLEM
diffuse	NN	I-PROBLEM	I-PROBLEM
inflammatory	JJ	I-PROBLEM	I-PROBLEM
reaction	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
had	VBD	O	O
already	RB	O	O
set	VBN	O	O
in	IN	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
that	IN	O	O
neither	DT	O	B-TREATMENT
distal	JJ	B-TREATMENT	I-TREATMENT
pancreatic	JJ	I-TREATMENT	I-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT
nor	CC	O	O
roux-en-y	JJ	B-TREATMENT	B-TREATMENT
drainage	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
feasible	JJ	O	O
.	.	O	O

four	CD	B-TREATMENT	B-TREATMENT
large	JJ	I-TREATMENT	I-TREATMENT
flat	JJ	I-TREATMENT	I-TREATMENT
jackson-pratt	NN	I-TREATMENT	I-TREATMENT
drains	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
placed	VBN	O	O
,	,	O	O
and	CC	O	O
gastrostomy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
jejunostomy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
cholecystostomy	NN	B-TREATMENT	B-TREATMENT
tubes	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
subclavian	JJ	I-TREATMENT	I-TREATMENT
quinton	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
were	VBD	O	O
placed	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
&apos;s	NN	O	O
hemodynamics	NNS	O	O
had	VBD	O	O
improved	VBN	O	O
markedly	RB	O	O
with	IN	O	O
the	DT	B-TREATMENT	O
evacuation	NN	I-TREATMENT	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
peritoneal	JJ	I-PROBLEM	I-PROBLEM
pancreatic	JJ	I-PROBLEM	I-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
so	RB	O	O
that	IN	O	O
he	PRP	O	O
was	VBD	O	O
no	RB	O	O
longer	JJR	O	O
on	IN	O	O
pressors	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

however	RB	O	O
,	,	O	O
upon	IN	O	O
transfer	NN	O	O
from	IN	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
table	NN	O	O
to	TO	O	O
the	DT	O	O
ricu	NN	O	O
bed	NN	O	O
,	,	O	O
he	PRP	O	O
suffered	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
cardiac	JJ	I-PROBLEM	I-PROBLEM
arrest	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
upon	IN	O	O
investigation	NN	B-TEST	O
was	VBD	O	O
a	DT	B-PROBLEM	O
primary	JJ	I-PROBLEM	O
respiratory	NN	I-PROBLEM	O
arrest	NN	I-PROBLEM	O
;	:	O	O
the	DT	B-TEST	B-TEST
initial	JJ	I-TEST	I-TEST
arterial	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
gas	NN	I-TEST	I-TEST
was	VBD	O	O
32/88/6.92	CD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
successfully	RB	O	O
resuscitated	VBN	O	O
after	IN	O	O
fifteen	JJ	O	O
minutes	NNS	O	O
of	IN	O	O
cardiopulmonary	JJ	B-TREATMENT	B-TREATMENT
resuscitation	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
ricu	NN	O	O
.	.	O	O

continuous	JJ	B-TREATMENT	B-TREATMENT
venovenous	JJ	I-TREATMENT	I-TREATMENT
hemodialysis	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
july	NN	O	O
5	CD	O	O
,	,	O	O
and	CC	O	O
continued	VBN	O	O
for	IN	O	O
most	JJS	O	O
of	IN	O	O
the	DT	O	O
remainder	NN	O	O
of	IN	O	O
the	DT	O	O
patient	JJ	O	O
&apos;s	JJ	O	O
course	NN	O	O
.	.	O	O

vancomycin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
aztreonam	NNS	B-TREATMENT	B-TREATMENT
were	VBD	O	O
given	VBN	O	O
for	IN	O	O
gram	JJ	B-PROBLEM	O
negative	JJ	I-PROBLEM	O
coccobacilli	NN	I-PROBLEM	O
(	(	O	O
later	RB	O	O
identified	VBN	O	O
as	IN	O	O
bacteroides	NNS	B-PROBLEM	O
)	)	O	O
that	WDT	O	O
had	VBD	O	O
grown	VBN	O	O
in	IN	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
and	CC	O	O
gram	JJ	B-PROBLEM	O
negative	JJ	I-PROBLEM	O
rods	NNS	I-PROBLEM	O
(	(	I-PROBLEM	O
enterobacter	NN	I-PROBLEM	O
)	)	I-PROBLEM	O
in	IN	O	O
his	PRP$	B-TEST	O
peritoneal	NN	I-TEST	O
fluid	NN	I-TEST	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
kept	VBN	O	O
sedated	JJ	B-TREATMENT	O
and	CC	O	O
paralyzed	JJ	B-TREATMENT	O
because	IN	O	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
severe	JJ	I-PROBLEM	I-PROBLEM
adult	NN	I-PROBLEM	I-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	JJ	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

total	JJ	B-TREATMENT	B-TREATMENT
parenteral	JJ	I-TREATMENT	I-TREATMENT
nutrition	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
july	NN	O	O
5	CD	O	O
.	.	O	O

initial	JJ	O	O
improvement	NN	O	O
was	VBD	O	O
followed	VBN	O	O
by	IN	O	O
recurrence	NN	O	O
of	IN	O	O
low	JJ	B-PROBLEM	B-PROBLEM
svr	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
high	JJ	B-PROBLEM	B-PROBLEM
cardiac	NN	I-PROBLEM	I-PROBLEM
output	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
ongoing	VBG	B-PROBLEM	O
acidosis	NN	I-PROBLEM	B-PROBLEM
,	,	O	O
requiring	VBG	O	O
norepinephrine	JJ	B-TREATMENT	B-TREATMENT
infusion	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
the	DT	O	O
30	CD	O	O
to	TO	O	O
40	CD	O	O
mcg	NNS	O	O
per	IN	O	O
minute	NN	O	O
range	NN	O	O
;	:	O	O
drainage	NN	B-PROBLEM	B-TREATMENT
from	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
jackson-pratt	JJ	I-TREATMENT	I-TREATMENT
drains	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
minimal	JJ	O	O
despite	IN	O	O
irrigation	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
manipulation	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
returned	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
on	IN	O	O
july	NN	O	O
10	CD	O	O
,	,	O	O
where	WRB	O	O
several	JJ	B-PROBLEM	B-PROBLEM
loculated	VBD	I-PROBLEM	I-PROBLEM
thin	JJ	I-PROBLEM	I-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
collections	NNS	I-PROBLEM	I-PROBLEM
were	VBD	O	O
drained	VBN	O	O
and	CC	O	O
obviously	RB	B-PROBLEM	O
necrotic	JJ	I-PROBLEM	B-PROBLEM
tissue	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
debrided	VBN	O	O
.	.	O	O

it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
to	TO	O	O
place	VB	O	O
more	JJR	B-TREATMENT	B-TREATMENT
drains	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
pack	VB	O	O
the	DT	O	O
lesser	JJR	O	O
sac	NN	O	O
with	IN	O	O
adaptic	JJ	B-TREATMENT	B-PROBLEM
and	CC	O	O
laparotomy	JJ	B-TREATMENT	B-TREATMENT
pads	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
abdomen	NN	O	O
was	VBD	O	O
left	VBN	O	O
open	JJ	O	O
,	,	O	O
with	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
margins	NNS	I-PROBLEM	I-PROBLEM
connected	VBN	O	O
by	IN	O	O
a	DT	O	O
sheet	NN	O	O
of	IN	O	O
marlex	JJ	B-TREATMENT	B-TREATMENT
mesh	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
prevent	VB	O	O
evisceration	NN	B-PROBLEM	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
returned	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
on	IN	O	O
july	NN	O	O
12	CD	O	O
,	,	O	O
13	CD	O	O
,	,	O	O
16	CD	O	O
,	,	O	O
19	CD	O	O
,	,	O	O
21	CD	O	O
,	,	O	O
and	CC	O	O
23	CD	O	O
for	IN	O	O
packing	VBG	B-TREATMENT	O
change	NN	I-TREATMENT	O
,	,	O	O
irrigation	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
debridement	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

tracheostomy	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
also	RB	O	O
performed	VBN	O	O
on	IN	O	O
july	NN	O	O
17	CD	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
diffuse	NN	I-PROBLEM	I-PROBLEM
peritonitis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
intense	JJ	B-PROBLEM	B-PROBLEM
inflammation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
infection	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
patchy	JJ	B-PROBLEM	B-PROBLEM
necrosis	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
peritoneal	JJ	I-PROBLEM	I-PROBLEM
surfaces	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
of	IN	O	O
the	DT	O	B-PROBLEM
distal	JJ	O	I-PROBLEM
pancreas	NN	O	I-PROBLEM
.	.	O	O

the	DT	O	O
subsequent	JJ	O	O
overall	JJ	O	O
course	NN	O	O
was	VBD	O	O
a	DT	O	B-PROBLEM
slow	JJ	O	I-PROBLEM
downhill	NN	O	I-PROBLEM
one	CD	O	O
,	,	O	O
with	IN	O	O
ongoing	JJ	B-PROBLEM	B-PROBLEM
extreme	JJ	I-PROBLEM	I-PROBLEM
hyperdynamic	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
cardiac	JJ	B-TEST	B-TEST
output	NN	I-TEST	I-TEST
12	CD	O	O
to	TO	O	O
15	CD	O	O
liters	NNS	O	O
per	IN	O	O
minute	NN	O	O
)	)	O	O
and	CC	O	O
catabolic	JJ	B-PROBLEM	B-PROBLEM
state	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
july	NN	O	O
26	CD	O	O
,	,	O	O
abdominal	JJ	B-TREATMENT	B-TREATMENT
irrigation	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
debridement	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
performed	VBN	O	O
in	IN	O	O
the	DT	O	O
ricu	NN	O	O
;	:	O	O
this	DT	O	O
was	VBD	O	O
repeated	VBN	O	O
daily	RB	O	O
for	IN	O	O
the	DT	O	O
next	JJ	O	O
three	CD	O	O
days	NNS	O	O
.	.	O	O

on	IN	O	O
july	NN	O	O
29	CD	O	O
,	,	O	O
the	DT	B-PROBLEM	B-PROBLEM
septic	JJ	I-PROBLEM	I-PROBLEM
state	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
low	JJ	B-PROBLEM	B-PROBLEM
svr	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
acidosis	NN	B-PROBLEM	B-PROBLEM
accelerated	VBN	O	O
beyond	IN	O	O
the	DT	O	O
control	NN	O	O
of	IN	O	O
maximal	JJ	B-TREATMENT	B-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
gradually	RB	O	O
fell	VBD	O	O
,	,	O	O
and	CC	O	O
he	PRP	O	O
died	VBD	O	O
early	RB	O	O
on	IN	O	O
july	NN	O	O
30	CD	O	O
,	,	O	O
1993	CD	O	O
.	.	O	O

severe	JJ	B-PROBLEM	B-PROBLEM
blunt	NN	I-PROBLEM	I-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
trauma	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
rupture	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
liver	NN	I-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	O
left	VBD	I-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
vein	NN	I-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	O
pancreas	NNS	I-PROBLEM	B-PROBLEM
,	,	I-PROBLEM	O
and	CC	I-PROBLEM	O
transverse	JJ	I-PROBLEM	O
mesocolon	NN	I-PROBLEM	O
.	.	O	O

1.	CD	O	O
7-2-93	JJ	O	O
,	,	O	O
emergency	NN	O	O
room	NN	O	O
exploratory	NN	B-TEST	O
laparotomy	NN	I-TEST	B-TREATMENT
,	,	O	O
repair	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
liver	NN	B-PROBLEM	B-PROBLEM
laceration	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
repair	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
torn	JJ	B-PROBLEM	B-PROBLEM
transverse	NN	I-PROBLEM	I-PROBLEM
mesocolon	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
repair	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
serosal	JJ	B-PROBLEM	B-PROBLEM
tear	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
transverse	NN	I-PROBLEM	I-PROBLEM
colon	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
ligation	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
division	NN	B-TREATMENT	O
of	IN	O	O
ruptured	JJ	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
vein	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
exploration	NN	B-TEST	O
of	IN	I-TEST	O
pancreas	NNS	I-TEST	B-PROBLEM
,	,	O	O

2.	CD	O	O
7-4-93	JJ	O	O
,	,	O	O
exploratory	JJ	B-TEST	B-TEST
laparotomy	NN	I-TEST	I-TEST
,	,	O	O
irrigation	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
debridement	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
pancreatic	JJ	B-TREATMENT	B-TREATMENT
drainage	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
gastrostomy	NN	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
jejunostomy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
cholecystostomy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
placement	NN	B-TREATMENT	B-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
subclavian	JJ	I-TREATMENT	I-TREATMENT
quinton	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
,	,	O	O

3.	CD	O	O
7-10-93	JJ	O	O
,	,	O	O
abdominal	JJ	B-TREATMENT	B-TREATMENT
irrigation	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
debridement	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
packing	NN	B-TREATMENT	O
of	IN	I-TREATMENT	O
pancreas	NNS	I-TREATMENT	B-PROBLEM
,	,	O	O

4.	CD	O	O
7-12-93	JJ	O	O
,	,	O	O
7-14	JJ	O	O
,	,	O	O
7-20	JJ	O	O
,	,	O	O
7-22	JJ	O	O
,	,	O	O
and	CC	O	O
7-24	NNS	O	O
,	,	O	O
were	VBD	O	O
the	DT	O	O
same	JJ	O	O
as	IN	O	O
7-10-93	JJ	O	O
,	,	O	O
and	CC	O	O
7-17	NNP	O	O
was	VBD	O	O
the	DT	O	O
same	JJ	O	O
with	IN	O	O
the	DT	O	O
addition	NN	O	O
of	IN	O	O
tracheostomy	NN	B-TREATMENT	B-TREATMENT
were	VBD	O	O
same	JJ	O	O
as	IN	O	O
7-10	JJ	O	O
,	,	O	O

severe	JJ	B-PROBLEM	B-PROBLEM
necrotizing	VBG	I-PROBLEM	I-PROBLEM
pancreatitis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
diffuse	NN	B-PROBLEM	B-PROBLEM
peritonitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

sulfonamides	NNS	B-TREATMENT	B-PROBLEM
/	VBP	O	O
zithromax	CD	B-TREATMENT	B-TREATMENT
/	NNP	O	I-TREATMENT
floxin	NN	B-TREATMENT	I-TREATMENT
/	NN	O	O
penicillins	VBZ	B-TREATMENT	B-TREATMENT
/	JJ	O	O
neurontin	JJ	B-TREATMENT	B-TREATMENT
/	NN	O	I-TREATMENT
demerol	NN	B-TREATMENT	I-TREATMENT
/	NNP	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
/	NNP	O	O
ativan	NN	B-TREATMENT	B-TREATMENT

pyridium	NN	B-TREATMENT	B-TREATMENT
200	CD	O	O
mg	NN	O	O
po	NN	O	O
three	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
for	IN	O	O
uti	NN	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
x	VBP	O	O
2	CD	O	O
days	NNS	O	O
.	.	O	O

1)	CD	O	O
staph	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

sepsis	NN	B-PROBLEM	B-PROBLEM
related	VBN	O	O
to	TO	O	O
picc	VB	B-TREATMENT	B-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

2)	CD	O	O
previous	JJ	B-PROBLEM	B-PROBLEM
anoxic	NN	I-PROBLEM	I-PROBLEM

1)	CD	O	O
staph.	JJ	B-PROBLEM	O
sepsis	NN	I-PROBLEM	B-PROBLEM
related	VBN	O	O
to	TO	O	O
picc	VB	B-TREATMENT	B-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

2)	CD	O	O
previous	JJ	B-PROBLEM	B-PROBLEM
anoxicbrain	NN	I-PROBLEM	I-PROBLEM
damage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3)	CD	O	O
previous	JJ	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4)	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

5)	CD	O	O
status	NN	O	O
post	NN	O	O
cabg	NN	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
11/97	CD	O	O
.	.	O	O

6)	CD	O	O
paroxysmal	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

7)	CD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
chronic	JJ	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

positive	JJ	B-PROBLEM	O
blood	NN	I-PROBLEM	B-TEST
cultures	NNS	I-PROBLEM	I-TEST
with	IN	O	O
staph.	JJ	B-PROBLEM	B-TREATMENT
aureus	JJ	I-PROBLEM	I-TREATMENT
sensitiveto	NN	O	I-TREATMENT
methicillin	NN	B-TREATMENT	I-TREATMENT
.	.	O	O

hydralazine	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mgs	NN	O	O
po	NN	O	O
t.i.d.	NN	O	O
,	,	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
0.125	CD	O	O
mgs	NN	O	O
po	NN	O	O
q.d.	NN	O	O
,	,	O	O
thiamine	VB	B-TREATMENT	B-TREATMENT
100	CD	O	O
mgs	NN	O	O
po	NN	O	O
q.d.	NN	O	O
,	,	O	O
multi-vitamin	JJ	B-TREATMENT	B-TREATMENT
1	CD	O	O
tab.	NN	O	O
po	NN	O	O
q.d.	NN	O	O
,	,	O	O
peri	SYM	B-TREATMENT	B-TEST
-	:	I-TREATMENT	O
colace	NN	I-TREATMENT	B-TREATMENT
100	CD	O	O
mgs	NN	O	O
po	NN	O	O
t.i.d.	NN	O	O
,	,	O	O
folate	VBP	B-TREATMENT	B-TEST
1	CD	O	O
mg	NN	O	O
po	NN	O	O
q.d.	NN	O	O
,	,	O	O
norvasc	RB	B-TREATMENT	B-TEST
2.5	CD	O	O
mgs	NNS	O	O
po	JJ	O	O
q.hs	NN	O	O
,	,	O	O
ritalin	VBZ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mgs	NN	O	O
po	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
trazodone	NN	B-TREATMENT	B-TREATMENT
25	CD	O	O
mgs	NN	O	O
po	NN	O	O
q.hs	NN	O	O
,	,	O	O
nafcillin	RB	B-TREATMENT	O
2	CD	O	O
gramsiv	NN	O	O
q.4h	NN	O	O
which	WDT	O	O
wil	VBZ	O	O
conclude	NN	O	O
at	IN	O	O
the	DT	O	O
end	NN	O	O
of	IN	O	O
the	DT	O	O
day	NN	O	O
on	IN	O	O
1/16/98	CD	O	O
,	,	O	O
atroventnebulizer	NN	B-TREATMENT	O
prn	NN	O	O
,	,	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
nebulizer	NN	I-TREATMENT	I-TREATMENT
prn	NN	O	O
,	,	O	O
tylenol	VBZ	B-TREATMENT	B-TREATMENT
650	CD	O	O
mgs	NN	O	O
po	NN	O	O
q.4h	NN	O	O
prn	NN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

mr.	NN	O	O
gach	NN	O	O
is	VBZ	O	O
an	DT	O	O
80	CD	O	O
year	NN	O	O
old	JJ	O	O
man	NN	O	O
with	IN	O	O
aprevious	JJ	O	O
history	NN	O	O
of	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
who	WP	O	O
was	VBD	O	O
transferred	VBN	O	O
from	IN	O	O
linghs	JJ	O	O
county	NN	O	O
medical	JJ	O	O
center	NN	O	O
to	TO	O	O
oaksgekesser/	VB	O	O
memorial	JJ	O	O
hospital	NN	O	O
because	IN	O	O
of	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
apparent	JJ	I-PROBLEM	I-PROBLEM
infected	VBN	I-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
including	VBG	O	O
the	DT	B-TREATMENT	B-TREATMENT
picc	NN	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
his	PRP$	O	O
right	JJ	O	O
elbow	NN	O	O
and	CC	O	O
positive	JJ	B-PROBLEM	O
blood	NN	I-PROBLEM	B-TEST
cultures	NNS	I-PROBLEM	I-TEST
for	IN	O	O
staph.	JJ	B-PROBLEM	B-PROBLEM
aureus	NN	I-PROBLEM	I-PROBLEM
associated	VBN	O	O
with	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarctions	NNS	I-PROBLEM	I-PROBLEM
in	IN	O	O
1981	CD	O	O
,	,	O	O
1992	CD	O	O
and	CC	O	O
08/97	CD	O	O
with	IN	O	O
thelast	JJ	O	O
episode	NN	O	O
complicated	VBN	O	O
by	IN	O	O
anoxic	JJ	B-PROBLEM	B-PROBLEM
encephalopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
gradually	RB	O	O
improved	VBD	O	O
but	CC	O	O
had	VBD	O	O
recurrent	VBN	B-PROBLEM	B-PROBLEM
angina	RB	I-PROBLEM	I-PROBLEM
requiring	VBG	O	I-PROBLEM
cardiac	JJ	B-TEST	I-PROBLEM
catheterization	NN	I-TEST	I-PROBLEM
,	,	O	O
demonstrating	VBG	O	O
90%	CD	O	O
left	VBD	O	O
main	JJ	O	O
,	,	O	O
95%	CD	O	O
ostial	JJ	O	O
lad	NN	O	O
and	CC	O	O
30	CD	O	O
to	TO	O	O
40%	CD	O	O
mid-lad	NN	O	O
with	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
occluded	JJ	I-PROBLEM	I-PROBLEM
rca	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

cabg	NN	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
two	CD	B-TREATMENT	B-TREATMENT
vessel	JJ	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
done	VBN	O	O
on	IN	O	O
11/18/97	CD	O	O
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
picc	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
in	IN	O	O
his	PRP$	O	B-PROBLEM
left	JJ	O	I-PROBLEM
antecubital	JJ	O	I-PROBLEM
fossa	NN	O	I-PROBLEM
and	CC	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
new	JJ	O	O
years	NNS	O	O
eve	VBP	O	O
he	PRP	O	O
developed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
102	CD	O	O
and	CC	O	O
became	VBD	O	O
lethargic	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	O
picc	NN	I-TREATMENT	O
line	NN	I-TREATMENT	O
site	NN	I-TREATMENT	O
was	VBD	O	O
erythematous	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
grew	VBD	O	O
out	RP	O	O
4	CD	O	O
out	IN	O	O
of	IN	O	O
4	CD	O	O
bottles	NNS	O	O
for	IN	O	O
gram	NN	B-PROBLEM	B-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
cocci	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
thereafter	RB	O	O
proved	VBD	O	O
to	TO	O	O
be	VB	O	O
staph.	JJ	B-PROBLEM	B-PROBLEM
aureus	JJ	I-PROBLEM	I-PROBLEM
methicillin	NN	B-TREATMENT	I-PROBLEM
sensitive	NN	O	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
no	DT	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

includes	VBZ	O	O
ischemic	JJ	B-PROBLEM	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
done	VBN	O	O
on	IN	O	O
11/13/97	CD	O	O
showing	VBG	O	O
an	DT	B-TEST	B-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
28%	CD	O	O
and	CC	O	O
lv	JJR	O	O
that	DT	O	O
is	VBZ	O	O
diffusely	RB	B-PROBLEM	B-PROBLEM
hypokinetic	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

1)	CD	O	O
dementia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O

2)	CD	O	O
paroxysmal	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation,	NN	I-PROBLEM	I-PROBLEM

3)	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O

4)	CD	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
vascular	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
previous	JJ	B-TREATMENT	B-PROBLEM
left	JJ	I-TREATMENT	I-PROBLEM
femoral	JJ	I-TREATMENT	I-PROBLEM
popliteal	NN	I-TREATMENT	I-PROBLEM
bypass	NN	I-TREATMENT	I-PROBLEM
,	,	O	O

5)	CD	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O

6)	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
insufficiency,	NN	I-PROBLEM	I-PROBLEM

7)	CD	O	O
copd	NN	B-PROBLEM	O
,	,	O	O

8)	CD	O	O
previous	JJ	B-TREATMENT	B-PROBLEM
abdominal	JJ	I-TREATMENT	I-PROBLEM
aortic	JJ	I-TREATMENT	I-PROBLEM
aneurysm	NN	I-TREATMENT	I-PROBLEM
repair	NN	I-TREATMENT	I-PROBLEM
in	IN	O	O
1981	CD	O	O
,	,	O	O

9)	CD	O	B-PROBLEM
benign	JJ	B-PROBLEM	I-PROBLEM
prostatic	JJ	I-PROBLEM	I-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM
status	NN	O	O
post	NN	O	O
turp	NN	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
1982	CD	O	O
.	.	O	O

aspirin	RB	B-TREATMENT	B-TREATMENT
325	CD	O	O
mgs	NNS	O	O
po	JJ	O	O
q.d.	NN	O	O
,	,	O	O
prilosec	VBP	B-TREATMENT	B-TREATMENT
20	CD	O	O
mgs	NN	O	O
po	NN	O	O
q.d.	NN	O	O
,	,	O	O
azmacort	RB	B-TREATMENT	O
2	CD	O	O
puffs	NNS	O	O
q.i.d.	JJ	O	O
prn	NN	O	O
,	,	O	O
atrovent	JJ	B-TREATMENT	B-TREATMENT
2	CD	O	O
puffs	NNS	O	O
q.i.d.	JJ	O	O
prn	NN	O	O
,	,	O	O
heparin	VBZ	B-TREATMENT	B-TREATMENT
5,000	CD	O	O
units	NNS	O	O
subcu.	JJ	O	O
b.i.d.	NN	O	O
,	,	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
0.125	CD	O	O
mgs	NN	O	O
po	NN	O	O
q.d.	NN	O	O
,	,	O	O
wellbutrin	WP	B-TREATMENT	B-TREATMENT
37.5	CD	O	O
mgs	NN	O	O
po	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
kaopectate	VB	B-TREATMENT	O
prn	NN	O	O
,	,	O	O
betoptic	JJ	B-TREATMENT	O
0.25%	CD	O	O
ou	JJ	O	O
q.d.	NN	O	O
,	,	O	O
ritalin	VBZ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mgs	NN	O	O
po	NN	O	O
q.a.m.	NN	O	O
and	CC	O	O
at	IN	O	O
noon	JJ	O	O
time	NN	O	O
,	,	O	O
norvasc	RB	B-TREATMENT	B-TEST
2.5	CD	O	O
mgs	NNS	O	O
po	JJ	O	O
q.d.	NN	O	O

the	DT	O	O
patient	NN	O	O
reported	VBD	O	O
disorientation	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
ambien	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
halcyon	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

no	DT	O	O
other	JJ	B-PROBLEM	B-PROBLEM
medical	JJ	I-PROBLEM	I-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
other	JJ	O	O
than	IN	O	O
stated	VBN	O	O
above	IN	O	O
.	.	O	O

elderly	JJ	O	O
white	JJ	O	O
male	NN	O	O
who	WP	O	O
was	VBD	O	O
somnolent	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
looking	VBG	O	O
his	PRP$	O	O
stated	JJ	O	O
age	NN	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
was	VBD	O	O
97.5	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
90	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
20	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
104/60	CD	O	O
,	,	O	O
o2	PRP	B-TEST	O
sat.	VBD	I-TEST	O
97%.	CD	O	O

eyes	NNS	O	O
-	:	O	O
pupils	NNS	O	O
equal	JJ	O	O
,	,	O	O
round	NN	O	O
,	,	O	O
reactive	JJ	O	O
to	TO	O	O
light	JJ	O	O
,	,	O	O
sclera	JJ	O	B-PROBLEM
non-icteric	JJ	B-PROBLEM	I-PROBLEM
.	.	O	O

neck	SYM	O	B-TEST
-	:	O	O
supple	NN	O	O
without	IN	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
thyromegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

lungs	NNS	O	O
-	:	O	O
clear	JJ	O	O
to	TO	O	O
percussion	NN	B-TEST	B-TEST
and	CC	O	O
auscultation	NN	B-TEST	B-TEST
on	IN	O	O
both	DT	O	O
sides	NNS	O	O
.	.	O	O

cardiovascular	JJ	O	B-TEST
examination	NN	O	I-TEST
-	:	O	O
normal	JJ	O	O
jugular	JJ	O	O
venous	JJ	O	B-TEST
pressure	NN	O	I-TEST
,	,	O	O
normal	JJ	O	O
carotid	NN	O	O
upstrokes	NNS	O	O
with	IN	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
there	EX	O	O
are	VBP	O	O
distant	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
sounds	VBZ	I-PROBLEM	I-PROBLEM
,	,	O	O
s1	NN	O	O
and	CC	O	O
s2	NN	O	O
are	VBP	O	O
normal	JJ	O	O
,	,	O	O
there	EX	O	O
are	VBP	O	O
no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM
detected	VBD	O	I-PROBLEM
.	.	O	O

abdomen	NNS	O	O
-	:	O	O
soft	JJ	O	O
,	,	O	O
non-tender	JJ	B-PROBLEM	B-PROBLEM
without	IN	O	O
organomegaly	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

extremities	NNS	O	O
-	:	O	O
without	IN	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

neurologic	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
-	:	O	O
somnolent	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
awake	NN	O	O
,	,	O	O
arousable	JJ	O	O
to	TO	O	O
commands	NNS	O	O
,	,	O	O
though	IN	O	O
he	PRP	O	O
falls	VBZ	O	O
asleep	RB	O	O
rapidly	RB	O	O
.	.	O	O

deep	JJ	B-TEST	B-TEST
tendon	NN	I-TEST	I-TEST
reflexes	NNS	I-TEST	I-TEST
are	VBP	O	O
2+	CD	O	O
and	CC	O	O
symmetric	JJ	O	O
,	,	O	O
toes	NNS	O	O
were	VBD	O	O
up	RB	B-PROBLEM	O
going	VBG	I-PROBLEM	O
bilaterally	RB	I-PROBLEM	O
.	.	O	O

sodium	NN	B-TEST	B-TEST
131	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.5	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
45	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
2.0	CD	O	O
,	,	O	O
glucose	RB	B-TEST	B-TEST
134	CD	O	O
,	,	O	O
bilirubin	VBD	B-TEST	B-TEST
0.4.	CD	O	O
blood	NN	B-TEST	B-TEST
gas	NN	I-TEST	I-TEST
on	IN	O	O
5	CD	B-TREATMENT	B-TREATMENT
liters	NNS	I-TREATMENT	I-TREATMENT
nasal	JJ	I-TREATMENT	I-TREATMENT
o2	SYM	I-TREATMENT	I-TREATMENT
-	:	O	I-TREATMENT
po2	NN	B-TEST	I-TREATMENT
106	CD	O	O
,	,	O	O
pco227	NN	B-TEST	O
,	,	O	O
ph	JJ	B-TEST	O
7.41	CD	O	O
.	.	O	O

blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
were	VBD	O	O
obtained	VBN	O	O
,	,	O	O
urine	JJ	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
were	VBD	O	O
obtained	VBN	O	O
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	JJ	I-TEST	I-TEST
-	:	O	O
low	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
volumes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
bibasilar	JJ	B-PROBLEM	B-PROBLEM
opacities	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
heart	NN	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

ekg	SYM	B-TEST	B-TEST
-	:	O	O
technically	RB	O	O
poor	JJ	O	O
tracing	VBG	O	O
with	IN	O	O
what	WP	O	O
appears	VBZ	O	O
to	TO	O	O
be	VB	O	O
normal	JJ	O	O
sinus	NNS	O	O
rhythm	VBP	O	O
with	IN	O	O
very	RB	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
p	NN	I-PROBLEM	I-PROBLEM
waves	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
there	EX	O	O
are	VBP	O	O
q-waves	NNS	B-PROBLEM	O
in	IN	I-PROBLEM	O
leads	NNS	I-PROBLEM	O
v1	NNS	I-PROBLEM	O
and	CC	I-PROBLEM	O
v2	NN	I-PROBLEM	O
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
in	IN	O	O
v3	NN	O	O
.	.	O	O

there	EX	O	O
are	VBP	O	O
non-specific	JJ	B-PROBLEM	B-PROBLEM
st	JJ	I-PROBLEM	I-PROBLEM
t	NN	I-PROBLEM	I-PROBLEM
wave	VBP	I-PROBLEM	I-PROBLEM
changes.	NN	I-PROBLEM	I-PROBLEM

the	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
at	IN	O	O
linghs	NNS	O	O
county	RB	O	O
medical	JJ	O	O
center	NN	O	O
grew	VBD	O	O
out	RP	O	O
staph.	JJ	B-PROBLEM	B-PROBLEM
aureus	RB	I-PROBLEM	I-PROBLEM
sensitive	JJ	O	I-PROBLEM
to	TO	O	I-PROBLEM
methicillin	VB	B-TREATMENT	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
obtained	VBD	O	O
a	DT	O	O
oaksgekesser/	JJ	O	O
memorial	JJ	O	O
hospital	NN	O	O
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
obtained	VBN	O	O
at	IN	O	O
oaksgekesser/	JJ	O	O
memorial	JJ	O	O
hospital	NN	O	O
obtained	VBD	O	O
as	IN	O	O
a	DT	B-TEST	B-TEST
transthoracic	NN	I-TEST	I-TEST
echocardiogram	NN	I-TEST	I-TEST
showed	VBD	O	O
an	DT	B-TEST	B-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
33%	CD	O	O
,	,	O	O
wall	NN	B-TEST	O
thickness	NN	I-TEST	O
12	CD	O	O
mms	NN	O	O
at	IN	O	O
the	DT	O	O
septum	NN	O	O
,	,	O	O
posterior	VBP	B-TEST	O
wall	NN	I-TEST	O
11	CD	O	O
mms.	NN	O	O
,	,	O	O
left	VBD	B-TEST	B-TEST
atrial	JJ	I-TEST	I-TEST
size	NN	I-TEST	I-TEST
40	CD	O	O
mms	NN	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
anteroseptal	JJ	B-PROBLEM	O
hypokinesis	NN	I-PROBLEM	O
with	IN	O	O
mid	NN	B-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
apical	JJ	I-PROBLEM	I-PROBLEM
akinesis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

a	DT	B-TEST	B-TEST
lumbar	NN	I-TEST	I-TEST
puncture	NN	I-TEST	I-TEST
was	VBD	O	O
obtained	VBN	O	O
which	WDT	O	O
showed	VBD	O	O
normal	JJ	O	O
pressure	NN	O	O
and	CC	O	O
no	DT	O	O
cells	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
csf	JJ	I-TEST	I-TEST
culture	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
stool	NN	I-TEST	I-TEST
assay	NN	I-TEST	I-TEST
was	VBD	O	O
taken	VBN	O	O
for	IN	O	O
clostridium	NN	B-PROBLEM	B-PROBLEM
difficile	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
gradually	RB	O	O
improved	VBN	O	O
on	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
current	JJ	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
was	VBD	O	O
quite	RB	O	O
awake	JJ	O	O
and	CC	O	O
alert	JJ	O	O
,	,	O	O
though	IN	O	O
still	RB	O	O
appeared	VBN	O	O
to	TO	O	O
have	VB	O	O
some	DT	O	O
evidence	NN	O	O
of	IN	O	O
dementia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
disorientation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
encouraged	VBN	O	O
to	TO	O	O
eat	VB	O	O
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
not	RB	O	O
to	TO	O	O
place	VB	O	O
either	RB	O	O
a	DT	B-TREATMENT	B-TREATMENT
feeding	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
or	CC	O	O
to	TO	O	O
start	VB	O	O
tpn	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
still	RB	O	O
needs	VBZ	O	O
much	JJ	B-TREATMENT	O
intensive	JJ	I-TREATMENT	O
rehabilitation	NN	I-TREATMENT	O
,	,	O	O
encouragement	NN	O	O
to	TO	O	O
eat	VB	O	O
and	CC	O	O
encouragement	VB	O	O
to	TO	O	O
get	VB	O	O
out	IN	O	O
of	IN	O	O
bed	NN	O	O
to	TO	O	O
use	VB	O	O
the	DT	O	O
bathroom	NN	O	O
rather	RB	O	O
than	IN	O	O
abed	VB	B-TREATMENT	O
pain	NN	I-TREATMENT	B-PROBLEM
or	CC	O	O
a	DT	B-TREATMENT	B-TREATMENT
diaper	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
being	VBG	O	O
transferred	VBN	O	O
to	TO	O	O
linghs	VB	O	O
county	RB	O	O
medical	JJ	O	O
center	NN	O	O
for	IN	O	O
further	JJ	B-TREATMENT	B-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

briefly	NN	O	O
,	,	O	O
this	DT	O	O
68	CD	O	O
year	NN	O	O
old	JJ	O	O
male	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
diabetes	VBZ	B-PROBLEM	B-PROBLEM
mellitus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
vascular	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
was	VBD	O	O
admitted	VBN	O	O
originally	RB	O	O
to	TO	O	O
the	DT	O	O
podiatry	NN	O	O
service	NN	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
patellar	JJ	I-PROBLEM	I-PROBLEM
mid-foot	JJ	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
underwent	JJ	O	O
angiogram	NN	B-TEST	B-TEST
on	IN	O	O
2013-08-28	JJ	O	O
,	,	O	O
to	TO	O	O
evaluate	VB	O	O
his	PRP$	O	O
circulation	NN	O	O
and	CC	O	O
found	VBN	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
poor	JJ	I-PROBLEM	I-PROBLEM
circulation	NN	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
leg	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
vascular	JJ	O	O
surgery	NN	O	O
service	NN	O	O
for	IN	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
iliac	JJ	I-TREATMENT	I-TREATMENT
stenting	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
that	DT	O	O
time	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
was	VBD	O	O
followed	VBN	O	O
by	IN	O	O
cardiology	NN	O	O
and	CC	O	O
for	IN	O	O
preoperative	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
had	VBD	O	O
a	DT	B-TEST	B-TEST
stress	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
which	WDT	O	O
was	VBD	O	O
positive	JJ	B-PROBLEM	O
and	CC	O	O
he	PRP	O	O
became	VBD	O	O
diaphoretic	JJ	B-PROBLEM	B-PROBLEM
but	CC	O	O
denied	VBD	O	O
any	DT	B-PROBLEM	B-PROBLEM
chest	JJS	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

atropine	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
given	VBN	O	O
and	CC	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
returned	VBD	O	O
to	TO	O	O
the	DT	O	O
70s	CD	O	O
and	CC	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
returned	VBD	O	O
to	TO	O	O
the	DT	O	O
120s	CD	O	O
over	IN	O	O
80s	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
denied	VBD	O	O
any	DT	O	B-PROBLEM
orthopnea	NN	B-PROBLEM	I-PROBLEM
,	,	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
paroxysmal	JJ	B-PROBLEM	B-PROBLEM
nocturnal	JJ	I-PROBLEM	I-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
cough	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
occasional	JJ	B-PROBLEM	B-PROBLEM
leg	NN	I-PROBLEM	I-PROBLEM
swelling	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1	CD	O	O
.	.	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
status	NN	O	O
post	NN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
2006	CD	O	O
and	CC	O	O
1997	CD	O	O
and	CC	O	O
status	NN	O	B-TREATMENT
post	NN	O	I-TREATMENT
percutaneous	JJ	B-TREATMENT	I-TREATMENT
transluminal	JJ	I-TREATMENT	I-TREATMENT
coronary	NN	I-TREATMENT	I-TREATMENT
angioplasty	JJ	I-TREATMENT	I-TREATMENT
times	NNS	O	O
two	CD	O	O
.	.	O	O

2.	CD	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	VBP	I-PROBLEM	I-PROBLEM
type	NN	I-PROBLEM	I-PROBLEM
2	CD	I-PROBLEM	I-PROBLEM
since	IN	O	O
age	NN	O	O
25	CD	O	O
;	:	O	O
now	RB	O	O
currently	RB	O	O
on	IN	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
which	WDT	O	O
is	VBZ	O	O
complicated	VBN	O	O
by	IN	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
neuropathy	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
nephropathy	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
charcot	NN	B-PROBLEM	B-TEST
's	POS	I-PROBLEM	I-TEST
foot	NN	I-PROBLEM	I-TEST
.	.	O	O

3.	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
vascular	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
status	NN	O	O
post	NN	O	O
left	VBD	B-TREATMENT	B-TREATMENT
iliac	JJ	I-TREATMENT	I-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
and	CC	O	I-TREATMENT
right	JJ	B-TREATMENT	I-TREATMENT
femoral	JJ	I-TREATMENT	I-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

5.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

6.	CD	O	O
high	JJ	B-PROBLEM	B-PROBLEM
cholesterol	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

7.	CD	O	O
question	NN	O	O
of	IN	O	O
tendonitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1.	CD	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
70/30	CD	O	O
,	,	O	O
40	CD	O	O
units	NNS	O	O
q.	JJ	O	O
a.m.	RB	O	O
and	CC	O	O
40	CD	O	O
units	NNS	O	O
q.	CD	O	O
p.m.	NN	O	O

2.	CD	O	O
diovan	NN	B-TREATMENT	B-TREATMENT
160	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

3.	CD	O	O
nortriptyline	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	VBD	O	O
h.s.	NN	O	O

4.	CD	O	O
norvasc	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

5.	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

6.	CD	O	O
hydrochlorothiazide	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
15	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
;	:	O	O
his	PRP$	B-TEST	B-TEST
vital	JJ	I-TEST	I-TEST
signs	NNS	I-TEST	I-TEST
were	VBD	O	O
stable	JJ	O	O
.	.	O	O

his	PRP$	O	O
neck	NN	O	O
was	VBD	O	O
supple	RB	O	O
;	:	O	O
he	PRP	O	O
had	VBD	O	O
no	DT	O	O
jugular	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
distention	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	O	B-TEST
carotids	NNS	O	I-TEST
were	VBD	O	O
two	CD	O	O
plus	CC	O	O
bilaterally	RB	O	O
without	IN	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

his	PRP$	O	O
heart	NN	O	O
was	VBD	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
with	IN	O	O
no	DT	O	O
murmurs	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
rubs	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
gallops	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

his	PRP$	O	O
abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
femoral	JJ	I-PROBLEM	I-PROBLEM
bruits	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
he	PRP	O	O
had	VBD	O	O
one	CD	B-TEST	O
plus	CC	I-TEST	O
popliteal	JJ	I-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
.	.	O	O

his	PRP$	B-TEST	B-TEST
pedal	NN	I-TEST	I-TEST
pulses	NNS	I-TEST	I-TEST
are	VBP	O	O
absent	JJ	B-PROBLEM	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
bun	NN	I-TEST	I-TEST
was	VBD	O	O
13	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
1.7	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
43	CD	O	O
and	CC	O	O
the	DT	B-TEST	B-TEST
cholesterol	NN	I-TEST	I-TEST
was	VBD	O	O
208	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
admitted	VBN	O	O
to	TO	O	O
this	DT	O	O
hospital	NN	O	O
through	IN	O	O
the	DT	O	O
podiatry	NN	O	O
service	NN	O	O
;	:	O	O
however	RB	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
stress	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
showed	VBD	O	O
multi-vessel	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

podiatry	NN	O	O
continued	VBD	O	O
to	TO	O	O
follow	VB	O	O
for	IN	O	O
evaluation	NN	B-TEST	B-TEST
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
foot	NN	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
having	VBG	O	O
acetic	JJ	B-TREATMENT	B-PROBLEM
acid	JJ	I-TREATMENT	I-PROBLEM
wet-to-dry	JJ	I-TREATMENT	I-PROBLEM
dressing	NN	I-TREATMENT	I-PROBLEM
changes	NNS	I-TREATMENT	I-PROBLEM
,	,	O	O
0.25%	CD	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

vascular	JJ	O	O
surgery	NN	O	O
was	VBD	O	O
following	VBG	O	O
at	IN	O	O
the	DT	O	O
same	JJ	O	O
time	NN	O	O
and	CC	O	O
decided	VBD	O	O
that	IN	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
iliac	NN	I-TREATMENT	I-TREATMENT
stenting	NN	I-TREATMENT	I-TREATMENT
would	MD	O	O
be	VB	O	O
the	DT	B-TREATMENT	O
most	RBS	I-TREATMENT	O
optimum	JJ	I-TREATMENT	O
treatment	NN	I-TREATMENT	O
currently	RB	O	O
and	CC	O	O
suggested	VBD	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
should	MD	O	O
be	VB	O	O
worked	VBN	O	O
up	RP	O	O
for	IN	O	O
cardiac	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
prior	RB	O	O
to	TO	O	O
re-vascularization	NN	B-TREATMENT	O
.	.	O	O

medicine	NN	O	O
was	VBD	O	O
also	RB	O	O
consulted	VBN	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
for	IN	O	O
high	JJ	B-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
pressure	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
for	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
biceps	NNS	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

while	IN	O	O
having	VBG	O	O
angiography	NN	B-TEST	B-TEST
,	,	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
transient	JJ	I-PROBLEM	I-PROBLEM
increase	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
and	CC	O	O
became	VBD	O	O
diaphoretic	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
thus	RB	O	O
precipitated	VBD	O	O
the	DT	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
for	IN	O	O
cardiac	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
managed	VBN	O	O
on	IN	O	O
the	DT	O	O
medical	JJ	O	O
service	NN	O	O
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
drop	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
blood	NN	B-TEST	I-PROBLEM
pressure	NN	I-TEST	I-PROBLEM
and	CC	O	O
cardiac	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
.	.	O	O

he	PRP	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	B-TEST
cardiac	JJ	O	I-TEST
catheterization	NN	O	I-TEST
laboratory	NN	O	I-TEST
which	WDT	O	O
showed	VBD	O	O
multi-vessel	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
cardiothoracic	NN	O	B-TREATMENT
surgery	NN	O	I-TREATMENT
was	VBD	O	O
consulted	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
on	IN	O	O
2013-09-04	JJ	O	O
,	,	O	O
where	WRB	O	O
a	DT	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
times	NNS	O	O
four	CD	O	O
was	VBD	O	O
performed	VBN	O	O
,	,	O	O
left	VBD	B-TREATMENT	O
internal	JJ	I-TREATMENT	O
mammary	JJ	I-TREATMENT	O
artery	NN	I-TREATMENT	O
to	TO	I-TREATMENT	O
left	VB	I-TREATMENT	O
anterior	JJ	I-TREATMENT	O
descending	NN	I-TREATMENT	O
,	,	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	O
diagonal	VB	I-TREATMENT	O
,	,	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	O
obtuse	VB	I-TREATMENT	O
marginal	JJ	I-TREATMENT	O
and	CC	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	O
pc	VB	I-TREATMENT	O
by	IN	O	O
dr.	JJ	O	O
wright	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
slowly	RB	O	O
weaned	VBN	O	O
from	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
ventilator	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
be	VB	O	O
extubated	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
be	VB	O	O
weaned	VBN	O	O
to	TO	O	O
six	CD	B-TREATMENT	B-TREATMENT
liters	NNS	I-TREATMENT	I-TREATMENT
nasal	JJ	I-TREATMENT	I-TREATMENT
cannula	NN	I-TREATMENT	I-TREATMENT
after	IN	O	O
extubation	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
however	RB	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
on	IN	O	O
chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
that	IN	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
apical	JJ	I-PROBLEM	I-PROBLEM
pneumothorax	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
chest	NN	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
showed	VBD	O	O
resolution	NN	O	O
of	IN	O	O
that	DT	B-PROBLEM	B-PROBLEM
pneumothorax	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
mellitus	VBP	I-PROBLEM	I-PROBLEM
but	CC	O	O
continued	VBD	O	O
to	TO	O	O
improve	VB	O	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
chest	JJS	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
in	IN	O	O
place	NN	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-TREATMENT
high	JJ	I-PROBLEM	I-TREATMENT
chest	NN	I-PROBLEM	I-TREATMENT
tube	NN	I-PROBLEM	I-TREATMENT
output	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
foley	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
removed	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
.	.	O	O

physical	JJ	O	B-TREATMENT
therapy	NN	O	I-TREATMENT
was	VBD	O	O
consulted	VBN	O	O
in	IN	O	O
order	NN	O	O
to	TO	O	O
assess	VB	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
ambulation	NN	O	O
and	CC	O	O
mobility	NN	O	O
,	,	O	O
however	RB	O	O
,	,	O	O
with	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
foot	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
associated	VBN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
it	PRP	O	O
was	VBD	O	O
difficult	JJ	O	O
to	TO	O	O
assess	VB	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
.	.	O	O

after	IN	O	O
arriving	VBG	O	O
on	IN	O	O
the	DT	O	O
floor	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
an	DT	O	O
episode	NN	O	O
of	IN	O	O
rapid	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
resolved	VBD	O	O
,	,	O	O
however	RB	O	O
,	,	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
also	RB	O	O
given	VBN	O	O
due	JJ	O	O
to	TO	O	O
some	DT	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
oxygen	NN	I-PROBLEM	I-PROBLEM
need	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
episodes	NNS	O	O
of	IN	O	O
rapid	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
while	IN	O	O
on	IN	O	O
the	DT	O	O
floor	NN	O	O
,	,	O	O
which	WDT	O	O
required	VBD	O	O
continued	JJ	O	B-TREATMENT
diuresis	NN	B-TREATMENT	I-TREATMENT
as	RB	O	O
well	RB	O	O
as	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
lopressor	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
chest	JJS	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
foley	NN	B-TREATMENT	B-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
were	VBD	O	O
removed	VBN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
three	CD	O	O
,	,	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
aggressive	JJ	B-TREATMENT	B-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
physical	JJ	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
nebulizer	NN	B-TREATMENT	B-TREATMENT
treatments	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
dressing	NN	I-TREATMENT	I-TREATMENT
changes	NNS	I-TREATMENT	I-TREATMENT
for	IN	I-TREATMENT	O
his	PRP$	I-TREATMENT	B-PROBLEM
foot	NN	I-TREATMENT	I-PROBLEM
continued	VBD	O	O
per	IN	O	O
the	DT	O	O
podiatry	NN	O	O
service	NN	O	O
and	CC	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
leg	NN	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
slowly	RB	O	O
healing	VBG	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
multiple	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
rapid	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
again	RB	O	O
required	VBD	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
lopressor	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

amiodarone	NN	B-TREATMENT	B-TREATMENT
boluses	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
given	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
400	CD	O	O
three	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
of	IN	O	O
p.o.	NN	B-TREATMENT	O
amiodarone	NN	I-TREATMENT	B-TREATMENT
,	,	O	O
aggressive	JJ	B-TREATMENT	B-PROBLEM
pulmonary	JJ	I-TREATMENT	I-PROBLEM
toilet	NN	I-TREATMENT	I-PROBLEM
and	CC	O	O
continued	JJ	B-TREATMENT	B-TREATMENT
diuresis	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
done	VBN	O	O
,	,	O	O
however	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
difficulties	NNS	I-PROBLEM	I-PROBLEM
when	WRB	O	I-PROBLEM
in	IN	O	I-PROBLEM
rapid	JJ	B-PROBLEM	I-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
evaluated	VBN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
five	CD	O	O
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
should	MD	O	O
be	VB	O	O
transferred	VBN	O	O
back	RB	O	O
to	TO	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
respiratory	JJ	B-PROBLEM	B-PROBLEM
difficulties	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
back	RB	O	O
to	TO	O	O
the	DT	O	O
surgical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
where	WRB	O	O
he	PRP	O	O
was	VBD	O	O
aggressively	RB	O	O
diuresed	VBN	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
his	PRP$	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
was	VBD	O	O
controlled	VBN	O	O
and	CC	O	O
chest	JJS	B-TREATMENT	B-TREATMENT
physical	JJ	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
nebulizer	NN	B-TREATMENT	B-TREATMENT
treatments	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
done	VBN	O	O
.	.	O	O

also	RB	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
rise	VB	O	O
to	TO	O	O
32.0	CD	O	O
;	:	O	O
this	DT	O	O
was	VBD	O	O
most	RBS	O	O
likely	JJ	O	O
due	JJ	O	O
to	TO	O	O
a	DT	B-PROBLEM	B-PROBLEM
secondary	JJ	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	O
his	PRP$	I-PROBLEM	O
foot	NN	I-PROBLEM	O
and	CC	O	O
zosyn	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
started	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
do	VB	O	O
well	RB	O	O
and	CC	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
recurrent	NN	I-PROBLEM	I-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
slowly	RB	O	O
improved	VBN	O	O
;	:	O	O
p.o.	JJ	O	O
doses	NNS	O	O
of	IN	O	O
lopressor	JJ	B-TREATMENT	O
slowly	RB	O	O
increased	VBN	O	O
to	TO	O	O
get	VB	O	O
better	JJR	O	O
control	NN	O	O
of	IN	O	O
his	PRP$	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
be	VB	O	O
controlled	VBN	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
in	IN	O	O
the	DT	O	O
50s	CD	O	O
to	TO	O	O
60s	CD	O	O
with	IN	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

following	VBG	O	O
initiation	NN	O	O
of	IN	O	O
his	PRP$	B-TREATMENT	O
zosyn	NN	I-TREATMENT	B-TREATMENT
,	,	O	O
the	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
continued	VBD	O	O
to	TO	O	O
improve	VB	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
planned	VBN	O	O
for	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
picc	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
long-term	JJ	B-TREATMENT	B-TREATMENT
intravenous	JJ	I-TREATMENT	I-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
with	IN	O	O
good	JJ	O	O
control	NN	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
50s	CD	O	O
to	TO	O	O
60s	CD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
also	RB	O	O
started	VBN	O	O
on	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
preoperative	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
of	IN	O	O
amlodipine	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
losartan	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
improvement	NN	O	O
of	IN	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
also	RB	O	O
reduced	VBN	O	O
to	TO	O	O
400	CD	O	O
mg	NNS	O	O
q.	JJ	O	O
day	NN	O	O
of	IN	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

pulmonary	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
at	IN	O	O
this	DT	O	O
time	NN	O	O
for	IN	O	O
this	DT	B-PROBLEM	O
difficulty	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
diuresis	NN	I-PROBLEM	B-TREATMENT
and	CC	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

they	PRP	O	O
continued	VBD	O	O
to	TO	O	O
agree	VB	O	O
with	IN	O	O
the	DT	O	B-TREATMENT
management	NN	O	I-TREATMENT
of	IN	O	O
the	DT	O	O
patient	NN	O	O
and	CC	O	O
with	IN	O	O
aggressive	JJ	B-TREATMENT	B-PROBLEM
pulmonary	JJ	I-TREATMENT	I-PROBLEM
toilet	NN	I-TREATMENT	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
diuresis	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
nebulizer	JJ	B-TREATMENT	B-TREATMENT
treatment	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

pulmonary	JJ	B-TREATMENT	O
toilet	NN	I-TREATMENT	O
and	CC	O	O
aggressive	JJ	B-TREATMENT	B-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
physical	JJ	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
continued	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
be	VB	O	O
weaned	VBN	O	O
from	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
oxygen	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

furthermore	RB	O	O
,	,	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
foley	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
removed	VBN	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
anti-coagulation	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
his	PRP$	O	B-PROBLEM
episodes	NNS	O	I-PROBLEM
of	IN	O	I-PROBLEM
atrial	JJ	B-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
been	VBN	O	O
started	VBN	O	O
on	IN	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
in	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
and	CC	O	O
that	DT	O	O
was	VBD	O	O
continued	VBN	O	O
.	.	O	O

coumadin	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
then	RB	O	O
begun	VBN	O	O
with	IN	O	O
a	DT	B-TEST	O
goal	NN	I-TEST	O
inr	NN	I-TEST	O
of	IN	O	O
2.0	CD	O	O
to	TO	O	O
3.0	CD	O	O
.	.	O	O

podiatry	NN	O	O
and	CC	O	O
vascular	JJ	O	B-TREATMENT
surgery	NN	O	I-TREATMENT
were	VBD	O	O
reconsulted	VBN	O	O
to	TO	O	O
assess	VB	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
needs	NNS	O	O
for	IN	O	O
revascularization	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
foot	NN	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
could	MD	O	O
be	VB	O	O
discharged	VBN	O	O
in	IN	O	O
follow-up	JJ	O	O
with	IN	O	O
vascular	JJ	O	B-TREATMENT
surgery	NN	O	I-TREATMENT
for	IN	O	O
revascularization	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
podiatry	NN	O	O
thereafter	RB	O	O
.	.	O	O

on	IN	O	O
2013-08-28	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
picc	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
placed	VBN	O	O
for	IN	O	O
a	DT	O	B-TREATMENT
six	CD	O	I-TREATMENT
week	NN	O	I-TREATMENT
course	NN	O	I-TREATMENT
of	IN	O	I-TREATMENT
intravenous	JJ	B-TREATMENT	I-TREATMENT
zosyn	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
foot	NN	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
also	RB	O	O
continued	VBN	O	O
.	.	O	O

1.	CD	O	O
regular	JJ	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

2.	CD	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
7.5	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
for	IN	O	O
an	DT	B-TEST	B-TEST
inr	JJ	I-TEST	I-TEST
goal	NN	I-TEST	I-TEST
of	IN	O	O
2.0	CD	O	O
to	TO	O	O
3.0	CD	O	O
and	CC	O	O
adjust	VBP	O	O
the	DT	O	O
dose	NN	O	O
accordingly	RB	O	O
.	.	O	O

3.	CD	O	O
acetic	JJ	B-TREATMENT	B-PROBLEM
acid	RB	I-TREATMENT	I-PROBLEM
0.25%	CD	O	I-PROBLEM
wet-to-dry	JJ	B-TREATMENT	I-PROBLEM
dressing	NN	I-TREATMENT	I-PROBLEM
changes	NNS	I-TREATMENT	I-PROBLEM
q.	VBP	O	O
day	NN	O	O
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
foot	NN	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
400	CD	O	O
mg	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

5.	CD	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
nebulizers	NNS	I-TREATMENT	I-TREATMENT
q.	VBP	O	O
four	CD	O	O
hours	NNS	O	O
and	CC	O	O
q.	VB	O	O
two	CD	O	O
hours	NNS	O	O
p.r.n.	VBP	O	O

6.	CD	O	O
losartan	JJ	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

7.	CD	O	O
iron	NN	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

8.	CD	O	O
albuterol	JJ	B-TREATMENT	B-TREATMENT
ipratropium	NN	B-TREATMENT	I-TREATMENT
two	CD	O	O
puffs	NNS	O	O
four	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

9.	CD	O	O
zosyn	NN	B-TREATMENT	B-TREATMENT
4.5	CD	O	O
grams	NNS	O	O
intravenously	RB	O	O
q.	RB	O	O
six	CD	O	O
hours	NNS	O	O
times	RB	O	O
six	CD	O	O
weeks	NNS	O	O
;	:	O	O
started	VBN	O	O
on	IN	O	O
09-10	NN	O	O
.	.	O	O

10.	CD	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

11.	CD	O	O
amlodipine	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

12.	CD	O	O
nortriptyline	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	VBD	O	O
h.s.	NN	O	O

13.	CD	O	O
mecsazopam	$	B-TREATMENT	B-TREATMENT
15	CD	O	O
to	TO	O	O
30	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
q.	JJ	O	O
h.s.	NN	O	O
p.r.n.	NN	O	O

14.	CD	O	O
dulcolax	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
or	CC	O	O
p.r.	JJ	O	O
q.	JJ	O	O
day	NN	O	O
p.r.n.	VB	O	O

15.	CD	O	O
milk	NN	B-TREATMENT	O
of	IN	I-TREATMENT	O
magnesia	NN	I-TREATMENT	B-TREATMENT
30	CD	O	O
cc	NN	O	O
,	,	O	O
p.o.	NN	O	O
q.	JJ	O	O
h.s.	NN	O	O
p.r.n.	NN	O	O

16.	CD	O	O
percocet	JJ	B-TREATMENT	B-TREATMENT
one	CD	O	O
to	TO	O	O
two	CD	O	O
tablets	NNS	O	O
p.o.	VBP	O	O
q.	RB	O	O
four	CD	O	O
hours	NNS	O	O
p.r.n.	VBP	O	O

17.	CD	O	O
zantac	NN	B-TREATMENT	B-TREATMENT
150	CD	O	O
p.o.	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

18.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

20.	CD	O	O
lasix	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	RB	O	O
intravenous	JJ	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

21.	CD	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

4.	CD	O	O
he	PRP	O	O
is	VBZ	O	O
also	RB	O	O
instructed	VBN	O	O
to	TO	O	O
follow-up	JJ	O	O
with	IN	O	O
vascular	JJ	O	B-TREATMENT
surgery	NN	O	I-TREATMENT
and	CC	O	O
podiatry	NN	O	B-TREATMENT
for	IN	O	O
revascularization	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
the	DT	O	O
appropriate	JJ	O	O
time	NN	O	O
frame	NN	O	O
.	.	O	O

1.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
status	NN	O	O
post	NN	O	O
myocardial	JJ	B-PROBLEM	B-TREATMENT
infarction	NN	I-PROBLEM	I-TREATMENT
status	NN	O	I-TREATMENT
post	NN	O	I-TREATMENT
percutaneous	JJ	B-TREATMENT	I-TREATMENT
transluminal	JJ	I-TREATMENT	I-TREATMENT
coronary	NN	I-TREATMENT	I-TREATMENT
angioplasty	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
status	NN	O	O
post	NN	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

2.	CD	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	VBP	I-PROBLEM	I-PROBLEM
type	JJ	I-PROBLEM	I-PROBLEM
2	CD	I-PROBLEM	I-PROBLEM
,	,	O	O
now	RB	O	O
currently	RB	O	O
on	IN	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

3.	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
vascular	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
status	NN	O	O
post	NN	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
iliac	NN	I-TREATMENT	I-TREATMENT
stenting	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

5.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

6.	CD	O	O
high	JJ	B-PROBLEM	B-PROBLEM
cholesterol	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

7.	CD	O	O
question	NN	O	O
tendonitis	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
biceps	NNS	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

8.	CD	O	O
left	JJ	B-PROBLEM	B-PROBLEM
foot	NN	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
status	NN	O	O
post	NN	O	O
debridement	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

carcinoma	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
kidney	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypovolemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
liver	NN	I-PROBLEM	I-PROBLEM

carcinoma	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
kidney	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypovolemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
liver	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
intrathoracic	NN	B-PROBLEM	B-PROBLEM
lymphadenopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

(	(	O	O
at	IN	O	O
time	NN	O	O
of	IN	O	O
admission	NN	O	O
)	)	O	O
the	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
100/65	CD	O	O
;	:	O	O

no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
neck	NN	O	O
revealed	VBD	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

liver	RB	B-PROBLEM	O
massively	RB	I-PROBLEM	O
enlarged	VBD	I-PROBLEM	O
down	RB	O	O
15	CD	O	O
cm	NN	O	O
.	.	O	O

neurological	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
:	:	O	O

(	(	O	O
at	IN	O	O
time	NN	O	O
of	IN	O	O
admission	NN	O	O
)	)	O	O
hematocrit	NN	B-TEST	B-TEST
32.7	CD	O	O
;	:	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
9,000	CD	O	O
;	:	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
336,000	CD	O	O
;	:	O	O
sodium	NN	B-TEST	B-TEST
126	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.3	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
93	CD	O	O
,	,	O	O
co2	NN	B-TEST	B-TEST
19	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
36	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
1.5	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
sugar	NN	I-TEST	I-TEST
84	CD	O	O
,	,	O	O
calcium	NN	B-TEST	B-TEST
11.7	CD	O	O
;	:	O	O
the	DT	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	JJ	I-TEST	I-TEST
normal	JJ	O	O
.	.	O	O

kub	NN	B-TEST	O
:	:	O	O

consistent	NN	O	O
with	IN	O	O
adynamic	JJ	B-PROBLEM	B-PROBLEM
ileus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

sulfonamides	NNS	B-TREATMENT	B-PROBLEM

svd	NN	B-TREATMENT	O

d&c	NN	B-TREATMENT	O

supracervical	JJ	B-TREATMENT	B-TREATMENT
hysterectomy	NN	I-TREATMENT	I-TREATMENT

reexploration	NN	B-TEST	O
with	IN	O	O
vaginal	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
ligation	NN	I-TREATMENT	I-TREATMENT

multiple	JJ	B-TREATMENT	B-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT

36	CD	O	O
yo	JJ	O	O
g3p2	NN	O	O
at	IN	O	O
38+5	CD	O	O
weeks	NNS	O	O
ga	RB	O	O
presented	VBN	O	O
to	TO	O	O
l&d	VB	O	O
for	IN	O	O
elective	JJ	B-TREATMENT	O
induction	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
labor	NN	I-TREATMENT	B-PROBLEM
.	.	O	O

narcolepsy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

r	NN	B-PROBLEM	B-PROBLEM
inguinal	JJ	I-PROBLEM	I-PROBLEM
hernia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

svdx2	NN	B-TREATMENT	O

vital	JJ	B-TEST	B-TEST
signs	NNS	I-TEST	I-TEST
stable	JJ	O	O
on	IN	O	O
admission	NN	O	O
.	.	O	O

abd	NN	B-PROBLEM	O
gravid	NN	I-PROBLEM	O
,	,	O	O
nt	NN	B-PROBLEM	B-PROBLEM

ext	NN	O	O
without	IN	O	O
edema	NN	B-PROBLEM	B-PROBLEM

2016-12-15	JJ	O	O
03:31	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
wbc	SYM	B-TEST	B-TEST
-	:	O	O
6.2	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.82	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
12.2	CD	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
34.5	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
91	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
32.0	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
35.4	CD	O	O
*	NN	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
12.7	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
246	CD	O	O

2016-12-21	JJ	O	O
07:45	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	B-TEST	B-TEST
-	:	O	O
6.6	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
2.79	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
8.5	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
23.9	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
86	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
30.5	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
35.7	CD	O	O
*	NN	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
16.9	CD	O	O
*	JJ	O	O
plt	NN	B-TEST	B-TEST
ct	SYM	I-TEST	I-TEST
-	:	O	O
222	CD	O	O
#	#	O	O

after	IN	O	O
admission	NN	O	O
to	TO	O	O
l&d	VB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
administered	VBN	O	O
pitocin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
elective	JJ	B-TREATMENT	O
induction	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
labor	NN	I-TREATMENT	B-PROBLEM
and	CC	O	O
progressed	VBD	O	O
uneventfully	RB	O	O
and	CC	O	O
went	VBD	O	O
on	IN	O	O
to	TO	O	O
deliver	VB	O	O
a	DT	O	O
viable	JJ	O	O
female	NN	O	O
infant	NN	O	O
,	,	O	O
weight	NN	B-TEST	B-TEST
3595	CD	O	O
g	NN	O	O
,	,	O	O
apgars	VBZ	B-TEST	B-TEST
11-11	JJ	O	O
.	.	O	O

ebl	NN	B-PROBLEM	O
during	IN	O	O
delivery	NN	O	B-TREATMENT
was	VBD	O	O
300	CD	O	O
cc	NN	O	O
.	.	O	O

soon	RB	O	O
after	IN	O	O
transfer	NN	O	O
,	,	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
post	NN	I-PROBLEM	I-PROBLEM
partum	NN	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
transfer	NN	O	O
back	RB	O	O
to	TO	O	O
l&d	NN	O	O
,	,	O	O
bimanual	JJ	B-TREATMENT	B-TREATMENT
massage	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
administration	NN	O	O
of	IN	O	O
various	JJ	B-TREATMENT	O
uterotonics	NNS	I-TREATMENT	O
,	,	O	O
namely	RB	O	O
pitocin	JJ	B-TREATMENT	B-TREATMENT
100	CD	O	O
u	NN	O	O
,	,	O	O
methergine	NN	B-TREATMENT	O
x	NN	O	O
1	CD	O	O
,	,	O	O
hemabate	NN	B-TREATMENT	O
x	NN	O	O
1	CD	O	O
,	,	O	O
and	CC	O	O
cytotec	JJ	B-TREATMENT	B-TREATMENT
1000	CD	O	O
mcgs	NN	O	O
with	IN	O	O
minimal	JJ	O	B-PROBLEM
response	NN	O	I-PROBLEM
.	.	O	O

patient	JJ	O	B-TREATMENT
underwent	JJ	O	I-TREATMENT
suction	NN	B-TREATMENT	I-TREATMENT
curettage	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
finally	RB	O	O
a	DT	B-TREATMENT	B-TREATMENT
supercervical	JJ	I-TREATMENT	I-TREATMENT
hysterectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

ebl	NN	B-PROBLEM	O
4000	CD	O	O
cc	NN	O	O
;	:	O	O
ivf	JJ	B-TREATMENT	O
6000	CD	O	O
cc	NN	O	O
crystalloid	NN	B-TREATMENT	O
;	:	O	O
u/o	JJ	B-TEST	O
3500	CD	O	O
cc	NN	O	O
.	.	O	O

8	CD	B-TREATMENT	O
units	NNS	I-TREATMENT	O
rbc	VBP	I-TREATMENT	O
,	,	O	O
6ffp	CD	B-TREATMENT	O
,	,	O	O
1	CD	B-TREATMENT	O
cryo	NN	I-TREATMENT	O
,	,	O	O
1	CD	B-TREATMENT	O
pack	NN	I-TREATMENT	O
plt	NN	I-TREATMENT	O
.	.	O	O

after	IN	O	O
this	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
the	DT	O	O
patient	NN	O	O
again	RB	O	O
hemorrhaged	VBN	O	O
in	IN	O	O
the	DT	O	O
icu	NN	O	O
and	CC	O	O
was	VBD	O	O
taken	VBN	O	O
back	RB	O	O
to	TO	O	O
the	DT	O	O
or	CC	O	O
for	IN	O	O
reexploration	NN	B-TEST	B-PROBLEM
and	CC	O	O
ligation	NN	B-TREATMENT	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
bleeding	JJ	I-PROBLEM	I-PROBLEM
vaginal	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

ebl	JJ	B-PROBLEM	O
3500	CD	O	O
;	:	O	O
ivf	JJ	B-TREATMENT	O
4000	CD	O	O
;	:	O	O
uo	JJ	B-TEST	O
45	CD	O	O
;	:	O	O
rbc	VB	B-TREATMENT	B-TEST
9u	CD	O	O
;	:	O	O
plt	CC	B-TREATMENT	O
12	CD	O	O
pack	NN	O	O
;	:	O	O
1u	CD	B-TREATMENT	O
cryo	NN	I-TREATMENT	O
;	:	O	O
6u	CD	B-TREATMENT	O
ffp	NN	I-TREATMENT	O
.	.	O	O

for	IN	O	O
details	NNS	O	O
of	IN	O	O
these	DT	B-TREATMENT	B-TREATMENT
procedures	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
please	VB	O	O
see	VB	O	O
op	JJ	O	O
notes	NNS	O	O
dictated	VBN	O	O
by	IN	O	O
dr.	JJ	O	O
day	NN	O	O
on	IN	O	O
2016-12-16	JJ	O	O
.	.	O	O

overall	JJ	O	O
,	,	O	O
the	DT	O	O
pt	NN	O	O
maintained	VBD	O	O
good	JJ	O	O
bp	NN	B-TEST	O
throughout	IN	O	O
and	CC	O	O
was	VBD	O	O
on	IN	O	O
pressors	NNS	B-TREATMENT	B-TREATMENT
only	RB	O	O
briefly	NN	O	O
.	.	O	O

hct	NN	B-TEST	B-TEST
was	VBD	O	O
maintained	VBN	O	O
in	IN	O	O
stable	JJ	O	O
range	NN	O	O
with	IN	O	O
product	NN	B-TREATMENT	B-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

her	PRP$	B-TEST	B-TEST
vital	JJ	I-TEST	I-TEST
signs	NNS	I-TEST	I-TEST
were	VBD	O	O
stable	JJ	O	O
,	,	O	O
she	PRP	O	O
remained	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
off	IN	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

her	PRP$	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
controlled	VBN	O	O
with	IN	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
motrin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
foley	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
removed	VBN	O	O
and	CC	O	O
she	PRP	O	O
voided	VBD	O	O
without	IN	O	O
problems	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

cylert	NN	B-TREATMENT	O
.	.	O	O

1.	CD	O	O
ibuprofen	JJ	B-TREATMENT	B-TREATMENT
600	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q6h	NN	O	O
(	(	O	O
every	DT	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

2.	CD	O	O
oxycodone	CD	B-TREATMENT	B-TREATMENT
-	:	I-TREATMENT	I-TREATMENT
acetaminophen	NN	I-TREATMENT	I-TREATMENT
5-325	JJ	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
tablets	NNS	O	O
po	JJ	O	O
q4-6h	JJ	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
to	TO	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

full	JJ	O	O
term	NN	O	O
pregnancy	NN	O	O
,	,	O	O
s/p	NN	O	O
svd	NN	B-TREATMENT	B-TREATMENT

uterine	JJ	B-PROBLEM	O
atony	NN	I-PROBLEM	O
,	,	O	O
postpartum	NN	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM

severe	JJ	B-PROBLEM	B-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM

6	CD	O	O
wks	NN	O	O
for	IN	O	O
postpartum	NN	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST

monday	NN	O	O
for	IN	O	O
staple	JJ	B-TREATMENT	B-TREATMENT
removal	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

right	JJ	B-PROBLEM	B-PROBLEM
hip	NN	I-PROBLEM	I-PROBLEM
osteoarthritis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

asthma	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
gastroesophageal	JJ	B-PROBLEM	B-PROBLEM
reflux	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
constipation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

right	JJ	B-TREATMENT	B-TREATMENT
total	NN	I-TREATMENT	I-TREATMENT
hip	NN	I-TREATMENT	I-TREATMENT
arthroplasty	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

right	JJ	B-PROBLEM	B-PROBLEM
hip	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
62-year-old	JJ	O	O
hospice	NN	O	O
chaplain	NN	O	O
who	WP	O	O
was	VBD	O	O
referred	VBN	O	O
by	IN	O	O
dr.	NN	O	O
tomedankell	NN	O	O
flowayles	NNS	O	O
and	CC	O	O
dr.	NN	O	O
es	VBP	O	O
oarekote	NN	O	O
for	IN	O	O
evaluation	NN	B-TEST	B-TEST
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
hip	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
states	VBZ	O	O
that	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
has	VBZ	O	O
been	VBN	O	O
of	IN	O	O
seven	CD	O	O
to	TO	O	O
eight	CD	O	O
durations	NNS	O	O
,	,	O	O
and	CC	O	O
rated	VBN	O	O
as	IN	O	O
moderate	JJ	O	O
to	TO	O	O
severe	VB	O	O
(	(	O	O
7/10	CD	O	O
)	)	O	O
.	.	O	O

he	PRP	O	O
does	VBZ	O	O
not	RB	O	O
use	VB	O	O
a	DT	B-TREATMENT	B-TREATMENT
cane	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
he	PRP	O	O
requires	VBZ	O	O
a	DT	O	O
bannister	NN	O	O
for	IN	O	O
going	VBG	O	O
up	RB	O	O
and	CC	O	O
down	RB	O	O
stairs	NNS	O	O
.	.	O	O

he	PRP	O	O
uses	VBZ	O	O
a	DT	B-TREATMENT	B-TREATMENT
walker	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

asthma	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
history	NN	O	O
of	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
non-small-cell	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
removed	VBN	O	O
from	IN	O	O
his	PRP$	O	O
right	NN	O	O
lung	NN	O	O
by	IN	O	O
dr.	JJ	O	O
vital	JJ	O	O
four	CD	O	O
years	NNS	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
,	,	O	O
status	NN	O	O
post	NN	O	O
chemotherapy	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
radiation	NN	B-TREATMENT	O
for	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
non-small-cell	JJ	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
gastroesophageal	JJ	B-PROBLEM	B-PROBLEM
reflux	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
history	NN	O	O
of	IN	O	O
constipation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

prilosec	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
20	CD	O	O
mg.	NN	O	O
po	NN	O	O
q.day	NN	O	O
;	:	O	O
singulair	NN	B-TREATMENT	O
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
walks	VBZ	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
limp	NN	I-PROBLEM	I-PROBLEM
related	VBN	O	O
to	TO	O	O
his	PRP$	O	B-TREATMENT
right	JJ	O	I-TREATMENT
hip	NN	O	I-TREATMENT
.	.	O	O

his	PRP$	O	O
right	JJ	O	O
hip	NN	O	O
is	VBZ	O	O
irritable	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
10-degree	JJ	I-PROBLEM	I-PROBLEM
fixed	JJ	I-PROBLEM	I-PROBLEM
flexion	NN	I-PROBLEM	I-PROBLEM
contracture	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-PROBLEM
x-rays	JJ	I-TEST	I-PROBLEM
show	NN	O	I-PROBLEM
advanced	VBD	B-PROBLEM	I-PROBLEM
osteoarthritis	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
hip	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
62-year-old	JJ	O	O
male	NN	O	O
with	IN	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
osteoarthritis	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
hip	NN	I-PROBLEM	I-PROBLEM
who	WP	O	O
after	IN	O	O
discussion	NN	O	O
,	,	O	O
including	VBG	O	O
the	DT	O	O
nature	NN	O	O
,	,	O	O
risks	NNS	O	O
,	,	O	O
benefits	NNS	O	O
and	CC	O	O
alternative	JJ	O	B-TREATMENT
treatment	NN	O	I-TREATMENT
plans	NNS	O	O
,	,	O	O
signed	VBD	O	O
informed	JJ	O	O
consent	NN	O	O
for	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
total	NN	I-TREATMENT	I-TREATMENT
hip	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
on	IN	O	O
march	NN	O	O
11	CD	O	O
,	,	O	O
2002	CD	O	O
,	,	O	O
and	CC	O	O
underwent	VBD	O	O
an	DT	B-TREATMENT	B-TREATMENT
uncomplicated	JJ	I-TREATMENT	I-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
total	NN	I-TREATMENT	I-TREATMENT
hip	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
and	CC	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
post	NN	O	O
anesthesia	NN	O	B-TREATMENT
care	NN	O	I-TREATMENT
unit	NN	O	I-TREATMENT
and	CC	O	O
then	RB	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
in	IN	O	O
stable	JJ	O	O
condition	NN	O	O
.	.	O	O

on	IN	O	O
postoperative	JJ	B-TEST	O
check	NN	I-TEST	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
doing	VBG	O	O
well	RB	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
his	PRP$	B-TEST	B-TEST
vital	JJ	I-TEST	I-TEST
signs	NNS	I-TEST	I-TEST
were	VBD	O	O
stable	JJ	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
34.7	CD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
dvt	NN	B-TREATMENT	B-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
ancef	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
routine	JJ	B-TREATMENT	B-TREATMENT
antimicrobial	JJ	I-TREATMENT	I-TREATMENT
coverage	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
posterior	JJ	B-TREATMENT	B-PROBLEM
hip	NN	I-TREATMENT	I-PROBLEM
dislocation	NN	I-TREATMENT	I-PROBLEM
precautions	NNS	I-TREATMENT	I-PROBLEM
and	CC	O	O
was	VBD	O	O
out	IN	O	O
of	IN	O	O
bed	NN	O	O
with	IN	O	O
physical	JJ	O	B-TREATMENT
therapy	NN	O	I-TREATMENT
and	CC	O	O
occupational	JJ	O	B-TREATMENT
therapy	NN	O	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
vital	JJ	I-TEST	I-TEST
signs	NNS	I-TEST	I-TEST
were	VBD	O	O
stable	JJ	O	O
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
two	CD	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
,	,	O	O
vital	JJ	B-TEST	B-TEST
signs	NNS	I-TEST	I-TEST
were	VBD	O	O
stable	JJ	O	O
.	.	O	O

his	PRP$	B-PROBLEM	B-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
clean	JJ	O	O
,	,	O	O
dry	JJ	O	O
and	CC	O	O
intact	JJ	O	O
with	IN	O	O
no	DT	O	O
erythema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
34.8	CD	O	O
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
three	CD	O	O
,	,	O	O
lower	JJR	B-TEST	B-TEST
extremity	NN	I-TEST	I-TEST
noninvasive	JJ	I-TEST	I-TEST
ultrasounds	NNS	I-TEST	I-TEST
were	VBD	O	O
performed	VBN	O	O
,	,	O	O
which	WDT	O	O
showed	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
deep	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
thrombosis	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremities	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

folic	JJ	B-TREATMENT	B-TREATMENT
acid	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
1	CD	O	O
mg.	NN	O	O
po	NN	O	O
q.d.;	NN	O	O
multivitamin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
one	CD	O	O
capsule	NN	O	O
po	NN	O	O
q.day	NN	O	O
;	:	O	O

ferrous	JJ	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
325	CD	O	O
mg.	NN	O	O
po	NN	O	O
t.i.d.;	NN	O	O

colace	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
100	CD	O	O
mg.	NN	O	O
po	NN	O	O
t.i.d.;	NN	O	O

tylenol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
650	CD	O	O
mg.	NN	O	O
po	NN	O	O
q.4	NN	O	O
hours	NNS	O	O
,	,	O	O
p.r.n.	NN	O	B-PROBLEM
pain	NN	B-PROBLEM	I-PROBLEM
;	:	O	O

milk	NN	B-TREATMENT	O
of	IN	I-TREATMENT	O
magnesia	NN	I-TREATMENT	B-PROBLEM
,	,	O	O
30	CD	O	O
ml.	NN	O	O
po	NN	O	O
q.day	NN	O	O
,	,	O	O
p.r.n.	JJ	O	B-PROBLEM
constipation	NN	B-PROBLEM	I-PROBLEM
;	:	O	O

coumadin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
2.5	CD	O	O
mg.	NN	O	O
po	NN	O	O
q.p.m.	NN	O	O
,	,	O	O
dose	VB	O	O
to	TO	O	O
vary	JJ	O	O
per	IN	O	O
inr	JJ	B-TEST	O
level	NN	I-TEST	O
;	:	O	O

percocet	NN	B-TREATMENT	B-TREATMENT
5/325	CD	O	O
mg.	NN	O	O
s	NN	O	O
,	,	O	O
one	CD	O	O
to	TO	O	O
two	CD	O	O
tablets	NNS	O	O
po	VBP	O	O
q.4	NN	O	O
to	TO	O	O
6	CD	O	O
hours	NNS	O	O
p.r.n.	JJ	O	O
pain	NN	B-PROBLEM	B-PROBLEM
;	:	O	O

singulair	NN	B-TREATMENT	O
,	,	O	O
10	CD	O	O
mg.	NN	O	O
po	NN	O	O
q.h.s.;	NN	O	O

nexium	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
10	CD	O	O
mg.	NN	O	O
po	NN	O	O
q.day	NN	O	O
;	:	O	O

metamucil	NN	B-TREATMENT	B-TREATMENT
instant	JJ	I-TREATMENT	I-TREATMENT
mix	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
one	CD	O	O
teaspoon	NN	O	O
po	NN	O	O
q.day	NN	O	O
;	:	O	O

peri-colace	NN	B-TREATMENT	O
,	,	O	O
two	CD	O	O
capsules	NNS	O	O
po	VBP	O	O
b.i.d.;	JJ	O	O
dulcolax	NN	B-TREATMENT	O
,	,	O	O
10	CD	O	O
mg.	NN	O	O
pr	NN	O	O
q.day	NN	O	O
,	,	O	O
p.r.n.	JJ	O	O
constipation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
to	TO	O	O
follow-up	JJ	O	O
with	IN	O	O
dr.	JJ	O	O
class	NN	O	O
six	CD	O	O
weeks	NNS	O	O
from	IN	O	O
the	DT	O	O
date	NN	O	O
of	IN	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
staples	NNS	I-TREATMENT	I-TREATMENT
should	MD	O	O
be	VB	O	O
removed	VBN	O	O
10	CD	O	O
to	TO	O	O
14	CD	O	O
days	NNS	O	O
from	IN	O	O
the	DT	O	O
date	NN	O	O
of	IN	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

if	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
dry	JJ	O	O
,	,	O	O
he	PRP	O	O
may	MD	O	O
shower	VB	O	O
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
to	TO	O	O
ambulate	VB	O	O
with	IN	O	O
crutches	NNS	B-TREATMENT	B-TREATMENT
or	CC	O	O
a	DT	B-TREATMENT	B-TREATMENT
walker	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
be	VB	O	O
on	IN	O	O
posterior	JJ	B-TREATMENT	B-PROBLEM
hip	NN	I-TREATMENT	I-PROBLEM
dislocation	NN	I-TREATMENT	I-PROBLEM
precautions	NNS	I-TREATMENT	I-PROBLEM
for	IN	O	O
three	CD	O	O
months	NNS	O	O
following	VBG	O	O
the	DT	O	O
date	NN	O	O
of	IN	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
should	MD	O	O
be	VB	O	O
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
anticoagulation	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
three	CD	O	O
weeks	NNS	O	O
from	IN	O	O
the	DT	O	O
date	NN	O	O
of	IN	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
twice	JJ	O	O
weekly	JJ	O	O
blood	NN	B-TEST	O
draws	NN	I-TEST	O
for	IN	O	O
inr	NN	B-TEST	O
with	IN	O	O
a	DT	O	O
goal	NN	O	O
of	IN	O	O
1.5	CD	O	O
to	TO	O	O
2.0	CD	O	O
.	.	O	O

after	IN	O	O
initial	JJ	B-TEST	B-TEST
trauma	JJ	I-TEST	I-TEST
assessment	NN	I-TEST	I-TEST
and	CC	O	O
initiation	NN	O	B-TREATMENT
of	IN	O	I-TREATMENT
resuscitation	NN	B-TREATMENT	I-TREATMENT
,	,	O	O
a	DT	B-TEST	B-TEST
ct	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
.	.	O	O

images	NNS	B-TEST	O
of	IN	I-TEST	O
his	PRP$	I-TEST	B-TEST
head	NN	I-TEST	I-TEST
,	,	I-TEST	I-TEST
abdomen	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
and	CC	I-TEST	I-TEST
thorax	NN	I-TEST	I-TEST
were	VBD	O	O
obtained	VBN	O	O
.	.	O	O

his	PRP$	B-PROBLEM	B-PROBLEM
injuries	NNS	I-PROBLEM	I-PROBLEM
included	VBD	O	I-PROBLEM
bilateral	JJ	B-PROBLEM	I-PROBLEM
zygomal	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
orbital	JJ	I-PROBLEM	B-PROBLEM
rim	NN	I-PROBLEM	I-PROBLEM
fractures	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
temporal	JJ	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
,	,	O	I-PROBLEM
bilateral	JJ	B-PROBLEM	I-PROBLEM
frontal	JJ	I-PROBLEM	I-PROBLEM
contusions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
a	DT	B-PROBLEM	O
right	JJ	I-PROBLEM	O
temporal	JJ	I-PROBLEM	O
epidural	JJ	I-PROBLEM	O
versus	NN	O	O
subdural	JJ	B-PROBLEM	B-PROBLEM
hematoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
anterior	JJ	O	O
and	CC	O	O
posterior	NN	O	B-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
frontal	JJ	O	I-PROBLEM
sinus	NN	O	I-PROBLEM
was	VBD	O	O
fractured	VBN	B-PROBLEM	O
with	IN	O	O
communication	NN	B-PROBLEM	O
with	IN	I-PROBLEM	O
the	DT	I-PROBLEM	B-PROBLEM
ethmoid	JJ	I-PROBLEM	I-PROBLEM
air	NN	I-PROBLEM	I-PROBLEM
cells	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
presumably	RB	O	O
caused	VBD	O	O
air	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
orbit	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

initial	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
revealed	VBD	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
in	IN	O	O
the	DT	O	O
80s	CD	O	O
,	,	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
150/80s	CD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
intubated	VBN	B-TREATMENT	O
with	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
abrasions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
swelling	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
contusions	NNS	B-PROBLEM	O
of	IN	I-PROBLEM	O
his	PRP$	I-PROBLEM	O
face	NN	I-PROBLEM	O
.	.	O	O

his	PRP$	B-TEST	B-PROBLEM
boston	NN	I-TEST	I-PROBLEM
coma	NN	I-TEST	I-PROBLEM
scale	NN	I-TEST	I-PROBLEM
was	VBD	O	O
16	CD	O	O
.	.	O	O

the	DT	B-TEST	O
response	NN	I-TEST	O
was	VBD	O	O
brisk	JJ	O	O
.	.	O	O

initial	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
revealed	VBD	O	O
corticate	JJ	B-PROBLEM	B-PROBLEM
posturing	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
by	IN	O	O
the	DT	O	O
trauma	NN	O	O
team	NN	O	O
.	.	O	O

he	PRP	O	O
withdrew	VBD	O	O
to	TO	O	O
noxious	JJ	B-TEST	B-TEST
stimuli	NNS	I-TEST	I-TEST
equally	RB	O	O
and	CC	O	O
purposefully	RB	O	O
after	IN	O	O
20	CD	O	O
minutes	NNS	O	O
in	IN	O	O
the	DT	O	B-PROBLEM
trauma	NN	O	I-PROBLEM
bay	NN	O	I-PROBLEM
.	.	O	O

upon	IN	O	O
arrival	NN	O	O
,	,	O	O
neurosurgery	RB	O	O
promptly	RB	O	O
placed	VBN	O	O
v.	NN	B-TREATMENT	O
holtzen	NN	I-TREATMENT	O
bolt	NN	I-TREATMENT	O
.	.	O	O

this	DT	O	O
allowed	VBD	O	O
continuous	JJ	B-TEST	B-TEST
monitoring	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
intracranial	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
.	.	O	O

notably	RB	O	O
,	,	O	O
intracranial	JJ	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
17	CD	O	O
when	WRB	O	O
the	DT	B-TREATMENT	O
bolt	NN	I-TREATMENT	O
was	VBD	O	O
placed	VBN	O	O
.	.	O	O

during	IN	O	O
his	PRP$	O	O
hospitalization	NN	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
intracranial	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
monitored	VBN	O	O
very	RB	O	O
closely	RB	O	O
and	CC	O	O
maintained	VBD	O	O
to	TO	O	O
a	DT	O	O
level	NN	O	O
of	IN	O	O
less	JJR	O	O
than	IN	O	O
20	CD	O	O
.	.	O	O

to	TO	O	O
do	VB	O	O
this	DT	O	O
,	,	O	O
mannitol	VBZ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
q.	VBD	O	O
6h.	CD	O	O
was	VBD	O	O
used	VBN	O	O
.	.	O	O

while	IN	O	O
using	VBG	O	O
mannitol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
his	PRP$	B-TEST	B-TEST
serum	NN	I-TEST	I-TEST
osmolalities	NNS	I-TEST	I-TEST
were	VBD	O	O
followed	VBN	O	O
closely	RB	O	O
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
to	TO	O	O
monitoring	VBG	O	O
his	PRP$	B-TEST	B-TEST
intracranial	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
,	,	O	O
his	PRP$	B-TEST	B-TEST
systemic	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
pressures	NNS	I-TEST	I-TEST
were	VBD	O	O
maintained	VBN	O	O
in	IN	O	O
such	JJ	O	O
a	DT	O	O
manner	NN	O	O
that	IN	O	O
his	PRP$	B-TEST	B-TEST
cerebral	JJ	I-TEST	I-TEST
perfusion	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
maintained	VBN	O	O
at	IN	O	O
70	CD	O	O
mmhg	NN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
parameter	NN	I-TEST	I-TEST
monitor	NN	I-TEST	I-TEST
for	IN	O	O
his	PRP$	O	B-PROBLEM
neurologic	JJ	O	I-PROBLEM
status	NN	O	I-PROBLEM
paco2	NN	B-TEST	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
maintained	VBN	O	O
between	IN	O	O
35	CD	O	O
and	CC	O	O
40	CD	O	O
during	IN	O	O
his	PRP$	O	B-TREATMENT
hospitalization	NN	O	I-TREATMENT
.	.	O	O

mr.	NN	O	O
roach	NN	O	O
was	VBD	O	O
kept	VBN	O	O
sedated	VBN	B-TREATMENT	O
with	IN	O	O
propofol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
was	VBD	O	O
given	VBN	O	O
fentanyl	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
/	NN	O	O
or	CC	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
boluses	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

neurologic	JJ	B-TEST	B-TEST
checks	NNS	I-TEST	I-TEST
were	VBD	O	O
followed	VBN	O	O
initially	RB	O	O
every	DT	O	O
one	CD	O	O
hour	NN	O	O
and	CC	O	O
then	RB	O	O
every	DT	O	O
two	CD	O	O
hours	NNS	O	O
to	TO	O	O
monitor	VB	O	O
for	IN	O	O
change	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
neurologic	JJ	I-PROBLEM	I-PROBLEM
examination	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

during	IN	O	O
his	PRP$	O	O
hospitalization	NN	O	O
,	,	O	O
two	CD	O	O
subsequent	JJ	O	O
cat	NN	B-TEST	B-TEST
scans	NNS	I-TEST	I-TEST
were	VBD	O	O
obtained	VBN	O	O
;	:	O	O
one	CD	O	O
on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
two	CD	O	O
.	.	O	O

this	DT	B-TEST	B-TEST
cat	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
revealed	VBD	O	O
possible	JJ	O	O
worsening	NN	O	B-PROBLEM
and	CC	O	O
was	VBD	O	O
read	VBN	O	O
as	IN	O	O
epidural	JJ	B-PROBLEM	O
versus	IN	O	O
subdural	JJ	B-PROBLEM	B-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

after	IN	O	O
a	DT	O	O
discussion	NN	O	O
with	IN	O	O
both	DT	O	O
radiology	NN	O	O
and	CC	O	O
neurosurgery	NN	O	O
,	,	O	O
the	DT	O	O
decision	NN	O	O
was	VBD	O	O
made	VBN	O	O
that	IN	O	O
the	DT	O	B-PROBLEM
worsening	NN	O	I-PROBLEM
did	VBD	O	O
not	RB	O	O
appear	VB	O	O
significant	JJ	O	O
,	,	O	O
and	CC	O	O
this	DT	O	O
was	VBD	O	O
not	RB	O	O
accompanied	VBN	O	O
by	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
change	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
clinical	JJ	I-PROBLEM	I-PROBLEM
condition	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
intracranial	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
remained	VBD	O	O
stable	JJ	O	O
,	,	O	O
and	CC	O	O
his	PRP$	B-TEST	B-TEST
clinical	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
unchanged	JJ	O	O
.	.	O	O

an	DT	B-TEST	B-TEST
additional	JJ	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
was	VBD	O	O
obtained	VBN	O	O
on	IN	O	O
hospital	NN	O	O
day	NN	O	O
three	CD	O	O
.	.	O	O

this	DT	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
unchanged	JJ	O	O
from	IN	O	O
the	DT	B-TEST	B-TEST
previous	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
.	.	O	O

again	RB	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
intracranial	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
and	CC	O	O
neurologic	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
remained	VBD	O	O
the	DT	O	O
same	JJ	O	O
,	,	O	O
and	CC	O	O
conservative	JJ	B-TREATMENT	B-TREATMENT
treatment	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
opted	VBN	O	O
for	IN	O	O
.	.	O	O

as	IN	O	O
described	VBN	O	O
in	IN	O	O
previous	JJ	O	O
section	NN	O	O
,	,	O	O
neo-synephrine	JJ	B-TREATMENT	O
and	CC	O	O
eventually	RB	O	O
levophed	VBN	B-TREATMENT	O
were	VBD	O	O
used	VBN	O	O
to	TO	O	O
maintain	VB	O	O
a	DT	B-TEST	B-TEST
coronary	JJ	I-TEST	I-TEST
perfusion	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
greater	JJR	O	O
than	IN	O	O
70	CD	O	O
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
pulmonary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
four	CD	O	O
.	.	O	O

this	DT	B-TREATMENT	B-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
when	WRB	O	O
the	DT	O	O
patient	NN	O	O
started	VBD	O	O
to	TO	O	O
demonstrate	VB	O	O
septic	JJ	B-PROBLEM	B-PROBLEM
physiology	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
for	IN	O	O
increasing	VBG	O	O
pressor	NN	B-TREATMENT	B-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

mr.	NN	O	O
roach	NN	O	O
was	VBD	O	O
n.p.o.	RB	B-TREATMENT	O
from	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
his	PRP$	O	O
admission	NN	O	O
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
orogastric	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
passed	VBN	O	O
.	.	O	O

initially	RB	O	O
during	IN	O	O
admission	NN	O	O
,	,	O	O
carafate	NN	B-TREATMENT	O
was	VBD	O	O
given	VBN	O	O
down	RP	O	O
the	DT	B-TREATMENT	O
orogastric	JJ	I-TREATMENT	O
tube	NN	I-TREATMENT	O
.	.	O	O

however	RB	O	O
,	,	O	O
on	IN	O	O
a	DT	B-TEST	B-TEST
routine	JJ	I-TEST	I-TEST
chest	NN	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
shot	NN	O	I-TEST
on	IN	O	O
hospital	NN	O	O
day	NN	O	O
three	CD	O	O
,	,	O	O
a	DT	B-PROBLEM	B-TEST
mediastinum	NN	I-PROBLEM	I-TEST
was	VBD	O	O
noted	VBN	O	O
.	.	O	O

this	DT	O	O
raised	VBD	O	O
the	DT	O	O
question	NN	O	O
of	IN	O	O
potential	JJ	O	B-PROBLEM
esophageal	JJ	B-PROBLEM	I-PROBLEM
rupture	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

at	IN	O	O
this	DT	O	O
point	NN	O	O
,	,	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
carafate	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
switched	VBN	O	O
to	TO	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
protonix	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
strictly	RB	B-TREATMENT	O
n.p.o.	JJ	I-TREATMENT	O

throughout	IN	O	O
mr.	JJ	O	O
richard	JJ	O	O
admission	NN	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
remained	VBD	O	O
stable	JJ	O	O
in	IN	O	O
the	DT	O	O
low	JJ	O	O
30s	CD	O	O
.	.	O	O

as	IN	O	O
will	MD	O	O
be	VB	O	O
discussed	VBN	O	O
in	IN	O	O
the	DT	O	O
infectious	JJ	O	O
disease	NN	O	O
section	NN	O	O
,	,	O	O
he	PRP	O	O
developed	VBD	O	O
an	DT	O	O
episode	NN	O	O
of	IN	O	O
what	WP	O	O
appeared	VBD	O	O
to	TO	O	O
be	VB	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
his	PRP$	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
peaked	VBD	O	O
at	IN	O	O
23	CD	O	O
.	.	O	O

mr.	NN	O	O
roach	NN	O	O
was	VBD	O	O
on	IN	O	O
pneumo	JJ	B-TREATMENT	B-TREATMENT
boots	NNS	I-TREATMENT	I-TREATMENT
spontaneous	JJ	I-TREATMENT	I-TREATMENT
compression	NN	I-TREATMENT	I-TREATMENT
devices	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
deep	JJ	B-TREATMENT	B-PROBLEM
venous	JJ	I-TREATMENT	I-PROBLEM
thrombosis	NN	I-TREATMENT	I-PROBLEM
prophylaxis	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
not	RB	O	O
a	DT	O	O
candidate	NN	O	O
for	IN	O	O
subcutaneous	JJ	B-TREATMENT	B-TREATMENT
heparin	NN	I-TREATMENT	I-TREATMENT
as	IN	O	O
we	PRP	O	O
were	VBD	O	O
concerned	VBN	O	O
of	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
intracranial	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

an	DT	B-TREATMENT	B-TEST
inferior	JJ	I-TREATMENT	I-TEST
vena	NN	I-TREATMENT	I-TEST
cava	NN	I-TREATMENT	I-TEST
filter	NN	I-TREATMENT	I-TEST
was	VBD	O	O
considered	VBN	O	O
but	CC	O	O
was	VBD	O	O
deferred	VBN	O	O
,	,	O	O
as	IN	O	O
it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
that	IN	O	O
mr.	FW	O	O
roach	NN	O	O
was	VBD	O	O
too	RB	B-PROBLEM	O
unstable	JJ	I-PROBLEM	O
to	TO	O	O
undergo	VB	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

mr.	NN	O	O
marian	JJ	O	O
blood	NN	B-TEST	B-TEST
sugar	NN	I-TEST	I-TEST
was	VBD	O	O
maintained	VBN	O	O
under	IN	O	O
tight	JJ	O	O
control	NN	O	O
from	IN	O	O
100	CD	O	O
to	TO	O	O
130	CD	O	O
using	VBG	O	O
a	DT	B-TREATMENT	B-TREATMENT
regular	JJ	I-TREATMENT	I-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
sliding-scale	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

mr.	NN	O	O
roach	NN	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
spike	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
white	JJ	I-PROBLEM	B-TEST
blood	NN	I-PROBLEM	I-TEST
cell	NN	I-PROBLEM	I-TEST
count	NN	I-PROBLEM	I-TEST
and	CC	O	O
developed	VBD	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
were	VBD	O	O
pertinent	JJ	O	O
for	IN	O	O
one	CD	O	O
bottle	NN	O	O
of	IN	O	O
gram	JJ	B-PROBLEM	O
-	:	I-PROBLEM	O
positive	JJ	I-PROBLEM	O
coagulase	NN	I-PROBLEM	B-TEST
-	:	I-PROBLEM	O
negative	JJ	I-PROBLEM	O
staphylococcus	NN	I-PROBLEM	O
which	WDT	O	O
grew	VBD	O	O
from	IN	O	O
08-25	JJ	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
preliminary	JJ	I-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
including	VBG	O	O
sputum	NN	O	B-TEST
from	IN	O	O
08-25	JJ	O	O
grew	VBD	O	O
escherichia	JJ	B-PROBLEM	B-PROBLEM
coli	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

sputum	NN	B-TEST	B-TEST
from	IN	O	O
08-27	JJ	O	O
grew	VBD	O	O
gram-negative	JJ	B-PROBLEM	B-TREATMENT
rods	NNS	I-PROBLEM	I-TREATMENT
,	,	O	O
not	RB	O	O
yet	RB	O	O
speciated	VBN	O	O
,	,	O	O
and	CC	O	O
from	IN	O	O
08-27	CD	O	O
a	DT	B-TEST	B-TEST
bronchoalveolar	JJ	I-TEST	I-TEST
lavage	NN	I-TEST	I-TEST
grew	VBD	O	O
1+	CD	B-PROBLEM	O
gram-negative	JJ	I-PROBLEM	B-TREATMENT
rods	NNS	I-PROBLEM	I-TREATMENT
and	CC	O	O
4+	CD	B-PROBLEM	O
polymorphonuclear	JJ	I-PROBLEM	B-PROBLEM
lymphocytes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

throughout	IN	O	O
this	DT	O	O
time	NN	O	O
,	,	O	O
mr.	FW	O	O
richard	JJ	O	O
temperature	NN	B-TEST	O
continued	VBD	O	O
to	TO	O	O
increase	VB	O	O
and	CC	O	O
was	VBD	O	O
such	JJ	O	O
that	IN	O	O
on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
four	CD	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
maximum	NN	I-TEST	I-TEST
was	VBD	O	O
42.2	CD	O	O
degrees	NNS	O	O
centigrade	NN	O	O
.	.	O	O

during	IN	O	O
his	PRP$	O	O
hospitalization	NN	O	O
,	,	O	O
his	PRP$	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
his	PRP$	B-PROBLEM	B-TREATMENT
gram-negative	JJ	I-PROBLEM	I-TREATMENT
rods	NNS	I-PROBLEM	I-TREATMENT
,	,	O	O
imipenem	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

initially	RB	O	O
,	,	O	O
he	PRP	O	O
had	VBD	O	O
been	VBN	O	O
placed	VBN	O	O
on	IN	O	O
clindamycin	NN	B-TREATMENT	B-TREATMENT
to	TO	O	O
cover	VB	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
drain	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
but	CC	O	O
his	PRP$	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
became	VBD	O	O
positive	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
his	PRP$	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
increased	VBD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
switched	VBN	O	O
from	IN	O	O
clindamycin	NN	B-TREATMENT	B-TREATMENT
to	TO	O	I-TREATMENT
the	DT	B-TREATMENT	I-TREATMENT
imipenem	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

vancomycin	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
added	VBN	O	O
when	WRB	O	O
we	PRP	O	O
had	VBD	O	O
the	DT	B-PROBLEM	O
positive	JJ	I-PROBLEM	O
blood	NN	I-PROBLEM	B-TEST
culture	NN	I-PROBLEM	I-TEST
.	.	O	O

with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
102	CD	O	O
,	,	O	O
up	RB	O	O
to	TO	O	O
42	CD	O	O
degrees	NNS	O	O
centigrade	VBN	O	O
,	,	O	O
aggressive	JJ	B-TREATMENT	B-TREATMENT
measures	NNS	I-TREATMENT	I-TREATMENT
including	VBG	O	I-TREATMENT
cooling	VBG	B-TREATMENT	I-TREATMENT
blankets	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
alcohol	NN	B-TREATMENT	B-TEST
swabs	NN	I-TREATMENT	I-TEST
,	,	O	O
and	CC	O	O
fans	NNS	B-TREATMENT	O
were	VBD	O	O
used	VBN	O	O
in	IN	O	O
an	DT	O	O
attempt	NN	O	O
to	TO	O	O
bring	VB	O	O
his	PRP$	B-TEST	B-TEST
body	NN	I-TEST	I-TEST
temperature	NN	I-TEST	I-TEST
down	RP	O	O
.	.	O	O

hypercarbia	NN	B-PROBLEM	O
would	MD	O	O
result	VB	O	O
and	CC	O	O
increase	VB	O	O
in	IN	O	O
cerebral	JJ	O	O
perfusion	NN	O	O
,	,	O	O
paralysis	NN	B-TREATMENT	B-PROBLEM
was	VBD	O	O
initiated	VBN	O	O
to	TO	O	O
decrease	VB	O	O
genesis	NN	O	B-TEST
of	IN	O	I-TEST
carbon	NN	O	I-TEST
dioxide	NN	O	I-TEST
secreted	VBD	O	O
during	IN	O	O
shivering	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

as	IN	O	O
discussed	VBN	O	O
in	IN	O	O
the	DT	O	O
infectious	JJ	O	O
disease	NN	O	O
section	NN	O	O
,	,	O	O
mr.	FW	O	O
roach	NN	O	O
developed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
likely	RB	O	O
from	IN	O	O
gram-negative	JJ	B-PROBLEM	B-PROBLEM
organisms	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
most	JJS	O	O
likely	JJ	O	O
from	IN	O	O
escherichia	JJ	B-PROBLEM	B-PROBLEM
coli	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

for	IN	O	O
this	DT	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
he	PRP	O	O
was	VBD	O	O
placed	VBN	O	O
empirically	RB	O	O
on	IN	O	O
imipenem	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

on	IN	O	O
hospital	NN	O	O
day	NN	O	O
three	CD	O	O
,	,	O	O
mr.	FW	O	O
roach	NN	O	O
had	VBD	O	O
developed	VBN	O	O
an	DT	O	O
episode	NN	O	O
of	IN	O	O
tachycardia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
tachypnea	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

for	IN	O	O
this	DT	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
angiogram	NN	I-TEST	I-TEST
was	VBD	O	O
obtained	VBN	O	O
which	WDT	O	O
demonstrated	VBD	O	O
no	DT	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
embolism	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
four	CD	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
routine	JJ	I-TEST	I-TEST
chest	NN	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
left-sided	JJ	I-PROBLEM	I-PROBLEM
pneumothorax	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

for	IN	O	O
this	DT	O	O
,	,	O	O
a	DT	B-TREATMENT	B-TREATMENT
left	JJ	I-TREATMENT	I-TREATMENT
#34	NN	I-TREATMENT	I-TREATMENT
caucasian	JJ	I-TREATMENT	I-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
.	.	O	O

on	IN	O	O
the	DT	O	O
evening	NN	O	O
of	IN	O	O
hospital	JJ	O	O
day	NN	O	O
four	CD	O	O
,	,	O	O
mr.	FW	O	O
roach	NN	O	O
had	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
acute	JJ	I-PROBLEM	I-PROBLEM
episode	NN	I-PROBLEM	I-PROBLEM
whereby	WRB	O	O
his	PRP$	B-TEST	B-TEST
central	JJ	I-TEST	I-TEST
venous	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
rose	VBD	O	O
sharply	RB	O	O
and	CC	O	O
immediately	RB	O	O
followed	VBN	O	O
by	IN	O	O
a	DT	O	O
period	NN	O	O
of	IN	O	O
asystole	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

urgent	JJ	B-TREATMENT	B-TREATMENT
resuscitation	NN	I-TREATMENT	I-TREATMENT
measures	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
initiated	VBN	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TEST
measures	NNS	I-TREATMENT	I-TEST
included	VBD	O	O
attempts	NNS	O	B-PROBLEM
at	IN	O	I-PROBLEM
pacing	NN	B-TREATMENT	I-PROBLEM
.	.	O	O

epinephrine	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
atropine	NN	B-TREATMENT	B-TREATMENT
were	VBD	O	O
administered	VBN	O	O
as	IN	O	O
were	VBD	O	O
bicarbonate	NN	B-TREATMENT	B-TEST
and	CC	O	O
calcium	NN	B-TREATMENT	B-TEST
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	O	B-TEST
differential	JJ	O	I-TEST
diagnosis	NN	O	I-TEST
of	IN	O	O
asystole	NN	B-PROBLEM	B-TREATMENT
preceded	VBN	O	O
by	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
acute	JJ	I-PROBLEM	I-PROBLEM
rise	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
central	JJ	I-PROBLEM	I-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
pressure	NN	I-PROBLEM	I-PROBLEM
included	VBD	O	I-PROBLEM
attention	NN	B-PROBLEM	I-PROBLEM
pneumothorax	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
cardiac	JJ	B-PROBLEM	B-PROBLEM
tamponade	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
embolism	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

during	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
resuscitation	NN	I-TREATMENT	I-TREATMENT
afterwards	NNS	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
that	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
patent	NN	I-TREATMENT	I-TREATMENT
left	VBD	I-TREATMENT	I-TREATMENT
chest	JJS	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
present	JJ	O	O
in	IN	O	O
the	DT	O	O
left	NN	O	O
chest	NN	O	O
,	,	O	O
so	RB	O	O
initially	RB	O	O
neo-decompression	NN	B-TREATMENT	O
was	VBD	O	O
attempted	VBN	O	O
in	IN	O	O
the	DT	O	O
right	JJ	O	O
chest	NN	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
sign	NN	O	O
of	IN	O	O
attention	NN	B-PROBLEM	B-PROBLEM
pneumothorax	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
decompression	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
a	DT	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
.	.	O	O

during	IN	O	O
this	DT	O	O
time	NN	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
needle	JJ	I-TEST	I-TEST
aspiration	NN	I-TEST	I-TEST
of	IN	O	O
what	WP	O	O
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
the	DT	O	B-PROBLEM
pericardium	NN	O	I-PROBLEM
was	VBD	O	O
performed	VBN	O	O
revealing	VBG	O	O
bloody	JJ	B-PROBLEM	B-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
coming	VBG	O	O
back	RB	O	O
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
left	JJ	I-TREATMENT	I-TREATMENT
anterior	JJ	I-TREATMENT	I-TREATMENT
thoracotomy	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
made	VBN	O	O
by	IN	O	O
the	DT	O	O
cardiac	JJ	O	O
surgery	NN	O	O
fellow	NN	O	O
who	WP	O	O
was	VBD	O	O
present	JJ	O	O
.	.	O	O

after	IN	O	O
30	CD	O	O
minutes	NNS	O	O
of	IN	O	O
active	JJ	B-TREATMENT	B-TREATMENT
resuscitation	NN	I-TREATMENT	I-TREATMENT
including	VBG	O	O
internal	JJ	B-TREATMENT	B-TREATMENT
cardiac	JJ	I-TREATMENT	I-TREATMENT
massage	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
there	EX	O	O
was	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
return	NN	O	O
of	IN	O	O
vital	JJ	B-TEST	B-TEST
signs	NNS	I-TEST	I-TEST
or	CC	O	O
electric	JJ	B-TEST	O
activity	NN	I-TEST	O
to	TO	I-TEST	O
the	DT	I-TEST	O
heart	NN	I-TEST	O
as	IN	O	O
noted	VBN	O	O
on	IN	O	O
electrocardiogram	JJ	B-TEST	B-TEST
monitors	NNS	I-TEST	I-TEST
.	.	O	O

resuscitation	NN	B-TREATMENT	B-TEST
was	VBD	O	O
terminated	VBN	O	O
at	IN	O	O
1914	CD	O	O
on	IN	O	O
08-27	NN	O	O
.	.	O	O

after	IN	O	O
the	DT	O	B-TREATMENT
termination	NN	O	I-TREATMENT
of	IN	O	I-TREATMENT
resuscitation	NN	B-TREATMENT	I-TREATMENT
,	,	O	O
both	CC	O	O
the	DT	O	B-TREATMENT
anesthesia	NN	O	I-TREATMENT
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
attending	NN	O	O
and	CC	O	O
the	DT	O	O
surgical	JJ	O	O
attending	NN	O	O
were	VBD	O	O
present	JJ	O	O
to	TO	O	O
discuss	VB	O	O
the	DT	O	O
proceedings	NNS	O	O
events	NNS	O	O
with	IN	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
family	NN	O	O
members	NNS	O	O
including	VBG	O	O
his	PRP$	O	O
next	JJ	O	O
of	IN	O	O
kin	NN	O	O
,	,	O	O
his	PRP$	O	O
mother	NN	O	O
.	.	O	O

permission	NN	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
postmortem	NN	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
granted	VBN	O	O
.	.	O	O

maintenance	NN	B-TREATMENT	B-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

maintenance	NN	B-TREATMENT	B-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

malignant	JJ	B-PROBLEM	B-PROBLEM
fibrous	JJ	I-PROBLEM	I-PROBLEM
histiocytoma	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
duodenum	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
metastases	VBZ	B-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
liver	VB	I-PROBLEM	I-PROBLEM
,	,	O	O
anemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

intravenous	JJ	B-TREATMENT	B-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
12/4/95	CD	O	O
through	IN	O	O
12/8/95	CD	O	O
.	.	O	O

ativan	RB	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	NN	O	O
or	CC	O	O
trilafon	VB	B-TREATMENT	B-TREATMENT
4	CD	O	O
mg	NN	O	O
q	NN	O	O
4	CD	O	O
hours	NNS	O	O
prn	JJ	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
carafate	VB	B-TREATMENT	O
one	CD	O	O
gram	NN	O	O
q.i.d.	NN	O	O

this	DT	O	O
63-year-old	JJ	O	O
man	NN	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
duodenum	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
discovered	VBN	O	O
in	IN	O	O
02/95	CD	O	O
.	.	O	O

a	DT	B-PROBLEM	B-PROBLEM
leiomyosarcoma	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
resected	VBN	B-TREATMENT	O
after	IN	O	O
embolization	NN	B-TREATMENT	B-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
splenic	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

however	RB	O	O
,	,	O	O
it	PRP	O	O
could	MD	O	O
not	RB	O	O
be	VB	O	O
completely	RB	O	O
excised	VBN	O	O
,	,	O	O
moreover	RB	O	O
the	DT	B-PROBLEM	B-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
metastasized	VBD	O	I-PROBLEM
to	TO	O	I-PROBLEM
the	DT	O	I-PROBLEM
liver	NN	O	I-PROBLEM
was	VBD	O	O
discovered	VBN	O	O
on	IN	O	O
follow	VB	B-TEST	B-TEST
up	RP	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
in	IN	O	O
06/95	CD	O	O
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
receiving	VBG	O	O
chemotherapy	NN	B-TREATMENT	B-TREATMENT
since	IN	O	O
then	RB	O	O
.	.	O	O

vital	JJ	B-TEST	B-TEST
signs	NNS	I-TEST	I-TEST
are	VBP	O	O
normal	JJ	O	O
.	.	O	O

the	DT	O	O
neck	NN	O	O
is	VBZ	O	O
without	IN	O	O
adenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

heart	NN	O	O
without	IN	O	O
gallop	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

abdomen	NNS	O	O
without	IN	O	O
mass	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

extremities	NNS	O	O
without	IN	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

neurological	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
intact	NN	O	O
.	.	O	O

hematocrit	NN	B-TEST	B-TEST
33	CD	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
4.4	CD	O	O
,	,	O	O
with	IN	O	O
28%	CD	O	O
monos	NNS	B-TEST	B-TEST
and	CC	O	O
30%	CD	O	O
polys	NN	B-TEST	O
and	CC	O	O
bands	NNS	B-TEST	B-TEST
.	.	O	O

platelets	NNS	B-TEST	B-TEST
253	CD	O	O
thousand	NN	O	O
.	.	O	O

creatinine	NN	B-TEST	B-TEST
0.6	CD	O	O
,	,	O	O
sgot	VBD	B-TEST	B-TEST
52	CD	O	O
,	,	O	O
bilirubin	VBD	B-TEST	B-TEST
0.5	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
hydrated	VBN	O	O
well	RB	O	O
and	CC	O	O
given	VBN	O	O
adriamycin	NNS	B-TREATMENT	B-TREATMENT
27	CD	O	O
mg	NNS	O	O
and	CC	O	O
dtic	JJ	B-TREATMENT	B-TREATMENT
450	CD	O	O
mg	JJ	O	O
daily	RB	O	O
for	IN	O	O
four	CD	O	O
days	NNS	O	O
.	.	O	O

he	PRP	O	O
also	RB	O	O
got	VBD	O	O
ifosfamide	RB	B-TREATMENT	B-TREATMENT
3.6	CD	O	O
grams	NNS	O	O
a	DT	O	O
day	NN	O	O
with	IN	O	O
mesna	NN	B-TREATMENT	O
.	.	O	O

he	PRP	O	O
tolerated	VBD	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
well	RB	O	O
and	CC	O	O
was	VBD	O	O
discharged	VBN	O	O
in	IN	O	O
good	JJ	O	O
condition	NN	O	O
.	.	O	O

patient	NN	O	O
recorded	VBD	O	O
as	IN	O	O
having	VBG	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
to	TO	O	O
drugs	NNS	B-TREATMENT	B-TREATMENT

chief	JJ	O	O
complaint	NN	O	O
:	:	O	O
s/p	JJ	O	B-PROBLEM
fall	NN	O	I-PROBLEM
with	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
arm	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

orif	NN	B-TREATMENT	B-PROBLEM
left	VBD	B-PROBLEM	I-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
radius	NN	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM

he	PRP	O	O
fell	VBD	O	O
15-20	JJ	O	O
feet	NNS	O	O
onto	IN	O	O
concrete	NN	O	O
,	,	O	O
denies	VBZ	O	O
any	DT	O	B-PROBLEM
loss	NN	B-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
consiousness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

tachycardiac	JJ	B-PROBLEM	O
120-140	CD	O	O
,	,	O	O
regular	JJ	O	O

clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST

soft	JJ	O	O
non-tender	JJ	B-PROBLEM	B-PROBLEM
non-distended	JJ	B-PROBLEM	I-PROBLEM

left	VBN	B-PROBLEM	O
elbow	NN	I-PROBLEM	O
,	,	I-PROBLEM	O
gross	JJ	I-PROBLEM	B-PROBLEM
deformity	NN	I-PROBLEM	I-PROBLEM
swelling	VBG	I-PROBLEM	I-PROBLEM
over	IN	I-PROBLEM	I-PROBLEM
dorsal	JJ	I-PROBLEM	I-PROBLEM
forearm	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
gross	JJ	B-PROBLEM	B-PROBLEM
deformity	NN	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
wrist	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
skin	JJ	B-PROBLEM	B-PROBLEM
lacerations	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

+	JJ	O	O
sensation	NN	O	O
,	,	O	O
movment	NN	O	O
,	,	O	O
pulses	NNS	O	B-TEST
,	,	O	O
some	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
rom	NN	O	O

he	PRP	O	O
was	VBD	O	O
intoxicated	VBN	O	O
and	CC	O	O
tachycardic	VBN	B-PROBLEM	B-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
trauma	NN	O	I-PROBLEM
bay	NN	O	I-PROBLEM
.	.	O	O

his	PRP$	B-PROBLEM	B-PROBLEM
injuries	NNS	I-PROBLEM	I-PROBLEM
were	VBD	O	O
identified	VBN	O	O
as	IN	O	O
a	DT	B-PROBLEM	O
left	NN	I-PROBLEM	O
elbow	NN	I-PROBLEM	O
disloaction	NN	I-PROBLEM	O
with	IN	O	O
was	VBD	O	O
reduced	VBN	O	O
and	CC	O	O
splinted	VBN	O	O
.	.	O	O

also	RB	O	O
a	DT	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
radius	NN	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
was	VBD	O	O
reduced	VBN	O	O
and	CC	O	O
splinted	VBN	O	O
.	.	O	O

also	RB	O	O
a	DT	B-PROBLEM	O
left	NN	I-PROBLEM	O
non	NN	I-PROBLEM	O
displaced	VBD	I-PROBLEM	O
sacral	JJ	I-PROBLEM	B-PROBLEM
wing	NN	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
left	VBD	B-PROBLEM	B-PROBLEM
inferior	JJ	I-PROBLEM	I-PROBLEM
pubic	JJ	I-PROBLEM	I-PROBLEM
ramus	NN	I-PROBLEM	I-PROBLEM
fx	NN	I-PROBLEM	I-PROBLEM
extending	VBG	O	O
the	DT	O	O
to	TO	O	O
inferior	VB	O	B-PROBLEM
acetabulum	NN	O	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
trauma	NN	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
due	JJ	O	O
to	TO	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
not	RB	O	O
resolved	VBN	O	O
with	IN	O	O
pain	JJ	B-TREATMENT	B-TREATMENT
medication	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
2019-10-11	JJ	O	O
he	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
had	VBD	O	O
good	JJ	O	O
effect	NN	O	O
.	.	O	O

also	RB	O	O
on	IN	O	O
2019-10-11	JJ	O	O
he	PRP	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
for	IN	O	O
an	DT	B-TREATMENT	B-PROBLEM
orif	NN	I-TREATMENT	I-PROBLEM
of	IN	O	I-PROBLEM
his	PRP$	B-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
radius	NN	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-PROBLEM	B-PROBLEM
pelvis	NN	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
are	VBP	O	O
closed	VBN	O	O
treated	JJ	O	O
and	CC	O	O
he	PRP	O	O
can	MD	O	O
be	VB	O	O
weight	JJ	O	O
bearing	NN	O	O
as	IN	O	O
tolerated	VBN	O	O
on	IN	O	O
his	PRP$	O	B-TREATMENT
right	JJ	O	I-TREATMENT
leg	NN	O	I-TREATMENT
and	CC	O	O
and	CC	O	O
nonweight	JJ	O	B-PROBLEM
bearing	NN	O	I-PROBLEM
on	IN	O	I-PROBLEM
his	PRP$	O	I-PROBLEM
left	JJ	O	I-PROBLEM
leg	NN	O	I-PROBLEM
.	.	O	O

he	PRP	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
without	IN	O	O
difficulty	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
continued	VBD	O	O
to	TO	O	O
be	VB	O	O
well	RB	O	O
controlled	VBN	O	O
with	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
lopressor	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

throught	NN	O	O
the	DT	O	O
stay	NN	O	O
his	PRP$	B-TEST	B-TEST
labs	NN	I-TEST	I-TEST
remained	VBD	O	O
normal	JJ	O	O
and	CC	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
controlled	VBD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
instructed	VBN	O	O
to	TO	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
dr.	JJ	O	O
conway	NN	O	O
in	IN	O	O
2	CD	O	O
weeks	NNS	O	O
and	CC	O	O
an	DT	O	O
appointment	NN	O	O
was	VBD	O	O
made	VBN	O	O
on	IN	O	O
11-15	NNS	O	O
for	IN	O	O
him	PRP	O	O
at	IN	O	O
the	DT	O	O
louis	NN	O	O
schubert	VBP	O	O
community	NN	O	O
health	NN	O	O
center	NN	O	O
to	TO	O	O
follow	VB	O	O
his	PRP$	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
and	CC	O	O
continued	VBD	O	O
need	NN	O	O
for	IN	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

1.	CD	O	O
docusate	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

2.	CD	O	O
enoxaparin	JJ	B-TREATMENT	B-TREATMENT
30	CD	O	O
mg	NN	O	O
/	VBD	O	O
0.3	CD	O	O
ml	NN	O	O
syringe	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
30	CD	O	O
mg	JJ	O	O
syringe	NN	O	O
subcutaneous	JJ	O	O
q12h	NN	O	O
(	(	O	O
every	DT	O	O
12	CD	O	O
hours	NNS	O	O
)	)	O	O
for	IN	O	O
4	CD	O	O
weeks	NNS	O	O
.	.	O	O

3.	CD	O	O
oxycodone	CD	B-TREATMENT	B-TREATMENT
-	:	O	I-TREATMENT
acetaminophen	NN	B-TREATMENT	I-TREATMENT
5-325	JJ	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
tablets	NNS	O	O
po	JJ	O	O
q4-6h	JJ	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
to	TO	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

4.	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
tartrate	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
0.5	CD	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

continue	NN	O	O
to	TO	O	O
wear	VB	O	O
your	PRP$	B-TREATMENT	B-TREATMENT
left	JJ	I-TREATMENT	I-TREATMENT
arm	NN	I-TREATMENT	I-TREATMENT
splint	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
but	CC	O	O
take	VB	O	O
it	PRP	O	O
off	RP	O	O
daily	JJ	O	O
to	TO	O	O
inspect	VB	O	O
your	PRP$	O	O
skin	NN	O	O

continue	VB	O	O
your	PRP$	B-TREATMENT	B-TREATMENT
lovenox	JJ	I-TREATMENT	I-TREATMENT
injections	NNS	I-TREATMENT	I-TREATMENT
as	IN	O	O
instructed	JJ	O	O

if	IN	O	O
you	PRP	O	O
notice	VBP	O	O
any	DT	O	B-PROBLEM
increase	NN	B-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
swelling	VBG	I-PROBLEM	I-PROBLEM
or	CC	O	O
erythemia	NN	B-PROBLEM	B-PROBLEM
at	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
incisions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
if	IN	O	O
you	PRP	O	O
become	VBP	O	O
short	JJ	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
if	IN	O	O
you	PRP	O	O
have	VBP	O	O
a	DT	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
greater	JJR	O	O
than	IN	O	O
101.4	CD	O	O
please	NN	O	O
call	VB	O	O
the	DT	O	O
office	NN	O	O
or	CC	O	O
go	VB	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O

treatments	NNS	O	B-TREATMENT
frequency	NN	O	O
:	:	O	O
splint	NN	B-TREATMENT	O
to	TO	I-TREATMENT	O
left	VB	I-TREATMENT	O
arm	NN	I-TREATMENT	O

they	PRP	O	O
will	MD	O	O
monitor	VB	O	O
your	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
and	CC	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
and	CC	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

erosive	JJ	B-PROBLEM	B-PROBLEM
esophagitis	NN	I-PROBLEM	I-PROBLEM

no	DT	O	O
cpr	NN	B-TREATMENT	B-PROBLEM
/	VBZ	O	O
no	DT	O	O
defib	NN	B-TREATMENT	B-PROBLEM
/	NN	O	O

robitussin	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
guaifenesin	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
10	CD	O	O
milliliters	NNS	O	O
po	VBP	O	O
q4h	JJ	O	O
prn	JJ	O	O
cough	NN	B-PROBLEM	B-PROBLEM
flagyl	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
metronidazole	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
500	CD	O	O
mg	NN	O	O
po	NN	O	O
tid	NN	O	O
x	$	O	O
5	CD	O	O
days	NNS	O	O
starting	VBG	O	O
today	NN	O	O
(	(	O	O
08/08	CD	O	O
)	)	O	O
nitroglycerin	NN	B-TREATMENT	B-TREATMENT
1/150	CD	O	O
(	(	O	O
0.4	CD	O	O
mg	NN	O	O
)	)	O	O
1	CD	O	O
tab	NN	O	O
sl	NN	O	O
q5min	NN	O	O
x	VBD	O	O
3	CD	O	O
prn	JJ	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

sbp	NN	B-TEST	O
&lt;	VBZ	O	O
100	CD	O	O
ambien	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
zolpidem	JJ	I-TREATMENT	I-TREATMENT
tartrate	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
5	CD	O	O
mg	NN	O	O
po	NN	O	O
qhs	NN	O	O
prn	NN	O	O
insomnia	NN	B-PROBLEM	B-PROBLEM

5	CD	B-TREATMENT	O
levofloxacin	JJ	I-TREATMENT	B-TREATMENT
250	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
x	$	O	O
5	CD	O	O
days	NNS	O	O
starting	VBG	O	O
today	NN	O	O
(	(	O	O
08/08	CD	O	O
)	)	O	O

potentially	RB	O	O
serious	JJ	B-PROBLEM	O
interaction	NN	I-PROBLEM	O
:	:	O	O

haloperidol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT

potentially	RB	O	O
serious	JJ	B-PROBLEM	O
interaction	NN	I-PROBLEM	O
:	:	O	O

haloperidol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT

override	RB	O	O
added	VBD	O	O
on	IN	O	O
08/07/01	CD	O	O
by	IN	O	O
ziskfuscjalk	NN	O	O
,	,	O	O
acri	NN	O	O
,	,	O	O
m.d.	NN	O	O
on	IN	O	O
order	NN	O	O
for	IN	O	O
haldol	NN	B-TREATMENT	B-TREATMENT
im	NN	I-TREATMENT	O
(	(	O	O
ref	JJ	O	O
#	#	O	O
09647807	CD	O	O
)	)	O	O

potentially	RB	O	O
serious	JJ	B-PROBLEM	O
interaction	NN	I-PROBLEM	O
:	:	O	O

levofloxacin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
haloperidol	NN	B-TREATMENT	B-TREATMENT

override	RB	O	O
added	VBD	O	O
on	IN	O	O
08/07/01	CD	O	O
by	IN	O	O
ziskfuscjalk	NN	O	O
,	,	O	O
acri	NN	O	O
,	,	O	O
m.d.	NN	O	O
on	IN	O	O
order	NN	O	O
for	IN	O	O
haldol	NN	B-TREATMENT	B-TREATMENT
po	NN	I-TREATMENT	I-TREATMENT
(	(	O	O
ref	JJ	O	O
#	#	O	O
60739147	CD	O	O
)	)	O	O

potentially	RB	O	O
serious	JJ	B-PROBLEM	O
interaction	NN	I-PROBLEM	O
:	:	O	O

levofloxacin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
haloperidol	NN	B-TREATMENT	B-TREATMENT

omeprazole	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
po	NN	O	O
bid	NN	O	O
x	VBZ	O	O
45	CD	O	O
days	NNS	O	O
atenolol	RB	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	JJ	O	O
po	NN	O	O
bid	NN	O	O

dr.	NN	O	O
scaher	CC	O	O
grend	NN	O	O
,	,	O	O
rammco	NN	O	B-TEST
8/20	CD	O	O
,	,	O	O
3:30pm	CD	O	O
scheduled	VBN	O	O
,	,	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM

hematemesis	NN	B-PROBLEM	B-PROBLEM

responsible	JJ	O	O
after	IN	O	O
study	NN	O	O
for	IN	O	O
causing	VBG	O	O
admission	NN	O	O
)	)	O	O
erosive	VBP	B-PROBLEM	B-PROBLEM
esophagitis	NN	I-PROBLEM	I-PROBLEM

conditions	NNS	O	O
,	,	O	O
infections	NNS	O	O
,	,	O	O
complications	NNS	O	O
,	,	O	O
affecting	VBG	O	O
treatment	NN	O	O
/	NNP	O	O
stay	NN	O	O
right	RB	B-PROBLEM	B-PROBLEM
scrotal	JJ	I-PROBLEM	I-PROBLEM
hydrocele	NN	I-PROBLEM	I-PROBLEM
bph	NN	B-PROBLEM	I-PROBLEM
(	(	I-PROBLEM	I-PROBLEM
benign	JJ	I-PROBLEM	I-PROBLEM
prostatic	JJ	I-PROBLEM	I-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM
)	)	I-PROBLEM	I-PROBLEM
?	.	O	O
nph	NN	B-PROBLEM	B-PROBLEM
(	(	O	O
?	.	O	O
hydrocephalus	NN	B-PROBLEM	B-PROBLEM
)	)	O	I-PROBLEM
dementia	NN	B-PROBLEM	I-PROBLEM
(	(	I-PROBLEM	I-PROBLEM
dementia	NN	I-PROBLEM	I-PROBLEM
)	)	I-PROBLEM	I-PROBLEM

esophagogastroduodenoscopy	NN	B-TREATMENT	B-TEST

86	CD	O	O
yo	NNS	O	O
male	NN	O	O
with	IN	O	O
one	CD	O	O
day	NN	O	O
of	IN	O	O
hematemesis	NN	B-PROBLEM	B-PROBLEM
(	(	O	O
history	NN	O	O
unclear	RB	O	O
)	)	O	O
.	.	O	O

no	DT	O	O
known	JJ	O	B-PROBLEM
tb	NN	B-PROBLEM	I-PROBLEM
or	CC	O	O
ca	MD	B-PROBLEM	O
history	NN	O	O
.	.	O	O

no	DT	O	O
sob	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
?	.	O	O
fever	NN	B-PROBLEM	B-PROBLEM
at	IN	O	O
home	NN	O	O
.	.	O	O

no	DT	O	O
known	VBN	O	B-PROBLEM
dysphagia	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

also	RB	O	O
c	VBP	O	O
/	JJ	O	O
o	JJ	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
substernal	JJ	B-PROBLEM	B-PROBLEM
discomfort	NN	I-PROBLEM	I-PROBLEM
for	IN	O	O
past	JJ	O	O
few	JJ	O	O
days	NNS	O	O
.	.	O	O

in	IN	O	O
ed	JJ	O	O
hr	NN	B-TEST	O
70	CD	O	O
,	,	O	O
bp	NN	B-TEST	B-TEST
130/80	CD	O	O
,	,	O	O
o2sat	VBD	B-TEST	O
96%	CD	O	O
.	.	O	O

hct	NN	B-TEST	B-TEST
44	CD	O	O
.	.	O	O

cxr	NN	B-TEST	O
notable	JJ	O	O
for	IN	O	O
rll	JJ	B-PROBLEM	B-PROBLEM
infiltrate	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
old	JJ	B-PROBLEM	O
b	NN	I-PROBLEM	O
upper	JJ	I-PROBLEM	O
lung	NN	I-PROBLEM	O
field	NN	I-PROBLEM	O
granulomas	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

chest	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
notable	JJ	O	O
for	IN	O	O
esophageal	JJ	B-PROBLEM	B-PROBLEM
diverticulum	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
thickened	VBD	B-PROBLEM	B-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
1/3	CD	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
esophagus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
suspicious	JJ	O	O
for	IN	O	O
malignancy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

+	JJ	O	B-PROBLEM
alveolar	JJ	B-PROBLEM	I-PROBLEM
opacities	NNS	I-PROBLEM	I-PROBLEM
c	VBP	O	I-PROBLEM
/	JJ	O	I-PROBLEM
w	NN	O	I-PROBLEM
alveolar	JJ	B-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
aspirated	VBN	B-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

also	RB	O	O
with	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
cystic	JJ	I-PROBLEM	I-PROBLEM
hypodensities	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
liver	NN	I-PROBLEM	I-PROBLEM
seen	VBN	O	O
in	IN	O	O
previous	JJ	O	B-TEST
scans	NNS	B-TEST	I-TEST
.	.	O	O

throughout	IN	O	O
admission	NN	O	O
,	,	O	O
hematemesis	NN	B-PROBLEM	B-PROBLEM
flow	NN	O	I-PROBLEM
decreased	VBN	O	I-PROBLEM
while	IN	O	O
on	IN	O	O
ppi	NN	B-TREATMENT	O
and	CC	O	O
clear	JJ	B-TREATMENT	B-TREATMENT
liquids	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

egd	RB	B-TEST	O
08/08/01	CD	O	O
showed	VBD	O	O
mulitple	JJ	B-PROBLEM	B-PROBLEM
non-bleeding	JJ	I-PROBLEM	I-PROBLEM
linear	JJ	I-PROBLEM	I-PROBLEM
erosions	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
irregular	JJ	I-PROBLEM	I-PROBLEM
circumfrencial	JJ	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
ge	NN	I-PROBLEM	I-PROBLEM
junction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

tolerated	VBN	O	O
advancement	NN	O	O
to	TO	O	O
a	DT	B-TREATMENT	B-TREATMENT
soft	JJ	I-TREATMENT	I-TREATMENT
mechanical	JJ	I-TREATMENT	I-TREATMENT
diet	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
.	.	O	O

started	VBN	O	O
on	IN	O	O
omeprazole	NN	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
po	NN	O	O
bid	NN	O	O
x6	NNP	O	O
wks	NN	O	O
.	.	O	O

cp	NN	B-PROBLEM	O
,	,	O	O
low	JJ	O	B-PROBLEM
prob	NN	O	I-PROBLEM
with	IN	O	O
atypical	JJ	B-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
ck	NN	B-TEST	O
&apos;s	NNP	O	O
x3	NNP	O	O
flat	JJ	O	O
,	,	O	O
and	CC	O	O
no	DT	O	O
further	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
cp	NN	B-PROBLEM	O
during	IN	O	O
the	DT	O	O
admission	NN	O	O
.	.	O	O

bp	NN	B-TEST	O
remained	VBD	O	O
stable	JJ	O	O
throughout	IN	O	O
the	DT	O	O
admission	NN	O	O
;	:	O	O
initially	RB	O	O
,	,	O	O
bp	JJ	B-TREATMENT	B-TREATMENT
meds	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
held	VBN	O	O
,	,	O	O
but	CC	O	O
as	IN	O	O
vs	JJ	B-TEST	O
remai	NN	O	O
ned	VBD	O	O
stable	JJ	O	O
and	CC	O	O
bleeding	VBG	B-PROBLEM	B-PROBLEM
subsided	VBN	O	I-PROBLEM
,	,	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
titrated	VBN	O	O
up	RB	O	O
to	TO	O	O
25	CD	O	O
mg	NNS	O	O
po	JJ	O	O
tid	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
switched	VBN	O	O
back	RB	O	O
to	TO	O	O
his	PRP$	O	O
home	NN	O	O
dose	NN	O	O
of	IN	O	O
atenolol	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	JJ	O	O
po	NN	O	O
bid	NN	O	O

levo	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
presumed	JJ	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
/	NNP	O	O
pneuomonitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

h	NN	O	O
/	NNP	O	O
o	RB	O	O
obstructive	JJ	B-PROBLEM	B-PROBLEM
uropathy	JJ	I-PROBLEM	I-PROBLEM
--	:	O	O
uop	NN	B-TEST	O
was	VBD	O	O
erratic	JJ	O	B-PROBLEM
,	,	O	O
but	CC	O	O
no	DT	O	O
foley	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
needed	VBN	O	O
.	.	O	O

bun	NN	B-TEST	B-TEST
/	NN	O	I-TEST
cr	NN	B-TEST	I-TEST
were	VBD	O	O
stable	JJ	O	O
.	.	O	O

started	VBN	O	O
on	IN	O	O
clear	JJ	B-TREATMENT	B-TREATMENT
liquids	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

once	RB	O	B-PROBLEM
bleed	VBN	B-PROBLEM	I-PROBLEM
ing	NN	I-PROBLEM	I-PROBLEM
stopped	VBD	O	O
,	,	O	O
advanced	VBD	O	O
diet	JJ	O	O
to	TO	O	O
soft-mechanical	JJ	B-TREATMENT	O
.	.	O	O

dnr	NN	B-TREATMENT	O
,	,	O	O
no	DT	O	O
cpr	NN	B-TREATMENT	O
,	,	O	O
may	MD	O	O
intubate	VB	O	O
for	IN	O	O
airway	NN	B-TREATMENT	B-TREATMENT
protection	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
call	VB	O	O
son	NN	O	O
.	.	O	O

if	IN	O	O
biopsy	VBN	O	O
results	NNS	O	O
abnormal	JJ	B-PROBLEM	O
,	,	O	O
will	MD	O	O
need	VB	O	O
follow-up	JJ	B-TEST	B-TEST
intra-esophageal	JJ	I-TEST	I-TEST
ultrasound	NN	I-TEST	I-TEST
by	IN	O	O
gi	JJ	O	O
service	NN	O	O
.	.	O	O

you	PRP	O	O
have	VBP	O	O
been	VBN	O	O
admitted	VBN	O	O
for	IN	O	O
evaluation	NN	B-TEST	B-TEST
of	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
esophageal	JJ	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

you	PRP	O	O
have	VBP	O	O
some	DT	B-PROBLEM	B-PROBLEM
erosions	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
esophagus	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
are	VBP	O	O
no	RB	O	O
longer	RB	O	B-PROBLEM
bleeding	VBG	B-PROBLEM	I-PROBLEM
.	.	O	O

you	PRP	O	O
will	MD	O	O
need	VB	O	O
to	TO	O	O
continue	VB	O	O
to	TO	O	O
take	VB	O	O
special	JJ	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
these	DT	B-PROBLEM	B-PROBLEM
erosions	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

if	IN	O	O
you	PRP	O	O
experience	VBP	O	O
further	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
discomfort	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
swallowing	NN	O	O
,	,	O	O
you	PRP	O	O
must	MD	O	O
tell	VB	O	O
your	PRP$	O	O
nurse	NN	O	O
and	CC	O	O
call	VB	O	O
your	PRP$	O	O
doctor	NN	O	O
right	RB	O	O
away	RB	O	O
.	.	O	O

you	PRP	O	O
may	MD	O	O
need	VB	O	O
to	TO	O	O
have	VB	O	O
further	JJ	B-TEST	B-TEST
studies	NNS	I-TEST	I-TEST
at	IN	O	O
a	DT	O	O
later	JJ	O	O
date	NN	O	O
.	.	O	O

continue	VB	O	O
all	DT	O	B-TREATMENT
your	PRP$	B-TREATMENT	I-TREATMENT
previous	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
as	IN	O	O
directed	VBN	O	O
.	.	O	O

2	CD	O	O
)	)	O	O
schedule	NN	O	O
gi	JJ	O	O
follow-up	JJ	O	O
if	IN	O	O
biopsy	JJ	O	O
results	NNS	O	O
abnormal	JJ	B-PROBLEM	O
or	CC	O	O
if	IN	O	O
continued	VBN	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3	LS	O	O
)	)	O	O
consider	VB	O	O
oncology	JJ	O	O
follow-up	NN	O	O
if	IN	O	O
biopsies	NNS	B-TEST	B-TEST
suggestive	VBP	O	O
of	IN	O	O
malignancy	NN	B-PROBLEM	B-PROBLEM

4	CD	O	O
)	)	O	O
omeprazole	VBD	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
po	NN	O	O
bid	NN	O	O
x6	NNP	O	O
wks	NN	O	O
.	.	O	O

his	PRP$	O	O
hospital	JJ	O	O
course	NN	O	O
began	VBD	O	O
on	IN	O	O
2014-02-13	JJ	O	O
when	WRB	O	O
he	PRP	O	O
underwent	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
carotid	NN	I-TREATMENT	I-TREATMENT
endarterectomy	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
95%	CD	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
carotid	NN	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	O	O
postoperative	JJ	O	O
course	NN	O	O
was	VBD	O	O
complicated	VBN	O	O
by	IN	O	O
nonspecific	JJ	B-PROBLEM	B-PROBLEM
t	NNS	I-PROBLEM	I-PROBLEM
wave	VBP	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
consistent	JJ	O	O
with	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
postoperatively	RB	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
hematoma	NN	B-PROBLEM	B-PROBLEM
formation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
hematoma	NN	I-PROBLEM	I-PROBLEM
formation	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
rapidly	RB	O	O
expanding	VBG	O	O
and	CC	O	O
he	PRP	O	O
received	VBD	O	O
an	DT	B-TREATMENT	B-TREATMENT
emergent	JJ	I-TREATMENT	I-TREATMENT
surgical	JJ	I-TREATMENT	I-TREATMENT
airway	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
.	.	O	O

this	DT	B-TREATMENT	B-TREATMENT
emergent	JJ	I-TREATMENT	I-TREATMENT
cricothyroidotomy	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
converted	VBN	O	O
then	RB	O	O
to	TO	O	O
a	DT	B-TREATMENT	B-TREATMENT
formal	JJ	I-TREATMENT	I-TREATMENT
tracheostomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

during	IN	O	O
his	PRP$	O	O
subsequent	JJ	O	O
hospital	NN	O	O
course	NN	O	O
,	,	O	O
he	PRP	O	O
had	VBD	O	O
an	DT	B-PROBLEM	B-TREATMENT
additional	JJ	I-PROBLEM	I-TREATMENT
chf	NN	I-PROBLEM	I-TREATMENT
exacerbation	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
medically	RB	O	O
managed	VBN	O	O
and	CC	O	O
eventually	RB	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
tracheostomy	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
decannulated	VBN	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
just	RB	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
to	TO	O	O
mass.	VB	O	O
eye	NN	O	O
&	CC	O	O
ear	JJ	O	O
infirmary	NN	O	O
he	PRP	O	O
had	VBD	O	O
another	DT	B-PROBLEM	B-PROBLEM
acute	JJ	I-PROBLEM	I-PROBLEM
decompensation	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
chf	JJ	B-PROBLEM	B-PROBLEM
exacerbation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	B-TREATMENT
necessitated	JJ	O	I-TREATMENT
emergent	NN	B-TREATMENT	I-TREATMENT
intubation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

with	IN	O	O
ekg	JJ	B-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
consistent	VBP	O	O
with	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
mass.	NN	O	O
eye	NN	O	O
&	CC	O	O
ear	JJ	O	O
infirmary	NN	O	O
for	IN	O	O
further	JJ	O	B-TREATMENT
management	NN	O	I-TREATMENT
.	.	O	O

1.	CD	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
type	JJ	I-PROBLEM	I-PROBLEM
2	CD	I-PROBLEM	I-PROBLEM
treated	VBN	O	O
with	IN	O	O
oral	JJ	B-TREATMENT	B-TREATMENT
medication	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

2.	CD	O	O
cerebrovascular	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
left	VBD	B-TREATMENT	B-TREATMENT
carotid	JJ	I-TREATMENT	I-TREATMENT
endarterectomy	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
2008	CD	O	O
.	.	O	O

3.	CD	O	O
status	NN	O	O
post	NN	O	O
right	RB	B-PROBLEM	O
cerebrovascular	JJ	I-PROBLEM	O
accident	NN	I-PROBLEM	O
in	IN	O	O
2009	CD	O	O
with	IN	O	O
residual	JJ	B-PROBLEM	B-PROBLEM
left-sided	JJ	I-PROBLEM	I-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
status	NN	O	O
post	NN	O	O
right	RB	B-TREATMENT	O
carotid	VBZ	I-TREATMENT	O
endarterectomy	VB	I-TREATMENT	B-TREATMENT
on	IN	O	O
2014-02-13	JJ	O	O
.	.	O	O

5.	CD	O	O
fall	NN	O	O
from	IN	O	O
standing	VBG	O	O
on	IN	O	O
2014-01-29	JJ	O	O
with	IN	O	O
resultant	NN	O	B-PROBLEM
displaced	VBN	B-PROBLEM	I-PROBLEM
radial	JJ	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
reduced	VBN	O	O
,	,	O	O
closed	VBD	O	O
,	,	O	O
and	CC	O	O
casted	VBD	O	O
.	.	O	O

6.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

7.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
history	NN	O	O
of	IN	O	O
catheterization	NN	B-TEST	B-TREATMENT
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
to	TO	O	O
the	DT	O	O
saint	NN	O	O
vincent	NN	O	O
hospital	NN	O	O
.	.	O	O

8.	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-TEST	B-TEST
baseline	JJ	I-TEST	I-TEST
creatinine	NN	I-TEST	I-TEST
of	IN	O	O
2.0	CD	O	O
to	TO	O	O
2.7.	CD	O	O

1.	CD	O	O
lovenox	JJ	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	NN	O	O
per	IN	O	O
kilogram	NN	O	O
subcutaneously	RB	O	O
b.i.d.	VBD	O	O

2.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
81	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

3.	CD	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

4.	CD	O	O
lansoprazole	JJ	B-TREATMENT	B-TREATMENT
30	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

5.	CD	O	O
regular	JJ	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

6.	CD	O	O
captopril	NN	B-TREATMENT	B-TREATMENT
6.25	CD	O	O
mg	NN	O	O
q.i.d.	NN	O	O

7.	CD	O	O
lasix	JJ	B-TREATMENT	B-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
2	CD	O	O
per	IN	O	O
hour	NN	O	O
.	.	O	O

8.	CD	O	O
versed	JJ	B-TREATMENT	B-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

9.	CD	O	O
tpn	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
gentleman	NN	O	O
who	WP	O	O
is	VBZ	O	O
intubated	VBN	B-TREATMENT	O
,	,	O	O
comfortable	JJ	O	O
,	,	O	O
with	IN	O	O
minimal	JJ	B-TREATMENT	B-TREATMENT
sedation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
with	IN	O	O
a	DT	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
of	IN	O	O
99.1	CD	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
pulse	NN	I-TEST	I-TEST
was	VBD	O	O
in	IN	O	O
the	DT	O	O
70s	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
119/58	CD	O	O
.	.	O	O

his	PRP$	B-TEST	O
cvp	NN	I-TEST	O
is	VBZ	O	O
ranging	VBG	O	O
from	IN	O	O
07-27	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
intubated	VBN	O	B-TREATMENT
and	CC	O	O
has	VBZ	O	O
a	DT	B-TREATMENT	B-TREATMENT
nasogastric	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	O	O
neck	NN	O	O
has	VBZ	O	O
a	DT	B-PROBLEM	B-TREATMENT
well-healed	JJ	I-PROBLEM	I-TREATMENT
right	NN	I-PROBLEM	I-TREATMENT
carotid	NN	I-PROBLEM	I-TREATMENT
endarterectomy	JJ	I-PROBLEM	I-TREATMENT
scar	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

there	EX	O	O
is	VBZ	O	O
also	RB	O	O
a	DT	B-PROBLEM	B-PROBLEM
well-healing	JJ	I-PROBLEM	I-PROBLEM
tracheostomy	NN	I-PROBLEM	I-PROBLEM
scar	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
lungs	NNS	O	O
were	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	O	O
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBN	B-PROBLEM	B-PROBLEM
with	IN	O	O
normoactive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
.	.	O	O

the	DT	O	O
extremities	NNS	O	O
were	VBD	O	O
without	IN	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
left	JJ	O	O
arm	NN	O	O
was	VBD	O	O
in	IN	O	O
a	DT	B-TREATMENT	O
cast	NN	I-TREATMENT	O
.	.	O	O

upon	IN	O	O
admission	NN	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
medically	RB	O	O
managed	VBN	O	O
for	IN	O	O
chf	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
underwent	NN	O	O
a	DT	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
on	IN	O	O
2014-03-06	JJ	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
revealed	VBD	O	O
70%	CD	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
main	JJ	I-PROBLEM	I-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
90%	CD	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lad	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
80%	CD	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
circumflex	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
90%	CD	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
om2	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
proximally	RB	I-PROBLEM	I-PROBLEM
occluded	VBN	I-PROBLEM	I-PROBLEM
right	RB	I-PROBLEM	I-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

after	IN	O	O
reviewing	VBG	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
data	NNS	I-TEST	I-TEST
,	,	O	O
a	DT	O	B-TEST
consultation	NN	O	I-TEST
was	VBD	O	O
made	VBN	O	O
with	IN	O	O
cardiothoracic	JJ	O	B-TREATMENT
surgery	NN	O	I-TREATMENT
who	WP	O	O
deemed	VBD	O	O
that	IN	O	O
he	PRP	O	O
was	VBD	O	O
a	DT	O	O
good	JJ	O	O
candidate	NN	O	O
for	IN	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

over	IN	O	O
the	DT	O	O
ensuing	JJ	O	O
days	NNS	O	O
,	,	O	O
mr.	JJ	O	O
nina	NNP	O	O
chf	NN	B-PROBLEM	O
was	VBD	O	O
managed	VBN	O	O
by	IN	O	O
the	DT	O	O
ccu	NN	O	O
team	NN	O	O
and	CC	O	O
he	PRP	O	O
received	VBD	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
what	WP	O	O
was	VBD	O	O
now	RB	O	O
determined	VBN	O	O
to	TO	O	O
be	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
klebsiella	NN	I-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
a	DT	O	O
full	JJ	O	O
course	NN	O	O
of	IN	O	O
zosyn	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
underwent	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	O
four	CD	I-TREATMENT	O
vessels	NNS	I-TREATMENT	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
saphenous	JJ	I-TREATMENT	I-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	O
his	PRP$	I-TREATMENT	O
lad	NN	I-TREATMENT	O
and	CC	I-TREATMENT	O
diagonal	NN	I-TREATMENT	O
in	IN	O	O
a	DT	O	O
sequential	JJ	O	O
fashion	NN	O	O
,	,	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	O
his	PRP$	I-TREATMENT	O
pda	NN	I-TREATMENT	O
and	CC	O	O
a	DT	B-TREATMENT	B-TREATMENT
saphenous	JJ	I-TREATMENT	I-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	O
his	PRP$	I-TREATMENT	O
om	NN	I-TREATMENT	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
performed	VBN	O	O
by	IN	O	O
dr.	NN	O	O
streeter	NN	O	O
and	CC	O	O
assisted	VBN	O	O
by	IN	O	O
dr	NN	O	O
.	.	O	O
.....................	VB	O	O

the	DT	O	O
patient	NN	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
without	IN	O	O
complication	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
cardiac	NN	O	O

surgery	JJ	O	O
recovery	NN	O	O
unit	NN	O	O
without	IN	O	O
complication	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

his	PRP$	O	O
postoperative	JJ	O	O
course	NN	O	O
was	VBD	O	O
complicated	VBN	O	O
by	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
which	WDT	O	O
was	VBD	O	O
managed	VBN	O	O
medically	RB	O	O
.	.	O	O

during	IN	O	O
his	PRP$	O	O
postoperative	JJ	O	O
course	NN	O	O
,	,	O	O
he	PRP	O	O
did	VBD	O	O
not	RB	O	O
suffer	VB	O	O
from	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
arrhythmias	JJ	I-PROBLEM	I-PROBLEM
nor	CC	O	O
did	VBD	O	O
he	PRP	O	O
have	VB	O	O
any	DT	O	O
episode	NN	O	O
of	IN	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
stable	JJ	I-TREATMENT	I-TREATMENT
antihypertensive	JJ	I-TREATMENT	I-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
appropriate	VBP	O	O
for	IN	O	O
someone	NN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
decreased	JJ	I-PROBLEM	I-PROBLEM
ejection	NN	I-PROBLEM	I-PROBLEM
fraction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mr.	NN	O	O
knueppel	NNP	O	O
had	VBD	O	O
had	VBN	O	O
a	DT	O	O
long	JJ	O	O
protracted	JJ	O	O
period	NN	O	O
of	IN	O	O
intubation	NN	B-TREATMENT	B-TREATMENT
prior	RB	O	O
to	TO	O	O
the	DT	O	O
operation	NN	B-TREATMENT	O
.	.	O	O

the	DT	O	O
status	NN	O	O
of	IN	O	O
mr.	NN	O	O
nina	NNP	O	O
pulmonary	JJ	O	O
system	NN	O	O
necessitated	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
prolonged	JJ	I-TREATMENT	I-TREATMENT
postoperative	JJ	I-TREATMENT	I-TREATMENT
intubation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

after	IN	O	O
a	DT	O	B-PROBLEM
very	RB	O	I-PROBLEM
slow	JJ	O	I-PROBLEM
wean	NN	O	I-PROBLEM
from	IN	O	O
ventilatory	JJ	B-TREATMENT	B-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
mr.	NN	O	O
knueppel	NNP	O	O
was	VBD	O	O
successfully	RB	O	O
extubated	VBN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
nine	CD	O	O
.	.	O	O

he	PRP	O	O
continued	VBD	O	O
to	TO	O	O
be	VB	O	O
very	RB	O	O
tenuous	JJ	O	O
from	IN	O	O
a	DT	O	O
pulmonary	JJ	O	O
point	NN	O	O
of	IN	O	O
view	NN	O	O
and	CC	O	O
required	VBN	O	O
frequent	JJ	B-TREATMENT	B-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
pt	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
he	PRP	O	O
had	VBD	O	O
chest	JJS	B-TREATMENT	O
pt	NN	I-TREATMENT	O
performed	VBN	O	O
at	IN	O	O
very	RB	O	O
regular	JJ	O	O
intervals	NNS	O	O
by	IN	O	O
the	DT	O	O
icu	JJ	O	O
staff	NN	O	O
.	.	O	O

mr.	NN	O	O
knueppel	NNP	O	O
had	VBD	O	O
an	DT	B-TREATMENT	B-TREATMENT
emergent	JJ	I-TREATMENT	I-TREATMENT
cricothyroidotomy	NN	I-TREATMENT	I-TREATMENT
followed	VBN	O	O
by	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
formal	JJ	I-TREATMENT	I-TREATMENT
tracheostomy	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
the	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
much	JJ	B-PROBLEM	B-PROBLEM
scarring	VBG	I-PROBLEM	I-PROBLEM
surrounding	VBG	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
larynx	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

as	IN	O	O
is	VBZ	O	O
expected	VBN	O	O
,	,	O	O
mr.	FW	O	O
knueppel	NNP	O	O
failed	VBD	O	O
a	DT	B-TEST	B-TEST
swallowing	NN	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
early	RB	O	O
on	IN	O	O
in	IN	O	O
his	PRP$	O	O
boston	NN	O	O
regional	JJ	O	O
medical	JJ	O	O
centerr	NN	O	O
hospital	NN	O	O
course	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
study	NN	I-TEST	I-TEST
was	VBD	O	O
repeated	VBN	O	O
and	CC	O	O
yet	RB	O	O
again	RB	O	O
mr.	JJ	O	O
knueppel	NNP	O	O
was	VBD	O	O
unable	JJ	O	O
to	TO	O	O
swallow	VB	O	O
without	IN	O	O
evidence	NN	O	O
of	IN	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

after	IN	O	O
a	DT	O	O
prolonged	JJ	O	O
period	NN	O	O
of	IN	O	O
being	VBG	O	O
fed	VBN	O	O
via	IN	O	O
nasogastric	JJ	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
mr.	NN	O	O
knueppel	NNP	O	O
finally	RB	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
formal	JJ	I-TREATMENT	I-TREATMENT
percutaneous	JJ	I-TREATMENT	I-TREATMENT
endoscopic	NN	I-TREATMENT	I-TREATMENT
gastrostomy	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
placed	VBN	O	O
in	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
.	.	O	O

this	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
performed	VBN	O	O
by	IN	O	O
dr.	NN	O	O
kevin	NN	O	O
taussig	NN	O	O
and	CC	O	O
assisted	VBN	O	O
by	IN	O	O
dr.	NN	O	O
carla	NN	O	O
solan	NN	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
performed	VBN	O	O
under	IN	O	O
endoscopic	NN	B-TREATMENT	O
guidance	NN	I-TREATMENT	O
in	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
without	IN	O	O
complication	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

mr.	NN	O	O
knueppel	NNP	O	O
robertson	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
radius	NN	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
prior	RB	O	O
to	TO	O	O
arriving	VBG	O	O
to	TO	O	O
the	DT	O	O
hospital	NN	O	O
.	.	O	O

this	DT	B-PROBLEM	O
injury	NN	I-PROBLEM	O
had	VBD	O	O
been	VBN	O	O
reduced	VBN	O	O
and	CC	O	O
casted	VBN	O	O
at	IN	O	O
the	DT	O	O
outside	JJ	O	O
institution	NN	O	O
.	.	O	O

postoperatively	RB	O	O
,	,	O	O
there	EX	O	O
was	VBD	O	O
much	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
associated	VBN	O	O
in	IN	O	O
the	DT	O	O
postoperative	JJ	O	O
course	NN	O	O
from	IN	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-TREATMENT	B-TEST
cast	NN	I-TREATMENT	I-TEST
was	VBD	O	O
removed	VBN	O	O
by	IN	O	O
the	DT	O	O
orthopedic	JJ	O	O
service	NN	O	O
in	IN	O	O
anticipation	NN	O	O
of	IN	O	O
this	DT	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
to	TO	O	O
avoid	VB	O	O
compartment	JJ	B-PROBLEM	O
syndrome	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	O
cast	NN	I-TREATMENT	O
was	VBD	O	O
replaced	VBN	O	O
by	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
plaster	NN	I-TREATMENT	I-TREATMENT
splint	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

mr.	NNS	O	O
knueppel	NNP	O	O
should	MD	O	O
follow-up	VB	O	O
with	IN	O	O
his	PRP$	O	B-TREATMENT
orthopedic	JJ	O	I-TREATMENT
surgeon	NN	O	I-TREATMENT
in	IN	O	O
the	DT	O	O
worcester	NN	O	O
state	NN	O	O
hospital	NN	O	O
for	IN	O	O
reassessment	NN	B-TEST	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
possible	JJ	O	O
removal	NN	B-TREATMENT	B-TREATMENT
of	IN	O	I-TREATMENT
the	DT	B-TREATMENT	I-TREATMENT
splint	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
well	RB	O	O
controlled	VBN	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
tolerating	VBG	O	O
tube	NN	B-TREATMENT	B-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

1.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
,	,	I-TREATMENT	O
four	CD	I-TREATMENT	O
vessels	NNS	I-TREATMENT	O
.	.	O	O

2.	CD	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
klebsiella	NN	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
failed	VBD	B-PROBLEM	B-TEST
swallow	NN	I-PROBLEM	I-TEST
study	NN	I-PROBLEM	I-TEST
status	NN	O	O
post	NN	O	O
percutaneous	JJ	B-TREATMENT	B-TREATMENT
endoscopic	NN	I-TREATMENT	I-TREATMENT
gastrostomy	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

5.	CD	O	O
central	JJ	B-TEST	B-TEST
line	NN	I-TEST	I-TEST
culture	NN	I-TEST	I-TEST
positive	JJ	O	O
for	IN	O	O
coagulase	NN	B-PROBLEM	B-TEST
-	:	I-PROBLEM	O
negative	JJ	I-PROBLEM	O
staphylococcus	NN	I-PROBLEM	B-PROBLEM
aureus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
a	DT	B-TREATMENT	O
14	CD	I-TREATMENT	O
day	NN	I-TREATMENT	O
treatment	NN	I-TREATMENT	O
with	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
removal	NN	B-TREATMENT	B-TREATMENT
of	IN	O	I-TREATMENT
the	DT	B-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

1.	CD	O	O
methylphenidate	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

2.	CD	O	O
lasix	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

3.	CD	O	O
captopril	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O

4.	CD	O	O
glyburide	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

5.	CD	O	O
miconazole	JJ	B-TREATMENT	B-TREATMENT
powder	NN	I-TREATMENT	I-TREATMENT
2%	CD	O	O
,	,	O	O
apply	RB	O	O
q.i.d.	JJ	O	O
p.r.n.	NN	O	O

6.	CD	O	O
paxil	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

7.	CD	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
nebulizer	JJ	I-TREATMENT	I-TREATMENT
solution	NN	I-TREATMENT	I-TREATMENT
one	CD	O	O
nebulizer	NN	O	B-TREATMENT
q.	VB	O	O
four	CD	O	O
hours	NNS	O	O
.	.	O	O

8.	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O

9.	CD	O	O
heparin	JJ	B-TREATMENT	B-TREATMENT
5,000	CD	O	O
units	NNS	O	O
subcutaneously	RB	O	O
q.	RB	O	O
12	CD	O	O
hours	NNS	O	O
.	.	O	O

10.	CD	O	O
amlodipine	JJ	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

11.	CD	O	O
percocet	JJ	B-TREATMENT	B-TREATMENT
one	CD	O	O
to	TO	O	O
two	CD	O	O
tablets	NNS	O	O
p.o.	VBP	O	O
q.	RB	O	O
four	CD	O	O
hours	NNS	O	O
p.r.n.	RB	O	O
pain	VBP	B-PROBLEM	B-PROBLEM
.	.	O	O

12.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

13.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

14.	CD	O	O
tube	JJ	B-TREATMENT	B-TREATMENT
feedings	NNS	I-TREATMENT	I-TREATMENT
;	:	O	O
mr.	CC	O	O
knueppel	VB	O	O
is	VBZ	O	O
to	TO	O	O
be	VB	O	O
discharged	VBN	O	O
on	IN	O	O
tube	NN	B-TREATMENT	B-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
promote	NN	B-TREATMENT	O
,	,	I-TREATMENT	O
with	IN	I-TREATMENT	O
fiber	JJ	I-TREATMENT	O
full-strength	NN	I-TREATMENT	O
at	IN	O	O
80	CD	O	O
cc	NNS	O	O
per	IN	O	O
hour	NN	O	O
around	IN	O	O
the	DT	O	O
clock	NN	O	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
peg	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
should	MD	O	O
be	VB	O	O
flushed	VBN	O	O
with	IN	O	O
30	CD	O	O
cc	NNS	O	O
of	IN	O	O
water	NN	O	O
after	IN	O	O
every	DT	O	O
use	NN	O	O
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
also	RB	O	O
to	TO	O	O
be	VB	O	O
strict	JJ	B-TREATMENT	O
n.p.o.	NN	I-TREATMENT	O

he	PRP	O	O
should	MD	O	O
be	VB	O	O
n.p.o.	RB	B-TREATMENT	O
until	IN	O	O
he	PRP	O	O
has	VBZ	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
swallow	JJ	I-TEST	I-TEST
evaluation	NN	I-TEST	I-TEST
which	WDT	O	O
demonstrates	VBZ	O	O
his	PRP$	O	O
ability	NN	O	O
to	TO	O	O
swallow	VB	O	O
without	IN	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
should	MD	O	O
follow-up	VB	O	O
with	IN	O	O
his	PRP$	O	B-TREATMENT
orthopedic	JJ	O	I-TREATMENT
surgeon	NN	O	I-TREATMENT
at	IN	O	O
the	DT	O	O
next	JJ	O	O
convenient	NN	O	O
time	NN	O	O
to	TO	O	O
determine	VB	O	O
the	DT	O	O
length	NN	O	O
of	IN	O	O
duration	NN	O	O
of	IN	O	O
his	PRP$	B-TREATMENT	O
casting	NN	I-TREATMENT	O
.	.	O	O

mr.	NN	O	O
knueppel	NNP	O	O
is	VBZ	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
a	DT	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
of	IN	O	O
97.1	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
77	CD	O	O
,	,	O	O
sinus	NN	O	B-PROBLEM
rhythm	NN	O	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
142/68	CD	O	O
,	,	O	O
breathing	VBG	O	O
21	CD	O	O
breaths	NNS	O	O
per	IN	O	O
minute	NN	O	O
,	,	O	O
94%	CD	O	O
on	IN	O	O
2	CD	B-TREATMENT	B-TREATMENT
liters	NNS	I-TREATMENT	I-TREATMENT
nasal	JJ	I-TREATMENT	I-TREATMENT
cannula	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	O	B-TEST
head	NN	O	I-TEST
was	VBD	O	O
normocephalic	JJ	O	O
,	,	O	O
atraumatic	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
lungs	NNS	O	O
were	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	O	O
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
peg	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
in	IN	I-TREATMENT	O
his	PRP$	I-TREATMENT	O
left	JJ	I-TREATMENT	O
upper	JJ	I-TREATMENT	O
quadrant	NN	I-TREATMENT	O
.	.	O	O

the	DT	B-PROBLEM	O
site	NN	I-PROBLEM	O
was	VBD	O	O
clean	JJ	O	O
and	CC	O	O
dry	JJ	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
necrosis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
erythema	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
exudate	NN	B-PROBLEM	B-PROBLEM
at	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
site	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
trace	NN	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
both	DT	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremities	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	O	B-PROBLEM
right	NN	O	I-PROBLEM
lower	RBR	O	I-PROBLEM
extremity	NN	O	I-PROBLEM
has	VBZ	O	O
ecchymosis	RB	B-PROBLEM	B-PROBLEM
related	VBN	O	O
to	TO	O	O
a	DT	B-PROBLEM	B-TREATMENT
saphenectomy	JJ	I-PROBLEM	I-TREATMENT
site	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

this	DT	B-PROBLEM	B-PROBLEM
ecchymosis	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
much	RB	O	O
improved	VBN	O	O
from	IN	O	O
previous	JJ	B-TEST	B-TEST
examinations	NNS	I-TEST	I-TEST
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
warmth	NN	I-PROBLEM	I-PROBLEM
over	IN	O	I-PROBLEM
this	DT	O	I-PROBLEM
area	NN	O	I-PROBLEM
nor	CC	O	O
is	VBZ	O	O
there	RB	O	O
any	DT	B-PROBLEM	O
exudate	NN	I-PROBLEM	O
from	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
wounds	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

all	DT	O	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
wounds	NNS	I-PROBLEM	I-PROBLEM
including	VBG	O	O
sternotomy	NN	B-PROBLEM	B-TREATMENT
wound	NN	I-PROBLEM	I-TREATMENT
were	VBD	O	O
clean	JJ	O	O
,	,	O	O
dry	JJ	O	O
,	,	O	O
and	CC	O	O
intact	JJ	O	O
.	.	O	O

right	JJ	B-PROBLEM	B-PROBLEM
foot	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
71	CD	O	O
year	NN	O	O
old	JJ	O	O
white	JJ	O	O
female	NN	O	O
with	IN	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
ovarian	JJ	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
who	WP	O	O
recently	RB	O	O
underwent	VBD	O	O
an	DT	B-TEST	B-TEST
exploratory	JJ	I-TEST	I-TEST
laparotomy	NN	I-TEST	I-TEST
on	IN	O	O
5/2	CD	O	O
by	IN	O	O
dr.	NN	O	O
korcblinknud	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
widely	RB	B-PROBLEM	B-PROBLEM
metastatic	JJ	I-PROBLEM	I-PROBLEM
ovarian	JJ	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
sigmoid	JJ	B-PROBLEM	B-PROBLEM
narrowing	NN	I-PROBLEM	I-PROBLEM
near	IN	O	I-PROBLEM
a	DT	B-PROBLEM	I-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
ovarian	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
distal	JJ	B-PROBLEM	O
ileal	NN	I-PROBLEM	O
narrowing	NN	I-PROBLEM	O
by	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
ovarian	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
an	DT	B-TREATMENT	B-TREATMENT
ileostomy	NN	I-TREATMENT	I-TREATMENT
performed	VBD	O	O
and	CC	O	O
had	VBD	O	O
had	VBN	O	O
her	PRP$	O	O
first	JJ	O	O
course	NN	O	O
of	IN	O	O
chemotherapy	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
later	RB	O	O
debulking	VBG	B-TREATMENT	B-TREATMENT
operation	NN	I-TREATMENT	I-TREATMENT
by	IN	O	O
dr.	NN	O	O
median	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
well	RB	O	O
at	IN	O	O
home	NN	O	O
until	IN	O	O
8:30	CD	O	O
p.m.	NN	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
admission	NN	O	O
,	,	O	O
when	WRB	O	O
she	PRP	O	O
developed	VBD	O	O
acute	JJ	O	B-PROBLEM
onset	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
right	JJ	B-PROBLEM	I-PROBLEM
foot	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
was	VBD	O	O
worse	JJR	O	O
with	IN	O	O
walking	NN	O	O
.	.	O	O

she	PRP	O	O
complained	VBD	O	O
of	IN	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
numbness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
foot	NN	I-PROBLEM	I-PROBLEM
over	IN	O	I-PROBLEM
time	NN	O	I-PROBLEM
,	,	O	O
and	CC	O	O
was	VBD	O	O
seen	VBN	O	O
at	IN	O	O
sephsandpot	NN	O	O
center	NN	O	O
,	,	O	O
where	WRB	O	O
she	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
palpable	JJ	O	B-PROBLEM
right	JJ	O	I-PROBLEM
femoral	NN	O	I-PROBLEM
and	CC	O	O
popliteal	NN	O	B-TEST
pulses	NNS	O	I-TEST
,	,	O	O
and	CC	O	O
no	DT	B-PROBLEM	O
pedal	JJ	I-PROBLEM	B-TEST
pulses	NNS	I-PROBLEM	I-TEST
.	.	O	O

she	PRP	O	O
had	VBD	O	O
previous	JJ	O	O
history	NN	O	O
of	IN	O	O
claudication	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

significant	JJ	O	O
for	IN	O	O
glaucoma	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
right	JJ	B-TREATMENT	B-TREATMENT
knee	NN	I-TREATMENT	I-TREATMENT
arthroscopic	NN	I-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
1988	CD	O	O
,	,	O	O
appendectomy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
dilation	NN	B-TREATMENT	B-TREATMENT
and	CC	I-TREATMENT	I-TREATMENT
curettage	NN	I-TREATMENT	I-TREATMENT
times	NNS	O	O
two	CD	O	O
,	,	O	O
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
hiatus	NN	I-PROBLEM	I-PROBLEM
hernia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

lorazepam	RB	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg.	NNS	O	O
po	JJ	O	O
q6	JJ	O	O
hours	NNS	O	O
prn	NN	O	O
,	,	O	O
and	CC	O	O
timoptic	JJ	B-TREATMENT	B-TREATMENT
0.5%	CD	O	I-TREATMENT
1	CD	O	O
drop	NN	O	O
b.i.d.	NN	O	O

iodine	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
shellfish	JJ	O	B-PROBLEM
cause	NN	O	I-PROBLEM
throat	NN	B-PROBLEM	I-PROBLEM
tightening	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

showed	VBD	O	O
a	DT	O	O
71	CD	O	O
year	NN	O	O
old	JJ	O	O
white	JJ	O	O
female	NN	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
vital	JJ	I-TEST	I-TEST
signs	NNS	I-TEST	I-TEST
were	VBD	O	O
blood	JJ	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
155/82	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
88	CD	O	O
,	,	O	O
temperature	NN	B-TEST	B-TEST
96.0.	CD	O	O

her	PRP$	O	B-TEST
right	JJ	O	I-TEST
foot	NN	O	I-TEST
was	VBD	O	O
without	IN	B-PROBLEM	O
capillary	JJ	I-PROBLEM	B-TEST
refill	NN	I-PROBLEM	I-TEST
,	,	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
marked	JJ	I-PROBLEM	I-PROBLEM
change	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
temperature	NN	B-TEST	I-PROBLEM
at	IN	O	O
a	DT	O	O
level	NN	O	O
of	IN	O	O
the	DT	O	B-PROBLEM
mid	NN	O	I-PROBLEM
calf	NN	O	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
decreased	VBN	B-PROBLEM	B-PROBLEM
sensation	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
touch	VB	B-TEST	O
over	IN	O	O
the	DT	O	O
entire	JJ	O	O
foot	NN	O	O
.	.	O	O

radial	NN	B-TEST	O
,	,	I-TEST	O
carotid	NN	I-TEST	B-PROBLEM
and	CC	I-TEST	O
femoral	JJ	I-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
were	VBD	O	O
symmetric	JJ	O	O
and	CC	O	O
strong	JJ	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
popliteal	NN	I-TEST	I-TEST
pulse	NN	I-TEST	I-TEST
on	IN	I-TEST	O
the	DT	I-TEST	O
right	JJ	I-TEST	O
side	NN	I-TEST	O
was	VBD	O	O
diminished	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	B-PROBLEM	O
dorsal	NN	I-PROBLEM	B-PROBLEM
,	,	I-PROBLEM	O
pedal	JJ	I-PROBLEM	B-TEST
pulse	NN	I-PROBLEM	I-TEST
on	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
right	NN	I-PROBLEM	O
.	.	O	O

on	IN	O	O
5/14/92	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
received	VBD	O	O
an	DT	B-TEST	B-TEST
arteriogram	NN	I-TEST	I-TEST
which	WDT	O	O
demonstrated	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
embolus	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
profunda	NN	I-PROBLEM	I-PROBLEM
/	NNP	I-PROBLEM	O
femoral	JJ	I-PROBLEM	B-TREATMENT
artery	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

there	EX	O	O
was	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
occlusion	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
proximal	JJ	I-PROBLEM	I-PROBLEM
calf	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
of	IN	O	O
the	DT	O	B-PROBLEM
peroneal	NN	O	I-PROBLEM
and	CC	O	I-PROBLEM
anterior	JJ	O	I-PROBLEM
tibial	JJ	O	I-PROBLEM
arteries	NNS	O	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
occlusion	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
posterior	JJ	I-PROBLEM	I-PROBLEM
tibial	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
at	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
ankle	NN	O	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
taken	VBN	O	O
urgently	RB	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
,	,	O	O
where	WRB	O	O
she	PRP	O	O
underwent	JJ	O	O
embolectomy	NN	B-TREATMENT	B-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
profunda	NN	I-TREATMENT	I-TREATMENT
superficial	JJ	I-TREATMENT	I-TREATMENT
femoral	JJ	I-TREATMENT	I-TREATMENT
vessels	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	B-TEST	B-PROBLEM
estimated	VBN	I-TEST	I-PROBLEM
blood	NN	I-TEST	I-PROBLEM
loss	NN	I-TEST	I-PROBLEM
was	VBD	O	O
200	CD	O	O
cc.	NN	O	O
and	CC	O	O
she	PRP	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
.	.	O	O

postoperatively	RB	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
again	RB	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
cold	JJ	I-PROBLEM	I-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
lower	RBR	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
diminished	JJ	B-PROBLEM	B-PROBLEM
pulses	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
again	RB	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
,	,	O	O
where	WRB	O	O
she	PRP	O	O
underwent	VBD	O	O
a	DT	B-TEST	B-TEST
right	JJ	I-TEST	I-TEST
popliteal	NN	I-TEST	I-TEST
exploration	NN	I-TEST	I-TEST
and	CC	O	O
thrombectomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
again	RB	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
and	CC	O	O
did	VBD	O	O
well	RB	O	O
postoperatively	RB	O	O
.	.	O	O

on	IN	O	O
5/19	CD	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
done	VBN	O	O
which	WDT	O	O
was	VBD	O	O
to	TO	O	O
be	VB	O	O
evaluated	VBN	O	O
as	IN	O	O
an	DT	O	O
out	IN	O	O
patient	NN	O	O
.	.	O	O

thromboembolus	NN	B-PROBLEM	B-TREATMENT
to	TO	I-PROBLEM	I-TREATMENT
the	DT	I-PROBLEM	I-TREATMENT
right	JJ	I-PROBLEM	I-TREATMENT
profunda	NN	I-PROBLEM	I-TREATMENT
femoris	NN	I-PROBLEM	I-TREATMENT
,	,	I-PROBLEM	O
and	CC	I-PROBLEM	O
right	JJ	I-PROBLEM	B-TREATMENT
superficial	JJ	I-PROBLEM	I-TREATMENT
femoral	JJ	I-PROBLEM	I-TREATMENT
artery	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

patient	NN	O	O
recorded	VBD	O	O
as	IN	O	O
having	VBG	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
to	TO	O	O
drugs	NNS	B-TREATMENT	B-TREATMENT

chief	JJ	O	O
complaint	NN	O	O
:	:	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
/	NNP	O	O
nausea	NN	B-PROBLEM	B-PROBLEM

intubation	NN	B-TREATMENT	B-TREATMENT

ir	NN	B-TREATMENT	O
guided	VBD	I-TREATMENT	O
nephrostomy	JJ	I-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
78	CD	O	O
y/o	NN	O	O
wf	NN	O	O
w/a	NN	O	O
pmh	NN	O	O
significant	JJ	O	O
for	IN	O	O
htn	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
afib	NN	B-PROBLEM	B-PROBLEM
who	WP	O	O
presented	VBD	O	O
to	TO	O	O
an	DT	O	O
osh	JJ	O	O
w/	NN	O	O
complaints	NNS	O	O
of	IN	O	O
abd	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	O
r	JJ	I-PROBLEM	O
ureteral	JJ	I-PROBLEM	O
stone	NN	I-PROBLEM	O
w/	NN	O	O
resultant	JJ	O	O
hydronephrosis	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
nantucket	VB	O	O
cottage	NN	O	O
hospital	NN	O	O
for	IN	O	O
ureteral	JJ	B-TREATMENT	B-TREATMENT
stent	JJ	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

her	PRP$	B-TEST	B-TEST
inr	NN	I-TEST	I-TEST
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
elevated	VBN	B-PROBLEM	O
when	WRB	O	O
admitted	VBN	O	O
and	CC	O	O
,	,	O	O
in	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
waiting	VBG	O	O
for	IN	O	O
this	DT	O	O
to	TO	O	O
normalize	VB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
spiked	VBD	O	O
a	DT	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
to	TO	O	O
105	CD	O	O
and	CC	O	O
became	VBD	O	O
hypotensive	JJ	B-PROBLEM	B-PROBLEM
to	TO	O	O
the	DT	O	O
70s	NNS	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
bolused	VBN	O	O
w/out	IN	O	O
effect	NN	O	O
and	CC	O	O
had	VBD	O	O
little	JJ	O	O
response	NN	O	O
to	TO	O	O
neo	VB	B-TREATMENT	O
so	RB	O	O
she	PRP	O	O
was	VBD	O	O
changed	VBN	O	O
to	TO	O	O
levophed	VB	B-TREATMENT	O
,	,	O	O
given	VBN	O	O
doses	NNS	O	O
of	IN	O	O
cipro	JJ	B-TREATMENT	B-TREATMENT
/	FW	O	I-TREATMENT
vanco	FW	B-TREATMENT	I-TREATMENT
/	FW	O	O
gent	NN	B-TREATMENT	B-PROBLEM
and	CC	O	O
transferred	VBD	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
csru	NN	O	O
for	IN	O	O
management	NN	O	O
.	.	O	O

in	IN	O	O
the	DT	O	O
cmed	NN	O	O
,	,	O	O
urology	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
received	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
r	NN	I-TREATMENT	I-TREATMENT
nephrostomy	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

however	RB	O	O
,	,	O	O
tube	EX	B-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
complicated	VBN	O	O
by	IN	O	O
renal	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
puncture	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
afib	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
increased	VBD	B-PROBLEM	B-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
intubated	VBN	O	B-TREATMENT
for	IN	O	O
this	DT	B-PROBLEM	B-PROBLEM
hypoxia	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
treated	VBN	O	O
with	IN	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
metoprolol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
diltiazem	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
weaned	VBN	O	O
off	RP	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
pressors	NNS	I-TREATMENT	I-TREATMENT
on	IN	O	O
02-21	JJ	O	O
and	CC	O	O
maintained	VBD	O	O
her	PRP$	O	B-TEST
pressure	NN	O	I-TEST
w/out	IN	O	I-TEST
additional	JJ	B-TREATMENT	I-TEST
fluid	NN	I-TREATMENT	I-TEST
boluses	NNS	I-TREATMENT	I-TEST
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
sedation	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
weaned	VBN	O	O
down	RP	O	O
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
successfully	RB	O	O
extubated	VBN	O	O
shortly	RB	O	O
thereafter	RB	O	O
.	.	O	O

ucx	JJ	B-TEST	O
grew	VBD	O	O
proteus	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
her	PRP$	B-TREATMENT	B-TEST
abx	NN	I-TREATMENT	I-TEST
were	VBD	O	O
changed	VBN	O	O
to	TO	O	O
levaquin	VB	B-TREATMENT	O
alone	RB	O	O
and	CC	O	O
she	PRP	O	O
remained	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
for	IN	O	O
>	JJ	O	O
24	CD	O	O
hr	NN	O	O
on	IN	O	O
this	DT	B-TREATMENT	B-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
trouble	NN	O	B-PROBLEM
with	IN	O	O
afib	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
required	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
dilt	JJ	I-TREATMENT	I-TREATMENT
gtt	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
the	DT	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
call-out	NN	O	O
to	TO	O	O
control	VB	O	O
this	DT	O	O
rhythm	NN	O	O
but	CC	O	O
she	PRP	O	O
was	VBD	O	O
transitioned	VBN	O	O
to	TO	O	O
po	VB	B-TREATMENT	O
diltiazem	NN	I-TREATMENT	B-TREATMENT
and	CC	O	O
has	VBZ	O	O
been	VBN	O	O
in	IN	O	O
nsr	JJ	O	O
since	IN	O	O
this	DT	O	O
time	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
restarted	VBN	O	O
on	IN	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
prior	RB	O	O
to	TO	O	O
d/c	VB	O	O
as	IN	O	O
a	DT	O	B-TREATMENT
bridge	NN	O	I-TREATMENT
to	TO	O	I-TREATMENT
therapeutic	JJ	B-TREATMENT	I-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
anticoagulation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

1.	CD	O	O
htn	NN	B-PROBLEM	B-PROBLEM

2.	CD	O	O
a.fib	NN	B-PROBLEM	B-TREATMENT
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT

3.	CD	O	O
cataract	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM

4.	CD	O	O
01-22	NN	O	O
closed	JJ	B-PROBLEM	O
fracture	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
radius	NN	I-PROBLEM	O
s/p	NN	O	O
closed	VBD	B-TREATMENT	B-TREATMENT
reduction	NN	I-TREATMENT	I-TREATMENT

5.	CD	O	O
mv	NN	B-PROBLEM	O
,	,	I-PROBLEM	O
av	NN	I-PROBLEM	O
,	,	I-PROBLEM	O
tv	NN	I-PROBLEM	B-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM

brother	NN	O	O
with	IN	O	O
"	NNP	O	O
heart	NN	B-PROBLEM	O
trouble	NN	I-PROBLEM	O
"	NN	O	O
.	.	O	O

pleasant	JJ	O	O
obese	JJ	O	O
female	NN	O	O
in	IN	O	O
nad	NN	B-PROBLEM	O
,	,	O	O
in	IN	O	O
wrist	NN	B-TREATMENT	O
restraints	NNS	I-TREATMENT	O

eomi	NN	O	O
,	,	O	O
perrla	NN	O	B-PROBLEM
,	,	O	O
mm	NN	B-PROBLEM	O
dry	NN	I-PROBLEM	O
,	,	O	O
o/p	CD	O	O
clear	JJ	O	O

rrr	NN	O	O
,	,	O	O
s1/s2	JJ	O	O
intact	NN	O	O
,	,	O	O
3/6	CD	B-PROBLEM	O
sem	NN	I-PROBLEM	O
at	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
usb	NN	I-PROBLEM	O

s/nt/nd	NN	B-PROBLEM	O
,	,	O	O
obese	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
+bs	VB	O	O

r	NN	B-TREATMENT	O
nephrostomy	JJ	I-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
place	NN	O	O
and	CC	O	O
draining	NN	O	O

ext	NN	O	O
:	:	O	O
brace	NN	B-TREATMENT	O
on	IN	I-TREATMENT	O
l	JJ	I-TREATMENT	O
wrist	NN	I-TREATMENT	O
,	,	O	O
2+	CD	B-PROBLEM	B-PROBLEM
le	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM

cxr	JJ	B-TEST	O
2013-02-21	JJ	O	O
:	:	O	O

right	JJ	B-TREATMENT	O
subclavian	JJ	I-TREATMENT	O
cv	NN	I-TREATMENT	O
line	NN	I-TREATMENT	O
overlies	NNS	O	O
proximal	JJ	O	O
svc	NN	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
cardiomegaly	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	I-PROBLEM
tortuosity	NN	B-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
thoracic	NN	I-PROBLEM	I-PROBLEM
aorta	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
small	JJ	B-PROBLEM	B-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusions	NNS	I-PROBLEM	I-PROBLEM
consistent	JJ	O	O
with	IN	O	O
chf	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
pneumothorax	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

overall	JJ	O	O
appearances	NNS	O	O
are	VBP	O	O
essentially	RB	O	O
unchanged	JJ	O	O
since	IN	O	O
the	DT	B-TEST	O
prior	JJ	I-TEST	O
film	NN	I-TEST	O
of	IN	O	O
2013-02-20	JJ	O	O
,	,	O	O
apart	RB	O	O
from	IN	O	O
removal	NN	B-TREATMENT	B-TREATMENT
of	IN	O	I-TREATMENT
the	DT	B-TREATMENT	I-TREATMENT
et	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

ct	NN	B-TEST	B-TEST
abd	VBZ	I-TEST	I-TEST
2013-02-18	CD	O	O
:	:	O	O

1)	CD	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
severe	VB	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
hydroureteronephrosis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
two	CD	B-PROBLEM	O
obstructing	VBG	I-PROBLEM	O
distal	JJ	I-PROBLEM	B-TREATMENT
right	JJ	I-PROBLEM	I-TREATMENT
ureteral	JJ	I-PROBLEM	I-TREATMENT
stones	NNS	I-PROBLEM	I-TREATMENT
,	,	O	O
8	CD	O	O
mm	NN	O	O
and	CC	O	O
6	CD	O	O
mm	NN	O	O
respectively	RB	O	O
.	.	O	O

2)	CD	O	O
probable	JJ	O	O
obstructing	VBG	B-PROBLEM	O
5	CD	I-PROBLEM	O
mm	NN	I-PROBLEM	O
right	RB	I-PROBLEM	O
mid	JJ	I-PROBLEM	B-PROBLEM
ureteral	JJ	I-PROBLEM	I-PROBLEM
calculus	NN	I-PROBLEM	I-PROBLEM
causing	VBG	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
hydroureter	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
though	IN	O	O
it	PRP	O	O
is	VBZ	O	O
difficult	JJ	O	O
to	TO	O	O
tell	VB	O	O
definitively	RB	O	O
if	IN	O	O
this	DT	B-PROBLEM	O
stone	NN	I-PROBLEM	O
is	VBZ	O	O
within	IN	O	O
or	CC	O	O
just	RB	O	O
medial	JJ	O	O
to	TO	O	O
the	DT	O	O
right	JJ	O	O
ureter	NN	O	O
on	IN	O	O
this	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
without	IN	I-TEST	O
iv	JJ	I-TEST	O
contrast	NN	I-TEST	O
.	.	O	O

3)	CD	O	O
small	JJ	B-PROBLEM	B-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusions	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

4)	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
calcification	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

echo	JJ	B-TEST	B-TEST
2013-02-19	CD	O	O
:	:	O	O

1.	CD	O	O
the	DT	O	O
left	NN	O	O
atrium	NN	O	O
is	VBZ	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
dilated	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
the	DT	B-TEST	B-TEST
left	NN	I-TEST	I-TEST
ventricular	JJ	I-TEST	I-TEST
cavity	NN	I-TEST	I-TEST
size	NN	I-TEST	I-TEST
is	VBZ	O	O
normal	JJ	O	O
.	.	O	O

due	JJ	O	O
to	TO	O	O
suboptimal	VB	O	B-PROBLEM
technical	JJ	O	I-PROBLEM
quality	NN	O	I-PROBLEM
,	,	O	O
a	DT	B-PROBLEM	B-PROBLEM
focal	JJ	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
motion	NN	I-PROBLEM	I-PROBLEM
abnormality	NN	I-PROBLEM	I-PROBLEM
cannot	NN	O	O
be	VB	O	O
fully	RB	O	O
excluded	VBN	O	O
.	.	O	O

overall	JJ	B-TEST	B-TEST
left	VBD	I-TEST	I-TEST
ventricular	JJ	I-TEST	I-TEST
systolic	JJ	I-TEST	I-TEST
function	NN	I-TEST	I-TEST
is	VBZ	O	O
normal	JJ	O	O
lvef	JJ	B-TEST	O
>	NNP	O	O
55%	CD	O	O
)	)	O	O
.	.	O	O

3.	CD	O	O
the	DT	O	O
right	NN	O	O
ventricular	NN	O	O
cavity	NN	O	O
is	VBZ	O	O
dilated	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

right	RB	B-TEST	B-TEST
ventricular	JJ	I-TEST	I-TEST
systolic	JJ	I-TEST	I-TEST
function	NN	I-TEST	I-TEST
appears	VBZ	O	O
depressed	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

4.	CD	O	O
the	DT	O	O
aortic	JJ	O	O
valve	NN	O	O
leaflets	NNS	O	O
(	(	O	O
3	CD	O	O
)	)	O	O
are	VBP	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
thickened	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
valve	NN	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

5.	CD	O	O
the	DT	O	O
mitral	JJ	O	O
valve	NN	O	O
leaflets	NNS	O	O
are	VBP	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
thickened	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
annular	JJ	I-PROBLEM	I-PROBLEM
calcification	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

trivial	JJ	B-PROBLEM	B-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
present	JJ	O	O
.	.	O	O

6.	CD	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
severe	VB	I-PROBLEM	I-PROBLEM
[	JJ	I-PROBLEM	I-PROBLEM
3+	CD	I-PROBLEM	I-PROBLEM
]	JJ	I-PROBLEM	I-PROBLEM
tricuspid	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
seen	VBN	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2013-02-18	JJ	O	O
05:49	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
wbc	SYM	B-TEST	B-TEST
-	:	O	O
36.6	CD	O	O
*	NN	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
4.29	CD	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
13.4	CD	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
38.8	CD	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
91	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
31.3	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.6	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
13.2	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
132	CD	O	O
*	NN	O	O

2013-02-27	JJ	O	O
05:17	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	B-TEST	B-TEST
-	:	O	O
11.8	CD	O	O
*	NN	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.61	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
10.8	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
32.2	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
89	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
29.8	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
33.5	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
13.2	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
346	CD	O	O

2013-02-18	JJ	O	O
05:49	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
pt	NN	B-TEST	I-TEST
-	:	O	O
20.6	CD	O	O
*	NN	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
31.6	CD	O	O
inr	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
pt	JJ	I-TEST	I-TEST
)-	CD	I-TEST	I-TEST
3.0	CD	O	O

2013-02-27	JJ	O	O
05:17	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
pt	NN	B-TEST	I-TEST
-	:	O	O
15.5	CD	O	O
*	NN	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
75.0	CD	O	O
*	JJ	O	O
inr	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
pt	JJ	I-TEST	I-TEST
)-	CD	I-TEST	I-TEST
1.6	CD	O	O

2013-02-18	JJ	O	O
05:49	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	O
glucose	VB	B-TEST	B-TEST
-	:	O	O
127	CD	O	O
*	JJ	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
26	CD	O	O
*	NN	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.7	CD	O	O
*	NN	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
136	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
3.9	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
103	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
20	CD	O	O
*	NN	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
17	CD	O	O

2013-02-27	JJ	O	O
05:17	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
97	CD	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
14	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.2	CD	O	O
*	NN	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
144	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
3.9	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
106	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
29	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
13	CD	O	O

2013-02-22	JJ	O	O
03:00	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
alt	NN	B-TEST	I-TEST
-	:	O	O
52	CD	O	O
*	NN	O	O
ast	VBD	B-TEST	B-TEST
-	:	O	O
50	CD	O	O
*	JJ	O	O
ld	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
ldh	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
300	CD	O	O
*	JJ	O	O
ck	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
cpk	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
41	CD	O	O
alkphos	SYM	B-TEST	B-TEST
-	:	O	O
280	CD	O	O
*	NN	O	O
totbili	SYM	B-TEST	B-TEST
-	:	O	O
0.8	CD	O	O

2013-02-18	JJ	O	O
05:49	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
calcium	NN	B-TEST	I-TEST
-	:	O	O
7.7	CD	O	O
*	NN	O	O
phos	NN	B-TEST	B-TEST
-	:	O	O
3.3	CD	O	O
mg	SYM	B-TEST	O
-	:	O	O
1.1	CD	O	O
*	NN	O	O

2013-02-27	JJ	O	O
05:17	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
calcium	NN	B-TEST	I-TEST
-	:	O	O
8.7	CD	O	O
phos	NN	B-TEST	B-TEST
-	:	O	O
4.0	CD	O	O
mg	SYM	B-TEST	O
-	:	O	O
1.9	CD	O	O

78	CD	O	O
year	NN	O	O
old	JJ	O	O
female	NN	O	O
with	IN	O	O
history	NN	O	O
of	IN	O	O
htn	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
a.fib	JJ	B-PROBLEM	O
presenting	VBG	O	O
with	IN	O	O
ureteral	JJ	B-PROBLEM	B-TREATMENT
stone	NN	I-PROBLEM	I-TREATMENT
,	,	O	O
hydronephrosis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
urosepsis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
originally	RB	O	O
had	VBD	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
leukocytosis	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
er	NN	O	O
and	CC	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
ccu	NN	O	O
.	.	O	O

in	IN	O	O
the	DT	O	O
cmed	NN	O	O
,	,	O	O
urology	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
received	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
r	NN	I-TREATMENT	I-TREATMENT
nephrostomy	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

however	RB	O	O
,	,	O	O
tube	EX	B-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
complicated	VBN	O	O
by	IN	O	O
renal	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
puncture	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
afib	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
increased	VBD	B-PROBLEM	B-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
intubated	VBN	O	B-TREATMENT
for	IN	O	O
this	DT	B-PROBLEM	B-PROBLEM
hypoxia	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
treated	VBN	O	O
with	IN	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
metoprolol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
diltiazem	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
weaned	VBN	O	O
off	RP	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
pressors	NNS	I-TREATMENT	I-TREATMENT
on	IN	O	O
02-21	JJ	O	O
and	CC	O	O
maintained	VBD	O	O
her	PRP$	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
w/out	IN	O	I-TEST
additional	JJ	B-TREATMENT	I-TEST
fluid	NN	I-TREATMENT	I-TEST
boluses	NNS	I-TREATMENT	I-TEST
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
sedation	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
weaned	VBN	O	O
down	RP	O	O
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
successfully	RB	O	O
extubated	VBN	O	O
shortly	RB	O	O
thereafter	RB	O	O
.	.	O	O

ucx	JJ	B-TEST	O
grew	VBD	O	O
proteus	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
her	PRP$	B-TREATMENT	B-TEST
abx	NN	I-TREATMENT	I-TEST
were	VBD	O	O
changed	VBN	O	O
to	TO	O	O
levaquin	VB	B-TREATMENT	O
alone	RB	O	O
and	CC	O	O
she	PRP	O	O
remained	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
for	IN	O	O
>	JJ	O	O
24hr	CD	O	O
on	IN	O	O
this	DT	B-TREATMENT	B-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
trouble	NN	O	B-PROBLEM
with	IN	O	O
afib	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
required	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
dilt	JJ	I-TREATMENT	I-TREATMENT
gtt	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
the	DT	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
call-out	NN	O	O
to	TO	O	O
control	VB	O	O
this	DT	O	O
rhythm	NN	O	O
but	CC	O	O
she	PRP	O	O
was	VBD	O	O
transitioned	VBN	O	O
to	TO	O	O
po	VB	B-TREATMENT	O
diltiazem	NN	I-TREATMENT	B-TREATMENT
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
call-out	NN	O	B-PROBLEM
.	.	O	O

1.	CD	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
-	:	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
septic	JJ	B-PROBLEM	B-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
er	NN	O	I-PROBLEM
and	CC	O	O
her	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
eventually	RB	O	O
grew	VBD	O	O
proteus	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

her	PRP$	B-TEST	O
bcx	NN	I-TEST	O
remained	VBD	O	O
negative	JJ	O	O
throughout	IN	O	O
her	PRP$	O	O
stay	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
levaquin	NN	B-TREATMENT	B-TREATMENT
on	IN	O	O
the	DT	O	O
floor	NN	O	O
and	CC	O	O
will	MD	O	O
complete	VB	O	O
a	DT	O	O
14d	CD	O	O
course	NN	O	O
at	IN	O	O
rehab	NN	O	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
since	IN	O	O
she	PRP	O	O
was	VBD	O	O
called	VBN	O	O
out	RP	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
.	.	O	O

2.	CD	O	O
ureteral	JJ	B-PROBLEM	B-TREATMENT
stone	NN	I-PROBLEM	I-TREATMENT
-	:	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
nephrostomy	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
placed	VBN	O	O
by	IN	O	O
ir	NN	O	O
to	TO	O	O
relieve	VB	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
hydronephrosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
followed	VBN	O	O
by	IN	O	O
urology	NN	O	O
during	IN	O	O
her	PRP$	O	O
stay	NN	O	O
and	CC	O	O
will	MD	O	O
see	VB	O	O
them	PRP	O	O
again	RB	O	O
2	CD	O	O
wk	NN	O	O
after	IN	O	O
d/c	NN	O	O
for	IN	O	O
definitive	JJ	B-TREATMENT	O
treatment	NN	I-TREATMENT	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
nephrolithiasis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

at	IN	O	O
this	DT	O	O
time	NN	O	O
,	,	O	O
urology	NN	O	O
will	MD	O	O
coordinate	VB	O	O
removal	NN	B-TREATMENT	O
of	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
nephrostomy	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
ir	NN	O	O
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
nephrostomy	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
draining	VBG	O	B-PROBLEM
clear	JJ	O	I-PROBLEM
yellow	JJ	O	I-PROBLEM
urine	NN	O	I-PROBLEM
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
d/c	NN	O	B-PROBLEM
.	.	O	O

3.	CD	O	O
a.fib	SYM	B-PROBLEM	B-TEST
-	:	O	O
the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
controlled	VBN	O	O
with	IN	O	O
beta	NN	B-TREATMENT	B-TREATMENT
blockers	NNS	I-TREATMENT	I-TREATMENT
at	IN	O	O
home	NN	O	O
.	.	O	O

once	RB	O	O
on	IN	O	O
the	DT	O	O
floor	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
one	CD	O	O
episode	NN	O	O
of	IN	O	O
afib	JJ	B-PROBLEM	O
w/	NN	O	O
rvr	NN	B-PROBLEM	O
that	WDT	O	O
responded	VBD	O	O
immediately	RB	O	O
to	TO	O	O
iv	VB	B-TREATMENT	O
metoprolol	NN	I-TREATMENT	B-TREATMENT
.	.	O	O

because	IN	O	O
of	IN	O	O
this	DT	O	O
,	,	O	O
the	DT	B-TREATMENT	B-TREATMENT
patient	NN	I-TREATMENT	I-TREATMENT
's	POS	I-TREATMENT	I-TREATMENT
diltiazem	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
stopped	VBN	O	O
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
tid	NN	B-TREATMENT	B-TREATMENT
metoprolol	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

after	IN	O	O
this	DT	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
no	DT	O	O
further	JJ	B-PROBLEM	B-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
rate	NN	I-TREATMENT	I-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
maintained	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
heparin	NN	I-TREATMENT	I-TREATMENT
gtt	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
bridge	NN	O	O
to	TO	O	O
coumadin	VB	B-TREATMENT	B-TREATMENT
while	IN	O	O
on	IN	O	O
the	DT	O	O
floor	NN	O	O
after	IN	O	O
this	DT	O	O
was	VBD	O	O
cleared	VBN	O	O
by	IN	O	O
ir	NN	O	O
and	CC	O	O
urology	NN	O	O
.	.	O	O

she	PRP	O	O
will	MD	O	O
be	VB	O	O
d/c	JJ	O	O
w/out	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
heparin	NN	I-TREATMENT	I-TREATMENT
as	IN	O	O
she	PRP	O	O
is	VBZ	O	O
trending	VBG	O	O
upwards	NNS	O	O
with	IN	O	O
her	PRP$	B-TEST	B-TEST
inr	NN	I-TEST	I-TEST
and	CC	O	O
has	VBZ	O	O
no	DT	O	O
mr	NN	B-PROBLEM	B-PROBLEM
paul	NN	I-PROBLEM	I-PROBLEM
paquettec	JJ	I-PROBLEM	I-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
will	MD	O	O
continue	VB	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
rehab	NN	O	O
to	TO	O	O
achieve	VB	O	O
an	DT	B-TEST	O
inr	NN	I-TEST	O
between	IN	O	O
03-22	NNP	O	O
.	.	O	O

4.	CD	O	O
delirium	NN	B-PROBLEM	B-PROBLEM
-	:	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
troubles	NNS	O	B-PROBLEM
with	IN	O	O
agitation	NN	B-PROBLEM	B-PROBLEM
while	IN	O	O
in	IN	O	O
the	DT	O	O
cmed	JJ	O	O
ccu	NN	O	O
.	.	O	O

she	PRP	O	O
received	VBD	O	O
prn	JJ	B-TREATMENT	O
haldol	NN	I-TREATMENT	O
w/	NN	O	O
little	JJ	O	B-PROBLEM
effect	NN	O	I-PROBLEM
and	CC	O	O
improved	VBN	O	O
as	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
cleared	VBD	O	O
.	.	O	O

medications	NNS	O	B-TREATMENT
on	IN	O	O
admission	NN	O	O
:	:	O	O
toprol	NN	B-TREATMENT	B-TREATMENT
(	(	O	I-TREATMENT
unknown	JJ	O	I-TREATMENT
dose	NN	O	I-TREATMENT
)	)	O	I-TREATMENT
coumadin	VBZ	B-TREATMENT	I-TREATMENT
1	CD	O	O
mg	NN	O	O
qhs	NN	O	O

1.	CD	O	O
bisacodyl	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	RB	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
constipation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2.	CD	O	O
docusate	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

3.	CD	O	O
levofloxacin	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q24h	NN	O	O
(	(	O	O
every	DT	O	O
24	CD	O	O
hours	NNS	O	O
)	)	O	O
for	IN	O	O
7	CD	O	O
days	NNS	O	O
.	.	O	O

4.	CD	O	O
warfarin	JJ	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
hs	NN	O	O
(	(	O	O
at	IN	O	O
bedtime	NN	O	O
)	)	O	O
.	.	O	O

5.	CD	O	O
miconazole	JJ	B-TREATMENT	B-TREATMENT
nitrate	RB	I-TREATMENT	I-TREATMENT
2	CD	O	O
%	NN	O	O
powder	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
appl	RB	O	O
topical	JJ	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

6.	CD	O	O
ipratropium	NN	B-TREATMENT	B-TREATMENT
bromide	RB	I-TREATMENT	I-TREATMENT
0.02	CD	O	O
%	NN	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
neb	NN	O	O
inhalation	NN	O	O
q6h	NN	O	O
(	(	O	O
every	DT	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

7.	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
tartrate	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

8.	CD	O	O
polyvinyl	NN	B-TREATMENT	O
alcohol	RB	I-TREATMENT	O
1.4	CD	O	O
%	NN	O	O
drops	JJ	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
drops	NNS	O	O
ophthalmic	JJ	O	O
prn	NN	O	O
(	(	O	O
as	IN	O	O
needed	VBN	O	O
)	)	O	O
.	.	O	O

9.	CD	O	O
acetaminophen	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
tablets	NNS	O	O
po	JJ	O	O
q4-6h	JJ	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
to	TO	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

10.	CD	O	O
outpatient	JJ	B-TEST	O
lab	NN	I-TEST	O
work	NN	I-TEST	O
please	NN	O	O
have	VB	O	O
your	PRP$	B-TEST	B-TEST
inr	NN	I-TEST	I-TEST
checked	VBD	O	O
at	IN	O	O
the	DT	O	O
rehab	NN	O	O
center	NN	O	O
with	IN	O	O
a	DT	O	O
goal	NN	O	O
of	IN	O	O
03-22	NN	O	O
.	.	O	O

urosepsis	NN	B-PROBLEM	B-PROBLEM

nephrolithiasis	NN	B-PROBLEM	B-PROBLEM

atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM

please	VB	O	O
take	VB	O	O
your	PRP$	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
as	IN	O	O
directed	JJ	O	O

stage	NN	B-PROBLEM	B-PROBLEM
3c	CD	I-PROBLEM	I-PROBLEM
papillary	JJ	I-PROBLEM	I-PROBLEM
serous	JJ	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
ovary	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

stage	NN	B-PROBLEM	B-PROBLEM
3c	CD	I-PROBLEM	I-PROBLEM
papillary	JJ	I-PROBLEM	I-PROBLEM
serous	JJ	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
ovary	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
seventy-one	JJ	O	O
year	NN	O	O
old	JJ	O	O
white	JJ	O	O
female	NN	O	O
with	IN	O	O
stenotic	JJ	B-PROBLEM	B-PROBLEM
area	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
mid	NN	I-PROBLEM	I-PROBLEM
sigmoid	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
noticed	VBN	O	O
on	IN	O	O
barium	NN	B-TEST	B-TREATMENT
enema	NN	I-TEST	I-TREATMENT
.	.	O	O

the	DT	B-TEST	B-TEST
ultrasound	NN	I-TEST	I-TEST
showed	VBD	O	O
ascites	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
question	NN	O	O
of	IN	O	O
pelvic	JJ	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
explored	VBN	O	O
by	IN	O	O
general	JJ	O	B-TREATMENT
surgery	NN	O	I-TREATMENT
,	,	O	O
who	WP	O	O
saw	VBD	O	O
the	DT	B-PROBLEM	B-PROBLEM
3c	CD	I-PROBLEM	I-PROBLEM
ovarian	JJ	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
had	VBD	O	O
an	DT	B-TREATMENT	B-TREATMENT
omentectomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
ileostomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
one	CD	O	O
cycle	NN	O	O
of	IN	O	O
cytoxan	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
cisplatin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
subsequently	RB	O	O
underwent	JJ	O	O
debulking	VBG	B-TREATMENT	O
in	IN	O	O
june	NN	O	O
1992	CD	O	O
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
total	JJ	I-TREATMENT	I-TREATMENT
abdominal	JJ	I-TREATMENT	I-TREATMENT
hysterectomy/	NN	I-TREATMENT	I-TREATMENT
bilateral	JJ	B-TREATMENT	I-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
omentectomy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
splenectomy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
rectosigmoid	JJ	B-TREATMENT	B-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
a	DT	B-TREATMENT	O
take	VBP	I-TREATMENT	O
down	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
the	DT	I-TREATMENT	B-TREATMENT
ileostomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

also	RB	O	O
ileal	JJ	B-TREATMENT	B-TREATMENT
cecal	JJ	I-TREATMENT	I-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
mdr	NN	B-TEST	O
showed	VBD	O	O
that	IN	O	O
cisplatin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
vp	$	B-TREATMENT	O
16	CD	I-TREATMENT	O
were	VBD	O	O
more	RBR	O	O
effective	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
now	RB	O	O
presents	VBZ	O	O
for	IN	O	O
line	NN	O	B-TREATMENT
1	CD	O	O
,	,	O	O
cycle	NN	O	O
4	CD	O	O
to	TO	O	O
15	CD	O	O
of	IN	O	O
vp	NN	B-TREATMENT	O
16	CD	I-TREATMENT	O
and	CC	I-TREATMENT	O
cisplatin	JJ	I-TREATMENT	B-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

as	IN	O	O
above	RB	O	O
,	,	O	O
including	VBG	O	O
an	DT	B-TREATMENT	B-TREATMENT
embolectomy	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
june	NN	O	O
1992	CD	O	O
.	.	O	O

coumadin	NN	B-TREATMENT	B-TREATMENT
2.5	CD	O	O
mg.	NN	O	O
five	CD	O	O
times	NNS	O	O
a	DT	O	O
week	NN	O	O
,	,	O	O
ativan	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
lomotil	JJ	B-TREATMENT	O
prn	NN	O	O
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
has	VBZ	O	O
shellfish	JJ	B-PROBLEM	B-PROBLEM
allergy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
question	NN	O	O
of	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
iodine	NN	I-PROBLEM	I-PROBLEM
allergy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
physical	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
well	RB	O	O
appearing	NN	O	O
,	,	O	O
elderly	JJ	O	O
white	JJ	O	O
female	NN	O	O
,	,	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
is	VBZ	O	O
120/82	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
88	CD	O	O
,	,	O	O
weight	VBD	B-TEST	B-TEST
125	CD	O	O
pounds	NNS	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
,	,	I-TEST	I-TEST
eyes	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
ears	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
nose	RB	I-TEST	I-TEST
,	,	I-TEST	I-TEST
throat	NN	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
was	VBD	O	O
notable	JJ	O	O
for	IN	O	O
alopecia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
otherwise	RB	O	O
unremarkable	JJ	O	O
.	.	O	O

chest	NN	O	O
was	VBD	O	O
clear	JJ	O	O
,	,	O	O
bilateral	JJ	B-TEST	B-TEST
cardiac	NN	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
showed	VBD	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
except	IN	O	O
for	IN	O	O
mild	NN	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
quadrant	JJ	I-PROBLEM	I-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	O
well	NN	I-PROBLEM	O
healed	VBN	I-PROBLEM	O
,	,	I-PROBLEM	O
midline	JJ	I-PROBLEM	B-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
scar	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
other	JJ	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
quadrant	JJ	I-PROBLEM	I-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

exam	NN	B-TEST	B-TEST
was	VBD	O	O
nonfocal	JJ	O	O
,	,	O	O
and	CC	O	O
there	EX	O	O
was	VBD	O	O
no	DT	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
lymphadenopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

notable	JJ	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
of	IN	O	O
9.5	CD	O	O
,	,	O	O
anc	RB	B-TEST	B-TREATMENT
7.7	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
26	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
of	IN	O	O
248	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
12.	CD	O	O
and	CC	O	O
1.2	CD	O	O
respectively	RB	O	O
,	,	O	O
magnesium	NN	B-TEST	B-TEST
1.1	CD	O	O
,	,	O	O
calcium	NN	B-TEST	B-TEST
8.7	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
hospital	NN	O	O
and	CC	O	O
received	VBD	O	O
two	CD	O	O
units	NNS	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
of	IN	O	O
26	CD	O	O
,	,	O	O
and	CC	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TEST
magnesium	NN	I-TREATMENT	I-TEST
repleted	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
received	VBD	O	O
three	CD	O	O
days	NNS	O	O
of	IN	O	O
chemotherapy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
consisting	VBG	O	O
of	IN	O	O
45	CD	O	O
mg.	NN	O	O
of	IN	O	O
cisplatin	NN	B-TREATMENT	B-TREATMENT
160	CD	O	O
mg.	NN	O	O
of	IN	O	O
vp	NN	B-TREATMENT	O
16	CD	I-TREATMENT	O
,	,	O	O
and	CC	O	O
tolerated	VBD	O	O
chemotherapy	NN	B-TREATMENT	B-TREATMENT
resonably	RB	O	O
well	RB	O	O
.	.	O	O

serial	JJ	B-TEST	O
pts	NNS	I-TEST	O
were	VBD	O	O
obtained	VBN	O	O
,	,	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
an	DT	B-TEST	O
initial	JJ	I-TEST	O
pt	NN	I-TEST	O
of	IN	O	O
10.9	CD	O	O
on	IN	O	O
admission	NN	O	O
,	,	O	O
despite	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
home	NN	O	O
.	.	O	O

the	DT	B-TEST	O
patient	NN	I-TEST	O
&apos;s	JJ	I-TEST	O
pro	JJ	I-TEST	O
time	NN	I-TEST	O
bumped	VBD	O	O
to	TO	O	O
19.5	CD	O	O
on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
#	#	O	O
3	CD	O	O
,	,	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
instructed	VBN	O	O
to	TO	O	O
continue	VB	O	O
with	IN	O	O
2	CD	O	O
1/2	CD	O	O
mg.	NN	O	O
qhs	NN	O	O
and	CC	O	O
is	VBZ	O	O
to	TO	O	O
followup	VB	O	O
with	IN	O	O
anticoagulation	NN	O	B-TREATMENT
clinic	NN	O	I-TREATMENT
in	IN	O	O
one	CD	O	O
week	NN	O	O
for	IN	O	O
further	JJ	B-TEST	B-TEST
pro	JJ	I-TEST	I-TEST
time	NN	I-TEST	I-TEST
checks	NNS	I-TEST	I-TEST
and	CC	O	O
adjustments	NNS	B-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
did	VBD	O	O
develop	VB	O	O
some	DT	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
during	IN	O	O
infusion	NN	B-TREATMENT	O
of	IN	I-TREATMENT	O
her	PRP$	I-TREATMENT	O
vp	NN	I-TREATMENT	O
16	CD	I-TREATMENT	O
to	TO	O	O
the	DT	O	O
170/100	CD	O	O
range	NN	O	O
,	,	O	O
which	WDT	O	O
apparently	RB	O	O
happened	VBD	O	O
during	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
prior	JJ	I-TREATMENT	I-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
instructed	VBN	O	O
to	TO	O	O
followup	VB	O	O
with	IN	O	O
her	PRP	O	O
internist	NN	O	O
regarding	VBG	O	O
further	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
should	MD	O	O
be	VB	O	O
assessed	VBN	O	O
regarding	VBG	O	O
further	JJ	B-TREATMENT	B-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
as	IN	O	O
an	DT	O	O
inpatient	NN	O	O
,	,	O	O
or	CC	O	O
while	IN	O	O
receiving	VBG	O	O
chemotherapy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
discharged	VBN	O	O
home	NN	O	O
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
2.5	CD	O	O
mg.	NN	O	O
po	NN	O	O
q	NN	O	O
d	NN	O	O
,	,	O	O
and	CC	O	O
ativan	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
lomotil	JJ	B-TREATMENT	O
prn	NN	O	O
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
62	CD	O	O
year	NN	O	O
old	JJ	O	O
gentleman	NN	O	O
who	WP	O	O
underwent	VBD	O	O
an	DT	B-TEST	B-TEST
exercise	NN	I-TEST	I-TEST
treadmill	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
for	IN	O	O
screening	VBG	B-TEST	O
through	IN	O	O
the	DT	O	O
beth	NN	O	O
israel	JJ	O	O
deaconess	JJ	O	O
hospital-needham	JJ	O	O
clinic	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
test	NN	I-TEST	I-TEST
was	VBD	O	O
positive	JJ	O	O
for	IN	O	O
ekg	JJ	B-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
no	DT	O	O
history	NN	O	O
of	IN	O	O
chest	NN	B-PROBLEM	O
pain;	NN	I-PROBLEM	O
no	DT	O	O
history	NN	O	O
of	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
referred	VBN	O	O
to	TO	O	O
cambridge	VB	O	O
health	NN	O	O
alliance	NN	O	O
for	IN	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
.	.	O	O

cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
showed	VBD	O	O
an	DT	B-TEST	B-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
50%	CD	O	O
,	,	O	O
left	VBD	B-TEST	B-TEST
ventricular	JJ	I-TEST	I-TEST
end	NN	I-TEST	I-TEST
diastolic	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
20	CD	O	O
,	,	O	O
90%	CD	B-PROBLEM	O
left	VBD	I-PROBLEM	B-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
descending	VBG	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
,	,	O	I-PROBLEM
80%	CD	B-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
circumflex	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
80%	CD	B-PROBLEM	B-PROBLEM
mid	NN	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
80%	CD	B-PROBLEM	I-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
right	RB	I-PROBLEM	I-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
referred	VBN	O	O
to	TO	O	O
dr.	VB	O	O
rota	NN	O	O
for	IN	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

1.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2.	CD	O	O
type	NN	B-PROBLEM	B-PROBLEM
2	CD	I-PROBLEM	I-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
mellitus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

5.	CD	O	O
gout	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

6.	CD	O	O
gastroesophageal	JJ	B-PROBLEM	B-PROBLEM
reflux	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

7.	CD	O	O
history	NN	O	O
of	IN	O	O
salivary	JJ	B-TREATMENT	B-PROBLEM
gland	NN	I-TREATMENT	I-PROBLEM
removal	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
glucophage	NN	B-TREATMENT	B-TREATMENT
xr	NN	O	I-TREATMENT
1000	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

2.	CD	O	O
avandia	JJ	B-TREATMENT	B-TREATMENT
4	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

3.	CD	O	O
diovan	NN	B-TREATMENT	B-TREATMENT
160	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

4.	CD	O	O
atenolol	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

5.	CD	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

6.	CD	O	O
niaspan	JJ	B-TREATMENT	O
500	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

7.	CD	O	O
enteric-coated	JJ	B-TREATMENT	B-TREATMENT
aspirin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
saint	VB	O	O
vincent	JJ	O	O
hospital	NN	O	O
on	IN	O	O
2017-04-26	JJ	O	O
and	CC	O	O
underwent	JJ	O	O
a	DT	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
times	NNS	O	O
four	CD	O	O
with	IN	O	O
left	VBN	B-TREATMENT	O
internal	JJ	I-TREATMENT	O
mammary	JJ	I-TREATMENT	O
artery	NN	I-TREATMENT	O
to	TO	I-TREATMENT	O
left	VB	I-TREATMENT	O
anterior	JJ	I-TREATMENT	O
descending	NN	I-TREATMENT	O
,	,	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	I-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	O
pda	VB	I-TREATMENT	O
and	CC	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	O
obtuse	VB	I-TREATMENT	O
marginal	JJ	I-TREATMENT	O
with	IN	O	O
dr.	JJ	O	O
rota	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
in	IN	O	O
stable	JJ	O	O
condition	NN	O	O
on	IN	O	O
neo-synephrine	JJ	B-TREATMENT	B-TREATMENT
infusion	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
weaned	VBN	O	O
the	DT	O	O
next	JJ	O	O
day	NN	O	O
from	IN	O	O
mechanical	JJ	B-TREATMENT	B-TEST
ventilation	NN	I-TREATMENT	I-TEST
on	IN	O	O
his	PRP$	O	O
first	JJ	O	O
postoperative	JJ	O	O
night	NN	O	O
.	.	O	O

postoperative	JJ	O	O
days	NNS	O	O
one	CD	O	O
and	CC	O	O
two	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
require	VB	O	O
neo-synephrine	JJ	B-TREATMENT	O
to	TO	O	O
maintain	VB	O	O
systolic	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressures	NNS	I-TEST	I-TEST
greater	JJR	O	O
than	IN	O	O
100	CD	O	O
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
two	CD	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
23.1	CD	O	O
;	:	O	O
he	PRP	O	O
was	VBD	O	O
transfused	VBN	O	O
one	CD	O	O
unit	NN	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
as	RB	O	O
well	RB	O	O
as	IN	O	O
given	VBN	O	O
a	DT	O	O
dose	NN	O	O
of	IN	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	B-TREATMENT	O
neo-synephrine	NN	I-TREATMENT	O
was	VBD	O	O
weaned	VBN	O	O
off	RP	O	O
by	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
three	CD	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
patient	NN	I-TREATMENT	I-TREATMENT
's	POS	I-TREATMENT	I-TREATMENT
chest	JJS	I-TREATMENT	I-TREATMENT
tubes	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
removed	VBN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
three	CD	O	O
without	IN	O	O
incident	NN	B-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
low	JJ	B-TREATMENT	B-TREATMENT
dose	JJ	I-TREATMENT	I-TREATMENT
lasix	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
which	WDT	O	O
he	PRP	O	O
tolerated	VBD	O	O
well	RB	O	O
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
four	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
from	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
to	TO	O	O
the	DT	O	O
regular	JJ	O	O
part	NN	O	O
of	IN	O	O
the	DT	O	O
hospital	NN	O	O
where	WRB	O	O
he	PRP	O	O
began	VBD	O	O
working	VBG	O	O
with	IN	O	O
physical	JJ	O	B-TREATMENT
therapy	NN	O	I-TREATMENT
and	CC	O	O
on	IN	O	O
his	PRP$	O	O
first	JJ	O	O
session	NN	O	O
he	PRP	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
ambulate	VB	O	O
500	CD	O	O
feet	NNS	O	O
and	CC	O	O
climb	VB	O	O
one	CD	O	O
flight	NN	O	O
of	IN	O	O
stairs	NNS	O	O
while	IN	O	O
remaining	VBG	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
without	IN	O	O
requiring	VBG	O	O
any	DT	B-TREATMENT	B-TREATMENT
oxygen	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
patient	NN	I-TREATMENT	I-TREATMENT
's	POS	I-TREATMENT	I-TREATMENT
epicardial	JJ	I-TREATMENT	I-TREATMENT
pacing	NN	I-TREATMENT	I-TREATMENT
wires	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
removed	VBN	O	O
without	IN	O	O
incident	NN	B-PROBLEM	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
cleared	VBN	O	O
for	IN	O	O
discharge	NN	O	O
to	TO	O	O
home	NN	O	O
.	.	O	O

temperature	NN	B-TEST	B-TEST
maximum	VBZ	I-TEST	I-TEST
99.8	CD	O	O
f.	NN	O	O
;	:	O	O
pulse	CC	B-TEST	B-TEST
76	CD	O	O
and	CC	O	O
sinus	JJ	O	B-PROBLEM
rhythm	NN	O	I-PROBLEM
;	:	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
107/61	CD	O	O
;	:	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
18	CD	O	O
;	:	O	O
room	NN	B-TEST	B-TEST
air	NN	I-TEST	I-TEST
oxygen	NN	I-TEST	I-TEST
saturation	NN	I-TEST	I-TEST
95%	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
weight	NN	I-TEST	I-TEST
on	IN	O	O
05-01	NN	O	O
was	VBD	O	O
101.4	CD	O	O
.	.	O	O

white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
5.8	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
23.5	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
118	CD	O	O
.	.	O	O

sodium	NN	B-TEST	B-TEST
140	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
3.9	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
103	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
18	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
11	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
0.8	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
144	CD	O	O
.	.	O	O

pt	NN	B-TEST	O
29	CD	O	O
,	,	O	O
inr	NN	B-TEST	B-TEST
1.1	CD	O	O
and	CC	O	O
ptt	$	B-TEST	B-TEST
22.9	CD	O	O
.	.	O	O

neurological	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
is	VBZ	O	O
non-focal	JJ	O	O
.	.	O	O

heart	NN	O	O
is	VBZ	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
without	IN	O	O
rub	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

respiratory	JJ	B-TEST	B-TEST
breath	NN	I-TEST	I-TEST
sounds	NNS	I-TEST	I-TEST
are	VBP	O	O
clear	JJ	O	O
bilaterally	RB	O	O
,	,	O	O
decreased	VBN	B-PROBLEM	B-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
bases	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

abdomen	NNS	O	O
with	IN	O	O
positive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
,	,	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBD	B-PROBLEM	B-PROBLEM
,	,	O	O
tolerating	VBG	O	O
a	DT	O	O
regular	JJ	O	O
diet	NN	O	O
.	.	O	O

sternal	JJ	B-TREATMENT	B-TREATMENT
incision	NN	I-TREATMENT	I-TREATMENT
staples	NNS	I-TREATMENT	I-TREATMENT
are	VBP	O	O
intact	JJ	O	O
and	CC	O	O
open	JJ	O	O
to	TO	O	O
air	NN	O	O
.	.	O	O

incision	NN	B-PROBLEM	O
is	VBZ	O	O
clean	JJ	O	O
and	CC	O	O
dry	JJ	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
erythema	NN	B-PROBLEM	B-PROBLEM
and	CC	O	I-PROBLEM
sternum	NN	O	I-PROBLEM
is	VBZ	O	O
stable	JJ	O	O
.	.	O	O

right	RB	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
vein	NN	I-PROBLEM	I-PROBLEM
harvest	NN	I-PROBLEM	I-PROBLEM
site	NN	I-PROBLEM	I-PROBLEM
has	VBZ	O	O
a	DT	O	O
moderate	JJ	O	O
amount	NN	O	O
of	IN	O	O
ecchymosis	NN	B-PROBLEM	B-PROBLEM
at	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
very	RB	O	I-PROBLEM
distal	JJ	O	I-PROBLEM
portion	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
ankle	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
a	DT	O	O
minimum	JJ	O	O
amount	NN	O	O
of	IN	O	O
serosanguinous	JJ	B-PROBLEM	B-TREATMENT
drainage	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
erythema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
status	NN	O	O
post	NN	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
times	NNS	O	O
four	CD	O	O
.	.	O	O

3.	CD	O	O
type	NN	B-PROBLEM	B-PROBLEM
2	CD	I-PROBLEM	I-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
mellitus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
postoperative	JJ	B-PROBLEM	B-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
atenolol	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

2.	CD	O	O
lasix	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	NN	O	O
day	NN	O	O
times	NNS	O	O
seven	CD	O	O
days	NNS	O	O
.	.	O	O

3.	CD	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
20	CD	O	O
meq	NN	O	O
p.o.	NN	O	O
q.	NN	O	O
day	NN	O	O
times	NNS	O	O
seven	CD	O	O
days	NNS	O	O
.	.	O	O

4.	CD	O	O
niferex	JJ	B-TREATMENT	B-TREATMENT
150	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	NN	O	O
day	NN	O	O
times	NNS	O	O
one	CD	O	O
month	NN	O	O
.	.	O	O

5.	CD	O	O
vitamin	JJ	B-TREATMENT	B-TREATMENT
c	NN	I-TREATMENT	I-TREATMENT
500	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
times	VBZ	O	O
one	CD	O	O
month	NN	O	O
.	.	O	O

6.	CD	O	O
multivitamin	NN	B-TREATMENT	B-TREATMENT
one	CD	O	O
p.o.	NN	O	O
q.	NN	O	O
day	NN	O	O
times	NNS	O	O
one	CD	O	O
month	NN	O	O
.	.	O	O

7.	CD	O	O
ambien	JJ	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
h.s.	NN	O	O
p.r.n.	NN	O	O

8.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

9.	CD	O	O
avandia	JJ	B-TREATMENT	B-TREATMENT
4	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

10.	CD	O	O
glucophage	NN	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

11.	CD	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

12.	CD	O	O
zantac	NN	B-TREATMENT	B-TREATMENT
150	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

13.	CD	O	O
niaspan	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

14.	CD	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
5/325	CD	O	O
one	CD	O	O
to	TO	O	O
two	CD	O	O
p.o.	NNS	O	O
q.	RB	O	O
four	CD	O	O
to	TO	O	O
six	CD	O	O
hours	NNS	O	O
p.r.n.	VBP	O	O

3.	CD	O	O
the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
to	TO	O	O
return	VB	O	O
to	TO	O	O
smith	VB	O	O
on	IN	O	O
or	CC	O	O
about	IN	O	O
05-17	JJ	O	O
to	TO	O	O
have	VB	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
staples	NNS	I-TREATMENT	I-TREATMENT
removed	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
presented	VBN	O	O
with	IN	O	O
a	DT	O	O
chief	JJ	O	O
complaint	NN	O	O
of	IN	O	O
sscp	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

following	VBG	O	O
evaluation	NN	B-TEST	B-TEST
and	CC	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
the	DT	O	O
patient	NN	O	O
&apos;s	JJ	O	O
disposition	NN	O	O
at	IN	O	O
the	DT	O	O
end	NN	O	O
of	IN	O	O
the	DT	O	O
visit	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
as	IN	O	O
an	DT	O	O
inpatient	NN	O	O
to	TO	O	O
well	RB	O	O
general	JJ	O	O
hospital	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
preliminary	JJ	O	O
admitting	VBG	O	O
physician	NN	O	O
is	VBZ	O	O
reke	JJ	O	O
,	,	O	O
atota	JJ	O	O
s	NN	O	O
and	CC	O	O
the	DT	O	O
preliminary	JJ	O	O
diagnosis	NN	O	O
is	VBZ	O	O
acs	JJ	B-PROBLEM	O
..	NN	O	O

the	DT	O	O
patient	NN	O	O
originally	RB	O	O
presented	VBN	O	O
to	TO	O	O
her	PRP$	O	O
pcp	NN	O	O
approximately	RB	O	O
one	CD	O	O
week	NN	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
here	RB	O	O
with	IN	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
cough	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
fatigue	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
given	VBN	O	O
a	DT	B-TREATMENT	B-PROBLEM
z-pak	NN	I-TREATMENT	I-PROBLEM
for	IN	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
along	IN	O	O
with	IN	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

despite	IN	O	O
this	DT	O	O
,	,	O	O
she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
worsen	VB	O	O
and	CC	O	O
became	VBD	O	O
febrile	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

at	IN	O	O
the	DT	O	O
hospital	NN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
rocephin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
levaquin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
seen	VBN	O	O
on	IN	O	O
chest	JJ	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
.	.	O	O

she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
respiratory	JJ	I-PROBLEM	I-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
hypoxia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
also	RB	O	O
significantly	RB	B-PROBLEM	O
tachypneic	VBZ	I-PROBLEM	O
.	.	O	O

at	IN	O	O
this	DT	O	O
time	NN	O	O
,	,	O	O
repeat	NN	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	JJ	I-TEST	I-TEST
showed	VBD	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
diffuse	NN	I-PROBLEM	I-PROBLEM
infiltrates	VBZ	I-PROBLEM	I-PROBLEM
consistent	JJ	O	O
with	IN	O	O
ards	NNS	B-PROBLEM	O
.	.	O	O

hypothyroidism	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

depression	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

anxiety	NN	B-PROBLEM	B-PROBLEM
disorder	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
levoxyl	JJ	B-TREATMENT	O
112	CD	O	O
mcg	NN	O	O
q.d.	NN	O	O

2.	CD	O	O
prozac	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

3.	CD	O	O
codeine	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
cough	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
vital	JJ	B-TEST	O
signs:	NN	I-TEST	O

temperature	NN	B-TEST	B-TEST
101.4	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
101/62	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
80	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
19	CD	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
ventilator	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
settings	NNS	O	O
of	IN	O	O
assist	NN	B-TREATMENT	O
control	NN	I-TREATMENT	O
at	IN	O	O
500/12	CD	O	O
and	CC	O	O
a	DT	B-TREATMENT	O
peep	NN	I-TREATMENT	O
of	IN	O	O
5	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
intubated	VBN	B-TREATMENT	O
and	CC	O	O
sedated	VBN	B-TREATMENT	B-TREATMENT
,	,	O	O
but	CC	O	O
easily	RB	O	O
arousable	JJ	O	O
.	.	O	O

sclerae	NN	O	O
are	VBP	O	O
anicteric	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

et	NN	B-TREATMENT	O
tube	NN	I-TREATMENT	O
is	VBZ	O	O
in	IN	O	O
place	NN	O	O
.	.	O	O

faint	NN	B-PROBLEM	B-PROBLEM
scattered	VBD	I-PROBLEM	I-PROBLEM
wheezes	NNS	I-PROBLEM	I-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

labs	NNS	B-TEST	B-TEST
on	IN	O	O
admission	NN	O	O
from	IN	O	O
outside	JJ	O	O
hospital	NN	O	O
,	,	O	O
cbc	NN	B-TEST	B-TEST
notable	JJ	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
21.9	CD	O	O
with	IN	O	O
hematocrit	NN	B-TEST	B-TEST
of	IN	O	O
36.3	CD	O	O
and	CC	O	O
normal	JJ	O	O
platelets	NNS	O	O
.	.	O	O

chem-7	NN	B-TEST	B-TEST
notable	JJ	O	O
for	IN	O	O
potassium	NN	B-TEST	B-TEST
of	IN	O	O
3.2	CD	O	O
and	CC	O	O
bicarbonate	NN	B-TEST	B-TEST
of	IN	O	O
30	CD	O	O
.	.	O	O

lfts	NNS	B-TEST	O
show	VBP	O	O
an	DT	B-PROBLEM	B-PROBLEM
elevated	JJ	I-PROBLEM	I-PROBLEM
alt	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
52	CD	O	O
and	CC	O	O
ast	NN	B-TEST	B-TEST
of	IN	O	O
101	CD	O	O
with	IN	O	O
normal	JJ	O	O
alkaline	JJ	O	B-TEST
phosphatase	NN	O	I-TEST
and	CC	O	O
total	JJ	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
.	.	O	O

latest	JJS	B-TEST	B-TEST
arterial	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
gas	NN	I-TEST	I-TEST
with	IN	O	O
ph	NN	B-TEST	O
of	IN	O	O
7.45	CD	O	O
,	,	O	O
pco2	NN	B-TEST	O
43	CD	O	O
and	CC	O	O
po2	$	B-TEST	B-TREATMENT
155	CD	O	O
on	IN	O	O
100	CD	B-TREATMENT	O
percent	NN	I-TREATMENT	O
oxygen	NN	I-TREATMENT	B-TREATMENT
via	IN	O	I-TREATMENT
ventilator	NN	B-TREATMENT	I-TREATMENT
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
shows	NNS	O	O
right	RB	B-PROBLEM	B-PROBLEM
middle	JJ	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
infiltrates	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

ekg	NN	B-TEST	O
shows	VBZ	O	O
normal	JJ	O	O
sinus	NNS	O	O
rhythm	VBP	O	O
at	IN	O	O
70	CD	O	O
beats	NNS	O	O
per	IN	O	O
minute	NN	O	O
with	IN	O	O
normal	JJ	O	O
axis	NNS	O	O
and	CC	O	O
intervals	NNS	O	O
,	,	O	O
borderline	NN	B-PROBLEM	B-PROBLEM
lvh	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
what	WP	O	O
appeared	VBD	O	O
to	TO	O	O
be	VB	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
respiratory	JJ	I-PROBLEM	I-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
secondary	JJ	O	O
to	TO	O	O
community	NN	B-PROBLEM	O
-	:	I-PROBLEM	O
acquired	VBN	I-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
maintained	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
ventilator	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
ventilated	VBD	O	O
according	VBG	O	O
to	TO	O	O
ardsnet	NN	O	B-TREATMENT
protocol	NN	O	I-TREATMENT
.	.	O	O

for	IN	O	O
antibiotic	JJ	B-TREATMENT	B-TREATMENT
coverage	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
levaquin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
ceftriaxone	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

over	IN	O	O
the	DT	O	O
next	JJ	O	O
two	CD	O	O
days	NNS	O	O
after	IN	O	O
admission	NN	O	O
,	,	O	O
the	DT	B-TREATMENT	O
patient	NN	I-TREATMENT	O
's	POS	I-TREATMENT	B-TREATMENT
vent	JJ	I-TREATMENT	I-TREATMENT
settings	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
gradually	RB	O	O
weaned	VBN	O	O
,	,	O	O
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
extubated	VBN	O	O
two	CD	O	O
days	NNS	O	O
after	IN	O	O
being	VBG	O	O
transferred	VBN	O	O
to	TO	O	O
this	DT	O	O
hospital	NN	O	O
.	.	O	O

after	IN	O	O
extubation	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
oxygenating	VBG	O	O
well	RB	O	O
on	IN	O	O
face	NN	B-TREATMENT	B-TREATMENT
mask	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
did	VBD	O	O
continue	VB	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
persistent	JJ	I-PROBLEM	I-PROBLEM
fairly	RB	I-PROBLEM	I-PROBLEM
severe	JJ	I-PROBLEM	I-PROBLEM
cough	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
however	RB	O	O
,	,	O	O
her	PRP	B-PROBLEM	B-PROBLEM
cough	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
weak	JJ	B-PROBLEM	B-PROBLEM
due	JJ	O	O
to	TO	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
muscle	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
repeated	VBN	B-PROBLEM	O
coughing	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	O
cough	NN	I-PROBLEM	O
was	VBD	O	O
mostly	RB	B-PROBLEM	B-PROBLEM
nonproductive	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

as	IN	O	O
there	EX	O	O
was	VBD	O	O
no	DT	O	O
identified	JJ	B-PROBLEM	B-PROBLEM
bacterial	JJ	I-PROBLEM	I-PROBLEM
pathogen	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
any	DT	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
triple	JJ	I-TREATMENT	I-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
first	JJ	O	O
several	JJ	O	O
days	NNS	O	O
of	IN	O	O
the	DT	O	O
hospitalization	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
also	RB	O	O
on	IN	O	O
round-the-clock	JJ	B-TREATMENT	O
atrovent	NN	I-TREATMENT	O
and	CC	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
nebulizers	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

once	RB	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
out	IN	O	O
of	IN	O	O
the	DT	O	O
icu	NN	O	O
and	CC	O	O
after	IN	O	O
extubation	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
the	DT	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
gradually	RB	O	O
narrowed	VBN	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
vancomycin	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
levaquin	NN	B-TREATMENT	B-TREATMENT
were	VBD	O	O
discontinued	VBN	O	O
after	IN	O	O
approximately	RB	O	O
four	CD	O	O
days	NNS	O	O
in	IN	O	O
the	DT	O	O
hospital	NN	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
ceftriaxone	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
after	IN	O	O
four	CD	O	O
days	NNS	O	O
in	IN	O	O
the	DT	O	O
hospital	NN	O	O
,	,	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
to	TO	O	O
continue	VB	O	O
on	IN	O	O
levaquin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
gradual	JJ	O	O
improvement	NN	O	O
in	IN	O	O
her	PRP$	B-TEST	B-PROBLEM
oxygenation	NN	I-TEST	I-PROBLEM
.	.	O	O

pain	NN	B-TREATMENT	B-PROBLEM
control	NN	I-TREATMENT	O
:	:	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
fairly	RB	B-PROBLEM	B-PROBLEM
significant	JJ	I-PROBLEM	I-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
secondary	JJ	O	O
to	TO	O	O
persistent	JJ	B-PROBLEM	B-PROBLEM
cough	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
a	DT	O	B-TREATMENT
regimen	NN	O	I-TREATMENT
of	IN	O	I-TREATMENT
ms	NN	B-TREATMENT	I-TREATMENT
contin	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
oxycodone	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
breakthrough	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
helped	VBD	O	O
her	PRP	O	O
somewhat	RB	O	O
though	IN	O	O
she	PRP	O	O
has	VBZ	O	O
continued	VBN	O	O
to	TO	O	O
have	VB	O	O
difficulty	NN	B-PROBLEM	B-PROBLEM
coughing	VBG	I-PROBLEM	I-PROBLEM
due	JJ	O	O
to	TO	O	O
the	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

tylenol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
ibuprofen	NN	B-TREATMENT	B-TREATMENT
were	VBD	O	O
also	RB	O	O
added	VBN	O	O
for	IN	O	O
better	JJR	O	O
control	NN	O	O
.	.	O	O

transaminitis	NN	B-PROBLEM	O
:	:	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
mild	VBN	B-PROBLEM	B-PROBLEM
transaminitis	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
admission	NN	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
this	DT	O	O
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
due	JJ	O	O
to	TO	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
significant	JJ	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

anemia	NN	B-PROBLEM	B-PROBLEM
:	:	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
reticulocyte	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
showed	VBD	O	O
inadequate	JJ	B-PROBLEM	B-PROBLEM
production	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

iron	NN	B-TEST	B-TEST
studies	NNS	I-TEST	I-TEST
showed	VBD	O	O
a	DT	O	B-PROBLEM
mixed	JJ	O	I-PROBLEM
picture	NN	O	I-PROBLEM
with	IN	O	O
decreased	JJ	B-PROBLEM	B-PROBLEM
iron	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
decreased	VBD	B-PROBLEM	O
iron	NN	I-PROBLEM	B-TREATMENT
to	TO	I-PROBLEM	O
tibc	VB	I-PROBLEM	O
ratio	JJ	I-PROBLEM	O
suggestive	NN	O	O
of	IN	O	O
iron-deficiency	NN	B-PROBLEM	B-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
also	RB	O	O
normal	JJ	O	O
to	TO	O	O
high	JJ	B-PROBLEM	B-PROBLEM
mcv	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

b12	NN	B-TEST	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
low	JJ	B-PROBLEM	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
given	VBN	O	O
an	DT	O	B-TREATMENT
injection	NN	O	I-TREATMENT
of	IN	O	O
im	JJ	B-TREATMENT	O
b12	NN	I-TREATMENT	O
while	IN	O	O
in	IN	O	O
the	DT	O	O
hospital	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
also	RB	O	O
started	VBN	O	O
on	IN	O	O
iron	NN	B-TREATMENT	B-TREATMENT
supplementation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

hypothyroidism	NN	B-PROBLEM	B-PROBLEM
:	:	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
synthroid	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
chronic	JJ	I-PROBLEM	I-PROBLEM
hypothyroidism	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

community-acquired	JJ	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

acute	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

iron-deficiency	NN	B-PROBLEM	O
anemia	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

hypothyroidism	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1.	CD	O	O
levothyroxine	JJ	B-TREATMENT	B-TREATMENT
75	CD	O	O
mcg	NN	O	O
q.d.	NN	O	O

2.	CD	O	O
prozac	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

3.	CD	O	O
levaquin	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
q.d.	NN	O	O
for	IN	O	O
7	CD	O	O
days	NNS	O	O
after	IN	O	O
discharge	NN	O	O
.	.	O	O

4.	CD	O	O
guaifenesin	NN	B-TREATMENT	B-TREATMENT
syrup	NN	I-TREATMENT	I-TREATMENT
p.r.n.	JJ	O	O
cough	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

5.	CD	O	O
oxycodone	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
q.4	NN	O	O
h.	NN	O	O
p.r.n.	NN	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

6.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O

7.	CD	O	O
ms	NN	B-TREATMENT	B-TREATMENT
contin	NN	I-TREATMENT	I-TREATMENT
30	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O

8.	CD	O	O
ibuprofen	JJ	B-TREATMENT	B-TREATMENT
800	CD	O	O
mg	NN	O	O
q.8	NN	O	O
h	NN	O	O
.	.	O	O

9.	CD	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
1	CD	O	O
to	TO	O	O
2	CD	O	O
puffs	NNS	O	O
q.6	JJ	O	O
h.	JJ	O	O
p.r.n.	NN	O	O

10.	CD	O	O
atrovent	JJ	B-TREATMENT	B-TREATMENT
1	CD	O	O
puff	NN	O	O
q.6	NN	O	O
h.	NN	O	O
p.r.n.	NN	O	O

she	PRP	O	O
is	VBZ	O	O
also	RB	O	O
to	TO	O	O
call	VB	O	O
her	PRP$	O	O
pcp	NN	O	O
if	IN	O	O
she	PRP	O	O
has	VBZ	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
shortness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
presented	VBN	O	O
with	IN	O	O
a	DT	O	O
chief	JJ	O	O
complaint	NN	O	O
of	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
leg	NN	I-PROBLEM	I-PROBLEM
fx	NN	I-PROBLEM	I-PROBLEM
hip	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

following	VBG	O	O
evaluation	NN	B-TEST	B-TEST
and	CC	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
the	DT	O	O
patient	NN	O	O
&apos;s	JJ	O	O
disposition	NN	O	O
at	IN	O	O
the	DT	O	O
end	NN	O	O
ofthe	NN	O	O
visit	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
as	IN	O	O
an	DT	O	O
inpatient	NN	O	O
to	TO	O	O
bri	VB	O	O
health	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
preliminary	JJ	O	O
admitting	VBG	O	O
physician	NN	O	O
is	VBZ	O	O
heagleinchird	JJ	O	O
,	,	O	O
jeansia	JJ	O	B-PROBLEM
s	NN	O	I-PROBLEM
and	CC	O	O
the	DT	O	O
preliminary	JJ	O	O
diagnosis	NN	O	O
is	VBZ	O	O
hip	JJ	B-PROBLEM	B-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
45	CD	O	O
-	:	O	O
year-old	JJ	O	O
female	NN	O	O
here	RB	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
diagnostic	JJ	I-TEST	I-TEST
cerebral	JJ	I-TEST	I-TEST
angiogram	NN	I-TEST	I-TEST
with	IN	O	O
coiling	NN	B-TREATMENT	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
vital	JJ	I-TEST	I-TEST
signs	NNS	I-TEST	I-TEST
were	VBD	O	O
stable	JJ	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
102/82	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
was	VBD	O	O
71	CD	O	O
.	.	O	O

her	PRP$	B-TEST	O
spo2	NN	I-TEST	O
was	VBD	O	O
98	CD	O	O
percent	NN	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

1.	CD	O	O
plavix	JJ	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
times	NNS	O	O
6	CD	O	O
doses	NNS	O	O
.	.	O	O

2.	CD	O	O
xanax	CD	B-TREATMENT	O
q.d.	NN	O	O

3.	CD	O	O
prozac	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

4.	CD	O	O
cyclobenzaprine	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

5.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NN	O	O
times	NNS	O	O
3	CD	O	O
doses	NNS	O	O
.	.	O	O

6.	CD	O	O
vitamin	JJ	B-TREATMENT	B-TREATMENT
e	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

tubal	JJ	B-TREATMENT	B-TREATMENT
ligation	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
1986	CD	O	O
.	.	O	O

cystectomy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
1992	CD	O	O
and	CC	O	O
1998	CD	O	O
.	.	O	O

breast	NN	B-TREATMENT	B-PROBLEM
lesion	NN	I-TREATMENT	I-PROBLEM
excision	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
1989	CD	O	O
.	.	O	O

tetracycline	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
complaint	NN	O	O
of	IN	O	O
headaches	NNS	B-PROBLEM	B-PROBLEM
in	IN	O	O
the	DT	O	O
past	NN	O	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
fibromyalgia	VBN	B-PROBLEM	B-PROBLEM
and	CC	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
slurred	JJ	B-PROBLEM	B-PROBLEM
speech	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
2017-09-13	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
brought	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
and	CC	O	O
underwent	NN	O	O
a	DT	B-TREATMENT	B-TREATMENT
coiling	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
stent	JJ	B-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
carotid	NN	I-PROBLEM	I-PROBLEM
ophthalmic	JJ	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	JJ	O	O
underwent	JJ	O	O
coiling	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
stent	JJ	B-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
without	IN	O	O
complications	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

postoperative	JJ	B-TEST	O
check	NN	I-TEST	O
,	,	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
vital	JJ	I-TEST	I-TEST
signs	NNS	I-TEST	I-TEST
were	VBD	O	O
stable	JJ	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
was	VBD	O	O
96.3	CD	O	O
degrees	NNS	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
128/63	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
pulse	NN	I-TEST	I-TEST
was	VBD	O	O
61	CD	O	O
,	,	O	O
respirations	NNS	B-TEST	B-TEST
12	CD	O	O
,	,	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
o2	JJ	I-TEST	I-TEST
saturation	NN	I-TEST	I-TEST
was	VBD	O	O
98	CD	O	O
percent	NN	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
labs	NN	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
7.7	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
of	IN	O	O
33.3	CD	O	O
,	,	O	O
and	CC	O	O
platelets	NNS	B-TEST	B-TEST
were	VBD	O	O
305	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
coags	NNS	I-TEST	I-TEST
,	,	O	O
her	PRP$	B-TEST	O
pt	NN	I-TEST	O
was	VBD	O	O
14.5	CD	O	O
,	,	O	O
ptt	NN	B-TEST	B-TEST
was	VBD	O	O
143.4	CD	O	O
,	,	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
inr	NN	I-TEST	I-TEST
was	VBD	O	O
1.3	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
electrolytes	NNS	I-TEST	I-TEST
were	VBD	O	O
all	DT	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

on	IN	O	O
physical	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
awake	RB	O	O
,	,	O	O
alert	NN	O	O
,	,	O	O
and	CC	O	O
oriented	VBD	O	O
times	NNS	O	O
3	CD	O	O
.	.	O	O

her	PRP$	O	B-TEST
strength	NN	O	I-TEST
was	VBD	O	O
05-31	JJ	O	O
throughout	IN	O	O
except	IN	O	O
for	IN	O	O
right	NN	O	O
was	VBD	O	O
not	RB	O	O
tested	VBN	O	O
due	JJ	O	O
to	TO	O	O
the	DT	B-PROBLEM	O
angiocele	NN	I-PROBLEM	O
in	IN	I-PROBLEM	O
her	PRP$	I-PROBLEM	O
groin	NN	I-PROBLEM	O
.	.	O	O

angiocele	NN	B-PROBLEM	O
was	VBD	O	O
intact	JJ	O	O
without	IN	O	O
hematoma	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
she	PRP	O	O
exhibited	VBD	O	O
strong	JJ	O	B-TEST
pedal	NN	O	I-TEST
pulses	NNS	O	I-TEST
on	IN	O	O
the	DT	O	O
right	JJ	O	O
side	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
assessment	NN	I-TEST	I-TEST
at	IN	O	O
that	DT	O	O
time	NN	O	O
was	VBD	O	O
she	PRP	O	O
was	VBD	O	O
neurologically	RB	O	O
stable	JJ	O	O
.	.	O	O

the	DT	O	O
plan	NN	O	O
was	VBD	O	O
q.	JJ	O	O
1-hour	JJ	O	B-TEST
neuro	NN	B-TEST	I-TEST
checks	NNS	I-TEST	I-TEST
.	.	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
heparin	NN	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
800	CD	O	O
per	IN	O	O
hour	NN	O	O
.	.	O	O

her	PRP$	B-TEST	O
ptt	NN	I-TEST	O
goes	VBZ	O	O
50	CD	O	O
to	TO	O	O
60	CD	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
.	.	O	O

she	PRP	O	O
exhibited	VBD	O	O
no	DT	O	O
drift	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TREATMENT
ips	NNS	I-TEST	I-TREATMENT
were	VBD	O	O
full	JJ	O	O
at	IN	O	O
5/5	CD	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
no	DT	O	O
hematoma	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
groin	NN	I-PROBLEM	I-PROBLEM
site	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
vital	JJ	I-TEST	I-TEST
signs	NNS	I-TEST	I-TEST
were	VBD	O	O
stable	JJ	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
of	IN	O	O
97.8	CD	O	O
degrees	NNS	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
104	CD	O	O
to	TO	O	O
121	CD	O	O
over	IN	O	O
50s	CD	O	O
.	.	O	O

pulse	NN	B-TEST	B-TEST
was	VBD	O	O
60	CD	O	O
to	TO	O	O
70	CD	O	O
.	.	O	O

respirations	NNS	B-TEST	B-TEST
were	VBD	O	O
15	CD	O	O
,	,	O	O
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
saturating	VBG	O	O
at	IN	O	O
96	CD	O	O
percent	NN	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

her	PRP$	B-TEST	B-TREATMENT
ptt	NN	I-TEST	I-TREATMENT
at	IN	O	O
that	DT	O	O
time	NN	O	O
was	VBD	O	O
67.8	CD	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NN	O	O
q.d.	NN	O	O
and	CC	O	O
plavix	NN	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

postoperative	JJ	O	O
day	NN	O	O
2	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
stable	JJ	O	O
without	IN	O	O
events	NNS	O	O
,	,	O	O
all	DT	B-TEST	B-TEST
vital	JJ	I-TEST	I-TEST
signs	NNS	I-TEST	I-TEST
were	VBD	O	O
stable	JJ	O	O
.	.	O	O

angio	JJ	B-PROBLEM	B-PROBLEM
site	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
clean	JJ	O	O
,	,	O	O
dry	JJ	O	O
,	,	O	O
and	CC	O	O
intact	JJ	O	O
without	IN	O	O
bleeding	VBG	B-PROBLEM	B-PROBLEM
or	CC	O	O
drainage	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1.	CD	O	O
plavix	JJ	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

2.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

she	PRP	O	O
is	VBZ	O	O
to	TO	O	O
continue	VB	O	O
taking	VBG	O	O
medications	NNS	B-TREATMENT	B-TREATMENT
as	IN	O	O
prescribed	NN	O	O
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
status	NN	O	O
post	NN	O	O
coiling	VBG	B-TREATMENT	O
with	IN	O	O
stent	JJ	B-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
carotid	NN	I-PROBLEM	I-PROBLEM
ophthalmic	JJ	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
also	RB	O	O
to	TO	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
her	PRP$	O	O
primary	JJ	O	O
care	NN	O	O
physician	NN	O	O
to	TO	O	O
review	VB	O	O
her	PRP$	B-TREATMENT	B-PROBLEM
hypertensive	JJ	I-TREATMENT	I-PROBLEM
medications	NNS	I-TREATMENT	I-PROBLEM
.	.	O	O

coiling	VBG	B-TREATMENT	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
stent	JJ	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
carotid	NN	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

failed	VBD	B-PROBLEM	O
coronary	JJ	I-PROBLEM	B-TREATMENT
artery	NN	I-PROBLEM	I-TREATMENT
bypass	NN	I-PROBLEM	I-TREATMENT
graft	NN	I-PROBLEM	I-TREATMENT
,	,	O	O
prior	JJ	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
elevated	VBN	B-PROBLEM	B-PROBLEM
cholesterol	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
renal	JJ	B-PROBLEM	B-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

08/20/98	CD	O	O
dual	JJ	B-TREATMENT	B-TREATMENT
chamber	NN	I-TREATMENT	I-TREATMENT
pacemaker	NN	I-TREATMENT	I-TREATMENT
generator	NN	I-TREATMENT	I-TREATMENT
change	NN	I-TREATMENT	I-TREATMENT
(	(	O	O
cpi	JJ	O	O
1276	CD	O	O
meridian	JJ	O	O
dr	NN	O	O
)	)	O	O
.	.	O	O

08/15/98	CD	O	O
bilateral	JJ	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
;	:	O	O
08/15/98	CD	O	O
left	VBD	B-TEST	O
ventriculography	NN	I-TEST	O
;	:	O	O
08/15/98	CD	O	O
bilateral	JJ	B-TEST	B-TEST
coronary	JJ	I-TEST	I-TEST
angiography	NN	I-TEST	I-TEST
;	:	O	O
08/15/98	CD	O	B-TREATMENT
bypass	NN	B-TEST	I-TREATMENT
graft	NN	I-TEST	I-TREATMENT
angiography	NN	I-TEST	I-TREATMENT
;	:	O	O
08/15/98	CD	O	O
internal	JJ	B-TEST	O
mammary	JJ	I-TEST	O
artery	NN	I-TEST	O
angiography	NN	I-TEST	B-TEST
.	.	O	O

aspirin	RB	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg.	NNS	O	O
po	JJ	O	O
q.d.	NN	O	O

lipitor	NN	B-TREATMENT	B-TREATMENT
80	CD	O	O
mg.	NN	O	O
po	NN	O	O
q.d.	NN	O	O

toprol	NN	B-TREATMENT	B-TREATMENT
xl	VBZ	I-TREATMENT	I-TREATMENT
50	CD	O	O
mg.	NN	O	O
po	NN	O	O
q.d.	NN	O	O

lasix	RB	B-TREATMENT	B-TREATMENT
80	CD	O	O
mg.	NNS	O	O
q.a.m.	RB	O	O
and	CC	O	O
40	CD	O	O
mg.	NNS	O	O
q.p.m.	RB	O	O

potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
20	CD	O	O
meq.	NN	O	O
po	NN	O	O
b.i.d.	NN	O	O

citracal	JJ	B-TREATMENT	O
1	CD	O	O
packet	NN	O	O
q.d.	NN	O	O

imdur	NN	B-TREATMENT	B-TREATMENT
60	CD	O	O
mg.	NN	O	O
po	NN	O	O
q.d.	NN	O	O

vitamin	NN	B-TREATMENT	B-TEST
e	VBZ	I-TREATMENT	I-TEST
400	CD	O	O
international	JJ	O	O
units	NNS	O	O
q.d.	VBP	O	O

prilosec	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg.	NN	O	O
po	NN	O	O
q.d.	NN	O	O

she	PRP	O	O
is	VBZ	O	O
referred	VBN	O	O
for	IN	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
angina	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
rheumatoid	JJ	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
as	IN	O	O
a	DT	O	O
child	NN	O	O
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
noted	VBD	O	O
but	CC	O	O
no	DT	O	O
further	JJ	B-TEST	B-TEST
testing	NN	I-TEST	I-TEST
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
used	VBN	O	O
antibiotic	JJ	B-TREATMENT	B-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
since	IN	O	O
1980	CD	O	O
.	.	O	O

in	IN	O	O
1980	CD	O	O
she	PRP	O	O
had	VBD	O	O
quadruple	JJ	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
by	IN	O	O
dr.	NN	O	O
elks	NNS	O	O
at	IN	O	O
feargunwake	JJ	O	O
otacaa	NN	O	O
community	NN	O	O
hospital	NN	O	O
and	CC	O	O
did	VBD	O	O
well	RB	O	O
until	IN	O	O
1988	CD	O	O
when	WRB	O	O
she	PRP	O	O
had	VBD	O	O
exertional	JJ	B-PROBLEM	B-PROBLEM
angina	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
stress	NN	I-PROBLEM	I-PROBLEM
test	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
found	VBD	O	O
that	IN	O	O
three	CD	B-TREATMENT	O
or	CC	I-TREATMENT	O
four	CD	I-TREATMENT	B-TREATMENT
grafts	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
occluded	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

in	IN	O	O
october	NNP	O	O
,	,	O	O
1989	CD	O	O
,	,	O	O
dr.	VBZ	O	O
no	DT	O	O
re-did	JJ	O	B-TREATMENT
her	PRP$	B-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
operation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
left	VBN	I-TREATMENT	I-TREATMENT
internal	JJ	I-TREATMENT	I-TREATMENT
mammary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
left	VBN	I-TREATMENT	I-TREATMENT
anterior	JJ	I-TREATMENT	I-TREATMENT
descending	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
obtuse	NN	I-TREATMENT	I-TREATMENT
marginal	JJ	I-TREATMENT	I-TREATMENT
1	CD	I-TREATMENT	O
and	CC	O	O
a	DT	B-TREATMENT	B-TREATMENT
saphenous	JJ	I-TREATMENT	I-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
obtuse	NN	I-TREATMENT	I-TREATMENT
marginal	JJ	I-TREATMENT	I-TREATMENT
2	CD	I-TREATMENT	O
.	.	O	O

in	IN	O	O
1993	CD	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
ddd	NN	I-TREATMENT	I-TREATMENT
pacemaker	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
complete	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
block	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
exertional	JJ	B-PROBLEM	B-PROBLEM
angina	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
that	DT	O	O
time	NN	O	O
.	.	O	O

in	IN	O	O
november	NNP	O	O
,	,	O	O
1997	CD	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
as	IN	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
ona	VB	O	O
hospital	NN	O	O
where	WRB	O	O
a	DT	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
tight	JJ	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
internal	JJ	I-PROBLEM	I-PROBLEM
mammary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
left	VB	B-PROBLEM	O
anterior	RP	I-PROBLEM	O
descending	VBG	I-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
high	JJ	O	B-PROBLEM
grade	NN	O	I-PROBLEM
saphenous	JJ	O	I-PROBLEM
vein	NN	O	I-PROBLEM
graft	NN	O	I-PROBLEM
to	TO	O	I-PROBLEM
obtuse	VB	B-PROBLEM	I-PROBLEM
marginal	JJ	I-PROBLEM	I-PROBLEM
1	CD	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
patent	NN	O	B-TREATMENT
obtuse	VBP	O	I-TREATMENT
marginal	JJ	O	I-TREATMENT
2	CD	O	I-TREATMENT
graft	NN	O	I-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
normal	JJ	O	O
left	JJ	O	O
ventricular	JJ	O	O
function	NN	O	O
with	IN	O	O
apical	JJ	B-PROBLEM	B-PROBLEM
tip	NN	I-PROBLEM	I-PROBLEM
akinesis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

since	IN	O	O
that	DT	O	O
time	NN	O	O
she	PRP	O	O
has	VBZ	O	O
continued	VBN	O	O
to	TO	O	O
have	VB	O	O
exertional	JJ	B-PROBLEM	B-PROBLEM
left	VBN	I-PROBLEM	I-PROBLEM
chest	JJS	I-PROBLEM	I-PROBLEM
burning	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
radiating	VBG	O	O
to	TO	O	O
the	DT	O	O
left	VBN	O	O
neck	NN	O	O
and	CC	O	O
arm	NN	O	O
,	,	O	O
relieved	VBN	O	O
by	IN	O	O
nitroglycerin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
turned	VBN	O	O
down	RP	O	O
for	IN	O	O
re-do	JJ	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
that	DT	O	O
time	NN	O	O
and	CC	O	O
did	VBD	O	O
not	RB	O	O
have	VB	O	O
a	DT	B-TREATMENT	B-TREATMENT
percutaneous	JJ	I-TREATMENT	I-TREATMENT
transluminal	JJ	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
angioplasty	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

because	IN	O	O
these	DT	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
have	VBP	O	O
been	VBN	O	O
increasing	VBG	O	O
,	,	O	O
particularly	RB	O	O
at	IN	O	O
cardiac	JJ	O	O
rehabilitation	NN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
referred	VBN	O	O
here	RB	O	O
.	.	O	O

in	IN	O	O
may	MD	O	O
,	,	O	O
1998	CD	O	O
she	PRP	O	O
had	VBD	O	O
an	DT	B-TEST	B-TEST
exercise	NN	I-TEST	I-TEST
tolerance	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
in	IN	O	O
which	WDT	O	O
her	PRP$	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
went	VBD	O	O
to	TO	O	O
112	CD	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
fell	VBD	O	O
to	TO	O	O
95	CD	O	O
systolic	NN	O	B-TEST
.	.	O	O

she	PRP	O	O
had	VBD	O	O
diffuse	NN	B-PROBLEM	B-PROBLEM
ischemic	JJ	I-PROBLEM	I-PROBLEM
st	NN	I-PROBLEM	I-PROBLEM
segment	NN	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
increased	VBD	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
uptake	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
reversible	JJ	I-PROBLEM	I-PROBLEM
anterior	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
lateral	JJ	I-PROBLEM	I-PROBLEM
defect	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
had	VBD	O	O
no	DT	O	O
syncope	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

her	PRP$	O	B-TEST
cardiac	JJ	O	I-TEST
risk	NN	O	I-TEST
factors	NNS	O	I-TEST
are	VBP	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
elevated	VBN	B-PROBLEM	B-PROBLEM
cholesterol	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
a	DT	O	O
very	RB	O	O
strong	JJ	O	O
family	NN	O	O
history	NN	O	O
of	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	O	O
mother	NN	O	O
,	,	O	O
sister	NN	O	O
and	CC	O	O
brother	NN	O	O
dying	NN	O	O
of	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
also	RB	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
lactose	JJ	B-PROBLEM	B-PROBLEM
intolerance	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
peptic	JJ	B-PROBLEM	B-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
remote	JJ	I-PROBLEM	I-PROBLEM
gastrointestinal	JJ	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
ectopic	NN	I-PROBLEM	I-PROBLEM
pregnancies	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
mid	JJ	B-PROBLEM	I-PROBLEM
term	NN	I-PROBLEM	I-PROBLEM
miscarriages	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
total	JJ	I-TREATMENT	I-TREATMENT
abdominal	JJ	I-TREATMENT	I-TREATMENT
hysterectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

her	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
120/70	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
60	CD	O	O
and	CC	O	O
regular	JJ	O	O
.	.	O	O

neck	NN	O	O
veins	NNS	O	O
are	VBP	O	O
not	RB	O	O
distended	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
12	CD	O	O
.	.	O	O

no	DT	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

1/6	CD	B-PROBLEM	O
systolic	JJ	I-PROBLEM	B-PROBLEM
ejection	NN	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

peripheral	JJ	B-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
intact	JJ	O	O
.	.	O	O

neurological	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
non-focal	JJ	O	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
includes	VBZ	O	O
an	DT	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
that	WDT	O	O
shows	VBZ	O	O
ddd	RP	B-TREATMENT	B-PROBLEM
pacing	VBG	I-TREATMENT	I-PROBLEM
.	.	O	O

hematocrit	NN	B-TEST	B-TEST
39	CD	O	O
percent	NN	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
4500	CD	O	O
,	,	O	O
pt	NN	B-TEST	O
and	CC	O	O
ptt	NN	B-TEST	B-TEST
normal	JJ	O	O
.	.	O	O

sodium	NN	B-TEST	B-TEST
140	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.2	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
105	CD	O	O
,	,	O	O
carbon	NN	B-TEST	B-TEST
dioxide	NN	I-TEST	I-TEST
30	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
24	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
1.0	CD	O	O
.	.	O	O

there	RB	O	O
,	,	O	O
her	PRP	B-TEST	B-TEST
pulmonary	JJ	I-TEST	I-TEST
wedge	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
12	CD	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
right	JJ	I-TEST	I-TEST
atrial	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
4	CD	O	O
and	CC	O	O
pulmonary	JJ	B-TEST	B-TREATMENT
artery	NN	I-TEST	I-TREATMENT
pressure	NN	I-TEST	I-TREATMENT
44/17	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
left	JJ	I-TEST	I-TEST
ventricular	JJ	I-TEST	I-TEST
contraction	NN	I-TEST	I-TEST
showed	VBD	O	O
akinesis	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
dyskinesis	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
apex	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	O	O
native	JJ	O	O
right	NN	O	O
and	CC	O	O
left	VBD	O	O
anterior	RP	O	O
descending	VBG	O	O
vessels	NNS	O	O
were	VBD	O	O
occluded	VBN	B-PROBLEM	O
as	IN	O	O
was	VBD	O	O
an	DT	O	B-PROBLEM
obtuse	NN	O	I-PROBLEM
marginal	JJ	O	I-PROBLEM
branch	NN	O	I-PROBLEM
.	.	O	O

the	DT	O	O
saphenous	JJ	O	O
vein	NN	O	O
to	TO	O	O
the	DT	O	B-PROBLEM
high	JJ	O	I-PROBLEM
diagonal	NN	O	I-PROBLEM
or	CC	O	O
high	JJ	O	B-PROBLEM
obtuse	IN	O	I-PROBLEM
marginal	NN	O	I-PROBLEM
was	VBD	O	O
occluded	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
left	JJ	O	O
internal	JJ	O	O
mammary	JJ	O	O
artery	NN	O	O
to	TO	O	O
the	DT	O	O
left	VBN	O	O
anterior	JJ	O	O
descending	NN	O	O
was	VBD	O	O
also	RB	O	O
occluded	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
saphenous	JJ	I-TREATMENT	I-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	O
the	DT	I-TREATMENT	O
second	JJ	I-TREATMENT	O
obtuse	IN	I-TREATMENT	O
marginal	NN	I-TREATMENT	O
was	VBD	O	O
open	JJ	O	O
with	IN	O	O
no	DT	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
there	EX	O	O
was	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
outflow	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
obtuse	NN	I-PROBLEM	O
marginal	JJ	I-PROBLEM	O
2	CD	I-PROBLEM	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
as	IN	O	O
the	DT	O	O
obtuse	NN	O	O
marginal	JJ	O	O
2	CD	O	O
fed	VBD	O	O
the	DT	O	O
posterior	JJ	O	O
descending	NN	O	O
artery	NN	O	O
.	.	O	O

this	DT	O	O
was	VBD	O	O
considered	VBN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
culprit	NN	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
was	VBD	O	O
considered	VBN	O	O
too	RB	O	O
high	JJ	O	O
risk	NN	O	O
for	IN	O	O
angioplasty	JJ	B-TREATMENT	B-TREATMENT
because	IN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
severe	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	B-TREATMENT	I-PROBLEM
graft	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

she	PRP	O	O
would	MD	O	O
not	RB	O	O
sense	VB	O	O
the	DT	O	B-PROBLEM
atrial	JJ	O	I-PROBLEM
contraction	NN	O	I-PROBLEM
and	CC	O	O
the	DT	O	O
fire	NN	O	O
and	CC	O	O
this	DT	O	O
occasionally	RB	O	O
led	VBN	O	O
to	TO	O	O
competition	NN	B-PROBLEM	O
of	IN	I-PROBLEM	O
firing	NN	I-PROBLEM	O
.	.	O	O

the	DT	B-TEST	B-TEST
p	NN	I-TEST	I-TEST
wave	VBP	I-TEST	I-TEST
amplitude	NN	I-TEST	I-TEST
was	VBD	O	O
.6	JJ	O	O
and	CC	O	O
this	DT	O	O
could	MD	O	O
not	RB	O	O
be	VB	O	O
totally	RB	O	O
sensed	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
management	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
evaluation	NN	B-TEST	B-TEST
of	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
pacemaker	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

it	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
that	IN	O	O
she	PRP	O	O
became	VBD	O	O
very	RB	B-PROBLEM	B-PROBLEM
symptomatic	JJ	I-PROBLEM	I-PROBLEM
when	WRB	O	O
she	PRP	O	O
was	VBD	O	O
not	RB	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
beta	NN	I-TREATMENT	I-TREATMENT
blocker	NN	I-TREATMENT	I-TREATMENT
but	CC	O	O
that	IN	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
beta	NN	I-TREATMENT	I-TREATMENT
blocker	NN	I-TREATMENT	I-TREATMENT
she	PRP	O	O
had	VBD	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
pacemaker	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
pacemaker	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
set	VBN	O	O
to	TO	O	O
a	DT	O	O
vvi	NN	O	O
mode	NN	O	O
which	WDT	O	O
sensed	VBD	O	O
appropriately	RB	O	O
.	.	O	O

when	WRB	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
pacemaker	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
in	IN	O	O
a	DT	O	O
sinus	NN	O	O
rhythm	NN	O	O
without	IN	O	O
a	DT	B-TREATMENT	B-PROBLEM
beta	NN	I-TREATMENT	I-PROBLEM
blocker	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
she	PRP	O	O
had	VBD	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
angina	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

carotid	JJ	B-TEST	B-TEST
non-invasive	JJ	I-TEST	I-TEST
testing	NN	I-TEST	I-TEST
was	VBD	O	O
unremarkable	JJ	O	O
.	.	O	O

he	PRP	O	O
felt	VBD	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
not	RB	O	O
a	DT	O	B-TREATMENT
coronary	JJ	O	I-TREATMENT
artery	NN	O	I-TREATMENT
bypass	NN	O	I-TREATMENT
graft	NN	O	I-TREATMENT
candidate	NN	O	I-TREATMENT
because	IN	O	O
of	IN	O	O
the	DT	B-PROBLEM	O
lack	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
conduit	NN	I-PROBLEM	O
and	CC	O	O
because	IN	O	O
of	IN	O	O
the	DT	O	O
presence	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

for	IN	O	O
this	DT	O	O
reason	NN	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
to	TO	O	O
maximize	VB	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
beta	NN	I-TREATMENT	I-TREATMENT
blockers	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
nitrates	NNS	B-TREATMENT	B-PROBLEM
.	.	O	O

on	IN	O	O
august	JJ	O	O
20	CD	O	O
,	,	O	O
under	IN	O	O
local	JJ	B-TREATMENT	B-TREATMENT
anesthesia	VBP	I-TREATMENT	I-TREATMENT
the	DT	O	I-TREATMENT
right	JJ	O	I-TREATMENT
pectoral	JJ	O	I-TREATMENT
region	NN	O	I-TREATMENT
was	VBD	O	O
explored	VBN	O	O
and	CC	O	O
the	DT	O	O
leads	NNS	O	O
disconnected	VBD	O	O
and	CC	O	O
the	DT	B-TREATMENT	B-TEST
pulse	JJ	I-TREATMENT	I-TEST
generator	NN	I-TREATMENT	I-TEST
changed	VBD	O	O
to	TO	O	O
a	DT	B-TREATMENT	B-TEST
cpi	NN	I-TREATMENT	I-TEST
unit	NN	I-TREATMENT	I-TEST
in	IN	O	O
which	WDT	O	O
the	DT	O	O
sensitivity	NN	O	O
could	MD	O	O
be	VB	O	O
adjusted	VBN	O	O
to	TO	O	O
.15	VB	O	O
mm.	NN	O	O
,	,	O	O
which	WDT	O	O
permitted	VBD	O	O
appropriate	JJ	O	O
atrial	JJ	O	O
sensing	NN	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
nothing	NN	O	O
wrong	JJ	O	O
with	IN	O	O
the	DT	B-TREATMENT	O
prior	JJ	I-TREATMENT	O
generator	NN	I-TREATMENT	O
and	CC	O	O
nothing	NN	O	O
wrong	JJ	O	O
with	IN	O	O
the	DT	B-TREATMENT	O
leads	NNS	I-TREATMENT	O
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
resumed	VBN	O	O
.	.	O	O

she	PRP	O	O
ambulated	VBD	O	O
without	IN	O	O
difficulty	NN	O	B-PROBLEM
and	CC	O	O
was	VBD	O	O
discharged	VBN	O	O
to	TO	O	O
home	VB	O	O
to	TO	O	O
be	VB	O	O
followed	VBN	O	O
medically	RB	O	O
for	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
following	VBG	O	O
two	CD	B-TREATMENT	B-TREATMENT
failed	JJ	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
by	IN	O	O
dr.	NN	O	O
brendniungand	NN	O	O
asilbekote	NN	O	O
in	IN	O	O
bi	JJ	O	O
masase	NN	O	O
,	,	O	O
ks	NN	O	O
.	.	O	O

clindamycin	NN	B-TREATMENT	B-TREATMENT
/	NNP	O	O
erythromycin	VBZ	B-TREATMENT	B-TREATMENT
base	NN	I-TREATMENT	I-TREATMENT
/	NNP	O	O
amoxicillin	NN	B-TREATMENT	B-TREATMENT
/	NNP	O	O
keflex	NNP	B-TREATMENT	B-TREATMENT
/	NNP	O	O
wellbutrin	NN	B-TREATMENT	B-TREATMENT

chief	JJ	O	O
complaint	NN	O	O
:	:	O	O
syncope	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
heywood	NN	O	O
memorial	JJ	O	O
hospital	NN	O	O
4	CD	O	O

central	JJ	B-TREATMENT	B-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
attempted	VBN	O	O
but	CC	O	O
never	RB	O	O
placed	VBD	O	O

57	CD	O	O
y/o	NNS	O	O
f	JJ	O	O
with	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
medical	JJ	I-PROBLEM	I-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
including	VBG	O	O
polyendocrine	JJ	B-PROBLEM	B-PROBLEM
deficiency	NN	I-PROBLEM	I-PROBLEM
comprised	VBD	O	O
of	IN	O	O
adrenal	JJ	B-PROBLEM	B-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
dm	NN	B-PROBLEM	O
,	,	O	O
premature	NN	B-PROBLEM	B-PROBLEM
ovarian	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypoparathyroidism	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
addison	NN	B-PROBLEM	B-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
also	RB	O	O
breast	NN	B-PROBLEM	O
ca	MD	I-PROBLEM	O
and	CC	O	O
depression	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
multiple	JJ	O	O
suicide	NN	O	O
attempts	NNS	O	O
in	IN	O	O
the	DT	O	O
past	NN	O	O
who	WP	O	O
originally	RB	O	O
presented	VBN	O	O
s/p	JJ	O	O
tylenol	NN	B-PROBLEM	B-TREATMENT
with	IN	I-PROBLEM	O
codeine	NN	I-PROBLEM	B-PROBLEM
overdose	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
was	VBD	O	O
intubated	VBN	O	B-TREATMENT
and	CC	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
ficu	NN	O	O
.	.	O	O

subsequently	RB	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
transfered	VBN	O	O
to	TO	O	O
the	DT	O	O
psychiatric	JJ	O	O
mary	JJ	O	O
lane	NN	O	O
hospital	NN	O	O
in	IN	O	O
boston	NNP	O	O
medical	JJ	O	O
center	NN	O	O
4	CD	O	O
for	IN	O	O
further	JJ	B-TEST	O
psychiatric	JJ	I-TEST	O
w/u	NN	I-TEST	O
.	.	O	O

this	DT	O	O
morning	NN	O	O
,	,	O	O
2017-07-12	CD	O	O
,	,	O	O
ms.	FW	O	O
gallegos	NNS	O	B-PROBLEM
king	VBG	O	I-PROBLEM
feeling	VBG	O	I-PROBLEM
weaker	JJR	B-PROBLEM	I-PROBLEM
than	IN	I-PROBLEM	I-PROBLEM
usual	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
noted	VBD	O	O
that	IN	O	O
she	PRP	O	O
had	VBD	O	O
increased	VBN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
back	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
she	PRP	O	O
attributed	VBD	O	O
to	TO	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
arthritis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

later	RB	O	O
that	DT	O	O
am	VBP	O	O
,	,	O	O
she	PRP	O	O
stood	VBD	O	O
from	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
wheelchair	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
prodrome	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
lh	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
then	RB	O	O
reports	NNS	O	O
loc	NN	B-PROBLEM	O
and	CC	O	O
fall	NN	O	B-PROBLEM
.	.	O	O

she	PRP	O	O
denies	VBZ	O	O
any	DT	B-PROBLEM	B-PROBLEM
tunnel	NN	I-PROBLEM	I-PROBLEM
vision	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
darkened	VBN	B-PROBLEM	B-PROBLEM
vision	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
focal	JJ	B-PROBLEM	B-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
this	DT	O	O
morning	NN	O	O
.	.	O	O

no	DT	O	O
bowel	NN	B-PROBLEM	B-PROBLEM
/	VBZ	I-PROBLEM	O
bladder	JJR	I-PROBLEM	O
incont	NN	I-PROBLEM	O
,	,	O	O
no	DT	O	O
aura	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
postictal	JJ	B-PROBLEM	B-TREATMENT
state	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

she	PRP	O	O
does	VBZ	O	O
not	RB	O	O
describe	VB	O	O
decreased	JJ	B-PROBLEM	O
po	NNS	I-PROBLEM	O
intake	VBP	I-PROBLEM	O
from	IN	O	O
her	PRP$	O	O
norm	NN	O	O
this	DT	O	O
morning	NN	O	O
,	,	O	O
but	CC	O	O
did	VBD	O	O
feel	VB	O	O
dehydrated	VBN	B-PROBLEM	B-PROBLEM
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
her	PRP$	O	B-PROBLEM
fall	NN	O	I-PROBLEM
.	.	O	O

loc	NN	B-PROBLEM	O
was	VBD	O	O
unwitnessed	VBN	O	O
.	.	O	O

early	RB	O	O
this	DT	O	O
morning	NN	O	O
before	IN	O	O
breakfast	NN	O	O
her	PRP$	B-TEST	O
bs	NN	I-TEST	O
was	VBD	O	O
reportedly	RB	O	O
145	CD	O	O
,	,	O	O
and	CC	O	O
after	IN	O	O
loc	NN	B-PROBLEM	O
,	,	O	O
her	PRP$	B-TEST	B-TEST
bs	NN	I-TEST	I-TEST
was	VBD	O	O
reportedly	RB	O	O
207	CD	O	O
.	.	O	O

she	PRP	O	O
reports	VBZ	O	O
that	IN	O	O
her	PRP$	B-TEST	O
bp	NN	I-TEST	O
was	VBD	O	O
read	VBN	O	O
at	IN	O	O
60/48	CD	O	O
after	IN	O	O
her	PRP$	O	B-PROBLEM
fall	NN	O	I-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
systolic	JJ	I-TEST	I-TEST
bp	NN	I-TEST	I-TEST
measurements	NNS	I-TEST	I-TEST
have	VBP	O	O
been	VBN	O	O
running	VBG	O	O
around	RB	O	O
100-110	CD	O	O
over	IN	O	O
the	DT	O	O
past	JJ	O	O
few	JJ	O	O
weeks	NNS	O	O
.	.	O	O

she	PRP	O	O
denies	VBZ	O	O
any	DT	B-PROBLEM	B-PROBLEM
recent	JJ	I-PROBLEM	I-PROBLEM
nausea	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
had	VBD	O	O
an	DT	O	O
episode	NN	O	O
of	IN	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
last	JJ	O	O
week	NN	O	O
.	.	O	O

she	PRP	O	O
denies	VBZ	O	O
any	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
with	IN	I-PROBLEM	O
urination	NN	I-PROBLEM	B-PROBLEM
or	CC	O	O
incontinence	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
also	RB	O	O
denies	VBZ	O	O
any	DT	B-PROBLEM	B-PROBLEM
recent	JJ	I-PROBLEM	I-PROBLEM
cough	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
chest	NN	B-PROBLEM	B-PROBLEM
palpitations	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
heart	NN	B-PROBLEM	B-PROBLEM
racing	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
reports	VBZ	O	O
2	CD	O	O
nights	NNS	O	O
with	IN	O	O
soaking	VBG	B-PROBLEM	B-PROBLEM
ns	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

denies	NNS	O	O
subj	VBP	B-PROBLEM	B-PROBLEM
/	JJ	I-PROBLEM	I-PROBLEM
obj	JJ	I-PROBLEM	I-PROBLEM
fevers	NNS	I-PROBLEM	I-PROBLEM
or	CC	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
describes	VBZ	O	O
her	PRP$	O	O
mood	NN	O	O
as	IN	O	O
depressed	JJ	B-PROBLEM	O
,	,	O	O
however	RB	O	O
she	PRP	O	O
denies	VBZ	O	O
suicidal	JJ	B-PROBLEM	B-PROBLEM
ideation	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
this	DT	O	O
time	NN	O	O
.	.	O	O

she	PRP	O	O
reports	VBZ	O	O
that	IN	O	O
she	PRP	O	O
took	VBD	O	O
all	DT	B-TREATMENT	O
her	PRP$	I-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
as	IN	O	O
usual	JJ	O	O
this	DT	O	O
morning	NN	O	O
,	,	O	O
with	IN	O	O
no	DT	O	O
changes	NNS	O	B-PROBLEM
.	.	O	O

1)	CD	O	O
polyendocrine	JJ	B-PROBLEM	B-PROBLEM
deficiency	NN	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
type	NN	I-PROBLEM	I-PROBLEM
i	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
is	VBZ	O	O
comprised	VBN	O	O
of	IN	O	O
the	DT	O	O
following	NN	O	O
:	:	O	O

a)	JJ	O	B-PROBLEM
hypoparathyroidism	NN	B-PROBLEM	I-PROBLEM
,	,	O	O
dxed	JJ	O	B-TEST
1954	CD	O	O

b)	NN	O	B-PROBLEM
addison	NN	B-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
dxed	JJ	O	B-TEST
1960	CD	O	O

c)	JJ	O	B-PROBLEM
premature	NN	B-PROBLEM	I-PROBLEM
ovarian	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
dxed	JJ	O	B-TEST
1967	CD	O	O

d)	NN	O	B-PROBLEM
alopecia	NN	B-PROBLEM	I-PROBLEM
areata	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
totalis	NN	I-PROBLEM	B-TREATMENT
,	,	O	O
dxed	VBD	O	O
1970s	CD	O	O

e)	RB	O	B-PROBLEM
mucocutaneous	JJ	B-PROBLEM	I-PROBLEM
candidiasis	NN	I-PROBLEM	I-PROBLEM

f)	NN	O	B-PROBLEM
diabetes	VBZ	B-PROBLEM	I-PROBLEM
type	IN	I-PROBLEM	I-PROBLEM
i	NN	I-PROBLEM	I-PROBLEM

2)	CD	O	O
colonic	JJ	B-PROBLEM	B-PROBLEM
dysfunction	NN	I-PROBLEM	I-PROBLEM
alternating	VBG	O	I-PROBLEM
with	IN	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
constipation	NN	B-PROBLEM	B-PROBLEM

3)	CD	O	O
?	.	O	O
unstable	JJ	B-PROBLEM	B-PROBLEM
serum	NN	I-PROBLEM	I-PROBLEM
calcium	NN	I-PROBLEM	I-PROBLEM
since	IN	O	O
1999	CD	O	O

4)	CD	O	B-PROBLEM
generalized	JJ	B-PROBLEM	I-PROBLEM
osteoarthritis	NN	I-PROBLEM	I-PROBLEM

5)	CD	O	O
depression	NN	B-PROBLEM	B-PROBLEM
requiring	VBG	O	O
ect	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
the	DT	O	O
past	NN	O	O

6)	CD	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
neuropathy	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremities	NNS	I-PROBLEM	I-PROBLEM

7)	CD	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
cataracts	NNS	I-PROBLEM	I-PROBLEM

8)	CD	O	O
pvd	NN	B-PROBLEM	O

9)	CD	O	O
spontaneous	JJ	B-PROBLEM	B-PROBLEM
dislocation	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
hip	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
2014	CD	O	O

10)	CD	O	O
gerd	NN	B-PROBLEM	O

11)	CD	O	O
low	JJ	B-PROBLEM	B-PROBLEM
grade	NN	I-PROBLEM	I-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM

12)	CD	O	O
elevated	VBN	B-PROBLEM	B-PROBLEM
liver	NN	I-PROBLEM	I-PROBLEM
enzymes	NNS	I-PROBLEM	I-PROBLEM

13)	CD	O	O
h/o	JJ	O	O
amputation	NN	B-TREATMENT	B-PROBLEM
of	IN	I-TREATMENT	O
right	JJ	I-TREATMENT	O
2nd	CD	I-TREATMENT	O
toe	NN	I-TREATMENT	O
secondary	JJ	O	O
to	TO	O	O
osteomyelitis	VB	B-PROBLEM	B-PROBLEM
in	IN	O	O
2005	CD	O	O

14)	CD	O	O
h/o	JJ	O	O
hemorrhoidectomy	NN	B-TREATMENT	B-TREATMENT
in	IN	O	O
2007	CD	O	O

15)	CD	O	O
h/o	NN	O	O
left	VBD	B-TREATMENT	B-PROBLEM
hip	JJ	I-TREATMENT	I-PROBLEM
joint	JJ	I-TREATMENT	I-PROBLEM
replacement	NN	I-TREATMENT	I-PROBLEM
in	IN	O	O
2008	CD	O	O

16)	CD	O	O
h/o	JJ	O	O
total	JJ	B-TREATMENT	O
hysterectomy	NN	I-TREATMENT	B-TREATMENT
in	IN	O	O
2009	CD	O	O

17)	CD	O	O
h/o	NN	O	O
breast	NN	B-PROBLEM	O
ca	MD	I-PROBLEM	O
s/p	VB	O	O
mastectomies	NNS	B-TREATMENT	B-TREATMENT

18)	CD	O	O
recent	JJ	O	O
suicide	NN	O	O
attempt	NN	O	O
with	IN	O	O
tylenol	NN	B-TREATMENT	B-TREATMENT
#3	NN	I-TREATMENT	O
requiring	VBG	O	O
cmed	VBN	O	O
admission	NN	O	O
but	CC	O	O
relatively	RB	O	B-PROBLEM
jennifer	JJ	O	I-PROBLEM
transaminitis	NN	B-PROBLEM	I-PROBLEM
with	IN	O	O
full	JJ	O	O
recovery	NN	O	O

medically	RB	O	O
savvy	JJ	O	O
-	:	O	O
has	VBZ	O	O
spent	VBN	O	O
much	RB	O	O
of	IN	O	O
her	PRP$	O	O
life	NN	O	O
in	IN	O	O
the	DT	O	O
hospital	NN	O	O
with	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
multiple	JJ	I-PROBLEM	I-PROBLEM
medical	JJ	I-PROBLEM	I-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

family	NN	O	O
history	NN	O	O
:	:	O	O
father	NN	O	O
with	IN	O	O
history	NN	O	O
of	IN	O	O
liver	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
a	DT	O	O
late	JJ	O	O
age	NN	O	O

t	RB	B-TEST	O
98.4	CD	O	O
rr	NN	B-TEST	B-TEST
20	CD	O	O
sat	VBD	B-TEST	O
100%	CD	O	O
ra	NN	O	O
,	,	O	O
p	VBP	B-TEST	O
100	CD	O	O
in	IN	O	O
bed	NN	O	O
&	CC	O	O
same	JJ	O	O
standing	NN	O	O
,	,	O	O
bp	NN	B-TEST	O
=	VBD	O	O
120/65	CD	O	O
in	IN	O	O
bed	NN	O	O
,	,	O	O
same	JJ	O	O
standing	NN	O	O
.	.	O	O

nad	RB	B-PROBLEM	O
,	,	O	O
cooperative	JJ	O	O
and	CC	O	O
conversant	JJ	O	O
,	,	O	O
able	JJ	O	O
to	TO	O	O
ambulate	VB	O	O
independently	RB	O	O
around	IN	O	O
room	NN	O	O
using	VBG	O	O
crutches	NNS	B-TREATMENT	B-TREATMENT

ncat	NN	B-PROBLEM	O
,	,	O	O
no	DT	O	O
tenderness	NN	B-PROBLEM	B-PROBLEM
to	TO	O	O
palpation	NN	B-TEST	B-TEST
of	IN	I-TEST	I-TEST
scalp	NN	I-TEST	I-TEST
,	,	O	O
perrl	NN	O	O
,	,	O	O
eomi	NN	O	O
,	,	O	O
alopecia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
scleral	JJ	B-PROBLEM	B-PROBLEM
icterus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
mucus	NN	B-PROBLEM	B-PROBLEM
membranes	NNS	I-PROBLEM	I-PROBLEM
moderately	RB	I-PROBLEM	I-PROBLEM
dry	JJ	I-PROBLEM	I-PROBLEM
,	,	O	O
slight	JJ	O	O
amount	NN	O	O
of	IN	O	O
crusted	VBN	B-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	O
tip	NN	I-PROBLEM	O
of	IN	O	O
r	NN	O	O
nostril	NN	O	O
from	IN	O	O
fall	NN	B-PROBLEM	B-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM

neck	NN	O	O
:	:	O	O
supple	NN	O	O
,	,	O	O
no	DT	O	O
supraclavicular	JJ	B-PROBLEM	B-PROBLEM
lad	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
jvd	NN	B-PROBLEM	B-PROBLEM

cv	NN	O	O
:	:	O	O
tachycardic	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
regular	JJ	O	O
rhythm	NN	O	O
,	,	O	O
iii/vi	JJ	B-PROBLEM	B-PROBLEM
systolic	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
crescendo-decrescendo	NN	B-PROBLEM	O
at	IN	I-PROBLEM	O
usb	JJ	I-PROBLEM	O
bilaterally	RB	I-PROBLEM	O
.	.	O	O

harsher	PRP$	B-PROBLEM	B-PROBLEM
holosystolic	JJ	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
apex	JJ	I-PROBLEM	O
heard	NN	O	O
best	JJS	O	O
with	IN	O	O
bell	NN	O	O
.	.	O	O

ctab	NNS	O	O
aside	RB	O	O
from	IN	O	O
slightly	RB	B-PROBLEM	B-PROBLEM
dull	JJ	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
sounds	NNS	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
bases	NNS	I-PROBLEM	I-PROBLEM

abd	NN	O	O
:	:	O	O
soft	JJ	O	O
,	,	O	O
slightly	RB	B-PROBLEM	B-PROBLEM
obese	JJ	I-PROBLEM	I-PROBLEM
,	,	O	O
nondistended	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
+bs	VB	O	O

ext	NN	O	O
:	:	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
/	VBZ	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
2+	CD	B-TEST	O
peripheral	JJ	I-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
,	,	O	O
small	JJ	B-PROBLEM	B-PROBLEM
1	CD	I-PROBLEM	I-PROBLEM
cm	JJ	I-PROBLEM	I-PROBLEM
abrasion	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	O
r	NN	I-PROBLEM	O
knee	NN	I-PROBLEM	O
,	,	O	O
no	DT	O	O
active	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
brusing	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
limited	JJ	O	O

rom	NN	B-PROBLEM	O
,	,	O	O
no	DT	O	O
signs	NNS	O	O
of	IN	O	O
effusion	NN	B-PROBLEM	B-PROBLEM

a&ox3	NN	O	O
,	,	O	O
no	DT	O	O
asterixis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
strength	NN	O	B-TEST
4+	CD	O	O
/	NN	O	O
5	CD	O	O
equal	JJ	O	O
throughout	IN	O	O
,	,	O	O
sensation	NN	O	O
light	VBD	O	O
touch	JJ	O	O
intact	JJ	O	O
,	,	O	O
toes	NNS	O	O
upgoing	VBG	O	O
bilaterally	RB	O	O
,	,	O	O
no	DT	O	O
pronator	NN	B-PROBLEM	B-PROBLEM
drift	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

gait	NN	O	O
does	VBZ	O	O
not	RB	O	O
appear	VB	O	O
unsteady	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
uses	VBZ	O	O
crutches	NNS	B-TREATMENT	B-TREATMENT
for	IN	O	O
support	NN	O	O
.	.	O	O

2017-07-12	JJ	O	O
10:40	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	B-TEST	B-TEST
-	:	O	O
17.1	CD	O	O
*	NN	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.37	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
10.1	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
30.1	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
89	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
30.0	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
33.6	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
18.8	CD	O	O
*	JJ	O	O
plt	NN	B-TEST	B-TEST
ct	SYM	I-TEST	I-TEST
-	:	O	O
526	CD	O	O
*	NN	O	O

2017-07-12	JJ	O	O
10:40	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
neuts	NNS	B-TEST	B-TEST
-	:	O	O
86	CD	O	O
*	NN	O	O
bands	NNS	B-TEST	B-TEST
-	:	O	O
5	CD	O	O
lymphs	SYM	B-TEST	B-TEST
-	:	O	O
4	CD	O	O
*	JJ	O	O
monos	NNS	B-TEST	B-TEST
-	:	O	O
5	CD	O	O
eos	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
baso	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
atyps	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
metas	NNS	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
myelos	SYM	B-TEST	B-TEST
-	:	O	O
0	CD	O	O

2017-07-12	JJ	O	O
10:40	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
plt	NN	B-TEST	I-TEST
smr	SYM	I-TEST	I-TEST
-	:	O	O
high	JJ	B-PROBLEM	O
plt	NN	I-PROBLEM	B-TEST
ct	SYM	I-PROBLEM	I-TEST
-	:	O	O
526	CD	O	O
*	NN	O	O

2017-07-13	JJ	O	O
05:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
pt	NN	B-TEST	I-TEST
-	:	O	O
11.3	CD	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
24.9	CD	O	O
inr	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
pt	JJ	I-TEST	I-TEST
)-	CD	I-TEST	I-TEST
1.0	CD	O	O

2017-07-11	JJ	O	O
08:00	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
137	CD	O	O
*	JJ	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
19	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.0	CD	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
142	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
4.0	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
105	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
29	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
12	CD	O	O

2017-07-13	JJ	O	O
05:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
alt	NN	B-TEST	I-TEST
-	:	O	O
85	CD	O	O
*	NN	O	O
ast	VBD	B-TEST	B-TEST
-	:	O	O
238	CD	O	O
*	JJ	O	O
ld	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
ldh	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
316	CD	O	O
*	JJ	O	O
ck	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
cpk	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
55	CD	O	O
alkphos	SYM	B-TEST	B-TEST
-	:	O	O
122	CD	O	O
*	JJ	O	O
amylase	NN	B-TEST	B-TEST
-	:	O	O
65	CD	O	O
totbili	SYM	B-TEST	B-TEST
-	:	O	O
0.3	CD	O	O

2017-07-13	JJ	O	O
05:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
lipase	NN	B-TEST	B-TEST
-	:	O	O
35	CD	O	O

2017-07-14	JJ	O	O
05:20	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
ck	NN	B-TEST	I-TEST
-	:	I-TEST	I-TEST
mb	NN	I-TEST	I-TEST
-	:	O	O
notdone	NN	O	O
ctropnt	NN	B-TEST	O
-<	VBD	O	O
0.01	CD	O	O

2017-07-13	JJ	O	O
01:12	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
ck	NN	B-TEST	I-TEST
-	:	I-TEST	I-TEST
mb	NN	I-TEST	I-TEST
-	:	O	O
2	CD	O	O
ctropnt	NN	B-TEST	B-TEST
-<	CD	O	O
0.01	CD	O	O

2017-07-13	JJ	O	O
05:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
ck	NN	B-TEST	I-TEST
-	:	I-TEST	I-TEST
mb	NN	I-TEST	I-TEST
-	:	O	O
notdone	NN	O	O
ctropnt	NN	B-TEST	O
-<	VBD	O	O
0.01	CD	O	O

2017-07-11	JJ	O	O
08:00	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
albumin	NN	B-TEST	I-TEST
-	:	O	O
3.4	CD	O	O
calcium	NN	B-TEST	B-TEST
-	:	O	O
8.0	CD	O	O
*	NN	O	O
phos	NN	B-TEST	B-TEST
-	:	O	O
5.0	CD	O	O
*	NN	O	O
mg	SYM	B-TEST	O
-	:	O	O
1.6	CD	O	O

2017-07-13	JJ	O	O
01:12	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
hbsag	SYM	B-TEST	B-TEST
-	:	O	O
negative	JJ	O	O
hbsab	NN	B-TEST	O
-	:	O	O
negative	JJ	O	O
hbcab	NN	B-TEST	O
-	:	O	O
negative	JJ	O	O

2017-07-13	JJ	O	O
05:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
acetmnp	NN	B-TEST	O
-	:	O	O
neg	NN	O	O

2017-07-13	JJ	O	O
01:12	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
hcv	NN	B-TEST	I-TEST
ab	SYM	I-TEST	I-TEST
-	:	O	O
negative	JJ	O	O

2017-07-13	JJ	O	B-TEST
08:40	CD	O	I-TEST
am	VBP	O	I-TEST
blood	NN	B-TEST	I-TEST
type	NN	B-TEST	I-TEST
-	:	O	O
art	NN	O	O
po2	VBZ	B-TEST	O
-	:	O	O
72	CD	O	O
*	NN	O	O
pco2	NN	B-TEST	B-TEST
-	:	O	O
34	CD	O	O
*	NN	O	O
ph	NN	B-TEST	B-TEST
-	:	O	O
7.46	CD	O	O
*	NN	O	O
calhco3	NN	B-TEST	B-TEST
-	:	O	O
25	CD	O	O
base	NN	B-TEST	B-TEST
xs	NNP	I-TEST	I-TEST
-	:	O	O
0	CD	O	O

2017-07-13	JJ	O	O
08:40	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
lactate	NN	B-TEST	I-TEST
-	:	O	O
2.0	CD	O	O

2017-07-13	JJ	O	O
08:40	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
freeca	NN	B-TEST	I-TEST
-	:	O	O
0.90	CD	O	O
*	NN	O	O

ekg	NN	B-TEST	O
:	:	O	O

2017-07-12	JJ	O	O
nsr	NN	O	O
,	,	O	O
normal	JJ	O	O
axis	NN	O	O
,	,	O	O
likely	JJ	O	O
v1	NN	B-PROBLEM	O
and	CC	I-PROBLEM	O
v2	NN	I-PROBLEM	O
reversal	NN	I-PROBLEM	O
,	,	O	O
twi	NN	B-PROBLEM	O
in	IN	I-PROBLEM	O
v2	NN	I-PROBLEM	O
,	,	O	O
?	.	O	O
st	JJ	B-PROBLEM	O
depr	NN	I-PROBLEM	O
<	VBD	O	O
0.5	CD	O	O
mm	NN	O	O
in	IN	O	O
ii	NN	O	O
and	CC	O	O
v5/6	NN	O	B-TEST
-	:	O	O
repeat	NN	B-TEST	O
ekg	NN	I-TEST	O
without	IN	O	O
these	DT	B-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
change	NN	O	O
from	IN	O	O
prior	JJ	B-TEST	O
ekg	NN	I-TEST	O
.	.	O	O

cxr	JJ	B-TEST	O
2017-07-12	CD	O	O
:	:	O	O

no	DT	O	O
effusions	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
pneumothorax	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

multiple	NN	B-PROBLEM	B-PROBLEM
healed	VBD	I-PROBLEM	I-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
rib	NN	I-PROBLEM	I-PROBLEM
fractures	NNS	I-PROBLEM	I-PROBLEM
are	VBP	O	O
demonstrated	VBN	O	O
.	.	O	O

clips	NNS	B-TREATMENT	O
in	IN	I-TREATMENT	O
the	DT	I-TREATMENT	O
left	NN	I-TREATMENT	O
axilla	NN	I-TREATMENT	O
demonstrate	NN	O	O
prior	JJ	B-TREATMENT	B-TREATMENT
lymph	NN	I-TREATMENT	I-TREATMENT
node	DT	I-TREATMENT	I-TREATMENT
dissection	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

overall	JJ	O	O
,	,	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
cardiopulmonary	JJ	I-PROBLEM	I-PROBLEM
abnormality	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2017-07-13	JJ	O	O
cxr	NN	B-TEST	O
:	:	O	O

aside	RB	O	O
from	IN	O	O
low	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
volumes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
the	DT	O	O
lungs	NNS	O	O
are	VBP	O	O
clear	JJ	O	O
.	.	O	O

clips	NNS	B-TREATMENT	O
in	IN	I-TREATMENT	O
the	DT	I-TREATMENT	O
left	NN	I-TREATMENT	O
axilla	NN	I-TREATMENT	O
denote	NN	O	O
prior	RB	B-TREATMENT	B-TREATMENT
lymph	JJ	I-TREATMENT	I-TREATMENT
node	JJ	I-TREATMENT	I-TREATMENT
dissection	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

multiple	JJ	B-PROBLEM	B-PROBLEM
bilateral	NN	I-PROBLEM	I-PROBLEM
healed	VBD	I-PROBLEM	I-PROBLEM
rib	NN	I-PROBLEM	I-PROBLEM
fractures	NNS	I-PROBLEM	I-PROBLEM
are	VBP	O	O
present	JJ	O	O
.	.	O	O

2017-07-13	JJ	O	O
ruq	NN	B-TEST	O
u/s	NN	I-TEST	O
:	:	O	O

no	DT	O	O
evidence	NN	O	O
of	IN	O	O
bile	JJ	B-PROBLEM	B-PROBLEM
duct	NN	I-PROBLEM	I-PROBLEM
dilatation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
gallbladder	NN	B-PROBLEM	B-PROBLEM
polyp	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
possible	JJ	O	O
tiny	JJ	B-PROBLEM	B-PROBLEM
stones	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
cholecystitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2017-07-14	JJ	O	O
echo	NN	B-TEST	O
:	:	O	O

there	EX	O	O
is	VBZ	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
symmetric	JJ	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
left	NN	I-TEST	I-TEST
ventricular	JJ	I-TEST	I-TEST
cavity	NN	I-TEST	I-TEST
size	NN	I-TEST	I-TEST
is	VBZ	O	O
normal	JJ	O	O
.	.	O	O

overall	JJ	B-TEST	B-TEST
left	VBD	I-TEST	I-TEST
ventricular	JJ	I-TEST	I-TEST
systolic	JJ	I-TEST	I-TEST
function	NN	I-TEST	I-TEST
is	VBZ	O	O
normal	JJ	O	O
(	(	O	O
lvef	JJ	B-TEST	O
>	$	O	O
55%	CD	O	O
).	NN	O	O

right	RB	B-TEST	O
ventricular	JJ	I-TEST	O
chamber	NN	I-TEST	O
size	NN	I-TEST	O
and	CC	O	O
free	JJ	O	O
wall	NN	O	O
motion	NN	O	O
are	VBP	O	O
normal	JJ	O	O
.	.	O	O

the	DT	O	O
aortic	JJ	O	O
valve	NN	O	O
leaflets	NNS	O	O
are	VBP	O	O
moderately	RB	B-PROBLEM	B-PROBLEM
thickened	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
valve	NN	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

trace	NN	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
seen	VBN	O	O
.	.	O	O

the	DT	O	O
mitral	JJ	O	O
valve	NN	O	O
leaflets	NNS	O	O
are	VBP	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
thickened	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
mitral	JJ	B-PROBLEM	B-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
seen	VBN	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
pericardial	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
are	VBP	O	O
no	DT	O	O
echocardiographic	JJ	O	B-TEST
signs	NNS	O	I-TEST
of	IN	O	O
tamponade	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

compared	VBN	O	O
with	IN	O	O
the	DT	O	O
report	NN	O	O
of	IN	O	O
the	DT	B-TEST	B-TEST
prior	JJ	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
(	(	O	O
images	NNS	O	O
unavailable	JJ	O	O
for	IN	O	O
review	NN	O	O
)	)	O	O
of	IN	O	O
2017-06-13	JJ	O	O
,	,	O	O
there	EX	O	O
is	VBZ	O	O
no	DT	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
change	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2017-07-17	JJ	O	O
04:50	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	B-TEST	B-TEST
-	:	O	O
7.2	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
2.69	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
8.0	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
24.0	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
89	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
29.7	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
33.3	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
18.7	CD	O	O
*	JJ	O	O
plt	NN	B-TEST	B-TEST
ct	SYM	I-TEST	I-TEST
-	:	O	O
363	CD	O	O

2017-07-17	JJ	O	O
04:50	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
plt	NN	B-TEST	I-TEST
ct	VBD	I-TEST	I-TEST
-	:	O	O
363	CD	O	O

2017-07-17	JJ	O	O
04:50	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
60	CD	O	O
*	JJ	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
13	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
0.9	CD	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
147	CD	O	O
*	NN	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
3.0	CD	O	O
*	NN	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
109	CD	O	O
*	NN	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
29	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
12	CD	O	O

2017-07-17	JJ	O	O
04:50	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
alt	NN	B-TEST	I-TEST
-	:	O	O
73	CD	O	O
*	NN	O	O
ast	VBD	B-TEST	B-TEST
-	:	O	O
50	CD	O	O
*	JJ	O	O
ld	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
ldh	JJ	I-TEST	I-TEST
)-	JJ	O	I-TEST
195	CD	O	O
alkphos	SYM	B-TEST	B-TEST
-	:	O	O
112	CD	O	O
totbili	SYM	B-TEST	B-TEST
-	:	O	O
0.3	CD	O	O

2017-07-15	JJ	O	O
06:47	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
lipase	NN	B-TEST	B-TEST
-	:	O	O
17	CD	O	O

2017-07-17	JJ	O	O
04:50	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
calcium	NN	B-TEST	I-TEST
-	:	O	O
8.2	CD	O	O
*	NN	O	O
phos	NN	B-TEST	B-TEST
-	:	O	O
3.2	CD	O	O
mg	SYM	B-TEST	O
-	:	O	O
1.5	CD	O	O
*	NN	O	O

2017-07-13	JJ	O	O
01:12	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
hbsag	SYM	B-TEST	B-TEST
-	:	O	O
negative	JJ	O	O
hbsab	NN	B-TEST	O
-	:	O	O
negative	JJ	O	O
hbcab	NN	B-TEST	O
-	:	O	O
negative	JJ	O	O

2017-07-13	JJ	O	O
05:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
acetmnp	NN	B-TEST	O
-	:	O	O
neg	NN	O	O

2017-07-13	JJ	O	O
01:12	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
hcv	NN	B-TEST	I-TEST
ab	SYM	I-TEST	I-TEST
-	:	O	O
negative	JJ	O	O

57	CD	O	O
yo	NNS	O	O
f	JJ	O	O
with	IN	O	O
h/o	JJ	O	O
polyglandular	JJ	B-PROBLEM	B-PROBLEM
autoimmune	NN	I-PROBLEM	I-PROBLEM
syndrome	VBN	I-PROBLEM	I-PROBLEM
initially	RB	O	O
admitted	VBN	O	O
in	IN	O	O
may	MD	O	O
to	TO	O	O
ficu	VB	O	O
for	IN	O	O
suicide	NN	B-PROBLEM	B-PROBLEM
overdose	RB	I-PROBLEM	I-PROBLEM
then	RB	O	O
transferred	VBN	O	O
to	TO	O	O
whittier	VB	O	O
rehab	JJ	O	O
hospital	NN	O	O
4	CD	O	O
for	IN	O	O
depression	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
who	WP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
medical	JJ	O	O
floor	NN	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
syncopal	JJ	I-PROBLEM	I-PROBLEM
episode	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
to	TO	O	O
60	CD	B-TEST	O
systolic	NN	I-TEST	B-TEST
that	WDT	O	O
returned	VBD	O	O
to	TO	O	O
baseline	VB	O	O
with	IN	O	O
2.5l	CD	O	O
ivf	NNS	B-TREATMENT	O
who	WP	O	O
was	VBD	O	O
subsequently	RB	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
csru	NN	O	O
for	IN	O	O
a	DT	O	O
recurrent	JJ	O	O
episode	NN	O	O
of	IN	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
concern	NN	O	O
for	IN	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

initially	RB	O	O
when	WRB	O	O
she	PRP	O	O
arrived	VBD	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
she	PRP	O	O
was	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
,	,	O	O
normotensive	JJ	O	O
without	IN	O	O
signs	NNS	O	O
of	IN	O	O
orthostasis	NN	B-PROBLEM	B-TREATMENT
,	,	O	O
had	VBD	O	O
a	DT	O	O
negative	JJ	O	O
ua	NN	O	O
,	,	O	O
a	DT	O	B-TEST
clear	JJ	O	I-TEST
chest	NN	O	I-TEST
xray	NN	O	I-TEST
and	CC	O	O
no	DT	O	O
signs	NNS	O	B-PROBLEM
/	VBP	O	O
symptoms	NNS	O	B-PROBLEM
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
slightly	RB	B-PROBLEM	B-PROBLEM
tachycardic	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
initially	RB	O	O
not	RB	O	O
started	VBN	O	O
on	IN	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
given	VBN	O	O
a	DT	B-TREATMENT	B-TREATMENT
standing	VBG	I-TREATMENT	I-TREATMENT
ivf	JJ	I-TREATMENT	I-TREATMENT
order	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

overnight	JJ	O	O
she	PRP	O	O
became	VBD	O	O
febrile	JJ	B-PROBLEM	B-PROBLEM
to	TO	O	O
102.3	CD	O	O
,	,	O	O
increasingly	RB	B-PROBLEM	O
tachycardic	JJ	I-PROBLEM	O
to	TO	O	O
125	CD	O	O
,	,	O	O
and	CC	O	O
hypotensive	JJ	B-PROBLEM	B-PROBLEM
to	TO	O	I-PROBLEM
80	CD	B-TEST	I-PROBLEM
systolic	NN	I-TEST	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
stress	NN	B-TREATMENT	B-TREATMENT
dose	JJ	I-TREATMENT	I-TREATMENT
steroids	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
levo	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
vanco	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
given	VBN	O	O
4l	CD	O	B-TREATMENT
of	IN	O	I-TREATMENT
fluid	NN	B-TREATMENT	I-TREATMENT
boluses	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
transfered	VBD	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
csru	NN	O	O
.	.	O	O

in	IN	O	O
the	DT	O	O
cmed	JJ	O	O
csru	NN	O	O
,	,	O	O
repeated	VBN	O	O
attempts	NNS	O	O
to	TO	O	O
place	VB	O	O
lines	NNS	B-TREATMENT	O
were	VBD	O	O
unsuccessful	JJ	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
above	JJ	I-TREATMENT	I-TREATMENT
treatments	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
continued	VBN	O	O
.	.	O	O

urine	JJ	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
returned	VBN	O	O
with	IN	O	O
10-100,000	CD	O	O
organisms	NNS	B-PROBLEM	B-TEST
coag	JJ	O	I-TEST
negative	JJ	O	O
staph	NN	B-PROBLEM	O
.	.	O	O

blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
remained	VBD	O	O
negative	JJ	O	O
.	.	O	O

vital	JJ	B-TEST	B-TEST
signs	NNS	I-TEST	I-TEST
stabilized	VBN	O	O
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
transfered	VBN	O	O
back	RB	O	O
to	TO	O	O
the	DT	O	O
medical	JJ	O	O
floor	NN	O	O
after	IN	O	O
2	CD	O	O
days	NNS	O	O
in	IN	O	O
the	DT	O	O
icu	NN	O	O
.	.	O	O

stress	NN	B-TREATMENT	B-TEST
dose	JJ	I-TREATMENT	I-TEST
steroids	NNS	I-TREATMENT	I-TEST
were	VBD	O	O
planned	VBN	O	O
for	IN	O	O
a	DT	O	O
7	CD	O	O
day	NN	O	O
course	NN	O	O
,	,	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
were	VBD	O	O
peeled	VBN	O	O
back	RB	O	O
to	TO	O	O
levofloxacin	VB	B-TREATMENT	B-TREATMENT
alone	RB	O	O
,	,	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
r	NN	I-TEST	I-TEST
hip	NN	I-TEST	I-TEST
film	NN	I-TEST	I-TEST
revealed	VBD	O	O
no	DT	O	O
loosening	NN	B-PROBLEM	B-PROBLEM
nor	CC	O	O
inflammation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

echo	NN	B-TEST	B-TEST
showed	VBD	O	O
normal	JJ	O	O
function	NN	O	O
,	,	O	O
trace	NN	B-PROBLEM	B-PROBLEM
ar	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
no	DT	O	O
mr	NN	B-PROBLEM	O
.	.	O	O

on	IN	O	O
the	DT	O	O
floor	NN	O	O
the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
stable	JJ	O	O
hemodynamically	RB	O	O
without	IN	O	O
recurrent	NN	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
stable	JJ	O	O
for	IN	O	O
transfer	NN	O	O
back	RB	O	O
to	TO	O	O
franciscan	JJ	O	O
children	NNS	O	O
's	POS	O	O
hospital	NN	O	O
&	CC	O	O
rehab	NN	O	O
center	NN	O	O
4	CD	O	O
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
,	,	O	O
her	PRP$	B-TEST	B-TEST
potassium	NN	I-TEST	I-TEST
had	VBD	O	O
been	VBN	O	O
low	JJ	B-PROBLEM	O
despite	IN	O	O
repletion	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
na	NN	B-TEST	O
was	VBD	O	O
elevated	VBN	B-PROBLEM	B-PROBLEM
,	,	O	O
as	IN	O	O
was	VBD	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
.	.	O	O

on	IN	O	O
recommendation	NN	O	O
from	IN	O	O
endocrine	NN	O	O
,	,	O	O
her	PRP$	B-TREATMENT	B-TEST
fludrocortisone	NN	I-TREATMENT	I-TEST
was	VBD	O	O
decreased	VBN	O	O
from	IN	O	O
0.2	CD	O	O
to	TO	O	O
0.1	CD	O	O
(	(	O	O
higher	JJR	O	O
than	IN	O	O
required	VBN	O	O
doses	NNS	O	B-TREATMENT
of	IN	O	I-TREATMENT
fludrocort	NN	B-TREATMENT	I-TREATMENT
can	MD	O	O
cause	VB	O	O
these	DT	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O
)	)	O	O
.	.	O	O

1.	CD	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
:	:	O	O

patient	NN	O	O
presented	VBN	O	O
after	IN	O	O
episode	NN	O	O
of	IN	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
syncope	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
mass.	JJ	O	O
mental	JJ	O	O
health	NN	O	O
center	NN	O	O
5	CD	O	O
.	.	O	O

initially	RB	O	O
it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
that	IN	O	O
this	DT	O	O
was	VBD	O	O
a	DT	O	O
result	NN	O	O
of	IN	O	O
poor	JJ	B-PROBLEM	O
po	NNS	I-PROBLEM	O
intake	VBP	I-PROBLEM	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
without	IN	O	O
orthostatic	JJ	B-PROBLEM	B-TEST
vital	NN	I-PROBLEM	I-TEST
signs	NNS	I-PROBLEM	I-TEST
nor	CC	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
no	DT	O	O
symptoms	NNS	O	B-PROBLEM
of	IN	O	O
infectious	JJ	B-PROBLEM	O
source	NN	I-PROBLEM	O
,	,	O	O
normal	JJ	O	O
ua	JJ	O	O
,	,	O	O
normal	JJ	O	B-TEST
chest	NN	O	I-TEST
xray	NN	O	I-TEST
,	,	O	O
and	CC	O	O
no	DT	O	O
symptoms	NNS	O	B-PROBLEM
nor	CC	O	O
signs	NNS	O	B-PROBLEM
of	IN	O	I-PROBLEM
injury	NN	B-PROBLEM	I-PROBLEM
after	IN	O	O
her	PRP$	O	B-PROBLEM
fall	NN	O	I-PROBLEM
with	IN	O	O
syncope	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

neuro	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
was	VBD	O	O
normal	JJ	O	O
.	.	O	O

subsequently	RB	O	O
overnight	VBN	O	O
,	,	O	O
she	PRP	O	O
developed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
102.3	CD	O	O
and	CC	O	O
recurrent	JJ	B-PROBLEM	B-PROBLEM
hypotension	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
tachycardia	NN	B-PROBLEM	B-PROBLEM
that	WDT	O	O
was	VBD	O	O
concerning	VBG	O	O
for	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
infectious	JJ	I-PROBLEM	I-PROBLEM
source	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
still	RB	O	O
had	VBD	O	O
no	DT	O	O
localizing	JJ	O	B-PROBLEM
signs	NNS	O	I-PROBLEM
of	IN	O	I-PROBLEM
infection	NN	B-PROBLEM	I-PROBLEM
and	CC	O	O
culture	NN	B-TEST	B-TEST
data	NNS	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
to	TO	O	O
be	VB	O	O
negative	JJ	O	O
.	.	O	O

ruq	VB	B-TEST	O
us	PRP	I-TEST	O
was	VBD	O	O
ordered	VBN	O	O
and	CC	O	O
returned	VBN	O	O
without	IN	O	O
signs	NNS	O	O
of	IN	O	O
infection	NN	B-PROBLEM	B-PROBLEM
later	RB	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
stress	NN	B-TREATMENT	B-TREATMENT
dose	JJ	I-TREATMENT	I-TREATMENT
steroids	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
cultures	NNS	B-TEST	B-TEST
drawn	VBN	O	O
,	,	O	O
was	VBD	O	O
given	VBN	O	O
tylenol	NN	B-TREATMENT	B-TREATMENT
(	(	O	I-TREATMENT
tylenol	JJ	B-TEST	I-TREATMENT
screen	NN	I-TEST	I-TREATMENT
prior	RB	O	O
to	TO	O	O
this	DT	O	O
dose	NN	O	O
was	VBD	O	O
negative	JJ	O	O
,	,	O	O
as	IN	O	O
was	VBD	O	O
a	DT	B-TEST	B-TEST
urine	JJ	I-TEST	I-TEST
tox	NN	I-TEST	I-TEST
)	)	O	O
,	,	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
metronidazole	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
to	TO	O	O
cover	VB	O	O
emperically	RB	O	O
for	IN	O	O
hospital	NN	B-PROBLEM	O
aquired	VBD	I-PROBLEM	O
pneumonia	NN	I-PROBLEM	B-PROBLEM
,	,	O	O
gi	NN	B-PROBLEM	O
sources	NNS	I-PROBLEM	O
,	,	O	O
and	CC	O	O
a	DT	O	B-PROBLEM
potential	JJ	O	I-PROBLEM
hip	NN	B-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
transaminases	NNS	I-TEST	I-TEST
were	VBD	O	O
slightly	RB	B-PROBLEM	B-PROBLEM
elevated	VBN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
was	VBD	O	O
later	RB	O	O
attributed	VBN	O	O
to	TO	O	O
shock	VB	B-PROBLEM	O
liver	RB	I-PROBLEM	O
as	IN	O	O
a	DT	O	O
result	NN	O	O
of	IN	O	O
her	PRP$	O	O
period	NN	O	O
of	IN	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

lipase	NN	B-TEST	B-TEST
and	CC	O	O
amylase	NN	B-TEST	B-TEST
remained	VBD	O	O
normal	JJ	O	O
.	.	O	O

in	IN	O	O
the	DT	O	O
icu	NN	O	O
she	PRP	O	O
also	RB	O	O
received	VBD	O	O
an	DT	B-TEST	B-TEST
echo	NN	I-TEST	I-TEST
that	WDT	O	O
revealed	VBD	O	O
normal	JJ	O	O
function	NN	O	O
and	CC	O	O
little	JJ	B-PROBLEM	B-PROBLEM
valvular	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
she	PRP	O	O
has	VBZ	O	O
two	CD	B-PROBLEM	O
loud	JJ	I-PROBLEM	B-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
murmurs	NNS	I-PROBLEM	I-PROBLEM
on	IN	O	O
exam	NN	B-TEST	B-TEST
)	)	O	O
,	,	O	O
and	CC	O	O
a	DT	B-TEST	B-PROBLEM
hip	NN	I-TEST	I-PROBLEM
film	NN	I-TEST	I-PROBLEM
revealing	VBG	O	O
no	DT	O	O
inflammation	NN	B-PROBLEM	B-PROBLEM
nor	CC	O	O
loosening	NN	B-PROBLEM	O
.	.	O	O

urine	JJ	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
twice	RB	O	O
grew	VBD	O	O
10-100,000	CD	O	O
coag	NNS	B-PROBLEM	B-TEST
negative	JJ	O	O
staph	NN	B-PROBLEM	O
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
could	MD	O	O
not	RB	O	O
be	VB	O	O
placed	VBN	O	O
for	IN	O	O
technical	JJ	O	O
reasons	NNS	O	O
,	,	O	O
however	RB	O	O
after	IN	O	O
4l	CD	O	O
ns	NN	B-TREATMENT	O
on	IN	O	O
the	DT	O	O
floor	NN	O	O
and	CC	O	O
01-30	NN	O	O
more	RBR	O	O
in	IN	O	O
the	DT	O	O
icu	NN	O	O
via	IN	O	O
peripheral	JJ	B-TREATMENT	O
iv	NN	I-TREATMENT	O
's	POS	I-TREATMENT	O
she	PRP	O	O
was	VBD	O	O
stable	JJ	O	O
.	.	O	O

she	PRP	O	O
remained	VBD	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
with	IN	O	O
good	JJ	O	O
uop	NN	O	O
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
being	VBG	O	O
started	VBN	O	O
on	IN	O	O
abx	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
stress	NN	B-TREATMENT	B-TREATMENT
dose	JJ	I-TREATMENT	I-TREATMENT
steroids	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
steroids	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
thought	VBN	O	O
to	TO	O	O
have	VB	O	O
helped	VBN	O	O
significantly	RB	O	O
in	IN	O	O
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
addison	NN	B-PROBLEM	B-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
with	IN	O	O
possibely	RB	O	B-PROBLEM
superimposed	VBN	B-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
planned	VBN	O	O
for	IN	O	O
a	DT	O	O
7	CD	O	O
day	NN	O	O
course	NN	O	O
of	IN	O	O
stress	NN	B-TREATMENT	B-TREATMENT
dose	NN	I-TREATMENT	I-TREATMENT
steroids	NNS	I-TREATMENT	I-TREATMENT
followed	VBN	O	O
by	IN	O	O
a	DT	O	O
return	NN	O	O
to	TO	O	O
her	PRP$	B-TREATMENT	O
basal	NN	I-TREATMENT	O
predinisone	NN	I-TREATMENT	O
/	NNP	O	O
fludrocortisone	NN	B-TREATMENT	B-TREATMENT
dose	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

2.	CD	O	O
elevated	JJ	B-PROBLEM	B-PROBLEM
lfts	NNS	I-PROBLEM	I-PROBLEM
:	:	O	O

lfts	NNS	B-TEST	O
wre	WDT	O	O
elevated	VBN	B-PROBLEM	O
at	IN	O	O
presentation	NN	O	O
.	.	O	O

initially	RB	O	O
the	DT	O	O
differential	NN	O	O
was	VBD	O	O
thought	VBN	O	O
to	TO	O	O
include	VB	O	O
shock	NN	B-PROBLEM	B-PROBLEM
liver	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hepatitis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cholangitis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
choledocholithiasis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

hepatitis	NN	B-TEST	B-TEST
serologies	NNS	I-TEST	I-TEST
were	VBD	O	O
negative	JJ	O	O
and	CC	O	O
the	DT	O	O
pt	NN	O	O
was	VBD	O	O
eventually	RB	O	O
felt	VBN	O	O
to	TO	O	O
have	VB	O	O
had	VBN	O	O
shock	VBN	B-PROBLEM	O
liver	RB	I-PROBLEM	O
from	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
hypotensive	JJ	I-PROBLEM	I-PROBLEM
episode	NN	I-PROBLEM	I-PROBLEM
as	IN	O	O
the	DT	B-PROBLEM	O
transaminitis	NN	I-PROBLEM	O
resolved	VBD	O	O
over	IN	O	O
time	NN	O	O
.	.	O	O

3.	CD	O	O
hypoparathyroidism	NN	B-PROBLEM	B-PROBLEM
:	:	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
chronic	JJ	I-PROBLEM	I-PROBLEM
problem	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

calcium	NN	B-TEST	B-TEST
levels	NNS	I-TEST	I-TEST
were	VBD	O	O
followed	VBN	O	O
with	IN	O	O
a	DT	O	O
goal	NN	O	O
to	TO	O	O
keep	VB	O	O
them	PRP	O	O
around	RB	O	O
8.0	CD	O	O
by	IN	O	O
continuing	VBG	O	B-PROBLEM
calcium	NN	B-TREATMENT	I-PROBLEM
carbonate	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
calcitriol	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
pt	NN	O	O
required	VBN	O	O
calcium	NN	B-TREATMENT	B-TREATMENT
gluconate	NN	I-TREATMENT	I-TREATMENT
x1	VBD	O	O
the	DT	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

per	IN	O	O
endocrine	NN	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
,	,	O	O
the	DT	O	O
pt	NN	O	O
may	MD	O	O
need	VB	O	O
an	DT	O	B-PROBLEM
increase	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
calcium	NN	B-TREATMENT	I-PROBLEM
po	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
but	CC	O	O
at	IN	O	O
this	DT	O	O
time	NN	O	O
they	PRP	O	O
recommended	VBD	O	O
no	DT	O	O
change	NN	O	O
.	.	O	O

4.	CD	O	O
addison	JJ	B-PROBLEM	B-TREATMENT
's-	CD	I-PROBLEM	O
the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
on	IN	O	O
basal	NN	B-TREATMENT	B-TREATMENT
prednisone	NN	I-TREATMENT	I-TREATMENT
/	NNP	O	O
fludrocortisone	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

these	DT	O	O
were	VBD	O	O
initially	RB	O	O
continued	VBN	O	O
as	IN	O	O
above	NN	O	O
and	CC	O	O
later	RB	O	O
,	,	O	O
when	WRB	O	O
she	PRP	O	O
became	VBD	O	O
hypotensive	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
febrile	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
stress	JJ	B-TREATMENT	B-TEST
dose	JJ	I-TREATMENT	I-TEST
steroids	NNS	I-TREATMENT	I-TEST
were	VBD	O	O
started	VBN	O	O
and	CC	O	O
planned	VBN	O	O
for	IN	O	O
a	DT	O	O
7	CD	O	O
day	NN	O	O
course	NN	O	O
followed	VBN	O	O
by	IN	O	O
a	DT	O	O
return	NN	O	O
to	TO	O	O
her	PRP$	O	O
prior	JJ	O	O
dose	NN	O	O
of	IN	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
,	,	O	O
her	PRP$	B-TEST	B-TEST
potassium	NN	I-TEST	I-TEST
had	VBD	O	O
been	VBN	O	O
low	JJ	B-PROBLEM	O
despite	IN	O	O
repletion	NN	B-TREATMENT	B-TREATMENT
,	,	O	O

na	NN	B-TEST	O
was	VBD	O	O
elevated	VBN	B-PROBLEM	B-PROBLEM
,	,	O	O
as	IN	O	O
was	VBD	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
.	.	O	O

on	IN	O	O
recommendation	NN	O	O
from	IN	O	O
endocrine	NN	O	O
,	,	O	O
her	PRP$	B-TREATMENT	B-TEST
fludrocortisone	NN	I-TREATMENT	I-TEST
was	VBD	O	O
decreased	VBN	O	O
from	IN	O	O
0.2	CD	O	O
to	TO	O	O
0.1	CD	O	O
(	(	O	O
higher	JJR	O	O
than	IN	O	O
required	VBN	O	O
doses	NNS	O	B-TREATMENT
of	IN	O	I-TREATMENT
fludrocort	NN	B-TREATMENT	I-TREATMENT
can	MD	O	O
cause	VB	O	O
these	DT	B-PROBLEM	O
symptoms.	NNS	I-PROBLEM	O
)	)	O	O
.	.	O	O

5.	CD	O	O
dm	NN	B-PROBLEM	O
:	:	O	O

she	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
her	PRP$	O	O
prior	JJ	O	O
dose	NN	O	O
of	IN	O	O
steroids	NNS	B-TREATMENT	B-TREATMENT
with	IN	O	O
sliding	VBG	B-TREATMENT	O
scale	JJ	I-TREATMENT	O
per	IN	O	O
patient	NN	O	O
using	VBG	O	O
a	DT	B-TREATMENT	B-TREATMENT
1:15	CD	I-TREATMENT	I-TREATMENT
carb	NN	I-TREATMENT	I-TREATMENT
counting	VBG	I-TREATMENT	O
scheme	NN	I-TREATMENT	O
with	IN	O	O
a	DT	B-TREATMENT	O
1:30	CD	I-TREATMENT	O
correction	NN	I-TREATMENT	O
factor	NN	I-TREATMENT	O
.	.	O	O

on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
her	PRP$	B-TREATMENT	O
glargine	NN	I-TREATMENT	O
was	VBD	O	O
decreased	VBN	O	O
by	IN	O	O
one	CD	O	O
unit	NN	O	O
because	IN	O	O
her	PRP$	B-TEST	B-TEST
glucose	NN	I-TEST	I-TEST
remained	VBD	O	O
somewhat	RB	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
mornings	NNS	O	I-PROBLEM
.	.	O	O

6.	CD	O	O
r	NN	B-PROBLEM	B-PROBLEM
hip	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

later	RB	O	O
in	IN	O	O
her	PRP$	O	O
hospital	NN	O	O
course	NN	O	O
,	,	O	O
the	DT	O	O
pt	NN	O	O
complained	VBD	O	O
of	IN	O	O
hip	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-PROBLEM
r	NN	I-TEST	I-PROBLEM
hip	NN	I-TEST	I-PROBLEM
film	NN	I-TEST	I-PROBLEM
was	VBD	O	O
negative	JJ	O	O
for	IN	O	O
pathology	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
failure	NN	B-PROBLEM	B-PROBLEM
of	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
hip	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

pain	NN	B-PROBLEM	B-PROBLEM
was	VBD	O	O
controlled	VBN	O	O
with	IN	O	O
tylenol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
the	DT	O	O
pt	NN	O	O
was	VBD	O	O
reassured	VBN	O	O
.	.	O	O

the	DT	O	O
pt	NN	O	O
uses	VBZ	O	O
a	DT	B-TREATMENT	B-TREATMENT
wheelchair	NN	I-TREATMENT	I-TREATMENT
often	RB	O	O
at	IN	O	O
baseline	NN	O	O
due	JJ	O	O
to	TO	O	O
pain	VB	B-PROBLEM	B-PROBLEM
from	IN	O	O
arthritis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

7.	CD	O	O
depression	NN	B-PROBLEM	B-PROBLEM
:	:	O	O

the	DT	O	O
pt	NN	O	O
was	VBD	O	O
being	VBG	O	O
treated	VBN	O	O
at	IN	O	O
mediplex	JJ	O	O
rehab	NN	O	O
hospital	NN	O	O
4	CD	O	O
for	IN	O	O
suicidal	JJ	B-PROBLEM	B-PROBLEM
ideation	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	O	B-PROBLEM
suicide	JJ	O	I-PROBLEM
attempt	NN	O	I-PROBLEM
on	IN	O	O
original	JJ	O	O
admission	NN	O	O
with	IN	O	O
tylenol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
oxycodone	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
been	VBN	O	O
depressed	VBN	B-PROBLEM	O
for	IN	O	O
some	DT	O	O
time	NN	O	O
but	CC	O	O
her	PRP$	O	O
loved	JJ	O	O
ones	NNS	O	O
were	VBD	O	O
very	RB	O	O
surprised	JJ	O	O
at	IN	O	O
her	PRP$	O	O
attempt	NN	O	O
.	.	O	O

she	PRP	O	O
remained	VBD	O	O
very	RB	B-PROBLEM	B-PROBLEM
depressed	JJ	I-PROBLEM	I-PROBLEM
at	IN	O	O
her	PRP$	O	O
inpatient	JJ	O	O
admission	NN	O	O
and	CC	O	O
refractory	NN	B-PROBLEM	O
to	TO	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

one	CD	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
her	PRP$	O	O
transfer	NN	O	O
to	TO	O	O
the	DT	O	O
medical	JJ	O	O
floor	NN	O	O
she	PRP	O	O
was	VBD	O	O
sectioned	VBN	O	O
to	TO	O	O
initiate	VB	O	O
ect	NN	B-TREATMENT	O
,	,	O	O
which	WDT	O	O
she	PRP	O	O
had	VBD	O	O
previously	RB	O	O
refused	VBN	O	O
.	.	O	O

as	IN	O	O
a	DT	O	O
result	NN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
maintained	VBN	O	O
on	IN	O	O
her	PRP	B-TREATMENT	B-TREATMENT
ativan	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
mirtazapine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
risperidone	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
duloxetine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
did	VBD	O	O
not	RB	O	O
exhibit	VB	O	O
psychotic	JJ	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
denied	VBD	O	O
any	DT	B-PROBLEM	B-PROBLEM
suicidality	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
did	VBD	O	O
endorse	DT	O	O
depression	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
denied	VBD	O	O
hi	NN	B-PROBLEM	O
,	,	O	O
si	NN	B-PROBLEM	O
,	,	O	O
and	CC	O	O
illusions	NNS	B-PROBLEM	O
/	VBP	O	O
hallucinations	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
did	VBD	O	O
have	VB	O	O
heparin	VBN	B-TREATMENT	B-TREATMENT
subcutaneously	RB	I-TREATMENT	O
while	IN	O	O
on	IN	O	O
the	DT	O	O
medical	JJ	O	O
floor	NN	O	O
and	CC	O	O
in	IN	O	O
the	DT	O	O
icu	NN	O	O
.	.	O	O

she	PRP	O	O
remained	VBD	O	O
full	JJ	B-TREATMENT	O
code	NN	I-TREATMENT	O
throughout	IN	O	O
the	DT	O	O
hospitalization	NN	O	O
.	.	O	O

fludrocortisone	NN	B-TREATMENT	B-TREATMENT
acetate	NN	I-TREATMENT	I-TREATMENT
0.2	CD	O	O
mg	NN	O	O
po	JJ	O	O
daily	JJ	O	O
07-12	NN	O	O
@	NN	O	O
1033	CD	O	O

acetaminophen	RB	B-TREATMENT	B-TREATMENT
650	CD	O	O
mg	JJ	O	O
po	JJ	O	O
bid	NN	O	O
07-11	CD	O	O
@	NN	O	O
1503	CD	O	O
view	NN	O	O

ibuprofen	NN	B-TREATMENT	B-TREATMENT
400	CD	O	O
mg	NN	O	O
po	NN	O	O
bid	NN	O	O
07-11	CD	O	O
@	NN	O	O
1503	CD	O	O
view	NN	O	O

ibuprofen	NN	B-TREATMENT	B-TREATMENT
400	CD	O	O
mg	NN	O	O
po	NN	O	O
q8h	NN	O	O
:	:	O	O
prn	JJ	O	O
07-11	CD	O	O
@	JJ	O	O
1503	CD	O	O
view	NN	O	O

insulin	NN	B-TREATMENT	B-TREATMENT
sc	NN	I-TREATMENT	I-TREATMENT
(	(	O	O
per	IN	O	O
insulin	NN	O	B-TREATMENT
flowsheet	NN	O	I-TREATMENT
)	)	O	I-TREATMENT

risperidone	NN	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	NN	O	O
po	NN	O	O
hs	VBD	O	O
07-10	CD	O	O
@	JJ	O	O
1135	CD	O	O
view	NN	O	O

risperidone	NN	B-TREATMENT	B-TREATMENT
0.5	CD	O	O
mg	NN	O	O
po	JJ	O	O
daily	JJ	O	O
07-10	CD	O	O
@	JJ	O	O
1135	CD	O	O
view	NN	O	O

potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
20	CD	O	O
meq	NN	O	O
po	NN	O	O
bid	NN	O	O

calcium	NN	B-TREATMENT	B-TREATMENT
carbonate	NN	I-TREATMENT	I-TREATMENT
1500	CD	O	O
mg	NN	O	O
po	NN	O	O
tid	IN	O	O
07-04	CD	O	O
@	JJ	O	O
1126	CD	O	O
view	NN	O	O

mirtazapine	NN	B-TREATMENT	B-TREATMENT
15	CD	O	O
mg	NN	O	O
po	NN	O	O
hs	VBD	O	O
07-03	CD	O	O
@	JJ	O	O
1220	CD	O	O
view	NN	O	O

duloxetine	NN	B-TREATMENT	B-TREATMENT
30	CD	O	O
mg	NN	O	O
po	NN	O	O
bid	VBD	O	O
start	NN	O	O
:	:	O	O
in	IN	O	O
am	VBP	O	O
07-03	JJ	O	O
@	NN	O	O
1214	CD	O	O

psyllium	NN	B-TREATMENT	B-TREATMENT
1	CD	O	O
pkt	NN	O	O
po	NN	O	O
tid	NN	O	O
:	:	O	O
prn	JJ	O	O
06-30	CD	O	O
@	JJ	O	O
1248	CD	O	O
view	NN	O	O

memantine	NN	B-TREATMENT	B-TREATMENT
*	NNP	O	O
n	VBZ	O	O
f*	JJ	O	O
10	CD	O	O
mg	JJ	O	O
oral	JJ	O	O
daily	JJ	O	O
06-27	CD	O	O
@	JJ	O	O
1124	CD	O	O
view	NN	O	O

calcitriol	NN	B-TREATMENT	B-TREATMENT
0.25	CD	O	O
mcg	NN	O	O
po	NN	O	O
every	DT	O	O
other	JJ	O	O
day	NN	O	O
t/th/s/s	VB	O	O

calcitriol	NN	B-TREATMENT	B-TREATMENT
0.5	CD	O	O
mcg	NN	O	O
po	NN	O	O
every	DT	O	O
other	JJ	O	O
day	NN	O	O
06-27	CD	O	O
@	NN	O	O
1051	CD	O	O

lorazepam	RB	B-TREATMENT	B-TREATMENT
2	CD	O	O
mg	NNS	O	O
po	JJ	O	O
hs	JJ	O	O
06-23	CD	O	O
@	JJ	O	O
1215	CD	O	O
view	NN	O	O

alendronate	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
70	CD	O	O
mg	NN	O	O
po	NN	O	O
qsun	JJ	O	O
06-22	CD	O	O
@	JJ	O	O
1106	CD	O	O
view	NN	O	O

lactulose	RB	B-TREATMENT	B-TREATMENT
60	CD	O	O
ml	NNS	O	O
po	JJ	O	O
qthur	JJ	O	O
06-21	JJ	O	O
@	NN	O	O
1600	CD	O	O
view	NN	O	O

milk	NN	B-TREATMENT	B-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
magnesia	NN	I-TREATMENT	I-TREATMENT
60	CD	O	O
ml	NN	O	O
po	NN	O	O
qthur	VBD	O	O
06-21	CD	O	O
@	JJ	O	O
1600	CD	O	O
view	NN	O	O

arimidex	NN	B-TREATMENT	O
*	NNP	O	O
n	VBZ	O	O
f*	JJ	O	O
1	CD	O	O
mg	JJ	O	O
oral	JJ	O	O
daily	JJ	O	O
06-21	CD	O	O
@	JJ	O	O
1414	CD	O	O
view	NN	O	O

magnesium	NN	B-TREATMENT	B-TREATMENT
oxide	RB	I-TREATMENT	I-TREATMENT
400	CD	O	O
mg	JJ	O	O
po	JJ	O	O
bid	NN	O	O
06-20	CD	O	O
@	NN	O	O
2017	CD	O	O
view	NN	O	O

atorvastatin	RB	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NNS	O	O
po	JJ	O	O
daily	JJ	O	O
06-20	CD	O	O
@	JJ	O	O
2017	CD	O	O
view	NN	O	O

docusate	NN	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
po	NN	O	O
tid	IN	O	O
06-20	JJ	O	O
@	JJ	O	O
2017	CD	O	O
view	NN	O	O

pantoprazole	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
po	NN	O	O
q24h	JJ	O	O
06-20	CD	O	O
@	JJ	O	O
2017	CD	O	O
view	NN	O	O

prednisone	NN	B-TREATMENT	B-TREATMENT
2.5	CD	O	O
mg	NN	O	O
po	NN	O	O
q3pm	JJ	O	O
06-20	CD	O	O
@	JJ	O	O
2017	CD	O	O
view	NN	O	O

prednisone	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
po	NN	O	O
qam	JJ	O	O
06-20	CD	O	O
@	JJ	O	O
2017	CD	O	O
view	NN	O	O

chlorothiazide	RB	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NNS	O	O
po	JJ	O	O
daily	JJ	O	O
06-20	CD	O	O
@	JJ	O	O
2017	CD	O	O
view	NN	O	O

aspirin	RB	B-TREATMENT	B-TREATMENT
81	CD	O	O
mg	NNS	O	O
po	JJ	O	O
daily	JJ	O	O

multivitamins	NNS	B-TREATMENT	B-TREATMENT
1	CD	O	O
cap	NN	O	O
po	NNS	O	O
daily	RB	O	O

clindamycin	NN	B-TREATMENT	B-TREATMENT
/	NNP	O	O
erythromycin	VBZ	B-TREATMENT	B-TREATMENT
base	NN	I-TREATMENT	I-TREATMENT
/	NNP	O	O
amoxicillin	NN	B-TREATMENT	B-TREATMENT
/	NNP	O	O
keflex	NNP	B-TREATMENT	B-TREATMENT
/	NNP	O	O
wellbutrin	NN	B-TREATMENT	B-TREATMENT

1.	CD	O	O
risperidone	NN	B-TREATMENT	B-TREATMENT
0.5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
hs	NN	O	O
(	(	O	O
at	IN	O	O
bedtime	NN	O	O
)	)	O	O
.	.	O	O

2.	CD	O	O
risperidone	NN	B-TREATMENT	B-TREATMENT
0.5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

3.	CD	O	O
mirtazapine	NN	B-TREATMENT	B-TREATMENT
15	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
hs	NN	O	O
(	(	O	O
at	IN	O	O
bedtime	NN	O	O
)	)	O	O
.	.	O	O

4.	CD	O	O
duloxetine	JJ	B-TREATMENT	B-TREATMENT
30	CD	O	O
mg	NN	O	O
capsule	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

5.	CD	O	O
calcitriol	NN	B-TREATMENT	B-TREATMENT
0.25	CD	O	O
mcg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
every	DT	O	O
other	JJ	O	O
day	NN	O	O
(	(	O	O
every	DT	O	O
other	JJ	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

6.	CD	O	O
calcitriol	NN	B-TREATMENT	B-TREATMENT
0.5	CD	O	O
mcg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
every	DT	O	O
other	JJ	O	O
day	NN	O	O
(	(	O	O
every	DT	O	O
other	JJ	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

7.	CD	O	O
alendronate	JJ	B-TREATMENT	B-TREATMENT
70	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
qsun	NN	O	O
(	(	O	O
every	DT	O	O
sunday	NN	O	O
)	)	O	O
.	.	O	O

8.	CD	O	O
lactulose	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
g	NN	O	O
/	VBD	O	O
15	CD	O	O
ml	NN	O	O
syrup	NN	O	O
sig	NN	O	O
:	:	O	O
sixty	NN	O	O
(	(	O	O
60	CD	O	O
)	)	O	O
ml	NN	O	O
po	NN	O	O
every	DT	O	O
thursday	NN	O	O
(	(	O	O
)	)	O	O
.	.	O	O

9.	CD	O	O
magnesium	NN	B-TREATMENT	B-TREATMENT
hydroxide	NN	I-TREATMENT	I-TREATMENT
400	CD	O	O
mg	NN	O	O
/	VBD	O	O
5	CD	O	O
ml	JJ	O	O
suspension	NN	O	O
sig	NN	O	O
:	:	O	O
thirty	NN	O	O
(	(	O	O
30	CD	O	O
)	)	O	O
ml	NN	O	O
po	NN	O	O
q6h	NN	O	O
(	(	O	O
every	DT	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

10.	CD	O	O
anastrozole	JJ	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	RB	O	O
(	(	O	O
)	)	O	O
.	.	O	O

11.	CD	O	O
atorvastatin	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

12.	CD	O	O
docusate	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

13.	CD	O	O
pantoprazole	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
q24h	NN	O	O
(	(	O	O
every	DT	O	O
24	CD	O	O
hours	NNS	O	O
)	)	O	O
.	.	O	O

14.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
81	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
chewable	JJ	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
chewable	JJ	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

15.	CD	O	O
multivitamin	NN	B-TREATMENT	B-TREATMENT
capsule	NN	I-TREATMENT	I-TREATMENT
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
cap	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

16.	CD	O	O
ibuprofen	JJ	B-TREATMENT	B-TREATMENT
400	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

17.	CD	O	O
ferrous	JJ	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
325	CD	O	O
(	(	O	O
65	CD	O	O
)	)	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

18.	CD	O	O
maalox	JJ	B-TREATMENT	O
200-200-20	JJ	O	O
mg	NN	O	O
/	$	O	O
5	CD	O	O
ml	JJ	O	O
suspension	NN	O	O
sig	NN	O	O
:	:	O	O
fifteen	NN	O	O
(	(	O	O
15	CD	O	O
)	)	O	O
ml	NN	O	O
po	NN	O	O
prn	NN	O	O
(	(	O	O
as	IN	O	O
needed	VBN	O	O
)	)	O	O
.	.	O	O

19.	CD	O	O
levofloxacin	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q24h	NN	O	O
(	(	O	O
every	DT	O	O
24	CD	O	O
hours	NNS	O	O
)	)	O	O
for	IN	O	O
2	CD	O	O
days	NNS	O	O
.	.	O	O

20.	CD	O	O
calcium	NN	B-TREATMENT	B-TREATMENT
carbonate	NN	I-TREATMENT	I-TREATMENT
500	CD	O	O
mg	NN	O	O
tablet	NN	O	O
,	,	O	O
chewable	JJ	O	O
sig	NN	O	O
:	:	O	O
three	CD	O	O
(	(	O	O
3	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
chewable	JJ	O	O
po	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

21.	CD	O	O
calcium	NN	B-TREATMENT	B-TREATMENT
carbonate	NN	I-TREATMENT	I-TREATMENT
500	CD	O	O
mg	NN	O	O
tablet	NN	O	O
,	,	O	O
chewable	JJ	O	O
sig	NN	O	O
:	:	O	O
three	CD	O	O
(	(	O	O
3	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
chewable	JJ	O	O
po	NN	O	O
qid	NN	O	O
(	(	O	O
4	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

22.	CD	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
porcine	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
5,000	CD	O	O
unit	NN	O	O
/	NNP	O	O
ml	NN	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
5000	CD	O	O
(	(	O	O
5000	CD	O	O
)	)	O	O
units	NNS	O	O
injection	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

23.	CD	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

24.	CD	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
2.5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q	NN	O	O
3pm	CD	O	O
(	(	O	O
)	)	O	O
.	.	O	O

25.	CD	O	O
chlorothiazide	JJ	B-TREATMENT	O
250	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

26.	CD	O	O
fludrocortisone	NN	B-TREATMENT	B-TREATMENT
0.1	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

27.	CD	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
10	CD	O	O
meq	NN	O	O
capsule	NN	O	O
,	,	O	O
sustained	VBD	O	O
release	NN	O	O
sig	NN	O	O
:	:	O	O
four	CD	O	O
(	(	O	O
4	CD	O	O
)	)	O	O
capsule	NN	O	O
,	,	O	O
sustained	VBD	O	O
release	NN	O	O
po	NN	O	O
daily	RB	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

28.	CD	O	O
lorazepam	JJ	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
0.5	CD	O	O
tablet	NN	O	O
po	NN	O	O
q6h	NN	O	O
(	(	O	O
every	DT	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

29.	CD	O	O
memantine	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	RB	O	O
(	(	O	O
)	)	O	O
.	.	O	O

30.	CD	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
glargine	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
unit	NN	O	O
/	NNP	O	O
ml	NN	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
as	IN	O	O
instructed	VBN	O	O
subcutaneous	JJ	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
:	:	O	O
7	CD	O	O
units	NNS	O	O
in	IN	O	O
the	DT	O	O
morning	NN	O	O
,	,	O	O
18	CD	O	O
units	NNS	O	O
in	IN	O	O
the	DT	O	O
evening	NN	O	O
.	.	O	O

hypotension	NN	B-PROBLEM	B-PROBLEM

early	JJ	B-PROBLEM	B-PROBLEM
sepsis	NN	I-PROBLEM	I-PROBLEM

adrenal	JJ	B-PROBLEM	B-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM

diabetes	NNS	B-PROBLEM	B-PROBLEM
i	VBP	I-PROBLEM	O

hypocalcemia	NN	B-PROBLEM	B-PROBLEM
(	(	O	I-PROBLEM
hypoparathyroidism	NN	B-PROBLEM	I-PROBLEM
)	)	O	I-PROBLEM

depression	NN	B-PROBLEM	B-PROBLEM

transaminitis	NN	B-PROBLEM	B-PROBLEM

stable	JJ	O	O
vitals	NNS	O	O
,	,	O	O
depressed	VBD	B-PROBLEM	B-PROBLEM
.	.	O	O

you	PRP	O	O
were	VBD	O	O
admitted	VBN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
pressure	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
developed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

you	PRP	O	O
are	VBP	O	O
finishing	VBG	O	O
a	DT	O	O
course	NN	O	O
of	IN	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
have	VBP	O	O
been	VBN	O	O
stable	JJ	O	O
for	IN	O	O
days	NNS	O	O
.	.	O	O

if	IN	O	O
you	PRP	O	O
lose	VBP	O	O
consciousness	NN	O	O
,	,	O	O
develop	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
bp	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
have	VBP	O	O
lightheadedness	VBN	B-PROBLEM	B-PROBLEM
with	IN	O	O
standing	NN	O	O
,	,	O	O
develop	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
have	VBP	O	O
other	JJ	B-PROBLEM	B-PROBLEM
worrisome	NN	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
please	VB	O	O
seek	VB	O	O
medical	JJ	B-TREATMENT	B-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

cardiogenic	JJ	B-PROBLEM	B-PROBLEM
shock	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

including	VBG	O	O
cardiomyopathy	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
aortic	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
aortic	JJ	B-TREATMENT	B-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
status	NN	O	O
post	NN	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	VBG	I-TREATMENT	I-TREATMENT
with	IN	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
65	CD	O	O
year	NN	O	O
old	JJ	O	O
male	NN	O	O
who	WP	O	O
sustained	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
first	RB	O	O
in	IN	O	O
1978	CD	O	O
,	,	O	O
with	IN	O	O
course	NN	O	O
thereafter	RB	O	O
including	VBG	O	O
a	DT	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
by	IN	O	O
dr.	NN	O	O
wierst	NN	O	O
______________at	NNP	O	O
noughwell	RB	O	O
entanbon	VBZ	O	O
health	NN	O	O
in	IN	O	O
1986	CD	O	O
.	.	O	O

in	IN	O	O
1991	CD	O	O
he	PRP	O	O
presented	VBD	O	O
with	IN	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
he	PRP	O	O
underwent	JJ	O	O
porcine	JJ	B-TREATMENT	B-TREATMENT
aortic	JJ	I-TREATMENT	I-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

in	IN	O	O
the	DT	O	O
seven	CD	O	O
to	TO	O	O
eight	CD	O	O
months	NNS	O	O
preceding	VBG	O	O
admission	NN	O	O
,	,	O	O
he	PRP	O	O
developed	VBD	O	O
recurrent	JJ	B-PROBLEM	B-PROBLEM
angina	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
exertion	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
in	IN	O	O
early	JJ	O	O
december	NN	O	O
,	,	O	O
1993	CD	O	O
.	.	O	O

significant	JJ	O	O
for	IN	O	O
vertebrobasilar	JJ	B-PROBLEM	B-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
bipolar	JJ	B-PROBLEM	B-PROBLEM
mood	NN	I-PROBLEM	I-PROBLEM
disorder	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
baseline	JJ	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

procardia	NN	B-TREATMENT	B-PROBLEM
sustained	VBD	I-TREATMENT	O
release	NN	I-TREATMENT	O
60	CD	O	O
mg.	NN	O	O
po	NN	O	O
q.day	NN	O	O
,	,	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
.25	NNP	O	I-TREATMENT
mg.	NN	O	O
po	NN	O	O
q.day	NN	O	O
,	,	O	O
lasix	VBZ	B-TREATMENT	B-TREATMENT
30	CD	O	O
mg.	NN	O	O
(	(	O	O
interval	JJ	O	O
unspecified	VBN	O	O
)	)	O	O
,	,	O	O
prozac	$	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg.	NN	O	O
po	NN	O	O
q.day	NN	O	O
,	,	O	O
lovestatin	VBZ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg.	NN	O	O
po	NN	O	O
bid	NN	O	O
,	,	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
q.	JJ	O	O
day	NN	O	O
and	CC	O	O
supplemental	JJ	B-TREATMENT	B-TREATMENT
potassium	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

remarkable	NN	O	O
for	IN	O	O
an	DT	O	O
oriented	VBN	O	O
,	,	O	O
alert	JJ	O	O
male	NN	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
decreased	JJ	B-PROBLEM	B-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
sounds	NNS	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
right	JJ	I-PROBLEM	O
base	NN	I-PROBLEM	O
consistent	NN	O	O
with	IN	O	O
effusion	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
3/6	CD	I-PROBLEM	I-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
murmur	FW	I-PROBLEM	I-PROBLEM
consistent	NN	O	O
with	IN	O	O
aortic	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
pulse	NN	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
was	VBD	O	O
intact	JJ	O	O
.	.	O	O

cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
demonstrated	VBD	O	O
elevated	JJ	B-PROBLEM	B-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
left-sided	JJ	I-PROBLEM	B-PROBLEM
filling	NN	I-PROBLEM	I-PROBLEM
pressures	NNS	I-PROBLEM	I-PROBLEM
at	IN	O	O
rest	NN	O	O
,	,	O	O
with	IN	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
normal	JJ	O	O
cardiac	JJ	O	O
index	NN	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
70	CD	O	I-PROBLEM
millimeter	NN	O	I-PROBLEM
peak	NN	O	I-PROBLEM
gradient	NN	O	I-PROBLEM
,	,	O	O
native	JJ	B-PROBLEM	B-PROBLEM
three	CD	I-PROBLEM	I-PROBLEM
vessel	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
patent	NN	B-TREATMENT	B-TREATMENT
left	VBD	I-TREATMENT	I-TREATMENT
internal	JJ	I-TREATMENT	I-TREATMENT
mammary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
left	NN	I-TREATMENT	I-TREATMENT
circumflex	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
dissection	NN	B-PROBLEM	B-TEST
of	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
left	NN	I-PROBLEM	O
main	JJ	I-PROBLEM	O
was	VBD	O	O
induced	VBN	O	O
by	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
tip	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
patent	NN	I-TREATMENT	I-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
internal	JJ	I-TREATMENT	I-TREATMENT
mammary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
left	VBN	I-TREATMENT	I-TREATMENT
anterior	JJ	I-TREATMENT	I-TREATMENT
descending	VBG	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
and	CC	I-TREATMENT	O
diagonal	NN	I-TREATMENT	O
was	VBD	O	O
noted	VBN	O	O
,	,	O	O
and	CC	O	O
a	DT	B-TREATMENT	B-TREATMENT
patent	NN	I-TREATMENT	I-TREATMENT
saphenous	JJ	I-TREATMENT	I-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
posterior	JJ	I-TREATMENT	I-TREATMENT
descending	NN	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
present	JJ	O	O
.	.	O	O

also	RB	O	O
of	IN	O	O
note	NN	O	O
,	,	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
induced	VBN	O	O
by	IN	O	O
dye	NN	B-TREATMENT	O
and	CC	O	O
anxiety	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
treated	VBN	O	O
with	IN	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
oxygen	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
nitroglycerin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

post-procedure	NN	O	O
he	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
ccu	NN	O	O
because	IN	O	O
of	IN	O	O
the	DT	O	O
history	NN	O	O
of	IN	O	O
left	NN	B-PROBLEM	B-TREATMENT
main	JJ	I-PROBLEM	I-TREATMENT
dissection	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

he	PRP	O	O
remained	VBD	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
but	CC	O	O
of	IN	O	O
note	NN	O	O
,	,	O	O
would	MD	O	O
not	RB	O	O
tolerate	VB	O	O
a	DT	B-TEST	B-TEST
transesophageal	NN	I-TEST	I-TEST
echo	NN	I-TEST	I-TEST
because	IN	O	O
of	IN	O	O
anxiety-he	NN	B-PROBLEM	O
would	MD	O	O
not	RB	O	O
swallow	VB	O	O
the	DT	B-TREATMENT	O
probe	NN	I-TREATMENT	O
.	.	O	O

transthoracic	NN	B-TEST	B-TEST
echo	NN	I-TEST	I-TEST
demonstrated	VBD	O	O
gradients	NNS	O	O
of	IN	O	O
100	CD	O	O
peak	NN	O	O
and	CC	O	O
65	CD	O	O
mean	NN	O	O
across	IN	O	O
the	DT	O	O
aortic	JJ	O	O
valve	NN	O	O
and	CC	O	O
there	EX	O	O
was	VBD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
ejection	NN	B-TEST	B-TEST
fraction	NN	I-TEST	I-TEST
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
18%	CD	O	O
with	IN	O	O
global	JJ	B-PROBLEM	B-PROBLEM
hypokinesis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
next	JJ	O	O
several	JJ	O	O
days	NNS	O	O
were	VBD	O	O
remarkable	JJ	O	O
for	IN	O	O
events	NNS	O	O
in	IN	O	O
which	WDT	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
quite	RB	B-PROBLEM	B-PROBLEM
agitated	JJ	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
evaluated	VBN	O	O
by	IN	O	O
psychiatry	NN	O	O
and	CC	O	O
treated	VBN	O	O
with	IN	O	O
ativan	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
then	RB	O	O
evaluated	VBN	O	O
by	IN	O	O
cardiac	JJ	O	O
surgery	NN	O	O
for	IN	O	O
probable	JJ	O	B-TREATMENT
re-do	JJ	B-TREATMENT	I-TREATMENT
aortic	JJ	I-TREATMENT	I-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
possible	JJ	O	O
re-do	JJ	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

in	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
preoperative	JJ	B-TEST	B-TEST
workup	NN	I-TEST	I-TEST
,	,	O	O
mr.	NN	O	O
has	VBZ	O	O
was	VBD	O	O
evaluated	VBN	O	O
completely	RB	O	O
by	IN	O	O
psychiatry	NN	O	O
with	IN	O	O
diagnoses	NNS	O	O
including	VBG	O	O
underlying	VBG	B-PROBLEM	B-PROBLEM
chronic	JJ	I-PROBLEM	I-PROBLEM
depression	NN	I-PROBLEM	I-PROBLEM
well-controlled	VBD	O	O
on	IN	O	O
prozac	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
underlying	VBG	B-PROBLEM	B-PROBLEM
organ	JJ	I-PROBLEM	I-PROBLEM
brain	NN	I-PROBLEM	I-PROBLEM
vulnerability	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
unclear	JJ	O	O
etiology	NN	O	O
,	,	O	O
possibly	RB	O	O
microvascular	JJ	B-PROBLEM	B-PROBLEM
infarct	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
paranoid	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
belligerent	NN	I-PROBLEM	B-PROBLEM
behavior	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
possibly	RB	O	O
due	JJ	O	O
to	TO	O	O
medications	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

on	IN	O	O
december	$	O	O
12	CD	O	O
the	DT	O	O
patient	NN	O	O
underwent	NN	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
including	VBG	O	O
a	DT	B-TREATMENT	B-TREATMENT
re-do	JJ	I-TREATMENT	I-TREATMENT
aortic	JJ	I-TREATMENT	I-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
#	#	B-TREATMENT	O
25	CD	I-TREATMENT	O
st.	JJ	I-TREATMENT	O
jude	NN	I-TREATMENT	O
and	CC	O	O
re-do	JJ	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	VBG	I-TREATMENT	I-TREATMENT
times	NNS	I-TREATMENT	O
one	CD	I-TREATMENT	O
;	:	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
posterior	JJ	I-TREATMENT	I-TREATMENT
descending	NN	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
as	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
veno-venous	JJ	I-TREATMENT	I-TREATMENT
jump	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
surgical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
postoperatively	RB	O	O
with	IN	O	O
stable	JJ	O	O
hemodynamics	NNS	O	O
on	IN	O	O
lidocaine	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
one	CD	O	O
,	,	O	O
dobutamine	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
200	CD	O	O
and	CC	O	O
nipride	RB	B-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
extubated	VBN	O	O
by	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#	#	O	O
1	CD	O	O
but	CC	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
relatively	RB	B-PROBLEM	O
hypoxemic	JJ	I-PROBLEM	O
with	IN	O	O
high	JJ	B-PROBLEM	B-PROBLEM
oxygen	NN	I-PROBLEM	I-PROBLEM
requirement	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

chest	JJS	B-TEST	B-PROBLEM
x-ray	JJ	I-TEST	I-PROBLEM
demonstrating	NN	O	I-PROBLEM
pulmonary	JJ	B-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

aggressive	JJ	B-TREATMENT	B-TREATMENT
diuresis	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
undertaken	JJ	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
responded	VBD	O	O
,	,	O	O
albeit	IN	O	O
sluggishly	RB	O	O
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
he	PRP	O	O
remained	VBD	O	O
agitated	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

this	DT	O	O
was	VBD	O	O
attributed	VBN	O	O
to	TO	O	O
mild	VB	B-PROBLEM	B-PROBLEM
hypoxia	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
/	NN	O	O
or	CC	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
underlying	JJ	I-PROBLEM	I-PROBLEM
psychiatric	JJ	I-PROBLEM	I-PROBLEM
diagnoses	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
haldol	NN	B-TREATMENT	B-TREATMENT
appropriately	RB	O	O
.	.	O	O

on	IN	O	O
day	NN	O	O
#	#	O	O
2	CD	O	O
the	DT	O	O
patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
diurese	VB	O	O
and	CC	O	O
this	DT	O	O
was	VBD	O	O
maintained	VBN	O	O
with	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
lasix/	NN	I-TREATMENT	I-TREATMENT
mannitol	NN	I-TREATMENT	I-TREATMENT
infusion	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-TEST	B-TEST
urine	JJ	I-TEST	I-TEST
output	NN	I-TEST	I-TEST
remained	VBD	O	O
at	IN	O	O
150	CD	O	O
to	TO	O	O
200	CD	O	O
cc.	NNS	O	O
an	DT	O	O
hour	NN	O	O
.	.	O	O

despite	IN	O	O
this	DT	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	JJ	I-TEST	I-TEST
continued	VBD	O	O
to	TO	O	O
show	VB	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
the	DT	O	O
clinical	JJ	O	O
picture	NN	O	O
correlated	VBN	O	O
.	.	O	O

he	PRP	O	O
required	VBD	O	O
anti-hypertensive	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
initially	RB	O	O
with	IN	O	O
nipride	JJ	B-TREATMENT	O
which	WDT	O	O
was	VBD	O	O
changed	VBN	O	O
to	TO	O	O
hydralazine	VB	B-TREATMENT	B-TREATMENT
to	TO	O	O
avoid	VB	O	O
shunting	NN	B-PROBLEM	O
.	.	O	O

he	PRP	O	O
received	VBD	O	O
several	JJ	O	O
units	NNS	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
to	TO	O	O
increase	VB	O	O
his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
and	CC	O	O
oncotic	JJ	B-TEST	B-PROBLEM
pressure	NN	I-TEST	I-PROBLEM
.	.	O	O

very	RB	O	O
early	RB	O	O
in	IN	O	O
the	DT	O	O
morning	NN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#	#	O	O
3	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
became	VBD	O	O
acutely	RB	B-PROBLEM	B-PROBLEM
hypoxic	JJ	I-PROBLEM	I-PROBLEM
after	IN	O	O
several	JJ	O	O
hours	NNS	O	O
of	IN	O	O
marginal	JJ	B-PROBLEM	B-PROBLEM
oxygenation	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
respiratory	JJ	B-TEST	B-PROBLEM
rates	NNS	I-TEST	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
thirties	NNS	O	I-PROBLEM
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
urgently	RB	O	O
intubated	VBN	O	B-TREATMENT
,	,	O	O
without	IN	O	O
complication	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

with	IN	O	O
positive	JJ	B-TREATMENT	B-TREATMENT
pressure	NN	I-TREATMENT	I-TREATMENT
ventilation	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
continued	JJ	B-TREATMENT	B-TREATMENT
diuresis	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
his	PRP$	B-TEST	B-TEST
arterial	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
gases	NNS	I-TEST	I-TEST
improved	VBN	O	O
.	.	O	O

exception	NN	O	O
was	VBD	O	O
a	DT	O	O
ten	JJ	O	O
beat	NN	O	O
run	NN	O	O
of	IN	O	O
ventricular	JJ	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
thought	VBN	O	O
to	TO	O	O
be	VB	O	O
ischemic	JJ	B-PROBLEM	B-PROBLEM
in	IN	O	I-PROBLEM
origin	NN	O	I-PROBLEM
and	CC	O	O
treated	VBN	O	O
with	IN	O	O
nitrates	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
lidocaine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

his	PRP$	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
blossomed	VBD	O	O
to	TO	O	O
demonstrate	VB	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
infiltrate	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
the	DT	O	O
patient	NN	O	O
began	VBD	O	O
to	TO	O	O
produce	VB	O	O
sputum	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

infectious	JJ	O	O
disease	NN	O	O
consultation	NN	O	O
was	VBD	O	O
obtained	VBN	O	O
for	IN	O	O
evaluation	NN	B-TEST	B-TEST
of	IN	O	I-TEST
his	PRP$	B-PROBLEM	I-TEST
purulent	NN	I-PROBLEM	I-TEST
sputum	NN	I-PROBLEM	I-TEST
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
covered	VBN	O	O
with	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
ceftazidime	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

cardiology	NN	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
commented	VBN	O	O
on	IN	O	O
the	DT	B-PROBLEM	O
patient	NN	I-PROBLEM	O
&apos;s	NN	I-PROBLEM	B-PROBLEM
increasing	VBG	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
ectopy	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
suggested	VBD	O	O
that	IN	O	O
these	DT	O	O
were	VBD	O	O
due	JJ	O	O
to	TO	O	O
an	DT	B-PROBLEM	O
r	NN	I-PROBLEM	O
and	CC	I-PROBLEM	O
t	NN	I-PROBLEM	O
phenomenon	NN	I-PROBLEM	O
from	IN	O	O
his	PRP$	B-TREATMENT	B-PROBLEM
pacer	NN	I-TREATMENT	I-PROBLEM
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
prolonged	JJ	B-PROBLEM	B-PROBLEM
qt	NN	I-PROBLEM	I-PROBLEM
interval	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

consequently	RB	O	O
his	PRP$	B-TREATMENT	O
pronestyl	NN	I-TREATMENT	O
was	VBD	O	O
discontinued	VBN	O	O
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
given	VBN	O	O
magnesium	NN	B-TREATMENT	B-TREATMENT
to	TO	O	O
bring	VB	O	O
his	PRP$	B-TEST	O
level	NN	I-TEST	O
above	IN	O	O
2	CD	O	O
.	.	O	O

on	IN	O	O
the	DT	O	O
evening	NN	O	O
of	IN	O	O
the	DT	O	O
18th	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
remain	VB	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
,	,	O	O
although	IN	O	O
his	PRP$	B-TEST	B-TEST
oxygenation	NN	I-TEST	I-TEST
was	VBD	O	O
clearly	RB	O	O
deteriorating	VBG	O	O
and	CC	O	O
more	RBR	O	O
marginal	JJ	O	O
.	.	O	O

on	IN	O	O
60%	CD	O	O
fio2	NN	B-TREATMENT	O
his	PRP$	O	O
po2	NN	B-TEST	O
was	VBD	O	O
63	CD	O	O
.	.	O	O

it	PRP	O	O
was	VBD	O	O
increased	VBN	O	O
to	TO	O	O
65%	CD	O	O
with	IN	O	O
po2	NN	B-TEST	O
of	IN	O	O
81	CD	O	O
.	.	O	O

at	IN	O	O
approximately	RB	O	O
7:50	CD	O	O
a.m.	RB	O	O
,	,	O	O
house	NN	O	O
officer	NN	O	O
was	VBD	O	O
called	VBN	O	O
to	TO	O	O
the	DT	O	O
room	NN	O	O
for	IN	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
70/40	CD	O	O
with	IN	O	O
falling	VBG	B-PROBLEM	B-PROBLEM
oxygen	NN	I-PROBLEM	I-PROBLEM
saturations	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
immediately	RB	O	O
given	VBN	O	O
400	CD	O	O
mg.	NN	O	O
of	IN	O	O
calcium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
i.v.	NN	I-TREATMENT	I-TREATMENT
push	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
ventilator	NN	B-TREATMENT	B-TREATMENT
disconnected	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
manually	RB	B-TREATMENT	O
ventilated	VBN	I-TREATMENT	O
.	.	O	O

within	IN	O	O
one	CD	O	O
minute	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
lost	VBD	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
and	CC	O	O
cpr	NN	B-TREATMENT	O
was	VBD	O	O
initiated	VBN	O	O
and	CC	O	O
code	NN	O	O
was	VBD	O	O
called	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
initially	RB	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
rhythm	VBN	O	O
consistent	JJ	O	O
with	IN	O	O
emv	NN	B-PROBLEM	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
bolused	VBN	O	O
with	IN	O	O
levophed	JJ	B-TREATMENT	O
and	CC	O	O
given	VBN	O	O
some	DT	O	B-PROBLEM
volume	NN	O	I-PROBLEM
while	IN	O	I-PROBLEM
compressions	NNS	B-TREATMENT	I-PROBLEM
continued	VBD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
&apos;s	NNP	I-TEST	I-TEST
prothrombin	NN	I-TEST	I-TEST
time	NN	I-TEST	I-TEST
had	VBD	O	O
been	VBN	O	O
23	CD	O	O
early	RB	O	O
the	DT	O	O
same	JJ	O	O
morning	NN	O	O
and	CC	O	O
tamponade	NN	B-PROBLEM	B-PROBLEM
was	VBD	O	O
considered	VBN	O	O
and	CC	O	O
thoracotomy	JJ	B-TREATMENT	B-TREATMENT
instruments	NNS	I-TREATMENT	I-TREATMENT
obtained	VBN	O	O
.	.	O	O

the	DT	O	O
chest	NN	O	O
was	VBD	O	O
opened	VBN	O	O
partially	RB	O	O
and	CC	O	O
through	IN	O	O
sub-xyphoid	JJ	O	B-TREATMENT
area	NN	O	I-TREATMENT
it	PRP	O	O
was	VBD	O	O
determined	VBN	O	O
that	IN	O	O
there	EX	O	O
was	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
tamponade	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

compressions	NNS	B-TREATMENT	B-TEST
were	VBD	O	O
continued	VBN	O	O
and	CC	O	O
adequate	JJ	O	O
pulse	NN	O	O
was	VBD	O	O
felt	VBN	O	O
and	CC	O	O
arterial	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
gases	NNS	I-TEST	I-TEST
demonstrated	VBD	O	O
adequate	JJ	O	O
oxygenation	NN	O	O
and	CC	O	O
perfusion	NN	O	B-TEST
.	.	O	O

the	DT	B-TEST	O
patient	NN	I-TEST	O
&apos;s	NNP	I-TEST	O
rhythm	NN	I-TEST	O
degenerated	VBD	O	O
to	TO	O	O
ventricular	JJ	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
shocked	VBN	O	O
,	,	O	O
initially	RB	O	O
without	IN	O	O
response	NN	O	O
but	CC	O	O
after	IN	O	O
several	JJ	O	O
doses	NNS	O	O
of	IN	O	O
epinephine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
one-half	JJ	O	O
mg.	NN	O	O
of	IN	O	O
atropine	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
a	DT	O	B-TREATMENT
bolus	NN	O	I-TREATMENT
of	IN	O	I-TREATMENT
lidocaine	NN	B-TREATMENT	I-TREATMENT
we	PRP	O	O
were	VBD	O	O
able	JJ	O	O
to	TO	O	O
obtain	VB	O	O
a	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
and	CC	O	O
rhythm	NN	B-TEST	O
only	RB	O	O
briefly	NN	O	O
,	,	O	O
and	CC	O	O
quickly	RB	O	O
deteriorated	VBD	O	O
back	RB	O	O
to	TO	O	O
ventricular	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

further	RB	O	O
attempts	NNS	O	O
at	IN	O	O
resuscitation	NN	B-TREATMENT	O
were	VBD	O	O
unsuccessful	JJ	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
pronounced	VBN	O	O
dead	JJ	O	O
at	IN	O	O
8:30	CD	O	O
a.m.	NN	O	O

lipitor	NN	B-TREATMENT	B-TREATMENT
/	CD	O	O
codeine	NN	B-TREATMENT	B-TREATMENT

gib	NN	B-PROBLEM	B-TEST

endoscopy	NN	B-TEST	B-TEST
2020-01-20	JJ	O	O

42	CD	O	O
yom	NN	O	O
with	IN	O	O
pmh	NN	O	O
of	IN	O	O
htn	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hyperchol	NN	B-PROBLEM	O
admitted	VBD	O	O
to	TO	O	O
osh	VB	O	O
1	CD	O	O
day	NN	O	O
ago	IN	O	O
with	IN	O	O
black	JJ	B-PROBLEM	B-PROBLEM
tarry	NN	I-PROBLEM	I-PROBLEM
stools	NNS	I-PROBLEM	I-PROBLEM
x	VBP	O	O
2	CD	O	O
days	NNS	O	O
.	.	O	O

patient	JJ	O	O
states	NNS	O	O
that	IN	O	O
he	PRP	O	O
had	VBD	O	O
chronically	RB	O	O
had	VBN	O	O
loose	JJ	B-PROBLEM	B-PROBLEM
stools	NNS	I-PROBLEM	I-PROBLEM
but	CC	O	O
over	IN	O	O
2	CD	O	O
preeceeding	JJ	O	O
days	NNS	O	O
noticed	VBD	O	O
the	DT	O	O
stool	NN	O	O
to	TO	O	O
be	VB	O	O
dark	JJ	B-PROBLEM	O
and	CC	O	O
tarry	NN	B-PROBLEM	O
.	.	O	O

+	JJ	O	O
epigastric	JJ	B-PROBLEM	B-PROBLEM
discomfort	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
gurgling	VBG	B-PROBLEM	B-PROBLEM
gas-like	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
association	NN	O	O
with	IN	O	O
food	NN	O	O
.	.	O	O

+	NN	O	O
lightheadedness	NN	B-PROBLEM	B-PROBLEM
when	WRB	O	O
he	PRP	O	O
stood	VBD	O	O
up	RP	O	O
prompting	VBG	O	O
him	PRP	O	O
to	TO	O	O
go	VB	O	O
to	TO	O	O
osh	VB	O	O
nellie	NNS	O	O
.	.	O	O

he	PRP	O	O
states	VBZ	O	O
that	IN	O	O
he	PRP	O	O
takes	VBZ	O	O
asa	JJ	B-TREATMENT	O
daily	JJ	O	O
and	CC	O	O
takes	VBZ	O	O
motrin	$	B-TREATMENT	B-TREATMENT
800	CD	O	O
mg	NN	O	O
tid	NN	O	O
sometimes	RB	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
last	JJ	O	O
use	NN	O	O
2	CD	O	O
wks	NN	O	O
pta	NN	O	O
.	.	O	O

denies	NNS	O	O
brbpr	VBP	B-PROBLEM	O
,	,	O	O
n/v/d	UH	B-PROBLEM	O
.	.	O	O

denies	NNS	O	O
recent	JJ	B-PROBLEM	B-PROBLEM
fevers	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

denies	NNS	O	O
any	DT	B-PROBLEM	O
hemetemesis	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

at	IN	O	O
osh	JJ	O	O
initial	JJ	B-TEST	B-TEST
hct	NN	I-TEST	I-TEST
=	VBD	O	O
26	CD	O	O
,	,	O	O
and	CC	O	O
22	CD	O	O
upon	IN	O	O
repeat	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
also	RB	O	O
orthostatic	JJ	B-PROBLEM	O
given	VBN	O	O
3	CD	O	O
units	NNS	O	O
prbc	NN	B-TREATMENT	O
and	CC	O	O
ivf	NN	B-TREATMENT	O
.	.	O	O

egd	RB	B-TEST	O
attempted	VBN	O	O
but	CC	O	O
pt	VBP	O	O
unable	JJ	O	O
to	TO	O	O
tolerate	VB	O	O
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
now	RB	O	O
transferred	VBN	O	O
to	TO	O	O
mediplex	VB	O	O
rehab	JJ	O	O
hospital	NN	O	O
for	IN	O	O
futher	JJR	B-TEST	B-TEST
workup	NN	I-TEST	I-TEST
and	CC	O	O
rx	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

states	NNS	O	O
that	IN	O	O
lightheadedness	NN	B-PROBLEM	B-PROBLEM
is	VBZ	O	O
resolved	VBN	O	O
.	.	O	O

htn	NN	B-PROBLEM	B-PROBLEM

hyperchol	NN	B-PROBLEM	O
h/o	NN	O	O
a.	NN	B-PROBLEM	B-PROBLEM
fib	VBD	I-PROBLEM	I-PROBLEM
6	CD	O	O
yrs	NN	O	O
ago	RB	O	O
->	NNP	O	O
cardioverted	VBD	O	O
.	.	O	O

family	NN	O	O
hx	NN	O	O
:	:	O	O
father	NN	O	O
with	IN	O	O
lung	NN	B-PROBLEM	B-PROBLEM
ca	MD	I-PROBLEM	I-PROBLEM
.	.	O	O

t	NN	B-TEST	O
:	:	O	O
98	CD	O	O

p	NN	B-TEST	O
:	:	O	O
66	CD	O	O

r	NN	B-TEST	O
:	:	O	O
15	CD	O	O

bp	NN	B-TEST	O
:	:	O	O
122/51	CD	O	O

sao2	NN	B-TEST	O
:	:	O	O
100%	CD	O	O
ra	NN	O	O

general	JJ	O	O
:	:	O	O
young	JJ	O	O
male	NN	O	O
in	IN	O	O
nad	NN	B-PROBLEM	O
,	,	O	O
awake	VBP	O	O
alert	NN	O	O
oriented	VBN	O	O

neck	NN	O	O
:	:	O	O
supple	NN	O	O
,	,	O	O
no	DT	O	O
jvd	NN	B-PROBLEM	B-PROBLEM

lungs	NNS	O	O
cta	VBP	O	O
bilaterally	RB	O	O
without	IN	O	O
r/r/w	NN	B-PROBLEM	O

rrr	NN	O	O
,	,	O	O
nl.	JJ	O	O
s1s2	NN	O	O
,	,	O	O
no	DT	O	O
m/r/g	NN	B-PROBLEM	B-PROBLEM
noted	VBD	O	O

abdomen	NNS	O	O
:	:	O	O
obese	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
soft	JJ	O	O
,	,	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
epigastric	JJ	I-PROBLEM	I-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
nabs	NN	O	O

no	DT	O	O
c/c/e	NN	B-PROBLEM	B-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM
,	,	O	O
2+	CD	B-TEST	O
radial	NN	I-TEST	O
,	,	I-TEST	O
dp	NN	I-TEST	O
and	CC	I-TEST	O
pt	NN	I-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
b/l	VBP	I-TEST	O
.	.	O	O

rectal	NN	O	O
:	:	O	O
no	DT	O	O
hemrroiids	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
guiac	JJ	B-PROBLEM	B-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
brown	JJ	I-PROBLEM	I-PROBLEM
stool	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

osh	RB	O	O
27.5	CD	O	O
hct	NN	B-TEST	B-TEST
at	IN	O	O
2:50	CD	O	O
am	VBP	O	O
01-20	JJ	O	O
.	.	O	O

ekg	NN	B-TEST	O
:	:	O	O

osh	SYM	O	B-TEST
-	:	O	O
sinus	NN	B-PROBLEM	B-PROBLEM
tach	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
108	CD	O	O
,	,	O	O
nl	RB	O	O
axis	NN	O	O
,	,	O	O
nl	JJ	O	O
intevals	NNS	O	O
.	.	O	O

no	DT	O	O
st-t	JJ	B-PROBLEM	B-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

pt	SYM	B-TEST	B-TEST
-	:	O	O
13.2	CD	O	O
*	NN	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
27.2	CD	O	O
inr	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
pt	JJ	I-TEST	I-TEST
)-	CD	I-TEST	I-TEST
1.1	CD	O	O

plt	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
-	:	O	O
259	CD	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
9.3	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.21	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
9.6	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
27.3	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
85	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
29.9	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
35.2	CD	O	O
*	NN	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
15.6	CD	O	O
*	NN	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
8.0	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.20	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
9.6	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
27.8	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
87	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
30.1	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.7	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
15.7	CD	O	O
*	NN	O	O

plt	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
-	:	O	O
264	CD	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
7.4	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.38	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
10.1	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
29.2	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
86	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
29.8	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.5	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
15.5	CD	O	O

42	CD	O	O
yom	NN	O	O
with	IN	O	O
h/o	NN	O	O
nsaid	VBN	B-TREATMENT	O
use	NN	O	O
transferred	VBN	O	O
from	IN	O	O
osh	JJ	O	O
with	IN	O	O
black	JJ	B-PROBLEM	B-PROBLEM
tarry	NN	I-PROBLEM	I-PROBLEM
stools	NNS	I-PROBLEM	I-PROBLEM
at	IN	O	O
home	NN	O	O
.	.	O	O

patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
cmed	VB	O	O
ccu	NN	O	O
with	IN	O	O
tid	JJ	O	O
hct	NN	B-TEST	B-TEST
check	NN	I-TEST	I-TEST
.	.	O	O

gi	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
and	CC	O	O
performed	VBN	O	O
endoscopy	NN	B-TEST	O
under	IN	O	O
general	JJ	B-TREATMENT	B-TREATMENT
anesthesia	NN	I-TREATMENT	I-TREATMENT
which	WDT	O	O
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
non	JJ	I-PROBLEM	I-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
gastritis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

patient	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
bid	NN	O	O
ppi	NN	B-TREATMENT	O
,	,	O	O
h	NN	B-TREATMENT	O
.	.	O	O

pylori	JJ	B-TEST	B-TEST
serology	NN	I-TEST	I-TEST
checked	VBD	O	O
(	(	O	O
pending	VBG	O	O
at	IN	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
)	)	O	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TEST
antihypertensives	NNS	I-TREATMENT	I-TEST
were	VBD	O	O
held	VBN	O	O
given	VBN	O	O
concern	NN	O	O
for	IN	O	O
gi	NN	B-PROBLEM	B-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
should	MD	O	O
be	VB	O	O
restarted	VBN	O	O
at	IN	O	O
follow	VB	O	O
up	RP	O	O
appointment	NN	O	O
with	IN	O	O
pcp	NN	O	O
.	.	O	O

marie	NN	O	O
was	VBD	O	O
discharged	VBN	O	O
with	IN	O	O
goal	NN	B-TREATMENT	O
ppi	NN	I-TREATMENT	O
twice	RB	O	O
day	NN	O	O
for	IN	O	O
1	CD	O	O
month	NN	O	O
followed	VBN	O	O
by	IN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

medications	NNS	B-TREATMENT	B-TREATMENT
on	IN	O	O
transfer	NN	O	O
:	:	O	O
esmopreazole	JJ	B-TREATMENT	O
40	CD	O	O
mg	JJ	O	O
iv	NN	O	O
bid	NN	O	O
hydrochlorthiazide	RB	B-TREATMENT	O
25	CD	O	O
mg	JJ	O	O
daily	JJ	O	O
lisinopril	VBZ	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	JJ	O	O
daily	JJ	O	O
loratadine	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	JJ	O	O
daily	JJ	O	O
metprolol	NN	B-TREATMENT	B-TREATMENT
150	CD	O	O
mg	JJ	O	O
daily	JJ	B-TREATMENT	O
multivitamin	NN	I-TREATMENT	B-TREATMENT
niacin	RB	I-TREATMENT	I-TREATMENT
500	CD	O	O
mg	NNS	O	O
daily	RB	O	O

asa	RB	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NNS	O	O
daily	RB	O	O

motrin	NN	B-TREATMENT	B-TREATMENT
800	CD	O	O
mg	NN	O	O
tid	NN	O	O

lisinopril	RB	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NNS	O	O
daily	RB	O	O

hydrochlorthiazide	RB	B-TREATMENT	O
25	CD	O	O
mg	NNS	O	O
daily	RB	O	O

toprol	NN	B-TREATMENT	B-TREATMENT
xl	VBZ	I-TREATMENT	I-TREATMENT
150	CD	O	O
mg	JJ	O	O
daily	JJ	O	O

niaspan	RB	B-TREATMENT	O
500	CD	O	O
mg	NNS	O	O
daily	RB	O	O

loratidine	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	JJ	O	O
daily	RB	O	O
.	.	O	O

1.	CD	O	O
niacin	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
capsule	NN	O	O
,	,	O	O
sustained	VBD	O	O
release	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
,	,	O	O
sustained	VBD	O	O
release	NN	O	O
po	NN	O	O
daily	RB	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

2.	CD	O	O
pantoprazole	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
q12h	NN	O	O
(	(	O	O
every	DT	O	O
12	CD	O	O
hours	NNS	O	O
)	)	O	O
:	:	O	O

gi	NN	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM

peptic	JJ	B-PROBLEM	B-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM

gastritis	NN	B-PROBLEM	B-PROBLEM

hypertension	NN	B-PROBLEM	B-PROBLEM

hypercholestrolemia	NN	B-PROBLEM	B-PROBLEM

please	NN	O	O
continue	VB	O	O
to	TO	O	O
take	VB	O	O
all	DT	B-TREATMENT	O
your	PRP$	I-TREATMENT	O
medicaitons	NNS	I-TREATMENT	O
and	CC	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
your	PRP$	O	O
appointments	NNS	O	O
as	IN	O	O
below	NN	O	O
.	.	O	O

you	PRP	O	O
should	MD	O	O
avoid	VB	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
motrin	NN	B-TREATMENT	B-TREATMENT
or	CC	O	O
any	DT	B-TREATMENT	B-PROBLEM
other	JJ	I-TREATMENT	I-PROBLEM
nonsteroidal	JJ	I-TREATMENT	I-PROBLEM
antiinflammatory	NN	I-TREATMENT	I-PROBLEM
agents	NNS	I-TREATMENT	I-PROBLEM
.	.	O	O

you	PRP	O	O
should	MD	O	O
restart	VB	O	O
your	PRP$	B-TREATMENT	B-TREATMENT
bp	NN	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
after	IN	O	O
you	PRP	O	O
see	VBP	O	O
your	PRP$	O	O
pcp	NN	O	O
.	.	O	O

if	IN	O	O
you	PRP	O	O
have	VBP	O	O
any	DT	B-PROBLEM	B-PROBLEM
further	JJ	I-PROBLEM	I-PROBLEM
black	JJ	I-PROBLEM	I-PROBLEM
stools	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
bleeding	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
lightheadedness	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
any	DT	B-PROBLEM	B-PROBLEM
other	JJ	I-PROBLEM	I-PROBLEM
concerning	NN	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
please	VB	O	O
contact	VB	O	O
your	PRP$	O	O
pcp	NN	O	O
or	CC	O	O
return	NN	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
presented	VBN	O	O
with	IN	O	O
a	DT	O	O
chief	JJ	O	O
complaint	NN	O	O
of	IN	O	O
sob	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
fever	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

following	VBG	O	O
evaluation	NN	B-TEST	B-TEST
and	CC	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
the	DT	O	O
patient	NN	O	O
&apos;s	JJ	O	O
disposition	NN	O	O
at	IN	O	O
the	DT	O	O
end	NN	O	O
of	IN	O	O
the	DT	O	O
visit	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
as	IN	O	O
an	DT	O	O
inpatient	NN	O	O
to	TO	O	O
ph	VB	O	O
university	NN	O	O
of	IN	O	O
medical	JJ	O	O
center	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
preliminary	JJ	O	O
admitting	VBG	O	O
physician	NN	O	O
is	VBZ	O	O
chird	JJ	O	O
,	,	O	O
grajord	JJ	O	O
c	NN	O	O
and	CC	O	O
the	DT	O	O
preliminary	JJ	O	O
diagnosis	NN	O	O
is	VBZ	O	O
pna	JJ	B-PROBLEM	O
.	.	O	O

patient	NN	O	O
recorded	VBD	O	O
as	IN	O	O
having	VBG	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
to	TO	O	O
drugs	NNS	B-TREATMENT	B-TREATMENT

abdomenal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
nausea	NN	B-PROBLEM	B-PROBLEM

small	JJ	B-TREATMENT	B-TREATMENT
bowel	NN	I-TREATMENT	I-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT

58	CD	O	O
year-old	JJ	O	O
female	NN	O	O
s/p	NN	O	O
gastric	JJ	B-TREATMENT	B-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
03-01	NN	O	O
without	IN	O	O
complications	NNS	B-PROBLEM	B-PROBLEM
post-operatively	RB	O	O
,	,	O	O
now	RB	O	O
presents	VBZ	O	O
with	IN	O	O
abomenal	JJ	B-PROBLEM	O
and	CC	I-PROBLEM	O
and	CC	I-PROBLEM	O
ascociated	VBD	I-PROBLEM	B-PROBLEM
nausea	NN	I-PROBLEM	I-PROBLEM
since	IN	O	O
the	DT	O	O
night	NN	O	O
before	IN	O	O
admission	NN	O	O
.	.	O	O

pain	NN	B-PROBLEM	B-PROBLEM
is	VBZ	O	O
diffused	VBN	O	O
,	,	O	O
06-05	JJ	O	O
out	IN	O	O
of	IN	O	O
10	CD	O	O
in	IN	O	O
intensity	NN	O	O
,	,	O	O
and	CC	O	O
has	VBZ	O	O
not	RB	O	O
improved	VBN	O	O
overnight	NN	O	O
.	.	O	O

no	DT	O	O
flatus	NN	B-PROBLEM	B-PROBLEM
x	VBZ	O	O
1	CD	O	O
day	NN	O	O
.	.	O	O

obesity	NN	B-PROBLEM	B-PROBLEM

hypertension	NN	B-PROBLEM	B-PROBLEM

gerd	NN	B-PROBLEM	B-PROBLEM

hyperlipidemia	NN	B-PROBLEM	B-PROBLEM

appendectomy	NN	B-TREATMENT	B-TREATMENT

ovarian	JJ	B-PROBLEM	B-PROBLEM
cyst	NN	I-PROBLEM	I-PROBLEM

afebrile	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
pulse	JJ	B-TEST	B-TEST
70-80	NN	O	I-TEST
's	POS	O	I-TEST
,	,	O	O
vital	JJ	B-TEST	O
stable	JJ	O	O
and	CC	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O

alert	NN	O	O
,	,	O	O
anicterus	NN	B-PROBLEM	O
,	,	O	O
oropharynx	CD	O	O
clear	JJ	O	O

no	DT	O	O
lymphanopathy	NN	B-PROBLEM	B-PROBLEM

lungs	NNS	O	O
clear	JJ	O	O
to	TO	O	O
ascultation	VB	B-TEST	O

abdomen	NNS	O	O
soft	JJ	O	O
,	,	O	O
non-distended	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
diffuse	NN	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
peritomeal	NN	B-PROBLEM	B-PROBLEM

extremities	NNS	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM

ct	NN	B-TEST	B-TEST
pelvis	NN	I-TEST	I-TEST
(	(	O	O
07-17	JJ	O	O
)	)	O	O
an	DT	B-PROBLEM	B-PROBLEM
abnormal	JJ	I-PROBLEM	I-PROBLEM
loop	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
slightly	RB	B-PROBLEM	I-PROBLEM
dilated	VBN	I-PROBLEM	I-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
fecalization	NN	B-PROBLEM	B-TREATMENT
and	CC	O	O
possible	JJ	O	O
bowel	NN	B-PROBLEM	B-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
thickening	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
obstruction	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
likely	JJ	O	O
secondary	JJ	O	O
to	TO	O	O
closed	JJ	B-PROBLEM	O
loop	NN	I-PROBLEM	O
obstruction	NN	I-PROBLEM	O
.	.	O	O

this	DT	O	O
could	MD	O	O
be	VB	O	O
due	JJ	O	O
to	TO	O	O
internal	JJ	B-PROBLEM	O
hernia	NN	I-PROBLEM	B-PROBLEM
or	CC	O	O
could	MD	O	O
be	VB	O	O
stricture	RB	B-PROBLEM	O
related	VBN	O	O
.	.	O	O

other	JJ	O	B-PROBLEM
differential	JJ	O	I-PROBLEM
includes	VBZ	O	I-PROBLEM
ischemia	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

infectious	JJ	B-PROBLEM	O
etiology	NN	I-PROBLEM	O
is	VBZ	O	O
less	RBR	O	O
likely	JJ	O	O
due	JJ	O	O
to	TO	O	O
the	DT	O	O
focal	JJ	O	O
nature	NN	O	O
of	IN	O	O
the	DT	O	O
involvement	NN	O	O
.	.	O	O

upon	IN	O	O
presentation	NN	O	O
to	TO	O	O
the	DT	O	O
hospital	NN	O	O
and	CC	O	O
intial	JJ	B-TEST	B-TEST
work-up	NN	I-TEST	I-TEST
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
immediately	RB	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
for	IN	O	O
an	DT	B-TEST	B-TEST
exploratory	JJ	I-TEST	I-TEST
laporatomy	NN	I-TEST	I-TEST
.	.	O	O

intraoperatively	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
small	JJ	B-PROBLEM	B-PROBLEM
bowel	NNS	I-PROBLEM	I-PROBLEM
obstruction	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
ischemic	JJ	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
post-operatively	RB	O	I-PROBLEM
,	,	O	O
making	VBG	O	O
good	JJ	O	O
urine	NN	O	O
,	,	O	O
ambulating	VBG	O	O
,	,	O	O
eating	VBG	O	O
a	DT	O	O
regular	JJ	O	O
diet	NN	O	O
without	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
complications	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
oxycodone-acetaminophen	JJ	B-TREATMENT	O
5-325	JJ	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
tablets	NNS	O	O
po	JJ	O	O
q4-6h	JJ	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
to	TO	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

2.	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
tartrate	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
0.5	CD	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

small	JJ	B-PROBLEM	B-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
obstruction	NN	I-PROBLEM	I-PROBLEM

ischemic	JJ	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM

please	VB	O	O
take	VB	O	O
medications	NNS	B-TREATMENT	B-TREATMENT
as	IN	O	O
prescribed	JJ	O	O
and	CC	O	O
read	JJ	O	O
warning	NN	O	O
labels	NNS	O	O
carefully	RB	O	O
.	.	O	O

if	IN	O	O
signs	NNS	O	B-PROBLEM
and	CC	O	I-PROBLEM
symptoms	NNS	O	I-PROBLEM
of	IN	O	I-PROBLEM
wound	JJ	B-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
such	JJ	O	O
as	IN	O	O
sudden	JJ	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
increased	VBD	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
/	NNP	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
purulent	JJ	B-PROBLEM	B-PROBLEM
discharge	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
please	VB	O	O
go	VB	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
or	CC	O	O
call	NN	O	O
.	.	O	O

pad	NN	O	O
dry	NN	O	O
--	:	O	O
do	VBP	O	O
not	RB	O	O
scrub	VB	O	B-PROBLEM
wound	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

s	NN	O	O
/	NNP	O	O
p	VBZ	O	O
ventral	JJ	B-TREATMENT	B-TREATMENT
hernia	NN	I-TREATMENT	I-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT

colace	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
docusate	JJ	I-TREATMENT	I-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	JJ	O	O
po	NN	O	O
bid	NN	O	O
percocet	VBZ	B-TREATMENT	O
1-2	JJ	O	O
tab	NN	O	O
po	NN	O	O
q4h	NN	O	O
prn	NN	O	O
pain	NN	B-PROBLEM	B-PROBLEM

dr.	NN	O	O
grendwierst	RB	O	O
1-2	JJ	O	O
weeks	NNS	O	O
,	,	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM

s	NN	O	O
/	NNP	O	O
p	VBZ	O	O
ventral	JJ	B-TREATMENT	B-TREATMENT
hernia	NN	I-TREATMENT	I-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT

responsible	JJ	O	O
after	IN	O	O
study	NN	O	O
for	IN	O	O
causing	VBG	O	O
admission	NN	O	O
)	)	O	O
s	NN	O	O
/	NNP	O	O
p	VBZ	O	O
ventral	JJ	B-TREATMENT	B-TREATMENT
hernia	NN	I-TREATMENT	I-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT

conditions	NNS	O	O
,	,	O	O
infections	NNS	O	O
,	,	O	O
complications	NNS	O	O
,	,	O	O
affecting	VBG	O	O
treatment	NN	O	O
/	NNP	O	O
stay	NN	O	O
s	RB	O	O
/	NNP	O	O
p	NN	O	O
roux	NN	B-TREATMENT	B-TREATMENT
en	IN	I-TREATMENT	I-TREATMENT
y	NN	I-TREATMENT	I-TREATMENT
gastric	JJ	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

s	NN	O	O
/	CD	O	O
p	JJ	O	B-PROBLEM
c-section	NN	B-TREATMENT	I-PROBLEM
b12	NN	B-PROBLEM	I-PROBLEM
deficiency	NN	I-PROBLEM	I-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM

gerd	NN	B-TREATMENT	O
operations	NNS	I-TREATMENT	O
and	CC	O	O
procedures	NNS	B-TREATMENT	O
:	:	O	O

02/14/03	CD	O	O
grendwierst	NN	O	O
,	,	O	O
sonlyn	JJ	O	O
r.	NN	O	O
,	,	O	O
m.d.	JJ	O	O
ventral	JJ	B-TREATMENT	B-TREATMENT
hernia	NN	I-TREATMENT	I-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT
w	JJ	I-TREATMENT	I-TREATMENT
/	NNP	I-TREATMENT	I-TREATMENT
mesh	NN	I-TREATMENT	I-TREATMENT

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
39	CD	O	O
year	NN	O	O
old	JJ	O	O
female	NN	O	O
,	,	O	O
s	JJ	O	O
/	NNP	O	O
p	NN	O	O
roux-en-y	NN	B-TREATMENT	B-TREATMENT
gastric	JJ	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
09/06	CD	O	O
who	WP	O	O
is	VBZ	O	O
admitted	VBN	O	O
for	IN	O	O
elective	JJ	B-TREATMENT	B-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
ventral	JJ	I-PROBLEM	I-PROBLEM
hernia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
went	VBD	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
on	IN	O	O
2/14/03	CD	O	O
for	IN	O	O
repair	NN	B-TREATMENT	B-TREATMENT
of	IN	O	I-TREATMENT
the	DT	B-PROBLEM	I-TREATMENT
hernia	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
hospital	NN	O	O
overnight	VBD	O	O
for	IN	O	O
pai	NN	B-TREATMENT	B-TREATMENT
n	JJ	I-TREATMENT	I-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
large	JJ	O	O
amounts	NNS	O	O
of	IN	O	O
dissection	NN	B-PROBLEM	B-PROBLEM
during	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
did	VBD	O	O
well	RB	O	O
overnight	JJ	O	O
with	IN	O	O
minimal	JJ	B-PROBLEM	B-TREATMENT
pain	NN	I-PROBLEM	I-TREATMENT
medication	NN	I-PROBLEM	I-TREATMENT
requirements	NNS	I-PROBLEM	I-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
no	DT	O	O
complaints	NNS	O	O
of	IN	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
was	VBD	O	O
tolerating	VBG	O	O
po&apos;s	RB	O	O
well	RB	O	O
.	.	O	O

keep	VB	O	O
the	DT	B-TREATMENT	B-TREATMENT
dressing	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
and	CC	O	O
dry	JJ	O	O
for	IN	O	O
48	CD	O	O
hours	NNS	O	O
after	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

avoid	NN	O	O
getting	VBG	O	O
the	DT	B-PROBLEM	B-TREATMENT
incision	NN	I-PROBLEM	I-TREATMENT
soaking	VBG	O	I-TREATMENT
wet	NN	O	I-TREATMENT
.	.	O	O

take	VB	O	O
the	DT	B-TREATMENT	B-TREATMENT
pain	NN	I-TREATMENT	I-TREATMENT
medication	NN	I-TREATMENT	I-TREATMENT
as	IN	O	O
prescribed	NN	O	O
.	.	O	O

you	PRP	O	O
can	MD	O	O
take	VB	O	O
regular	JJ	O	O
tylenol	NN	B-TREATMENT	O
or	CC	O	O
motrin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
use	VB	O	O
the	DT	B-TREATMENT	O
percocet	NN	I-TREATMENT	O
for	IN	O	O
breakthrough	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

return	NN	O	O
to	TO	O	O
the	DT	O	O
er	NN	O	O
or	CC	O	O
call	VB	O	O
your	PRP$	O	O
doctor	NN	O	O
if	IN	O	O
you	PRP	O	O
develop	VBP	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
notice	RB	O	O
pus	NN	B-PROBLEM	B-PROBLEM
from	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
develop	VB	O	O
surrounding	VBG	B-PROBLEM	B-PROBLEM
redness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
have	VBP	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
have	VBP	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
where	WRB	O	O
you	PRP	O	O
can	MD	O	O
&apos;t	VB	O	O
keep	VB	O	O
anything	NN	O	O
down	RP	O	O
or	CC	O	O
develop	VB	O	O
any	DT	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
that	WDT	O	O
concern	NN	O	O
you	PRP	O	O
.	.	O	O

prenatal	JJ	B-TEST	B-TEST
screens	NNS	I-TEST	I-TEST
were	VBD	O	O
o	RB	O	O
positive	JJ	O	O
,	,	O	O
antibody	JJ	B-TEST	B-TEST
negative	JJ	O	O
,	,	O	O
hepatitis	JJ	B-TEST	B-TEST
surface	NN	I-TEST	I-TEST
antigen	NN	I-TEST	I-TEST
negative	JJ	O	O
,	,	O	O
rapid	JJ	B-TEST	B-TEST
plasma	NN	I-TEST	I-TEST
reagent	NN	I-TEST	I-TEST
nonreactive	JJ	O	O
,	,	O	O
rubella	NN	B-TEST	B-TEST
immune	NN	O	O
,	,	O	O
group	NN	B-TEST	O
b	VBD	I-TEST	O
strep	RB	I-TEST	B-TEST
negative	JJ	O	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
delivered	VBN	O	O
by	IN	O	O
spontaneous	JJ	O	B-TREATMENT
vaginal	JJ	O	I-TREATMENT
delivery	NN	O	I-TREATMENT
with	IN	O	O
apgar	JJ	B-TEST	B-TEST
scores	NNS	I-TEST	I-TEST
of	IN	O	O
8	CD	O	O
at	IN	O	O
one	CD	O	O
minute	NN	O	O
and	CC	O	O
8	CD	O	O
at	IN	O	O
five	CD	O	O
minutes	NNS	O	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
the	DT	O	O
baby	NN	O	O
lucas	NN	O	O
is	VBZ	O	O
well	RB	O	O
appearing	VBG	O	O
,	,	O	O
no	DT	O	O
jaundice	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
is	VBZ	O	O
regular	JJ	O	O
without	IN	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

pulses	NNS	B-TEST	B-TEST
are	VBP	O	O
2+	CD	O	O
and	CC	O	O
symmetrical	JJ	O	O
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
is	VBZ	O	O
soft	JJ	O	O
and	CC	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
no	DT	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
weight	NN	I-TEST	I-TEST
is	VBZ	O	O
3.160	CD	O	O
kilograms	NNS	O	O
(	(	O	O
7	CD	O	O
pounds	NNS	O	O
3	CD	O	O
ounces	NNS	O	O
)	)	O	O
at	IN	O	O
birth	NN	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	O	B-TEST
regular	JJ	O	I-TEST
heart	NN	O	I-TEST
rate	NN	O	I-TEST
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
no	DT	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
pulses	NNS	B-TEST	B-TEST
were	VBD	O	O
2+	CD	O	O
and	CC	O	O
symmetric	JJ	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
baby	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
weight	NN	I-TEST	I-TEST
was	VBD	O	O
3.160	CD	O	O
kilograms	NNS	O	O
(	(	O	O
7	CD	O	O
pounds	NNS	O	O
3	CD	O	O
ounces	NNS	O	O
).	VBP	O	O

he	PRP	O	O
is	VBZ	O	O
breast	JJ	O	O
and	CC	O	O
bottle	JJ	O	O
feeding	NN	O	O
every	DT	O	O
3	CD	O	O
hours	NNS	O	O
with	IN	O	O
expressed	VBN	O	B-TREATMENT
breast	NN	O	I-TREATMENT
milk	NN	O	I-TREATMENT
and	CC	O	O
/	NN	O	O
or	CC	O	O
enfamil	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

his	PRP$	B-TEST	B-TEST
discharge	NN	I-TEST	I-TEST
weight	NN	I-TEST	I-TEST
is	VBZ	O	O
3025	CD	O	O
gm	NN	O	O
,	,	O	O
and	CC	O	O
has	VBZ	O	O
been	VBN	O	O
stable	JJ	O	O
for	IN	O	O
past	JJ	O	O
2	CD	O	O
days	NNS	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
baby	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
bilirubin	NN	I-TEST	I-TEST
on	IN	O	O
2018-12-31	JJ	O	O
,	,	O	O
was	VBD	O	O
15.5	CD	O	O
/	JJ	O	O
0.5	CD	O	O
at	IN	O	O
which	WDT	O	O
time	NN	O	O
double	JJ	B-TREATMENT	O
phototherapy	NN	I-TREATMENT	B-TREATMENT
was	VBD	O	O
started	VBN	O	O
.	.	O	O

on	IN	O	O
01-01	NN	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
was	VBD	O	O
17.3	CD	O	O
/	JJ	O	O
0.4	CD	O	O
at	IN	O	O
which	WDT	O	O
time	NN	O	O
triple	NN	B-TREATMENT	B-TREATMENT
phototherapy	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
started	VBN	O	O
and	CC	O	O
then	RB	O	O
his	PRP$	B-TEST	O
subsequent	NN	I-TEST	O
bilirubins	NNS	I-TEST	O
are	VBP	O	O
16.5	CD	O	O
/	JJ	O	O
0.4	CD	O	O
on	IN	O	O
2019-01-01	JJ	O	O
,	,	O	O
and	CC	O	O
16.2	CD	O	O
/	NNS	O	O
0.5	CD	O	O
on	IN	O	O
2019-01-02	JJ	O	O
.	.	O	O

phototherapy	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
on	IN	O	O
2019-01-04	JJ	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
of	IN	O	O
12.1	CD	O	O
,	,	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
rebound	NN	I-TEST	I-TEST
bilirubin	NN	I-TEST	I-TEST
will	MD	O	O
be	VB	O	O
checked	VBN	O	O
on	IN	O	O
01-05	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
on	IN	O	O
01-02	NN	O	O
,	,	O	O
was	VBD	O	O
61	CD	O	O
with	IN	O	O
a	DT	B-TEST	O
reticulocyte	NN	I-TEST	O
of	IN	O	O
2.6%	CD	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
type	NN	I-TEST	I-TEST
is	VBZ	O	O
a+	JJ	O	O
,	,	O	O
coombs	JJ	B-TEST	B-TEST
negative	JJ	O	O
.	.	O	O

auditory	NN	B-TEST	B-TEST
hearing	VBG	I-TEST	I-TEST
screening	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
with	IN	O	O
automated	JJ	O	B-TEST
brainstem	NN	O	I-TEST
responses	NNS	O	I-TEST
.	.	O	O

1.	CD	O	O
continue	NN	O	O
breast	NN	O	O
feeding	VBG	O	O
with	IN	O	O
post-feed	JJ	B-TREATMENT	B-TREATMENT
supplemental	JJ	I-TREATMENT	I-TREATMENT
ebm	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

2.	CD	O	O
follow-up	JJ	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
in	IN	O	O
1	CD	O	O
day	NN	O	O
;	:	O	O
f/u	NN	O	O
with	IN	O	O
pmd	NN	O	O
in	IN	O	O
1-3	JJ	O	O
days	NNS	O	O
.	.	O	O

4.	CD	O	O
car	NN	B-TEST	O
seat	NN	I-TEST	O
position	NN	I-TEST	O
and	CC	I-TEST	O
screening	NN	I-TEST	O
:	:	O	O
not	RB	O	O
applicable	JJ	O	O
.	.	O	O

5.	CD	O	O
state	NN	B-TEST	B-TEST
newborn	JJ	I-TEST	I-TEST
screens	NNS	I-TEST	I-TEST
were	VBD	O	O
sent	VBN	O	O
on	IN	O	O
2018-12-31	JJ	O	O
,	,	O	O
and	CC	O	O
the	DT	O	O
results	NNS	O	O
are	VBP	O	O
pending	VBG	O	O
.	.	O	O

6.	CD	O	O
immunizations	NNS	B-TREATMENT	B-TREATMENT
received	VBD	O	O
:	:	O	O
hepatitis	NN	B-TREATMENT	B-PROBLEM
b	NN	I-TREATMENT	I-PROBLEM
vaccine	NN	I-TREATMENT	I-PROBLEM
on	IN	O	O
12-31	CD	O	O
,	,	O	O
2006	CD	O	O
.	.	O	O

7.	CD	O	O
immunization	NN	B-TREATMENT	O
recommended	VBD	O	O
:	:	O	O

influenza	JJ	B-TREATMENT	B-TREATMENT
immunization	NN	I-TREATMENT	I-TREATMENT
is	VBZ	O	O
recommended	VBN	O	O
annually	RB	O	O
in	IN	O	O
the	DT	O	O
fall	NN	O	O
for	IN	O	O
all	DT	O	O
infants	NNS	O	O
once	IN	O	O
they	PRP	O	O
reach	VBP	O	O
6	CD	O	O
months	NNS	O	O
of	IN	O	O
age	NN	O	O
.	.	O	O

before	IN	O	O
this	DT	O	O
age	NN	O	O
(	(	O	O
and	CC	O	O
for	IN	O	O
the	DT	O	O
first	JJ	O	O
24	CD	O	O
months	NNS	O	O
of	IN	O	O
the	DT	O	O
child	NN	O	O
's	POS	O	O
life	NN	O	O
)	)	O	O
,	,	O	O
immunization	NN	B-TREATMENT	B-TREATMENT
against	IN	O	O
influenza	NN	B-PROBLEM	B-PROBLEM
is	VBZ	O	O
recommended	VBN	O	O
for	IN	O	O
all	DT	O	O
household	NN	O	O
contacts	NNS	O	O
and	CC	O	O
out	IN	O	O
of	IN	O	O
home	NN	O	O
caregivers	NNS	O	O
.	.	O	O

2.	CD	O	O
exaggerated	JJ	B-PROBLEM	B-PROBLEM
physiologic	JJ	I-PROBLEM	I-PROBLEM
hyperbilirubinemia	NN	I-PROBLEM	I-PROBLEM
responsive	NN	O	O
to	TO	O	O
phototherapy	VB	B-TREATMENT	B-TREATMENT
.	.	O	O

self	NN	B-PROBLEM	B-PROBLEM
inflicted	VBN	I-PROBLEM	I-PROBLEM
gunshot	JJ	I-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	O
the	DT	I-PROBLEM	O
head	NN	I-PROBLEM	O
.	.	O	O

self	NN	B-PROBLEM	B-PROBLEM
inflicted	VBN	I-PROBLEM	I-PROBLEM
gunshot	JJ	I-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	O
the	DT	I-PROBLEM	O
head	NN	I-PROBLEM	O
.	.	O	O

hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
poor	JJ	B-PROBLEM	B-PROBLEM
dentition	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

suture	NN	B-TREATMENT	O
of	IN	O	O
right	JJ	B-PROBLEM	B-PROBLEM
temporal	JJ	I-PROBLEM	I-PROBLEM
head	NN	I-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
performed	VBN	O	O
on	IN	O	O
april	NN	O	O
14	CD	O	O
,	,	O	O
1994	CD	O	O
.	.	O	O

mr.	NN	O	O
le	NN	O	O
is	VBZ	O	O
a	DT	O	O
seventy	NN	O	O
three	CD	O	O
year	NN	O	O
old	JJ	O	O
male	NN	O	O
who	WP	O	O
presents	VBZ	O	O
to	TO	O	O
the	DT	O	O
fairm	NN	O	O
of	IN	O	O
ijordcompmac	JJ	O	O
hospital	NN	O	O
,	,	O	O
following	VBG	O	O
a	DT	B-PROBLEM	B-PROBLEM
self	NN	I-PROBLEM	I-PROBLEM
inflicted	VBN	I-PROBLEM	I-PROBLEM
gunshot	JJ	I-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	O
the	DT	I-PROBLEM	O
head	NN	I-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
sister	NN	O	O
died	VBD	O	O
eight	CD	O	O
years	NNS	O	O
prior	RB	O	O
to	TO	O	O
the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
admission	NN	O	O
of	IN	O	O
leukemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
he	PRP	O	O
otherwise	RB	O	O
has	VBZ	O	O
no	DT	O	O
next	JJ	O	O
of	IN	O	O
kin	NN	O	O
with	IN	O	O
the	DT	O	O
exception	NN	O	O
of	IN	O	O
one	CD	O	O
brother	NN	O	O
in	IN	O	O
washington	NN	O	O
,	,	O	O
with	IN	O	O
whom	WP	O	O
his	PRP$	O	O
relationship	NN	O	O
is	VBZ	O	O
tenuous	JJ	O	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
denies	VBZ	O	O
any	DT	B-PROBLEM	B-PROBLEM
suicidal	NN	I-PROBLEM	I-PROBLEM
or	CC	I-PROBLEM	O
homicidal	JJ	I-PROBLEM	B-PROBLEM
ideation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O

2.	CD	O	O
poor	JJ	B-PROBLEM	B-PROBLEM
dentition	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
an	DT	O	O
obese	JJ	O	O
male	NN	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
vital	JJ	I-TEST	I-TEST
signs	NNS	I-TEST	I-TEST
temperature	NN	B-TEST	I-TEST
98.0	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
78	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
186/69	CD	O	O
,	,	O	O
respirations	NNS	B-TEST	B-TEST
18	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
,	,	I-TEST	I-TEST
eyes	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
ears	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
nose	RB	I-TEST	I-TEST
,	,	I-TEST	I-TEST
throat	NN	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
revealed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
entry	NN	I-PROBLEM	I-PROBLEM
wound	VBD	I-PROBLEM	I-PROBLEM
approximately	RB	O	O
1	CD	O	O
1/2	CD	O	O
inches	NNS	O	O
above	IN	O	O
the	DT	O	O
right	JJ	O	O
ear	NN	O	O
,	,	O	O
which	WDT	O	O
is	VBZ	O	O
approximately	RB	O	O
1	CD	O	O
cm.	NNS	O	O
in	IN	O	O
length	NN	O	B-TEST
and	CC	O	O
surrounded	VBN	O	O
by	IN	O	O
powder	NN	B-PROBLEM	B-PROBLEM
burn	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
lump	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
parietal	JJ	I-PROBLEM	I-PROBLEM
region	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
corresponds	VBZ	O	O
with	IN	O	O
the	DT	O	O
bullet	NN	O	O
seen	VBN	O	O
on	IN	O	O
the	DT	B-TEST	B-TEST
computerized	JJ	I-TEST	I-TEST
tomography	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
bruising	VBG	B-PROBLEM	B-PROBLEM
about	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
eyes	NNS	I-PROBLEM	O
or	CC	I-PROBLEM	O
mastoid	NN	I-PROBLEM	B-PROBLEM
sinuses	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
there	EX	O	O
is	VBZ	O	O
no	DT	O	O
fluid	NN	B-PROBLEM	B-PROBLEM
from	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
nose	NN	I-PROBLEM	I-PROBLEM
or	CC	I-PROBLEM	O
ears	NNS	I-PROBLEM	O
.	.	O	O

the	DT	O	O
neck	NN	O	O
was	VBD	O	O
supple	JJ	O	O
,	,	O	O
and	CC	O	O
without	IN	O	O
adenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
lungs	NNS	O	O
are	VBP	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
sounds	VBZ	I-TEST	I-TEST
are	VBP	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
and	CC	O	O
no	DT	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
rub	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
gallop	NN	B-PROBLEM	B-PROBLEM
are	VBP	O	O
appreciated	VBN	O	O
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
is	VBZ	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBN	B-PROBLEM	B-PROBLEM
,	,	O	O
without	IN	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
are	VBP	O	O
no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
the	DT	B-TEST	O
bowel	NN	I-TEST	O
sounds	NNS	I-TEST	O
are	VBP	O	O
present	JJ	O	O
.	.	O	O

the	DT	O	O
extremities	NNS	O	O
are	VBP	O	O
well	RB	O	O
perfused	VBN	O	O
and	CC	O	O
there	EX	O	O
is	VBZ	O	O
no	DT	O	O
clubbing	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

examination	NN	B-TEST	B-TEST
revealed	VBD	O	O
a	DT	O	O
patient	NN	O	O
who	WP	O	O
was	VBD	O	O
alert	JJ	O	O
and	CC	O	O
oriented	VBD	O	O
x	NNP	O	O
3	CD	O	O
,	,	O	O
with	IN	O	O
short	JJ	O	B-PROBLEM
term	NN	O	I-PROBLEM
recall	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
2/3	CD	O	I-PROBLEM
objects	NNS	O	I-PROBLEM
at	IN	O	O
five	CD	O	O
minutes	NNS	O	O
and	CC	O	O
fluent	JJ	O	O
speech	NN	O	O
.	.	O	O

he	PRP	O	O
demonstrated	VBD	O	O
poor	JJ	B-PROBLEM	B-PROBLEM
ability	NN	I-PROBLEM	I-PROBLEM
for	IN	I-PROBLEM	O
abstract	JJ	I-PROBLEM	B-PROBLEM
thinking	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
pupils	NNS	O	O
equal	JJ	O	O
,	,	O	O
round	NN	O	O
,	,	O	O
reactive	JJ	O	O
to	TO	O	O
light	JJ	O	O
and	CC	O	O
accommodation	NN	O	O
,	,	O	O
and	CC	O	O
the	DT	B-TEST	B-TREATMENT
extra	JJ	I-TEST	I-TREATMENT
ocular	JJ	I-TEST	I-TREATMENT
movements	NNS	I-TEST	I-TREATMENT
are	VBP	O	O
intact	JJ	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
deep	JJ	I-TEST	I-TEST
tendon	NN	I-TEST	I-TEST
reflexes	NNS	I-TEST	I-TEST
are	VBP	O	O
2+	CD	O	O
and	CC	O	O
symmetrical	JJ	O	O
throughout	IN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
panel	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
serum	NN	I-TEST	I-TEST
electrolytes	NNS	I-TEST	I-TEST
is	VBZ	O	O
normal	JJ	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
is	VBZ	O	O
9.4	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
47.1	CD	O	O
,	,	O	O
and	CC	O	O
the	DT	B-TEST	B-TEST
platelets	NNS	I-TEST	I-TEST
253,000	CD	O	O
.	.	O	O

blood	NN	B-TEST	B-TEST
coagulation	NN	I-TEST	I-TEST
times	NNS	I-TEST	O
are	VBP	O	O
normal	JJ	O	O
.	.	O	O

serum	NN	B-TEST	B-TEST
toxic	NN	I-TEST	I-TEST
screen	NN	I-TEST	I-TEST
is	VBZ	O	O
negative	JJ	O	O
.	.	O	O

leukocyte	JJ	B-TEST	B-TEST
differential	JJ	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
reveals	NNS	O	O
64	CD	B-TEST	O
neutrophils	NNS	I-TEST	B-TEST
,	,	O	O
24%	CD	B-TEST	O
lymphocytes	NNS	I-TEST	B-TEST
,	,	O	O
8%	CD	B-TEST	O
monocytes	NNS	I-TEST	O
,	,	O	O
2%	CD	B-TEST	O
eosinophils	NNS	I-TEST	B-PROBLEM
,	,	O	O
and	CC	O	O
2%	CD	B-TEST	O
basophils	NNS	I-TEST	O
.	.	O	O

a	DT	B-TEST	B-TEST
panel	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
serum	NN	I-TEST	I-TEST
enzymes	NNS	I-TEST	I-TEST
suggest	VBP	O	O
normal	JJ	O	O
hepatic	JJ	O	O
function	NN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
computerized	JJ	I-TEST	I-TEST
tomography	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
reveals	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
external	JJ	I-PROBLEM	I-PROBLEM
skull	NN	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
approximately	RB	O	O
1-2	JJ	O	O
millemeters	NNS	O	O
in	IN	O	O
size	NN	O	O
,	,	O	O
near	IN	O	O
the	DT	O	O
right	JJ	O	O
frontoparietal	NN	O	O
apex	NN	O	O
.	.	O	O

a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
parietal	NN	I-PROBLEM	I-PROBLEM
contusion	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
also	RB	O	O
identified	VBN	O	O
,	,	O	O
with	IN	O	O
blood	NN	O	B-TEST
tracking	VBG	O	O
into	IN	O	O
the	DT	O	O
middle	JJ	O	O
focus	NN	O	O
.	.	O	O

standard	RB	B-TEST	O
12	CD	I-TEST	O
lead	JJ	I-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
revealed	VBD	O	O
normal	JJ	O	O
sinus	NN	O	O
rhythm	NN	O	O
at	IN	O	O
a	DT	B-TEST	O
rate	NN	I-TEST	O
of	IN	O	O
85	CD	O	O
,	,	O	O
with	IN	O	O
poor	JJ	B-PROBLEM	B-PROBLEM
r	NNS	I-PROBLEM	I-PROBLEM
wave	VBP	I-PROBLEM	I-PROBLEM
progression	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
leads	NNS	O	I-PROBLEM
v1	VBP	O	O
through	IN	O	O
v3	NN	O	O
suggesting	VBG	O	O
the	DT	O	O
possibility	NN	O	O
of	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
old	JJ	I-PROBLEM	I-PROBLEM
anteroseptal	JJ	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

nonspecific	JJ	B-PROBLEM	B-PROBLEM
st	NN	I-PROBLEM	I-PROBLEM
segment	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
t	NN	I-PROBLEM	I-PROBLEM
wave	NN	I-PROBLEM	I-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
are	VBP	O	O
present	JJ	O	O
as	IN	O	O
well	RB	O	O
.	.	O	O

prior	RB	O	O
to	TO	O	O
his	PRP$	O	O
admission	NN	O	O
,	,	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NNP	I-PROBLEM	I-PROBLEM
gunshot	NN	I-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
sutured	VBN	O	O
close	RB	O	O
in	IN	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
suicide	JJ	B-TREATMENT	B-TREATMENT
precautions	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
was	VBD	O	O
hydrated	VBN	O	O
with	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
infusion	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
intravenous	JJ	I-TREATMENT	I-TREATMENT
fluid	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
seen	VBN	O	O
in	IN	O	O
consultation	NN	O	O
by	IN	O	O
the	DT	O	O
psychiatry	NN	O	O
service	NN	O	O
,	,	O	O
who	WP	O	O
began	VBD	O	O
a	DT	O	B-TEST
battery	NN	O	I-TEST
of	IN	O	I-TEST
testing	VBG	B-TEST	I-TEST
,	,	O	O
which	WDT	O	O
continues	VBZ	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

the	DT	O	O
consulting	VBG	O	O
psychiatrist	NN	O	O
recommended	VBD	O	O
a	DT	O	O
minimum	NN	O	O
of	IN	O	O
2	CD	B-TREATMENT	O
point	NN	I-TREATMENT	O
restraints	NNS	I-TREATMENT	O
at	IN	O	O
all	DT	O	O
times	NNS	O	O
,	,	O	O
and	CC	O	O
recommended	VBD	O	O
the	DT	O	O
patient	NN	O	O
be	VB	O	O
monitored	VBN	O	O
by	IN	O	O
a	DT	O	O
sitter	NN	O	O
.	.	O	O

the	DT	O	O
chief	JJ	O	O
obstacle	NN	O	O
was	VBD	O	O
bringing	VBG	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
under	IN	O	O
control	NN	O	B-TREATMENT
and	CC	O	O
this	DT	O	O
was	VBD	O	O
ultimately	RB	O	O
achieved	VBN	O	O
with	IN	O	O
a	DT	O	O
combination	NN	O	O
of	IN	O	O
captopril	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
nifedipine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

after	IN	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
had	VBD	O	O
stabilized	VBN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
neurology	NN	O	O
ward	NN	O	O
.	.	O	O

close	JJ	B-TEST	B-TEST
monitoring	NN	I-TEST	I-TEST
demonstrated	VBD	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
to	TO	O	O
be	VB	O	O
stable	JJ	O	O
and	CC	O	O
within	IN	O	O
an	DT	O	O
acceptable	JJ	O	O
rang	NN	O	O
on	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
dosage	NN	I-TREATMENT	I-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
had	VBD	O	O
undergone	JJ	O	O
full	JJ	B-TEST	O
psychiatric	JJ	I-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
,	,	O	O
and	CC	O	O
was	VBD	O	O
prepared	VBN	O	O
for	IN	O	O
transfer	NN	O	O
to	TO	O	O
a	DT	O	O
psychiatric	JJ	O	O
hospital	NN	O	O
.	.	O	O

therefore	RB	O	O
,	,	O	O
because	IN	O	O
of	IN	O	O
his	PRP$	O	O
need	NN	O	O
for	IN	O	O
intense	JJ	B-TREATMENT	O
psychiatric	JJ	I-TREATMENT	O
care	NN	I-TREATMENT	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
discharged	VBN	O	O
to	TO	O	O
the	DT	O	O
vo	JJ	O	O
black	JJ	O	O
doylestrictshore	NN	O	O
ft.	NN	O	O
clinics	NNS	O	O
medical	JJ	O	O
center	NN	O	O
on	IN	O	O
the	DT	O	O
7th	JJ	O	O
hospital	NN	O	O
day	NN	O	O
.	.	O	O

dilantin	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg.	NN	O	O
po	NN	O	O
tid	NN	O	O
,	,	O	O
mylanta	FW	B-TREATMENT	B-TREATMENT
30	CD	O	O
cc.	NN	O	O
po	NN	O	O
q	VBD	O	O
4	CD	O	O
hours	NNS	O	O
prn	RB	O	O
,	,	O	O
dyspepsia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
milk	NN	B-TREATMENT	O
of	IN	I-TREATMENT	O
magnesia	NN	I-TREATMENT	B-TREATMENT
30	CD	O	O
cc.	NN	O	O
po	NN	O	O
q	VBD	O	O
4	CD	O	O
hours	NNS	O	O
prn	JJ	O	O
constipation	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cimetidine	VBP	B-TREATMENT	B-TREATMENT
400	CD	O	O
mg.	JJ	O	O
po	NN	O	O
bid	NN	O	O
,	,	O	O
haloperidol	VBZ	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg.	NN	O	O
po	NN	O	O
or	CC	O	O
im	VB	O	O
q	JJ	O	O
3	CD	O	O
hours	NNS	O	O
prn	JJ	O	O
agitation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg.	NN	O	O
po	NN	O	O
bid	NN	O	O
,	,	O	O
captopril	VBP	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg.	NN	O	O
po	NN	O	O
tid	NN	O	O
,	,	O	O
nifedipine	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg.	NN	O	O
po	NN	O	O
q	VBD	O	O
6	CD	O	O
hours	NNS	O	O
and	CC	O	O
nifedipine	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg.	NN	O	O
po	NN	O	O
or	CC	O	O
sublingual	JJ	O	B-TREATMENT
q	NN	O	I-TREATMENT
3	CD	O	O
hours	NNS	O	O
prn	VBP	O	O
systolic	JJ	B-PROBLEM	B-TEST
blood	NN	I-PROBLEM	I-TEST
pressure	NN	I-PROBLEM	I-TEST
greater	JJR	I-PROBLEM	O
than	IN	I-PROBLEM	O
160	CD	I-PROBLEM	O
millemeters	NNS	I-PROBLEM	O
of	IN	I-PROBLEM	O
mercury	NN	I-PROBLEM	O
.	.	O	O

mother	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
nantucket	NN	O	O
cottage	NN	O	O
hospital	NN	O	O
from	IN	O	O
lawrence	NN	O	O
general	JJ	O	O
hospital	NN	O	O
hospital	NN	O	O
on	IN	O	O
05-01	JJ	O	O
with	IN	O	O
cervical	JJ	O	B-PROBLEM
effacement	NN	O	I-PROBLEM
and	CC	O	O
preterm	JJ	B-PROBLEM	B-PROBLEM
labor	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
magnesium	NN	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
previously	RB	O	O
been	VBN	O	O
admitted	VBN	O	O
here	RB	O	O
at	IN	O	O
the	DT	O	O
24th	CD	O	O
week	NN	O	O
after	IN	O	O
a	DT	O	O
motor	NN	O	O
vehicle	NN	O	O
accident.	IN	O	O
she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
tocolysis	NN	B-TREATMENT	B-PROBLEM
and	CC	O	O
betamethasone	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
that	DT	O	O
time	NN	O	O
.	.	O	O

due	JJ	O	O
to	TO	O	O
progressing	VBG	O	B-PROBLEM
labor	NN	O	I-PROBLEM
and	CC	O	O
presentation	NN	O	O
of	IN	O	O
twins	NNS	O	O
,	,	O	O
delivery	NN	O	B-TREATMENT
was	VBD	O	O
by	IN	O	O
cesarean	JJ	B-TREATMENT	B-TREATMENT
section	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

prenatal	JJ	B-TEST	B-TEST
screens	NNS	I-TEST	I-TEST
were	VBD	O	O
notable	JJ	O	O
for	IN	O	O
blood	NN	B-TEST	B-TEST
type	NN	I-TEST	I-TEST
0	CD	O	O
positive	JJ	O	O
,	,	O	O
antibody	JJ	B-TEST	B-TEST
negative	JJ	O	O
,	,	O	O
hepatitis	NN	B-TEST	B-TEST
b	NN	I-TEST	I-TEST
surface	NN	I-TEST	I-TEST
antigen	NN	I-TEST	I-TEST
negative	JJ	O	O
,	,	O	O
rpr	JJ	B-TEST	O
nonreactive	NN	O	O
.	.	O	O

rubella	NN	B-TEST	B-TEST
status	NN	I-TEST	I-TEST
was	VBD	O	O
not	RB	O	O
documented	VBN	O	O
.	.	O	O

group	NN	B-TEST	O
b	VBD	I-TEST	O
strep	NN	I-TEST	B-PROBLEM
status	NN	I-TEST	I-PROBLEM
was	VBD	O	O
unknown	JJ	O	O
.	.	O	O

infant	NN	O	O
emerged	VBD	O	O
from	IN	O	O
the	DT	B-PROBLEM	O
breech	JJ	I-PROBLEM	O
position	NN	I-PROBLEM	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
given	VBN	O	O
blow-by	JJ	B-TREATMENT	B-TREATMENT
oxygen	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
stimulation	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

her	PRP$	B-TEST	B-TEST
apgars	NNS	I-TEST	I-TEST
were	VBD	O	O
7	CD	O	O
at	IN	O	O
1	CD	O	O
minute	NN	O	O
and	CC	O	O
9	CD	O	O
at	IN	O	O
5	CD	O	O
minutes	NNS	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
brought	VBN	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
csru	NN	O	O
for	IN	O	O
further	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
physical	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
reveals	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
non	JJ	I-PROBLEM	I-PROBLEM
dysmorphic	JJ	I-PROBLEM	I-PROBLEM
infant	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
well	RB	O	O
saturated	VBN	O	O
and	CC	O	O
perfused	VBN	O	O
with	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
bruises	NNS	I-PROBLEM	I-PROBLEM
noted	VBD	O	I-PROBLEM
over	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
upper	JJ	O	I-PROBLEM
legs	NN	O	I-PROBLEM
,	,	O	O
left	VBD	O	O
arm	NN	O	O
and	CC	O	O
chest	NN	O	O
.	.	O	O

no	DT	O	O
bony	NN	B-PROBLEM	B-PROBLEM
abnormalities	VBZ	I-PROBLEM	I-PROBLEM
or	CC	O	O
petechiae	NN	B-PROBLEM	B-PROBLEM
noted	VBN	O	O
.	.	O	O

normal	JJ	O	O
s1	NN	O	O
and	CC	O	O
s2	NN	O	O
without	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
infant	NN	O	O
did	VBD	O	O
not	RB	O	O
require	VB	O	O
supplemental	JJ	B-TREATMENT	B-TREATMENT
oxygen	NN	I-TREATMENT	I-TREATMENT
or	CC	O	O
respiratory	JJ	B-TREATMENT	B-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

since	IN	O	O
that	DT	O	O
time	NN	O	O
,	,	O	O
jadiara	NN	O	O
has	VBZ	O	O
always	RB	O	O
been	VBN	O	O
in	IN	O	O
room	NN	O	O
air	NN	O	O
without	IN	O	O
requiring	VBG	O	O
supplemental	JJ	B-TREATMENT	B-TREATMENT
oxygen	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
apnea	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
prematurity	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
treated	VBN	O	O
with	IN	O	O
caffeine	NN	B-TREATMENT	B-TREATMENT
until	IN	O	O
2017-06-04	JJ	O	O
.	.	O	O

since	IN	O	O
that	DT	O	O
time	NN	O	O
,	,	O	O
she	PRP	O	O
has	VBZ	O	O
had	VBN	O	O
very	RB	B-PROBLEM	O
rare	JJ	I-PROBLEM	B-PROBLEM
spells	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
none	NN	O	O
for	IN	O	O
over	IN	O	O
one	CD	O	O
week	NN	O	O
by	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
15	CD	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
eventually	RB	O	O
prompting	VBG	O	O
evaluation	NN	B-TEST	B-TEST
by	IN	I-TEST	O
echo	NN	I-TEST	B-TEST
.	.	O	O

the	DT	B-TEST	B-TEST
echo	NN	I-TEST	I-TEST
revealed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
anomalous	JJ	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
coronary	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
one	CD	O	O
end	NN	O	O
entering	VBG	O	O
the	DT	O	B-PROBLEM
right	JJ	O	I-PROBLEM
ventricular	NN	O	I-PROBLEM
outflow	IN	O	I-PROBLEM
tract	NN	O	I-PROBLEM
and	CC	O	O
the	DT	O	O
other	JJ	O	O
end	NN	O	O
not	RB	O	O
clearly	RB	O	O
defined	VBN	O	O
.	.	O	O

it	PRP	O	O
was	VBD	O	O
unable	JJ	O	O
to	TO	O	O
be	VB	O	O
delineated	VBN	O	O
whether	IN	O	O
this	DT	O	O
represented	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
anomalous	JJ	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
arising	VBG	I-PROBLEM	O
from	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
pulmonary	JJ	I-PROBLEM	O
artery	NN	I-PROBLEM	O
(	(	I-PROBLEM	O
lcapa	NN	I-PROBLEM	O
)	)	I-PROBLEM	O
or	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
fistula	NN	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	O
the	DT	I-PROBLEM	O
pulmonar	NN	I-PROBLEM	O
artery	NN	I-PROBLEM	O
.	.	O	O

the	DT	O	O
right	JJ	O	O
coronary	NN	O	O
was	VBD	O	O
prominent	JJ	O	O
,	,	O	O
and	CC	O	O
there	RB	O	O
appeared	VBD	O	O
to	TO	O	O
be	VB	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
collateral	NN	I-PROBLEM	I-PROBLEM
vessels	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
posterior	JJ	I-PROBLEM	I-PROBLEM
apical	JJ	I-PROBLEM	I-PROBLEM
myocardium	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
apical	JJ	I-PROBLEM	I-PROBLEM
muscular	NN	I-PROBLEM	I-PROBLEM
vsd	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
also	RB	O	O
noted	VBN	O	O
.	.	O	O

several	JJ	B-TEST	O
additional	JJ	I-TEST	O
echos	NN	I-TEST	O
were	VBD	O	O
performed	VBN	O	O
,	,	O	O
including	VBG	O	O
an	DT	B-TEST	B-TEST
echo	NN	I-TEST	I-TEST
in	IN	O	O
the	DT	O	O
cardiology	NN	O	O
department	NN	O	O
at	IN	O	O
healthsouth	NN	O	O
rehab	JJ	O	O
hospital	NN	O	O
of	IN	O	O
western	JJ	O	O
mass.	NN	O	O
,	,	O	O
but	CC	O	O
the	DT	O	O
anatomy	NN	O	O
of	IN	O	O
the	DT	O	O
left	JJ	O	O
coronary	JJ	O	O
artery	NN	O	O
could	MD	O	O
not	RB	O	O
be	VB	O	O
further	RB	O	O
defined	VBN	O	O
.	.	O	O

due	JJ	O	O
to	TO	O	O
the	DT	O	O
risks	NNS	O	O
of	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
ischemia	NN	I-PROBLEM	I-PROBLEM
if	IN	O	O
this	DT	O	O
represented	VBD	O	O
an	DT	B-PROBLEM	O
lcapa	NN	I-PROBLEM	O
,	,	O	O
the	DT	O	O
infant	NN	O	O
was	VBD	O	O
followed	VBN	O	O
with	IN	O	O
regular	JJ	B-TEST	O
echos	NN	I-TEST	O
and	CC	O	O
ekgs	NN	B-TEST	O
during	IN	O	O
the	DT	O	O
remainder	NN	O	O
of	IN	O	O
hospitalization	NN	O	O
,	,	O	O
with	IN	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
ischemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
valvular	JJ	B-PROBLEM	B-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
compromised	VBD	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
function	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
will	MD	O	O
be	VB	O	O
continued	VBN	O	O
to	TO	O	O
be	VB	O	O
followed	VBN	O	O
closely	RB	O	O
by	IN	O	O
cardiology	NN	O	O
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
,	,	O	O
with	IN	O	O
likely	JJ	O	O
plans	NNS	O	O
for	IN	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
and	CC	O	O
surgical	JJ	B-TREATMENT	B-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT
when	WRB	O	O
she	PRP	O	O
grows	VBZ	O	O
to	TO	O	O
3.5	CD	O	O
to	TO	O	O
4	CD	O	O
kg	NNS	O	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
was	VBD	O	O
initially	RB	O	O
maintained	VBN	O	O
on	IN	O	O
ivf	NN	B-TREATMENT	O
,	,	O	O
with	IN	O	O
introduction	NN	O	O
of	IN	O	O
enteral	JJ	B-TREATMENT	B-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
2	CD	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
advanced	VBN	O	O
to	TO	O	O
full	JJ	B-TREATMENT	B-TREATMENT
volume	NN	I-TREATMENT	I-TREATMENT
enteral	JJ	I-TREATMENT	I-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
by	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
7	CD	O	O
,	,	O	O
and	CC	O	O
then	RB	O	O
to	TO	O	O
a	DT	B-TREATMENT	B-TEST
maximum	JJ	I-TREATMENT	I-TEST
caloric	JJ	I-TREATMENT	I-TEST
density	NN	I-TREATMENT	I-TEST
of	IN	O	O
28	CD	O	O
cals	NNS	O	O
/	JJ	O	O
oz	NN	O	O
.	.	O	O

by	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
,	,	O	O
infant	NN	O	O
is	VBZ	O	O
feedign	JJ	O	O
bm	NN	O	O
or	CC	O	O
enfamil	VB	B-TREATMENT	B-TREATMENT
24	CD	O	O
cals	NNS	O	O
/	JJ	O	O
oz	JJ	O	O
po	NN	O	O
ad	NN	O	O
lib	NN	O	O
,	,	O	O
with	IN	O	O
adequate	JJ	O	O
intake	NN	O	O
and	CC	O	O
adequate	JJ	O	O
weight	NN	O	O
gain	NN	O	O
.	.	O	O

last	JJ	B-TEST	B-TEST
nutrition	NN	I-TEST	I-TEST
labs	NNS	I-TEST	I-TEST
were	VBD	O	O
on	IN	O	O
06-20	JJ	O	O
with	IN	O	O
ap	NN	B-TEST	O
of	IN	O	O
208	CD	O	O
,	,	O	O
ca	MD	B-TEST	O
10.8	CD	O	O
,	,	O	O
and	CC	O	O
phos	VBZ	B-TEST	B-TEST
7.4.	CD	O	O

the	DT	O	O
infant	NN	O	O
required	VBN	O	O
phototherapy	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
hyperbilirubinemia	NN	B-PROBLEM	B-PROBLEM
through	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
7	CD	O	O
,	,	O	O
with	IN	O	O
peak	JJ	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
of	IN	O	O
7	CD	O	O
/	JJ	O	O
0.3	CD	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
3	CD	O	O
,	,	O	O
and	CC	O	O
last	JJ	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
of	IN	O	O
4.9	CD	O	O
/	JJ	O	O
0.3	CD	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
9	CD	O	O
.	.	O	O

cbc	NN	B-TEST	B-TEST
and	CC	O	O
blood	NN	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
were	VBD	O	O
obtained	VBN	O	O
upon	IN	O	O
admission	NN	O	O
revealing	VBG	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
9.0	CD	O	O
with	IN	O	O
25	CD	B-TEST	O
polys	NNS	I-TEST	B-TEST
and	CC	O	O
0	CD	B-TEST	O
bands	NNS	I-TEST	O
;	:	O	O
hematocrit	NN	B-TEST	B-TEST
was	VBD	O	O
46.9%	CD	O	O
and	CC	O	O
platelets	NNS	B-TEST	B-TEST
of	IN	O	O
222,000	CD	O	O
.	.	O	O

baby	NN	O	O
received	VBD	O	O
48	CD	O	O
hours	NNS	O	O
of	IN	O	O
ampicillin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
gentamycin	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
negative	JJ	O	O
cultures	NNS	O	O
and	CC	O	O
a	DT	O	O
stable	JJ	O	O
clinical	JJ	O	O
course	NN	O	O
.	.	O	O

infant	NN	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
supplemental	JJ	B-TREATMENT	B-TREATMENT
iron	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
did	VBD	O	O
not	RB	O	O
receive	VB	O	O
any	DT	B-TREATMENT	B-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

last	JJ	B-TEST	B-TEST
hct	NN	I-TEST	I-TEST
was	VBD	O	O
30.6	CD	O	O
on	IN	O	O
06-20	NN	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
reticulocyte	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
6.5%.	CD	O	O

initial	JJ	B-TEST	B-TEST
opthalmologic	JJ	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
on	IN	O	O
06-05	NN	O	O
revealed	VBN	O	O
immature	NN	B-PROBLEM	B-PROBLEM
retinas	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
zone	NN	O	O
3	CD	O	O
,	,	O	O
and	CC	O	O
repeat	NN	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
on	IN	O	O
06-26	JJ	O	O
revealed	JJ	O	O
mature	NN	O	O
retinas	VBZ	O	O
bilaterally	RB	O	O
.	.	O	O

infant	NN	O	O
passed	VBD	O	O
hearing	VBG	B-TEST	O
screen	NN	I-TEST	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

enfamil	NN	B-TREATMENT	B-TREATMENT
or	CC	O	I-TREATMENT
breast	NN	O	I-TREATMENT
milk	NN	O	I-TREATMENT
24	CD	O	O
calories	NNS	O	O
per	IN	O	O
oz	NN	O	O
,	,	O	O
with	IN	O	O
enfamil	JJ	O	B-TREATMENT
powder	NN	O	I-TREATMENT
.	.	O	O

ferinsol	RB	B-TREATMENT	B-TREATMENT
0.2	CD	O	O
ml	NNS	O	O
po	JJ	O	O
qd	NN	O	O
.	.	O	O

newborn	JJ	B-TEST	O
screen	NN	I-TEST	O
:	:	O	O

sent	NN	O	O
as	IN	O	O
per	IN	O	O
protocol;	NN	O	O
one	CD	B-TEST	O
specimen	NN	I-TEST	O
from	IN	O	O
2017-05-28	JJ	O	O
returned	VBN	O	O
with	IN	O	O
borderline	NN	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
thyroxine	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
repeat	NN	B-TEST	O
was	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

hepatitis	NN	B-TREATMENT	B-TREATMENT
b	NN	I-TREATMENT	I-TREATMENT
vaccine	NN	I-TREATMENT	I-TREATMENT
given	VBN	O	O
06-17	CD	O	O
.	.	O	O

car	NN	B-TEST	B-TEST
seat	NN	I-TEST	I-TEST
safety	NN	I-TEST	I-TEST
screening	VBG	I-TEST	I-TEST
passed	VBN	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

due	JJ	O	O
to	TO	O	O
breech	VB	B-PROBLEM	O
presentation	NN	I-PROBLEM	O
,	,	O	O
a	DT	B-TEST	B-TEST
hip	NN	I-TEST	I-TEST
ultrasound	NN	I-TEST	I-TEST
can	MD	O	O
be	VB	O	O
considered	VBN	O	O
in	IN	O	O
2-4	JJ	O	O
weeks	NNS	O	O
.	.	O	O

1.	CD	O	O
prematurity	NN	B-PROBLEM	B-PROBLEM
at	IN	O	O
31	CD	O	O
weeks	NNS	O	O
,	,	O	O
twin	JJ	O	O
#1	NN	O	O
.	.	O	O

2.	CD	O	O
breech	JJ	B-PROBLEM	B-PROBLEM
presentation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
suspect	NN	O	I-PROBLEM
ruled	VBD	O	O
out	RP	O	O
with	IN	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

4.	CD	O	O
physiologic	JJ	B-PROBLEM	B-PROBLEM
jaundice	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

5.	CD	O	O
apnea	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
prematurity	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

6.	CD	O	O
anemia	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
prematurity	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

7.	CD	O	O
aberrant	JJ	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

8.	CD	O	O
muscular	JJ	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
septal	NN	I-PROBLEM	I-PROBLEM
defect	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

ovarian	JJ	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

ovarian	JJ	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

papanicolaou	NN	B-TEST	O
smear	VBP	I-TEST	O
positive	JJ	O	O
for	IN	O	O
somomabodies	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
incontinence	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

total	JJ	B-TREATMENT	B-TREATMENT
abdominal	JJ	I-TREATMENT	I-TREATMENT
hysterectomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
lysis	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
adhesions	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
open	JJ	B-TREATMENT	B-TREATMENT
laparoscopy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
birch	NN	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
suprapubic	JJ	B-TREATMENT	B-TREATMENT
bladder	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
52	CD	O	O
year	NN	O	O
old	JJ	O	O
female	NN	O	O
with	IN	O	O
gravida	JJ	O	O
3	CD	O	O
para	NN	O	O
3	CD	O	O
who	WP	O	O
presents	VBZ	O	O
with	IN	O	O
complains	NNS	O	O
of	IN	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
enlarged	VBD	B-PROBLEM	O
ovary	JJ	I-PROBLEM	O
by	IN	O	O
ultrasound	NN	B-TEST	B-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
also	RB	O	O
complaining	VBG	O	O
of	IN	O	O
several	JJ	B-PROBLEM	O
years	NNS	I-PROBLEM	O
urinary	JJ	I-PROBLEM	B-PROBLEM
incontinence	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
&apos;s	JJ	O	O
recent	JJ	O	O
history	NN	O	O
is	VBZ	O	O
also	RB	O	O
notable	JJ	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
papanicolaou	NN	I-TEST	I-TEST
smear	NN	I-TEST	I-TEST
which	WDT	O	O
revealed	VBD	O	O
somomabodies	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
had	VBD	O	O
vaginal	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
april	JJ	O	O
1992	CD	O	O
following	VBG	O	O
radiation	NN	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
initially	RB	O	O
presented	VBN	O	O
with	IN	O	O
hypercalcemia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
underwent	NN	O	O
a	DT	B-TREATMENT	B-TREATMENT
parathyroidectomy	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
june	NN	O	O
22	CD	O	O
,	,	O	O
1993	CD	O	O
.	.	O	O

it	PRP	O	O
was	VBD	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
that	IN	O	O
her	PRP$	B-TEST	B-PROBLEM
abnormal	JJ	I-TEST	I-PROBLEM
papanicolaou	NN	I-TEST	I-PROBLEM
smear	NN	I-TEST	I-PROBLEM
was	VBD	O	O
obtained	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
now	RB	O	O
admitted	VBN	O	O
for	IN	O	O
exploratory	JJ	B-TEST	B-TEST
laparotomy	NN	I-TEST	I-TEST
.	.	O	O

the	DT	O	O
past	JJ	O	O
medical	JJ	O	O
history	NN	O	O
is	VBZ	O	O
notable	JJ	O	O
for	IN	O	O
lymphosarcoma	NN	B-PROBLEM	B-PROBLEM
in	IN	O	O
1970	CD	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
radiation	NN	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

in	IN	O	O
1980	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
axillary	JJ	I-PROBLEM	I-PROBLEM
recurrence	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
radiation	NN	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
hyperparathyroidism	NN	B-PROBLEM	B-PROBLEM
secondary	JJ	O	O
to	TO	O	O
papillary	JJ	B-PROBLEM	B-PROBLEM
thyroid	NN	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
history	NN	O	O
is	VBZ	O	O
also	RB	O	O
notable	JJ	O	O
for	IN	O	O
gallstones	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
kidney	NN	B-PROBLEM	B-TREATMENT
stones	NNS	I-PROBLEM	I-TREATMENT
,	,	O	O
episodic	JJ	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
pancreatitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

of	IN	O	O
note	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
also	RB	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
incontinence	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
has	VBZ	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
past	JJ	O	O
surgical	JJ	O	O
history	NN	O	O
is	VBZ	O	O
notable	JJ	O	O
for	IN	O	O
the	DT	B-TREATMENT	O
removal	NN	I-TREATMENT	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
thyroid	JJ	I-PROBLEM	I-PROBLEM
nodule	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
february	JJ	O	O
1989	CD	O	O
.	.	O	O

this	DT	O	O
revealed	VBD	O	O
papillary	JJ	B-PROBLEM	B-PROBLEM
thyroid	NN	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
the	DT	O	O
patient	NN	O	O
received	VBD	O	O
radioactive	JJ	B-TREATMENT	B-TREATMENT
iodine	JJ	I-TREATMENT	I-TREATMENT
ablation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

in	IN	O	O
june	NN	O	O
1993	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
parathyroidectomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
also	RB	O	O
of	IN	O	O
note	NN	O	O
,	,	O	O
in	IN	O	O
september	NN	O	O
1992	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
an	DT	B-TEST	B-TEST
exploratory	JJ	I-TEST	I-TEST
laparotomy	NN	I-TEST	I-TEST
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
pancreatitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

include	VBP	O	O
librax	$	B-TREATMENT	B-TREATMENT
1	CD	O	O
po	NN	O	O
before	IN	O	O
meals	NNS	O	O
,	,	O	O
pancrease	NN	B-TREATMENT	B-TREATMENT
2	CD	O	O
tabs	NN	O	O
before	IN	O	O
meals	NNS	O	O
,	,	O	O
synthroid	JJ	B-TREATMENT	B-TREATMENT
0.125	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
.	.	O	O

tenormin	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
bid	NN	O	O
,	,	O	O
valium	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
bid	NN	O	O
to	TO	O	O
tid	VB	O	O
,	,	O	O
premarin	VB	B-TREATMENT	B-TREATMENT
0.625	CD	O	O
mg	NN	O	O
qd	NN	O	O
,	,	O	O
provera	NN	B-TREATMENT	B-TREATMENT
2.5	CD	O	O
mg	NN	O	O
qod	NN	O	O
,	,	O	O
desyrel	VBZ	B-TREATMENT	O
50	CD	O	O
mg	NN	O	O
qhs	NN	O	O
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
include	VBP	O	O
septra	JJ	B-TREATMENT	O
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
&apos;s	NNP	I-TEST	I-TEST
preoperative	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
is	VBZ	O	O
notable	JJ	O	O
for	IN	O	O
normal	JJ	O	O
breasts	NNS	O	O
,	,	O	O
normal	JJ	O	O
heart	NN	O	O
and	CC	O	O
lungs	NNS	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
pelvic	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
is	VBZ	O	O
normal	JJ	O	O
except	IN	O	O
for	IN	O	O
the	DT	O	O
presence	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	O
full	JJ	I-PROBLEM	O
right	NN	I-PROBLEM	O
ovary	NN	I-PROBLEM	O
.	.	O	O

the	DT	B-TEST	B-TEST
rectovaginal	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
is	VBZ	O	O
normal	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
judged	VBN	O	O
to	TO	O	O
be	VB	O	O
at	IN	O	O
risk	NN	O	O
secondary	JJ	O	O
to	TO	O	O
her	PRP$	O	O
history	NN	O	O
of	IN	O	O
somomabodies	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
vaginal	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	O	B-TEST
differential	JJ	O	I-TEST
diagnosis	NN	O	I-TEST
included	VBD	O	O
ovarian	JJ	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
underwent	VBD	O	O
an	DT	B-TREATMENT	B-TREATMENT
open	JJ	I-TREATMENT	I-TREATMENT
laparoscopy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
total	JJ	B-TREATMENT	B-TREATMENT
abdominal	JJ	I-TREATMENT	I-TREATMENT
hysterectomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
lysis	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
adhesions	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
birch	NN	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
suprapubic	JJ	B-TREATMENT	B-TREATMENT
foley	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
and	CC	O	I-TREATMENT
jackson-pratt	JJ	B-TREATMENT	I-TREATMENT
drain	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	B-TEST	B-PROBLEM
estimated	VBN	I-TEST	I-PROBLEM
blood	NN	I-TEST	I-PROBLEM
loss	NN	I-TEST	I-PROBLEM
was	VBD	O	O
300	CD	O	O
cc	NN	O	O
.	.	O	O

there	EX	O	O
were	VBD	O	O
no	DT	O	O
complications	NNS	B-PROBLEM	B-PROBLEM
during	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
the	DT	O	O
patient	NN	O	O
returned	VBD	O	O
to	TO	O	O
the	DT	O	O
recovery	NN	O	O
room	NN	O	O
in	IN	O	O
stable	JJ	O	O
condition	NN	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
calcium	NN	I-TEST	I-TEST
was	VBD	O	O
followed	VBN	O	O
daily	JJ	O	O
and	CC	O	O
repleted	VBD	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
jackson-pratt	JJ	I-TREATMENT	I-TREATMENT
drain	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
removed	VBN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
two	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
of	IN	O	O
101.6	CD	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
two	CD	O	O
.	.	O	O

her	PRP$	O	O
lungs	NNS	O	O
revealed	VBD	O	O
coarse	JJ	B-PROBLEM	B-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
sounds	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
nebulizer	NN	B-TREATMENT	B-TREATMENT
treatment	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
did	VBD	O	O
well	RB	O	O
and	CC	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
suprapubic	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
clamped	VBN	B-TREATMENT	O
starting	VBG	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
four	CD	O	O
.	.	O	O

at	IN	O	O
this	DT	O	O
time	NN	O	O
,	,	O	O
her	PRP$	B-TEST	B-TEST
post-void	JJ	I-TEST	I-TEST
residuals	NNS	I-TEST	I-TEST
range	VBP	O	O
from	IN	O	O
2	CD	O	O
cc	NN	O	O
to	TO	O	O
25	CD	O	O
cc	NN	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
suprapubic	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
therefore	RB	O	O
discontinued	VBN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
chest	JJ	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
secondary	JJ	O	O
to	TO	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NNP	I-PROBLEM	I-PROBLEM
coarse	VBZ	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
sounds	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
however	RB	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
was	VBD	O	O
clear	JJ	O	O
except	IN	O	O
for	IN	O	O
a	DT	O	O
small	JJ	O	O
amount	NN	O	O
of	IN	O	O
atelectasis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

final	JJ	B-TEST	B-TEST
pathology	NN	I-TEST	I-TEST
revealed	VBD	O	O
right	JJ	O	B-TREATMENT
fallopian	JJ	O	I-TREATMENT
tube	NN	O	I-TREATMENT
and	CC	O	O
ovary	JJ	O	O
with	IN	O	O
benign	JJ	B-PROBLEM	B-PROBLEM
paratubal	JJ	I-PROBLEM	I-PROBLEM
cysts	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
adhesions	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	B-TEST
cervix	NN	O	I-TEST
revealed	VBD	O	O
squamous	JJ	B-PROBLEM	B-PROBLEM
metaplasia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
discharged	VBN	O	O
home	NN	O	O
on	IN	O	O
admission	NN	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
she	PRP	O	O
will	MD	O	O
take	VB	O	O
ciprofloxacin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
nine	CD	O	O
more	JJR	O	O
days	NNS	O	O
.	.	O	O

she	PRP	O	O
will	MD	O	O
also	RB	O	O
take	VB	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

1.	CD	O	O
stage	NN	B-PROBLEM	B-PROBLEM
iv	JJ	I-PROBLEM	I-PROBLEM
endometrial	JJ	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM

2.	CD	O	O
stage	NN	B-PROBLEM	B-PROBLEM
iii-c	JJ	I-PROBLEM	I-PROBLEM
ovarian	JJ	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM

1.	CD	O	O
stage	NN	B-PROBLEM	B-PROBLEM
iv	JJ	I-PROBLEM	I-PROBLEM
endometrial	JJ	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM

2.	CD	O	O
stage	NN	B-PROBLEM	B-PROBLEM
iii-c	JJ	I-PROBLEM	I-PROBLEM
ovarian	JJ	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM

chemotherapy	NN	B-TREATMENT	B-TREATMENT
of	IN	O	I-TREATMENT
ifex	NN	B-TREATMENT	I-TREATMENT
,	,	O	O
mesna	NN	B-TREATMENT	O
and	CC	O	O
vp-16	NN	B-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
31	CD	O	O
year	NN	O	O
old	JJ	O	O
gravida	NN	O	O
0	CD	O	O
with	IN	O	O
stage	NN	B-PROBLEM	B-PROBLEM
iv	JJ	I-PROBLEM	I-PROBLEM
endometrial	JJ	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
stage	VB	B-PROBLEM	I-PROBLEM
iii-c	JJ	I-PROBLEM	I-PROBLEM
ovarian	JJ	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
vs	NN	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
endometrial	JJ	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
for	IN	O	O
line	NN	O	B-TREATMENT
2	CD	O	O
,	,	O	O
cycle	NN	B-TREATMENT	O
1	CD	I-TREATMENT	O
chemotherapy	NN	I-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
presented	VBN	O	O
in	IN	O	O
10-90	JJ	O	O
,	,	O	O
with	IN	O	O
heavy	JJ	B-PROBLEM	B-PROBLEM
bleeding	VBG	I-PROBLEM	I-PROBLEM
per	IN	I-PROBLEM	I-PROBLEM
vagina	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

d	NN	B-TEST	O
and	CC	I-TEST	O
c	NN	I-TEST	O
showed	VBD	O	O
grade	JJ	B-PROBLEM	B-PROBLEM
ii-iii	JJ	I-PROBLEM	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
squamous	JJ	B-PROBLEM	B-PROBLEM
differentiation	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
wellla	NN	O	O
uxinny	JJ	O	O
:	:	O	O
mount	NN	O	O
medical	JJ	O	O
center	NN	O	O
in	IN	O	O
com	JJ	O	O
st.	NN	O	O
,	,	O	O
tton	NN	O	B-PROBLEM
,	,	O	O
arkansas	RB	O	O
32167	CD	O	O
.	.	O	O

the	DT	O	O
patient	JJ	O	O
underwent	JJ	O	O
tah	NN	B-TREATMENT	O
/	NNP	O	O
bso	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
partial	JJ	B-TREATMENT	B-TREATMENT
omentectomy	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
ctmc	NN	O	O
in	IN	O	O
10-90	JJ	O	O
.	.	O	O

at	IN	O	O
that	DT	O	O
time	NN	O	O
,	,	O	O
tumor	NN	B-PROBLEM	B-TEST
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
studding	VBG	B-PROBLEM	B-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
diaphragm	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
gross	JJ	B-PROBLEM	B-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
omentum	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
large	JJ	I-PROBLEM	O
bowel	NN	I-PROBLEM	O
,	,	O	O
tumor	NN	B-PROBLEM	O
through	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
uterine	JJ	I-PROBLEM	O
serosa	NN	I-PROBLEM	O
.	.	O	O

pathology	NN	B-TEST	B-TEST
showed	VBD	O	O
grade	JJ	B-PROBLEM	B-PROBLEM
ii-iii	JJ	I-PROBLEM	I-PROBLEM
papillary	JJ	I-PROBLEM	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
endometrium	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
squamous	JJ	B-PROBLEM	B-PROBLEM
differentiation	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
focally	RB	B-PROBLEM	B-PROBLEM
invasive	JJ	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
superficial	JJ	B-PROBLEM	I-PROBLEM
myometrium	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
ovary	JJ	O	O
showed	VBD	O	O
papillary	JJ	B-PROBLEM	B-PROBLEM
serous	JJ	I-PROBLEM	I-PROBLEM
adeno	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
omental	JJ	B-PROBLEM	O
involvement	NN	I-PROBLEM	O
consistent	NN	O	O
with	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
endometroid	JJ	I-PROBLEM	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
question	NN	O	O
was	VBD	O	O
whether	IN	O	O
or	CC	O	O
not	RB	O	O
whether	IN	O	O
she	PRP	O	O
had	VBD	O	O
two	CD	B-PROBLEM	O
primaries	NNS	I-PROBLEM	O
vs	VBP	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
endometrial	JJ	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	JJ	O	O
underwent	JJ	O	O
6	CD	O	O
cycles	NNS	O	O
of	IN	O	O
cap	NN	B-TREATMENT	B-TREATMENT
in	IN	O	I-TREATMENT
pemrancetul	JJ	O	I-TREATMENT
tonsst.	NN	O	I-TREATMENT
.	.	O	O

however	RB	O	O
,	,	O	O
during	IN	O	O
the	DT	B-TREATMENT	O
fourth	JJ	I-TREATMENT	O
cycle	NN	I-TREATMENT	O
,	,	O	O
cytoxan	NN	B-TREATMENT	O
was	VBD	O	O
dropped	VBN	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
ca-125	NN	I-TEST	I-TEST
on	IN	O	O
6-27-91	JJ	O	O
,	,	O	O
was	VBD	O	O
249	CD	O	O
and	CC	O	O
on	IN	O	O
8-29-91	JJ	O	O
,	,	O	O
was	VBD	O	O
734	CD	O	O
.	.	O	O

in	IN	O	O
05-92	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
wellla	VB	O	O
uxinny	JJ	O	O
:	:	O	O
mount	NN	O	O
medical	JJ	O	O
center	NN	O	O
with	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
leg	NN	I-PROBLEM	I-PROBLEM
dvt	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
started	VBD	O	O
on	IN	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
discharged	VBN	O	O
from	IN	O	O
there	RB	O	O
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
no	DT	O	O
complaints	NNS	O	B-PROBLEM
except	IN	O	O
anxiety	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

coumadin	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
po	NN	O	O
q	NN	O	O
d	NN	O	O
,	,	O	O
tagamet	VBD	B-TREATMENT	O
400	CD	O	O
mg	NN	O	O
po	NN	O	O
q	NN	O	O
d	NN	O	O
,	,	O	O
amoxicillin	NN	B-TREATMENT	B-TREATMENT
which	WDT	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
labor	NN	O	O
day	NN	O	O
,	,	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
sore	NN	I-PROBLEM	I-PROBLEM
throat	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
ativan	$	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	NN	O	O
po	NN	O	O
prn	NN	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
/	NNP	O	O
anxiety	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	JJ	O	O
gets	VBZ	O	O
hives	NNS	B-PROBLEM	O
to	TO	O	O
aspirin	VB	B-TREATMENT	B-TREATMENT
and	CC	O	O
tomatoes	NNS	O	O
also	RB	O	O
cause	VBP	O	O
her	PRP$	O	B-PROBLEM
hives	NNS	B-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	O
temp	NN	I-TEST	O
was	VBD	O	O
99.4	CD	O	O
,	,	O	O
bp	NN	B-TEST	B-TEST
114/78	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
128	CD	O	O
and	CC	O	O
respirations	NNS	B-TEST	B-TEST
20	CD	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
an	DT	O	O
anxious	JJ	O	O
female	NN	O	O
,	,	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

heent	NN	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
showed	VBD	O	O
perrla	NN	O	B-PROBLEM
,	,	O	O
eomi	NN	O	O
,	,	O	O
oropharynx	JJ	O	B-PROBLEM
benign	NN	O	I-PROBLEM
.	.	O	O

the	DT	O	O
lungs	NNS	O	O
were	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	NN	B-TEST	B-TEST
.	.	O	O

cv	NN	O	O
was	VBD	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
without	IN	O	O
murmurs	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
,	,	O	O
positive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
,	,	O	O
non	JJ	B-PROBLEM	B-PROBLEM
tender	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
large	JJ	B-PROBLEM	O
,	,	I-PROBLEM	O
hard	JJ	I-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
occupying	VBG	O	I-PROBLEM
the	DT	O	I-PROBLEM
lower	JJR	O	I-PROBLEM
abdomen	NNS	O	I-PROBLEM
and	CC	O	I-PROBLEM
left	VBD	O	I-PROBLEM
upper	JJ	O	I-PROBLEM
quadrant	NN	O	I-PROBLEM
.	.	O	O

the	DT	O	O
extremities	NNS	O	O
were	VBD	O	O
non	JJ	B-PROBLEM	O
tender	NN	I-PROBLEM	O
without	IN	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
was	VBD	O	O
136	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
3.0	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
98	CD	O	O
,	,	O	O
co2	NN	B-TEST	B-TREATMENT
20	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
8	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
0.8	CD	O	O
and	CC	O	O
glucose	VB	B-TEST	B-TEST
94	CD	O	O
,	,	O	O
alt	RB	B-TEST	O
5	CD	O	O
,	,	O	O
ast	RB	B-TEST	B-TEST
10	CD	O	O
,	,	O	O
ldh	VBD	B-TEST	O
166	CD	O	O
,	,	O	O
alkaline	JJ	B-TEST	B-TEST
phosphatase	NN	I-TEST	I-TEST
81	CD	O	O
,	,	O	O
total	JJ	B-TEST	B-TEST
bili	NN	I-TEST	I-TEST
0.6	CD	O	O
,	,	O	O
direct	JJ	B-TEST	B-TEST
bili	NN	I-TEST	I-TEST
.3	NN	O	I-TEST
,	,	O	O
albumin	RB	B-TEST	B-TEST
3.3	CD	O	O
,	,	O	O
calcium	NN	B-TEST	B-TEST
8.8	CD	O	O
and	CC	O	O
uric	JJ	B-TEST	B-TEST
acid	NN	I-TEST	I-TEST
3.1	CD	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
ca-125	NN	B-TEST	B-TREATMENT
which	WDT	O	O
was	VBD	O	O
pending	VBG	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
31.1	CD	O	O
,	,	O	O
wbc	VBD	B-TEST	B-TEST
11.6	CD	O	O
and	CC	O	O
151,000	CD	O	O
platelets	NNS	B-TEST	B-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
thus	RB	O	O
stage	JJ	B-PROBLEM	O
iv	JJ	I-PROBLEM	O
endometrial	JJ	I-PROBLEM	O
and	CC	O	O
stage	JJ	B-PROBLEM	O
iii-c	JJ	I-PROBLEM	O
ovarian	JJ	I-PROBLEM	O
vs	NN	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
endometrial	NN	I-PROBLEM	I-PROBLEM
for	IN	I-PROBLEM	O
line	NN	I-PROBLEM	O
ii	NN	I-PROBLEM	O
,	,	O	O
cycle	NN	B-TREATMENT	B-TREATMENT
i	NN	I-TREATMENT	I-TREATMENT
chemotherapy	VBP	I-TREATMENT	I-TREATMENT
ifex	NN	B-TREATMENT	I-TREATMENT
,	,	O	O
mesna	NN	B-TREATMENT	O
and	CC	O	O
vp-16	NN	B-TREATMENT	O
.	.	O	O

the	DT	O	O
plan	NN	O	O
was	VBD	O	O
for	IN	O	O
urinalysis	JJ	B-TEST	B-TEST
q	NN	O	I-TEST
d	NN	O	I-TEST
.	.	O	O

with	IN	O	O
the	DT	O	O
history	NN	O	O
of	IN	O	O
dvt	NN	B-PROBLEM	O
,	,	O	O
we	PRP	O	O
plan	VBP	O	O
coumadin	JJ	B-TREATMENT	B-TREATMENT
and	CC	O	O
check	VB	O	O
her	PRP$	B-TEST	B-TEST
coags	NNS	I-TEST	I-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
tachycardiac	VBN	B-PROBLEM	O
on	IN	O	O
admission	NN	O	O
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
she	PRP	O	O
was	VBD	O	O
dehydrated	VBN	B-PROBLEM	B-PROBLEM
and	CC	O	O
/	CD	O	O
or	CC	O	O
anxious	JJ	B-PROBLEM	B-PROBLEM
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
her	PRP$	B-TEST	B-TEST
initial	JJ	I-TEST	I-TEST
evaluation	NN	I-TEST	I-TEST
.	.	O	O

ekg	NN	B-TEST	O
showed	VBD	O	O
sinus	JJ	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
incomplete	JJ	B-PROBLEM	B-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
bundle	NN	I-PROBLEM	I-PROBLEM
branch	NN	I-PROBLEM	I-PROBLEM
block	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

when	WRB	O	O
compared	VBN	O	O
with	IN	O	O
ecg	NN	B-TEST	O
of	IN	O	O
11-06-90	JJ	O	O
,	,	O	O
there	EX	O	O
was	VBD	O	O
borderline	NN	O	B-TEST
criteria	NNS	O	I-TEST
for	IN	O	O
anterior	JJ	B-PROBLEM	O
mi	NNS	I-PROBLEM	O
although	IN	O	O
the	DT	O	O
patient	NN	O	O
denied	VBD	O	O
any	DT	B-PROBLEM	B-PROBLEM
chest	JJS	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
any	DT	O	O
point	NN	O	O
.	.	O	O

the	DT	O	O
patient	JJ	O	O
underwent	JJ	O	O
chemotherapy	NN	B-TREATMENT	B-TREATMENT
on	IN	O	O
the	DT	O	O
following	JJ	O	O
doses	NNS	O	O
:	:	O	O

ifex	NN	B-TREATMENT	O
1.2	CD	O	O
grams	NNS	O	O
per	IN	O	O
meter	NN	O	O
squared	VBD	O	O
x	JJ	O	O
3	CD	O	O
days	NNS	O	O
,	,	O	O
mesna	VBP	B-TREATMENT	O
1.2	CD	O	O
grams	NNS	O	O
per	IN	O	O
meter	NN	O	O
squared	VBD	O	O
x	JJ	O	O
3	CD	O	O
days	NNS	O	O
continuous	JJ	B-TREATMENT	B-TREATMENT
iv	JJ	I-TREATMENT	I-TREATMENT
infusion	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
vp-16	JJ	B-TREATMENT	O
mixed	JJ	O	O
with	IN	O	O
250	CD	O	O
cc	NNS	O	O
iv	JJ	B-TREATMENT	O
fluid	NN	I-TREATMENT	O
given	VBN	O	O
over	IN	O	O
1	CD	O	O
hour	NN	O	O
each	DT	O	O
day	NN	O	O
for	IN	O	O
3	CD	O	O
days	NNS	O	O
.	.	O	O

she	PRP	O	O
also	RB	O	O
had	VBD	O	O
mesna	VBN	B-TREATMENT	O
dose	NN	I-TREATMENT	O
of	IN	O	O
.6	JJ	O	O
grams	NNS	O	O
per	IN	O	O
meter	NN	O	O
squared	VBN	O	O
after	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
ifex	JJ	I-TREATMENT	I-TREATMENT
/	JJ	O	I-TREATMENT
mesna	NN	B-TREATMENT	I-TREATMENT
were	VBD	O	O
completed	VBN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
urinalysis	NN	I-TEST	I-TEST
on	IN	O	O
admission	NN	O	O
was	VBD	O	O
significant	JJ	O	O
for	IN	O	O
red	JJ	B-PROBLEM	B-TEST
blood	NN	I-PROBLEM	I-TEST
cells	NNS	I-PROBLEM	I-TEST
which	WDT	O	O
were	VBD	O	O
tntc	NNS	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
uric	JJ	B-TEST	B-PROBLEM
acid	NN	I-TEST	I-PROBLEM
.	.	O	O

because	IN	O	O
it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
bleeding	VBG	O	B-PROBLEM
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
contaminated	VBN	O	O
,	,	O	O
she	PRP	O	O
received	VBD	O	O
her	PRP	O	B-TREATMENT
ifex	JJ	B-TREATMENT	I-TREATMENT
/	JJ	O	I-TREATMENT
mesna	NN	B-TREATMENT	I-TREATMENT
.	.	O	O

a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
straight	JJ	I-TEST	I-TEST
cath	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
for	IN	O	O
rbc	NN	B-PROBLEM	B-TEST
's	POS	I-PROBLEM	I-TEST
.	.	O	O

after	IN	O	O
1	CD	O	O
day	NN	O	O
of	IN	O	O
chemotherapy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
8-10	JJ	B-PROBLEM	B-PROBLEM
rbc	NN	I-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
urine	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
by	IN	O	O
the	DT	O	O
second	JJ	O	O
day	NN	O	O
of	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
ifex	JJ	I-TREATMENT	I-TREATMENT
infusion	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
she	PRP	O	O
had	VBD	O	O
50-80	JJ	B-PROBLEM	B-PROBLEM
rbc	NN	I-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
urine	NN	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
a	DT	B-PROBLEM	O
few	JJ	I-PROBLEM	O
transitional	JJ	I-PROBLEM	O
epithelial	JJ	I-PROBLEM	O
cells	NNS	I-PROBLEM	O
.	.	O	O

because	IN	O	O
of	IN	O	O
this	DT	O	O
finding	NN	O	O
,	,	O	O
her	PRP$	B-TREATMENT	O
ifex	NN	I-TREATMENT	O
was	VBD	O	O
stopped	VBN	O	O
before	IN	O	O
completion	NN	O	O
of	IN	O	O
her	PRP$	O	O
second	JJ	O	O
day	NN	O	O
of	IN	O	O
infusion	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

her	PRP$	B-TREATMENT	O
mesna	NN	I-TREATMENT	O
alone	NN	O	O
was	VBD	O	O
continued	VBN	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
for	IN	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
infusion	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
did	VBD	O	O
receive	VB	O	O
her	PRP$	B-TREATMENT	O
vp-16	NN	I-TREATMENT	O
without	IN	O	O
complication	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

other	JJ	O	B-PROBLEM
significant	JJ	O	I-PROBLEM
issues	NNS	O	I-PROBLEM
were	VBD	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
hematocrit	NN	I-TEST	I-TEST
on	IN	O	O
admission	NN	O	O
at	IN	O	O
31.1	CD	O	O
which	WDT	O	O
dwindled	VBD	O	O
down	RB	O	O
to	TO	O	O
26.2	CD	O	O
by	IN	O	O
9-10	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
counselled	VBN	O	O
and	CC	O	O
received	VBN	O	O
2	CD	O	O
units	NNS	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
rbc	NN	I-TREATMENT	I-TREATMENT
's	POS	I-TREATMENT	I-TREATMENT
at	IN	O	O
that	DT	O	O
time	NN	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
hematocrit	NN	I-TEST	I-TEST
bumped	VBD	O	O
only	RB	O	O
to	TO	O	O
28.1	CD	O	O
and	CC	O	O
a	DT	O	O
repeat	NN	O	O
later	RB	O	O
on	IN	O	O
9-11	CD	O	O
,	,	O	O
showed	VBD	O	O
hematocrit	NN	B-TEST	B-TEST
of	IN	O	O
27.6	CD	O	O
.	.	O	O

at	IN	O	O
this	DT	O	O
time	NN	O	O
,	,	O	O
an	DT	O	O
additional	JJ	O	O
2	CD	O	O
units	NNS	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	O
rbc	NN	I-TREATMENT	B-TEST
's	POS	I-TREATMENT	I-TEST
were	VBD	O	O
transfused	VBN	O	O
.	.	O	O

the	DT	O	O
third	JJ	O	O
issue	NN	O	O
was	VBD	O	O
that	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
anticoagulation	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
grossly	RB	O	O
out	IN	O	O
of	IN	O	O
control	NN	O	B-TREATMENT
on	IN	O	O
admission	NN	O	O
with	IN	O	O
pt	NN	B-TEST	O
of	IN	O	O
25.6	CD	O	O
and	CC	O	O
ptt	NN	B-TEST	O
of	IN	O	O
42.2	CD	O	O
.	.	O	O

her	PRP$	O	O
repeat	NN	O	O
on	IN	O	O
9-8	CD	O	O
,	,	O	O
was	VBD	O	O
36.0	CD	O	O
/	JJ	O	O
68.2	CD	O	O
and	CC	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
held	VBN	O	O
.	.	O	O

she	PRP	O	O
received	VBD	O	O
no	DT	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
during	IN	O	O
her	PRP$	O	O
admission	NN	O	O
and	CC	O	O
by	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
,	,	O	O
her	PRP$	B-TEST	O
pt	NN	I-TEST	O
was	VBD	O	O
down	RB	O	O
to	TO	O	O
16.2	CD	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
restarted	VBN	O	O
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
2.5	CD	O	O
mg	NN	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
hematocrit	NN	I-TEST	I-TEST
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
was	VBD	O	O
35.6	CD	O	O
showing	VBG	O	O
significant	JJ	O	B-PROBLEM
bump	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
her	PRP$	B-TEST	I-PROBLEM
count	NN	I-TEST	I-PROBLEM
after	IN	O	O
her	PRP$	O	O
second	JJ	O	O
two	CD	O	O
units	NNS	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
rbc	NN	I-TREATMENT	I-TREATMENT
's	POS	I-TREATMENT	I-TREATMENT
.	.	O	O

her	PRP$	B-TEST	O
pt	NN	I-TEST	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
was	VBD	O	O
13.2	CD	O	O
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
2.5	CD	O	O
mg	NN	O	O
po	NN	O	O
q	NN	O	O
d	NN	O	O
as	IN	O	O
mentioned	VBN	O	O
.	.	O	O

on	IN	O	O
9-28-92	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
will	MD	O	O
return	VB	O	O
for	IN	O	O
chemotherapy	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
she	PRP	O	O
will	MD	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
her	PRP$	O	O
primary	JJ	O	O
doctor	NN	O	O
,	,	O	O
dr.	NN	O	O
jescspald	NN	O	O
,	,	O	O
for	IN	O	O
repeat	NN	B-TEST	O
pt	NN	I-TEST	O
and	CC	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
dosing	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
monday	NN	O	O
,	,	O	O
9-14-02	CD	O	O
.	.	O	O

76-year-old	JJ	O	O
male	NN	O	O
with	IN	O	O
right	JJ	B-PROBLEM	B-PROBLEM
hip	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
x	NNP	O	O
five	CD	O	O
years	NNS	O	O
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
often	RB	O	O
severely	RB	O	O
and	CC	O	O
increasing	VBG	O	O
at	IN	O	O
night	NN	O	O
especially	RB	O	O
when	WRB	O	O
he	PRP	O	O
is	VBZ	O	O
lying	VBG	O	B-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
right	JJ	O	I-PROBLEM
side	NN	O	I-PROBLEM
.	.	O	O

tonsillectomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

history	NN	O	O
of	IN	O	O
high	JJ	B-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
pressure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
enlarged	VBD	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

zantac	NN	B-TREATMENT	O
.	.	O	O

furosemide	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

aerobid	NN	B-TREATMENT	O
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM

the	DT	O	O
abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
and	CC	O	O
non-tender	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

left	VBN	O	O
hip	NN	O	O
shows	VBZ	O	O
flexion	NN	B-TEST	B-PROBLEM
and	CC	O	O
extension	NN	B-TEST	B-TREATMENT
40	CD	O	O
.	.	O	O

right	JJ	B-TEST	B-PROBLEM
hip	NN	I-TEST	I-PROBLEM
flexion	NN	I-TEST	I-PROBLEM
and	CC	O	O
extension	NN	B-TEST	B-TREATMENT
40	CD	O	O
and	CC	O	O
0	CD	O	O
.	.	O	O

right	JJ	B-PROBLEM	B-PROBLEM
hip	NN	I-PROBLEM	I-PROBLEM
pain	VBP	I-PROBLEM	I-PROBLEM
degenerative	JJ	B-PROBLEM	I-PROBLEM
joint	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
for	IN	O	O
right	JJ	B-TREATMENT	B-TREATMENT
total	JJ	I-TREATMENT	I-TREATMENT
hip	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
hospital	NN	O	O
as	IN	O	O
a	DT	O	O
postoperative	JJ	O	O
admit	NN	O	O
on	IN	O	O
december	NN	O	O
7	CD	O	O
for	IN	O	O
total	JJ	B-TREATMENT	B-TREATMENT
hip	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

for	IN	O	O
further	JJ	O	O
details	NNS	O	O
of	IN	O	O
this	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
see	VBP	O	O
operative	JJ	O	O
note	NN	O	O
.	.	O	O

however	RB	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	O	O
report	NN	O	O
of	IN	O	O
emesis	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
coffee	NN	I-PROBLEM	I-PROBLEM
grounds	NNS	I-PROBLEM	I-PROBLEM
on	IN	O	O
postoperative	JJ	O	O
night	NN	O	O
#1	NN	O	O
.	.	O	O

this	DT	O	O
with	IN	O	O
no	DT	O	O
electrocardiogram	NN	B-PROBLEM	B-TEST
changes	NNS	I-PROBLEM	O
.	.	O	O

due	JJ	O	O
to	TO	O	O
this	DT	O	O
gi	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
and	CC	O	O
felt	VBD	O	O
that	IN	O	O
he	PRP	O	O
would	MD	O	O
be	VB	O	O
a	DT	O	O
candidate	NN	O	O
for	IN	O	O
esophagogastroduodenoscopy	NN	B-TEST	B-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
placed	VBN	O	O
nothing	NN	B-TREATMENT	O
by	IN	I-TREATMENT	O
mouth	NN	I-TREATMENT	O
and	CC	O	O
the	DT	B-TEST	B-TEST
esophagogastroduodenoscopy	NN	I-TEST	I-TEST
was	VBD	O	O
done	VBN	O	O
by	IN	O	O
the	DT	O	O
gi	NN	O	O
service	NN	O	O
.	.	O	O

findings	NNS	O	O
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
mallory	NN	I-PROBLEM	I-PROBLEM
weiss	JJ	I-PROBLEM	I-PROBLEM
tear	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
nonspecific	JJ	B-PROBLEM	B-PROBLEM
duodenitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
zantac	NN	B-TREATMENT	B-TREATMENT
150	CD	O	O
mg.	NN	O	O
po	NN	O	O
b.i.d.	NN	O	O
and	CC	O	O
h	NN	B-TEST	B-TEST
pylori	NN	I-TEST	I-TEST
serology	NN	I-TEST	I-TEST
was	VBD	O	O
sent	VBN	O	O
.	.	O	O

post	NN	O	O
egd	VB	B-TEST	O
his	PRP$	O	O
diet	NN	O	O
was	VBD	O	O
advanced	JJ	O	O
slowly	RB	O	O
and	CC	O	O
he	PRP	O	O
did	VBD	O	O
exceptionally	RB	O	O
well	RB	O	O
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
he	PRP	O	O
was	VBD	O	O
tolerating	VBG	O	O
a	DT	O	O
full	JJ	O	O
diet	NN	O	O
,	,	O	O
out	IN	O	O
of	IN	O	O
bed	NN	O	O
with	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
tolerated	VBN	O	O
on	IN	O	O
po.	NN	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
intact	JJ	O	O
with	IN	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
infection	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
calf	NN	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
lower	JJR	B-TEST	B-TEST
extremity	NN	I-TEST	I-TEST
arterial	JJ	I-TEST	I-TEST
non-invasive	JJ	I-TEST	I-TEST
studies	NNS	I-TEST	I-TEST
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
physical	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
unremarkable	JJ	O	O
and	CC	O	O
he	PRP	O	O
had	VBD	O	O
no	DT	O	O
recurrent	NN	O	B-PROBLEM
symptoms	NNS	O	I-PROBLEM
of	IN	O	O
coffee	NN	B-PROBLEM	B-PROBLEM
ground	NN	I-PROBLEM	I-PROBLEM
emesis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
79	CD	O	O
-	:	O	O
year-old	JJ	O	O
female	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
cataracts	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
glaucoma	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
who	WP	O	O
fell	VBD	O	O
and	CC	O	O
tripped	VBD	O	O
over	IN	O	O
a	DT	O	O
wheelchair	NN	O	O
of	IN	O	O
a	DT	O	O
friend	NN	O	O
with	IN	O	O
no	DT	O	O
loss	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
consciousness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
dizziness	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
no	DT	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
.	.	O	O

heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
was	VBD	O	O
77	CD	O	O
.	.	O	O

blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
132/48	CD	O	O
.	.	O	O

respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
was	VBD	O	O
17	CD	O	O
.	.	O	O

sats	NNS	B-TEST	B-TEST
96%	CD	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
was	VBD	O	O
97.6	CD	O	O
.	.	O	O

chest	NN	O	O
was	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	O	O
.	.	O	O

no	DT	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
clubbing	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

head	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
front	JJ	I-PROBLEM	I-PROBLEM
focal	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
occipital	JJ	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
adjacent	NN	O	I-PROBLEM
to	TO	O	O
the	DT	O	O
falx	NN	O	O
with	IN	O	O
intraparenchymal	JJ	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
epidural	JJ	B-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	O
subdural	JJ	I-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
near	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
falx	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
no	DT	O	O
shift	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

ct	NN	B-TEST	B-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
c	JJ	I-TEST	I-TEST
spine	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
and	CC	O	O
her	PRP$	O	B-TEST
cervical	JJ	O	I-TEST
spine	NN	O	I-TEST
was	VBD	O	O
cleared	VBN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
icu	NN	O	O
for	IN	O	O
close	JJ	B-TEST	B-PROBLEM
neurosurgical	JJ	I-TEST	I-PROBLEM
and	CC	I-TEST	I-PROBLEM
neurological	JJ	I-TEST	I-PROBLEM
observation	NN	I-TEST	I-PROBLEM
.	.	O	O

repeat	NN	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
showed	VBD	O	O
stable	JJ	B-PROBLEM	B-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
will	MD	O	O
be	VB	O	O
discharged	VBN	O	O
to	TO	O	O
home	NN	O	O
with	IN	O	O
followup	JJ	O	O
with	IN	O	O
dr.	JJ	O	O
wilson	NN	O	O
in	IN	O	O
two	CD	O	O
weeks	NNS	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
.	.	O	O

1.	CD	O	O
levofloxacin	JJ	B-TREATMENT	B-TREATMENT
250	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.24h.	NN	O	O
x3	NNP	O	O
days	NNS	O	O
.	.	O	O

2.	CD	O	O
dilantin	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O

3.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

4.	CD	O	O
timoptic	JJ	B-TREATMENT	B-TREATMENT
0.25	CD	O	O
one	CD	O	O
drop	NN	O	O
o.u.	NN	O	O
b.i.d.	NN	O	O

5.	CD	O	O
lantoprost	JJS	B-TREATMENT	O
0.005	CD	O	O
ophthalmic	JJ	O	O
solution	NN	O	O
one	CD	O	O
drop	NN	O	O
o.u.	VBD	O	O
q.h.s.	NN	O	O

6.	CD	O	O
zantac	NN	B-TREATMENT	B-TREATMENT
150	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

7.	CD	O	O
insulin-sliding	JJ	B-TREATMENT	O
scale	NN	I-TREATMENT	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
40	CD	O	O
units	NNS	O	O
of	IN	O	O
humalog	NN	B-TREATMENT	O
in	IN	O	O
the	DT	O	O
a.m.	NN	O	O
and	CC	O	O
20	CD	O	O
at	IN	O	O
night	NN	O	O
.	.	O	O

she	PRP	O	O
will	MD	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
dr.	JJ	O	O
perez	NNS	O	O
in	IN	O	O
two	CD	O	O
weeks	NNS	O	O
with	IN	O	O
repeat	NN	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
.	.	O	O

1.	CD	O	O
prostate	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
alzheimer	NN	B-PROBLEM	B-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
an	DT	O	O
87-year-old	JJ	O	O
male	NN	O	O
with	IN	O	O
stage	NN	B-PROBLEM	B-TEST
d	NN	I-PROBLEM	I-TEST
prostate	NN	I-PROBLEM	I-TEST
was	VBD	O	O
cancer	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
fluid	JJ	B-TREATMENT	B-TEST
hydration	NN	I-TREATMENT	I-TEST
on	IN	O	O
the	DT	O	O
10th	CD	O	O
of	IN	O	O
march	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
initially	RB	O	O
diagnosed	VBN	O	O
with	IN	O	O
prostate	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
august	NN	O	O
of	IN	O	O
1989	CD	O	O
.	.	O	O

he	PRP	O	O
presented	VBD	O	O
with	IN	O	O
gross	JJ	B-PROBLEM	B-PROBLEM
hematuria	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
that	DT	O	O
time	NN	O	O
.	.	O	O

subsequent	JJ	B-TEST	B-TEST
prostatic	JJ	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	B-PROBLEM	B-TEST
gleason	NN	I-PROBLEM	I-TEST
's	POS	I-PROBLEM	I-TEST
iv	NN	I-PROBLEM	I-TEST
,	,	I-PROBLEM	O
plus	CC	I-PROBLEM	O
v	JJ	I-PROBLEM	B-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
the	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
showed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
irregular	JJ	I-PROBLEM	I-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
prostate	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
tumor	NN	B-PROBLEM	B-PROBLEM
invasion	NN	I-PROBLEM	I-PROBLEM
into	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
bladder	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
evidence	NN	O	O
of	IN	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
retroperitoneal	NN	I-PROBLEM	I-PROBLEM
lymph	NN	I-PROBLEM	I-PROBLEM
node	JJ	I-PROBLEM	I-PROBLEM
spread	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
also	RB	O	O
evidence	NN	O	O
of	IN	O	O
bone	NN	B-PROBLEM	B-PROBLEM
metastasis	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
that	DT	O	O
time	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
in	IN	O	O
october	NN	O	O
of	IN	O	O
1991	CD	O	O
for	IN	O	O
urinary	JJ	B-PROBLEM	B-PROBLEM
retention	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
fluid	JJ	B-TREATMENT	B-TREATMENT
rehydration	NN	I-TREATMENT	I-TREATMENT
and	CC	O	I-TREATMENT
foley	JJ	B-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

over	IN	O	O
the	DT	O	O
past	JJ	O	O
one	CD	O	O
month	NN	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
wife	NN	O	O
has	VBZ	O	O
noticed	VBN	O	O
a	DT	B-PROBLEM	O
marked	JJ	I-PROBLEM	O
decrease	NN	I-PROBLEM	O
in	IN	I-PROBLEM	O
p.o.	JJ	I-PROBLEM	O
intake	NN	I-PROBLEM	O
and	CC	O	O
also	RB	O	O
noted	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
weight	JJ	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
approximately	RB	O	O
ten	JJ	O	O
pounds	NNS	O	O
in	IN	O	O
the	DT	O	O
preceding	VBG	O	O
two	CD	O	O
weeks	NNS	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
been	VBN	O	O
lethargic	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
bed	VBD	B-PROBLEM	O
ridden	NN	I-PROBLEM	O
for	IN	O	O
the	DT	O	O
past	JJ	O	O
two	CD	O	O
weeks	NNS	O	O
,	,	O	O
although	IN	O	O
there	EX	O	O
was	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
over	IN	O	O
this	DT	O	O
time	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
now	RB	O	O
admitted	VBN	O	O
for	IN	O	O
fluid	JJ	B-TREATMENT	B-TREATMENT
rehydration	NN	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
observation	NN	B-TEST	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
a	DT	B-TEST	B-TEST
recumbent	NN	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
128/16	CD	O	O
,	,	O	O
pulse	NN	B-TEST	B-TEST
of	IN	O	O
76	CD	O	O
,	,	O	O
and	CC	O	O
standing	VBG	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
110/60	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
pulse	NN	I-TEST	I-TEST
of	IN	O	O
88	CD	O	O
.	.	O	O

respirations	NNS	B-TEST	B-TEST
are	VBP	O	O
unlabored	VBN	B-PROBLEM	O
at	IN	O	O
16	CD	O	O
.	.	O	O

noted	VBN	O	O
for	IN	O	O
nonicteric	JJ	B-PROBLEM	B-PROBLEM
sclerae	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
lungs	NNS	O	O
that	WDT	O	O
are	VBP	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	NN	B-TEST	B-TEST
.	.	O	O

no	DT	O	O
cva	NN	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
appreciated	VBN	O	O
in	IN	O	O
the	DT	O	O
heart	NN	O	O
and	CC	O	O
the	DT	O	O
heart	NN	O	O
appears	VBZ	O	O
to	TO	O	O
be	VB	O	O
in	IN	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
.	.	O	O

without	IN	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

soft	JJ	O	O
and	CC	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

decreased	VBN	B-PROBLEM	B-PROBLEM
turgor	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
dry	JJ	B-PROBLEM	B-PROBLEM
mucous	JJ	I-PROBLEM	I-PROBLEM
membranes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

white	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
7.75	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
of	IN	O	O
46.2%	CD	O	O
,	,	O	O
sodium	NN	B-TEST	B-TEST
144	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
3.9	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
25	CD	O	O
,	,	O	O
and	CC	O	O
bun	NN	B-TEST	B-TEST
was	VBD	O	O
1.4	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
sugar	NN	I-TEST	I-TEST
of	IN	O	O
88	CD	O	O
.	.	O	O

urinalysis	NN	B-TEST	B-TEST
demonstrated	VBD	O	O
30-50	JJ	B-PROBLEM	B-PROBLEM
white	JJ	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
cells	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
red	JJ	B-PROBLEM	B-TEST
blood	NN	I-PROBLEM	I-TEST
cells	NNS	I-PROBLEM	I-TEST
too	RB	O	O
numerous	JJ	O	O
to	TO	O	O
count	VB	O	O
and	CC	O	O
2+	CD	B-PROBLEM	B-PROBLEM
bacteria	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
with	IN	O	O
a	DT	O	O
diagnosis	NN	O	O
of	IN	O	O
prostate	NN	B-PROBLEM	B-PROBLEM
ca	MD	I-PROBLEM	I-PROBLEM
,	,	O	O
for	IN	O	O
fluid	JJ	B-TREATMENT	B-TREATMENT
rehydration	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

initially	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
begun	VBN	O	O
on	IN	O	O
bactrim	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
presumptive	JJ	O	B-PROBLEM
urinary	JJ	B-PROBLEM	I-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
the	DT	O	O
initial	JJ	O	O
course	NN	O	O
of	IN	O	O
his	PRP$	O	O
hospitalization	NN	O	O
,	,	O	O
he	PRP	O	O
took	VBD	O	O
p.o.'	NN	O	O
s	NN	O	O
poorly	RB	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
however	RB	O	O
,	,	O	O
and	CC	O	O
his	PRP$	B-TEST	B-TEST
electrolytes	NNS	I-TEST	I-TEST
were	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

by	IN	O	O
hospital	JJ	O	O
day	NN	O	O
number	NN	O	O
six	CD	O	O
,	,	O	O
however	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
became	VBD	O	O
febrile	JJ	B-PROBLEM	B-PROBLEM
to	TO	O	O
100.7	CD	O	O
and	CC	O	O
repeat	NN	B-TEST	B-TEST
urinalysis	NN	I-TEST	I-TEST
showed	VBD	O	O
20-30	JJ	B-PROBLEM	B-PROBLEM
white	JJ	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
cells	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
1+	CD	B-PROBLEM	B-PROBLEM
bacteria	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

antibiotics	NNS	B-TREATMENT	B-TREATMENT
were	VBD	O	O
switched	VBN	O	O
to	TO	O	O
iv	VB	B-TREATMENT	O
ciprofloxacin	NN	I-TREATMENT	B-TREATMENT
and	CC	O	O
the	DT	O	O
patient	NN	O	O
defervesced	VBD	O	O
;	:	O	O
however	RB	O	O
,	,	O	O
by	IN	O	O
hospital	JJ	O	O
day	NN	O	O
number	NN	O	O
seven	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
passing	VBG	O	B-PROBLEM
very	RB	O	I-PROBLEM
little	JJ	O	I-PROBLEM
urine	NN	O	I-PROBLEM
through	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
condom	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
electrolyte	NN	B-TEST	B-TEST
screen	NN	I-TEST	I-TEST
and	CC	O	I-TEST
electrolytes	NNS	B-TEST	I-TEST
from	IN	O	O
hospital	JJ	O	O
day	NN	O	O
number	NN	O	O
seven	CD	O	O
showed	VBD	O	O
a	DT	B-TEST	O
bun	NN	I-TEST	O
of	IN	O	O
27	CD	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
of	IN	O	O
2.7	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
vigorously	RB	B-TREATMENT	O
fluid	JJ	I-TREATMENT	O
rehydrated	VBD	I-TREATMENT	O
;	:	O	O
however	RB	O	O
,	,	O	O
by	IN	O	O
hospital	JJ	O	O
day	NN	O	O
number	NN	O	O
nine	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
was	VBD	O	O
22	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
was	VBD	O	O
3.5	CD	O	O
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
foley	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
with	IN	O	O
the	DT	O	O
recovery	NN	O	O
of	IN	O	O
approximately	RB	O	O
800	CD	O	O
cc	NN	O	O
of	IN	O	O
urine	NN	O	O
.	.	O	O

blood	NN	B-TEST	B-TEST
electrolytes	NNS	I-TEST	I-TEST
were	VBD	O	O
remarkable	JJ	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
of	IN	O	O
148	CD	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
potassium	NN	I-TEST	I-TEST
of	IN	O	O
5.1	CD	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TEST
patient	NN	I-TREATMENT	I-TEST
's	POS	I-TREATMENT	I-TEST
fluid	JJ	I-TREATMENT	I-TEST
hydration	NN	I-TREATMENT	I-TEST
from	IN	O	O
d5	JJ	B-TREATMENT	B-TREATMENT
one-half	JJ	I-TREATMENT	I-TREATMENT
normal	JJ	I-TREATMENT	I-TREATMENT
saline	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
20	CD	O	O
meq	NN	O	O
of	IN	O	O
k	NN	B-TREATMENT	O
to	TO	O	O
d5w	VB	B-TREATMENT	O
and	CC	O	O
acuchecks	VB	B-TEST	O
from	IN	O	O
this	DT	O	O
time	NN	O	O
showed	VBD	O	O
blood	NN	B-TEST	B-TEST
sugars	NNS	I-TEST	I-TEST
routinely	RB	O	O
between	IN	O	O
20	CD	O	O
and	CC	O	O
50	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
given	VBN	O	O
one	CD	O	O
amp	NN	O	O
of	IN	O	O
d50	NN	B-TREATMENT	O
for	IN	O	O
each	DT	B-TEST	O
acucheck	NN	I-TEST	O
for	IN	O	O
blood	NN	B-TEST	B-TEST
sugars	NNS	I-TEST	I-TEST
of	IN	O	O
less	JJR	O	O
than	IN	O	O
40	CD	O	O
.	.	O	O

gradually	RB	O	O
over	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
the	DT	O	O
following	JJ	O	O
days	NNS	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
electrolytes	NNS	I-TEST	I-TEST
again	RB	O	O
normalized	VBD	O	O
;	:	O	O
however	RB	O	O
,	,	O	O
as	IN	O	O
the	DT	O	O
patient	NN	O	O
continues	VBZ	O	O
to	TO	O	O
take	VB	O	O
p.o.'	NN	O	O
s	NNS	O	O
poorly	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
on	IN	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
hydration	NN	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
number	NN	O	O
fourteen	NN	O	O
,	,	O	O
electrolytes	NNS	B-TEST	B-TEST
were	VBD	O	O
sodium	NN	B-TEST	B-TEST
of	IN	O	O
140	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
3.9	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
of	IN	O	O
11	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
1.3	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
sugar	NN	I-TEST	I-TEST
of	IN	O	O
125	CD	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
magnesium	NN	I-TEST	I-TEST
of	IN	O	O
1.9	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
transferred	VBN	O	O
to	TO	O	O
el	VB	O	O
hospital	NN	O	O
,	,	O	O
still	RB	O	O
receiving	VBG	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
hydration	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
a	DT	O	O
rate	NN	O	O
currently	RB	O	O
of	IN	O	O
50	CD	O	O
cc	NNS	O	O
an	DT	O	O
hour	NN	O	O
of	IN	O	O
d5	JJ	B-TREATMENT	O
one-half	JJ	I-TREATMENT	O
normal	JJ	I-TREATMENT	O
with	IN	O	O
20	CD	O	O
meq	NN	O	O
of	IN	O	O
k	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
foley	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
in	IN	O	O
place	NN	O	O
and	CC	O	O
the	DT	B-TREATMENT	B-TREATMENT
bacitracin	JJ	I-TREATMENT	I-TREATMENT
ointment	NN	I-TREATMENT	I-TREATMENT
should	MD	O	O
be	VB	O	O
applied	VBN	O	O
to	TO	O	O
the	DT	O	O
urethral	JJ	O	O
meatus	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

periodic	JJ	B-TEST	B-TEST
urinalysis	NN	I-TEST	I-TEST
should	MD	O	O
be	VB	O	O
conducted	VBN	O	O
to	TO	O	O
monitor	VB	O	O
the	DT	O	O
development	NN	O	O
of	IN	O	O
possible	JJ	O	O
urinary	JJ	B-PROBLEM	B-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

it	PRP	O	O
should	MD	O	O
be	VB	O	O
noted	VBN	O	O
that	DT	O	O
while	NN	O	O
in	IN	O	O
the	DT	O	O
hospital	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
received	VBD	O	O
an	DT	B-TEST	B-TEST
abdominal	JJ	I-TEST	I-TEST
ultrasound	NN	I-TEST	I-TEST
which	WDT	O	O
is	VBZ	O	O
significant	JJ	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
grossly	RB	I-PROBLEM	I-PROBLEM
enlarged	VBN	I-PROBLEM	I-PROBLEM
liver	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
foci	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
discharged	VBN	O	O
on	IN	O	O
mylanta	NN	B-TREATMENT	B-TREATMENT
30	CD	O	O
cc	NN	O	O
with	IN	O	O
meals	NNS	O	O
,	,	O	O
carafate	VBP	B-TREATMENT	O
1	CD	O	O
gm	NN	O	O
q.	NN	O	O
6	CD	O	O
,	,	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
5000	CD	O	O
units	NNS	O	O
subcutaneous	JJ	O	O
b.i.d.	NN	O	O
until	IN	O	O
the	DT	O	O
patient	NN	O	O
regains	VBZ	O	O
full	JJ	O	O
activity	NN	O	O
and	CC	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
hydration	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
foley	NN	I-TREATMENT	I-TREATMENT
should	MD	O	O
be	VB	O	O
in	IN	O	O
place	NN	O	O
until	IN	O	O
a	DT	O	O
follow-up	JJ	O	O
appointment	NN	O	O
with	IN	O	O
dr.	JJ	O	O
aarhalt	NN	O	O
can	MD	O	O
be	VB	O	O
scheduled	VBN	O	O
in	IN	O	O
approximately	RB	O	O
one	CD	O	O
to	TO	O	O
two	CD	O	O
weeks	NNS	O	O
at	IN	O	O
which	WDT	O	O
time	NN	O	O
a	DT	O	O
decision	NN	O	O
regarding	VBG	O	O
the	DT	O	O
status	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
urinary	JJ	I-PROBLEM	I-PROBLEM
obstruction	NN	I-PROBLEM	I-PROBLEM
will	MD	O	O
be	VB	O	O
addressed	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
discharged	VBN	O	O
to	TO	O	O
milton/haverhill	VB	O	O
per	IN	O	O
family	NN	O	O
request	NN	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
comfort	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
hospice	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

tylenol	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
acetaminophen	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
650	CD	O	O
mg	NN	O	O
po	NN	O	O
q4h	NN	O	O
starting	VBG	O	O
today	NN	O	O
(	(	O	O
11/02	CD	O	O
)	)	O	O
prn	NN	O	O
headache	NN	B-PROBLEM	B-PROBLEM

do	VB	O	O
not	RB	O	O
take	VB	O	O
more	JJR	O	O
than	IN	O	O
4gm	CD	O	O
/	JJ	O	O
day	NN	O	O
acetylsalicylic	JJ	B-TREATMENT	O
acid	RB	I-TREATMENT	O
325	CD	O	O
mg	NNS	O	O
po	JJ	O	O
daily	JJ	O	O
phoslo	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
calcium	JJ	I-TREATMENT	I-TREATMENT
acetate	NN	I-TREATMENT	I-TREATMENT
(	(	O	I-TREATMENT
1	CD	O	I-TREATMENT
gelcap	NN	O	I-TREATMENT
=	VBD	O	O
667	CD	O	O
mg	NN	O	O
)	)	O	O
)	)	O	O
1,334	CD	O	O
mg	NN	O	O
po	NN	O	O
tid	NN	O	O

please	VB	O	O
give	VB	O	O
with	IN	O	O
meals	NNS	O	B-TREATMENT
flovent	JJ	B-TREATMENT	I-TREATMENT
hfa	NN	I-TREATMENT	I-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
fluticasone	JJ	I-TREATMENT	I-TREATMENT
propionate	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
44	CD	O	O
mcg	JJ	O	O
inh	NN	O	O
bid	NN	O	O
labetalol	VBZ	B-TREATMENT	B-TREATMENT
hcl	$	I-TREATMENT	I-TREATMENT
300	CD	O	O

sbp	NN	B-TEST	O
&lt;	VBZ	O	O
100	CD	O	O
or	CC	O	O
hr	VB	B-TEST	O
&lt;	CD	O	O
55	CD	O	O

cozaar	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
losartan	JJ	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
50	CD	O	O

sbp	NN	B-TEST	O
&lt;	VBZ	O	O
100	CD	O	O

nephrocaps	NNS	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
nephro-vit	JJ	I-TREATMENT	I-TREATMENT
rx	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
1	CD	O	O
tab	JJ	O	O
po	NNS	O	O
daily	RB	O	O

potentially	RB	O	O
serious	JJ	B-PROBLEM	O
interaction	NN	I-PROBLEM	O
:	:	O	O

simvastatin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
niacin	NN	B-TREATMENT	B-TREATMENT
,	,	O	I-TREATMENT
vit.	JJ	B-TREATMENT	I-TREATMENT
b-3	NN	I-TREATMENT	I-TREATMENT

zocor	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
simvastatin	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
40	CD	O	O
mg	NN	O	O
po	NN	O	O
bedtime	NN	O	O

override	RB	O	O
added	VBD	O	O
on	IN	O	O
10/30/06	CD	O	O
by	IN	O	O
felsapprydefusc	NN	O	B-PROBLEM
,	,	O	O
eri	JJ	O	O
n.	NN	O	O
,	,	O	O
m.d.	NN	O	O
on	IN	O	O
order	NN	O	O
for	IN	O	O
nephrocaps	NNS	B-TREATMENT	O
po	NNS	I-TREATMENT	O
(	(	O	O
ref	JJ	O	O
#	#	O	O
581988585	CD	O	O
)	)	O	O

potentially	RB	O	O
serious	JJ	B-PROBLEM	O
interaction	NN	I-PROBLEM	O
:	:	O	O

simvastatin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
niacin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
vit	NN	B-TREATMENT	B-TREATMENT
.	.	I-TREATMENT	O

b-3	NN	B-TREATMENT	O

house	NN	O	O
/	VBD	O	O
2	CD	O	O
gm	NN	O	O
na	NNS	O	O
/	VBP	O	O
low	JJ	O	B-PROBLEM
saturated	VBD	O	I-PROBLEM
fat	JJ	O	I-PROBLEM
low	JJ	O	I-PROBLEM
cholesterol	NN	O	I-PROBLEM
/	VBZ	O	O
2	CD	O	O
gram	NN	O	O
k+	NN	O	O
,	,	O	O
renal	JJ	B-TREATMENT	O
diet	JJ	I-TREATMENT	O
&lt;	NN	O	O
i	NN	O	O
&gt;	VBP	O	O
&lt;	JJ	O	O
fdi	NN	O	O
&gt;	NN	O	O

hemodialysis	NN	B-TREATMENT	B-TREATMENT
mwf	NN	O	I-TREATMENT
,	,	O	O
dr.	JJ	O	O
gaetz	JJ	O	O
220-871-6906	JJ	O	O
1-2	JJ	O	O
weeks	NNS	O	O
,	,	O	O
dr.	RB	O	O
clow	JJ	O	O
836-771-4924	JJ	O	O
1	CD	O	O
week	NN	O	O
,	,	O	O
cardiology	NN	O	O
clinic	JJ	O	O
452-860-1428	JJ	O	O
,	,	O	O
please	VB	O	O
call	NN	O	O
to	TO	O	O
make	VB	O	O
an	DT	O	O
appointment	NN	O	O
in	IN	O	O
1-2	JJ	O	O
weeks	NNS	O	O
with	IN	O	O
a	DT	O	O
cardiology	NN	O	O
fellow	NN	O	O
,	,	O	O

nka	NN	B-PROBLEM	O

ihss	NN	B-PROBLEM	B-PROBLEM
af	NN	B-PROBLEM	I-PROBLEM
esrd	NN	B-PROBLEM	I-PROBLEM
on	IN	O	O
hd	NN	B-TREATMENT	O
,	,	O	O
iga	JJ	B-PROBLEM	B-PROBLEM
nephropathy	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
transplant	JJ	O	O
list	NN	O	O
,	,	O	O
copd	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
s	JJ	O	O
/	NNP	O	O
p	NN	O	O
pacemaker	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
afib	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
bph	NN	B-PROBLEM	B-TEST
s	NN	O	I-TEST
/	NNP	O	O
p	NN	O	O
turp	NN	B-TREATMENT	O
,	,	O	O
htn	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
gout	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
h	NN	O	O
/	NNP	O	O
o	RB	O	O
positive	JJ	B-PROBLEM	O
ppd	NN	I-PROBLEM	O
mr	NN	B-PROBLEM	O

hemodialysis	NN	B-TREATMENT	B-TREATMENT
s	NN	O	O
/	NNP	O	O
p	VBZ	O	O
abdominal	JJ	B-TEST	B-TREATMENT
fat	JJ	I-TEST	I-TREATMENT
pad	NN	I-TEST	I-TREATMENT
biopsy	NN	I-TEST	I-TREATMENT
11/2/06	CD	O	O

62	CD	O	O
yo	JJ	O	O
m	NN	O	O
w	NN	O	O
/	NNP	O	O
iga	NN	B-PROBLEM	B-PROBLEM
nephropathy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
developmental	JJ	B-PROBLEM	O
delay	NN	I-PROBLEM	O
,	,	O	O
began	VBD	O	O
hd	JJ	B-TREATMENT	O
7/31	CD	O	O
.	.	O	O

was	VBD	O	O
seen	VBN	O	O
in	IN	O	O
dialysis	NN	O	B-TREATMENT
on	IN	O	O
day	NN	O	O
of	IN	O	O
admission	NN	O	O
and	CC	O	O
was	VBD	O	O
seen	VBN	O	O
to	TO	O	O
have	VB	O	O
&quot;	NNP	B-PROBLEM	B-PROBLEM
raccoon	VB	I-PROBLEM	I-PROBLEM
eyes	NNS	I-PROBLEM	I-PROBLEM
&quot;	NNP	I-PROBLEM	I-PROBLEM
and	CC	O	O
hd	JJ	O	O
staff	NN	O	O
was	VBD	O	O
worried	VBN	O	O
about	IN	O	O
sending	VBG	O	O
home	NN	O	O
.	.	O	O

head	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
w	NN	O	O
/	NNP	O	O
o	NN	O	O
bleed	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

trauma	JJ	B-TEST	B-PROBLEM
series	NN	I-TEST	I-PROBLEM
normal	JJ	O	O
.	.	O	O

pt	NN	O	O
denies	NNS	O	O
abuse	VBP	O	O
or	CC	O	O
loc	VBP	B-PROBLEM	O
associated	VBN	O	O
w	JJ	O	O
/	NNP	O	O
fall	NN	O	B-PROBLEM
,	,	O	O
but	CC	O	O
has	VBZ	O	O
noticed	VBN	O	O
several	JJ	O	O
recent	JJ	O	O
falls	NNS	O	O
.	.	O	O

recent	JJ	B-TEST	O
neuro	NN	I-TEST	O
w	NN	I-TEST	O
/	NNP	I-TEST	O
u	JJ	I-TEST	O
including	VBG	O	O
eeg	NN	B-TEST	O
,	,	O	O
carotid	NN	B-TEST	B-PROBLEM
u	JJ	I-TEST	I-PROBLEM
/	NNP	I-TEST	I-PROBLEM
s	NN	I-TEST	I-PROBLEM
,	,	O	O
head	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
(	(	O	O
old	JJ	B-PROBLEM	B-PROBLEM
stroke	NN	I-PROBLEM	I-PROBLEM
)	)	O	I-PROBLEM
,	,	O	O
dobutamine-mibi	JJ	B-TEST	B-PROBLEM
(	(	O	I-PROBLEM
fixed	VBN	B-PROBLEM	I-PROBLEM
defect	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
small	JJ	B-PROBLEM	B-PROBLEM
inferolateral	JJ	I-PROBLEM	I-PROBLEM
reversible	NN	I-PROBLEM	I-PROBLEM
)	)	O	I-PROBLEM
were	VBD	O	O
all	DT	O	O
negative	JJ	O	O
.	.	O	O

esrd	NN	B-PROBLEM	B-PROBLEM
from	IN	O	O
iga	NN	B-PROBLEM	O
,	,	O	O
s	JJ	O	O
/	NNP	O	O
p	NN	O	O
ppi	NN	B-TREATMENT	O
after	IN	O	O
nodal	JJ	B-TREATMENT	B-TREATMENT
ablation	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
htn	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
copd	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypothyroid	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypertrophic	JJ	B-PROBLEM	B-PROBLEM

t	NN	B-TEST	O
96.5	CD	O	O
,	,	O	O
bp	NN	B-TEST	B-TEST
145/97	CD	O	O
,	,	O	O
p	NN	B-TEST	O
70	CD	O	O
,	,	O	O
pox	VBD	B-TEST	B-PROBLEM
98%	CD	O	I-PROBLEM
gen	NN	O	I-PROBLEM
ao	NN	O	I-PROBLEM
x	VBD	O	O
3	CD	O	O
,	,	O	O
raccoon	NN	B-PROBLEM	B-PROBLEM
eyes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
large	JJ	B-PROBLEM	B-PROBLEM
forehead	NN	I-PROBLEM	I-PROBLEM
hematoma	NN	I-PROBLEM	I-PROBLEM

soft	JJ	O	O
,	,	O	O
nt	JJ	B-PROBLEM	O

1+	CD	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
b	NN	I-PROBLEM	I-PROBLEM
/	NN	I-PROBLEM	O
l	NN	I-PROBLEM	O

warm	NN	O	O
,	,	O	O
smooth	CC	O	O
,	,	O	O
no	DT	O	O
rashes	NNS	B-PROBLEM	B-PROBLEM

clean	JJ	O	O
w	NN	O	O
/	NNP	O	O
o	VBZ	O	O
inflammation	NN	B-PROBLEM	B-PROBLEM

k	NN	B-TEST	B-TEST
3.5	CD	O	O
,	,	O	O
creat	NN	B-TEST	B-TEST
3.8	CD	O	O
,	,	O	O
trop-i	JJ	B-TEST	O
0.45	CD	O	O
,	,	O	O
inr	NN	B-TEST	B-TEST
1.6	CD	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
telemetry	NN	B-TEST	B-TEST
and	CC	O	O
had	VBD	O	O
no	DT	O	O
telemetry	NN	B-PROBLEM	B-PROBLEM
events	NNS	I-PROBLEM	I-PROBLEM
while	IN	O	O
an	DT	O	O
inpatient	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
also	RB	O	O
seen	VBN	O	O
by	IN	O	O
the	DT	O	O
electrophysiology	NN	O	O
service	NN	O	O
,	,	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
pacemaker	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
interrogated	VBN	O	O
and	CC	O	O
working	VBG	O	O
fine	NN	O	O
,	,	O	O
with	IN	O	O
no	DT	O	O
signs	NNS	O	O
of	IN	O	O
recent	JJ	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
arrhythmia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
his	PRP$	O	O
undergoing	VBG	O	O
a	DT	B-TEST	O
tte	NN	I-TEST	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
to	TO	O	O
rule	VB	O	O
out	RP	O	O
a	DT	B-PROBLEM	B-PROBLEM
thrombus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
tte	NN	I-TEST	I-TEST
showed	VBD	O	O
ef	JJ	B-TEST	O
45-50%	JJ	O	O
,	,	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
clvh	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
abnormal	JJ	B-PROBLEM	B-PROBLEM
diastolic	JJ	I-PROBLEM	I-PROBLEM
function	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
mr	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
tr	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
lae	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
a	DT	O	O
question	NN	O	O
of	IN	O	O
ionfiltrative	JJ	B-PROBLEM	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
the	DT	O	O
patient	JJ	O	O
underwent	JJ	O	O
abdominal	JJ	B-TEST	B-TEST
fat	NN	I-TEST	I-TEST
pad	NN	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
to	TO	O	O
assess	VB	O	O
for	IN	O	O
amyloidosis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
also	RB	O	O
currently	RB	O	O
has	VBZ	O	O
an	DT	B-TEST	O
spep	NN	I-TEST	O
/	NN	O	O
upep/beta	JJ	B-TEST	B-TREATMENT
2	CD	I-TEST	O
microglobulin	NN	I-TEST	B-TEST
/	NNP	O	I-TEST
ace	NN	B-TEST	I-TEST
test	NN	I-TEST	I-TEST
that	WDT	O	O
are	VBP	O	O
currently	RB	O	O
pending	VBG	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
carotid	VBN	B-TEST	B-TEST
ultrasound	JJ	I-TEST	I-TEST
studies	NNS	I-TEST	I-TEST
3	CD	O	O
months	NNS	O	O
ago	IN	O	O
that	DT	O	O
were	VBD	O	O
normal	JJ	O	O
without	IN	O	O
evidence	NN	O	O
for	IN	O	O
stenosis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2.	CD	O	O
renal	JJ	O	O
-	:	O	O
cont	NN	O	O
mwf	NN	O	O
hd	NN	B-TREATMENT	O
;	:	O	O
electrolytes	NNS	B-TEST	B-TEST
have	VBP	O	O
been	VBN	O	O
stable	JJ	O	O
.	.	O	O

perhaps	RB	O	O
his	PRP$	O	O
recent	JJ	O	O
falls	NNS	O	O
are	VBP	O	O
related	VBN	O	O
to	TO	O	O
orthostatic	JJ	B-PROBLEM	B-PROBLEM
hypotension	NN	I-PROBLEM	I-PROBLEM
after	IN	O	O
dialysis	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

3.	CD	O	O
cv	NN	O	O
-the	NN	O	O
pt	NN	O	O
has	VBZ	O	O
a	DT	O	B-PROBLEM
small	JJ	O	I-PROBLEM
area	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
reversible	JJ	B-PROBLEM	I-PROBLEM
ischemia	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
recent	JJ	B-TEST	O
mibi	NN	I-TEST	O
,	,	O	O
and	CC	O	O
has	VBZ	O	O
troponins	NNS	B-PROBLEM	B-PROBLEM
persistently	RB	I-PROBLEM	I-PROBLEM
elevated	VBN	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
troponins	NNS	I-TEST	I-TEST
remained	VBD	O	O
lower	JJR	O	O
than	IN	O	O
his	PRP$	O	B-TEST
baseline	NN	O	I-TEST
levels	NNS	O	I-TEST
and	CC	O	O
there	EX	O	O
was	VBD	O	O
no	DT	O	O
suspicion	NN	O	O
of	IN	O	O
acs	NN	B-PROBLEM	O
causing	VBG	O	O
syncope	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
continued	VBD	O	O
on	IN	O	O
his	PRP$	B-TREATMENT	O
zocor	NN	I-TREATMENT	O
,	,	O	O
cozaar	NN	B-TREATMENT	B-PROBLEM
and	CC	O	O
labetalol	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

we	PRP	O	O
will	MD	O	O
now	RB	O	O
hold	VB	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
given	VBN	O	O
his	PRP$	O	B-PROBLEM
recent	JJ	O	I-PROBLEM
falls	NNS	O	I-PROBLEM
and	CC	O	O
bleeding	VBG	B-PROBLEM	B-PROBLEM
risk	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
aspirin	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
restarted	VBN	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

4.	CD	O	O
endo	SYM	O	B-TEST
-	:	O	O
tsh	NN	B-TEST	O
was	VBD	O	O
4.7	CD	O	O
and	CC	O	O
normal	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	B-PROBLEM	B-TREATMENT
macrocytosis	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

his	PRP$	B-TEST	B-TEST
b12	NN	I-TEST	I-TEST
level	NN	I-TEST	I-TEST
was	VBD	O	O
418	CD	O	O
and	CC	O	O
normal	JJ	O	O
.	.	O	O

he	PRP	O	O
does	VBZ	O	O
have	VB	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
b12	JJ	B-PROBLEM	B-PROBLEM
deficiency	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
past	NN	O	O
,	,	O	O
and	CC	O	O
evidence	NN	O	O
for	IN	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
neuropathy	NN	I-PROBLEM	I-PROBLEM
ble	JJ	I-PROBLEM	O
which	WDT	O	O
may	MD	O	O
also	RB	O	O
be	VB	O	O
contributing	VBG	O	O
to	TO	O	O
his	PRP$	O	B-PROBLEM
recent	JJ	O	I-PROBLEM
falls	NNS	O	I-PROBLEM
.	.	O	O
?	.	O	O
etoh	NN	O	O

watch	NN	O	O
for	IN	O	O
etoh	JJ	B-PROBLEM	O
wd	NN	I-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
no	DT	O	O
signs	NNS	O	O
of	IN	O	O
alcohol	NN	B-PROBLEM	B-PROBLEM
withdrawal	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
serum	NN	I-TEST	I-TEST
toxicology	NN	I-TEST	I-TEST
screen	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

copd	NN	B-PROBLEM	O
and	CC	O	O
r	VB	B-PROBLEM	O
pleural	JJ	I-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
off	RB	O	O
oxygen	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
stable	JJ	O	O
.	.	O	O

r	NN	B-PROBLEM	B-PROBLEM
complex	JJ	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
cyst	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
bladder	NN	B-PROBLEM	B-PROBLEM
diverticula	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
need	VB	O	O
a	DT	B-TEST	B-TEST
follow	VB	I-TEST	I-TEST
up	RP	I-TEST	I-TEST
ultrasound	NN	I-TEST	I-TEST
to	TO	O	O
further	JJ	O	O
evaluate	VB	O	O
these	DT	B-PROBLEM	O
incidental	JJ	I-PROBLEM	O
findings	NNS	I-PROBLEM	O
seen	VBN	O	O
on	IN	O	O
imaging	VBG	B-TEST	O
upon	JJ	O	O
admission	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
&apos;s	NNP	I-TEST	I-TEST
urinalysis	NN	I-TEST	I-TEST
was	VBD	O	O
normal	JJ	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
no	DT	O	O
fecal	JJ	B-PROBLEM	B-PROBLEM
leukocytes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
c.difficile	JJ	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
is	VBZ	O	O
negative	JJ	O	O
on	IN	O	O
prelim	NN	O	B-TREATMENT
read	NN	O	I-TREATMENT
,	,	O	O
however	RB	O	O
very	RB	O	O
low	JJ	O	O
suspicion	NN	O	O
given	VBN	O	O
no	DT	O	O
recent	JJ	B-TREATMENT	O
antibiotic	JJ	I-TREATMENT	O
use	NN	I-TREATMENT	O
.	.	O	O

please	VB	O	O
return	NN	O	O
to	TO	O	O
the	DT	O	O
hospital	NN	O	O
if	IN	O	O
you	PRP	O	O
have	VBP	O	O
falls	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
headache	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
visual	JJ	B-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
muscle	NN	B-PROBLEM	B-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1)	CD	O	O
hemodialysis	NN	B-TREATMENT	B-TREATMENT

2)	CD	O	O
please	NN	O	O
do	VB	O	O
not	RB	O	O
take	VB	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

3)	CD	O	O
please	NN	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
pcp	NN	O	O
to	TO	O	O
have	VB	O	O
ultrasound	NN	B-TEST	B-TEST
of	IN	I-TEST	I-TEST
right	JJ	I-TEST	I-TEST
kidney	NN	I-TEST	I-TEST
and	CC	I-TEST	O
bladder	NN	I-TEST	O
to	TO	O	O
assess	VB	O	O
right	JJ	B-PROBLEM	B-PROBLEM
kidney	NN	I-PROBLEM	I-PROBLEM
cyst	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
bladder	NN	B-PROBLEM	I-PROBLEM
diverticula	NN	I-PROBLEM	I-PROBLEM
seen	VBN	O	O
incidentally	RB	O	O

4)	CD	O	O
please	NN	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
dr.	NNS	O	O
clow	VBP	O	O
to	TO	O	O
follow	VB	O	O
up	RP	O	O
results	NNS	O	O
of	IN	O	O
abdominal	JJ	B-TEST	B-TREATMENT
fat	JJ	I-TEST	I-TREATMENT
pad	NN	I-TEST	I-TREATMENT
biopsy	NN	I-TEST	I-TREATMENT
and	CC	O	O
blood	NN	B-TEST	B-TEST
tests	NNS	I-TEST	I-TEST
to	TO	O	O
assess	VB	O	O
for	IN	O	O
amyloid	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

readmitted	VBN	O	O
for	IN	O	O
hyperbilirubinemia	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
#5	NN	O	O
.	.	O	O

prenatal	JJ	B-TEST	B-TEST
screens	NNS	I-TEST	I-TEST
were	VBD	O	O
o+	RB	O	O
,	,	O	O
antibody	NN	B-TEST	B-TEST
negative	JJ	O	O
,	,	O	O
hepatitis	JJ	B-TEST	B-TEST
surface	NN	I-TEST	I-TEST
antigen	NN	I-TEST	I-TEST
negative	JJ	O	O
,	,	O	O
rapid	JJ	B-TEST	B-TEST
plasma	NN	I-TEST	I-TEST
reagin	NN	I-TEST	I-TEST
nonreactive	JJ	O	O
,	,	O	O
rubella	NN	B-TEST	B-TEST
immune	NN	O	O
,	,	O	O
group	NN	B-TEST	O
b	VBD	I-TEST	O
strep	RB	I-TEST	B-PROBLEM
positive	JJ	O	I-PROBLEM
.	.	O	O

the	DT	O	O
infant	NN	O	O
delivered	VBD	O	O
vaginally	RB	O	O
with	IN	O	O
apgar	JJ	B-TEST	B-TEST
scores	NNS	I-TEST	I-TEST
of	IN	O	O
9	CD	O	O
at	IN	O	O
one	CD	O	O
minute	NN	O	O
and	CC	O	O
9	CD	O	O
at	IN	O	O
five	CD	O	O
minutes	NNS	O	O
.	.	O	O

alleyne	RB	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
type	NN	I-TEST	I-TEST
is	VBZ	O	O
o+	JJ	O	O
/	NNP	O	O
coombs	NN	B-TEST	O
negative	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
readmitted	VBN	O	O
for	IN	O	O
phototherapy	NN	B-TREATMENT	B-TREATMENT
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
#5	NN	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
of	IN	O	O
23.3	CD	O	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
thomas	NN	O	O
was	VBD	O	O
well-appearing	JJ	O	O
though	IN	O	O
slightly	RB	B-PROBLEM	O
sleepy	VBN	I-PROBLEM	O
with	IN	O	O
jaundice	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
was	VBD	O	O
regular	JJ	O	O
without	IN	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
pulses	NNS	B-TEST	B-TEST
were	VBD	O	O
2+	CD	O	O
and	CC	O	O
symmetrical	JJ	O	O
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
and	CC	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
no	DT	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
weight	NN	I-TEST	I-TEST
was	VBD	O	O
3.505	CD	O	O
(	(	O	O
7	CD	O	O
pounds	NNS	O	O
/	JJ	O	O
12	CD	O	O
ounces	NNS	O	O
)	)	O	O
on	IN	O	O
readmission	NN	O	O
.	.	O	O

his	PRP$	B-TEST	O
tone	NN	I-TEST	O
was	VBD	O	O
normal	JJ	O	O
with	IN	O	O
normal	JJ	O	O
neonatal	JJ	O	O
reflexes	NNS	O	O
.	.	O	O

breath	NN	B-TEST	B-TEST
sounds	NNS	I-TEST	I-TEST
are	VBP	O	O
clear	JJ	O	O
and	CC	O	O
equal	JJ	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	O	B-TEST
regular	JJ	O	I-TEST
heart	NN	O	I-TEST
rate	NN	O	I-TEST
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
no	DT	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
pulses	NNS	B-TEST	B-TEST
were	VBD	O	O
2+	CD	O	O
and	CC	O	O
symmetric	JJ	O	O
.	.	O	O

alleyne	JJ	O	B-TEST
birth	NN	B-TEST	I-TEST
weight	NN	I-TEST	I-TEST
was	VBD	O	O
3.710	CD	O	O
kg	NN	O	O
(	(	O	O
8	CD	O	O
pounds	NNS	O	O
/	JJ	O	O
3	CD	O	O
ounces	NNS	O	O
).	VBP	O	O

his	PRP$	B-TEST	B-TEST
weight	NN	I-TEST	I-TEST
on	IN	O	O
this	DT	O	O
admission	NN	O	O
was	VBD	O	O
3.505	CD	O	O
kg	NN	O	O
(	(	O	O
7	CD	O	O
pounds	NNS	O	O
/	JJ	O	O
12	CD	O	O
ounces	NNS	O	O
).	VBP	O	O

his	PRP$	B-TEST	B-TEST
discharge	NN	I-TEST	I-TEST
weight	NN	I-TEST	I-TEST
is	VBZ	O	O
3585	CD	O	O
grams	NN	O	O
(	(	O	O
7	CD	O	O
pounds	NNS	O	O
13	CD	O	O
ounces	NNS	O	O
)	)	O	O
.	.	O	O

alleyne	RB	O	B-TEST
bilirubin	NN	B-TEST	I-TEST
on	IN	O	O
2018-05-09	JJ	O	O
was	VBD	O	O
10.4	CD	O	O
;	:	O	O
at	IN	O	O
which	WDT	O	O
time	NN	O	O
he	PRP	O	O
was	VBD	O	O
discharged	VBN	O	O
to	TO	O	O
home	NN	O	O
.	.	O	O

at	IN	O	O
the	DT	O	O
primary	JJ	O	O
pediatrician	NN	O	O
's	POS	O	O
office	NN	O	O
on	IN	O	O
2018-05-12	JJ	O	O
his	PRP$	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
had	VBD	O	O
been	VBN	O	O
23	CD	O	O
,	,	O	O
at	IN	O	O
which	WDT	O	O
time	NN	O	O
he	PRP	O	O
was	VBD	O	O
readmitted	VBN	O	O
to	TO	O	O
the	DT	O	O
healthsouth	NN	O	O
rehab	JJ	O	O
hospital	NN	O	O
of	IN	O	O
western	JJ	O	O
mass.	NNS	O	O
and	CC	O	O
double	JJ	B-TREATMENT	B-TREATMENT
phototherapy	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
started	VBN	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
on	IN	O	O
05-13	NN	O	O
was	VBD	O	O
18.4	CD	O	O
;	:	O	O
and	CC	O	O
on	IN	O	O
05-14	NN	O	O
it	PRP	O	O
was	VBD	O	O
14.7	CD	O	O
.	.	O	O

phototherapy	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
on	IN	O	O
2018-05-14	JJ	O	O
,	,	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
rebound	NN	I-TEST	I-TEST
bilirubin	NN	I-TEST	I-TEST
will	MD	O	O
be	VB	O	O
checked	VBN	O	O
in	IN	O	O
the	DT	O	O
pediatrician	NN	O	O
's	POS	O	O
office	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
on	IN	O	O
05-12	NN	O	O
was	VBD	O	O
48.7	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
reticulocyte	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
1.9	CD	O	O
,	,	O	O
and	CC	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
type	NN	I-TEST	I-TEST
is	VBZ	O	O
o+	JJ	O	O
/	NNP	O	O
coombs	NN	B-TEST	O
negative	NN	O	O
.	.	O	O

auditory	NN	B-TEST	B-TEST
hearing	VBG	I-TEST	I-TEST
screening	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
with	IN	O	O
automated	JJ	O	O
auditory	NN	O	O
brain	NN	O	O
stem	NN	O	O
responses	NNS	O	O
,	,	O	O
and	CC	O	O
the	DT	O	O
infant	NN	O	O
passed	VBD	O	O
both	DT	O	O
ears	NNS	O	O
on	IN	O	O
his	PRP$	O	O
previous	JJ	O	O
admission	NN	O	O
.	.	O	O

hearing	VBG	B-TEST	B-TEST
screens	NNS	I-TEST	I-TEST
were	VBD	O	O
repeated	VBN	O	O
on	IN	O	O
2018-05-13	JJ	O	O
and	CC	O	O
he	PRP	O	O
passed	VBD	O	O
both	DT	O	O
ears	NNS	O	O
.	.	O	O

4.	CD	O	O
car	NN	B-TEST	O
seat	NN	I-TEST	O
positioning	VBG	I-TEST	O
screen	NN	I-TEST	O
:	:	O	O

5.	CD	O	O
state	NN	B-TEST	B-TEST
newborn	JJ	I-TEST	I-TEST
screens	NNS	I-TEST	I-TEST
were	VBD	O	O
sent	VBN	O	O
on	IN	O	O
2018-05-09	JJ	O	O
;	:	O	O
and	CC	O	O
results	NNS	O	O
are	VBP	O	O
pending	VBG	O	O
.	.	O	O

on	IN	O	O
his	PRP$	O	O
previous	JJ	O	O
admission	NN	O	O
,	,	O	O
terrance	NN	O	O
received	VBD	O	O
hepatitis	NN	B-TREATMENT	B-TREATMENT
b	NN	I-TREATMENT	I-TREATMENT
vaccine	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
2018-05-09	JJ	O	O
.	.	O	O

6.	CD	O	O
immunization	NN	B-TREATMENT	B-TREATMENT
recommended	VBD	O	O
:	:	O	O

influenza	JJ	B-TREATMENT	B-TREATMENT
immunization	NN	I-TREATMENT	I-TREATMENT
is	VBZ	O	O
recommended	VBN	O	O
annually	RB	O	O
in	IN	O	O
the	DT	O	O
fall	NN	O	O
for	IN	O	O
all	DT	O	O
infants	NNS	O	O
once	IN	O	O
they	PRP	O	O
reach	VBP	O	O
6	CD	O	O
months	NNS	O	O
of	IN	O	O
age	NN	O	O
.	.	O	O

before	IN	O	O
this	DT	O	O
age	NN	O	O
(	(	O	O
and	CC	O	O
for	IN	O	O
the	DT	O	O
first	JJ	O	O
24	CD	O	O
months	NNS	O	O
of	IN	O	O
the	DT	O	B-TREATMENT
child	NN	O	I-TREATMENT
's	POS	O	I-TREATMENT
life	NN	O	I-TREATMENT
)	)	O	I-TREATMENT
immunization	NN	B-TREATMENT	I-TREATMENT
against	IN	O	O
influenza	NN	B-PROBLEM	B-PROBLEM
is	VBZ	O	O
recommended	VBN	O	O
for	IN	O	O
household	NN	O	O
contacts	NNS	O	O
and	CC	O	O
out	IN	O	O
of	IN	O	O
home	NN	O	O
caregivers	NNS	O	O
.	.	O	O

2.	CD	O	O
exaggerated	JJ	B-PROBLEM	B-PROBLEM
physiologic	JJ	I-PROBLEM	I-PROBLEM
hyperbilirubinemia	NN	I-PROBLEM	I-PROBLEM
responsive	NN	O	O
to	TO	O	O
phototherapy	VB	B-TREATMENT	B-TREATMENT
.	.	O	O

progressive	JJ	B-PROBLEM	B-PROBLEM
acanthamoeba	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
65-year-old	JJ	O	O
man	NN	O	O
with	IN	O	O
refractory	JJ	B-PROBLEM	B-PROBLEM
cll	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
non-myeloblative	JJ	B-TREATMENT	B-TREATMENT
stem	NN	I-TREATMENT	I-TREATMENT
cell	NN	I-TREATMENT	I-TREATMENT
transplant	NN	I-TREATMENT	I-TREATMENT
approximately	RB	O	O
nine	CD	O	O
months	NNS	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
,	,	O	O
and	CC	O	O
status	NN	O	O
post	NN	O	O
prolonged	VBD	O	O
recent	JJ	O	O
retelk	JJ	O	O
county	NN	O	O
medical	JJ	O	O
center	NN	O	O
stay	NN	O	O
for	IN	O	O
acanthamoeba	JJ	B-PROBLEM	B-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
skin	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
sinuses	NNS	O	I-PROBLEM
,	,	O	O
complicated	VBN	O	O
by	IN	O	O
ars	NNS	B-PROBLEM	O
due	JJ	O	O
to	TO	O	O
medication	NN	B-PROBLEM	B-TREATMENT
toxicity	NN	I-PROBLEM	I-TREATMENT
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
gvhd	NN	B-PROBLEM	O
and	CC	O	O
recent	JJ	B-PROBLEM	B-PROBLEM
cmv	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
readmitted	VBN	O	O
for	IN	O	O
new	JJ	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
creatinine	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hepatomegaly	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
fluid	NN	B-PROBLEM	B-TEST
surge	NN	I-PROBLEM	I-TEST
spacing	NN	I-PROBLEM	I-TEST
,	,	O	O
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
hyponatremia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

patient	NN	O	O
initially	RB	O	O
presented	VBN	O	O
in	IN	O	O
1991	CD	O	O
with	IN	O	O
cervical	JJ	B-PROBLEM	B-PROBLEM
lymphadenopathy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
mace	NN	B-TREATMENT	B-TREATMENT
/	NNP	O	I-TREATMENT
cytabom	NN	B-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
did	VBD	O	O
well	RB	O	O
until	IN	O	O
1997	CD	O	O
,	,	O	O
when	WRB	O	O
he	PRP	O	O
received	VBD	O	O
six	CD	O	O
cycles	NNS	O	O
of	IN	O	O
fludarabine	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

in	IN	O	O
november	NNP	O	O
,	,	O	O
2001	CD	O	O
,	,	O	O
he	PRP	O	O
progressed	VBD	O	O
to	TO	O	O
leukemic	JJ	B-PROBLEM	B-PROBLEM
phase	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
received	VBD	O	O
rituxan	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
cvp	NN	B-TREATMENT	O
.	.	O	O

started	VBN	O	O
campath	NN	B-TREATMENT	O
in	IN	O	O
july	NN	O	O
,	,	O	O
2001	CD	O	O
,	,	O	O
complicated	VBN	O	O
by	IN	O	O
lymphopenia	NN	B-PROBLEM	B-PROBLEM
/	NNP	O	O
neutropenia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
cmv	NN	B-PROBLEM	B-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
underwent	JJ	O	B-TREATMENT
mud	NN	B-TREATMENT	I-TREATMENT
stem	NN	I-TREATMENT	I-TREATMENT
cell	NN	I-TREATMENT	I-TREATMENT
transplant	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
december	NN	O	O
,	,	O	O
2002	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
bone	VBN	B-TEST	B-TEST
marrow	NN	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
,	,	O	O
august	RB	O	O
,	,	O	O
2003	CD	O	O
,	,	O	O
for	IN	O	O
persistent	JJ	B-PROBLEM	B-PROBLEM
pancytopenia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
revealing	VBG	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
hypercelluarity	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
80%	CD	B-PROBLEM	B-PROBLEM
leukemic	JJ	I-PROBLEM	I-PROBLEM
cells	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
again	RB	O	O
treated	VBN	O	O
with	IN	O	O
campath	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
had	VBD	O	O
recurrent	VBN	B-PROBLEM	B-PROBLEM
fever	RB	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
association	NN	O	I-PROBLEM
with	IN	O	O
sinus	NN	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
ct	JJ	B-TEST	B-TEST
scan	JJ	I-TEST	I-TEST
showing	NN	O	O
left	VBD	B-PROBLEM	B-PROBLEM
maxillary	JJ	I-PROBLEM	I-PROBLEM
sinusitis	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
association	NN	O	I-PROBLEM
with	IN	O	O
new	JJ	B-PROBLEM	B-PROBLEM
skin	NN	I-PROBLEM	I-PROBLEM
nodules	NNS	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	O
right	JJ	I-PROBLEM	B-TREATMENT
elbow	NN	I-PROBLEM	I-TREATMENT
and	CC	I-PROBLEM	O
buttocks	NNS	I-PROBLEM	O
.	.	O	O

patient	NN	O	O
was	VBD	O	O
hospitalized	VBN	O	O
september	RB	O	O
26	CD	O	O
to	TO	O	O
november	VB	O	O
11	CD	O	O
for	IN	O	O
what	WP	O	O
was	VBD	O	O
diagnosed	VBN	O	O
by	IN	O	O
skin	NN	B-TEST	B-TEST
biopsy	NN	I-TEST	I-TEST
and	CC	O	O
sinus	JJ	B-TEST	B-PROBLEM
washings	NNS	I-TEST	I-PROBLEM
as	IN	O	O
acanthamoeba	JJ	B-PROBLEM	B-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
skin	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
sinuses	NNS	O	I-PROBLEM
,	,	O	O
without	IN	O	O
any	DT	O	O
progression	NN	O	O
to	TO	O	O
neurologic	JJ	B-PROBLEM	B-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
as	IN	O	O
assessed	VBN	O	O
by	IN	O	O
head	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
and	CC	O	O
mri	NN	B-TEST	O
)	)	O	O
.	.	O	O

id	NN	O	O
consult	NN	O	O
was	VBD	O	O
obtained	VBN	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
initially	RB	O	O
treated	VBN	O	O
with	IN	O	O
azithromycin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
itraconazole	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
pentamidine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
with	IN	O	O
progression	NN	O	B-PROBLEM
of	IN	O	I-PROBLEM
skin	JJ	B-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

subsequent	JJ	O	O
discontinuance	NN	O	O
of	IN	O	O
azithromycin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
trial	NN	B-TREATMENT	O
of	IN	I-TREATMENT	O
5-fc	JJ	I-TREATMENT	O
,	,	O	O
with	IN	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
neutropenia	JJ	I-PROBLEM	I-PROBLEM
requiring	VBG	O	O
discontinuance	NN	O	O
,	,	O	O
change	NN	O	O
if	IN	O	O
itraconazole	JJ	B-TREATMENT	B-TREATMENT
to	TO	O	O
voriconazole	VB	B-TREATMENT	B-TREATMENT
,	,	O	O
given	VBN	O	O
continued	VBD	B-PROBLEM	O
neutropenia	JJ	I-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
trial	NN	O	O
of	IN	O	O
sulfadiazine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
discontinued	VBN	O	O
for	IN	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
ars	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
was	VBD	O	O
maintained	VBN	O	O
on	IN	O	O
p.o.	JJ	B-TREATMENT	B-TREATMENT
voriconazole	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
pentamidine	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
with	IN	O	O
pentamidine	JJ	B-TREATMENT	B-TREATMENT
nasal	JJ	I-TREATMENT	I-TREATMENT
washings	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
with	IN	O	O
re-ct	NN	B-TEST	O
of	IN	I-TEST	O
sinuses	NNS	I-TEST	B-PROBLEM
near	IN	O	O
end	NN	O	O
of	IN	O	O
stay	NN	O	O
showing	VBG	O	O
no	DT	O	O
change	NN	O	B-PROBLEM
in	IN	O	I-PROBLEM
disease	NN	B-PROBLEM	I-PROBLEM
burden	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
had	VBN	O	O
recurrent	VBN	B-PROBLEM	B-PROBLEM
cmb	JJ	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
campath	NN	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
requiring	VBG	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
foscarnet	NN	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
during	IN	O	O
stay	NN	O	O
,	,	O	O
with	IN	O	O
inability	NN	O	B-PROBLEM
to	TO	O	O
tolerate	VB	O	O
valganciclovir	JJ	B-TREATMENT	B-TREATMENT
maintenance	NN	I-TREATMENT	I-TREATMENT
suppression	NN	I-TREATMENT	I-TREATMENT
subsequently	RB	O	O
due	JJ	O	O
to	TO	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
ars	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

hypercapture	NN	B-TEST	O
near	IN	O	O
end	NN	O	O
of	IN	O	O
stay	NN	O	O
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

patient	NN	O	O
experienced	VBD	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
on	IN	O	I-PROBLEM
chronic	JJ	B-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
previous	JJ	B-TEST	B-TEST
baseline	NN	I-TEST	I-TEST
creatinine	NN	I-TEST	I-TEST
1.6	CD	O	O
,	,	O	O
felt	VBD	O	O
to	TO	O	O
be	VB	O	O
due	JJ	O	O
to	TO	O	O
medication	NN	B-PROBLEM	B-TREATMENT
toxicity	NN	I-PROBLEM	I-TREATMENT
,	,	O	O
requiring	VBG	O	O
kayexalate	NN	B-TREATMENT	O
and	CC	O	O
phoslo	NN	B-TREATMENT	O
to	TO	O	O
manage	VB	O	O
electrolytes	NNS	B-TEST	B-TREATMENT
,	,	O	O
but	CC	O	O
never	RB	O	O
any	DT	O	O
need	NN	O	O
for	IN	O	O
hemodialysis	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
with	IN	O	O
mild	JJ	O	O
improvement	NN	O	O
of	IN	O	O
creatinine	NN	B-TEST	B-TEST
by	IN	O	O
discharge	NN	O	O
,	,	O	O
with	IN	O	O
peak	JJ	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
3.4	CD	O	O
,	,	O	O
discharge	NN	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
2.6	CD	O	O
.	.	O	O

patient	NN	O	O
struggled	VBD	O	O
with	IN	O	O
gvhd	NN	B-PROBLEM	O
,	,	O	O
with	IN	O	O
extensive	JJ	B-PROBLEM	O
skin	NN	I-PROBLEM	O
involvement	NN	I-PROBLEM	O
,	,	O	O
taking	VBG	O	O
cellcept	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
cyclosporine	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
time	NN	O	O
of	IN	O	O
last	JJ	O	O
admission	NN	O	O
.	.	O	O

cellcept	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
infection	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
but	CC	O	O
attempts	NNS	O	O
to	TO	O	O
decrease	VB	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
or	CC	O	O
cyclosporine	NN	B-TREATMENT	B-TREATMENT
were	VBD	O	O
unsuccessful	JJ	O	O
.	.	O	O

patient	JJ	O	O
returns	NNS	O	O
from	IN	O	O
rehabilitation	NN	B-TREATMENT	B-TREATMENT
after	IN	O	O
discharge	NN	O	O
on	IN	O	O
november	JJ	O	O
11	CD	O	O
,	,	O	O
with	IN	O	O
new	JJ	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
up	RB	O	O
to	TO	O	O
102.0	CD	O	O
in	IN	O	O
dsci	NN	O	O
clinic	NN	O	O
,	,	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
hepatomegaly	NN	I-PROBLEM	I-PROBLEM
as	IN	O	O
assessed	VBN	O	O
by	IN	O	O
examination	NN	B-TEST	B-TEST
in	IN	O	O
clinic	NN	O	O
,	,	O	O
and	CC	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
creatinine	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

denies	NNS	O	O
cough	VBP	B-PROBLEM	B-PROBLEM
,	,	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
dysuria	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
neck	NN	B-PROBLEM	B-PROBLEM
stiffness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
new	JJ	B-PROBLEM	B-PROBLEM
skin	NN	I-PROBLEM	I-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
red	JJ	I-PROBLEM	I-PROBLEM
petechiae	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
sinus	NN	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
reports	NNS	O	O
persistent	JJ	B-PROBLEM	B-PROBLEM
mild	RB	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
discomfort	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
recent	JJ	B-PROBLEM	B-PROBLEM
poor	JJ	I-PROBLEM	I-PROBLEM
appetite	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

refractory	NN	B-PROBLEM	B-PROBLEM
cll	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
bone	NN	B-PROBLEM	B-TREATMENT
marrow	NN	I-PROBLEM	I-TREATMENT
involvement	NN	I-PROBLEM	O
,	,	O	O
status	NN	O	O
post	NN	O	O
mud	NN	B-TREATMENT	B-PROBLEM
,	,	I-TREATMENT	O
mini-allo	JJ	I-TREATMENT	B-TREATMENT
stem	NN	I-TREATMENT	I-TREATMENT
cell	NN	I-TREATMENT	I-TREATMENT
transplant	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
december	NN	O	O
,	,	O	O
2002	CD	O	O
,	,	O	O
acanthamoeba	JJ	B-PROBLEM	B-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
skin	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
sinuses	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
recently	RB	O	O
treated	VBN	O	O
with	IN	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
pentamidine	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
p.o.	JJ	B-TREATMENT	B-TREATMENT
voriconazole	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
history	NN	O	O
of	IN	O	O
recurrent	NN	B-PROBLEM	B-PROBLEM
cmb	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
recent	JJ	B-PROBLEM	B-PROBLEM
ars	NNS	I-PROBLEM	I-PROBLEM
on	IN	O	I-PROBLEM
cri	NN	B-PROBLEM	I-PROBLEM
,	,	O	O
thought	VBD	O	O
due	JJ	O	O
to	TO	O	O
medication	NN	B-PROBLEM	B-TREATMENT
toxicity	NN	I-PROBLEM	I-TREATMENT
(	(	O	O
creatinine	NN	B-TEST	B-TEST
on	IN	O	O
discharge	NN	O	O
from	IN	O	O
retelk	JJ	O	O
county	NN	O	O
medical	JJ	O	O
center	NN	O	O
on	IN	O	O
october	$	O	O
16	CD	O	O
was	VBD	O	O
2.6)	CD	O	O
.	.	O	O

no	DT	O	O
history	NN	O	O
of	IN	O	O
hemodialysis	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

graft	NN	B-PROBLEM	O
versus	NN	I-PROBLEM	O
host	NN	I-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
recently	RB	O	O
on	IN	O	O
cyclosporine	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
b.i.d.	NN	O	O
and	CC	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
60	CD	O	O
q.d.	NN	O	O

history	NN	O	O
of	IN	O	O
svt	NN	B-PROBLEM	O
.	.	O	O

pentamidine	NN	B-TREATMENT	B-TREATMENT
300	CD	O	O
mg	NN	O	O
iv	NN	O	O
q.	VBD	O	O
36	CD	O	O
hours	NNS	O	O
,	,	O	O
pentamidine	NN	B-TREATMENT	B-TREATMENT
nasal	NN	I-TREATMENT	I-TREATMENT
wash	VBZ	I-TREATMENT	I-TREATMENT
60	CD	O	O
mg	NN	O	O
per	IN	O	O
6	CD	O	O
ml	NN	O	O
of	IN	O	O
sterile	JJ	B-TREATMENT	O
water	NN	I-TREATMENT	O
q.d.	NN	O	O
,	,	O	O
voriconazole	JJ	B-TREATMENT	B-TREATMENT
200	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
acyclovir	RB	B-TREATMENT	B-TREATMENT
400	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
b.i.d.	NN	O	O
,	,	O	O
cyclosporine	VBP	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
60	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
,	,	O	O
gcsf	VBP	B-TREATMENT	O
480	CD	O	O
mcg	NN	O	O
iv	NN	O	O
q.d.	NN	O	O
,	,	O	O
epogen	VBZ	B-TREATMENT	O
40,000	CD	O	O
units	NNS	O	O
subcu	RB	O	O
q.	JJ	O	O
week	NN	O	O
,	,	O	O
protonix	VBP	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
q.d.	NN	O	O
,	,	O	O
simethicone	NN	B-TREATMENT	B-TREATMENT
80	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	NN	O	O
8	CD	O	O
,	,	O	O
nitroglycerin	JJ	B-TREATMENT	B-TREATMENT
paste	NN	I-TREATMENT	I-TREATMENT
1	CD	O	O
&quot;	NNP	O	O
q.	VBD	O	O
4	CD	O	O
h.	NN	O	O
p.r.n.	NN	O	O
,	,	O	O
flunisolide	RB	B-TREATMENT	B-PROBLEM
nasal	JJ	I-TREATMENT	I-PROBLEM
inhaler	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
2	CD	O	O
puffs	NNS	O	O
q.	RB	O	O
8	CD	O	O
,	,	O	O
oxycodone	CD	B-TREATMENT	B-TREATMENT
10-15	JJ	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	VBD	O	O
6	CD	O	O
p.r.n.	NN	O	O
,	,	O	O
sudafed	VBD	B-TREATMENT	O
30	CD	O	O
mg	NN	O	O
q.	NN	O	O
6	CD	O	O
p.o.	NN	O	O
p.r.n.	NN	O	O
,	,	O	O
fluconazole	JJ	B-TREATMENT	B-TREATMENT
2%	CD	I-TREATMENT	I-TREATMENT
cream	NN	I-TREATMENT	I-TREATMENT
b.i.d.	NN	O	O
to	TO	O	O
erythematous	JJ	B-PROBLEM	B-PROBLEM
skin	NN	I-PROBLEM	I-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
ditropan	VBP	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
tylenol	VBZ	B-TREATMENT	B-TREATMENT
650	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	VBD	O	O
4	CD	O	O
h.	NN	O	O
p.r.n.	NN	O	O
,	,	O	O
ambien	JJ	B-TREATMENT	O
5-10	JJ	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
h.s.	NN	O	O
p.r.n.	NN	O	O
,	,	O	O
neurontin	RB	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NNS	O	O
q.	JJ	O	O
a.m.	RB	O	O
,	,	O	O
200	CD	O	O
mg	NN	O	O
q.	CD	O	O
p.m.	NN	O	O
,	,	O	O
aquaphor	NN	B-TREATMENT	B-TREATMENT
cream	NN	I-TREATMENT	I-TREATMENT
b.i.d.	NN	O	O
p.r.n.	NN	O	O
,	,	O	O
lotrimin	VBZ	B-TREATMENT	B-TEST
1%	CD	I-TREATMENT	O
cream	NN	I-TREATMENT	O
b.i.d.	NN	O	O
to	TO	O	O
feet	NNS	O	O
,	,	O	O
dulcolax	JJ	B-TREATMENT	O
5-10	JJ	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
p.r.n.	NN	O	O
,	,	O	O
phoslo	VBP	B-TREATMENT	B-TEST
667	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O
,	,	O	O
peridex	NN	B-TREATMENT	B-TREATMENT
0.12%	CD	O	O
,	,	O	O
15	CD	O	O
ml	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
mouthwash	NN	O	B-TREATMENT
,	,	O	O
benadryl	JJ	B-TREATMENT	B-TREATMENT
25-50	JJ	O	O
mg	NN	O	O
q.	JJ	O	O
4-6	JJ	O	O
h.	NN	O	O
p.r.n.	NN	O	O
pruritus	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
sarna	JJ	B-TREATMENT	B-TREATMENT
cream	NN	I-TREATMENT	I-TREATMENT
q.d.	NN	O	O
p.r.n.	NN	O	O
pruritus	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nystatin	RB	B-TREATMENT	B-TREATMENT
5	CD	O	O
ml	NNS	O	O
p.o.	JJ	O	O
q.i.d.	JJ	O	O
swish	NN	O	O
and	CC	O	O
!	.	O	O

spit	NN	O	O
,	,	O	O
folate	VBP	O	B-TEST
1	CD	B-TREATMENT	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
,	,	O	O
vitamin	NN	O	B-TREATMENT
e	VBD	B-TREATMENT	O
400	CD	I-TREATMENT	O
units	NNS	O	O
p.o.	JJ	O	O
q.d.	NN	O	O
,	,	O	O
haldol	VBD	O	B-TREATMENT
2	CD	B-TREATMENT	O
mg	NN	O	O
iv	NN	O	O
q.	VBD	O	O
6	CD	O	O
p.r.n.	NN	O	O
agitation	NN	O	B-PROBLEM
,	,	B-PROBLEM	O
colace	NN	O	B-TREATMENT
100	CD	B-TREATMENT	O
mg	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
senna	VBD	O	B-TREATMENT
2	CD	B-TREATMENT	O
tablets	NNS	O	O
p.o.	VBP	O	O
b.i.d.	NN	O	O

bactrim	NN	B-TREATMENT	B-TREATMENT
(	(	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
rash	NN	I-PROBLEM	I-PROBLEM
)	)	O	I-PROBLEM
,	,	O	O
ganciclovir	FW	B-TREATMENT	B-TREATMENT
(	(	O	O
rash	NN	B-PROBLEM	O
,	,	O	O
has	VBZ	O	O
been	VBN	O	O
desensitized	VBN	O	O
)	)	O	O
.	.	O	O

comfortable	JJ	O	O
,	,	O	O
conversational	JJ	O	O
,	,	O	O
appears	VBZ	O	O
same	JJ	O	O
as	IN	O	O
week	NN	O	O
prior	RB	O	O
,	,	O	O
no	DT	O	O
apparent	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pupils	NNS	O	O
were	VBD	O	O
equal	JJ	O	O
,	,	O	O
round	NN	O	O
,	,	O	O
reactive	JJ	O	O
to	TO	O	O
light	JJ	O	O
,	,	O	O
anicteric	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

regular	JJ	O	O
,	,	O	O
normal	JJ	O	O
s1	NN	O	O
and	CC	O	O
s2	NN	O	O
,	,	O	O
no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
gallops	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
rubs	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

jvp	NN	B-TEST	B-PROBLEM
flat	NN	O	I-PROBLEM
.	.	O	O

lungs	NNS	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	I-TEST	O
.	.	O	O

normoactive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
,	,	O	O
soft	JJ	O	O
,	,	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
upper	NN	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
not	RB	O	O
dissimilar	JJ	O	O
from	IN	O	O
week	NN	O	O
prior	RB	O	O
,	,	O	O
pronounced	VBD	B-PROBLEM	O
hepatomegaly	NN	I-PROBLEM	B-PROBLEM
with	IN	O	O
liver	NN	O	B-PROBLEM
edge	VBP	O	I-PROBLEM
7	CD	O	I-PROBLEM
cm	NN	O	I-PROBLEM
below	IN	O	I-PROBLEM
costal	JJ	O	I-PROBLEM
margin	NN	O	I-PROBLEM
,	,	O	O
midclavicular	JJ	O	B-TREATMENT
line	NN	O	I-TREATMENT
,	,	O	O
no	DT	O	O
splenomegaly	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
cva	NN	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

slightly	RB	B-PROBLEM	O
cool	JJ	I-PROBLEM	O
,	,	O	O
3-4+	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM
.	.	O	O

erythematous	JJ	B-PROBLEM	B-PROBLEM
eruption	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
80%	CD	O	O
of	IN	O	O
body	NN	O	O
,	,	O	O
not	RB	O	O
much	JJ	O	O
change	NN	O	O
from	IN	O	O
week	NN	O	O
prior	RB	O	O
.	.	O	O

erythematous	JJ	B-PROBLEM	B-PROBLEM
nodules	NNS	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	O
arms	NNS	I-PROBLEM	B-TREATMENT
at	IN	O	O
elbows	NNS	O	O
and	CC	O	O
on	IN	O	O
right	JJ	O	O
thigh	NN	O	O
,	,	O	O
as	IN	O	O
previous	JJ	O	O
.	.	O	O

sodium	NN	B-TEST	B-TEST
129	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
3.0	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
70	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
5.0	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
23	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
99	CD	O	O
,	,	O	O
alt	RB	B-TEST	O
36	CD	O	O
,	,	O	O
ast	RB	B-TEST	B-TEST
30	CD	O	O
,	,	O	O
alkaline	JJ	B-TEST	B-TEST
phosphatase	NN	I-TEST	I-TEST
215	CD	O	O
,	,	O	O
total	JJ	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
1.1	CD	O	O
,	,	O	O
albumin	RB	B-TEST	B-TEST
2.6	CD	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
2.0	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
30.5	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
60	CD	O	O
.	.	O	O

patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
diagnosis	NN	O	O
and	CC	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
new	JJ	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

workup	NN	B-TEST	B-TEST
on	IN	I-TEST	O
admission	NN	I-TEST	O
included	VBD	O	O
a	DT	B-TEST	B-TEST
chest	JJ	I-TEST	I-TEST
x-ray	JJ	I-TEST	I-TEST
negative	NN	O	O
for	IN	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
an	DT	B-TEST	B-TEST
mri	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
liver	NN	I-TEST	I-TEST
to	TO	O	O
investigate	VB	O	O
for	IN	O	O
focal	JJ	B-PROBLEM	B-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
no	DT	O	O
evidence	NN	O	O
for	IN	O	O
abscess	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
focal	JJ	B-PROBLEM	B-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
report	NN	O	O
.	.	O	O

blood	NN	B-TEST	B-TEST
and	CC	I-TEST	I-TEST
urine	JJ	I-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
with	IN	O	O
only	RB	O	O
positive	JJ	O	O
culture	NN	O	B-TEST
a	DT	B-TEST	I-TEST
blood	NN	I-TEST	I-TEST
culture	NN	I-TEST	I-TEST
on	IN	O	O
november	NN	O	O
20	CD	O	O
,	,	O	O
with	IN	O	O
one	CD	O	O
of	IN	O	O
two	CD	O	O
bottles	NNS	O	O
positive	JJ	O	O
for	IN	O	O
coagulase	NN	B-PROBLEM	B-TEST
negative	JJ	I-PROBLEM	O
staphylococcus	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
cmv	NN	I-TEST	I-TEST
hypercapture	NN	I-TEST	I-TEST
,	,	O	O
negative	JJ	O	O
for	IN	O	O
presence	NN	O	O
of	IN	O	O
cmv	NN	B-PROBLEM	O
.	.	O	O

a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
cat	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
sinuses	NNS	I-TEST	I-TEST
with	IN	O	O
finding	NN	O	O
of	IN	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
thickening	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
maxillary	JJ	I-PROBLEM	I-PROBLEM
sinus	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
both	DT	O	O
sets	NNS	O	O
of	IN	O	O
ethmoid	JJ	O	B-PROBLEM
air	NN	O	I-PROBLEM
cells	NNS	O	I-PROBLEM
since	IN	O	O
prior	JJ	O	B-TEST
study	NN	O	I-TEST
of	IN	O	O
november	$	O	O
9	CD	O	O
,	,	O	O
indicating	VBG	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
acanthamoeba	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
any	DT	O	O
possible	JJ	O	O
superinfection	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
bacterial	JJ	B-PROBLEM	B-PROBLEM
sinusitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

in	IN	O	O
the	DT	O	O
days	NNS	O	O
following	VBG	O	O
admission	NN	O	O
,	,	O	O
there	EX	O	O
was	VBD	O	O
clear	JJ	O	O
evidence	NN	O	O
for	IN	O	O
progression	NN	O	B-PROBLEM
of	IN	O	I-PROBLEM
erythematous	JJ	B-PROBLEM	I-PROBLEM
nodules	NNS	I-PROBLEM	I-PROBLEM
over	IN	I-PROBLEM	O
both	DT	I-PROBLEM	O
arms	NNS	I-PROBLEM	O
and	CC	O	O
right	JJ	O	O
thigh	NN	O	O
at	IN	O	O
foci	NN	O	O
of	IN	O	O
acanthamoeba	JJ	B-PROBLEM	B-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
suggesting	VBG	O	O
progressive	JJ	B-PROBLEM	O
skin	NN	I-PROBLEM	O
involvement	NN	I-PROBLEM	O
with	IN	O	O
acanthamoeba	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

infectious	JJ	O	O
disease	NN	O	O
consult	NN	O	O
was	VBD	O	O
obtained	VBN	O	O
and	CC	O	O
recommendation	NN	O	O
was	VBD	O	O
to	TO	O	O
switch	VB	O	O
from	IN	O	O
voriconazole	NN	B-TREATMENT	B-TREATMENT
to	TO	O	O
itraconazole	VB	B-TREATMENT	B-TREATMENT
,	,	O	O
on	IN	O	O
which	WDT	O	O
there	EX	O	O
was	VBD	O	O
more	RBR	O	O
existing	JJ	O	O
data	NNS	O	O
on	IN	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
acanthamoeba	JJ	B-PROBLEM	B-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pentamidine	NN	B-TREATMENT	B-TREATMENT
intravenous	JJ	I-TREATMENT	I-TREATMENT
and	CC	I-TREATMENT	I-TREATMENT
nasal	JJ	I-TREATMENT	I-TREATMENT
washings	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
continued	VBN	O	O
.	.	O	O

clinical	JJ	O	O
progression	NN	O	O
of	IN	O	O
skin	NN	B-PROBLEM	O
and	CC	I-PROBLEM	O
sinus	JJ	I-PROBLEM	B-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
maximal	JJ	B-TREATMENT	B-TREATMENT
antimicrobial	JJ	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
continued	VBD	O	O
,	,	O	O
with	IN	O	O
emergence	NN	O	O
on	IN	O	O
november	JJ	O	O
20	CD	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
new	JJ	I-PROBLEM	I-PROBLEM
right-sided	JJ	I-PROBLEM	I-PROBLEM
ptosis	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
association	NN	O	I-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
homonymous	JJ	I-PROBLEM	I-PROBLEM
hemianopsia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
fleeting	VBG	B-PROBLEM	B-PROBLEM
confusion	NN	I-PROBLEM	I-PROBLEM
while	IN	O	O
febrile	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
prompting	VBG	O	B-TEST
head	NN	B-TEST	I-TEST
mri	NN	I-TEST	I-TEST
which	WDT	O	O
revealed	VBD	O	O
a	DT	O	B-PROBLEM
large	JJ	O	I-PROBLEM
5	CD	O	I-PROBLEM
x	JJ	O	I-PROBLEM
2	CD	O	I-PROBLEM
x	JJ	O	I-PROBLEM
4.3	CD	O	I-PROBLEM
cm	JJ	O	I-PROBLEM
region	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
right	JJ	O	I-PROBLEM
occipital	JJ	O	I-PROBLEM
lobe	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
hemorrhage	NN	B-PROBLEM	I-PROBLEM
and	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
with	IN	O	O
dural	JJ	B-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	O
,	,	I-PROBLEM	O
likely	RB	I-PROBLEM	O
,	,	I-PROBLEM	O
leptomeningeal	JJ	I-PROBLEM	B-PROBLEM
enhancement	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
association	NN	O	I-PROBLEM
with	IN	O	O
small	JJ	B-PROBLEM	B-PROBLEM
foci	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
cerebellum	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
pons	NNS	O	I-PROBLEM
,	,	O	O
concerning	VBG	O	O
for	IN	O	O
early	JJ	B-PROBLEM	B-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
similar	JJ	O	I-PROBLEM
type	NN	O	I-PROBLEM
.	.	O	O

idiosyncratic	JJ	B-PROBLEM	B-PROBLEM
reaction	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
cyclosporine	VB	B-TREATMENT	B-TREATMENT
was	VBD	O	O
considered	VBN	O	O
as	IN	O	O
cause	NN	O	O
for	IN	O	O
cerebritis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
cyclosporine	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
much	RB	O	O
more	RBR	O	O
likely	JJ	O	O
explanation	NN	O	O
is	VBZ	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
acanthamoeba	NN	B-PROBLEM	I-PROBLEM
with	IN	O	O
new	JJ	B-PROBLEM	B-PROBLEM
neurologic	JJ	I-PROBLEM	I-PROBLEM
involvement	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

most	RBS	O	O
likely	JJ	O	O
source	NN	O	O
of	IN	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
was	VBD	O	O
judged	VBN	O	O
to	TO	O	O
be	VB	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
acanthamoeba	JJ	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
even	RB	O	O
on	IN	O	O
maximal	JJ	B-TREATMENT	B-TREATMENT
antimicrobial	JJ	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

a	DT	B-TEST	B-TEST
single	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
culture	NN	I-TEST	I-TEST
positive	JJ	O	O
for	IN	O	O
coagulase	NN	B-PROBLEM	B-TEST
negative	JJ	I-PROBLEM	O
staphylococcus	NN	I-PROBLEM	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
a	DT	O	O
course	NN	O	O
of	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
picc	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
a	DT	B-TEST	B-TEST
chest	JJ	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
on	IN	O	O
november	$	O	O
20	CD	O	O
indicating	VBG	O	O
possible	JJ	O	O
developing	VBG	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
resulted	VBD	O	O
in	IN	O	O
a	DT	O	O
course	NN	O	O
of	IN	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
for	IN	O	O
both	DT	O	O
possible	JJ	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
treatment	NN	B-TREATMENT	O
of	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
bacterial	JJ	I-PROBLEM	I-PROBLEM
superinfection	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
acanthamoeba	JJ	B-PROBLEM	I-PROBLEM
sinusitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
experienced	VBD	O	O
steady	JJ	O	B-PROBLEM
decline	NN	O	I-PROBLEM
,	,	O	O
with	IN	O	O
persistent	JJ	B-PROBLEM	B-PROBLEM
fevers	NNS	I-PROBLEM	I-PROBLEM
despite	IN	O	O
all	DT	B-TREATMENT	O
above	IN	I-TREATMENT	O
measures	NNS	I-TREATMENT	O
,	,	O	O
progressive	JJ	O	B-PROBLEM
areas	NNS	O	I-PROBLEM
of	IN	O	I-PROBLEM
skin	JJ	B-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
more	RBR	O	O
frequent	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
confusion	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
decreasing	VBG	B-PROBLEM	O
oxygen	NN	I-PROBLEM	B-TEST
saturation	NN	I-PROBLEM	I-TEST
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
fluid	NN	B-PROBLEM	B-PROBLEM
surge	NN	I-PROBLEM	I-PROBLEM
spacing	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
november	JJ	O	O
30	CD	O	O
,	,	O	O
a	DT	O	O
family	NN	O	O
meeting	NN	O	O
with	IN	O	O
patient	NN	O	O
&apos;s	NN	O	O
daughter	NN	O	O
and	CC	O	O
spouse	NN	O	O
,	,	O	O
along	IN	O	O
with	IN	O	O
primary	JJ	O	O
oncologist	NN	O	O
,	,	O	O
dr.	NN	O	O
tomedankell	NN	O	O
bile	NN	O	O
,	,	O	O
attending	VBG	O	O
physician	NN	O	O
,	,	O	O
dr.	NN	O	O
mellerny	NN	O	O
close	RB	O	O
,	,	O	O
and	CC	O	O
house	NN	O	O
staff	NN	O	O
,	,	O	O
was	VBD	O	O
held	VBN	O	O
to	TO	O	O
discuss	VB	O	O
patient	JJ	B-PROBLEM	B-PROBLEM
&apos;s	NNP	I-PROBLEM	I-PROBLEM
critical	JJ	I-PROBLEM	I-PROBLEM
condition	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
inability	NN	O	B-PROBLEM
to	TO	O	I-PROBLEM
prevent	VB	O	I-PROBLEM
progression	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
skin	NN	B-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	O
sinus	NN	I-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
neurological	JJ	I-PROBLEM	I-PROBLEM
acanthamoeba	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
maximal	JJ	B-TREATMENT	B-TREATMENT
antimicrobial	JJ	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

decision	NN	O	O
was	VBD	O	O
made	VBN	O	O
to	TO	O	O
withdraw	VB	O	O
aggressive	JJ	B-TREATMENT	B-TREATMENT
measures	NNS	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
with	IN	O	O
priority	NN	O	O
on	IN	O	O
patient	JJ	O	O
&apos;s	NN	O	O
comfort	NN	O	O
.	.	O	O

pentamidine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
itraconazole	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
levaquin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
acyclovir	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
gcsf	NN	B-TREATMENT	O
were	VBD	O	O
discontinued	VBN	O	O
,	,	O	O
along	IN	O	O
with	IN	O	O
other	JJ	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
nonessential	JJ	O	I-TREATMENT
to	TO	O	I-TREATMENT
patient	VB	O	I-TREATMENT
&apos;s	JJ	O	I-TREATMENT
comfort	NN	O	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
made	VBN	O	O
comfortable	JJ	O	O
with	IN	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
for	IN	O	O
air	NN	B-PROBLEM	B-PROBLEM
hunger	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
sinus	VBD	B-TREATMENT	B-TREATMENT
suctioning	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
continued	VBN	O	O
to	TO	O	O
relieve	VB	O	O
congestion	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
in	IN	O	O
conjunction	NN	O	O
with	IN	O	O
continuation	NN	O	B-TREATMENT
of	IN	O	I-TREATMENT
nasal	JJ	B-TREATMENT	I-TREATMENT
sprays	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

tylenol	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
continued	VBN	O	O
to	TO	O	O
control	VB	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
continued	VBN	O	O
to	TO	O	O
control	VB	O	O
inflammation	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
prevent	JJ	O	O
precipitation	NN	O	O
of	IN	O	O
adrenal	JJ	B-PROBLEM	B-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
recorded	VBD	O	O
as	IN	O	O
having	VBG	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
to	TO	O	O
drugs	NNS	B-TREATMENT	B-TREATMENT

end	NN	B-PROBLEM	B-PROBLEM
stage	NN	I-PROBLEM	I-PROBLEM
liver	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM

piggyback	NN	B-TREATMENT	B-PROBLEM
orthotopic	NN	I-TREATMENT	I-PROBLEM
liver	NN	I-TREATMENT	I-PROBLEM
transplant	NN	I-TREATMENT	I-PROBLEM

liver	NN	B-TEST	B-TEST
biopsy	NN	I-TEST	I-TEST

mr.	NN	O	O
reese	NN	O	O
is	VBZ	O	O
a	DT	O	O
70	CD	O	O
-	:	O	O
year-old	JJ	O	O
gentleman	NN	O	O
with	IN	O	O
end	NN	B-PROBLEM	B-PROBLEM
stage	NN	I-PROBLEM	I-PROBLEM
liver	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
secondary	JJ	O	O
to	TO	O	O
alcoholic	JJ	B-PROBLEM	B-PROBLEM
cirrhosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

of	IN	O	O
note	NN	O	O
,	,	O	O
he	PRP	O	O
underwent	JJ	O	O
radiofrequency	NN	B-TREATMENT	B-TREATMENT
ablation	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	O
two	CD	I-TREATMENT	B-PROBLEM
small	JJ	I-TREATMENT	I-PROBLEM
liver	NN	I-TREATMENT	I-PROBLEM
nodules	NNS	I-TREATMENT	I-PROBLEM
,	,	O	O
one	CD	O	O
in	IN	O	O
segment	NN	O	O
vi	NN	O	O
and	CC	O	O
the	DT	O	B-PROBLEM
other	JJ	O	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
caudate	NN	O	I-PROBLEM
lobe	NN	O	I-PROBLEM
.	.	O	O

cytology	NN	B-TEST	B-TEST
on	IN	O	I-TEST
these	DT	B-PROBLEM	I-TEST
nodules	NNS	I-PROBLEM	I-TEST
was	VBD	O	O
suspicious	JJ	O	O
for	IN	O	O
hepatocellular	JJ	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
ablation	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
done	VBN	O	O
on	IN	O	O
2013-12-04	JJ	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
decompensation	NN	O	B-PROBLEM
of	IN	O	I-PROBLEM
his	PRP$	B-PROBLEM	I-PROBLEM
cirrhosis	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
2011	CD	O	O
with	IN	O	O
ascites	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
sbp	NN	B-PROBLEM	O
.	.	O	O

he	PRP	O	O
also	RB	O	O
had	VBD	O	O
encephalopathy	CC	B-PROBLEM	B-PROBLEM
during	IN	O	O
that	DT	O	O
period	NN	O	O
.	.	O	O

the	DT	O	O
liver	NN	O	O
was	VBD	O	O
from	IN	O	O
a	DT	O	O
62	CD	O	O
year-old	JJ	O	O
gentleman	NN	O	O
who	WP	O	O
had	VBD	O	O
died	VBN	O	O
from	IN	O	O
cva	NN	B-PROBLEM	O
with	IN	O	O
normal	JJ	O	O
liver	NN	O	O
function	NN	O	O
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
no	DT	O	O
history	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
gi	JJ	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
or	CC	O	I-PROBLEM
varices	NNS	B-PROBLEM	I-PROBLEM
by	IN	O	O
endoscopy	NN	B-TEST	B-TEST
.	.	O	O

his	PRP$	O	O
past	JJ	O	O
medical	JJ	O	O
history	NN	O	O
is	VBZ	O	O
also	RB	O	O
remarkable	JJ	O	O
for	IN	O	O
non-insulin	JJ	B-PROBLEM	B-PROBLEM
dependent	NN	I-PROBLEM	I-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
underwent	NN	O	O
a	DT	B-TREATMENT	B-TREATMENT
cabg	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
1998	CD	O	O
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
gastroesophageal	NN	B-PROBLEM	B-PROBLEM
reflux	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
anemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
also	RB	O	O
has	VBZ	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
prior	JJ	I-TREATMENT	I-TREATMENT
inguinal	JJ	I-TREATMENT	I-TREATMENT
hernia	NN	I-TREATMENT	I-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
pre-operative	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
,	,	O	O
he	PRP	O	O
was	VBD	O	O
awake	RB	O	O
,	,	O	O
alert	NN	O	O
,	,	O	O
and	CC	O	O
oriented	VBD	O	O
x3	NNP	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
not	RB	O	O
in	IN	O	O
any	DT	B-PROBLEM	O
apparent	JJ	I-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
with	IN	O	O
normal	JJ	O	O
vitals	NNS	O	O
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
6	CD	O	O
feet	NNS	O	O
1	CD	O	O
inches	NNS	O	O
tall	JJ	O	O
and	CC	O	O
has	VBZ	O	O
a	DT	B-TEST	B-TEST
pre-op	JJ	I-TEST	I-TEST
weight	NN	I-TEST	I-TEST
of	IN	O	O
181	CD	O	O
pounds	NNS	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
no	DT	O	O
pallor	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
obvious	JJ	B-PROBLEM	B-PROBLEM
jaundice	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
no	DT	O	O
asterixis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
palmar	VBN	B-PROBLEM	B-PROBLEM
erythema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
clubbing	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
no	DT	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

his	PRP$	O	B-TEST
chest	NN	O	I-TEST
was	VBD	O	O
clear	JJ	O	O
to	TO	O	O
ascultation	NN	B-TEST	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
sounds	VBZ	I-TEST	I-TEST
were	VBD	O	O
regular	JJ	O	O
rate	NN	O	O
rhythm	NN	O	O
.	.	O	O

his	PRP$	O	O
abdomen	NNS	O	O
is	VBZ	O	O
soft	JJ	O	O
and	CC	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
viscera	NN	B-PROBLEM	O
was	VBD	O	O
felt	VBN	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
no	DT	O	O
pedal	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
or	CC	O	I-PROBLEM
lower	JJR	B-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
neurological	JJ	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
was	VBD	O	O
intact	JJ	O	O
.	.	O	O

2014-12-30	JJ	O	O
10:34	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
alt	NN	B-TEST	I-TEST
-	:	O	O
699	CD	O	O
*	NN	O	O
ast	NN	B-TEST	B-TEST
-	:	O	O
1434	CD	O	O
*	NN	O	O
alkphos	SYM	B-TEST	B-TEST
-	:	O	O
65	CD	O	O
amylase	NN	B-TEST	B-TEST
-	:	O	O
46	CD	O	O
totbili	SYM	B-TEST	B-TEST
-	:	O	O
5.9	CD	O	O
*	NN	O	O

2015-01-01	JJ	O	O
11:46	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
alt	NN	B-TEST	I-TEST
-	:	O	O
1423	CD	O	O
*	NN	O	O
ast	IN	B-TEST	O
-	:	O	O
1066	CD	O	O
*	NN	O	O
alkphos	SYM	B-TEST	B-TEST
-	:	O	O
72	CD	O	O
totbili	SYM	B-TEST	B-TEST
-	:	O	O
6.2	CD	O	O
*	NN	O	O

2015-01-19	JJ	O	O
04:47	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
alt	NN	B-TEST	I-TEST
-	:	O	O
355	CD	O	O
*	NN	O	O
ast	VBD	B-TEST	B-TEST
-	:	O	O
90	CD	O	O
*	NN	O	O
alkphos	SYM	B-TEST	B-TEST
-	:	O	O
352	CD	O	O
*	NN	O	O
totbili	SYM	B-TEST	B-TEST
-	:	O	O
3.2	CD	O	O
*	NN	O	O

mr.	NN	O	O
reese	JJ	O	O
jones	VBZ	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
.	.	O	O

within	IN	O	O
the	DT	O	O
fist	JJ	O	O
few	JJ	O	O
days	NNS	O	O
after	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
his	PRP$	B-TEST	B-TEST
liver	JJ	I-TEST	I-TEST
function	NN	I-TEST	I-TEST
tests	NNS	I-TEST	I-TEST
were	VBD	O	O
elevated	VBN	B-PROBLEM	O
to	TO	O	O
as	RB	O	O
high	JJ	O	O
as	IN	O	O
1484	CD	O	O
for	IN	O	O
alt	NN	B-TEST	B-PROBLEM
,	,	O	O
915	CD	O	O
for	IN	O	O
ast	NN	B-TEST	B-TEST
,	,	O	O
and	CC	O	O
7.6	CD	O	O
for	IN	O	O
total	JJ	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
.	.	O	O

his	PRP$	B-TEST	B-TEST
alk	NN	I-TEST	I-TEST
phos	NN	I-TEST	I-TEST
were	VBD	O	O
inititially	RB	O	O
low	JJ	B-PROBLEM	O
a	DT	O	O
few	JJ	O	O
days	NNS	O	O
after	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
operation	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
but	CC	O	O
it	PRP	O	O
rised	VBD	O	O
up	RB	O	O
to	TO	O	O
422	CD	O	O
two	CD	O	O
weeks	NNS	O	O
after	IN	O	O
,	,	O	O
but	CC	O	O
down-trended	JJ	O	B-PROBLEM
,	,	O	O
as	IN	O	O
with	IN	O	O
the	DT	O	O
rest	NN	O	O
of	IN	O	O
his	PRP$	B-TEST	B-TEST
liver	NN	I-TEST	I-TEST
function	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
by	IN	O	O
the	DT	O	O
time	NN	O	O
he	PRP	O	O
left	VBD	O	O
the	DT	O	O
hospital	NN	O	O
.	.	O	O

several	JJ	O	B-TEST
tests	NNS	O	I-TEST
,	,	O	O
including	VBG	O	O
duplex	JJ	B-TEST	B-TEST
ultrasound	NN	I-TEST	I-TEST
,	,	O	I-TEST
ct	NN	B-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
abdomen	NNS	I-TEST	I-TEST
,	,	O	I-TEST
and	CC	O	I-TEST
abdominal	JJ	B-TEST	I-TEST
a-gram	NN	I-TEST	I-TEST
all	DT	O	I-TEST
showed	VBD	O	I-TEST
patent	NN	O	I-TEST
right	NN	O	I-TEST
and	CC	O	O
left	VBD	O	O
hepatic	JJ	O	O
arteries	NNS	O	O
arising	VBG	O	O
from	IN	O	O
the	DT	O	O
celiac	JJ	O	O
trunk	NN	O	O
.	.	O	O

an	DT	B-TEST	O
ercp	NN	I-TEST	O
was	VBD	O	O
also	RB	O	O
done	VBN	O	O
,	,	O	O
showing	VBG	O	O
a	DT	B-PROBLEM	B-PROBLEM
filling	VBG	I-PROBLEM	I-PROBLEM
defect	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
narrowed	JJ	I-PROBLEM	I-PROBLEM
donor	NN	I-PROBLEM	I-PROBLEM
duct	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
no	DT	O	O
strictures	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
sphincterotomy	NN	I-TREATMENT	I-TREATMENT
wss	NN	O	I-TREATMENT
done	VBN	O	O
to	TO	O	O
drain	VB	O	O
the	DT	B-PROBLEM	O
sludge	NN	I-PROBLEM	O
from	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
central	JJ	I-PROBLEM	O
common	JJ	I-PROBLEM	O
duct	NN	I-PROBLEM	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
resulting	VBG	O	O
from	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
sphincterotomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
but	CC	O	O
it	PRP	O	O
was	VBD	O	O
controlled	VBN	O	O
by	IN	O	O
epinepherine	NN	B-TREATMENT	B-TREATMENT
injections	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

initial	JJ	B-TEST	B-TEST
biopsy	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
allograft	NN	I-TEST	I-TEST
three	CD	O	O
days	NNS	O	O
after	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
operation	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
consistent	JJ	O	O
with	IN	O	O
preservation	NN	B-PROBLEM	O
/	NNP	I-PROBLEM	O
ischemic	JJ	I-PROBLEM	B-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

result	NN	O	O
of	IN	O	O
a	DT	B-TEST	B-TEST
second	JJ	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
,	,	O	O
which	WDT	O	O
was	VBD	O	O
done	VBN	O	O
three	CD	O	O
weeks	NNS	O	O
after	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
operation	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
is	VBZ	O	O
still	RB	O	O
pending	VBG	O	O
.	.	O	O

during	IN	O	O
his	PRP$	O	O
hospital	NN	O	O
stay	NN	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
glucose	NN	I-TEST	I-TEST
were	VBD	O	O
elevated	VBN	B-PROBLEM	O
and	CC	O	O
labile	JJ	B-PROBLEM	O
ranging	VBG	O	O
from	IN	O	O
below	IN	B-PROBLEM	O
normal	JJ	I-PROBLEM	O
values	NNS	I-PROBLEM	O
[	VBP	O	O
40-60	JJ	O	O
's]	CD	O	O
to	TO	O	O
the	DT	O	O
200-300	JJ	O	O
's	POS	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
completely	RB	O	O
assymptomatic	JJ	B-PROBLEM	O
while	IN	O	O
below	IN	B-PROBLEM	O
normal	JJ	I-PROBLEM	O
values	NNS	I-PROBLEM	O
.	.	O	O

at	IN	O	O
one	CD	O	O
point	NN	O	O
,	,	O	O
he	PRP	O	O
had	VBD	O	O
to	TO	O	O
be	VB	O	O
on	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

however	RB	O	O
with	IN	O	O
the	DT	O	O
help	NN	O	O
of	IN	O	O
albano	NN	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
glucose	NN	I-TEST	I-TEST
began	VBD	O	O
to	TO	O	O
normalize	VB	O	O
.	.	O	O

also	RB	O	O
,	,	O	O
he	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
afebrile	IN	B-PROBLEM	O
with	IN	O	O
stable	JJ	O	O
vitals	NNS	O	O
,	,	O	O
tolerating	VBG	O	O
a	DT	O	O
regular	JJ	O	O
diet	NN	O	O
,	,	O	O
producing	VBG	O	O
good	JJ	O	O
urine	NN	O	O
and	CC	O	O
adequate	JJ	O	O
stool	NN	O	O
.	.	O	O

furthermore	RB	O	O
,	,	O	O
he	PRP	O	O
has	VBZ	O	O
had	VBN	O	O
no	DT	O	O
complaints	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
including	VBG	O	O
pain	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
while	IN	O	O
his	PRP$	B-TEST	B-TEST
lab	NN	I-TEST	I-TEST
values	NNS	I-TEST	I-TEST
are	VBP	O	O
normalizing	VBG	O	O
.	.	O	O

he	PRP	O	O
will	MD	O	O
be	VB	O	O
discharged	VBN	O	O
to	TO	O	O
home	NN	O	O
,	,	O	O
in	IN	O	O
good	JJ	O	O
condition	NN	O	O
,	,	O	O
with	IN	O	O
very	RB	O	O
specific	JJ	O	O
intructions	NNS	O	O
to	TO	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
albano	NN	O	O
for	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
diabetic	JJ	I-TREATMENT	I-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
the	DT	O	O
transplant	NN	O	O
clinic	NN	O	O
for	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
transplant	NN	I-TREATMENT	I-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

1.	CD	O	O
trimethoprim	JJ	B-TREATMENT	O
-	:	I-TREATMENT	O
sulfamethoxazole	JJ	I-TREATMENT	O
80-400	JJ	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

2.	CD	O	O
pantoprazole	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
q24h	NN	O	O
(	(	O	O
every	DT	O	O
24	CD	O	O
hours	NNS	O	O
)	)	O	O
.	.	O	O

3.	CD	O	O
mycophenolate	NN	B-TREATMENT	B-TREATMENT
mofetil	NN	I-TREATMENT	I-TREATMENT
500	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

4.	CD	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
three	CD	O	O
(	(	O	O
3	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

5.	CD	O	O
valganciclovir	JJ	B-TREATMENT	B-TREATMENT
450	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

6.	CD	O	O
ursodiol	JJ	B-TREATMENT	B-TREATMENT
300	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

7.	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
tartrate	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1.5	CD	O	O
tablets	NNS	O	O
po	JJ	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

8.	CD	O	O
acetaminophen	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
tablets	NNS	O	O
po	JJ	O	O
q4-6h	JJ	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
to	TO	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

9.	CD	O	O
fluconazole	JJ	B-TREATMENT	B-TREATMENT
200	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q24h	NN	O	O
(	(	O	O
every	DT	O	O
24	CD	O	O
hours	NNS	O	O
)	)	O	O
.	.	O	O

10.	CD	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
ss	NN	I-TREATMENT	O
and	CC	O	O
fixed	VBN	B-TREATMENT	O
dose	NN	I-TREATMENT	O

fingerstick	JJ	B-TEST	B-TEST
qachs	NN	O	I-TEST
,	,	O	O
3	CD	O	O
am	VBP	O	O
insulin	JJ	B-TREATMENT	B-TREATMENT
sc	NN	I-TREATMENT	I-TREATMENT
fixed	VBN	I-TREATMENT	O
dose	JJ	I-TREATMENT	O
orders	NNS	O	O

insulin	NN	B-TREATMENT	B-TREATMENT
sc	NN	I-TREATMENT	I-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT

11.	CD	O	O
tacrolimus	JJ	B-TREATMENT	B-TREATMENT
0.5	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
three	CD	O	O
(	(	O	O
3	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

12.	CD	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
nph	JJ	I-TREATMENT	I-TREATMENT
human	JJ	I-TREATMENT	I-TREATMENT
recomb	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
unit	NN	O	O
/	NNP	O	O
ml	NN	O	O
cartridge	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
subcutaneous	NN	O	O
at	IN	O	O
breakfast	NN	O	O
:	:	O	O
please	NN	O	O
take	VB	O	O
as	IN	O	O
prescribed	VBN	O	O
by	IN	O	O
albano	NN	O	O
/	NNP	O	O
transplant	NN	O	O
team	NN	O	O
.	.	O	O

13.	CD	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
regular	JJ	I-TREATMENT	O
human	JJ	I-TREATMENT	O
300	CD	O	O
unit	NN	O	O
/	VBD	O	O
3	CD	O	O
ml	JJ	O	O
insulin	NN	O	O
pen	JJ	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
subcutaneous	JJ	O	O
four	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
:	:	O	O
please	VB	O	O
take	VB	O	O
as	IN	O	O
prescribed	VBN	O	O
by	IN	O	O
albano	NN	O	O
/	NNP	O	O
transplant	NN	O	O
team	NN	O	O
.	.	O	O

14.	CD	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
syringe	NN	I-TREATMENT	I-TREATMENT
needless	NN	I-TREATMENT	I-TREATMENT
(	(	O	I-TREATMENT
disp	NN	O	I-TREATMENT
)	)	O	I-TREATMENT
1	CD	O	O
ml	JJ	O	O
syringe	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
miscell.	NN	O	O
as	IN	O	O
directed	VBN	O	O
by	IN	O	O
albano	NN	O	O
/	NNP	O	O
trasplant	NN	O	O
.	.	O	O

end	NN	B-PROBLEM	B-PROBLEM
stage	NN	I-PROBLEM	I-PROBLEM
liver	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM

please	VB	O	O
take	VB	O	O
medications	NNS	B-TREATMENT	B-TREATMENT
as	IN	O	O
prescribed	JJ	O	O
and	CC	O	O
read	JJ	O	O
warning	NN	O	O
labels	NNS	O	O
carefully	RB	O	O
.	.	O	O

if	IN	O	O
symptoms	NNS	O	B-PROBLEM
such	JJ	O	O
as	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
/	NNP	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
/	NNP	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
/	NNP	O	O
redness	NN	B-PROBLEM	B-PROBLEM
/	NNP	O	O
purulent	NN	B-PROBLEM	B-PROBLEM
discharge	NN	I-PROBLEM	I-PROBLEM
from	IN	O	I-PROBLEM
incision	NN	B-PROBLEM	I-PROBLEM
,	,	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
jaundice	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
please	VB	O	O
call	NN	O	O
or	CC	O	O
go	VB	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
immediately	RB	O	O
.	.	O	O

pat	NN	O	B-PROBLEM
incision	NN	B-PROBLEM	I-PROBLEM
wounds	VBZ	I-PROBLEM	I-PROBLEM
dry	JJ	O	I-PROBLEM
,	,	O	O
do	VBP	O	O
not	RB	O	O
scrub	VB	O	B-PROBLEM
wound	NN	B-PROBLEM	I-PROBLEM
when	WRB	O	O
showering	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
presented	VBN	O	O
with	IN	O	O
a	DT	O	O
chief	JJ	O	O
complaint	NN	O	O
of	IN	O	O
weak	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

following	VBG	O	O
evaluation	NN	B-TEST	B-TEST
and	CC	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
the	DT	O	O
patient	NN	O	O
&apos;s	JJ	O	O
disposition	NN	O	O
at	IN	O	O
the	DT	O	O
end	NN	O	O
of	IN	O	O
the	DT	O	O
visit	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
as	IN	O	O
an	DT	O	O
inpatient	NN	O	O
to	TO	O	O
fairm	NN	O	O
of	IN	O	O
ijordcompmac	JJ	O	O
hospital	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
preliminary	JJ	O	O
admitting	VBG	O	O
physician	NN	O	O
is	VBZ	O	O
sapsclyss	JJ	O	O
,	,	O	O
leo	JJ	O	O
r	NN	O	O
and	CC	O	O
the	DT	O	O
preliminary	JJ	O	O
diagnosis	NN	O	O
is	VBZ	O	O
weakness	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

patient	NN	O	O
recorded	VBD	O	O
as	IN	O	O
having	VBG	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
to	TO	O	O
drugs	NNS	B-TREATMENT	B-TREATMENT

fever	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
tachycardia	NN	B-PROBLEM	B-PROBLEM

patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
58	CD	O	O
year	NN	O	O
old	JJ	O	O
male	NN	O	O
with	IN	O	O
a	DT	O	O
recent	JJ	O	O
admission	NN	O	O
for	IN	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
s/p	JJ	O	O
negative	JJ	O	O
exploratory	NN	O	O
laparotomy	NN	O	B-TREATMENT
for	IN	O	O
suspected	JJ	O	O
intussuception	NN	B-PROBLEM	O
now	RB	O	O
returns	VBZ	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
with	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
tachycardia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

patient	NN	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
for	IN	O	O
terrible	JJ	B-PROBLEM	B-PROBLEM
vasculopathy	JJ	I-PROBLEM	I-PROBLEM
s/p	NN	O	O
recent	JJ	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
bka	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
dry	JJ	B-PROBLEM	B-PROBLEM
gangrene	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
stump	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

post-operatively	RB	O	O
,	,	O	O
his	PRP$	O	O
course	NN	O	O
was	VBD	O	O
complicated	VBN	O	O
by	IN	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
necessitating	VBG	O	O
an	DT	O	O
urgent	JJ	O	O
return	NN	O	O
to	TO	O	O
the	DT	O	O
icu	NN	O	O
and	CC	O	O
was	VBD	O	O
intubated	VBN	O	B-TREATMENT
.	.	O	O

after	IN	O	O
multuple	NN	O	O
failed	VBD	O	O
attempts	NNS	O	O
at	IN	O	O
extubation	NN	B-TREATMENT	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
trached	VBN	O	O
.	.	O	O

patient	NN	O	O
then	RB	O	O
did	VBD	O	O
well	RB	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
trach	NN	I-TREATMENT	I-TREATMENT
mask	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
rehab	VB	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
admission	NN	O	O
but	CC	O	O
now	RB	O	O
returns	VBZ	O	O
with	IN	O	O
tachycardia	NN	B-PROBLEM	B-PROBLEM
to	TO	O	O
the	DT	O	O
120	CD	O	O
's	POS	O	O
,	,	O	O
and	CC	O	O
fever	RB	B-PROBLEM	B-PROBLEM
to	TO	O	O
102	CD	O	O
degrees	NNS	O	O
f	RB	O	O
.	.	O	O

pvd	NN	B-PROBLEM	O
s/p	NN	O	O
multiple	NN	B-PROBLEM	B-PROBLEM
failed	VBD	I-PROBLEM	I-PROBLEM
femoral	JJ	I-PROBLEM	I-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
bypass	NN	I-PROBLEM	I-PROBLEM

diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	VBP	I-PROBLEM	I-PROBLEM

cad	NN	B-PROBLEM	O
s/p	NN	O	O
cabg	NN	B-TREATMENT	B-TREATMENT
2003	CD	O	O
s/p	NN	O	O

ex	JJ	B-TEST	O
lap	CD	I-TEST	O
05-23	JJ	O	O

t	RB	B-TEST	O
101	CD	O	O
hr	NN	B-TEST	B-TEST
120	CD	O	O
bp	NN	B-TEST	O
144/90	CD	O	O
rr	NN	B-TEST	B-TEST
18	CD	O	O
spo2	NN	B-TEST	O
99%	CD	O	O
on	IN	O	O
70%	CD	O	O
tm	NN	B-TREATMENT	O

moderately	RB	B-PROBLEM	B-PROBLEM
distressed	JJ	I-PROBLEM	I-PROBLEM

coarse	JJ	B-PROBLEM	B-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
sounds	NNS	I-PROBLEM	I-PROBLEM
b/l	VBP	I-PROBLEM	I-PROBLEM

tachycardic	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nl	JJ	O	O
s1	NN	O	O
and	CC	O	O
s2	NN	O	O

abd	NN	O	O
soft	JJ	O	O
,	,	O	O
nt/nd	JJ	B-PROBLEM	O

right	JJ	B-PROBLEM	O
aka	NN	I-PROBLEM	O
stump	NN	I-PROBLEM	O
with	IN	O	O
dry	JJ	B-PROBLEM	B-PROBLEM
gangrene	NN	I-PROBLEM	I-PROBLEM

mri	JJ	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
:	:	O	O

the	DT	O	B-TEST
diffusion	NN	O	I-TEST
images	NNS	O	I-TEST
demonstrate	VBP	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
slow	JJ	B-PROBLEM	B-PROBLEM
diffusion	NN	I-PROBLEM	I-PROBLEM
to	TO	O	I-PROBLEM
indicate	VB	O	I-PROBLEM
acute	JJ	B-PROBLEM	I-PROBLEM
infarct	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
moderate	JJ	B-PROBLEM	O
prominence	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
ventricles	NNS	I-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	O
sulci	NN	I-PROBLEM	B-PROBLEM
,	,	O	O
inappropriate	NN	O	O
for	IN	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
age	NN	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
midline	NN	B-PROBLEM	B-PROBLEM
shift	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
mass	NN	B-PROBLEM	B-PROBLEM
effect	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hydrocephalus	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
territorial	JJ	B-PROBLEM	B-PROBLEM
infarct	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

following	VBG	O	O
gadolinium	NN	B-TEST	B-TEST
,	,	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
abnormal	JJ	B-PROBLEM	B-PROBLEM
parenchymal	NN	I-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	O
vascular	JJ	I-PROBLEM	O
,	,	I-PROBLEM	O
or	CC	I-PROBLEM	O
meningeal	VB	I-PROBLEM	B-PROBLEM
enhancement	JJ	I-PROBLEM	O
seen	VBN	O	O
.	.	O	O

gastric	JJ	B-TEST	B-TEST
biopsy	NN	I-TEST	I-TEST
:	:	O	O
negative	JJ	O	O
for	IN	O	O
h.	JJ	B-PROBLEM	B-PROBLEM
pylori	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
chest	JJ	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
on	IN	O	O
admission	NN	O	O
showed	VBD	O	O
effusions	NNS	B-PROBLEM	B-PROBLEM
consistent	JJ	O	O
with	IN	O	O
chf	NN	B-PROBLEM	O
along	IN	O	O
with	IN	O	O
overlying	VBG	B-PROBLEM	B-TEST
pnumonia	NN	I-PROBLEM	I-TEST
.	.	O	O

urine	JJ	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
were	VBD	O	O
significant	JJ	O	O
for	IN	O	O
klebsiella	NN	B-PROBLEM	B-PROBLEM
uti	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
sputum	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
were	VBD	O	O
significant	JJ	O	O
for	IN	O	O
mrsa	NN	B-PROBLEM	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
fluconazole	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
underwent	JJ	O	O
picc	JJ	B-TREATMENT	B-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
06-18	NN	O	O
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
trach	NN	I-TREATMENT	I-TREATMENT
collar	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
06-19	NN	O	O
.	.	O	O

gi	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
for	IN	O	O
colonoscopy	NN	B-TEST	B-TREATMENT
.	.	O	O

he	PRP	O	O
tolerated	VBD	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
trach	NN	I-TREATMENT	I-TREATMENT
collar	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
tube	NN	B-TREATMENT	B-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
at	IN	O	O
goal	NN	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
fluconazole	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
.	.	O	O

he	PRP	O	O
underwent	VBD	O	O
a	DT	B-PROBLEM	B-TEST
failed	JJ	I-PROBLEM	I-TEST
bedside	NN	I-PROBLEM	I-TEST
swallow	NN	I-PROBLEM	I-TEST
study	NN	I-PROBLEM	I-TEST
.	.	O	O

based	VBN	O	O
on	IN	O	O
a	DT	B-TEST	B-TEST
chest	JJ	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
that	WDT	O	O
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
hydro-pneumothorax	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
lung	NN	O	I-PROBLEM
,	,	O	O
a	DT	O	B-TREATMENT
thoracic	NN	O	I-TREATMENT
surgery	NN	O	I-TREATMENT
consult	NN	O	O
was	VBD	O	O
obtained	VBN	O	O
,	,	O	O
though	IN	O	O
no	DT	O	O
specific	JJ	B-TREATMENT	B-PROBLEM
interventions	NNS	I-TREATMENT	I-PROBLEM
were	VBD	O	O
warranted	VBN	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
.	.	O	O

on	IN	O	O
06-23	CD	O	O
the	DT	B-TREATMENT	B-TREATMENT
patient	NN	I-TREATMENT	I-TREATMENT
's	POS	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
feed	NN	I-TREATMENT	I-TREATMENT
were	VBD	O	O
changed	VBN	O	O
from	IN	O	O
respalor	NN	B-TREATMENT	O
to	TO	O	O
deliver	VB	B-TREATMENT	O
2.0	CD	I-TREATMENT	O
to	TO	O	O
give	VB	O	O
increased	JJ	O	B-PROBLEM
calories	NNS	O	I-PROBLEM
.	.	O	O

on	IN	O	O
06-25	NN	O	O
,	,	O	O
urine	JJ	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
grew	VBD	O	O
out	RP	O	O
vre	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
c	NN	I-TEST	I-TEST
diff	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

he	PRP	O	O
experienced	VBD	O	O
low	JJ	B-PROBLEM	B-PROBLEM
grade	NN	I-PROBLEM	I-PROBLEM
fevers	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
pan-cultured	JJ	O	O
on	IN	O	O
06-26	NN	O	O
for	IN	O	O
continued	JJ	B-PROBLEM	B-PROBLEM
fevers	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
06-27	NN	O	O
,	,	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
nutrition	NN	I-TREATMENT	I-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
was	VBD	O	O
changed	VBN	O	O
to	TO	O	O
deliver	VB	B-TREATMENT	O
2.0	CD	I-TREATMENT	O
at	IN	O	O
70	CD	O	O
cc	NN	O	O
/	NNP	O	O
hr	NN	O	O
with	IN	O	O
15	CD	O	O
g	NNS	O	O
promod	NN	B-TREATMENT	O
.	.	O	O

on	IN	O	O
06-28	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
experienced	VBD	O	O
pvc	NN	B-PROBLEM	O
's	POS	I-PROBLEM	O
.	.	O	O

an	DT	B-TEST	B-TEST
ekg	NN	I-TEST	I-TEST
showed	VBD	O	O
st	JJ	B-PROBLEM	B-PROBLEM
segment	NN	I-PROBLEM	I-PROBLEM
depression	NN	I-PROBLEM	I-PROBLEM
along	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
lateral	JJ	O	I-PROBLEM
pre-cordial	JJ	O	I-PROBLEM
leads	NNS	O	I-PROBLEM
.	.	O	O

serial	JJ	B-TEST	B-TEST
enzymes	NNS	I-TEST	I-TEST
showed	VBD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
elevation	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
troponins	NNS	B-TEST	I-PROBLEM
.	.	O	O

the	DT	O	O
cardiology	NN	O	O
service	NN	O	O
simply	RB	O	O
recommended	VBD	O	O
increasing	VBG	O	O
the	DT	B-TREATMENT	O
beta-blockade	NN	I-TREATMENT	O
and	CC	O	O
maximizing	VBG	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
electrolyte	NN	O	O
status	NN	O	O
.	.	O	O

pt	NN	B-TREATMENT	B-TEST
's	POS	I-TREATMENT	I-TEST
vancomycin	NN	I-TREATMENT	I-TEST
was	VBD	O	O
stopped	VBN	O	O
after	IN	O	O
14	CD	O	O
days	NNS	O	O
of	IN	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

hiv	JJ	B-TEST	B-TEST
test	NN	I-TEST	I-TEST
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
negative	JJ	O	O
.	.	O	O

mri	NNS	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
was	VBD	O	O
obtained	VBN	O	O
to	TO	O	O
further	RBR	O	O
w/u	VB	O	O
patient	NN	B-PROBLEM	B-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
apparent	JJ	I-PROBLEM	I-PROBLEM
cognitive	JJ	I-PROBLEM	I-PROBLEM
decline	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mri	NN	B-TEST	B-TEST
showed	VBD	O	O
prominent	JJ	B-PROBLEM	B-PROBLEM
sulci	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
enlarged	VBD	B-PROBLEM	O
ventricles	NNS	I-PROBLEM	O
abnormal	JJ	O	O
for	IN	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
age	NN	O	O
.	.	O	O

due	JJ	O	O
to	TO	O	O
concerns	NNS	O	O
for	IN	O	O
dementia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
neurology	NN	O	O
consult	NN	O	O
was	VBD	O	O
obtained	VBN	O	O
.	.	O	O

neurology	NN	O	O
felt	VBD	O	O
that	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
cognitive	JJ	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
were	VBD	O	O
consistent	JJ	O	O
w/	JJ	O	O
metabolic	NN	B-PROBLEM	B-PROBLEM
encephalopathy	NN	I-PROBLEM	I-PROBLEM
due	JJ	O	O
to	TO	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
multiple	JJ	I-PROBLEM	I-PROBLEM
medical	JJ	I-PROBLEM	I-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

underlying	VBG	B-PROBLEM	B-PROBLEM
dementia	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
possible	JJ	O	O
but	CC	O	O
difficult	JJ	O	O
to	TO	O	O
assess	VB	O	O
with	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
overlying	VBG	I-PROBLEM	I-PROBLEM
delerium	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
pull	VB	O	O
out	RP	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
doboff	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

pt	NN	O	O
had	VBD	O	O
egd	VBN	B-TEST	O
performed	VBN	O	O
to	TO	O	O
evaluate	VB	O	O
his	PRP$	B-PROBLEM	O
poor	JJ	I-PROBLEM	O
nutritional	JJ	I-PROBLEM	O
status	NN	I-PROBLEM	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
gastric	JJ	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
high	JJ	B-TREATMENT	O
dose	NN	I-TREATMENT	O
ppi	NN	I-TREATMENT	O
was	VBD	O	O
started	VBN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
gastric	JJ	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
and	CC	O	O
the	DT	B-TEST	B-TEST
serology	NN	I-TEST	I-TEST
were	VBD	O	O
both	DT	O	O
negative	JJ	O	O
for	IN	O	O
h.	JJ	B-PROBLEM	B-PROBLEM
pylori	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

peg	JJ	B-TREATMENT	O
placement	NN	I-TREATMENT	O
was	VBD	O	O
unsuccessful	JJ	O	O
by	IN	O	O
gi	NNS	O	O
due	JJ	O	O
to	TO	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
anantomy	NN	O	B-TREATMENT
.	.	O	O

07-05	CD	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
j	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
placed	VBN	O	O
in	IN	O	O
interventional	JJ	O	O
radiology	NN	O	O
for	IN	O	O
nutritional	JJ	B-TREATMENT	B-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
re-started	VBN	O	O
on	IN	O	O
tube	NN	B-TREATMENT	B-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

07-06	JJ	O	O
patient	NN	O	O
failed	VBD	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
swallow	JJ	I-TEST	I-TEST
evaluation	NN	I-TEST	I-TEST
due	JJ	O	O
to	TO	O	O
discoordinated	VBN	B-PROBLEM	O
swallow	NN	I-PROBLEM	O
.	.	O	O

07-07	CD	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
taken	VBN	O	O
for	IN	O	O
colonoscopy	NN	B-TEST	B-TREATMENT
and	CC	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	O	O
normal	JJ	O	O
colon	NN	O	O
to	TO	O	O
cecum	VB	O	B-PROBLEM
.	.	O	O

07-12	CD	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
c	JJ	B-PROBLEM	B-PROBLEM
diff	JJ	I-PROBLEM	I-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
14	CD	O	O
day	NN	O	O
course	NN	O	O
of	IN	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

on	IN	O	O
07-18	NN	O	O
,	,	O	O
as	IN	O	O
his	PRP$	O	O
mental	JJ	O	O
status	NN	O	O
improved	VBD	O	O
,	,	O	O
he	PRP	O	O
did	VBD	O	O
well	RB	O	O
at	IN	O	O
the	DT	B-TEST	O
bed	JJ	I-TEST	O
side	NN	I-TEST	O
swall	NN	I-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
.	.	O	O

on	IN	O	O
07-19	NN	O	O
,	,	O	O
he	PRP	O	O
underwent	VBD	O	O
video	RB	B-TEST	B-TEST
swallow	JJ	I-TEST	I-TEST
evaluation	NN	I-TEST	I-TEST
and	CC	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
tolerate	VB	O	O
ground	NN	B-TREATMENT	O
consistent	JJ	I-TREATMENT	O
food	NN	I-TREATMENT	O
and	CC	O	O
thin	JJ	B-TREATMENT	B-TREATMENT
liquids	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
meds	NNS	I-TREATMENT	I-TREATMENT
should	MD	O	O
be	VB	O	O
crushed	VBN	O	O
and	CC	O	O
mixed	JJ	O	O
with	IN	O	O
puree	JJ	B-TREATMENT	B-PROBLEM
thick	NN	I-TREATMENT	I-PROBLEM
liquid	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
gained	VBN	O	O
30	CD	B-PROBLEM	O
lb	JJ	I-PROBLEM	O
since	IN	O	O
the	DT	B-TREATMENT	O
tubefeed	NN	I-TREATMENT	O
was	VBD	O	O
initiated	VBN	O	O
(	(	O	O
70	CD	O	O
lb	NN	O	O
to	TO	O	O
100	CD	O	O
lb	NN	O	O
)	)	O	O
during	IN	O	O
this	DT	O	O
admission	NN	O	O
.	.	O	O

he	PRP	O	O
will	MD	O	O
still	RB	O	O
need	VB	O	O
to	TO	O	O
be	VB	O	O
on	IN	O	O
tubefeed	NN	B-TREATMENT	O
to	TO	O	O
support	VB	O	O
his	PRP$	O	O
nutrition	NN	O	O
until	IN	O	O
he	PRP	O	O
is	VBZ	O	O
cleared	VBN	O	O
by	IN	O	O
a	DT	O	O
nutritionist	NN	O	O
.	.	O	O

he	PRP	O	O
did	VBD	O	O
much	RB	O	O
better	RBR	O	O
with	IN	O	O
pt	NN	B-TREATMENT	O
and	CC	O	O
ot	NN	B-TREATMENT	O
at	IN	O	O
the	DT	O	O
end	NN	O	O
after	IN	O	O
his	PRP$	O	O
mental	JJ	O	O
status	NN	O	O
improved	VBN	O	O
.	.	O	O

as	IN	O	O
noted	VBN	O	O
above	IN	O	O
,	,	O	O
his	PRP$	B-PROBLEM	O
mental	JJ	I-PROBLEM	O
status	NN	I-PROBLEM	O
change	NN	I-PROBLEM	O
was	VBD	O	O
likely	JJ	O	O
toxic-metabolic	JJ	B-PROBLEM	O
from	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
started	VBD	O	O
to	TO	O	O
develop	VB	O	O
more	JJR	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
around	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
right	JJ	I-PROBLEM	O
stump	NN	I-PROBLEM	O
since	IN	O	O
07-17	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
seen	VBN	O	O
by	IN	O	O
the	DT	O	O
vascular	JJ	O	O
surgery	NN	O	O
who	WP	O	O
felt	VBD	O	O
that	IN	O	O
he	PRP	O	O
is	VBZ	O	O
too	RB	O	O
medically	RB	B-PROBLEM	O
sick	JJ	I-PROBLEM	O
and	CC	O	O
malnourished	VBN	B-PROBLEM	O
to	TO	O	O
have	VB	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
this	DT	O	O
time	NN	O	O
.	.	O	O

initially	RB	O	O
,	,	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
controlled	VBN	O	O
with	IN	O	O
titrating	VBG	O	B-TREATMENT
up	RP	O	I-TREATMENT
the	DT	B-TREATMENT	I-TREATMENT
oxycontin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
then	RB	O	O
developed	VBD	O	O
urinary	JJ	B-PROBLEM	B-PROBLEM
retention	NN	I-PROBLEM	I-PROBLEM
requiring	VBG	O	O
foley	JJ	B-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

after	IN	O	O
he	PRP	O	O
passed	VBD	O	O
the	DT	B-TEST	O
video	NN	I-TEST	O
swallowing	NN	I-TEST	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
tolerating	VBG	O	O
ground	NN	B-TREATMENT	O
consistent	JJ	I-TREATMENT	O
solids	NNS	I-TREATMENT	O
.	.	O	O

on	IN	O	O
07-24	NN	O	O
,	,	O	O
he	PRP	O	O
had	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
emesis	NN	I-PROBLEM	I-PROBLEM
x	NN	O	O
1	CD	O	O
,	,	O	O
and	CC	O	O
had	VBD	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
+	JJ	O	O
interstital	JJ	B-PROBLEM	B-PROBLEM
markings	NNS	I-PROBLEM	I-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	NN	O	I-PROBLEM
on	IN	O	O
cxr	NN	B-TEST	O
,	,	O	O
fever	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
leukocytosis	NN	B-PROBLEM	B-PROBLEM
)	)	O	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
flagyl	JJ	I-TREATMENT	I-TREATMENT
course	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
extended	VBN	O	O
,	,	O	O
and	CC	O	O
vanc	NN	B-TREATMENT	B-TREATMENT
/	NN	O	O
levo	NN	B-TREATMENT	B-TREATMENT
were	VBD	O	O
added	VBN	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
sputum	NN	I-TEST	I-TEST
showed	VBD	O	O
many	JJ	B-PROBLEM	B-PROBLEM
gpc	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
later	RB	O	O
grew	VBD	O	O
staph	JJ	B-PROBLEM	B-PROBLEM
aureus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

given	VBN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
recent	JJ	I-PROBLEM	I-PROBLEM
mrsa	NN	I-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
he	PRP	O	O
will	MD	O	O
be	VB	O	O
treated	VBN	O	O
with	IN	O	O
2	CD	O	O
week	NN	O	O
course	NN	O	O
of	IN	O	O
vanc	NN	B-TREATMENT	B-TREATMENT
/	NNP	O	O
levo	VBZ	B-TREATMENT	B-TREATMENT
/	NNP	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
seen	VBN	O	O
by	IN	O	O
the	DT	O	O
pain	NN	O	O
service	NN	O	O
who	WP	O	O
recommended	VBD	O	O
to	TO	O	O
discontinue	VB	O	O
oxycontin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
start	VB	O	O
neurontin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
msir	NN	B-TREATMENT	O
,	,	O	O
and	CC	O	O
lidocaine	JJ	B-TREATMENT	B-TREATMENT
patch	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
addition	NN	O	O
to	TO	O	O
the	DT	B-TREATMENT	O
standing	VBG	I-TREATMENT	O
tylenol	NN	I-TREATMENT	B-TREATMENT
.	.	O	O

on	IN	O	O
07-25	NN	O	O
,	,	O	O
his	PRP$	B-TREATMENT	O
j-tube	NN	I-TREATMENT	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
obstructed	VBN	B-PROBLEM	O
but	CC	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
be	VB	O	O
flushed	VBN	O	O
by	IN	O	O
ir	NN	O	O
on	IN	O	O
07-26	NN	O	O
.	.	O	O

tubefeed	NN	B-TREATMENT	O
was	VBD	O	O
resumed	VBN	O	O
without	IN	O	O
any	DT	B-PROBLEM	O
difficulty	NN	I-PROBLEM	O
since	IN	O	O
.	.	O	O

since	IN	O	O
oxycontin	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
,	,	O	O
the	DT	B-TREATMENT	B-TREATMENT
foley	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
removed	VBN	O	O
on	IN	O	O
07-27	NN	O	O
and	CC	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
void	VB	O	O
without	IN	O	O
any	DT	B-PROBLEM	O
difficulty	NN	I-PROBLEM	O
.	.	O	O

lopressor	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
bid	NN	O	O

percocet	NN	B-TREATMENT	B-TREATMENT

nebulizer	NN	B-TREATMENT	B-TREATMENT

lipitor	NN	B-TREATMENT	B-TREATMENT

klonopin	NN	B-TREATMENT	B-TREATMENT
0.5	CD	O	O
mg	NN	O	O
tid	NN	O	O

riss	NN	B-TREATMENT	B-PROBLEM

heparin	NN	B-TREATMENT	B-TREATMENT
sc	NN	I-TREATMENT	I-TREATMENT

lasix	RB	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NNS	O	O
tid	NN	O	O

prevacid	NN	B-TREATMENT	B-TREATMENT

milk	NN	B-TREATMENT	B-TEST
of	IN	I-TREATMENT	I-TEST
mag	NN	I-TREATMENT	I-TEST

multivitamin	NN	B-TREATMENT	B-TREATMENT

papain	NN	B-TREATMENT	B-TREATMENT

zinc	NN	B-TREATMENT	B-TREATMENT

1.	CD	O	O
albuterol	SYM	B-TREATMENT	B-TREATMENT
-	:	O	I-TREATMENT
ipratropium	NN	B-TREATMENT	I-TREATMENT
103-18	JJ	O	O
mcg	NN	O	O
/	NNP	O	O
actuation	NN	O	O
aerosol	NN	O	O
sig	NN	O	O
:	:	O	O
02-19	JJ	O	O
puffs	NNS	O	O
inhalation	NN	O	O
q6h	NN	O	O
(	(	O	O
every	DT	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

2.	CD	O	O
multivitamins	NNS	B-TREATMENT	B-TREATMENT
tablet	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
chewable	JJ	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
cap	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

3.	CD	O	O
magnesium	NN	B-TREATMENT	B-TREATMENT
hydroxide	NN	I-TREATMENT	I-TREATMENT
400	CD	O	O
mg	NN	O	O
/	VBD	O	O
5	CD	O	O
ml	JJ	O	O
suspension	NN	O	O
sig	NN	O	O
:	:	O	O
thirty	NN	O	O
(	(	O	O
30	CD	O	O
)	)	O	O
ml	NN	O	O
po	NN	O	O
q6h	NN	O	O
(	(	O	O
every	DT	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

4.	CD	O	O
ipratropium	NN	B-TREATMENT	B-TREATMENT
bromide	RB	I-TREATMENT	I-TREATMENT
0.02	CD	O	O
%	NN	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
inhalation	NN	O	O
q6h	NN	O	O
(	(	O	O
every	DT	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
.	.	O	O

5.	CD	O	O
heparin	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
porcine	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
5,000	CD	O	O
unit	NN	O	O
/	NNP	O	O
ml	NN	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
injection	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

6.	CD	O	O
atorvastatin	JJ	B-TREATMENT	B-TREATMENT
calcium	NN	I-TREATMENT	I-TREATMENT
20	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

7.	CD	O	O
papain	NN	B-TREATMENT	B-TREATMENT
-	:	I-TREATMENT	I-TREATMENT
urea	JJ	I-TREATMENT	I-TREATMENT
830,000-10	JJ	O	I-TREATMENT
unit	NN	O	I-TREATMENT
-%	NNP	O	I-TREATMENT
spray	NN	O	I-TREATMENT
,	,	O	O
non-aerosol	JJ	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
appl	RB	O	O
topical	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

8.	CD	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
regular	JJ	I-TREATMENT	O
human	JJ	I-TREATMENT	O
100	CD	O	O
unit	NN	O	O
/	NNP	O	O
ml	NN	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
sliding	VBG	B-TREATMENT	B-TREATMENT
scale	JJ	I-TREATMENT	I-TREATMENT
injection	NN	I-TREATMENT	I-TREATMENT
asdir	NN	O	I-TREATMENT
(	(	O	O
as	IN	O	O
directed	VBN	O	O
)	)	O	O
:	:	O	O
see	VB	O	O
the	DT	B-TREATMENT	B-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

9.	CD	O	O
zinc	NN	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
220	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

10.	CD	O	O
ascorbic	JJ	B-TREATMENT	B-TREATMENT
acid	RB	I-TREATMENT	I-TREATMENT
500	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

11.	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
tartrate	NN	I-TREATMENT	I-TREATMENT
50	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

12.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
81	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
chewable	JJ	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
chewable	JJ	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

13.	CD	O	O
clopidogrel	NN	B-TREATMENT	B-TREATMENT
bisulfate	NN	I-TREATMENT	I-TREATMENT
75	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

14.	CD	O	O
metronidazole	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
for	IN	O	O
6	CD	O	O
days	NNS	O	O
:	:	O	O
last	JJ	O	O
day	NN	O	O
2017-07-25	JJ	O	O
.	.	O	O

15.	CD	O	O
acetaminophen	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q6h	NN	O	O
(	(	O	O
every	DT	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
.	.	O	O

16.	CD	O	O
olanzapine	JJ	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	RB	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
confusion	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

17.	CD	O	O
protonix	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

18.	CD	O	O
morphine	JJ	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
15	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
tablets	NNS	O	O
po	JJ	O	O
q4-6h	JJ	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
to	TO	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

19.	CD	O	O
levofloxacin	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q24h	NN	O	O
(	(	O	O
every	DT	O	O
24	CD	O	O
hours	NNS	O	O
)	)	O	O
:	:	O	O
last	JJ	O	O
day	NN	O	O
08-07	NNP	O	O
.	.	O	O

20.	CD	O	O
vancomycin	JJ	B-TREATMENT	B-TREATMENT
hcl	NN	I-TREATMENT	I-TREATMENT
in	IN	O	I-TREATMENT
dextrose	JJ	B-TREATMENT	I-TREATMENT
1	CD	O	O
g	NN	O	O
/	VBD	O	O
200	CD	O	O
ml	NN	O	O
piggyback	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
intravenous	JJ	O	O
q	$	O	O
12h	CD	O	O
(	(	O	O
every	DT	O	O
12	CD	O	O
hours	NNS	O	O
)	)	O	O
:	:	O	O
last	JJ	O	O
day	NN	O	O
08-07	NNP	O	O
.	.	O	O

21.	CD	O	O
gabapentin	NN	B-TREATMENT	B-TREATMENT
300	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

22.	CD	O	O
lidocaine	JJ	B-TREATMENT	B-TREATMENT
5	CD	O	O
%(	JJ	O	O
700	CD	O	O
mg	NN	O	O
/	NNP	O	O
patch	NN	O	O
)	)	O	O
adhesive	JJ	O	O
patch	NN	O	O
,	,	O	O
medicated	VBN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
adhesive	JJ	O	O
patch	NN	O	O
,	,	O	O
medicated	VBD	O	O
topical	JJ	O	O
qd	NN	O	O
(	(	O	O
)	)	O	O
.	.	O	O

23.	CD	O	O
morphine	JJ	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
2	CD	O	O
mg	NN	O	O
/	NNP	O	O
ml	NN	O	O
syringe	NN	O	O
sig	NN	O	O
:	:	O	O
02-19	JJ	O	O
injection	NN	O	O
q12h	NN	O	O
(	(	O	O
every	DT	O	O
12	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

24.	CD	O	O
prochlorperazine	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q6h	NN	O	O
(	(	O	O
every	DT	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

1)	CD	O	O
gangrenous	JJ	B-PROBLEM	B-PROBLEM
leg	NN	I-PROBLEM	I-PROBLEM

2)	CD	O	O
urinary	JJ	B-PROBLEM	B-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM

3)	CD	O	O
mrsa	NNS	B-PROBLEM	O
pneumonia	NN	I-PROBLEM	B-PROBLEM

4)	CD	O	O
failure	NN	B-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
thrive	VB	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
weight	VB	B-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM

5)	CD	O	O
altered	VBD	B-PROBLEM	B-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM

6)	CD	O	O
gastric	JJ	B-PROBLEM	B-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM

7)	CD	O	O
c.diff	NN	B-PROBLEM	B-PROBLEM
colitis	NN	I-PROBLEM	I-PROBLEM

1)	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM

2)	CD	O	O
anemia	NN	B-PROBLEM	B-PROBLEM

3)	CD	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM

4)	CD	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
vascular	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM

5)	CD	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	VBP	I-PROBLEM	I-PROBLEM

6)	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM

hemodynamically	RB	O	O
stable	JJ	O	O
,	,	O	O
pt	VB	O	O
doing	VBG	O	O
much	JJ	O	O
better	RBR	O	O
with	IN	O	O
physical	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
passed	VBD	O	O
video	NN	B-TEST	B-TEST
swallow	JJ	I-TEST	I-TEST
evaluation	NN	I-TEST	I-TEST
tolerating	VBG	O	O
po	NN	O	O
.	.	O	O

patient	NN	O	O
needs	VBZ	O	O
to	TO	O	O
take	VB	O	O
all	DT	O	O
of	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
as	IN	O	O
directed	VBN	O	O
.	.	O	O

patient	NN	O	O
needs	VBZ	O	O
to	TO	O	O
continue	VB	O	O
the	DT	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
feed	NN	I-TREATMENT	I-TREATMENT
nutrition	NN	I-TREATMENT	I-TREATMENT
until	IN	O	O
re-assessed	JJ	O	O
by	IN	O	O
the	DT	O	O
nutrionist	NN	O	O
.	.	O	O

he	PRP	O	O
needs	VBZ	O	O
to	TO	O	O
seek	VB	O	O
medical	JJ	O	O
attention	NN	O	O
if	IN	O	O
he	PRP	O	O
develops	VBZ	O	O
fever	RB	B-PROBLEM	B-PROBLEM
,	,	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
any	DT	B-PROBLEM	B-PROBLEM
other	JJ	I-PROBLEM	I-PROBLEM
concerning	NN	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

no	DT	O	O
cpr	NN	B-TREATMENT	B-PROBLEM
/	VBZ	O	O
no	DT	O	O
defib	NN	B-TREATMENT	B-PROBLEM
/	VBZ	O	O
no	DT	O	O
intubation	NN	B-TREATMENT	B-PROBLEM
/	VBZ	O	O
no	DT	O	O
pressors	NNS	B-TREATMENT	B-TREATMENT

albuterol	NN	B-TREATMENT	B-TREATMENT
inhaler	NN	I-TREATMENT	I-TREATMENT
2	CD	O	O
puff	NN	O	O
inh	NN	O	O
qid	NN	O	O
prn	NN	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
wheezing	VBG	B-PROBLEM	B-PROBLEM
vitamin	NN	B-TREATMENT	B-TREATMENT
c	NN	I-TREATMENT	I-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
ascorbic	JJ	I-TREATMENT	I-TREATMENT
acid	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
500	CD	O	O
mg	JJ	O	O
po	NN	O	O
bid	NN	O	O
miacalcin	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
calcitonin	JJ	I-TREATMENT	I-TREATMENT
-	:	I-TREATMENT	I-TREATMENT
salmon	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
1	CD	O	O
spray	NN	O	O
inh	NN	O	O
qd	NN	O	O

1mag	CD	B-TREATMENT	B-TREATMENT
citrate	NN	I-TREATMENT	I-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
citrate	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
magnesia	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
300	CD	O	O
milliliters	NNS	O	O
po	VBP	O	O
qd	JJ	O	O
prn	NN	O	O
constipation	NN	B-PROBLEM	B-PROBLEM
colace	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
docusate	JJ	I-TREATMENT	I-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
po	NN	O	O
tid	VBD	O	O
glyburide	RB	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	JJ	O	O
po	NN	O	O
bid	NN	O	O
starting	VBG	O	O
in	IN	O	O
am	VBP	O	O
on	IN	O	O
12/21/04	CD	O	O
lactulose	JJ	B-TREATMENT	B-TREATMENT
30	CD	O	O
milliliters	NNS	O	O
po	VBP	O	O
q6	NN	O	O

diarrhea	NN	B-PROBLEM	B-PROBLEM

senna	JJ	B-TREATMENT	B-TREATMENT
tablets	NNS	I-TREATMENT	I-TREATMENT
2	CD	O	O
tab	JJ	O	O
po	RB	O	O
bid	VBD	O	O
simethicone	RB	B-TREATMENT	B-TREATMENT
160	CD	O	O
mg	NNS	O	O
po	JJ	O	O
qid	NN	O	O
starting	VBG	O	O
today	NN	O	O
(	(	O	O
12/23	CD	O	O
)	)	O	O
prn	NN	O	O

gas	NN	B-PROBLEM	O
,	,	O	O
upset	JJ	B-PROBLEM	B-PROBLEM
stomach	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

tamoxifen	RB	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NNS	O	O
po	JJ	O	O
qd	NN	O	O

override	RB	O	O
added	VBD	O	O
on	IN	O	O
12/19/04	CD	O	O
by	IN	O	O
sapmoores	NNS	O	O
,	,	O	O
nell	RB	O	O
rilet	NN	O	O
,	,	O	O
m.d.	NN	O	O
on	IN	O	O
order	NN	O	O
for	IN	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
po	NN	I-TREATMENT	I-TREATMENT
(	(	O	O
ref	JJ	O	O
#	#	O	O
88006031	CD	O	O
)	)	O	O

potentially	RB	O	O
serious	JJ	B-PROBLEM	O
interaction	NN	I-PROBLEM	O
:	:	O	O

tamoxifen	NN	B-TREATMENT	B-TREATMENT
citrate	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT

aware	JJ	O	O
mvi	RBR	B-TREATMENT	O
therapeutic	JJ	I-TREATMENT	B-TREATMENT
w	NN	I-TREATMENT	I-TREATMENT
/	NN	I-TREATMENT	I-TREATMENT
minerals	NNS	I-TREATMENT	I-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
therap	VB	I-TREATMENT	I-TREATMENT
vits	NNS	I-TREATMENT	I-TREATMENT
/	NNP	I-TREATMENT	I-TREATMENT
minerals	NNS	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
1	CD	O	O
tab	NN	O	O
po	NN	O	O
qd	NN	O	O
pilocarpine	NN	B-TREATMENT	B-TREATMENT
4%	CD	I-TREATMENT	O
solution	NN	I-TREATMENT	B-TREATMENT
1	CD	O	I-TREATMENT
drop	NN	O	I-TREATMENT
os	NN	O	I-TREATMENT
qid	JJ	O	I-TREATMENT
flonase	NN	B-TREATMENT	I-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
fluticasone	JJ	I-TREATMENT	I-TREATMENT
nasal	NN	I-TREATMENT	I-TREATMENT
spray	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
2	CD	O	I-TREATMENT
spray	JJ	O	I-TREATMENT
inh	NN	O	I-TREATMENT
bid	NN	O	O

2	CD	B-TREATMENT	O
alphagan	NN	I-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
brimonidine	JJ	I-TREATMENT	I-TREATMENT
tartrate	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
1	CD	O	O
drop	NN	O	O
os	NN	O	O
bid	NN	O	O

2	CD	B-TREATMENT	O
levofloxacin	JJ	I-TREATMENT	B-TREATMENT
250	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
x	$	O	O
1	CD	O	O
days	NNS	O	O
starting	VBG	O	O
today	NN	O	O
(	(	O	O
12/21	CD	O	O
)	)	O	O

administer	RB	O	O
iron	NN	B-TREATMENT	B-TREATMENT
products	NNS	I-TREATMENT	I-TREATMENT
a	DT	O	O
minimum	NN	O	O
of	IN	O	O
2	CD	O	O
hours	NNS	O	O
before	IN	O	O
or	CC	O	O
after	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
levofloxacin	NN	I-TREATMENT	I-TREATMENT
or	CC	O	O
ciprofloxacin	NN	B-TREATMENT	B-TREATMENT
dose	VBP	O	O
dose	NN	O	O

if	IN	O	O
on	IN	O	O
tube	NN	B-TREATMENT	B-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
please	VB	O	O
cycle	NN	O	O
(	(	O	O
hold	VB	O	O
1	CD	O	O
hr	NN	O	O
before	IN	O	O
to	TO	O	O
2	CD	O	O
hr	NNS	O	O
after	IN	O	O
)	)	O	O

potentially	RB	O	O
serious	JJ	B-PROBLEM	O
interaction	NN	I-PROBLEM	O
:	:	O	O

tamoxifen	NN	B-TREATMENT	B-TREATMENT
citrate	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT

celexa	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
citalopram	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
20	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
calcium	NN	B-TREATMENT	B-TREATMENT
carb	NN	I-TREATMENT	I-TREATMENT
+	NNP	I-TREATMENT	O
d	NN	I-TREATMENT	O
(	(	O	O
600mg	CD	O	O
elem	NN	B-TREATMENT	O
ca	MD	I-TREATMENT	O
+	VB	I-TREATMENT	O
vit	NN	I-TREATMENT	B-TREATMENT
d/200	NN	I-TREATMENT	I-TREATMENT
iu	NN	O	I-TREATMENT
)	)	O	I-TREATMENT
1	CD	O	O
tab	JJ	O	O
po	RB	O	O
bid	NN	O	O
lumigan	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
bimatoprost	$	I-TREATMENT	I-TREATMENT
0.03%	CD	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
1	CD	O	O
drop	NN	O	O
ou	NN	O	O
qhs	NN	O	O

cefuroxime	JJ	B-TREATMENT	B-TREATMENT
axetiladmit	NN	O	I-TREATMENT
diagnosis	NN	O	O
:	:	O	O

abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

responsible	JJ	O	O
after	IN	O	O
study	NN	O	O
for	IN	O	O
causing	VBG	O	O
admission	NN	O	O
)	)	O	O
abdominal	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

conditions	NNS	O	O
,	,	O	O
infections	NNS	O	O
,	,	O	O
complications	NNS	O	O
,	,	O	O
affecting	VBG	O	O
treatment	NN	O	O
/	NNP	O	O
stay	NN	O	O
allergies	NNS	B-PROBLEM	B-PROBLEM
-	:	O	O
pcn	NN	B-TREATMENT	O
-	:	O	O
rash	NN	B-PROBLEM	B-PROBLEM
-	:	O	O
bactrim	SYM	B-TREATMENT	O
-	:	O	O
hives	VBZ	B-PROBLEM	O
-	:	O	O
erythro	NN	B-TREATMENT	O
-	:	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
-	:	O	O
ceclor	NN	B-TREATMENT	B-TEST
-	:	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
-	:	O	O
clarythro	NN	B-TREATMENT	O
=	NN	O	O
rash	NN	B-PROBLEM	O

67	CD	O	O
y/o	JJ	O	O
f	NN	O	O
w/	NN	O	O
hx	NN	O	B-PROBLEM
poliomyelitis	NN	B-PROBLEM	I-PROBLEM
,	,	O	O
breast	NN	B-PROBLEM	O
ca	MD	I-PROBLEM	O
stable	VB	O	O
on	IN	O	O
tamoxifen	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
vent	JJ	B-PROBLEM	B-PROBLEM
dependent	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
an	DT	B-TREATMENT	O
iron	NN	I-TREATMENT	O
lung	NN	I-TREATMENT	O
admitted	VBD	O	O
w/	JJ	O	O
1	CD	O	O
day	NN	O	O
hx	NN	O	O
of	IN	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pt	NN	O	O
was	VBD	O	O
recently	RB	O	O
admitted	VBN	O	O
1	CD	O	O
week	NN	O	O
ago	RB	O	O
w/	VBD	O	O
epigastric	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pain	NN	B-PROBLEM	B-PROBLEM
worse	NN	O	O
with	IN	O	O
movement	NN	O	O
.	.	O	O

she	PRP	O	O
denies	VBZ	O	O
any	DT	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
brbpr	NN	B-PROBLEM	O
,	,	O	O
melena	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
dysuria	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
admision	NN	O	B-TREATMENT
,	,	O	O
t	NN	B-TEST	O
97.5	CD	O	O
,	,	O	O
hr	NN	B-TEST	B-TEST
86	CD	O	O
,	,	O	O
bp	NN	B-TEST	B-TEST
111/47	CD	O	O
,	,	O	O
r	NN	B-TEST	O
20	CD	O	O
.	.	O	O

sat	RB	B-TEST	B-TEST
94%	CD	O	O
on	IN	O	O
4l	CD	B-TREATMENT	O
.	.	O	O

exam	NN	B-TEST	B-TEST
notable	JJ	O	O
for	IN	O	O
hyperactive	JJ	B-PROBLEM	B-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
sounds	VBZ	I-PROBLEM	I-PROBLEM
with	IN	O	O
abd	JJ	B-PROBLEM	B-PROBLEM
distention	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
tenderness	NN	B-PROBLEM	B-PROBLEM
to	TO	O	O
palpation	NN	B-TEST	B-TEST
at	IN	I-TEST	I-TEST
llq	NN	I-TEST	I-TEST
and	CC	O	O
rlq	NN	O	O
.	.	O	O

no	DT	O	O
rebound	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
guarding	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

abd	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
showed	VBD	O	O
stable	JJ	O	O
findings	NNS	O	O
compared	VBN	O	O
to	TO	O	O
12/10/04	CD	O	O
except	IN	O	O
for	IN	O	O
distended	JJ	B-PROBLEM	B-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
colon	NN	I-PROBLEM	I-PROBLEM
consistent	JJ	O	O
with	IN	O	O
ileus	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

pt	NN	O	B-TEST
&apos;s	NNP	O	I-TEST
clinical	JJ	O	I-TEST
picture	NN	O	I-TEST
was	VBD	O	O
consistent	JJ	O	O
with	IN	O	O
constipation-related	JJ	B-PROBLEM	B-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pt	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
bowel	NN	B-TREATMENT	B-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
with	IN	O	O
senna	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
magcitrate	NN	B-TREATMENT	B-PROBLEM
and	CC	O	O
lactulose	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

her	PRP$	B-PROBLEM	B-TEST
abd	JJ	I-PROBLEM	I-TEST
distention	NN	I-PROBLEM	I-TEST
and	CC	O	O
tenderness	NN	B-PROBLEM	B-PROBLEM
improved	VBN	O	O
after	IN	O	O
bowel	NN	O	O
movement	NN	O	O
.	.	O	O

pt	NN	O	O
was	VBD	O	O
levo	JJ	B-TREATMENT	B-TREATMENT
250mg	CD	O	O
x	JJ	O	O
3	CD	O	O
days	NNS	O	O
for	IN	O	O
uti	JJ	B-PROBLEM	B-PROBLEM
(	(	O	I-PROBLEM
pyuria	NNS	B-PROBLEM	I-PROBLEM
on	IN	O	O
admisstion	NN	O	O
)	)	O	O
.	.	O	O

pt	NN	O	O
has	VBZ	O	O
been	VBN	O	O
using	VBG	O	O
iron	NN	B-TREATMENT	B-TREATMENT
lung	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
breathing	NN	O	B-PROBLEM
and	CC	O	O
has	VBZ	O	O
been	VBN	O	O
satting	VBG	O	O
well	RB	O	O
duing	VBG	O	O
her	PRP$	O	O
hospital	NN	O	O
course	NN	O	O
.	.	O	O

1.	CD	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
dilated	VBN	B-PROBLEM	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
a	DT	O	O
27	CD	O	O
week	NN	O	B-PROBLEM
intrauterine	JJ	B-PROBLEM	I-PROBLEM
pregnancy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

5.	CD	O	O
asthma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

6.	CD	O	O
history	NN	O	O
of	IN	O	O
atrioseptal	JJ	B-PROBLEM	B-PROBLEM
defect	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
28	CD	O	O
-	:	O	O
year-old	NN	O	O
,	,	O	O
gravida	NN	O	O
3	CD	O	O
,	,	O	O
para	NN	O	O
1	CD	O	O
,	,	O	O
at	IN	O	O
approximately	RB	O	O
27	CD	O	O
weeks	NNS	O	O
gestation	NN	O	O
,	,	O	O
who	WP	O	O
was	VBD	O	O
admitted	VBN	O	O
on	IN	O	O
2014-05-12	JJ	O	O
due	JJ	O	O
to	TO	O	O
increasing	VBG	O	B-PROBLEM
symptoms	NNS	O	I-PROBLEM
of	IN	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
known	VBN	B-PROBLEM	B-PROBLEM
dilated	VBN	I-PROBLEM	I-PROBLEM
cardiomyopathy	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-TEST	B-TEST
baseline	NN	I-TEST	I-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
approximately	RB	O	O
25%	CD	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
been	VBN	O	O
managed	VBN	O	O
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
during	IN	O	O
her	PRP$	O	B-PROBLEM
pregnancy	NN	O	I-PROBLEM
and	CC	O	O
was	VBD	O	O
on	IN	O	O
multiple	JJ	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
including	VBG	O	O
lasix	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
daily	RB	O	O
,	,	O	O
hydralazine	PRP	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	JJ	O	O
daily	RB	O	O
,	,	O	O
toprol	NN	B-TREATMENT	B-TREATMENT
xl	VBD	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	JJ	O	O
daily	RB	O	O
,	,	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
0.5	CD	O	O
mg	JJ	O	O
daily	JJ	O	O
and	CC	O	O
lovenox	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
twice	RB	O	O
daily	RB	O	O
subcutaneously	RB	O	O
.	.	O	O

she	PRP	O	O
also	RB	O	O
took	VBD	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
on	IN	O	O
a	DT	O	O
p.r.n.	JJ	O	O
basis	NN	O	O
for	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
asthma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
known	VBN	B-PROBLEM	B-PROBLEM
allergy	NNS	I-PROBLEM	I-PROBLEM
to	TO	O	O
penicillin	VB	B-TREATMENT	B-TREATMENT
,	,	O	O
vancomycin	FW	B-TREATMENT	B-TREATMENT
and	CC	O	O
erythromycin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
symptoms	NNS	O	B-PROBLEM
of	IN	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
decreased	VBN	B-PROBLEM	B-PROBLEM
fetal	JJ	I-PROBLEM	I-PROBLEM
movement	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

fetal	JJ	B-TEST	B-TEST
monitoring	NN	I-TEST	I-TEST
initially	RB	O	O
on	IN	O	O
admission	NN	O	O
was	VBD	O	O
appropriate	JJ	O	O
for	IN	O	O
gestational	JJ	O	O
age	NN	O	O
.	.	O	O

on	IN	O	O
physical	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
,	,	O	O
she	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
elevated	VBD	I-PROBLEM	I-PROBLEM
pressures	NNS	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
140	CD	O	O
to	TO	O	O
150/90	CD	O	O
range	NN	O	O
,	,	O	O
and	CC	O	O
jugular	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
distension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

after	IN	O	O
consultation	NN	O	O
with	IN	O	O
cardiology	NN	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
anesthesia	NN	O	B-TREATMENT
on	IN	O	O
call	NN	O	O
that	IN	O	O
evening	NN	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
to	TO	O	O
transfer	VB	O	O
the	DT	O	O
patient	NN	O	O
to	TO	O	O
the	DT	O	O
icu	NN	O	O
for	IN	O	O
intensive	JJ	B-TEST	B-TEST
monitoring	NN	I-TEST	I-TEST
.	.	O	O

central	JJ	B-TREATMENT	B-TREATMENT
iv	JJ	I-TREATMENT	I-TREATMENT
access	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
obtained	VBN	O	O
.	.	O	O

symptoms	NNS	O	B-PROBLEM
of	IN	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
gradually	RB	O	I-PROBLEM
abated	VBN	O	I-PROBLEM
over	IN	O	O
the	DT	O	O
next	JJ	O	O
48	CD	O	O
to	TO	O	O
72	CD	O	O
hours	NNS	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
given	VBN	O	O
antenatal	JJ	B-TREATMENT	B-TREATMENT
corticosteroids	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
fetal	JJ	O	B-PROBLEM
lung	NN	O	I-PROBLEM
maturity	NN	O	I-PROBLEM
.	.	O	O

after	IN	O	O
discussion	NN	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
to	TO	O	O
attempt	VB	O	O
to	TO	O	O
obtain	VB	O	O
28	CD	O	O
weeks	NNS	O	O
gestation	NN	O	O
and	CC	O	O
then	RB	O	O
deliver	VB	O	O
electively	RB	O	O
by	IN	O	O
cesarean	JJ	B-TREATMENT	B-TREATMENT
section	NN	I-TREATMENT	I-TREATMENT
given	VBN	O	O
the	DT	B-PROBLEM	O
decompensation	NN	I-PROBLEM	O
in	IN	O	O
the	DT	O	O
third	JJ	O	O
trimester	NN	O	O
.	.	O	O

the	DT	O	O
patient	JJ	O	O
underwent	JJ	O	O
primary	JJ	B-TREATMENT	B-TREATMENT
low	JJ	I-TREATMENT	I-TREATMENT
transverse	NN	I-TREATMENT	I-TREATMENT
cesarean	NN	I-TREATMENT	I-TREATMENT
section	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
2014-05-19	JJ	O	O
at	IN	O	O
approximately	RB	O	O
28	CD	O	O
weeks	NNS	O	O
gestation	NN	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
cesarean	JJ	I-TREATMENT	I-TREATMENT
section	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
performed	VBN	O	O
on	IN	O	O
the	DT	O	O
west	NN	O	O
campus	NN	O	O
in	IN	O	O
the	DT	O	O
cardiothoracic	NN	O	O
surgical	JJ	O	O
suite	NN	O	O
.	.	O	O

this	DT	O	O
was	VBD	O	O
performed	VBN	O	O
in	IN	O	O
this	DT	O	O
location	NN	O	O
in	IN	O	O
case	NN	O	O
any	DT	B-PROBLEM	O
acute	JJ	I-PROBLEM	B-PROBLEM
cardiac	JJ	I-PROBLEM	I-PROBLEM
decompensation	NN	I-PROBLEM	I-PROBLEM
occurred	VBD	O	O
during	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
cesarean	JJ	B-TREATMENT	B-TREATMENT
section	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

cardiothoracic	NN	O	B-TREATMENT
surgery	NN	O	I-TREATMENT
was	VBD	O	O
on	IN	O	O
standby	NN	O	O
during	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
required	VBD	O	O
several	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
diuresis	NN	B-TREATMENT	B-TREATMENT
due	JJ	O	O
to	TO	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
shortness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#1	NNP	O	O
and	CC	O	O
postoperative	JJ	O	O
day	NN	O	O
#2	VBD	O	O
due	JJ	O	O
to	TO	O	O
worsening	VBG	O	B-PROBLEM
symptoms	NNS	O	I-PROBLEM
of	IN	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
fluid	JJ	B-PROBLEM	B-TEST
shifts	NNS	I-PROBLEM	I-TEST
that	WDT	O	O
normally	RB	O	O
occur	VBP	O	O
during	IN	O	O
the	DT	O	O
postpartum	JJ	O	O
period	NN	O	O
.	.	O	O

she	PRP	O	O
did	VBD	O	O
well	RB	O	O
during	IN	O	O
the	DT	O	O
remainder	NN	O	O
of	IN	O	O
her	PRP$	O	B-TREATMENT
postoperative	JJ	O	I-TREATMENT
course	NN	O	I-TREATMENT
and	CC	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
medication	NN	I-TREATMENT	I-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
that	IN	O	O
she	PRP	O	O
had	VBD	O	O
been	VBN	O	O
on	IN	O	O
during	IN	O	O
the	DT	O	O
antepartum	JJ	O	O
period	NN	O	O
.	.	O	O

of	IN	O	O
note	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
also	RB	O	O
underwent	JJ	O	O
tubal	JJ	B-TREATMENT	B-TREATMENT
ligation	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
cesarean	JJ	B-TREATMENT	B-TREATMENT
section	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

toprol	NN	B-TREATMENT	B-TREATMENT
xl	VBZ	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	JJ	O	O
daily	RB	O	O
,	,	O	O
hydralazine	PRP	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	JJ	O	O
daily	RB	O	O
,	,	O	O
lasix	VBD	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
,	,	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
0.75	CD	O	O
mg	JJ	O	O
daily	RB	O	O
,	,	O	O
lovenox	VBD	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
twice	RB	O	O
daily	RB	O	O
subcutaneously	RB	O	O
and	CC	O	O
albuterol	VB	B-TREATMENT	B-TREATMENT
p.r.n.	NN	O	O

acute	JJ	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

acute	JJ	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

status	NN	O	O
post	NN	O	O
aortic	JJ	B-TREATMENT	B-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
status	NN	O	O
post	NN	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

percutaneous	JJ	B-TREATMENT	B-TREATMENT
angioplasty	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
4/9/95	CD	O	O
.	.	O	O

directional	JJ	B-TREATMENT	B-TREATMENT
angioplasty	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
,	,	I-TREATMENT	O
left	VBD	I-TREATMENT	O
main	JJ	I-TREATMENT	O
and	CC	I-TREATMENT	O
left	VBD	I-TREATMENT	O
anterior	RP	I-TREATMENT	O
descending	VBG	I-TREATMENT	O
vessels	NNS	I-TREATMENT	O
.	.	O	O

lanoxin	NN	B-TREATMENT	B-TREATMENT
0.375	CD	O	O
mg.	JJ	O	O
daily	RB	O	O
.	.	O	O

coumadin	NN	B-TREATMENT	B-TREATMENT
as	IN	O	O
adjusted	VBN	O	O
by	IN	O	O
prothrombin	NN	B-TEST	B-TEST
times	NNS	I-TEST	O
,	,	O	O
isordil	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg.	NN	O	O
tid	NN	O	O
,	,	O	O
micronase	NN	B-TREATMENT	B-TREATMENT
1.25	CD	O	O
mg.	JJ	O	O
daily	RB	O	O
,	,	O	O
aspirin	VBZ	B-TREATMENT	B-TREATMENT
81	CD	O	O
mg.	JJ	O	O
daily	RB	O	O
,	,	O	O
nitroglycerin	RB	B-TREATMENT	B-TREATMENT
0.3	CD	O	O
mg.	NNS	O	O
sl	JJ	O	O
prn	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
seventy	NN	O	O
two	CD	O	O
year	NN	O	O
old	JJ	O	O
man	NN	O	O
who	WP	O	O
a	DT	O	O
number	NN	O	O
of	IN	O	O
years	NNS	O	O
ago	RB	O	O
underwent	JJ	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
another	DT	O	O
institution	NN	O	O
.	.	O	O

in	IN	O	O
1992	CD	O	O
he	PRP	O	O
underwent	VBD	O	O
redo	JJ	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
aortic	JJ	B-TREATMENT	B-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

in	IN	O	O
april	JJ	O	O
1994	CD	O	O
he	PRP	O	O
presented	VBD	O	O
with	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
acute	JJ	I-PROBLEM	I-PROBLEM
inferior	JJ	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
given	VBN	O	O
streptokinase	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
had	VBD	O	O
recurrent	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
went	VBD	O	O
to	TO	O	O
the	DT	O	O
catheter	NN	O	O
laboratory	NN	O	O
where	WRB	O	O
a	DT	B-PROBLEM	B-PROBLEM
proximal	JJ	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
angioplastied	VBN	O	O
.	.	O	O

a	DT	O	O
relook	JJ	O	O
several	JJ	O	O
days	NNS	O	O
later	RB	O	O
led	VBD	O	O
to	TO	O	O
a	DT	B-TREATMENT	B-TREATMENT
repeat	NN	I-TREATMENT	I-TREATMENT
percutaneous	JJ	I-TREATMENT	I-TREATMENT
transluminal	JJ	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
angioplasty	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
has	VBZ	O	O
stable	VBN	B-PROBLEM	O
,	,	I-PROBLEM	O
mild	JJ	I-PROBLEM	B-PROBLEM
angina	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
subsequently	RB	O	O
,	,	O	O
mostly	RB	O	O
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
stress	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
admission	NN	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
involved	VBN	O	O
in	IN	O	O
a	DT	O	O
minor	JJ	O	O
motor	NN	O	O
vehicle	NN	O	O
accident	NN	O	O
,	,	O	O
and	CC	O	O
there	EX	O	O
was	VBD	O	O
some	DT	O	O
apparent	JJ	O	O
controversy	NN	O	O
with	IN	O	O
the	DT	O	O
driver	NN	O	O
of	IN	O	O
the	DT	O	O
other	JJ	O	O
vehicle	NN	O	O
,	,	O	O
during	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
which	WDT	O	O
he	PRP	O	O
developed	VBD	O	O
substernal	JJ	B-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
radiating	VBG	O	O
to	TO	O	O
the	DT	O	O
left	JJ	O	O
arm	NN	O	O
and	CC	O	O
shoulder	NN	O	B-PROBLEM
.	.	O	O

this	DT	O	O
waxed	NN	O	O
and	CC	O	O
waned	VBD	O	O
for	IN	O	O
thirty	NN	O	O
to	TO	O	O
sixty	VB	O	O
minutes	NNS	O	O
,	,	O	O
and	CC	O	O
he	PRP	O	O
took	VBD	O	O
a	DT	O	O
number	NN	O	O
of	IN	O	O
nitroglycerins	NNS	B-TREATMENT	B-PROBLEM
.	.	O	O

after	IN	O	O
returning	VBG	O	O
home	NN	O	O
after	IN	O	O
conferring	VBG	O	O
with	IN	O	O
his	PRP$	O	O
wife	NN	O	O
,	,	O	O
and	CC	O	O
the	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
lasted	VBD	O	O
another	DT	O	O
half	JJ	O	O
hour	NN	O	O
,	,	O	O
he	PRP	O	O
came	VBD	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
showed	VBD	O	O
increased	VBN	B-PROBLEM	B-PROBLEM
t	NNS	I-PROBLEM	I-PROBLEM
wave	VBP	I-PROBLEM	I-PROBLEM
inversions	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
v3	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
v4	NN	O	O
and	CC	O	O
1	CD	O	O
mm	NN	O	O
.	.	O	O

st	NN	B-PROBLEM	B-PROBLEM
segment	NN	I-PROBLEM	I-PROBLEM
depression	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
v3	NN	I-PROBLEM	O
through	IN	O	O
v6	NN	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
largely	RB	O	O
benign	JJ	O	O
after	IN	O	O
he	PRP	O	O
was	VBD	O	O
made	VBN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
free	JJ	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
pulse	NN	I-TEST	I-TEST
was	VBD	O	O
75	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
120/80	CD	O	O
,	,	O	O
respirations	NNS	B-TEST	B-TEST
18	CD	O	O
,	,	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	B-TEST
jugular	NN	O	I-TEST
veins	NNS	O	I-TEST
were	VBD	O	O
not	RB	O	O
distended	VBN	B-PROBLEM	B-PROBLEM
,	,	O	O
the	DT	B-TEST	B-TEST
carotid	NN	I-TEST	I-TEST
volume	NN	I-TEST	I-TEST
was	VBD	O	O
diminished	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
were	VBD	O	O
normal	JJ	B-TREATMENT	O
prothetic	JJ	I-TREATMENT	O
valves	NNS	I-TREATMENT	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
grade	JJ	I-PROBLEM	I-PROBLEM
ii-ii	JJ	I-PROBLEM	I-PROBLEM
apical	JJ	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
was	VBD	O	O
negative	JJ	O	O
and	CC	O	O
there	EX	O	O
was	VBD	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
feet	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
demonstrated	VBD	O	O
normal	JJ	O	O
sinus	NNS	O	O
rhythm	VBP	O	O
with	IN	O	O
poor	JJ	B-PROBLEM	B-PROBLEM
r	NNS	I-PROBLEM	I-PROBLEM
wave	VBP	I-PROBLEM	I-PROBLEM
progression	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
left	VBD	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
enlargement	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
t	NN	B-PROBLEM	I-PROBLEM
wave	VBP	I-PROBLEM	I-PROBLEM
inversion	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
leads	VBZ	I-PROBLEM	O
v	RB	I-PROBLEM	O
4	CD	I-PROBLEM	O
,	,	I-PROBLEM	O
5	CD	I-PROBLEM	O
,	,	O	O
and	CC	O	O

patient	NN	O	O
recorded	VBD	O	O
as	IN	O	O
having	VBG	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
to	TO	O	O
drugs	NNS	B-TREATMENT	B-TREATMENT

chief	JJ	O	O
complaint	NN	O	O
:	:	O	O
change	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM

intubation	NN	B-TREATMENT	B-TREATMENT

central	JJ	B-TREATMENT	B-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT

64	CD	O	O
f	NN	O	O
with	IN	O	O
breast	NN	B-PROBLEM	O
ca	MD	I-PROBLEM	O
s/p	VB	O	O
mastectomy	JJ	B-TREATMENT	B-TREATMENT
17	CD	O	O
y	NN	O	O
ago	IN	O	O
with	IN	O	O
local	JJ	B-PROBLEM	O
recurrence	NN	I-PROBLEM	O
leading	VBG	O	O
to	TO	O	O
paralysis	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	O
l	NN	I-PROBLEM	O
arm	NN	I-PROBLEM	O
~	NNP	O	O
5-6	CD	O	O
y	NN	O	O
ago	RB	O	O
.	.	O	O

now	RB	O	O
declining	VBG	O	O
gradually	RB	O	O
since	IN	O	O
january	NN	O	O
(	(	O	O
30	CD	B-PROBLEM	O
lbs	NNS	I-PROBLEM	O
weight	JJ	I-PROBLEM	B-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
becoming	VBG	O	O
more	RBR	B-PROBLEM	O
confused	JJ	I-PROBLEM	O
,	,	O	O
decreased	JJ	B-PROBLEM	B-PROBLEM
appetite	NN	I-PROBLEM	I-PROBLEM
).	NN	O	O

patient	NN	O	O
declined	VBD	O	O
workup	JJ	B-TEST	B-TEST
/	NNP	O	I-TEST
imaging	NN	B-TEST	I-TEST
for	IN	O	O
mets	NNS	B-PROBLEM	O
as	IN	O	O
outpatient	NN	O	O
.	.	O	O

over	IN	O	O
the	DT	O	O
last	JJ	O	O
2	CD	O	O
weeks	NNS	O	O
,	,	O	O
husband	NN	O	O
reports	NNS	O	O
patient	JJ	O	O
becoming	VBG	O	O
increasingly	RB	B-PROBLEM	B-PROBLEM
weak	JJ	I-PROBLEM	I-PROBLEM
,	,	O	O
unable	JJ	O	O
to	TO	O	O
leave	VB	O	O
bed	NN	O	O
,	,	O	O
confused	VBN	B-PROBLEM	B-PROBLEM
,	,	O	O
unable	JJ	O	O
to	TO	O	O
feed	VB	O	O
herself	PRP	O	O
.	.	O	O

seen	VBN	O	O
by	IN	O	O
vna	NN	O	O
and	CC	O	O
noted	VBD	O	O
to	TO	O	O
be	VB	O	O
tachycardic	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
sent	VBD	O	O
to	TO	O	O
middleboroughfor	VB	O	B-TEST
evaluation	NN	B-TEST	I-TEST
.	.	O	O

now	RB	O	O
sent	VBN	O	O
in	IN	O	O
to	TO	O	O
amesbury	VB	O	O
by	IN	O	O
vna	NN	O	O
because	IN	O	O
of	IN	O	O
asymptomatic	JJ	B-PROBLEM	B-PROBLEM
sinus	NN	I-PROBLEM	I-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

transferred	VBN	O	O
here	RB	O	O
for	IN	O	O
workup	NN	B-TEST	B-TEST
for	IN	O	O
cns	JJ	B-PROBLEM	B-PROBLEM
mets	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
admission	NN	O	O
.	.	O	O

in	IN	O	O
john	NN	O	O
,	,	O	O
vs	SYM	B-TEST	O
-	:	O	O
99.6	CD	O	O
,	,	O	O
135	CD	O	O
,	,	O	O
122/65	CD	O	O
,	,	O	O
20	CD	O	O
.	.	O	O

neurosurg	RB	O	O
evaluated	VBN	O	O
pt	NN	O	O
and	CC	O	O
felt	VBD	O	O
to	TO	O	O
not	RB	O	O
be	VB	O	O
surgical	JJ	O	O
candidate	NN	O	O
;	:	O	O
recommended	VBN	O	O
dilantin	NN	B-TREATMENT	B-TREATMENT
load	NN	I-TREATMENT	I-TREATMENT
and	CC	O	I-TREATMENT
decadron	NN	B-TREATMENT	I-TREATMENT
.	.	O	O

received	VBN	O	O
lorazepam	JJ	B-TREATMENT	B-TREATMENT
prior	RB	O	O
to	TO	O	O
ct	VB	B-TEST	B-TEST
scan	JJ	I-TEST	I-TEST
.	.	O	O

intubated	VBN	O	B-TREATMENT
for	IN	O	O
ms	NN	B-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
lethargy	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
concern	NN	O	O
for	IN	O	O
airway	NN	B-TREATMENT	B-TREATMENT
protection	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

post	NN	O	O
intubation	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
hypotensive	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
started	VBD	O	O
on	IN	O	O
dopamine	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
transitioned	VBD	O	O
to	TO	O	O
levophed	VB	B-TREATMENT	O
.	.	O	O

received	VBN	O	O
vancomycin	JJ	B-TREATMENT	B-TREATMENT
/	JJ	O	O
levafloxacin	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
osh	NN	O	O
.	.	O	O

received	VBN	O	O
metronidazole	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
ricky	NN	O	O
in	IN	O	O
mediplex	JJ	O	O
rehab	NN	O	O
hospital	NN	O	O
.	.	O	O

in	IN	O	O
cmed	JJ	O	O
ccu	NN	O	O
,	,	O	O
pt.	RB	O	O
responsive	JJ	O	O
to	TO	O	O
noxious	JJ	B-TEST	B-TEST
stimuli	NNS	I-TEST	I-TEST
only	RB	O	O
.	.	O	O

1.	CD	O	O
left	VBD	O	O
breast	NN	O	O
status	NN	O	O
post	NN	O	O
radical	JJ	B-TREATMENT	B-TREATMENT
mastectomy	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
2002	CD	O	O
with	IN	O	O
adjuvant	JJ	B-TREATMENT	B-TREATMENT
tamoxifen	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
five	CD	O	O
years	NNS	O	O
.	.	O	O

this	DT	O	O
was	VBD	O	O
followed	VBN	O	O
by	IN	O	O
later	RBR	O	O
development	NN	O	O
of	IN	O	O
lymphedema	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
left	VBD	B-PROBLEM	O
arm	NN	I-PROBLEM	O
(	(	I-PROBLEM	O
distal	JJ	I-PROBLEM	O
>	NNP	I-PROBLEM	O
proximal	NN	I-PROBLEM	O
)	)	I-PROBLEM	O
weakness	NN	I-PROBLEM	B-PROBLEM
due	JJ	O	O
to	TO	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
axilla	NN	I-PROBLEM	I-PROBLEM
ensheathing	VBG	I-PROBLEM	I-PROBLEM
nerve	NN	I-PROBLEM	I-PROBLEM
plexus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

treated	VBN	O	O
with	IN	O	O
course	NN	O	O
of	IN	O	O
local	JJ	B-TREATMENT	O
xrt	NN	I-TREATMENT	O
in	IN	O	O
springfield	NN	O	O
municipal	JJ	O	O
hospital	NN	O	O
and	CC	O	O
tamoxifen	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

switched	VBN	O	O
to	TO	O	O
arimedex	VB	B-TREATMENT	O
in	IN	O	O
2019-02-10	JJ	O	O
due	JJ	O	O
to	TO	O	O
vaginal	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
tamoxifen	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

self	NN	O	O
discontinued	VBN	O	O
arimedex	NN	B-TREATMENT	O
last	JJ	O	O
month	NN	O	O
.	.	O	O

no	DT	O	O
prior	JJ	O	O
history	NN	O	O
of	IN	O	O
intracranial	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
arm	NN	I-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	O
brachial	JJ	I-PROBLEM	B-PROBLEM
plexus	NN	I-PROBLEM	I-PROBLEM
resulting	VBG	O	I-PROBLEM
in	IN	O	I-PROBLEM
left	JJ	B-PROBLEM	I-PROBLEM
arm	NN	I-PROBLEM	I-PROBLEM
paresis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
as	IN	O	O
above	IN	O	O

maternal	JJ	O	O
aunt	NN	O	O
with	IN	O	O
breast	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

father	RB	O	O
deceased	VBN	O	O
from	IN	O	O
complications	NNS	B-PROBLEM	B-PROBLEM
from	IN	O	O
ms	NN	B-PROBLEM	O
.	.	O	O

t	NN	B-TEST	O
99.8	CD	O	O

hr	NN	B-TEST	B-TEST
124	CD	O	O

sbp	NN	B-TEST	O
135/58	CD	O	O

rr	NN	B-TEST	B-TEST
16	CD	O	O

ox	RB	B-TEST	B-TREATMENT
100	CD	O	O

cachectic	JJ	B-PROBLEM	O
,	,	O	O
lays	VBZ	O	O
with	IN	O	O
eyes	NNS	O	O
closed	VBD	O	O
.	.	O	O

temporal	JJ	B-PROBLEM	O
wasting	NN	I-PROBLEM	O
.	.	O	O

nc/at	NN	B-PROBLEM	O
.	.	O	O

anicteric	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

mucosa	NN	B-PROBLEM	B-PROBLEM
dry	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
r/r/w	NN	B-PROBLEM	O
.	.	O	O

tachycardic	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
regular	JJ	O	O
.	.	O	O

no	DT	O	O
m/r/g	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

soft	JJ	O	O
,	,	O	O
nt	JJ	B-PROBLEM	O
,	,	O	O
nd	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
+	JJ	O	O
nabs	NN	O	O
.	.	O	O

no	DT	O	O
rebound	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
guarding	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
hsm	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

wasted	VBN	B-PROBLEM	O
.	.	O	O

legs	NNS	O	O
are	VBP	O	O
rigid	JJ	B-PROBLEM	O
.	.	O	O

head	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
there	EX	O	O
is	VBZ	O	O
diffuse	JJ	B-PROBLEM	B-PROBLEM
metastatic	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

three	CD	B-PROBLEM	B-PROBLEM
discrete	JJ	I-PROBLEM	I-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
are	VBP	O	O
seen	VBN	O	O
within	IN	O	O
the	DT	O	O
left	JJ	O	O
frontal	NN	O	O
,	,	O	O
right	JJ	O	B-PROBLEM
occipital	NN	O	I-PROBLEM
,	,	O	O
and	CC	O	O
left	VBD	O	B-PROBLEM
parietal	JJ	O	I-PROBLEM
lobes	NNS	O	I-PROBLEM
with	IN	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
surrounding	VBG	I-PROBLEM	I-PROBLEM
vasogenic	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	B-TEST
largest	JJS	I-PROBLEM	I-TEST
single	JJ	I-PROBLEM	I-TEST
lesion	NN	I-PROBLEM	I-TEST
measures	VBZ	O	I-TEST
3.7	CD	O	O
x	NN	O	O
3.4	CD	O	O
cm	NN	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
surrounding	VBG	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
10	CD	O	O
mm	NNS	O	O
rightward	JJ	B-PROBLEM	B-PROBLEM
shift	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
normally	RB	I-PROBLEM	I-PROBLEM
midline	JJ	I-PROBLEM	I-PROBLEM
structures	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
associated	JJ	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
effect	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lateral	JJ	I-PROBLEM	I-PROBLEM
ventricles	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	B-TEST
basilar	JJ	O	I-TEST
cistern	NN	O	I-TEST
is	VBZ	O	O
preserved	VBN	O	O
and	CC	O	O
there	EX	O	O
is	VBZ	O	O
no	DT	O	O
uncal	JJ	B-PROBLEM	B-PROBLEM
herniation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

ct	NN	B-TEST	B-TEST
torso	NN	I-TEST	I-TEST

1.	CD	O	O
right	JJ	B-PROBLEM	B-PROBLEM
middle	NN	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
nodule	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
suspicious	JJ	O	O
for	IN	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
right	JJ	B-PROBLEM	B-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
opacities	NNS	I-PROBLEM	I-PROBLEM
which	WDT	O	O
appear	VBP	O	O
confluent	NN	B-PROBLEM	O
,	,	O	O
most	RBS	O	O
suggestive	JJ	O	O
of	IN	O	O
infectious	JJ	B-PROBLEM	B-PROBLEM
etiology	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
however	RB	O	O
,	,	O	O
cannot	VBP	O	O
entirely	RB	O	O
exclude	JJ	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

recommend	NN	O	O
follow	VB	B-TEST	O
up	RP	I-TEST	O
ct	NN	I-TEST	O
to	TO	O	O
ensure	VB	O	O
resolution	NN	O	O
.	.	O	O

3.	CD	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
hypodense	NN	I-PROBLEM	I-PROBLEM
liver	NN	I-PROBLEM	I-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
which	WDT	O	O
are	VBP	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
enhancing	VBG	I-PROBLEM	I-PROBLEM
,	,	O	O
most	JJS	O	O
consistent	JJ	O	O
with	IN	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
certainly	RB	O	O
could	MD	O	O
be	VB	O	O
malignant	JJ	B-PROBLEM	B-PROBLEM
given	VBN	O	O
today	NN	B-TEST	O
's	POS	I-TEST	O
findings	NNS	I-TEST	O
and	CC	O	O
history	NN	O	O
of	IN	O	O
breast	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

5.	CD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
bony	NN	B-PROBLEM	B-PROBLEM
metastases	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

metastatic	JJ	B-PROBLEM	B-PROBLEM
breast	NN	I-PROBLEM	I-PROBLEM
ca	MD	I-PROBLEM	I-PROBLEM
-	:	O	I-PROBLEM
large	JJ	B-PROBLEM	I-PROBLEM
brain	NN	I-PROBLEM	I-PROBLEM
mets	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
midline	JJ	B-PROBLEM	B-PROBLEM
shift	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

intubated	VBN	O	B-TREATMENT
for	IN	O	O
airway	NN	B-TREATMENT	B-TREATMENT
protection	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

treated	VBN	O	O
with	IN	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
dilantin	NN	I-TREATMENT	I-TREATMENT
and	CC	O	I-TREATMENT
decadron	NN	B-TREATMENT	I-TREATMENT
.	.	O	O

dilantin	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
stopped	VBN	O	O
.	.	O	O

will	MD	O	O
go	VB	O	O
home	NN	O	O
with	IN	O	O
prn	JJ	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
ativan	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
pr	JJ	B-TREATMENT	B-TREATMENT
decadron	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

pnuemonia	SYM	B-PROBLEM	B-TEST
-	:	O	O
possible	JJ	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

completed	VBN	O	O
a	DT	O	O
7	CD	O	O
day	NN	O	O
course	NN	O	O
of	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

1.	CD	O	O
morphine	JJ	B-TREATMENT	B-TREATMENT
concentrate	NN	I-TREATMENT	I-TREATMENT
20	CD	O	O
mg	NN	O	O
/	NNP	O	O
ml	NN	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
2.5-20	JJ	O	O
mg	NN	O	O
po	NN	O	O
q1-2h	NN	O	O
(	(	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2.	CD	O	O
lorazepam	JJ	B-TREATMENT	B-TREATMENT
0.5	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
0.5-2	JJ	O	O
mg	NN	O	O
po	NN	O	O
q4-6h	NN	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
to	TO	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
aggitation	NN	B-PROBLEM	B-PROBLEM
/	JJ	O	I-PROBLEM
seizure	NN	B-PROBLEM	I-PROBLEM
:	:	O	O
please	NN	O	O
dispense	NN	O	O
liquid	NN	O	O
.	.	O	O

3.	CD	O	O
dexamethasone	NN	B-TREATMENT	B-TREATMENT
4	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q8h	NN	O	O
(	(	O	O
every	DT	O	O
8	CD	O	O
hours	NNS	O	O
)	)	O	O
:	:	O	O
please	VB	O	O
give	VB	O	O
8	CD	O	O
mg	JJ	O	O
suppository	NN	O	O
.	.	O	O

breast	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
75	CD	O	O
year	NN	O	O
old	JJ	O	O
hispanic	JJ	O	O
male	NN	O	O
with	IN	O	O
insulin	JJ	B-PROBLEM	B-PROBLEM
dependent	NN	I-PROBLEM	I-PROBLEM
diabetes	VBZ	I-PROBLEM	I-PROBLEM
mellitus	RBS	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
a	DT	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
above-knee	JJ	I-TREATMENT	I-TREATMENT
amputation	NN	I-TREATMENT	I-TREATMENT
about	IN	O	O
five	CD	O	O
years	NNS	O	O
ago	RB	O	O
,	,	O	O
who	WP	O	O
reportedly	RB	O	O
approximately	RB	O	O
four	CD	O	O
months	NNS	O	O
ago	RB	O	O
,	,	O	O
he	PRP	O	O
developed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
ulceration	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
great	JJ	I-PROBLEM	I-PROBLEM
toe	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
progressively	RB	O	O
worsened	VBD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
seen	VBN	O	O
by	IN	O	O
a	DT	O	O
doctor	NN	O	O
in	IN	O	O
arizona	NN	O	O
and	CC	O	O
treated	VBN	O	O
with	IN	O	O
dressing	NN	B-TREATMENT	B-TREATMENT
changes	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
debridement	NN	B-TREATMENT	B-TREATMENT
until	IN	O	O
approximately	RB	O	O
six	CD	O	O
weeks	NNS	O	O
ago	RB	O	O
,	,	O	O
when	WRB	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
were	VBD	O	O
started	VBN	O	O
with	IN	O	O
ciprofloxacin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
seen	VBN	O	O
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
suggested	VBN	O	O
that	IN	O	O
he	PRP	O	O
should	MD	O	O
have	VB	O	O
an	DT	B-TREATMENT	B-TREATMENT
amputation	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
he	PRP	O	O
decided	VBD	O	O
to	TO	O	O
come	VB	O	O
to	TO	O	O
fairm	VB	O	O
of	IN	O	O
ijordcompmac	JJ	O	O
hospital	NN	O	O
for	IN	O	O
further	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
.	.	O	O

insulin	NN	B-PROBLEM	B-PROBLEM
dependent	NN	I-PROBLEM	I-PROBLEM
diabetes	VBZ	I-PROBLEM	I-PROBLEM
mellitus	NN	I-PROBLEM	I-PROBLEM
for	IN	O	O
fifteen	JJ	O	O
years	NNS	O	O
.	.	O	O

right	JJ	B-TREATMENT	B-TREATMENT
above-knee	JJ	I-TREATMENT	I-TREATMENT
amputation	NN	I-TREATMENT	I-TREATMENT
five	CD	O	O
years	NNS	O	O
ago	RB	O	O
,	,	O	O
status	NN	O	O
post	NN	O	O
motor	NN	O	O
vehicle	NN	O	O
accident	NN	O	O
.	.	O	O

he	PRP	O	O
sustained	VBD	O	O
left	VBD	B-PROBLEM	B-PROBLEM
humerus	JJ	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
left	VBD	B-PROBLEM	B-PROBLEM
tib-fib	JJ	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

tylenol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
ciprofloxacin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
about	RB	O	O
16	CD	O	O
units	NNS	O	O
of	IN	O	O
nph	JJ	B-TREATMENT	B-PROBLEM
qa.m.	NN	O	I-PROBLEM

on	IN	O	O
review	NN	B-TEST	O
of	IN	I-TEST	O
systems	NNS	I-TEST	O
,	,	O	O
denies	VBZ	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
has	VBZ	O	O
pain	VBN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
foot	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
physical	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
reveals	VBZ	O	O
him	PRP	O	O
to	TO	O	O
be	VB	O	O
an	DT	O	O
elderly	JJ	O	O
gentleman	NN	O	O
who	WP	O	O
is	VBZ	O	O
alert	JJ	O	O
and	CC	O	O
oriented	JJ	O	O
and	CC	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
,	,	I-TEST	I-TEST
eyes	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
ears	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
nose	RB	I-TEST	I-TEST
,	,	I-TEST	I-TEST
throat	NN	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
unremarkable	JJ	O	O
.	.	O	O

chest	NN	O	O
was	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	NN	B-TEST	B-TEST
and	CC	O	O
percussion	NN	B-TEST	B-TEST
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBD	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
visceromegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
rectal	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
showed	VBD	O	O
normal	JJ	O	O
prostate	NN	O	O
,	,	O	O
guaiac	JJ	B-TEST	B-TEST
negative	NN	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
neurological	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
nonfocal	JJ	O	O
.	.	O	O

pulses	NNS	B-TEST	B-TEST
remained	VBD	O	O
,	,	O	O
aside	RB	O	O
from	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
above-knee	JJ	I-TREATMENT	I-TREATMENT
amputation	NN	I-TREATMENT	I-TREATMENT
on	IN	I-TREATMENT	O
the	DT	I-TREATMENT	O
right	JJ	I-TREATMENT	O
side	NN	I-TREATMENT	O
,	,	O	O
they	PRP	O	O
remained	VBD	O	O
symmetrical	JJ	O	B-PROBLEM
bilaterally	RB	O	I-PROBLEM
with	IN	O	O
3+	CD	B-TEST	O
carotid	NNS	I-TEST	O
,	,	O	O
2+	CD	B-TEST	B-PROBLEM
brachial	NN	I-TEST	I-PROBLEM
,	,	O	O
1+	CD	B-TEST	O
radial	NN	I-TEST	O
,	,	O	O
3+	CD	B-TEST	O
femoral	NN	I-TEST	O
.	.	O	O

significant	JJ	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
6.0	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
35.9	CD	O	O
,	,	O	O
electrolytes	NNS	B-TEST	B-TEST
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
of	IN	O	O
13	CD	O	O
and	CC	O	O
0.8	CD	O	O
,	,	O	O
amylase	NN	B-TEST	B-TEST
of	IN	O	O
56	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
an	DT	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
ischemic	JJ	I-PROBLEM	I-PROBLEM
change	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
ruled	VBD	O	O
out	RP	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
cardiopulmonary	JJ	I-PROBLEM	I-PROBLEM
process	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

left	JJ	B-PROBLEM	B-PROBLEM
foot	NN	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
consistent	VBP	O	O
with	IN	O	O
osteomyelitis	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
great	JJ	I-PROBLEM	I-PROBLEM
toe	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
a	DT	O	B-TEST
question	NN	O	I-TEST
of	IN	O	I-TEST
evaluation	NN	B-TEST	I-TEST
of	IN	I-TEST	O
circulation	NN	I-TEST	O
to	TO	O	O
the	DT	O	O
left	NN	O	O
great	JJ	O	O
toe	NN	O	O
and	CC	O	O
also	RB	O	O
possible	JJ	O	O
debridement	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
possibly	RB	O	O
a	DT	B-TREATMENT	B-PROBLEM
toe	NN	I-TREATMENT	I-PROBLEM
amputation	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

08-27-92	NN	O	O
,	,	O	O
left	VBD	B-TEST	B-PROBLEM
foot	NN	I-TEST	I-PROBLEM
film	NN	I-TEST	I-PROBLEM
,	,	O	O
correlation	NN	O	O
,	,	O	O
patient	JJ	O	O
consistent	NN	O	O
with	IN	O	O
osteomyelitis	NN	B-PROBLEM	B-PROBLEM
involving	VBG	I-PROBLEM	O
the	DT	I-PROBLEM	O
first	JJ	I-PROBLEM	O
digit	NN	I-PROBLEM	O
and	CC	O	O
possibly	RB	O	O
the	DT	O	B-PROBLEM
second	JJ	O	I-PROBLEM
digit	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	JJ	O	I-PROBLEM
foot	NN	O	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	JJ	I-TEST	I-TEST
reveals	NNS	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
lower	JJR	B-TEST	B-TEST
extremity	NN	I-TEST	I-TEST
arterial	JJ	I-TEST	I-TEST
non-invasive	JJ	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
good	JJ	O	B-PROBLEM
arterial	JJ	O	I-PROBLEM
hemodynamics	NNS	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	NN	O	I-PROBLEM
lower	JJR	O	I-PROBLEM
extremity	NN	O	I-PROBLEM
,	,	O	O
perfusion	NN	O	B-TEST
to	TO	O	I-TEST
the	DT	O	I-TEST
tm	NN	O	I-TEST
level	NN	O	I-TEST
,	,	O	O
but	CC	O	O
there	EX	O	O
was	VBD	O	O
evidence	NN	O	O
of	IN	O	O
diabetic	JJ	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
vessel	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
spasm	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
digits	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
arterial	JJ	O	O
circulation	NN	O	O
is	VBZ	O	O
adequate	JJ	O	O
for	IN	O	O
healing	VBG	O	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
great	JJ	I-PROBLEM	I-PROBLEM
toe	NN	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
noncompressible	JJ	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
thigh	JJ	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
calf	JJ	I-PROBLEM	I-PROBLEM
pressures	NNS	I-PROBLEM	I-PROBLEM
highly	RB	B-PROBLEM	I-PROBLEM
calcified	VBN	I-PROBLEM	I-PROBLEM
arterial	JJ	I-PROBLEM	I-PROBLEM
system	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
09-03-92	JJ	O	O
,	,	O	O
patient	JJ	O	O
underwent	NN	O	O
a	DT	B-TREATMENT	B-PROBLEM
left	JJ	I-TREATMENT	I-PROBLEM
great	JJ	I-TREATMENT	I-PROBLEM
toe	NN	I-TREATMENT	I-PROBLEM
buttontoe	NN	I-TREATMENT	I-PROBLEM
amputation	NN	I-TREATMENT	I-PROBLEM
under	IN	O	I-PROBLEM
regional	JJ	B-TREATMENT	I-PROBLEM
ankle	NN	I-TREATMENT	I-PROBLEM
block	NN	I-TREATMENT	I-PROBLEM
for	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
osteomyelitis	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
great	JJ	I-PROBLEM	I-PROBLEM
toe	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
.	.	O	O

there	EX	O	O
were	VBD	O	O
no	DT	O	O
complications	NNS	B-PROBLEM	B-PROBLEM
during	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

there	EX	O	O
was	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
small	JJ	I-TREATMENT	I-TREATMENT
penrose	NN	I-TREATMENT	I-TREATMENT
drain	NN	I-TREATMENT	I-TREATMENT
postoperatively	RB	O	O
that	DT	O	O
was	VBD	O	O
placed	VBN	O	O
intraoperatively	RB	O	O
and	CC	O	O
discontinued	VBN	O	O
on	IN	O	O
approximately	RB	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
three	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
preoperatively	RB	O	O
treated	VBN	O	O
with	IN	O	O
about	IN	O	O
a	DT	O	O
seven	CD	O	O
day	NN	O	O
course	NN	O	O
of	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
unasyn	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
postoperatively	RB	O	O
treated	VBN	O	O
for	IN	O	O
approximately	RB	O	O
four	CD	O	O
days	NNS	O	O
of	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
unasyn	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
discharged	VBN	O	O
home	NN	O	O
in	IN	O	O
stable	JJ	O	O
condition	NN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
five	CD	O	O
,	,	O	O
without	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
complications	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
buttontoe	JJ	B-TREATMENT	B-PROBLEM
amputation	NN	I-TREATMENT	I-PROBLEM
of	IN	I-TREATMENT	I-PROBLEM
the	DT	I-TREATMENT	I-PROBLEM
left	JJ	I-TREATMENT	I-PROBLEM
foot	NN	I-TREATMENT	I-PROBLEM
healing	VBG	O	O
well	RB	O	O
,	,	O	O
without	IN	O	O
any	DT	O	B-PROBLEM
further	JJ	B-PROBLEM	I-PROBLEM
complications	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

included	VBD	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
pre-admission	NN	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
55	CD	O	O
-	:	O	O
year-old	JJ	O	O
male	NN	O	O
with	IN	O	O
critical	JJ	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
who	WP	O	O
was	VBD	O	O
referred	VBN	O	O
to	TO	O	O
dr.	VB	O	O
brenda	NN	O	O
hummer	NN	O	O
for	IN	O	O
discussion	NN	O	O
for	IN	O	O
surgical	JJ	B-TREATMENT	B-TREATMENT
options	NNS	I-TREATMENT	I-TREATMENT
to	TO	O	O
free	VB	O	O
this	DT	B-PROBLEM	O
condition	NN	I-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
reportedly	RB	O	O
had	VBD	O	O
been	VBN	O	O
experiencing	VBG	O	B-PROBLEM
increasing	VBG	B-PROBLEM	I-PROBLEM
fatigue	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
exertion	NN	O	O
for	IN	O	O
the	DT	O	O
year	NN	O	O
prior	RB	O	O
to	TO	O	O
his	PRP$	O	O
admission	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
reported	VBD	O	O
increasingly	RB	O	O
frequent	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
dizziness	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
accompanied	VBN	O	O
with	IN	O	O
coughing	VBG	B-PROBLEM	B-PROBLEM
spells	NNS	I-PROBLEM	I-PROBLEM
after	IN	O	O
walking	VBG	O	O
approximately	RB	O	O
a	DT	O	O
half	NN	O	O
a	DT	O	O
mile	NN	O	O
or	CC	O	O
climbing	VBG	O	O
three	CD	O	O
flights	NNS	O	O
of	IN	O	O
stairs	NNS	O	O
.	.	O	O

on	IN	O	O
2010-05-27	JJ	O	O
,	,	O	O
an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
was	VBD	O	O
done	VBN	O	O
which	WDT	O	O
revealed	VBD	O	O
critical	JJ	B-PROBLEM	B-PROBLEM
fibrocalcific	NN	I-PROBLEM	I-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-TEST	B-TEST
peak	JJ	I-TEST	I-TEST
gradient	NN	I-TEST	I-TEST
of	IN	O	O
125	CD	O	O
mmhg	NNS	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
mean	JJ	I-TEST	I-TEST
gradient	NN	I-TEST	I-TEST
of	IN	O	O
74	CD	O	O
mmhg	NN	O	O
,	,	O	O
an	DT	B-TEST	B-TEST
oak	JJ	I-TEST	I-TEST
bluffs	NNS	I-TEST	I-TEST
of	IN	O	O
0.44	CD	O	O
,	,	O	O
and	CC	O	O
1+	CD	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
subsequently	RB	O	O
underwent	VBD	O	O
a	DT	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
on	IN	O	O
2010-06-01	JJ	O	O
,	,	O	O
which	WDT	O	O
demonstrated	VBD	O	O
no	DT	O	O
hemodynamically	RB	B-PROBLEM	B-PROBLEM
significant	JJ	I-PROBLEM	I-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
critical	JJ	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
consistent	NN	O	O
with	IN	O	O
his	PRP$	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
results	NNS	I-TEST	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
subsequently	RB	O	O
scheduled	VBN	O	O
for	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
mechanical	JJ	I-TREATMENT	I-TREATMENT
aortic	JJ	I-TREATMENT	I-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
aortic	JJ	B-TREATMENT	B-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
2010-06-07	JJ	O	O
.	.	O	O

1.	CD	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

2.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

3.	CD	O	O
seasonal	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
arthritis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1.	CD	O	O
metformin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

2.	CD	O	O
celexa	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

3.	CD	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

4.	CD	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

5.	CD	O	O
toprol	NN	B-TREATMENT	B-TREATMENT
xl	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
allergic	JJ	B-PROBLEM	B-PROBLEM
to	TO	O	O
penicillin	VB	B-TREATMENT	B-TREATMENT
and	CC	O	O
shell	VB	O	O
fish	NN	O	O
.	.	O	O

on	IN	O	O
2010-06-07	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
underwent	NN	O	O
a	DT	B-TREATMENT	B-TREATMENT
mechanical	JJ	I-TREATMENT	I-TREATMENT
aortic	JJ	I-TREATMENT	I-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
23	CD	I-TREATMENT	I-TREATMENT
mm	NN	I-TREATMENT	I-TREATMENT
carbomedics	NNS	I-TREATMENT	I-TREATMENT
mechanical	JJ	I-TREATMENT	I-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
a	DT	B-TREATMENT	B-PROBLEM
supra	JJ	I-TREATMENT	I-PROBLEM
coronary	JJ	I-TREATMENT	I-PROBLEM
aortic	JJ	I-TREATMENT	I-PROBLEM
graft	NN	I-TREATMENT	I-PROBLEM
with	IN	O	O
gelweave	JJ	B-TREATMENT	O
28	CD	O	O
mm	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
time	NN	I-TREATMENT	O
of	IN	O	O
155	CD	O	O
minutes	NNS	O	O
and	CC	O	O
a	DT	B-TREATMENT	O
crossclamp	JJ	I-TREATMENT	O
time	NN	I-TREATMENT	O
of	IN	O	O

the	DT	O	B-TEST
patient	NN	O	I-TEST
's	POS	O	I-TEST
pericardium	NN	O	I-TEST
was	VBD	O	O
left	VBN	O	O
open	JJ	O	O
;	:	O	O
lines	NNS	B-TREATMENT	O
placed	VBD	O	O
included	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
radial	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
a	DT	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
ij	NN	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
;	:	O	O
both	DT	O	O
ventricular	JJ	B-TREATMENT	O
and	CC	I-TREATMENT	O
atrial	JJ	I-TREATMENT	B-TREATMENT
wires	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
placed	VBN	O	O
;	:	O	O
two	CD	B-TREATMENT	B-TREATMENT
mediastinal	JJ	I-TREATMENT	I-TREATMENT
tubes	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
placed	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
subsequently	RB	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
cardiac	NN	O	O
surgery	NN	O	O
recovery	NN	O	O
unit	NN	O	O
,	,	O	O
intubated	VBN	B-TREATMENT	B-TREATMENT
,	,	O	O
for	IN	O	O
further	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
and	CC	O	O
management	NN	O	O
.	.	O	O

on	IN	O	O
transfer	NN	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
mean	JJ	I-TEST	I-TEST
arterial	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
76	CD	O	O
,	,	O	O
cvp	NN	B-TEST	O
12	CD	O	O
,	,	O	O
pad	NN	B-TEST	B-TEST
17	CD	O	O
,	,	O	O
and	CC	O	O
his	PRP$	B-TEST	B-TEST
bennie	NN	I-TEST	I-TEST
was	VBD	O	O
25	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
av	RB	B-TREATMENT	O
paced	VBN	I-TREATMENT	O
at	IN	O	O
a	DT	O	O
rate	NN	O	O
of	IN	O	O
88	CD	O	O
beats	NNS	O	O
per	IN	O	O
minute	NN	O	O
.	.	O	O

active	JJ	B-TREATMENT	O
drips	NNS	I-TREATMENT	O
included	VBD	O	O
milrinone	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
levophed	VBN	B-TREATMENT	O
,	,	O	O
propofol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
one	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
successfully	RB	O	O
weaned	VBN	O	O
and	CC	O	O
extubated	VBN	O	O
without	IN	O	O
complication	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
then	RB	O	O
advanced	JJ	O	O
to	TO	O	O
oral	JJ	O	O
intake	NN	O	O
which	WDT	O	O
he	PRP	O	O
tolerated	VBD	O	O
without	IN	O	O
complication	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
two	CD	O	O
,	,	O	O
the	DT	B-TREATMENT	B-TREATMENT
patient	NN	I-TREATMENT	I-TREATMENT
's	POS	I-TREATMENT	I-TREATMENT
chest	JJS	I-TREATMENT	I-TREATMENT
tubes	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
removed	VBN	O	O
without	IN	O	O
complication	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
subsequently	RB	O	O
cleared	VBN	O	O
for	IN	O	O
transfer	NN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
evaluated	VBN	O	O
by	IN	O	O
physical	JJ	O	B-TREATMENT
therapy	NN	O	I-TREATMENT
,	,	O	O
who	WP	O	O
declared	VBD	O	O
him	PRP	O	O
a	DT	O	O
suitable	JJ	O	O
candidate	NN	O	O
for	IN	O	O
discharge	NN	O	O
directly	RB	O	O
to	TO	O	O
home	NN	O	O
following	VBG	O	O
resolution	NN	O	O
of	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
medical	JJ	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
advanced	VBN	O	O
to	TO	O	O
a	DT	O	O
full	JJ	O	O
regular	JJ	O	O
diet	NN	O	O
,	,	O	O
which	WDT	O	O
he	PRP	O	O
tolerated	VBD	O	O
without	IN	O	O
complication	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
had	VBD	O	O
adequate	JJ	B-TREATMENT	O
pain	NN	I-TREATMENT	O
control	NN	I-TREATMENT	O
provided	VBD	O	O
via	IN	O	O
oral	JJ	B-TREATMENT	B-TREATMENT
pain	NN	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
begun	VBN	O	O
on	IN	O	O
anticoagulation	NN	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
a	DT	B-TEST	B-TEST
target	NN	I-TEST	I-TEST
inr	NN	I-TEST	I-TEST
of	IN	O	O
2.5	CD	O	O
.	.	O	O

on	IN	O	O
the	DT	O	O
evening	NN	O	O
of	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
four	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	O	O
transient	JJ	O	O
episode	NN	O	O
of	IN	O	O
disorientation	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
confusion	NN	B-PROBLEM	B-PROBLEM
which	WDT	O	O
subsequently	RB	O	O
resolved	VBD	O	O
spontaneously	RB	O	O
.	.	O	O

by	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
five	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
stable	JJ	O	O
.	.	O	O

his	PRP$	B-PROBLEM	B-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
clean	JJ	O	O
,	,	O	O
dry	JJ	O	O
,	,	O	O
and	CC	O	O
intact	JJ	O	O
with	IN	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
cellulitis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
purulent	JJ	B-PROBLEM	B-TREATMENT
drainage	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
tolerant	NN	O	O
of	IN	O	O
a	DT	O	O
full	JJ	O	O
regular	JJ	O	O
diet	NN	O	O
and	CC	O	O
had	VBD	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
well	RB	O	O
controlled	VBN	O	O
via	IN	O	O
oral	JJ	B-TREATMENT	B-TREATMENT
pain	NN	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
inr	NN	I-TEST	I-TEST
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
2.3	CD	O	O
.	.	O	O

1.	CD	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

2.	CD	O	O
lasix	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	VBD	O	O
12	CD	O	O
hours	NNS	O	O
times	RB	O	O
seven	CD	O	O
days	NNS	O	O
.	.	O	O

3.	CD	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
20	CD	O	O
meq	NN	O	O
p.o.	NN	O	O
q.	VBD	O	O
12	CD	O	O
hours	NNS	O	O
times	RB	O	O
seven	CD	O	O
days	NNS	O	O
.	.	O	O

4.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

5.	CD	O	O
metformin	NN	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

6.	CD	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
5/325	CD	O	O
one	CD	O	O
to	TO	O	O
two	CD	O	O
tablets	NNS	O	O
p.o.	VBP	O	O
q.	RB	O	O
four	CD	O	O
to	TO	O	O
six	CD	O	O
hours	NNS	O	O
p.r.n.	VBP	O	O

7.	CD	O	O
celexa	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

8.	CD	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

9.	CD	O	O
warfarin	JJ	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
times	NNS	O	O
four	CD	O	O
days	NNS	O	O
,	,	O	O
after	IN	O	O
which	WDT	O	O
point	VBP	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
dosage	NN	O	O
schedule	NN	O	O
is	VBZ	O	O
to	TO	O	O
be	VB	O	O
coordinated	VBN	O	O
by	IN	O	O
his	PRP$	O	O
pcp	NN	O	O
,	,	O	O
dr.	NN	O	O
jerold	NN	O	O
esqueda	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
to	TO	O	O
maintain	VB	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
incisions	NNS	I-PROBLEM	I-PROBLEM
clean	VBP	O	O
and	CC	O	O
dry	JJ	O	O
at	IN	O	O
all	DT	O	O
times	NNS	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
may	MD	O	O
shower	VB	O	O
but	CC	O	O
should	MD	O	O
pat	VB	O	O
dry	JJ	O	B-PROBLEM
incisions	NNS	B-PROBLEM	I-PROBLEM
afterwards	NNS	O	I-PROBLEM
;	:	O	O
no	DT	O	O
bathing	NN	O	B-PROBLEM
or	CC	O	O
swimming	NN	O	O
until	IN	O	O
further	JJ	O	O
notice	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
may	MD	O	O
resume	VB	O	O
a	DT	B-TREATMENT	B-TREATMENT
heart	NN	I-TREATMENT	I-TREATMENT
healthy	JJ	I-TREATMENT	I-TREATMENT
diet	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

no	DT	O	O
driving	VBG	O	O
while	IN	O	O
taking	VBG	O	O
prescription	NN	B-TREATMENT	B-TREATMENT
pain	NN	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
to	TO	O	O
have	VB	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
managed	VBN	O	O
by	IN	O	O
his	PRP$	O	O
primary	JJ	O	O
care	NN	O	O
provider	NN	O	O
,	,	O	O
dr.	NN	O	O
jerold	NN	O	O
esqueda	NN	O	O
,	,	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
target	NN	I-TEST	I-TEST
inr	NN	I-TEST	I-TEST
of	IN	O	O
2.5	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
to	TO	O	O
report	VB	O	O
to	TO	O	O
dr.	VB	O	O
jones	NNS	O	O
office	NN	O	O
on	IN	O	O
2010-06-14	NN	O	O
for	IN	O	O
an	DT	B-TEST	B-TEST
initial	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
draw	NN	I-TEST	I-TEST
and	CC	O	O
subsequent	JJ	B-TREATMENT	O
coumadin	NN	I-TREATMENT	B-TREATMENT
titration	NN	I-TREATMENT	I-TREATMENT
;	:	O	O
coumadin	NN	B-TEST	B-TEST
levels	NNS	I-TEST	I-TEST
are	VBP	O	O
to	TO	O	O
be	VB	O	O
monitored	VBN	O	O
per	IN	O	O
his	PRP$	O	O
pcp	NN	O	O
david	NN	O	O
.	.	O	O

mediastinal	JJ	B-PROBLEM	B-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mediastinal	JJ	B-PROBLEM	B-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

history	NN	O	O
of	IN	O	O
colon	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
obstructive	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
obesity	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
history	NN	O	O
of	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

january	JJ	O	O
3	CD	O	O
,	,	O	O
1994	CD	O	O
,	,	O	O
median	JJ	B-TEST	B-TREATMENT
sternotomy	NN	I-TEST	I-TREATMENT
with	IN	O	O
mediastinal	JJ	B-TEST	B-TEST
exploration	NN	I-TEST	I-TEST
,	,	O	O
radical	JJ	B-TREATMENT	B-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT
of	IN	O	I-TREATMENT
tumor	NN	B-PROBLEM	I-TREATMENT
and	CC	O	O
aortopulmonary	JJ	B-PROBLEM	O
window	NN	I-PROBLEM	O
;	:	O	O
partial	JJ	B-TREATMENT	B-PROBLEM
resection	NN	I-TREATMENT	I-PROBLEM
of	IN	I-TREATMENT	I-PROBLEM
adjacent	JJ	I-TREATMENT	I-PROBLEM
lung	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
en	JJ	B-TREATMENT	O
bloc	NN	I-TREATMENT	O
resection	NN	I-TREATMENT	B-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
vagus	NN	I-TREATMENT	I-TREATMENT
and	CC	I-TREATMENT	O
phrenic	JJ	I-TREATMENT	B-PROBLEM
nerves	NNS	I-TREATMENT	I-PROBLEM
;	:	O	O
partial	JJ	B-TREATMENT	B-TREATMENT
pericardectomy	NN	I-TREATMENT	I-TREATMENT
;	:	O	O
fiberoptic	JJ	B-TEST	B-TEST
bronchoscopy	NN	I-TEST	I-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
66	CD	O	O
year	NN	O	O
old	JJ	O	O
white	JJ	O	O
female	NN	O	O
with	IN	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
colon	NN	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
superhilar	JJ	I-PROBLEM	I-PROBLEM
region	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
who	WP	O	O
presents	VBZ	O	O
for	IN	O	O
bronchoscopy	NN	B-TEST	B-TEST
,	,	O	I-TEST
mediastinal	JJ	B-TEST	I-TEST
exploration	NN	I-TEST	I-TEST
and	CC	O	O
resection	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
in	IN	O	O
her	PRP$	O	O
usual	JJ	O	O
state	NN	O	O
of	IN	O	O
health	NN	O	O
until	IN	O	O
she	PRP	O	O
experienced	VBD	O	O
the	DT	O	O
onset	NN	O	O
of	IN	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
early	JJ	O	O
1992	CD	O	O
.	.	O	O

in	IN	O	O
december	NN	O	O
of	IN	O	O
1992	CD	O	O
,	,	O	O
she	PRP	O	O
underwent	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
transverse	JJ	I-TREATMENT	I-TREATMENT
colectomy	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
colon	NN	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
duke	JJ	B-PROBLEM	B-PROBLEM
&apos;s	JJ	I-PROBLEM	I-PROBLEM
grade	NN	I-PROBLEM	I-PROBLEM
b-ii	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
lymph	NN	O	B-TEST
nodes	NNS	O	I-TEST
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

she	PRP	O	O
received	VBD	O	O
postoperative	JJ	B-TREATMENT	B-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

in	IN	O	O
september	NN	O	O
of	IN	O	O
1992	CD	O	O
,	,	O	O
she	PRP	O	O
underwent	VBD	O	O
an	DT	B-TEST	B-TEST
exploratory	JJ	I-TEST	I-TEST
laparotomy	NN	I-TEST	I-TEST
because	IN	O	O
of	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
increased	JJ	I-PROBLEM	I-PROBLEM
level	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
cea	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
her	PRP$	B-TEST	I-PROBLEM
blood	NN	I-TEST	I-PROBLEM
with	IN	O	O
the	DT	O	O
presence	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
liver	JJ	I-PROBLEM	I-PROBLEM
abnormality	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
computerized	JJ	B-TEST	B-TEST
tomography	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
.	.	O	O

the	DT	B-TEST	B-TEST
exploratory	JJ	I-TEST	I-TEST
laparotomy	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
rise	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
her	PRP$	B-TEST	I-PROBLEM
cea	NN	I-TEST	I-PROBLEM
level	NN	I-TEST	I-PROBLEM
which	WDT	O	O
prompted	VBD	O	O
a	DT	B-TEST	O
further	JJ	I-TEST	O
work	NN	I-TEST	O
up	RB	I-TEST	O
.	.	O	O

in	IN	O	O
september	NN	O	O
of	IN	O	O
1993	CD	O	O
,	,	O	O
an	DT	B-TEST	B-TEST
abdominal	JJ	I-TEST	I-TEST
and	CC	I-TEST	I-TEST
pelvic	JJ	I-TEST	I-TEST
computerized	JJ	I-TEST	I-TEST
tomography	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
and	CC	O	O
in	IN	O	O
june	NN	O	O
of	IN	O	O
1993	CD	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	O
negative	JJ	I-TEST	O
bone	NN	I-TEST	B-TEST
scan	NN	I-TEST	I-TEST
.	.	O	O

in	IN	O	O
december	NN	O	O
of	IN	O	O
1994	CD	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
thoracic	JJ	I-TEST	I-TEST
computerized	JJ	I-TEST	I-TEST
tomography	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
four	CD	I-PROBLEM	I-PROBLEM
centimeter	NN	I-PROBLEM	I-PROBLEM
soft	JJ	I-PROBLEM	I-PROBLEM
tissue	NN	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
suprahilar	JJ	I-PROBLEM	I-PROBLEM
region	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
adjacent	JJ	O	O
to	TO	O	O
the	DT	B-PROBLEM	O
aortopulmonary	JJ	I-PROBLEM	O
window	NN	I-PROBLEM	O
.	.	O	O

she	PRP	O	O
also	RB	O	O
experienced	VBD	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
hoarseness	NN	I-PROBLEM	I-PROBLEM
over	IN	O	O
the	DT	O	O
preceding	JJ	O	O
months	NNS	O	O
,	,	O	O
which	WDT	O	O
was	VBD	O	O
due	JJ	O	O
to	TO	O	O
left	JJ	B-PROBLEM	B-PROBLEM
vocal	JJ	I-PROBLEM	I-PROBLEM
cord	NN	I-PROBLEM	I-PROBLEM
paralysis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
also	RB	O	O
complains	VBZ	O	O
of	IN	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
shortness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
for	IN	O	O
the	DT	O	O
preceding	VBG	O	O
month	NN	O	O
and	CC	O	O
now	RB	O	O
presents	NNS	O	O
for	IN	O	O
mediastinal	JJ	B-TEST	B-TEST
exploration	NN	I-TEST	I-TEST
and	CC	O	O
resection	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
her	PRP$	O	O
probable	JJ	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
previous	JJ	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
1983	CD	O	O
,	,	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
history	NN	O	O
of	IN	O	O
breast	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
history	NN	O	O
of	IN	O	O
colon	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
past	JJ	O	O
surgical	JJ	O	O
history	NN	O	O
is	VBZ	O	O
notable	JJ	O	O
for	IN	O	O
a	DT	O	B-TREATMENT
1971	CD	O	I-TREATMENT
mastectomy	NN	B-TREATMENT	I-TREATMENT
on	IN	I-TREATMENT	O
the	DT	I-TREATMENT	O
right	NN	I-TREATMENT	O
,	,	O	O
1937	CD	O	B-TREATMENT
appendectomy	NN	B-TREATMENT	I-TREATMENT
,	,	O	O
1991	CD	O	O
cholecystectomy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
1992	CD	O	O
transverse	NN	B-TREATMENT	O
colectomy	NN	I-TREATMENT	B-TREATMENT
,	,	O	O
1992	CD	O	O
exploratory	NN	B-TEST	B-TEST
laparotomy	NN	I-TEST	I-TEST
,	,	O	O
1991	CD	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
cataract	NN	I-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

levoxine	NN	B-TREATMENT	B-TREATMENT
0.125	CD	O	O
mg	NN	O	O
po	NN	O	O
q.day	NN	O	O
,	,	O	O
vasotec	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
po	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
maxzide	RB	B-TREATMENT	O
75/50	CD	O	O
,	,	O	O
30	CD	O	O
mg	NN	O	O
po	NN	O	O
q.day	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
allergic	JJ	B-PROBLEM	B-PROBLEM
to	TO	O	I-PROBLEM
sulfa	VB	B-TREATMENT	I-PROBLEM
.	.	O	O

on	IN	O	O
physical	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
,	,	O	O
she	PRP	O	O
is	VBZ	O	O
an	DT	O	O
obese	JJ	O	O
white	JJ	O	O
female	NN	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
hoarse	JJ	I-PROBLEM	I-PROBLEM
voice	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
,	,	I-TEST	I-TEST
eyes	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
ears	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
nose	RB	I-TEST	I-TEST
,	,	I-TEST	I-TEST
throat	NN	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
shows	VBZ	O	O
that	IN	O	O
she	PRP	O	O
is	VBZ	O	O
normocephalic	JJ	O	O
,	,	O	O
atraumatic	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
extra	JJ	O	O
ocular	JJ	O	O
movements	NNS	O	O
are	VBP	O	O
intact	JJ	O	O
,	,	O	O
pupils	JJ	O	O
equal	JJ	O	O
,	,	O	O
round	NN	O	O
,	,	O	O
reactive	JJ	O	O
to	TO	O	O
light	JJ	O	O
and	CC	O	O
accommodation	NN	O	O
,	,	O	O
and	CC	O	O
the	DT	O	O
oropharynx	NN	O	O
was	VBD	O	O
clear	JJ	O	O
,	,	O	O
neck	NN	O	O
was	VBD	O	O
supple	RB	O	O
without	IN	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
either	DT	O	O
axillary	JJ	O	B-PROBLEM
or	CC	O	O
supraclavicular	JJ	O	B-PROBLEM
.	.	O	O

chest	NN	O	O
is	VBZ	O	O
clear	JJ	O	O
with	IN	O	O
decreased	JJ	B-PROBLEM	B-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
sounds	NNS	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
base	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
a	DT	B-TREATMENT	B-TREATMENT
previous	JJ	I-TREATMENT	I-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
mastectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
without	IN	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
rub	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
gallop	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

obese	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
well	RB	I-PROBLEM	I-PROBLEM
healed	VBN	I-PROBLEM	I-PROBLEM
surgical	JJ	I-PROBLEM	I-PROBLEM
incisions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
positive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
rectal	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
is	VBZ	O	O
guaiac	JJ	B-TEST	O
negative	JJ	O	O
without	IN	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
clubbing	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
neurological	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
is	VBZ	O	O
nonfocal	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
brought	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
on	IN	O	O
january	JJ	O	O
3	CD	O	O
,	,	O	O
1994	CD	O	O
where	WRB	O	O
she	PRP	O	O
underwent	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
median	JJ	I-TREATMENT	I-TREATMENT
sternotomy	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
removal	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
mediastinal	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
situated	VBN	O	O
in	IN	O	O
the	DT	B-PROBLEM	O
aortopulmonary	JJ	I-PROBLEM	O
window	NN	I-PROBLEM	O
and	CC	O	O
was	VBD	O	O
sent	VBN	O	O
to	TO	O	O
pathology	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
frozen	JJ	I-TEST	I-TEST
section	NN	I-TEST	I-TEST
analysis	NN	I-TEST	I-TEST
revealed	VBD	O	O
this	DT	O	O
to	TO	O	O
be	VB	O	O
adenocarcinoma	RB	B-PROBLEM	B-PROBLEM
,	,	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
from	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
colon	NN	I-PROBLEM	O
most	RBS	O	O
likely	JJ	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
placed	VBD	O	O
intraoperatively	RB	O	O
and	CC	O	O
another	DT	O	O
placed	VBN	O	O
postoperatively	RB	O	O
in	IN	O	O
the	DT	O	O
recovery	NN	O	O
room	NN	O	O
,	,	O	O
for	IN	O	O
what	WP	O	O
was	VBD	O	O
presumed	VBN	O	O
to	TO	O	O
be	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
drained	VBD	O	O
only	RB	O	O
a	DT	O	O
small	JJ	O	O
amount	NN	O	O
of	IN	O	O
fluid	NN	O	B-PROBLEM
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
likely	JJ	O	O
that	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
made	VBN	O	O
to	TO	O	O
look	VB	O	O
more	JJR	O	O
severe	JJ	O	O
in	IN	O	O
the	DT	O	O
presence	NN	O	O
of	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
hemidiaphragm	JJ	I-PROBLEM	I-PROBLEM
elevation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	B-TREATMENT	B-TREATMENT
additional	JJ	I-TREATMENT	I-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
removed	VBN	O	O
the	DT	O	O
following	JJ	O	O
day	NN	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
postoperative	JJ	I-TEST	I-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
31	CD	O	O
,	,	O	O
compared	VBN	O	O
to	TO	O	O
a	DT	B-TEST	B-TEST
preoperative	JJ	I-TEST	I-TEST
level	NN	I-TEST	I-TEST
of	IN	O	O
43	CD	O	O
.	.	O	O

mediastinal	JJ	B-TREATMENT	B-TEST
chest	JJS	I-TREATMENT	I-TEST
tube	NN	I-TREATMENT	I-TEST
was	VBD	O	O
removed	VBN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
three	CD	O	O
.	.	O	O

percocet	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
status	NN	O	O
post	NN	O	O
off	IN	B-TREATMENT	O
pump	NN	I-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
times	NNS	O	O
three	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
63	CD	O	O
year	NN	O	O
old	JJ	O	O
gentleman	NN	O	O
who	WP	O	O
had	VBD	O	O
initially	RB	O	O
presented	VBN	O	O
with	IN	O	O
exertional	JJ	B-PROBLEM	B-TEST
chest	NN	I-PROBLEM	I-TEST
pressure	NN	I-PROBLEM	I-TEST
several	JJ	O	O
weeks	NNS	O	O
prior	RB	O	O
to	TO	O	O
this	DT	O	O
admission	NN	O	O
that	WDT	O	O
would	MD	O	O
resolve	VB	O	O
with	IN	O	O
rest	NN	O	O
.	.	O	O

stress	NN	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
demonstrated	VBD	O	O
an	DT	B-TEST	B-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
40%	CD	O	O
,	,	O	O
hypokinesis	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
akinesis	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
inferior	JJ	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
apex	NN	I-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
which	WDT	O	O
revealed	VBD	O	O
three	CD	B-PROBLEM	B-PROBLEM
vessel	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
the	DT	O	O
patient	NN	O	O
now	RB	O	O
presents	VBZ	O	O
for	IN	O	O
elective	JJ	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

1.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2.	CD	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

3.	CD	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
end	NN	B-PROBLEM	B-PROBLEM
stage	NN	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

5.	CD	O	O
status	NN	O	O
post	NN	O	O
cadaveric	JJ	B-TREATMENT	B-TREATMENT
kidney	NN	I-TREATMENT	I-TREATMENT
transplant	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
2012-09-21	JJ	O	O
.	.	O	O

6.	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
allograft	NN	I-PROBLEM	I-PROBLEM
nephropathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

7.	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

8.	CD	O	O
history	NN	O	O
of	IN	O	O
upper	JJ	B-PROBLEM	B-PROBLEM
gastrointestinal	JJ	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

9.	CD	O	O
depression	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

10.	CD	O	O
gout	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

11.	CD	O	O
question	NN	O	O
of	IN	O	O
transient	JJ	B-PROBLEM	B-PROBLEM
ischemic	JJ	I-PROBLEM	I-PROBLEM
attack	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

12.	CD	O	O
status	NN	O	O
post	NN	O	O
left	VBD	B-TREATMENT	B-PROBLEM
av	JJ	I-TREATMENT	I-PROBLEM
fistula	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
once	RB	O	O
daily	RB	O	O
.	.	O	O

2.	CD	O	O
neoral	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
three	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

3.	CD	O	O
diltiazem	JJ	B-TREATMENT	B-TREATMENT
240	CD	O	O
mg	NN	O	O
once	RB	O	O
daily	RB	O	O
.	.	O	O

4.	CD	O	O
allopurinol	JJ	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
once	RB	O	O
daily	RB	O	O
.	.	O	O

5.	CD	O	O
hydralazine	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

6.	CD	O	O
enalapril	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

7.	CD	O	O
avandia	JJ	B-TREATMENT	B-TREATMENT
4	CD	O	O
mg	NN	O	O
once	RB	O	O
daily	RB	O	O
.	.	O	O

8.	CD	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
once	RB	O	O
daily	RB	O	O
.	.	O	O

9.	CD	O	O
bactrim	JJ	B-TREATMENT	B-TREATMENT
double	JJ	I-TREATMENT	I-TREATMENT
strength	NN	I-TREATMENT	I-TREATMENT
once	RB	O	O
daily	JJ	O	O
.	.	O	O

10.	CD	O	O
hydrochlorothiazide	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
once	RB	O	O
daily	RB	O	O
.	.	O	O

11.	CD	O	O
toprol	NN	B-TREATMENT	B-TREATMENT
xl	VBD	I-TREATMENT	I-TREATMENT
25	CD	O	O
mg	NN	O	O
once	RB	O	O
daily	RB	O	O
.	.	O	O

12.	CD	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
once	RB	O	O
daily	RB	O	O
.	.	O	O

preoperative	JJ	O	B-TEST
laboratory	NN	O	I-TEST
values	NNS	O	I-TEST
showed	VBD	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
6.8	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
33.3	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST

inr	RB	B-TEST	O
1.1	CD	O	O
.	.	O	O

chem7	NN	B-TEST	B-PROBLEM
showed	VBD	O	O
sodium	JJ	B-TEST	B-TEST
138	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.1	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
107	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
20	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
urea	JJ	I-TEST	I-TEST
nitrogen	NN	I-TEST	I-TEST
49	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
2.5	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
156	CD	O	O
.	.	O	O

calcium	NN	B-TEST	B-TEST
9.2	CD	O	O
,	,	O	O
magnesium	NN	B-TEST	B-TEST
1.8	CD	O	O
,	,	O	O
and	CC	O	O
phosphorus	RB	B-TEST	B-TEST
4.2	CD	O	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
in	IN	O	O
general	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
in	IN	O	O
no	DT	O	O
acute	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
comfortable	JJ	O	O
.	.	O	O

vital	JJ	B-TEST	B-TEST
signs	NNS	I-TEST	I-TEST
showed	VBD	O	O
temperature	NN	B-TEST	B-TEST
96.3	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
64	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
170/70	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
20	CD	O	O
,	,	O	O
oxygen	NN	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST
98%	CD	O	O
in	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

head	NN	B-TEST	B-TEST
,	,	I-TEST	I-TEST
eyes	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
ears	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
nose	RB	I-TEST	I-TEST
and	CC	I-TEST	I-TEST
throat	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
is	VBZ	O	O
normocephalic	JJ	O	O
and	CC	O	O
atraumatic	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

anicteric	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
chest	NN	O	O
is	VBZ	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	O	O
.	.	O	O

neck	NN	O	O
was	VBD	O	O
supple	JJ	O	O
with	IN	O	O
no	DT	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

cardiovascular	NN	O	O
shows	NNS	O	O
grade	VBP	B-PROBLEM	B-PROBLEM
ii/vi	JJ	I-PROBLEM	I-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
ejection	NN	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
is	VBZ	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBD	B-PROBLEM	B-PROBLEM
,	,	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
umbilical	JJ	I-PROBLEM	I-PROBLEM
hernia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

extremities	NNS	O	O
are	VBP	O	O
warm	JJ	O	O
,	,	O	O
noncyanotic	JJ	B-PROBLEM	O
and	CC	O	O
nonedematous	JJ	B-PROBLEM	O
times	NNS	O	O
four	CD	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
initially	RB	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
medical	JJ	O	O
service	NN	O	O
for	IN	O	O
optimization	NN	O	O
prior	RB	O	O
to	TO	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
given	VBN	O	O
stress	NN	B-TREATMENT	B-TREATMENT
dose	JJ	I-TREATMENT	I-TREATMENT
steroids	NNS	I-TREATMENT	I-TREATMENT
on	IN	O	O
the	DT	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
closely	RB	O	O
followed	VBN	O	O
from	IN	O	O
his	PRP$	O	O
admission	NN	O	O
through	IN	O	O
to	TO	O	O
his	PRP$	O	O
discharge	NN	O	O
by	IN	O	O
the	DT	O	O
renal	JJ	O	O
service	NN	O	O
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
transplant	NN	I-PROBLEM	I-PROBLEM
issues	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
2016-02-15	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
and	CC	O	O
had	VBD	O	O
an	DT	B-TREATMENT	B-TREATMENT
off	RP	I-TREATMENT	I-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
performed	VBN	O	O
with	IN	O	O
the	DT	B-TREATMENT	O
left	JJ	I-TREATMENT	O
internal	JJ	I-TREATMENT	O
mammary	JJ	I-TREATMENT	O
artery	NN	I-TREATMENT	O
to	TO	I-TREATMENT	O
the	DT	I-TREATMENT	O
left	VBN	I-TREATMENT	O
anterior	JJ	I-TREATMENT	O
descending	NN	I-TREATMENT	O
,	,	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	O
obtuse	VB	I-TREATMENT	B-PROBLEM
marginal	JJ	I-TREATMENT	I-PROBLEM
and	CC	O	I-PROBLEM
posterior	JJ	O	I-PROBLEM
descending	NN	O	I-PROBLEM
artery	NN	O	I-PROBLEM
.	.	O	O

for	IN	O	O
details	NNS	O	O
of	IN	O	O
this	DT	B-TREATMENT	B-TREATMENT
operation	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
please	VB	O	O
see	VB	O	O
the	DT	O	O
previously	RB	O	O
dictated	VBN	O	O
operative	JJ	O	O
note	NN	O	O
.	.	O	O

postoperatively	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
csru	NN	O	O
for	IN	O	O
close	JJ	B-TEST	B-TEST
monitoring	NN	I-TEST	I-TEST
.	.	O	O

on	IN	O	O
the	DT	O	O
evening	NN	O	O
of	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
zero	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
decreased	VBN	B-PROBLEM	B-PROBLEM
urine	JJ	I-PROBLEM	I-PROBLEM
output	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
lasix	JJ	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
diuresis	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
renal	JJ	O	O
service	NN	O	O
continued	VBD	O	O
to	TO	O	O
follow	VB	O	O
close	JJ	B-TREATMENT	O
management	NN	I-TREATMENT	O
of	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
immunosuppression	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
one	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
extubated	VBN	O	O
and	CC	O	O
awakened	VBN	O	O
from	IN	O	O
sedation	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
did	VBD	O	O
well	RB	O	O
on	IN	O	O
this	DT	O	O
and	CC	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
levophed	JJ	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
weaned	VBN	O	O
to	TO	O	O
off	RP	O	O
as	IN	O	O
tolerated	VBN	O	O
.	.	O	O

over	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
his	PRP$	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
stay	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
received	VBD	O	O
six	CD	O	O
units	NNS	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
hematocrit	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
four	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
platelet	NN	I-PROBLEM	I-PROBLEM
level	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
43,000	CD	O	O
.	.	O	O

heparin	NN	B-TEST	B-TREATMENT
induced	VBD	I-TEST	O
thrombocytopenia	IN	I-TEST	B-TEST
antibody	NN	I-TEST	I-TEST
panel	NN	I-TEST	I-TEST
was	VBD	O	O
sent	VBN	O	O
.	.	O	O

chest	NN	B-TREATMENT	B-TREATMENT
tubes	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
removed	VBN	O	O
when	WRB	O	O
output	NN	B-TEST	O
was	VBD	O	O
low	JJ	O	O
.	.	O	O

pacing	VBG	B-TREATMENT	B-TREATMENT
wires	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
removed	VBN	O	O
.	.	O	O

ultimately	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
discharged	VBN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
six	CD	O	O
tolerating	VBG	O	O
a	DT	O	O
regular	JJ	O	O
diet	NN	O	O
,	,	O	O
adequate	JJ	O	O
pain	NN	B-TREATMENT	O
control	NN	I-TREATMENT	O
on	IN	O	O
p.o.	NN	B-TREATMENT	B-TREATMENT
pain	NN	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
ambulating	VBG	O	O
well	RB	O	O
with	IN	O	O
clearance	NN	O	B-TREATMENT
of	IN	O	I-TREATMENT
physical	JJ	O	I-TREATMENT
therapy	NN	O	I-TREATMENT
.	.	O	O

cardiac	NN	B-TREATMENT	O
and	CC	I-TREATMENT	O
diabetic	JJ	I-TREATMENT	B-TREATMENT
diet	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
chest	NN	O	O
is	VBZ	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	O	O
without	IN	O	O
sternal	JJ	B-PROBLEM	B-PROBLEM
click	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
discharge	NN	B-PROBLEM	O
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
is	VBZ	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

extremities	NNS	O	O
are	VBP	O	O
warm	JJ	O	O
,	,	O	O
noncyanotic	JJ	B-PROBLEM	O
,	,	O	O
minimal	JJ	B-PROBLEM	B-PROBLEM
peripheral	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
5/325	CD	O	O
one	CD	O	O
to	TO	O	O
two	CD	O	O
q4hours	NNS	O	O
p.r.n.	VBP	O	O

2.	CD	O	O
plavix	JJ	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
once	RB	O	O
daily	RB	O	O
.	.	O	O

3.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NN	O	O
once	RB	O	O
daily	RB	O	O
.	.	O	O

4.	CD	O	O
bactrim	JJ	B-TREATMENT	B-TREATMENT
double	JJ	I-TREATMENT	I-TREATMENT
strength	NN	I-TREATMENT	I-TREATMENT
one	CD	O	O
tablet	NN	O	O
once	RB	O	O
daily	RB	O	O
.	.	O	O

5.	CD	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
once	RB	O	O
daily	RB	O	O
.	.	O	O

6.	CD	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
once	RB	O	O
daily	RB	O	O
.	.	O	O

7.	CD	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

8.	CD	O	O
hydralazine	NN	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
q6hours	NNS	O	O
.	.	O	O

9.	CD	O	O
cyclosporin	NN	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

10.	CD	O	O
rosiglitazone	NN	B-TREATMENT	B-TREATMENT
4	CD	O	O
mg	NN	O	O
once	RB	O	O
daily	RB	O	O
.	.	O	O

he	PRP	O	O
should	MD	O	O
follow-up	VB	O	O
with	IN	O	O
his	PRP$	O	O
cardiologist	NN	O	O
in	IN	O	O
one	CD	O	O
to	TO	O	O
two	CD	O	O
weeks	NNS	O	O
for	IN	O	O
optimization	NN	O	O
of	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
should	MD	O	O
return	VB	O	O
or	CC	O	O
contact	VB	O	O
the	DT	O	O
office	NN	O	O
if	IN	O	O
he	PRP	O	O
has	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
sternal	JJ	B-PROBLEM	B-PROBLEM
discharge	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
other	JJ	B-PROBLEM	B-PROBLEM
significant	JJ	I-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

aspiration	NN	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

aspiration	NN	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

dementia	NN	B-PROBLEM	B-PROBLEM
;	:	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
a	DT	O	O
108-year-old	JJ	O	O
nursing	NN	O	O
home	NN	O	O
resident	NN	O	O
,	,	O	O
who	WP	O	O
was	VBD	O	O
admitted	VBN	O	O
with	IN	O	O
a	DT	O	O
two-day	JJ	O	O
history	NN	O	O
of	IN	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
secretions	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	O	O
24-hour	JJ	O	O
history	NN	O	O
of	IN	O	O
elevated	VBN	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

despite	IN	O	O
augmentin	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NNP	I-PROBLEM	I-PROBLEM
delirium	NN	I-PROBLEM	I-PROBLEM
worsened	VBD	O	O
in	IN	O	O
the	DT	O	O
24	CD	O	O
hours	NNS	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
,	,	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
was	VBD	O	O
up	RB	O	O
to	TO	O	O
102	CD	O	O
.	.	O	O

recurrent	NN	B-PROBLEM	B-PROBLEM
urinary	JJ	I-PROBLEM	I-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infections	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
most	JJS	O	O
recently	RB	O	O
on	IN	O	O
2/23/97	CD	O	O
;	:	O	O
recurrent	JJ	B-PROBLEM	B-PROBLEM
aspiration	NN	I-PROBLEM	I-PROBLEM
pneumonias	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
most	RBS	O	O
recently	RB	O	O
on	IN	O	O
2/21/97	CD	O	O
;	:	O	O
multi-infarct	JJ	B-PROBLEM	B-PROBLEM
dementia	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
associated	JJ	B-PROBLEM	B-PROBLEM
dysphasia	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
mitral	JJ	B-PROBLEM	B-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
history	NN	O	O
of	IN	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
pernicious	JJ	B-PROBLEM	B-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
stasis	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
status	NN	O	O
post	NN	O	O
left	VBD	B-PROBLEM	B-PROBLEM
femoral	JJ	I-PROBLEM	I-PROBLEM
neck	NN	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

augmentin	RB	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NNS	O	O
t.i.d.	NN	O	O

senokot	VB	B-TREATMENT	O
one	CD	O	O
q.h.s.	NN	O	O

sertraline	NN	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
q.day	NN	O	O
.	.	O	O

aspirin	RB	B-TREATMENT	B-TREATMENT
81	CD	O	O
mg	NN	O	O
q.day	NN	O	O
.	.	O	O

vitamin	NN	B-TREATMENT	B-TREATMENT
b12	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
mcg	NN	O	O
im	JJ	O	O
q.month	NN	O	O
.	.	O	O

urecholine	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
t.i.d.	NN	O	O
colace	NN	B-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
resides	VBZ	O	O
in	IN	O	O
the	DT	O	O
pcaer,ter	NN	O	O
medical	JJ	O	O
center	NN	O	O
,	,	O	O
is	VBZ	O	O
nonambulatory	JJ	B-PROBLEM	O
,	,	O	O
and	CC	O	O
her	PRP$	O	O
code	NN	O	O
status	NN	O	O
is	VBZ	O	O
do	VBP	O	O
not	RB	O	O
resuscitate	VB	O	O
/	NNS	O	O
do	VBP	O	O
not	RB	O	O
intubate	VB	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
nonverbal	JJ	B-PROBLEM	O
,	,	O	O
but	CC	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
open	VB	O	O
her	PRP$	O	O
eyes	NNS	O	O
and	CC	O	O
nod	NN	O	O
.	.	O	O

no	DT	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
was	VBD	O	O
102.2	CD	O	O
;	:	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
135/64	CD	O	O
;	:	O	O
pulse	JJ	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
108	CD	O	O
;	:	O	O
respirations	NNS	B-TEST	B-TEST
24	CD	O	O
;	:	O	O
oxygen	NN	B-TEST	B-TEST
saturations	NNS	I-TEST	I-TEST
on	IN	I-TEST	O
room	NN	I-TEST	O
air	NN	I-TEST	O
94%	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
,	,	I-TEST	I-TEST
eyes	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
ears	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
nose	RB	I-TEST	I-TEST
and	CC	I-TEST	I-TEST
throat	VB	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
revealed	VBD	O	O
no	DT	O	O
ocular	JJ	B-PROBLEM	B-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

neck	SYM	O	B-TEST
-	:	O	O
no	DT	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
;	:	O	O
no	DT	O	O
carotid	NN	B-PROBLEM	B-PROBLEM
bruits	VBZ	I-PROBLEM	I-PROBLEM
;	:	O	O
jugular	JJ	B-TEST	B-PROBLEM
venous	JJ	I-TEST	I-PROBLEM
pressure	NN	I-TEST	I-PROBLEM
not	RB	O	I-PROBLEM
elevated	VBN	B-PROBLEM	I-PROBLEM
;	:	O	O
no	DT	O	O
goiter	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

chest	JJS	O	O
-	:	O	O
reduced	VBN	B-PROBLEM	B-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
sounds	NNS	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
bases	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
faint	JJ	B-PROBLEM	B-PROBLEM
inspiratory	NN	I-PROBLEM	I-PROBLEM
rhonchi	VBD	I-PROBLEM	I-PROBLEM
anteriorly	RB	I-PROBLEM	I-PROBLEM
.	.	O	O

cardiac	JJ	O	B-TEST
-	:	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
with	IN	O	O
frequent	JJ	B-PROBLEM	B-PROBLEM
premature	NN	I-PROBLEM	I-PROBLEM
beats	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
2/6	CD	I-PROBLEM	I-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
ejection	NN	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
apex	NN	I-PROBLEM	O
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
was	VBD	O	O
non-tender	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
hepatomegaly	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
normal	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
.	.	O	O

extremities	NNS	O	O
-	:	O	O
1+	CD	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
2+	CD	B-TEST	B-PROBLEM
pulses	NNS	I-TEST	I-PROBLEM
.	.	O	O

skin	SYM	O	B-TEST
-	:	O	O
intact	JJ	O	O
with	IN	O	O
diaper	NN	B-TREATMENT	O
.	.	O	O

the	DT	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
was	VBD	O	O
142	CD	O	O
;	:	O	O
potassium	NN	B-TEST	B-TEST
4.5	CD	O	O
;	:	O	O
chloride	JJ	B-TEST	B-TEST
105	CD	O	O
;	:	O	O
bicarbonate	NN	B-TEST	B-TEST
27	CD	O	O
;	:	O	O
bun	NN	B-TEST	B-TEST
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
31	CD	O	O
and	CC	O	O
1.3	CD	O	O
;	:	O	O
glucose	JJ	B-TEST	B-TEST
107	CD	O	O
;	:	O	O
total	JJ	B-TEST	B-TEST
protein	NN	I-TEST	I-TEST
7.7	CD	O	O
;	:	O	O
albumin	JJ	B-TEST	B-TEST
3.2	CD	O	O
;	:	O	O
globulin	NN	B-TEST	B-TEST
4.5	CD	O	O
;	:	O	O
uric	JJ	B-TEST	B-TEST
acid	NN	I-TEST	I-TEST
4.2	CD	O	O
;	:	O	O
alkaline	JJ	B-TEST	B-TEST
phosphatase	NN	I-TEST	I-TEST
114	CD	O	O
;	:	O	O
serum	JJ	B-TEST	B-TEST
glutamic	JJ	I-TEST	I-TEST
oxaloacetic	JJ	I-TEST	I-TEST
transaminase	NN	I-TEST	I-TEST
46	CD	O	O
;	:	O	O
lactic	JJ	B-TEST	B-TREATMENT
acid	NN	I-TEST	I-TREATMENT
dehydrogenase	NN	I-TEST	I-TREATMENT
370	CD	O	O
;	:	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
11,000	CD	O	O
with	IN	O	O
83	CD	O	B-PROBLEM
polymorphonuclear	JJ	B-TEST	I-PROBLEM
leukocytes	NNS	I-TEST	I-PROBLEM
;	:	O	O
hematocrit	VBZ	B-TEST	B-TEST
42	CD	O	O
;	:	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
227,000	CD	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
chest	NN	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
showed	VBD	O	O
consolidation	JJ	B-PROBLEM	B-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
lyin	NN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobes	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
a	DT	O	O
presumed	JJ	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
for	IN	O	O
rehydration	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
clindamycin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
ofloxacin	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
renal	JJ	O	O
dose	NN	O	O
to	TO	O	O
cover	VB	O	O
the	DT	B-PROBLEM	B-PROBLEM
aspiration	NN	I-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
positive	JJ	B-PROBLEM	O
urine	JJ	I-PROBLEM	B-TEST
culture	NN	I-PROBLEM	I-TEST
,	,	O	O
which	WDT	O	O
subsequently	RB	O	O
came	VBD	O	O
back	RB	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
wheezing	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
responded	VBD	O	O
well	RB	O	O
to	TO	O	O
albuterol	VB	B-TREATMENT	B-TREATMENT
nebulizers	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
generally	RB	O	O
doing	VBG	O	O
well	RB	O	O
with	IN	O	O
resolution	NN	O	O
of	IN	O	O
her	PRP$	B-TEST	B-PROBLEM
temperature	NN	I-TEST	I-PROBLEM
until	IN	O	O
4/1/97	CD	O	O
at	IN	O	O
9:20	CD	O	O
p.m.	NN	O	O
,	,	O	O
when	WRB	O	O
she	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
unresponsive	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
fixed	JJ	B-PROBLEM	B-PROBLEM
dilated	VBN	I-PROBLEM	I-PROBLEM
pupils	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
recorded	VBD	O	O
as	IN	O	O
having	VBG	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
to	TO	O	O
drugs	NNS	B-TREATMENT	B-TREATMENT

altered	VBN	B-PROBLEM	B-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM

intubatation	NN	B-TREATMENT	B-PROBLEM

central	JJ	B-TREATMENT	B-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT

52	CD	O	O
y.o.	NNS	O	O
male	JJ	O	O
with	IN	O	O
esld	JJ	B-PROBLEM	O
due	JJ	O	O
to	TO	O	O
hcv	VB	B-PROBLEM	O
/	NNP	O	O
etoh	JJ	B-PROBLEM	B-PROBLEM
cirrhosis	NN	I-PROBLEM	I-PROBLEM
now	RB	O	O
with	IN	O	O
delta	JJ	B-PROBLEM	B-PROBLEM
ms	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

recently	RB	O	O
d/c	VBZ	O	O
'd	MD	O	O
on	IN	O	O
05-15	NN	O	O
after	IN	O	O
admission	NN	O	O
for	IN	O	O
hepatic	JJ	B-PROBLEM	B-PROBLEM
encephalopathy	JJ	I-PROBLEM	I-PROBLEM
versus	NN	O	O
opiate	NN	B-PROBLEM	O
abuse	NN	I-PROBLEM	O
.	.	O	O

brought	VBN	O	O
in	IN	O	O
by	IN	O	O
family	NN	O	O
for	IN	O	O
ams	NNS	B-PROBLEM	O
.	.	O	O

no	DT	O	O
hx	NN	O	O
available	JJ	O	O
at	IN	O	O
youville	NNP	O	O
hospital	NN	O	O
katherine	NN	O	O
,	,	O	O
except	IN	O	O
for	IN	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

increasing	VBG	B-PROBLEM	B-PROBLEM
tachypnea	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
tachycardia	NN	B-PROBLEM	B-PROBLEM
in	IN	O	O
leola	NN	O	O
,	,	O	O
cxr	NN	B-TEST	O
with	IN	O	O
likely	JJ	O	O
aspiration	NN	B-PROBLEM	O
pna	NN	I-PROBLEM	O
versus	NN	O	O
chf	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
intubated	VBN	B-TREATMENT	B-TREATMENT
.	.	O	O

started	VBN	O	O
on	IN	O	O
levo	NN	B-TREATMENT	B-TREATMENT
/	NNP	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
/	NNP	O	O
ceftriaxone	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
sbp	NN	B-PROBLEM	O
and	CC	O	O
questionable	JJ	O	O
meningitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1.	CD	O	O
hcv/etoh	JJ	B-PROBLEM	B-PROBLEM
cirrhosis	NN	I-PROBLEM	I-PROBLEM

2.	CD	O	O
h/o	NN	O	O
sbp	NN	B-PROBLEM	B-PROBLEM

3.	CD	O	O
esoph	JJ	B-PROBLEM	B-PROBLEM
varices	NNS	I-PROBLEM	I-PROBLEM
(	(	I-PROBLEM	I-PROBLEM
grade	VB	I-PROBLEM	I-PROBLEM
i	NN	I-PROBLEM	I-PROBLEM
)	)	I-PROBLEM	I-PROBLEM

4.	CD	O	O
depression	NN	B-PROBLEM	B-PROBLEM

6.	CD	O	O
recurrent	NN	B-PROBLEM	B-PROBLEM
arf	NN	I-PROBLEM	I-PROBLEM

7.	CD	O	O
h/o	JJ	O	O
seizure	NN	B-PROBLEM	B-PROBLEM

8.	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
lbp	NN	I-PROBLEM	I-PROBLEM

9.	CD	O	O
anemia	NN	B-PROBLEM	B-PROBLEM

his	PRP$	O	O
father	NN	O	O
had	VBD	O	O
hemochromatosis	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
dmii	NN	B-PROBLEM	O
.	.	O	O

101.8	CD	O	O
,	,	O	O
100	CD	O	O
,	,	O	O
144/92	CD	O	O
,	,	O	O
18	CD	O	O
,	,	O	O
98%	CD	O	O
3lnc	CD	O	O
lying	NN	O	O
in	IN	O	O
bed	NN	O	O
,	,	O	O
oriented	VBD	O	O
hospital	NN	O	O
only	RB	O	O
scleral	JJ	B-PROBLEM	B-PROBLEM
icterus	NN	I-PROBLEM	I-PROBLEM
tachy	NN	B-PROBLEM	I-PROBLEM
but	CC	O	O
reg	NN	B-PROBLEM	O
diffusely	RB	I-PROBLEM	O
ttp	JJ	I-PROBLEM	O
and	CC	O	O
guaiac	JJ	B-TEST	B-TEST
negative	JJ	O	O
non-pitting	JJ	B-PROBLEM	O
brawny	NN	I-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
lichenification	NN	B-PROBLEM	O

pertinent	JJ	O	O
results	NNS	O	O
:	:	O	O
wbc	JJ	B-TEST	B-TEST
6.7	CD	O	O
46%	CD	O	O
pmn	NN	O	O
40%	CD	O	O
bands	NNS	B-TEST	B-TEST
,	,	O	O
na	RB	B-TEST	O
128	CD	O	O
tbili	NN	B-TEST	B-TEST
9.1	CD	O	O
,	,	O	O
alb	RB	B-TEST	B-TREATMENT
2.3	CD	O	O
,	,	O	O
inr	NN	B-TEST	B-TEST
2.1	CD	O	O
,	,	O	O
lactate	VBP	B-TEST	B-TEST
4.4	CD	O	O
ecg	NN	B-TEST	O
unremarkable	JJ	O	O

1st	CD	B-TEST	O
cxr	NN	I-TEST	O
normal	JJ	O	O
;	:	O	O
2nd	CD	O	O
prior	NN	O	O
to	TO	O	O
intubation	VB	B-TREATMENT	B-TREATMENT
?	.	O	O
rll	JJ	B-PROBLEM	B-PROBLEM
opacity	NN	I-PROBLEM	I-PROBLEM
(	(	O	I-PROBLEM
mild	JJ	B-PROBLEM	I-PROBLEM
chf	NN	I-PROBLEM	I-PROBLEM
?	.	O	O
)	)	O	O
ascites	VBZ	B-PROBLEM	O
:	:	O	O

2900	CD	B-TEST	O
wbc	NN	I-TEST	B-TEST
98%	CD	O	O
pmn	NN	O	O
,	,	O	O
suspcious	JJ	O	O
for	IN	O	O
intra	JJ	B-PROBLEM	B-PROBLEM
/	NNP	I-PROBLEM	I-PROBLEM
extracellular	NN	I-PROBLEM	I-PROBLEM
bact	NN	I-PROBLEM	I-PROBLEM

sbp	NN	B-PROBLEM	O
:	:	O	O

pt	NN	O	O
admitted	VBN	O	O
with	IN	O	O
e	JJ	B-PROBLEM	B-PROBLEM
coli	NNS	I-PROBLEM	I-PROBLEM
spb	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
bacteremia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
ceftriaxone	NN	B-TREATMENT	B-TREATMENT
2	CD	O	O
gm	NN	O	O
iv	JJ	O	O
daily	JJ	O	O
with	IN	O	O
multiple	JJ	B-TREATMENT	B-PROBLEM
repeat	NN	I-TREATMENT	I-PROBLEM
paracenteses	NNS	I-TREATMENT	I-PROBLEM
.	.	O	O

repeat	NN	B-TEST	B-TEST
taps	NNS	I-TEST	I-TEST
did	VBD	O	O
not	RB	O	O
revealed	VBN	O	O
evidence	NN	O	O
of	IN	O	O
infection	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

patient	NN	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
14	CD	O	O
days	NNS	O	O
of	IN	O	O
levoflox	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

resp	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

unclear	JJ	O	O
etiology	NN	O	O
,	,	O	O
but	CC	O	O
likely	JJ	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
event	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
monica	NN	O	I-PROBLEM
.	.	O	O

treated	VBN	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

weaning	NN	O	O
and	CC	O	O
potential	JJ	B-TREATMENT	O
extubation	NN	I-TREATMENT	O
complicated	VBN	O	O
by	IN	O	O
mechanical	JJ	B-PROBLEM	B-PROBLEM
disadvantage	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
large	JJ	B-PROBLEM	B-PROBLEM
ascites	NNS	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
continued	VBN	B-PROBLEM	O
somnolence	NN	I-PROBLEM	B-PROBLEM
(	(	O	O
off	IN	O	O
sedation	NN	B-TREATMENT	B-TREATMENT
).	NN	O	O

we	PRP	O	O
performed	VBD	O	O
frequent	JJ	B-TREATMENT	O
large	JJ	I-TREATMENT	O
vol	NN	I-TREATMENT	O
taps	NNS	I-TREATMENT	O
and	CC	O	O
attempted	VBD	O	O
to	TO	O	O
give	VB	O	O
diuretics	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
but	CC	O	O
were	VBD	O	O
limited	VBN	O	O
by	IN	O	O
renal	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
ascites	NNS	I-PROBLEM	I-PROBLEM
quickly	RB	O	O
accumulated	VBD	O	O
after	IN	O	O
each	DT	B-TREATMENT	B-TREATMENT
tap	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

cirrhosis	NN	B-PROBLEM	B-PROBLEM
:	:	O	O

end-stage	JJ	B-PROBLEM	B-PROBLEM
cirrhosis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
refractory	NN	B-PROBLEM	B-PROBLEM
ascites	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

each	DT	O	O
time	NN	O	O
we	PRP	O	O
have	VBP	O	O
initiated	VBN	O	B-TREATMENT
diuretics	NNS	B-TREATMENT	I-TREATMENT
,	,	O	O
creatinine	NN	B-TEST	B-TEST
rose	VBD	O	O
.	.	O	O

patient	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
nadolol	NN	B-TREATMENT	B-TREATMENT
(	(	O	O
as	IN	O	O
bp	NN	B-TEST	O
tolerated	VBN	O	O
)	)	O	O
and	CC	O	O
lactulose	$	B-TREATMENT	B-TREATMENT
)	)	O	I-TREATMENT

renal	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

creatinine	NN	B-PROBLEM	B-TEST
elevation	NN	I-PROBLEM	O
appears	VBZ	O	O
to	TO	O	O
be	VB	O	O
related	VBN	O	O
to	TO	O	O
both	DT	O	B-PROBLEM
elevated	VBN	B-PROBLEM	I-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
pressures	NNS	I-PROBLEM	I-PROBLEM
from	IN	O	O
ascites	NNS	B-PROBLEM	B-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
to	TO	O	O
attempts	NNS	O	O
at	IN	O	O
diuresis	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

ams	NNS	B-PROBLEM	O
:	:	O	O

likely	JJ	O	O
hepatic	JJ	B-PROBLEM	B-PROBLEM
encepholopathy	NN	I-PROBLEM	I-PROBLEM
initially	RB	O	O
,	,	O	O
and	CC	O	O
later	RBR	O	O
likely	RB	O	O
related	VBN	O	O
to	TO	O	O
sedation	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
delayed	JJ	B-PROBLEM	O
clearance	NN	I-PROBLEM	O
from	IN	O	O
liver	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
became	VBD	O	O
increasingly	RB	O	B-PROBLEM
hypotensive	JJ	B-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
rising	VBG	I-PROBLEM	I-PROBLEM
cr	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
eventually	RB	O	O
becoming	VBG	O	O
pressor	NN	B-PROBLEM	B-PROBLEM
dependent	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

family	NN	O	O
meeting	NN	O	O
was	VBD	O	O
held	VBN	O	O
to	TO	O	O
discuss	VB	O	O
grave	JJ	O	O
prognosis	NN	O	O
,	,	O	O
and	CC	O	O
patient	NN	O	O
was	VBD	O	O
made	VBN	O	O
cmo	NN	B-TREATMENT	O
.	.	O	O

atypical	JJ	B-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

ecasa	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
aspirin	JJ	I-TREATMENT	I-TREATMENT
enteric	RB	I-TREATMENT	I-TREATMENT
coated	VBN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
81	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
levoxyl	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
levothyroxine	JJ	I-TREATMENT	I-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
25	CD	O	O
mcg	NN	O	O
po	NN	O	O
qd	NN	O	O
synarel	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
nafarelin	JJ	I-TREATMENT	I-TREATMENT
acetate	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
1	CD	O	O
puff	JJ	O	O
na	TO	O	O
bid	VB	O	O
nitroglycerin	RB	B-TREATMENT	B-TREATMENT
1/150	CD	O	O
(	(	O	O
0.4	CD	O	O
mg	NN	O	O
)	)	O	O
1	CD	O	O
tab	NN	O	O
sl	NN	O	O
q5min	NN	O	O
x	VBD	O	O
3	CD	O	O
doses	NNS	O	O
prn	JJ	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
multivitamin	NN	B-TREATMENT	B-TREATMENT
therapeutic	JJ	I-TREATMENT	I-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
therapeutic	JJ	I-TREATMENT	I-TREATMENT
multivi	NN	I-TREATMENT	I-TREATMENT
...	:	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
1	CD	O	O
tab	NN	O	O
po	NN	O	O
qd	NN	O	O

potentially	RB	O	O
serious	JJ	B-PROBLEM	O
interaction	NN	I-PROBLEM	O
:	:	O	O

simvastatin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
niacin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
vit	NN	O	B-TREATMENT
.	.	O	O

ok	JJ	O	O
toprol	NN	B-TREATMENT	B-TREATMENT
xl	NNP	I-TREATMENT	I-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
metoprolol	NN	I-TREATMENT	I-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
sust.	JJ	I-TREATMENT	I-TREATMENT
rel.	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
)	)	O	I-TREATMENT
200	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O

8	CD	O	O
plavix	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
clopidogrel	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
75	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
atorvastatin	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
40	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O

potentially	RB	O	O
serious	JJ	B-PROBLEM	O
interaction	NN	I-PROBLEM	O
:	:	O	O

niacin	RB	B-TREATMENT	B-TREATMENT
,	,	O	O
vit	NN	O	B-TREATMENT
.	.	O	O

b-3	NN	O	O
and	CC	O	O
atorvastatin	NN	B-TREATMENT	B-TREATMENT
calcium	NN	I-TREATMENT	I-TREATMENT

morphine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O

leuprolide	JJ	B-TREATMENT	O
admit	NN	O	O
diagnosis	NN	O	O
:	:	O	O

chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

responsible	JJ	O	O
after	IN	O	O
study	NN	O	O
for	IN	O	O
causing	VBG	O	O
admission	NN	O	O
)	)	O	O
atypical	JJ	B-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

s	NN	O	O
/	NNP	O	O
p	NN	O	O
inferior	JJ	B-PROBLEM	O
stemi	NN	I-PROBLEM	O
(	(	O	O
2/17	CD	O	O
)	)	O	O
with	IN	O	O
stent	NN	B-TREATMENT	B-TREATMENT
to	TO	I-TREATMENT	O
rca	VB	I-TREATMENT	O
;	:	O	O
tte	NN	B-TEST	O
(	(	O	O
2/17	CD	O	O
)	)	O	O
-	:	O	O
lvef	JJ	B-TEST	B-TREATMENT
55-60%	JJ	O	I-TREATMENT
,	,	O	O
inferobasal	JJ	B-PROBLEM	B-PROBLEM
hk	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
cervical	JJ	B-PROBLEM	B-PROBLEM
spinal	JJ	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
;	:	O	O
gerd	NN	B-PROBLEM	O
;	:	O	O
endometriosis	CC	B-PROBLEM	B-PROBLEM
s	VB	O	I-PROBLEM
/	JJ	O	O
p	NN	O	O
laparotomy	NN	B-TEST	B-TREATMENT
and	CC	O	O
l	JJ	B-TREATMENT	B-TREATMENT
oophorectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

ett	SYM	B-TEST	B-TEST
-	:	O	O
mibi	NN	B-TEST	O
5/27/05	CD	O	O
-	:	O	O
normal	JJ	O	O
,	,	O	O
no	DT	O	O
e	NN	O	B-PROBLEM
/	VBZ	O	O
o	JJ	O	O
ischemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

45	CD	O	O
yo	JJ	O	O
f	NN	O	O
s	NN	O	O
/	NNP	O	O
p	NN	O	O
recent	JJ	B-PROBLEM	O
inferior	JJ	I-PROBLEM	O
stemi	NN	I-PROBLEM	O
(	(	O	O
2/17	CD	O	O
)	)	O	O
w/	NN	O	O
100%	CD	O	O
rca	NN	O	O
stented	VBD	O	O
-&gt;	JJ	O	O
0%	CD	O	O
,	,	O	O
and	CC	O	O
residual	JJ	B-PROBLEM	O
lad	NN	I-PROBLEM	O
/	NNP	I-PROBLEM	O
diag1/lcx	NN	I-PROBLEM	B-PROBLEM
/	NNP	I-PROBLEM	I-PROBLEM
om2	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

developed	VBN	O	O
burning	VBG	B-PROBLEM	B-PROBLEM
chest	JJS	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
before	IN	O	O
bedtime	NN	O	O
the	DT	O	O
night	NN	O	O
pta	NN	O	O
.	.	O	O

no	DT	O	O
associated	JJ	O	B-PROBLEM
sxs	NN	B-PROBLEM	I-PROBLEM
/	NNP	O	O
radiation	NN	B-PROBLEM	O
.	.	O	O

slept	RB	O	O
well	RB	O	O
,	,	O	O
but	CC	O	O
on	IN	O	O
the	DT	O	O
am	VBP	O	O
of	IN	O	O
admission	NN	O	O
had	VBD	O	O
same	JJ	B-PROBLEM	B-PROBLEM
burning	NN	I-PROBLEM	I-PROBLEM
across	IN	I-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
(	(	O	I-PROBLEM
&quot;	FW	O	I-PROBLEM
deeper	JJR	O	I-PROBLEM
than	IN	O	I-PROBLEM
heartburn	VB	B-PROBLEM	I-PROBLEM
&quot;	JJ	O	I-PROBLEM
)	)	O	I-PROBLEM
so	RB	O	O
went	VBD	O	O
to	TO	O	O
her	PRP$	O	O
md	NN	O	O
&apos;s	JJ	O	O
office	NN	O	O
.	.	O	O

transient	JJ	B-PROBLEM	B-PROBLEM
diaphoresis	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
md	NN	O	O
&apos;s	NNP	O	O
office	NN	O	O
that	WDT	O	O
patient	NN	O	O
attributed	VBD	O	O
to	TO	O	O
heat	VB	O	O
in	IN	O	O
room	NN	O	O
.	.	O	O

patient	NN	O	O
says	VBZ	O	O
pain	NN	B-PROBLEM	B-PROBLEM
is	VBZ	O	O
similar	JJ	O	O
in	IN	O	O
location	NN	O	O
and	CC	O	O
quality	NN	O	O
to	TO	O	O
the	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
she	PRP	O	O
had	VBD	O	O
with	IN	O	O
her	PRP	B-PROBLEM	B-PROBLEM
mi	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
although	IN	O	O
with	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
mi	NN	I-PROBLEM	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
much	RB	O	O
more	JJR	O	O
intense	JJ	O	O
(	(	O	O
20x	CD	O	O
worse	NN	O	O
)	)	O	O
.	.	O	O

this	DT	O	O
is	VBZ	O	O
1st	CD	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
since	IN	O	O
mi	NN	B-PROBLEM	O
(	(	O	O
though	IN	O	O
patient	NN	O	O
reports	NNS	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
baseline	NN	I-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
tightness	IN	I-PROBLEM	I-PROBLEM
x8-10	JJ	O	O
years	NNS	O	O
of	IN	O	O
unclear	JJ	O	O
etiology	NN	O	O
)	)	O	O
.	.	O	O

cp	NN	B-PROBLEM	O
/	NN	O	O
burning	VBG	B-PROBLEM	O
lasted	VBD	O	O
several	JJ	O	O
hours	NNS	O	O
and	CC	O	O
was	VBD	O	O
relieved	VBN	O	O
after	IN	O	O
she	PRP	O	O
received	VBD	O	O
maalox	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
lidocaine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
ntg	RB	B-TREATMENT	O
in	IN	O	O
the	DT	O	O
ed	NN	O	O
.	.	O	O

she	PRP	O	O
reports	VBZ	O	O
compliance	NN	O	O
with	IN	O	O
her	PRP$	B-TREATMENT	O
asa	NN	I-TREATMENT	O
+	NN	O	O
plavix	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
active	JJ	O	O
at	IN	O	O
baseline	NN	O	O
,	,	O	O
participating	VBG	O	O
in	IN	O	O
cardiac	JJ	B-TREATMENT	O
rehab	NN	I-TREATMENT	O
for	IN	O	O
2	CD	O	O
hrs	NNS	O	O
/	JJ	O	O
week	NN	O	O
and	CC	O	O
running	VBG	O	O
up	RB	O	O
and	CC	O	O
down	RB	O	O
stairs	NNS	O	O
at	IN	O	O
home	NN	O	O
without	IN	O	O
cp	JJ	B-PROBLEM	O
/	NNP	O	O
sob	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

in	IN	O	O
ed	JJ	O	O
vitals	NNS	B-TEST	O
p86	VBP	B-TEST	O
bp	RB	B-TEST	O
127/88	CD	O	O
sat	VBD	B-TEST	O
100%	CD	O	O
.	.	O	O

nad	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
jvd	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

ctab.	NN	O	O
nl	NN	O	O
s1s2	NN	O	O
,	,	O	O
reg	NN	O	O
,	,	O	O
no	DT	O	O
m	NN	B-PROBLEM	O
/	NNP	O	O
r.	VBZ	B-PROBLEM	O
no	DT	O	O
chest	NN	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

abd	NN	O	O
soft	JJ	O	O
,	,	O	O
nt	JJ	B-PROBLEM	O
/	NNP	O	O
nd	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nabs.	JJ	O	O
ext	NN	O	O
wwp	NN	O	O
,	,	O	O
no	DT	O	O
c	NN	B-PROBLEM	B-PROBLEM
/	NNP	O	O
c/e	NN	B-PROBLEM	O
,	,	O	O
2+dp	CD	B-TEST	O
&apos;s	NN	O	O
b	NN	O	O
/	NNP	O	O
l.	NN	O	O

trop	NN	B-TEST	O
&lt;	NNP	I-TEST	O
assay	NN	I-TEST	O
,	,	O	O
ck	NN	B-TEST	B-TEST
67	CD	O	O
,	,	O	O
mb	VBD	B-TEST	O
0.2	CD	O	O
.	.	O	O

ekg	SYM	B-TEST	B-TEST
-	:	O	O
old	JJ	B-PROBLEM	O
twi	NN	I-PROBLEM	O
iii	NN	I-PROBLEM	O
.	.	O	O

a	DT	O	O
/	JJ	O	O
p	NN	B-TEST	O
:	:	O	O

45f	CD	O	O
with	IN	O	O
recent	JJ	B-PROBLEM	B-PROBLEM
inferior	JJ	I-PROBLEM	I-PROBLEM
stemi	NN	I-PROBLEM	I-PROBLEM
s	NN	O	I-PROBLEM
/	NNP	O	O
p	NN	O	O
stent	NN	B-TREATMENT	B-TREATMENT
to	TO	I-TREATMENT	O
rca	VB	I-TREATMENT	O
.	.	O	O

(	(	O	O
i	NN	O	O
)	)	O	O
romi	NN	B-TEST	O
negative	JJ	O	O
.	.	O	O

ett	NN	B-TEST	O
mibi	NN	B-TEST	O
4/14	CD	O	O
without	IN	O	O
e	NN	O	O
/	NNP	O	O
o	NN	O	O
ischemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O
?	.	O	O

gerd	NN	B-PROBLEM	O
as	IN	O	O
etiology	NN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
burning	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

cont	NN	O	O
asa	NN	B-TREATMENT	O
,	,	O	O
statin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
plavix	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
bblkr	NN	B-TREATMENT	O
.	.	O	O

(	(	O	O
p	NN	O	O
)	)	O	O
most	RBS	O	O
recent	JJ	O	O
echo	NN	B-TEST	O
:	:	O	O

ef	RB	B-TEST	B-TEST
55%	CD	O	O
and	CC	O	O
inf	JJ	B-PROBLEM	O
/	NNP	I-PROBLEM	O
post	NN	I-PROBLEM	B-PROBLEM
hk	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

(	(	O	O
r	NN	O	O
)	)	O	O
patient	NN	O	O
had	VBD	O	O
no	DT	O	O
events	NNS	O	O
on	IN	O	O
tele	NN	B-TEST	O
.	.	O	O

continue	NN	O	O
levoxyl	NN	B-TREATMENT	O
for	IN	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
synarel	NN	B-TREATMENT	O
for	IN	O	O
endometriosis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

cervical	JJ	B-PROBLEM	B-PROBLEM
spondylosis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
tylenol	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

h	NN	O	O
/	JJ	O	O
o	JJ	O	O
gerd-	JJ	B-PROBLEM	B-PROBLEM
nexium	NN	B-TREATMENT	I-PROBLEM
.	.	O	O

if	IN	O	O
you	PRP	O	O
develop	VBP	O	O
recurrent	JJ	B-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
any	DT	B-PROBLEM	B-PROBLEM
other	JJ	I-PROBLEM	I-PROBLEM
concerning	NN	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
call	VB	O	O
your	PRP$	O	O
doctor	NN	O	O
or	CC	O	O
return	NN	O	O
to	TO	O	O
the	DT	O	O
hospital	NN	O	O
.	.	O	O

continue	VB	O	O
taking	VBG	O	O
all	DT	O	O
of	IN	O	O
your	PRP$	B-TREATMENT	B-TREATMENT
regular	JJ	I-TREATMENT	I-TREATMENT
home	NN	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

patient	NN	O	O
recorded	VBD	O	O
as	IN	O	O
having	VBG	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
to	TO	O	O
drugs	NNS	B-TREATMENT	B-TREATMENT

right	JJ	B-PROBLEM	B-PROBLEM
parietal	NN	I-PROBLEM	I-PROBLEM
wound	VBD	I-PROBLEM	I-PROBLEM
dehiscence	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

csf	NN	B-PROBLEM	B-TEST
leak	NN	I-PROBLEM	I-TEST
.	.	O	O

perforated	VBN	B-PROBLEM	B-PROBLEM
diverticulitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

lumbar	NN	B-TREATMENT	B-TREATMENT
drain	NN	I-TREATMENT	I-TREATMENT
placement	JJ	I-TREATMENT	I-TREATMENT
2012-05-24	JJ	O	O

exploratory	JJ	B-TEST	B-TEST
laparotomy	JJ	I-TEST	I-TEST
2012-05-26	JJ	O	O

abdominal	JJ	B-TREATMENT	O
washtou	NN	I-TREATMENT	O
2012-05-26	JJ	O	O

sigmoid	JJ	B-TREATMENT	B-TREATMENT
colectomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
hartmans	NNS	B-TREATMENT	O
pouch	JJ	I-TREATMENT	O
2012-05-26	JJ	O	O

lumbar	NN	B-TREATMENT	B-TREATMENT
drain	NN	I-TREATMENT	I-TREATMENT
placement	JJ	I-TREATMENT	I-TREATMENT
2012-05-29	JJ	O	O

ct-guided	JJ	B-TREATMENT	B-PROBLEM
aspiration	NN	I-TREATMENT	I-PROBLEM
06-01	NN	O	I-PROBLEM
for	IN	O	O
pelvic	JJ	B-PROBLEM	B-PROBLEM
abscess	NN	I-PROBLEM	I-PROBLEM

reveision	NN	B-TREATMENT	B-TREATMENT
right	RB	I-TREATMENT	I-TREATMENT
craniotomy	VBZ	I-TREATMENT	I-TREATMENT
06-03	JJ	O	O

revsion	NN	B-TREATMENT	B-PROBLEM
of	IN	I-TREATMENT	I-PROBLEM
bone	NN	I-TREATMENT	I-PROBLEM
flap	NN	I-TREATMENT	I-PROBLEM
06-03	NN	O	I-PROBLEM

emergent	JJ	B-TREATMENT	B-TREATMENT
intubation	NN	I-TREATMENT	I-TREATMENT
06-04	NN	O	I-TREATMENT

picc	JJ	B-TREATMENT	B-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
2012-06-08	JJ	O	O

57	CD	O	O
yo	NN	O	O
right	RB	O	O
handed	VBD	O	O
male	NN	O	O
with	IN	O	O
seizure	NN	B-PROBLEM	B-PROBLEM
history	NN	I-PROBLEM	I-PROBLEM
since	IN	O	O
1988	CD	O	O
,	,	O	O
s/p	JJ	O	B-TREATMENT
craniotomies	NNS	B-TREATMENT	I-TREATMENT
x	VBP	O	O
3	CD	O	O
(	(	O	O
most	RBS	O	O
recently	RB	O	O
05-05	VBP	O	O
)	)	O	O
for	IN	O	O
oligodendroglioma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
began	VBD	O	O
having	VBG	O	O
generalized	VBN	B-PROBLEM	B-PROBLEM
tonic	JJ	I-PROBLEM	I-PROBLEM
-	:	I-PROBLEM	I-PROBLEM
clonic	NN	I-PROBLEM	I-PROBLEM
seizures	NNS	I-PROBLEM	I-PROBLEM
in	IN	O	O
1988	CD	O	O
,	,	O	O
which	WDT	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
were	VBD	O	O
thought	VBN	O	O
to	TO	O	O
be	VB	O	O
related	VBN	O	O
to	TO	O	O
asthma	VB	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

at	IN	O	O
this	DT	O	O
time	NN	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
,	,	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
dilantin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
phenobarbital	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

however	RB	O	O
,	,	O	O
he	PRP	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
left	VBN	B-PROBLEM	B-PROBLEM
arm	JJ	I-PROBLEM	I-PROBLEM
focal	JJ	I-PROBLEM	I-PROBLEM
motor	NN	I-PROBLEM	I-PROBLEM
seizures	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
problems	NNS	B-PROBLEM	I-PROBLEM
thinking	VBG	I-PROBLEM	I-PROBLEM
.	.	O	O

in	IN	O	O
2001-08-31	JJ	O	O
he	PRP	O	O
stopped	VBD	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
medication	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
generalized	VBN	I-PROBLEM	I-PROBLEM
tonic	JJ	I-PROBLEM	I-PROBLEM
-	:	I-PROBLEM	O
clonic	JJ	I-PROBLEM	B-PROBLEM
seizure	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
12/94	CD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
diagnosed	VBN	O	O
by	IN	O	O
biopsy	NN	B-TEST	B-TEST
with	IN	O	O
oligodendroglioma	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
gross	JJ	B-TREATMENT	B-TREATMENT
total	JJ	I-TREATMENT	I-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT
by	IN	O	O
dr.	NN	O	O
redner	NN	O	O
in	IN	O	O

95	CD	O	O
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
low-grade	JJ	I-PROBLEM	I-PROBLEM
oligodendroglioma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
followed	VBN	O	O
by	IN	O	O
dr.	JJ	O	O
gregory	NN	O	O
dumas	NN	O	B-PROBLEM
,	,	O	O
with	IN	O	O
serial	JJ	B-TEST	B-TEST
mri	NN	I-TEST	I-TEST
's.	NN	I-TEST	I-TEST

in	IN	O	O
2011-05-02	JJ	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
requiring	VBG	O	O
more	JJR	B-TREATMENT	O
ativan	NNS	I-TREATMENT	B-TREATMENT
to	TO	O	O
control	VB	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
seizures	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
was	VBD	O	O
increasingly	RB	B-PROBLEM	B-PROBLEM
disoriented	VBN	I-PROBLEM	I-PROBLEM
and	CC	O	O
forgetful	JJ	B-PROBLEM	O
with	IN	O	O
headaches	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
repeat	NN	I-TREATMENT	I-TREATMENT
total	JJ	I-TREATMENT	I-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
4/04	CD	O	O
by	IN	O	O
dr.	NN	O	O
peter	NN	O	O
hoadley	NN	O	O
at	IN	O	O
hallmark	NN	O	O
health	NN	O	O
system	NN	O	O
which	WDT	O	O
revealed	VBD	O	O
anaplastic	JJ	B-PROBLEM	B-PROBLEM
oligodendroglioma	NN	I-PROBLEM	I-PROBLEM
grade	NN	I-PROBLEM	I-PROBLEM
iii	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
radiation	NN	B-TREATMENT	O
following	VBG	O	O
the	DT	B-TREATMENT	B-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
was	VBD	O	O
doing	VBG	O	O
well	RB	O	O
on	IN	O	O
monthly	JJ	B-TREATMENT	O
temodar	NN	I-TREATMENT	O
until	IN	O	O
2012-04-23	JJ	O	O
when	WRB	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
marked	JJ	I-PROBLEM	I-PROBLEM
change	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
behavior	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
his	PRP$	O	B-TEST
balance	NN	O	I-TEST
was	VBD	O	O
off	RB	O	O
,	,	O	O
speech	NN	B-PROBLEM	O
slurred	VBD	I-PROBLEM	O
,	,	O	O
and	CC	O	O
he	PRP	O	O
had	VBD	O	O
difficulty	NN	B-PROBLEM	B-PROBLEM
using	VBG	I-PROBLEM	O
the	DT	I-PROBLEM	O
computer	NN	I-PROBLEM	O
.	.	O	O

a	DT	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
mri	NN	I-TEST	I-TEST
on	IN	O	O
2012-04-24	JJ	O	O
revealed	JJ	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
infiltration	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
mass	NN	B-PROBLEM	B-PROBLEM
effect	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
underwent	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
craniotomy	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
resection	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
gliadel	NN	B-TREATMENT	O
wafers	NNS	I-TREATMENT	O
on	IN	O	O
2012-05-02	JJ	O	O
at	IN	O	O
hallmark	NN	O	O
health	NN	O	O
system	NN	O	O
by	IN	O	O
dr.	JJ	O	O
ackley	NN	O	O
.	.	O	O

came	VBD	O	O
for	IN	O	O
neurosurgery	NN	O	O
follow	VBP	O	O
up	RP	O	O
on	IN	O	O
05-21	NN	O	O
,	,	O	O
and	CC	O	O
had	VBD	O	O
been	VBN	O	O
having	VBG	O	O
clear	JJ	B-PROBLEM	O
fluid	NN	I-PROBLEM	O
leaking	VBG	O	O
from	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
frontal	JJ	B-PROBLEM	B-PROBLEM
headache	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
imbalance	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
bumping	VBG	O	O
into	IN	O	O
things	NNS	O	O
with	IN	O	O
his	PRP$	O	B-PROBLEM
left	JJ	O	I-PROBLEM
leg	NN	O	I-PROBLEM
and	CC	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
tremors	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
lumbar	NN	B-TREATMENT	B-TREATMENT
drain	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT

right	JJ	B-PROBLEM	B-PROBLEM
parietal	NN	I-PROBLEM	I-PROBLEM
oligodendroglioma	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
as	IN	O	O
above	IN	O	O
status	NN	O	O
post	NN	O	O
craniotomy	NN	B-TREATMENT	B-TREATMENT
x	$	O	O
3	CD	O	O
(	(	O	O
'95	CD	O	O
,	,	O	O
'04	CD	O	O
,	,	O	O
'05	CD	O	O
)	)	O	O

hernia	NN	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
x	CD	O	O
3	CD	O	O

right	JJ	B-PROBLEM	B-PROBLEM
hand	NN	I-PROBLEM	I-PROBLEM
ganglion	NN	I-PROBLEM	I-PROBLEM
cyst	NN	I-PROBLEM	I-PROBLEM
removed	VBD	O	O

asthma	NN	B-PROBLEM	B-PROBLEM

abdomen	NNS	O	O
soft	JJ	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
nondistended	VBD	B-PROBLEM	B-PROBLEM

no	DT	O	O
pronator	NN	B-PROBLEM	B-PROBLEM
drift	NN	I-PROBLEM	I-PROBLEM

strength	NN	B-TEST	B-TEST
5/5	CD	O	O
throughout	IN	O	O

2+	CD	B-TEST	O
reflexes	NNS	I-TEST	B-TEST
throughout	IN	O	O

no	DT	O	O
dysmetria	NN	B-PROBLEM	B-PROBLEM

wbc	SYM	B-TEST	B-TEST
-	:	O	O
6.3	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
4.17	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
13.7	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
40.2	CD	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
96	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
32.7	CD	O	O
*	NN	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.0	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
13.6	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
143	CD	O	O
*	NN	O	O
pt	NN	B-TEST	B-TEST
-	:	O	O
11.9	CD	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
21.1	CD	O	O
*	JJ	O	O
inr	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
pt	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
0.9	CD	O	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
207	CD	O	O
*	JJ	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
17	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
0.9	CD	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
134	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
4.6	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
93	CD	O	O
*	NN	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
35	CD	O	O
*	NN	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
11	CD	O	O
calcium	NN	B-TEST	B-TEST
-	:	O	O
8.3	CD	O	O
*	NN	O	O
phos	NN	B-TEST	B-TEST
-	:	O	O
1.8	CD	O	O
*#	NN	O	O
mg	SYM	B-TEST	O
-	:	O	O
2.1	CD	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
6.5	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.20	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
10.5	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
30.7	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
96	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
32.8	CD	O	O
*	NN	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.2	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
14.3	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
227	CD	O	O
pt	NN	B-TEST	O
-	:	O	O
13.4	CD	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
24.6	CD	O	O
inr	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
pt	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
1.1	CD	O	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
117	CD	O	O
*	JJ	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
12	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
0.6	CD	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
140	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
4.2	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
102	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
32	CD	O	O
*	NN	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
10	CD	O	O
calcium	NN	B-TEST	B-TEST
-	:	O	O
9.0	CD	O	O
phos	NN	B-TEST	B-TEST
-	:	O	O
3.9	CD	O	O
mg	SYM	B-TEST	O
-	:	O	O
2.0	CD	O	O

diverticular	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
colon	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

1.	CD	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
diverticula	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
rupture	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
diverticulum	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
pericolic	JJ	B-PROBLEM	B-PROBLEM
abscess	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

ct	JJ	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
2012-06-11	CD	O	O
:	:	O	O

1)	CD	O	O
overall	JJ	O	O
,	,	O	O
a	DT	O	B-PROBLEM
slight	JJ	O	I-PROBLEM
decrease	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
effect	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
associated	VBN	O	O
with	IN	O	O
the	DT	O	B-PROBLEM
postoperative	JJ	O	I-PROBLEM
changes	NNS	O	I-PROBLEM
.	.	O	O

2)	CD	O	O
slight	JJ	O	B-PROBLEM
increase	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
epidural	JJ	B-PROBLEM	I-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
collection	NN	I-PROBLEM	I-PROBLEM
adjacent	NN	O	I-PROBLEM
to	TO	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
craniotomy	NN	I-PROBLEM	I-PROBLEM
site	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

ct	JJ	B-TEST	B-TEST
abdomen	NNS	I-TEST	I-TEST
2012-06-18	CD	O	O
:	:	O	O

small	JJ	B-PROBLEM	B-PROBLEM
residual	JJ	I-PROBLEM	I-PROBLEM
collection	NN	I-PROBLEM	I-PROBLEM
anterior	NN	O	I-PROBLEM
to	TO	O	I-PROBLEM
the	DT	O	I-PROBLEM
rectum	NN	O	I-PROBLEM
,	,	O	O
smaller	JJR	O	O
than	IN	O	O
on	IN	O	O
the	DT	B-TEST	B-TEST
prior	JJ	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
,	,	O	O
and	CC	O	O
without	IN	O	O
substantial	JJ	B-PROBLEM	B-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
components	NNS	I-PROBLEM	I-PROBLEM
to	TO	O	O
allow	VB	O	O
drainage	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

wound	JJ	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
(	(	O	O
final	JJ	O	O
2012-06-05	NN	O	O
)	)	O	O
:	:	O	O

(	(	O	O
pelvic	JJ	B-PROBLEM	B-PROBLEM
abscess	NN	I-PROBLEM	I-PROBLEM
)	)	O	I-PROBLEM

due	JJ	O	O
to	TO	O	O
mixed	JJ	B-PROBLEM	B-PROBLEM
bacterial	JJ	I-PROBLEM	I-PROBLEM
types	NNS	I-PROBLEM	I-PROBLEM
(	(	O	O
>=	$	O	O
3	CD	O	O
colony	NN	O	O
types	NNS	O	O
)	)	O	O
an	DT	B-TEST	O
abbreviated	JJ	I-TEST	O
workup	NN	I-TEST	B-TEST
is	VBZ	O	O
performed	VBN	O	O
appropriate	JJ	O	O
to	TO	O	O
the	DT	O	O
isolates	NNS	O	O
recovered	VBD	O	O
from	IN	O	O
the	DT	O	O
site	NN	O	O
(	(	O	O
including	VBG	O	O
a	DT	B-TEST	O
screen	NN	I-TEST	O
for	IN	O	O
pseudomonas	NN	B-PROBLEM	B-PROBLEM
aeruginosa	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
staphylococcus	VB	B-PROBLEM	B-PROBLEM
aureus	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
beta	NN	B-PROBLEM	B-TREATMENT
streptococcus	NN	I-PROBLEM	I-TREATMENT
)	)	O	O
.	.	O	O

enterococcus	NN	B-PROBLEM	B-PROBLEM
sp.	NN	I-PROBLEM	I-PROBLEM

sparse	JJ	B-PROBLEM	B-PROBLEM
growth	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pseudomonas	NNS	B-PROBLEM	B-PROBLEM
aeruginosa	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

sparse	JJ	B-PROBLEM	B-PROBLEM
growth	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

corynebacterium	NN	B-PROBLEM	B-PROBLEM
species	NNS	I-PROBLEM	I-PROBLEM
(	(	I-PROBLEM	I-PROBLEM
diphtheroids	NNS	I-PROBLEM	I-PROBLEM
)	)	I-PROBLEM	O
.	.	O	O

sparse	JJ	B-PROBLEM	B-PROBLEM
growth	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

enterococcus	NN	B-PROBLEM	B-PROBLEM
sp	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pseudomonas	NNS	B-PROBLEM	B-PROBLEM
aeruginosa	VBP	I-PROBLEM	I-PROBLEM

ampicillin------------	NN	B-TREATMENT	B-PROBLEM

cefepime--------------	NN	B-TREATMENT	O

ceftazidime-----------	NN	B-TREATMENT	O

ciprofloxacin---------	NN	B-TREATMENT	O

gentamicin------------	NN	B-TREATMENT	B-PROBLEM

imipenem--------------	NN	B-TREATMENT	O

levofloxacin----------	NN	B-TREATMENT	B-TREATMENT

meropenem-------------	NN	B-TREATMENT	O

penicillin------------	NN	B-TREATMENT	B-PROBLEM

piperacillin----------	NN	B-TREATMENT	O

piperacillin/tazo-----	NN	B-TREATMENT	O

tobramycin------------	NN	B-TREATMENT	O

vancomycin------------	NN	B-TREATMENT	O

wound	JJ	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
(	(	O	O
final	JJ	O	O
2012-06-05	NN	O	O
)	)	O	O
:	:	O	O

(	(	O	O
from	IN	O	O
or	CC	B-TREATMENT	O
revision	VB	I-TREATMENT	B-TREATMENT
craniotomy	NN	I-TREATMENT	I-TREATMENT
)	)	O	I-TREATMENT

staph	NN	B-PROBLEM	B-PROBLEM
aureus	NN	I-PROBLEM	I-PROBLEM
coag	NN	I-PROBLEM	I-PROBLEM
+	NN	O	O
.	.	O	O

sparse	JJ	B-PROBLEM	B-PROBLEM
growth	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

oxacillin	NN	B-PROBLEM	B-PROBLEM
resistant	JJ	I-PROBLEM	I-PROBLEM
staphylococci	NN	I-PROBLEM	I-PROBLEM
must	MD	O	O
be	VB	O	O
reported	VBN	O	O
as	IN	O	O
also	RB	O	O
resistant	VBP	B-PROBLEM	O
to	TO	O	O
other	JJ	O	O
penicillins	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
cephalosporins	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
carbacephems	NNS	B-TREATMENT	O
,	,	O	O
carbapenems	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
beta-lactamase	JJ	B-TREATMENT	B-TREATMENT
inhibitor	NN	I-TREATMENT	I-TREATMENT
combinations	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

rifampin	NN	B-TREATMENT	B-TREATMENT
should	MD	O	O
not	RB	O	O
be	VB	O	O
used	VBN	O	O
alone	RB	O	O
for	IN	O	O
therapy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

please	VB	O	O
contact	VB	O	O
the	DT	O	O
microbiology	NN	O	O
laboratory	NN	O	O
(	(	O	O
2313-08-31	JJ	O	O
)	)	O	O
immediately	RB	O	O
if	IN	O	O
sensitivity	NN	O	O
to	TO	O	O
clindamycin	VB	B-TREATMENT	B-TREATMENT
is	VBZ	O	O
required	VBN	O	O
on	IN	O	O
this	DT	O	B-TREATMENT
patient	NN	O	I-TREATMENT
's	POS	O	I-TREATMENT
isolate	NN	O	I-TREATMENT
.	.	O	O

staph	NN	B-PROBLEM	B-PROBLEM
aureus	NN	I-PROBLEM	I-PROBLEM
coag	NN	I-PROBLEM	I-PROBLEM
+	NN	O	I-PROBLEM

erythromycin----------	NN	B-TREATMENT	O

gentamicin------------	JJ	B-TREATMENT	B-PROBLEM
<=0.5	NN	O	I-PROBLEM
s	NN	O	I-PROBLEM

levofloxacin----------	NN	B-TREATMENT	B-TREATMENT

oxacillin-------------	NN	B-TREATMENT	B-PROBLEM

penicillin------------	JJ	B-TREATMENT	O
=>0.5	NN	O	O
r	NN	O	O

rifampin--------------	JJ	B-TREATMENT	O
<=0.5	NN	O	O
s	NN	O	O

tetracycline----------	NN	B-TREATMENT	O

vancomycin------------	NN	B-TREATMENT	O

brief	JJ	O	O
hospital	JJ	O	O
course	NN	O	O
:	:	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
on	IN	O	O
2012-05-24	JJ	O	O
after	IN	O	O
having	VBG	O	O
drainage	NN	B-PROBLEM	B-PROBLEM
from	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
for	IN	O	O
the	DT	O	O
last	JJ	O	O
couple	NN	O	O
of	IN	O	O
days	NNS	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
seen	VBN	O	O
in	IN	O	O
the	DT	O	O
brain	NN	O	O
tumor	NN	O	O
clinic	NN	O	O
on	IN	O	O
05-21	JJ	O	O
and	CC	O	O
stitches	NNS	B-TREATMENT	O
were	VBD	O	O
placed	VBN	O	O
in	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
however	RB	O	O
it	PRP	O	O
continued	VBD	O	O
to	TO	O	O
leak	VB	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
lumbar	NN	I-TREATMENT	I-TREATMENT
drain	NN	I-TREATMENT	I-TREATMENT
placed	VBD	O	O
.	.	O	O

he	PRP	O	O
c/o	VBZ	O	O
of	IN	O	O
abd	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
distension	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
05-25	NN	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
kub	NN	I-TEST	I-TEST
done	VBN	O	O
which	WDT	O	O
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

on	IN	O	O
05-26	NN	O	O
he	PRP	O	O
continued	VBD	O	O
to	TO	O	O
c/o	VB	O	O
of	IN	O	O
epigastric	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
had	VBD	O	O
a	DT	B-TEST	B-TEST
chest	JJ	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
done	VBN	O	O
to	TO	O	O
due	VB	O	O
to	TO	O	O
decreased	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
sounds	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	JJ	I-TEST	I-TEST
showed	VBD	O	O
free	JJ	B-PROBLEM	B-PROBLEM
air	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

general	JJ	O	B-TREATMENT
surgery	NN	O	I-TREATMENT
was	VBD	O	O
consulted	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
or	CC	O	O
for	IN	O	O
exploratory	JJ	B-TEST	B-TEST
laproratomy	NN	I-TEST	I-TEST
.	.	O	O

he	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
perforated	VBN	I-PROBLEM	I-PROBLEM
sigmoid	NN	I-PROBLEM	I-PROBLEM
diverticulum	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
colostomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
partial	JJ	B-TREATMENT	B-TREATMENT
colectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

patient	NN	O	O
recovered	VBN	O	O
well	RB	O	O
from	IN	O	O
colocetomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
an	DT	B-PROBLEM	B-PROBLEM
abd	NN	I-PROBLEM	I-PROBLEM
abcess	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
drained	VBN	O	O
via	IN	O	O
ct	NN	B-TEST	O
guidance	NN	I-TEST	O
on	IN	O	O
06-01	NN	O	O
.	.	O	O

on	IN	O	O
06-02	JJ	O	B-TREATMENT
his	PRP$	B-TREATMENT	I-TREATMENT
lumbar	NN	I-TREATMENT	I-TREATMENT
drain	NN	I-TREATMENT	I-TREATMENT
pulled	VBD	O	O
out	RP	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
to	TO	O	O
have	VB	O	O
it	PRP	O	O
replaced	VBN	O	O
,	,	O	O
however	RB	O	O
,	,	O	O
because	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
head	NN	I-PROBLEM	I-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
began	VBD	O	O
to	TO	O	O
leak	VB	O	O
again	RB	O	O
.	.	O	O

on	IN	O	O
06-03	NN	O	O
he	PRP	O	O
was	VBD	O	O
taken	VBN	O	O
back	RB	O	O
to	TO	O	O
the	DT	O	O
or	CC	O	O
for	IN	O	O
debridement	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
head	NN	I-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
removal	NN	B-TREATMENT	B-TREATMENT
of	IN	O	I-TREATMENT
the	DT	B-PROBLEM	I-TREATMENT
remaining	VBG	I-PROBLEM	I-TREATMENT
gliadel	NN	I-PROBLEM	I-TREATMENT
waffers	NNS	I-PROBLEM	I-TREATMENT
.	.	O	O

he	PRP	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
,	,	O	O
postop	VB	O	O
however	RB	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
grand	JJ	I-PROBLEM	I-PROBLEM
mal	JJ	I-PROBLEM	I-PROBLEM
seizure	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
intubated	VBN	O	B-TREATMENT
and	CC	O	O
sent	VBN	O	O
to	TO	O	O
the	DT	O	O
icu	NN	O	O
.	.	O	O

id	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
for	IN	O	O
both	DT	O	O
the	DT	B-PROBLEM	O
abd	NN	I-PROBLEM	O
abcess	NN	I-PROBLEM	O
and	CC	O	O
possible	JJ	O	O
meningitis	NN	B-PROBLEM	B-PROBLEM
given	VBN	O	O
the	DT	B-PROBLEM	O
large	JJ	I-PROBLEM	O
amount	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
wbc	NN	I-PROBLEM	B-TEST
in	IN	O	I-TEST
the	DT	B-TEST	I-TEST
csf	NN	I-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
.	.	O	O

patient	NN	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
1	CD	O	O
gm	NN	O	O
iv	NN	O	O
q12	NN	O	O
and	CC	O	O
zosyn	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
kept	VBN	O	O
on	IN	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
until	IN	O	O
06-17	NNP	O	O
.	.	O	O

neurologically	RB	O	O
he	PRP	O	O
slowly	RB	O	O
woke	VBD	O	O
up	RP	O	O
after	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
seizures	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
extubated	VBN	O	O
on	IN	O	O
06-03	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
transfered	VBN	O	O
to	TO	O	O
the	DT	O	O
step	NN	O	O
down	RB	O	O
unit	NN	O	O
and	CC	O	O
had	VBD	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
lumbar	NN	I-TREATMENT	I-TREATMENT
drain	NN	I-TREATMENT	I-TREATMENT
slowly	RB	O	O
weaned	VBD	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
lumbar	NN	I-TREATMENT	I-TREATMENT
drain	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
d/ced	VBN	O	O
on	IN	O	O
06-14	NN	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
which	WDT	O	O
remains	VBZ	O	O
stable	JJ	O	O
and	CC	O	O
head	NN	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
remain	VBP	O	O
dry	JJ	O	O
.	.	O	O

pt	NN	O	O
and	CC	O	O
ot	NN	O	O
are	VBP	O	O
recommending	VBG	O	O
rehab	NN	B-TREATMENT	O
.	.	O	O

he	PRP	O	O
will	MD	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
dr	NN	O	O
fisher	VBP	O	O
the	DT	O	O
general	JJ	O	O
surgeon	NN	O	O
in	IN	O	O
two	CD	O	O
weeks	NNS	O	O
and	CC	O	O
follow	VB	O	O
up	RP	O	O
in	IN	O	O
the	DT	O	O
brain	NN	O	O
tumor	NN	O	O
clinic	NN	O	O
in	IN	O	O
two	CD	O	O
weeks	NNS	O	O
for	IN	O	O
stitch	NN	B-TREATMENT	B-TREATMENT
removal	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

h	NN	O	O
ewas	NN	O	O
switched	VBN	O	O
to	TO	O	O
oral	JJ	B-TREATMENT	B-TREATMENT
cipro	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
pelvic	JJ	I-PROBLEM	I-PROBLEM
abcess	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
will	MD	O	O
continue	VB	O	O
it	PRP	O	O
until	IN	O	O
he	PRP	O	O
has	VBZ	O	O
his	PRP$	O	O
followup	NN	O	O
with	IN	O	O
infectious	JJ	O	O
disease	NN	O	O
in	IN	O	O
2	CD	O	O
weeks	NNS	O	O
.	.	O	O

neurontin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
keppra	NN	B-TREATMENT	O
,	,	O	O
lamictal	JJ	B-TREATMENT	O
,	,	O	O
decadron	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
multivitamin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
murray	NN	O	O
,	,	O	O
calcium	NN	B-TREATMENT	B-TEST

1.	CD	O	O
heparin	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
porcine	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
5,000	CD	O	O
unit	NN	O	O
/	NNP	O	O
ml	NN	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
injection	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

2.	CD	O	O
diphenhydramine	NN	B-TREATMENT	B-TREATMENT
hcl	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
q6h	NN	O	O
(	(	O	O
every	DT	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

3.	CD	O	O
albuterol	SYM	B-TREATMENT	B-TREATMENT
-	:	I-TREATMENT	I-TREATMENT
ipratropium	NN	I-TREATMENT	I-TREATMENT
103-18	JJ	O	O
mcg	NN	O	O
/	NNP	O	O
actuation	NN	O	O
aerosol	NN	O	O
sig	NN	O	O
:	:	O	O
03-04	JJ	O	O
puffs	NNS	O	O
inhalation	NN	O	O
q4h	NN	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

4.	CD	O	O
acetaminophen	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
tablets	NNS	O	O
po	JJ	O	O
q4-6h	JJ	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
to	TO	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

5.	CD	O	O
fluticasone	NN	B-TREATMENT	B-TREATMENT
-	:	I-TREATMENT	I-TREATMENT
salmeterol	NN	I-TREATMENT	I-TREATMENT
250-50	JJ	O	O
mcg	NN	O	O
/	NNP	O	O
dose	JJ	O	O
disk	NN	O	O
with	IN	O	O
device	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
disk	NN	O	O
with	IN	O	O
device	JJ	O	O
inhalation	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

6.	CD	O	O
lamotrigine	JJ	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1.5	CD	O	O
tablets	NNS	O	O
po	JJ	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

7.	CD	O	O
levetiracetam	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
three	CD	O	O
(	(	O	O
3	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

8.	CD	O	O
ibuprofen	JJ	B-TREATMENT	B-TREATMENT
400	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q8h	NN	O	O
(	(	O	O
every	DT	O	O
8	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

9.	CD	O	O
docusate	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

10.	CD	O	O
pantoprazole	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
40	CD	O	O
mg	NN	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
q24h	NN	O	O
(	(	O	O
every	DT	O	O
24	CD	O	O
hours	NNS	O	O
)	)	O	O
.	.	O	O

11.	CD	O	O
ciprofloxacin	NN	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q12h	NN	O	O
(	(	O	O
every	DT	O	O
12	CD	O	O
hours	NNS	O	O
)	)	O	O
for	IN	O	O
2	CD	O	O
weeks.	JJ	O	O
tablet	NN	O	O
(	(	O	O
s	NN	O	O
)	)	O	O

12.	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
tartrate	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
0.5	CD	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

13.	CD	O	O
lorazepam	JJ	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
hs	NN	O	O
(	(	O	O
at	IN	O	O
bedtime	NN	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

14.	CD	O	O
dexamethasone	NN	B-TREATMENT	B-TREATMENT
2	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q12h	NN	O	O
(	(	O	O
every	DT	O	O
12	CD	O	O
hours	NNS	O	O
)	)	O	O
.	.	O	O

15.	CD	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
regular	JJ	I-TREATMENT	O
human	JJ	I-TREATMENT	O
100	CD	O	O
unit	NN	O	O
/	NNP	O	O
ml	NN	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
injection	NN	O	O
asdir	NN	O	O
(	(	O	O
as	IN	O	O
directed	VBN	O	O
)	)	O	O
:	:	O	O
51-150	JJ	O	O
0	CD	O	O
units	NNS	O	O

16.	CD	O	O
hydralazine	NN	B-TREATMENT	B-TREATMENT
hcl	NN	I-TREATMENT	I-TREATMENT
20	CD	O	O
mg	NN	O	O
/	NNP	O	O
ml	NN	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
0.5	CD	O	B-TREATMENT
syringe	NN	O	I-TREATMENT
injection	NN	O	I-TREATMENT
q4hr	NN	O	I-TREATMENT
(	(	O	I-TREATMENT
)	)	O	I-TREATMENT
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
sbp	JJ	B-PROBLEM	O
>	JJ	O	O
150	CD	O	O
.	.	O	O

cerebrospinal	JJ	B-PROBLEM	B-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
leak	NN	I-PROBLEM	I-PROBLEM

chronic	JJ	O	B-PROBLEM
steroid	NN	O	I-PROBLEM
use	NN	O	I-PROBLEM
wound	NN	B-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM

perforated	VBN	B-PROBLEM	B-PROBLEM
sigmoid	JJ	I-PROBLEM	I-PROBLEM
diverticulum	NN	I-PROBLEM	I-PROBLEM
status	NN	O	O
post	NN	O	O
exploratory	NN	B-TEST	B-TEST
laparotomy	NN	I-TEST	I-TEST

status	NN	O	O
post	NN	O	O
sigmoid	NN	B-TREATMENT	B-TREATMENT
colectomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
hartmans	NNS	B-TREATMENT	B-TREATMENT
pouch	JJ	I-TREATMENT	I-TREATMENT
and	CC	O	O
washout	NN	B-TREATMENT	B-PROBLEM

post	NN	B-PROBLEM	O
operative	JJ	I-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
fever	NN	B-PROBLEM	I-PROBLEM
status	NN	O	O
post	NN	O	O
reveision	NN	B-TREATMENT	B-TREATMENT
right	RB	I-TREATMENT	I-TREATMENT
craniotomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
revsion	NN	B-TREATMENT	B-PROBLEM
of	IN	I-TREATMENT	I-PROBLEM
bone	NN	I-TREATMENT	I-PROBLEM
flap	NN	I-TREATMENT	I-PROBLEM
change	NN	B-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM

seizure	NN	B-PROBLEM	B-PROBLEM

conant	JJ	B-PROBLEM	B-PROBLEM
palsy	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
left	NN	B-PROBLEM	B-PROBLEM
sided	VBD	I-PROBLEM	I-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM

respiratory	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
requiring	VBG	O	O
intubation	NN	B-TREATMENT	B-TREATMENT

methicillin	NN	B-PROBLEM	B-PROBLEM
resistant	JJ	I-PROBLEM	I-PROBLEM
staph	NN	I-PROBLEM	I-PROBLEM
aureus	JJ	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
central	JJ	I-PROBLEM	I-PROBLEM
nervous	JJ	I-PROBLEM	I-PROBLEM
system	NN	I-PROBLEM	I-PROBLEM

pelvic	JJ	B-PROBLEM	B-PROBLEM
abscess	NN	I-PROBLEM	I-PROBLEM
oligodendroglioma	NN	B-PROBLEM	I-PROBLEM

asthma	NN	B-PROBLEM	B-PROBLEM

s/p	JJ	O	B-TREATMENT
craniotomy	NN	B-TREATMENT	I-TREATMENT
x	VBD	O	O
3	CD	O	O

hernia	NN	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
x	CD	O	O
3	CD	O	O

call	NN	O	O
with	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
spiking	VBG	I-PROBLEM	I-PROBLEM
fevers	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
leakage	NN	B-PROBLEM	B-PROBLEM
from	IN	O	O
your	PRP$	B-PROBLEM	B-PROBLEM
head	NN	I-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
increase	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
headaches	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
confusion	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
blurry	JJ	B-PROBLEM	B-PROBLEM
vision	NN	I-PROBLEM	I-PROBLEM
severe	JJ	B-PROBLEM	I-PROBLEM
neck	NN	I-PROBLEM	I-PROBLEM
stiffness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
redness	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
swelling	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
discharge	VB	B-PROBLEM	O
around	IN	O	O
your	PRP$	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
site	NN	I-PROBLEM	I-PROBLEM

call	VB	O	O
your	PRP$	O	O
general	JJ	O	O
surgeon	NN	O	O
if	IN	O	O
you	PRP	O	O
experience	VBP	O	O
increased	VBN	B-PROBLEM	B-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
decreased	VBD	B-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	O
increased	VBD	I-PROBLEM	B-TREATMENT
ostomy	JJ	I-PROBLEM	I-TREATMENT
output	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

ischemic	JJ	B-PROBLEM	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
orthotopic	JJ	B-TREATMENT	B-PROBLEM
heart	NN	I-TREATMENT	I-PROBLEM
transplantation	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
hyperlipidemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
graft	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
medical	JJ	B-PROBLEM	O
noncompliance	NN	I-PROBLEM	O
.	.	O	O

cardiac	JJ	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
.	.	O	O

mr.	NN	O	O
vessels	NNS	O	O
is	VBZ	O	O
a	DT	O	O
49-year-old	JJ	O	O
man	NN	O	O
status	NN	O	O
post	NN	O	O
orthotopic	IN	B-TREATMENT	B-TREATMENT
heart	NN	I-TREATMENT	I-TREATMENT
transplantation	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
1991	CD	O	O
at	IN	O	O
dautenorwe	JJ	O	O
stuart	NN	O	O
erec	VBZ	O	O
hillpa	NN	O	O
of	IN	O	O
hospital	NN	O	O
who	WP	O	O
is	VBZ	O	O
admitted	VBN	O	O
with	IN	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mr.	NN	O	O
vessels	NNS	O	O
&apos;s	VBP	O	O
postoperative	JJ	O	O
course	NN	O	O
has	VBZ	O	O
been	VBN	O	O
marked	VBN	O	O
by	IN	O	O
cmv	JJ	B-PROBLEM	B-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
poorly	RB	B-PROBLEM	B-PROBLEM
controlled	VBN	I-PROBLEM	I-PROBLEM
lipids	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
vascular	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
of	IN	O	O
1.8	CD	O	O
or	CC	O	O
so	RB	O	O
.	.	O	O

recently	RB	O	O
he	PRP	O	O
had	VBD	O	O
documented	VBN	O	O
coronary	JJ	B-TEST	B-TEST
angiography	NN	I-TEST	I-TEST
based	VBN	O	O
on	IN	O	O
a	DT	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
performed	VBN	O	O
in	IN	O	O
january	JJ	O	O
1996	CD	O	O
with	IN	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
diffuse	VB	I-PROBLEM	I-PROBLEM
atherosclerosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
angiogram	NN	I-TEST	I-TEST
performed	VBD	O	O
a	DT	O	O
year	NN	O	O
later	RB	O	O
showed	VBD	O	O
marked	JJ	O	B-PROBLEM
progression	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
coronary	JJ	B-PROBLEM	I-PROBLEM
allograft	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
biopsy	NN	I-TEST	I-TEST
at	IN	O	O
that	DT	O	O
time	NN	O	O
revealed	VBD	O	O
grade	JJ	B-PROBLEM	B-PROBLEM
1b	CD	I-PROBLEM	I-PROBLEM
rejection	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
endothelialitis	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
eosinophils	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
pulsed	JJ	B-TREATMENT	B-TREATMENT
iv	NN	I-TREATMENT	I-TREATMENT
steroids	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
imuran	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
was	VBD	O	O
augmented	VBN	O	O
with	IN	O	O
mycophenolate	NN	B-TREATMENT	B-TREATMENT
mofetil	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
showed	VBD	O	O
cariogenic	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
faring	VBG	O	O
poorly	RB	O	O
.	.	O	O

prior	RB	O	O
to	TO	O	O
admission	NN	O	O
he	PRP	O	O
was	VBD	O	O
seen	VBN	O	O
approximately	RB	O	O
1	CD	O	O
week	NN	O	O
in	IN	O	O
the	DT	O	O
office	NN	O	O
with	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
congestive	JJ	I-PROBLEM	I-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
then	RB	O	O
revealed	VBD	O	O
an	DT	B-TEST	B-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
40%	CD	O	O
and	CC	O	O
an	DT	B-TEST	B-TEST
endomyocardial	JJ	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
revealed	VBD	O	O
no	DT	O	O
ejection	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

notable	JJ	O	O
for	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
allograft	NN	I-PROBLEM	I-PROBLEM
vasculopathy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hyperlipidemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
vascular	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
cmv	JJ	B-PROBLEM	B-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
depression	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
tricuspid	JJ	B-PROBLEM	B-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

examination	NN	B-TEST	B-TEST
revealed	VBD	O	O
a	DT	O	O
tired	JJ	O	O
,	,	O	O
fatigued	VBN	O	O
man	NN	O	O
with	IN	O	O
cool	JJ	B-PROBLEM	O
extremities	NNS	I-PROBLEM	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
is	VBZ	O	O
130/80	CD	O	O
and	CC	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
was	VBD	O	O
100.	CD	O	O
jugular	JJ	B-TEST	B-TEST
venous	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
increasing	VBG	O	O
.	.	O	O

carotids	NNS	B-TEST	B-TEST
were	VBD	O	O
2+	CD	O	O
.	.	O	O

crackles	NNS	B-PROBLEM	B-PROBLEM
were	VBD	O	O
increased	VBN	O	O
1/4	CD	O	O
of	IN	O	O
the	DT	O	O
way	NN	O	O
up	RP	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
ventricular	NN	I-PROBLEM	I-PROBLEM
heave	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
an	DT	B-PROBLEM	B-TEST
s3	NN	I-PROBLEM	I-TEST
galop	NN	I-PROBLEM	I-TEST
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
and	CC	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
a	DT	O	B-PROBLEM
palpable	JJ	O	I-PROBLEM
liver	NN	O	I-PROBLEM
edge	NN	O	I-PROBLEM
and	CC	O	O
the	DT	B-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
were	VBD	O	O
diminished	VBN	O	O
.	.	O	O

revealed	VBD	O	O
a	DT	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
136	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.5	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
47	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
2.4	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
136.	CD	O	O
hematocrit	NN	B-TEST	B-TEST
40%	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
revealed	VBD	O	O
poor	JJ	B-PROBLEM	B-PROBLEM
r	NN	I-PROBLEM	I-PROBLEM
wave	NN	I-PROBLEM	I-PROBLEM
progression	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
marked	VBD	B-PROBLEM	B-PROBLEM
decrease	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
all	DT	I-PROBLEM	I-PROBLEM
volts	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
revealed	VBD	O	O
prominent	JJ	B-PROBLEM	O
pulmonary	JJ	I-PROBLEM	O
vessels	NNS	I-PROBLEM	O
and	CC	O	O
enlarged	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
hospital	NN	O	O
via	IN	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
where	WRB	O	O
a	DT	B-TEST	B-TEST
bedside	NN	I-TEST	I-TEST
echocardiogram	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
revealed	VBD	O	O
no	DT	O	O
pericardial	JJ	B-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
an	DT	B-TEST	B-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
30%	CD	O	O
and	CC	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
dysfunction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

hydrocortisone	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
given	VBN	O	O
1	CD	O	O
g	NN	O	O
in	IN	O	O
an	DT	O	O
attempt	NN	O	O
to	TO	O	O
reverse	VB	O	O
what	WP	O	O
was	VBD	O	O
thought	VBN	O	O
to	TO	O	O
be	VB	O	O
aggressive	JJ	B-PROBLEM	B-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
allograft	NN	I-PROBLEM	I-PROBLEM
vasculopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
diuresed	VBD	O	O
and	CC	O	O
responded	VBD	O	O
to	TO	O	O
lasix	VB	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
administered	VBN	O	O
in	IN	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
and	CC	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
a	DT	O	O
monitored	VBN	O	O
bed	NN	O	O
.	.	O	O

at	IN	O	O
4:30	CD	O	O
am	VBP	O	O
the	DT	O	O
following	JJ	O	O
morning	NN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
found	VBN	O	O
in	IN	O	O
cardiac	JJ	B-PROBLEM	O
arrest	NN	I-PROBLEM	O
.	.	O	O

despite	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
epinephrine	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
multiple	JJ	O	O
attempts	NNS	O	O
at	IN	O	O
defibrillation	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
unable	JJ	O	O
to	TO	O	O
be	VB	O	O
resuscitated	VBN	O	O
.	.	O	O

upon	IN	O	O
arrival	NN	O	O
of	IN	O	O
the	DT	O	O
covering	VBG	O	O
access	NN	O	O
physician	IN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
being	VBG	O	O
ventilated	VBN	O	O
mechanically	RB	O	O
and	CC	O	O
cpr	NN	B-TREATMENT	O
was	VBD	O	O
being	VBG	O	O
performed	VBN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
rhythm	NN	I-TEST	I-TEST
revealed	VBD	O	O
sinus	JJ	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
no	DT	O	O
palpable	JJ	O	B-PROBLEM
or	CC	O	O
measurable	JJ	B-TEST	B-PROBLEM
blood	NN	I-TEST	I-PROBLEM
pressure	NN	I-TEST	I-PROBLEM
.	.	O	O

there	EX	O	O
were	VBD	O	O
also	RB	O	O
runs	NNS	O	O
of	IN	O	O
ventricular	JJ	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
generated	VBD	O	O
into	IN	O	O
ventricular	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
was	VBD	O	O
refractory	NN	O	O
to	TO	O	O
multiple	VB	B-TREATMENT	O
cardioversions	NNS	I-TREATMENT	O
.	.	O	O

a	DT	B-TEST	B-TEST
pericardiocentesis	NN	I-TEST	I-TEST
was	VBD	O	O
attempted	VBN	O	O
with	IN	O	O
no	DT	O	O
yield	NN	O	O
of	IN	O	O
pericardial	JJ	O	B-PROBLEM
fluid	NN	O	I-PROBLEM
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
transvenous	JJ	I-TREATMENT	I-TREATMENT
pacing	NN	I-TREATMENT	I-TREATMENT
wire	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
attempted	VBN	O	O
and	CC	O	O
a	DT	O	B-TEST
pacing	NN	O	I-TEST
rhythm	NN	O	I-TEST
was	VBD	O	O
obtained	VBN	O	O
but	CC	O	O
with	IN	O	O
no	DT	O	O
palpable	JJ	B-TEST	B-PROBLEM
blood	NN	I-TEST	I-PROBLEM
pressure	NN	I-TEST	I-PROBLEM
.	.	O	O

in	IN	O	O
total	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
defibrillated	VBN	O	O
10	CD	O	O
times	NNS	O	O
,	,	O	O
given	VBN	O	O
5	CD	O	O
courses	NNS	O	O
of	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
epinephrine	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
one	CD	O	O
course	NN	O	O
of	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
atropine	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
calcium	NN	I-TREATMENT	I-TREATMENT
x	VBZ	O	O
1	CD	O	O
in	IN	O	O
addition	NN	O	O
to	TO	O	O
an	DT	B-TREATMENT	B-TREATMENT
amp	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
bicarbonate	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
resuscitation	NN	I-TREATMENT	I-TREATMENT
efforts	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
discontinued	VBN	O	O
at	IN	O	O
4:15	CD	O	O
am	VBP	O	O
and	CC	O	O
were	VBD	O	O
begun	VBN	O	O
at	IN	O	O
3:38	CD	O	O
am	VBP	O	O
.	.	O	O

an	DT	B-TEST	B-TEST
autopsy	JJ	I-TEST	I-TEST
permission	NN	O	I-TEST
was	VBD	O	O
granted	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
inr	NN	B-TEST	O
of	IN	O	O
3.2	CD	O	O
that	WDT	O	O
came	VBD	O	O
back	RB	O	O
on	IN	O	O
date	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

please	NN	O	O
hold	VB	O	O
dose	NN	O	O
of	IN	O	O
warfarin	NN	B-TREATMENT	B-TREATMENT
on	IN	O	O
the	DT	O	O
night	NN	O	O
of	IN	O	O
the	DT	O	O
16	CD	O	O
,	,	O	O
and	CC	O	O
please	VB	O	O
recheck	VB	O	O
inr	NN	B-TEST	O
on	IN	O	O
2016-11-16	JJ	O	O
and	CC	O	O
dose	JJ	O	B-TREATMENT
warfarin	NNS	B-TREATMENT	I-TREATMENT
appropriately	RB	O	O
for	IN	O	O
inr	NN	B-TEST	O
of	IN	O	O
2	CD	O	O
to	TO	O	O
2.5.	CD	O	O

wound	NN	B-PROBLEM	B-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

incision	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
drainage	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
wound	JJ	B-PROBLEM	B-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
3/7/02	CD	O	O
.	.	O	O

abdominal	JJ	B-TEST	B-TEST
pelvic	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
on	IN	O	O
3/10/02	CD	O	O
.	.	O	O

fistulogram	NN	B-TEST	B-TEST
on	IN	O	O
3/11/02	CD	O	O
.	.	O	O

intravenous	JJ	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
79-year-old	JJ	O	O
man	NN	O	O
status	NN	O	O
postradical	JJ	B-TREATMENT	B-TREATMENT
cystoprostatectomy	NN	I-TREATMENT	I-TREATMENT
with	IN	I-TREATMENT	O
ileal	JJ	I-TREATMENT	B-TREATMENT
loop	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
locally	RB	B-PROBLEM	B-PROBLEM
invasive	JJ	I-PROBLEM	I-PROBLEM
prostate	NN	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	B-TREATMENT	B-TREATMENT
operation	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
performed	VBN	O	O
2/11/02	CD	O	O
by	IN	O	O
dr.	NN	O	O
doje	NN	O	O
para	NN	O	O
.	.	O	O

the	DT	O	O
postoperative	JJ	O	O
course	NN	O	O
was	VBD	O	O
complicated	VBN	O	O
by	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
transfer	NN	O	O
to	TO	O	O
the	DT	O	O
cardiac	JJ	O	O
step-down	JJ	O	O
unit	NN	O	O
.	.	O	O

this	DT	O	O
transfer	NN	O	O
occurred	VBD	O	O
around	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
8	CD	O	O
for	IN	O	O
anticoagulation	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
load	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
anticoagulation	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
stopped	VBN	O	O
due	RB	O	O
to	TO	O	O
concern	NN	O	O
for	IN	O	O
postoperative	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
complained	VBD	O	O
of	IN	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
presented	VBD	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
on	IN	O	O
3/7/02	CD	O	O
,	,	O	O
complaining	VBG	O	O
of	IN	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
since	IN	O	O
monday	NN	O	O
3/2/02	CD	O	O
.	.	O	O

he	PRP	O	O
developed	VBD	O	O
erythema	VB	B-PROBLEM	B-PROBLEM
around	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
wednesday	NN	O	O
and	CC	O	O
was	VBD	O	O
seen	VBN	O	O
by	IN	O	O
dr.	NN	O	O
para	NN	O	O
,	,	O	O
who	WP	O	O
started	VBD	O	O
keflex	NNP	B-TREATMENT	B-TREATMENT
and	CC	O	O
obtained	VBD	O	O
a	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
which	WDT	O	O
demonstrated	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
collection	NN	I-PROBLEM	I-PROBLEM
at	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
site	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
erythema	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
fevers	NNS	I-PROBLEM	I-PROBLEM
continued	VBD	O	O
as	RB	O	O
high	JJ	O	O
as	IN	O	O
102.5	CD	O	O
degrees	NNS	O	O
f	VBP	O	O
with	IN	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
on	IN	O	O
the	DT	O	O
morning	NN	O	O
of	IN	O	O
admission	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
draining	VBG	O	B-PROBLEM
pus	NN	B-PROBLEM	I-PROBLEM
from	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
site	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
subsequent	JJ	O	O
relief	NN	O	O
of	IN	O	O
discomfort	NN	B-PROBLEM	B-PROBLEM
at	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
site	NN	O	I-PROBLEM
.	.	O	O

hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
gout	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

cystoprostatectomy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
inguinal	JJ	I-TREATMENT	I-TREATMENT
hernia	NN	I-TREATMENT	I-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

keflex	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
qid	NN	O	O
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
presentation	NN	O	O
,	,	O	O
temperature	NN	B-TEST	B-TEST
99.3	CD	O	O
degrees	NNS	O	O
f	RB	O	O
,	,	O	O
other	JJ	B-TEST	B-TEST
vital	JJ	I-TEST	I-TEST
signs	NNS	I-TEST	I-TEST
were	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
in	IN	O	O
no	DT	O	O
acute	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
non-toxic	JJ	B-PROBLEM	O
.	.	O	O

clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	O	O
.	.	O	O

abdomen	NNS	O	O
soft	JJ	O	O
and	CC	O	O
there	EX	O	O
was	VBD	O	O
wound	NN	B-PROBLEM	B-PROBLEM
erythema	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
three	CD	B-PROBLEM	O
areas	NNS	I-PROBLEM	O
of	IN	I-PROBLEM	O
dehiscence	NN	I-PROBLEM	B-PROBLEM
draining	VBG	O	O
foul-smelling	JJ	B-PROBLEM	O
,	,	I-PROBLEM	O
purulent	JJ	I-PROBLEM	B-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	B-TEST
fascia	NN	O	I-TEST
appeared	VBD	O	O
intact	JJ	O	O
by	IN	O	O
probing	VBG	B-TEST	O
.	.	O	O

the	DT	B-TREATMENT	B-PROBLEM
stoma	NN	I-TREATMENT	I-PROBLEM
was	VBD	O	O
pink	JJ	O	O
and	CC	O	O
functional	JJ	O	O
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
midline	JJ	I-PROBLEM	I-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
for	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
radical	JJ	I-TREATMENT	I-TREATMENT
cystoprostatectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
16.9	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
32.2	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
418	CD	O	O
,	,	O	O
sodium	NN	B-TEST	B-TEST
131	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
3.4	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
102	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
21.4	CD	O	O
,	,	O	O
bun27	NN	B-TEST	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
1.4	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
150	CD	O	O
.	.	O	O

ct	NNS	B-TEST	B-TEST
scan	JJ	I-TEST	I-TEST
3/5/02	CD	O	O
:	:	O	O

a	DT	B-PROBLEM	B-TEST
fluid	JJ	I-PROBLEM	I-TEST
collection	NN	I-PROBLEM	I-TEST
external	NN	I-PROBLEM	I-TEST
to	TO	I-PROBLEM	I-TEST
the	DT	I-PROBLEM	I-TEST
fascia	JJ	I-PROBLEM	I-TEST
consistent	NN	O	O
with	IN	O	O
site	NN	O	O
of	IN	O	O
erythema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

after	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
further	RBR	O	O
opened	VBN	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
ampicillin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
flagyl	JJ	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
bid	NN	I-TREATMENT	I-TREATMENT
dressing	VBG	I-TREATMENT	I-TREATMENT
change	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
packing	NN	B-TREATMENT	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
stable	JJ	O	O
vital	JJ	O	O
signs	NNS	O	O
and	CC	O	O
good	JJ	O	O
urine	NN	O	B-TEST
output	NN	O	I-TEST
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
erythema	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
improving	VBG	O	O
and	CC	O	O
the	DT	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
packed	VBN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

wound	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
remained	VBD	O	O
negative	JJ	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
.	.	O	O

we	PRP	O	O
continued	VBD	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
ampicillin	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

by	IN	O	O
hospital	JJ	O	O
day	NN	O	O
4	CD	O	O
,	,	O	O
he	PRP	O	O
remained	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
throughout	IN	O	O
his	PRP$	O	O
hospital	NN	O	O
course	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
wound	NN	I-TEST	I-TEST
cultures	VBZ	I-TEST	I-TEST
demonstrated	VBN	O	O
gram-positive	JJ	B-PROBLEM	B-PROBLEM
cocci	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
clusters	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
gram-negative	JJ	B-PROBLEM	B-TREATMENT
rods	NNS	I-PROBLEM	I-TREATMENT
.	.	O	O

blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
remained	VBD	O	O
negative	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
we	PRP	O	O
obtained	VBD	O	O
a	DT	B-TEST	B-TEST
ct	JJ	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
to	TO	O	O
check	VB	O	O
for	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
enterocutaneous	JJ	I-PROBLEM	I-PROBLEM
fistula	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

we	PRP	O	O
discontinued	VBD	O	O
his	PRP$	B-TREATMENT	O
flagyl	NN	I-TREATMENT	B-TREATMENT
on	IN	O	O
that	DT	O	O
day	NN	O	O
.	.	O	O

we	PRP	O	O
contacted	VBD	O	O
the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
primary	JJ	O	O
care	NN	O	O
physician	NN	O	O
,	,	O	O
dr.	NN	O	O
aslinke	NN	O	O
______	NNP	O	O
,	,	O	O
regarding	VBG	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
cardiac	JJ	I-TREATMENT	I-TREATMENT
medication	NN	I-TREATMENT	I-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

we	PRP	O	O
agreed	VBD	O	O
that	IN	O	O
he	PRP	O	O
should	MD	O	O
resume	VB	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
atenolol	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
dressing	NN	I-TREATMENT	I-TREATMENT
changes	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

we	PRP	O	O
changed	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
dressings	NNS	I-TREATMENT	I-TREATMENT
tid	VBP	O	O
instead	RB	O	O
of	IN	O	O
bid	NN	O	O
for	IN	O	O
continued	JJ	B-PROBLEM	B-TREATMENT
drainage	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

the	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
scan	VBD	I-TEST	I-TEST
that	DT	O	O
was	VBD	O	O
obtained	VBN	O	O
on	IN	O	O
3/10/02	CD	O	O
demonstrated	JJ	O	O
no	DT	O	O
connection	NN	O	O
between	IN	O	O
bowel	NN	O	O
and	CC	O	O
the	DT	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	O
drainage	NN	I-PROBLEM	O
had	VBD	O	O
been	VBN	O	O
decreasing	VBG	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
be	VB	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
the	DT	O	O
following	JJ	O	O
day	NN	O	O
,	,	O	O
3/11/02	CD	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
fistulogram	NN	I-TEST	I-TEST
was	VBD	O	O
obtained	VBN	O	O
which	WDT	O	O
was	VBD	O	O
negative	JJ	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
fistula	NN	I-PROBLEM	I-PROBLEM
from	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
bowel	NN	I-PROBLEM	O
to	TO	O	O
the	DT	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
ampicillin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

her	PRP$	O	O
remained	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
stable	JJ	O	O
vital	JJ	O	O
signs	NNS	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
comfortable	JJ	O	O
and	CC	O	O
erythema	JJ	B-PROBLEM	B-PROBLEM
continued	VBN	O	O
to	TO	O	O
decrease	VB	O	O
with	IN	O	O
improvemeent	NN	O	O
in	IN	O	O
the	DT	O	O
appearance	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

in	IN	O	O
consultation	NN	O	O
with	IN	O	O
infectious	JJ	O	B-PROBLEM
disease	NN	O	I-PROBLEM
,	,	O	O
it	PRP	O	O
was	VBD	O	O
agreed	VBN	O	O
to	TO	O	O
discharge	VB	O	O
the	DT	O	O
patient	NN	O	O
on	IN	O	O
augmentin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	I-TREATMENT
coverage	NN	O	I-TREATMENT
.	.	O	O

we	PRP	O	O
obtained	VBD	O	O
sensitivities	NNS	B-TEST	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
bacteria	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
intravenous	JJ	I-TREATMENT	I-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
discontinued	VBN	O	O
.	.	O	O

he	PRP	O	O
remaineda	VBZ	O	O
febrile	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
daily	JJ	O	O
improvement	NN	O	O
in	IN	O	O
the	DT	O	O
appearance	NN	O	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
7	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
stable	JJ	O	O
vital	JJ	O	O
signs	NNS	O	O
.	.	O	O

his	PRP$	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
demonstrated	VBD	O	O
no	DT	O	O
erythema	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
dark	JJ	I-PROBLEM	I-PROBLEM
drainage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
be	VB	O	O
discharged	VBN	O	O
with	IN	O	O
wh	NN	O	O
and	CC	O	O
continued	VBD	B-TREATMENT	B-TREATMENT
dressing	VBG	I-TREATMENT	I-TREATMENT
changes	NNS	I-TREATMENT	I-TREATMENT
bid	NN	O	O
.	.	O	O

1.	CD	O	O
the	DT	O	O
patient	NN	O	O
will	MD	O	O
be	VB	O	O
sent	VBN	O	O
home	NN	O	O
on	IN	O	O
7	CD	O	O
days	NNS	O	O
of	IN	O	O
augmentin	JJ	B-TREATMENT	B-TREATMENT
po	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

percocet	NN	B-TREATMENT	B-TREATMENT
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

norvasc	RB	B-TREATMENT	B-TEST
2.5	CD	O	O
mg	NNS	O	O
po	JJ	O	O
qd	NN	O	O
.	.	O	O

augmentin	RB	B-TREATMENT	B-TREATMENT
500/125	CD	O	O
1	CD	O	O
tab	NN	O	O
po	NN	O	O
tid	NN	O	O
x	$	O	O
7	CD	O	O
days	NNS	O	O
.	.	O	O

morphine	NN	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
/	NNP	O	O
codeine	NN	B-TREATMENT	B-TREATMENT
/	NNP	O	O
keflex	NNP	B-TREATMENT	B-TREATMENT
/	NNP	O	O
sudafed	VBD	B-TREATMENT	O

fever	RB	B-PROBLEM	B-PROBLEM
/	NNP	O	O
+	NNP	O	O
bc	NN	B-PROBLEM	O
w/	NN	O	O
h/o	NN	O	O
mv	NN	B-PROBLEM	B-PROBLEM
endocarditis	NN	I-PROBLEM	I-PROBLEM

mitral	JJ	B-TREATMENT	B-TREATMENT
valve	NNS	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
31	CD	B-TREATMENT	O
mm	NNS	I-TREATMENT	O
sjm	JJ	I-TREATMENT	O
biocor	JJ	I-TREATMENT	B-TREATMENT
tissue	NN	I-TREATMENT	I-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
/	NNP	I-TREATMENT	O
della	NN	I-TREATMENT	O

copeland	NN	B-TREATMENT	O
resection	NN	I-TREATMENT	B-TREATMENT
on	IN	O	O
2019-03-19	JJ	O	O

mr.	NN	O	O
pizano	NN	O	O
is	VBZ	O	O
a	DT	O	O
75	CD	O	O
y/o	NN	O	O
man	NN	O	O
who	WP	O	O
has	VBZ	O	O
a	DT	O	O
pmhx	NN	O	O
significant	JJ	O	O
for	IN	O	O
enterococcus	JJ	B-PROBLEM	B-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
valve	NN	I-PROBLEM	I-PROBLEM
endocarditis	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
has	VBZ	O	O
been	VBN	O	O
treated	VBN	O	O
since	IN	O	O
09-19	NN	O	O
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
had	VBD	O	O
2	CD	O	O
6	CD	O	O
week	NN	O	O
courses	NNS	O	O
of	IN	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
with	IN	O	O
recurrent	JJ	B-PROBLEM	B-PROBLEM
bacteremia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-PROBLEM
tee	NN	I-TEST	I-PROBLEM
on	IN	O	O
2019-01-22	JJ	O	O
which	WDT	O	O
revealed	VBD	O	O
thickened	VBD	B-PROBLEM	B-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
leaflets	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
small	JJ	B-PROBLEM	B-PROBLEM
vegetations	NNS	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	O
both	DT	I-PROBLEM	O
anterior	JJ	I-PROBLEM	O
and	CC	I-PROBLEM	O
posterior	JJ	I-PROBLEM	O
leaflets	NNS	I-PROBLEM	O
with	IN	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
severe	VB	I-PROBLEM	I-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
preserved	VBN	O	O
lv	JJ	O	O
systolic	JJ	O	O
function	NN	O	O
with	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
tr	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
ar	NN	B-PROBLEM	O
and	CC	O	O
lae	NN	B-PROBLEM	O
without	IN	O	O
abscess	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
tee	NN	I-TEST	I-TEST
on	IN	O	O
02-19	NN	O	O
which	WDT	O	O
revealed	VBD	O	O
4	CD	B-PROBLEM	O
+	JJ	I-PROBLEM	O
mr	NN	I-PROBLEM	O
.	.	O	O

thomasine	NN	O	O
was	VBD	O	O
tranferred	VBN	O	O
from	IN	O	O
mwmc	NN	O	O
(	(	O	O
where	WRB	O	O
he	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
on	IN	O	O
02-15	NN	O	O
with	IN	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
positive	JJ	B-PROBLEM	O
blood	NN	I-PROBLEM	B-TEST
cultures	NNS	I-PROBLEM	I-TEST
)	)	O	O
to	TO	O	O
idmc	VB	O	O
for	IN	O	O
further	JJ	B-TREATMENT	B-TREATMENT
treatment	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
possibly	RB	O	O
mvr	NNS	B-TREATMENT	B-PROBLEM
.	.	O	O

past	JJ	O	O
medical	JJ	O	O
history	NN	O	O
:	:	O	O
h/o	JJ	O	O
mitral	JJ	B-PROBLEM	B-PROBLEM
valve	NN	I-PROBLEM	I-PROBLEM
endocarditis	NN	I-PROBLEM	I-PROBLEM

hypertension	NN	B-PROBLEM	B-PROBLEM

h/o	NN	O	O
cva	NN	B-PROBLEM	B-PROBLEM

spinal	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
s/p	NN	O	O
lumbar	NN	B-TREATMENT	B-TREATMENT
laminectomy	NN	I-TREATMENT	I-TREATMENT
x	VBD	O	O
3	CD	O	O

parkinson	NN	B-PROBLEM	B-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM

h/o	NN	O	O
paranoid	NN	B-PROBLEM	B-PROBLEM
delusions	NNS	I-PROBLEM	I-PROBLEM

mgus	NN	B-PROBLEM	O
vs	NN	O	O
mm	NN	B-PROBLEM	O

elderly	JJ	O	O
man	NN	O	O
in	IN	O	O
nad	JJ	B-PROBLEM	O
,	,	O	O
vss	NN	O	B-PROBLEM

nc/at	RB	B-PROBLEM	O
,	,	O	O
perrla	NN	O	B-PROBLEM
,	,	O	O
eomi	NN	O	O
,	,	O	O
poor	JJ	B-PROBLEM	B-PROBLEM
dentition	NN	I-PROBLEM	I-PROBLEM

supple	NN	O	O
,	,	O	O
from	IN	O	O
,	,	O	O
-	:	O	O
thyromegaly	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
-	:	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
carotids	NNS	B-TEST	B-TEST
2	CD	O	O
+	NNS	O	O

bilat	NN	O	B-PROBLEM
w/out	NN	O	I-PROBLEM
bruits	NNS	B-PROBLEM	I-PROBLEM

ctab	SYM	O	B-TEST
-	:	O	O
w/r/r	NN	B-PROBLEM	O

rrr	NN	O	O
,	,	O	O
+	NNP	O	O
s1s2	NN	O	O
,	,	O	O
02-18	CD	O	O
mumrmur	NN	B-PROBLEM	O

soft	JJ	O	O
nt/nd	NNS	B-PROBLEM	O
,	,	O	O
+	NNP	O	O
bs	NN	O	O
without	IN	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
hepatomegaly	JJ	B-PROBLEM	B-PROBLEM
/	CD	O	O
splenomegaly	NN	B-PROBLEM	B-PROBLEM

warm	NN	O	O
,	,	O	O
dry	JJ	O	O
-	:	O	O
c/c/e	NN	B-PROBLEM	O
,	,	O	O
pulses	VBZ	B-TEST	B-TEST
2+	CD	O	O
throughout	IN	O	O

skin	NN	O	O
:	:	O	O
well-healed	JJ	B-PROBLEM	B-PROBLEM
surgical	JJ	I-PROBLEM	I-PROBLEM
scars	NNS	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
back	NN	I-PROBLEM	I-PROBLEM

nad	JJ	B-PROBLEM	O
/	NNP	O	O
vss	NN	O	B-PROBLEM

rrr	NN	O	O
,	,	O	O
sternum	NN	O	B-TEST
stable	JJ	O	O
,	,	O	O
incision	JJ	B-PROBLEM	B-TREATMENT
clean	NN	O	I-TREATMENT
and	CC	O	O
dry	JJ	O	O
,	,	O	O
no	DT	O	O
erythema	NN	B-PROBLEM	B-PROBLEM
/	VBZ	O	O
drainage	NN	B-PROBLEM	B-TREATMENT

abdm	NN	O	O
:	:	O	O
soft	JJ	O	O
,	,	O	O
nt	JJ	B-PROBLEM	O
/	NNP	O	O
nd	NN	B-PROBLEM	B-PROBLEM
/	NNP	O	O
nabs	NN	B-PROBLEM	O

ext	NN	O	O
:	:	O	O
warm	NN	O	O
well	NN	O	O
perfused	VBN	O	O
,	,	O	O
no	DT	O	O
c/c/e	NN	B-PROBLEM	B-PROBLEM

glucose	JJ	B-TEST	B-TEST
-	:	O	O
94	CD	O	O
urea	JJ	B-TEST	B-TEST
n	SYM	I-TEST	I-TEST
-	:	O	O
21	CD	O	O
*	NN	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.3	CD	O	O
*	JJ	O	O
sodium	NN	B-TEST	B-TEST
-	:	O	O
138	CD	O	O
potassium	NN	B-TEST	B-TEST
-	:	O	O
5.0	CD	O	O
chloride	NN	B-TEST	B-TEST
-	:	O	O
105	CD	O	O
total	JJ	B-TEST	B-TEST
co2	NN	I-TEST	I-TEST
-	:	O	O
25	CD	O	O
anion	NN	B-TEST	B-TEST
gap	NN	I-TEST	I-TEST
-	:	O	O
13	CD	O	O

alt	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
sgpt	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
6	CD	O	O
ast	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
sgot	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
20	CD	O	O
ld	NN	B-TEST	O
(	(	I-TEST	B-TEST
ldh	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
255	CD	O	O
*	JJ	O	O
alk	NN	B-TEST	B-TEST
phos	SYM	I-TEST	B-TEST
-	:	O	O
134	CD	O	O
*	JJ	O	O
tot	NN	B-TEST	O
bili	SYM	I-TEST	B-TEST
-	:	O	O
0.4	CD	O	O

calcium	NN	B-TEST	B-TEST
-	:	O	O
9.3	CD	O	O
phosphate	NN	B-TEST	B-TEST
-	:	O	O
3.7	CD	O	O
magnesium	NN	B-TEST	B-TEST
-	:	O	O
2.3	CD	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
4.9	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
4.27	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
11.3	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
35.1	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
82	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
26.4	CD	O	O
*	NN	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
32.2	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
17.4	CD	O	O
*	NN	O	O

neuts	NNS	B-TEST	B-TEST
-	:	O	O
66.3	CD	O	O
lymphs	SYM	B-TEST	B-TEST
-	:	O	O
25.0	CD	O	O
monos	NNS	B-TEST	B-TEST
-	:	O	O
5.7	CD	O	O
eos	SYM	B-TEST	B-TEST
-	:	O	O
0.1	CD	O	O
basos	SYM	B-TEST	B-TEST
-	:	O	O
2.9	CD	O	O
*	NN	O	O

plt	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
-	:	O	O
187	CD	O	O

pt	SYM	B-TEST	B-TEST
-	:	O	O
13.1	CD	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
30.1	CD	O	O
inr	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
pt	JJ	I-TEST	I-TEST
)-	CD	I-TEST	I-TEST
1.1	CD	O	O

2019-02-28	JJ	O	O
06:27	CD	O	O
pm	NN	O	O
urine	NN	B-TEST	O

color	NN	B-TEST	B-TEST
-	:	O	O
amber	NN	O	O
appear	JJ	B-TEST	O
-	:	O	O
clear	JJ	O	O
sp	NN	B-TEST	O
stickney	NN	I-TEST	O
-	:	O	O
1.015	CD	O	O

2019-03-23	JJ	O	O
05:31	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
8.6	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.43	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
9.9	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
28.7	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
84	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
28.9	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.5	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
17.8	CD	O	O
*	JJ	O	O
plt	NN	B-TEST	B-TEST
ct	SYM	I-TEST	I-TEST
-	:	O	O
120	CD	O	O
*	NN	O	O

2019-03-25	JJ	O	O
01:53	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O

glucose	JJ	B-TEST	B-TEST
-	:	O	O
95	CD	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
35	CD	O	O
*	NN	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.4	CD	O	O
*	NN	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
136	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
4.9	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
105	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
21	CD	O	O
*	NN	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
15	CD	O	O

2019-03-25	JJ	O	O
04:47	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
pt	NN	B-TEST	I-TEST
-	:	O	O
14.1	CD	O	O
*	NN	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
29.4	CD	O	O
inr	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
pt	JJ	I-TEST	I-TEST
)-	JJ	O	I-TEST
1.3	CD	O	O
*	NN	O	O

as	IN	O	O
mentioned	VBN	O	O
in	IN	O	O
the	DT	O	O
hpi	NN	O	O
,	,	O	O
mr.	FW	O	O
mcculley	NNP	O	O
was	VBD	O	O
transferred	VBN	O	O
from	IN	O	O
mwmc	NN	O	O
to	TO	O	O
nantucket	VB	O	O
cottage	NN	O	O
hospital	NN	O	O
for	IN	O	O
ongoing	VBG	O	O
care	NN	O	O
(	(	O	O
?	.	O	O
mvr	NN	B-TREATMENT	O
).	NN	O	O

iv	NN	B-TREATMENT	O
daptomycin	NN	I-TREATMENT	B-TREATMENT
was	VBD	O	O
continued	VBN	O	O
via	IN	O	O
picc	NN	B-TREATMENT	B-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
which	WDT	O	O
was	VBD	O	O
inserted	VBN	O	O
on	IN	O	O
02-20	NN	O	O
at	IN	O	O
mwmc	NN	O	O
.	.	O	O

mr	NN	O	O
stutts	NN	O	O
had	VBD	O	O
an	DT	B-TEST	B-TEST
extensive	JJ	I-TEST	I-TEST
preop	NN	I-TEST	I-TEST
evaluation	NN	I-TEST	I-TEST
including	VBG	O	O
cardiology	NN	O	O
,	,	O	O
infectious	JJ	O	B-PROBLEM
diseases	NNS	O	I-PROBLEM
,	,	O	O
orthopedics	NNS	O	O
,	,	O	O
psychiatry	NN	O	O
and	CC	O	O
ethics	NNS	O	O
services	NNS	O	O
.	.	O	O

at	IN	O	O
that	DT	O	O
time	NN	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
mitral	JJ	I-TREATMENT	I-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
aortoomy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
left	VBD	B-TREATMENT	B-TREATMENT
atrial	JJ	I-TREATMENT	I-TREATMENT
appendage	NN	I-TREATMENT	I-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-TREATMENT	O
bypass	NN	I-TREATMENT	O
time	NN	I-TREATMENT	O
was	VBD	O	O
103	CD	O	O
minutes	NNS	O	O
/	VBP	O	O
crossclamp	JJ	B-TREATMENT	B-PROBLEM
89	CD	O	I-PROBLEM
mins	NNS	O	I-PROBLEM
.	.	O	O

he	PRP	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
and	CC	O	O
was	VBD	O	O
transferred	VBN	O	O
from	IN	O	O
the	DT	O	O
or	CC	O	O
to	TO	O	O
the	DT	O	O
csru	NN	O	O
on	IN	O	O
epinephrinne	NN	B-TREATMENT	O
and	CC	O	O
propofol	JJ	B-TREATMENT	B-TREATMENT
infusions	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

following	VBG	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
his	PRP$	B-TREATMENT	I-TREATMENT
anesthesia	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
reversed	VBN	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
weaned	VBN	O	O
from	IN	O	O
ventilator	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
successfully	RB	O	O
extubated	VBN	O	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
iv	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
also	RB	O	O
weaned	VBN	O	O
to	TO	O	O
off	RP	O	O
.	.	O	O

on	IN	O	O
pod1	PDT	O	B-TEST
his	PRP$	B-TREATMENT	I-TEST
pa	NN	I-TREATMENT	I-TEST
line	NN	I-TREATMENT	I-TEST
and	CC	O	O
chest	NN	B-TREATMENT	B-TREATMENT
tubes	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
removed	VBN	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
also	RB	O	O
started	VBN	O	O
on	IN	O	O
beta	NN	B-TREATMENT	B-TREATMENT
blockers	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
diuretics	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

over	IN	O	O
the	DT	O	O
next	JJ	O	O
several	JJ	O	O
days	NNS	O	O
with	IN	O	O
the	DT	O	O
assisstance	NN	O	O
of	IN	O	O
the	DT	O	O
nursing	NN	O	O
staff	NN	O	O
and	CC	O	O
physical	JJ	O	B-TREATMENT
therapy	NN	O	I-TREATMENT
the	DT	O	O
patients	NNS	O	O
activity	NN	O	O
level	NN	O	O
was	VBD	O	O
advanced	JJ	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
transitioned	VBN	O	O
to	TO	O	O
all	DT	B-TREATMENT	B-TREATMENT
oral	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
with	IN	O	O
the	DT	O	O
exception	NN	O	O
of	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

it	PRP	O	O
should	MD	O	O
be	VB	O	O
noted	VBN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
did	VBD	O	O
have	VB	O	O
episodes	NNS	O	O
of	IN	O	O
postoperative	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
he	PRP	O	O
was	VBD	O	O
seen	VBN	O	O
by	IN	O	O
the	DT	O	O

electrophysiology	NN	O	O
service	NN	O	O
,	,	O	O
started	VBN	O	O
on	IN	O	O
procainamide	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

aricept	IN	B-TREATMENT	O
10	CD	O	O
mg	NN	O	O
qd	NN	O	O
,	,	O	O
aspirin	RB	B-TREATMENT	B-TREATMENT
81	CD	O	O
mg	NN	O	O
qd	NN	O	O
,	,	O	O
folic	JJ	B-TREATMENT	B-TREATMENT
acid	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
gabapentin	NN	B-TREATMENT	B-TREATMENT
200	CD	O	O
mg	NN	O	O
tid	NN	O	O
,	,	O	O
lopressor	VBZ	B-TREATMENT	B-TREATMENT
12.5	CD	O	O
mg	NN	O	O
bid	NN	O	O
,	,	O	O
lisinopril	VBZ	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
qd	NN	O	O
,	,	O	O
daptomycin	VBZ	B-TREATMENT	B-TREATMENT
420	CD	O	O
mg	NN	O	O
iv	NN	O	O
qd	NN	O	O
,	,	O	O
protonix	VBP	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
qd	NN	O	O
,	,	O	O
seroquel	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
tid	NN	O	O
,	,	O	O
heparin	JJ	B-TREATMENT	B-TREATMENT
5000	CD	O	O
units	NNS	O	O
sq	VBD	O	O
tid	NN	O	O
,	,	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
bid	NN	O	O
,	,	O	O
lactulose	VBP	B-TREATMENT	B-TREATMENT
15	CD	O	O
mg	JJ	O	O
bid	NN	O	O
,	,	O	O
comtan	VBP	B-TREATMENT	O
200	CD	O	O
mg	NN	O	O
qd	NN	O	O
,	,	O	O
mirapex	FW	B-TREATMENT	B-TREATMENT
1.5	CD	O	O
mg	NN	O	O
tid	NN	O	O
,	,	O	O
sinemet	VBD	B-TREATMENT	B-TREATMENT
50	CD	O	O
/	JJ	O	O
200	CD	O	O
mg	NN	O	O
tid	NN	O	O

1.	CD	O	O
furosemide	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
for	IN	O	O
2	CD	O	O
weeks	NNS	O	O
.	.	O	O

2.	CD	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
20	CD	O	O
meq	NN	O	O
packet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
packet	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
for	IN	O	O
2	CD	O	O
weeks	NNS	O	O
.	.	O	O

3.	CD	O	O
docusate	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

4.	CD	O	O
pantoprazole	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
q24h	NN	O	O
(	(	O	O
every	DT	O	O
24	CD	O	O
hours	NNS	O	O
)	)	O	O
.	.	O	O

5.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
81	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

6.	CD	O	O
magnesium	NN	B-TREATMENT	B-TREATMENT
hydroxide	NN	I-TREATMENT	I-TREATMENT
400	CD	O	O
mg	NN	O	O
/	VBD	O	O
5	CD	O	O
ml	JJ	O	O
suspension	NN	O	O
sig	NN	O	O
:	:	O	O
thirty	NN	O	O
(	(	O	O
30	CD	O	O
)	)	O	O
ml	NN	O	O
po	NN	O	O
hs	NN	O	O
(	(	O	O
at	IN	O	O
bedtime	NN	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
constipation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

7.	CD	O	O
entacapone	NN	B-TREATMENT	B-TREATMENT
200	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

8.	CD	O	O
pramipexole	JJ	B-TREATMENT	B-TREATMENT
0.25	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
six	CD	O	O
(	(	O	O
6	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

9.	CD	O	O
carbidopa	SYM	B-TREATMENT	B-TEST
-	:	I-TREATMENT	O
levodopa	NN	I-TREATMENT	B-TREATMENT
50	CD	O	O
-	:	O	O
200	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sustained	VBD	O	O
release	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
.	.	O	O

10.	CD	O	O
quetiapine	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

11.	CD	O	O
procainamide	JJ	B-TREATMENT	B-TREATMENT
250	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
three	CD	O	O
(	(	O	O
3	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
q6h	NN	O	O
(	(	O	O
every	DT	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
:	:	O	O
x	$	O	O
6	CD	O	O
weeks	NNS	O	O
.	.	O	O

12.	CD	O	O
acetaminophen	SYM	B-TREATMENT	B-TEST
-	:	I-TREATMENT	O
codeine	NN	I-TREATMENT	B-TREATMENT
300-30	JJ	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q4h	NN	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

13.	CD	O	O
warfarin	JJ	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
as	IN	O	O
directed	VBN	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
.	.	O	O

14.	CD	O	O
daptomycin	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	JJ	O	O
recon	NN	O	O
soln	NN	O	O
sig	NN	O	O
:	:	O	O
four	CD	O	O
90y	CD	O	O
(	(	O	O
480	CD	O	O
)	)	O	O
mg	NN	O	O
intravenous	JJ	O	O
q24h	NN	O	O
(	(	O	O
every	DT	O	O
24	CD	O	O
hours	NNS	O	O
)	)	O	O
:	:	O	O
thru	JJ	O	O
05-02	NN	O	O
.	.	O	O

extended	VBN	B-TREATMENT	O
care	NN	I-TREATMENT	O

discharge	NN	O	O
diagnosis	NN	O	O
:	:	O	O
mitral	JJ	B-PROBLEM	B-PROBLEM
valve	NN	I-PROBLEM	I-PROBLEM
endocarditis	NN	I-PROBLEM	I-PROBLEM
s/p	NN	O	O
mv	CD	B-TREATMENT	B-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT

htn	NN	B-PROBLEM	B-PROBLEM

s/p	NN	O	O
cva	NN	B-PROBLEM	B-PROBLEM

spinal	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
s/p	NN	O	O
lumbar	NN	B-TREATMENT	B-TREATMENT
laminectomy	NN	I-TREATMENT	I-TREATMENT

parkingson	NN	B-PROBLEM	O
's	POS	I-PROBLEM	O

h/o	NN	O	O
paranoid	NN	B-PROBLEM	B-PROBLEM
delusions	NNS	I-PROBLEM	I-PROBLEM

mgus	NN	B-PROBLEM	O
vs	NN	O	O
mm	NN	B-PROBLEM	O

wash	JJ	O	B-PROBLEM
incisions	NNS	B-PROBLEM	I-PROBLEM
with	IN	O	O
warm	JJ	O	O
water	NN	O	O
and	CC	O	O
gentle	JJ	O	B-TREATMENT
soap	NN	O	I-TREATMENT
.	.	O	O

do	VB	O	O
not	RB	O	O
apply	VB	O	O
lotions	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
creams	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
ointments	NNS	B-TREATMENT	B-TREATMENT
or	CC	O	O
powders	NNS	B-TREATMENT	B-TREATMENT
to	TO	O	I-TREATMENT
incision	NN	B-PROBLEM	I-TREATMENT
.	.	O	O

please	VB	O	O
contact	JJ	O	O
office	NN	O	O
if	IN	O	O
you	PRP	O	O
develop	VBP	O	O
a	DT	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
more	JJR	O	O
than	IN	O	O
101.5	CD	O	O
or	CC	O	O
notice	JJ	O	B-PROBLEM
drainage	NN	B-PROBLEM	I-PROBLEM
from	IN	O	O
chest	JJ	B-PROBLEM	B-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

cervical	JJ	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
ureteral	JJ	I-PROBLEM	I-PROBLEM
obstruction	NN	I-PROBLEM	I-PROBLEM
secondary	JJ	O	O
to	TO	O	O
the	DT	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

uremia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

ileus	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

bilateral	JJ	B-TREATMENT	B-TREATMENT
ureteral	JJ	I-TREATMENT	I-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

this	DT	O	O
78-year-old	JJ	O	O
woman	NN	O	O
had	VBD	O	O
stage	NN	B-PROBLEM	B-PROBLEM
iiib	JJ	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
cervix	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
she	PRP	O	O
has	VBZ	O	O
known	VBN	B-PROBLEM	B-PROBLEM
periaortic	JJ	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
splenic	JJ	I-PROBLEM	I-PROBLEM
metastases	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

when	WRB	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
diagnosed	VBN	O	O
,	,	O	O
she	PRP	O	O
underwent	JJ	O	O
total	JJ	B-TREATMENT	B-TREATMENT
abdominal	JJ	I-TREATMENT	I-TREATMENT
hysterectomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
pelvic	JJ	B-TREATMENT	B-TREATMENT
lymphadenectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
extensive	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
uterus	NN	I-PROBLEM	O
,	,	I-PROBLEM	O
ovarian	JJ	I-PROBLEM	B-TREATMENT
tubes	NN	I-PROBLEM	I-TREATMENT
,	,	I-PROBLEM	O
omentum	NN	I-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
periaortic	JJ	I-PROBLEM	I-PROBLEM
lymph	NN	I-PROBLEM	I-PROBLEM
nodes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

postoperatively	RB	O	O
,	,	O	O
she	PRP	O	O
developed	VBD	O	O
ileus	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
then	RB	O	O
finally	RB	O	O
she	PRP	O	O
recovered	VBD	O	O
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
discharged	VBN	O	O
to	TO	O	O
the	DT	O	O
nursing	NN	O	O
home	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
readmitted	VBN	O	O
because	IN	O	O
of	IN	O	O
a	DT	O	B-PROBLEM
problem	NN	O	I-PROBLEM
with	IN	O	O
uremia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
high	JJ	B-PROBLEM	B-PROBLEM
bun	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
creatinine	NN	I-PROBLEM	B-TEST
when	WRB	O	O
she	PRP	O	O
seen	VBN	O	O
in	IN	O	O
the	DT	O	O
office	NN	O	O
and	CC	O	O
the	DT	B-TEST	B-TREATMENT
bun	NN	I-TEST	I-TREATMENT
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
was	VBD	O	O
ordered	VBN	O	O
.	.	O	O

the	DT	B-TEST	O
bun	NN	I-TEST	O
was	VBD	O	O
70	CD	O	O
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
was	VBD	O	O
4.6	CD	O	O
and	CC	O	O
for	IN	O	O
this	DT	O	O
reason	NN	O	O
she	PRP	O	O
had	VBD	O	O
ultrasound	NN	B-TEST	B-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
kidney	NN	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
hydronephrosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
hospital	NN	O	O
for	IN	O	O
ureteral	JJ	B-TREATMENT	B-TREATMENT
stent	JJ	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
admission	NN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
generally	RB	O	O
stable	JJ	O	O
and	CC	O	O
she	PRP	O	O
had	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
disease	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
pelvis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
bleeding	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
no	DT	O	O
other	JJ	B-PROBLEM	B-PROBLEM
abnormality	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

dr.	NN	O	O
jescdrig	NN	O	O
was	VBD	O	O
called	VBN	O	O
and	CC	O	O
a	DT	O	B-TEST
consultation	NN	O	I-TEST
was	VBD	O	O
done	VBN	O	O
and	CC	O	O
he	PRP	O	O
placed	VBD	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
ureteral	JJ	I-TREATMENT	I-TREATMENT
stents	NNS	I-TREATMENT	I-TREATMENT
in	IN	I-TREATMENT	O
her	PRP$	I-TREATMENT	O
kidneys	NNS	I-TREATMENT	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
dropped	VBN	O	O
her	PRP$	B-TEST	B-TREATMENT
bun	NN	I-TEST	I-TREATMENT
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
to	TO	O	O
normal	JJ	O	O
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
may	MD	O	O
be	VB	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	O
her	PRP$	I-PROBLEM	B-PROBLEM
skin	NN	I-PROBLEM	I-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
right	JJ	O	I-PROBLEM
paraumbilical	JJ	O	I-PROBLEM
area	NN	O	I-PROBLEM
.	.	O	O

because	IN	O	O
of	IN	O	O
her	PRP$	O	O
age	NN	O	O
and	CC	O	O
mental	JJ	O	B-PROBLEM
condition	NN	O	I-PROBLEM
and	CC	O	O
the	DT	O	O
fact	NN	O	O
that	IN	O	O
she	PRP	O	O
had	VBD	O	O
cerebral	JJ	B-PROBLEM	B-PROBLEM
atrophy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
the	DT	O	O
decision	NN	O	O
was	VBD	O	O
made	VBN	O	O
for	IN	O	O
comfort	NN	O	O
unless	IN	O	O
she	PRP	O	O
has	VBZ	O	O
any	DT	B-PROBLEM	B-PROBLEM
further	JJ	I-PROBLEM	I-PROBLEM
problem	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
no	DT	O	O
further	JJ	O	B-TREATMENT
chemotherapy	NN	B-TREATMENT	I-TREATMENT
or	CC	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
will	MD	O	O
be	VB	O	O
given	VBN	O	O
.	.	O	O

the	DT	O	O
possibility	NN	O	O
that	IN	O	O
she	PRP	O	O
may	MD	O	O
need	VB	O	O
to	TO	O	O
receive	VB	O	O
radiation	NN	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
this	DT	O	O
area	NN	O	O
to	TO	O	O
prevent	VB	O	O
her	PRP	O	O
from	IN	O	O
getting	VBG	O	O
further	JJ	B-PROBLEM	O
obstruction	NN	I-PROBLEM	O
was	VBD	O	O
also	RB	O	O
brought	VBN	O	O
up	RP	O	O
.	.	O	O

indeed	RB	O	O
,	,	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
she	PRP	O	O
was	VBD	O	O
conscious	JJ	O	O
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
cooperative	JJ	O	O
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
communicate	VB	O	O
very	RB	O	O
nicely	RB	O	O
with	IN	O	O
everyone	NN	O	O
including	VBG	O	O
her	PRP$	O	O
family	NN	O	O
,	,	O	O
except	IN	O	O
for	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
instability	NN	I-PROBLEM	I-PROBLEM
that	IN	O	O
she	PRP	O	O
had	VBD	O	O
because	IN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
cerebral	JJ	I-PROBLEM	I-PROBLEM
atrophy	NN	I-PROBLEM	I-PROBLEM
due	JJ	O	O
to	TO	O	O
senility	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

morphine	NN	B-TREATMENT	B-TREATMENT

major	JJ	O	O
surgical	JJ	O	O
or	CC	O	O
invasive	JJ	O	B-TREATMENT
procedure	NN	O	I-TREATMENT
:	:	O	O
s/p	NN	O	B-TREATMENT
right	RB	B-TREATMENT	I-TREATMENT
hip	NN	I-TREATMENT	I-TREATMENT
orif	NN	I-TREATMENT	I-TREATMENT

s/p	NN	O	O
intubation	NN	B-TREATMENT	B-TREATMENT

75	CD	O	O
yo	NNS	O	O
f	JJ	O	O
with	IN	O	O
cad	JJ	B-PROBLEM	O
s/p	NN	O	O
mi	NN	B-PROBLEM	O
x4	NNP	O	O
(	(	O	O
s/p	JJ	O	O
lad	NN	B-TREATMENT	B-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
'09	POS	O	O
and	CC	O	O
rca	VB	B-TREATMENT	B-TREATMENT
stent	JJ	I-TREATMENT	I-TREATMENT
x	NN	O	O
2	CD	O	O
in	IN	O	O
'00	CD	O	O
and	CC	O	O
'04	PRP	O	O
)	)	O	O
,	,	O	O
chf	NN	B-PROBLEM	O
with	IN	O	O
ef	JJ	B-TEST	O
55%	CD	O	O
,	,	O	O
paf	NN	B-PROBLEM	O
,	,	O	O
inducible	JJ	B-PROBLEM	O
vtach	NN	I-PROBLEM	O
s/p	NN	O	O
aicd	JJ	B-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
sick	JJ	B-PROBLEM	B-PROBLEM
sinus	NN	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
s/p	NN	O	O
pacer	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
copd	NN	B-PROBLEM	O
with	IN	O	O
restrictive	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

per	IN	O	O
daughter	NN	O	O
,	,	O	O
pt	NN	O	O
was	VBD	O	O
in	IN	O	O
her	PRP$	O	O
usoh	JJ	O	O
until	IN	O	O
two	CD	O	O
days	NNS	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
when	WRB	O	O
she	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
superficial	JJ	I-PROBLEM	I-PROBLEM
ulcerations	NNS	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	O
her	PRP$	I-PROBLEM	O
foot	NN	I-PROBLEM	O
with	IN	O	O
erythema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

pt	NN	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
bridgewater	VB	O	O
chelsea	NN	O	B-PROBLEM
soldier	NN	O	I-PROBLEM
's	POS	O	O
home	NN	O	O
hospital	NN	O	O
and	CC	O	O
started	VBD	O	O
on	IN	O	O
unasyn	JJ	B-TREATMENT	B-TREATMENT
iv	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

pt	NN	O	O
awoke	NN	O	O
later	RB	O	O
that	IN	O	O
night	NN	O	O
and	CC	O	O
felt	VBD	O	O
unsteady	JJ	B-PROBLEM	B-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
feet	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
sustained	VBD	O	O
a	DT	O	B-PROBLEM
mechanical	JJ	O	I-PROBLEM
fall	NN	O	I-PROBLEM
.	.	O	O

per	IN	O	O
daughter	NN	O	O
,	,	O	O
pt	NN	O	O
did	VBD	O	O
not	RB	O	O
note	VB	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
tachycardia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
had	VBD	O	O
a	DT	O	O
good	JJ	O	O
po	NN	O	O
intake	NN	O	O
and	CC	O	O
no	DT	O	O
noted	JJ	B-PROBLEM	B-PROBLEM
seizure	NN	I-PROBLEM	I-PROBLEM
activity	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pt	NN	O	O
was	VBD	O	O
in	IN	O	O
severe	JJ	B-PROBLEM	O
"	NNP	I-PROBLEM	O
back	RB	I-PROBLEM	B-PROBLEM
pain	VBP	I-PROBLEM	I-PROBLEM
"	NN	I-PROBLEM	O
as	IN	O	O
per	IN	O	O
daughter	NN	O	O
which	WDT	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
dilaudid	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

ct	NN	B-TEST	B-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
neck	NN	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	O	O
possible	JJ	O	O
c1	NN	B-PROBLEM	B-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
the	DT	B-TEST	O
x-ray	NN	I-TEST	O
at	IN	O	O
the	DT	O	O
osh	NN	O	O
revealed	VBD	O	O
intratrochanteric	JJ	B-PROBLEM	B-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
femur	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pt	NN	O	O
was	VBD	O	O
subsequently	RB	O	O
transferred	VBN	O	O
to	TO	O	O
hallmark	VB	O	O
health	NN	O	O
system	NN	O	O
for	IN	O	O
orthopaedic	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
.	.	O	O

in	IN	O	O
monica	NN	O	O
at	IN	O	O
hallmark	NN	O	O
health	NN	O	O
system	NN	O	O
,	,	O	O
pt	NN	O	O
was	VBD	O	O
seen	VBN	O	O
by	IN	O	O
the	DT	O	O
trauma	NN	O	O
service	NN	O	O
where	WRB	O	O
a	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
neck	NN	I-TEST	I-TEST
revealed	VBD	O	O
no	DT	O	O
fracture	NN	B-PROBLEM	B-PROBLEM
(	(	O	O
however	RB	O	O
,	,	O	O
the	DT	B-TREATMENT	O
c-collar	NN	I-TREATMENT	O
was	VBD	O	O
maintained	VBN	O	O
secondary	JJ	O	O
to	TO	O	O
pain	VB	B-PROBLEM	B-PROBLEM
)	)	O	O
.	.	O	O

the	DT	O	O
orthopaedic	JJ	O	O
service	NN	O	O
recommended	VBD	O	O
emergent	JJ	B-TREATMENT	O
repair	NN	I-TREATMENT	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
intratrochanteric	JJ	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
secondary	JJ	O	O
to	TO	O	O
instability	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
monica	NN	O	O
stay	NN	O	O
was	VBD	O	O
complicated	VBN	O	O
by	IN	O	O
runs	NNS	O	O
of	IN	O	O
afib	NN	B-PROBLEM	B-PROBLEM
to	TO	O	O
133	CD	O	O
requiring	VBG	O	O
iv	NN	B-TREATMENT	B-TREATMENT
lopressor	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

pt	NN	O	O
is	VBZ	O	O
very	RB	B-PROBLEM	B-PROBLEM
sob	JJ	I-PROBLEM	I-PROBLEM
at	IN	O	O
baseline	NN	O	O
,	,	O	O
not	RB	O	O
on	IN	O	O
home	NN	B-TREATMENT	B-TREATMENT
ox	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
no	DT	O	O
cp	NN	B-PROBLEM	B-PROBLEM
at	IN	O	O
rest	NN	O	O
,	,	O	O
no	DT	O	O
le	NN	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
pnd	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
stable	JJ	B-PROBLEM	O
orthopnea	NN	I-PROBLEM	O
(	(	O	O
2	CD	O	O
pillows	NNS	O	O
)	)	O	O
.	.	O	O

pt	NN	O	O
ambulates	VBZ	O	O
10	CD	O	O
feet	NNS	O	O
with	IN	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
fatigue	NN	I-PROBLEM	I-PROBLEM
as	IN	O	O
per	IN	O	O
daughter	NN	O	O
.	.	O	O

(	(	O	O
?	.	O	O
dec	NN	B-PROBLEM	O
in	IN	I-PROBLEM	O
exercise	NN	I-PROBLEM	O
tolerance	NN	I-PROBLEM	O
)	)	O	O
.	.	O	O

cmed	VBN	O	O
ccu	JJ	O	O
change	NN	O	O
include	VBP	O	O
discontinuation	NN	O	O
of	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
secondary	JJ	O	O
to	TO	O	O
inc	VB	O	O
risk	NN	O	O
of	IN	O	O
upper	JJ	B-PROBLEM	B-PROBLEM
gi	NN	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

digoxin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
norvasc	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
imdur	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
also	RB	O	O
discontinued	VBN	O	O
.	.	O	O

75	CD	O	O
yo	NNS	O	O
f	JJ	O	O
with	IN	O	O
cad	JJ	B-PROBLEM	O
s/p	NN	O	O
stenting	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
vt	NN	B-PROBLEM	O
,	,	O	O
sss	JJ	B-PROBLEM	O
s/p	NN	O	O
pacer	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
copd	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
presented	VBN	O	O
to	TO	O	O
osh	VB	O	O
2016-03-21	JJ	O	O
with	IN	O	O
foot	JJ	B-PROBLEM	B-PROBLEM
ulceration	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

started	VBN	O	O
on	IN	O	O
unasyn	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
in	IN	O	O
hospital	NN	O	O
suffered	VBD	O	O
mech.	JJ	O	B-PROBLEM
fall	NN	O	I-PROBLEM
with	IN	O	O
hip	NN	B-PROBLEM	B-PROBLEM
fx	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

medically	RB	B-TEST	O
eval	JJ	I-TEST	O
not	RB	O	O
high	JJ	B-TREATMENT	B-PROBLEM
risk	NN	I-TREATMENT	I-PROBLEM
surgery	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
preop	VBP	B-TREATMENT	O
beta	NN	I-TREATMENT	B-TREATMENT
blocker	NN	I-TREATMENT	I-TREATMENT
given	VBN	O	O
.	.	O	O

orif	NN	B-TREATMENT	O
with	IN	O	O
repair	NN	B-TREATMENT	B-TREATMENT
of	IN	O	I-TREATMENT
neck	JJ	B-PROBLEM	I-TREATMENT
fracture	NN	I-PROBLEM	I-TREATMENT
2016-03-23	CD	O	O
.	.	O	O

expected	VBN	B-TREATMENT	O
prolonged	JJ	I-TREATMENT	B-TREATMENT
extubation	NN	I-TREATMENT	I-TREATMENT
course	NN	I-TREATMENT	I-TREATMENT
given	VBN	O	O
copd	JJ	B-PROBLEM	O
history	NN	I-PROBLEM	O
,	,	O	O
as	IN	O	O
with	IN	O	O
colon	NN	B-TREATMENT	B-TREATMENT
ca	MD	I-TREATMENT	I-TREATMENT
resection	VB	I-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

late	JJ	O	O
03-23	NN	O	O
found	VBD	O	O
with	IN	O	O
afib	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
rvr	NN	B-PROBLEM	O
,	,	O	O
given	VBN	O	O
beta	NN	B-TREATMENT	B-TREATMENT
blocker	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
min.	JJ	O	O
response	NN	O	O
,	,	O	O
started	VBD	O	B-TREATMENT
dilt.	JJ	B-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

received	VBD	O	O
2	CD	B-TREATMENT	O
mg	NNS	I-TREATMENT	O
dilaudid	NN	I-TREATMENT	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
o/n	NN	O	I-PROBLEM
.	.	O	O

this	DT	O	O
am	VBP	O	O
with	IN	O	O
respiratory	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
continued	VBD	B-PROBLEM	O
tachycardia	NN	I-PROBLEM	B-PROBLEM
on	IN	O	O
dilt.	NN	B-TREATMENT	B-TREATMENT
gtt	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

transferred	VBN	O	O
to	TO	O	O
unit	NN	O	O
and	CC	O	O
urgently	RB	O	O
intubated	VBN	O	B-TREATMENT
(	(	O	I-TREATMENT
labs	JJ	B-TEST	I-TREATMENT
below.	NN	O	I-TREATMENT
)	)	O	I-TREATMENT

of	IN	O	O
note	NN	O	O
,	,	O	O
a	DT	B-TREATMENT	O
ngt	NN	I-TREATMENT	O
by	IN	O	O
xray	NN	B-TEST	B-TEST
was	VBD	O	O
not	RB	O	O
in	IN	O	O
correct	JJ	O	O
position	NN	O	O
?	.	O	O
lungs	NNS	O	O
->	VBD	O	O
possibly	RB	O	O
used	VBN	O	O
for	IN	O	O
medication	NN	B-TREATMENT	B-TREATMENT
administration	NN	I-TREATMENT	O
this	DT	O	O
am	VBP	O	O
.	.	O	O

1.	CD	O	O
cad	NN	B-PROBLEM	O
s/p	NN	O	B-TREATMENT
lad	JJ	B-TREATMENT	I-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
'	POS	O	O
98	CD	O	O
+	NNS	O	O
rca	JJ	B-TREATMENT	O
stet	NN	I-TREATMENT	O
in	IN	O	O
'	POS	O	O
00	CD	O	O
with	IN	O	O
repeat	NN	B-TREATMENT	B-TREATMENT
rca	NN	I-TREATMENT	I-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
'	POS	O	O
04	CD	O	O
.	.	O	O

last	JJ	B-TEST	O
cath	NN	I-TEST	O
in	IN	O	O
9-04	CD	O	O

2.	CD	O	O
paf	NN	B-PROBLEM	B-TREATMENT

3.	CD	O	O
dm	NN	B-PROBLEM	O

4.	CD	O	O
sick	JJ	B-PROBLEM	B-PROBLEM
sinus	NN	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
s/p	JJ	O	O
pacer	NN	B-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
'	POS	O	O
98	CD	O	O

5.	CD	O	O
depression	NN	B-PROBLEM	B-PROBLEM

6.	CD	O	O
copd	NN	B-PROBLEM	B-PROBLEM
(	(	O	O
no	DT	O	O
pft	NN	B-TEST	O
available	JJ	O	O
)	)	O	O

7.	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
restrictive	JJ	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
no	DT	O	O
pft	NN	B-TEST	O
available	JJ	O	O
)	)	O	O

8.	CD	O	O
htn	NN	B-PROBLEM	B-PROBLEM

9.	CD	O	O
hyperlipidemia	NN	B-PROBLEM	B-PROBLEM

10.	CD	O	O
obesity	NN	B-PROBLEM	B-PROBLEM

11.	CD	O	O
s/p	NN	O	O
tah	NN	B-TREATMENT	B-TREATMENT

12.	CD	O	O
s/p	JJ	O	B-TREATMENT
colonic	JJ	B-TREATMENT	I-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT
secondary	JJ	O	O
to	TO	O	O
perforation	VB	B-PROBLEM	O
s/p	JJ	O	O
polypectomy	NN	B-TREATMENT	B-TREATMENT

13.	CD	O	O
inducible	JJ	B-PROBLEM	O
vtach	NN	I-PROBLEM	O
on	IN	O	O
ep	NN	B-TEST	B-TEST
study	NN	I-TEST	I-TEST
with	IN	O	O
aicd	JJ	B-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
11-01	JJ	O	O

14.	CD	O	O
chf	NN	B-PROBLEM	B-TREATMENT

15.	CD	O	O
upper	JJ	B-PROBLEM	B-PROBLEM
gi	NNS	I-PROBLEM	I-PROBLEM
bleed	VBD	I-PROBLEM	I-PROBLEM

vs	NN	B-TEST	O
:	:	O	O

hr	NN	B-TEST	O
:	:	O	O
133	CD	O	O

bp	NN	B-TEST	O
:	:	O	O
110/80	CD	O	O

gen	NN	O	O
:	:	O	O
sedated	VBN	B-TREATMENT	O
but	CC	O	O
a+o	JJ	O	O
x3	NN	O	O

heent	NN	O	O
:	:	O	O
cervical	JJ	B-TREATMENT	B-TREATMENT
collar	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
place	NN	O	O

cv	NN	O	O
:	:	O	O
tachycardia	NN	B-PROBLEM	B-PROBLEM

abd	NN	O	O
:	:	O	O
+	NN	O	O
bs	NN	O	O
,	,	O	O
soft	JJ	O	O
,	,	O	O
nt	JJ	B-PROBLEM	O
,	,	O	O
nd	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
bs	JJ	O	O
+	NN	O	O

ext	NN	O	O
:	:	O	O
no	DT	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
r	NN	B-PROBLEM	O
leg	NN	I-PROBLEM	O
shortened	VBD	I-PROBLEM	O
and	CC	I-PROBLEM	O
rotated	VBD	I-PROBLEM	O
,	,	O	O
+	NNP	O	O
cellulitis	NN	B-PROBLEM	B-PROBLEM

wbc	SYM	B-TEST	B-TEST
-	:	O	O
12.7	CD	O	O
*	NN	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
4.32	CD	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
10.5	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
33.2	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
77	CD	O	O
*	NN	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
24.2	CD	O	O
*	NN	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
31.5	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
15.4	CD	O	O

neuts	NNS	B-TEST	B-TEST
-	:	O	O
90.5	CD	O	O
*	NN	O	O
lymphs	SYM	B-TEST	B-TEST
-	:	O	O
5.1	CD	O	O
*	JJ	O	O
monos	NNS	B-TEST	B-TEST
-	:	O	O
3.7	CD	O	O
eos	SYM	B-TEST	B-TEST
-	:	O	O
0.6	CD	O	O
basos	SYM	B-TEST	B-TEST
-	:	O	O
0.2	CD	O	O

hypochrom	SYM	B-TEST	B-TEST
-	:	O	O
3+	CD	O	O
poikilocy	NN	B-TEST	B-TEST
-	:	O	O
1+	CD	O	O
microcyt	SYM	B-TEST	O
-	:	O	O
2+	CD	O	O

plt	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
-	:	O	O
324	CD	O	O

pt	SYM	B-TEST	B-TEST
-	:	O	O
13.6	CD	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
25.2	CD	O	O
inr	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
pt	JJ	I-TEST	I-TEST
)-	CD	I-TEST	I-TEST
1.2	CD	O	O

glucose	JJ	B-TEST	B-TEST
-	:	O	O
191	CD	O	O
*	JJ	O	O
urea	JJ	B-TEST	B-TEST
n	SYM	I-TEST	I-TEST
-	:	O	O
14	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
0.6	CD	O	O
sodium	NN	B-TEST	B-TEST
-	:	O	O
141	CD	O	O
potassium	NN	B-TEST	B-TEST
-	:	O	O
3.5	CD	O	O
chloride	NN	B-TEST	B-TEST
-	:	O	O
101	CD	O	O
total	JJ	B-TEST	B-TEST
co2	NN	I-TEST	I-TEST
-	:	O	O
28	CD	O	O
anion	NN	B-TEST	B-TEST
gap	NN	I-TEST	I-TEST
-	:	O	O
16	CD	O	O

calcium	NN	B-TEST	B-TEST
-	:	O	O
8.8	CD	O	O
phosphate	NN	B-TEST	B-TEST
-	:	O	O
4.4	CD	O	O
magnesium	NN	B-TEST	B-TEST
-	:	O	O
1.9	CD	O	O

2016-03-22	JJ	O	O
11:25	CD	O	O
am	VBP	O	O
urine	JJ	B-TEST	O

color	NN	B-TEST	B-TEST
-	:	O	O
yellow	NN	O	O
appear	VBP	B-TEST	O
-	:	O	O
clear	JJ	O	O
sp	NN	B-TEST	O
barajas	SYM	I-TEST	O
-	:	O	O
1.020	CD	O	O

2016-03-22	JJ	O	O
11:25	CD	O	O
am	VBP	O	O
urine	JJ	B-TEST	O

blood	NN	B-TEST	B-TEST
-	:	O	I-TEST
lg	NN	B-TEST	I-TEST
nitrite	JJ	I-TEST	I-TEST
-	:	O	O
neg	NN	O	O
protein	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
250	CD	O	O
ketone	NN	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
bilirubin	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
urobilngn	JJ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
ph	SYM	B-TEST	B-TEST
-	:	O	O
6.5	CD	O	O

leuk	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O

2016-03-22	JJ	O	O
11:25	CD	O	O
am	VBP	O	O
urine	JJ	B-TEST	O

rbc	LS	B-TEST	B-TEST
-	:	O	O
0-2	JJ	O	O
wbc	JJ	B-TEST	B-TEST
-	:	O	O
04-02	JJ	O	B-PROBLEM
bacteria	NNS	B-TEST	I-PROBLEM
-	:	O	O
occ	NN	B-TEST	O
yeast	SYM	I-TEST	B-TEST
-	:	O	O
none	NN	O	O
epi	SYM	B-TEST	O
-	:	O	O
0	CD	O	O

2016-03-22	JJ	O	O
11:25	CD	O	O
am	VBP	O	O
urine	JJ	B-TEST	O

hyaline	NN	B-TEST	B-TEST
-	:	O	O
3	CD	O	O
*	NN	O	O

ck	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
cpk	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
178	CD	O	O
*	NN	O	O

ck-mb	JJ	B-TEST	B-TEST
-	:	O	O
7	CD	O	O

d-dimer	JJ	B-TEST	O
-	:	O	O
1748	CD	O	O
*	NN	O	O

ck	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
cpk	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
153	CD	O	O
*	NN	O	O

ck-mb	JJ	B-TEST	B-TEST
-	:	O	O
5	CD	O	O
ctropnt	NN	B-TEST	B-TEST
-<	CD	O	O
0.01	CD	O	O

'	POS	O	O
00	CD	O	O
tte	NN	B-TEST	O
:	:	O	O

ef	JJ	B-TEST	O
50-55%	JJ	O	O
;	:	O	O
mild	VB	B-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
moderate	VB	I-PROBLEM	I-PROBLEM
mr	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
left	VBD	O	O
atrium	NN	O	O
is	VBZ	O	O
moderately	RB	B-PROBLEM	B-PROBLEM
dilated	VBN	I-PROBLEM	I-PROBLEM
,	,	O	O
trace	NN	B-PROBLEM	B-PROBLEM
ar	NN	I-PROBLEM	I-PROBLEM

cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
:	:	O	O
inferior	JJ	B-PROBLEM	O
,	,	I-PROBLEM	O
posterobasilar	JJ	I-PROBLEM	B-PROBLEM
hypokinesis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
1	CD	B-PROBLEM	O
+	NN	I-PROBLEM	O
mr	NN	I-PROBLEM	O
,	,	O	O
ef	RB	B-TEST	B-TEST
48%	CD	O	O
,	,	O	O
mid	NN	O	O
rca	NN	O	O
50%	CD	O	O
,	,	O	O
distal	JJ	O	O
rca	NN	O	O
40%	CD	O	O
,	,	O	O
mid	NN	O	O
lad	JJ	O	O
50%	CD	O	O
,	,	O	O
om3	FW	B-PROBLEM	O
diffusely	RB	I-PROBLEM	O
diseased	VBN	I-PROBLEM	O
s/p	NN	O	O
stenting	NN	B-TREATMENT	B-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
rca	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
drug	NN	B-TREATMENT	B-TREATMENT
eluting	VBG	I-TREATMENT	I-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
10%	CD	B-TEST	B-PROBLEM
residual	JJ	I-TEST	I-PROBLEM
flow	NN	I-TEST	I-PROBLEM
.	.	O	O

2016-03-22	JJ	O	B-TEST
cxr	NN	B-TEST	I-TEST
:	:	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
cardiomegaly	NN	I-PROBLEM	I-PROBLEM
without	IN	O	O
chf	NN	B-PROBLEM	O
,	,	O	O
no	DT	O	O
effusions	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
left	VBD	B-PROBLEM	B-PROBLEM
retrocardiac	JJ	I-PROBLEM	I-PROBLEM
opacity	NN	I-PROBLEM	I-PROBLEM
consistent	NN	O	O
with	IN	O	O
atelectasis	NN	B-PROBLEM	B-PROBLEM
vs.	FW	O	O
consolidation	NN	B-PROBLEM	B-PROBLEM

2016-03-22	JJ	O	B-TEST
ct	JJ	B-TEST	I-TEST
c-spine	NN	I-TEST	I-TEST
:	:	O	O

1)	CD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
fracture	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
cervical	JJ	I-PROBLEM	I-PROBLEM
spine	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
definite	JJ	B-PROBLEM	B-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
c1	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
identified	VBN	O	O
to	TO	O	O
correlate	VB	O	O
with	IN	O	O
the	DT	O	O
history	NN	O	O
of	IN	O	O
questioned	JJ	O	B-PROBLEM
c1	JJ	B-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
outside	JJ	O	O
hospital	NN	O	O
.	.	O	O

2)	CD	O	O
extensive	JJ	B-PROBLEM	B-PROBLEM
degenerative	JJ	I-PROBLEM	I-PROBLEM
change	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
cervical	JJ	I-PROBLEM	I-PROBLEM
spine	NN	I-PROBLEM	I-PROBLEM
."	NN	O	I-PROBLEM

2016-03-22	JJ	O	B-TEST
femur	NN	B-TEST	I-TEST
&	CC	I-TEST	I-TEST
r	NN	I-TEST	I-TEST
knee	NN	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
:	:	O	O

1)	CD	O	O
comminuted	JJ	B-PROBLEM	B-PROBLEM
intertrochanteric	JJ	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
femur	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
avulsion	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lesser	JJR	I-PROBLEM	I-PROBLEM
trochanter	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
displacement	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
angulation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2)	CD	O	O
no	DT	O	O
other	JJ	B-PROBLEM	B-PROBLEM
definite	JJ	I-PROBLEM	I-PROBLEM
fractures	NNS	I-PROBLEM	I-PROBLEM
identified.	VBP	O	I-PROBLEM
degenerative	JJ	B-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lumbosacral	JJ	I-PROBLEM	I-PROBLEM
spine	NN	I-PROBLEM	I-PROBLEM
."	NN	O	I-PROBLEM

2016-04-01	JJ	O	B-TEST
flexion	NN	B-TEST	I-TEST
extension	NN	I-TEST	I-TEST
xrays	NNS	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
cervical	JJ	I-TEST	I-TEST
spine	NN	I-TEST	I-TEST
:	:	O	O

mild	JJ	O	B-PROBLEM
degree	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
instability	NN	B-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	O
level	JJ	I-PROBLEM	O
c3-c4	NN	I-PROBLEM	O
as	IN	O	O
described	NN	O	O
.	.	O	O

possibility	NN	O	O
of	IN	O	O
arch	JJ	B-PROBLEM	O
element	NN	I-PROBLEM	O
in	IN	I-PROBLEM	O
this	DT	I-PROBLEM	O
region	NN	I-PROBLEM	O
cannot	NN	O	O
be	VB	O	O
excluded	VBN	O	O
.	.	O	O

75	CD	O	O
yo	JJ	O	O
f	NN	O	O
s/p	NN	O	O
mix4	NN	B-PROBLEM	B-TREATMENT
,	,	O	O
numerous	JJ	B-TEST	B-TREATMENT
cath	NN	I-TEST	I-TREATMENT
,	,	O	O
paf	NN	B-PROBLEM	O
,	,	O	O
inducible	JJ	B-PROBLEM	O
vtach	NN	I-PROBLEM	O
s/p	NN	O	O
aicd	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
pacer	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
copd	NN	I-PROBLEM	I-PROBLEM
/	NNP	O	I-PROBLEM
restrictive	JJ	B-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
s/p	VBD	O	O
fall	NN	O	B-PROBLEM
with	IN	O	O
intertrochanteric	JJ	B-PROBLEM	B-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

as	IN	O	O
per	NN	O	O
cmed	VBD	O	O
ccu	NN	O	O
,	,	O	O
pt	NN	O	O
requires	VBZ	O	O
emergent	JJ	B-TREATMENT	O
repair	NN	I-TREATMENT	O
of	IN	O	O
intertrochanteric	JJ	B-PROBLEM	B-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
preserve	VB	O	O
neurovascular	JJ	O	O
function	NN	O	O
.	.	O	O

pt	NN	O	O
is	VBZ	O	O
a	DT	O	O
moderate	JJ	O	O
risk	NN	O	O
for	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
needed	JJ	I-TREATMENT	I-TREATMENT
emergent	NN	I-TREATMENT	I-TREATMENT
non-cardiac	JJ	I-TREATMENT	I-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

pt	NN	O	O
is	VBZ	O	O
medically	RB	O	O
cleared	VBN	O	O
for	IN	O	O
procedure	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
likely	RB	O	O
has	VBZ	O	O
some	DT	B-PROBLEM	O
mile	NN	I-PROBLEM	O
rate	NN	I-PROBLEM	O
related	VBN	I-PROBLEM	O
ischemia	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

---	JJ	O	O
pre-op	JJ	B-TREATMENT	O
b-blocker	NN	I-TREATMENT	O
with	IN	O	O
goal	NN	B-TEST	O
hr	NN	I-TEST	O
<	VBD	O	O
70	CD	O	O

---	RB	O	O
no	DT	O	O
real	JJ	O	B-PROBLEM
utility	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
mibi	NN	B-TREATMENT	I-PROBLEM
/	NNP	O	O
cath	NN	B-TEST	B-TEST
prior	RB	O	O
to	TO	O	O
procedure	VB	B-TREATMENT	O
gien	JJ	O	O
previous	JJ	B-TEST	O
caths	NNS	I-TEST	O
with	IN	O	O
no	DT	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
to	TO	O	O
be	VB	O	O
intervened	VBN	O	O
on	IN	O	O
.	.	O	O

---	JJ	O	O
v-tach	NN	B-PROBLEM	O
:	:	O	O
pt	NN	O	O
has	VBZ	O	O
aicd	VBN	B-TREATMENT	O
in	IN	O	O
place	NN	O	O
,	,	O	O
however	RB	O	O
b-blocker	NN	B-TREATMENT	O
should	MD	O	O
contorl	VB	O	O
vtach	NN	B-PROBLEM	O
for	IN	O	O
now	RB	O	O
.	.	O	O

---	JJ	O	O
b-blocker	NN	B-TREATMENT	O
iv	NN	I-TREATMENT	O
,	,	O	O
dilt	JJ	B-TREATMENT	O
prn	NN	O	O
for	IN	O	O
paf	NN	B-PROBLEM	B-PROBLEM

---	NN	O	O
hold	VBP	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
afib	NN	B-PROBLEM	B-PROBLEM
given	VBN	O	O
hx	NN	O	O
of	IN	O	O
upper	JJ	B-PROBLEM	B-PROBLEM
gib	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
in	IN	O	O
am	VBP	O	O

---	NN	O	O
continue	NN	O	O
asa	NN	B-TREATMENT	O
,	,	O	O
plavix	NN	B-TREATMENT	B-TREATMENT

---	NN	O	O
romi	NN	B-PROBLEM	O
,	,	O	O
check	VB	O	O
am	VBP	O	O
ecg	VB	B-TEST	O

2.	CD	O	O
copd	JJ	B-PROBLEM	B-PROBLEM
/	NNP	O	I-PROBLEM
restrictive	NN	B-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

---	JJ	O	O
nebs	JJ	B-TREATMENT	O
/	NN	O	O
mdi	NN	B-TREATMENT	O
prn	NN	O	O

---	NN	O	O
no	DT	O	O
need	NN	O	O
for	IN	O	O
steroids	NNS	B-TREATMENT	B-TREATMENT
now	RB	O	O

---	NNS	O	O
expect	VBP	O	O
prolonged	JJ	B-PROBLEM	B-TREATMENT
wean	JJ	I-PROBLEM	I-TREATMENT
given	VBN	O	O
previous	JJ	O	O
history	NN	O	O
of	IN	O	O
prolonged	JJ	B-PROBLEM	B-TREATMENT
wean	JJ	I-PROBLEM	I-TREATMENT
s/p	NN	O	I-TREATMENT
colonic	JJ	B-TREATMENT	I-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT

---	RB	O	B-TEST
incentive	JJ	B-TREATMENT	I-TEST
spirometry	NN	I-TREATMENT	I-TEST
for	IN	O	O
atelectasis	NN	B-PROBLEM	B-PROBLEM

3.	CD	O	O
hip	JJ	B-PROBLEM	B-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

---	JJ	O	B-PROBLEM
pain	NN	B-TREATMENT	I-PROBLEM
control	NN	I-TREATMENT	I-PROBLEM
with	IN	O	O
diluadid	NN	B-TREATMENT	B-PROBLEM
,	,	O	O
tylenol	NN	B-TREATMENT	B-TREATMENT

---	JJ	O	O
lovenox	NN	B-TREATMENT	O
tonight	NN	O	O
x1	NN	O	O
,	,	O	O
hold	VBP	O	O
am	VBP	O	O
dose	JJ	O	O
per	IN	O	O
cmed	VBN	O	O
ccu	NN	O	O

4.	CD	O	O
anemia	NN	B-PROBLEM	B-PROBLEM
:	:	O	O

---	NN	O	B-TEST
iron	NN	B-TEST	I-TEST
studies	NNS	I-TEST	I-TEST

---	NN	O	B-PROBLEM
tsh	NN	B-TEST	I-PROBLEM

---	NN	O	O
no	DT	O	O
need	NN	O	B-PROBLEM
fortransfusion	NN	B-TREATMENT	I-PROBLEM
currently	RB	O	O
,	,	O	O
keep	VB	O	O
hct	NN	B-TEST	B-TEST
>	CD	O	O
30	CD	O	O

5.	CD	O	O
hypokalemia	NN	B-PROBLEM	B-PROBLEM
:	:	O	O

---	RB	O	O
60iv	CD	B-TREATMENT	O
k	NNS	I-TREATMENT	O
now	RB	O	O

---	NN	O	O
continue	VBP	O	O
po	NN	B-TREATMENT	O
k	NN	I-TREATMENT	O

---	RB	O	O
check	NN	O	O
lytes	NNS	B-TEST	O
in	IN	O	O
pm	NN	O	O

6.	CD	O	O
cellulitis	NN	B-PROBLEM	B-PROBLEM
:	:	O	O

---	NN	O	O
continue	VBP	O	O
unasyn	NN	B-TREATMENT	B-TREATMENT

---	NNS	O	O
hold	VBP	O	O
off	RP	O	O
on	IN	O	O
x-rays	NNS	B-TEST	O
for	IN	O	O
now	RB	O	O

7.	CD	O	O
dm	NN	B-PROBLEM	O
:	:	O	O

---	NN	O	O
riss	SYM	B-TREATMENT	B-TEST
-	:	O	O
tight	JJ	O	B-PROBLEM
glucose	JJ	B-TREATMENT	I-PROBLEM
control	NN	I-TREATMENT	I-PROBLEM
pre-op	NN	O	I-PROBLEM

8.	CD	O	O
ppx	NN	B-TREATMENT	O
:	:	O	O

---	JJ	O	B-PROBLEM
protonix	NN	B-TREATMENT	I-PROBLEM
,	,	O	O
lovenox	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
r	NN	B-TREATMENT	O
boot	NN	I-TREATMENT	O
as	IN	O	O
per	IN	O	O
cmed	NN	O	O
ccu	NN	O	O

npo	NN	B-TREATMENT	O

orif	NN	B-TREATMENT	O
with	IN	O	O
repair	NN	B-TREATMENT	B-TREATMENT
of	IN	O	I-TREATMENT
neck	JJ	B-PROBLEM	I-TREATMENT
fracture	NN	I-PROBLEM	I-TREATMENT
2016-03-23	CD	O	O
.	.	O	O

had	VBD	O	O
expected	VBN	O	O
prolonged	JJ	B-PROBLEM	B-PROBLEM
post-op	JJ	I-PROBLEM	I-PROBLEM
extubation	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
pacu	NN	O	I-PROBLEM
given	VBN	O	O
copd	JJ	B-PROBLEM	O
history	NN	I-PROBLEM	O
,	,	O	O
as	IN	O	O
with	IN	O	O
colon	NN	B-TREATMENT	B-TREATMENT
ca	MD	I-TREATMENT	I-TREATMENT
resection	VB	I-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

late	JJ	O	O
03-23	NN	O	O
found	VBD	O	O
with	IN	O	O
afib	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
rvr	NN	B-PROBLEM	O
,	,	O	O
given	VBN	O	O
beta	NN	B-TREATMENT	B-TREATMENT
blocker	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
min.	JJ	O	O
response	NN	O	O
,	,	O	O
started	VBD	O	B-TREATMENT
dilt.	JJ	B-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

received	VBD	O	O
2	CD	B-TREATMENT	O
mg	NNS	I-TREATMENT	O
dilaudid	NN	I-TREATMENT	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
o/n	NN	O	I-PROBLEM
.	.	O	O

on	IN	O	O
03-24	JJ	O	O
am	VBP	O	O
p/w	JJ	O	O
with	IN	O	O
respiratory	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
continued	VBD	B-PROBLEM	O
tachycardia	NN	I-PROBLEM	B-PROBLEM
on	IN	O	O
dilt.	NN	B-TREATMENT	B-TREATMENT
gtt.	NN	I-TREATMENT	I-TREATMENT

of	IN	O	O
note	NN	O	O
,	,	O	O
there	EX	O	O
was	VBD	O	O
a	DT	O	O
question	NN	O	O
of	IN	O	O
misplaced	JJ	B-PROBLEM	B-PROBLEM
ngt	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

when	WRB	O	O
ngt	JJ	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
pulled	VBN	O	O
out	RP	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
respiratory-like	JJ	O	B-PROBLEM
secretions	NNS	O	I-PROBLEM
.	.	O	O

concern	NN	O	O
for	IN	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
of	IN	O	I-PROBLEM
mediations	NNS	B-TREATMENT	I-PROBLEM
to	TO	O	O
lungs	NNS	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
evaluation	NN	O	B-TEST
of	IN	O	I-TEST
cxr	NN	B-TEST	I-TEST
revealed	VBN	O	O
ngt	RB	B-PROBLEM	B-PROBLEM
coiled	VBN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
esophagus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pt	NN	B-PROBLEM	B-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
most	RBS	O	O
likely	JJ	O	O
on	IN	O	O
setting	VBG	O	O
of	IN	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
vs.	FW	O	O
pneumonitis	NN	B-PROBLEM	B-PROBLEM
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
depressed	JJ	B-PROBLEM	B-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
secondary	JJ	O	O
to	TO	O	O
post-operative	JJ	B-TREATMENT	B-TREATMENT
narcotics	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

pt	NN	O	O
was	VBD	O	O
pan-cultured	JJ	O	O
and	CC	O	O
switched	VBD	O	O
from	IN	O	O
unasyn	NN	B-TREATMENT	B-TREATMENT
(	(	O	O
started	VBN	O	O
at	IN	O	O
osh	NN	O	O
for	IN	O	O
foot	JJ	B-PROBLEM	B-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
)	)	O	O
to	TO	O	O
zosyn	VB	B-TREATMENT	B-TREATMENT
.	.	O	O

vanco	NN	B-TREATMENT	O
was	VBD	O	O
added	VBN	O	O
for	IN	O	O
possible	JJ	O	O
nosocomial	JJ	B-PROBLEM	B-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

cta	NN	B-TEST	O
was	VBD	O	O
performed	VBN	O	O
which	WDT	O	O
was	VBD	O	O
negative	JJ	O	O
for	IN	O	O
pe	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
but	CC	O	O
revealed	VBD	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
patchy	NN	I-PROBLEM	I-PROBLEM
ground	NN	I-PROBLEM	I-PROBLEM
glass	NN	I-PROBLEM	I-PROBLEM
opacities	NNS	I-PROBLEM	I-PROBLEM
c/w	VBP	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
vs.	FW	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
vs.	FW	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

pt	NN	O	O
was	VBD	O	O
weaned	VBN	O	O
down	RP	O	O
on	IN	O	O
ventilator	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
minimal	JJ	B-PROBLEM	B-PROBLEM
secretions	NNS	I-PROBLEM	I-PROBLEM
noted	VBD	O	O
.	.	O	O

on	IN	O	O
03-27	JJ	O	O
,	,	O	O
pt	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
depressed	VBN	B-PROBLEM	B-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
off	IN	O	O
all	DT	B-TREATMENT	B-TREATMENT
sedating	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
;	:	O	O
mental	JJ	O	O
status	NN	O	O
improved	VBN	O	O
over	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
the	DT	O	O
day	NN	O	O
.	.	O	O

atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
rate-controlled	VBN	O	O
on	IN	O	O
dilt	JJ	B-TREATMENT	B-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

dilt	JJ	B-TREATMENT	B-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
and	CC	O	O
metoprolol	RB	B-TREATMENT	B-TREATMENT
titrated	VBD	O	O
up	RP	O	O
.	.	O	O

cardiac	JJ	B-TEST	B-TEST
enzymes	NNS	I-TEST	I-TEST
were	VBD	O	O
cycled	VBN	O	O
in	IN	O	O
setting	NN	O	O
of	IN	O	O
rapid	JJ	B-PROBLEM	B-PROBLEM
af	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
were	VBD	O	O
flat	JJ	O	O
.	.	O	O

initially	RB	O	O
,	,	O	O
pt	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
dry	JJ	B-PROBLEM	O
with	IN	O	O
low	JJ	B-PROBLEM	B-PROBLEM
fena	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
given	VBN	O	O
ivf	NNS	B-TREATMENT	O
.	.	O	O

then	RB	O	O
,	,	O	O
noted	VBD	O	O
to	TO	O	O
be	VB	O	O
volume	NN	B-PROBLEM	B-PROBLEM
overloaded	VBN	I-PROBLEM	I-PROBLEM
and	CC	O	O
diuresed	VBN	O	O
with	IN	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

pt	NN	O	O
had	VBD	O	O
depressed	VBN	B-PROBLEM	B-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
transfer	NN	O	O
to	TO	O	O
cmed	VB	O	O
in	IN	O	O
setting	NN	O	O
of	IN	O	O
narcotics	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
then	RB	O	O
started	VBN	O	O
on	IN	O	O
propofol	NN	B-TREATMENT	B-TREATMENT
while	IN	O	O
intubated	VBN	B-TREATMENT	B-TREATMENT
.	.	O	O

head	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
for	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
mass	NN	B-PROBLEM	B-PROBLEM
effect	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
stroke	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

mental	JJ	O	O
status	NN	O	O
improved	VBD	O	O
during	IN	O	O
times	NNS	O	O
when	WRB	O	O
propofol	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
held	VBN	O	O
.	.	O	O

on	IN	O	O
03-27	JJ	O	O
,	,	O	O
pt	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
significantly	RB	B-PROBLEM	O
depressed	VBN	I-PROBLEM	O
m.s.	NN	I-PROBLEM	O
off	IN	O	O
propol	NN	B-TREATMENT	B-TREATMENT
improved	VBD	O	O
off	RP	O	O
sedation	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

all	DT	B-TREATMENT	B-TREATMENT
sedating	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
including	VBG	O	O
prn	NN	B-TREATMENT	O
narcotics	NNS	I-TREATMENT	O
were	VBD	O	O
held	VBN	O	O
and	CC	O	O
mental	JJ	O	O
status	NN	O	O
cleared	VBD	O	O
somewhat	RB	O	O
.	.	O	O

s/p	JJ	O	B-TREATMENT
hip	NN	B-TREATMENT	I-TREATMENT
fx	JJ	I-TREATMENT	I-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT
:	:	O	O
started	VBN	O	O
on	IN	O	O
lovenox	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
anti-coagulation	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

given	VBN	O	O
standing	VBG	B-TREATMENT	B-TREATMENT
nsaid	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
tylenol	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
pain	NN	B-TREATMENT	B-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

opiates	NNS	B-TREATMENT	B-TREATMENT
used	VBD	O	O
very	RB	O	O
sparingly	RB	O	O
in	IN	O	O
setting	VBG	O	O
of	IN	O	O
ms	NNS	B-PROBLEM	B-PROBLEM
change	VBP	I-PROBLEM	I-PROBLEM

resp	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
/	JJ	O	O
copd	NN	B-PROBLEM	O
:	:	O	O

initially	RB	O	O
got	VBD	O	O
steroids	NNS	B-TREATMENT	B-TREATMENT
upon	IN	O	I-TREATMENT
intubation	NN	B-TREATMENT	I-TREATMENT
.	.	O	O

still	RB	O	O
tachypneic	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	I-PROBLEM
hypoxic	NN	B-PROBLEM	I-PROBLEM
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

?	.	O	O
copd	NN	B-PROBLEM	O
vs	NN	O	O
atelectasis	NN	B-PROBLEM	B-PROBLEM
as	IN	O	O
cause	NN	O	O
of	IN	O	O
hypoxia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

-	:	O	O
atrovent	NN	B-TREATMENT	B-PROBLEM
standing	NN	O	I-PROBLEM
.	.	O	O

prn	NN	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
only	RB	O	O
given	VBN	O	O
a	DT	B-PROBLEM	B-PROBLEM
fib	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
rvr	NN	B-PROBLEM	O

-	:	O	O
inhaled	VBD	B-TREATMENT	B-TREATMENT
steroids	NNS	I-TREATMENT	I-TREATMENT

fever	NN	B-PROBLEM	B-PROBLEM
:	:	O	O

had	VBD	O	O
received	VBN	O	O
unasyn	JJ	B-TREATMENT	B-TREATMENT
,	,	O	O
vanc	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
zosyn	NN	B-TREATMENT	B-TREATMENT
during	IN	O	O
hospital	JJ	O	O
course	NN	O	O
for	IN	O	O
cellulitis	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
other	JJ	O	O
unclear	JJ	O	O
reasons	NNS	O	O
,	,	O	O
including	VBG	O	O
possible	JJ	O	O
vent	NN	B-PROBLEM	B-TREATMENT
associated	VBN	I-PROBLEM	O
pna	NN	I-PROBLEM	O
.	.	O	O

afebrile	JJ	B-PROBLEM	B-PROBLEM
>	$	O	O
24	CD	O	O
hours	NNS	O	O
off	IN	O	O
abx	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

-	:	O	O
culture	NN	B-TEST	O
if	IN	O	O
spikes	NNS	O	B-PROBLEM
.	.	O	O

no	DT	O	O
abx	NN	B-TREATMENT	B-PROBLEM
unless	IN	O	O
source	NN	O	O
found	VBD	O	O

a.fib	NN	B-PROBLEM	O
with	IN	O	O
rvr	NN	B-PROBLEM	O
-	:	O	O
has	VBZ	O	O
ppm	VBN	B-TREATMENT	O
,	,	O	O
so	RB	O	O
can	MD	O	O
have	VB	O	O
lot	NN	O	O
of	IN	O	O
nodal	JJ	B-TREATMENT	B-TREATMENT
agents	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

now	RB	O	O
rate	NN	O	O
controlled	VBN	O	O
on	IN	O	O
metop	NN	B-TREATMENT	O
125	CD	O	O
tid	NN	O	O
and	CC	O	O
dilt	NN	B-TREATMENT	O
.	.	O	O

-	:	O	O
continue	NN	O	O
nodal	JJ	B-TREATMENT	B-TREATMENT
agents	NNS	I-TREATMENT	I-TREATMENT

-	:	O	O
consider	NN	O	O
anti	NNS	B-TREATMENT	O
coag	NN	I-TREATMENT	O
for	IN	O	O
cva	NN	B-TREATMENT	O
prevention	NN	I-TREATMENT	O
,	,	O	O
but	CC	O	O
wait	VBP	O	O
until	IN	O	O
ambulating	VBG	O	O
better	JJR	O	O

cad	NN	B-PROBLEM	O
:	:	O	O
on	IN	O	O
asa	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
b	NN	B-TREATMENT	O
blocker	NN	I-TREATMENT	O
,	,	O	O
ace	NN	B-TREATMENT	O
.	.	O	O

no	DT	O	O
statin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

heme	NN	O	B-TEST
-	:	O	O
anemic	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

possible	JJ	O	O
anemia	NN	B-PROBLEM	B-PROBLEM
03-02	JJ	O	I-PROBLEM
operative	JJ	B-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

follow	JJ	O	O
hct	VBD	B-TEST	O
daily	JJ	O	O
goal	NN	O	O
>	VBD	O	O
28	CD	O	O

had	VBD	O	O
fall	NN	O	B-PROBLEM
pta	NN	O	I-PROBLEM
with	IN	O	O
?	.	O	O
fx	NN	B-PROBLEM	O
on	IN	O	O
initial	JJ	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
,	,	O	O
neg	JJ	O	B-PROBLEM
fx	NN	B-PROBLEM	I-PROBLEM
on	IN	O	O
f/u	JJ	B-TEST	O
ct	NN	I-TEST	O
.	.	O	O

-	:	O	O
flex	NN	B-TEST	O
/	NNP	I-TEST	O
ext	NN	I-TEST	O
films	NNS	I-TEST	O
done	VBN	O	O

-	:	O	O
will	MD	O	O
clear	VB	O	O
with	IN	O	O
neursurg	JJ	O	O
prior	JJ	O	O
to	TO	O	O
removing	VBG	O	B-PROBLEM
hard	JJ	B-TREATMENT	I-PROBLEM
collar	NN	I-TREATMENT	I-PROBLEM

overnight	VBN	O	O
on	IN	O	O
pt	NN	O	O
's	POS	O	O
first	JJ	O	O
evening	NN	O	O
on	IN	O	O
the	DT	O	O
floor	NN	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
episode	NN	O	O
of	IN	O	O
desaturation	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
inc	JJ	B-PROBLEM	B-TREATMENT
o2	JJ	I-PROBLEM	I-TREATMENT
requirement	NN	I-PROBLEM	I-TREATMENT
(	(	O	O
4l	CD	O	O
->	RB	O	O
6l	CD	O	O
->	JJ	O	O
sating	VBG	B-TEST	O
91%	CD	O	O
on	IN	O	O
nrb	NN	B-TREATMENT	O
)	)	O	O
-	:	O	O
cxr	NN	B-TEST	O
with	IN	O	O
worsening	VBG	B-PROBLEM	O
-	:	O	O
non	NN	O	O
responsive	NN	O	O
to	TO	O	O
lasix	VB	B-TREATMENT	B-TREATMENT
.	.	O	O

family	NN	O	O
meeting	NN	O	O
held	VBD	O	O
and	CC	O	O
pt	NNS	O	O
made	VBD	O	O
clear	JJ	O	O
wishes	NNS	O	O
after	IN	O	O
extubation	NN	B-TREATMENT	O
that	IN	O	O
she	PRP	O	O
does	VBZ	O	O
not	RB	O	O
want	VB	O	O
to	TO	O	O
be	VB	O	O
intubated	VBN	O	O
again	RB	O	O
and	CC	O	O
made	VBD	O	O
dnr	NNS	B-TREATMENT	O
/	JJ	O	O
dni	NN	B-TREATMENT	O
.	.	O	O

no	DT	O	O
bipap	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

now	RB	O	O
pt	VBZ	O	O
lethargic	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
min	NN	B-PROBLEM	O
responsive	NN	I-PROBLEM	O
.	.	O	O

all	DT	O	O
four	CD	O	O
children	NNS	O	O
in	IN	O	O
pts	NNS	O	O
room	NN	O	O
and	CC	O	O
agree	VB	O	O
on	IN	O	O
cmo	NNS	B-TREATMENT	O
-	:	O	O
want	VBP	O	O
to	TO	O	O
d/c	VB	O	O
c-collar	JJ	B-TREATMENT	O
and	CC	O	O
start	JJ	O	B-TREATMENT
morphine	NN	B-TREATMENT	I-TREATMENT
ggt	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

although	IN	O	O
dr.	JJ	O	O
ray	NN	O	O
will	MD	O	O
be	VB	O	O
covering	VBG	O	O
pt	JJ	O	O
today	NN	O	O
,	,	O	O
dr.	NN	O	O
stephanie	NN	O	O
wilson	NN	O	O
spoke	VBD	O	O
with	IN	O	O
family	NN	O	O
this	DT	O	O
morning	NN	O	O
and	CC	O	O
has	VBZ	O	O
noted	VBN	O	O
that	IN	O	O
pt	NN	O	O
is	VBZ	O	O
cmo	JJ	B-TREATMENT	O
.	.	O	O

ep	NN	O	O
was	VBD	O	O
called	VBN	O	O
to	TO	O	O
deactivate	VB	O	O
pt	JJ	O	O
dual	JJ	B-TREATMENT	O
chamber	NN	I-TREATMENT	O
icd	NN	I-TREATMENT	O
as	IN	O	O
per	IN	O	O
family	NN	O	O
wishes	NNS	O	O
.	.	O	O

on	IN	O	O
exam	NN	B-TEST	B-TEST
,	,	O	O
pt	NN	O	O
lethargic	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
responsive	JJ	O	O
to	TO	O	O
pain	VB	B-PROBLEM	B-PROBLEM
but	CC	O	O
not	RB	O	O
voice	NN	O	O
,	,	O	O
with	IN	O	O
nrb	NN	B-TREATMENT	O
in	IN	O	O
place	NN	O	O
;	:	O	O
obvious	JJ	B-PROBLEM	O
inc	NN	I-PROBLEM	O
wob	NN	I-PROBLEM	O
.	.	O	O

iv	NN	B-TREATMENT	O
in	IN	I-TREATMENT	O
r	JJ	I-TREATMENT	O
foot	NN	I-TREATMENT	O
for	IN	O	O
access	NN	O	O
.	.	O	O

afebrile	NN	B-PROBLEM	B-PROBLEM
;	:	O	O

bp	NN	B-TEST	O
:	:	O	O
159-161-139-98	JJ	O	O
(	(	O	O
after	IN	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
)/	NN	O	I-TREATMENT
69	CD	O	O
hr	NN	B-TEST	O
:	:	O	O
148	CD	O	O
-->	$	O	O
88	CD	O	O
;	:	O	O
rr	NN	B-TEST	O
:	:	O	O
28-40	JJ	O	O
o2	NN	B-TEST	O
:	:	O	O
94%	CD	O	O
nrb	NN	B-TREATMENT	O

as	IN	O	O
above	NN	O	O
,	,	O	O
made	VBN	O	O
cmo	NN	B-TREATMENT	O
after	IN	O	O
meeting	VBG	O	O
with	IN	O	O
nf	JJ	O	O
team	NN	O	O
and	CC	O	O
family	NN	O	O
and	CC	O	O
reconfirmed	VBN	O	O
with	IN	O	O
primary	JJ	O	O
medical	JJ	O	O
team	NN	O	O
on	IN	O	O
04-02	NN	O	O
.	.	O	O

start	NN	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
ggt	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
titrate	NN	O	O
to	TO	O	O
comfort	NN	O	O
.	.	O	O

d/c	NN	O	B-TEST
'ed	POS	O	I-TEST
all	DT	B-TEST	I-TEST
lab	NN	I-TEST	I-TEST
draws	VBZ	I-TEST	I-TEST
/	JJ	O	I-TEST
vitals	NNS	B-TEST	I-TEST
.	.	O	O

prn	NN	B-TREATMENT	O
nebs	NN	I-TREATMENT	B-TREATMENT
for	IN	O	O
comfort	NN	O	O
.	.	O	O

morhpine	NN	B-TREATMENT	O
ggt	NN	I-TREATMENT	O
titrated	VBD	O	O
up	RB	O	O
to	TO	O	O
18	CD	O	O
mg	NNS	O	O
/	JJ	O	O
hr	NN	O	O
by	IN	O	O
monday	JJ	O	O
morning	NN	O	O
and	CC	O	O
pt	NN	O	O
expired	VBD	O	O
04-04	CD	O	O
at	IN	O	O
7:40	CD	O	O
am	VBP	O	O
.	.	O	O

1.	CD	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
2	CD	O	O
mg	NN	O	O
once	RB	O	O
daily	JJ	O	O
(	(	O	O
stopped	VBN	O	O
recently	RB	O	O
due	JJ	O	O
to	TO	O	O
risk	NN	O	O
of	IN	O	O
gi	NNS	B-PROBLEM	B-PROBLEM
bleed	VBN	I-PROBLEM	I-PROBLEM
)	)	O	I-PROBLEM

2.	CD	O	O
zoloft	JJ	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
once	RB	O	O
daily	JJ	O	O

3.	CD	O	O
toprol	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
bid	NN	O	O

4.	CD	O	O
lasix	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NNS	O	O
bid	NN	O	O

5.	CD	O	O
as	IN	B-TREATMENT	O
81	CD	O	O
mg	NN	O	O
once	RB	O	O
daily	JJ	O	O

6.	CD	O	O
plavix	JJ	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
once	RB	O	O
daily	JJ	O	O

7.	CD	O	O
kcl	$	B-TREATMENT	B-TREATMENT
40	CD	O	O
meq	NN	O	O
once	RB	O	O
daily	JJ	O	O

8.	CD	O	O
prandin	JJ	B-TREATMENT	B-TREATMENT
0.5	CD	O	O
mg	NN	O	O
once	RB	O	O
daily	JJ	O	O

9.	CD	O	O
unasyn	JJ	B-TREATMENT	B-TREATMENT
3	CD	O	I-TREATMENT
giv	NN	O	I-TREATMENT
q8hours	NNS	O	I-TREATMENT

morphine	NN	B-TREATMENT	B-TREATMENT
->	NNP	O	O
confusion	NN	B-PROBLEM	B-PROBLEM
/	NNP	O	O
delerium	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

adult	NN	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	JJ	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

adult	NN	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	JJ	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

acute	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
72	CD	O	O
year	NN	O	O
old	JJ	O	O
white	JJ	O	O
male	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
four	CD	I-TREATMENT	I-TREATMENT
vessel	NN	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
1983	CD	O	O
,	,	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hepatitis	NN	B-PROBLEM	B-PROBLEM
c	NNS	I-PROBLEM	I-PROBLEM
positive	JJ	O	I-PROBLEM
cirrhosis	NN	B-PROBLEM	I-PROBLEM
history	NN	O	I-PROBLEM
with	IN	O	O
history	NN	O	O
of	IN	O	O
portal	JJ	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
status	NN	O	O
post	NN	O	O
an	DT	B-PROBLEM	B-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
gastrointestinal	JJ	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
4-10-98	JJ	O	O
,	,	O	O
who	WP	O	O
presents	VBZ	O	O
from	IN	O	O
sondi	JJ	O	O
memorial	NN	O	O
for	IN	O	O
work	NN	B-TEST	O
up	RB	I-TEST	O
of	IN	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
infiltrates	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
presented	VBD	O	O
to	TO	O	O
sondi	VB	O	O
memorial	JJ	O	O
on	IN	O	O
4-10-98	JJ	O	O
with	IN	O	O
fatigue	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
fall	NN	O	B-PROBLEM
,	,	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
of	IN	O	O
29	CD	O	O
,	,	O	O
baseline	NN	O	B-TEST
37	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transfused	VBN	O	O
two	CD	B-TREATMENT	O
units	NNS	I-TREATMENT	O
and	CC	O	O
an	DT	B-TEST	B-TEST
esophagogastroduodenoscopy	NN	I-TEST	I-TEST
done	VBN	O	O
where	WRB	O	O
it	PRP	O	O
showed	VBD	O	O
gastritis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
candidal	JJ	B-PROBLEM	B-PROBLEM
esophagitis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
portal	JJ	B-PROBLEM	B-PROBLEM
hypertensive	NN	I-PROBLEM	I-PROBLEM
gastropathy	NN	I-PROBLEM	I-PROBLEM
without	IN	O	I-PROBLEM
varices	NNS	B-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
colonoscopy	NN	I-TEST	I-TEST
showed	VBD	O	O
anteriordysplasia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
bleeding	NN	B-PROBLEM	B-PROBLEM
was	VBD	O	O
seen	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
discharged	VBN	O	O
after	IN	O	O
one	CD	O	O
week	NN	O	O
on	IN	O	O
iron	NN	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
4-24	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
seen	VBN	O	O
again	RB	O	O
at	IN	O	O
sondi	JJ	O	O
memorial	NN	O	O
when	WRB	O	O
he	PRP	O	O
experienced	VBD	O	O
at	IN	O	O
home	NN	O	O
a	DT	O	O
fall	NN	O	O
,	,	O	O
no	DT	O	O
loss	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
consciousness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
positive	JJ	O	B-PROBLEM
substernal	JJ	B-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
pleuritic	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
cough	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
went	VBD	O	O
to	TO	O	O
sondi	VB	O	O
memorial	JJ	O	O
where	WRB	O	O
he	PRP	O	O
ruled	VBD	O	O
out	RP	O	O
for	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
left	VBN	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
infiltrate	NN	I-PROBLEM	I-PROBLEM
/	NNP	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
started	VBD	O	O
on	IN	O	O
cefuroxime	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

his	PRP$	O	B-PROBLEM
respiratory	NN	O	I-PROBLEM
condition	NN	O	I-PROBLEM
continued	VBD	O	O
to	TO	O	O
deteriorate	VB	O	O
despite	IN	O	O
aggressive	JJ	B-TREATMENT	B-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
physical	JJ	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
possible	JJ	O	O
blood	NN	O	O
,	,	O	O
given	VBN	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
became	VBD	O	O
hypotensive	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
hypoxic	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
intubated	JJ	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
expanding	VBG	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
infiltrates	NNS	I-PROBLEM	I-PROBLEM
on	IN	O	O
chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
,	,	O	O
developed	VBD	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
minimal	JJ	B-PROBLEM	B-PROBLEM
urine	JJ	I-PROBLEM	I-PROBLEM
output	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
less	JJR	O	O
than	IN	O	O
10	CD	O	O
cc	NNS	O	O
an	DT	O	O
hour	NN	O	O
,	,	O	O
started	VBD	O	O
on	IN	O	O
dopamine	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
hemodynamic	JJ	B-PROBLEM	B-PROBLEM
instability	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
was	VBD	O	O
obtained	VBN	O	O
on	IN	O	O
4-26	JJ	O	O
which	WDT	O	O
showed	VBD	O	O
concentric	JJ	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
normal	JJ	O	O
_____	NN	O	O
left	VBD	O	O
ventricular	JJ	O	O
function	NN	O	O
,	,	O	O
severe	RB	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
dilatation	NN	I-PROBLEM	I-PROBLEM
with	IN	O	I-PROBLEM
septal	JJ	B-PROBLEM	I-PROBLEM
hypokinesis	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
flattening	VBG	I-PROBLEM	O
with	IN	O	O
a	DT	O	O
question	NN	O	O
of	IN	O	O
right	JJ	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
apical	JJ	I-PROBLEM	I-PROBLEM
clot	NN	I-PROBLEM	I-PROBLEM
raised	VBN	O	O
with	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
tricuspid	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
increased	VBD	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
pressure	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
approximately	RB	O	O
70	CD	O	O
millimeters	NNS	O	O
,	,	O	O
consistent	JJ	O	O
with	IN	O	O
fairly	RB	B-PROBLEM	B-PROBLEM
severe	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
x	VBP	O	O
two	CD	O	O
sent	VBD	O	O
off	IN	O	O
with	IN	O	O
no	DT	O	O
growth	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
ruled	VBD	O	O
out	RP	O	O
for	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
flat	JJ	O	B-TREATMENT
creatine	NN	B-TEST	I-TREATMENT
kinases	NNS	I-TEST	I-TREATMENT
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
sent	VBN	O	O
to	TO	O	O
oaksgekesser/	VB	O	O
memorial	JJ	O	O
hospital	NN	O	O
for	IN	O	O
further	JJ	B-TEST	O
work	NN	I-TEST	O
up	RB	I-TEST	O
.	.	O	O

at	IN	O	O
the	DT	O	O
oaksgekesser/	JJ	O	O
memorial	JJ	O	O
hospital	NN	O	O
he	PRP	O	O
was	VBD	O	O
quite	RB	B-PROBLEM	O
hypotensive	JJ	I-PROBLEM	O
,	,	O	O
requiring	VBG	O	O
dopamine	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
1,000	CD	O	O
,	,	O	O
levo	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
12	CD	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	JJ	I-TEST	I-TEST
showed	NN	O	O
diffuse	IN	B-PROBLEM	O
patchy	JJ	I-PROBLEM	B-PROBLEM
infiltrates	NNS	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
patchy	NN	I-PROBLEM	I-PROBLEM
infiltrates	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
right	JJ	B-PROBLEM	I-PROBLEM
hemidiaphragm	NN	I-PROBLEM	I-PROBLEM
elevated	VBD	I-PROBLEM	I-PROBLEM
,	,	O	O
consistent	JJ	O	O
with	IN	O	O
adult	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	JJ	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
possible	JJ	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
urinalysis	NN	I-TEST	I-TEST
was	VBD	O	O
obtained	VBN	O	O
which	WDT	O	O
showed	VBD	O	O
blood	NN	B-PROBLEM	B-TEST
,	,	O	I-TEST
urine	JJ	B-PROBLEM	I-TEST
sediment	NN	I-PROBLEM	I-TEST
was	VBD	O	O
active	JJ	B-PROBLEM	O
with	IN	O	O
positive	JJ	O	B-PROBLEM
dysmorphic	JJ	B-PROBLEM	I-PROBLEM
cells	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
red	JJ	B-PROBLEM	B-TEST
cell	NN	I-PROBLEM	I-TEST
casts	NNS	I-PROBLEM	I-TEST
,	,	O	O
and	CC	O	O
1+	CD	B-PROBLEM	O
albumin	NN	I-PROBLEM	B-TEST
with	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
protein	NN	I-PROBLEM	I-PROBLEM
uria	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
anca	VBN	B-TEST	O
,	,	O	O
anti-gbm	JJ	B-TEST	O
,	,	O	O
anti-streptolycin	JJ	B-TEST	O
,	,	O	O
ana	JJ	B-TEST	O
,	,	O	O
upep	JJ	B-TEST	O
,	,	O	O
spep	JJ	B-TEST	O
,	,	O	O
renal	JJ	B-TEST	B-TEST
ultrasound	NN	I-TEST	I-TEST
,	,	O	O
hepatitis	NN	B-TEST	B-PROBLEM
c	NNS	I-TEST	I-PROBLEM
cryoglobulin	VBP	I-TEST	I-PROBLEM
sent	VBN	O	O
out	RP	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
bronchoscopy	NN	I-TEST	I-TEST
immediately	RB	O	O
done	VBN	O	O
which	WDT	O	O
showed	VBD	O	O
no	DT	O	O
fresh	JJ	B-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
just	RB	O	O
old	JJ	B-PROBLEM	B-PROBLEM
clot	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-TREATMENT	B-TREATMENT
pulmonary	JJ	I-TREATMENT	I-TREATMENT
arterial	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
placed	VBN	O	O
in	IN	O	O
the	DT	O	O
right	JJ	O	O
internal	JJ	O	O
jugular	NN	O	O
vein	NN	O	O
.	.	O	O

question	NN	O	O
of	IN	O	O
pulmonary-renal	JJ	B-PROBLEM	B-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
raised	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
subsequently	RB	O	O
deteriorated	VBN	O	O
over	IN	O	O
time	NN	O	O
,	,	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
cvvh	NN	B-TREATMENT	O
and	CC	O	O
suffered	VBD	O	B-PROBLEM
significant	JJ	B-PROBLEM	I-PROBLEM
complications	NNS	I-PROBLEM	I-PROBLEM
without	IN	O	O
improvement	NN	O	O
of	IN	O	O
his	PRP$	O	B-PROBLEM
pulmonary	JJ	O	I-PROBLEM
/	NNP	O	I-PROBLEM
renal	JJ	O	I-PROBLEM
situation	NN	O	I-PROBLEM
.	.	O	O

a	DT	O	O
family	NN	O	O
meeting	NN	O	O
was	VBD	O	O
held	VBN	O	O
on	IN	O	O
5-2-98	JJ	O	O
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
should	MD	O	O
be	VB	O	O
made	VBN	O	O
comfort	NN	B-TREATMENT	O
care	NN	I-TREATMENT	O
only	RB	O	O
.	.	O	O

all	DT	O	O
cvvh	NN	B-TREATMENT	O
and	CC	O	O
the	DT	B-TREATMENT	B-TREATMENT
ventilator	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
removed	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
spontaneously	RB	O	O
passed	VBN	O	O
away	RP	O	O
on	IN	O	O
5-2-98	JJ	O	O
,	,	O	O
at	IN	O	O
4:55	CD	O	O
p.m.	NN	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
56	JJ	O	O
year-old	JJ	O	O
gentleman	NN	O	O
with	IN	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
reports	NNS	O	O
having	VBG	O	O
been	VBN	O	O
told	VBN	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
murmur	VBZ	I-PROBLEM	I-PROBLEM
many	JJ	O	O
years	NNS	O	O
ago	RB	O	O
but	CC	O	O
just	RB	O	O
recently	RB	O	O
diagnosed	VBN	O	O
with	IN	O	O
aortic	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
had	VBN	O	O
mild	VBN	B-PROBLEM	B-PROBLEM
dyspnea	NNS	I-PROBLEM	I-PROBLEM
on	IN	O	O
exertion	NN	O	O
increasing	VBG	O	O
over	IN	O	O
the	DT	O	O
past	JJ	O	O
couple	NN	O	O
of	IN	O	O
months	NNS	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
.	.	O	O

an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
in	IN	O	O
2011-09-05	JJ	O	O
revealed	VBD	O	O
a	DT	B-TEST	B-TEST
left	JJ	I-TEST	I-TEST
ventricular	JJ	I-TEST	I-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
20	CD	O	O
to	TO	O	O
25%	CD	O	O
.	.	O	O

2.	CD	O	O
insulin	NN	B-PROBLEM	B-PROBLEM
dependent	NN	I-PROBLEM	I-PROBLEM
diabetes	VBZ	I-PROBLEM	I-PROBLEM
mellitus	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
proteinuria	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

4.	CD	O	O
aortic	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

5.	CD	O	O
cellulitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

6.	CD	O	O
gangrene	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
second	JJ	I-PROBLEM	I-PROBLEM
toe	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
2010-06-06	JJ	O	O
followed	VBN	O	O
by	IN	O	O
an	DT	B-TREATMENT	B-PROBLEM
amputation	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

7.	CD	O	O
left	JJ	B-TREATMENT	B-TREATMENT
common	JJ	I-TREATMENT	I-TREATMENT
femoral	JJ	I-TREATMENT	I-TREATMENT
dorsalis	NN	I-TREATMENT	I-TREATMENT
pedis	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

8.	CD	O	O
right	JJ	B-TREATMENT	B-TREATMENT
leg	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
1999	CD	O	O
.	.	O	O

9.	CD	O	O
right	RB	B-TREATMENT	O
below	IN	I-TREATMENT	O
the	DT	I-TREATMENT	B-TREATMENT
knee	NN	I-TREATMENT	I-TREATMENT
amputation	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
2008	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
states	VBZ	O	O
he	PRP	O	O
has	VBZ	O	O
no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NN	O	O
po	NN	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

2.	CD	O	O
vasotec	JJ	B-TREATMENT	B-TREATMENT
7.5	CD	O	O
mg	NN	O	O
po	NN	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

3.	CD	O	O
humalog	NN	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
meals	NNS	O	O
and	CC	O	O
at	IN	O	O
bedtime	NN	O	O
.	.	O	O

4.	CD	O	O
humulin	NN	B-TREATMENT	B-TREATMENT
walters	NNS	I-TREATMENT	I-TREATMENT
insulin	VBP	I-TREATMENT	I-TREATMENT
24	CD	O	O
units	NNS	O	O
subcutaneous	JJ	O	O
q	JJ	O	O
a.m.	NN	O	O
and	CC	O	O
8	CD	O	O
to	TO	O	O
16	CD	O	O
in	IN	O	O
the	DT	O	O
evening	NN	O	O
depending	VBG	O	O
upon	IN	O	O
where	WRB	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
sugar	NN	I-TEST	I-TEST
has	VBZ	O	O
been	VBN	O	O
.	.	O	O

preoperative	JJ	B-TEST	B-TEST
laboratory	NN	I-TEST	I-TEST
values	NNS	I-TEST	I-TEST
were	VBD	O	O
unremarkable	JJ	O	O
.	.	O	O

the	DT	O	O
patient	JJ	O	O
underwent	JJ	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
on	IN	O	O
2011-10-17	JJ	O	O
which	WDT	O	O
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
20%	CD	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
vein	NN	I-PROBLEM	I-PROBLEM
osteal	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
70%	CD	B-PROBLEM	B-PROBLEM
lad	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
an	DT	B-PROBLEM	B-PROBLEM
80%	CD	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
coronary	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
on	IN	O	O
2011-10-18	JJ	O	O
where	WRB	O	O
he	PRP	O	O
underwent	VBD	O	O
an	DT	B-TREATMENT	B-TREATMENT
aortic	JJ	I-TREATMENT	I-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
#23	NNP	B-TREATMENT	O
mm	VBP	I-TREATMENT	O
pericardial	JJ	I-TREATMENT	B-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
as	RB	O	O
well	RB	O	O
as	IN	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
times	NNS	O	O
two	CD	O	O
with	IN	O	O
a	DT	O	B-PROBLEM
lima	NN	O	I-PROBLEM
to	TO	O	O
the	DT	O	O
lad	NN	O	O
and	CC	O	O
saphenous	JJ	O	B-PROBLEM
vein	NN	O	I-PROBLEM
to	TO	O	I-PROBLEM
the	DT	O	I-PROBLEM
acute	JJ	O	I-PROBLEM
marginal	NN	O	I-PROBLEM
.	.	O	O

postoperatively	RB	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transported	VBN	O	O
to	TO	O	O
the	DT	O	O
cardiac	NN	O	O
surgery	NN	O	O
recovery	NN	O	O
unit	NN	O	O
on	IN	O	O
milrinone	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
neo-synephrine	JJ	B-TREATMENT	O
and	CC	O	O
levophed	JJ	B-TREATMENT	B-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
weaned	VBN	O	O
from	IN	O	O
mechanical	JJ	B-TREATMENT	B-TREATMENT
ventilation	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
subsequently	RB	O	O
extubated	VBN	O	O
on	IN	O	O
the	DT	O	O
night	NN	O	O
of	IN	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
remained	VBD	O	O
on	IN	O	O
levophed	VBN	B-TREATMENT	O
,	,	O	O
milrinone	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
neo-synephrine	JJ	B-TREATMENT	B-TREATMENT
drips	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
was	VBD	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
.	.	O	O

n.	JJ	O	O
saez	NN	O	O
clinic	NN	O	O
consult	NN	O	O
was	VBD	O	O
obtained	VBN	O	O
due	JJ	O	O
to	TO	O	O
hyperglycemia	VB	B-PROBLEM	B-PROBLEM
and	CC	O	O
the	DT	O	O
need	NN	O	O
for	IN	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
the	DT	B-TREATMENT	O
milrinone	NN	I-TREATMENT	O
was	VBD	O	O
weaned	VBN	O	O
down	RP	O	O
.	.	O	O

the	DT	B-TREATMENT	O
levophed	VBN	I-TREATMENT	O
had	VBD	O	O
been	VBN	O	O
discontinued	VBN	O	O
as	IN	O	O
the	DT	B-TREATMENT	O
neo-synephrine	JJ	I-TREATMENT	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
beginning	VBG	O	O
to	TO	O	O
progress	VB	O	O
hemodynamically	RB	O	O
.	.	O	O

upon	IN	O	O
discontinuation	NN	O	O
of	IN	O	O
the	DT	B-TREATMENT	O
milrinone	NN	I-TREATMENT	O
the	DT	B-TEST	O
patient	NN	I-TEST	O
's	POS	I-TEST	O
sv02	NN	I-TEST	O
had	VBD	O	O
dropped	VBN	O	O
significantly	RB	O	O
in	IN	O	O
the	DT	O	O
low	JJ	O	O
50	CD	O	O
s.	NN	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
decreased	VBN	B-PROBLEM	B-PROBLEM
exercise	NN	I-PROBLEM	I-PROBLEM
tolerance	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
therefore	NN	O	O
was	VBD	O	O
placed	VBN	O	O
back	RP	O	O
on	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
milrinone	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
keep	VB	O	O
his	PRP$	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
index	NN	I-TEST	I-TEST
greater	JJR	O	O
than	IN	O	O
2.0	CD	O	O
.	.	O	O

over	IN	O	O
the	DT	O	O
next	JJ	O	O
couple	NN	O	O
of	IN	O	O
days	NNS	O	O
it	PRP	O	O
was	VBD	O	O
very	RB	O	O
slowly	RB	O	O
decreased	VBN	O	O
as	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
ace	NN	I-TREATMENT	I-TREATMENT
inhibitors	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
increased	VBN	O	O
orally	RB	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
ultimately	RB	O	O
was	VBD	O	O
weaned	VBN	O	O
off	RP	O	O
the	DT	B-TREATMENT	O
milrinone	NN	I-TREATMENT	O
,	,	O	O
transitioned	VBD	O	O
to	TO	O	O
captopril	VB	B-TREATMENT	B-TREATMENT
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
five	CD	O	O
and	CC	O	O
remained	VBD	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
.	.	O	O

once	RB	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
remained	VBN	O	O
off	IN	O	O
of	IN	O	O
inotropics	NNS	B-TREATMENT	O
for	IN	O	O
approximately	RB	O	O
24	CD	O	O
hours	NNS	O	O
,	,	O	O
he	PRP	O	O
had	VBD	O	O
been	VBN	O	O
given	VBN	O	O
diuretics	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
ace	NN	B-TREATMENT	B-TREATMENT
inhibitors	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
remained	VBD	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
from	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
to	TO	O	O
the	DT	O	O
telemetry	NN	O	O
floor	NN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
six	CD	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
physical	JJ	I-TEST	I-TEST
therapy	NN	I-TEST	I-TEST
evaluation	NN	I-TEST	I-TEST
was	VBD	O	O
obtained	VBN	O	O
for	IN	O	O
assistance	NN	O	O
and	CC	O	O
mobility	NN	O	O
.	.	O	O

cardiac	JJ	B-TREATMENT	B-TREATMENT
rehabilitation	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
initiated	VBN	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
.	.	O	O

it	PRP	O	O
was	VBD	O	O
their	PRP$	O	O
recommendation	NN	O	O
to	TO	O	O
continue	VB	O	O
ace	NN	B-TREATMENT	B-TREATMENT
inhibitors	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
to	TO	O	O
continue	VB	O	O
daily	JJ	B-TEST	O
weights	NNS	I-TEST	O
,	,	O	O
to	TO	O	O
switch	VB	O	O
the	DT	O	O
patient	NN	O	O
to	TO	O	O
a	DT	B-TREATMENT	O
long	JJ	I-TREATMENT	O
acting	JJ	I-TREATMENT	O
beta-blocker	NN	I-TREATMENT	O
and	CC	O	O
to	TO	O	O
enroll	VB	O	O
the	DT	O	O
patient	NN	O	O
in	IN	O	O
postoperative	JJ	B-TREATMENT	B-TREATMENT
cardiac	JJ	I-TREATMENT	I-TREATMENT
rehabilitation	NN	I-TREATMENT	I-TREATMENT
as	RB	O	O
well	RB	O	O
as	IN	O	O
to	TO	O	O
make	VB	O	O
sure	JJ	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
on	IN	O	O
statin	NN	B-TREATMENT	B-TREATMENT
drugs	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
over	IN	O	O
the	DT	O	O
next	JJ	O	O
few	JJ	O	O
days	NNS	O	O
,	,	O	O
continued	VBD	O	O
to	TO	O	O
increase	VB	O	O
with	IN	O	O
physical	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
ambulation	NN	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
sugars	NNS	I-TEST	I-TEST
were	VBD	O	O
followed	VBN	O	O
by	IN	O	O
the	DT	O	O
cape	NN	O	O
cod	NN	O	O
hospital	NN	O	O
clinic	JJ	O	O
service	NN	O	O
and	CC	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
has	VBZ	O	O
been	VBN	O	O
adjusted	VBN	O	O
accordingly	RB	O	O
.	.	O	O

temperature	NN	B-TEST	B-TEST
96.9	CD	O	O
f	NN	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
84	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
18	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
106/59	CD	O	O
.	.	O	O

most	RBS	B-TEST	O
recent	JJ	I-TEST	O
laboratory	NN	I-TEST	O
values	NNS	I-TEST	O
are	VBP	O	O
from	IN	O	O
2011-10-25	CD	O	O
which	WDT	O	O
revealed	VBD	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
8.4000	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
35	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
202,000.	CD	O	O
sodium	NN	B-TEST	B-TEST
133	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.4	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
93	CD	O	O
,	,	O	O
co2	NN	B-TEST	B-TEST
30	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
24	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
0.7	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
198	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
finger	NN	I-TEST	I-TEST
stick	VBD	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
glucose	NN	I-TEST	I-TEST
levels	NNS	I-TEST	I-TEST
range	VBP	O	O
from	IN	O	O
151	CD	O	O
to	TO	O	O
390	CD	O	O
over	IN	O	O
the	DT	O	O
past	JJ	O	O
24	CD	O	O
hours	NNS	O	O
and	CC	O	O
his	PRP$	B-TREATMENT	B-TEST
insulin	NN	I-TREATMENT	I-TEST
scale	NN	I-TREATMENT	I-TEST
has	VBZ	O	O
been	VBN	O	O
adjusted	VBN	O	O
upward	RB	O	O
to	TO	O	O
compensate	VB	O	O
for	IN	O	O
that	DT	O	O
.	.	O	O

pulmonary	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
he	PRP	O	O
is	VBZ	O	O
clear	JJ	O	O
upper	JJ	O	O
lobes	NN	O	O
,	,	O	O
diminished	VBD	B-PROBLEM	B-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
bases	NNS	I-PROBLEM	I-PROBLEM
left	VBD	O	I-PROBLEM
greater	JJR	O	I-PROBLEM
than	IN	O	I-PROBLEM
right	NN	O	I-PROBLEM
.	.	O	O

coronary	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
is	VBZ	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
.	.	O	O

his	PRP$	O	B-TEST
sternum	NN	O	I-TEST
is	VBZ	O	O
stable.	JJ	O	B-PROBLEM
his	PRP$	B-PROBLEM	I-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
clean	JJ	O	O
and	CC	O	O
dry	JJ	O	B-TREATMENT
steri	NN	B-TREATMENT	I-TREATMENT
strips	NNS	I-TREATMENT	I-TREATMENT
intact	JJ	O	O
.	.	O	O

his	PRP$	O	O
extremities	NNS	O	O
are	VBP	O	O
warm	JJ	O	O
and	CC	O	O
well	RB	O	O
perfused	VBN	O	O
with	IN	O	O
minimal	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
foot	NN	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
his	PRP$	O	O
right	JJ	O	O
stump	NN	O	O
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
able	JJ	O	O
to	TO	O	O
apply	VB	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
prosthesis	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
ambulate	NN	O	O
as	RB	O	O
well	RB	O	O
.	.	O	O

1.	CD	O	O
lasix	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
po	NN	O	O
bid	NN	O	O
.	.	O	O

2.	CD	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
20	CD	O	O
milliequivalents	NNS	O	O
po	JJ	O	O
bid	NN	O	O
.	.	O	O

3.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
po	NN	O	O
bid	NN	O	O
.	.	O	O

4.	CD	O	O
zantac	NN	B-TREATMENT	B-TREATMENT
150	CD	O	O
mg	NN	O	O
po	NN	O	O
bid	NN	O	O
.	.	O	O

5.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
.	.	O	O

6.	CD	O	O
captopril	NN	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
po	NN	O	O
tid	NN	O	O
.	.	O	O

7.	CD	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
0.25	CD	O	O
mg	NN	O	O
po	NN	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

8.	CD	O	O
atorvastatin	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
po	NN	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

9.	CD	O	O
toprol	NN	B-TREATMENT	B-TREATMENT
xl	VBD	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
po	NN	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

10.	CD	O	O
bollin	JJ	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
18	CD	O	O
units	NNS	O	O
subcutaneous	JJ	O	O
q	JJ	O	O
a.m.	NN	O	O
,	,	O	O
richard	JJ	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
14	CD	O	O
units	NNS	O	O
subcutaneous	JJ	O	O
q	CD	O	O
p.m.	NN	O	O

11.	CD	O	O
sliding	VBG	B-TREATMENT	B-TREATMENT
scale	JJ	I-TREATMENT	I-TREATMENT
humalog	NN	I-TREATMENT	I-TREATMENT
regular	JJ	I-TREATMENT	I-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
breakfast	NN	O	O
is	VBZ	O	O
blood	VBN	B-TEST	O
glucose	NN	I-TEST	B-TEST
of	IN	O	O
151	CD	O	O
to	TO	O	O
200	CD	O	O
equal	JJ	O	O
4	CD	O	O
units	NNS	O	O
,	,	O	O
201	CD	O	O
to	TO	O	O
250	CD	O	O
equal	JJ	O	O
6	CD	O	O
units	NNS	O	O
,	,	O	O
251	CD	O	O
to	TO	O	O
350	CD	O	O
equal	JJ	O	O
12	CD	O	O
units	NNS	O	O
,	,	O	O
greater	JJR	O	O
than	IN	O	O
350	CD	O	O
equals	NNS	O	O
15	CD	O	O
units	NNS	O	O
.	.	O	O

for	IN	O	O
lunch	NN	O	B-TEST
blood	NN	B-TEST	I-TEST
glucose	NN	I-TEST	I-TEST
of	IN	O	O
101	CD	O	O
to	TO	O	O
150	CD	O	O
equals	NNS	O	O
4	CD	O	O
units	NNS	O	O
,	,	O	O
151	CD	O	O
to	TO	O	O
200	CD	O	O
equals	NNS	O	O
7	CD	O	O
units	NNS	O	O
,	,	O	O
201	CD	O	O
to	TO	O	O
250	CD	O	O
equals	NNS	O	O
8	CD	O	O
units	NNS	O	O
,	,	O	O
251	CD	O	O
to	TO	O	O
350	CD	O	O
equals	NNS	O	O
12	CD	O	O
units	NNS	O	O
,	,	O	O
greater	JJR	O	O
than	IN	O	O
350	CD	O	O
equals	NNS	O	O
15	CD	O	O
units	NNS	O	O
.	.	O	O

dinner	NN	O	O
blood	NN	B-TEST	O
glucose	VBD	I-TEST	B-TEST
101	CD	O	O
to	TO	O	O
150	CD	O	O
equals	NNS	O	O
2	CD	O	O
units	NNS	O	O
,	,	O	O
151	CD	O	O
to	TO	O	O
200	CD	O	O
equals	NNS	O	O
3	CD	O	O
units	NNS	O	O
,	,	O	O
201	CD	O	O
to	TO	O	O
250	CD	O	O
equals	NNS	O	O
6	CD	O	O
units	NNS	O	O
,	,	O	O
251	CD	O	O
to	TO	O	O
350	CD	O	O
equals	NNS	O	O
12	CD	O	O
units	NNS	O	O
,	,	O	O
greater	JJR	O	O
than	IN	O	O
350	CD	O	O
equals	NNS	O	O
15	CD	O	O
units	NNS	O	O
.	.	O	O

1.	CD	O	O
aortic	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
type	NN	B-PROBLEM	B-PROBLEM
i	NN	I-PROBLEM	I-PROBLEM
diabetes	VBZ	I-PROBLEM	I-PROBLEM
mellitus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
vascular	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
also	RB	O	O
to	TO	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
his	PRP$	O	O
primary	JJ	O	O
care	NN	O	O
physician	NN	O	O
for	IN	O	O
diabetes	JJ	B-TREATMENT	B-PROBLEM
management	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
to	TO	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
dr.	NNS	O	O
east	RB	O	O
here	RB	O	O
at	IN	O	O
the	DT	O	O
heart	NN	O	O
failure	NN	O	O
clinic	NN	O	O
to	TO	O	O
continue	VB	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
cardiac	JJ	B-TREATMENT	B-TREATMENT
rehabilitation	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
heart	NN	B-TREATMENT	B-PROBLEM
failure	NN	I-TREATMENT	I-PROBLEM
management	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

acute	JJ	B-PROBLEM	B-PROBLEM
inferior	JJ	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

gout	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

stent	JJ	B-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	O
the	DT	I-TREATMENT	O
rca	NN	I-TREATMENT	O
on	IN	O	O
october	$	O	O
15	CD	O	O
,	,	O	O
1999	CD	O	O
.	.	O	O

right	JJ	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
and	CC	O	O
coronary	JJ	B-TEST	B-TEST
angiography	NN	I-TEST	I-TEST
on	IN	O	O
october	$	O	O
15	CD	O	O
,	,	O	O
1999	CD	O	O
.	.	O	O

aspirin	RB	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg.	NN	O	O
qday	NN	O	O
.	.	O	O

plavix	NN	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg.	NN	O	O
qday	NN	O	O
for	IN	O	O
four	CD	O	O
weeks	NNS	O	O
.	.	O	O

atenolol	RB	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg.	NN	O	O
qday	NN	O	O
.	.	O	O

mr.	NN	O	O
factor	NN	O	O
is	VBZ	O	O
a	DT	O	O
76	CD	O	O
year	NN	O	O
old	JJ	O	O
white	JJ	O	O
male	NN	O	O
with	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
inferior	JJ	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
who	WP	O	O
was	VBD	O	O
urgently	RB	O	O
transferred	VBN	O	O
by	IN	O	O
dr.	JJ	O	O
lenni	NNS	O	O
factor	NN	O	O
for	IN	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
and	CC	O	O
possible	JJ	O	O
angioplasty	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

his	PRP$	O	O
only	JJ	O	O
cardiac	JJ	O	O
risk	NN	O	O
factor	NN	O	O
includes	VBZ	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
night	NN	O	O
of	IN	O	O
oct	NN	O	O
14	CD	O	O
,	,	O	O
1999	CD	O	O
the	DT	O	O
patient	NN	O	O
developed	VBD	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
discomfort	NN	I-PROBLEM	I-PROBLEM
associated	VBN	O	O
with	IN	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
showed	VBD	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
inferior	JJ	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

due	JJ	O	O
to	TO	O	O
unknown	JJ	O	O
duration	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
chest	JJS	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
the	DT	O	O
patient	NN	O	O
wastransferred	VBD	O	O
urgently	RB	O	O
to	TO	O	O
the	DT	O	O
tgcho	NN	O	O
for	IN	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
.	.	O	O

shortly	RB	O	O
after	IN	O	O
aggrastat	NN	B-TREATMENT	O
was	VBD	O	O
started	VBN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
became	VBD	O	O
pain	JJ	B-PROBLEM	B-PROBLEM
free	JJ	O	O
.	.	O	O

hypertension	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
gout	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
115/77	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
64	CD	O	O
.	.	O	O

jvp	NN	B-TEST	O
6	CD	O	O
cm	NN	O	O
.	.	O	O

carotid	NN	B-TEST	B-PROBLEM
upstroke	NN	I-TEST	I-PROBLEM
was	VBD	O	O
normal	JJ	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
an	DT	B-PROBLEM	O
s4	NN	I-PROBLEM	O
.	.	O	O

femoral	JJ	B-TEST	O
and	CC	I-TEST	O
distal	JJ	I-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
were	VBD	O	O
full	JJ	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
pedaledema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
neurological	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
nonfocal	JJ	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
normal	JJ	O	O
sinus	NN	O	O
rhythm	NN	O	O
at	IN	O	O
62	CD	O	O
beats	NNS	O	O
per	IN	O	O
minute	NN	O	O
,	,	O	O
small	JJ	B-PROBLEM	B-PROBLEM
qwaves	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
3	CD	I-PROBLEM	O
and	CC	I-PROBLEM	O
f	NNS	I-PROBLEM	O
,	,	O	O
st	JJ	B-PROBLEM	B-PROBLEM
elevation	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
2	CD	I-PROBLEM	O
,	,	I-PROBLEM	O
3	CD	I-PROBLEM	O
,	,	I-PROBLEM	O
and	CC	I-PROBLEM	O
f.	JJ	I-PROBLEM	B-PROBLEM
st	NN	B-PROBLEM	I-PROBLEM
depression	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
1	CD	I-PROBLEM	O
,	,	I-PROBLEM	O
l	NN	I-PROBLEM	O
and	CC	I-PROBLEM	O
v2	NN	I-PROBLEM	O
and	CC	I-PROBLEM	O
3	CD	I-PROBLEM	O
.	.	O	O

peak	NN	B-TEST	B-TEST
cpk	NN	I-TEST	I-TEST
1117	CD	O	O
.	.	O	O

total	JJ	B-TEST	B-TEST
cholesterol	NN	I-TEST	I-TEST
142	CD	O	O
.	.	O	O

ldl	RB	B-TEST	O
56	CD	O	O
.	.	O	O

hdl	NN	B-TEST	B-TREATMENT
30	CD	O	O
.	.	O	O

triglycerides	NNS	B-TEST	B-TEST
281	CD	O	O
.	.	O	O

coronary	JJ	B-TEST	B-TEST
angiography	NN	I-TEST	I-TEST
,	,	O	I-TEST
right	JJ	B-TEST	I-TEST
heart	NN	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
and	CC	O	O
percutaneous	JJ	B-TREATMENT	B-TREATMENT
intervention	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
rca	NN	I-TREATMENT	I-TREATMENT
were	VBD	O	O
performed	VBN	O	O
from	IN	O	O
the	DT	O	O
right	JJ	O	O
groin	NN	O	O
without	IN	O	O
complications	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
proximal	JJ	O	O
rca	NN	O	O
was	VBD	O	O
totally	RB	B-PROBLEM	O
occluded	VBN	I-PROBLEM	O
with	IN	O	O
good	JJ	O	O
left	NN	O	O
to	TO	O	O
right	JJ	O	O
collaterals	NNS	O	O
.	.	O	O

the	DT	O	O
lad	NN	O	O
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
40%	CD	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
proximal	JJ	I-PROBLEM	I-PROBLEM
segment	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
circumflex	NN	O	O
showed	VBD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
atherosclerotic	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	B-TEST
rca	NN	I-PROBLEM	I-TEST
occlusion	NN	I-PROBLEM	I-TEST
was	VBD	O	O
successfully	RB	O	O
dilated	VBN	O	O
and	CC	O	O
sent	VBN	O	O
using	VBG	O	O
a	DT	B-TREATMENT	O
3.0	CD	I-TREATMENT	O
x	NN	I-TREATMENT	O
23	CD	I-TREATMENT	O
mm	NN	I-TREATMENT	O
duet	NN	I-TREATMENT	O
with	IN	O	O
post	NN	B-TREATMENT	O
stent	NN	I-TREATMENT	B-TREATMENT
dilatation	NN	I-TREATMENT	I-TREATMENT
up	RB	O	O
to	TO	O	O
16	CD	O	O
atmospheres	NNS	O	O
.	.	O	O

following	VBG	O	O
intervention	NN	B-TREATMENT	B-TEST
right	JJ	B-TEST	I-TEST
heart	NN	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
to	TO	O	O
rule	VB	O	O
out	RP	O	O
rv	NN	B-PROBLEM	B-PROBLEM
infarct	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	O
ra	NN	I-TEST	O
was	VBD	O	O
5	CD	O	O
.	.	O	O

pa	NN	B-TEST	O
was	VBD	O	O
19/7	CD	O	O
with	IN	O	O
a	DT	B-TEST	O
mean	NN	I-TEST	O
of	IN	O	O
13	CD	O	O
.	.	O	O

pcw	NN	B-TEST	O
was	VBD	O	O
11	CD	O	O
.	.	O	O

of	IN	O	O
note	NN	O	O
there	EX	O	O
was	VBD	O	O
a	DT	B-PROBLEM	O
clear	JJ	I-PROBLEM	O
a	DT	I-PROBLEM	O
wave	NN	I-PROBLEM	O
in	IN	O	O
the	DT	B-TEST	O
rv	NN	I-TEST	O
tracing	NN	I-TEST	O
,	,	O	O
suggestive	NN	O	O
of	IN	O	O
rv	NN	B-PROBLEM	B-PROBLEM
infarct	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
next	JJ	O	O
day	NN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
quite	RB	B-PROBLEM	O
confused	JJ	I-PROBLEM	B-PROBLEM
and	CC	O	O
disoriented	VBN	B-PROBLEM	B-PROBLEM
,	,	O	O
which	WDT	O	O
gradually	RB	O	O
disappeared	VBD	O	O
.	.	O	O

an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
to	TO	O	O
evaluate	VB	O	O
the	DT	B-TEST	O
lv	NN	I-TEST	O
function	NN	I-TEST	O
,	,	O	O
which	WDT	O	O
showed	VBD	O	O
an	DT	B-TEST	B-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
53%	CD	O	O
with	IN	O	O
inferoposteriorakinesis	NN	B-PROBLEM	B-TREATMENT
/	JJ	O	O
hypokinesis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
next	JJ	O	O
day	NN	O	O
the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
mental	JJ	O	O
status	NN	O	O
came	VBD	O	O
back	RB	O	O
to	TO	O	O
baseline	NN	O	O
and	CC	O	O
he	PRP	O	O
remained	VBD	O	O
free	JJ	O	O
of	IN	O	O
angina	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

betalactams	NNS	B-TREATMENT	B-PROBLEM
/	VBP	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT

chief	JJ	O	O
complaint	NN	O	O
:	:	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM

major	JJ	O	O
surgical	JJ	O	O
or	CC	O	O
invasive	JJ	O	B-TREATMENT
procedure	NN	O	I-TREATMENT
:	:	O	O
s/p	JJ	O	O
intracranial	JJ	B-TREATMENT	B-TREATMENT
pressure	NN	I-TREATMENT	I-TREATMENT
bolt	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
58	JJ	O	O
-	:	O	O
year-old	JJ	O	O
man	NN	O	O
with	IN	O	O
history	NN	O	O
of	IN	O	O
iddm	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
pvd	NN	B-PROBLEM	O
,	,	O	O
status	NN	O	O
post	NN	O	O
toe	NN	B-TREATMENT	B-PROBLEM
amputations	NNS	I-TREATMENT	I-PROBLEM
,	,	O	O
diabetic	JJ	B-PROBLEM	B-PROBLEM
neuropathy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
retinopathy	VB	B-PROBLEM	B-PROBLEM
recently	RB	O	O
admitted	VBN	O	O
to	TO	O	O
mclean	VB	O	O
hospital	NN	O	O
from	IN	O	O
2017-01-13	JJ	O	O
,	,	O	O
through	IN	O	O
2017-01-18	JJ	O	O
,	,	O	O
with	IN	O	O
a	DT	O	O
diagnosis	NN	O	O
of	IN	O	O
right	JJ	B-PROBLEM	B-PROBLEM
heel	NN	I-PROBLEM	I-PROBLEM
diabetic	JJ	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
mssa	JJ	B-PROBLEM	B-PROBLEM
osteomyelitis	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
calcaneus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
mssa	FW	B-PROBLEM	O
bacteremia	NN	I-PROBLEM	B-PROBLEM
,	,	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
interstitial	JJ	I-PROBLEM	I-PROBLEM
nephritis	NN	I-PROBLEM	I-PROBLEM
secondary	JJ	O	O
to	TO	O	O
oxacillin	VB	B-TREATMENT	O
,	,	O	O
and	CC	O	O
rll	VB	B-PROBLEM	O
pna	NN	I-PROBLEM	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
sent	VBN	O	O
home	NN	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
picc	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
iv	NN	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
returned	VBD	O	O
to	TO	O	O
the	DT	O	O
wing	VBG	O	O
memorial	JJ	O	O
&	CC	O	O
medical	JJ	O	O
center	NN	O	O
intubated	VBN	B-TREATMENT	O
from	IN	O	O
an	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
on	IN	O	O
2017-02-04	JJ	O	O
,	,	O	O
for	IN	O	O
respiratory	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
sent	VBN	O	O
to	TO	O	O
cmed	VB	O	O
csru	NN	O	B-PROBLEM
.	.	O	O

prior	RB	O	O
to	TO	O	O
his	PRP$	O	O
re-admission	NN	O	O
,	,	O	O
his	PRP$	O	O
sister	NN	O	O
had	VBD	O	O
noted	VBN	O	O
that	IN	O	O
he	PRP	O	O
was	VBD	O	O
having	VBG	O	O
some	DT	B-PROBLEM	B-PROBLEM
shaking	VBG	I-PROBLEM	I-PROBLEM
chills	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
heavy	JJ	B-PROBLEM	B-PROBLEM
breathing	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

when	WRB	O	O
he	PRP	O	O
came	VBD	O	O
back	RB	O	O
to	TO	O	O
faulkner	VB	O	O
hospital	JJ	O	O
hospital	NN	O	O
for	IN	O	O
confusion	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
diaphoresis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
his	PRP$	B-TEST	B-TEST
initial	JJ	I-TEST	I-TEST
oxygen	NN	I-TEST	I-TEST
sat	VBD	I-TEST	I-TEST
was	VBD	O	O
only	RB	O	O
80%	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
fingerstick	NN	I-TEST	I-TEST
of	IN	O	O
29	CD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
given	VBN	O	O
d50	NN	B-TREATMENT	O
,	,	O	O
but	CC	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
was	VBD	O	O
therefore	RB	O	O
intubated	JJ	O	B-TREATMENT
and	CC	O	O
transferred	VBD	O	O
to	TO	O	O
the	DT	O	O
austen	JJ	O	O
riggs	NN	O	O
center	NN	O	O
where	WRB	O	O
he	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
multifocal	JJ	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
bacteremia	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
enterobacter	NN	B-PROBLEM	O
and	CC	O	O
mssa	NN	B-PROBLEM	O
.	.	O	O

past	JJ	O	O
medical	JJ	O	O
history	NN	O	O
:	:	O	O
diabetes	VBZ	B-PROBLEM	B-PROBLEM
type	IN	I-PROBLEM	O
1	CD	I-PROBLEM	O
since	IN	O	O
age	NN	O	O
24	CD	O	O
after	IN	O	O
pancreatic	JJ	B-PROBLEM	B-PROBLEM
trauma	NN	I-PROBLEM	I-PROBLEM

diabetic	JJ	B-PROBLEM	B-PROBLEM
retinopathy	NN	I-PROBLEM	I-PROBLEM

direct	JJ	B-PROBLEM	B-PROBLEM
neuropathy	NN	I-PROBLEM	I-PROBLEM

pvd	NN	B-PROBLEM	O

status	NN	O	O
post	NN	O	O
multiple	NN	B-TREATMENT	B-PROBLEM
toe	NN	I-TREATMENT	I-PROBLEM
amputations	NNS	I-TREATMENT	I-PROBLEM

recent	JJ	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
heel	NN	I-PROBLEM	I-PROBLEM
osteomyelitis	NN	I-PROBLEM	I-PROBLEM

recent	JJ	B-PROBLEM	O
mssa	NN	I-PROBLEM	O
bacteremia	NN	I-PROBLEM	B-PROBLEM

multifocal	JJ	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM

acute	JJ	B-PROBLEM	B-PROBLEM
interstitial	JJ	I-PROBLEM	I-PROBLEM
nephritis	NN	I-PROBLEM	I-PROBLEM

cataract	NN	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
transfer	NN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
from	IN	O	O
the	DT	O	O
cmed	VBN	O	O
csru	NN	O	O
on	IN	O	O
2017-02-15	JJ	O	O
temp	NN	B-TEST	O
:	:	O	O

97.4	CD	O	O
hr	NN	B-TEST	O
:	:	O	O

78	CD	O	O
bp	NN	B-TEST	O
:	:	O	O

141/64	CD	O	O
rr	NN	B-TEST	O
:	:	O	O

20	CD	O	O
o2sat	NNS	B-TEST	O
:	:	O	O

94-95%	CD	O	O
on	IN	O	O
3l	CD	B-TREATMENT	O
nc	NNS	I-TREATMENT	O

gen	NN	O	O
:	:	O	O
somnolent	NN	B-PROBLEM	B-PROBLEM
but	CC	O	O
arousable	JJ	O	O
to	TO	O	O
voice	VB	O	O

rrr	NN	O	O
,	,	O	O
no	DT	O	O
m/r/g	NN	B-PROBLEM	B-PROBLEM

lungs	NNS	O	O
:	:	O	O
crackles	NNS	B-PROBLEM	B-PROBLEM
bibasilar	VBP	I-PROBLEM	I-PROBLEM

abd	NN	O	O
:	:	O	O
soft	JJ	O	O
,	,	O	O
slightly	RB	B-PROBLEM	B-PROBLEM
distended	VBN	I-PROBLEM	I-PROBLEM
,	,	O	O
nontender	FW	B-PROBLEM	B-PROBLEM
,	,	O	O
+bs	FW	O	O

2+	CD	B-PROBLEM	B-PROBLEM
pitting	VBG	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
b	NN	I-PROBLEM	I-PROBLEM
le	NN	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
knee	VB	I-PROBLEM	I-PROBLEM
,	,	O	O
nonpitting	VBG	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
b	NN	I-PROBLEM	I-PROBLEM
hands	NNS	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
arms	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

1+	CD	B-TEST	O
dp	NN	I-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
bilaterally	RB	I-TEST	O
.	.	O	O

missing	VBG	B-PROBLEM	O
r	NN	I-PROBLEM	O
1st	CD	I-PROBLEM	O
toe	NN	I-PROBLEM	O
and	CC	I-PROBLEM	O
l	NN	I-PROBLEM	O
2nd	CD	I-PROBLEM	O
toe	NN	I-PROBLEM	O
.	.	O	O

wound	NN	B-TREATMENT	B-TEST
vac	NN	I-TREATMENT	I-TEST
in	IN	O	O
place	NN	O	O
on	IN	O	O
r	JJ	O	O
foot	NN	O	O
.	.	O	O

l	NN	B-TREATMENT	O
picc	NN	I-TREATMENT	O
(	(	O	O
2017-02-14	JJ	O	O
)	)	O	O
.	.	O	O

not	RB	O	O
following	VBG	O	O
commands	NNS	O	O
but	CC	O	O
moves	VBZ	O	O
ue	VBP	O	O
's	POS	O	O
to	TO	O	O
try	VB	O	O
to	TO	O	O
pull	VB	O	O
out	RP	O	O
ng	JJ	B-TREATMENT	O
tube	NN	I-TREATMENT	O
.	.	O	O

ct	JJ	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
2017-02-06	JJ	O	I-TEST

1.	CD	O	O
extensive	JJ	B-PROBLEM	B-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
diffuse	NN	I-PROBLEM	I-PROBLEM
ground	NN	I-PROBLEM	I-PROBLEM
glass	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
more	RBR	O	B-PROBLEM
confluent	JJ	O	I-PROBLEM
areas	NNS	O	I-PROBLEM
of	IN	O	I-PROBLEM
consolidation	NN	B-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
both	DT	I-PROBLEM	O
lungs	NNS	I-PROBLEM	O
consistent	NN	O	O
with	IN	O	O
the	DT	B-TEST	B-TEST
recent	JJ	I-TEST	I-TEST
chest	NN	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
.	.	O	O

this	DT	B-PROBLEM	O
non	JJ	I-PROBLEM	O
-	:	I-PROBLEM	O
specific	JJ	I-PROBLEM	O
pattern	NN	I-PROBLEM	O
could	MD	O	O
represent	VB	O	O
diffuse	VB	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
complicated	VBN	O	O
by	IN	O	O
ards	NNS	B-PROBLEM	O
.	.	O	O

this	DT	O	O
would	MD	O	O
likely	RB	O	O
less	RBR	O	O
represent	JJ	O	O
asymmetric	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
small	JJ	B-PROBLEM	B-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusions	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

echo	JJ	B-TEST	B-TEST
2018-02-06	JJ	O	O

1.	CD	O	O
no	DT	O	O
spontaneous	JJ	B-PROBLEM	B-PROBLEM
echo	NN	I-PROBLEM	I-PROBLEM
contrast	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
thrombus	NN	B-PROBLEM	B-PROBLEM
is	VBZ	O	O
seen	VBN	O	O
in	IN	O	O
the	DT	O	O
body	NN	O	O
of	IN	O	O
the	DT	O	O
left	JJ	O	O
atrium	NN	O	O
or	CC	O	O
left	VBN	O	O
atrial	JJ	O	O
appendage	NN	O	O
.	.	O	O

no	DT	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
septal	NN	I-PROBLEM	I-PROBLEM
defect	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
seen	VBN	O	O
by	IN	O	O
2d	CD	B-TEST	O
or	CC	I-TEST	O
color	NN	I-TEST	B-TEST
doppler	NN	I-TEST	I-TEST
.	.	O	O

2.	CD	O	O
left	VBD	B-TEST	B-PROBLEM
ventricular	JJ	I-TEST	I-PROBLEM
wall	NN	I-TEST	I-PROBLEM
thickness	NN	I-TEST	I-PROBLEM
,	,	O	O
cavity	NN	B-TEST	O
size	NN	I-TEST	O
,	,	O	O
and	CC	O	O
systolic	JJ	B-TEST	O
function	NN	I-TEST	O
are	VBP	O	O
normal	JJ	O	O
(	(	O	O
lvef	JJ	B-TEST	O
>	NNP	O	O
55%	CD	O	O
)	)	O	O
.	.	O	O

3.	CD	O	O
right	JJ	B-TEST	O
ventricular	JJ	I-TEST	O
chamber	NN	I-TEST	O
size	NN	I-TEST	O
and	CC	O	O
free	JJ	B-TEST	O
wall	NN	I-TEST	O
motion	NN	I-TEST	O
are	VBP	O	O
normal	JJ	O	O
.	.	O	O

4.	CD	O	O
the	DT	O	O
ascending	NN	O	O
,	,	O	O
transverse	NN	O	O
and	CC	O	O
descending	VBG	O	B-PROBLEM
thoracic	NN	O	I-PROBLEM
aorta	NNS	O	I-PROBLEM
are	VBP	O	O
normal	JJ	O	O
in	IN	O	O
diameter	NN	O	O
and	CC	O	O
free	JJ	O	O
of	IN	O	O
atherosclerotic	JJ	B-PROBLEM	B-PROBLEM
plaque	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
vegetations	NNS	B-PROBLEM	B-PROBLEM
are	VBP	O	O
seen	VBN	O	O
on	IN	O	O
the	DT	O	O
aortic	JJ	O	O
valve	NN	O	O
.	.	O	O

trace	NN	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
seen	VBN	O	O
.	.	O	O

6.	CD	O	O
the	DT	O	O
mitral	JJ	O	O
valve	NN	O	O
appears	VBZ	O	O
structurally	RB	O	O
normal	JJ	O	O
with	IN	O	O
trivial	JJ	B-PROBLEM	B-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
mass	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
vegetation	NN	B-PROBLEM	B-PROBLEM
is	VBZ	O	O
seen	VBN	O	O
on	IN	O	O
the	DT	O	O
mitral	JJ	O	O
valve	NN	O	O
.	.	O	O

7.	CD	O	O
no	DT	O	O
vegetation	NN	B-PROBLEM	B-PROBLEM
/	FW	O	O
mass	NN	B-PROBLEM	B-PROBLEM
is	VBZ	O	O
seen	VBN	O	O
on	IN	O	O
the	DT	O	O
pulmonic	JJ	O	O
valve	NN	O	O
.	.	O	O

8.	CD	O	O
there	EX	O	O
is	VBZ	O	O
a	DT	O	B-PROBLEM
trivial	JJ	O	I-PROBLEM
/	NN	O	I-PROBLEM
physiologic	JJ	B-PROBLEM	I-PROBLEM
pericardial	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

head	NN	B-TEST	B-TEST
ct	VBD	I-TEST	I-TEST
2017-02-08	JJ	O	O

no	DT	O	O
intracranial	JJ	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
identified	VBN	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
mass	NN	B-PROBLEM	B-PROBLEM
effect	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
shift	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
normally	RB	I-PROBLEM	I-PROBLEM
midline	JJ	I-PROBLEM	I-PROBLEM
structures	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
major	JJ	B-PROBLEM	B-PROBLEM
vascular	JJ	I-PROBLEM	I-PROBLEM
territorial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
identified	VBN	O	O
.	.	O	O

no	DT	O	O
osseous	JJ	B-PROBLEM	B-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
are	VBP	O	O
seen	VBN	O	O
.	.	O	O

no	DT	O	O
intracranial	JJ	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
ct	JJ	B-TEST	B-TEST
evidence	NN	O	I-TEST
of	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

eeg	JJ	B-TEST	O
2017-02-10	JJ	O	O

this	DT	O	O
is	VBZ	O	O
an	DT	B-PROBLEM	B-PROBLEM
abnormal	JJ	I-PROBLEM	I-PROBLEM
eeg	NN	I-PROBLEM	I-PROBLEM
due	JJ	O	O
to	TO	O	O
the	DT	O	O
presence	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
voltage	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
slow	VB	B-PROBLEM	I-PROBLEM
background	NN	I-PROBLEM	I-PROBLEM
consistent	NN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
severe	JJ	I-PROBLEM	I-PROBLEM
encephalopathy	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
toxic	NN	O	I-PROBLEM
,	,	O	O
metabolic	JJ	O	O
,	,	O	O
or	CC	O	O
anoxic	JJ	O	B-PROBLEM
etiology	NN	O	I-PROBLEM
.	.	O	O

note	NN	O	O
that	IN	O	O
with	IN	O	O
the	DT	O	O
documented	JJ	O	O
movements	NNS	O	O
of	IN	O	O
the	DT	O	B-PROBLEM
patient	NN	O	I-PROBLEM
's	POS	O	I-PROBLEM
head	NN	O	I-PROBLEM
and	CC	O	I-PROBLEM
mouth	NN	O	I-PROBLEM
,	,	O	O
no	DT	O	O
change	NN	O	O
on	IN	O	O
the	DT	B-TEST	O
eeg	NN	I-TEST	O
was	VBD	O	O
seen	VBN	O	O
.	.	O	O

no	DT	O	O
evidence	NN	O	O
of	IN	O	O
ongoing	VBG	B-PROBLEM	B-PROBLEM
seizures	NNS	I-PROBLEM	I-PROBLEM
was	VBD	O	O
seen	VBN	O	O
.	.	O	O

cultures	NNS	B-TEST	B-TEST
:	:	O	O

urine	NN	B-TEST	B-TEST
:	:	O	O

2017-02-04	JJ	O	O
and	CC	O	O
2017-02-07	JJ	O	O
and	CC	O	O
2017-02-11	JJ	O	O
:	:	O	O
yeast	NN	B-PROBLEM	B-TEST

sputum	NN	B-TEST	B-TEST
2017-02-04	JJ	O	O

enterobacter	NN	B-PROBLEM	O
cloacae	NN	I-PROBLEM	O

iv	NN	B-TREATMENT	B-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
tip	VBD	I-TREATMENT	O
2017-02-05:	JJ	O	O

staphylococcus	NN	B-PROBLEM	B-PROBLEM
,	,	I-PROBLEM	O
coagulase	NN	I-PROBLEM	B-TEST
negative	JJ	I-PROBLEM	O
sensitive	JJ	O	O
to	TO	O	O
vanc	VB	B-TREATMENT	O

blood	NN	B-TEST	O
:	:	O	O

enterobacter	NN	B-PROBLEM	O
cloacae	NN	I-PROBLEM	O

enterococcus	NN	B-PROBLEM	B-PROBLEM
faecium	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

staphylococcus	NN	B-PROBLEM	B-PROBLEM
,	,	I-PROBLEM	O
coagulase	NN	I-PROBLEM	B-TEST
negative	JJ	I-PROBLEM	O
.	.	O	O

stool	JJ	B-TEST	O
2017-02-07	JJ	O	O
:	:	O	O
c.	NN	B-PROBLEM	B-TEST
diff	NN	I-PROBLEM	I-TEST
negative	JJ	O	O

1)	CD	O	O
respiratory	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
this	DT	O	O
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
likely	JJ	O	O
03-15	JJ	O	O
worsening	VBG	B-PROBLEM	O
pna	NN	I-PROBLEM	O
.	.	O	O

pt	NN	O	O
remained	VBD	O	O
intubated	JJ	B-TREATMENT	B-TREATMENT
until	IN	O	O
2017-02-14	JJ	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
difficulty	NN	O	B-PROBLEM
weaning	VBG	O	I-PROBLEM
from	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
vent	NN	I-TREATMENT	I-TREATMENT
due	JJ	O	O
to	TO	O	O
difficulties	NNS	B-PROBLEM	B-PROBLEM
with	IN	I-PROBLEM	I-PROBLEM
neurological	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
he	PRP	O	O
remained	VBD	O	O
drowsy	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
unresponsive	JJ	B-PROBLEM	B-PROBLEM
for	IN	O	O
many	JJ	O	O
days	NNS	O	O
)	)	O	O
but	CC	O	O
eventually	RB	O	O
awoke	VBD	O	O
enough	JJ	O	O
and	CC	O	O
was	VBD	O	O
extubated	VBN	O	O
without	IN	O	O
difficulty	NN	O	B-PROBLEM
and	CC	O	O
remained	VBD	O	O
stable	JJ	O	O
on	IN	O	O
3l	CD	B-TREATMENT	O
nc	NNS	I-TREATMENT	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
but	CC	O	O
a	DT	O	O
few	JJ	O	O
days	NNS	O	O
later	RB	O	O
began	VBD	O	O
to	TO	O	O
show	VB	O	O
signs	NNS	O	O
of	IN	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
transferred	VBN	O	O
back	RB	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
csru	NN	O	O
for	IN	O	O
reintubation	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
likely	JJ	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
event	NN	I-PROBLEM	I-PROBLEM
leading	VBG	O	O
to	TO	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
some	DT	O	O
component	NN	O	O
of	IN	O	O
pulm	NN	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
extubated	VBN	O	O
a	DT	O	O
few	JJ	O	O
days	NNS	O	O
later	RB	O	O
and	CC	O	O
transferred	VBD	O	O
back	RB	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
where	WRB	O	O
his	PRP$	O	O
pulm	NN	O	O
status	NN	O	O
improved	VBD	O	O
dramatically	RB	O	O
with	IN	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
continued	JJ	B-TREATMENT	B-TREATMENT
nebulizer	NN	I-TREATMENT	I-TREATMENT
treatments	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

however	RB	O	O
,	,	O	O
on	IN	O	O
2017-03-01	JJ	O	O
at	IN	O	O
6	CD	O	O
am	VBP	O	O
the	DT	O	O
pt	NN	O	O
was	VBD	O	O
found	VBN	O	O
with	IN	O	O
labored	JJ	B-PROBLEM	B-PROBLEM
respirations	NNS	I-PROBLEM	I-PROBLEM
(	(	O	O
rr	VB	B-TEST	O
=	RB	O	O
24	CD	O	O
)	)	O	O
and	CC	O	O
sao2	$	B-TEST	O
89%	CD	O	O
,	,	O	O
which	WDT	O	O
improved	VBD	O	O
to	TO	O	O
only	RB	O	O
sao290	VB	B-TEST	O
-	:	O	O
91%	CD	O	O
on	IN	O	O
100%	CD	O	O
nrb	NNS	B-TREATMENT	O
.	.	O	O

abg	NN	B-TEST	B-TEST
(	(	O	O
7.42	CD	O	O
/	RB	O	O
38	CD	O	O
/	JJ	O	O
88	CD	O	O
)	)	O	O
was	VBD	O	O
performed	VBN	O	O
,	,	O	O
80	CD	O	O
mg	NN	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
given	VBN	O	O
and	CC	O	O
the	DT	O	O
patietn	NN	O	O
had	VBD	O	O
foley	NN	B-TREATMENT	B-TREATMENT
placed	VBN	O	O
and	CC	O	O
had	VBD	O	O
good	JJ	O	O
urine	NN	O	B-TEST
output	NN	O	I-TEST
and	CC	O	O
good	JJ	O	O
mentation	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
also	RB	O	O
given	VBN	O	O
nebulizers	NNS	B-TREATMENT	B-TREATMENT
without	IN	O	O
improvement	NN	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
radiograph	NN	I-TEST	I-TEST
had	VBD	O	O
fluffy	JJ	B-PROBLEM	B-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
infiltrates	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

although	IN	O	O
the	DT	O	O
pt	NN	O	O
was	VBD	O	O
w/o	JJ	O	B-PROBLEM
fever	NN	B-PROBLEM	I-PROBLEM
,	,	O	O
he	PRP	O	O
had	VBD	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
readmitted	VBN	O	O
tot	IN	O	O
he	PRP	O	O
cmed	VBD	O	O
csru	NN	O	O
for	IN	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
likely	RB	O	O
secondary	JJ	O	O
to	TO	O	O
a	DT	B-PROBLEM	B-PROBLEM
recurrent	JJ	I-PROBLEM	I-PROBLEM
aspiration	NN	I-PROBLEM	I-PROBLEM
event	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
meropenem	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
started	VBD	O	O
on	IN	O	O
bipap	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
aggressively	RB	O	O
suctioned	VBN	O	O
in	IN	O	O
an	DT	O	O
attempt	NN	O	O
to	TO	O	O
avoid	VB	O	B-TREATMENT
intubation	NN	B-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
03-02	NN	O	O
at	IN	O	O
10	CD	O	O
am	VBP	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
acutechange	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
bradycardia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
pinpoint	NN	B-PROBLEM	O
pupils	NNS	I-PROBLEM	O
,	,	O	O
decerebrate	NN	B-PROBLEM	B-PROBLEM
posturing	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
increased	VBD	B-PROBLEM	B-PROBLEM
tone	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
extremities	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
unresponsiveness	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
brought	VBN	O	O
to	TO	O	O
ct	VB	O	O
immediately	RB	O	O
for	IN	O	O
stat	JJ	B-TEST	B-TEST
scan	JJ	I-TEST	I-TEST
and	CC	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
massive	JJ	I-PROBLEM	I-PROBLEM
occipital	NN	I-PROBLEM	I-PROBLEM
spontaneous	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
into	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
l	NN	I-PROBLEM	O
ventricle	NN	I-PROBLEM	O
requiring	VBG	O	O
ventricular	JJ	B-TREATMENT	B-TREATMENT
drainage	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

neurosurgery	NN	O	O
was	VBD	O	O
immediately	RB	O	O
called	VBN	O	O
for	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
evd	NN	I-TREATMENT	I-TREATMENT
and	CC	O	I-TREATMENT
anesthesia	NN	O	I-TREATMENT
was	VBD	O	O
called	VBN	O	O
stat	NN	O	O
to	TO	O	O
the	DT	O	O
bedside	NN	O	O
for	IN	O	O
intubation	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
10:45	CD	O	O
am	VBP	O	O
in	IN	O	O
order	NN	O	O
to	TO	O	O
assist	VB	O	O
in	IN	O	O
hyperventilation	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

after	IN	O	O
endotracheal	JJ	B-TREATMENT	B-TREATMENT
intubation	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
maps	NNS	B-TEST	O
were	VBD	O	O
maintained	VBN	O	O
between	IN	O	O
70	CD	O	O
and	CC	O	O
90	CD	O	O
,	,	O	O
dilantin	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
dose	JJ	O	O
to	TO	O	O
maintain	VB	O	O
an	DT	O	O
appropriate	JJ	O	O
level	NN	O	O
.	.	O	O

l	NN	B-TREATMENT	O
frontal	JJ	I-TREATMENT	O
icp	NN	I-TREATMENT	O
bolt	NN	I-TREATMENT	O
was	VBD	O	O
placed	VBN	O	O
by	IN	O	O
neurosurgery	NN	O	O
under	IN	O	O
sterile	JJ	O	O
conditions	NNS	O	O
on	IN	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

mannitol	NN	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
iv	NN	O	O
x	VBD	O	O
1	CD	O	O
then	RB	O	O
50	CD	O	O
gm	NNS	O	O
iv	JJ	O	O
tid	NN	O	O
was	VBD	O	O
begun	VBN	O	O
to	TO	O	O
maintain	VB	O	O
serum	JJ	B-TEST	O
osm	JJ	I-TEST	O
>	NN	O	O
320	CD	O	O
and	CC	O	O
na	JJ	B-TEST	O
>	NN	O	O
147	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
hyperventilated	VBN	B-TREATMENT	O
to	TO	O	O
goal	NN	B-TEST	O
pco2	VB	I-TEST	O
30-35	JJ	O	O
with	IN	O	O
icp	JJ	B-TEST	O
improvement	NN	O	O
.	.	O	O

serial	JJ	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
studies	NNS	I-TEST	I-TEST
and	CC	O	O
neurologic	JJ	B-TEST	B-TEST
exams	NNS	I-TEST	I-TEST
were	VBD	O	O
performed	VBN	O	O
but	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
unchaged	JJ	O	O
,	,	O	O
unresponsive	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
posturing	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
no	DT	B-PROBLEM	O
spontaneous	JJ	I-PROBLEM	B-PROBLEM
movement	NN	I-PROBLEM	I-PROBLEM
despite	IN	O	O
icp	JJ	B-TEST	O
being	VBG	O	O
maintained	VBN	O	O
in	IN	O	O
good	JJ	O	O
range	NN	O	O
(	(	O	O
<	JJ	O	O
20	CD	O	O
).	NN	O	O

on	IN	O	O
2017-03-03	JJ	O	O
,	,	O	O
a	DT	O	O
family	NN	O	O
meeting	NN	O	O
resulted	VBD	O	O
in	IN	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
code	NN	O	O
being	VBG	O	O
changed	VBN	O	O
to	TO	O	O
comfort	VB	B-TREATMENT	B-TREATMENT
measures	NNS	I-TREATMENT	I-TREATMENT
only	RB	I-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
terminally	RB	O	O
extubated	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
morphine	NN	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
ativan	NN	B-TREATMENT	B-TREATMENT
titrated	VBN	O	O
for	IN	O	O
agonal	JJ	B-PROBLEM	B-PROBLEM
breathing	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
discomfort	NN	B-PROBLEM	I-PROBLEM
;	:	O	O
scopolamine	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
used	VBN	O	O
as	IN	O	O
an	DT	O	O
adjunct	JJ	O	O
to	TO	O	O
control	VB	O	O
secretions	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
appeared	VBD	O	O
comfortable	JJ	O	O
when	WRB	O	O
he	PRP	O	O
died	VBD	O	O
at	IN	O	O
12:27	CD	O	O
pm	NN	O	O
on	IN	O	O
2017-03-04	JJ	O	O
.	.	O	O

the	DT	O	O
family	NN	O	O
refused	VBD	O	O
autopsy	NN	B-TEST	B-TEST
or	CC	O	I-TEST
post-mortem	JJ	B-TEST	I-TEST
examination	NN	I-TEST	I-TEST
to	TO	O	O
deduce	VB	O	O
secondary	JJ	O	O
causes	NNS	O	O
of	IN	O	O
death	NN	O	B-PROBLEM
.	.	O	O

2.	CD	O	O
id	JJ	O	O
-	:	O	O
bacteremia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
pna	NN	B-PROBLEM	O
:	:	O	O

pt	NN	B-TREATMENT	B-TREATMENT
's	POS	I-TREATMENT	I-TREATMENT
triple	JJ	I-TREATMENT	I-TREATMENT
lumen	NNS	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
growing	VBG	O	B-PROBLEM
coag	JJ	B-PROBLEM	I-PROBLEM
neg	JJ	I-PROBLEM	I-PROBLEM
staph	NN	I-PROBLEM	I-PROBLEM
.	.	O	O
and	CC	O	O
picc	JJ	B-TREATMENT	B-TREATMENT
tip	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
sputum	NN	B-TEST	B-TEST
growing	VBG	O	O
enterobacter	JJ	B-PROBLEM	O
cloacae	NN	I-PROBLEM	O
.	.	O	O

the	DT	B-TREATMENT	O
picc	NN	I-TREATMENT	O
was	VBD	O	O
d/c	JJ	O	B-PROBLEM
'ed	NNP	O	I-PROBLEM
and	CC	O	O
pt	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
(	(	O	O
for	IN	O	O
course	NN	O	O
of	IN	O	O
6	CD	O	O
weeks	NNS	O	O
)	)	O	O
and	CC	O	O
meropenem	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
added	VBN	O	O
on	IN	O	O
02-09	NNP	O	O
(	(	O	O
for	IN	O	O
3	CD	O	O
week	NN	O	O
course	NN	O	O
).	NN	O	O

tee	NN	B-TEST	O
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

pt	NN	O	O
finished	VBD	O	O
the	DT	O	O
3	CD	O	O
week	NN	O	O
course	NN	O	O
of	IN	O	O
meropenem	NN	B-TREATMENT	B-TREATMENT
while	IN	O	O
in	IN	O	O
house	NN	O	O
and	CC	O	O
was	VBD	O	O
discharged	VBN	O	O
to	TO	O	O
rehab	VB	O	O
on	IN	O	O
day	NN	O	O
34/42	CD	O	O
of	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
vancomycin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

3)	CD	O	O
ain	NN	B-PROBLEM	O
:	:	O	O

pt	NN	O	O
received	VBD	O	O
oxacillin	RP	B-TREATMENT	B-TREATMENT
during	IN	O	O
his	PRP$	O	O
prior	JJ	O	O
hospitalization	NN	O	O
and	CC	O	O
had	VBD	O	O
ain	VBN	B-PROBLEM	O
from	IN	O	O
this	DT	B-TREATMENT	B-TREATMENT
medication	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
this	DT	O	O
admission	NN	O	O
he	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
taper	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

fluoroquinolones	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
other	JJ	O	B-PROBLEM
renal	JJ	O	I-PROBLEM
toxins	NNS	O	I-PROBLEM
were	VBD	O	O
avoided	VBN	O	O
.	.	O	O

renal	JJ	O	O
function	NN	O	O
gradually	RB	O	O
improved	VBN	O	O
and	CC	O	O
cr	NN	B-TEST	O
trended	VBD	O	O
down	RB	O	O
from	IN	O	O
peak	NN	O	O
of	IN	O	O
7.6	CD	O	O
to	TO	O	O
1.4	CD	O	O
.	.	O	O

before	IN	O	O
the	DT	O	O
patient	NN	O	O
acutely	RB	O	O
decompensated	VBD	O	O
as	IN	O	O
above	IN	O	O
,	,	O	O
the	DT	O	O
plan	NN	O	O
was	VBD	O	O
for	IN	O	O
steroid	JJ	B-TREATMENT	B-TREATMENT
taper	NN	I-TREATMENT	I-TREATMENT
:	:	O	O

4)	CD	O	O
foot	JJ	B-PROBLEM	B-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
:	:	O	O
the	DT	O	O
pt	NN	O	O
was	VBD	O	O
followed	VBN	O	O
by	IN	O	O
podiatry	NN	O	O
and	CC	O	O
had	VBD	O	O
several	JJ	B-TREATMENT	O
further	JJ	I-TREATMENT	O
debridement	NN	I-TREATMENT	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
r	NN	I-PROBLEM	I-PROBLEM
heel	NN	I-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
abx	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
podiatry	NN	O	O
following	NN	O	O
,	,	O	O
changed	VBD	O	O
vac	JJ	B-TREATMENT	O
q3	JJ	O	O
days	NNS	O	O
.	.	O	O

5)	CD	O	O
encephalopathy	NN	B-PROBLEM	B-PROBLEM
:	:	O	O
it	PRP	O	O
was	VBD	O	O
unclear	JJ	O	O
why	WRB	O	O
the	DT	O	O
pt	NN	O	O
's	POS	O	O
mental	JJ	O	O
status	NN	O	O
initially	RB	O	O
did	VBD	O	O
not	RB	O	O
improve	VB	O	O
more	RBR	O	O
quickly	RB	O	O
after	IN	O	O
all	DT	B-TREATMENT	B-TREATMENT
sedatives	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
removed	VBN	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
extubated	VBN	O	O
.	.	O	O

his	PRP$	O	B-TEST
ms	NN	O	I-TEST
waxed	NN	O	O
and	CC	O	O
waned	VBD	O	O
for	IN	O	O
many	JJ	O	O
days	NNS	O	O
and	CC	O	O
uremia	JJ	B-PROBLEM	B-PROBLEM
vs.	FW	O	I-PROBLEM
failure	NN	B-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	O
clear	JJ	I-PROBLEM	B-TREATMENT
sedatives	NNS	I-PROBLEM	I-TREATMENT
were	VBD	O	O
considered	VBN	O	O
(	(	O	O
although	IN	O	O
pt	NN	O	O
was	VBD	O	O
making	VBG	O	O
urine	JJ	O	B-TEST
and	CC	O	I-TEST
lft	NN	B-TEST	I-TEST
's	POS	I-TEST	I-TEST
are	VBP	O	O
wnl	JJ	O	O
).	NN	O	O

the	DT	O	O
pt	NN	O	O
had	VBD	O	O
an	DT	B-TEST	B-PROBLEM
eeg	NN	I-TEST	I-PROBLEM
and	CC	O	O
2	CD	B-TEST	O
head	NN	I-TEST	B-TEST
ct	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
which	WDT	O	O
did	VBD	O	O
not	RB	O	O
show	VB	O	B-PROBLEM
anoxic	JJ	B-PROBLEM	I-PROBLEM
brain	NN	I-PROBLEM	I-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
bleeding	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
gradually	RB	O	O
improved	VBD	O	O
and	CC	O	O
was	VBD	O	O
a&ox3	VBN	O	O
and	CC	O	O
near	JJ	O	O
baseline	NN	O	O
before	IN	O	O
amesbury	NN	O	O
hospital	NN	O	O
transferred	VBD	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
csru	NN	O	B-PROBLEM
in	IN	O	I-PROBLEM
respiratory	NN	B-PROBLEM	I-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

6)	CD	O	O
dm	NN	B-PROBLEM	O
:	:	O	O

pt	NN	O	O
was	VBD	O	O
maintained	VBN	O	O
on	IN	O	O
ssi	NN	B-TREATMENT	O
with	IN	O	O
small	JJ	O	O
amount	NN	O	O
of	IN	O	O
standing	VBG	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
while	IN	O	O
he	PRP	O	O
was	VBD	O	O
npo	RB	B-TREATMENT	O
and	CC	O	O
then	RB	O	O
his	PRP$	B-TREATMENT	O
dose	NN	I-TREATMENT	O
was	VBD	O	O
gradually	RB	O	O
increased	VBN	O	O
as	IN	O	O
he	PRP	O	O
received	VBD	O	O
tube	JJ	B-TREATMENT	B-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
pt	NN	O	O
had	VBD	O	O
an	DT	B-TREATMENT	B-TREATMENT
ng	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
placed	VBD	O	O
and	CC	O	O
received	VBD	O	O
tube	NNS	B-TREATMENT	B-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
the	DT	O	O
majority	NN	O	O
of	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
hospitalization	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

upon	IN	O	O
extubation	NN	B-TREATMENT	O
and	CC	O	O
transfer	NN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
he	PRP	O	O
pulled	VBD	O	O
out	RP	O	O
the	DT	B-TREATMENT	O
ng	JJ	I-TREATMENT	O
tube	NN	I-TREATMENT	O
time	NN	O	O
several	JJ	O	O
times	NNS	O	O
and	CC	O	O
required	JJ	O	O
restraints	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

albumin	NN	B-TEST	B-TEST
was	VBD	O	O
very	RB	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
and	CC	O	O
pt	NN	O	O
had	VBD	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
edema	JJ	I-PROBLEM	I-PROBLEM
likely	JJ	O	O
03-15	NN	O	O
this	DT	O	O
.	.	O	O

pump	NN	O	O
/	NN	O	O
htn	NN	B-PROBLEM	B-PROBLEM
:	:	O	O
pt	NN	O	O
had	VBD	O	O
episodes	NNS	O	O
of	IN	O	O
both	DT	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
during	IN	O	O
his	PRP$	O	O
stay	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
managed	VBN	O	O
with	IN	O	O
metoprolol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
hydralazine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
amlodipine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

near	IN	O	O
discharge	NN	O	O
his	PRP$	B-TEST	O
bp	NN	I-TEST	O
was	VBD	O	O
controlled	VBN	O	O
with	IN	O	O
metoprolol	NN	B-TREATMENT	B-TREATMENT
only	RB	O	O
.	.	O	O

9)	CD	O	O
hypernatremia	SYM	B-PROBLEM	B-TEST
-	:	O	O
while	NN	O	O
in	IN	O	O
the	DT	O	O
cmed	JJ	O	O
csru	NN	O	O
the	DT	O	O
pt	NN	O	O
developed	VBD	O	O
hypernatremia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

this	DT	O	O
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
likely	JJ	O	O
03-15	JJ	O	O
intravascular	JJ	B-PROBLEM	B-PROBLEM
volume	NN	I-PROBLEM	I-PROBLEM
depletion	NN	I-PROBLEM	I-PROBLEM
since	IN	O	O
the	DT	B-TEST	B-TEST
pt	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
albumin	NN	I-TEST	I-TEST
was	VBD	O	O
so	RB	B-PROBLEM	O
low	JJ	I-PROBLEM	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
third	JJ	O	O
spacing	VBG	O	O
all	DT	O	O
of	IN	O	O
his	PRP$	O	B-PROBLEM
fluid	NN	O	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
volume	NN	O	B-PROBLEM
resuscitated	VBN	O	I-PROBLEM
and	CC	O	O
managed	VBN	O	O
with	IN	O	O
d5w	NN	B-TREATMENT	B-PROBLEM
and	CC	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
as	RB	O	O
well	RB	O	O
as	IN	O	O
receving	VBG	O	B-TREATMENT
fw	JJ	B-TREATMENT	I-TREATMENT
boluses	NNS	I-TREATMENT	I-TREATMENT
with	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
ng	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	B-PROBLEM	O
hypernatremia	NN	I-PROBLEM	O
fully	RB	O	O
resolved	VBD	O	O
when	WRB	O	O
he	PRP	O	O
resumed	VBD	O	O
eating	VBG	O	O
on	IN	O	O
his	PRP$	O	O
own	JJ	O	O
and	CC	O	O
had	VBD	O	O
access	NN	O	O
to	TO	O	O
free	JJ	O	O
water	NN	O	O
.	.	O	O

10)	CD	O	O
anemia	NN	B-PROBLEM	B-PROBLEM
:	:	O	O

pt	NN	B-TEST	B-TEST
's	POS	I-TEST	I-TEST
hct	NN	I-TEST	I-TEST
trended	VBD	O	O
down	RB	O	O
slowly	RB	O	O
throughout	IN	O	O
his	PRP$	O	O
hospitalization	NN	O	O
.	.	O	O

labs	NNS	B-TEST	B-TEST
were	VBD	O	O
consistent	JJ	O	O
with	IN	O	O
anemia	NN	B-PROBLEM	B-PROBLEM
of	IN	O	I-PROBLEM
chronic	JJ	B-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
transfused	VBN	O	O
3	CD	B-TREATMENT	O
units	NNS	I-TREATMENT	O
prbc	VBP	I-TREATMENT	O
's	POS	I-TREATMENT	O
near	IN	O	O
the	DT	O	O
end	NN	O	O
of	IN	O	O
his	PRP$	O	O
hospitalization	NN	O	O
and	CC	O	O
had	VBD	O	O
an	DT	O	B-TREATMENT
appropriate	JJ	O	I-TREATMENT
bump	NN	O	I-TREATMENT
.	.	O	O

when	WRB	O	O
the	DT	O	B-TEST
pt	NN	O	I-TEST
's	POS	O	I-TEST
ms	NN	O	I-TEST
improved	VBD	O	O
to	TO	O	O
near	VB	O	O
baseline	NN	O	O
before	IN	O	O
again	RB	O	O
decompensating	NN	O	O
,	,	O	O
he	PRP	O	O
became	VBD	O	O
extremely	RB	B-PROBLEM	B-PROBLEM
tearful	JJ	I-PROBLEM	I-PROBLEM
and	CC	O	O
expressed	JJ	O	O
feelings	NNS	O	O
of	IN	O	O
depression	NN	B-PROBLEM	B-PROBLEM
after	IN	O	O
being	VBG	O	O
in	IN	O	O
the	DT	O	O
hospital	NN	O	O
for	IN	O	O
so	RB	O	O
long	RB	O	O
.	.	O	O

he	PRP	O	O
expressed	VBD	O	O
interest	NN	O	O
in	IN	O	O
taking	VBG	O	O
an	DT	B-TREATMENT	O
anti-depressant	JJ	I-TREATMENT	O
for	IN	O	O
a	DT	O	O
short	JJ	O	O
time	NN	O	O
while	IN	O	O
he	PRP	O	O
was	VBD	O	O
recovering	VBG	O	O
and	CC	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
celexa	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

medications	NNS	O	B-TREATMENT
on	IN	O	O
admission	NN	O	O
:	:	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
1g	CD	O	O
iv	NN	O	O
q48	NN	O	O

mvi	NN	B-TREATMENT	O

neurontin	RB	B-TREATMENT	B-TREATMENT
300	CD	O	O
qd	NN	O	O

riss	NN	B-TREATMENT	B-PROBLEM

prednisone	NN	B-TREATMENT	B-TREATMENT
taper	NN	I-TREATMENT	I-TREATMENT
60	CD	O	O
qd	NN	O	O

prilosec	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
qd	NN	O	O

metoprolol	RB	B-TREATMENT	B-TREATMENT
25	CD	O	O
bid	NN	O	O

lantus	NN	B-TREATMENT	B-TEST
480	CD	O	O
qd	NN	O	O

calcium	NN	B-TREATMENT	B-TEST
carbonate	NN	I-TREATMENT	I-TEST
tid	NN	O	O
with	IN	O	O
meals	NNS	O	O

discharge	NN	O	O
diagnosis	NN	O	O
:	:	O	O
subarachnoid	JJ	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM

diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitis	VBP	I-PROBLEM	I-PROBLEM
(	(	O	I-PROBLEM
pancreatic	JJ	B-PROBLEM	I-PROBLEM
trauma	NN	I-PROBLEM	I-PROBLEM
)	)	O	I-PROBLEM

acute	JJ	B-PROBLEM	B-PROBLEM
interstitial	JJ	I-PROBLEM	I-PROBLEM
nephritis	NN	I-PROBLEM	I-PROBLEM
(	(	O	I-PROBLEM
oxacillin	NN	B-TREATMENT	I-PROBLEM
)	)	O	I-PROBLEM

peripheral	JJ	B-PROBLEM	B-PROBLEM
neuropathy	NN	I-PROBLEM	I-PROBLEM

peripheral	JJ	B-PROBLEM	B-PROBLEM
vascular	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM

digital	JJ	B-PROBLEM	B-PROBLEM
necrosis	NN	I-PROBLEM	I-PROBLEM

multiple	JJ	B-TREATMENT	B-PROBLEM
toe	NN	I-TREATMENT	I-PROBLEM
amputations	NNS	I-TREATMENT	I-PROBLEM

diabetic	JJ	B-PROBLEM	B-PROBLEM
nephropathy	NN	I-PROBLEM	I-PROBLEM

hypertension	NN	B-PROBLEM	B-PROBLEM

mssa	NN	B-PROBLEM	O
bacteremia	NN	I-PROBLEM	B-PROBLEM

enterococcal	JJ	B-PROBLEM	B-PROBLEM
bacteremia	NN	I-PROBLEM	I-PROBLEM

enterbactor	NN	B-PROBLEM	B-PROBLEM
cloacae	NN	I-PROBLEM	I-PROBLEM
bacteremia	NN	I-PROBLEM	I-PROBLEM

multifocal	JJ	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM

respiratory	NN	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM

mssa	NN	B-PROBLEM	O
osteomyelitis	NN	I-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
calcaneous	JJ	I-PROBLEM	I-PROBLEM

toxic	NN	B-PROBLEM	B-PROBLEM
/	NNP	I-PROBLEM	I-PROBLEM
metabolic	NN	I-PROBLEM	I-PROBLEM
encephalopathy	NN	I-PROBLEM	I-PROBLEM

hypernatremia	NN	B-PROBLEM	B-PROBLEM

pulmonary	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
mediastinal	JJ	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
inferior	JJ	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
bronchiectasis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
.	.	O	O

vq	JJ	B-TEST	B-TEST
scan	NN	I-TEST	I-TEST
,	,	O	I-TEST
lower	JJR	B-TEST	I-TEST
extremities	NNS	I-TEST	I-TEST
noninvasive	JJ	I-TEST	I-TEST
doppler	NN	I-TEST	I-TEST
studies	NNS	I-TEST	I-TEST
and	CC	O	O
overnight	JJ	B-TEST	B-TEST
oximetry	NN	I-TEST	I-TEST
saturation	NN	I-TEST	I-TEST
monitoring	NN	I-TEST	I-TEST
.	.	O	O

mr.	NN	O	O
state	NN	O	O
is	VBZ	O	O
an	DT	O	O
81-year-old	JJ	O	O
man	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
restrictive	JJ	B-PROBLEM	O
and	CC	I-PROBLEM	O
obstructive	JJ	I-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
dilated	VBN	B-PROBLEM	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
inferior	JJ	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
anterior	JJ	B-PROBLEM	B-PROBLEM
mediastinal	JJ	I-PROBLEM	I-PROBLEM
masses	NNS	I-PROBLEM	I-PROBLEM
admitted	VBN	O	O
with	IN	O	O
acute	JJ	O	B-PROBLEM
onset	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
pulmonary	JJ	B-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
inadvertently	RB	O	O
decreasing	VBG	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
from	IN	O	O
80	CD	O	O
mg.	NNS	O	O
po	RB	O	O
40	CD	O	O
mg.	NNS	O	O
a	DT	O	O
day	NN	O	O
mr.	NN	O	O
state	NN	O	O
had	VBD	O	O
sudden	JJ	B-PROBLEM	B-PROBLEM
onset	NN	I-PROBLEM	I-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
after	IN	O	O
approximate	JJ	O	O
day	NN	O	O
and	CC	O	O
a	DT	O	B-PROBLEM
half	JJ	O	I-PROBLEM
prodrome	JJ	B-PROBLEM	I-PROBLEM
culminating	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
severe	JJ	B-PROBLEM	I-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

upon	IN	O	O
arrival	NN	O	O
in	IN	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
mr.	NN	B-TEST	O
state	NN	I-TEST	B-TEST
&apos;s	JJ	I-TEST	I-TEST
saturations	NNS	I-TEST	I-TEST
were	VBD	O	O
in	IN	O	O
the	DT	O	O
mid	NN	O	O
80s	CD	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
promptly	RB	O	O
rendered	VBN	O	O
more	RBR	O	O
comfortable	JJ	O	O
with	IN	O	O
high	JJ	B-TREATMENT	B-PROBLEM
flow	NN	I-TREATMENT	I-PROBLEM
oxygen	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
nitrates	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
lasix	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
was	VBD	O	O
relatively	RB	O	O
unrevealing	JJ	O	O
for	IN	O	O
interstitial	JJ	B-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	I-PROBLEM
alveolar	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
with	IN	O	O
clinical	JJ	O	O
improvement	NN	O	O
ensued	VBN	O	O
with	IN	O	O
the	DT	O	B-TREATMENT
immediate	JJ	B-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
as	IN	O	O
noted	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
denied	VBD	O	O
angina	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
syncope	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
preceding	VBG	B-PROBLEM	B-PROBLEM
worsening	VBG	I-PROBLEM	I-PROBLEM
orthopnea	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
paroxysmal	JJ	B-PROBLEM	B-PROBLEM
nocturnal	JJ	I-PROBLEM	I-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
palpitations	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hematemesis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
melena	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

is	VBZ	O	O
notable	JJ	O	O
for	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
inferior	JJ	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
restrictive	JJ	B-PROBLEM	O
and	CC	I-PROBLEM	O
obstructive	JJ	I-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
an	DT	B-TEST	O
fev1	NN	I-TEST	O
of	IN	O	O
.9	NNP	O	O
and	CC	O	O
fvc	NN	B-TEST	O
of	IN	O	O
1.34	CD	O	O
and	CC	O	O
a	DT	O	O
moderate	JJ	O	O
at	IN	O	O
best	JJS	O	O
response	NN	O	O
to	TO	O	O
bronchodilators	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
a	DT	O	B-TEST
negative	JJ	O	I-TEST
sestamibi	NN	O	I-TEST
scan	JJ	O	I-TEST
in	IN	O	O
may	MD	O	O
,	,	O	O
1999	CD	O	O
apart	NN	O	O
from	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
severe	JJ	I-PROBLEM	I-PROBLEM
fixed	VBN	I-PROBLEM	I-PROBLEM
inferolateral	JJ	I-PROBLEM	I-PROBLEM
defect	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
systolic	JJ	B-PROBLEM	B-PROBLEM
dysfunction	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
recent	JJ	B-TEST	B-TEST
echocardiography	NN	I-TEST	I-TEST
revealing	VBG	O	O
an	DT	B-TEST	O
lvid	NN	I-TEST	O
of	IN	O	O
62	CD	O	O
mm.	NNS	O	O
and	CC	O	O
ejection	NN	B-TEST	B-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
28	CD	O	O
percent	NN	O	O
,	,	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
mild-to-moderate	JJ	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-TEST	B-TEST
peak	JJ	I-TEST	I-TEST
gradient	NN	I-TEST	I-TEST
of	IN	O	O
33	CD	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
mean	JJ	I-TEST	I-TEST
gradient	NN	I-TEST	I-TEST
of	IN	O	O
19	CD	O	O
and	CC	O	O
a	DT	B-TEST	O
valve	JJ	I-TEST	O
area	NN	I-TEST	O
of	IN	O	O
1.4	CD	O	O
cm.	NN	O	O
squared	VBN	O	O
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
mr.	NN	O	O
state	NN	O	O
has	VBZ	O	O
an	DT	B-PROBLEM	B-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
mediastinal	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
2x2x1.7	CD	O	O
cm.	NN	O	O
by	IN	O	O
recent	JJ	B-TEST	O
computerized	JJ	I-TEST	B-TEST
tomography	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
without	IN	O	O
surrounding	VBG	B-PROBLEM	O
or	CC	I-PROBLEM	O
adjacent	JJ	I-PROBLEM	B-PROBLEM
adenopathy	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
parenchymal	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
apart	RB	O	O
from	IN	O	O
bronchiectasis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
cardiomyopathy	NN	I-TEST	I-TEST
work	NN	I-TEST	I-TEST
up	RB	I-TEST	I-TEST
entailed	VBD	O	O
a	DT	O	O
negative	JJ	O	O
ana	NN	O	O
,	,	O	O
negative	JJ	O	O
spep	NN	O	O
,	,	O	O
upep	JJ	B-TEST	O
and	CC	O	O
benz-jones	JJ	B-TEST	B-TEST
proteins	NNS	I-TEST	I-TEST
,	,	O	O
normal	JJ	O	O
ferritin	NN	O	O
,	,	O	O
thyroid	JJ	B-TEST	B-TREATMENT
stimulating	VBG	I-TEST	I-TREATMENT
hormone	NN	I-TEST	I-TREATMENT
and	CC	O	O
a	DT	B-TEST	O
recent	JJ	I-TEST	O
work	NN	I-TEST	O
up	RB	I-TEST	O
for	IN	O	O
possible	JJ	O	O
bimomatous	JJ	B-PROBLEM	B-PROBLEM
associated	VBN	O	I-PROBLEM
myasthenia	NN	B-PROBLEM	I-PROBLEM
gravis	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
155/60	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
70	CD	O	O
with	IN	O	O
occasional	JJ	B-PROBLEM	B-PROBLEM
premature	NN	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
contractions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
respirations	NNS	B-TEST	B-TEST
14	CD	O	O
.	.	O	O

mr.	NN	O	O
state	NN	O	O
was	VBD	O	O
dyspneic	JJ	B-PROBLEM	O
speaking	NN	O	O
in	IN	O	O
short	JJ	O	O
sentences	NNS	O	O
initially	RB	O	O
on	IN	O	O
high	JJ	B-TREATMENT	B-TREATMENT
flow	NN	I-TREATMENT	I-TREATMENT
oxygen	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

jugular	JJ	B-TEST	B-TEST
venous	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
8	CD	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
brisk	JJ	I-PROBLEM	I-PROBLEM
inspiratory	NN	I-PROBLEM	I-PROBLEM
descent	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
thyromegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

carotids	NNS	B-TEST	B-TEST
were	VBD	O	O
2+	CD	O	O
.	.	O	O

breath	NN	O	B-TEST
sounds	NNS	O	I-TEST
were	VBD	O	O
decreased	VBN	B-PROBLEM	O
at	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
bases	NNS	I-PROBLEM	O
only	RB	O	O
with	IN	O	O
distant	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
sounds	VBZ	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	O
2	CD	I-PROBLEM	O
out	IN	I-PROBLEM	O
of	IN	I-PROBLEM	O
6	CD	I-PROBLEM	B-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
ejection	NN	I-PROBLEM	I-PROBLEM
murmur	FW	I-PROBLEM	I-PROBLEM
consistent	NN	O	O
with	IN	O	O
aortic	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
gallavardin	NNS	B-PROBLEM	B-TREATMENT
like	IN	I-PROBLEM	O
radiation	NN	I-PROBLEM	O
to	TO	I-PROBLEM	O
the	DT	I-PROBLEM	O
apex	NN	I-PROBLEM	O
.	.	O	O

soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
hepatojugular	JJ	B-PROBLEM	B-PROBLEM
reflex	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
pulsations	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
rash	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
the	DT	B-TEST	B-TEST
neurological	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
non-focal	JJ	O	O
.	.	O	O

notable	JJ	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
of	IN	O	O
145	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
3.6	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
23	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
1.3	CD	O	O
,	,	O	O
glucose	RB	B-TEST	B-TEST
104	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
42	CD	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
8.7	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
235	CD	O	O
and	CC	O	O
a	DT	B-TEST	O
pt	NN	I-TEST	O
of	IN	O	O
12.9	CD	O	O
seconds	NNS	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
urinalysis	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
troponin	NN	I-TEST	I-TEST
i	NN	I-TEST	I-TEST
was	VBD	O	O
less	JJR	O	O
than	IN	O	O
.4	NN	O	O
and	CC	O	O
the	DT	B-TEST	B-TEST
creatine	NN	I-TEST	I-TEST
kinase	NN	I-TEST	I-TEST
was	VBD	O	O
114	CD	O	O
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
revealed	VBD	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
cardiomegaly	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
no	DT	O	O
clear	JJ	B-PROBLEM	B-PROBLEM
interstitial	NN	I-PROBLEM	I-PROBLEM
or	CC	I-PROBLEM	O
alveolar	JJ	I-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
atelectasis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
/	NN	O	O
or	CC	O	O
scarring	NN	B-PROBLEM	B-PROBLEM
at	IN	I-PROBLEM	O
both	DT	I-PROBLEM	O
lung	NN	I-PROBLEM	O
bases	NNS	I-PROBLEM	O
.	.	O	O

the	DT	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
revealed	VBD	O	O
normal	JJ	O	O
sinus	NNS	O	O
rhythm	VBP	O	O
with	IN	O	O
premature	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
complexes	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
right	JJ	B-PROBLEM	I-PROBLEM
bundle	NN	I-PROBLEM	I-PROBLEM
branch	NN	I-PROBLEM	I-PROBLEM
block	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
hemiblock	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
old	JJ	B-PROBLEM	B-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
hospital	NN	O	O
and	CC	O	O
underwent	NN	O	O
an	DT	B-TREATMENT	B-TREATMENT
approximate	JJ	I-TREATMENT	I-TREATMENT
1.5	CD	I-TREATMENT	I-TREATMENT
liter	NN	I-TREATMENT	I-TREATMENT
diuresis	NN	I-TREATMENT	I-TREATMENT
within	IN	O	O
the	DT	O	O
first	JJ	O	O
24	CD	O	O
hours	NNS	O	O
with	IN	O	O
improvement	NN	O	O
in	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
improvement	NN	O	O
in	IN	O	O
his	PRP$	B-TEST	B-TEST
oxygen	NN	I-TEST	I-TEST
saturations	NNS	I-TEST	I-TEST
.	.	O	O

after	IN	O	O
a	DT	O	O
long	JJ	O	O
discussion	NN	O	O
with	IN	O	O
the	DT	O	O
patient	NN	O	O
and	CC	O	O
his	PRP$	O	O
family	NN	O	O
it	PRP	O	O
was	VBD	O	O
determined	VBN	O	O
that	IN	O	O
a	DT	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
would	MD	O	O
be	VB	O	O
prudent	JJ	O	O
.	.	O	O

prior	RB	O	O
to	TO	O	O
catheterization	VB	B-TEST	B-TEST
a	DT	B-TEST	I-TEST
vq	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
which	WDT	O	O
revealed	VBD	O	O
a	DT	O	B-PROBLEM
moderate	JJ	O	I-PROBLEM
probability	NN	O	I-PROBLEM
for	IN	O	O
pe	NN	B-PROBLEM	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
subsegmental	JJ	I-PROBLEM	I-PROBLEM
defect	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lingular	NN	I-PROBLEM	I-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	NN	O	I-PROBLEM
lung	NN	O	I-PROBLEM
.	.	O	O

subsequent	JJ	B-TEST	B-TEST
lower	JJR	I-TEST	I-TEST
extremities	NNS	I-TEST	I-TEST
noninvasive	JJ	I-TEST	I-TEST
studies	NNS	I-TEST	I-TEST
and	CC	O	I-TEST
d-dimer	JJ	B-TEST	I-TEST
test	NN	I-TEST	I-TEST
were	VBD	O	O
both	DT	O	O
negative	JJ	O	O
rendering	VBG	O	O
the	DT	O	O
probability	NN	O	O
of	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
embolism	NN	I-PROBLEM	I-PROBLEM
less	JJR	O	I-PROBLEM
than	IN	O	I-PROBLEM
2	CD	O	I-PROBLEM
percent	NN	O	I-PROBLEM
.	.	O	O

it	PRP	O	O
was	VBD	O	O
not	RB	O	O
felt	VBN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
would	MD	O	O
be	VB	O	O
in	IN	O	O
need	NN	O	O
of	IN	O	O
chronic	JJ	B-TREATMENT	B-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
lieu	NN	O	O
of	IN	O	O
this	DT	O	B-PROBLEM
low	JJ	O	I-PROBLEM
probability	NN	O	I-PROBLEM
findings	NNS	O	I-PROBLEM
in	IN	O	I-PROBLEM
toto	NN	O	I-PROBLEM
.	.	O	O

coronary	JJ	B-TEST	B-TEST
angiography	NN	I-TEST	I-TEST
revealed	VBD	O	O
occlusion	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
proximally	RB	I-PROBLEM	I-PROBLEM
with	IN	O	O
insignificant	JJ	B-PROBLEM	O
plaquing	NN	I-PROBLEM	O
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
left	NN	I-PROBLEM	O
anterior	JJ	I-PROBLEM	O
descending	VBG	I-PROBLEM	O
artery	NN	I-PROBLEM	O
and	CC	O	O
circumflex	JJ	O	O
arteries	NNS	O	O
.	.	O	O

after	IN	O	O
a	DT	B-TREATMENT	O
approximate	JJ	I-TREATMENT	O
3	CD	I-TREATMENT	O
liter	NN	I-TREATMENT	O
total	JJ	I-TREATMENT	B-TEST
diuresis	NN	I-TREATMENT	I-TEST
the	DT	B-TEST	I-TEST
right	JJ	I-TEST	I-TEST
atrial	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
5	CD	O	O
,	,	O	O
pulmonary	JJ	B-TEST	B-TEST
capillary	JJ	I-TEST	I-TEST
wedge	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
14	CD	O	O
,	,	O	O
pulmonary	JJ	B-TEST	B-TEST
vacuolar	NN	I-TEST	I-TEST
resistance	NN	I-TEST	I-TEST
353	CD	O	O
and	CC	O	O
the	DT	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
output	NN	I-TEST	I-TEST
depressed	VBD	O	O
at	IN	O	O
2.95	CD	O	O
liters	NNS	O	O
per	IN	O	O
minute	NN	O	O
,	,	O	O
or	CC	O	O
a	DT	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
index	NN	I-TEST	I-TEST
of	IN	O	O
1.7	CD	O	O
liters	NNS	O	O
per	IN	O	O
minute	NN	O	O
.	.	O	O

based	VBN	O	O
upon	IN	O	O
these	DT	O	O
findings	NNS	O	O
it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
that	IN	O	O
mr.	NN	O	O
state	NN	O	O
most	RBS	O	O
likely	JJ	O	O
has	VBZ	O	O
multi-factorial	JJ	B-PROBLEM	B-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
owing	VBG	O	O
to	TO	O	O
both	DT	O	O
his	PRP$	B-PROBLEM	B-TREATMENT
ventilatory	NN	I-PROBLEM	I-TREATMENT
limitation	NN	I-PROBLEM	I-TREATMENT
and	CC	O	O
to	TO	O	O
a	DT	B-PROBLEM	B-PROBLEM
chronic	JJ	I-PROBLEM	I-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
output	NN	I-PROBLEM	I-PROBLEM
state	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TREATMENT	B-TEST
isordil	NN	I-TREATMENT	I-TEST
was	VBD	O	O
increased	VBN	O	O
in	IN	O	O
hospital	NN	O	O
and	CC	O	O
blood	NN	B-TREATMENT	B-TREATMENT
pressure	NN	I-TREATMENT	I-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
relative	JJ	O	B-PROBLEM
episodic	NN	O	I-PROBLEM
with	IN	O	O
systolic	JJ	B-TEST	B-TEST
pressures	NNS	I-TEST	I-TEST
ranging	VBG	O	O
between	IN	O	O
100	CD	O	O
and	CC	O	O
160	CD	O	O
.	.	O	O

future	JJ	O	O
adjustments	NNS	O	O
will	MD	O	O
be	VB	O	O
made	VBN	O	O
at	IN	O	O
home	NN	O	O
pending	VBG	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
measures	NNS	I-TEST	I-TEST
.	.	O	O

at	IN	O	O
a	DT	O	O
goal	NN	O	O
weight	NN	B-TEST	O
of	IN	O	O
142	CD	O	O
pounds	NNS	O	O
,	,	O	O
mr.	NN	B-TEST	O
state	NN	I-TEST	O
&apos;s	VBD	I-TEST	O
filling	VBG	I-TEST	B-TEST
pressures	NNS	I-TEST	I-TEST
appeared	VBD	O	O
ideal	JJ	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
wedge	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
14	CD	O	O
and	CC	O	O
his	PRP$	O	B-TEST
goal	NN	O	I-TEST
weight	NN	O	I-TEST
range	NN	O	I-TEST
will	MD	O	O
be	VB	O	O
between	IN	O	O
142	CD	O	O
and	CC	O	O
44	CD	O	O
pounds	NNS	O	O
at	IN	O	O
home	NN	O	O
.	.	O	O

imdur	NN	B-TREATMENT	B-TREATMENT
120	CD	O	O
mg.	NN	O	O
po	NN	O	O
q.d.	NN	O	O
captopril	NN	B-TREATMENT	B-TREATMENT
100mg.	CD	O	O
po	NN	O	O
t.i.d.	NN	O	O
lasix	VBD	B-TREATMENT	B-TREATMENT
80	CD	O	O
mg.	NN	O	O
po	NN	O	O
q.d.	NN	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
40	CD	O	O
meq.	NN	O	O
po	NN	O	O
q.d.	NN	O	O
coreg	NN	B-TREATMENT	O
12.5	CD	O	O
mg.	NN	O	O
b.i.d.	NN	O	O
cozaar	NN	B-TREATMENT	O
100	CD	O	O
mg.	NN	O	O
b.i.d.	NN	O	O
plavix	NN	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg.	NN	O	O
q.d.	NN	O	O
allopurinol	VBD	B-TREATMENT	B-TREATMENT
300	CD	O	O
mg.	NN	O	O
q.d.	NN	O	O
pulmacort	NN	B-TREATMENT	O
and	CC	O	O
serevent	NN	B-TREATMENT	B-TREATMENT
inhalers	NNS	I-TREATMENT	I-TREATMENT
2	CD	O	O
puffs	NNS	O	O
b.i.d.	VBD	O	O
zocor	$	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg.	NN	O	O
q.d.	NN	O	O
prilosec	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg.	NN	O	O
q.d.	NN	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg.	NN	O	O
t.i.d.	NN	O	O

patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
26	CD	O	O
-	:	O	O
year-old	JJ	O	O
female	NN	O	O
with	IN	O	O
a	DT	O	O
past	JJ	O	O
medical	JJ	O	O
history	NN	O	O
significant	JJ	O	O
for	IN	O	O
nonischemic	JJ	B-PROBLEM	B-PROBLEM
dilated	VBN	I-PROBLEM	I-PROBLEM
cardiomyopathy	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
an	DT	B-TEST	B-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
15-20%	JJ	O	O
,	,	O	O
who	WP	O	O
presents	VBZ	O	O
with	IN	O	O
a	DT	O	O
one-week	JJ	O	O
history	NN	O	O
of	IN	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
shortness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
reports	VBZ	O	O
orthopnea	NN	B-PROBLEM	O
with	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
increasing	VBG	I-PROBLEM	I-PROBLEM
pillow	JJ	I-PROBLEM	I-PROBLEM
requirement	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
2-4	JJ	O	O
with	IN	O	O
paroxysmal	JJ	B-PROBLEM	B-PROBLEM
nocturnal	JJ	I-PROBLEM	I-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
also	RB	O	O
reports	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
6-pound	JJ	I-PROBLEM	I-PROBLEM
weight	NN	I-PROBLEM	I-PROBLEM
gain	NN	I-PROBLEM	I-PROBLEM
over	IN	O	O
the	DT	O	O
last	JJ	O	O
four	CD	O	O
days	NNS	O	O
with	IN	O	O
associated	JJ	O	B-PROBLEM
lower	JJR	B-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
also	RB	O	O
reports	VBZ	O	O
positional	JJ	B-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
is	VBZ	O	O
worse	JJR	O	O
with	IN	O	O
lying	VBG	O	O
down	RP	O	O
and	CC	O	O
relieved	VBN	O	O
with	IN	O	O
sitting	VBG	O	O
up	RP	O	O
.	.	O	O

she	PRP	O	O
denies	VBZ	O	O
any	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
activity	NN	O	O
.	.	O	O

she	PRP	O	O
also	RB	O	O
reports	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
cough	JJ	I-PROBLEM	I-PROBLEM
productive	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
green	JJ	B-PROBLEM	I-PROBLEM
sputum	NN	I-PROBLEM	I-PROBLEM
for	IN	O	O
approximately	RB	O	O
one	CD	O	O
week	NN	O	O
.	.	O	O

she	PRP	O	O
does	VBZ	O	O
report	NN	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
but	CC	O	O
no	DT	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

in	IN	O	O
the	DT	O	O
emergency	NN	O	O
department	NN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
nesiritide	JJ	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
responded	VBD	O	O
well	RB	O	O
with	IN	O	O
2000	CD	O	O
cc	NN	O	O
urine	JJ	O	B-TEST
output	NN	O	I-TEST
.	.	O	O

1.	CD	O	O
nonischemic	JJ	B-PROBLEM	B-PROBLEM
dilated	VBN	I-PROBLEM	I-PROBLEM
cardiomyopathy	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
an	DT	B-TEST	B-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
15-20%	JJ	O	B-PROBLEM
.	.	O	O

2.	CD	O	O
status	NN	O	O
post	NN	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
in	IN	O	O
2011-11-19	CD	O	O
which	WDT	O	O
showed	VBD	O	O
normal	JJ	O	O
coronaries	NNS	O	O
.	.	O	O

1.	CD	O	O
toprol	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

2.	CD	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

3.	CD	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

4.	CD	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

5.	CD	O	O
flovent	NN	B-TREATMENT	O
.	.	O	O

6.	CD	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

7.	CD	O	O
lisinopril	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
family	NN	O	O
history	NN	O	O
of	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
of	IN	O	O
98.1	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
130/99	CD	O	O
,	,	O	O
pulse	NN	B-TEST	B-TEST
of	IN	O	O
111	CD	O	O
,	,	O	O
respiratory	JJ	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
16	CD	O	O
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
in	IN	O	O
no	DT	O	O
apparent	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
obese	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
slightly	RB	B-PROBLEM	B-PROBLEM
tachypneic	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
jvd	NN	B-PROBLEM	O
to	TO	O	O
angle	VB	O	O
of	IN	O	O
the	DT	O	O
jaw	NN	O	O
,	,	O	O
no	DT	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
got	VBD	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
basilar	JJ	I-PROBLEM	I-PROBLEM
crackles	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
wheezing	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

cardiac	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
:	:	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	O	O
normal	JJ	O	O
s1	NN	O	O
,	,	O	O
s2	NN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
2/6	CD	I-PROBLEM	I-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
ejection	NN	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
sternal	JJ	I-PROBLEM	I-PROBLEM
border	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	O	B-PROBLEM
positive	JJ	O	I-PROBLEM
s4	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	O	O
abdomen	NNS	O	O
was	VBD	O	O
obese	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2+	CD	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
knees	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
9.3	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
of	IN	O	O
37.7	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
of	IN	O	O
293	CD	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	O
ck	NN	I-TEST	O
of	IN	O	O
212	CD	O	O
and	CC	O	O
mb	NN	B-TEST	O
of	IN	O	O
21	CD	O	O
,	,	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
troponin	NN	I-TEST	I-TEST
of	IN	O	O
0.56	CD	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	O
chem-7	JJ	I-TEST	O
which	WDT	O	O
was	VBD	O	O
normal	JJ	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
an	DT	B-TEST	O
inr	NN	I-TEST	O
of	IN	O	O
1.5	CD	O	O
on	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
showed	VBD	O	O
right	JJ	B-PROBLEM	B-PROBLEM
patchy	NN	I-PROBLEM	I-PROBLEM
opacity	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

ekg	NN	B-TEST	O
showed	VBD	O	O
sinus	JJ	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
borderline	NN	B-PROBLEM	O
left	VBD	I-PROBLEM	O
axis	RB	I-PROBLEM	O
,	,	O	O
normal	JJ	O	O
intervals	NNS	O	O
,	,	O	O
lvh	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
left	VBD	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
enlargement	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
q	NN	B-PROBLEM	B-PROBLEM
waves	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
p-r	JJ	B-PROBLEM	B-PROBLEM
depressions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
st	NN	B-PROBLEM	B-PROBLEM
segment	NN	I-PROBLEM	I-PROBLEM
elevations	NNS	I-PROBLEM	I-PROBLEM
or	CC	O	O
depression	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1.	CD	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

patient	NN	O	O
was	VBD	O	O
diuresed	VBN	O	O
effectively	RB	O	O
with	IN	O	O
nesiritide	JJ	B-TREATMENT	B-TREATMENT
and	CC	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

patient	NN	B-TEST	B-TEST
's	POS	I-TEST	I-TEST
weight	NN	I-TEST	I-TEST
on	IN	O	O
admission	NN	O	O
was	VBD	O	O
250	CD	O	O
pounds	NNS	O	O
,	,	O	O
and	CC	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
was	VBD	O	O
244	CD	O	O
pounds	NNS	O	O
which	WDT	O	O
was	VBD	O	O
back	RB	O	O
to	TO	O	O
her	PRP$	B-TEST	B-TREATMENT
dry	JJ	I-TEST	I-TREATMENT
weight	NN	I-TEST	I-TREATMENT
.	.	O	O

patient	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
her	PRP	B-TREATMENT	B-TREATMENT
toprol	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
her	PRP	B-TREATMENT	O
lisinopril	NN	I-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
digoxin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

patient	NN	B-TREATMENT	B-TREATMENT
's	POS	I-TREATMENT	I-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
held	VBN	O	O
for	IN	O	O
right	JJ	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
and	CC	O	O
biopsy	NN	B-TEST	B-TEST
,	,	O	O
and	CC	O	O
then	RB	O	O
ep	VB	B-TEST	B-TEST
study	NN	I-TEST	I-TEST
with	IN	O	O
icd	JJ	B-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

patient	NN	O	O
did	VBD	O	O
have	VB	O	O
woodrow	NN	O	B-PROBLEM
betty	NN	O	I-PROBLEM
,	,	O	O
spep	NN	B-TEST	O
,	,	O	O
and	CC	O	O
anticardiolipin	VB	B-TEST	B-TEST
antibody	NN	I-TEST	I-TEST
sent	NN	O	O
for	IN	O	O
further	JJ	B-TEST	B-TEST
workup	NN	I-TEST	I-TEST
of	IN	O	O
the	DT	O	O
etiology	NN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
courtney	NN	O	O
,	,	O	O
spep	NN	B-TEST	O
,	,	O	O
and	CC	O	O
anticardiolipin	IN	B-TEST	B-TEST
antibody	NN	I-TEST	I-TEST
were	VBD	O	O
all	DT	O	O
negative	JJ	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
cks	NNS	I-TEST	I-TEST
did	VBD	O	O
trend	NN	O	O
down	RP	O	O
over	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
her	PRP$	O	O
hospital	NN	O	O
stay	NN	O	O
,	,	O	O
and	CC	O	O
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
her	PRP$	O	B-PROBLEM
known	JJ	O	I-PROBLEM
clean	JJ	O	I-PROBLEM
coronaries	NNS	O	I-PROBLEM
on	IN	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
in	IN	O	O
2011-11-19	JJ	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
believed	VBN	O	O
that	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
myocarditis	NN	I-PROBLEM	I-PROBLEM
might	MD	O	O
be	VB	O	O
the	DT	O	O
cause	NN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
elevated	JJ	I-PROBLEM	I-PROBLEM
cardiac	JJ	I-PROBLEM	I-PROBLEM
enzymes	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
also	RB	O	O
could	MD	O	O
have	VB	O	O
exacerbated	VBN	O	B-PROBLEM
her	PRP$	B-PROBLEM	I-PROBLEM
congestive	JJ	I-PROBLEM	I-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
did	VBD	O	O
receive	VB	O	O
a	DT	B-TEST	B-TEST
right	JJ	I-TEST	I-TEST
heart	NN	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
,	,	O	O
which	WDT	O	O
showed	VBD	O	O
elevated	VBD	B-PROBLEM	B-PROBLEM
wedge	NN	I-PROBLEM	I-PROBLEM
pressures	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
biopsy	NN	B-TEST	B-TEST
specimens	NNS	I-TEST	I-TEST
were	VBD	O	O
obtained	VBN	O	O
of	IN	O	O
the	DT	O	O
right	JJ	O	O
ventricle	NN	O	O
.	.	O	O

the	DT	O	O
results	NNS	O	O
of	IN	O	O
these	DT	B-TEST	B-TEST
biopsies	NNS	I-TEST	I-TEST
are	VBP	O	O
still	RB	O	O
pending	VBG	O	O
in	IN	O	O
pathology	NN	O	O
.	.	O	O

post	NN	O	O
right	JJ	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
and	CC	O	I-TEST
right	JJ	B-TEST	I-TEST
ventricular	NN	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
sent	VBN	O	O
to	TO	O	O
the	DT	O	O
ccu	NN	O	O
for	IN	O	O
a	DT	B-TREATMENT	B-TEST
swan	NN	I-TREATMENT	I-TEST
-	:	I-TREATMENT	O
guided	JJ	I-TREATMENT	O
therapy	NN	I-TREATMENT	O
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
elevated	JJ	I-PROBLEM	I-PROBLEM
wedge	NN	I-PROBLEM	I-PROBLEM
pressures	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
low	JJ	B-PROBLEM	B-PROBLEM
cardiac	NN	I-PROBLEM	I-PROBLEM
output	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

in	IN	O	O
the	DT	O	O
ccu	NN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
put	VBN	O	O
on	IN	O	O
milrinone	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
good	JJ	O	O
results	NNS	O	O
.	.	O	O

patient	NN	O	O
was	VBD	O	O
also	RB	O	O
seen	VBN	O	O
by	IN	O	O
the	DT	O	O
pulmonary	JJ	O	O
service	NN	O	O
here	RB	O	O
and	CC	O	O
had	VBD	O	O
pulmonary	JJ	B-TEST	B-TEST
function	NN	I-TEST	I-TEST
tests	NNS	I-TEST	I-TEST
done	VBN	O	O
as	IN	O	O
part	NN	O	O
of	IN	O	O
a	DT	B-TEST	B-TEST
pretransplant	JJ	I-TEST	I-TEST
workup	NN	I-TEST	I-TEST
.	.	O	O

patient	NN	O	O
did	VBD	O	O
receive	VB	O	O
an	DT	B-TREATMENT	B-TREATMENT
icd	NN	I-TREATMENT	I-TREATMENT
during	IN	O	O
this	DT	O	O
hospital	JJ	O	O
admission	NN	O	O
without	IN	O	O
complication	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

patient	NN	O	O
was	VBD	O	O
in	IN	O	O
bigeminy	NN	B-PROBLEM	B-PROBLEM
during	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
her	PRP$	O	O
hospital	NN	O	O
stay	NN	O	O
,	,	O	O
and	CC	O	O
did	VBD	O	O
have	VB	O	O
frequent	JJ	O	O
runs	NNS	O	O
of	IN	O	O
ectopy	NN	B-PROBLEM	B-TREATMENT
as	IN	O	O
noted	VBN	O	O
on	IN	O	O
telemetry	NN	B-TEST	B-TEST
.	.	O	O

2.	CD	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
lower	RBR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
infiltrate	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

patient	NN	O	O
did	VBD	O	O
report	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
cough	JJ	I-PROBLEM	I-PROBLEM
productive	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
green	JJ	B-PROBLEM	I-PROBLEM
sputum	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
admission	NN	O	O
.	.	O	O

she	PRP	O	O
received	VBD	O	O
a	DT	O	O
full	JJ	O	O
course	NN	O	O
of	IN	O	O
azithromycin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
this	DT	O	O
with	IN	O	O
resolution	NN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
cough	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
sputum	NN	B-PROBLEM	B-TEST
production	NN	I-PROBLEM	I-TEST
.	.	O	O

on	IN	O	O
discharge	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
restarted	VBN	O	O
on	IN	O	O
her	PRP	B-TREATMENT	O
coumadin	NN	I-TREATMENT	B-TREATMENT
,	,	O	O
which	WDT	O	O
was	VBD	O	O
held	VBN	O	O
for	IN	O	O
her	PRP$	B-TEST	B-TEST
right	JJ	I-TEST	I-TEST
heart	NN	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
,	,	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
biopsy	NN	I-TEST	I-TEST
,	,	O	O
and	CC	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
icd	JJ	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
also	RB	O	O
continued	VBN	O	O
on	IN	O	O
all	DT	B-TREATMENT	O
her	PRP$	I-TREATMENT	B-PROBLEM
heart	NN	I-TREATMENT	I-PROBLEM
failure	NN	I-TREATMENT	I-PROBLEM
medications	NNS	I-TREATMENT	I-PROBLEM
including	VBG	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
toprol	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
her	PRP	B-TREATMENT	O
lisinopril	NN	I-TREATMENT	B-TREATMENT
,	,	O	O
her	PRP	B-TREATMENT	B-TREATMENT
digoxin	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
lasix	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

nonischemic	RB	B-PROBLEM	B-PROBLEM
dilated	VBN	I-PROBLEM	I-PROBLEM
cardiomyopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
375	CD	O	O
mcg	NN	O	O
and	CC	O	O
250	CD	O	O
mcg	NN	O	O
alternating	VBG	O	O
doses	NNS	O	O
each	DT	O	O
day	NN	O	O
.	.	O	O

2.	CD	O	O
lisinopril	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

3.	CD	O	O
toprol	NN	B-TREATMENT	B-TREATMENT
xl	VBD	I-TREATMENT	O
75	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

4.	CD	O	O
flovent	JJ	B-TREATMENT	B-TREATMENT
110	CD	O	O
mcg	NN	O	O
two	CD	O	O
puffs	NNS	O	O
b.i.d.	VBP	O	O

5.	CD	O	O
albuterol	JJ	B-TREATMENT	B-TREATMENT
1-2	JJ	O	O
puffs	NNS	O	O
q.6h.	JJ	O	O
prn	NN	O	O
.	.	O	O

6.	CD	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.h.s.	NN	O	O

7.	CD	O	O
lasix	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

8.	CD	O	O
keflex	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
x6	NN	O	O
doses	NNS	O	O
.	.	O	O

patient	NN	O	O
will	MD	O	O
also	RB	O	O
followup	VB	O	O
with	IN	O	O
her	PRP	O	O
primary	JJ	O	O
care	NN	O	O
provider	NN	O	O
,	,	O	O
dr.	NN	O	O
sandra	NN	O	O
lamar	NN	O	O
for	IN	O	O
check	NN	O	O
of	IN	O	O
her	PRP$	B-TEST	O
inr	NN	I-TEST	O
in	IN	O	O
one	CD	O	O
week	NN	O	O
's	POS	O	O
time	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
presented	VBN	O	O
with	IN	O	O
a	DT	O	O
chief	JJ	O	O
complaint	NN	O	O
of	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
/	JJ	O	O
assault	NN	O	B-PROBLEM
.	.	O	O

following	VBG	O	O
evaluation	NN	B-TEST	B-TEST
and	CC	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
the	DT	O	O
patient	NN	O	O
&apos;s	JJ	O	O
disposition	NN	O	O
at	IN	O	O
the	DT	O	O
end	NN	O	O
of	IN	O	O
the	DT	O	O
visit	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
observation	NN	O	O
at	IN	O	O
ph	JJ	O	O
university	NN	O	O
of	IN	O	O
medical	JJ	O	O
center	NN	O	O
.	.	O	O

your	PRP$	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
under	IN	O	O
the	DT	O	O
care	NN	O	O
of	IN	O	O
shuffcuch	JJ	O	O
,	,	O	O
seysharmse	JJ	O	O
n	NN	O	O
with	IN	O	O
a	DT	O	O
preliminary	JJ	O	O
diagnosis	NN	O	O
of	IN	O	O
vertebral	JJ	B-PROBLEM	B-PROBLEM
fractures	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
recorded	VBD	O	O
as	IN	O	O
having	VBG	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
to	TO	O	O
drugs	NNS	B-TREATMENT	B-TREATMENT

hypoxia	NN	B-PROBLEM	B-PROBLEM

cc	NN	O	O
:	:	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM

86	CD	O	O
yo	JJ	O	O
man	NN	O	O
with	IN	O	O
h/o	JJ	O	O
cva	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
chf	NN	B-PROBLEM	O
,	,	O	O
recent	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
who	WP	O	O
p/w	VBP	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
from	IN	O	O
his	PRP$	O	O
nh	NN	O	O
.	.	O	O

per	IN	O	O
the	DT	O	O
pt	NN	O	O
's	POS	O	O
daughter	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
had	VBN	O	O
2-3	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
asp	JJ	B-PROBLEM	O
pna	NN	I-PROBLEM	O
in	IN	O	O
the	DT	O	O
last	JJ	O	O
2	CD	O	O
months	NNS	O	O
,	,	O	O
for	IN	O	O
which	WDT	O	O
he	PRP	O	O
has	VBZ	O	O
received	VBN	O	O
iv	JJ	B-TREATMENT	O
abx	NN	I-TREATMENT	O
at	IN	O	O
the	DT	O	O
nh	NN	O	O
with	IN	O	O
apparent	JJ	O	O
resolution	NN	O	O
of	IN	O	O
symptoms	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

of	IN	O	O
note	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
daughter	NN	O	O
and	CC	O	O
son-in-law	NN	O	O
confirm	NN	O	O
his	PRP$	O	O
desire	NN	O	O
to	TO	O	O
be	VB	O	O
dnr/dni	JJ	B-TREATMENT	O
,	,	O	O
stating	VBG	O	O
that	IN	O	O
they	PRP	O	O
want	VBP	O	O
him	PRP	O	O
to	TO	O	O
be	VB	O	O
comfortable	JJ	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
when	WRB	O	O
asked	VBN	O	O
if	IN	O	O
she	PRP	O	O
thinks	VBZ	O	O
he	PRP	O	O
would	MD	O	O
want	VB	O	O
comfort	NN	B-TREATMENT	B-TREATMENT
measures	NNS	I-TREATMENT	I-TREATMENT
even	RB	O	O
if	IN	O	O
it	PRP	O	O
meant	VBD	O	O
that	IN	O	O
his	PRP$	O	B-PROBLEM
respiratory	NN	O	I-PROBLEM
status	NN	O	I-PROBLEM
would	MD	O	I-PROBLEM
worsen	VB	O	I-PROBLEM
,	,	O	O
the	DT	O	O
pt	NN	O	O
's	POS	O	O
daughter	NN	O	O
says	VBZ	O	O
that	IN	O	O
he	PRP	O	O
would	MD	O	O
not	RB	O	O
.	.	O	O

in	IN	O	O
particular	JJ	O	O
,	,	O	O
she	PRP	O	O
feels	VBZ	O	O
that	IN	O	O
the	DT	O	O
pt	NN	O	O
would	MD	O	O
not	RB	O	O
want	VB	O	O
a	DT	B-TREATMENT	B-TREATMENT
morphine	NN	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
if	IN	O	O
it	PRP	O	O
would	MD	O	O
negatively	RB	O	O
impact	VB	O	O
his	PRP$	O	O
respiratory	NN	O	O
function	NN	O	O
.	.	O	O

-	:	O	O
dm2	NN	B-PROBLEM	O
,	,	O	O
with	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
background	NN	I-PROBLEM	I-PROBLEM
diabetic	JJ	I-PROBLEM	I-PROBLEM
retinopathy	NN	I-PROBLEM	I-PROBLEM

-	:	O	O
cva	NN	B-PROBLEM	O
x	VBZ	O	O
2	CD	O	O
,	,	O	O
1970	CD	O	O
and	CC	O	O
1996	CD	O	O

-	:	O	O
htn	NN	B-PROBLEM	B-PROBLEM

-	:	O	O
cad	NN	B-PROBLEM	B-PROBLEM

-	:	O	O
chf	NN	B-PROBLEM	O
,	,	O	O
lvef	VBZ	B-TEST	O
unknown	JJ	O	O

-	:	O	O
pvd	NN	B-PROBLEM	O
,	,	O	O
s/p	JJ	O	O
femoral-popliteal	JJ	B-TREATMENT	B-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT

-	:	O	O
renal	NN	B-PROBLEM	B-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
ca	MD	I-PROBLEM	I-PROBLEM
,	,	O	O
s/p	VB	O	O
left	VBN	B-TREATMENT	B-TREATMENT
nephrectomy	JJ	I-TREATMENT	I-TREATMENT
1992	CD	O	O

-	:	O	O
bph	NN	B-PROBLEM	B-PROBLEM

-	:	O	O
dementia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
since	IN	O	O
2000	CD	O	O
,	,	O	O
baseline	NN	B-TEST	O
mmse	NN	I-TEST	O
21/29	CD	O	O

-	:	O	O
s/p	NN	O	B-PROBLEM
fall	NN	O	I-PROBLEM
with	IN	O	O
right	JJ	B-PROBLEM	B-PROBLEM
hip	NN	I-PROBLEM	I-PROBLEM
fx	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
orif	NN	B-TREATMENT	O

-	:	O	O
moderate	NN	B-PROBLEM	B-PROBLEM
r	NN	I-PROBLEM	I-PROBLEM
sided	VBD	I-PROBLEM	I-PROBLEM
macular	JJ	I-PROBLEM	I-PROBLEM
degeneration	NN	I-PROBLEM	I-PROBLEM

-	:	O	O
depression	NN	B-PROBLEM	B-PROBLEM

-	:	O	O
s/p	NN	O	B-TREATMENT
right	JJ	B-TREATMENT	I-TREATMENT
inguinal	JJ	I-TREATMENT	I-TREATMENT
hernia	NN	I-TREATMENT	I-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT

t	NN	B-TEST	O
102.8	CD	O	O

hr	NN	B-TEST	B-TEST
113	CD	O	O

bp	NN	B-TEST	B-TEST
157/85	CD	O	O

rr	NN	B-TEST	B-TEST
35	CD	O	O

sat	RB	B-TEST	B-TEST
97%	CD	O	O
on	IN	O	O
bipap	NN	B-TREATMENT	B-TREATMENT

gen	NN	O	O
:	:	O	O
frail	NN	B-PROBLEM	O
,	,	O	O
elderly	JJ	O	O
caucasian	JJ	O	O
man	NN	O	O
lying	VBG	O	O
in	IN	O	O
stretcher	NN	O	O
,	,	O	O
hob	NN	O	O
at	IN	O	O
45	CD	O	O
degrees	NNS	O	O
,	,	O	O
breathing	VBG	O	B-PROBLEM
in	IN	O	I-PROBLEM
moderate	JJ	B-PROBLEM	I-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
accessory	JJ	B-PROBLEM	O
muscle	NN	I-PROBLEM	O
use	NN	I-PROBLEM	O

bipap	NN	B-TREATMENT	B-TREATMENT
mask	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
place	NN	O	O
with	IN	O	O
no	DT	O	O
apparent	JJ	B-PROBLEM	B-PROBLEM
leak	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
eyes	NNS	O	O
closed	VBD	O	O
,	,	O	O
mouth	NN	O	O
open	JJ	O	O
,	,	O	O
no	DT	O	O
rhinorhea	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
oral	JJ	B-PROBLEM	O
discharge	NN	I-PROBLEM	O
visible	JJ	O	O

jvp	NN	B-TEST	O
flat	JJ	O	O

cv	NN	O	O
:	:	O	O
difficult	JJ	O	O
to	TO	O	O
assess	VB	O	O
heart	NN	O	B-PROBLEM
sounds	VBZ	O	I-PROBLEM
over	IN	O	I-PROBLEM
respiratory	JJ	O	I-PROBLEM
sounds	NNS	O	I-PROBLEM
,	,	O	O
but	CC	O	O
appears	VBZ	O	O
to	TO	O	O
have	VB	O	O
rrr	NN	O	O
,	,	O	O
nl	JJ	O	O
s1	NN	O	O
s2	NN	O	O
,	,	O	O
no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM

r	VB	O	O
lower	JJR	O	O
01-20	NN	O	O
with	IN	O	O
coarse	JJ	B-PROBLEM	B-PROBLEM
bs	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
rales	NNS	B-PROBLEM	I-PROBLEM
;	:	O	O
l	JJ	O	O
side	NN	O	O
clear	JJ	O	O
;	:	O	O
no	DT	O	O
wheezing	NN	B-PROBLEM	B-PROBLEM

abd	NN	O	O
:	:	O	O
thin	JJ	O	O
,	,	O	O
nd	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
nt	JJ	B-PROBLEM	O
,	,	O	O
soft	JJ	O	O
,	,	O	O
no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
palpable	JJ	O	I-PROBLEM

ext	NN	O	O
:	:	O	O
thin	NN	O	O
,	,	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
old	JJ	I-PROBLEM	I-PROBLEM
well-healed	JJ	I-PROBLEM	I-PROBLEM
scars	NNS	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
r	NN	I-PROBLEM	I-PROBLEM
leg	NN	I-PROBLEM	I-PROBLEM

skin	NN	O	O
:	:	O	O
warm	JJ	O	O
and	CC	O	O
dry	JJ	O	O
,	,	O	O
no	DT	O	O
rash	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
breakdown	NN	B-PROBLEM	B-PROBLEM
noted	VBD	O	O
though	RB	O	O
could	MD	O	O
not	RB	O	O
examine	VB	O	O
sacrum	NN	O	B-PROBLEM

neuro	NN	O	O
:	:	O	O
reactive	NN	O	B-PROBLEM
to	TO	O	I-PROBLEM
pain	VB	B-TEST	I-PROBLEM
,	,	O	O
otherwise	RB	O	O

2014-01-20	JJ	O	O
05:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	B-TEST	B-TEST
-	:	O	O
10.9	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
4.63	CD	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
13.6	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
40.3	CD	O	O
#	#	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
87	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
29.3	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
33.7	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
14.0	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
393	CD	O	O
#	#	O	O

2014-01-20	JJ	O	O
05:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
neuts	NNS	B-TEST	B-TEST
-	:	O	O
82.6	CD	O	O
*	NN	O	O
lymphs	SYM	B-TEST	B-TEST
-	:	O	O
14.5	CD	O	O
*	JJ	O	O
monos	NNS	B-TEST	B-TEST
-	:	O	O
2.2	CD	O	O
eos	SYM	B-TEST	B-TEST
-	:	O	O
0.2	CD	O	O
baso	SYM	B-TEST	B-TEST
-	:	O	O
0.4	CD	O	O

2014-01-20	JJ	O	O
02:08	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
pt	NN	B-TEST	I-TEST
-	:	O	O
13.2	CD	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
27.4	CD	O	O
inr	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
pt	JJ	I-TEST	I-TEST
)-	CD	I-TEST	I-TEST
1.2	CD	O	O

2014-01-20	JJ	O	O
05:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
plt	NN	B-TEST	I-TEST
ct	VBD	I-TEST	I-TEST
-	:	O	O
393	CD	O	O
#	#	O	O

2014-01-20	JJ	O	O
05:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
334	CD	O	O
*	JJ	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
22	CD	O	O
*	NN	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
0.9	CD	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
144	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
5.0	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
108	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
25	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
16	CD	O	O

2014-01-20	JJ	O	O
02:08	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
ck	NN	B-TEST	I-TEST
(	(	I-TEST	I-TEST
cpk	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
275	CD	O	O
*	NN	O	O

2014-01-20	JJ	O	O
05:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
alt	NN	B-TEST	I-TEST
-	:	O	O
15	CD	O	O
ast	IN	B-TEST	O
-	:	O	O
22	CD	O	O
ld	NN	B-TEST	O
(	(	I-TEST	B-TEST
ldh	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
254	CD	O	O
*	JJ	O	O
ck	NN	B-TEST	B-TEST
(	(	I-TEST	I-TEST
cpk	JJ	I-TEST	I-TEST
)-	JJ	I-TEST	I-TEST
398	CD	O	O
*	NN	O	O
alkphos	SYM	B-TEST	B-TEST
-	:	O	O
125	CD	O	O
*	NN	O	O
totbili	SYM	B-TEST	B-TEST
-	:	O	O
0.5	CD	O	O

2014-01-20	JJ	O	O
02:08	CD	O	O
pm	JJ	O	O
blood	NN	B-TEST	B-TEST
ck-mb	JJ	B-TEST	B-TEST
-	:	O	O
9	CD	O	O
ctropnt	NN	B-TEST	B-TEST
-	:	O	O
0.08	CD	O	O
*	NN	O	O

2014-01-20	JJ	O	O
05:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
ctropnt	NN	B-TEST	B-TEST
-	:	O	O
0.05	CD	O	O
*	NN	O	O

2014-01-20	JJ	O	O
05:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
ck-mb	JJ	B-TEST	B-TEST
-	:	O	O
7	CD	O	O

2014-01-20	JJ	O	O
05:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
albumin	NN	B-TEST	I-TEST
-	:	O	O
3.2	CD	O	O
*	JJ	O	O
calcium	NN	B-TEST	B-TEST
-	:	O	O
9.3	CD	O	O
phos	NN	B-TEST	B-TEST
-	:	O	O
4.2	CD	O	O
mg	SYM	B-TEST	O
-	:	O	O
1.8	CD	O	O

abg	NN	B-TEST	B-TEST
s:	NN	I-TEST	I-TEST

2014-01-20	JJ	O	O
10:46	CD	O	O
pm	NN	O	B-TEST
blood	NN	B-TEST	I-TEST
type	NN	O	I-TEST
-	:	O	O
art	NN	B-TEST	O
po2	VBZ	B-TEST	O
-	:	O	O
148	CD	O	O
*	NN	O	O
pco2	NN	B-TEST	B-TEST
-	:	O	O
129	CD	O	O
*	NN	O	O
ph	NN	B-TEST	B-TEST
-	:	O	O
7.03	CD	O	O
*	NN	O	O
calhco3	NN	B-TEST	B-TEST
-	:	O	O
37	CD	O	O
*	JJ	O	O
base	NN	B-TEST	B-TEST
xs	NNP	I-TEST	I-TEST
-	:	O	O
-1	NN	O	O

2014-01-20	JJ	O	O
11:49	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
type	NN	O	I-TEST
-	:	O	O
art	NN	B-TEST	O
peep	VBZ	B-TREATMENT	O
-	:	O	O
5	CD	O	O
fio2	JJ	B-TREATMENT	O
-	:	O	O
60	CD	O	O
po2	NN	B-TEST	O
-	:	O	O
75	CD	O	O
*	NN	O	O
pco2	NN	B-TEST	B-TEST
-	:	O	O
56	CD	O	O
*	NN	O	O
ph	NN	B-TEST	B-TEST
-	:	O	O
7.29	CD	O	O
*	NN	O	O
calhco3	NN	B-TEST	B-TEST
-	:	O	O
28	CD	O	O
base	NN	B-TEST	B-TEST
xs	NNP	I-TEST	I-TEST
-	:	O	O
0	CD	O	O
intubat	NN	O	B-TEST
-	:	O	O
not	RB	O	O
intuba	JJ	O	O
comment	NN	O	O
-	:	O	O
bipap	NN	B-TREATMENT	B-TREATMENT

2014-01-20	JJ	O	O
10:46	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	O
glucose	VB	B-TEST	B-TEST
-	:	O	O
114	CD	O	O
*	NN	O	O
lactate	NN	B-TEST	B-TEST
-	:	O	O
1.8	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
4.8	CD	O	O

2014-01-20	JJ	O	O
11:49	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
lactate	NN	B-TEST	I-TEST
-	:	O	O
3.0	CD	O	O
*	NN	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
5.1	CD	O	O

2014-01-20	JJ	O	O
11:49	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
freeca	NN	B-TEST	I-TEST
-	:	O	O
1.19	CD	O	O

cxr	NN	B-TEST	O
:	:	O	O

focal	JJ	B-PROBLEM	B-PROBLEM
consolidation	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
medial	JJ	I-PROBLEM	I-PROBLEM
aspect	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
right	NN	O	I-PROBLEM
lower	RBR	O	I-PROBLEM
lung	NN	O	I-PROBLEM

this	DT	O	O
86	CD	O	O
yo	NN	O	O
man	NN	O	O
with	IN	O	O
h/o	JJ	O	O
cva	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
chf	NN	B-PROBLEM	O
,	,	O	O
recent	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
presented	VBN	O	O
with	IN	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
from	IN	O	O
his	PRP$	O	O
nh	NN	O	O
,	,	O	O
likely	RB	O	O
from	IN	O	O
new	JJ	O	B-PROBLEM
rll	NN	B-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
zosyn	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
vanco	NN	B-TREATMENT	O
for	IN	O	O
his	PRP$	B-PROBLEM	O
presumed	JJ	I-PROBLEM	O
aspiration	NN	I-PROBLEM	O
,	,	O	O
"	NNP	B-PROBLEM	O
hospital	NN	I-PROBLEM	O
"	NN	I-PROBLEM	O
aquired	VBD	I-PROBLEM	O
pna	NN	I-PROBLEM	O
.	.	O	O

pe	NN	B-PROBLEM	O
was	VBD	O	O
considered	VBN	O	O
but	CC	O	O
less	RBR	O	O
likely	JJ	O	O
given	VBN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
fevers	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
clear	JJ	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
cxr	NN	B-TEST	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
supported	VBN	O	O
on	IN	O	O
bipap	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
his	PRP$	O	B-PROBLEM
respiratory	NN	O	I-PROBLEM
status	NN	O	I-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
abg	NN	I-TEST	I-TEST
was	VBD	O	O
attempted	VBN	O	O
in	IN	O	O
the	DT	O	O
deanna	NN	O	O
however	RB	O	O
it	PRP	O	O
was	VBD	O	O
limited	VBN	O	O
by	IN	O	O
pt	NN	B-PROBLEM	O
discomfort	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

abg	NN	B-TEST	B-TEST
on	IN	O	O
arrival	NN	O	O
to	TO	O	O
the	DT	O	O
icu	NN	O	O
was	VBD	O	O
7.29/56/75	CD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
bipap	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
and	CC	O	O
sputum	JJ	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
were	VBD	O	O
sent	VBN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
given	VBN	O	O
some	DT	B-TREATMENT	O
prn	JJ	I-TREATMENT	O
morphine	NN	I-TREATMENT	B-TREATMENT
for	IN	O	O
comfort	NN	O	O
.	.	O	O

in	IN	O	O
the	DT	O	O
evening	NN	O	O
of	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
admission	NN	O	O
he	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
increasingly	RB	B-PROBLEM	B-PROBLEM
somnolent	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
abg	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
which	WDT	O	O
was	VBD	O	O
7.03/129/148	CD	O	O
.	.	O	O

based	VBN	O	O
upon	IN	O	O
this	DT	O	O
wish	JJ	O	O
the	DT	B-TREATMENT	O
bipap	NN	I-TREATMENT	O
was	VBD	O	O
removed	VBN	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
nasal	JJ	B-TREATMENT	B-TREATMENT
cannula	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
written	VBN	O	O
for	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
morphine	NN	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
however	RB	O	O
he	PRP	O	O
expired	VBD	O	O
before	IN	O	O
this	DT	O	O
could	MD	O	O
be	VB	O	O
initiated	VBN	O	O
.	.	O	O

elevated	VBN	B-PROBLEM	B-PROBLEM
lactate	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

this	DT	O	O
was	VBD	O	O
concerning	VBG	O	O
for	IN	O	O
early	JJ	B-PROBLEM	B-PROBLEM
sepsis	NN	I-PROBLEM	I-PROBLEM
given	VBN	O	O
rll	JJ	B-PROBLEM	O
pna	NN	I-PROBLEM	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressures	NNS	I-TEST	I-TEST
remained	VBD	O	O
elevated	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
hydrated	VBN	O	O
with	IN	O	O
ns	JJ	B-TREATMENT	O
conservatively	RB	O	O
,	,	O	O
given	VBN	O	O
h/o	NN	O	O
chf	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

dm2	NN	B-PROBLEM	O
:	:	O	O

he	PRP	O	O
was	VBD	O	O
covered	VBN	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
while	IN	O	O
unstable	JJ	O	O

cad	NN	B-PROBLEM	O
:	:	O	O

he	PRP	O	O
was	VBD	O	O
not	RB	O	O
taking	VBG	O	O
any	DT	B-TREATMENT	B-TREATMENT
po	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
per	IN	O	O
hunt	NN	O	O
center	NN	O	O
rehab	NN	O	O
so	IN	O	O
all	JJ	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
held	VBN	O	O
.	.	O	O

-	:	O	O
paxil	NN	B-TREATMENT	B-TREATMENT

-	:	O	O
terazosin	NN	B-TREATMENT	B-TREATMENT

-	:	O	O
glucophage	NN	B-TREATMENT	B-TREATMENT

-	:	O	O
glyburide	NN	B-TREATMENT	B-TREATMENT

-	:	O	O
atenolol	NN	B-TREATMENT	B-TREATMENT

-	:	O	O
imdur	NN	B-TREATMENT	B-TREATMENT

pneumonia	NN	B-PROBLEM	B-PROBLEM

bilateral	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
nodules	NNS	I-PROBLEM	I-PROBLEM

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
50	CD	O	O
year-old	JJ	O	O
female	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
nodules	NNS	I-PROBLEM	I-PROBLEM
dating	VBG	O	O
back	RB	O	O
to	TO	O	O
the	DT	O	O
july	NN	O	O
of	IN	O	O
1995	CD	O	O
discovered	VBD	O	O
on	IN	O	O
a	DT	B-TEST	B-TEST
work-up	NN	I-TEST	I-TEST
for	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
adrenal	JJ	I-PROBLEM	I-PROBLEM
abnormality	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

diffuse	NN	B-PROBLEM	B-PROBLEM
adenopathy	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
and	CC	O	O
an	DT	O	B-TEST
attempt	NN	O	I-TEST
was	VBD	O	O
made	VBN	O	O
at	IN	O	O
axillary	JJ	B-TEST	B-TEST
node	NN	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
which	WDT	O	O
was	VBD	O	O
aborted	VBN	O	O
secondary	JJ	O	O
to	TO	O	O
positioning	VBG	O	O
difficulty	NN	O	O
and	CC	O	O
difficult	JJ	B-PROBLEM	B-TREATMENT
intubation	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
since	IN	O	O
then	RB	O	O
lost	VBN	O	O
to	TO	O	O
follow-up	JJ	B-TEST	O
with	IN	O	O
a	DT	O	O
recently	RB	O	O
re-establish	JJ	O	O
primary	NN	O	O
care	NN	O	O
practitioner	NN	O	O
contact	NN	O	O
.	.	O	O

follow-up	JJ	B-TEST	B-TEST
chest	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
on	IN	O	O
october	$	O	O
26	CD	O	O
,	,	O	O
1997	CD	O	O
at	IN	O	O
the	DT	O	O
ver	NN	O	O
medical	JJ	O	O
center	NN	O	O
showed	VBD	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
nodules	NNS	I-PROBLEM	I-PROBLEM
in	IN	O	O
abundant	JJ	O	O
number	NN	O	O
,	,	O	O
very	RB	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
nodes	NNS	I-PROBLEM	I-PROBLEM
seen	VBN	O	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
mediastinum	NN	O	I-PROBLEM
but	CC	O	O
no	DT	O	O
hilar	JJ	B-PROBLEM	B-PROBLEM
adenopathy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
adrenal	JJ	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
on	IN	O	O
august	JJ	O	O
6	CD	O	O
,	,	O	O
1997	CD	O	O
revealed	VBD	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
nodules	NNS	I-PROBLEM	I-PROBLEM
increasing	VBG	O	O
in	IN	O	O
size	NN	O	O
since	IN	O	O
july	NN	O	O
22	CD	O	O
,	,	O	O
1995	CD	O	O
.	.	O	O

she	PRP	O	O
denies	VBZ	O	O
any	DT	B-PROBLEM	O
hypertension	NN	I-PROBLEM	B-PROBLEM
,	,	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
diabetes	VBZ	B-PROBLEM	B-PROBLEM
mellitus	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
status	NN	O	O
post	NN	O	O
an	DT	B-TREATMENT	B-TREATMENT
open	JJ	I-TREATMENT	I-TREATMENT
cholecystectomy	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
1968	CD	O	O
,	,	O	O
status	NN	O	O
post	NN	O	O
hysterectomy	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
axillary	JJ	B-TEST	B-TEST
node	NN	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
which	WDT	O	O
failed	VBD	O	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
hiatal	JJ	B-PROBLEM	B-TREATMENT
hernia	NN	I-PROBLEM	I-TREATMENT
and	CC	O	I-TREATMENT
umbilical	JJ	B-TREATMENT	I-TREATMENT
hernia	NN	I-TREATMENT	I-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
also	RB	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
adrenal	JJ	I-PROBLEM	I-PROBLEM
disorder	NN	I-PROBLEM	I-PROBLEM
treated	VBN	O	O
with	IN	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
in	IN	O	O
the	DT	O	O
past	JJ	O	O
,	,	O	O
but	CC	O	O
not	RB	O	O
currently	RB	O	O
.	.	O	O

1)	CD	O	O
spironolactone	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

2)	CD	O	O
advil	JJ	B-TREATMENT	O
p.r.n.	NN	O	O

3)	CD	O	B-TREATMENT
topical	JJ	B-TREATMENT	I-TREATMENT
steroids	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
eczema	NN	B-PROBLEM	B-PROBLEM
p.r.n.	NN	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
140/80	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
86	CD	O	O
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
a	DT	O	O
pleasant	JJ	O	O
,	,	O	O
obese	JJ	O	B-PROBLEM
,	,	O	O
black	JJ	O	O
female	NN	O	O
in	IN	O	O
no	DT	O	O
apparent	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

her	PRP$	O	O
skin	NN	O	O
is	VBZ	O	O
intact	JJ	O	O
without	IN	O	O
lesions	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
heent	NN	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
is	VBZ	O	O
benign	JJ	O	O
.	.	O	O

her	PRP$	O	O
neck	NN	O	O
is	VBZ	O	O
slightly	RB	B-PROBLEM	B-PROBLEM
tender	VBN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
firm	NN	I-PROBLEM	I-PROBLEM
thyroid	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

her	PRP$	O	O
lungs	NNS	O	O
have	VBP	O	O
decreased	VBN	B-PROBLEM	B-PROBLEM
sounds	NNS	I-PROBLEM	I-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
fields	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
well	RB	I-PROBLEM	I-PROBLEM
healed	VBN	I-PROBLEM	I-PROBLEM
umbilical	JJ	I-PROBLEM	I-PROBLEM
hernia	NN	I-PROBLEM	I-PROBLEM
scar	NN	I-PROBLEM	I-PROBLEM
for	IN	I-PROBLEM	O
approximately	RB	I-PROBLEM	O
2	CD	I-PROBLEM	O
1/2	CD	I-PROBLEM	O
cm	NN	I-PROBLEM	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
no	DT	O	O
clubbing	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
on	IN	I-PROBLEM	O
her	PRP$	I-PROBLEM	O
extremities	NNS	I-PROBLEM	O
.	.	O	O

pulmonary	JJ	B-TEST	B-TEST
function	NN	I-TEST	I-TEST
tests	NNS	I-TEST	I-TEST
on	IN	O	O
september	NN	O	O
27	CD	O	O
,	,	O	O
1997	CD	O	O
revealed	VBD	O	O
an	DT	B-TEST	O
fvc	NN	I-TEST	O
of	IN	O	O
2.7	CD	O	O
which	WDT	O	O
is	VBZ	O	O
112%	CD	O	O
and	CC	O	O
fev1	NN	B-TEST	O
of	IN	O	O
2.23	CD	O	O
which	WDT	O	O
is	VBZ	O	O
123%	CD	O	O
.	.	O	O

her	PRP$	O	B-TEST
admission	NN	O	I-TEST
laboratory	NN	O	I-TEST
data	NNS	O	I-TEST
includes	VBZ	O	I-TEST
serum	JJ	B-TEST	I-TEST
chemistries	NNS	I-TEST	I-TEST
with	IN	O	O
a	DT	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
of	IN	O	O
144	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.1	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
101	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
28	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
10	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
0.9	CD	O	O
and	CC	O	O
glucose	VB	B-TEST	B-TEST
of	IN	O	O
93	CD	O	O
.	.	O	O

white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
is	VBZ	O	O
7.65	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
of	IN	O	O
42	CD	O	O
and	CC	O	O
platelets	NNS	B-TEST	B-TEST
of	IN	O	O
345	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
urinalysis	NN	I-TEST	I-TEST
shows	VBZ	O	O
2+	CD	B-PROBLEM	B-PROBLEM
bacteria	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
2+	CD	B-PROBLEM	B-PROBLEM
squamous	JJ	I-PROBLEM	I-PROBLEM
epithelium	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
greater	JJR	B-PROBLEM	O
than	IN	I-PROBLEM	O
10,000	CD	I-PROBLEM	O
mixed	JJ	I-PROBLEM	B-PROBLEM
bacteria	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
on	IN	O	O
august	JJ	O	O
6	CD	O	O
,	,	O	O
1997	CD	O	O
revealed	VBD	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
nodules	NNS	I-PROBLEM	I-PROBLEM
increased	VBN	O	O
in	IN	O	O
size	NN	O	O
as	IN	O	O
previously	RB	O	O
mentioned	VBN	O	O
.	.	O	O

pt	NN	B-TEST	O
was	VBD	O	O
11.7	CD	O	O
,	,	O	O
ptt	NN	B-TEST	B-TEST
26.7	CD	O	O
and	CC	O	O
inr	NN	B-TEST	O
of	IN	O	O
0.9	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
on	IN	O	O
december	NN	O	O
5	CD	O	O
,	,	O	O
1997	CD	O	O
and	CC	O	O
underwent	JJ	O	O
left	NN	B-TREATMENT	B-TEST
lung	NN	I-TREATMENT	I-TEST
wedge	VBP	I-TREATMENT	I-TEST
thoracoscopic	NN	I-TREATMENT	I-TEST
resection	NN	I-TREATMENT	I-TEST
and	CC	O	I-TEST
bronchoscopy	NN	B-TREATMENT	I-TEST
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
chest	JJS	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
pulled	VBN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
one	CD	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
did	VBD	O	O
quite	RB	O	O
well	RB	O	O
and	CC	O	O
remained	VBD	O	O
inhouse	NN	O	O
for	IN	O	O
observation	NN	B-TEST	O
until	IN	O	O
december	NNP	O	O
7	CD	O	O
,	,	O	O
1997	CD	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
discharged	VBN	O	O
to	TO	O	O
home	NN	O	O
in	IN	O	O
stable	JJ	O	O
condition	NN	O	O
.	.	O	O

1)	CD	O	O
lac-hydrin	JJ	B-TREATMENT	O
12%	CD	O	O
topically	RB	O	O
b.i.d.	JJ	O	O

2)	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O

3)	CD	O	O
tylenol	JJ	B-TREATMENT	B-TREATMENT
#	#	I-TREATMENT	I-TREATMENT
3	CD	I-TREATMENT	I-TREATMENT
tablets	NNS	O	I-TREATMENT
rather	RB	O	O
than	IN	O	O
percocet	VB	B-TREATMENT	B-TREATMENT
,	,	O	O
1-2	JJ	O	O
tablets	NNS	O	O
p.o.	VBP	O	O
q.4-6h.	JJ	O	O
p.r.n.	NN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

4)	CD	O	O
spironolactone	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
64-year-old	JJ	O	O
female	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
diabetes	VBZ	B-PROBLEM	B-PROBLEM
mellitus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
dilated	VBD	B-PROBLEM	B-PROBLEM
cardiomyopathy	NNS	I-PROBLEM	I-PROBLEM
(	(	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
transthoracic	JJ	I-TEST	I-TEST
echocardiogram	NN	I-TEST	I-TEST
in	IN	O	O
2016-01-13	JJ	O	O
showing	VBG	O	O
an	DT	B-TEST	B-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
40%	CD	O	O
,	,	O	O
posterior	NN	B-PROBLEM	O
and	CC	I-PROBLEM	O
inferior	JJ	I-PROBLEM	B-PROBLEM
apical	JJ	I-PROBLEM	I-PROBLEM
akinesis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
large	JJ	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
thrombus	NN	I-PROBLEM	I-PROBLEM
).	NN	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
from	IN	O	O
2016-01-21	JJ	O	O
to	TO	O	O
2016-02-03	JJ	O	O
;	:	O	O
at	IN	O	O
which	WDT	O	O
time	NN	O	O
she	PRP	O	O
was	VBD	O	O
ruled	VBN	O	O
out	RP	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
which	WDT	O	O
revealed	VBD	O	O
3-vessel	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
normal	JJ	O	O
left	NN	O	O
main	JJ	O	O
,	,	O	O
mid	JJ	O	B-TREATMENT
left	VBD	O	I-TREATMENT
anterior	JJ	O	I-TREATMENT
descending	VBG	O	I-TREATMENT
artery	NN	O	I-TREATMENT
60%	CD	O	O
,	,	O	O
diffuse	RB	B-PROBLEM	B-PROBLEM
90%	CD	I-PROBLEM	I-PROBLEM
mid	JJ	I-PROBLEM	I-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
the	DT	O	O
origin	NN	O	O
of	IN	O	O
the	DT	O	O
diagonal	JJ	O	O
,	,	O	O
serial	JJ	O	O
70%	CD	O	O
and	CC	O	O
90%	CD	B-PROBLEM	O
left	VBD	I-PROBLEM	B-PROBLEM
circumflex	JJ	I-PROBLEM	I-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
90%	CD	O	O
first	JJ	O	O
obtuse	NN	O	O
marginal	NN	O	O
,	,	O	O
and	CC	O	O
mid	RB	O	B-TREATMENT
right	JJ	O	I-TREATMENT
coronary	JJ	O	I-TREATMENT
artery	NN	O	I-TREATMENT
60%	CD	O	O
.	.	O	O

during	IN	O	O
initial	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
for	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
80%	CD	O	O
to	TO	O	O
90%	CD	O	O
of	IN	O	O
the	DT	B-PROBLEM	O
right	JJ	I-PROBLEM	O
coronary	JJ	I-PROBLEM	O
artery	NN	I-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
found	VBN	O	O
;	:	O	O
for	IN	O	O
which	WDT	O	O
she	PRP	O	O
underwent	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
internal	JJ	I-TREATMENT	I-TREATMENT
carotid	NN	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
discharged	VBN	O	O
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
a	DT	O	O
goal	NN	O	O
inr	NN	B-TEST	O
of	IN	O	O
2.5	CD	O	O
to	TO	O	O
3	CD	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
then	RB	O	O
admitted	VBN	O	O
again	RB	O	O
on	IN	O	O
2016-03-30	JJ	O	O
for	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
elective	JJ	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

at	IN	O	O
surgery	NN	B-TREATMENT	O
,	,	O	O
the	DT	O	O
descending	VBG	O	O
aorta	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
calcified	VBN	B-PROBLEM	O
,	,	O	O
and	CC	O	O
an	DT	B-TEST	B-TEST
intraoperative	JJ	I-TEST	I-TEST
transesophageal	NN	I-TEST	I-TEST
echocardiogram	NN	I-TEST	I-TEST
revealed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
irregular	JJ	I-PROBLEM	I-PROBLEM
intra-aortic	JJ	I-PROBLEM	I-PROBLEM
pedunculated	VBN	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

given	VBN	O	O
the	DT	B-PROBLEM	B-PROBLEM
elevated	JJ	I-PROBLEM	I-PROBLEM
stroke	NN	I-PROBLEM	I-PROBLEM
risk	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
aortic	JJ	B-TREATMENT	I-PROBLEM
cross-clamping	NN	I-TREATMENT	I-PROBLEM
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
this	DT	O	O
finding	NN	O	O
,	,	O	O
the	DT	O	O
plan	NN	O	O
for	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
aborted	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
then	RB	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
coronary	JJ	O	O
care	NN	O	O
unit	NN	O	O
service	NN	O	O
for	IN	O	O
medical	JJ	O	B-TREATMENT
management	NN	O	I-TREATMENT
in	IN	O	O
anticipation	NN	O	O
of	IN	O	O
possible	JJ	O	O
percutaneous	JJ	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
intervention	NN	I-TREATMENT	I-TREATMENT
later	RBR	O	O
in	IN	O	O
the	DT	O	O
admission	NN	O	O
.	.	O	O

1.	CD	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

3.	CD	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

4.	CD	O	O
asthma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

5.	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
back	RB	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

6.	CD	O	O
cholelithiasis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

7.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
as	IN	O	O
noted	VBN	O	O
previously	RB	O	O
).	JJ	O	O

8.	CD	O	O
dilated	VBN	B-PROBLEM	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
also	RB	O	O
as	RB	O	O
noted	VBN	O	O
above	IN	O	O
).	NN	O	O

1.	CD	O	O
dopamine	JJ	B-TREATMENT	B-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
3	CD	O	O
.	.	O	O

2.	CD	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
2	CD	O	O
.	.	O	O

3.	CD	O	O
regular	JJ	B-TREATMENT	O
10	CD	O	O
units	NNS	O	O
intravenously	RB	O	O
q.6h.	RB	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

4.	CD	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
as	IN	O	O
needed	VBN	O	O
.	.	O	O

5.	CD	O	O
sucralfate	JJ	B-TREATMENT	O
1	CD	O	O
g	NN	O	O
via	IN	O	O
nasogastric	JJ	O	B-TREATMENT
tube	NN	O	I-TREATMENT
q.6h.	NN	O	I-TREATMENT

6.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
once	RB	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

7.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
twice	RB	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

8.	CD	O	O
flonase	NN	B-TREATMENT	B-TREATMENT
2	CD	O	O
puffs	NNS	O	O
twice	RB	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

9.	CD	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
once	RB	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

10.	CD	O	O
protonix	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
once	RB	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

11.	CD	O	O
plavix	JJ	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
once	RB	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

physical	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
revealed	VBD	O	O
temperature	NN	B-TEST	B-TEST
was	VBD	O	O
99.3	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
was	VBD	O	O
66	CD	O	O
in	IN	O	O
a	DT	O	O
normal	JJ	O	O
sinus	NN	O	O
rhythm	NN	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
132/51	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
was	VBD	O	O
22	CD	O	O
,	,	O	O
and	CC	O	O
oxygen	NN	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST
was	VBD	O	O
100%	CD	O	O
on	IN	O	O
3	CD	B-TREATMENT	B-TREATMENT
liters	NNS	I-TREATMENT	I-TREATMENT
nasal	JJ	I-TREATMENT	I-TREATMENT
cannula	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

swan	NN	B-TEST	O
showed	VBD	O	O
a	DT	B-TEST	O
pa	NN	I-TEST	O
of	IN	O	O
29/11	CD	O	O
,	,	O	O
svr	NN	B-TEST	O
of	IN	O	O
14/9	CD	O	O
,	,	O	O
cardiac	JJ	B-TEST	B-TEST
output	NN	I-TEST	I-TEST
of	IN	O	O
3.86	CD	O	O
,	,	O	O
cardiac	JJ	B-TEST	B-TEST
index	NN	I-TEST	I-TEST
of	IN	O	O
2.14	CD	O	O
.	.	O	O

urine	JJ	B-TEST	B-TEST
output	NN	I-TEST	I-TEST
of	IN	O	O
30	CD	O	O
cc	NN	O	O
to	TO	O	O
100	CD	O	O
cc	NNS	O	O
per	IN	O	O
hour	NN	O	O
over	IN	O	O
the	DT	O	O
last	JJ	O	O
four	CD	O	O
hours	NNS	O	O
.	.	O	O

chest	NN	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
showed	VBD	O	O
30	CD	O	O
cc	NNS	O	O
per	IN	O	O
hour	NN	O	O
over	IN	O	O
the	DT	O	O
last	JJ	O	O
four	CD	O	O
hours	NNS	O	O
.	.	O	O

in	IN	O	O
no	DT	O	O
apparent	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
denied	VBD	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

head	NN	B-TEST	B-TEST
,	,	I-TEST	I-TEST
eyes	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
ears	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
nose	RB	I-TEST	I-TEST
,	,	I-TEST	I-TEST
and	CC	I-TEST	I-TEST
throat	NN	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
without	IN	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

lungs	NNS	O	O
were	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
anteriorly	RB	O	O
.	.	O	O

heart	NN	O	O
was	VBD	O	O
regular	JJ	O	O
in	IN	O	O
rate	NN	B-TEST	O
and	CC	O	O
rhythm	NN	B-TEST	O
.	.	O	O

normal	JJ	O	O
first	JJ	B-TEST	O
heart	NN	I-TEST	O
sounds	NNS	I-TEST	O
and	CC	O	O
second	JJ	B-TEST	B-PROBLEM
heart	NN	I-TEST	I-PROBLEM
sounds	VBZ	I-TEST	I-PROBLEM
.	.	O	O

no	DT	O	O
audible	JJ	B-PROBLEM	B-PROBLEM
murmurs	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
nondistended	VBD	B-PROBLEM	B-PROBLEM
with	IN	O	O
active	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
.	.	O	O

extremities	NNS	O	O
were	VBD	O	O
without	IN	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

neurologic	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
nonfocal	JJ	O	O
.	.	O	O

lines	NNS	B-TREATMENT	O
included	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
antecubital	JJ	I-TREATMENT	I-TREATMENT
peripheral	JJ	I-TREATMENT	I-TREATMENT
intravenous	JJ	I-TREATMENT	I-TREATMENT
.	.	O	O

chest	JJS	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
in	IN	O	O
place	NN	O	O
in	IN	O	O
left	JJ	O	B-TREATMENT
internal	JJ	O	I-TREATMENT
jugular	NN	O	I-TREATMENT
an	DT	B-TREATMENT	I-TREATMENT
pulmonary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

laboratories	NNS	B-TEST	B-TEST
revealed	VBD	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
12.7	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
was	VBD	O	O
32.4	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
were	VBD	O	O
140	CD	O	O
,	,	O	O
and	CC	O	O
mean	JJ	B-TEST	B-TEST
cell	NN	I-TEST	I-TEST
volume	NN	I-TEST	I-TEST
was	VBD	O	O
80	CD	O	O
.	.	O	O

patient	NN	O	O
was	VBD	O	O
4.4	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
urea	JJ	I-TEST	I-TEST
nitrogen	NN	I-TEST	I-TEST
was	VBD	O	O
14	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
was	VBD	O	O
0.6	CD	O	O
,	,	O	O
and	CC	O	O
glucose	NN	B-TEST	B-TEST
was	VBD	O	O
147	CD	O	O
.	.	O	O

inr	NN	B-TEST	O
was	VBD	O	O
1.2	CD	O	O
,	,	O	O
partial	JJ	B-TEST	B-TEST
thromboplastin	NN	I-TEST	I-TEST
time	NN	I-TEST	I-TEST
was	VBD	O	O
23.7	CD	O	O
,	,	O	O
and	CC	O	O
prothrombin	JJ	B-TEST	B-TEST
time	NN	I-TEST	I-TEST
was	VBD	O	O
13.4	CD	O	O
.	.	O	O

free	JJ	B-TEST	B-TEST
calcium	NN	I-TEST	I-TEST
was	VBD	O	O
0.95	CD	O	O
on	IN	O	O
03-30	NN	O	O
.	.	O	O

phosphate	NN	B-TEST	O
was	VBD	O	O
3.6	CD	O	O
and	CC	O	O
magnesium	NN	B-TEST	B-TEST
was	VBD	O	O
2.2	CD	O	O
.	.	O	O

arterial	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
gas	NN	I-TEST	I-TEST
at	IN	O	O
3	CD	O	O
a.m.	RB	O	O
demonstrated	VBD	O	O
7.4/45/125	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
64-year-old	JJ	O	O
female	NN	O	O
with	IN	O	O
3-vessel	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
who	WP	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
coronary	JJ	O	O
care	NN	O	O
unit	NN	O	O
service	NN	O	O
for	IN	O	O
western	JJ	O	B-PROBLEM
mass	NN	O	I-PROBLEM
.	.	O	O

hospital	NN	O	O
medical	JJ	O	O
optimization	NN	O	O
and	CC	O	O
management	NN	O	B-TREATMENT
following	VBG	O	O
an	DT	B-TREATMENT	B-TREATMENT
aborted	JJ	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
when	WRB	O	O
a	DT	B-PROBLEM	B-PROBLEM
mobile	JJ	I-PROBLEM	I-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
atheroma	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
plavix	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
statin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

once	RB	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
titrated	VBN	O	O
off	RP	O	O
dopamine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
the	DT	B-TREATMENT	B-TREATMENT
beta	NN	I-TREATMENT	I-TREATMENT
blocker	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
ace	NN	B-TREATMENT	B-TREATMENT
inhibitor	NN	I-TREATMENT	I-TREATMENT
were	VBD	O	O
restarted	VBN	O	O
.	.	O	O

with	IN	O	O
regard	NN	O	O
to	TO	O	O
the	DT	B-PROBLEM	B-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
thrombus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
her	PRP$	O	B-TEST
goal	NN	O	I-TEST
inr	NN	B-TEST	I-TEST
remained	VBD	O	O
2.5	CD	O	O
to	TO	O	O
3	CD	O	O
;	:	O	O
and	CC	O	O
the	DT	O	O
goal	NN	O	O
was	VBD	O	O
to	TO	O	O
start	VB	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
once	RB	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
stable	JJ	O	O
from	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
thoracotomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
chest	NN	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT

by	IN	O	O
04-01	NNP	O	O
,	,	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
two	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
doing	VBG	O	O
well	RB	O	O
and	CC	O	O
the	DT	B-TREATMENT	B-TREATMENT
chest	JJS	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
still	RB	O	O
had	VBD	O	O
transcutaneous	JJ	B-TREATMENT	B-TREATMENT
pacing	VBG	I-TREATMENT	I-TREATMENT
wires	NNS	I-TREATMENT	I-TREATMENT
in	IN	O	O
place	NN	O	O
.	.	O	O

likewise	RB	O	O
,	,	O	O
on	IN	O	O
04-01	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
weaned	VBN	O	O
off	RP	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
without	IN	O	O
difficulty	NN	O	B-PROBLEM
.	.	O	O

thus	RB	O	O
,	,	O	O
the	DT	B-TREATMENT	B-TREATMENT
beta	NN	I-TREATMENT	I-TREATMENT
blocker	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
ace	NN	B-TREATMENT	B-TREATMENT
inhibitor	NN	I-TREATMENT	I-TREATMENT
were	VBD	O	O
started	VBN	O	O
to	TO	O	O
be	VB	O	O
titrated	VBN	O	O
up	RP	O	O
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
wellbutrin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
smoking	VBG	O	O
cessation	NN	O	O
.	.	O	O

at	IN	O	O
this	DT	O	O
point	NN	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
determined	VBN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
would	MD	O	O
not	RB	O	O
receive	VB	O	O
percutaneous	JJ	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
intervention	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
this	DT	O	O
admission	NN	O	O
and	CC	O	O
would	MD	O	O
likely	RB	O	O
be	VB	O	O
discharged	VBN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
for	IN	O	O
stabilization	NN	O	O
with	IN	O	O
followup	NN	O	O
.	.	O	O

after	IN	O	O
evaluation	NN	B-TEST	B-TEST
and	CC	O	O
a	DT	O	O
discussion	NN	O	O
with	IN	O	O
dr.	JJ	O	O
gunter	NN	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
determined	VBN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
no	RB	O	O
longer	RBR	O	O
needed	VBN	O	O
anticoagulation	NN	B-TREATMENT	B-TREATMENT
since	IN	O	O
there	EX	O	O
was	VBD	O	O
no	DT	O	O
aortic	JJ	B-PROBLEM	B-PROBLEM
thrombus	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
only	RB	O	O
an	DT	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
plaque	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
there	EX	O	O
was	VBD	O	O
no	DT	O	O
anterior/apical	JJ	B-PROBLEM	B-PROBLEM
akinesis	NN	I-PROBLEM	I-PROBLEM
noted	VBD	O	O
.	.	O	O

at	IN	O	O
this	DT	O	O
point	NN	O	O
,	,	O	O
the	DT	B-PROBLEM	B-TEST
left	NN	I-PROBLEM	I-TEST
ventricular	JJ	I-PROBLEM	I-TEST
thrombus	NN	I-PROBLEM	I-TEST
(	(	O	O
for	IN	O	O
which	WDT	O	O
she	PRP	O	O
was	VBD	O	O
initially	RB	O	O
started	JJ	O	O
therapy	NN	B-TREATMENT	O
for	IN	O	O
)	)	O	O
was	VBD	O	O
no	DT	O	O
longer	RBR	O	O
present	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
slight	JJ	I-PROBLEM	I-PROBLEM
hematocrit	NN	I-PROBLEM	I-PROBLEM
drop	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
transfused	VBN	O	O
one	CD	B-TREATMENT	O
unit	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
packed	JJ	I-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
a	DT	O	B-TEST
goal	NN	O	I-TEST
hematocrit	NN	B-TEST	I-TEST
of	IN	O	O
greater	JJR	O	O
than	IN	O	O
30	CD	O	O
.	.	O	O

by	IN	O	O
04-03	NNP	O	O
,	,	O	O
captopril	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
atenolol	NN	B-TREATMENT	B-TREATMENT
were	VBD	O	O
started	VBN	O	O
,	,	O	O
and	CC	O	O
the	DT	B-TREATMENT	B-PROBLEM
patient	NN	I-TREATMENT	I-PROBLEM
's	POS	I-TREATMENT	I-PROBLEM
leg	JJ	I-TREATMENT	I-PROBLEM
bandage	NN	I-TREATMENT	I-PROBLEM
from	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
harvest	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
removed	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
do	VB	O	O
well	RB	O	O
on	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
medical	JJ	I-TREATMENT	I-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
was	VBD	O	O
without	IN	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
any	DT	B-PROBLEM	B-PROBLEM
other	JJ	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

with	IN	O	O
dr.	JJ	O	O
gunter	NN	O	O
for	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
eventual	JJ	I-TREATMENT	I-TREATMENT
percutaneous	JJ	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
intervention	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
her	PRP$	O	O
surgeon	NN	O	O
(	(	O	O
dr.	JJ	O	O
halcomb	NN	O	O
)	)	O	O
following	VBG	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
thoracotomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

1.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
3-vessel	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
status	NN	B-TREATMENT	O
post	NN	I-TREATMENT	O
aborted	VBD	I-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
due	JJ	O	O
to	TO	O	O
mobile	VB	B-PROBLEM	O
aortic	JJ	I-PROBLEM	B-PROBLEM
atheroma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

4.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
once	RB	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

2.	CD	O	O
docusate	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
twice	RB	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

3.	CD	O	O
fluticasone	NN	B-TREATMENT	B-TREATMENT
2	CD	O	O
puffs	NNS	O	O
inhaled	JJ	O	O
twice	RB	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

4.	CD	O	O
protonix	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
once	RB	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

5.	CD	O	O
plavix	JJ	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
once	RB	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

6.	CD	O	O
pravastatin	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
once	RB	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

7.	CD	O	O
bupropion	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
twice	RB	O	O
per	IN	O	O
day	NN	O	O
(	(	O	O
for	IN	O	O
smoking	VBG	O	O
cessation	NN	O	O
).	NN	O	O

8.	CD	O	O
atenolol	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
once	RB	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

9.	CD	O	O
lisinopril	JJ	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
once	RB	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

right	JJ	B-PROBLEM	B-PROBLEM
thyroid	NN	I-PROBLEM	I-PROBLEM
papillary	JJ	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

right	JJ	B-PROBLEM	B-PROBLEM
thyroid	NN	I-PROBLEM	I-PROBLEM
papillary	JJ	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
iliac	NN	I-PROBLEM	I-PROBLEM
bone	NN	I-PROBLEM	I-PROBLEM
metastases	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
eosinophilia	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

3.	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
leg	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

5.	CD	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

6.	CD	O	O
left	VBD	B-PROBLEM	B-TREATMENT
subclavian	JJ	I-PROBLEM	I-TREATMENT
vein	NN	I-PROBLEM	I-TREATMENT
thrombosis	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

7.	CD	O	O
urinary	JJ	B-PROBLEM	B-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
74	CD	O	O
year	NN	O	O
old	JJ	O	O
female	NN	O	O
with	IN	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
papillary	JJ	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
thyroid	NN	I-PROBLEM	I-PROBLEM
who	WP	O	O
presented	VBD	O	O
to	TO	O	O
the	DT	O	O
fairm	NN	O	O
of	IN	O	O
ijordcompmac	JJ	O	O
hospital	NN	O	O
on	IN	O	O
4/28/93	CD	O	O
with	IN	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
weight	JJ	B-PROBLEM	B-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
in	IN	O	O
a	DT	O	O
good	JJ	O	O
state	NN	O	O
of	IN	O	O
health	NN	O	O
until	IN	O	O
january	NN	O	O
of	IN	O	O
1993	CD	O	O
when	WRB	O	O
she	PRP	O	O
developed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
serious	JJ	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
tract	JJ	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
associated	VBN	O	O
with	IN	O	O
weakness	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
fatigue	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
also	RB	O	O
reported	VBN	O	O
a	DT	B-PROBLEM	B-PROBLEM
weight	JJ	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	O
15	CD	I-PROBLEM	O
pounds	NNS	I-PROBLEM	O
over	IN	O	O
the	DT	O	O
past	JJ	O	O
two	CD	O	O
months	NNS	O	O
.	.	O	O

although	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
tract	JJ	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
seemed	VBD	O	O
to	TO	O	O
be	VB	O	O
resolving	VBG	O	O
,	,	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
persisted	VBN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
work	NN	I-TEST	I-TEST
up	RB	I-TEST	I-TEST
begun	VBN	O	O
by	IN	O	O
her	PRP$	O	O
internist	NN	O	O
,	,	O	O
dr.	NN	O	O
brain	NN	O	O
,	,	O	O
revealed	VBD	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
49,000	CD	O	O
with	IN	O	O
50%	CD	B-TEST	O
eosinophils	NNS	I-TEST	B-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
box	VB	O	O
memorial	JJ	O	O
hospital	NN	O	O
nursing	NN	O	O
home	NN	O	O
for	IN	O	O
further	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
.	.	O	O

data	NNS	O	O
collected	VBD	O	O
there	EX	O	O
included	VBD	O	O
a	DT	B-TEST	B-TEST
chest	NN	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
which	WDT	O	O
was	VBD	O	O
unremarkable	JJ	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
liver	NN	I-TEST	I-TEST
function	NN	I-TEST	I-TEST
tests	NNS	I-TEST	I-TEST
showed	VBD	O	O
an	DT	B-TEST	B-TEST
alkaline	JJ	I-TEST	I-TEST
phosphatase	NN	I-TEST	I-TEST
of	IN	O	O
303	CD	O	O
,	,	O	O
ldh	VBD	B-TEST	O
310	CD	O	O
,	,	O	O
sgot	VBD	B-TEST	B-TEST
66	CD	O	O
,	,	O	O
albumin	RB	B-TEST	B-TEST
2.5	CD	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
peripheral	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
smear	NN	I-TEST	I-TEST
showed	VBD	O	O
mature	NN	O	B-PROBLEM
eosinophils	NNS	O	I-PROBLEM
in	IN	O	I-PROBLEM
increased	JJ	B-PROBLEM	I-PROBLEM
numbers	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

chromosomal	JJ	B-TEST	B-TEST
studies	NNS	I-TEST	I-TEST
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
bone	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
showed	VBD	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
uptake	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
manubrium	NN	I-PROBLEM	O
at	IN	O	O
the	DT	O	O
site	NN	O	O
of	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
old	JJ	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
in	IN	O	O
the	DT	O	O
right	JJ	O	O
supraclavicular	JJ	O	O
area	NN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
thyroid	NN	I-TEST	I-TEST
ultrasound	NN	I-TEST	I-TEST
showed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
inferior	JJ	I-PROBLEM	I-PROBLEM
thyroid	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
was	VBD	O	O
followed	VBN	O	O
by	IN	O	O
an	DT	B-TEST	B-TEST
abdominal	JJ	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
enlarged	JJ	I-PROBLEM	I-PROBLEM
spleen	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
a	DT	B-PROBLEM	B-PROBLEM
lytic	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
iliac	NN	I-PROBLEM	I-PROBLEM
bone	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
benign	JJ	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
cyst	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

biopsy	NN	B-TEST	B-TEST
of	IN	I-TEST	O
the	DT	I-TEST	B-PROBLEM
lytic	JJ	I-TEST	I-PROBLEM
lesion	NN	I-TEST	I-PROBLEM
was	VBD	O	O
consistent	JJ	O	O
with	IN	O	O
metastases	NNS	B-PROBLEM	B-PROBLEM
papillary	JJ	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
thyroid	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TREATMENT
upper	JJ	I-TEST	I-TREATMENT
gastrointestinal	NN	I-TEST	I-TREATMENT
was	VBD	O	O
unremarkable	JJ	O	O
.	.	O	O

the	DT	B-TEST	O
small	JJ	I-TEST	O
bowel	NN	I-TEST	O
follow	VBP	I-TEST	O
through	IN	I-TEST	O
was	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
thyroid	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
revealed	VBD	O	O
decreased	JJ	B-PROBLEM	B-PROBLEM
function	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
displacement	NN	B-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
thyroid	NN	I-PROBLEM	I-PROBLEM
by	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
cold	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
located	VBN	O	I-PROBLEM
inferiorly	RB	O	I-PROBLEM
with	IN	O	I-PROBLEM
calcifications	NNS	B-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
side	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
chest	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
also	RB	O	O
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
nodule	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
necrotic	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
involving	VBG	O	O
the	DT	O	O
right	NN	O	O
lung	NN	O	O
posteriorly	RB	O	O
.	.	O	O

she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
profound	JJ	B-PROBLEM	B-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
a	DT	B-PROBLEM	B-PROBLEM
decreased	JJ	I-PROBLEM	I-PROBLEM
appetite	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
weight	JJ	B-PROBLEM	B-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
also	RB	O	O
developed	VBD	O	O
lower	JJR	B-PROBLEM	B-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
left	VBN	B-PROBLEM	B-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
swelling	VBG	I-PROBLEM	I-PROBLEM
associated	VBN	O	O
with	IN	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
shortness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
exertion	NN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
needle	JJ	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
right	JJ	I-TEST	I-TEST
thyroid	NN	I-TEST	I-TEST
nodule	NN	I-TEST	I-TEST
showed	VBD	O	O
papillary	JJ	B-PROBLEM	B-PROBLEM
thyroid	NN	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
reports	VBZ	O	O
no	DT	O	O
history	NN	O	O
of	IN	O	O
radiation	NN	B-PROBLEM	B-PROBLEM
exposure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
family	NN	O	O
history	NN	O	O
of	IN	O	O
thyroid	JJ	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
recent	JJ	O	B-PROBLEM
travels	NNS	O	I-PROBLEM
or	CC	O	O
exposure	NN	B-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	O
tuberculosis	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

includes	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
good	JJ	O	O
heart	NN	B-TREATMENT	O
rate	NN	I-TREATMENT	O
control	NN	I-TREATMENT	O
on	IN	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
reports	VBZ	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

lanoxin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
0.25	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
;	:	O	O
lasix	CC	B-TREATMENT	B-TREATMENT
,	,	O	O
20	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
pleasant	JJ	O	O
,	,	O	O
elderly	JJ	O	O
female	NN	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
vital	JJ	I-TEST	I-TEST
signs	NNS	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
126/72	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
84	CD	O	O
,	,	O	O
respirations	NNS	B-TEST	B-TEST
22	CD	O	O
,	,	O	O
temperature	NN	B-TEST	B-TEST
98.6	CD	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	O
3	CD	I-PROBLEM	O
x	NN	I-PROBLEM	O
4	CD	I-PROBLEM	O
cm	JJ	I-PROBLEM	O
firm	NN	I-PROBLEM	O
,	,	I-PROBLEM	O
nontender	RB	I-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
thyroid	NN	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
seemed	VBD	O	O
to	TO	O	O
be	VB	O	O
fixed	VBN	O	O
to	TO	O	O
the	DT	O	B-PROBLEM
trachea	NN	O	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
no	DT	O	O
jugular	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
distention	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
lungs	NNS	O	O
exhibited	VBD	O	O
right	JJ	B-PROBLEM	B-PROBLEM
basilar	NN	I-PROBLEM	I-PROBLEM
dullness	VB	I-PROBLEM	I-PROBLEM
one	CD	O	O
quarter	NN	O	O
of	IN	O	O
the	DT	O	O
way	NN	O	O
up	RP	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
no	DT	O	O
definite	JJ	B-PROBLEM	O
s3	NN	I-PROBLEM	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
4+	CD	B-PROBLEM	O
edema	NN	I-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
knees	NNS	I-PROBLEM	I-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
admission	NN	O	O
the	DT	B-TEST	O
white	JJ	I-TEST	B-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
67.3	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
differential	NN	I-TEST	I-TEST
of	IN	O	O
21%	CD	B-TEST	O
polys	NN	I-TEST	B-TEST
,	,	O	O
16%	CD	B-TEST	O
bands	NNS	I-TEST	B-TEST
,	,	O	O
3%	CD	B-TEST	O
lymphocytes	NNS	I-TEST	B-TEST
,	,	O	O
2%	CD	B-TEST	O
monocytes	NNS	I-TEST	O
,	,	O	O
57%	CD	B-TEST	O
eosinophils	NNS	I-TEST	B-TEST
and	CC	O	O
1%	CD	B-TEST	O
myelocytes	NNS	I-TEST	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
38.8	CD	O	O
,	,	O	O
hemoglobin	NN	B-TEST	B-TEST
13.7	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
155,000	CD	O	O
,	,	O	O
pt	NN	B-TEST	O
12.7/10.1	CD	O	O
,	,	O	O
ptt	NN	B-TEST	B-TEST
33.9	CD	O	O
,	,	O	O
erythrocyte	JJ	B-TEST	B-TEST
sedimentation	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
18	CD	O	O
,	,	O	O
calcium	NN	B-TEST	B-TEST
7.5	CD	O	O
,	,	O	O
phosphorus	NN	B-TEST	B-TEST
3.5	CD	O	O
,	,	O	O
sodium	NN	B-TEST	B-TEST
136	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
3.7	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
15	CD	O	O
,	,	O	O
total	JJ	B-TEST	B-TEST
protein	NN	I-TEST	I-TEST
5.9	CD	O	O
,	,	O	O
albumin	RB	B-TEST	B-TEST
2.3	CD	O	O
,	,	O	O
globulin	NN	B-TEST	B-TEST
3.6	CD	O	O
,	,	O	O
alkaline	JJ	B-TEST	B-TEST
phosphatase	NN	I-TEST	I-TEST
379	CD	O	O
,	,	O	O
sgot	VBD	B-TEST	B-TEST
37	CD	O	O
,	,	O	O
digoxin	NN	B-TEST	B-TEST
level	NN	I-TEST	I-TEST
0.7	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
dr.	VB	O	O
shatermivaet	JJ	O	O
s	NN	O	O
brain	NN	O	O
on	IN	O	O
4/28/93	CD	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
papillary	JJ	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
thyroid	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
bone	NN	B-PROBLEM	O
involvement	NN	I-PROBLEM	O
and	CC	O	O
possible	JJ	O	O
lung	NN	B-PROBLEM	O
involvement	NN	I-PROBLEM	O
.	.	O	O

work	NN	B-TEST	O
up	RP	I-TEST	O
was	VBD	O	O
begun	VBN	O	O
for	IN	O	O
the	DT	O	O
possible	JJ	O	O
myeloproliferative	JJ	B-PROBLEM	B-PROBLEM
/	NNP	I-PROBLEM	I-PROBLEM
myelodysplastic	JJ	I-PROBLEM	I-PROBLEM
disorder	NN	I-PROBLEM	I-PROBLEM
associated	VBN	O	O
with	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
hyper-eosinophilic	JJ	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

accordingly	RB	O	O
,	,	O	O
an	DT	O	O
oncology	NN	O	O
consult	NN	O	O
was	VBD	O	O
called	VBN	O	O
on	IN	O	O
4/29/93	CD	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
bone	NN	I-TEST	I-TEST
marrow	NN	I-TEST	I-TEST
aspirate	NN	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
.	.	O	O

this	DT	O	O
revealed	VBD	O	O
maturation	NN	O	O
of	IN	O	O
leukocytes	NNS	O	B-PROBLEM
to	TO	O	O
all	DT	O	O
stages	NNS	O	O
with	IN	O	O
markedly	RB	B-PROBLEM	B-PROBLEM
increased	VBN	I-PROBLEM	I-PROBLEM
eosinophilic	JJ	I-PROBLEM	I-PROBLEM
proliferation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
lung	NN	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
on	IN	O	O
4/30/93	CD	O	O
without	IN	O	O
definitive	JJ	O	O
results	NNS	O	O
.	.	O	O

during	IN	O	O
this	DT	O	O
time	NN	O	O
the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
coagulation	NN	O	O
status	NN	O	O
had	VBD	O	O
improved	VBN	O	O
with	IN	O	O
vitamin	JJ	B-TREATMENT	B-TREATMENT
k	NNS	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
pts	NNS	B-TEST	O
normalizing	VBG	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
suffer	VB	O	O
from	IN	O	O
edema	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	O	O
vascular	JJ	O	O
radiology	NN	O	O
consult	NN	O	O
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
thrombosis	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
subclavian	JJ	I-PROBLEM	I-PROBLEM
vein	NN	I-PROBLEM	I-PROBLEM
extending	VBG	O	I-PROBLEM
into	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
axillary	JJ	O	I-PROBLEM
vein	NN	O	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
thrombosis	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
internal	JJ	I-PROBLEM	I-PROBLEM
jugular	NN	I-PROBLEM	I-PROBLEM
vein	NN	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
and	CC	O	O
was	VBD	O	O
completely	RB	O	O
negative	JJ	O	O
for	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
metastatic	JJ	I-PROBLEM	I-PROBLEM
process	NN	I-PROBLEM	I-PROBLEM
involving	VBG	O	O
the	DT	O	O
brain	NN	O	O
.	.	O	O

thus	RB	O	O
,	,	O	O
a	DT	B-TREATMENT	B-TREATMENT
heparin	NN	I-TREATMENT	I-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
begun	VBN	O	O
.	.	O	O

meanwhile	RB	O	O
,	,	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NNP	I-PROBLEM	I-PROBLEM
eosinophilia	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
a	DT	B-TREATMENT	O
trial	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
prednisone	NN	I-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
also	RB	O	O
developed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
mild	JJ	I-PROBLEM	I-PROBLEM
urinary	JJ	I-PROBLEM	I-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
responded	VBD	O	O
to	TO	O	O
bactrim	VB	B-TREATMENT	O
,	,	O	O
but	CC	O	O
which	WDT	O	O
was	VBD	O	O
subsequently	RB	O	O
stopped	VBN	O	O
because	IN	O	O
of	IN	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
conclusions	NNS	O	O
at	IN	O	O
this	DT	O	O
time	NN	O	O
of	IN	O	O
the	DT	O	O
thyroid	JJ	O	O
cytologist	NN	O	O
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
the	DT	O	O
bone	NN	O	O
pathologist	NN	O	O
,	,	O	O
were	VBD	O	O
that	IN	O	O
the	DT	O	O
findings	NNS	O	O
were	VBD	O	O
diagnostic	JJ	O	O
of	IN	O	O
papillary	JJ	B-PROBLEM	B-PROBLEM
thyroid	NN	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
metastases	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

dr.	JJ	O	O
trial	NN	O	O
was	VBD	O	O
subsequently	RB	O	O
consulted	VBN	O	O
on	IN	O	O
5/5	CD	O	O
for	IN	O	O
surgical	JJ	B-TREATMENT	B-TREATMENT
intervention	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
5/6/93	CD	O	O
the	DT	O	O
patient	NN	O	O
underwent	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
thyroidectomy	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
sacrifice	NN	O	B-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
right	JJ	O	I-PROBLEM
recurrent	NN	O	I-PROBLEM
laryngeal	RB	O	I-PROBLEM
nerve	RB	O	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
the	DT	O	O
right	JJ	O	O
sternothyroid	NN	O	O
muscle	NN	O	B-PROBLEM
and	CC	O	I-PROBLEM
lower	JJR	O	I-PROBLEM
parathyroid	NN	O	I-PROBLEM
gland	NN	O	I-PROBLEM
.	.	O	O

she	PRP	O	O
underwent	JJ	O	O
autotransplantation	NN	B-TREATMENT	B-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
upper	JJ	I-TREATMENT	I-TREATMENT
parathyroid	NN	I-TREATMENT	I-TREATMENT
gland	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
repair	NN	B-TREATMENT	B-TREATMENT
of	IN	O	I-TREATMENT
a	DT	B-TREATMENT	I-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
posterior	NN	I-TREATMENT	I-TREATMENT
membranous	JJ	I-TREATMENT	I-TREATMENT
tracheotomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

her	PRP$	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
was	VBD	O	O
well	RB	O	O
controlled	VBN	O	O
on	IN	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

on	IN	O	O
the	DT	O	O
ward	NN	O	O
she	PRP	O	O
continued	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
gentle	JJ	I-TREATMENT	I-TREATMENT
diuresis	NN	I-TREATMENT	I-TREATMENT
as	RB	O	O
well	RB	O	O
as	IN	O	O
solu-medrol	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

calcium	NN	B-TEST	B-TEST
levels	NNS	I-TEST	I-TEST
remained	VBD	O	O
7.2	CD	O	O
to	TO	O	O
7.5	CD	O	O
postoperatively	RB	O	O
.	.	O	O

she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
improve	VB	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
slight	JJ	I-PROBLEM	I-PROBLEM
hoarseness	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
her	PRP$	I-PROBLEM	O
voice	NN	I-PROBLEM	O
that	WDT	O	O
was	VBD	O	O
expected	VBN	O	O
.	.	O	O

she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
exhibit	VB	O	O
asymptomatic	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

anticoagulation	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
begun	VBN	O	O
on	IN	O	O
the	DT	O	O
third	JJ	O	O
postoperative	JJ	O	O
day	NN	O	O
with	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
effectively	RB	B-TREATMENT	O
anticoagulated	VBN	I-TREATMENT	O
with	IN	O	O
a	DT	B-TEST	O
pt	NN	I-TEST	O
in	IN	O	O
the	DT	O	O
range	NN	O	O
between	IN	O	O
15	CD	O	O
and	CC	O	O
17	CD	O	O
over	IN	O	O
a	DT	O	O
control	NN	O	O
of	IN	O	O
10	CD	O	O
.	.	O	O

she	PRP	O	O
also	RB	O	O
received	VBD	O	O
a	DT	O	B-TREATMENT
radiation	NN	O	I-TREATMENT
therapy	NN	O	I-TREATMENT
consult	NN	O	O
for	IN	O	O
local	JJ	B-TREATMENT	B-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
invasive	JJ	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

metastatic	JJ	B-PROBLEM	B-PROBLEM
papillary	JJ	I-PROBLEM	I-PROBLEM
thyroid	NN	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

coumadin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
5	CD	O	O
mg	NN	O	O
po	NN	O	O
alternating	VBG	O	O
with	IN	O	O
2.5	CD	O	O
mg	NNS	O	O
po	VBP	O	O
;	:	O	O
prednisolone	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
30	CD	O	O
mg	NN	O	O
po	NN	O	O
bid	NN	O	O
;	:	O	O
hydrochlorothiazide	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
50	CD	O	O
mg	NN	O	O
po	NN	O	O
bid	NN	O	O
;	:	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
40	CD	O	O
meq	NN	O	O
po	NN	O	O
bid	NN	O	O
;	:	O	O
augmentin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
500	CD	O	O
mg	NN	O	O
po	NN	O	O
tid	NN	O	O
;	:	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
0.125	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
;	:	O	O
tylenol	CC	B-TREATMENT	B-TREATMENT
,	,	O	O
650	CD	O	O
mg	NN	O	O
po	NN	O	O
q4h	NN	O	O
prn	NN	O	O
;	:	O	O
carafate	NN	B-TREATMENT	O
,	,	O	O
1	CD	O	O
gram	NN	O	O
po	NN	O	O
bid	NN	O	O
;	:	O	O
synthroid	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
0.125	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
discharged	VBN	O	O
home	NN	O	O
with	IN	O	O
terchestlumnesamp	JJ	O	O
medical	JJ	O	O
center	NN	O	O
referral	NN	O	O
for	IN	O	O
weekly	JJ	B-TEST	O
blood	NN	I-TEST	B-TEST
tests	NNS	I-TEST	I-TEST
,	,	O	O
potassium	NN	B-TEST	B-TEST
and	CC	O	O
pt	NN	B-TEST	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
also	RB	O	O
to	TO	O	O
keep	VB	O	O
her	PRP$	B-TREATMENT	B-PROBLEM
left	JJ	I-TREATMENT	I-PROBLEM
arm	NN	I-TREATMENT	I-PROBLEM
elevated	VBD	I-TREATMENT	I-PROBLEM
and	CC	O	O
to	TO	O	O
remain	VB	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
low	JJ	I-TREATMENT	I-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
diet	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
will	MD	O	O
be	VB	O	O
maintained	VBN	O	O
on	IN	O	O
a	DT	B-TEST	O
pt	NN	I-TEST	O
between	IN	O	O
15	CD	O	O
and	CC	O	O
17	CD	O	O
with	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

arrangements	NNS	O	O
will	MD	O	O
be	VB	O	O
made	VBN	O	O
for	IN	O	O
radiation	NN	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	O
the	DT	I-TREATMENT	O
right	JJ	I-TREATMENT	O
neck	NN	I-TREATMENT	O
and	CC	I-TREATMENT	O
right	JJ	I-TREATMENT	B-PROBLEM
iliac	NN	I-TREATMENT	I-PROBLEM
crest	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

change	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

per	IN	O	O
record	NN	O	O
,	,	O	O
she	PRP	O	O
has	VBZ	O	O
had	VBN	O	O
multiple	JJ	O	B-PROBLEM
episodes	NNS	O	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
last	JJ	O	I-PROBLEM
week	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
changes	NNS	B-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
localizing	VBG	O	O
etiology	NN	O	O
of	IN	O	O
delta	JJ	B-PROBLEM	B-PROBLEM
ms	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

that	IN	O	O
evening	VBG	O	O
she	PRP	O	O
was	VBD	O	O
unresponsive	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
brought	VBN	O	O
to	TO	O	O
amesbury	VB	O	O
hospital	JJ	O	O
hospital	NN	O	O
.	.	O	O

there	EX	O	O
her	PRP$	B-TEST	B-TREATMENT
oxygen	NN	I-TEST	I-TREATMENT
she	PRP	O	O
was	VBD	O	O
sating	VBG	O	O
65%	CD	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
,	,	O	O
increased	VBD	O	O
to	TO	O	O
98%	CD	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
nonrebreather	JJ	I-TREATMENT	I-TREATMENT
mask	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

there	EX	O	O
an	DT	B-TEST	B-TEST
abg	NN	I-TEST	I-TEST
was	VBD	O	O
done	VBN	O	O
which	WDT	O	O
showed	VBD	O	O
an	DT	B-TEST	B-TEST
abg	NN	I-TEST	I-TEST
of	IN	O	O
7.42	CD	O	O
,	,	O	O
62	CD	O	O
,	,	O	O
and	CC	O	O
55	CD	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
that	WDT	O	O
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
that	WDT	O	O
was	VBD	O	O
questionable	JJ	O	O
left	VBD	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
infiltrate	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

lumbar	NN	B-TEST	B-TEST
puncture	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
and	CC	O	O
the	DT	B-TEST	B-TEST
micro	NN	I-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
are	VBP	O	O
still	RB	O	O
pending	VBG	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
seen	VBN	O	O
by	IN	O	O
psychiatry	NN	O	O
at	IN	O	O
the	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
,	,	O	O
but	CC	O	O
noted	VBD	O	O
there	EX	O	O
was	VBD	O	O
no	DT	O	O
psychoses	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
but	CC	O	O
delirium	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
also	RB	O	O
had	VBD	O	O
a	DT	B-TEST	O
k	NN	I-TEST	O
of	IN	O	O
6.0	CD	O	O
and	CC	O	O
given	VBN	O	O
30	CD	O	O
of	IN	O	O
kayexalate	NN	B-TREATMENT	O
,	,	O	O
5	CD	O	O
of	IN	O	O
haldol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
2	CD	O	O
mg	NN	O	O
of	IN	O	O
ativan	NN	B-TREATMENT	B-TREATMENT
given	VBN	O	O
for	IN	O	O

agitation	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
2	CD	O	O
mg	NN	O	O
of	IN	O	O
ceftriaxone	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
given	VBN	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
of	IN	O	O
101.3	CD	O	O
with	IN	O	O
a	DT	O	O
concern	NN	O	O
for	IN	O	O
meningitis	NN	B-PROBLEM	B-PROBLEM
as	IN	O	O
a	DT	B-TEST	O
lp	NN	I-TEST	O
was	VBD	O	O
done	VBN	O	O
prior	RB	O	O
.	.	O	O

on	IN	O	O
arrival	NN	O	O
to	TO	O	O
mass.	VB	O	O
eye	NN	O	O
&	CC	O	O
ear	JJ	O	O
infirmary	NN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
unresponsive	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
an	DT	B-TEST	B-TEST
oxygen	NN	I-TEST	I-TEST
saturation	NN	I-TEST	I-TEST
of	IN	O	O
72%	CD	O	O
on	IN	O	O
6	CD	B-TREATMENT	O
liters	NNS	I-TREATMENT	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
50%	CD	B-TREATMENT	B-TREATMENT
vent	NN	I-TREATMENT	I-TREATMENT
mask	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
which	WDT	O	O
improved	VBD	O	O
her	PRP	B-TEST	B-TEST
oxygenation	NN	I-TEST	I-TEST
to	TO	O	O
97%	CD	O	O
.	.	O	O

patient	NN	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
bipap	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

original	JJ	B-TEST	O
abg	NN	I-TEST	O
here	RB	O	O
before	IN	O	O
bipap	NN	B-TREATMENT	B-TEST
was	VBD	O	O
7.19	CD	O	O
,	,	O	O
102	CD	O	O
,	,	O	O
and	CC	O	O
92	CD	O	O
.	.	O	O

after	IN	O	O
being	VBG	O	O
placed	VBN	O	O
on	IN	O	O
bipap	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
her	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
decreased	VBD	B-PROBLEM	O
to	TO	O	O
the	DT	O	O
80s	CD	O	O
.	.	O	O

she	PRP	O	O
responded	VBD	O	O
to	TO	O	O
1	CD	O	O
liter	NN	O	O
of	IN	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
normal	JJ	B-TREATMENT	B-TREATMENT
saline	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
remained	VBD	O	O
stable	JJ	O	O
.	.	O	O

patient	NN	O	O
had	VBD	O	O
peripheral	JJ	B-TREATMENT	O
iv	NN	I-TREATMENT	O
x1	NN	O	O
placed	VBD	O	O
and	CC	O	O
right	JJ	B-TREATMENT	B-TREATMENT
femoral	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
placed	VBN	O	O
in	IN	O	O
the	DT	O	O
matthew	NN	O	O
.	.	O	O

when	WRB	O	O
laying	VBG	O	O
flat	JJ	O	O
,	,	O	O
her	PRP$	B-TEST	B-TEST
sats	NNS	I-TEST	I-TEST
decreased	VBD	B-PROBLEM	O
to	TO	O	O
50%	CD	O	O
on	IN	O	O
30%	CD	O	O
fio2	NN	B-TREATMENT	O
,	,	O	O
peep	NN	B-TREATMENT	O
of	IN	O	O
10	CD	O	O
,	,	O	O
and	CC	O	O
pressure	NN	B-TREATMENT	B-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
5	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
abg	NN	I-TEST	I-TEST
at	IN	O	O
the	DT	O	O
time	NN	O	O
was	VBD	O	O
7.24	CD	O	O
,	,	O	O
91	CD	O	O
,	,	O	O
and	CC	O	O
38	CD	O	O
.	.	O	O

once	RB	O	O
the	DT	O	O
patient	NN	O	O
sat	VBD	O	O
up	RP	O	O
,	,	O	O
her	PRP$	B-TEST	B-TEST
sats	NNS	I-TEST	I-TEST
improved	VBN	O	O
and	CC	O	O
her	PRP$	O	B-TEST
airway	NN	O	I-TEST
was	VBD	O	O
no	RB	O	O
longer	RB	O	B-PROBLEM
obstructed	VBN	O	I-PROBLEM
.	.	O	O

after	IN	O	O
a	DT	O	O
history	NN	O	O
on	IN	O	O
bipap	NN	B-TREATMENT	B-TREATMENT
about	IN	O	O
a	DT	O	O
half	NN	O	O
an	DT	O	O
hour	NN	O	O
,	,	O	O
her	PRP$	B-TEST	B-TEST
abg	NN	I-TEST	I-TEST
was	VBD	O	O
7.29	CD	O	O
,	,	O	O
79	CD	O	O
,	,	O	O
and	CC	O	O
106	CD	O	O
on	IN	O	O
30%	CD	O	B-TREATMENT
pressure	NN	B-TREATMENT	I-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
5	CD	O	O
and	CC	O	O
peep	NN	B-TREATMENT	O
of	IN	O	O
10	CD	O	O
.	.	O	O

she	PRP	O	O
denied	VBD	O	O
any	DT	O	B-PROBLEM
pain	NN	B-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
not	RB	O	O
answering	VBG	O	O
questions	NNS	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
.	.	O	O

1.	CD	O	O
obstructive-sleep	JJ	B-PROBLEM	O
apnea	NN	I-PROBLEM	B-PROBLEM
?	.	O	O

2.	CD	O	O
morbid	JJ	B-PROBLEM	B-PROBLEM
obesity	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
unknown	JJ	O	O
ef	NN	B-TEST	O
.	.	O	O

4.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

5.	CD	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

6.	CD	O	O
depression	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

8.	CD	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
exertion	NN	O	O
.	.	O	O

9.	CD	O	O
history	NN	O	O
of	IN	O	O
fibroids	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

10.	CD	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1.	CD	O	O
lasix	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
q.d.	NN	O	O

2.	CD	O	O
senna	JJ	B-TREATMENT	B-TREATMENT
two	CD	O	I-TREATMENT
tablets	NNS	O	I-TREATMENT
q.6h.	VBP	O	O

3.	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O

4.	CD	O	O
metformin	NN	B-TREATMENT	B-TREATMENT
1,000	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O

5.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

6.	CD	O	O
niferex	JJ	B-TREATMENT	O
one	CD	O	O
tablet	NN	O	O
b.i.d.	NN	O	O

7.	CD	O	O
cozaar	NN	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

8.	CD	O	O
ranitidine	NN	B-TREATMENT	B-TREATMENT
150	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

9.	CD	O	O
peroxetine	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

10.	CD	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
:	:	O	O

nph	RB	B-TREATMENT	O
70	CD	O	O
units	NNS	O	O
q.a.m.	RB	O	O
,	,	O	O
50	CD	O	O
units	NNS	O	O
q.p.m.	RB	O	O
,	,	O	O
regular	JJ	B-TREATMENT	O
insulin-sliding	JJ	I-TREATMENT	O
scale	NN	I-TREATMENT	O
.	.	O	O

11.	CD	O	O
subq	JJ	B-TREATMENT	B-TREATMENT
heparin	NN	I-TREATMENT	I-TREATMENT
5,000	CD	O	O
q.8h.	NN	O	O

12.	CD	O	O
lactulose	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

13.	CD	O	O
multivitamins	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

14.	CD	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
inhalers	NNS	I-TREATMENT	I-TREATMENT
prn	VBP	O	O
.	.	O	O

penicillin	NN	B-TREATMENT	B-TREATMENT
:	:	O	O

shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
108	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
140/82	CD	O	O
,	,	O	O
oxygen	NN	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST
96%	CD	O	O
,	,	O	O
respiratory	JJ	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
22	CD	O	O
on	IN	O	O
bipap	NN	B-TREATMENT	B-TREATMENT
5/10/30%	CD	O	O
.	.	O	O

in	IN	O	O
general	JJ	O	O
,	,	O	O
sleepy	JJ	B-PROBLEM	B-PROBLEM
but	CC	O	O
arousable	JJ	O	O
.	.	O	O

arousable	JJ	O	O
intermittently	RB	O	O
to	TO	O	O
voice	NN	B-TEST	O
.	.	O	O

pupils	NNS	B-TEST	O
3	CD	O	O
mm	NNS	O	O
reactive	JJ	O	O
.	.	O	O

obese	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
unable	JJ	O	O
to	TO	O	O
assess	VB	O	O
lymphadenopathy	JJ	B-PROBLEM	B-PROBLEM
or	CC	O	O
jugular	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
distention	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

poor	JJ	B-PROBLEM	B-PROBLEM
effort	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
wheezes	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
rales	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
rhonchi	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

distant	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
sounds	VBZ	I-PROBLEM	I-PROBLEM
,	,	O	O
tachycardia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
regular	JJ	O	O
rhythm	NN	B-TEST	O
.	.	O	O

abdomen	NNS	O	O
is	VBZ	O	O
obese	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
decreased	VBD	B-PROBLEM	B-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
sounds	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

obese	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
2+	CD	O	O
pulses	NNS	B-TEST	B-TEST
.	.	O	O

white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
12.8	CD	O	O
(	(	O	O
79%	CD	O	O
polys	NN	B-TEST	B-TEST
,	,	O	O
13%	CD	O	O
lymphocytes	NNS	B-TEST	B-TEST
,	,	O	O
8	CD	O	O
monocytes	NNS	B-TEST	O
,	,	O	O
nucleated	VBD	B-TEST	O
rbcs	JJ	I-TEST	O
1%	CD	O	O
),hematocrit	NN	B-TEST	O
31.7	CD	O	O
.	.	O	O

potassium	NN	B-TEST	B-TEST
5.2	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
1.3	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
35	CD	O	O
,	,	O	O
glucose	RB	B-TEST	B-TEST
152	CD	O	O
,	,	O	O
d	NN	B-TEST	B-TEST
dimer	NN	I-TEST	I-TEST
1636	CD	O	O
,	,	O	O
inr	VBZ	B-TEST	B-TEST
1.3	CD	O	O
.	.	O	O

urinalysis	NN	B-TEST	B-TEST
:	:	O	O

moderate	JJ	B-TEST	B-PROBLEM
leukocytes	NNS	I-TEST	I-PROBLEM
,	,	O	O
06-09	JJ	O	O
rbcs	NN	B-TEST	O
,	,	O	O
21-50	JJ	O	O
lymphocytes	NNS	B-TEST	B-TEST
,	,	O	O
many	JJ	B-PROBLEM	B-PROBLEM
bacteria	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
06-09	JJ	O	O
epithelial	JJ	B-TEST	O
cells	NNS	I-TEST	O
.	.	O	O

tox	NN	B-TEST	B-TEST
screen	NN	I-TEST	I-TEST
negative	JJ	O	O
.	.	O	O

urine	JJ	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
pending	VBG	O	O
.	.	O	O

white	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
11.8	CD	O	O
(	(	O	O
90%	CD	O	O
polys	NN	B-TEST	B-TEST
,	,	O	O
4%	CD	O	O
lymphocytes	NNS	B-TEST	B-TEST
,	,	O	O
5%	CD	O	O
monocytes	NNS	B-TEST	O
,	,	O	O
1%	CD	O	O
basophils	NNS	B-TEST	O
,	,	O	O
3%	CD	O	O
nucleated	JJ	B-TEST	O
rbcs	NN	I-TEST	O
).	NN	O	O

potassium	NN	B-TEST	B-TEST
6.6	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
1.4	CD	O	O
,	,	O	O
alkaline	JJ	B-TEST	B-TEST
phosphatase	NN	I-TEST	I-TEST
302	CD	O	O
,	,	O	O
t	EX	B-TEST	O
bilirubin	NN	I-TEST	B-TEST
0.6	CD	O	O
,	,	O	O
ast	RB	B-TEST	B-TEST
25	CD	O	O
,	,	O	O
alt	RB	B-TEST	O
84	CD	O	O
,	,	O	O
ck	NN	B-TEST	O
of	IN	O	O
15	CD	O	O
,	,	O	O
troponin	NN	B-TEST	B-TEST
0.01	CD	O	O
.	.	O	O

chest	JJ	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
:	:	O	O

left	VBD	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
basal	NN	I-PROBLEM	I-PROBLEM
opacity	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

ekg	NN	B-TEST	O
:	:	O	O

sinus	JJ	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
106	CD	O	O
beats	NNS	B-TEST	O
per	IN	I-TEST	O
minute	NN	I-TEST	O
,	,	O	O
left	VBD	B-PROBLEM	B-PROBLEM
axis	JJ	I-PROBLEM	I-PROBLEM
deviation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
t-wave	JJ	B-PROBLEM	B-PROBLEM
inversions	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
leads	NNS	I-PROBLEM	I-PROBLEM
i	NNS	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
avl	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
are	VBP	O	O
old	JJ	O	O
.	.	O	O

no	DT	O	O
qrs	NN	B-PROBLEM	B-PROBLEM
widening	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
no	DT	O	O
peak	JJ	B-PROBLEM	B-PROBLEM
t	NN	I-PROBLEM	I-PROBLEM
waves	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
is	VBZ	O	O
in	IN	O	O
comparison	NN	O	O
to	TO	O	O
2015-09-27	JJ	O	O
ekg	NN	B-TEST	O
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	JJ	I-TEST	I-TEST
rotated	VBD	O	O
low	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
volumes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
hazy	JJ	B-PROBLEM	B-PROBLEM
opacities	NNS	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
bases	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

echocardiogram	NN	B-TEST	B-TEST
in	IN	O	O
2010	CD	O	O
:	:	O	O

mild-to-moderate	JJ	B-PROBLEM	O
mr	NN	I-PROBLEM	O
,	,	O	O
tr	NN	B-PROBLEM	O
.	.	O	O

1.	CD	O	O
hypercarbic	JJ	B-PROBLEM	B-PROBLEM
respiratory	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
issues	NNS	I-PROBLEM	I-PROBLEM
:	:	O	O

the	DT	O	O
patient	NN	O	O
presented	VBN	O	O
with	IN	O	O
changes	NNS	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
pco2	NN	B-TEST	O
of	IN	O	O
100	CD	O	O
,	,	O	O
ph	NN	B-TEST	O
of	IN	O	O
7.19	CD	O	O
,	,	O	O
decreasing	VBG	B-PROBLEM	O
sats	NNS	I-PROBLEM	O
on	IN	O	O
arrival	NN	O	O
likely	JJ	O	O
element	NN	O	O
of	IN	O	O
obstructive-sleep	JJ	B-PROBLEM	B-PROBLEM
apnea	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
cmed	NN	O	O
and	CC	O	O
had	VBD	O	O
multiple	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
apnea	NN	B-PROBLEM	B-PROBLEM
throughout	IN	O	O
the	DT	O	O
night	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
pressure	NN	B-TREATMENT	B-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
which	WDT	O	O
improved	VBD	O	O
her	PRP	B-TEST	B-TEST
saturations	NNS	I-TEST	I-TEST
and	CC	O	O
decreased	VBD	O	B-PROBLEM
her	PRP$	B-PROBLEM	I-PROBLEM
hypercarbia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
improved	VBD	O	O
that	IN	O	O
her	PRP$	B-TEST	B-PROBLEM
mental	JJ	I-TEST	I-PROBLEM
status	NN	I-TEST	I-PROBLEM
with	IN	O	O
improvement	NN	O	O
of	IN	O	O
her	PRP$	B-TEST	B-PROBLEM
oxygenation	NN	I-TEST	I-PROBLEM
and	CC	O	O
ventilation	NN	O	B-TREATMENT
as	RB	O	O
well	RB	O	O
as	IN	O	O
for	IN	O	O
correction	NN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
respiratory	JJ	I-PROBLEM	I-PROBLEM
acidosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
was	VBD	O	O
eventually	RB	O	O
placed	VBN	O	O
on	IN	O	O
bipap	NN	B-TREATMENT	B-TREATMENT
on	IN	O	O
hospital	NN	O	O
day	NN	O	O
three	CD	O	O
,	,	O	O
on	IN	O	O
the	DT	O	O
date	NN	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
of	IN	O	O
bipap	JJ	B-TREATMENT	O
settings	NNS	O	O
of	IN	O	O
12/8/5	CD	B-TREATMENT	O
liters	NNS	I-TREATMENT	O
of	IN	I-TREATMENT	O
oxygen	NN	I-TREATMENT	B-TREATMENT
with	IN	O	O
saturations	NNS	B-TEST	B-TEST
of	IN	O	O
96%	CD	O	O
with	IN	O	O
a	DT	B-TEST	O
gas	NN	I-TEST	O
of	IN	O	O
7.38	CD	O	O
,	,	O	O
67	CD	O	O
,	,	O	O
and	CC	O	O
91	CD	O	O
with	IN	O	O
an	DT	O	O
aim	NN	O	O
of	IN	O	O
a	DT	O	O
goal	NN	O	O
pco2	NN	B-TEST	O
of	IN	O	O
67	CD	O	O
.	.	O	O

she	PRP	O	O
only	RB	O	O
had	VBD	O	O
one	CD	O	O
episode	NN	O	O
of	IN	O	O
apnea	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
the	DT	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

2.	CD	O	O
delta	JJ	B-PROBLEM	B-PROBLEM
ms/mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
issues	NNS	I-PROBLEM	I-PROBLEM
:	:	O	O

most	RBS	O	O
likely	JJ	O	O
her	PRP$	B-PROBLEM	O
waxing	NN	I-PROBLEM	O
and	CC	I-PROBLEM	O
waning	VBG	I-PROBLEM	B-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
hypercarbia/hypoxia	NN	B-PROBLEM	B-PROBLEM
compounded	VBN	O	O
by	IN	O	O
infection	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	O
pneumonia	NN	I-PROBLEM	B-PROBLEM
and	CC	O	O
uti	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

with	IN	O	O
improvements	NNS	O	O
of	IN	O	O
her	PRP$	B-TEST	B-TREATMENT
ventilation	NN	I-TEST	I-TREATMENT
and	CC	O	O
oxygenation	NN	B-TEST	B-TEST
and	CC	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
her	PRP$	B-PROBLEM	O
uti	JJ	I-PROBLEM	O
and	CC	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
her	PRP$	O	B-PROBLEM
mental	JJ	O	I-PROBLEM
status	NN	O	I-PROBLEM
greatly	RB	O	O
improved	VBN	O	O
on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
two	CD	O	O
without	IN	O	O
further	JJ	B-PROBLEM	O
waxing	NN	I-PROBLEM	O
and	CC	I-PROBLEM	O
waning	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

b12	NN	B-TEST	O
,	,	O	O
folate	NN	B-TEST	B-TREATMENT
,	,	O	O
rpr	NN	B-TEST	B-TEST
were	VBD	O	O
all	DT	O	O
sent	NN	O	O
that	WDT	O	O
were	VBD	O	O
unremarkable	JJ	O	O
as	IN	O	O
causes	NNS	O	O
for	IN	O	O
delta	JJ	B-PROBLEM	B-PROBLEM
ms	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

we	PRP	O	O
are	VBP	O	O
awaiting	VBG	O	O
results	NNS	O	O
of	IN	O	O
the	DT	B-TEST	B-TEST
lumbar	NN	I-TEST	I-TEST
puncture	NN	I-TEST	I-TEST
from	IN	O	O
the	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
,	,	O	O
but	CC	O	O
on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
two	CD	O	O
.	.	O	O

those	DT	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
are	VBP	O	O
still	RB	O	O
pending	VBG	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
.	.	O	O

patient	NN	O	O
was	VBD	O	O
also	RB	O	O
given	VBN	O	O
multivites	NNS	B-TREATMENT	O
.	.	O	O

3.	CD	O	O
fever	JJ	B-PROBLEM	B-PROBLEM
issues	NNS	I-PROBLEM	I-PROBLEM
:	:	O	O

the	DT	O	O
patient	NN	O	O
initially	RB	O	O
presented	VBN	O	O
with	IN	O	O
t	JJ	B-TEST	O
max	NN	I-TEST	O
of	IN	O	O
101.3	CD	O	O
at	IN	O	O
outside	JJ	O	O
hospital	NN	O	O
with	IN	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
white	JJ	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
counts	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	O	B-TEST
positive	JJ	O	I-TEST
urinalysis	NN	B-PROBLEM	I-TEST
.	.	O	O

a	DT	B-TEST	B-TEST
chest	JJ	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
with	IN	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
patchy	NN	I-PROBLEM	I-PROBLEM
infiltrates	NNS	I-PROBLEM	I-PROBLEM
likely	JJ	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
uti	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

upon	IN	O	O
calling	VBG	O	O
the	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
,	,	O	O
the	DT	O	B-TEST
urine	NN	O	I-TEST
was	VBD	O	O
growing	VBG	O	O
out	RP	O	O
klebsiella	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
patient	NN	O	O
was	VBD	O	O
given	VBN	O	O
a	DT	O	O
10	CD	O	O
day	NN	O	O
course	NN	O	O
of	IN	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
to	TO	O	O
cover	VB	O	O
both	DT	O	O
the	DT	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
uti	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
and	CC	O	O
urine	JJ	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
are	VBP	O	O
still	RB	O	O
pending	VBG	O	O
at	IN	O	O
this	DT	O	O
hospital	NN	O	O
visit	NN	O	O
and	CC	O	O
the	DT	O	B-TEST
csf	NN	B-TEST	I-TEST
fluid	NN	I-TEST	I-TEST
from	IN	O	O
whitter	NN	O	O
rehabilitation	NN	O	O
hospital	NN	O	O
needs	NNS	O	O
to	TO	O	O
be	VB	O	O
further	RB	O	O
evaluated	VBN	O	O
.	.	O	O

patient	NN	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
was	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-TEST
decreasing	VBG	I-PROBLEM	I-TEST
white	JJ	I-PROBLEM	I-TEST
count	NN	I-PROBLEM	I-TEST
x48	NN	O	I-TEST
hours	NNS	O	O
.	.	O	O

4.	CD	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
issues	NNS	I-PROBLEM	I-PROBLEM
:	:	O	O

creatinine	NN	B-TEST	B-TEST
initially	RB	O	O
presented	VBD	O	O
at	IN	O	O
1.3	CD	O	O
.	.	O	O

patient	NN	O	O
is	VBZ	O	O
known	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	O	O
baseline	NN	O	O
of	IN	O	O
1.0	CD	O	O
,	,	O	O
most	RBS	O	O
likely	JJ	O	O
hypovolemia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
prerenal	NN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
fena	NN	I-TEST	I-TEST
was	VBD	O	O
sent	VBN	O	O
,	,	O	O
was	VBD	O	O
0.3%	CD	O	O
.	.	O	O

patient	NN	O	O
was	VBD	O	O
gently	RB	O	O
hydrated	VBN	O	O
and	CC	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
started	VBD	O	O
up	RP	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
p.o.	NN	I-TREATMENT	I-TREATMENT
diet	JJ	I-TREATMENT	I-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
two	CD	O	O
,	,	O	O
her	PRP$	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
returned	VBN	O	O
to	TO	O	O
0.8	CD	O	O
,	,	O	O
and	CC	O	O
she	PRP	O	O
remained	VBD	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
of	IN	O	O
0.8	CD	O	O
for	IN	O	O
the	DT	O	O
remainder	NN	O	O
of	IN	O	O
her	PRP$	O	O
hospital	NN	O	O
stay	NN	O	O
.	.	O	O

patient's	NN	B-TEST	B-TEST
k	NN	I-TEST	I-TEST
was	VBD	O	O
followed	VBN	O	O
,	,	O	O
and	CC	O	O
trended	VBD	O	O
back	RB	O	O
down	RB	O	O
to	TO	O	O
normal	JJ	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
at	IN	O	O
3.9	CD	O	O
.	.	O	O

5.	CD	O	O
elevated	JJ	B-PROBLEM	B-PROBLEM
transaminases	NNS	I-PROBLEM	I-PROBLEM
:	:	O	O

patient	NN	O	O
had	VBD	O	O
no	DT	O	O
right	JJ	B-PROBLEM	B-PROBLEM
upper	NN	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

stewart	JJ	B-TEST	O
sign	NN	I-TEST	O
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
right	JJ	I-TEST	I-TEST
upper	NN	I-TEST	I-TEST
quadrant	NN	I-TEST	I-TEST
ultrasound	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
that	IN	O	O
showed	VBD	O	O
no	DT	O	O
hepatic	JJ	B-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	O
biliary	JJ	I-PROBLEM	B-PROBLEM
pathology	NN	I-PROBLEM	I-PROBLEM
likely	RB	O	O
due	JJ	O	O
to	TO	O	O
acute	VB	B-PROBLEM	B-PROBLEM
phase	NN	I-PROBLEM	I-PROBLEM
stress	NN	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
given	VBN	O	O
the	DT	O	O
fact	NN	O	O
that	IN	O	O
she	PRP	O	O
had	VBD	O	O
no	DT	O	O
clinical	JJ	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
need	NN	O	O
to	TO	O	O
followup	VB	O	O
these	DT	B-TEST	B-PROBLEM
transaminases	NNS	I-TEST	I-PROBLEM
.	.	O	O

6.	CD	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
history	NN	O	I-PROBLEM
:	:	O	O

patient	NN	O	O
was	VBD	O	O
stable	JJ	O	O
without	IN	O	O
evidence	NN	O	O
of	IN	O	O
chf	NN	B-PROBLEM	O
on	IN	O	O
chest	JJ	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
.	.	O	O

followed	VBD	O	O
her	PRP	B-TEST	O
sats	NNS	I-TEST	O
likely	JJ	O	O
due	JJ	O	O
to	TO	O	O
obstructive-sleep	JJ	B-PROBLEM	B-TEST
apnea	NN	I-PROBLEM	I-TEST
and	CC	O	O
hypoventilation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

patient	NN	O	O
was	VBD	O	O
restarted	VBN	O	O
on	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
beta	NN	I-TREATMENT	I-TREATMENT
blocker	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
.......-	JJ	O	B-PROBLEM
receptor	NN	B-TREATMENT	I-PROBLEM
blocker	NN	I-TREATMENT	I-PROBLEM
on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
two	CD	O	O
given	VBN	O	O
that	IN	O	O
her	PRP$	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
had	VBD	O	O
stabilized	VBN	O	O
.	.	O	O

patient	NN	O	O
had	VBD	O	O
no	DT	O	O
further	JJ	B-PROBLEM	B-PROBLEM
cardiac	NN	I-PROBLEM	I-PROBLEM
issues	NNS	I-PROBLEM	I-PROBLEM
at	IN	O	O
this	DT	O	O
time	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
on	IN	O	O
telemetry	NN	B-TEST	B-TEST
without	IN	O	O
any	DT	O	O
episodes	NNS	O	O
of	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
rhythm	JJ	I-PROBLEM	I-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
vaginal	JJ	I-PROBLEM	I-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
x2	JJ	O	O
days	NNS	O	O
.	.	O	O

patient	NN	O	O
had	VBD	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
fibroids	NNS	B-PROBLEM	B-PROBLEM
during	IN	O	O
this	DT	O	B-TREATMENT
hospitalization	NN	O	I-TREATMENT
.	.	O	O

followed	VBD	O	O
her	PRP$	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
.	.	O	O

her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
remained	VBD	O	O
stable	JJ	O	O
throughout	IN	O	O
this	DT	O	O
course	NN	O	O
.	.	O	O

patient	NN	O	O
is	VBZ	O	O
strongly	RB	O	O
encouraged	VBN	O	O
to	TO	O	O
followup	VB	O	O
with	IN	O	O
her	PRP	O	O
outside	JJ	O	O
primary	JJ	O	O
care	NN	O	O
provider	NN	O	O
to	TO	O	O
followup	VB	O	O
for	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
vaginal	JJ	I-PROBLEM	I-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
given	VBN	O	O
her	PRP$	O	O
history	NN	O	O
of	IN	O	O
fibroids	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
question	NN	O	O
metaplasia	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
endometrium	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
remained	VBD	O	O
stable	JJ	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
nucleated	JJ	B-PROBLEM	O
rbcs	NN	I-PROBLEM	O
likely	RB	O	O
secondary	JJ	O	O
to	TO	O	O
stress	VB	B-PROBLEM	B-PROBLEM
and	CC	O	I-PROBLEM
hypoxia	VB	B-PROBLEM	I-PROBLEM
during	IN	O	O
this	DT	O	O
admission	NN	O	O
.	.	O	O

hemolysis	NN	B-TEST	B-TEST
laboratories	NNS	I-TEST	I-TEST
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

patient	NN	O	O
was	VBD	O	O
restarted	VBN	O	O
on	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
iron	NN	I-TREATMENT	I-TREATMENT
supplementation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

reticulocyte	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
that	IN	O	O
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
npo	RB	B-TREATMENT	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
decrease	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

we	PRP	O	O
slowly	RB	O	O
advanced	VBD	O	O
her	PRP	O	O
diet	NN	O	O
as	IN	O	O
her	PRP$	O	B-PROBLEM
mental	JJ	O	I-PROBLEM
status	NN	O	I-PROBLEM
improved	VBN	O	O
and	CC	O	O
repleted	VBD	O	O
her	PRP$	B-TEST	B-TEST
electrolytes	NNS	I-TEST	I-TEST
,	,	O	O
and	CC	O	O
started	VBD	O	O
on	IN	O	O
her	PRP	B-TREATMENT	B-TREATMENT
p.o.	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
two	CD	O	O
.	.	O	O

10.	CD	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
:	:	O	O

patient	NN	O	O
had	VBD	O	O
q.i.d.	JJ	O	O
fingersticks	NNS	B-TEST	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
humalog	NN	I-TREATMENT	I-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
nph	JJ	B-TREATMENT	B-TREATMENT
doses	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
cut	VBN	O	O
in	IN	O	O
half	NN	O	O
while	IN	O	O
she	PRP	O	O
was	VBD	O	O
npo	RB	B-TREATMENT	O
,	,	O	O
and	CC	O	O
they	PRP	O	O
were	VBD	O	O
brought	VBN	O	O
back	RB	O	O
to	TO	O	O
her	PRP$	B-TREATMENT	O
normal	JJ	I-TREATMENT	O
doses	NNS	I-TREATMENT	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
with	IN	O	O
a	DT	O	O
full	JJ	O	O
diet	NN	O	O
.	.	O	O

12.	CD	O	O
prophylaxis	NN	B-TREATMENT	B-TREATMENT
:	:	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
on	IN	O	O
subq	JJ	B-TREATMENT	B-TREATMENT
heparin	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
dvt	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
ranitidine	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
gi	NN	B-TREATMENT	B-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
to	TO	O	O
be	VB	O	O
discharged	VBN	O	O
today	NN	O	O
to	TO	O	O
lahey	VB	O	O
clinic	JJ	O	O
-	:	O	O
north	NN	O	O
shore	VBP	O	O
hospital	NN	O	O
for	IN	O	O
long-term	JJ	B-TREATMENT	B-TREATMENT
pulmonary	JJ	I-TREATMENT	I-TREATMENT
........	NN	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
further	JJ	O	B-TEST
evaluation	NN	B-TEST	I-TEST
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
obstructive-sleep	JJ	I-PROBLEM	I-PROBLEM
apnea	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
,	,	O	O
and	CC	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
remained	VBD	O	O
stable	JJ	O	O
,	,	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
oxygen	NN	I-TEST	I-TEST
saturations	NNS	I-TEST	I-TEST
were	VBD	O	O
well	RB	O	O
above	IN	O	O
90%	CD	O	O
during	IN	O	O
the	DT	O	O
daytime	NN	O	O
on	IN	O	O
2	CD	B-TREATMENT	B-TREATMENT
liters	NNS	I-TREATMENT	I-TREATMENT
nasal	JJ	I-TREATMENT	I-TREATMENT
cannula	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
at	IN	O	O
night	NN	O	O
on	IN	O	O
the	DT	B-TREATMENT	B-TEST
bipap	NN	I-TREATMENT	I-TEST
settings	NNS	O	I-TEST

1.	CD	O	O
nph	JJ	B-TREATMENT	O
70	CD	O	O
units	NNS	O	O
q.a.m.	RB	O	O
,	,	O	O
50	CD	O	O
units	NNS	O	O
q.p.m.	RB	O	O

2.	CD	O	O
humalog	NN	B-TREATMENT	B-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

3.	CD	O	O
subq	JJ	B-TREATMENT	B-TREATMENT
heparin	NN	I-TREATMENT	I-TREATMENT
5,000	CD	O	O
units	NNS	O	O
t.i.d.	VBP	O	O

4.	CD	O	O
ranitidine	NN	B-TREATMENT	B-TREATMENT
150	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

5.	CD	O	O
multivitamin	NN	B-TREATMENT	B-TREATMENT
x1	NN	O	I-TREATMENT
.	.	O	O

6.	CD	O	O
losartan	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

7.	CD	O	O
iron	NN	B-TREATMENT	B-TREATMENT
supplementation	NN	I-TREATMENT	I-TREATMENT
150	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

8.	CD	O	O
levofloxacin	JJ	B-TREATMENT	B-TREATMENT
day	NN	O	O
four	CD	O	O
of	IN	O	O
10	CD	O	O
to	TO	O	O
be	VB	O	O
completed	VBN	O	O
for	IN	O	O
a	DT	O	O
full	JJ	O	O
10-day	JJ	O	O
course	NN	O	O
,	,	O	O
500	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

9.	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

10.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

papillary	JJ	B-PROBLEM	B-PROBLEM
adenocarcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

papillary	JJ	B-PROBLEM	B-PROBLEM
adenocarcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
flexible	JJ	I-TEST	I-TEST
bronchoscopy	NN	I-TEST	I-TEST
and	CC	O	O
extrapleural-pleural	JJ	B-TREATMENT	B-TREATMENT
lobectomy	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
12-4-93	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
47	CD	O	O
year	NN	O	O
old	JJ	O	O
white	JJ	O	O
male	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
emphysema	NN	B-PROBLEM	B-PROBLEM
who	WP	O	O
presents	VBZ	O	O
for	IN	O	O
admission	NN	O	O
with	IN	O	O
a	DT	O	O
diagnosis	NN	O	O
of	IN	O	O
broncho-alveolar	JJ	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
is	VBZ	O	O
scheduled	VBN	O	O
for	IN	O	O
flexible	JJ	B-TEST	B-TEST
bronchoscopy	NN	I-TEST	I-TEST
,	,	O	O
mediastinoscopy	NN	B-TEST	B-TEST
and	CC	O	O
thoracotomy	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
questionable	JJ	O	O
pneumonectomy	NN	B-TREATMENT	B-TREATMENT
by	IN	O	O
dr.	VBG	O	O
an	DT	O	O
on	IN	O	O
12-4-93	NNS	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
native	NN	O	O
of	IN	O	O
nahuter	NN	O	B-PROBLEM
with	IN	O	O
a	DT	O	O
70+	CD	O	O
pack	NN	O	O
year	NN	O	O
smoking	VBG	O	O
history	NN	O	O
(	(	O	O
2	CD	O	O
1/2-3	JJ	O	O
pack	NN	O	O
per	IN	O	O
day	NN	O	O
x	$	O	O
35	CD	O	O
years	NNS	O	O
)	)	O	O
whose	WP$	O	B-PROBLEM
symptoms	NNS	O	I-PROBLEM
began	VBD	O	O
last	JJ	O	O
12/92	CD	O	O
when	WRB	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
persistent	JJ	I-PROBLEM	I-PROBLEM
cough	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
fever	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

in	IN	O	O
six	CD	O	O
months	NNS	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
hospitalized	VBN	O	O
for	IN	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
x	NNP	O	O
four	CD	O	O
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
had	VBD	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
paroxysmal	JJ	B-PROBLEM	B-PROBLEM
nocturnal	JJ	I-PROBLEM	I-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
though	IN	O	O
denies	NNS	O	O
orthopnea	VBP	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
hemoptysis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
sweats	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
when	WRB	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
resolved	VBD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
noticed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	O
weight	NN	I-PROBLEM	B-TEST
of	IN	O	O
approximately	RB	O	O
25	CD	O	O
pounds	NNS	O	O
over	IN	O	O
a	DT	O	O
few	JJ	O	O
months	NNS	O	O
with	IN	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
fatigue	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
lower	JJR	B-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-PROBLEM	B-PROBLEM
&quot;	JJ	I-PROBLEM	I-PROBLEM
spot	NN	I-PROBLEM	I-PROBLEM
&quot;	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
was	VBD	O	O
noted	VBN	O	O
in	IN	O	O
october	NN	O	O
of	IN	O	O
1993	CD	O	O
,	,	O	O
after	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
cleared	VBD	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
follow	JJ	I-TEST	I-TEST
up	RP	I-TEST	I-TEST
chest	JJS	I-TEST	I-TEST
computerized	JJ	I-TEST	I-TEST
tomography	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
led	VBD	O	O
to	TO	O	O
a	DT	B-TEST	B-TEST
tissue	NN	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
via	IN	O	I-TEST
flexible	JJ	B-TEST	I-TEST
bronchoscopy	NN	I-TEST	I-TEST
in	IN	O	O
07/93	CD	O	O
.	.	O	O

tissue	NN	O	O
returned	VBN	O	O
well	RB	B-PROBLEM	O
differentiated	JJ	I-PROBLEM	B-PROBLEM
adenocarcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	O	O
appetite	NN	O	O
has	VBZ	O	O
been	VBN	O	O
good	JJ	O	O
and	CC	O	O
he	PRP	O	O
has	VBZ	O	O
only	RB	O	O
complained	VBN	O	O
of	IN	O	O
occasional	JJ	B-PROBLEM	B-PROBLEM
sharp	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
under	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
rib	NN	I-PROBLEM	I-PROBLEM
cage	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
right	RB	O	O
greater	JJR	O	O
than	IN	O	O
left	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
allergic	JJ	B-PROBLEM	B-PROBLEM
to	TO	O	O
percodan	VB	B-TREATMENT	O
,	,	O	O
which	WDT	O	O
gives	VBZ	O	O
him	PRP	O	O
itchiness	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

triamcinolone	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
one	CD	O	O
tablet	NN	O	O
po	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
dosage	NN	O	O
unknown	JJ	O	O
,	,	O	O
xanax	JJ	B-TREATMENT	B-TREATMENT
one	CD	O	O
tablet	NN	O	O
po	NN	O	O
t.i.d.	NN	O	O
,	,	O	O
prn	JJ	O	O
anxiety	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
dosage	NN	O	O
unknown	JJ	O	O
,	,	O	O
ms	JJ	B-TREATMENT	B-TREATMENT
contin	NN	I-TREATMENT	I-TREATMENT
prn	NN	O	O
.	.	O	O

distant	JJ	B-PROBLEM	B-PROBLEM
peptic	JJ	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
thumb	NN	B-PROBLEM	O
and	CC	I-PROBLEM	O
middle	JJ	I-PROBLEM	O
finger	NN	I-PROBLEM	O
lost	VBD	I-PROBLEM	O
secondary	JJ	O	O
to	TO	O	O
lawnmower	VB	O	O
accident	NN	O	O
at	IN	O	O
age	NN	O	O
five	CD	O	O
years	NNS	O	O
,	,	O	O
no	DT	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
vascular	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
status	NN	O	O
post	NN	O	O
partial	JJ	B-TREATMENT	B-TREATMENT
gastrectomy	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
peptic	JJ	B-PROBLEM	B-PROBLEM
ulcer	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
1965	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
review	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
systems	NNS	I-TEST	I-TEST
was	VBD	O	O
notable	JJ	O	O
for	IN	O	O
anxiety	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
physical	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
,	,	O	O
he	PRP	O	O
is	VBZ	O	O
a	DT	O	O
cachectic	JJ	O	O
white	JJ	O	O
male	NN	O	O
looking	VBG	O	O
older	JJR	O	O
than	IN	O	O
his	PRP$	O	O
stated	JJ	O	O
age	NN	O	O
,	,	O	O
who	WP	O	O
is	VBZ	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
,	,	I-TEST	I-TEST
eyes	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
ears	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
nose	RB	I-TEST	I-TEST
,	,	I-TEST	I-TEST
throat	NN	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

the	DT	O	O
neck	NN	O	O
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
1	CD	I-PROBLEM	I-PROBLEM
x	NN	I-PROBLEM	I-PROBLEM
1	CD	I-PROBLEM	I-PROBLEM
centimeter	NN	I-PROBLEM	I-PROBLEM
submaxillary	JJ	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
lymph	NN	I-PROBLEM	I-PROBLEM
node	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

it	PRP	O	O
was	VBD	O	O
otherwise	RB	O	O
supple	JJ	O	O
,	,	O	O
with	IN	O	O
no	DT	O	O
thyromegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

his	PRP$	O	B-TEST
chest	NN	O	I-TEST
and	CC	O	I-TEST
axillae	NN	O	I-TEST
showed	VBD	O	O
no	DT	O	O
supraclavicular	NN	B-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	O
axillary	JJ	I-PROBLEM	B-PROBLEM
adenopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	B-TEST
lung	NN	O	I-TEST
sounds	NNS	O	I-TEST
were	VBD	O	O
rhonchorous	JJ	B-PROBLEM	O
,	,	O	O
otherwise	RB	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	NN	B-TEST	B-TEST
and	CC	O	O
percussion	NN	B-TEST	B-TEST
.	.	O	O

cardiovascular	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
:	:	O	O

regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
normal	JJ	O	O
sl	NN	O	O
and	CC	O	O
s2	NN	O	O
,	,	O	O
no	DT	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
rub	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
gallop	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

scaphoid	NN	O	O
,	,	O	O
positive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
,	,	O	O
no	DT	O	O
palpable	JJ	B-PROBLEM	B-PROBLEM
masses	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
parasagittal	JJ	I-PROBLEM	I-PROBLEM
scar	NN	I-PROBLEM	I-PROBLEM
right	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
midline	NN	O	I-PROBLEM
.	.	O	O

pulses	NNS	B-TEST	B-TEST
were	VBD	O	O
2+	CD	O	O
and	CC	O	O
symmetrical	JJ	O	O
,	,	O	O
no	DT	O	O
clubbing	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
neurological	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
nonfocal	JJ	O	O
.	.	O	O

admission	NN	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
of	IN	O	O
136	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
3.8	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
99	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
27.3	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
of	IN	O	O
13	CD	O	O
and	CC	O	O
0.6	CD	O	O
,	,	O	O
glucose	RB	B-TEST	B-TEST
86	CD	O	O
,	,	O	O
calcium	NN	B-TEST	B-TEST
9.3	CD	O	O
,	,	O	O
liver	JJR	B-TEST	B-TEST
function	NN	I-TEST	I-TEST
tests	NNS	I-TEST	I-TEST
notable	JJ	O	O
for	IN	O	O
an	DT	O	B-TEST
albumin	NN	B-TEST	I-TEST
of	IN	O	O
2.5	CD	O	O
,	,	O	O
globulin	NN	B-TEST	B-TEST
4.5	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
complete	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
on	IN	I-TEST	O
admission	NN	I-TEST	O
showed	VBD	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
14.5	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
31.0	CD	O	O
,	,	O	O
hemoglobin	VBD	B-TEST	B-TEST
10.3	CD	O	O
and	CC	O	O
platelet	VB	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
478,000	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
arterial	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
gases	NNS	I-TEST	I-TEST
on	IN	O	O
room	NN	O	O
air	NN	O	O
were	VBD	O	O
7.46/70/41	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
pulmonary	JJ	I-TEST	I-TEST
function	NN	I-TEST	I-TEST
tests	NNS	I-TEST	I-TEST
revealed	VBD	O	O
an	DT	B-TEST	O
fev1	NN	I-TEST	O
of	IN	O	O
1.51	CD	O	O
,	,	O	O
fvc	RB	B-TEST	O
2.72	CD	O	O
,	,	O	O
and	CC	O	O
fev1/fvc	JJ	B-TEST	B-TEST
ratio	NN	I-TEST	I-TEST
of	IN	O	O
56%	CD	O	O
.	.	O	O

dlco	NN	B-TEST	B-TEST
was	VBD	O	O
2	CD	O	O
,	,	O	O
or	CC	O	O
19%	CD	O	O
of	IN	O	O
predicted	VBN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
quantitative	JJ	I-TEST	I-TEST
v	NN	I-TEST	I-TEST
/	NNP	I-TEST	I-TEST
q	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
was	VBD	O	O
also	RB	O	O
done	VBN	O	O
preoperatively	RB	O	O
and	CC	O	O
pulmonary	JJ	O	O
consult	NN	O	O
was	VBD	O	O
obtained	VBN	O	O
preoperatively	RB	O	O
.	.	O	O

pulmonary	NN	O	O
recommended	VBD	O	O
that	IN	O	O
he	PRP	O	O
just	RB	O	O
be	VB	O	O
started	VBN	O	O
on	IN	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	I-TREATMENT
atrovent	NN	B-TREATMENT	I-TREATMENT
metered	VBD	I-TREATMENT	I-TREATMENT
dose	JJ	I-TREATMENT	I-TREATMENT
inhalers	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
2	CD	O	O
puffs	NNS	O	O
q6h	RB	O	O
,	,	O	O
prior	RB	O	O
to	TO	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
underwent	VBD	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
12-4-93	JJ	O	O
,	,	O	O
without	IN	O	O
complications	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

findings	NNS	O	O
included	VBD	O	O
thickened	JJ	B-PROBLEM	B-PROBLEM
pleura	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
adhesions	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
an	DT	B-PROBLEM	B-PROBLEM
abscess	NN	I-PROBLEM	I-PROBLEM
near	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
margin	NN	I-PROBLEM	I-PROBLEM
major	JJ	I-PROBLEM	I-PROBLEM
fissure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
firm	JJ	I-PROBLEM	I-PROBLEM
nodule	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
oxygen	JJ	B-TEST	B-TEST
saturations	NNS	I-TEST	I-TEST
of	IN	O	O
99%	CD	O	O
with	IN	O	O
an	DT	B-TEST	O
fi02	NN	I-TEST	O
of	IN	O	O
40%	CD	O	O
and	CC	O	O
had	VBD	O	O
no	DT	O	O
complaints	NNS	O	B-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-PROBLEM
left	VBD	I-TEST	I-PROBLEM
lower	JJR	I-TEST	I-PROBLEM
lobe	NN	I-TEST	I-PROBLEM
micro	NN	I-TEST	I-PROBLEM
results	NNS	O	O
revealed	VBD	O	O
alpha	JJ	B-PROBLEM	B-PROBLEM
hemolytic	JJ	I-PROBLEM	I-PROBLEM
streptococcus	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
culture	NN	B-TEST	B-TEST
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
then	RB	O	O
switched	VBN	O	O
to	TO	O	O
penicillin	VB	B-TREATMENT	B-TREATMENT
and	CC	O	O
gentamicin	VB	B-TREATMENT	B-TREATMENT
after	IN	O	O
being	VBG	O	O
started	VBN	O	O
on	IN	O	O
triples	NNS	O	O
of	IN	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
ampicillin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
had	VBD	O	O
low	JJ	B-PROBLEM	B-PROBLEM
grade	NN	I-PROBLEM	I-PROBLEM
temperatures	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
though	RB	O	O
did	VBD	O	O
not	RB	O	O
spike	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
high	JJ	I-PROBLEM	I-PROBLEM
temperature	NN	I-PROBLEM	I-PROBLEM
during	IN	O	O
his	PRP$	O	B-TREATMENT
hospital	JJ	O	I-TREATMENT
course	NN	O	I-TREATMENT
.	.	O	O

his	PRP$	O	O
hospital	NN	O	O
course	NN	O	O
was	VBD	O	O
otherwise	RB	O	O
uneventful	JJ	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
discharged	VBN	O	O
in	IN	O	O
stable	JJ	O	O
condition	NN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
,	,	O	O
afebrile	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
on	IN	O	O
the	DT	O	O
morning	NN	O	O
of	IN	O	O
discharge	NN	O	O
was	VBD	O	O
unchanged	JJ	O	O
from	IN	O	O
the	DT	O	O
previous	JJ	O	O
day	NN	O	O
,	,	O	O
with	IN	O	O
slight	JJ	B-PROBLEM	B-PROBLEM
increase	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
completed	VBN	O	O
six	CD	O	O
days	NNS	O	O
of	IN	O	O
penicillin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
was	VBD	O	O
discharged	VBN	O	O
on	IN	O	O
ciprofloxacin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
the	DT	O	O
next	JJ	O	O
seven	CD	O	O
days	NNS	O	O
.	.	O	O

tylenol	RB	B-TREATMENT	B-TREATMENT
#	#	I-TREATMENT	O
3	CD	I-TREATMENT	O
,	,	O	O
xanax	NNP	B-TREATMENT	B-TREATMENT
,	,	O	O
ciprofloxacin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
49-year-old	JJ	O	O
gravida	NN	O	O
iii	NN	O	O
,	,	O	O
para	NN	O	O
ii	NN	O	O
,	,	O	O
who	WP	O	O
was	VBD	O	O
sent	VBN	O	O
from	IN	O	O
her	PRP$	O	O
primary	JJ	O	O
care	NN	O	O
physician	NN	O	O
's	POS	O	O
office	NN	O	O
secondary	NN	O	O
to	TO	O	O
lower	VB	B-PROBLEM	O
abdominal	JJ	I-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
status	NN	O	O
post	NN	O	O
uterine	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
embolization	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
2009-01-07	JJ	O	O
secondary	JJ	O	O
to	TO	O	O
fibroids	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
had	VBD	O	O
continuing	VBG	B-PROBLEM	B-PROBLEM
vaginal	JJ	I-PROBLEM	I-PROBLEM
discharge	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
was	VBD	O	O
diagnosed	VBN	O	O
with	IN	O	O
bacterial	JJ	B-PROBLEM	B-PROBLEM
vaginosis	NN	I-PROBLEM	I-PROBLEM
one	CD	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
,	,	O	O
and	CC	O	O
was	VBD	O	O
given	VBN	O	O
a	DT	O	B-TREATMENT
prescription	NN	O	I-TREATMENT
for	IN	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
noted	VBD	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
two	CD	O	O
days	NNS	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
,	,	O	O
which	WDT	O	O
became	VBD	O	O
more	RBR	O	O
severe	JJ	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
.	.	O	O

she	PRP	O	O
went	VBD	O	O
to	TO	O	O
her	PRP$	O	O
primary	JJ	O	O
care	NN	O	O
physician	NN	O	O
's	POS	O	O
office	NN	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
admission	NN	O	O
complaining	NN	O	O
of	IN	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
she	PRP	O	O
stated	VBD	O	O
was	VBD	O	O
constant	JJ	O	O
but	CC	O	O
intermittently	RB	O	O
sharper	JJR	O	O
at	IN	O	O
times	NNS	O	O
.	.	O	O

she	PRP	O	O
also	RB	O	O
complained	VBD	O	O
of	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
loose	JJ	I-PROBLEM	I-PROBLEM
stools	NNS	I-PROBLEM	I-PROBLEM
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
admission	NN	O	O
,	,	O	O
no	DT	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
was	VBD	O	O
100.4	CD	O	O
in	IN	O	O
the	DT	O	O
office	NN	O	O
,	,	O	O
and	CC	O	O
she	PRP	O	O
had	VBD	O	O
no	DT	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
sent	VBN	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
ct	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
her	PRP$	I-TEST	I-TEST
abdomen	NNS	I-TEST	I-TEST
,	,	O	O
which	WDT	O	O
revealed	VBD	O	O
fluid	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
question	NN	O	O
of	IN	O	O
gas	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
endometrial	JJ	I-PROBLEM	I-PROBLEM
cavity	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
sent	VBN	O	O
to	TO	O	O
pinewood	VB	O	O
,	,	O	O
norfolk	FW	O	O
for	IN	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
admission	NN	B-TREATMENT	O
.	.	O	O

cesarean	JJ	B-TREATMENT	B-TREATMENT
section	NN	I-TREATMENT	I-TREATMENT
x	VBD	O	O
2	CD	O	O
,	,	O	O
spontaneous	JJ	B-PROBLEM	B-PROBLEM
abortion	NN	I-PROBLEM	I-PROBLEM
x	VBD	O	O
1	CD	O	O
.	.	O	O

some	DT	B-PROBLEM	O
spotting	NN	I-PROBLEM	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
,	,	O	O
but	CC	O	O
not	RB	O	O
a	DT	O	O
normal	JJ	O	O
period	NN	O	O
.	.	O	O

lupron	NN	B-TREATMENT	O
x	NNP	O	O
three	CD	O	O
months	NNS	O	O
prior	RB	O	O
to	TO	O	O
embolization	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

fibroid	JJ	B-PROBLEM	O
uterus	NN	I-PROBLEM	O
status	NN	O	O
post	NN	O	O
embolization	NN	B-TREATMENT	B-TREATMENT
on	IN	O	O
2009-01-07	JJ	O	O
.	.	O	O

dilatation	NN	B-TREATMENT	B-TREATMENT
and	CC	I-TREATMENT	I-TREATMENT
curettage	NN	I-TREATMENT	I-TREATMENT
x	VBP	O	O
1	CD	O	O
for	IN	O	O
sab	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

history	NN	O	O
of	IN	O	O
herpes	NNS	B-PROBLEM	B-PROBLEM
simplex	JJ	I-PROBLEM	I-PROBLEM
virus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
last	JJ	O	O
outbreak	NN	O	O
in	IN	O	O
2000	CD	O	O
.	.	O	O

no	DT	O	O
history	NN	O	O
of	IN	O	O
abnormal	JJ	B-PROBLEM	B-PROBLEM
pap	NN	I-PROBLEM	I-PROBLEM
smears	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

cesarean	JJ	B-TREATMENT	B-TREATMENT
section	NN	I-TREATMENT	I-TREATMENT
x	VBD	O	O
2	CD	O	O
,	,	O	O
dilatation	NN	B-TREATMENT	B-TREATMENT
and	CC	I-TREATMENT	I-TREATMENT
curettage	NN	I-TREATMENT	I-TREATMENT
x	NN	O	O
1	CD	O	O
,	,	O	O
neck	NN	B-TREATMENT	B-TREATMENT
fusion	NN	I-TREATMENT	I-TREATMENT
after	IN	O	O
motor	NN	O	O
vehicle	NN	O	O
accident	NN	O	O
,	,	O	O
shoulder	NN	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
after	IN	O	O
motor	NN	O	O
vehicle	NN	O	O
accident	NN	O	O
.	.	O	O

flagyl	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

temperature	NN	B-TEST	B-TEST
100.4	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
108	CD	O	O
,	,	O	O
respirations	NNS	B-TEST	B-TEST
20	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
110/70	CD	O	O
,	,	O	O
oxygen	NN	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST
100%	CD	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

in	IN	O	O
general	JJ	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	O	O
abdomen	NNS	O	O
was	VBD	O	O
notable	JJ	O	O
for	IN	O	O
voluntary	JJ	B-PROBLEM	O
guarding	NN	I-PROBLEM	O
but	CC	O	O
no	DT	O	O
involuntary	JJ	B-PROBLEM	B-PROBLEM
guarding	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
rebound	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
mild	VB	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
greater	JJR	O	I-PROBLEM
than	IN	O	I-PROBLEM
left	VBD	O	I-PROBLEM
lower	JJR	O	I-PROBLEM
quadrant	NN	O	I-PROBLEM
,	,	O	O
nondistended	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
pelvic	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
notable	JJ	O	O
for	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
brownish	JJ	I-PROBLEM	I-PROBLEM
discharge	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	O	O
uterus	NN	O	O
and	CC	O	O
adnexa	NN	O	O
were	VBD	O	O
difficult	JJ	O	O
to	TO	O	O
assess	VB	O	O
secondary	JJ	O	O
to	TO	O	O
voluntary	JJ	B-PROBLEM	B-PROBLEM
tensing	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
abdomen	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
49-year-old	JJ	O	O
gravida	NN	O	O
iii	NN	O	O
,	,	O	O
para	NN	O	O
ii	NN	O	O
,	,	O	O
status	NN	B-TREATMENT	O
post	NN	I-TREATMENT	O
uterine	JJ	I-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
embolization	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
2009-01-07	JJ	O	O
due	JJ	O	O
to	TO	O	O
uterine	JJ	B-PROBLEM	B-PROBLEM
fibroids	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
continued	JJ	B-PROBLEM	B-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
ct	NN	B-TEST	B-TEST
scan	JJ	I-TEST	I-TEST
revealing	NN	O	I-TEST
fluid	NN	B-PROBLEM	I-TEST
and	CC	I-PROBLEM	O
gas	NN	I-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
endometrial	JJ	I-PROBLEM	I-PROBLEM
cavity	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
and	CC	O	O
was	VBD	O	O
initially	RB	O	O
started	VBN	O	O
on	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
ampicillin	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
clindamycin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

her	PRP$	B-TEST	B-TEST
initial	JJ	I-TEST	I-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
11.3	CD	O	O
,	,	O	O
with	IN	O	O
a	DT	O	O
normal	JJ	O	O
differential	NN	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
sedimentation	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
was	VBD	O	O
elevated	VBN	B-PROBLEM	B-PROBLEM
at	IN	O	O
110	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
electrolytes	NNS	I-TEST	I-TEST
were	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
maintained	VBN	O	O
on	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
number	NN	O	O
three	CD	O	O
,	,	O	O
her	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
came	VBD	O	O
back	RB	O	O
positive	JJ	B-PROBLEM	O
in	IN	O	O
the	DT	B-TEST	B-TEST
anaerobic	JJ	I-TEST	I-TEST
culture	NN	I-TEST	I-TEST
for	IN	O	O
gram-positive	JJ	B-PROBLEM	B-PROBLEM
cocci	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
pairs	NNS	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
clusters	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

further	JJ	B-TEST	B-TEST
identification	NN	I-TEST	I-TEST
revealed	VBD	O	O
staphylococcus	JJ	B-PROBLEM	B-PROBLEM
coag-negative	JJ	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
was	VBD	O	O
sensitive	JJ	O	O
to	TO	O	O
gentamicin	VB	B-TREATMENT	B-TREATMENT
and	CC	O	O
clindamycin	VB	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
her	PRP	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
was	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
until	IN	O	O
hospital	JJ	O	O
day	NN	O	O
number	NN	O	O
five	CD	O	O
,	,	O	O
when	WRB	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
temperature	NN	I-PROBLEM	I-PROBLEM
spike	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
102.3	CD	O	O
.	.	O	O

repeat	NN	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
were	VBD	O	O
sent	VBN	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
12.8	CD	O	O
,	,	O	O
with	IN	O	O
a	DT	O	O
normal	JJ	O	O
differential	NN	O	O
.	.	O	O

at	IN	O	O
this	DT	O	O
time	NN	O	O
,	,	O	O
an	DT	O	O
infectious	JJ	O	O
disease	NN	O	O
consult	NN	O	O
was	VBD	O	O
obtained	VBN	O	O
,	,	O	O
and	CC	O	O
the	DT	O	O
recommendation	NN	O	O
was	VBD	O	O
to	TO	O	O
discontinue	VB	O	O
the	DT	B-TREATMENT	B-TREATMENT
ampicillin	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
clindamycin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
start	VB	O	O
her	PRP$	O	O
on	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
unasyn	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
underwent	VBD	O	O
a	DT	B-TEST	B-TEST
pelvic	JJ	I-TEST	I-TEST
ultrasound	NN	I-TEST	I-TEST
and	CC	O	O
an	DT	B-TEST	B-TEST
abdomen	NNS	I-TEST	I-TEST
and	CC	I-TEST	I-TEST
pelvis	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
,	,	O	O
which	WDT	O	O
revealed	VBD	O	O
continued	VBD	B-PROBLEM	B-PROBLEM
air	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
endometrial	JJ	I-PROBLEM	I-PROBLEM
cavity	NN	I-PROBLEM	I-PROBLEM
vs.	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
fundal	JJ	I-PROBLEM	I-PROBLEM
fibroid	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

discussion	NN	O	O
was	VBD	O	O
had	VBN	O	O
at	IN	O	O
this	DT	O	O
time	NN	O	O
with	IN	O	O
the	DT	O	O
patient	NN	O	O
regarding	VBG	O	O
whether	IN	O	O
or	CC	O	O
not	RB	O	O
this	DT	O	O
represented	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
infected	JJ	I-PROBLEM	I-PROBLEM
abscess	NN	I-PROBLEM	I-PROBLEM
vs.	IN	O	O
post-surgical	JJ	B-PROBLEM	B-PROBLEM
change	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

possible	JJ	O	O
drainage	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
abscess	NN	I-PROBLEM	I-PROBLEM
vs.	FW	O	O
hysterectomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
requested	VBD	O	O
an	DT	O	O
outside	JJ	O	O
second	JJ	O	O
opinion	NN	O	O
,	,	O	O
as	IN	O	O
she	PRP	O	O
was	VBD	O	O
reluctant	JJ	O	O
to	TO	O	O
undergo	VB	O	O
hysterectomy	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
this	DT	O	O
time	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
discharged	VBN	O	O
to	TO	O	O
home	NN	O	O
on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
number	NN	O	O
eight	CD	O	O
,	,	O	O
on	IN	O	O
oral	JJ	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
ct	JJ	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
in	IN	O	O
one	CD	O	O
week	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
also	RB	O	O
to	TO	O	O
obtain	VB	O	O
a	DT	O	O
second	JJ	O	O
opinion	NN	O	O
regarding	VBG	O	O
the	DT	O	O
question	NN	O	O
of	IN	O	O
possible	JJ	O	O
surgical	JJ	B-TREATMENT	B-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

post-infarction	NN	B-PROBLEM	B-PROBLEM
unstable	JJ	I-PROBLEM	I-PROBLEM
angina	JJ	I-PROBLEM	I-PROBLEM
pectoris	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

post-infarction	NN	B-PROBLEM	B-PROBLEM
unstable	JJ	I-PROBLEM	I-PROBLEM
angina	JJ	I-PROBLEM	I-PROBLEM
pectoris	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

inferior	JJ	B-PROBLEM	B-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
ventricular	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
arrest	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
paroxysmal	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
psychosis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

3-27-93	JJ	O	O
,	,	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
and	CC	O	O
coronary	JJ	B-TEST	B-TEST
and	CC	I-TEST	I-TEST
left	VBD	I-TEST	I-TEST
ventricular	JJ	I-TEST	I-TEST
angiography	NN	I-TEST	I-TEST
;	:	O	O
4-2-93	JJ	O	O
,	,	O	O
exercise	JJ	B-TEST	B-TEST
tolerance	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
with	IN	I-TEST	O
thallium	NN	I-TEST	B-TEST
.	.	O	O

vasotec	JJ	B-TREATMENT	O
5	CD	O	O
mg	NN	O	O
po	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
isordil	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
po	NN	O	O
q.i.d.	NN	O	O
,	,	O	O
ticlopidine	VB	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
po	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
metoprolol	FW	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
po	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
ciprofloxacin	VBP	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
po	NN	O	O
q12h	NN	O	O
x	NNP	O	O
seven	CD	O	O
days	NNS	O	O
,	,	O	O
nitroglycerin	JJ	B-TREATMENT	B-TREATMENT
0.3	CD	O	O
mg	NN	O	O
sublingually	RB	O	O
prn	JJ	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
73	CD	O	O
year	NN	O	O
old	JJ	O	O
female	NN	O	O
who	WP	O	O
was	VBD	O	O
transferred	VBN	O	O
for	IN	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
after	IN	O	O
ventricular	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
arrest	NN	I-PROBLEM	O
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
acute	JJ	I-PROBLEM	I-PROBLEM
inferior	JJ	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
urinary	JJ	I-PROBLEM	I-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
on	IN	O	O
3-16-93	JJ	O	O
to	TO	O	O
diy	VB	O	O
hospital	NN	O	O
for	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
e.	JJ	I-PROBLEM	I-PROBLEM
coli	NNS	I-PROBLEM	I-PROBLEM
urinary	JJ	I-PROBLEM	I-PROBLEM
tract	JJ	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
readmitted	VBN	O	O
on	IN	O	O
3-20-93	JJ	O	O
because	IN	O	O
of	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
a	DT	O	B-PROBLEM
sudden	JJ	O	I-PROBLEM
onset	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
ventricular	JJ	B-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
arrest	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
successfully	RB	O	O
cardioverted	VBN	O	O
back	RB	O	O
to	TO	O	O
rapid	VB	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
finally	RB	O	O
to	TO	O	O
sinus	VB	O	O
rhythm	NN	O	O
,	,	O	O
where	WRB	O	O
an	DT	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
then	RB	O	O
showed	VBD	O	O
st	JJ	B-PROBLEM	B-PROBLEM
elevation	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
inferior	JJ	I-PROBLEM	I-PROBLEM
leads	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

peak	NN	B-TEST	B-TEST
cpk	NN	I-TEST	I-TEST
was	VBD	O	O
2494	CD	O	O
with	IN	O	O
18%	CD	B-TEST	O
mb	NN	I-TEST	O
's	POS	I-TEST	O
.	.	O	O

she	PRP	O	O
required	VBD	O	O
intubation	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
mild	NN	B-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
moderate	VB	I-PROBLEM	I-PROBLEM
congestive	JJ	I-PROBLEM	I-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
treated	VBN	O	O
with	IN	O	O
diuretics	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
nitroglycerin	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
post-infarction	NN	B-PROBLEM	B-PROBLEM
angina	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
was	VBD	O	O
transferred	VBN	O	O
here	RB	O	O
for	IN	O	O
angiography	NN	B-TEST	B-TEST
and	CC	O	O
possible	JJ	O	O
percutaneous	JJ	B-TREATMENT	B-TREATMENT
transluminal	JJ	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
angioplasty	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
physical	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
is	VBZ	O	O
130/80	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
74	CD	O	O
and	CC	O	O
regular	JJ	O	O
,	,	O	O
respirations	NNS	B-TEST	B-TEST
14	CD	O	O
.	.	O	O

her	PRP$	O	B-TEST
chest	NN	O	I-TEST
demonstrated	VBD	O	O
bibasilar	JJ	B-PROBLEM	B-PROBLEM
crackles	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
jugular	JJ	I-TEST	I-TEST
venous	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
seven	CD	O	O
centimeters	NNS	O	O
,	,	O	O
carotid	JJ	B-TEST	B-PROBLEM
upstroke	NN	I-TEST	I-PROBLEM
normal	JJ	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	O	O
normal	JJ	O	O
sl	NN	O	O
and	CC	O	O
s2	NN	O	O
was	VBD	O	O
normally	RB	O	B-PROBLEM
split	VBN	O	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
an	DT	B-PROBLEM	O
s4	NN	I-PROBLEM	O
,	,	O	O
no	DT	O	O
s3	NN	B-PROBLEM	O
,	,	O	O
grade	VBD	B-PROBLEM	B-PROBLEM
ii/vi	JJ	I-PROBLEM	I-PROBLEM
apical	JJ	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
systole	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
rubs	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
calf	NN	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

peripheral	JJ	B-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
were	VBD	O	O
2+	CD	O	O
and	CC	O	O
symmetrical	JJ	O	O
bilaterally	RB	O	O
.	.	O	O

on	IN	O	O
3-27-93	JJ	O	O
,	,	O	O
patient	JJ	O	O
underwent	JJ	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
,	,	O	O
coronary	JJ	B-TEST	B-TEST
and	CC	I-TEST	I-TEST
left	VBD	I-TEST	I-TEST
ventricular	JJ	I-TEST	I-TEST
angiography	NN	I-TEST	I-TEST
without	IN	O	O
complications	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

review	NN	O	B-TEST
of	IN	O	I-TEST
these	DT	B-TEST	I-TEST
angiograms	NNS	I-TEST	I-TEST
demonstrated	VBD	O	O
a	DT	O	B-PROBLEM
dominant	JJ	O	I-PROBLEM
right	JJ	O	I-PROBLEM
coronary	JJ	O	I-PROBLEM
artery	NN	O	I-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
focal	JJ	I-PROBLEM	I-PROBLEM
50%	CD	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
mid-portion	NN	I-PROBLEM	O
.	.	O	O

the	DT	O	O
left	JJ	O	O
anterior	JJ	O	O
descending	NN	O	O
had	VBD	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
plaques	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
50%	CD	I-PROBLEM	I-PROBLEM
proximal	JJ	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
anterior	NN	I-PROBLEM	I-PROBLEM
oblique	JJ	I-PROBLEM	I-PROBLEM
caudal	JJ	I-PROBLEM	I-PROBLEM
view	NN	O	I-PROBLEM
.	.	O	O

the	DT	O	O
proximal	JJ	O	O
diagonal	JJ	O	O
d1	NN	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
50%	CD	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
circumflex	NN	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
long	JJ	I-PROBLEM	I-PROBLEM
30%	CD	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
proximally	RB	O	I-PROBLEM
and	CC	O	O
an	DT	B-PROBLEM	B-PROBLEM
80%	CD	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
the	DT	O	O
origin	NN	O	O
of	IN	O	O
the	DT	O	O
second	JJ	O	O
major	JJ	O	O
marginal	JJ	O	O
artery	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
left	NN	I-TEST	I-TEST
ventricular	JJ	I-TEST	I-TEST
angiogram	NN	I-TEST	I-TEST
showed	VBD	O	O
akinesis	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
posterobasal	NN	I-PROBLEM	O
walls	NNS	I-PROBLEM	O
,	,	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
hypokinesis	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
diaphragmatic	JJ	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
trace	NN	B-PROBLEM	B-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
maintained	VBN	O	O
on	IN	O	O
heparin	JJ	B-TREATMENT	B-TREATMENT
anticoagulation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

an	DT	B-TEST	B-TEST
exercise	NN	I-TEST	I-TEST
tolerance	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
with	IN	I-TEST	O
thallium	NN	I-TEST	B-TEST
was	VBD	O	O
to	TO	O	O
be	VB	O	O
performed	VBN	O	O
in	IN	O	O
order	NN	O	O
to	TO	O	O
assess	VB	O	O
myocardial	JJ	O	B-PROBLEM
viability	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
infarct	NN	I-PROBLEM	I-PROBLEM
zone	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
complex	JJ	O	O
and	CC	O	O
there	EX	O	O
was	VBD	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
obtuse	NN	I-PROBLEM	I-PROBLEM
marginal	JJ	I-PROBLEM	I-PROBLEM
1	CD	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
no	DT	O	O
further	JJ	B-PROBLEM	B-PROBLEM
angina	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
4-2-93	JJ	O	O
,	,	O	O
she	PRP	O	O
underwent	VBD	O	O
a	DT	B-TEST	B-TEST
persantine	NN	I-TEST	I-TEST
thallium	NN	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
.	.	O	O

this	DT	O	O
showed	VBD	O	O
no	DT	O	O
diagnostic	JJ	B-PROBLEM	B-TEST
electrocardiogram	NN	I-PROBLEM	I-TEST
changes	NNS	I-PROBLEM	O
for	IN	O	O
ischemia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
no	DT	O	O
angina	JJ	B-PROBLEM	B-PROBLEM
pectoris	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
thallium	NN	I-TEST	I-TEST
images	VBZ	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
region	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
persistently	RB	I-PROBLEM	I-PROBLEM
reduced	VBN	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
flow	NN	I-PROBLEM	I-PROBLEM
involving	VBG	O	O
the	DT	O	O
apex	NN	O	O
and	CC	O	O
inferoposterior	JJ	O	B-PROBLEM
segments	NNS	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	NN	O	I-PROBLEM
ventricular	NN	O	I-PROBLEM
wall	NN	O	I-PROBLEM
.	.	O	O

this	DT	O	O
was	VBD	O	O
consistent	JJ	O	O
with	IN	O	O
scar	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
definite	JJ	B-PROBLEM	B-PROBLEM
perfusion	NN	I-PROBLEM	I-PROBLEM
abnormality	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
circumflex	JJ	I-PROBLEM	I-PROBLEM
zone	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

large	JJ	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
middle	JJ	I-PROBLEM	I-PROBLEM
cerebral	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
stroke	VBD	I-PROBLEM	I-PROBLEM
along	IN	O	O
with	IN	O	O
posterior	JJ	B-PROBLEM	B-PROBLEM
cerebral	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
strokes	NNS	I-PROBLEM	I-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
is	VBZ	O	O
an	DT	O	O
86	CD	O	O
year	NN	O	O
old	JJ	O	O
woman	NN	O	O
who	WP	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
vascular	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
emboli	NN	I-PROBLEM	I-PROBLEM
who	WP	O	O
was	VBD	O	O
admitted	VBN	O	O
on	IN	O	O
2013-09-06	JJ	O	O
,	,	O	O
to	TO	O	O
the	DT	O	O
neurologic	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
service	NN	O	O
after	IN	O	O
collapsing	VBG	O	O
at	IN	O	O
home	NN	O	O
at	IN	O	O
8:30	CD	O	O
p.m	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
right	RB	B-PROBLEM	B-PROBLEM
sided	VBN	I-PROBLEM	I-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
noted	VBN	O	O
by	IN	O	O
her	PRP$	O	O
husband	NN	O	O
to	TO	O	O
have	VB	O	O
vomited	VBN	O	B-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
found	VBN	O	O
comatose	RB	B-PROBLEM	O
at	IN	O	O
home	NN	O	O
by	IN	O	O
ems	NNS	O	O
and	CC	O	O
was	VBD	O	O
brought	VBN	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
department	NN	O	O
.	.	O	O

on	IN	O	O
arrival	NN	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
department	NN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
of	IN	O	O
98.2	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
164/110	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
28	CD	O	O
,	,	O	O
and	CC	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
74	CD	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
responsive	JJ	B-PROBLEM	O
only	RB	I-PROBLEM	O
to	TO	I-PROBLEM	O
painful	VB	I-PROBLEM	B-TEST
stimuli	NN	I-PROBLEM	I-TEST
at	IN	O	O
this	DT	O	O
time	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
intubated	VBN	O	B-TREATMENT
for	IN	O	O
airway	NN	B-TREATMENT	B-TREATMENT
protection	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
received	VBN	O	O
multiple	JJ	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
prior	RB	O	O
to	TO	O	O
her	PRP$	B-TEST	B-TEST
initial	JJ	I-TEST	I-TEST
neurologic	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
.	.	O	O

she	PRP	O	O
was	VBD	O	O
also	RB	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
cold	JJ	I-PROBLEM	I-PROBLEM
distal	NN	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
operated	VBN	O	O
on	IN	O	O
and	CC	O	O
she	PRP	O	O
is	VBZ	O	O
now	RB	O	O
status	NN	O	O
post	NN	O	O
left	VBD	B-TREATMENT	B-TREATMENT
brachial	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
embolectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

throughout	IN	O	O
her	PRP$	O	O
course	NN	O	O
on	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
service	NN	O	O
,	,	O	O
she	PRP	O	O
has	VBZ	O	O
remained	VBN	O	O
unresponsive	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
imaging	VBG	B-TEST	B-TEST
studies	NNS	I-TEST	I-TEST
consistent	JJ	O	O
with	IN	O	O
a	DT	O	B-PROBLEM
large	JJ	O	I-PROBLEM
left	NN	O	I-PROBLEM
middle	JJ	O	I-PROBLEM
cerebral	JJ	O	I-PROBLEM
artery	NN	O	I-PROBLEM
and	CC	O	O
posterior	JJ	B-PROBLEM	B-PROBLEM
cerebral	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
distribution	NN	I-PROBLEM	I-PROBLEM
cerebral	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
mass	NN	B-PROBLEM	B-PROBLEM
effect	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
midline	NN	B-PROBLEM	I-PROBLEM
shift	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
evidence	NN	O	O
of	IN	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
occipital	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
cerebellar	JJ	I-PROBLEM	B-PROBLEM
infarctions	NNS	I-PROBLEM	I-PROBLEM
as	IN	O	O
well	RB	O	O
.	.	O	O

discussion	NN	O	O
with	IN	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
family	NN	O	O
by	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
service	NN	O	O
has	VBZ	O	O
resulted	VBN	O	O
in	IN	O	O
focusing	VBG	O	O
on	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
comfort	NN	I-TREATMENT	I-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

based	VBN	O	O
on	IN	O	O
this	DT	O	O
,	,	O	O
she	PRP	O	O
is	VBZ	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
neurology	NN	O	O
service	NN	O	O
for	IN	O	O
focus	NN	O	O
on	IN	O	O
comfort	NN	B-TREATMENT	B-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

1.	CD	O	O
breast	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
lumpectomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

2.	CD	O	O
mitral	JJ	B-TREATMENT	B-TREATMENT
commissurectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

3.	CD	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
vascular	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

5.	CD	O	O
arterial	JJ	B-PROBLEM	B-PROBLEM
emboli	NN	I-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	O
left	VBD	I-PROBLEM	B-TREATMENT
femoral	JJ	I-PROBLEM	I-TREATMENT
artery	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

6.	CD	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
intravenous	JJ	I-TREATMENT	I-TREATMENT
q	NN	O	I-TREATMENT
6	CD	O	O
hours	NNS	O	O
.	.	O	O

2.	CD	O	O
morphine	JJ	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
1	CD	O	O
mg	NN	O	O
intravenous	JJ	O	O
p.r.n.	NN	O	O

penicillin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
sulfa	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
quinidine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

on	IN	O	O
the	DT	O	O
date	NN	O	O
of	IN	O	O
transfer	NN	O	O
,	,	O	O
temperature	NN	B-TEST	B-TEST
98.5	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
80	CD	O	O
and	CC	O	O
irregular	JJ	B-PROBLEM	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
140/60	CD	O	O
,	,	O	O
oxygen	NN	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST
100%	CD	O	O
in	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

in	IN	O	O
general	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
minimally	RB	B-PROBLEM	O
responsive	JJ	I-PROBLEM	O
woman	NN	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

head	NN	O	B-TEST
and	CC	O	I-TEST
neck	NN	O	I-TEST
-	:	O	O
normocephalic	NN	O	O
,	,	O	O
supple	NN	O	O
,	,	O	O
no	DT	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

cardiovascular	JJ	O	O
-	:	O	O
irregular	JJ	B-PROBLEM	B-PROBLEM
rhythm	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
normal	JJ	O	O
rate	NN	O	O
.	.	O	O

pulmonary	JJ	O	B-TEST
-	:	O	O
good	JJ	O	O
air	NN	O	O
movement	NN	O	O
,	,	O	O
but	CC	O	O
occasional	JJ	B-PROBLEM	O
rhonchi	NN	I-PROBLEM	O
.	.	O	O

abdomen	NNS	O	O
reveals	NNS	O	O
positive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
,	,	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

extremities	NNS	O	O
-	:	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

neurologic	JJ	O	B-PROBLEM
-	:	O	O
the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
unresponsive	JJ	B-PROBLEM	B-PROBLEM
to	TO	O	I-PROBLEM
verbal	VB	B-TEST	I-PROBLEM
stimuli	NN	I-TEST	I-PROBLEM
,	,	O	O
withdrawals	VBZ	O	O
the	DT	O	O
left	JJ	O	O
extremities	NNS	O	O
to	TO	O	O
noxious	JJ	B-TEST	B-PROBLEM
stimulation	NN	I-TEST	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
a	DT	B-PROBLEM	O
left	JJ	I-PROBLEM	O
gaze	NN	I-PROBLEM	O
preference	NN	I-PROBLEM	O
.	.	O	O

the	DT	O	O
fundi	NN	O	O
belmont	NN	O	O
difficult	JJ	O	O
to	TO	O	O
visualize	VB	O	O
but	CC	O	O
there	EX	O	O
is	VBZ	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
papilledema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

reflexes	NNS	B-TEST	B-TEST
are	VBP	O	O
down	RB	B-PROBLEM	O
on	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
right	JJ	I-PROBLEM	O
side	NN	I-PROBLEM	O
.	.	O	O

white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
11.5	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
31.0	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
290,000	CD	O	O
.	.	O	O

inr	RB	B-TEST	O
3.0	CD	O	O
.	.	O	O

potassium	NN	B-TEST	B-TEST
was	VBD	O	O
3.0	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
131	CD	O	O
.	.	O	O

mr	NN	B-TEST	B-TEST
studies	NNS	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
middle	JJ	I-PROBLEM	I-PROBLEM
cerebral	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
smaller	JJR	I-PROBLEM	I-PROBLEM
posterior	JJ	I-PROBLEM	I-PROBLEM
circulation	NN	I-PROBLEM	I-PROBLEM
infarctions	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

briefly	NN	O	O
,	,	O	O
she	PRP	O	O
is	VBZ	O	O
an	DT	O	O
86	CD	O	O
year	NN	O	O
old	JJ	O	O
woman	NN	O	O
who	WP	O	O
has	VBZ	O	O
suffered	VBN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
cardioembolic	JJ	I-PROBLEM	I-PROBLEM
cerebral	JJ	I-PROBLEM	I-PROBLEM
infarctions	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
multiple	JJ	I-PROBLEM	I-PROBLEM
arterial	JJ	I-PROBLEM	I-PROBLEM
territories	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
remained	VBN	O	O
unresponsive	JJ	B-PROBLEM	B-PROBLEM
throughout	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
hospitalization	NN	O	I-PROBLEM
and	CC	O	O
currently	RB	O	O
only	RB	O	O
withdraws	VBZ	O	O
to	TO	O	O
pain	VB	B-PROBLEM	B-PROBLEM
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
low	JJ	I-TREATMENT	I-TREATMENT
dose	JJ	I-TREATMENT	I-TREATMENT
morphine	NN	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
initiated	VBN	O	O
after	IN	O	O
further	RB	O	O
serious	JJ	O	O
discussion	NN	O	O
with	IN	O	O
her	PRP$	O	O
husband	NN	O	O
and	CC	O	O
nieces	NNS	O	O
and	CC	O	O
nephews	NNS	O	O
.	.	O	O

the	DT	O	O
family	NN	O	O
did	VBD	O	O
not	RB	O	O
want	VB	O	O
postmortem	NN	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
.	.	O	O

coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

non-insulin	JJ	B-PROBLEM	B-PROBLEM
dependent	NN	I-PROBLEM	I-PROBLEM
diabetes	VBZ	I-PROBLEM	I-PROBLEM
mellitus	RBS	I-PROBLEM	I-PROBLEM
,	,	O	O
history	NN	O	O
of	IN	O	O
gastric	JJ	B-PROBLEM	B-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
history	NN	O	O
of	IN	O	O
etoh	NN	O	O
abuse	NN	O	O
.	.	O	O

september	NN	O	O
11	CD	O	O
,	,	O	O
1994	CD	O	O
,	,	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

coumadin	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
po	NN	O	O
q.day	NN	O	O
,	,	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
0.25	CD	O	O
mg	NN	O	O
po	NN	O	O
q.day	NN	O	O
,	,	O	O
metoprolol	FW	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
po	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
baby	NN	B-TREATMENT	O
aspirin	VBD	I-TREATMENT	B-TREATMENT
80	CD	O	O
mg	NN	O	O
po	NN	O	O
q.day	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
be	VB	O	O
followed	VBN	O	O
by	IN	O	O
the	DT	O	O
anticoagulation	NN	O	O
clinic	NN	O	O
for	IN	O	O
prothrombin	JJ	B-TEST	B-TEST
time	NN	I-TEST	I-TEST
level	NN	I-TEST	I-TEST
evaluations	NNS	I-TEST	I-TEST
and	CC	O	O
appropriate	JJ	B-TREATMENT	O
coumadin	NN	I-TREATMENT	B-TREATMENT
doses	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
66	CD	O	O
year	NN	O	O
old	JJ	O	O
portuguese	JJ	O	O
speaking	VBG	O	O
gentleman	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
diabetes	VBZ	B-PROBLEM	B-PROBLEM
mellitus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
cholesterol	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
history	NN	O	O
of	IN	O	O
tobacco	NN	O	O
use	NN	O	O
,	,	O	O
who	WP	O	O
is	VBZ	O	O
status	NN	O	O
post	NN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
september	NN	O	O
of	IN	O	O
1993	CD	O	O
and	CC	O	O
february	NN	O	O
of	IN	O	O
1993	CD	O	O
,	,	O	O
who	WP	O	O
presented	VBD	O	O
with	IN	O	O
new	JJ	O	B-PROBLEM
onset	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
left	JJ	B-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
arm	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
for	IN	O	O
two	CD	O	O
days	NNS	O	O
.	.	O	O

apparently	RB	O	O
,	,	O	O
patient	NN	O	O
was	VBD	O	O
in	IN	O	O
his	PRP$	O	O
usual	JJ	O	O
state	NN	O	O
of	IN	O	O
health	NN	O	O
until	IN	O	O
two	CD	O	O
days	NNS	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
when	WRB	O	O
he	PRP	O	O
noted	VBD	O	O
new	JJ	O	O
onset	NN	O	O
of	IN	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
arm	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
confined	VBN	O	O
to	TO	O	O
his	PRP$	O	B-PROBLEM
left	JJ	O	I-PROBLEM
side	NN	O	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
chest	JJS	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
considered	VBN	O	O
mild	JJ	O	O
but	CC	O	O
persistent	JJ	O	O
with	IN	O	O
episodes	NNS	O	O
lasting	VBG	O	O
twenty	NN	O	O
minutes	NNS	O	O
.	.	O	O

he	PRP	O	O
came	VBD	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
with	IN	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
july	NN	O	O
22	CD	O	O
,	,	O	O
1994	CD	O	O
,	,	O	O
relieved	VBN	O	O
with	IN	O	O
sublingual	JJ	B-TREATMENT	B-TREATMENT
nitroglycerin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

no	DT	O	O
history	NN	O	O
of	IN	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

denies	NNS	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
pleuritic	JJ	B-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
cough	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
showed	VBD	O	O
pseudonormalization	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
t	NN	I-PROBLEM	I-PROBLEM
waves	NNS	I-PROBLEM	I-PROBLEM
in	IN	O	O
v1	NN	O	O
through	IN	O	O
v6	NN	O	O
and	CC	O	O
q	NN	B-PROBLEM	O
waves	NNS	I-PROBLEM	O
in	IN	I-PROBLEM	O
v1	NN	I-PROBLEM	O
through	IN	O	O
v3	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
past	IN	O	O
cardiac	JJ	O	O
history	NN	O	O
is	VBZ	O	O
significant	JJ	O	O
for	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
september	NN	O	O
of	IN	O	O
1993	CD	O	O
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
non-q	JJ	I-PROBLEM	I-PROBLEM
wave	NN	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
february	NN	O	O
of	IN	O	O
1993	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
in	IN	O	O
september	NN	O	O
of	IN	O	O
1993	CD	O	O
had	VBD	O	O
3-4	JJ	B-PROBLEM	B-PROBLEM
millimeter	NN	I-PROBLEM	I-PROBLEM
st	NN	I-PROBLEM	I-PROBLEM
segment	NN	I-PROBLEM	I-PROBLEM
elevation	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
v1	NN	I-PROBLEM	I-PROBLEM
through	IN	O	I-PROBLEM
v4	NN	O	I-PROBLEM
and	CC	O	I-PROBLEM
depression	NN	B-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
ii	NN	I-PROBLEM	O
,	,	I-PROBLEM	O
iii	NN	I-PROBLEM	O
,	,	I-PROBLEM	O
and	CC	I-PROBLEM	O
avf	NN	I-PROBLEM	O
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
,	,	O	O
patient	NN	O	O
had	VBD	O	O
bright	VBN	B-PROBLEM	B-PROBLEM
red	JJ	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
per	FW	I-PROBLEM	I-PROBLEM
rectum	NN	I-PROBLEM	I-PROBLEM
as	IN	O	O
well	RB	O	O
and	CC	O	O
patient	JJ	O	O
had	VBD	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
at	IN	O	O
the	DT	O	O
time	NN	O	O
which	WDT	O	O
showed	VBD	O	O
95%	CD	O	O
left	VBD	O	O
anterior	JJ	O	O
descending	NN	O	O
,	,	O	O
which	WDT	O	O
was	VBD	O	O
percutaneous	JJ	O	B-TREATMENT
transluminal	JJ	O	I-TREATMENT
coronary	NN	O	I-TREATMENT
angioplastied	VBD	O	O
and	CC	O	O
had	VBD	O	O
intra-aortic	JJ	B-TREATMENT	B-TREATMENT
balloon	NN	I-TREATMENT	I-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	O
cpk	NN	I-TEST	O
of	IN	O	O
over	IN	O	O
5000	CD	O	O
with	IN	O	O
mb	JJ	B-TEST	B-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
26.7	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-TEST	B-PROBLEM
44%	CD	I-TEST	I-PROBLEM
ejection	NN	I-TEST	I-PROBLEM
fraction	NN	I-TEST	I-PROBLEM
with	IN	O	O
anterior	JJ	B-PROBLEM	B-PROBLEM
akinesis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
septal	JJ	B-PROBLEM	I-PROBLEM
hypokinesis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
exercise	NN	I-PROBLEM	I-PROBLEM
tolerance	NN	I-PROBLEM	I-PROBLEM
test	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
thallium	NN	O	B-TEST
and	CC	O	O
repeat	NN	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
showed	VBD	O	O
left	JJ	O	B-PROBLEM
anterior	JJ	O	I-PROBLEM
descending	VBG	O	I-PROBLEM
being	VBG	O	I-PROBLEM
patent	NN	O	I-PROBLEM
and	CC	O	I-PROBLEM
distal	JJ	B-PROBLEM	I-PROBLEM
posterior	NN	I-PROBLEM	I-PROBLEM
descending	VBG	I-PROBLEM	I-PROBLEM
artery	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
circumflex	JJ	B-PROBLEM	B-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
after	IN	I-PROBLEM	O
the	DT	I-PROBLEM	B-TREATMENT
obtuse	NN	I-PROBLEM	I-TREATMENT
marginal	JJ	I-PROBLEM	I-TREATMENT
1	CD	I-PROBLEM	O
.	.	O	O

in	IN	O	O
february	NN	O	O
of	IN	O	O
1993	CD	O	O
,	,	O	O
patient	NN	O	O
again	RB	O	O
presented	VBN	O	O
with	IN	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
ruled	VBN	O	O
in	IN	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
non-q	JJ	I-PROBLEM	I-PROBLEM
wave	NN	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
cpk	JJ	B-TEST	O
peak	NN	I-TEST	O
of	IN	O	O
219	CD	O	O
and	CC	O	O
mb	NN	B-TEST	O
of	IN	O	O
20.9	CD	O	O
.	.	O	O

repeat	NN	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
showed	VBD	O	O
re-stenosis	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
proximal	JJ	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
descending	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
had	VBD	O	O
been	VBN	O	O
percutaneous	JJ	O	B-TREATMENT
transluminal	JJ	O	I-TREATMENT
coronary	NN	O	I-TREATMENT
angioplastied	VBD	O	O
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
first	JJ	I-PROBLEM	I-PROBLEM
obtuse	NN	I-PROBLEM	I-PROBLEM
marginal	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
moderate	JJ	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
severe	VB	I-PROBLEM	I-PROBLEM
left	VBN	I-PROBLEM	I-PROBLEM
circumflex	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
after	IN	O	O
the	DT	O	O
third	JJ	O	O
obtuse	IN	O	O
marginal	JJ	O	O
.	.	O	O

he	PRP	O	O
also	RB	O	O
had	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
akinetic	JJ	I-PROBLEM	I-PROBLEM
anterolateral	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
apical	JJ	I-PROBLEM	I-PROBLEM
ventricle	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

again	RB	O	O
,	,	O	O
patient	JJ	O	B-PROBLEM
&apos;s	NN	O	I-PROBLEM
cardiac	JJ	O	I-PROBLEM
risk	NN	O	I-PROBLEM
factors	NNS	O	I-PROBLEM
include	VBP	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
diabetes	VBZ	B-PROBLEM	B-PROBLEM
mellitus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
cholesterol	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	O	O
positive	JJ	O	O
family	NN	O	O
history	NN	O	O
and	CC	O	O
tobacco	NN	O	O
use	NN	O	O
.	.	O	O

in	IN	O	O
the	DT	O	O
past	JJ	O	O
,	,	O	O
patient	NN	O	O
had	VBD	O	O
been	VBN	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
non-compliant	JJ	B-PROBLEM	O
with	IN	O	O
cardiac	JJ	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
continues	VBZ	O	O
to	TO	O	O
smoke	VB	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
non-insulin	JJ	B-PROBLEM	B-PROBLEM
dependent	NN	I-PROBLEM	I-PROBLEM
diabetes	VBZ	I-PROBLEM	I-PROBLEM
mellitus	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
diet-controlled	JJ	O	O
,	,	O	O
status	NN	O	O
post	NN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarctions	NNS	I-PROBLEM	I-PROBLEM
x	VBP	O	O
two	CD	O	O
as	IN	O	O
mentioned	VBN	O	O
above	IN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
status	NN	O	O
post	NN	O	O
appendectomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

lower	JJR	B-PROBLEM	B-PROBLEM
gastrointestinal	JJ	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
february	NN	O	O
of	IN	O	O
1993	CD	O	O
which	WDT	O	O
was	VBD	O	O
not	RB	O	O
worked	VBN	O	O
up	RP	O	O
due	JJ	O	O
to	TO	O	O
patient	JJ	O	O
deferment	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
allergic	JJ	B-PROBLEM	B-PROBLEM
to	TO	O	O
penicillin	VB	B-TREATMENT	B-TREATMENT
,	,	O	O
develops	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
rash	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

metoprolol	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
po	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
isordil	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
po	NN	O	O
t.i.d.	NN	O	O
,	,	O	O
ecotrin	JJ	B-TREATMENT	B-TREATMENT
aspirin	NN	I-TREATMENT	I-TREATMENT
q.day	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
physical	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
revealed	VBD	O	O
him	PRP	O	O
to	TO	O	O
be	VB	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
blood	JJ	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
130/80	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
pulse	JJ	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
56	CD	O	O
and	CC	O	O
respirations	NNS	B-TEST	B-TEST
of	IN	O	O
24	CD	O	O
.	.	O	O

in	IN	O	O
general	JJ	O	O
,	,	O	O
he	PRP	O	O
is	VBZ	O	O
a	DT	O	O
well	RB	O	O
developed	VBN	O	O
,	,	O	O
well	RB	O	O
nourished	JJ	O	O
man	NN	O	O
breathing	VBG	O	O
easily	RB	O	O
,	,	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

multiple	JJ	B-PROBLEM	B-PROBLEM
stigmata	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
burns	NNS	B-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
arm	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
chest	NN	I-PROBLEM	O
.	.	O	O

on	IN	O	O
head	NN	B-TEST	B-TEST
,	,	I-TEST	I-TEST
eyes	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
ears	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
nose	RB	I-TEST	I-TEST
,	,	I-TEST	I-TEST
throat	NN	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
,	,	O	O
pupils	VBZ	O	O
equal	JJ	O	O
,	,	O	O
round	NN	O	O
,	,	O	O
reactive	JJ	O	O
to	TO	O	O
light	JJ	O	O
and	CC	O	O
accommodation	NN	O	O
,	,	O	O
fundus	NN	O	B-TEST
was	VBD	O	O
sharp	JJ	O	O
,	,	O	O
oral	JJ	O	B-TREATMENT
mucosa	NN	O	I-TREATMENT
was	VBD	O	O
clear	JJ	O	O
.	.	O	O

no	DT	O	O
jugular	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
distention	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
five	CD	O	O
centimeters	NNS	O	O
,	,	O	O
neck	NN	O	O
was	VBD	O	O
supple	JJ	O	O
,	,	O	O
full	JJ	O	O
range	NN	O	O
of	IN	O	O
movement	NN	O	O
,	,	O	O
no	DT	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
adenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

lungs	NNS	O	O
had	VBD	O	O
bibasilar	JJ	B-PROBLEM	B-PROBLEM
rales	NNS	I-PROBLEM	I-PROBLEM
1/4	CD	O	O
of	IN	O	O
the	DT	O	O
way	NN	O	O
up	IN	O	O
bilaterally	RB	O	O
,	,	O	O
otherwise	RB	O	O
clear	JJ	O	O
.	.	O	O

ii	NN	B-PROBLEM	O
/	NNP	I-PROBLEM	O
vi	VBZ	I-PROBLEM	O
systolic	JJ	I-PROBLEM	B-PROBLEM
ejection	NN	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
sternal	JJ	I-PROBLEM	I-PROBLEM
border	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
positive	JJ	O	O
s3	NN	B-PROBLEM	O
,	,	O	O
question	NN	O	O
of	IN	O	O
s4	NN	B-PROBLEM	O
,	,	O	O
otherwise	RB	O	O
point	NN	O	O
of	IN	O	O
maximal	JJ	B-TEST	O
impulse	NN	I-TEST	O
was	VBD	O	O
laterally	RB	B-PROBLEM	O
displaced	VBN	I-PROBLEM	O
.	.	O	O

surgical	JJ	B-PROBLEM	B-PROBLEM
midline	NN	I-PROBLEM	I-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
previous	JJ	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
history	NN	O	O
of	IN	O	O
gastric	JJ	B-PROBLEM	B-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBD	B-PROBLEM	B-PROBLEM
,	,	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
obese	JJ	I-PROBLEM	I-PROBLEM
with	IN	O	O
liver	JJ	O	B-PROBLEM
edge	NN	O	I-PROBLEM
two	CD	O	I-PROBLEM
centimeters	NNS	O	I-PROBLEM
below	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
right	JJ	O	I-PROBLEM
costal	NN	O	I-PROBLEM
margin	NN	O	I-PROBLEM
.	.	O	O

no	DT	O	O
evidence	NN	O	O
of	IN	O	O
clubbing	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
rectal	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
trace	JJ	B-PROBLEM	B-PROBLEM
guaiac	JJ	I-PROBLEM	I-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
pulses	NNS	B-TEST	B-TEST
distally	RB	I-TEST	O
,	,	O	O
1+	CD	B-TEST	O
femorals	NNS	I-TEST	O
,	,	O	O
1+	CD	B-TEST	O
dorsalis	NN	I-TEST	B-TEST
pedis	NN	I-TEST	I-TEST
.	.	O	O

the	DT	B-TEST	B-TEST
neurological	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
otherwise	RB	O	O
nonfocal	JJ	O	O
with	IN	O	O
mentioned	JJ	O	O
left	VBD	O	O
upper	JJ	O	O
extremity	NN	O	O
3/5	CD	O	O
strength	NN	O	O
with	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
5/5	CD	O	O
on	IN	O	O
the	DT	O	O
left	NN	O	O
lower	JJR	O	O
extremity	NN	O	O
.	.	O	O

admission	NN	B-TEST	O
hematocrit	NN	I-TEST	B-TEST
44	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
of	IN	O	O
13	CD	O	O
and	CC	O	O
0.9	CD	O	O
,	,	O	O
prothrombin	JJ	B-TEST	B-TEST
time	NN	I-TEST	I-TEST
and	CC	O	O
partial	JJ	B-TEST	O
thromboplastin	NN	I-TEST	O
time	NN	I-TEST	O
normal	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
chest	NN	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
showed	VBD	O	O
q	JJ	B-PROBLEM	O
waves	NNS	I-PROBLEM	O
in	IN	I-PROBLEM	O
v1	NN	I-PROBLEM	O
through	IN	O	O
v6	NN	O	O
,	,	O	O
t	JJ	B-PROBLEM	O
wave	VBP	I-PROBLEM	O
pseudonormalization	NN	I-PROBLEM	O
in	IN	I-PROBLEM	O
v1	NN	I-PROBLEM	O
through	IN	O	O
v6	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
rule	NN	O	O
out	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
ruled	VBD	O	O
in	IN	O	O
for	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
cpk	JJ	B-TEST	B-TEST
maximum	NN	O	I-TEST
on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
number	NN	O	O
one	CD	O	O
peak	NN	B-TEST	O
of	IN	O	O
186	CD	O	O
and	CC	O	O
iso	NN	B-TEST	O
of	IN	O	O
23.8	CD	O	O
and	CC	O	O
index	NN	B-TEST	O
of	IN	O	O
12.8	CD	O	O
on	IN	O	O
september	NN	O	O
2	CD	O	O
,	,	O	O
1994	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
received	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
appropriate	JJ	I-TREATMENT	I-TREATMENT
protocol	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
heparin	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
beta	NN	B-TREATMENT	B-TREATMENT
blockers	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
rate	NN	B-TREATMENT	O
and	CC	I-TREATMENT	O
blood	NN	I-TREATMENT	B-TREATMENT
pressure	NN	I-TREATMENT	I-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
on	IN	O	O
the	DT	O	O
date	NN	O	O
of	IN	O	O
september	NN	O	O
5	CD	O	O
,	,	O	O
1994	CD	O	O
had	VBD	O	O
cardiac	VBN	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
normal	JJ	O	O
resting	VBG	O	O
hemodynamics	NNS	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	O	B-PROBLEM
small	JJ	O	I-PROBLEM
non-dominant	JJ	O	I-PROBLEM
right	JJ	O	I-PROBLEM
coronary	NN	O	I-PROBLEM
artery	NN	O	I-PROBLEM
,	,	O	O
left	VBD	O	O
anterior	RP	O	O
descending	VBG	O	O
showed	VBD	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
proximal	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
more	RBR	B-PROBLEM	B-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	O
diagonal	JJ	I-PROBLEM	O
one	CD	I-PROBLEM	O
.	.	O	O

the	DT	O	O
left	NN	O	O
circumflex	NN	O	O
was	VBD	O	O
dominant	JJ	O	O
with	IN	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	O
obtuse	IN	I-PROBLEM	O
marginal	JJ	I-PROBLEM	O
one	CD	I-PROBLEM	O
,	,	O	O
with	IN	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
mid-circumflex	JJ	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
posterior	NN	I-PROBLEM	I-PROBLEM
descending	VBG	I-PROBLEM	I-PROBLEM
artery	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	O
left	NN	I-TEST	O
ventriculography	NN	I-TEST	O
shows	VBZ	O	O
anterior	JJ	B-PROBLEM	B-PROBLEM
akinesis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
apical	JJ	B-PROBLEM	B-PROBLEM
severe	JJ	I-PROBLEM	I-PROBLEM
hypokinesis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
moderately	RB	I-PROBLEM	I-PROBLEM
depressed	JJ	I-PROBLEM	I-PROBLEM
ejection	NN	I-PROBLEM	I-PROBLEM
fraction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
cardiac	JJ	B-TEST	B-TEST
output	NN	I-TEST	I-TEST
of	IN	O	O
3.9	CD	O	O
,	,	O	O
index	NN	B-TEST	O
of	IN	O	O
2.0	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
seen	VBN	O	O
in	IN	O	O
consultation	NN	O	O
by	IN	O	O
cardiac	JJ	O	O
surgery	NN	O	O
for	IN	O	O
evaluation	NN	B-TEST	B-TEST
of	IN	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
stable	JJ	B-TEST	O
hematocrit	NN	I-TEST	B-TEST
of	IN	O	O
38%	CD	O	O
on	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
heparin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	B-TEST	O
carotid	NN	I-TEST	O
noninvasives	NNS	I-TEST	O
preoperatively	RB	O	O
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

dental	JJ	B-TEST	O
consult	NN	I-TEST	O
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

on	IN	O	O
the	DT	O	O
date	NN	O	O
of	IN	O	O
september	NN	O	O
11	CD	O	O
,	,	O	O
1994	CD	O	O
,	,	O	O
patient	JJ	O	O
underwent	NN	O	O
a	DT	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	VBG	I-TREATMENT	I-TREATMENT
with	IN	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
posterior	JJ	I-TREATMENT	I-TREATMENT
descending	NN	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
circumflex	NN	B-TREATMENT	B-PROBLEM
and	CC	I-TREATMENT	O
diagonal	JJ	I-TREATMENT	O
and	CC	I-TREATMENT	O
left	VBD	I-TREATMENT	O
internal	JJ	I-TREATMENT	O
mammary	JJ	I-TREATMENT	O
artery	NN	I-TREATMENT	O
to	TO	I-TREATMENT	O
the	DT	I-TREATMENT	O
left	VBN	I-TREATMENT	O
anterior	JJ	I-TREATMENT	O
descending	NN	I-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	O	B-TREATMENT
bypass	NN	O	I-TREATMENT
time	NN	O	O
of	IN	O	O
one	CD	O	O
hour	NN	O	O
and	CC	O	O
fifty	JJ	O	O
minutes	NNS	O	O
with	IN	O	O
good	JJ	O	O
urine	NN	O	B-TEST
output	NN	O	I-TEST
and	CC	O	O
pre-bypass	NN	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
output	NN	I-TEST	I-TEST
of	IN	O	O
4.0	CD	O	O
,	,	O	O
post-chest	JJ	B-TEST	B-TREATMENT
closure	NN	I-TEST	I-TREATMENT
5.3	CD	O	O
,	,	O	O
arrived	VBN	O	O
to	TO	O	O
the	DT	O	O
surgical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
on	IN	O	O
nipride	NN	B-TREATMENT	O
,	,	O	O
lidocaine	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
1	CD	O	O
and	CC	O	O
fentanyl/	NNS	B-TREATMENT	B-TEST
versed	VBD	B-TREATMENT	O
of	IN	O	O
10	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
postoperative	JJ	I-TEST	I-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
26%	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	O	B-TREATMENT
routine	JJ	O	I-TREATMENT
postoperative	JJ	O	I-TREATMENT
course	NN	O	I-TREATMENT
in	IN	O	O
the	DT	O	O
surgical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
with	IN	O	O
a	DT	B-TEST	B-TREATMENT
postoperative	JJ	I-TEST	I-TREATMENT
bun	NN	I-TEST	I-TREATMENT
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
of	IN	O	O
11	CD	O	O
and	CC	O	O
1.2	CD	O	O
with	IN	O	O
good	JJ	O	O
urine	JJ	O	B-TEST
output	NN	O	I-TEST
of	IN	O	O
over	IN	O	O
100	CD	O	O
an	DT	O	O
hour	NN	O	O
and	CC	O	O
patient	JJ	O	O
received	VBN	O	O
two	CD	O	O
units	NNS	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
fresh	JJ	B-TREATMENT	B-TREATMENT
frozen	JJ	I-TREATMENT	I-TREATMENT
plasma	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
platelets	NNS	B-TREATMENT	B-TEST
for	IN	O	O
increasing	VBG	B-PROBLEM	B-TREATMENT
chest	JJS	I-PROBLEM	I-TREATMENT
tube	NN	I-PROBLEM	I-TREATMENT
drainage	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
&apos;s	VBZ	O	O
only	RB	O	O
post-surgical	JJ	O	B-TREATMENT
intensive	JJ	O	I-TREATMENT
care	NN	O	I-TREATMENT
unit	NN	O	I-TREATMENT
course	NN	O	I-TREATMENT
was	VBD	O	O
remarkable	JJ	O	O
for	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
requiring	VBG	O	O
nipride	RB	B-TREATMENT	O
and	CC	O	O
bleeding	VBG	B-PROBLEM	B-PROBLEM
which	WDT	O	O
was	VBD	O	O
controlled	VBN	O	O
with	IN	O	O
fresh	JJ	B-TREATMENT	B-TREATMENT
frozen	JJ	I-TREATMENT	I-TREATMENT
plasma	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
platelets	NNS	B-TREATMENT	B-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	O
stable	JJ	I-TEST	O
hematocrit	NN	I-TEST	B-TEST
of	IN	O	O
30%	CD	O	O
with	IN	O	O
cpk	NN	B-TEST	B-TEST
&apos;s	NNP	I-TEST	I-TEST
postoperatively	RB	O	I-TEST
maximum	JJ	B-TEST	I-TEST
mb	JJ	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
78	CD	O	O
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
three	CD	O	O
,	,	O	O
patient	JJ	O	O
went	VBD	O	O
into	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
was	VBD	O	O
treated	VBN	O	O
appropriately	RB	O	O
with	IN	O	O
metoprolol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
converted	VBD	O	O
back	RB	O	O
to	TO	O	O
sinus	VB	O	O
rhythm	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
need	VB	O	O
diuresis	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
postoperative	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
up	RP	O	O
on	IN	O	O
fih	NNS	O	O
were	VBD	O	O
coumadin	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
baby	NN	B-TREATMENT	O
aspirin	NN	I-TREATMENT	B-TREATMENT
,	,	O	O
isordil	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
po	NN	O	O
t.i.d.	NN	O	O
,	,	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
.25	NN	O	I-TREATMENT
q.day	NN	O	O
,	,	O	O
metoprolol	FW	B-TREATMENT	B-TREATMENT
25	CD	O	O
po	NN	O	O
b.i.d.	NN	O	O
______________	NN	O	O

chest	NN	B-TREATMENT	B-TREATMENT
tubes	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	I-TREATMENT
wires	NNS	B-TREATMENT	I-TREATMENT
were	VBD	O	O
all	DT	O	O
discontinued	VBN	O	O
according	VBG	O	O
to	TO	O	O
protocol	NN	B-TREATMENT	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
four	CD	O	O
.	.	O	O

the	DT	B-TREATMENT	O
isordil	NN	I-TREATMENT	O
was	VBD	O	O
also	RB	O	O
discontinued	VBN	O	O
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NN	I-PROBLEM	I-PROBLEM
incisions	NNS	I-PROBLEM	I-PROBLEM
sternal	JJ	O	I-PROBLEM
and	CC	O	I-PROBLEM
right	JJ	O	I-PROBLEM
leg	NN	O	I-PROBLEM
were	VBD	O	O
clean	JJ	O	O
and	CC	O	O
healing	VBG	O	O
well	RB	O	O
,	,	O	O
normal	JJ	O	O
sinus	NN	O	O
rhythm	NN	O	O
at	IN	O	O
70-80	JJ	O	O
,	,	O	O
with	IN	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
98-110/60	CD	O	O
and	CC	O	O
patient	NN	O	O
was	VBD	O	O
doing	VBG	O	O
well	RB	O	O
,	,	O	O
recovering	VBG	O	O
,	,	O	O
ambulating	VBG	O	O
,	,	O	O
tolerating	VBG	O	O
regular	JJ	O	O
diet	NN	O	O
and	CC	O	O
last	JJ	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
was	VBD	O	O
39%	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TREATMENT
bun	NN	I-TEST	I-TREATMENT
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
of	IN	O	O
15	CD	O	O
and	CC	O	O
1.0	CD	O	O
,	,	O	O
prothrombin	JJ	B-TEST	B-TEST
time	NN	I-TEST	I-TEST
level	NN	I-TEST	I-TEST
of	IN	O	O
13.8	CD	O	O
,	,	O	O
chest	JJS	B-TEST	B-TEST
x-ray	JJ	I-TEST	I-TEST
prior	NN	O	O
to	TO	O	O
discharge	VB	O	O
showed	VB	O	O
small	JJ	B-PROBLEM	B-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
effusions	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
cardiomegaly	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
subsegmental	JJ	B-PROBLEM	B-PROBLEM
atelectasis	NN	I-PROBLEM	I-PROBLEM
bibasilar	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
electrocardiogram	NN	B-TEST	B-TEST
showed	VBD	O	O
normal	JJ	O	O
sinus	NNS	O	O
rhythm	VBP	O	O
with	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
enlargement	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
ischemic	JJ	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
on	IN	O	O
electrocardiogram	NN	B-TEST	B-TEST
.	.	O	O

patient	NN	O	O
needs	VBZ	O	O
anticoagulation	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
large	JJ	B-TREATMENT	B-TREATMENT
saphenous	JJ	I-TREATMENT	I-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
prevent	VB	O	O
any	DT	O	O
possibility	NN	O	O
of	IN	O	O
thrombosis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
32-year-old	JJ	O	O
white	JJ	O	O
female	NN	O	O
with	IN	O	O
history	NN	O	O
of	IN	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
type	VBP	I-PROBLEM	O
1	CD	I-PROBLEM	O
and	CC	O	O
migraines	NNS	B-PROBLEM	B-PROBLEM
who	WP	O	O
presented	VBD	O	O
with	IN	O	O
complaints	NNS	O	O
of	IN	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
for	IN	O	O
24	CD	O	O
hours	NNS	O	O
.	.	O	O

patient	NN	O	O
states	NNS	O	O
she	PRP	O	O
was	VBD	O	O
unable	JJ	O	O
to	TO	O	O
take	VB	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
usual	JJ	I-TREATMENT	I-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
because	IN	O	O
she	PRP	O	O
was	VBD	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
denied	VBD	O	O
any	DT	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
dysuria	NNS	B-PROBLEM	B-PROBLEM
but	CC	O	O
does	VBZ	O	O
state	NN	O	O
she	PRP	O	O
had	VBD	O	O
her	PRP	B-PROBLEM	B-PROBLEM
usual	JJ	I-PROBLEM	I-PROBLEM
migraine	NN	I-PROBLEM	I-PROBLEM
headache	NN	I-PROBLEM	I-PROBLEM
the	DT	O	O
night	NN	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
arterial	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
gases	NNS	I-TEST	I-TEST
in	IN	O	O
the	DT	O	O
emergency	NN	O	O
department	NN	O	O
were	VBD	O	O
7.19	CD	O	O
,	,	O	O
22	CD	O	O
and	CC	O	O
109	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TREATMENT
bicarbonate	NN	I-TEST	I-TREATMENT
of	IN	O	O
9	CD	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
fingerstick	NN	I-TEST	I-TEST
of	IN	O	O
greater	JJR	O	O
than	IN	O	O
500	CD	O	O
.	.	O	O

patient	NN	O	O
was	VBD	O	O
given	VBN	O	O
two	CD	B-TREATMENT	O
boluses	NNS	I-TREATMENT	O
of	IN	I-TREATMENT	O
15	CD	I-TREATMENT	O
units	NNS	I-TREATMENT	O
of	IN	I-TREATMENT	O
regular	JJ	I-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
one	CD	O	O
unit	NN	O	O
per	IN	O	O
hour	NN	O	O
and	CC	O	O
given	VBN	O	O
a	DT	B-TREATMENT	O
total	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
five	CD	I-TREATMENT	O
liters	NNS	I-TREATMENT	O
of	IN	I-TREATMENT	O
normal	JJ	I-TREATMENT	B-TREATMENT
saline	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

her	PRP$	B-TEST	B-TEST
fingersticks	NNS	I-TEST	I-TEST
decreased	VBN	O	O
with	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
the	DT	B-TREATMENT	B-TREATMENT
intravenous	JJ	I-TREATMENT	I-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
frequent	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
sugar	NN	I-TEST	I-TEST
monitoring	NN	I-TEST	I-TEST
and	CC	O	O
chem-7	JJ	B-TEST	B-TEST
monitoring	NN	I-TEST	I-TEST
.	.	O	O

her	PRP$	B-TEST	B-TEST
anion	NN	I-TEST	I-TEST
gap	NN	I-TEST	I-TEST
closed	VBD	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
fingersticks	NNS	I-TEST	I-TEST
were	VBD	O	O
less	JJR	O	O
than	IN	O	O
200	CD	O	O
.	.	O	O

her	PRP$	B-TREATMENT	B-TEST
nph	NN	I-TREATMENT	I-TEST
and	CC	O	O
a	DT	B-TREATMENT	O
regular	JJ	I-TREATMENT	O
sliding	NN	I-TREATMENT	O
scale	NN	I-TREATMENT	O
were	VBD	O	O
started	VBN	O	O
and	CC	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
denied	VBD	O	O
any	DT	B-PROBLEM	B-PROBLEM
more	RBR	I-PROBLEM	I-PROBLEM
gastrointestinal	JJ	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

includes	VBZ	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
diagnosed	VBN	O	O
at	IN	O	O
age	NN	O	O
14	CD	O	O
.	.	O	O

multiple	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
diabetic	JJ	B-PROBLEM	B-PROBLEM
ketoacidosis	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
past	NN	O	O
,	,	O	O
migraine	NN	B-PROBLEM	B-PROBLEM
headaches	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
attention	NN	B-PROBLEM	I-PROBLEM
deficit	NN	I-PROBLEM	I-PROBLEM
disorder	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

included	VBN	O	O
wellbutrin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
imitrex	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
tylenol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
humalog	NN	B-TREATMENT	B-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
nph	JJ	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
two	CD	O	O
units	NNS	O	O
in	IN	O	O
the	DT	O	O
morning	NN	O	O
,	,	O	O
7	CD	O	O
units	NNS	O	O
at	IN	O	O
noon	NN	O	O
and	CC	O	O
13	CD	O	O
units	NNS	O	O
at	IN	O	O
bedtime	NN	O	O
.	.	O	O

patient	NN	O	O
has	VBZ	O	O
allergies	NNS	B-PROBLEM	B-PROBLEM
to	TO	O	O
penicillin	VB	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
gets	VBZ	O	O
hives	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

bactrim	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
she	PRP	O	O
gets	VBZ	O	O
hives	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

percocet	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
erythromycin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
she	PRP	O	O
gets	VBZ	O	O
gastrointestinal	JJ	B-PROBLEM	B-PROBLEM
upset	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
keflex	VB	B-TREATMENT	I-PROBLEM
she	PRP	O	I-PROBLEM
gets	VBZ	O	I-PROBLEM
hives	NNS	B-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
cesarean	JJ	I-TREATMENT	I-TREATMENT
section	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
eight	CD	O	O
months	NNS	O	O
.	.	O	O

hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

includes	VBZ	O	O
a	DT	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
of	IN	O	O
99.9	CD	O	O
.	.	O	O

pulse	NN	B-TEST	B-TEST
of	IN	O	O
94	CD	O	O
.	.	O	O

blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
138/49	CD	O	O
.	.	O	O

patient	NN	O	O
was	VBD	O	O
generally	RB	B-PROBLEM	O
ill-appearing	JJ	I-PROBLEM	O
and	CC	O	O
nauseated	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
but	CC	O	O
alert	JJ	O	O
and	CC	O	O
oriented	VBD	O	O
times	NNS	O	O
three	CD	O	O
.	.	O	O

neck	NN	O	O
supple	NN	O	O
,	,	O	O
no	DT	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

chest	NN	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	NN	B-TEST	B-TEST
.	.	O	O

abdomen	NNS	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

neurological	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
:	:	O	O

cranial	JJ	B-TEST	O
nerves	NNS	I-TEST	O
ii	VBP	I-TEST	O
through	IN	I-TEST	O
xii	NNS	I-TEST	O
are	VBP	O	O
intact	JJ	O	O
,	,	O	O
nonfocal	JJ	O	O
,	,	O	O
moving	VBG	O	O
all	DT	O	O
extremities	NNS	O	O
.	.	O	O

white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
22.8	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
of	IN	O	O
42.1	CD	O	O
.	.	O	O

sodium	NN	B-TEST	B-TEST
of	IN	O	O
136	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
96	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
8	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
25	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
1.2	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
720	CD	O	O
.	.	O	O

arterial	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
gases	NNS	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-TEST	O
ph	NN	I-TEST	O
of	IN	O	O
7.19	CD	O	O
,	,	O	O
pco2	NN	B-TEST	O
of	IN	O	O
22	CD	O	O
and	CC	O	O
po2	NN	B-TEST	O
of	IN	O	O
102	CD	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
potassium	NN	I-TEST	I-TEST
of	IN	O	O
3.9	CD	O	O
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
for	IN	O	O
infiltrate	NN	B-PROBLEM	O
.	.	O	O

electrocardiogram	NN	B-TEST	B-TEST
was	VBD	O	O
normal	JJ	O	O
sinus	JJ	O	O
rhythm	NN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
t	NN	I-PROBLEM	I-PROBLEM
wave	NN	I-PROBLEM	I-PROBLEM
inversion	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
v2	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
no	DT	O	O
st	JJ	B-PROBLEM	B-PROBLEM
segment	NN	I-PROBLEM	I-PROBLEM
elevations	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

as	IN	O	O
above	NN	O	O
,	,	O	O
and	CC	O	O
once	RB	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
,	,	O	O
patient	NN	O	O
had	VBD	O	O
fingersticks	NNS	B-TEST	O
monitored	VBN	O	O
every	DT	O	O
four	CD	O	O
hours	NNS	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

patient	NN	O	O
reached	VBD	O	O
goal	NN	O	O
of	IN	O	O
fingersticks	NNS	B-TEST	O
between	IN	O	O
50	CD	O	O
and	CC	O	O
300	CD	O	O
,	,	O	O
which	WDT	O	O
is	VBZ	O	O
what	WP	O	O
she	PRP	O	O
maintains	VBZ	O	O
at	IN	O	O
home	NN	O	O
.	.	O	O

sliding	VBG	B-TREATMENT	B-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
adjusted	VBN	O	O
as	IN	O	O
necessary	JJ	O	O
.	.	O	O

patient	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
until	IN	O	O
taking	VBG	O	O
good	JJ	O	O
po	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
elevated	VBN	I-PROBLEM	I-PROBLEM
white	JJ	I-PROBLEM	I-PROBLEM
count	NN	I-PROBLEM	I-PROBLEM
upon	IN	O	O
admission	NN	O	O
,	,	O	O
however	RB	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
came	VBD	O	O
down	RB	O	O
to	TO	O	O
7.1	CD	O	O
and	CC	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
,	,	O	O
patient	NN	O	O
was	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
no	DT	O	O
clear	JJ	O	O
etiology	NN	O	O
for	IN	O	O
elevated	JJ	B-PROBLEM	B-PROBLEM
white	JJ	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
admission	NN	O	O
,	,	O	O
questionably	RB	O	O
secondary	JJ	O	O
to	TO	O	O
short	JJ	B-PROBLEM	B-PROBLEM
gastrointestinal	JJ	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
however	RB	O	O
,	,	O	O
patient	NN	O	O
is	VBZ	O	O
completely	RB	O	O
symptom	JJ	O	O
free	JJ	O	O
upon	IN	O	O
discharge	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
electrolytes	NNS	I-TEST	I-TEST
were	VBD	O	O
repleted	VBN	O	O
as	IN	O	O
necessary	JJ	O	O
.	.	O	O

potassium	NN	B-TREATMENT	B-TEST
was	VBD	O	O
given	VBN	O	O
with	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
intravenous	JJ	I-TREATMENT	I-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	I-TREATMENT
phosphate	NN	B-TREATMENT	I-TREATMENT
will	MD	O	O
be	VB	O	O
repleted	VBN	O	O
as	IN	O	O
patient	NN	O	O
increases	VBZ	O	O
her	PRP$	O	O
po	JJ	O	O
intake	NN	O	O
.	.	O	O

1.	CD	O	O
diabetic	JJ	B-PROBLEM	B-PROBLEM
ketoacidosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
viral	JJ	B-PROBLEM	B-PROBLEM
gastroenteritis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

includes	VBZ	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
regular	JJ	I-TREATMENT	I-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
her	PRP$	B-TREATMENT	B-TEST
nph	JJ	I-TREATMENT	I-TEST
fixed	JJ	O	I-TEST
scale	NN	O	I-TEST
of	IN	O	O
7	CD	O	O
units	NNS	O	O
in	IN	O	O
the	DT	O	O
morning	NN	O	O
,	,	O	O
2	CD	O	O
units	NNS	O	O
at	IN	O	O
noon	NN	O	O
and	CC	O	O
13	CD	O	O
units	NNS	O	O
at	IN	O	O
bedtime	NN	O	O
.	.	O	O

patient	NN	O	O
was	VBD	O	O
instructed	VBN	O	O
to	TO	O	O
decrease	VB	O	O
her	PRP$	B-TREATMENT	O
evening	NN	I-TREATMENT	O
dose	NN	I-TREATMENT	O
if	IN	O	O
she	PRP	O	O
does	VBZ	O	O
not	RB	O	O
continue	VB	O	O
to	TO	O	O
take	VB	O	O
good	JJ	O	O
po	NN	O	O
.	.	O	O

patient	NN	O	O
will	MD	O	O
also	RB	O	O
continue	VB	O	O
on	IN	O	O
her	PRP	B-TREATMENT	B-TREATMENT
wellbutrin	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
imitrex	NN	B-TREATMENT	B-TREATMENT
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
migraines	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

non-q	JJ	B-PROBLEM	B-PROBLEM
wave	VBP	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

non-q	JJ	B-PROBLEM	B-PROBLEM
wave	VBP	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

status	NN	O	O
post	NN	O	O
anterior	RB	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
05-93	NNP	O	O
,	,	O	O
status	NN	O	B-TREATMENT
post	NN	O	I-TREATMENT
percutaneous	JJ	B-TREATMENT	I-TREATMENT
transluminal	JJ	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
angioplasty	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
left	JJ	I-TREATMENT	I-TREATMENT
anterior	JJ	I-TREATMENT	I-TREATMENT
descending	VBG	I-TREATMENT	I-TREATMENT
in	IN	O	O
05-93	NNP	O	O
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
diabetes	VBZ	B-PROBLEM	B-PROBLEM
mellitus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

coronary	JJ	B-TREATMENT	B-TEST
angiography	NN	I-TREATMENT	I-TEST
,	,	O	O
exercise	NN	B-TEST	B-TEST
tolerance	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
with	IN	I-TEST	O
thallium	NN	I-TEST	B-TEST
.	.	O	O

metoprolol	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
po	NN	O	O
bid	NN	O	O
,	,	O	O
isordil	VBP	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
po	NN	O	O
tid	NN	O	O
,	,	O	O
enteric	RB	B-TREATMENT	B-TREATMENT
coated	VBD	I-TREATMENT	I-TREATMENT
aspirin	JJ	I-TREATMENT	I-TREATMENT
1	CD	O	O
po	NN	O	O
qd	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
65	CD	O	O
year	NN	O	O
old	JJ	O	O
portuguese	JJ	O	O
male	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
i	NN	O	I-PROBLEM
may	MD	O	O
1993	CD	O	O
and	CC	O	O
is	VBZ	O	O
status	NN	O	O
post	NN	O	O
a	DT	B-TREATMENT	B-TREATMENT
percutaneous	JJ	I-TREATMENT	I-TREATMENT
transluminal	JJ	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
angioplasty	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	O
the	DT	I-TREATMENT	O
lad	NN	I-TREATMENT	O
who	WP	O	O
presented	VBD	O	O
on	IN	O	O
10-24-93	JJ	O	O
with	IN	O	O
crushing	VBG	B-PROBLEM	B-PROBLEM
substernal	JJ	I-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
no	DT	O	O
prior	JJ	O	O
cardiac	JJ	O	O
history	NN	O	O
until	IN	O	O
may	MD	O	O
1993	CD	O	O
when	WRB	O	O
on	IN	O	O
5-24	NN	O	O
he	PRP	O	O
had	VBD	O	O
crushing	VBG	B-PROBLEM	B-PROBLEM
chest	JJS	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
radiated	VBD	O	O
to	TO	O	O
his	PRP$	O	O
left	JJ	O	O
arm	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
found	VBN	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
to	TO	O	O
have	VB	O	O
3-4	JJ	B-PROBLEM	B-PROBLEM
mm	NNS	I-PROBLEM	I-PROBLEM
st	VBP	I-PROBLEM	I-PROBLEM
segment	NN	I-PROBLEM	I-PROBLEM
elevations	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
v1	NN	I-PROBLEM	I-PROBLEM
through	IN	O	I-PROBLEM
v4	NN	O	I-PROBLEM
at	IN	O	I-PROBLEM
pre	JJ	O	I-PROBLEM
health	NN	O	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
fairm	VB	O	O
of	IN	O	O
ijordcompmac	JJ	O	O
hospital	NN	O	O
and	CC	O	O
had	VBD	O	O
4-7	JJ	B-PROBLEM	B-PROBLEM
mm	NNS	I-PROBLEM	I-PROBLEM
st	VBP	I-PROBLEM	I-PROBLEM
segment	NN	I-PROBLEM	I-PROBLEM
elevations	NNS	I-PROBLEM	I-PROBLEM
across	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
precordium	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
q&apos;s	NN	B-PROBLEM	O
in	IN	I-PROBLEM	O
v1	NN	I-PROBLEM	O
and	CC	I-PROBLEM	O
v2	NN	I-PROBLEM	O
,	,	O	O
2	CD	B-PROBLEM	O
mm	NN	I-PROBLEM	O
st	NN	I-PROBLEM	B-PROBLEM
elevation	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
avl	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
1-2	JJ	B-PROBLEM	B-PROBLEM
mm	NN	I-PROBLEM	I-PROBLEM
reciprocal	JJ	I-PROBLEM	I-PROBLEM
st	NN	I-PROBLEM	I-PROBLEM
depression	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
ii	NN	I-PROBLEM	O
,	,	I-PROBLEM	O
iii	NN	I-PROBLEM	O
,	,	I-PROBLEM	O
and	CC	I-PROBLEM	O
f.	NN	I-PROBLEM	O

on	IN	O	O
physical	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
at	IN	O	O
that	DT	O	O
time	NN	O	O
he	PRP	O	O
had	VBD	O	O
bright	VBN	B-PROBLEM	B-PROBLEM
red	JJ	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
per	IN	I-PROBLEM	I-PROBLEM
rectum	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
therefore	RB	O	O
lysis	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
deferred	VBN	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
taken	VBN	O	O
directly	RB	O	O
to	TO	O	O
the	DT	O	B-TEST
cardiac	JJ	O	I-TEST
catheterization	NN	O	I-TEST
lab	NN	O	I-TEST
.	.	O	O

the	DT	O	B-TEST
cardiac	JJ	O	I-TEST
catheterization	NN	O	I-TEST
results	NNS	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
revealed	VBD	O	O
a	DT	B-TEST	B-TEST
right	JJ	I-TEST	I-TEST
atrial	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
7	CD	O	O
,	,	O	O
pulmonary	JJ	B-TEST	B-TEST
artery	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
29/16	CD	O	O
,	,	O	O
rv	NN	B-TEST	O
33/8	CD	O	O
,	,	O	O
pulmonary	JJ	B-TEST	B-TEST
capillary	JJ	I-TEST	I-TEST
wedge	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
16	CD	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
95%	CD	I-PROBLEM	I-PROBLEM
proximal	NN	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
descending	VBG	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
ptca	JJ	O	O
&apos;d	NN	O	O
to	TO	O	O
a	DT	O	O
residual	NN	O	O
of	IN	O	O
30%	CD	O	O
and	CC	O	O
an	DT	B-TREATMENT	B-TREATMENT
intra-aortic	JJ	I-TREATMENT	I-TREATMENT
balloon	NN	I-TREATMENT	I-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
.	.	O	O

he	PRP	O	O
also	RB	O	O
had	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
mild	NNS	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
moderate	VB	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
the	DT	O	O
om1	NN	O	O
noted	VBD	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
cardiac	JJ	O	O
care	NN	O	O
unit	NN	O	O
where	WRB	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
peak	JJ	I-TEST	I-TEST
cpk	NN	I-TEST	I-TEST
of	IN	O	O
5,042	CD	O	O
and	CC	O	O
26.7%	CD	O	O
mb&apos;s	NN	B-TEST	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
intra-aortic	JJ	I-TREATMENT	I-TREATMENT
balloon	NN	I-TREATMENT	I-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
weaned	VBN	O	O
without	IN	O	O
problems	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
beta	NN	B-TREATMENT	B-TREATMENT
blockers	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
therefore	RB	O	O
they	PRP	O	O
were	VBD	O	O
not	RB	O	O
started	VBN	O	O
.	.	O	O

on	IN	O	O
day	NN	O	O
six	CD	O	O
,	,	O	O
an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
showed	VBD	O	O
an	DT	B-TEST	B-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
44%	CD	O	O
with	IN	O	O
anterior	JJ	B-PROBLEM	B-PROBLEM
akinesis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
septal	JJ	B-PROBLEM	I-PROBLEM
hypokinesis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
day	NN	O	O
nine	CD	O	O
,	,	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
low	JJ	I-TEST	I-TEST
level	NN	I-TEST	I-TEST
exercise	NN	I-TEST	I-TEST
tolerance	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
with	IN	I-TEST	O
thallium	NN	I-TEST	B-TEST
which	WDT	O	O
was	VBD	O	O
positive	JJ	O	O
for	IN	O	O
2.5	CD	B-PROBLEM	B-PROBLEM
mm	JJ	I-PROBLEM	I-PROBLEM
horizontal	JJ	I-PROBLEM	I-PROBLEM
depressions	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
ii	NN	I-PROBLEM	O
,	,	I-PROBLEM	O
iii	NN	I-PROBLEM	O
,	,	I-PROBLEM	O
and	CC	I-PROBLEM	O
avf	NN	I-PROBLEM	O
,	,	O	O
and	CC	O	O
1.5	CD	B-PROBLEM	B-PROBLEM
mm	NN	I-PROBLEM	I-PROBLEM
downsloping	VBG	I-PROBLEM	I-PROBLEM
st	JJ	I-PROBLEM	I-PROBLEM
depressions	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
v5	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
v6	NN	I-PROBLEM	O
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
anteroseptal	JJ	I-PROBLEM	I-PROBLEM
redistribution	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
thallium	NN	B-TREATMENT	B-TEST
.	.	O	O

therefore	RB	O	O
,	,	O	O
he	PRP	O	O
went	VBD	O	O
to	TO	O	O
repeat	VB	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
which	WDT	O	O
revealed	VBD	O	O
that	IN	O	O
the	DT	O	O
left	JJ	O	O
anterior	JJ	O	O
descending	VBG	O	O
site	NN	O	O
was	VBD	O	O
patent	NN	O	O
and	CC	O	O
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
pda	NN	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
circumflex	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
after	IN	O	O
the	DT	O	O
om	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
discharged	VBN	O	O
to	TO	O	O
home	NN	O	O
and	CC	O	O
is	VBZ	O	O
supposed	VBN	O	O
to	TO	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
dr.	JJ	O	O
shuffburle	NN	O	O
of	IN	O	O
gastroenterology	NN	O	O
for	IN	O	O
work	NN	B-TEST	O
up	RB	I-TEST	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
bright	JJ	I-PROBLEM	I-PROBLEM
red	JJ	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
per	IN	I-PROBLEM	I-PROBLEM
rectum	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
is	VBZ	O	O
supposed	VBN	O	O
to	TO	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
dr.	JJ	O	O
amesin	NN	O	O
of	IN	O	O
cardiology	NN	O	O
and	CC	O	O
dr.	JJ	O	O
shuffpasc	NN	O	O
of	IN	O	O
dingclearf	NN	O	O
alllirefaith	NN	O	O
memorial	JJ	O	O
hospital	NN	O	O
.	.	O	O

he	PRP	O	O
went	VBD	O	O
home	NN	O	O
and	CC	O	O
did	VBD	O	O
not	RB	O	O
take	VB	O	O
any	DT	O	O
of	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
smoked	VBD	O	O
and	CC	O	O
drank	VBD	O	O
heavily	RB	O	O
throughout	IN	O	O
the	DT	O	O
several	JJ	O	O
months	NNS	O	O
.	.	O	O

on	IN	O	O
the	DT	O	O
a.m.	NN	O	O
of	IN	O	O
10-24-93	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
developed	VBD	O	O
crushing	VBG	B-PROBLEM	B-PROBLEM
substernal	JJ	I-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
came	VBD	O	O
to	TO	O	O
the	DT	O	O
fairm	NN	O	O
of	IN	O	O
ijordcompmac	JJ	O	O
hospital	NN	O	O
emergency	NN	O	O
ward	NN	O	O
where	WRB	O	O
he	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
ashen	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
diaphoretic	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
oxygen	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
five	CD	B-TREATMENT	O
sublingual	JJ	I-TREATMENT	B-TREATMENT
nitroglycerins	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
was	VBD	O	O
eventually	RB	O	O
made	VBN	O	O
pain	NN	O	B-PROBLEM
free	JJ	O	O
with	IN	O	O
that	DT	B-TREATMENT	B-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	O	B-TEST
cardiac	JJ	O	I-TEST
risk	NN	O	I-TEST
factors	NNS	O	I-TEST
included	VBD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
diabetes	VBZ	B-PROBLEM	B-PROBLEM
mellitus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cigarette	NN	O	O
smoking	NN	O	O
,	,	O	O
and	CC	O	O
a	DT	O	O
positive	JJ	O	O
family	NN	O	O
history	NN	O	O
.	.	O	O

his	PRP$	O	O
past	JJ	O	O
medical	JJ	O	O
history	NN	O	O
included	VBD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
non-insulin	JJ	B-PROBLEM	B-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
mellitus	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
is	VBZ	O	O
diet	JJ	O	O
controlled	VBN	O	O
.	.	O	O

his	PRP$	O	O
past	JJ	O	O
surgical	JJ	O	O
history	NN	O	O
had	VBD	O	O
included	VBN	O	O
gastric	JJ	B-TREATMENT	B-PROBLEM
ulcer	NN	I-TREATMENT	I-PROBLEM
surgery	NN	I-TREATMENT	I-PROBLEM
and	CC	O	O
appendectomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
on	IN	O	O
isordil	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
tid	NN	O	O
and	CC	O	O
enteric	JJ	B-TREATMENT	B-TREATMENT
coated	VBN	I-TREATMENT	I-TREATMENT
aspirin	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
but	CC	O	O
he	PRP	O	O
was	VBD	O	O
not	RB	O	O
taking	VBG	O	O
either	CC	O	O
of	IN	O	O
these	DT	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	B-TEST	B-TEST
physical	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
on	IN	I-TEST	O
admission	NN	I-TEST	O
revealed	VBD	O	O
a	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
110/70	CD	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
66	CD	O	O
,	,	O	O
respirations	NNS	B-TEST	B-TEST
of	IN	O	O
24	CD	O	O
,	,	O	O
temperature	NN	B-TEST	B-TEST
of	IN	O	O
98	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
heent	NN	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
revealed	VBD	O	O
the	DT	O	O
extra	JJ	O	O
ocular	JJ	O	O
movements	NNS	O	O
intact	JJ	O	O
.	.	O	O

there	EX	O	O
were	VBD	O	O
no	DT	O	O
hypertensive	JJ	B-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	O
diabetic	JJ	I-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
neck	NN	O	O
was	VBD	O	O
suppled	VBN	O	O
,	,	O	O
with	IN	O	O
no	DT	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
no	DT	O	O
jugular	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
distention	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	O
carotids	NNS	I-TEST	O
were	VBD	O	O
1+	CD	O	O
without	IN	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
heart	NN	O	O
was	VBD	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
s4	NN	O	O
,	,	O	O
s1	NN	O	O
,	,	O	O
s2	NN	O	O
,	,	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
i	JJ	I-PROBLEM	I-PROBLEM
/	NN	I-PROBLEM	I-PROBLEM
vi	NN	I-PROBLEM	I-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
lower	RBR	I-PROBLEM	I-PROBLEM
sternal	JJ	I-PROBLEM	I-PROBLEM
border	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
lungs	NNS	O	O
were	VBD	O	O
clear	JJ	O	O
,	,	O	O
except	IN	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
few	JJ	I-PROBLEM	I-PROBLEM
dry	JJ	I-PROBLEM	I-PROBLEM
crackles	NNS	I-PROBLEM	I-PROBLEM
bibasilarly	RB	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
midline	NN	I-PROBLEM	I-PROBLEM
scar	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
scar	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
soft	JJ	O	O
and	CC	O	O
nontender	JJ	B-PROBLEM	B-PROBLEM
wit	NN	O	I-PROBLEM
positive	JJ	O	I-PROBLEM
bowel	NN	O	I-PROBLEM
sounds	NNS	O	I-PROBLEM
.	.	O	O

the	DT	O	B-TEST
liver	NN	O	I-TEST
edge	NN	O	I-TEST
was	VBD	O	O
2	CD	O	O
cm	NN	O	O
below	IN	O	O
the	DT	O	O
right	JJ	O	O
costal	NN	O	O
margin	NN	O	O
,	,	O	O
but	CC	O	O
smooth	CC	O	O
and	CC	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
splenomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
femoral	JJ	I-TEST	I-TEST
pulses	NNS	I-TEST	I-TEST
were	VBD	O	O
diminished	VBN	B-PROBLEM	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
intertrigo	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
femoral	JJ	I-PROBLEM	I-PROBLEM
region	NN	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
his	PRP$	O	O
axillae	NN	O	O
.	.	O	O

the	DT	O	O
extremities	NNS	O	O
revealed	VBD	O	O
no	DT	O	O
clubbing	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
were	VBD	O	O
1+	CD	O	O
bilaterally	RB	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
skin	NN	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
revealed	VBD	O	O
changes	NNS	O	O
consistent	JJ	O	O
with	IN	O	O
vitiligo	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
rectal	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
guaiac	JJ	B-TEST	B-TEST
negative	JJ	O	O
.	.	O	O

the	DT	O	B-TEST
laboratory	NN	O	I-TEST
data	NNS	O	I-TEST
revealed	VBD	O	O
normal	JJ	O	O
electrolytes	NNS	O	O
,	,	O	O
bun	NN	O	B-TEST
and	CC	O	O
creatinine	NN	O	B-TEST
,	,	O	O
normal	JJ	O	O
liver	NN	O	B-TEST
function	NN	O	I-TEST
tests	NNS	O	I-TEST
,	,	O	O
a	DT	B-TEST	O
first	JJ	I-TEST	O
cpk	NN	I-TEST	O
of	IN	O	O
140	CD	O	O
,	,	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
of	IN	O	O
43.1	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
portable	JJ	I-TEST	I-TEST
chest	NN	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
showed	VBD	O	O
clear	JJ	O	O
lungs	NNS	O	O
,	,	O	O
slight	VBD	B-PROBLEM	B-PROBLEM
enlarged	JJ	I-PROBLEM	I-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
mildly	RB	I-PROBLEM	I-PROBLEM
elevated	JJ	I-PROBLEM	I-PROBLEM
hemidiaphragm	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
was	VBD	O	O
normal	JJ	O	O
sinus	JJ	O	O
rhythm	NN	O	O
at	IN	O	O
81	CD	O	O
,	,	O	O
with	IN	O	O
normal	JJ	O	O
intervals	NNS	O	O
and	CC	O	O
normal	JJ	O	O
axis	NN	O	O
,	,	O	O
had	VBD	O	O
poor	JJ	B-PROBLEM	B-PROBLEM
r-wave	JJ	I-PROBLEM	I-PROBLEM
progression	NN	I-PROBLEM	I-PROBLEM
consistent	NN	O	O
with	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
old	JJ	I-PROBLEM	I-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
had	VBD	O	O
flipped	VBN	B-PROBLEM	O
t-waves	NNS	I-PROBLEM	O
in	IN	I-PROBLEM	O
v1	NN	I-PROBLEM	O
through	IN	O	O
v5	NN	O	O
,	,	O	O
which	WDT	O	O
were	VBD	O	O
of	IN	O	O
no	DT	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
change	NN	I-PROBLEM	I-PROBLEM
since	IN	O	O
his	PRP$	B-TEST	B-TEST
last	JJ	I-TEST	I-TEST
ekg	NN	I-TEST	I-TEST
on	IN	O	O
5-25-93	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
step	NN	O	O
down	RP	O	O
unit	NN	O	O
for	IN	O	O
a	DT	O	O
rule	NN	O	O
out	IN	O	O
mi	NN	B-TREATMENT	B-PROBLEM
protocol	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
nitroglycerin	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

no	DT	O	O
beta	NN	B-TREATMENT	B-TREATMENT
blockers	NNS	I-TREATMENT	I-TREATMENT
was	VBD	O	O
started	VBN	O	O
because	IN	O	O
of	IN	O	O
his	PRP$	O	O
history	NN	O	O
of	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
beta	NN	B-TREATMENT	B-TREATMENT
blockers	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
because	IN	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
only	RB	O	O
110/70	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
ruled	VBD	O	O
in	IN	O	O
for	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-TEST	B-TEST
peak	JJ	I-TEST	I-TEST
cpk	NN	I-TEST	I-TEST
of	IN	O	O
219	CD	O	O
and	CC	O	O
20.9%	CD	B-TEST	O
mb	NN	I-TEST	O
fraction	NN	I-TEST	O
.	.	O	O

this	DT	O	O
was	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
non-q	JJ	I-PROBLEM	I-PROBLEM
wave	NN	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
as	IN	O	O
there	EX	O	O
were	VBD	O	O
no	DT	O	O
diagnostic	JJ	B-PROBLEM	B-TEST
electrocardiogram	NN	I-PROBLEM	I-TEST
changes	NNS	I-PROBLEM	O
.	.	O	O

on	IN	O	O
10-27-93	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
went	VBD	O	O
to	TO	O	O
the	DT	O	B-TEST
cath	NN	O	I-TEST
lab	NN	O	I-TEST
which	WDT	O	O
revealed	VBD	O	O
a	DT	O	B-PROBLEM
small	JJ	O	I-PROBLEM
nondominant	JJ	O	I-PROBLEM
right	JJ	O	I-PROBLEM
coronary	JJ	O	I-PROBLEM
artery	NN	O	I-PROBLEM
without	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
a	DT	B-PROBLEM	B-PROBLEM
restenosis	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
proximal	JJ	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
descending	VBG	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
had	VBD	O	O
been	VBN	O	O
ptca	JJ	B-TREATMENT	B-TREATMENT
&apos;d	NNP	I-TREATMENT	I-TREATMENT
,	,	O	O
a	DT	B-PROBLEM	B-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
first	JJ	I-PROBLEM	O
om	NN	I-PROBLEM	O
,	,	O	O
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
moderately	RB	I-PROBLEM	I-PROBLEM
severe	JJ	I-PROBLEM	I-PROBLEM
left	VBN	I-PROBLEM	I-PROBLEM
circumflex	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
after	IN	I-PROBLEM	O
the	DT	I-PROBLEM	B-TREATMENT
om3	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

the	DT	B-TEST	B-TEST
left	JJ	I-TEST	I-TEST
ventriculogram	NN	I-TEST	I-TEST
revealed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
akinetic	JJ	I-PROBLEM	I-PROBLEM
anterolateral	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
apical	JJ	I-PROBLEM	I-PROBLEM
ventricle	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

given	VBN	O	O
the	DT	O	O
results	NNS	O	O
of	IN	O	O
this	DT	B-TEST	B-PROBLEM
cardiac	JJ	I-TEST	I-PROBLEM
catheterization	NN	I-TEST	I-PROBLEM
,	,	O	O
which	WDT	O	O
were	VBD	O	O
not	RB	O	O
significantly	RB	O	O
changed	VBN	O	O
from	IN	O	O
his	PRP$	B-TEST	B-TEST
previous	JJ	I-TEST	I-TEST
cardiac	JJ	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
prior	RB	O	O
to	TO	O	O
the	DT	B-TREATMENT	O
ptca	NN	I-TREATMENT	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
elected	VBN	O	O
to	TO	O	O
attempt	VB	O	O
to	TO	O	O
medically	RB	O	O
manage	VB	O	O
the	DT	O	O
patient	NN	O	O
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
beta	NN	I-TREATMENT	I-TREATMENT
blocker	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
started	VBN	O	O
with	IN	O	O
metoprolol	NN	B-TREATMENT	B-TREATMENT
initially	RB	O	O
at	IN	O	O
25	CD	O	O
mg	JJ	O	O
po	NN	O	O
bid	NN	O	O
and	CC	O	O
eventually	RB	O	O
increased	VBD	O	O
to	TO	O	O
50	CD	O	O
mg	NNS	O	O
po	JJ	O	O
bid	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
ambulated	VBD	O	O
extensively	RB	O	O
on	IN	O	O
the	DT	O	O
fih	JJ	O	O
20	CD	O	O
floor	NN	O	O
each	DT	O	O
day	NN	O	O
without	IN	O	O
any	DT	O	O
episodes	NNS	O	O
of	IN	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
11-2-93	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
underwent	VBD	O	O
a	DT	B-TEST	B-TEST
low	JJ	I-TEST	I-TEST
level	NN	I-TEST	I-TEST
treadmill	NN	I-TEST	I-TEST
exercise	VBP	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
with	IN	O	O
thallium	NN	B-TEST	B-TEST
imaging	NN	I-TEST	I-TEST
.	.	O	O

this	DT	B-TEST	B-TEST
treadmill	JJ	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
was	VBD	O	O
done	VBN	O	O
on	IN	O	O
medications	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
including	VBG	O	O
beta	NN	B-TREATMENT	B-TREATMENT
blockers	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
in	IN	O	O
hopes	NNS	O	O
to	TO	O	O
assess	VB	O	O
an	DT	O	O
amount	NN	O	O
of	IN	O	O
ischemia	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
exercise	VB	O	O
for	IN	O	O
approximately	RB	O	O
nine	CD	O	O
minutes	NNS	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
modified	VBN	I-TREATMENT	I-TREATMENT
bruce	NN	I-TREATMENT	I-TREATMENT
protocol	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
however	RB	O	O
,	,	O	O
he	PRP	O	O
did	VBD	O	O
not	RB	O	O
reach	VB	O	O
his	PRP$	O	O
predicted	JJ	O	O
maximal	JJ	O	B-TEST
heart	NN	O	I-TEST
rate	NN	O	I-TEST
while	IN	O	O
he	PRP	O	O
was	VBD	O	O
on	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
beta	NN	I-TREATMENT	I-TREATMENT
blockade	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

there	EX	O	O
were	VBD	O	O
no	DT	O	O
diagnostic	JJ	B-PROBLEM	B-TEST
electrocardiogram	NN	I-PROBLEM	I-TEST
changes	NNS	I-PROBLEM	O
during	IN	O	O
the	DT	B-TEST	B-TEST
treadmill	NN	I-TEST	I-TEST
exercise	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
,	,	O	O
although	IN	O	O
he	PRP	O	O
did	VBD	O	O
have	VB	O	O
0.5	CD	B-PROBLEM	O
to	TO	I-PROBLEM	O
1	CD	I-PROBLEM	O
mm	NNS	I-PROBLEM	O
st	JJ	I-PROBLEM	B-PROBLEM
depression	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
ii	NN	I-PROBLEM	O
,	,	I-PROBLEM	O
iii	NN	I-PROBLEM	O
,	,	I-PROBLEM	O
and	CC	I-PROBLEM	O
avf	NN	I-PROBLEM	O
.	.	O	O

the	DT	B-TEST	B-TEST
study	NN	I-TEST	I-TEST
was	VBD	O	O
halted	VBN	O	O
for	IN	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
there	EX	O	O
was	VBD	O	O
no	DT	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

thallium	NN	B-TEST	B-TEST
images	NNS	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
moderate	JJ	I-PROBLEM	I-PROBLEM
sized	JJ	I-PROBLEM	I-PROBLEM
region	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
ischemic	JJ	I-PROBLEM	I-PROBLEM
but	CC	I-PROBLEM	I-PROBLEM
viable	JJ	I-PROBLEM	I-PROBLEM
myocardium	NN	I-PROBLEM	I-PROBLEM
involving	VBG	O	O
the	DT	O	O
anteroseptal	NN	O	O
and	CC	O	O
lateral	JJ	O	O
segments	NNS	O	O
of	IN	O	O
the	DT	O	O
left	JJ	O	O
ventricle	NN	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
also	RB	O	O
some	DT	O	O
evidence	NN	O	O
of	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
dysfunction	NN	I-PROBLEM	I-PROBLEM
during	IN	O	O
the	DT	B-TEST	B-TEST
test	NN	I-TEST	I-TEST
.	.	O	O

these	DT	B-TEST	B-TEST
images	NNS	I-TEST	I-TEST
were	VBD	O	O
essentially	RB	O	O
unchanged	JJ	O	O
compared	VBN	O	O
with	IN	O	O
the	DT	B-TEST	O
previous	JJ	I-TEST	O
thallium	NN	I-TEST	B-TEST
images	NNS	I-TEST	I-TEST
in	IN	O	O
may	MD	O	O
1993	CD	O	O
.	.	O	O

after	IN	O	O
extensive	JJ	O	O
discussion	NN	O	O
between	IN	O	O
myself	PRP	O	O
,	,	O	O
dr.	VBZ	O	O
amesin	NN	O	O
,	,	O	O
and	CC	O	O
dr.	JJ	O	O
scgach	NN	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
elected	VBN	O	O
to	TO	O	O
discharge	VB	O	O
the	DT	O	O
patient	NN	O	O
to	TO	O	O
home	NN	O	O
with	IN	O	O
medical	JJ	B-TREATMENT	B-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
extremely	RB	O	O
reluctant	JJ	O	O
to	TO	O	O
undergo	VB	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
although	IN	O	O
he	PRP	O	O
understands	VBZ	O	O
that	IN	O	O
this	DT	O	O
may	MD	O	O
become	VB	O	O
necessary	JJ	O	O
in	IN	O	O
the	DT	O	O
future	NN	O	O
.	.	O	O

previously	RB	O	O
he	PRP	O	O
had	VBD	O	O
not	RB	O	O
taken	VBN	O	O
any	DT	O	O
of	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
medicines	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
smoked	VBD	O	B-PROBLEM
heavily	RB	O	I-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
outside	NN	O	I-PROBLEM
and	CC	O	O
not	RB	O	O
kept	VB	O	O
any	DT	O	O
of	IN	O	O
his	PRP$	O	O
appointments	NNS	O	O
.	.	O	O

the	DT	O	O
importance	NN	O	O
of	IN	O	O
quitting	VBG	O	O
smoking	NN	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
continuing	VBG	O	O
to	TO	O	O
follow	VB	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
medical	JJ	I-TREATMENT	I-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
was	VBD	O	O
emphasized	VBN	O	O
to	TO	O	O
the	DT	O	O
daughter	NN	O	O
and	CC	O	O
to	TO	O	O
the	DT	O	O
patient	NN	O	O
.	.	O	O

she	PRP	O	O
will	MD	O	O
be	VB	O	O
actively	RB	O	O
involved	VBN	O	O
in	IN	O	O
encouraging	VBG	O	O
the	DT	O	O
patient	NN	O	O
to	TO	O	O
comply	VB	O	O
with	IN	O	O
this	DT	B-TREATMENT	B-TREATMENT
medical	JJ	I-TREATMENT	I-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
also	RB	O	O
to	TO	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
dr.	JJ	O	O
amesin	NN	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
dr.	NN	O	O
lfsquarc	NN	O	O
on	IN	O	O
the	DT	O	O
outside	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
guaiac	JJ	B-TEST	B-TEST
negative	JJ	O	O
throughout	IN	O	O
the	DT	O	O
entire	JJ	O	O
hospitalization	NN	O	O
.	.	O	O

despite	IN	O	O
being	VBG	O	O
on	IN	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
a	DT	O	O
short	JJ	O	O
time	NN	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
remained	VBD	O	O
very	RB	O	O
stable	JJ	O	O
with	IN	O	O
only	RB	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
dip	NN	I-PROBLEM	I-PROBLEM
after	IN	O	O
the	DT	B-TREATMENT	B-TEST
catheterization	NN	I-TREATMENT	I-TEST
was	VBD	O	O
done	VBN	O	O
.	.	O	O

he	PRP	O	O
will	MD	O	O
need	VB	O	O
to	TO	O	O
be	VB	O	O
followed	VBN	O	O
up	RP	O	O
as	IN	O	O
an	DT	O	O
out	RP	O	O
patient	NN	O	O
for	IN	O	O
guaiac	JJ	B-PROBLEM	B-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
stools	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
possibly	RB	O	O
worked	VBD	O	O
up	RP	O	O
for	IN	O	O
this	DT	O	O
in	IN	O	O
the	DT	O	O
future	NN	O	O
.	.	O	O

patient	NN	O	O
recorded	VBD	O	O
as	IN	O	O
having	VBG	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
to	TO	O	O
drugs	NNS	B-TREATMENT	B-TREATMENT

change	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM

hpi	NN	O	O
:	:	O	O
this	DT	O	O
is	VBZ	O	O
a	DT	O	O
79	CD	O	O
y/o	NN	O	O
m	NN	O	O
with	IN	O	O
h/o	NN	O	O
of	IN	O	O
htn	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
dm	NN	B-PROBLEM	O
,	,	O	O
recent	JJ	B-PROBLEM	O
cva	NN	I-PROBLEM	O
theresa	NN	O	O
,	,	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
vent	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
trached	VBN	B-TREATMENT	O
,	,	O	O
esrd	VB	B-PROBLEM	O
on	IN	O	O
hd	NN	B-TREATMENT	O
who	WP	O	O
was	VBD	O	O
sent	VBN	O	O
from	IN	O	O
rehab	NN	O	O
facility	NN	O	O
for	IN	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

per	IN	O	O
refferal	JJ	O	O
notes	NNS	O	O
,	,	O	O
he	PRP	O	O
went	VBD	O	O
to	TO	O	O
hemodyalisis	VB	B-TREATMENT	O
today	NN	O	O
in	IN	O	O
the	DT	O	O
morning	NN	O	O
.	.	O	O

at	IN	O	O
about	RB	O	O
2:30	CD	O	O
pm	NN	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

in	IN	O	O
that	DT	O	O
setting	NN	O	O
he	PRP	O	O
was	VBD	O	O
hypotensive	JJ	B-PROBLEM	O
down	RB	O	O
to	TO	O	O
the	DT	O	O
92/45	CD	O	O
,	,	O	O
and	CC	O	O
was	VBD	O	O
given	VBN	O	O
1	CD	B-TREATMENT	O
l	JJ	I-TREATMENT	O
ns	NN	I-TREATMENT	O
.	.	O	O

fs	NN	B-TEST	O
was	VBD	O	O
also	RB	O	O
checked	JJ	O	O
179	CD	O	O
.	.	O	O

at	IN	O	O
that	DT	O	O
time	NN	O	O
,	,	O	O
it	PRP	O	O
seems	VBZ	O	O
that	IN	O	O
he	PRP	O	O
had	VBD	O	O
been	VBN	O	O
on	IN	O	O
t	NN	B-TREATMENT	O
peace	NN	I-TREATMENT	O
since	IN	O	O
4	CD	O	O
am	VBP	O	O
today	NN	O	O
.	.	O	O

at	IN	O	O
2:30	CD	O	O
he	PRP	O	O
was	VBD	O	O
also	RB	O	O
found	VBN	O	O
with	IN	O	O
sats	NNS	B-TEST	O
in	IN	O	O
the	DT	O	O
90%	CD	O	O
.	.	O	O

abg	NN	B-TEST	B-TEST
done	VBN	O	O
7.1	CD	O	O
,	,	O	O
89/72	CD	O	O
-	:	O	O
he	PRP	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
ac	JJ	B-TREATMENT	O
600	CD	O	O
/	JJ	O	O
0.4	CD	O	O
and	CC	O	O
6	CD	O	O
peep	JJ	B-TREATMENT	O
-	:	O	O
sats	VBZ	B-TEST	O
up	IN	O	O
to	TO	O	O
94%	CD	O	O
.	.	O	O

given	VBN	O	O
persistent	JJ	B-PROBLEM	B-PROBLEM
lethargy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
patient	NN	O	O
was	VBD	O	O
sent	VBN	O	O
to	TO	O	O
falkener	VB	O	O
amanda	NN	O	O
.	.	O	O

of	IN	O	O
note	NN	O	O
,	,	O	O
after	IN	O	O
interview	NN	O	O
with	IN	O	O
hcp	NN	O	O
,	,	O	O
at	IN	O	O
around	IN	O	O
07-23	NNP	O	O
,	,	O	O
patient	NN	O	O
started	VBD	O	O
having	VBG	O	O
episodes	NNS	O	O
of	IN	O	O
dizziness	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
had	VBD	O	O
unstable	JJ	B-PROBLEM	B-PROBLEM
gait	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
peg	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
tracheostomy	NN	B-TREATMENT	B-TREATMENT
prior	RB	O	O
to	TO	O	O
d/c	VB	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
been	VBN	O	O
chronicallyl	JJ	B-PROBLEM	B-TREATMENT
vent	JJ	I-PROBLEM	I-TREATMENT
dependent	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

in	IN	O	O
the	DT	O	O
amanda	NN	O	O
:	:	O	O
vs	NN	B-TEST	O
t	VBZ	B-TEST	O
103	CD	O	O
rectal	JJ	O	O
bp90/44	NN	B-TEST	O
hr	NN	B-TEST	O
:	:	O	O
84	CD	O	O
rr	NN	B-TEST	B-TEST
16	CD	O	O
sats	NNS	B-TEST	O
:	:	O	O
98	CD	O	O
+	NN	B-PROBLEM	O
guiac	JJ	I-PROBLEM	B-PROBLEM
stool	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
received	VBD	O	O
tylenol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
levofloxacin	VBZ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
iv	NN	O	O
,	,	O	O
flagyl	VBP	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
and	CC	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
i	NN	B-TREATMENT	O
l	VBP	I-TREATMENT	O
ns	NN	I-TREATMENT	O
.	.	O	O

cva	NN	B-PROBLEM	O
theresa	NN	O	O
/	NN	O	O
2006	CD	O	O

htn	NN	B-PROBLEM	B-PROBLEM

dm	NN	B-PROBLEM	O

cri	NN	B-PROBLEM	O
on	IN	O	O
hd	NN	B-TREATMENT	O
since	IN	O	O
theresa	NN	O	O
(	(	O	O
tu,	JJ	O	O
thurs,	NN	O	O
sat	VBD	O	O
)	)	O	O

neuropathy	RB	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
leg	NN	I-PROBLEM	I-PROBLEM

s/p	NN	O	O
ccy	NN	B-TREATMENT	B-TREATMENT

brother	NN	O	O
died	VBD	O	O
cerebral	JJ	B-PROBLEM	B-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM

brother	NN	O	B-PROBLEM
sabina	NN	B-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM

brother	NN	O	B-PROBLEM
prostate	NN	B-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM

vitals	NNS	B-TEST	B-TEST
:	:	O	O
t	NN	B-TEST	O
:	:	O	O
99	CD	O	O
p	NN	B-TEST	O
:	:	O	O
84	CD	O	O
bp	NN	B-TEST	O
:	:	O	O
145/62	CD	O	O
ac	NN	B-TREATMENT	O
:	:	O	O
600	CD	O	O
,	,	O	O
x	VBD	O	O
12	CD	O	O
/	JJ	O	O
0.5	CD	O	O
/	JJ	O	O
5	CD	O	O
sao2	NN	B-TEST	O
:	:	O	O
100%	CD	O	O

heent	NN	O	O
:	:	O	O
peerla	NN	O	B-PROBLEM
,	,	O	O
no	DT	O	O
jvd	NN	B-PROBLEM	B-PROBLEM
.	.	O	O
+	JJ	O	O
tracheostomy	NN	B-TREATMENT	B-TREATMENT

decrease	NN	B-PROBLEM	B-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
sounds	VBZ	I-PROBLEM	I-PROBLEM
bases	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

cardiac	NN	O	O
:	:	O	O
rrr	NN	O	O
,	,	O	O
nl	RB	O	O
.	.	O	O
s1s2	NN	O	O
,	,	O	O
soft	JJ	B-PROBLEM	B-PROBLEM
holosytolic	NN	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
apex	NN	I-PROBLEM	I-PROBLEM

abdomen	NNS	O	O
:	:	O	O
soft	JJ	O	O
,	,	O	O
nt/nd	JJ	B-PROBLEM	O
,	,	O	O
normoactive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
,	,	O	O
no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
organomegaly	RB	B-PROBLEM	B-PROBLEM
noted	VBN	O	O
.	.	O	O

+	JJ	O	O
g	NN	B-TREATMENT	O
tube	NN	I-TREATMENT	O

extremities	NNS	O	O
:	:	O	O
left	VBD	B-TREATMENT	O
arm	NN	I-TREATMENT	O
avf	NN	I-TREATMENT	O

1+	CD	B-PROBLEM	O
trace	NN	I-PROBLEM	B-PROBLEM
edemalymphadenopathy	NN	I-PROBLEM	I-PROBLEM
noted	VBD	O	O
.	.	O	O

skin	NN	O	O
:	:	O	O
no	DT	O	O
rashes	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
small	JJ	B-PROBLEM	B-PROBLEM
decubit	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
back	NN	I-PROBLEM	O
.	.	O	O

decreased	VBN	B-PROBLEM	B-PROBLEM
reflexes	NNS	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremities	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

agap	NN	B-TEST	B-PROBLEM
=	VBZ	O	O
14	CD	O	O

ck	NN	B-TEST	O
:	:	O	O
29	CD	O	O
mb	NN	B-TEST	O
:	:	O	O
notdone	RB	O	O
trop	NN	B-TEST	O
-*	NNP	O	O
t	NN	O	O
*:	VBD	O	O
0.44	CD	O	O

ctropnt	NN	B-TEST	B-TEST
>	VBZ	O	O
0.10	CD	O	O
ng	JJ	O	O
/	NNP	O	O
ml	NN	O	O
suggests	VBZ	O	O
acute	VBP	B-PROBLEM	B-PROBLEM
mi	NN	I-PROBLEM	I-PROBLEM

ca	MD	B-TEST	O
:	:	O	O
8.6	CD	O	O
mg	NN	B-TEST	O
:	:	O	O
2.4	CD	O	O
p	NN	B-TEST	O
:	:	O	O
5.0	CD	O	O

probnp	NN	B-TEST	O
:	:	O	O
11065	CD	O	O

wbc	NN	B-TEST	B-TEST
15.2	CD	O	O
plat	NN	B-TEST	O
395	CD	O	O

hct	NN	B-TEST	B-TEST
:	:	O	O
28.4	CD	O	O

n	NNS	B-TEST	O
:	:	O	O
89.8	CD	O	O
band	NN	B-TEST	O
:	:	O	O
0	CD	O	O
l	NN	B-TEST	O
:	:	O	O
5.8	CD	O	O
m	NN	B-TEST	O
:	:	O	O
4.1	CD	O	O
e	NN	B-TEST	O
:	:	O	O
0.3	CD	O	O
bas	NN	B-TEST	O
:	:	O	O
0.1	CD	O	O
pt	NN	B-TEST	O
:	:	O	O
12.1	CD	O	O
ptt	NN	B-TEST	O
:	:	O	O
37.5	CD	O	O
inr	NN	B-TEST	O
:	:	O	O
1.0	CD	O	O

k	NN	B-TEST	O
:	:	O	O
5.5	CD	O	O
lactate	NN	B-TEST	B-TEST
:	:	O	O
1.3	CD	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
79	CD	O	O
y/o	NN	O	O
m	NN	O	O
with	IN	O	O
h/o	NN	O	O
htn	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
dm	NN	B-PROBLEM	O
,	,	O	O
recent	JJ	B-PROBLEM	O
cva	NN	I-PROBLEM	O
,	,	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
ventilatory	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
cri	NN	B-PROBLEM	O
on	IN	O	O
hd	NN	B-TREATMENT	O
who	WP	O	O
presents	VBZ	O	O
with	IN	O	O
change	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
ms	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
febrile	NN	B-PROBLEM	B-PROBLEM
in	IN	O	O
the	DT	O	O
amanda	NN	O	O
,	,	O	O
admitted	VBN	O	O
to	TO	O	O
cmed	VB	O	O
.	.	O	O

#	#	O	O
altered	VBD	B-PROBLEM	B-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
:	:	O	O
ct	NNS	B-TEST	B-TEST
scan	VBP	I-TEST	I-TEST
with	IN	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
new	JJ	B-PROBLEM	B-PROBLEM
intracraneal	JJ	I-PROBLEM	I-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
febrile	NN	B-PROBLEM	O
in	IN	O	O
the	DT	O	O
amanda	NN	O	O
.	.	O	O

high	JJ	B-PROBLEM	B-PROBLEM
wbc	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

it	PRP	O	O
was	VBD	O	O
thought	VBN	O	O
that	IN	O	O
it	PRP	O	O
could	MD	O	O
have	VB	O	O
been	VBN	O	O
a	DT	O	O
combination	NN	O	O
of	IN	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypercapnia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	I-PROBLEM
infection	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
initially	RB	O	O
started	VBN	O	O
on	IN	O	O
broad	JJ	B-TREATMENT	B-TREATMENT
spectrum	NN	I-TREATMENT	I-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

despite	IN	O	O
having	VBG	O	O
a	DT	B-PROBLEM	B-PROBLEM
profund	NN	I-PROBLEM	I-PROBLEM
limitation	NN	I-PROBLEM	I-PROBLEM
communicating	VBG	I-PROBLEM	O
given	VBN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
neurological	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
his	PRP$	B-PROBLEM	O
mental	JJ	I-PROBLEM	O
changes	NNS	I-PROBLEM	O
seemed	VBD	O	O
to	TO	O	O
improved	VBN	O	O
initially	RB	O	O
.	.	O	O

however	RB	O	O
later	RB	O	O
on	IN	O	O
during	IN	O	O
his	PRP$	O	O
course	NN	O	O
,	,	O	O
his	PRP$	O	O
mental	JJ	O	O
status	NN	O	O
deteriorated	VBD	O	O
,	,	O	O
being	VBG	O	O
even	RB	O	O
less	RBR	B-PROBLEM	O
responsive	JJ	I-PROBLEM	O
.	.	O	O

patient	NN	O	O
febrile	NN	B-PROBLEM	O
and	CC	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
high	JJ	I-PROBLEM	I-PROBLEM
wbc	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
admission	NN	O	O
.	.	O	O

after	IN	O	O
starting	VBG	O	O
broad	JJ	B-TREATMENT	B-TREATMENT
spectrum	NN	I-TREATMENT	I-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
-	:	O	O
cefepime	NN	B-TREATMENT	O
-	:	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
(	(	O	O
for	IN	O	O
initial	JJ	O	O
concern	NN	O	O
of	IN	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
),	IN	O	O
he	PRP	O	O
responded	VBD	O	O
clinically	RB	O	O
.	.	O	O

urine	JJ	B-TEST	B-TEST
cx	NN	I-TEST	I-TEST
from	IN	O	O
rehab	NN	O	O
showed	VBD	O	O
gram	JJ	B-PROBLEM	O
negative	JJ	I-PROBLEM	O
rods	NNS	I-PROBLEM	O
>	VBP	B-PROBLEM	O
100	CD	I-PROBLEM	O
k	NN	I-PROBLEM	O
enterobacter	NN	I-PROBLEM	O
cloacae	NN	I-PROBLEM	O
.	.	O	O

urine	JJ	B-TEST	B-TEST
cx	NN	I-TEST	I-TEST
in	IN	O	O
house	NN	O	O
grew	VBD	O	O
citrobacter	JJR	B-PROBLEM	O
freundi	NN	I-PROBLEM	O
and	CC	O	O
his	PRP$	B-TEST	B-TEST
sputum	NN	I-TEST	I-TEST
grew	VBD	O	O
acinetobacter	RB	B-PROBLEM	B-PROBLEM
baummani	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

since	IN	O	O
there	EX	O	O
was	VBD	O	O
no	DT	O	O
more	JJR	O	O
evidence	NN	O	O
of	IN	O	O
gram	NN	B-PROBLEM	B-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
infections	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
and	CC	O	O
cefepime	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
kept	VBN	O	O
.	.	O	O

#	#	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
:	:	O	O
in	IN	O	O
the	DT	O	O
amanda	NN	O	O
,	,	O	O
high	JJ	B-PROBLEM	B-PROBLEM
wbc	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
possible	JJ	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

also	RB	O	O
possible	JJ	O	O
source	NN	O	B-PROBLEM
sinus	NN	B-PROBLEM	I-PROBLEM
infections	NNS	I-PROBLEM	I-PROBLEM
given	VBN	O	O
findings	NNS	O	O
on	IN	O	O
intial	JJ	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
(	(	O	O
see	VB	O	O
summary	JJ	O	O
in	IN	O	O
significant	JJ	O	O
studies	NNS	O	O
).	IN	O	O
he	PRP	O	O
did	VBD	O	O
not	RB	O	O
spike	VB	O	O
any	DT	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
after	IN	O	O
being	VBG	O	O
transfer	NN	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
from	IN	O	O
the	DT	O	O
amanda	NN	O	O
.	.	O	O

#	#	O	O
resp	NN	O	O
:	:	O	O
patient	NN	O	O
was	VBD	O	O
intermitentely	RB	O	O
switched	VBN	O	O
from	IN	O	O
ac	NN	B-TREATMENT	O
to	TO	O	O
pressure	VB	B-TREATMENT	B-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
trials	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

then	RB	O	B-TEST
trach	NN	B-TREATMENT	I-TEST
mask	NN	I-TREATMENT	I-TEST
trials	NNS	I-TREATMENT	I-TEST
were	VBD	O	O
done	VBN	O	O
.	.	O	O

he	PRP	O	O
tolerated	VBD	O	O
this	DT	O	O
well	NN	O	O
,	,	O	O
although	IN	O	O
he	PRP	O	O
required	VBD	O	O
ps	JJ	B-TREATMENT	O
overnight	NN	O	O
.	.	O	O

#	#	O	O
esrd	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
hemodyalisis	NN	B-TREATMENT	O
:	:	O	O
renal	JJ	O	O
service	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
and	CC	O	O
hd	NN	B-TREATMENT	O
was	VBD	O	O
continued	VBN	O	O
.	.	O	O

rhythm	NN	B-TEST	O
:	:	O	O
nsr	NN	O	O
,	,	O	O
not	RB	O	O
tachycardic	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

pump	NN	B-TEST	O
:	:	O	O
with	IN	O	O
trace	NN	O	B-PROBLEM
of	IN	O	I-PROBLEM
lower	JJR	B-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

x	JJ	B-TEST	B-TEST
ray	NN	I-TEST	I-TEST
suggested	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
admission	NN	O	O
.	.	O	O

despite	IN	O	O
this	DT	O	O
findings	NNS	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
supported	VBN	O	O
with	IN	O	O
40%	CD	B-TREATMENT	O
fio2	NNS	I-TREATMENT	O
most	RBS	O	O
of	IN	O	O
the	DT	O	O
time	NN	O	O
.	.	O	O

cad	NN	B-PROBLEM	O
:	:	O	O
on	IN	O	O
admission	NN	O	O
ck	NN	B-TEST	O
low	JJ	O	O
normal	JJ	O	O
,	,	O	O
mb	JJ	B-TEST	O
not	RB	O	O
done	VBN	O	O
.	.	O	O

troponin	NN	B-TEST	B-TEST
0.44.	CD	O	O

it	PRP	O	O
was	VBD	O	O
more	RBR	O	O
likely	JJ	O	O
due	JJ	O	O
to	TO	O	O
cri	VB	B-PROBLEM	O
.	.	O	O

second	JJ	O	O
set	VBD	O	O
12	CD	O	O
hours	NNS	O	O
apart	RB	O	O
,	,	O	O
showed	VBD	O	O
no	DT	O	O
changes	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

s/p	JJ	O	B-PROBLEM
stroke	NN	B-PROBLEM	I-PROBLEM
:	:	O	O
continue	NN	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
statin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
plavix	NN	B-TREATMENT	B-TREATMENT

#	#	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
:	:	O	O
per	IN	O	O
referral	JJ	O	O
form	NN	O	O
.	.	O	O

intially	RB	O	O
concern	NN	O	O
for	IN	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
high	JJ	B-PROBLEM	B-TEST
blood	NN	I-PROBLEM	I-TEST
count	NN	I-PROBLEM	I-TEST
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
bp	NN	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
held	VBN	O	O
on	IN	O	O
admission	NN	O	O
.	.	O	O

patient	NN	O	O
did	VBD	O	O
not	RB	O	O
require	VB	O	O
pressors	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
remained	VBD	O	O
stable	JJ	O	O
and	CC	O	O
bp	JJ	B-TREATMENT	B-TREATMENT
meds	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
restarted	VBN	O	O
.	.	O	O

tube	NN	B-TREATMENT	B-TREATMENT
feedings	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
started	VBN	O	O
thorugh	IN	O	O
peg	NN	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
2013-09-08	JJ	O	O
,	,	O	O
patient	NN	O	O
pulled	VBD	O	O
out	RP	O	O
peg	JJ	B-TREATMENT	O
tube	NN	I-TREATMENT	O
.	.	O	O

temporary	JJ	B-TREATMENT	B-TREATMENT
foley	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
and	CC	O	O
on	IN	O	O
2013-09-11	CD	O	O
,	,	O	O

on	IN	O	O
2013-09-12	JJ	O	O
after	IN	O	O
deterioration	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
also	RB	I-PROBLEM	O
of	IN	I-PROBLEM	O
his	PRP$	I-PROBLEM	B-TEST
blood	NN	I-PROBLEM	I-TEST
pressure	NN	I-PROBLEM	I-TEST
,	,	O	O
goals	NNS	O	O
of	IN	O	O
care	NN	O	O
were	VBD	O	O
discussed	VBN	O	O
with	IN	O	O
his	PRP$	O	B-PROBLEM
hcp	NN	O	I-PROBLEM
.	.	O	O

it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
to	TO	O	O
direct	JJ	O	O
goals	NNS	O	O
of	IN	O	O
care	NN	O	O
towards	NNS	O	O
confort	NN	B-TREATMENT	B-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

novolin	RB	B-TREATMENT	B-TREATMENT
16	CD	O	I-TREATMENT
u	JJ	O	I-TREATMENT
q	NN	O	I-TREATMENT
12h	CD	O	O

aranesp	RB	B-TREATMENT	B-TREATMENT
40	CD	O	O
mcg	NNS	O	O
sc	NN	O	O

prozac	NN	B-TREATMENT	B-TREATMENT
liquid	VBD	I-TREATMENT	I-TREATMENT
20	CD	O	O
mg	NN	O	O
q	NN	O	O
am	VBP	O	O

heparin	NN	B-TREATMENT	B-TREATMENT
3000	CD	O	O
u	JJ	O	O
tu	NN	O	O
,	,	O	O
thursday	NN	O	O
saturday	NN	O	O

norvasc	RB	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	JJ	O	O
daily	JJ	O	O
gt	NN	O	O

tylenol	NN	B-TREATMENT	B-TREATMENT
prn	NN	O	O

reglan	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
q	NN	O	O
6h	CD	O	O
,	,	O	O

fergon	NN	B-TREATMENT	B-TEST
300	CD	O	O
mg	NN	O	O
bid	NN	O	O

plavix	NN	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
gt	NN	O	O

nephrocaps	NNS	B-TREATMENT	B-TEST
1	CD	O	O
daily	JJ	O	O

novolin	RB	B-TREATMENT	B-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT

heparin	NN	B-TREATMENT	B-TREATMENT
sc	NN	O	I-TREATMENT
5000	CD	O	O
q	NN	O	O
8h	CD	O	O

protonix	NN	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
daily	JJ	O	O
gt	NN	O	O

combivent	NN	B-TREATMENT	B-TREATMENT
2	CD	O	O
puff	NN	O	O
qid	NN	O	O
inh	NN	O	O

zocor	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
tab	NN	O	O
/	NNP	O	O
day	NN	O	O
gt	NN	O	O

aspirin	RB	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NNS	O	O
tab	NN	O	O

ferrlecit	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
ferric	JJ	I-TREATMENT	I-TREATMENT
gluconate	NN	I-TREATMENT	I-TREATMENT
mo-we	JJ	O	O
fr	NN	O	O
iv	NN	O	O

1.	CD	O	O
change	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM

2.	CD	O	O
urinary	JJ	B-PROBLEM	B-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM

3.	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM

1.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM

2.	CD	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	VBP	I-PROBLEM	I-PROBLEM

3.	CD	O	O
end	NN	B-PROBLEM	B-PROBLEM
stage	NN	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
hd	NN	B-TREATMENT	O

ms.	NN	O	O
less	CC	O	O
is	VBZ	O	O
a	DT	O	O
79	CD	O	O
year	NN	O	O
old	JJ	O	O
white	JJ	O	O
female	NN	O	O
with	IN	O	O
history	NN	O	O
of	IN	O	O
non	NN	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
diagnosed	VBN	O	O
in	IN	O	O
02/95	CD	O	O
.	.	O	O

she	PRP	O	O
underwent	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
stage	NN	B-PROBLEM	O
i	NN	I-PROBLEM	O
in	IN	O	O
10/95	CD	O	O
and	CC	O	O
treated	VBD	O	O
with	IN	O	O
xrt	NNP	B-TREATMENT	O
.	.	O	O

she	PRP	O	O
presented	VBD	O	O
to	TO	O	O
the	DT	O	O
hospital	NN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
numb	JJ	I-PROBLEM	I-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
leg	NN	I-PROBLEM	I-PROBLEM
this	DT	O	O
morning	NN	O	O
and	CC	O	O
underwent	NN	O	O
an	DT	B-TREATMENT	B-TREATMENT
emergent	JJ	I-TREATMENT	I-TREATMENT
embolectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
status	NN	O	O
post	NN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
1990	CD	O	O
,	,	O	O
peptic	JJ	B-PROBLEM	B-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

medications	NNS	B-TREATMENT	B-TREATMENT
on	IN	I-TREATMENT	O
admission	NN	I-TREATMENT	O
were	VBD	O	O
coumadin	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
synthroid	NN	B-TREATMENT	I-TREATMENT
,	,	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
zantac	NN	B-TREATMENT	O
.	.	O	O

on	IN	O	O
1/14/96	CD	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
dialysis	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
1/18/96	CD	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
acute	JJ	I-PROBLEM	I-PROBLEM
change	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
underwent	NN	O	O
an	DT	B-TEST	B-TEST
emergent	JJ	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
massive	JJ	I-PROBLEM	I-PROBLEM
subarachnoid	NN	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
bleeding	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
subarachnoid	JJ	I-PROBLEM	I-PROBLEM
space	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
throughout	IN	O	O
the	DT	O	O
ventricles	NNS	O	O
.	.	O	O

she	PRP	O	O
also	RB	O	O
had	VBD	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
hydrocephalus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

follow	VB	B-TEST	B-TEST
up	RP	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
showed	VBD	O	O
worsening	NN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
hydrocephalus	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
ventriculostomy	NN	I-TREATMENT	I-TREATMENT
placed	VBN	O	O
in	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
.	.	O	O

she	PRP	O	O
failed	VBD	O	O
to	TO	O	O
improve	VB	O	O
following	VBG	O	O
placement	NN	O	B-TREATMENT
of	IN	O	I-TREATMENT
the	DT	B-TREATMENT	I-TREATMENT
ventriculostomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
her	PRP$	O	O
poor	JJ	O	O
prognosis	NN	O	O
was	VBD	O	O
discussed	VBN	O	O
with	IN	O	O
the	DT	O	O
family	NN	O	O
.	.	O	O

the	DT	O	O
family	NN	O	O
at	IN	O	O
that	DT	O	O
point	NN	O	O
considering	VBG	O	O
the	DT	O	O
multiple	NN	O	O
system	NN	O	O
involvement	NN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
diseases	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
decided	VBD	O	O
to	TO	O	O
make	VB	O	O
the	DT	O	O
patient	NN	O	O
dnr	NN	B-TREATMENT	O
and	CC	O	O
withdraw	JJ	O	O
care	NN	B-TREATMENT	O
.	.	O	O

the	DT	O	B-TEST
medical	JJ	O	I-TEST
examiner	NN	O	I-TEST
was	VBD	O	O
called	VBN	O	O
and	CC	O	O
the	DT	O	O
case	NN	O	O
was	VBD	O	O
discussed	VBN	O	O
,	,	O	O
and	CC	O	O
he	PRP	O	O
declined	VBD	O	O
autopsy	NN	B-TEST	O
of	IN	O	O
the	DT	O	O
case	NN	O	O
.	.	O	O

status	NN	O	O
post	NN	O	O
total	JJ	B-TREATMENT	B-TREATMENT
abdominal	JJ	I-TREATMENT	I-TREATMENT
hysterectomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

1)	CD	O	O
menorrhagia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2)	CD	O	O
pelvic	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3)	CD	O	O
endometriosis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

tah-bso	NN	B-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
42	CD	O	O
year	NN	O	O
old	JJ	O	O
gravida	NN	O	O
ii	NN	O	O
,	,	O	O
para	NN	O	O
i	NNS	O	O
female	VBP	O	O
with	IN	O	O
a	DT	O	O
long	JJ	O	O
history	NN	O	O
of	IN	O	O
menorrhagia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
pelvic	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
also	RB	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
endometriosis	NN	B-PROBLEM	B-PROBLEM
that	WDT	O	O
is	VBZ	O	O
symptomatic	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
used	VBD	O	O
danocrine	NN	B-TREATMENT	O
for	IN	O	O
approximately	RB	O	O
nine	CD	O	O
months	NNS	O	O
and	CC	O	O
was	VBD	O	O
pain	RB	B-PROBLEM	B-PROBLEM
free	JJ	O	O
,	,	O	O
but	CC	O	O
was	VBD	O	O
unable	JJ	O	B-PROBLEM
to	TO	O	I-PROBLEM
tolerate	VB	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
side	NN	I-PROBLEM	I-PROBLEM
effects	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
status	NN	O	O
post	NN	O	O
several	JJ	B-TEST	B-TREATMENT
laparoscopies	NNS	I-TEST	I-TREATMENT
in	IN	O	O
the	DT	O	O
past	NN	O	O
with	IN	O	O
which	WDT	O	O
she	PRP	O	O
was	VBD	O	O
diagnosed	VBN	O	O
with	IN	O	O
endometriosis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
recently	RB	O	O
been	VBN	O	O
on	IN	O	O
depo-provera	NN	B-TREATMENT	O
and	CC	O	O
has	VBZ	O	O
had	VBN	O	O
episodes	NNS	O	O
of	IN	O	O
break-through	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
for	IN	O	O
six	CD	O	O
weeks	NNS	O	O
at	IN	O	O
a	DT	O	O
time	NN	O	O
.	.	O	O

she	PRP	O	O
desired	VBD	O	O
surgical	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
12/12/96	CD	O	O
she	PRP	O	O
had	VBD	O	O
an	DT	B-TREATMENT	B-TREATMENT
uncomplicated	JJ	I-TREATMENT	I-TREATMENT
total	JJ	I-TREATMENT	I-TREATMENT
abdominal	JJ	I-TREATMENT	I-TREATMENT
hysterectomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

estimated	VBN	B-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
100	CD	O	O
cc	NN	O	O
and	CC	O	O
she	PRP	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
.	.	O	O

on	IN	O	O
postop	JJ	O	O
day	NN	O	O
number	NN	O	O
one	CD	O	O
she	PRP	O	O
was	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
and	CC	O	O
doing	VBG	O	O
well	RB	O	O
with	IN	O	O
a	DT	B-TREATMENT	O
pca	NN	I-TREATMENT	O
for	IN	O	O
pain	NN	B-TREATMENT	B-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
postop	JJ	O	O
day	NN	O	O
number	NN	O	O
two	CD	O	O
she	PRP	O	O
was	VBD	O	O
also	RB	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
had	VBD	O	O
not	RB	O	O
passed	VBN	O	O
any	DT	B-PROBLEM	O
flatus	NN	I-PROBLEM	O
yet	RB	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
34.2	CD	O	O
and	CC	O	O
stable	JJ	O	O
from	IN	O	O
her	PRP$	O	B-TEST
preoperative	JJ	O	I-TEST
value	NN	O	I-TEST
.	.	O	O

on	IN	O	O
postop	JJ	O	O
day	NN	O	O
number	NN	O	O
three	CD	O	O
her	PRP$	O	O
abdomen	NNS	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
distended	VBN	B-PROBLEM	B-PROBLEM
with	IN	O	O
a	DT	B-TEST	O
few	JJ	I-TEST	O
bowel	NN	I-TEST	O
sounds	NNS	I-TEST	O
and	CC	O	O
she	PRP	O	O
still	RB	O	O
had	VBD	O	O
not	RB	O	O
passed	VBN	O	O
gas	NN	B-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
decreased	VBD	O	O
the	DT	O	O
amount	NN	O	O
of	IN	O	O
demerol	NN	B-TREATMENT	B-TREATMENT
she	PRP	O	O
was	VBD	O	O
using	VBG	O	O
and	CC	O	O
supplemented	VBN	O	O
with	IN	O	O
tylenol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
continued	VBD	O	O
her	PRP$	O	O
frequent	JJ	O	O
ambulation	NN	O	O
.	.	O	O

on	IN	O	O
postop	JJ	O	O
day	NN	O	O
number	NN	O	O
four	CD	O	O
she	PRP	O	O
had	VBD	O	O
passed	VBN	O	B-PROBLEM
flatus	NN	B-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
feeling	VBG	O	O
much	JJ	O	O
better	RBR	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
discharged	VBN	O	O
to	TO	O	O
home	NN	O	O
in	IN	O	O
good	JJ	O	O
condition	NN	O	O
on	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
following	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

demerol	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

motrin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

colace	NN	B-TREATMENT	B-TREATMENT
stool	NN	I-TREATMENT	I-TREATMENT
softener	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

mixed	JJ	B-PROBLEM	B-PROBLEM
mesodermal	JJ	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mixed	JJ	B-PROBLEM	B-PROBLEM
mesodermal	JJ	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

(	(	O	O
1	CD	O	O
)	)	O	O
status	NN	O	O
post	NN	O	O
hysterectomy	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
oophorectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

(	(	O	O
2	CD	O	O
)	)	O	O
abdominal	NN	B-PROBLEM	B-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
hernia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

(	(	O	O
3	CD	O	O
)	)	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
june	NN	O	O
26	CD	O	O
,	,	O	O
1994	CD	O	B-PROBLEM
tumor	NN	B-TREATMENT	I-PROBLEM
debulking	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
pelvic	JJ	B-TREATMENT	B-TREATMENT
lymph	NN	I-TREATMENT	I-TREATMENT
node	NN	I-TREATMENT	I-TREATMENT
dissection	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
lysis	NN	B-TREATMENT	B-TREATMENT
of	IN	O	I-TREATMENT
adhesions	NNS	B-PROBLEM	I-TREATMENT
,	,	O	I-TREATMENT
abdominal	JJ	B-TREATMENT	I-TREATMENT
wall	NN	I-TREATMENT	I-TREATMENT
hernia	NN	I-TREATMENT	I-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
an	DT	O	O
81	CD	O	O
year	NN	O	O
old	JJ	O	O
female	NN	O	O
,	,	O	O
g2	NN	O	O
,	,	O	O
p2	NN	O	O
,	,	O	O
who	WP	O	O
status	NN	O	O
post	NN	O	O
total	JJ	B-TREATMENT	B-TREATMENT
abdominal	JJ	I-TREATMENT	I-TREATMENT
hysterectomy-bilateral	JJ	I-TREATMENT	I-TREATMENT
salpingo-oophorectomy	JJ	I-TREATMENT	I-TREATMENT
one	CD	O	O
years	NNS	O	O
ago	RB	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
mixed	JJ	I-PROBLEM	I-PROBLEM
mesodermal	JJ	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
who	WP	O	O
presents	VBZ	O	O
with	IN	O	O
vaginal	JJ	B-PROBLEM	B-PROBLEM
apex	NN	I-PROBLEM	I-PROBLEM
recurrence	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	O	B-TEST
normal	JJ	O	I-TEST
pelvic	JJ	O	I-TEST
examination	NN	O	I-TEST
and	CC	O	I-TEST
ct	JJ	B-TEST	I-TEST
scan	NN	I-TEST	I-TEST
in	IN	O	O
february	NN	O	O
of	IN	O	O
1993	CD	O	O
but	CC	O	O
one	CD	O	O
month	NN	O	O
prior	RB	O	O
to	TO	O	O
this	DT	O	O
admission	NN	O	O
starting	VBG	O	O
bleeding	VBG	B-PROBLEM	O
per	IN	I-PROBLEM	O
vagina	NN	I-PROBLEM	O
.	.	O	O

an	DT	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
revealed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
apicovaginal	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
consistent	NN	O	O
with	IN	O	O
recurrent	JJ	B-PROBLEM	B-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
computerized	JJ	I-TEST	I-TEST
tomography	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
which	WDT	O	O
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
central	JJ	I-PROBLEM	I-PROBLEM
recurrence	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
biopsy	NN	B-TEST	B-TEST
of	IN	O	O
this	DT	B-PROBLEM	B-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
positive	JJ	O	O
.	.	O	O

she	PRP	O	O
presents	VBZ	O	O
now	RB	O	O
for	IN	O	O
excision	NN	B-TREATMENT	B-PROBLEM
of	IN	O	I-PROBLEM
her	PRP$	B-PROBLEM	I-PROBLEM
local	JJ	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
recurrence	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

halcion	NN	B-TREATMENT	B-TEST
0.25	CD	O	O
mg.	NN	O	O
p.o.	NN	O	O
q.h.s.	NN	O	O
,	,	O	O

valium	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg.	NN	O	O
p.o.	NN	O	O
p.r.n	NN	O	O
and	CC	O	O
methyclothiazide	$	B-TREATMENT	O
5	CD	O	O
mg.	NN	O	O
q.d.	NN	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
is	VBZ	O	O
97.9	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
160/80	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
92	CD	O	O
,	,	O	O
her	PRP$	B-TEST	B-TEST
heent	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
reveals	NNS	O	O
anicteric	JJ	B-PROBLEM	B-PROBLEM
sclerae	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
her	PRP$	O	O
left	JJ	O	O
eye	NN	O	O
has	VBZ	O	O
slightly	RB	B-PROBLEM	B-PROBLEM
relaxed	VBN	I-PROBLEM	I-PROBLEM
inferoorbital	JJ	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	O	B-TEST
chest	NN	O	I-TEST
is	VBZ	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	NN	B-TEST	B-TEST
.	.	O	O

her	PRP$	O	O
heart	NN	O	O
has	VBZ	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
with	IN	O	O
i	JJ	B-PROBLEM	O
/	VBP	I-PROBLEM	O
vi	JJ	I-PROBLEM	B-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
ejection	NN	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
base	NN	I-PROBLEM	O
.	.	O	O

abdomen	NNS	O	O
is	VBZ	O	O
obese	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
soft	JJ	O	O
,	,	O	O
non-tender	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
without	IN	O	O
palpable	JJ	B-PROBLEM	B-PROBLEM
masses	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

extremities	NNS	O	O
two	CD	B-TEST	O
plus	CC	I-TEST	O
pulses	NNS	I-TEST	B-TEST
bilaterally	RB	I-TEST	O
and	CC	O	O
nonpitting	VBG	B-PROBLEM	B-PROBLEM
edema	VB	I-PROBLEM	I-PROBLEM
up	IN	I-PROBLEM	O
to	TO	I-PROBLEM	O
the	DT	I-PROBLEM	O
knees	NNS	I-PROBLEM	O
in	IN	O	O
both	DT	O	O
legs	NNS	O	O
.	.	O	O

sodium	NN	B-TEST	B-TEST
142	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
3.3	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
98	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
34	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
14/0.9	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
alkaline	JJ	I-TEST	I-TEST
phosphatase	NN	I-TEST	I-TEST
is	VBZ	O	O
77	CD	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
12.5	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
42.6	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
268	CD	O	O
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
patient	NN	O	O
with	IN	O	O
recurrence	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
mixed	JJ	I-PROBLEM	I-PROBLEM
mesodermal	JJ	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
vaginal	JJ	I-PROBLEM	O
apex	NN	I-PROBLEM	O
who	WP	O	O
presents	VBZ	O	O
for	IN	O	O
local	JJ	B-TREATMENT	B-TREATMENT
excision	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
that	DT	O	O
day	NN	O	O
she	PRP	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
where	WRB	O	O
she	PRP	O	O
underwent	VBD	O	O
an	DT	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
under	IN	O	O
anesthesia	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
an	DT	B-TEST	B-TEST
exploratory	JJ	I-TEST	I-TEST
laparotomy	NN	I-TEST	I-TEST
with	IN	O	O
lysis	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
adhesions	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
tumor	NN	B-TREATMENT	B-PROBLEM
debulking	NN	I-TREATMENT	I-PROBLEM
and	CC	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
pelvic	JJ	I-TREATMENT	I-TREATMENT
lymph	NN	I-TREATMENT	I-TREATMENT
node	DT	I-TREATMENT	I-TREATMENT
dissection	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

an	DT	B-PROBLEM	B-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
hernia	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
also	RB	O	O
repaired	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
without	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
complications	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	B-TREATMENT	B-TEST
vaginal	JJ	I-TREATMENT	I-TEST
pack	NN	I-TREATMENT	I-TEST
was	VBD	O	O
removed	VBN	O	O
on	IN	O	O
the	DT	O	O
second	JJ	O	O
postoperative	JJ	O	O
day	NN	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
foley	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

by	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
three	CD	O	O
she	PRP	O	O
had	VBD	O	O
return	NN	O	O
of	IN	O	O
normal	JJ	O	O
bowel	NN	O	O
function	NN	O	O
and	CC	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
tolerate	VB	O	O
a	DT	O	O
regular	JJ	O	O
diet	NN	O	O
without	IN	O	O
any	DT	B-PROBLEM	O
difficulty	NN	I-PROBLEM	O
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
jackson-pratt	JJ	I-TREATMENT	I-TREATMENT
drain	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
removed	VBN	O	O
on	IN	O	O
june	NN	O	O
30	CD	O	O
,	,	O	O
1994	CD	O	O
,	,	O	O
postoperative	JJ	O	O
day	NN	O	O
four	CD	O	O
.	.	O	O

on	IN	O	O
that	DT	O	O
day	NN	O	O
she	PRP	O	O
was	VBD	O	O
feeling	VBG	O	O
well	RB	O	O
enough	RB	O	O
,	,	O	O
eating	VBG	O	O
well	RB	O	O
,	,	O	O
and	CC	O	O
voiding	VBG	O	O
without	IN	O	O
difficulty	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

her	PRP$	B-TREATMENT	O
only	JJ	I-TREATMENT	O
additional	JJ	I-TREATMENT	B-TREATMENT
medication	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
discharge	NN	O	O
is	VBZ	O	O
percocet	VBN	B-TREATMENT	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

in	IN	O	O
addition	NN	O	O
dr.	FW	O	O
blincarour	NN	O	O
from	IN	O	O
radiation	NN	O	O
oncology	NN	O	O
saw	VBD	O	O
the	DT	O	O
patient	NN	O	O
and	CC	O	O
recommended	VBD	O	O
pelvic	JJ	B-TREATMENT	B-TREATMENT
radiation	NN	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
wishes	VBZ	O	O
to	TO	O	O
get	VB	O	O
her	PRP$	B-TREATMENT	O
radiation	NN	I-TREATMENT	O
in	IN	O	O
o	NN	O	O
and	CC	O	O
has	VBZ	O	O
spoken	VBN	O	O
to	TO	O	O
her	PRP$	O	O
primary	JJ	O	O
care	NN	O	O
physician	JJ	O	O
regarding	VBG	O	O
this	DT	O	O
.	.	O	O

of	IN	O	O
note	PDT	O	B-PROBLEM
the	DT	O	I-PROBLEM
pelvic	JJ	O	I-PROBLEM
lymph	NN	O	I-PROBLEM
nodes	NNS	O	I-PROBLEM
which	WDT	O	O
were	VBD	O	O
dissected	VBN	O	O
were	VBD	O	O
positive	JJ	O	O
for	IN	O	O
tumor	NN	B-PROBLEM	B-PROBLEM
by	IN	O	O
frozen	JJ	B-TEST	O
section	NN	I-TEST	O
analysis	NN	I-TEST	O
.	.	O	O

the	DT	B-TEST	O
permanent	JJ	I-TEST	O
pathology	NN	I-TEST	O
sections	NNS	I-TEST	O
are	VBP	O	O
still	RB	O	O
pending	VBG	O	O
.	.	O	O

renal	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
an	DT	O	O
83-year-old	JJ	O	O
male	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
steroid-treated	JJ	B-PROBLEM	B-PROBLEM
polymyalgia	NN	I-PROBLEM	I-PROBLEM
rheumatica	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
benign	JJ	B-PROBLEM	B-PROBLEM
prostatic	JJ	I-PROBLEM	I-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
high	JJ	B-PROBLEM	B-PROBLEM
cholesterol	NN	I-PROBLEM	I-PROBLEM
who	WP	O	O
presented	VBD	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
lower	JJR	I-TEST	I-TEST
extremity	NN	I-TEST	I-TEST
peripheral	JJ	I-TEST	I-TEST
angiography	NN	I-TEST	I-TEST
for	IN	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
foot	NN	I-PROBLEM	I-PROBLEM
ulcers	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
an	DT	B-PROBLEM	B-TEST
evaluated	VBN	I-PROBLEM	I-TEST
blood	NN	I-PROBLEM	I-TEST
urea	JJ	I-PROBLEM	I-TEST
nitrogen	NN	I-PROBLEM	I-TEST
,	,	I-PROBLEM	O
and	CC	I-PROBLEM	O
creatinine	NN	I-PROBLEM	B-TEST
,	,	I-PROBLEM	O
and	CC	I-PROBLEM	O
potassium	NN	I-PROBLEM	B-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
notes	VBZ	O	O
he	PRP	O	O
developed	VBD	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
foot	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
ulcers	NNS	B-PROBLEM	B-TEST
four	CD	O	O
months	NNS	O	O
ago	RB	O	O
.	.	O	O

due	JJ	O	O
to	TO	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
worsening	VBG	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
glucose	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
he	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

his	PRP$	B-PROBLEM	B-PROBLEM
foot	NN	I-PROBLEM	I-PROBLEM
ulcers	NNS	I-PROBLEM	I-PROBLEM
continued	VBD	O	O
to	TO	O	O
develop	VB	O	O
,	,	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
complained	VBD	O	O
of	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
feet	NNS	I-PROBLEM	I-PROBLEM
;	:	O	O
primarily	RB	O	O
at	IN	O	O
night	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
referred	VBN	O	O
to	TO	O	O
for	IN	O	O
vascular	JJ	O	O
consultation	NN	O	O
because	IN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
ulcerations	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
pain	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
scheduled	VBN	O	O
for	IN	O	O
a	DT	O	O
lower	JJR	O	O

extremity	NN	B-TEST	B-TEST
angiography	NN	I-TEST	I-TEST
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
admission	NN	O	O
,	,	O	O
but	CC	O	O
due	JJ	O	O
to	TO	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
the	DT	O	I-PROBLEM
procedure	NN	O	I-PROBLEM
was	VBD	O	O
cancelled	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
showed	VBD	O	O
peaked	JJ	B-PROBLEM	B-PROBLEM
t	NN	I-PROBLEM	I-PROBLEM
waves	NNS	I-PROBLEM	I-PROBLEM
on	IN	O	O
electrocardiogram	NN	B-TEST	B-TEST
,	,	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
medicine	VB	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
denied	VBD	O	O
any	DT	O	B-PROBLEM
oliguria	NN	B-PROBLEM	I-PROBLEM
,	,	O	O
hematuria	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
dysuria	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
foamy	JJ	B-PROBLEM	B-PROBLEM
urine	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
flank	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
urinary	JJ	B-PROBLEM	B-PROBLEM
hesitancy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
complained	VBN	O	O
of	IN	O	O
fatigue	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
anorexia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
10-pound	JJ	I-PROBLEM	I-PROBLEM
weight	NN	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
last	JJ	O	O
four	CD	O	O
months	NNS	O	O
.	.	O	O

he	PRP	O	O
gets	VBZ	O	O
short	JJ	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
one	CD	O	O
flight	NN	O	O
of	IN	O	O
stairs	NNS	O	O
.	.	O	O

he	PRP	O	O
denies	VBZ	O	O
any	DT	B-PROBLEM	O
fevers	NNS	I-PROBLEM	B-PROBLEM
,	,	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
recent	JJ	B-PROBLEM	B-PROBLEM
infections	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
orthopnea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hematemesis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
melena	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
hematochezia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
notes	VBZ	O	O
he	PRP	O	O
has	VBZ	O	O
had	VBD	O	O
hoarseness	VBN	B-PROBLEM	B-PROBLEM
for	IN	O	O
the	DT	O	O
last	JJ	O	O
two	CD	O	O
to	TO	O	O
three	CD	O	O
weeks	NNS	O	O
.	.	O	O

1.	CD	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	JJ	I-PROBLEM	I-PROBLEM
times	NNS	O	O
four	CD	O	O
years	NNS	O	O
;	:	O	O
recently	RB	O	O
started	VBD	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
metformin	NN	B-TREATMENT	B-TREATMENT
due	JJ	O	O
to	TO	O	O
his	PRP$	B-TREATMENT	O
concurrent	NN	I-TREATMENT	O
steroid	NN	I-TREATMENT	O
use	NN	I-TREATMENT	O
.	.	O	O

last	JJ	O	B-TEST
hemoglobin	NN	B-TEST	I-TEST
a1c	NN	I-TEST	I-TEST
was	VBD	O	O
11.4	CD	O	O
.	.	O	O

2.	CD	O	O
polymyalgia	NN	B-PROBLEM	B-PROBLEM
rheumatica	NN	I-PROBLEM	I-PROBLEM
diagnosed	VBD	O	O
four	CD	O	O
years	NNS	O	O
ago	RB	O	O
;	:	O	O
on	IN	O	O
steroids	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

3.	CD	O	O
benign	JJ	B-PROBLEM	B-PROBLEM
prostatic	JJ	I-PROBLEM	I-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
transurethral	JJ	B-TREATMENT	B-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
prostate	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

4.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

5.	CD	O	O
high	JJ	B-PROBLEM	B-PROBLEM
cholesterol	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

6.	CD	O	O
lower	JJR	B-PROBLEM	B-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

methylprednisolone	NN	B-TREATMENT	B-TREATMENT
4	CD	O	O
mg	NN	O	O
q.	NN	O	O
a.m.	NN	O	O
and	CC	O	O
2	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.h.s.	NN	O	O
,	,	O	O
spironolactone	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
,	,	O	O
metformin	NN	B-TREATMENT	B-TREATMENT
1500	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.h.s.	NN	O	O
,	,	O	O
pravastatin	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.h.s.	NN	O	O
,	,	O	O
lisinopril	VBZ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	NN	O	O
a.m.	NN	O	O
,	,	O	O
lasix	VBZ	B-TREATMENT	B-TREATMENT
80	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	NN	O	O
a.m.	NN	O	O
,	,	O	O
tylenol	NN	B-TREATMENT	B-TREATMENT
as	IN	O	O
needed	VBN	O	O
,	,	O	O
insulin	JJ	B-TREATMENT	B-TREATMENT
regular	JJ	I-TREATMENT	I-TREATMENT
22	CD	O	O
units	NNS	O	O
in	IN	O	O
the	DT	O	O
morning	NN	O	O
and	CC	O	O
12	CD	O	O
units	NNS	O	O
at	IN	O	O
night	NN	O	O
(	(	O	O
lispro	JJ	B-TREATMENT	O
regular	NN	I-TREATMENT	O
).	NN	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

type	NN	B-PROBLEM	B-PROBLEM
1	CD	I-PROBLEM	I-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
twin	NN	O	I-PROBLEM
brother	NN	O	I-PROBLEM
,	,	O	O
type	NN	B-PROBLEM	B-PROBLEM
2	CD	I-PROBLEM	I-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
in	IN	O	O
mother	NN	O	O
and	CC	O	O
brother	NN	O	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
temperature	NN	B-TEST	B-TEST
was	VBD	O	O
98.1	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
140/70	CD	O	O
,	,	O	O
pulse	NN	B-TEST	B-TEST
was	VBD	O	O
95	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
was	VBD	O	O
18	CD	O	O
,	,	O	O
oxygen	NN	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST
was	VBD	O	O
98%	CD	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

in	IN	O	O
general	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
a	DT	O	O
thin	JJ	O	O
white	JJ	O	O
male	NN	O	O
,	,	O	O
lying	VBG	O	O
in	IN	O	O
bed	NN	O	O
,	,	O	O
in	IN	O	O
no	DT	O	O
acute	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
hoarse	JJ	I-PROBLEM	I-PROBLEM
voice	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

sclerae	NN	O	O
were	VBD	O	O
anicteric	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

neck	NN	O	O
revealed	VBD	O	O
no	DT	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
thyromegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
jugular	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
distention	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

cardiovascular	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
.	.	O	O

a	DT	B-PROBLEM	B-PROBLEM
2/6	CD	I-PROBLEM	I-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
sternal	JJ	I-PROBLEM	I-PROBLEM
border	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

lungs	NNS	O	O
were	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	O	O
with	IN	O	O
faint	NN	B-PROBLEM	B-PROBLEM
lower	RBR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
crackles	NNS	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

back	RB	O	O
revealed	VBN	O	O
no	DT	O	O
costovertebral	JJ	B-PROBLEM	B-PROBLEM
angle	NN	I-PROBLEM	I-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
and	CC	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
rebound	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
guarding	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

extremities	NNS	O	O
revealed	VBD	O	O
2+	CD	B-TEST	O
femoral	JJ	I-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
bilaterally	RB	I-TEST	O
,	,	O	O
1+	CD	B-TEST	O
dorsalis	NN	I-TEST	B-TEST
pedis	NN	I-TEST	I-TEST
pulses	VBZ	I-TEST	I-TEST
bilaterally	RB	I-TEST	O
.	.	O	O

no	DT	O	O
lower	JJR	B-PROBLEM	B-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

left	JJ	O	O
foot	NN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
dry	JJ	I-PROBLEM	I-PROBLEM
crusted	JJ	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
over	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
medial	JJ	O	I-PROBLEM
aspect	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
first	JJ	O	I-PROBLEM
metatarsal	NN	O	I-PROBLEM
head	NN	O	I-PROBLEM
and	CC	O	I-PROBLEM
the	DT	O	I-PROBLEM
lateral	JJ	O	I-PROBLEM
posterior	JJ	O	I-PROBLEM
heel	NN	O	I-PROBLEM
.	.	O	O

on	IN	O	O
the	DT	B-PROBLEM	O
right	JJ	I-PROBLEM	O
foot	NN	I-PROBLEM	B-PROBLEM
dry	JJ	I-PROBLEM	I-PROBLEM
crusted	VBD	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
over	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
medial	JJ	O	I-PROBLEM
aspect	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
first	JJ	O	I-PROBLEM
metatarsal	NN	O	I-PROBLEM
head	NN	O	I-PROBLEM
and	CC	O	I-PROBLEM
medial	JJ	O	I-PROBLEM
posterior	NN	O	I-PROBLEM
heel	NN	O	I-PROBLEM
.	.	O	O

neurologic	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
grossly	RB	O	O
intact	JJ	O	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
11	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
was	VBD	O	O
30	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
were	VBD	O	O
269	CD	O	O
.	.	O	O

sodium	NN	B-TEST	B-TEST
was	VBD	O	O
139	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
was	VBD	O	O
6.1	CD	O	O
,	,	O	O
chloride	NN	B-TEST	B-TEST
was	VBD	O	O
102	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
was	VBD	O	O
18	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
urea	JJ	I-TEST	I-TEST
nitrogen	NN	I-TEST	I-TEST
was	VBD	O	O
100	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
was	VBD	O	O
2.3	CD	O	O
,	,	O	O
and	CC	O	O
blood	NN	B-TEST	B-TEST
glucose	NN	I-TEST	I-TEST
was	VBD	O	O
189	CD	O	O
.	.	O	O

fena	NN	B-TEST	O
was	VBD	O	O
0.37	CD	O	O
.	.	O	O

renal	JJ	B-TEST	B-TEST
ultrasound	NN	I-TEST	I-TEST
was	VBD	O	O
normal	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
an	DT	O	O
83	CD	O	O
-	:	O	O
year-old	JJ	O	O
male	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
steroid-treated	JJ	B-PROBLEM	B-PROBLEM
polymyalgia	NN	I-PROBLEM	I-PROBLEM
rheumatica	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
benign	JJ	B-PROBLEM	B-PROBLEM
prostatic	JJ	I-PROBLEM	I-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
high	JJ	B-PROBLEM	B-PROBLEM
cholesterol	NN	I-PROBLEM	I-PROBLEM
without	IN	O	O
presented	VBN	O	O
to	TO	O	O
the	DT	O	O
hospital	NN	O	O
for	IN	O	O
lower	JJR	B-TEST	B-PROBLEM
extremity	NN	I-TEST	I-PROBLEM
angiograph	NN	I-TEST	I-PROBLEM
;	:	O	O
however	RB	O	O
,	,	O	O
that	DT	O	O
was	VBD	O	O
deferred	VBN	O	O
due	JJ	O	O
to	TO	O	O
new	JJ	B-PROBLEM	B-PROBLEM
onset	VBN	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
renal	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
initially	RB	O	O
thought	VBN	O	O
to	TO	O	O
be	VB	O	O
prerenal	JJ	B-PROBLEM	O
,	,	O	O
and	CC	O	O
his	PRP$	O	O
renal	JJ	O	O
status	NN	O	O
improved	VBN	O	O
after	IN	O	O
hydration	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
increased	VBD	B-TREATMENT	B-PROBLEM
oral	JJ	I-TREATMENT	I-PROBLEM
intake	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

he	PRP	O	O
did	VBD	O	O
have	VB	O	O
a	DT	B-TEST	B-TEST
magnetic	JJ	I-TEST	I-TEST
resonance	NN	I-TEST	I-TEST
angiography	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
his	PRP$	I-TEST	I-TEST
kidneys	NNS	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
right-sided	JJ	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	O	B-TEST
renal	JJ	O	I-TEST
function	NN	O	I-TEST
fluctuated	VBD	O	O
throughout	IN	O	O
his	PRP$	O	O
hospital	NN	O	O
stay	NN	O	O
,	,	O	O
and	CC	O	O
when	WRB	O	O
he	PRP	O	O
was	VBD	O	O
in	IN	O	O
the	DT	O	O
medical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
he	PRP	O	O
did	VBD	O	O
have	VB	O	O
decreased	VBN	B-PROBLEM	B-PROBLEM
urine	JJ	I-PROBLEM	I-PROBLEM
output	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
cardiogenic	JJ	B-PROBLEM	B-PROBLEM
shock	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
with	IN	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
peripheral	JJ	I-PROBLEM	I-PROBLEM
vascular	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

during	IN	O	O
his	PRP$	O	O
hospital	NN	O	O
stay	NN	O	O
,	,	O	O
he	PRP	O	O
developed	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
nonsustained	JJ	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
also	RB	O	O
became	VBD	O	O
hypotensive	JJ	B-PROBLEM	B-PROBLEM
on	IN	O	O
07-02	NN	O	O
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
infection	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
central	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
placed	VBN	O	O
and	CC	O	O
went	VBD	O	O
into	IN	O	O
sustained	VBN	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
lidocaine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

after	IN	O	O
being	VBG	O	O
treated	VBN	O	O
with	IN	O	O
lidocaine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
the	DT	O	O
patient	NN	O	O
became	VBD	O	O
apneic	JJ	B-PROBLEM	B-PROBLEM
requiring	VBG	O	O
intubation	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
transfer	NN	O	O
to	TO	O	O
the	DT	O	O
coronary	JJ	O	O
care	NN	O	O
unit	NN	O	O
.	.	O	O

his	PRP$	B-PROBLEM	B-PROBLEM
nonsustained	JJ	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
lidocaine	JJ	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

it	PRP	O	O
was	VBD	O	O
found	VBN	O	O
that	IN	O	O
he	PRP	O	O
had	VBD	O	O
elevated	VBN	B-PROBLEM	B-PROBLEM
troponins	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
likely	JJ	O	O
an	DT	B-PROBLEM	B-PROBLEM
ischemic	JJ	I-PROBLEM	I-PROBLEM
event	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
the	DT	O	O
07-02	NN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
echocardiogram	NN	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
decreased	JJ	I-PROBLEM	I-PROBLEM
ejection	NN	I-PROBLEM	I-PROBLEM
fraction	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
prior	JJ	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
which	WDT	O	O
revealed	VBD	O	O
3-vessel	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

cardiothoracic	NN	O	B-TREATMENT
surgery	NN	O	I-TREATMENT
was	VBD	O	O
consulted	VBN	O	O
,	,	O	O
and	CC	O	O
due	JJ	O	O
to	TO	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
acute	JJ	I-PROBLEM	I-PROBLEM
illness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
they	PRP	O	O
wanted	VBD	O	O
to	TO	O	O
re-evaluate	VB	O	O
after	IN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
extubated	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
intermittent	JJ	O	B-PROBLEM
episodes	NNS	O	I-PROBLEM
of	IN	O	I-PROBLEM
ventricular	JJ	B-PROBLEM	I-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
lidocaine	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
eventually	RB	O	O
changed	VBN	O	O
over	IN	O	O
to	TO	O	O
amiodarone	VB	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
cardiogenic	JJ	B-PROBLEM	B-PROBLEM
shock	NN	I-PROBLEM	I-PROBLEM
requiring	VBG	O	O
pressors	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

of	IN	O	O
note	NN	O	O
,	,	O	O
he	PRP	O	O
likely	RB	O	O
suffered	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
second	JJ	I-PROBLEM	I-PROBLEM
ischemic	JJ	I-PROBLEM	I-PROBLEM
event	NN	I-PROBLEM	I-PROBLEM
during	IN	O	O
his	PRP$	O	O
coronary	JJ	O	O
care	NN	O	O
unit	NN	O	O
stay	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
did	VBD	O	O
have	VB	O	O
a	DT	B-TEST	B-TREATMENT
swan-ganz	JJ	I-TEST	I-TREATMENT
catheter	NN	I-TEST	I-TREATMENT
in	IN	O	O
place	NN	O	O
and	CC	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
cardiac	NN	I-PROBLEM	I-PROBLEM
output	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
initially	RB	O	O
treated	VBN	O	O
with	IN	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
infiltrate	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
urinary	JJ	I-PROBLEM	I-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
then	RB	O	O
developed	VBD	O	O
positive	JJ	B-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
cultures	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
staphylococcus	JJ	B-PROBLEM	B-PROBLEM
aureus	NNS	I-PROBLEM	I-PROBLEM
sensitive	JJ	O	O
to	TO	O	O
levofloxacin	VB	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
that	DT	O	O
was	VBD	O	O
continued	VBN	O	O
.	.	O	O

when	WRB	O	O
the	DT	O	O
patient	NN	O	O
became	VBD	O	O
hypotensive	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
required	JJ	O	O
intubation	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
pressors	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
broadened	VBN	O	O
,	,	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
put	VBN	O	O
on	IN	O	O
stress-dose	JJ	B-TREATMENT	B-TREATMENT
steroids	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
staphylococcus	NN	I-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
required	VBN	O	O
intubation	NN	B-TREATMENT	B-TREATMENT
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
and	CC	O	I-PROBLEM
ventricular	JJ	B-PROBLEM	I-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
actually	RB	O	O
extubated	VBN	O	O
on	IN	O	O
07-09	JJ	O	O
,	,	O	O
but	CC	O	O
then	RB	O	O
reintubated	VBD	O	O
one	CD	O	O
hour	NN	O	O
later	RB	O	O
due	JJ	O	O
to	TO	O	O
hypoxia	VB	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
also	RB	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
staphylococcus	NN	I-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

right	JJ	B-PROBLEM	B-PROBLEM
occipital	NN	I-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	O
cerebral	JJ	I-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

right	JJ	B-PROBLEM	B-PROBLEM
occipital	NN	I-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	O
cerebral	JJ	I-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

old	JJ	B-PROBLEM	B-PROBLEM
inferior	JJ	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
1984	CD	O	O
.	.	O	O

head	NN	B-TEST	B-TEST
magnetic	JJ	I-TEST	I-TEST
resonance	NN	I-TEST	I-TEST
imaging	NN	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
and	CC	O	O
magnetic	JJ	B-TEST	B-TEST
resonance	NN	I-TEST	I-TEST
imaging	VBG	I-TEST	I-TEST
angiogram	NN	I-TEST	I-TEST
with	IN	I-TEST	O
and	CC	I-TEST	O
without	IN	I-TEST	O
gadolinium	NN	I-TEST	B-TEST
.	.	O	O

head	NN	B-TEST	B-TEST
computerized	VBD	I-TEST	I-TEST
tomography	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
,	,	O	O
echocardiogram	NN	B-TEST	B-TEST
,	,	O	I-TEST
transcranial	JJ	B-TEST	I-TEST
dopplers	NNS	I-TEST	I-TEST
,	,	O	O
carotid	NN	B-TEST	B-PROBLEM
noninvasives	NNS	I-TEST	I-PROBLEM
,	,	O	O
holter	NN	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
,	,	O	O
electroencephalogram	NN	B-TEST	B-TEST
,	,	O	I-TEST
and	CC	O	I-TEST
visual	JJ	B-TEST	I-TEST
field	NN	I-TEST	I-TEST
testing	NN	I-TEST	I-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
72-year-old	JJ	O	O
right-handed	JJ	O	O
gentleman	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
status	NN	O	O
post	NN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
1984	CD	O	O
.	.	O	O

also	RB	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
noninsulin	JJ	B-PROBLEM	B-PROBLEM
dependent	JJ	I-PROBLEM	I-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
mellitus	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
now	RB	O	O
presenting	VBG	O	O
with	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
blurry	NN	I-PROBLEM	I-PROBLEM
vision	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
side	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
is	VBZ	O	O
homonymous	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
sudden	JJ	O	O
onset	NN	O	O
of	IN	O	O
blurred	JJ	B-PROBLEM	B-PROBLEM
vision	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
where	WRB	O	O
the	DT	O	O
right	JJ	O	O
side	NN	O	O
of	IN	O	O
his	PRP$	O	O
wife	NN	O	O
&apos;s	NNP	O	O
face	NN	O	O
looked	VBD	O	O
blurred	VBN	O	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
did	VBD	O	O
not	RB	O	O
notice	JJ	O	O
change	NN	B-PROBLEM	O
of	IN	I-PROBLEM	O
vision	NN	I-PROBLEM	B-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
background	NN	O	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
blurred	JJ	I-PROBLEM	I-PROBLEM
vision	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
homonymous	JJ	O	O
,	,	O	O
which	WDT	O	O
he	PRP	O	O
had	VBD	O	O
blurred	VBN	O	B-PROBLEM
in	IN	O	I-PROBLEM
each	DT	O	I-PROBLEM
eye	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	JJ	O	I-PROBLEM
visual	JJ	O	I-PROBLEM
field	NN	O	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	O
same	JJ	I-PROBLEM	O
blurred	JJ	I-PROBLEM	B-PROBLEM
vision	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
also	RB	O	O
noticed	VBN	O	O
later	RB	O	O
when	WRB	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
watching	VBG	O	O
television	NN	O	O
and	CC	O	O
also	RB	O	O
when	WRB	O	O
he	PRP	O	O
was	VBD	O	O
reading	VBG	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
referred	VBN	O	O
to	TO	O	O
ph	VB	O	O
university	NN	O	O
of	IN	O	O
medical	JJ	O	O
center	NN	O	O
for	IN	O	O
rule	NN	O	O
out	IN	O	O
transient	NN	B-PROBLEM	B-PROBLEM
ischemic	JJ	I-PROBLEM	I-PROBLEM
attack	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
rule	NN	O	O
out	IN	O	O
stroke	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	JJ	O	O
denies	VBZ	O	O
any	DT	B-PROBLEM	O
nausea	NN	I-PROBLEM	B-PROBLEM
,	,	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
ataxia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
motor	NN	B-PROBLEM	B-PROBLEM
deficits	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
speech	NN	B-PROBLEM	B-PROBLEM
deficits	NNS	I-PROBLEM	I-PROBLEM
or	CC	O	O
sensory	JJ	B-PROBLEM	B-PROBLEM
deficits	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
lightly	RB	O	O
bumped	VBD	O	O
his	PRP$	O	O
head	NN	O	O
on	IN	O	O
the	DT	O	O
top	JJ	O	O
three	CD	O	O
times	NNS	O	O
on	IN	O	O
the	DT	O	O
previous	JJ	O	O
night	NN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
frontal	JJ	B-PROBLEM	B-PROBLEM
headaches	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
tight	JJ	I-PROBLEM	I-PROBLEM
neck	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	JJ	O	O
denies	VBZ	O	O
any	DT	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

is	VBZ	O	O
significant	JJ	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
1984	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
been	VBN	O	O
on	IN	O	O
cardiac	JJ	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
since	IN	O	O
and	CC	O	O
has	VBZ	O	O
had	VBN	O	O
no	DT	O	O
new	JJ	B-PROBLEM	B-PROBLEM
episodes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
been	VBN	O	O
diagnosed	VBN	O	O
with	IN	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	NNS	I-PROBLEM	I-PROBLEM
since	IN	O	O
1991	CD	O	O
and	CC	O	O
has	VBZ	O	O
been	VBN	O	O
maintained	VBN	O	O
on	IN	O	O
glipizide	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

in	IN	O	O
1992	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
been	VBN	O	O
diagnosed	VBN	O	O
with	IN	O	O
bladder	NN	B-PROBLEM	B-PROBLEM
papilloma	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
has	VBZ	O	O
been	VBN	O	O
cystoscoped	VBN	O	O
seven	CD	O	O
times	NNS	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	O	O
family	NN	O	O
history	NN	O	O
of	IN	O	O
prostate	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
stroke	NN	B-PROBLEM	I-PROBLEM
but	CC	O	O
no	DT	O	O
history	NN	O	O
of	IN	O	O
migraines	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

lopressor	NN	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
po	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
cardizem	VBP	B-TREATMENT	B-TREATMENT
30	CD	O	O
mg	NN	O	O
po	NN	O	O
q.i.d.	NN	O	O
,	,	O	O
zantac	VBZ	B-TREATMENT	B-TREATMENT
150	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
,	,	O	O
isordil	JJ	B-TREATMENT	B-TREATMENT
60	CD	O	O
mg	NN	O	O
po	NN	O	O
q	NN	O	O
a.m.	NN	O	O
,	,	O	O
60	CD	O	O
mg	NN	O	O
po	NN	O	O
q	NN	O	O
noon	NN	O	O
,	,	O	O
30	CD	O	O
mg	NN	O	O
po	NN	O	O
q	CD	O	O
p.m.	NN	O	O
and	CC	O	O
30	CD	O	O
mg	NN	O	O
po	NN	O	O
q	NN	O	O
hs	NN	O	O
,	,	O	O
glipizide	JJ	B-TREATMENT	B-TREATMENT
po	NN	O	I-TREATMENT
5	CD	O	O
mg	NN	O	O
q	NN	O	O
a.m.	NN	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
stable	JJ	O	O
vital	JJ	O	O
signs	NNS	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
,	,	I-TEST	I-TEST
eyes	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
ears	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
nose	RB	I-TEST	I-TEST
,	,	I-TEST	I-TEST
throat	NN	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
unremarkable	JJ	O	O
.	.	O	O

the	DT	O	O
neck	NN	O	O
was	VBD	O	O
supple	JJ	O	O
and	CC	O	O
no	DT	O	O
goiter	NN	B-PROBLEM	B-PROBLEM
was	VBD	O	O
noticed	VBN	O	O
,	,	O	O
no	DT	O	O
bruit	NN	B-PROBLEM	B-PROBLEM
was	VBD	O	O
noticed	VBN	O	O
.	.	O	O

the	DT	O	O
heart	NN	O	O
had	VBD	O	O
normal	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
with	IN	O	O
normal	JJ	O	O
sl	NNS	O	O
and	CC	O	O
s2	NN	O	O
and	CC	O	O
no	DT	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
heard	VBN	O	O
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
,	,	O	O
flat	JJ	O	O
,	,	O	O
nontender	FW	B-PROBLEM	B-PROBLEM
,	,	O	O
with	IN	O	O
normal	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
and	CC	O	O
no	DT	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
was	VBD	O	O
noticed	VBN	O	O
.	.	O	O

no	DT	O	O
mass	NN	B-PROBLEM	B-PROBLEM
was	VBD	O	O
noticed	VBN	O	O
.	.	O	O

capillary	JJ	B-TEST	B-TEST
refill	NN	I-TEST	I-TEST
was	VBD	O	O
normal	JJ	O	O
and	CC	O	O
there	EX	O	O
was	VBD	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
calves	NNS	O	O
were	VBD	O	O
nontender	JJR	B-PROBLEM	O
.	.	O	O

on	IN	O	O
neurological	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
alert	JJ	O	O
,	,	O	O
oriented	VBN	O	O
to	TO	O	O
time	NN	O	O
,	,	O	O
place	NN	O	O
and	CC	O	O
person	NN	O	O
.	.	O	O

for	IN	O	O
cranial	JJ	O	O
nerves	NNS	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
minimal	JJ	B-PROBLEM	B-PROBLEM
blurred	VBN	I-PROBLEM	I-PROBLEM
vision	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
extra	JJ	I-TEST	I-TEST
ocular	JJ	I-TEST	I-TEST
movements	NNS	I-TEST	I-TEST
were	VBD	O	O
full	JJ	O	O
with	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
terminal	JJ	I-PROBLEM	I-PROBLEM
nystagmus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
2-3	JJ	O	B-TEST
beats	NNS	O	I-TEST
,	,	O	O
in	IN	O	O
the	DT	O	O
right	JJ	O	O
lateral	JJ	O	O
gaze	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
light	JJ	I-TEST	I-TEST
reflex	NN	I-TEST	I-TEST
was	VBD	O	O
slightly	RB	B-PROBLEM	B-PROBLEM
slow	JJ	I-PROBLEM	I-PROBLEM
but	CC	O	O
equal	JJ	O	O
and	CC	O	O
intact	JJ	O	O
direct	JJ	O	O
and	CC	O	O
indirectly	RB	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
conduction	NN	B-PROBLEM	B-PROBLEM
hearing	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
side	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
had	VBD	O	O
been	VBN	O	O
old	JJ	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
motor	NN	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
,	,	O	O
the	DT	O	O
tone	NN	O	O
and	CC	O	O
bulk	NN	O	O
were	VBD	O	O
normal	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
no	DT	O	O
pronator	NN	B-PROBLEM	B-PROBLEM
drift	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
side	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
the	DT	B-TEST	O
strength	NN	I-TEST	O
of	IN	O	O
5	CD	O	O
minus	NNS	O	O
on	IN	O	O
the	DT	O	O
upper	JJ	O	O
and	CC	O	O
lower	JJR	O	O
extremities	NNS	O	O
,	,	O	O
distally	RB	O	O
and	CC	O	O
proximally	RB	O	O
.	.	O	O

the	DT	O	O
coordination	NN	O	O
was	VBD	O	O
intact	JJ	O	O
for	IN	O	O
finger-nose-finger	JJ	B-TEST	B-PROBLEM
test	NN	I-TEST	I-PROBLEM
,	,	O	O
rapid	JJ	O	B-PROBLEM
alternating	VBG	O	I-PROBLEM
hand	NN	O	I-PROBLEM
movements	NNS	O	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
heel-shin-test	NN	I-TEST	I-TEST
was	VBD	O	O
slightly	RB	B-PROBLEM	B-PROBLEM
clumsy	JJ	I-PROBLEM	I-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM
but	CC	O	O
the	DT	O	O
knee	NN	O	O
tapping	NN	O	O
was	VBD	O	O
normal	JJ	O	O
bilaterally	RB	O	O
.	.	O	O

sensory	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
:	:	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
decreased	VBN	B-PROBLEM	B-PROBLEM
vibratory	JJ	I-PROBLEM	I-PROBLEM
sense	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremities	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
worse	JJR	O	B-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	JJ	O	I-PROBLEM
side	NN	O	I-PROBLEM
.	.	O	O

the	DT	B-TEST	O
babinski	NN	I-TEST	O
&apos;s	NN	I-TEST	O
were	VBD	O	O
negative	JJ	O	O
bilaterally	RB	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
cross	NN	I-TEST	I-TEST
extension	NN	I-TEST	I-TEST
reflex	NN	I-TEST	I-TEST
was	VBD	O	O
positive	JJ	O	O
on	IN	O	O
the	DT	O	O
left	NN	O	O
.	.	O	O

complete	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
:	:	O	O

white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cells	NNS	I-TEST	I-TEST
7	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
42.7%	CD	O	O
,	,	O	O
hemoglobin	NN	B-TEST	B-TEST
14.3	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
161	CD	O	O
.	.	O	O

69%	CD	B-TEST	O
polys	NN	I-TEST	B-TEST
,	,	O	O
60%	CD	B-TEST	O
lymphs	NN	I-TEST	B-TEST
,	,	O	O
10%	CD	B-TEST	O
monos	NNS	I-TEST	B-TEST
,	,	O	O
5%	CD	B-TEST	O
eos	NN	I-TEST	B-TEST
.	.	O	O

prothrombin	JJ	B-TEST	B-TEST
time	NN	I-TEST	I-TEST
11.7	CD	O	O
,	,	O	O
partial	JJ	B-TEST	B-TEST
thromboplastin	NN	I-TEST	I-TEST
time	NN	I-TEST	I-TEST
30.4	CD	O	O
.	.	O	O

over	IN	B-TEST	O
100	CD	I-TEST	O
red	JJ	I-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cells	NNS	I-TEST	I-TEST
per	IN	O	O
high	JJ	O	O
powered	JJ	O	O
field	NN	O	O
,	,	O	O
20-50	JJ	B-TEST	O
white	JJ	I-TEST	O
blood	NN	I-TEST	O
cells	NNS	I-TEST	O
per	IN	O	O
high	JJ	O	O
powered	JJ	O	O
field	NN	O	O
.	.	O	O

sodium	NN	B-TEST	B-TEST
139	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.7	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
106	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
21.6	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
22	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
1.6	CD	O	O
,	,	O	O
glucose	RB	B-TEST	B-TEST
107	CD	O	O
,	,	O	O
amylase	NN	B-TEST	B-TEST
120	CD	O	O
,	,	O	O
calcium	NN	B-TEST	B-TEST
8.7	CD	O	O
,	,	O	O
phosphorus	NN	B-TEST	B-TEST
3.3	CD	O	O
,	,	O	O
magnesium	NN	B-TEST	B-TEST
1.9	CD	O	O
,	,	O	O
total	JJ	B-TEST	B-TEST
protein	NN	I-TEST	I-TEST
7.5	CD	O	O
,	,	O	O
albumin	RB	B-TEST	B-TEST
3.9	CD	O	O
,	,	O	O
globulin	NN	B-TEST	B-TEST
3.6	CD	O	O
,	,	O	O
uric	JJ	B-TEST	B-TEST
acid	NN	I-TEST	I-TEST
5.6	CD	O	O
,	,	O	O
alkaline	JJ	B-TEST	B-TEST
phosphatase	NN	I-TEST	I-TEST
43	CD	O	O
,	,	O	O
got	VBD	B-TEST	O
42	CD	O	O
,	,	O	O
ldh	VBD	B-TEST	O
549	CD	O	O
with	IN	O	O
hemolyzed	JJ	B-TEST	B-PROBLEM
sample	NN	I-TEST	I-PROBLEM
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
revealed	VBD	O	O
no	DT	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

electrocardiogram	NN	B-TEST	B-TEST
revealed	VBD	O	O
q-waves	NNS	B-PROBLEM	O
in	IN	I-PROBLEM	O
leads	NNS	I-PROBLEM	O
ii	RB	I-PROBLEM	O
,	,	I-PROBLEM	O
iii	NN	I-PROBLEM	O
and	CC	I-PROBLEM	O
avf	NN	I-PROBLEM	O
.	.	O	O

a	DT	B-TEST	B-TEST
computerized	JJ	I-TEST	I-TEST
tomography	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
revealed	VBD	O	O
right	JJ	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
occipital	JJ	I-PROBLEM	I-PROBLEM
low-density	JJ	I-PROBLEM	I-PROBLEM
area	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

head	NN	B-TEST	B-TEST
magnetic	JJ	I-TEST	I-TEST
resonance	NN	I-TEST	I-TEST
imaging	NN	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
and	CC	O	O
magnetic	JJ	B-TEST	B-TEST
resonance	NN	I-TEST	I-TEST
imaging	VBG	I-TEST	I-TEST
angiogram	NN	I-TEST	I-TEST
obtained	VBN	O	O
on	IN	O	O
may	MD	O	O
11	CD	O	O
,	,	O	O
1995	CD	O	O
,	,	O	O
revealed	VBD	O	O
subacute	NN	B-PROBLEM	B-PROBLEM
right	RB	I-PROBLEM	I-PROBLEM
lateral	JJ	I-PROBLEM	I-PROBLEM
occipital	JJ	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
decreased	VBD	B-PROBLEM	B-PROBLEM
flow	NN	I-PROBLEM	I-PROBLEM
related	VBN	I-PROBLEM	O
enhancement	NN	I-PROBLEM	O
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
left	NN	I-PROBLEM	O
posterior	JJ	I-PROBLEM	O
communicating	VBG	I-PROBLEM	O
artery	NN	I-PROBLEM	O
with	IN	O	O
respect	NN	O	O
to	TO	O	O
that	DT	O	O
on	IN	O	O
the	DT	O	O
right	NN	O	O
.	.	O	O

the	DT	O	O
right	NN	O	O
suggested	VBD	O	O
decreased	JJ	B-PROBLEM	B-PROBLEM
flow	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

carotid	NN	B-TEST	B-TEST
noninvasives	NNS	I-TEST	I-TEST
revealed	VBD	O	O
minimal	JJ	B-PROBLEM	B-PROBLEM
carotid	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

transcranial	JJ	B-TEST	O
dopplers	NNS	I-TEST	O
:	:	O	O

holter	NN	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
:	:	O	O

no	DT	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
arrhythmias	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

electroencephalogram	NN	B-TEST	B-TEST
:	:	O	O

visual	JJ	B-TEST	B-TEST
field	NN	I-TEST	I-TEST
testing	NN	I-TEST	I-TEST
:	:	O	O

small	JJ	B-PROBLEM	B-PROBLEM
wedge-shaped	JJ	I-PROBLEM	I-PROBLEM
visual	JJ	I-PROBLEM	I-PROBLEM
field	NN	I-PROBLEM	I-PROBLEM
defect	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
right	JJ	I-PROBLEM	O
eye	NN	I-PROBLEM	O
,	,	O	O
suggesting	VBG	O	B-PROBLEM
retinal	JJ	B-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

echocardiogram	NN	B-TEST	B-TEST
revealing	VBG	O	O
segmental	JJ	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
dysfunction	NN	I-PROBLEM	I-PROBLEM
involving	VBG	O	O
inferoseptal	JJ	O	O
,	,	O	O
inferior	JJ	O	B-PROBLEM
and	CC	O	I-PROBLEM
posterior	JJ	O	I-PROBLEM
segments	NNS	O	I-PROBLEM
at	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
base	NN	O	I-PROBLEM
and	CC	O	O
mid	JJ	O	B-PROBLEM
ventricular	JJ	O	I-PROBLEM
level	NN	O	I-PROBLEM
.	.	O	O

overall	JJ	B-TEST	O
left	VBD	I-TEST	O
ventricle	NN	I-TEST	O
systolic	JJ	I-TEST	O
function	NN	I-TEST	O
moderately	RB	B-PROBLEM	O
impaired	JJ	I-PROBLEM	O
with	IN	O	O
and	CC	B-TEST	O
estimated	VBN	I-TEST	O
ejection	NN	I-TEST	O
fraction	NN	I-TEST	O
of	IN	O	O
35%	CD	O	O
.	.	O	O

otherwise	RB	O	O
,	,	O	O
there	EX	O	O
was	VBD	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
tricuspid	JJ	B-PROBLEM	B-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
mitral	JJ	B-PROBLEM	B-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
aortic	JJ	B-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
were	VBD	O	O
no	DT	O	O
clots	NNS	B-PROBLEM	B-PROBLEM
seen	VBN	O	O
on	IN	O	O
the	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
occipital	JJ	I-PROBLEM	I-PROBLEM
cerebral	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
heparin	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
had	VBD	O	O
the	DT	B-TEST	B-TEST
studies	NNS	I-TEST	I-TEST
as	IN	O	O
described	VBN	O	O
above	IN	O	O
for	IN	O	O
rule	NN	O	O
out	IN	O	O
source	NN	O	O
of	IN	O	O
embolic	JJ	B-PROBLEM	B-PROBLEM
strokes	NNS	I-PROBLEM	I-PROBLEM
including	VBG	O	O
carotid	NN	B-TEST	B-PROBLEM
noninvasives	NNS	I-TEST	I-PROBLEM
,	,	O	O
transcranial	JJ	B-TEST	B-TEST
dopplers	NNS	I-TEST	I-TEST
,	,	O	O
holter	NN	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
and	CC	O	O
echocardiogram	NN	B-TEST	B-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
had	VBD	O	O
serial	JJ	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
,	,	O	O
which	WDT	O	O
showed	VBD	O	O
no	DT	O	O
change	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
had	VBD	O	O
serial	JJ	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
kinase	NN	I-TEST	I-TEST
with	IN	I-TEST	I-TEST
mb	JJ	I-TEST	I-TEST
fractions	NNS	I-TEST	I-TEST
studied	VBN	O	O
,	,	O	O
which	WDT	O	O
revealed	VBD	O	O
mb	NNS	B-TEST	O
fraction	NN	I-TEST	O
too	RB	B-PROBLEM	O
low	JJ	I-PROBLEM	O
to	TO	O	O
be	VB	O	O
tested	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
experienced	VBD	O	O
a	DT	O	O
feeling	NN	O	O
of	IN	O	O
moving	VBG	O	O
back	RB	O	O
and	CC	O	O
forth	NN	O	O
when	WRB	O	O
lying	VBG	O	O
down	RP	O	O
with	IN	O	O
neck	NN	O	O
extended	VBN	O	O
during	IN	O	O
the	DT	B-TEST	B-TEST
magnetic	JJ	I-TEST	I-TEST
resonance	NN	I-TEST	I-TEST
imaging	NN	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
and	CC	O	O
also	RB	O	O
in	IN	O	O
bed	NN	O	O
.	.	O	O

this	DT	B-PROBLEM	B-PROBLEM
moving	VBG	I-PROBLEM	I-PROBLEM
sense	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
normal	JJ	O	O
electroencephalogram	NN	O	O
,	,	O	O
was	VBD	O	O
thought	VBN	O	O
to	TO	O	O
be	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
mild	JJ	I-PROBLEM	I-PROBLEM
vestibular	JJ	I-PROBLEM	I-PROBLEM
dysfunction	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
from	IN	O	O
the	DT	O	O
acute	JJ	O	O
episode	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
stroke	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
have	VB	O	O
these	DT	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
only	RB	O	O
when	WRB	O	O
the	DT	O	O
eyes	NNS	O	O
are	VBP	O	O
closed	VBN	O	O
.	.	O	O

our	PRP$	O	O
opinion	NN	O	O
was	VBD	O	O
not	RB	O	O
to	TO	O	O
intervene	VB	O	O
or	CC	O	O
have	VB	O	O
any	DT	B-TEST	B-PROBLEM
further	JJ	I-TEST	I-PROBLEM
studies	NNS	I-TEST	I-PROBLEM
for	IN	O	O
acute	JJ	O	B-PROBLEM
period	NN	O	I-PROBLEM
and	CC	O	O
to	TO	O	O
continued	VB	O	O
to	TO	O	O
observe	VB	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
did	VBD	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
hypotensive	JJ	I-PROBLEM	I-PROBLEM
episode	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
the	DT	B-TEST	B-TEST
systolic	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
80	CD	O	O
,	,	O	O
after	IN	O	O
the	DT	O	O
patient	NN	O	O
received	VBD	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
regular	JJ	I-TREATMENT	I-TREATMENT
cardiac	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
been	VBN	O	O
off	RP	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
regular	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
since	IN	O	O
during	IN	O	O
the	DT	O	O
admission	NN	O	O
and	CC	O	O
will	MD	O	O
be	VB	O	O
discharged	VBN	O	O
off	RP	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

otherwise	RB	O	O
,	,	O	O
there	EX	O	O
were	VBD	O	O
no	DT	O	O
further	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
blurred	JJ	B-PROBLEM	B-PROBLEM
vision	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
stable	JJ	O	O
with	IN	O	O
an	DT	O	B-PROBLEM
unchanged	JJ	O	I-PROBLEM
neurological	JJ	B-TEST	I-PROBLEM
and	CC	I-TEST	O
physical	JJ	I-TEST	B-TEST
examination	NN	I-TEST	I-TEST
and	CC	O	O
was	VBD	O	O
discharged	VBN	O	O
on	IN	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
,	,	O	O
on	IN	O	O
may	MD	O	O
14	CD	O	O
,	,	O	O
1995	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
stable	JJ	O	O
with	IN	O	O
the	DT	B-TEST	B-TEST
physical	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
as	IN	O	O
described	VBN	O	O
above	IN	O	O
.	.	O	O

medications	NNS	B-TREATMENT	B-TREATMENT
-	:	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
,	,	O	O
glipizide	RB	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NNS	O	O
po	JJ	O	O
qd	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
be	VB	O	O
discharged	VBN	O	O
home	NN	O	O
without	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
regular	JJ	I-TREATMENT	I-TREATMENT
cardiac	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
also	RB	O	O
be	VB	O	O
followed	VBN	O	O
by	IN	O	O
his	PRP$	O	O
regular	JJ	O	O
urologist	NN	O	O
at	IN	O	O
ochtuheihugh	IN	O	O
put	NN	O	O
university	NN	O	O
medical	JJ	O	O
center	NN	O	O
within	IN	O	O
one	CD	O	O
week	NN	O	O
after	IN	O	O
discharge	NN	O	O
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
continuing	VBG	I-PROBLEM	I-PROBLEM
hematuria	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

in	IN	O	O
brief	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
64	CD	O	O
-	:	O	O
year-old	JJ	O	O
male	NN	O	O
with	IN	O	O
a	DT	O	O
significant	JJ	O	O
history	NN	O	O
for	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
three	CD	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarctions	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
also	RB	O	O
status	NN	O	O
post	NN	O	O
five	CD	B-TREATMENT	B-TREATMENT
vessel	NN	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
'	POS	O	O
89	CD	O	O
and	CC	O	O
status	NN	O	B-TREATMENT
post	NN	O	I-TREATMENT
multiple	RB	B-TREATMENT	I-TREATMENT
percutaneous	JJ	I-TREATMENT	I-TREATMENT
transluminal	JJ	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
angioplasties	NNS	I-TREATMENT	I-TREATMENT
who	WP	O	O
recently	RB	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
done	VBN	O	O
in	IN	O	O
mississippi	NN	O	O
and	CC	O	O
stent	NN	B-TREATMENT	B-TREATMENT
placed	VBN	O	O
in	IN	O	O
2013-03-24	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
did	VBD	O	O
well	RB	O	O
until	IN	O	O
approximately	RB	O	O
three	CD	O	O
to	TO	O	O
four	CD	O	O
weeks	NNS	O	O
prior	RB	O	O
to	TO	O	O
presentation	NN	O	O
when	WRB	O	O
he	PRP	O	O
began	VBD	O	O
to	TO	O	O
experience	VB	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
exertion	NN	O	O
.	.	O	O

one	CD	O	O
week	NN	O	O
prior	RB	O	O
to	TO	O	O
presentation	NN	O	O
,	,	O	O
he	PRP	O	O
had	VBD	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
leading	VBG	O	O
to	TO	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
at	IN	O	O
springfield	NN	O	O
on	IN	O	O
07-30	NN	O	O
which	WDT	O	O
showed	VBD	O	O
narrowing	NN	B-PROBLEM	O
of	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
an	DT	B-TEST	B-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
approximately	RB	O	O
20%	CD	O	O
.	.	O	O

no	DT	O	O
intervention	NN	B-TREATMENT	O
was	VBD	O	O
done	VBN	O	O
at	IN	O	O
that	DT	O	O
point	NN	O	O
.	.	O	O

on	IN	O	O
the	DT	O	O
evening	NN	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
awoken	VBN	O	O
with	IN	O	O
chest	JJ	B-PROBLEM	B-PROBLEM
pressure	NN	I-PROBLEM	I-PROBLEM
radiating	VBG	O	I-PROBLEM
to	TO	O	I-PROBLEM
the	DT	O	I-PROBLEM
neck	NN	O	I-PROBLEM
anginal	JJ	O	I-PROBLEM

equivalent	NN	O	O
which	WDT	O	O
was	VBD	O	O
relieved	VBN	O	O
by	IN	O	O
sublingual	JJ	B-TREATMENT	B-TREATMENT
nitroglycerin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

this	DT	O	O
episode	NN	O	O
happened	VBD	O	O
three	CD	O	O
times	NNS	O	O
that	WDT	O	O
night	NN	O	O
and	CC	O	O
finally	RB	O	O
on	IN	O	O
the	DT	O	O
fourth	JJ	O	O
re-awakening	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
presented	VBD	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
department	NN	O	O
at	IN	O	O
springfield	NN	O	O
and	CC	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
faulkner	NN	O	O
hospital	NN	O	O
for	IN	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
revascularization	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

1.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM

2.	CD	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
x3	NN	I-PROBLEM	O

3.	CD	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT

4.	CD	O	O
systemic	JJ	B-PROBLEM	B-PROBLEM
lupus	NN	I-PROBLEM	I-PROBLEM
erythematosus	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
remission	NN	O	I-PROBLEM

1.	CD	O	O
coreg	NN	B-TREATMENT	O
6.25	CD	O	O
mg	NN	O	O
po	NN	O	O
bid	NN	O	O

2.	CD	O	O
lasix	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O

3.	CD	O	O
imdur	JJ	B-TREATMENT	B-TREATMENT
30	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O

4.	CD	O	O
k-dur	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
milliequivalents	NNS	O	O
po	JJ	O	O
qd	NN	O	O

5.	CD	O	O
zestril	NN	B-TREATMENT	B-TREATMENT
2.5	CD	O	O
mg	NN	O	O
po	NN	O	O
bid	NN	O	O

6.	CD	O	O
multivitamin	NN	B-TREATMENT	B-TREATMENT

7.	CD	O	O
folate	NN	B-TREATMENT	B-TREATMENT

he	PRP	O	O
has	VBZ	O	O
no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
stable	JJ	O	O
vital	JJ	O	O
signs	NNS	O	O

regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
with	IN	O	O
a	DT	B-PROBLEM	O
2	CD	I-PROBLEM	O
out	IN	I-PROBLEM	O
of	IN	I-PROBLEM	O
6	CD	I-PROBLEM	B-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
ejection	NN	I-PROBLEM	I-PROBLEM
murmur	FW	I-PROBLEM	I-PROBLEM
heard	NN	O	O
loudest	NN	O	O
at	IN	O	O
the	DT	O	O
apex	NN	O	O
.	.	O	O

clear	JJ	O	O
to	TO	O	O
auscultation	NN	B-TEST	B-TEST
.	.	O	O

soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
clubbing	VBG	B-PROBLEM	B-PROBLEM
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
44	CD	O	O
.	.	O	O

white	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
8	CD	O	O
.	.	O	O

potassium	NN	B-TEST	B-TEST
was	VBD	O	O
3.9	CD	O	O
.	.	O	O

bun	NN	B-TEST	B-TEST
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
was	VBD	O	O
18	CD	O	O
and	CC	O	O
0.9	CD	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
troponin	NN	I-TEST	I-TEST
was	VBD	O	O
29.7	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
medically	RB	O	O
managed	VBN	O	O
initially	RB	O	O
and	CC	O	O
then	RB	O	O
underwent	JJ	O	O
on	IN	O	O
2013-08-09	JJ	O	O
,	,	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	VBG	I-TREATMENT	I-TREATMENT
x2	NNP	O	I-TREATMENT
and	CC	O	O
a	DT	B-TREATMENT	B-TREATMENT
mitral	JJ	I-TREATMENT	I-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
annuloplasty	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
placement	NN	B-TREATMENT	B-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
intra-aortic	JJ	I-TREATMENT	I-TREATMENT
balloon	NN	I-TREATMENT	I-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#1	NNP	O	O
,	,	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
balloon	NN	I-TREATMENT	I-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
weaned	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
at	IN	O	O
2	CD	B-TREATMENT	O
units	NNS	I-TREATMENT	O
of	IN	I-TREATMENT	O
packed	JJ	I-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
also	RB	O	O
began	VBD	O	O
to	TO	O	O
wean	VB	O	O
off	RP	O	O
the	DT	B-TREATMENT	B-TREATMENT
ventilator	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#1	NNP	O	O
in	IN	O	O
the	DT	O	O
evening	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
go	VB	O	O
into	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
for	IN	O	O
which	WDT	O	O
he	PRP	O	O
was	VBD	O	O
controlled	VBN	O	O
and	CC	O	O
started	VBN	O	O
on	IN	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
after	IN	O	O
which	WDT	O	O
he	PRP	O	O
converted	VBD	O	O
again	RB	O	O
to	TO	O	O
normal	JJ	O	O
sinus	NN	O	O
rhythm	NN	O	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
balloon	NN	I-TREATMENT	I-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
had	VBD	O	O
already	RB	O	O
been	VBN	O	O
removed	VBN	O	O
and	CC	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#3	NNP	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
on	IN	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
in	IN	O	O
normal	JJ	O	O
sinus	NN	O	O
rhythm	NN	O	O
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#4	NNP	O	O
,	,	O	O
he	PRP	O	O
remained	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
stable	JJ	O	O
vital	JJ	O	O
signs	NNS	O	O
on	IN	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
25	CD	O	O
mg	JJ	O	O
po	NN	O	O
bid	NN	O	O
and	CC	O	O
an	DT	B-TREATMENT	B-TREATMENT
amiodarone	NN	I-TREATMENT	I-TREATMENT
dose	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
left	JJ	I-TREATMENT	I-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
at	IN	O	O
this	DT	O	O
time	NN	O	O
and	CC	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
removed	VBN	O	O
the	DT	O	O
following	JJ	O	O
day	NN	O	O
on	IN	O	O

he	PRP	O	O
remains	VBZ	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
stable	JJ	O	O
vital	JJ	O	O
signs	NNS	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
ambulating	VBG	O	O
to	TO	O	O
a	DT	O	B-TEST
level	NN	O	I-TEST
5	CD	O	O
with	IN	O	O
physical	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
wishes	NNS	O	O
to	TO	O	O
be	VB	O	O
discharged	VBN	O	O
home	NN	O	O
today	NN	O	O
.	.	O	O

1.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM

2.	CD	O	O
mitral	JJ	B-PROBLEM	B-PROBLEM
valve	NN	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
x2	NN	O	I-TREATMENT
and	CC	O	O
mitral	JJ	B-TREATMENT	B-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
annuloplasty	NN	I-TREATMENT	I-TREATMENT

1.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM

2.	CD	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
x3	NN	O	O

3.	CD	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT

1.	CD	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
po	NN	O	O
bid	NN	O	O

2.	CD	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
taper	NN	I-TREATMENT	I-TREATMENT
400	CD	O	O
mg	NN	O	O
po	NN	O	O
tid	NN	O	O
x4	NNP	O	O
days	NNS	O	O
,	,	O	O
then	RB	O	O
bid	VB	O	O
x7	NNP	O	O
days	NNS	O	O
,	,	O	O
qd	JJ	O	O
x7	NNP	O	O
days	NNS	O	O
,	,	O	O
then	RB	O	O
200	CD	O	O
mg	NNS	O	O
po	JJ	O	O
qd	NN	O	O

3.	CD	O	O
lasix	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O

4.	CD	O	O
k-dur	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
milliequivalents	NNS	O	O
po	JJ	O	O
qd	NN	O	O

5.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
81	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O

6.	CD	O	O
percocet	JJ	B-TREATMENT	B-TREATMENT
1	CD	O	O
to	TO	O	O
2	CD	O	O
po	NNS	O	O
q	RB	O	O
4	CD	O	O
to	TO	O	O
6	CD	O	O
hours	NNS	O	O
prn	NN	O	O

7.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
po	NN	O	O
bid	NN	O	O

8.	CD	O	O
percocet	NN	B-TREATMENT	B-TREATMENT

9.	CD	O	O
protonix	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O

ho	NN	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST

nka	NN	B-PROBLEM	O

pp	NN	B-PROBLEM	B-TEST
/	CD	O	O
pps	NN	B-PROBLEM	O

principal	JJ	O	O
discharge	NN	O	O
diagnosis	NN	O	O
;	:	O	O
responsible	JJ	O	O
after	IN	O	O
study	NN	O	O
for	IN	O	O
causing	VBG	O	O
admission	NN	O	O
)	)	O	O
pp	NN	B-PROBLEM	O

other	JJ	O	O
diagnosis	NN	O	O
;	:	O	O
conditions	NNS	O	O
,	,	O	O
infections	NNS	O	O
,	,	O	O
complications	NNS	O	O
,	,	O	O
affecting	VBG	O	O
treatment	NN	O	O
/	NNP	O	O
stay	NN	O	O
pp	NN	B-PROBLEM	O

epidural	JJ	B-TREATMENT	B-TREATMENT

pps	NN	B-PROBLEM	O
,	,	O	O

bilateral	JJ	B-TREATMENT	B-TREATMENT
tubal	JJ	I-TREATMENT	I-TREATMENT
ligation	NN	I-TREATMENT	I-TREATMENT

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
73	CD	O	O
year	NN	O	O
old	JJ	O	O
male	NN	O	O
with	IN	O	O
a	DT	O	O
recent	JJ	O	O
history	NN	O	O
of	IN	O	O
paroxysmal	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
who	WP	O	O
presented	VBD	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
department	NN	O	O
with	IN	O	O
the	DT	O	O
chief	JJ	O	O
complaint	NN	O	O
of	IN	O	O
syncope	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
discharged	VBN	O	O
from	IN	O	O
the	DT	O	O
hospital	NN	O	O
for	IN	O	O
orthopedics	NNS	O	O
with	IN	O	O
the	DT	O	O
diagnosis	NN	O	O
of	IN	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
embolism	NN	I-PROBLEM	I-PROBLEM
about	IN	O	O
six	CD	O	O
months	NNS	O	O
prior	RB	O	O
to	TO	O	O
the	DT	O	O
current	JJ	O	O
admission	NN	O	O
and	CC	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
warfarin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

one	CD	O	O
month	NN	O	O
prior	RB	O	O
to	TO	O	O
this	DT	O	O
admission	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
reports	VBZ	O	O
not	RB	O	O
feeling	VBG	O	O
well	RB	O	O
with	IN	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
gastric	JJ	I-PROBLEM	I-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	O	O
few	JJ	O	O
weeks	NNS	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
,	,	O	O
he	PRP	O	O
fell	VBD	O	O
down	RB	O	O
on	IN	O	O
his	PRP$	O	O
back	NN	O	O
and	CC	O	O
started	VBD	O	O
taking	VBG	O	O
ibuprofen	NN	B-TREATMENT	B-TREATMENT
1000	CD	O	O
mg	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
vioxx	NN	B-TREATMENT	O
in	IN	O	O
addition	NN	O	O
to	TO	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
aspirin	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
coumadin	JJ	B-TREATMENT	B-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
night	NN	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
found	VBN	O	O
by	IN	O	O
his	PRP$	O	O
wife	NN	O	O
on	IN	O	O
the	DT	O	O
bathroom	NN	O	O
floor	NN	O	O
in	IN	O	O
a	DT	O	B-TEST
pool	NN	O	I-TEST
of	IN	O	I-TEST
urine	NN	O	I-TEST
,	,	O	O
unresponsive	JJ	B-PROBLEM	B-PROBLEM
without	IN	O	O
any	DT	O	O
body	NN	O	O
movements	NNS	O	O
,	,	O	O
post-ictal	JJ	B-PROBLEM	B-PROBLEM
state	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
reports	VBZ	O	O
some	DT	B-PROBLEM	B-PROBLEM
nausea	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
epigastric	JJ	B-PROBLEM	B-TEST
pressure	NN	I-PROBLEM	I-TEST
which	WDT	O	O
is	VBZ	O	O
post-prandial	JJ	O	O
.	.	O	O

he	PRP	O	O
denies	VBZ	O	O
any	DT	O	O
emesis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
melena	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
constipation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

denies	NNS	O	O
incontinence	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
does	VBZ	O	O
have	VB	O	O
diaphoresis	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
weakness	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
orthostatic	JJ	O	B-PROBLEM
changes	NNS	O	I-PROBLEM
.	.	O	O

in	IN	O	O
the	DT	O	O
emergency	NN	O	O
department	NN	O	O
,	,	O	O
stool	NN	B-TEST	B-TEST
guaiac	NN	I-TEST	I-TEST
was	VBD	O	O
trace	JJ	B-PROBLEM	B-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

hematocrit	NN	B-TEST	B-TEST
was	VBD	O	O
24.8	CD	O	O
,	,	O	O
with	IN	O	O
a	DT	O	O
baseline	NN	O	O
of	IN	O	O
46	CD	O	O
.	.	O	O

gastric	JJ	B-TREATMENT	B-TEST
lavage	NN	I-TREATMENT	I-TEST
was	VBD	O	O
grossly	RB	O	O
positive	JJ	O	O
for	IN	O	O
coffee	NN	B-PROBLEM	B-PROBLEM
ground	NN	I-PROBLEM	I-PROBLEM
material	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
inr	NN	I-TEST	I-TEST
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
4.4	CD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
given	VBN	O	O
vitamin	JJ	B-TREATMENT	B-TREATMENT
k	NN	I-TREATMENT	I-TREATMENT
10	CD	O	O
mg	NN	O	O
subcutaneously	RB	O	O
,	,	O	O
2.5	CD	O	O
liters	NNS	O	O
of	IN	O	O
normal	JJ	B-TREATMENT	B-TREATMENT
saline	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
two	CD	O	O
units	NNS	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
two	CD	O	O
units	NNS	O	O
of	IN	O	O
fresh	JJ	B-TREATMENT	B-TREATMENT
frozen	JJ	I-TREATMENT	I-TREATMENT
plasma	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
transferred	VBD	O	O
to	TO	O	O
the	DT	O	O
medical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
further	JJ	O	B-TREATMENT
management	NN	O	I-TREATMENT
.	.	O	O

1.	CD	O	O
hyperthyroid	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
status	NN	O	O
post	NN	O	O
radioactive	JJ	B-TREATMENT	B-TREATMENT
iodine	NN	I-TREATMENT	I-TREATMENT
ablation	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
now	RB	O	O
hypothyroid	VBZ	B-PROBLEM	O
on	IN	O	O
levoxyl	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

2.	CD	O	O
history	NN	O	O
of	IN	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
embolism	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
etiology	NN	O	O
unknown	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
five	CD	O	O
months	NNS	O	O
prior	RB	O	O
to	TO	O	O
this	DT	O	O
admission	NN	O	O
.	.	O	O

3.	CD	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

well	RB	O	O
controlled	VBN	O	O
on	IN	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

last	JJ	B-TEST	B-TEST
total	JJ	I-TEST	I-TEST
cholesterol	NN	I-TEST	I-TEST
was	VBD	O	O
168	CD	O	O
in	IN	O	O
2015-08-24	JJ	O	O
.	.	O	O

4.	CD	O	O
paroxysmal	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
embolism	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
only	RB	O	O
significant	JJ	O	O
for	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
inguinal	JJ	I-TREATMENT	I-TREATMENT
hernia	NN	I-TREATMENT	I-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

penicillin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

1.	CD	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
three	CD	O	O
times	NNS	O	O
a	DT	O	O
week	NN	O	O
.	.	O	O

2.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
81	CD	O	O
.	.	O	O

3.	CD	O	O
propranolol	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
three	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

4.	CD	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
6.25	CD	O	O
mg	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

5.	CD	O	O
levoxyl	JJ	B-TREATMENT	B-TREATMENT
100	CD	O	O
meq	JJ	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

6.	CD	O	O
ambien	JJ	B-TREATMENT	O
p.r.n.	NN	O	O

7.	CD	O	O
vitamins	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

8.	CD	O	O
vioxx	NN	B-TREATMENT	O
times	NNS	O	O
three	CD	O	O
weeks	NNS	O	O
.	.	O	O

significant	JJ	O	O
for	IN	O	O
mother	NN	O	O
who	WP	O	O
has	VBZ	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
and	CC	O	I-PROBLEM
stroke	NN	B-PROBLEM	I-PROBLEM
at	IN	O	O
the	DT	O	O
age	NN	O	O
of	IN	O	O
70	CD	O	O
.	.	O	O

temperature	NN	B-TEST	B-TEST
was	VBD	O	O
100.3	CD	O	O
f.	NN	O	O
;	:	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
was	VBD	O	O
115	CD	O	O
.	.	O	O

in	IN	O	O
general	JJ	O	O
,	,	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pupils	NNS	O	O
equally	RB	O	O
round	VBP	O	O
and	CC	O	O
reactive	VBP	O	O
to	TO	O	O
light	NN	B-TEST	O
and	CC	O	O
accommodation	NN	B-TEST	O
bilaterally	RB	O	O
.	.	O	O

regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
normal	JJ	O	O
s1	NN	O	O
,	,	O	O
s2	NN	O	O
,	,	O	O
no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
rubs	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
gallops	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

pulmonary	JJ	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
anteriorly	RB	O	O
.	.	O	O

abdomen	NNS	O	O
soft	JJ	O	O
,	,	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
distended	VBD	I-PROBLEM	I-PROBLEM
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
positive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
.	.	O	O

extremities	NNS	O	O
with	IN	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
one	CD	O	O
to	TO	O	O
two	CD	O	O
pulses	NNS	O	B-TEST
in	IN	O	O
all	DT	O	O
four	CD	O	O
extremities	NNS	O	O
.	.	O	O

sodium	NN	B-TEST	B-TEST
141	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.4	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
108	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
23	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
57	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
0.7	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
115	CD	O	O
.	.	O	O

white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
11.0	CD	O	O
,	,	O	O
differential	NN	B-TEST	O
with	IN	O	O
76	CD	O	O
neutrophils	NNS	B-TEST	B-TEST
,	,	O	O
2	CD	O	O
monos	NNS	B-TEST	B-TEST
,	,	O	O
21	CD	O	O
lymphocytes	NNS	B-TEST	B-TEST
,	,	O	O
and	CC	O	O
no	DT	O	O
eosinophils	NNS	B-TEST	B-PROBLEM
.	.	O	O

hematocrit	NN	B-TEST	B-TEST
24.8	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
223	CD	O	O
,	,	O	O
inr	NN	B-TEST	B-TEST
2.4	CD	O	O
,	,	O	O
ck	NN	B-TEST	B-TEST
234	CD	O	O
.	.	O	O

ct	JJ	B-TEST	B-TEST
scan	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
showed	VBD	O	O
no	DT	O	O
hemorrhage	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

ekg	RB	B-TEST	O
showed	VBD	O	O
normal	JJ	O	O
sinus	NN	O	O
rhythm	NN	O	O
at	IN	O	O
90	CD	O	O
with	IN	O	O
normal	JJ	O	O
intervals	NNS	O	O
and	CC	O	O
st	NNS	B-PROBLEM	B-PROBLEM
wave	VBP	I-PROBLEM	I-PROBLEM
inversions	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
early	JJ	B-PROBLEM	B-PROBLEM
r	NN	I-PROBLEM	I-PROBLEM
wave	NN	I-PROBLEM	I-PROBLEM
progression	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
medical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
further	JJ	O	B-TREATMENT
management	NN	O	I-TREATMENT
for	IN	O	O
acute	NN	B-PROBLEM	B-PROBLEM
gi	NN	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
gastrointestinal	JJ	B-PROBLEM	B-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

the	DT	O	O
patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
receive	VB	O	O
blood	NN	B-TREATMENT	B-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
on	IN	O	O
the	DT	O	O
floor	NN	O	O
and	CC	O	O
serial	JJ	B-TEST	B-PROBLEM
hematocrits	NNS	I-TEST	I-PROBLEM
with	IN	O	O
serial	JJ	B-TEST	B-TEST
inr	NN	I-TEST	I-TEST
checks	NNS	I-TEST	I-TEST
were	VBD	O	O
drawn	VBN	O	O
.	.	O	O

as	IN	O	O
he	PRP	O	O
was	VBD	O	O
receiving	VBG	O	O
his	PRP$	O	B-TREATMENT
third	JJ	O	I-TREATMENT
unit	NN	O	I-TREATMENT
of	IN	O	I-TREATMENT
packed	JJ	B-TREATMENT	I-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
the	DT	O	O
patient	NN	O	O
became	VBD	O	O
tachycardic	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
short	JJ	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
raised	VBD	O	O
from	IN	O	O
98.6	CD	O	O
f.	NN	O	O
,	,	O	O
to	TO	O	O
101.0	CD	O	O
f.	NNS	O	O

he	PRP	O	O
was	VBD	O	O
shown	VBN	O	O
to	TO	O	O
have	VB	O	O
rigors	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	B-TEST
transfusion	NN	I-TREATMENT	I-TEST
was	VBD	O	O
stopped	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
given	VBN	O	O
tylenol	RB	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	NN	O	O
with	IN	O	O
epinephrine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
100	CD	O	O
mg	NN	O	O
of	IN	O	O
hydrocortisone	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
25	CD	O	O
mg	NN	O	O
of	IN	O	O
benadryl	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
demerol	NN	B-TREATMENT	B-TREATMENT
15	CD	I-TREATMENT	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
pepcid	NN	B-TREATMENT	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
emesis	NN	B-PROBLEM	B-PROBLEM
times	NNS	O	O
three	CD	O	O
of	IN	O	O
75	CD	O	O
cc	NN	O	O
of	IN	O	O
coffee	NN	B-PROBLEM	B-PROBLEM
ground	NN	I-PROBLEM	I-PROBLEM
material	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
desaturated	VBD	O	O
to	TO	O	O
the	DT	O	O
low	JJ	O	O
80	CD	O	O
s	NN	O	O
and	CC	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
non-rebreather	JJ	I-TREATMENT	I-TREATMENT
mask	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-TEST	B-TEST
saturations	NNS	I-TEST	I-TEST
improved	VBN	O	O
quickly	RB	O	O
on	IN	O	O
100%	CD	B-TREATMENT	B-TREATMENT
non-rebreather	JJ	I-TREATMENT	I-TREATMENT
mask	NN	I-TREATMENT	I-TREATMENT
within	IN	O	O
15	CD	O	O
to	TO	O	O
20	CD	O	O
minutes	NNS	O	O
.	.	O	O

shortly	RB	O	O
after	IN	O	O
his	PRP$	O	O
mental	JJ	O	O
status	NN	O	O
changed	VBD	O	O
;	:	O	O
he	PRP	O	O
became	VBD	O	O
disoriented	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
euphoric	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
continued	VBD	O	O
to	TO	O	O
be	VB	O	O
in	IN	O	O
this	DT	O	O
state	NN	O	O
for	IN	O	O
two	CD	O	O
more	JJR	O	O
hours	NNS	O	O
.	.	O	O

after	IN	O	O
that	DT	O	O
period	NN	O	O
of	IN	O	O
time	NN	O	O
,	,	O	O
his	PRP$	O	O
mental	JJ	O	O
status	NN	O	O
gradually	RB	O	O
improved	VBN	O	O
and	CC	O	O
he	PRP	O	O
continued	VBD	O	O
to	TO	O	O
receive	VB	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
requiring	VBG	O	O
a	DT	O	O
total	NN	O	O
of	IN	O	O
ten	JJ	O	O
units	NNS	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
four	CD	O	O
units	NNS	O	O
of	IN	O	O
fresh	JJ	B-TREATMENT	B-TREATMENT
frozen	JJ	I-TREATMENT	I-TREATMENT
plasma	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
reach	VB	O	O
a	DT	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
of	IN	O	O
30.0	CD	O	O
,	,	O	O
which	WDT	O	O
remained	VBD	O	O
stable	JJ	O	O
for	IN	O	O
the	DT	O	O
duration	NN	O	O
of	IN	O	O
his	PRP$	O	O
stay	NN	O	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
high	JJ	B-TREATMENT	B-TREATMENT
dose	JJ	I-TREATMENT	I-TREATMENT
proton	NN	I-TREATMENT	I-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
inhibitors	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
prophylaxis	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

on	IN	O	O
wednesday	NN	O	O
,	,	O	O
11-25	JJ	O	O
,	,	O	O
an	DT	B-TEST	B-TEST
esophagogastroduodenoscopy	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
and	CC	O	O
was	VBD	O	O
significant	JJ	O	O
for	IN	O	O
the	DT	O	O
following	JJ	O	O
findings	NNS	O	O
:	:	O	O

medium	NN	B-PROBLEM	B-TREATMENT
hiatal	NN	I-PROBLEM	I-TREATMENT
hernia	NN	I-PROBLEM	I-TREATMENT
,	,	O	O
barrett's	NN	B-PROBLEM	B-PROBLEM
esophagus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
erosion	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
gastroesophageal	JJ	I-PROBLEM	I-PROBLEM
junction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
granularity	NN	B-PROBLEM	O
,	,	O	O
erythema	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
congestion	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
antrum	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
pre-pyloric	JJ	O	I-PROBLEM
region	NN	O	I-PROBLEM
compatible	JJ	O	O
with	IN	O	O
gastritis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

erosions	NNS	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
antrum	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
pre-pyloric	JJ	I-PROBLEM	B-PROBLEM
region	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
granularity	NN	B-PROBLEM	O
,	,	O	O
erythema	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
congestion	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
bulb	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
posterior	JJ	I-PROBLEM	I-PROBLEM
bulb	NN	I-PROBLEM	I-PROBLEM
compatible	JJ	O	O
with	IN	O	O
duodenitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

it	PRP	O	O
was	VBD	O	O
recommended	VBN	O	O
by	IN	O	O
gastroenterology	NN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
to	TO	O	O
stay	VB	O	O
off	RP	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
at	IN	O	O
least	JJS	O	O
four	CD	O	O
to	TO	O	O
six	CD	O	O
weeks	NNS	O	O
at	IN	O	O
discharge	NN	O	O
to	TO	O	O
prevent	VB	O	O
further	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

during	IN	O	O
transfusion	NN	B-PROBLEM	B-PROBLEM
reaction	NN	I-PROBLEM	I-PROBLEM
episode	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
an	DT	O	O
episode	NN	O	O
of	IN	O	O
tachycardia	NN	B-PROBLEM	B-PROBLEM
ranging	VBG	O	O
from	IN	O	O
134	CD	O	O
to	TO	O	O
158	CD	O	O
,	,	O	O
for	IN	O	O
one	CD	O	O
to	TO	O	O
two	CD	O	O
hours	NNS	O	O
.	.	O	O

ekg	NN	B-TEST	O
during	IN	O	O
this	DT	O	O
episode	NN	O	O
was	VBD	O	O
taken	VBN	O	O
and	CC	O	O
showed	VBN	O	O
sinus	JJ	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
however	RB	O	O
,	,	O	O
serial	JJ	B-TEST	B-TEST
enzymes	NNS	I-TEST	I-TEST
were	VBD	O	O
significant	JJ	O	O
for	IN	O	O
ck	NN	B-TEST	O
peaking	NN	O	O
at	IN	O	O
1075	CD	O	O
,	,	O	O
mb	FW	B-TEST	O
peaking	VBG	O	O
at	IN	O	O
114	CD	O	O
and	CC	O	O
mb	JJ	B-TEST	B-TEST
index	NN	I-TEST	I-TEST
peaking	VBG	O	O
at	IN	O	O
10.8	CD	O	O
,	,	O	O
consistent	NN	O	O
with	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
damage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
day	NN	O	O
following	VBG	O	O
this	DT	O	O
episode	NN	O	O
,	,	O	O
ekg	NN	B-TEST	O
showed	VBD	O	O
loss	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
r	NN	I-PROBLEM	I-PROBLEM
wave	VBP	I-PROBLEM	I-PROBLEM
progression	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
anterior	JJ	O	I-PROBLEM
leads	NNS	O	I-PROBLEM
and	CC	O	O
q	NN	B-PROBLEM	O
waves	NNS	I-PROBLEM	O
in	IN	I-PROBLEM	O
leads	NNS	I-PROBLEM	O
iii	NNS	I-PROBLEM	O
and	CC	O	O
avf	JJ	B-PROBLEM	O
consistent	NN	O	O
with	IN	O	O
anteroseptal	JJ	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
pressures	NNS	I-TEST	I-TEST
remained	VBD	O	O
stable	JJ	O	O
during	IN	O	O
his	PRP$	O	O
stay	NN	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
no	DT	O	O
episodes	NNS	O	O
of	IN	O	O
arrhythmia	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
telemetry	NN	B-TEST	B-TEST
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
attributed	VBN	O	O
to	TO	O	O
demand	VB	B-PROBLEM	B-PROBLEM
ischemia	JJ	I-PROBLEM	I-PROBLEM
secondary	JJ	O	O
to	TO	O	O
acute	VB	B-PROBLEM	B-PROBLEM
hematocrit	JJ	I-PROBLEM	I-PROBLEM
drop	NN	I-PROBLEM	I-PROBLEM
exacerbated	VBN	O	O
by	IN	O	O
tachycardia	NN	B-PROBLEM	B-PROBLEM
secondary	JJ	O	O
to	TO	O	O
blood	VB	B-PROBLEM	O
transfusion	NN	I-PROBLEM	B-PROBLEM
reaction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

further	JJ	B-TEST	B-TEST
cardiologic	VBD	I-TEST	I-TEST
work-up	NN	I-TEST	I-TEST
was	VBD	O	O
suggested	VBN	O	O
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
at	IN	O	O
four	CD	O	O
to	TO	O	O
six	CD	O	O
weeks	NNS	O	O
post	RB	O	O
discharge	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
lisinopril	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

3.	CD	O	O
after	IN	O	O
ten	JJ	O	O
units	NNS	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
four	CD	O	O
units	NNS	O	O
of	IN	O	O
fresh	JJ	B-TREATMENT	B-TREATMENT
frozen	JJ	I-TREATMENT	I-TREATMENT
plasma	NN	I-TREATMENT	I-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
hematocrit	NN	I-TEST	I-TEST
remained	VBD	O	O
stable	JJ	O	O
at	IN	O	O
above	IN	O	O
30	CD	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
inr	NN	I-TEST	I-TEST
decreased	VBD	O	O
to	TO	O	O
1.3	CD	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

he	PRP	O	O
required	VBD	O	O
no	DT	O	B-TREATMENT
blood	NN	B-TREATMENT	I-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
four	CD	O	O
days	NNS	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

4.	CD	O	O
history	NN	O	O
of	IN	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
embolism	NN	I-PROBLEM	I-PROBLEM
likely	RB	O	O
secondary	JJ	O	O
to	TO	O	O
frequent	JJ	O	B-PROBLEM
flying	NN	O	I-PROBLEM
.	.	O	O

the	DT	O	O
need	NN	O	O
for	IN	O	O
further	JJ	B-TREATMENT	O
anti-coagulation	NN	I-TREATMENT	O
was	VBD	O	O
discussed	VBN	O	O
with	IN	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
attending	NN	O	O
,	,	O	O
dr.	JJ	O	O
coleman	NN	O	O
,	,	O	O
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
not	RB	O	O
to	TO	O	O
continue	VB	O	O
anti-coagulation	NN	B-TREATMENT	B-TREATMENT
due	JJ	O	O
to	TO	O	O
increased	VBN	O	O
risk	NN	B-PROBLEM	O
of	IN	I-PROBLEM	O
gastrointestinal	JJ	I-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
restarted	VBN	O	O
on	IN	O	O
levothyroxine	NN	B-TREATMENT	B-TREATMENT
soon	RB	O	O
after	IN	O	O
admission	NN	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
hemoglobin	NN	I-TEST	I-TEST
a1c	NN	I-TEST	I-TEST
was	VBD	O	O
sent	VBN	O	O
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
pending	VBG	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

6.	CD	O	O
single	JJ	B-PROBLEM	O
mental	JJ	I-PROBLEM	O
status	NN	I-PROBLEM	O
change	NN	I-PROBLEM	O
times	NNS	O	O
two	CD	O	O
hours	NNS	O	O
during	IN	O	O
episode	NN	O	O
of	IN	O	O
blood	NN	B-PROBLEM	B-PROBLEM
transfusion	NN	I-PROBLEM	I-PROBLEM
reaction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

was	VBD	O	O
most	RBS	O	O
likely	JJ	O	O
due	JJ	O	O
to	TO	O	O
multiple	VB	B-TREATMENT	O
drugs	NNS	I-TREATMENT	B-TREATMENT
administered	VBN	O	O
during	IN	O	O
the	DT	O	O
episode	NN	O	O
including	VBG	O	O
demerol	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

7.	CD	O	O
prophylaxis	NN	B-TREATMENT	O
:	:	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
sent	VBN	O	O
home	NN	O	O
on	IN	O	O
proton	NN	B-TREATMENT	B-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
inhibitors	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-TEST	B-TEST
helicobacter	NN	I-TEST	I-TEST
pylori	NN	I-TEST	I-TEST
serology	NN	I-TEST	I-TEST
was	VBD	O	O
sent	VBN	O	O
and	CC	O	O
was	VBD	O	O
pending	VBG	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
discharged	VBN	O	O
to	TO	O	O
home	NN	O	O
on	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
following	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

1.	CD	O	O
lisinopril	JJ	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

2.	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
37.5	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

3.	CD	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

4.	CD	O	O
pantoprazole	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

5.	CD	O	O
levothyroxine	JJ	B-TREATMENT	B-TREATMENT
100	CD	O	O
micrograms	NNS	O	O
p.o.	JJ	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

metastatic	JJ	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	O
the	DT	I-PROBLEM	O
liver	NN	I-PROBLEM	O
.	.	O	O

metastatic	JJ	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	O
the	DT	I-PROBLEM	O
liver	NN	I-PROBLEM	O
.	.	O	O

diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	VBP	I-PROBLEM	I-PROBLEM
,	,	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
neuropathy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
rectal	JJ	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
premature	NN	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
contractions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
right	JJ	B-PROBLEM	B-PROBLEM
hemidiaphragmatic	JJ	I-PROBLEM	I-PROBLEM
paralysis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

10-02-94	JJ	O	O
left	VBD	B-TREATMENT	O
hepatectomy	NN	I-TREATMENT	B-TREATMENT
,	,	O	O
10-01-94	JJ	O	B-PROBLEM
celiac	NN	B-TEST	I-PROBLEM
and	CC	I-TEST	O
superior	JJ	I-TEST	B-TEST
mesenteric	JJ	I-TEST	I-TEST
angiogram	NN	I-TEST	I-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
60	CD	O	O
year	NN	O	O
old	JJ	O	O
diabetic	NN	O	O
who	WP	O	O
underwent	VBD	O	O
an	DT	B-TREATMENT	B-TEST
apr	NN	I-TREATMENT	I-TEST
in	IN	O	O
1989	CD	O	O
for	IN	O	O
rectal	JJ	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
has	VBZ	O	O
been	VBN	O	O
doing	VBG	O	O
following	VBG	O	O
radiation	NN	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
5fu	CD	B-TREATMENT	O
.	.	O	O

he	PRP	O	O
recently	RB	O	O
developed	VBD	O	O
fatigue	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
workup	NN	B-TEST	B-TEST
disclosed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
liver	NN	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
biopsied	VBN	O	O
and	CC	O	O
revealed	VBN	O	O
to	TO	O	O
be	VB	O	O
poorly	RB	B-PROBLEM	B-PROBLEM
differentiated	VBN	I-PROBLEM	I-PROBLEM
neoplasm	NN	I-PROBLEM	I-PROBLEM
most	RBS	O	O
consistent	JJ	O	O
with	IN	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
rectal	NN	I-PROBLEM	I-PROBLEM
discontinued	VBN	I-PROBLEM	O
.	.	O	O

remarkable	JJ	O	O
for	IN	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
premature	NN	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
contractions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
rectal	JJ	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
diabetic	JJ	B-PROBLEM	B-PROBLEM
neuropathy	JJ	I-PROBLEM	I-PROBLEM
both	DT	O	O
peripherally	RB	O	O
and	CC	O	O
involving	VBG	O	O
the	DT	O	O
right	JJ	O	O
diaphragm	NN	O	O
.	.	O	O

diabeta	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg.	NN	O	O
po.	NN	O	O
bid	NN	O	O
.	.	O	O

serax	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg.	NN	O	O
po.	NN	O	O
qhs	NN	O	O
.	.	O	O

sudafed	RB	B-TREATMENT	O
30	CD	O	O
mg.	JJ	O	O
po.	NN	O	O
bid	NN	O	O
.	.	O	O

theo-dur	JJ	B-TREATMENT	B-TEST
300	CD	O	O
mg.	JJ	O	O
po.	NN	O	O
bid	NN	O	O
.	.	O	O

betoptic	JJ	B-TREATMENT	O
0.5%	CD	O	O
one	CD	O	O
drop	NN	O	O
ou	NN	O	O
bid	NN	O	O
,	,	O	O
propene	NN	B-TREATMENT	B-TREATMENT
0.1%	CD	O	O
one	CD	O	O
drop	NN	O	O
ou	NN	O	O
bid	NN	O	O
,	,	O	O
pred-forte	JJ	B-TREATMENT	O
1%	CD	O	O
one	CD	O	O
drop	NN	O	O
os	NN	O	O
bid	NN	O	O
,	,	O	O
percocet	VBP	B-TREATMENT	B-TREATMENT
two	CD	O	O
tabs.	JJ	O	O
po.	NN	O	O
q4hours	NNS	O	O
prn	VBP	O	O
.	.	O	O

proventil	NN	B-TREATMENT	B-TREATMENT
2	CD	O	O
puffs	NNS	O	O
q6hours	RB	O	O
prn	VBP	O	O
.	.	O	O

includes	VBZ	O	O
and	CC	O	O
abdominoperineal	JJ	B-TREATMENT	B-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
1989	CD	O	O
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM

demonstrated	VBD	O	O
an	DT	O	O
obese	JJ	O	O
man	NN	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
140/75	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
90	CD	O	O
and	CC	O	O
irregular	JJ	B-PROBLEM	O
,	,	O	O
respirations	NNS	B-TEST	B-TEST
20	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
,	,	I-TEST	I-TEST
eyes	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
ears	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
nose	RB	I-TEST	I-TEST
,	,	I-TEST	I-TEST
throat	NN	I-TEST	I-TEST
and	CC	I-TEST	I-TEST
neck	NN	I-TEST	I-TEST
examinations	NNS	I-TEST	I-TEST
were	VBD	O	O
unremarkable	JJ	O	O
.	.	O	O

cardiac	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
remarkable	JJ	O	O
for	IN	O	O
frequent	JJ	B-PROBLEM	B-PROBLEM
ectopic	NN	I-PROBLEM	I-PROBLEM
beats	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
lung	NN	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
clear	JJ	O	O
but	CC	O	O
breath	JJ	B-TEST	B-TEST
sounds	NNS	I-TEST	I-TEST
were	VBD	O	O
more	RBR	O	O
pronounced	JJ	O	O
on	IN	O	O
the	DT	O	O
left	NN	O	O
than	IN	O	O
the	DT	O	O
right	NN	O	O
.	.	O	O

soft	JJ	O	O
,	,	O	O
obese	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
epigastric	JJ	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
upper	NN	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

an	DT	B-TREATMENT	B-TREATMENT
intact	JJ	I-TREATMENT	I-TREATMENT
colostomy	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
present	JJ	O	O
.	.	O	O

no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
could	MD	O	O
be	VB	O	O
palpated	VBN	O	B-PROBLEM
secondary	JJ	O	O
to	TO	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NNP	I-PROBLEM	I-PROBLEM
extreme	JJ	I-PROBLEM	I-PROBLEM
obesity	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
neurological	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
remarkable	JJ	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
peripheral	JJ	I-PROBLEM	I-PROBLEM
neuropathy	JJ	I-PROBLEM	I-PROBLEM
including	VBG	O	O
decreased	JJ	B-PROBLEM	B-PROBLEM
sensation	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremities	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
decreased	JJ	B-PROBLEM	B-PROBLEM
strength	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremities	NNS	I-PROBLEM	I-PROBLEM
most	RBS	O	I-PROBLEM
pronounced	VBN	O	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
legs	NNS	O	I-PROBLEM
and	CC	O	I-PROBLEM
feet	NNS	O	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
chest	JJ	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
demonstrated	VBD	O	O
right	JJ	B-PROBLEM	B-PROBLEM
hemidiaphragmatic	JJ	I-PROBLEM	I-PROBLEM
elevation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
was	VBD	O	O
remarkable	JJ	O	O
for	IN	O	O
trigeminy	NN	B-PROBLEM	B-PROBLEM
at	IN	O	O
91	CD	O	O
per	IN	O	O
minute	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
and	CC	O	O
underwent	JJ	O	O
celiac	NN	B-TEST	O
and	CC	I-TEST	O
superior	JJ	I-TEST	B-PROBLEM
mesenteric	JJ	I-TEST	I-PROBLEM
artery	NN	I-TEST	I-PROBLEM
angiography	NN	I-TEST	I-PROBLEM
which	WDT	O	O
demonstrated	VBD	O	O
a	DT	O	B-PROBLEM
patent	NN	O	I-PROBLEM
celiac	NN	O	I-PROBLEM
and	CC	O	O
superior	JJ	O	B-PROBLEM
mesenteric	JJ	O	I-PROBLEM
artery	NN	O	I-PROBLEM
with	IN	O	O
normal	JJ	O	O
branching	VBG	O	O
pattern	NN	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
preoperative	JJ	I-TEST	I-TEST
workup	NN	I-TEST	I-TEST
was	VBD	O	O
completed	VBN	O	O
and	CC	O	O
included	VBD	O	O
a	DT	O	B-TEST
normal	JJ	O	I-TEST
white	JJ	O	I-TEST
count	NN	O	I-TEST
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
42	CD	O	O
.	.	O	O

on	IN	O	O
10-02-94	CD	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
brought	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
where	WRB	O	O
he	PRP	O	O
underwent	JJ	O	O
exploratory	JJ	B-TEST	B-TEST
laparotomy	NN	I-TEST	I-TEST
and	CC	O	O
left	VBD	B-TREATMENT	B-TREATMENT
hepatectomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
cholecystectomy	NN	B-TREATMENT	B-TREATMENT
by	IN	O	O
dr.	NN	O	O
duhenile	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
2000	CD	I-PROBLEM	I-PROBLEM
cc.	NN	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
autotransfused	VBN	O	O
two	CD	O	O
units	NNS	O	O
of	IN	O	O
blood	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

in	IN	O	O
the	DT	O	O
postoperative	JJ	O	O
course	NN	O	O
mr.	NN	O	O
fyfe	NN	O	O
did	VBD	O	O
surprisingly	RB	O	O
well	RB	O	O
given	VBN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
underlying	VBG	I-PROBLEM	I-PROBLEM
medical	JJ	I-PROBLEM	I-PROBLEM
condition	NN	I-PROBLEM	I-PROBLEM
.	.	O	O
,	,	O	O

he	PRP	O	O
did	VBD	O	O
require	VB	O	O
two	CD	O	O
units	NNS	O	O
of	IN	O	O
transfused	JJ	B-TREATMENT	B-PROBLEM
blood	NN	I-TREATMENT	I-PROBLEM
but	CC	O	O
otherwise	RB	O	O
did	VBD	O	O
quite	RB	O	O
well	RB	O	O
and	CC	O	O
was	VBD	O	O
extubated	VBN	O	O
on	IN	O	O
the	DT	O	O
night	NN	O	O
of	IN	O	O
surgery	NN	O	B-TREATMENT
.	.	O	O

he	PRP	O	O
continued	VBD	O	O
to	TO	O	O
manifest	VB	O	O
occasional	JJ	B-PROBLEM	B-PROBLEM
premature	NN	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
contractions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
these	DT	O	O
were	VBD	O	O
unchanged	JJ	O	O
from	IN	O	O
preoperatively	RB	O	O
and	CC	O	O
the	DT	O	O
patient	JJ	O	O
otherwise	NN	O	O
did	VBD	O	O
well	RB	O	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
nasogastric	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
begun	VBN	O	O
on	IN	O	O
clear	JJ	B-TREATMENT	B-TREATMENT
liquids	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
subsequently	RB	O	O
advanced	VBD	O	O
to	TO	O	O
a	DT	O	O
regular	JJ	O	O
diet	NN	O	O
without	IN	O	O
difficulty	NN	O	B-PROBLEM
.	.	O	O

both	DT	O	O
of	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
jackson-pratt	JJ	I-TREATMENT	I-TREATMENT
drains	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
removed	VBN	O	O
without	IN	O	O
incident	NN	O	O
.	.	O	O

by	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#	#	O	O
7	CD	O	O
,	,	O	O
mr.	FW	O	O
fyfe	NN	O	O
was	VBD	O	O
tolerating	VBG	O	O
a	DT	B-TREATMENT	O
regular	JJ	I-TREATMENT	O
ada	NN	I-TREATMENT	O
1800	CD	I-TREATMENT	O
kilocalorie	NN	I-TREATMENT	O
diet	NN	I-TREATMENT	O
without	IN	O	O
difficulty	NN	O	O
with	IN	O	O
all	DT	O	O
of	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
tubes	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
drains	NNS	B-TREATMENT	B-TREATMENT
removed	VBN	O	O
.	.	O	O

his	PRP$	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
healing	VBG	O	O
well	RB	O	O
and	CC	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
colostomy	NN	I-TREATMENT	I-TREATMENT
functioning	VBG	O	O
appropriately	RB	O	O
without	IN	O	O
significant	JJ	O	B-PROBLEM
difficulty	NN	O	I-PROBLEM
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
being	VBG	O	O
transferred	VBN	O	O
back	RB	O	O
to	TO	O	O
the	DT	O	O
per	NN	O	O
naplesspecrycet	NN	O	O
hospital	NN	O	O
in	IN	O	O
stable	JJ	O	O
condition	NN	O	O
on	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
same	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
which	WDT	O	O
he	PRP	O	O
was	VBD	O	O
on	IN	O	O
preoperatively	RB	O	O
.	.	O	O

these	DT	O	O
include	VBP	O	O
diabeta	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg.	NN	O	O
po.	NN	O	O
bid	NN	O	O
.	.	O	O

serax	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg.	NN	O	O
po.	NN	O	O
qhs	NN	O	O
.	.	O	O

sudafed	RB	B-TREATMENT	O
30	CD	O	O
po.	JJ	O	O
bid	NN	O	O
.	.	O	O

theo-dur	JJ	B-TREATMENT	B-TEST
300	CD	O	O
mg.	JJ	O	O
po.	NN	O	O
bid	NN	O	O
.	.	O	O

betoptic	JJ	B-TREATMENT	O
0.5%	CD	O	O
one	CD	O	O
drop	NN	O	O
ou	NN	O	O
bid	NN	O	O
,	,	O	O
propene	NN	B-TREATMENT	B-TREATMENT
0.1%	CD	O	O
one	CD	O	O
drop	NN	O	O
ou	NN	O	O
bid	NN	O	O
.	.	O	O

pred-forte	JJ	B-TREATMENT	O
1%	CD	O	O
one	CD	O	O
drop	NN	O	O
os	NN	O	O
bid	NN	O	O
.	.	O	O

percocet	NN	B-TREATMENT	B-TREATMENT
two	CD	O	O
tabs	NN	O	O
po.	NN	O	O
q4h	NN	O	O
prn	NN	O	O
.	.	O	O

proventil	NN	B-TREATMENT	B-TREATMENT
2	CD	O	O
puffs	NNS	O	O
q6hours	RB	O	O
prn	VBP	O	O
..	NNS	O	B-PROBLEM

baby	NN	O	O
barbara	NN	O	O
stead	NN	O	O
is	VBZ	O	O
a	DT	O	O
term	NN	O	O
infant	NN	O	O
admitted	VBN	O	O
with	IN	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
head	NN	I-PROBLEM	I-PROBLEM
circumference	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
bruising	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

o	RB	B-TEST	O
positive	JJ	O	O
,	,	O	O
antibody	JJ	B-TEST	B-TEST
negative	JJ	O	O
,	,	O	O
hepatitis	NN	B-TEST	B-TEST
b	NN	I-TEST	I-TEST
surface	NN	I-TEST	I-TEST
antigen	NN	I-TEST	I-TEST
negative	JJ	O	O
,	,	O	O
rpr	JJ	B-TEST	O
nonreactive	JJ	O	O
,	,	O	O
rubella	NN	B-TEST	B-TEST
immune	NN	I-TEST	O

pregnancy	NN	O	O
was	VBD	O	O
complicated	VBN	O	O
by	IN	O	O
oligohydramnios	NNS	B-PROBLEM	B-TEST
with	IN	O	O
an	DT	B-TEST	O
afi	NN	I-TEST	O
of	IN	O	O
3.5	CD	O	O
and	CC	O	O
by	IN	O	O
multiple	JJ	B-TEST	O
evaluations	NNS	I-TEST	O
for	IN	O	O
decreased	JJ	B-PROBLEM	B-PROBLEM
fetal	JJ	I-PROBLEM	I-PROBLEM
movement	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
spontaneous	JJ	B-PROBLEM	O
onset	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
labor	NN	I-PROBLEM	B-PROBLEM
progressing	VBG	O	O
through	IN	O	O
vacuum	NN	B-TREATMENT	B-TREATMENT
assisted	VBN	I-TREATMENT	I-TREATMENT
vaginal	JJ	I-TREATMENT	I-TREATMENT
delivery	NN	I-TREATMENT	I-TREATMENT
under	IN	O	I-TREATMENT
epidural	JJ	B-TREATMENT	I-TREATMENT
anesthesia	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

clear	JJ	O	B-PROBLEM
amniotic	JJ	O	I-PROBLEM
fluid	NN	O	I-PROBLEM
,	,	O	O
no	DT	O	O
antepartum	JJ	B-PROBLEM	B-PROBLEM
maternal	JJ	I-PROBLEM	I-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
fetal	JJ	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
antepartum	NN	B-TREATMENT	B-TREATMENT
antibiotic	JJ	I-TREATMENT	I-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

baby	NN	O	O
was	VBD	O	O
vigorous	JJ	O	O
at	IN	O	O
delivery	NN	O	O
,	,	O	O
was	VBD	O	O
bulb	JJ	B-TREATMENT	B-TREATMENT
suction	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
dried	VBN	O	O
,	,	O	O
and	CC	O	O
had	VBD	O	O
free	JJ	B-TREATMENT	B-TREATMENT
flow	NN	I-TREATMENT	I-TREATMENT
oxygen	NN	I-TREATMENT	I-TREATMENT
administered	VBD	O	O
briefly	NN	O	O
.	.	O	O

apgars	NNS	B-TEST	B-TEST
were	VBD	O	O
nine	CD	O	O
and	CC	O	O
nine	CD	O	O
.	.	O	O

in	IN	O	O
the	DT	O	O
newborn	JJ	O	O
nursery	NN	O	O
,	,	O	O
he	PRP	O	O
initially	RB	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
caput	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
increased	VBD	O	O
in	IN	O	O
the	DT	O	O
amount	NN	O	O
of	IN	O	O
swelling	VBG	B-PROBLEM	B-PROBLEM
and	CC	O	O
bruising	VBG	B-PROBLEM	O
in	IN	O	O
the	DT	O	O
subsequent	JJ	O	O
24	CD	O	O
hours	NNS	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
then	RB	O	O
referred	VBN	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
ccu	NN	O	O
for	IN	O	O
assessment	NN	B-TEST	O
and	CC	O	O
management	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
increased	VBN	I-PROBLEM	I-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

birth	NN	B-TEST	B-TEST
weight	NN	I-TEST	I-TEST
was	VBD	O	O
3850	CD	O	O
grams	NNS	O	O
.	.	O	O

head	NN	B-TEST	B-TEST
circumference	NN	I-TEST	I-TEST
was	VBD	O	O
41	CD	O	O
cm	NN	O	O
.	.	O	O

heent	NN	B-TEST	O
was	VBD	O	O
significant	JJ	O	O
for	IN	O	O
swelling	VBG	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
scalp	JJ	I-PROBLEM	I-PROBLEM
tissue	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
generalized	JJ	O	I-PROBLEM
distribution	NN	O	I-PROBLEM
with	IN	O	O
ecchymosis	NN	B-PROBLEM	B-PROBLEM
extending	VBG	O	O
from	IN	O	O
the	DT	O	O
occiput	NN	O	O
to	TO	O	O
the	DT	O	B-PROBLEM
posterior	JJ	O	I-PROBLEM
auricular	JJ	O	I-PROBLEM
area	NN	O	I-PROBLEM
and	CC	O	O
dorsal	JJ	O	O
aspect	NN	O	O
of	IN	O	O
the	DT	O	O
neck	NN	O	O
to	TO	O	O
the	DT	O	B-PROBLEM
mid	JJ	O	I-PROBLEM
cervical	JJ	O	I-PROBLEM
level	NN	O	I-PROBLEM
.	.	O	O

no	DT	O	O
nasal	JJ	B-PROBLEM	B-PROBLEM
flaring	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
retractions	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
good	JJ	O	B-PROBLEM
breath	NN	O	I-PROBLEM
sounds	NNS	O	I-PROBLEM
bilaterally	RB	O	I-PROBLEM
,	,	O	O
no	DT	O	O
crackles	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

femoral	JJ	B-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
normal	JJ	O	O
,	,	O	O
s1	JJ	O	O
,	,	O	O
s2	JJ	O	O
were	VBD	O	O
normal	JJ	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
1/6	CD	I-PROBLEM	I-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
ejection	NN	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
upper	JJ	O	I-PROBLEM
left	VBD	O	I-PROBLEM
sternal	JJ	O	I-PROBLEM
border	NN	O	I-PROBLEM
without	IN	O	O
radiation	NN	B-PROBLEM	O
.	.	O	O

abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
organomegaly	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

bowel	NN	B-TEST	B-TEST
sounds	NNS	I-TEST	I-TEST
are	VBP	O	O
active	JJ	O	O
and	CC	O	O
patent	NN	O	O
.	.	O	O

cns	NN	O	O
active	JJ	O	O
,	,	O	O
responsive	JJ	O	O
to	TO	O	O
stimulation	NN	B-TEST	O
.	.	O	O

tone	NN	B-TEST	O
is	VBZ	O	O
normal	JJ	O	O
,	,	O	O
moving	VBG	O	O
all	DT	O	O
limbs	NNS	O	O
symmetrically	RB	O	O
,	,	O	O
irritable	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
palpation	NN	B-TEST	B-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
scalp	NN	I-TEST	I-TEST
.	.	O	O

suck	NN	B-TEST	O
,	,	O	O
root	NN	B-TEST	O
,	,	O	O
gag	NN	B-TEST	B-PROBLEM
,	,	O	O
grasp	NN	B-TEST	O
,	,	O	O
and	CC	O	O
morrow	NN	B-TEST	O
were	VBD	O	O
normal	JJ	O	O
.	.	O	O

pale	NN	O	B-PROBLEM
as	IN	O	O
above	IN	O	O
,	,	O	O
nonicteric	JJ	B-PROBLEM	O
.	.	O	O

normal	JJ	O	O
spine	NN	O	O
,	,	O	O
hip	NN	O	B-PROBLEM
,	,	O	O
clavicles	NNS	O	B-PROBLEM
,	,	O	O
small	JJ	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
the	DT	O	O
site	NN	O	O
of	IN	O	O
previous	JJ	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
quadriceps	NNS	I-TREATMENT	I-TREATMENT
intramuscular	JJ	I-TREATMENT	I-TREATMENT
injection	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

an	DT	B-TEST	B-TEST
initial	JJ	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
had	VBD	O	O
revealed	VBN	O	O
extracranial	JJ	B-PROBLEM	B-PROBLEM
soft	JJ	I-PROBLEM	I-PROBLEM
tissue	NN	I-PROBLEM	I-PROBLEM
swelling	VBG	I-PROBLEM	I-PROBLEM
most	JJS	O	O
prominently	RB	O	O
at	IN	O	O
the	DT	O	O
right	JJ	O	O
frontal-parietal-occipital	JJ	O	O
area	NN	O	O
extending	VBG	O	O
to	TO	O	O
the	DT	O	O
left	NN	O	O
and	CC	O	O
to	TO	O	O
the	DT	O	B-PROBLEM
upper	JJ	O	I-PROBLEM
cervical	JJ	O	I-PROBLEM
region	NN	O	I-PROBLEM
.	.	O	O

no	DT	O	O
gross	JJ	B-PROBLEM	B-PROBLEM
intraparenchymal	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

but	CC	O	O
upon	IN	O	O
further	JJ	O	O
radiology	NN	O	O
attending	VBG	O	O
stoughton	NN	O	O
,	,	O	O
there	EX	O	O
was	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
occipital	JJ	I-PROBLEM	I-PROBLEM
subdural	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
noted	VBD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
initial	JJ	I-TEST	I-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
21.2	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
186	CD	O	O
.	.	O	O

pt	NN	B-TEST	O
was	VBD	O	O
14.6	CD	O	O
,	,	O	O
ptt	VBD	B-TEST	B-TEST
77	CD	O	O
with	IN	O	O
an	DT	B-TEST	O
inr	NN	I-TEST	O
of	IN	O	O
1.4	CD	O	O
.	.	O	O

fibrinogen	NN	B-TEST	B-TEST
was	VBD	O	O
192	CD	O	O
.	.	O	O

d-dimer	NN	B-TEST	O
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
term	NN	O	O
infant	NN	O	O
with	IN	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
subgaleal	JJ	I-PROBLEM	I-PROBLEM
hematoma	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
apparent	JJ	O	O
extension	NN	O	O
over	IN	O	O
the	DT	O	O
past	JJ	O	O
six	CD	O	O
hours	NNS	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
also	RB	O	O
elevation	NN	B-PROBLEM	B-TREATMENT
of	IN	O	I-TREATMENT
the	DT	B-TEST	I-TREATMENT
ptt	NN	I-TEST	I-TREATMENT
suggesting	VBG	O	O
possible	JJ	O	O
inborn	JJ	B-PROBLEM	B-PROBLEM
coagulopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
also	RB	O	O
critical	JJ	B-PROBLEM	O
anemia	NN	I-PROBLEM	B-PROBLEM
secondary	JJ	O	O
to	TO	O	O
the	DT	B-PROBLEM	B-PROBLEM
subgaleal	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
ccu	NN	O	O
for	IN	O	O
further	JJ	B-TREATMENT	B-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

patient	NN	O	O
has	VBZ	O	O
been	VBN	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
maintaining	VBG	O	O
sats	NNS	B-TEST	O
above	IN	O	O
95%	CD	O	O
.	.	O	O

no	DT	O	O
apnea	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
bradycardia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
initial	JJ	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
admission	NN	O	O
likely	RB	O	O
secondary	JJ	O	O
to	TO	O	O
severe	VB	B-PROBLEM	B-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
has	VBZ	O	O
since	IN	O	O
resolved	VBN	O	O
.	.	O	O

patient	NN	O	O
was	VBD	O	O
restarted	VBN	O	O
on	IN	O	O
po	NN	O	B-TREATMENT
feeds	NNS	O	I-TREATMENT
as	IN	O	O
of	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
three	CD	O	O
after	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
had	VBD	O	O
stabilized	VBN	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
admission	NN	I-TEST	I-TEST
weight	NN	I-TEST	I-TEST
was	VBD	O	O
3850	CD	O	O
grams	NNS	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
weight	NN	I-TEST	I-TEST
on	IN	I-TEST	O
discharge	NN	I-TEST	O
was	VBD	O	O
4055	CD	O	O
.	.	O	O

given	VBN	O	O
the	DT	O	O
significant	JJ	O	O
amount	NN	O	O
of	IN	O	O
bleeding	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
baby	NN	O	O
was	VBD	O	O
started	VBN	O	O
prophylactically	RB	O	O
on	IN	O	O
phototherapy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

his	PRP$	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
peaked	VBD	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
three	CD	O	O
at	IN	O	O
5.4	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
subsequent	JJ	I-TEST	I-TEST
bilirubin	NN	I-TEST	I-TEST
of	IN	O	O
4.6	CD	O	O
at	IN	O	O
which	WDT	O	O
time	NN	O	O
phototherapy	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
.	.	O	O

given	VBN	O	O
the	DT	O	B-PROBLEM
rapid	JJ	O	I-PROBLEM
extension	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
subgaleal	NN	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
coagulopathy	JJ	B-TEST	B-TEST
workup	NN	I-TEST	I-TEST
was	VBD	O	O
initiated	VBN	O	O
revealing	VBG	O	O
an	DT	B-PROBLEM	B-PROBLEM
elevated	JJ	I-PROBLEM	I-PROBLEM
ptt	NN	I-PROBLEM	I-PROBLEM
level	NN	I-PROBLEM	O
of	IN	O	O
77	CD	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
factor	NN	B-TEST	O
8	CD	I-TEST	O
level	NN	I-TEST	O
that	WDT	O	O
was	VBD	O	O
below	IN	O	O
detection	NN	O	O
in	IN	O	O
the	DT	O	O
presence	NN	O	O
of	IN	O	O
normal	JJ	O	O
factors	NNS	O	O
5	CD	O	O
,	,	O	O
9	CD	O	O
,	,	O	O
10	CD	O	O
,	,	O	O
and	CC	O	O
11	CD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	O
50	CD	I-TREATMENT	O
units	NNS	I-TREATMENT	O
/	VBP	I-TREATMENT	O
kg	JJ	I-TREATMENT	O
bolus	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
factor	NN	I-TREATMENT	O
8	CD	I-TREATMENT	O
followed	VBN	O	O
by	IN	O	O
continuous	JJ	B-TREATMENT	O
factor	NN	I-TREATMENT	O
8	CD	I-TREATMENT	O
infusions	NNS	I-TREATMENT	B-TREATMENT
at	IN	O	O
50	CD	O	O
units	NNS	O	O
/	VBP	O	O
kg	JJ	O	O
/	NNP	O	O
day	NN	O	O
divided	VBD	O	O
until	IN	O	O
hourly	JJ	O	O
infusion	NN	O	O
rates	NNS	O	O
at	IN	O	O
05-10	NNP	O	O
.	.	O	O

subsequent	JJ	B-TEST	O
factor	NN	I-TEST	O
8	CD	I-TEST	O
levels	NNS	I-TEST	O
varied	VBN	O	O
with	IN	O	O
an	DT	B-TEST	B-TEST
initial	JJ	I-TEST	I-TEST
factor	NN	I-TEST	I-TEST
8	CD	I-TEST	O
level	NN	I-TEST	O
of	IN	O	O
18	CD	O	O
after	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
bolus	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
which	WDT	O	O
he	PRP	O	O
received	VBD	O	O
another	DT	O	O
bolus	NN	O	O
of	IN	O	O
factor	NN	B-TREATMENT	O
8	CD	I-TREATMENT	O
of	IN	O	O
50	CD	O	O
units	NNS	O	O
/	NNP	O	O
kg	NN	O	O
and	CC	O	O
increased	VBD	B-TREATMENT	B-PROBLEM
factor	NN	I-TREATMENT	I-PROBLEM
8	CD	I-TREATMENT	I-PROBLEM
infusion	NN	I-TREATMENT	I-PROBLEM
rate	NN	I-TREATMENT	I-PROBLEM
to	TO	O	O
65	CD	O	O
units	NNS	O	O
/	VBP	O	O
kg	JJ	O	O
/	NNP	O	O
day	NN	O	O
.	.	O	O

as	IN	O	O
of	IN	O	O
05-17	NN	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
switched	VBN	O	O
over	IN	O	O
to	TO	O	O
bolus	VB	B-TREATMENT	B-TREATMENT
infusion	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
preparation	NN	O	O
of	IN	O	O
continued	JJ	B-TREATMENT	O
home	NN	I-TREATMENT	O
factor	NN	I-TREATMENT	O
8	CD	I-TREATMENT	O
administration	NN	I-TREATMENT	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
peak	NN	I-TEST	I-TEST
level	NN	I-TEST	I-TEST
after	IN	O	O
a	DT	O	O
bolus	NN	O	O
of	IN	O	O
75	CD	O	O
units	NNS	O	O
/	NNP	O	O
kg	NN	O	O
of	IN	O	O
factor	NN	B-TREATMENT	O
8	CD	I-TREATMENT	O
was	VBD	O	O
131	CD	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
trough	JJ	I-TEST	I-TEST
level	NN	I-TEST	I-TEST
at	IN	O	O
20	CD	O	O
hours	NNS	O	O
after	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
bolus	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
was	VBD	O	O
29	CD	O	O
.	.	O	O

he	PRP	O	O
will	MD	O	O
continue	VB	O	O
to	TO	O	O
receive	VB	O	O
factor	NN	B-TREATMENT	B-TREATMENT
8	CD	I-TREATMENT	O
bolus	JJ	I-TREATMENT	O
q	NNS	O	O
day	NN	O	O
for	IN	O	O
a	DT	O	O
total	NN	O	O
of	IN	O	O
2-3	JJ	O	O
weeks	NNS	O	O
in	IN	O	O
light	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
intracranial	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
will	MD	O	O
be	VB	O	O
followed	VBN	O	O
by	IN	O	O
hematology	NN	O	O
visiting	VBG	O	O
nurse	JJ	O	B-TEST
michael	NN	O	I-TEST
edwards	NNS	O	I-TEST
level	NN	O	I-TEST
checks	NNS	O	I-TEST
at	IN	O	O
home	NN	O	O
.	.	O	O

currently	RB	O	O
,	,	O	O
the	DT	B-TREATMENT	O
infusion	NN	I-TREATMENT	O
of	IN	O	O
factor	NN	B-TREATMENT	O
8	CD	I-TREATMENT	O
are	VBP	O	O
going	VBG	O	O
through	IN	O	O
a	DT	B-TREATMENT	B-PROBLEM
jugular	NN	I-TREATMENT	I-PROBLEM
broviac	NN	I-TREATMENT	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
05-15	NN	O	O
for	IN	O	O
administration	NN	O	O
of	IN	O	O
factor	NN	B-TREATMENT	O
.	.	O	O

his	PRP$	B-TEST	O
last	JJ	I-TEST	O
ptt	NN	I-TEST	O
on	IN	O	O
05-16	NN	O	O
was	VBD	O	O
68.3	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
last	JJ	I-TEST	I-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
on	IN	O	O
05-16	NN	O	O
of	IN	O	O
54.5	CD	O	O
.	.	O	O

baby	NN	O	O
mary	JJ	O	O
stead	NN	O	O
initially	RB	O	O
presented	VBN	O	O
with	IN	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
subgaleal	JJ	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
subdural	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
ct	VBP	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
on	IN	O	O
05-15	NN	O	O
had	VBD	O	O
shown	VBN	O	O
the	DT	O	O
resolution	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
subdural	JJ	I-PROBLEM	I-PROBLEM
hematoma	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
significant	JJ	O	O
improvement	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
subgaleal	JJ	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
ultrasound	NN	I-TEST	I-TEST
on	IN	O	O
05-14	NN	O	O
reveals	NNS	O	O
no	DT	O	O
interventricular	JJ	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
circumference	NN	I-TEST	I-TEST
on	IN	O	O
05-18	NN	O	O
was	VBD	O	O
36.5	CD	O	O
cm	NN	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
maximum	JJ	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
circumference	NN	I-TEST	I-TEST
on	IN	O	O

teaching	NN	O	O
has	VBZ	O	O
been	VBN	O	O
completed	VBN	O	O
on	IN	O	O
the	DT	O	O
care	NN	O	O
of	IN	O	O
the	DT	B-TREATMENT	O
boviak	NN	I-TREATMENT	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
administration	NN	O	O
of	IN	O	O
factor	NN	B-TREATMENT	O
8	CD	I-TREATMENT	O
.	.	O	O

hearing	VBG	B-TEST	B-TEST
screen	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
automated	JJ	O	O
auditory	NN	O	O
brain	NN	O	O
stem	NN	O	O
responses	NNS	O	O
and	CC	O	O
baby	NN	O	O
david	NNS	O	O
stead	VBP	O	O

baby	NN	O	O
julian	JJ	O	O
stead	NN	O	O
had	VBD	O	O
been	VBN	O	O
stable	JJ	O	O
with	IN	O	O
improvement	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
subgaleal	NN	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
good	JJ	O	O
peak	NN	O	O
and	CC	O	O
trough	JJ	O	B-PROBLEM
factor	NN	O	I-PROBLEM
8	CD	O	I-PROBLEM
levels	NNS	O	I-PROBLEM
after	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
bolus	JJ	I-TREATMENT	I-TREATMENT
infusion	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

factor	NN	B-TREATMENT	B-TEST
8	CD	I-TREATMENT	O
boluses	NNS	I-TREATMENT	B-TREATMENT
at	IN	O	O
75	CD	O	O
units	NNS	O	O
/	VBP	O	O
kg	JJ	O	O
/	NNP	O	O
day	NN	O	O
.	.	O	O

3.	CD	O	O
car	NN	B-TEST	B-TEST
seat	NN	I-TEST	I-TEST
position	NN	I-TEST	I-TEST
screening	VBG	I-TEST	I-TEST
passed	VBN	O	O
.	.	O	O

4.	CD	O	O
state	NN	B-TEST	B-TEST
newborn	JJ	I-TEST	I-TEST
screen	NN	I-TEST	I-TEST
sent	NN	O	O
.	.	O	O

received	VBN	O	O
hepatitis	NN	B-TREATMENT	B-TREATMENT
b	NN	I-TREATMENT	I-TREATMENT
vaccination	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
05-16	NN	O	O
.	.	O	O

1.	CD	O	O
factor	NN	B-PROBLEM	B-PROBLEM
8	CD	I-PROBLEM	I-PROBLEM
deficiency	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
subgaleal	JJ	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
resolved	VBN	O	O
.	.	O	O

3.	CD	O	O
small	JJ	B-PROBLEM	B-PROBLEM
occipital	JJ	I-PROBLEM	I-PROBLEM
subdural	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
resolved	VBD	O	O

right	JJ	B-PROBLEM	B-PROBLEM
shoulder	NN	I-PROBLEM	I-PROBLEM
instability	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

in	IN	O	O
1989	CD	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
dunking	VBG	O	O
a	DT	O	O
basketball	NN	O	O
and	CC	O	O
injured	VBD	O	B-PROBLEM
his	PRP$	O	I-PROBLEM
right	JJ	O	I-PROBLEM
shoulder	NN	O	I-PROBLEM
with	IN	O	O
abduction	NN	B-PROBLEM	B-PROBLEM
external	JJ	I-PROBLEM	I-PROBLEM
rotation	NN	I-PROBLEM	I-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
had	VBN	O	O
persistent	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
over	IN	O	O
the	DT	O	O
years	NNS	O	O
which	WDT	O	O
has	VBZ	O	O
worsened	VBN	O	O
in	IN	O	O
the	DT	O	O
past	JJ	O	O
several	JJ	O	O
months	NNS	O	O
including	VBG	O	O
inability	NN	B-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
sleep	VB	I-PROBLEM	I-PROBLEM
.	.	O	O

knee	NN	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

in	IN	O	O
clinic	JJ	O	O
his	PRP$	B-TEST	B-TEST
cervical	JJ	I-TEST	I-TEST
spine	NN	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
benign	JJ	O	O
.	.	O	O

shoulder	NN	B-TEST	B-PROBLEM
elevation	NN	I-TEST	I-PROBLEM
is	VBZ	O	O
170	CD	O	O
degrees	NNS	O	O
with	IN	O	O
70	CD	O	O
degrees	NNS	O	O
of	IN	O	O
external	JJ	O	B-TEST
rotation	NN	O	I-TEST
and	CC	O	I-TEST
internal	JJ	O	I-TEST
rotation	NN	O	I-TEST
of	IN	O	I-TEST
the	DT	O	I-TEST
right	JJ	O	I-TEST
shoulder	NN	O	I-TEST
to	TO	O	O
t9	VB	O	O
vertebra	JJ	O	O
versus	NN	O	O
t7	NN	O	B-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	NN	O	I-PROBLEM
.	.	O	O

mild	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
resistive	JJ	B-TEST	B-TEST
test	NN	I-TEST	I-TEST
and	CC	O	O
his	PRP$	B-TEST	B-TEST
pigott	NN	I-TEST	I-TEST
sign	NN	I-TEST	I-TEST
is	VBZ	O	O
mildly	RB	O	B-PROBLEM
positive	JJ	O	I-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
right	NN	O	I-PROBLEM
,	,	O	O
negative	JJ	O	O
on	IN	O	O
the	DT	O	O
left	NN	O	O
.	.	O	O

laxity	NN	B-PROBLEM	B-PROBLEM
is	VBZ	O	O
noted	VBN	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
markedly	RB	B-PROBLEM	B-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
apprehension	NN	I-PROBLEM	I-PROBLEM
sign	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
hospital	NN	O	O
and	CC	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
for	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
open	JJ	I-TREATMENT	I-TREATMENT
bankart	NN	I-TREATMENT	I-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
biceps	NNS	B-TREATMENT	B-PROBLEM
tenodesis	NN	I-TREATMENT	I-PROBLEM
(	(	O	O
please	VB	O	O
see	VB	O	O
the	DT	O	O
operative	JJ	O	O
note	NN	O	O
for	IN	O	O
full	JJ	O	O
details	NNS	O	O
)	)	O	O
.	.	O	O

his	PRP$	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
intact	JJ	O	O
,	,	O	O
clean	JJ	O	O
and	CC	O	O
dry	JJ	O	O
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
covered	VBN	O	O
with	IN	O	O
perioperative	JJ	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
discharged	VBN	O	O
to	TO	O	O
home	NN	O	O
on	IN	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

percocet	JJ	B-TREATMENT	B-TREATMENT
1-2	JJ	O	I-TREATMENT
tablets	NNS	O	I-TREATMENT
po	JJ	O	O
q.4-6	JJ	O	O
hours	NNS	O	O
prn	VBP	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

continuing	VBG	O	O
throughout	IN	O	O
his	PRP$	O	O
course	NN	O	O
he	PRP	O	O
had	VBD	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
infectious	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
issues	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
developed	VBD	O	O
zoster	NN	B-PROBLEM	B-PROBLEM
for	IN	O	O
which	WDT	O	O
he	PRP	O	O
received	VBD	O	O
a	DT	B-TREATMENT	O
course	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
acyclovir	NN	I-TREATMENT	B-TREATMENT
.	.	O	O

his	PRP$	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
came	VBD	O	O
back	RB	O	O
as	IN	O	O
noted	VBN	O	O
with	IN	O	O
klebsiella	NN	B-PROBLEM	B-PROBLEM
ultimately	RB	O	I-PROBLEM
in	IN	O	I-PROBLEM
his	PRP$	B-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
mrsa	NN	B-PROBLEM	O
in	IN	O	O
his	PRP$	O	B-TEST
sputum	NN	O	I-TEST
.	.	O	O

he	PRP	O	O
had	VBD	O	O
multiple	JJ	B-PROBLEM	O
sources	NNS	I-PROBLEM	O
of	IN	I-PROBLEM	O
yeast	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

currently	RB	O	O
his	PRP$	B-PROBLEM	O
only	JJ	I-PROBLEM	O
yeast	NN	I-PROBLEM	O
source	NN	I-PROBLEM	O
is	VBZ	O	O
urine	JJ	O	O
.	.	O	O

also	RB	O	O
in	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
the	DT	O	O
month	NN	O	O
that	IN	O	O
he	PRP	O	O
was	VBD	O	O
in	IN	O	O
the	DT	O	O
icu	NN	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
left	VBN	I-TREATMENT	I-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
placed	VBD	O	O
for	IN	O	O
fluid	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
then	RB	O	O
a	DT	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
placed	VBD	O	O
ultimately	RB	O	O
for	IN	O	O
fluid	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
developed	VBD	O	O
another	DT	O	O
round	NN	O	O
of	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
atn	NN	B-PROBLEM	O
and	CC	O	O
casts	NNS	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
urine	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
also	RB	O	O
started	VBD	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
gallstones	NNS	B-PROBLEM	B-PROBLEM
with	IN	O	O
cholestasis	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
the	DT	O	B-TREATMENT
medication	NN	O	I-TREATMENT
ursodiol	NN	B-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
received	VBD	O	O
a	DT	O	O
course	NN	O	O
of	IN	O	O
cefepime	NN	B-TREATMENT	B-TREATMENT
also	RB	O	O
.	.	O	O

he	PRP	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
multiple	JJ	B-TREATMENT	B-TREATMENT
dressing	NN	I-TREATMENT	I-TREATMENT
changes	NNS	I-TREATMENT	I-TREATMENT
after	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
split	NN	I-TREATMENT	I-TREATMENT
thickness	NN	I-TREATMENT	I-TREATMENT
skin	JJ	I-TREATMENT	I-TREATMENT
grafts	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
which	WDT	O	O
he	PRP	O	O
does	VBZ	O	O
to	TO	O	O
this	DT	O	O
day	NN	O	O
.	.	O	O

in	IN	O	O
early	JJ	O	O
november	NN	O	O
he	PRP	O	O
started	VBD	O	O
dialysis	NN	B-TREATMENT	B-TREATMENT
after	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
permcath	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
dobbhoff	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
removed	VBN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
use	VB	O	O
a	DT	B-TREATMENT	B-TREATMENT
passy-muir	JJ	I-TREATMENT	I-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
intermittently	RB	O	O
for	IN	O	O
his	PRP$	B-TREATMENT	B-PROBLEM
trach	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

on	IN	O	O
12-23	NNS	O	O
he	PRP	O	O
went	VBD	O	O
back	RB	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
for	IN	O	O
open	JJ	B-PROBLEM	B-TREATMENT
jejunostomy	NN	I-PROBLEM	I-TREATMENT
tube	NN	I-PROBLEM	I-TREATMENT
dehiscence	NN	I-PROBLEM	O
site	NN	I-PROBLEM	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
j	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
is	VBZ	O	O
now	RB	O	O
functioning	VBG	O	O
.	.	O	O

this	DT	O	O
was	VBD	O	O
repaired	VBN	O	O
and	CC	O	O
stay	VB	B-TREATMENT	B-TREATMENT
sutures	NNS	I-TREATMENT	I-TREATMENT
are	VBP	O	O
in	IN	O	O
place	NN	O	O
.	.	O	O

on	IN	O	O
11-24	JJ	O	O
he	PRP	O	O
received	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
permanent	JJ	I-TREATMENT	I-TREATMENT
ddd	NN	I-TREATMENT	I-TREATMENT
pacemaker	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
a	DT	B-TREATMENT	O
lead	NN	I-TREATMENT	O
that	WDT	O	O
was	VBD	O	O
externally	RB	O	O
placed	VBN	O	O
on	IN	O	O
his	PRP$	O	B-TEST
chest	JJS	O	I-TEST
wall	NN	O	I-TEST
due	JJ	O	O
to	TO	O	O
his	PRP$	O	O
healing	NN	O	O
and	CC	O	O
infected	JJ	B-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

from	IN	O	O
the	DT	O	O
point	NN	O	O
of	IN	O	O
discharge	NN	O	O
today	NN	O	O
on	IN	O	O
12-31	JJ	O	O
his	PRP$	B-TEST	O
most	RBS	I-TEST	O
recent	JJ	I-TEST	O
labs	NNS	I-TEST	O
are	VBP	O	O
as	IN	O	O
follows	VBZ	O	O
.	.	O	O

white	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
13.9	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
35.9	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
81,000	CD	O	O
.	.	O	O

sodium	NN	B-TEST	B-TEST
139	CD	O	O
,	,	O	O
k	VBD	B-TEST	O
4.8	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
109	CD	O	O
,	,	O	O
co2	NN	B-TEST	B-TEST
31	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
33	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
2.2	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
sugar	NN	I-TEST	I-TEST
164	CD	O	O
.	.	O	O

albumin	RB	B-TEST	B-TEST
2.5	CD	O	O
.	.	O	O

vancomycin	JJ	B-TEST	B-TEST
level	NN	I-TEST	I-TEST
was	VBD	O	O
21	CD	O	O
.	.	O	O

he	PRP	O	O
occasionally	RB	O	O
gets	VBZ	O	O
agitated	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
does	VBZ	O	O
have	VB	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
pacing	VBG	I-TREATMENT	I-TREATMENT
lead	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
external	JJ	I-TREATMENT	I-TREATMENT
pacemaker	NN	I-TREATMENT	I-TREATMENT
ddd	NN	I-TREATMENT	I-TREATMENT
available	JJ	O	O
to	TO	O	O
him	PRP	O	O
and	CC	O	O
is	VBZ	O	O
being	VBG	O	O
followed	VBN	O	O
by	IN	O	O
the	DT	O	O
ep	JJ	O	O
service	NN	O	O
and	CC	O	O
dr.	JJ	O	O
janet	NN	O	O
gutkin	NN	O	O
for	IN	O	O
further	JJ	O	B-TREATMENT
outpatient	JJ	O	I-TREATMENT
treatment	NN	O	I-TREATMENT
of	IN	O	O
this	DT	O	O

from	IN	O	O
a	DT	O	O
respiratory	JJ	O	O
point	NN	O	O
of	IN	O	O
view	NN	O	O
,	,	O	O
he	PRP	O	O
is	VBZ	O	O
on	IN	O	O
cpap	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
pressure	NN	B-TREATMENT	B-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
5	CD	O	O
and	CC	O	O
5	CD	O	O
at	IN	O	O
40%	CD	O	O
.	.	O	O

he	PRP	O	O
does	VBZ	O	O
use	VB	O	O
the	DT	B-TREATMENT	B-TREATMENT
passy-muir	JJ	I-TREATMENT	I-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
intermittently	RB	O	O
for	IN	O	O
his	PRP$	B-TREATMENT	B-PROBLEM
trach	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
trach	NN	I-TREATMENT	I-TREATMENT
collar	NN	I-TREATMENT	I-TREATMENT
this	DT	O	O
week	NN	O	O
during	IN	O	O
the	DT	O	O
day	NN	O	O
only	RB	O	O
and	CC	O	O
rested	VBN	O	O
on	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
ventilator	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O

abdominally	RB	O	O
,	,	O	O
he	PRP	O	O
does	VBZ	O	O
have	VB	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
midabdominal	JJ	I-PROBLEM	I-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
good	JJ	O	O
approximated	VBN	O	O
margins	NNS	O	O
and	CC	O	O
stay	NN	B-TREATMENT	B-TREATMENT
sutures	NNS	I-TREATMENT	I-TREATMENT
in	IN	O	O
place	NN	O	O
.	.	O	O

from	IN	O	O
a	DT	O	O
gi	JJ	O	O
point	NN	O	O
of	IN	O	O
view	NN	O	O
,	,	O	O
he	PRP	O	O
is	VBZ	O	O
receiving	VBG	O	O
promote	JJ	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
through	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
jejunostomy	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-PROBLEM	B-PROBLEM
chest	JJS	I-PROBLEM	I-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
granulating	VBG	O	O
in	IN	O	O
well	RB	O	O
.	.	O	O

he	PRP	O	O
currently	RB	O	O
receives	VBZ	O	O
saline	JJ	B-TREATMENT	B-TREATMENT
washes	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
adaptic	JJ	B-TREATMENT	B-TREATMENT
dressing	NN	I-TREATMENT	I-TREATMENT
changes	NNS	I-TREATMENT	I-TREATMENT
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

from	IN	O	O
a	DT	O	O
cmed	JJ	O	O
ccu	NN	O	O
point	NN	O	O
of	IN	O	O
view	NN	O	O
,	,	O	O
he	PRP	O	O
gets	VBZ	O	O
straight	RB	B-TREATMENT	O
cathed	VBN	I-TREATMENT	O
every	DT	O	O
other	JJ	O	O
day	NN	O	O
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
a	DT	B-TREATMENT	B-TREATMENT
left	JJ	I-TREATMENT	I-TREATMENT
subclavian	JJ	I-TREATMENT	I-TREATMENT
permcath	NN	I-TREATMENT	I-TREATMENT
access	NN	O	I-TREATMENT
for	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
dialysis	NN	I-TREATMENT	I-TREATMENT
which	WDT	O	O
takes	VBZ	O	O
place	NN	O	O
on	IN	O	O
monday	NN	O	O
,	,	O	O
wednesday	JJ	O	O
and	CC	O	O
friday	JJ	O	O
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
hitt	JJ	B-TEST	O
negative	JJ	O	O
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
received	VBN	O	O
no	DT	O	O
transfusions	NNS	B-TREATMENT	B-TREATMENT
in	IN	O	O
the	DT	O	O
past	JJ	O	O
week	NN	O	O
or	CC	O	O
so	RB	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
has	VBZ	O	O
been	VBN	O	O
stable	JJ	O	O
in	IN	O	O
the	DT	O	O
mid-30s	NN	O	O
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
a	DT	B-TREATMENT	B-TREATMENT
picc	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
place	NN	O	O
for	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
which	WDT	O	O
are	VBP	O	O
as	IN	O	O
follows	VBZ	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
picc	NN	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
12-29	JJ	O	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
currently	RB	O	O
are	VBP	O	O
vancomycin	JJ	B-TREATMENT	B-TREATMENT
,	,	O	O
ceftazidime	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
fluconazole	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
caspofungin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

i	NN	O	O
will	MD	O	O
give	VB	O	O
doses	NNS	O	O
and	CC	O	O
administration	NN	O	O
information	NN	O	O
in	IN	O	O
his	PRP$	O	O
list	NN	O	O
of	IN	O	O
discharge	NN	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
albumin	NN	I-TEST	I-TEST
today	NN	O	O
is	VBZ	O	O
2.5	CD	O	O
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
being	VBG	O	O
covered	VBN	O	O
by	IN	O	O
regular	JJ	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

exam	NN	B-TEST	B-TEST
today	NN	O	O
shows	VBZ	O	O
he	PRP	O	O
is	VBZ	O	O
neurologically	RB	O	O
alert	JJ	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
coarse	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
sounds	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
is	VBZ	O	O
granulating	VBG	O	O
in	IN	O	O
.	.	O	O

1.	CD	O	O
docusate	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

2.	CD	O	O
ursodiol	JJ	B-TREATMENT	B-TREATMENT
300	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

3.	CD	O	O
ascorbic	JJ	B-TREATMENT	B-TREATMENT
acid	RB	I-TREATMENT	I-TREATMENT
500	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
q.d.	NN	O	O

4.	CD	O	O
zinc	NN	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
220	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

5.	CD	O	O
lansoprazole	JJ	B-TREATMENT	B-TREATMENT
oral	JJ	I-TREATMENT	I-TREATMENT
solution	NN	I-TREATMENT	I-TREATMENT
30	CD	O	O
mg	NN	O	O
per	IN	O	O
gastric	JJ	O	O
tube	NN	O	O
q.d.	NN	O	O

6.	CD	O	O
caspofungin	NN	B-TREATMENT	B-TREATMENT
acetate	NN	I-TREATMENT	I-TREATMENT
50	CD	O	O
mg	NN	O	O
iv	NN	O	O
q.d.	NN	O	O
,	,	O	O
day	NN	O	O
23	CD	O	O
of	IN	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
patient	NN	O	O
should	MD	O	O
remain	VB	O	O
on	IN	O	O
it	PRP	O	O
indefinitely	RB	O	O
.	.	O	O

7.	CD	O	O
nephrocaps	NNS	B-TREATMENT	B-TEST
one	CD	O	O
cap	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

if	IN	O	O
on	IN	O	O
dialysis,	NN	B-TREATMENT	O
please	NN	O	O
take	VB	O	O
after	IN	O	O
dialysis	NN	B-TREATMENT	B-TREATMENT
treatment	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

8.	CD	O	O
metoclopramide	JJ	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
take	VBP	O	O
30	CD	O	O
minutes	NNS	O	O
before	IN	O	O
meals	NNS	O	O
.	.	O	O

9.	CD	O	O
fluconazole	JJ	B-TREATMENT	B-TREATMENT
200	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.h.d.	NN	O	O

patient	NN	O	O
should	MD	O	O
remain	VB	O	O
on	IN	O	O
this	DT	O	B-TREATMENT
medication	NN	B-TREATMENT	I-TREATMENT
.	.	O	O

10.	CD	O	O
magnesium	NN	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
2	CD	O	O
gm	NN	O	O
in	IN	O	O
100	CD	O	O
ml	NN	O	O
of	IN	O	O
d5w	NN	B-TREATMENT	O
iv	NN	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
repletion	NN	O	O
p.r.n.	NN	O	O

11.	CD	O	O
miconazole	JJ	B-TREATMENT	B-TREATMENT
powder	NN	I-TREATMENT	I-TREATMENT
2%	CD	O	O
one	CD	O	O
application	NN	O	O
t.p.	NN	O	O
t.i.d.	NN	O	O
p.r.n.	NN	O	O

12.	CD	O	O
acetaminophen	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NN	O	O
to	TO	O	O
650	CD	O	O
mg	NNS	O	O
p.o.	RB	O	O
q.four	VBP	O	O
to	TO	O	O
six	CD	O	O
hours	NNS	O	O
p.r.n.	VBP	O	O

13.	CD	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
one	CD	O	O
to	TO	O	O
two	CD	O	O
puffs	NNS	O	O
inhaled	VBD	O	O
q.	RB	O	O
six	CD	O	O
hours	NNS	O	O
p.r.n.	VBP	O	O

14.	CD	O	O
bisacodyl	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
per	IN	O	O
rectum	NN	O	O
h.s.	NN	O	O
as	IN	O	O
needed	VBN	O	O
p.r.n.	NN	O	O

15.	CD	O	O
hydralazine	JJ	B-TREATMENT	B-TREATMENT
hydrochloride	RB	I-TREATMENT	I-TREATMENT
10	CD	O	O
mg	NNS	O	O
iv	JJ	O	O
q.	RB	O	O
six	CD	O	O
hours	NNS	O	O
p.r.n.	VBP	O	O
systolic	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
greater	JJR	O	O
than	IN	O	O
140	CD	O	O
.	.	O	O

16.	CD	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
1	CD	O	O
gm	NN	O	O
iv	NN	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
vancomycin	JJ	B-TEST	B-TREATMENT
level	NN	I-TEST	I-TREATMENT
less	JJR	O	O
than	IN	O	O
15	CD	O	O
.	.	O	O

this	DT	O	O
is	VBZ	O	O
day	NN	O	O
23	CD	O	O
of	IN	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
an	DT	O	O
approximate	JJ	O	O
six	CD	O	O
week	NN	O	O
course	NN	O	O
.	.	O	O

17.	CD	O	O
ceftazidime	NN	B-TREATMENT	B-TREATMENT
1	CD	O	O
gm	NN	O	O
iv	NN	O	O
q.h.d.	NN	O	O
after	IN	O	O
dialysis	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

18.	CD	O	O
alteplase	NN	B-TREATMENT	B-TREATMENT
for	IN	O	I-TREATMENT
catheter	NN	O	I-TREATMENT
clearance	NN	O	I-TREATMENT
2	CD	O	O
mg	NN	O	O
iv	NN	O	O
once	RB	O	O
times	VBZ	O	O
one	CD	O	O
dose	NN	O	O
for	IN	O	O
indwelling	VBG	B-TREATMENT	B-TREATMENT
permcath	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

1.	CD	O	O
status	NN	O	O
post	NN	O	O
aortic	JJ	B-TREATMENT	B-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	VBG	I-TREATMENT	I-TREATMENT
times	NNS	O	O
four	CD	O	O
.	.	O	O

2.	CD	O	O
status	NN	O	O
post	NN	O	O
sternal	JJ	B-TREATMENT	B-TREATMENT
debridement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

3.	CD	O	O
status	NN	O	O
post	NN	O	O
skin	NN	B-TREATMENT	B-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	O	I-TREATMENT
chest	VB	B-PROBLEM	I-TREATMENT
incision	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

4.	CD	O	O
status	NN	O	B-TREATMENT
post	NN	O	I-TREATMENT
open	JJ	B-TREATMENT	I-TREATMENT
jejunostomy	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
,	,	O	I-TREATMENT
open	JJ	B-TREATMENT	I-TREATMENT
left	VBD	I-TREATMENT	I-TREATMENT
subclavian	JJ	I-TREATMENT	I-TREATMENT
permcath	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

5.	CD	O	O
status	NN	O	O
post	NN	O	O
ddd	NN	B-TREATMENT	B-TREATMENT
pacer	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
with	IN	O	I-TREATMENT
external	JJ	B-TREATMENT	I-TREATMENT
generator	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

6.	CD	O	O
status	NN	O	B-TREATMENT
post	NN	O	I-TREATMENT
abdominal	JJ	B-TREATMENT	I-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT
of	IN	O	I-TREATMENT
wound	JJ	B-PROBLEM	I-TREATMENT
dehiscence	NN	I-PROBLEM	I-TREATMENT
of	IN	I-PROBLEM	I-TREATMENT
jejunostomy	NN	I-PROBLEM	I-TREATMENT
site	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

7.	CD	O	O
status	NN	O	B-TREATMENT
post	NN	O	I-TREATMENT
percutaneous	JJ	B-TREATMENT	I-TREATMENT
tracheostomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

8.	CD	O	O
status	NN	O	O
post	NN	O	O
acute	VBP	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

9.	CD	O	O
status	NN	O	O
post	NN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

10.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

11.	CD	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

12.	CD	O	O
asthma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

13.	CD	O	O
peptic	JJ	B-PROBLEM	B-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
status	NN	O	O
post	NN	O	O
gastrectomy	NN	B-TREATMENT	B-TREATMENT
30	CD	O	O
years	NNS	O	O
ago	RB	O	O
.	.	O	O

14.	CD	O	O
colon	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
status	NN	O	O
post	NN	O	O
colectomy	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
xrt	NNP	B-TREATMENT	O
four	CD	O	O
years	NNS	O	O
ago	RB	O	O
.	.	O	O

15.	CD	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
vascular	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
history	NN	O	O
of	IN	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
claudication	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

16.	CD	O	O
copd	NN	B-PROBLEM	O
with	IN	O	O
asbestosis	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
chest	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
.	.	O	O

small	JJ	B-PROBLEM	B-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

chemotherapy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

briefly	NN	O	O
this	DT	O	O
is	VBZ	O	O
a	DT	O	O
hispanic	JJ	O	O
patient	NN	O	O
with	IN	O	O
history	NN	O	O
of	IN	O	O
advanced	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
small	JJ	O	B-PROBLEM
cell	NN	O	I-PROBLEM
in	IN	O	O
histology	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
presented	VBD	O	O
with	IN	O	O
almost	RB	B-PROBLEM	O
a	DT	I-PROBLEM	B-PROBLEM
stridor	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
mediastinal	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
oncology	NN	O	O
service	NN	O	O
after	IN	O	O
discussions	NNS	O	O
about	IN	O	O
the	DT	O	O
utility	NN	O	O
of	IN	O	O
chemotherapy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

in	IN	O	O
the	DT	O	O
oncology	NN	O	O
floor	NN	O	O
he	PRP	O	O
received	VBD	O	O
carboplatin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
etoposide	NN	B-TREATMENT	B-TREATMENT
to	TO	O	O
which	WDT	O	O
he	PRP	O	O
reacted	VBD	O	O
well	RB	O	O
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
35-year-old	JJ	O	O
gentleman	NN	O	O
with	IN	O	O
hiv	NN	B-PROBLEM	O
on	IN	O	O
haart	NN	B-TREATMENT	O
with	IN	O	O
last	JJ	B-TEST	B-TEST
cd4	JJ	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
268	CD	O	O
and	CC	O	O
undetectable	JJ	O	O
viral	JJ	B-TEST	O
load	NN	I-TEST	O
who	WP	O	O
was	VBD	O	O
referred	VBN	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
via	IN	O	O
his	PRP$	O	O
pcp	NN	O	O
for	IN	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
throat	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

his	PRP$	B-PROBLEM	B-PROBLEM
throat	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
began	VBD	O	O
2	CD	O	O
to	TO	O	O
3	CD	O	O
days	NNS	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
,	,	O	O
initially	RB	O	O
treated	VBN	O	O
with	IN	O	O
ibuprofen	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
seen	VBN	O	O
in	IN	O	O
an	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
emergency	NN	O	O
room	NN	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
where	WRB	O	O
he	PRP	O	O
received	VBD	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
penicillin	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
was	VBD	O	O
sent	VBN	O	O
home	NN	O	O
.	.	O	O

in	IN	O	O
clinic	JJ	O	O
today	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
desaturated	VBD	O	O
to	TO	O	O
low	VB	O	O
90	CD	O	O
s	NN	O	O
with	IN	O	O
ambulation	NN	O	O
and	CC	O	O
also	RB	O	O
had	VBD	O	O
complaints	NNS	O	O
of	IN	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
swelling	VBG	I-PROBLEM	I-PROBLEM
"	NN	O	O
like	IN	O	O
my	PRP$	O	O
throat	NN	O	O
is	VBZ	O	O
going	VBG	O	O
to	TO	O	O
close	VB	O	O
up	RP	O	O
"	NN	O	O
with	IN	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
drooling	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
unable	JJ	O	O
to	TO	O	O
swallow	VB	O	O
the	DT	B-TREATMENT	B-TREATMENT
hiv	NN	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

also	RB	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
low-grade	JJ	B-PROBLEM	B-PROBLEM
temperature	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
99	CD	O	O
to	TO	O	O
100	CD	O	O
degrees	NNS	O	O
with	IN	O	O
productive	JJ	B-PROBLEM	B-PROBLEM
cough	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
yellow	JJ	B-PROBLEM	B-TEST
sputum	NN	I-PROBLEM	I-TEST
times	NNS	O	O
1	CD	O	O
day	NN	O	O
with	IN	O	O

right	JJ	B-PROBLEM	B-PROBLEM
ear	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
subjective	JJ	B-PROBLEM	B-PROBLEM
shortness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
describes	VBZ	O	O
whole	JJ	B-PROBLEM	B-PROBLEM
body	NN	I-PROBLEM	I-PROBLEM
numbness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
currently	RB	O	O
notes	VBZ	O	O
improvement	NN	O	O
in	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
throat	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
after	IN	O	O
some	DT	B-TREATMENT	B-TREATMENT
decadron	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
clindamycin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
seen	VBN	O	O
by	IN	O	O
cmed	JJ	O	O
csru	NN	O	O
in	IN	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
and	CC	O	O
the	DT	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
was	VBD	O	O
consistent	JJ	O	O
with	IN	O	O
supraglottitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

review	NN	B-TEST	B-TEST
of	IN	I-TEST	I-TEST
systems	NNS	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
for	IN	O	O
history	NN	O	O
of	IN	O	O
opportunistic	JJ	B-PROBLEM	B-PROBLEM
infections	NNS	I-PROBLEM	I-PROBLEM
or	CC	O	O
prior	JJ	O	B-PROBLEM
hospitalizations	NNS	O	I-PROBLEM
.	.	O	O

of	IN	O	O
note	NN	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
cd4	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
less	JJR	O	O
than	IN	O	O
200	CD	O	O
last	JJ	O	O
winter	NN	O	O
.	.	O	O

he	PRP	O	O
believes	VBZ	O	O
he	PRP	O	O
is	VBZ	O	O
up-to-date	JJ	O	O
on	IN	O	O
all	PDT	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
vaccines	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

hiv	NN	B-PROBLEM	O
times	NNS	O	O
13	CD	O	O
years	NNS	O	O
.	.	O	O

last	JJ	B-TEST	B-TEST
cd4	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
268	CD	O	O
,	,	O	O
viral	JJ	B-TEST	B-PROBLEM
load	NN	I-TEST	I-PROBLEM
undetectable	JJ	O	I-PROBLEM
,	,	O	O
followed	VBD	O	O
at	IN	O	O
the	DT	O	O
boston	NN	O	O
regional	JJ	O	O
medical	JJ	O	O
centerr	NN	O	O
clinic	NN	O	O
by	IN	O	O
dr.	JJ	O	O
taylor	NN	O	O
.	.	O	O

history	NN	O	O
of	IN	O	O
anal	JJ	B-PROBLEM	B-PROBLEM
warts	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
rectal	JJ	B-PROBLEM	I-PROBLEM
abscesses	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
fistula	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

positive	JJ	O	O
for	IN	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

negative	JJ	O	O
for	IN	O	O
cad	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

mother	NN	O	O
with	IN	O	O
throat	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
atazanavir	JJ	B-TREATMENT	B-TREATMENT
300	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

2.	CD	O	O
ritonavir	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

3.	CD	O	O
tenofovir	JJ	B-TREATMENT	B-TREATMENT
300	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

4.	CD	O	O
didanosine	JJ	B-TREATMENT	B-TREATMENT
250	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

vital	JJ	B-TEST	B-TEST
signs	NNS	I-TEST	I-TEST
:	:	O	O

temperature	NN	B-TEST	B-TEST
100.1	CD	O	O
degrees	NNS	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
134/79	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
100	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
17	CD	O	O
,	,	O	O
and	CC	O	O
saturations	NNS	B-TEST	B-TEST
95	CD	O	O
percent	NN	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

heent	NN	O	O
:	:	O	O
positive	JJ	O	B-PROBLEM
hoarse	NN	B-PROBLEM	I-PROBLEM
whisper	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

positive	JJ	O	B-PROBLEM
drooling	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

negative	JJ	O	O
trismus	NN	B-PROBLEM	O
or	CC	O	O
stridor	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

bilateral	JJ	B-PROBLEM	B-PROBLEM
tonsillar	JJ	I-PROBLEM	I-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
white	JJ	B-PROBLEM	B-PROBLEM
exudate	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

right	JJ	O	B-TREATMENT
external	JJ	O	I-TREATMENT
auditory	NN	O	I-TREATMENT
canal	NN	O	I-TREATMENT
was	VBD	O	O
occluded	VBN	B-PROBLEM	B-PROBLEM
bycerumen	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
left	VBD	O	O
external	JJ	O	O
auditory	JJ	O	O
canal	JJ	O	O
clear	JJ	O	O
with	IN	O	O
tympanic	JJ	O	B-PROBLEM
membrane	NN	O	I-PROBLEM
intact	NN	O	I-PROBLEM
.	.	O	O

positive	JJ	O	B-PROBLEM
anterior	JJ	B-PROBLEM	I-PROBLEM
cervical	JJ	I-PROBLEM	I-PROBLEM
lymphadenopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

regular	JJ	O	O
and	CC	O	O
tachycardic	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

bilateral	JJ	B-PROBLEM	B-PROBLEM
coarse	NN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
sounds	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

negative	JJ	O	O
rhonchi	NN	B-PROBLEM	O
,	,	O	O
rales	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
wheezes	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

soft	JJ	O	O
and	CC	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

white	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
18.3	CD	O	O
,	,	O	O
neutrophils	VBZ	B-TEST	B-TEST
89	CD	O	O
percent	NN	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
41	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
261	CD	O	O
,	,	O	O
inr	NN	B-TEST	B-TEST
1.2	CD	O	O
,	,	O	O
and	CC	O	O
chem-7	JJ	B-TEST	O
otherwise	NN	O	O
normal	JJ	O	O
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
for	IN	O	O
effusions	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
pneumothorax	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

neck	NN	O	O
with	IN	O	O
soft	JJ	B-PROBLEM	B-PROBLEM
tissue	NN	I-PROBLEM	I-PROBLEM
prominence	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
epiglottitis	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
uvula	JJ	I-PROBLEM	O
consistent	NN	O	O
with	IN	O	O
epiglottitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

fiberoptic	JJ	B-TEST	B-TEST
scope	NN	I-TEST	I-TEST
showed	VBD	O	O
swelling	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
epiglottitis	NN	I-PROBLEM	I-PROBLEM
extending	VBG	O	O
down	RP	O	O
to	TO	O	O
the	DT	O	O
right	JJ	O	O
aryepiglottic	JJ	O	O
fold	NN	O	O
obscuring	VBG	O	O
view	NN	O	O
of	IN	O	O
the	DT	O	O
right	JJ	O	O
vocal	JJ	O	O
cord	NN	O	O
.	.	O	O

left	RB	O	B-PROBLEM
vocal	JJ	O	I-PROBLEM
cord	NN	O	I-PROBLEM
with	IN	O	O
glottic	JJ	O	B-PROBLEM
airway	NN	O	I-PROBLEM
visible	JJ	O	I-PROBLEM
but	CC	O	O
narrow	JJ	B-PROBLEM	O
.	.	O	O

positive	JJ	O	B-PROBLEM
edema	NN	B-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
supraglottitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
35-year-old	JJ	O	O
gentleman	NN	O	O
with	IN	O	O
hiv	NN	B-PROBLEM	O
on	IN	O	O
haart	NN	B-TREATMENT	O
,	,	O	O
last	JJ	B-TEST	B-TEST
cd4	NN	I-TEST	I-TEST
count	VBD	I-TEST	I-TEST
268	CD	O	O
with	IN	O	O
undetectable	JJ	O	B-PROBLEM
viral	JJ	B-TEST	I-PROBLEM
load	NN	I-TEST	I-PROBLEM
who	WP	O	O
was	VBD	O	O
initially	RB	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
csru	NN	O	O
for	IN	O	O
supraglottitis	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
epiglottitis	NN	B-PROBLEM	B-PROBLEM
/	NNP	O	O
supraglottitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
observed	VBN	O	O
in	IN	O	O
the	DT	O	O
cmed	JJ	O	O
csru	NN	O	O
for	IN	O	O
48	CD	O	O
hours	NNS	O	O
and	CC	O	O
noted	VBD	O	O
to	TO	O	O
have	VB	O	O
decrease	NN	O	B-PROBLEM
in	IN	O	I-PROBLEM
swelling	VBG	B-PROBLEM	I-PROBLEM
on	IN	O	O
serial	JJ	B-TEST	B-TEST
exams	NNS	I-TEST	I-TEST
.	.	O	O

he	PRP	O	O
was	VBD	O	O
followed	VBN	O	O
by	IN	O	O
the	DT	O	O
cmed	JJ	O	O
csru	NN	O	O
service	NN	O	O
and	CC	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
iv	NN	B-TREATMENT	B-TREATMENT
decadron	NN	I-TREATMENT	I-TREATMENT
initially	RB	O	O
in	IN	O	O
addition	NN	O	O
to	TO	O	O
iv	VB	B-TREATMENT	O
unasyn	NN	I-TREATMENT	B-TREATMENT
,	,	O	O
which	WDT	O	O
he	PRP	O	O
tolerated	VBD	O	O
well	RB	O	O
.	.	O	O

his	PRP$	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
improving	VBG	O	O
and	CC	O	O
was	VBD	O	O
starting	VBG	O	O
to	TO	O	O
tolerate	VB	O	O
p.o.	NN	O	O

his	PRP$	O	B-TEST
airway	NN	O	I-TEST
and	CC	O	O
symptoms	NNS	B-PROBLEM	B-PROBLEM
continued	VBD	O	O
to	TO	O	O
improve	VB	O	O
and	CC	O	O
remained	VBD	O	O
stable	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
stable	JJ	O	O
for	IN	O	O
transfer	NN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
,	,	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
over	IN	O	O
72	CD	O	O
hours	NNS	O	O
of	IN	O	O
iv	JJ	B-TREATMENT	O
unasyn	NN	I-TREATMENT	O
,	,	O	O
and	CC	O	O
then	RB	O	O
transitioned	VBD	O	O
to	TO	O	O
oral	JJ	O	B-TREATMENT
regimen	NNS	O	I-TREATMENT
of	IN	O	I-TREATMENT
augmentin	NN	B-TREATMENT	I-TREATMENT
to	TO	O	O
be	VB	O	O
continued	VBN	O	O
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
.	.	O	O

eventually	RB	O	O
,	,	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
iv	JJ	I-TREATMENT	I-TREATMENT
steroids	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
transitioned	VBN	O	O
to	TO	O	O
a	DT	B-TREATMENT	B-TREATMENT
p.o.	NN	I-TREATMENT	I-TREATMENT
steroid	NN	I-TREATMENT	I-TREATMENT
taper	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
which	WDT	O	O
he	PRP	O	O
tolerated	VBD	O	O
well	RB	O	O
,	,	O	O
and	CC	O	O
was	VBD	O	O
discharged	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
steroid	JJ	I-TREATMENT	I-TREATMENT
taper	NN	I-TREATMENT	I-TREATMENT
also	RB	O	O
with	IN	O	O
cmed	JJ	O	O
csru	JJ	O	O
follow-up	NN	O	O
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
.	.	O	O

his	PRP$	O	B-TEST
oxygenation	NN	O	I-TEST
and	CC	O	O
symptoms	NNS	B-PROBLEM	B-PROBLEM
remained	VBD	O	O
stable	JJ	O	O
and	CC	O	O
again	RB	O	O
tolerated	JJ	O	O
p.o.	NN	O	O
without	IN	O	O
difficulty	NN	O	B-PROBLEM
.	.	O	O

eventually	RB	O	O
,	,	O	O
as	IN	O	O
the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
,	,	O	O
his	PRP$	O	B-TEST
airway	NN	O	I-TEST
remained	VBD	O	O
stable	JJ	O	O
,	,	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
tolerating	VBG	O	O
po	NN	O	O
s,	NN	O	O
he	PRP	O	O
was	VBD	O	O
transitioned	VBN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
where	WRB	O	O
he	PRP	O	O
remained	VBD	O	O
otherwise	RB	O	O
stable	JJ	O	O
and	CC	O	O
asymptomatic	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
remained	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
during	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
his	PRP$	O	O
stay	NN	O	O
after	IN	O	O
transfer	NN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
and	CC	O	O
per	IN	O	O
cmed	VBN	O	O
csru	NN	O	O
was	VBD	O	O
to	TO	O	O
be	VB	O	O
discharged	VBN	O	O
on	IN	O	O
a	DT	O	B-TREATMENT
2-week	JJ	O	I-TREATMENT
course	NN	O	I-TREATMENT
of	IN	O	I-TREATMENT
augmentin	NN	B-TREATMENT	I-TREATMENT
with	IN	O	O
follow-up	JJ	O	O
with	IN	O	O
dr.	JJ	O	O
thibodeau	NN	O	O
in	IN	O	O
2	CD	O	O
weeks	NNS	O	O
'	POS	O	O
time	NN	O	O
in	IN	O	O
addition	NN	O	O
to	TO	O	O
a	DT	B-TREATMENT	B-TREATMENT
medrol	NN	I-TREATMENT	I-TREATMENT
dosepak	NN	I-TREATMENT	O
.	.	O	O

1.	CD	O	O
hiv	NN	B-PROBLEM	O
.	.	O	O

once	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
tolerating	VBG	O	O
p.o.	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
restarted	VBN	O	O
on	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
haart	NN	I-TREATMENT	I-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
remained	VBD	O	O
stable	JJ	O	O
from	IN	O	O
that	DT	O	O
perspective	NN	O	O
.	.	O	O

epiglottitis	NN	B-PROBLEM	B-PROBLEM
/	NNP	O	O
supraglottitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

hiv	NN	B-PROBLEM	O
.	.	O	O

1.	CD	O	O
menthol	SYM	B-TREATMENT	B-TEST
-	:	I-TREATMENT	O
cetylpyridinium	NN	I-TREATMENT	B-TREATMENT
lozenges	VBZ	I-TREATMENT	I-TREATMENT
1	CD	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

2.	CD	O	O
tenofovir	JJ	B-TREATMENT	B-TREATMENT
300	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

3.	CD	O	O
didanosine	JJ	B-TREATMENT	B-TREATMENT
250	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

4.	CD	O	O
atazanavir	JJ	B-TREATMENT	B-TREATMENT
300	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

5.	CD	O	O
ritonavir	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

6.	CD	O	O
calcium	NN	B-TREATMENT	B-TREATMENT
carbonate	NN	I-TREATMENT	I-TREATMENT
500	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

7.	CD	O	O
methylprednisolone	NN	B-TREATMENT	B-TREATMENT
4	CD	O	O
mg	NN	O	O
tablets	NNS	O	O
per	IN	O	O
taper	NN	O	B-TREATMENT
regimen	NNS	O	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
also	RB	O	O
discharged	VBN	O	O
on	IN	O	O
augmentin	NN	B-TREATMENT	B-TREATMENT
xr	NN	I-TREATMENT	I-TREATMENT
1000	CD	O	O
mg	NN	O	O
/	VBD	O	O
62.5	CD	O	O
mg	NN	O	O
sustained	VBD	O	O
release	NN	O	O
1	CD	O	O
tablet	NN	O	O
q.	NN	O	O
12h	CD	O	O
.	.	O	O
for	IN	O	O
2	CD	O	O
weeks	NNS	O	O
.	.	O	O

sob	NN	B-PROBLEM	B-PROBLEM

copd	NN	B-PROBLEM	B-PROBLEM
exacerbation	NN	I-PROBLEM	I-PROBLEM
(	(	I-PROBLEM	I-PROBLEM
emphysema	NN	I-PROBLEM	I-PROBLEM
)	)	I-PROBLEM	I-PROBLEM

prednisone	NN	B-TREATMENT	B-TREATMENT
,	,	O	I-TREATMENT
nebulizers	NNS	B-TREATMENT	I-TREATMENT
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
shows	NNS	O	O
question	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
nodule	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
may	MD	O	O
be	VB	O	O
cancer	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

prednisone	NN	B-TREATMENT	B-TREATMENT
60	CD	O	O
mg	JJ	O	O
daily	RB	O	O
for	IN	O	O
4	CD	O	O
days	NNS	O	O
.	.	O	O

continue	NN	O	O
inhalers	NNS	B-TREATMENT	B-TREATMENT
as	IN	O	O
prescribed	NN	O	O
.	.	O	O

call	NN	O	O
dr.	NN	O	O
linketerf	NN	O	O
tomorrow	NN	O	O
and	CC	O	O
make	VB	O	O
an	DT	O	O
appointment	NN	O	O
for	IN	O	O
follow-up	NN	O	B-PROBLEM
on	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
nodule	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
52	JJ	O	O
-	:	O	O
year-old	JJ	O	O
female	NN	O	O
with	IN	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
cardiopulmonary	JJ	I-PROBLEM	I-PROBLEM
history	NN	I-PROBLEM	I-PROBLEM
who	WP	O	O
presented	VBD	O	O
with	IN	O	O
a	DT	O	O
chief	JJ	O	O
complaint	NN	O	O
of	IN	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
exertion	NN	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
exertional	JJ	B-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
tightness	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
acute-on-chronic	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
stated	VBD	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
began	VBD	O	O
in	IN	O	O
2011	CD	O	O
and	CC	O	O
have	VBP	O	O
increased	VBN	O	B-PROBLEM
in	IN	O	I-PROBLEM
intensity	NN	O	I-PROBLEM
and	CC	O	O
frequency	NN	O	O
every	DT	O	O
since	IN	O	O
then	RB	O	O
.	.	O	O

she	PRP	O	O
reports	VBZ	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
exertion	NN	O	O
and	CC	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
tightness	NN	I-PROBLEM	I-PROBLEM
daily	RB	O	O
which	WDT	O	O
worsened	VBD	O	O
significantly	RB	O	O
one	CD	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
.	.	O	O

says	VBZ	O	O
that	IN	O	O
she	PRP	O	O
could	MD	O	O
not	RB	O	O
walk	VB	O	O
a	DT	O	O
few	JJ	O	O
yards	NNS	O	O
without	IN	O	O
developing	VBG	O	B-PROBLEM
symptoms	NNS	B-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
describes	VBZ	O	O
the	DT	B-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
tightness	NN	I-PROBLEM	I-PROBLEM
as	IN	O	O
substernal	JJ	O	O
and	CC	O	O
epigastric	JJ	O	O
.	.	O	O

she	PRP	O	O
denied	VBD	O	O
any	DT	B-PROBLEM	B-PROBLEM
associated	JJ	I-PROBLEM	I-PROBLEM
nausea	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
diaphoresis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
lightheadedness	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
dizziness	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
does	VBZ	O	O
have	VB	O	O
radiation	NN	B-PROBLEM	O
of	IN	I-PROBLEM	O
the	DT	I-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
her	PRP$	O	O
neck	NN	O	O
and	CC	O	O
jaw	NN	O	B-PROBLEM
bilaterally	RB	O	I-PROBLEM
.	.	O	O

she	PRP	O	O
also	RB	O	O
describes	VBZ	O	O
a	DT	B-PROBLEM	B-TEST
fast	JJ	I-PROBLEM	I-TEST
heart	NN	I-PROBLEM	I-TEST
rate	NN	I-PROBLEM	I-TEST
and	CC	O	O
palpitations	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
stated	VBD	O	O
her	PRP	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
improved	VBN	O	O
with	IN	O	O
rest	NN	O	O
,	,	O	O
and	CC	O	O
she	PRP	O	O
denied	VBD	O	O
any	DT	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
beginning	VBG	O	O
when	WRB	O	O
she	PRP	O	O
was	VBD	O	O
at	IN	O	O
rest	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
reports	VBZ	O	O
a	DT	B-TEST	B-TEST
previous	JJ	I-TEST	I-TEST
workup	NN	I-TEST	I-TEST
which	WDT	O	O
included	VBD	O	O
a	DT	O	B-TEST
negative	JJ	O	I-TEST
exercise	NN	O	I-TEST
treadmill	NN	O	I-TEST
test	NN	O	I-TEST
,	,	O	O
a	DT	O	O
normal	JJ	O	O
mibi	NN	O	O
in	IN	O	O
2011-04-10	JJ	O	O
,	,	O	O
and	CC	O	O
a	DT	O	O
normal	JJ	O	O
echocardiogram	NN	O	B-TEST
in	IN	O	O
2012	CD	O	O
(	(	O	O
except	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
borderline	NN	I-PROBLEM	I-PROBLEM
mild	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
)	)	O	I-PROBLEM
with	IN	O	O
an	DT	B-TEST	B-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
55%	CD	O	O
.	.	O	O

review	NN	B-TEST	B-TEST
of	IN	I-TEST	I-TEST
systems	NNS	I-TEST	I-TEST
was	VBD	O	O
significant	JJ	O	O
for	IN	O	O
menopausal	NN	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
(	(	O	O
for	IN	O	O
which	WDT	O	O
she	PRP	O	O
has	VBZ	O	O
attempted	VBN	O	O
hormone	CD	B-TREATMENT	B-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
discontinued	VBN	O	O
in	IN	O	O
2014	CD	O	O
).	NN	O	O

she	PRP	O	O
also	RB	O	O
reports	VBZ	O	O
difficulty	NN	B-PROBLEM	B-PROBLEM
sleeping	VBG	I-PROBLEM	I-PROBLEM
,	,	O	O
daytime	JJ	B-PROBLEM	B-PROBLEM
sleepiness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
sleeps	VBZ	O	O
on	IN	O	O
elevated	JJ	B-TREATMENT	B-TREATMENT
pillows	NNS	I-TREATMENT	I-TREATMENT
secondary	JJ	O	O
to	TO	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
gastroesophageal	JJ	I-PROBLEM	I-PROBLEM
reflux	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

occasional	JJ	B-PROBLEM	B-PROBLEM
paroxysmal	JJ	I-PROBLEM	I-PROBLEM
nocturnal	JJ	I-PROBLEM	I-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
past	JJ	O	O
but	CC	O	O
none	NN	O	O
recently	RB	O	O
.	.	O	O

occasional	JJ	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
left	VBD	O	O
greater	JJR	O	O
than	IN	O	O
right	NN	O	O
.	.	O	O

no	DT	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	O
urinary	JJ	I-PROBLEM	B-PROBLEM
complaints	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
gastroesophageal	JJ	B-PROBLEM	B-PROBLEM
reflux	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
grave's	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
radiation	NN	B-TREATMENT	B-TREATMENT
resulting	VBG	O	O
in	IN	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

3.	CD	O	O
migraines	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

synthroid	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
prilosec	VBP	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
,	,	O	O
fioricet	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
celebrex	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

penicillin	NN	B-TREATMENT	B-TREATMENT
causes	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
rash	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

diabetes	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
grave's	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
no	DT	O	O
history	NN	O	O
of	IN	O	O
cardiopulmonary	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
does	VBZ	O	O
use	VB	O	O
herbal	JJ	B-TREATMENT	B-TREATMENT
remedies	NNS	I-TREATMENT	I-TREATMENT
including	VBG	O	O
primrose	JJ	B-TREATMENT	B-PROBLEM
oil	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
siberian	JJ	B-TREATMENT	B-TREATMENT
ginseng	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
use	NN	O	O
of	IN	O	O
wallerian	JJ	B-TREATMENT	B-TREATMENT
root	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

vital	JJ	B-TEST	B-TEST
signs	NNS	I-TEST	I-TEST
were	VBD	O	O
temperature	NN	B-TEST	B-TEST
of	IN	O	O
98.4	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
74	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
130/91	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
21	CD	O	O
,	,	O	O
satting	VBG	O	B-TEST
98%	CD	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

neck	NN	O	O
was	VBD	O	O
supple	JJ	O	O
,	,	O	O
no	DT	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
thyromegaly	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
jugular	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
distention	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
no	DT	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

lungs	NNS	O	O
had	VBD	O	O
scant	JJ	B-PROBLEM	B-PROBLEM
crackles	NNS	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
base	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
middle	JJ	I-PROBLEM	I-PROBLEM
field	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
otherwise	RB	O	O
clear	JJ	O	O
.	.	O	O

no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
parasternal	JJ	B-PROBLEM	B-PROBLEM
heave	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

gastrointestinal	JJ	O	O
revealed	VBD	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
nondistended	VBD	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

extremities	NNS	O	O
had	VBD	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
2+	CD	B-TEST	B-PROBLEM
distal	JJ	I-TEST	I-PROBLEM
pedis	NN	I-TEST	I-PROBLEM
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
admission	NN	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
11.1	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
37.7	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
326	CD	O	O
.	.	O	O

sodium	NN	B-TEST	B-TEST
140	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
105	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
28	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
17	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
0.8	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
76	CD	O	O
.	.	O	O

creatine	NN	B-TEST	B-TREATMENT
kinase	NN	I-TEST	I-TREATMENT
100	CD	O	O
,	,	O	O
mb	FW	B-TEST	B-TEST
4	CD	O	O
,	,	O	O
troponin	NN	B-TEST	B-TEST
of	IN	O	O
less	JJR	O	O
than	IN	O	O
0.3	CD	O	O
.	.	O	O

electrocardiogram	NN	B-TEST	B-TEST
revealed	VBD	O	O
left	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
right	JJ	B-PROBLEM	B-PROBLEM
ventricular	NN	I-PROBLEM	I-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
poor	JJ	B-PROBLEM	B-PROBLEM
r	NN	I-PROBLEM	I-PROBLEM
wave	NN	I-PROBLEM	I-PROBLEM
progression	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
were	VBD	O	O
new	JJ	O	O
.	.	O	O

also	RB	O	O
,	,	O	O
t	NNS	B-PROBLEM	B-PROBLEM
wave	VBP	I-PROBLEM	I-PROBLEM
inversions	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
ii	NN	I-PROBLEM	O
,	,	I-PROBLEM	O
iii	NN	I-PROBLEM	O
,	,	I-PROBLEM	O
avf	NN	I-PROBLEM	O
,	,	I-PROBLEM	O
v1	VBP	I-PROBLEM	O
through	IN	I-PROBLEM	O
v5	NN	I-PROBLEM	O
;	:	O	O
new	JJ	B-PROBLEM	B-PROBLEM
evolving	VBG	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
bundle-branch	JJ	I-PROBLEM	I-PROBLEM
block	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
52	JJ	O	O
-	:	O	O
year-old	JJ	O	O
female	NN	O	O
with	IN	O	O
no	DT	O	O
known	JJ	O	O
history	NN	O	O
of	IN	O	O
cardiac	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
presenting	VBG	O	O
with	IN	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
exertion	NN	O	O
and	CC	O	O
chest	NN	B-PROBLEM	B-PROBLEM
tightness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
who	WP	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
evaluation	NN	B-TEST	B-TEST
and	CC	O	O
management	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
complaints	NNS	O	O
of	IN	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
exertion	NN	O	O
and	CC	O	O
chest	NN	B-PROBLEM	B-TEST
pressure	NN	I-PROBLEM	I-TEST
which	WDT	O	O
could	MD	O	O
be	VB	O	O
consistent	JJ	O	O
with	IN	O	O
angina	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

however	RB	O	O
,	,	O	O
given	VBN	O	O
the	DT	O	O
long	JJ	O	O
duration	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
negative	JJ	O	O
workup	NN	O	O
in	IN	O	O
the	DT	O	O
past	NN	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
thought	VBN	O	O
to	TO	O	O
be	VB	O	O
unlikely	JJ	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
aspirin	NN	I-TREATMENT	I-TREATMENT
as	RB	O	O
well	RB	O	O
as	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
beta	NN	I-TREATMENT	I-TREATMENT
blocker	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
a	DT	B-TEST	O
rule	NN	I-TEST	O
out	IN	I-TEST	O
myocardial	JJ	I-TEST	B-PROBLEM
infarction	NN	I-TEST	I-PROBLEM
protocol	NN	I-TEST	I-PROBLEM
was	VBD	O	O
initiated	VBN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
stress	NN	I-TEST	I-TEST
thallium	NN	I-TEST	I-TEST
was	VBD	O	O
planned	VBN	O	O
for	IN	O	O
the	DT	O	O
day	NN	O	O
following	VBG	O	O
admission	NN	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
on	IN	O	O
the	DT	O	O
night	NN	O	O
of	IN	O	O
admission	NN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
found	VBN	O	O
lying	VBG	O	O
in	IN	O	O
her	PRP$	O	O
bed	NN	O	O
diaphoretic	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
obtunded	VBD	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
a	DT	O	B-TEST
code	NN	O	I-TEST
was	VBD	O	O
called	VBN	O	O
.	.	O	O

further	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	O	B-PROBLEM
strong	JJ	O	I-PROBLEM
palpable	JJ	O	I-PROBLEM
pulse	NN	O	I-PROBLEM
with	IN	O	O
a	DT	B-TEST	B-TEST
systolic	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
in	IN	O	O
the	DT	O	O
130	CD	O	O
s	NN	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
in	IN	O	O
the	DT	O	O
80	CD	O	O
s.	NN	O	O

she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
fluid	NN	I-TREATMENT	I-TREATMENT
bolus	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	JJ	O	O
quickly	RB	O	O
responded	VBD	O	O
to	TO	O	O
a	DT	B-TREATMENT	B-TREATMENT
fluid	NN	I-TREATMENT	I-TREATMENT
bolus	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
became	VBD	O	O
interactive	JJ	O	O
.	.	O	O

she	PRP	O	O
reported	VBD	O	O
that	IN	O	O
she	PRP	O	O
was	VBD	O	O
sitting	VBG	O	B-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
commode	NN	O	I-PROBLEM
urinating	NN	O	I-PROBLEM
and	CC	O	O
began	VBD	O	O
to	TO	O	O
feel	VB	O	O
nauseous	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
presyncopal	JJ	B-PROBLEM	O
.	.	O	O

she	PRP	O	O
denied	VBD	O	O
any	DT	B-PROBLEM	B-PROBLEM
chest	JJS	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
pressure	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
no	DT	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
during	IN	O	O
this	DT	O	O
event	NN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
rhythm	NN	I-TEST	I-TEST
check	NN	I-TEST	I-TEST
obtained	VBD	O	O
during	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
this	DT	O	O
event	NN	O	O
demonstrated	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
pause	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
six	CD	I-PROBLEM	I-PROBLEM
seconds	NNS	I-PROBLEM	I-PROBLEM
followed	VBN	O	O
by	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
junctional	JJ	I-PROBLEM	I-PROBLEM
escape	NN	I-PROBLEM	I-PROBLEM
rhythm	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
obtained	VBN	O	O
after	IN	O	O
the	DT	O	O
code	NN	O	O
demonstrated	VBD	O	O
no	DT	O	O
acute	NN	B-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	B-PROBLEM	B-PROBLEM
acute	JJ	I-PROBLEM	I-PROBLEM
bradycardic	JJ	I-PROBLEM	I-PROBLEM
event	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
felt	VBN	O	O
likely	RB	O	O
secondary	JJ	O	O
to	TO	O	O
her	PRP$	B-TREATMENT	B-PROBLEM
new	JJ	I-TREATMENT	I-PROBLEM
beta	NN	I-TREATMENT	I-PROBLEM
blocker	NN	I-TREATMENT	I-PROBLEM
in	IN	O	O
conjunction	NN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
vagal	JJ	I-PROBLEM	I-PROBLEM
response	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

it	PRP	O	O
was	VBD	O	O
determined	VBN	O	O
to	TO	O	O
stop	VB	O	O
the	DT	B-TREATMENT	O
beta	NN	I-TREATMENT	O
blocker	NN	I-TREATMENT	O
,	,	O	O
and	CC	O	O
atropine	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
placed	VBN	O	O
at	IN	O	O
the	DT	O	O
bedside	NN	O	O
.	.	O	O

on	IN	O	O
the	DT	O	O
following	JJ	O	O
day	NN	O	O
the	DT	O	O
patient	NN	O	O
underwent	VBD	O	O
an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
which	WDT	O	O
demonstrated	VBD	O	O
dilated	VBD	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
ventricle	NN	I-PROBLEM	I-PROBLEM
secondary	JJ	O	O
to	TO	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
dysfunction	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-TEST	B-TEST
pulmonary	JJ	I-TEST	I-TEST
artery	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
greater	JJR	O	O
than	IN	O	O
100	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
stress	JJ	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
was	VBD	O	O
cancelled	VBN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
angiogram	NN	I-TEST	I-TEST
was	VBD	O	O
ordered	VBN	O	O
to	TO	O	O
evaluate	VB	O	O
for	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
thromboembolic	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
as	IN	O	O
a	DT	O	O
potential	JJ	O	O
cause	NN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
ruled	VBN	O	O
out	RP	O	O
for	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
three	CD	O	O
sets	NNS	O	O
of	IN	O	O
normal	JJ	O	O
enzymes	NNS	O	O
and	CC	O	O
continued	VBD	O	O
to	TO	O	O
be	VB	O	O
monitored	VBN	O	O
on	IN	O	O
telemetry	NN	B-TEST	B-TEST
.	.	O	O

a	DT	O	B-TEST
pulmonary	JJ	O	I-TEST
consultation	NN	O	I-TEST
was	VBD	O	O
obtained	VBN	O	O
to	TO	O	O
evaluate	VB	O	O
for	IN	O	O
possible	JJ	O	O
etiology	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	O
patient	NN	I-PROBLEM	O
's	POS	I-PROBLEM	O
hypotension	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
little	JJ	O	O
evidence	NN	O	O
to	TO	O	O
suggest	VB	O	O
any	DT	B-PROBLEM	B-PROBLEM
cardiac	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
given	VBN	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
grave's	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
an	DT	B-PROBLEM	I-PROBLEM
autoimmune	JJ	I-PROBLEM	I-PROBLEM
process	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
possible	JJ	O	O
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
consideration	NN	O	O
was	VBD	O	O
given	VBN	O	O
to	TO	O	O
sarcoidosis	VB	B-PROBLEM	B-PROBLEM
,	,	O	O
human	JJ	B-PROBLEM	B-PROBLEM
immunodeficiency	NN	I-PROBLEM	I-PROBLEM
virus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
drug-induced	JJ	O	O
given	VBN	O	O
her	PRP$	O	O
history	NN	O	O
of	IN	O	O
herbal	JJ	B-TREATMENT	B-TREATMENT
medication	NN	I-TREATMENT	I-TREATMENT
use	NN	O	I-TREATMENT
.	.	O	O

it	PRP	O	O
was	VBD	O	O
recommended	VBN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
begin	NN	O	O
anticoagulation	NN	B-TREATMENT	B-TREATMENT
given	VBN	O	O
the	DT	O	O
severity	NN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

it	PRP	O	O
was	VBD	O	O
also	RB	O	O
planned	VBN	O	O
to	TO	O	O
undergo	VB	O	O
a	DT	B-TEST	B-TEST
right	JJ	I-TEST	I-TEST
heart	NN	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
with	IN	O	O
a	DT	B-TEST	B-PROBLEM
vasodilation	NN	I-TEST	I-PROBLEM
trial	NN	I-TEST	I-PROBLEM
by	IN	O	O
the	DT	O	O
catheterization	NN	O	O
laboratory	NN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
right	JJ	I-TEST	I-TEST
heart	NN	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
on	IN	O	O
2014-12-05	JJ	O	O
.	.	O	O

a	DT	B-TEST	B-TREATMENT
pharmacologic	JJ	I-TEST	I-TREATMENT
pulmonary	JJ	I-TEST	I-TREATMENT
vasodilator	NN	I-TEST	I-TREATMENT
challenge	NN	I-TEST	I-TREATMENT
was	VBD	O	O
performed	VBN	O	O
with	IN	O	O
a	DT	O	B-PROBLEM
positive	JJ	O	I-PROBLEM
response	NN	O	I-PROBLEM
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
ct	JJ	I-TEST	I-TEST
angiogram	NN	I-TEST	I-TEST
of	IN	I-TEST	O
the	DT	I-TEST	O
chest	NN	I-TEST	O
with	IN	O	O
pulmonary	JJ	B-TEST	B-PROBLEM
embolism	NN	I-TEST	I-PROBLEM
protocol	NN	I-TEST	I-PROBLEM
showed	VBD	O	O
no	DT	O	O
intravascular	JJ	B-PROBLEM	B-PROBLEM
filling	NN	I-PROBLEM	I-PROBLEM
defect	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
did	VBD	O	O
show	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
ground-glass	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
scattered	VBD	B-PROBLEM	B-PROBLEM
adenopathy	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

therefore	RB	O	O
,	,	O	O
in	IN	O	O
the	DT	O	O
end	NN	O	O
left	VBD	B-PROBLEM	O
atrial	JJ	I-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
essentially	RB	O	O
ruled	VBN	O	O
out	RP	O	O
as	IN	O	O
a	DT	O	O
primary	JJ	O	O
cause	NN	O	O
.	.	O	O

chronic	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
embolus	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
less	RBR	O	O
likely	JJ	O	O
given	VBN	O	O
her	PRP$	O	B-TEST
negative	JJ	O	I-TEST
ct	NN	O	I-TEST
angiogram	NN	O	I-TEST
.	.	O	O

chronic	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
unlikely	JJ	O	O
given	VBN	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
normal	JJ	O	O
pulmonary	JJ	O	B-TEST
function	NN	O	I-TEST
tests	NNS	O	I-TEST
and	CC	O	O
dlco	NN	B-TEST	B-TREATMENT
in	IN	O	O
2012	CD	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
a	DT	O	B-TEST
normal	JJ	O	I-TEST
ct	NN	O	I-TEST
angiogram	NN	O	I-TEST
.	.	O	O

collagen	NN	B-PROBLEM	B-PROBLEM
vascular	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
could	MD	O	O
not	RB	O	O
be	VB	O	O
definitively	RB	O	O
ruled	VBN	O	O
out	RP	O	O
;	:	O	O
however	RB	O	O
,	,	O	O
given	VBN	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
lack	NN	O	O
of	IN	O	O
connective	JJ	B-PROBLEM	B-PROBLEM
tissue	NN	I-PROBLEM	I-PROBLEM
disorder	NN	I-PROBLEM	I-PROBLEM
stigmata	VBD	I-PROBLEM	I-PROBLEM
it	PRP	O	I-PROBLEM
was	VBD	O	O
thought	VBN	O	O
to	TO	O	O
be	VB	O	O
less	RBR	O	O
likely	JJ	O	O
,	,	O	O
and	CC	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
human	JJ	I-TEST	I-TEST
immunodeficiency	NN	I-TEST	I-TEST
virus	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

therefore	RB	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
most	RBS	O	O
likely	JJ	O	O
experiencing	VBG	O	O
a	DT	B-PROBLEM	B-PROBLEM
primary	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

consideration	NN	O	O
was	VBD	O	O
given	VBN	O	O
to	TO	O	O
treating	VBG	O	O
the	DT	O	O
patient	NN	O	O
with	IN	O	O
a	DT	O	O
course	NN	O	O
of	IN	O	O
calcium	NN	B-TREATMENT	B-TREATMENT
channel	NN	I-TREATMENT	I-TREATMENT
blocker	NN	I-TREATMENT	I-TREATMENT
;	:	O	O
however	RB	O	O
,	,	O	O
given	VBN	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
poor	JJ	O	O
response	NN	O	O
to	TO	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
it	PRP	O	O
was	VBD	O	O
determined	VBN	O	O
that	IN	O	O
this	DT	O	O
would	MD	O	O
not	RB	O	O
be	VB	O	O
optimal	JJ	O	O
treatment	NN	O	O
for	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

therefore	RB	O	O
,	,	O	O
her	PRP	O	O
insurance	NN	O	O
company	NN	O	O
was	VBD	O	O
contacted	VBN	O	O
regarding	VBG	O	O
the	DT	O	O
potential	NN	O	O
of	IN	O	O
flolan	NN	B-TREATMENT	O
as	IN	O	O
a	DT	O	B-TREATMENT
treatment	NN	O	I-TREATMENT
.	.	O	O

plans	NNS	O	O
were	VBD	O	O
made	VBN	O	O
for	IN	O	O
placement	NN	O	O
of	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
hickman	JJ	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
initiation	NN	O	O
of	IN	O	O
flolan	NN	B-TREATMENT	B-TREATMENT
treatment	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

however	RB	O	O
,	,	O	O
on	IN	O	O
12-07	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
once	RB	O	O
again	RB	O	O
experienced	VBD	O	O
an	DT	O	O
episode	NN	O	O
of	IN	O	O
unresponsiveness	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

upon	IN	O	O
arrival	NN	O	O
by	IN	O	O
the	DT	O	O
physician	NN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
awake	RB	O	O
,	,	O	O
alert	NN	O	O
,	,	O	O
and	CC	O	O
oriented	VBN	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
pulse	NN	I-TEST	I-TEST
in	IN	O	O
the	DT	O	O
80	CD	O	O
s,	NN	O	O
with	IN	O	O
pressure	NN	B-TEST	O
in	IN	O	O
the	DT	O	O
80	CD	O	O
s,	NN	O	O
and	CC	O	O
satting	VBG	O	B-TEST
100%	CD	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

she	PRP	O	O
described	VBD	O	O
this	DT	O	O
episode	NN	O	O
as	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
uncomfortable	JJ	I-PROBLEM	I-PROBLEM
feeling	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
2	CD	O	O
liters	NNS	O	O
of	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
with	IN	O	O
a	DT	O	B-PROBLEM
bump	NN	O	I-PROBLEM
in	IN	O	O
her	PRP$	B-TEST	B-TEST
systolic	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
to	TO	O	O
the	DT	O	O
90	CD	O	O
s.	NN	O	O

review	NN	O	B-TEST
of	IN	O	I-TEST
telemetry	NN	B-TEST	I-TEST
revealed	VBD	O	O
an	DT	O	O
8	CD	O	O
to	TO	O	O
9	CD	O	O
beat	NN	O	O
episode	NN	O	O
of	IN	O	O
nonsustained	JJ	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
followed	VBN	O	O
by	IN	O	O
an	DT	O	O
episode	NN	O	O
of	IN	O	O
bradycardia	NN	B-PROBLEM	B-PROBLEM
to	TO	O	O
60	CD	O	O
beats	NNS	O	O
per	IN	O	O
minute	NN	O	O
.	.	O	O

the	DT	O	O
etiology	NN	O	O
of	IN	O	O
these	DT	B-PROBLEM	B-PROBLEM
cardiovascular	JJ	I-PROBLEM	I-PROBLEM
episodes	NNS	I-PROBLEM	I-PROBLEM
was	VBD	O	O
unclear	JJ	O	O
,	,	O	O
but	CC	O	O
was	VBD	O	O
felt	VBN	O	O
likely	RB	O	O
secondary	JJ	O	O
to	TO	O	O
the	DT	B-PROBLEM	O
patient	NN	I-PROBLEM	O
's	POS	I-PROBLEM	O
tenuous	JJ	I-PROBLEM	O
cardiovascular	JJ	I-PROBLEM	O
status	NN	I-PROBLEM	O
given	VBN	O	O
the	DT	O	O
fact	NN	O	O
that	IN	O	O
she	PRP	O	O
had	VBD	O	O
clear	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
was	VBD	O	O
very	RB	B-PROBLEM	O
preload	JJ	I-PROBLEM	O
dependent	NN	I-PROBLEM	O
,	,	O	O
and	CC	O	O
had	VBD	O	O
an	DT	O	B-TEST
intact	JJ	O	I-TEST
left	VBD	O	I-TEST
ventricular	JJ	O	I-TEST
function	NN	O	I-TEST
but	CC	O	O
with	IN	O	O
cardiac	JJ	B-PROBLEM	B-TEST
output	NN	I-PROBLEM	I-TEST
limited	VBD	I-PROBLEM	O
due	JJ	O	O
to	TO	O	O
left	JJ	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
compression	NN	I-PROBLEM	I-PROBLEM
by	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
dilated	JJ	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
ventricle	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

given	VBN	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
persistent	JJ	I-PROBLEM	I-PROBLEM
hypotensive	JJ	I-PROBLEM	I-PROBLEM
episodes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
decreased	VBD	B-PROBLEM	B-PROBLEM
urine	JJ	I-PROBLEM	I-PROBLEM
output	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
she	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
back	RB	O	O
to	TO	O	O
the	DT	O	O
medical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
management	NN	O	O
prior	RB	O	O
to	TO	O	O
initiation	NN	O	O
of	IN	O	O
flolan	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
12-08	JJ	O	O
,	,	O	O
the	DT	B-TREATMENT	B-TREATMENT
hickman	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
in	IN	O	O
preparation	NN	O	O
of	IN	O	O
flolan	JJ	B-TREATMENT	B-PROBLEM
administration	NN	O	I-PROBLEM
.	.	O	O

during	IN	O	O
the	DT	O	O
mass.	JJ	O	O
mental	JJ	O	O
health	NN	O	O
center	NN	O	O
medical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
stay	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
exquisitely	RB	B-PROBLEM	O
preload	VB	I-PROBLEM	O
dependent	NN	I-PROBLEM	O
and	CC	O	O
responded	VBD	O	O
well	RB	O	O
to	TO	O	O
aggressive	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
as	IN	O	O
needed	VBN	O	O
to	TO	O	O
maintain	VB	O	O
her	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
with	IN	O	O
a	DT	B-TEST	B-TEST
systolic	NN	I-TEST	I-TEST
of	IN	O	O
greater	JJR	O	O
than	IN	O	O
90	CD	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
no	DT	O	O
further	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
bradycardia	NN	B-PROBLEM	B-PROBLEM
during	IN	O	O
her	PRP$	O	O
medical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
stay	NN	O	O
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
urine	JJ	I-TEST	I-TEST
output	NN	I-TEST	I-TEST
improved	VBD	O	O
dramatically	RB	O	O
with	IN	O	O
hydration	NN	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
suggesting	VBG	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
urine	JJ	I-PROBLEM	I-PROBLEM
output	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
secondary	JJ	O	O
to	TO	O	O
decreased	JJ	B-PROBLEM	B-PROBLEM
cardiac	JJ	I-PROBLEM	I-PROBLEM
output	NN	I-PROBLEM	I-PROBLEM
secondary	JJ	O	O
to	TO	O	O
low	JJ	B-PROBLEM	B-PROBLEM
preload	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
be	VB	O	O
followed	VBN	O	O
by	IN	O	O
the	DT	O	O
electrophysiology	NN	O	O
service	NN	O	O
,	,	O	O
who	WP	O	O
determined	VBD	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
demonstrating	VBG	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
vasal	NN	I-PROBLEM	I-PROBLEM
sensitivity	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
bradycardia	NN	B-PROBLEM	B-PROBLEM
necessitating	VBG	O	O
pacemaker	NN	B-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

this	DT	O	O
was	VBD	O	O
to	TO	O	O
be	VB	O	O
deferred	VBN	O	O
until	IN	O	O
after	IN	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
her	PRP$	B-TREATMENT	O
hickman	NN	I-TREATMENT	O
in	IN	O	O
place	NN	O	O
.	.	O	O

because	IN	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
pulmonary	JJ	I-TEST	I-TEST
pressures	NNS	I-TEST	I-TEST
responded	VBD	O	O
so	RB	O	O
well	RB	O	O
to	TO	O	O
adenosine	VB	B-TREATMENT	B-TEST
during	IN	O	I-TEST
right	JJ	B-TEST	I-TEST
heart	NN	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
,	,	O	O
it	PRP	O	O
was	VBD	O	O
thought	VBN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
would	MD	O	O
be	VB	O	O
a	DT	O	O
good	JJ	O	O
candidate	NN	O	O
for	IN	O	O
flolan	NN	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

flolan	NN	B-TREATMENT	O
was	VBD	O	O
initiated	VBN	O	O
on	IN	O	O
12-08	NNS	O	O
at	IN	O	O
5	CD	O	O
nanograms	NNS	O	O
per	IN	O	O
kilogram	NN	O	O
per	IN	O	O
minute	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
monitored	VBN	O	O
for	IN	O	O
symptoms	NNS	B-PROBLEM	B-PROBLEM
of	IN	O	O
flolan	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
including	VBG	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
first	RB	B-PROBLEM	B-PROBLEM
bite	JJ	I-PROBLEM	I-PROBLEM
jaw	NN	I-PROBLEM	I-PROBLEM
claudication	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

over	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
the	DT	O	O
hospital	NN	O	O
stay	VBD	O	O
the	DT	B-TREATMENT	O
patient	NN	I-TREATMENT	O
's	POS	I-TREATMENT	O
flolan	NN	I-TREATMENT	O
dose	NN	I-TREATMENT	O
was	VBD	O	O
titrated	VBN	O	O
to	TO	O	O
receive	VB	O	O
maximum	JJ	O	O
benefit	NN	O	O
without	IN	O	O
precipitating	VBG	O	B-PROBLEM
symptoms	NNS	O	I-PROBLEM
of	IN	O	O
flolan	NN	B-PROBLEM	B-PROBLEM
overdose	VBP	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
stable	JJ	O	O
on	IN	O	O
her	PRP$	B-TREATMENT	O
current	JJ	I-TREATMENT	O
flolan	NN	I-TREATMENT	O
dose	NN	I-TREATMENT	O
and	CC	O	O
was	VBD	O	O
therefore	RB	O	O
transferred	VBN	O	O
back	RB	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
high	JJ	I-TEST	I-TEST
resolution	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
was	VBD	O	O
requested	VBN	O	O
to	TO	O	O
further	RBR	O	O
evaluate	VB	O	O
for	IN	O	O
possible	JJ	O	O
secondary	JJ	O	O
cause	NN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
primary	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
however	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
refused	VBD	O	O
it	PRP	O	O
at	IN	O	O
this	DT	O	O
time	NN	O	O
.	.	O	O

plans	NNS	O	O
for	IN	O	O
placement	NN	O	O
of	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
pacemaker	NN	I-TREATMENT	I-TREATMENT
were	VBD	O	O
initiated	VBN	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
on	IN	O	O
the	DT	O	O
night	NN	O	O
prior	RB	O	O
to	TO	O	O
the	DT	O	O
planned	VBN	O	O
surgical	JJ	O	O
date	NN	O	O
the	DT	O	O
patient	NN	O	O
suffered	VBD	O	O
an	DT	O	O
episode	NN	O	O
of	IN	O	O
bleeding	VBG	B-PROBLEM	B-PROBLEM
from	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
hickman	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
site	NN	O	I-TREATMENT
.	.	O	O

surgery	NN	O	B-TREATMENT
was	VBD	O	O
notified	VBN	O	O
and	CC	O	O
pressure	NN	B-TREATMENT	O
was	VBD	O	O
applied	VBN	O	O
;	:	O	O
however	RB	O	O
,	,	O	O
it	PRP	O	O
did	VBD	O	O
not	RB	O	O
stop	VB	O	O
oozing	NN	O	B-PROBLEM
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
surgicel	NN	I-TREATMENT	I-TREATMENT
dressing	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
and	CC	O	O
prolonged	JJ	B-TREATMENT	B-PROBLEM
pressure	NN	I-TREATMENT	I-PROBLEM
resulted	VBD	O	O
in	IN	O	O
resolution	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
an	DT	B-TREATMENT	B-TREATMENT
extra	JJ	I-TREATMENT	I-TREATMENT
stitch	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
in	IN	O	O
an	DT	O	O
effort	NN	O	O
to	TO	O	O
stop	VB	O	O
the	DT	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

following	VBG	O	O
this	DT	O	O
episode	VBZ	O	O
the	DT	O	O
patient	NN	O	O
felt	VBD	O	O
like	IN	O	O
she	PRP	O	O
was	VBD	O	O
"	RB	O	O
too	RB	B-PROBLEM	O
stressed	JJ	I-PROBLEM	O
"	NN	O	O
for	IN	O	O
pacemaker	NN	B-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

therefore	RB	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
monitored	VBN	O	O
over	IN	O	O
the	DT	O	O
next	JJ	O	O
few	JJ	O	O
days	NNS	O	O
for	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
further	JJ	I-PROBLEM	I-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
events	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

over	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
the	DT	O	O
next	JJ	O	O
few	JJ	O	O
days	NNS	O	O
the	DT	O	O
patient	NN	O	O
became	VBD	O	O
more	RBR	O	O
accustomed	JJ	O	O
to	TO	O	O
her	PRP$	B-TREATMENT	O
flolan	NN	I-TREATMENT	O
,	,	O	O
and	CC	O	O
flolan	NN	B-TREATMENT	O
teaching	NN	O	O
was	VBD	O	O
continued	VBN	O	O
.	.	O	O

she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
occasional	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
dizziness	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
whenever	WRB	O	O
the	DT	O	O
alarm	NN	O	O
sounded	VBD	O	O
suggesting	VBG	O	O
that	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
flolan	NN	I-TREATMENT	I-TREATMENT
bag	NN	I-TREATMENT	I-TREATMENT
needed	VBN	O	O
to	TO	O	O
be	VB	O	O
changed	VBN	O	O
.	.	O	O

on	IN	O	O
12-15	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
went	VBD	O	O
for	IN	O	O
placement	NN	O	O
of	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
pacemaker	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
dual-mode	NN	B-TREATMENT	O
,	,	I-TREATMENT	O
dual-pacing	JJ	I-TREATMENT	O
,	,	I-TREATMENT	O
dual-sensing	JJ	I-TREATMENT	B-TREATMENT
pacemaker	NN	I-TREATMENT	I-TREATMENT
placed	VBN	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
lower	JJR	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
at	IN	O	O
60	CD	O	O
ppm	NN	O	O
,	,	O	O
and	CC	O	O
upper	JJ	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
120	CD	O	O
ppm	NN	O	O
with	IN	O	O
a	DT	B-TEST	O
paced	JJ	I-TEST	O
av	NN	I-TEST	O
of	IN	O	O
150	CD	O	O
msec	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
recovered	VBD	O	O
well	RB	O	O
from	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
pacemaker	NN	B-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
tolerating	VBG	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
flolan	NN	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
received	VBN	O	O
a	DT	O	O
full	JJ	O	O
course	NN	O	O
of	IN	O	O
flolan	NN	B-TREATMENT	O
teaching	NN	I-TREATMENT	O
and	CC	O	O
reported	VBD	O	O
that	IN	O	O
she	PRP	O	O
and	CC	O	O
her	PRP$	O	O
husband	NN	O	O
felt	VBD	O	O
comfortable	JJ	O	O
with	IN	O	O
the	DT	O	O
administration	NN	O	O
of	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
medication	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
home	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
set	VBN	O	O
up	RP	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-PROBLEM
primary	JJ	I-TREATMENT	I-PROBLEM
pulmonary	JJ	I-TREATMENT	I-PROBLEM
hypertension	NN	I-TREATMENT	I-PROBLEM
support	NN	I-TREATMENT	O
group	NN	I-TREATMENT	O
,	,	O	O
and	CC	O	O
home	NN	B-TREATMENT	O
services	NNS	I-TREATMENT	O
were	VBD	O	O
arranged	VBN	O	O
to	TO	O	O
help	VB	O	O
her	PRP	O	O
in	IN	O	O
the	DT	O	O
initiation	NN	O	O
of	IN	O	O
flolan	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

following	VBG	O	O
pacemaker	NN	B-TREATMENT	B-TREATMENT
placement	VBD	I-TREATMENT	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
no	DT	O	O
further	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
bradycardia	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
telemetry	NN	B-TEST	B-TEST
,	,	O	O
and	CC	O	O
therefore	RB	O	O
she	PRP	O	O
was	VBD	O	O
discharged	VBN	O	O
in	IN	O	O
satisfactory	JJ	O	O
condition	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
no	DT	O	O
signs	NNS	O	B-PROBLEM
or	CC	O	O
symptoms	NNS	O	B-PROBLEM
of	IN	O	O
infection	NN	B-PROBLEM	B-PROBLEM
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
admission	NN	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
relatively	RB	I-PROBLEM	I-PROBLEM
elevated	JJ	I-PROBLEM	I-PROBLEM
white	JJ	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
count	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
remained	VBD	O	O
stable	JJ	O	O
over	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
her	PRP$	O	O
hospital	NN	O	O
stay	NN	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
near	IN	O	O
the	DT	O	O
end	NN	O	O
of	IN	O	O
her	PRP$	O	O
hospitalization	NN	O	O
the	DT	O	O
patient	NN	O	O
began	VBD	O	O
describing	VBG	O	O
increased	VBN	B-PROBLEM	B-PROBLEM
urinary	JJ	I-PROBLEM	I-PROBLEM
frequency	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
persisted	VBD	O	O
once	RB	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
foley	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
removed	VBN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
urinalysis	NN	I-TEST	I-TEST
was	VBD	O	O
positive	JJ	B-PROBLEM	O
and	CC	O	O
urine	JJ	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
grew	VBD	O	O
enterococcus	NN	B-PROBLEM	B-PROBLEM
which	WDT	O	O
was	VBD	O	O
pan	RB	O	O
sensitive	JJ	O	O
.	.	O	O

therefore	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
complete	VB	O	O
a	DT	O	O
10	CD	O	O
-	:	O	O
day	NN	O	O
course	NN	O	O
.	.	O	O

following	VBG	O	O
initiation	NN	O	B-TREATMENT
of	IN	O	I-TREATMENT
the	DT	B-TREATMENT	I-TREATMENT
antibiotic	JJ	I-TREATMENT	I-TREATMENT
the	DT	B-TEST	I-TREATMENT
patient	NN	I-TEST	I-TREATMENT
's	POS	I-TEST	I-TREATMENT
white	JJ	I-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
quickly	RB	O	O
came	VBD	O	O
down	RB	O	O
,	,	O	O
and	CC	O	O
she	PRP	O	O
remained	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
still	RB	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
mildly	RB	I-PROBLEM	I-PROBLEM
elevated	JJ	I-PROBLEM	I-PROBLEM
white	JJ	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
count	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
was	VBD	O	O
asymptomatic	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
a	DT	O	O
normal	JJ	O	O
temperature	NN	O	O
.	.	O	O

she	PRP	O	O
will	MD	O	O
complete	VB	O	O
two	CD	O	O
more	JJR	O	O
days	NNS	O	O
of	IN	O	O
levaquin	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
bun	NN	I-TEST	I-TEST
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
were	VBD	O	O
followed	VBN	O	O
over	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
her	PRP$	O	O
hospital	NN	O	O
stay	NN	O	O
.	.	O	O

it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
that	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
decreased	JJ	I-PROBLEM	I-PROBLEM
urine	NN	I-PROBLEM	I-PROBLEM
output	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
secondary	JJ	O	O
to	TO	O	O
her	PRP$	B-PROBLEM	O
preload	NN	I-PROBLEM	O
dependence	NN	I-PROBLEM	O
,	,	O	O
and	CC	O	O
that	IN	O	O
her	PRP$	B-TEST	B-TEST
urine	JJ	I-TEST	I-TEST
output	NN	I-TEST	I-TEST
increased	VBD	O	O
significantly	RB	O	O
when	WRB	O	O
she	PRP	O	O
was	VBD	O	O
adequately	RB	O	O
hydrated	VBN	O	O
in	IN	O	O
the	DT	O	O
medical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
gastroesophageal	NN	B-PROBLEM	B-PROBLEM
reflux	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
protonix	NN	B-TREATMENT	B-TREATMENT
over	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
her	PRP$	O	O
hospital	NN	O	O
stay	NN	O	O
and	CC	O	O
had	VBD	O	O
no	DT	O	O
further	JJ	B-PROBLEM	B-PROBLEM
gastrointestinal	JJ	I-PROBLEM	I-PROBLEM
issues	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
hematocrit	NN	I-TEST	I-TEST
remained	VBD	O	O
stable	JJ	O	O
over	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
her	PRP$	O	O
hospital	NN	O	O
stay	NN	O	O
.	.	O	O

despite	IN	O	O
bleeding	VBG	B-PROBLEM	B-PROBLEM
from	IN	O	O
the	DT	B-TREATMENT	O
hickman	NN	I-TREATMENT	O
site	NN	I-TREATMENT	O
,	,	O	O
she	PRP	O	O
did	VBD	O	O
not	RB	O	O
require	VB	O	O
any	DT	B-TREATMENT	B-TREATMENT
transfusion	NN	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

her	PRP$	B-TEST	B-TEST
electrolytes	NNS	I-TEST	I-TEST
were	VBD	O	O
checked	VBN	O	O
on	IN	O	O
a	DT	O	O
daily	JJ	O	O
basis	NN	O	O
and	CC	O	O
remained	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
,	,	O	O
being	VBG	O	O
replaced	VBN	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
her	PRP$	B-TREATMENT	O
regular	JJ	I-TREATMENT	O
synthroid	NN	I-TREATMENT	O
dose	NN	I-TREATMENT	O
.	.	O	O

she	PRP	O	O
will	MD	O	O
need	VB	O	O
a	DT	B-TEST	B-PROBLEM
tsh	NN	I-TEST	I-PROBLEM
and	CC	O	O
t4	NN	B-TEST	O
checked	VBD	O	O
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	B-TREATMENT	O
full	JJ	I-TREATMENT	O
code	NN	I-TREATMENT	O
.	.	O	O

9.	CD	O	O
flolan	JJ	B-TREATMENT	O
administration	NN	I-TREATMENT	O
:	:	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
tolerating	VBG	O	O
a	DT	B-TREATMENT	O
flolan	NN	I-TREATMENT	O
dose	NN	I-TREATMENT	O
of	IN	O	O
5	CD	O	O
nanograms	NNS	O	O
per	IN	O	O
kilogram	NN	O	O
per	IN	O	O
minute	NN	O	O
.	.	O	O

a	DT	O	B-TEST
physical	JJ	O	I-TEST
therapy	NN	O	I-TEST
consultation	NN	O	I-TEST
was	VBD	O	O
obtained	VBN	O	O
to	TO	O	O
initiate	VB	O	O
a	DT	B-TEST	O
6	CD	I-TEST	O
-	:	I-TEST	O
minute	NN	I-TEST	O
walk	VBP	I-TEST	O
test	NN	I-TEST	O
.	.	O	O

on	IN	O	O
room	NN	O	O
air	NN	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
oxygen	NN	I-TEST	I-TEST
saturation	NN	I-TEST	I-TEST
was	VBD	O	O
95%	CD	O	O
and	CC	O	O
dropped	VBD	O	O
to	TO	O	O
88%	CD	O	O
following	VBG	O	O
a	DT	O	O
6	CD	O	O
-	:	O	O
minute	NN	O	O
walk	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
discharged	VBN	O	O
to	TO	O	O
home	NN	O	O
with	IN	O	O
appropriate	JJ	O	O
flolan	NN	B-TREATMENT	O
teaching	VBG	I-TREATMENT	O
and	CC	O	O
supplies	NNS	O	B-TREATMENT
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
follow	VBN	O	O
up	RP	O	O
with	IN	O	O
dr.	NN	O	O
schwartz	NN	O	O
in	IN	O	O
the	DT	O	O
clinic	NN	O	O
on	IN	O	O
monday	NN	O	O
,	,	O	O
12-22	JJ	O	O
,	,	O	O
at	IN	O	O
2:30	CD	O	O
p.m.	NN	O	O
to	TO	O	O
check	VB	O	O
her	PRP$	B-TEST	B-TEST
inr	NN	I-TEST	I-TEST
and	CC	O	O
digoxin	NN	B-TEST	B-TEST
level	NN	I-TEST	I-TEST
.	.	O	O

she	PRP	O	O
also	RB	O	O
has	VBZ	O	O
follow	VBN	O	O
up	RP	O	O
with	IN	O	O
dr.	JJ	O	O
savage	NN	O	O
in	IN	O	O
the	DT	O	O
pulmonary	JJ	O	O
clinic	NN	O	O
on	IN	O	O
12-25	NNS	O	O
at	IN	O	O
12:15	CD	O	O
p.m.	NN	O	O
for	IN	O	O
management	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
2	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.6h.	NN	O	O

2.	CD	O	O
tylenol	JJ	B-TREATMENT	B-TREATMENT
no.	NN	I-TREATMENT	I-TREATMENT
3	CD	I-TREATMENT	O
one	CD	O	O
to	TO	O	O
two	CD	O	O
tablets	NNS	O	O
p.o.	VBP	O	O
q.4h.	JJ	O	O
p.r.n.	NN	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

3.	CD	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
0.125	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

4.	CD	O	O
levofloxacin	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	JJ	O	O
times	NNS	O	O
two	CD	O	O
days	NNS	O	O
.	.	O	O

5.	CD	O	O
protonix	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

6.	CD	O	O
tylenol	JJ	B-TREATMENT	B-TREATMENT
650	CD	O	O
mg	JJ	O	O
p.o.	JJ	O	O
q.4-6h.	JJ	O	O
p.r.n.	NN	O	O
for	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

7.	CD	O	O
synthroid	JJ	B-TREATMENT	B-TREATMENT
125	CD	O	O
mcg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

8.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

9.	CD	O	O
lactulose	JJ	B-TREATMENT	B-TREATMENT
30	CD	O	O
cc	NN	O	O
p.o.	NN	O	O
q.6h.	NN	O	O
p.r.n.	NN	O	O
for	IN	O	O
constipation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

10.	CD	O	O
flolan	JJ	B-TREATMENT	O
5	CD	O	O
nanograms	NNS	O	O
per	IN	O	O
kilograms	NNS	O	O
per	IN	O	O
minute	NN	O	O
,	,	O	O
continuous	JJ	O	B-TREATMENT
infusion	NN	O	I-TREATMENT
.	.	O	O

11.	CD	O	O
oxygen	NN	B-TREATMENT	B-TREATMENT
per	IN	O	O
nasal	NN	B-TREATMENT	B-TREATMENT
cannula	NN	I-TREATMENT	I-TREATMENT
as	IN	O	O
needed	VBN	O	O
.	.	O	O

cellulitis	NN	B-PROBLEM	B-PROBLEM

attending	VBG	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST

levofloxacin	RB	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NNS	O	O
po	JJ	O	O
qd	JJ	O	O
x	$	O	O
14	CD	O	O
days	NNS	O	O

administer	RB	O	O
iron	NN	B-TREATMENT	B-TREATMENT
products	NNS	I-TREATMENT	I-TREATMENT
a	DT	O	O
minimum	NN	O	O
of	IN	O	O
2	CD	O	O
hours	NNS	O	O
before	IN	O	O
or	CC	O	O
after	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
levofloxacin	NN	I-TREATMENT	I-TREATMENT
or	CC	O	O
ciprofloxacin	NN	B-TREATMENT	B-TREATMENT
dose	VBP	I-TREATMENT	O
dose	JJ	O	O
if	IN	O	O
on	IN	O	O
tube	NN	B-TREATMENT	B-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
please	VB	O	O
cycle	NN	O	O
(	(	O	O
hold	VB	O	O
1	CD	O	O
hr	NN	O	O
before	IN	O	O
to	TO	O	O
2	CD	O	O
hr	NNS	O	O
after	IN	O	O
)	)	O	O
take	VB	O	O
2	CD	O	O
hours	NNS	O	O
before	IN	O	O
or	CC	O	O
2	CD	O	O
hours	NNS	O	O
after	IN	O	O
dairy	NN	O	B-TREATMENT
products	NNS	O	I-TREATMENT
.	.	O	O

penicillins	NNS	B-TREATMENT	B-TREATMENT

cellulitis	NN	B-PROBLEM	B-PROBLEM

responsible	JJ	O	O
after	IN	O	O
study	NN	O	O
for	IN	O	O
causing	VBG	O	O
admission	NN	O	O
)	)	O	O
cellulitis	NN	B-PROBLEM	B-PROBLEM

conditions	NNS	O	O
,	,	O	O
infections	NNS	O	O
,	,	O	O
complications	NNS	O	O
,	,	O	O
affecting	VBG	O	O
treatment	NN	O	O
/	NNP	O	O
stay	NN	O	O
cellulitis	NN	B-PROBLEM	B-PROBLEM

ct	NN	B-TEST	O
of	IN	I-TEST	O
neck	NN	I-TEST	O
with	IN	I-TEST	O
contrast	NN	I-TEST	B-PROBLEM

pt	NN	O	O
is	VBZ	O	O
22	CD	O	O
y	NN	O	O
/	NNP	O	O
o	VBZ	O	O
female	JJ	O	O
with	IN	O	O
hx	NN	O	O
of	IN	O	O
hiv	NN	B-PROBLEM	O
and	CC	O	O
cd4	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
of	IN	O	O
297	CD	O	O
who	WP	O	O
presented	VBD	O	O
to	TO	O	O
ed	VB	O	O
on	IN	O	O
01/14	CD	O	O
with	IN	O	O
sebaceous	JJ	B-PROBLEM	B-PROBLEM
cyst	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
was	VBD	O	O
infected	VBN	B-PROBLEM	O
.	.	O	O

cyst	NN	B-PROBLEM	B-TEST
was	VBD	O	O
drained	VBN	O	O
and	CC	O	O
pt	NN	O	O
was	VBD	O	O
sent	VBN	O	O
home	NN	O	O
with	IN	O	O
duracef	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
did	VBD	O	O
not	RB	O	O
fill	VB	O	O
script	NN	B-TREATMENT	O
for	IN	O	O
2	CD	O	O
days	NNS	O	O
and	CC	O	O
even	RB	O	O
then	RB	O	O
was	VBD	O	O
not	RB	B-PROBLEM	O
compliant	JJ	I-PROBLEM	O
with	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
meds	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
now	RB	O	O
returns	VBZ	O	O
to	TO	O	O
ed	VB	O	O
with	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
erythema	NN	B-PROBLEM	B-PROBLEM
from	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
midline	NN	I-PROBLEM	I-PROBLEM
posterior	JJ	I-PROBLEM	I-PROBLEM
neck	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
her	PRP$	O	B-PROBLEM
submental	JJ	O	I-PROBLEM
area	NN	O	I-PROBLEM
and	CC	O	O
2-3	JJ	O	O
d	NN	O	O
of	IN	O	O
intermittent	JJ	B-PROBLEM	B-PROBLEM
fevers	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O
+	JJ	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
dysphagia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
trouble	NN	O	B-PROBLEM
hearing	NN	O	I-PROBLEM
.	.	O	O

hiv	NN	B-PROBLEM	O
,	,	O	O
viral	JJ	B-TEST	B-TEST
load	NN	I-TEST	I-TEST
954	CD	O	O
,	,	O	O
7/03	CD	O	O
-	:	O	O
h.	NN	B-PROBLEM	O
pylori	NN	I-PROBLEM	O
pos.	NN	O	O
,	,	O	O
asthma	NN	B-PROBLEM	B-PROBLEM

smokes	NNS	O	O
2-3	JJ	O	O
cig	JJ	O	O
/	NNP	O	O
day	NN	O	O
,	,	O	O
occ	NN	O	O
etoh	NN	O	O
,	,	O	O
and	CC	O	O
no	DT	O	O
drugs	NNS	O	B-TREATMENT
except	IN	O	O
marijuana	NN	O	B-TEST
exam	NN	B-TEST	I-TEST
:	:	O	O

exam	NN	B-TEST	B-TEST
sig.	NN	O	I-TEST
for	IN	O	O
erthyema	NN	B-PROBLEM	O
as	IN	O	O
described	VBN	O	O
previously	RB	O	O
and	CC	O	O
tenderness	VB	B-PROBLEM	B-PROBLEM
to	TO	O	O
minimal	JJ	B-TEST	B-PROBLEM
palpation	NN	I-TEST	I-PROBLEM
.	.	O	O

neck	NN	B-TEST	O
ct	NN	I-TEST	O
neg	NN	O	O
for	IN	O	O
abcess	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

pt	NN	O	O
with	IN	O	O
wbc	NN	B-TEST	B-TEST
of	IN	O	O
15.4	CD	O	O
with	IN	O	O
70%	CD	B-TEST	O
seg	NNS	I-TEST	O
.	.	O	O

(1)	NN	O	O
id	SYM	O	O
-	:	O	O
pt	NN	O	O
received	VBD	O	O
clinda	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
ancef	NN	B-TREATMENT	B-TREATMENT
in	IN	O	O
ed	NN	O	O
.	.	O	O

will	MD	O	O
cont	VB	O	O
ancef	RB	B-TREATMENT	O
1q8	CD	O	O
overnight	JJ	O	O
and	CC	O	O
trans	NNS	O	O
to	TO	O	O
keflex	VB	B-TREATMENT	O
.	.	O	O

cd4	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
.	.	O	O

bacitracin	NN	B-TREATMENT	B-TREATMENT
oint	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

percocet	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

(2)	NN	O	B-TREATMENT
gi	SYM	O	I-TREATMENT
-	:	O	I-TREATMENT
nexium	NN	B-TREATMENT	I-TREATMENT

(3)	NN	O	O
fen	SYM	O	O
-	:	O	O
ns	NN	B-TREATMENT	O
overnight	NN	O	O

(4)	NN	O	O
pulm	SYM	O	O
-	:	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
inhalers	NNS	I-TREATMENT	I-TREATMENT
prn	VBP	O	O
patient	JJ	O	O
seems	VBZ	O	O
to	TO	O	O
be	VB	O	O
improving	VBG	O	O
and	CC	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
resting	VBG	O	O
comfortably	RB	O	O
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
erythematous	JJ	I-PROBLEM	I-PROBLEM
region	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
retreating	VBG	O	O
and	CC	O	O
the	DT	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
cleaned	VBD	O	O
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
ready	JJ	O	O
to	TO	O	O
be	VB	O	O
sent	VBN	O	O
home	NN	O	O
with	IN	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

repeat	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
was	VBD	O	O
neg.	JJ	O	O
for	IN	O	O
abcess	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
fascitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1	CD	O	O
-	:	O	O
be	VB	O	O
sure	JJ	O	O
to	TO	O	O
finish	VB	O	O
all	DT	O	B-TREATMENT
antibiotic	JJ	B-TREATMENT	I-TREATMENT
even	RB	O	O
if	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
subsides	NNS	O	I-PROBLEM
adn	VBP	O	I-PROBLEM
inflammation	NN	B-PROBLEM	I-PROBLEM
goes	VBZ	O	O
down	RB	O	O
.	.	O	O

2	CD	O	O
-	:	O	O
clean	NN	O	B-PROBLEM
wound	NN	B-PROBLEM	I-PROBLEM

1	CD	O	O
-	:	O	O
fill	NN	O	O
rx	NN	O	O
for	IN	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
today	NN	O	O
and	CC	O	O
take	VB	O	O
until	IN	O	O
finished	VBN	O	O
even	RB	O	O
if	IN	O	O
neck	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
subsides	NNS	O	I-PROBLEM
x	VBP	O	O
14	CD	O	O
days	NNS	O	O

2	CD	O	O
-	:	O	O
clean	NN	O	B-PROBLEM
wound	NN	B-PROBLEM	I-PROBLEM

3	LS	O	O
-	:	O	O
return	NN	O	O
to	TO	O	O
ed	VB	O	O
or	CC	O	O
call	VB	O	O
pcp	NN	O	O
if	IN	O	O
neck	DT	B-PROBLEM	B-PROBLEM
inflammation	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
red	JJ	B-PROBLEM	B-PROBLEM
swollen	JJ	I-PROBLEM	I-PROBLEM
area	NN	I-PROBLEM	I-PROBLEM
does	VBZ	O	O
not	RB	O	O
continue	VB	O	O
to	TO	O	O
get	VB	O	O
better	JJR	O	O
or	CC	O	O
if	IN	O	O
temperature	JJ	B-PROBLEM	B-TEST
returns	NNS	O	I-TEST
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
56	JJ	O	O
-	:	O	O
year-old	JJ	O	O
man	NN	O	O
without	IN	O	O
any	DT	O	O
significant	JJ	O	O
past	JJ	O	O
medical	JJ	O	O
history	NN	O	O
who	WP	O	O
presented	VBD	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
after	IN	O	O
the	DT	O	O
sudden	JJ	O	O
onset	NN	O	O
of	IN	O	O
headache	NN	B-PROBLEM	B-PROBLEM
while	IN	O	O
he	PRP	O	O
was	VBD	O	O
riding	VBG	O	O
a	DT	O	B-TREATMENT
bicycle	NN	O	I-TREATMENT
.	.	O	O

he	PRP	O	O
characterized	VBD	O	O
this	DT	B-PROBLEM	B-PROBLEM
headache	NN	I-PROBLEM	I-PROBLEM
as	IN	O	O
the	DT	B-PROBLEM	O
worst	JJS	I-PROBLEM	O
headache	NN	I-PROBLEM	O
of	IN	O	O
his	PRP$	O	O
life	NN	O	O
and	CC	O	O
had	VBD	O	O
associated	VBN	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
times	NNS	O	O
one	CD	O	O
.	.	O	O

he	PRP	O	O
also	RB	O	O
complained	VBD	O	O
of	IN	O	O
dizziness	NN	B-PROBLEM	B-PROBLEM
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
headache	NN	B-PROBLEM	B-PROBLEM
onset	NN	O	I-PROBLEM
.	.	O	O

he	PRP	O	O
presented	VBD	O	O
to	TO	O	O
the	DT	O	O
edith	JJ	O	O
nourse	JJ	O	O
rogers	NNS	O	O
memorial	JJ	O	O
va	JJ	O	O
hospital	NN	O	O
emergency	NN	O	O
room	NN	O	O
,	,	O	O
where	WRB	O	O
an	DT	B-TEST	B-TEST
initial	JJ	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
was	VBD	O	O
read	VBN	O	O
as	IN	O	O
negative	JJ	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
lumbar	NN	I-TEST	I-TEST
puncture	NN	I-TEST	I-TEST
was	VBD	O	O
done	VBN	O	O
,	,	O	O
in	IN	O	O
which	WDT	O	O
tube	NN	O	B-TREATMENT
1	CD	O	O
showed	VBD	O	O
4800	CD	B-TEST	O
red	JJ	I-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cells	NNS	I-TEST	I-TEST
and	CC	O	O
tube	NN	O	B-TREATMENT
4	CD	O	O
showed	VBD	O	O
4000	CD	B-TEST	O
red	JJ	I-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cells	NNS	I-TEST	I-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
sent	VBN	O	O
for	IN	O	O
an	DT	B-TEST	B-TEST
mri	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
,	,	O	O
which	WDT	O	O
raised	VBD	O	O
the	DT	O	O
question	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
posterior	JJ	I-PROBLEM	I-PROBLEM
cerebral	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
was	VBD	O	O
revealed	VBN	O	O
and	CC	O	O
,	,	O	O
on	IN	O	O
second	JJ	O	O
analysis	NN	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
thought	VBN	O	O
that	IN	O	O
it	PRP	O	O
was	VBD	O	O
suspicious	JJ	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
subarachnoid	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
suprasellar	JJ	I-PROBLEM	I-PROBLEM
cistern	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
then	RB	O	O
admitted	VBN	O	O
for	IN	O	O
further	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
.	.	O	O

the	DT	O	O
past	JJ	O	O
medical	JJ	O	O
history	NN	O	O
was	VBD	O	O
significant	JJ	O	O
for	IN	O	O
left	JJ	B-TREATMENT	B-TREATMENT
shoulder	NN	I-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
2014-03-06	JJ	O	O
for	IN	O	O
repair	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
"	NNP	I-PROBLEM	I-PROBLEM
minor	JJ	I-PROBLEM	I-PROBLEM
rotator	NN	I-PROBLEM	I-PROBLEM
cuff	NN	I-PROBLEM	I-PROBLEM
tear	JJ	I-PROBLEM	I-PROBLEM
"	NN	O	I-PROBLEM
and	CC	O	O
removal	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
osteophytes	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
on	IN	O	O
no	DT	O	O
medications	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

there	EX	O	O
were	VBD	O	O
no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
father	NN	O	O
had	VBD	O	O
leukemia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
the	DT	O	O
mother	NN	O	O
had	VBD	O	O
gastrointestinal	JJ	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
family	NN	O	O
history	NN	O	O
of	IN	O	O
aneurysms	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
physical	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
resting	VBG	O	O
comfortably	RB	O	O
when	WRB	O	O
seen	VBN	O	O
,	,	O	O
slightly	RB	B-PROBLEM	B-PROBLEM
sleepy	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
first	JJ	O	O
but	CC	O	O
readily	RB	O	O
arousable	JJ	O	O
,	,	O	O
awake	VB	O	O
,	,	O	O
alert	VB	O	O
,	,	O	O
oriented	VBN	O	O
and	CC	O	O
conversant	JJ	O	O
.	.	O	O

of	IN	O	O
note	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
been	VBN	O	O
given	VBN	O	O
2	CD	O	O
mg	NN	O	O
of	IN	O	O
ativan	NN	B-TREATMENT	B-TREATMENT
before	IN	O	O
the	DT	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
rigidity	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
but	CC	O	O
the	DT	O	O
neck	NN	O	O
was	VBD	O	O
slightly	RB	B-PROBLEM	B-PROBLEM
painful	JJ	I-PROBLEM	I-PROBLEM
at	IN	O	I-PROBLEM
extreme	JJ	B-TEST	I-PROBLEM
flexion	NN	I-TEST	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
general	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
essentially	RB	O	O
unremarkable	JJ	O	O
,	,	O	O
as	IN	O	O
per	IN	O	O
previous	JJ	O	O
notes	NNS	O	O
.	.	O	O

on	IN	O	O
examination	NN	B-TEST	B-TEST
of	IN	I-TEST	O
the	DT	I-TEST	O
extremities	NNS	I-TEST	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
moved	VBD	O	O
all	DT	O	O
extremities	NNS	O	O
and	CC	O	O
had	VBD	O	O
strength	NN	O	O
of	IN	O	O
5/5	CD	O	O
in	IN	O	O
all	DT	O	O
of	IN	O	O
the	DT	O	O
muscle	NN	O	O

the	DT	B-TEST	B-TEST
sensory	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
intact	JJ	O	O
to	TO	O	O
light	JJ	B-TEST	B-TEST
touch	NN	I-TEST	I-TEST
.	.	O	O

there	EX	O	O
was	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
very	RB	I-PROBLEM	I-PROBLEM
slight	JJ	I-PROBLEM	I-PROBLEM
inward	NN	I-PROBLEM	I-PROBLEM
pronator	NN	I-PROBLEM	I-PROBLEM
drift	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
hand	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

finger	NN	B-TEST	B-TEST
-	:	I-TEST	I-TEST
nose	JJ	I-TEST	I-TEST
-	:	I-TEST	I-TEST
finger	NN	I-TEST	I-TEST
testing	VBG	I-TEST	I-TEST
and	CC	O	O
heel	VB	B-TEST	B-TEST
-	:	I-TEST	O
to	TO	I-TEST	O
-	:	I-TEST	O
shin	JJ	I-TEST	B-TEST
testing	VBG	I-TEST	I-TEST
were	VBD	O	O
normal	JJ	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
ataxia	NN	B-PROBLEM	B-PROBLEM
noted	VBD	O	O
.	.	O	O

laboratory	NN	B-TEST	B-TEST
values	NNS	I-TEST	I-TEST
were	VBD	O	O
as	IN	O	O
per	IN	O	O
the	DT	O	O
history	NN	O	O
of	IN	O	O
present	JJ	O	B-PROBLEM
illness	NN	O	I-PROBLEM
.	.	O	O

neurological	JJ	B-TEST	B-TEST
imaging	NN	I-TEST	I-TEST
data	NNS	O	I-TEST
was	VBD	O	O
as	IN	O	O
per	IN	O	O
the	DT	O	O
history	NN	O	O
of	IN	O	O
present	JJ	O	B-PROBLEM
illness	NN	O	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
surgical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
,	,	O	O
where	WRB	O	O
a	DT	B-TEST	O
continued	JJ	I-TEST	O
cerebral	JJ	I-TEST	B-TEST
angiogram	NN	I-TEST	I-TEST
was	VBD	O	O
done	VBN	O	O
that	DT	O	O
was	VBD	O	O
essentially	RB	O	O
normal	JJ	O	O
,	,	O	O
without	IN	O	O
evidence	NN	O	O
of	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
obvious	JJ	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
observed	VBN	O	O
for	IN	O	O
two	CD	O	O
days	NNS	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
ct	JJ	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
showing	VBG	O	O
no	DT	O	O
changes	NNS	B-PROBLEM	O
from	IN	O	O
the	DT	B-TEST	B-TEST
previous	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
headache	NN	I-PROBLEM	I-PROBLEM
stabilized	VBN	O	O
after	IN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
discharged	VBN	O	O
with	IN	O	O
strict	JJ	O	O
instructions	NNS	O	O
to	TO	O	O
return	VB	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
,	,	O	O
should	MD	O	O
there	RB	O	O
be	VB	O	O
an	DT	O	B-PROBLEM
exacerbation	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
symptoms	NNS	B-PROBLEM	I-PROBLEM
.	.	O	O

ruled	VBN	O	O
out	RP	O	O
subarachnoid	JJ	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
ventricular	JJ	B-PROBLEM	B-PROBLEM
ectopy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
cardiomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

5.	CD	O	O
sinus	JJ	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

6.	CD	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

7.	CD	O	O
paraphimosis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

8.	CD	O	O
right	JJ	B-PROBLEM	B-PROBLEM
bundle	NN	I-PROBLEM	I-PROBLEM
branch	NN	I-PROBLEM	I-PROBLEM
block	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

9.	CD	O	O
pericarditis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

heparin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
consisting	VBG	O	O
of	IN	O	O
thrombocytopenia	NN	B-PROBLEM	B-PROBLEM
;	:	O	O
pronestyl	CC	B-TREATMENT	O
,	,	O	O
consisting	VBG	O	O
of	IN	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	VBG	I-TREATMENT	I-TREATMENT
x	JJ	I-TREATMENT	O
3	CD	I-TREATMENT	O
.	.	O	O

insertion	NN	B-TREATMENT	O
of	IN	I-TREATMENT	O
intra-aortic	JJ	I-TREATMENT	B-TREATMENT
balloon	NN	I-TREATMENT	I-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

bilateral	JJ	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
.	.	O	O

left	VBN	B-TEST	O
ventriculography	NN	I-TEST	O
.	.	O	O

bilateral	JJ	B-TEST	B-TEST
coronary	JJ	I-TEST	I-TEST
angiography	NN	I-TEST	I-TEST
.	.	O	O

signal	JJ	B-TEST	O
average	JJ	I-TEST	O
ekg	NN	I-TEST	O
.	.	O	O

digoxin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
.25	NNP	O	O
mg	NNP	O	O
po	NN	O	O
qd	NN	O	O
;	:	O	O
ecotrin	CC	B-TREATMENT	O
,	,	O	O
325	CD	O	O
mg	NN	O	O
qd	NN	O	O
;	:	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
2.5	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
;	:	O	O
lisinopril	CC	B-TREATMENT	B-TREATMENT
,	,	O	O
2.5	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
;	:	O	O
micronase	NN	B-TREATMENT	O
,	,	O	O
5	CD	O	O
mg	NN	O	O
po	NN	O	O
bid	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
47	CD	O	O
year	NN	O	O
old	JJ	O	O
patient	NN	O	O
of	IN	O	O
dr.	NN	O	O
laymie	NN	O	O
fournier	NN	O	O
and	CC	O	O
dr.	NN	O	O
leebjescobe	NN	O	O
in	IN	O	O
co	NN	O	O
in	IN	O	O
saorlirv	NN	O	B-PROBLEM
frea	NN	O	I-PROBLEM
,	,	O	O
west	JJS	O	O
virginia	NN	O	O
who	WP	O	O
was	VBD	O	O
well	RB	O	O
until	IN	O	O
a	DT	O	B-PROBLEM
bout	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
double	JJ	B-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
may	MD	O	O
1992	CD	O	O
,	,	O	O
at	IN	O	O
which	WDT	O	O
time	NN	O	O
he	PRP	O	O
was	VBD	O	O
hospitalized	VBN	O	O
at	IN	O	O
centdick	NN	O	O
naco	FW	O	O
hospital	JJ	O	O
medical	JJ	O	O
center	NN	O	O
.	.	O	O

he	PRP	O	O
also	RB	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
diabetes	VBZ	B-PROBLEM	B-PROBLEM
mellitus	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	O	O
transient	JJ	O	O
episode	NN	O	O
of	IN	O	O
headache	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
disorientation	NN	B-PROBLEM	B-PROBLEM
at	IN	O	O
that	DT	O	O
time	NN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
and	CC	O	I-TEST
mri	JJ	B-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
corroborated	VBN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
cerebral	JJ	I-PROBLEM	I-PROBLEM
infarcts	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
a	DT	O	O
family	NN	O	O
history	NN	O	O
of	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
as	IN	O	O
well	RB	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
also	RB	O	O
placed	VBN	O	O
on	IN	O	O
vasotec	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

a	DT	B-TEST	B-TEST
holter	NN	I-TEST	I-TEST
monitor	NN	I-TEST	I-TEST
showed	VBD	O	O
ventricular	JJ	B-PROBLEM	B-PROBLEM
ectopy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
thallium	NN	I-TEST	I-TEST
stress	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
showed	VBD	O	O
tachycardia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
fall	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
pressure	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
low	JJ	O	B-PROBLEM
level	NN	O	I-PROBLEM
exercise	NN	O	I-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
showed	VBD	O	O
global	JJ	B-PROBLEM	B-PROBLEM
hypokinesis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

accordingly	RB	O	O
he	PRP	O	O
was	VBD	O	O
referred	VBN	O	O
for	IN	O	O
further	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
.	.	O	O

blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
140/100	CD	O	O
,	,	O	O
phosphorus	NN	B-TEST	B-TEST
94	CD	O	O
,	,	O	O
weight	VBD	B-TEST	B-TEST
181	CD	O	O
lb	NN	O	O
.	.	O	O

loud	JJ	B-PROBLEM	O
s4	NN	I-PROBLEM	O
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
ii	JJ	I-PROBLEM	I-PROBLEM
/	NN	I-PROBLEM	I-PROBLEM
vi	NN	I-PROBLEM	I-PROBLEM
regurgitant	JJ	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

peripheral	JJ	B-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
intact	JJ	O	O
.	.	O	O

sodium	NN	B-TEST	B-TEST
140	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.0	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
104	CD	O	O
,	,	O	O
co2	NN	B-TEST	B-TEST
28	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
14	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
1.1	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
243	CD	O	O
.	.	O	O

cholesterol	NN	B-TEST	B-TEST
197	CD	O	O
,	,	O	O
triglycerides	NNS	B-TEST	B-TEST
118	CD	O	O
,	,	O	O
hdl	NN	B-TEST	B-TEST
31	CD	O	O
,	,	O	O
ldl	VBD	B-TEST	O
142	CD	O	O
,	,	O	O
total	JJ	B-TEST	B-TEST
protein	NN	I-TEST	I-TEST
6.2	CD	O	O
,	,	O	O
bilirubin	NN	B-TEST	B-TEST
1.0	CD	O	O
,	,	O	O
alkaline	JJ	B-TEST	B-TEST
phosphatase	NN	I-TEST	I-TEST
72	CD	O	O
,	,	O	O
sgot	VBD	B-TEST	B-TEST
23	CD	O	O
.	.	O	O

hematocrit	NN	B-TEST	B-TEST
on	IN	O	O
admission	NN	O	O
was	VBD	O	O
43%	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
6600	CD	O	O
.	.	O	O

mcv	NN	B-TEST	B-TEST
was	VBD	O	O
85	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	B-TEST
cardiac	JJ	O	I-TEST
catheterization	NN	O	I-TEST
laboratory	NN	O	I-TEST
,	,	O	O
where	WRB	O	O
he	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
initially	RB	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-TEST	B-TEST
pulmonary	JJ	I-TEST	I-TEST
wedge	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
45	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-PROBLEM
pulmonary	JJ	I-TEST	I-PROBLEM
artery	NN	I-TEST	I-PROBLEM
pressure	NN	I-TEST	I-PROBLEM
of	IN	O	O
82/40	CD	O	O
.	.	O	O

this	DT	O	O
lowered	VBD	O	O
with	IN	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
nitroglycerin	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

selective	JJ	B-TEST	B-TEST
coronary	NN	I-TEST	I-TEST
angiography	NN	I-TEST	I-TEST
showed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
occluded	JJ	I-PROBLEM	I-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
its	PRP$	I-PROBLEM	I-PROBLEM
midportion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
an	DT	O	B-TREATMENT
80%	CD	O	I-TREATMENT
distal	NN	O	I-TREATMENT
left	VBD	O	O
main	JJ	O	O
,	,	O	O
a	DT	O	O
90%	CD	O	O
proximal	NN	O	O
circumflex	NN	O	O
,	,	O	O
and	CC	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
significant	JJ	I-PROBLEM	I-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
lad	NN	I-PROBLEM	O
.	.	O	O

his	PRP$	O	B-PROBLEM
left	JJ	O	I-PROBLEM
ventricle	NN	O	I-PROBLEM
ejection	NN	O	I-PROBLEM
showed	VBD	O	I-PROBLEM
diffuse	IN	B-PROBLEM	I-PROBLEM
hypokinesis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
that	IN	O	O
,	,	O	O
because	IN	O	O
of	IN	O	O
the	DT	O	O
evidence	NN	O	O
of	IN	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
critical	JJ	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
main	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
he	PRP	O	O
should	MD	O	O
be	VB	O	O
admitted	VBN	O	O
for	IN	O	O
further	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
.	.	O	O

indeed	RB	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
diuretics	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
nitrates	NNS	B-TREATMENT	B-TREATMENT
along	IN	O	O
with	IN	O	O
cessation	NN	O	O
of	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
aspirin	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
put	VBN	O	O
on	IN	O	O
iv	NN	B-TREATMENT	B-TREATMENT
heparin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
some	DT	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
ectopy	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
holter	NN	B-TEST	O
monitor	NN	I-TEST	O
.	.	O	O

he	PRP	O	O
developed	VBD	O	O
epigastric	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
07/31	CD	O	O
which	WDT	O	O
previously	RB	O	O
had	VBD	O	O
been	VBN	O	O
ignored	VBN	O	O
but	CC	O	O
in	IN	O	O
retrospect	NN	O	O
was	VBD	O	O
probably	RB	O	O
his	PRP$	B-PROBLEM	O
anginal	JJ	I-PROBLEM	O
equivalent	NN	I-PROBLEM	O
.	.	O	O

he	PRP	O	O
also	RB	O	O
had	VBD	O	O
multifocal	JJ	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
ectopy	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
that	DT	O	O
time	NN	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
further	JJ	I-PROBLEM	I-PROBLEM
anterolateral	JJ	I-PROBLEM	I-PROBLEM
st	NN	I-PROBLEM	I-PROBLEM
segment	NN	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

therefore	RB	O	O
,	,	O	O
he	PRP	O	O
did	VBD	O	O
have	VB	O	O
unstable	JJ	B-PROBLEM	B-PROBLEM
angina	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
critical	JJ	I-PROBLEM	I-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
anatomy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
seen	VBN	O	O
in	IN	O	O
consultation	NN	O	O
by	IN	O	O
the	DT	O	O
electrophysiology	NN	O	O
service	NN	O	O
,	,	O	O
dr.	NN	O	O
slusslashgodle	NN	O	O
,	,	O	O
who	WP	O	O
said	VBD	O	O
that	IN	O	O
he	PRP	O	O
had	VBD	O	O
no	DT	O	O
indication	NN	O	O
for	IN	O	O
patch	NN	B-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

on	IN	O	O
08/02/93	CD	O	O
,	,	O	O
an	DT	B-TREATMENT	B-TREATMENT
intra-aortic	JJ	I-TREATMENT	I-TREATMENT
balloon	NN	I-TREATMENT	I-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
;	:	O	O
then	RB	O	O
,	,	O	O
dr.	JJ	O	O
thorebreutz	NN	O	O
took	VBD	O	O
him	PRP	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
,	,	O	O
where	WRB	O	O
he	PRP	O	O
had	VBD	O	O
quadruple	JJ	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
left	VBN	I-TREATMENT	I-TREATMENT
internal	JJ	I-TREATMENT	I-TREATMENT
mammary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	O
the	DT	I-TREATMENT	O
lad	NN	I-TREATMENT	O
,	,	O	O
a	DT	O	B-PROBLEM
single	JJ	O	I-PROBLEM
saphenous	JJ	O	I-PROBLEM
vein	NN	O	I-PROBLEM
to	TO	O	O
the	DT	O	O
right	JJ	O	O
coronary	JJ	O	O
artery	NN	O	O
with	IN	O	O
280	CD	O	O
cc	NNS	O	O
per	IN	O	O
minute	NN	O	O
flow	NN	O	O
,	,	O	O
and	CC	O	O
a	DT	B-TREATMENT	B-TREATMENT
saphenous	JJ	I-TREATMENT	I-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
snake	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	O
the	DT	I-TREATMENT	O
diagonal	JJ	I-TREATMENT	O
and	CC	O	O
circumflex	JJ	O	O
with	IN	O	O
150	CD	O	O
cc	NNS	O	O
per	IN	O	O
minute	NN	O	O
flow	NN	O	O
.	.	O	O

a	DT	B-PROBLEM	B-TREATMENT
paraphimosis	NN	I-PROBLEM	I-TREATMENT
was	VBD	O	O
noted	VBN	O	O
and	CC	O	O
treated	VBN	O	O
by	IN	O	O
dr.	NN	O	O
ryna	NN	O	O
jescdrig	NN	O	O
.	.	O	O

after	IN	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
he	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
ongoing	JJ	I-PROBLEM	I-PROBLEM
sinus	NN	I-PROBLEM	I-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
occasional	JJ	B-PROBLEM	B-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
premature	NN	I-PROBLEM	I-PROBLEM
beats	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
intra-aortic	JJ	I-TREATMENT	I-TREATMENT
balloon	NN	I-TREATMENT	I-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
weaned	VBN	O	O
the	DT	O	O
following	JJ	O	O
day	NN	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
out	IN	O	O
of	IN	O	O
the	DT	O	O
surgical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
seen	VBN	O	O
in	IN	O	O
consultation	NN	O	O
by	IN	O	O
the	DT	O	O
nutrition	NN	O	O
service	NN	O	O
,	,	O	O
who	WP	O	O
followed	VBD	O	O
him	PRP	O	O
for	IN	O	O
dietary	JJ	O	B-TREATMENT
management	NN	O	I-TREATMENT
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
mellitus	VBP	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
08/05	CD	O	O
it	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
that	IN	O	O
his	PRP$	B-TEST	B-TEST
platelet	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
had	VBD	O	O
fallen	VBN	O	O
from	IN	O	O
171,000	CD	O	O
to	TO	O	O
54,000	CD	O	O
;	:	O	O
this	DT	O	O
was	VBD	O	O
thought	VBN	O	O
to	TO	O	O
be	VB	O	O
associated	VBN	O	O
with	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
heparin	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
indeed	RB	O	O
,	,	O	O
when	WRB	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
,	,	O	O
since	IN	O	O
it	PRP	O	O
had	VBD	O	O
been	VBN	O	O
restarted	VBN	O	O
after	IN	O	O
surgery	NN	O	B-TREATMENT
,	,	O	O
his	PRP$	B-TEST	B-TEST
platelet	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
rebounded	VBD	O	O
to	TO	O	O
normal	JJ	O	O
.	.	O	O

therefore	RB	O	O
,	,	O	O
he	PRP	O	O
does	VBZ	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
thrombocytopenic	JJ	I-PROBLEM	I-PROBLEM
reaction	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
heparin	VB	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
did	VBD	O	O
have	VB	O	O
runs	NNS	O	O
of	IN	O	O
nonsustained	JJ	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
were	VBD	O	O
clinically	RB	O	O
stable	JJ	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
bundle	NN	I-PROBLEM	I-PROBLEM
branch	NN	I-PROBLEM	I-PROBLEM
block	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
at	IN	O	O
increased	VBN	O	O
risk	NN	O	O
for	IN	O	O
future	JJ	O	O
events	NNS	O	O
because	IN	O	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
ejection	NN	I-PROBLEM	I-PROBLEM
fraction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
he	PRP	O	O
is	VBZ	O	O
clinically	RB	O	O
stable	JJ	O	O
on	IN	O	O
ace	NN	B-TREATMENT	B-TREATMENT
inhibitors	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
understands	VBZ	O	O
that	IN	O	O
he	PRP	O	O
does	VBZ	O	O
have	VB	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
left	VBN	I-PROBLEM	I-PROBLEM
ventricle	NN	I-PROBLEM	I-PROBLEM
dysfunction	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
requires	VBZ	O	O
monitoring	NN	B-TEST	O
of	IN	I-TEST	O
his	PRP$	I-TEST	B-TEST
prothrombin	NN	I-TEST	I-TEST
times	NNS	I-TEST	O
and	CC	I-TEST	O
his	PRP$	I-TEST	B-PROBLEM
arrhythmias	NN	I-TEST	I-PROBLEM
;	:	O	O
these	DT	O	O
will	MD	O	O
be	VB	O	O
done	VBN	O	O
in	IN	O	O
grovea	NN	O	O
co	NN	O	O
terburgperv	NN	O	O
portnew	NN	O	O
.	.	O	O

lamictal	JJ	B-TREATMENT	O
/	NNP	O	O
keflex	NNP	B-TREATMENT	B-TREATMENT
/	NNP	O	O
navane	NN	B-TREATMENT	O
/	NNP	O	O
inderal	JJ	B-TREATMENT	B-TREATMENT
/	NNP	O	I-TREATMENT
depakote	NN	B-TREATMENT	I-TREATMENT

transfer	NN	O	O
from	IN	O	O
osh	NN	O	O
,	,	O	O
seizure	NN	B-PROBLEM	B-PROBLEM

lumbar	NN	B-TEST	B-TEST
puncture	NN	I-TEST	I-TEST

ms.	NN	O	O
swanson	NN	O	O
is	VBZ	O	O
a	DT	O	O
53	JJ	O	O
yo	NN	O	O
woman	NN	O	O
with	IN	O	O
pmh	NN	O	O
significant	JJ	O	O
for	IN	O	O
seizure	NN	B-PROBLEM	B-PROBLEM
disorder	NN	I-PROBLEM	I-PROBLEM
,	,	O	I-PROBLEM
brain	NN	B-PROBLEM	I-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
?	.	O	O
atypical	JJ	B-PROBLEM	B-PROBLEM
multiple	JJ	I-PROBLEM	I-PROBLEM
sclerosis	NN	I-PROBLEM	I-PROBLEM
who	WP	O	O
presents	VBZ	O	O
with	IN	O	O
right	JJ	B-PROBLEM	B-PROBLEM
face	NN	I-PROBLEM	I-PROBLEM
twitch	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
right	JJ	B-PROBLEM	I-PROBLEM
arm	NN	I-PROBLEM	I-PROBLEM
shaking	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
lives	VBZ	O	O
in	IN	O	O
an	DT	O	O
assisted	JJ	O	O
living	NN	O	O
,	,	O	O
and	CC	O	O
was	VBD	O	O
noted	VBN	O	O
yesterday	NN	O	O
to	TO	O	O
have	VB	O	O
generalized	VBN	B-PROBLEM	B-PROBLEM
tonic-clonic	JJ	I-PROBLEM	I-PROBLEM
activity	NN	I-PROBLEM	I-PROBLEM
beginning	VBG	O	O
on	IN	O	O
the	DT	O	O
right	JJ	O	O
side	NN	O	O
and	CC	O	O
lasting	JJ	O	O
90	CD	O	O
minutes	NNS	O	O
.	.	O	O

ems	NNS	O	O
gave	VBD	O	O
her	PRP	O	O
valium	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
pr	NN	O	O
at	IN	O	O
the	DT	O	O
facility	NN	O	O
and	CC	O	O
brought	VBD	O	O
her	PRP	O	O
to	TO	O	O
barnstable	JJ	O	O
county	NN	O	O
hospital	NN	O	O
.	.	O	O

she	PRP	O	O
persisted	VBD	O	O
with	IN	O	O
right	NN	B-PROBLEM	B-PROBLEM
sided	VBN	I-PROBLEM	I-PROBLEM
seizure	NN	I-PROBLEM	I-PROBLEM
activity	NN	I-PROBLEM	I-PROBLEM
there	RB	O	O
and	CC	O	O
was	VBD	O	O
given	VBN	O	O
valium	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
and	CC	O	O
ativan	$	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	NN	O	O
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
loaded	VBN	O	O
with	IN	O	O
dilantin	NN	B-TREATMENT	B-TREATMENT
1000	CD	O	O
mg	NN	O	O
.	.	O	O

here	RB	O	O
she	PRP	O	O
was	VBD	O	O
given	VBN	O	O
an	DT	B-TREATMENT	B-TREATMENT
additional	JJ	I-TREATMENT	I-TREATMENT
valium	NN	I-TREATMENT	I-TREATMENT
5	CD	O	O
mg	NN	O	O
x	NN	O	O
2	CD	O	O
and	CC	O	O
ativan	$	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	NN	O	O
x	VBD	O	O
3	CD	O	O
for	IN	O	O
persistent	JJ	B-PROBLEM	B-PROBLEM
twitching	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
face	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
right	JJ	I-PROBLEM	O
hand	NN	I-PROBLEM	O
.	.	O	O

since	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
ativan	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
facial	JJ	I-PROBLEM	I-PROBLEM
twitching	NN	I-PROBLEM	I-PROBLEM
has	VBZ	O	O
apparently	RB	O	O
improved	VBN	O	O
,	,	O	O
but	CC	O	O
she	PRP	O	O
continues	VBZ	O	O
to	TO	O	O
have	VB	O	O
hand	NN	B-PROBLEM	B-PROBLEM
twitches	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
also	RB	O	O
had	VBD	O	O
an	DT	B-TEST	B-PROBLEM
eeg	NN	I-TEST	I-PROBLEM
,	,	O	O
which	WDT	O	O
showed	VBD	O	O
left	VBD	B-PROBLEM	B-PROBLEM
sided	VBN	I-PROBLEM	I-PROBLEM
slowing	VBG	I-PROBLEM	I-PROBLEM
on	IN	O	O
preliminary	JJ	O	O
read	NN	O	O
.	.	O	O

apparently	RB	O	O
she	PRP	O	O
has	VBZ	O	O
a	DT	O	O
long	JJ	O	O
history	NN	O	O
of	IN	O	O
seizure	NN	B-PROBLEM	B-PROBLEM
disorder	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
possibly	RB	O	O
from	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
traumatic	JJ	B-PROBLEM	B-PROBLEM
brain	NN	I-PROBLEM	I-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
though	IN	O	O
per	IN	O	O
dr.	NN	O	O
paula	NN	O	O
,	,	O	O

records	NNS	O	O
from	IN	O	O
that	DT	O	O
hospitalization	NN	O	O
indicate	VB	O	O
she	PRP	O	O
may	MD	O	O
have	VB	O	O
only	RB	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
very	RB	I-PROBLEM	I-PROBLEM
mild	JJ	I-PROBLEM	I-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
)	)	O	I-PROBLEM
and	CC	O	O
has	VBZ	O	O
been	VBN	O	O
managed	VBN	O	O
on	IN	O	O
dilantin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
keppra	NN	B-TREATMENT	O
.	.	O	O

since	IN	O	O
she	PRP	O	O
has	VBZ	O	O
seen	VBN	O	O
dr.	NNS	O	O
ollie	RB	O	O
,	,	O	O
she	PRP	O	O
has	VBZ	O	O
had	VBN	O	O
at	IN	O	O
least	JJS	O	O
two	CD	O	O
episodes	NNS	O	O
of	IN	O	O
status	NN	B-PROBLEM	O
epilepticus	NN	I-PROBLEM	O
and	CC	O	O
one	CD	B-PROBLEM	O
generalized	JJ	I-PROBLEM	B-PROBLEM
seizure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
less	RBR	I-PROBLEM	I-PROBLEM
significant	JJ	I-PROBLEM	I-PROBLEM
seizures	NNS	I-PROBLEM	I-PROBLEM
which	WDT	O	O
are	VBP	O	O
characterized	VBN	O	O
by	IN	O	O
left	NN	B-PROBLEM	O
gaze	NN	I-PROBLEM	O
preference	NN	I-PROBLEM	O
and	CC	O	O
left	VBD	B-PROBLEM	B-PROBLEM
sided	VBN	I-PROBLEM	I-PROBLEM
tonic-clonic	JJ	I-PROBLEM	I-PROBLEM
activity	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
dilantin	NN	I-TEST	I-TEST
levels	NNS	I-TEST	I-TEST
had	VBD	O	O
been	VBN	O	O
somewhat	RB	O	O
difficult	JJ	O	O
to	TO	O	O
control	VB	O	O
.	.	O	O

he	PRP	O	O
tried	VBD	O	O
adding	VBG	O	O
lamictal	JJ	B-TREATMENT	O
,	,	O	O
but	CC	O	O
this	DT	O	O
caused	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
rash	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
her	PRP$	O	O
last	JJ	O	O
visit	NN	O	O
(	(	O	O
2015-03-18	JJ	O	O
)	)	O	O
dr.	NN	O	O
bradley	NN	O	O
had	VBD	O	O
discussed	VBN	O	O
the	DT	O	O
addition	NN	O	O
of	IN	O	O
a	DT	B-TREATMENT	O
third	JJ	I-TREATMENT	O
castelluccio	NN	I-TREATMENT	O
,	,	O	O
possibly	RB	O	O
zonegran	NN	B-TREATMENT	B-PROBLEM
(	(	O	O
less	RBR	O	O
likely	RB	O	O
topamax	JJ	B-TREATMENT	B-TREATMENT
),	NNS	O	I-TREATMENT
to	TO	O	I-TREATMENT
the	DT	B-TREATMENT	I-TREATMENT
dilantin	NN	I-TREATMENT	I-TREATMENT
200	CD	O	O
mg	NN	O	O
bid	NN	O	O
and	CC	O	O
keppra	NN	B-TREATMENT	O
1500	CD	O	O
mg	NN	O	O
bid	NN	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
several	JJ	B-TEST	B-TEST
dilantin	NN	I-TEST	I-TEST
levels	NNS	I-TEST	I-TEST
drawn	VBN	O	O
since	IN	O	O
her	PRP$	O	O
last	JJ	O	O
visit	NN	O	O
,	,	O	O
with	IN	O	O
15.4	CD	O	O
in	IN	O	O
05	CD	O	O
-	:	O	O
23.5	CD	O	O
in	IN	O	O
theresa	NN	O	O
,	,	O	O
and	CC	O	O
3.09	CD	O	O
-	:	O	O
18	CD	O	O
.	.	O	O

her	PRP$	O	O
sister	NN	O	O
reports	NNS	O	O
that	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
medication	NN	I-TREATMENT	I-TREATMENT
dose	NN	I-TREATMENT	I-TREATMENT
had	VBD	O	O
been	VBN	O	O
changed	VBN	O	O
to	TO	O	O
200	CD	O	O
mg	NNS	O	O
qam	RB	O	O
and	CC	O	O
100	CD	O	O
mg	NN	O	O
qpm	NN	O	O
in	IN	O	O
theresa	NN	O	O
,	,	O	O
and	CC	O	O
a	DT	O	O
review	NN	O	O
of	IN	O	O
her	PRP$	O	O
union	NN	O	O
hospital	NN	O	O
-	:	O	O
north	NN	O	O
shore	RB	O	O
medical	JJ	O	O
center	NN	O	O
records	NNS	O	O
indicates	VBZ	O	O
that	IN	O	O
this	DT	O	O
may	MD	O	O
have	VB	O	O
occurred	VBN	O	O
in	IN	O	O
an	DT	O	O
urgent	JJ	O	O
care	NN	O	O
appointment	NN	O	O
secondary	JJ	O	O
to	TO	O	O
slurred	VB	B-PROBLEM	B-PROBLEM
speech	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	O	B-PROBLEM
recent	JJ	O	I-PROBLEM
fall	NN	O	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	O
non-trough	JJ	I-PROBLEM	O
level	NN	I-PROBLEM	O
of	IN	O	O
15.9	CD	O	O
.	.	O	O

according	VBG	O	O
to	TO	O	O
her	PRP$	O	O
sister	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
no	DT	B-PROBLEM	O
short-term	JJ	I-PROBLEM	B-PROBLEM
memory	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	JJ	O	O
walks	NNS	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
walker	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
baseline	NN	O	O
and	CC	O	O
goes	VBZ	O	O
out	RP	O	O
for	IN	O	O
dinner	NN	O	O
and	CC	O	O
shopping	NN	O	O
with	IN	O	O
her	PRP$	O	O
sister	NN	O	O
.	.	O	O

ms.	NN	O	O
swanson	NN	O	O
also	RB	O	O
carries	VBZ	O	O
a	DT	O	O
diagnosis	NN	O	O
of	IN	O	O
"	NNP	O	O
atypical	JJ	B-PROBLEM	B-PROBLEM
ms	NN	I-PROBLEM	I-PROBLEM
",	NN	O	I-PROBLEM
which	WDT	O	O
she	PRP	O	O
brought	VBD	O	O
with	IN	O	O
her	PRP	O	O
to	TO	O	O
dr.	VB	O	O
billie	NN	O	O
.	.	O	O

according	VBG	O	O
to	TO	O	O
dr.	JJ	O	O
nicole	NN	O	O
,	,	O	O
she	PRP	O	O
has	VBZ	O	O
had	VBN	O	O
stable	JJ	B-PROBLEM	O
deficits	NNS	I-PROBLEM	O
for	IN	O	O
many	JJ	O	O
years	NNS	O	O
without	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
flare-like	JJ	I-PROBLEM	I-PROBLEM
episodes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
an	DT	B-TEST	B-TEST
mri	NN	I-TEST	I-TEST
in	IN	O	O
2014	CD	O	O
that	WDT	O	O
showed	VBD	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
plaque-like	JJ	I-PROBLEM	I-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
these	DT	O	O
were	VBD	O	O
entirely	RB	O	O
stable	JJ	O	O
since	IN	O	O
2010	CD	O	O
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
not	RB	O	O
undergoing	JJ	O	O
any	DT	B-TREATMENT	O
treatment	NN	I-TREATMENT	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
not	RB	O	O
had	VBN	O	O
an	DT	B-TEST	B-TREATMENT
lp	NN	I-TEST	I-TREATMENT
as	RB	O	O
far	RB	O	O
as	IN	O	O
dr.	JJ	O	O
ginger	NN	O	O
knows	NNS	O	O
.	.	O	O

h/o	JJ	O	O
head	NN	B-PROBLEM	B-PROBLEM
trauma	NN	I-PROBLEM	I-PROBLEM

atypical	JJ	B-PROBLEM	B-PROBLEM
ms	NN	I-PROBLEM	I-PROBLEM

seizures	NNS	B-PROBLEM	B-PROBLEM

depression	NN	B-PROBLEM	B-PROBLEM

hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM

vs	NN	B-TEST	O
:	:	O	O
t99.5	NN	O	O
,	,	O	O
bp	NN	B-TEST	B-TEST
126/72	CD	O	O
,	,	O	O
hr	NN	B-TEST	B-TEST
99	CD	O	O
,	,	O	O
rr	NN	B-TEST	B-TEST
15	CD	O	O
,	,	O	O
sao2	VBD	B-TEST	B-TEST
99%	CD	O	O
/	NNS	O	O
ra	NN	O	O

genl	NN	O	O
:	:	O	O
lying	NN	O	O
in	IN	O	O
bed	NN	O	O
,	,	O	O
right	JJ	O	O
hand	NN	O	O
moving	VBG	O	O
rhythmically	RB	O	O
,	,	O	O
ngt	NNS	B-TREATMENT	O
in	IN	O	O
place	NN	O	O

ms	NN	O	O
:	:	O	O
not	RB	B-PROBLEM	O
following	VBG	I-PROBLEM	O
commands	NNS	I-PROBLEM	O
,	,	O	O
withdraws	NNS	O	O
to	TO	O	O
noxious	JJ	B-TEST	B-PROBLEM
stimuli	NNS	I-TEST	I-PROBLEM
,	,	O	O
making	VBG	O	B-PROBLEM
incomprehensible	JJ	B-PROBLEM	I-PROBLEM
vocalizations	NNS	I-PROBLEM	I-PROBLEM

motor	NN	O	O
:	:	O	O
moving	VBG	O	O
right	JJ	O	O
hand	NN	O	O
rhythmically	RB	O	O
with	IN	O	O
occasional	JJ	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
face	NN	I-PROBLEM	I-PROBLEM
twitching	VBG	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
.	.	O	O

moves	NNS	O	O
all	DT	O	O
extremities	NNS	O	O
to	TO	O	O
stimuli	VB	B-TEST	O
,	,	O	O
l	FW	O	O
>	CD	O	O
r	NN	O	O

sensation	NN	O	O
:	:	O	O
intact	JJ	O	O
to	TO	O	O
noxious	JJ	B-TEST	B-TEST
stimuli	NNS	I-TEST	I-TEST
in	IN	O	O
all	DT	O	O
four	CD	O	O
extremities	NNS	O	O

afebrile	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
vss	NN	O	B-PROBLEM

no	DT	O	O
dysarthria	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
speech	JJ	O	B-PROBLEM
fluent	NN	O	I-PROBLEM
.	.	O	O

2015-09-20	JJ	O	O
03:54	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	B-TEST	B-TEST
-	:	O	O
11.4	CD	O	O
*#	NN	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.96	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
12.1	CD	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
35.1	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
88	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
30.6	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.6	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
13.1	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
152	CD	O	O

2015-09-28	JJ	O	O
07:50	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
neuts	NNS	B-TEST	B-TEST
-	:	O	O
83.3	CD	O	O
*	NN	O	O
lymphs	SYM	B-TEST	B-TEST
-	:	O	O
10.1	CD	O	O
*	JJ	O	O
monos	NNS	B-TEST	B-TEST
-	:	O	O
5.3	CD	O	O
eos	SYM	B-TEST	B-TEST
-	:	O	O
1.1	CD	O	O
baso	SYM	B-TEST	B-TEST
-	:	O	O
0.2	CD	O	O

2015-09-20	JJ	O	O
03:54	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
pt	NN	B-TEST	I-TEST
-	:	O	O
12.3	CD	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
26.7	CD	O	O
inr(pt)	JJ	B-TEST	O
-	:	O	O
1.1	CD	O	O

2015-09-20	JJ	O	O
03:54	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
97	CD	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
12	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
0.4	CD	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
137	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
3.8	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
101	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
26	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
14	CD	O	O

2015-09-20	JJ	O	O
03:54	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
albumin	NN	B-TEST	I-TEST
-	:	O	O
4.0	CD	O	O
calcium	NN	B-TEST	B-TEST
-	:	O	O
8.0	CD	O	O
*	NN	O	O
phos	NN	B-TEST	B-TEST
-	:	O	O
2.9	CD	O	O
mg	SYM	B-TEST	O
-	:	O	O
2.0	CD	O	O

2015-09-20	JJ	O	O
03:54	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
alt	NN	B-TEST	I-TEST
-	:	O	O
14	CD	O	O
ast	IN	B-TEST	O
-	:	O	O
18	CD	O	O
alkphos	SYM	B-TEST	B-TEST
-	:	O	O
92	CD	O	O
totbili	SYM	B-TEST	B-TEST
-	:	O	O
0.3	CD	O	O

2015-09-20	JJ	O	O
03:54	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
phenyto	NN	B-TEST	I-TEST
-	:	O	O
18.4	CD	O	O

2015-09-29	JJ	O	O
07:25	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
phenyto	NN	B-TEST	I-TEST
-	:	O	O
5.1	CD	O	O
*	NN	O	O

2015-09-22	JJ	O	O
03:04	CD	O	O
pm	NN	O	B-TEST
urine	NN	B-TEST	I-TEST
color	NN	B-TEST	I-TEST
-	:	O	O
straw	NN	O	O
appear	VBP	B-TEST	O
-	:	O	O
clear	JJ	O	O
sp	NN	O	O
dixon	SYM	B-TEST	O
-	:	O	O
1.010	CD	O	O

2015-09-22	JJ	O	O
03:04	CD	O	O
pm	JJ	O	O
urine	JJ	B-TEST	B-TEST
blood	NN	B-TEST	I-TEST
-	:	O	I-TEST
sm	NN	O	I-TEST
nitrite	JJ	B-TEST	I-TEST
-	:	O	O
neg	NN	O	O
protein	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
ketone	NN	B-TEST	B-TEST
-	:	O	O
15	CD	O	O
bilirub	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
urobiln	JJ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
ph	SYM	B-TEST	B-TEST
-	:	O	O
5.0	CD	O	O
leuks	SYM	B-TEST	B-TEST
-	:	O	O
mod	NN	O	O

2015-09-22	JJ	O	O
03:04	CD	O	O
pm	JJ	O	O
urine	JJ	B-TEST	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
6	CD	O	O
*	NN	O	O
wbc	SYM	B-TEST	B-TEST
-	:	O	O
29	CD	O	O
*	NN	O	O
bacteri	SYM	B-TEST	B-TEST
-	:	O	I-TEST
occ	NN	B-TEST	I-TEST
yeast	SYM	I-TEST	I-TEST
-	:	O	O
none	NN	O	O
epi	SYM	B-TEST	O
-	:	O	O
<	NN	O	O
1	CD	O	O

2015-09-28	JJ	O	O
03:04	CD	O	O
pm	NN	O	B-TEST
urine	NN	B-TEST	I-TEST
color	NN	B-TEST	I-TEST
-	:	O	O
yellow	NN	O	O
appear	VBP	B-TEST	O
-	:	O	O
clear	JJ	O	O
sp	NN	B-TEST	O
brown	SYM	I-TEST	O
-	:	O	O
1.015	CD	O	O

2015-09-28	JJ	O	O
03:04	CD	O	O
pm	JJ	O	O
urine	JJ	B-TEST	B-TEST
blood	NN	B-TEST	I-TEST
-	:	O	I-TEST
lg	NN	B-TEST	I-TEST
nitrite	JJ	I-TEST	I-TEST
-	:	O	O
neg	NN	O	O
protein	SYM	B-TEST	B-TEST
-	:	O	I-TEST
tr	NN	O	I-TEST
glucose	JJ	B-TEST	I-TEST
-	:	O	O
neg	NN	O	O
ketone	NN	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
bilirub	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
urobiln	JJ	B-TEST	B-TEST
-	:	O	O
0.2	CD	O	O
ph	NN	B-TEST	B-TEST
-	:	O	O
6.5	CD	O	O
leuks	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O

2015-09-28	JJ	O	O
03:04	CD	O	O
pm	JJ	O	O
urine	JJ	B-TEST	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
01-04	JJ	O	O
*	NN	O	O
wbc	SYM	B-TEST	B-TEST
-	:	O	O
04-19	JJ	O	O
bacteri	NN	B-TEST	O
-	:	O	O
few	JJ	O	O
yeast	JJ	B-TEST	B-TEST
-	:	O	O
none	NN	O	O
epi	SYM	B-TEST	O
-	:	O	O
0-2	NN	O	O

2015-09-25	JJ	O	O
02:20	CD	O	O
pm	JJ	O	B-TEST
cerebrospinal	JJ	B-TEST	I-TEST
fluid	NN	I-TEST	I-TEST
(	(	I-TEST	I-TEST
csf	NN	I-TEST	I-TEST
)	)	O	I-TEST
wbc	VBD	B-TEST	B-TEST
-	:	O	O
6	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
2	CD	O	O
*	NN	O	O
polys	NN	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
lymphs	SYM	B-TEST	B-TEST
-	:	O	O
92	CD	O	O
monos	NNS	B-TEST	B-TEST
-	:	O	O
8	CD	O	O

2015-09-25	JJ	O	O
02:20	CD	O	O
pm	JJ	O	B-TEST
cerebrospinal	JJ	B-TEST	I-TEST
fluid	NN	I-TEST	I-TEST
(	(	I-TEST	I-TEST
csf	NN	I-TEST	I-TEST
)	)	O	I-TEST
wbc	VBD	B-TEST	B-TEST
-	:	O	O
6	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
polys	NN	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
lymphs	SYM	B-TEST	B-TEST
-	:	O	O
95	CD	O	O
monos	NNS	B-TEST	B-TEST
-	:	O	O
5	CD	O	O

2015-09-25	JJ	O	O
02:20	CD	O	O
pm	JJ	O	B-TEST
cerebrospinal	JJ	B-TEST	I-TEST
fluid	NN	I-TEST	I-TEST
(	(	I-TEST	I-TEST
csf	NN	I-TEST	I-TEST
)	)	O	I-TEST
totprot	NN	B-TEST	I-TEST
-	:	O	O
56	CD	O	O
*	NN	O	O
glucose	VBD	B-TEST	B-TEST
-	:	O	O
77	CD	O	O

2015-09-25	JJ	O	O
02:20	CD	O	O
pm	JJ	O	B-TEST
cerebrospinal	JJ	B-TEST	I-TEST
fluid	NN	I-TEST	I-TEST
(	(	I-TEST	I-TEST
csf	NN	I-TEST	I-TEST
)	)	O	I-TEST
angiotensin	VBZ	B-TEST	I-TEST
1	CD	I-TEST	O
converting	VBG	I-TEST	O
enzyme	SYM	I-TEST	B-TEST
-	:	O	O
pnd	NN	O	O

2015-09-25	JJ	O	O
02:20	CD	O	O
pm	JJ	O	B-TEST
cerebrospinal	JJ	B-TEST	I-TEST
fluid	NN	I-TEST	I-TEST
(	(	I-TEST	I-TEST
csf	NN	I-TEST	I-TEST
)	)	O	I-TEST
vdrl	FW	B-TEST	I-TEST
-	:	O	O
pnd	NN	O	O

2015-09-25	JJ	O	O
02:20	CD	O	O
pm	JJ	O	B-TEST
cerebrospinal	JJ	B-TEST	I-TEST
fluid	NN	I-TEST	I-TEST
(	(	I-TEST	I-TEST
csf	NN	I-TEST	I-TEST
)	)	O	I-TEST
ernest	JJS	B-TEST	I-TEST
virus	NN	I-TEST	I-TEST
(	(	I-TEST	I-TEST
jcv	NN	I-TEST	I-TEST
)	)	I-TEST	I-TEST
dna	NN	I-TEST	I-TEST
detection	NN	I-TEST	I-TEST
by	IN	I-TEST	O
polymerase	NN	I-TEST	B-TEST
chain	NN	I-TEST	I-TEST
reaction	NN	I-TEST	I-TEST
(	(	I-TEST	I-TEST
pcr	JJ	I-TEST	I-TEST
)-	CD	O	I-TEST
pnd	NN	O	I-TEST

2015-09-25	JJ	O	O
02:20	CD	O	O
pm	JJ	O	B-TEST
cerebrospinal	JJ	B-TEST	I-TEST
fluid	NN	I-TEST	I-TEST
(	(	I-TEST	I-TEST
csf	NN	I-TEST	I-TEST
)	)	O	I-TEST
varicella	NN	B-TEST	I-TEST
dna	NN	I-TEST	I-TEST
(	(	I-TEST	I-TEST
pcr	JJ	I-TEST	I-TEST
)-	CD	O	I-TEST
pnd	NN	O	I-TEST

2015-09-25	JJ	O	O
02:20	CD	O	O
pm	JJ	O	B-TEST
cerebrospinal	JJ	B-TEST	I-TEST
fluid	NN	I-TEST	I-TEST
(	(	I-TEST	I-TEST
csf	NN	I-TEST	I-TEST
)	)	O	I-TEST
herpes	VBZ	B-TEST	I-TEST
simplex	JJ	I-TEST	I-TEST
virus	NN	I-TEST	I-TEST
pcr	SYM	I-TEST	I-TEST
-	:	O	O
pnd	NN	O	O

2015-09-25	JJ	O	O
02:20	CD	O	O
pm	JJ	O	B-TEST
cerebrospinal	JJ	B-TEST	I-TEST
fluid	NN	I-TEST	I-TEST
(	(	I-TEST	I-TEST
csf	NN	I-TEST	I-TEST
)	)	O	I-TEST
ebv	VBZ	B-TEST	I-TEST
-	:	I-TEST	O
pcr	NN	I-TEST	O
-	:	O	O
pnd	NN	O	O

2015-09-25	JJ	O	O
02:20	CD	O	O
pm	JJ	O	B-TEST
cerebrospinal	JJ	B-TEST	I-TEST
fluid	NN	I-TEST	I-TEST
(	(	I-TEST	I-TEST
csf	NN	I-TEST	I-TEST
)	)	I-TEST	I-TEST
cytomegalovirus	NN	B-TEST	I-TEST
-	:	I-TEST	O
pcr	NN	I-TEST	O
-	:	O	O
negative	JJ	O	O

cryptococcus	NN	B-PROBLEM	O
:	:	O	O
negative	JJ	O	O

csf	NNS	B-TEST	B-TEST
negative	JJ	O	O

blood	NN	B-TEST	B-TEST
cx	NN	I-TEST	I-TEST
ngtd	NN	O	O

urine	JJ	B-TEST	B-TEST
cx	NN	I-TEST	I-TEST
lactobacillus	NN	B-PROBLEM	I-TEST

csf	JJ	B-TEST	B-TEST
cytology	NN	I-TEST	I-TEST
:	:	O	O
negative	JJ	O	O
for	IN	O	O
malignant	JJ	B-PROBLEM	B-PROBLEM
cells	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

reactive	JJ	B-PROBLEM	B-PROBLEM
lymphoid	NN	I-PROBLEM	I-PROBLEM
cells	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

immunotyping	VBG	B-TEST	O
negative	JJ	O	O
.	.	O	O

cxr	JJ	B-TEST	O
09-28	NN	O	O
:	:	O	O
no	DT	O	O
evidence	NN	O	O
for	IN	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
change	NN	O	O
since	IN	O	O
prior	JJ	B-TEST	B-TEST
study	NN	I-TEST	I-TEST
of	IN	O	O
2015-09-24	JJ	O	O
.	.	O	O

ct	JJ	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
findings	NNS	O	I-TEST
:	:	O	O
there	EX	O	O
is	VBZ	O	O
moderately	RB	B-PROBLEM	B-PROBLEM
severe	JJ	I-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	I-PROBLEM
confluent	JJ	I-PROBLEM	I-PROBLEM
periventricular	JJ	I-PROBLEM	I-PROBLEM
white	JJ	I-PROBLEM	I-PROBLEM
matter	NN	I-PROBLEM	I-PROBLEM
hypodensity	NN	I-PROBLEM	I-PROBLEM
surrounding	VBG	O	I-PROBLEM
the	DT	O	I-PROBLEM
frontal	JJ	O	I-PROBLEM
horns	NNS	O	I-PROBLEM
,	,	O	O
posterior	JJ	O	B-PROBLEM
horns	NNS	O	I-PROBLEM
,	,	O	O
and	CC	O	O
more	JJR	O	O
superiorly	RB	O	O
,	,	O	O
involving	VBG	O	O
the	DT	O	O
centra	JJ	O	O
semiovale	NN	O	O
.	.	O	O

these	DT	O	O
findings	NNS	O	O
are	VBP	O	O
unchanged	JJ	O	O
from	IN	O	O
prior	JJ	B-TEST	O
studies	NNS	I-TEST	O
,	,	O	O
and	CC	O	O
may	MD	O	O
relate	VB	O	O
to	TO	O	O
the	DT	B-PROBLEM	O
"	NNP	I-PROBLEM	O
atypical	JJ	I-PROBLEM	O
"	NNP	I-PROBLEM	O
demyelinating	NN	I-PROBLEM	B-PROBLEM
process	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
suggested	VBN	O	O
in	IN	O	O
the	DT	O	O
indication	NN	O	O
on	IN	O	O
the	DT	B-TEST	O
prior	JJ	I-TEST	O
mri	NN	I-TEST	O
;	:	O	O
however	RB	O	O
,	,	O	O
they	PRP	O	O
are	VBP	O	O
non-specific	JJ	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
acute	NN	B-PROBLEM	B-PROBLEM
intra	JJ	I-PROBLEM	I-PROBLEM
-	:	I-PROBLEM	O
or	CC	I-PROBLEM	O
extra	JJ	I-PROBLEM	O
-	:	I-PROBLEM	O
axial	JJ	I-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
shift	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
normally	RB	I-PROBLEM	I-PROBLEM
midline	JJ	I-PROBLEM	I-PROBLEM
structures	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
ventricles	NNS	O	O
are	VBP	O	O
mildly	RB	B-PROBLEM	O
prominent	JJ	I-PROBLEM	O
,	,	O	O
but	CC	O	O
are	VBP	O	O
unchanged	JJ	O	O
from	IN	O	O
the	DT	B-TEST	B-TEST
prior	JJ	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
interval	JJ	B-PROBLEM	B-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
focal	JJ	I-PROBLEM	I-PROBLEM
gray	JJ	I-PROBLEM	I-PROBLEM
-	:	I-PROBLEM	O
white	JJ	I-PROBLEM	B-PROBLEM
matter	NN	I-PROBLEM	I-PROBLEM
differentiation	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
suggest	VB	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
though	IN	O	O
ct	NN	B-TEST	O
is	VBZ	O	O
not	RB	O	O
sensitive	JJ	O	O
in	IN	O	O
the	DT	O	O
early	JJ	O	O
stages	NNS	O	O
.	.	O	O

no	DT	O	O
focal	JJ	B-PROBLEM	B-PROBLEM
masses	NNS	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
seen	VBN	O	O
.	.	O	O

1)	CD	O	O
no	DT	O	O
intracranial	JJ	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
mass	NN	B-PROBLEM	B-PROBLEM
effect	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
no	DT	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
interval	JJ	I-PROBLEM	I-PROBLEM
change	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
ct	NN	B-TEST	O
of	IN	O	O
2015-07-20	JJ	O	O
.	.	O	O

2)	CD	O	O
diffuse	NN	B-PROBLEM	O
,	,	I-PROBLEM	O
confluent	JJ	I-PROBLEM	B-PROBLEM
periventricular	JJ	I-PROBLEM	I-PROBLEM
white	JJ	I-PROBLEM	I-PROBLEM
matter	NN	I-PROBLEM	I-PROBLEM
hypodensity	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
may	MD	O	O
relate	VB	O	O
to	TO	O	O
an	DT	B-PROBLEM	B-PROBLEM
underlying	VBG	I-PROBLEM	I-PROBLEM
demyelinating	NN	I-PROBLEM	I-PROBLEM
process	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
as	IN	O	O
suggested	VBN	O	O
in	IN	O	O
the	DT	O	O
indication	NN	O	O
provided	VBD	O	O
for	IN	O	O
the	DT	B-TEST	O
prior	JJ	I-TEST	O
mri	NN	I-TEST	O
).	NN	O	O

the	DT	B-PROBLEM	O
markedly	RB	I-PROBLEM	O
low	JJ	I-PROBLEM	O
-	:	I-PROBLEM	O
attenation	NN	I-PROBLEM	O
(	(	O	O
14-15	JJ	O	O
hu	NN	O	O
)	)	O	O
centered	VBD	O	O
within	IN	O	O
this	DT	O	O
process	NN	O	O
suggests	VBZ	O	O
either	CC	O	O
irreversible	JJ	B-PROBLEM	B-PROBLEM
demyelination	NN	I-PROBLEM	I-PROBLEM
with	IN	O	I-PROBLEM
cavitation	NN	B-PROBLEM	I-PROBLEM
("	NNP	I-PROBLEM	I-PROBLEM
black	JJ	I-PROBLEM	I-PROBLEM
hole	NN	I-PROBLEM	I-PROBLEM
"),	NN	O	I-PROBLEM
or	CC	O	O
lacunar	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	O
a	DT	I-PROBLEM	B-TREATMENT
vascular	JJ	I-PROBLEM	I-TREATMENT
basis	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

generalized	VBN	O	O
and	CC	O	O
marked	VBN	B-PROBLEM	B-PROBLEM
callosal	NN	I-PROBLEM	I-PROBLEM
atrophy	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
on	IN	O	O
the	DT	B-TEST	O
mr	NN	I-TEST	O
)	)	O	O
also	RB	O	O
suggest	VBP	O	O
advanced	JJ	B-PROBLEM	O
,	,	I-PROBLEM	O
irreversible	JJ	I-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3)	CD	O	O
no	DT	O	O
mass	NN	B-PROBLEM	B-PROBLEM
is	VBZ	O	O
appreciated	VBN	O	O
on	IN	O	O
this	DT	B-TEST	B-TEST
limited	JJ	I-TEST	I-TEST
non-contrast	JJ	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
;	:	O	O
if	IN	O	O
clinically	RB	O	O
concerned	VBN	O	O
,	,	O	O
an	DT	B-TEST	B-TEST
mri	NN	I-TEST	I-TEST
with	IN	I-TEST	I-TEST
gadolinium	NN	I-TEST	I-TEST
is	VBZ	O	O
recommended	VBN	O	O
.	.	O	O

mri	NN	B-TEST	O
:	:	O	O
there	EX	O	O
is	VBZ	O	O
a	DT	O	O
similar	JJ	O	O
configuration	NN	O	O
of	IN	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
t2	JJ	I-PROBLEM	I-PROBLEM
signal	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
periventricular	JJ	O	I-PROBLEM
white	JJ	O	I-PROBLEM
matter	NN	O	I-PROBLEM
of	IN	O	O
both	DT	O	O
cerebral	JJ	O	O
hemispheres	NNS	O	O
,	,	O	O
suggesting	VBG	O	O
demyelinating	VBG	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

as	IN	O	O
previously	RB	O	O
noted	VBN	O	O
,	,	O	O
there	EX	O	O
is	VBZ	O	O
associated	JJ	B-PROBLEM	B-PROBLEM
volume	NN	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
thinning	VBG	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
corpus	NN	I-PROBLEM	I-PROBLEM
callosum	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
slight	VBD	B-PROBLEM	B-PROBLEM
widening	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
ventricles	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
post-contrast	JJ	B-TEST	O
images	NNS	I-TEST	O
,	,	O	O
there	EX	O	O
is	VBZ	O	O
a	DT	O	O
probably	RB	O	O
stable	JJ	O	O
appearance	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	O
5	CD	I-PROBLEM	O
mm	NN	I-PROBLEM	O
linear	NN	I-PROBLEM	O
,	,	I-PROBLEM	O
focal	JJ	I-PROBLEM	B-PROBLEM
area	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
enhancement	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
centrum	NN	I-PROBLEM	I-PROBLEM
semiovale	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
of	IN	O	O
uncertain	JJ	O	O
etiology	NN	O	O
.	.	O	O

also	RB	O	O
ehancing	VBG	O	O
is	VBZ	O	O
3	CD	B-PROBLEM	O
mm	NN	I-PROBLEM	B-PROBLEM
linear	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
hippocampal	JJ	I-PROBLEM	I-PROBLEM
cortex	NN	I-PROBLEM	I-PROBLEM
anteriorly	RB	I-PROBLEM	I-PROBLEM
,	,	O	O
not	RB	O	O
seen	VBN	O	O
on	IN	O	O
the	DT	O	O
08-20	JJ	O	O
mr	NN	B-TEST	O
,	,	O	O
but	CC	O	O
that	IN	B-TEST	B-TEST
study	NN	I-TEST	I-TEST
was	VBD	O	O
very	RB	O	O
motion	JJ	O	O
-	:	O	O
degraded	VBN	O	B-PROBLEM
.	.	O	O

the	DT	O	O
hippocampus	NN	O	O
would	MD	O	O
be	VB	O	O
a	DT	O	O
most	RBS	O	O
unusual	JJ	O	O
site	NN	O	O
for	IN	O	O
involvement	NN	O	O
by	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
sclerosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
apparent	JJ	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
mass	NN	B-PROBLEM	B-PROBLEM
effect	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
changes	NNS	B-PROBLEM	O
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
overall	JJ	I-PROBLEM	O
morphology	NN	I-PROBLEM	O
of	IN	O	O
the	DT	O	O
brain	NN	O	O
are	VBP	O	O
identified	VBN	O	O
.	.	O	O

1.	CD	O	O
stable	JJ	O	O
appearance	NN	O	O
of	IN	O	O
confluent	JJ	O	O
areas	NNS	O	O
of	IN	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
t2	JJ	I-PROBLEM	I-PROBLEM
signal	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
periventricular	JJ	I-PROBLEM	I-PROBLEM
white	JJ	I-PROBLEM	I-PROBLEM
matter	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
consistent	JJ	O	O
with	IN	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
demyelinating	VBG	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
enhancing	VBG	B-PROBLEM	B-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
centrum	NN	I-PROBLEM	I-PROBLEM
semiovale	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
also	RB	O	O
left	VBD	O	B-PROBLEM
hippocampal	JJ	O	I-PROBLEM
cortex	NN	O	I-PROBLEM
.	.	O	O

this	DT	B-PROBLEM	B-PROBLEM
former	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
evident	JJ	O	O
on	IN	O	O
mr	NN	B-TEST	O
dating	VBG	O	O
back	RB	O	O
to	TO	O	O
2014-08-15	CD	O	O
,	,	O	O
though	EX	O	O
is	VBZ	O	O
more	RBR	O	O
prominent	JJ	O	O
at	IN	O	O
this	DT	O	O
time	NN	O	O
,	,	O	O
likely	RB	O	O
due	JJ	O	O
to	TO	O	O
less	JJR	O	O
motion	JJ	O	B-TEST
degradation	NN	O	I-TEST
of	IN	O	I-TEST
the	DT	B-TEST	I-TEST
current	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
.	.	O	O

etiology	NN	O	O
of	IN	O	O
these	DT	B-PROBLEM	B-PROBLEM
enhancing	VBG	I-PROBLEM	I-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
uncertain	JJ	O	O
,	,	O	O
but	CC	O	O
could	MD	O	O
be	VB	O	O
atypical	JJ	B-PROBLEM	B-PROBLEM
manifestations	NNS	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
demyelination	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

eeg	NN	B-TEST	O
:	:	O	O

abnormality	NN	O	B-PROBLEM
#1:	NN	O	I-PROBLEM
throughout	IN	O	O
the	DT	O	O
recording	NN	O	O
there	EX	O	O
were	VBD	O	O
frequent	JJ	O	O
bursts	NNS	O	O
of	IN	O	O
generalized	JJ	B-PROBLEM	B-PROBLEM
theta	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
delta	NN	I-PROBLEM	I-PROBLEM
slowing	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

facial	JJ	B-PROBLEM	B-PROBLEM
twitching	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
described	VBN	O	O
by	IN	O	O
the	DT	O	O
technologist	NN	O	O
and	CC	O	O
seen	VBN	O	O
on	IN	O	O
the	DT	B-TEST	O
video	NN	I-TEST	O
.	.	O	O

this	DT	O	O
is	VBZ	O	O
primarily	RB	O	B-PROBLEM
right-sided	JJ	B-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	O
facial	JJ	I-PROBLEM	B-PROBLEM
movement	NN	I-PROBLEM	I-PROBLEM
clinically	RB	O	I-PROBLEM
and	CC	O	O
did	VBD	O	O
not	RB	O	O
appear	VB	O	O
to	TO	O	O
involve	VB	O	O
the	DT	O	O
forehead	NN	O	O
or	CC	O	O
cmed	VBN	O	B-PROBLEM
csru	NN	O	I-PROBLEM
.	.	O	O

there	EX	O	O
were	VBD	O	O
no	DT	O	O
clear	JJ	O	B-PROBLEM
eeg	NN	B-TEST	I-PROBLEM
correlate	NN	O	I-PROBLEM
.	.	O	O

abnormality	NN	O	B-TEST
#2:	VBZ	O	I-TEST
the	DT	B-TEST	I-TEST
background	NN	I-TEST	I-TEST
voltages	NNS	I-TEST	I-TEST
were	VBD	O	O
occasionally	RB	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	JJ	O	I-PROBLEM
side	NN	O	I-PROBLEM
,	,	O	O
and	CC	O	O
there	EX	O	O
were	VBD	O	O
additional	JJ	B-PROBLEM	O
bursts	NNS	I-PROBLEM	O
of	IN	I-PROBLEM	O
delta	NN	I-PROBLEM	B-PROBLEM
slowing	VBG	I-PROBLEM	O
seen	VBN	O	O
broadly	RB	O	O
on	IN	O	O
the	DT	O	O
left	JJ	O	O
side	NN	O	O
alone	RB	O	O
.	.	O	O

abnormality	NN	O	B-TEST
#3:	VBZ	O	I-TEST
the	DT	O	I-TEST
background	NN	O	I-TEST
rhythms	NN	O	I-TEST
were	VBD	O	O
dominated	VBN	O	O
by	IN	O	O
much	JJ	B-PROBLEM	O
faster	JJR	I-PROBLEM	O
beta	NN	I-PROBLEM	B-TREATMENT
rhythm	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

hyperventilation	NN	B-TREATMENT	B-PROBLEM
:	:	O	O
could	MD	O	O
not	RB	O	O
be	VB	O	O
performed	VBN	O	O
.	.	O	O

intermittent	JJ	B-TEST	B-PROBLEM
photic	JJ	I-TEST	I-PROBLEM
stimulation	NN	I-TEST	I-PROBLEM
:	:	O	O
could	MD	O	O
not	RB	O	O
be	VB	O	O
performed	VBN	O	O
.	.	O	O

cardiac	JJ	B-TEST	B-TEST
monitor	NN	I-TEST	I-TEST
:	:	O	O
showed	VBD	O	O
a	DT	O	O
generally	RB	O	O
regular	JJ	O	O
rhythm	NN	O	O
.	.	O	O

impression	NN	O	O
:	:	O	O
abnormal	JJ	B-PROBLEM	B-PROBLEM
portable	JJ	I-PROBLEM	I-PROBLEM
eeg	NN	I-PROBLEM	I-PROBLEM
due	JJ	O	O
to	TO	O	O
the	DT	B-PROBLEM	O
bursts	NNS	I-PROBLEM	O
of	IN	I-PROBLEM	O
generalized	JJ	I-PROBLEM	B-PROBLEM
slowing	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
additional	JJ	B-PROBLEM	B-PROBLEM
left-sided	JJ	I-PROBLEM	I-PROBLEM
slowing	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
voltage	NN	B-PROBLEM	I-PROBLEM
dimunition	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
along	IN	O	O
with	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
slowing	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
background	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
generalized	JJ	O	O
and	CC	O	O
background	NN	O	B-TEST
features	NNS	O	I-TEST
indicate	VBP	O	O
a	DT	B-PROBLEM	B-PROBLEM
wide-spread	JJ	I-PROBLEM	I-PROBLEM
encephalopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	O
left	NN	I-PROBLEM	O
sided	VBD	I-PROBLEM	O
slowing	NN	I-PROBLEM	O
and	CC	O	O
voltage	NN	B-PROBLEM	B-TREATMENT
reduction	NN	I-PROBLEM	I-TREATMENT
surpassed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
additional	JJ	I-PROBLEM	I-PROBLEM
dysfunction	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
side	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
possibly	RB	O	O
wide-spread	JJ	B-PROBLEM	B-PROBLEM
cortical	JJ	I-PROBLEM	I-PROBLEM
dysfunction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
a	DT	O	O
possibility	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
structural	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
the	DT	B-PROBLEM	B-PROBLEM
encephalopathy	NN	I-PROBLEM	I-PROBLEM
dominated	VBD	O	I-PROBLEM
the	DT	O	I-PROBLEM
overall	JJ	O	I-PROBLEM
picture	NN	O	I-PROBLEM
.	.	O	O

there	EX	O	O
were	VBD	O	O
no	DT	O	O
clear	JJ	B-PROBLEM	B-PROBLEM
epileptiform	NN	I-PROBLEM	I-PROBLEM
discharges	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
eeg	NN	O	B-TEST
correlate	NN	O	I-TEST
was	VBD	O	O
established	VBN	O	O
for	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
facial	JJ	I-PROBLEM	I-PROBLEM
twitching	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
lack	NN	O	O
of	IN	O	O
eeg	JJ	O	O
correlate	NN	O	O
to	TO	O	O
the	DT	B-PROBLEM	B-PROBLEM
facial	JJ	I-PROBLEM	I-PROBLEM
twitching	NN	I-PROBLEM	I-PROBLEM
does	VBZ	O	O
not	RB	O	O
exclude	VB	O	O
a	DT	O	O
central	JJ	O	O
cause	NN	O	O
(	(	O	O
and	CC	O	O
,	,	O	O
indeed	RB	O	O
,	,	O	O
this	DT	O	O
appeared	VBD	O	O
most	RBS	O	O
likely	JJ	O	O
based	VBN	O	O
on	IN	O	O
the	DT	O	O
clinical	JJ	O	O
and	CC	O	O
video	JJ	B-TEST	O
observations	NNS	I-TEST	O
).	VBP	O	O

53	CD	O	O
yo	JJ	O	O
woman	NN	O	O
with	IN	O	O
h/o	JJ	O	O
seizure	NN	B-PROBLEM	B-PROBLEM
disorder	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
demyelinating	VBG	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	I-PROBLEM
and	CC	O	I-PROBLEM
brain	NN	B-PROBLEM	I-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
presents	NNS	O	O
with	IN	O	O
prolonged	JJ	B-PROBLEM	B-PROBLEM
seizure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
now	RB	O	O
unresponsive	JJ	B-PROBLEM	O
with	IN	O	O
persistent	JJ	B-PROBLEM	B-PROBLEM
twitching	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
arm	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
face	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
is	VBZ	O	O
most	RBS	O	O
consistent	JJ	O	O
with	IN	O	O
complex	JJ	B-PROBLEM	B-PROBLEM
partial	JJ	I-PROBLEM	I-PROBLEM
seizures	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	O	O
focus	NN	O	O
in	IN	O	O
the	DT	O	O
left	NN	O	O
hemisphere	RB	O	O
,	,	O	O
most	JJS	O	O
likely	JJ	O	O
the	DT	O	O
motor	NN	O	O
strip	NN	O	O
.	.	O	O

in	IN	O	O
the	DT	O	O
past	NN	O	O
,	,	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
seizures	NNS	I-PROBLEM	I-PROBLEM
were	VBD	O	O
on	IN	O	O
the	DT	O	O
left	JJ	O	O
side	NN	O	O
,	,	O	O
which	WDT	O	O
implies	VBZ	O	O
that	IN	O	O
she	PRP	O	O
now	RB	O	O
has	VBZ	O	O
a	DT	O	O
new	JJ	O	O
focus	NN	O	O
.	.	O	O

it	PRP	O	O
is	VBZ	O	O
possible	JJ	O	O
that	IN	O	O
this	DT	O	O
is	VBZ	O	O
secondary	JJ	O	O
to	TO	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
underlying	JJ	I-PROBLEM	I-PROBLEM
demyelinating	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
per	IN	O	O
report	NN	O	O
this	DT	O	O
has	VBZ	O	O
not	RB	O	O
been	VBN	O	O
very	RB	O	O
active	JJ	O	O
.	.	O	O

other	JJ	O	O
possibilities	NNS	O	O
include	VBP	O	O
infection	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
including	VBG	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
uti	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

it	PRP	O	O
is	VBZ	O	O
likely	JJ	O	O
that	IN	O	O
these	DT	B-PROBLEM	B-PROBLEM
seizures	NNS	I-PROBLEM	I-PROBLEM
began	VBD	O	O
due	JJ	O	O
to	TO	O	O
subtherapeutic	JJ	B-PROBLEM	B-TEST
dilantin	NN	I-PROBLEM	I-TEST
levels	NNS	I-PROBLEM	I-TEST
on	IN	O	O
her	PRP$	B-TREATMENT	O
new	JJ	I-TREATMENT	O
dose	NN	I-TREATMENT	O
of	IN	O	O
200	CD	O	O
mg	NNS	O	O
/	VBD	O	O
100	CD	O	O
mg	NN	O	O
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
seizure	NN	I-TREATMENT	I-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
is	VBZ	O	O
difficult	JJ	O	O
,	,	O	O
given	VBN	O	O
the	DT	B-TREATMENT	O
higher	JJR	I-TREATMENT	O
doses	NNS	I-TREATMENT	O
were	VBD	O	O
causing	VBG	O	O
her	PRP$	O	B-PROBLEM
to	TO	O	I-PROBLEM
fall	VB	O	I-PROBLEM
and	CC	O	I-PROBLEM
slur	VB	O	I-PROBLEM
her	PRP$	O	I-PROBLEM
speech	NN	O	I-PROBLEM
.	.	O	O

discussed	VBN	O	O
with	IN	O	O
dr.	NN	O	O
joaquin	NN	O	O
the	DT	O	O
addition	NN	O	O
of	IN	O	O
an	DT	B-TREATMENT	O
alternate	NN	I-TREATMENT	O
castelluccio	NN	I-TREATMENT	O
with	IN	O	O
the	DT	O	O
possibility	NN	O	O
of	IN	O	O
tapering	VBG	O	O
down	RP	O	O
the	DT	B-TREATMENT	O
dilantin	NN	I-TREATMENT	O
in	IN	O	O
the	DT	O	O
future	NN	O	O
,	,	O	O
and	CC	O	O
he	PRP	O	O
agreed	VBD	O	O
that	IN	O	O
she	PRP	O	O
may	MD	O	O
benefit	VB	O	O
from	IN	O	O
zonegran	NN	B-TREATMENT	O
.	.	O	O

cannot	NN	O	O
use	NN	O	O
lamictal	NN	B-TREATMENT	O
or	CC	O	O
depakote	NN	B-TREATMENT	O
due	JJ	O	O
to	TO	O	O
reactions	NNS	B-PROBLEM	O
.	.	O	O

topamax	NN	B-TREATMENT	O
is	VBZ	O	O
another	DT	O	O
possibility	NN	O	O
,	,	O	O
but	CC	O	O
not	RB	O	O
ideal	VB	O	O
in	IN	O	O
a	DT	O	O
patient	NN	O	O
with	IN	O	O
preexisting	VBG	B-PROBLEM	B-PROBLEM
cognitive	JJ	I-PROBLEM	I-PROBLEM
deficits	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
zonegran	NN	B-TREATMENT	O
at	IN	O	O
50	CD	O	O
mg	NNS	O	O
daily	RB	O	O
with	IN	O	O
plans	NNS	O	O
to	TO	O	O
increase	VB	O	O
by	IN	O	O
50	CD	O	O
mg	NNS	O	O
every	DT	O	O
other	JJ	O	O
week	NN	O	O
to	TO	O	O
a	DT	O	O
goal	NN	O	O
dose	NN	O	O
of	IN	O	O
200	CD	O	O
mg	NNS	O	O
/	JJ	O	O
day	NN	O	O
;	:	O	O
she	PRP	O	O
was	VBD	O	O
on	IN	O	O
100	CD	O	O
mg	JJ	O	O
daily	RB	O	O
at	IN	O	O
discharge	NN	O	O
and	CC	O	O
should	MD	O	O
have	VB	O	O
her	PRP$	O	O
dose	NN	O	O
increased	VBN	O	O
on	IN	O	O
10-12	JJ	O	O
and	CC	O	O
again	RB	O	O
on	IN	O	O
10-26	NNS	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
keppra	NN	B-TREATMENT	O
and	CC	O	O
dilantin	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
trough	NN	B-TEST	B-PROBLEM
checked	VBN	O	O
frequently	RB	O	O
and	CC	O	O
adjustment	NN	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

ativan	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
used	VBN	O	O
for	IN	O	O
breakthrough	NN	B-PROBLEM	B-PROBLEM
seizures	NNS	I-PROBLEM	I-PROBLEM
(	(	O	I-PROBLEM
facial	JJ	B-PROBLEM	I-PROBLEM
twitching	NN	I-PROBLEM	I-PROBLEM
).	NN	O	O

mri/mra	NN	B-TEST	O
showed	VBD	O	O
new	JJ	B-PROBLEM	B-PROBLEM
temporal	JJ	I-PROBLEM	I-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
it	PRP	O	O
is	VBZ	O	O
unclear	JJ	O	O
if	IN	O	O
these	DT	O	O
are	VBP	O	O
the	DT	O	O
cause	NN	O	O
or	CC	O	O
effect	NN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
seizures	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
will	MD	O	O
need	VB	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
mri	NN	I-TEST	I-TEST
in	IN	O	O
several	JJ	O	O
months	NNS	O	O
for	IN	O	O
further	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
.	.	O	O

lp	NN	B-TEST	O
was	VBD	O	O
done	VBN	O	O
and	CC	O	O
had	VBD	O	O
no	DT	O	O
changes	NNS	O	O
to	TO	O	O
suggest	VB	O	O
a	DT	O	O
different	JJ	O	O
etiology	NN	O	O
(	(	O	O
ie	JJ	O	O
negative	JJ	O	O
cytology	NN	O	O
and	CC	O	O
negative	JJ	O	O
immunophenotyping	NN	O	O
).	NN	O	O

oligoclonal	JJ	B-TEST	B-TREATMENT
bands	NNS	I-TEST	I-TREATMENT
were	VBD	O	O
not	RB	O	O
assessed	VBN	O	O
as	IN	O	O
there	EX	O	O
was	VBD	O	O
not	RB	O	O
enough	JJ	O	O
csf	NN	B-TEST	O
per	IN	O	O
the	DT	O	O
laboratory	NN	O	O
.	.	O	O

she	PRP	O	O
will	MD	O	O
need	VB	O	O
repeated	VBN	B-TEST	B-PROBLEM
dilantin	JJ	I-TEST	I-PROBLEM
troughs	NNS	I-TEST	I-PROBLEM
with	IN	O	O
one	CD	O	O
time	NN	O	O
dose	NN	O	O
when	WRB	O	O
trough	NN	O	B-PROBLEM
is	VBZ	O	O
subtherapeutic	JJ	O	O
.	.	O	O

angiotensin	RB	B-TEST	B-TREATMENT
1	CD	I-TEST	O
converting	VBG	I-TEST	O
enzyme	NN	I-TEST	B-TREATMENT

ebv-pcr	NN	B-TEST	O

herpes	NNS	B-TEST	B-PROBLEM
simplex	JJ	I-TEST	I-PROBLEM
virus	NN	I-TEST	I-PROBLEM
pcr	NN	I-TEST	I-PROBLEM

ernest	JJS	B-TEST	B-TEST
virus	NN	I-TEST	I-TEST
(	(	I-TEST	I-TEST
jcv	NN	I-TEST	I-TEST
)	)	I-TEST	I-TEST
dna	NN	B-TEST	I-TEST
pcr	NN	I-TEST	I-TEST

lyme	NN	B-TEST	B-PROBLEM
,	,	O	O
total	JJ	B-TEST	B-TREATMENT
eia	NN	I-TEST	I-TREATMENT
with	IN	O	O
reflex	NN	B-TEST	B-TREATMENT
to	TO	I-TEST	O
csf	VB	I-TEST	B-TEST
ratio	NN	I-TEST	I-TEST

varicella	NN	B-TEST	B-TEST
dna	NN	I-TEST	I-TEST
(	(	I-TEST	O
pcr	NN	I-TEST	O
)	)	I-TEST	O

vdrl	NN	B-TEST	O

2.	CD	O	O
atypical	JJ	B-PROBLEM	B-PROBLEM
ms	NN	I-PROBLEM	I-PROBLEM
:	:	O	O
discussed	VBN	O	O
with	IN	O	O
her	PRP$	O	O
outpt	JJ	O	O
neurologist	NN	O	O
(	(	O	O
dr.	JJ	O	O
ford	NN	O	O
in	IN	O	O
boston	NNP	O	O
medical	JJ	O	O
center	NN	O	O
);	VBZ	O	O
no	DT	O	O
current	JJ	O	O
role	NN	O	O
for	IN	O	O
ms	JJ	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

mri	NN	B-TEST	B-TEST
was	VBD	O	O
performed	VBN	O	O
and	CC	O	O
showed	VBD	O	O
new	JJ	B-PROBLEM	B-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
vs	VBP	O	O
sz	JJ	B-PROBLEM	B-PROBLEM
effects	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
temporal	JJ	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
also	RB	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
new	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
her	PRP$	B-TEST	O
last	JJ	I-TEST	O
mri	NN	I-TEST	O
in	IN	O	O
the	DT	O	O
centrum	NN	O	O
semiovale	NN	O	O
.	.	O	O

lp	NN	B-TEST	O
was	VBD	O	O
done	VBN	O	O
to	TO	O	O
evaluate	VB	O	O
for	IN	O	O
malignancy	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
no	DT	O	O
malignant	JJ	B-PROBLEM	B-PROBLEM
cells	NNS	I-PROBLEM	I-PROBLEM
were	VBD	O	O
seen	VBN	O	O
.	.	O	O

immunotyping	NN	B-TEST	O
was	VBD	O	O
negative	JJ	O	O
as	RB	O	O
well	RB	O	O
(	(	O	O
per	IN	O	O
verbal	FW	O	O
report	NN	O	O
).	NN	O	O

unfortunately	RB	O	O
,	,	O	O
oligoclonal	JJ	B-TEST	B-TREATMENT
bands	NNS	I-TEST	I-TREATMENT
could	MD	O	O
not	RB	O	O
be	VB	O	O
sent	VBN	O	O
from	IN	O	O
the	DT	O	O
csf	NN	O	O
(	(	O	O
lab	JJ	O	O
sent	NN	O	O
csf	NN	O	O
for	IN	O	O
other	JJ	B-TEST	B-PROBLEM
studies	NNS	I-TEST	I-PROBLEM
and	CC	O	O
there	EX	O	O
was	VBD	O	O
not	RB	O	O
enough	JJ	O	O
left	NN	O	O
over	IN	O	O
for	IN	O	O
ocb	JJ	B-TEST	O
s).	NN	I-TEST	O

given	VBN	O	O
that	IN	O	O
she	PRP	O	O
does	VBZ	O	O
have	VB	O	O
new	JJ	B-PROBLEM	B-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
on	IN	O	O
mri	NN	B-TEST	O
,	,	O	O
if	IN	O	O
ocb	JJ	B-TEST	O
s	NN	I-TEST	O
were	VBD	O	O
sent	VBN	O	O
this	DT	O	O
would	MD	O	O
have	VB	O	O
weighed	VBN	O	O
in	IN	O	O
in	IN	O	O
her	PRP$	O	B-TEST
dx	NN	O	I-TEST
of	IN	O	I-TEST
ms	NN	B-PROBLEM	I-TEST
,	,	O	O
and	CC	O	O
it's	NN	O	O
possible	JJ	O	O
she	PRP	O	O
could	MD	O	O
benefit	VB	O	O
from	IN	O	O
ms	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
family	NN	O	O
is	VBZ	O	O
confident	JJ	O	O
in	IN	O	O
any	DT	O	O
decision	NN	O	O
dr.	NN	O	O
ford	NN	O	O
would	MD	O	O
make	VB	O	O
re	NN	O	O
:	:	O	O
therapy	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
her	PRP$	B-PROBLEM	B-TEST
ms	NN	I-PROBLEM	I-TEST
.	.	O	O

3.	CD	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
on	IN	O	O
admission	NN	O	O
:	:	O	O
pt	NN	O	O
w/	WRB	O	O
positive	JJ	B-PROBLEM	B-PROBLEM
u/a	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
treated	VBN	O	O
with	IN	O	O
bactrim	JJ	B-TREATMENT	B-TREATMENT
x	JJ	O	O
3	CD	O	O
days	NNS	O	O
with	IN	O	O
defervescence	NN	O	O
.	.	O	O

4.	CD	O	O
depression	NN	B-PROBLEM	B-PROBLEM
:	:	O	O
continue	NN	O	O
escitalopram	NN	B-TREATMENT	O
;	:	O	O
assess	CC	O	O
need	VBP	O	O
to	TO	O	O
change	VB	O	O
medication	NN	B-TREATMENT	B-TREATMENT
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
.	.	O	O

5.	CD	O	O
fen	NN	O	O
:	:	O	O
ngt	NN	B-TREATMENT	O
was	VBD	O	O
placed	VBN	O	O
given	VBN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
altered	JJ	I-PROBLEM	I-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
she	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
unable	JJ	O	O
to	TO	O	O
pass	VB	O	O
a	DT	B-TEST	B-TEST
swallow	JJ	I-TEST	I-TEST
evaluation	NN	I-TEST	I-TEST
,	,	O	O
but	CC	O	O
has	VBZ	O	O
improved	VBN	O	O
.	.	O	O

dilantin	NN	B-TREATMENT	B-TREATMENT
200/100	CD	O	O

keppra	NN	B-TREATMENT	O
1500	CD	O	O
mg	NN	O	O
bid	NN	O	O

lexapro	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	JJ	O	O
q	NNS	O	O
day	NN	O	O

folate	NN	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	NN	O	O
q	NN	O	O
day	NN	O	O

calcium	NN	B-TREATMENT	B-TEST
1	CD	O	O
tab	NN	O	O
bid	NN	O	O

1.	CD	O	O
zonisamide	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
):	NNP	O	O
increase	NN	O	O
by	IN	O	O
50	CD	O	O
mg	NNS	O	O
every	DT	O	O
other	JJ	O	O
week	NN	O	O
(	(	O	O
next	JJ	O	O
increase	NN	O	O
2015-10-12	JJ	O	O
).	NN	O	O

2.	CD	O	O
phenytoin	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
tablet	NN	O	O
,	,	O	O
chewable	JJ	O	O
sig	NN	O	O
:	:	O	O
four	CD	O	O
(	(	O	O
4	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
chewable	JJ	O	O
po	NN	O	O
qam	NN	O	O
(	(	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
(	(	O	O
in	IN	O	O
the	DT	O	O
morning	NN	O	O
)).	NN	O	O

3.	CD	O	O
phenytoin	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
tablet	NN	O	O
,	,	O	O
chewable	JJ	O	O
sig	NN	O	O
:	:	O	O
three	CD	O	O
(	(	O	O
3	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
chewable	JJ	O	O
po	NN	O	O
qpm	NN	O	O
(	(	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
(	(	O	O
in	IN	O	O
the	DT	O	O
evening	NN	O	O
)).	NN	O	O

4.	CD	O	O
phenytoin	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
tablet	NN	O	O
,	,	O	O
chewable	JJ	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
chewable	JJ	O	O
po	NN	O	O
every	DT	O	O
other	JJ	O	O
day	NN	O	O
(	(	O	O
every	DT	O	O
other	JJ	O	O
day	NN	O	O
).	VB	O	O

5.	CD	O	O
levetiracetam	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
four	CD	O	O
(	(	O	O
4	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

6.	CD	O	O
escitalopram	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

7.	CD	O	O
folic	JJ	B-TREATMENT	B-TREATMENT
acid	RB	I-TREATMENT	I-TREATMENT
1	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

8.	CD	O	O
lansoprazole	JJ	B-TREATMENT	B-TREATMENT
30	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
rapid	JJ	O	B-PROBLEM
dissolve	NN	O	I-PROBLEM
,	,	O	O
dr	JJ	O	O
turner	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
rapid	JJ	O	B-PROBLEM
dissolve	NN	O	I-PROBLEM
,	,	O	O
dr	JJ	O	O
hughes	NNS	O	O
daily	RB	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

9.	CD	O	O
docusate	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
150	CD	O	O
mg	NN	O	O
/	VBD	O	O
15	CD	O	O
ml	NN	O	O
liquid	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
hundred	VBD	O	O
(	(	O	O
100	CD	O	O
)	)	O	O
mg	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

10.	CD	O	O
senna	JJ	B-TREATMENT	B-TREATMENT
8.6	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

11.	CD	O	O
bisacodyl	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
suppository	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
suppository	NN	O	O
rectal	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	RB	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
constipation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

12.	CD	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
porcine	NN	I-TREATMENT	I-TREATMENT
)	)	O	I-TREATMENT
5,000	CD	O	O
unit	NN	O	O
/	NNP	O	O
ml	NN	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
5000	CD	O	O
(	(	O	O
5000	CD	O	O
)	)	O	O
units	NNS	O	O
injection	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

seizure	NN	B-PROBLEM	B-PROBLEM

history	NN	O	O
of	IN	O	O
atypical	JJ	B-PROBLEM	B-PROBLEM
multiple	JJ	I-PROBLEM	I-PROBLEM
sclerosis	NN	I-PROBLEM	I-PROBLEM

memory	NN	B-PROBLEM	B-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM

status	NN	O	B-PROBLEM
post	NN	O	I-PROBLEM
brain	NN	B-PROBLEM	I-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM

urinary	JJ	B-PROBLEM	B-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM

take	VB	O	O
all	DT	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
as	IN	O	O
prescribed	NN	O	O
.	.	O	O

please	VB	O	O
increase	NN	O	O
zonegran	NN	B-TREATMENT	O
dose	NN	I-TREATMENT	O
by	IN	O	O
50	CD	O	O
every	DT	O	O
other	JJ	O	O
week	NN	O	O
until	IN	O	O
it	PRP	O	O
reaches	VBZ	O	O
200	CD	O	O
mg	JJ	O	O
daily	RB	O	O
,	,	O	O
with	IN	O	O
first	JJ	O	O
dose	JJ	O	O
change	NN	O	O
10-12	CD	O	O
to	TO	O	O
150	CD	O	O
mg	NNS	O	O
daily	RB	O	O
and	CC	O	O
second	JJ	O	O
dose	JJ	O	O
change	NN	O	O
10-26	JJ	O	O
to	TO	O	O
200	CD	O	O
mg	NNS	O	O
daily	RB	O	O
.	.	O	O

call	VB	O	O
the	DT	O	O
doctor	NN	O	O
or	CC	O	O
go	VB	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
with	IN	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
seizure	NN	I-PROBLEM	I-PROBLEM
frequency	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
unresponsiveness	RB	B-PROBLEM	B-PROBLEM
,	,	O	O
new	JJ	B-PROBLEM	B-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
numbness	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
any	DT	B-PROBLEM	B-PROBLEM
other	JJ	I-PROBLEM	I-PROBLEM
concerning	NN	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

please	NN	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
mri	NN	I-TEST	I-TEST
in	IN	O	O
several	JJ	O	O
months	NNS	O	O
to	TO	O	O
evaluate	VB	O	O
new	JJ	B-PROBLEM	B-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
brain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

vulvar	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
43-year-old	JJ	O	O
gravida	NN	O	O
ii	NN	O	O
para	NN	O	O
ii	JJ	O	O
white	JJ	O	O
female	NN	O	O
referred	VBN	O	O
by	IN	O	O
dr.	NN	O	O
ca	MD	O	O
shuff	VB	O	O
for	IN	O	O
evaluation	NN	B-TEST	B-TEST
.	.	O	O

she	PRP	O	O
was	VBD	O	O
in	IN	O	O
her	PRP$	O	O
usual	JJ	O	O
state	NN	O	O
of	IN	O	O
good	JJ	O	O
health	NN	O	O
until	IN	O	O
december	NN	O	O
when	WRB	O	O
she	PRP	O	O
was	VBD	O	O
seen	VBN	O	O
emergently	RB	O	O
for	IN	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
perforated	JJ	I-PROBLEM	I-PROBLEM
colon	NN	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

that	DT	O	O
area	NN	O	O
was	VBD	O	O
resected	VBN	O	O
with	IN	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
had	VBN	O	O
subsequent	VBN	B-TEST	O
cea&apos;s	NN	I-TEST	O
and	CC	O	O
scans	NNS	B-TEST	B-TEST
which	WDT	O	O
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

a	DT	B-PROBLEM	B-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
on	IN	O	O
her	PRP$	O	B-TEST
vulva	NN	O	I-TEST
which	WDT	O	O
was	VBD	O	O
biopsied	VBN	O	O
and	CC	O	O
revealed	VBN	O	O
squamous	JJ	B-PROBLEM	B-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
situ	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

as	IN	O	O
above	IN	O	O
with	IN	O	O
colostomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

on	IN	O	O
admission	NN	O	O
included	VBD	O	O
heent	NN	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
which	WDT	O	O
was	VBD	O	O
normal	JJ	O	O
.	.	O	O

abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
and	CC	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

vulva	NN	O	B-PROBLEM
and	CC	O	I-PROBLEM
right	JJ	O	I-PROBLEM
labia	NN	O	I-PROBLEM
replaced	VBN	O	O
by	IN	O	O
reddish	JJ	B-PROBLEM	B-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
somewhat	RB	O	O
raised	VBD	O	O
in	IN	O	O
the	DT	O	O
center	NN	O	O
extending	VBG	O	O
from	IN	O	O
adjacent	JJ	O	O
to	TO	O	O
the	DT	O	O
cuterus	NN	O	O
to	TO	O	O
the	DT	O	O
posterior	JJ	O	O
forchette	NN	O	O
.	.	O	O

otherwise	RB	O	O
,	,	O	O
her	PRP	B-TEST	B-TEST
pelvic	JJ	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

stage	NN	B-PROBLEM	B-PROBLEM
ii	RB	I-PROBLEM	I-PROBLEM
squamous	JJ	I-PROBLEM	I-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
vulva	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
plan	NN	O	O
was	VBD	O	O
for	IN	O	O
right	JJ	B-TREATMENT	B-TREATMENT
radical	JJ	I-TREATMENT	I-TREATMENT
vulvectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

1.	CD	O	O
vulvectomy	NN	B-TREATMENT	B-TREATMENT
:	:	O	O

the	DT	O	O
patient	NN	O	O
on	IN	O	O
2/8/90	CD	O	O
underwent	NN	O	O
a	DT	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
radical	JJ	I-TREATMENT	I-TREATMENT
vulvectomy	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
excellent	JJ	O	O
results	NNS	O	O
and	CC	O	O
negative	JJ	O	O
margins	NNS	O	O
on	IN	O	O
frozen	JJ	B-TEST	O
section	NN	I-TEST	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
kept	VBN	O	O
on	IN	O	O
bedrest	JJS	B-TREATMENT	O
for	IN	O	O
two	CD	O	O
days	NNS	O	O
and	CC	O	O
then	RB	O	O
was	VBD	O	O
ambulating	VBG	O	O
and	CC	O	O
voiding	VBG	O	O
well	RB	O	O
without	IN	O	O
trouble	NN	O	B-PROBLEM
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
three	CD	O	O
when	WRB	O	O
the	DT	B-TREATMENT	B-TREATMENT
foley	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
doing	VBG	O	O
betadine	JJ	B-TREATMENT	B-TREATMENT
paint	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
blow	NN	O	O
drying	VBG	O	O
the	DT	O	O
area	NN	O	O
several	JJ	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
and	CC	O	O
after	IN	O	O
each	DT	O	O
bowel	NN	O	O
movement	NN	O	O
and	CC	O	O
urine	NN	O	B-TEST
without	IN	O	O
incident	NN	O	O
.	.	O	O

patient	NN	O	O
recorded	VBD	O	O
as	IN	O	O
having	VBG	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
to	TO	O	O
drugs	NNS	B-TREATMENT	B-TREATMENT

chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

2014-04-18	CD	O	O
off	IN	B-TREATMENT	O
pump	NN	I-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	VBG	I-TREATMENT	I-TREATMENT
utilizing	VBG	O	I-TREATMENT
the	DT	O	I-TREATMENT
left	JJ	O	I-TREATMENT
internal	JJ	O	I-TREATMENT
mammary	JJ	O	I-TREATMENT
artery	NN	O	I-TREATMENT
to	TO	O	O
left	VB	O	O
anterior	RP	O	O
descending	VBG	O	O
artery	NN	O	O
,	,	O	O
free	JJ	O	O
right	NN	O	O
internal	JJ	O	O
mammary	NN	O	O
to	TO	O	O
obtuse	VB	O	O
marginal	JJ	O	O
and	CC	O	O
vein	JJ	B-TREATMENT	B-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	O
diagonal	VB	I-TREATMENT	O
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
60	CD	O	O
year	NN	O	O
old	JJ	O	O
male	NN	O	O
with	IN	O	O
new	JJ	B-PROBLEM	B-PROBLEM
onset	VBN	I-PROBLEM	I-PROBLEM
chest	JJS	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

nuclear	JJ	B-TEST	B-TEST
myocardial	JJ	I-TEST	I-TEST
perfusion	NN	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
was	VBD	O	O
notable	JJ	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
moderate	JJ	I-PROBLEM	I-PROBLEM
fixed	VBN	I-PROBLEM	I-PROBLEM
defect	NN	I-PROBLEM	I-PROBLEM
within	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
inferior	JJ	I-PROBLEM	O
wall	NN	I-PROBLEM	O
and	CC	O	O
cardiac	JJ	O	B-PROBLEM
apex	NN	O	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
however	RB	O	O
appeared	VBD	O	O
preserved	VBN	O	O
at	IN	O	O
73%	CD	O	O
with	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
inferior	JJ	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
hypokinesis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

subsequent	JJ	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
at	IN	O	O
nantucket	JJ	O	O
cottage	NN	O	O
hospital	NN	O	O
hospital	NN	O	O
on	IN	O	O
2014-04-16	JJ	O	O
was	VBD	O	O
significant	JJ	O	O
for	IN	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
two	CD	I-PROBLEM	I-PROBLEM
vessel	NN	I-PROBLEM	I-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

angiography	NN	B-TEST	B-TEST
revealed	VBD	O	O
a	DT	B-PROBLEM	O
right	JJ	I-PROBLEM	O
dominant	NN	I-PROBLEM	O
system	NN	I-PROBLEM	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
40%	CD	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
distal	NN	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
main,	JJ	I-PROBLEM	I-PROBLEM
several	JJ	B-PROBLEM	I-PROBLEM
tight	JJ	I-PROBLEM	I-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
proximal	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
mid	NN	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
descending	VBG	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
90%	CD	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
proximal	JJ	I-PROBLEM	I-PROBLEM
circumflex	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
right	JJ	O	O
coronary	JJ	O	O
artery	NN	O	O
had	VBD	O	O
mild	VBN	B-PROBLEM	B-PROBLEM
diffuse	IN	I-PROBLEM	I-PROBLEM
plaquing	VBG	I-PROBLEM	I-PROBLEM
but	CC	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
focal	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

based	VBN	O	O
upon	IN	O	O
the	DT	O	O
above	JJ	O	O
results	NNS	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
mediplex	NN	O	O
rehab	NN	O	O
hospital	NN	O	O
for	IN	O	O
surgical	JJ	B-TREATMENT	B-TREATMENT
revascularization	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

asthma	NN	B-PROBLEM	B-PROBLEM

benign	JJ	B-PROBLEM	B-PROBLEM
prostatic	JJ	I-PROBLEM	I-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM

history	NN	O	O
of	IN	O	O
nephrolithiasis	NN	B-PROBLEM	B-PROBLEM

hemorrhoids	NNS	B-PROBLEM	B-PROBLEM

mother	NN	O	O
suffer	NN	O	O
mi	NN	B-PROBLEM	O
in	IN	O	O
her	PRP$	O	O
50	CD	O	O
's,	POS	O	O
died	VBN	O	O
at	IN	O	O
age	NN	O	O
59	CD	O	O
.	.	O	O

father	RB	O	O
died	VBN	O	O
from	IN	O	O
mi	NN	B-PROBLEM	O
at	IN	O	O
age	NN	O	O
72	CD	O	O
.	.	O	O

vitals	NNS	B-TEST	B-TEST
:	:	O	O
t	NN	B-TEST	O
98.9	CD	O	O
,	,	O	O
bp	NN	B-TEST	B-TEST
148/70	CD	O	O
,	,	O	O
hr	NN	B-TEST	B-TEST
57	CD	O	O
,	,	O	O
rr	NN	B-TEST	B-TEST
20	CD	O	O
,	,	O	O
sat	VBD	B-TEST	B-TEST
95	CD	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O

general	JJ	O	O
:	:	O	O
well	RB	O	O
developed	VB	O	O
male	NN	O	O
in	IN	O	O
no	DT	O	O
acute	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM

neck	NN	O	O
:	:	O	O
supple	NN	O	O
,	,	O	O
no	DT	O	O
jvd	NN	B-PROBLEM	B-PROBLEM
,	,	O	O

heart	NN	O	O
:	:	O	O
regular	JJ	O	O
rate	NN	O	O
,	,	O	O
normal	JJ	O	O
s1s2	NN	O	O
,	,	O	O
no	DT	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
rub	NN	B-PROBLEM	B-PROBLEM

abdomen	NNS	O	O
:	:	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
normoactive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O

ext	NN	O	O
:	:	O	O
warm	NN	O	O
,	,	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
varicosities	NNS	B-PROBLEM	B-PROBLEM

pulses	NNS	B-TEST	B-TEST
:	:	O	O
2+	CD	O	O
distally	RB	O	O
,	,	O	O
no	DT	O	O
carotid	NN	B-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	O
femoral	JJ	I-PROBLEM	B-PROBLEM
bruits	NNS	I-PROBLEM	I-PROBLEM

2014-04-17	JJ	O	O
03:58	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
wbc	SYM	B-TEST	B-TEST
-	:	O	O
6.3	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
4.60	CD	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
15.4	CD	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
42.9	CD	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
93	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
33.4	CD	O	O
*	NN	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
35.8	CD	O	O
*	NN	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
12.8	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
168	CD	O	O

2014-04-17	JJ	O	O
03:58	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
pt	NN	B-TEST	I-TEST
-	:	O	O
13.2	CD	O	O
*	NN	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
30.3	CD	O	O
inr(pt)	JJ	B-TEST	O
-	:	O	O
1.2	CD	O	O
*	NN	O	O

2014-04-17	JJ	O	O
03:58	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	O
glucose	VB	B-TEST	B-TEST
-	:	O	O
92	CD	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
15	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.3	CD	O	O
*	NN	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
142	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
4.5	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
104	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
26	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
17	CD	O	O

2014-04-17	JJ	O	O
03:58	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
alt	SYM	B-TEST	B-TEST
-	:	O	O
18	CD	O	O
ast	IN	B-TEST	O
-	:	O	O
20	CD	O	O
alkphos	SYM	B-TEST	B-TEST
-	:	O	O
53	CD	O	O
amylase	NN	B-TEST	B-TEST
-	:	O	O
98	CD	O	O
totbili	SYM	B-TEST	B-TEST
-	:	O	O
0.6	CD	O	O

2014-04-17	JJ	O	O
03:58	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
%hba1c	NNP	B-TEST	I-TEST
-	:	O	O
5.8	CD	O	O
[hgb]	SYM	B-TEST	O
-	:	O	O
done	VBN	O	O
[a1c]	SYM	B-TEST	O
-	:	O	O
done	VBN	O	O

2014-04-22	JJ	O	O
07:10	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	B-TEST	B-TEST
-	:	O	O
6.5	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
2.89	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
9.3	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
26.4	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
92	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
32.3	CD	O	O
*	NN	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
35.2	CD	O	O
*	NN	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
13.8	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
155	CD	O	O

2014-04-22	JJ	O	O
07:10	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
97	CD	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
11	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.3	CD	O	O
*	NN	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
142	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
4.4	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
103	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
34	CD	O	O
*	NN	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
9	CD	O	O

2014-04-22	JJ	O	O
07:10	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
mg	NN	B-TEST	O
-	:	O	O
2.0	CD	O	O

2014-04-22	JJ	O	B-TEST
chest	JJS	B-TEST	I-TEST
x-ray	JJ	I-TEST	I-TEST
:	:	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
pneumothorax	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

persistent	JJ	B-PROBLEM	B-PROBLEM
bibasilar	JJ	I-PROBLEM	I-PROBLEM
atelectasis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
tiny	JJ	B-PROBLEM	B-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusions	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

stable	JJ	B-PROBLEM	O
postoperative	JJ	I-PROBLEM	O
cardiac	NN	I-PROBLEM	O
and	CC	I-PROBLEM	O
mediastinal	JJ	I-PROBLEM	B-PROBLEM
widening	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2014-04-24	JJ	O	O
06:35	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	B-TEST	B-TEST
-	:	O	O
6.7	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
2.96	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
9.1	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
28.0	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
94	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
30.9	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
32.7	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
13.6	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
234	CD	O	O
#	#	O	O

2014-04-25	JJ	O	O
06:45	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
93	CD	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
13	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.4	CD	O	O
*	NN	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
141	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
4.6	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
102	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
31	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
13	CD	O	O

2014-04-24	JJ	O	O
06:35	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
96	CD	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
13	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.4	CD	O	O
*	NN	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
143	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
4.8	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
104	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
33	CD	O	O
*	NN	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
11	CD	O	O

mr.	NN	O	O
chester	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
cardiac	JJ	O	O
surgical	JJ	O	O
service	NN	O	O
and	CC	O	O
underwent	JJ	O	O
routine	JJ	B-TEST	B-TEST
preoperative	JJ	I-TEST	I-TEST
evaluation	NN	I-TEST	I-TEST
.	.	O	O

he	PRP	O	O
remained	VBD	O	O
pain	RB	B-PROBLEM	B-PROBLEM
free	JJ	O	O
on	IN	O	O
medical	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

workup	NN	B-TEST	B-TEST
was	VBD	O	O
unremarkable	JJ	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
cleared	VBN	O	O
for	IN	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

on	IN	O	O
04-18	NNP	O	O
,	,	O	O
dr.	NN	O	O
oneill	NN	O	O
performed	VBD	O	O
off	RP	B-TREATMENT	O
pump	NN	I-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

following	VBG	O	O
the	DT	B-TREATMENT	B-TREATMENT
operation	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
he	PRP	O	O
was	VBD	O	O
brought	VBN	O	O
to	TO	O	O
the	DT	O	O
csru	NN	O	O
for	IN	O	O
invasive	JJ	B-TEST	B-TEST
monitoring	NN	I-TEST	I-TEST
.	.	O	O

given	VBN	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
bradycardia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
he	PRP	O	O
was	VBD	O	O
slow	JJ	B-PROBLEM	O
to	TO	I-PROBLEM	O
wean	VB	I-PROBLEM	O
from	IN	O	O
neosynephrine	NN	B-TREATMENT	O
.	.	O	O

low	JJ	B-TREATMENT	O
dose	NN	I-TREATMENT	O
beta	NN	I-TREATMENT	B-TREATMENT
blockade	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
eventually	RB	O	O
resumed	VBN	O	O
.	.	O	O

chest	NN	B-TREATMENT	B-TREATMENT
tubes	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	I-TREATMENT
pacing	VBG	B-TREATMENT	I-TREATMENT
wires	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
removed	VBN	O	O
without	IN	O	O
complication	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
maintained	VBD	O	O
a	DT	O	O
normal	JJ	O	O
sinus	NN	O	O
rhythm	NN	O	O
without	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
arrhythmias	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
remained	VBD	O	O
in	IN	O	O
sinus	NN	B-PROBLEM	B-PROBLEM
bradycardia	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
rate	NN	O	O
50-60	NN	O	O
)	)	O	O
and	CC	O	O
tolerated	VBD	O	O
low	JJ	B-TREATMENT	B-TREATMENT
dose	JJ	I-TREATMENT	I-TREATMENT
beta	NN	I-TREATMENT	I-TREATMENT
blockade	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
pod	NN	O	O
#6	IN	O	O
his	PRP$	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
became	VBD	O	O
slightly	RB	B-PROBLEM	B-PROBLEM
elevated	VBN	I-PROBLEM	I-PROBLEM
at	IN	O	O
1.4	CD	O	O
,	,	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
lasix	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
and	CC	O	O
the	DT	O	O
following	JJ	O	O
day	NN	O	O
his	PRP$	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
was	VBD	O	O
stable	JJ	O	O
at	IN	O	O
1.4	CD	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
discharge	NN	I-TEST	I-TEST
chest	JJS	I-TEST	I-TEST
x-ray	JJ	I-TEST	I-TEST
showed	VBD	O	O
persistent	JJ	B-PROBLEM	B-PROBLEM
bibasilar	JJ	I-PROBLEM	I-PROBLEM
atelectasis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
only	JJ	O	O
tiny	JJ	B-PROBLEM	B-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusions	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

of	IN	O	O
note	NN	O	O
,	,	O	O
he	PRP	O	O
will	MD	O	O
need	VB	O	O
to	TO	O	O
remain	VB	O	O
on	IN	O	O
plavix	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
three	CD	O	O
months	NNS	O	O
postop	VB	O	O
given	VBN	O	O
the	DT	B-TREATMENT	B-TREATMENT
off	RP	I-TREATMENT	I-TREATMENT
pump	JJ	I-TREATMENT	I-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
he	PRP	O	O
will	MD	O	O
need	VB	O	O
to	TO	O	O
remain	VB	O	O
on	IN	O	O
imdur	NN	B-TREATMENT	B-TREATMENT
given	VBN	O	O
use	NN	O	O
of	IN	O	O
his	PRP$	O	B-TREATMENT
right	JJ	O	I-TREATMENT
internal	JJ	O	I-TREATMENT
mammary	JJ	O	I-TREATMENT
artery	NN	O	I-TREATMENT
as	IN	O	O
a	DT	B-TREATMENT	O
"	NNP	I-TREATMENT	O
free	JJ	I-TREATMENT	O
"	NNP	I-TREATMENT	O
arterial	NN	I-TREATMENT	O
graft	NN	I-TREATMENT	O
in	IN	O	O
preventing	VBG	O	O

vasospasm	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

lopressor	NN	B-TREATMENT	B-PROBLEM
?	.	O	O
dose	VB	O	O

aspirin	RB	B-TREATMENT	B-TREATMENT
325	CD	O	O
qd	NN	O	O

zocor	NN	B-TREATMENT	B-TREATMENT
40	CD	O	O
qd	NN	O	O

iv	NN	B-TREATMENT	O
heparin	NN	I-TREATMENT	B-TREATMENT

1.	CD	O	O
furosemide	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
for	IN	O	O
5	CD	O	O
days	NNS	O	O
.	.	O	O

2.	CD	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
10	CD	O	O
meq	NN	O	O
capsule	NN	O	O
,	,	O	O
sustained	VBD	O	O
release	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
capsule	NN	O	O
,	,	O	O
sustained	VBD	O	O
release	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
for	IN	O	O
5	CD	O	O
days	NNS	O	O
.	.	O	O

3.	CD	O	O
docusate	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

4.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
81	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

5.	CD	O	O
oxycodone	CD	B-TREATMENT	B-TREATMENT
-	:	I-TREATMENT	I-TREATMENT
acetaminophen	NN	I-TREATMENT	I-TREATMENT
5-325	JJ	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
tablets	NNS	O	O
po	JJ	O	O
every	DT	O	O
4-6	JJ	O	O
hours	NNS	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

6.	CD	O	O
simvastatin	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

7.	CD	O	O
fluticasone	NN	B-TREATMENT	B-TREATMENT
-	:	I-TREATMENT	I-TREATMENT
salmeterol	NN	I-TREATMENT	I-TREATMENT
250-50	JJ	O	O
mcg	NN	O	O
/	NNP	O	O
dose	JJ	O	O
disk	NN	O	O
with	IN	O	O
device	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
disk	NN	O	O
with	IN	O	O
device	JJ	O	O
inhalation	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

8.	CD	O	O
isosorbide	JJ	B-TREATMENT	B-TREATMENT
mononitrate	NN	I-TREATMENT	I-TREATMENT
30	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sustained	VBD	O	O
release	NN	O	O
24	CD	O	O
hr	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
sustained	VBD	O	O
release	NN	O	O
24	CD	O	O
hr	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

9.	CD	O	O
clopidogrel	NN	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

10.	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
succinate	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sustained	VBD	O	O
release	NN	O	O
24	CD	O	O
hr	NN	O	O
sig	NN	O	O
:	:	O	O
0.5	CD	O	O
(	(	O	O
half	NN	O	O
)	)	O	O
tablet	NN	O	O
sustained	VBD	O	O
release	NN	O	O
24	CD	O	O
hr	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
-	:	O	O
s/p	NN	O	O
off	IN	B-TREATMENT	O
pump	NN	I-TREATMENT	B-TREATMENT
cabg	NN	I-TREATMENT	I-TREATMENT

sinus	NN	B-PROBLEM	B-PROBLEM
bradycardia	NN	I-PROBLEM	I-PROBLEM

asthma	NN	B-PROBLEM	B-PROBLEM

bph	NN	B-PROBLEM	B-PROBLEM

nephrolithiasis	NN	B-PROBLEM	B-PROBLEM

follow	JJ	O	B-TREATMENT
medications	NNS	B-TREATMENT	I-TREATMENT
on	IN	O	O
discharge	NN	O	O
instructions	NNS	O	O
.	.	O	O

shower	JJR	O	O
daily	RB	O	O
,	,	O	O
let	VB	O	O
water	NN	O	O
flow	NN	O	O
over	IN	O	O
wounds	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
pat	NN	O	O
dry	NN	O	O
with	IN	O	O
a	DT	O	B-TREATMENT
towel	NN	O	I-TREATMENT
.	.	O	O

do	VB	O	O
not	RB	O	O
use	VB	O	O
creams	NNS	O	B-TREATMENT
,	,	O	O
lotions	NNS	O	B-TREATMENT
,	,	O	O
or	CC	O	O
powders	NNS	O	B-TREATMENT
on	IN	O	O
wounds	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

call	VB	O	O
our	PRP$	O	O
office	NN	O	O
for	IN	O	O
sternal	JJ	B-PROBLEM	B-TREATMENT
drainage	NN	I-PROBLEM	I-TREATMENT
,	,	O	O
temp	EX	B-PROBLEM	B-TEST
.>	CD	O	O
101.5	CD	O	O

the	DT	O	O
patient	NN	O	O
presented	VBN	O	O
with	IN	O	O
a	DT	O	O
chief	JJ	O	O
complaint	NN	O	O
of	IN	O	O
rlq	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

following	VBG	O	O
evaluation	NN	B-TEST	B-TEST
and	CC	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
the	DT	O	O
patient	NN	O	O
&apos;s	JJ	O	O
disposition	NN	O	O
at	IN	O	O
the	DT	O	O
end	NN	O	O
of	IN	O	O
the	DT	O	O
visit	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
as	IN	O	O
an	DT	O	O
inpatient	NN	O	O
to	TO	O	O
ro	VB	O	O
woodma	NN	O	O
healthcare	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
preliminary	JJ	O	O
admitting	VBG	O	O
physician	NN	O	O
is	VBZ	O	O
dalejesc	JJ	O	O
,	,	O	O
oie	JJ	O	O
and	CC	O	O
the	DT	O	O
preliminary	JJ	O	O
admitting	NN	O	O
diagnosis	NN	O	O
is	VBZ	O	O
cholecystitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

penicillins	NNS	B-TREATMENT	B-TREATMENT

dyspnea	NN	B-PROBLEM	B-PROBLEM

this	DT	O	O
is	VBZ	O	O
an	DT	O	O
83	CD	O	O
y/o	NNS	O	O
female	JJ	O	O
with	IN	O	O
moderate	JJ	B-PROBLEM	O
as	IN	I-PROBLEM	O
,	,	O	O
s/p	VBD	O	O
mvr	JJ	B-TREATMENT	B-TREATMENT
27	CD	O	O
years	NNS	O	O
ago	RB	O	O
,	,	O	O
s/p	NN	O	B-TEST
ppm	NN	B-TREATMENT	I-TEST
,	,	O	O
dm	NN	B-PROBLEM	O
,	,	O	O
chf	NN	B-PROBLEM	O
,	,	O	O
p/w	JJ	O	O
dsypnea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
work	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breathing	VBG	I-PROBLEM	I-PROBLEM
x	JJ	O	O
4-5	JJ	O	O
days	NNS	O	O
.	.	O	O

per	IN	O	O
family	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
had	VBN	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
chf/volume	JJ	I-PROBLEM	I-PROBLEM
overload	NN	I-PROBLEM	I-PROBLEM
over	IN	O	O
the	DT	O	O
last	JJ	O	O
several	JJ	O	O
weeks	NNS	O	O
,	,	O	O
requiring	VBG	O	O
supplemental	JJ	B-TREATMENT	B-TREATMENT
o2	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
rehab	NN	O	O
.	.	O	O

over	IN	O	O
the	DT	O	O
last	JJ	O	O
few	JJ	O	O
days	NNS	O	O
,	,	O	O
she	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
more	JJR	B-PROBLEM	O
short	JJ	I-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
having	VBG	O	O
sats	NNS	B-TEST	O
to	TO	O	O
60%	CD	O	O
on	IN	O	O
ra	NN	O	O
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
lasix	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
increased	VBN	O	O
to	TO	O	O
60	CD	O	O
mg	NNS	O	O
bid	NN	O	O
.	.	O	O

beginning	VBG	O	O
today	NN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
in	IN	O	O
hypoxic	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
87-91%	JJ	O	O
on	IN	O	O
2l/nc	CD	B-TREATMENT	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
increased	VBN	O	O
to	TO	O	O
5l	CD	O	O
,	,	O	O
with	IN	O	O
her	PRP$	B-TEST	O
sats	NNS	I-TEST	O
going	VBG	O	O
up	RB	O	O
to	TO	O	O
97%	CD	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
also	RB	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
more	JJR	B-PROBLEM	O
confused	JJ	I-PROBLEM	O
over	IN	O	O
the	DT	O	O
last	JJ	O	O
few	JJ	O	O
days	NNS	O	O
and	CC	O	O
especially	RB	O	O
today	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
given	VBN	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
2	CD	B-TREATMENT	O
mg	NN	I-TREATMENT	O
iv	NN	I-TREATMENT	O
morphine	NN	I-TREATMENT	B-TREATMENT
at	IN	O	O
new	JJ	O	O
england	NN	O	O
sinai	NN	O	O
hospital	NN	O	O
&	CC	O	O
rehab	NN	O	O
center	NN	O	O
rehab	NN	O	O
,	,	O	O
and	CC	O	O
sent	VBD	O	O
to	TO	O	O
nantucket	JJ	O	O
cottage	NN	O	O
hospital	NN	O	O
for	IN	O	O
further	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
.	.	O	O

en	IN	O	O
route	NN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
given	VBN	O	O
additional	JJ	B-TREATMENT	B-TREATMENT
lasix	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
60	CD	O	O
mg	NNS	O	O
iv	JJ	O	O
and	CC	O	O
nitro	JJ	B-TREATMENT	B-TREATMENT
spray	NN	I-TREATMENT	I-TREATMENT
x	VBD	O	O
2	CD	O	O
.	.	O	O

in	IN	O	O
the	DT	O	O
deanna	NN	O	O
,	,	O	O
her	PRP$	B-TEST	O
vs	NN	I-TEST	O
were	VBD	O	O
tc	JJ	B-TEST	O
97.2	CD	O	O
,	,	O	O
bp	NN	B-TEST	B-TEST
146/25	CD	O	O
,	,	O	O
hr	NN	B-TEST	B-TEST
70	CD	O	O
,	,	O	O
rr	NN	B-TEST	B-TEST
27	CD	O	O
,	,	O	O
sao2	VBD	B-TEST	O
95%/nrb	CD	B-TREATMENT	O
.	.	O	O

foley	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
placed	VBN	O	O
in	IN	O	O
deanna	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
given	VBN	O	O
40	CD	O	O
mg	JJ	O	O
iv	NN	B-TREATMENT	O
lasix	NN	I-TREATMENT	B-TREATMENT
and	CC	O	O
325	CD	O	O
mg	NN	O	O
asa	NN	B-TREATMENT	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
bipap	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
comfort	NN	O	B-TREATMENT
at	IN	O	O
30%	CD	O	O
fio2	NN	B-TREATMENT	O
,	,	O	O
5	CD	O	O
peep	NN	B-TREATMENT	O
,	,	O	O
12	CD	O	O
ps	NN	B-TREATMENT	O
.	.	O	O

admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
csru	NN	O	O
for	IN	O	O
further	JJ	B-TREATMENT	B-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

per	IN	O	O
family	NN	O	O
,	,	O	O
besides	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
sob	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
had	VBN	O	O
no	DT	O	O
other	JJ	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
including	VBG	O	O
f/c/s	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cp	NN	B-PROBLEM	O
,	,	O	O
palpitations	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
abd	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
n/v/diarrhea	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
had	VBD	O	O
decreased	VBN	B-PROBLEM	B-PROBLEM
appetite	RB	I-PROBLEM	I-PROBLEM
over	IN	O	O
the	DT	O	O
last	JJ	O	O
few	JJ	O	O
days	NNS	O	O
in	IN	O	O
the	DT	O	O
context	NN	O	O
of	IN	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
confusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
moderate	JJ	B-PROBLEM	O
as	IN	I-PROBLEM	O

2.	CD	O	O
s/p	NN	O	B-TREATMENT
mvr	NN	B-TREATMENT	I-TREATMENT

3.	CD	O	O
s/p	NN	O	B-TEST
ppm	NN	B-TREATMENT	I-TEST

4.	CD	O	O
a	DT	B-PROBLEM	B-PROBLEM
fib	NN	I-PROBLEM	I-PROBLEM

5.	CD	O	O
dm	JJ	B-PROBLEM	O
2	CD	I-PROBLEM	O
on	IN	O	O
insulin	NN	B-TREATMENT	B-TREATMENT

6.	CD	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM

7.	CD	O	O
gout	NN	B-PROBLEM	B-PROBLEM

8.	CD	O	O
depression	NN	B-PROBLEM	B-PROBLEM

9.	CD	O	O
?	.	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
fibrosis	NN	I-PROBLEM	I-PROBLEM

10.	CD	O	O
chf/cad	NN	B-PROBLEM	O
,	,	O	O
last	JJ	B-TEST	O
ef	NN	I-TEST	O
55%	CD	O	O
4/06	CD	O	O

mother	NN	O	O
with	IN	O	O
h/o	NN	O	O
emphysema	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cad	NN	B-PROBLEM	B-PROBLEM

on	IN	O	O
bipap	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
nad	NN	B-PROBLEM	B-PROBLEM

neck	NN	O	O
:	:	O	O
+	NN	O	O
elevated	VBD	B-PROBLEM	B-PROBLEM
jvd	NN	I-PROBLEM	I-PROBLEM
to	TO	O	I-PROBLEM
earlobe	VB	O	I-PROBLEM
,	,	O	O
supple	VB	O	O

chest	NN	O	O
:	:	O	O
decreased	VBN	B-PROBLEM	B-PROBLEM
bs	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
bases	NNS	O	O
with	IN	O	O
few	JJ	B-PROBLEM	B-PROBLEM
crackles	NNS	I-PROBLEM	I-PROBLEM
b/l	VBP	I-PROBLEM	I-PROBLEM

cv	NN	O	O
:	:	O	O
rrr	NN	O	O
3/6	CD	O	O
hsm	NN	B-PROBLEM	O
,	,	O	O
loudest	JJS	O	O
at	IN	O	O
lusb	NN	O	O

abd	NN	O	O
:	:	O	O
soft	JJ	O	O
,	,	O	O
nt/nd	JJ	B-PROBLEM	O
,	,	O	O
nabs	JJ	O	O

ext	NN	O	O
:	:	O	O
2	CD	O	O
+	NN	O	O
pitting	VBG	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
b/l	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
warm	JJ	O	O
with	IN	O	O
faint	NN	O	B-PROBLEM
dp	NN	O	I-PROBLEM

wbc	SYM	B-TEST	B-TEST
-	:	O	O
9.6	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
4.02	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
11.4	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
36.3	CD	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
90	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
28.4	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
31.4	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
17.8	CD	O	O
*	NN	O	O

neuts	NNS	B-TEST	B-TEST
-	:	O	O
87.0	CD	O	O
*	NN	O	O
lymphs	SYM	B-TEST	B-TEST
-	:	O	O
6.7	CD	O	O
*	JJ	O	O
monos	NNS	B-TEST	B-TEST
-	:	O	O
5.0	CD	O	O
eos	SYM	B-TEST	B-TEST
-	:	O	O
0.9	CD	O	O
basos	SYM	B-TEST	B-TEST
-	:	O	O
0.4	CD	O	O

plt	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
-	:	O	O
161	CD	O	O

pt	SYM	B-TEST	B-TEST
-	:	O	O
23.2	CD	O	O
*	JJ	O	O
inr	NN	B-TEST	O
(	(	O	O
pt	NN	O	O
)	)	O	O
-	:	O	O
2.3	CD	O	O
*	NN	O	O

ctropnt	SYM	B-TEST	B-TEST
-	:	O	O
0.08	CD	O	O
*	NN	O	O

ck	NN	B-TEST	O
(	(	I-TEST	O
cpk	NN	I-TEST	O
)	)	I-TEST	O
-	:	O	O
37	CD	O	O

ctropnt	SYM	B-TEST	B-TEST
-	:	O	O
0.08	CD	O	O
*	NN	O	O

ck-mb	JJ	B-TEST	B-TEST
-	:	O	O
notdone	NN	O	O
probnp	NN	B-TEST	O
-	:	O	O
5313	CD	O	O
*	NN	O	O

glucose	JJ	B-TEST	B-TEST
-	:	O	O
173	CD	O	O
*	JJ	O	O
urea	JJ	B-TEST	B-TEST
n	SYM	I-TEST	I-TEST
-	:	O	O
52	CD	O	O
*	NN	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.5	CD	O	O
*	JJ	O	O
sodium	NN	B-TEST	B-TEST
-	:	O	O
145	CD	O	O
potassium	NN	B-TEST	B-TEST
-	:	O	O
4.8	CD	O	O
chloride	NN	B-TEST	B-TEST
-	:	O	O
100	CD	O	O
total	JJ	B-TEST	B-TEST
co2	NN	I-TEST	I-TEST
-	:	O	O
40	CD	O	O
*	JJ	O	O
anion	NN	B-TEST	B-TEST
gap	NN	I-TEST	I-TEST
-	:	O	O
10	CD	O	O

type	NN	O	O
-	:	O	O
art	NN	B-TEST	O
po2	VBZ	I-TEST	O
-	:	O	O
249	CD	O	O
*	NN	O	O
pco2	NN	B-TEST	B-TEST
-	:	O	O
99	CD	O	O
*	NN	O	O
ph	NN	B-TEST	B-TEST
-	:	O	O
7.28	CD	O	O
*	JJ	O	O
total	NN	B-TEST	B-TEST
co2	NN	I-TEST	I-TEST
-	:	O	O
49	CD	O	O
*	JJ	O	O
base	NN	B-TEST	B-TEST
xs	NNP	I-TEST	I-TEST
-	:	O	O
15	CD	O	O
intubated	JJ	O	O
-	:	O	O
not	RB	O	O
intuba	VB	O	O

type	NN	O	O
-	:	O	O
art	NN	B-TEST	O
temp	SYM	I-TEST	B-TEST
-	:	O	O
37.0	CD	O	O
o2-90	JJ	O	O
o2	NN	B-TREATMENT	O
flow	NN	I-TREATMENT	O
-	:	O	O
5	CD	O	O
po2	NN	B-TEST	O
-	:	O	O
63	CD	O	O
*	NN	O	O
pco2	NN	B-TEST	B-TEST
-	:	O	O
81	CD	O	O
*	NN	O	O
ph	NN	B-TEST	B-TEST
-	:	O	O
7.39	CD	O	O
total	JJ	B-TEST	B-TEST
co2	NN	I-TEST	I-TEST
-	:	O	O
51	CD	O	O
*	JJ	O	O
base	NN	B-TEST	B-TEST
xs	NNP	I-TEST	I-TEST
-	:	O	O
19	CD	O	O
aado2	SYM	B-TEST	B-TEST
-	:	O	O
513	CD	O	O
req	NN	B-TEST	O
o2	SYM	I-TEST	O
-	:	O	O
84	CD	O	O

echo	NN	B-TEST	B-TEST
:	:	O	O
the	DT	O	O
left	JJ	O	O
atrium	NN	O	O
is	VBZ	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
dilated	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
symmetric	JJ	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
left	NN	I-TEST	I-TEST
ventricular	JJ	I-TEST	I-TEST
cavity	NN	I-TEST	I-TEST
size	NN	I-TEST	I-TEST
is	VBZ	O	O
normal	JJ	O	O
.	.	O	O

overall	JJ	B-TEST	B-TEST
left	VBD	I-TEST	I-TEST
ventricular	JJ	I-TEST	I-TEST
systolic	JJ	I-TEST	I-TEST
function	NN	I-TEST	I-TEST
is	VBZ	O	O
normal	JJ	O	O
(	(	O	O
lvef	JJ	B-TEST	O
70%	CD	O	O
).	NN	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
ventricular	JJ	B-PROBLEM	B-PROBLEM
septal	NN	I-PROBLEM	I-PROBLEM
defect	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
right	JJ	O	O
ventricular	NN	O	O
free	JJ	O	O
wall	NN	O	O
is	VBZ	O	O
hypertrophied	VBN	B-PROBLEM	O
.	.	O	O

the	DT	O	O
right	JJ	O	O
ventricular	NN	O	O
cavity	NN	O	O
is	VBZ	O	O
dilated	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

right	RB	B-TEST	B-TEST
ventricular	JJ	I-TEST	I-TEST
systolic	JJ	I-TEST	I-TEST
function	NN	I-TEST	I-TEST
appears	VBZ	O	O
depressed	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
aortic	JJ	O	O
arch	NN	O	O
is	VBZ	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
dilated	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
are	VBP	O	O
focal	JJ	B-PROBLEM	B-PROBLEM
calcifications	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
arch	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
are	VBP	O	O
three	CD	B-PROBLEM	O
aortic	JJ	I-PROBLEM	O
valve	NN	I-PROBLEM	O
leaflets	NNS	I-PROBLEM	O
.	.	O	O

the	DT	O	O
aortic	JJ	O	O
valve	NN	O	O
leaflets	NNS	O	O
are	VBP	O	O
moderately	RB	B-PROBLEM	B-PROBLEM
thickened	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
at	IN	O	O
least	JJS	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
valve	NN	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
bileaflet	NN	I-TREATMENT	I-TREATMENT
mitral	JJ	I-TREATMENT	I-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
prosthesis	NN	I-TREATMENT	I-TREATMENT
is	VBZ	O	O
present	JJ	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
gradients	NNS	I-TEST	I-TEST
are	VBP	O	O
higher	JJR	O	O
than	IN	O	O
expected	VBN	O	O
for	IN	O	O
this	DT	O	B-TREATMENT
type	NN	O	I-TREATMENT
of	IN	O	I-TREATMENT
prosthesis	NN	B-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
tricuspid	JJ	O	O
valve	NN	O	O
leaflets	NNS	O	O
are	VBP	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
thickened	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-PROBLEM
end-diastolic	JJ	I-TEST	I-PROBLEM
pulmonic	JJ	I-TEST	I-PROBLEM
regurgitation	NN	I-TEST	I-PROBLEM
velocity	NN	I-TEST	I-PROBLEM
is	VBZ	O	O
increased	VBN	B-PROBLEM	B-PROBLEM
suggesting	VBG	O	I-PROBLEM
pulmonary	JJ	B-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
diastolic	JJ	I-PROBLEM	I-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
pericardial	JJ	B-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

compared	VBN	O	O
with	IN	O	O
the	DT	O	O
findings	NNS	O	O
of	IN	O	O
the	DT	B-TEST	B-TEST
prior	JJ	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
(	(	O	O
images	NNS	O	O
reviewed	VBN	O	O
)	)	O	O
of	IN	O	O
2013-06-18	JJ	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
gradient	NN	I-TEST	I-TEST
across	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
mitral	JJ	I-TREATMENT	I-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
prosthesis	NN	I-TREATMENT	I-TREATMENT
is	VBZ	O	O
increased	VBN	B-PROBLEM	O
.	.	O	O

impression	NN	O	O
:	:	O	O
ap	NN	B-TEST	B-TEST
chest	NN	I-TEST	I-TEST
compared	VBN	O	O
to	TO	O	O
07-30	CD	O	O
through	IN	O	O
26	CD	O	O
:	:	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
unchanged	JJ	O	O
.	.	O	O

bilateral	JJ	B-PROBLEM	B-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
small	JJ	O	I-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
right	NN	O	I-PROBLEM
and	CC	O	I-PROBLEM
moderate	VB	O	I-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	NN	O	I-PROBLEM
is	VBZ	O	O
stable	JJ	O	O
.	.	O	O

severe	JJ	B-PROBLEM	B-PROBLEM
cardiomegaly	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
left	VBD	B-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
atelectasis	NN	I-PROBLEM	I-PROBLEM
unchanged	JJ	O	O
.	.	O	O

no	DT	O	O
pneumothorax	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

transvenous	JJ	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
ventricular	NN	I-TREATMENT	I-TREATMENT
pacer	NN	I-TREATMENT	I-TREATMENT
lead	NN	I-TREATMENT	I-TREATMENT
in	IN	O	I-TREATMENT
standard	JJ	O	I-TREATMENT
placement	NN	O	I-TREATMENT
.	.	O	O

ecg	NN	B-TEST	O
:	:	O	O
ventricular	NN	O	B-TEST
paced	VBD	O	I-TEST
rhythm	NN	O	I-TEST
.	.	O	O

compared	VBN	O	O
to	TO	O	O
the	DT	B-TEST	O
previous	JJ	I-TEST	O
tracing	NN	I-TEST	O
of	IN	O	O
2014-07-30	JJ	O	O
no	DT	O	O
significant	JJ	O	B-PROBLEM
change	NN	O	I-PROBLEM
.	.	O	O

rate	NN	B-TEST	O
pr	NNS	B-TEST	O
qrs	VBP	B-TEST	O
qt/qtc	JJ	B-TEST	O
p	NN	B-TEST	O
qrs	NN	B-TEST	O
t	VBD	B-TEST	O
70	CD	O	O
0	CD	O	O
160	CD	O	O
466/486.42	CD	O	O
0	CD	O	O
-71	NNS	O	O
112	CD	O	O

a/p	SYM	O	B-TEST
-	:	O	O
83yo	CD	O	O
f	NN	O	O
with	IN	O	O
valvular	JJ	B-PROBLEM	B-PROBLEM
disorder	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
af	NN	B-PROBLEM	O
,	,	O	O
and	CC	O	O
h/o	NN	O	O
cad	NN	B-PROBLEM	B-PROBLEM
a/w	NN	O	I-PROBLEM
hypercarbic	JJ	B-PROBLEM	I-PROBLEM
respiratory	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

#	#	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
-	:	O	O
she	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
csru	NN	O	O
for	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
repiratory	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
thought	VBN	O	O
to	TO	O	O
be	VB	O	O
secondary	JJ	O	O
to	TO	O	O
chf	VB	B-PROBLEM	O
.	.	O	O

pt	NN	O	O
was	VBD	O	O
diuresed	VBN	O	O
with	IN	O	O
iv	JJ	B-TREATMENT	O
lasix	NN	I-TREATMENT	B-TREATMENT
/	NNP	O	O
acetazolamide	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
given	VBN	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
morphine	NN	I-TREATMENT	I-TREATMENT
/	NNP	O	O
prn	NN	O	O
for	IN	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
bipap	NN	B-TREATMENT	B-TEST
was	VBD	O	O
tried	VBN	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
hypercarbia	NN	B-PROBLEM	B-PROBLEM
(	(	O	O
04-11	JJ	O	O
metabolic	JJ	B-PROBLEM	O
alkalosis	NN	I-PROBLEM	O
)	)	O	O
remained	VBD	O	O
in	IN	O	O
the	DT	O	O
90s	CD	O	O
.	.	O	O

pt	NN	O	O
was	VBD	O	O
mentating	VBG	O	O
okay	NN	O	O
,	,	O	O
having	VBG	O	O
conversations	NNS	O	O
with	IN	O	O
intermittent	JJ	B-PROBLEM	B-PROBLEM
somnolence	NN	I-PROBLEM	I-PROBLEM
despite	IN	O	O
hypercarbia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

tte	NN	B-TEST	O
showed	VBD	O	O
preserved	JJ	O	O
ef	NN	O	O
with	IN	O	O
moderate	JJ	B-PROBLEM	O
as	IN	I-PROBLEM	O
and	CC	O	O
moderate	VB	B-PROBLEM	B-PROBLEM
ms	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
mod	NN	B-PROBLEM	O
pulm	NN	I-PROBLEM	O
htn	NN	I-PROBLEM	O
.	.	O	O

cardiology	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
and	CC	O	O
thought	VBN	O	B-TEST
ms	NNS	B-PROBLEM	I-TEST
harold	VBD	O	O
holcomb	NN	O	O
to	TO	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
pulm	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
pulm	NN	B-PROBLEM	B-TREATMENT
htn	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

cardiology	NN	O	O
recommended	VBD	O	O
d/cing	VBG	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
starting	VBG	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

family	NN	O	O
declined	VBD	O	O
valvuloplasty	NN	B-TREATMENT	O
.	.	O	O

for	IN	O	O
possible	JJ	O	O
copd	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
pt	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
steroids	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
nebs	NNS	B-TREATMENT	B-TREATMENT
on	IN	O	O
08-03	NN	O	O
.	.	O	O

pt	NN	O	O
is	VBZ	O	O
currently	RB	O	O
satting	VBG	B-TEST	O
90s	CD	O	O
on	IN	O	O
1	CD	O	O
l	NN	O	O
nc	NN	B-TREATMENT	O
while	IN	O	O
sitting	VBG	O	O
in	IN	O	O
a	DT	O	O
chair	NN	O	O
but	CC	O	O
needs	VBZ	O	O
more	RBR	B-TREATMENT	O
o2	JJ	I-TREATMENT	O
when	WRB	O	O
supine	NN	O	B-PROBLEM
.	.	O	O

pt	NN	O	O
is	VBZ	O	O
a	DT	O	O
mouth	NN	O	O
breather	NN	O	O
and	CC	O	O
occasionally	RB	O	O
needs	VBZ	O	O
a	DT	B-TREATMENT	B-TREATMENT
face	NN	I-TREATMENT	I-TREATMENT
mask	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

pt	NN	O	O
will	MD	O	O
need	VB	O	O
i/os	RB	B-TEST	B-TEST
monitored	VBN	O	O
to	TO	O	O
goal	NN	O	O
even	RB	O	O
to	TO	O	O
slightly	RB	O	O
negative	JJ	O	O
as	IN	O	O
she	PRP	O	O
was	VBD	O	O
diursed	VBN	O	B-TREATMENT
4.8	CD	O	O
l	NN	O	O
during	IN	O	O
her	PRP$	O	O
cmed	JJ	O	O
stay	NN	O	O
.	.	O	O

depending	VBG	O	O
on	IN	O	O
her	PRP	B-TEST	O
i/o	NN	I-TEST	O
,	,	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
acetazolamide	NN	B-TREATMENT	B-TREATMENT
can	MD	O	O
be	VB	O	O
decreased	VBN	O	B-PROBLEM
or	CC	O	O
discontinued	VBN	O	O
.	.	O	O

#	#	O	O
h/o	NN	O	O
cad	SYM	B-PROBLEM	B-PROBLEM
-	:	O	O
there	EX	O	O
were	VBD	O	O
new	JJ	O	B-PROBLEM
changes	NNS	O	I-PROBLEM
on	IN	O	O
ekg	NN	B-TEST	O
but	CC	O	O
pt	NN	O	O
was	VBD	O	O
ruled	VBN	O	O
out	RP	O	O
with	IN	O	O
3	CD	O	O
sets	NNS	O	O
of	IN	O	O
negative	JJ	O	O
cardiac	JJ	O	B-TEST
enzymes	NNS	O	I-TEST
.	.	O	O

pt	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
bb	NN	B-TREATMENT	O
,	,	O	O
asa	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
nitrates	NNS	B-TREATMENT	B-PROBLEM
.	.	O	O

#	#	O	O
acid	NN	O	B-PROBLEM
/	NNP	O	O
base	NN	O	O
status	NN	O	O
-	:	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
acidosis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
metabolic	JJ	O	O
compensation	NN	O	O
.	.	O	O

pt	NN	O	O
failed	VBD	O	O
bipap	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
pco2	NN	B-TEST	O
remained	VBN	O	O
in	IN	O	O
the	DT	O	O
90s	CD	O	O
but	CC	O	O
maintaining	VBG	O	B-PROBLEM
mentation	NN	O	I-PROBLEM
.	.	O	O

#	#	O	O
renal	JJ	B-PROBLEM	B-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
-	:	O	O
baseline	NN	B-TEST	O
cr	NN	I-TEST	O
unknown	JJ	O	O
,	,	O	O
may	MD	O	O
have	VB	O	O
cri	NN	B-PROBLEM	B-PROBLEM
from	IN	O	O
dm	NN	B-PROBLEM	O
.	.	O	O

creatinine	NN	B-TEST	B-TEST
stayed	VBD	O	O
stable	JJ	O	O
from	IN	O	O
1.3-1.5	JJ	O	O
.	.	O	O

will	MD	O	O
need	VB	O	O
to	TO	O	O
renally	VB	O	O
dose	VB	O	O
all	DT	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

#	#	O	O
a	DT	B-PROBLEM	B-PROBLEM
fib	NN	I-PROBLEM	I-PROBLEM
-	:	O	O
continued	VBN	O	O
bb	NN	B-TREATMENT	O
.	.	O	O

per	IN	O	O
cardiology	NN	O	O
consult	NN	O	O
recs	NN	O	O
,	,	O	O
discontinued	VBN	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
started	VBD	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

due	JJ	O	O
to	TO	O	O
elevated	JJ	B-PROBLEM	B-PROBLEM
inr	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
held	VBN	O	O
.	.	O	O

pt	NN	O	O
needs	NNS	O	O
to	TO	O	O
be	VB	O	O
on	IN	O	O
amiodarone	JJ	B-TREATMENT	B-TREATMENT
400mg	CD	O	O
bid	NN	O	O
x	VBD	O	O
7	CD	O	O
days	NNS	O	O
(	(	O	O
loading	VBG	O	O
dose	NN	O	O
)	)	O	O
and	CC	O	O
then	RB	O	O
400mg	CD	O	O
daily	RB	O	O
for	IN	O	O
maintenance	NN	O	O
.	.	O	O

#	#	O	O
dm	SYM	B-PROBLEM	B-TEST
-	:	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
standing	VBG	O	O
+	NNP	O	O
hiss	NN	O	B-PROBLEM
,	,	O	O
fs	NN	O	O
qid	NN	O	O

#	#	O	O
depression	NN	B-PROBLEM	B-PROBLEM
-	:	O	O
continued	VBD	B-TREATMENT	O
home	NN	I-TREATMENT	B-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT

#	#	O	O
f/e/n	SYM	O	O
-	:	O	O
npo	NN	O	O
initially	RB	O	O
while	IN	O	O
on	IN	O	O
bipap	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
now	RB	O	O
low	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
cardiac	NN	I-TREATMENT	I-TREATMENT
diet	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

#	#	O	O
ppx	SYM	O	B-TEST
-	:	O	O
supratherpeutic	JJ	B-PROBLEM	B-PROBLEM
inr	NN	I-PROBLEM	I-PROBLEM

#	#	O	O
access	NN	O	O
-	:	O	O
piv	NN	B-TREATMENT	O

no	DT	O	O
pressors	NNS	B-TREATMENT	B-PROBLEM
or	CC	O	O
central	JJ	B-TREATMENT	B-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
per	IN	O	O
hcp	NN	O	O
.	.	O	O

coumadin	NN	B-TREATMENT	B-TREATMENT
2.5	CD	O	O
mg	NN	O	O
/	VBD	O	O
3	CD	O	O
mg	NN	O	O

insulin	NN	B-TREATMENT	B-TEST
-	:	O	O
humulin	NN	B-TREATMENT	O
n	RB	I-TREATMENT	O
36	CD	O	O
u	JJ	O	O
daily	JJ	O	O
/	$	O	O
14	CD	O	O
u	JJ	O	O
qhs	NN	O	O

lasix	RB	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NNS	O	O
bid	NN	O	O

venlafaxine	NN	B-TREATMENT	B-TREATMENT
xr	$	O	I-TREATMENT
75	CD	O	O
mg	NN	O	O
qd	NN	O	O

sorbitol	NN	B-TREATMENT	B-TREATMENT

metoprolol	NN	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
bid	NN	O	O

imdur	NN	B-TREATMENT	B-TREATMENT
30	CD	O	O
mg	NN	O	O
qd	NN	O	O

hydralazine	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
bid	NN	O	O

digoxin	NN	B-TREATMENT	B-TREATMENT
0.125	CD	O	O
qd	NN	O	O

oscal	JJ	B-TREATMENT	O
250	CD	O	O
mg	NN	O	O
+	NNP	O	O
d	NN	O	O

tylenol	NN	B-TREATMENT	B-TREATMENT
prn	NN	O	O

morphine	NN	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
4	CD	O	O
mg	NN	O	O
q2	NN	O	O
hrs	NN	O	O
prn	NN	O	O

1.	CD	O	O
nph	NN	B-TREATMENT	B-TREATMENT

2.	CD	O	O
humalog	NN	B-TREATMENT	B-TREATMENT

3.	CD	O	O
venlafaxine	JJ	B-TREATMENT	B-TREATMENT
37.5	CD	O	O
mg	NN	O	O
capsule	NN	O	O
,	,	O	O
sust	NN	O	O
.	.	O	O
release	VB	O	O
24	CD	O	O
hr	JJ	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
,	,	O	O
sust	NN	O	O
.	.	O	O
release	VB	O	O
24	CD	O	O
hr	JJ	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

4.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

5.	CD	O	O
isosorbide	JJ	B-TREATMENT	B-TREATMENT
mononitrate	NN	I-TREATMENT	I-TREATMENT
30	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sustained	VBD	O	O
release	NN	O	O
24	CD	O	O
hr	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
sustained	VBD	O	O
release	NN	O	O
24	CD	O	O
hr	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

6.	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
tartrate	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

7.	CD	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
sulfate	VB	I-TREATMENT	I-TREATMENT
0.083	CD	O	O
%	NN	O	O
(	(	O	O
0.83	CD	O	O
mg	NN	O	O
/	NNP	O	O
ml	NN	O	O
)	)	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
inhalation	NN	O	O
q6h	NN	O	O
(	(	O	O
every	DT	O	O
6	CD	O	O
hours	NNS	O	O
).	VBP	O	O

8.	CD	O	O
ipratropium	NN	B-TREATMENT	B-TREATMENT
bromide	RB	I-TREATMENT	I-TREATMENT
0.02	CD	O	O
%	NN	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
inhalation	NN	O	O
q6h	NN	O	O
(	(	O	O
every	DT	O	O
6	CD	O	O
hours	NNS	O	O
).	VBP	O	O

9.	CD	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
sulfate	VB	I-TREATMENT	I-TREATMENT
0.083	CD	O	O
%	NN	O	O
(	(	O	O
0.83	CD	O	O
mg	NN	O	O
/	NNP	O	O
ml	NN	O	O
)	)	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
inhalation	NN	O	O
q2h	NN	O	O
(	(	O	O
every	DT	O	O
2	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

10.	CD	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
)	)	O	O
for	IN	O	O
4	CD	O	O
days	NNS	O	O
.	.	O	O

11.	CD	O	O
furosemide	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
/	NNP	O	O
ml	NN	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
forty	NN	O	O
(	(	O	O
40	CD	O	O
)	)	O	O
mg	NN	O	O
injection	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

12.	CD	O	O
acetazolamide	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
500	CD	O	O
mg	NN	O	O
recon	NN	O	O
soln	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
hundred	VBD	O	O
fifty	NNS	O	O
(	(	O	O
250	CD	O	O
)	)	O	O
recon	NN	O	O
soln	NN	O	O
injection	NN	O	O
q12h	NN	O	O
(	(	O	O
every	DT	O	O
12	CD	O	O
hours	NNS	O	O
).	VBP	O	O

13.	CD	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
2	CD	O	O
mg	NN	O	O
/	NNP	O	O
ml	NN	O	O
syringe	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
mg	NN	O	O
injection	NN	O	O
q4h	NN	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

14.	CD	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
200	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
for	IN	O	O
7	CD	O	O
days	NNS	O	O
.	.	O	O

15.	CD	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
400	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
:	:	O	O
after	IN	O	O
finishing	VBG	O	O
400mg	CD	O	O
bid	NN	O	O
x	VBD	O	O
6	CD	O	O
days	NNS	O	O
.	.	O	O

diastolic	JJ	B-PROBLEM	B-PROBLEM
congestive	JJ	I-PROBLEM	I-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM

aortic	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM

mitral	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM

possible	JJ	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
obstructive	JJ	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM

coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM

chronic	JJ	B-PROBLEM	B-PROBLEM
kidney	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM

depression	NN	B-PROBLEM	B-PROBLEM

diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	VBP	I-PROBLEM	I-PROBLEM

stable	JJ	O	O
,	,	O	O
satting	VBG	O	B-TEST
98%	CD	O	O
on	IN	O	O
1l	CD	B-TREATMENT	O
via	IN	I-TREATMENT	O
nc	NN	I-TREATMENT	O
,	,	O	O
sitting	VBG	O	O
up	RP	O	O
in	IN	O	O
a	DT	O	O
chair	NN	O	O

please	VB	O	O
call	VB	O	O
your	PRP$	O	O
doctor	NN	O	O
at	IN	O	O
the	DT	O	O
rehabilitation	NN	O	O
if	IN	O	O
you	PRP	O	O
develop	VBP	O	O
any	DT	O	B-PROBLEM
shortness	NN	B-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
any	DT	B-PROBLEM	B-PROBLEM
other	JJ	I-PROBLEM	I-PROBLEM
concerning	NN	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

please	VB	O	O
take	VB	O	O
medications	NNS	B-TREATMENT	B-TREATMENT
as	IN	O	O
instructed	VBN	O	O
.	.	O	O

gastric	JJ	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM

gastric	JJ	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM

hypothyroidism	NN	B-PROBLEM	B-PROBLEM
following	VBG	O	O
near	IN	B-TREATMENT	O
total	JJ	I-TREATMENT	B-TREATMENT
thyroidectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
1/12/92	CD	O	O
near	IN	B-TREATMENT	O
total	JJ	I-TREATMENT	B-TREATMENT
gastrectomy	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
retrocolic	JJ	B-TREATMENT	O
bill-roth	JJ	I-TREATMENT	O
ii	NN	I-TREATMENT	O
gastrojejunostomy	NN	I-TREATMENT	B-TREATMENT
,	,	O	O
portal	JJ	B-TREATMENT	B-TREATMENT
node	NN	I-TREATMENT	I-TREATMENT
dissection	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
repair	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
ventral	JJ	B-PROBLEM	B-PROBLEM
hernia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
needle	JJ	B-TREATMENT	B-TREATMENT
jejunostomy	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

ms.	NN	O	O
tikrhalt	NN	O	O
is	VBZ	O	O
an	DT	O	O
86	CD	O	O
year	NN	O	O
old	JJ	O	O
female	NN	O	O
,	,	O	O
previously	RB	O	O
healthy	JJ	O	O
,	,	O	O
who	WP	O	O
presents	VBZ	O	O
with	IN	O	O
a	DT	O	O
3	CD	O	O
month	NN	O	O
history	NN	O	O
of	IN	O	O
dysphagia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
subsequent	JJ	I-TEST	I-TEST
workup	NN	I-TEST	I-TEST
including	VBG	O	O
upper	JJ	B-TEST	B-PROBLEM
gastrointestinal	JJ	I-TEST	I-PROBLEM
series	NN	I-TEST	I-PROBLEM
and	CC	O	O
abdominal	JJ	B-TEST	B-TEST
computerized	JJ	I-TEST	I-TEST
tomography	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
suggested	VBD	O	O
the	DT	O	O
presence	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
gastric	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

endoscopy	NN	B-TEST	B-TEST
with	IN	O	I-TEST
biopsy	NN	B-TEST	I-TEST
revealed	VBN	O	O
gastric	JJ	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
poorly	RB	O	O
differentiated	VBN	O	O
,	,	O	O
within	IN	O	O
the	DT	O	O
body	NN	O	O
of	IN	O	O
the	DT	O	B-PROBLEM
stomach	NN	O	I-PROBLEM
along	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
greater	JJR	O	I-PROBLEM
curvature	NN	O	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
subsequently	RB	O	O
referred	VBN	O	O
to	TO	O	O
dr.	VB	O	O
ko	NN	O	O
for	IN	O	O
a	DT	O	O
possible	JJ	O	O
resection	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
this	DT	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
reports	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
10	CD	I-PROBLEM	I-PROBLEM
pound	NN	I-PROBLEM	I-PROBLEM
weight	VBD	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
over	IN	O	O
the	DT	O	O
past	JJ	O	O
several	JJ	O	O
months	NNS	O	O
.	.	O	O

she	PRP	O	O
denies	VBZ	O	O
any	DT	B-PROBLEM	B-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

significant	JJ	O	O
for	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
appendectomy	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
the	DT	O	O
distant	JJ	O	O
past	NN	O	O
,	,	O	O
cholecystectomy	NN	B-TREATMENT	B-TREATMENT
in	IN	O	O
the	DT	O	O
past	JJ	O	O
,	,	O	O
history	NN	O	O
of	IN	O	O
of	IN	O	O
cesarean	JJ	B-TREATMENT	B-TREATMENT
section	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
the	DT	O	O
past	NN	O	O
and	CC	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
near	JJ	B-TREATMENT	B-TREATMENT
total	JJ	I-TREATMENT	I-TREATMENT
thyroidectomy	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
nodular	JJ	B-PROBLEM	B-PROBLEM
goiter	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
past	NN	O	O
.	.	O	O

her	PRP$	B-TREATMENT	O
only	JJ	I-TREATMENT	O
medication	NN	I-TREATMENT	B-TREATMENT
is	VBZ	O	O
thyrolar	JJ	B-TREATMENT	O
for	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
relative	JJ	I-PROBLEM	I-PROBLEM
hypothyroidism	NN	I-PROBLEM	I-PROBLEM
following	VBG	O	O
resection	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

there	EX	O	O
is	VBZ	O	O
a	DT	O	O
question	NN	O	O
of	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
allergy	NN	I-PROBLEM	I-PROBLEM
to	TO	O	I-PROBLEM
tylenol	VB	B-TREATMENT	I-PROBLEM
.	.	O	O

she	PRP	O	O
denies	VBZ	O	O
any	DT	O	O
history	NN	O	O
of	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
diabetes	VBZ	B-PROBLEM	B-PROBLEM
mellitus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
peptic	JJ	B-PROBLEM	B-PROBLEM
ulcer	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

interestingly	RB	O	O
,	,	O	O
she	PRP	O	O
reports	VBZ	O	O
that	IN	O	O
both	DT	O	O
her	PRP$	O	O
mother	NN	O	O
and	CC	O	O
father	NN	O	O
died	VBD	O	O
of	IN	O	O
stomach	NN	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
physical	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
she	PRP	O	O
is	VBZ	O	O
an	DT	O	O
elderly	JJ	O	O
but	CC	O	O
spry	JJ	O	O
white	JJ	O	O
female	NN	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	O	B-TEST
sclera	NN	O	I-TEST
were	VBD	O	O
nonicteric	JJ	B-PROBLEM	O
.	.	O	O

her	PRP$	O	O
neck	NN	O	O
was	VBD	O	O
supple	RB	O	O
without	IN	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
noted	VBN	O	O
.	.	O	O

her	PRP$	O	O
lungs	NNS	O	O
were	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	NN	B-TEST	B-TEST
.	.	O	O

her	PRP$	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
unremarkable	JJ	O	O
.	.	O	O

examination	NN	B-TEST	B-TEST
of	IN	I-TEST	I-TEST
her	PRP$	I-TEST	I-TEST
abdomen	NNS	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
flat	JJ	I-PROBLEM	I-PROBLEM
nontender	NN	I-PROBLEM	I-PROBLEM
abdomen	NNS	I-PROBLEM	I-PROBLEM
without	IN	O	O
palpable	JJ	B-PROBLEM	B-PROBLEM
masses	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
were	VBD	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
well	RB	I-PROBLEM	I-PROBLEM
healed	VBN	I-PROBLEM	I-PROBLEM
surgical	JJ	I-PROBLEM	I-PROBLEM
scars	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
guaiac	JJ	B-TEST	B-TEST
negative	JJ	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
cva	JJ	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
spinal	JJ	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
noted	VBD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
were	VBD	O	O
intact	JJ	O	O
throughout	IN	O	O
.	.	O	O

sodium	NN	B-TEST	B-TEST
139	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
3.7	CD	O	O
and	CC	O	O
bun	NN	B-TEST	B-TEST
of	IN	O	O
19	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
37.2	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
6.6	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
direct	NN	I-TEST	I-TEST
and	CC	O	O
total	JJ	B-TEST	O
were	VBD	O	O
0.1	CD	O	O
and	CC	O	O
0.3	CD	O	O
respectively	RB	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
alkaline	JJ	I-TEST	I-TEST
phosphatase	NN	I-TEST	I-TEST
was	VBD	O	O
134	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
demonstrated	VBD	O	O
normal	JJ	O	O
sinus	NN	O	O
rhythm	NN	O	O
without	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
ischemic	JJ	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
was	VBD	O	O
unremarkable	JJ	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
assessment	NN	I-TEST	I-TEST
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
admission	NN	O	O
was	VBD	O	O
that	IN	O	O
of	IN	O	O
an	DT	O	O
86	CD	O	O
year	NN	O	O
old	JJ	O	O
female	NN	O	O
with	IN	O	O
poorly	RB	B-PROBLEM	B-PROBLEM
differentiated	VBN	I-PROBLEM	I-PROBLEM
gastric	JJ	I-PROBLEM	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
admitted	VBN	O	O
for	IN	O	O
resection	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

on	IN	O	O
1/12/92	CD	O	O
she	PRP	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
where	WRB	O	O
she	PRP	O	O
underwent	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
neart	JJ	I-TREATMENT	I-TREATMENT
total	JJ	I-TREATMENT	I-TREATMENT
gastrectomy	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
a	DT	B-TREATMENT	O
retrocolic	JJ	I-TREATMENT	O
bill-roth	JJ	I-TREATMENT	O
ii	NN	I-TREATMENT	O
gastrojejunostomy	NN	I-TREATMENT	B-TREATMENT
reconstruction	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

in	IN	O	O
addition	NN	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
ventral	JJ	I-PROBLEM	I-PROBLEM
hernia	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
upon	IN	O	O
abdominal	JJ	B-TEST	B-PROBLEM
exploration	NN	I-TEST	I-PROBLEM
within	IN	O	O
a	DT	B-TREATMENT	B-PROBLEM
previous	JJ	I-TREATMENT	I-PROBLEM
surgical	JJ	I-TREATMENT	I-PROBLEM
incision	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

this	DT	O	O
was	VBD	O	O
repaired	VBN	B-TREATMENT	O
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
needle	JJ	I-TREATMENT	I-TREATMENT
jejunostomy	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
operation	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
facilitate	VB	O	O
postoperative	JJ	B-TREATMENT	O
nutrition	NN	I-TREATMENT	O
.	.	O	O

with	IN	O	O
regards	NNS	O	O
to	TO	O	O
the	DT	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
there	EX	O	O
was	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
along	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
greater	JJR	O	I-PROBLEM
curvature	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
body	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
stomach	NN	O	I-PROBLEM
,	,	O	O
and	CC	O	O
several	JJ	O	B-PROBLEM
perigastric	JJ	O	I-PROBLEM
lymph	NN	O	I-PROBLEM
nodes	NNS	O	I-PROBLEM
which	WDT	O	O
were	VBD	O	O
taken	VBN	O	O
with	IN	O	O
the	DT	B-TEST	O
specimen	NNS	I-TEST	O
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
there	EX	O	O
were	VBD	O	O
at	IN	O	O
least	JJS	O	O
two	CD	O	O
lymph	JJ	O	O
nodes	NNS	O	O
within	IN	O	O
the	DT	O	O
porta	NN	O	O
hepatis	NN	O	O
which	WDT	O	O
were	VBD	O	O
dissected	VBN	B-TREATMENT	O
free	JJ	I-TREATMENT	O
and	CC	O	O
taken	VBN	O	O
en	JJ	O	O
bloc	NN	O	O
with	IN	O	O
the	DT	B-TEST	O
specimen	NNS	I-TEST	O
.	.	O	O

the	DT	O	O
remainder	NN	O	O
of	IN	O	O
her	PRP$	O	O
abdomen	NNS	O	O
was	VBD	O	O
unremarkable	JJ	O	O
without	IN	O	O
evidence	NN	O	O
of	IN	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
spread	NN	I-PROBLEM	I-PROBLEM
elsewhere	RB	O	O
,	,	O	O
including	VBG	O	O
the	DT	O	O
liver	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
and	CC	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
recovery	NN	O	O
room	NN	O	O
in	IN	O	O
good	JJ	O	O
condition	NN	O	O
.	.	O	O

her	PRP$	B-PROBLEM	B-PROBLEM
wounds	NNS	I-PROBLEM	I-PROBLEM
healed	VBN	O	O
well	RB	O	O
without	IN	O	O
incident	NN	O	O
and	CC	O	O
the	DT	B-TREATMENT	B-TREATMENT
needle	JJ	I-TREATMENT	I-TREATMENT
jejunostomy	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
utilized	VBN	O	O
on	IN	O	O
the	DT	O	O
first	JJ	O	O
postoperative	JJ	O	O
day	NN	O	O
right	VBD	O	O
up	RB	O	O
until	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
,	,	O	O
infusing	VBG	O	O
vivonex	NNS	B-TREATMENT	O
t.e.n.	NN	I-TREATMENT	O

the	DT	O	O
patient	NN	O	O
tolerated	VBD	O	O
this	DT	O	O
without	IN	O	O
difficulty	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
patient	NN	I-TREATMENT	I-TREATMENT
's	POS	I-TREATMENT	I-TREATMENT
nasogastric	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
removed	VBN	O	O
on	IN	O	O
the	DT	O	O
3rd	CD	O	O
postoperative	JJ	O	O
day	NN	O	O
,	,	O	O
and	CC	O	O
with	IN	O	O
the	DT	O	O
passage	NN	O	O
of	IN	O	O
flatus	NN	O	B-PROBLEM
and	CC	O	O
good	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
noted	VBD	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
liquid	NN	I-TREATMENT	I-TREATMENT
diet	NN	I-TREATMENT	I-TREATMENT
which	WDT	O	O
was	VBD	O	O
advanced	JJ	O	O
slowly	RB	O	O
.	.	O	O

as	IN	O	O
mentioned	VBN	O	O
,	,	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
wounds	NNS	I-PROBLEM	I-PROBLEM
healed	VBN	O	O
well	RB	O	O
without	IN	O	O
incident	NN	O	O
and	CC	O	O
the	DT	B-TREATMENT	B-TREATMENT
staples	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
removed	VBN	O	O
on	IN	O	O
the	DT	O	O
10th	JJ	O	O
postoperative	JJ	O	O
day	NN	O	O
just	RB	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
difficulties	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	I-PROBLEM
confusion	NN	B-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
early	JJ	O	O
postoperative	NN	O	O
period	NN	O	O
which	WDT	O	O
were	VBD	O	O
attributable	JJ	O	O
to	TO	O	O
her	PRP$	O	O
advanced	JJ	O	O
age	NN	O	O
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
sundowning	JJ	I-PROBLEM	I-PROBLEM
effect	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

surgical	JJ	O	B-TEST
pathology	NN	O	I-TEST
report	NN	O	I-TEST
was	VBD	O	O
completed	VBN	O	O
prior	JJ	O	O
to	TO	O	O
discharge	VB	O	O
which	WDT	O	O
revealed	VBD	O	O
poorly	RB	B-PROBLEM	B-PROBLEM
differentiated	VBN	I-PROBLEM	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM	I-PROBLEM
ulcerating	NN	O	I-PROBLEM
and	CC	O	O
extending	VBG	O	O
through	IN	O	O
the	DT	O	O
wall	NN	O	O
into	IN	O	O
the	DT	O	O
serosa	NN	O	O
of	IN	O	O
the	DT	O	O
stomach	NN	O	O
.	.	O	O

metastatic	JJ	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
present	JJ	O	O
in	IN	O	O
3	CD	O	O
of	IN	O	O
3	CD	O	B-TREATMENT
lymph	NN	O	I-TREATMENT
nodes	NNS	O	I-TREATMENT
.	.	O	O

the	DT	O	B-TREATMENT
gastric	JJ	O	I-TREATMENT
resection	NN	O	I-TREATMENT
margins	NNS	O	I-TREATMENT
were	VBD	O	O
free	JJ	O	O
of	IN	O	O
carcinoma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
the	DT	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
she	PRP	O	O
complained	VBD	O	O
of	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
dysuria	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
a	DT	B-TEST	B-TEST
urine	JJ	I-TEST	I-TEST
specimen	NN	I-TEST	I-TEST
was	VBD	O	O
obtained	VBN	O	O
,	,	O	O
which	WDT	O	O
showed	VBD	O	O
numerous	JJ	B-PROBLEM	B-PROBLEM
white	JJ	I-PROBLEM	I-PROBLEM
cells	NNS	I-PROBLEM	I-PROBLEM
consistent	JJ	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
urinary	JJ	I-PROBLEM	I-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
empirically	RB	O	O
on	IN	O	O
bactrim	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
while	IN	O	O
culture	NN	B-TEST	O
and	CC	O	O
sensitivity	NN	B-TEST	O
results	NNS	O	O
were	VBD	O	O
pending	VBG	O	O
and	CC	O	O
remained	VBD	O	O
pending	VBG	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
this	DT	O	O
dictation	NN	O	O
.	.	O	O

bactrim	NN	B-TREATMENT	B-TREATMENT
,	,	I-TREATMENT	O
single	JJ	I-TREATMENT	O
strength	NN	I-TREATMENT	O
,	,	O	O
one	CD	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
times	NNS	O	O
10	CD	O	O
days	NNS	O	O
,	,	O	O
initiated	VBD	O	O
9/27/92	CD	O	O
,	,	O	O
synthroid	VBD	B-TREATMENT	B-TREATMENT
0.1	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.day	NN	O	O
,	,	O	O
ferrous	JJ	B-TREATMENT	B-TREATMENT
gluconate	NN	I-TREATMENT	I-TREATMENT
300	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O
and	CC	O	O
folate	VB	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

she	PRP	O	O
will	MD	O	O
be	VB	O	O
seen	VBN	O	O
by	IN	O	O
visiting	VBG	O	O
nurses	NNS	O	O
association	NN	O	O
to	TO	O	O
help	VB	O	O
with	IN	O	O
general	JJ	O	O
aspects	NNS	O	O
of	IN	O	O
daily	JJ	O	O
living	NN	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
adequate	JJ	O	O
diet	JJ	O	O
planning	NN	O	O
following	VBG	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
gastric	JJ	I-TREATMENT	I-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

patient	NN	O	O
recorded	VBD	O	O
as	IN	O	O
having	VBG	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	O
drugs	NNS	I-PROBLEM	B-TREATMENT

on	IN	O	O
2019-04-12	JJ	O	O
he	PRP	O	O
was	VBD	O	O
transfused	VBN	O	O
with	IN	O	O
2	CD	O	O
units	NNS	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
due	JJ	O	O
to	TO	O	O
post-operative	JJ	B-PROBLEM	B-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mr.	JJ	O	O
minton	NNP	O	O
did	VBD	O	O
not	RB	O	O
get	VB	O	O
his	PRP$	B-TREATMENT	O
ivig	NN	I-TREATMENT	O
until	IN	O	O
2019-04-14	JJ	O	O
.	.	O	O

the	DT	B-TREATMENT	O
infusion	NN	I-TREATMENT	O
was	VBD	O	O
completed	VBN	O	O
without	IN	O	O
incidence	NN	O	O
.	.	O	O

he	PRP	O	O
remained	VBD	O	O
stable	JJ	O	O
with	IN	O	O
his	PRP$	B-TEST	B-TEST
vital	JJ	I-TEST	I-TEST
signs	NNS	I-TEST	I-TEST
and	CC	O	O
lab	NN	B-TEST	O
data	NNS	I-TEST	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

2019-04-15	JJ	O	O
09:25	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	I-TEST	B-TEST
-	:	O	O
3.8	CD	O	O
*	NN	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
2.88	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
8.9	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
25.9	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
90	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
30.9	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.3	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
16.4	CD	O	O
*	JJ	O	O
plt	NN	B-TEST	B-TEST
ct	SYM	I-TEST	I-TEST
-	:	O	O
194	CD	O	O

2019-04-14	JJ	O	O
08:50	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	I-TEST	B-TEST
-	:	O	O
6.5	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.02	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
9.4	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
27.1*	CD	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
90	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
31.0	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.6	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
16.3	CD	O	O
*	JJ	O	O
plt	NN	B-TEST	B-TEST
ct	SYM	I-TEST	I-TEST
-	:	O	O
169	CD	O	O

2019-04-13	JJ	O	O
08:40	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	I-TEST	B-TEST
-	:	O	O
6.7	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.07	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
9.3	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
27.1	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
88	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
30.4	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.5	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
16.2	CD	O	O
*	JJ	O	O
plt	NN	B-TEST	B-TEST
ct	SYM	I-TEST	I-TEST
-	:	O	O
144	CD	O	O
*	NN	O	O

2019-04-12	JJ	O	O
08:00	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
hct	SYM	I-TEST	B-TEST
-	:	O	O
26.5	CD	O	O
*	NN	O	O

2019-04-12	JJ	O	O
06:35	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
hct	NN	I-TEST	I-TEST
-	:	O	O
23.6	CD	O	O
*	NN	O	O

2019-04-11	JJ	O	O
12:55	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
hct	SYM	I-TEST	B-TEST
-	:	O	O
27.1	CD	O	O
*	NN	O	O

2019-04-11	JJ	O	O
09:50	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	I-TEST	B-TEST
-	:	O	O
4.8	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.02	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
9.5	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
26.7	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
89	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
31.4	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
35.5	CD	O	O
*	NN	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
15.2	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
103	CD	O	O
*	NN	O	O

2019-04-11	JJ	O	O
06:27	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	I-TEST	B-TEST
-	:	O	O
4.4	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.03	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
9.5	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
26.7	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
88	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
31.2	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
35.4	CD	O	O
*	NN	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
14.7	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
94	CD	O	O
*	NN	O	O

2019-04-10	JJ	O	O
06:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	I-TEST	B-TEST
-	:	O	O
4.6	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
2.81	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
8.9	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
24.8	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
88	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
31.7	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
36.0	CD	O	O
*	NN	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
15.2	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
95	CD	O	O
*	NN	O	O

2019-04-09	JJ	O	O
06:45	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	I-TEST	B-TEST
-	:	O	O
5.0	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.33	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
10.4	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
29.2	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
88	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
31.2	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
35.5	CD	O	O
*	NN	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
15.0	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
72	CD	O	O
*	NN	O	O

2019-04-08	JJ	O	O
12:27	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	I-TEST	B-TEST
-	:	O	O
4.9	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.11	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
9.9	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
27.1	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
87	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
32.0	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
36.6	CD	O	O
*	NN	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
15.5	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
107	CD	O	O
*	NN	O	O

2019-04-07	JJ	O	O
04:53	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
wbc	SYM	I-TEST	B-TEST
-	:	O	O
4.4	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
2.92	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
9.6	CD	O	O
*#	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
25.8	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
88	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
32.8	CD	O	O
*	NN	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
37.1	CD	O	O
*	NN	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
14.9	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
81	CD	O	O
*	NN	O	O

2019-04-07	JJ	O	O
11:00	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	I-TEST	B-TEST
-	:	O	O
4.4	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
2.34	CD	O	O
*#	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
7.5	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
21.2	CD	O	O
*#	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
91	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
32.1	CD	O	O
*	NN	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
35.4	CD	O	O
*	NN	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
14.5	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
94	CD	O	O
*	NN	O	O

2019-04-07	JJ	O	O
06:00	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	I-TEST	B-TEST
-	:	O	O
3.2	CD	O	O
*#	NN	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.14	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
10.0	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
28.9	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
92	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
32.0	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.8	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
14.1	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
82	CD	O	O
*#	NN	O	O

2019-04-06	JJ	O	O
10:40	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	I-TEST	B-TEST
-	:	O	O
2.1	CD	O	O
*	NN	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.51	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
10.9	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
31.7	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
90	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
31.1	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.5	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
14.3	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
50	CD	O	O
*	NN	O	O

2019-04-15	JJ	O	O
09:25	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
plt	NN	I-TEST	I-TEST
ct	VBD	I-TEST	I-TEST
-	:	O	O
194	CD	O	O

2019-04-14	JJ	O	O
08:50	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
plt	NN	I-TEST	I-TEST
ct	VBD	I-TEST	I-TEST
-	:	O	O
169	CD	O	O

2019-04-14	JJ	O	O
08:50	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
pt	NN	I-TEST	I-TEST
-	:	O	O
12.0	CD	O	O
inr(pt)	JJ	B-TEST	O
-	:	O	O
1.0	CD	O	O

2019-04-15	JJ	O	O
09:25	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
glucose	JJ	I-TEST	B-TEST
-	:	O	O
134	CD	O	O
*	JJ	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
19	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
0.8	CD	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
135	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
3.5	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
100	CD	O	O
hco3	NN	B-TEST	O
-	:	O	O
28	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
11	CD	O	O

1.	CD	O	O
cholecalciferol	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
vitamin	JJ	I-TREATMENT	I-TREATMENT
d3	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
400	CD	O	O
unit	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

2.	CD	O	O
pantoprazole	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
q24h	NN	O	O
(	(	O	O
every	DT	O	O
24	CD	O	O
hours	NNS	O	O
).	VBP	O	O

3.	CD	O	O
lorazepam	JJ	B-TREATMENT	B-TREATMENT
0.5	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
anxiety	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

4.	CD	O	O
acetaminophen	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q4h	NN	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
hours	NNS	O	O
).	VBP	O	O

5.	CD	O	O
lisinopril	JJ	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

6.	CD	O	O
senna	JJ	B-TREATMENT	B-TREATMENT
8.6	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

7.	CD	O	O
docusate	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

8.	CD	O	O
enoxaparin	JJ	B-TREATMENT	B-TREATMENT
30	CD	O	O
mg	NN	O	O
/	VBD	O	O
0.3	CD	O	O
ml	NN	O	O
syringe	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
subcutaneous	JJ	O	O
q12h	NN	O	O
(	(	O	O
every	DT	O	O
12	CD	O	O
hours	NNS	O	O
)	)	O	O
for	IN	O	O
4	CD	O	O
weeks	NNS	O	O
.	.	O	O

9.	CD	O	O
oxycodone	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
q4-6h	NN	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
to	TO	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

10.	CD	O	O
bisacodyl	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
daily	JJ	O	O
(	(	O	O
daily	RB	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

11.	CD	O	O
magnesium	NN	B-TREATMENT	B-TREATMENT
hydroxide	NN	I-TREATMENT	I-TREATMENT
400	CD	O	O
mg	NN	O	O
/	VBD	O	O
5	CD	O	O
ml	JJ	O	O
suspension	NN	O	O
sig	NN	O	O
:	:	O	O
thirty	NN	O	O
(	(	O	O
30	CD	O	O
)	)	O	O
ml	NN	O	O
po	NN	O	O
q6h	NN	O	O
(	(	O	O
every	DT	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

12.	CD	O	O
trazodone	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
hs	NN	O	O
(	(	O	O
at	IN	O	O
bedtime	NN	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
insomnia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

end-stage	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

end-stage	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
right	JJ	B-TREATMENT	B-TREATMENT
nephrectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

2.	CD	O	O
cadaveric	JJ	B-TREATMENT	B-TREATMENT
renal	JJ	I-TREATMENT	I-TREATMENT
transplant	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

3.	CD	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
thrombosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	B-TREATMENT
transplant	JJ	B-TREATMENT	I-TREATMENT
nephrectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

5.	CD	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
emboli	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

6.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

7.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

8.	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
obstructive	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

9.	CD	O	O
hypercoagulable	JJ	B-PROBLEM	O
state	NN	I-PROBLEM	O
.	.	O	O

10.	CD	O	O
perforated	JJ	B-PROBLEM	O
viscus	NN	I-PROBLEM	O
.	.	O	O

11.	CD	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
abscesses	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

12.	CD	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

13.	CD	O	O
respiratory	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
a	DT	O	O
53-year-old	JJ	O	O
male	NN	O	O
with	IN	O	O
a	DT	O	O
longstanding	JJ	O	O
history	NN	O	O
of	IN	O	O
renal	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
complications	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
problems	NNS	B-PROBLEM	I-PROBLEM
related	VBN	O	O
to	TO	O	O
vascular	JJ	O	O
access	NN	O	O
and	CC	O	O
hypercoagulable	JJ	B-PROBLEM	B-PROBLEM
state	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

these	DT	O	O
culminated	VBN	O	O
in	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
attempted	JJ	I-TREATMENT	I-TREATMENT
cadaveric	NN	I-TREATMENT	I-TREATMENT
kidney	NN	I-TREATMENT	I-TREATMENT
transplant	NN	I-TREATMENT	I-TREATMENT
undertaken	VBN	O	O
on	IN	O	O
12/16/97	CD	O	O
,	,	O	O
which	WDT	O	O
was	VBD	O	O
complicated	VBN	O	O
by	IN	O	O
thrombosis	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
necrosis	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
cadaveric	JJ	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
vein	NN	I-PROBLEM	I-PROBLEM
within	IN	O	O
24	CD	O	O
hours	NNS	O	O
.	.	O	O

this	DT	O	O
required	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
transplant	JJ	I-TREATMENT	I-TREATMENT
nephrectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
course	NN	O	O
was	VBD	O	O
subsequently	RB	O	O
characterized	VBN	O	O
by	IN	O	O
recurrent	NN	B-PROBLEM	B-PROBLEM
pneumonias	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
possibly	RB	O	O
due	JJ	O	O
to	TO	O	O
aspiration	NN	B-PROBLEM	O
,	,	O	O
and	CC	O	O
by	IN	O	O
hemodynamic	JJ	B-PROBLEM	B-PROBLEM
instability	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
medical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
from	IN	O	O
the	DT	O	O
transplant	NN	O	O
service	NN	O	O
for	IN	O	O
ventilatory	JJ	B-TREATMENT	B-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
transfer	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
not	RB	O	O
sedated	VBN	B-TREATMENT	O
,	,	O	O
but	CC	O	O
was	VBD	O	O
unresponsive	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
extremely	RB	B-PROBLEM	O
dyssynchronous	JJ	I-PROBLEM	O
with	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
ventilator	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
substantial	JJ	B-PROBLEM	O
auto	NN	I-PROBLEM	O
peep	NN	I-PROBLEM	O
with	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
elevated	VBN	I-PROBLEM	I-PROBLEM
dead	JJ	I-PROBLEM	I-PROBLEM
space	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
pulmonary	JJ	I-TEST	I-TEST
arteriogram	NN	I-TEST	I-TEST
on	IN	O	O
01/03/98	CD	O	O
demonstrated	JJ	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
emboli	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
likely	RB	O	O
less	JJR	O	O
than	IN	O	O
one	CD	O	O
week	NN	O	O
old	JJ	O	O
,	,	O	O
possibly	RB	O	O
introduced	VBN	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
vein	NN	I-PROBLEM	I-PROBLEM
thrombosis	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
12/19/97	CD	O	O
.	.	O	O

an	DT	B-TREATMENT	B-TEST
inferior	JJ	I-TREATMENT	I-TEST
vena	NN	I-TREATMENT	I-TEST
cava	NN	I-TREATMENT	I-TEST
filter	NN	I-TREATMENT	I-TEST
was	VBD	O	O
placed	VBN	O	O
;	:	O	O
lower	JJR	B-TEST	B-TEST
extremity	NN	I-TEST	I-TEST
noninvasive	JJ	I-TEST	I-TEST
studies	NNS	I-TEST	I-TEST
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
required	VBN	O	O
high	JJ	B-TREATMENT	O
pressures	NNS	I-TREATMENT	O
to	TO	O	O
ventilate	VB	O	O
adequately	RB	O	O
,	,	O	O
possibly	RB	O	O
related	VBN	O	O
to	TO	O	O
an	DT	B-PROBLEM	B-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
compartment	NN	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
undergone	JJ	O	B-TREATMENT
two	CD	B-TREATMENT	I-TREATMENT
abdominal	JJ	I-TREATMENT	I-TREATMENT
procedures	NNS	I-TREATMENT	I-TREATMENT
following	VBG	O	I-TREATMENT
explantation	NN	O	I-TREATMENT
.	.	O	O

the	DT	O	O
physiology	NN	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
transfer	NN	O	O
to	TO	O	O
the	DT	O	O
medical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
was	VBD	O	O
consistent	JJ	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
septic	JJ	I-PROBLEM	I-PROBLEM
process	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

ct	JJ	B-TEST	B-TEST
scan	JJ	I-TEST	I-TEST
demonstrated	VBN	O	O
retroperitoneal	JJ	B-PROBLEM	B-PROBLEM
collection	NN	I-PROBLEM	I-PROBLEM
containing	VBG	O	O
both	DT	O	O
free	JJ	B-PROBLEM	O
air	NN	I-PROBLEM	O
and	CC	O	O
extravasated	VBD	B-PROBLEM	B-PROBLEM
contrast	NN	I-PROBLEM	I-PROBLEM
material	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

for	IN	O	O
the	DT	O	O
concern	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
perforated	JJ	I-PROBLEM	I-PROBLEM
viscus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
exploratory	JJ	B-TEST	B-TEST
laparotomy	NN	I-TEST	I-TEST
on	IN	O	O
01/06/98	CD	O	O
,	,	O	O
during	IN	O	O
which	WDT	O	O
the	DT	O	O
bowel	NN	O	O
was	VBD	O	O
run	VBN	O	O
without	IN	O	O
evidence	NN	O	O
of	IN	O	O
perforation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
unstable	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
fluoroscopy	VB	B-TEST	O
,	,	O	O
where	WRB	O	O
oral	JJ	B-TEST	B-TEST
contrast	NN	I-TEST	I-TEST
was	VBD	O	O
demonstrated	VBN	O	O
to	TO	O	O
be	VB	O	O
extravasating	VBG	O	O
through	IN	O	O
a	DT	O	B-PROBLEM
posterior	JJ	O	I-PROBLEM
duodenum	NN	O	I-PROBLEM
.	.	O	O

for	IN	O	O
this	DT	O	O
reason	NN	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
taken	VBN	O	O
again	RB	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
on	IN	O	O
01/08/98	CD	O	O
,	,	O	O
at	IN	O	O
which	WDT	O	O
time	NN	O	O
a	DT	B-TREATMENT	B-TREATMENT
gastrojejunostomy	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
performed	VBN	O	O
with	IN	O	O
stapling	VBG	B-TREATMENT	B-PROBLEM
across	IN	I-TREATMENT	I-PROBLEM
the	DT	I-TREATMENT	I-PROBLEM
gastroduodenal	JJ	I-TREATMENT	I-PROBLEM
junction	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
introduction	NN	O	O
of	IN	O	O
five	CD	B-TREATMENT	O
jackson-pratt	JJ	I-TREATMENT	B-PROBLEM
drains	NNS	I-TREATMENT	I-PROBLEM
into	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
retroperitoneal	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
cholecystotomy	NN	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
gastrostomy	NN	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
jejunostomy	NN	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
extensive	JJ	I-PROBLEM	I-PROBLEM
estimated	VBN	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
requiring	VBG	O	O
multiple	JJ	B-TREATMENT	B-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
products	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
fluid	JJ	B-TREATMENT	B-TREATMENT
resuscitation	NN	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

accompanying	VBG	O	O
this	DT	O	O
during	IN	O	O
this	DT	O	O
period	NN	O	O
were	VBD	O	O
elevations	NNS	B-PROBLEM	B-PROBLEM
in	IN	O	I-PROBLEM
liver	NN	B-TEST	I-PROBLEM
function	NN	I-TEST	I-PROBLEM
studies	NNS	I-TEST	I-PROBLEM
and	CC	O	O
amylase	NN	B-TEST	B-TEST
and	CC	O	O
lipase	NN	B-TEST	B-TEST
consistent	NN	O	O
with	IN	O	O
pancreatic	JJ	B-PROBLEM	B-PROBLEM
inflammation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
aggressively	RB	O	O
treated	VBN	O	O
with	IN	O	O
fluid	JJ	B-TREATMENT	B-TREATMENT
resuscitation	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
pressors	NNS	B-TREATMENT	B-TREATMENT
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
septic	JJ	I-PROBLEM	I-PROBLEM
physiology	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
cardiac	JJ	B-PROBLEM	B-PROBLEM
tamponade	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
specific	JJ	B-PROBLEM	B-PROBLEM
underlying	JJ	I-PROBLEM	I-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
dysfunction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
appropriate	JJ	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
serratia	NN	I-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
process	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
have	VB	O	O
an	DT	B-PROBLEM	B-PROBLEM
underlying	VBG	I-PROBLEM	I-PROBLEM
hypercoagulable	JJ	I-PROBLEM	I-PROBLEM
state	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
thought	VBD	O	O
to	TO	O	O
be	VB	O	O
the	DT	O	O
source	NN	O	O
for	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
repeated	JJ	I-PROBLEM	I-PROBLEM
clots	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

because	IN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
however	RB	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
that	IN	O	O
full	JJ	B-TREATMENT	O
heparinization	NN	I-TREATMENT	O
would	MD	O	O
not	RB	O	O
be	VB	O	O
prudent	JJ	O	O
,	,	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
pneumo-boots	NNS	B-TREATMENT	B-PROBLEM
and	CC	O	O
subcutaneous	JJ	B-TREATMENT	B-TREATMENT
heparin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

attention	NN	O	O
was	VBD	O	O
paid	VBN	O	O
to	TO	O	O
a	DT	O	O
variety	NN	O	O
of	IN	O	O
metabolic	JJ	B-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
electrolyte	JJ	I-PROBLEM	I-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
were	VBD	O	O
corrected	VBN	O	O
appropriately	RB	O	O
.	.	O	O

nonetheless	RB	O	O
,	,	O	O
mr.	NN	O	O
less	JJR	O	O
continued	VBD	O	O
to	TO	O	O
remain	VB	O	O
critically	RB	B-PROBLEM	O
ill	VB	I-PROBLEM	O
with	IN	O	O
only	JJ	O	O
very	RB	O	O
transient	JJ	O	O
mild	NN	O	O
improvement	NN	O	O
with	IN	O	O
drainage	NN	B-TREATMENT	B-TREATMENT
of	IN	O	I-TREATMENT
additional	JJ	B-PROBLEM	I-TREATMENT
retroperitoneal	NN	I-PROBLEM	I-TREATMENT
fluid	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

he	PRP	O	O
remained	VBD	O	O
pressor	JJ	B-PROBLEM	B-PROBLEM
dependent	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
dependent	JJ	B-PROBLEM	O
upon	IN	O	O
mechanical	JJ	B-TREATMENT	O
ventilatory	NN	I-TREATMENT	O
assistance	NN	I-TREATMENT	O
.	.	O	O

his	PRP$	O	O
course	NN	O	O
was	VBD	O	O
complicated	VBN	O	O
by	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
requiring	VBG	O	O
cardioversion	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
had	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
ongoing	JJ	I-PROBLEM	I-PROBLEM
requirement	NN	I-PROBLEM	I-PROBLEM
for	IN	O	O
high	JJ	B-TREATMENT	B-TREATMENT
volume	NN	I-TREATMENT	I-TREATMENT
resuscitation	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
was	VBD	O	O
persistently	RB	B-PROBLEM	B-PROBLEM
acidotic	JJ	I-PROBLEM	I-PROBLEM
despite	IN	O	O
cv-vvh	NN	B-TREATMENT	O
in	IN	O	O
the	DT	O	O
face	NN	O	O
of	IN	O	O
bicarbonate	JJ	B-TREATMENT	B-TREATMENT
replenishment	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
appeared	VBD	O	O
to	TO	O	O
have	VB	O	O
stool	NN	O	O
from	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
jackson-pratt	JJ	I-PROBLEM	I-PROBLEM
site	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
right	JJ	B-PROBLEM	I-PROBLEM
oblique	NN	I-PROBLEM	I-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

bloody	JJ	B-PROBLEM	B-PROBLEM
drainage	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
increasingly	RB	I-PROBLEM	I-PROBLEM
distended	VBN	I-PROBLEM	I-PROBLEM
abdomen	NNS	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
.	.	O	O

it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
continued	VBN	O	B-PROBLEM
massive	JJ	B-PROBLEM	I-PROBLEM
retroperitoneal	NN	I-PROBLEM	I-PROBLEM
contamination	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
probable	JJ	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
enteric	JJ	I-PROBLEM	I-PROBLEM
fistulae	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
ischemic	JJ	I-PROBLEM	I-PROBLEM
bowel	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

dr.	NN	O	O
cantsleddjesc	NN	O	O
felt	VBD	O	O
that	IN	O	O
no	DT	O	O
surgical	JJ	B-TREATMENT	B-TREATMENT
approach	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
this	DT	B-PROBLEM	B-PROBLEM
problem	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
further	JJ	B-TREATMENT	B-PROBLEM
intervention	NN	I-TREATMENT	I-PROBLEM
or	CC	O	O
radiologic	NN	B-TREATMENT	B-TREATMENT
procedures	NNS	I-TREATMENT	I-TREATMENT
would	MD	O	O
be	VB	O	O
helpful	JJ	O	O
.	.	O	O

all	DT	O	O
physicians	NNS	O	O
and	CC	O	O
the	DT	O	O
family	NN	O	O
were	VBD	O	O
in	IN	O	O
agreement	NN	O	O
that	IN	O	O
the	DT	O	O
most	RBS	O	O
appropriate	JJ	O	O
approach	NN	O	O
was	VBD	O	O
to	TO	O	O
institute	VB	O	O
comfort	NN	B-TREATMENT	B-TREATMENT
measures	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

+loc	NN	B-PROBLEM	O
,	,	O	O
gcs:14	NN	B-TEST	O
.	.	O	O

she	PRP	O	O
brought	VBD	O	O
by	IN	O	O
ems	NNS	O	O
to	TO	O	O
nantucket	VB	O	O
cottage	NN	O	O
hospital	NN	O	O
for	IN	O	O
furher	JJR	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
.	.	O	O

2.	CD	O	O
h/o	NN	O	O
depression	NN	B-PROBLEM	B-PROBLEM

3.	CD	O	O
?	.	O	O
h/o	NN	O	O
hypomania	NN	B-PROBLEM	B-PROBLEM

4.	CD	O	O
l5-s1	JJ	B-PROBLEM	B-PROBLEM
spondylolisthesis	NN	I-PROBLEM	I-PROBLEM

all	DT	O	O
:	:	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM

o	NN	O	O
:	:	O	O
t	NN	B-TEST	O
:	:	O	O
100.1	CD	O	O
bp	NN	B-TEST	O
:	:	O	O
162/84	CD	O	O
hr	NN	B-TEST	O
:	:	O	O
80	CD	O	O
rr	NN	B-TEST	O
:	:	O	O
20	CD	O	O
o2sats	NNS	B-TEST	O
:	:	O	O
100	CD	O	O

gen	NN	O	O
:	:	O	O
lying	NN	O	O
in	IN	O	O
strecther	NN	O	O
,	,	O	O
nad	RB	B-PROBLEM	O
,	,	O	O
shaking	VBG	B-PROBLEM	B-PROBLEM
om	JJ	I-PROBLEM	I-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremities	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

heent	NN	O	O
:	:	O	O
neck	NN	O	O
supple	NN	O	O
,	,	O	O
right	RB	O	O
cmed	VBN	O	O
ccu	JJ	O	O
ecchymotic	JJ	B-PROBLEM	O
and	CC	O	O
edematous	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
c-collor	NN	B-TREATMENT	B-TREATMENT
in	IN	O	O
place	NN	O	O
.	.	O	O

abd	NN	O	O
:	:	O	O
soft	JJ	O	O
,	,	O	O
nt	JJ	B-PROBLEM	O
,	,	O	O
bs+	NN	O	B-PROBLEM

extrem	NN	O	O
:	:	O	O
cool	NN	O	O
,	,	O	O
no	DT	O	O
c/c/e	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

mental	JJ	O	O
status	NN	O	O
:	:	O	O
awake	NN	O	O
and	CC	O	O
alert	NN	O	O
,	,	O	O
cooperative	JJ	O	O
with	IN	O	O
exam	JJ	B-TEST	B-TEST
,	,	O	O
normal	JJ	O	O
affect	NN	O	O
.	.	O	O

no	DT	O	O
dysarthria	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
paraphasic	JJ	B-PROBLEM	B-PROBLEM
errors	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

visual	JJ	O	O
fields	NNS	O	O
are	VBP	O	O
full	JJ	O	O
to	TO	O	O
confrontation	NN	B-TEST	B-PROBLEM
.	.	O	O

iii	NN	O	O
,	,	O	O
iv	NN	O	O
,	,	O	O
vi:	FW	O	O
extraocular	JJ	O	O
movements	NNS	O	O
intact	JJ	O	O
bilaterally	RB	O	O
without	IN	O	O
nystagmus	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

viii:	NN	O	O
hearing	VBG	O	O
intact	JJ	O	O
to	TO	O	O
finger	VB	B-TEST	O
rub	VB	I-TEST	O
bilaterally	RB	O	O
.	.	O	O

xii:	JJ	O	B-PROBLEM
tongue	NN	O	I-PROBLEM
midline	NN	O	I-PROBLEM
without	IN	O	O
fasciculations	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
abnormal	JJ	B-PROBLEM	B-PROBLEM
movements	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
tremors	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

strength	NN	B-TEST	O
full	JJ	O	O
power	NN	O	O
05-31	JJ	O	O
execept	NN	O	O
right	JJ	O	O
dubord	NN	O	O
03-31	NN	O	O
.	.	O	O

no	DT	O	O
pronator	NN	B-PROBLEM	B-PROBLEM
drift	NN	I-PROBLEM	I-PROBLEM

sensation	NN	B-TEST	O
:	:	O	O
intact	JJ	O	O
to	TO	O	O
light	JJ	B-TEST	B-TEST
touch	NN	I-TEST	I-TEST
,	,	O	O
propioception	NN	B-TEST	O
,	,	O	O
pinprick	JJ	B-TEST	B-PROBLEM
execept	NN	O	I-PROBLEM
decreased	VBN	B-PROBLEM	I-PROBLEM
sensation	NN	I-PROBLEM	I-PROBLEM
l5-s1	JJ	I-PROBLEM	I-PROBLEM
distrubution	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

reflexes	NNS	B-TEST	B-TEST
:	:	O	O

right	NN	O	O
:	:	O	O
b	SYM	B-TEST	O
-	:	O	O
2	CD	O	O
;	:	O	O
t	SYM	B-TEST	B-TEST
-	:	O	O
2	CD	O	O
;	:	O	O
br	SYM	B-TEST	B-TEST
-	:	O	O
2	CD	O	O
;	:	O	O
pa	SYM	B-TEST	B-TEST
-	:	O	O
2	CD	O	O
;	:	O	O
ac	SYM	B-TEST	B-TEST
-	:	O	O
2	CD	O	O

left	NN	O	O
:	:	O	O
b	SYM	B-TEST	O
-	:	O	O
2	CD	O	O
;	:	O	O
t	SYM	B-TEST	B-TEST
-	:	O	O
2	CD	O	O
;	:	O	O
br	SYM	B-TEST	B-TEST
-	:	O	O
2	CD	O	O
;	:	O	O
pa	SYM	B-TEST	B-TEST
-	:	O	O
2	CD	O	O
;	:	O	O
ac	SYM	B-TEST	B-TEST
-	:	O	O
2	CD	O	O

coordination	NN	O	O
:	:	O	O
normal	JJ	O	O
finger-nose-finger	NN	B-TEST	O

2013-03-27	JJ	O	O
12:59	CD	O	O
am	VBP	O	O
urine	JJ	B-TEST	B-TEST
color	NN	I-TEST	I-TEST
-	:	O	O
yellow	NN	O	O
appear	VBP	B-TEST	O
-	:	O	O
clear	JJ	O	O
sp	NN	B-TEST	O
stickney	NN	I-TEST	O
-	:	O	O
1.032	CD	O	O

2013-03-27	JJ	O	O
12:59	CD	O	O
am	VBP	O	O
urine	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
-	:	O	O
neg	NN	O	O
nitrite	JJ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
protein	SYM	B-TEST	B-TEST
-	:	O	I-TEST
tr	NN	O	I-TEST
glucose	JJ	B-TEST	I-TEST
-	:	O	O
neg	NN	O	O
ketone	NN	B-TEST	B-TEST
-	:	O	O
50	CD	O	O
bilirubin	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
urobilngn	JJ	B-TEST	B-TEST
-	:	O	O
1	CD	O	O
ph	NN	B-TEST	O
-	:	O	O
7.0	CD	O	O
leuk	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O

2013-03-27	JJ	O	O
12:59	CD	O	O
am	VBP	O	O
urine	JJ	B-TEST	B-TEST
rbc-	JJ	I-TEST	I-TEST
0-2	JJ	O	I-TEST
wbc	NN	B-TEST	I-TEST
-	:	O	O
0	CD	O	O
bacteria	NNS	B-TEST	B-TEST
-	:	O	O
none	NN	O	O
yeast	SYM	B-TEST	B-TEST
-	:	O	O
none	NN	O	O
epi	SYM	B-TEST	O
-	:	O	O
0-2	NN	O	O

2013-03-27	JJ	O	O
12:59	CD	O	O
am	VBP	O	O
wbc	JJ	B-TEST	B-TEST
-	:	O	O
5.0	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
4.23	CD	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
13.4	CD	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
38.5	CD	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
91	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
31.8	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.9	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
12.7	CD	O	O

2013-03-27	JJ	O	O
12:59	CD	O	O
am	VBP	O	O
plt	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
-	:	O	O
213	CD	O	O

2013-03-27	JJ	O	O
12:59	CD	O	O
am	VBP	O	O
urine	JJ	B-TEST	B-TEST
bnzodzpn	NN	I-TEST	I-TEST
-	:	O	O
neg	NN	O	O
barbitrt	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
opiates	VBZ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
cocaine	NN	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
amphetmn	SYM	B-TEST	B-TEST
-	:	O	O
pos	NN	O	B-TEST
mthdone	NN	B-TEST	I-TEST
-	:	O	O
neg	NN	O	O

2013-03-27	JJ	O	O
01:09	CD	O	O
am	VBP	O	O
hgb	JJ	B-TEST	B-TEST
-	:	O	O
13.4	CD	O	O
calchct	NN	B-TEST	B-TEST
-	:	O	O
40	CD	O	O
o2	NN	B-TEST	B-TEST
sat	VBD	I-TEST	I-TEST
-	:	O	O
95	CD	O	O
carboxyhb	NN	B-TEST	O
-	:	O	O
1.2	CD	O	O
met	VBD	B-TEST	O
hgb	NN	I-TEST	B-TEST
-	:	O	O
0.2	CD	O	O

2013-03-27	JJ	O	O
12:59	CD	O	O
am	VBP	O	O
urea	JJ	B-TEST	B-TEST
n	JJ	I-TEST	I-TEST
-	:	O	O
21	CD	O	O
*	NN	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
0.8	CD	O	O

2013-03-27	JJ	O	O
02:25	CD	O	O
am	VBP	O	O
pt	JJ	B-TEST	O
-	:	O	O
13.2	CD	O	O
*	NN	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
22.9	CD	O	O
inr(pt)	JJ	B-TEST	O
-	:	O	O
1.2	CD	O	O
*	NN	O	O

chest	NN	B-TEST	B-TEST
and	CC	I-TEST	I-TEST
pelvis	JJ	I-TEST	I-TEST
x-rays	NNS	I-TEST	I-TEST
were	VBD	O	O
negative	JJ	O	O
for	IN	O	O
fractures	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
her	PRP$	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
demonstrated	VBD	O	O
intraparenchymal	JJ	B-PROBLEM	O
and	CC	I-PROBLEM	O
extraaxial	JJ	I-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
(	(	I-PROBLEM	I-PROBLEM
mostly	RB	I-PROBLEM	I-PROBLEM
subarachnoid	VBN	I-PROBLEM	I-PROBLEM
)	)	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
cerebral	JJ	I-PROBLEM	I-PROBLEM
hemispheres	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
right	RB	O	O
greater	JJR	O	O
than	IN	O	O
left	JJR	O	O
,	,	O	O
in	IN	O	O
a	DT	O	O
pattern	NN	O	O
indicating	VBG	O	O
contrecoup	JJ	B-PROBLEM	B-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
her	PRP$	I-TEST	I-TEST
c-spine	NN	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	O	O
possible	JJ	O	O
fracture	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
c7	NN	I-PROBLEM	I-PROBLEM
pedicle	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
her	PRP$	I-TEST	I-TEST
chest	NN	I-TEST	I-TEST
revealed	VBD	O	O
bliateral	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
nodules	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
thyroid	NN	I-PROBLEM	I-PROBLEM
nodule	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
her	PRP$	I-TEST	I-TEST
sinues	NNS	I-TEST	I-TEST
revealed	VBD	O	O
no	DT	O	O
fractures	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

x-rays	NNS	B-TEST	O
of	IN	I-TEST	O
her	PRP$	I-TEST	B-PROBLEM
right	JJ	I-TEST	I-PROBLEM
lower	JJR	I-TEST	I-PROBLEM
extremity	NN	I-TEST	I-PROBLEM
were	VBD	O	O
negative	JJ	O	O
for	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
acute	JJ	I-PROBLEM	I-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

our	PRP$	O	O
recommendations	NNS	O	O
were	VBD	O	O
to	TO	O	O
load	VB	O	O
her	PRP$	O	O
with	IN	O	O
dilantin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
then	RB	O	O
continue	VB	O	O
at	IN	O	O
100	CD	O	O
mg	NN	O	O
po	NN	O	O
tid	NN	O	O
.	.	O	O

the	DT	O	O
orthopedics	NNS	O	O
spine	JJ	O	O
service	NN	O	O
saw	VBD	O	O
her	PRP$	O	O
and	CC	O	O
put	VB	O	O
her	PRP$	O	O
in	IN	O	O
a	DT	B-TREATMENT	O
c-collar	JJ	I-TREATMENT	O
.	.	O	O

a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
ct	VBD	I-TEST	I-TEST
12	CD	O	O
hours	NNS	O	O
after	IN	O	O
the	DT	O	O
first	JJ	O	O
was	VBD	O	O
largely	RB	O	O
unchanged	JJ	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
having	VBG	O	O
some	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
issues	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
making	VBG	O	O
her	PRP$	O	O
"	JJ	O	O
jittery	NN	B-PROBLEM	O
."	NN	O	O

on	IN	O	O
hd	NN	O	O
2	CD	O	O
she	PRP	O	O
was	VBD	O	O
switched	VBN	O	O
to	TO	O	O
fioricet	VB	B-TREATMENT	B-TREATMENT
,	,	O	O
which	WDT	O	O
helped	VBD	O	O
with	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
headaches	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
repeact	JJ	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
was	VBD	O	O
unchanged	JJ	O	O
.	.	O	O

an	DT	B-TEST	B-TEST
mri	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
her	PRP$	I-TEST	I-TEST
c-spine	NN	I-TEST	I-TEST
was	VBD	O	O
done	VBN	O	O
to	TO	O	O
evaluate	VB	O	O
for	IN	O	O
ligamentous	JJ	B-PROBLEM	B-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
this	DT	O	O
was	VBD	O	O
extremely	RB	B-TEST	O
limited	JJ	I-TEST	B-TEST
examination	NN	I-TEST	I-TEST
due	JJ	O	O
to	TO	O	O
patient	JJ	O	O
motion	NN	O	O
and	CC	O	O
the	DT	O	O
signal	NN	O	O
in	IN	O	O
the	DT	O	O
spinal	JJ	O	O
cord	NN	O	O
could	MD	O	O
not	RB	O	O
be	VB	O	O
adequately	RB	O	O
assessed	VBN	O	O
for	IN	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

as	IN	O	O
per	NN	O	O
cmed	VBD	O	O
csru	JJ	O	O
spine	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
instructed	VBN	O	O
to	TO	O	O
follow-up	NN	O	O
in	IN	O	O
2	CD	O	O
weeks	NNS	O	O
for	IN	O	O
repeat	NN	B-TEST	B-TEST
x-rays	NNS	I-TEST	I-TEST
.	.	O	O

on	IN	O	O
discharge	NN	O	O
she	PRP	O	O
was	VBD	O	O
awake	RB	O	O
,	,	O	O
alert	NN	O	O
and	CC	O	O
orientated	VBD	O	O
x3	NNS	O	O
with	IN	O	O
c/o	JJ	O	B-PROBLEM
mild	JJ	B-PROBLEM	I-PROBLEM
headache	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
full	JJ	B-TEST	B-TEST
strength	NN	I-TEST	I-TEST
motor	NN	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
,	,	O	O
no	DT	O	O
pronator	NN	B-PROBLEM	B-PROBLEM
drift	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
perrla	NN	O	B-PROBLEM
with	IN	O	O
full	JJ	O	O
eom	NN	O	O
s.	NN	O	O

she	PRP	O	O
was	VBD	O	O
ambulating	VBG	O	O
without	IN	O	O
difficulties	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
04-01	JJ	O	O
she	PRP	O	O
was	VBD	O	O
seen	VBN	O	O
by	IN	O	O
physical	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
thought	VBN	O	O
to	TO	O	O
benefit	VB	O	O
from	IN	O	O
acute	JJ	B-TREATMENT	B-TREATMENT
rehabilitation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
that	DT	O	O
showed	VBD	O	O
resolution	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
subarachnoid	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

follow-up	NN	O	O
in	IN	O	O
1	CD	O	O
month	NN	O	O
with	IN	O	O
neurosurgery	NN	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
was	VBD	O	O
arranged	VBN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
discharged	VBN	O	O
on	IN	O	O
fioricet	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
dilantin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
counseled	VBN	O	O
to	TO	O	O
follow-up	JJ	O	O
with	IN	O	O
her	PRP$	O	O
pcp	JJ	O	O
f	JJ	O	O
6-12	JJ	O	O
months	NNS	O	O
regading	VBG	O	O
the	DT	B-PROBLEM	O
right	JJ	I-PROBLEM	O
thyroid	NN	I-PROBLEM	B-PROBLEM
nodule	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
the	DT	B-PROBLEM	B-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
nodules	NNS	I-PROBLEM	I-PROBLEM
seen	VBN	O	O
on	IN	O	O
her	PRP$	B-TEST	B-TEST
chest	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
.	.	O	O

1.	CD	O	O
celexa	NN	B-TREATMENT	B-TREATMENT

2.	CD	O	O
premarin	NN	B-TREATMENT	B-TREATMENT

3.	CD	O	O
trazodone	NN	B-TREATMENT	B-TREATMENT

4.	CD	O	O
6-mp	JJ	B-TREATMENT	O

5.	CD	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT

1.	CD	O	O
phenytoin	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
extended	VBD	I-TREATMENT	O
100	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
for	IN	O	O
1	CD	O	O
months	NNS	O	O
.	.	O	O

2.	CD	O	O
acetaminophen	SYM	B-TREATMENT	B-TREATMENT
-	:	O	I-TREATMENT
caff	NN	B-TREATMENT	I-TREATMENT
-	:	O	O
butalbital	JJ	B-TREATMENT	O
504-61-78	JJ	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
01-28	JJ	O	O
tablets	NNS	O	O
po	JJ	O	O
q4-6h	JJ	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
to	TO	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
1	CD	O	O
months	NNS	O	O
.	.	O	O

3.	CD	O	O
citalopram	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

4.	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
tartrate	NN	I-TREATMENT	I-TREATMENT
25	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

5.	CD	O	O
hydromorphone	NN	B-TREATMENT	B-TREATMENT
2	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
tablets	NNS	O	O
po	VBP	O	O
q4h	NN	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

6.	CD	O	O
docusate	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
100	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
):	NNP	O	O
use	NN	O	O
while	IN	O	O
taking	VBG	O	O
narcotics	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

7.	CD	O	O
phenytoin	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
extended	VBD	I-TREATMENT	O
100	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

head	NN	B-PROBLEM	B-PROBLEM
trauma	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
subarachnoid	JJ	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM

c7	NN	B-PROBLEM	B-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM

call	NN	O	O
for	IN	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
headache	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
any	DT	B-PROBLEM	B-PROBLEM
other	JJ	I-PROBLEM	I-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

please	VB	O	O
take	VB	O	O
fioricet	NN	B-TREATMENT	B-TREATMENT
as	IN	O	O
directed	VBN	O	O
for	IN	O	O
headaches	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

please	VB	O	O
do	VB	O	O
not	RB	O	O
drive	VB	O	O
while	IN	O	O
on	IN	O	O
this	DT	B-TREATMENT	B-TREATMENT
medication	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

please	NN	O	O
continue	VB	O	O
to	TO	O	O
wear	VB	O	O
your	PRP$	B-TREATMENT	O
c-collar	JJ	I-TREATMENT	O
at	IN	O	O
all	DT	O	O
times	NNS	O	O
.	.	O	O

please	NN	O	O
continue	VB	O	O
dilantin	NN	B-TREATMENT	B-TREATMENT
as	IN	O	O
directed	VBN	O	O
for	IN	O	O
seizure	NN	B-TREATMENT	B-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

follow	VB	O	O
up	RP	O	O
with	IN	O	O
dr.	JJ	O	O
kelley	NN	O	O
in	IN	O	O
4	CD	O	O
weeks	NNS	O	O
with	IN	O	O
head	NN	B-TEST	B-TEST
ct	SYM	I-TEST	I-TEST
-	:	O	O
call	NN	O	O
716	CD	O	O
3268	CD	O	O

please	NN	O	O
also	RB	O	O
follow-up	JJ	O	O
with	IN	O	O
dr.	JJ	O	O
obrecht	NN	O	O
of	IN	O	O
cmed	JJ	O	O
ccu	JJ	O	O
spine	NN	O	O
in	IN	O	O
2	CD	O	O
weeks	NNS	O	O
for	IN	O	O
flexion	NN	B-TEST	B-TEST
/	CD	I-TEST	O
extension	NN	I-TEST	B-TEST
x-rays	NNS	I-TEST	I-TEST
((	VBP	O	O
228	CD	O	O
)	)	O	O
411-7660	CD	O	O
)	)	O	O

please	VB	O	O
follow-up	JJ	O	O
with	IN	O	O
your	PRP$	O	O
pcp	NN	O	O
n	IN	O	O
6-12	JJ	O	O
months	NNS	O	O
reguading	VBG	O	O
the	DT	B-PROBLEM	O
right	JJ	I-PROBLEM	O
thyroid	NN	I-PROBLEM	B-PROBLEM
nodule	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
the	DT	B-PROBLEM	B-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
nodules	NNS	I-PROBLEM	I-PROBLEM
seen	VBN	O	O
on	IN	O	O
your	PRP$	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
.	.	O	O

hepatocellular	JJ	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
hepatitis	NN	B-PROBLEM	B-PROBLEM
c	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

hepatocellular	JJ	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
hepatitis	NN	B-PROBLEM	B-PROBLEM
c	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

liver	NN	B-TREATMENT	B-TREATMENT
transplant	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

native	JJ	B-TREATMENT	B-TREATMENT
hepatectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

re-exploration	NN	B-TEST	O
for	IN	O	O
bleeding	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

mr.	NN	O	O
villesatelkscurb	NN	O	O
is	VBZ	O	O
a	DT	O	O
fifty	JJ	O	O
year	NN	O	O
old	JJ	O	O
black	JJ	O	O
gentleman	NN	O	O
with	IN	O	O
a	DT	O	O
long	JJ	O	O
history	NN	O	O
of	IN	O	O
hepatitis	NN	B-PROBLEM	B-PROBLEM
c	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
believed	VBN	O	O
to	TO	O	O
be	VB	O	O
contracted	VBN	O	O
during	IN	O	O
transfusions	NNS	B-TREATMENT	B-TREATMENT
in	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
previous	JJ	I-PROBLEM	I-PROBLEM
trauma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
recently	RB	O	O
prior	RB	O	O
to	TO	O	O
this	DT	O	O
admission	NN	O	O
,	,	O	O
had	VBD	O	O
a	DT	B-PROBLEM	O
rise	NN	I-PROBLEM	O
in	IN	I-PROBLEM	O
his	PRP$	I-PROBLEM	O
alpha	NN	I-PROBLEM	O
feta	NN	I-PROBLEM	B-TREATMENT
protein	NN	I-PROBLEM	I-TREATMENT
and	CC	O	O
a	DT	B-TEST	B-TEST
biopsy	NN	I-TEST	I-TEST
of	IN	I-TEST	O
his	PRP$	I-TEST	O
liver	NN	I-TEST	O
had	VBD	O	O
shown	VBN	O	O
hepatocellular	JJ	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
liver	NN	B-TEST	B-TEST
transplant	NN	I-TEST	I-TEST
workup	NN	I-TEST	I-TEST
and	CC	O	O
to	TO	O	O
await	VB	O	O
liver	NN	B-TREATMENT	B-TREATMENT
transplant	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

significant	JJ	O	O
for	IN	O	O
motor	NN	O	O
vehicle	NN	O	O
accident	NN	O	O
in	IN	O	O
1966	CD	O	O
,	,	O	O
requiring	VBG	O	O
exploratory	JJ	B-TEST	B-TEST
laparotomy	NN	I-TEST	I-TEST
and	CC	O	O
splenectomy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
tonsillectomy	NN	B-TREATMENT	B-TREATMENT
as	IN	O	O
a	DT	O	O
child	NN	O	O
,	,	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
in	IN	O	O
the	DT	O	O
past	NN	O	O
,	,	O	O
hepatitis	NN	B-PROBLEM	B-PROBLEM
c	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
recent	JJ	O	O
diagnosis	NN	O	O
of	IN	O	O
hepatocellular	JJ	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
admission	NN	O	B-TREATMENT
medications	NNS	B-TREATMENT	I-TREATMENT
included	VBD	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
iron	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

significant	JJ	O	O
for	IN	O	O
normal	JJ	O	O
head	NN	O	O
,	,	O	O
eyes	NNS	O	O
,	,	O	O
ears	NNS	O	O
,	,	O	O
nose	RB	O	O
,	,	O	O
throat	NN	O	B-TEST
exam	NN	O	I-TEST
with	IN	O	O
no	DT	O	O
scleral	JJ	B-PROBLEM	B-PROBLEM
icterus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
no	DT	O	O
appreciable	JJ	B-PROBLEM	B-PROBLEM
ascites	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
did	VBD	O	O
have	VB	O	O
clubbing	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
palmar	NN	B-PROBLEM	B-PROBLEM
erythema	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
ankle	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

bilirubin	NN	B-TEST	B-TEST
to	TO	O	O
be	VB	O	O
.6	VBN	O	O
.	.	O	O

sgot	NN	B-TEST	O
of	IN	O	O
80	CD	O	O
.	.	O	O

preoperatively	RB	O	O
,	,	O	O
the	DT	O	O
patient	JJ	O	O
underwent	JJ	O	O
chemo-embolization	NN	B-TREATMENT	O
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
hepatocellular	JJ	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
july	NN	O	O
15	CD	O	O
,	,	O	O
1992	CD	O	O
,	,	O	O
a	DT	O	O
liver	NN	O	O
became	VBD	O	O
available	JJ	O	O
,	,	O	O
and	CC	O	O
the	DT	O	O
patient	JJ	O	O
underwent	JJ	O	O
hepatectomy	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
orthotopic	NN	B-TREATMENT	B-TREATMENT
liver	NN	I-TREATMENT	I-TREATMENT
transplant	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
operation	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
complicated	VBN	O	O
by	IN	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
coagulopathy	JJ	I-PROBLEM	I-PROBLEM
requiring	VBG	O	O
fifty-nine	JJ	O	B-TREATMENT
units	NNS	O	I-TREATMENT
of	IN	O	I-TREATMENT
packed	JJ	B-TREATMENT	I-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
64	CD	O	O
units	NNS	O	O
of	IN	O	O
ffp	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
34	CD	O	O
units	NNS	O	O
of	IN	O	O
platelets	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

postoperatively	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
coagulopathy	JJ	I-PROBLEM	I-PROBLEM
requiring	VBG	O	I-PROBLEM
re-exploration	NN	B-TEST	I-PROBLEM
on	IN	O	O
postoperatively	RB	O	O
day	NN	O	O
2	CD	O	O
,	,	O	O
with	IN	O	O
findings	NNS	O	O
only	RB	O	O
of	IN	O	O
hematoma	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
no	DT	O	O
active	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

initially	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
did	VBD	O	O
well	RB	O	O
in	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
,	,	O	O
mentally	RB	O	O
alert	JJ	O	O
,	,	O	O
and	CC	O	O
oriented	VBD	O	O
,	,	O	O
however	RB	O	O
,	,	O	O
he	PRP	O	O
continued	VBD	O	O
to	TO	O	O
be	VB	O	O
coagulopathic	JJ	B-PROBLEM	O
and	CC	O	O
was	VBD	O	O
requiring	VBG	O	O
large	JJ	B-TREATMENT	O
amounts	NNS	I-TREATMENT	O
of	IN	I-TREATMENT	O
blood	NN	I-TREATMENT	B-TREATMENT
and	CC	O	I-TREATMENT
ffp	JJ	B-TREATMENT	I-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
resultant	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
developed	VBD	O	O
renal	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
felt	VBD	O	O
to	TO	O	O
be	VB	O	O
atn	JJ	B-PROBLEM	O
secondary	JJ	O	O
to	TO	O	O
ischemia	VB	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
kidneys	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
intubated	VBN	B-TREATMENT	B-TREATMENT
in	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
twelve	JJ	O	O
days	NNS	O	O
prior	RB	O	O
to	TO	O	O
his	PRP$	O	B-PROBLEM
death	NN	O	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
daily	JJ	B-TREATMENT	O
transfusions	NNS	I-TREATMENT	B-TREATMENT
of	IN	O	I-TREATMENT
ffp	NN	B-TREATMENT	I-TREATMENT
and	CC	O	O
blood	NN	B-TREATMENT	B-TEST
,	,	O	O
and	CC	O	O
continued	VBD	O	O
coagulopathy	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
also	RB	O	O
developed	VBD	O	O
thrombocytopenia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
requiring	VBG	O	O
persistent	JJ	B-TREATMENT	B-TREATMENT
platelet	NN	I-TREATMENT	I-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
on	IN	O	O
a	DT	O	O
daily	JJ	O	O
basis	NN	O	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
immunosuppression	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
okt3	JJ	B-TREATMENT	O
and	CC	O	O
solu	JJ	B-TREATMENT	B-TREATMENT
medrol	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
he	PRP	O	O
underwent	JJ	O	O
hemodialysis	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
ultra	JJ	B-TREATMENT	B-TREATMENT
filtration	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
remove	VB	O	O
fluid	NN	O	O
.	.	O	O

while	IN	O	O
in	IN	O	O
the	DT	O	O
icu	NN	O	O
he	PRP	O	O
developed	VBD	O	O
seizures	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
requiring	VBG	O	O
large	JJ	B-TREATMENT	O
amounts	NNS	I-TREATMENT	O
of	IN	I-TREATMENT	O
intravenous	JJ	I-TREATMENT	B-TREATMENT
valium	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
break	VB	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
seizures	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
maintained	VBN	O	O
on	IN	O	O
tegretol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
dilantin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

however	RB	O	O
,	,	O	O
he	PRP	O	O
became	VBD	O	O
progressively	RB	O	B-PROBLEM
more	RBR	O	I-PROBLEM
mentally	RB	B-PROBLEM	I-PROBLEM
obtunded	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

during	IN	O	O
the	DT	B-PROBLEM	O
seizure	NN	I-PROBLEM	O
,	,	O	O
he	PRP	O	O
bit	VBD	O	O
his	PRP$	O	O
tongue	NN	O	O
,	,	O	O
resulting	VBG	O	O
in	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
from	IN	I-PROBLEM	O
his	PRP$	I-PROBLEM	O
tongue	NN	I-PROBLEM	O
,	,	O	O
which	WDT	O	O
was	VBD	O	O
sutured	VBN	B-TREATMENT	O
by	IN	O	O
the	DT	O	O
ent	NN	O	O
service	NN	O	O
,	,	O	O
however	RB	O	O
,	,	O	O
his	PRP$	B-PROBLEM	O
continued	VBN	I-PROBLEM	O
coagulopathy	NN	I-PROBLEM	B-PROBLEM
resulted	VBD	O	I-PROBLEM
in	IN	O	I-PROBLEM
bleeding	VBG	B-PROBLEM	I-PROBLEM
from	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
nasopharynx	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
could	MD	O	O
never	RB	O	O
be	VB	O	O
identified	VBN	O	O
,	,	O	O
and	CC	O	O
also	RB	O	O
upper	JJ	B-PROBLEM	B-PROBLEM
gastrointestinal	JJ	I-PROBLEM	I-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

endoscopy	NN	B-TEST	B-TEST
never	RB	O	O
revealed	VBD	O	O
specific	JJ	O	O
sources	NNS	O	O
of	IN	O	O
bleeding	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
although	IN	O	O
he	PRP	O	O
appeared	VBD	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
diffuse	NN	I-PROBLEM	I-PROBLEM
duodenitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
pitressin	NN	B-TREATMENT	B-TREATMENT
to	TO	O	O
try	VB	O	O
to	TO	O	O
control	VB	O	O
the	DT	B-PROBLEM	B-PROBLEM
gastrointestinal	JJ	I-PROBLEM	I-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
he	PRP	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
became	VBD	O	O
progressively	RB	B-PROBLEM	B-PROBLEM
hypotensive	JJ	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
eventual	JJ	B-PROBLEM	B-PROBLEM
bradycardia	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
cardiac	JJ	B-PROBLEM	O
arrest	NN	I-PROBLEM	O
.	.	O	O

mr.	NN	O	O
bruno	NN	O	O
is	VBZ	O	O
a	DT	O	O
60	CD	O	O
year	NN	O	O
old	JJ	O	O
gentleman	NN	O	O
who	WP	O	O
initially	RB	O	O
presented	VBN	O	O
with	IN	O	O
hematemesis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hemoptysis	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
on	IN	O	O
work-up	NN	B-TEST	B-TEST
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
left	VBN	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobe	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
previously	RB	O	O
underwent	JJ	O	O
bronchoscopy	NN	B-TEST	B-TEST
with	IN	I-TEST	I-TEST
washings	NNS	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
to	TO	O	O
be	VB	O	O
negative	JJ	O	O
for	IN	O	O
malignant	JJ	B-PROBLEM	B-PROBLEM
cells	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
showed	VBD	O	O
atypical	JJ	B-PROBLEM	B-PROBLEM
bronchial	JJ	I-PROBLEM	I-PROBLEM
epithelial	JJ	I-PROBLEM	I-PROBLEM
cells	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
likely	RB	O	O
to	TO	O	O
be	VB	O	O
reactive	JJ	B-TEST	O
.	.	O	O

1.	CD	O	O
rectal	JJ	B-PROBLEM	O
fissure	NN	I-PROBLEM	O
.	.	O	O

2.	CD	O	O
lumpectomy	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
breast	NN	I-PROBLEM	I-PROBLEM
nodule	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
knee	NN	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

4.	CD	O	O
hand	NN	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
no	DT	O	O
home	NN	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	B-TEST	B-TEST
review	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
systems	NNS	I-TEST	I-TEST
was	VBD	O	O
essentially	RB	O	O
negative	JJ	O	O
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
showed	VBD	O	O
a	DT	O	O
gentleman	NN	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
afebrile	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

chest	NN	O	O
was	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	O	O
.	.	O	O

abdomen	NNS	O	O
is	VBZ	O	O
benign	JJ	O	O
,	,	O	O
no	DT	O	O
mass	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
underwent	VBD	O	O
a	DT	B-TREATMENT	B-TEST
left	JJ	I-TREATMENT	I-TEST
bronchoscopy	NN	I-TREATMENT	I-TEST
and	CC	O	O
lower	JJR	B-TREATMENT	O
lobectomy	NN	I-TREATMENT	B-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
left	JJ	I-TREATMENT	I-TREATMENT
side	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
operation	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
subsequently	RB	O	O
complicated	VBN	O	O
by	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
postoperative	JJ	I-PROBLEM	I-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
to	TO	O	O
be	VB	O	O
taken	VBN	O	O
back	RB	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
where	WRB	O	O
a	DT	B-TREATMENT	B-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
left	JJ	I-TREATMENT	I-TREATMENT
pulmonary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
performed	VBN	O	O
.	.	O	O

during	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
operation	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
the	DT	O	O
patient	NN	O	O
received	VBD	O	O
13	CD	O	O
units	NNS	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
four	CD	O	O
units	NNS	O	O
of	IN	O	O
fresh	JJ	B-TREATMENT	B-TREATMENT
frozen	JJ	I-TREATMENT	I-TREATMENT
plasma	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
one	CD	O	O
unit	NN	O	O
of	IN	O	O
platelets	NNS	B-TREATMENT	B-TEST
with	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
estimated	VBN	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
1500	CD	O	O
cc	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
to	TO	O	O
be	VB	O	O
stable	JJ	O	O
on	IN	O	O
the	DT	O	O
floor	NN	O	O
with	IN	O	O
subsequent	JJ	O	B-TEST
monitoring	NN	O	I-TEST
of	IN	O	I-TEST
hematocrit	NN	B-TEST	I-TEST
within	IN	O	O
a	DT	O	O
normal	JJ	O	O
stable	JJ	O	O
range	NN	O	O
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
successfully	RB	O	O
extubated	VBN	O	O
on	IN	O	O
08-12	NN	O	O
and	CC	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
in	IN	O	O
stable	JJ	O	O
condition	NN	O	O
where	WRB	O	O
the	DT	O	O
pain	NN	O	O
service	NN	O	O
is	VBZ	O	O
managing	VBG	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
epidural	JJ	I-TREATMENT	I-TREATMENT
with	IN	O	O
very	RB	O	O
good	JJ	O	O
effect	NN	O	O
and	CC	O	O
he	PRP	O	O
is	VBZ	O	O
tolerating	VBG	O	O
a	DT	O	O
regular	JJ	O	O
p.o.	NN	O	O
diet	NN	O	O
and	CC	O	O
is	VBZ	O	O
making	VBG	O	O
adequate	JJ	O	O
amount	NN	O	O
of	IN	O	O
urine	NN	O	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
epidural	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
successfully	RB	O	O
discontinued	VBN	O	O
and	CC	O	O
he	PRP	O	O
is	VBZ	O	O
discharged	VBN	O	O
to	TO	O	O
home	VB	O	O
on	IN	O	O
08-15	JJ	O	O
with	IN	O	O
instructions	NNS	O	O
to	TO	O	O
follow-up	JJ	O	O
with	IN	O	O
dr.	JJ	O	O
cordova	NN	O	O
in	IN	O	O
the	DT	O	O
office	NN	O	O
within	IN	O	O
the	DT	O	O
next	JJ	O	O
one	CD	O	O
to	TO	O	O
two	CD	O	O
weeks	NNS	O	O
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
discharged	VBN	O	O
to	TO	O	O
home	NN	O	O
with	IN	O	O
pain	NN	B-TREATMENT	B-TREATMENT
medication	NN	I-TREATMENT	I-TREATMENT
which	WDT	O	O
is	VBZ	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

left	VBN	B-PROBLEM	B-PROBLEM
lung	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
status	NN	O	O
post	NN	O	O
resection	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

cp	NNS	B-PROBLEM	O
standardized	VBD	I-PROBLEM	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
given	VBN	O	O
printed	JJ	O	O
instructions	NNS	O	O
for	IN	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
english	JJ	O	O
)	)	O	O
.	.	O	O

lt	NN	B-PROBLEM	B-PROBLEM
arm/	NN	I-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

ekg	RB	B-TEST	O
=	NNP	O	O
normal	JJ	O	O
,	,	O	O
cxr	JJ	B-TEST	O
normal	JJ	O	O
,	,	O	O
ddimer	JJ	B-TEST	B-TEST
/	NNP	O	I-TEST
cardiac	NN	B-TEST	I-TEST
enzymes	NNS	I-TEST	I-TEST
negative	JJ	O	O

ibuprofen	NN	B-TREATMENT	B-TREATMENT
as	IN	O	O
needed	VBN	O	O

the	DT	O	O
infant	NN	O	O
is	VBZ	O	O
a	DT	O	O
32	CD	O	O
and	CC	O	O
03-05	JJ	O	O
week	NN	O	O
male	NN	O	O
,	,	O	O
twin	VB	O	O
a	DT	O	O
,	,	O	O
who	WP	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
neonatal	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
management	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
prematurity	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

serologies	NNS	B-TEST	O
:	:	O	O

a	DT	O	O
positive	JJ	O	O
,	,	O	O
antibody	JJ	B-TEST	B-TEST
negative	JJ	O	O
,	,	O	O
hepatitis	NN	B-TEST	B-TEST
b	NN	I-TEST	I-TEST
surface	NN	I-TEST	I-TEST
antigen	NN	I-TEST	I-TEST
negative	JJ	O	O
,	,	O	O
rpr	JJ	B-TEST	O
nonreactive	JJ	O	O
,	,	O	O
rubella	NN	B-TEST	B-TEST
immune	NN	O	O
,	,	O	O
gbs	JJ	B-TEST	O
unknown	NN	O	O
.	.	O	O

pregnancy	NN	B-PROBLEM	O
notable	JJ	O	O
for:	NN	O	O

2.	CD	O	O
ivf	NN	B-TREATMENT	O
with	IN	O	O
diamniotic	JJ	O	B-PROBLEM
,	,	O	O
dichorionic	JJ	O	O
twins	NNS	O	O
.	.	O	O

3.	CD	O	O
at	IN	O	O
29-30	JJ	O	O
week	NN	O	O
gestation	NN	O	O
concern	NN	O	O
for	IN	O	O
fetal	JJ	B-PROBLEM	B-PROBLEM
decelerations	NNS	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
twin	NN	O	I-PROBLEM
a	DT	O	I-PROBLEM
,	,	O	O
admitted	VBN	O	O
to	TO	O	O
cambridge	VB	O	O
health	NN	O	O
alliance	NN	O	O
,	,	O	O
completed	VBD	O	O
a	DT	O	O
course	NN	O	O
of	IN	O	O
betamethasone	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
discharged	VBD	O	O
to	TO	O	O
home	NN	O	O
.	.	O	O

4.	CD	O	O
elevated	VBD	B-PROBLEM	O
one	CD	I-PROBLEM	O
hour	NN	I-PROBLEM	O
glucose	JJ	I-PROBLEM	B-TEST
tolerance	NN	I-PROBLEM	I-TEST
test	NN	I-PROBLEM	I-TEST
,	,	O	O
normal	JJ	O	O
three	CD	O	O
hour	NN	O	O
glucose	JJ	O	B-TEST
tolerance	NN	O	I-TEST
test	NN	O	I-TEST
.	.	O	O

5.	CD	O	O
declined	VBD	O	O
triple	JJ	B-TEST	O
screen	NN	I-TEST	O
and	CC	O	O
amniocentesis	NN	B-TEST	B-TREATMENT
.	.	O	O

presented	VBN	O	O
with	IN	O	O
spontaneous	JJ	B-PROBLEM	O
,	,	I-PROBLEM	O
premature	JJ	I-PROBLEM	B-PROBLEM
rupture	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
membranes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
maternal	JJ	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

delivery	NN	B-TREATMENT	B-TREATMENT
by	IN	I-TREATMENT	O
cesarean	JJ	I-TREATMENT	B-TREATMENT
section	NN	I-TREATMENT	I-TREATMENT
secondary	JJ	O	O
to	TO	O	O
twin	VB	B-PROBLEM	O
b	NN	I-PROBLEM	O
breech	NN	I-PROBLEM	O
presentation	NN	I-PROBLEM	O
.	.	O	O

apgars	NNS	B-TEST	B-TEST
eight	CD	O	O
at	IN	O	O
one	CD	O	O
minute	NN	O	O
and	CC	O	O
eight	CD	O	O
at	IN	O	O
five	CD	O	O
minutes	NNS	O	O
.	.	O	O

birth	NN	B-TEST	B-TEST
weight	NN	I-TEST	I-TEST
1865	CD	O	O
grams	NN	O	O
.	.	O	O

1.	CD	O	O
respiratory	NN	O	O
-	:	O	O
the	DT	O	O
infant	NN	O	O
has	VBZ	O	O
remained	VBN	O	O
in	IN	O	O
room	NN	O	O
air	NN	O	O
throughout	IN	O	O
this	DT	O	O
hospitalization	NN	O	O
with	IN	O	O
respiratory	JJ	B-TEST	O
rates	NNS	I-TEST	O
40	CD	O	O
s	NN	O	O
to	TO	O	O
50	CD	O	O
s,	NNS	O	O
oxygen	JJ	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST
greater	JJR	O	O
than	IN	O	O
94%	CD	O	O
.	.	O	O

one	CD	B-PROBLEM	O
apnea	NN	I-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	O
bradycardia	NN	I-PROBLEM	B-PROBLEM
event	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
self	PRP	O	O
resolved	VBD	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
four	CD	O	O
.	.	O	O

2.	CD	O	O
cardiovascular	JJ	O	O
-	:	O	O
the	DT	O	O
infant	NN	O	O
was	VBD	O	O
noted	VBN	O	O
on	IN	O	O
cr-monitor	NN	B-TEST	O
to	TO	O	O
have	VB	O	O
premature	NN	B-PROBLEM	B-PROBLEM
ventricular	NN	I-PROBLEM	I-PROBLEM
contractions	NNS	I-PROBLEM	I-PROBLEM
which	WDT	O	O
resolved	VBD	O	O
spontaneously	RB	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
twelve	JJ	I-TEST	I-TEST
lead	NN	I-TEST	I-TEST
electrocardiogram	NN	I-TEST	I-TEST
was	VBD	O	O
recommended	VBN	O	O
if	IN	O	O
this	DT	O	O
persists	VBZ	O	O
.	.	O	O

no	DT	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

heart	NN	B-TEST	B-TEST
rates	NNS	I-TEST	I-TEST
140	CD	O	O
s	NN	O	O
to	TO	O	O
150	CD	O	O
s.	NN	O	O

mean	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
has	VBZ	O	O
been	VBN	O	O
46	CD	O	O
to	TO	O	O
54	CD	O	O
.	.	O	O

3.	CD	O	O
fluid	NN	O	B-TEST
,	,	O	I-TEST
electrolytes	NNS	O	I-TEST
and	CC	O	O
nutrition	NN	O	O
-	:	O	O
the	DT	O	O
infant	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
enteral	JJ	B-TREATMENT	B-TREATMENT
feedings	NNS	I-TREATMENT	I-TREATMENT
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
one	CD	O	O
and	CC	O	O
advanced	VBD	O	O
to	TO	O	O
full	JJ	B-TREATMENT	B-TREATMENT
volume	NN	I-TREATMENT	I-TREATMENT
feedings	NNS	I-TREATMENT	I-TREATMENT
by	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
four	CD	O	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
was	VBD	O	O
initially	RB	O	O
started	VBN	O	O
on	IN	O	O
80	CD	O	O
cc	NN	O	O
/	NNP	O	O
kg	NN	O	O
/	NNP	O	O
day	NN	O	O
of	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
fluid	NN	I-TREATMENT	I-TREATMENT
d10w	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
advanced	VBD	O	O
to	TO	O	O
150	CD	O	O
cc	NNS	O	O
/	JJ	O	O
kg	JJ	O	O
/	NNP	O	O
day	NN	O	O
by	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
four	CD	O	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
did	VBD	O	O
not	RB	O	O
receive	VB	O	O
parenteral	JJ	B-TREATMENT	B-TREATMENT
nutrition	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	B-TEST	B-TEST
most	RBS	I-TEST	I-TEST
recent	JJ	I-TEST	I-TEST
electrolytes	NNS	I-TEST	I-TEST
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
two	CD	O	O
showed	VBD	O	O
a	DT	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
of	IN	O	O
145	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
111	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
3.8	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
21	CD	O	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
is	VBZ	O	O
currently	RB	O	O
receiving	VBG	O	O
breast	NN	O	B-TREATMENT
milk	NN	O	I-TREATMENT
22	CD	O	O
calories	NNS	O	O
per	IN	O	O
ounce	NN	O	O
or	CC	O	O
premature	NN	O	B-PROBLEM
enfamil	VBP	O	O
22	CD	O	O
calories	NNS	O	O
per	IN	O	O
ounce	NN	O	O
,	,	O	O
150	CD	O	O
cc	NN	O	O
/	NNP	O	O
kg	NN	O	O
/	NNP	O	O
day	NN	O	O
p.o.	NN	O	O
and	CC	O	O
gavage	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	B-TEST	O
most	RBS	I-TEST	O
recent	JJ	I-TEST	O
weight	NN	I-TEST	O
today	NN	O	O
is	VBZ	O	O
1810	CD	O	O
grams	NN	O	O
which	WDT	O	O
was	VBD	O	O
no	DT	O	O
change	NN	O	O
from	IN	O	O
the	DT	O	O
previous	JJ	O	O
day	NN	O	O
.	.	O	O

4.	CD	O	O
gastrointestinal	JJ	O	O
-	:	O	O
the	DT	O	O
infant	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
single	JJ	B-TREATMENT	O
phototherapy	NN	I-TREATMENT	B-TREATMENT
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
two	CD	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
maximum	JJ	I-TEST	I-TEST
bilirubin	JJ	I-TEST	I-TEST
level	NN	I-TEST	I-TEST
of	IN	O	O
9.1	CD	O	O
with	IN	O	O
a	DT	B-TEST	O
direct	NN	I-TEST	O
of	IN	O	O
0.3	CD	O	O
.	.	O	O

phototherapy	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
five	CD	O	O
and	CC	O	O
the	DT	B-TEST	B-TEST
rebound	NN	I-TEST	I-TEST
bilirubin	VBD	I-TEST	I-TEST
level	NN	I-TEST	I-TEST
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
six	CD	O	O
is	VBZ	O	O
7.7	CD	O	O
with	IN	O	O
a	DT	B-TEST	O
direct	NN	I-TEST	O
of	IN	O	O
0.2	CD	O	O
.	.	O	O

5.	CD	O	O
hematology	NN	O	O
-	:	O	O
the	DT	B-TEST	O
most	RBS	I-TEST	O
recent	JJ	I-TEST	O
hematocrit	NN	I-TEST	B-TEST
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
two	CD	O	O
was	VBD	O	O
45.8%	CD	O	O
.	.	O	O

hematocrit	NN	B-TEST	B-TEST
on	IN	I-TEST	O
admission	NN	I-TEST	O
was	VBD	O	O
54.0%	CD	O	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
has	VBZ	O	O
not	RB	O	O
received	VBN	O	O
any	DT	B-TREATMENT	B-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
this	DT	O	I-TREATMENT
hospitalization	NN	O	I-TREATMENT
.	.	O	O

6.	CD	O	O
infectious	JJ	O	B-PROBLEM
disease	NN	O	I-PROBLEM
-	:	O	O
the	DT	O	O
infant	NN	O	O
received	VBD	O	O
48	CD	O	O
hours	NNS	O	O
of	IN	O	O
ampicillin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
rule	NN	O	O
out	IN	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
complete	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
on	IN	I-TEST	O
admission	NN	I-TEST	O
showed	VBD	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
8.0	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
54.0%	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
190,000	CD	O	O
,	,	O	O
11	CD	O	O

neutrophils	NNS	B-TEST	B-TEST
,	,	O	O
0	CD	O	O
bands	NNS	B-TEST	B-TEST
.	.	O	O

a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
complete	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
two	CD	O	O
showed	VBD	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
6.3	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
45.8%	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
199,000	CD	O	O
,	,	O	O
37	CD	O	O
neutrophils	NNS	B-TEST	B-TEST
,	,	O	O
0	CD	O	O
bands	NNS	B-TEST	B-TEST
,	,	O	O
53	CD	O	O
lymphocytes	NNS	B-TEST	B-TEST
.	.	O	O

blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
remained	VBD	O	O
negative	JJ	O	O
to	TO	O	O
date	NN	O	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
does	VBZ	O	O
not	RB	O	O
meet	VB	O	O
criteria	NNS	O	O
for	IN	O	O
head	NN	B-TEST	B-TEST
ultrasound	NN	I-TEST	I-TEST
.	.	O	O

8.	CD	O	O
sensory	JJ	O	B-TEST
-	:	O	I-TEST
hearing	NN	B-TEST	I-TEST
screening	NN	I-TEST	I-TEST
is	VBZ	O	O
recommended	VBN	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

the	DT	O	O
infants	NNS	O	O
are	VBP	O	O
legally	RB	O	O
under	IN	O	O
the	DT	O	O
parents	NNS	O	O
'	POS	O	O
names	NNS	O	O
and	CC	O	O
they	PRP	O	O
are	VBP	O	O
involved	VBN	O	O
with	IN	O	O
the	DT	B-TREATMENT	O
infant	NN	I-TREATMENT	O
's	POS	I-TREATMENT	O
care	NN	I-TREATMENT	O
.	.	O	O

car	NN	B-TEST	B-TEST
seat	NN	I-TEST	I-TEST
position	NN	I-TEST	I-TEST
screening	NN	I-TEST	I-TEST
:	:	O	O

state	NN	B-TEST	O
newborn	JJ	I-TEST	O
screen	NN	I-TEST	O
:	:	O	O

screens	NNS	B-TEST	O
have	VBP	O	O
been	VBN	O	O
sent	VBN	O	O
and	CC	O	O
results	NNS	O	O
are	VBP	O	O
pending	VBG	O	O
.	.	O	O

immunizations	NNS	B-TREATMENT	O
:	:	O	O

the	DT	O	O
infant	NN	O	O
has	VBZ	O	O
not	RB	O	O
received	VBN	O	O
any	DT	B-TREATMENT	B-TREATMENT
immunizations	NNS	I-TREATMENT	I-TREATMENT
this	DT	O	I-TREATMENT
hospitalization	NN	O	I-TREATMENT
.	.	O	O

synagis	NN	B-TREATMENT	B-TREATMENT
rsv	NN	I-TREATMENT	I-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
should	MD	O	O
be	VB	O	O
considered	VBN	O	O
from	IN	O	O
october	VBN	O	O
through	IN	O	O
april	NN	O	O
for	IN	O	O
infants	NNS	O	O
who	WP	O	O
meet	VBP	O	O
any	DT	O	O
of	IN	O	O
the	DT	O	O
following	JJ	O	O
three	CD	O	O
criteria	NNS	O	O
:	:	O	O

c.	NN	O	B-PROBLEM
neuromuscular	JJ	B-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O

d.	NN	O	O
airway	NN	B-PROBLEM	B-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
or	CC	O	O

3.	CD	O	O
with	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
prematurity	NN	B-PROBLEM	B-PROBLEM
32	CD	I-PROBLEM	O
and	CC	I-PROBLEM	O
4/7	CD	I-PROBLEM	O
weeks	NNS	I-PROBLEM	O
,	,	O	O
twin	JJ	O	O
#1	NN	O	O
.	.	O	O

2.	CD	O	O
rule	NN	O	O
out	IN	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
ruled	VBD	O	O
out	RP	O	O
.	.	O	O

3.	CD	O	O
apnea	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
prematurity	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
indirect	JJ	B-PROBLEM	B-PROBLEM
hyperbilirubinemia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pelvic	JJ	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM

pelvic	JJ	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
benign	JJ	B-PROBLEM	B-PROBLEM
mucinous	JJ	I-PROBLEM	I-PROBLEM
cystadenoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

total	JJ	B-TREATMENT	B-TREATMENT
abdominal	JJ	I-TREATMENT	I-TREATMENT
hysterectomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	I-TREATMENT
right	JJ	B-TREATMENT	I-TREATMENT
lymph	NN	I-TREATMENT	I-TREATMENT
node	JJ	I-TREATMENT	I-TREATMENT
dissection	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
appendectomy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
omental	JJ	B-TEST	B-TEST
biopsy	NN	I-TEST	I-TEST
,	,	O	O
and	CC	O	O
pelvic	JJ	B-TREATMENT	B-PROBLEM
washings	NNS	I-TREATMENT	I-PROBLEM
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
56-year-old	JJ	O	O
menopausal	NN	O	O
female	JJ	O	O
g3	NN	O	O
,	,	O	O
p3	NN	O	O
who	WP	O	O
presented	VBD	O	O
initially	RB	O	O
for	IN	O	O
evaluation	NN	B-TEST	B-TEST
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
pelvic	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
while	IN	O	O
recently	RB	O	O
vacationing	VBG	O	O
in	IN	O	O
an	DT	O	O
saintcafield	NN	O	O
terland	NN	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	O
physical	JJ	I-TEST	O
over	IN	O	O
there	RB	O	O
,	,	O	O
and	CC	O	O
the	DT	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
included	VBD	O	O
an	DT	B-TEST	B-TEST
ultrasound	NN	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
ovarian	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
seen	VBN	O	O
in	IN	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
here	RB	O	O
on	IN	O	O
08/31/04	CD	O	O
where	WRB	O	O
they	PRP	O	O
performed	VBD	O	O
an	DT	B-TEST	B-TEST
abdominal	JJ	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
that	WDT	O	O
showed	VBD	O	O
a	DT	B-PROBLEM	O
14	CD	I-PROBLEM	O
x	NN	I-PROBLEM	O
14	CD	I-PROBLEM	O
x	JJ	I-PROBLEM	O
10	CD	I-PROBLEM	O
cm	JJ	I-PROBLEM	B-PROBLEM
pelvic	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
enlarged	JJ	I-PROBLEM	I-PROBLEM
lymph	NN	I-PROBLEM	I-PROBLEM
nodes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
thus	RB	O	O
sent	VBN	O	O
to	TO	O	O
gyn	VB	O	O
for	IN	O	O
further	JJ	B-TEST	B-TEST
workup	NN	I-TEST	I-TEST
and	CC	O	O
is	VBZ	O	O
now	RB	O	O
here	RB	O	O
for	IN	O	O
surgical	JJ	B-TREATMENT	B-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
pelvic	JJ	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
ca-125	NN	I-TEST	I-TEST
is	VBZ	O	O
9	CD	O	O
.	.	O	O

tubal	JJ	B-TREATMENT	B-TREATMENT
ligation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

g3	NN	O	O
,	,	O	O
p3	NN	O	O
,	,	O	O
spontaneous	JJ	B-TREATMENT	B-TREATMENT
vaginal	JJ	I-TREATMENT	I-TREATMENT
delivery	NN	I-TREATMENT	I-TREATMENT
x3	NN	O	O
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
history	NN	O	O
of	IN	O	O
gyn	NN	B-PROBLEM	O
,	,	O	O
cancers	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
breast	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
#	#	O	O
1	CD	O	O
where	WRB	O	O
she	PRP	O	O
underwent	VBD	O	O
an	DT	B-TREATMENT	B-TREATMENT
uncomplicated	JJ	I-TREATMENT	I-TREATMENT
total	JJ	I-TREATMENT	I-TREATMENT
abdominal	JJ	I-TREATMENT	I-TREATMENT
hysterectomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	I-TREATMENT
right	JJ	B-TREATMENT	I-TREATMENT
lymph	NN	I-TREATMENT	I-TREATMENT
node	JJ	I-TREATMENT	I-TREATMENT
dissection	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
appendectomy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
omental	JJ	B-TEST	B-TEST
biopsy	NN	I-TEST	I-TEST
,	,	O	O
pelvic	JJ	B-TREATMENT	B-PROBLEM
washings	NNS	I-TREATMENT	I-PROBLEM
,	,	O	O
and	CC	O	O
pap	NN	B-TREATMENT	B-TEST
of	IN	I-TREATMENT	I-TEST
the	DT	I-TREATMENT	I-TEST
diaphragm	NN	I-TREATMENT	I-TEST
.	.	O	O

an	DT	B-PROBLEM	B-PROBLEM
estimated	VBN	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
100	CD	O	O
cc	NN	O	O
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
frozen	JJ	B-TEST	B-TEST
section	NN	I-TEST	I-TEST
revealed	VBD	O	O
benign	RB	B-PROBLEM	B-PROBLEM
mucinous	JJ	I-PROBLEM	I-PROBLEM
cystadenoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

by	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#3	NNP	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
tolerating	VBG	O	O
p.o.&apos;	NN	O	O
s	NN	O	O
,	,	O	O
tolerating	VBG	O	O
oral	JJ	B-TREATMENT	B-TREATMENT
pain	NN	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
ambulating	VBG	O	O
,	,	O	O
passing	VBG	O	B-PROBLEM
flatus	NN	O	I-PROBLEM
,	,	O	O
and	CC	O	O
having	VBG	O	O
a	DT	O	O
bowel	NN	O	O
movement	NN	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
preoperatively	RB	O	O
was	VBD	O	O
36	CD	O	O
and	CC	O	O
postoperatively	RB	O	O
was	VBD	O	O
33	CD	O	O
and	CC	O	O
then	RB	O	O
32	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
did	VBD	O	O
have	VB	O	O
some	DT	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
postoperatively	RB	I-PROBLEM	O
;	:	O	O
however	RB	O	O
,	,	O	O
her	PRP	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
remained	VBD	O	O
stable	JJ	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
asymptomatic	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
ekg	NN	I-TEST	I-TEST
was	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

her	PRP$	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
improved	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
discharged	VBN	O	O
home	NN	O	O
in	IN	O	O
stable	JJ	O	O
condition	NN	O	O
with	IN	O	O
prescriptions	NNS	O	B-TREATMENT
for	IN	O	O
colace	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
motrin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
as	IN	O	O
needed	VBN	O	O
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
58	JJ	O	O
-	:	O	O
year-old	JJ	O	O
woman	NN	O	O
who	WP	O	O
was	VBD	O	O
transferred	VBN	O	O
from	IN	O	O
shaugnessy-kaplan	JJ	O	O
rehab	NN	O	O
hospital	NN	O	O
hospital	NN	O	O
for	IN	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	O	O
long	JJ	O	O
history	NN	O	O
of	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
tobacco	NN	O	O
abuse	NN	O	O
,	,	O	O
and	CC	O	O
family	NN	O	O
history	NN	O	O
of	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
who	WP	O	O
was	VBD	O	O
in	IN	O	O
the	DT	O	O
usual	JJ	O	O
state	NN	O	O
of	IN	O	O
health	NN	O	O
until	IN	O	O
saturday	JJ	O	O
previous	JJ	O	O
to	TO	O	O
admission	NN	O	O
when	WRB	O	O
she	PRP	O	O
experienced	VBD	O	O
bilateral	JJ	B-PROBLEM	O
arm	NN	I-PROBLEM	O
and	CC	I-PROBLEM	O
chest	JJS	I-PROBLEM	B-PROBLEM
discomfort	NN	I-PROBLEM	I-PROBLEM
while	IN	O	O
carrying	VBG	O	O
groceries	NNS	O	B-TREATMENT
.	.	O	O

her	PRP$	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
resolved	VBN	O	O
with	IN	O	O
rest	NN	B-TREATMENT	O
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
same	JJ	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
occurred	VBD	O	O
again	RB	O	O
the	DT	O	O
same	JJ	O	O
evening	NN	O	O
with	IN	O	O
exertion	NN	O	O
and	CC	O	O
then	RB	O	O
were	VBD	O	O
again	RB	O	O
relieved	VBN	O	O
with	IN	O	O
rest	NN	B-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
presented	VBD	O	O
to	TO	O	O
the	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
emergency	NN	O	O
room	NN	O	O
where	WRB	O	O
she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
lovenox	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
beta	NN	B-TREATMENT	B-TREATMENT
blocker	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
ruled	VBD	O	O
out	RP	O	O
for	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
by	IN	O	O
cpk	NN	B-TEST	O
and	CC	O	O
troponin	NN	B-TEST	B-TEST
and	CC	O	O
had	VBD	O	O
non	VBN	B-PROBLEM	B-PROBLEM
diagnostic	JJ	I-PROBLEM	I-PROBLEM
ekg	NN	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
being	VBG	O	O
transferred	VBN	O	O
to	TO	O	O
arbour-fuller	JJ	O	O
hospital	NN	O	O
for	IN	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
.	.	O	O

results	NNS	O	O
of	IN	O	O
the	DT	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
indicated	VBD	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
three	CD	B-PROBLEM	B-PROBLEM
vessel	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
a	DT	O	O
candidate	NN	O	O
for	IN	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

her	PRP$	O	O
risk	NN	O	O
factors	NNS	O	O
:	:	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
tobacco	NN	O	O
abuse	NN	O	O
(	(	O	O
one	CD	O	O
pack	NN	O	O
per	IN	O	O
day	NN	O	O
times	NNS	O	O
45	CD	O	O
years	NNS	O	O
),	JJ	O	O
family	NN	O	O
history	NN	O	O
(	(	O	O
father	NN	O	O
diagnosed	VBN	O	O
with	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
his	PRP$	O	O
50	CD	O	O
's,	POS	O	O
patient	NN	O	O
's	POS	O	O
mother	NN	O	O
had	VBD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
patient	NN	O	O
's	POS	O	O
brother	NN	O	O
has	VBZ	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
).	NN	O	O

hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
(	(	O	O
total	JJ	B-TEST	B-TEST
cholesterol	NN	I-TEST	I-TEST
on	IN	O	O
admission	NN	O	O
300	CD	O	O
's	POS	O	O
several	JJ	O	O
years	NNS	O	O
ago	RB	O	O
).	VBD	O	O

the	DT	O	O
patient	JJ	O	O
denies	VBZ	O	O
any	DT	O	O
history	NN	O	O
of	IN	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

status	NN	O	O
post	NN	O	O
cva	NN	B-PROBLEM	O
times	NNS	O	O
two	CD	O	O
in	IN	O	O
2010	CD	O	O
,	,	O	O
arthritis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
remote	NN	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
remote	NN	B-PROBLEM	B-PROBLEM
pleurisy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
psoriasis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

status	NN	O	O
post	NN	O	O
tubal	JJ	B-TREATMENT	B-TREATMENT
ligation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

at	IN	O	O
home	NN	O	O
,	,	O	O
aggrenox	RB	B-TREATMENT	B-TREATMENT
250	CD	O	O
mg	NNS	O	O
po	JJ	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

sulfa	NN	B-TREATMENT	B-TREATMENT
causes	VBZ	O	O
rash	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
a	DT	O	O
son	NN	O	O
who	WP	O	O
is	VBZ	O	O
mentally	RB	B-PROBLEM	B-PROBLEM
handicapped	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
admission	NN	O	B-TEST
vital	JJ	B-TEST	I-TEST
signs	NNS	I-TEST	I-TEST
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
71	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
134/75	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
20	CD	O	O
.	.	O	O

neck	NN	O	O
,	,	O	O
no	DT	O	O
jugulovenous	JJ	B-PROBLEM	B-PROBLEM
distension	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
carotids	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
bruit	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	O
either	CC	I-PROBLEM	O
right	JJ	I-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
carotid	NN	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

lungs	NNS	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	O	O
.	.	O	O

heart	NN	O	O
,	,	O	O
s1	NN	B-TEST	O
and	CC	O	O
s2	NN	B-TEST	O
appreciated	VBD	O	O
,	,	O	O
no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
rubs	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
gallops	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

abdomen	NNS	O	O
soft	JJ	O	O
,	,	O	O
non	RB	B-PROBLEM	B-PROBLEM
distended	VBD	I-PROBLEM	I-PROBLEM
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
ecchymosis	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
mid	JJ	I-PROBLEM	I-PROBLEM
abdomen	NNS	I-PROBLEM	I-PROBLEM
,	,	O	I-PROBLEM
left	VBD	O	I-PROBLEM
of	IN	O	I-PROBLEM
midline	NN	O	I-PROBLEM
,	,	O	O
likely	RB	O	O
secondary	JJ	O	O
to	TO	O	O
lovenox	VB	B-TREATMENT	B-TREATMENT
injections	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

extremities	NNS	O	O
,	,	O	O
no	DT	O	O
bruit	NN	B-PROBLEM	B-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
or	CC	I-PROBLEM	O
right	JJ	I-PROBLEM	B-PROBLEM
femoral	JJ	I-PROBLEM	I-PROBLEM
arteries	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

dp	NN	B-TEST	O
and	CC	I-TEST	O
pt	NN	I-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
are	VBP	O	O
2+	CD	O	O
bilaterally	RB	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
pedal	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
there	EX	O	O
is	VBZ	O	O
evidence	NN	O	O
of	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
psoriasis	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremities	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
right	RB	O	O
greater	JJR	O	O
than	IN	O	O
left	NN	O	O
.	.	O	O

cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
performed	VBN	O	O
on	IN	O	O
2013-01-03	JJ	O	O
:	:	O	O
three	CD	B-PROBLEM	B-PROBLEM
vessel	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
dominant	NN	I-PROBLEM	I-PROBLEM
system	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

left	VBN	O	O
main	JJ	O	O
coronary	JJ	O	O
artery	NN	O	O
with	IN	O	O
short	JJ	O	B-PROBLEM
vessel	NN	O	I-PROBLEM
without	IN	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	O
lad	NN	I-PROBLEM	O
diffusely	RB	I-PROBLEM	O
diseased	VBD	I-PROBLEM	O
proximal	JJ	I-PROBLEM	O
section	NN	I-PROBLEM	O
up	RB	O	O
to	TO	O	O
50%	CD	O	O
with	IN	O	O
focal	JJ	O	B-PROBLEM
70%	CD	B-PROBLEM	I-PROBLEM
mid	NN	I-PROBLEM	I-PROBLEM
segment	NN	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

d1	NN	O	O
was	VBD	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
diseased	VBN	I-PROBLEM	I-PROBLEM
diffusely	RB	I-PROBLEM	I-PROBLEM
.	.	O	O

left	VBN	O	O
circumflex	NN	O	O
had	VBD	O	O
80%	CD	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
a	DT	I-PROBLEM	O
large	JJ	I-PROBLEM	O
om1	NN	I-PROBLEM	O
branch	NN	I-PROBLEM	O
.	.	O	O

the	DT	O	O
right	JJ	O	O
coronary	JJ	O	O
artery	NN	O	O
was	VBD	O	O
diffusely	RB	B-PROBLEM	B-PROBLEM
diseased	VBN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
mid	NN	I-PROBLEM	I-PROBLEM
segment	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
serial	JJ	B-PROBLEM	B-PROBLEM
80-90%	JJ	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

limited	JJ	B-TEST	O
hemodynamics	NNS	I-TEST	O
showed	VBD	O	O
elevated	JJ	B-PROBLEM	B-PROBLEM
lv	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
diastolic	JJ	I-PROBLEM	B-TEST
pressure	NN	I-PROBLEM	I-TEST
(	(	O	O
21	CD	O	O
mmhg	NN	O	O
).	NN	O	O

left	VBN	B-TEST	O
ventriculogram	NN	I-TEST	O
demonstrates	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
mild	JJ	I-PROBLEM	I-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
left	VBD	B-TEST	B-TEST
ventricular	JJ	I-TEST	I-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
58%	CD	O	O
with	IN	O	O
normal	JJ	O	O
regional	JJ	B-TEST	O
wall	NN	I-TEST	O
motion	NN	I-TEST	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
edith	VB	O	O
nourse	JJ	O	O
rogers	NNS	O	O
memorial	JJ	O	O
va	JJ	O	O
hospital	NN	O	O
and	CC	O	O
brought	VBD	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
on	IN	O	O
2013-01-04	JJ	O	O
by	IN	O	O
dr.	JJ	O	O
van	NN	O	O
der	NN	O	O
talbot	NN	O	O
where	WRB	O	O
she	PRP	O	O
received	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
times	NNS	O	O
three	CD	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
an	DT	B-TREATMENT	B-TREATMENT
anastomosis	NN	I-TREATMENT	I-TREATMENT
between	IN	I-TREATMENT	O
the	DT	I-TREATMENT	O
left	JJ	I-TREATMENT	O
internal	JJ	I-TREATMENT	O
mammary	JJ	I-TREATMENT	O
artery	NN	I-TREATMENT	O
and	CC	I-TREATMENT	O
the	DT	I-TREATMENT	O
left	JJ	I-TREATMENT	O
anterior	JJ	I-TREATMENT	O
descending	VBG	I-TREATMENT	O
artery	NN	I-TREATMENT	O
,	,	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	O
rca	VB	I-TREATMENT	O
,	,	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	O
om	VB	I-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
and	CC	O	O
was	VBD	O	O
transported	VBN	O	O
to	TO	O	O
the	DT	O	O
cardiac	NN	O	O
surgery	NN	O	O
recovery	NN	O	O
room	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
extubated	VBN	O	O
on	IN	O	O
arrival	NN	O	O
in	IN	O	O
the	DT	O	O
cardiac	NN	O	O
surgery	NN	O	O
recovery	NN	O	O
room	NN	O	O
but	CC	O	O
was	VBD	O	O
on	IN	O	O
no	DT	O	O
drips	NNS	B-TREATMENT	B-PROBLEM
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#2	VBD	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
foley	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
chest	JJS	B-TREATMENT	B-TREATMENT
tubes	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
discontinued	VBN	O	O
.	.	O	O

by	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#3	NNP	O	O
she	PRP	O	O
began	VBD	O	O
ambulating	VBG	O	O
with	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
great	JJ	I-PROBLEM	I-PROBLEM
hesitancy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

foley	NN	B-TREATMENT	B-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
removed	VBN	O	O
.	.	O	O

by	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#5	IN	O	O
she	PRP	O	O
was	VBD	O	O
ambulating	VBG	O	O
at	IN	O	O
level	NN	O	O
iv	NN	O	O
,	,	O	O
was	VBD	O	O
tolerating	VBG	O	O
po	NN	O	O
,	,	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
void	VB	O	O
and	CC	O	O
felt	VB	O	O
comfortable	JJ	O	O
to	TO	O	O
go	VB	O	O
to	TO	O	O
rehab	VB	B-TREATMENT	O
.	.	O	O

1.	CD	O	O
status	NN	O	O
post	NN	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
times	NNS	O	O
three	CD	O	O
on	IN	O	O
2013-01-04	JJ	O	O
.	.	O	O

toprol	NN	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
po	NN	O	O
bid	NN	O	O
,	,	O	O
furosemide	RB	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	JJ	O	O
po	NN	O	O
bid	NN	O	O
times	NNS	O	O
one	CD	O	O
week	NN	O	O
,	,	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
20	CD	O	O
meq	NN	O	O
po	NNS	O	O
bid	VBP	O	O
while	IN	O	O
on	IN	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
po	NNS	O	O
bid	VBP	O	O
while	IN	O	O
on	IN	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
enteric	RB	B-TREATMENT	B-TREATMENT
coated	VBD	I-TREATMENT	I-TREATMENT
aspirin	JJ	I-TREATMENT	I-TREATMENT
325	CD	O	O
mg	NN	O	O
po	NN	O	O
q	JJ	O	O
day	NN	O	O
,	,	O	O
indocin	VB	B-TREATMENT	O
25	CD	O	O
mg	JJ	O	O
po	NN	O	O
bid	NN	O	O
,	,	O	O
sarna	JJ	B-TREATMENT	B-TREATMENT
cream	NN	I-TREATMENT	I-TREATMENT
applied	VBD	O	O
to	TO	O	O
affected	JJ	O	O
area	NN	O	O
prn	NN	O	O
,	,	O	O
percocet	JJ	B-TREATMENT	B-TREATMENT
1-2	JJ	O	O
tabs	NN	O	O
po	NN	O	O
q	VBD	O	O
4-6	JJ	O	O
hours	NNS	O	O
prn	NN	O	O
,	,	O	O
ibuprofen	JJ	B-TREATMENT	B-TREATMENT
400	CD	O	O
mg	NN	O	O
po	NN	O	O
q	VBD	O	O
6	CD	O	O
hours	NNS	O	O
prn	RB	O	O
,	,	O	O
tylenol	VBD	B-TREATMENT	B-TREATMENT
650	CD	O	O
mg	NN	O	O
po	NN	O	O
q	VBD	O	O
4-6	JJ	O	O
hours	NNS	O	O
prn	NN	O	O
,	,	O	O
ativan	RB	B-TREATMENT	B-TREATMENT
0.5	CD	O	O
mg	NNS	O	O
po	JJ	O	O
q	RB	O	O
8	CD	O	O
hours	NNS	O	O
prn	NN	O	O
.	.	O	O

right	RB	B-PROBLEM	B-PROBLEM
middle	JJ	I-PROBLEM	I-PROBLEM
cerebral	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
infarct	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

right	RB	B-PROBLEM	B-PROBLEM
middle	JJ	I-PROBLEM	I-PROBLEM
cerebral	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
infarct	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

urinary	JJ	B-PROBLEM	B-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

urinary	JJ	B-PROBLEM	B-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
e.	JJ	B-PROBLEM	B-PROBLEM
coli	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

mri	NN	B-TEST	O
/	NNP	O	O
mra	NN	B-TEST	O
.	.	O	O

echocardiogram	NN	B-TEST	B-TEST
,	,	O	I-TEST
neurovascular	JJ	B-TEST	I-TEST
ultrasound	NN	I-TEST	I-TEST
.	.	O	O

patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
73-year-old	JJ	O	O
retired	JJ	O	O
cook	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
cervical	JJ	B-PROBLEM	B-PROBLEM
myelopathy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
who	WP	O	O
is	VBZ	O	O
admitted	VBN	O	O
for	IN	O	O
new	JJ	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
hemiparesis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
undergone	JJ	O	B-TREATMENT
c-spine	JJ	B-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
spinal	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	O	O
question	NN	O	O
of	IN	O	O
myelopathy	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
radiculopathy	NN	B-PROBLEM	B-PROBLEM
in	IN	O	O
1992	CD	O	O
with	IN	O	O
residual	JJ	B-PROBLEM	B-PROBLEM
spastic	JJ	I-PROBLEM	I-PROBLEM
paresis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
monoparesis	NN	B-PROBLEM	B-TREATMENT
of	IN	I-PROBLEM	I-TREATMENT
the	DT	I-PROBLEM	I-TREATMENT
left	JJ	I-PROBLEM	I-TREATMENT
upper	JJ	I-PROBLEM	I-TREATMENT
extremity	NN	I-PROBLEM	I-TREATMENT
,	,	O	O
but	CC	O	O
was	VBD	O	O
ambulatory	JJ	O	O
until	IN	O	O
a	DT	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
.	.	O	O

he	PRP	O	O
also	RB	O	O
at	IN	O	O
baseline	NN	O	O
has	VBZ	O	O
had	VBN	O	O
urinary	JJ	B-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
fecal	JJ	I-PROBLEM	I-PROBLEM
urgencies	NNS	I-PROBLEM	I-PROBLEM
/	VBP	O	O
incontinence	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

his	PRP$	O	O
history	NN	O	O
is	VBZ	O	O
now	RB	O	O
that	IN	O	O
he	PRP	O	O
has	VBZ	O	O
had	VBD	O	O
a	DT	O	O
week	NN	O	O
of	IN	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
left	VBN	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
to	TO	O	O
the	DT	O	O
point	NN	O	O
of	IN	O	O
being	VBG	O	O
unable	JJ	O	O
to	TO	O	O
move	VB	O	O
the	DT	O	O
left	JJ	O	O
hand	NN	O	O
and	CC	O	O
one	CD	O	O
day	NN	O	O
of	IN	O	O
being	VBG	O	O
unable	JJ	O	O
to	TO	O	O
walk	VB	O	O
secondary	JJ	O	O
to	TO	O	O
left	VB	B-PROBLEM	B-PROBLEM
leg	JJ	I-PROBLEM	I-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	O	B-PROBLEM
marked	JJ	O	I-PROBLEM
tendency	NN	O	I-PROBLEM
to	TO	O	I-PROBLEM
fall	VB	O	I-PROBLEM
leftward	NN	O	I-PROBLEM
.	.	O	O

notable	JJ	O	O
for	IN	O	O
anemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
narcolepsy	NN	B-PROBLEM	B-PROBLEM
for	IN	O	O
the	DT	O	O
past	JJ	O	O
6	CD	O	O
years	NNS	O	O
on	IN	O	O
dexedrine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
impotence	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
decreased	JJ	B-PROBLEM	B-PROBLEM
testosterone	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	B-TREATMENT
post	NN	O	I-TREATMENT
implant	NN	B-TREATMENT	I-TREATMENT
,	,	O	O
peptic	JJ	B-PROBLEM	B-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
duodenal	JJ	B-TREATMENT	B-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
cervical	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
decompression	NN	B-TREATMENT	B-TREATMENT
&apos;92	NNP	O	I-TREATMENT
,	,	O	O
hernia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
herniorrhaphy	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

medications	NNS	B-TREATMENT	B-TREATMENT
on	IN	O	O
admission	NN	O	O
:	:	O	O

dexedrine	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
per	IN	O	O
day	NN	O	O
and	CC	O	O
motrin	$	B-TREATMENT	B-TREATMENT
600	CD	O	O
mg	NN	O	O
tid	NN	O	O
.	.	O	O

physical	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
:	:	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
older	JJR	O	O
,	,	O	O
black	JJ	O	O
gentleman	NN	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
left	JJ	B-TEST	B-PROBLEM
upper	JJ	I-TEST	I-PROBLEM
extremity	NN	I-TEST	I-PROBLEM
flex	NN	I-TEST	I-PROBLEM
across	IN	O	I-PROBLEM
his	PRP$	O	I-PROBLEM
chest	NN	O	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	O
temperatureis	NN	I-TEST	O
98.9	CD	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
is	VBZ	O	O
150/90	CD	O	O
.	.	O	O

rate	NN	B-TEST	B-TEST
76	CD	O	O
.	.	O	O

respirations	NNS	B-TEST	B-TEST
16	CD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
edentulous	JJ	B-PROBLEM	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
mild	VBN	B-PROBLEM	B-PROBLEM
copper	NN	I-PROBLEM	I-PROBLEM
wiring	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
i	JJ	I-PROBLEM	I-PROBLEM
/	NN	I-PROBLEM	I-PROBLEM
vi	NN	I-PROBLEM	I-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
sternal	JJ	I-PROBLEM	I-PROBLEM
border	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

heart	NN	B-TEST	B-TEST
sounds	VBZ	I-TEST	I-TEST
were	VBD	O	O
normal	JJ	O	O
and	CC	O	O
regular	JJ	O	O
.	.	O	O

breath	NN	B-TEST	B-TEST
sounds	NNS	I-TEST	I-TEST
were	VBD	O	O
equal	JJ	O	O
bilaterally	RB	O	O
with	IN	O	O
course	NN	B-PROBLEM	O
rhonchi	NN	I-PROBLEM	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
midline	JJ	I-PROBLEM	I-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
scar	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
reducible	JJ	I-PROBLEM	I-PROBLEM
umbilical	JJ	I-PROBLEM	I-PROBLEM
hernia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

abdomen	NNS	O	O
was	VBD	O	O
otherwise	RB	O	O
soft	JJ	O	O
and	CC	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
2+	CD	B-TEST	B-PROBLEM
carotids	NNS	I-TEST	I-PROBLEM
,	,	O	O
no	DT	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
gynecomastia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1+	CD	B-TEST	O
right	JJ	I-TEST	O
posterior	NN	I-TEST	O
tibialis	NNS	I-TEST	O
,	,	O	O
2+	CD	B-TEST	B-PROBLEM
left	VBD	I-TEST	I-PROBLEM
posterior	JJ	I-TEST	I-PROBLEM
tibialis	NNS	I-TEST	I-PROBLEM
,	,	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
ichthyotic	JJ	B-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
were	VBD	O	O
present	JJ	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
hip	NN	I-TEST	I-TEST
flexion	NN	I-TEST	I-TEST
was	VBD	O	O
4+	CD	O	O
on	IN	O	O
the	DT	O	O
right	NN	O	O
and	CC	O	O
4-	JJ	O	O
on	IN	O	O
the	DT	O	O
left	NN	O	O
;	:	O	O
extension	NN	B-TEST	B-TEST
5	CD	O	O
on	IN	O	O
the	DT	O	O
right	NN	O	O
,	,	O	O
4+	CD	O	O
on	IN	O	O
the	DT	O	O
left	NN	O	O
;	:	O	O
knee	CC	B-TEST	O
flexion	NN	I-TEST	B-TEST
evidently	RB	O	O
trace	VBZ	O	O
on	IN	O	O
the	DT	O	O
right	NN	O	O
and	CC	O	O
4-	JJ	O	O
on	IN	O	O
the	DT	O	O
left	NN	O	O
with	IN	O	O
knee	JJ	B-TEST	B-PROBLEM
extension	NN	I-TEST	I-PROBLEM
5-	NN	O	I-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	NN	O	I-PROBLEM
,	,	O	O
5	CD	O	O
on	IN	O	O
the	DT	O	O
right	NN	O	O
;	:	O	O
knee	VB	B-TEST	B-TEST
flexion	NN	I-TEST	I-TEST
4-	CD	O	O
on	IN	O	O
the	DT	O	O
left	NN	O	O
,	,	O	O
trace	NN	O	B-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
right	NN	O	I-PROBLEM
;	:	O	O
ankle	CC	B-TEST	O
dorsi	VB	I-TEST	B-TEST
flexion	NN	I-TEST	I-TEST
4-	CD	O	O
on	IN	O	O
the	DT	O	O
left	NN	O	O
,	,	O	O
trace	NN	O	B-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
right	NN	O	I-PROBLEM
.	.	O	O

reflexes	NNS	B-TEST	B-TEST
4+	CD	O	O
overall	JJ	O	O
in	IN	O	O
the	DT	O	O
upper	JJ	O	O
extremities	NNS	O	O
and	CC	O	O
3+	CD	O	O
overall	JJ	O	O
in	IN	O	O
the	DT	O	O
lower	JJR	O	O
extremities	NNS	O	O
,	,	O	O
an	DT	O	B-PROBLEM
upgoing	JJ	O	I-PROBLEM
left	NN	O	I-PROBLEM
toe	NN	O	I-PROBLEM
and	CC	O	O
a	DT	O	O
down	RP	O	O
going	VBG	O	O
right	JJ	O	O
toe	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
perseverative	JJ	I-PROBLEM	I-PROBLEM
and	CC	O	O
inattentive	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

laboratory	NN	B-TEST	O
data	NNS	I-TEST	O
:	:	O	O

sodium	NN	B-TEST	B-TEST
141	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
3.6	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
14	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
1.1	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
37%	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
177	CD	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
4.1	CD	O	O
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
showed	VBD	O	O
degenerative	JJ	B-PROBLEM	B-PROBLEM
joint	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
an	DT	B-PROBLEM	O
ill	NN	I-PROBLEM	O
defined	VBD	I-PROBLEM	O
left	VBD	I-PROBLEM	O
hemi-diaphragm	NN	I-PROBLEM	O
without	IN	O	O
air	NN	B-PROBLEM	B-PROBLEM
space	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
the	DT	O	O
lateral	JJ	O	O
view	NN	O	O
,	,	O	O
surgical	JJ	B-TREATMENT	B-TREATMENT
clips	NNS	I-TREATMENT	I-TREATMENT
in	IN	I-TREATMENT	O
the	DT	I-TREATMENT	O
abdomen	NNS	I-TREATMENT	O
.	.	O	O

ekg	RB	B-TEST	O
showed	VBD	O	O
normal	JJ	O	O
sinus	NN	O	O
rhythm	NN	O	O
,	,	O	O
no	DT	O	O
st	NN	B-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	I-PROBLEM
t	NN	I-PROBLEM	I-PROBLEM
wave	NN	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

hospital	NN	O	O
course	NN	O	O
and	CC	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
:	:	O	O

mr.	NN	O	O
finger	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
what	WP	O	O
appeared	VBD	O	O
to	TO	O	O
be	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
stroke	JJ	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
involving	VBG	O	I-PROBLEM
his	PRP$	O	I-PROBLEM
left	JJ	O	I-PROBLEM
middle	JJ	O	I-PROBLEM
cerebral	JJ	O	I-PROBLEM
artery	NN	O	I-PROBLEM
territory	NN	O	I-PROBLEM
.	.	O	O

he	PRP	O	O
underwent	VBD	O	O
neurovascular	JJ	B-TEST	B-TEST
doppler	NN	I-TEST	I-TEST
studies	NNS	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
no	DT	O	O
significant	JJ	O	B-PROBLEM
change	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
either	DT	O	I-PROBLEM
common	JJ	O	I-PROBLEM
carotid	NN	O	I-PROBLEM
or	CC	O	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	JJ	O	I-PROBLEM
common	JJ	O	I-PROBLEM
internal	JJ	O	I-PROBLEM
ophthalmic	JJ	O	I-PROBLEM
system	NN	O	I-PROBLEM
.	.	O	O

however	RB	O	O
,	,	O	O
there	EX	O	O
were	VBD	O	O
hemodynamic	JJ	B-PROBLEM	B-TEST
changes	NNS	I-PROBLEM	I-TEST
which	WDT	O	O
raised	VBD	O	O
the	DT	O	O
question	NN	O	O
of	IN	O	O
right	JJ	B-PROBLEM	B-PROBLEM
siphon	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

transcranial	JJ	B-TEST	B-TEST
dopplers	NNS	I-TEST	I-TEST
showed	VBD	O	O
no	DT	O	O
abnormalities	NNS	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
ophthalmic	JJ	I-PROBLEM	I-PROBLEM
siphon	NN	I-PROBLEM	I-PROBLEM
systems	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
distal	JJ	O	O
vertebrals	NNS	O	O
,	,	O	O
or	CC	O	O
proximal	JJ	O	B-PROBLEM
basilar	JJ	O	I-PROBLEM
artery	NN	O	I-PROBLEM
.	.	O	O

over	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
the	DT	O	O
first	JJ	O	O
hospital	NN	O	O
day	NN	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
&apos;s	NNP	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
deteriorated	VBN	O	O
in	IN	O	O
a	DT	O	O
manner	NN	O	O
that	WDT	O	O
appeared	VBD	O	O
to	TO	O	O
be	VB	O	O
blood	JJ	O	B-TEST
pressure	NN	O	I-TEST
dependent	NN	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
been	VBN	O	O
started	VBN	O	O
on	IN	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
from	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
his	PRP$	O	O
admission	NN	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
computerized	JJ	I-TEST	I-TEST
tomography	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
had	VBD	O	O
showed	VBN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
lacunes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
right	RB	O	O
greater	JJR	O	O
than	IN	O	O
left	VBN	O	O
,	,	O	O
and	CC	O	O
the	DT	O	O
deep	JJ	O	O
gray	NN	O	O
and	CC	O	O
white	JJ	O	O
matters	NNS	O	O
suspicious	JJ	O	O
for	IN	O	O
proximal	JJ	B-PROBLEM	B-PROBLEM
middle	JJ	I-PROBLEM	I-PROBLEM
cerebral	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
stem	NN	I-PROBLEM	I-PROBLEM
occlusion	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
stenosis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

mri	NN	B-TEST	O
/	NNP	O	O
mra	NN	B-TEST	O
was	VBD	O	O
performed	VBN	O	O
with	IN	O	O
diffusion	NN	O	B-TREATMENT
weighted	VBN	O	O
images	NNS	O	O
,	,	O	O
showing	VBG	O	O
subcortical	JJ	B-PROBLEM	B-PROBLEM
white	JJ	I-PROBLEM	I-PROBLEM
matter	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
basal	NN	B-PROBLEM	B-PROBLEM
ganglia	NN	I-PROBLEM	I-PROBLEM
infarcts	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
preserved	VBD	O	O
middle	JJ	O	B-PROBLEM
cerebral	JJ	O	I-PROBLEM
artery	NN	O	I-PROBLEM
territory	NN	O	I-PROBLEM
cortex	NN	O	I-PROBLEM
.	.	O	O

because	IN	O	O
of	IN	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
,	,	O	O
dependence	NN	O	O
of	IN	O	O
his	PRP$	O	B-PROBLEM
left	NN	O	I-PROBLEM
sided	VBD	O	I-PROBLEM
extremities	NNS	O	I-PROBLEM
,	,	O	O
the	DT	O	O
lower	JJR	O	O
leg	NN	O	O
specifically	RB	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
where	WRB	O	O
he	PRP	O	O
underwent	JJ	O	O
hypertensive	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
several	JJ	O	O
days	NNS	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
systolic	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
goal	NN	O	I-TEST
was	VBD	O	O
initially	RB	O	O
170-190	JJ	O	O
,	,	O	O
which	WDT	O	O
he	PRP	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
achieve	VB	O	O
spontaneously	RB	O	O
for	IN	O	O
the	DT	O	O
most	JJS	O	O
part	NN	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
due	JJ	O	O
to	TO	O	O
the	DT	O	O
absence	NN	O	O
of	IN	O	O
clear	JJ	O	O
benefit	NN	O	O
at	IN	O	O
this	DT	O	O
level	NN	O	O
,	,	O	O
and	CC	O	O
further	JJ	B-PROBLEM	B-PROBLEM
deterioration	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
sided	VBD	I-PROBLEM	I-PROBLEM
strength	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
this	DT	O	O
goal	NN	O	O
was	VBD	O	O
increased	VBN	O	O
and	CC	O	O
neo-synephrine	JJ	B-TREATMENT	O
was	VBD	O	O
added	VBN	O	O
to	TO	O	O
his	PRP$	O	B-TREATMENT
regimen	NNS	O	I-TREATMENT
to	TO	O	O
achieve	VB	O	O
mean	JJ	B-TEST	B-PROBLEM
arterial	JJ	I-TEST	I-PROBLEM
pressures	NNS	I-TEST	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
110-120	JJ	O	I-PROBLEM
range	NN	O	I-PROBLEM
.	.	O	O

this	DT	O	O
strategy	NN	O	O
and	CC	O	O
its	PRP$	O	O
incumbent	JJ	O	O
risks	NNS	O	O
,	,	O	O
particularly	RB	O	O
in	IN	O	O
a	DT	O	O
patient	NN	O	O
on	IN	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
were	VBD	O	O
discussed	VBN	O	O
at	IN	O	O
length	NN	O	O
with	IN	O	O
both	DT	O	O
the	DT	O	O
patient	NN	O	O
and	CC	O	O
his	PRP$	O	O
family	NN	O	O
,	,	O	O
who	WP	O	O
were	VBD	O	O
very	RB	O	O
clear	JJ	O	O
in	IN	O	O
wanting	VBG	O	O
to	TO	O	O
proceed	VB	O	O
with	IN	O	O
all	DT	O	O
possible	JJ	O	O
efforts	NNS	O	O
to	TO	O	O
save	VB	O	O
the	DT	O	O
use	NN	O	O
of	IN	O	O
his	PRP$	O	B-PROBLEM
left	JJ	O	I-PROBLEM
leg	NN	O	I-PROBLEM
.	.	O	O

he	PRP	O	O
also	RB	O	O
,	,	O	O
as	IN	O	O
neo-synephrinewas	JJ	B-TREATMENT	O
tapered	NN	O	O
,	,	O	O
developed	VBD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
sensory	JJ	I-PROBLEM	I-PROBLEM
findings	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
in	IN	O	O
particular	JJ	O	B-PROBLEM
diminished	VBD	B-PROBLEM	I-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
fiber	JJ	I-PROBLEM	I-PROBLEM
sensibility	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
hand	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
although	IN	O	O
he	PRP	O	O
at	IN	O	O
times	NNS	O	O
,	,	O	O
including	VBG	O	O
near	IN	O	O
the	DT	O	O
end	NN	O	O
of	IN	O	O
his	PRP$	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
stay	NN	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-TEST
right	JJ	I-PROBLEM	I-TEST
gaze	NN	I-PROBLEM	I-TEST
preference	NN	I-PROBLEM	I-TEST
.	.	O	O

in	IN	O	O
terms	NNS	O	O
of	IN	O	O
exploring	VBG	O	O
his	PRP$	O	O
visual	JJ	O	O
space	NN	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
look	VB	O	O
to	TO	O	O
the	DT	O	O
left	NN	O	O
,	,	O	O
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
not	RB	O	O
possible	JJ	O	O
to	TO	O	O
elicit	VB	O	O
clear	JJ	O	O
evidence	NN	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
field	NN	I-PROBLEM	I-PROBLEM
deficit	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
followed	VBN	O	O
by	IN	O	O
speech	NN	O	O
and	CC	O	O
swallowing	VBG	O	O
service	NN	O	O
,	,	O	O
who	WP	O	O
assisted	VBD	O	O
in	IN	O	O
the	DT	B-TREATMENT	O
management	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
po	NNS	I-TREATMENT	O
intake	VBP	I-TREATMENT	O
which	WDT	O	O
gradually	RB	O	O
improved	VBD	O	O
,	,	O	O
although	IN	O	O
he	PRP	O	O
clearly	RB	O	O
had	VBD	O	O
problems	NNS	O	O
with	IN	O	O
manipulation	NN	O	B-TREATMENT
of	IN	O	I-TREATMENT
food	NN	O	I-TREATMENT
in	IN	O	O
the	DT	O	O
left	JJ	O	O
side	NN	O	O
of	IN	O	O
his	PRP$	O	O
mouth	NN	O	O
and	CC	O	O
would	MD	O	O
tend	VB	O	O
to	TO	O	O
accumulate	VB	O	O
a	DT	O	B-PROBLEM
pouch	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
food	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
his	PRP$	O	I-PROBLEM
left	JJ	O	I-PROBLEM
cheek	NN	O	I-PROBLEM
.	.	O	O

i	NN	O	O
should	MD	O	O
mention	VB	O	O
that	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
pressure	NN	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
at	IN	O	O
times	NNS	O	O
limited	VBN	O	O
by	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
severe	JJ	I-PROBLEM	I-PROBLEM
headache	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
although	IN	O	O
he	PRP	O	O
also	RB	O	O
had	VBD	O	O
this	DT	O	O
off	RP	O	O
the	DT	B-TREATMENT	O
pressor	NN	I-TREATMENT	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
several	JJ	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
imaging	VBG	I-TEST	I-TEST
studies	NNS	I-TEST	I-TEST
during	IN	O	O
his	PRP$	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
stay	NN	O	O
which	WDT	O	O
showed	VBD	O	O
further	JJ	B-PROBLEM	B-PROBLEM
demarcation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
not	RB	O	O
extension	NN	B-PROBLEM	O
of	IN	I-PROBLEM	O
his	PRP$	I-PROBLEM	B-PROBLEM
prior	JJ	I-PROBLEM	I-PROBLEM
infarct	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
both	DT	O	O
on	IN	O	O
computerized	JJ	B-TEST	B-TEST
tomography	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
and	CC	O	I-TEST
dwi	JJ	B-TEST	I-TEST
images	NNS	I-TEST	I-TEST
.	.	O	O

additionally	RB	O	O
,	,	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
perfusion	NN	I-TEST	I-TEST
,	,	I-TEST	O
diffusion	NN	I-TEST	B-TEST
mr	NN	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
earlier	RBR	O	O
on	IN	O	O
,	,	O	O
which	WDT	O	O
suggested	VBD	O	O
the	DT	O	O
presence	NN	O	O
of	IN	O	O
viable	JJ	B-PROBLEM	O
penumbra	NN	I-PROBLEM	O
,	,	O	O
including	VBG	O	O
the	DT	O	B-PROBLEM
overlying	NN	O	I-PROBLEM
cortex	NN	O	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
regular	JJ	O	O
neurology	NN	O	O
floor	NN	O	O
once	IN	O	O
it	PRP	O	O
became	VBD	O	O
clear	JJ	O	O
that	IN	O	O
he	PRP	O	O
was	VBD	O	O
not	RB	O	O
receiving	VBG	O	O
any	DT	O	O
significant	JJ	O	O
benefit	NN	O	O
from	IN	O	O
hypertensive	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

at	IN	O	O
this	DT	O	O
time	NN	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
neurologic	JJ	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
is	VBZ	O	O
notable	JJ	O	O
for	IN	O	O
hemiplegia	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
arm	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
hemiparesis	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
leg	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
mild	VB	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
fiber	NNP	I-PROBLEM	I-PROBLEM
sensory	JJ	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
arm	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
otherwise	RB	O	O
fairly	RB	O	O
intact	JJ	O	O
mental	JJ	O	O
status	NN	O	O
,	,	O	O
cranial	JJ	O	O
nerve	NN	O	O
function	NN	O	O
,	,	O	O
and	CC	O	O
right	RB	O	B-PROBLEM
sided	VBD	O	I-PROBLEM
motor	NN	O	I-PROBLEM
and	CC	O	O
sensory	JJ	O	O
function	NN	O	O
.	.	O	O

he	PRP	O	O
will	MD	O	O
be	VB	O	O
discharged	VBN	O	O
to	TO	O	O
rehab	VB	O	O
on	IN	O	O
a	DT	O	B-TREATMENT
regimen	NN	O	I-TREATMENT
of	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
po	NN	O	O
today	NN	O	O
then	RB	O	O
daily	RB	O	O
for	IN	O	O
an	DT	O	B-TEST
inr	JJ	B-TEST	I-TEST
goal	NN	O	I-TEST
of	IN	O	O
2-3	JJ	O	O
,	,	O	O
ofloxacin	JJ	B-TREATMENT	B-TREATMENT
400	CD	O	O
mg	JJ	O	O
po	NN	O	O
bid	NN	O	O
to	TO	O	O
be	VB	O	O
discontinued	VBN	O	O
on	IN	O	O
11/05/96	CD	O	O
,	,	O	O
dexedrine	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
,	,	O	O
omeprazole	JJ	B-TREATMENT	B-TREATMENT
20mg	CD	O	O
po	NN	O	O
qd	NN	O	O
,	,	O	O
erythromycin	FW	B-TREATMENT	B-TREATMENT
eye	NN	I-TREATMENT	I-TREATMENT
ointment	JJ	I-TREATMENT	I-TREATMENT
ou	JJ	O	O
bid	NN	O	O
,	,	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
its	PRP$	O	O
present	JJ	O	O
rate	NN	O	O
adjusting	VBG	O	O
per	IN	O	O
partial	JJ	B-TEST	O
thromboplastin	NN	I-TEST	O
time	NN	I-TEST	O
bid	NN	O	O
,	,	O	O
and	CC	O	O
discontinuing	VBG	O	O
when	WRB	O	O
the	DT	B-TREATMENT	O
coumadin	NN	I-TREATMENT	O
is	VBZ	O	O
therapeutic	JJ	O	O
,	,	O	O
tylenol	JJ	B-TREATMENT	B-TREATMENT
650	CD	O	O
mg	NN	O	O
po	NN	O	O
q4	NN	O	O
prn	NN	O	O
,	,	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
po	NN	O	O
bid	NN	O	O
.	.	O	O

mrs.	NN	O	O
gonzalez	NN	O	O
is	VBZ	O	O
a	DT	O	O
patient	NN	O	O
with	IN	O	O
a	DT	O	O
prior	JJ	O	O
medical	JJ	O	O
history	NN	O	O
including	VBG	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
iron-deficiency	NN	B-PROBLEM	B-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
osteoporosis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
increased	VBD	B-PROBLEM	B-PROBLEM
cholesterol	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
peptic	JJ	B-PROBLEM	B-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
constipation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
status	NN	O	O
post	NN	O	O
appendectomy	NN	B-TREATMENT	B-TREATMENT
as	RB	O	O
well	RB	O	O
as	IN	O	O
status	NN	O	O
post	NN	O	O
hysterectomy	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
from	IN	O	O
an	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
for	IN	O	O
evaluation	NN	B-TEST	B-TEST
and	CC	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
adenocarcinoma	NN	B-PROBLEM	B-PROBLEM
involving	VBG	O	O
the	DT	O	O
transverse	NN	O	O
colon	NN	O	O
and	CC	O	O
gallbladder	NN	O	B-PROBLEM
.	.	O	O

at	IN	O	O
the	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
already	RB	O	O
seemed	VBN	O	O
some	DT	B-TEST	B-TEST
workup	NN	I-TEST	I-TEST
for	IN	O	O
a	DT	O	O
couple	JJ	O	O
weeks	NNS	O	O
duration	NN	O	O
of	IN	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
occasionally	RB	O	O
radiated	VBD	O	O
to	TO	O	O
her	PRP$	O	O
back	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
also	RB	O	O
complaining	VBG	O	O
of	IN	O	O
fatigue	NN	B-PROBLEM	B-PROBLEM
for	IN	O	O
two	CD	O	O
weeks	NNS	O	O
but	CC	O	O
a	DT	O	O
good	JJ	O	O
appetite	NN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
denied	VBD	O	O
weight	JJ	B-PROBLEM	B-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
melena	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
bright	RB	B-PROBLEM	B-PROBLEM
red	JJ	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
per	IN	I-PROBLEM	I-PROBLEM
rectum	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
cat	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
abdomen	NNS	I-TEST	I-TEST
showed	VBD	O	O
air-fluid	JJ	B-PROBLEM	B-PROBLEM
levels	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
gallbladder	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

it	PRP	O	O
also	RB	O	O
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
thickened	JJ	I-PROBLEM	I-PROBLEM
gallbladder	NN	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
dilated	JJ	I-PROBLEM	I-PROBLEM
common	JJ	I-PROBLEM	I-PROBLEM
bile	NN	I-PROBLEM	I-PROBLEM
duct	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

incidentally	RB	O	O
,	,	O	O
it	PRP	O	O
also	RB	O	O
showed	VBD	O	O
diverticulosis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
hida	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
at	IN	O	O
the	DT	O	O
other	JJ	O	O
hospital	NN	O	O
did	VBD	O	O
not	RB	O	O
show	VB	O	O
filling	NN	B-PROBLEM	O
of	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
gallbladder	NN	I-PROBLEM	O
indicating	VBG	O	O
some	DT	O	O
sort	NN	O	O
of	IN	O	O

cystic	JJ	B-PROBLEM	B-PROBLEM
duct	NN	I-PROBLEM	I-PROBLEM
obstruction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
first	JJ	I-TEST	I-TEST
imaging	NN	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
that	WDT	O	O
was	VBD	O	O
done	VBN	O	O
at	IN	O	O
hahnemann	NN	O	O
general	JJ	O	O
hospital	NN	O	O
was	VBD	O	O
a	DT	B-TEST	O
mrcp	NN	I-TEST	O
which	WDT	O	O
revealed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
enhanced	JJ	I-PROBLEM	I-PROBLEM
thickened	JJ	I-PROBLEM	I-PROBLEM
gallbladder	NN	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
consistent	NN	O	O
with	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
cholecystitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	O	B-TEST
differential	JJ	O	I-TEST
according	VBG	O	I-TEST
to	TO	O	I-TEST
the	DT	B-TEST	I-TEST
imaging	NN	I-TEST	I-TEST
included	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
fistula	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
adjacent	JJ	B-PROBLEM	O
inflammatory	JJ	I-PROBLEM	O
change	NN	I-PROBLEM	O
but	CC	O	O
also	RB	O	O
carcinoma	VBD	B-PROBLEM	B-PROBLEM
or	CC	O	O
adenomatosis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

in	IN	O	O
addition,	NN	O	O
also	RB	O	O
the	DT	B-TEST	O
mrcp	NN	I-TEST	O
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
near	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
region	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
neck	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
gallbladder	NN	O	I-PROBLEM
.	.	O	O

of	IN	O	O
note	NN	O	O
,	,	O	O
at	IN	O	O
the	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
,	,	O	O
an	DT	B-TEST	B-TEST
endoscopy	NN	I-TEST	I-TEST
and	CC	O	O
colonoscopy	NN	B-TEST	B-TEST
were	VBD	O	O
performed	VBN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
colonoscopy	NN	I-TEST	I-TEST
showed	VBD	O	O
two	CD	B-PROBLEM	B-PROBLEM
polyps	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
also	RB	O	O
a	DT	O	O
region	NN	O	O
in	IN	O	O
the	DT	O	O
transverse	NN	O	O
colon	NN	O	O
that	WDT	O	O
was	VBD	O	O
biopsied	VBN	O	O
.	.	O	O

this	DT	B-TEST	B-TEST
biopsy	NN	I-TEST	I-TEST
came	VBD	O	O
back	RB	O	O
as	IN	O	O
positive	JJ	O	O
for	IN	O	O
adenocarcinoma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
diagnosis	NN	O	O
of	IN	O	O
adenocarcinoma	NN	B-PROBLEM	B-PROBLEM
was	VBD	O	O
already	RB	O	O
established	VBN	O	O
prior	RB	O	O
to	TO	O	O
her	PRP$	O	O
admission	NN	O	O
at	IN	O	O
this	DT	O	O
hospital	NN	O	O
.	.	O	O

given	VBN	O	O
a	DT	B-TREATMENT	B-TREATMENT
low-residual	JJ	I-TREATMENT	I-TREATMENT
diet	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
her	PRP	O	O
belly	RB	O	O
cleaned	VBD	O	O
with	IN	O	O
hibiclens	NNS	B-TREATMENT	O
one	CD	O	O
a	DT	O	O
day	NN	O	O
and	CC	O	O
once	RB	O	O
an	DT	B-TEST	O
adequate	JJ	I-TEST	O
preoperative	JJ	I-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
given	VBN	O	O
a	DT	B-TREATMENT	O
bowel	NN	I-TREATMENT	O
prep	NN	I-TREATMENT	O
on	IN	O	O
monday	JJ	O	O
afternoon	NN	O	O
and	CC	O	O
evening	NN	O	O
in	IN	O	O
preparation	NN	O	O
for	IN	O	O
an	DT	O	O

exploratory	JJ	B-TEST	B-TEST
laparotomy	NN	I-TEST	I-TEST
on	IN	O	O
tuesday	NN	O	O
,	,	O	O
2014-07-29	JJ	O	O
.	.	O	O

on	IN	O	O
the	DT	O	O
morning	NN	O	O
of	IN	O	O
2014-07-29	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
and	CC	O	O
underwent	NN	O	O
a	DT	B-TREATMENT	B-TREATMENT
cholecystectomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
partial	JJ	B-TREATMENT	B-TREATMENT
hepatectomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
partial	JJ	B-TREATMENT	B-TREATMENT
lymph	NN	I-TREATMENT	I-TREATMENT
node	NN	I-TREATMENT	I-TREATMENT
dissection	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
a	DT	B-TREATMENT	B-TREATMENT
colocolostomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
partial	JJ	B-TREATMENT	B-TREATMENT
colectomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
in	IN	O	O
addition	NN	O	O
a	DT	B-TREATMENT	B-TREATMENT
gastrostomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
a	DT	B-TREATMENT	B-TREATMENT
feeding	JJ	I-TREATMENT	I-TREATMENT
jejunostomy	NN	I-TREATMENT	I-TREATMENT
were	VBD	O	O
also	RB	O	O
put	VBN	O	O
in	IN	O	O
place	NN	O	O
.	.	O	O

please	NN	O	O
refer	NN	O	O
to	TO	O	O
the	DT	O	O
previously	RB	O	O
dictated	VBN	O	O
operative	JJ	O	O
notes	NNS	O	O
for	IN	O	O
the	DT	O	O
details	NNS	O	O
of	IN	O	O
this	DT	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

briefly	NN	O	O
,	,	O	O
the	DT	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
2014-07-29	JJ	O	O
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
gallbladder	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
cholecystocolonic	JJ	I-PROBLEM	I-PROBLEM
fistula	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
crossed	VBD	O	O
into	IN	O	O
the	DT	O	O
liver	NN	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
adenopathy	NN	I-PROBLEM	I-PROBLEM
around	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
portal	JJ	I-PROBLEM	O
nodes	NNS	I-PROBLEM	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
retroperitoneal	NN	B-PROBLEM	B-PROBLEM
nodes	NNS	I-PROBLEM	I-PROBLEM
around	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
inferior	JJ	I-PROBLEM	I-PROBLEM
vena	NN	I-PROBLEM	I-PROBLEM
cava	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
the	DT	I-PROBLEM	O
hepatic	JJ	I-PROBLEM	O
artery	NN	I-PROBLEM	O
.	.	O	O

in	IN	O	O
addition	NN	O	O
to	TO	O	O
the	DT	B-TREATMENT	B-TREATMENT
gastrostomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	I-TREATMENT
feeding	VBG	B-TREATMENT	I-TREATMENT
jejunostomy	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
two	CD	B-TREATMENT	B-TREATMENT
belmont-gardner	NN	I-TREATMENT	I-TREATMENT
drains	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
placed	VBN	O	O
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
postoperatively	RB	O	O
was	VBD	O	O
controlled	VBN	O	O
with	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
epidural	JJ	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

however	RB	O	O
,	,	O	O
the	DT	B-TREATMENT	O
epidural	JJ	I-TREATMENT	O
had	VBD	O	O
the	DT	O	O
consequence	NN	O	O
of	IN	O	O
causing	VBG	O	O
a	DT	O	O
bit	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
hypotension	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
patient	NN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
surgical	JJ	O	O
icu	NN	O	O
for	IN	O	O
the	DT	O	O
first	JJ	O	O
postoperative	JJ	O	O
day	NN	O	O
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
low	JJ	B-PROBLEM	B-PROBLEM
hematocrits	NNS	I-PROBLEM	I-PROBLEM
which	WDT	O	O
required	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
transfusion	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
packed	JJ	I-TREATMENT	I-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
two	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
out	RP	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
doing	VBG	O	O
better	RBR	O	O
in	IN	O	O
terms	NNS	O	O
of	IN	O	O
pain	NN	B-TREATMENT	B-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
dilaudid	JJ	I-TREATMENT	I-TREATMENT
pca	NN	I-TREATMENT	I-TREATMENT
machine	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
two	CD	O	O
,	,	O	O
interestingly	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
complaining	VBG	O	O
of	IN	O	O
sensitivity	NN	B-PROBLEM	O
to	TO	I-PROBLEM	O
light	NN	I-PROBLEM	O
from	IN	O	O
an	DT	O	O
unknown	JJ	O	O
etiology	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
's	POS	O	O
postoperative	JJ	O	O
course	NN	O	O
was	VBD	O	O
unremarkable	JJ	O	O
aside	RB	O	O
from	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
photophobia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

following	VBG	O	O
that	IN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
slowly	RB	O	O
advanced	JJ	O	O
to	TO	O	O
clear	JJ	B-TREATMENT	B-TREATMENT
liquids	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
to	TO	O	O
a	DT	O	O
regular	JJ	O	O
diet	NN	O	O
once	IN	O	O
her	PRP$	O	O
bowels	NNS	O	O
began	VBD	O	O
working	VBG	O	O
when	WRB	O	O
she	PRP	O	O
began	VBD	O	O
having	VBG	O	O
flatus	NN	O	B-PROBLEM
.	.	O	O

her	PRP$	O	O
bowel	NN	O	O
function	NN	O	O
was	VBD	O	O
slow	JJ	O	O
to	TO	O	O
develop	VB	O	O
and	CC	O	O
she	PRP	O	O
needed	VBD	O	O
to	TO	O	O
remain	VB	O	O
n.p.o.	JJ	B-TREATMENT	O
until	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
six	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
also	RB	O	O
given	VBN	O	O
supplemental	JJ	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
feedings	NNS	I-TREATMENT	I-TREATMENT
to	TO	O	O
supplement	VB	O	O
her	PRP$	O	B-TEST
calories	NNS	O	I-TEST
and	CC	O	O
caloric	JJ	O	B-TEST
intake	NN	O	I-TEST
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
seven	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
tolerating	VBG	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
clear	JJ	I-TREATMENT	I-TREATMENT
liquid	JJ	I-TREATMENT	I-TREATMENT
diet	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
p.o.	NN	B-TREATMENT	B-TREATMENT
medicines	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
first	JJ	I-TREATMENT	I-TREATMENT
belmont-gardner	NN	I-TREATMENT	I-TREATMENT
drain	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
pulled	VBN	O	O
due	JJ	O	O
to	TO	O	O
scant	JJ	O	O
output	NN	O	O
.	.	O	O

by	IN	O	O
2014-08-09	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
tolerating	VBG	O	O
a	DT	O	O
full	JJ	O	O
solid	JJ	O	O
diet	NN	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
discharged	VBN	O	O
to	TO	O	O
home	NN	O	O
with	IN	O	O
services	NNS	O	O
including	VBG	O	O
tube	JJ	B-TREATMENT	B-TREATMENT
feedings	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
her	PRP$	O	B-TREATMENT
home	NN	O	I-TREATMENT
care	NN	O	I-TREATMENT
.	.	O	O

1.	CD	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
gallbladder	NN	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
status	NN	O	O
post	NN	O	O
cholecystectomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

3.	CD	O	O
status	NN	O	O
post	NN	O	O
transverse	NN	B-TREATMENT	B-TREATMENT
colectomy	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
anastomosis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

4.	CD	O	O
g	JJ	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

5.	CD	O	O
feeding	VBG	B-TREATMENT	B-TREATMENT
jejunostomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

6.	CD	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

7.	CD	O	O
blood	NN	B-PROBLEM	B-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
requiring	VBG	O	O
transfusion	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

1.	CD	O	O
levothyroxine	JJ	B-TREATMENT	B-TREATMENT
100	CD	O	O
micrograms	NNS	O	O
orally	RB	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

2.	CD	O	O
pantoprazole	JJ	B-TREATMENT	B-TREATMENT
one	CD	O	O
tablet	NN	O	O
once	IN	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

3.	CD	O	O
ambien	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NNS	O	O
orally	RB	O	O
before	IN	O	O
bed	NN	O	O
.	.	O	O

4.	CD	O	O
tylenol	JJ	B-TREATMENT	B-TREATMENT
#	#	O	I-TREATMENT
3	CD	O	O
one	CD	O	O
tablet	NN	O	O
every	DT	O	O
four	CD	O	O
hours	NNS	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

5.	CD	O	O
reglan	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
four	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
before	IN	O	O
meals	NNS	O	O
and	CC	O	O
at	IN	O	O
bedtime	NN	O	O
.	.	O	O

6.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

follow-up	NN	O	O
with	IN	O	O
the	DT	O	O
visiting	VBG	O	O
nurses	NNS	O	O
association	NN	O	O
to	TO	O	O
arrange	VB	O	O
assistance	NN	O	O
with	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
feeding	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O

necrotizing	VBG	B-PROBLEM	B-PROBLEM
pancreatitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

necrotizing	VBG	B-PROBLEM	B-PROBLEM
pancreatitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
wegener	NN	B-PROBLEM	B-PROBLEM
&apos;s	JJ	I-PROBLEM	I-PROBLEM
granulomatosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
anterior	RB	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
1993	CD	O	O
.	.	O	O

3.	CD	O	O
left	VBD	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
dementia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

5.	CD	O	O
gallstone	NN	B-PROBLEM	B-PROBLEM
pancreatitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

6.	CD	O	O
fungal	JJ	B-PROBLEM	B-PROBLEM
cystitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

7.	CD	O	O
intra-abdominal	JJ	B-PROBLEM	B-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

8.	CD	O	O
total	JJ	B-PROBLEM	B-TREATMENT
parenteral	JJ	I-PROBLEM	I-TREATMENT
nutrition	NN	I-PROBLEM	I-TREATMENT
dependent	NN	I-PROBLEM	O
.	.	O	O

exploratory	JJ	B-TEST	B-TEST
laparotomy	NN	I-TEST	I-TEST
,	,	O	O
left	VBD	B-TREATMENT	B-TREATMENT
colectomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	I-TREATMENT
end-transverse	JJ	B-TREATMENT	I-TREATMENT
colostomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
drainage	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
pancreatic	JJ	B-PROBLEM	B-PROBLEM
necrosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mr.	JJ	O	O
mass	NN	O	O
was	VBD	O	O
a	DT	O	O
56	CD	O	O
year	NN	O	O
old	JJ	O	O
white	JJ	O	O
male	NN	O	O
who	WP	O	O
was	VBD	O	O
transferred	VBN	O	O
from	IN	O	O
vassdiysey	JJ	O	O
medical	JJ	O	O
center	NN	O	O
for	IN	O	O
rule	NN	O	O
out	IN	O	O
pancreatic	JJ	B-PROBLEM	B-PROBLEM
pseudocyst	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mr.	JJ	O	O
mass	NNP	O	O
had	VBD	O	O
a	DT	O	O
past	JJ	O	O
medical	JJ	O	O
history	NN	O	O
which	WDT	O	O
included	VBD	O	O
wegener	NN	B-PROBLEM	B-PROBLEM
&apos;s	NNP	I-PROBLEM	I-PROBLEM
granulomatosis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
history	NN	O	O
of	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
gallstone	NN	B-PROBLEM	B-PROBLEM
pancreatitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
vassdiysey	VB	O	O
medical	JJ	O	O
center	NN	O	O
with	IN	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
recurrent	NN	I-PROBLEM	I-PROBLEM
pancreatitis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
amylase	NN	I-TEST	I-TEST
on	IN	O	O
admission	NN	O	O
there	EX	O	O
was	VBD	O	O
1,961	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
two	CD	O	O
recent	JJ	O	O
admissions	NNS	O	O
for	IN	O	O
pancreatitis	NN	B-PROBLEM	B-PROBLEM
in	IN	O	O
january	JJ	O	O
1994	CD	O	O
,	,	O	O
and	CC	O	O
august	JJ	O	O
1994	CD	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
amylase	NN	I-TEST	I-TEST
decreased	VBD	O	O
to	TO	O	O
51	CD	O	O
,	,	O	O
and	CC	O	O
the	DT	O	O
increased	VBN	O	O
back	RB	O	O
to	TO	O	O
151	CD	O	O
on	IN	O	O
hospital	JJ	O	O
day	NN	O	O
#10	NNP	O	O
.	.	O	O

at	IN	O	O
that	DT	O	O
time	NN	O	O
,	,	O	O
he	PRP	O	O
spiked	VBD	O	O
a	DT	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
to	TO	O	O
103	CD	O	O
.	.	O	O

he	PRP	O	O
also	RB	O	O
became	VBD	O	O
increasingly	RB	B-PROBLEM	B-PROBLEM
confused	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
computerized	JJ	I-TEST	I-TEST
tomography	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
done	VBN	O	O
on	IN	O	O
4/16/95	CD	O	O
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
&quot;	NNP	I-PROBLEM	I-PROBLEM
pseudocyst	NN	I-PROBLEM	I-PROBLEM
&quot;	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
ph	VB	O	O
university	NN	O	O
of	IN	O	O
medical	JJ	O	O
center	NN	O	O
for	IN	O	O
further	JJ	B-TEST	B-TEST
surgical	JJ	I-TEST	I-TEST
evaluation	NN	I-TEST	I-TEST
.&apos;	NN	O	O

2.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
anterior	RB	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
in	IN	O	O
1993	CD	O	O
.	.	O	O

ejection	NN	B-TEST	B-TEST
fraction	NN	I-TEST	I-TEST
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
35%	CD	O	O
in	IN	O	O
1993	CD	O	O
.	.	O	O

recent	JJ	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
suggests	VBZ	O	I-TEST
ejection	NN	B-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
15%	CD	O	O
.	.	O	O

3.	CD	O	O
wegener	NN	B-PROBLEM	B-PROBLEM
&apos;s	JJ	I-PROBLEM	I-PROBLEM
granulomatosis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
associated	VBN	B-PROBLEM	O
chronic	JJ	I-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
dementia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

vitamin	NN	B-TREATMENT	B-TREATMENT
k	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
10	CD	O	O
mg.	NN	O	O
,	,	O	O
im	NN	O	O
,	,	O	O
q-week	JJ	O	O
.	.	O	O

2.	CD	O	O
pepcid	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
20	CD	O	O
mg.	NN	O	O
,	,	O	O
intravenously	RB	O	O
,	,	O	O
q12h.	NN	O	O

3.	CD	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
0.125	CD	O	O
mg.	NN	O	O
,	,	O	O
intravenously	RB	O	O
,	,	O	O
qd	NN	O	O
.	.	O	O

4.	CD	O	O
imipenem	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
500	CD	O	O
mg.	NN	O	O
,	,	O	O
intravenously	RB	O	O
,	,	O	O
q6h.	NN	O	O

5.	CD	O	O
nitropaste	NN	B-TREATMENT	O
,	,	O	O
one-half	JJ	O	O
inch	NN	O	O
to	TO	O	O
chest	VB	O	O
wall	NN	O	O
,	,	O	O
q6h.	NN	O	O

6.	CD	O	O
vasotec	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

7.	CD	O	O
alterajel	NN	B-TREATMENT	O
.	.	O	O

8.	CD	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
20	CD	O	O
mg.	NN	O	O
,	,	O	O
po	NN	O	O
,	,	O	O
qd	NN	O	O
.	.	O	O

9.	CD	O	O
haldol	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

10.	CD	O	O
demerol	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
prn	NN	O	O
.	.	O	O

ativan	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

in	IN	O	O
general	JJ	O	O
,	,	O	O
confused	JJ	O	B-PROBLEM
white	JJ	O	I-PROBLEM
man	NN	O	I-PROBLEM
,	,	O	O
in	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

temperature	NN	B-TEST	B-TEST
was	VBD	O	O
102	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
was	VBD	O	O
110	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
was	VBD	O	O
22	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
113/63	CD	O	O
.	.	O	O

rales	NNS	B-PROBLEM	B-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
base	NN	I-PROBLEM	I-PROBLEM
,	,	O	I-PROBLEM
bilateral	JJ	B-PROBLEM	I-PROBLEM
decreased	VBN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
sounds	NNS	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
bases	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
s1	NN	O	O
and	CC	O	O
s2	NN	O	O
,	,	O	O
no	DT	O	O
extra	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
sounds	VBZ	I-PROBLEM	I-PROBLEM
,	,	O	O
abdomen	NNS	B-PROBLEM	B-PROBLEM
distended	VBD	I-PROBLEM	I-PROBLEM
with	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
epigastric	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
noted	VBD	O	O
,	,	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
tender	NN	I-PROBLEM	I-PROBLEM
to	TO	O	I-PROBLEM
palpation	NN	B-TEST	I-PROBLEM
,	,	O	O
no	DT	O	O
guarding	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
neurological	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
nonfocal	JJ	O	O
.	.	O	O

white	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
14.4	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
was	VBD	O	O
36.2	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
217	CD	O	O
,	,	O	O
sodium	NN	B-TEST	B-TEST
was	VBD	O	O
135	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
was	VBD	O	O
3.3	CD	O	O
,	,	O	O
chloride	NN	B-TEST	B-TEST
was	VBD	O	O
99	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
was	VBD	O	O
25	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
was	VBD	O	O
40	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
was	VBD	O	O
1.9	CD	O	O
,	,	O	O
glucose	NN	B-TEST	B-TEST
was	VBD	O	O
124	CD	O	O
,	,	O	O
urinalysis	NN	B-TEST	B-TEST
was	VBD	O	O
negative	JJ	O	O
,	,	O	O
pt	NN	B-TEST	O
was	VBD	O	O
12.2	CD	O	O
,	,	O	O
ptt	NN	B-TEST	B-TEST
was	VBD	O	O
24.5	CD	O	O
,	,	O	O
calcium	NN	B-TEST	B-TEST
was	VBD	O	O
7.8	CD	O	O
,	,	O	O
phosphorus	NN	B-TEST	B-TEST
was	VBD	O	O
3.7	CD	O	O
,	,	O	O
albumin	NN	B-TEST	B-TEST
was	VBD	O	O
2.3	CD	O	O
,	,	O	O
total	JJ	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
was	VBD	O	O
1.3	CD	O	O
,	,	O	O
alkaline	JJ	B-TEST	B-TEST
phosphatase	NN	I-TEST	I-TEST
was	VBD	O	O
202	CD	O	O
,	,	O	O
sgpt	NN	B-TEST	B-TEST
was	VBD	O	O
32	CD	O	O
,	,	O	O
sgot	VBD	B-TEST	O
was	VBD	O	O
64	CD	O	O
,	,	O	O
ldh	NN	B-TEST	O
was	VBD	O	O
998	CD	O	O
,	,	O	O
amylase	NN	B-TEST	B-TEST
was	VBD	O	O
150	CD	O	O
.	.	O	O

ekg	NN	B-TEST	O
revealed	VBD	O	O
sinus	JJ	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
107	CD	O	O
beats	NNS	O	O
per	IN	O	O
minute	NN	O	O
.	.	O	O

evidence	NN	O	O
of	IN	O	O
old	JJ	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
septal	JJ	I-PROBLEM	I-PROBLEM
infarct	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

chest	JJ	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
:	:	O	O

large	JJ	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
ventricle	NN	I-PROBLEM	I-PROBLEM
,	,	O	I-PROBLEM
bilateral	JJ	B-PROBLEM	I-PROBLEM
atelectasis	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
effusion	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

abdominal	JJ	B-TEST	B-TEST
computerized	JJ	I-TEST	I-TEST
tomography	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
:	:	O	O

pancreatitis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
fluid	NN	B-PROBLEM	B-PROBLEM
collection	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lesser	JJR	I-PROBLEM	I-PROBLEM
sac	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-PROBLEM	B-PROBLEM
perisplenic	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
which	WDT	O	O
appeared	VBD	O	O
to	TO	O	O
communicate	VB	O	O
with	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
lesser	JJR	I-PROBLEM	I-PROBLEM
sac	NN	I-PROBLEM	I-PROBLEM
collection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

gallbladder	NN	O	B-PROBLEM
was	VBD	O	O
visualized	VBN	O	O
with	IN	O	O
stones	NNS	B-PROBLEM	O
.	.	O	O

in	IN	O	O
summary	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
considered	VBN	O	O
to	TO	O	O
have	VB	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
necrotizing	VBG	I-PROBLEM	I-PROBLEM
pancreatitis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
cardiac	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
,	,	O	O
placed	VBN	O	O
on	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
imipenem	NN	I-TREATMENT	I-TREATMENT
,	,	I-TREATMENT	O
intravenously	RB	I-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
total	JJ	B-TREATMENT	B-TREATMENT
parenteral	JJ	I-TREATMENT	I-TREATMENT
nutrition	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
4/17/95	CD	O	O
,	,	O	O
gi	FW	O	B-TREATMENT
interventional	JJ	O	I-TREATMENT
radiology	NN	O	I-TREATMENT
performed	VBD	O	O
drainage	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
the	DT	B-PROBLEM	B-TEST
peripancreatic	JJ	I-PROBLEM	I-TEST
fluid	NN	I-PROBLEM	I-TEST
collection	NN	I-PROBLEM	I-TEST
.	.	O	O

approximately	RB	O	O
one	CD	O	O
liter	NN	O	O
of	IN	O	O
brownish	JJ	B-PROBLEM	B-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
obtained	VBN	O	O
and	CC	O	O
sent	VBN	O	O
for	IN	O	O
culture	NN	B-TEST	B-TEST
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
drainage	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
left	VBN	O	O
in	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
pseudocyst	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
persantine	NN	I-TEST	I-TEST
thallium	NN	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
demonstrated	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
infarct	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
involving	VBG	O	O
the	DT	O	O
posteroseptal	NN	O	O
,	,	O	O
anteroseptal	JJ	O	B-TREATMENT
areas	NNS	O	I-TREATMENT
.	.	O	O

left	VBD	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
also	RB	O	O
noted	VBN	O	O
;	:	O	O
however	RB	O	O
,	,	O	O
no	DT	O	O
ischemia	NN	B-PROBLEM	B-PROBLEM
was	VBD	O	O
seen	VBN	O	O
.	.	O	O

an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
was	VBD	O	O
done	VBN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
showed	VBD	O	O
terrible	JJ	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
function	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
percutaneous	JJ	I-TREATMENT	I-TREATMENT
drainage	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
high	JJ	O	B-PROBLEM
output	NN	O	I-PROBLEM
.	.	O	O

the	DT	O	O
fluid	NN	O	O
was	VBD	O	O
sent	VBN	O	O
for	IN	O	O
amylase	NN	B-TEST	B-TEST
,	,	O	O
which	WDT	O	O
came	VBD	O	O
back	RB	O	O
53,230	CD	O	O
.	.	O	O

on	IN	O	O
4/28/95	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
new	JJ	O	B-PROBLEM
onset	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
abdominal	JJ	B-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
had	VBD	O	O
bumped	VBN	O	O
from	IN	O	O
8.3	CD	O	O
on	IN	O	O
admission	NN	O	O
to	TO	O	O
18.5	CD	O	O
,	,	O	O
on	IN	O	O
4/27	CD	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
computerized	JJ	I-TEST	I-TEST
tomography	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
abdomen	NNS	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
.	.	O	O

approximately	RB	O	O
100	CD	O	O
cc.&apos;s	NN	O	O
of	IN	O	O
thick	JJ	B-PROBLEM	B-PROBLEM
brownish	JJ	I-PROBLEM	I-PROBLEM
material	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
aspirated	VBN	O	O
through	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
indwelling	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	B-TEST	B-TEST
computerized	JJ	I-TEST	I-TEST
tomography	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
showed	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
tip	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
good	JJ	O	O
position	NN	O	O
.	.	O	O

because	IN	O	O
of	IN	O	O
the	DT	B-PROBLEM	O
patient	NN	I-PROBLEM	O
&apos;s	NN	I-PROBLEM	O
deteriorating	VBG	I-PROBLEM	O
state	NN	I-PROBLEM	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
brought	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
on	IN	O	O
4/28/95	CD	O	O
.	.	O	O

an	DT	B-TEST	B-TEST
exploratory	JJ	I-TEST	I-TEST
laparotomy	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
.	.	O	O

the	DT	O	B-TEST
splenic	JJ	O	I-TEST
flexure	NN	O	I-TEST
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
purulent	JJ	I-PROBLEM	I-PROBLEM
exudative	JJ	I-PROBLEM	I-PROBLEM
process	NN	I-PROBLEM	I-PROBLEM
along	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
antimesenteric	JJ	I-PROBLEM	O
surface	NN	I-PROBLEM	O
.	.	O	O

thus	RB	O	O
,	,	O	O
the	DT	O	B-PROBLEM
splenic	JJ	O	I-PROBLEM
flexure	NN	O	I-PROBLEM
and	CC	O	O
a	DT	O	O
portion	NN	O	O
of	IN	O	O
the	DT	O	O
descending	VBG	O	O
colon	NN	O	O
were	VBD	O	O
resected	VBN	B-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
underwent	NN	O	O
a	DT	B-TREATMENT	B-TREATMENT
left	JJ	I-TREATMENT	I-TREATMENT
colectomy	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
end	JJ	B-TREATMENT	B-TREATMENT
transverse	NN	I-TREATMENT	I-TREATMENT
colostomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
oversewing	NN	B-TREATMENT	O
of	IN	I-TREATMENT	O
the	DT	I-TREATMENT	O
descending	NN	I-TREATMENT	O
colon	NN	I-TREATMENT	O
.	.	O	O

drainage	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
pancreatic	JJ	I-PROBLEM	I-PROBLEM
necrosis	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
also	RB	O	O
done	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
fairly	RB	O	O
well	RB	O	O
,	,	O	O
and	CC	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
then	RB	O	O
extubated	VBN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#2	NNP	O	O
,	,	O	O
but	CC	O	O
remained	VBD	O	O
pressor-dependent	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
remained	VBD	O	O
on	IN	O	O
imipenem	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
also	RB	O	O
started	VBN	O	O
.	.	O	O

thereafter	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-PROBLEM	O
long	JJ	I-PROBLEM	O
and	CC	I-PROBLEM	O
complicated	JJ	I-PROBLEM	B-TREATMENT
postoperative	JJ	I-PROBLEM	I-TREATMENT
course	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

he	PRP	O	O
had	VBD	O	O
repeated	VBN	O	O
episodes	NNS	O	O
of	IN	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
to	TO	O	O
80-90	JJ	B-TEST	O
systolic/40-50	JJ	I-TEST	O
diastolic	NN	I-TEST	O
.	.	O	O

he	PRP	O	O
also	RB	O	O
had	VBD	O	O
repeated	VBN	B-PROBLEM	B-PROBLEM
temperature	NN	I-PROBLEM	I-PROBLEM
spikes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

after	IN	O	O
repeated	VBN	B-TEST	O
work	NN	I-TEST	O
ups	RB	I-TEST	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
that	IN	O	O
these	DT	O	O
were	VBD	O	O
probably	RB	O	O
due	JJ	O	O
to	TO	O	O
remaining	VBG	B-PROBLEM	O
infection	NN	I-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
peripancreatic	JJ	I-PROBLEM	I-PROBLEM
area	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
drainage	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
from	IN	I-TREATMENT	O
the	DT	I-TREATMENT	O
peripancreatic	JJ	I-TREATMENT	O
area	NN	I-TREATMENT	O
was	VBD	O	O
gradually	RB	O	O
advanced	JJ	O	O
,	,	O	O
and	CC	O	O
eventually	RB	O	O
discontinued	VBN	O	O
.	.	O	O

mr.	JJ	O	O
mass	NN	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
multiple	JJ	O	B-TREATMENT
courses	NNS	O	I-TREATMENT
of	IN	O	I-TREATMENT
antibiotics	NNS	B-TREATMENT	I-TREATMENT
.	.	O	O

most	RBS	O	O
recently	RB	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
on	IN	O	O
a	DT	O	O
28	CD	O	O
day	NN	O	O
course	NN	O	O
of	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
ofloxacin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
for	IN	O	O
blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
that	WDT	O	O
were	VBD	O	O
positive	JJ	O	O
for	IN	O	O
gram	JJ	B-PROBLEM	B-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
cocci	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
enteric	JJ	B-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
non-enteric	JJ	I-PROBLEM	B-TEST
gram	NN	I-PROBLEM	I-TEST
negative	JJ	I-PROBLEM	O
rods	NNS	I-PROBLEM	O
.	.	O	O

this	DT	B-TREATMENT	O
28	CD	I-TREATMENT	O
day	NN	I-TREATMENT	O
course	NN	I-TREATMENT	O
was	VBD	O	O
completed	VBN	O	O
on	IN	O	O
07/15/95	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
also	RB	O	O
treated	VBN	O	O
initially	RB	O	O
with	IN	O	O
amphotericin-b	JJ	B-TREATMENT	O
and	CC	O	O
then	RB	O	O
with	IN	O	O
fluconazole	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
a	DT	B-TEST	B-TEST
computerized	JJ	I-TEST	I-TEST
tomography	NN	I-TEST	I-TEST
guided	VBD	I-TEST	I-TEST
aspirate	NN	I-TEST	I-TEST
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
collection	NN	I-PROBLEM	I-PROBLEM
around	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
pancreas	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
grew	VBD	O	O
candida	NNS	B-PROBLEM	B-PROBLEM
albicans	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
had	VBD	O	O
several	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
fungal	JJ	B-PROBLEM	B-PROBLEM
cystitis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
torulopsis	NN	B-PROBLEM	B-PROBLEM
glabrata	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
going	VBG	O	O
from	IN	O	O
his	PRP$	B-TEST	B-TEST
urine	NN	I-TEST	I-TEST
.	.	O	O

he	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
amphotericin-b	JJ	B-TREATMENT	B-PROBLEM
bladder	NN	I-TREATMENT	I-PROBLEM
washes	NNS	I-TREATMENT	I-PROBLEM
for	IN	O	O
this	DT	O	O
.	.	O	O

mr.	JJ	O	O
mass	NN	O	O
was	VBD	O	O
initially	RB	O	O
anticoagulated	VBN	B-TREATMENT	O
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
did	VBD	O	O
have	VB	O	O
problems	NNS	B-PROBLEM	O
with	IN	O	O
po	JJ	O	B-PROBLEM
intake	NN	O	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
repeated	VBN	O	B-PROBLEM
bouts	NNS	O	I-PROBLEM
of	IN	O	I-PROBLEM
small-volume	JJ	B-PROBLEM	I-PROBLEM
emesis	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
may	MD	O	O
have	VB	O	O
been	VBN	O	O
secondary	JJ	O	O
to	TO	O	O
reflux	VB	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
a	DT	O	B-TREATMENT
variety	NN	O	I-TREATMENT
of	IN	O	I-TREATMENT
anti-emetics	NNS	B-TREATMENT	I-TREATMENT
,	,	O	O
most	JJS	O	O
recently	RB	O	O
granisetron	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
with	IN	O	O
only	JJ	O	B-PROBLEM
mild	JJ	O	I-PROBLEM
success	NN	O	I-PROBLEM
.	.	O	O

he	PRP	O	O
remained	VBD	O	O
total	JJ	B-PROBLEM	B-TREATMENT
parenteral	JJ	I-PROBLEM	I-TREATMENT
nutrition-dependent	NN	I-PROBLEM	I-TREATMENT
throughout	IN	O	O
his	PRP$	O	O
hospital	NN	O	O
course	NN	O	O
.	.	O	O

by	IN	O	O
the	DT	O	O
end	NN	O	O
of	IN	O	O
june	NN	O	O
,	,	O	O
it	PRP	O	O
became	VBD	O	O
clear	JJ	O	O
that	IN	O	O
mr.	JJ	O	O
mass	NNP	O	O
would	MD	O	O
require	VB	O	O
aggressive	JJ	B-TREATMENT	B-TREATMENT
surgical	JJ	I-TREATMENT	I-TREATMENT
intervention	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
order	NN	O	O
to	TO	O	O
eradicate	VB	O	O
his	PRP$	B-PROBLEM	B-TEST
intra-abdominal	JJ	I-PROBLEM	I-TEST
bursts	NNS	I-PROBLEM	I-TEST
of	IN	I-PROBLEM	O
intermittent	JJ	I-PROBLEM	B-PROBLEM
sepsis	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
however	RB	O	O
,	,	O	O
long	JJ	O	O
discussions	NNS	O	O
with	IN	O	O
the	DT	O	O
patient	NN	O	O
and	CC	O	O
his	PRP$	O	O
wife	NN	O	O
,	,	O	O
who	WP	O	O
was	VBD	O	O
his	PRP$	O	B-TREATMENT
health-care	JJ	O	I-TREATMENT
proxy	NN	O	I-TREATMENT
,	,	O	O
revealed	VBD	O	O
that	IN	O	O
they	PRP	O	O
felt	VBD	O	O
that	IN	O	O
no	DT	O	O
further	JJ	B-TREATMENT	B-PROBLEM
aggressive	JJ	I-TREATMENT	I-PROBLEM
intervention	NN	I-TREATMENT	I-PROBLEM
be	VB	O	O
attempted	VBN	O	O
.	.	O	O

of	IN	O	O
note	NN	O	O
,	,	O	O
given	VBN	O	O
the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
do	VBP	O	O
not	RB	O	O
resuscitate	VB	O	O
status	NN	O	O
and	CC	O	O
the	DT	B-PROBLEM	O
risk	NN	I-PROBLEM	O
for	IN	I-PROBLEM	O
bleeding	NN	I-PROBLEM	B-PROBLEM
,	,	O	O
the	DT	B-TREATMENT	B-TREATMENT
patient	NN	I-TREATMENT	I-TREATMENT
&apos;s	NNP	I-TREATMENT	I-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
stopped	VBN	O	O
without	IN	O	O
incident	JJ	O	O
several	JJ	O	O
weeks	NNS	O	O
before	IN	O	O
transfer	NN	O	O
.	.	O	O

1.	CD	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
5,000	CD	O	O
units	NNS	O	O
,	,	O	O
sc.	NN	O	O
,	,	O	O
b.i.d.	NN	O	O

2.	CD	O	O
lisinopril	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
20	CD	O	O
mg.	NN	O	O
,	,	O	O
po	NN	O	O
,	,	O	O
qd	NN	O	O
.	.	O	O

3.	CD	O	O
isordil	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
10	CD	O	O
mg.	NN	O	O
,	,	O	O
po	NN	O	O
,	,	O	O
t.i.d.	NN	O	O

4.	CD	O	O
nitropaste	NN	B-TREATMENT	O
,	,	O	O
1	CD	O	O
inch	NN	O	O
to	TO	O	O
chest	VB	O	O
wall	NN	O	O
,	,	O	O
q8h.	NN	O	O

5.	CD	O	O
carafate	NN	B-TREATMENT	O
,	,	O	O
one	CD	O	O
gram	NN	O	O
,	,	O	O
po	NN	O	O
or	CC	O	O
per	IN	O	O
nasogastric	JJ	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
q.i.d.	NN	O	O
,	,	O	O
cardizem	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
30	CD	O	O
mg.	NN	O	O
,	,	O	O
po	NN	O	O
,	,	O	O
q6h	NN	O	O
,	,	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
0.25	CD	O	O
mg.	NN	O	O
,	,	O	O
po	NN	O	O
or	CC	O	O
intravenously	RB	O	B-TREATMENT
,	,	O	O
qd	NN	O	O
,	,	O	O
fluconazole	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
200	CD	O	O
mg.	NN	O	O
,	,	O	O
qd	NN	O	O
,	,	O	O
for	IN	O	O
five	CD	O	O
more	JJR	O	O
days	NNS	O	O
,	,	O	O
after	IN	O	O
transfer	NN	O	O
,	,	O	O
for	IN	O	O
a	DT	O	O
total	NN	O	O
of	IN	O	O
a	DT	O	O
14	CD	O	O
day	NN	O	O
course	NN	O	O
,	,	O	O
total	JJ	B-TREATMENT	B-TREATMENT
parenteral	JJ	I-TREATMENT	I-TREATMENT
nutrition	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
meet	VB	O	O
the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
nutritional	JJ	O	O
needs	NNS	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
an	DT	B-TREATMENT	B-TREATMENT
ostomy	JJ	I-TREATMENT	I-TREATMENT
appliance	NN	I-TREATMENT	I-TREATMENT
around	IN	O	O
the	DT	O	O
former	JJ	O	O
site	NN	O	O
of	IN	O	O
his	PRP$	B-TREATMENT	B-PROBLEM
pancreatic	JJ	I-TREATMENT	I-PROBLEM
fistula	NN	I-TREATMENT	I-PROBLEM
drain	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

this	DT	O	O
area	NN	O	O
has	VBZ	O	O
continued	VBN	O	O
to	TO	O	O
drain	VB	O	O
and	CC	O	O
it	PRP	O	O
is	VBZ	O	O
felt	VBN	O	O
that	IN	O	O
it	PRP	O	O
could	MD	O	O
be	VB	O	O
best	RB	O	O
managed	VBN	O	O
by	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
ostomy	JJ	I-TREATMENT	I-TREATMENT
appliance	NN	I-TREATMENT	I-TREATMENT
and	CC	O	I-TREATMENT
stoma	NN	B-TREATMENT	I-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
also	RB	O	O
treated	VBN	O	O
with	IN	O	O
shots	NNS	B-TREATMENT	O
of	IN	I-TREATMENT	O
morphine	NN	I-TREATMENT	B-TREATMENT
for	IN	O	O
intermittent	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mr.	NN	O	O
olander	NN	O	O
had	VBD	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
the	DT	O	O
combination	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
gunshot	NN	I-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	O
the	DT	I-PROBLEM	O
right	JJ	I-PROBLEM	O
distal	NN	I-PROBLEM	O
femur	NN	I-PROBLEM	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
requirements	NNS	O	O
for	IN	O	O
urgent	JJ	B-TREATMENT	B-TREATMENT
open	JJ	I-TREATMENT	I-TREATMENT
reduction	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
internal	JJ	B-TREATMENT	B-TREATMENT
fixation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
dropped	VBD	O	O
down	RB	O	O
to	TO	O	O
the	DT	O	O
level	NN	O	O
of	IN	O	O
20	CD	O	O
.	.	O	O

although	IN	O	O
he	PRP	O	O
remained	VBD	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
,	,	O	O
we	PRP	O	O
elected	VBD	O	O
to	TO	O	O
move	VB	O	O
ahead	RB	O	O
and	CC	O	O
transfuse	VB	O	O
him	PRP	O	O
with	IN	O	O
nonautologous	JJ	B-TREATMENT	B-TREATMENT
prbc	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

left	VBN	B-TREATMENT	B-PROBLEM
axillary	JJ	I-TREATMENT	I-PROBLEM
node	NN	I-TREATMENT	I-PROBLEM
dissection	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
breast	NN	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
49	CD	O	O
year	NN	O	O
old	JJ	O	O
previously	RB	O	O
healthy	JJ	O	O
female	NN	O	O
,	,	O	O
who	WP	O	O
was	VBD	O	O
diagnosed	VBN	O	O
in	IN	O	O
june	NN	O	O
,	,	O	O
1992	CD	O	O
,	,	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
breast	NN	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
after	IN	O	O
she	PRP	O	O
presented	VBD	O	O
with	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
breast	NN	I-PROBLEM	I-PROBLEM
discomfort	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
side	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
underwent	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
wide	JJ	I-TREATMENT	I-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
breast	NN	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
by	IN	O	O
dr.	NN	O	O
ausguall	NN	O	O
on	IN	O	O
8/17/93	CD	O	O
.	.	O	O

pathology	NN	B-TEST	O
of	IN	O	O
this	DT	B-TREATMENT	B-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
grade	NN	I-PROBLEM	I-PROBLEM
iii	NN	I-PROBLEM	I-PROBLEM
/	NNP	I-PROBLEM	I-PROBLEM
iii	NN	I-PROBLEM	I-PROBLEM
infiltrating	VBG	I-PROBLEM	I-PROBLEM
ductal	JJ	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
now	RB	O	O
presents	VBZ	O	O
for	IN	O	O
left	JJ	B-TREATMENT	B-TREATMENT
axillary	JJ	I-TREATMENT	I-TREATMENT
node	NN	I-TREATMENT	I-TREATMENT
dissection	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
to	TO	O	O
complete	VB	O	O
her	PRP$	O	O
staging	NN	O	O
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

is	VBZ	O	O
negative	JJ	O	O
,	,	O	O
there	EX	O	O
is	VBZ	O	O
no	DT	O	O
breast	NN	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
pleasant	JJ	O	O
female	NN	O	O
,	,	O	O
in	IN	O	O
no	DT	O	O
apparent	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
vital	JJ	I-TEST	I-TEST
signs	NNS	I-TEST	I-TEST
are	VBP	O	O
stable	JJ	O	O
,	,	O	O
she	PRP	O	O
is	VBZ	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

reveals	NNS	O	O
no	DT	O	O
adenopathy	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
extra	JJ	O	O
ocular	JJ	O	O
movements	NNS	O	O
intact	JJ	O	O
,	,	O	O
pupils	JJ	O	O
equal	JJ	O	O
,	,	O	O
round	NN	O	O
,	,	O	O
reactive	JJ	O	O
to	TO	O	O
light	JJ	O	O
and	CC	O	O
accommodation	NN	O	O
.	.	O	O

regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
normal	JJ	O	O
first	JJ	O	O
and	CC	O	O
second	JJ	O	B-PROBLEM
heart	NN	O	I-PROBLEM
sounds	VBZ	O	I-PROBLEM
,	,	O	O
no	DT	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
rub	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
gallop	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
lungs	NNS	O	O
were	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	NN	B-TEST	B-TEST
and	CC	O	O
percussion	NN	B-TEST	B-TEST
.	.	O	O

soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBD	B-PROBLEM	B-PROBLEM
,	,	O	O
positive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
,	,	O	O
there	EX	O	O
is	VBZ	O	O
no	DT	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

reveals	NNS	O	O
a	DT	B-PROBLEM	B-PROBLEM
well	RB	I-PROBLEM	I-PROBLEM
healed	VBN	I-PROBLEM	I-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
side	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
there	EX	O	O
are	VBP	O	O
no	DT	O	O
axillary	JJ	O	B-PROBLEM
lymph	NN	O	I-PROBLEM
nodes	NNS	O	I-PROBLEM
palpable	JJ	O	I-PROBLEM
on	IN	O	O
both	DT	O	O
sides	NNS	O	O
.	.	O	O

reveal	NN	O	O
no	DT	O	O
clubbing	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

sodium	NN	B-TEST	B-TEST
140	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.4	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
14/.9	CD	O	O
,	,	O	O
glucose	RB	B-TEST	B-TEST
95	CD	O	O
,	,	O	O
prothrombin	JJ	B-TEST	B-TEST
time	NN	I-TEST	I-TEST
10.0	CD	O	O
,	,	O	O
with	IN	O	O
a	DT	O	B-TREATMENT
control	NN	O	I-TREATMENT
of	IN	O	O
10.2	CD	O	O
,	,	O	O
partial	JJ	B-TEST	B-TEST
thromboplastin	NN	I-TEST	I-TEST
time	NN	I-TEST	I-TEST
26.9	CD	O	O
,	,	O	O
urinalysis	NN	B-TEST	B-TEST
negative	JJ	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
5.8	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
37.5	CD	O	O
,	,	O	O
hemoglobin	NN	B-TEST	B-TEST
13.4	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
274,000	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
reveals	NNS	O	O
normal	JJ	O	O
sinus	JJ	O	O
rhythm	NN	O	O
at	IN	O	O
66	CD	O	O
beats	NNS	O	O
per	IN	O	O
minute	NN	O	O
,	,	O	O
with	IN	O	O
no	DT	O	O
st	NN	B-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
there	EX	O	O
is	VBZ	O	O
r	JJ	B-PROBLEM	B-PROBLEM
wave	JJ	I-PROBLEM	I-PROBLEM
progression	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
on	IN	O	O
9/14/93	CD	O	O
,	,	O	O
and	CC	O	O
underwent	NN	O	O
on	IN	O	O
that	DT	O	O
same	JJ	O	O
day	NN	O	O
,	,	O	O
a	DT	B-TREATMENT	B-PROBLEM
left	JJ	I-TREATMENT	I-PROBLEM
axillary	JJ	I-TREATMENT	I-PROBLEM
lymph	NN	I-TREATMENT	I-PROBLEM
nodes	NNS	I-TREATMENT	I-PROBLEM
dissection	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
by	IN	O	O
dr.	NN	O	O
ausguall	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
,	,	O	O
there	EX	O	O
were	VBD	O	O
no	DT	O	O
complications	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

at	IN	O	O
that	DT	O	O
time	NN	O	O
her	PRP$	B-TREATMENT	O
jp	NN	I-TREATMENT	O
was	VBD	O	O
still	RB	O	O
in	IN	O	O
place	NN	O	O
.	.	O	O

patient	NN	O	O
will	MD	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
dr.	NN	O	O
ausguall	NN	O	O
,	,	O	O
in	IN	O	O
about	IN	O	O
4-5	JJ	O	O
days	NNS	O	O
,	,	O	O
at	IN	O	O
which	WDT	O	O
time	NN	O	O
the	DT	B-TREATMENT	O
jp	NN	I-TREATMENT	O
drain	NN	I-TREATMENT	O
will	MD	O	O
be	VB	O	O
removed	VBN	O	O
.	.	O	O

percocet	JJ	B-TREATMENT	B-TREATMENT
1-2	JJ	O	I-TREATMENT
tablets	NNS	O	I-TREATMENT
po	VBP	O	O
q3-4	JJ	O	O
prn	NN	O	O
.	.	O	O

patient	NN	O	O
recorded	VBD	O	O
as	IN	O	O
having	VBG	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
to	TO	O	O
drugs	NNS	B-TREATMENT	B-TREATMENT

abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

intubation	NN	B-TREATMENT	B-TREATMENT

ercp	NN	B-TEST	O
with	IN	O	O
stent	NN	B-TREATMENT	B-TREATMENT

blood	NN	B-TREATMENT	B-TEST
transfusion	NN	I-TREATMENT	I-TEST

pt	NN	O	O
is	VBZ	O	O
a	DT	O	O
78	CD	O	O
yo	NN	O	O
male	NN	O	O
with	IN	O	O
h/o	PDT	O	O
a	DT	B-PROBLEM	B-PROBLEM
fib	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
s/p	JJ	O	O
multiple	JJ	B-PROBLEM	B-TREATMENT
cva	NN	I-PROBLEM	I-TREATMENT
s,	NN	I-PROBLEM	I-TREATMENT
chf	NN	B-PROBLEM	I-TREATMENT
,	,	O	O
htn	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
dm2	RB	B-PROBLEM	O
admitted	VBN	O	O
to	TO	O	O
mediplex	VB	O	O
rehab	JJ	O	O
hospital	NN	O	O
robert	NN	O	O
on	IN	O	O
02-01	JJ	O	O
with	IN	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
n/v	NN	B-PROBLEM	B-PROBLEM
since	IN	O	O
that	DT	O	O
morning	NN	O	O
.	.	O	O

pt	NN	B-TEST	B-TEST
's	POS	I-TEST	I-TEST
vitals	NNS	I-TEST	I-TEST
on	IN	O	O
admission	NN	O	O
wer	NN	O	O
significant	JJ	O	O
for	IN	O	O
t	NN	B-TEST	O
104	CD	O	O
,	,	O	O
sbp	VBD	B-TEST	O
100	CD	O	O
s,	NN	O	O
hr	NN	B-TEST	O
in	IN	O	O
the	DT	O	O
120	CD	O	O
s.	NN	O	O

ruq	NN	B-TEST	O
u/s	NN	I-TEST	O
demonstrated	VBD	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
gallstones	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
sludges	NNS	B-PROBLEM	O
without	IN	O	O
evidence	NN	O	O
of	IN	O	O
pericholecystic	JJ	B-PROBLEM	B-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
dilatation	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
gallbladder	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

surgery	NN	O	B-TREATMENT
was	VBD	O	O
consulted	VBN	O	O
for	IN	O	O
concern	NN	O	O
of	IN	O	O
cholangitis	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
probable	JJ	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

pt	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
ccu	NN	O	O
,	,	O	O
intubated	VBD	B-TREATMENT	B-TREATMENT
overnight	JJ	O	O
for	IN	O	O
ercp	JJ	B-TEST	B-TREATMENT
procedure	NN	I-TEST	I-TREATMENT
and	CC	O	O
fluid	JJ	B-TREATMENT	B-TREATMENT
resuscitation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
zosyn	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

pt	NN	B-TEST	B-TEST
's	POS	I-TEST	I-TEST
inr	NN	I-TEST	I-TEST
was	VBD	O	O
eleveted	VBN	B-PROBLEM	O
as	IN	O	O
he	PRP	O	O
was	VBD	O	O
on	IN	O	O
home	NN	B-TREATMENT	B-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
given	VBN	O	O
4	CD	B-TREATMENT	O
units	NNS	I-TREATMENT	O
ffp	VBN	I-TREATMENT	O
in	IN	O	O
anticipation	NN	O	O
of	IN	O	O
ercp	FW	B-TEST	O
the	DT	O	O
following	JJ	O	O
day	NN	O	O
.	.	O	O

on	IN	O	O
02-02	JJ	O	O
ercp	NN	B-TEST	O
demonstrated	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
filling	NN	I-PROBLEM	I-PROBLEM
defect	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
distal	JJ	I-PROBLEM	O
duct	NN	I-PROBLEM	O
representing	VBG	O	O
a	DT	B-PROBLEM	O
stone	NN	I-PROBLEM	O
with	IN	O	O
cbd	JJ	B-PROBLEM	B-PROBLEM
dilatation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
biliary	JJ	I-TREATMENT	I-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
after	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
removal	NN	I-TREATMENT	I-TREATMENT
of	IN	O	I-TREATMENT
the	DT	B-PROBLEM	I-TREATMENT
stone	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

1)	CD	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM

2)	CD	O	O
s/p	JJ	O	O
mvr	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
mechanical	JJ	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT

3)	CD	O	O
chf	NN	B-PROBLEM	O
ef	NN	B-TEST	O
15%	CD	O	O

4)	CD	O	O
htn	NN	B-PROBLEM	B-PROBLEM

5)	CD	O	O
multiple	JJ	B-PROBLEM	O
cva	NN	I-PROBLEM	O
s	NN	I-PROBLEM	O
(	(	O	O
last	JJ	O	O
1998	CD	O	O
)	)	O	O

6)	CD	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM

7)	CD	O	O
type	NN	B-PROBLEM	O
ii	NN	I-PROBLEM	O
dm	NN	I-PROBLEM	O

8)	CD	O	O
multiple	JJ	B-PROBLEM	O
prior	RB	I-PROBLEM	O
uti	JJ	I-PROBLEM	O

t	NN	B-TEST	O
:	:	O	O
99.0	CD	O	O
;	:	O	O
bp	CC	B-TEST	O
142/61	CD	O	O
;	:	O	O
pulse	JJ	B-TEST	B-TEST
65	CD	O	O
;	:	O	O
resp	VB	B-TEST	B-TREATMENT
20	CD	O	O
;	:	O	O
o2	PRP	B-TEST	B-TEST
sat	VBD	I-TEST	I-TEST
96%	CD	O	O
ra	NN	O	O

gen	NN	O	O
-	:	O	O
alert	NN	O	O
,	,	O	O
no	DT	O	O
acute	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM

heent	NN	O	O
-	:	O	O
mucous	JJ	B-PROBLEM	B-PROBLEM
membranes	NNS	I-PROBLEM	I-PROBLEM
slightly	RB	I-PROBLEM	I-PROBLEM
dry	VBP	I-PROBLEM	I-PROBLEM

neck	SYM	O	B-TEST
-	:	O	O
no	DT	O	O
jvd	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
cervical	JJ	B-PROBLEM	B-PROBLEM
lymphadenopathy	NN	I-PROBLEM	I-PROBLEM

cv	SYM	O	O
-	:	O	O
normal	JJ	O	O
s1/s2	NN	O	O
,	,	O	O
irreg	NN	B-PROBLEM	O
irreg	NN	I-PROBLEM	O

abd	SYM	O	B-TEST
-	:	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
distension	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
normoactive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O

extr	SYM	O	B-TEST
-	:	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2+	CD	O	O
dp	NN	B-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
bilaterally	RB	O	O

neur	NN	O	O
:	:	O	O
a	DT	O	O
&	CC	O	O
o	NN	O	O
x3	NN	O	O
,	,	O	O
dysarthric	JJ	B-PROBLEM	B-PROBLEM
speech	NN	I-PROBLEM	I-PROBLEM
,	,	O	O

cn	NN	O	O
:	:	O	O
mild	NN	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
facial	JJ	I-PROBLEM	I-PROBLEM
droop	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
o/w	JJ	O	O
appears	VBZ	O	O
intact	JJ	O	O
;	:	O	O
4/5	CD	O	O
strength	NN	O	O
on	IN	O	O
flex	NN	O	B-TREATMENT
at	IN	O	O
elbows	NNS	O	O
b/l	VBP	O	O
,	,	O	O
legs	JJ	O	O
06-22	JJ	O	O
strength	NN	O	O
,	,	O	O
dtr	NN	O	O
s	NN	O	O
intact	JJ	O	O
,	,	O	O
sensation	NN	O	O
intact	JJ	O	O

skin	SYM	O	B-TEST
-	:	O	O
no	DT	O	O
rash	NN	B-PROBLEM	B-PROBLEM

ercp	JJ	O	O
report	NN	O	O
:	:	O	O
four	CD	B-TEST	O
fluoroscopic	NN	I-TEST	B-TEST
images	NNS	I-TEST	I-TEST
and	CC	O	O
ercp	NNS	B-TEST	O
are	VBP	O	O
provided	VBN	O	O
.	.	O	O

a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
filling	NN	I-PROBLEM	I-PROBLEM
defect	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
seen	VBN	O	O
in	IN	O	O
the	DT	O	O
distal	JJ	O	O
duct	NN	O	O
representing	VBG	O	O
a	DT	B-PROBLEM	O
stone	NN	I-PROBLEM	O
.	.	O	O

the	DT	O	O
common	JJ	O	O
duct	NN	O	O
is	VBZ	O	O
dilated	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

subsequent	JJ	B-TREATMENT	B-TREATMENT
biliary	JJ	I-TREATMENT	I-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
after	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
removal	NN	I-TREATMENT	I-TREATMENT
of	IN	O	I-TREATMENT
the	DT	B-PROBLEM	I-TREATMENT
stone	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
:	:	O	O

2019-02-01	JJ	O	O
(	(	O	O
4	CD	O	O
of	IN	O	O
4	CD	O	O
bottles	NNS	O	O
)	)	O	O
e.coli	VBP	B-PROBLEM	O

cxr	NN	B-TEST	O
:	:	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

echo	NN	B-TEST	B-TEST
:	:	O	O

the	DT	O	O
left	JJ	O	O
atrium	NN	O	O
is	VBZ	O	O
markedly	RB	B-PROBLEM	B-PROBLEM
dilated	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
symmetric	JJ	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	B-TEST
left	NN	O	I-TEST
ventricular	JJ	O	I-TEST
cavity	NN	O	I-TEST
is	VBZ	O	O
moderately	RB	B-PROBLEM	B-PROBLEM
dilated	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
global	JJ	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
hypokinesis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

overall	JJ	O	B-TEST
left	VBD	O	I-TEST
ventricular	JJ	O	I-TEST
systolic	JJ	O	I-TEST
function	NN	O	I-TEST
is	VBZ	O	O
moderately	RB	B-PROBLEM	B-PROBLEM
depressed	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

right	RB	B-TEST	O
ventricular	JJ	I-TEST	O
chamber	NN	I-TEST	O
size	NN	I-TEST	O
and	CC	O	O
free	JJ	O	O
wall	NN	O	O
motion	NN	O	O
are	VBP	O	O
normal	JJ	O	O
.	.	O	O

right	RB	B-TEST	B-TEST
ventricular	JJ	I-TEST	I-TEST
systolic	JJ	I-TEST	I-TEST
function	NN	I-TEST	I-TEST
is	VBZ	O	O
normal	JJ	O	O
.	.	O	O

[	NN	O	B-TEST
intrinsic	JJ	B-TEST	I-TEST
right	JJ	I-TEST	I-TEST
ventricular	NN	I-TEST	I-TEST
systolic	JJ	I-TEST	I-TEST
function	NN	I-TEST	I-TEST
is	VBZ	O	O
likely	JJ	O	O
more	RBR	B-PROBLEM	O
depressed	JJ	I-PROBLEM	O
given	VBN	O	O
the	DT	O	O
severity	NN	O	O
of	IN	O	O
tricuspid	JJ	B-PROBLEM	B-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
.]	NN	O	I-PROBLEM

the	DT	O	O
aortic	JJ	O	O
valve	NN	O	O
leaflets	NNS	O	O
(	(	O	O
3	CD	O	O
)	)	O	O
are	VBP	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
thickened	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
aortic	JJ	B-PROBLEM	B-PROBLEM
valve	NN	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mild	NN	B-PROBLEM	B-PROBLEM
(	(	I-PROBLEM	I-PROBLEM
1+	CD	I-PROBLEM	I-PROBLEM
)	)	I-PROBLEM	I-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
seen	VBN	O	O
.	.	O	O

a	DT	B-TREATMENT	B-TREATMENT
bileaflet	NN	I-TREATMENT	I-TREATMENT
mitral	JJ	I-TREATMENT	I-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
prosthesis	NN	I-TREATMENT	I-TREATMENT
is	VBZ	O	O
present	JJ	O	O
.	.	O	O

the	DT	B-TEST	O
transmitral	JJ	I-TEST	O
gradient	NN	I-TEST	O
is	VBZ	O	O
normal	JJ	O	O
for	IN	O	O
this	DT	B-TREATMENT	B-TREATMENT
prosthesis	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

no	DT	O	O
mitral	JJ	B-PROBLEM	B-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
seen	VBN	O	O
.	.	O	O

mild	NN	B-PROBLEM	B-PROBLEM
(	(	I-PROBLEM	I-PROBLEM
1+	CD	I-PROBLEM	I-PROBLEM
)	)	I-PROBLEM	I-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
seen	VBN	O	O
.	.	O	O

[	NNS	O	O
due	JJ	O	O
to	TO	O	O
acoustic	JJ	O	O
shadowing	NN	O	O
,	,	O	O
the	DT	O	B-PROBLEM
severity	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
mitral	JJ	B-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
may	MD	O	O
be	VB	O	O
significantly	RB	O	O
underestimated	JJ	O	O
.]	NN	O	O

the	DT	O	O
tricuspid	JJ	O	O
valve	NN	O	O
leaflets	NNS	O	O
are	VBP	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
thickened	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

moderate	JJ	B-PROBLEM	B-PROBLEM
[	$	I-PROBLEM	I-PROBLEM
2+	CD	I-PROBLEM	I-PROBLEM
]	NNP	I-PROBLEM	I-PROBLEM
tricuspid	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
seen	VBN	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
pericardial	JJ	B-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2019-02-01	JJ	O	O
03:20	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
wbc	SYM	B-TEST	B-TEST
-	:	O	O
11.7	CD	O	O
*#	NN	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
4.72	CD	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
14.1	CD	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
42.7	CD	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
91	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
29.9	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
33.1	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
14.9	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
91	CD	O	O
*	NN	O	O

2019-02-01	JJ	O	O
03:20	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	O
neuts	NNS	B-TEST	B-TEST
-	:	O	O
94.6	CD	O	O
*	NN	O	O
bands	NNS	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
lymphs	SYM	B-TEST	B-TEST
-	:	O	O
2.7	CD	O	O
*	JJ	O	O
monos	NNS	B-TEST	B-TEST
-	:	O	O
1.9	CD	O	O
*	NN	O	O
eos	SYM	B-TEST	B-TEST
-	:	O	O
0.4	CD	O	O
baso	SYM	B-TEST	B-TEST
-	:	O	O
0.4	CD	O	O

2019-02-01	JJ	O	O
03:20	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
pt	NN	B-TEST	I-TEST
-	:	O	O
28.0	CD	O	O
*	NN	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
26.7	CD	O	O
inr(pt)	JJ	B-TEST	O
-	:	O	O
2.9	CD	O	O
*	NN	O	O

2019-02-01	JJ	O	O
03:20	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	O
glucose	VB	B-TEST	B-TEST
-	:	O	O
202	CD	O	O
*	JJ	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
31	CD	O	O
*	NN	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.3	CD	O	O
*	NN	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
141	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
4.0	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
102	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
27	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
16	CD	O	O

2019-02-01	JJ	O	O
03:20	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
alt	SYM	B-TEST	B-TEST
-	:	O	O
167	CD	O	O
*	NN	O	O
ast	VBD	B-TEST	B-TEST
-	:	O	O
218	CD	O	O
*	NN	O	O
alkphos	SYM	B-TEST	B-TEST
-	:	O	O
108	CD	O	O
amylase	NN	B-TEST	B-TEST
-	:	O	O
117	CD	O	O
*	NN	O	O
totbili	SYM	B-TEST	B-TEST
-	:	O	O
3.6	CD	O	O
*	NN	O	O

2019-02-02	JJ	O	O
03:54	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	O
lipase	NN	B-TEST	B-TEST
-	:	O	O
992	CD	O	O
*	NN	O	O

2019-02-01	JJ	O	O
03:20	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
albumin	SYM	B-TEST	B-TEST
-	:	O	O
4.8	CD	O	O
calcium	NN	B-TEST	B-TEST
-	:	O	O
9.4	CD	O	O
phos	NN	B-TEST	B-TEST
-	:	O	O
1.9	CD	O	O
*	NN	O	O
mg	SYM	B-TEST	O
-	:	O	O
2.0	CD	O	O

2019-02-01	JJ	O	O
04:15	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
digoxin	NN	B-TEST	I-TEST
-	:	O	O
0.3	CD	O	O
*	NN	O	O

2019-02-01	JJ	O	O
11:43	CD	O	O
pm	NN	O	B-TEST
blood	NN	B-TEST	I-TEST
type	NN	I-TEST	I-TEST
-	:	O	O
art	NN	O	O
temp	SYM	B-TEST	B-TEST
-	:	O	O
38.3	CD	O	O
peep	JJ	B-TREATMENT	O
-	:	O	O
5	CD	O	O
po2	NN	B-TEST	O
-	:	O	O
115	CD	O	O
*	NN	O	O
pco2	NN	B-TEST	B-TEST
-	:	O	O
36	CD	O	O
ph	NN	B-TEST	B-TEST
-	:	O	O
7.33	CD	O	O
*	NN	O	O
caltco2	NN	B-TEST	B-TEST
-	:	O	O
20	CD	O	O
*	JJ	O	O
base	NN	B-TEST	B-TEST
xs	NNP	I-TEST	I-TEST
-	:	O	I-TEST
-6	NN	O	I-TEST
intubat	NN	O	I-TEST
-	:	O	O
intubated	VBN	B-TREATMENT	B-TREATMENT

2019-02-01	JJ	O	B-TEST
04:06	CD	O	I-TEST
pm	NN	O	I-TEST
blood	NN	B-TEST	I-TEST
lactate	NN	B-TEST	I-TEST
-	:	O	O
3.4	CD	O	O
*	NN	O	O

2019-02-01	JJ	O	O
08:00	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
lactate	NN	B-TEST	I-TEST
-	:	O	O
6.4	CD	O	O
*	NN	O	O

2019-02-06	JJ	O	O
06:30	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	B-TEST	B-TEST
-	:	O	O
7.4	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.82	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
11.3	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
34.7	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
91	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
29.5	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
32.5	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
15.1	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
92	CD	O	O
*	NN	O	O

2019-02-09	JJ	O	O
04:45	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
pt	NN	B-TEST	I-TEST
-	:	O	O
19.6	CD	O	O
*	NN	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
74.9	CD	O	O
*	NN	O	O
inr(pt)	NN	B-TEST	B-TEST
-	:	O	O
1.9	CD	O	O
*	NN	O	O

2019-02-07	JJ	O	O
09:00	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
124	CD	O	O
*	JJ	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
26	CD	O	O
*	NN	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.2	CD	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
140	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
3.7	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
102	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
29	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
13	CD	O	O

2019-02-07	JJ	O	O
09:00	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
alt	NN	B-TEST	I-TEST
-	:	O	O
62	CD	O	O
*	NN	O	O
ast	VBD	B-TEST	B-TEST
-	:	O	O
45	CD	O	O
*	NN	O	O
alkphos	SYM	B-TEST	B-TEST
-	:	O	O
105	CD	O	O
totbili	SYM	B-TEST	B-TEST
-	:	O	O
2.2	CD	O	O
*	NN	O	O

2019-02-04	JJ	O	O
02:40	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
lipase	NN	B-TEST	B-TEST
-	:	O	O
74	CD	O	O
*	NN	O	O

2019-02-07	JJ	O	O
09:00	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
mg	NN	B-TEST	O
-	:	O	O
2.0	CD	O	O

2019-02-04	JJ	O	O
02:50	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
lactate	NN	B-TEST	I-TEST
-	:	O	O
1.0	CD	O	O

pt	NN	O	O
is	VBZ	O	O
a	DT	O	O
78	CD	O	O
yo	NN	O	O
male	NN	O	O
with	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
s/p	JJ	O	O
multiple	JJ	B-PROBLEM	B-TREATMENT
cva	NN	I-PROBLEM	I-TREATMENT
s,	NN	I-PROBLEM	I-TREATMENT
chf	NN	B-PROBLEM	I-TREATMENT
,	,	O	O
htn	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
dm2	NN	B-PROBLEM	O
transferred	VBD	O	O
from	IN	O	O
the	DT	O	O
cmed	VBN	O	O
ccu	NN	O	O
s/p	NN	O	O
intervention	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
cholangitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1)	CD	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
cholangitis	NN	I-PROBLEM	I-PROBLEM
:	:	O	O
pt	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
icu	NN	O	O
,	,	O	O
intubated	VBN	O	B-TREATMENT
,	,	O	O
and	CC	O	O
ercp	NN	B-TEST	O
performed	NN	O	O
,	,	O	O
likely	RB	O	O
stone	NN	B-PROBLEM	O
obstructing	VBG	O	O
cbd	NN	O	O
.	.	O	O

stent	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
placed	VBN	O	O
and	CC	O	O
patient	NN	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
(	(	O	O
zosyn	SYM	B-TREATMENT	B-TEST
-	:	O	O
>	NN	O	O
ciprofloxacin	NN	B-TREATMENT	B-TREATMENT
).	NN	O	O

per	IN	O	O
ercp	NN	O	O
fellow	NN	O	O
,	,	O	O
plan	NN	O	O
is	VBZ	O	O
for	IN	O	O
patient	NN	O	O
to	TO	O	O
return	VB	O	O
in	IN	O	O
four	CD	O	O
weeks	NNS	O	O
to	TO	O	O
see	VB	O	O
dr.	JJ	O	O
suzanne	NN	O	O
davis	NN	O	O
,	,	O	O
at	IN	O	O
which	WDT	O	O
time	NN	O	O
he	PRP	O	O
will	MD	O	O
likely	RB	O	O
have	VB	O	O
repeat	NN	B-TEST	B-TEST
cholangiogram	NN	I-TEST	I-TEST
and	CC	O	O
removal	NN	B-TREATMENT	B-TREATMENT
of	IN	O	I-TREATMENT
stent	NN	B-TREATMENT	I-TREATMENT
and	CC	O	O
stone	NN	B-PROBLEM	O
.	.	O	O

if	IN	O	O
this	DT	O	O
is	VBZ	O	O
still	RB	O	O
problematic	JJ	O	O
,	,	O	O
pt	NN	O	O
may	MD	O	O
also	RB	O	O
need	VB	O	O
a	DT	B-TREATMENT	B-TREATMENT
sphincterotomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

pt	NN	O	O
is	VBZ	O	O
to	TO	O	O
continue	VB	O	O
ciprofloxacin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
a	DT	O	O
complete	JJ	O	O
14	CD	O	O
day	NN	O	O
course	NN	O	O
.	.	O	O

2)	CD	O	O
mechanical	JJ	B-TREATMENT	O
mitral	JJ	I-TREATMENT	O
valve	NN	I-TREATMENT	O
:	:	O	O
anticoagulation	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
reversed	VBN	O	O
for	IN	O	O
ercp	NN	B-TEST	O
.	.	O	O

after	IN	O	O
this	DT	O	O
he	PRP	O	O
was	VBD	O	O
anticoagulated	VBN	O	O
with	IN	O	O
heparin	JJ	B-TREATMENT	B-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

inr	NN	B-TEST	O
was	VBD	O	O
1.9	CD	O	O
on	IN	O	O
discharge	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
given	VBN	O	O
sc	JJ	B-TREATMENT	B-TREATMENT
lovenox	NN	I-TREATMENT	I-TREATMENT
x	VBD	O	O
1	CD	O	O
and	CC	O	O
will	MD	O	O
continue	VB	O	O
this	DT	O	O
the	DT	O	O
day	NN	O	O
after	IN	O	O
discharge	NN	O	O
bid	NN	O	O
for	IN	O	O
one	CD	O	O
day	NN	O	O
.	.	O	O

vna	NN	O	O
will	MD	O	O
check	VB	O	O
his	PRP$	B-TEST	B-TEST
inr	NN	I-TEST	I-TEST
at	IN	O	O
home	NN	O	O
and	CC	O	O
page	VB	O	O
his	PRP$	O	O
pcp	NN	O	O
with	IN	O	O
the	DT	O	O
results	NNS	O	O
.	.	O	O

3)	CD	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
:	:	O	O
rate	NN	O	O
controlled	VBN	O	O
and	CC	O	O
on	IN	O	O
warfarin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

while	IN	O	O
in	IN	O	O
the	DT	O	O
hospital	NN	O	O
he	PRP	O	O
had	VBD	O	O
several	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
pauses	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
none	NN	O	O
longer	JJR	O	O
than	IN	O	O
2.5	CD	O	O
seconds	NNS	O	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TEST
digoxin	NN	I-TREATMENT	I-TEST
was	VBD	O	O
held	VBN	O	O
and	CC	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
metoprolol	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
titrated	VBN	O	O
down	RP	O	O
from	IN	O	O
his	PRP$	B-TREATMENT	O
home	NN	I-TREATMENT	O
dose	NN	I-TREATMENT	O
.	.	O	O

once	RB	O	O
the	DT	B-TREATMENT	B-TREATMENT
digoxin	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
no	RB	O	O
longer	RB	O	B-PROBLEM
having	VBG	O	I-PROBLEM
effect	NN	O	I-PROBLEM
,	,	O	O
metoprolol	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
titrated	VBN	O	O
back	RB	O	O
to	TO	O	O
home	NN	O	O
dose	NN	O	O
.	.	O	O

4)	CD	O	O
chf	NN	B-PROBLEM	O
:	:	O	O
pt	NN	O	O
was	VBD	O	O
oxygen	JJ	B-PROBLEM	B-PROBLEM
dependent	NN	I-PROBLEM	I-PROBLEM
for	IN	O	O
most	JJS	O	O
of	IN	O	O
the	DT	O	O
hospital	NN	O	O
course	NN	O	O
,	,	O	O
cxr	NN	B-TEST	O
was	VBD	O	O
consistent	JJ	O	O
with	IN	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
diuresed	VBN	O	O
with	IN	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
good	JJ	O	O
effect	NN	O	O
.	.	O	O

volume	NN	B-PROBLEM	B-PROBLEM
overload	NN	I-PROBLEM	I-PROBLEM
likely	RB	O	O
ocurred	VBN	O	O
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
given	VBN	O	O
in	IN	O	O
the	DT	O	O
icu	NN	O	O
.	.	O	O

did	VBD	O	O
not	RB	O	O
require	VB	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
on	IN	O	O
discharge	NN	O	O
.	.	O	O

5)	CD	O	O
e.	JJ	B-PROBLEM	B-PROBLEM
coli	NNS	I-PROBLEM	I-PROBLEM
bacteremia	VBP	I-PROBLEM	I-PROBLEM
/	JJ	O	I-PROBLEM
sepsis	NN	B-PROBLEM	I-PROBLEM
:	:	O	O
source	NN	O	O
of	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
cholangitis	NN	I-PROBLEM	I-PROBLEM
as	IN	O	O
above	NN	O	O
.	.	O	O

pt	NN	O	O
required	VBD	O	O
3	CD	O	O
day	NN	O	O
stay	VB	O	O
in	IN	O	O
the	DT	O	O
surgical	JJ	O	O
icu	NN	O	O
and	CC	O	O
intubation	NN	B-TREATMENT	B-TREATMENT
as	IN	O	O
above	NN	O	O
.	.	O	O

6)	CD	O	O
intubation	NN	B-TREATMENT	O
:	:	O	O
pt	NN	O	O
was	VBD	O	O
97%	CD	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
on	IN	O	O
arrival	NN	O	O
to	TO	O	O
cindy	VB	O	O
,	,	O	O
developed	VBN	O	O
rapid	JJ	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
reponse	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
a	DT	B-PROBLEM	B-PROBLEM
fib	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
treated	VBN	O	O
,	,	O	O
but	CC	O	O
after	IN	O	O
that	DT	O	O
period	NN	O	O
of	IN	O	O
time	NN	O	O
required	VBN	O	O
oxygen	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
presumably	RB	O	O
for	IN	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

in	IN	O	O
the	DT	O	O
lori	JJ	O	O
pt	NN	O	O
was	VBD	O	O
given	VBN	O	O
3l	CD	B-TREATMENT	O
ns	NN	I-TREATMENT	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
1	CD	O	O
unit	NN	O	O
of	IN	O	O
ffp	NN	B-TREATMENT	O
,	,	O	O
and	CC	O	O
oxygen	NN	B-PROBLEM	B-TREATMENT
requirements	NNS	I-PROBLEM	I-TREATMENT
contimued	VBN	O	O
to	TO	O	O
climb	VB	O	O
.	.	O	O

in	IN	O	O
the	DT	O	O
cmed	JJ	O	O
ccu	NN	O	O
pt	NN	O	O
was	VBD	O	O
intubated	VBN	O	B-TREATMENT
for	IN	O	O
ercp	JJ	B-TEST	B-TREATMENT
procedure	NN	I-TEST	I-TREATMENT
.	.	O	O

lisinopril	RB	B-TREATMENT	B-TREATMENT
2.5	CD	O	O
qday	NN	O	O
,	,	O	O
buspiron	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
po	NN	O	O
qday	NN	O	O
,	,	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
doxasozin	VBZ	B-TREATMENT	B-TREATMENT
8	CD	O	O
mg	NN	O	O
qhs	NN	O	O
,	,	O	O
glyburide	RB	B-TREATMENT	B-TREATMENT
2.5	CD	O	O
mg	NN	O	O
qday	NN	O	O
,	,	O	O
metoprolol	FW	B-TREATMENT	B-TREATMENT
bid	NN	O	I-TREATMENT
,	,	O	O
atorvastatin	VBZ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
qday	NN	O	O
,	,	O	O
warfarin	WP	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
qday	NN	O	O

1.	CD	O	O
ciprofloxacin	NN	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q12h	NN	O	O
(	(	O	O
every	DT	O	O
12	CD	O	O
hours	NNS	O	O
)	)	O	O
for	IN	O	O
6	CD	O	O
days	NNS	O	O
.	.	O	O

2.	CD	O	O
medications	NNS	B-TREATMENT	B-TREATMENT

continue	VB	O	O
all	DT	B-TREATMENT	B-TREATMENT
other	JJ	I-TREATMENT	I-TREATMENT
home	NN	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
except	IN	O	O
do	VBP	O	O
not	RB	O	O
take	VB	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

acute	NN	B-PROBLEM	B-PROBLEM
cholangitis	NN	I-PROBLEM	I-PROBLEM

anticoagulation	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
mechanical	JJ	I-TREATMENT	I-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT

atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM

diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	VBP	I-PROBLEM	I-PROBLEM

congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM

please	NN	O	O
continue	VB	O	O
ciprofloxacin	JJ	B-TREATMENT	B-TREATMENT
antibiotic	JJ	I-TREATMENT	I-TREATMENT
until	IN	O	O
2019-02-14	JJ	O	O
.	.	O	O

dr.	NN	O	O
mcfarlane	NN	O	O
is	VBZ	O	O
the	DT	O	O
doctor	NN	O	O
who	WP	O	O
performed	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
place	VB	O	O
a	DT	B-TREATMENT	B-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
in	IN	I-TREATMENT	O
your	PRP$	I-TREATMENT	O
bile	NN	I-TREATMENT	O
duct	NN	I-TREATMENT	O
(	(	O	O
a	DT	O	O
tube	NN	O	O
that	WDT	O	O
drains	VBZ	O	O
the	DT	O	O
liver	NN	O	O
).	NN	O	O

his	PRP$	O	O
nurse	NN	O	O
is	VBZ	O	O
going	VBG	O	O
to	TO	O	O
contact	VB	O	O
you	PRP	O	O
at	IN	O	O
home	NN	O	O
to	TO	O	O
schedule	VB	O	O
a	DT	O	O
time	NN	O	O
for	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
repeat	NN	I-TREATMENT	I-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
remove	VB	O	O
that	DT	B-TREATMENT	B-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

it	PRP	O	O
will	MD	O	O
be	VB	O	O
called	VBN	O	O
in	IN	O	O
to	TO	O	O
dr.	VB	O	O
hamasaki	JJ	O	O
office	NN	O	O
and	CC	O	O
he	PRP	O	O
will	MD	O	O
call	VB	O	O
you	PRP	O	O
to	TO	O	O
see	VB	O	O
how	WRB	O	O
to	TO	O	O
change	VB	O	O
your	PRP$	B-TREATMENT	B-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

you	PRP	O	O
will	MD	O	O
also	RB	O	O
take	VB	O	O
lovenox	NN	B-TREATMENT	B-TREATMENT
subcutaneous	JJ	I-TREATMENT	I-TREATMENT
injections	NNS	I-TREATMENT	I-TREATMENT
tomorrow	NN	O	I-TREATMENT
,	,	O	O
2019-02-10	JJ	O	O
.	.	O	O

continue	VB	O	O
all	DT	O	O
of	IN	O	O
your	PRP$	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
except	IN	O	O
for	IN	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

dr.	NN	O	O
mcfarlane	NN	O	O
is	VBZ	O	O
the	DT	O	O
doctor	NN	O	O
who	WP	O	O
performed	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
place	VB	O	O
a	DT	B-TREATMENT	B-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
in	IN	I-TREATMENT	O
your	PRP$	I-TREATMENT	O
bile	NN	I-TREATMENT	O
duct	NN	I-TREATMENT	O
(	(	O	O
a	DT	O	O
tube	NN	O	O
that	WDT	O	O
drains	VBZ	O	O
the	DT	O	O
liver	NN	O	O
).	NN	O	O

his	PRP$	O	O
nurse	NN	O	O
is	VBZ	O	O
going	VBG	O	O
to	TO	O	O
contact	VB	O	O
you	PRP	O	O
at	IN	O	O
home	NN	O	O
to	TO	O	O
schedule	VB	O	O
a	DT	O	O
time	NN	O	O
for	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
repeat	NN	I-TREATMENT	I-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
remove	VB	O	O
that	DT	B-TREATMENT	B-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

before	IN	O	O
you	PRP	O	O
have	VBP	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
dr.	JJ	O	O
morris	NN	O	O
you	PRP	O	O
will	MD	O	O
need	VB	O	O
to	TO	O	O
talk	VB	O	O
to	TO	O	O
dr.	VB	O	O
moya	NN	O	O
to	TO	O	O
see	VB	O	O
if	IN	O	O
you	PRP	O	O
need	VBP	O	O
to	TO	O	O
stop	VB	O	O
your	PRP$	B-TREATMENT	B-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
/	NN	O	O
warfarin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
a	DT	O	O
few	JJ	O	O
days	NNS	O	O
.	.	O	O

ampullary	JJ	B-PROBLEM	B-PROBLEM
adenocarcinoma	NN	I-PROBLEM	I-PROBLEM

ampullary	JJ	B-PROBLEM	B-PROBLEM
adenocarcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
50	CD	O	O
year	NN	O	O
old	JJ	O	O
man	NN	O	O
in	IN	O	O
his	PRP$	O	O
usual	JJ	O	O
state	NN	O	O
of	IN	O	O
health	NN	O	O
until	IN	O	O
two	CD	O	O
weeks	NNS	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
when	WRB	O	O
the	DT	O	O
patient	NN	O	O
developed	VBD	O	O
epigastric	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
after	IN	O	O
meals	NNS	O	O
.	.	O	O

the	DT	O	O
next	JJ	O	O
morning	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
felt	VBD	O	O
dizzy	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
went	VBD	O	O
to	TO	O	O
his	PRP$	O	O
private	JJ	O	O
medical	JJ	O	O
doctor	NN	O	O
at	IN	O	O
eifro	JJ	O	O
medical	JJ	O	O
center	NN	O	O
,	,	O	O
and	CC	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
elevated	VBN	B-PROBLEM	B-PROBLEM
bilirubins	NNS	I-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	O
alkaline	JJ	I-PROBLEM	B-TEST
phosphatase	NN	I-PROBLEM	I-TEST
,	,	I-PROBLEM	O
and	CC	I-PROBLEM	O
transaminases	NNS	I-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
reported	VBD	O	O
fatigue	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
noted	VBN	O	O
coca	NN	B-PROBLEM	B-PROBLEM
cola	NN	I-PROBLEM	I-PROBLEM
colored	VBD	I-PROBLEM	I-PROBLEM
urine	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
been	VBN	O	O
constipated	VBN	B-PROBLEM	B-PROBLEM
with	IN	O	O
hard	JJ	B-PROBLEM	B-PROBLEM
stool	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
no	DT	O	O
bright	JJ	B-PROBLEM	B-PROBLEM
red	JJ	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
per	IN	I-PROBLEM	I-PROBLEM
rectum	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
reported	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
18	CD	I-PROBLEM	I-PROBLEM
lb	NN	I-PROBLEM	I-PROBLEM
weight	NN	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
over	IN	O	O
the	DT	O	O
last	JJ	O	O
4-5	JJ	O	O
months	NNS	O	O
.	.	O	O

significant	JJ	O	O
only	RB	O	O
for	IN	O	O
history	NN	O	O
of	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

serax	NN	B-TREATMENT	O
p.r.n.	NN	O	O
insomnia	NN	B-PROBLEM	B-PROBLEM
;	:	O	O
iron	NN	B-TREATMENT	B-TREATMENT
;	:	O	O
mvi	NN	B-TREATMENT	O
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

bp	NN	B-TEST	B-TEST
120/80	CD	O	O
,	,	O	O
temp	RB	B-TEST	B-TEST
96	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
78	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
18	CD	O	O
.	.	O	O

no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
skin	NN	O	O
is	VBZ	O	O
jaundiced	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

notable	JJ	O	O
for	IN	O	O
scleral	JJ	B-PROBLEM	B-PROBLEM
icterus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	I-TEST	O
,	,	O	O
no	DT	O	O
wheezes	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
rales	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
rhonchi	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
no	DT	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

soft	JJ	O	O
,	,	O	O
bowel	JJ	O	O
sounds	NNS	O	O
present	JJ	O	O
,	,	O	O
tenderness	JJ	B-PROBLEM	B-PROBLEM
present	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
epigastrium	NN	O	I-PROBLEM
to	TO	O	I-PROBLEM
moderate	VB	B-TEST	I-PROBLEM
palpation	NN	I-TEST	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
rebound	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
no	DT	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
incisional	JJ	B-PROBLEM	B-PROBLEM
scars	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

warm	NN	O	O
,	,	O	O
with	IN	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
palpable	JJ	O	B-TEST
pulses	NNS	O	I-TEST
bilaterally	RB	O	O
.	.	O	O

na	RB	B-TEST	O
134	CD	O	O
,	,	O	O
k	VBD	B-TEST	O
4.2	CD	O	O
,	,	O	O
cl	NN	B-TEST	B-TEST
98	CD	O	O
,	,	O	O
bicarb	NN	B-TEST	B-TEST
26	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
11	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
0.5	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
119	CD	O	O
.	.	O	O

cbc	SYM	B-TEST	B-TEST
-	:	O	I-TEST
white	JJ	B-TEST	I-TEST
count	NN	I-TEST	I-TEST
7.5	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
28.5	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
452	CD	O	O
.	.	O	O

pt	NN	B-TEST	O
16.2	CD	O	O
,	,	O	O
ptt	NN	B-TEST	B-TEST
34.7	CD	O	O
,	,	O	O
inr	RB	B-TEST	B-TEST
1.8	CD	O	O
.	.	O	O

ldh	NN	B-TEST	O
254	CD	O	O
,	,	O	O
amylase	NN	B-TEST	B-TEST
727	CD	O	O
,	,	O	O
lipase	NN	B-TEST	B-TEST
8600	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
preoperatively	RB	O	O
for	IN	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
on	IN	O	O
7/4/98	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
&apos;s	NN	I-TEST	I-TEST
workup	VBD	I-TEST	I-TEST
up	RB	I-TEST	I-TEST
until	IN	O	O
that	DT	O	O
time	NN	O	O
included	VBD	O	O
a	DT	O	B-PROBLEM
diagnosis	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
periampullary	JJ	B-PROBLEM	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
was	VBD	O	O
proven	VBN	O	O
by	IN	O	O
egd	NN	B-TEST	O
directed	VBN	I-TEST	O
biopsy	NN	I-TEST	O
,	,	O	O
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
was	VBD	O	O
biopsied	VBN	O	O
and	CC	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
an	DT	B-PROBLEM	B-PROBLEM
oncocytoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
7/4/98	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
underwent	NN	O	O
a	DT	B-TREATMENT	B-TREATMENT
whipple	JJ	I-TREATMENT	I-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
which	WDT	O	O
proceeded	VBD	O	O
without	IN	O	O
complications	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	O
ng	JJ	I-TREATMENT	O
tube	NN	I-TREATMENT	O
was	VBD	O	O
d/c&apos;d	VBN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#2	NNP	O	O
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#4	NNP	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
began	VBD	O	O
tolerating	VBG	O	O
clear	JJ	B-TREATMENT	B-TREATMENT
liquids	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
his	PRP$	O	O
diet	NN	O	O
was	VBD	O	O
advanced	VBN	O	O
as	IN	O	O
tolerated	VBN	O	O
by	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
#6	NNP	O	O
and	CC	O	O
7	CD	O	O
.	.	O	O

sandostatin	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mcg	NN	O	O
subcu.	NN	O	O
b.i.d.	NN	O	O
;	:	O	O
percocet	CC	B-TREATMENT	O
1-2	JJ	O	O
tabs	JJ	O	O
q.3-4h.	JJ	O	O
p.r.n.	NN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
;	:	O	O
axid	CC	B-TREATMENT	O
150	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
;	:	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
54	JJ	O	O
year-old	JJ	O	O
female	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
breast	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
known	VBN	B-PROBLEM	B-PROBLEM
brain	NN	I-PROBLEM	I-PROBLEM
mets	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
history	NN	O	O
of	IN	O	O
pe	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
recent	JJ	B-TREATMENT	B-TREATMENT
radiation	NN	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
steroids	NNS	B-TREATMENT	B-TREATMENT
who	WP	O	O
presented	VBD	O	O
in	IN	O	O
2012-04-23	JJ	O	O
with	IN	O	O
myopathy	NN	B-PROBLEM	B-PROBLEM
presumed	VBN	O	O
secondary	JJ	O	O
to	TO	O	O
sterids	NNS	B-TREATMENT	O
,	,	O	O
which	WDT	O	O
have	VBP	O	O
been	VBN	O	O
given	VBN	O	O
for	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
brain	NN	I-PROBLEM	I-PROBLEM
mets	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
later	RB	O	O
sent	VBN	O	O
to	TO	O	O
rehab	VB	O	O
,	,	O	O
but	CC	O	O
returned	VBD	O	O
early	RB	O	O
in	IN	O	O
april	NN	O	O
with	IN	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
cough	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
exertion	NN	O	O
with	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
to	TO	O	O
101	CD	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
levaquin	JJ	B-TREATMENT	B-TREATMENT
given	VBN	O	O
her	PRP$	B-TEST	B-PROBLEM
temperatures	NNS	I-TEST	I-PROBLEM
and	CC	O	O
differential	JJ	O	O
diagnosis	NN	O	O
of	IN	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
pe	NN	I-PROBLEM	I-PROBLEM
burden	NN	I-PROBLEM	I-PROBLEM
load	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
infections	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
questionable	JJ	O	O
lymphangitic	JJ	B-PROBLEM	B-PROBLEM
spread	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
her	PRP$	B-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
did	VBD	O	O
not	RB	O	O
experience	VB	O	O
improvement	NN	O	O
in	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
readmitted	VBN	O	O
on	IN	O	O
06-11	NN	O	O
with	IN	O	O
continued	JJ	B-PROBLEM	B-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

review	NN	O	O
of	IN	O	O
cta	NN	B-TEST	O
showed	VBD	O	O
no	DT	O	O
pe	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
but	CC	O	O
there	RB	O	O
was	VBD	O	O
ground	NN	B-PROBLEM	B-PROBLEM
glass	NN	I-PROBLEM	I-PROBLEM
opacities	NNS	I-PROBLEM	I-PROBLEM
on	IN	O	I-PROBLEM
ct	NN	B-TEST	I-PROBLEM
,	,	O	O
so	RB	O	O
pcp	NN	B-PROBLEM	O
was	VBD	O	O
considered	VBN	O	O
highly	RB	O	O
unlikely	JJ	O	O
given	VBN	O	O
her	PRP$	O	O
recent	JJ	O	O
history	NN	O	O
of	IN	O	O
steroid	NN	B-TREATMENT	O
use	NN	I-TREATMENT	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
induced	JJ	I-TEST	I-TEST
sputum	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
and	CC	O	O
bol	NN	B-TEST	B-TREATMENT
was	VBD	O	O
done	VBN	O	O
and	CC	O	O
also	RB	O	O
negative	JJ	O	O
.	.	O	O

sputum	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
given	VBN	O	O
bactrim	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
she	PRP	O	O
had	VBD	O	O
improvement	NN	O	O
in	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
shortness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
after	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
bactrim	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
started	VBN	O	O
and	CC	O	O
improved	VBN	O	O
room	NN	O	O
air	NN	O	O
sats	NNS	O	O
and	CC	O	O
was	VBD	O	O
sent	VBN	O	O
home	NN	O	O
on	IN	O	O
bactrim	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
presented	VBD	O	O
on	IN	O	O
clinic	NN	O	O
on	IN	O	O
06-20	JJ	O	O
with	IN	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
for	IN	O	O
which	WDT	O	O
she	PRP	O	O
was	VBD	O	O
given	VBN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
spiked	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
103	CD	O	O
with	IN	O	O
blood	NN	B-TEST	B-TEST
pressures	NNS	I-TEST	I-TEST
hypertensive	VBP	B-PROBLEM	O
into	IN	O	O
the	DT	B-TEST	O
systolic	JJ	I-TEST	O
80	CD	O	O
s	NN	O	O
and	CC	O	O
with	IN	O	O
rigors	NNS	B-PROBLEM	O
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
showed	VBD	O	O
a	DT	O	O
question	NN	O	O
of	IN	O	O
left	NN	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
opacity	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
given	VBN	O	O
vancomycin	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
a	DT	O	B-TEST
gram	NN	O	I-TEST
of	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

today	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
found	VBN	O	O
in	IN	O	O
the	DT	O	O
bathroom	NN	O	O
and	CC	O	O
became	VBD	O	O
hypoxic	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
saturations	NNS	B-TEST	B-TEST
in	IN	O	O
the	DT	O	O
80	CD	O	O
s	NN	O	O
and	CC	O	O
was	VBD	O	O
responsive	JJ	O	O
to	TO	O	O
oxygen	VB	B-TREATMENT	O
,	,	O	O
but	CC	O	O
was	VBD	O	O
still	RB	O	O
tachypneic	VBN	B-PROBLEM	O
without	IN	O	O
improvement	NN	O	O
and	CC	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
nonrebreather	NN	B-TREATMENT	O
.	.	O	O

currently	RB	O	O
the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
further	JJ	B-TREATMENT	B-TREATMENT
medical	JJ	I-TREATMENT	I-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

currently	RB	O	O
the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
short	JJ	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
without	IN	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
dysphagia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1.	CD	O	O
breast	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
side	NN	I-PROBLEM	I-PROBLEM
diagnosed	VBN	O	O
in	IN	O	O
1982	CD	O	O
status	NN	O	O
post	NN	O	O
1995	CD	O	B-TREATMENT
mastectomy	NN	B-TREATMENT	I-TREATMENT
with	IN	O	O
5	CD	O	O
out	IN	O	O
of	IN	O	O
9	CD	O	B-PROBLEM
positive	JJ	B-PROBLEM	I-PROBLEM
lymph	NN	I-PROBLEM	I-PROBLEM
nodes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
chemotherapy	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
bone	NN	B-TREATMENT	B-TREATMENT
marrow	NN	I-TREATMENT	I-TREATMENT
transplant	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
then	RB	O	O
later	RB	O	O
with	IN	O	O
tamoxifen	NN	B-TREATMENT	B-TREATMENT
from	IN	O	O
2004	CD	O	O
to	TO	O	O
2001	CD	O	O
.	.	O	O

in	IN	O	O
2011	CD	O	O
she	PRP	O	O
had	VBD	O	O
mediastinal	JJ	B-PROBLEM	B-PROBLEM
lymphadenopathy	NN	I-PROBLEM	I-PROBLEM
treated	VBN	O	O
with	IN	O	O
taxol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
changed	VBD	O	O
to	TO	O	O
navelbine	VB	B-TREATMENT	O
on	IN	O	O
03-28	NN	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
diagnosed	VBN	O	O
brain	NN	B-PROBLEM	O
mets	NNS	I-PROBLEM	O
in	IN	O	O
2012-03-25	JJ	O	O
right	JJ	O	O
side	NN	O	O
cerebella	NN	O	O
and	CC	O	O
parietal	NN	O	O
for	IN	O	O
which	WDT	O	O
she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
chemotherapy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
radiation	NN	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
decadron	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

2.	CD	O	O
history	NN	O	O
of	IN	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
embolism	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
2012-04-23	JJ	O	O
treated	VBN	O	O
with	IN	O	O
only	RB	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
secondary	JJ	O	O
to	TO	O	O
brain	NN	B-PROBLEM	O
mets	NNS	I-PROBLEM	O
.	.	O	O

3.	CD	O	O
asthma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

4.	CD	O	O
gastritis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1.	CD	O	O
protonix	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

2.	CD	O	O
megace	NN	B-TREATMENT	B-TREATMENT
400	CD	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

3.	CD	O	O
colace	NN	B-TREATMENT	B-TREATMENT
200	CD	O	O
b.i.d.	NN	O	O

4.	CD	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

5.	CD	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
subq.	NN	O	O

6.	CD	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
40	CD	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

8.	CD	O	O
clindamycin	NN	B-TREATMENT	B-TREATMENT
900	CD	O	O
q	NN	O	O
8	CD	O	O
.	.	O	O

9.	CD	O	O
levaquin	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

penicillin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

on	IN	O	O
examination	NN	B-TEST	B-TEST
on	IN	O	O
transfer	NN	O	O
to	TO	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
she	PRP	O	O
is	VBZ	O	O
febrile	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
grade	NN	I-PROBLEM	I-PROBLEM
temperature	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
100.1	CD	O	O
,	,	O	O
tachycardic	NN	B-PROBLEM	B-PROBLEM
to	TO	O	O
110	CD	O	O
,	,	O	O
hypotensive	JJ	B-PROBLEM	B-TREATMENT
85/49	CD	O	O
,	,	O	O
tachypneic	NN	B-PROBLEM	B-PROBLEM
into	IN	O	O
the	DT	O	O
50	CD	O	O
s	NN	O	O
and	CC	O	O
60	CD	O	O
s,	NN	O	O
95%	CD	O	O
on	IN	O	O
nonrebreather	NN	B-TREATMENT	O
.	.	O	O

in	IN	O	O
general	JJ	O	O
,	,	O	O
she	PRP	O	O
is	VBZ	O	O
extremely	RB	B-PROBLEM	B-PROBLEM
tachypneic	JJ	I-PROBLEM	I-PROBLEM
,	,	O	O
difficulty	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
speaking	VBG	I-PROBLEM	I-PROBLEM
words	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	O	O
heart	NN	O	O
is	VBZ	O	O
regular	JJ	O	O
without	IN	O	O
murmurs	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
rubs	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
gallops	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
slightly	RB	B-PROBLEM	B-PROBLEM
tachycardic	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
pulmonary	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
shows	VBZ	O	O
she	PRP	O	O
has	VBZ	O	O
bronchial	JJ	O	B-PROBLEM
breath	NN	O	I-PROBLEM
sounds	VBZ	O	I-PROBLEM
with	IN	O	O
dry	JJ	B-PROBLEM	B-PROBLEM
crackles	NNS	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
bases	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

abdominal	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
benign	JJ	O	O
.	.	O	O

extremities	NNS	O	O
no	DT	O	O
clubbing	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
3.2	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
26.6	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
130	CD	O	O
,	,	O	O
chemistry	NN	B-TEST	O
is	VBZ	O	O
131	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
3.0	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
105	CD	O	O
,	,	O	O
bicarb	NN	B-TEST	B-TEST
17	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
10	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
0.5	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
105	CD	O	O
.	.	O	O

calcium	NN	B-TEST	B-TEST
7.3	CD	O	O
,	,	O	O
phos	NN	B-TEST	B-TEST
1.8	CD	O	O
,	,	O	O
magnesium	NN	B-TEST	B-TEST
1.5	CD	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	O
gas	NN	I-TEST	O
showing	VBG	O	O
7.36	CD	O	O
,	,	O	O
31	CD	O	O
,	,	O	O
96	CD	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
from	IN	O	O
the	DT	O	O
29th	CD	O	O
of	IN	O	O
her	PRP$	O	O
abdomen	NNS	O	O
and	CC	O	O
pelvis	NN	O	O
showing	NN	O	O
marked	VBD	B-PROBLEM	B-PROBLEM
increased	JJ	I-PROBLEM	I-PROBLEM
consolidations	NNS	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
base	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
question	NN	O	O
of	IN	O	O
new	JJ	B-PROBLEM	B-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
sided	VBD	I-PROBLEM	I-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
febrile	JJ	B-PROBLEM	B-PROBLEM
hypotension	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	O	O
question	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
new	JJ	I-PROBLEM	I-PROBLEM
infiltrate	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
her	PRP$	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
.	.	O	O

the	DT	O	O
exact	JJ	O	O
etiology	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
presumed	VBN	O	O
to	TO	O	O
be	VB	O	O
questionable	JJ	O	O
multifactorial	JJ	O	B-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
concern	NN	O	O
about	IN	O	O
possible	JJ	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

also	RB	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
pe	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
also	RB	O	O
there	EX	O	O
was	VBD	O	O
concern	NN	O	O
about	IN	O	O
possible	JJ	O	O
lymphangitic	JJ	B-PROBLEM	B-PROBLEM
spread	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
her	PRP$	B-PROBLEM	I-PROBLEM
breast	NN	I-PROBLEM	I-PROBLEM
ca	MD	I-PROBLEM	I-PROBLEM
.	.	O	O

given	VBN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
fevers	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
broad	JJ	B-TREATMENT	B-TREATMENT
spectrum	NN	I-TREATMENT	I-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
initially	RB	O	O
started	VBD	O	O
on	IN	O	O
ceptaz	NN	B-TREATMENT	O
,	,	O	O
levaquin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
__________	NN	O	O
and	CC	O	O
clindamycin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

lab	NN	O	B-TEST
two	CD	B-TREATMENT	O
antibiotics	NNS	I-TREATMENT	B-TREATMENT
were	VBD	O	O
added	VBN	O	O
considering	VBG	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
thought	VBN	O	O
to	TO	O	O
be	VB	O	O
a	DT	O	O
relatively	RB	O	O
high	JJ	O	O
risk	NN	O	O
for	IN	O	O
pcp	JJ	B-PROBLEM	O
douglas	NNS	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
initially	RB	O	O
trialed	VBN	O	O
on	IN	O	O
bipap	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
but	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
increasingly	RB	B-PROBLEM	O
dyspneic	JJ	I-PROBLEM	O
,	,	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
stress	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
ultimately	RB	O	O
needed	VBN	O	O
to	TO	O	O
be	VB	O	O
intubated	VBN	O	O
on	IN	O	O
06-22	NN	O	O
.	.	O	O

earlier	RBR	O	O
during	IN	O	O
her	PRP$	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
course	NN	O	O
she	PRP	O	O
underwent	JJ	O	O
bronchoscopy	NN	B-TEST	B-TEST
,	,	O	O
which	WDT	O	O
was	VBD	O	O
sent	VBN	O	O
for	IN	O	O
cytology	NN	B-TEST	B-TEST
and	CC	O	I-TEST
multiple	JJ	B-PROBLEM	I-TEST
bacterial	JJ	I-PROBLEM	I-TEST
pathogens	NNS	I-PROBLEM	I-TEST
all	DT	O	O
of	IN	O	O
which	WDT	O	O
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

ultimately	RB	O	O
her	PRP$	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
course	NN	O	O
continued	VBD	O	O
and	CC	O	O
she	PRP	O	O
began	VBD	O	O
to	TO	O	O
defervesce	VB	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
bacterial	JJ	I-TEST	I-TEST
studies	NNS	I-TEST	I-TEST
particulaly	VBP	O	O
from	IN	O	O
bal	JJ	B-TEST	B-TREATMENT
lavage	NN	I-TEST	I-TREATMENT
were	VBD	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
negative	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
multiple	JJ	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
withdrawn	NN	O	O
.	.	O	O

clindamycin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
_______________	NN	O	O
was	VBD	O	O
discontinued	VBN	O	O
early	RB	O	O
in	IN	O	O
hospital	JJ	O	O
course	NN	O	O
.	.	O	O

her	PRP$	B-TEST	O
pcp	NN	I-TEST	O
was	VBD	O	O
thought	VBN	O	O
to	TO	O	O
be	VB	O	O
negative	JJ	O	O
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
levaquin	NN	B-TREATMENT	B-TREATMENT
were	VBD	O	O
also	RB	O	O
discontinued	VBN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
later	RB	O	O
continued	VBN	O	O
on	IN	O	O
ceftazidine	NN	B-TREATMENT	O
and	CC	O	O
clindamycin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
possible	JJ	O	O
gram	NN	B-PROBLEM	B-PROBLEM
negative	JJ	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
also	RB	O	O
for	IN	O	O
possible	JJ	O	O
post	NN	B-PROBLEM	B-PROBLEM
obstructive	JJ	I-PROBLEM	I-PROBLEM
picture	NN	I-PROBLEM	I-PROBLEM
that	IN	O	O
she	PRP	O	O
would	MD	O	O
be	VB	O	O
at	IN	O	O
risk	NN	O	O
for	IN	O	O
given	VBN	O	O
her	PRP$	O	B-TREATMENT
pulmonary	JJ	O	I-TREATMENT
anatomy	NN	O	I-TREATMENT
.	.	O	O

as	IN	O	O
the	DT	O	O
hubbard	NN	O	O
regional	JJ	O	O
hospital	NN	O	O
hospital	NN	O	O
course	NN	O	O
went	VBD	O	O
on	IN	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
respiratory	NN	O	O
did	VBD	O	O
not	RB	O	O
show	VB	O	O
mild	JJ	O	O
improvement	NN	O	O
on	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
ventilator	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

unfortunately	RB	O	B-PROBLEM
her	PRP$	O	I-PROBLEM
mental	JJ	O	I-PROBLEM
status	NN	O	I-PROBLEM
failed	VBD	O	O
to	TO	O	O
improve	VB	O	O
despite	IN	O	O
having	VBG	O	O
been	VBN	O	O
off	IN	O	O
all	DT	B-TREATMENT	B-TREATMENT
sedative	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
several	JJ	O	O
days	NNS	O	O
.	.	O	O

later	RB	O	O
in	IN	O	O
her	PRP$	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
course	NN	O	O
family	NN	O	O
meetings	NNS	O	O
took	VBD	O	O
place	NN	O	O
and	CC	O	O
given	VBN	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
overall	JJ	O	O
poor	JJ	O	O
prognosis	NN	O	O
with	IN	O	O
decreased	JJ	B-PROBLEM	B-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
would	MD	O	O
become	VB	O	O
cmo	NN	B-TREATMENT	O
.	.	O	O

however	RB	O	O
,	,	O	O
she	PRP	O	O
is	VBZ	O	O
cmo	JJ	B-TREATMENT	O
and	CC	O	O
will	MD	O	O
not	RB	O	O
be	VB	O	O
intubated	VBN	O	O
for	IN	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
initially	RB	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
thought	VBD	O	O
to	TO	O	O
be	VB	O	O
exhibiting	VBG	O	B-PROBLEM
septic	JJ	B-PROBLEM	I-PROBLEM
physiology	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
hypotensive	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
required	VBD	O	O
aggressive	JJ	B-TREATMENT	B-TREATMENT
intravenous	JJ	I-TREATMENT	I-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
later	RB	O	O
required	VBN	O	O
pressor	NN	B-TREATMENT	B-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
neo-synephrine	JJ	B-TREATMENT	O
.	.	O	O

later	RB	O	O
during	IN	O	O
her	PRP$	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
course	NN	O	O
she	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
somewhat	RB	B-PROBLEM	B-PROBLEM
overloaded	JJ	I-PROBLEM	I-PROBLEM
and	CC	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
cut	VBN	O	O
back	RB	O	O
.	.	O	O

it	PRP	O	O
was	VBD	O	O
quite	RB	O	O
difficult	JJ	O	O
weaning	VBG	O	O
her	PRP$	O	O
off	NN	O	O
of	IN	O	O
neo-synephrine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
also	RB	O	O
given	VBN	O	O
stress	NN	B-TREATMENT	B-TREATMENT
dose	JJ	I-TREATMENT	I-TREATMENT
steroids	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

later	RB	O	O
in	IN	O	O
her	PRP$	O	O
hospital	NN	O	O
course	NN	O	O
she	PRP	O	O
also	RB	O	O
had	VBD	O	O
an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
for	IN	O	O
question	NN	O	O
of	IN	O	O
new	JJ	O	B-PROBLEM
ecg	JJ	O	I-PROBLEM
findings	NNS	O	I-PROBLEM
in	IN	O	I-PROBLEM
her	PRP$	O	I-PROBLEM
inferior	JJ	O	I-PROBLEM
leads	NNS	O	I-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
,	,	O	O
however	RB	O	O
,	,	O	O
was	VBD	O	O
essentially	RB	O	O
normal	JJ	O	O
with	IN	O	O
an	DT	B-TEST	B-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
55%	CD	O	O
without	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
gross	JJ	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
motion	NN	I-PROBLEM	I-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
or	CC	O	O
valvular	JJ	B-PROBLEM	B-PROBLEM
pathology	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

as	IN	O	O
mentioned	VBN	O	O
above	IN	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
hemodynamic	JJ	O	O
status	NN	O	O
was	VBD	O	O
tenuous	JJ	B-PROBLEM	O
throughout	IN	O	O
her	PRP$	O	O
hospital	JJ	O	O
course	NN	O	O
as	IN	O	O
it	PRP	O	O
was	VBD	O	O
difficult	JJ	O	O
to	TO	O	O
wean	VB	O	O
the	DT	O	O
patient	NN	O	O
off	IN	O	O
of	IN	O	O
neo-synephrine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

by	IN	O	O
06-28	NNP	O	O
,	,	O	O
however	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
been	VBN	O	O
off	RB	O	O
of	IN	O	O
neo-synephrine	JJ	B-TREATMENT	O
,	,	O	O
but	CC	O	O
at	IN	O	O
this	DT	O	O
time	NN	O	O
as	IN	O	O
mentioned	VBN	O	O
above	IN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
deemed	VBN	O	O
to	TO	O	O
be	VB	O	O
cmo	JJ	B-TREATMENT	O
per	IN	O	O
discussion	NN	O	O
with	IN	O	O
physicians	NNS	O	B-TREATMENT
and	CC	O	O
her	PRP$	O	O
husband	NN	O	O
/	NNP	O	O
health	NN	O	O
care	NN	O	O
proxy	NN	O	O
.	.	O	O

patient	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
known	JJ	B-PROBLEM	B-PROBLEM
malignancy	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
also	RB	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
embolisms	NNS	I-PROBLEM	I-PROBLEM
from	IN	O	O
2012-04-23	CD	O	O
.	.	O	O

earlier	RBR	O	O
in	IN	O	O
her	PRP$	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
course	NN	O	O
the	DT	O	O
team	NN	O	O
was	VBD	O	O
concerned	VBN	O	O
about	IN	O	O
possible	JJ	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
embolisms	NNS	I-PROBLEM	I-PROBLEM
as	IN	O	O
a	DT	O	O
possible	JJ	O	O
source	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
respiratory	JJ	I-PROBLEM	I-PROBLEM
decompensation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

however	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
also	RB	O	O
had	VBD	O	O
brain	NN	B-PROBLEM	B-PROBLEM
metastasis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
at	IN	O	O
this	DT	O	O
point	NN	O	O
anticoagulation	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
thought	VBN	O	O
to	TO	O	O
be	VB	O	O
a	DT	O	B-TREATMENT
contraindication	NN	O	I-TREATMENT
given	VBN	O	O
risk	NN	O	O
for	IN	O	O
hemorrhage	NN	B-PROBLEM	B-PROBLEM
into	IN	O	I-PROBLEM
these	DT	B-PROBLEM	I-PROBLEM
tumors	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
did	VBD	O	O
have	VB	O	O
lower	JJR	B-TEST	B-TEST
extremity	NN	I-TEST	I-TEST
doppler	NN	I-TEST	I-TEST
ultrasounds	NNS	I-TEST	I-TEST
,	,	O	O
which	WDT	O	O
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

as	IN	O	O
mentioned	VBN	O	O
above	IN	O	O
patient	NN	O	O
initially	RB	O	O
hypotension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
febrile	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
in	IN	O	O
respiratory	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
presumed	VBN	O	O
to	TO	O	O
be	VB	O	O
septic	JJ	B-PROBLEM	O
source	NN	I-PROBLEM	O
likely	JJ	O	O
pulmonary	NN	O	O
.	.	O	O

initially	RB	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
broad	JJ	B-TREATMENT	B-TREATMENT
spectrum	NN	I-TREATMENT	I-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
including	VBG	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
ceptaz	NN	B-TREATMENT	O
,	,	O	O
levaquin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
clindamycin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
_________.	NN	O	O

all	DT	O	O
of	IN	O	O
her	PRP$	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
are	VBP	O	O
negative	JJ	O	O
to	TO	O	O
date	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
negative	JJ	O	O
for	IN	O	O
pcp	NN	B-PROBLEM	O
and	CC	O	O
subsequently	RB	O	O
_____________	NNP	O	O
was	VBD	O	O
continued	VBN	O	O
and	CC	O	O
clindamycin	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
changed	VBN	O	O
for	IN	O	O
anaerobic	JJ	B-TREATMENT	B-TREATMENT
coverage	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

in	IN	O	O
addition	NN	O	O
her	PRP$	B-TREATMENT	O
vancomycin	NN	I-TREATMENT	B-TREATMENT
and	CC	O	O
levaquin	NN	B-TREATMENT	B-TREATMENT
were	VBD	O	O
also	RB	O	O
discontinued	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
during	IN	O	O
the	DT	O	O
majority	NN	O	O
of	IN	O	O
her	PRP$	O	B-TREATMENT
hospital	JJ	O	I-TREATMENT
course	NN	O	I-TREATMENT
.	.	O	O

by	IN	O	O
virtue	NN	O	O
of	IN	O	O
discussions	NNS	O	O
on	IN	O	O
06-28	JJ	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
deemed	VBN	O	O
to	TO	O	O
be	VB	O	O
cmo	VBN	B-TREATMENT	O
and	CC	O	O
all	DT	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
withdrawn	VBN	O	O
at	IN	O	O
this	DT	O	O
point	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
an	DT	B-TEST	B-TEST
abdominal	JJ	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
earlier	RBR	O	O
in	IN	O	O
her	PRP$	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
course	NN	O	O
,	,	O	O
which	WDT	O	O
was	VBD	O	O
essentially	RB	O	O
negative	JJ	O	O
for	IN	O	O
an	DT	B-PROBLEM	B-TEST
intraabdominal	JJ	I-PROBLEM	I-TEST
pathology	NN	I-PROBLEM	I-TEST
.	.	O	O

she	PRP	O	O
was	VBD	O	O
initially	RB	O	O
supported	VBN	O	O
with	IN	O	O
tube	NN	B-TREATMENT	B-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
during	IN	O	O
her	PRP$	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
course	NN	O	O
,	,	O	O
but	CC	O	O
at	IN	O	O
this	DT	O	O
point	NN	O	O
the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
cmo	JJ	B-TREATMENT	O
and	CC	O	O
tube	JJ	B-TREATMENT	B-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
have	VBP	O	O
been	VBN	O	O
subsequently	RB	O	O
discontinued	VBN	O	O
.	.	O	O

ultimately	RB	O	O
it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
by	IN	O	O
06-28	NN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
shown	VBN	O	O
minimal	JJ	O	O
improvement	NN	O	O
and	CC	O	O
minimal	JJ	O	O
evidence	NN	O	O
of	IN	O	O
improvement	NN	O	O
status	NN	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
at	IN	O	O
this	DT	O	O
point	NN	O	O
for	IN	O	O
the	DT	O	O
patient	NN	O	O
to	TO	O	O
be	VB	O	O
extubated	VBN	O	O
and	CC	O	O
to	TO	O	O
move	VB	O	O
toward	IN	O	O
cmo	NN	B-TREATMENT	B-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

subsequently	RB	O	O
all	DT	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
blood	NN	B-TEST	B-TEST
draws	NNS	I-TEST	I-TEST
and	CC	O	O
supportive	JJ	B-TREATMENT	B-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
pressure	NN	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
withdrawn	VBN	O	O
.	.	O	O

currently	RB	O	O
she	PRP	O	O
is	VBZ	O	O
comfortable	JJ	O	O
with	IN	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
ativan	NN	B-TREATMENT	B-TREATMENT
prn.	NN	O	I-TREATMENT

currently	RB	O	O
plans	NNS	O	O
are	VBP	O	O
in	IN	O	O
the	DT	O	O
making	NN	O	O
for	IN	O	O
arranging	VBG	O	O
for	IN	O	O
the	DT	O	O
patient	NN	O	O
to	TO	O	O
have	VB	O	O
home	NN	B-TREATMENT	B-TREATMENT
hospice	NN	I-TREATMENT	I-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

1.	CD	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
breast	NN	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
end	NN	I-PROBLEM	I-PROBLEM
stage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
respiratory	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
unclear	JJ	O	O
etiology	NN	O	O
,	,	O	O
presumed	VBD	O	O
secondary	JJ	O	O
to	TO	O	O
possible	JJ	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
questionable	JJ	O	O
lymphangitic	JJ	B-PROBLEM	B-PROBLEM
spread	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
presumed	VBD	O	O
pulmonary	JJ	O	O
source	NN	O	O
.	.	O	O

1.	CD	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
prn	NN	O	O
.	.	O	O

2.	CD	O	O
ativan	JJ	B-TREATMENT	B-TREATMENT
prn	NN	O	O
.	.	O	O

3.	CD	O	O
tylenol	JJ	B-TREATMENT	B-TREATMENT
prn	NN	O	O
.	.	O	O

4.	CD	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	I-TREATMENT
atrovent	JJ	B-TREATMENT	I-TREATMENT
nebs	NN	I-TREATMENT	I-TREATMENT
prn	NN	O	O
.	.	O	O

left	JJ	B-PROBLEM	B-PROBLEM
parietal	JJ	I-PROBLEM	I-PROBLEM
glioblastoma	NN	I-PROBLEM	I-PROBLEM
multiforme	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
is	VBZ	O	O
an	DT	O	O
88	CD	O	O
year	NN	O	O
old	JJ	O	O
female	NN	O	O
with	IN	O	O
fatigue	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
decreased	VBN	B-PROBLEM	B-PROBLEM
short	JJ	I-PROBLEM	I-PROBLEM
term	NN	I-PROBLEM	I-PROBLEM
memory	NN	I-PROBLEM	I-PROBLEM
for	IN	O	O
the	DT	O	O
past	JJ	O	O
six	CD	O	O
months	NNS	O	O
.	.	O	O

the	DT	O	O
past	JJ	O	O
six	CD	O	O
weeks	NNS	O	O
,	,	O	O
she	PRP	O	O
has	VBZ	O	O
also	RB	O	O
been	VBN	O	O
complaining	VBG	O	O
of	IN	O	O
hot	JJ	B-PROBLEM	B-PROBLEM
sensation	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
tingling	VBG	B-PROBLEM	B-PROBLEM
sensation	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
hands	NNS	I-PROBLEM	I-PROBLEM
bilaterally	RB	I-PROBLEM	I-PROBLEM
.	.	O	O

for	IN	O	O
the	DT	O	O
past	JJ	O	O
five	CD	O	O
weeks	NNS	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
experienced	VBN	O	O
dragging	NN	B-PROBLEM	O
of	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
right	JJ	I-PROBLEM	O
leg	NN	I-PROBLEM	O
with	IN	O	O
weakness	NN	B-PROBLEM	B-PROBLEM
throughout	IN	O	O
that	DT	O	O
side	NN	O	O
.	.	O	O

head	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
was	VBD	O	O
done	VBN	O	O
which	WDT	O	O
patient	NN	O	O
reported	VBD	O	O
demonstrated	JJ	O	O
three	CD	B-PROBLEM	O
lesions	NNS	I-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
parietal	JJ	I-PROBLEM	I-PROBLEM
region	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
brain	NN	O	I-PROBLEM
.	.	O	O

bone	NN	B-TEST	B-TEST
scan	JJ	I-TEST	I-TEST
,	,	O	I-TEST
ct	NN	B-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
abdomen	NNS	I-TEST	I-TEST
,	,	O	I-TEST
chest	JJS	B-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
,	,	O	O
and	CC	O	O
mammogram	NNS	B-TEST	B-TEST
were	VBD	O	O
all	DT	O	O
negative	JJ	O	O
.	.	O	O

patient	NN	O	O
noted	VBD	O	O
the	DT	B-PROBLEM	O
foot	NN	I-PROBLEM	O
dragging	VBG	I-PROBLEM	O
to	TO	O	O
have	VB	O	O
worsened	VBN	O	O
over	IN	O	O
the	DT	O	O
past	JJ	O	O
few	JJ	O	O
weeks	NNS	O	O
but	CC	O	O
improved	VBN	O	O
since	IN	O	O
on	IN	O	O
decadron	IN	B-TREATMENT	O
the	DT	O	O
past	JJ	O	O
week	NN	O	O
before	IN	O	O
admission	NN	O	O
.	.	O	O

patient	NN	O	O
is	VBZ	O	O
now	RB	O	O
admitted	VBN	O	O
for	IN	O	O
elective	JJ	B-TEST	B-PROBLEM
left	JJ	I-TEST	I-PROBLEM
parietal	JJ	I-TEST	I-PROBLEM
stereotactic	JJ	I-TEST	I-PROBLEM
biopsy	NN	I-TEST	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

significant	JJ	O	O
for	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
basal	NN	B-PROBLEM	B-TEST
cell	NN	I-PROBLEM	I-TEST
carcinoma	NN	I-PROBLEM	I-TEST
of	IN	I-PROBLEM	I-TEST
the	DT	I-PROBLEM	I-TEST
nose	JJ	I-PROBLEM	I-TEST
six	CD	O	O
years	NNS	O	O
ago	RB	O	O
,	,	O	O
cataracts	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
a	DT	B-TREATMENT	B-TREATMENT
hysterectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

hydrochlorothiazide	RB	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NNS	O	O
q.d.	NN	O	O
and	CC	O	O
decadron	NN	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O

on	IN	O	O
admission	NN	O	O
demonstrated	VBD	O	O
a	DT	O	O
well-developed	JJ	O	O
,	,	O	O
well-nourished	JJ	O	O
female	NN	O	O
in	IN	O	O
no	DT	O	O
apparent	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
dragging	VBG	O	I-PROBLEM
her	PRP$	O	I-PROBLEM
right	JJ	O	I-PROBLEM
foot	NN	O	I-PROBLEM
.	.	O	O

head	NN	O	O
was	VBD	O	O
atraumatic	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
normocephalic	JJ	O	O
with	IN	O	O
pupils	NNS	O	O
equal	JJ	O	O
,	,	O	O
round	NN	O	O
,	,	O	O
and	CC	O	O
reactive	JJ	O	O
to	TO	O	O
light	NN	O	O
.	.	O	O

clear	JJ	O	O
to	TO	O	O
auscultation	NN	B-TEST	B-TEST
.	.	O	O

examination	NN	B-TEST	B-TEST
demonstrated	VBD	O	O
a	DT	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
without	IN	O	O
any	DT	B-PROBLEM	O
murmurs	NNS	I-PROBLEM	B-PROBLEM
noted	VBN	O	O
.	.	O	O

benign	NN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-TREATMENT
hysterectomy	NN	I-PROBLEM	I-TREATMENT
scar	NN	I-PROBLEM	I-TREATMENT
which	WDT	O	O
was	VBD	O	O
well	RB	O	O
healed	VBN	O	O
.	.	O	O

examination	NN	B-TEST	B-TEST
showed	VBD	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
alert	JJ	O	O
and	CC	O	O
oriented	VBD	O	O
times	NNS	O	O
three	CD	O	O
,	,	O	O
short	JJ	O	B-PROBLEM
term	NN	O	I-PROBLEM
memory	NN	O	I-PROBLEM
was	VBD	O	O
deficient	JJ	B-PROBLEM	O
,	,	O	O
patient	JJ	O	O
remembered	VBD	O	O
zero	CD	O	O
out	IN	O	O
of	IN	O	O
three	CD	O	O
things	NNS	O	O
to	TO	O	O
remember	VB	O	O
at	IN	O	O
one	CD	O	O
minute	NN	O	O
,	,	O	O
speech	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
fluent	JJ	O	O
,	,	O	O
and	CC	O	O
cranial	JJ	O	O
nerves	NNS	O	O
ii-xii	JJ	O	O
were	VBD	O	O
intact	JJ	O	O
.	.	O	O

on	IN	O	O
motor	NN	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
,	,	O	O
patient	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
of	IN	O	O
normal	JJ	O	O
motor	NN	O	O
function	NN	O	O
throughout	IN	O	O
except	IN	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
slight	JJ	I-PROBLEM	I-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
dorsi	NN	I-PROBLEM	I-PROBLEM
flexion	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
plantar	NN	I-PROBLEM	B-PROBLEM
flexion	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
both	DT	O	O
noted	VBD	O	O
to	TO	O	O
be	VB	O	O
about	IN	O	O
4/5	CD	O	O
and	CC	O	O
sensory	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
intact	JJ	O	O
throughout	IN	O	O
.	.	O	O

patient	NN	O	B-PROBLEM
's	POS	O	I-PROBLEM
gait	NN	O	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
foot	NN	I-PROBLEM	I-PROBLEM
drag	NN	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
right	JJ	B-PROBLEM	B-PROBLEM
foot	NN	I-PROBLEM	I-PROBLEM
drop	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
on	IN	O	O
april	NN	O	O
21	CD	O	O
where	WRB	O	O
patient	JJ	O	O
underwent	NN	O	O
a	DT	B-TEST	B-TEST
left	JJ	I-TEST	I-TEST
parietal	JJ	I-TEST	I-TEST
stereotactic	NN	I-TEST	I-TEST
guided	VBD	I-TEST	I-TEST
brain	NN	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
.	.	O	O

patient	NN	O	O
tolerated	VBD	O	O
the	DT	B-TEST	B-TREATMENT
procedure	NN	I-TEST	I-TREATMENT
well	RB	O	O
without	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
complications	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
recovery	NN	O	O
room	NN	O	O
awake	NN	O	O
and	CC	O	O
stable	JJ	O	O
then	RB	O	O
subsequently	RB	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
.	.	O	O

patient	NN	O	O
did	VBD	O	O
well	RB	O	O
post-operatively	RB	O	O
,	,	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
sided	VBN	I-PROBLEM	I-PROBLEM
deficit	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
physical	JJ	O	B-TREATMENT
therapy	NN	O	I-TREATMENT
and	CC	O	O
occupational	JJ	O	B-TREATMENT
therapy	NN	O	I-TREATMENT
visited	VBD	O	O
the	DT	O	O
patient	NN	O	O
,	,	O	O
worked	VBD	O	O
with	IN	O	O
the	DT	O	O
patient	NN	O	O
,	,	O	O
and	CC	O	O
determined	VBD	O	O
that	IN	O	O
patient	NN	O	O
needed	VBN	O	O
rehabilitation	NN	B-TREATMENT	O
with	IN	O	O
physical	JJ	O	B-TREATMENT
therapy	NN	O	I-TREATMENT
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
to	TO	O	O
receive	VB	O	O
rehabilitation	NN	B-TREATMENT	B-TREATMENT
to	TO	O	O
increase	VB	O	O
her	PRP$	O	B-PROBLEM
mobility	NN	O	I-PROBLEM
and	CC	O	O
strength	NN	O	O
,	,	O	O
rehabilitation	NN	B-TREATMENT	O
potential	NN	O	O
is	VBZ	O	O
good	JJ	O	O
,	,	O	O
and	CC	O	O
she	PRP	O	O
is	VBZ	O	O
to	TO	O	O
receive	VB	O	O
the	DT	O	B-TREATMENT
following	JJ	O	I-TREATMENT
medications	NNS	O	I-TREATMENT
at	IN	O	O
that	DT	O	O
facility	NN	O	O
:	:	O	O

decadron	NN	B-TREATMENT	B-TREATMENT
3	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.6h.	NN	O	O
times	NNS	O	O
one	CD	O	O
week	NN	O	O
then	RB	O	O
2	CD	O	O
mg	NNS	O	O
p.o.q.6h.	JJ	O	O
thereafter	RB	O	O
,	,	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
heparin	JJ	B-TREATMENT	B-TREATMENT
5000	CD	O	O
units	NNS	O	O
subcutaneously	RB	O	O
b.i.d.	VBP	O	O
until	IN	O	O
ambulating	VBG	O	O
well	RB	O	O
,	,	O	O
hydrochlorothiazide	RB	B-TREATMENT	B-TREATMENT
25mg	CD	O	O
q.d.	NN	O	O
,	,	O	O
dilantin	VBZ	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
zantac	VBZ	B-TREATMENT	B-TREATMENT
150	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
and	CC	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
p.r.n.	NN	O	O

pathology	NN	O	B-TEST
of	IN	O	I-TEST
the	DT	B-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
demonstrated	VBD	O	O
glioblastoma	JJ	B-PROBLEM	B-PROBLEM
multiforme	NN	I-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	O
grade	NN	I-PROBLEM	O
iii/iii	NN	I-PROBLEM	O
.	.	O	O

chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
back	RB	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mr.	NN	O	O
hohlt	NN	O	O
is	VBZ	O	O
a	DT	O	O
76	CD	O	O
-	:	O	O
year-old	JJ	O	O
man	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hyperlipidemia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
prior	JJ	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
percutaneous	JJ	I-TREATMENT	I-TREATMENT
transluminal	JJ	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
angioplasty	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
2005	CD	O	O
at	IN	O	O
the	DT	O	O
cambridge	NN	O	O
health	NN	O	O
alliance	NN	O	O
.	.	O	O

he	PRP	O	O
states	VBZ	O	O
that	IN	O	O
he	PRP	O	O
has	VBZ	O	O
experienced	VBN	O	B-PROBLEM
pain	NN	B-PROBLEM	I-PROBLEM
and	CC	O	O
tightness	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	O
his	PRP$	I-PROBLEM	O
back	NN	I-PROBLEM	O
radiating	NN	O	O
into	IN	O	O
both	DT	O	O
shoulders	NNS	O	O
starting	VBG	O	O
on	IN	O	O
2016-09-02	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
denies	VBZ	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
dizziness	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
diaphoresis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
lasted	VBD	O	O
for	IN	O	O
30	CD	O	O
seconds	NNS	O	O
following	VBG	O	O
pushing	VBG	O	O
a	DT	O	B-TREATMENT
wheelbarrow	NN	O	I-TREATMENT
and	CC	O	O
resolved	VBN	O	O
with	IN	O	O
rest	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
denied	VBD	O	O
any	DT	O	O
prior	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
any	DT	O	O
since	IN	O	O
2005	CD	O	O
following	VBG	O	O
the	DT	O	O
initial	JJ	O	O
episode	NN	O	O
of	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
then	RB	O	O
presented	VBD	O	O
to	TO	O	O
mass.	VB	O	O
mental	JJ	O	O
health	NN	O	O
center	NN	O	O
where	WRB	O	O
he	PRP	O	O
was	VBD	O	O
ruled	VBN	O	O
out	RP	O	O
for	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
by	IN	O	O
enzymes	NNS	B-TEST	B-TEST
and	CC	O	I-TEST
electrocardiograms	NNS	B-TEST	I-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
underwent	VBD	O	O
a	DT	O	B-TEST
negative	JJ	O	I-TEST
evaluation	NN	O	I-TEST
for	IN	O	O
dissecting	VBG	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
2016-09-03	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
began	VBD	O	O
experiencing	VBG	O	B-PROBLEM
continuing	VBG	B-PROBLEM	I-PROBLEM
chest	JJS	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
increasing	VBG	O	B-PROBLEM
intensity	NN	O	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
nitroglycerin	JJ	B-TREATMENT	B-TREATMENT
paste	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
iv	JJ	B-TREATMENT	O
integrelin	NN	I-TREATMENT	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
plavix	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

at	IN	O	O
that	DT	O	O
time	NN	O	O
,	,	O	O
he	PRP	O	O
ruled	VBD	O	O
in	IN	O	O
for	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
nst	JJ	I-PROBLEM	I-PROBLEM
emi	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-TEST	B-TEST
peak	JJ	I-TEST	I-TEST
ck	NN	I-TEST	I-TEST
of	IN	O	O
412	CD	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
troponin	NN	I-TEST	I-TEST
of	IN	O	O
6.23	CD	O	O
.	.	O	O

electrocardiograms	NNS	B-TEST	B-TEST
progressed	VBD	O	O
to	TO	O	O
inverted	VB	B-PROBLEM	B-PROBLEM
t	NN	I-PROBLEM	I-PROBLEM
waves	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
v5	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
v6	NN	I-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
now	RB	O	O
transferred	VBN	O	O
to	TO	O	O
cambridge	VB	O	O
health	NN	O	O
alliance	NN	O	O
for	IN	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
.	.	O	O

hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hyperlipidemia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
imi	NN	B-PROBLEM	O
in	IN	O	O
2005	CD	O	O
.	.	O	O

partial	JJ	B-TREATMENT	B-TREATMENT
thyroidectomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
herniorrhaphy	NN	B-TREATMENT	B-PROBLEM
,	,	O	O
percutaneous	JJ	B-TREATMENT	B-TREATMENT
transluminal	JJ	I-TREATMENT	I-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
angioplasty	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	O
the	DT	I-TREATMENT	O
rca	NN	I-TREATMENT	O
in	IN	O	O
2005	CD	O	O
,	,	O	O
left	VBD	B-TREATMENT	B-TREATMENT
knee	NN	I-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
as	RB	O	O
well	RB	O	O
as	IN	O	O
tonsil	NN	B-TREATMENT	B-TREATMENT
and	CC	I-TREATMENT	O
adenoid	JJ	I-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
flomax	JJ	B-TREATMENT	B-TREATMENT
0.4	CD	O	O
q.d.	NN	O	O

2.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
q.d.	NN	O	O

3.	CD	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
q.d.	NN	O	O

4.	CD	O	O
naproxen	JJ	B-TREATMENT	B-TREATMENT
p.r.n.	NN	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
several	JJ	B-TREATMENT	B-TREATMENT
vitamins	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
supplements	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

5.	CD	O	O
zestoretic	JJ	B-TREATMENT	B-PROBLEM
with	IN	O	O
an	DT	O	O
unknown	JJ	O	O
dose	NN	O	O
.	.	O	O

1.	CD	O	O
captopril	NN	B-TREATMENT	B-TREATMENT
25	CD	O	O
t.i.d.	NN	O	O

2.	CD	O	O
protonix	JJ	B-TREATMENT	B-TREATMENT
q.d.	RB	O	O
40	CD	O	O
.	.	O	O

3.	CD	O	O
nitroglycerin	JJ	B-TREATMENT	B-TREATMENT
paste	NN	I-TREATMENT	I-TREATMENT
1	CD	O	O
inch	NN	O	O
q.	RB	O	O
6	CD	O	O
hours	NNS	O	O
.	.	O	O

4.	CD	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
25	CD	O	O
b.i.d.	NN	O	O

5.	CD	O	O
plavix	JJ	B-TREATMENT	B-TREATMENT
75	CD	O	O
q.d.	NN	O	O

6.	CD	O	O
lovenox	JJ	B-TREATMENT	B-TREATMENT
90	CD	O	O
b.i.d.	NN	O	O

7.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
q.d.	NN	O	O

8.	CD	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
q.d.	NN	O	O

father	RB	O	O
died	VBN	O	O
in	IN	O	O
his	PRP$	O	O
80	CD	O	O
's	POS	O	O
of	IN	O	O
pacemaker	NN	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
also	RB	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
his	PRP$	O	O
70	CD	O	O
's.	NNS	O	O

heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
is	VBZ	O	O
55	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
is	VBZ	O	O
129/79	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
is	VBZ	O	O
22	CD	O	O
,	,	O	O
o2	JJR	B-TEST	B-TEST
sat	NN	I-TEST	I-TEST
is	VBZ	O	O
96	CD	O	O
percent	NN	O	O
on	IN	O	O
2	CD	B-TREATMENT	O
liters	NNS	I-TREATMENT	O
.	.	O	O

in	IN	O	O
general	JJ	O	O
,	,	O	O
well-appearing	JJ	O	O
man	NN	O	O
,	,	O	O
lying	VBG	O	O
on	IN	O	O
a	DT	O	B-TREATMENT
stretcher	NN	O	I-TREATMENT
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2	CD	B-TEST	O
plus	CC	I-TEST	O
carotids	NNS	I-TEST	O
with	IN	O	O
no	DT	O	O
jugular	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
distention	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
no	DT	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
no	DT	O	O
thyromegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

fine	JJ	B-PROBLEM	B-PROBLEM
crackles	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
bases	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
otherwise	RB	O	O
clear	JJ	O	O
.	.	O	O

regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
s1	NN	O	O
and	CC	O	O
s2	NN	O	O
with	IN	O	O
no	DT	O	O
murmurs	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
rubs	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
gallops	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

abdomen	NNS	O	O
:	:	O	O
soft	JJ	O	O
and	CC	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
nondistended	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
normal	JJ	O	O
active	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
and	CC	O	O
no	DT	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

pulses	NNS	B-TEST	B-TEST
are	VBP	O	O
2	CD	O	O
plus	JJ	O	O
femoral	JJ	O	O
bilaterally	RB	O	O
,	,	O	O
2	CD	O	O
plus	CC	O	O
dorsalis	JJ	O	B-TEST
pedis	NN	O	I-TEST
as	RB	O	O
well	RB	O	O
as	IN	O	O
posterior	JJ	O	B-PROBLEM
tibial	JJ	O	I-PROBLEM
bilaterally	RB	O	I-PROBLEM
.	.	O	O

no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

chest	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
done	VBN	O	O
at	IN	O	O
the	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
showed	VBD	O	O
no	DT	O	O
gallstones	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

left	VBN	O	O
kidney	NN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
cyst	NN	I-PROBLEM	I-PROBLEM
splenic	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
no	DT	O	O
triple	NN	B-PROBLEM	O
a	DT	I-PROBLEM	O
.	.	O	O

electrocardiogram	NN	B-TEST	B-TEST
has	VBZ	O	O
sinus	VBN	O	O
rhythm	NN	O	O
with	IN	O	O
q	JJ	B-PROBLEM	O
wave	NN	I-PROBLEM	O
in	IN	I-PROBLEM	O
2	CD	I-PROBLEM	O
,	,	I-PROBLEM	O
3	CD	I-PROBLEM	O
,	,	I-PROBLEM	O
and	CC	I-PROBLEM	O
f	NN	I-PROBLEM	O
,	,	O	O
flattened	VBD	B-PROBLEM	B-PROBLEM
t	JJ	I-PROBLEM	I-PROBLEM
waves	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lateral	JJ	I-PROBLEM	I-PROBLEM
leads	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
sinus	NN	O	B-TEST
rhythm	NN	O	I-TEST
at	IN	O	O
a	DT	O	O
rate	NN	O	O
of	IN	O	O
56	CD	O	O
.	.	O	O

white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
is	VBZ	O	O
8.3	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
42.7	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
180	CD	O	O
,	,	O	O
inr	NN	B-TEST	O
was	VBD	O	O
1.1	CD	O	O
,	,	O	O
sodium	NN	B-TEST	B-TEST
135	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.0	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
99	CD	O	O
,	,	O	O
co2	NN	B-TEST	B-TEST
33	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
13	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
1.0	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
96	CD	O	O
.	.	O	O

while	IN	O	O
on	IN	O	O
transfer	NN	O	O
,	,	O	O
the	DT	O	O
patient	JJ	O	O
underwent	JJ	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
.	.	O	O

in	IN	O	O
summary	JJ	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
showed	VBD	O	O
left	VBD	O	O
main	JJ	O	O
with	IN	O	O
no	DT	O	O
obstructive	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
lad	VBZ	O	O
with	IN	O	O
70	CD	B-PROBLEM	O
percent	NN	I-PROBLEM	B-PROBLEM
serial	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
left	VBD	O	B-PROBLEM
circumflex	NN	O	I-PROBLEM
with	IN	O	O
70	CD	O	O
percent	NN	O	O
proximal	NN	O	O
,	,	O	O
om1	NN	O	O
and	CC	O	O
om2	VB	O	O
both	DT	O	O
70	CD	B-PROBLEM	O
percent	NN	I-PROBLEM	B-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
rca	NN	O	O
with	IN	O	O
nonobstructive	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
ejection	NN	O	O

fraction	NN	B-TEST	O
of	IN	O	O
25	CD	O	O
percent	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
referred	VBN	O	O
to	TO	O	O
ct	VB	O	O
surgery	NN	O	B-TREATMENT
who	WP	O	O
was	VBD	O	O
seen	VBN	O	O
and	CC	O	O
accepted	VBN	O	O
for	IN	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

in	IN	O	O
summary	JJ	O	O
,	,	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
times	NNS	O	O
4	CD	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-PROBLEM
lima	NN	I-TREATMENT	I-PROBLEM
to	TO	I-TREATMENT	O
the	DT	I-TREATMENT	O
lad	NN	I-TREATMENT	O
,	,	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
om1	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
om2	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
diagonal	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
operation	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
and	CC	O	O
was	VBD	O	O
transferred	VBN	O	O
from	IN	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
to	TO	O	O
the	DT	O	O
cardiothoracic	NN	O	O
icu	NN	O	O
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
transfer	NN	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
av	RB	B-TREATMENT	O
paced	VBN	I-TREATMENT	O
at	IN	O	O
a	DT	O	O
rate	NN	O	O
of	IN	O	O
88	CD	O	O
beats	NNS	O	O
per	IN	O	O
minute	NN	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
propofol	VBN	B-TREATMENT	B-TREATMENT
at	IN	O	O
30	CD	O	O
mc	NNS	O	O
per	IN	O	O
kg	NN	O	O
per	IN	O	O
minute	NN	O	O
and	CC	O	O
neo-synephrine	JJ	B-TREATMENT	O
to	TO	O	O
maintain	VB	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
anesthesia	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
reversed	VBN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
weaned	VBN	O	O
from	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
ventilator	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
successfully	RB	O	O
extubated	VBN	O	O
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
1	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
neo-synephrine	JJ	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
maintain	VB	O	O
an	DT	O	O
adequate	JJ	O	O
blood	NN	O	O

he	PRP	O	O
remained	VBD	O	O
in	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
as	IN	O	O
he	PRP	O	O
was	VBD	O	O
unable	JJ	O	O
to	TO	O	O
be	VB	O	O
weaned	VBN	O	O
off	IN	O	O
of	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
neo-synephrine	JJ	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
1	CD	O	O
,	,	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
swan-ganz	JJ	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
removed	VBN	O	O
as	RB	O	O
well	RB	O	O
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
2	CD	O	O
,	,	O	O
another	DT	O	O
attempt	NN	O	O
was	VBD	O	O
made	VBN	O	O
to	TO	O	O
wean	VB	O	O
the	DT	O	O
patient	NN	O	O
off	IN	O	O
of	IN	O	O
neo-synephrine	JJ	B-TREATMENT	O
unsuccessfully	RB	O	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
chest	JJS	I-TREATMENT	I-TREATMENT
tubes	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
removed	VBN	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
because	IN	O	O
he	PRP	O	O
could	MD	O	O
not	RB	O	O
be	VB	O	O
weaned	VBN	O	O
from	IN	O	O
the	DT	B-TREATMENT	O
neo-synephrine	JJ	I-TREATMENT	O
,	,	O	O
he	PRP	O	O
again	RB	O	O
remained	VBD	O	O
in	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
3	CD	O	O
,	,	O	O
an	DT	O	O
additional	JJ	O	O
attempt	NN	O	O
was	VBD	O	O
made	VBN	O	O
to	TO	O	O
wean	VB	O	O
the	DT	O	O
patient	NN	O	O
from	IN	O	O
his	PRP$	B-TREATMENT	O
neo-synephrine	JJ	I-TREATMENT	O
unsuccessfully	RB	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
received	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
unit	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
packed	JJ	I-TREATMENT	I-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
in	IN	O	O
an	DT	O	O
additional	JJ	O	O
attempt	NN	O	O
to	TO	O	O
wean	VB	O	O
from	IN	O	O
neo-synephrine	JJ	B-TREATMENT	O
.	.	O	O

this	DT	O	O
also	RB	O	O
did	VBD	O	O
not	RB	O	O
help	VB	O	O
in	IN	O	O
the	DT	O	O
attempt	NN	O	O
to	TO	O	O
wean	VB	O	O
from	IN	O	O
neo-synephrine	JJ	B-TREATMENT	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
foley	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
removed	VBN	O	O
and	CC	O	O
he	PRP	O	O
remained	VBD	O	O
again	RB	O	O
in	IN	O	O
the	DT	O	O
icu	NN	O	O
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
4	CD	O	O
,	,	O	O
additional	JJ	O	O
attempts	NNS	O	O
were	VBD	O	O
made	VBN	O	O
to	TO	O	O
wean	VB	O	O
the	DT	O	O
patient	NN	O	O
off	IN	O	O
of	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
neo-synephrine	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
however	RB	O	O
,	,	O	O
he	PRP	O	O
continued	VBD	O	O
to	TO	O	O
drop	VB	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
whenever	WRB	O	O
an	DT	O	O
attempt	NN	O	O
was	VBD	O	O
made	VBN	O	O
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
5	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
finally	RB	O	O
weaned	VBN	O	O
off	IN	O	O
of	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
neo-synephrine	JJ	I-TREATMENT	I-TREATMENT
and	CC	O	I-TREATMENT
diuresis	NN	B-TREATMENT	I-TREATMENT
was	VBD	O	O
begun	VBN	O	O
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
6	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
for	IN	O	O
continuing	VBG	B-TREATMENT	B-TREATMENT
postoperative	JJ	I-TREATMENT	I-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
cardiac	JJ	B-TREATMENT	B-TREATMENT
rehabilitation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
this	DT	O	O
dictation	NN	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
physical	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
is	VBZ	O	O
as	IN	O	O
follows	VBZ	O	O
:	:	O	O
vital	JJ	B-TEST	B-TEST
signs	NNS	I-TEST	I-TEST
were	VBD	O	O
temperature	JJ	B-TEST	B-TEST
99	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
84	CD	O	O
in	IN	O	O
sinus	NN	O	O
rhythm	NN	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
114/63	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
was	VBD	O	O
18	CD	O	O
,	,	O	O
o2	FW	B-TEST	B-TEST
sat	VBD	I-TEST	I-TEST
was	VBD	O	O
94	CD	O	O
percent	NN	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

weight	NN	B-TEST	B-TEST
preoperatively	RB	O	O
was	VBD	O	O
88.5	CD	O	O
kilos	NN	O	O
,	,	O	O
at	IN	O	O
discharge	NN	O	O
was	VBD	O	O
90.4	CD	O	O
kilos	NN	O	O
.	.	O	O

white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
8.8	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
29.7	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
367	CD	O	O
,	,	O	O
sodium	NN	B-TEST	B-TEST
139	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.7	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
102	CD	O	O
,	,	O	O
co2	NN	B-TEST	B-TEST
27	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
17	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
1.1	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
95	CD	O	O
.	.	O	O

clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	I-TEST	O
.	.	O	O

no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

sternum	NN	O	B-TEST
is	VBZ	O	O
stable	JJ	O	O
,	,	O	O
incision	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
staples	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
opened	VBD	O	O
to	TO	O	O
air	NN	O	O
,	,	O	O
clean	JJ	O	O
and	CC	O	O
dry	JJ	O	O
.	.	O	O

abdomen	NNS	O	O
:	:	O	O
soft	JJ	O	O
and	CC	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBD	B-PROBLEM	B-PROBLEM
with	IN	O	O
positive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
.	.	O	O

warm	NN	O	O
and	CC	O	O
well	RB	O	O
profuse	VB	O	O
with	IN	O	O
1	CD	B-PROBLEM	O
to	TO	I-PROBLEM	O
2	CD	I-PROBLEM	O
plus	CC	I-PROBLEM	O
edema	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

right	RB	B-PROBLEM	O
saphenous	JJ	I-PROBLEM	B-TREATMENT
vein	NN	I-PROBLEM	I-TREATMENT
graft	NN	I-PROBLEM	I-TREATMENT
site	NN	I-PROBLEM	I-TREATMENT
with	IN	O	I-TREATMENT
steri-strips	NNS	B-TREATMENT	I-TREATMENT
,	,	O	O
open	JJ	O	O
to	TO	O	O
air	NN	O	O
,	,	O	O
clean	JJ	O	O
and	CC	O	O
dry	JJ	O	O
.	.	O	O

1.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
grafting	VBG	I-TREATMENT	I-TREATMENT
times	NNS	O	O
4	CD	O	O
with	IN	O	O
lima	NN	B-TREATMENT	B-PROBLEM
to	TO	I-TREATMENT	O
the	DT	I-TREATMENT	O
lad	NN	I-TREATMENT	O
,	,	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	O
om1	VB	I-TREATMENT	O
,	,	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	I-TREATMENT
om2	VB	I-TREATMENT	I-TREATMENT
and	CC	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
diagonal	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

2.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

3.	CD	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

4.	CD	O	O
status	NN	O	B-TREATMENT
post	NN	O	I-TREATMENT
partial	JJ	B-TREATMENT	I-TREATMENT
thyroidectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

5.	CD	O	O
status	NN	O	B-TREATMENT
post	NN	O	I-TREATMENT
hernia	NN	B-TREATMENT	I-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

6.	CD	O	O
status	NN	O	O
post	NN	O	O
left	VBD	B-TREATMENT	B-TREATMENT
knee	NN	I-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

7.	CD	O	O
status	NN	O	O
post	NN	O	O
tonsil	NN	B-TREATMENT	B-TREATMENT
and	CC	I-TREATMENT	O
adenoid	JJ	I-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

1.	CD	O	O
atorvastatin	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

2.	CD	O	O
plavix	JJ	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
q.d.	NN	O	O
times	NNS	O	O
3	CD	O	O
months	NNS	O	O
.	.	O	O

3.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NN	O	O
q.d.	NN	O	O

4.	CD	O	O
lasix	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
q.d.	JJ	O	O
times	NNS	O	O
two	CD	O	O
weeks	NNS	O	O
.	.	O	O

5.	CD	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
20	CD	O	O
meq	NN	O	O
q.d.	JJ	O	O
times	NNS	O	O
two	CD	O	O
weeks	NNS	O	O
.	.	O	O

6.	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
12.5	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O

7.	CD	O	O
percocet	JJ	B-TREATMENT	B-TREATMENT
1	CD	O	O
to	TO	O	O
2	CD	O	O
tabs	NNS	O	O
q.	RB	O	O
4	CD	O	O
hours	NNS	O	O
p.r.n.	NN	O	O

gastrointestinal	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM

gi	NNS	B-PROBLEM	B-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
is	VBZ	O	O
an	DT	O	O
84-year-old	JJ	O	O
male	NN	O	O
who	WP	O	O
was	VBD	O	O
transferred	VBN	O	O
from	IN	O	O
an	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-TEST
low	JJ	I-PROBLEM	I-TEST
hematocrit	NN	I-PROBLEM	I-TEST
of	IN	O	O
21	CD	O	O
and	CC	O	O
with	IN	O	O
guaiac-positive	JJ	B-PROBLEM	B-PROBLEM
stool	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
,	,	O	O
he	PRP	O	O
experienced	VBD	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
exertion	NN	O	O
,	,	O	O
and	CC	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
admission	NN	O	O
he	PRP	O	O
collapsed	VBD	O	O
and	CC	O	O
complained	VBD	O	O
of	IN	O	O
substantial	JJ	B-PROBLEM	B-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
denied	VBD	O	O
any	DT	B-PROBLEM	O
melana	NN	I-PROBLEM	O
,	,	O	O
any	DT	B-PROBLEM	B-PROBLEM
hematemesis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
an	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
at	IN	O	O
which	WDT	O	O
time	NN	O	O
it	PRP	O	O
was	VBD	O	O
found	VBN	O	O
that	IN	O	O
his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
21	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
90/60	CD	O	O
,	,	O	O
and	CC	O	O
his	PRP$	B-TEST	B-TEST
inr	NN	I-TEST	I-TEST
was	VBD	O	O
3.3	CD	O	O
.	.	O	O

of	IN	O	O
note	NN	O	O
,	,	O	O
he	PRP	O	O
is	VBZ	O	O
anti-coagulated	JJ	B-TREATMENT	O
for	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
artificial	JJ	I-TREATMENT	I-TREATMENT
heart	NN	I-TREATMENT	I-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
at	IN	O	O
that	DT	O	O
point	NN	O	O
given	VBN	O	O
1	CD	B-TREATMENT	O
unit	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
packed	JJ	I-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
further	JJ	O	O
questioning	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
reported	VBD	O	O
that	IN	O	O
he	PRP	O	O
started	VBD	O	O
to	TO	O	O
feel	VB	O	O
&quot;	JJ	O	O
different	JJ	O	O
&quot;	JJ	O	O
several	JJ	O	O
days	NNS	O	O
ago	RB	O	O
with	IN	O	O
slowing	VBG	B-PROBLEM	O
and	CC	I-PROBLEM	O
difficult	JJ	I-PROBLEM	O
ambulation	NN	I-PROBLEM	O
progressing	VBG	O	O
to	TO	O	O
complete	VB	O	O
inability	NN	O	B-PROBLEM
to	TO	O	I-PROBLEM
ambulate	VB	O	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
also	RB	O	O
short	JJ	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
ambulation	NN	O	O
,	,	O	O
but	CC	O	O
he	PRP	O	O
does	VBZ	O	O
have	VB	O	O
baseline	JJ	B-PROBLEM	B-PROBLEM
shortness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
exertion	NN	O	O
.	.	O	O

he	PRP	O	O
denied	VBD	O	O
any	DT	B-PROBLEM	B-PROBLEM
chest	JJS	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
dysuria	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
loss	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
consciousness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
any	DT	O	O
history	NN	O	O
of	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
was	VBD	O	O
last	JJ	O	O
admitted	JJ	O	O
to	TO	O	O
padrugmoff	VB	O	O
hospital	NN	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
of	IN	O	O
24.5	CD	O	O
,	,	O	O
and	CC	O	O
was	VBD	O	O
asymptomatic	JJ	B-PROBLEM	B-PROBLEM
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
.	.	O	O

at	IN	O	O
that	DT	O	O
time	NN	O	O
,	,	O	O
he	PRP	O	O
had	VBD	O	O
guaiac-positive	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
had	VBD	O	O
a	DT	B-TEST	B-PROBLEM
small	JJ	I-TEST	I-PROBLEM
bowel	NN	I-TEST	I-PROBLEM
follow	VBP	I-TEST	O
through	IN	I-TEST	O
which	WDT	O	O
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
transfused	VBN	O	O
4	CD	B-TREATMENT	O
units	NNS	I-TREATMENT	O
during	IN	O	O
that	DT	O	O
admission	NN	O	O
and	CC	O	O
discharged	VBN	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
of	IN	O	O
34	CD	O	O
on	IN	O	O
vitamin	NN	B-TREATMENT	B-TREATMENT
c	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
iron	NN	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
of	IN	O	O
97.4	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
65	CD	O	O
,	,	O	O
pressure	NN	B-TEST	B-TEST
107/52	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
22	CD	O	O
and	CC	O	O
saturating	VBG	B-TEST	O
100%	CD	O	O
on	IN	O	O
2	CD	O	O
l	NN	O	O
of	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
nasal	JJ	I-TREATMENT	I-TREATMENT
cannula	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

general	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
at	IN	O	O
the	DT	O	O
time	NN	O	O
was	VBD	O	O
notable	JJ	O	O
for	IN	O	O
pale	JJ	B-PROBLEM	B-PROBLEM
mucous	JJ	I-PROBLEM	I-PROBLEM
membranes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
left	VBD	B-PROBLEM	B-PROBLEM
lateral	JJ	I-PROBLEM	I-PROBLEM
eye	NN	I-PROBLEM	I-PROBLEM
deviation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
clear	JJ	O	O
lungs	NNS	O	O
,	,	O	O
2/6	CD	B-PROBLEM	B-PROBLEM
holosystolic	JJ	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
best	JJS	O	O
heard	NN	O	O
at	IN	O	O
the	DT	O	O
apex	NN	O	O
,	,	O	O
abdomen	NNS	O	O
was	VBD	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
distended	JJ	I-PROBLEM	I-PROBLEM
but	CC	O	O
was	VBD	O	O
soft	JJ	O	O
and	CC	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
his	PRP$	O	O
extremities	NNS	O	O
were	VBD	O	O
without	IN	O	O
edema	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
skin	NN	O	O
without	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
rashes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

history	NN	O	O
of	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
status	NN	O	O
post	NN	O	O
two-vessel	JJ	B-TREATMENT	B-TREATMENT
cabg	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
1986	CD	O	O
,	,	O	O
also	RB	O	O
he	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
for	IN	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
aortic	JJ	B-TREATMENT	B-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
mitral	JJ	B-TREATMENT	B-TREATMENT
valve	NNS	I-TREATMENT	I-TREATMENT
replacement	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
st.	JJ	B-TREATMENT	O
jude	NN	I-TREATMENT	O
&apos;s	NNP	I-TREATMENT	O
valve	NN	I-TREATMENT	O
in	IN	O	O
09/2001	CD	O	O
,	,	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
history	NN	O	O
of	IN	O	O
prior	JJ	B-PROBLEM	B-PROBLEM
gi	NNS	I-PROBLEM	I-PROBLEM
bleed	VBP	I-PROBLEM	I-PROBLEM
requiring	VBG	O	O
blood	NN	B-TREATMENT	B-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
during	IN	O	O
which	WDT	O	O
he	PRP	O	O
also	RB	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
colonoscopy	NN	I-TEST	I-TEST
on	IN	O	O
05/2003	CD	O	O
which	WDT	O	O
demonstrated	VBD	O	O
no	DT	O	O
neoplasia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
scattered	VBD	B-PROBLEM	B-PROBLEM
diverticuli	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
,	,	O	O
following	VBG	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
first	JJ	I-PROBLEM	I-PROBLEM
gi	NN	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
had	VBD	O	O
an	DT	B-TEST	B-TEST
eeg	NN	I-TEST	I-TEST
done	VBN	O	O
in	IN	O	O
07/2003	CD	O	O
which	WDT	O	O
showed	VBD	O	O
gastritis	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
oozing	VBG	B-PROBLEM	B-PROBLEM
and	CC	O	O
evidence	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
recent	JJ	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

included	VBN	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
diovan	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
torsemide	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
flomax	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
protonix	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
senekot	NN	B-TREATMENT	O
,	,	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
vitamin	FW	B-TREATMENT	B-TREATMENT
c	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
iron	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
a	DT	B-TREATMENT	B-TREATMENT
multivitamin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
a	DT	O	O
wife	NN	O	O
with	IN	O	O
alzheimer	JJ	B-PROBLEM	B-PROBLEM
&apos;s	NNS	I-PROBLEM	I-PROBLEM
who	WP	O	O
lives	VBZ	O	O
in	IN	O	O
a	DT	O	O
skilled-nursing	JJ	O	O
facility	NN	O	O
.	.	O	O

notable	JJ	O	O
for	IN	O	O
a	DT	B-TEST	B-TREATMENT
bun	NN	I-TEST	I-TREATMENT
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
of	IN	O	O
78	CD	O	O
,	,	O	O
1.7	CD	O	O
;	:	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
,	,	O	O
potassium	NN	B-TEST	B-TEST
139	CD	O	O
and	CC	O	O
3.6	CD	O	O
;	:	O	O
chloride	NN	B-TEST	B-TREATMENT
and	CC	O	O
bicarb	NN	B-TEST	B-TEST
108	CD	O	O
,	,	O	O
21	CD	O	O
.	.	O	O

white	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
7	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
24.2	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
183	CD	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
inr	NN	I-TEST	I-TEST
was	VBD	O	O
also	RB	O	O
3.4	CD	O	O
.	.	O	O

ptt	NN	B-TEST	B-TEST
was	VBD	O	O
55	CD	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
ekg	NN	I-TEST	I-TEST
was	VBD	O	O
notable	JJ	O	O
for	IN	O	O
right	JJ	B-PROBLEM	B-PROBLEM
bundle	NN	I-PROBLEM	I-PROBLEM
branch	NN	I-PROBLEM	I-PROBLEM
block	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
left	VBD	B-PROBLEM	B-PROBLEM
axis	JJ	I-PROBLEM	I-PROBLEM
deviation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
was	VBD	O	O
in	IN	O	O
sinus	JJ	O	B-PROBLEM
rhythm	NN	O	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	O
ua	NN	I-TEST	O
had	VBD	O	O
10-17	JJ	B-PROBLEM	B-PROBLEM
white	JJ	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
cells	NNS	I-PROBLEM	I-PROBLEM
;	:	O	O
trace	NN	B-PROBLEM	B-PROBLEM
leukocyte	NN	I-PROBLEM	I-PROBLEM
esterase	NN	I-PROBLEM	I-PROBLEM
hyaline	NN	B-PROBLEM	I-PROBLEM
casts	VBZ	I-PROBLEM	I-PROBLEM
numbering	VBG	O	O
60-70	JJ	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
was	VBD	O	O
notable	JJ	O	O
for	IN	O	O
clear	JJ	O	O
lungs	NNS	O	O
with	IN	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
infiltrates	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
small	JJ	B-PROBLEM	B-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
effusions	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

patient	NN	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-TEST	B-TEST
troponin	NN	I-TEST	I-TEST
of	IN	O	O
0.71	CD	O	O
on	IN	O	O
admission	NN	O	O
with	IN	O	O
a	DT	B-TEST	O
ck	NN	I-TEST	O
of	IN	O	O
46	CD	O	O
and	CC	O	O
ckmb	NN	B-TEST	O
of	IN	O	O
3.4	CD	O	O
.	.	O	O

at	IN	O	O
that	DT	O	O
time	NN	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
likely	JJ	O	O
having	VBG	O	O
a	DT	B-PROBLEM	B-PROBLEM
repeat	NN	I-PROBLEM	I-PROBLEM
gi	NN	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
while	IN	O	O
he	PRP	O	O
was	VBD	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
,	,	O	O
he	PRP	O	O
had	VBD	O	O
evidently	RB	O	O
lost	VBN	O	O
a	DT	O	O
substantial	JJ	O	O
amount	NN	O	O
of	IN	O	O
blood	NN	O	B-PROBLEM
.	.	O	O

patient	NN	O	O
was	VBD	O	O
transfused	VBN	O	O
2	CD	B-TREATMENT	O
units	NNS	I-TREATMENT	O
of	IN	I-TREATMENT	O
packed	JJ	I-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
overnight	RB	O	O
,	,	O	O
the	DT	O	O
first	JJ	O	O
night	NN	O	O
after	IN	O	O
admission	NN	O	O
and	CC	O	O
his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
bumped	VBD	O	O
up	RP	O	O
appropriately	RB	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
proton	NN	I-TREATMENT	I-TREATMENT
pump	NN	I-TREATMENT	I-TREATMENT
inhibitor	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
on	IN	O	O
iron	NN	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
vitamin	NN	B-TREATMENT	B-TREATMENT
c	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
held	VBN	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
given	VBN	O	O
the	DT	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
even	RB	O	O
though	IN	O	O
it	PRP	O	O
was	VBD	O	O
important	JJ	O	O
to	TO	O	O
keep	VB	O	O
his	PRP$	B-TEST	O
inr	JJ	I-TEST	O
2.5-3.5	JJ	O	O
,	,	O	O
given	VBN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
artificial	JJ	I-TREATMENT	I-TREATMENT
valve	NN	I-TREATMENT	I-TREATMENT
it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
that	IN	O	O
the	DT	O	O
risk	NN	O	O
of	IN	O	O
continued	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
to	TO	O	O
great	JJ	O	O
to	TO	O	O
continue	VB	O	O
the	DT	B-TREATMENT	B-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
subsequently	RB	O	O
seen	VBN	O	O
by	IN	O	O
the	DT	O	O
gi	NN	O	O
team	NN	O	O
who	WP	O	O
performed	VBD	O	O
an	DT	B-TEST	B-TEST
upper	JJ	I-TEST	I-TEST
endoscopy	NN	I-TEST	I-TEST
which	WDT	O	O
demonstrated	VBD	O	O
the	DT	O	O
following	NN	O	O
:	:	O	O

in	IN	O	O
the	DT	O	O
esophagus	NN	O	O
,	,	O	O
there	EX	O	O
was	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
hiatal	NN	I-PROBLEM	I-PROBLEM
hernia	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
in	IN	O	O
the	DT	O	O
stomach	NN	O	O
there	EX	O	O
is	VBZ	O	O
evidence	NN	O	O
of	IN	O	O
erosive	JJ	B-PROBLEM	B-PROBLEM
gastritis	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
body	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
stomach	NN	O	I-PROBLEM
and	CC	O	I-PROBLEM
the	DT	O	I-PROBLEM
antrum	NN	O	I-PROBLEM
,	,	O	O
the	DT	O	O
mucous	JJ	O	O
appeared	VBD	O	O
edematous	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
polyp	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
found	VBN	O	O
in	IN	O	O
the	DT	O	O
fundus	NN	O	O
which	WDT	O	O
stigmata	NN	B-PROBLEM	O
of	IN	O	O
old	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
an	DT	B-TREATMENT	B-TEST
endoclip	NN	I-TREATMENT	I-TEST
was	VBD	O	O
applied	VBN	O	O
to	TO	O	O
this	DT	O	O
.	.	O	O

another	DT	B-PROBLEM	B-PROBLEM
polyp	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
found	VBN	O	O
in	IN	O	O
the	DT	O	O
antrum	NN	O	O
and	CC	O	O
cold	JJ	B-TEST	B-TEST
biopsies	NNS	I-TEST	I-TEST
were	VBD	O	O
obtained	VBN	O	O
there	RB	O	O
.	.	O	O

in	IN	O	O
the	DT	O	B-PROBLEM
duodenum	NN	O	I-PROBLEM
,	,	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
avm	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
in	IN	O	O
the	DT	O	O
second	JJ	O	O
portion	NN	O	O
of	IN	O	O
the	DT	O	B-PROBLEM
duodenum	NN	O	I-PROBLEM
and	CC	O	O
was	VBD	O	O
cauterized	VBN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
biopsy	NN	I-TEST	I-TEST
subsequently	RB	O	O
demonstrated	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
hyperplastic	JJ	I-PROBLEM	I-PROBLEM
polyp	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
acute	NN	B-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	O
chronic	JJ	I-PROBLEM	B-PROBLEM
inflammation	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
erosion	NN	B-PROBLEM	I-PROBLEM
and	CC	O	O
reactive	JJ	B-PROBLEM	B-PROBLEM
epithelial	JJ	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
but	CC	O	O
no	DT	O	O
dysplasia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

also	RB	O	O
of	IN	O	O
note	NN	O	O
,	,	O	O
prior	RB	O	O
to	TO	O	O
the	DT	B-TEST	O
upper	JJ	I-TEST	O
endoscopy	NN	I-TEST	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
received	VBD	O	O
fresh	JJ	B-TREATMENT	B-TREATMENT
frozen	JJ	I-TREATMENT	I-TREATMENT
plasma	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
reverse	VB	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
anticoagulation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

patient	NN	O	O
remained	VBD	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
during	IN	O	O
and	CC	O	O
after	IN	O	O
the	DT	B-TEST	B-TREATMENT
upper	JJ	I-TEST	I-TREATMENT
endoscopy	NN	I-TEST	I-TREATMENT
and	CC	O	O
his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
remained	VBD	O	O
above	IN	O	O
30	CD	O	O
following	VBG	O	O
this	DT	O	O
until	IN	O	O
the	DT	O	O
point	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
last	JJ	I-TEST	I-TEST
recorded	JJ	I-TEST	I-TEST
hematocrit	NN	I-TEST	I-TEST
on	IN	O	O
discharge	NN	O	O
was	VBD	O	O
31.3	CD	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
last	JJ	I-TEST	I-TEST
bun	NN	I-TEST	I-TEST
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
were	VBD	O	O
42	CD	O	O
and	CC	O	O
1.5	CD	O	O
with	IN	O	O
an	DT	B-TEST	O
inr	NN	I-TEST	O
of	IN	O	O
2.5	CD	O	O
.	.	O	O

consideration	NN	O	O
was	VBD	O	O
given	VBN	O	O
to	TO	O	O
performing	VBG	O	O
a	DT	B-TEST	B-TREATMENT
repeat	NN	I-TEST	I-TREATMENT
colonoscopy	NN	I-TEST	I-TREATMENT
.	.	O	O

this	DT	O	O
was	VBD	O	O
discussed	VBN	O	O
with	IN	O	O
the	DT	O	O
gi	NN	O	O
service	NN	O	O
who	WP	O	O
felt	VBD	O	O
that	IN	O	O
this	DT	O	O
was	VBD	O	O
not	RB	O	O
necessary	JJ	O	O
given	VBN	O	O
the	DT	B-TEST	B-TREATMENT
recent	JJ	I-TEST	I-TREATMENT
colonoscopy	NN	I-TEST	I-TREATMENT
that	IN	O	O
he	PRP	O	O
had	VBD	O	O
had	VBN	O	O
in	IN	O	O
05/2003	CD	O	O
.	.	O	O

ischemia	NN	B-PROBLEM	B-PROBLEM
:	:	O	O

patient	JJ	B-PROBLEM	B-TEST
&apos;s	NNP	I-PROBLEM	I-TEST
troponin	NN	I-PROBLEM	I-TEST
bump	NN	I-PROBLEM	I-TEST
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
likely	JJ	O	O
to	TO	O	O
demand	VB	B-PROBLEM	B-PROBLEM
ischemia	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
gi	NN	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
it	PRP	O	O
was	VBD	O	O
not	RB	O	O
felt	VBD	O	O
that	IN	O	O
he	PRP	O	O
was	VBD	O	O
having	VBG	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
discharge	NN	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
aspirin	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
simvastatin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
lopressor	NN	I-TREATMENT	I-TREATMENT
which	WDT	O	O
was	VBD	O	O
initially	RB	O	O
held	VBN	O	O
,	,	O	O
and	CC	O	O
subsequently	RB	O	O
restarted	VBN	O	O
.	.	O	O

patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
be	VB	O	O
in	IN	O	O
a-fib.	JJ	B-PROBLEM	O
throughout	IN	O	O
the	DT	O	O
admission	NN	O	O
and	CC	O	O
was	VBD	O	O
restarted	VBN	O	O
on	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
concurrently	RB	O	O
with	IN	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

heparin	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
subsequently	RB	O	O
dcd	JJ	O	O
once	RB	O	O
his	PRP$	B-TEST	O
inr	NN	I-TEST	O
reached	VBD	O	O
a	DT	O	O
therapeutic	JJ	O	O
level	NN	O	O
between	IN	O	O
2.5-3.5	JJ	O	O
.	.	O	O

his	PRP$	B-TEST	O
last	JJ	I-TEST	O
reported	JJ	I-TEST	O
inr	NN	I-TEST	O
on	IN	O	O
discharge	NN	O	O
was	VBD	O	O
2.5	CD	O	O
.	.	O	O

patient	NN	O	O
had	VBD	O	O
,	,	O	O
as	IN	O	O
noted	VBN	O	O
above	IN	O	O
,	,	O	O
his	PRP$	B-TREATMENT	B-TEST
anticoagulation	NN	I-TREATMENT	I-TEST
was	VBD	O	O
initially	RB	O	O
reversed	VBN	O	O
despite	IN	O	O
his	PRP$	O	B-TREATMENT
having	VBG	O	I-TREATMENT
artificial	JJ	B-TREATMENT	I-TREATMENT
valves	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

however	RB	O	O
,	,	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
coumadin	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
subsequently	RB	O	O
restarted	VBN	O	O
and	CC	O	O
he	PRP	O	O
achieved	VBD	O	O
therapeutic	JJ	O	O
inr	NN	B-TEST	O
levels	NNS	I-TEST	O
before	IN	O	O
discharge	NN	O	O
.	.	O	O

patient	NN	O	O
,	,	O	O
during	IN	O	O
this	DT	O	O
hospital	JJ	O	O
course	NN	O	O
,	,	O	O
became	VBD	O	O
hypervolemic	JJ	B-PROBLEM	B-PROBLEM
likely	JJ	O	O
due	JJ	O	O
to	TO	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
diuretics	NNS	I-TREATMENT	I-TREATMENT
being	VBG	O	O
held	VBN	O	O
and	CC	O	O
due	JJ	O	O
to	TO	O	O
his	PRP$	O	O
receiving	VBG	O	O
blood	NN	B-TREATMENT	B-TREATMENT
products	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
diuresed	VBN	O	O
initially	RB	O	O
with	IN	O	O
one	CD	O	O
dose	NN	O	O
of	IN	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
subsequently	RB	O	O
with	IN	O	O
one	CD	O	O
dose	NN	O	O
of	IN	O	O
torsemide	NN	B-TREATMENT	B-TREATMENT
after	IN	O	O
it	PRP	O	O
was	VBD	O	O
discovered	VBN	O	O
that	IN	O	O
he	PRP	O	O
developed	VBD	O	O
thrombocytopenia	VB	B-PROBLEM	B-PROBLEM
on	IN	O	O
a	DT	O	O
prior	JJ	O	O
admission	NN	O	O
in	IN	O	O
reaction	NN	O	O
to	TO	O	O
lasix	VB	B-TREATMENT	B-TREATMENT
.	.	O	O

of	IN	O	O
note	NN	O	O
,	,	O	O
he	PRP	O	O
did	VBD	O	O
not	RB	O	O
become	VB	O	O
thrombocytopenic	JJ	B-PROBLEM	O
on	IN	O	O
this	DT	O	O
admission	NN	O	O
.	.	O	O

was	VBD	O	O
discharged	VBN	O	O
on	IN	O	O
11/16/2003	CD	O	O
in	IN	O	O
stable	JJ	O	O
condition	NN	O	O
with	IN	O	O
the	DT	B-TEST	O
last	JJ	I-TEST	O
recorded	JJ	I-TEST	O
hematocrit	NN	I-TEST	B-TEST
of	IN	O	O
31.3	CD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
asked	VBN	O	O
to	TO	O	O
continue	VB	O	O
on	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
nexium	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
iron	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
vitamin	NN	B-TREATMENT	B-TREATMENT
c	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
other	JJ	I-TREATMENT	I-TREATMENT
home	NN	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
final	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
on	IN	O	O
discharge	NN	O	O
were	VBD	O	O
as	IN	O	O
follows	VBZ	O	O
:	:	O	O

aspirin	RB	B-TREATMENT	B-TREATMENT
325	CD	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
restarted	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	O
ppi	NN	I-TREATMENT	O
,	,	O	O
also	RB	O	O
on	IN	O	O
iron	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
vitamin	FW	B-TREATMENT	B-TREATMENT
c	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
lopressor	VBZ	B-TREATMENT	B-TREATMENT
12.5	CD	O	I-TREATMENT
b.i.d	NN	O	I-TREATMENT
.	.	O	O

of	IN	O	O
note	NN	O	O
,	,	O	O
this	DT	O	O
was	VBD	O	O
at	IN	O	O
a	DT	O	O
decreased	JJ	O	O
dose	NN	O	O
compared	VBN	O	O
to	TO	O	O
that	DT	O	O
which	WDT	O	O
he	PRP	O	O
came	VBD	O	O
in	IN	O	O
on	IN	O	O
,	,	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
7.5	CD	O	O
,	,	O	O
mg	NN	O	O
,	,	O	O
torsemide	RB	B-TREATMENT	B-TREATMENT
100	CD	O	O
q.d.	NN	O	O
,	,	O	O
sucralfate	NN	B-TREATMENT	O
,	,	O	O
simvastatin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
diovan	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

cardiac	JJ	B-PROBLEM	O
arrest	NN	I-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
49	CD	O	O
year	NN	O	O
old	JJ	O	O
man	NN	O	O
who	WP	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
medical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
status	NN	O	O
post	NN	O	O
cardiac	JJ	B-PROBLEM	O
arrest	NN	I-PROBLEM	O
.	.	O	O

information	NN	O	O
was	VBD	O	O
very	RB	O	O
limited	JJ	O	O
regarding	VBG	O	O
the	DT	O	O
circumstances	NNS	O	O
of	IN	O	O
his	PRP$	B-PROBLEM	O
cardiac	JJ	I-PROBLEM	O
arrest	NN	I-PROBLEM	O
.	.	O	O

reportedly	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
at	IN	O	O
a	DT	O	O
local	JJ	O	O
restaurant	NN	O	O
where	WRB	O	O
he	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
unresponsive	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
asystolic	JJ	B-PROBLEM	O
but	CC	O	O
regained	VBD	O	O
a	DT	O	B-TEST
perfusing	NN	O	I-TEST
rhythm	NN	O	I-TEST
after	IN	O	O
2	CD	O	O
mg	NN	O	O
of	IN	O	O
epinephrine	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
2	CD	O	O
mg	NN	O	O
of	IN	O	O
atropine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
remained	VBD	O	O
unresponsive	JJ	B-PROBLEM	B-PROBLEM
despite	IN	O	O
the	DT	O	O
administration	NN	O	O
of	IN	O	O
narcan	JJ	B-TREATMENT	O
.	.	O	O

ct	JJ	B-TEST	B-TEST
examinations	NNS	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
,	,	I-TEST	I-TEST
chest	NN	I-TEST	I-TEST
,	,	I-TEST	I-TEST
abdomen	NNS	I-TEST	I-TEST
and	CC	I-TEST	O
pelvis	NNS	I-TEST	O
were	VBD	O	O
all	DT	O	O
unremarkable	JJ	O	O
.	.	O	O

initial	JJ	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	JJ	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
retrocardiac	NN	I-PROBLEM	I-PROBLEM
opacity	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
prominent	JJ	B-PROBLEM	B-PROBLEM
interstitium	NN	I-PROBLEM	I-PROBLEM
though	IN	O	O
his	PRP$	O	B-TEST
lung	NN	O	I-TEST
volumes	NNS	O	I-TEST
were	VBD	O	O
low	JJ	B-PROBLEM	O
.	.	O	O

subsequent	JJ	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	JJ	I-TEST	I-TEST
showed	VBD	O	O
right	JJ	B-TREATMENT	B-TREATMENT
main	JJ	I-TREATMENT	I-TREATMENT
stem	NN	I-TREATMENT	I-TREATMENT
intubation	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
collapse	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
had	VBD	O	O
corrected	VBN	O	O
with	IN	O	O
withdrawal	NN	B-TREATMENT	O
of	IN	I-TREATMENT	O
the	DT	I-TREATMENT	B-TREATMENT
endotracheal	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
then	RB	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
medical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
induced	JJ	B-TREATMENT	B-PROBLEM
hypothermia	NN	I-TREATMENT	I-PROBLEM
given	VBN	O	O
his	PRP$	O	B-PROBLEM
hemodynamic	JJ	O	I-PROBLEM
stability	NN	O	I-PROBLEM
,	,	O	O
ongoing	VBG	B-PROBLEM	O
unresponsiveness	NN	I-PROBLEM	B-PROBLEM
and	CC	O	O
recent	JJ	B-PROBLEM	O
out	IN	I-PROBLEM	O
of	IN	I-PROBLEM	O
hospital	NN	I-PROBLEM	O
cardiac	JJ	I-PROBLEM	O
arrest	NN	I-PROBLEM	O
.	.	O	O

1)	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2)	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
back	RB	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
s/p	JJ	O	B-TREATMENT
lumbar	NN	B-TREATMENT	I-TREATMENT
discectomy	NN	I-TREATMENT	I-TREATMENT
x	VBD	O	O
2	CD	O	O
.	.	O	O

3)	CD	O	O
cirrhosis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

4)	CD	O	O
h/o	JJ	O	O
stab	NN	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
complicated	VBN	O	O
by	IN	O	O
pneumothorax	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

5)	CD	O	O
h/o	NNS	O	O
lower	JJR	B-PROBLEM	B-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
cellulitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

6)	CD	O	O
s/p	JJ	O	O
cholecystectomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

7)	CD	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
neuropathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
oxycontin	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q	VBD	O	O
12hours	CD	O	O
.	.	O	O

2.	CD	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

3.	CD	O	O
nortriptyline	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

4.	CD	O	O
neurontin	JJ	B-TREATMENT	B-TREATMENT
1800	CD	O	O
mg	NN	O	O
four	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O

he	PRP	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
abuse	NN	O	O
of	IN	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
according	VBG	O	O
to	TO	O	O
his	PRP$	O	O
brother	NN	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
recently	RB	O	O
filled	VBN	O	O
a	DT	O	O
prescription	NN	O	O
for	IN	O	O
560	CD	O	O
tablets	NNS	O	O
of	IN	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
as	RB	O	O
well	RB	O	O
as	IN	O	O
60	CD	O	O
tablets	NNS	O	O
of	IN	O	O
oxycontin	NN	B-TREATMENT	B-TREATMENT
early	JJ	O	O
last	JJ	O	O
month	NN	O	O
.	.	O	O

negative	JJ	O	O
for	IN	O	O
any	DT	O	O
history	NN	O	O
of	IN	O	O
sudden	JJ	B-PROBLEM	B-PROBLEM
death	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
admission	NN	O	O
,	,	O	O
temperature	NN	B-TEST	B-TEST
was	VBD	O	O
96.2	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
150/80	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
92	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
16	CD	O	O
.	.	O	O

in	IN	O	O
general	JJ	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
unarousible	JJ	B-PROBLEM	O
,	,	O	O
intubated	VBN	B-TREATMENT	B-TREATMENT
,	,	O	O
not	RB	O	O
on	IN	O	O
any	DT	B-TREATMENT	B-TREATMENT
sedation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

they	PRP	O	O
were	VBD	O	O
minimally	RB	B-PROBLEM	B-PROBLEM
reactive	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	O	B-TEST
sclerae	NN	O	I-TEST
were	VBD	O	O
anicteric	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
unremarkable	JJ	O	O
without	IN	O	O
murmurs	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
lungs	NNS	O	O
were	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	I-TEST	O
.	.	O	O

his	PRP$	O	O
abdomen	NNS	O	O
had	VBD	O	O
normal	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
,	,	O	O
soft	JJ	O	O
and	CC	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

extremities	NNS	O	O
had	VBD	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
excoriations	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

neurologic	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
-	:	O	O
he	PRP	O	O
was	VBD	O	O
unarousible	JJ	B-PROBLEM	O
and	CC	O	O
without	IN	O	O
sedation	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
no	DT	B-PROBLEM	O
spontaneous	JJ	I-PROBLEM	B-PROBLEM
movements	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

flaccid	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

extremities	NNS	O	O
-	:	O	O
babinski	NN	B-TEST	O
reflex	NN	I-TEST	O
was	VBD	O	O
equivocal	JJ	O	O
bilaterally	RB	O	O
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
admission	NN	O	O
,	,	O	O
laboratories	NNS	B-TEST	B-TEST
were	VBD	O	O
remarkable	JJ	O	O
for	IN	O	O
a	DT	B-TEST	B-TREATMENT
partial	JJ	I-TEST	I-TREATMENT
thromboplastin	NN	I-TEST	I-TREATMENT
time	NN	I-TEST	O
of	IN	O	O
31.7	CD	O	O
,	,	O	O
inr	NN	B-TEST	B-TEST
1.4	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
3.2	CD	O	O
,	,	O	O
glucose	RB	B-TEST	B-TEST
182	CD	O	O
,	,	O	O
lactate	NN	B-TEST	B-TEST
was	VBD	O	O
initially	RB	O	O
6.6	CD	O	O
.	.	O	O

urine	JJ	B-TEST	B-TEST
toxicology	NN	I-TEST	I-TEST
screen	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

serum	NN	B-TEST	B-TEST
toxicology	NN	I-TEST	I-TEST
screen	NN	I-TEST	I-TEST
was	VBD	O	O
positive	JJ	O	O
for	IN	O	O
tca	NN	B-TREATMENT	O
s.	NN	I-TREATMENT	O

tylenol	JJ	B-TEST	B-TEST
level	NN	I-TEST	I-TEST
was	VBD	O	O
15	CD	O	O
.	.	O	O

alcohol	NN	B-TEST	B-TEST
level	NN	I-TEST	I-TEST
was	VBD	O	O
199	CD	O	O
.	.	O	O

initial	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
gas	NN	I-TEST	I-TEST
was	VBD	O	O
7.31/46/500/77	CD	O	O
.	.	O	O

cardiac	JJ	B-PROBLEM	B-TEST
arrest	NN	I-PROBLEM	I-TEST
-	:	O	O
his	PRP$	B-PROBLEM	O
arrest	NN	I-PROBLEM	O
was	VBD	O	O
of	IN	O	O
unknown	JJ	O	O
etiology	NN	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
admission	NN	O	O
.	.	O	O

no	DT	O	O
further	JJ	O	O
history	NN	O	O
was	VBD	O	O
ever	RB	O	O
gained	VBN	O	O
about	IN	O	O
his	PRP$	B-PROBLEM	O
cardiac	NN	I-PROBLEM	O
arrest	NN	I-PROBLEM	O
throughout	IN	O	O
his	PRP$	O	O
hospitalization	NN	O	O
.	.	O	O

ct	NN	B-TEST	B-TEST
angiogram	NN	I-TEST	I-TEST
had	VBD	O	O
been	VBN	O	O
negative	JJ	O	O
for	IN	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
embolism	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
on	IN	O	O
2013-04-26	JJ	O	O
,	,	O	O
which	WDT	O	O
showed	VBD	O	O
a	DT	O	O
normal	JJ	O	O
ejection	NN	O	O
fraction	NN	O	O
and	CC	O	O
trivial	JJ	B-PROBLEM	B-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
otherwise	RB	O	O
no	DT	O	O
obvious	JJ	B-PROBLEM	B-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
were	VBD	O	O
seen	VBN	O	O
.	.	O	O

given	VBN	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
an	DT	B-PROBLEM	O
out	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
hospital	NN	I-PROBLEM	O
arrest	NN	I-PROBLEM	O
,	,	O	O
remained	VBD	O	O
unresponsive	JJ	B-PROBLEM	B-PROBLEM
despite	IN	O	I-PROBLEM
hemodynamic	JJ	O	I-PROBLEM
stability	NN	O	I-PROBLEM
,	,	O	O
he	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
induced	JJ	B-TREATMENT	B-PROBLEM
hypothermia	NN	I-TREATMENT	I-PROBLEM
and	CC	O	O
with	IN	O	O
cold	JJ	B-TREATMENT	B-PROBLEM
packs	NNS	I-TREATMENT	I-PROBLEM
and	CC	O	O
a	DT	B-TREATMENT	B-TREATMENT
cooling	NN	I-TREATMENT	I-TREATMENT
blanket	NN	I-TREATMENT	I-TREATMENT
were	VBD	O	O
placed	VBN	O	O
with	IN	O	O
goals	NNS	O	O
of	IN	O	O
reducing	VBG	O	O
his	PRP$	B-TEST	B-TEST
core	NN	I-TEST	I-TEST
body	NN	I-TEST	I-TEST
temperature	NN	I-TEST	I-TEST
to	TO	O	O
32	CD	O	O
degrees	NNS	O	O
celsius	VBP	O	O
for	IN	O	O
a	DT	O	O
period	NN	O	O
of	IN	O	O
twelve	NN	O	O
hours	NNS	O	O
at	IN	O	O
which	WDT	O	O
point	NN	O	O
he	PRP	O	O
would	MD	O	O
be	VB	O	O
rewarmed	VBN	O	O
over	IN	O	O
the	DT	O	O
subsequent	JJ	O	O
six	CD	O	O
hours	NNS	O	O
.	.	O	O

neurology	NN	O	O
-	:	O	O
the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
unresponsive	JJ	B-PROBLEM	B-PROBLEM
after	IN	O	I-PROBLEM
the	DT	B-TREATMENT	I-PROBLEM
induced	JJ	I-TREATMENT	I-PROBLEM
hypothermia	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
noticed	VBN	O	O
to	TO	O	O
develop	VB	O	O
myoclonic	JJ	B-PROBLEM	B-PROBLEM
jerks	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
occasional	JJ	O	B-PROBLEM
fluttering	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
his	PRP$	O	I-PROBLEM
eyelids	NNS	O	I-PROBLEM
.	.	O	O

electroencephalogram	NN	B-TEST	B-TEST
revealed	VBD	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
experiencing	VBG	O	B-PROBLEM
persistent	JJ	B-PROBLEM	I-PROBLEM
seizure	NN	I-PROBLEM	I-PROBLEM
activity	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

neurology	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
treated	VBN	O	O
very	RB	O	O
aggressively	RB	O	O
,	,	O	O
loaded	VBD	O	O
with	IN	O	O
multiple	JJ	B-TREATMENT	B-TREATMENT
drugs	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
including	VBG	O	O
ativan	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
propofol	JJ	B-TREATMENT	B-TREATMENT
drips	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
demonstrate	VB	O	O
seizure	NN	B-PROBLEM	O
activity	NN	I-PROBLEM	O
despite	IN	O	O
this	DT	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
loaded	VBN	O	O
with	IN	O	O
dilantin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
ultimately	RB	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-PROBLEM
pentobarb	NN	I-TREATMENT	I-PROBLEM
coma	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

after	IN	O	O
multiple	JJ	O	O
attempts	NNS	O	O
of	IN	O	O
weaning	VBG	O	O
the	DT	B-TREATMENT	O
pentobarb	NN	I-TREATMENT	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
continually	RB	O	O
reverting	VBG	O	O
to	TO	O	O
status	NN	B-PROBLEM	O
epilepticus	NN	I-PROBLEM	O
which	WDT	O	O
was	VBD	O	O
never	RB	O	O
able	JJ	O	O
to	TO	O	O
be	VB	O	O
suppressed	VBN	O	O
.	.	O	O

infectious	JJ	O	B-PROBLEM
disease	NN	O	I-PROBLEM
-	:	O	O
over	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
his	PRP$	O	O
hospital	NN	O	O
stay	NN	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
rose	VBD	O	O
to	TO	O	O
a	DT	O	O
peak	NN	O	O
of	IN	O	O
17	CD	O	O
.	.	O	O

multiple	JJ	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
were	VBD	O	O
done	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
ultimately	RB	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
methicillin	VBN	B-PROBLEM	B-PROBLEM
resistant	JJ	I-PROBLEM	I-PROBLEM
staphylococcus	NN	I-PROBLEM	I-PROBLEM
aureus	NN	I-PROBLEM	I-PROBLEM
bacteremia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
urinary	JJ	B-PROBLEM	B-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

for	IN	O	O
all	PDT	O	B-PROBLEM
these	DT	B-PROBLEM	I-PROBLEM
infections	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
also	RB	O	O
on	IN	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
presumed	JJ	O	O
aspiration	NN	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
his	PRP$	O	O
admission	NN	O	O
.	.	O	O

blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
cleared	VBN	O	O
by	IN	O	O
2013-05-03	JJ	O	O
.	.	O	O

sputum	JJ	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
as	RB	O	O
late	RB	O	O
as	IN	O	O
2013-05-10	JJ	O	O
,	,	O	O
however	RB	O	O
was	VBD	O	O
still	RB	O	O
positive	JJ	O	O
for	IN	O	O
coagulase	NN	B-PROBLEM	B-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
staphylococcus	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
methicillin	RBS	B-PROBLEM	B-PROBLEM
resistant	JJ	I-PROBLEM	I-PROBLEM
staphylococcus	NN	I-PROBLEM	I-PROBLEM
aureus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
gravely	RB	B-PROBLEM	O
ill	JJ	I-PROBLEM	O
throughout	IN	O	O
his	PRP$	O	O
hospital	NN	O	O
stay	NN	O	O
and	CC	O	O
had	VBD	O	O
multiple	JJ	O	O
meetings	NNS	O	O
were	VBD	O	O
held	VBN	O	O
with	IN	O	O
his	PRP$	O	O
family	NN	O	O
with	IN	O	O
his	PRP$	O	O
son	NN	O	O
being	VBG	O	O
his	PRP$	O	O
next	NN	O	O
of	IN	O	O
kin	NN	O	O
.	.	O	O

ultimately	RB	O	O
it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
wishes	NNS	O	O
would	MD	O	O
be	VB	O	O
to	TO	O	O
not	RB	O	O
be	VB	O	O
maintained	VBN	O	O
in	IN	O	O
a	DT	O	B-PROBLEM
vegetative	JJ	O	I-PROBLEM
state	NN	O	I-PROBLEM
and	CC	O	O
given	VBN	O	O
his	PRP$	O	O
poor	JJ	O	O
prognosis	NN	O	O
ultimately	RB	O	O
the	DT	O	O
decision	NN	O	O
was	VBD	O	O
made	VBN	O	O
to	TO	O	O
pursue	VB	O	O
comfort	NN	B-TREATMENT	B-TREATMENT
measures	NNS	I-TREATMENT	I-TREATMENT
only	RB	O	O
.	.	O	O

the	DT	O	O
family	NN	O	O
did	VBD	O	O
consent	NN	O	O
to	TO	O	O
a	DT	B-TEST	B-TEST
postmortem	NN	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
.	.	O	O

cardiac	JJ	B-PROBLEM	O
arrest	NN	I-PROBLEM	O
.	.	O	O

anoxic	NN	B-PROBLEM	B-PROBLEM
brain	NN	I-PROBLEM	I-PROBLEM
injury	NN	I-PROBLEM	I-PROBLEM

status	NN	B-PROBLEM	O
epilepticus	NN	I-PROBLEM	O

methicillin	NN	B-PROBLEM	B-PROBLEM
resistant	JJ	I-PROBLEM	I-PROBLEM
staphylococcus	NN	I-PROBLEM	I-PROBLEM
aureus	NN	I-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mrsa	NN	B-PROBLEM	B-PROBLEM
urinary	JJ	I-PROBLEM	I-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mrsa	NN	B-PROBLEM	O
bacteremia	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

respiratory	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM

1	CD	O	O
)	)	O	O
thrombotic	JJ	B-PROBLEM	B-PROBLEM
thrombocytopenic	JJ	I-PROBLEM	I-PROBLEM
purpura	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2	CD	O	O
)	)	O	O
bronchiolitis	NN	B-PROBLEM	B-PROBLEM
obliterans	NNS	I-PROBLEM	I-PROBLEM
organizing	VBG	I-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3	LS	O	O
)	)	O	O
renal	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
requiring	VBG	O	O
chronic	JJ	B-TREATMENT	B-TREATMENT
dialysis	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
63	JJ	O	O
year-old	JJ	O	O
woman	NN	O	O
transferred	VBD	O	O
from	IN	O	O
pre	JJ	O	O
health	NN	O	O
on	IN	O	O
june	NN	O	O
19	CD	O	O
,	,	O	O
1998	CD	O	O
to	TO	O	O
the	DT	O	O
verg	NNP	O	O
medical	JJ	O	O
center	NN	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
evaluation	NN	B-TEST	B-TEST
of	IN	O	O
thrombotic	JJ	B-PROBLEM	B-PROBLEM
thrombocytopenic	JJ	I-PROBLEM	I-PROBLEM
purpura	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
bronchiolitis	NN	B-PROBLEM	B-PROBLEM
obliterans	NNS	I-PROBLEM	I-PROBLEM
organizing	VBG	I-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
may	MD	O	O
12	CD	O	O
,	,	O	O
1998	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
presented	VBD	O	O
to	TO	O	O
pre	VB	O	O
health	NN	O	O
with	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cough	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
a	DT	B-TEST	B-TEST
chest	JJ	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
revealing	VBG	O	O
a	DT	B-PROBLEM	B-PROBLEM
patchy	NN	I-PROBLEM	I-PROBLEM
infiltrate	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
clindamycin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
erythromycin	NN	B-TREATMENT	B-TREATMENT
which	WDT	O	O
were	VBD	O	O
changed	VBN	O	O
to	TO	O	O
trovan	VB	B-TREATMENT	B-TREATMENT
and	CC	O	O
then	RB	O	O
transferred	VBD	O	O
to	TO	O	O
a	DT	O	O
hospital	NN	O	O
.	.	O	O

on	IN	O	O
may	MD	O	O
27	CD	O	O
,	,	O	O
1998	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
desaturated	VBD	O	O
to	TO	O	O
40%	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
of	IN	O	O
100.5	CD	O	O
degrees	NNS	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
oxygen	NN	I-TEST	I-TEST
saturations	NNS	I-TEST	I-TEST
improved	VBN	O	O
to	TO	O	O
only	RB	O	O
92%	CD	O	O
on	IN	O	O
100%	CD	B-TREATMENT	B-TREATMENT
face	NN	I-TREATMENT	I-TREATMENT
mask	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
pre	VB	O	O
health	NN	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
there	RB	O	O
revealed	VBD	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
infiltrates	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
vq	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
was	VBD	O	O
high	JJ	O	B-PROBLEM
probability	NN	O	I-PROBLEM
,	,	O	O
but	CC	O	O
no	DT	O	O
pulmonary	JJ	B-TEST	B-TEST
angiogram	NN	I-TEST	I-TEST
was	VBD	O	O
done	VBN	O	O
and	CC	O	O
an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	O	O
normal	JJ	O	O
left	JJ	O	O
ventricle	NN	O	O
with	IN	O	O
no	DT	O	O
wall	NN	B-PROBLEM	B-PROBLEM
motion	NN	I-PROBLEM	I-PROBLEM
abnormality	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
an	DT	B-TEST	B-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
75%	CD	O	O
.	.	O	O

on	IN	O	O
may	MD	O	O
24	CD	O	O
,	,	O	O
1998	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
ct	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
chest	JJS	I-TEST	I-TEST
which	WDT	O	O
revealed	VBD	O	O
diffuse	NN	B-PROBLEM	B-PROBLEM
alveolar	JJ	I-PROBLEM	I-PROBLEM
infiltrates	NNS	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
base	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
mediastinal	JJ	B-PROBLEM	B-PROBLEM
lymphadenopathy	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusions	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

at	IN	O	O
this	DT	O	O
point	NN	O	O
,	,	O	O
a	DT	O	O
diagnosis	NN	O	O
of	IN	O	O
lupus	NN	B-PROBLEM	B-PROBLEM
was	VBD	O	O
considered	VBN	O	O
and	CC	O	O
her	PRP$	B-TEST	B-PROBLEM
ana	NN	I-TEST	I-PROBLEM
was	VBD	O	O
1:640	CD	O	O
and	CC	O	O
her	PRP$	B-TEST	B-PROBLEM
rheumatoid	JJ	I-TEST	I-PROBLEM
factor	NN	I-TEST	I-PROBLEM
and	CC	O	O
anca	NN	B-TEST	O
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
steroid	JJ	I-TREATMENT	I-TREATMENT
trial	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
that	DT	O	O
point	NN	O	O
.	.	O	O

her	PRP$	O	B-TEST
pleural	JJ	O	I-TEST
fluid	NN	O	I-TEST
was	VBD	O	O
tapped	VBN	O	O
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
negative	JJ	O	O
for	IN	O	O
malignancy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
june	NN	O	O
11	CD	O	O
,	,	O	O
1998	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
video	NN	I-TEST	I-TEST
assisted	VBN	I-TEST	I-TEST
thoracoscopic	NN	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
of	IN	I-TEST	O
the	DT	I-TEST	O
right	NN	I-TEST	O
lung	NN	I-TEST	O
which	WDT	O	O
revealed	VBD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
interstitial	JJ	I-PROBLEM	I-PROBLEM
pneumonitis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
bronchiolitis	NN	I-PROBLEM	I-PROBLEM
obliterans	VBZ	I-PROBLEM	I-PROBLEM
organizing	VBG	I-PROBLEM	I-PROBLEM
pneumonia-like	JJ	I-PROBLEM	I-PROBLEM
reaction	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-TREATMENT	B-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
then	RB	O	O
started	VBN	O	O
on	IN	O	O
40	CD	O	O
mg	NN	O	O
of	IN	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
q.	JJ	O	O
day	NN	O	O
.	.	O	O

from	IN	O	O
may	MD	O	O
27	CD	O	O
,	,	O	O
1998	CD	O	O
through	IN	O	O
june	NN	O	O
19	CD	O	O
,	,	O	O
1998	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	O	B-PROBLEM
decline	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
her	PRP$	B-TEST	I-PROBLEM
platelets	NNS	I-TEST	I-PROBLEM
from	IN	O	O
394	CD	O	O
to	TO	O	O
28	CD	O	O
with	IN	O	O
a	DT	O	O
stable	JJ	O	O
hematocrit	NN	O	B-TEST
of	IN	O	O
32	CD	O	O
to	TO	O	O
33	CD	O	O
and	CC	O	O
a	DT	B-PROBLEM	O
rise	NN	I-PROBLEM	O
in	IN	O	O
creatinine	NN	B-TEST	B-TEST
from	IN	O	O
1.0	CD	O	O
to	TO	O	O
3.8	CD	O	O
.	.	O	O

on	IN	O	O
june	NN	O	O
19	CD	O	O
,	,	O	O
1998	CD	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
verg	NNP	O	O
medical	JJ	O	O
center	NN	O	O
medical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
evaluation	NN	B-TEST	B-TEST
of	IN	O	O
possible	JJ	O	O
thrombotic	JJ	B-PROBLEM	B-PROBLEM
thrombocytopenic	NN	I-PROBLEM	I-PROBLEM
purpura	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1	CD	O	O
)	)	O	O
cerebrovascular	JJ	B-PROBLEM	O
accident	NN	I-PROBLEM	O
in	IN	O	O
1995	CD	O	O
in	IN	O	O
the	DT	O	O
pontine	JJ	O	O
region	NN	O	O
secondary	JJ	O	O
to	TO	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2	CD	O	O
)	)	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

3	LS	O	O
)	)	O	O
status	NN	O	O
post	NN	O	O
hysterectomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

4	CD	O	O
)	)	O	O
status	NN	O	O
post	NN	O	O
appendectomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

1	CD	O	O
)	)	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
inhaler	$	I-TREATMENT	I-TREATMENT
4	CD	O	O
puffs	NNS	O	O
q.i.d.	NN	O	O

2	CD	O	O
)	)	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
p.r.n.	NN	O	O

3	LS	O	O
)	)	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

4	CD	O	O
)	)	O	O
inderal	JJ	B-TREATMENT	O
40	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.i.d.	NN	O	O

5	CD	O	O
)	)	O	O
thiamine	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

6	CD	O	O
)	)	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
p.r.n.	NN	O	O

7	CD	O	O
)	)	O	O
atrovent	NN	B-TREATMENT	B-TREATMENT
inhaler	NN	I-TREATMENT	I-TREATMENT
4	CD	O	O
puffs	NNS	O	O
q.i.d.	NN	O	O

8	CD	O	O
)	)	O	O
folic	JJ	B-TREATMENT	B-PROBLEM
acid	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

9	CD	O	O
)	)	O	O
premarin	NN	B-TREATMENT	B-TREATMENT
0.625	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

10	CD	O	O
)	)	O	O
omeprazole	VBD	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

11	CD	O	O
)	)	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

father	RB	O	O
died	VBN	O	O
at	IN	O	O
age	NN	O	O
56	CD	O	O
of	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mother	NN	O	O
died	VBD	O	O
at	IN	O	O
age	NN	O	O
68	CD	O	O
of	IN	O	O
pancreatic	JJ	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

brother	NN	O	O
has	VBZ	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
family	NN	O	O
history	NN	O	O
of	IN	O	O
hematologic	NN	B-PROBLEM	B-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

laboratory	NN	B-TEST	B-TEST
studies	NNS	I-TEST	I-TEST
on	IN	O	O
admission	NN	O	O
were	VBD	O	O
notable	JJ	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
of	IN	O	O
131	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
6.2	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
111	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
3.9	CD	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
23	CD	O	O
,	,	O	O
hematocrit	VBD	B-TEST	B-TEST
27	CD	O	O
with	IN	O	O
2+	CD	B-PROBLEM	O
schistocytes	NNS	I-PROBLEM	O
and	CC	O	O
2+	CD	B-PROBLEM	O
spherocytes	NNS	I-PROBLEM	O
on	IN	O	O
the	DT	B-TEST	O
smear	NN	I-TEST	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
92	CD	O	O
and	CC	O	O
ldh	$	B-TEST	O
496	CD	O	O
.	.	O	O

1	CD	O	O
)	)	O	O
bronchiolitis	NN	B-PROBLEM	B-PROBLEM
obliterans	NNS	I-PROBLEM	I-PROBLEM
organizing	VBG	I-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

the	DT	B-TEST	O
video	NN	I-TEST	O
assisted	VBD	I-TEST	O
thoracoscopic	NN	I-TEST	B-TEST
study	NN	I-TEST	I-TEST
at	IN	O	O
the	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
was	VBD	O	O
consistent	JJ	O	O
with	IN	O	O
bronchiolitis	NN	B-PROBLEM	B-PROBLEM
obliterans	NNS	I-PROBLEM	I-PROBLEM
organizing	VBG	I-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
steroids	NNS	B-TREATMENT	B-TREATMENT
throughout	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
her	PRP$	O	O
stay	NN	O	O
.	.	O	O

this	DT	O	O
was	VBD	O	O
changed	VBN	O	O
to	TO	O	O
solu-medrol	JJ	B-TREATMENT	O
part	NN	O	O
way	NN	O	O
through	IN	O	O
the	DT	O	O
course	NN	O	O
due	JJ	O	O
to	TO	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
hematologic	NN	I-PROBLEM	I-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
see	VBP	O	O
below	IN	O	O
.	.	O	O

by	IN	O	O
discharge	NN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
returned	VBN	O	O
to	TO	O	O
40	CD	O	O
mg	NN	O	O
of	IN	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
q.	NN	O	O
day	NN	O	O
times	NNS	O	O
one	CD	O	O
month	NN	O	O
to	TO	O	O
be	VB	O	O
followed	VBN	O	O
by	IN	O	O
a	DT	B-TREATMENT	B-PROBLEM
slow	JJ	I-TREATMENT	I-PROBLEM
taper	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NNP	I-PROBLEM	I-PROBLEM
bronchiolitis	NN	I-PROBLEM	I-PROBLEM
obliterans	NNS	I-PROBLEM	I-PROBLEM
organizing	VBG	I-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
appeared	VBD	O	O
to	TO	O	O
improve	VB	O	O
slowly	RB	O	O
throughout	IN	O	O
her	PRP$	O	O
hospital	JJ	O	O
course	NN	O	O
,	,	O	O
however	RB	O	O
on	IN	O	O
july	NN	O	O
12	CD	O	O
,	,	O	O
1998	CD	O	O
,	,	O	O
after	IN	O	O
starting	VBG	O	O
dialysis	NN	B-TREATMENT	B-TREATMENT
(	(	O	O
see	VB	O	O
below	IN	O	O
)	)	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
desaturated	VBD	O	O
and	CC	O	O
required	VBD	O	O
supplemental	JJ	B-TREATMENT	B-TREATMENT
oxygen	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

repeat	NN	B-TEST	B-TEST
chest	RBS	I-TEST	I-TEST
x-rays	NNS	I-TEST	I-TEST
and	CC	O	O
chest	JJS	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
scans	NNS	I-TEST	I-TEST
appeared	VBD	O	O
consistent	JJ	O	O
with	IN	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
volume	NN	B-PROBLEM	B-PROBLEM
overload	NN	I-PROBLEM	I-PROBLEM
given	VBN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
eventually	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
pulmonary	JJ	O	O
status	NN	O	O
did	VBD	O	O
improve	VB	O	O
after	IN	O	O
significant	JJ	B-TREATMENT	B-TREATMENT
volume	NN	I-TREATMENT	I-TREATMENT
removal	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
dialysis	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
several	JJ	O	O
weeks	NNS	O	O
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
her	PRP$	O	O
discharge	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
still	RB	O	O
requiring	VBG	O	O
two	CD	O	O
liters	NNS	O	O
of	IN	O	O
supplemental	JJ	B-TREATMENT	B-TREATMENT
oxygen	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
maintain	VB	O	O
her	PRP$	B-TEST	B-TEST
oxygen	NN	I-TEST	I-TEST
saturations	NNS	I-TEST	I-TEST
in	IN	O	O
the	DT	O	O
mid	NN	O	O
90%	CD	O	O
.	.	O	O

2	CD	O	O
)	)	O	O
thrombotic	JJ	B-PROBLEM	B-PROBLEM
thrombocytopenic	JJ	I-PROBLEM	I-PROBLEM
purpura	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
initially	RB	O	O
admitted	VBN	O	O
with	IN	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
28	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
of	IN	O	O
32	CD	O	O
,	,	O	O
ldh	NN	B-TEST	O
of	IN	O	O
496	CD	O	O
with	IN	O	O
2+	CD	B-PROBLEM	O
schistocytes	NNS	I-PROBLEM	O
and	CC	O	O
2+	CD	B-PROBLEM	O
spherocytes	NNS	I-PROBLEM	O
on	IN	O	O
her	PRP$	B-TEST	B-TEST
smear	NN	I-TEST	I-TEST
.	.	O	O

this	DT	O	O
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
consistent	JJ	O	O
with	IN	O	O
thrombotic	JJ	B-PROBLEM	B-PROBLEM
thrombocytopenic	JJ	I-PROBLEM	I-PROBLEM
purpura	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
on	IN	O	O
june	NN	O	O
20	CD	O	O
,	,	O	O
1998	CD	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
daily	JJ	B-TREATMENT	O
plasma	NN	I-TREATMENT	O
exchange	NN	I-TREATMENT	O
which	WDT	O	O
continued	VBD	O	O
through	IN	O	O
july	NN	O	O
27	CD	O	O
,	,	O	O
1999	CD	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
also	RB	O	O
changed	VBN	O	O
to	TO	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
solu-medrol	JJ	I-TREATMENT	I-TREATMENT
50	CD	O	O
mg	JJ	O	O
q.	NNS	O	O
day	NN	O	O
which	WDT	O	O
was	VBD	O	O
changed	VBN	O	O
back	RB	O	O
to	TO	O	O
40	CD	O	O
mg	NN	O	O
of	IN	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
platelet	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
initially	RB	O	O
rose	VBD	O	O
to	TO	O	O
a	DT	O	O
maximum	NN	O	O
of	IN	O	O
159	CD	O	O
on	IN	O	O
july	NN	O	O
3	CD	O	O
,	,	O	O
1998	CD	O	O
,	,	O	O
then	RB	O	O
they	PRP	O	O
steadily	RB	O	O
fell	VBD	O	O
to	TO	O	O
a	DT	O	O
low	NN	O	O
of	IN	O	O
60	CD	O	O
on	IN	O	O
july	NN	O	O
20	CD	O	O
,	,	O	O
1999	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
ldh	NN	I-TEST	I-TEST
which	WDT	O	O
peaked	VBD	O	O
at	IN	O	O
1255	CD	O	O
decreased	VBD	O	O
to	TO	O	O
the	DT	O	O
mid	NN	O	O
200s	CD	O	O
,	,	O	O
but	CC	O	O
remained	VBD	O	O
elevated	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	O
few	JJ	I-PROBLEM	O
schistocytes	NNS	I-PROBLEM	O
on	IN	O	O
her	PRP$	B-TEST	B-TEST
smear	NN	I-TEST	I-TEST
,	,	O	O
but	CC	O	O
it	PRP	O	O
was	VBD	O	O
much	RB	O	O
decreased	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
required	VBN	O	O
red	JJ	B-TREATMENT	B-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cell	NN	I-TREATMENT	I-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
approximately	RB	O	O
two	CD	O	O
units	NNS	O	O
every	DT	O	O
seven	CD	O	O
to	TO	O	O
ten	VB	O	O
days	NNS	O	O
to	TO	O	O
maintain	VB	O	O
her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
.	.	O	O

eventually	RB	O	O
,	,	O	O
her	PRP	B-TREATMENT	B-TEST
plasma	VBP	I-TREATMENT	I-TEST
exchange	NN	I-TREATMENT	I-TEST
was	VBD	O	O
tapered	VBN	O	O
to	TO	O	O
a	DT	O	O
smaller	JJR	O	O
and	CC	O	O
smaller	JJR	O	O
dose	JJ	O	O
each	DT	O	O
day	NN	O	O
and	CC	O	O
then	RB	O	O
discontinued	VBD	O	O
altogether	RB	O	O
after	IN	O	O
july	NN	O	O
27	CD	O	O
,	,	O	O
1999	CD	O	O
.	.	O	O

after	IN	O	O
this	DT	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
&apos;s	NNP	I-TEST	I-TEST
platelet	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
rose	VBD	O	O
to	TO	O	O
a	DT	O	O
maximum	NN	O	O
of	IN	O	O
177	CD	O	O
on	IN	O	O
discharge	NN	O	O
.	.	O	O

it	PRP	O	O
is	VBZ	O	O
felt	VBN	O	O
that	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NNP	I-PROBLEM	I-PROBLEM
thrombotic	JJ	I-PROBLEM	I-PROBLEM
thrombocytopenic	NN	I-PROBLEM	I-PROBLEM
purpura	NN	I-PROBLEM	I-PROBLEM
has	VBZ	O	O
resolved	VBN	O	O
.	.	O	O

she	PRP	O	O
will	MD	O	O
continue	VB	O	O
on	IN	O	O
her	PRP	B-TREATMENT	O
prednisone	NN	I-TREATMENT	B-TREATMENT
for	IN	O	O
one	CD	O	O
month	NN	O	O
as	IN	O	O
above	IN	O	O
for	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
bronchiolitis	NN	I-PROBLEM	I-PROBLEM
obliterans	VBZ	I-PROBLEM	I-PROBLEM
organizing	VBG	I-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-TREATMENT	B-PROBLEM
very	RB	I-TREATMENT	I-PROBLEM
slow	JJ	I-TREATMENT	I-PROBLEM
taper	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
presented	VBN	O	O
in	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-TEST	O
bun	NN	I-TEST	O
of	IN	O	O
101	CD	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
of	IN	O	O
3.7	CD	O	O
.	.	O	O

throughout	IN	O	O
the	DT	O	O
month	NN	O	O
of	IN	O	O
june	NN	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-TREATMENT
rising	VBG	I-PROBLEM	I-TREATMENT
potassium	NN	I-PROBLEM	I-TREATMENT
phosphate	NN	I-PROBLEM	I-TREATMENT
and	CC	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
volume	NN	I-PROBLEM	I-PROBLEM
overload	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
decreasing	VBG	O	O
response	NN	O	O
to	TO	O	O
diuretics	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
finally	RB	O	O
initiated	VBN	O	O
on	IN	O	O
dialysis	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
ultrafiltration	NN	B-TREATMENT	B-TREATMENT
on	IN	O	O
july	NN	O	O
12	CD	O	O
,	,	O	O
1998	CD	O	O
.	.	O	O

the	DT	O	O
opinion	NN	O	O
of	IN	O	O
the	DT	O	O
renal	JJ	O	O
consult	NN	O	O
was	VBD	O	O
that	IN	O	O
this	DT	O	O
was	VBD	O	O
permanent	JJ	B-PROBLEM	O
and	CC	I-PROBLEM	O
non-reversible	JJ	I-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
since	IN	O	O
it	PRP	O	O
did	VBD	O	O
not	RB	O	O
improve	VB	O	O
with	IN	O	O
dialysis	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
the	DT	O	O
patient	NN	O	O
will	MD	O	O
continue	VB	O	O
on	IN	O	O
dialysis	NN	B-TREATMENT	B-TREATMENT
three	CD	O	O
times	NNS	O	O
per	IN	O	O
week	NN	O	O
.	.	O	O

she	PRP	O	O
required	VBD	O	O
approximately	RB	O	O
five	CD	O	O
liters	NNS	O	O
of	IN	O	O
ultrafiltration	NN	B-TREATMENT	B-TREATMENT
fluid	NN	I-TREATMENT	I-TREATMENT
removal	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
each	DT	O	O
dialysis	NN	O	B-TREATMENT
session	NN	O	I-TREATMENT
due	JJ	O	O
to	TO	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
significant	JJ	I-PROBLEM	I-PROBLEM
volume	NN	I-PROBLEM	I-PROBLEM
overload	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

during	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
dialysis	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	O	O
great	JJ	O	O
improvement	NN	O	O
in	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
her	PRP$	B-TEST	B-TEST
oxygen	NN	I-TEST	I-TEST
saturation	NN	I-TEST	I-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
line	NN	I-PROBLEM	I-PROBLEM
infections	NNS	I-PROBLEM	I-PROBLEM
during	IN	O	O
her	PRP$	O	O
admission	NN	O	O
including	VBG	O	O
a	DT	B-PROBLEM	O
confirmed	JJ	I-PROBLEM	O
coag.	NN	I-PROBLEM	O
negative	JJ	I-PROBLEM	O
staphylococcus	NN	I-PROBLEM	B-PROBLEM
line	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
positive	JJ	B-PROBLEM	O
blood	NN	I-PROBLEM	B-TEST
cultures	NNS	I-PROBLEM	I-TEST
on	IN	O	O
june	NN	O	O
23	CD	O	O
,	,	O	O
1998	CD	O	O
,	,	O	O
july	RB	O	O
4	CD	O	O
,	,	O	O
1998	CD	O	O
,	,	O	O
july	RB	O	O
8	CD	O	O
,	,	O	O
1998	CD	O	O
and	CC	O	O
july	RB	O	O
9	CD	O	O
,	,	O	O
1998	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
eventually	RB	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
left	JJ	I-TREATMENT	I-TREATMENT
subclavian	JJ	I-TREATMENT	I-TREATMENT
tesio	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
placed	VBN	O	O
and	CC	O	O
a	DT	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
brachial	NN	I-TREATMENT	I-TREATMENT
picc	NN	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
placed	VBN	O	O
on	IN	O	O
july	NN	O	O
10	CD	O	O
,	,	O	O
1998	CD	O	O
which	WDT	O	O
remained	VBD	O	O
patent	NN	O	B-TREATMENT
and	CC	O	O
uninfected	JJ	B-PROBLEM	O
.	.	O	O

she	PRP	O	O
received	VBD	O	O
a	DT	B-TREATMENT	O
full	JJ	I-TREATMENT	O
three	CD	I-TREATMENT	O
week	NN	I-TREATMENT	O
course	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
vancomycin	NN	I-TREATMENT	B-TREATMENT
and	CC	O	O
also	RB	O	O
received	VBD	O	O
a	DT	B-TREATMENT	O
three	CD	I-TREATMENT	O
week	NN	I-TREATMENT	O
course	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
ceftazidime	NN	I-TREATMENT	B-TREATMENT
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
fungal	JJ	I-PROBLEM	I-PROBLEM
urinary	JJ	I-PROBLEM	I-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
treated	VBN	O	O
with	IN	O	O
amphojel	JJ	B-TREATMENT	B-TREATMENT
bladder	NN	I-TREATMENT	I-TREATMENT
irrigation	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
which	WDT	O	O
was	VBD	O	O
followed	VBN	O	O
by	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
klebsiella	NN	I-PROBLEM	I-PROBLEM
urinary	JJ	I-PROBLEM	I-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
for	IN	O	O
which	WDT	O	O
she	PRP	O	O
received	VBD	O	O
levofloxacin	JJ	B-TREATMENT	B-TREATMENT
times	NNS	O	O
fourteen	JJ	O	O
days	NNS	O	O
.	.	O	O

she	PRP	O	O
also	RB	O	O
received	VBD	O	O
a	DT	B-TREATMENT	O
fourteen	JJ	I-TREATMENT	O
day	NN	I-TREATMENT	O
course	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
acyclovir	NN	I-TREATMENT	B-TREATMENT
which	WDT	O	O
was	VBD	O	O
begun	VBN	O	O
on	IN	O	O
june	NN	O	O
21	CD	O	O
,	,	O	O
1998	CD	O	O
for	IN	O	O
perianal	JJ	B-PROBLEM	B-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
consistent	JJ	O	O
with	IN	O	O
herpes	NNS	B-PROBLEM	B-PROBLEM
simplex	JJ	I-PROBLEM	I-PROBLEM
virus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
also	RB	O	O
on	IN	O	O
fluconazole	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
oral	JJ	I-PROBLEM	I-PROBLEM
thrush	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
inadvertently	RB	O	O
continued	VBN	O	O
for	IN	O	O
a	DT	O	O
total	NN	O	O
of	IN	O	O
thirty	JJ	O	O
days	NNS	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
also	RB	O	O
started	VBN	O	O
on	IN	O	O
bactrim	NN	B-TREATMENT	B-TREATMENT
one	CD	I-TREATMENT	O
double	JJ	I-TREATMENT	O
strength	NN	I-TREATMENT	O
tablet	NN	O	O
q.o.d.	NN	O	O
as	IN	O	O
prophylaxis	NN	O	B-TREATMENT
for	IN	O	O
pneumocystis	NN	B-PROBLEM	B-PROBLEM
carinii	NN	I-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
while	IN	O	O
on	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
high	JJ	I-TREATMENT	I-TREATMENT
dose	JJ	I-TREATMENT	I-TREATMENT
steroids	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
with	IN	O	O
a	DT	O	O
question	NN	O	O
of	IN	O	O
lupus	NN	B-PROBLEM	B-PROBLEM
given	VBN	O	O
her	PRP$	B-TEST	O
ana	NN	I-TEST	O
of	IN	O	O
1:640	CD	O	O
although	IN	O	O
her	PRP$	B-TEST	B-PROBLEM
rheumatoid	JJ	I-TEST	I-PROBLEM
factor	NN	I-TEST	I-PROBLEM
and	CC	O	O
anca	NN	B-TEST	O
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

unfortunately	RB	O	O
throughout	IN	O	O
her	PRP$	O	O
admission	NN	O	O
,	,	O	O
we	PRP	O	O
were	VBD	O	O
unable	JJ	O	O
to	TO	O	O
test	VB	O	O
any	DT	B-TEST	O
more	JJR	I-TEST	O
titers	NNS	I-TEST	O
since	IN	O	O
she	PRP	O	O
was	VBD	O	O
receiving	VBG	O	O
daily	RB	B-TREATMENT	O
plasma	JJ	I-TREATMENT	O
exchange	NN	I-TREATMENT	O
.	.	O	O

a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
ana	NN	I-TEST	I-TEST
,	,	O	O
rheumatoid	JJ	B-TEST	B-PROBLEM
factor	NN	I-TEST	I-PROBLEM
and	CC	O	O
anca	NN	B-TEST	O
may	MD	O	O
be	VB	O	O
repeated	VBN	O	O
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
.	.	O	O

1	CD	O	O
)	)	O	O
the	DT	O	O
patient	NN	O	O
will	MD	O	O
follow-up	VB	O	O
with	IN	O	O
her	PRP$	O	O
primary	JJ	O	O
care	NN	O	O
physician	NN	O	O
,	,	O	O
dr.	NN	O	B-TEST
tamarg	NN	O	I-TEST
study	NN	O	I-TEST
,	,	O	O
in	IN	O	O
arvus	NN	O	O
after	IN	O	O
she	PRP	O	O
is	VBZ	O	O
discharged	VBN	O	O
from	IN	O	O
rehabilitation	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

2	CD	O	O
)	)	O	O
the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
being	VBG	O	O
discharged	VBN	O	O
to	TO	O	O
a	DT	O	O
hospital	NN	O	O
where	WRB	O	O
she	PRP	O	O
will	MD	O	O
receive	VB	O	O
onsite	JJ	B-TREATMENT	B-TREATMENT
hemodialysis	NN	I-TREATMENT	I-TREATMENT
three	CD	O	O
times	NNS	O	O
per	IN	O	O
week	NN	O	O
on	IN	O	O
monday	NN	O	O
,	,	O	O
wednesday	JJ	O	O
and	CC	O	O
friday	JJ	O	O
.	.	O	O

3	LS	O	O
)	)	O	O
the	DT	O	O
patient	NN	O	O
will	MD	O	O
continue	VB	O	O
to	TO	O	O
have	VB	O	O
her	PRP$	B-TEST	B-PROBLEM
cbc	NN	I-TEST	I-PROBLEM
,	,	O	O
ldh	NN	B-TEST	O
,	,	O	O
bilirubin	NN	B-TEST	B-TEST
,	,	O	O
chem-7	JJ	B-TEST	O
and	CC	O	O
magnesium	NN	B-TEST	B-TREATMENT
and	CC	O	O
calcium	NN	B-TEST	B-TEST
checked	VBN	O	O
with	IN	O	O
each	DT	B-TREATMENT	B-TREATMENT
dialysis	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
the	DT	O	O
results	NNS	O	O
will	MD	O	O
be	VB	O	O
faxed	VBN	O	O
to	TO	O	O
dr.	VB	O	O
ian	JJ	O	O
zineisfreierm	NN	O	O
,	,	O	O
the	DT	O	O
hematology	NN	O	O
attending	VBG	O	O
at	IN	O	O
fax	JJ	O	O
number	NN	O	O
751-329-8840	JJ	O	O
.	.	O	O

4	CD	O	O
)	)	O	O
the	DT	O	O
patient	NN	O	O
will	MD	O	O
eventually	RB	O	O
need	VB	O	O
a	DT	B-TREATMENT	B-PROBLEM
permanent	JJ	I-TREATMENT	I-PROBLEM
dialysis	NN	I-TREATMENT	I-PROBLEM
fistula	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	O
left	NN	I-TREATMENT	O
subclavian	JJ	I-TREATMENT	O
tesio	NN	I-TREATMENT	O
which	WDT	O	O
she	PRP	O	O
has	VBZ	O	O
in	IN	O	O
place	NN	O	O
will	MD	O	O
last	JJ	O	O
for	IN	O	O
several	JJ	O	O
months	NNS	O	O
in	IN	O	O
the	DT	O	O
mean	JJ	O	O
time	NN	O	O
.	.	O	O

she	PRP	O	O
would	MD	O	O
like	VB	O	O
to	TO	O	O
arrange	VB	O	O
to	TO	O	O
have	VB	O	O
her	PRP$	B-TREATMENT	B-PROBLEM
fistula	NN	I-TREATMENT	I-PROBLEM
placed	VBN	O	O
at	IN	O	O
pre	JJ	O	O
health	NN	O	O
and	CC	O	O
the	DT	O	B-TREATMENT
vascular	JJ	O	I-TREATMENT
surgeons	NNS	O	I-TREATMENT
there	EX	O	O
should	MD	O	O
be	VB	O	O
contacted	VBN	O	O
regarding	VBG	O	O
this	DT	O	O
.	.	O	O

5	CD	O	O
)	)	O	O
the	DT	O	O
patient	NN	O	O
will	MD	O	O
need	VB	O	O
packed	NNS	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cell	NN	I-TREATMENT	I-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
with	IN	O	O
dialysis	NN	B-TREATMENT	B-TREATMENT
when	WRB	O	O
her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
falls	VBZ	O	O
below	IN	O	O
26	CD	O	O
.	.	O	O

6	CD	O	O
)	)	O	O
the	DT	O	O
patient	NN	O	O
will	MD	O	O
continue	VB	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
prednisone	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
40	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	NN	O	O
day	NN	O	O
times	NNS	O	O
one	CD	O	O
month	NN	O	O
(	(	O	O
this	DT	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
july	NN	O	O
27	CD	O	O
,	,	O	O
1999	CD	O	O
)	)	O	O
and	CC	O	O
then	RB	O	O
she	PRP	O	O
will	MD	O	O
begin	VB	O	O
a	DT	B-TREATMENT	B-TREATMENT
slow	JJ	I-TREATMENT	I-TREATMENT
taper	NN	I-TREATMENT	I-TREATMENT
as	IN	O	O
guided	VBN	O	O
by	IN	O	O
pulmonary	NN	O	O
.	.	O	O

1	CD	O	O
)	)	O	O
calcitriol	NN	B-TREATMENT	B-TREATMENT
0.25	CD	O	O
mcg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

2	CD	O	O
)	)	O	O
tums	NN	B-TREATMENT	O
1250	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O

3	LS	O	O
)	)	O	O
premarin	NN	B-TREATMENT	B-TREATMENT
0.625	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

4	CD	O	O
)	)	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

5	CD	O	O
)	)	O	O
humulin	NN	B-TREATMENT	O
sliding	VBG	I-TREATMENT	O
scale	JJ	I-TREATMENT	O
q.a.c.	NN	O	O
and	CC	O	O
q.h.s.	NN	O	O

6	CD	O	O
)	)	O	O
labetalol	NN	B-TREATMENT	B-TREATMENT
400	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O

7	CD	O	O
)	)	O	O
omeprazole	VBD	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

8	CD	O	O
)	)	O	O
serax	NN	B-TREATMENT	O
15	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.h.s.	NN	O	O
p.r.n.	NN	O	O
insomnia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

9	CD	O	O
)	)	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	NN	O	O
day	NN	O	O
times	NNS	O	O
thirty	JJ	O	O
days	NNS	O	O
beginning	VBG	O	O
on	IN	O	O
july	NN	O	O
27	CD	O	O
,	,	O	O
1999	CD	O	O
to	TO	O	O
be	VB	O	O
followed	VBN	O	O
by	IN	O	O
a	DT	B-TREATMENT	B-PROBLEM
slow	JJ	I-TREATMENT	I-PROBLEM
taper	NN	I-TREATMENT	I-PROBLEM
as	IN	O	O
directed	VBN	O	O
by	IN	O	O
the	DT	O	O
pulmonologist	NN	O	O
.	.	O	O

10	CD	O	O
)	)	O	O
metamucil	NN	B-TREATMENT	O
one	CD	O	O
packet	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

11	CD	O	O
)	)	O	O
amlodipine	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

12	CD	O	O
)	)	O	O
bactrim	NN	B-TREATMENT	O
double	JJ	I-TREATMENT	O
strength	NN	I-TREATMENT	O
one	CD	O	O
tablet	NN	O	O
p.o.	NN	O	O
q.o.d.	NN	O	O

13	CD	O	O
)	)	O	O
nephrocaps	FW	B-TREATMENT	O
one	CD	O	O
tablet	NN	O	O
p.o.	NN	O	O
q.	JJ	O	O
day	NN	O	O
.	.	O	O

14	CD	O	O
)	)	O	O
epogen	NN	B-TREATMENT	O
1,000	CD	O	O
units	NNS	O	O
subcutaneously	RB	O	O
three	CD	O	O
times	NNS	O	O
per	IN	O	O
week	NN	O	O
.	.	O	O

15	CD	O	O
)	)	O	O
iron	NN	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
300	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O

surgery	NN	B-TREATMENT	B-TREATMENT

tetracycline	NN	B-TREATMENT	B-TREATMENT

s/p	NN	O	O
i&d	NN	B-TREATMENT	B-TREATMENT
(	(	O	O
03-17	CD	O	O
)	)	O	O

s/p	JJ	O	O
debridement	NN	B-TREATMENT	B-TREATMENT
(	(	O	O
03-18	CD	O	O
)	)	O	O

he	PRP	O	O
developed	VBD	O	O
right	JJ	B-PROBLEM	B-PROBLEM
foot	NN	I-PROBLEM	I-PROBLEM
pain	VBP	I-PROBLEM	I-PROBLEM
the	DT	O	O
sunday	NN	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
and	CC	O	O
was	VBD	O	O
seen	VBN	O	O
by	IN	O	O
his	PRP$	O	O
podiatrist	NN	O	O
,	,	O	O
who	WP	O	O
diagnosed	VBD	O	O
him	PRP	O	O
with	IN	O	O
gout	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
given	VBN	O	O
colchicine	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

mr.	NNS	O	O
morton	NNP	O	O
then	RB	O	O
developed	VBD	O	O
more	JJR	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
warmth	NN	B-PROBLEM	O
to	TO	I-PROBLEM	O
his	PRP$	I-PROBLEM	O
right	JJ	I-PROBLEM	O
foot	NN	I-PROBLEM	O
later	RB	O	O
in	IN	O	O
the	DT	O	O
week	NN	O	O
and	CC	O	O
presented	VBN	O	O
to	TO	O	O
the	DT	O	O
youville	NNP	O	O
hospital	NN	O	O
-	:	O	O
woody	NN	O	B-PROBLEM
monica	NN	O	I-PROBLEM
.	.	O	O

at	IN	O	O
this	DT	O	O
hospital	NN	O	O
he	PRP	O	O
underwent	VBD	O	O
an	DT	B-TREATMENT	B-TEST
i&d	NN	I-TREATMENT	I-TEST
(	(	O	O
03-17	JJ	O	O
)	)	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
foot	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
subsequently	RB	O	O
underwent	JJ	O	O

re-exploration	NN	B-TEST	O
(	(	O	O
03-18	CD	O	O
)	)	O	O
for	IN	O	O
developing	VBG	B-PROBLEM	B-PROBLEM
necrotizing	JJ	I-PROBLEM	I-PROBLEM
fascitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pmh	NN	O	O
:	:	O	O
prostate	NN	B-PROBLEM	O
ca	MD	I-PROBLEM	O
,	,	O	O
glaucoma	VB	B-PROBLEM	B-PROBLEM

psh	NN	O	O
:	:	O	O
rih	NN	B-TREATMENT	O
repair	NN	I-TREATMENT	B-TREATMENT
,	,	O	O
s/p	NN	O	O
turp	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
s/p	JJ	O	O
thyroid	NN	B-TREATMENT	B-TREATMENT
excision	NN	I-TREATMENT	I-TREATMENT

heent	NN	O	O
:	:	O	O
eomi	NN	O	O
,	,	O	O
anicteric,	JJ	B-PROBLEM	O
op	NN	O	O
pink	NN	O	O

neck	NN	O	O
:	:	O	O
no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
supple	NN	O	O

cv	NN	O	O
:	:	O	O
rrr	NN	O	O
,	,	O	O
no	DT	O	O
m/r	NN	B-PROBLEM	B-PROBLEM

gi	NN	O	O
:	:	O	O
soft/nt/nd	NN	B-PROBLEM	O

ext	NN	O	O
:	:	O	O
r	JJ	O	O
foot	NN	O	O
with	IN	O	O
erythema	JJ	B-PROBLEM	B-PROBLEM
/	NNP	O	I-PROBLEM
swelling	NN	B-PROBLEM	I-PROBLEM
;	:	O	O
muscle	NN	O	B-PROBLEM
and	CC	O	O
tendons	NNS	O	O
exposed	VBN	O	O
,	,	O	O
with	IN	O	O
necrotic	JJ	B-PROBLEM	B-PROBLEM
edges	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
some	DT	B-PROBLEM	B-PROBLEM
fibrinous	JJ	I-PROBLEM	I-PROBLEM
exudate	NN	I-PROBLEM	I-PROBLEM

mri	JJ	B-TEST	O
rle	VBZ	I-TEST	O
03-21	NN	O	O

"	RB	O	O
1.	CD	B-PROBLEM	O
7	CD	I-PROBLEM	O
cm	NN	I-PROBLEM	O
linear	JJ	I-PROBLEM	B-TEST
fluid	JJ	I-PROBLEM	I-TEST
collection	NN	I-PROBLEM	I-TEST
running	VBG	O	O
between	IN	O	O
the	DT	O	O
anterior	NN	O	O
and	CC	O	O
lateral	JJ	O	B-TEST
muscle	NN	O	I-TEST
compartments	NNS	O	I-TEST
,	,	O	O
extending	VBG	O	O
from	IN	O	O
a	DT	O	B-PROBLEM
large	JJ	O	I-PROBLEM
area	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
soft	JJ	B-PROBLEM	I-PROBLEM
tissue	NN	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
seen	VBN	O	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
distal	JJ	O	I-PROBLEM
lateral	JJ	O	I-PROBLEM
foreleg	NN	O	I-PROBLEM
to	TO	O	I-PROBLEM
roughly	RB	O	I-PROBLEM
the	DT	O	I-PROBLEM
mid	NN	O	I-PROBLEM
tibia	NN	O	I-PROBLEM
/	NNP	O	I-PROBLEM
fibula	NN	O	I-PROBLEM
,	,	O	O
18	CD	O	O
cm	NN	O	O
distal	NN	O	O
to	TO	O	O
the	DT	O	O
knee	NN	O	O
joint	JJ	O	O
line	NN	O	O
.	.	O	O

the	DT	B-PROBLEM	O
collection	NN	I-PROBLEM	O
is	VBZ	O	O
largest	JJS	O	O
at	IN	O	O
its	PRP$	O	O
most	JJS	O	O
proximal	JJ	O	O
extent	NN	O	O
,	,	O	O
measuring	VBG	O	O
1.4	CD	O	O
x	JJ	O	O
0.7	CD	O	O
cm	NN	O	O
in	IN	O	O
the	DT	O	O
transverse	JJ	O	O
dimension	NN	O	O
.	.	O	O

2.	CD	O	O
non-specific	JJ	B-PROBLEM	B-PROBLEM
myositis	NN	I-PROBLEM	I-PROBLEM
involving	VBG	O	O
multiple	JJ	O	O
muscle	NN	O	O
groups	NNS	O	O
in	IN	O	O
the	DT	O	B-PROBLEM
foreleg	NN	O	I-PROBLEM
,	,	O	O
most	JJS	O	B-PROBLEM
severe	JJ	O	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
anterior	NN	O	I-PROBLEM
,	,	O	O
lateral	JJ	O	O
,	,	O	O
and	CC	O	O
posterior	JJ	O	B-PROBLEM
deep	JJ	O	I-PROBLEM
compartments	NNS	O	I-PROBLEM
.	.	O	O

3.	CD	O	O
tendinosis	NN	B-PROBLEM	B-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
posterior	JJ	O	I-PROBLEM
tibialis	NN	O	I-PROBLEM
and	CC	O	O
peroneus	NN	O	B-PROBLEM
brevis	NN	O	I-PROBLEM
tendons	NNS	O	I-PROBLEM
.	.	O	O

no	DT	O	O
tendon	NN	B-PROBLEM	B-PROBLEM
tear	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4.	CD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
abnormal	JJ	B-PROBLEM	B-PROBLEM
bone	NN	I-PROBLEM	I-PROBLEM
marrow	VBD	I-PROBLEM	I-PROBLEM
signal	JJ	I-PROBLEM	I-PROBLEM
intensity	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
intraosseous	JJ	B-PROBLEM	B-PROBLEM
abscess	NN	I-PROBLEM	I-PROBLEM
."	NN	O	I-PROBLEM

rle	JJ	B-TEST	O
angio	VBZ	I-TEST	O
03-21	NN	O	O

"	RB	O	O
1.	CD	O	O
mild	NNS	B-PROBLEM	B-PROBLEM
but	CC	I-PROBLEM	I-PROBLEM
multifocal	JJ	I-PROBLEM	I-PROBLEM
atherosclerotic	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
involving	VBG	O	O
the	DT	O	O
infrarenal	JJ	O	O
aorta	NN	O	O
and	CC	O	O
iliac	JJ	O	O
arteries	NNS	O	O
,	,	O	O
with	IN	O	O
no	DT	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
pressure	NN	I-PROBLEM	I-PROBLEM
gradient	NN	I-PROBLEM	I-PROBLEM
associated	VBN	O	O
.	.	O	O

2.	CD	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
segmental	JJ	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
(	(	O	I-PROBLEM
approx.	JJ	O	I-PROBLEM
5-6	JJ	O	I-PROBLEM
cm	NN	O	I-PROBLEM
long	RB	O	I-PROBLEM
)	)	O	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
mid	NN	O	I-PROBLEM
right	JJ	O	I-PROBLEM
superficial	JJ	O	I-PROBLEM
femoral	JJ	O	I-PROBLEM
artery	NN	O	I-PROBLEM
.	.	O	O

3.	CD	O	O
high	JJ	B-PROBLEM	B-PROBLEM
bifurcation	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
popliteal	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
at	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
knee	NN	O	I-PROBLEM
level	NN	O	I-PROBLEM
.	.	O	O

4.	CD	O	O
in	IN	O	O
the	DT	O	O
proximal	JJ	O	O
calf	NN	O	O
,	,	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
occlusion	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
two	CD	I-PROBLEM	I-PROBLEM
terminal	JJ	I-PROBLEM	I-PROBLEM
branches	NNS	I-PROBLEM	I-PROBLEM
arising	VBG	O	O
from	IN	O	O
this	DT	O	B-PROBLEM
popliteal	JJ	O	I-PROBLEM
bifurcation	NN	O	I-PROBLEM
(	(	O	O
likely	JJ	O	O
the	DT	O	B-PROBLEM
anterior	JJ	O	I-PROBLEM
tibial	NN	O	I-PROBLEM
and	CC	O	O
the	DT	O	O
peroneal	NN	O	O
arteries	NNS	O	O
).	VBP	O	O

two	CD	B-PROBLEM	O
significant	JJ	I-PROBLEM	O
focal	JJ	I-PROBLEM	O
stenoses	NNS	I-PROBLEM	O
of	IN	I-PROBLEM	O
the	DT	I-PROBLEM	B-TREATMENT
distal	JJ	I-PROBLEM	I-TREATMENT
right	JJ	I-PROBLEM	I-TREATMENT
anterior	JJ	I-PROBLEM	I-TREATMENT
tibial	JJ	I-PROBLEM	I-TREATMENT
artery	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

right	RB	O	B-PROBLEM
posterior	JJ	O	I-PROBLEM
tibial	JJ	O	I-PROBLEM
artery	NN	O	I-PROBLEM
completely	RB	B-PROBLEM	I-PROBLEM
occluded	VBD	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
penicillin	NN	B-TREATMENT	B-TREATMENT
g	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
clindamycin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
for	IN	O	O
empiric	JJ	B-TREATMENT	B-TREATMENT
coverage	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
group	NN	B-PROBLEM	B-TEST
a	DT	I-PROBLEM	I-TEST
strep	JJ	I-PROBLEM	I-TEST
growth	NN	I-PROBLEM	I-TEST
from	IN	O	O
the	DT	B-TEST	O
new	JJ	I-TEST	O
england	NN	I-TEST	O
baptist	NN	I-TEST	O
hospital-bryce	JJ	I-TEST	O
cultures	NNS	I-TEST	O
.	.	O	O

he	PRP	O	O
continued	VBD	O	O
to	TO	O	O
undergo	VB	O	O
bid	NN	B-TREATMENT	B-TREATMENT
dressing	VBG	I-TREATMENT	I-TREATMENT
changes	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

per	IN	O	O
their	PRP$	O	O
recommendations	NNS	O	O
,	,	O	O
silvadine	NN	B-TREATMENT	O
was	VBD	O	O
applied	VBN	O	O
to	TO	O	O
the	DT	O	O
tendons	NNS	O	O
to	TO	O	O
prevent	VB	O	O
dessication	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
angiogram	NN	I-TEST	I-TEST
on	IN	O	O
hd#4	NN	O	O
showed	VBD	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
tibial	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
sfa	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
dp	NN	O	O
artery	NN	O	O
was	VBD	O	O
seen	VBN	O	O
.	.	O	O

the	DT	O	O
vascular	JJ	O	O
team	NN	O	O
recommended	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
femoral-peroneal	JJ	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
revascularization	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
performed	VBD	O	O
this	DT	B-TREATMENT	O
operation	NN	I-TREATMENT	O
on	IN	O	O
hd#5	NN	O	O
.	.	O	O

he	PRP	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
,	,	O	O
please	VB	O	O
see	VB	O	O
dr.	JJ	O	O
allgood	NN	O	O
operative	JJ	O	O
note	NN	O	O
for	IN	O	O
detail	NN	O	O
.	.	O	O

on	IN	O	O
pod#1	NN	O	O
,	,	O	O
mr.	JJ	O	O
morton	NNP	O	O
received	VBD	O	O
2	CD	O	O
units	NNS	O	O
of	IN	O	O
prbcs	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
post-op	JJ	B-PROBLEM	B-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
hct	JJ	B-TEST	B-TEST
25	CD	O	O
).	NN	O	O

mr.	NN	O	O
morton	NNP	O	O
continued	VBD	O	O
to	TO	O	O
be	VB	O	O
followed	VBN	O	O
by	IN	O	O
infectious	JJ	O	O
disease	NN	O	O
,	,	O	O
whose	WP$	O	O
recommendations	NNS	O	O
were	VBD	O	O
to	TO	O	O
complete	VB	O	O
a	DT	O	O
01-28	JJ	O	O
week	NN	O	O
course	NN	O	O
of	IN	O	O
penicillin	NN	B-TREATMENT	B-TREATMENT
g	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
clindamycin	NN	B-TREATMENT	B-TREATMENT
after	IN	O	O
the	DT	O	O
foot	NN	O	O
was	VBD	O	O
completely	RB	O	O
debrided	VBN	O	O
and	CC	O	O
the	DT	B-TREATMENT	O
skin	NN	I-TREATMENT	O
flaps	NNS	I-TREATMENT	O
completed	VBN	O	O
.	.	O	O

his	PRP$	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
continued	VBD	O	O
to	TO	O	O
heal	VB	O	O
well	RB	O	O
and	CC	O	O
by	IN	O	O
pod	NN	O	O
#6	FW	O	O
a	DT	B-TREATMENT	B-TREATMENT
vac	NN	I-TREATMENT	I-TREATMENT
dressing	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
.	.	O	O

he	PRP	O	O
received	VBD	O	O
a	DT	B-TREATMENT	O
picc	NN	I-TREATMENT	O
on	IN	O	O
pod#7	NN	O	B-TREATMENT
for	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
long-term	JJ	I-TREATMENT	I-TREATMENT
antibiotic	JJ	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
,	,	O	O
mr.	JJ	O	O
morton	NNP	O	O
had	VBD	O	O
good	JJ	O	B-PROBLEM
pain	NN	O	I-PROBLEM
control	NN	O	I-PROBLEM
,	,	O	O
was	VBD	O	O
tolerating	VBG	O	O
a	DT	O	O
regular	JJ	O	O
diet	NN	O	O
,	,	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
well-healing	JJ	I-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
treated	VBD	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
vac	NN	I-TREATMENT	I-TREATMENT
dressing	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
was	VBD	O	O
to	TO	O	O
continue	VB	O	O
his	PRP$	B-TREATMENT	O
iv	NN	I-TREATMENT	O
pcn	NN	I-TREATMENT	O
g	NN	I-TREATMENT	O
and	CC	O	O
clindamycin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

timolol	NN	B-TREATMENT	B-TREATMENT
.5%	NN	O	I-TREATMENT

right	RB	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
necrosing	VBG	I-PROBLEM	O
fascitis	JJ	I-PROBLEM	O
history	NN	O	O
of	IN	O	O
prostate	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
s/p	NN	O	I-PROBLEM
turp	NN	B-TREATMENT	I-PROBLEM
glaucoma	NN	B-PROBLEM	I-PROBLEM

if	IN	O	O
you	PRP	O	O
have	VBP	O	O
any	DT	B-PROBLEM	O
fevers/chills	NNS	I-PROBLEM	O
,	,	O	O
nausea/vomiting	VBG	B-PROBLEM	O
,	,	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
foot	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
please	VB	O	O
seek	JJ	O	O
medical	JJ	O	O
attention	NN	O	O
.	.	O	O

mevacor	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
;	:	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
t.i.d.	NN	O	O
;	:	O	O
carafate	VB	B-TREATMENT	O
1	CD	O	O
gram	JJ	O	O
q.i.d.	NN	O	O
;	:	O	O
serax	CC	B-TREATMENT	O
15	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.6.h.	NN	O	O
to	TO	O	O
hold	VB	O	O
for	IN	O	O
somnolence	NN	B-PROBLEM	B-PROBLEM
;	:	O	O
thiamine	CC	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
im	NN	O	O
q.d.	NN	O	O
,	,	O	O
folate	VBP	B-TREATMENT	B-TEST
1	CD	O	O
mg	NN	O	O
q.d.	NN	O	O
,	,	O	O
multivitamin	FW	B-TREATMENT	B-TREATMENT
1	CD	O	O
q.d.	NN	O	O
,	,	O	O
percocet	JJ	B-TREATMENT	B-TREATMENT
1-2	JJ	O	O
tabs	NN	O	O
p.o.	NN	O	O
q.4.h.	NN	O	O
p.r.n.	NN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
dulcolax	VBZ	B-TREATMENT	B-TREATMENT
2	CD	O	O
tabs	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
,	,	O	O
p.r.n.	VBZ	O	O
no	DT	B-PROBLEM	O
stool	NN	I-PROBLEM	B-PROBLEM
x	RB	O	O
48	CD	O	O
hours	NNS	O	O
;	:	O	O
tylenol	CC	B-TREATMENT	B-TREATMENT
650	CD	O	O
p.o.	NN	O	O
q.4.h.	NN	O	O
p.r.n.	NN	O	O
and	CC	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
7500	CD	O	O
units	NNS	O	O
subcu.	VBD	O	O
b.i.d.	NN	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
61	JJ	O	O
-	:	O	O
year-old	JJ	O	O
white	JJ	O	O
male	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
5-vessel	JJ	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
2009-09-11	JJ	O	O
,	,	O	O
who	WP	O	O
presents	VBZ	O	O
for	IN	O	O
elective	JJ	B-TEST	B-TREATMENT
right	JJ	I-TEST	I-TREATMENT
heart	NN	I-TEST	I-TREATMENT
catheterization	NN	I-TEST	I-TREATMENT
and	CC	O	O
pericardiocentesis	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
did	VBD	O	O
well	RB	O	O
after	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
10-14	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
transthoracic	NN	I-TEST	I-TEST
echocardiogram	NN	I-TEST	I-TEST
which	WDT	O	O
revealed	VBD	O	O
a	DT	B-PROBLEM	O
new	JJ	I-PROBLEM	O
,	,	I-PROBLEM	O
moderate-to-large	JJ	I-PROBLEM	B-PROBLEM
sized	VBN	I-PROBLEM	I-PROBLEM
pericardial	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
asymptomatic	JJ	B-PROBLEM	B-PROBLEM
at	IN	O	O
this	DT	O	O
time	NN	O	O
,	,	O	O
and	CC	O	O
the	DT	O	O
decision	NN	O	O
was	VBD	O	O
made	VBN	O	O
to	TO	O	O
monitor	VB	O	O
him	PRP	O	O
and	CC	O	O
to	TO	O	O
start	VB	O	O
him	PRP	O	O
on	IN	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
follow-up	JJ	B-TEST	B-TEST
transthoracic	JJ	I-TEST	I-TEST
echocardiogram	NN	I-TEST	I-TEST
on	IN	O	O
11-04	JJ	O	O
which	WDT	O	O
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
slightly	RB	I-PROBLEM	I-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	O	O
few	JJ	O	O
days	NNS	O	O
later	RB	O	O
,	,	O	O
on	IN	O	O
11-07	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
began	VBD	O	O
to	TO	O	O
develop	VB	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
exertion	NN	O	O
with	IN	O	O
normal	JJ	O	O
activity	NN	O	O
.	.	O	O

he	PRP	O	O
also	RB	O	O
noted	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
new	JJ	I-PROBLEM	I-PROBLEM
two	CD	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
three-pillow	JJ	I-PROBLEM	I-PROBLEM
orthopnea	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
paroxysmal	JJ	B-PROBLEM	B-PROBLEM
nocturnal	JJ	I-PROBLEM	I-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
11-08	JJ	O	O
,	,	O	O
he	PRP	O	O
had	VBD	O	O
an	DT	O	O
episode	NN	O	O
of	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
shortness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
chest	NN	B-PROBLEM	B-TEST
pressure	NN	I-PROBLEM	I-TEST
which	WDT	O	O
he	PRP	O	O
describes	VBZ	O	O
as	IN	O	O
different	JJ	O	O
from	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
typical	JJ	I-PROBLEM	I-PROBLEM
angina	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
minimal	JJ	O	B-PROBLEM
exertion	NN	O	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	JJ	O	O
spoke	NN	O	O
with	IN	O	O
his	PRP$	O	O
cardiologist	NN	O	O
who	WP	O	O
referred	VBD	O	O
him	PRP	O	O
for	IN	O	O
pericardiocentesis	NN	B-TREATMENT	B-PROBLEM
for	IN	O	O
persistent	NN	B-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	O
symptomatic	JJ	I-PROBLEM	B-PROBLEM
pericardial	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
right	JJ	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
elevated	VBN	B-PROBLEM	B-PROBLEM
right-sided	JJ	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
left-sided	JJ	I-PROBLEM	B-PROBLEM
filling	NN	I-PROBLEM	I-PROBLEM
pressures	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-TEST	B-TEST
pulmonary	JJ	I-TEST	I-TEST
capillary	JJ	I-TEST	I-TEST
wedge	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
19	CD	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
right	JJ	I-TEST	I-TEST
atrial	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
16	CD	O	O
.	.	O	O

after	IN	O	O
600	CD	O	O
cc	NN	O	O
of	IN	O	O
serosanguineous	JJ	B-PROBLEM	B-PROBLEM
pericardial	JJ	I-PROBLEM	I-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
removed	VBN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-TEST	B-TEST
pulmonary	JJ	I-TEST	I-TEST
capillary	JJ	I-TEST	I-TEST
wedge	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
9	CD	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
right	JJ	I-TEST	I-TEST
atrial	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
2	CD	O	O
;	:	O	O
indicating	VBG	O	O
resolution	NN	O	O
of	IN	O	O
tamponade	JJ	B-PROBLEM	B-PROBLEM
physiology	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
5-vessel	JJ	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
2009-09-11	JJ	O	O
.	.	O	O

left	VBN	O	O
internal	JJ	O	O
mammary	JJ	O	O
artery	NN	O	O
to	TO	O	O
left	VB	O	O
anterior	RP	O	O
descending	VBG	O	O
artery	NN	O	O
,	,	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	O	I-TREATMENT
left	VB	O	I-TREATMENT
anterior	RP	O	I-TREATMENT
descending	VBG	O	I-TREATMENT
artery	NN	O	I-TREATMENT
to	TO	O	O
diagonal	VB	O	O
,	,	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	O	I-TREATMENT
right	VB	O	I-TREATMENT
posterior	JJ	O	I-TREATMENT
descending	VBG	O	I-TREATMENT
artery	NN	O	I-TREATMENT
,	,	O	O
and	CC	O	O
saphenous	JJ	B-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
first	JJ	O	O
obtuse	IN	O	O
marginal	JJ	O	O
.	.	O	O

2.	CD	O	O
type	NN	B-PROBLEM	B-PROBLEM
1	CD	I-PROBLEM	I-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
mellitus	VBP	I-PROBLEM	I-PROBLEM
for	IN	O	O
50	CD	O	O
years	NNS	O	O
.	.	O	O

3.	CD	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

4.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

5.	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-TEST	B-TEST
baseline	JJ	I-TEST	I-TEST
creatinine	NN	I-TEST	I-TEST
of	IN	O	O
1.1	CD	O	O
to	TO	O	O
1.4	CD	O	O
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

atenolol	RB	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
q.d.	NN	O	O
,	,	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
,	,	O	O
baby	NN	B-TREATMENT	O
aspirin	VBD	I-TREATMENT	B-TREATMENT
81	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
,	,	O	O
iron	NN	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
81	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
,	,	O	O
lasix	VBZ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
,	,	O	O
accupril	RB	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
q.d.	NN	O	O
,	,	O	O
hydrochlorothiazide	RB	B-TREATMENT	B-TREATMENT
12.5	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
q.d.	NN	O	O
,	,	O	O
nph	JJ	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
18	CD	O	O
units	NNS	O	O
q.a.m.	RB	O	O
and	CC	O	O
10	CD	O	O
units	NNS	O	O
q.p.m.	RB	O	O
,	,	O	O
humalog	VBD	B-TREATMENT	O
sliding-scale	JJ	I-TREATMENT	O
q.a.m.	NN	O	O
and	CC	O	O
q.p.m.	NN	O	B-PROBLEM

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
of	IN	O	O
100.9	CD	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
148	CD	O	O
to	TO	O	O
162/45	CD	O	O
to	TO	O	O
54	CD	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
85	CD	O	O
to	TO	O	O
87	CD	O	O
,	,	O	O
breathing	VBG	O	O
at	IN	O	O
17	CD	O	O
to	TO	O	O
23	CD	O	O
,	,	O	O
satting	VBG	O	B-TEST
100%	CD	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

in	IN	O	O
general	JJ	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
alert	JJ	O	O
and	CC	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	O	O
neck	NN	O	O
was	VBD	O	O
supple	RB	O	O
without	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
jugular	JJ	I-PROBLEM	I-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
distention	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

heent	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
revealed	VBD	O	O
his	PRP$	O	O
pupils	NNS	O	O
were	VBD	O	O
equal	JJ	O	O
,	,	O	O
round	NN	O	O
,	,	O	O
and	CC	O	O
reactive	JJ	O	O
to	TO	O	O
light	NN	O	O
.	.	O	O

his	PRP$	O	B-TEST
sclerae	NN	O	I-TEST
were	VBD	O	O
anicteric	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

cardiovascular	NN	O	O
revealed	VBD	O	O
a	DT	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
heart	NN	B-PROBLEM	B-TEST
sounds	VBZ	I-PROBLEM	I-TEST
muffled	VBN	I-PROBLEM	O
,	,	O	O
no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

respiratory	NN	O	O
revealed	VBD	O	O
bibasilar	JJ	B-PROBLEM	B-PROBLEM
rales	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
nondistended	VBD	B-PROBLEM	B-PROBLEM
,	,	O	O
positive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
.	.	O	O

extremities	NNS	O	O
revealed	VBD	O	O
trace	NN	B-PROBLEM	B-PROBLEM
lower	RBR	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
right	RB	O	O
greater	JJR	O	O
than	IN	O	O
left	VBD	O	O
,	,	O	O
2+	CD	B-TEST	O
dorsalis	NN	I-TEST	B-TEST
pedis	NN	I-TEST	I-TEST
and	CC	I-TEST	O
posterior	JJ	I-TEST	B-PROBLEM
tibialis	NN	I-TEST	I-PROBLEM
pulses	NNS	I-TEST	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
2+	CD	B-TEST	O
femoral	JJ	I-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
bilaterally	RB	O	O
.	.	O	O

no	DT	O	O
hematomas	NN	B-PROBLEM	B-PROBLEM
were	VBD	O	O
noted	VBN	O	O
,	,	O	O
but	CC	O	O
a	DT	B-PROBLEM	B-TREATMENT
soft	JJ	I-PROBLEM	I-TREATMENT
right	JJ	I-PROBLEM	I-TREATMENT
femoral	JJ	I-PROBLEM	I-TREATMENT
bruit	NN	I-PROBLEM	I-TREATMENT
was	VBD	O	O
heard	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
9.5	CD	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
of	IN	O	O
34.5	CD	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
platelet	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
194	CD	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
chem-7	NN	I-TEST	I-TEST
revealed	VBD	O	O
sodium	NN	B-TEST	B-TEST
of	IN	O	O
132	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
of	IN	O	O
43	CD	O	O
,	,	O	O
chloride	NN	B-TEST	B-TEST
of	IN	O	O
97	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
of	IN	O	O
28	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
of	IN	O	O
25	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
of	IN	O	O
1.3	CD	O	O
,	,	O	O
glucose	NN	B-TEST	B-TEST
of	IN	O	O
220	CD	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
an	DT	B-TEST	O
inr	NN	I-TEST	O
of	IN	O	O
1.1	CD	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
calcium	NN	I-TEST	I-TEST
of	IN	O	O
8.4	CD	O	O
,	,	O	O
phosphate	NN	B-TEST	O
of	IN	O	O
2.5	CD	O	O
,	,	O	O
magnesium	NN	B-TEST	B-TEST
of	IN	O	O
1.9	CD	O	O
.	.	O	O

pericardial	JJ	B-TEST	B-TEST
fluid	NN	I-TEST	I-TEST
analysis	NN	I-TEST	I-TEST
was	VBD	O	O
consistent	JJ	O	O
with	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
exudative	JJ	I-PROBLEM	I-PROBLEM
etiology	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
an	DT	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
with	IN	O	O
normal	JJ	O	O
sinus	NNS	O	O
rhythm	VBP	O	O
at	IN	O	O
70	CD	O	O
,	,	O	O
normal	JJ	O	O
axis	NN	O	O
,	,	O	O
normal	JJ	O	O
intervals	NNS	O	O
,	,	O	O
low	JJ	B-PROBLEM	B-PROBLEM
voltage	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
limb	NN	I-PROBLEM	O
leads	VBZ	I-PROBLEM	O
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
on	IN	O	O
admission	NN	O	O
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
on	IN	O	O
11-10	JJ	O	O
which	WDT	O	O
revealed	VBD	O	O
the	DT	O	O
following	NN	O	O
:	:	O	O

global	JJ	B-TEST	B-TEST
left	VBD	I-TEST	I-TEST
ventricular	JJ	I-TEST	I-TEST
systolic	JJ	I-TEST	I-TEST
function	NN	I-TEST	I-TEST
appeared	VBD	O	O
grossly	RB	O	O
preserved	VBN	O	O
.	.	O	O

due	JJ	O	O
to	TO	O	O
technical	JJ	O	B-PROBLEM
quality	NN	O	I-PROBLEM
a	DT	B-PROBLEM	I-PROBLEM
focal	JJ	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
motion	NN	I-PROBLEM	I-PROBLEM
abnormality	NN	I-PROBLEM	I-PROBLEM
could	MD	O	O
not	RB	O	O
be	VB	O	O
fully	RB	O	O
excluded	VBN	O	O
.	.	O	O

the	DT	O	O
aortic	JJ	O	O
valve	NN	O	O
leaflets	NNS	O	O
were	VBD	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
thickened	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
mitral	JJ	O	O
valve	NN	O	O
leaflets	NNS	O	O
were	VBD	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
thickened	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
pericardial	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
up	IN	O	O
to	TO	O	O
greater	JJR	O	O
than	IN	O	O
6	CD	O	O
cm	JJ	O	O
wide	JJ	O	O
anterior	NN	O	O
to	TO	O	O
the	DT	O	O
right	JJ	O	O
ventricle	NN	O	O
).	NN	O	O

the	DT	O	O
right	JJ	O	O
ventricle	NN	O	O
was	VBD	O	O
compressed	VBN	B-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
coronary	JJ	O	O
care	NN	O	O
unit	NN	O	O
after	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
therapeutic	JJ	I-TREATMENT	I-TREATMENT
pericardiocentesis	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
home	NN	I-TREATMENT	I-TREATMENT
cardiac	NN	I-TREATMENT	I-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
but	CC	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
indomethacin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
post	NN	B-PROBLEM	B-PROBLEM
pericardiotomy	NN	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

over	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
the	DT	O	O
night	NN	O	O
the	DT	O	O
patient	NN	O	O
drained	VBD	O	O
an	DT	O	O
additional	JJ	O	O
400	CD	O	O
cc	NN	O	O
of	IN	O	O
serosanguineous	JJ	B-PROBLEM	B-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
pericardial	JJ	I-TREATMENT	I-TREATMENT
drain	NN	I-TREATMENT	I-TREATMENT
pouch	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

by	IN	O	O
the	DT	O	O
next	JJ	O	O
morning	NN	O	O
,	,	O	O
the	DT	O	O
degree	NN	O	O
of	IN	O	O
drainage	NN	B-PROBLEM	B-TREATMENT
had	VBD	O	O
decreased	VBN	O	O
considerably	RB	O	O
with	IN	O	O
only	RB	O	O
60	CD	O	O
cc	NNS	O	O
drained	VBN	O	O
over	IN	O	O
six	CD	O	O
hours	NNS	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
transthoracic	NN	I-TEST	I-TEST
echocardiogram	NN	I-TEST	I-TEST
prior	RB	O	O
to	TO	O	B-TREATMENT
drain	VB	B-TREATMENT	I-TREATMENT
removal	NN	I-TREATMENT	I-TREATMENT
which	WDT	O	O
revealed	VBD	O	O
the	DT	O	O
following	NN	O	O
:	:	O	O

a	DT	B-PROBLEM	B-PROBLEM
trivial	JJ	I-PROBLEM	I-PROBLEM
/	NN	I-PROBLEM	I-PROBLEM
physiologic	JJ	I-PROBLEM	I-PROBLEM
pericardial	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
one	CD	O	O
day	NN	O	O
post	VB	O	O
pericardiocentesis	NN	B-TREATMENT	B-PROBLEM
with	IN	O	O
no	DT	O	O
change	NN	O	O
from	IN	O	O
the	DT	B-TEST	B-TEST
study	NN	I-TEST	I-TEST
immediately	RB	O	O
post	JJ	O	O
pericardiocentesis	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
pericardial	JJ	I-TREATMENT	I-TREATMENT
drain	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
removed	VBN	O	O
without	IN	O	O
any	DT	B-PROBLEM	O
difficulty	NN	I-PROBLEM	O
.	.	O	O

the	DT	B-TREATMENT	B-TEST
pericardial	JJ	I-TREATMENT	I-TEST
fluid	NN	I-TREATMENT	I-TEST
bag	NN	I-TREATMENT	I-TEST
was	VBD	O	O
removed	VBN	O	O
without	IN	O	O
any	DT	B-PROBLEM	O
difficulty	NN	I-PROBLEM	O
with	IN	O	O
the	DT	O	O
decision	NN	O	O
to	TO	O	O
monitor	VB	O	O
the	DT	O	O
patient	NN	O	O
overnight	NN	O	O
and	CC	O	O
repeat	VB	O	B-TEST
the	DT	B-TEST	I-TEST
echocardiogram	NN	I-TEST	I-TEST
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
enlarged	VBN	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
layer	VB	O	O
on	IN	O	O
a	DT	B-TEST	B-TREATMENT
lateral	JJ	I-TEST	I-TREATMENT
decubitus	NN	I-TEST	I-TREATMENT
film	NN	I-TEST	I-TREATMENT
.	.	O	O

we	PRP	O	O
decided	VBD	O	O
to	TO	O	O
perform	VB	O	O
a	DT	B-TREATMENT	B-TREATMENT
therapeutic	JJ	I-TREATMENT	I-TREATMENT
thoracentesis	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
prepped	VBN	O	O
and	CC	O	O
draped	VBN	O	O
in	IN	O	O
a	DT	O	B-TREATMENT
sterile	JJ	O	I-TREATMENT
fashion	NN	O	I-TREATMENT
,	,	O	O
and	CC	O	O
1150	CD	O	O
cc	NN	O	O
of	IN	O	O
fluid	NN	B-PROBLEM	B-PROBLEM
were	VBD	O	O
drained	VBN	B-TREATMENT	O
.	.	O	O

a	DT	B-TEST	B-TEST
chest	JJ	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
was	VBD	O	O
obtained	VBN	O	O
post	NN	O	O
thoracentesis	NN	B-TREATMENT	B-TREATMENT
which	WDT	O	O
revealed	VBD	O	O
a	DT	O	B-PROBLEM
significant	JJ	O	I-PROBLEM
decrease	NN	O	I-PROBLEM
in	IN	O	O
the	DT	O	O
size	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
evidence	NN	O	O
of	IN	O	O
pneumothorax	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
the	DT	O	O
morning	NN	O	O
of	IN	O	O
admission	NN	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	O
markedly	RB	I-TEST	O
improved	VBN	I-TEST	O
lung	NN	I-TEST	B-TEST
examination	NN	I-TEST	I-TEST
with	IN	O	O
increased	JJ	O	B-PROBLEM
air	NN	O	I-PROBLEM
movement	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	JJ	O	I-PROBLEM
base	NN	O	I-PROBLEM
.	.	O	O

he	PRP	O	O
denied	VBD	O	O
any	DT	B-PROBLEM	O
shortness	NN	I-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
had	VBD	O	O
oxygen	VBN	B-TEST	B-TEST
saturations	NNS	I-TEST	I-TEST
in	IN	O	O
the	DT	O	O
90	CD	O	O
s	NN	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
echocardiogram	NN	I-TEST	I-TEST
which	WDT	O	O
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
trivial	JJ	I-PROBLEM	I-PROBLEM
/	NN	I-PROBLEM	I-PROBLEM
physiologic	JJ	I-PROBLEM	I-PROBLEM
pericardial	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
post	NN	B-PROBLEM	B-PROBLEM
pericardiotomy	NN	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
status	NN	O	O
post	NN	O	O
pericardiocentesis	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

3.	CD	O	O
status	NN	O	O
post	NN	O	O
thoracentesis	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

4.	CD	O	O
type	NN	B-PROBLEM	B-PROBLEM
1	CD	I-PROBLEM	I-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
mellitus	VBP	I-PROBLEM	I-PROBLEM
for	IN	O	O
50	CD	O	O
years	NNS	O	O
.	.	O	O

5.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

6.	CD	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

7.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

8.	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
indomethacin	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O
for	IN	O	O
seven	CD	O	O
days.	NNS	O	O

2.	CD	O	O
atenolol	JJ	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

3.	CD	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

4.	CD	O	O
baby	NN	B-TREATMENT	B-TREATMENT
aspirin	VBD	I-TREATMENT	I-TREATMENT
81	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

5.	CD	O	O
iron	NN	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
81	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

6.	CD	O	O
accupril	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

7.	CD	O	O
hydrochlorothiazide	JJ	B-TREATMENT	B-TREATMENT
12.5	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

8.	CD	O	O
nph	JJ	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
18	CD	O	O
units	NNS	O	O
q.a.m.	RB	O	O
and	CC	O	O
10	CD	O	O
units	NNS	O	O
q.p.m.	RB	O	O

9.	CD	O	O
humalog	NN	B-TREATMENT	B-TREATMENT
sliding-scale	JJ	I-TREATMENT	I-TREATMENT
q.a.m.	NN	O	I-TREATMENT
and	CC	O	O
q.p.m.	NN	O	B-PROBLEM

vaginal	JJ	B-TREATMENT	B-TREATMENT
delivery	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
first	JJ	B-PROBLEM	B-PROBLEM
degree	NN	I-PROBLEM	I-PROBLEM
laceration	NN	I-PROBLEM	I-PROBLEM

advanced	JJ	B-PROBLEM	B-PROBLEM
maternal	JJ	I-PROBLEM	I-PROBLEM
age	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
depression	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
history	NN	O	O
of	IN	O	O
;	:	O	O
hepatitis	NN	B-PROBLEM	B-PROBLEM
c	VBZ	I-PROBLEM	I-PROBLEM
antibody	JJ	I-PROBLEM	I-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
;	:	O	O
polyneuropathy	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
history	NN	O	O
of	IN	O	O
;	:	O	O
problems	NNS	O	O
with	IN	O	O
abuse	NN	O	O
,	,	O	O
history	NN	O	O
of	IN	O	O
;	:	O	O
rh	JJ	O	B-PROBLEM
nonsensitization	NN	O	I-PROBLEM
;	:	O	O
stopped	VBD	O	B-PROBLEM
smoking	VBG	O	I-PROBLEM
this	DT	O	I-PROBLEM
pregnancy	NN	O	I-PROBLEM
,	,	O	O
history	NN	O	O
of	IN	O	O

spontaneous	JJ	B-TREATMENT	B-TREATMENT
vertex	NNS	I-TREATMENT	I-TREATMENT
vaginal	JJ	I-TREATMENT	I-TREATMENT
delivery	NN	I-TREATMENT	I-TREATMENT

active	JJ	B-PROBLEM	B-PROBLEM
labor	NN	I-PROBLEM	I-PROBLEM

height	NN	B-TEST	O
normal	JJ	O	O
66	CD	O	O
heent	NN	O	O
normal	JJ	O	O
mouth	NN	O	O
normal	JJ	O	O
neck	NN	O	O
normal	JJ	O	O
breasts	NNS	O	O
normal	JJ	O	O
nipples	NNS	O	O
normal	JJ	O	O
chest	JJS	O	O
normal	JJ	O	O
cor	NN	O	O
normal	JJ	O	O
abdomen	NNS	O	O
normal	JJ	O	O
extrem	JJ	O	O
normal	JJ	O	O
skin	NN	B-PROBLEM	O
mottled	VBN	I-PROBLEM	O
on	IN	I-PROBLEM	O
both	DT	I-PROBLEM	O
lower	JJR	I-PROBLEM	O
extremities	NNS	I-PROBLEM	O
.	.	O	O

nodes	NNS	O	O
normal	JJ	O	O
vulva	NN	O	O
normal	JJ	O	O
vagina	NN	O	O
normal	JJ	O	O
cervix	NN	O	O
normal	JJ	O	O
os	NN	O	O
normal	JJ	O	O
adnexae	NN	O	O
normal	JJ	O	O
uterus	JJ	O	O
normal	JJ	O	O
uterine	JJ	B-TEST	O
size	NN	I-TEST	O
in	IN	O	O
weeks	NNS	O	O
15	CD	O	O
hospital	JJ	O	O
course	NN	O	O
(	(	O	O
include	VBP	O	O
complications	NNS	O	B-PROBLEM
if	IN	O	O
any	DT	O	O
)	)	O	O
:	:	O	O

active	JJ	B-PROBLEM	B-PROBLEM
labor	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
delivered	VBD	O	O
a	DT	O	O
2809	CD	O	O
gram	NN	O	O
male	NN	O	O
infant	NN	O	O
on	IN	O	O
03/16/2002	CD	O	O
at	IN	O	O
02:50	CD	O	O
am	VBP	O	O
with	IN	O	O
apgar	JJ	B-TEST	B-TEST
scores	NNS	I-TEST	I-TEST
of	IN	O	O
7	CD	O	O
and	CC	O	O
9	CD	O	O
at	IN	O	O
one	CD	O	O
and	CC	O	O
five	CD	O	O
minutes	NNS	O	O
respectively	RB	O	O
at	IN	O	O
38.0	CD	O	O
weeks	NNS	O	O
gestation	NN	O	O
via	IN	O	O
spontaneous	JJ	B-TREATMENT	B-TREATMENT
vertex	FW	I-TREATMENT	I-TREATMENT
vaginal	JJ	I-TREATMENT	I-TREATMENT
delivery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

depression	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

postpartum	NN	B-TREATMENT	O
rh	NN	I-TREATMENT	O
immune	JJ	I-TREATMENT	O
globulin	NN	I-TREATMENT	O
:	:	O	O

postpartum	NN	B-TREATMENT	B-PROBLEM
measles	NNS	I-TREATMENT	I-PROBLEM
/	VBP	I-TREATMENT	O
mumps/rubella	JJ	I-TREATMENT	B-TREATMENT
vaccine	NN	I-TREATMENT	I-TREATMENT
:	:	O	O

multivitamins	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	O
folate	NN	B-TREATMENT	B-TREATMENT
(	(	O	I-TREATMENT
stuart	JJ	B-TREATMENT	I-TREATMENT
prenatal	NN	I-TREATMENT	I-TREATMENT
with	IN	O	I-TREATMENT
folate	NN	B-TREATMENT	I-TREATMENT
)	)	O	I-TREATMENT
;	:	O	O
fluoxetine	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
prozac	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT

patient	NN	O	O
recorded	VBD	O	O
as	IN	O	O
having	VBG	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	O
drugs	NNS	I-PROBLEM	B-TREATMENT

altered	VBN	B-PROBLEM	B-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM

diaphoresis	NN	B-PROBLEM	B-PROBLEM

abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

lap	RB	B-TREATMENT	O
converted	VBN	O	O
to	TO	O	O
open	VB	B-TREATMENT	O
cholecystectomy	NN	I-TREATMENT	B-TREATMENT

her	PRP$	O	O
family	NN	O	O
memebers	NNS	O	O
stated	VBD	O	O
that	IN	O	O
she	PRP	O	O
was	VBD	O	O
found	VBN	O	O
at	IN	O	O
home	NN	O	O
with	IN	O	O
altered	JJ	B-PROBLEM	B-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
diaphoresis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
diabetic	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

mental	JJ	O	O
status	NN	O	O
improved	VBN	O	O
after	IN	O	O
binasal	NN	B-TREATMENT	B-TREATMENT
cannula	NN	I-TREATMENT	I-TREATMENT
oxygen	NN	I-TREATMENT	I-TREATMENT
applied	VBN	O	O
,	,	O	O
at	IN	O	O
which	WDT	O	O
time	NN	O	O
she	PRP	O	O
localized	VBD	O	O
right	JJ	B-PROBLEM	B-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
developed	VBD	O	O
leukocytosis	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
transaminasemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

dm	NN	B-PROBLEM	O
on	IN	O	O
insulin	NN	B-TREATMENT	B-TREATMENT

htn	NN	B-PROBLEM	B-PROBLEM

gerd	NN	B-PROBLEM	B-PROBLEM

pvd	NN	B-PROBLEM	O

osteo-arthritis	NN	B-PROBLEM	B-PROBLEM

osteoporosis	NN	B-PROBLEM	B-PROBLEM

anemia	NN	B-PROBLEM	B-PROBLEM

cholelithiasis	NN	B-PROBLEM	B-PROBLEM

left	JJ	B-PROBLEM	B-PROBLEM
humeral	JJ	I-PROBLEM	I-PROBLEM
fracture	NN	I-PROBLEM	I-PROBLEM

b/l	NN	B-PROBLEM	B-PROBLEM
cataracts	NNS	I-PROBLEM	I-PROBLEM
s/p	VBP	O	O
surgery	NN	B-TREATMENT	B-TREATMENT

s/p	JJ	O	B-TREATMENT
uterine	JJ	B-TREATMENT	I-TREATMENT
myomectomy	NN	I-TREATMENT	I-TREATMENT

walks	NNS	O	O
without	IN	O	O
cane	NN	B-TREATMENT	B-PROBLEM

denies	NNS	O	O
cad	VBP	B-PROBLEM	B-PROBLEM

t	NN	B-TEST	O
:	:	O	O
99.2	CD	O	O
hr	NN	B-TEST	B-TEST
97	CD	O	O
bp	NN	B-TEST	O
131/68	CD	O	O
rr	NN	B-TEST	O
:	:	O	O
20	CD	O	O
spo2	NN	B-TEST	O
100%	CD	O	O
on	IN	O	O
ra	NN	O	O

no	DT	O	O
mumur	NN	B-PROBLEM	B-PROBLEM
/	VBZ	O	O
regurgiation	NN	B-PROBLEM	B-PROBLEM
/	NNP	O	I-PROBLEM
gallop	NN	B-PROBLEM	I-PROBLEM

+	NN	O	O
haskell	NN	B-TEST	O
sign	NN	I-TEST	O
,	,	O	O
right	JJ	B-PROBLEM	B-PROBLEM
upper	NN	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

nondistended	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
rebounding	NN	B-PROBLEM	B-PROBLEM

skin	NN	O	O
:	:	O	O
no	DT	O	O
c/c/e	NN	B-PROBLEM	B-PROBLEM

neuro	NN	O	O
:	:	O	O
cn	JJ	O	O
ii-xii	JJ	O	O
intact	NN	O	O
,	,	O	O
no	DT	O	O
dysdiadokinesis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

decreased	VBN	B-PROBLEM	B-PROBLEM
babinski	NN	I-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM

2015-04-16	JJ	O	O
07:10	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
albumin	SYM	B-TEST	B-TEST
-	:	O	O
3.8	CD	O	O
calcium	NN	B-TEST	B-TEST
-	:	O	O
9.0	CD	O	O
phos	NN	B-TEST	B-TEST
-	:	O	O
2.6	CD	O	O
*#	NN	O	O
mg	SYM	B-TEST	O
-	:	O	O
1.9	CD	O	O

2015-04-16	JJ	O	O
07:10	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
alt	SYM	B-TEST	B-TEST
-	:	O	O
295	CD	O	O
*	NN	O	O
ast	VBD	B-TEST	B-TEST
-	:	O	O
56	CD	O	O
*	NN	O	O
ck(cpk)	NN	B-TEST	B-TEST
-	:	O	O
60	CD	O	O
alkphos	SYM	B-TEST	B-TEST
-	:	O	O
208	CD	O	O
*	JJ	O	O
amylase	NN	B-TEST	B-TEST
-	:	O	O
23	CD	O	O
totbili	SYM	B-TEST	B-TEST
-	:	O	O
1.6	CD	O	O
*	NN	O	O

2015-04-16	JJ	O	O
07:10	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	O
glucose	VB	B-TEST	B-TEST
-	:	O	O
280	CD	O	O
*	JJ	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
18	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
1.0	CD	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
135	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
4.2	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
98	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
22	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
19	CD	O	O

2015-04-16	JJ	O	O
07:10	CD	O	O
pm	NN	O	O
blood	NN	B-TEST	B-TEST
wbc	SYM	B-TEST	B-TEST
-	:	O	O
18.4	CD	O	O
*#	NN	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
4.27	CD	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
11.9	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
34.8	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
82	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
27.9	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.1	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
15.0	CD	O	O
plt	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
-	:	O	O
317	CD	O	O

2015-04-24	JJ	O	O
06:35	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	B-TEST
alt	NN	B-TEST	I-TEST
-	:	O	O
82	CD	O	O
*	NN	O	O
ast	VBD	B-TEST	B-TEST
-	:	O	O
62	CD	O	O
*	NN	O	O
alkphos	SYM	B-TEST	B-TEST
-	:	O	O
145	CD	O	O
*	JJ	O	O
amylase	NN	B-TEST	B-TEST
-	:	O	O
51	CD	O	O
totbili	SYM	B-TEST	B-TEST
-	:	O	O
0.4	CD	O	O

2015-04-24	JJ	O	O
06:35	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
134	CD	O	O
*	JJ	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
8	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
0.6	CD	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
144	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
3.7	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
106	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
31	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
11	CD	O	O

2015-04-24	JJ	O	O
06:35	CD	O	O
am	VBP	O	O
blood	NN	B-TEST	O
wbc	NN	B-TEST	B-TEST
-	:	O	O
10.5	CD	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.49	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
9.6	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
28.0	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
80	CD	O	O
*	NN	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
27.5	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.3	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
15.8	CD	O	O
*	JJ	O	O
plt	NN	B-TEST	B-TEST
ct	SYM	I-TEST	I-TEST
-	:	O	O
504	CD	O	O
*	NN	O	O

gb	JJ	B-TEST	O
us	PRP	I-TEST	O
2015-04-16	JJ	O	O

1.	CD	O	O
distended	VBD	B-PROBLEM	B-PROBLEM
gallbladder	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
impacted	JJ	B-PROBLEM	B-PROBLEM
1.6	CD	I-PROBLEM	I-PROBLEM
cm	NN	I-PROBLEM	I-PROBLEM
gallstone	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
focal	JJ	B-PROBLEM	B-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
thickening	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
positive	JJ	B-PROBLEM	O
sonallan	NN	I-PROBLEM	O
stephens	VBZ	I-PROBLEM	O
sign	JJ	I-PROBLEM	O
-	:	O	O
findings	NNS	O	O
consistent	JJ	O	O
with	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
cholecystitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
right	JJ	B-PROBLEM	B-PROBLEM
renal	NN	I-PROBLEM	I-PROBLEM
cysts	NNS	I-PROBLEM	I-PROBLEM
-	:	O	I-PROBLEM
lower	JJR	B-PROBLEM	I-PROBLEM
pole	JJ	I-PROBLEM	I-PROBLEM
cyst	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
unchanged	JJ	O	O
from	IN	O	O
prior	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
of	IN	O	O
2010-10-25	JJ	O	O
and	CC	O	O
upper	JJ	B-PROBLEM	B-PROBLEM
pole	NN	I-PROBLEM	I-PROBLEM
exophytic	JJ	I-PROBLEM	I-PROBLEM
cyst	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
not	RB	O	O
previously	RB	O	O
seen	VBN	O	O
sonstacy	NN	O	O
.	.	O	O

ercp	JJ	B-TEST	O
report	NN	O	O
2015-04-21	JJ	O	O

1.	CD	O	O
successful	JJ	O	O
removal	NN	B-TREATMENT	O
of	IN	O	O
cbd	NN	B-PROBLEM	B-PROBLEM
stone	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
placement	NN	O	B-TREATMENT
of	IN	O	I-TREATMENT
plastic	NN	B-TREATMENT	I-TREATMENT
biliary	JJ	I-TREATMENT	I-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
confirmed	VBN	B-PROBLEM	O
cystic	JJ	I-PROBLEM	B-PROBLEM
duct	NN	I-PROBLEM	I-PROBLEM
leak	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

ms	NN	O	B-TEST
malek	NN	O	I-TEST
was	VBD	O	O
admitted	VBN	O	O
on	IN	O	O
2015-04-16	JJ	O	O
due	JJ	O	O
to	TO	O	O
altered	JJ	B-PROBLEM	B-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
acute	VB	B-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
quadrant	JJ	I-PROBLEM	I-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

gallbladder	NN	B-TEST	B-PROBLEM
ultra	JJ	I-TEST	I-PROBLEM
sound	NN	I-TEST	I-PROBLEM
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
distended	JJ	I-PROBLEM	I-PROBLEM
1.6	CD	I-PROBLEM	I-PROBLEM
cm	NN	I-PROBLEM	I-PROBLEM
non	NN	I-PROBLEM	I-PROBLEM
mobile	JJ	I-PROBLEM	I-PROBLEM
stone	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
neck	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
2015-04-17	JJ	O	O
she	PRP	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
or	CC	O	O
for	IN	O	O
lap	RB	B-TREATMENT	O
converted	VBN	O	O
to	TO	O	O
open	VB	B-TREATMENT	O
cholecystectomy	NN	I-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
,	,	O	O
see	VBP	O	O
op	JJ	O	O
report	NN	O	O
for	IN	O	O
details	NNS	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
extubated	VBN	B-TREATMENT	O
and	CC	O	O
recovered	VBN	O	O
well	RB	O	O
in	IN	O	O
pacu	NN	O	O
.	.	O	O

she	PRP	O	O
remained	VBD	O	O
npo	JJ	B-TREATMENT	O
with	IN	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
foley	VBP	B-TREATMENT	B-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
dilaudid	JJ	B-TREATMENT	B-TREATMENT
iv	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
pain	NN	B-TREATMENT	B-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
unasyn	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
antibiotic	JJ	B-TREATMENT	B-TREATMENT
coverage	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
returned	VBD	O	O
to	TO	O	O
cmed	VB	O	O
for	IN	O	O
further	JJ	B-TEST	B-TEST
monitoring	NN	I-TEST	I-TEST
.	.	O	O

she	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
low	JJ	B-PROBLEM	B-PROBLEM
urine	JJ	I-PROBLEM	I-PROBLEM
output	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
times	NNS	O	O
.	.	O	O

she	PRP	O	O
responded	VBD	O	O
well	RB	O	O
to	TO	O	O
fluid	VB	B-TREATMENT	O
bolusing	NN	I-TREATMENT	O
.	.	O	O

she	PRP	O	O
remained	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
,	,	O	O
she	PRP	O	O
was	VBD	O	O
given	VBN	O	O
ice	JJ	O	B-TREATMENT
chips	NNS	O	I-TREATMENT
.	.	O	O

pod#2	NN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
somewhat	RB	O	O
uncontrolled	JJ	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
dilaudid	JJ	B-TREATMENT	B-TREATMENT
pca	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
fair	JJ	O	B-PROBLEM
effect	NN	O	I-PROBLEM
.	.	O	O

urine	JJ	B-TEST	B-TEST
output	NN	I-TEST	I-TEST
remained	VBD	O	O
adequate	JJ	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
monitored	VBN	O	O
on	IN	O	O
telemetry	NN	B-TEST	B-TEST
for	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
recieved	VBD	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
beta	NN	I-TREATMENT	I-TREATMENT
blockers	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

pod#3	NN	O	O
she	PRP	O	O
was	VBD	O	O
advanced	VBN	O	O
to	TO	O	O
sips	NNS	B-TREATMENT	B-PROBLEM
and	CC	I-TREATMENT	O
clears	NNS	I-TREATMENT	O
,	,	O	O
foley	VBP	B-TREATMENT	B-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
.	.	O	O

pod#4	NN	O	O
,	,	O	O
bilious	JJ	B-PROBLEM	B-PROBLEM
drainage	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
in	IN	O	O
her	PRP$	B-TREATMENT	O
jp	NN	I-TREATMENT	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
exam	NN	B-TEST	B-TEST
.	.	O	O

she	PRP	O	O
was	VBD	O	O
held	VBN	O	O
npo	RB	B-TREATMENT	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
ercp	VB	B-TEST	O
where	WRB	O	O
sphincterotomy	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
performed	VBN	O	O
and	CC	O	O
biliary	JJ	B-TREATMENT	B-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
placed	VBN	O	O
.	.	O	O

she	PRP	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
and	CC	O	O
returned	VBN	O	O
to	TO	O	O
cc6	VB	O	O
post-procedure	NN	O	O
.	.	O	O

jp	NN	B-TREATMENT	O
remained	VBD	O	O
intact	JJ	O	O
with	IN	O	O
serosainguinous	JJ	B-PROBLEM	B-PROBLEM
drainage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pod#5	NN	O	O
she	PRP	O	O
c/o	VBD	O	O
difficulty	NN	B-PROBLEM	B-PROBLEM
voiding	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
pt	NN	O	O
was	VBD	O	O
straight	VBN	B-TREATMENT	O
cathed	VBN	I-TREATMENT	O
after	IN	O	O
bladder	NN	B-TEST	B-TEST
scan	NN	I-TEST	I-TEST
was	VBD	O	O
obtained	VBN	O	O
and	CC	O	O
revealed	VBN	O	O
>	$	O	O
600	CD	O	O
ccs	NN	O	O
urine	NN	O	O
.	.	O	O

pod#	NN	O	O
05-25	CD	O	O
she	PRP	O	O
continued	VBD	O	O
with	IN	O	O
intermittent	JJ	O	B-PROBLEM
complaints	NNS	O	I-PROBLEM
of	IN	O	I-PROBLEM
urinary	JJ	B-PROBLEM	I-PROBLEM
retention	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

renal	JJ	B-TEST	O
function	NN	I-TEST	O
remained	VBD	O	O
normal	JJ	O	O
.	.	O	O

she	PRP	O	O
did	VBD	O	O
not	RB	O	O
require	VB	O	O
further	JJ	B-TREATMENT	B-TEST
straight	JJ	I-TREATMENT	I-TEST
catheterization	NN	I-TREATMENT	I-TEST
.	.	O	O

she	PRP	O	O
was	VBD	O	O
advanced	VBN	O	O
to	TO	O	O
clear	JJ	B-TREATMENT	O
liquids	NNS	I-TREATMENT	O
again	RB	O	O
without	IN	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

her	PRP$	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
well	RB	O	O
controlled	VBN	O	O
by	IN	O	O
tylenol	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

her	PRP$	O	O
home	NN	O	O
regimen	NN	O	O
of	IN	O	O
lantus	NN	B-TREATMENT	O
was	VBD	O	O
resumed	VBN	O	O
for	IN	O	O
elevated	JJ	B-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
glucose	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
required	VBD	O	O
disimpaction	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
had	VBD	O	O
hard	JJ	B-PROBLEM	B-PROBLEM
stool	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
rectum	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
initiated	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
bowel	NN	I-TREATMENT	I-TREATMENT
regimen	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
had	VBD	O	O
no	DT	O	O
further	JJ	O	O
incidents	NNS	O	O
of	IN	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
constipation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

appropriate	NN	O	O
follow	VB	O	O
up	IN	O	O
appointments	NNS	O	O
are	VBP	O	O
recommended	VBN	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
prescriptions	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
should	MD	O	O
return	VB	O	O
in	IN	O	O
6	CD	O	O
weeks	NNS	O	O
for	IN	O	O
removal	NN	B-TREATMENT	B-TREATMENT
of	IN	O	I-TREATMENT
biliary	JJ	B-TREATMENT	I-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

tramadol	RB	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day)	NN	O	O
.	.	O	O

2.	CD	O	O
senna	JJ	B-TREATMENT	B-TREATMENT
8.6	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

3.	CD	O	O
nortriptyline	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

4.	CD	O	O
atenolol	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

5.	CD	O	O
buspirone	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

6.	CD	O	O
clonazepam	NN	B-TREATMENT	B-TREATMENT
0.5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

7.	CD	O	O
cholecalciferol	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
vitamin	JJ	I-TREATMENT	I-TREATMENT
d3	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
400	CD	O	O
unit	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

8.	CD	O	O
pantoprazole	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
q24h	NN	O	O
(	(	O	O
every	DT	O	O
24	CD	O	O
hours	NNS	O	O
).	VBP	O	O

9.	CD	O	O
docusate	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
50	CD	O	O
mg	NN	O	O
/	VBD	O	O
5	CD	O	O
ml	NN	O	O
liquid	NN	O	O
sig	NN	O	O
:	:	O	O
ten	NN	O	O
(	(	O	O
10	CD	O	O
)	)	O	O
ml	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

10.	CD	O	O
hexavitamin	JJ	B-TREATMENT	O
tablet	NN	I-TREATMENT	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
cap	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

11.	CD	O	O
dicyclomine	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

12.	CD	O	O
atorvastatin	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

15.	CD	O	O
bisacodyl	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

16.	CD	O	O
acetaminophen	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
tablets	NNS	O	O
po	JJ	O	O
q4-6h	JJ	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
to	TO	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

17.	CD	O	O
ibuprofen	JJ	B-TREATMENT	B-TREATMENT
600	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q8h	NN	O	O
(	(	O	O
every	DT	O	O
8	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

18.	CD	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	JJ	I-TREATMENT	I-TREATMENT
insulin	NN	B-TREATMENT	I-TREATMENT
sc	NN	I-TREATMENT	I-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	JJ	I-TREATMENT	I-TREATMENT
q6h	NN	B-TREATMENT	I-TREATMENT
regular	JJ	I-TREATMENT	I-TREATMENT
glucose	JJ	I-TREATMENT	I-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
dose	VBD	I-TREATMENT	O
0-60	JJ	O	O
mg	NN	O	O
/	NNP	O	O
dl	VBZ	O	O
01-20	JJ	O	O
amp	JJ	O	O
d50	NN	O	O
61-120	JJ	O	O
mg	NN	O	O
/	NNP	O	O
dl	VBZ	O	O
0	CD	O	O
units	NNS	O	O
121-140	JJ	O	O
mg	NN	O	O
/	NNP	O	O
dl	VBZ	O	O
3	CD	O	O
units	NNS	O	O
141-160	JJ	O	O
mg/dl	JJ	O	O
5	CD	O	O
units	NNS	O	O
161-180	JJ	O	O
mg/dl	NN	O	O
7	CD	O	O

19.	CD	O	O
lantus	JJ	B-TREATMENT	O
30	CD	O	O
units	NNS	O	O
lantus	JJ	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
breakfast	NN	O	O

1.	CD	O	O
tramadol	JJ	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

2.	CD	O	O
senna	JJ	B-TREATMENT	B-TREATMENT
8.6	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

3.	CD	O	O
nortriptyline	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

4.	CD	O	O
atenolol	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

5.	CD	O	O
buspirone	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

6.	CD	O	O
clonazepam	NN	B-TREATMENT	B-TREATMENT
0.5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

7.	CD	O	O
cholecalciferol	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
vitamin	JJ	I-TREATMENT	I-TREATMENT
d3	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
400	CD	O	O
unit	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

8.	CD	O	O
pantoprazole	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
q24h	NN	O	O
(	(	O	O
every	DT	O	O
24	CD	O	O
hours	NNS	O	O
).	VBP	O	O

9.	CD	O	O
docusate	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
50	CD	O	O
mg	NN	O	O
/	VBD	O	O
5	CD	O	O
ml	NN	O	O
liquid	NN	O	O
sig	NN	O	O
:	:	O	O
ten	NN	O	O
(	(	O	O
10	CD	O	O
)	)	O	O
ml	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

10.	CD	O	O
hexavitamin	JJ	B-TREATMENT	O
tablet	NN	I-TREATMENT	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
cap	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

11.	CD	O	O
dicyclomine	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

12.	CD	O	O
atorvastatin	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	JJ	O	O
daily	JJ	O	O
(	(	O	O
daily	JJ	O	O
).	NN	O	O

13.	CD	O	O
amoxicillin-pot	JJ	B-TREATMENT	B-TREATMENT
clavulanate	NN	I-TREATMENT	I-TREATMENT
875-125	JJ	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
for	IN	O	O
4	CD	O	O
days	NNS	O	O
.	.	O	O

14.	CD	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
porcine	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
5,000	CD	O	O
unit	NN	O	O
/	NNP	O	O
ml	NN	O	O
solution	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
injection	NN	O	O
injection	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

15.	CD	O	O
bisacodyl	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
two	CD	O	O
(	(	O	O
2	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

16.	CD	O	O
acetaminophen	JJ	B-TREATMENT	B-TREATMENT
325	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
1-2	JJ	O	O
tablets	NNS	O	O
po	JJ	O	O
q4-6h	JJ	O	O
(	(	O	O
every	DT	O	O
4	CD	O	O
to	TO	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

17.	CD	O	O
ibuprofen	JJ	B-TREATMENT	B-TREATMENT
600	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q8h	NN	O	O
(	(	O	O
every	DT	O	O
8	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

18.	CD	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT

insulin	NN	B-TREATMENT	B-TREATMENT
sc	NN	I-TREATMENT	I-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT

glucose	JJ	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
dose	NN	I-TREATMENT	I-TREATMENT

30	CD	O	O
units	NNS	O	O
lantus	JJ	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
breakfast	NN	O	O

acute	NN	B-PROBLEM	B-PROBLEM
cholecystitis	NN	I-PROBLEM	I-PROBLEM

gangrenous	JJ	B-PROBLEM	B-PROBLEM
cholecystitis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
perforation	NN	B-PROBLEM	B-PROBLEM

please	VB	O	O
call	VB	O	O
your	PRP$	O	O
surgeon	NN	O	O
if	IN	O	O
you	PRP	O	O
develop	VBP	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
fever	RB	B-PROBLEM	B-PROBLEM
greater	JJR	O	O
than	IN	O	O
101.5	CD	O	O
,	,	O	O
foul	JJ	B-PROBLEM	B-PROBLEM
smelling	NN	I-PROBLEM	I-PROBLEM
or	CC	I-PROBLEM	O
colorful	JJ	I-PROBLEM	B-PROBLEM
drainage	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
your	PRP$	B-PROBLEM	B-PROBLEM
incisions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
redness	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
swelling	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
distention	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
persistent	JJ	B-PROBLEM	B-PROBLEM
nausea	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
inability	NN	B-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
eat	VB	I-PROBLEM	I-PROBLEM
or	CC	I-PROBLEM	I-PROBLEM
drink	VB	I-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
any	DT	B-PROBLEM	B-PROBLEM
other	JJ	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
which	WDT	O	O
are	VBP	O	O
concerning	VBG	O	O
to	TO	O	O
you	PRP	O	O
.	.	O	O

if	IN	O	O
there	EX	O	O
is	VBZ	O	O
clear	JJ	B-PROBLEM	O
drainage	NN	I-PROBLEM	O
from	IN	O	O
your	PRP$	B-PROBLEM	B-PROBLEM
incisions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
cover	NN	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
dry	JJ	I-TREATMENT	I-TREATMENT
dressing	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

leave	VB	O	O
white	JJ	B-TREATMENT	B-TREATMENT
strips	NNS	I-TREATMENT	I-TREATMENT
above	IN	O	O
your	PRP$	B-PROBLEM	B-PROBLEM
incisions	NNS	I-PROBLEM	I-PROBLEM
in	IN	O	O
place	NN	O	O
,	,	O	O
allow	VB	O	O
them	PRP	O	O
to	TO	O	O
fall	VB	O	O
off	RP	O	O
on	IN	O	O
their	PRP$	O	O
own	JJ	O	O
.	.	O	O

medications	NNS	O	B-TREATMENT
:	:	O	O
resume	VB	O	O
your	PRP$	B-TREATMENT	B-TREATMENT
home	NN	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

you	PRP	O	O
should	MD	O	O
take	VB	O	O
a	DT	B-TREATMENT	B-TREATMENT
stool	NN	I-TREATMENT	I-TREATMENT
softener	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
twice	RB	O	O
daily	RB	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
constipation	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

you	PRP	O	O
will	MD	O	O
be	VB	O	O
given	VBN	O	O
pain	JJ	B-TREATMENT	B-TREATMENT
medication	NN	I-TREATMENT	I-TREATMENT
which	WDT	O	O
may	MD	O	O
make	VB	O	O
you	PRP	O	O
drowsy	VB	B-PROBLEM	O
.	.	O	O

no	DT	O	O
driving	VBG	O	O
while	IN	O	O
taking	VBG	O	O
pain	JJ	B-TREATMENT	B-TREATMENT
medicine	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

you	PRP	O	O
will	MD	O	O
be	VB	O	O
contacted	VBN	O	O
by	IN	O	O
the	DT	O	O
gastrointestinal	JJ	O	O
doctors	NNS	O	O
pat	VBP	O	O
barrow	VB	O	O
the	DT	B-TREATMENT	O
removal	NN	I-TREATMENT	O
of	IN	O	O
your	PRP$	B-TREATMENT	B-TREATMENT
biliary	JJ	I-TREATMENT	I-TREATMENT
stent	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
6	CD	O	O
weeks	NNS	O	O
.	.	O	O

ruptured	VBN	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
aneurism	NN	I-PROBLEM	I-PROBLEM

ruptured	VBN	B-PROBLEM	B-PROBLEM
parathyroid	JJ	I-PROBLEM	I-PROBLEM
adenoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
arrived	VBD	O	O
intubated	JJ	B-TREATMENT	B-TREATMENT
and	CC	O	O
was	VBD	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
despite	IN	O	O
concerns	NNS	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
dissecting	JJ	I-PROBLEM	I-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
arch	NN	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
initially	RB	O	O
presented	VBD	O	O
to	TO	O	O
brottlake	VB	O	O
medical	JJ	O	O
center	NN	O	O
on	IN	O	O
9/15/00	CD	O	O
complaining	NN	O	O
of	IN	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
onset	NN	I-PROBLEM	I-PROBLEM
dysphasia	NN	I-PROBLEM	I-PROBLEM
to	TO	O	I-PROBLEM
liquids	NNS	O	I-PROBLEM
and	CC	O	O
solids	NNS	O	O
.	.	O	O

while	IN	O	O
she	PRP	O	O
was	VBD	O	O
in	IN	O	O
brottlake	JJ	O	O
medical	JJ	O	O
center	NN	O	O
,	,	O	O
she	PRP	O	O
developed	VBD	O	O
new	JJ	B-PROBLEM	B-PROBLEM
onset	NN	I-PROBLEM	I-PROBLEM
stridor	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
an	DT	O	O
ent	NN	O	O
consult	NN	O	O
was	VBD	O	O
obtained	VBN	O	O
.	.	O	O

they	PRP	O	O
attempted	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
fiberoptic	JJ	I-TREATMENT	I-TREATMENT
intubation	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
#	#	I-TREATMENT	I-TREATMENT
6	CD	I-TREATMENT	I-TREATMENT
endotracheal	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
found	VBD	O	O
a	DT	B-PROBLEM	O
5	CD	I-PROBLEM	O
mm	NN	I-PROBLEM	O
severely	RB	I-PROBLEM	O
compressed	VBD	I-PROBLEM	O
airway	RB	I-PROBLEM	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
also	RB	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-TEST
differential	JJ	I-PROBLEM	I-TEST
systolic	JJ	I-PROBLEM	I-TEST
blood	NN	I-PROBLEM	I-TEST
pressure	NN	I-PROBLEM	I-TEST
and	CC	O	O
ecchymosis	NN	B-PROBLEM	B-PROBLEM
on	IN	I-PROBLEM	O
her	PRP$	I-PROBLEM	B-TREATMENT
anterior	JJ	I-PROBLEM	I-TREATMENT
chest	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

given	VBN	O	O
these	DT	O	O
findings	NNS	O	O
,	,	O	O
she	PRP	O	O
underwent	VBD	O	O
a	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
retrotracheal	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
appeared	VBD	O	O
to	TO	O	O
obliterate	VB	O	O
the	DT	O	O
esophagus	NN	O	O
.	.	O	O

this	DT	O	O
raised	VBD	O	O
concerns	NNS	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
verg	VB	O	O
medical	JJ	O	O
center	NN	O	O
emergently	RB	O	O
.	.	O	O

at	IN	O	O
the	DT	O	O
ingree	NN	O	O
and	CC	O	O
ot	NN	O	O
of	IN	O	O
weamanshy	JJ	O	O
medical	JJ	O	O
center	NN	O	O
,	,	O	O
she	PRP	O	O
underwent	VBD	O	O
an	DT	B-TEST	B-TEST
emergent	JJ	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
with	IN	O	I-TEST
iv	JJ	B-TEST	I-TEST
contrast	NN	I-TEST	I-TEST
.	.	O	O

this	DT	O	O
revealed	VBD	O	O
no	DT	O	O
extravasation	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
contrast	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
no	DT	O	O
aortic	JJ	B-PROBLEM	B-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

however	RB	O	O
,	,	O	O
it	PRP	O	O
did	VBD	O	O
show	VB	O	O
an	DT	B-PROBLEM	B-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
mediastinal	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
compressing	VBG	O	I-PROBLEM
the	DT	O	I-PROBLEM
trachea	NN	O	I-PROBLEM
with	IN	O	O
a	DT	O	B-PROBLEM
density	NN	O	I-PROBLEM
consistent	NN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
hematoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

severe	JJ	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
angina	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
gerd	NN	B-PROBLEM	O
,	,	O	O
peptic	JJ	B-PROBLEM	B-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
billroth	DT	B-TREATMENT	O
ii	NN	I-TREATMENT	O
,	,	O	O
ovarian	JJ	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
tah-bso	NN	B-TREATMENT	O
in	IN	O	O
1987	CD	O	O
with	IN	O	O
a	DT	O	O
negative	JJ	O	O
second	JJ	O	O
look	NN	O	O
laparotomy	NN	O	B-TREATMENT
in	IN	O	O
1988	CD	O	O
,	,	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
ear	JJ	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

celexa	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.;	NN	O	O
lasix	VBD	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.;	NN	O	O
capoten	VBD	B-TREATMENT	O
50	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.;	NN	O	O
pepcid	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.;	NN	O	O
cardizem	VBD	B-TREATMENT	O
180	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.;	NN	O	O
xanax	VBD	B-TREATMENT	O
0.5	CD	O	O
mg	NN	O	O
tabs	NN	O	O
.	.	O	O

on	IN	O	O
transfer	NN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
on	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
preadmission	NN	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
plus	CC	O	O
unasyn	JJ	B-TREATMENT	B-TREATMENT
and	CC	O	O
tigan	JJ	B-TREATMENT	O
250	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.6h.	NN	O	O
p.r.n.	NN	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
intubated	VBN	B-TREATMENT	O
.	.	O	O

temperature	NN	B-TEST	B-TEST
98.6	CD	O	O
,	,	O	O
66	CD	O	O
.	.	O	O

right	JJ	B-TEST	O
arm	NN	I-TEST	O
was	VBD	O	O
180/80	CD	O	O
,	,	O	O
left	VBD	B-TEST	O
188/72	CD	O	O
,	,	O	O
and	CC	O	O
a-line	NN	B-TEST	B-TREATMENT
was	VBD	O	O
151/61	CD	O	O
.	.	O	O

tidal	JJ	B-TREATMENT	B-TEST
volume	NN	I-TREATMENT	I-TEST
is	VBZ	O	O
700	CD	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-TEST
rate	NN	I-TREATMENT	I-TEST
of	IN	O	O
10	CD	O	O
,	,	O	O
10	CD	O	O
of	IN	O	O
pressure	NN	B-TREATMENT	B-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
10	CD	O	O
of	IN	O	O
peep	NN	B-TREATMENT	O
,	,	O	O
and	CC	O	O
100%	CD	B-TREATMENT	O
fio2	NN	I-TREATMENT	O
,	,	O	O
satting	VBG	O	B-TEST
100%	CD	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
sedated	VBN	B-TREATMENT	O
and	CC	O	O
spontaneously	RB	O	O
moving	VBG	O	O
all	DT	O	O
four	CD	O	O
extremities	NNS	O	O
.	.	O	O

edematous	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
crepitus	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
neck	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	B-TEST
superior	JJ	O	I-TEST
clavicular	JJ	O	I-TEST
area	NN	O	I-TEST
showed	VBD	O	O
no	DT	O	O
signs	NNS	O	O
of	IN	O	O
central	JJ	B-TREATMENT	B-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
access	NN	I-TREATMENT	O
attempts	NNS	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
3	CD	I-PROBLEM	I-PROBLEM
cm	NN	I-PROBLEM	I-PROBLEM
mobile	RB	I-PROBLEM	I-PROBLEM
gelatinous	JJ	I-PROBLEM	I-PROBLEM
well-circumscribed	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
supraclavicular	JJ	I-PROBLEM	I-PROBLEM
region	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	O	B-PROBLEM
anterior	JJ	O	I-PROBLEM
neck	NN	O	I-PROBLEM
and	CC	O	O
chest	NN	O	O
had	VBD	O	O
a	DT	B-PROBLEM	O
1	CD	I-PROBLEM	O
cm	NN	I-PROBLEM	O
to	TO	I-PROBLEM	O
2	CD	I-PROBLEM	O
cm	JJ	I-PROBLEM	O
area	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
ecchymosis	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
expiratory	NN	I-PROBLEM	I-PROBLEM
wheezes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

it	PRP	O	O
was	VBD	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

it	PRP	O	O
was	VBD	O	O
obese	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
midline	NN	I-PROBLEM	I-PROBLEM
defect	NN	I-PROBLEM	I-PROBLEM
consistent	NN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
ventral	JJ	I-PROBLEM	I-PROBLEM
hernia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
smaller	JJR	I-PROBLEM	I-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
defect	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
lower	RBR	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
the	DT	O	O
right	JJ	O	O
side	NN	O	O
,	,	O	O
2+	CD	B-TEST	O
femoral	JJ	I-TEST	O
,	,	O	O
popliteal	JJ	B-TEST	O
,	,	O	O
dp	NN	B-TEST	O
,	,	O	O
pt	NN	B-TEST	O
,	,	O	O
and	CC	O	O
radial	JJ	B-TEST	O
;	:	O	O
on	IN	O	O
the	DT	O	O
left	JJ	O	O
side	NN	O	O
,	,	O	O
2+	CD	B-TEST	O
femoral	JJ	I-TEST	O
,	,	O	O
popliteal	JJ	B-TEST	O
,	,	O	O
dp	NN	B-TEST	O
,	,	O	O
pt	NN	B-TEST	O
,	,	O	O
and	CC	O	O
radial	NN	B-TEST	O
.	.	O	O

cbc	NN	B-TEST	B-TEST
was	VBD	O	O
8.7	CD	O	O
,	,	O	O
25.3	CD	O	O
,	,	O	O
and	CC	O	O
184	CD	O	O
.	.	O	O

coags	NNS	B-TEST	B-TEST
12.2	CD	O	O
,	,	O	O
24.8	CD	O	O
,	,	O	O
and	CC	O	O
1.0	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
gas	NN	I-TEST	I-TEST
was	VBD	O	O
7.47/40/332	CD	O	O
.	.	O	O

electrolytes	NNS	B-TEST	B-TEST
were	VBD	O	O
143	CD	O	O
,	,	O	O
3.4	CD	O	O
,	,	O	O
105	CD	O	O
,	,	O	O
28	CD	O	O
,	,	O	O
24	CD	O	O
,	,	O	O
3	CD	O	O
,	,	O	O
and	CC	O	O
131	CD	O	O
.	.	O	O

ekg	RB	B-TEST	O
showed	VBD	O	O
normal	JJ	O	O
sinus	NNS	O	O
rhythm	VBP	O	O
with	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
ventricular	JJ	I-PROBLEM	I-PROBLEM
hypertrophy	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
incomplete	JJ	B-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
bundle	JJ	I-PROBLEM	I-PROBLEM
branch	NN	I-PROBLEM	I-PROBLEM
block	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

ct	NN	B-TEST	B-TEST
scan	NN	I-TEST	I-TEST
showed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
mediastinal	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
compressing	VBG	O	I-PROBLEM
the	DT	O	I-PROBLEM
trachea	NN	O	I-PROBLEM
with	IN	O	O
air	NN	O	O
.	.	O	O

it	PRP	O	O
was	VBD	O	O
consistent	JJ	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
hematoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

ms.	NN	O	O
shuffa	NN	O	O
underwent	VBD	O	O
an	DT	B-TEST	B-TEST
egd	NN	I-TEST	I-TEST
and	CC	O	I-TEST
flexible	JJ	B-TEST	I-TEST
bronchoscopy	NN	I-TEST	I-TEST
on	IN	O	O
9/16/00	CD	O	O
shortly	RB	O	O
after	IN	O	O
she	PRP	O	O
arrived	VBD	O	O
.	.	O	O

this	DT	O	O
showed	VBD	O	O
tracheal	JJ	B-PROBLEM	B-TEST
compressions	NNS	I-PROBLEM	I-TEST
but	CC	O	O
no	DT	O	O
other	JJ	B-PROBLEM	B-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
that	WDT	O	O
were	VBD	O	O
obvious	JJ	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
and	CC	O	O
remained	VBD	O	O
on	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
ventilator	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	B-TEST
differential	JJ	O	I-TEST
diagnoses	NNS	O	I-TEST
at	IN	O	O
this	DT	O	O
point	NN	O	O
consisted	VBD	O	O
of	IN	O	O
hematoma	NN	B-PROBLEM	B-PROBLEM
vs.	FW	O	O
neoplasm	NN	B-PROBLEM	B-PROBLEM
vs.	FW	O	O
an	DT	B-PROBLEM	B-PROBLEM
abscess	NN	I-PROBLEM	I-PROBLEM
vs.	FW	O	O
a	DT	B-PROBLEM	B-PROBLEM
thyroid	JJ	I-PROBLEM	I-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
9/22/00	CD	O	O
,	,	O	O
she	PRP	O	O
underwent	VBD	O	O
a	DT	B-TEST	B-TEST
cervical	JJ	I-TEST	I-TEST
mediastinoscopy	NN	I-TEST	I-TEST
.	.	O	O

a	DT	B-TEST	B-TEST
biopsy	NN	I-TEST	I-TEST
of	IN	O	O
this	DT	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
consistent	JJ	O	O
with	IN	O	O
hematoma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
operative	JJ	O	O
report	NN	O	O
shows	VBZ	O	O
that	IN	O	O
there	EX	O	O
was	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
abnormal	JJ	I-PROBLEM	I-PROBLEM
area	NN	I-PROBLEM	I-PROBLEM
below	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
trachea	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
the	DT	O	O
left	NN	O	O
which	WDT	O	O
represented	VBD	O	O
a	DT	O	B-PROBLEM
cavity	NN	O	I-PROBLEM
between	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
esophagus	NN	O	I-PROBLEM
,	,	O	O
trachea	NN	O	B-PROBLEM
,	,	O	O
aorta	NN	O	O
,	,	O	O
and	CC	O	O
spine	NN	O	O
that	WDT	O	O
was	VBD	O	O
full	JJ	O	O
of	IN	O	O
clot	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
active	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
the	DT	O	O
time	NN	O	O
.	.	O	O

over	IN	O	O
the	DT	O	O
next	JJ	O	O
several	JJ	O	O
days	NNS	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
on	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
ventilator	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
elevated	JJ	I-PROBLEM	I-PROBLEM
calcium	NN	I-PROBLEM	I-PROBLEM
level	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
raised	VBD	O	O
the	DT	O	O
suspicion	NN	O	O
that	IN	O	O
this	DT	B-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
could	MD	O	O
be	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
hematoma	NN	I-PROBLEM	I-PROBLEM
coming	VBG	O	O
from	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
ruptured	VBN	I-PROBLEM	I-PROBLEM
parathyroid	NN	I-PROBLEM	I-PROBLEM
adenoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
ionized	JJ	I-TEST	I-TEST
calcium	NN	I-TEST	I-TEST
was	VBD	O	O
elevated	VBN	B-PROBLEM	O
as	IN	O	O
was	VBD	O	O
the	DT	B-TEST	O
parathormone	NN	I-TEST	O
level	NN	I-TEST	O
.	.	O	O

given	VBN	O	O
these	DT	O	O
findings	NNS	O	O
,	,	O	O
she	PRP	O	O
underwent	VBD	O	O
a	DT	B-TEST	B-TEST
sestamibi	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
.	.	O	O

the	DT	B-TEST	B-TEST
sestamibi	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
showed	VBD	O	O
findings	NNS	O	O
that	WDT	O	O
were	VBD	O	O
consistent	JJ	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
parathyroid	JJ	I-PROBLEM	I-PROBLEM
adenoma	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
thyroid	NN	O	I-PROBLEM
.	.	O	O

at	IN	O	O
this	DT	O	O
time	NN	O	O
,	,	O	O
it	PRP	O	O
was	VBD	O	O
believed	VBN	O	O
that	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
clot	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
due	JJ	O	O
to	TO	O	O
a	DT	B-PROBLEM	B-PROBLEM
rupture	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
this	DT	B-PROBLEM	I-PROBLEM
parathyroid	JJ	I-PROBLEM	I-PROBLEM
adenoma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
underwent	VBD	O	O
a	DT	B-TEST	B-TEST
parathyroid	JJ	I-TEST	I-TEST
exploration	NN	I-TEST	I-TEST
with	IN	O	O
resection	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
ruptured	JJ	I-PROBLEM	I-PROBLEM
ectopic	NN	I-PROBLEM	I-PROBLEM
right	RB	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
parathyroid	NN	I-PROBLEM	I-PROBLEM
adenoma	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
a	DT	B-TEST	B-TEST
biopsy	NN	I-TEST	I-TEST
of	IN	I-TEST	O
a	DT	I-TEST	O
normal	JJ	I-TEST	O
left	NN	I-TEST	O
and	CC	I-TEST	O
right	JJ	I-TEST	B-PROBLEM
lower	JJR	I-TEST	I-PROBLEM
parathyroids	NNS	I-TEST	I-PROBLEM
,	,	O	O
resection	NN	B-TREATMENT	B-TREATMENT
of	IN	I-TREATMENT	O
a	DT	I-TREATMENT	B-PROBLEM
left	JJ	I-TREATMENT	I-PROBLEM
upper	JJ	I-TREATMENT	I-PROBLEM
parathyroid	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
and	CC	O	O
tracheostomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
and	CC	O	O
was	VBD	O	O
transferred	VBN	O	O
back	RB	O	O
to	TO	O	O
the	DT	O	O
surgical	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
with	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
new	JJ	I-TREATMENT	I-TREATMENT
tracheostomy	NN	I-TREATMENT	I-TREATMENT
working	VBG	O	O
well	RB	O	O
.	.	O	O

her	PRP$	O	O
postoperative	JJ	O	O
course	NN	O	O
was	VBD	O	O
complicated	VBN	O	O
by	IN	O	O
serosanguineous	JJ	B-PROBLEM	B-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
required	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
continued	VBD	O	O
to	TO	O	O
drop	VB	O	O
over	IN	O	O
the	DT	O	O
next	JJ	O	O
couple	NN	O	O
of	IN	O	O
days	NNS	O	O
despite	IN	O	O
normal	JJ	O	O
platelet	NN	O	O
count	NN	O	O
,	,	O	O
normal	JJ	O	O
coags	NNS	O	O
,	,	O	O
and	CC	O	O
no	DT	O	O
obvious	JJ	O	B-PROBLEM
source	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
bleeding	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

it	PRP	O	O
was	VBD	O	O
believed	VBN	O	O
that	IN	O	O
she	PRP	O	O
was	VBD	O	O
continuing	VBG	O	B-PROBLEM
to	TO	O	I-PROBLEM
bleed	VB	B-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
underwent	VBD	O	O
an	DT	B-TEST	B-TEST
extensive	JJ	I-TEST	I-TEST
workup	NN	I-TEST	I-TEST
by	IN	O	O
hematology	NN	O	O
that	WDT	O	O
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
diatheses	NNS	I-PROBLEM	I-PROBLEM
of	IN	O	O
unknown	JJ	O	O
etiology	NN	O	O
.	.	O	O

it	PRP	O	O
turns	VBZ	O	O
out	RP	O	O
that	IN	O	O
several	JJ	O	O
people	NNS	O	O
in	IN	O	O
her	PRP$	O	O
family	NN	O	O
have	VBP	O	O
a	DT	B-PROBLEM	B-PROBLEM
similar	JJ	I-PROBLEM	I-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
diathesis	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
unknown	JJ	O	O
etiology	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
became	VBD	O	O
intermittently	RB	B-PROBLEM	B-PROBLEM
agitated	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

we	PRP	O	O
have	VBP	O	O
been	VBN	O	O
giving	VBG	O	O
her	PRP$	B-TREATMENT	O
haldol	NN	I-TREATMENT	O
at	IN	O	O
bedtime	NN	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
ativan	NN	B-TREATMENT	B-TREATMENT
p.r.n.	NN	O	O
throughout	IN	O	O
the	DT	O	O
day	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
&apos;s	NNP	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
has	VBZ	O	O
been	VBN	O	O
ranging	VBG	O	O
from	IN	O	O
approximately	RB	O	O
140	CD	O	O
to	TO	O	O
160	CD	O	O
systolic	NN	O	B-TEST
.	.	O	O

this	DT	O	O
is	VBZ	O	O
on	IN	O	O
a	DT	O	B-TREATMENT
current	JJ	O	I-TREATMENT
regimen	NN	O	I-TREATMENT
of	IN	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
per	IN	O	O
ng	FW	B-TREATMENT	O
tube	NN	I-TREATMENT	O
t.i.d.	NN	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
diltiazem	NN	B-TREATMENT	B-TREATMENT
60	CD	O	O
mg	NN	O	O
per	IN	O	O
ng	FW	B-TREATMENT	O
tube	NN	I-TREATMENT	O
t.i.d.	NN	O	O
,	,	O	O
and	CC	O	O
lisinopril	VBZ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
per	IN	O	O
ng	FW	B-TREATMENT	O
tube	NN	I-TREATMENT	O
q.d.	IN	O	O
she	PRP	O	O
occasionally	RB	O	O
gets	VBZ	O	O
hypertensive	JJ	B-PROBLEM	B-PROBLEM
when	WRB	O	O
she	PRP	O	O
is	VBZ	O	O
agitated	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

for	IN	O	O
this	DT	O	O
,	,	O	O
we	PRP	O	O
have	VBP	O	O
given	VBN	O	O
her	PRP$	O	B-TREATMENT
10	CD	O	O
mg	NN	O	O
of	IN	O	O
hydralazine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

her	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
responds	VBZ	O	I-TEST
well	RB	O	O
to	TO	O	O
this	DT	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
developed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
femoral	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
pseudoaneurysm	NN	I-PROBLEM	I-PROBLEM
after	IN	O	O
placement	NN	B-TREATMENT	O
of	IN	I-TREATMENT	O
a	DT	I-TREATMENT	O
greenfield	NN	I-TREATMENT	O
filter	NN	I-TREATMENT	O
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
is	VBZ	O	O
approximately	RB	O	O
2.5	CD	O	O
cm	NNS	O	O
.	.	O	O

they	PRP	O	O
elected	VBD	O	O
not	RB	O	O
to	TO	O	O
inject	VB	O	O
it	PRP	O	O
with	IN	O	O
thrombin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

they	PRP	O	O
asked	VBD	O	O
that	IN	O	O
the	DT	O	O
patient	JJ	O	O
follow-up	NN	O	O
with	IN	O	O
dr.	JJ	O	O
ear	NN	O	O
in	IN	O	O
approximately	RB	O	O
three	CD	O	O
to	TO	O	O
four	CD	O	O
weeks	NNS	O	O
so	RB	O	O
that	IN	O	O
this	DT	B-PROBLEM	B-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
can	MD	O	O
be	VB	O	O
assessed	VBN	O	O
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
on	IN	O	O
cpap	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
a	DT	B-TREATMENT	O
peep	NN	I-TREATMENT	O
of	IN	O	O
7.5	CD	O	O
and	CC	O	O
a	DT	B-TREATMENT	B-TREATMENT
pressure	NN	I-TREATMENT	I-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
9	CD	O	O
.	.	O	O

she	PRP	O	O
seems	VBZ	O	O
to	TO	O	O
be	VB	O	O
tolerating	VBG	O	O
this	DT	O	O
well	NN	O	O
as	IN	O	O
she	PRP	O	O
has	VBZ	O	O
an	DT	B-TEST	B-TEST
o2	JJ	I-TEST	I-TEST
sat	NN	I-TEST	I-TEST
of	IN	O	O
100%	CD	O	O
on	IN	O	O
40%	CD	B-TREATMENT	O
fio2	NN	I-TREATMENT	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
shows	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
hematoma	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
had	VBD	O	O
greatly	RB	O	O
improved	VBN	O	O
in	IN	O	O
the	DT	O	O
last	JJ	O	O
few	JJ	O	O
days	NNS	O	O
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
tracheostomy	NN	I-TREATMENT	I-TREATMENT
is	VBZ	O	O
functioning	VBG	O	O
well	RB	O	O
,	,	O	O
and	CC	O	O
we	PRP	O	O
have	VBP	O	O
had	VBD	O	O
no	DT	O	O
problems	NNS	B-PROBLEM	B-PROBLEM
with	IN	O	O
it	PRP	O	O
.	.	O	O

we	PRP	O	O
had	VBD	O	O
her	PRP	O	O
down	RP	O	O
to	TO	O	O
a	DT	B-TREATMENT	B-TREATMENT
low	JJ	I-TREATMENT	I-TREATMENT
pressure	NN	I-TREATMENT	I-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
7	CD	O	O
in	IN	O	O
the	DT	O	O
last	JJ	O	O
week	NN	O	O
.	.	O	O

with	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
pressure	NN	I-TREATMENT	I-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
7	CD	O	O
,	,	O	O
she	PRP	O	O
became	VBD	O	O
tachypneic	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
had	VBD	O	O
to	TO	O	O
be	VB	O	O
brought	VBN	O	O
back	RB	O	O
up	IN	O	O
to	TO	O	O
10	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
oxygen	NN	I-TEST	I-TEST
saturation	NN	I-TEST	I-TEST
has	VBZ	O	O
always	RB	O	O
been	VBN	O	O
good	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
getting	VBG	O	O
tube	JJ	B-TREATMENT	B-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
via	IN	O	O
her	PRP$	B-TREATMENT	B-TEST
ng	JJ	I-TREATMENT	I-TEST
tube	NN	I-TREATMENT	I-TEST
of	IN	O	I-TEST
full	JJ	B-TREATMENT	I-TEST
strength	NN	I-TREATMENT	I-TEST
jevity	NN	I-TREATMENT	I-TEST
of	IN	O	O
75	CD	O	O
cc	NNS	O	O
per	IN	O	O
hour	NN	O	O
.	.	O	O

last	JJ	O	O
week	NN	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
copious	JJ	B-PROBLEM	B-PROBLEM
amounts	NNS	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
stool	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
range	NN	O	O
of	IN	O	O
500	CD	O	O
cc	NN	O	O
to	TO	O	O
1000	CD	O	O
cc	NN	O	O
of	IN	O	O
liquid	JJ	O	B-TREATMENT
stool	NN	O	I-TREATMENT
per	IN	O	O
day	NN	O	O
.	.	O	O

stool	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
have	VBP	O	O
been	VBN	O	O
sent	VBN	O	O
numerous	JJ	O	O
times	NNS	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
analysis	NN	B-TEST	O
for	IN	O	O
c.	NN	B-PROBLEM	B-PROBLEM
difficile	NN	I-PROBLEM	I-PROBLEM
toxin	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

we	PRP	O	O
believe	VBP	O	O
the	DT	O	O
this	DT	O	O
was	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
osmotic	JJ	I-PROBLEM	I-PROBLEM
diarrhea	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

since	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
have	VBP	O	O
been	VBN	O	O
changed	VBN	O	O
from	IN	O	O
full	JJ	B-TREATMENT	O
strength	NN	I-TREATMENT	O
nephro	NN	I-TREATMENT	O
to	TO	O	O
jevity	NN	B-TREATMENT	O
,	,	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
diarrhea	NN	I-PROBLEM	I-PROBLEM
has	VBZ	O	O
resolved	VBN	O	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
taking	VBG	O	O
zantac	NN	B-TREATMENT	O
,	,	O	O
and	CC	O	O
the	DT	B-TEST	O
ph	NN	I-TEST	O
of	IN	I-TEST	O
her	PRP$	I-TEST	B-TREATMENT
ng	JJ	I-TEST	I-TREATMENT
tube	NN	I-TEST	I-TREATMENT
residuals	NNS	I-TEST	I-TREATMENT
have	VBP	O	O
been	VBN	O	O
in	IN	O	O
the	DT	O	O
5	CD	O	O
to	TO	O	O
8	CD	O	O
range	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
had	VBN	O	O
hypernatremia	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

we	PRP	O	O
believe	VBP	O	O
her	PRP	O	O
to	TO	O	O
still	RB	O	O
be	VB	O	O
total	JJ	B-PROBLEM	B-PROBLEM
body	NN	I-PROBLEM	I-PROBLEM
overloaded	VBD	I-PROBLEM	I-PROBLEM
.	.	O	O

over	IN	O	O
the	DT	O	O
last	JJ	O	O
several	JJ	O	O
days	NNS	O	O
,	,	O	O
we	PRP	O	O
have	VBP	O	O
been	VBN	O	O
giving	VBG	O	O
her	PRP$	O	O
approximately	RB	O	O
500	CD	O	O
cc	NNS	O	O
to	TO	O	O
1000	CD	O	O
cc	NN	O	O
of	IN	O	O
free	JJ	B-TREATMENT	O
water	NN	I-TREATMENT	O
through	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
ng	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

we	PRP	O	O
also	RB	O	O
have	VBP	O	O
been	VBN	O	O
diuresing	VBG	O	O
her	PRP$	O	O
with	IN	O	O
bumex	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

this	DT	O	O
seems	VBZ	O	O
to	TO	O	O
trend	NN	O	O
her	PRP$	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
down	RP	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
bun	NN	I-TEST	I-TEST
and	CC	O	O
creatinine	NN	B-TEST	B-TEST
have	VBP	O	O
been	VBN	O	O
normal	JJ	O	O
,	,	O	O
and	CC	O	O
she	PRP	O	O
has	VBZ	O	O
always	RB	O	O
made	VBN	O	O
good	JJ	O	O
urine	NN	O	O
.	.	O	O

as	IN	O	O
stated	VBN	O	O
before	IN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
continued	VBD	O	O
to	TO	O	O
ooze	VB	O	O
into	IN	O	O
her	PRP$	O	O
pleural	JJ	O	O
space	NN	O	O
well	RB	O	O
after	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
definitive	JJ	I-TREATMENT	I-TREATMENT
operation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
an	DT	B-TEST	B-TEST
extensive	JJ	I-TEST	I-TEST
workup	NN	I-TEST	I-TEST
by	IN	O	O
hematology	NN	O	O
which	WDT	O	O
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
bleeding	JJ	I-PROBLEM	I-PROBLEM
diathesis	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
unknown	JJ	O	O
origin	NN	O	O
.	.	O	O

before	IN	O	O
we	PRP	O	O
removed	VBD	O	O
her	PRP	B-TREATMENT	B-TREATMENT
chest	JJS	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
we	PRP	O	O
had	VBD	O	O
to	TO	O	O
give	VB	O	O
her	PRP$	B-TREATMENT	O
platelets	NNS	I-TREATMENT	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
no	DT	O	O
problems	NNS	B-PROBLEM	B-PROBLEM
with	IN	O	O
this	DT	O	O
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
,	,	O	O
her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
is	VBZ	O	O
stable	JJ	O	O
in	IN	O	O
the	DT	O	O
28	CD	O	O
to	TO	O	O
33	CD	O	O
range	NN	O	O
.	.	O	O

i	NN	O	O
stress	NN	O	O
that	IN	O	O
she	PRP	O	O
cannot	VBD	O	O
be	VB	O	O
anticoagulated	VBN	B-TREATMENT	O
.	.	O	O

we	PRP	O	O
have	VBP	O	O
given	VBN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
lovenox	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
the	DT	O	O
past	NN	O	O
,	,	O	O
and	CC	O	O
she	PRP	O	O
continues	VBZ	O	O
to	TO	O	O
bleed	VB	O	B-PROBLEM
.	.	O	O

therefore	RB	O	O
,	,	O	O
she	PRP	O	O
is	VBZ	O	O
on	IN	O	O
no	DT	O	O
dvt	NN	B-TREATMENT	B-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
does	VBZ	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
iliac	JJ	I-PROBLEM	I-PROBLEM
deep	JJ	I-PROBLEM	I-PROBLEM
vein	NN	I-PROBLEM	I-PROBLEM
thrombosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
a	DT	B-TREATMENT	O
greenfield	NN	I-TREATMENT	O
filter	NN	I-TREATMENT	O
in	IN	O	O
place	NN	O	O
,	,	O	O
and	CC	O	O
this	DT	O	O
is	VBZ	O	O
her	PRP$	O	O
only	JJ	O	O
dvt	NN	B-TREATMENT	B-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
urinary	JJ	I-PROBLEM	I-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
growing	VBG	O	O
enterobacter	RBR	B-PROBLEM	O
cloacae	NN	I-PROBLEM	O
that	WDT	O	O
is	VBZ	O	O
sensitive	JJ	O	O
only	RB	O	O
to	TO	O	O
macrodantin	VB	B-TREATMENT	B-TREATMENT
from	IN	O	O
her	PRP$	B-TEST	B-TEST
urine	JJ	I-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
.	.	O	O

interestingly	RB	O	O
enough	RB	O	O
,	,	O	O
she	PRP	O	O
also	RB	O	O
has	VBZ	O	O
enterobacter	NN	B-PROBLEM	O
cloacae	NN	I-PROBLEM	O
growing	VBG	O	O
out	IN	O	O
of	IN	O	O
her	PRP$	O	B-PROBLEM
sputum	NN	O	I-PROBLEM
.	.	O	O

this	DT	O	O
is	VBZ	O	O
also	RB	O	O
sensitive	JJ	O	O
only	RB	O	O
to	TO	O	O
macrodantin	VB	B-TREATMENT	B-TREATMENT
.	.	O	O

we	PRP	O	O
do	VBP	O	O
not	RB	O	O
believe	VB	O	O
that	IN	O	O
she	PRP	O	O
has	VBZ	O	O
any	DT	B-PROBLEM	B-PROBLEM
respiratory	JJ	I-PROBLEM	I-PROBLEM
process	NN	I-PROBLEM	I-PROBLEM
going	VBG	O	O
on	IN	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
just	RB	O	O
begun	VBN	O	O
on	IN	O	O
macrodantin	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
and	CC	O	O
should	MD	O	O
continue	VB	O	O
100	CD	O	O
mg	NNS	O	O
per	IN	O	O
ng	NN	B-TREATMENT	O
tube	NN	I-TREATMENT	O
q.i.d.	NN	O	O
for	IN	O	O
a	DT	O	O
ten	JJ	O	O
day	NN	O	O
course	NN	O	O
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
foley	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
changed	VBN	O	O
the	DT	O	O
day	NN	O	O
before	IN	O	O
discharge	NN	O	O
.	.	O	O

8.	CD	O	B-TREATMENT
tubes	NNS	B-TREATMENT	I-TREATMENT
,	,	O	I-TREATMENT
lines	NNS	B-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
drains	NNS	B-TREATMENT	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	B-TREATMENT	B-TREATMENT
tracheostomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
ng	JJ	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
a	DT	B-TREATMENT	B-TREATMENT
foley	JJ	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
central	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
which	WDT	O	O
was	VBD	O	O
left	VBN	B-TREATMENT	O
subclavian	JJ	I-TREATMENT	O
quad	NN	I-TREATMENT	O
lumen	NNS	I-TREATMENT	O
,	,	O	O
was	VBD	O	O
removed	VBN	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

albuterol	NN	B-TREATMENT	B-TREATMENT
nebulizers	NNS	I-TREATMENT	I-TREATMENT
2.5	CD	O	O
mg	NN	O	O
q.4h.	NN	O	O
and	CC	O	O
atrovent	NN	B-TREATMENT	B-TREATMENT
nebulizers	NNS	I-TREATMENT	I-TREATMENT
0.5	CD	O	O
mg	NN	O	O
q.4h.	NN	O	O
,	,	O	O
please	VB	O	O
alternate	VB	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	I-TREATMENT
atrovent	NN	B-TREATMENT	I-TREATMENT
;	:	O	O
rocaltrol	CC	B-TREATMENT	O
0.25	CD	O	O
mcg	NN	O	O
per	IN	O	O
ng	FW	B-TREATMENT	O
tube	NN	I-TREATMENT	O
q.d.;	NN	O	O
calcium	NN	B-TREATMENT	B-TREATMENT
carbonate	NN	I-TREATMENT	I-TREATMENT
1250	CD	O	O
mg	NN	O	O
per	IN	O	O
ng	FW	B-TREATMENT	O
tube	NN	I-TREATMENT	B-TREATMENT
q.i.d.;	NN	O	I-TREATMENT
vitamin	NN	B-TREATMENT	I-TREATMENT
b12	NN	I-TREATMENT	I-TREATMENT
1000	CD	O	O
mcg	NN	O	O
im	NN	O	O
q.	JJ	O	O
month	NN	O	O
,	,	O	O
next	JJ	O	O
dose	NN	O	O
is	VBZ	O	O
due	JJ	O	O
nov	RB	O	O
18	CD	O	O
;	:	O	O
diltiazem	CC	B-TREATMENT	B-TREATMENT
60	CD	O	O
mg	NN	O	O
per	IN	O	O
ng	FW	B-TREATMENT	O
tube	NN	I-TREATMENT	O
t.i.d.;	VBP	O	O
ferrous	JJ	B-TREATMENT	B-TREATMENT
sulfate	NN	I-TREATMENT	I-TREATMENT
300	CD	O	O
mg	NN	O	O
per	IN	O	O
ng	FW	B-TREATMENT	O
t.i.d.;	NN	O	O
haldol	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
iv	NN	O	O
q.h.s.;	NN	O	O
hydralazine	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
iv	NN	O	O
q.6h.	NN	O	O
p.r.n.	JJ	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
;	:	O	O
lisinopril	CC	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
per	IN	O	O
ng	FW	B-TREATMENT	O
tube	NN	I-TREATMENT	O
q.d.;	NN	O	O
ativan	VBD	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	NNS	O	O
per	IN	O	O
ng	NN	B-TREATMENT	O
tube	NN	I-TREATMENT	O
q.h.s.;	NN	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
per	IN	O	O
ng	FW	B-TREATMENT	O
tube	NN	I-TREATMENT	O
t.i.d.;	NN	O	O
zantac	NN	B-TREATMENT	O
150	CD	O	O
mg	NN	O	O
per	IN	O	O
ng	FW	B-TREATMENT	O
tube	NN	I-TREATMENT	O
b.i.d.;	NN	O	O
multivitamin	VBD	B-TREATMENT	B-TREATMENT
10	CD	O	O
ml	NNS	O	O
per	IN	O	O
ng	NN	B-TREATMENT	O
tube	NN	I-TREATMENT	O
q.d.;	VBD	O	O
macrodantin	$	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
per	IN	O	O
ng	FW	B-TREATMENT	O
tube	NN	I-TREATMENT	O
q.i.d.	NN	O	O
x	$	O	O
10	CD	O	O
days	NNS	O	O
beginning	VBG	O	O
on	IN	O	O
11/3/00	CD	O	O
.	.	O	O

stable	JJ	O	O
,	,	O	O
with	IN	O	O
active	JJ	B-PROBLEM	B-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
being	VBG	O	I-PROBLEM
respiratory	JJ	B-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
urinary	JJ	B-PROBLEM	B-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
bleeding	VBG	B-PROBLEM	B-PROBLEM
diathesis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
,	,	O	O
sodium	NN	B-TEST	B-TEST
145	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.1	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
109	CD	O	O
,	,	O	O
bicarb	NN	B-TEST	B-TEST
31	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
0.7	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
43	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
116	CD	O	O
.	.	O	O

cbc	NN	B-TEST	B-TEST
14.9	CD	O	O
,	,	O	O
29.2	CD	O	O
(	(	O	O
which	WDT	O	O
is	VBZ	O	O
stable	JJ	O	O
)	)	O	O
,	,	O	O
and	CC	O	O
398	CD	O	O
.	.	O	O

pt	NN	B-TEST	O
12	CD	O	O
,	,	O	O
ptt	NN	B-TEST	B-TEST
27	CD	O	O
,	,	O	O
and	CC	O	O
inr	RB	B-TEST	O
1.0	CD	O	O
.	.	O	O

magnesium	NN	B-TEST	B-TEST
of	IN	O	O
1.9	CD	O	O
.	.	O	O

calcium	NN	B-TEST	B-TEST
8.1	CD	O	O
.	.	O	O

discharge	NN	O	O
summary	JJ	O	O
addendum	NN	O	O
:	:	O	O
the	DT	O	O
patient	NN	O	O
during	IN	O	O
her	PRP$	O	O
admission	NN	O	O
from	IN	O	O
2015-01-19	JJ	O	O
to	TO	O	O
2015-01-22	JJ	O	O
during	IN	O	O
that	DT	O	O
admission	NN	O	O
she	PRP	O	O
had	VBD	O	O
an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
which	WDT	O	O
revealed	VBD	O	O
essentially	RB	O	O
an	DT	B-TEST	B-TEST
ejection	NN	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
40%	CD	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
patent	NN	I-PROBLEM	I-PROBLEM
foramen	NNS	I-PROBLEM	I-PROBLEM
ovale	VBP	I-PROBLEM	I-PROBLEM
mildly	RB	B-PROBLEM	I-PROBLEM
dilated	VBN	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
atrium	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

it	PRP	O	O
also	RB	O	O
showed	VBD	O	O
intraseptal	JJ	B-PROBLEM	O
and	CC	I-PROBLEM	O
inferior	JJ	I-PROBLEM	B-PROBLEM
akinesis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

additionally	RB	O	O
because	IN	O	O
of	IN	O	O
her	PRP$	O	O
history	NN	O	O
of	IN	O	O
contrast	NN	B-PROBLEM	B-PROBLEM
allergy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
she	PRP	O	O
was	VBD	O	O
given	VBN	O	O
solu-medrol	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
milligrams	NNS	O	O
iv	JJ	O	O
prior	RB	O	O
to	TO	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
did	VBD	O	O
not	RB	O	O
have	VB	O	O
any	DT	B-PROBLEM	B-PROBLEM
untoward	JJ	I-PROBLEM	I-PROBLEM
affects	NNS	I-PROBLEM	I-PROBLEM
or	CC	O	O
allergic	JJ	B-PROBLEM	B-PROBLEM
reactions	NNS	I-PROBLEM	I-PROBLEM
to	TO	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
68	CD	O	O
year	NN	O	O
old	JJ	O	O
male	NN	O	O
status	NN	O	O
post	NN	O	O
three	CD	O	O
and	CC	O	O
a	DT	O	O
half	JJ	O	O
cycles	NNS	O	O
of	IN	O	O
adjuvant	JJ	B-TREATMENT	B-TREATMENT
eap	JJ	I-TREATMENT	I-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	O	O
good	JJ	O	O
response	NN	O	O
to	TO	O	O
preoperative	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
negative	JJ	O	O
nodes	NNS	O	O
,	,	O	O
and	CC	O	O
is	VBZ	O	O
admitted	VBN	O	O
for	IN	O	O
the	DT	O	O
final	JJ	O	O
portion	NN	O	O
of	IN	O	O
his	PRP$	B-TREATMENT	O
postoperative	JJ	I-TREATMENT	O
cycles	NNS	I-TREATMENT	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
the	DT	O	O
week	NN	O	O
before	IN	O	O
was	VBD	O	O
decreased	VBN	O	O
because	IN	O	O
the	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
dropped	VBD	O	O
to	TO	O	O
2.8	CD	O	O
.	.	O	O

in	IN	O	O
the	DT	O	O
interim	NN	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
rose	VBD	O	O
again	RB	O	O
to	TO	O	O
4.2	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
of	IN	O	O
30.5	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
196	CD	O	O
thousand	NN	O	O
.	.	O	O

on	IN	O	O
physical	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
on	IN	O	O
admission	NN	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
146/80	CD	O	O
,	,	O	O
weight	VBD	B-TEST	B-TEST
146	CD	O	O
,	,	O	O
temperature	NN	B-TEST	B-TEST
98.6	CD	O	O
,	,	O	O
and	CC	O	O
pulse	NN	B-TEST	B-TEST
of	IN	O	O
92	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
demonstrated	VBD	O	O
single	JJ	O	O
s1	NN	O	O
,	,	O	O
s2	NN	O	O
,	,	O	O
no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
abdominal	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
neurological	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
nonfocal	JJ	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
was	VBD	O	O
1.3	CD	O	O
and	CC	O	O
dropping	VBG	O	O
to	TO	O	O
1.1	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
was	VBD	O	O
0.2	CD	O	O
,	,	O	O
sgot	VBD	B-TEST	B-TREATMENT
20	CD	O	O
,	,	O	O
magnesium	NN	B-TEST	B-TEST
of	IN	O	O
1.4	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
4.0	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
190	CD	O	O
,	,	O	O
with	IN	O	O
62%	CD	O	O
polys	NNS	B-TEST	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
adriamycin	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
,	,	O	O
cis-platinum	JJ	B-TREATMENT	O
40	CD	O	O
mg	NN	O	O
,	,	O	O
preceded	VBN	O	O
by	IN	O	O
mannitol	NN	B-TREATMENT	B-TREATMENT
12.5	CD	O	I-TREATMENT
grams	NNS	O	I-TREATMENT
intravenous	JJ	O	I-TREATMENT
bolus	NN	O	I-TREATMENT
,	,	O	O
and	CC	O	O
zofran	VBD	B-TREATMENT	B-TREATMENT
11	CD	O	O
mg	NNS	O	O
on	IN	O	O
two	CD	O	O
occasions	NNS	O	O
given	VBN	O	O
as	IN	O	O
an	DT	B-TREATMENT	O
antiemetic	JJ	I-TREATMENT	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
well	RB	O	O
tolerated	VBN	O	O
.	.	O	O

1.	CD	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O

2.	CD	O	O
adenocarcinoma	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
esophagus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O

3.	CD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
hypomagnesemia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

intravenous	JJ	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
chemotherapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

slow-mag	JJ	B-TREATMENT	B-TEST
2	CD	O	O
tablets	NNS	O	O
po	JJ	O	O
bid	NN	O	O
,	,	O	O
ativan	VBZ	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	NN	O	O
sublingually	RB	O	O
q4h	JJ	O	O
prn	NN	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
5235	CD	O	O
-	:	O	O
gram	NN	O	O
full-term	JJ	O	O
male	JJ	O	O
infant	NN	O	O
of	IN	O	O
a	DT	O	B-PROBLEM
diabetic	JJ	O	I-PROBLEM
mother	NN	O	I-PROBLEM
born	VBN	O	O
by	IN	O	O
repeat	NN	B-TREATMENT	B-TREATMENT
cesarean	JJ	I-TREATMENT	I-TREATMENT
section	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
a	DT	O	O
29-year-old	JJ	O	O
gravida	NN	O	O
1	CD	O	O
,	,	O	O
para	NN	O	O
2	CD	O	O
,	,	O	O
woman	NN	O	O
.	.	O	O

prenatal	JJ	B-TEST	B-TEST
screens	NNS	I-TEST	I-TEST
benign	NN	O	I-TEST
.	.	O	O

group	NN	B-TEST	B-TEST
b	VBD	I-TEST	I-TEST
strep	JJ	I-TEST	I-TEST
status	NN	I-TEST	I-TEST
negative	JJ	O	O
.	.	O	O

pregnancy	NN	O	O
complicated	VBN	O	O
by	IN	O	O
insulin-dependent	JJ	B-PROBLEM	B-PROBLEM
gestational	JJ	I-PROBLEM	I-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

apgar	NN	B-TEST	B-TEST
scores	NNS	I-TEST	I-TEST
were	VBD	O	O
8	CD	O	O
at	IN	O	O
1	CD	O	O
minute	NN	O	O
and	CC	O	O
9	CD	O	O
at	IN	O	O
5	CD	O	O
minutes	NNS	O	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
admitted	VBD	O	O
to	TO	O	O
the	DT	O	O
neonatal	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
a	DT	B-TEST	B-TREATMENT
dextrose	JJ	I-TEST	I-TREATMENT
stick	NN	I-TEST	I-TREATMENT
of	IN	O	O
20	CD	O	O
in	IN	O	O
the	DT	O	O
delivery	NN	O	O
room	NN	O	O
.	.	O	O

birth	NN	B-TEST	B-TEST
weight	NN	I-TEST	I-TEST
was	VBD	O	O
5235	CD	O	O
grams	NNS	O	O
,	,	O	O
length	NN	B-TEST	B-TEST
was	VBD	O	O
56	CD	O	O
cm	NN	O	O
,	,	O	O
and	CC	O	O
head	NN	B-TEST	B-TEST
circumference	NN	I-TEST	I-TEST
was	VBD	O	O
37.5	CD	O	O
cm	NN	O	O
.	.	O	O

bilateral	JJ	B-TEST	B-TEST
breath	NN	I-TEST	I-TEST
sounds	NNS	I-TEST	I-TEST
were	VBD	O	O
clear	JJ	O	O
and	CC	O	O
equal	JJ	O	O
.	.	O	O

no	DT	O	O
grunting	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
flaring	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
retracting	VBG	B-PROBLEM	O
.	.	O	O

no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
and	CC	O	O
nondistended	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
infant	NN	O	O
has	VBZ	O	O
remained	VBN	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
throughout	IN	O	O
his	PRP$	O	O
hospitalization	NN	O	O
with	IN	O	O
oxygen	JJ	B-TEST	B-TEST
saturations	NNS	I-TEST	I-TEST
of	IN	O	O
greater	JJR	O	O
than	IN	O	O
95	CD	O	O
percent	NN	O	O
.	.	O	O

respiratory	NN	B-TEST	B-PROBLEM
rates	NNS	I-TEST	I-PROBLEM
have	VBP	O	O
been	VBN	O	O
40	CD	O	O
s	NN	O	O
to	TO	O	O
60	CD	O	O
s.	NN	O	O

the	DT	O	O
infant	NN	O	O
has	VBZ	O	O
had	VBN	O	O
two	CD	B-PROBLEM	O
spontaneous	JJ	I-PROBLEM	O
desaturations	NNS	I-PROBLEM	O
which	WDT	O	O
quickly	RB	O	O
self-resolved	VBD	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
one	CD	O	O
.	.	O	O

no	DT	O	O
apnea	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
bradycardia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
infant	NN	O	O
has	VBZ	O	O
remained	VBN	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
with	IN	O	O
heart	NN	B-TEST	O
rates	NNS	I-TEST	O
in	IN	O	O
the	DT	O	O
120	CD	O	O
s	NN	O	O
to	TO	O	O
140	CD	O	O
s	NNS	O	O
and	CC	O	O
mean	VB	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressures	NNS	I-TEST	I-TEST
of	IN	O	O
57	CD	O	O
to	TO	O	O
60	CD	O	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
neonatal	JJ	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
hypoglycemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
infant	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
enteral	JJ	B-TREATMENT	B-TREATMENT
feedings	NNS	I-TREATMENT	I-TREATMENT
of	IN	O	O
enfamil	JJ	B-TREATMENT	B-TREATMENT
20	CD	I-TREATMENT	O
calories	NNS	I-TREATMENT	O
per	IN	I-TREATMENT	O
ounce	NN	I-TREATMENT	O
by	IN	O	O
mouth	NN	O	O
ad	NN	O	O
lib	NN	O	O
and	CC	O	O
maintained	VBD	O	O
glucoses	NNS	B-TEST	O
in	IN	O	O
the	DT	O	O
middle	NN	O	O
to	TO	O	O
high	VB	O	O
40	CD	O	O
s	NNS	O	O
taking	VBG	O	O
by	IN	B-TREATMENT	O
mouth	JJ	I-TREATMENT	O
feedings	NNS	I-TREATMENT	O
every	DT	O	O
two	CD	O	O
to	TO	O	O
three	CD	O	O
hours	NNS	O	O
by	IN	O	O
mouth	NN	O	O
ad	NN	O	O
lib	NN	O	O
.	.	O	O

on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
one	CD	O	O
,	,	O	O
the	DT	O	O
infant	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TREATMENT
dextrose	JJ	I-TEST	I-TREATMENT
stick	NN	I-TEST	I-TREATMENT
of	IN	O	O
34	CD	O	O
.	.	O	O

at	IN	O	O
that	DT	O	O
time	NN	O	O
,	,	O	O
an	DT	B-TREATMENT	B-TREATMENT
intravenous	JJ	I-TREATMENT	I-TREATMENT
of	IN	O	I-TREATMENT
d-10-w	NN	B-TREATMENT	I-TREATMENT
was	VBD	O	O
started	VBN	O	O
at	IN	O	O
80	CD	O	O
cc	NN	O	O
/	NNP	O	O
kilogram	FW	O	O
per	IN	O	O
day	NN	O	O
.	.	O	O

on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
two	CD	O	O
,	,	O	O
the	DT	O	O
infant	NN	O	O
began	VBD	O	O
to	TO	O	O
wean	VB	O	O
off	RP	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
this	DT	O	O
was	VBD	O	O
completed	VBN	O	O
by	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
four	CD	O	O
.	.	O	O

calories	NNS	O	O
were	VBD	O	O
increased	VBN	O	O
to	TO	O	O
similac	VB	B-TREATMENT	O
24	CD	I-TREATMENT	O
calories	NNS	I-TREATMENT	O
per	IN	I-TREATMENT	O
ounce	NN	I-TREATMENT	O
.	.	O	O

before	IN	O	O
discharge	NN	O	O
to	TO	O	O
the	DT	O	O
newborn	JJ	O	O
nursery	NN	O	O
,	,	O	O
the	DT	O	O
infant	NN	O	O
was	VBD	O	O
taking	VBG	O	O
similac	JJ	B-TREATMENT	O
22	CD	I-TREATMENT	O
calories	NNS	I-TREATMENT	O
per	IN	I-TREATMENT	O
ounce	NN	I-TREATMENT	O
by	IN	O	O
mouth	NN	O	O
ad	NN	O	O
lib	NN	O	O
and	CC	O	O
maintaining	VBG	O	B-TREATMENT
dextrose	JJ	B-TEST	I-TREATMENT
sticks	NNS	I-TEST	I-TREATMENT
in	IN	O	O
the	DT	O	O
60	CD	O	O
s.	NN	O	O

weight	NN	B-TEST	B-TEST
on	IN	O	O
discharge	NN	O	O
was	VBD	O	O
5200	CD	O	O
grams	NNS	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
hearing	NN	I-TEST	I-TEST
screen	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
with	IN	O	O
automated	JJ	B-TEST	O
auditory	NN	I-TEST	O
brain	NN	I-TEST	O
stem	NN	I-TEST	O
responses	NNS	I-TEST	O
and	CC	O	O
the	DT	O	O
infant	NN	O	O
passed	VBN	O	O
on	IN	O	O
both	DT	O	O
ears	NNS	O	O
.	.	O	O

similac	NN	B-TREATMENT	B-TEST
22	CD	I-TREATMENT	O
calories	NNS	I-TREATMENT	O
per	IN	I-TREATMENT	O
ounce	NN	I-TREATMENT	O
by	IN	O	O
mouth	NN	O	O
ad	NN	O	O
lib	NN	O	O
with	IN	O	O
a	DT	O	O
goal	NN	O	O
of	IN	O	O
decreasing	VBG	O	O
to	TO	O	O
20	CD	B-TREATMENT	O
calories	NNS	I-TREATMENT	O
per	IN	I-TREATMENT	O
ounce	NN	I-TREATMENT	O
for	IN	O	O
dextrose	JJ	B-TEST	B-TEST
sticks	NNS	I-TEST	I-TEST
of	IN	O	O
greater	JJR	O	O
than	IN	O	O
60	CD	O	O
.	.	O	O

2.	CD	O	O
medications	NNS	B-TREATMENT	B-TREATMENT
:	:	O	O

3.	CD	O	O
a	DT	B-TEST	B-TEST
state	NN	I-TEST	I-TEST
newborn	JJ	I-TEST	I-TEST
screen	NN	I-TEST	I-TEST
was	VBD	O	O
sent	VBN	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
three	CD	O	O
;	:	O	O
the	DT	O	O
results	NNS	O	O
are	VBP	O	O
pending	VBG	O	O
.	.	O	O

4.	CD	O	O
received	VBD	O	O
hepatitis	NN	B-TREATMENT	B-TREATMENT
b	NN	I-TREATMENT	I-TREATMENT
vaccine	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
2012-09-30	JJ	O	O
.	.	O	O

1.	CD	O	O
large	JJ	B-PROBLEM	O
for	IN	I-PROBLEM	O
gestational	JJ	I-PROBLEM	O
age	NN	I-PROBLEM	O
.	.	O	O

3.	CD	O	O
hypoglycemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

primary	JJ	B-TREATMENT	O
c	NNS	I-TREATMENT	O
/	VBP	I-TREATMENT	O
s	NN	I-TREATMENT	O
for	IN	O	O
breech	NN	B-PROBLEM	B-PROBLEM

attending	VBG	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST

ibuprofen	JJ	B-TREATMENT	B-TREATMENT
400-600	JJ	O	O
mg	NN	O	O
po	NN	O	O
q6h	NN	O	O
prn	NN	O	O
pain	NN	B-PROBLEM	B-PROBLEM

oxycodone	RB	B-TREATMENT	B-TREATMENT
5-10	JJ	O	O
mg	NN	O	O
po	NN	O	O
q3h	NN	O	O
prn	NN	O	O
pain	NN	B-PROBLEM	B-PROBLEM

if	IN	O	O
pt	VBN	O	O
received	VBD	O	O
post	NN	B-TREATMENT	O
partum	NN	I-TREATMENT	B-TREATMENT
spinal	JJ	I-TREATMENT	I-TREATMENT
morphine	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
do	VBP	O	O
not	RB	O	O
administer	VB	O	O
oxycodone	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
18	CD	O	O
hours	NNS	O	O
after	IN	O	O
morphine	JJ	B-TREATMENT	B-TREATMENT
administration	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

prenatal	JJ	B-TREATMENT	B-TREATMENT
multivitamins	NNS	I-TREATMENT	I-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
stuartnatal	JJ	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
1	CD	O	O

penicillins	NNS	B-TREATMENT	B-TREATMENT

breech	NN	B-PROBLEM	B-PROBLEM
failed	VBD	I-PROBLEM	I-PROBLEM
version	NN	I-PROBLEM	I-PROBLEM
pregnancy	NN	I-PROBLEM	I-PROBLEM

responsible	JJ	O	O
after	IN	O	O
study	NN	O	O
for	IN	O	O
causing	VBG	O	O
admission	NN	O	O
)	)	O	O
primary	JJ	B-TREATMENT	O
c	JJ	I-TREATMENT	O
/	NN	I-TREATMENT	O
s	NN	I-TREATMENT	O
for	IN	O	O
breech	NN	B-PROBLEM	B-PROBLEM

scheduled	VBN	B-TREATMENT	O
c	NNS	I-TREATMENT	O
/	VBP	I-TREATMENT	O
s	NN	I-TREATMENT	O
for	IN	O	O
breech	NN	B-PROBLEM	B-PROBLEM

vaginal	JJ	B-TREATMENT	B-TREATMENT
delivery	NN	I-TREATMENT	I-TREATMENT
:	:	O	O

undelivered	JJ	B-PROBLEM	O

breech	NN	B-PROBLEM	O
,	,	O	O

uterine	JJ	B-TREATMENT	B-PROBLEM
incision	NN	I-TREATMENT	I-PROBLEM
type	NN	I-TREATMENT	I-PROBLEM
:	:	O	O

initial	JJ	B-TEST	B-TEST
newborn	JJ	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
:	:	O	O

no	DT	O	O
observed	JJ	B-PROBLEM	B-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM

prenatal	JJ	B-TEST	B-TEST
screens	NNS	I-TEST	I-TEST
:	:	O	O
blood	NN	B-TEST	B-TEST
type	NN	I-TEST	I-TEST
a	DT	O	O
positive	JJ	O	O
,	,	O	O
antibody	JJ	B-TEST	B-TEST
negative	JJ	O	O
,	,	O	O
rubella	NN	B-TEST	B-TEST
immune	NN	O	O
,	,	O	O
rpr	NN	B-TEST	O
nonreactive	JJ	O	O
,	,	O	O
hepatitis	NN	B-TEST	B-TEST
b	NN	I-TEST	I-TEST
surface	NN	I-TEST	I-TEST
antigen	NN	I-TEST	I-TEST
negative	JJ	O	O
,	,	O	O
gbs	JJ	B-TEST	O
unknown	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
born	VBN	O	O
by	IN	O	O
repeat	NN	B-TREATMENT	B-TEST
c-section	NN	I-TREATMENT	I-TEST
.	.	O	O

there	EX	O	O
was	VBD	O	O
artificial	JJ	B-TREATMENT	B-PROBLEM
rupture	NN	I-TREATMENT	I-PROBLEM
of	IN	I-TREATMENT	I-PROBLEM
membranes	NNS	I-TREATMENT	I-PROBLEM
was	VBD	O	O
performed	VBN	O	O
at	IN	O	O
the	DT	B-TREATMENT	O
delivery	NN	I-TREATMENT	O
.	.	O	O

mother	RB	O	O
received	VBN	O	O
epidural	JJ	B-TREATMENT	B-TREATMENT
and	CC	O	I-TREATMENT
spinal	JJ	B-TREATMENT	I-TREATMENT
anesthesia	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

apgars	NNS	B-TEST	B-TEST
were	VBD	O	O
9	CD	O	O
and	CC	O	O
9	CD	O	O
at	IN	O	O
1	CD	O	O
and	CC	O	O
5	CD	O	O
minutes	NNS	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
newborn	JJ	O	O
nursery	NN	O	O
for	IN	O	O
further	JJ	B-TREATMENT	B-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

in	IN	O	O
the	DT	O	O
newborn	JJ	O	O
nursery	NN	O	O
he	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
po	NN	B-TREATMENT	B-TREATMENT
feedings	NNS	I-TREATMENT	I-TREATMENT
on	IN	O	O
demand	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
large	JJ	B-PROBLEM	O
for	IN	I-PROBLEM	O
gestational	JJ	I-PROBLEM	O
age	NN	I-PROBLEM	O
with	IN	O	O
a	DT	B-TEST	B-TEST
weight	NN	I-TEST	I-TEST
of	IN	O	O
4525	CD	O	O
grams	NNS	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
d-sticks	NNS	I-TEST	I-TEST
were	VBD	O	O
greater	JJR	O	O
than	IN	O	O
80	CD	O	O
.	.	O	O

at	IN	O	O
5	CD	O	O
hours	NNS	O	O
of	IN	O	O
life	NN	O	O
he	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
grunting	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
flaring	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
e.c.	NN	O	O
bovell	NN	O	O
consult	NN	O	O
was	VBD	O	O
done	VBN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
in	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	O	O
diagnosis	NN	O	O
of	IN	O	O
transient	JJ	B-PROBLEM	B-PROBLEM
tachypnea	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
newborn	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
made	VBN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
observed	VBN	O	O
in	IN	O	O
the	DT	O	O
nursery	NN	O	O
for	IN	O	O
progression	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

at	IN	O	O
16	CD	O	O
hours	NNS	O	O
of	IN	O	O
life	NN	O	O
he	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
increased	VBN	B-PROBLEM	B-PROBLEM
work	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breathing	VBG	I-PROBLEM	I-PROBLEM
with	IN	O	O
tachypnea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
flaring	VBG	B-PROBLEM	B-PROBLEM
and	CC	O	I-PROBLEM
grunting	VBG	B-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
also	RB	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
axillary	JJ	B-TEST	B-PROBLEM
temperature	NN	I-TEST	I-PROBLEM
of	IN	O	O
100.4	CD	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
rectal	JJ	I-TEST	I-TEST
temperature	NN	I-TEST	I-TEST
of	IN	O	O
100.9	CD	O	O
.	.	O	O

at	IN	O	O
this	DT	O	O
point	NN	O	O
cmed	VBD	O	O
was	VBD	O	O
consulted	VBN	O	O
again	RB	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
triage	NN	O	O
for	IN	O	O
further	JJ	B-TREATMENT	B-TREATMENT
care	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

birth	NN	B-TEST	B-TEST
weight	NN	I-TEST	I-TEST
of	IN	O	O
4525	CD	O	O
grams	NNS	O	O
which	WDT	O	O
is	VBZ	O	O
greater	JJR	O	O
than	IN	O	O
90th	CD	O	O
percentile	NN	O	O
;	:	O	O
length	CC	B-TEST	O
54	CD	O	O
cm	NN	O	O
which	WDT	O	O
is	VBZ	O	O
greater	JJR	O	O
than	IN	O	O
90th	CD	O	O
percentile	NN	O	O
;	:	O	O
head	NN	B-TEST	B-TEST
circumference	NN	I-TEST	I-TEST
37	CD	O	O
cm	NN	O	O
which	WDT	O	O
is	VBZ	O	O
greater	JJR	O	O
than	IN	O	O
90th	CD	O	O
percentile	NN	O	O
.	.	O	O

d-sticks	NNS	B-TEST	O
of	IN	O	O
117	CD	O	O
.	.	O	O

large	JJ	B-PROBLEM	O
for	IN	I-PROBLEM	O
gestational	JJ	I-PROBLEM	O
age	NN	I-PROBLEM	O
appearance	NN	I-PROBLEM	O
of	IN	O	O
an	DT	O	O
infant	NN	O	O
with	IN	O	O
tachypnea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
grunting	VBG	B-PROBLEM	B-PROBLEM
and	CC	O	O
flaring	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

bilateral	JJ	B-TEST	B-TEST
red	JJ	I-TEST	I-TEST
reflexes	NNS	I-TEST	I-TEST
.	.	O	O

mild	JJ	B-PROBLEM	B-PROBLEM
flaring	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

respiratory	NN	O	O
:	:	O	O
tachypneic	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
retractions	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
increased	VBD	B-PROBLEM	B-PROBLEM
work	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breathing	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
clear	JJ	O	O
and	CC	O	O
equal	JJ	O	B-PROBLEM
breath	NN	O	I-PROBLEM
sounds	NNS	O	I-PROBLEM
.	.	O	O

normal	JJ	O	O
s1	NN	O	O
and	CC	O	O
s2	NN	O	O
without	IN	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

brachial	JJ	B-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
equal	JJ	O	I-TEST
femoral	JJ	B-TEST	I-TEST
pulses	NNS	I-TEST	I-TEST
and	CC	O	O
are	VBP	O	O
2+	CD	O	O
.	.	O	O

abdomen	NNS	O	O
:	:	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

normal	JJ	O	O
tone	NN	O	O
and	CC	O	O
neonatal	JJ	B-TEST	B-TEST
reflexes	NNS	I-TEST	I-TEST
.	.	O	O

skin	NN	O	O
pink	NN	O	O
and	CC	O	O
capillary	JJ	B-TEST	B-TEST
refill	NN	I-TEST	I-TEST
less	JJR	O	O
than	IN	O	O
2	CD	O	O
seconds	NNS	O	O
.	.	O	O

spine	NN	O	O
straight	NN	O	O
and	CC	O	O
no	DT	O	O
abnormalities	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

respiratory	NN	O	O
:	:	O	O
the	DT	O	O
infant	NN	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
cpap	NN	B-TREATMENT	B-TREATMENT
on	IN	O	O
admission	NN	O	O
to	TO	O	O
the	DT	O	O
cmed	VBN	O	O
and	CC	O	O
remained	VBN	O	O
on	IN	O	O
cpap	NN	B-TREATMENT	B-TREATMENT
until	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
2	CD	O	O
at	IN	O	O
which	WDT	O	O
time	NN	O	O
he	PRP	O	O
weaned	VBD	O	O
to	TO	O	O
nasal	VB	B-TREATMENT	B-TREATMENT
cannula	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
then	RB	O	O
subsequently	RB	O	O
to	TO	O	O
room	NN	O	O
air	NN	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
3	CD	O	O
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
remained	VBN	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
since	IN	O	O
that	DT	O	O
time	NN	O	O
and	CC	O	O
has	VBZ	O	O
had	VBN	O	O
no	DT	O	O
issues	NNS	O	O
with	IN	O	O
apnea	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
desaturation	NN	B-PROBLEM	B-PROBLEM
since	IN	O	O
being	VBG	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

initial	JJ	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
in	IN	O	O
the	DT	O	O
cmed	NN	O	O
showed	VBD	O	O
haziness	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
patchy	JJ	B-PROBLEM	B-PROBLEM
areas	NNS	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
side	NN	I-PROBLEM	I-PROBLEM
consistent	JJ	O	O
with	IN	O	O
concerns	NNS	O	O
for	IN	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
infant	NN	O	O
was	VBD	O	O
treated	VBN	O	O
for	IN	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
from	IN	O	O
admission	NN	O	O
to	TO	O	O
the	DT	O	O
cmed	NN	O	O
.	.	O	O

cardiovascular	NN	O	O
:	:	O	O
the	DT	O	O
infant	NN	O	O
has	VBZ	O	O
maintained	VBN	O	O
stable	JJ	O	O
cardiovascular	JJ	O	O
status	NN	O	O
with	IN	O	O
normal	JJ	O	O
heart	NN	O	O
rates	NNS	O	O
and	CC	O	O
blood	NN	B-TEST	B-TEST
pressures	NNS	I-TEST	I-TEST
and	CC	O	O
no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

fluids	NNS	O	O
,	,	O	O
electrolytes	NNS	O	B-TEST
and	CC	O	O
nutrition	NN	O	O
:	:	O	O
the	DT	O	O
infant	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
iv	NN	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
on	IN	O	O
admission	NN	O	O
to	TO	O	O
the	DT	O	O
cmed	NN	O	O
.	.	O	O

electrolytes	NNS	B-TEST	B-TEST
were	VBD	O	O
measured	VBN	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
2	CD	O	O
and	CC	O	O
were	VBD	O	O
stable	JJ	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
.	.	O	O

no	DT	O	O
further	JJ	B-TEST	B-TEST
electrolytes	NNS	I-TEST	I-TEST
have	VBP	O	O
been	VBN	O	O
measured	VBN	O	O
.	.	O	O

enteral	JJ	B-TREATMENT	B-TREATMENT
feedings	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
initiated	VBN	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
3	CD	O	O
and	CC	O	O
the	DT	O	O
infant	NN	O	O
has	VBZ	O	O
been	VBN	O	O
ad	NN	B-TREATMENT	O
lib	NN	I-TREATMENT	O
po	NN	I-TREATMENT	O
feeding	VBG	I-TREATMENT	O
on	IN	O	O
demand	NN	O	O
since	IN	O	O
that	DT	O	O
time	NN	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
discharge	NN	I-TEST	I-TEST
weight	NN	I-TEST	I-TEST
is	VBZ	O	O
4180	CD	O	O
grams	NN	O	O
.	.	O	O

bilirubin	NN	B-TEST	B-TEST
level	NN	I-TEST	I-TEST
was	VBD	O	O
peaked	VBN	O	O
on	IN	O	O
day	NN	O	O
of	IN	O	O
life	NN	O	O
4	CD	O	O
to	TO	O	O
10.9/0.3	CD	O	O
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
required	VBN	O	O
no	DT	O	O
phototherapy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

hematology	NN	O	O
:	:	O	O
hematocrit	NN	B-TEST	B-TEST
was	VBD	O	O
done	VBN	O	O
on	IN	O	O
admission	NN	O	O
to	TO	O	O
the	DT	O	O
cmed	NN	O	O
.	.	O	O

hematocrit	NN	B-TEST	B-TEST
was	VBD	O	O
41	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
404,000	CD	O	O
.	.	O	O

no	DT	O	O
further	JJ	O	B-PROBLEM
hematocrit	NN	B-TEST	I-PROBLEM
or	CC	O	O
platelets	NNS	B-TEST	B-TEST
have	VBP	O	O
been	VBN	O	O
measured	VBN	O	O
.	.	O	O

blood	NN	B-TEST	B-TEST
typing	NN	I-TEST	I-TEST
has	VBZ	O	O
been	VBN	O	O
done	VBN	O	O
on	IN	O	O
this	DT	O	O
infant	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
baby	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
type	NN	I-TEST	I-TEST
is	VBZ	O	O
b	JJ	O	O
negative	JJ	O	O
,	,	O	O
antibody	JJ	B-TEST	B-TEST
negative	JJ	O	O
.	.	O	O

infectious	JJ	O	O
disease	NN	O	O
:	:	O	O
cbc	NN	B-TEST	B-TEST
and	CC	O	O
blood	NN	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
were	VBD	O	O
screened	VBN	O	O
on	IN	O	O
admission	NN	O	O
.	.	O	O

cbc	NN	B-TEST	B-TEST
was	VBD	O	O
benign	JJ	O	O
with	IN	O	O
22,000	CD	O	O
whites	NNS	B-TEST	O
,	,	O	O
80	CD	O	O
poly	NN	B-TEST	O
's,	POS	I-TEST	O
0	CD	O	O
bands	NNS	B-TEST	B-TEST
,	,	O	O
15	CD	O	O
lymphs	NN	B-TEST	B-TEST
.	.	O	O

ampicillin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
gentamycin	NN	B-TREATMENT	B-TREATMENT
were	VBD	O	O
initiated	VBN	O	O
on	IN	O	O
admission	NN	O	O
and	CC	O	O
an	DT	B-TEST	B-TEST
lp	NN	I-TEST	I-TEST
was	VBD	O	O
done	VBN	O	O
due	JJ	O	O
to	TO	O	O
the	DT	O	O
clinical	JJ	O	O
issues	NNS	O	O
of	IN	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
fever	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
admission	NN	O	O
to	TO	O	O
the	DT	O	O
cmed	NN	O	O
.	.	O	O

csf	NN	B-TEST	B-TEST
showed	VBD	O	I-TEST
white	JJ	B-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
7	CD	O	O
,	,	O	O
reds	VBZ	B-TEST	O
4	CD	O	O
,	,	O	O
protein	RB	B-TEST	B-TEST
119	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
69	CD	O	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
was	VBD	O	O
treated	VBN	O	O
for	IN	O	O
7	CD	O	O
days	NNS	O	O
of	IN	O	O
presumed	JJ	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
ampicillin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
gentamycin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

antibiotics	NNS	B-TREATMENT	B-TREATMENT
were	VBD	O	O
discontinued	VBN	O	O
on	IN	O	O
the	DT	O	O
evening	NN	O	O
of	IN	O	O
2015-04-28	JJ	O	O
.	.	O	O

sensory	NN	O	O
:	:	O	O
hearing	NN	B-TEST	B-TEST
screen	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
with	IN	O	O
automated	JJ	B-TEST	O
auditory	NN	I-TEST	O
brain	NN	I-TEST	O
stem	NN	I-TEST	O
responses	NNS	I-TEST	O
and	CC	O	O
the	DT	O	O
results	NNS	O	O
was	VBD	O	O
the	DT	O	O
infant	JJ	O	O
passing	NN	O	O
in	IN	O	O
both	DT	O	O
ears	NNS	O	O
.	.	O	O

there	EX	O	O
are	VBP	O	O
no	DT	O	O
active	JJ	B-PROBLEM	B-PROBLEM
ongoing	NN	I-PROBLEM	I-PROBLEM
issues	NNS	I-PROBLEM	I-PROBLEM
at	IN	O	O
this	DT	O	O
time	NN	O	O
.	.	O	O

1.	CD	O	O
ad	NN	B-TREATMENT	O
lib	NN	I-TREATMENT	O
po	JJ	I-TREATMENT	O
feedings	NNS	I-TREATMENT	O
of	IN	O	O
similac	NN	B-TREATMENT	B-TREATMENT
20	CD	I-TREATMENT	O
cal	JJ	I-TREATMENT	O
/	NN	I-TREATMENT	O
oz	NN	I-TREATMENT	O
with	IN	I-TREATMENT	O
iron	NN	I-TREATMENT	B-TREATMENT
.	.	O	O

2.	CD	O	O
medications	NNS	B-TREATMENT	B-TREATMENT
:	:	O	O
none	NN	O	O
.	.	O	O

3.	CD	O	O
state	NN	B-TEST	B-TEST
newborn	JJ	I-TEST	I-TEST
screen	NN	I-TEST	I-TEST
was	VBD	O	O
sent	VBN	O	O
on	IN	O	O
2015-04-24	JJ	O	O
and	CC	O	O
results	NNS	O	O
are	VBP	O	O
pending	VBG	O	O
.	.	O	O

4.	CD	O	O
immunizations	NNS	B-TREATMENT	B-TREATMENT
received	VBD	O	O
:	:	O	O
hepatitis	NN	B-TREATMENT	B-TREATMENT
b	NN	I-TREATMENT	I-TREATMENT
vaccine	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
given	VBN	O	O
on	IN	O	O
2015-04-25	JJ	O	O
.	.	O	O

5.	CD	O	O
immunizations	NNS	B-TREATMENT	B-TREATMENT
recommended	VBD	O	O
:	:	O	O

6.	CD	O	O
synagis	JJ	B-TREATMENT	B-TREATMENT
rsv	NN	I-TREATMENT	I-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
should	MD	O	O
be	VB	O	O
considered	VBN	O	O
from	IN	O	O
november	CC	O	O
through	IN	O	O
march	NN	O	O
for	IN	O	O
infants	NNS	O	O
who	WP	O	O
meet	VBP	O	O
any	DT	O	O
of	IN	O	O
the	DT	O	O
following	JJ	O	O
three	CD	O	O
criteria	NNS	O	O
.	.	O	O

daycare	NN	O	O
during	IN	O	O
the	DT	O	O
rsv	NN	O	O
season	NN	O	O
a	DT	O	O
smoker	NN	O	O
in	IN	O	O
the	DT	O	O
household	NN	O	O
,	,	O	O
neuromuscular	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	I-PROBLEM
airway	NN	B-PROBLEM	I-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
school	NN	O	O
age	NN	O	O
siblings	NNS	O	O

c.	NN	O	O
with	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

7.	CD	O	O
influenza	JJ	B-TREATMENT	B-TREATMENT
immunization	NN	I-TREATMENT	I-TREATMENT
is	VBZ	O	O
recommended	VBN	O	O
annually	RB	O	O
in	IN	O	O
the	DT	O	O
fall	NN	O	O
for	IN	O	O
all	DT	O	O
infants	NNS	O	O
once	IN	O	O
they	PRP	O	O
reach	VBP	O	O
6	CD	O	O
months	NNS	O	O
of	IN	O	O
age	NN	O	O
.	.	O	O

before	IN	O	O
this	DT	O	O
age	NN	O	O
and	CC	O	O
for	IN	O	O
the	DT	O	O
first	JJ	O	O
24	CD	O	O
months	NNS	O	O
of	IN	O	O
the	DT	O	O
child	NN	O	O
's	POS	O	O
life	NN	O	O
,	,	O	O
immunization	NN	B-TREATMENT	B-TREATMENT
against	IN	O	O
influenza	NN	B-PROBLEM	B-PROBLEM
is	VBZ	O	O
recommended	VBN	O	O
for	IN	O	O
household	NN	O	O
contacts	NNS	O	O
and	CC	O	O
out	IN	O	O
of	IN	O	O
home	NN	O	O
caregivers	NNS	O	O
.	.	O	O

1.	CD	O	O
presumed	JJ	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
treated	VBN	O	O
.	.	O	O

2.	CD	O	O
large	JJ	B-PROBLEM	O
for	IN	I-PROBLEM	O
gestational	JJ	I-PROBLEM	O
age	NN	I-PROBLEM	O
term	NN	O	O
male	NN	O	O
.	.	O	O

3.	CD	O	O
respiratory	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
resolved	VBN	O	O
.	.	O	O

4.	CD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
hyperbilirubinemia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
resolving	VBG	O	O
.	.	O	O

infrarenal	JJ	B-PROBLEM	B-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
;	:	O	O

2.	CD	O	O
gastroesophageal	JJ	B-PROBLEM	B-PROBLEM
reflux	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
;	:	O	O

3.	CD	O	O
osteoarthritis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

endovascular	JJ	B-TREATMENT	B-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
bifurcated	JJ	B-TREATMENT	B-PROBLEM
device	NN	I-TREATMENT	I-PROBLEM
on	IN	O	O
september	NN	O	O
9	CD	O	O
,	,	O	O
2003	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
an	DT	O	O
84	CD	O	O
year	NN	O	O
old	JJ	O	O
male	NN	O	O
,	,	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
who	WP	O	O
was	VBD	O	O
discovered	VBN	O	O
to	TO	O	O
have	VB	O	O
an	DT	B-PROBLEM	B-PROBLEM
asymptomatic	JJ	I-PROBLEM	I-PROBLEM
7	CD	I-PROBLEM	I-PROBLEM
cm	JJ	I-PROBLEM	I-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
ct	JJ	B-TEST	B-TEST
scan	JJ	I-TEST	I-TEST
obtained	VBN	O	O
in	IN	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
back	RB	O	O
in	IN	O	O
may	MD	O	O
.	.	O	O

at	IN	O	O
that	DT	O	O
time	NN	O	O
he	PRP	O	O
had	VBD	O	O
presented	VBN	O	O
with	IN	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
acute	JJ	B-PROBLEM	B-TREATMENT
cholecystectomy	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

he	PRP	O	O
underwent	VBD	O	O
an	DT	B-TREATMENT	B-TREATMENT
uncomplicated	JJ	I-TREATMENT	I-TREATMENT
laparoscopic	NN	I-TREATMENT	I-TREATMENT
cholecystectomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
presents	VBZ	O	O
at	IN	O	O
this	DT	O	O
time	NN	O	O
for	IN	O	O
endovascular	JJ	B-TREATMENT	B-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
this	DT	B-PROBLEM	B-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
;	:	O	O

2.	CD	O	O
gastroesophageal	JJ	B-PROBLEM	B-PROBLEM
reflux	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
;	:	O	O

3.	CD	O	O
h.	NN	B-PROBLEM	O
pylori	NN	I-PROBLEM	O
positive	JJ	I-PROBLEM	O
,	,	O	O
status	NN	O	B-TREATMENT
post	NN	O	I-TREATMENT
therapy	NN	B-TREATMENT	I-TREATMENT
;	:	O	O

4.	CD	O	O
osteoarthritis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1.	CD	O	O
craniotomy	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
meningoma	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
february	JJ	O	O
,	,	O	O
1994	CD	O	O
;	:	O	O

2.	CD	O	O
laparoscopic	JJ	B-TREATMENT	B-TREATMENT
cholecystectomy	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
may	MD	O	O
,	,	O	O
2002	CD	O	O
.	.	O	O

1.	CD	O	O
aspirin	JJ	B-TREATMENT	B-TREATMENT
81	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
;	:	O	O

2.	CD	O	O
atenolol	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
;	:	O	O

3.	CD	O	O
protonics	NNS	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NNS	O	O
po	JJ	O	O
qd	NN	O	O
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
152/74	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
60	CD	O	O
,	,	O	O
respirations	NNS	B-TEST	B-TEST
16	CD	O	O
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
no	DT	O	O
carotid	NN	B-PROBLEM	B-PROBLEM
bruits	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

heart	NN	O	O
is	VBZ	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
without	IN	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

abdomen	NNS	O	O
is	VBZ	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
pulsatile	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
epigastrium	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

extremities	NNS	O	O
reveals	VBZ	O	O
a	DT	B-TEST	O
2+	CD	I-TEST	O
femoral	JJ	I-TEST	O
and	CC	I-TEST	O
pedal	JJ	I-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
bilaterally	RB	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
vascular	VB	O	O
surgery	NN	O	O
service	NN	O	O
as	IN	O	O
a	DT	O	O
same	JJ	O	O
day	NN	O	O
admission	NN	O	O
,	,	O	O
and	CC	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
for	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
uncomplicated	JJ	I-TREATMENT	I-TREATMENT
endovascular	JJ	I-TREATMENT	I-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
anurx	RB	B-TREATMENT	B-PROBLEM
modular	JJ	I-TREATMENT	I-PROBLEM
bifurcated	VBD	I-TREATMENT	I-PROBLEM
graft	NN	I-TREATMENT	I-PROBLEM
was	VBD	O	O
placed	VBN	O	O
,	,	O	O
and	CC	O	O
both	DT	O	O
common	JJ	O	O
femoral	JJ	O	O
arteries	NNS	O	O
were	VBD	O	O
repaired	VBN	O	O
in	IN	O	O
the	DT	O	O
usual	JJ	O	O
fashion	NN	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
pulsatile	JJ	B-TEST	B-TEST
pulse	JJ	I-TEST	I-TEST
volume	NN	I-TEST	I-TEST
recordings	NNS	I-TEST	I-TEST
,	,	O	O
in	IN	O	O
both	DT	O	O
lower	JJR	O	O
extremities	NNS	O	O
,	,	O	O
and	CC	O	O
both	DT	O	O
renal	JJ	O	O
arteries	NNS	O	O
were	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
patent	NN	O	O
,	,	O	O
as	IN	O	O
were	VBD	O	O
both	DT	O	O
internal	JJ	O	O
iliac	NN	O	O
arteries	NNS	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
angiogram	NN	I-TEST	I-TEST
in	IN	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
,	,	O	O
revealed	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
endo	JJ	I-PROBLEM	I-PROBLEM
leak	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
did	VBD	O	O
have	VB	O	O
an	DT	O	O
episode	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
prolonged	JJ	I-PROBLEM	I-PROBLEM
sinus	NN	I-PROBLEM	I-PROBLEM
pause	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
recovery	NN	O	O
room	NN	O	O
,	,	O	O
which	WDT	O	O
resulted	VBD	O	O
in	IN	O	O
transient	JJ	B-PROBLEM	B-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
consciousness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
responded	VBD	O	O
to	TO	O	O
a	DT	B-TREATMENT	B-TREATMENT
neo-synephrine	JJ	I-TREATMENT	I-TREATMENT
bolus	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
and	CC	O	O
had	VBD	O	O
no	DT	O	O
further	JJ	B-PROBLEM	B-PROBLEM
complications	NNS	I-PROBLEM	I-PROBLEM
from	IN	O	O
this	DT	O	O
standpoint	NN	O	O
.	.	O	O

dr.	JJ	O	O
rosean	NN	O	O
fletcher	NN	O	O
,	,	O	O
of	IN	O	O
the	DT	O	O
cardiology	NN	O	O
department	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
,	,	O	O
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
his	PRP$	O	O
opinion	NN	O	O
that	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
sinus	NN	I-PROBLEM	I-PROBLEM
pause	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
related	VBN	O	O
to	TO	O	O
increased	VBN	B-PROBLEM	B-PROBLEM
vagal	JJ	I-PROBLEM	I-PROBLEM
tone	NN	I-PROBLEM	I-PROBLEM
postoperatively	RB	O	O
,	,	O	O
perhaps	RB	O	O
secondary	JJ	O	O
to	TO	O	O
the	DT	B-TREATMENT	O
epidural	JJ	I-TREATMENT	O
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
the	DT	B-TREATMENT	O
patient	NN	I-TREATMENT	O
&apos;s	NNP	I-TREATMENT	O
atenolol	NN	I-TREATMENT	O
use	NN	I-TREATMENT	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TEST
atenolol	NN	I-TREATMENT	I-TEST
was	VBD	O	O
held	VBN	O	O
,	,	O	O
and	CC	O	O
he	PRP	O	O
had	VBD	O	O
no	DT	O	O
further	JJ	B-PROBLEM	B-PROBLEM
pauses	NNS	I-PROBLEM	I-PROBLEM
during	IN	O	O
his	PRP$	O	O
stay	NN	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
postoperative	JJ	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
showed	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
endo	JJ	B-PROBLEM	B-PROBLEM
leak	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
graft	NN	B-PROBLEM	B-PROBLEM
kinking	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

however	RB	O	O
,	,	O	O
he	PRP	O	O
did	VBD	O	O
develop	VB	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
ecchymosis	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
both	DT	I-PROBLEM	I-PROBLEM
groins	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
extending	VBG	O	O
down	RP	O	O
into	IN	O	O
his	PRP$	O	B-PROBLEM
scrotum	NN	O	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
significant	JJ	B-PROBLEM	B-PROBLEM
groin	NN	I-PROBLEM	I-PROBLEM
hematomas	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
adequately	RB	O	O
controlled	VBN	O	O
with	IN	O	O
oral	JJ	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
will	MD	O	O
be	VB	O	O
visited	VBN	O	O
by	IN	O	O
ldamc	NN	O	B-TREATMENT
for	IN	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
and	CC	O	I-TEST
incision	NN	B-TEST	I-TEST
checks	NNS	I-TEST	I-TEST
.	.	O	O

admission	NN	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

acute	JJ	B-PROBLEM	B-PROBLEM
inferior	JJ	I-PROBLEM	I-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
right	JJ	B-PROBLEM	I-PROBLEM
ventricular	NN	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
61	JJ	O	O
-	:	O	O
year-old	JJ	O	O
caucasian-speaking	JJ	O	O
woman	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
tobacco	NN	O	O
use	NN	O	O
who	WP	O	O
developed	VBD	O	O
waxing	VBG	B-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
waning	VBG	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
substernal	JJ	I-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
radiation	NN	B-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
shoulder	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
2011-11-17	JJ	O	O
which	WDT	O	O
lasted	VBD	O	O
that	IN	O	O
entire	JJ	O	O
day	NN	O	O
.	.	O	O

upon	IN	O	O
waking	VBG	O	O
on	IN	O	O
the	DT	O	O
morning	NN	O	O
of	IN	O	O
admission	NN	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
10/10	CD	O	B-PROBLEM
chest	JJS	B-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
associated	VBN	O	O
with	IN	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
presented	VBD	O	O
to	TO	O	O
charlton	VB	O	O
memorial	JJ	O	O
hospital	NN	O	O
hospital	NN	O	O
emergency	NN	O	O
department	NN	O	O
with	IN	O	O
inferior	JJ	B-PROBLEM	B-PROBLEM
st	JJ	I-PROBLEM	I-PROBLEM
elevations	NNS	I-PROBLEM	I-PROBLEM
;	:	O	O
at	IN	O	O
which	WDT	O	O
time	NN	O	O
she	PRP	O	O
became	VBD	O	O
acutely	RB	B-PROBLEM	B-PROBLEM
hypotensive	JJ	I-PROBLEM	I-PROBLEM
to	TO	O	O
a	DT	B-TEST	B-TEST
systolic	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
70	CD	O	O
to	TO	O	O
80	CD	O	O
after	IN	O	O
receiving	VBG	O	O
one	CD	O	B-TREATMENT
ublingual	JJ	B-TREATMENT	I-TREATMENT
nitroglycerin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
then	RB	O	O
became	VBD	O	O
bradycardic	JJ	B-PROBLEM	B-PROBLEM
which	WDT	O	O
responded	VBD	O	O
to	TO	O	O
atropine	VB	B-TREATMENT	B-TREATMENT
and	CC	O	I-TREATMENT
intravenous	JJ	B-TREATMENT	I-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
given	VBN	O	O
aspirin	RB	B-TREATMENT	B-TREATMENT
,	,	O	O
plavix	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

immediately	RB	O	O
prior	JJ	O	O
to	TO	O	O
transfer	VB	O	O
to	TO	O	O
worcester	VB	O	O
state	NN	O	O
hospital	NN	O	O
,	,	O	O
she	PRP	O	O
went	VBD	O	O
into	IN	O	O
ventricular	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
arrest	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
12:30	CD	O	O
p.m.	NN	O	O
,	,	O	O
at	IN	O	O
which	WDT	O	O
time	NN	O	O
she	PRP	O	O
was	VBD	O	O
intubated	VBN	B-TREATMENT	B-TREATMENT
and	CC	O	O
defibrillated	VBN	B-TREATMENT	O
back	RB	O	O
to	TO	O	O
sinus	VB	O	B-PROBLEM
rhythm	NN	O	I-PROBLEM
after	IN	O	I-PROBLEM
five	CD	B-TREATMENT	I-PROBLEM
shocks	NNS	I-TREATMENT	I-PROBLEM
.	.	O	O

she	PRP	O	O
received	VBD	O	O
an	DT	B-TREATMENT	B-TREATMENT
amiodarone	NN	I-TREATMENT	I-TREATMENT
bolus	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
150	CD	O	O
mg	NNS	O	O
intravenously	RB	O	O
and	CC	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
an	DT	B-TREATMENT	B-TREATMENT
amiodarone	NN	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
while	IN	O	O
cmed	VBN	O	O
csru-flighted	JJ	O	O
to	TO	O	O
boston	VB	O	O
regional	JJ	O	O
medical	JJ	O	O
centerr	NN	O	O
where	WRB	O	O
she	PRP	O	O
underwent	VBD	O	O
a	DT	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
.	.	O	O

the	DT	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
total	JJ	I-PROBLEM	I-PROBLEM
occlusion	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
proximal	JJ	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
diffuse	VB	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
received	VBD	O	O
three	CD	B-TREATMENT	B-TREATMENT
stents	NNS	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	O
the	DT	I-TREATMENT	O
right	JJ	I-TREATMENT	O
coronary	NN	I-TREATMENT	O
artery	NN	I-TREATMENT	O
which	WDT	O	O
was	VBD	O	O
complicated	VBN	O	O
by	IN	O	O
a	DT	B-PROBLEM	B-TREATMENT
proximal	JJ	I-PROBLEM	I-TREATMENT
dissection	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
good	JJ	O	O
post	NN	B-TEST	O
percutaneous	JJ	I-TEST	B-TREATMENT
coronary	JJ	I-TEST	I-TREATMENT
intervention	NN	I-TEST	I-TREATMENT
angiographic	JJ	I-TEST	O
results	NNS	I-TEST	O
.	.	O	O

incidentally	RB	O	O
,	,	O	O
an	DT	B-TEST	B-TEST
aortogram	NN	I-TEST	I-TEST
during	IN	O	O
the	DT	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
debakey	JJ	I-PROBLEM	I-PROBLEM
class	NN	I-PROBLEM	I-PROBLEM
i	NN	I-PROBLEM	I-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
ascending	VBG	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
pulmonary	JJ	I-TEST	I-TEST
capillary	JJ	I-TEST	I-TEST
wedge	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
20	CD	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
catheterization	NN	B-TEST	B-TEST
.	.	O	O

she	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
coronary	JJ	O	O
care	NN	O	O
unit	NN	O	O
in	IN	O	O
stable	JJ	O	O
condition	NN	O	O
and	CC	O	O
still	RB	O	O
intubated	VBN	B-TREATMENT	O
.	.	O	O

hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

"	NN	O	O
flumaran	NN	B-TREATMENT	O
"	NN	O	O
for	IN	O	O
circulatory	NN	B-PROBLEM	B-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
receives	VBZ	O	O
this	DT	B-TREATMENT	B-TREATMENT
medication	NN	I-TREATMENT	I-TREATMENT
by	IN	O	O
mail	NN	O	O
from	IN	O	O
her	PRP$	O	O
relatives	NNS	O	O
in	IN	O	O
jill	NN	O	O
.	.	O	O

amiodarone	NN	B-TREATMENT	B-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

2.	CD	O	O
integrilin	JJ	B-TREATMENT	B-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

3.	CD	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

a	DT	O	O
question	NN	O	O
of	IN	O	O
a	DT	B-TREATMENT	B-PROBLEM
sulfa	NN	I-TREATMENT	I-PROBLEM
allergy	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

family	NN	O	O
history	NN	O	O
is	VBZ	O	O
not	RB	O	O
significant	JJ	O	O
for	IN	O	O
any	DT	O	O
early	JJ	O	O
history	NN	O	O
of	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

examination	NN	B-TEST	B-TEST
on	IN	O	O
admission	NN	O	O
to	TO	O	O
the	DT	O	O
coronary	JJ	O	O
care	NN	O	O
unit	NN	O	O
revealed	VBD	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
100/57	CD	O	O
,	,	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
mean	JJ	I-TEST	I-TEST
arterial	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
of	IN	O	O
75	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
was	VBD	O	O
sinus	VBN	O	B-TEST
rhythm	NN	O	I-TEST
at	IN	O	O
75	CD	O	O
,	,	O	O
temperature	NN	B-TEST	B-TEST
was	VBD	O	O
97.6	CD	O	O
,	,	O	O
oxygen	NN	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST
was	VBD	O	O
99%	CD	O	O
on	IN	O	O
assist	NN	B-TREATMENT	O
control	NN	I-TREATMENT	O
with	IN	O	O
a	DT	B-TREATMENT	B-TEST
tidal	JJ	I-TREATMENT	I-TEST
volume	NN	I-TREATMENT	I-TEST
of	IN	O	O
600	CD	O	O
on	IN	O	O
60%	CD	O	O
fio2	NN	B-TREATMENT	O
,	,	O	O
5	CD	O	O
of	IN	O	O
positive	JJ	B-TREATMENT	B-PROBLEM
end-expiratory	JJ	I-TREATMENT	I-PROBLEM
pressure	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

in	IN	O	O
general	JJ	O	O
,	,	O	O
she	PRP	O	O
was	VBD	O	O
sedated	VBN	B-TREATMENT	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
,	,	O	O
responsive	JJ	O	O
to	TO	O	O
stimuli	VB	O	O
,	,	O	O
and	CC	O	O
was	VBD	O	O
following	VBG	O	O
commands	NNS	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
carotids	NNS	I-TEST	I-TEST
were	VBD	O	O
2+	CD	O	O
bilaterally	RB	O	O
.	.	O	O

her	PRP$	O	O
lungs	NNS	O	O
were	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
anteriorly	RB	O	O
.	.	O	O

her	PRP$	O	B-TEST
heart	NN	O	I-TEST
revealed	VBD	O	O
a	DT	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
faint	JJ	I-PROBLEM	I-PROBLEM
second	JJ	I-PROBLEM	I-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
sound	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
second	JJ	O	I-PROBLEM
heart	NN	O	I-PROBLEM
sound	NN	O	I-PROBLEM
.	.	O	O

no	DT	O	O
audible	JJ	B-PROBLEM	B-PROBLEM
extra	JJ	I-PROBLEM	I-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
sounds	VBZ	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	O	O
abdomen	NNS	O	O
was	VBD	O	O
obese	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
had	VBD	O	O
positive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
.	.	O	O

it	PRP	O	O
was	VBD	O	O
soft	JJ	O	O
and	CC	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
peripheral	JJ	B-PROBLEM	B-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
2+	CD	B-TEST	O
peripheral	JJ	I-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
bilaterally	RB	I-TEST	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
laboratories	NNS	I-TEST	I-TEST
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
transfer	NN	O	O
to	TO	O	O
saint	VB	O	O
vincent	JJ	O	O
hospital	NN	O	O
revealed	VBD	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
11.5	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
was	VBD	O	O
42	CD	O	O
on	IN	O	O
admission	NN	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
were	VBD	O	O
242	CD	O	O
.	.	O	O

chemistry-7	NN	B-TEST	B-TEST
was	VBD	O	O
unremarkable	JJ	O	O
.	.	O	O

creatine	NN	B-TEST	B-TEST
kinase	NN	I-TEST	I-TEST
on	IN	O	O
admission	NN	O	O
was	VBD	O	O
309	CD	O	O
,	,	O	O
with	IN	O	O
a	DT	B-TEST	O
mb	NN	I-TEST	O
of	IN	O	O
19.6	CD	O	O
,	,	O	O
an	DT	B-TEST	B-TEST
index	NN	I-TEST	I-TEST
of	IN	O	O
6.3	CD	O	O
,	,	O	O
and	CC	O	O
an	DT	B-TEST	B-TEST
initial	JJ	I-TEST	I-TEST
troponin	NN	I-TEST	I-TEST
of	IN	O	O
0.73	CD	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
chest	JJ	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
revealed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
enlarged	JJ	I-PROBLEM	I-PROBLEM
mediastinum	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
clear	JJ	O	O
lung	NN	O	O
fields	NNS	O	O
bilaterally	RB	O	O
.	.	O	O

initial	JJ	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
showed	VBD	O	O
a	DT	O	O
normal	JJ	O	O
sinus	NN	O	O
rhythm	NN	O	O
at	IN	O	O
65	CD	O	O
,	,	O	O
normal	JJ	O	O
axis	NN	O	O
,	,	O	O
2-mm	JJ	B-PROBLEM	B-PROBLEM
st	NN	I-PROBLEM	I-PROBLEM
elevations	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
lead	JJ	I-PROBLEM	I-PROBLEM
iii	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
1-mm	JJ	B-PROBLEM	B-PROBLEM
st	NN	I-PROBLEM	I-PROBLEM
elevations	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
avf	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
v1	NN	I-PROBLEM	O
,	,	O	O
1-mm	JJ	B-PROBLEM	B-PROBLEM
st	NN	I-PROBLEM	I-PROBLEM
depressions	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
i	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
avl	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
consistent	JJ	O	O
with	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
inferior	JJ	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
ventricular	NN	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

right-sided	JJ	B-TEST	B-TEST
electrocardiograms	NNS	I-TEST	I-TEST
showed	VBD	O	O
1-mm	JJ	B-PROBLEM	B-PROBLEM
st	JJ	I-PROBLEM	I-PROBLEM
elevations	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
v4	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
consistent	JJ	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
ventricular	NN	I-PROBLEM	I-PROBLEM
infarct	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

electrocardiogram	NN	B-TEST	B-TEST
status	NN	O	O
post	NN	O	O
percutaneous	JJ	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
intervention	NN	I-TREATMENT	I-TREATMENT
revealed	VBD	O	O
a	DT	O	O
normal	JJ	O	O
sinus	NN	O	O
rhythm	NN	O	O
at	IN	O	O
84	CD	O	O
,	,	O	O
with	IN	O	O
a	DT	O	O

normal	JJ	O	O
axis	NN	O	O
,	,	O	O
and	CC	O	O
normalizing	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
inferior	JJ	I-PROBLEM	I-PROBLEM
st	NN	I-PROBLEM	I-PROBLEM
segments	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
q	JJ	O	O
waves	NNS	O	O
evolving	VBG	O	O
in	IN	O	O
leads	NNS	O	O
iii	NNS	O	O
and	CC	O	O
avf	NN	O	O
.	.	O	O

an	DT	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
status	NN	O	O
post	NN	O	O
percutaneous	JJ	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
intervention	NN	I-TREATMENT	I-TREATMENT
revealed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
akinetic	JJ	I-PROBLEM	I-PROBLEM
inferior	NN	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
ventricle	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
ascending	VBG	O	O
aorta	NN	O	O
measuring	VBG	O	O
5	CD	O	O
cm	NN	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
effusion	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
the	DT	O	O
night	NN	O	O
of	IN	O	O
admission	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
experienced	VBD	O	O
post	NN	B-PROBLEM	O
catheterization	NN	I-PROBLEM	B-TREATMENT
hypotension	NN	I-PROBLEM	I-TREATMENT
which	WDT	O	O
required	VBD	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
dopamine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

electrocardiogram	VB	B-TEST	B-TEST
the	DT	O	O
following	JJ	O	O
morning	NN	O	O
revealed	VBD	O	O
normalization	NN	O	O
of	IN	O	O
her	PRP$	O	B-PROBLEM
st	JJ	O	I-PROBLEM
segments	NNS	O	I-PROBLEM
with	IN	O	O
evolution	NN	B-PROBLEM	O
of	IN	I-PROBLEM	O
q	NN	I-PROBLEM	O
waves	NNS	I-PROBLEM	O
.	.	O	O

her	PRP$	B-TREATMENT	B-TEST
dopamine	NN	I-TREATMENT	I-TEST
was	VBD	O	O
weaned	VBN	O	O
off	RP	O	O
the	DT	O	O
following	JJ	O	O
day	NN	O	O
,	,	O	O
and	CC	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
heparin	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
secondary	JJ	O	O
to	TO	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
groin	NN	I-PROBLEM	I-PROBLEM
hematoma	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
had	VBD	O	O
developed	VBN	O	O
after	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
sheath	NN	I-TREATMENT	I-TREATMENT
had	VBD	O	O
been	VBN	O	O
pulled	VBN	O	O
out	RP	O	O
by	IN	O	O
the	DT	O	O
fellow	NN	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
creatine	NN	I-TEST	I-TEST
kinases	NNS	I-TEST	I-TEST
climbed	VBD	O	O
;	:	O	O
reaching	VBG	O	O
a	DT	O	O
peak	NN	O	O
of	IN	O	O
3523	CD	O	O
,	,	O	O
which	WDT	O	O
was	VBD	O	O
down	RB	O	O
to	TO	O	O
1500	CD	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

for	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
catheterization	NN	B-TEST	B-TREATMENT
,	,	O	O
she	PRP	O	O
was	VBD	O	O
given	VBN	O	O
integrilin	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
18	CD	O	O
hours	NNS	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
continued	VBN	O	O
on	IN	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
plavix	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

for	IN	O	O
her	PRP$	O	B-TEST
rhythm	NN	O	I-TEST
,	,	O	O
amiodarone	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
as	IN	O	O
she	PRP	O	O
was	VBD	O	O
maintained	VBN	O	O
in	IN	O	O
sinus	NN	O	B-PROBLEM
rhythm	NN	O	I-PROBLEM
after	IN	O	O
moving	VBG	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
.	.	O	O

for	IN	O	O
pump	NN	O	O
,	,	O	O
once	RB	O	O
transferred	VBN	O	O
out	IN	O	O
of	IN	O	O
the	DT	O	O
coronary	JJ	O	O
care	NN	O	O
unit	NN	O	O
on	IN	O	O
2011-11-20	JJ	O	O
,	,	O	O
a	DT	B-TREATMENT	B-TREATMENT
beta	NN	I-TREATMENT	I-TREATMENT
blocker	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
begun	VBN	O	O
at	IN	O	O
12.5	CD	O	O
mg	NN	O	O
of	IN	O	O
lopressor	NN	B-TREATMENT	O
p.o.	NN	O	O
b.i.d.	NN	O	O
which	WDT	O	O
was	VBD	O	O
titrated	VBN	O	O
to	TO	O	O
25	CD	O	O
mg	NN	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

also	RB	O	O
,	,	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
,	,	O	O
for	IN	O	O
increased	VBN	B-TREATMENT	B-PROBLEM
afterload	NN	I-TREATMENT	I-PROBLEM
reduction	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
lisinopril	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

on	IN	O	O
2011-11-21	JJ	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
experienced	VBD	O	O
atypical	JJ	B-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
made	VBN	O	O
worse	NN	O	O
with	IN	O	O
inspiration	NN	O	O
and	CC	O	O
movement	NN	O	O
.	.	O	O

it	PRP	O	O
was	VBD	O	O
not	RB	O	O
associated	VBN	O	O
with	IN	O	O
any	DT	B-PROBLEM	O
nausea	NN	I-PROBLEM	B-PROBLEM
or	CC	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
pain	JJ	B-PROBLEM	B-PROBLEM
secondary	JJ	O	O
to	TO	O	O
her	PRP$	B-PROBLEM	B-TEST
self-extubation	NN	I-PROBLEM	I-TEST
and	CC	O	O
noncardiac	JJ	B-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
was	VBD	O	O
checked	VBN	O	O
which	WDT	O	O
revealed	VBD	O	O
no	DT	O	O
st	NN	B-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
there	EX	O	O
was	VBD	O	O
no	DT	O	O
increase	NN	O	O
in	IN	O	O
her	PRP$	O	O
downward	JJ	O	O
trending	NN	O	O
creatine	NN	B-TEST	B-TREATMENT
phosphokinases	NNS	I-TEST	I-TREATMENT
.	.	O	O

no	DT	O	O
further	JJ	B-TREATMENT	B-TREATMENT
intervention	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
done	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
tylenol	NN	B-TREATMENT	B-TREATMENT
orally	RB	I-TREATMENT	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
ativan	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
anxiety	NN	B-PROBLEM	B-PROBLEM
that	IN	O	O
she	PRP	O	O
had	VBD	O	O
about	IN	O	O
going	VBG	O	O
home	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
pain	RB	B-PROBLEM	B-PROBLEM
free	JJ	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

regarding	VBG	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
ascending	NN	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
cardiothoracic	NN	O	B-TREATMENT
surgery	NN	O	I-TREATMENT
was	VBD	O	O
consulted	VBN	O	O
regarding	VBG	O	O
further	JJ	B-TEST	B-TEST
workup	NN	I-TEST	I-TEST
.	.	O	O

at	IN	O	O
their	PRP$	O	O
request	NN	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
ct	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
chest	NN	I-TEST	I-TEST
with	IN	O	I-TEST
contrast	NN	B-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
on	IN	O	O
the	DT	O	O
day	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

dr.	NN	O	O
streeter	NN	O	O
from	IN	O	O
cardiothoracic	NN	O	B-TREATMENT
surgery	NN	O	I-TREATMENT
will	MD	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
the	DT	O	O
patient	NN	O	O
for	IN	O	O
further	JJ	B-TREATMENT	B-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
approximately	RB	O	O
one	CD	O	O
month	NN	O	O
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
.	.	O	O

she	PRP	O	O
complained	VBD	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
sore	NN	I-PROBLEM	I-PROBLEM
throat	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
likely	RB	O	O
the	DT	O	O
etiology	NN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
atypical	JJ	I-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
complaints	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
resolved	VBN	O	O
with	IN	O	O
tylenol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
as	IN	O	O
needed	JJ	O	O
doses	NNS	O	O
of	IN	O	O
oxycodone	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

her	PRP$	O	O
lungs	NNS	O	O
remained	VBD	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	O	O
throughout	IN	O	O
the	DT	O	O
remainder	NN	O	O
of	IN	O	O
her	PRP$	O	B-TREATMENT
hospital	JJ	O	I-TREATMENT
course	NN	O	I-TREATMENT
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
this	DT	O	O
dictation	NN	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
her	PRP$	I-TEST	I-TEST
chest	NN	I-TEST	I-TEST
was	VBD	O	O
still	RB	O	O
pending	VBG	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
electrolytes	NNS	I-TEST	I-TEST
sere	RB	O	O
managed	VBN	O	O
daily	RB	O	O
and	CC	O	O
repleted	VBN	O	O
on	IN	O	O
an	DT	O	O
as	IN	O	O
needed	JJ	O	O
basis	NN	O	O
.	.	O	O

she	PRP	O	O
did	VBD	O	O
receive	VB	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
k-phos	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
phosphorous	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
1.5	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
phosphorous	JJ	I-TEST	I-TEST
rose	VBD	O	O
appropriately	RB	O	O
to	TO	O	O
3.6	CD	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

2.	CD	O	O
in	IN	O	O
addition	NN	O	O
,	,	O	O
as	IN	O	O
stated	VBN	O	O
above	IN	O	O
,	,	O	O
dr.hastings	NNS	O	O
office	NN	O	O
from	IN	O	O
cardiothoracic	NN	O	B-TREATMENT
surgery	NN	O	I-TREATMENT
will	MD	O	O
be	VB	O	O
in	IN	O	O
contact	NN	O	O
with	IN	O	O
ms.	JJ	O	O
williams	NNS	O	O
to	TO	O	O
arrange	VB	O	O
followup	NN	O	O
for	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
ascending	VBG	I-PROBLEM	I-PROBLEM
aortic	JJ	I-PROBLEM	I-PROBLEM
aneurysm	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
approximately	RB	O	O
one	CD	O	O
month	NN	O	O
.	.	O	O

1.	CD	O	O
lisinopril	JJ	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

2.	CD	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O

3.	CD	O	O
plavix	JJ	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

4.	CD	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

5.	CD	O	O
protonix	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

6.	CD	O	O
enteric-coated	JJ	B-TREATMENT	B-TREATMENT
aspirin	NN	I-TREATMENT	I-TREATMENT
325	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

1.	CD	O	O
inferior	JJ	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
right	JJ	B-PROBLEM	I-PROBLEM
ventricular	NN	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

status	NN	O	O
post	NN	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
and	CC	O	O
stents	NNS	B-TREATMENT	B-TREATMENT
times	NNS	O	O
three	CD	O	O
of	IN	O	O
the	DT	O	O
right	JJ	O	O
coronary	JJ	O	O
artery	NN	O	O
.	.	O	O

2.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

3.	CD	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
75	CD	O	O
year	NN	O	O
old	JJ	O	O
righthanded	VBD	O	O
caucasian	JJ	O	O
female	NN	O	O
who	WP	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
fairm	NN	O	O
of	IN	O	O
ijordcompmac	JJ	O	O
hospital	NN	O	O
because	IN	O	O
of	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
facial	JJ	I-PROBLEM	I-PROBLEM
droop	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
hand	NN	B-PROBLEM	I-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
after	IN	O	O
glaucoma	NN	B-TREATMENT	B-TREATMENT
laser	NN	I-TREATMENT	I-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
sas	NN	O	O
general	JJ	O	O
hospital	NN	O	O
for	IN	O	O
further	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
of	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
setting	NN	O	O
of	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
medical	JJ	I-PROBLEM	I-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
o.d.	VBN	B-TREATMENT	O
glaucoma	NN	I-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
1400	CD	O	O
hours	NNS	O	O
,	,	O	O
on	IN	O	O
may	MD	O	O
12th	CD	O	O
,	,	O	O
1992	CD	O	O
.	.	O	O

soon	RB	O	O
after	IN	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
the	DT	O	O
patient	NN	O	O
noted	VBD	O	O
her	PRP$	O	B-PROBLEM
left	JJ	O	I-PROBLEM
lower	JJR	O	I-PROBLEM
face	NN	O	I-PROBLEM
and	CC	O	O
hand	NN	O	O
were	VBD	O	O
weak	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
brought	VBN	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
where	WRB	O	O
she	PRP	O	O
was	VBD	O	O
evaluated	VBN	O	O
and	CC	O	O
determined	VBN	O	O
to	TO	O	O
have	VB	O	O
had	VBN	O	O
a	DT	B-PROBLEM	B-PROBLEM
cerebrovascular	JJ	I-PROBLEM	I-PROBLEM
accident	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
absolutely	RB	O	O
no	DT	O	O
neurologic	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
past	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
review	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
systems	NNS	I-TEST	I-TEST
is	VBZ	O	O
negative	JJ	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
two	CD	O	O
days	NNS	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
,	,	O	O
one	CD	O	O
family	NN	O	O
member	NN	O	O
noted	VBD	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
transient	NN	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
facial	JJ	I-PROBLEM	I-PROBLEM
droop	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
potassium	NN	I-TEST	I-TEST
three	CD	O	O
days	NNS	O	O
prior	RB	O	O
to	TO	O	O
surgery	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
2.8	CD	O	O
,	,	O	O
the	DT	B-TEST	B-TEST
level	NN	I-TEST	I-TEST
being	VBG	O	O
normalized	VBN	O	O
with	IN	O	O
p.o.	JJ	B-TREATMENT	B-TEST
kay	NN	I-TREATMENT	I-TEST
ciel	NN	I-TREATMENT	I-TEST
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
mi	NN	B-PROBLEM	O
in	IN	O	O
1989	CD	O	O
,	,	O	O
no	DT	O	O
angina	NN	B-PROBLEM	B-PROBLEM
before	IN	O	O
or	CC	O	O
after	IN	O	O
.	.	O	O

#	#	O	O
2.	CD	O	O
history	NN	O	O
of	IN	O	O
m.	NN	B-PROBLEM	O
kansasaii	NN	I-PROBLEM	O
with	IN	O	O
workup	NN	B-TEST	B-TEST
by	IN	O	O
dr.	NN	O	O
screen	NN	O	O
at	IN	O	O
sas	JJ	O	O
general	JJ	O	O
hospital	NN	O	O
proceeding	VBG	O	O
currently	RB	O	O
.	.	O	O

#	#	O	O
3.	CD	O	O
history	NN	O	O
of	IN	O	O
breast	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

in	IN	O	O
december	NN	O	O
1990	CD	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
lumpectomy	NN	I-TREATMENT	I-TREATMENT
,	,	I-TREATMENT	O
from	IN	I-TREATMENT	O
left	VBN	I-TREATMENT	O
breast	NN	I-TREATMENT	O
,	,	O	O
and	CC	O	O
xrt	NNP	B-TREATMENT	O
x	NNP	O	O
35	CD	O	O
.	.	O	O

no	DT	O	O
axillary	JJ	B-TREATMENT	B-PROBLEM
dissection	NN	I-TREATMENT	I-PROBLEM
was	VBD	O	O
done	VBN	O	O
because	IN	O	O
she	PRP	O	O
was	VBD	O	O
status	NN	O	O
post	NN	O	O
mi	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
received	VBD	O	O
tamoxifen	JJ	B-TREATMENT	B-TREATMENT
briefly	NN	O	I-TREATMENT
.	.	O	O

mammogram	NN	B-TEST	B-TEST
was	VBD	O	O
normal	JJ	O	O
7/92	CD	O	O
,	,	O	O
and	CC	O	O
5/92	CD	O	O
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
allergic	JJ	B-PROBLEM	B-PROBLEM
to	TO	O	O
amoxicillin	VB	B-TREATMENT	B-TREATMENT
,	,	O	O
having	VBG	O	O
developed	VBN	O	O
a	DT	B-PROBLEM	B-PROBLEM
rash	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
does	VBZ	O	O
not	RB	O	O
smoke	VB	O	O
,	,	O	O
does	VBZ	O	O
not	RB	O	O
drink	VB	O	O
.	.	O	O

dyazide	RB	B-TREATMENT	O
one	CD	O	O
p.o.	NN	O	O
q.d.	NN	O	O
propanolol	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg.	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O
isordil	NN	B-TREATMENT	O
5	CD	O	O
mg.	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O
glaucoma	NN	B-TREATMENT	B-PROBLEM
drops	NNS	I-TREATMENT	I-PROBLEM
.	.	O	O

blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
118/75	CD	O	O
,	,	O	O
pulse	RB	B-TEST	B-TEST
88	CD	O	O
,	,	O	O
respirations	NNS	B-TEST	B-TEST
20	CD	O	O
,	,	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

head	NN	B-TEST	B-TEST
and	CC	I-TEST	I-TEST
neck	NN	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
was	VBD	O	O
unremarkable	JJ	O	O
,	,	O	O
except	IN	O	O
for	IN	O	O
the	DT	O	O
right	NN	O	O
eye	NN	O	O
being	VBG	O	O
patched	VBN	O	O
over	IN	O	O
.	.	O	O

back	RB	O	O
was	VBD	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
jugular	JJ	B-TEST	B-TEST
venous	JJ	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
normal	JJ	O	O
,	,	O	O
no	DT	O	O
carotid	NN	B-PROBLEM	B-PROBLEM
bruit	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
;	:	O	O
murmur	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
rub	NN	B-PROBLEM	O
,	,	O	O
gallop	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
click	NN	B-PROBLEM	O
and	CC	O	O
ectopy	NN	B-PROBLEM	B-TREATMENT
were	VBD	O	O
absent	JJ	O	O
.	.	O	O

rectal	JJ	B-TEST	O
tone	NN	I-TEST	O
was	VBD	O	O
normal	JJ	O	O
,	,	O	O
guaiac	JJ	B-TEST	B-TEST
negative	JJ	O	O
stool	NN	O	O
.	.	O	O

without	IN	O	O
clubbing	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
stigmata	NN	B-PROBLEM	B-PROBLEM
of	IN	O	I-PROBLEM
subacute	JJ	B-PROBLEM	I-PROBLEM
bacterial	JJ	I-PROBLEM	I-PROBLEM
endocarditis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

extensive	JJ	B-TEST	B-TEST
mental	NN	I-TEST	I-TEST
status	NN	I-TEST	I-TEST
testing	VBG	I-TEST	I-TEST
was	VBD	O	O
normal	JJ	O	O
,	,	O	O
except	IN	O	O
for	IN	O	O
recalling	VBG	O	O
only	RB	O	O
one	CD	O	O
out	NN	O	O
of	IN	O	O
three	CD	O	O
objects	NNS	O	O
at	IN	O	O
five	CD	O	O
minutes	NNS	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
a	DT	O	O
touch	JJ	O	O
an	DT	B-PROBLEM	B-PROBLEM
anosognosia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

visual	JJ	O	O
fields	NNS	O	O
were	VBD	O	O
full	JJ	O	O
o.s.	NN	O	O
,	,	O	O
visual	JJ	B-TEST	B-TEST
acuity	NN	I-TEST	I-TEST
was	VBD	O	O
20/70	CD	O	O
o.s.	NN	O	O

pupil	JJ	B-TEST	O
o.s.	RB	I-TEST	O
reacted	VBD	O	O
to	TO	O	O
light	NN	O	O
.	.	O	O

eoms	NNS	O	O
with	IN	O	O
full	JJ	O	O
range	NN	O	O
of	IN	O	O
movement	NN	O	O
,	,	O	O
no	DT	O	O
nystagmus	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

inferior	JJ	B-PROBLEM	B-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
weak	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
gag	NN	B-PROBLEM	B-PROBLEM
was	VBD	O	O
present	JJ	O	O
.	.	O	O

dtrs	NN	B-TEST	O
showed	VBD	O	O
a	DT	O	B-PROBLEM
mild	JJ	O	I-PROBLEM
decrease	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
left	JJ	B-PROBLEM	I-PROBLEM
biceps	NNS	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
brachioradialis	NN	I-PROBLEM	B-TEST
reflexes	NNS	I-PROBLEM	I-TEST
,	,	O	O
otherwise	RB	O	O
normal	JJ	O	O
tone	NN	O	O
,	,	O	O
symmetrical	JJ	O	B-TEST
reflexes	NNS	O	I-TEST
,	,	O	O
downgoing	VBG	O	O
toes	NNS	O	O
.	.	O	O

no	DT	O	O
atrophy	NN	B-PROBLEM	B-PROBLEM
was	VBD	O	O
noted	VBN	O	O
.	.	O	O

sensory	NN	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
showed	VBD	O	O
some	DT	O	B-PROBLEM
leftsided	JJ	B-PROBLEM	I-PROBLEM
errors	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
pinprick	NN	O	B-PROBLEM
and	CC	O	I-PROBLEM
proprioception	NN	O	I-PROBLEM
.	.	O	O

finger	NN	B-TEST	O
/	VBD	I-TEST	O
to/nose	NN	I-TEST	B-PROBLEM
was	VBD	O	O
with	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
dysmetria	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
exaggerated	VBN	O	O
on	IN	O	O
tracking	VBG	O	O
;	:	O	O
rapid	JJ	O	B-PROBLEM
alternating	VBG	O	O
movements	NNS	O	O
normal	JJ	O	O
,	,	O	O
heel-to-shin	JJ	B-TEST	O
was	VBD	O	O
good	JJ	O	O
with	IN	O	O
few	JJ	B-PROBLEM	B-PROBLEM
errors	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

chest	NN	B-TEST	B-TEST
xray	NN	I-TEST	I-TEST
showed	VBD	O	O
expanded	JJ	O	B-PROBLEM
lungs	NNS	O	I-PROBLEM
with	IN	O	O
biapical	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
opacities	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

ekg	NN	B-TEST	O
:	:	O	O

left	VBN	B-PROBLEM	B-PROBLEM
bundle	JJ	I-PROBLEM	I-PROBLEM
branch	NN	I-PROBLEM	I-PROBLEM
block	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

urinalysis	NN	B-TEST	B-TEST
was	VBD	O	O
unremarkable	JJ	O	O
.	.	O	O

bun	NN	B-TEST	B-TEST
27	CD	O	O
,	,	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
of	IN	O	O
.9	NNP	O	O
,	,	O	O
glucose	NN	B-TEST	B-TEST
was	VBD	O	O
182	CD	O	O
,	,	O	O
but	CC	O	O
otherwise	RB	O	O
electrolytes	NNS	B-TEST	B-TEST
were	VBD	O	O
normal	JJ	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
admitting	VBG	I-TEST	I-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
45%	CD	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
7,700	CD	O	O
,	,	O	O
with	IN	O	O
an	DT	B-TEST	B-TEST
mcv	NN	I-TEST	I-TEST
of	IN	O	O
92	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
were	VBD	O	O
normal	JJ	O	O
at	IN	O	O
263,000	CD	O	O
.	.	O	O

albumin	RB	B-TEST	B-TEST
2.5	CD	O	O
.	.	O	O

#	#	O	O
1.	CD	O	O
cerebrovascular	JJ	B-PROBLEM	B-PROBLEM
accident	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
suffered	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
mild	NN	I-PROBLEM	I-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
attributed	VBN	O	O
to	TO	O	O
stenosis	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
internal	JJ	I-PROBLEM	I-PROBLEM
carotid	NN	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
was	VBD	O	O
determined	VBN	O	O
by	IN	O	O
head	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
,	,	O	I-TEST
head	NN	B-TEST	I-TEST
mri	NN	I-TEST	I-TEST
,	,	O	I-TEST
head	NN	B-TEST	I-TEST
mra	NN	I-TEST	I-TEST
,	,	O	I-TEST
carotid	VBP	B-TEST	I-TEST
noninvasive	JJ	I-TEST	I-TEST
studies	NNS	I-TEST	I-TEST
,	,	O	O
transcranial	JJ	B-TEST	B-TEST
dopplers	NNS	I-TEST	I-TEST
.	.	O	O

the	DT	O	O
possibility	NN	O	O
of	IN	O	O
a	DT	O	O
cardiac	JJ	O	O
origin	NN	O	O
was	VBD	O	O
evaluated	VBN	O	O
by	IN	O	O
echocardiogram	NN	B-TEST	B-TEST
and	CC	O	I-TEST
holter	NN	B-TEST	I-TEST
monitor	NN	I-TEST	I-TEST
.	.	O	O

her	PRP$	B-TEST	B-TEST
echocardiogram	NN	I-TEST	I-TEST
curiously	RB	O	O
showed	VBD	O	O
a	DT	O	O
normal	JJ	O	O
left	JJ	O	O
ventricular	JJ	O	O
size	NN	O	O
and	CC	O	O
systolic	JJ	O	O
function	NN	O	O
,	,	O	O
a	DT	B-PROBLEM	B-PROBLEM
patent	NN	I-PROBLEM	I-PROBLEM
foramen	NNS	I-PROBLEM	I-PROBLEM
ovale	JJ	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
a	DT	B-PROBLEM	O
trace	NN	I-PROBLEM	O
right	NN	I-PROBLEM	O
to	TO	I-PROBLEM	O
left	VB	I-PROBLEM	B-TREATMENT
shunt	NN	I-PROBLEM	I-TREATMENT
,	,	O	O
as	IN	O	O
determined	VBN	O	O
by	IN	O	O
bubble	JJ	B-TEST	B-TEST
study	NN	I-TEST	I-TEST
,	,	O	O
trace	NN	B-PROBLEM	O
mr	NN	I-PROBLEM	O
was	VBD	O	O
present	JJ	O	O
.	.	O	O

previous	JJ	B-TEST	O
echoes	NNS	I-TEST	O
have	VBP	O	O
shown	VBN	O	O
mvp	NNS	B-PROBLEM	O
at	IN	O	O
the	DT	O	O
ona	JJ	O	O
hospital	NN	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
holter	NN	I-TEST	I-TEST
showed	VBD	O	O
up	IN	O	O
to	TO	O	O
12	CD	O	O
beats	NNS	O	O
of	IN	O	O
svt	NN	B-PROBLEM	O
,	,	O	O
but	CC	O	O
was	VBD	O	O
otherwise	RB	O	O
unremarkable	JJ	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
anticoagulated	VBN	O	O
with	IN	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
after	IN	O	O
several	JJ	O	O
days	NNS	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
started	VBN	O	O
.	.	O	O

her	PRP$	B-TREATMENT	B-TEST
exact	JJ	I-TREATMENT	I-TEST
coumadin	NN	I-TREATMENT	I-TEST
dose	NN	I-TREATMENT	I-TEST
is	VBZ	O	O
undetermined	VBN	O	O
at	IN	O	O
this	DT	O	O
point	NN	O	O
,	,	O	O
however	RB	O	O
it	PRP	O	O
looks	VBZ	O	O
like	IN	O	O
it	PRP	O	O
will	MD	O	O
be	VB	O	O
something	NN	O	O
around	IN	O	O
5	CD	O	O
mg	NNS	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

her	PRP$	B-TEST	O
pro	JJ	I-TEST	O
time	NN	I-TEST	O
and	CC	O	O
ptt	NNS	B-TEST	B-TEST
have	VBP	O	O
normalized	VBN	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

she	PRP	O	O
needs	VBZ	O	O
to	TO	O	O
be	VB	O	O
given	VBN	O	O
5	CD	O	O
mg	NN	O	O
of	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
tonight	NN	O	I-TREATMENT
,	,	O	O
5/22/92	CD	O	O
.	.	O	O

in	IN	O	O
addition	NN	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
should	MD	O	O
be	VB	O	O
started	VBN	O	O
to	TO	O	O
drip	VB	O	O
on	IN	O	O
arrival	NN	O	O
at	IN	O	O
400	CD	O	O
units	NNS	O	O
an	DT	O	O
hour	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
received	VBN	O	O
physical	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
occupational	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
her	PRP$	O	O
recovery	NN	O	O
is	VBZ	O	O
near	IN	O	O
complete	JJ	O	O
.	.	O	O

during	IN	O	O
evaluation	NN	B-TEST	B-TEST
of	IN	I-TEST	O
her	PRP$	I-TEST	B-PROBLEM
neurologic	JJ	I-TEST	I-PROBLEM
status	NN	I-TEST	I-PROBLEM
,	,	O	O
it	PRP	O	O
was	VBD	O	O
determined	VBN	O	O
that	IN	O	O
for	IN	O	O
several	JJ	O	O
months	NNS	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
been	VBN	O	O
too	RB	B-PROBLEM	O
unsteady	JJ	I-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
ambulate	VB	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	B-TEST	O
our	PRP$	I-TEST	B-TEST
exam	NN	I-TEST	I-TEST
she	PRP	O	O
is	VBZ	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	O	O
significant	JJ	O	O
amount	NN	O	O
of	IN	O	O
ataxia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
especially	RB	O	B-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
midline	NN	O	I-PROBLEM
and	CC	O	O
the	DT	O	O
exact	JJ	O	O
cause	NN	O	O
of	IN	O	O
this	DT	O	O
is	VBZ	O	O
unknown	JJ	O	O
.	.	O	O

there	EX	O	O
are	VBP	O	O
multiple	JJ	O	O
possible	JJ	O	O
contributions	NNS	O	O
and	CC	O	O
this	DT	O	O
is	VBZ	O	O
where	WRB	O	O
her	PRP$	O	O
need	NN	O	O
for	IN	O	O
careful	JJ	B-TEST	B-TEST
internal	JJ	I-TEST	I-TEST
medical	JJ	I-TEST	I-TEST
evaluation	NN	I-TEST	I-TEST
has	VBZ	O	O
arisen	VBN	O	O
.	.	O	O

at	IN	O	O
the	DT	O	O
time	NN	O	O
we	PRP	O	O
were	VBD	O	O
to	TO	O	O
embark	VB	O	O
on	IN	O	O
this	DT	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
,	,	O	O
the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
family	NN	O	O
strongly	RB	O	O
requested	VBD	O	O
that	IN	O	O
she	PRP	O	O
be	VB	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
sas	NN	O	O
general	JJ	O	O
hospital	NN	O	O
.	.	O	O

what	WP	O	O
follows	VBZ	O	O
is	VBZ	O	O
a	DT	O	O
summary	NN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
medical	JJ	I-PROBLEM	I-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
their	PRP$	O	O
possible	JJ	O	O
relationship	NN	O	O
to	TO	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
ataxia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	B-PROBLEM	B-PROBLEM
ataxia	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
likely	JJ	O	O
due	JJ	O	O
to	TO	O	O
some	DT	O	B-PROBLEM
cerebellar	JJ	O	I-PROBLEM
function	NN	O	I-PROBLEM
,	,	O	O
though	IN	O	O
this	DT	O	O
is	VBZ	O	O
not	RB	O	O
certain	JJ	O	O
.	.	O	O

moreover	RB	O	O
her	PRP$	B-TEST	O
mri	NN	I-TEST	O
did	VBD	O	O
not	RB	O	O
show	VB	O	O
any	DT	B-PROBLEM	B-PROBLEM
discrete	JJ	I-PROBLEM	I-PROBLEM
cerebellar	JJ	I-PROBLEM	I-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

our	PRP$	O	O
leading	VBG	O	O
theory	NN	O	O
at	IN	O	O
this	DT	O	O
point	NN	O	O
is	VBZ	O	O
that	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
cerebellar	JJ	I-PROBLEM	I-PROBLEM
dysfunction	NN	I-PROBLEM	I-PROBLEM
relates	VBZ	O	O
to	TO	O	O
perineoplastic	JJ	B-PROBLEM	B-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
relating	VBG	O	O
to	TO	O	O
her	PRP$	O	O
history	NN	O	O
of	IN	O	O
breast	NN	B-PROBLEM	O
ca	MD	I-PROBLEM	O
.	.	O	O

as	IN	O	O
i	NN	O	O
mentioned	VBD	O	O
above	IN	O	O
,	,	O	O
her	PRP$	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
was	VBD	O	O
limited	VBN	O	O
by	IN	O	O
her	PRP$	O	B-PROBLEM
cardiologic	NN	O	I-PROBLEM
status	NN	O	I-PROBLEM
at	IN	O	O
the	DT	O	O
time	NN	O	O
.	.	O	O

while	IN	O	O
mammogram	NNS	B-TEST	B-TEST
and	CC	O	I-TEST
ca-15.3	NN	B-TEST	I-TEST
and	CC	O	I-TEST
breast	NN	B-TEST	I-TEST
exam	NNS	I-TEST	I-TEST
are	VBP	O	O
all	DT	O	O
normal	JJ	O	O
,	,	O	O
the	DT	O	O
idea	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
perineoplastic	JJ	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
or	CC	O	O
without	IN	O	O
concomitant	JJ	B-PROBLEM	B-TREATMENT
breast	NN	I-PROBLEM	I-TREATMENT
ca	MD	I-PROBLEM	O
has	VBZ	O	O
reared	VBN	O	O
its	PRP$	O	O
head	NN	O	O
.	.	O	O

two	CD	O	O
possible	JJ	O	O
markers	NNS	O	O
are	VBP	O	O
anti-hu	JJ	B-PROBLEM	B-PROBLEM
syndrome	JJ	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
anti-yo	JJ	B-TEST	I-PROBLEM
antibody	NN	I-TEST	I-PROBLEM
.	.	O	O

these	DT	B-TEST	B-TEST
tests	NNS	I-TEST	I-TEST
were	VBD	O	O
sent	VBN	O	O
on	IN	O	O
the	DT	O	O
18th	CD	O	O
and	CC	O	O
are	VBP	O	O
pending	VBG	O	O
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
.	.	O	O

the	DT	B-TEST	O
results	NNS	I-TEST	O
can	MD	O	O
be	VB	O	O
obtained	VBN	O	O
by	IN	O	O
paging	VBG	O	O
me	PRP	O	O
,	,	O	O
do	VBP	O	O
a.	JJ	O	O
joasscchird	NN	O	O
,	,	O	O
m.d.	NN	O	O
at	IN	O	O
834-364-2251	JJ	O	O
.	.	O	O

i	NN	O	O
will	MD	O	O
be	VB	O	O
happy	JJ	O	O
to	TO	O	O
furnish	VB	O	O
the	DT	B-TEST	O
results	NNS	I-TEST	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
mi	NN	B-PROBLEM	O
in	IN	O	O
1989	CD	O	O
.	.	O	O

echocardiogram	NN	B-TEST	B-TEST
no	RB	O	O
longer	RBR	O	O
shows	VBZ	O	O
wall	DT	B-PROBLEM	B-PROBLEM
motion	NN	I-PROBLEM	I-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

ekg	NN	B-TEST	O
,	,	O	O
when	WRB	O	O
the	DT	O	O
patient	NN	O	O
goes	VBZ	O	O
out	IN	O	O
of	IN	O	O
left	JJ	B-PROBLEM	B-PROBLEM
bundle	JJ	I-PROBLEM	I-PROBLEM
branch	NN	I-PROBLEM	I-PROBLEM
block	NN	I-PROBLEM	I-PROBLEM
transiently	RB	O	O
shows	VBZ	O	O
an	DT	B-PROBLEM	B-PROBLEM
anterolateral	JJ	I-PROBLEM	I-PROBLEM
q/wave	NN	I-PROBLEM	I-PROBLEM
inversion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

we	PRP	O	O
would	MD	O	O
like	VB	O	O
to	TO	O	O
discontinue	VB	O	O
her	PRP$	B-TREATMENT	O
isordil	NN	I-TREATMENT	O
to	TO	O	O
improve	VB	O	O
upon	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
orthostatic	JJ	I-PROBLEM	I-PROBLEM
hypotension	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
we	PRP	O	O
are	VBP	O	O
not	RB	O	O
certain	JJ	O	O
whether	IN	O	O
her	PRP$	O	O
heart	NN	O	O
will	MD	O	O
tolerate	VB	O	O
this	DT	O	O
.	.	O	O

persantine	NN	B-TEST	B-TREATMENT
thallium	NN	I-TEST	I-TREATMENT
is	VBZ	O	O
scheduled	VBN	O	O
at	IN	O	O
this	DT	O	O
time	NN	O	O
,	,	O	O
but	CC	O	O
is	VBZ	O	O
yet	RB	O	O
to	TO	O	O
be	VB	O	O
performed	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
orthostatic	JJ	B-PROBLEM	B-PROBLEM
hypotension	NN	I-PROBLEM	I-PROBLEM
x	NNP	O	O
many	JJ	O	O
years	NNS	O	O
.	.	O	O

during	IN	O	O
her	PRP$	O	O
hospitalization	NN	O	O
,	,	O	O
we	PRP	O	O
confirmed	VBD	O	O
the	DT	O	O
presence	NN	O	O
of	IN	O	O
this	DT	O	O
,	,	O	O
even	RB	O	O
when	WRB	O	O
she	PRP	O	O
was	VBD	O	O
hydrated	VBN	O	O
with	IN	O	O
saline	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
to	TO	O	O
a	DT	B-TEST	B-TEST
fractional	JJ	I-TEST	I-TEST
excretion	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
sodium	NN	I-TEST	I-TEST
of	IN	O	O
2%	CD	O	O
.	.	O	O

studies	NNS	B-TEST	B-TEST
of	IN	I-TEST	O
her	PRP$	I-TEST	B-PROBLEM
autonomic	JJ	I-TEST	I-PROBLEM
system	NN	I-TEST	I-PROBLEM
did	VBD	O	O
not	RB	O	O
document	VB	O	O
any	DT	B-PROBLEM	O
dysautonomia	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

studies	NNS	B-TEST	B-TEST
of	IN	I-TEST	I-TEST
skin	NN	I-TEST	I-TEST
galvanic	JJ	I-TEST	I-TEST
conduction	NN	I-TEST	I-TEST
were	VBD	O	O
normal	JJ	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
rr	NN	I-TEST	I-TEST
interval	JJ	I-TEST	I-TEST
evaluation	NN	I-TEST	I-TEST
was	VBD	O	O
not	RB	O	O
abnormal	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

this	DT	O	O
is	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
chronic	JJ	I-PROBLEM	I-PROBLEM
problem	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
may	MD	O	O
be	VB	O	O
contributing	VBG	O	O
to	TO	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
current	JJ	I-PROBLEM	I-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
inability	NN	B-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
walk	VB	I-PROBLEM	I-PROBLEM
.	.	O	O

florinef	NN	B-TREATMENT	O
is	VBZ	O	O
to	TO	O	O
be	VB	O	O
considered	VBN	O	O
,	,	O	O
however	RB	O	O
stopping	VBG	O	O
the	DT	B-TREATMENT	O
isordil	NN	I-TREATMENT	O
is	VBZ	O	O
one	CD	O	O
goal	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
bronchiectasis	NN	B-PROBLEM	B-PROBLEM
from	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
childhood	NN	I-PROBLEM	I-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

in	IN	O	O
addition	NN	O	O
there	EX	O	O
is	VBZ	O	O
a	DT	O	O
distant	JJ	O	O
history	NN	O	O
of	IN	O	O
m.	NN	B-PROBLEM	B-PROBLEM
kansasaii	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
has	VBZ	O	O
been	VBN	O	O
evaluated	VBN	O	O
by	IN	O	O
dr.	NN	O	O
screen	NN	O	O
at	IN	O	O
sas	JJ	O	O
general	JJ	O	O
hospital	NN	O	O
and	CC	O	O
probably	RB	O	O
relates	VBZ	O	O
to	TO	O	O
her	PRP$	B-TEST	B-TEST
lung	NN	I-TEST	I-TEST
xray	NN	I-TEST	I-TEST
.	.	O	O

ct	NN	B-TEST	B-TEST
at	IN	O	O
the	DT	O	O
ona	JJ	O	O
hospital	NN	O	O
in	IN	O	O
1989	CD	O	O
showed	VBD	O	O
similar	JJ	O	O
findings	NNS	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
chest	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
was	VBD	O	O
to	TO	O	O
be	VB	O	O
performed	VBN	O	O
and	CC	O	O
may	MD	O	O
be	VB	O	O
yielding	VBG	O	O
.	.	O	O

a	DT	B-TEST	O
ppd	NN	I-TEST	O
was	VBD	O	O
placed	VBN	O	O
and	CC	O	O
is	VBZ	O	O
to	TO	O	O
be	VB	O	O
read	VBN	O	O
on	IN	O	O
saturday	NN	O	O
,	,	O	O
4	CD	O	O
26th	CD	O	O
.	.	O	O

the	DT	O	B-TEST
left	NN	O	I-TEST
volar	JJ	O	I-TEST
forearm	NN	O	I-TEST
has	VBZ	O	O
the	DT	B-TEST	O
ppd	NN	I-TEST	O
just	RB	O	O
proximal	JJ	O	O
to	TO	O	O
the	DT	O	O
wrist	NN	O	O
crease	NN	O	O
and	CC	O	O
a	DT	B-TEST	B-PROBLEM
candida	NN	I-TEST	I-PROBLEM
albicans	VBZ	I-TEST	I-PROBLEM
placed	VBN	O	O
just	RB	O	O
distal	JJ	O	O
to	TO	O	O
the	DT	O	O
antecubital	JJ	O	O
fossa	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
deep	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
thrombosis	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
1990	CD	O	O
,	,	O	O
for	IN	O	O
which	WDT	O	O
she	PRP	O	O
received	VBD	O	O
6	CD	O	O
months	NNS	O	O
of	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

dopplers	NNS	B-TEST	O
of	IN	I-TEST	O
her	PRP$	I-TEST	B-PROBLEM
lower	JJR	I-TEST	I-PROBLEM
extremities	NNS	I-TEST	I-PROBLEM
were	VBD	O	O
negative	JJ	O	O
on	IN	O	O
this	DT	O	O
admission	NN	O	O
.	.	O	O

it	PRP	O	O
is	VBZ	O	O
doubtful	JJ	O	O
that	IN	O	O
she	PRP	O	O
has	VBZ	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
pe	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
this	DT	O	O
is	VBZ	O	O
one	CD	O	O
consideration	NN	O	O
.	.	O	O

it	PRP	O	O
is	VBZ	O	O
likely	JJ	O	O
that	IN	O	O
she	PRP	O	O
has	VBZ	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
so	RB	O	O
this	DT	O	O
is	VBZ	O	O
a	DT	O	O
consideration	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
hyponatremia	NN	I-PROBLEM	I-PROBLEM
during	IN	O	O
this	DT	O	O
hospitalization	NN	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
sodium	NN	I-TEST	I-TEST
as	RB	O	O
low	JJ	O	O
as	IN	O	O
131	CD	O	O
.	.	O	O

we	PRP	O	O
think	VBP	O	O
this	DT	O	O
is	VBZ	O	O
likely	JJ	O	O
due	JJ	O	O
to	TO	O	O
an	DT	B-PROBLEM	O
siadh	NN	I-PROBLEM	O
as	IN	O	O
she	PRP	O	O
is	VBZ	O	O
euvolemic	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
glaucoma	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
are	VBP	O	O
as	IN	O	O
listed	VBN	O	O
below	IN	O	O
.	.	O	O

propanolol	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg.	NN	O	O
p.o.	NN	O	O
t.i.d.	NN	O	O
[	NNP	O	O
hold	NN	O	O
for	IN	O	O
sbp	NN	B-TEST	O
less	JJR	O	O
than	IN	O	O
110	CD	O	O
]	NNS	O	O
,	,	O	O
isosorbide	RB	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg.	NNS	O	O
p.o.	JJ	O	O
t.i.d.	NN	O	O
,	,	O	O
hold	NN	O	O
for	IN	O	O
sbp	NN	B-TEST	O
less	JJR	O	O
than	IN	O	O
110	CD	O	O
,	,	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg.	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
pilocarpine	NN	B-TREATMENT	B-TREATMENT
4%	CD	O	O
one	CD	O	O
drop	NN	O	O
q.i.d.	NN	O	O
o.d.	JJ	O	O
pilocarpine	NN	B-TREATMENT	B-TREATMENT
2%	CD	O	O
one	CD	O	O
drop	NN	O	O
b.i.d.	VBD	O	O
o.s.	JJ	O	O
betasan	JJ	B-TREATMENT	O
0.5%	CD	O	O
one	CD	O	O
drop	NN	O	O
b.i.d.	NN	O	O
o.d.	NN	O	O
.	.	O	O

bacitracin	NN	B-TREATMENT	B-TREATMENT
ointment	NN	I-TREATMENT	I-TREATMENT
one	CD	O	O
drop	NN	O	O
o.d.	VBD	O	O
q.h.s.	JJ	O	O
ciprofloxacin	NN	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg.	NN	O	O
one	CD	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
x	VBD	O	O
four	CD	O	O
more	JJR	O	O
days	NNS	O	O
[	VBP	O	O
until	IN	O	O
5/25/92	CD	O	O
]	NNS	O	O
,	,	O	O
for	IN	O	O
recently	RB	B-PROBLEM	O
discovered	VBN	I-PROBLEM	O
siderobacter	NN	I-PROBLEM	O
uti	NN	I-PROBLEM	O
.	.	O	O

coumadin	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg.	NN	O	O
p.o.	NN	O	O
q.h.s.	NN	O	O

she	PRP	O	O
needs	VBZ	O	O
her	PRP	B-TREATMENT	O
dose	NN	I-TREATMENT	O
on	IN	O	O
5/22/92	CD	O	O
.	.	O	O

heparin	NN	B-TREATMENT	B-TREATMENT
i.v.	NN	I-TREATMENT	I-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
at	IN	O	O
400	CD	O	O
units	NNS	O	O
per	IN	O	O
hour	NN	O	O
,	,	O	O
on	IN	O	O
her	PRP$	O	O
arrival	NN	O	O
.	.	O	O

in	IN	O	O
addition	NN	O	O
the	DT	O	O
patient	NN	O	O
requires	VBZ	O	O
occupational	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
physical	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

amoxicillin	NN	B-PROBLEM	B-TREATMENT
rash	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

small	JJ	B-PROBLEM	B-PROBLEM
stroke	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
nearly	RB	O	O
recovered	VBN	O	O
,	,	O	O
likely	JJ	O	O
embolic	NN	B-PROBLEM	O
from	IN	I-PROBLEM	O
carotid	JJ	I-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

glaucoma	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
under	IN	O	O
therapy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
status	NN	O	O
post	NN	O	O
laser	NN	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
o.d.	NN	I-TREATMENT	O

orthostatic	JJ	B-PROBLEM	B-PROBLEM
hypotension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

ataxia	NN	B-PROBLEM	B-PROBLEM
with	IN	O	I-PROBLEM
gait	JJ	B-PROBLEM	I-PROBLEM
abnormality	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

history	NN	O	O
of	IN	O	O
breast	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

history	NN	O	O
of	IN	O	O
atypical	JJ	B-PROBLEM	B-PROBLEM
mycobacterial	JJ	I-PROBLEM	I-PROBLEM
colonization	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

history	NN	O	O
of	IN	O	O
dvt	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

hyponatremia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
mi	NN	B-PROBLEM	O
in	IN	O	O
1989	CD	O	O
.	.	O	O

medicine	NN	B-TREATMENT	B-TREATMENT

morphine	NN	B-TREATMENT	B-TREATMENT
/	CD	O	O
latex	NN	B-TREATMENT	B-TREATMENT

gib	NN	B-PROBLEM	B-TEST
,	,	O	O
hematemesis	NN	B-PROBLEM	B-PROBLEM

egd	NN	B-TEST	O
with	IN	O	O
esophageal	JJ	B-TREATMENT	B-PROBLEM
varices	NNS	I-TREATMENT	I-PROBLEM
sclerosis	NN	I-TREATMENT	I-PROBLEM

42	CD	O	O
year	NN	O	O
old	JJ	O	O
female	NN	O	O
with	IN	O	O
h/o	JJ	O	O
cholangiocarcinoma	NN	B-PROBLEM	B-PROBLEM
dx	NN	O	I-PROBLEM
in	IN	O	O
2009	CD	O	O
s/p	NN	O	O
resection	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
with	IN	O	O
recent	JJ	B-TEST	B-PROBLEM
ct	NNS	I-TEST	I-PROBLEM
showing	VBG	O	O
met	VBD	B-PROBLEM	O
cholangiocarcinoma	NN	I-PROBLEM	B-PROBLEM
in	IN	O	O
9/2004	CD	O	O
.	.	O	O

pt	NN	O	O
was	VBD	O	O
recently	RB	O	O
admitted	VBN	O	O
for	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
due	JJ	O	O
to	TO	O	O
cholangitis	VB	B-PROBLEM	B-PROBLEM
on	IN	O	O
10-18	JJ	O	O
and	CC	O	O
had	VBD	O	O
chemo	NN	B-TREATMENT	B-TREATMENT
(	(	O	I-TREATMENT
cddp	NN	B-TREATMENT	I-TREATMENT
and	CC	O	I-TREATMENT
gemcitabine	NN	B-TREATMENT	I-TREATMENT
)	)	O	I-TREATMENT
on	IN	O	O
monday	NN	O	O
,	,	O	O
10-21	JJ	O	O
.	.	O	O

since	IN	O	O
chemo	NN	B-TREATMENT	O
pt	NN	O	O
has	VBZ	O	O
intermittent	VBN	B-PROBLEM	B-PROBLEM
nausea	RB	I-PROBLEM	I-PROBLEM
adequately	RB	O	I-PROBLEM
controlled	VBN	O	O
by	IN	O	O
zofran	NN	B-TREATMENT	O
and	CC	O	O
compazine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

pt	NN	O	O
was	VBD	O	O
doing	VBG	O	O
well	RB	O	O
till	VB	O	O
night	NN	O	O
of	IN	O	O
admission	NN	O	O
when	WRB	O	O
she	PRP	O	O
developed	VBD	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
/	NN	O	O
vomitting	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
sizable	JJ	O	O
amount	NN	O	O
of	IN	O	O
hemoptysis	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
clots	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

has	VBZ	O	O
low	JJ	B-PROBLEM	B-PROBLEM
grade	VBN	I-PROBLEM	I-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
since	IN	O	O
chemo	NN	B-TREATMENT	B-TREATMENT
but	CC	O	O
otherwise	RB	O	O
ros	NN	B-TEST	B-TEST
was	VBD	O	O
neg	JJ	O	O
for	IN	O	O
shaking	VBG	B-PROBLEM	B-PROBLEM
chills	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
sob	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
coughing	VBG	B-PROBLEM	B-PROBLEM
,	,	O	O
constipation	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
diarrhea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
tarry	NN	B-PROBLEM	O
stools	NNS	I-PROBLEM	O
,	,	O	O
abd	RB	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

pt	NN	O	O
has	VBZ	O	O
reported	VBN	O	O
gaining	VBG	O	O
30	CD	O	O
lbs	JJ	O	O
since	IN	O	O
08-31	JJ	O	O
due	JJ	O	O
to	TO	O	O
ascites	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

in	IN	O	O
monica	NN	O	O
:	:	O	O
vitals	NNS	B-TEST	B-TEST
:	:	O	O
t	NN	B-TEST	O
98.8	CD	O	O
p	NN	B-TEST	O
98	CD	O	O
bp	NN	B-TEST	O
136/68	CD	O	O
r	NN	B-TEST	O
29	CD	O	O
sat	VBD	B-TEST	B-TEST
98%	CD	O	O
rapt	NN	O	O
had	VBD	O	O
ng	VBN	B-TREATMENT	B-TEST
lavage	NN	I-TREATMENT	I-TEST
which	WDT	O	O
evantually	RB	O	O
cleared	VBD	O	O
up	RP	O	O
,	,	O	O
also	RB	O	O
was	VBD	O	O
transfused	VBN	O	O
1u	CD	B-TREATMENT	O
prbc	NN	I-TREATMENT	O
,	,	O	O
gi	NN	O	O
consult	NN	O	O
called	VBN	O	O
,	,	O	O
also	RB	O	O
got	VBD	O	O
zofran	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
protonix	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

1.	CD	O	O
ca	MD	O	O
hx-klatskin	JJ	B-PROBLEM	O
tumor	NN	I-PROBLEM	O
originally	RB	O	O
diagnosed	VBD	O	O
2010-08-28	JJ	O	O
after	IN	O	O
presenting	VBG	O	O
with	IN	O	O
painless	JJ	B-PROBLEM	B-PROBLEM
jaundice	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2010-10-01	JJ	O	O
pt	NN	O	O
underwent	JJ	O	O
ex.	NN	B-TEST	B-TREATMENT
lap	NN	I-TEST	I-TREATMENT
with	IN	O	O
en	JJ	B-TREATMENT	B-PROBLEM
bloc	NN	I-TREATMENT	I-PROBLEM
resection	NN	I-TREATMENT	I-PROBLEM
of	IN	I-TREATMENT	I-PROBLEM
l	NN	I-TREATMENT	I-PROBLEM
liver	NN	I-TREATMENT	I-PROBLEM
lobe	NN	I-TREATMENT	I-PROBLEM
,	,	I-TREATMENT	O
biliary	JJ	I-TREATMENT	B-PROBLEM
tree	NN	I-TREATMENT	I-PROBLEM
,	,	I-TREATMENT	O
and	CC	I-TREATMENT	O
portal	JJ	I-TREATMENT	B-TREATMENT
vein	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

reconstructed	VBN	B-TREATMENT	O
portal	JJ	I-TREATMENT	O
vein	NN	I-TREATMENT	O
followed	VBN	O	O
by	IN	O	O
roux-en-y	JJ	B-TREATMENT	B-TREATMENT
hepaticojejunostomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

per	IN	O	O
notes	NNS	O	O
,	,	O	O
pathology	NN	B-TEST	B-TEST
demonstrated	VBD	O	O
biliary	JJ	B-PROBLEM	B-PROBLEM
ductal	JJ	I-PROBLEM	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM	I-PROBLEM
(	(	O	I-PROBLEM
t3n0m0	NN	B-PROBLEM	I-PROBLEM
)	)	O	I-PROBLEM
stage	NN	O	I-PROBLEM
margit	NN	O	I-PROBLEM
.	.	O	O

since	IN	O	O
presentation	NN	O	O
,	,	O	O
patient	NN	O	O
had	VBD	O	O
multiple	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
cholangitis	NN	B-PROBLEM	B-PROBLEM
(	(	O	O
08-06	JJ	O	O
in	IN	O	O
past	JJ	O	O
3	CD	O	O
years	NNS	O	O
with	IN	O	O
last	JJ	O	O
on	IN	O	O
10-18	JJ	O	O
),	NNP	O	O
always	RB	O	O
short	RB	O	O
lived	VBD	O	O
and	CC	O	O
treated	VBD	O	O
with	IN	O	O
antimicrobial	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
on	IN	O	O
ciprofloxacin	NN	B-TREATMENT	B-TREATMENT
proph	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
about	RB	O	O
1	CD	O	O
year	NN	O	O
.	.	O	O

followed	VBN	O	O
with	IN	O	O
yearly	JJ	B-TEST	B-TEST
abdominal	JJ	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
without	IN	O	O
radiographic	JJ	B-PROBLEM	B-PROBLEM
progression	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

cat	NN	B-TEST	B-TEST
scan	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
on	IN	O	O
2013-09-20	JJ	O	O
at	IN	O	O
kindred	VBN	O	O
park	NN	O	O
view	NN	O	O
specialty	NN	O	O
hospital	NN	O	O
of	IN	O	O
springfield	NN	O	O
,	,	O	O
which	WDT	O	O
revealed	VBD	O	O
that	IN	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
recurrence	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
occlusion	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
portal	JJ	I-PROBLEM	I-PROBLEM
vein	NN	I-PROBLEM	I-PROBLEM
occluding	VBG	B-PROBLEM	I-PROBLEM
bile	JJ	I-PROBLEM	I-PROBLEM
ducts	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
hepatic	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
nearly	RB	I-PROBLEM	O
completely	RB	I-PROBLEM	O
occluded	VBN	I-PROBLEM	O
,	,	O	O
and	CC	O	O
much	JJ	B-PROBLEM	B-PROBLEM
ascites	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
diuretics	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
was	VBD	O	O
was	VBD	O	O
seen	VBN	O	O
at	IN	O	O
hallmark	NN	O	O
health	NN	O	O
system	NN	O	O
heme	JJ	O	O
/	NN	O	O
on	IN	O	O
clinic	JJ	O	O
10-09	JJ	O	O
and	CC	O	O
had	VBD	O	O
repeat	NN	B-TEST	B-TEST
ct	NNS	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
which	WDT	O	O
revealed	VBD	O	O
metastatic	JJ	B-PROBLEM	B-PROBLEM
cholangiocarcinoma	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
mets	NNS	B-PROBLEM	O
to	TO	I-PROBLEM	O
the	DT	I-PROBLEM	O
ovaries	NNS	I-PROBLEM	O
,	,	O	O
with	IN	O	O
tremendous	JJ	B-PROBLEM	B-PROBLEM
increase	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
metastatic	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	RB	O	O
was	VBD	O	O
there	EX	O	O
was	VBD	O	O
obstructive	JJ	B-PROBLEM	B-PROBLEM
uropathy	JJ	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
side	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
questionable	JJ	O	O
gastric	JJ	B-PROBLEM	B-PROBLEM
outlet	NN	I-PROBLEM	I-PROBLEM
obstruction	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
peritoneal	JJ	B-PROBLEM	B-TREATMENT
carcinomatosis	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

2.	CD	O	O
cholecystectomy	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
age	NN	O	O
25	CD	O	O

3.	CD	O	O
mva-multiple	JJ	B-TREATMENT	B-TREATMENT
orthopedic	NN	I-TREATMENT	I-TREATMENT
procedures	NNS	I-TREATMENT	I-TREATMENT

4.	CD	O	O
strabismus	NN	B-PROBLEM	B-PROBLEM

her	PRP$	O	O
maternal	JJ	O	O
grandmother	NN	O	O
had	VBD	O	O
breast	VBN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
her	PRP$	O	O
80	CD	O	O
s	NN	O	O
and	CC	O	O
her	PRP$	O	O
dad	NN	O	O
's	POS	O	O
grandmother	NN	O	O
had	VBD	O	O
stomach	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
died	VBD	O	O
in	IN	O	O
her	PRP$	O	O
50	CD	O	O
s.	NN	O	O

on	IN	O	O
her	PRP$	O	B-TEST
mom	NN	O	I-TEST
's	POS	O	I-TEST
side	NN	O	I-TEST
is	VBZ	O	O
an	DT	B-PROBLEM	O
extensive	JJ	I-PROBLEM	O
family	NN	I-PROBLEM	O
cardiac	JJ	I-PROBLEM	O
history	NN	I-PROBLEM	O
.	.	O	O

vital	NN	B-TEST	O
:	:	O	O
afebrile	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
96	CD	O	O
,	,	O	O
108/51	CD	O	O
,	,	O	O
o2sat99%ra	NN	B-TEST	O

general	JJ	O	O
:	:	O	O
pleasant	JJ	O	O
female	NN	O	O
in	IN	O	O
no	DT	O	O
apparent	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
jaundiced	VBD	B-PROBLEM	B-PROBLEM
skin	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

heent	NN	O	O
:	:	O	O
sclera	NN	B-PROBLEM	O
icteric	NN	I-PROBLEM	O
,	,	O	O
op	JJ	O	O
clear	JJ	O	O
,	,	O	O
eomi	RB	O	O
,	,	O	O
perrl	NN	O	O
.	.	O	O

nodes	NNS	O	O
:	:	O	O
no	DT	O	O
supraclavicular	NN	B-PROBLEM	B-PROBLEM
,	,	I-PROBLEM	O
submandibular	JJ	I-PROBLEM	O
,	,	I-PROBLEM	O
axillary	JJ	I-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	I-PROBLEM
inguinal	JJ	I-PROBLEM	I-PROBLEM
lymphadenopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

lungs	NNS	O	O
:	:	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	O	O
.	.	O	O

abdomen	NNS	O	O
:	:	O	O
soft	JJ	O	O
and	CC	O	O
distended	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
but	CC	O	O
no	DT	O	O
actual	JJ	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

guaiac	NN	B-TEST	O
neg	NN	O	O
by	IN	O	O
monica	NN	O	O

back	RB	O	O
:	:	O	O
no	DT	O	O
cva	NN	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

extremities	NNS	O	O
:	:	O	O
no	DT	O	O
clubbing	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
but	CC	O	O
+	NNP	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

glucose	JJ	B-TEST	B-TEST
-	:	O	O
112	CD	O	O
*	JJ	O	O
urea	JJ	B-TEST	B-TEST
n	SYM	I-TEST	I-TEST
-	:	O	O
14	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
0.8	CD	O	O
sodium	NN	B-TEST	B-TEST
-	:	O	O
133	CD	O	O
potassium	NN	B-TEST	B-TEST
-	:	O	O
4.0	CD	O	O
chloride	NN	B-TEST	B-TEST
-	:	O	O
97	CD	O	O
total	JJ	B-TEST	B-TEST
co2	NN	I-TEST	I-TEST
-	:	O	O
23	CD	O	O
anion	NN	B-TEST	B-TEST
gap	NN	I-TEST	I-TEST
-	:	O	O
17	CD	O	O

alt(sgpt)	SYM	B-TEST	B-TEST
-	:	O	O
149	CD	O	O
*	NN	O	O
ast(sgot)	SYM	B-TEST	B-TEST
-	:	O	O
83	CD	O	O
*	JJ	O	O
alk	NN	B-TEST	B-TEST
phos	SYM	I-TEST	B-TEST
-	:	O	O
663	CD	O	O
*	JJ	O	O
amylase	NN	B-TEST	B-TEST
-	:	O	O
37	CD	O	O
tot	NN	B-TEST	O
bili	SYM	I-TEST	B-TEST
-	:	O	O
8.2	CD	O	O
*	NN	O	O

lipase	NN	B-TEST	B-TEST
-	:	O	O
42	CD	O	O

iron	NN	B-TEST	B-TEST
-	:	O	O
52	CD	O	O

caltibc	SYM	B-TEST	B-TEST
-	:	O	O
230	CD	O	O
*	NN	O	O
ferritin	NN	B-TEST	B-TEST
-	:	O	O
197	CD	O	O
*	NN	O	O
trf	SYM	B-TEST	B-TEST
-	:	O	O
177	CD	O	O
*	NN	O	O

wbc	SYM	B-TEST	B-TEST
-	:	O	O
3.0	CD	O	O
*	NN	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
2.25	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
7.2	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
20.9	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
93	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
31.8	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
34.3	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
14.7	CD	O	O

neuts	NNS	B-TEST	B-TEST
-	:	O	O
79.7	CD	O	O
*	NN	O	O
bands	NNS	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
lymphs	SYM	B-TEST	B-TEST
-	:	O	O
13.3	CD	O	O
*	JJ	O	O
monos	NNS	B-TEST	B-TEST
-	:	O	O
4.6	CD	O	O
eos	SYM	B-TEST	B-TEST
-	:	O	O
2.2	CD	O	O
basos	SYM	B-TEST	B-TEST
-	:	O	O
0.2	CD	O	O

hypochrom	SYM	B-TEST	B-TEST
-	:	O	O
1+	CD	O	O
anisocyt	JJ	B-TEST	O
-	:	O	O
normal	JJ	O	O
poikilocy	JJ	B-TEST	O
-	:	O	O
1+	CD	O	O
macrocyt	SYM	B-TEST	B-TEST
-	:	O	O
normal	JJ	O	O
microcyt	JJ	B-TEST	O
-	:	O	O
normal	JJ	O	O
polychrom	JJ	B-TEST	O
-	:	O	O
normal	JJ	O	O
ovalocyt	JJ	B-TEST	O
-	:	O	O
1+	CD	O	O

plt	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
-	:	O	O
88	CD	O	O
*	NN	O	O

pt	SYM	B-TEST	B-TEST
-	:	O	O
13.4	CD	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
25.9	CD	O	O
inr(pt)	JJ	B-TEST	O
-	:	O	O
1.1	CD	O	O

ret	NN	B-TEST	O
aut	SYM	I-TEST	O
-	:	O	O
0.3	CD	O	O
*	NN	O	O

2013-10-27	JJ	O	O
01:30	CD	O	O
am	VBP	O	O
urine	JJ	B-TEST	O

color	NN	B-TEST	B-TEST
-	:	O	O
amber	NN	O	O
appear	VBP	B-TEST	O
-	:	O	O
slhazy	JJ	O	O
sp	NN	B-TEST	O
barajas	SYM	I-TEST	O
-	:	O	O
1.025	CD	O	O

2013-10-27	JJ	O	O
01:30	CD	O	O
am	VBP	O	O
urine	JJ	B-TEST	O

blood	NN	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
nitrite	JJ	B-TEST	B-TEST
-	:	O	O
pos	NN	O	B-TEST
protein	SYM	B-TEST	B-TEST
-	:	O	O
30	CD	O	O
glucose	JJ	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O
ketone	NN	B-TEST	B-TEST
-	:	O	O
tr	NN	O	O
bilirubin	SYM	B-TEST	B-TEST
-	:	O	O
lg	NN	O	O
urobilngn	JJ	B-TEST	O
-	:	O	O
0.2	CD	O	O
ph	NN	B-TEST	B-TEST
-	:	O	O
5.5	CD	O	O
leuk	SYM	B-TEST	B-TEST
-	:	O	O
neg	NN	O	O

2013-10-27	JJ	O	O
01:30	CD	O	O
am	VBP	O	O
urine	JJ	B-TEST	O

rbc	LS	B-TEST	B-TEST
-	:	O	O
0-2	JJ	O	O
wbc	JJ	B-TEST	B-TEST
-	:	O	I-TEST
0-2	JJ	O	I-TEST
bacteria	NNS	B-TEST	I-TEST
-	:	O	O
mod	NN	O	O
yeast	SYM	B-TEST	B-TEST
-	:	O	O
none	NN	O	O
epi	SYM	B-TEST	O
-	:	O	O
03-01	JJ	O	O
renal	JJ	B-TEST	O
epi	NN	I-TEST	O
-	:	O	O
0-2	NN	O	O

2013-10-27	JJ	O	O
01:30	CD	O	O
am	VBP	O	O
urine	JJ	B-TEST	O

hyaline	JJ	B-TEST	B-TEST
-	:	O	O
0-2	NN	O	O

ct	NN	B-TEST	B-TEST
abd	NN	I-TEST	I-TEST
on	IN	O	O
2013-10-17	JJ	O	O
showed	NN	O	O
:	:	O	O

1.	CD	O	O
recurrent	NN	B-PROBLEM	B-PROBLEM
cholangiocarcinoma	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
with	IN	O	O
intrahepatic	JJ	B-PROBLEM	B-PROBLEM
bile	NN	I-PROBLEM	I-PROBLEM
duct	NN	I-PROBLEM	I-PROBLEM
dilatation	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
gastric	JJ	B-PROBLEM	I-PROBLEM
outlet	NN	I-PROBLEM	I-PROBLEM
obstruction	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
exact	JJ	O	O
extent	NN	O	O
of	IN	O	O
disease	NN	B-PROBLEM	B-PROBLEM
is	VBZ	O	O
unclear	JJ	O	O
,	,	O	O
but	CC	O	O
likely	RB	O	O
extensive	JJ	O	O
.	.	O	O

no	DT	O	O
evidence	NN	O	O
of	IN	O	O
portal	JJ	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
seen	VBN	O	O
.	.	O	O

2.	CD	O	O
large	JJ	B-PROBLEM	O
,	,	I-PROBLEM	O
cystic	JJ	I-PROBLEM	B-PROBLEM
,	,	I-PROBLEM	O
multiseptated	JJ	I-PROBLEM	B-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
arising	VBG	O	O
from	IN	O	O
the	DT	O	O
adnexa	NN	O	O
,	,	O	O
worrisome	NN	O	O
for	IN	O	O
second	JJ	B-PROBLEM	B-PROBLEM
primary	JJ	I-PROBLEM	I-PROBLEM
malignancy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
ascites	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
intraperitoneal	JJ	B-PROBLEM	B-PROBLEM
carcinomatosis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
which	WDT	O	O
can	MD	O	O
arise	VB	O	O
from	IN	O	O
either	DT	O	O
of	IN	O	O
the	DT	O	O
two	CD	O	O
processes	NNS	O	O
described	VBN	O	O
above	IN	O	O
.	.	O	O

4.	CD	O	O
hiatal	JJ	B-PROBLEM	B-TREATMENT
hernia	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

blood	NN	B-TEST	B-TEST
wbc	SYM	B-TEST	B-TEST
-	:	O	O
2.2	CD	O	O
*	NN	O	O
rbc	NN	B-TEST	B-TEST
-	:	O	O
3.09	CD	O	O
*	NN	O	O
hgb	NN	B-TEST	B-TEST
-	:	O	O
9.6	CD	O	O
*	NN	O	O
hct	NN	B-TEST	B-TEST
-	:	O	O
28.7	CD	O	O
*	NN	O	O
mcv	SYM	B-TEST	B-TEST
-	:	O	O
93	CD	O	O
mch	SYM	B-TEST	B-TEST
-	:	O	O
31.2	CD	O	O
mchc	SYM	B-TEST	B-TEST
-	:	O	O
33.6	CD	O	O
rdw	NN	B-TEST	B-TEST
-	:	O	O
17.0	CD	O	O
*	JJ	O	O
plt	NN	B-TEST	B-TEST
ct	SYM	I-TEST	I-TEST
-	:	O	O
89	CD	O	O
*	NN	O	O

blood	NN	B-TEST	B-TEST
neuts	NNS	I-TEST	B-TEST
-	:	O	O
89.7	CD	O	O
*	NN	O	O
bands	NNS	B-TEST	B-TEST
-	:	O	O
0	CD	O	O
lymphs	SYM	B-TEST	B-TEST
-	:	O	O
6.9	CD	O	O
*	JJ	O	O
monos	NNS	B-TEST	B-TEST
-	:	O	O
2.6	CD	O	O
eos	SYM	B-TEST	B-TEST
-	:	O	O
0.2	CD	O	O
baso	SYM	B-TEST	B-TEST
-	:	O	O
0.7	CD	O	O

blood	NN	B-TEST	B-TEST
pt	SYM	I-TEST	B-TEST
-	:	O	O
15.2	CD	O	O
*	NN	O	O
ptt	NN	B-TEST	B-TEST
-	:	O	O
29.7	CD	O	O
inr(pt)	JJ	B-TEST	O
-	:	O	O
1.5	CD	O	O

blood	NN	B-TEST	B-TEST
glucose	VB	B-TEST	I-TEST
-	:	O	O
117	CD	O	O
*	JJ	O	O
urean	JJ	B-TEST	B-TEST
-	:	O	O
11	CD	O	O
creat	NN	B-TEST	B-TEST
-	:	O	O
0.9	CD	O	O
na	SYM	B-TEST	B-TEST
-	:	O	O
135	CD	O	O
k	SYM	B-TEST	B-TEST
-	:	O	O
3.5	CD	O	O
cl	NN	B-TEST	B-TEST
-	:	O	O
97	CD	O	O
hco3	NN	B-TEST	B-TEST
-	:	O	O
28	CD	O	O
angap	NN	B-TEST	B-TEST
-	:	O	O
14	CD	O	O

blood	NN	B-TEST	B-TEST
alkphos	SYM	B-TEST	B-TEST
-	:	O	O
431	CD	O	O
*	NN	O	O
totbili	SYM	B-TEST	B-TEST
-	:	O	O
7.8	CD	O	O
*	NN	O	O

blood	NN	B-TEST	B-TEST
calcium	NN	B-TEST	I-TEST
-	:	O	O
8.3	CD	O	O
*	NN	O	O
phos	NN	B-TEST	B-TEST
-	:	O	O
3.5	CD	O	O
mg	SYM	B-TEST	O
-	:	O	O
1.9	CD	O	O

blood	NN	B-TEST	B-TEST
caltibc	SYM	B-TEST	B-TEST
-	:	O	O
230	CD	O	O
*	NN	O	O
ferritn	SYM	B-TEST	B-TEST
-	:	O	O
197	CD	O	O
*	NN	O	O
trf	SYM	B-TEST	B-TEST
-	:	O	O
177	CD	O	O
*	NN	O	O

1)	CD	O	O
gi	JJ	O	O
-	:	O	O
in	IN	O	O
the	DT	O	O
monica	NN	O	O
pt	NN	O	O
had	VBD	O	O
hct	NN	B-TEST	B-TEST
of	IN	O	O
20	CD	O	O
and	CC	O	O
bloody	JJ	B-PROBLEM	B-PROBLEM
ng	NN	I-PROBLEM	I-PROBLEM
lavage	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
did	VBD	O	O
not	RB	O	O
clear	JJ	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
transfused	VBN	O	O
1u	CD	B-TREATMENT	O
prbc	NN	I-TREATMENT	O
,	,	O	O
gi	NN	O	O
consult	NN	O	O
called	VBN	O	O
,	,	O	O
also	RB	O	O
got	VBD	O	O
zofran	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
protonix	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
ficu	NN	O	O
.	.	O	O

on	IN	O	O
arrival	NN	O	O
to	TO	O	O
unit	NN	O	O
pt	NN	O	O
had	VBD	O	O
egd	CC	B-TEST	O
which	WDT	O	O
revealed	VBD	O	O
grade	NN	B-PROBLEM	B-PROBLEM
iii	NN	I-PROBLEM	I-PROBLEM
esophageal	NN	I-PROBLEM	I-PROBLEM
varices	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
signs	NNS	O	O
of	IN	O	O
old	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
octreotide	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
nadolol	NN	B-TREATMENT	B-TREATMENT
to	TO	O	I-TREATMENT
control	VB	O	I-TREATMENT
portal	JJ	B-PROBLEM	I-TREATMENT
htn	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

pt	NN	O	O
was	VBD	O	O
stable	JJ	O	O
and	CC	O	O
had	VBD	O	O
appropriate	JJ	O	O
hct	NNS	B-PROBLEM	O
bump	VBP	I-PROBLEM	O
to	TO	O	O
25	CD	O	O
after	IN	O	O
2u	CD	B-TREATMENT	O
prbc	NN	I-TREATMENT	O
's.	NN	I-TREATMENT	O

she	PRP	O	O
also	RB	O	O
had	VBD	O	O
climbing	VBG	B-PROBLEM	B-TEST
bilirubin	NN	I-PROBLEM	I-TEST
and	CC	O	O
low	JJ	B-PROBLEM	B-PROBLEM
grade	NN	I-PROBLEM	I-PROBLEM
temp	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
zosyn	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
suspected	JJ	O	B-PROBLEM
biliary	JJ	B-PROBLEM	I-PROBLEM
obstruction	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
ascending	VBG	B-PROBLEM	B-PROBLEM
cholangitis	NN	I-PROBLEM	I-PROBLEM
coverage	NN	O	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
rescoped	VBN	O	O
on	IN	O	O
10-28	JJ	O	O
and	CC	O	O
varices	NNS	B-PROBLEM	B-PROBLEM
were	VBD	O	O
sclerosed	VBN	O	O
(	(	O	O
no	DT	O	O
banding	NN	B-TREATMENT	B-PROBLEM
due	JJ	O	O
to	TO	O	O
latex	VB	B-PROBLEM	B-TREATMENT
allergy	NN	I-PROBLEM	I-TREATMENT
)	)	O	I-TREATMENT
and	CC	O	O
diuretics	NNS	B-TREATMENT	B-TREATMENT
of	IN	O	I-TREATMENT
lasix	NN	B-TREATMENT	I-TREATMENT
and	CC	O	O
aldactone	NN	B-TREATMENT	B-TREATMENT
were	VBD	O	O
readded	VBN	O	O
for	IN	O	O
ascites	NNS	B-PROBLEM	B-PROBLEM
since	IN	O	O
bp	NN	B-TEST	O
stable	NN	O	O
.	.	O	O

10-29	JJ	O	O
she	PRP	O	O
was	VBD	O	O
transfused	VBN	O	O
another	DT	O	O
3u	CD	B-TREATMENT	O
prbc	NN	I-TREATMENT	B-TEST
's	POS	I-TREATMENT	I-TEST
with	IN	O	O
hct	JJ	B-PROBLEM	B-TEST
bump	NN	I-PROBLEM	I-TEST
to	TO	O	O
31.9	CD	O	O
and	CC	O	O
antibiotic	JJ	B-TREATMENT	B-TREATMENT
coverage	NN	I-TREATMENT	I-TREATMENT
broadend	NN	O	I-TREATMENT
to	TO	O	O
unasyn	VB	B-TREATMENT	O
,	,	O	O
ceftriaxone	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
because	IN	O	O
she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
spike	VB	O	O
,	,	O	O
and	CC	O	O
for	IN	O	O
sbp	JJ	B-TREATMENT	B-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

preprocedure	NN	O	O
of	IN	O	O
ptc	NN	B-TEST	B-PROBLEM
on	IN	O	O
10-30	JJ	O	O
she	PRP	O	O
was	VBD	O	O
transfused	VBN	O	O
1	CD	B-TREATMENT	O
unit	NN	I-TREATMENT	O
prbc	NN	I-TREATMENT	O
's,	POS	I-TREATMENT	O
2	CD	B-TREATMENT	O
platelets	NNS	I-TREATMENT	O
and	CC	O	O
2u	CD	B-TREATMENT	O
ffp	NN	I-TREATMENT	O
and	CC	O	O
procedure	NN	B-TEST	B-TREATMENT
went	VBD	O	O
without	IN	O	O
complication	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
transfer	NN	O	O
to	TO	O	O
the	DT	O	O
floor	NN	O	O
she	PRP	O	O
remained	VBD	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
with	IN	O	O
stable	JJ	O	O
hct	NN	O	O
and	CC	O	O
declining	VBG	B-PROBLEM	B-TEST
bilirubin	NN	I-PROBLEM	I-TEST
.	.	O	O

she	PRP	O	O
remained	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
so	RB	O	O
on	IN	O	O
11-02	JJ	O	B-TREATMENT
antibiotic	JJ	B-TREATMENT	I-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
was	VBD	O	O
weaned	VBN	O	O
to	TO	O	O
only	RB	O	O
levofloxacin	VB	B-TREATMENT	B-TREATMENT
.	.	O	O

liver	RB	O	B-TEST
teams	NNS	O	I-TEST
recommended	VBD	O	O
to	TO	O	O
repeat	VB	B-TEST	O
egd	NN	I-TEST	O
with	IN	O	O
non	JJ	B-TREATMENT	B-TREATMENT
latex	NNS	I-TREATMENT	I-TREATMENT
banding	VBG	I-TREATMENT	I-TREATMENT
in	IN	O	O
7-10	JJ	O	O
days	NNS	O	O
.	.	O	O

she	PRP	O	O
also	RB	O	O
went	VBD	O	O
home	NN	O	O
on	IN	O	O
naldolol	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
qd	NN	O	O
for	IN	O	O
portal	JJ	B-PROBLEM	O
htn	NN	I-PROBLEM	O
,	,	O	O
and	CC	O	O
her	PRP$	B-TREATMENT	O
home	NN	I-TREATMENT	O
doses	NNS	I-TREATMENT	O
of	IN	O	O
diuretics	NNS	B-TREATMENT	B-TREATMENT
to	TO	O	O
control	VB	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
ascites	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
us	PRP	B-TEST	O
finding	VBG	O	O
-	:	O	O
pt	NN	O	O
was	VBD	O	O
incidentally	RB	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
r	VBN	B-PROBLEM	B-PROBLEM
hydronephrosis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
r	NN	I-PROBLEM	I-PROBLEM
adenexal	JJ	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
her	PRP$	B-TEST	O
us	PRP	I-TEST	O
.	.	O	O

the	DT	B-PROBLEM	O
hydronephrosis	NN	I-PROBLEM	O
was	VBD	O	O
likely	RB	O	O
caused	VBN	O	O
by	IN	O	O
blockage	NN	B-PROBLEM	B-PROBLEM
by	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

given	VBN	O	O
her	PRP$	O	B-PROBLEM
disease	NN	O	I-PROBLEM
prognosis	NN	O	I-PROBLEM
and	CC	O	O
the	DT	O	O
fact	NN	O	O
that	IN	O	O
her	PRP$	O	O
other	JJ	O	O
kidney	NN	O	O
is	VBZ	O	O
functioning	VBG	O	O
well	RB	O	O
,	,	O	O
no	DT	O	O
intervention	NN	B-TREATMENT	O
was	VBD	O	O
done	VBN	O	O
.	.	O	O

also	RB	O	O
the	DT	B-PROBLEM	O
adenexal	JJ	I-PROBLEM	O
mass	NN	I-PROBLEM	O
may	MD	O	O
represent	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
second	JJ	I-PROBLEM	I-PROBLEM
primary	JJ	I-PROBLEM	I-PROBLEM
maligancy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
was	VBD	O	O
seen	VBN	O	O
on	IN	O	O
a	DT	B-TEST	B-TEST
prior	JJ	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
and	CC	O	O
her	PRP$	O	O
oncologist	NN	O	O
is	VBZ	O	O
aware	JJ	O	O
.	.	O	O

again	RB	O	O
given	VBN	O	O
the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
poor	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
prognosis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
there	EX	O	O
was	VBD	O	O
no	DT	O	O
intervention	NN	B-TREATMENT	O
made	VBD	O	O
at	IN	O	O
this	DT	O	O
time	NN	O	O
.	.	O	O

medications	NNS	O	B-TREATMENT
:	:	O	O
she	PRP	O	O
is	VBZ	O	O
on	IN	O	O
lasix	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
aldactone	RB	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
b.i.d.	NN	O	O
,	,	O	O
prilosec	VBP	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
daily	RB	O	O
,	,	O	O
ciprofloxacin	VBD	B-TREATMENT	B-TREATMENT
250	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
daily	RB	O	O
,	,	O	O
this	DT	O	O
is	VBZ	O	O
for	IN	O	O
prophylaxis	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
cholangitis	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
iron	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

1.	CD	O	O
pantoprazole	JJ	B-TREATMENT	B-TREATMENT
sodium	NN	I-TREATMENT	I-TREATMENT
40	CD	O	O
mg	NN	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
,	,	O	O
delayed	VBN	O	O
release	NN	O	O
(	(	O	O
e.c.	NN	O	O
)	)	O	O
po	NN	O	O
q12h	NN	O	O
(	(	O	O
every	DT	O	O
12	CD	O	O
hours	NNS	O	O
).	VBP	O	O

2.	CD	O	O
furosemide	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

3.	CD	O	O
spironolactone	NN	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
bid	NN	O	O
(	(	O	O
2	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

4.	CD	O	O
levofloxacin	JJ	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q24h	NN	O	O
(	(	O	O
every	DT	O	O
24	CD	O	O
hours	NNS	O	O
).	VBP	O	O

5.	CD	O	O
ursodiol	JJ	B-TREATMENT	B-TREATMENT
300	CD	O	O
mg	NN	O	O
capsule	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
capsule	NN	O	O
po	NN	O	O
tid	NN	O	O
(	(	O	O
3	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
).	NN	O	O

6.	CD	O	O
prochlorperazine	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
q6h	NN	O	O
(	(	O	O
every	DT	O	O
6	CD	O	O
hours	NNS	O	O
)	)	O	O
as	IN	O	O
needed	VBN	O	O
.	.	O	O

7.	CD	O	O
nystatin	JJ	B-TREATMENT	B-TREATMENT
100,000	CD	O	O
unit	NN	O	O
/	NNP	O	O
ml	NN	O	O
suspension	NN	O	O
sig	NN	O	O
:	:	O	O
five	CD	O	O
(	(	O	O
5	CD	O	O
)	)	O	O
ml	NN	O	O
po	RB	O	O
four	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
:	:	O	O
swish	JJ	O	O
and	CC	O	O
swallow	JJ	O	O
.	.	O	O

8.	CD	O	O
nadolol	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	JJ	O	O
tablet	NN	O	O
sig	NN	O	O
:	:	O	O
one	CD	O	O
(	(	O	O
1	CD	O	O
)	)	O	O
tablet	NN	O	O
po	NN	O	O
once	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

please	NN	O	O
have	VB	O	O
cbc	VBN	B-TEST	B-TEST
and	CC	O	I-TEST
alkaline	JJ	B-TEST	I-TEST
phosphatase	NN	I-TEST	I-TEST
and	CC	O	O
total	JJ	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
checked	VBD	O	O
on	IN	O	O
monday	JJ	O	O
11-04	JJ	O	O

cholangiocarcinoma	NN	B-PROBLEM	B-PROBLEM

biliary	JJ	B-PROBLEM	B-PROBLEM
obstruction	NN	I-PROBLEM	I-PROBLEM

grade	NN	B-PROBLEM	B-PROBLEM
iii	NN	I-PROBLEM	I-PROBLEM
esophageal	NN	I-PROBLEM	I-PROBLEM
varices	NNS	I-PROBLEM	I-PROBLEM

call	VB	O	O
your	PRP$	O	O
primary	JJ	O	O
care	NN	O	O
doctor	NN	O	O
,	,	O	O
oncologist	NN	O	O
,	,	O	O
or	CC	O	O
return	NN	O	O
to	TO	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
if	IN	O	O
you	PRP	O	O
have	VBP	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
nausea	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
,	,	O	I-PROBLEM
leg	NN	B-PROBLEM	I-PROBLEM
swelling	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
confusion	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

you	PRP	O	O
will	MD	O	O
have	VB	O	O
a	DT	B-TREATMENT	B-TREATMENT
banding	JJ	I-TREATMENT	I-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
9	CD	O	O
days	NNS	O	O
.	.	O	O

1.	CD	O	O
myelodysplastic	JJ	B-PROBLEM	B-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
symptomatic	JJ	B-PROBLEM	B-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM

2.	CD	O	O
rheumatoid	NN	B-PROBLEM	B-PROBLEM
arthritis	NN	I-PROBLEM	I-PROBLEM

3.	CD	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	VBP	I-PROBLEM	I-PROBLEM

4.	CD	O	O
history	NN	O	O
of	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
focal	JJ	I-PROBLEM	I-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM

5.	CD	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
dilated	JJ	B-PROBLEM	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
ejection	NN	B-TEST	B-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
30%	CD	O	O

6.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM

7.	CD	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
bronchiectasis	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
home	NN	B-TREATMENT	B-TREATMENT
o2	NN	I-TREATMENT	I-TREATMENT

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
69-year-old	JJ	O	O
male	NN	O	O
with	IN	O	O
multiple	JJ	B-PROBLEM	B-PROBLEM
medical	JJ	I-PROBLEM	I-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
known	VBN	B-PROBLEM	O
transfusion	NN	I-PROBLEM	B-PROBLEM
dependent	NN	I-PROBLEM	I-PROBLEM
secondary	JJ	O	O
to	TO	O	O
myelodysplastic	JJ	B-PROBLEM	B-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
admitted	VBN	O	O
with	IN	O	O
decreased	JJ	B-PROBLEM	B-PROBLEM
hematocrit	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
had	VBN	O	O
multiple	VBN	O	O
previous	JJ	O	O
admissions	NNS	O	O
for	IN	O	O
cardiac	NN	B-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
had	VBN	O	O
chronic	VBN	B-PROBLEM	B-PROBLEM
anemia	NN	I-PROBLEM	I-PROBLEM
since	IN	O	O
1990	CD	O	O
,	,	O	O
but	CC	O	O
a	DT	B-TEST	B-TEST
bone	NN	I-TEST	I-TEST
marrow	NN	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
in	IN	O	O
07-92	JJ	O	O
,	,	O	O
was	VBD	O	O
consistent	JJ	O	O
with	IN	O	O
myelodysplastic	JJ	B-PROBLEM	B-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

over	IN	O	O
the	DT	O	O
past	JJ	O	O
several	JJ	O	O
months	NNS	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
had	VBN	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
transfusing	NN	I-PROBLEM	I-PROBLEM
requirements	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TREATMENT	B-TEST
transfusions	NNS	I-TREATMENT	I-TEST
have	VBP	O	O
been	VBN	O	O
complicated	VBN	O	O
by	IN	O	O
fluid	NN	B-PROBLEM	B-PROBLEM
overload	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
secondary	JJ	O	O
to	TO	O	O
ischemia	VB	B-PROBLEM	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	O	O
last	JJ	O	O
admission	NN	O	O
was	VBD	O	O
9-14-93	CD	O	O
,	,	O	O
for	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
transfusion	NN	I-TREATMENT	I-TREATMENT
without	IN	O	O
complications	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
prior	RB	O	O
to	TO	O	O
admission	VB	O	O
the	DT	O	O
patient	NN	O	O
reports	NNS	O	O
having	VBG	O	O
several	JJ	O	O
days	NNS	O	O
of	IN	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
weakness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
dizziness	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
fatigue	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

apparently	RB	O	O
,	,	O	O
he	PRP	O	O
had	VBD	O	O
had	VBN	O	O
a	DT	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
hematocrit	NN	I-PROBLEM	I-PROBLEM
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
and	CC	O	O
was	VBD	O	O
checked	VBN	O	O
two	CD	O	O
weeks	NNS	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
but	CC	O	O
was	VBD	O	O
not	RB	O	O
given	VBN	O	O
transfusion	NN	B-TREATMENT	B-TREATMENT
because	IN	O	O
the	DT	O	O
patient	NN	O	O
did	VBD	O	O
not	RB	O	O
want	VB	O	O
to	TO	O	O
come	VB	O	O
in	IN	O	O
at	IN	O	O
that	DT	O	O
time	NN	O	O
.	.	O	O

aside	RB	O	O
from	IN	O	O
the	DT	O	O
above	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
felt	VBN	O	O
that	IN	O	O
baseline	NN	O	O
without	IN	O	O
fever	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
change	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
chronic	JJ	I-PROBLEM	I-PROBLEM
cough	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
no	DT	O	O
increase	NN	O	B-PROBLEM
in	IN	O	I-PROBLEM
his	PRP$	B-PROBLEM	I-PROBLEM
congestive	JJ	I-PROBLEM	I-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
no	DT	O	O
hemoptysis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
changed	VBN	O	B-PROBLEM
in	IN	O	I-PROBLEM
arthritis	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
did	VBD	O	O
report	VB	O	O
taking	VBG	O	O
a	DT	B-TREATMENT	B-TREATMENT
po	NN	I-TREATMENT	I-TREATMENT
antibiotic	JJ	I-TREATMENT	I-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
ciprofloxacin	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
for	IN	O	O
right	JJ	B-PROBLEM	B-PROBLEM
great	JJ	I-PROBLEM	I-PROBLEM
toe	JJ	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
question	NN	O	O
of	IN	O	O
cellulitis	NN	B-PROBLEM	B-PROBLEM
vs.	FW	O	O
paronychia	NN	B-PROBLEM	O
)	)	O	O
.	.	O	O

1.	CD	O	O
myelodysplastic	JJ	B-PROBLEM	B-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
/	NNP	O	O
ischemiccardiomyopathy	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
ejection	NN	B-TEST	B-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
30%	CD	O	O
.	.	O	O

3.	CD	O	O
history	NN	O	O
of	IN	O	O
mat	NN	B-PROBLEM	B-TREATMENT
for	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
obstructive	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
/	NNP	O	O
chronic	NN	B-PROBLEM	B-PROBLEM
bronchi	NN	I-PROBLEM	I-PROBLEM
ectasis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
on	IN	O	O
home	NN	B-TREATMENT	B-TREATMENT
oxygen	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

4.	CD	O	O
non	JJ	B-PROBLEM	B-PROBLEM
insulin	NN	I-PROBLEM	I-PROBLEM
dependent	NN	I-PROBLEM	I-PROBLEM
diabetes	VBZ	I-PROBLEM	I-PROBLEM
mellitus	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

5.	CD	O	O
rheumatoid	JJ	B-PROBLEM	B-PROBLEM
arthritis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

7.	CD	O	O
history	NN	O	O
of	IN	O	O
peptic	JJ	B-PROBLEM	B-PROBLEM
ulcer	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

8.	CD	O	O
cataracts	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
bilateral	JJ	B-TREATMENT	B-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

9.	CD	O	O
c3	NN	B-PROBLEM	B-PROBLEM
radiculopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

10.	CD	O	O
psoriasis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

11.	CD	O	O
history	NN	O	O
of	IN	O	O
hemoptysis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

12.	CD	O	O
status	NN	O	O
post	NN	O	O
turp	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

quinine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
quinidine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
bactrim	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
plaquenil	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

temperature	NN	B-TEST	B-TEST
98.8	CD	O	O
;	:	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
88-120	CD	O	O
and	CC	O	O
irregular	JJ	B-PROBLEM	O
;	:	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
118/78	CD	O	O
;	:	O	O
o2	JJ	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST
96%	CD	O	O
on	IN	O	O
2	CD	B-TREATMENT	O
liters	NNS	I-TREATMENT	O
.	.	O	O

bilateral	JJ	B-PROBLEM	B-PROBLEM
cataracts	NNS	I-PROBLEM	I-PROBLEM
;	:	O	O
neck	RB	O	O
appeared	VBD	O	O
to	TO	O	O
be	VB	O	O
somewhat	RB	B-PROBLEM	B-PROBLEM
asymmetric	JJ	I-PROBLEM	I-PROBLEM
thyroid	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
small	JJ	B-PROBLEM	B-PROBLEM
nodule	NN	I-PROBLEM	I-PROBLEM
barely	RB	O	I-PROBLEM
palpable	JJ	O	I-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	NN	O	I-PROBLEM
lobe	NN	O	I-PROBLEM
with	IN	O	O
the	DT	O	O
thyroid	NN	O	O
,	,	O	O
otherwise	RB	O	O
negative	JJ	O	O
.	.	O	O

no	DT	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
was	VBD	O	O
palpated	VBN	O	O
.	.	O	O

rales	NNS	B-PROBLEM	B-TEST
1/3	CD	O	O
of	IN	O	O
the	DT	O	O
way	NN	O	O
upbilaterally	RB	O	O
.	.	O	O

cardiovascular	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
revealed	VBD	O	O
jugular	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
distention	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
12	CD	O	O
cm	NN	O	O
,	,	O	O
no	DT	O	O
carotid	NN	B-PROBLEM	B-PROBLEM
bruits	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
was	VBD	O	O
tachycardic	JJ	B-PROBLEM	O
and	CC	O	O
regular	JJ	O	O
,	,	O	O
normal	JJ	O	O
s1	NN	O	O
and	CC	O	O
s2	NN	O	O
,	,	O	O
palpable	JJ	B-PROBLEM	B-PROBLEM
s4	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
was	VBD	O	O
auscultated	VBN	O	O
.	.	O	O

obese	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
soft	JJ	O	O
,	,	O	O
non-tender	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
bowel	JJ	O	B-TEST
sounds	NNS	O	I-TEST
were	VBD	O	O
present	JJ	O	O
.	.	O	O

heme	NN	B-TEST	B-TEST
negative	JJ	O	O
.	.	O	O

joint	JJ	B-PROBLEM	B-PROBLEM
deformities	NNS	I-PROBLEM	I-PROBLEM
consistent	VBP	O	O
with	IN	O	O
rheumatoid	JJ	B-PROBLEM	B-PROBLEM
arthritis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
right	JJ	O	O
mtp	NN	O	O
/	NNP	O	O
toe	NN	O	O
with	IN	O	O
minimal	JJ	B-PROBLEM	B-PROBLEM
erythema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

diffuse	NN	B-PROBLEM	B-PROBLEM
psoriasis	NN	I-PROBLEM	I-PROBLEM
over	IN	I-PROBLEM	I-PROBLEM
trunk	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
arms	NNS	I-PROBLEM	O
.	.	O	O

neurological	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
non-focal	JJ	O	O
.	.	O	O

sma-7	NN	B-TEST	B-TEST
was	VBD	O	O
unremarkable	JJ	O	O
aside	RB	O	O
form	VBP	O	O
a	DT	B-TEST	B-TEST
creatinine	NN	I-TEST	I-TEST
of	IN	O	O
1.6	CD	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
glucose	NN	I-TEST	I-TEST
of	IN	O	O
207	CD	O	O
;	:	O	O
otherwise	RB	O	O
,	,	O	O
was	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

hematocrit	NN	B-TEST	B-TEST
was	VBD	O	O
22.4	CD	O	O
;	:	O	O
white	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
.59	NN	O	O
;	:	O	O
platelets	NNS	B-TEST	B-TEST
84.	CD	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
absolute	JJ	I-PROBLEM	I-PROBLEM
neutropenia	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-TEST	O
anc	NN	I-TEST	O
of	IN	O	O
318	CD	O	O
;	:	O	O
differential	NN	B-TEST	O
revealed	VBD	O	O
48	CD	O	O
segs	NNS	B-TEST	O
,	,	O	O
6	CD	O	O
bands	NNS	B-TEST	B-TEST
,	,	O	O
40	CD	O	O
lymphs	NN	B-TEST	B-TEST
,	,	O	O
4	CD	O	O
monos	NNS	B-TEST	B-TEST
.	.	O	O

digoxin	NN	B-TEST	B-TEST
level	NN	I-TEST	I-TEST
was	VBD	O	O
1.4	CD	O	O
.	.	O	O

theo-dur	JJ	B-TEST	B-TEST
level	NN	I-TEST	I-TEST
was	VBD	O	O
15	CD	O	O
.	.	O	O

pt	NN	B-TEST	O
was	VBD	O	O
12.5	CD	O	O
;	:	O	O
ptt	NN	B-TEST	B-TEST
27.0	CD	O	O
.	.	O	O

urinalysis	NN	B-TEST	B-TEST
was	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	NN	I-TEST	I-TEST
showed	VBD	O	O
enlarged	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
vascular	NN	I-PROBLEM	I-PROBLEM
redistribution	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
gross	JJ	B-PROBLEM	B-PROBLEM
congestive	JJ	I-PROBLEM	I-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
.	.	O	O

ekg	NN	B-TEST	O
showed	VBD	O	O
question	NN	O	O
of	IN	O	O
mat	NN	B-PROBLEM	B-TREATMENT
vs.	FW	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-TEST	O
ventricular	JJ	I-TEST	O
response	NN	I-TEST	O
of	IN	O	O
118	CD	O	O
,	,	O	O
axis	NN	B-TEST	B-TEST
was	VBD	O	O
0	CD	O	O
degrees	NNS	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
st	JJ	B-PROBLEM	O
scooping	NN	I-PROBLEM	O
in	IN	O	O
the	DT	O	O
lateral	JJ	O	O
leads	NNS	O	O
consistent	JJ	O	O
with	IN	O	O
dig	NN	B-TREATMENT	O
vs.	FW	O	O
a	DT	O	O
question	NN	O	O
of	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
ischemia	NN	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
significant	JJ	B-PROBLEM	O
change	NN	I-PROBLEM	O
from	IN	O	O
his	PRP$	B-TEST	O
baseline	NN	I-TEST	O
ekg	NN	I-TEST	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
and	CC	O	O
placed	VBN	O	O
in	IN	O	O
isolation	NN	B-TREATMENT	O
on	IN	O	O
neutropenic	JJ	B-TREATMENT	B-TREATMENT
precautions	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
transfused	VBN	O	O
with	IN	O	O
1/2	CD	B-TREATMENT	O
units	NNS	I-TREATMENT	O
of	IN	I-TREATMENT	O
packed	JJ	I-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
given	VBN	O	O
lasix	NNS	B-TREATMENT	B-TREATMENT
periodically	RB	O	O
to	TO	O	O
prevent	VB	O	O
him	PRP	O	O
from	IN	O	O
going	VBG	O	O
into	IN	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
has	VBZ	O	O
he	PRP	O	O
had	VBD	O	O
on	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
prior	JJ	I-TREATMENT	I-TREATMENT
transfusion	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

because	IN	O	O
his	PRP$	O	O
need	NN	O	O
for	IN	O	O
multiple	JJ	B-TREATMENT	B-PROBLEM
transfusionsm	NN	I-TREATMENT	I-PROBLEM
he	PRP	O	O
was	VBD	O	O
transfused	VBN	O	O
with	IN	O	O
radiated	JJ	B-TREATMENT	B-PROBLEM
leuco	JJ	I-TREATMENT	I-PROBLEM
four	CD	O	I-PROBLEM
units	NNS	O	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	O	O
good	JJ	O	O
bump	NN	O	O
in	IN	O	O
his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
,	,	O	O
more	JJR	O	O
than	IN	O	O
expected	VBN	O	O
from	IN	O	O
22	CD	O	O
to	TO	O	O
high	JJ	O	B-PROBLEM
20	CD	O	I-PROBLEM
&apos;s	JJ	O	I-PROBLEM
range	NN	O	I-PROBLEM
next	JJ	O	O
day	NN	O	O
after	IN	O	O
3	CD	O	O
1/2	CD	O	O
units	NNS	O	O
,	,	O	O
but	CC	O	O
later	RB	O	O
that	IN	O	O
evening	VBG	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
drop	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
so	RB	O	O
was	VBD	O	O
given	VBN	O	O
4	CD	O	O
more	JJR	O	O
1/2	CD	O	O
units	NNS	O	O
at	IN	O	O
this	DT	O	O
point	NN	O	O
for	IN	O	O
a	DT	O	B-TREATMENT
total	NN	O	I-TREATMENT
of	IN	O	I-TREATMENT
4	CD	B-TREATMENT	I-TREATMENT
units	NNS	I-TREATMENT	I-TREATMENT
packed	VBD	I-TREATMENT	I-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
again	RB	O	O
did	VBD	O	O
not	RB	O	O
bump	VB	O	O
his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
sufficiently	RB	O	O
and	CC	O	O
remained	VBD	O	O
in	IN	O	O
the	DT	O	O
high	JJ	O	O
20	CD	O	O
&apos;s	NN	O	O
after	IN	O	O
a	DT	O	O
total	NN	O	O
of	IN	O	O
4	CD	O	O
units	NNS	O	O
,	,	O	O
so	IN	O	O
he	PRP	O	O
was	VBD	O	O
given	VBN	O	O
2	CD	O	O
more	JJR	O	O
total	JJ	O	O
units	NNS	O	O
in	IN	O	O
1/2	CD	O	O
units	NNS	O	O
segments	VBZ	O	O
the	DT	O	O
following	JJ	O	O
day	NN	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
subsequently	RB	O	O
bumped	VBD	O	O
to	TO	O	O
greater	JJR	O	O
than	IN	O	O
30	CD	O	O
and	CC	O	O
was	VBD	O	O
discharged	VBN	O	O
with	IN	O	O
hematocrit	NN	B-TEST	B-TEST
of	IN	O	O
32	CD	O	O
on	IN	O	O
11-7-93	NNS	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
remained	VBD	O	O
asymptomatic	JJ	B-PROBLEM	B-PROBLEM
from	IN	O	O
a	DT	B-PROBLEM	O
chf	NN	I-PROBLEM	O
stand	NN	I-PROBLEM	O
point	NN	I-PROBLEM	O
and	CC	O	O
felt	VBD	O	O
much	RB	O	O
better	RBR	O	O
after	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

it	PRP	O	O
is	VBZ	O	O
unclear	JJ	O	O
why	WRB	O	O
the	DT	O	O
patient	NN	O	O
did	VBD	O	O
not	RB	O	O
bump	VB	O	O
his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
more	RBR	O	O
but	CC	O	O
he	PRP	O	O
did	VBD	O	O
not	RB	O	O
appear	VB	O	O
to	TO	O	O
be	VB	O	O
hemolyzing	VBG	O	O
from	IN	O	O
laboratory	NN	O	O
data	NNS	O	O
,	,	O	O
that	DT	O	O
is	VBZ	O	O
his	PRP$	B-TEST	O
ldh	NN	I-TEST	O
was	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
multiple	JJ	O	B-PROBLEM
stools	NNS	O	I-PROBLEM
were	VBD	O	O
guaiaced	VBN	O	O
and	CC	O	O
were	VBD	O	O
all	DT	O	O
guaiac	JJ	B-TEST	O
negative	JJ	O	O
.	.	O	O

prednisone	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
po	NN	O	O
q	JJ	O	O
day	NN	O	O
,	,	O	O
verapamil	FW	B-TREATMENT	B-TREATMENT
80	CD	O	O
mg	NN	O	O
po	NN	O	O
t.i.d.	NN	O	O
,	,	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
0.25	CD	O	O
mg	NN	O	O
po	NN	O	O
q	JJ	O	O
day	NN	O	O
,	,	O	O
isordil	VB	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
po	NN	O	O
t.i.d.	NN	O	O
,	,	O	O
theo-dur	JJ	B-TREATMENT	B-TEST
200	CD	O	O
mg	NN	O	O
po	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
lasix	VBZ	B-TREATMENT	B-TREATMENT
80mg	CD	O	O
q	NN	O	O
am	VBP	O	O
,	,	O	O
40	CD	O	O
mg	NN	O	O
po	NN	O	O
q	NN	O	O
pm	NN	O	O
,	,	O	O
enalapril	VBZ	B-TREATMENT	B-TREATMENT
2.5	CD	O	O
mg	NN	O	O
po	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
pepcid	VBP	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
po	NN	O	O
b.i.d.	NN	O	O

prenatal	NN	B-TEST	B-TEST
screens	NNS	I-TEST	I-TEST
-	:	O	O
blood	NN	B-TEST	O
type	NN	I-TEST	O
o	NN	O	O
positive	JJ	O	O
,	,	O	O
antibody	JJ	B-TEST	B-TEST
screen	JJ	I-TEST	I-TEST
negative	JJ	O	O
,	,	O	O
hepatitis	NN	B-TEST	B-TEST
b	NN	I-TEST	I-TEST
surface	NN	I-TEST	I-TEST
antigen	NN	I-TEST	I-TEST
negative	JJ	O	O
,	,	O	O
rpr	JJ	B-TEST	O
nonreactive	JJ	O	O
,	,	O	O
rubella	NN	B-TEST	B-TEST
immune	NN	O	O
.	.	O	O

gbs	NN	B-PROBLEM	B-TEST
negative	JJ	O	O
.	.	O	O

maternal	JJ	O	O
history	NN	O	O
notable	JJ	O	O
for	IN	O	O
hypothyroidism	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
levoxyl	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

primary	JJ	B-TREATMENT	B-TREATMENT
cesarean	JJ	I-TREATMENT	I-TREATMENT
section	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
previous	JJ	O	B-PROBLEM
pregnancy	NN	O	I-PROBLEM
for	IN	O	O
arrest	NN	B-PROBLEM	O
of	IN	I-PROBLEM	O
descent	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

other	JJ	B-TREATMENT	B-TREATMENT
meds	NNS	I-TREATMENT	I-TREATMENT
:	:	O	O
paxil	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

this	DT	O	B-PROBLEM
pregnancy	NN	O	I-PROBLEM
is	VBZ	O	O
complicated	VBN	O	O
by	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
cyst	NN	I-PROBLEM	I-PROBLEM
noted	VBD	O	I-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
umbilical	JJ	O	I-PROBLEM
cord	NN	O	I-PROBLEM
on	IN	O	O
fetal	JJ	B-TEST	B-TEST
ultrasound	NN	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
at	IN	O	O
18	CD	O	O
weeks	NNS	O	O
gestation	NN	O	O
.	.	O	O

no	DT	O	O
perineal	JJ	B-PROBLEM	B-PROBLEM
sepsis	NN	I-PROBLEM	I-PROBLEM
risk	NN	I-PROBLEM	I-PROBLEM
factors	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
maternal	JJ	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
prolonged	JJ	B-PROBLEM	B-PROBLEM
rupture	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
membranes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

anesthesia	NN	B-TREATMENT	B-TREATMENT
by	IN	O	O
epidural	JJ	B-TREATMENT	O
.	.	O	O

apgars	NNS	B-TEST	B-TEST
were	VBD	O	O
8	CD	O	O
and	CC	O	O
9	CD	O	O
.	.	O	O

weight	NN	B-TEST	B-TEST
3.325	CD	O	O
kg	NN	O	O
,	,	O	O
length	NN	B-TEST	B-TEST
was	VBD	O	O
20	CD	O	O
inches	NNS	O	O
i.e.	JJ	O	O
51	CD	O	O
cm	NN	O	O
,	,	O	O
head	NN	B-TEST	B-TEST
circumference	NN	I-TEST	I-TEST
34.5	CD	O	O
cm	NN	O	O
.	.	O	O

nondysmorphic	JJ	B-PROBLEM	B-PROBLEM
infant	NN	O	I-PROBLEM
.	.	O	O

active	JJ	O	O
,	,	O	O
pink	VBP	O	O
newborn	VBN	O	O
in	IN	O	O
no	DT	O	O
distress	NN	B-PROBLEM	B-PROBLEM
on	IN	O	I-PROBLEM
radiate	NN	B-TREATMENT	I-PROBLEM
warmer	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2+	CD	B-TEST	O
femoral	JJ	I-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
.	.	O	O

umbilical	JJ	O	B-PROBLEM
cord	NN	O	I-PROBLEM
with	IN	O	O
braintree	JJ	O	B-PROBLEM
jelly	NN	B-PROBLEM	I-PROBLEM
cysts	NNS	I-PROBLEM	I-PROBLEM
but	CC	O	O
also	RB	O	O
with	IN	O	O
pink	JJ	B-PROBLEM	B-PROBLEM
tubular	JJ	I-PROBLEM	I-PROBLEM
discoloration	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
base	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
sacral	JJ	B-PROBLEM	B-PROBLEM
anomalies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

cardiovascular	NN	O	O
:	:	O	O
no	DT	O	O
cardiovascular	JJ	B-PROBLEM	B-PROBLEM
issues	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

fluids	NNS	O	O
,	,	O	O
electrolytes	NNS	O	B-TEST
and	CC	O	O
nutrition	NN	O	O
:	:	O	O
infant	NN	O	O
initiated	VBD	O	O
on	IN	O	O
60	CD	O	O
cc	NNS	O	O
per	IN	O	O
kg	FW	O	O
per	IN	O	O
day	NN	O	O
of	IN	O	O
d10w	NN	B-TREATMENT	B-PROBLEM
.	.	O	O

d-sticks	NNS	B-TEST	O
have	VBP	O	O
been	VBN	O	O
stable	JJ	O	O
.	.	O	O
infant	NN	O	O
is	VBZ	O	O
allowed	VBN	O	O
to	TO	O	O
ad	NN	O	B-TEST
lib	NN	O	I-TEST
breast	NN	O	I-TEST
feed	NN	O	I-TEST
which	WDT	O	O
he	PRP	O	O
is	VBZ	O	O
doing	VBG	O	O
vigorously	RB	O	O
.	.	O	O

an	DT	B-TEST	B-TEST
abdominal	JJ	I-TEST	I-TEST
ultrasound	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
.	.	O	O

initial	JJ	O	O
impression	NN	O	O
included	VBD	O	O
omphalocele	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
further	JJ	B-TEST	B-TEST
imaging	NN	I-TEST	I-TEST
of	IN	I-TEST	O
the	DT	I-TEST	O
bowel	NN	I-TEST	O
to	TO	O	O
be	VB	O	O
done	VBN	O	O
.	.	O	O

surgery	NN	O	B-TREATMENT
was	VBD	O	O
consulted	VBN	O	O
and	CC	O	O
dr.	JJ	O	O
boston	NN	O	O
took	VBD	O	O
patient	NN	O	O
to	TO	O	O
or	CC	O	O
for	IN	O	O
exploration	NN	B-TEST	B-PROBLEM
of	IN	I-TEST	I-PROBLEM
cord	NN	I-TEST	I-PROBLEM
on	IN	O	O
04-01	NN	O	O
.	.	O	O

urachal	JJ	B-PROBLEM	B-PROBLEM
duct	NN	I-PROBLEM	I-PROBLEM
remnanr	NN	I-PROBLEM	I-PROBLEM
found	VBD	O	O
,	,	O	O
removed	VBN	O	O
and	CC	O	O
bladder	NN	O	O
repaired	VBN	O	O
.	.	O	O

hematology	NN	O	O
:	:	O	O
hematocrit	NN	B-TEST	B-TEST
on	IN	O	O
admission	NN	O	O
was	VBD	O	O
52.8	CD	O	O
.	.	O	O

the	DT	O	O
infant	NN	O	O
does	VBZ	O	O
not	RB	O	O
require	VB	O	O
a	DT	B-TREATMENT	B-PROBLEM
new	JJ	I-TREATMENT	I-PROBLEM
blood	NN	I-TREATMENT	I-PROBLEM
transfusion	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

infectious	JJ	O	O
disease	NN	O	O
:	:	O	O
cbc	NN	B-TEST	B-TEST
and	CC	O	O
blood	NN	B-TEST	B-TEST
culture	NN	I-TEST	I-TEST
obtained	VBN	O	O
on	IN	O	O
admission	NN	O	O
.	.	O	O

initial	JJ	B-TEST	O
cbc	NN	I-TEST	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
20	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
386	CD	O	O
,	,	O	O
63	CD	O	O
polys	NN	B-TEST	B-TEST
,	,	O	O
2	CD	O	O
bands	NNS	B-TEST	B-TEST
,	,	O	O
23	CD	O	O
lymphs	NN	B-TEST	B-TEST
.	.	O	O

blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
remained	VBD	O	O
negative	JJ	O	O
at	IN	O	O
this	DT	O	O
time	NN	O	O
.	.	O	O

infant	NN	O	O
has	VBZ	O	O
not	RB	O	O
received	VBN	O	O
any	DT	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

sensory	NN	O	O
:	:	O	O
hearing	NN	B-TEST	O
screen	NN	I-TEST	O
has	VBZ	O	O
not	RB	O	O
yet	RB	O	O
been	VBN	O	O
performed	VBN	O	O
but	CC	O	O
should	MD	O	O
be	VB	O	O
done	VBN	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

urachal	JJ	B-PROBLEM	B-PROBLEM
duct	NN	I-PROBLEM	I-PROBLEM
remnant	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
dressing	VBG	B-TREATMENT	O
to	TO	O	O
remain	VB	O	O
in	IN	O	O
place	NN	O	O
for	IN	O	O
10	CD	O	O
days	NNS	O	O
unless	IN	O	O
signs	NNS	O	O
of	IN	O	O
bleeding	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
infection	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
is	VBZ	O	O
soiled	VBN	O	O
.	.	O	O

gastrointestinal	JJ	B-PROBLEM	B-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM

sepsis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1	CD	O	O
)	)	O	O
gastrointestinal	JJ	B-PROBLEM	B-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

2	CD	O	O
)	)	O	O
hepatic	JJ	B-PROBLEM	B-PROBLEM
encephalopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3	LS	O	O
)	)	O	O
end	NN	B-PROBLEM	B-PROBLEM
stage	NN	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
dialysis	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
dark	JJ	B-PROBLEM	B-PROBLEM
stools	NNS	I-PROBLEM	I-PROBLEM
per	IN	I-PROBLEM	I-PROBLEM
rectum	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
to	TO	O	O
be	VB	O	O
somewhat	RB	B-PROBLEM	B-PROBLEM
fluid	JJ	I-PROBLEM	I-PROBLEM
overloaded	VBN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
and	CC	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	O	B-PROBLEM
significant	JJ	O	I-PROBLEM
hematocrit	NN	B-PROBLEM	I-PROBLEM
drop	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
33.8	CD	O	O
to	TO	O	O
24.3	CD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
found	VBN	O	O
operation	NN	O	O
be	VB	O	O
short	JJ	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
dialysis	VB	B-TREATMENT	B-TREATMENT
for	IN	O	O
apparent	JJ	B-PROBLEM	B-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
overload	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-PROBLEM	B-PROBLEM
gastrointestinal	JJ	I-PROBLEM	I-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
issues	NNS	I-PROBLEM	I-PROBLEM
were	VBD	O	O
investigated	VBN	O	O
with	IN	O	O
an	DT	B-TEST	B-TREATMENT
upper	JJ	I-TEST	I-TREATMENT
endoscopy	NN	I-TEST	I-TREATMENT
which	WDT	O	O
revealed	VBD	O	O
multiple	JJ	O	B-PROBLEM
superficial	JJ	O	I-PROBLEM
gastric	JJ	B-PROBLEM	I-PROBLEM
ulcerations	NNS	I-PROBLEM	I-PROBLEM
consistent	NN	O	O
with	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
non-steroidal	JJ	I-PROBLEM	I-PROBLEM
anti-inflammatory	JJ	I-PROBLEM	I-PROBLEM
drugs	NNS	I-PROBLEM	I-PROBLEM
gastropathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
been	VBN	O	O
discharged	VBN	O	O
on	IN	O	O
one	CD	B-TREATMENT	O
aspirin	NN	I-TREATMENT	B-TREATMENT
a	DT	O	O
day	NN	O	O
with	IN	O	O
20	CD	O	O
of	IN	O	O
prilosec	NN	B-TREATMENT	B-TREATMENT
b.i.d.	NN	O	O

the	DT	B-TREATMENT	B-TREATMENT
aspirin	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
and	CC	O	O
he	PRP	O	O
had	VBD	O	O
no	DT	O	O
further	JJ	O	B-PROBLEM
problems	NNS	O	I-PROBLEM
with	IN	O	O
gastrointestinal	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	O	O
stable	JJ	O	O
hematocrit	NN	B-TEST	O
the	DT	O	O
rest	NN	O	O
of	IN	O	O
his	PRP$	O	B-TREATMENT
hospitalization	NN	O	I-TREATMENT
.	.	O	O

during	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
his	PRP$	O	O
hospitalization	NN	O	O
,	,	O	O
he	PRP	O	O
became	VBD	O	O
increasingly	RB	B-PROBLEM	B-PROBLEM
lethargic	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
extensive	JJ	I-TEST	I-TEST
work-up	NN	I-TEST	I-TEST
was	VBD	O	O
done	VBN	O	O
for	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
metabolic	JJ	I-PROBLEM	I-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
unrevealing	VBG	O	O
.	.	O	O

he	PRP	O	O
responded	VBD	O	O
somewhat	RB	O	O
to	TO	O	O
lactulose	VB	B-TREATMENT	O
for	IN	O	O
hepatic	JJ	B-PROBLEM	B-PROBLEM
encephalopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
one	CD	B-PROBLEM	O
positive	JJ	I-PROBLEM	O
blood	NN	I-PROBLEM	B-TEST
culture	NN	I-PROBLEM	I-TEST
for	IN	O	O
vancomycin	NN	B-PROBLEM	B-TREATMENT
resistant	JJ	I-PROBLEM	I-TREATMENT
enterococcus	NN	I-PROBLEM	I-TREATMENT
.	.	O	O

in	IN	O	O
the	DT	O	O
few	JJ	O	O
days	NNS	O	O
prior	RB	O	O
to	TO	O	O
his	PRP$	O	O
demise	NN	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
intermittently	RB	O	B-PROBLEM
somewhat	RB	B-PROBLEM	I-PROBLEM
lethargic	JJ	I-PROBLEM	I-PROBLEM
buton	IN	O	O
the	DT	O	O
morning	NN	O	O
of	IN	O	O
june	NN	O	O
25	CD	O	O
,	,	O	O
1999	CD	O	O
,	,	O	O
his	PRP$	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
increased	VBN	O	O
from	IN	O	O
8	CD	O	O
to	TO	O	O
13,000	CD	O	O
.	.	O	O

that	DT	O	O
day	NN	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
acutely	RB	B-PROBLEM	B-PROBLEM
short	JJ	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
a	DT	B-TEST	B-TEST
respiratory	JJ	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
40	CD	O	O
and	CC	O	O
oxygen	JJ	B-TEST	B-TEST
saturations	NNS	I-TEST	I-TEST
in	IN	O	O
the	DT	O	O
mid	NN	O	O
seventies	NNS	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
put	VBN	O	O
on	IN	O	O
100%	CD	B-TREATMENT	O
nonrebreather	NN	I-TREATMENT	O
and	CC	O	O
his	PRP$	B-TEST	B-TEST
oxygen	NN	I-TEST	I-TEST
saturations	NNS	I-TEST	I-TEST
improved	VBN	O	O
to	TO	O	O
the	DT	O	B-PROBLEM
low	JJ	O	I-PROBLEM
nineties	NNS	O	I-PROBLEM
.	.	O	O

nasal	JJ	B-TREATMENT	B-TREATMENT
trumpet	NN	I-TREATMENT	I-TREATMENT
suction	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
done	VBN	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
food	NN	O	O
like	IN	O	O
material	NN	O	O
that	WDT	O	O
was	VBD	O	O
easily	RB	O	O
suctioned	VBN	O	O
out	RP	O	O
.	.	O	O

blood	NN	B-TEST	B-TEST
gases	NNS	I-TEST	I-TEST
were	VBD	O	O
done	VBN	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-TEST	O
ph	NN	I-TEST	O
of	IN	O	O
7.2	CD	O	O
with	IN	O	O
a	DT	B-TEST	O
pco2	NN	I-TEST	O
of	IN	O	O
21	CD	O	O
.	.	O	O

fingerstick	NN	B-TEST	B-TEST
glucose	NN	I-TEST	I-TEST
revealed	VBD	O	O
a	DT	B-TEST	B-TEST
sugar	NN	I-TEST	I-TEST
of	IN	O	O
12	CD	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
stat	JJ	I-TEST	I-TEST
panel	NN	I-TEST	I-TEST
7	CD	I-TEST	O
confirmed	VBD	O	O
that	IN	O	O
the	DT	B-TEST	B-TEST
sugar	NN	I-TEST	I-TEST
was	VBD	O	O
23	CD	O	O
and	CC	O	O
that	IN	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
new	JJ	I-TEST	I-TEST
anion	NN	I-TEST	I-TEST
gap	NN	I-TEST	I-TEST
of	IN	O	O
40	CD	O	O
.	.	O	O

repeat	NN	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
gas	NN	I-TEST	I-TEST
was	VBD	O	O
done	VBN	O	O
which	WDT	O	O
was	VBD	O	O
almost	RB	O	O
identical	JJ	O	O
to	TO	O	O
the	DT	O	O
first	JJ	O	O
.	.	O	O

in	IN	O	O
the	DT	O	O
acute	NN	O	O
setting	NN	O	O
,	,	O	O
he	PRP	O	O
had	VBD	O	O
been	VBN	O	O
started	VBN	O	O
on	IN	O	O
levofloxacin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

these	DT	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
continued	VBN	O	O
but	CC	O	O
the	DT	O	O
family	NN	O	O
decided	VBD	O	O
that	IN	O	O
they	PRP	O	O
wanted	VBD	O	O
us	PRP	O	O
to	TO	O	O
emphasize	VB	O	O
the	DT	O	O
comfort	NN	O	O
of	IN	O	O
the	DT	O	O
patient	NN	O	O
and	CC	O	O
pursue	VB	O	O
no	DT	O	O
further	JJ	B-TREATMENT	B-PROBLEM
invasive	JJ	I-TREATMENT	I-PROBLEM
measures	NNS	I-TREATMENT	I-PROBLEM
.	.	O	O

the	DT	O	O
family	NN	O	O
declined	VBD	O	O
an	DT	B-TEST	B-TEST
autopsy	NN	I-TEST	I-TEST
saying	VBG	O	O
that	IN	O	O
they	PRP	O	O
felt	VBD	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
been	VBN	O	O
through	IN	O	O
enough	RB	O	O
.	.	O	O

medicine	NN	B-TREATMENT	B-TREATMENT

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
33	CD	O	O
-	:	O	O
year-old	JJ	O	O
asian-caucasian	JJ	O	O
male	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
type	NN	B-PROBLEM	B-PROBLEM
1	CD	I-PROBLEM	I-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
asthma	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
alcohol	NN	O	O
abuse	NN	O	O
,	,	O	O
and	CC	O	O
personality	NN	B-PROBLEM	B-PROBLEM
disorder	NN	I-PROBLEM	I-PROBLEM
/	NNP	O	O
depression	NN	B-PROBLEM	B-PROBLEM
admitted	VBD	O	O
on	IN	O	O
2010-08-28	JJ	O	O
for	IN	O	O
persistent	JJ	B-PROBLEM	B-PROBLEM
hypoglycemia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
complained	VBD	O	O
of	IN	O	O
diaphoresis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
confusion	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
dizziness	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
lightheadedness	NN	B-PROBLEM	B-PROBLEM
after	IN	O	O
drinking	VBG	O	O
a	DT	O	O
24	CD	O	O
ounce	NN	O	O
beer	NN	O	O
and	CC	O	O
taking	VBG	O	O
at	IN	O	O
least	JJS	O	O
an	DT	O	O
extra	JJ	O	O
15	CD	O	O
units	NNS	O	O
of	IN	O	O
nph	JJ	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
the	DT	O	O
evening	NN	O	O
of	IN	O	O
2010-08-27	JJ	O	O
(	(	O	O
later	RB	O	O
reported	VBN	O	O
over	IN	O	O
70	CD	O	O
u	JJ	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
administered	VBD	O	O
from	IN	O	O
2.30	CD	O	O
pm	NN	O	O
until	IN	O	O
time	NN	O	O
of	IN	O	O
presentation	NN	O	O
)	)	O	O
followed	VBN	O	O
by	IN	O	O
not	RB	O	O
eating	VBG	O	O
dinner	NN	O	O
.	.	O	O

his	PRP$	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
mildly	RB	O	O
improved	VBN	O	O
after	IN	O	O
eating	VBG	O	O
a	DT	O	B-TREATMENT
candy	NN	O	I-TREATMENT
bar	NN	O	I-TREATMENT
.	.	O	O

the	DT	O	B-TEST
ems	NN	O	I-TEST
was	VBD	O	O
called	VBN	O	O
and	CC	O	O
found	VBD	O	O
his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
sugar	NN	I-TEST	I-TEST
at	IN	O	O
the	DT	O	O
time	NN	O	O
to	TO	O	O
be	VB	O	O
61	CD	O	O
and	CC	O	O
noted	VBD	O	O
to	TO	O	O
be	VB	O	O
41	CD	O	O
in	IN	O	O
the	DT	O	O
emergency	NN	O	O
department	NN	O	O
.	.	O	O

he	PRP	O	O
denied	VBD	O	O
any	DT	B-PROBLEM	B-PROBLEM
seizure	NN	I-PROBLEM	I-PROBLEM
activity	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
loss	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
consciousness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
incontinence	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
change	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
urinary	JJ	I-PROBLEM	I-PROBLEM
or	CC	I-PROBLEM	I-PROBLEM
bowel	JJ	I-PROBLEM	I-PROBLEM
habits	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
suicidal	JJ	B-PROBLEM	B-PROBLEM
ideation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
depressed	VBN	B-PROBLEM	O
recently	RB	O	O
regarding	VBG	O	O
stress	NN	O	O
with	IN	O	O
his	PRP$	O	B-TREATMENT
home	NN	O	I-TREATMENT
life	NN	O	I-TREATMENT
and	CC	O	O
on	IN	O	O
the	DT	O	O
night	NN	O	O
of	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
extra	JJ	I-TREATMENT	I-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
doses	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
his	PRP$	O	O
wife	NN	O	O
had	VBD	O	O
just	RB	O	O
kicked	VBN	O	O
him	PRP	O	O
out	IN	O	O
of	IN	O	O
the	DT	O	O
house	NN	O	O
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
had	VBD	O	O
four	CD	O	O
past	JJ	O	O
hospitalizations	NNS	O	O
for	IN	O	O
attempted	JJ	B-PROBLEM	B-PROBLEM
suicide	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
insulin	NN	B-PROBLEM	B-TREATMENT
overdosing	VBG	I-PROBLEM	I-TREATMENT
,	,	O	O
usually	RB	O	O
denied	VBN	O	O
.	.	O	O

in	IN	O	O
the	DT	O	O
emergency	NN	O	O
department	NN	O	O
,	,	O	O
he	PRP	O	O
received	VBD	O	O
3.5	CD	O	O
amps	NNS	O	O
of	IN	O	O
d50	NN	B-TREATMENT	O
and	CC	O	O
then	RB	O	O
d5	VB	B-TREATMENT	O
normal	JJ	I-TREATMENT	B-TREATMENT
saline	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
d10	NN	B-TREATMENT	B-TREATMENT
normal	JJ	I-TREATMENT	I-TREATMENT
saline	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
blood	NN	B-TEST	B-TEST
sugars	NNS	I-TEST	I-TEST
that	WDT	O	O
were	VBD	O	O
slow	JJ	B-PROBLEM	O
to	TO	I-PROBLEM	O
increase	VB	I-PROBLEM	O
leading	VBG	O	O
the	DT	O	O
icu	NN	O	O
team	NN	O	O
to	TO	O	O
suspect	VB	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
taken	VBN	O	O
more	RBR	O	O
insulin	JJ	B-TREATMENT	O
than	IN	O	O
he	PRP	O	O
admitted	VBD	O	O
.	.	O	O

he	PRP	O	O
also	RB	O	O
had	VBD	O	O
a	DT	O	O
very	RB	O	O
positive	JJ	O	O
tox	NN	B-TEST	O
screen	NN	I-TEST	O
for	IN	O	O
alcohol	NN	O	B-TREATMENT
.	.	O	O

his	PRP$	B-TEST	B-TEST
fingersticks	NNS	I-TEST	I-TEST
are	VBP	O	O
currently	RB	O	O
in	IN	O	O
the	DT	O	O
200	CD	O	O
s	NN	O	O
and	CC	O	O
his	PRP$	O	O
normal	JJ	O	O
blood	NN	O	O
glucose	NN	O	B-TEST
at	IN	O	O
home	NN	O	O
ranges	NNS	O	O
between	IN	O	O
90-200	CD	O	O
per	IN	O	O
the	DT	O	O
patient	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
now	RB	O	O
complains	VBZ	O	O
of	IN	O	O
increased	VBN	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
/	NN	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
rib	NN	I-PROBLEM	I-PROBLEM
cage	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
new	JJ	B-PROBLEM	B-PROBLEM
headache	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
also	RB	O	O
complains	VBZ	O	O
of	IN	O	O
chronic	NN	B-PROBLEM	B-PROBLEM
photophobia	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
is	VBZ	O	O
unchanged	JJ	O	O
.	.	O	O

he	PRP	O	O
denied	VBD	O	O
visual	JJ	B-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
lightheadedness	NN	B-PROBLEM	B-PROBLEM
of	IN	O	I-PROBLEM
dizziness	NN	B-PROBLEM	I-PROBLEM
currently	RB	O	O
,	,	O	O
neck	NN	B-PROBLEM	B-PROBLEM
stiffness	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
pain	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
any	DT	I-PROBLEM	I-PROBLEM
other	JJ	I-PROBLEM	I-PROBLEM
area	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1.	CD	O	O
insulin-dependent	JJ	B-PROBLEM	B-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

2.	CD	O	O
depression	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

3.	CD	O	O
asthma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

5.	CD	O	O
hypercholesterolemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

humalog	NN	B-TREATMENT	B-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	JJ	I-TREATMENT	I-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

2.	CD	O	O
nph	JJ	B-TREATMENT	B-TREATMENT
12	CD	O	O
units	NNS	O	O
q.a.m.	RB	O	O
,	,	O	O
7	CD	O	O
units	NNS	O	O
q.p.m.	RB	O	O
with	IN	O	O
normal	JJ	B-TREATMENT	O
home	NN	I-TREATMENT	O
dose	NN	I-TREATMENT	O
being	VBG	O	O
30	CD	O	O
units	NNS	O	O
q.a.m.	RB	O	O
and	CC	O	O
15	CD	O	O
units	NNS	O	O
q.p.m.	RB	O	O

3.	CD	O	O
thiamine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

4.	CD	O	O
folate	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

5.	CD	O	O
multivitamin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

6.	CD	O	O
fluticasone	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

7.	CD	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
inhaler	NN	I-TREATMENT	I-TREATMENT
p.r.n.	NN	O	O

8.	CD	O	O
neutra-phos	JJ	B-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

grandmother	NN	O	O
with	IN	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

mother	NN	O	O
with	IN	O	O
asthma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

physical	JJ	O	B-TEST
examination	NN	O	I-TEST
on	IN	O	O
transfer	NN	O	O
:	:	O	O
vital	JJ	B-TEST	B-TEST
signs	NNS	I-TEST	I-TEST
:	:	O	O

t	NN	B-TEST	O
maximum	NN	I-TEST	O
98.6	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
90s-130s	CD	O	O
/	JJ	O	O
80s-90s	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
70s	CD	O	O
to	TO	O	O
80s	CD	O	O
,	,	O	O
respirations	NNS	B-TEST	B-TEST
18	CD	O	O
,	,	O	O
oxygen	NN	B-TEST	B-TEST
saturation	NN	I-TEST	I-TEST
98%	CD	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
a	DT	O	O
soft-spoken	JJ	O	O
male	NN	O	O
resting	NN	O	O
in	IN	O	O
his	PRP$	O	O
bed	NN	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

sclerae	NN	O	O
were	VBD	O	O
anicteric	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

supple	NN	O	O
,	,	O	O
no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

regular	JJ	O	O
rate	NN	O	O
,	,	O	O
no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
rubs	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
gallops	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	O	O
.	.	O	O

normoactive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
,	,	O	O
soft	JJ	O	O
,	,	O	O
mildly	RB	B-PROBLEM	B-PROBLEM
tender	NN	I-PROBLEM	I-PROBLEM
at	IN	I-PROBLEM	O
right	JJ	I-PROBLEM	O
upper	JJ	I-PROBLEM	O
quadrant	NN	I-PROBLEM	O
just	RB	O	O
inferior	RB	O	O
to	TO	O	O
the	DT	O	O
lower	JJR	O	O
ribs	NN	O	O
,	,	O	O
no	DT	O	O
epigastric	JJ	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

depressed	JJ	B-PROBLEM	B-PROBLEM
affect	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

denied	VBN	O	O
suicidal	JJ	B-PROBLEM	B-PROBLEM
ideation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

cbc	NN	B-TEST	B-TEST
with	IN	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
6.2	CD	O	O
,	,	O	O
hemoglobin	NN	B-TEST	B-TEST
13.3	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
39.4	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
307,000	CD	O	O
.	.	O	O

sodium	NN	B-TEST	B-TEST
142	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.1	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
104	CD	O	O
,	,	O	O
bicarbonate	NN	B-TEST	B-TEST
30	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
7	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
0.7	CD	O	O
,	,	O	O
glucose	VBD	B-TEST	B-TEST
41	CD	O	O
.	.	O	O

calcium	NN	B-TEST	B-TEST
9.6	CD	O	O
,	,	O	O
magnesium	NN	B-TEST	B-TEST
2.2	CD	O	O
,	,	O	O
phosphorus	NN	B-TEST	B-TEST
7.4	CD	O	O
,	,	O	O
vitamin	FW	B-TEST	B-TEST
b12	VBP	I-TEST	I-TEST
level	NN	I-TEST	I-TEST
320	CD	O	O
,	,	O	O
folate	NN	B-TEST	B-TEST
9.5	CD	O	O
,	,	O	O
tsh	NN	B-TEST	B-TEST
1.4	CD	O	O
,	,	O	O
acetone	RB	B-TEST	B-TEST
negative	JJ	O	O
.	.	O	O

serum	NN	B-TEST	B-TEST
tox	NN	I-TEST	I-TEST
screen	NN	I-TEST	I-TEST
,	,	O	O
alcohol	NN	O	B-TREATMENT
32	CD	O	O
mg	NN	O	O
per	IN	O	O
deciliter	NN	O	O
,	,	O	O
negative	JJ	O	O
for	IN	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
benzos	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
barbiturates	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
tca	NN	B-TREATMENT	O
.	.	O	O

urine	JJ	B-TEST	B-TEST
tox	NN	I-TEST	I-TEST
screen	NN	I-TEST	I-TEST
negative	JJ	O	O
for	IN	O	O
benzos	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
barbiturates	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
opiates	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
cocaine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
amphetamines	NNS	B-TREATMENT	B-TREATMENT
,	,	O	O
and	CC	O	O
methadone	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

telemetry	NN	B-TEST	B-TEST
was	VBD	O	O
notable	JJ	O	O
for	IN	O	O
episodes	NNS	O	O
of	IN	O	O
sinus	JJ	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
120s	CD	O	O
to	TO	O	O
140s	CD	O	O
only	RB	O	O
.	.	O	O

1.	CD	O	O
hypoglycemia	NN	B-PROBLEM	B-PROBLEM
:	:	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
been	VBN	O	O
initially	RB	O	O
very	RB	B-PROBLEM	O
hypoglycemic	JJ	I-PROBLEM	O
on	IN	O	O
admission	NN	O	O
secondary	JJ	O	O
to	TO	O	O
overdosing	VBG	B-PROBLEM	O
on	IN	I-PROBLEM	O
insulin	NN	I-PROBLEM	B-TREATMENT
;	:	O	O
however	RB	O	O
,	,	O	O
with	IN	O	O
glucose	JJ	B-TREATMENT	B-TEST
repletion	NN	I-TREATMENT	I-TEST
both	DT	O	O
in	IN	O	O
the	DT	O	O
emergency	NN	O	O
department	NN	O	O
and	CC	O	O
in	IN	O	O
the	DT	O	O
icu	NN	O	O
,	,	O	O
this	DT	O	O
resolved	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
also	RB	O	O
began	VBD	O	O
to	TO	O	O
eat	VB	O	O
.	.	O	O

we	PRP	O	O
checked	VBD	O	O
fingerstick	JJ	B-TEST	O
glucoses	NNS	I-TEST	O
q.i.d.	NN	O	O
and	CC	O	O
at	IN	O	O
3:00	CD	O	O
a.m.	NN	O	O

his	PRP$	B-TEST	B-TEST
glucose	NN	I-TEST	I-TEST
on	IN	O	O
the	DT	O	O
morning	NN	O	O
of	IN	O	O
discharge	NN	O	O
was	VBD	O	O
about	RB	O	O
60	CD	O	O
so	IN	O	O
we	PRP	O	O
opted	VBD	O	O
to	TO	O	O
decrease	VB	O	O
his	PRP$	B-TREATMENT	O
p.m.	NN	I-TREATMENT	O
nph	RB	I-TREATMENT	O
dose	VBZ	I-TREATMENT	O
slightly	RB	O	O
for	IN	O	O
discharge	NN	O	O
and	CC	O	O
continue	VB	O	O
covering	VBG	O	O
him	PRP	O	O
with	IN	O	O
sliding	VBG	B-TREATMENT	B-TREATMENT
scale	JJ	I-TREATMENT	I-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

it	PRP	O	O
is	VBZ	O	O
likely	JJ	O	O
that	IN	O	O
he	PRP	O	O
required	VBD	O	O
a	DT	O	O
much	RB	O	O
greater	JJR	O	O
amount	NN	O	O
of	IN	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
due	JJ	O	O
to	TO	O	O
poor	JJ	B-PROBLEM	O
compliance	NN	I-PROBLEM	O
with	IN	O	O
richard	NN	B-TREATMENT	O
natalie	NN	I-TREATMENT	O
diet	NN	I-TREATMENT	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
been	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
diazepam	NN	I-TREATMENT	I-TREATMENT
ciwa	NN	I-TREATMENT	I-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
against	IN	O	O
dt	NN	B-PROBLEM	O
s;	NN	I-PROBLEM	O
however	RB	O	O
,	,	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-PROBLEM
very	RB	I-TEST	I-PROBLEM
low	JJ	I-TEST	I-PROBLEM
ciwa	NN	I-TEST	I-PROBLEM
scale	NN	I-TEST	I-PROBLEM
during	IN	O	O
his	PRP$	O	O
entire	JJ	O	O
admission	NN	O	O
and	CC	O	O
did	VBD	O	O
not	RB	O	O
need	VB	O	O
any	DT	B-TREATMENT	B-TREATMENT
benzodiazepines	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

3.	CD	O	O
depression	NN	B-PROBLEM	B-PROBLEM
vs.	FW	O	O
borderline	NN	B-PROBLEM	B-PROBLEM
personality	NN	I-PROBLEM	I-PROBLEM
disorder	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
had	VBN	O	O
several	JJ	O	O
admissions	NNS	O	O
in	IN	O	O
the	DT	O	O
past	NN	O	O
for	IN	O	O
attempted	JJ	B-PROBLEM	B-PROBLEM
suicide	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
overdose	NN	B-PROBLEM	B-PROBLEM
of	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
though	IN	O	O
he	PRP	O	O
denied	VBD	O	O
at	IN	O	O
this	DT	O	O
time	NN	O	O
attempting	VBG	O	O
to	TO	O	O
end	VB	O	O
his	PRP$	O	O
life	NN	O	O
,	,	O	O
it	PRP	O	O
appears	VBZ	O	O
that	IN	O	O
the	DT	O	O
social	JJ	O	O
situation	NN	O	O
of	IN	O	O
increased	JJ	B-PROBLEM	B-PROBLEM
stressors	NNS	I-PROBLEM	I-PROBLEM
corresponding	VBG	O	O
to	TO	O	O
this	DT	O	O
time	NN	O	O
suggest	VB	O	O
that	IN	O	O
this	DT	O	O
is	VBZ	O	O
not	RB	O	O
the	DT	O	O
truth	NN	O	O
.	.	O	O

he	PRP	O	O
received	VBD	O	O
a	DT	O	B-TREATMENT
one-to-one	JJ	B-TREATMENT	I-TREATMENT
sitter	NN	I-TREATMENT	I-TREATMENT
during	IN	O	O
his	PRP$	O	O
admission	NN	O	O
and	CC	O	O
will	MD	O	O
be	VB	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
psychiatry	NN	O	O
healthsouth	VBD	O	O
new	JJ	O	O
england	NN	O	O
rehab	NN	O	O
hospital	NN	O	O
to	TO	O	O
ensure	VB	O	O
the	DT	O	O
patient	NN	O	O
's	POS	O	O
safety	NN	O	O
and	CC	O	O
initiate	VB	O	O
further	JJ	B-TREATMENT	B-TREATMENT
antidepressant	JJ	I-TREATMENT	I-TREATMENT
treatment	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
will	MD	O	O
need	VB	O	O
close	RB	O	O
follow-up	JJ	O	O
regarding	VBG	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
depression	NN	I-PROBLEM	I-PROBLEM
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
,	,	O	O
although	IN	O	O
apparently	RB	O	O
this	DT	O	O
has	VBZ	O	O
been	VBN	O	O
set	VBN	O	O
up	RP	O	O
for	IN	O	O
him	PRP	O	O
in	IN	O	O
the	DT	O	O
past	NN	O	O
and	CC	O	O
he	PRP	O	O
had	VBD	O	O
not	RB	O	O
followed	VBN	O	O
through	IN	O	O
.	.	O	O

4.	CD	O	O
history	NN	O	O
of	IN	O	O
high	JJ	B-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
pressure	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

his	PRP$	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
fairly	RB	O	O
low	JJ	O	O
with	IN	O	O
a	DT	O	O
maximum	NN	O	O
of	IN	O	O
130s	CD	O	O
systolic	NN	O	B-TEST
during	IN	O	O
his	PRP$	O	O
admission	NN	O	O
,	,	O	O
thus	RB	O	O
we	PRP	O	O
did	VBD	O	O
not	RB	O	O
continue	VB	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
lisinopril	NN	I-TREATMENT	I-TREATMENT
which	WDT	O	O
he	PRP	O	O
had	VBD	O	O
been	VBN	O	O
on	IN	O	O
in	IN	O	O
the	DT	O	O
past	NN	O	O
.	.	O	O

5.	CD	O	O
right	JJ	B-PROBLEM	B-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
quadrant	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
:	:	O	O

we	PRP	O	O
obtained	VBD	O	O
a	DT	B-TEST	B-TEST
right	JJ	I-TEST	I-TEST
upper	NN	I-TEST	I-TEST
quadrant	NN	I-TEST	I-TEST
ultrasound	NN	I-TEST	I-TEST
as	RB	O	O
well	RB	O	O
as	IN	O	O
lfts	NNS	B-TEST	O
,	,	O	O
amylase	NN	B-TEST	B-TEST
,	,	O	O
and	CC	O	O
lipase	NN	B-TEST	B-TEST
which	WDT	O	O
were	VBD	O	O
all	DT	O	O
normal	JJ	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
cholecystitis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
gallstones	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
any	DT	B-PROBLEM	B-PROBLEM
abnormalities	NNS	I-PROBLEM	I-PROBLEM
with	IN	I-PROBLEM	O
the	DT	I-PROBLEM	B-PROBLEM
liver	NN	I-PROBLEM	I-PROBLEM
or	CC	I-PROBLEM	I-PROBLEM
kidneys	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

it	PRP	O	O
is	VBZ	O	O
possible	JJ	O	O
that	IN	O	O
he	PRP	O	O
has	VBZ	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
muscle	NN	I-PROBLEM	I-PROBLEM
strain	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
other	JJ	B-PROBLEM	B-PROBLEM
musculoskeletal	JJ	I-PROBLEM	I-PROBLEM
cause	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

6.	CD	O	O
prophylaxis	NN	B-TREATMENT	B-TREATMENT
:	:	O	O

he	PRP	O	O
was	VBD	O	O
put	VBN	O	O
on	IN	O	O
pepcid	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
gi	NN	B-TREATMENT	B-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
complied	VBD	O	O
with	IN	O	O
linda	NN	B-TREATMENT	O
chad	VBD	I-TREATMENT	O
diet	JJ	I-TREATMENT	O
while	IN	O	O
hospitalized	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
hyperphosphatemic	JJ	B-PROBLEM	O
secondary	JJ	O	O
to	TO	O	O
overadministration	NN	O	O
of	IN	O	O
neutra-phos	JJ	B-TREATMENT	B-PROBLEM
during	IN	O	O
his	PRP$	O	O
icu	JJ	O	O
stay	NN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
given	VBN	O	O
two	CD	O	O
doses	NNS	O	O
of	IN	O	O
calcium	NN	B-TREATMENT	B-TREATMENT
carbonate	NN	I-TREATMENT	I-TREATMENT
1	CD	O	O
gram	NN	O	O
,	,	O	O
and	CC	O	O
will	MD	O	O
most	RBS	O	O
likely	JJ	O	O
normalize	JJ	O	O
secondary	JJ	O	O
to	TO	O	O
both	DT	O	O
calcium	NN	O	B-TREATMENT
binding	NN	O	I-TREATMENT
and	CC	O	O
urinary	JJ	O	B-PROBLEM
excretion	NN	O	I-PROBLEM
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
asymptomatic	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

1.	CD	O	O
depression	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

2.	CD	O	O
insulin-dependent	JJ	B-PROBLEM	B-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
mellitus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

3.	CD	O	O
asthma	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

1.	CD	O	O
insulin	NN	B-TREATMENT	B-TREATMENT
nph	RB	I-TREATMENT	I-TREATMENT
10	CD	O	O
units	NNS	O	O
q.a.m.	RB	O	O
,	,	O	O
5	CD	O	O
units	NNS	O	O
q.p.m.	RB	O	O

2.	CD	O	O
humalog	NN	B-TREATMENT	B-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	JJ	I-TREATMENT	I-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
fingerstick	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
glucose	VBD	I-TEST	I-TEST
151-200	JJ	O	O
2	CD	O	O
units	NNS	O	O
;	:	O	O
201-250	JJ	O	O
4	CD	O	O
units	NNS	O	O
;	:	O	O
251-300	JJ	O	O
6	CD	O	O
units	NNS	O	O
;	:	O	O
301-350	JJ	O	O
8	CD	O	O
units	NNS	O	O
;	:	O	O
351-400	JJ	O	O
10	CD	O	O
units	NNS	O	O
;	:	O	O
greater	JJR	O	O
than	IN	O	O
400	CD	O	O
12	CD	O	O
units	NNS	O	O
.	.	O	O

3.	CD	O	O
multivitamin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

4.	CD	O	O
fluticasone	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

5.	CD	O	O
albuterol	NN	B-TREATMENT	B-TREATMENT
p.r.n.	NN	O	O

6.	CD	O	O
pepcid	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O

the	DT	O	O
patient	NN	O	O
will	MD	O	O
be	VB	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
inpatient	JJ	O	O
psychiatry	NN	O	O
unit	NN	O	O
on	IN	O	O
springfield	NN	O	O
municipal	JJ	O	O
hospital	NN	O	O
iv	NN	O	O
for	IN	O	O
further	JJ	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
and	CC	O	O
treatment	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
depression	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
possible	JJ	O	O
suicidal	JJ	B-PROBLEM	B-PROBLEM
ideation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
will	MD	O	O
follow-up	VB	O	O
with	IN	O	O
his	PRP$	O	O
primary	JJ	O	O
care	NN	O	O
doctor	NN	O	O
,	,	O	O
dr.	NN	O	O
gillis	NN	O	O
,	,	O	O
after	IN	O	O
discharge	NN	O	O
,	,	O	O
johannes	NNS	O	B-TEST
for	IN	O	O
diabetes	NNS	B-TREATMENT	B-PROBLEM
management	NN	I-TREATMENT	I-PROBLEM
,	,	O	O
and	CC	O	O
psychiatry	NN	O	O
for	IN	O	O
further	JJ	B-TREATMENT	B-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
impulsive	JJ	I-PROBLEM	I-PROBLEM
behaviors	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

increased	VBN	O	B-PROBLEM
acid	NN	B-PROBLEM	I-PROBLEM
reflux	NN	I-PROBLEM	I-PROBLEM

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
given	VBN	O	O
printed	JJ	O	O
instructions	NNS	O	O
for	IN	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
spanish	JJ	O	O
)	)	O	O
.	.	O	O

gerd	NN	B-PROBLEM	B-PROBLEM

h	NN	O	O
,	,	O	O
p,	NN	B-TEST	B-TEST
labs	NNS	B-TEST	I-TEST
,	,	O	O
mylanta	FW	B-TREATMENT	B-TREATMENT
/	FW	O	I-TREATMENT
viscous	JJ	B-TREATMENT	I-TREATMENT
lidocaine	NN	I-TREATMENT	I-TREATMENT

mylanta	NN	B-TREATMENT	B-TREATMENT
15	CD	O	O
cc	NN	O	O
mixed	JJ	O	O
with	IN	O	O
viscous	JJ	B-TREATMENT	B-TREATMENT
lidocaine	NN	I-TREATMENT	I-TREATMENT
every	DT	O	O
8	CD	O	O
hours	NNS	O	O
if	IN	O	O
needed	VBN	O	O
for	IN	O	O
severe	JJ	O	B-PROBLEM
pain	NN	B-PROBLEM	I-PROBLEM
only	RB	O	O
can	MD	O	O
use	VB	O	O
mylanta	NN	B-TREATMENT	O
without	IN	O	O
lidocaine	NN	B-TREATMENT	B-TREATMENT
more	RBR	O	O
frequently	RB	O	O
bland	VBP	B-TREATMENT	O
diet	JJ	I-TREATMENT	O
,	,	O	O
no	DT	O	O
caffeine	NN	O	B-TREATMENT
,	,	O	O
chilli	NN	O	B-TREATMENT
,	,	O	O
or	CC	O	O
alcohol	NN	O	O
...	:	O	O

return	NN	O	O
to	TO	O	O
ed	VB	O	O
if	IN	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
black	JJ	B-PROBLEM	B-PROBLEM
stools	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
blood	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
stool	NN	I-PROBLEM	I-PROBLEM

this	DT	O	O
is	VBZ	O	O
a	DT	O	O
44	CD	O	O
-	:	O	O
year-old	JJ	O	O
male	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
9/02	CD	O	O
,	,	O	O
status	NN	O	O
post	NN	O	O
stent	NN	B-TREATMENT	B-TREATMENT
proximal	NN	B-PROBLEM	I-TREATMENT
and	CC	I-PROBLEM	O
mid-rca	JJ	I-PROBLEM	B-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
om	JJ	B-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-PROBLEM
myoview	NN	I-TEST	I-PROBLEM
on	IN	O	O
05-04	NN	O	B-TREATMENT
which	WDT	O	O
showed	VBD	O	O
fixed	VBN	B-PROBLEM	B-PROBLEM
inferior	RB	I-PROBLEM	I-PROBLEM
wall	JJ	I-PROBLEM	I-PROBLEM
defect	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
ischemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
getting	VBG	O	O
short	JJ	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
exertion	NN	O	O
times	NNS	O	O
one	CD	O	O
month	NN	O	O
and	CC	O	O
also	RB	O	O
has	VBZ	O	O
occasional	JJ	B-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
tightness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
denies	VBZ	O	O
orthopnea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
edema	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
paroxysmal	JJ	B-PROBLEM	B-PROBLEM
nocturnal	JJ	I-PROBLEM	I-PROBLEM
dyspnea	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
diaphoresis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
claudication	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
also	RB	O	O
has	VBZ	O	O
history	NN	O	O
of	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
high	JJ	B-PROBLEM	B-PROBLEM
cholesterol	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
noninsulin	JJ	B-PROBLEM	B-PROBLEM
dependent	NN	I-PROBLEM	I-PROBLEM
diabetes	VBZ	I-PROBLEM	I-PROBLEM
mellitus	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
underwent	JJ	O	O
cardiac	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
today	NN	O	O
which	WDT	O	O
revealed	VBD	O	O
om	NNS	O	O
,	,	O	O
no	DT	O	O
obstructive	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
left	VBD	B-PROBLEM	B-PROBLEM
anterior	RP	I-PROBLEM	I-PROBLEM
descending	VBG	I-PROBLEM	I-PROBLEM
minimal	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
left	VBD	B-PROBLEM	B-PROBLEM
circumflex	JJ	I-PROBLEM	I-PROBLEM
40%	CD	I-PROBLEM	I-PROBLEM
mid-stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

right	RB	B-PROBLEM	O
coronary	JJ	I-PROBLEM	O
artery	RB	I-PROBLEM	O
100%	CD	I-PROBLEM	O
mid-stenosis	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

echo	NN	B-TEST	B-TEST
in	IN	O	O
9/02	CD	O	O
showed	VBD	O	O
lvf	NN	B-TEST	O
of	IN	O	O
75%	CD	O	O
with	IN	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
dilatation	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
descending	NN	I-PROBLEM	I-PROBLEM
aorta	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
now	RB	O	O
preop	JJ	O	O
for	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
coronary	JJ	I-TREATMENT	I-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

noninsulin	JJ	B-PROBLEM	B-PROBLEM
dependent	NN	I-PROBLEM	I-PROBLEM
diabetes	VBZ	I-PROBLEM	I-PROBLEM
mellitus	RBS	I-PROBLEM	I-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
high	JJ	B-PROBLEM	B-PROBLEM
cholesterol	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
in	IN	O	O
9/02	CD	O	O
.	.	O	O

status	NN	O	O
post	NN	O	O
stent	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

1.	CD	O	O
folic	JJ	B-TREATMENT	B-TREATMENT
acid	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

2.	CD	O	O
metformin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

3.	CD	O	O
norvasc	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

4.	CD	O	O
aspirin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

5.	CD	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

6.	CD	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

7.	CD	O	O
diovan	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

8.	CD	O	O
hydrochlorothiazide	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

penicillin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
sulfa	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
codeine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

strong	JJ	B-PROBLEM	B-PROBLEM
coronary	JJ	I-PROBLEM	I-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
in	IN	O	O
no	DT	O	O
acute	NN	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
vital	JJ	B-TEST	B-TEST
signs	NNS	I-TEST	I-TEST
stable	JJ	O	O
.	.	O	O

normocephalic	JJ	B-PROBLEM	O
,	,	O	O
atraumatic	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

full	JJ	O	O
range	NN	O	O
of	IN	O	O
motion	NN	O	O
,	,	O	O
no	DT	O	O
lymphadenopathy	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
thyromegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

carotids	NNS	B-TEST	B-TEST
2+	CD	O	O
bilaterally	RB	O	O
without	IN	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

lungs	NNS	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	O	O
.	.	O	O

no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
rubs	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
gallops	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

abdomen	NNS	B-PROBLEM	O
obese	JJ	I-PROBLEM	B-PROBLEM
,	,	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
without	IN	O	O
masses	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
hepatosplenomegaly	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
positive	JJ	O	O
bowel	NN	O	O
sounds	VBZ	O	O
without	IN	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
clubbing	VBG	B-PROBLEM	B-PROBLEM
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

pulses	NNS	B-TEST	B-TEST
2+	CD	O	O
bilaterally	RB	O	O
throughout	IN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
hospital	NN	O	O
on	IN	O	O
2015-06-10	JJ	O	O
and	CC	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
on	IN	O	O
2015-06-11	JJ	O	O
where	WRB	O	O
coronary	JJ	B-TREATMENT	B-TREATMENT
artery	NN	I-TREATMENT	I-TREATMENT
bypass	NN	I-TREATMENT	I-TREATMENT
graft	NN	I-TREATMENT	I-TREATMENT
times	NNS	O	O
four	CD	O	O
was	VBD	O	O
performed	VBN	O	O
.	.	O	O

he	PRP	O	O
initially	RB	O	O
required	VBD	O	O
nitroglycerin	JJ	B-TREATMENT	B-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
had	VBD	O	O
chest	VBN	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
and	CC	O	I-TREATMENT
pacing	NN	B-TREATMENT	I-TREATMENT
wires	NNS	I-TREATMENT	I-TREATMENT
in	IN	O	O
place	NN	O	O
.	.	O	O

received	VBN	O	O
perioperative	JJ	B-TREATMENT	B-TREATMENT
vancomycin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

postoperative	JJ	O	O
day	NN	O	O
one	CD	O	O
the	DT	B-TEST	B-TEST
chest	NN	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
collapsed	JJ	I-PROBLEM	I-PROBLEM
left	NN	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

peep	NN	B-TREATMENT	O
was	VBD	O	O
increased	VBN	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
chest	JJ	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
checked	VBD	O	O
the	DT	O	O
following	JJ	O	O
morning	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
subsequently	RB	O	O
did	VBD	O	O
well	RB	O	O
,	,	O	O
chest	JJS	B-TREATMENT	B-TREATMENT
tubes	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
removed	VBN	O	O
at	IN	O	O
the	DT	O	O
appropriate	JJ	O	O
time	NN	O	O
,	,	O	O
pacing	VBG	B-TREATMENT	B-TREATMENT
wires	NNS	I-TREATMENT	I-TREATMENT
removed	VBN	O	O
at	IN	O	O
the	DT	O	O
appropriate	JJ	O	O
time	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
discharged	VBN	O	O
to	TO	O	O
the	DT	O	O
regular	JJ	O	O
cardiothoracic	NN	O	O
floor	NN	O	O
where	WRB	O	O
his	PRP$	B-TREATMENT	B-TEST
anti-hypertensives	NNS	I-TREATMENT	I-TEST
were	VBD	O	O
manipulated	VBN	O	O
to	TO	O	O
improve	VB	O	O
his	PRP$	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
and	CC	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
.	.	O	O

should	MD	O	O
not	RB	O	O
drive	VB	O	O
while	IN	O	O
on	IN	O	O
pain	NN	B-TREATMENT	B-TREATMENT
medication	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
on	IN	O	O
lopressor	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

metformin	NN	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

lasix	RB	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
times	VB	O	O
seven	CD	O	O
days	NNS	O	O
.	.	O	O

potassium	NN	B-TREATMENT	B-TEST
20	CD	O	O
meq	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
times	VB	O	O
seven	CD	O	O
days	NNS	O	O
.	.	O	O

potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
20	CD	O	O
meq	NN	O	O
times	NNS	O	O
seven	CD	O	O
days	NNS	O	O
,	,	O	O
plavix	VBP	B-TREATMENT	B-TREATMENT
75	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q	JJ	O	O
day	NN	O	O
,	,	O	O
isosorbide	RB	B-TREATMENT	B-TREATMENT
60	CD	O	O
mg	NNS	O	O
q	JJ	O	O
day	NN	O	O
,	,	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
p.r.n.	NN	O	O
,	,	O	O
entericoated	VBD	B-TREATMENT	O
aspirin	RB	I-TREATMENT	B-TREATMENT
325	CD	O	O
mg	NNS	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
twice	RB	O	O
a	DT	O	O
day	NN	O	O
p.r.n.	NN	O	O

lipitor	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

folate	NN	B-TREATMENT	B-TREATMENT
1	CD	O	O
mg	NN	O	O
q	JJ	O	O
day	NN	O	O
.	.	O	O

rule	NN	O	O
out	IN	O	O
for	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM

rule	NN	O	O
out	IN	O	O
for	IN	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM

1	CD	O	O
)	)	O	O
aortic	JJ	B-PROBLEM	B-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
2	CD	O	O
)	)	O	O
parkinson	NN	B-PROBLEM	B-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
3	CD	O	O
)	)	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
colon	NN	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
4	CD	O	O
)	)	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
exercise	NN	I-TEST	I-TEST
tolerance	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
with	IN	O	I-TEST
imaging	NN	B-TEST	I-TEST
.	.	O	O

right	RB	B-PROBLEM	B-PROBLEM
sided	VBN	I-PROBLEM	I-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
by	IN	O	O
several	JJ	O	O
hours	NNS	O	O
.	.	O	O

miss	NN	O	B-PROBLEM
siehjesc	NN	O	I-PROBLEM
is	VBZ	O	O
an	DT	O	O
85-year-old	JJ	O	O
woman	NN	O	O
with	IN	O	O
a	DT	O	O
past	JJ	O	O
medical	JJ	O	O
history	NN	O	O
significant	JJ	O	O
for	IN	O	O
parkinson	NN	B-PROBLEM	B-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
ten	JJ	O	O
years	NNS	O	O
duration	NN	O	O
,	,	O	O
supraventricular	JJ	B-PROBLEM	B-PROBLEM
tachycardia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
colon	NN	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
who	WP	O	O
was	VBD	O	O
in	IN	O	O
her	PRP$	O	O
usual	JJ	O	O
state	NN	O	O
of	IN	O	O
health	NN	O	O
until	IN	O	O
11:30	CD	O	O
on	IN	O	O
the	DT	O	O
morning	NN	O	O
of	IN	O	O
admission	NN	O	O
when	WRB	O	O
she	PRP	O	O
felt	VBD	O	O
the	DT	O	O
acute	NN	O	O
on	IN	O	O
set	NN	O	O
of	IN	O	O
5	CD	O	O
out	IN	O	O
of	IN	O	O
10	CD	O	O
right	NN	B-PROBLEM	O
sided	VBD	I-PROBLEM	O
chest	JJS	I-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
radiation	NN	B-PROBLEM	O
to	TO	I-PROBLEM	O
her	PRP$	I-PROBLEM	B-PROBLEM
sternum	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
not	RB	O	O
to	TO	O	O
her	PRP$	O	B-PROBLEM
neck	NN	O	I-PROBLEM
or	CC	O	O
arms	NNS	O	B-PROBLEM
or	CC	O	O
back	RB	O	O
.	.	O	O

it	PRP	O	O
was	VBD	O	O
not	RB	O	O
relieved	VBN	O	O
by	IN	O	O
2	CD	B-TREATMENT	O
sublingual	JJ	I-TREATMENT	B-TREATMENT
nitroglycerins	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
did	VBD	O	O
state	NN	O	O
that	IN	O	O
she	PRP	O	O
experienced	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
shortness	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
her	PRP$	O	O
usual	JJ	O	O
anginal	JJ	O	O
equivalent	NN	O	O
)	)	O	O
and	CC	O	O
believes	VBZ	O	O
she	PRP	O	O
did	VBD	O	O
experience	VB	O	O
some	DT	B-PROBLEM	B-PROBLEM
lightheadedness	NN	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
,	,	O	O
but	CC	O	O
denies	VBZ	O	O
blacking	VBG	O	B-PROBLEM
out	RP	O	I-PROBLEM
or	CC	O	O
falling	VBG	O	B-PROBLEM
.	.	O	O

while	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
initially	RB	O	O
intermittent	JJ	O	O
,	,	O	O
it	PRP	O	O
became	VBD	O	O
steady	JJ	O	O
at	IN	O	O
about	IN	O	O
1:00	CD	O	O
p.m.	NN	O	O
at	IN	O	O
which	WDT	O	O
time	NN	O	O
she	PRP	O	O
presented	VBD	O	O
to	TO	O	O
the	DT	O	O
tecal	JJ	O	O
galecounxopt	NN	O	O
community	NN	O	O
hospital	NN	O	O
emergency	NN	O	O
room	NN	O	O
and	CC	O	O
following	VBG	O	O
this	DT	O	O
experience	NN	O	O
a	DT	O	O
spontaneous	JJ	O	O
remission	NN	O	O
of	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
sided	VBD	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

since	IN	O	O
that	DT	O	O
time	NN	O	O
she	PRP	O	O
has	VBZ	O	O
experience	NN	O	O
occasional	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
the	DT	B-PROBLEM	O
same	JJ	I-PROBLEM	O
focal	JJ	I-PROBLEM	B-PROBLEM
chest	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
finds	VBZ	O	O
that	IN	O	O
it	PRP	O	O
spontaneously	RB	O	O
remits	VBZ	O	O
.	.	O	O

it	PRP	O	O
is	VBZ	O	O
made	VBN	O	O
better	RB	O	O
by	IN	O	O
direct	JJ	B-TREATMENT	B-TEST
pressure	NN	I-TREATMENT	I-TEST
to	TO	I-TREATMENT	O
the	DT	I-TREATMENT	O
point	NN	I-TREATMENT	O
and	CC	O	O
she	PRP	O	O
recalls	VBZ	O	O
no	DT	O	O
factors	NNS	O	O
which	WDT	O	O
worsened	VBD	O	O
it	PRP	O	O
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
admitted	VBN	O	O
to	TO	O	O
rule	VB	O	O
out	RP	O	O
myocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

1	CD	O	O
)	)	O	O
parkinson	NN	B-PROBLEM	B-PROBLEM
's	POS	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
;	:	O	O

2	CD	O	O
)	)	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
;	:	O	O

3	LS	O	O
)	)	O	O
aorticsclerosis	NN	B-PROBLEM	B-PROBLEM
;	:	O	O

4	CD	O	O
)	)	O	O
history	NN	O	O
of	IN	O	O
colon	NN	B-PROBLEM	B-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
;	:	O	O

5	CD	O	O
)	)	O	O
severe	JJ	B-PROBLEM	B-PROBLEM
kyphosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

codeine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

1	CD	O	O
)	)	O	O
lasix	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg.	NN	O	O
po	NN	O	O
q.d.	NN	O	O

2	CD	O	O
)	)	O	O
sinemet	VBD	B-TREATMENT	O
25/100	CD	O	O
1	CD	O	O
t.i.d.	NN	O	O

3	LS	O	O
)	)	O	O
cogentin	NN	B-TREATMENT	O
0.5	CD	O	O
mg.	NN	O	O
1	CD	O	O
tabs	NN	O	O
po	NN	O	O
q.a.m.	NN	O	O
and	CC	O	O
1	CD	O	O
q.noon	NN	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
1	CD	O	O
q.h.s.	NN	O	O

4	CD	O	O
)	)	O	O
eldepryl	NN	B-TREATMENT	O
5	CD	O	O
mg.	NN	O	O
po	NN	O	O
b.i.d.	NN	O	O

5	CD	O	O
)	)	O	O
enteric	NN	B-TREATMENT	O
coated	VBD	I-TREATMENT	O
aspirin	RB	I-TREATMENT	B-TREATMENT
325	CD	O	O
mg.	NNS	O	O
po	JJ	O	O
q.d.	NN	O	O

6	CD	O	O
)	)	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
10	CD	O	O
meq.	NN	O	O
po	NN	O	O
q.d.	NN	O	O

is	VBZ	O	O
significant	JJ	O	O
for	IN	O	O
a	DT	O	O
father	NN	O	O
who	WP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
stroke	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
also	RB	O	O
suffered	VBD	O	O
from	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
denies	VBZ	O	O
any	DT	O	O
family	NN	O	O
history	NN	O	O
of	IN	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
vital	JJ	I-TEST	I-TEST
signs	NNS	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-TEST	B-TEST
temperature	NN	I-TEST	I-TEST
of	IN	O	O
96.8	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
80	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
180/78	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
18	CD	O	O
,	,	O	O
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
satting	VBG	B-TEST	B-TEST
95	CD	O	O
percent	NN	O	O
on	IN	O	O
two	CD	B-TREATMENT	B-TREATMENT
liters	NNS	I-TREATMENT	I-TREATMENT
nasal	JJ	I-TREATMENT	I-TREATMENT
cannula	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

in	IN	O	O
general	JJ	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
resting	VBG	O	O
comfortably	RB	O	O
in	IN	O	O
bed	NN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
visible	JJ	I-PROBLEM	I-PROBLEM
tremor	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
her	PRP$	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
hand	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
foot	NN	I-PROBLEM	O
.	.	O	O

the	DT	O	B-TEST
head	NN	O	I-TEST
,	,	O	I-TEST
eyes	NNS	O	I-TEST
,	,	O	I-TEST
ears	NNS	O	I-TEST
,	,	O	I-TEST
nose	RB	O	I-TEST
and	CC	O	I-TEST
throat	NN	O	I-TEST
,	,	O	O
normocephalic	JJ	O	O
,	,	O	O
atraumatic	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
pupils	JJ	O	O
equal	JJ	O	O
,	,	O	O
round	NN	O	O
,	,	O	O
reactive	JJ	O	O
to	TO	O	O
light	JJ	O	O
and	CC	O	O
accommodation	NN	O	O
,	,	O	O
extraocular	JJ	O	O
muscles	NNS	O	O
intact	JJ	O	O
,	,	O	O
sclera	JJ	B-PROBLEM	B-PROBLEM
anicteric	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

supple	NN	O	O
,	,	O	O
no	DT	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
nodes	NNS	B-PROBLEM	O
or	CC	O	O
thyromegaly	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

crackles	NNS	B-PROBLEM	B-PROBLEM
at	IN	I-PROBLEM	I-PROBLEM
both	DT	I-PROBLEM	I-PROBLEM
bases	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
kyphotic	JJ	B-PROBLEM	O
,	,	O	O
no	DT	O	O
costovertebral	JJ	B-PROBLEM	B-PROBLEM
angle	NN	I-PROBLEM	I-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
with	IN	O	O
1	CD	B-PROBLEM	O
out	IN	I-PROBLEM	O
of	IN	I-PROBLEM	O
6	CD	I-PROBLEM	B-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
ejection	NN	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

soft	JJ	O	O
,	,	O	O
well	RB	B-PROBLEM	B-PROBLEM
healed	VBN	I-PROBLEM	I-PROBLEM
scar	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
positive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
,	,	O	O
no	DT	O	O
tenderness	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
organomegaly	NN	B-PROBLEM	B-PROBLEM
noted	VBN	O	O
.	.	O	O

without	IN	O	O
clubbing	VBG	B-PROBLEM	B-PROBLEM
,	,	O	I-PROBLEM
claudication	NN	B-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

tremors	NNS	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
hand	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
foot	NN	I-PROBLEM	O
at	IN	O	O
rest	NN	O	O
.	.	O	O

equivocal	JJ	B-PROBLEM	O
cogwheeling	NN	I-PROBLEM	O
on	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
right	NN	I-PROBLEM	O
,	,	O	O
normal	JJ	O	O
tone	NN	O	O
on	IN	O	O
the	DT	O	O
left	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
's	POS	I-TEST	I-TEST
sma	JJ	I-TEST	I-TEST
7	CD	I-TEST	O
was	VBD	O	O
notable	JJ	O	O
for	IN	O	O
a	DT	B-TEST	O
bun	NN	I-TEST	O
of	IN	O	O
28	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
1.3	CD	O	O
,	,	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
glucose	NN	I-TEST	I-TEST
of	IN	O	O
102	CD	O	O
.	.	O	O

extended	JJ	O	B-TEST
chemistries	NNS	B-TEST	I-TEST
were	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
creatine	JJ	I-TEST	I-TEST
kinase	NN	I-TEST	I-TEST
of	IN	O	O
122	CD	O	O
and	CC	O	O
no	DT	O	O
measured	JJ	B-TEST	B-PROBLEM
methylene	NN	I-TEST	I-PROBLEM
blue	JJ	I-TEST	I-PROBLEM
fraction	NN	I-TEST	I-PROBLEM
given	VBN	O	I-PROBLEM
the	DT	O	I-PROBLEM
low	JJ	O	I-PROBLEM
value	NN	O	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
complete	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
notable	JJ	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
5.3,000	CD	O	O
,	,	O	O
hematocrit	VBD	B-TEST	B-TEST
39	CD	O	O
1/2	CD	O	O
and	CC	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
180,000	CD	O	O
and	CC	O	O
normal	JJ	O	O
coags	NNS	O	O
were	VBD	O	O
measured	VBN	O	O
.	.	O	O

portable	JJ	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
was	VBD	O	O
without	IN	O	O
evidence	NN	O	O
of	IN	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
proceeded	VBD	O	O
to	TO	O	O
rule	VB	O	O
out	RP	O	O
formyocardial	JJ	B-PROBLEM	B-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
by	IN	O	O
enzymes	NNS	B-TEST	B-TEST
.	.	O	O

additionally	RB	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
underwent	VBD	O	O
a	DT	B-TEST	B-TEST
exercise	NN	I-TEST	I-TEST
stress	NN	I-TEST	I-TEST
test	NN	I-TEST	I-TEST
on	IN	O	O
8/6/98	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
proceeding	VBG	O	O
from	IN	O	O
76	CD	O	O
to	TO	O	O
93	CD	O	O
beats	NNS	O	O
per	IN	O	O
minute	NN	O	O
.	.	O	O

there	EX	O	O
were	VBD	O	O
no	DT	O	O
electrocardiogram	JJ	B-PROBLEM	O
changes	NNS	I-PROBLEM	O
noted	VBD	O	O
and	CC	O	O
there	EX	O	O
were	VBD	O	O
no	DT	O	O
arrhythmias	NN	B-PROBLEM	B-PROBLEM
noted	VBD	O	O
as	RB	O	O
well	RB	O	O
.	.	O	O

during	IN	O	O
the	DT	B-TEST	O
test	NN	I-TEST	O
the	DT	O	O
patient	NN	O	O
experienced	VBD	O	O
no	DT	O	O
chest	JJ	B-PROBLEM	B-PROBLEM
pressure	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
pain	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
dyspnea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
nuclear	JJ	B-TEST	B-TEST
medical	JJ	I-TEST	I-TEST
imaging	NN	I-TEST	I-TEST
was	VBD	O	O
without	IN	O	O
evidence	NN	O	O
of	IN	O	O
ischemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
in	IN	O	O
this	DT	O	O
fashion	NN	O	O
discharged	VBD	O	O
from	IN	O	O
the	DT	O	O
service	NN	O	O
to	TO	O	O
continue	VB	O	O
on	IN	O	O
her	PRP	B-TREATMENT	B-TREATMENT
current	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
to	TO	O	O
call	VB	O	O
in	IN	O	O
oneweek	NN	O	O
to	TO	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
dr.	NN	O	O
sterpbreutzsterp	NN	O	O
and	CC	O	O
cardiology	NN	O	O
.	.	O	O

1)	CD	O	O
lasix	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg.	NN	O	O
po	NN	O	O
q.d.	NN	O	O

2)	CD	O	O
sinemet	VBD	B-TREATMENT	B-TREATMENT
25/100	CD	O	O
po	NN	O	O
t.i.d.	NN	O	O

3)	CD	O	O
cogentin	NN	B-TREATMENT	B-TREATMENT
0.5	CD	O	O
mg.	NN	O	O
2	CD	O	O
tabs	NN	O	O
q.a.m.	NN	O	O
,	,	O	O
1	CD	O	O
q.lunch	JJ	O	O
time	NN	O	O
,	,	O	O
1	CD	O	O
q.bed	JJ	O	O
time	NN	O	O
.	.	O	O

4)	CD	O	O
eldepryl	JJ	B-TREATMENT	O
5	CD	O	O
mg.	NN	O	O
po	NN	O	O
q.d.	NN	O	O

5)	CD	O	O
enteric	JJ	B-TREATMENT	B-TREATMENT
coated	VBD	I-TREATMENT	I-TREATMENT
aspirin	JJ	I-TREATMENT	I-TREATMENT
325	CD	O	O
mg.	NN	O	O
po	NN	O	O
q.d.	NN	O	O

6)	CD	O	O
potassium	NN	B-TREATMENT	B-TREATMENT
chloride	NN	I-TREATMENT	I-TREATMENT
10	CD	O	O
meq.	NN	O	O
po	NN	O	O
q.d.	NN	O	O

7)	CD	O	O
metoprolol	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg.	NN	O	O
po	NN	O	O
b.i.d.	NN	O	O

chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

lopressor	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
metoprolol	JJ	I-TREATMENT	I-TREATMENT
tartrate	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
12.5	CD	O	O
mg	JJ	O	O
po	NN	O	O
bid	NN	O	O

enalapril	JJ	B-TREATMENT	B-TREATMENT
maleate	NN	I-TREATMENT	I-TREATMENT
20	CD	O	O

dr.	NN	O	O
hashimoto	NN	O	O
,	,	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM

chest	JJ	B-PROBLEM	B-TEST
pressure	NN	I-PROBLEM	I-TEST
;	:	O	O
r	CC	O	O
/	VB	O	O
o	JJ	O	O
mi	NN	B-PROBLEM	B-PROBLEM

responsible	JJ	O	O
after	IN	O	O
study	NN	O	O
for	IN	O	O
causing	VBG	O	O
admission	NN	O	O
)	)	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
r	NN	O	O
/	CD	O	O
o	NN	O	O

mi	NN	B-PROBLEM	B-PROBLEM

echocardiogram	NN	B-TEST	B-TEST
mra	NN	B-TEST	I-TEST
kidney	NN	I-TEST	I-TEST

51	CD	O	O
yo	JJ	O	O
f	NN	O	O
h	NN	O	O
/	NNP	O	O
o	NN	O	O
htn	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hyperchol	NN	B-PROBLEM	B-TREATMENT
,	,	O	O
p	NN	O	O
/	NNP	O	O
w	NN	O	O
ss	NN	B-PROBLEM	B-TEST
chest	NN	I-PROBLEM	I-TEST
pressure	NN	I-PROBLEM	I-TEST
x	VBZ	O	O
3	CD	O	O
days	NNS	O	O
.	.	O	O

usoh	JJ	O	O
until	IN	O	O
3	CD	O	O
day	NN	O	O
pta	NN	O	O
,	,	O	O
dev	VB	O	B-TEST
new	JJ	B-PROBLEM	I-TEST
ss	JJ	I-PROBLEM	I-TEST
chest	NN	I-PROBLEM	I-TEST
pressure	NN	I-PROBLEM	I-TEST
sometimes	RB	O	O
rad	VBZ	O	O
to	TO	O	O
back	VB	O	O
and	CC	O	O
l	VB	O	O
neck	NN	O	O
/	NNP	O	O
jaw	NN	O	B-PROBLEM
.	.	O	O

pressure	NN	B-PROBLEM	B-PROBLEM
lasted	VBN	O	O
for	IN	O	O
hours	NNS	O	O
at	IN	O	O
a	DT	O	O
time	NN	O	O
.	.	O	O

variably	RB	O	O
assoc	NN	O	O
with	IN	O	O
sob	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
palpitations	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
tremulousness	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
diaphoresis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

pt	NN	O	O
has	VBZ	O	O
htn	VBN	B-PROBLEM	O
,	,	O	O
measured	VBN	O	O
bp	NN	B-TEST	O
home	NN	O	O
200/100	CD	O	O
.	.	O	O

reported	VBN	O	O
to	TO	O	O
a	DT	O	O
local	JJ	O	O
ed	NN	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
bp	VBN	B-TEST	O
up	RP	O	O
to	TO	O	O
200/100	CD	O	O
.	.	O	O

put	NN	O	O
on	IN	O	O
ntg	NN	B-TREATMENT	B-TREATMENT
drip	NN	I-TREATMENT	I-TREATMENT
without	IN	O	O
relief	NN	O	O
.	.	O	O

pain	NN	B-PROBLEM	B-PROBLEM
2/10	CD	O	O
persisted	VBN	O	O
,	,	O	O
relieved	VBN	O	O
by	IN	O	O
mso4	NN	B-TREATMENT	O
.	.	O	O

at	IN	O	O
elmvh	JJ	O	O
ed	NN	O	O
,	,	O	O
bp	VBD	B-TEST	O
160/87	CD	O	O
.	.	O	O

now	RB	O	O
adm	VBZ	O	O
for	IN	O	O
r	NN	O	O
/	NNP	O	O
o	NN	O	O
mi	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
eval	NN	B-TEST	B-TEST
of	IN	O	O
?	.	O	O
demand	NN	B-PROBLEM	B-PROBLEM
ischemia	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
plus	CC	O	O
w	JJ	B-TEST	O
/	NNP	I-TEST	O
u	NN	I-TEST	O
of	IN	O	O
htn	NN	B-PROBLEM	B-PROBLEM
urgency	NN	I-PROBLEM	I-PROBLEM
(	(	O	O
which	WDT	O	O
may	MD	O	O
be	VB	O	O
very	RB	O	B-PROBLEM
new	JJ	O	I-PROBLEM
in	IN	O	I-PROBLEM
onset	NN	O	I-PROBLEM
)	)	O	O
.	.	O	O

pe	NN	B-TEST	O
t97.5	NN	B-TEST	O
p59	NN	B-TEST	O
bp	NN	B-TEST	O
(	(	O	O
l	NN	O	O
)	)	O	O
180/86	CD	O	O
(	(	O	O
r	NN	O	O
)	)	O	O
186/98	CD	O	O
rr20	NN	B-TEST	B-TEST
98%	CD	O	O
2l	CD	B-TREATMENT	O
.	.	O	O

exam	NN	B-TEST	B-TEST
only	RB	O	O
notable	JJ	O	O
for	IN	O	O
ii	JJ	B-PROBLEM	B-PROBLEM
/	NNP	I-PROBLEM	I-PROBLEM
vi	NN	I-PROBLEM	I-PROBLEM
systolic	JJ	I-PROBLEM	I-PROBLEM
murmur	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

labs	NNS	B-TEST	B-TEST
only	RB	O	O
notable	JJ	O	O
for	IN	O	O
ck	NN	B-TEST	B-TEST
54	CD	O	O
(	(	O	O
nl	NN	O	O
)	)	O	O
,	,	O	O
trop	$	B-TEST	O
0.03	CD	O	O
,	,	O	O
hct	VBD	B-TEST	B-TEST
35.6	CD	O	O
mcv	NN	B-TEST	B-TEST
79	CD	O	O
.	.	O	O

ekg	NN	B-TEST	O
lbbb	NN	B-PROBLEM	O
nsr	NN	O	O
.	.	O	O

cxr	NN	B-TEST	B-TEST
negative	JJ	O	O
.	.	O	O

plan	NN	O	O
romi	VBZ	B-TEST	O
protocol	NN	I-TEST	O
.	.	O	O

cp	NN	B-TREATMENT	O
protocol	NN	I-TREATMENT	O
.	.	O	O

captopril	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
nitropaste	NN	B-TREATMENT	B-TREATMENT
to	TO	O	I-TREATMENT
control	VB	O	I-TREATMENT
pressure	NN	B-PROBLEM	I-TREATMENT
.	.	O	O

mso4	NN	B-TREATMENT	O
for	IN	O	O
cp	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

echo	NN	B-TEST	B-TEST
,	,	O	O
mra	NN	B-TEST	O
(	(	O	O
r	JJ	O	O
/	NNP	O	O
o	MD	O	O
dissection	NN	B-PROBLEM	O
)	)	O	O
,	,	O	O
urine	JJ	B-TEST	B-TEST
catecholamines	NNS	I-TEST	I-TEST
and	CC	O	O
vma	NN	B-TEST	B-PROBLEM
.	.	O	O

guaiac	NN	B-TEST	B-PROBLEM
all	DT	I-TEST	I-PROBLEM
stools	NNS	I-TEST	I-PROBLEM
,	,	O	O
check	VB	O	O
iron	NN	B-TEST	B-TEST
studies	NNS	I-TEST	I-TEST
.	.	O	O

1.	CD	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM

-	:	O	O
pt	NN	O	O
placed	VBN	O	O
on	IN	O	O
captopril	NN	B-TREATMENT	B-TREATMENT
25	CD	O	O
tid	NN	O	O
,	,	O	O
lopressor	VBZ	B-TREATMENT	B-TREATMENT
12.5	CD	O	O
bid	NN	O	O
and	CC	O	O
ntg	JJ	B-TREATMENT	O
paste	NN	I-TREATMENT	O
ss	NN	O	O
,	,	O	O
achieving	VBG	O	O
normal	JJ	O	O
bp	NN	O	O
w	NN	O	O
/	NNP	O	O
in	IN	O	O
5	CD	O	O
hrs	NN	O	O
of	IN	O	O
adm	NN	O	O
to	TO	O	O
floor	NN	O	O
.	.	O	O

her	PRP$	B-PROBLEM	O
cpress	NN	I-PROBLEM	O
dissappeared	VBD	O	O
over	IN	O	O
the	DT	O	O
same	JJ	O	O
timeframe	NN	O	O
.	.	O	O

-	:	O	O
pt	NN	O	O
r&apos;d	NN	O	O
/	NNP	O	O
o	NN	O	O
for	IN	O	O
mi	NN	B-PROBLEM	O
by	IN	O	O
cpk	NN	B-TEST	O
(	(	O	O
54-&gt;	JJ	O	O
38-&gt;	JJ	O	O
33	CD	O	O
)	)	O	O
and	CC	O	O
tpn	NN	B-TEST	B-TREATMENT
(	(	O	O
0.03	CD	O	O
)	)	O	O
,	,	O	O
and	CC	O	O
stable	JJ	O	O
ekg	NN	O	O
.	.	O	O

2.	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM

-	:	O	O
controlled	VBN	O	O
on	IN	O	O
captopril	NN	B-TREATMENT	B-TREATMENT
+	NN	O	I-TREATMENT
lopressor	NN	B-TREATMENT	I-TREATMENT
to	TO	O	O
110-130s	CD	O	O
;	:	O	O
ntg	CC	B-TREATMENT	O
paste	NN	I-TREATMENT	O
causing	VBG	O	O
30	CD	O	O
pt	JJ	O	O
drop	NN	O	O
so	RB	O	O
d	JJ	O	O
/	NNP	O	O
c&apos;d	NN	O	B-PROBLEM
.	.	O	O

-	:	O	O
mra	NN	B-TEST	O
kidney	NN	I-TEST	O
:	:	O	O

no	DT	O	O
stenosis	NN	B-PROBLEM	B-PROBLEM
;	:	O	O
no	DT	O	O
parenchymal	JJ	B-PROBLEM	B-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM

-	:	O	O
cxr	NN	B-TEST	O
:	:	O	O

no	DT	O	O
obvious	JJ	B-PROBLEM	B-PROBLEM
mediastinal	JJ	I-PROBLEM	I-PROBLEM
widening	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
no	DT	O	O
comp	NN	B-TEST	B-PROBLEM
arison	NN	I-TEST	I-PROBLEM
film	NN	I-TEST	I-PROBLEM
;	:	O	O
wnl	NN	O	B-PROBLEM

-	:	O	O
echo	NN	B-TEST	B-TEST
:	:	O	O

ef	JJ	B-TEST	B-TEST
55-60	CD	O	O
,	,	O	O
?	.	O	O
septal	JJ	B-PROBLEM	B-PROBLEM
flattening	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
tr	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
mr	NN	B-PROBLEM	O
,	,	O	O
trace	NN	B-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
-24h	NNP	B-TEST	I-PROBLEM
urine	NN	I-TEST	I-PROBLEM
study	NN	I-TEST	I-PROBLEM
:	:	O	O

sternal	JJ	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

status	NN	O	O
post	NN	O	O
orthotopic	NN	B-TREATMENT	B-TREATMENT
cardiac	NN	I-TREATMENT	I-TREATMENT
transplant	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

insulin	NN	B-PROBLEM	B-PROBLEM
dependent	NN	I-PROBLEM	I-PROBLEM
diabetes	VBZ	I-PROBLEM	I-PROBLEM
mellitus	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

dilated	VBN	B-PROBLEM	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
48-year-old	JJ	O	O
white	JJ	O	O
man	NN	O	O
who	WP	O	O
is	VBZ	O	O
20	CD	O	O
days	NNS	O	O
status	NN	O	O
post	NN	O	O
orthotopic	NN	B-TREATMENT	B-TREATMENT
cardiac	NN	I-TREATMENT	I-TREATMENT
transplant	NN	I-TREATMENT	I-TREATMENT
who	WP	O	O
was	VBD	O	O
readmitted	VBN	O	O
for	IN	O	O
sternal	JJ	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
insulin	VBN	B-PROBLEM	B-PROBLEM
dependent	JJ	I-PROBLEM	I-PROBLEM
diabetes	NNS	I-PROBLEM	I-PROBLEM
mellitus	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
dilated	JJ	I-PROBLEM	I-PROBLEM
cardiomyopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
progressive	JJ	O	B-PROBLEM
symptoms	NNS	O	I-PROBLEM
of	IN	O	O
congestive	JJ	B-PROBLEM	B-PROBLEM
heart	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
led	VBD	O	O
to	TO	O	O
his	PRP$	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST
of	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
cardiac	JJ	I-TREATMENT	I-TREATMENT
transplant	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
march	NN	O	O
of	IN	O	O
1991	CD	O	O
.	.	O	O

preoperatively	RB	O	O
,	,	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
severely	RB	I-PROBLEM	I-PROBLEM
dilated	JJ	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
ventricle	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
markedly	RB	B-PROBLEM	B-PROBLEM
diminished	VBN	I-PROBLEM	I-PROBLEM
function	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	O	B-TREATMENT
post	NN	O	I-TREATMENT
transplant	NN	O	I-TREATMENT
course	NN	O	O
was	VBD	O	O
initially	RB	O	O
complicated	VBN	O	O
by	IN	O	O
hyperglycemia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
seizure	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
number	NN	O	O
one	CD	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
predischarge	NN	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
.	.	O	O

he	PRP	O	O
felt	VBD	O	O
well	RB	O	O
at	IN	O	O
home	NN	O	O
without	IN	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
chills	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
rigors	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
were	VBD	O	O
no	DT	O	O
rashes	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
no	DT	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

when	WRB	O	O
he	PRP	O	O
was	VBD	O	O
seen	VBN	O	O
on	IN	O	O
2/3	CD	O	O
in	IN	O	O
the	DT	O	O
transplant	NN	O	O
clinic	NN	O	O
,	,	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
more	RBR	B-PROBLEM	B-PROBLEM
erythematous	JJ	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
referred	VBN	O	O
to	TO	O	O
the	DT	O	O
surgical	JJ	O	O
clinic	NN	O	O
where	WRB	O	O
the	DT	B-PROBLEM	B-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
opened	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
for	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
admission	NN	O	O
revealed	VBD	O	O
a	DT	O	B-PROBLEM
middle	JJ	O	I-PROBLEM
aged	VBN	O	O
man	NN	O	O
in	IN	O	O
no	DT	O	O
distress	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
was	VBD	O	O
152/88	CD	O	O
.	.	O	O

heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
90	CD	O	O
.	.	O	O

respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
14	CD	O	O
.	.	O	O

heent	NN	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
was	VBD	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

neck	NN	O	O
was	VBD	O	O
without	IN	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

cardiac	JJ	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
showed	VBD	O	O
a	DT	O	O
normal	JJ	O	O
pmi	NN	O	O
,	,	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
,	,	O	O
normal	JJ	O	O
s1	NN	O	O
,	,	O	O
physiologically	RB	B-PROBLEM	B-PROBLEM
split	JJ	I-PROBLEM	I-PROBLEM
s2	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
an	DT	B-PROBLEM	O
s4	NN	I-PROBLEM	O
.	.	O	O

there	EX	O	O
were	VBD	O	O
no	DT	O	O
murmurs	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
rubs	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

extremities	NNS	O	O
were	VBD	O	O
2+	CD	B-PROBLEM	B-PROBLEM
pedal	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
to	TO	O	I-PROBLEM
the	DT	O	I-PROBLEM
knees	NNS	O	I-PROBLEM
.	.	O	O

examination	NN	B-TEST	B-TEST
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
sternal	JJ	I-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
showed	VBD	O	O
an	DT	O	B-PROBLEM
opened	JJ	O	I-PROBLEM
area	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
mid	JJ	O	I-PROBLEM
region	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
serosanguineous	JJ	B-PROBLEM	B-TREATMENT
drainage	NN	I-PROBLEM	I-TREATMENT
and	CC	O	O
a	DT	B-PROBLEM	O
scant	JJ	I-PROBLEM	O
amount	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
thick	NN	I-PROBLEM	B-PROBLEM
,	,	I-PROBLEM	O
yellow	JJ	I-PROBLEM	B-PROBLEM
pus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
induration	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
admission	NN	O	O
revealed	VBD	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
9.46	CD	O	O
with	IN	O	O
89%	CD	O	O
polys	NNS	B-TEST	B-TEST
,	,	O	O
2%	CD	O	O
bands	NNS	B-TEST	B-TEST
,	,	O	O
7%	CD	O	O
lymphocytes	NNS	B-TEST	B-TEST
,	,	O	O
2%	CD	O	O
monocytes	NNS	B-TEST	B-TEST
.	.	O	O

cyclosporin	NN	B-TEST	B-TREATMENT
a	DT	I-TEST	O
level	NN	I-TEST	O
on	IN	O	O
admission	NN	O	O
was	VBD	O	O
179	CD	O	O
.	.	O	O

microscopic	NN	B-TEST	B-TEST
exam	NN	I-TEST	I-TEST
showed	VBD	O	O
4+	CD	B-PROBLEM	O
staph	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
ceftazidime	NN	B-TREATMENT	B-TREATMENT
while	IN	O	O
awaiting	VBG	O	O
wound	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
.	.	O	O

he	PRP	O	O
had	VBD	O	O
dressing	VBG	B-TREATMENT	B-TREATMENT
changes	NNS	I-TREATMENT	I-TREATMENT
twice	RB	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

cyclosporin	NN	B-TEST	B-TEST
levels	NNS	I-TEST	I-TEST
were	VBD	O	O
followed	VBN	O	O
and	CC	O	O
his	PRP$	B-TEST	B-TEST
sugars	NNS	I-TEST	I-TEST
were	VBD	O	O
followed	VBN	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
sliding	VBG	I-TREATMENT	I-TREATMENT
scale	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

during	IN	O	O
the	DT	O	O
first	JJ	O	O
two	CD	O	O
days	NNS	O	O
,	,	O	O
he	PRP	O	O
required	VBD	O	O
14	CD	B-TREATMENT	O
and	CC	I-TREATMENT	O
22	CD	I-TREATMENT	O
units	NNS	I-TREATMENT	O
of	IN	I-TREATMENT	O
additional	JJ	I-TREATMENT	B-TREATMENT
coverage	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

however	RB	O	O
,	,	O	O
by	IN	O	O
day	NN	O	O
three	CD	O	O
he	PRP	O	O
required	VBD	O	O
no	DT	O	O
additional	JJ	B-TREATMENT	B-TREATMENT
insulin	NN	I-TREATMENT	I-TREATMENT
coverage	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

on	IN	O	O
the	DT	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
,	,	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
intravenous	JJ	I-TREATMENT	I-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
discontinued	VBN	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
begun	VBN	O	O
on	IN	O	O
tetracycline	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

on	IN	O	O
discharge	NN	O	O
included	VBD	O	O
tetracycline	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
250	CD	O	O
mg	NN	O	O
po	NN	O	O
q.i.d.	NN	O	O
;	:	O	O
cyclosporin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
325	CD	O	O
mg	NN	O	O
po	NN	O	O
b.i.d.	NN	O	O
;	:	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
30	CD	O	O
mg	NN	O	O
po	NN	O	O
q	JJ	O	O
day	NN	O	O
;	:	O	O
bactrim	JJ	B-TREATMENT	B-TREATMENT
ds	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
one	CD	O	O
po	NN	O	O
q.o.d.	NN	O	O
;	:	O	O
diltiazem	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
30	CD	O	O
mg	NN	O	O
po	NN	O	O
q.i.d.	NN	O	O
;	:	O	O
mycostatin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
15	CD	O	O
cc	NN	O	O
swish	NN	O	O
and	CC	O	O
swallow	JJ	O	O
q.i.d.	NN	O	O
;	:	O	O
lasix	CC	B-TREATMENT	B-TREATMENT
,	,	O	O
40	CD	O	O
mg	NN	O	O
po	NN	O	O
q	JJ	O	O
day	NN	O	O
;	:	O	O
colace	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
100	CD	O	O
mg	NN	O	O
po	NN	O	O
q.i.d.	NN	O	O
;	:	O	O
carafate	NN	B-TREATMENT	O
,	,	O	O
1	CD	O	O
gram	NN	O	O
po	NN	O	O
q.i.d.	NN	O	O
;	:	O	O
imuran	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
50	CD	O	O
mg	NN	O	O
po	NN	O	O
t.i.d.	NN	O	O
;	:	O	O
nph	CC	B-TREATMENT	O
insulin	NN	I-TREATMENT	B-TREATMENT
,	,	O	O
44	CD	O	O
units	NNS	O	O
and	CC	O	O
10	CD	O	O
units	NNS	O	O
of	IN	O	O
regular	JJ	O	O
q	NN	O	O
a.m.	NN	O	O
;	:	O	O
nph	CC	B-TREATMENT	O
,	,	O	O
22	CD	O	O
units	NNS	O	O
and	CC	O	O
8	CD	O	O
units	NNS	O	O
of	IN	O	O
regular	JJ	O	O
q	CD	O	O
p.m.	NN	O	O

lumbar	NN	B-PROBLEM	B-PROBLEM
spinal	JJ	I-PROBLEM	I-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

l2	NN	B-TREATMENT	O
to	TO	I-TREATMENT	O
l5	VB	I-TREATMENT	O
laminectomy	NN	I-TREATMENT	B-TREATMENT
,	,	O	O
l2	CC	B-TREATMENT	O
through	IN	I-TREATMENT	O
l5	JJ	I-TREATMENT	O
posterior	JJ	I-TREATMENT	O
fusion	NN	I-TREATMENT	O
with	IN	O	O
segmental	JJ	B-TREATMENT	B-TEST
instrumentation	NN	I-TREATMENT	I-TEST
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
50-year-old	JJ	O	O
female	NN	O	O
with	IN	O	O
history	NN	O	O
of	IN	O	O
low	JJ	B-PROBLEM	B-PROBLEM
back	RB	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
radiating	NN	B-PROBLEM	O
to	TO	I-PROBLEM	O
both	DT	I-PROBLEM	O
legs	NNS	I-PROBLEM	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
overtime	RB	O	O
,	,	O	O
not	RB	O	O
controlled	VBN	O	O
by	IN	O	O
conservative	JJ	B-TREATMENT	B-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
therefore	RB	O	O
elected	VBD	O	O
to	TO	O	O
undergo	VB	O	O
surgical	JJ	B-TREATMENT	B-TREATMENT
treatment	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

her	PRP$	O	O
past	JJ	O	O
medical	JJ	O	O
history	NN	O	O
is	VBZ	O	O
notable	JJ	O	O
for	IN	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
lower	JJR	I-PROBLEM	I-PROBLEM
extremity	NN	I-PROBLEM	I-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
edema	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
takes	VBZ	O	O
lisinopril	JJ	B-TREATMENT	B-TREATMENT
/	NNP	O	O
hydrochlorothiazide	NN	B-TREATMENT	B-TREATMENT
20/25	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
,	,	O	O
vioxx	FW	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
,	,	O	O
lipitor	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
,	,	O	O
nortriptyline	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.h.s.	NN	O	O
,	,	O	O
neurontin	RB	B-TREATMENT	B-TREATMENT
300	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
t.i.d.	NN	O	O

she	PRP	O	O
has	VBZ	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
codeine	JJ	B-TREATMENT	B-TREATMENT
otherwise	RB	O	O
no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

past	JJ	O	O
surgical	JJ	O	O
history	NN	O	O
is	VBZ	O	O
notable	JJ	O	O
of	IN	O	O
d	NN	B-TEST	B-PROBLEM
and	CC	O	I-PROBLEM
c	NN	B-TEST	I-PROBLEM
in	IN	O	I-PROBLEM
1980	CD	O	I-PROBLEM
and	CC	O	I-PROBLEM
cyst	JJ	B-TREATMENT	I-PROBLEM
excision	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

on	IN	O	O
examination	NN	B-TEST	B-TEST
,	,	O	O
her	PRP$	O	O
lungs	NNS	O	O
were	VBD	O	O
clear	JJ	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
2+	CD	B-TEST	O
bilateral	JJ	I-TEST	O
dp	NN	I-TEST	O
and	CC	O	O
radial	JJ	B-TEST	B-TEST
pulses	NNS	I-TEST	I-TEST
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
swelling	VBG	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
both	DT	I-PROBLEM	O
lower	JJR	I-PROBLEM	O
extremities	NNS	I-PROBLEM	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
pain	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
straight	JJ	O	B-PROBLEM
leg	NN	O	I-PROBLEM
raise	NN	O	I-PROBLEM
,	,	O	O
left	VBD	O	O
greater	JJR	O	O
than	IN	O	O
right	NN	O	O
and	CC	O	O
5/5	CD	O	O
strength	NN	O	O
in	IN	O	O
right	JJ	O	O
quads	NNS	O	O
compared	VBN	O	O
to	TO	O	O
4/5	CD	O	O
on	IN	O	O
the	DT	O	O
left	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
on	IN	O	O
01/16/2003	CD	O	O
for	IN	O	O
decompression	NN	B-TREATMENT	B-TREATMENT
at	IN	I-TREATMENT	O
l2	NN	I-TREATMENT	O
,	,	I-TREATMENT	O
l5	NN	I-TREATMENT	O
and	CC	O	O
laminectomy	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
posterior	JJ	B-TREATMENT	B-PROBLEM
instrumented	VBN	I-TREATMENT	I-PROBLEM
fusion	NN	I-TREATMENT	I-PROBLEM
at	IN	I-TREATMENT	O
l3	NN	I-TREATMENT	O
to	TO	I-TREATMENT	O
l5	VB	I-TREATMENT	O
.	.	O	O

she	PRP	O	O
tolerated	VBD	O	O
the	DT	B-TREATMENT	B-TREATMENT
surgery	NN	I-TREATMENT	I-TREATMENT
well	RB	O	O
.	.	O	O

she	PRP	O	O
received	VBD	O	O
blood	NN	B-TREATMENT	B-TREATMENT
transfusions	NNS	I-TREATMENT	I-TREATMENT
intraoperatively	RB	O	O
and	CC	O	O
postoperatively	RB	O	O
in	IN	O	O
addition	NN	O	O
to	TO	O	O
autologous	JJ	B-TREATMENT	O
blood	NN	I-TREATMENT	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
stable	JJ	O	O
postoperatively	RB	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
neurologic	JJ	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
was	VBD	O	O
stable	JJ	O	O
postoperatively	RB	O	O
with	IN	O	O
5/5	CD	O	O
bilaterally	RB	O	O
,	,	O	O
tibial	JJ	O	O
,	,	O	O
ehl	JJ	O	O
,	,	O	O
fhl	JJ	O	O
,	,	O	O
gastroc	JJ	O	B-PROBLEM
soleus	NN	O	I-PROBLEM
,	,	O	O
and	CC	O	O
intact	JJ	O	O
quadriceps	NNS	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
fitted	VBN	O	O
for	IN	O	O
verholl	NN	B-TREATMENT	B-PROBLEM
aet	NN	I-TREATMENT	I-PROBLEM
over	IN	I-TREATMENT	I-PROBLEM
leg	JJ	I-TREATMENT	I-PROBLEM
brace	NN	I-TREATMENT	I-PROBLEM
and	CC	O	O
mobilized	VBN	O	O
out	IN	O	O
of	IN	O	O
the	DT	O	O
bed	NN	O	O
in	IN	O	O
the	DT	B-TREATMENT	O
brace	NN	I-TREATMENT	O
with	IN	O	O
physical	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

her	PRP$	B-PROBLEM	B-PROBLEM
wounds	NNS	I-PROBLEM	I-PROBLEM
were	VBD	O	O
stable	JJ	O	O
without	IN	O	O
any	DT	B-PROBLEM	B-PROBLEM
erythema	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
drainage	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
reported	VBD	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
on	IN	O	O
pain	NN	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

her	PRP$	B-TREATMENT	B-TREATMENT
pain	NN	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
changed	VBN	O	O
around	IN	O	O
until	IN	O	O
an	DT	O	O
acceptable	JJ	O	O
regime	NN	O	O
was	VBD	O	O
accomplished	VBN	O	O
.	.	O	O

she	PRP	O	O
should	MD	O	O
continue	VB	O	O
to	TO	O	O
wear	VB	O	O
the	DT	B-TREATMENT	O
brace	NN	I-TREATMENT	O
when	WRB	O	O
out	IN	O	O
of	IN	O	O
bed	NN	O	O
and	CC	O	O
there	EX	O	O
should	MD	O	O
be	VB	O	O
no	DT	O	O
heavy	JJ	O	O
lifting	NN	O	O
,	,	O	O
twisting	VBG	O	O
or	CC	O	O
bending	VBG	O	B-PROBLEM
activities	NNS	O	I-PROBLEM
.	.	O	O

tylenol	RB	B-TREATMENT	B-TREATMENT
650	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
q.4h.	JJ	O	O
p.r.n.	NN	O	O
,	,	O	O
benadryl	VBD	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.h.s.	NN	O	O
p.r.n.	NN	O	O
,	,	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.i.d.	NN	O	O
,	,	O	O
nortriptyline	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.h.s.	NN	O	O
,	,	O	O
simvastatin	VBD	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.h.s.	NN	O	O
,	,	O	O
metamucil	VB	B-TREATMENT	B-TEST
one	CD	O	O
packet	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
p.r.n.	NN	O	O
,	,	O	O
neurontin	RB	B-TREATMENT	B-TREATMENT
300	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
t.i.d.	NN	O	O
,	,	O	O
levsinex	VBZ	B-TREATMENT	O
0.375	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.12h.	NN	O	O
,	,	O	O
lisinopril	JJ	B-TREATMENT	B-TREATMENT
/	NNP	O	O
hydrochlorothiazide	NN	B-TREATMENT	B-TREATMENT
20/25	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
,	,	O	O
hydrocortisone	NN	B-TREATMENT	B-TREATMENT
topical	JJ	I-TREATMENT	I-TREATMENT
ointment	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
affected	JJ	B-PROBLEM	O
areas	NNS	I-PROBLEM	O
,	,	O	O
ms	NN	B-TREATMENT	B-TREATMENT
contin	NN	I-TREATMENT	I-TREATMENT
30	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
b.i.d.	NN	O	O
,	,	O	O
msir	RB	B-TREATMENT	O
15	CD	O	O
to	TO	O	O
30	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
q.4h.	JJ	O	O
p.r.n.	NN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
should	MD	O	O
continue	VB	O	O
to	TO	O	O
have	VB	O	O
dry	JJ	B-TREATMENT	B-TREATMENT
sterile	JJ	I-TREATMENT	I-TREATMENT
dressings	NNS	I-TREATMENT	I-TREATMENT
to	TO	O	O
her	PRP$	B-PROBLEM	O
back	NN	I-PROBLEM	O
and	CC	I-PROBLEM	O
iliac	NN	I-PROBLEM	B-PROBLEM
crest	NN	I-PROBLEM	I-PROBLEM
wounds	VBZ	I-PROBLEM	I-PROBLEM
until	IN	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
dr.	JJ	O	O
uph	NN	O	O
.	.	O	O

should	MD	O	O
there	RB	O	O
be	VB	O	O
any	DT	B-PROBLEM	B-PROBLEM
wound	JJ	I-PROBLEM	I-PROBLEM
erythema	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
drainage	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
please	VB	O	O
contact	JJ	O	O
dr.	NN	O	O
uph	JJ	O	O
&apos;s	NNP	O	O
office	NN	O	O
immediately	RB	O	O
.	.	O	O

abdominal	JJ	B-PROBLEM	B-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
collection	NN	I-PROBLEM	I-PROBLEM

ho	NN	B-TEST	B-TEST
evaluation	NN	I-TEST	I-TEST

motrin	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
ibuprofen	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
600	CD	O	O
mg	NN	O	O
po	NN	O	O
q6h	NN	O	O
prn	NN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
headache	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
temperature	NN	B-TEST	B-TEST
greater	JJR	O	O
than	IN	O	O
:	:	O	O

take	VB	O	O
with	IN	O	O
food	NN	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
metronidazole	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
500	CD	O	O
mg	NN	O	O
po	NN	O	O
q8h	NN	O	O
x	$	O	O
10	CD	O	O
days	NNS	O	O
starting	VBG	O	O
today	NN	O	O
(	(	O	O
04/12	CD	O	O
)	)	O	O

take	VB	O	O
for	IN	O	O
10	CD	O	O
days	NNS	O	O
or	CC	O	O
until	IN	O	B-TREATMENT
drains	NNS	B-TREATMENT	I-TREATMENT
come	VBP	O	O
out	RP	O	O
;	:	O	O
whichever	WDT	O	O
is	VBZ	O	O
of	IN	O	O
longer	JJR	O	O
duration	NN	O	O
.	.	O	O

take	VB	O	O
with	IN	O	O
food	NN	O	O
oxycodone	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
po	NN	O	O
q4h	NN	O	O
prn	NN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
levofloxacin	VBD	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
x	$	O	O
10	CD	O	O
days	NNS	O	O
starting	VBG	O	O
today	NN	O	O
(	(	O	O
04/12	CD	O	O
)	)	O	O

take	VB	O	O
for	IN	O	O
10	CD	O	O
days	NNS	O	O
or	CC	O	O
until	IN	O	B-TREATMENT
drains	NNS	B-TREATMENT	I-TREATMENT
come	VBP	O	O
out	RP	O	O
;	:	O	O
whichever	WDT	O	O
is	VBZ	O	O
of	IN	O	O
longer	JJR	O	O
duration	NN	O	O
.	.	O	O

administer	RB	O	O
iron	NN	B-TREATMENT	B-TREATMENT
products	NNS	I-TREATMENT	I-TREATMENT
a	DT	O	O
minimum	NN	O	O
of	IN	O	O
2	CD	O	O
hours	NNS	O	O
before	IN	O	O
or	CC	O	O
after	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
levofloxacin	NN	I-TREATMENT	I-TREATMENT
or	CC	O	O
ciprofloxacin	NN	B-TREATMENT	B-TREATMENT
dose	VBP	I-TREATMENT	O
dose	JJ	O	O
if	IN	O	O
on	IN	O	O
tube	NN	B-TREATMENT	B-TREATMENT
feeds	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
please	VB	O	O
cycle	NN	O	O
(	(	O	O
hold	VB	O	O
1	CD	O	O
hr	NN	O	O
before	IN	O	O
to	TO	O	O
2	CD	O	O
hr	NNS	O	O
after	IN	O	O
)	)	O	O

maalox-tablets	NNS	B-TREATMENT	O
quick	JJ	I-TREATMENT	O
dissolve	NN	I-TREATMENT	O
/	NNP	I-TREATMENT	O
chewable	JJ	I-TREATMENT	O
2	CD	O	O
tab	NN	O	O
po	NN	O	O
q6h	NN	O	O
protonix	NN	B-TREATMENT	B-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
pantoprazole	NN	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
40	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O

house	NN	B-TREATMENT	O
/	VBD	I-TREATMENT	O
low	JJ	I-TREATMENT	B-PROBLEM
residue	JJ	I-TREATMENT	I-PROBLEM
&lt;	NN	O	I-PROBLEM
fdi	NN	O	I-PROBLEM
&gt;	NN	O	I-PROBLEM

dr.	NN	O	O
liley	NN	O	O
,	,	O	O
call	VB	O	O
asap	NN	O	O
to	TO	O	O
schedule	VB	O	O
1-2	JJ	O	O
weeks	NNS	O	O
,	,	O	O
your	PRP$	O	O
primary	JJ	O	O
care	NN	O	O
physician	JJ	O	O
1-2	JJ	O	O
weeks	NNS	O	O
,	,	O	O
interventional	JJ	O	B-TREATMENT
radiology	NN	O	I-TREATMENT
,	,	O	O
call	VB	O	O
329-125-0028	JJ	O	O
to	TO	O	O
schedule	VB	O	O
an	DT	O	O
appointment	NN	O	O
when	WRB	O	O
drain	NN	B-TEST	B-TEST
outputs	NNS	I-TEST	I-TEST
are	VBP	O	O
less	JJR	O	O
than	IN	O	O
10cc	CD	O	O
/	JJ	O	O
day	NN	O	O
.	.	O	O
,	,	O	O

nka	NN	B-PROBLEM	O

abdominal	JJ	B-PROBLEM	B-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
collection	NN	I-PROBLEM	I-PROBLEM

responsible	JJ	O	O
after	IN	O	O
study	NN	O	O
for	IN	O	O
causing	VBG	O	O
admission	NN	O	O
)	)	O	O
abdominal	JJ	B-PROBLEM	B-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
collection	NN	I-PROBLEM	I-PROBLEM

conditions	NNS	O	O
,	,	O	O
infections	NNS	O	O
,	,	O	O
complications	NNS	O	O
,	,	O	O
affecting	VBG	O	O
treatment	NN	O	O
/	NNP	O	O
stay	NN	O	O
liver	RB	B-PROBLEM	B-PROBLEM
hemangioma	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
bph	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
gout	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
meningioma	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
gerd	NN	B-PROBLEM	O
,	,	O	O
episodic	JJ	B-PROBLEM	B-PROBLEM
vertigo	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
s	JJ	O	O
/	NNP	O	O
p	NN	O	O
r	NN	B-TREATMENT	B-TREATMENT
colectomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
subtotal	JJ	B-TREATMENT	B-TREATMENT
colectomy	NN	I-TREATMENT	I-TREATMENT

ir	JJ	B-TREATMENT	B-TREATMENT
drainage	NN	I-TREATMENT	I-TREATMENT
x2	NN	O	O

hpi	NN	O	O
this	DT	O	O
is	VBZ	O	O
a	DT	O	O
60	CD	O	O
yo	NN	O	O
gentleman	NN	O	O
who	WP	O	O
previously	RB	O	O
had	VBD	O	O
an	DT	B-TREATMENT	B-TREATMENT
ileocolic	JJ	I-TREATMENT	I-TREATMENT
resection	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
colon	NN	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
recurrent	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
colonoscopy	NN	B-TEST	B-TREATMENT
.	.	O	O

he	PRP	O	O
was	VBD	O	O
also	RB	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
malignant	JJ	I-PROBLEM	I-PROBLEM
lesion	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
his	PRP$	I-PROBLEM	I-PROBLEM
descending	NN	I-PROBLEM	I-PROBLEM
colon	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
subtotal	JJ	I-TREATMENT	I-TREATMENT
colectomy	NN	I-TREATMENT	I-TREATMENT
on	IN	O	O
03/22/05	CD	O	O
which	WDT	O	O
was	VBD	O	O
uncomplicated	VBN	O	O
.	.	O	O

postop	NN	O	O
he	PRP	O	O
has	VBZ	O	O
had	VBN	O	O
numerous	JJ	O	O
visits	NNS	O	O
to	TO	O	O
the	DT	O	O
ed	NN	O	O
for	IN	O	O
co	NN	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
sweats	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
sob	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

cts	NNS	B-TEST	B-TEST
chest	VBP	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
for	IN	O	O
pe	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
however	RB	O	O
it	PRP	O	O
did	VBD	O	O
reveal	VB	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
nodules	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
his	PRP$	I-PROBLEM	O
rml	NN	I-PROBLEM	O
which	WDT	O	O
need	VBP	O	O
fu	NNS	B-TEST	O
imaging	VBG	I-TEST	O
in	IN	O	O
3	CD	O	O
months	NNS	O	O
.	.	O	O

he	PRP	O	O
also	RB	O	O
had	VBD	O	O
bl	VBN	B-PROBLEM	B-PROBLEM
atelectasis	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
cxr	NN	B-TEST	O
.	.	O	O

ct	NN	B-TEST	B-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
abdomen	NNS	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
collection	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	O
the	DT	I-PROBLEM	O
rlq	NN	I-PROBLEM	O
which	WDT	O	O
appears	VBZ	O	O
to	TO	O	O
be	VB	O	O
amenable	JJ	O	O
to	TO	O	O
ir	VB	B-TREATMENT	B-TREATMENT
drainage	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
also	RB	O	O
has	VBZ	O	O
had	VBN	O	O
urine	JJ	B-TEST	O
and	CC	I-TEST	O
blood	NN	I-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
sent	VBD	O	O
from	IN	O	O
the	DT	O	O
ed	NN	O	O
on	IN	O	O
04/05	CD	O	O
and	CC	O	O
was	VBD	O	O
empirically	RB	O	O
started	VBN	O	O
on	IN	O	O
avalox	NN	B-TREATMENT	B-TREATMENT
last	JJ	O	O
pm	NN	O	O
.	.	O	O

pmh	NN	O	O
gerd	NN	B-PROBLEM	O
,	,	O	O
htn	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
gout	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
meningioma	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
liver	RB	B-PROBLEM	B-PROBLEM
hemangioma	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
episodic	JJ	B-PROBLEM	B-PROBLEM
vertigo	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
colon	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

meds	NNS	B-TREATMENT	B-TREATMENT

protonix	NN	B-TREATMENT	B-TREATMENT
40	CD	O	O
qd	NN	O	O
,	,	O	O
colchicine	VBP	B-TREATMENT	B-TREATMENT
6	CD	O	O
mg	JJ	O	O
bid	NN	O	O
,	,	O	O
meclizine	NN	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NN	O	O
qid	NN	O	O
prn	NN	O	O
,	,	O	O
glucosamine	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
oxycodone	NN	B-TREATMENT	B-TREATMENT
prn	NN	O	O
,	,	O	O
tessalon	NN	B-TREATMENT	O
prn	NN	O	O
.	.	O	O

all	DT	O	O
nkda	JJ	B-PROBLEM	O
sh	NN	O	O
no	DT	O	O
smoking	NN	O	B-PROBLEM
pe	NN	O	I-PROBLEM

gen	NN	O	O
-	:	O	O
nad	NN	B-PROBLEM	O

heent	NN	O	O
--	:	O	O
perrla	NN	O	B-PROBLEM
,	,	O	O
eomi	NN	O	O
,	,	O	O
mmm	NN	O	O
,	,	O	O
tongue	NN	O	B-PROBLEM
midline	NN	O	I-PROBLEM
,	,	O	O
op	JJ	O	O
clear	JJ	O	O
,	,	O	O
no	DT	O	O
masses	NNS	B-PROBLEM	B-PROBLEM

neck	NN	O	O
--	:	O	O
no	DT	O	O
jvd	NN	B-PROBLEM	B-PROBLEM
/	VBZ	O	O
lad/	NN	B-PROBLEM	B-PROBLEM
;	:	O	O
trachea	CC	O	B-TEST
midline	VB	O	I-TEST
card	NN	O	I-TEST
-	:	O	O
rrr	NN	O	O
,	,	O	O
s1/s2	NN	O	O
,	,	O	O
no	DT	O	O
m	NN	B-PROBLEM	B-PROBLEM
/	VBZ	O	O
r/g	NN	B-PROBLEM	B-PROBLEM

pulm	SYM	O	B-TEST
-	:	O	O
ctab	NN	O	O
no	DT	O	O
w	NN	B-PROBLEM	O
/	VBZ	I-PROBLEM	O
r	NN	I-PROBLEM	O
/	NNP	I-PROBLEM	O
r	NN	I-PROBLEM	O
abd	NN	O	O
-nt	NNP	B-PROBLEM	O
/	NNP	O	O
nd	NN	B-PROBLEM	B-PROBLEM
;	:	O	O
incision	NN	B-PROBLEM	B-PROBLEM
c	VBZ	O	I-PROBLEM
/	NNP	O	I-PROBLEM
d	NN	O	I-PROBLEM
/	NN	O	I-PROBLEM
i	NN	O	I-PROBLEM
;	:	O	O
discrete	JJ	B-PROBLEM	B-PROBLEM
3x3	CD	I-PROBLEM	I-PROBLEM
cm	NN	I-PROBLEM	I-PROBLEM
slightly	RB	I-PROBLEM	I-PROBLEM
firm	JJ	I-PROBLEM	I-PROBLEM
protuberant	NN	I-PROBLEM	I-PROBLEM
mass	NN	I-PROBLEM	I-PROBLEM
to	TO	I-PROBLEM	O
the	DT	I-PROBLEM	O
r	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
umbilicus	NN	I-PROBLEM	B-PROBLEM
;	:	O	O
no	DT	O	O
rebound	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
guarding	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

back	RB	O	O
-	:	O	O
no	DT	O	O
flank	NN	B-PROBLEM	B-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM

ext	JJ	O	O
-	:	O	O
wwp	NN	O	O
;	:	O	O
no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM

at	IN	O	O
that	DT	O	O
time	NN	O	O
he	PRP	O	O
was	VBD	O	O
made	VBN	O	O
npo	NN	B-TREATMENT	O
with	IN	O	O
ivf	NN	B-TREATMENT	O
,	,	O	O
placed	VBN	O	O
on	IN	O	O
ampicillin	NN	B-TREATMENT	B-TREATMENT
/	NNP	O	O
levofloxacin	VBZ	B-TREATMENT	B-TREATMENT
/	NNP	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
underwent	JJ	O	O
ir	JJ	B-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
a	DT	I-TREATMENT	I-TREATMENT
drainage	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
abdominopelvic	JJ	I-PROBLEM	I-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
collection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

overnight	RB	O	O
he	PRP	O	O
spiked	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
103	CD	O	O
and	CC	O	O
his	PRP$	B-TEST	O
wbc	NN	I-TEST	O
climbed	VBD	O	O
from	IN	O	O
11	CD	O	O
to	TO	O	O
13	CD	O	O
.	.	O	O

as	IN	O	O
a	DT	O	O
result	NN	O	O
,	,	O	O
ir	NN	O	O
reviewed	VBD	O	O
the	DT	B-TEST	B-TEST
patient	JJ	I-TEST	I-TEST
&apos;s	JJ	I-TEST	I-TEST
post-procedure	NN	I-TEST	I-TEST
imaging	NN	I-TEST	I-TEST
and	CC	O	O
felt	VBD	O	O
that	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
not	RB	O	O
adequately	RB	O	B-PROBLEM
draining	VBG	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NNP	I-PROBLEM	I-PROBLEM
fluid	NN	I-PROBLEM	I-PROBLEM
collection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
04/07	CD	O	O
they	PRP	O	O
took	VBD	O	O
the	DT	O	O
patient	NN	O	O
back	RB	O	O
to	TO	O	O
the	DT	O	O
ir	NN	O	O
suite	NN	O	O
and	CC	O	O
placed	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
second	JJ	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
location	NN	O	O
of	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
second	JJ	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
confirmed	VBN	O	O
that	IN	O	O
evening	NN	O	O
by	IN	O	O
a	DT	B-TEST	B-TEST
follow-up	JJ	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
which	WDT	O	O
revealed	VBD	O	O
good	JJ	O	O
placement	NN	O	O
.	.	O	O

the	DT	B-PROBLEM	B-PROBLEM
patient	NN	I-PROBLEM	I-PROBLEM
&apos;s	NN	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
from	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
catheters	NNS	I-TREATMENT	I-TREATMENT
was	VBD	O	O
controlled	VBN	O	O
with	IN	O	O
oxycodone	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
motrin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
received	VBD	O	O
chest	JJ	B-TREATMENT	O
pt	NN	I-TREATMENT	O
and	CC	O	O
was	VBD	O	O
encouraged	VBN	O	O
to	TO	O	O
ambulate	VB	O	O
frequently	RB	O	O
.	.	O	O

after	IN	O	O
catheter	NN	B-TREATMENT	B-TREATMENT
placement	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
sips	NNS	B-TREATMENT	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
advanced	VBN	O	O
to	TO	O	O
clears	NNS	B-TREATMENT	O
which	WDT	O	O
he	PRP	O	O
tolerated	VBD	O	O
and	CC	O	O
was	VBD	O	O
restarted	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
low	JJ	I-TREATMENT	I-TREATMENT
residue	JJ	I-TREATMENT	I-TREATMENT
diet	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
had	VBD	O	O
3	CD	B-TEST	B-TEST
specimens	NNS	I-TEST	I-TEST
sent	VBD	O	O
for	IN	O	O
c.	NN	B-PROBLEM	B-PROBLEM
difficile	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

the	DT	B-TEST	O
patient	NN	I-TEST	O
&apos;s	NNP	I-TEST	O
wbc	NN	I-TEST	O
trended	VBD	O	O
down	RB	O	O
to	TO	O	O
10.7	CD	O	O
at	IN	O	O
discharge	NN	O	O
from	IN	O	O
a	DT	O	O
peak	NN	O	O
of	IN	O	O
13	CD	O	O
on	IN	O	O
04/07	CD	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
remained	VBD	O	O
stable	JJ	O	O
.	.	O	O

he	PRP	O	O
received	VBD	O	O
dvt	JJ	B-TREATMENT	B-TREATMENT
prophylaxis	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
sc	JJ	B-TREATMENT	B-TREATMENT
heparin	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
04/05	CD	O	O
revealed	VBD	O	O
bacteroides	NNS	B-PROBLEM	B-PROBLEM
fragilis	VBP	I-PROBLEM	I-PROBLEM
;	:	O	O
04/06	CD	O	O
fluid	NN	B-TEST	B-TREATMENT
collection	NN	I-TEST	I-TREATMENT
drainage	NN	I-TEST	I-TREATMENT
from	IN	I-TEST	O
ir	NN	I-TEST	O
revealed	VBD	O	O

1)	CD	O	O
4+	CD	B-PROBLEM	O
alpha	JJ	I-PROBLEM	B-PROBLEM
hemolytic	JJ	I-PROBLEM	I-PROBLEM
strep	NN	I-PROBLEM	I-PROBLEM
,	,	O	O

2)	CD	O	O
2+	CD	B-PROBLEM	B-PROBLEM
e.	NN	I-PROBLEM	I-PROBLEM
coli	NNS	I-PROBLEM	I-PROBLEM
sensitive	VBP	O	O
to	TO	O	O
ampicillin	VB	B-TREATMENT	B-TREATMENT
and	CC	O	O
levofloxacin	VB	B-TREATMENT	B-TREATMENT
,	,	O	O

3)	CD	O	O
3+	CD	B-PROBLEM	O
enterococci	RB	I-PROBLEM	O
sensitive	JJ	O	O
to	TO	O	O
ampicillin	VB	B-TREATMENT	B-TREATMENT
and	CC	O	O
levofloxacin	VB	B-TREATMENT	B-TREATMENT
,	,	O	O

4)	CD	O	O
bacteroides	NNS	B-PROBLEM	B-PROBLEM
fragilis	JJ	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
clostridium	NN	B-PROBLEM	I-PROBLEM
perfringens	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

blood	NN	B-TEST	B-TEST
cultures	NNS	I-TEST	I-TEST
from	IN	O	O
04/07	CD	O	O
showed	VBD	O	O
ngtd	NN	B-PROBLEM	O
.	.	O	O

cdiff	NN	B-TEST	O
from	IN	O	O
04/08	CD	O	O
,	,	O	O
04/09	CD	O	O
,	,	O	O
04/10	CD	O	O
were	VBD	O	O
negative	JJ	O	O
.	.	O	O

mr.	NN	O	O
liley	NN	O	O
was	VBD	O	O
discharged	VBN	O	O
in	IN	O	O
stable	JJ	O	O
condition	NN	O	O
,	,	O	O
ambulating	VBG	O	O
and	CC	O	O
voiding	VBG	O	O
independently	RB	O	O
,	,	O	O
and	CC	O	O
with	IN	O	O
adequate	JJ	B-TREATMENT	B-TREATMENT
pain	NN	I-TREATMENT	I-TREATMENT
control	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

ldamc	NN	O	B-TREATMENT
services	NNS	O	I-TREATMENT
were	VBD	O	O
set-up	JJ	O	O
for	IN	O	O
care	NN	B-TREATMENT	O
of	IN	O	O
his	PRP$	B-TREATMENT	B-PROBLEM
ir	NN	I-TREATMENT	I-PROBLEM
drains	NNS	I-TREATMENT	I-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
abscessogram	NN	I-TEST	I-TEST
was	VBD	O	O
performed	VBN	O	O
on	IN	O	O
04/12/05	CD	O	O
and	CC	O	O
revealed	VBD	O	O
no	DT	O	O
fistula	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

-	:	O	O
seek	NN	O	O
medical	JJ	O	O
attention	NN	O	O
for	IN	O	O
fevers	NNS	B-PROBLEM	B-PROBLEM
(	(	O	O
temp	JJ	B-TEST	B-TEST
&gt;	NNP	O	I-TEST
101.5	CD	O	O
)	)	O	O
,	,	O	O
worsening	VBG	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
drainage	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
excessive	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
from	IN	O	I-PROBLEM
incision	NN	B-PROBLEM	I-PROBLEM
,	,	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
or	CC	O	O
any	DT	B-PROBLEM	B-PROBLEM
other	JJ	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
of	IN	O	O
concern	NN	O	O
.	.	O	O

-	:	O	O
follow	VB	O	O
up	RP	O	O
with	IN	O	O
your	PRP$	O	O
surgeon	NN	O	O
in	IN	O	O
1-2	JJ	O	O
weeks	NNS	O	O
for	IN	O	O
wound	NN	B-TEST	B-TEST
check	NN	I-TEST	I-TEST
.	.	O	O

-	:	O	O
please	NN	O	O
do	VB	O	O
not	RB	O	O
drive	VB	O	O
or	CC	O	O
consume	VB	O	O
alcohol	NN	O	O
while	IN	O	O
taking	VBG	O	O
pain	JJ	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

-	:	O	O
resume	NN	O	O
home	NN	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

tracheoesophageal	JJ	B-PROBLEM	B-PROBLEM
fistula	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

tracheoesophageal	JJ	B-PROBLEM	B-PROBLEM
fistula	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

diabetes	NNS	B-PROBLEM	B-PROBLEM
mellitus	VBP	I-PROBLEM	I-PROBLEM
,	,	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
sepsis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
respiratory	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
pleural	JJ	B-PROBLEM	B-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
postoperative	JJ	B-PROBLEM	B-PROBLEM
encephalopathy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
postoperative	JJ	B-PROBLEM	B-PROBLEM
myocardial	JJ	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
thrombocytopenia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

february	JJ	O	O
6	CD	O	O
,	,	O	O
1994	CD	O	O
,	,	O	O
rigid	JJ	B-TEST	B-TEST
bronchoscopy	NN	I-TEST	I-TEST
with	IN	O	I-TEST
biopsy	NN	B-TEST	I-TEST
and	CC	O	O
upper	JJ	B-TEST	B-TREATMENT
gastrointestinal	JJ	I-TEST	I-TREATMENT
endoscopy	NN	I-TEST	I-TREATMENT
.	.	O	O

on	IN	O	O
february	JJ	O	O
10	CD	O	O
,	,	O	O
1994	CD	O	O
,	,	O	O
flexible	JJ	B-TEST	B-TEST
bronchoscopy	NN	I-TEST	I-TEST
,	,	O	O
flexible	JJ	B-TEST	O
esophagoscopy	NN	I-TEST	O
,	,	O	O
rigid	JJ	B-TEST	B-TEST
bronchoscopy	NN	I-TEST	I-TEST
,	,	O	O
transhiatal	JJ	B-TREATMENT	B-TREATMENT
esophagectomy	NN	I-TREATMENT	I-TREATMENT
(	(	I-TREATMENT	I-TREATMENT
partial	JJ	I-TREATMENT	I-TREATMENT
)	)	I-TREATMENT	I-TREATMENT
,	,	O	O
substernal	JJ	B-TREATMENT	B-TREATMENT
gastric	JJ	I-TREATMENT	I-TREATMENT
interposition	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
jejunostomy	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

multiple	JJ	B-TEST	B-PROBLEM
bronchoscopies	NNS	I-TEST	I-PROBLEM
,	,	O	O
chest	JJS	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
insertion	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
a	DT	O	O
71	CD	O	O
year	NN	O	O
old	JJ	O	O
white	JJ	O	O
female	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
carcinoid	NN	B-PROBLEM	B-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
who	WP	O	O
presented	VBD	O	O
for	IN	O	O
evaluation	NN	B-TEST	B-TEST
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
tracheoesophageal	JJ	I-PROBLEM	I-PROBLEM
fistula	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
initially	RB	O	O
diagnosed	VBN	O	O
in	IN	O	O
1978	CD	O	O
with	IN	O	O
atypical	JJ	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
cell	NN	I-PROBLEM	I-PROBLEM
carcinoma	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
lung	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
treated	VBN	O	O
with	IN	O	O
chemotherapy	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
radiation	NN	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
until	IN	O	O
1980	CD	O	O
.	.	O	O

she	PRP	O	O
did	VBD	O	O
well	RB	O	O
for	IN	O	O
approximately	RB	O	O
twelve	JJ	O	O
years	NNS	O	O
until	IN	O	O
she	PRP	O	O
was	VBD	O	O
diagnosed	VBN	O	O
with	IN	O	O
carcinoid	JJ	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
same	JJ	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
upper	NN	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

this	DT	O	O
may	MD	O	O
have	VB	O	O
been	VBN	O	O
the	DT	B-PROBLEM	O
initial	JJ	I-PROBLEM	O
primary	JJ	I-PROBLEM	O
cancer	NN	I-PROBLEM	O
although	IN	O	O
it	PRP	O	O
is	VBZ	O	O
unclear	JJ	O	O
at	IN	O	O
present	NN	O	O
.	.	O	O

bronchoscopy	NN	B-TEST	B-TEST
at	IN	O	O
that	DT	O	O
time	NN	O	O
showed	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
endobronchial	JJ	I-PROBLEM	I-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
bronchus	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
unresectable	JJ	O	O
.	.	O	O

she	PRP	O	O
underwent	VBD	O	O
four	CD	B-TREATMENT	B-TREATMENT
treatments	NNS	I-TREATMENT	I-TREATMENT
of	IN	O	I-TREATMENT
brachytherapy	NN	B-TREATMENT	I-TREATMENT
in	IN	O	O
march	NN	O	O
through	IN	O	O
may	MD	O	O
of	IN	O	O
1993	CD	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
been	VBN	O	O
doing	VBG	O	O
reasonably	RB	O	O
well	RB	O	O
until	IN	O	O
december	NNS	O	O
of	IN	O	O
1993	CD	O	O
when	WRB	O	O
she	PRP	O	O
presented	VBD	O	O
with	IN	O	O
persistent	JJ	B-PROBLEM	B-PROBLEM
and	CC	I-PROBLEM	I-PROBLEM
worsening	JJ	I-PROBLEM	I-PROBLEM
cough	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
near	JJ	B-PROBLEM	B-PROBLEM
strangulation	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
attempts	NNS	O	O
at	IN	O	O
eating	VBG	O	O
solids	NNS	O	O
or	CC	O	O
drinking	NN	O	B-TREATMENT
liquids	NNS	O	I-TREATMENT
.	.	O	O

a	DT	B-TEST	B-TEST
bronchoscopy	NN	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
tracheoesophageal	JJ	I-PROBLEM	I-PROBLEM
fistula	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
an	DT	O	O
opening	NN	O	O
into	IN	O	O
the	DT	O	O
trachea	NN	O	O
above	IN	O	O
the	DT	O	O
carina	NN	O	O
and	CC	O	O
no	DT	O	O
tumor	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
lobe	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
on	IN	O	O
total	JJ	B-TREATMENT	B-TREATMENT
parenteral	JJ	I-TREATMENT	I-TREATMENT
nutrition	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
has	VBZ	O	O
been	VBN	O	O
nothing	NN	B-TREATMENT	O
by	IN	I-TREATMENT	O
mouth	NN	I-TREATMENT	O
since	IN	O	O
then	RB	O	O
.	.	O	O

a	DT	B-TEST	B-TEST
barium	NN	I-TEST	I-TEST
swallow	NN	I-TEST	I-TEST
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
showed	VBD	O	O
the	DT	O	O
presence	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
tracheoesophageal	JJ	I-PROBLEM	I-PROBLEM
fistula	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
entrance	NN	O	O
into	IN	O	O
the	DT	O	O
right	JJ	O	O
mainstem	NN	O	O
bronchus	RB	O	O
below	IN	O	O
the	DT	O	O
carina	NN	O	O
.	.	O	O

bronchitis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
asthma	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
carcinoid	JJ	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
history	NN	O	O
of	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
cerebrovascular	JJ	B-PROBLEM	B-PROBLEM
accident	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
status	NN	O	O
post	NN	O	O
appendectomy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
hysterectomy	NN	B-TREATMENT	B-TREATMENT
and	CC	O	I-TREATMENT
right	JJ	B-TREATMENT	I-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
bladder	NN	B-TREATMENT	O
suspension	NN	I-TREATMENT	O
and	CC	O	O
a	DT	B-TREATMENT	B-PROBLEM
tumor	NN	I-TREATMENT	I-PROBLEM
removal	NN	I-TREATMENT	I-PROBLEM
from	IN	I-TREATMENT	O
the	DT	I-TREATMENT	O
right	JJ	I-TREATMENT	O
neck	NN	I-TREATMENT	O
.	.	O	O

cefuroxime	NN	B-TREATMENT	B-TREATMENT
1.5	CD	O	O
grams	NNS	O	O
intravenously	RB	O	O
q8h	RB	O	O
,	,	O	O
solu-medrol	JJ	B-TREATMENT	B-TREATMENT
62.5	CD	O	O
mg	NN	O	O
intravenously	RB	O	O
q8h	RB	O	O
,	,	O	O
ventolin	NN	B-TREATMENT	B-TREATMENT
metered	VBD	I-TREATMENT	I-TREATMENT
dose	JJ	I-TREATMENT	I-TREATMENT
inhaler	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
2	CD	O	O
puffs	NNS	O	O
po	JJ	O	O
q.i.d.	NN	O	O
,	,	O	O
pepcid	VBP	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
intravenously	RB	O	O
b.i.d.	VBD	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
allergic	JJ	B-PROBLEM	B-PROBLEM
to	TO	O	O
penicillin	VB	B-TREATMENT	B-TREATMENT
,	,	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
codeine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
pleasant	JJ	O	O
white	JJ	O	O
female	NN	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
afebrile	JJ	B-PROBLEM	B-PROBLEM
with	IN	O	O
stable	JJ	O	O
vital	JJ	O	O
signs	NNS	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
head	NN	I-TEST	I-TEST
,	,	I-TEST	I-TEST
eyes	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
ears	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
nose	RB	I-TEST	I-TEST
,	,	I-TEST	I-TEST
throat	NN	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
unremarkable	JJ	O	O
.	.	O	O

neck	NN	O	O
shows	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
well	RB	I-PROBLEM	I-PROBLEM
healed	VBN	I-PROBLEM	I-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
collar	JJ	I-PROBLEM	I-PROBLEM
incision	NN	I-PROBLEM	I-PROBLEM
without	IN	O	O
adenopathy	JJ	B-PROBLEM	B-PROBLEM
or	CC	O	I-PROBLEM
bruit	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
lungs	NNS	O	O
showed	VBD	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
inspiratory	NN	I-PROBLEM	I-PROBLEM
wheeze	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
expiratory	NN	I-PROBLEM	I-PROBLEM
wheezes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
was	VBD	O	O
soft	JJ	O	O
,	,	O	O
nontender	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
nondistended	VBN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
clubbing	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
rectal	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
is	VBZ	O	O
guaiac	JJ	B-TEST	O
negative	JJ	O	O
with	IN	O	O
a	DT	O	O
minimal	JJ	O	O
amount	NN	O	O
of	IN	O	O
stool	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
on	IN	O	O
february	JJ	O	O
5	CD	O	O
,	,	O	O
1994	CD	O	O
and	CC	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
central	JJ	I-TREATMENT	I-TREATMENT
venous	JJ	I-TREATMENT	I-TREATMENT
line	NN	I-TREATMENT	I-TREATMENT
placed	VBN	O	O
in	IN	O	O
her	PRP$	O	B-TREATMENT
right	JJ	O	I-TREATMENT
subclavian	NN	O	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
brought	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
on	IN	O	O
february	JJ	O	O
6	CD	O	O
,	,	O	O
1994	CD	O	O
where	WRB	O	O
she	PRP	O	O
underwent	JJ	O	O
rigid	JJ	B-TEST	O
and	CC	I-TEST	O
flexible	JJ	I-TEST	B-TEST
bronchoscopy	NN	I-TEST	I-TEST
and	CC	O	O
upper	JJ	B-TEST	B-TREATMENT
gastrointestinal	JJ	I-TEST	I-TREATMENT
endoscopy	NN	I-TEST	I-TREATMENT
.	.	O	O

findings	NNS	O	O
included	VBD	O	O
necrotic	JJ	B-PROBLEM	B-PROBLEM
debris	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
distal	JJ	I-PROBLEM	I-PROBLEM
trachea	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
the	DT	O	O
carina	NN	O	O
and	CC	O	O
right	JJ	O	O
mainstem	NN	O	O
bronchus	NN	O	O
.	.	O	O

her	PRP$	B-TREATMENT	B-TEST
steroids	NNS	I-TREATMENT	I-TEST
were	VBD	O	O
weaned	VBN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
brought	VBN	O	O
to	TO	O	O
the	DT	O	O
operating	NN	O	O
room	NN	O	O
on	IN	O	O
february	JJ	O	O
10	CD	O	O
,	,	O	O
1994	CD	O	O
where	WRB	O	O
she	PRP	O	O
underwent	VBD	O	O
once	RB	O	B-TEST
again	RB	O	I-TEST
flexible	JJ	B-TEST	I-TEST
bronchoscopy	NN	I-TEST	I-TEST
and	CC	O	O
flexible	JJ	B-TEST	O
esophagoscopy	NN	I-TEST	O
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
rigid	JJ	B-TEST	B-TEST
bronchoscopy	NN	I-TEST	I-TEST
.	.	O	O

she	PRP	O	O
then	RB	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
transhiatal	JJ	I-TREATMENT	I-TREATMENT
esophagectomy	NN	I-TREATMENT	I-TREATMENT
which	WDT	O	O
was	VBD	O	O
partial	JJ	O	O
,	,	O	O
and	CC	O	O
a	DT	B-TREATMENT	B-TREATMENT
substernal	JJ	I-TREATMENT	I-TREATMENT
gastric	JJ	I-TREATMENT	I-TREATMENT
interposition	NN	I-TREATMENT	I-TREATMENT
as	RB	O	O
well	RB	O	O
as	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
jejunostomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	B-TEST	B-TEST
pathology	NN	I-TEST	I-TEST
report	NN	I-TEST	I-TEST
suggested	VBD	O	O
that	IN	O	O
the	DT	O	O
area	NN	O	O
was	VBD	O	O
involved	VBN	O	O
with	IN	O	O
radiation	NN	B-PROBLEM	B-PROBLEM
esophagitis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
focal	JJ	B-PROBLEM	B-PROBLEM
ulceration	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
remained	VBD	O	O
ventilator	JJ	B-PROBLEM	B-PROBLEM
dependent	NN	I-PROBLEM	I-PROBLEM
postoperatively	RB	O	O
and	CC	O	O
was	VBD	O	O
taken	VBN	O	O
to	TO	O	O
the	DT	O	O
respiratory	NN	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
maintained	VBN	O	O
on	IN	O	O
triple	NN	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
which	WDT	O	O
included	VBD	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
ceftazidime	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
gentamicin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
two	CD	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
an	DT	B-TEST	B-TEST
electroencephalogram	NN	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
seizure	NN	B-PROBLEM	B-PROBLEM
activity	NN	I-PROBLEM	I-PROBLEM
but	CC	O	O
some	DT	B-PROBLEM	B-PROBLEM
generalized	JJ	I-PROBLEM	I-PROBLEM
slowing	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
seen	VBN	O	O
in	IN	O	O
consultation	NN	O	O
by	IN	O	O
the	DT	O	O
neurology	NN	O	O
service	NN	O	O
for	IN	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
apparent	JJ	I-PROBLEM	I-PROBLEM
postoperative	JJ	I-PROBLEM	I-PROBLEM
encephalopathy	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
episodes	NNS	O	O
of	IN	O	O
shaking	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

an	DT	B-TEST	B-TEST
endoscopy	NN	I-TEST	I-TEST
was	VBD	O	O
also	RB	O	O
performed	VBN	O	O
on	IN	O	O
postoperative	JJ	O	O
day	NN	O	O
two	CD	O	O
which	WDT	O	O
showed	VBD	O	O
clean	JJ	O	B-TREATMENT
anastomosis	NN	B-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
received	VBD	O	O
multiple	JJ	B-TEST	O
bronchoscopies	NNS	I-TEST	O
for	IN	O	O
pulmonary	JJ	B-TREATMENT	B-TREATMENT
toilet	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
maintained	VBN	O	O
on	IN	O	O
tube	NN	B-TREATMENT	B-TREATMENT
feedings	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
the	DT	B-TREATMENT	B-TREATMENT
ventilator	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
echocardiogram	NN	I-TEST	I-TEST
on	IN	O	O
february	JJ	O	O
18	CD	O	O
showed	VBD	O	O
no	DT	O	O
significant	JJ	B-PROBLEM	O
change	NN	I-PROBLEM	O
of	IN	O	O
her	PRP$	B-TEST	B-TEST
previous	JJ	I-TEST	I-TEST
echocardiogram	NN	I-TEST	I-TEST
on	IN	O	O
february	JJ	O	O
11	CD	O	O
,	,	O	O
which	WDT	O	O
showed	VBD	O	O
only	RB	O	O
a	DT	B-PROBLEM	B-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
pericardial	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
pelvic	JJ	I-TEST	I-TEST
and	CC	I-TEST	I-TEST
abdominal	JJ	I-TEST	I-TEST
computerized	JJ	I-TEST	I-TEST
tomography	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
on	IN	O	O
february	JJ	O	O
18	CD	O	O
also	RB	O	O
showed	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
focal	JJ	I-PROBLEM	I-PROBLEM
collection	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
abscess	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
remained	VBD	O	O
intermittently	RB	B-PROBLEM	O
febrile	JJ	I-PROBLEM	O
despite	IN	O	O
numerous	JJ	B-TREATMENT	B-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

her	PRP$	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	JJ	I-TEST	I-TEST
showed	VBD	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
air	NN	I-PROBLEM	I-PROBLEM
space	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
consistent	JJ	O	O
with	IN	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
adult	NN	B-PROBLEM	B-PROBLEM
respiratory	JJ	I-PROBLEM	I-PROBLEM
distress	JJ	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
suffered	VBD	O	O
an	DT	O	O
episode	NN	O	O
of	IN	O	O
renal	JJ	B-PROBLEM	B-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
felt	RBR	O	O
attributable	JJ	O	O
to	TO	O	O
aminoglycoside	VB	B-PROBLEM	B-PROBLEM
toxicity	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	B-TREATMENT	B-TEST
steroids	NNS	I-TREATMENT	I-TEST
were	VBD	O	O
weaned	VBN	O	O
.	.	O	O

because	IN	O	O
of	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
prolonged	JJ	I-TREATMENT	I-TREATMENT
intubation	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
inability	NN	B-PROBLEM	B-PROBLEM
to	TO	I-PROBLEM	I-PROBLEM
wean	VB	I-PROBLEM	I-PROBLEM
,	,	O	O
on	IN	O	O
february	JJ	O	O
24	CD	O	O
,	,	O	O
1994	CD	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
tracheostomy	NN	I-TREATMENT	I-TREATMENT
placed	VBN	O	O
.	.	O	O

she	PRP	O	O
remained	VBD	O	O
in	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
coma	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
on	IN	O	O
february	JJ	O	O
26	CD	O	O
,	,	O	O
1994	CD	O	O
grew	VBD	O	O
out	RP	O	O
staphylococcus	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
for	IN	O	O
septicemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
sputum	NN	I-TEST	I-TEST
grew	VBD	O	O
out	RP	O	O
pseudomonas	JJ	B-PROBLEM	B-PROBLEM
aeruginosa	NN	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
urine	NN	I-TEST	I-TEST
contained	VBN	O	I-TEST
yeast	NN	B-PROBLEM	I-TEST
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
amphotericin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

on	IN	O	O
march	NN	O	O
3	CD	O	O
,	,	O	O
1994	CD	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
chest	NN	I-TEST	I-TEST
and	CC	I-TEST	I-TEST
abdominal	JJ	I-TEST	I-TEST
and	CC	I-TEST	I-TEST
pelvis	JJ	I-TEST	I-TEST
computerized	JJ	I-TEST	I-TEST
tomography	NN	I-TEST	I-TEST
scan	NN	I-TEST	I-TEST
showed	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
fluid	JJ	B-PROBLEM	B-PROBLEM
collections	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
large	JJ	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
however	RB	O	O
.	.	O	O

this	DT	O	O
was	VBD	O	O
drained	VBN	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
left	JJ	I-TREATMENT	I-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

her	PRP$	B-TEST	B-TEST
sputum	NN	I-TEST	I-TEST
then	RB	O	O
grew	VBD	O	O
out	RP	O	O
klebsiella	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
treated	VBN	O	O
with	IN	O	O
amikacin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
imipenem	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

she	PRP	O	O
developed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
pleural	JJ	I-PROBLEM	I-PROBLEM
effusion	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
right	JJ	I-TREATMENT	I-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
placed	VBD	O	O
.	.	O	O

attempts	NNS	O	O
were	VBD	O	O
made	VBN	O	O
to	TO	O	O
facilitate	VB	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
wean	JJ	I-TREATMENT	I-TREATMENT
by	IN	O	O
resting	VBG	O	O
her	PRP$	O	O
overnight	NN	O	O
with	IN	O	O
a	DT	O	O
combination	NN	O	O
of	IN	O	O
propafol	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
fentanyl	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

this	DT	O	O
was	VBD	O	O
tried	VBN	O	O
for	IN	O	O
approximately	RB	O	O
seven	CD	O	O
days	NNS	O	O
with	IN	O	O
no	DT	O	O
real	JJ	O	B-PROBLEM
progress	NN	O	I-PROBLEM
made	VBD	O	O
toward	IN	O	O
facilitating	VBG	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
vent	JJ	I-TREATMENT	I-TREATMENT
wean	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
require	VB	O	O
pressor	JJ	B-TREATMENT	B-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
the	DT	O	O
high	JJ	O	O
30	CD	O	O
&apos;s	NN	O	O
.	.	O	O

she	PRP	O	O
also	RB	O	O
fell	VBD	O	O
into	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
coma	NN	I-PROBLEM	I-PROBLEM
once	RB	O	O
again	RB	O	O
.	.	O	O

on	IN	O	O
march	NN	O	O
31	CD	O	O
,	,	O	O
1994	CD	O	O
,	,	O	O
her	PRP$	B-PROBLEM	B-TREATMENT
pressor	JJ	I-PROBLEM	I-TREATMENT
support	NN	I-PROBLEM	I-TREATMENT
requirement	NN	I-PROBLEM	I-TREATMENT
increased	VBD	O	O
and	CC	O	O
she	PRP	O	O
continued	VBD	O	O
to	TO	O	O
have	VB	O	O
tachypneic	JJ	B-PROBLEM	B-PROBLEM
episodes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

on	IN	O	O
april	JJ	O	O
2	CD	O	O
,	,	O	O
1994	CD	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
several	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
bradycardia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
asystole	NN	B-PROBLEM	B-TREATMENT
,	,	O	O
which	WDT	O	O
responded	VBD	O	O
only	RB	O	O
to	TO	O	B-TREATMENT
manual	JJ	B-TREATMENT	I-TREATMENT
ventilation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

discussions	NNS	O	O
were	VBD	O	O
held	VBN	O	O
with	IN	O	O
the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
family	NN	O	O
with	IN	O	O
regard	NN	O	O
to	TO	O	O
her	PRP$	O	O
previously	RB	O	O
expressed	VBN	O	O
wishes	NNS	O	O
not	RB	O	O
to	TO	O	O
be	VB	O	O
maintained	VBN	O	O
on	IN	O	O
artificial	JJ	B-TREATMENT	B-TREATMENT
life	NN	I-TREATMENT	I-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
extended	JJ	O	O
period	NN	O	O
of	IN	O	O
time	NN	O	O
with	IN	O	O
little	JJ	O	O
or	CC	O	O
no	DT	O	O
hope	NN	O	O
for	IN	O	O
recovery	NN	O	O
.	.	O	O

decision	NN	O	O
was	VBD	O	O
made	VBN	O	O
in	IN	O	O
conjunction	NN	O	O
with	IN	O	O
the	DT	O	O
family	NN	O	O
and	CC	O	O
dr.	NN	O	O
caslighlourdes	NNS	O	O
to	TO	O	O
terminate	VB	O	O
artificial	JJ	B-TREATMENT	B-TREATMENT
respiratory	NN	I-TREATMENT	I-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
removed	VBN	O	O
from	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
ventilator	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
placed	VBN	O	O
on	IN	O	O
a	DT	B-TREATMENT	O
t-piece	NN	I-TREATMENT	O
in	IN	I-TREATMENT	O
her	PRP$	I-TREATMENT	B-PROBLEM
trachea	NN	I-TREATMENT	I-PROBLEM
only	RB	O	O
and	CC	O	O
was	VBD	O	O
made	VBN	O	O
comfortable	JJ	O	O
with	IN	O	O
narcotics	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

they	PRP	O	O
have	VBP	O	O
declined	VBN	O	O
a	DT	B-TEST	B-TEST
post-mortem	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
.	.	O	O

adult	NN	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	JJ	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

adult	NN	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	JJ	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

urinary	JJ	B-PROBLEM	B-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
tracheostomy	NN	B-TREATMENT	B-TREATMENT
status	NN	O	O
,	,	O	O
diabetes	VBZ	B-PROBLEM	B-PROBLEM
mellitus	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

mr.	NN	O	O
stain	NN	O	O
was	VBD	O	O
transferred	VBN	O	O
from	IN	O	O
the	DT	O	O
oreiewlefell	NN	O	O
merkane	NN	O	O
i	NN	O	O
penaltbridgesgreat	VBP	O	O
university	NN	O	O
medical	JJ	O	O
center	NN	O	O
for	IN	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
failure	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
adult	NN	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
superimposed	VBN	O	O
on	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
chronic	JJ	B-PROBLEM	B-PROBLEM
obstructive	JJ	I-PROBLEM	I-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
perhaps	RB	O	B-PROBLEM
asthma	NN	B-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
ulcerative	JJ	B-PROBLEM	B-PROBLEM
colitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	O	O
only	RB	O	O
positive	JJ	O	O
result	NN	O	O
was	VBD	O	O
a	DT	B-TEST	B-TEST
sputum	JJ	I-TEST	I-TEST
culture	NN	I-TEST	I-TEST
for	IN	O	O
pseudomonas	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
this	DT	O	O
came	VBD	O	O
after	IN	O	O
he	PRP	O	O
had	VBD	O	O
already	RB	O	O
been	VBN	O	O
on	IN	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	B-TEST	B-TEST
physical	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
on	IN	O	O
transfer	NN	O	O
showed	VBD	O	O
an	DT	O	O
alert	JJ	O	O
male	NN	O	O
with	IN	O	O
temperature	NN	B-TEST	B-TEST
100	CD	O	O
degrees	NNS	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
120/64	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
80	CD	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
intubated	VBN	B-TREATMENT	O
with	IN	O	O
pressor	JJ	B-TREATMENT	B-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
25	CD	O	O
,	,	O	O
and	CC	O	O
peep	NN	B-TREATMENT	O
of	IN	O	O
12.5	CD	O	O
with	IN	O	O
70%	CD	O	O
fio2	NNS	B-TREATMENT	O
.	.	O	O

tracheostomy	NN	B-TREATMENT	B-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
in	IN	O	O
good	JJ	O	O
position	NN	O	O
.	.	O	O

there	EX	O	O
was	VBD	O	O
an	DT	B-PROBLEM	B-PROBLEM
audible	JJ	I-PROBLEM	I-PROBLEM
air	NN	I-PROBLEM	I-PROBLEM
leak	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	O	B-TEST
chest	NN	O	I-TEST
showed	VBD	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
rhonchi	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
abdomen	NNS	O	O
was	VBD	O	O
distended	VBN	B-PROBLEM	B-PROBLEM
with	IN	O	O
active	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
rectal	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
was	VBD	O	O
unremarkable	JJ	O	O
.	.	O	O

extremities	NNS	O	O
showed	VBD	O	O
trace	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
chest	NN	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
showed	VBD	O	O
diffuse	IN	B-PROBLEM	B-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
alveolar	JJ	I-PROBLEM	I-PROBLEM
infiltrates	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
greater	JJR	O	O
in	IN	O	O
the	DT	O	O
lower	JJR	O	O
lung	NN	O	O
fields	NNS	O	O
than	IN	O	O
in	IN	O	O
the	DT	O	O
upper	NN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
ekg	NN	I-TEST	I-TEST
showed	VBD	O	O
normal	JJ	O	O
sinus	NN	O	O
rhythm	NN	O	O
at	IN	O	O
83	CD	O	O
,	,	O	O
with	IN	O	O
an	DT	O	B-PROBLEM
11	CD	O	I-PROBLEM
degree	NN	O	I-PROBLEM
axis	NN	O	I-PROBLEM
,	,	O	O
non-specific	JJ	B-PROBLEM	B-PROBLEM
st-t	JJ	I-PROBLEM	I-PROBLEM
wave	NN	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
sputum	NN	I-TEST	I-TEST
gram	NN	I-TEST	I-TEST
stain	NN	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-PROBLEM	O
few	JJ	I-PROBLEM	O
polys	NN	I-PROBLEM	O
and	CC	O	O
no	DT	O	O
organisms	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
gas	NN	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-TEST	B-TEST
po2	NN	I-TEST	I-TEST
of	IN	O	O
56	CD	O	O
,	,	O	O
pco2	NN	B-TEST	O
of	IN	O	O
48	CD	O	O
and	CC	O	O
ph	NN	B-TEST	O
of	IN	O	O
7.47	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
seen	VBN	O	O
in	IN	O	O
consultation	NN	O	O
by	IN	O	O
dr.	NN	O	O
wire	NN	O	O
who	WP	O	O
felt	VBD	O	O
that	DT	O	B-TREATMENT
manipulation	NN	B-TREATMENT	I-TREATMENT
of	IN	I-TREATMENT	I-TREATMENT
the	DT	I-TREATMENT	I-TREATMENT
tracheal	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
the	DT	O	O
best	JJS	O	O
approach	NN	O	O
to	TO	O	O
the	DT	B-PROBLEM	B-PROBLEM
air	NN	I-PROBLEM	I-PROBLEM
leak	NN	I-PROBLEM	I-PROBLEM
since	IN	O	O
it	PRP	O	O
was	VBD	O	O
a	DT	B-TREATMENT	B-PROBLEM
new	JJ	I-TREATMENT	I-PROBLEM
trach	NN	I-TREATMENT	I-PROBLEM
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
requiring	VBG	O	O
such	JJ	O	B-TREATMENT
high	JJ	B-TREATMENT	I-TREATMENT
ventilator	NN	I-TREATMENT	I-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
that	IN	O	O
it	PRP	O	O
was	VBD	O	O
risky	JJ	O	O
to	TO	O	O
change	VB	O	O
it	PRP	O	O
.	.	O	O

he	PRP	O	O
also	RB	O	O
felt	VBD	O	O
that	IN	O	O
lung	NN	B-TEST	B-TEST
biopsy	NN	I-TEST	I-TEST
at	IN	O	O
this	DT	O	O
time	NN	O	O
was	VBD	O	O
rather	RB	O	O
risky	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
therefore	RB	O	O
completely	RB	B-TEST	O
cultured	VBN	I-TEST	O
again	RB	O	O
and	CC	O	O
begun	VBN	O	O
on	IN	O	O
antibiotic	JJ	B-TREATMENT	B-TREATMENT
coverage	NN	I-TREATMENT	I-TREATMENT
which	WDT	O	O
would	MD	O	O
take	VB	O	O
care	NN	O	O
of	IN	O	O
the	DT	B-PROBLEM	O
pseudomonas	NN	I-PROBLEM	O
he	PRP	O	O
was	VBD	O	O
known	VBN	O	O
to	TO	O	O
have	VB	O	O
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
steroids	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
tapered	VBN	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
also	RB	O	O
begun	VBN	O	O
on	IN	O	O
anti-candida	JJ	B-TREATMENT	B-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
urinary	JJ	I-PROBLEM	I-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
yeast	NN	B-PROBLEM	B-PROBLEM
being	VBG	O	O
seen	VBN	O	O
.	.	O	O

because	IN	O	O
of	IN	O	O
the	DT	O	O
story	NN	O	O
of	IN	O	O
hemoptysis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
he	PRP	O	O
also	RB	O	O
underwent	VBD	O	O
an	DT	B-TEST	B-PROBLEM
exotic	JJ	I-TEST	I-PROBLEM
bleeding	NN	I-TEST	I-PROBLEM
work	NN	I-TEST	I-PROBLEM
up	RB	I-TEST	O
for	IN	O	O
such	JJ	O	B-PROBLEM
things	NNS	O	I-PROBLEM
as	IN	O	O
wegner	NN	B-PROBLEM	O
&apos;s	NN	I-PROBLEM	O
and	CC	O	O
goodpasture	NN	B-PROBLEM	B-PROBLEM
&apos;s	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
continued	VBD	O	O
to	TO	O	O
require	VB	O	O
very	RB	B-TREATMENT	B-PROBLEM
high	JJ	I-TREATMENT	I-PROBLEM
fio2	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
dvt	NN	I-PROBLEM	I-PROBLEM
by	IN	O	O
ultrasound	NN	B-TEST	B-TEST
.	.	O	O

he	PRP	O	O
underwent	VBD	O	O
a	DT	B-TREATMENT	B-TEST
trial	NN	I-TREATMENT	I-TEST
of	IN	I-TREATMENT	O
tpa	NN	I-TREATMENT	O
followed	VBN	O	O
by	IN	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

this	DT	O	B-PROBLEM
produced	VBN	O	I-PROBLEM
substantially	RB	B-PROBLEM	I-PROBLEM
further	JJ	I-PROBLEM	I-PROBLEM
hemoptysis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
the	DT	O	O
need	NN	O	O
for	IN	O	O
transfusion	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
stabilized	VBD	O	O
from	IN	O	O
this	DT	O	O
,	,	O	O
but	CC	O	O
on	IN	O	O
the	DT	O	O
fifth	NN	O	O
while	IN	O	O
continuing	VBG	O	O
to	TO	O	O
have	VB	O	O
extremely	RB	B-PROBLEM	B-PROBLEM
ventilator	JJ	I-PROBLEM	I-PROBLEM
requirement	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

at	IN	O	O
that	DT	O	O
time	NN	O	O
,	,	O	O
therefore	RB	O	O
,	,	O	O
ventilator	NN	B-TREATMENT	B-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
withdrawn	VBN	O	O
under	IN	O	O
the	DT	B-TREATMENT	O
comfort	NN	I-TREATMENT	O
measures	NNS	I-TREATMENT	O
of	IN	O	O
morphine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

left	VBN	B-PROBLEM	B-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
temporal	JJ	I-PROBLEM	I-PROBLEM
intraparenchymal	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

left	VBN	B-PROBLEM	B-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
temporal	JJ	I-PROBLEM	I-PROBLEM
intraparenchymal	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
deep	RB	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
thrombosis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
embolus	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
right	JJ	B-PROBLEM	B-PROBLEM
frontal	NN	I-PROBLEM	I-PROBLEM
infarct	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
question	NN	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
supranuclear	NN	I-PROBLEM	I-PROBLEM
palsy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

magnetic	JJ	B-TEST	B-TEST
resonance	NN	I-TEST	I-TEST
imaging	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
brain	NN	I-TEST	I-TEST
on	IN	O	O
10/18/96	CD	O	O
.	.	O	O

arterial	JJ	B-TEST	B-TEST
catheterization	NN	I-TEST	I-TEST
on	IN	O	O
10/14/96	CD	O	O
,	,	O	O
head	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
on	IN	O	O
10/14/96	CD	O	O

granrivern	JJ	O	O
call	NN	O	O
is	VBZ	O	O
a	DT	O	O
79-year-old	JJ	O	O
right	NN	O	O
handed	VBD	O	O
white	JJ	O	O
male	NN	O	O
with	IN	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
questionable	JJ	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
supranuclear	NN	I-PROBLEM	I-PROBLEM
palsy	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
deep	RB	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
thrombosis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
pulmonary	JJ	B-PROBLEM	B-PROBLEM
embolus	NN	I-PROBLEM	I-PROBLEM
who	WP	O	O
presents	VBZ	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
change	NN	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	O	B-PROBLEM
fall	NN	O	I-PROBLEM
at	IN	O	O
home	NN	O	O
.	.	O	O

his	PRP$	O	O
family	NN	O	O
stated	VBD	O	O
that	IN	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
progressive	JJ	I-PROBLEM	I-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
decline	NN	I-PROBLEM	I-PROBLEM
over	IN	O	O
the	DT	O	O
past	JJ	O	O
three	CD	O	O
years	NNS	O	O
and	CC	O	O
was	VBD	O	O
initially	RB	O	O
diagnosed	VBN	O	O
with	IN	O	O
parkinson	NN	B-PROBLEM	B-PROBLEM
&apos;s	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
features	NNS	B-PROBLEM	O
consistent	JJ	O	O
with	IN	O	O
parkinsonism	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

this	DT	O	O
was	VBD	O	O
poorly	RB	O	O
responsive	JJ	O	O
to	TO	O	O
eldopa	VB	B-TREATMENT	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
later	RB	O	O
seen	VBN	O	O
by	IN	O	O
dr.	JJ	O	O
flo	JJ	O	O
cuchkote	NN	O	O
at	IN	O	O
the	DT	O	O
ph	NN	O	O
university	NN	O	O
of	IN	O	O
medical	JJ	O	O
center	NN	O	O
and	CC	O	O
diagnosed	VBN	O	O
with	IN	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
supranuclear	JJ	I-PROBLEM	I-PROBLEM
palsy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

over	IN	O	O
the	DT	O	O
five	CD	O	O
to	TO	O	O
six	CD	O	O
weeks	NNS	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
drop	NN	I-PROBLEM	I-PROBLEM
off	RP	I-PROBLEM	O
in	IN	I-PROBLEM	O
his	PRP$	I-PROBLEM	O
mental	JJ	I-PROBLEM	O
functioning	NN	I-PROBLEM	O
with	IN	O	O
more	RBR	O	O
frequent	JJ	O	O
episodes	NNS	O	O
of	IN	O	O
confusion	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
disorientation	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
requiring	VBG	O	O
more	JJR	O	O
assistance	NN	B-TREATMENT	O
with	IN	O	O
his	PRP$	O	O
activities	NNS	O	O
of	IN	O	O
daily	JJ	O	O
living	NN	O	O
.	.	O	O

he	PRP	O	O
also	RB	O	O
developed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
urinary	JJ	I-PROBLEM	I-PROBLEM
incontinence	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
definite	JJ	B-PROBLEM	B-PROBLEM
clonic	JJ	I-PROBLEM	I-PROBLEM
activity	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
known	JJ	B-PROBLEM	B-PROBLEM
incontinence	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-TEST	B-TEST
trauma	JJ	I-TEST	I-TEST
evaluation	NN	I-TEST	I-TEST
was	VBD	O	O
negative	JJ	O	O
and	CC	O	O
thus	RB	O	O
he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
neurology	NN	O	O
service	NN	O	O
.	.	O	O

coumadin	NN	B-TREATMENT	B-TREATMENT
4	CD	O	O
mgs	NN	O	O
po	NN	O	O
qhs	NN	O	O
,	,	O	O
vasotec	JJ	B-TREATMENT	B-TREATMENT
5	CD	O	O
mgs	NN	O	O
po	NN	O	O
qd	NN	O	O
,	,	O	O
lasix	JJ	B-TREATMENT	B-TREATMENT
prn	NN	O	O
,	,	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
0.25	CD	O	O
mgs	NN	O	O
poqd	NN	O	O
,	,	O	O
proscar	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
sinemet	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

no	DT	O	O
known	VBN	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
allergies	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

1)	CD	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
on	IN	O	O
coumadin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O

2)	CD	O	O
deep	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
thrombosis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
pulmonary	JJ	B-PROBLEM	I-PROBLEM
embolus	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
the	DT	O	O
wife	NN	O	O
states	NNS	O	O
since	IN	O	O
he	PRP	O	O
was	VBD	O	O
in	IN	O	O
the	DT	O	O
infantry	NN	O	O
in	IN	O	O
world	NN	O	O
war	NN	O	O
ii	NN	O	O
.	.	O	O

3)	CD	O	O
question	NN	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
supranuclear	NN	I-PROBLEM	I-PROBLEM
palsy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

4)	CD	O	O
old	JJ	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
frontal	NN	I-PROBLEM	I-PROBLEM
infarct	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

5)	CD	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
a	DT	O	O
father	NN	O	O
who	WP	O	O
had	VBD	O	O
dementia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
no	DT	O	O
history	NN	O	O
of	IN	O	O
strokes	NNS	B-PROBLEM	B-PROBLEM
or	CC	O	O
bleeding	VBG	B-PROBLEM	B-PROBLEM
disorders	NNS	I-PROBLEM	I-PROBLEM
in	IN	O	O
the	DT	O	O
family	NN	O	O
.	.	O	O

vital	JJ	B-TEST	B-TEST
signs	NNS	I-TEST	I-TEST
in	IN	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
were	VBD	O	O
210/100	CD	O	O
for	IN	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
70	CD	O	O
and	CC	O	O
irregular	JJ	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
.	.	O	O

in	IN	O	O
general	JJ	O	O
he	PRP	O	O
was	VBD	O	O
an	DT	O	O
intubated	JJ	O	O
elderly	JJ	O	O
frail	NN	O	O
appearing	VBG	O	O
white	JJ	O	O
male	NN	O	O
with	IN	O	O
blood	NN	B-PROBLEM	O
about	IN	I-PROBLEM	O
his	PRP$	I-PROBLEM	O
face	NN	I-PROBLEM	O
.	.	O	O

head	NN	B-TEST	B-TEST
,	,	I-TEST	I-TEST
eyes	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
ears	NNS	I-TEST	I-TEST
,	,	I-TEST	I-TEST
nose	RB	I-TEST	I-TEST
and	CC	I-TEST	I-TEST
throat	JJ	I-TEST	I-TEST
examination	NN	I-TEST	I-TEST
;	:	O	O
abrasions	NNS	B-PROBLEM	B-PROBLEM
about	IN	I-PROBLEM	O
his	PRP$	I-PROBLEM	B-PROBLEM
forehead	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
there	EX	O	O
was	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
minimal	JJ	I-PROBLEM	I-PROBLEM
swelling	NN	I-PROBLEM	I-PROBLEM
associated	VBN	O	O
.	.	O	O

his	PRP$	O	O
neck	NN	O	O
was	VBD	O	O
rigid	JJ	B-PROBLEM	O
;	:	O	O
1+	CD	B-TEST	O
carotids	NNS	I-TEST	O
without	IN	O	O
bruits	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

oropharynx	NN	O	O
was	VBD	O	O
intubated	VBN	B-TREATMENT	O
with	IN	O	O
blood	NN	B-PROBLEM	B-TEST
as	RB	O	O
well	RB	O	O
.	.	O	O

lungs	NNS	O	O
;	:	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	VB	B-TEST	B-TEST
bilaterally	RB	I-TEST	O
.	.	O	O

cardiovascular	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
;	:	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
with	IN	O	O
no	DT	O	O
murmurs	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
rubs	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
gallops	NNS	B-PROBLEM	B-PROBLEM
.	.	O	O

abdominal	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
;	:	O	O
soft	JJ	O	O
,	,	O	O
non-tender	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
non-distended	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
normal	JJ	O	O
active	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
.	.	O	O

no	DT	O	O
clubbing	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
cyanosis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
or	CC	O	O
edema	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
no	DT	B-PROBLEM	O
blink	NN	I-PROBLEM	B-PROBLEM
to	TO	O	I-PROBLEM
threat	NN	B-TEST	I-PROBLEM
.	.	O	O

according	VBG	O	O
to	TO	O	O
the	DT	O	O
family	NN	O	O
this	DT	B-PROBLEM	O
iansicoria	NN	I-PROBLEM	O
was	VBD	O	O
old	JJ	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
no	DT	O	O
gag	NN	B-PROBLEM	B-PROBLEM
to	TO	O	O
tube	VB	B-TREATMENT	B-TREATMENT
manipulation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

motor	NN	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
he	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
weak	JJ	I-PROBLEM	I-PROBLEM
withdrawal	NN	I-PROBLEM	I-PROBLEM
to	TO	O	I-PROBLEM
nail	VB	B-TEST	I-PROBLEM
bed	NN	I-TEST	I-PROBLEM
pressure	NN	I-TEST	I-PROBLEM
in	IN	O	I-PROBLEM
both	DT	O	I-PROBLEM
hands	NNS	O	I-PROBLEM
.	.	O	O

he	PRP	O	O
triple	VBD	O	O
flexed	JJ	O	B-PROBLEM
his	PRP$	O	I-PROBLEM
bilateral	JJ	O	I-PROBLEM
lower	JJR	O	I-PROBLEM
extremities	NNS	O	I-PROBLEM
to	TO	O	I-PROBLEM
pain	VB	B-PROBLEM	I-PROBLEM
.	.	O	O

his	PRP$	B-TEST	B-TEST
deep	JJ	I-TEST	I-TEST
tendon	NN	I-TEST	I-TEST
reflexes	NNS	I-TEST	I-TEST
were	VBD	O	O
2+	CD	O	B-PROBLEM
at	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
right	JJ	O	I-PROBLEM
brachial	NN	O	I-PROBLEM
radialis	NN	O	I-PROBLEM
and	CC	O	I-PROBLEM
right	JJ	O	I-PROBLEM
patella	NN	O	I-PROBLEM
;	:	O	O
everywhere	RB	O	O
else	RB	O	O
his	PRP$	B-TEST	B-TEST
reflexes	NNS	I-TEST	I-TEST
were	VBD	O	O
1	CD	O	O
.	.	O	O

sodium	NN	B-TEST	B-TEST
141	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
3.5	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
107	CD	O	O
,	,	O	O
bicarbonates	VBZ	B-TEST	B-TEST
23.8	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
23	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
1.1	CD	O	O
,	,	O	O
glucose	RB	B-TEST	B-TEST
165	CD	O	O
,	,	O	O
po2	NN	B-TEST	B-TREATMENT
377	CD	O	O
,	,	O	O
pco2	NN	B-TEST	O
32	CD	O	O
,	,	O	O
ph	NN	B-TEST	B-TEST
7.50	CD	O	O
,	,	O	O
asomus	RB	B-TEST	O
298	CD	O	O
,	,	O	O
toxic	JJ	B-TEST	B-TEST
screen	NN	I-TEST	I-TEST
negative	JJ	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
11.1	CD	O	O
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
39.6	CD	O	O
,	,	O	O
platelet	NN	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
137	CD	O	O
,	,	O	O
prothrombin	JJ	B-TEST	B-TEST
time	NN	I-TEST	I-TEST
25.2	CD	O	O
,	,	O	O
inr	NN	B-TEST	B-TEST
4.3	CD	O	O
,	,	O	O
partial	JJ	B-TEST	B-TEST
thromboplastin	NN	I-TEST	I-TEST
time	NN	I-TEST	I-TEST
34.7	CD	O	O
,	,	O	O
urinalysis	NN	B-TEST	B-TEST
1+	CD	B-PROBLEM	O
albumin,	IN	I-PROBLEM	O
0-5	JJ	B-PROBLEM	O
high	JJ	I-PROBLEM	O
link	NN	I-PROBLEM	O
caths	NNS	I-PROBLEM	O
,	,	O	O
cervical	JJ	B-TEST	B-TEST
spine	NN	I-TEST	I-TEST
negative	JJ	O	O
,	,	O	O
pelvis	JJ	B-TEST	O
negative	JJ	O	O
,	,	O	O
lumbar	JJ	B-TEST	B-TEST
spine	NN	I-TEST	I-TEST
;	:	O	O
negative	JJ	O	O
,	,	O	O
thoracic	JJ	B-TEST	B-TEST
spine	NN	I-TEST	I-TEST
negative	NN	O	O
.	.	O	O

chest	JJS	B-TEST	B-TEST
x-ray	JJ	I-TEST	I-TEST
clear	JJ	O	O
.	.	O	O

electrocardiogram	NN	B-TEST	B-TEST
showed	VBD	O	O
2	CD	O	O
mm	NN	O	O
of	IN	O	O
st	JJ	B-PROBLEM	B-PROBLEM
depressions	NNS	I-PROBLEM	I-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
v4-6	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

head	NN	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
2	CD	I-PROBLEM	I-PROBLEM
x	NN	I-PROBLEM	I-PROBLEM
2	CD	I-PROBLEM	I-PROBLEM
x	JJ	I-PROBLEM	I-PROBLEM
2	CD	I-PROBLEM	I-PROBLEM
left	VBD	I-PROBLEM	I-PROBLEM
anterior	JJ	I-PROBLEM	I-PROBLEM
temporal	JJ	I-PROBLEM	I-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
minimal	JJ	B-PROBLEM	B-PROBLEM
surrounding	VBG	I-PROBLEM	I-PROBLEM
edema	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
was	VBD	O	O
also	RB	O	O
evidence	NN	O	O
of	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
old	JJ	I-PROBLEM	I-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
frontal	NN	I-PROBLEM	I-PROBLEM
infarction	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
the	DT	O	O
neurology	NN	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
for	IN	O	O
intensive	JJ	B-TEST	B-TEST
monitoring	NN	I-TEST	I-TEST
due	JJ	O	O
to	TO	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
frail	JJ	I-PROBLEM	I-PROBLEM
condition	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
an	DT	B-TEST	B-TEST
electroencephalogram	NN	I-TEST	I-TEST
performed	VBN	O	O
on	IN	O	O
his	PRP$	O	O
initial	JJ	O	O
admittance	NN	O	O
to	TO	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
which	WDT	O	O
did	VBD	O	O
not	RB	O	O
show	VB	O	O
any	DT	O	O
evidence	NN	O	O
of	IN	O	O
seizure	NN	B-PROBLEM	B-PROBLEM
activity	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

it	PRP	O	O
did	VBD	O	O
,	,	O	O
however	RB	O	O
,	,	O	O
show	VBP	O	B-PROBLEM
diffuse	IN	B-PROBLEM	I-PROBLEM
slowing	VBG	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
given	VBN	O	O
1.5	CD	O	O
grams	NNS	O	O
of	IN	O	O
dilantin	NN	B-TREATMENT	B-TREATMENT
in	IN	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
2	CD	O	O
mgs	NN	O	O
of	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
ativan	NNS	I-TREATMENT	I-TREATMENT
which	WDT	O	O
did	VBD	O	O
little	JJ	O	O
to	TO	O	O
stop	VB	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
rhythmic	JJ	I-PROBLEM	I-PROBLEM
blinking	NN	I-PROBLEM	I-PROBLEM
that	IN	O	O
he	PRP	O	O
showed	VBD	O	O
from	IN	O	O
time	NN	O	O
to	TO	O	O
time	NN	O	O
on	IN	O	O
examination	NN	B-TEST	B-TEST
.	.	O	O

his	PRP$	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
;	:	O	O
his	PRP$	B-PROBLEM	B-TEST
high	JJ	I-PROBLEM	I-TEST
blood	NN	I-PROBLEM	I-TEST
pressure	NN	I-PROBLEM	I-TEST
was	VBD	O	O
controlled	VBN	O	O
with	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
nitroglycerine	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
the	DT	O	O
early	JJ	O	O
going	VBG	O	O
and	CC	O	O
then	RB	O	O
he	PRP	O	O
was	VBD	O	O
switched	VBN	O	O
to	TO	O	O
an	DT	B-TREATMENT	B-TREATMENT
oral	JJ	I-TREATMENT	I-TREATMENT
regimen	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
better	JJR	O	O
control	NN	O	O
after	IN	O	O
he	PRP	O	O
was	VBD	O	O
removed	VBN	O	O
from	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
.	.	O	O

he	PRP	O	O
did	VBD	O	O
consistently	RB	O	O
have	VB	O	O
more	RBR	O	B-PROBLEM
movement	NN	O	I-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	JJ	O	I-PROBLEM
side	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
his	PRP$	O	I-PROBLEM
body	NN	O	I-PROBLEM
than	IN	O	I-PROBLEM
on	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
right	NN	O	I-PROBLEM
,	,	O	O
but	CC	O	O
he	PRP	O	O
gradually	RB	O	O
became	VBD	O	O
more	RBR	O	O
awake	JJ	O	O
and	CC	O	O
alert	JJ	O	O
and	CC	O	O
communicative	JJ	O	O
and	CC	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
endotracheal	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
removed	VBN	O	O
on	IN	O	O
the	DT	O	O
second	JJ	O	O
day	NN	O	O
of	IN	O	O
admission	NN	O	O
.	.	O	O

his	PRP$	O	O
diagnosis	NN	O	O
of	IN	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
supranuclear	JJ	I-PROBLEM	I-PROBLEM
palsy	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
placed	VBN	O	O
under	IN	O	O
question	NN	O	O
on	IN	O	O
further	JJ	B-TEST	B-TEST
examination	NN	I-TEST	I-TEST
of	IN	I-TEST	O
his	PRP$	I-TEST	O
eye	NN	I-TEST	O
movement	NN	I-TEST	O
since	IN	O	O
he	PRP	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
have	VB	O	O
excellent	JJ	O	O
superior	JJ	O	O
gaze	NN	O	O
especially	RB	O	O
with	IN	O	O
the	DT	B-TEST	B-PROBLEM
bells	NNS	I-TEST	I-PROBLEM
phenomenon	NN	I-TEST	I-PROBLEM
which	WDT	O	O
would	MD	O	O
not	RB	O	O
be	VB	O	O
seen	VBN	O	O
with	IN	O	O
progressive	JJ	B-PROBLEM	B-PROBLEM
supranuclear	JJ	I-PROBLEM	I-PROBLEM
palsy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

it	PRP	O	O
was	VBD	O	O
felt	VBN	O	O
that	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
dementing	VBG	I-PROBLEM	I-PROBLEM
illness	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
rigidity	NN	B-PROBLEM	I-PROBLEM
was	VBD	O	O
most	RBS	O	O
likely	JJ	O	O
due	JJ	O	O
to	TO	O	O
some	DT	O	O
type	NN	O	O
of	IN	O	O
cortico-basal	JJ	B-PROBLEM	B-PROBLEM
ganglia	JJ	I-PROBLEM	I-PROBLEM
degeneration	NN	I-PROBLEM	I-PROBLEM
process	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
this	DT	O	O
was	VBD	O	O
not	RB	O	O
clarified	VBN	O	O
during	IN	O	O
this	DT	O	O
admission	NN	O	O
.	.	O	O

it	PRP	O	O
was	VBD	O	O
not	RB	O	O
felt	VBN	O	O
likely	JJ	O	O
to	TO	O	O
be	VB	O	O
due	JJ	O	O
to	TO	O	O
parkinson	VB	B-PROBLEM	B-PROBLEM
&apos;s	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
as	IN	O	O
he	PRP	O	O
had	VBD	O	O
no	DT	O	O
significant	JJ	O	O
response	NN	O	O
to	TO	O	O
eldopa	VB	B-TREATMENT	O
in	IN	O	O
the	DT	O	O
past	NN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
tremor	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
although	IN	O	O
he	PRP	O	O
was	VBD	O	O
quite	RB	B-PROBLEM	O
rigid	JJ	I-PROBLEM	O
and	CC	O	O
bradykinetic	JJ	B-PROBLEM	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
an	DT	B-TEST	B-TEST
magnetic	JJ	I-TEST	I-TEST
resonance	NN	I-TEST	I-TEST
imaging	NN	I-TEST	I-TEST
performed	VBN	O	O
on	IN	O	O
october	PRP	O	O
18	CD	O	O
,	,	O	O
1996	CD	O	O
.	.	O	O

this	DT	O	O
showed	VBD	O	O
the	DT	B-PROBLEM	B-PROBLEM
unchanged	JJ	I-PROBLEM	I-PROBLEM
left	JJ	I-PROBLEM	I-PROBLEM
temporal	JJ	I-PROBLEM	I-PROBLEM
parenchymal	NN	I-PROBLEM	I-PROBLEM
interparenchymal	JJ	I-PROBLEM	I-PROBLEM
hematoma	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
the	DT	B-PROBLEM	I-PROBLEM
old	JJ	I-PROBLEM	I-PROBLEM
embolic	JJ	I-PROBLEM	I-PROBLEM
right	NN	I-PROBLEM	I-PROBLEM
frontal	NN	I-PROBLEM	I-PROBLEM
infarct	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
there	EX	O	O
were	VBD	O	O
no	DT	O	O
new	JJ	B-PROBLEM	B-PROBLEM
lesions	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
his	PRP$	B-TEST	B-TEST
susceptibility	NN	I-TEST	I-TEST
studies	NNS	I-TEST	I-TEST
to	TO	O	O
suggest	VB	O	O
old	JJ	B-PROBLEM	B-PROBLEM
bleeds	NNS	I-PROBLEM	I-PROBLEM
which	WDT	O	O
might	MD	O	O
have	VB	O	O
been	VBN	O	O
consistent	JJ	O	O
with	IN	O	O
amylase	NN	B-PROBLEM	B-TEST
angiopathy	NN	I-PROBLEM	I-TEST
.	.	O	O

in	IN	O	O
addition	NN	O	O
,	,	O	O
he	PRP	O	B-TEST
gadolinium	VBD	B-TEST	I-TEST
scan	JJ	I-TEST	I-TEST
did	VBD	O	O
not	RB	O	O
show	VB	O	O
enhancement	NN	B-PROBLEM	O
at	IN	O	O
the	DT	O	O
area	NN	O	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
hemorrhage	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
so	RB	O	B-PROBLEM
tumor	NN	B-PROBLEM	I-PROBLEM
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
unlikely	JJ	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
this	DT	O	O
issue	NN	O	O
will	MD	O	O
need	VB	O	O
to	TO	O	O
be	VB	O	O
re-evaluated	JJ	O	O
in	IN	O	O
six	CD	O	O
months	NNS	O	O
time	NN	O	O
once	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
hematoma	NN	I-PROBLEM	I-PROBLEM
is	VBZ	O	O
less	RBR	O	O
prominent	JJ	O	O
to	TO	O	O
see	VB	O	O
if	IN	O	O
there	EX	O	O
is	VBZ	O	O
possibly	RB	O	O
an	DT	B-PROBLEM	B-PROBLEM
underlying	JJ	I-PROBLEM	I-PROBLEM
tumor	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
arterial	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
malformation	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
could	MD	O	O
be	VB	O	O
currently	RB	O	O
compressed	VBN	O	O
by	IN	O	O
the	DT	O	O
area	NN	O	O
of	IN	O	O
hemorrhage	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
etiology	NN	O	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
most	RBS	O	O
likely	JJ	O	O
secondary	JJ	O	O
to	TO	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
but	CC	O	O
these	DT	O	O
other	JJ	O	O
causes	NNS	O	O
could	MD	O	O
also	RB	O	O
not	RB	O	O
be	VB	O	O
ruled	VBN	O	O
out	RP	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
electrocardiogram	NN	I-TEST	I-TEST
was	VBD	O	O
concerning	VBG	O	O
for	IN	O	O
ischemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
on	IN	O	O
intravenous	JJ	B-TREATMENT	B-TREATMENT
tng	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
was	VBD	O	O
supratherapeutic	VBN	B-PROBLEM	O
on	IN	O	O
his	PRP$	B-TREATMENT	O
anti-coagulation	NN	I-TREATMENT	O
.	.	O	O

he	PRP	O	O
did	VBD	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
slight	JJ	I-PROBLEM	I-PROBLEM
elevation	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
his	PRP$	B-TEST	O
tpk	NN	I-TEST	O
with	IN	O	O
an	DT	O	O
additional	JJ	O	O
value	NN	O	O
of	IN	O	O
198	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
mb	JJ	I-TEST	I-TEST
fraction	NN	I-TEST	I-TEST
of	IN	O	O
5.7	CD	O	O
,	,	O	O
which	WDT	O	O
makes	VBZ	O	O
for	IN	O	O
a	DT	O	O
percentage	NN	O	O
of	IN	O	O
2.9	CD	O	O
.	.	O	O

that	DT	O	O
was	VBD	O	O
at	IN	O	O
the	DT	O	O
highest	JJS	O	O
percentage	NN	O	O
that	IN	O	O
he	PRP	O	O
had	VBD	O	O
and	CC	O	O
after	IN	O	O
this	DT	O	O
his	PRP$	O	O
percentage	NN	O	O
came	VBD	O	O
down	RB	O	O
to	TO	O	O
1.6	CD	O	O
,	,	O	O
1.0	CD	O	O
on	IN	O	O
subsequent	JJ	B-TEST	B-TREATMENT
ckmbs	NN	I-TEST	I-TREATMENT
and	CC	O	O
was	VBD	O	O
felt	VBN	O	O
that	IN	O	O
he	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
very	RB	I-PROBLEM	I-PROBLEM
small	JJ	I-PROBLEM	I-PROBLEM
&quot;	NNP	I-PROBLEM	I-PROBLEM
leaflet	NN	I-PROBLEM	I-PROBLEM
&quot;	NNP	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
remained	VBD	O	O
chest	JJS	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
free	JJ	O	O
throughout	IN	O	O
his	PRP$	O	O
admission	NN	O	O
.	.	O	O

after	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
initial	JJ	I-TREATMENT	I-TREATMENT
intubation	NN	I-TREATMENT	I-TREATMENT
he	PRP	O	O
remained	VBD	O	O
quite	RB	O	O
stable	JJ	O	O
.	.	O	O

he	PRP	O	O
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
at	IN	O	O
a	DT	B-PROBLEM	O
large	JJ	I-PROBLEM	O
aspiration	NN	I-PROBLEM	O
risk	NN	I-PROBLEM	O
given	VBN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
decreased	JJ	I-PROBLEM	I-PROBLEM
mental	JJ	I-PROBLEM	I-PROBLEM
status	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
the	DT	O	O
lack	NN	O	O
of	IN	O	O
presence	NN	O	O
of	IN	O	O
a	DT	B-TEST	B-PROBLEM
gag	NN	I-TEST	I-PROBLEM
reflex	NN	I-TEST	I-PROBLEM
.	.	O	O

however	RB	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
given	VBN	O	O
aggressive	JJ	B-TREATMENT	B-PROBLEM
pulmonary	JJ	I-TREATMENT	I-PROBLEM
toilets	NNS	I-TREATMENT	I-PROBLEM
including	VBG	O	O
chest	JJS	B-TREATMENT	B-TREATMENT
physical	JJ	I-TREATMENT	I-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
aspiration	NN	B-TREATMENT	B-TREATMENT
precautions	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
the	DT	O	O
patient	NN	O	O
did	VBD	O	O
not	RB	O	O
develop	VB	O	O
any	DT	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
symptoms	NNS	I-PROBLEM	I-PROBLEM
during	IN	O	O
his	PRP$	O	O
admission	NN	O	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
his	PRP$	B-TEST	B-TEST
prothrombin	JJ	I-TEST	I-TEST
time	NN	I-TEST	I-TEST
reversed	VBN	O	O
with	IN	O	O
vitamin	NN	B-TREATMENT	B-TREATMENT
k	NN	I-TREATMENT	I-TREATMENT
2	CD	O	O
mgs	NN	O	O
on	IN	O	O
admission	NN	O	O
subcutaneously	RB	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
two	CD	O	O
units	NNS	O	O
of	IN	O	O
fresh	JJ	B-TREATMENT	B-TREATMENT
frozen	JJ	I-TREATMENT	I-TREATMENT
plasma	NN	I-TREATMENT	I-TREATMENT
given	VBN	O	O
in	IN	O	O
the	DT	O	O
emergency	NN	O	O
room	NN	O	O
.	.	O	O

his	PRP$	O	B-TEST
anticoagulation	NN	O	I-TEST
status	NN	O	O
had	VBD	O	O
to	TO	O	O
be	VB	O	O
monitored	VBN	O	O
very	RB	O	O
closely	RB	O	O
due	JJ	O	O
to	TO	O	O
his	PRP$	O	O
history	NN	O	O
of	IN	O	O
deep	JJ	B-PROBLEM	B-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
thrombosis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
pulmonary	JJ	B-PROBLEM	I-PROBLEM
embolus	NN	I-PROBLEM	I-PROBLEM
as	RB	O	O
well	RB	O	O
as	IN	O	O
atrial	JJ	B-PROBLEM	B-PROBLEM
fibrillation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
but	CC	O	O
he	PRP	O	O
could	MD	O	O
not	RB	O	O
be	VB	O	O
placed	VBN	O	O
on	IN	O	O
a	DT	O	O
high	JJ	O	O
amount	NN	O	O
of	IN	O	O
anticoagulation	NN	B-TREATMENT	B-TREATMENT
because	IN	O	O
of	IN	O	O
the	DT	B-PROBLEM	B-PROBLEM
new	JJ	I-PROBLEM	I-PROBLEM
intraparenchymal	JJ	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
that	IN	O	O
his	PRP$	O	B-TEST
goal	NN	O	I-TEST
inr	NN	B-TEST	I-TEST
was	VBD	O	O
to	TO	O	O
be	VB	O	O
2.0	CD	O	O
.	.	O	O

he	PRP	O	O
did	VBD	O	O
drop	VB	O	O
below	IN	O	O
1.5	CD	O	O
at	IN	O	O
one	CD	O	O
time	NN	O	O
,	,	O	O
at	IN	O	O
which	WDT	O	O
time	NN	O	O
he	PRP	O	O
was	VBD	O	O
placed	VBN	O	O
on	IN	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
intravenous	JJ	I-TREATMENT	I-TREATMENT
to	TO	O	O
carry	VB	O	O
him	PRP	O	O
through	IN	O	O
that	DT	O	O
period	NN	O	O
,	,	O	O
but	CC	O	O
his	PRP$	B-TEST	O
discharge	NN	I-TEST	O
inr	NN	I-TEST	O
was	VBD	O	O
around	IN	O	O
2	CD	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
off	IN	O	O
of	IN	O	O
heparin	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
that	DT	O	O
time	NN	O	O
.	.	O	O

it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
that	IN	O	O
he	PRP	O	O
would	MD	O	O
have	VB	O	O
very	RB	O	O
close	JJ	O	O
monitoring	NN	B-TEST	O
of	IN	O	O
his	PRP$	O	B-TREATMENT
anticoagulation	NN	O	I-TREATMENT
status	NN	O	O
in	IN	O	O
the	DT	O	O
future	NN	O	O
to	TO	O	O
prevent	VB	O	O
further	JJ	B-PROBLEM	B-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
was	VBD	O	O
evaluated	VBN	O	O
by	IN	O	O
the	DT	O	O
speech	NN	O	O
and	CC	O	O
swallow	JJ	O	B-TEST
pathology	NN	O	I-TEST
group	NN	O	I-TEST
at	IN	O	O
the	DT	O	O
ph	NN	O	O
university	NN	O	O
of	IN	O	O
medical	JJ	O	O
center	NN	O	O
and	CC	O	O
it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
that	IN	O	O
he	PRP	O	O
was	VBD	O	O
able	JJ	O	O
to	TO	O	O
swallow	VB	O	O
on	IN	O	O
his	PRP$	O	O
own	JJ	O	O
with	IN	O	O
a	DT	B-TREATMENT	B-TREATMENT
soft	JJ	I-TREATMENT	I-TREATMENT
solid	JJ	I-TREATMENT	I-TREATMENT
diet	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
supervision	NN	O	O
.	.	O	O

thus	RB	O	O
,	,	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
nasogastric	JJ	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
discontinued	VBN	O	O
on	IN	O	O
october	PRP	O	O
19	CD	O	O
,	,	O	O
1996	CD	O	O
and	CC	O	O
he	PRP	O	O
tolerated	VBD	O	O
feeding	VBG	O	O
quite	RB	O	O
well	RB	O	O
.	.	O	O

in	IN	O	O
discussions	NNS	O	O
with	IN	O	O
the	DT	O	O
family	NN	O	O
,	,	O	O
given	VBN	O	O
his	PRP$	O	O
age	NN	O	O
and	CC	O	O
number	NN	O	O
of	IN	O	O
medical	JJ	B-PROBLEM	B-PROBLEM
problems	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
it	PRP	O	O
was	VBD	O	O
decided	VBN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
should	MD	O	O
be	VB	O	O
do	VB	O	O
not	RB	O	O
resuscitate	VB	O	O
should	MD	O	O
he	PRP	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
terminal	JJ	I-PROBLEM	I-PROBLEM
cardiac	JJ	I-PROBLEM	I-PROBLEM
event	NN	I-PROBLEM	I-PROBLEM
during	IN	O	O
his	PRP$	O	O
admission	NN	O	O
or	CC	O	O
during	IN	O	O
future	JJ	O	O
admissions	NNS	O	O
.	.	O	O

however	RB	O	O
,	,	O	O
he	PRP	O	O
was	VBD	O	O
still	RB	O	O
an	DT	B-TREATMENT	B-TREATMENT
intubation	NN	I-TREATMENT	I-TREATMENT
candidate	NN	O	I-TREATMENT
if	IN	O	O
it	PRP	O	O
were	VBD	O	O
felt	VBN	O	O
to	TO	O	O
be	VB	O	O
a	DT	B-TREATMENT	B-PROBLEM
short	JJ	I-TREATMENT	I-PROBLEM
term	NN	I-TREATMENT	I-PROBLEM
procedure	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

the	DT	O	O
family	NN	O	O
realizes	VBZ	O	O
that	IN	O	O
the	DT	O	B-PROBLEM
long	JJ	O	I-PROBLEM
term	NN	O	I-PROBLEM
outlook	NN	O	I-PROBLEM
for	IN	O	O
this	DT	O	O
patient	NN	O	O
is	VBZ	O	O
not	RB	O	O
very	RB	O	O
good	JJ	O	O
,	,	O	O
but	CC	O	O
they	PRP	O	O
would	MD	O	O
like	VB	O	O
to	TO	O	O
currently	RB	O	O
continue	VB	O	O
to	TO	O	O
provide	VB	O	O
him	PRP	O	O
with	IN	O	O
all	DT	B-TREATMENT	B-TREATMENT
support	NN	I-TREATMENT	I-TREATMENT
necessary	JJ	I-TREATMENT	O
,	,	O	O
short	JJ	O	B-TREATMENT
of	IN	O	I-TREATMENT
resuscitation	NN	B-TREATMENT	I-TREATMENT
measures	NNS	I-TREATMENT	I-TREATMENT
or	CC	O	O
heroic	NN	B-TREATMENT	B-TREATMENT
measures	NNS	I-TREATMENT	I-TREATMENT
should	MD	O	O
he	PRP	O	O
have	VB	O	O
a	DT	B-PROBLEM	O
cardiopulmonary	JJ	I-PROBLEM	O
arrest	NN	I-PROBLEM	O
.	.	O	O

dilantin	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mgs	NN	O	O
po	NN	O	O
tid	NN	O	O
,	,	O	O
carafate	VBP	B-TREATMENT	O
1	CD	O	O
gram	NN	O	O
po	NN	O	O
qid	NN	O	O
,	,	O	O
digoxin	NN	B-TREATMENT	B-TREATMENT
0.25	CD	O	O
mgs	NN	O	O
po	NN	O	O
qd	NN	O	O
,	,	O	O
isordil	JJ	B-TREATMENT	B-TREATMENT
20	CD	O	O
mgs	NN	O	O
po	NN	O	O
tid	NN	O	O
,	,	O	O
captopril	VBP	B-TREATMENT	B-TREATMENT
25	CD	O	O
mgs	NN	O	O
po	NN	O	O
tid	NN	O	O
,	,	O	O
lopressor	VBZ	B-TREATMENT	B-TREATMENT
50	CD	O	O
mgs	NN	O	O
po	NN	O	O
bid	NN	O	O
,	,	O	O
colace	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mgs	NN	O	O
po	NN	O	O
tid	NN	O	O
,	,	O	O
and	CC	O	O
coumadin	VBZ	B-TREATMENT	B-TREATMENT
2	CD	O	O
mgs	NN	O	O
po	NN	O	O
qhs	NN	O	O
.	.	O	O

cryptogenic	JJ	B-PROBLEM	B-PROBLEM
cirrhosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

cryptogenic	JJ	B-PROBLEM	B-PROBLEM
cirrhosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

variceal	NN	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

variceal	NN	B-TREATMENT	B-PROBLEM
banding	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
70-year-old	JJ	O	O
female	NN	O	O
with	IN	O	O
cryptogenic	JJ	B-PROBLEM	B-PROBLEM
cirrhosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
esophageal	JJ	B-PROBLEM	B-PROBLEM
varices	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
upper	JJ	I-PROBLEM	I-PROBLEM
gi	NN	I-PROBLEM	I-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
had	VBD	O	O
one	CD	O	O
pervious	JJ	O	O
episode	NN	O	O
of	IN	O	O
variceal	NN	B-PROBLEM	B-PROBLEM
bleeding	VBG	I-PROBLEM	I-PROBLEM
with	IN	O	O
an	DT	O	O
unclear	JJ	O	O
date	NN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
in	IN	O	O
her	PRP$	O	O
usual	JJ	O	O
state	NN	O	O
of	IN	O	O
health	NN	O	O
until	IN	O	O
one	CD	O	O
day	NN	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
when	WRB	O	O
she	PRP	O	O
felt	VBD	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
fatigue	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
vomiting	VBG	B-PROBLEM	B-PROBLEM
productive	NN	O	I-PROBLEM
of	IN	O	I-PROBLEM
bright	JJ	B-PROBLEM	I-PROBLEM
red	JJ	I-PROBLEM	I-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
coffee	NN	B-PROBLEM	I-PROBLEM
ground	NN	I-PROBLEM	I-PROBLEM
emesis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
also	RB	O	O
had	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
black	JJ	I-PROBLEM	I-PROBLEM
,	,	I-PROBLEM	O
tarry	JJ	I-PROBLEM	O
stool	NN	I-PROBLEM	O
in	IN	O	O
her	PRP$	B-TREATMENT	B-TREATMENT
colostomy	NN	I-TREATMENT	I-TREATMENT
bag	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

at	IN	O	O
vaila	NNP	O	O
medical	JJ	O	O
center	NN	O	O
,	,	O	O
she	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
of	IN	O	O
25	CD	O	O
and	CC	O	O
was	VBD	O	O
transfused	VBN	O	O
2	CD	O	O
units	NNS	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
had	VBD	O	O
an	DT	B-TEST	B-TREATMENT
upper	JJ	I-TEST	I-TREATMENT
endoscopy	NN	I-TEST	I-TREATMENT
at	IN	O	O
va	JJ	O	O
sit	NN	O	O
namar	NN	O	O
healthcare	NN	O	O
showing	VBG	O	O
an	DT	O	B-PROBLEM
esophagus	NN	O	I-PROBLEM
filled	VBN	O	O
with	IN	O	O
clots	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
small	JJ	O	O
amount	NN	O	O
of	IN	O	O
bleeding	VBG	B-PROBLEM	B-PROBLEM
varices	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
clot	NN	B-PROBLEM	B-PROBLEM
in	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
stomach	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
antral	JJ	B-PROBLEM	B-PROBLEM
gastritis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
and	CC	O	O
a	DT	O	B-PROBLEM
normal	JJ	O	I-PROBLEM
duodenum	NN	O	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
pitressin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
a	DT	B-TREATMENT	B-TREATMENT
blakemore	NN	I-TREATMENT	I-TREATMENT
tube	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
inserted	VBN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
to	TO	O	O
the	DT	O	O
ph	NN	O	O
university	NN	O	O
of	IN	O	O
medical	JJ	O	O
center	NN	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
where	WRB	O	O
on	IN	O	O
january	JJ	O	O
25	CD	O	O
in	IN	O	O
the	DT	O	O
morning	NN	O	O
her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
found	VBN	O	O
to	TO	O	O
be	VB	O	O
27.4	CD	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
transfused	VBN	O	O
another	DT	O	O
2	CD	O	O
units	NNS	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
over	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
the	DT	O	O
day	NN	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
improved	VBD	O	O
to	TO	O	O
29.4	CD	O	O
and	CC	O	O
then	RB	O	O
31.2	CD	O	O
.	.	O	O

the	DT	O	O
gi	NN	O	O
service	NN	O	O
was	VBD	O	O
consulted	VBN	O	O
and	CC	O	O
an	DT	B-TEST	B-TEST
upper	JJ	I-TEST	I-TEST
endoscopy	NN	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
showed	VBD	O	O
grade	JJ	B-PROBLEM	B-PROBLEM
iii	NN	I-PROBLEM	I-PROBLEM
varices	NNS	I-PROBLEM	I-PROBLEM
with	IN	O	O
no	DT	O	O
active	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
clean	JJ	I-PROBLEM	I-PROBLEM
base	NN	I-PROBLEM	I-PROBLEM
gastric	JJ	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
possibly	RB	O	O
secondary	JJ	O	O
to	TO	O	O
the	DT	B-TREATMENT	O
blakemore	NN	I-TREATMENT	O
tube	NN	I-TREATMENT	O
.	.	O	O

her	PRP$	B-PROBLEM	B-PROBLEM
varices	NNS	I-PROBLEM	I-PROBLEM
had	VBD	O	O
stigmata	NNS	B-PROBLEM	B-PROBLEM
of	IN	O	O
recent	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
were	VBD	O	O
banded	VBN	B-TREATMENT	O
successfully	RB	O	O
.	.	O	O

after	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
2	CD	O	O
more	JJR	O	O
units	NNS	O	O
of	IN	O	O
packed	JJ	B-TREATMENT	B-TREATMENT
red	JJ	I-TREATMENT	I-TREATMENT
blood	NN	I-TREATMENT	I-TREATMENT
cells	NNS	I-TREATMENT	I-TREATMENT
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
hemodynamically	RB	O	O
stable	JJ	O	O
and	CC	O	O
hematocrit	NN	B-TEST	B-TEST
was	VBD	O	O
stable	JJ	O	O
at	IN	O	O
31.2	CD	O	O
.	.	O	O

cryptogenic	JJ	B-PROBLEM	B-PROBLEM
cirrhosis	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
an	DT	B-TEST	O
unclear	JJ	I-TEST	O
work	NN	I-TEST	O
up	RB	I-TEST	O
.	.	O	O

diverticular	JJ	B-PROBLEM	B-PROBLEM
bleed	NN	I-PROBLEM	I-PROBLEM
requiring	VBG	O	O
colostomy	NNS	B-TREATMENT	B-TREATMENT
on	IN	O	O
may	MD	O	O
96	CD	O	O
.	.	O	O

spinal	JJ	B-PROBLEM	B-PROBLEM
stenosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

hysterectomy	NN	B-TREATMENT	B-TREATMENT
at	IN	O	O
the	DT	O	O
age	NN	O	O
of	IN	O	O
32	CD	O	O
.	.	O	O

no	DT	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
diabetes	NNS	B-PROBLEM	B-PROBLEM
and	CC	O	O
no	DT	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
medications	NNS	B-TREATMENT	B-TREATMENT
on	IN	O	O
transfer	NN	O	O
which	WDT	O	O
included	VBD	O	O
synthroid	NN	B-TREATMENT	B-TREATMENT
0.15	CD	O	O
mg	NN	O	O
qd	NN	O	O
,	,	O	O
zoloft	JJ	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
qd	NN	O	O
,	,	O	O
inderal	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
bid	NN	O	O
,	,	O	O
prilosec	VBP	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
qd	NN	O	O
,	,	O	O
neomycin	RB	B-TREATMENT	B-TREATMENT
500	CD	O	O
tid	NN	O	O
,	,	O	O
feosol	VBP	B-TREATMENT	B-TREATMENT
3	CD	O	O
mg	NN	O	O
and	CC	O	O
darvocet	NN	B-TREATMENT	B-TREATMENT
prn	NN	O	O
.	.	O	O

she	PRP	O	O
has	VBZ	O	O
allergies	NNS	B-PROBLEM	B-PROBLEM
to	TO	O	O
morphine	VB	B-TREATMENT	B-TREATMENT
,	,	O	O
percocet	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
codeine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
penicillin	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
xanax	NNP	B-TREATMENT	B-TREATMENT
and	CC	O	O
toradol	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

her	PRP$	O	O
husband	NN	O	O
died	VBD	O	O
of	IN	O	O
lung	NN	B-PROBLEM	B-PROBLEM
cancer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
is	VBZ	O	O
an	DT	O	O
obese	JJ	O	O
,	,	O	O
elderly	JJ	O	O
woman	NN	O	O
in	IN	O	O
no	DT	O	O
acute	JJ	B-PROBLEM	B-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

158/60	CD	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
heart	NN	I-TEST	I-TEST
rate	NN	I-TEST	I-TEST
of	IN	O	O
85	CD	O	O
,	,	O	O
temperature	NN	B-TEST	B-TEST
99.7	CD	O	O
,	,	O	O
respirations	NNS	B-TEST	B-TEST
14	CD	O	O
.	.	O	O

her	PRP$	O	B-TEST
neck	NN	O	I-TEST
showed	VBD	O	O
no	DT	O	O
jvd	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

lungs	NNS	O	O
clear	JJ	O	O
to	TO	O	O
auscultation	NN	B-TEST	B-TEST
.	.	O	O

her	PRP$	O	O
abdomen	NNS	O	O
was	VBD	O	O
obese	JJ	B-PROBLEM	B-PROBLEM
and	CC	O	O
distended	VBN	B-PROBLEM	B-PROBLEM
with	IN	O	O
good	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
,	,	O	O
large	JJ	B-PROBLEM	B-PROBLEM
ventral	JJ	I-PROBLEM	I-PROBLEM
hernia	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

colostomy	NN	B-TREATMENT	B-TREATMENT
with	IN	O	O
black	JJ	B-PROBLEM	B-PROBLEM
stool	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
some	DT	B-PROBLEM	B-PROBLEM
mid	JJ	I-PROBLEM	I-PROBLEM
epigastric	JJ	I-PROBLEM	I-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
no	DT	O	O
rebound	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

her	PRP$	O	B-TEST
heart	NN	O	I-TEST
showed	VBD	O	O
a	DT	O	O
regular	JJ	O	O
rate	NN	O	O
and	CC	O	O
rhythm	NN	O	O
with	IN	O	O
an	DT	O	O
s1-s2	JJ	O	O
,	,	O	O
no	DT	O	O
murmur	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
neurological	JJ	I-TEST	I-TEST
exam	NN	I-TEST	I-TEST
was	VBD	O	O
alert	JJ	O	O
and	CC	O	O
oriented	VBN	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
asterixis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

she	PRP	O	O
had	VBD	O	O
no	DT	O	O
spider	NN	B-PROBLEM	B-PROBLEM
angiomata	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
palmar	NN	B-PROBLEM	B-PROBLEM
erythema	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
xanthomas	NNP	B-PROBLEM	B-PROBLEM
and	CC	O	O
no	DT	O	O
caput	NN	B-PROBLEM	B-PROBLEM
medusae	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
did	VBD	O	O
not	RB	O	O
look	VB	O	O
teric	JJ	B-PROBLEM	O
(	(	O	O
???	JJ	O	O
)	)	O	O
.	.	O	O

notable	JJ	O	O
for	IN	O	O
sodium	NN	B-TEST	B-TEST
141	CD	O	O
,	,	O	O
potassium	NN	B-TEST	B-TEST
4.2	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
109	CD	O	O
,	,	O	O
bicarb	NN	B-TEST	B-TEST
19.8	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
38	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
1.2	CD	O	O
and	CC	O	O
glucose	JJ	B-TEST	B-TEST
388	CD	O	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
pneumonia	NN	I-PROBLEM	I-PROBLEM
of	IN	O	O
31	CD	O	O
,	,	O	O
calcium	NN	B-TEST	B-TEST
was	VBD	O	O
7.5	CD	O	O
,	,	O	O
phosphorous	JJ	B-TEST	B-TEST
3.0	CD	O	O
,	,	O	O
magnesium	NN	B-TEST	B-TEST
1.3	CD	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
bilirubin	NN	I-TEST	I-TEST
was	VBD	O	O
1.4	CD	O	O
total	NN	O	O
,	,	O	O
0.2	CD	O	O
direct	NN	B-TEST	O
.	.	O	O

alkaline	JJ	B-TEST	B-TEST
phosphatase	NN	I-TEST	I-TEST
101	CD	O	O
.	.	O	O

sgpt	NN	B-TEST	B-TEST
22	CD	O	O
,	,	O	O
sgot	VBD	B-TEST	B-TEST
41	CD	O	O
,	,	O	O
amylase	NN	B-TEST	B-TEST
31	CD	O	O
,	,	O	O
lipase	JJR	B-TEST	B-TEST
less	JJR	O	O
than	IN	O	O
1	CD	O	O
.	.	O	O

ldh	NN	B-TEST	O
was	VBD	O	O
38.9	CD	O	O
,	,	O	O
ck	NN	B-TEST	O
was	VBD	O	O
66	CD	O	O
,	,	O	O
her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
27.4	CD	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
8.0	CD	O	O
and	CC	O	O
her	PRP$	B-TEST	B-TEST
platelets	NNS	I-TEST	I-TEST
were	VBD	O	O
55	CD	O	O
.	.	O	O

pt	NN	B-TEST	O
was	VBD	O	O
14.5	CD	O	O
,	,	O	O
ptt	RB	B-TEST	B-TEST
25.5	CD	O	O
.	.	O	O

as	IN	O	O
described	VBN	O	O
above	IN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
transfused	VBN	O	O
an	DT	B-TREATMENT	O
additional	JJ	I-TREATMENT	O
2	CD	I-TREATMENT	O
units	NNS	I-TREATMENT	O
in	IN	O	O
the	DT	O	O
intensive	JJ	O	O
care	NN	O	O
unit	NN	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
also	RB	O	O
received	VBD	O	O
an	DT	B-TEST	B-TEST
upper	JJ	I-TEST	I-TEST
endoscopy	NN	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
and	CC	O	O
her	PRP$	B-PROBLEM	B-PROBLEM
varices	NNS	I-PROBLEM	I-PROBLEM
were	VBD	O	O
banded	VBN	B-TREATMENT	O
.	.	O	O

on	IN	O	O
transfer	NN	O	O
to	TO	O	O
the	DT	O	O
lemgarson	JJ	O	O
hospital	NN	O	O
service	NN	O	O
,	,	O	O
her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
was	VBD	O	O
31.2	CD	O	O
,	,	O	O
white	JJ	B-TEST	B-TEST
count	NN	I-TEST	I-TEST
11.1	CD	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
platelet	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
80	CD	O	O
.	.	O	O

her	PRP$	B-TEST	O
pt	NN	I-TEST	O
was	VBD	O	O
13.1	CD	O	O
,	,	O	O
ptt	RB	B-TEST	B-TEST
26.7	CD	O	O
.	.	O	O

the	DT	O	O
rest	NN	O	O
of	IN	O	O
her	PRP$	B-TEST	B-TEST
labs	NNS	I-TEST	I-TEST
were	VBD	O	O
unremarkable	JJ	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
on	IN	O	O
gi	NNS	B-TREATMENT	B-TREATMENT
bleed	VBN	I-TREATMENT	I-TREATMENT
precautions	NNS	I-TREATMENT	I-TREATMENT
at	IN	O	O
all	DT	O	O
times	NNS	O	O
,	,	O	O
was	VBD	O	O
too	RB	O	O
large	JJ	O	O
for	IN	O	O
iv	NN	B-TREATMENT	O
.	.	O	O

she	PRP	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
clot	NN	I-PROBLEM	I-PROBLEM
at	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
blood	NN	O	I-PROBLEM
bank	NN	O	I-PROBLEM
and	CC	O	O
she	PRP	O	O
had	VBD	O	O
bid	VBN	B-TEST	O
hematocrits	NNS	I-TEST	O
checked	VBN	O	O
.	.	O	O

she	PRP	O	O
was	VBD	O	O
kept	JJ	O	O
npo	RB	B-TREATMENT	O
until	IN	O	O
january	JJ	O	O
26	CD	O	O
when	WRB	O	O
she	PRP	O	O
began	VBD	O	O
to	TO	O	O
feel	VB	O	O
hungry	JJ	O	O
.	.	O	O

at	IN	O	O
that	DT	O	O
time	NN	O	O
clear	JJ	B-TREATMENT	O
liquids	NNS	I-TREATMENT	O
were	VBD	O	O
started	VBN	O	O
.	.	O	O

she	PRP	O	O
also	RB	O	O
began	VBD	O	O
nadolol	JJ	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
qd	NN	O	O
to	TO	O	O
reduce	VB	O	O
her	PRP$	B-PROBLEM	O
portal	JJ	I-PROBLEM	O
hypertension	NN	I-PROBLEM	B-PROBLEM
.	.	O	O

therefore	IN	O	O
we	PRP	O	O
decided	VBD	O	O
to	TO	O	O
work	VB	B-TEST	O
up	RP	I-TEST	O
her	PRP$	O	B-PROBLEM
cirrhosis	NN	B-PROBLEM	I-PROBLEM
.	.	O	O

she	PRP	O	O
was	VBD	O	O
described	VBN	O	O
as	IN	O	O
having	VBG	O	O
_______	JJ	O	O
cirrhosis	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
we	PRP	O	O
decided	VBD	O	O
that	IN	O	O
we	PRP	O	O
wanted	VBD	O	O
to	TO	O	O
try	VB	O	O
to	TO	O	O
figure	VB	O	O
out	RP	O	O
the	DT	O	O
etiology	NN	O	O
.	.	O	O

her	PRP$	B-TEST	B-TEST
ferritin	NN	I-TEST	I-TEST
and	CC	O	O
iron	NN	B-TEST	B-TEST
studies	NNS	I-TEST	I-TEST
did	VBD	O	O
not	RB	O	O
reveal	VB	O	O
any	DT	O	O
evidence	NN	O	O
of	IN	O	O
hemochromatosis	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
her	PRP$	B-TEST	B-TEST
hep	NN	I-TEST	I-TEST
serologies	NNS	I-TEST	I-TEST
were	VBD	O	O
all	DT	O	O
negative	JJ	O	O
.	.	O	O

she	PRP	O	O
also	RB	O	O
had	VBD	O	O
negative	JJ	O	O
antimitochondrial	JJ	O	O
antibody	NN	O	O
and	CC	O	O
she	PRP	O	O
also	RB	O	O
had	VBD	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
ceruloplasmin	NN	B-PROBLEM	B-TREATMENT
.	.	O	O

over	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
her	PRP$	O	O
admission	NN	O	O
were	VBD	O	O
also	RB	O	O
sent	VBN	O	O
an	DT	B-TEST	B-TREATMENT
alpha-1-antitrypsin	NN	I-TEST	I-TREATMENT
,	,	O	O
which	WDT	O	O
was	VBD	O	O
negative	JJ	O	O
.	.	O	O

she	PRP	O	O
did	VBD	O	O
very	RB	O	O
well	RB	O	O
over	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
her	PRP$	O	O
admission	NN	O	O
with	IN	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
further	JJ	B-PROBLEM	B-PROBLEM
bleeding	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
stayed	VBD	O	O
stable	JJ	O	O
at	IN	O	O
approximately	RB	O	O
32	CD	O	O
.	.	O	O

we	PRP	O	O
also	RB	O	O
did	VBD	O	O
an	DT	B-TEST	B-TEST
ultrasound	NN	I-TEST	I-TEST
guided	VBD	I-TEST	O
paracentesis	NN	I-TEST	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
peritoneal	NN	I-TEST	I-TEST
fluid	NN	I-TEST	I-TEST
showed	VBD	O	I-TEST
a	DT	B-TEST	I-TEST
glucose	NN	I-TEST	I-TEST
of	IN	O	O
244	CD	O	O
,	,	O	O
total	JJ	B-TEST	B-TEST
protein	NN	I-TEST	I-TEST
0.8	CD	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
albumin	NN	I-TEST	I-TEST
of	IN	O	O
0.5	CD	O	O
,	,	O	O
globulin	NN	B-TEST	B-TEST
0.3	CD	O	O
,	,	O	O
amylase	NN	B-TEST	B-TEST
16	CD	O	O
,	,	O	O
ldh	NN	B-TEST	O
of	IN	O	O
51	CD	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
serum	NN	I-TEST	I-TEST
albumin	NN	I-TEST	I-TEST
gradient	NN	I-TEST	I-TEST
was	VBD	O	O
1.8	CD	O	O
consistent	JJ	O	O
with	IN	O	O
portal	JJ	B-PROBLEM	B-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
showed	VBD	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
160	CD	O	O
with	IN	O	O
16%	CD	B-TEST	O
polys	NNS	I-TEST	O
.	.	O	O

she	PRP	O	O
therefore	RB	O	O
_________	VBD	O	O
criteria	NNS	O	O
for	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
spontaneous	JJ	I-PROBLEM	I-PROBLEM
bacterial	JJ	I-PROBLEM	I-PROBLEM
peritonitis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

her	PRP$	B-TEST	B-TEST
platelet	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
stayed	VBD	O	O
persistently	RB	B-PROBLEM	B-PROBLEM
low	JJ	I-PROBLEM	I-PROBLEM
and	CC	O	O
we	PRP	O	O
decided	VBD	O	O
that	IN	O	O
it	PRP	O	O
might	MD	O	O
be	VB	O	O
due	JJ	O	O
to	TO	O	O
cimetidine	VB	B-TREATMENT	B-TREATMENT
.	.	O	O

therefore	RB	O	O
we	PRP	O	O
switched	VBD	O	O
her	PRP	O	O
cimetidine	NN	B-TREATMENT	B-TREATMENT
to	TO	O	O
prilosec	VB	B-TREATMENT	O
.	.	O	O

after	IN	O	O
discussion	NN	O	O
with	IN	O	O
her	PRP$	O	O
private	JJ	O	O
physician	NN	O	O
,	,	O	O
dr.	JJ	O	O
joasscchird	NN	O	O
,	,	O	O
tel.	JJ	O	O
090-249-6079	NN	O	O
,	,	O	O
at	IN	O	O
va	JJ	O	O
sit	NN	O	O
namar	NN	O	O
healthcare	NN	O	O
and	CC	O	O
dr.	NN	O	O
acrookesjo	NN	O	O
at	IN	O	O
do	NN	O	O
of	IN	O	O
hospital	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
judged	VBN	O	O
to	TO	O	O
be	VB	O	O
fit	JJ	O	O
for	IN	O	O
discharge	NN	O	O
and	CC	O	O
she	PRP	O	O
was	VBD	O	O
sent	VBN	O	O
home	NN	O	O
with	IN	O	O
ah	NN	B-TREATMENT	O
and	CC	O	O
physical	JJ	B-TREATMENT	B-TREATMENT
therapy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

she	PRP	O	O
may	MD	O	O
require	VB	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
upper	JJ	I-TEST	I-TEST
endoscopy	NN	I-TEST	I-TEST
study	NN	I-TEST	I-TEST
to	TO	O	O
see	VB	O	O
if	IN	O	O
she	PRP	O	O
needs	VBZ	O	O
any	DT	B-TREATMENT	O
rebanding	NN	I-TREATMENT	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
however	RB	O	O
complained	VBD	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
persistent	JJ	I-PROBLEM	I-PROBLEM
wheeze	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
beta	NN	B-TREATMENT	B-TREATMENT
blocker	NN	I-TREATMENT	I-TREATMENT
,	,	O	O
therefore	IN	O	O
it	PRP	O	O
was	VBD	O	O
agreed	VBN	O	O
that	IN	O	O
we	PRP	O	O
would	MD	O	O
stop	VB	O	O
the	DT	B-TREATMENT	O
beta	NN	I-TREATMENT	O
blocker	NN	I-TREATMENT	O
until	IN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
followed	VBN	O	O
up	RP	O	O
as	IN	O	O
an	DT	O	O
outpatient	NN	O	O
.	.	O	O

zoloft	RB	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NNS	O	O
po	JJ	O	O
qd	NN	O	O
,	,	O	O
lactulose	JJ	B-TREATMENT	B-TREATMENT
15	CD	O	O
g	JJ	O	O
po	NN	O	O
bid	NN	O	O
,	,	O	O
synthroid	JJ	B-TREATMENT	B-TREATMENT
0.15	CD	O	O
mg	NN	O	O
po	NN	O	O
qd	NN	O	O
,	,	O	O
prilosec	VBP	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	JJ	O	O
po	NN	O	O
bid	NN	O	O
.	.	O	O

fever	NN	B-PROBLEM	B-PROBLEM

1.	CD	O	O
neutropenia	NN	B-PROBLEM	B-PROBLEM

2.	CD	O	O
cellulitis	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

3.	CD	O	O
fever	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
60-year-old	JJ	O	O
male	NN	O	O
with	IN	O	O
a	DT	O	O
past	JJ	O	O
medical	JJ	O	O
history	NN	O	O
notable	JJ	O	O
for	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
cabg	NN	B-TREATMENT	B-TREATMENT
x2	NN	O	O
in	IN	O	O
2001	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
felt	VBN	O	O
unwell	JJ	B-PROBLEM	O
since	IN	O	O
7/21	CD	O	O
after	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
non-q	JJ	I-PROBLEM	I-PROBLEM
wave	NN	I-PROBLEM	I-PROBLEM
mi	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
,	,	O	O
at	IN	O	O
this	DT	O	O
time	NN	O	O
,	,	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
statin	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
developed	VBN	O	O
in	IN	O	O
arthritis	NN	B-PROBLEM	B-PROBLEM
approximately	RB	O	O
one	CD	O	O
month	NN	O	O
later	RB	O	O
with	IN	O	O
joint	JJ	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
myalgia	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
fatigue	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
presumed	VBN	O	O
to	TO	O	O
have	VB	O	O
a	DT	B-PROBLEM	B-PROBLEM
rheumatoid	JJ	I-PROBLEM	I-PROBLEM
factor	NN	I-PROBLEM	I-PROBLEM
negative	JJ	I-PROBLEM	O
,	,	I-PROBLEM	O
rheumatoid	JJ	I-PROBLEM	B-PROBLEM
arthritis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
prescribed	VBN	O	O
naprosyn	RB	B-TREATMENT	B-TREATMENT
,	,	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
sulfasalazine	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	O
cabg	NN	I-TEST	O
review	NN	I-TEST	O
in	IN	O	O
2/21	CD	O	O
.	.	O	O

his	PRP$	B-TREATMENT	O
first	JJ	I-TREATMENT	O
cabg	NN	I-TREATMENT	O
was	VBD	O	O
in	IN	O	O
02/89	CD	O	O
.	.	O	O

since	IN	O	O
2/21	CD	O	O
,	,	O	O
he	PRP	O	O
has	VBZ	O	O
had	VBD	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
weight	JJ	I-PROBLEM	I-PROBLEM
loss	NN	I-PROBLEM	I-PROBLEM
of	IN	O	I-PROBLEM
30-49	JJ	O	I-PROBLEM
pounds	NNS	O	I-PROBLEM
,	,	O	O
night	NN	B-PROBLEM	B-PROBLEM
sweats	NNS	I-PROBLEM	I-PROBLEM
which	WDT	O	O
he	PRP	O	O
attributed	VBD	O	O
to	TO	O	O
the	DT	B-TREATMENT	O
prednisone	NN	I-TREATMENT	B-TREATMENT
and	CC	O	O
increased	VBD	B-PROBLEM	B-PROBLEM
fatigue	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
myalgias	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

in	IN	O	O
late	JJ	O	O
7/22	CD	O	O
,	,	O	O
sulfasalazine	NN	B-TREATMENT	B-TREATMENT
was	VBD	O	O
started	VBN	O	O
at	IN	O	O
one	CD	O	O
tab	NN	O	O
three	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
subsequently	RB	O	O
developed	VBN	O	O
diffuse	IN	B-PROBLEM	B-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
nausea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
vomiting	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
and	CC	O	O
decreased	VBD	B-PROBLEM	B-PROBLEM
p.o.	NNS	I-PROBLEM	I-PROBLEM
intake	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

a	DT	B-PROBLEM	B-PROBLEM
guaiac	JJ	I-PROBLEM	I-PROBLEM
positive	JJ	I-PROBLEM	I-PROBLEM
stool	NN	I-PROBLEM	I-PROBLEM
was	VBD	O	O
also	RB	O	O
noted	VBN	O	O
in	IN	O	O
the	DT	O	O
month	NN	O	O
of	IN	O	O
july	NN	O	O
.	.	O	O

10	CD	O	O
days	NNS	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
primary	JJ	O	O
care	NN	O	O
physician	NN	O	O
increased	VBD	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
sulfasalazine	NN	I-TREATMENT	I-TREATMENT
dose	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
two	CD	O	O
tabs	NNS	O	O
three	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
.	.	O	O

the	DT	B-TREATMENT	O
patient	NN	I-TREATMENT	O
&apos;s	NNP	I-TREATMENT	O
prednisone	NN	I-TREATMENT	B-TREATMENT
was	VBD	O	O
increased	VBN	O	O
to	TO	O	O
60	CD	O	O
mg	NNS	O	O
q.d.	RB	O	O
as	IN	O	O
the	DT	O	O
patient	NN	O	O
was	VBD	O	O
diagnosed	VBN	O	O
with	IN	O	O
an	DT	B-PROBLEM	B-PROBLEM
arthritis	NN	I-PROBLEM	I-PROBLEM
flare	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
prednisone	NN	I-TREATMENT	I-TREATMENT
dose	NN	I-TREATMENT	I-TREATMENT
was	VBD	O	O
gradually	RB	O	O
tapered	VBN	O	O
to	TO	O	O
20	CD	O	O
mg	NNS	O	O
q.d.	NN	O	O

the	DT	O	O
day	NN	O	O
before	IN	O	O
admission	NN	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
developed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
fever	NN	I-PROBLEM	I-PROBLEM
to	TO	O	O
102	CD	O	O
degrees	NNS	O	O
and	CC	O	O
increasing	VBG	B-PROBLEM	B-PROBLEM
abdominal	JJ	I-PROBLEM	I-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
presented	VBD	O	O
to	TO	O	O
an	DT	O	O
outside	JJ	O	O
hops	NN	O	O
where	WRB	O	O
he	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
leukopenic	JJ	B-PROBLEM	O
with	IN	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
0.6	CD	O	O
,	,	O	O
0	CD	O	O
neutrophils	NNS	B-TEST	B-TEST
,	,	O	O
a	DT	B-TEST	B-TEST
hematocrit	NN	I-TEST	I-TEST
of	IN	O	O
32	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
of	IN	O	O
326	CD	O	O
,	,	O	O
a	DT	B-TEST	B-TEST
mcv	NN	I-TEST	I-TEST
of	IN	O	O
79	CD	O	O
,	,	O	O
and	CC	O	O
rdw	NN	B-TEST	O
of	IN	O	O
22	CD	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
given	VBN	O	O
iv	JJ	B-TREATMENT	B-TREATMENT
fluids	NNS	I-TREATMENT	I-TREATMENT
and	CC	O	O
treated	VBN	O	O
with	IN	O	O
imipenem	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
transferred	VBN	O	O
to	TO	O	O
ca	MD	O	O
valley	VB	O	O
hospital	NN	O	O
ed	NN	O	O
,	,	O	O
where	WRB	O	O
it	PRP	O	O
was	VBD	O	O
noted	VBN	O	O
that	IN	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
face	NN	B-PROBLEM	O
and	CC	I-PROBLEM	O
neck	NN	I-PROBLEM	B-PROBLEM
swelling	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
as	RB	O	O
well	RB	O	O
as	IN	O	O
erythema	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
cervical	JJ	B-PROBLEM	B-PROBLEM
lymphadenopathy	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
states	VBZ	O	O
that	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
swelling	NN	I-PROBLEM	I-PROBLEM
of	IN	I-PROBLEM	O
his	PRP$	I-PROBLEM	O
face	NN	I-PROBLEM	O
began	VBD	O	O
two	CD	O	O
days	NNS	O	O
prior	RB	O	O
to	TO	O	O
admission	NN	O	O
and	CC	O	O
has	VBZ	O	O
doubled	VBN	O	O
since	IN	O	O
then	RB	O	O
.	.	O	O

in	IN	O	O
the	DT	O	O
emergency	NN	O	O
department	NN	O	O
,	,	O	O
ct	NN	B-TEST	B-TEST
of	IN	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
,	,	I-TEST	O
neck	NN	I-TEST	O
and	CC	I-TEST	O
abdomen	NNS	I-TEST	O
were	VBD	O	O
performed	VBN	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
the	DT	I-TEST	I-TEST
abdomen	NNS	I-TEST	I-TEST
was	VBD	O	O
without	IN	O	O
lymphadenopathy	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
revealed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
renal	JJ	I-PROBLEM	I-PROBLEM
cyst	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
otherwise	RB	O	O
unremarkable	JJ	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
ct	NN	I-TEST	I-TEST
of	IN	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
and	CC	I-TEST	I-TEST
neck	NN	I-TEST	I-TEST
was	VBD	O	O
likewise	RB	O	O
unremarkable	JJ	O	O
showing	VBG	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
fasciitis	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
deep	JJ	B-PROBLEM	B-PROBLEM
tissue	NN	I-PROBLEM	I-PROBLEM
thread	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
abscesses	NNS	B-PROBLEM	B-PROBLEM
were	VBD	O	O
noted	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
denies	VBZ	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
chest	NN	B-PROBLEM	B-PROBLEM
pain	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
orthopnea	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
dysuria	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
hematuria	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
visual	JJ	B-PROBLEM	B-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
rashes	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
blurry	NN	B-PROBLEM	B-PROBLEM
vision	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
mi	NN	B-PROBLEM	O
x2	NNP	O	O
,	,	O	O
cabg	NN	B-TREATMENT	B-TREATMENT
x2	NN	O	O
in	IN	O	O
02/89	CD	O	O
and	CC	O	O
2/21	CD	O	O
,	,	O	O
history	NN	O	O
of	IN	O	O
arthritis	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
history	NN	O	O
of	IN	O	O
bilateral	JJ	B-PROBLEM	B-PROBLEM
rotator	NN	I-PROBLEM	I-PROBLEM
cuff	NN	I-PROBLEM	I-PROBLEM
degeneration	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
tears	NNS	B-PROBLEM	I-PROBLEM
,	,	O	O
history	NN	O	O
of	IN	O	O
hypertension	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
history	NN	O	O
of	IN	O	O
hyperlipidemia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

sulfasalazine	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg	NN	O	O
q.d.	NN	O	O
,	,	O	O
naprosyn	RB	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg	NN	O	O
t.i.d.	NN	O	O
,	,	O	O
zestril	VBZ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
q.d.	NN	O	O
,	,	O	O
lopressor	VBZ	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg	NN	O	O
b.i.d.	NN	O	O
and	CC	O	O
iron	NN	B-TREATMENT	B-TREATMENT
supplementation	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

positive	JJ	O	O
for	IN	O	O
coronary	JJ	B-PROBLEM	B-PROBLEM
artery	NN	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
mi	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

no	DT	O	O
history	NN	O	O
of	IN	O	O
cancer	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
&apos;s	JJ	I-TEST	I-TEST
temperature	NN	I-TEST	I-TEST
was	VBD	O	O
102	CD	O	O
,	,	O	O
heart	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
118	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
pressure	NN	I-TEST	I-TEST
111/56	CD	O	O
,	,	O	O
respiratory	NN	B-TEST	B-TEST
rate	NN	I-TEST	I-TEST
28	CD	O	O
,	,	O	O
satting	VBG	B-TEST	B-TEST
92%	CD	O	O
on	IN	O	O
room	NN	O	O
air	NN	O	O
.	.	O	O

pupils	NNS	O	O
equal	JJ	O	O
,	,	O	O
round	NN	O	O
,	,	O	O
and	CC	O	O
reactive	JJ	O	O
to	TO	O	O
light	JJ	O	O
,	,	O	O
extraocular	JJ	O	O
movements	NNS	O	O
,	,	O	O
fundi	VBP	O	O
bilaterally	RB	O	O
without	IN	O	O
exudate	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
hemorrhage	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

on	IN	O	O
the	DT	O	O
left	JJ	O	O
nasolabial	JJ	O	O
,	,	O	O
there	EX	O	O
was	VBD	O	O
a	DT	B-PROBLEM	O
boil	NN	I-PROBLEM	O
with	IN	O	O
pus	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
surrounding	VBG	B-PROBLEM	B-PROBLEM
erythema	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
tenderness	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

left	VBN	O	O
eye	NN	O	O
with	IN	O	O
conjunctivae	NN	B-PROBLEM	B-PROBLEM
injected	VBN	I-PROBLEM	O
,	,	O	O
no	DT	O	O
exudate	NN	B-PROBLEM	B-PROBLEM
or	CC	O	O
pus	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

dentition	NN	B-PROBLEM	B-PROBLEM
very	RB	I-PROBLEM	I-PROBLEM
poor	JJ	I-PROBLEM	I-PROBLEM
,	,	O	I-PROBLEM
large	JJ	B-PROBLEM	I-PROBLEM
bilateral	JJ	I-PROBLEM	I-PROBLEM
neck	NN	I-PROBLEM	I-PROBLEM
and	CC	I-PROBLEM	O
submandibular	JJ	I-PROBLEM	B-PROBLEM
swelling	VBG	I-PROBLEM	I-PROBLEM
very	RB	B-PROBLEM	I-PROBLEM
tender	NN	I-PROBLEM	I-PROBLEM
to	TO	O	I-PROBLEM
palpation	NN	B-TEST	I-PROBLEM
.	.	O	O

scattered	VBN	B-PROBLEM	B-PROBLEM
bibasilar	JJ	I-PROBLEM	I-PROBLEM
rales	NNS	I-PROBLEM	I-PROBLEM
,	,	O	O
no	DT	O	O
wheezes	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

regular	JJ	O	O
rhythm	NN	O	O
,	,	O	O
tachycardia	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
murmurs	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
no	DT	O	O
jvd	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

obese	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
non-distended	JJ	B-PROBLEM	B-PROBLEM
,	,	O	O
positive	JJ	O	O
bowel	NN	O	O
sounds	NNS	O	O
,	,	O	O
mild	JJ	B-PROBLEM	B-PROBLEM
diffuse	NN	I-PROBLEM	I-PROBLEM
tenderness	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
edema	NN	B-PROBLEM	B-PROBLEM
,	,	O	O
positive	JJ	O	O
dorsalis	NN	O	B-TEST
pedis	NN	O	I-TEST
pulses	NNS	O	I-TEST
.	.	O	O

non-focal	JJ	O	O
,	,	O	O
alert	JJ	O	O
and	CC	O	O
oriented	JJ	O	O
x3	NN	O	O
,	,	O	O
5/5	CD	O	O
motor	NN	O	O
strength	NN	O	O
in	IN	O	O
the	DT	O	O
upper	JJ	O	O
extremities	NNS	O	O
and	CC	O	O
lower	JJR	O	O
extremities	NNS	O	O
,	,	O	O
babinski	NN	B-TEST	B-TEST
reflex	NN	I-TEST	I-TEST
,	,	O	O
toes	NNS	O	O
are	VBP	O	O
downgoing	VBG	O	O
.	.	O	O

remarkable	NN	O	O
for	IN	O	O
a	DT	B-TEST	B-TEST
white	JJ	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
of	IN	O	O
0.4	CD	O	O
,	,	O	O
with	IN	O	O
0	CD	O	O
neutrophils	NNS	B-TEST	B-TEST
,	,	O	O
0	CD	O	O
bands	NNS	B-TEST	B-TEST
,	,	O	O
19	CD	O	O
lymphs	NN	B-TEST	B-TEST
,	,	O	O
0	CD	O	O
monos	NNS	B-TEST	B-TEST
,	,	O	O
hematocrit	NN	B-TEST	B-TEST
28.8%	CD	O	O
,	,	O	O
platelets	NNS	B-TEST	B-TEST
300,000	CD	O	O
.	.	O	O

alt	RB	B-TEST	O
141	CD	O	O
,	,	O	O
ast	RB	B-TEST	B-TEST
40	CD	O	O
,	,	O	O
alk	VBP	B-TEST	O
phos	JJ	I-TEST	B-TEST
108	CD	O	O
,	,	O	O
and	CC	O	O
a	DT	B-TEST	B-TEST
total	JJ	I-TEST	I-TEST
bili	NN	I-TEST	I-TEST
of	IN	O	O
1.0.	CD	O	O
total	JJ	B-TEST	B-TEST
protein	NN	I-TEST	I-TEST
was	VBD	O	O
5.7	CD	O	O
,	,	O	O
albumin	RB	B-TEST	B-TEST
2.5	CD	O	O
and	CC	O	O
globulin	$	B-TEST	B-TREATMENT
3.2	CD	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
electrolyte	JJ	I-TEST	I-TEST
panel	NN	I-TEST	I-TEST
of	IN	O	I-TEST
sodium	NN	B-TEST	I-TEST
135	CD	O	O
,	,	O	O
sodium	NN	B-TEST	B-TEST
4.1	CD	O	O
,	,	O	O
chloride	RB	B-TEST	B-TEST
99	CD	O	O
,	,	O	O
bicarb	NN	B-TEST	B-TEST
30	CD	O	O
,	,	O	O
bun	NN	B-TEST	B-TEST
15	CD	O	O
,	,	O	O
creatinine	NN	B-TEST	B-TEST
2.1	CD	O	O
,	,	O	O
blood	NN	B-TEST	B-TEST
glucose	NN	I-TEST	I-TEST
of	IN	O	O
196	CD	O	O
.	.	O	O

iron	NN	B-TEST	B-TEST
studies	NNS	I-TEST	I-TEST
included	VBD	O	O
a	DT	B-TEST	B-TEST
ferritin	NN	I-TEST	I-TEST
of	IN	O	O
607	CD	O	O
,	,	O	O
an	DT	B-TEST	O
iron	NN	I-TEST	O
of	IN	O	O
10	CD	O	O
,	,	O	O
and	CC	O	O
a	DT	B-TEST	O
tibc	NN	I-TEST	O
of	IN	O	O
239	CD	O	O
.	.	O	O

ekg	NN	B-TEST	O
showed	VBD	O	O
tachycardia	NN	B-PROBLEM	B-PROBLEM
with	IN	O	O
a	DT	O	B-TEST
sinus	NN	O	I-TEST
rhythm	NN	O	I-TEST
of	IN	O	O
103	CD	O	O
,	,	O	O
normal	JJ	O	O
axis	NN	O	O
,	,	O	O
normal	JJ	O	O
intervals	NNS	O	O
,	,	O	O
no	DT	O	O
q-waves	NNS	B-PROBLEM	O
,	,	O	O
no	DT	O	O
st-t	JJ	B-PROBLEM	B-PROBLEM
wave	NN	I-PROBLEM	I-PROBLEM
changes	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
&apos;s	JJ	I-TEST	I-TEST
chest	JJS	I-TEST	I-TEST
x-ray	NN	I-TEST	I-TEST
at	IN	O	O
the	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
was	VBD	O	O
unremarkable	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
started	VBN	O	O
on	IN	O	O
ceftazidime	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
nafcillin	NN	B-TREATMENT	O
and	CC	O	O
flagyl	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
concern	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
soft	JJ	I-PROBLEM	I-PROBLEM
tissue	NN	I-PROBLEM	I-PROBLEM
infection	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

neutropenic	JJ	B-TREATMENT	B-PROBLEM
precautions	NNS	I-TREATMENT	I-PROBLEM
were	VBD	O	O
taken	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
bone	NN	I-TEST	I-TEST
marrow	NN	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
which	WDT	O	O
showed	VBD	O	O
myeloid	JJ	B-PROBLEM	B-PROBLEM
arrest	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
probable	JJ	O	O
neutropenia	NN	B-PROBLEM	B-PROBLEM
from	IN	O	O
a	DT	O	O
drug-related	JJ	O	O
cause	NN	O	O
presumed	VBD	O	O
to	TO	O	O
be	VB	O	O
the	DT	B-TREATMENT	B-PROBLEM
sulfasalazine	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

over	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
the	DT	O	O
hospitalization	NN	O	O
,	,	O	O
the	DT	B-TEST	O
patient	NN	I-TEST	O
&apos;s	NNP	I-TEST	O
white	JJ	I-TEST	B-TEST
blood	NN	I-TEST	I-TEST
cell	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
rose	VBD	O	O
from	IN	O	O
0.4	CD	O	O
to	TO	O	O
6.3	CD	O	O
after	IN	O	O
he	PRP	O	O
was	VBD	O	O
given	VBN	O	O
g-csf	JJ	B-TREATMENT	O
,	,	O	O
a	DT	O	O
course	NN	O	O
lasting	VBG	O	O
from	IN	O	O
9/28/01	CD	O	O
until	IN	O	O
9/30/01	CD	O	O
.	.	O	O

after	IN	O	O
the	DT	B-TREATMENT	O
g-csf	NN	I-TREATMENT	O
,	,	O	O
the	DT	B-TEST	B-TEST
absolute	NN	I-TEST	I-TEST
neutrophil	NN	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
was	VBD	O	O
greater	JJR	O	O
than	IN	O	O
8000	CD	O	O
.	.	O	O

on	IN	O	O
10/3/01	CD	O	O
,	,	O	O
the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
head	NN	I-TEST	I-TEST
and	CC	I-TEST	I-TEST
neck	NN	I-TEST	I-TEST
ct	NN	I-TEST	I-TEST
,	,	O	O
which	WDT	O	O
showed	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
parotitis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
left	VBD	B-PROBLEM	I-PROBLEM
submandibular	JJ	I-PROBLEM	I-PROBLEM
lymphadenopathy	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
some	DT	B-PROBLEM	B-PROBLEM
necrosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

no	DT	O	O
frank	JJ	B-PROBLEM	B-PROBLEM
abscesses	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TREATMENT	B-TREATMENT
patient	NN	I-TREATMENT	I-TREATMENT
&apos;s	NN	I-TREATMENT	I-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
changed	VBN	O	O
to	TO	O	O
clindamycin	VB	B-TREATMENT	B-TREATMENT
300	CD	O	O
mg	NN	O	O
q.i.d.	NN	O	O
and	CC	O	O
patient	NN	O	O
was	VBD	O	O
also	RB	O	O
put	VBN	O	O
on	IN	O	O
sialagogue	NN	B-TREATMENT	O
.	.	O	O

over	IN	O	O
the	DT	O	O
course	NN	O	O
of	IN	O	O
the	DT	O	O
hospitalization	NN	O	O
,	,	O	O
the	DT	B-PROBLEM	B-PROBLEM
swelling	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
tenderness	NN	B-PROBLEM	B-PROBLEM
and	CC	O	O
erythema	NN	B-PROBLEM	B-PROBLEM
have	VBP	O	O
steadily	RB	O	B-PROBLEM
decreased	VBN	O	I-PROBLEM
.	.	O	O

recommendations	NNS	O	O
on	IN	O	O
antibiotics	NNS	B-TREATMENT	B-TREATMENT
were	VBD	O	O
made	VBN	O	O
by	IN	O	O
infectious	JJ	O	O
disease	NN	O	O
team	NN	O	O
,	,	O	O
who	WP	O	O
was	VBD	O	O
consulted	VBN	O	O
.	.	O	O

rheumatology	NN	O	O
was	VBD	O	O
also	RB	O	O
consulted	VBN	O	O
for	IN	O	O
patient	NN	O	O
and	CC	O	O
after	IN	O	O
workup	NN	B-TEST	B-TEST
,	,	O	O
it	PRP	O	O
was	VBD	O	O
believed	VBN	O	O
that	IN	O	O
arthritis	NN	B-PROBLEM	B-PROBLEM
may	MD	O	O
be	VB	O	O
a	DT	O	B-PROBLEM
rheumatoid	JJ	B-PROBLEM	I-PROBLEM
factor	NN	I-PROBLEM	I-PROBLEM
negative	JJ	I-PROBLEM	O
,	,	I-PROBLEM	O
rheumatoid	JJ	I-PROBLEM	B-PROBLEM
polyarthritis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

rheumatology	NN	O	O
recommended	VBD	O	O
a	DT	B-TREATMENT	O
taper	NN	I-TREATMENT	O
of	IN	I-TREATMENT	O
his	PRP$	I-TREATMENT	B-TREATMENT
prednisone	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
20	CD	O	O
mg	NNS	O	O
q.d.	RB	O	O
and	CC	O	O
the	DT	O	O
patient	NN	O	O
will	MD	O	O
be	VB	O	O
followed	VBN	O	O
by	IN	O	O
the	DT	O	O
rheumatology	NN	O	O
service	NN	O	O
.	.	O	O

the	DT	O	O
oncology	NN	O	O
service	NN	O	O
was	VBD	O	O
also	RB	O	O
consulted	VBN	O	O
for	IN	O	O
patient	NN	O	O
and	CC	O	O
performed	VBD	O	O
a	DT	B-TEST	B-TEST
bone	NN	I-TEST	I-TEST
marrow	NN	I-TEST	I-TEST
biopsy	NN	I-TEST	I-TEST
.	.	O	O

the	DT	O	O
ent	JJ	O	O
physicians	NNS	O	O
did	VBD	O	O
not	RB	O	O
recommend	VB	O	O
any	DT	B-TREATMENT	O
procedures	NNS	I-TREATMENT	O
,	,	O	O
incision	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
drainage	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
parotitis	NN	I-PROBLEM	I-PROBLEM
or	CC	O	O
left	VBD	B-PROBLEM	B-PROBLEM
submandibular	JJ	I-PROBLEM	I-PROBLEM
cervical	JJ	I-PROBLEM	I-PROBLEM
lymph	NN	I-PROBLEM	I-PROBLEM
node	JJ	I-PROBLEM	I-PROBLEM
necrosis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
ent	NN	O	O
team	NN	O	O
recommended	VBD	O	O
watching	VBG	O	O
patient	JJ	O	O
in-house	NN	O	O
for	IN	O	O
two	CD	O	O
days	NNS	O	O
after	IN	O	O
his	PRP$	B-TEST	B-TEST
repeat	NN	I-TEST	I-TEST
imaging	VBG	I-TEST	I-TEST
on	IN	O	O
10/3/01	CD	O	O
,	,	O	O
and	CC	O	O
to	TO	O	O
continue	VB	O	O
antibiotic	JJ	B-TREATMENT	B-TREATMENT
coverage	NN	I-TREATMENT	I-TREATMENT
with	IN	O	O
clindamycin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
no	DT	O	O
positive	JJ	B-PROBLEM	B-PROBLEM
blood	NN	I-PROBLEM	I-PROBLEM
cultures	NNS	I-PROBLEM	I-PROBLEM
during	IN	O	O
his	PRP$	O	O
hospitalization	NN	O	O
and	CC	O	O
remained	VBD	O	O
afebrile	RB	B-PROBLEM	B-PROBLEM
after	IN	O	O
the	DT	O	O
second	JJ	O	O
day	NN	O	O
of	IN	O	O
admission	NN	O	O
.	.	O	O

topical	JJ	B-TREATMENT	O
bactroban	NN	I-TREATMENT	O
to	TO	O	O
be	VB	O	O
applied	VBN	O	O
three	CD	O	O
times	NNS	O	O
a	DT	O	O
day	NN	O	O
to	TO	O	O
affected	VBN	O	O
naris	NN	O	O
,	,	O	O
prednisone	NN	B-TREATMENT	B-TREATMENT
5	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.a.m.	NN	O	O
,	,	O	O
k-dur	JJ	B-TREATMENT	B-TREATMENT
10	CD	O	O
meq	NN	O	O
x2	NNP	O	O
p.o.	NN	O	O
q.d.	NN	O	O
,	,	O	O
oxycontin	RB	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
q.12h.	NN	O	O
,	,	O	O
clindamycin	VBP	B-TREATMENT	B-TREATMENT
300	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.i.d.	NN	O	O
,	,	O	O
lisinopril	VBZ	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d.	NN	O	O
,	,	O	O
atenolol	RB	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg	NNS	O	O
p.o.	JJ	O	O
q.d.	NN	O	O
,	,	O	O
trazodone	NN	B-TREATMENT	B-TREATMENT
100	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.h.s.	NN	O	O
,	,	O	O
prilosec	VBP	B-TREATMENT	B-TREATMENT
40	CD	O	O
mg	NN	O	O
p.o.	NN	O	O
q.d	NN	O	O
,	,	O	O
clotrimazole	JJ	B-TREATMENT	B-TREATMENT
1%	CD	I-TREATMENT	I-TREATMENT
cream	NN	I-TREATMENT	I-TREATMENT
topical	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
be	VB	O	O
applied	VBN	O	O
b.i.d.	NN	O	O

there	EX	O	O
were	VBD	O	O
no	DT	O	O
complications	NNS	B-PROBLEM	B-PROBLEM
during	IN	O	O
the	DT	O	O
patient	JJ	O	O
&apos;s	NNP	O	O
hospitalization	NN	O	O
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
discharged	VBN	O	O
in	IN	O	O
stable	JJ	O	O
condition	NN	O	O
.	.	O	O

gastric	JJ	B-PROBLEM	B-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
gastric	JJ	B-PROBLEM	I-PROBLEM
pericardial	JJ	I-PROBLEM	I-PROBLEM
fistula	NN	I-PROBLEM	I-PROBLEM
,	,	O	O

gastric	JJ	B-PROBLEM	B-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
gastric	JJ	B-PROBLEM	I-PROBLEM
pericardial	JJ	I-PROBLEM	I-PROBLEM
fistula	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
constricting	VBG	B-PROBLEM	B-PROBLEM
pericarditis	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
adult	NN	B-PROBLEM	B-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
status	NN	O	O
post	NN	O	O
gunshot	NN	B-PROBLEM	B-PROBLEM
wounds	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
paraplegia	NN	B-PROBLEM	B-PROBLEM
since	IN	O	O
1991	CD	O	O
of	IN	O	O
t4	NN	O	O
on	IN	O	O
down	RP	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	B-TREATMENT	O
greenfield	NN	I-TREATMENT	O
filter	NN	I-TREATMENT	O
in	IN	O	O
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
multiple	JJ	B-PROBLEM	O
decubiti	NN	I-PROBLEM	O
on	IN	I-PROBLEM	O
his	PRP$	I-PROBLEM	B-TEST
buttocks	NNS	I-PROBLEM	I-TEST
and	CC	I-PROBLEM	O
penis	NN	I-PROBLEM	O
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-PROBLEM
gastric	JJ	I-TREATMENT	I-PROBLEM
pull	NN	I-TREATMENT	I-PROBLEM
up	RB	I-TREATMENT	I-PROBLEM
in	IN	O	I-PROBLEM
1992	CD	O	I-PROBLEM
of	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
stomach	NN	O	I-PROBLEM
into	IN	O	I-PROBLEM
the	DT	O	I-PROBLEM
left	JJ	O	I-PROBLEM
thorax	NN	O	I-PROBLEM
and	CC	O	O
he	PRP	O	O
has	VBZ	O	O
a	DT	B-TREATMENT	B-TREATMENT
transverse	JJ	I-TREATMENT	I-TREATMENT
colostomy	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
a	DT	B-PROBLEM	B-PROBLEM
sinus	NN	I-PROBLEM	I-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	I-PROBLEM
the	DT	I-PROBLEM	I-PROBLEM
abdomen	NNS	I-PROBLEM	I-PROBLEM
.	.	O	O

bactrim	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
vancomycin	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

albuterol	NN	B-TREATMENT	B-TREATMENT
inhaler	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

amphotericin	NN	B-TREATMENT	B-TREATMENT
b	NN	I-TREATMENT	O
40	CD	O	O
mg.	NN	O	O
qday	NN	O	O
.	.	O	O

ceftazidime	NN	B-TREATMENT	B-TREATMENT
1	CD	O	O
gram	NN	O	O
intravenous	JJ	O	O
q	RB	O	O
8	CD	O	O
.	.	O	O

ciprofloxacin	NN	B-TREATMENT	B-TREATMENT
500	CD	O	O
mg.	NN	O	O
po.	NN	O	O
q12	NN	O	O
.	.	O	O

cisapride	RB	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg.	NNS	O	O
po.	JJ	O	O
qid	NN	O	O
.	.	O	O

dakin	JJ	B-TREATMENT	B-TEST
&apos;s	NNP	I-TREATMENT	I-TEST
solution	NN	I-TREATMENT	I-TEST
1/4	CD	O	O
strength	NN	O	O
to	TO	O	O
ulcer	NN	O	B-PROBLEM
of	IN	O	I-PROBLEM
penis	NN	O	I-PROBLEM
.	.	O	O

benadryl	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg.	NN	O	O
intravenous	JJ	O	O
tid	NN	O	O
prn	NN	O	O
.	.	O	O

______________	NN	O	B-TEST
capsule	NN	B-TREATMENT	I-TEST
1	CD	O	O
po.	NN	O	O
tid	NN	O	O
.	.	O	O

lasix	NN	B-TREATMENT	B-TREATMENT
prn	NN	O	O
.	.	O	O

nystatin	JJ	B-TREATMENT	B-TREATMENT
swish	JJ	I-TREATMENT	I-TREATMENT
and	CC	I-TREATMENT	I-TREATMENT
swallow	JJ	I-TREATMENT	I-TREATMENT
tid	NN	O	I-TREATMENT
.	.	O	O

percocet	NN	B-TREATMENT	B-TREATMENT
po.	NN	O	I-TREATMENT
q4	NN	O	O
to	TO	O	O
6	CD	O	O
prn	NN	O	O
.	.	O	O

trazodone	NN	B-TREATMENT	B-TREATMENT
50	CD	O	O
mg.	NN	O	O
qhs.	NN	O	O
multivitamins	VBZ	B-TREATMENT	B-TREATMENT
1	CD	O	O
po.	NN	O	O
qd	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
a	DT	O	O
25	CD	O	O
year	NN	O	O
old	JJ	O	O
who	WP	O	O
has	VBZ	O	O
a	DT	O	O
history	NN	O	O
of	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
gunshot	JJ	I-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
many	JJ	O	O
years	NNS	O	O
ago	RB	O	O
and	CC	O	O
has	VBZ	O	O
had	VBN	O	O
multiple	JJ	B-TREATMENT	B-TREATMENT
surgical	JJ	I-TREATMENT	I-TREATMENT
procedures	NNS	I-TREATMENT	I-TREATMENT
since	IN	O	O
then	RB	O	O
.	.	O	O

most	RBS	O	O
recently	RB	O	O
he	PRP	O	O
was	VBD	O	O
admitted	VBN	O	O
to	TO	O	O
an	DT	O	O
outside	JJ	O	O
hospital	NN	O	O
with	IN	O	O
a	DT	B-PROBLEM	B-PROBLEM
drug	NN	I-PROBLEM	I-PROBLEM
overdose	NN	I-PROBLEM	I-PROBLEM
in	IN	O	I-PROBLEM
adult	NN	B-PROBLEM	I-PROBLEM
respiratory	NN	I-PROBLEM	I-PROBLEM
distress	NN	I-PROBLEM	I-PROBLEM
syndrome	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
ultimately	RB	O	O
found	VBN	O	O
to	TO	O	O
have	VB	O	O
candidal	NNS	B-PROBLEM	B-PROBLEM
pericarditis	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
eventually	RB	O	O
led	VBD	O	O
to	TO	O	O
constrictive	VB	B-PROBLEM	B-PROBLEM
pericarditis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-PROBLEM
pericardial	JJ	I-TREATMENT	I-PROBLEM
window	NN	I-TREATMENT	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
barium	NN	I-TEST	I-TEST
swallow	NN	I-TEST	I-TEST
and	CC	O	O
endoscopy	NN	B-TEST	B-TEST
and	CC	O	O
was	VBD	O	O
said	VBD	O	O
not	RB	O	O
to	TO	O	O
have	VB	O	O
gastric	JJ	B-PROBLEM	B-PROBLEM
or	CC	I-PROBLEM	I-PROBLEM
pericardial	JJ	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
previous	JJ	B-TREATMENT	B-PROBLEM
substernal	JJ	I-TREATMENT	I-PROBLEM
gastric	JJ	I-TREATMENT	I-PROBLEM
bypass	NN	I-TREATMENT	I-PROBLEM
because	IN	O	O
of	IN	O	O
an	DT	B-PROBLEM	O
interruption	NN	I-PROBLEM	O
of	IN	I-PROBLEM	O
his	PRP$	I-PROBLEM	B-PROBLEM
esophagus	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
gunshot	NN	I-PROBLEM	I-PROBLEM
wound	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

he	PRP	O	O
had	VBD	O	O
been	VBN	O	O
noted	VBN	O	O
to	TO	O	O
have	VB	O	O
an	DT	B-PROBLEM	B-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
ultimately	RB	O	O
when	WRB	O	O
he	PRP	O	O
stabilized	VBD	O	O
it	PRP	O	O
was	VBD	O	O
our	PRP$	O	O
feeling	NN	O	O
that	IN	O	O
he	PRP	O	O
most	RBS	O	O
likely	JJ	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
gastric	JJ	I-PROBLEM	I-PROBLEM
pericardial	JJ	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
he	PRP	O	O
was	VBD	O	O
transferred	VBN	O	O
here	RB	O	O
for	IN	O	O
further	JJ	B-TREATMENT	B-TREATMENT
management	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

it	PRP	O	O
was	VBD	O	O
a	DT	O	B-PROBLEM
very	RB	O	I-PROBLEM
high	JJ	O	I-PROBLEM
risk	NN	O	I-PROBLEM
in	IN	O	I-PROBLEM
very	RB	B-PROBLEM	I-PROBLEM
poor	JJ	I-PROBLEM	I-PROBLEM
condition	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
a	DT	O	B-PROBLEM
cachectic	JJ	O	I-PROBLEM
malnourished	VBN	O	I-PROBLEM
edematous	JJ	O	I-PROBLEM
individuals	NNS	O	I-PROBLEM
who	WP	O	O
have	VBP	O	O
very	RB	B-PROBLEM	B-PROBLEM
high	JJ	I-PROBLEM	I-PROBLEM
venous	JJ	I-PROBLEM	I-PROBLEM
pressures	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
shortness	NN	B-PROBLEM	B-PROBLEM
of	IN	I-PROBLEM	I-PROBLEM
breath	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
family	NN	O	O
understood	VBD	O	O
that	IN	O	O
this	DT	O	O
was	VBD	O	O
a	DT	B-TREATMENT	B-TREATMENT
life	NN	I-TREATMENT	I-TREATMENT
saving	VBG	I-TREATMENT	I-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
only	RB	O	O
carried	VBD	O	O
with	IN	O	O
it	PRP	O	O
approximately	RB	O	O
50%	CD	O	O
chance	NN	O	O
of	IN	O	O
success	NN	O	B-PROBLEM
.	.	O	O

esophagoscopy	NN	B-TEST	B-TEST
,	,	O	I-TEST
bronchoscopy	NN	B-TEST	I-TEST
,	,	O	O
pericardectomy	NN	B-TREATMENT	B-TREATMENT
,	,	O	O
excision	NN	B-TREATMENT	B-PROBLEM
of	IN	O	I-PROBLEM
gastric	JJ	B-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
repair	NN	B-TREATMENT	B-TREATMENT
of	IN	O	O
gastric	JJ	B-PROBLEM	B-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
pectoralis	NN	B-TREATMENT	B-PROBLEM
major	JJ	I-TREATMENT	I-PROBLEM
myocutaneous	JJ	I-TREATMENT	I-PROBLEM
flap	NN	I-TREATMENT	I-PROBLEM
performed	VBN	O	O
on	IN	O	O
december	NN	O	O
4	CD	O	O
,	,	O	O
1995	CD	O	O
by	IN	O	O
dr.	NN	O	O
reg	NN	O	O
cranka	NN	O	O
and	CC	O	O
dr.	NN	O	O
win	VBP	O	O
shufffyfe	NN	O	O
.	.	O	O

in	IN	O	O
lieu	NN	O	O
of	IN	O	O
a	DT	O	O
standard	JJ	O	O
discharge	NN	O	O
summary	JJ	O	O
given	VBN	O	O
this	DT	O	O
patient	NN	O	O
&apos;s	NN	O	O
complicated	VBD	O	O
hospital	JJ	O	O
course	NN	O	O
and	CC	O	O
associated	JJ	B-PROBLEM	B-PROBLEM
illnesses	NNS	I-PROBLEM	I-PROBLEM
i	VBP	O	O
feel	VBP	O	O
it	PRP	O	O
best	JJS	O	O
to	TO	O	O
just	RB	O	O
provide	VB	O	O
a	DT	O	O
system	NN	O	O
summary	JJ	O	O
concerning	VBG	O	O
this	DT	O	O
patient	NN	O	O
&apos;s	NNP	O	O
current	JJ	O	O
status	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
on	IN	O	O
nortriptyline	NN	B-TREATMENT	B-TREATMENT
for	IN	O	O
depression	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
is	VBZ	O	O
a	DT	B-PROBLEM	O
paraplegic	NN	I-PROBLEM	O
from	IN	I-PROBLEM	O
t4	JJ	I-PROBLEM	O
down	RP	I-PROBLEM	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
however	RB	O	O
spends	VBZ	O	O
most	JJS	O	O
of	IN	O	O
his	PRP$	O	O
time	NN	O	O
at	IN	O	O
bedrest	JJS	O	O
due	JJ	O	O
to	TO	O	O
decubiti	VB	B-PROBLEM	B-PROBLEM
ulcer	JJ	I-PROBLEM	I-PROBLEM
disease	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
constrictive	JJ	B-PROBLEM	B-PROBLEM
pericarditis	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
was	VBD	O	O
relieved	VBN	O	O
by	IN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
surgical	JJ	I-TREATMENT	I-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

he	PRP	O	O
had	VBD	O	O
a	DT	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
catheterization	NN	I-TEST	I-TEST
on	IN	O	O
december	NN	O	O
1	CD	O	O
,	,	O	O
1995	CD	O	O
that	WDT	O	O
showed	VBD	O	O
no	DT	O	O
complications	NNS	B-PROBLEM	B-PROBLEM
,	,	O	O
elevated	VBD	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
pressure	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
moderate	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
hypertension	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
output	NN	I-TEST	I-TEST
was	VBD	O	O
five	CD	O	O
liters	NNS	O	O
per	IN	O	O
minute	NN	O	O
with	IN	O	O
an	DT	B-TEST	B-TEST
index	NN	I-TEST	I-TEST
at	IN	O	O
2.9	CD	O	O
liters	NNS	O	O
per	IN	O	O
minute	NN	O	O
per	IN	O	O
meter	NN	O	O
2	CD	O	O
which	WDT	O	O
is	VBZ	O	O
normal	JJ	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
underwent	JJ	O	O
cardiac	JJ	B-TEST	B-TEST
ultrasound	NN	I-TEST	I-TEST
on	IN	O	O
december	NN	O	O
11	CD	O	O
,	,	O	O
1995	CD	O	O
that	WDT	O	O
showed	VBD	O	O
abnormal	JJ	B-PROBLEM	B-PROBLEM
right	JJ	I-PROBLEM	I-PROBLEM
ventricle	NN	I-PROBLEM	I-PROBLEM
wall	NN	I-PROBLEM	I-PROBLEM
motion	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
trace	NN	B-PROBLEM	B-PROBLEM
mitral	JJ	I-PROBLEM	I-PROBLEM
regurgitation	NN	I-PROBLEM	I-PROBLEM
,	,	O	O
normal	JJ	O	O
left	VBD	O	O
ventricular	JJ	O	O
size	NN	O	O
and	CC	O	O
function	NN	O	O
with	IN	O	O
an	DT	B-TEST	O
estimated	VBN	I-TEST	O
ejection	NN	I-TEST	O
fraction	NN	I-TEST	O
of	IN	O	O
64%	CD	O	O
.	.	O	O

there	EX	O	O
is	VBZ	O	O
doppler	JJ	B-TEST	O
evidence	NN	O	O
of	IN	O	O
tricuspid	JJ	B-PROBLEM	B-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
and	CC	O	I-PROBLEM
right	JJ	B-PROBLEM	I-PROBLEM
atrial	JJ	I-PROBLEM	I-PROBLEM
dilatation	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
trace	JJ	B-PROBLEM	B-PROBLEM
pulmonary	JJ	I-PROBLEM	I-PROBLEM
insufficiency	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
right	JJ	O	O
ventricle	NN	O	O
is	VBZ	O	O
dilated	VBN	B-PROBLEM	B-PROBLEM
and	CC	O	O
diffusely	RB	B-PROBLEM	B-PROBLEM
hypokinetic	JJ	I-PROBLEM	I-PROBLEM
and	CC	O	O
there	EX	O	O
is	VBZ	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
constrictive	JJ	B-PROBLEM	B-PROBLEM
physiology	NN	I-PROBLEM	I-PROBLEM
which	WDT	O	O
was	VBD	O	O
seen	VBN	O	O
on	IN	O	O
december	NN	O	O
6	CD	O	O
,	,	O	O
1995	CD	O	O
.	.	O	O

a	DT	O	B-TEST
copy	NN	O	I-TEST
of	IN	O	I-TEST
this	DT	B-TEST	I-TEST
ultrasound	NN	I-TEST	I-TEST
is	VBZ	O	O
also	RB	O	O
found	VBN	O	O
in	IN	O	O
his	PRP$	O	O
records	NNS	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
on	IN	O	O
no	DT	O	O
specific	JJ	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
cardiac	JJ	I-PROBLEM	I-PROBLEM
condition	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
status	NN	O	O
post	NN	O	O
thoracotomy	NN	B-TREATMENT	B-TREATMENT
and	CC	O	O
has	VBZ	O	O
staples	NNS	B-TREATMENT	B-TREATMENT
and	CC	O	I-TREATMENT
sutures	NNS	B-TREATMENT	I-TREATMENT
on	IN	I-TREATMENT	O
his	PRP$	I-TREATMENT	B-TREATMENT
chest	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

these	DT	O	O
may	MD	O	O
be	VB	O	O
removed	VBN	O	O
when	WRB	O	O
the	DT	B-PROBLEM	B-PROBLEM
incisions	NNS	I-PROBLEM	I-PROBLEM
are	VBP	O	O
noted	VBN	O	O
to	TO	O	O
be	VB	O	O
well	RB	O	O
healed	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
approximately	RB	O	O
three	CD	O	O
weeks	NNS	O	O
following	VBG	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
several	JJ	O	O
of	IN	O	O
these	DT	B-TREATMENT	B-TREATMENT
stitches	NNS	I-TREATMENT	I-TREATMENT
will	MD	O	O
be	VB	O	O
removed	VBN	O	O
prior	RB	O	O
to	TO	O	O
discharge	VB	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
on	IN	O	O
oxygen	NN	B-TREATMENT	B-TREATMENT
by	IN	O	O
face	NN	B-TREATMENT	B-TREATMENT
mask	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
his	PRP$	B-TEST	B-TEST
saturations	NNS	I-TEST	I-TEST
have	VBP	O	O
been	VBN	O	O
remaining	VBG	O	O
normal	JJ	O	O
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
for	IN	O	O
his	PRP$	O	B-PROBLEM
respiratory	NN	O	I-PROBLEM
system	NN	O	I-PROBLEM
are	VBP	O	O
albuterol	JJ	B-TREATMENT	B-TREATMENT
nebulizer	JJ	I-TREATMENT	I-TREATMENT
0.5	CD	O	O
mg.	NN	O	O
2.5	CD	O	O
cc.	NN	O	O
q4hours	NNS	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
had	VBN	O	O
gastric	JJ	B-TREATMENT	B-TREATMENT
ulcer	JJ	I-TREATMENT	I-TREATMENT
repair	NN	I-TREATMENT	I-TREATMENT
and	CC	O	O
also	RB	O	O
has	VBZ	O	O
a	DT	B-TREATMENT	B-TREATMENT
colostomy	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	B-PROBLEM	B-PROBLEM
sinus	NN	I-PROBLEM	I-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
that	WDT	O	O
was	VBD	O	O
studied	VBN	O	O
with	IN	O	O
a	DT	B-TEST	B-TEST
fistulogram	NN	I-TEST	I-TEST
on	IN	O	O
december	NN	O	O
25	CD	O	O
,	,	O	O
1995	CD	O	O
.	.	O	O

this	DT	O	O
showed	VBD	O	O
no	DT	O	O
communication	NN	B-PROBLEM	O
with	IN	I-PROBLEM	O
the	DT	I-PROBLEM	B-PROBLEM
intestines	NNS	I-PROBLEM	I-PROBLEM
and	CC	O	O
was	VBD	O	O
simply	RB	O	O
a	DT	B-PROBLEM	B-PROBLEM
sinus	NN	I-PROBLEM	I-PROBLEM
tract	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

there	EX	O	O
is	VBZ	O	O
no	DT	O	O
fistula	NN	B-PROBLEM	B-PROBLEM
seen	VBN	O	O
.	.	O	O

dr.	NN	O	O
asha	NN	O	O
vengloan	NN	O	O
of	IN	O	O
general	JJ	O	B-TREATMENT
surgery	NN	O	I-TREATMENT
consulted	VBN	O	O
on	IN	O	O
the	DT	O	O
patient	NN	O	O
and	CC	O	O
concluded	VBD	O	O
the	DT	O	O
patient	NN	O	O
does	VBZ	O	O
not	RB	O	O
require	VB	O	O
any	DT	B-TREATMENT	B-TREATMENT
surgical	JJ	I-TREATMENT	I-TREATMENT
treatment	NN	I-TREATMENT	I-TREATMENT
of	IN	O	O
this	DT	B-PROBLEM	B-PROBLEM
problem	NN	I-PROBLEM	I-PROBLEM
at	IN	O	O
the	DT	O	O
current	JJ	O	O
time	NN	O	O
and	CC	O	O
the	DT	B-TREATMENT	B-TREATMENT
best	JJS	I-TREATMENT	I-TREATMENT
treatment	NN	I-TREATMENT	I-TREATMENT
for	IN	O	O
this	DT	O	O
situation	NN	O	O
would	MD	O	O
be	VB	O	O
to	TO	O	O
increase	VB	O	O
the	DT	O	O
patient	JJ	O	O
&apos;s	JJ	O	O
nutrition	NN	O	O
.	.	O	O

he	PRP	O	O
just	RB	O	O
claims	NNS	O	O
to	TO	O	O
have	VB	O	O
no	DT	B-PROBLEM	O
appetite	NN	I-PROBLEM	B-PROBLEM
and	CC	O	O
has	VBZ	O	O
very	RB	B-PROBLEM	B-PROBLEM
poor	JJ	I-PROBLEM	I-PROBLEM
effort	NN	I-PROBLEM	I-PROBLEM
with	IN	O	O
feeding	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
is	VBZ	O	O
able	JJ	O	O
to	TO	O	O
tolerate	VB	O	O
po.	JJ	B-TREATMENT	B-TREATMENT
medicines	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
an	DT	B-PROBLEM	B-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
on	IN	I-PROBLEM	O
his	PRP$	I-PROBLEM	O
penis	NN	I-PROBLEM	O
that	WDT	O	O
has	VBZ	O	O
been	VBN	O	O
treated	VBN	O	O
with	IN	O	O
dressing	NN	B-TREATMENT	B-TREATMENT
changes	NNS	I-TREATMENT	I-TREATMENT
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
a	DT	B-TREATMENT	B-TREATMENT
foley	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
in	IN	O	O
and	CC	O	O
when	WRB	O	O
the	DT	O	O
penile	NN	O	O
skin	NN	O	O
is	VBZ	O	O
very	RB	O	O
well	RB	O	O
healed	VBN	O	O
his	PRP$	B-TREATMENT	B-TREATMENT
foley	NN	I-TREATMENT	I-TREATMENT
catheter	NN	I-TREATMENT	I-TREATMENT
may	MD	O	O
be	VB	O	O
removed	VBN	O	O
.	.	O	O

until	IN	O	O
this	DT	O	O
time	NN	O	O
he	PRP	O	O
should	MD	O	O
be	VB	O	O
kept	VBN	O	O
on	IN	O	O
three	CD	O	O
times	NNS	O	O
daily	RB	O	O
wet	VBP	B-TREATMENT	B-PROBLEM
to	TO	I-TREATMENT	I-PROBLEM
dry	VB	I-TREATMENT	I-PROBLEM
dressing	NN	I-TREATMENT	I-PROBLEM
changes	NNS	I-TREATMENT	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
has	VBZ	O	O
multiple	JJ	B-PROBLEM	O
decubiti	NN	I-PROBLEM	O
over	IN	O	O
his	PRP$	O	O
body	NN	O	O
,	,	O	O
in	IN	O	O
particular	JJ	O	B-PROBLEM
his	PRP$	O	I-PROBLEM
perineum	NN	O	I-PROBLEM
and	CC	O	O
buttocks	NNS	O	O
have	VBP	O	O
large	JJ	B-PROBLEM	B-PROBLEM
decubiti	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

these	DT	B-PROBLEM	B-PROBLEM
wounds	NNS	I-PROBLEM	I-PROBLEM
should	MD	O	O
be	VB	O	O
treated	VBN	O	O
with	IN	O	O
three	CD	O	O
times	NNS	O	O
daily	RB	O	O
wet	VBP	B-TREATMENT	B-PROBLEM
to	TO	I-TREATMENT	I-PROBLEM
dry	VB	I-TREATMENT	I-PROBLEM
dressings	NNS	I-TREATMENT	I-PROBLEM
.	.	O	O

the	DT	B-TEST	B-TEST
patient	NN	I-TEST	I-TEST
&apos;s	NNP	I-TEST	I-TEST
white	JJ	I-TEST	I-TEST
count	NN	I-TEST	I-TEST
at	IN	O	O
the	DT	O	O
time	NN	O	O
of	IN	O	O
discharge	NN	O	O
is	VBZ	O	O
within	IN	O	O
normal	JJ	O	O
limits	NNS	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
remains	VBZ	O	O
on	IN	O	O
fluconazole	NN	B-TREATMENT	B-TREATMENT
.	.	O	O

his	PRP$	B-TREATMENT	B-TREATMENT
other	JJ	I-TREATMENT	I-TREATMENT
antibiotics	NNS	I-TREATMENT	I-TREATMENT
were	VBD	O	O
discontinued	VBN	O	O
.	.	O	O

his	PRP$	B-TEST	B-TEST
most	RBS	I-TEST	I-TEST
recent	JJ	I-TEST	I-TEST
cultures	NNS	I-TEST	I-TEST
are	VBP	O	O
negative	JJ	O	O
.	.	O	O

the	DT	B-TEST	B-TEST
chest	JJS	I-TEST	I-TEST
x-ray	JJ	I-TEST	I-TEST
shows	VBZ	O	O
no	DT	O	O
evidence	NN	O	O
of	IN	O	O
pneumonia	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

7.	CD	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

he	PRP	O	O
has	VBZ	O	O
been	VBN	O	O
placed	VBN	O	O
on	IN	O	O
oxycodone	NN	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg.	NN	O	O
po.	NN	O	O
q3hours	NNS	O	O
as	IN	O	O
needed	VBN	O	O
for	IN	O	O
pain	NN	B-PROBLEM	B-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
had	VBD	O	O
a	DT	B-TREATMENT	B-TEST
pca	NN	I-TREATMENT	I-TEST
and	CC	O	O
several	JJ	B-TREATMENT	B-TREATMENT
other	JJ	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
have	VBP	O	O
been	VBN	O	O
discontinued	VBN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
for	IN	O	O
sleep	NN	O	O
was	VBD	O	O
given	VBN	O	O
benadryl	RB	B-TREATMENT	B-TREATMENT
25	CD	O	O
to	TO	O	O
50	CD	O	O
mg.	NNS	O	O
qhs.	NN	O	O
and	CC	O	O
was	VBD	O	O
not	RB	O	O
allowed	VBN	O	O
any	DT	O	O
increases	NNS	O	O
in	IN	O	O
his	PRP$	B-TREATMENT	O
narcotics	NNS	I-TREATMENT	O
after	IN	O	O
weaning	VBG	O	O
him	PRP	O	O
down	RP	O	O
to	TO	O	O
just	RB	O	O
requiring	VBG	O	O
the	DT	B-TREATMENT	B-TREATMENT
oxycodone	NN	I-TREATMENT	I-TREATMENT
.	.	O	O

a	DT	O	O
complete	JJ	O	O
summary	NN	O	O
of	IN	O	O
the	DT	B-TREATMENT	B-TREATMENT
patient	NN	I-TREATMENT	I-TREATMENT
&apos;s	NN	I-TREATMENT	I-TREATMENT
medications	NNS	I-TREATMENT	I-TREATMENT
are	VBP	O	O
as	IN	O	O
follows	VBZ	O	O
:	:	O	O

cimetidine	NN	B-TREATMENT	B-TREATMENT
300	CD	O	O
mg.	NN	O	B-TREATMENT
intravenous	JJ	O	I-TREATMENT
q6hours	NNS	O	I-TREATMENT
.	.	O	O

albuterol	NN	B-TREATMENT	B-TREATMENT
nebulizer	VBZ	I-TREATMENT	I-TREATMENT
0.5	CD	O	O
mg.	NN	O	O
2.5	CD	O	O
cc.	NN	O	O
q4hours	NNS	O	O
.	.	O	O

senokot	NN	B-TREATMENT	O
two	CD	O	O
tablets	NNS	O	O
po.	VBP	O	O
bid	NN	O	O
or	CC	O	O
metamucil	VB	B-TREATMENT	B-TREATMENT
one	CD	O	O
tablespoon	NN	O	O
po.	NN	O	O
bid	NN	O	O
.	.	O	O

nortriptyline	JJ	B-TREATMENT	B-TREATMENT
25	CD	O	O
mg.	NN	O	O
po.	NN	O	O
qhs	NN	O	O
.	.	O	O

kcl	VB	B-TREATMENT	B-TREATMENT
40	CD	O	O
meq.	JJ	O	O
po.	NN	O	O
bid	NN	O	O
.	.	O	O

saline	NN	B-TREATMENT	B-TREATMENT
wet	NN	I-TREATMENT	I-TREATMENT
to	TO	I-TREATMENT	O
dry	VB	I-TREATMENT	B-TREATMENT
dressing	NN	I-TREATMENT	I-TREATMENT
changes	NNS	I-TREATMENT	I-TREATMENT
three	CD	O	O
times	NNS	O	O
daily	RB	O	O
to	TO	O	O
penis	VB	B-PROBLEM	O
and	CC	I-PROBLEM	O
pelvis	VB	I-PROBLEM	O
decubiti	NN	I-PROBLEM	O
,	,	O	O
40%	CD	B-TREATMENT	O
humidified	VBD	I-TREATMENT	O
oxygen	NN	I-TREATMENT	B-TREATMENT
,	,	O	O
fluconazole	JJ	B-TREATMENT	B-TREATMENT
200	CD	O	O
mg.	JJ	O	O
po.	NN	O	O
bid	NN	O	O
.	.	O	O

lasix	RB	B-TREATMENT	B-TREATMENT
2.5	CD	O	O
mg.	NNS	O	O
intravenous	JJ	O	O
qid	NNS	O	O
.	.	O	O

prilosec	NN	B-TREATMENT	B-TREATMENT
20	CD	O	O
mg.	NN	O	O
po.	NN	O	O
qd	NN	O	O
.	.	O	O

benadryl	RB	B-TREATMENT	B-TREATMENT
25	CD	O	O
to	TO	O	O
50	CD	O	O
mg.	NNS	O	O
po.	JJ	O	O
qhs	JJ	O	O
prn	NN	O	O
.	.	O	O

oxycodone	RB	B-TREATMENT	B-TREATMENT
10	CD	O	O
mg.	NNS	O	O
po.	JJ	O	O
q3	JJ	O	O
hours	NNS	O	O
prn	NN	O	O
.	.	O	O

the	DT	O	O
patient	NN	O	O
was	VBD	O	O
seen	VBN	O	O
at	IN	O	O
ph	JJ	O	O
university	NN	O	O
of	IN	O	O
medical	JJ	O	O
center	NN	O	O
for	IN	O	O
problem	NN	O	B-PROBLEM
regarding	VBG	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
constrictive	JJ	I-PROBLEM	I-PROBLEM
pericarditis	NN	I-PROBLEM	I-PROBLEM
and	CC	O	O
underwent	NN	O	O
a	DT	B-TREATMENT	B-TREATMENT
surgical	JJ	I-TREATMENT	I-TREATMENT
procedure	NN	I-TREATMENT	I-TREATMENT
to	TO	O	O
correct	VB	O	O
this	DT	O	O
.	.	O	O

followup	JJ	B-TEST	B-TEST
cardiac	JJ	I-TEST	I-TEST
studies	NNS	I-TEST	I-TEST
showed	VBD	O	O
there	EX	O	O
was	VBD	O	O
a	DT	O	O
resolution	NN	O	O
of	IN	O	O
his	PRP$	B-PROBLEM	B-PROBLEM
constrictive	JJ	I-PROBLEM	I-PROBLEM
pericarditis	NN	I-PROBLEM	I-PROBLEM
.	.	O	O

the	DT	O	O
patient	NN	O	O
also	RB	O	O
had	VBD	O	O
a	DT	B-PROBLEM	B-PROBLEM
gastric	JJ	I-PROBLEM	I-PROBLEM
ulcer	NN	I-PROBLEM	I-PROBLEM
repaired	VBN	O	O
at	IN	O	O
the	DT	O	O
same	JJ	O	O
time	NN	O	O
.	.	O	O

